FN Clarivate Analytics Web of Science
VR 1.0
PT J
AU Yohe, ST
   Herrera, VLM
   Colson, YL
   Grinstaff, MW
AF Yohe, Stefan T.
   Herrera, Victoria L. M.
   Colson, Yolonda L.
   Grinstaff, Mark W.
TI 3D superhydrophobic electrospun meshes as reinforcement materials for
   sustained local drug delivery against colorectal cancer cells
SO JOURNAL OF CONTROLLED RELEASE
LA English
DT Article
DE Superhydrophobic; Biomaterial; Local drug delivery; Electrospinning;
   Colorectal cancer; Recurrence
ID DNA TOPOISOMERASE-I; COLON-CANCER; PHARMACOKINETIC TRIAL; IRINOTECAN
   CPT-11; POLYMER IMPLANTS; PHASE-I; CAMPTOTHECIN; RELEASE; CHEMOTHERAPY;
   SURFACES
AB In this work we expand upon a recently reported local drug delivery device, where air is used as a degradable component of our material to control drug release (J. Am. Chem. Soc. 2012, 134, 2016-2019). We consider its potential use as a drug loaded strip to provide both mechanical stability to the anastomosis, and as a means to release drug locally over prolonged periods for prevention of locoregional recurrence in colorectal cancer. Specifically, we electrospun poly(epsilon-caprolactone) (PCL) with the hydrophobic polymer dopant poly(glycerol monostearate-co-epsilon-caprolactone) (PGC-C18) and used the resultant mesh to control the release of two anticancer drugs (CPT-11 and SN-38). The increase in mesh hydrophobicity with PGC-C18 addition slows drug release both by the traditional means of drug diffusion, as well as by increasing the stability of the entrapped air layer to delay drug release. We demonstrate that superhydrophobic meshes have mechanical properties appropriate for surgical buttressing of the anastomosis, permit non-invasive assessment of mesh location and documentation of drug release via ultrasound, and release chemotherapy over a prolonged period of time (>90 days) resulting in significant tumor cytotoxicity against a human colorectal cell line (HT-29). (C) 2012 Elsevier B. V. All rights reserved.
C1 [Colson, Yolonda L.] Brigham & Womens Hosp, Dept Surg, Div Thorac Surg, Boston, MA 02215 USA.
   [Yohe, Stefan T.; Grinstaff, Mark W.] Brigham & Womens Hosp, Dept Biomed Engn, Boston, MA 02215 USA.
   [Yohe, Stefan T.; Grinstaff, Mark W.] Brigham & Womens Hosp, Dept Chem, Boston, MA 02215 USA.
   [Herrera, Victoria L. M.] Boston Univ, Sch Med, Dept Cardiol, Boston, MA 02215 USA.
RP Colson, YL (reprint author), Brigham & Womens Hosp, Dept Surg, Div Thorac Surg, Boston, MA 02215 USA.
EM Yolonda_Colson@dfci.harvard.edu; mgrin@bu.edu
RI Grinstaff, Mark/U-2829-2017
OI Grinstaff, Mark/0000-0002-5453-3668
FU BU; BU Training Grant in Pharmacology and Experimental Therapeutics; BU
   MSE Innovation Grant; BU Nanotheranostics ARCBWH; CIMIT; Coulter
   Foundation; ARRC Ultrasound Micro-Imaging Core at BUSM; NIH [R25
   CA153955, R01CA149561]
FX This work was supported in part by BU, BU Training Grant in Pharmacology
   and Experimental Therapeutics, BU MSE Innovation Grant, BU
   Nanotheranostics ARCBWH, CIMIT, Coulter Foundation, ARRC Ultrasound
   Micro-Imaging Core at BUSM, NIH R25 CA153955, and NIH R01CA149561.
CR Balch Glen C., 2006, WORLD J GASTROENTERO, V12, P3186
   Benson AB, 2004, J CLIN ONCOL, V22, P3408, DOI 10.1200/JCO.2004.05.063
   BREM H, 1990, BIOMATERIALS, V11, P699, DOI 10.1016/0142-9612(90)90030-T
   BURKE TG, 1993, J MED CHEM, V36, P2580, DOI 10.1021/jm00069a020
   Colson Y.L., 2012, ADV MAT
   Consten Esther C. J., 2004, OBES SURG, V14, P1360
   Davis ME, 2008, NAT REV DRUG DISCOV, V7, P771, DOI 10.1038/nrd2614
   De Souza R, 2010, DRUG DELIV, V17, P365, DOI 10.3109/10717541003762854
   EricksonMiller CL, 1997, CANCER CHEMOTH PHARM, V39, P467, DOI 10.1007/s002800050600
   Exner AA, 2008, EXPERT OPIN DRUG DEL, V5, P775, DOI [10.1517/17425240802182034, 10.1517/17425247.5.7.775 ]
   Genzer J, 2006, BIOFOULING, V22, P339, DOI 10.1080/08927010600980223
   GIOVANELLA BC, 1989, SCIENCE, V246, P1046, DOI 10.1126/science.2555920
   Hoffman AS, 2008, J CONTROL RELEASE, V132, P153, DOI 10.1016/j.jconrel.2008.08.012
   HSIANG YH, 1985, J BIOL CHEM, V260, P4873
   Jambrik Z, 2004, AM J CARDIOL, V93, P1265, DOI 10.1016/j.amjcard.2004.02.012
   Jemal A, 2010, CA-CANCER J CLIN, V60, P277, DOI [10.1002/caac.20073, 10.3322/caac.20073]
   KAWATO Y, 1991, CANCER RES, V51, P4187
   Kim S, 2009, EUR J PHARM BIOPHARM, V71, P420, DOI 10.1016/j.ejpb.2008.09.021
   Kuzu MA, 1998, BRIT J SURG, V85, P236
   LANGER R, 1980, CHEM ENG COMMUN, V6, P1, DOI 10.1080/00986448008912519
   Lee CC, 2005, NAT BIOTECHNOL, V23, P1517, DOI 10.1038/nbt1171
   Li QY, 2006, CURR MED CHEM, V13, P2021, DOI 10.2174/092986706777585004
   Li XM, 2007, CHEM SOC REV, V36, P1350, DOI 10.1039/b602486f
   Liu R., 2010, ANN SURG ONCOL, V17, P184
   Liu R, 2012, ANN SURG ONCOL, V19, P199, DOI 10.1245/s10434-011-1871-4
   Mathijssen RHJ, 2001, CLIN CANCER RES, V7, P2182
   Moses MA, 2003, CANCER CELL, V4, P337, DOI 10.1016/S1535-6108(03)00276-9
   Nakajima A, 2001, MONATSH CHEM, V132, P31, DOI 10.1007/s007060170142
   Nosonovsky M, 2009, CURR OPIN COLLOID IN, V14, P270, DOI 10.1016/j.cocis.2009.05.004
   Pham QP, 2006, BIOMACROMOLECULES, V7, P2796, DOI 10.1021/bm060680j
   Pizzolato JF, 2003, LANCET, V361, P2235, DOI 10.1016/S0140-6736(03)13780-4
   ROTHENBERG ML, 1993, J CLIN ONCOL, V11, P2194, DOI 10.1200/JCO.1993.11.11.2194
   Rothenberg ML, 2001, ANN ONCOL, V12, P1631, DOI 10.1023/A:1013157727506
   Scappaticci FA, 2005, J SURG ONCOL, V91, P173, DOI 10.1002/jso.20301
   SHALABY WSW, 1992, BIOMATERIALS, V13, P289, DOI 10.1016/0142-9612(92)90052-P
   Sjovall A, 2007, ANN SURG ONCOL, V14, P432, DOI 10.1245/s10434-006-9243-1
   TANIZAWA A, 1994, J NATL CANCER I, V86, P836, DOI 10.1093/jnci/86.11.836
   Tillman BW, 2009, BIOMATERIALS, V30, P583, DOI 10.1016/j.biomaterials.2008.10.006
   Torchilin VP, 2006, ADV DRUG DELIVER REV, V58, P1532, DOI 10.1016/j.addr.2006.09.009
   WALL ME, 1966, J AM CHEM SOC, V88, P3888, DOI 10.1021/ja00968a057
   Weinberg BD, 2008, J PHARM SCI-US, V97, P1681, DOI 10.1002/jps.21038
   Wolinsky JB, 2007, MACROMOLECULES, V40, P7065, DOI 10.1021/ma071276v
   Wolinsky JB, 2012, J CONTROL RELEASE, V159, P14, DOI 10.1016/j.jconrel.2011.11.031
   Wolinsky JB, 2012, BIOMACROMOLECULES, V13, P406, DOI 10.1021/bm201443m
   Wolinsky JB, 2010, J CONTROL RELEASE, V144, P280, DOI 10.1016/j.jconrel.2010.02.022
   Xie JW, 2006, PHARM RES, V23, P1817, DOI 10.1007/s11095-006-9036-z
   Yohe ST, 2012, J AM CHEM SOC, V134, P2016, DOI 10.1021/ja211148a
   Zeng J, 2005, J CONTROL RELEASE, V105, P43, DOI 10.1016/j.j.conrel.2005.02.024
   Zhang JA, 2004, INT J PHARM, V270, P93, DOI 10.1016/j.ijpharm.2003.10.015
NR 49
TC 72
Z9 72
U1 2
U2 107
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0168-3659
J9 J CONTROL RELEASE
JI J. Control. Release
PD AUG 20
PY 2012
VL 162
IS 1
BP 92
EP 101
DI 10.1016/j.jconrel.2012.05.047
PG 10
WC Chemistry, Multidisciplinary; Pharmacology & Pharmacy
SC Chemistry; Pharmacology & Pharmacy
GA 992IP
UT WOS:000307769200011
PM 22684120
OA Green Accepted
DA 2018-10-19
ER

PT J
AU Reynolds, PM
   Pedersen, RH
   Riehle, MO
   Gadegaard, N
AF Reynolds, Paul M.
   Pedersen, Rasmus H.
   Riehle, Mathis O.
   Gadegaard, Nikolaj
TI A Dual Gradient Assay for the Parametric Analysis of Cell-Surface
   Interactions
SO SMALL
LA English
DT Article
ID CHEMICAL GRADIENTS; PLASMA POLYMERS; BIOMATERIALS; COMBINATORIAL;
   BIOFUNCTIONALIZATION; FIBROBLASTS; LIBRARIES; DISCHARGE
AB Cellular response to microgrooves is addressed using a new assay format, comprising orthogonal gradients of continuously varied groove pitch and depth. Dual layer etch masks are created using a combination of micropatterning and plasma polymer deposition. A silicon substrate with a constant groove width of 8 mu m and with ridge width increasing from 8 mu m in 0.5 mu m steps across 10 mm is fabricated by photolithography. A plasma-polymerized hexane film which is 120 nm thick at one end of these grooves, and 10 nm at the other, is deposited under a diffusion mask. Reactive etching of the patterned sample transfers a gradient of groove pitch and groove depth into the silicon substrate. A silicon master with a gradient of groove depth spanning more than two orders of magnitude ( less than 10 nm to over 1000 nm) is used to create an injection molding inlay for mass replication of the screening topography. Polycarbonate replicas are molded for use in cell culture studies, and the functionality of the topography as a high-throughput screening platform is investigated. The response of MDCK, h-TERT fibroblasts, and LE2 endothelial cells is examined, in terms of attachment and morphological response to the variation in topographical cues, with the aim of pinpointing the optimal combination of groove pitch and depth to elicit a tailored response from each cell type. When the range of topographical features screened on a single substrate is considered, this new assay represents a significant step forward in the parametric design and analysis of topographical cues at the biomaterial interface.
C1 [Reynolds, Paul M.; Pedersen, Rasmus H.; Gadegaard, Nikolaj] Univ Glasgow, Sch Engn, Div Biomed Engn, Glasgow G12 8LT, Lanark, Scotland.
   [Riehle, Mathis O.] Univ Glasgow, Inst Mol Cell & Syst Biol, Ctr Cell Engn, Glasgow G12 8QQ, Lanark, Scotland.
RP Gadegaard, N (reprint author), Univ Glasgow, Sch Engn, Div Biomed Engn, Glasgow G12 8LT, Lanark, Scotland.
EM Nikolaj.Gadegaard@glasgow.ac.uk
RI Riehle, Mathis/A-3427-2011; Gadegaard, Nikolaj/E-9243-2010; Reynolds,
   Paul/E-1856-2012
OI Riehle, Mathis/0000-0001-7988-1514; Gadegaard,
   Nikolaj/0000-0002-3396-846X; Reynolds, Paul/0000-0001-7614-0008
FU Engineering and Physical Sciences Research Council (EPSRC)
   [EP/F500424/1]; Glasgow Research Partnership in engineering (GRPe); EC
   [FP7-CP-IP214249-2]; Biotechnology and Biological Sciences Research
   Council [BB/E012256/1]
FX We would like to thank the staff and technicians of the James Watt
   Nanofabrication Centre for their assistance in fabrication of the master
   topography. Also special thanks to the members of the Centre for Cell
   Engineering for their help with cell culture studies. John
   Stormonth-Darling for his assistance in creating an injection molding
   inlay from the silicon master. The work has been partially funded by the
   Engineering and Physical Sciences Research Council (EPSRC), grant no
   EP/F500424/1 DTC in Cell and Proteomic Technologies, the Glasgow
   Research Partnership in engineering (GRPe), and the EC-funded project
   NAPANIL (Contract no. FP7-CP-IP214249-2).
CR Anderson DG, 2004, NAT BIOTECHNOL, V22, P863, DOI 10.1038/nbt981
   Berry BC, 2007, REV SCI INSTRUM, V78, DOI 10.1063/1.2755729
   Carpenter AE, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-10-r100
   Cranford S., 2010, NANOTECHNOL SCI APPL, P127
   Csaderova L, 2010, SMALL, V6, P2755, DOI 10.1002/smll.201000193
   Curtis A S G, 2004, Eur Cell Mater, V8, P27
   Dalby MJ, 2006, BIOMATERIALS, V27, P1306, DOI 10.1016/j.biomaterials.2005.08.028
   de Mel A, 2008, BIOMACROMOLECULES, V9, P2969, DOI 10.1021/bm800681k
   Ding YF, 2011, ADV MATER, V23, P421, DOI 10.1002/adma.201001757
   Falconnet D, 2006, BIOMATERIALS, V27, P3044, DOI 10.1016/j.biomaterials.2005.12.024
   Flemming RG, 1999, BIOMATERIALS, V20, P573, DOI 10.1016/S0142-9612(98)00209-9
   Fraser SA, 2008, J BIOMED MATER RES A, V86A, P725, DOI 10.1002/jbm.a.31519
   Gallant ND, 2007, ADV MATER, V19, P965, DOI 10.1002/adma.200602221
   GENGENBACH TR, 1994, J POLYM SCI POL CHEM, V32, P1399, DOI 10.1002/pola.1994.080320801
   Geysen HM, 2003, NAT REV DRUG DISCOV, V2, P222, DOI 10.1038/nrd10335
   IZZARD CS, 1976, J CELL SCI, V21, P129
   Kasemo B, 2002, SURF SCI, V500, P656, DOI 10.1016/S0039-6028(01)01809-X
   Khan F, 2010, BIOMATERIALS, V31, P2216, DOI 10.1016/j.biomaterials.2009.11.101
   Khandurina J, 2002, CURR OPIN CHEM BIOL, V6, P359, DOI 10.1016/S1367-5931(02)00323-X
   Kolind K, 2010, BIOMATERIALS, V31, P9182, DOI 10.1016/j.biomaterials.2010.08.048
   Kunzler TP, 2007, BIOMATERIALS, V28, P2175, DOI 10.1016/j.biomaterials.2007.01.019
   LANZA RP, 2000, PRINCIPLES TISSUE EN
   MEREDITH JE, 1993, MOL BIOL CELL, V4, P953
   Morgenthaler S, 2008, SOFT MATTER, V4, P419, DOI 10.1039/b715466f
   Pedersen RH, 2012, PLASMA PROCESS POLYM, V9, P22, DOI 10.1002/ppap.201100067
   Peters A, 2009, TISSUE ENG PART B-RE, V15, P225, DOI [10.1089/ten.teb.2009.0049, 10.1089/ten.TEB.2009.0049]
   PITT WG, 1989, J COLLOID INTERF SCI, V133, P223, DOI 10.1016/0021-9797(89)90295-6
   Ratner BD, 2004, ANNU REV BIOMED ENG, V6, P41, DOI 10.1146/annurev.bioeng.6.040803.140027
   Simon CG, 2011, ADV MATER, V23, P369, DOI 10.1002/adma.201001763
   Stormonth-Darling JM, 2012, MACROMOL MATER ENG, V297, P1075, DOI 10.1002/mame.201100397
   Teixeira AI, 2003, J CELL SCI, V116, P1881, DOI 10.1242/jcs.00383
   Unadkat HV, 2011, P NATL ACAD SCI USA, V108, P16565, DOI 10.1073/pnas.1109861108
   Voronin SA, 2007, J PHYS CHEM B, V111, P3419, DOI 10.1021/jp068488z
   Yang J, 2009, ADV MATER, V21, P300, DOI 10.1002/adma.200801942
   YASUDA H, 1975, J APPL POLYM SCI, V19, P531, DOI 10.1002/app.1975.070190216
   Yliperttula M, 2008, EUR J PHARM SCI, V35, P151, DOI 10.1016/j.ejps.2008.04.012
   Zelzer M, 2008, BIOMATERIALS, V29, P172, DOI 10.1016/j.biomaterials.2007.09.026
NR 37
TC 14
Z9 14
U1 2
U2 32
PU WILEY-V C H VERLAG GMBH
PI WEINHEIM
PA POSTFACH 101161, 69451 WEINHEIM, GERMANY
SN 1613-6810
EI 1613-6829
J9 SMALL
JI Small
PD AUG 20
PY 2012
VL 8
IS 16
BP 2541
EP 2547
DI 10.1002/smll.201200235
PG 7
WC Chemistry, Multidisciplinary; Chemistry, Physical; Nanoscience &
   Nanotechnology; Materials Science, Multidisciplinary; Physics, Applied;
   Physics, Condensed Matter
SC Chemistry; Science & Technology - Other Topics; Materials Science;
   Physics
GA 987BB
UT WOS:000307390300013
PM 22678878
DA 2018-10-19
ER

PT J
AU Ganesh, M
   Gross, R
AF Ganesh, Manoj
   Gross, Richard
TI Embedded enzymatic biomaterial degradation: Solution for tunable
   lifetime biomaterials
SO ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY
LA English
DT Meeting Abstract
CT 244th National Fall Meeting of the American-Chemical-Society (ACS)
CY AUG 19-23, 2012
CL Philadelphia, PA
SP Amer Chem Soc, Div Hist Chem, Amer Chem Soc
C1 [Ganesh, Manoj; Gross, Richard] NYU, Polytech Inst, Dept Chem & Biol Sci, Brooklyn, NY 11201 USA.
EM maddymanoj@gmail.com; rgross@poly.edu
RI Ganesh, Manoj/I-2434-2014
OI Ganesh, Manoj/0000-0001-8852-3161
NR 0
TC 0
Z9 0
U1 0
U2 2
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 0065-7727
J9 ABSTR PAP AM CHEM S
JI Abstr. Pap. Am. Chem. Soc.
PD AUG 19
PY 2012
VL 244
MA 209-POLY
PG 1
WC Chemistry, Multidisciplinary
SC Chemistry
GA 220XX
UT WOS:000324621808380
DA 2018-10-19
ER

PT J
AU Gong, M
   Zhang, L
   Zuo, Y
   Zou, Q
   Wang, YY
   Wang, L
   Li, YB
AF Gong, Mei
   Zhang, Li
   Zuo, Yi
   Zou, Qin
   Wang, Yanying
   Wang, Li
   Li, Yubao
TI Investigation on the interpenetrating polymer networks (ipns) of
   polyvinyl alcohol and poly(N-vinyl pyrrolidone) hydrogel and its in
   vitro bioassessment
SO JOURNAL OF APPLIED POLYMER SCIENCE
LA English
DT Article
DE interpenetrating polymer network; in situ synthesis; poly(vinyl
   alcohol); poly(N-vinyl pyrrolidone); hydrogel; cytocompatibility
ID POLY(VINYL ALCOHOL); BLENDS; MISCIBILITY; BEHAVIOR
AB Poly(vinyl alcohol) (PVA) and poly(N-vinyl pyrrolidone) (PVP) composite hydrogel with interpenetrating polymer networks (IPNs) was prepared by in situ polymerization and compared with pure PVA hydrogel. The prepared IPN hydrogel was characterized by infrared spectroscopy (IR), differential scanning calorimetry (DSC), dynamic mechanical analysis (DMA), X-ray photoelectron spectroscopy (XPS), and scanning electron microscopy. The mechanical property and cell culture were also tested. The results show that PVP can chemically bond with PVA and form uniform blend hydrogel. The content of PVP can affect the structure, crystallinity, glass transition temperature (Tg), and mechanical property of the hydrogel. The Tg of the PVA hydrogel is 2.7 degrees C while the Tg of the IPN hydrogel is -37 degrees C. The IPN hydrogel has lower glass transition temperature, corresponding to better elastic properties, and has better mechanical performance on stretch and compression than PVA hydrogel. The crystallinity (Xc) of PVA hydrogel and IPN hydrogel is 65.3 and 26.3%, respectively. The DMA curves and XPS analysis suggest that PVA and PVP are well miscible on a molecular level in the IPN hydrogel. The cell proliferation trend demonstrates that the addition of PVP has a positive influence on the cell growth and the IPN hydrogel may be used as a promising biomaterial for artificial cartilage substitute. (C) 2012 Wiley Periodicals, Inc. J Appl Polym Sci, 2012
C1 [Gong, Mei; Zhang, Li; Zuo, Yi; Zou, Qin; Wang, Li; Li, Yubao] Sichuan Univ, Res Ctr Nanobiomat, Analyt & Testing Ctr, Chengdu 610064, Peoples R China.
   [Wang, Yanying] Sichuan Univ, Coll Chem, Chengdu 610064, Peoples R China.
RP Li, YB (reprint author), Sichuan Univ, Res Ctr Nanobiomat, Analyt & Testing Ctr, Chengdu 610064, Peoples R China.
EM zoae@vip.sina.com; nic7504@scu.edu.cn
FU China 973 Project [2007CB936102]
FX Contract grant sponsor: China 973 Project; contract grant number:
   2007CB936102.
CR Abdel-Rahman EM, 1998, MED ENG PHYS, V20, P276, DOI 10.1016/S1350-4533(98)00010-1
   CASCONE MG, 1995, BIOMATERIALS, V16, P569, DOI 10.1016/0142-9612(95)91131-H
   Cassu SN, 1997, POLYMER, V38, P3907, DOI 10.1016/S0032-3861(96)00959-7
   Cowie J. M. G, 1988, ENCY POLYM SCI ENG
   FENG HQ, 1993, POLYMER, V34, P2516, DOI 10.1016/0032-3861(93)90581-T
   Julien M, 2007, BIOMATERIALS, V28, P956, DOI 10.1016/j.biomaterials.2006.10.018
   Kim SJ, 2003, J APPL POLYM SCI, V90, P881, DOI 10.1002/app.12794
   Kobayashi M, 2005, BIOMATERIALS, V26, P3243, DOI 10.1016/j.biomaterials.2004.08.028
   Martens P, 2000, POLYMER, V41, P7715, DOI 10.1016/S0032-3861(00)00123-3
   Mei G., 2009, FUNCT MAT, V3, P439
   Mishra S, 2006, J MATER SCI-MATER M, V17, P1305, DOI 10.1007/s10856-006-0605-9
   Pan YS, 2009, WEAR, V266, P699, DOI 10.1016/j.wear.2008.08.012
   PEPPAS NA, 1976, J APPL POLYM SCI, V20, P1457, DOI 10.1002/app.1976.070200604
   PEPPAS NA, 1982, J APPL POLYM SCI, V27, P4787, DOI 10.1002/app.1982.070271223
   Seabra AB, 2004, BIOMATERIALS, V25, P3773, DOI 10.1016/j.biomaterials.2003.10.035
   Seal BL, 2001, MAT SCI ENG R, V34, P147, DOI 10.1016/S0927-796X(01)00035-3
   Sperling L.H., 1981, INTERPENETRATING POL
   Thomas J, 2003, J BIOMED MATER RES A, V67A, P1329, DOI 10.1002/jbm.a.10119
   ZHANG XQ, 1992, POLYMER, V33, P712, DOI 10.1016/0032-3861(92)90326-R
   Zou Q, 2009, J BIOMED MATER RES B, V90B, P156, DOI 10.1002/jbm.b.31267
NR 20
TC 2
Z9 2
U1 6
U2 59
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0021-8995
J9 J APPL POLYM SCI
JI J. Appl. Polym. Sci.
PD AUG 15
PY 2012
VL 125
IS 4
BP 2799
EP 2806
DI 10.1002/app.36247
PG 8
WC Polymer Science
SC Polymer Science
GA 936ND
UT WOS:000303596200037
DA 2018-10-19
ER

PT J
AU Chakrapani, VY
   Gnanamani, A
   Giridev, VR
   Madhusoothanan, M
   Sekaran, G
AF Chakrapani, V. Yogeshwar
   Gnanamani, A.
   Giridev, V. R.
   Madhusoothanan, M.
   Sekaran, G.
TI Electrospinning of type I collagen and PCL nanofibers using acetic acid
SO JOURNAL OF APPLIED POLYMER SCIENCE
LA English
DT Article
DE electrospinning; biomaterial; biopolymer; nanofibers
ID TISSUE ENGINEERING APPLICATIONS; SCAFFOLDS; ELASTIN
AB Fabrication of nanofibrous biomaterials based on natural materials (collagen, gelatin, etc.) through various techniques is an important research topic. Electrospinning, a well-established technique for nanofiber production has also been extended for producing nanofibrous structures of natural materials. Collagen nanofiber production utilizes hexafluoro isopropanol (HFIP) as a solvent for electrospinning. Research efforts are now focused on replacing HFIP with an environmentally benign solvent. In this study, electrospinning of Type I collagen of bovine skin with polycaprolactone (PCL) as a blend and an environmentally benign solvent, acetic acid, was carried out. The samples produced were subjected to contact angle measurements, porosity estimation, SEM, FTIR, TGA, and DSC. Nanofibers in the range of 100-200 nm were produced with an optimum porosity of 60%. The instrumental analyses confirm the physical interaction between collagen and PCL. Electrospinning of collagen in an environmentally benign solvent has been carried out and its usage in tissue engineering is being investigated by our research group. (C) 2012 Wiley Periodicals, Inc. J Appl Polym Sci, 2012
C1 [Gnanamani, A.] Cent Leather Res Inst CSIR, Div Microbiol, Madras, Tamil Nadu, India.
   [Chakrapani, V. Yogeshwar; Giridev, V. R.; Madhusoothanan, M.] Anna Univ, Dept Text Technol, Chennai 600025, Tamil Nadu, India.
   [Sekaran, G.] Cent Leather Res Inst, Environm Technol Div, Chennai 600020, Tamil Nadu, India.
RP Gnanamani, A (reprint author), Cent Leather Res Inst CSIR, Div Microbiol, Madras, Tamil Nadu, India.
EM gnanamani3@gmail.com
CR Boland ED, 2004, FRONT BIOSCI-LANDMRK, V9, P1422, DOI 10.2741/1313
   Buttafoco L, 2006, BIOMATERIALS, V27, P724, DOI 10.1016/j.biomaterials.2005.06.024
   Chen R, 2010, COLLOID SURFACE B, V79, P315, DOI 10.1016/j.colsurfb.2010.03.043
   Chen ZG, 2010, ACTA BIOMATER, V6, P372, DOI 10.1016/j.actbio.2009.07.024
   Chong EJ, 2007, ACTA BIOMATER, V3, P321, DOI 10.1016/j.actbio.2007.01.002
   Cliche S, 2003, POULTRY SCI, V82, P503, DOI 10.1093/ps/82.3.503
   Dong B, 2009, MACROMOL RAPID COMM, V30, P539, DOI 10.1002/marc.200800634
   Grodzinski J J, 2006, POLYM ADVAN TECHNOL, V17, P395
   Lee JJ, 2009, J MATER SCI-MATER M, V20, P1927, DOI 10.1007/s10856-009-3743-z
   Matthews JA, 2002, BIOMACROMOLECULES, V3, P232, DOI 10.1021/bm015533u
   Pham QP, 2006, TISSUE ENG, V12, P1197, DOI 10.1089/ten.2006.12.1197
   Sell SA, 2008, BIOMED MATER, V3, DOI 10.1088/1748-6041/3/4/045001
   Shih YRV, 2006, STEM CELLS, V24, P2391, DOI 10.1634/stemcells.2006-0253
   Sia Samuel K., 2007, Birth Defects Research, V81, P354, DOI 10.1002/bdrc.20105
   Szentivanyi A, 2011, ADV DRUG DELIVER REV, V63, P209, DOI 10.1016/j.addr.2010.12.002
   Thomas V, 2007, BIOMACROMOLECULES, V8, P631, DOI 10.1021/bm060879w
   Venugopal J, 2005, NANOTECHNOLOGY, V16, P2138, DOI 10.1088/0957-4484/16/10/028
   Webster TJ, 2004, NANOTECHNOLOGY, V15, P48, DOI 10.1088/0957-4484/15/1/009
   XIUMEI M, 2007, FRONTIERS MAT SCI CH, V1, P20
   Zeugolis DI, 2008, BIOMATERIALS, V29, P2293, DOI 10.1016/j.biomaterials.2008.02.009
   Zhang YZ, 2005, BIOMACROMOLECULES, V6, P2583, DOI 10.1021/bm050314k
   Zhou J., 2010, INT J BIOL MACROMOL, V4, P514
NR 22
TC 47
Z9 49
U1 7
U2 167
PU WILEY-BLACKWELL
PI MALDEN
PA COMMERCE PLACE, 350 MAIN ST, MALDEN 02148, MA USA
SN 0021-8995
J9 J APPL POLYM SCI
JI J. Appl. Polym. Sci.
PD AUG 15
PY 2012
VL 125
IS 4
BP 3221
EP 3227
DI 10.1002/app.36504
PG 7
WC Polymer Science
SC Polymer Science
GA 936ND
UT WOS:000303596200088
DA 2018-10-19
ER

PT J
AU Sensenig, AT
   Lorentz, KA
   Kelly, SP
   Blackledge, TA
AF Sensenig, Andrew T.
   Lorentz, Kimberly A.
   Kelly, Sean P.
   Blackledge, Todd A.
TI Spider orb webs rely on radial threads to absorb prey kinetic energy
SO JOURNAL OF THE ROYAL SOCIETY INTERFACE
LA English
DT Article
DE prey capture; high-speed imaging; major ampullate silk; viscous
   dissipation
ID WEAVING SPIDERS; MECHANICAL-PROPERTIES; CAPTURE THREADS; SILK;
   EVOLUTION; BEHAVIOR; DESIGN; DIVERSIFICATION; ARCHITECTURES; BIOMATERIAL
AB The kinetic energy of flying insect prey is a formidable challenge for orb-weaving spiders. These spiders construct two-dimensional, round webs from a combination of stiff, strong radial silk and highly elastic, glue-coated capture spirals. Orb webs must first stop the flight of insect prey and then retain those insects long enough to be subdued by the spiders. Consequently, spider silks rank among the toughest known biomaterials. The large number of silk threads composing a web suggests that aerodynamic dissipation may also play an important role in stopping prey. Here, we quantify energy dissipation in orb webs spun by diverse species of spiders using data derived from high-speed videos of web deformation under prey impact. By integrating video data with material testing of silks, we compare the relative contributions of radial silk, the capture spiral and aerodynamic dissipation. Radial silk dominated energy absorption in all webs, with the potential to account for approximately 100 per cent of the work of stopping prey in larger webs. The most generous estimates for the roles of capture spirals and aerodynamic dissipation show that they rarely contribute more than 30 per cent and 10 per cent of the total work of stopping prey, respectively, and then only for smaller orb webs. The reliance of spider orb webs upon internal energy absorption by radial threads for prey capture suggests that the material properties of the capture spirals are largely unconstrained by the selective pressures of stopping prey and can instead evolve freely in response to alternative functional constraints such as adhering to prey.
C1 [Sensenig, Andrew T.] Tabor Coll, Dept Biol, Hillsboro, KS 67063 USA.
   [Lorentz, Kimberly A.; Kelly, Sean P.; Blackledge, Todd A.] Univ Akron, Dept Biol, Akron, OH 44325 USA.
   [Lorentz, Kimberly A.; Kelly, Sean P.; Blackledge, Todd A.] Univ Akron, Integrated Biosci Program, Akron, OH 44325 USA.
RP Sensenig, AT (reprint author), Tabor Coll, Dept Biol, Hillsboro, KS 67063 USA.
EM andrews@tabor.edu
FU NSF [IOS-0745379]; Tabor College Hope Scholarship
FX The authors thank Kenneth Kiger from the University of Maryland for some
   comments on early drafts of the manuscript. Brittany Lesher of the
   University of Akron assisted in collection of data. This work was
   supported by NSF award IOS-0745379 to T.A.B. and a Tabor College Hope
   Scholarship Grant to A.T.S. This is publication no. 30 of the University
   of Akron Field Station.
CR Agnarsson I, 2009, J ZOOL, V278, P134, DOI 10.1111/j.1469-7998.2009.00558.x
   Alam MS, 2007, MECH MATER, V39, P145, DOI 10.1016/j.mechmat.2006.04.005
   Aoyanagi Y, 2010, PHYS REV LETT, V104, DOI 10.1103/PhysRevLett.104.038102
   Blackledge TA, 2006, J EXP BIOL, V209, P2452, DOI 10.1242/jeb.02275
   Blackledge TA, 2005, J EXP BIOL, V208, P1937, DOI 10.1242/jeb.01597
   Blackledge TA, 2006, ETHOLOGY, V112, P1194, DOI 10.1111/j.1439-0310.2006.01277.x
   Blackledge TA, 2011, ADV INSECT PHYSIOL, V41, P175, DOI 10.1016/B978-0-12-415919-8.00004-5
   Blackledge TA, 2009, P NATL ACAD SCI USA, V106, P5229, DOI 10.1073/pnas.0901377106
   CRAIG CL, 1987, BIOL J LINN SOC, V30, P135, DOI 10.1111/j.1095-8312.1987.tb00294.x
   CRAIG CL, 1987, AM NAT, V129, P47, DOI 10.1086/284622
   Cranford SW, 2012, NATURE, V482, P72, DOI 10.1038/nature10739
   DENNY M, 1976, J EXP BIOL, V65, P483
   Diaz-Fleischer F, 2005, CAN J ZOOL, V83, P268, DOI 10.1139/Z04-176
   Foelix R., 1996, BIOL SPIDERS, P330
   Gosline JM, 1999, J EXP BIOL, V202, P3295
   Kelly SP, 2011, ZOOLOGY, V114, P233, DOI 10.1016/j.zool.2011.02.001
   Kline S. J., 1953, MECH ENG, V75, P3
   Ko FK, 2004, BIOMACROMOLECULES, V5, P780, DOI 10.1021/bm0345099
   LI SFY, 1994, J VAC SCI TECHNOL A, V12, P1891, DOI 10.1116/1.578978
   LIN LH, 1995, NATURE, V373, P146, DOI 10.1038/373146a0
   Nachtigall W, 2001, MATH METHOD APPL SCI, V24, P1401, DOI 10.1002/mma.188
   NENTWIG W, 1983, OECOLOGIA, V58, P418, DOI 10.1007/BF00385246
   Opell BD, 2002, J ARACHNOL, V30, P494, DOI 10.1636/0161-8202(2002)030[0494:ETSOIA]2.0.CO;2
   Opell BD, 1996, AM NAT, V148, P630, DOI 10.1086/285944
   Opell BD, 2007, J EXP BIOL, V210, P553, DOI 10.1242/jeb.02682
   Sahni V, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1019
   Sensenig A, 2010, J EVOLUTION BIOL, V23, P1839, DOI 10.1111/j.1420-9101.2010.02048.x
   STATSOFT, 2009, STATISTICA DAT AN SO
   SUTER RB, 1991, ETHOL ECOL EVOL, V3, P13, DOI 10.1080/08927014.1991.9525385
   Swanson BO, 2007, J EXP ZOOL PART A, V307A, P654, DOI 10.1002/jez.420
   Swanson BO, 2006, EVOLUTION, V60, P2539
   Tritton D. J., 1988, PHYS FLUID DYNAMICS
   TURNBULL AL, 1973, ANNU REV ENTOMOL, V18, P305, DOI 10.1146/annurev.en.18.010173.001513
   Uetz G.W., 1978, Bulletin of the British Arachnological Society, V4, P141
   WORK RW, 1976, TEXT RES J, V46, P485, DOI 10.1177/004051757604600704
NR 35
TC 39
Z9 40
U1 0
U2 26
PU ROYAL SOC
PI LONDON
PA 6-9 CARLTON HOUSE TERRACE, LONDON SW1Y 5AG, ENGLAND
SN 1742-5689
J9 J R SOC INTERFACE
JI J. R. Soc. Interface
PD AUG 7
PY 2012
VL 9
IS 73
BP 1880
EP 1891
DI 10.1098/rsif.2011.0851
PG 12
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA 966AY
UT WOS:000305810200017
PM 22431738
OA Green Published, Bronze
DA 2018-10-19
ER

PT J
AU Jin, J
   Zhang, C
   Jiang, W
   Luan, SF
   Yang, HW
   Yin, JH
   Stagnaro, P
AF Jin, Jing
   Zhang, Chang
   Jiang, Wei
   Luan, Shifang
   Yang, Huawei
   Yin, Jinghua
   Stagnaro, Paola
TI Melting grafting polypropylene with hydrophilic monomers for improving
   hemocompatibility
SO COLLOIDS AND SURFACES A-PHYSICOCHEMICAL AND ENGINEERING ASPECTS
LA English
DT Article
DE Polypropylene; PEG; NVP; Solvent inducement; Hemocompatibility
ID PROTEIN ADSORPTION; PLATELET-ADHESION; N-VINYLPYRROLIDONE;
   BLOCK-COPOLYMERS; SURFACE-TENSION; PLASMA; METHACRYLATE;
   FUNCTIONALIZATION; ANHYDRIDE; POLYMERS
AB Polypropylene was successfully grafted with poly (ethylene glycol) methacrylate (PEGMA) using N-vinyl pyrrolidone (NVP) as a co-grafted monomer through melting reactive grafting modification. The grafting degree of PEGMA could be obviously enhanced by the introduction of NVP at the NVP/PEGMA molar feeding ratio of 1.3. To improve the surface hydrophilicity further, hydrophilic monomers were enriched onto the surface by solvent inducement. The water contact angle of the copolymers decreased obviously and X-ray photoelectron spectroscopy (XPS) showed that the surface energy and the polar component of the modified films depended on the PEGMA grafting degree. The hemocompatibility of copolymers films were improved by increasing the PEGMA grafting degree and deteriorated by augmenting the NVP grafting degree. It was found that the balance of PEGMA grafting degree and NVP crosslinking was significant to the blood compatibility of the modified films. The biomaterial PP-g-(NVP-co-PEGMA) with the largest PEGMA grafting degree (up to 3.22 wt.%) and moderate NVP grafting degree (1.76 wt.%) could effectively resist to protein adsorption and suppress platelet adhesion. (c) 2012 Elsevier B.V. All rights reserved.
C1 [Jin, Jing; Zhang, Chang; Jiang, Wei; Luan, Shifang; Yang, Huawei; Yin, Jinghua] Chinese Acad Sci, Changchun Inst Appl Chem, State Key Lab Polymer Phys & Chem, Changchun 130022, Peoples R China.
   [Jin, Jing; Zhang, Chang; Yang, Huawei] Chinese Acad Sci, Grad Univ, Beijing 100049, Peoples R China.
   [Stagnaro, Paola] CNR, Ist Studio Macromol, I-16149 Genoa, Italy.
RP Jiang, W (reprint author), Chinese Acad Sci, Changchun Inst Appl Chem, State Key Lab Polymer Phys & Chem, Changchun 130022, Peoples R China.
EM wjiang@ciac.jl.cn; yinjh@ciac.jl.cn
RI Jiang, Wei/O-8445-2018
OI Jiang, Wei/0000-0003-4316-880X; Jin, Jing/0000-0002-2710-4243; Stagnaro,
   Paola/0000-0003-3437-1435
FU National Natural Science Foundation of China [50833005, 50920105302,
   50921062, 50725312]
FX The authors acknowledge the financial support of the National Natural
   Science Foundation of China (Project Nos. 50833005, 50920105302,
   50921062 and 50725312). The work has also been carried out in the
   framework of the Research Cooperation Agreement between the Chinese
   Academy of Sciences (CAS) and the National Research Council (CNR) of
   Italy.
CR ALFREY T, 1947, J POLYM SCI, V2, P101, DOI 10.1002/pol.1947.120020112
   Bunk JKG, 2010, COLLOID SURFACE A, V362, P47, DOI 10.1016/j.colsurfa.2010.03.039
   Chai JN, 2004, LANGMUIR, V20, P10919, DOI 10.1021/la048947s
   Dessouki AM, 1998, POLYM INT, V45, P67, DOI 10.1002/(SICI)1097-0126(199801)45:1<67::AID-PI896>3.0.CO;2-A
   Fowkes F. M., 1964, ADV CHEM SER, P99
   FUJIMOTO K, 1993, J BIOMED MATER RES, V27, P1559, DOI 10.1002/jbm.820271213
   GEORGIEV G, 1992, MACROMOLECULES, V25, P6302, DOI 10.1021/ma00049a029
   HERMANS J, 1982, J CHEM PHYS, V77, P2193, DOI 10.1063/1.444026
   Ikada Y., 1984, POLYM MED, P103
   Ishihara K, 2004, BIOMATERIALS, V25, P1115, DOI 10.1016/S0142-9612(03)00624-0
   KAELBLE DH, 1970, J ADHESION, V2, P66, DOI 10.1080/0021846708544582
   KAELBLE DH, 1970, J ADHESION, V2, P50, DOI 10.1080/0021846708544579
   Kauffman GW, 2001, J CHEM INF COMP SCI, V41, P408, DOI 10.1021/ci000139t
   Koh LB, 2010, BIOMATERIALS, V31, P1533, DOI 10.1016/j.biomaterials.2009.11.022
   Larsson A, 2007, BIOMACROMOLECULES, V8, P287, DOI 10.1021/bm060685g
   Lee JH, 1997, J BIOMED MATER RES, V34, P105, DOI 10.1002/(SICI)1097-4636(199701)34:1<105::AID-JBM14>3.0.CO;2-J
   Liu XM, 2011, LANGMUIR, V27, P4541, DOI 10.1021/la200349p
   Martin SJ, 2001, MACROMOLECULES, V34, P8934, DOI 10.1021/ma010645z
   Otsuka H, 2000, BIOMACROMOLECULES, V1, P39, DOI 10.1021/bm990005s
   OWENS DK, 1969, J APPL POLYM SCI, V13, P1741, DOI 10.1002/app.1969.070130815
   Pop-Georgievski O, 2011, BIOMACROMOLECULES, V12, P3232, DOI 10.1021/bm2007086
   Riquet AM, 2011, SURF ENG, V27, P234, DOI 10.1179/174329409X409413
   Sask KN, 2011, ACTA BIOMATER, V7, P2029, DOI 10.1016/j.actbio.2011.01.031
   Seo JH, 2008, BIOMATERIALS, V29, P1367, DOI 10.1016/j.biomaterials.2007.11.039
   Shi H., 2010, PHYS TECHNOLOGY MILL, P1
   Shi HC, 2010, REACT FUNCT POLYM, V70, P449, DOI 10.1016/j.reactfunctpolym.2010.04.008
   Tanaka M, 2000, BIOMATERIALS, V21, P1471, DOI 10.1016/S0142-9612(00)00031-4
   Tessmar JK, 2007, MACROMOL BIOSCI, V7, P23, DOI 10.1002/mabi.200600096
   Uyama Y, 1998, ADV POLYM SCI, V137, P1
   Wan LS, 2005, POLYMER, V46, P7715, DOI 10.1016/j.polymer.2005.05.147
   Wan LS, 2005, MACROMOL BIOSCI, V5, P229, DOI 10.1002/mabi.200400157
   Wetzels GMR, 1999, BIOMATERIALS, V20, P1879, DOI 10.1016/S0142-9612(99)00067-8
   Xing CM, 2005, MACROMOL CHEM PHYSIC, V206, P1106, DOI 10.1002/macp.200400534
   Xu FJ, 2005, BIOMACROMOLECULES, V6, P1759, DOI 10.1021/bm050071w
   Yang HW, 2012, POLYMER, V53, P1675, DOI 10.1016/j.polymer.2012.02.033
   Yang HW, 2010, REACT FUNCT POLYM, V70, P961, DOI 10.1016/j.reactfunctpolym.2010.10.001
   YASUDA H, 1977, J POLYM SCI POL CHEM, V15, P991, DOI 10.1002/pol.1977.170150420
   Yin LG, 2009, EUR POLYM J, V45, P191, DOI 10.1016/j.eurpolymj.2008.10.016
   Yu BZ, 2008, BIOSENS BIOELECTRON, V23, P1278, DOI 10.1016/j.bios.2007.11.010
   Zhao J., 2010, J MEMBRANE SCI, V369, P5
   Zhao J, 2010, APPL SURF SCI, V256, P7071, DOI 10.1016/j.apsusc.2010.05.028
   Zhu XF, 2010, POLYMER, V51, P3054, DOI 10.1016/j.polymer.2010.05.006
   Zou XP, 2002, PLASMAS POLYM, V7, P151, DOI 10.1023/A:1016243403102
NR 43
TC 9
Z9 12
U1 2
U2 50
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0927-7757
J9 COLLOID SURFACE A
JI Colloid Surf. A-Physicochem. Eng. Asp.
PD AUG 5
PY 2012
VL 407
BP 141
EP 149
DI 10.1016/j.colsurfa.2012.05.022
PG 9
WC Chemistry, Physical
SC Chemistry
GA 980JT
UT WOS:000306890200020
DA 2018-10-19
ER

PT J
AU Radhakumary, C
   Nair, PD
   Nair, CPR
   Mathew, S
AF Radhakumary, C.
   Nair, Prabha D.
   Nair, C. P. Reghunadhan
   Mathew, Suresh
TI Chitosan-graft-poly(vinyl acetate) for hemodialysis applications
SO JOURNAL OF APPLIED POLYMER SCIENCE
LA English
DT Article
DE graft copolymers; biomaterials; biodegradable; hemocompatible;
   hemodialysis
ID BLOOD COMPATIBILITY; CHITOSAN MEMBRANES; PERMEABILITY; BIOMATERIAL;
   BEADS; ASSAY; HEMA
AB Chitosan was graft copolymerized with vinyl acetate using ceric ammonium nitrate as the initiator. The chitosan-g-poly(vinyl acetate) (chitosan-g-PVAc) membranes were found to be blood compatible, noncytotoxic, and biodegradable. The physicochemical characterization of the membranes revealed that the membranes possess the synergistic effect of the natural-synthetic hybrids of chitosan and PVAc with excellent mechanical stability and tunable hydrophilic/hydrophobic characteristics. The permeation characteristics of chitosan-g-PVAc membranes for four different solutes creatinine, urea, glucose, and albumin was studied in vitro at 37 degrees C for assessment of the suitability of them as hemodialysis membranes. The studies showed that the membranes exhibit higher permeability to creatinine, urea, and glucose compared with the commercial cellulose membrane and are impermeable to the essential nutrient albumin. Hence, the need for the development of biocompatible, mechanically strong dialysis membranes could be addressed with the modification of chitosan through grafting with PVAc. Potential applications like artificial kidney, artificial pancreas, and so forth, are envisaged from these membranes. (c) 2012 Wiley Periodicals, Inc. J Appl Polym Sci, 2012
C1 [Radhakumary, C.; Nair, Prabha D.] Sree Chitra Tirunal Inst Med Sci & Technol, Biomed Technol Wing, Thiruvananthapuram 695012, Kerala, India.
   [Nair, C. P. Reghunadhan] Vikram Sarabhai Space Ctr, PSC Div, Thiruvananthapuram 695012, Kerala, India.
   [Mathew, Suresh] MG Univ, Sch Chem Sci, Kottayam 686560, Kerala, India.
RP Radhakumary, C (reprint author), Sree Chitra Tirunal Inst Med Sci & Technol, Biomed Technol Wing, Thiruvananthapuram 695012, Kerala, India.
EM gopinath_radha@yahoo.com
FU Kerala State Council for Science, Technology and Environment
FX The authors thank Director of Sree Chitra Tirunal Institute for Medical
   Sciences and Technology and Head of Biomedical Technology Wing for
   providing all the facilities and also Ms. L. Thomas for the AFM image
   and to "Kerala State Council for Science, Technology and Environment,"
   for the funding.
CR Amiji M. M., 1999, U.S. Pat., Patent No. [5,885,609, 5,904,927, 5885609]
   AMIJI MM, 1995, BIOMATERIALS, V16, P593, DOI 10.1016/0142-9612(95)93856-9
   [Anonymous], 2008, F75608 ASTM INT, DOI [10.1520/F0756-08, DOI 10.1520/F0756-08]
   [Anonymous], 2009, 109935 ISO
   Chen XG, 2002, J AGR FOOD CHEM, V50, P5915, DOI 10.1021/jf020151g
   Ching L. W., 2004, BIOMATERIALS, V25, P1947
   CIAPETTI G, 1993, BIOMATERIALS, V14, P359, DOI 10.1016/0142-9612(93)90055-7
   Claudio R., 2006, HEMODIAL INT, V10, pS48
   Domard A., 2002, POLYM BIOMATERIALS, V9, P187
   DUTTA P, 2002, POLYM REV, V42, P307
   Gupta KC, 2000, J APPL POLYM SCI, V76, P672, DOI 10.1002/(SICI)1097-4628(20000502)76:5<672::AID-APP9>3.0.CO;2-F
   Hajatdoost S, 1997, J CHEM SOC FARADAY T, V93, P1613, DOI 10.1039/a608447h
   HIRANO S, 1985, J BIOMED MATER RES, V19, P413, DOI 10.1002/jbm.820190406
   Krajewska B, 2001, J CHEM TECHNOL BIOT, V76, P636, DOI 10.1002/jctb.429.abs
   Kurt M., 1962, CLIN CHEM, V8, P215
   LARSEN K, 1972, CLIN CHIM ACTA, V41, P209, DOI 10.1016/0009-8981(72)90513-X
   Li YP, 2003, POLYM INT, V52, P285, DOI 10.1002/pi.1082
   LOWRY OH, 1951, J BIOL CHEM, V193, P265
   Malinauskas RA, 1997, ARTIF ORGANS, V21, P1255
   Mima S., 1976, U.S. Pat., Patent No. [3,962,158, 3962158]
   Mohd Nasir N.F., 2005, AM J APPL SCI, V2, P1578
   Paneva D, 2005, J BIOACT COMPAT POL, V20, P133, DOI 10.1177/0883911505051855
   Payet L, 2008, MACROMOLECULES, V41, P9376, DOI 10.1021/ma801192q
   Radhakumary C, 2007, J APPL POLYM SCI, V104, P1852, DOI 10.1002/app.25841
   Radhakumary C, 2006, J APPL POLYM SCI, V101, P2960, DOI 10.1002/app.23525
   Radhakumary C, 2009, J APPL POLYM SCI, V114, P2873, DOI 10.1002/app.30862
   Rehima H. A. A., 2005, J BIOACTIVE COMPAT P, V20, P51
   Saito A, 2006, THER APHER DIAL, V10, P342, DOI 10.1111/j.1744-9987.2006.00387.x
   SINGH DK, 1994, J APPL POLYM SCI, V53, P1115, DOI 10.1002/app.1994.070530814
   SINGH DK, 2000, REV MACROMOL CHEM C, V40, P69
   Vento R, 1998, MOL CELL BIOCHEM, V185, P7, DOI 10.1023/A:1006836428202
NR 31
TC 11
Z9 12
U1 2
U2 53
PU WILEY-BLACKWELL
PI MALDEN
PA COMMERCE PLACE, 350 MAIN ST, MALDEN 02148, MA USA
SN 0021-8995
J9 J APPL POLYM SCI
JI J. Appl. Polym. Sci.
PD AUG 5
PY 2012
VL 125
IS 3
BP 2022
EP 2033
DI 10.1002/app.36261
PG 12
WC Polymer Science
SC Polymer Science
GA 927IZ
UT WOS:000302902200040
DA 2018-10-19
ER

PT J
AU Davi, CP
   Galdino, LFMD
   Borelli, P
   Oliveira, ON
   Ferreira, M
AF Davi, Christiane P.
   Galdino, Luiz F. M. D.
   Borelli, Primavera
   Oliveira, Osvaldo N., Jr.
   Ferreira, Mariselma
TI Natural rubber latex LbL films: Characterization and growth of
   fibroblasts
SO JOURNAL OF APPLIED POLYMER SCIENCE
LA English
DT Article
DE biomaterials; interfaces; rubber; films
ID TREE HEVEA-BRASILIENSIS; BY-LAYER DEPOSITION; MULTILAYERED STRUCTURES;
   SILICA NANOPARTICLES; COLLOID PARTICLES; IMMUNOGLOBULIN-E; THIN-FILMS;
   ADSORPTION; PROTEINS; RELEASE
AB The recent biomedical applications of natural rubber (NR) latex, mostly in dry membranes, have motivated research into novel, more noble uses of this low-cost biomaterial. In this article, we provide the first report on the fabrication of layer-by-layer (LbL) films of NR alternated with the polyelectrolytes polyethylenimine (PEI) and polyallylamine hydrochloride (PAH). Stable (PAH/NR)n and (PEI/NR)n LbL films displayed similar physicochemical properties, but differed in terms of film morphology according to atomic force microscopy (AFM) and scanning electron microscopy (SEM) data. Most significantly, (PEI/NR)5 LbL films were made of smaller and flattened particles, which were not efficient for the growth and proliferation of normal human fibroblasts (NHF). In contrast, efficient NHF proliferation could be obtained with (PAH/NR)n LbL films, with the fibroblasts exhibiting the expected elongated morphology. Furthermore, cell growth did not occur for cast films of NR, thus demonstrating the suitability of the LbL method for this biologically related application. The differences between the two polyelectrolytes illustrate the importance of the film architecture and morphology, which open the way for exploiting the molecular control inherent in the LbL technique for further applications of NR-containing films. (c) 2012 Wiley Periodicals, Inc. J Appl Polym Sci, 2012
C1 [Davi, Christiane P.; Galdino, Luiz F. M. D.; Ferreira, Mariselma] Univ Fed ABC, Lab Eletroquim & Mat Nanoestruturados, Santo Andre, SP, Brazil.
   [Borelli, Primavera] Univ Sao Paulo, Dept Farmacol, Sao Paulo, Brazil.
   [Oliveira, Osvaldo N., Jr.] Univ Sao Paulo, Inst Fis Sao Carlos, Sao Carlos, SP, Brazil.
RP Ferreira, M (reprint author), Univ Fed ABC, Lab Eletroquim & Mat Nanoestruturados, Santo Andre, SP, Brazil.
EM mariselma.ferreira@ufabc.edu.br
RI Sao Carlos Institute of Physics, IFSC/USP/M-2664-2016; Moussa,
   Luciana/M-2257-2013; Oliveira, Osvaldo/A-1714-2008; Davi,
   Christiane/L-9391-2016; Ferreira, Mariselma/G-7234-2012
OI Oliveira, Osvaldo/0000-0002-5399-5860; 
FU UFABC; FAPESP; CNPq; Capes; Rede nBioNet (Brazil)
FX This work was supported by UFABC, FAPESP, CNPq, Capes, and Rede nBioNet
   (Brazil).
CR Adamczyk Z, 2008, J COLLOID INTERF SCI, V317, P1, DOI 10.1016/j.jcis.2007.09.034
   Adamczyk Z, 2007, APPL SURF SCI, V253, P5776, DOI 10.1016/j.apsusc.2006.12.051
   ALENIUS H, 1995, CLIN EXP ALLERGY, V25, P659, DOI 10.1111/j.1365-2222.1995.tb01114.x
   Balabanian Claudia A C A, 2006, J Oral Sci, V48, P201, DOI 10.2334/josnusd.48.201
   Cai KY, 2006, J MATER SCI-MATER M, V17, P929, DOI 10.1007/s10856-006-0182-y
   Chen JL, 2010, J BIOMED MATER RES A, V95A, P341, DOI 10.1002/jbm.a.32847
   Chopra V. L., 2005, HDB IND CROPS
   Coutinho J., 2005, Patent No. [WO 2005008932 A3, 2005008932]
   Coutinho J., 2005, [No title captured], Patent No. [US2005049331-A1, 2005049331]
   Crespilho FN, 2005, ENVIRON SCI TECHNOL, V39, P5385, DOI 10.1021/es050552n
   D'Auzac J, 1989, PHYSL RUBBER TREE LA
   Decher G, 1997, SCIENCE, V277, P1232, DOI 10.1126/science.277.5330.1232
   Erol M, 2006, LANGMUIR, V22, P11329, DOI 10.1021/la061790e
   Ferreira M., 2006, NSTI NAN 2006 BOST T, V2, P129
   Ferreira M, 2009, BRAZ J PHYS, V39, P564, DOI 10.1590/S0103-97332009000500010
   Frade MAC, 2001, INT J DERMATOL, V40, P238, DOI 10.1046/j.1365-4362.2001.00977-2.x
   Fukuda J, 2006, BIOMATERIALS, V27, P1479, DOI 10.1016/j.biomaterials.2005.09.015
   Guarneri F, 2006, CLIN EXP ALLERGY, V36, P916, DOI 10.1111/j.1365-2222.2006.02516.x
   Healey AM, 1996, POLYMER, V37, P4009, DOI 10.1016/0032-3861(96)00257-1
   Herculano RD, 2006, MACROMOL SYMP, V245, P529, DOI 10.1002/masy.200651376
   Herculano RD, 2010, MATER RES-IBERO-AM J, V13, P57, DOI 10.1590/S1516-14392010000100013
   Herculano RD, 2009, MATER RES-IBERO-AM J, V12, P253, DOI 10.1590/S1516-14392009000200023
   Hikita M, 2005, LANGMUIR, V21, P7299, DOI 10.1021/la050901r
   Israelachvili J. N., 1991, INTERMOLECULAR SURFA
   Kadowaki K, 2010, LANGMUIR, V26, P5670, DOI 10.1021/la903738n
   Lavalle P, 2002, MACROMOLECULES, V35, P4458, DOI 10.1021/ma0119833
   Liu G, 2009, J MATER RES, V24, P1317, DOI 10.1557/JMR.2009.0179
   Mao ZW, 2005, BIOCONJUGATE CHEM, V16, P1316, DOI 10.1021/bc049755b
   Marmur A, 2004, LANGMUIR, V20, P3517, DOI 10.1021/la036369u
   Mendelsohn JD, 2003, BIOMACROMOLECULES, V4, P96, DOI 10.1021/bm0256101
   Mendonca RJ, 2010, PHYTOTHER RES, V24, P764, DOI 10.1002/ptr.3043
   Morton M., 1987, RUBBER TECHNOLOGY
   Mrue F., 2010, Pele Nova Biotecnologia Sa, Patent No. [WO2009155678-A1, 2009155678]
   Mrue F., 2006, Pele Nova Biotecnologia Sa, Patent No. [BR200405995-A, 200405995]
   Mrue F., 2007, Pele Nova Biotecnologia Sa, Patent No. [WO2007048215-A1, 2007048215]
   Mrue F., 2007, [No title captured], Patent No. [US2009093404-A1, 2009093404]
   Mrue F., 2007, Pele Nova Biotecnologia Sa, Patent No. [WO2007059597-A2, 2007059597]
   Mrue Fatima, 2004, Mat. Res., V7, P277, DOI 10.1590/S1516-14392004000200010
   Neves WFP, 2006, J APPL POLYM SCI, V100, P702, DOI 10.1002/app.23416
   Neves-Junior WFP, 2006, BRAZ J PHYS, V36, P586, DOI 10.1590/S0103-97332006000400021
   Palosuo T, 2007, CLIN EXP ALLERGY, V37, P1502, DOI 10.1111/j.1365-2222.2007.02810.x
   Predeep P, 2006, J ELASTOM PLAST, V38, P333, DOI 10.1177/0095244306064949
   Rajangam K, 2006, NANO LETT, V6, P2086, DOI 10.1021/nl0613555
   Raposo M, 1998, BRAZ J PHYS, V28, P392
   Raulf-Heimsoth M, 2007, CLIN EXP ALLERGY, V37, P1657, DOI 10.1111/j.1365-2222.2007.02833.x
   Rippel MM, 2003, J COLLOID INTERF SCI, V268, P330, DOI 10.1016/j.jcis.2003.07.046
   Sangribsub S, 2005, EUR POLYM J, V41, P1531, DOI 10.1016/j.europolymj.2005.02.012
   SUSSMAN GL, 1995, ANN INTERN MED, V122, P43, DOI 10.7326/0003-4819-122-1-199501010-00007
   Volodkin D, 2008, SOFT MATTER, V4, P122, DOI 10.1039/b713563g
   Wen J, 1996, ANAL BIOCHEM, V240, P155, DOI 10.1006/abio.1996.0345
   Wittmer CR, 2008, BIOMATERIALS, V29, P4082, DOI 10.1016/j.biomaterials.2008.06.027
   Wood KC, 2005, LANGMUIR, V21, P1603, DOI 10.1021/la0476480
   Yang T, 2006, J CONTROL RELEASE, V115, P289, DOI 10.1016/j.jconrel.2006.08.015
   Yeang HY, 2006, CLIN EXP ALLERGY, V36, P1078, DOI 10.1111/j.1365-2222.2006.02531.x
   Zhou J, 2010, J COLLOID INTERF SCI, V345, P241, DOI 10.1016/j.jcis.2010.02.004
NR 55
TC 10
Z9 11
U1 1
U2 28
PU WILEY-BLACKWELL
PI MALDEN
PA COMMERCE PLACE, 350 MAIN ST, MALDEN 02148, MA USA
SN 0021-8995
J9 J APPL POLYM SCI
JI J. Appl. Polym. Sci.
PD AUG 5
PY 2012
VL 125
IS 3
BP 2137
EP 2147
DI 10.1002/app.36309
PG 11
WC Polymer Science
SC Polymer Science
GA 927IZ
UT WOS:000302902200054
DA 2018-10-19
ER

PT J
AU Benfenati, V
   Sagnella, A
   Chieco, C
   Di Virgilio, N
   Muccini, M
   Zamboni, R
   Rossi, F
AF Benfenati, Valentina
   Sagnella, Anna
   Chieco, Camilla
   Di Virgilio, Nicola
   Muccini, Michele
   Zamboni, Roberto
   Rossi, Federica
TI Silk Fibroin as Platform for Neural Cells and Hybrid Optoelectronics
SO JOURNAL OF BIOBASED MATERIALS AND BIOENERGY
LA English
DT Article; Proceedings Paper
CT 3rd International Conference on Innovative Natural Fibre Composites for
   Industrial Applications
CY OCT 12-14, 2011
CL Sapienza Univ Roma, Rome, ITALY
HO Sapienza Univ Roma
DE Silk Fibroin; Biocomposites; Bioelectronics; Biodegradable Materials;
   Organic Transistor; Organic Light Emitting Transistors;
   Neuroregenerative Medicine
ID LIGHT-EMITTING TRANSISTORS; NATURAL FIBERS; BIOMATERIALS; PROTEIN;
   DIODES
AB Natural fibres are increasingly used for non-textile application with high technological content for the possibility to create a bio-based material and then respond to the growing request for environmentally friendly products. Together with bast fibre broadly used for bio-composites materials, silk fibre produced by the Bombyx mori L. insect also found a huge field of high tech application in health industries and electronics, in particular for its principal component: the silk fibroin. Chemical and physical properties of silk fibroin have been extensively studied for its suitability as biomaterial. In particular rate controlled biodegradability, flexibility, mechanical resistance and optical transparency combined with its feasibility for different biomaterials forms (as sponge, hydrogel films) have made silk-fibroin a first choice natural biomaterial for its application as scaffold matrix for temporary medical implants in tissue engineering. Moreover, we recently defined a novel route for silk, employing silk fibroin thin films as organic electronic integrated components with electronic functionality in organic device. On these basis the activity of our research team was also targeted to define the effect of B. mori silk fibroin thin films, as scaffold or drug delivery matrix, on the viability and bioelectrical properties of different neural cells such as astrocytes and neurons. Future researches will be focused on the definition of a complete and sustainable chain, starting from the cultivation of the mulberry trees to the processing of fibroin for different uses, linking high tech applications to local resources, thus representing a new opportunity for rural area and farmer incomes.
C1 [Benfenati, Valentina; Muccini, Michele] CNR ISMN, Natl Res Council Italy, Inst Nanostruct Mat, I-40129 Bologna, Italy.
   [Sagnella, Anna; Zamboni, Roberto] CNR ISOF, Natl Res Council Italy, Inst Organ Synth & Photoreact, I-40129 Bologna, Italy.
   [Chieco, Camilla; Di Virgilio, Nicola; Rossi, Federica] CNR IBIMET, Natl Res Council Italy, Inst Biometeorol, I-40129 Bologna, Italy.
RP Benfenati, V (reprint author), CNR ISMN, Natl Res Council Italy, Inst Nanostruct Mat, Via P Gobetti 101, I-40129 Bologna, Italy.
EM vbenfenati@bo.ismn.cnr.it; n.divirgilio@ibimet.cnr.it
RI Benfenati, Valentina/D-4579-2016; Zamboni, Roberto/P-3610-2015; Muccini,
   Michele/D-6935-2018; Di Virgilio, Nicola/V-9521-2017; Rossi,
   Federica/D-2083-2018
OI Benfenati, Valentina/0000-0002-2858-8497; Zamboni,
   Roberto/0000-0003-3739-2207; Muccini, Michele/0000-0003-0489-8316; Di
   Virgilio, Nicola/0000-0001-6208-1799; Rossi,
   Federica/0000-0003-4428-4749
CR Arisi E, 2003, J APPL PHYS, V93, P7682, DOI 10.1063/1.1556118
   Atman G. H., 2003, BIOMATERIALS, V24, P401
   Benfenati V, 2006, J NEUROCHEM, V98, P430, DOI 10.1111/j.1471-4159.2006.03877.x
   Benfenati V, 2010, BIOMATERIALS, V31, P7883, DOI 10.1016/j.biomaterials.2010.07.013
   Capelli R, 2011, ORG ELECTRON, V12, P1146, DOI 10.1016/j.orgel.2011.04.005
   Capelli R, 2010, NAT MATER, V9, P496, DOI [10.1038/NMAT2751, 10.1038/nmat2751]
   CASTELLI WA, 1978, ORAL SURG ORAL MED O, V45, P179, DOI 10.1016/0030-4220(78)90083-X
   CUNIFF PM, 1994, POLYM ADVAN TECHNOL, V5, P401
   Diring S, 2009, J AM CHEM SOC, V131, P18177, DOI 10.1021/ja908061q
   Gomes HL, 2005, POLYM ADVAN TECHNOL, V16, P227, DOI 10.1002/pat.558
   Hofmann S, 2006, J CONTROL RELEASE, V111, P219, DOI 10.1016/j.jconrel.205.12.009
   Holbery J, 2006, JOM, V58, P11
   Irimia-Vladu M, 2010, ADV FUNCT MATER, V20, P4017
   Irimia-Vladu M, 2011, J MATER CHEM, V21, P1350, DOI 10.1039/c0jm02444a
   Lawrence BD, 2008, BIOMACROMOLECULES, V9, P1214, DOI 10.1021/bm701235f
   Muccini M, 2006, NAT MATER, V5, P605, DOI 10.1038/nmat1699
   Omenetto FG, 2008, NAT PHOTONICS, V2, P641, DOI 10.1038/nphoton.2008.207
   Rost C, 2004, SYNTHETIC MET, V146, P237, DOI 10.1016/j.synthmet.2004.08.003
   Tang X, 2009, J BIOMED MATER RES A, V91A, P166, DOI 10.1002/jbm.a.32212
   Venturi G., 1999, COLTURE FIBRA, P147
   Wambua P, 2003, COMPOS SCI TECHNOL, V63, P1259, DOI 10.1016/S0266-3538(03)00096-4
   Wang XQ, 2008, BIOMATERIALS, V29, P1054, DOI 10.1016/j.biomaterials.2007.11.003
   Wang YZ, 2006, BIOMATERIALS, V27, P6064, DOI 10.1016/j.biomaterials.2006.07.008
   Wollerdorfer M, 1998, IND CROP PROD, V8, P105, DOI 10.1016/S0926-6690(97)10015-2
   Xu ZX, 2007, APPL PHYS LETT, V90, DOI 10.1063/1.2740478
   Yang YM, 2009, POLYM DEGRAD STABIL, V94, P2213, DOI 10.1016/j.polymdegradstab.2009.09.002
   Yuen MY, 2008, ANGEW CHEM INT EDIT, V47, P9895, DOI 10.1002/anie.200802981
NR 27
TC 2
Z9 2
U1 2
U2 37
PU AMER SCIENTIFIC PUBLISHERS
PI VALENCIA
PA 26650 THE OLD RD, STE 208, VALENCIA, CA 91381-0751 USA
SN 1556-6560
J9 J BIOBASED MATER BIO
JI J. Biobased Mater. Bioenergy
PD AUG
PY 2012
VL 6
IS 4
SI SI
BP 508
EP 514
DI 10.1166/jbmb.2012.1238
PG 7
WC Chemistry, Applied; Energy & Fuels; Materials Science, Biomaterials
SC Chemistry; Energy & Fuels; Materials Science
GA 039QO
UT WOS:000311261800022
DA 2018-10-19
ER

PT J
AU Ahmed, S
AF Ahmed, Shahbaz
TI Research Highlights in Fullerene Chemistry
SO JOURNAL OF THE CHEMICAL SOCIETY OF PAKISTAN
LA English
DT Article
ID DERIVATIVES; WATER; C-60; KERATINOCYTES; NANOMATERIALS; CYTOTOXICITY;
   CELLS
AB This review reconsiders the recent trends in Fullerene chemistry in context to antimicrobial, neuroprotection, photochemical, antioxidant nature, diagnostic drug delivery, enzyme inhibition, fluorescence, catalytic, purification, radioprotection, biomaterial application, quantitative measurements and sensor technology. Although there is exponential increase in fullerenes chemistry but in real sense there is need to explore new innovations in terms of nanoparticals and composite materials. Major area that needs considerable attention is the quantitative analysis of fullerenes and issues in aqueous environments and sensor technology.
C1 Univ Educ, Dept Chem, Lahore, Pakistan.
RP Ahmed, S (reprint author), Univ Educ, Dept Chem, Multan Campus,Bosan Rd Multan, Lahore, Pakistan.
EM Shahbazuemultan@gmail.com
CR Adam E, 2008, NANO LETT, V8, P2351, DOI 10.1021/nl8011825
   Bijan B., 2012, J ENV PUBLIC HLTH, V10, P1115
   Carlos B., 2008, NEW YORK ACAD SCI, V1130, P224
   Carlw Markuskleber, 2009, ENVIRON SCI TECHNOL, V43, P6463
   Charles R., 1997, MATER CHEM, V7, P1075
   Chen M. X., 2011, ANALYST, V136, P4631
   Chen W, 2011, NANO LETT, V11, P3707, DOI 10.1021/nl201715q
   Chen Y, 2001, J PHYS CHEM SOLIDS, V62, P999, DOI 10.1016/S0022-3697(00)00242-0
   Constantopoulos T., 2010, ADV MATER, V22, P557
   Derfus AM, 2004, NANO LETT, V4, P11, DOI 10.1021/nl0347334
   Donaldson K, 2006, TOXICOL SCI, V92, P5, DOI 10.1093/toxsci/kfj130
   Duque G. J., 2009, ACS NANOTECHNOLOGY, V25, P2153
   Eva OR, 2004, ENV HLTH PERSPECT, V112, P1058
   Feuerstein M., 2006, J AM SOC MASS SPECTR, V17, P1203
   Gharbi N, 2005, NANO LETT, V5, P2578, DOI 10.1021/nl051866b
   Harald H., 2006, J MATER CHEM, V16, P45
   Herrero A. M., 2009, J AM CHEM SOC, V131, P9843
   Hiroyuki, 2011, ANAL SCI, V27, P893
   Hongjie A., 2012, ENVIRON TOXICOL CHEM, DOI [10.1002/etc.1752, DOI 10.1002/ETC.1752]
   Isobe H, 2006, MOL PHARMACEUT, V3, P124, DOI 10.1021/mp050068r
   Ji ZQ, 2006, J NANOPART RES, V8, P53, DOI 10.1007/s11051-005-9001-5
   Kotelnikova RA, 2003, J NANOPART RES, V5, P561, DOI 10.1023/B:NAN0.0000006070.61144.93
   Kurkina T., 2011, CELL MOL LIFE SCI, V69, P373
   Li QL, 2008, WATER RES, V42, P4591, DOI 10.1016/j.watres.2008.08.015
   Liu J, 2007, J CONTROL RELEASE, V117, P104, DOI 10.1016/j.jconrel.2006.10.008
   Marchesan S, 2005, BIOORG MED CHEM LETT, V15, P3615, DOI 10.1016/j.bmcl.2005.05.069
   Mashino T, 2005, BIOORG MED CHEM LETT, V15, P1107, DOI 10.1016/j.bmcl.2004.12.030
   Mroz P, 2007, FREE RADICAL BIO MED, V43, P711, DOI 10.1016/j.freeradbiomed.2007.05.005
   Rania B., 2007, INT J NANOMED, V2, P639
   References Clement S, 2005, J MATER CHEM, V15, P3559
   Rouse G. J., 2007, NANOTECHNOLOGY LETT, V7, P155
   Ryman-Rasmussen P. J., 2006, TOXICOL SCI, V91, P159
   Sadik OA, 2009, J ENVIRON MONITOR, V11, P1782, DOI 10.1039/b912860c
   Saeed Khalid, 2010, J CHEM SOC PAKISTAN, V32, P4
   Saito N, 2009, CHEM SOC REV, V38, P1897, DOI 10.1039/b804822n
   SCRIVENS WA, 1994, J AM CHEM SOC, V116, P4517, DOI 10.1021/ja00089a067
   Tatiana R. D., 2001, CROAT CHEM ACTA, V74, P743
   Tong ZH, 2007, ENVIRON SCI TECHNOL, V41, P2985, DOI 10.1021/es061953I
   Valiant M. R., 2007, J PROTEOME RES, V6, P44
   Wallace EJ, 2009, NANOTECHNOLOGY, V20, DOI 10.1088/0957-4484/20/4/045101
   Wang YQ, 2007, EXPERT REV PROTEOMIC, V4, P287, DOI 10.1586/14789450.4.2.287
   Wanida W, 2012, ANAL SCI, V28, P141
   Xia L, 2012, ANAL SCI, V28, P147
   Xiao L, 2006, BIOORG MED CHEM LETT, V16, P1590, DOI 10.1016/j.bmcl.2005.12.011
   Yadav BC, 2008, INT J NANOTECH APPL, V2, P15
   Youle RJ, 2005, NAT REV MOL CELL BIO, V6, P657, DOI 10.1038/nrm1697
   Yuan T. Z., 2011, NATURE COMMUNICATION, V10, P1431
NR 47
TC 1
Z9 1
U1 0
U2 11
PU CHEM SOC PAKISTAN
PI KARACHI
PA HEJ RES INST CHEM UNIV KARACHI, 75270 KARACHI, PAKISTAN
SN 0253-5106
J9 J CHEM SOC PAKISTAN
JI J. Chem. Soc. Pak.
PD AUG
PY 2012
VL 34
IS 4
BP 942
EP 945
PG 4
WC Chemistry, Multidisciplinary
SC Chemistry
GA 032KE
UT WOS:000310716400028
DA 2018-10-19
ER

PT J
AU Naveas, N
   Costa, VT
   Gallach, D
   Hernandez-Montelongo, J
   Palma, RJM
   Garcia-Ruiz, JP
   Manso-Silvan, M
AF Naveas, Nelson
   Torres Costa, Vicente
   Gallach, Dario
   Hernandez-Montelongo, Jacobo
   Martin Palma, Raul Jose
   Predenstinacion Garcia-Ruiz, Josefa
   Manso-Silvan, Miguel
TI Chemical stabilization of porous silicon for enhanced
   biofunctionalization with immunoglobulin
SO SCIENCE AND TECHNOLOGY OF ADVANCED MATERIALS
LA English
DT Article
DE biofunctionalization; porous silicon; nanostructured materials; material
   stability; protein adsorption; biomaterial
ID BIOSENSING APPLICATIONS; DRUG-DELIVERY; SURFACE; IMMUNOSENSOR;
   CHEMISTRY; DEVICES
AB Porous silicon (PSi) is widely used in biological experiments, owing to its biocompatibility and well-established fabrication methods that allow tailoring its surface. Nevertheless, there are some unresolved issues such as deciding whether the stabilization of PSi is necessary for its biological applications and evaluating the effects of PSi stabilization on the surface biofunctionalization with proteins. In this work we demonstrate that non-stabilized PSi is prone to detachment owing to the stress induced upon biomolecular adsorption. Biofunctionalized non-stabilized PSi loses the interference properties characteristic of a thin film, and groove-like structures resulting from a final layer collapse were observed by scanning electron microscopy. Likewise, direct PSi derivatization with 3-aminopropyl-triethoxysilane (APTS) does not stabilize PSi against immunoglobulin biofunctionalization. To overcome this problem, we developed a simple chemical process of stabilizing PSi (CoxPSi) for biological applications, which has several advantages over thermal stabilization (ToxPSi). The process consists of chemical oxidation in H2O2, surface derivatization with APTS and a curing step at 120 degrees C. This process offers integral homogeneous PSi morphology, hydrophilic surface termination (contact angle theta = 26 degrees) and highly efficient derivatized and biofunctionalized PSi surfaces (six times more efficient than ToxPSi). All these features are highly desirable for biological applications, such as biosensing, where our results can be used for the design and optimization of the biomolecular immobilization cascade on PSi surfaces.
C1 [Naveas, Nelson; Torres Costa, Vicente; Gallach, Dario; Hernandez-Montelongo, Jacobo; Martin Palma, Raul Jose; Manso-Silvan, Miguel] Univ Autonoma Madrid, Dept Appl Phys, E-28049 Madrid, Spain.
   [Predenstinacion Garcia-Ruiz, Josefa] Univ Autonoma Madrid, Dept Mol Biol, E-28049 Madrid, Spain.
RP Naveas, N (reprint author), Univ Autonoma Madrid, Dept Appl Phys, Ciudad Univ Cantoblanco, E-28049 Madrid, Spain.
EM nelson.naveas@estudiante.uam.es
RI Manso Silvan, Miguel/B-4947-2010; Gallach, Dario/D-7847-2011;
   Martin-Palma, Raul J/L-2720-2013
OI Manso Silvan, Miguel/0000-0002-5063-1607; Gallach,
   Dario/0000-0003-2154-6064; Martin-Palma, Raul J/0000-0003-3434-8331;
   Hernandez-Montelongo, Jacobo/0000-0002-1510-3470
FU Universidad Autonoma de Madrid
FX We thank Luis Garcia Pelayo for his invaluable assistance with materials
   processing and experimental protocols. This work was supported by a
   grant from the Universidad Autonoma de Madrid.
CR Alvarez SD, 2007, PHYS STATUS SOLIDI A, V204, P1439, DOI 10.1002/pssa.200674379
   Anderson SHC, 2003, PHYS STATUS SOLIDI A, V197, P331, DOI [10.1002/pssa.200306519, 10.1002/7pssa.200306519]
   Arroyo-Hernandez M, 2007, BIOSENS BIOELECTRON, V22, P2786, DOI 10.1016/j.bios.2006.10.039
   Hernandez MA, 2006, J NON-CRYST SOLIDS, V352, P2457, DOI 10.1016/j.jnoncrysol.2006.02.075
   Arroyo-Hernandez M, 2003, MAT SCI ENG C-BIO S, V23, P697, DOI 10.1016/j.msec.2003.09.159
   Bocking T, 2008, ADV FUNCT MATER, V18, P3827, DOI 10.1002/adfm.200800640
   Bonanno LM, 2007, BIOSENS BIOELECTRON, V23, P444, DOI 10.1016/j.bios.2007.05.008
   Bonanno LM, 2010, ANAL CHEM, V82, P9711, DOI 10.1021/ac101804s
   Buriak JM, 2006, PHILOS T ROY SOC A, V364, P217, DOI 10.1098/rsta.2005.1681
   Chen HJ, 1996, J APPL PHYS, V79, P3282, DOI 10.1063/1.361226
   Coffer JL, 2003, PHYS STATUS SOLIDI A, V197, P336, DOI 10.1002/pssa.200306520
   De Stefano L, 2006, J OPT A-PURE APPL OP, V8, pS540, DOI 10.1088/1464-4258/8/7/S37
   De Tommasi E, 2009, J PHYS CONDENS MATT, V21, P5
   De Tommasi E, 2008, SENSORS-BASEL, V8, P6549, DOI 10.3390/s8106549
   Guan B, 2011, LANGMUIR, V27, P328, DOI 10.1021/la102599m
   Hiraoui M, 2011, MATER CHEM PHYS, V128, P151, DOI 10.1016/j.matchemphys.2011.02.052
   Kleps I, 2009, J BIOMED NANOTECHNOL, V5, P300, DOI 10.1166/jbn.2009.1035
   Lopez-Garcia J, 2007, SENSOR ACTUAT B-CHEM, V126, P82, DOI 10.1016/j.snb.2006.10.050
   Martin-Palma RJ, 2004, J MATER RES, V19, P2415, DOI 10.1557/JMR.2004.0321
   Meskini O, 2007, TALANTA, V71, P1430, DOI 10.1016/j.talanta.2006.05.089
   Munoz-Noval A M-N A, 2011, J NANOPHOTONICS, V5, P10
   Ni M, 2009, INT J MOL SCI, V10, P5411, DOI 10.3390/ijms10125411
   Palestino G, 2008, LANGMUIR, V24, P13765, DOI 10.1021/la8015707
   Pap AE, 2005, APPL PHYS LETT, V86, DOI 10.1063/1.1853519
   Perelman LA, 2007, PHYS STATUS SOLIDI A, V204, P1394, DOI 10.1002/pssa.200674360
   Rong G, 2008, BIOSENS BIOELECTRON, V23, P1572, DOI 10.1016/j.bios.2008.01.017
   Salonen J, 2008, J PHARM SCI-US, V97, P632, DOI 10.1002/jps.20999
   SMITH RL, 1992, J APPL PHYS, V71, pR1, DOI 10.1063/1.350839
   Steinem C, 2004, TETRAHEDRON, V60, P11259, DOI 10.1016/j.tet.2004.06.130
   Taylor AE, 2003, J PHYSIOL-LONDON, V553, P333, DOI 10.1113/jphysiol.2003.053595
   Torres-Costa V, 2005, OPT MATER, V27, P1084, DOI 10.1016/j.optmat.2004.08.068
   Vinoba M, 2012, COLLOID SURFACE B, V90, P91, DOI 10.1016/j.colsurfb.2011.10.001
NR 32
TC 11
Z9 11
U1 3
U2 31
PU IOP PUBLISHING LTD
PI BRISTOL
PA TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND
SN 1468-6996
EI 1878-5514
J9 SCI TECHNOL ADV MAT
JI Sci. Technol. Adv. Mater.
PD AUG
PY 2012
VL 13
IS 4
AR 045009
DI 10.1088/1468-6996/13/4/045009
PG 7
WC Materials Science, Multidisciplinary
SC Materials Science
GA 029VX
UT WOS:000310526100011
PM 27877509
OA DOAJ Gold, Green Published
DA 2018-10-19
ER

PT J
AU Monaco, C
AF Monaco, Carlo
TI A Clinical Case Report on Indirect, Posterior Three-unit Resin-bonded
   FRC FPD
SO JOURNAL OF ADHESIVE DENTISTRY
LA English
DT Article
DE fiber reinforced composite; inlay-fixed partial dentures; adhesive
   system; resin composite
ID FIXED PARTIAL DENTURES; IN-VITRO EVALUATION; ZIRCONIA; SURVIVAL;
   BIOMATERIAL; STRENGTH; SURFACE; CROWNS
AB Purpose: This paper describes a clinical, conservative approach and the details of cavity preparation for the replacement of a maxillary first premolar using a minimally invasive preparation combined with the adhesive approach.
   Material and Methods: A patient with a missing first premolar was treated with a 3-unit indirect fiber-reinforced composite (FRC) fixed dental prosthesis (FDP). The preparation on the canine was a slot combined with modified wing to increase the amount of fiber in the restoration. Glass fiber (Vectris; Ivoclar Vivadent) was used in an anatomical shape for the framework and incrementally veneered with resin composite (Adoro; Ivoclar Vivadent). The cavities were prepared by etching enamel and dentin with orthophosphoric acid, priming the dentin, and applying a three-step adhesive system and dual-cured luting resin (Variolink II, Ivoclar Vivadent). Finally, the indirect FRC FDP was finished and polished with 15-mu m diamond burs (Composhape, Intensiv) and a polishing kit.
   Results: The patient was satisfied with the esthetics and function of the restoration, which has served without repair for 5 years. At the 5-year clinical follow-up, the restoration was found to be clinically successful.
   Conclusion: The correct cavity-preparation technique in combination with the FRC system could enhance the long-term survival of an inlay FDP.
C1 Univ Bologna, Div Prosthodont & Maxillofacial Rehabil, Dept Oral Sci, I-40125 Bologna, Italy.
RP Monaco, C (reprint author), Univ Bologna, Div Prosthodont & Maxillofacial Rehabil, Dept Oral Sci, Via S Vitale 59, I-40125 Bologna, Italy.
EM carlo.monaco2@unibo.it
CR Aboushelib MN, 2007, J PROSTHET DENT, V97, P379
   Behr M, 2003, INT J PROSTHODONT, V16, P239
   Blatz MB, 2004, J PROSTHET DENT, V91, P356, DOI 10.1016/j.prosdent.2004.02.001
   Chevalier J, 2006, BIOMATERIALS, V27, P535, DOI 10.1016/j.biomaterials.2005.07.034
   Creugers NHJ, 2000, J ORAL REHABIL, V27, P602, DOI 10.1046/j.1365-2842.2000.00553.x
   Denry I, 2008, DENT MATER, V24, P299, DOI 10.1016/j.dental.2007.05.007
   Deville S, 2006, BIOMATERIALS, V27, P2186, DOI 10.1016/j.biomaterials.2005.11.021
   Hickel R, 2007, J ADHES DENT, V9, P121
   Hussey DL, 1996, J DENT, V24, P251, DOI 10.1016/0300-5712(95)00073-9
   Kelly JR, 2008, DENT MATER, V24, P289, DOI 10.1016/j.dental.2007.05.005
   Kitayama S, 2010, DENT MATER, V26, P426, DOI 10.1016/j.dental.2009.11.159
   Loose M, 1998, Eur J Prosthodont Restor Dent, V6, P55
   Monaco C, 2003, INT J PROSTHODONT, V16, P319
   Monaco C, 2006, INT J PROSTHODONT, V19, P577
   Ohlmann B, 2008, J DENT, V36, P692, DOI 10.1016/j.jdent.2008.04.017
   Ozcan M, 2005, J PROSTHET DENT, V93, P337, DOI 10.1016/j.prosdent.2005.01.006
   Paszyna C, 1990, Dtsch Zahnarztl Z, V45, P406
   Perdigao J, 1999, Compend Contin Educ Dent, V20, P1151
   Phark JH, 2009, J PROSTHET DENT, V101, P29, DOI 10.1016/S0022-3913(08)60286-3
   Piconi C, 1999, BIOMATERIALS, V20, P1, DOI 10.1016/S0142-9612(98)00010-6
   Sorensen J A, 1999, Pract Periodontics Aesthet Dent, V11, P95
   Tan K, 2004, CLIN ORAL IMPLAN RES, V15, P654, DOI 10.1111/j.1600-0501.2004.01119.x
   Vallittu PK, 1999, J PROSTHET DENT, V82, P132, DOI 10.1016/S0022-3913(99)70145-9
   VALLITTU PK, 1999, J PROSTHET DENT, V25, P100
   van Heumen CCM, 2010, DENT MATER, V26, P954, DOI 10.1016/j.dental.2010.05.010
   Wolfart S, 2007, DENT MATER, V23, P1513, DOI 10.1016/j.dental.2006.12.006
NR 26
TC 1
Z9 1
U1 0
U2 9
PU QUINTESSENCE PUBLISHING CO INC
PI HANOVER PARK
PA 4350 CHANDLER DRIVE, HANOVER PARK, IL 60133 USA
SN 1461-5185
J9 J ADHES DENT
JI J. Adhes. Dent.
PD AUG
PY 2012
VL 14
IS 5
BP 479
EP 483
DI 10.3290/j.jad.a25686
PG 5
WC Dentistry, Oral Surgery & Medicine
SC Dentistry, Oral Surgery & Medicine
GA 022IH
UT WOS:000309951000008
PM 22724106
DA 2018-10-19
ER

PT J
AU Wang, Z
   Tang, ZR
   Qing, FZ
   Hong, YL
   Zhang, XD
AF Wang, Zhe
   Tang, Zhurong
   Qing, Fangzhu
   Hong, Youliang
   Zhang, Xingdong
TI APPLICATIONS OF CALCIUM PHOSPHATE NANOPARTICLES IN POROUS HARD TISSUE
   ENGINEERING SCAFFOLDS
SO NANO
LA English
DT Review
DE Calcium phosphate nanoparticles; tissue engineering; bone scaffold;
   porous structure; biomimetic
ID BETA-TRICALCIUM PHOSPHATE; NANO-HYDROXYAPATITE/CHITOSAN/CARBOXYMETHYL
   CELLULOSE; HYDROXYAPATITE/TITANIA COMPOSITE COATINGS; SOL-GEL TECHNIQUE;
   HYDROTHERMAL SYNTHESIS; CRYSTAL-GROWTH; IN-VITRO; NANOCRYSTALLINE
   HYDROXYAPATITE; NANOSTRUCTURED HYDROXYAPATITE; MECHANOCHEMICAL SYNTHESIS
AB To repair bone defects, an important approach is to fabricate tissue engineering scaffolds as substitutions to replace auto-/allologous bones. Currently, processing a biomaterial into three-dimensional porous scaffolds and incorporating the calcium phosphate (Ca-P) nanoparticles into scaffolds profile two main characteristics of bone tissue engineering scaffolds. Based on this fact, in this paper we describe the design principles of the Ca-P nanoparticle-based and porous bone tissue engineering scaffolds. Then we summarize a variety of the Ca-P nanoparticle-based scaffolds, including discussion of the integration of the Ca-P nanoparticles with ceramics and polymers, followed by introduction of safety of the Ca-P nanoparticles in scaffolds.
C1 [Wang, Zhe; Tang, Zhurong; Qing, Fangzhu; Hong, Youliang; Zhang, Xingdong] Sichuan Univ, Natl Engn Res Ctr Biomat, Chengdu 610064, Peoples R China.
RP Wang, Z (reprint author), Sichuan Univ, Natl Engn Res Ctr Biomat, Chengdu 610064, Peoples R China.
EM hyl@scu.edu.cn
FU National High-tech RD Program [2011AA030105]; National Natural Science
   Foundation of China [31170928]; National Basic Research Program, and
   Youth Scholar Fund [20090181120078]
FX This work is supported by the National High-tech R&D Program
   (2011AA030105), National Natural Science Foundation of China (Grant
   31170928), National Basic Research Program, and Youth Scholar Fund
   (20090181120078).
CR Ajayan P. M., 2003, NANOCOMPOSITE SCI TE
   Aoki H, 2000, J Mater Sci Mater Med, V11, P67, DOI 10.1023/A:1008993814033
   ARITA IH, 1995, BIOMATERIALS, V16, P403, DOI 10.1016/0142-9612(95)98858-B
   Bakhtiari L, 2010, J NANO RES-SW, V11, P67, DOI 10.4028/www.scientific.net/JNanoR.11.67
   Ban S, 2002, BIOMATERIALS, V23, P2965, DOI 10.1016/S0142-9612(02)00025-X
   BERGSMA JE, 1995, BIOMATERIALS, V16, P25, DOI 10.1016/0142-9612(95)91092-D
   Bertazzo S, 2010, COLLOID SURFACE B, V78, P177, DOI 10.1016/j.colsurfb.2010.02.027
   Bigi A, 2004, J SOLID STATE CHEM, V177, P3092, DOI 10.1016/j.jssc.2004.05.018
   Bilibin A., 2006, RUSS CHEM REV, V75, P133
   Bose S, 2003, CHEM MATER, V15, P4464, DOI 10.1021/cm0303437
   Cai S, 2005, CERAM INT, V31, P135, DOI 10.1016/j.ceramint.2004.04.012
   CALVERT P, 1988, J MATER SCI, V23, P3801, DOI 10.1007/BF01106796
   Cao LY, 2005, CERAM INT, V31, P1041, DOI 10.1016/j.ceramint.2004.11.002
   Chang MC, 2001, J MATER SCI LETT, V20, P1199, DOI 10.1023/A:1010914621089
   Chaudhry AA, 2006, CHEM COMMUN, P2286, DOI 10.1039/b518102j
   Chen JD, 2009, MATER SCI FORUM, V610-613, P1252, DOI 10.4028/www.scientific.net/MSF.610-613.1252
   Choi D, 2006, J AM CERAM SOC, V89, P444, DOI 10.1111/j.1551-2916.2005.00738.x
   Colfen H, 2003, ANGEW CHEM INT EDIT, V42, P2350, DOI 10.1002/anie.200200562
   Coreno AJ, 2005, OPT MATER, V27, P1281, DOI 10.1016/j.optmat.2004.11.025
   Cui FZ, 2007, MAT SCI ENG R, V57, P1, DOI 10.1016/j.mser.2007.04.001
   Cunniffe GM, 2010, J MATER SCI-MATER M, V21, P2293, DOI 10.1007/s10856-009-3964-1
   DACULSI G, 1988, J SUBMICR CYTOL PATH, V20, P379
   Descamps M, 2008, CERAM INT, V34, P1131, DOI 10.1016/j.ceramint.2007.01.004
   Descamps M, 2008, J EUR CERAM SOC, V28, P149, DOI 10.1016/j.jeurceramsoc.2007.05.025
   Destainville A, 2003, MATER CHEM PHYS, V80, P269, DOI 10.1016/S0254-0584(02)00466-2
   Deville S, 2006, BIOMATERIALS, V27, P5480, DOI 10.1016/j.biomaterials.2006.06.028
   Dorozhkin SV, 2009, MATERIALS, V2, P1975, DOI 10.3390/ma2041975
   Dorozhkin SV, 2010, ACTA BIOMATER, V6, P715, DOI 10.1016/j.actbio.2009.10.031
   Du C, 2000, J BIOMED MATER RES, V50, P518, DOI 10.1002/(SICI)1097-4636(20000615)50:4<518::AID-JBM7>3.0.CO;2-W
   Ducheyne P, 1999, BIOMATERIALS, V20, P2287, DOI 10.1016/S0142-9612(99)00181-7
   Emadi R, 2010, MATER LETT, V64, P993, DOI 10.1016/j.matlet.2010.01.085
   Engin NO, 1999, J EUR CERAM SOC, V19, P2569
   Erisken C, 2008, BIOMATERIALS, V29, P4065, DOI 10.1016/j.biomaterials.2008.06.022
   FLINT EB, 1991, SCIENCE, V253, P1397, DOI 10.1126/science.253.5026.1397
   Fu Q, 2008, J BIOMED MATER RES B, V86B, P125, DOI 10.1002/jbm.b.30997
   Gautier S, 1997, J EUR CERAM SOC, V17, P1361, DOI 10.1016/S0955-2219(97)89403-4
   Gonzalez-McQuire R, 2004, J MATER CHEM, V14, P2277, DOI 10.1039/b400317a
   Greenwald AS, 2001, J BONE JOINT SURG AM, V83A, P98, DOI 10.2106/00004623-200100022-00007
   Guan DH, 2008, APPL SURF SCI, V255, P324, DOI 10.1016/j.apsusc.2008.06.093
   Guan LM, 2004, J BIOMED MATER RES A, V71A, P480, DOI 10.1002/jbm.a.30173
   Guo XY, 2005, J AM CERAM SOC, V88, P1026, DOI 10.1111/j.1551-2916.2005.00198.x
   Han JK, 2006, MATER CHEM PHYS, V99, P235, DOI 10.1016/j.matchemphys.2005.10.017
   Hartgerink JD, 2001, SCIENCE, V294, P1684, DOI 10.1126/science.1063187
   He QJ, 2007, MATER LETT, V61, P141, DOI 10.1016/j.matlet.2006.04.082
   Heimann RB, 1997, EUR J MINERAL, V9, P597
   HENCH LL, 1991, J AM CERAM SOC, V74, P1487, DOI 10.1111/j.1151-2916.1991.tb07132.x
   Hench LL, 1998, J AM CERAM SOC, V81, P1705
   HENCH LL, 1993, INTRO BIOCERAMICS
   Hertz A, 2007, NANOMEDICINE-UK, V2, P899, DOI 10.2217/17435889.2.6.899
   Hollister SJ, 2005, NAT MATER, V4, P518, DOI 10.1038/nmat1421
   Hong YL, 2006, J MEMBRANE SCI, V276, P1, DOI 10.1016/j.memsci.2005.09.024
   Hong YL, 2010, MAT SCI ENG R, V70, P225, DOI 10.1016/j.mser.2010.06.010
   Hong YL, 2009, J PHYS CHEM B, V113, P5837, DOI 10.1021/jp9005444
   Jiang LY, 2008, J INORG MATER, V23, P135, DOI 10.3724/SP.J.1077.2008.00135
   Jiang LY, 2008, CARBOHYD POLYM, V74, P680, DOI 10.1016/j.carbpol.2008.04.035
   Jiang LY, 2009, J BIOMED SCI, V16, DOI 10.1186/1423-0127-16-65
   Jokanovic V, 2006, J MATER SCI-MATER M, V17, P539, DOI 10.1007/s10856-006-8937-z
   Karageorgiou V, 2005, BIOMATERIALS, V26, P5474, DOI 10.1016/j.biomaterials.2005.02.002
   Kim HM, 2010, J BIOMED MATER RES B, V94B, P380, DOI 10.1002/jbm.b.31664
   Kim HW, 2004, J BIOMED MATER RES B, V70B, P270, DOI 10.1002/jbm.b.30032
   Kim HW, 2004, J BIOMED MATER RES A, V68A, P522, DOI 10.1002/jbm.a..20094
   Kim IS, 2004, MAT SCI ENG B-SOLID, V111, P232, DOI 10.1016/j.mseb.2004.04.011
   Kim M, 2011, J EUR CERAM SOC, V31, P1541, DOI 10.1016/j.jeurceramsoc.2011.03.019
   Kim SS, 2006, BIOMATERIALS, V27, P1399, DOI 10.1016/j.biomaterials.2005.08.016
   Kim W, 2001, ULTRASON SONOCHEM, V8, P85, DOI 10.1016/S1350-4177(00)00034-1
   Kokubo T, 2008, WOODHEAD PUBL MATER, P1
   Kong LJ, 2006, EUR POLYM J, V42, P3171, DOI 10.1016/j.eurpolymj.2006.08.009
   Kothapalli CR, 2005, ACTA BIOMATER, V1, P653, DOI 10.1016/j.actbio.2005.06.005
   Kumar R, 2004, LANGMUIR, V20, P5196, DOI 10.1021/la049304f
   Kumta PN, 2005, ACTA BIOMATER, V1, P65, DOI 10.1016/j.actbio.2004.09.008
   Kuriakose TA, 2004, J CRYST GROWTH, V263, P517, DOI 10.1016/j.jcrysgro.2003.11.057
   LANGER R, 1993, SCIENCE, V260, P920, DOI 10.1126/science.8493529
   Launey ME, 2010, ANNU REV MATER RES, V40, P25, DOI 10.1146/annurev-matsci-070909-10442
   Laurencin CT, 2001, BIOMATERIALS, V22, P1271, DOI 10.1016/S0142-9612(00)00279-9
   LAURIE SWS, 1984, PLAST RECONSTR SURG, V73, P933, DOI 10.1097/00006534-198406000-00014
   Lee SI, 2000, J MATER SCI, V35, P1187, DOI 10.1023/A:1004732302802
   LeGeros RZ, 2002, CLIN ORTHOP RELAT R, P81
   Lemos AF, 2006, J EUR CERAM SOC, V26, P3639, DOI 10.1016/j.jeurceramsoc.2005.12.011
   Leong KF, 2003, BIOMATERIALS, V24, P2363, DOI 10.1016/S0142-9612(03)00030-9
   Li B., 2008, NANOCALCIUM PHOSPHAT
   Li B, 2008, APPL SURF SCI, V255, P357, DOI 10.1016/j.apsusc.2008.06.114
   Li B, 2009, ACTA BIOMATER, V5, P134, DOI 10.1016/j.actbio.2008.07.035
   Li H, 2003, BIOMATERIALS, V24, P949, DOI 10.1016/S0142-9612(02)00431-3
   LI J, 1995, BIOMATERIALS, V16, P417, DOI 10.1016/0142-9612(95)98860-G
   Lim GK, 1999, J MATER CHEM, V9, P1635, DOI 10.1039/a809644i
   Lin KL, 2007, MATER LETT, V61, P1683, DOI 10.1016/j.matlet.2006.07.099
   Liu C, 2007, APPL SURF SCI, V253, P6840, DOI 10.1016/j.apsusc.2007.01.119
   Liu CZ, 2009, ACTA BIOMATER, V5, P661, DOI 10.1016/j.actbio.2008.09.022
   Liu DM, 2002, BIOMATERIALS, V23, P1679, DOI 10.1016/S0142-9612(01)00295-2
   Liu JB, 2004, CHEM PHYS LETT, V396, P429, DOI 10.1016/j.cplett.2004.08.094
   Liu L, 2008, J BIOMAT SCI-POLYM E, V19, P325, DOI 10.1163/156856208783721010
   Lloyd-Jones D, 2009, CIRCULATION, V119, P480, DOI 10.1161/CIRCULATIONAHA.108.191259
   Lopez-Macipe A, 1998, J COLLOID INTERF SCI, V200, P114, DOI 10.1006/jcis.1997.5343
   Lu LC, 1996, MRS BULL, V21, P28
   Martin C, 1996, BIOMATERIALS, V17, P2373, DOI 10.1016/S0142-9612(96)00075-0
   Matsumoto T, 2006, DENT MATER J, V25, P360, DOI 10.4012/dmj.25.360
   MIKOS AG, 1993, BIOMATERIALS, V14, P323, DOI 10.1016/0142-9612(93)90049-8
   Milella E, 2001, BIOMATERIALS, V22, P1425, DOI 10.1016/S0142-9612(00)00300-8
   Moroni A, 2005, EXPERT REV MED DEVIC, V2, P465, DOI 10.1586/17434440.2.4.465
   Murugan R, 2006, MATER LETT, V60, P2844, DOI 10.1016/j.matlet.2006.01.104
   MUZZARELLI R, 1988, BIOMATERIALS, V9, P247, DOI 10.1016/0142-9612(88)90092-0
   Nakamura S, 2001, J NANOPART RES, V3, P57, DOI 10.1023/A:1011407814795
   Nath S, 2009, MAT SCI ENG C-BIO S, V29, P97, DOI 10.1016/j.msec.2008.05.019
   Ngiam M, 2009, BONE, V45, P4, DOI 10.1016/j.bone.2009.03.674
   Olszta MJ, 2007, MAT SCI ENG R, V58, P77, DOI 10.1016/j.mser.2007.05.001
   Ooms EM, 2002, J BIOMED MATER RES, V61, P9, DOI 10.1002/jbm.10029
   Pannone P. J., 2007, TRENDS BIOMATERIALS
   Park JB, 1992, BIOMATERIALS INTRO
   Peng HX, 2000, J EUR CERAM SOC, V20, P807, DOI 10.1016/S0955-2219(99)00229-0
   Peter M, 2010, CARBOHYD POLYM, V80, P687, DOI 10.1016/j.carbpol.2009.11.050
   Petit R, 1999, EUR J ORTHOP SURG TR, V9, P71, DOI DOI 10.1007/BF01695730
   Piconi C, 1999, BIOMATERIALS, V20, P1, DOI 10.1016/S0142-9612(98)00010-6
   Pushpakanth S, 2008, MATER CHEM PHYS, V107, P492, DOI 10.1016/j.matchemphys.2007.08.029
   Rao RR, 2002, MAT SCI ENG C-BIO S, V20, P187
   Roether JA, 2002, BIOMATERIALS, V23, P3871, DOI 10.1016/S0142-9612(02)00131-X
   Rusu VM, 2005, BIOMATERIALS, V26, P5414, DOI 10.1016/j.biomaterials.2005.01.051
   Saki M, 2009, YAKHTEH, V11, P55
   Sarikaya M, 1999, P NATL ACAD SCI USA, V96, P14183, DOI 10.1073/pnas.96.25.14183
   Sato K, 2006, J MATER SCI, V41, P5424, DOI 10.1007/s10853-006-0258-6
   Seeman NC, 2002, P NATL ACAD SCI USA, V99, P6451, DOI 10.1073/pnas.221458298
   SEGHI RR, 1995, J PROSTHET DENT, V74, P145, DOI 10.1016/S0022-3913(05)80177-5
   Shastri VP, 2009, ADV MATER, V21, P3246, DOI [10.1002/adma.200900608, 10.1002/adma.200990155]
   Siddharthan A., 2005, TRENDS BIOMATER ARTI, V18, P110
   Sofie SW, 2001, J AM CERAM SOC, V84, P1459
   Springer ING, 2001, BIOMATERIALS, V22, P2569, DOI 10.1016/S0142-9612(01)00148-X
   Sultana N, 2008, J EXP NANOSCI, V3, P121, DOI 10.1080/17458080701867429
   Sun LM, 2001, J BIOMED MATER RES, V58, P570, DOI 10.1002/jbm.1056.abs
   Sun YX, 2006, J PHYS CHEM SOLIDS, V68, P373, DOI 10.1016/j.jpcs.2006.11.026
   SUSLICK KS, 1990, SCIENCE, V247, P1439, DOI 10.1126/science.247.4949.1439
   Takemoto M, 2006, J BIOMED MATER RES A, V78A, P693, DOI 10.1002/jbm.a.30748
   [汤京龙 TANG Jinglong], 2009, [辐射研究与辐射工艺学报, Journal of Radiation Research and Radiation Processing], V27, P95
   Thein-Han WW, 2009, ACTA BIOMATER, V5, P1182, DOI 10.1016/j.actbio.2008.11.025
   Tian JT, 2001, J MATER SCI, V36, P3061, DOI 10.1023/A:1017935411108
   Venkatesan J, 2010, MAR DRUGS, V8, P2252, DOI 10.3390/md8082252
   Wang AL, 2007, MATER LETT, V61, P2084, DOI 10.1016/j.matlet.2006.08.019
   Wang F, 2005, MATER LETT, V59, P916, DOI 10.1016/j.matlet.2004.08.041
   WANG RZ, 1995, J MATER SCI LETT, V14, P490, DOI 10.1007/BF00665911
   Webster TJ, 2007, TISSUE ENG
   Wei J, 2003, J MATER SCI, V38, P3303, DOI 10.1023/A:1025194122977
   Weiner S, 1998, ANNU REV MATER SCI, V28, P271, DOI 10.1146/annurev.matsci.28.1.271
   Weng J, 1997, BIOMATERIALS, V18, P1027, DOI 10.1016/S0142-9612(97)00022-7
   Wu YJ, 2005, LANGMUIR, V21, P3232, DOI 10.1021/la046754z
   Xiao XF, 2006, SURF COAT TECH, V200, P4406, DOI 10.1016/j.surfcoat.2005.02.205
   Xiao YM, 2007, MATER LETT, V61, P59, DOI 10.1016/j.matlet.2006.04.005
   Xu AW, 2007, J MATER CHEM, V17, P415, DOI 10.1039/b611918m
   Yang XH, 1998, J MATER CHEM, V8, P2233, DOI 10.1039/a802067a
   Yang Z, 2005, J MATER SCI, V40, P1121, DOI 10.1007/s10853-005-6927-z
   Yeong KCB, 2001, BIOMATERIALS, V22, P2705, DOI 10.1016/S0142-9612(00)00257-X
   Yuan HP, 2000, BIOMATERIALS, V21, P1283, DOI 10.1016/S0142-9612(00)00016-8
   Zhai Y, 2005, CURR APPL PHYS, V5, P429, DOI 10.1016/j.cap.2005.01.004
   Zhang HF, 2012, CRYST GROWTH DES, V12, P2204, DOI 10.1021/cg200917y
   Zhang JC, 2010, INT J ORAL MAX SURG, V39, P469, DOI 10.1016/j.ijom.2010.01.013
   Zhang K, 2004, BIOMATERIALS, V25, P2489, DOI 10.1016/j.biomaterials.2003.09.033
   Zhang LJ, 2009, NANO TODAY, V4, P66, DOI 10.1016/j.nantod.2008.10.014
   Zhang SH, 2007, MATER LETT, V61, P1341, DOI 10.1016/j.matlet.2006.07.027
   Zhang SM, 2003, J MATER SCI-MATER M, V14, P641, DOI 10.1023/A:1024083309982
   Zhang XH, 2009, CERAM INT, V35, P1969, DOI 10.1016/j.ceramint.2008.10.027
   Zhao Y, 2009, J BIOMED MATER RES A, V91A, P1140, DOI 10.1002/jbm.a.32272
   Zhou H, 2011, ACTA BIOMATER, V7, P2769, DOI 10.1016/j.actbio.2011.03.019
   Zhou ZH, 2007, MATER RES BULL, V42, P1611, DOI 10.1016/j.materresbull.2006.11.041
   Zuo Y, 2007, MAT SCI ENG A-STRUCT, V452, P512, DOI 10.1016/j.msea.2006.11.138
NR 161
TC 11
Z9 11
U1 4
U2 109
PU WORLD SCIENTIFIC PUBL CO PTE LTD
PI SINGAPORE
PA 5 TOH TUCK LINK, SINGAPORE 596224, SINGAPORE
SN 1793-2920
EI 1793-7094
J9 NANO
JI Nano
PD AUG
PY 2012
VL 7
IS 4
AR 1230004
DI 10.1142/S1793292012300046
PG 18
WC Nanoscience & Nanotechnology; Materials Science, Multidisciplinary;
   Physics, Applied
SC Science & Technology - Other Topics; Materials Science; Physics
GA 016TM
UT WOS:000309542400001
OA Bronze
DA 2018-10-19
ER

PT J
AU Perelman-Karmon, M
   Kozlovsky, A
   Lilov, R
   Artzi, Z
AF Perelman-Karmon, Mally
   Kozlovsky, Avital
   Lilov, Roman
   Artzi, Zvi
TI Socket Site Preservation Using Bovine Bone Mineral With and Without a
   Bioresorbable Collagen Membrane
SO INTERNATIONAL JOURNAL OF PERIODONTICS & RESTORATIVE DENTISTRY
LA English
DT Article
ID HUMAN EXTRACTION SOCKETS; TOOTH EXTRACTION; HISTOLOGICAL OBSERVATIONS;
   QUANTITATIVE EXPRESSION; RIDGE PRESERVATION; ALVEOLAR RIDGE; PART 1;
   DEFECTS; DOG; REGENERATION
AB The purpose of this study was to compare extraction sites augmented with bovine bone mineral (BBM) with and without resorbable membrane coverage. BBM particles were grafted in fresh human extraction sockets of 23 patients; in 12 of these patients, a guided tissue regeneration (GTR) membrane was applied. After 9 months of histomorphometric evaluation, cylindric hard tissue specimens were obtained. Percent bone area fractions (BAFs) of the crestal, middle, and apical sections from each specimen were calculated using the point-counting technique. Changes in values were compared. In sites augmented with BBM, the mean BAF ranged from 22.8% (coronal) to 36.3% (apical) compared to sites augmented with BBM and collagen membrane (35.2% [coronal] to 47% [apical)). Comparison between the different depths and the two groups showed a distinct increase in BAF from coronal to apical regions (P < .001). This pattern was observed in both groups (P < .001) and was significantly higher in the group augmented with BBM and collagen membrane (P < .05). In the immediate postextraction phase, BBM as a grafted biomaterial preserved the socket volume and enabled newly formed bone for future implant site preparation. The amount of the osseous fraction increased with GTR membrane. (Int J Periodontics Restorative Dent 2012;32:459-465.)
C1 [Perelman-Karmon, Mally] SUNY Buffalo, Sch Dent Med, Dept Oral Sci, Buffalo, NY 14260 USA.
   [Kozlovsky, Avital; Artzi, Zvi] Tel Aviv Univ, Maurice & Gabriela Goldschleger Sch Dent Med, Dept Periodontol, IL-61390 Tel Aviv, Israel.
RP Artzi, Z (reprint author), Tel Aviv Univ, Sch Dent Med, IL-61390 Tel Aviv, Israel.
EM zviartzi@tau.ac.il
CR AMLER M H, 1960, J Am Dent Assoc, V61, P32
   Araujo MG, 2009, CLIN ORAL IMPLAN RES, V20, P433, DOI 10.1111/j.1600-0501.2009.01705.x
   Araujo MG, 2005, J CLIN PERIODONTOL, V32, P212, DOI 10.1111/j.1600-051X.2005.00642.x
   Artzi Z, 2005, J CLIN PERIODONTOL, V32, P193, DOI 10.1111/j.1600-051X.2005.00656.x
   Artzi Z, 2003, J PERIODONTOL, V74, P1143, DOI 10.1902/jop.2003.74.8.1143
   Artzi Z, 2003, J PERIODONTOL, V74, P1153, DOI 10.1902/jop.2003.74.8.1153
   Artzi Z, 2003, INT J PERIODONT REST, V23, P381
   Artzi Z, 1998, J PERIODONTOL, V69, P1062, DOI 10.1902/jop.1998.69.9.1062
   Artzi Z, 2001, INT J PERIODONT REST, V21, P395
   Artzi Z, 2000, J PERIODONTOL, V71, P1015, DOI 10.1902/jop.2000.71.6.1015
   Artzi Z, 2001, J PERIODONTOL, V72, P152, DOI 10.1902/jop.2001.72.2.152
   BELLHOUSE DR, 1981, BIOMETRICS, V37, P303, DOI 10.2307/2530419
   Berglundh T, 1997, CLIN ORAL IMPLAN RES, V8, P117, DOI 10.1034/j.1600-0501.1997.080206.x
   Camelo M, 1998, INT J PERIODONT REST, V18, P321
   Cardaropoli G, 2005, J CLIN PERIODONTOL, V32, P435, DOI 10.1111/j.1600-051X.2005.00692.x
   Cardaropoli G, 2003, J CLIN PERIODONTOL, V30, P809, DOI 10.1034/j.1600-051X.2003.00366.x
   CARLSSON GE, 1967, ACTA ODONTOL SCAND, V25, P45, DOI 10.3109/00016356709072522
   Chalkley HW, 1943, J NATL CANCER I, V4, P47
   DAHLIN C, 1988, PLAST RECONSTR SURG, V81, P672, DOI 10.1097/00006534-198805000-00004
   Dies F, 1996, CLIN ORAL IMPLAN RES, V7, P277, DOI 10.1034/j.1600-0501.1996.070310.x
   Hammerle CHF, 2008, CLIN ORAL IMPLAN RES, V19, P19, DOI 10.1111/j.1600-0501.2007.01407.x
   HANEY JM, 1993, J PERIODONTOL, V64, P883, DOI 10.1902/jop.1993.64.9.883
   Hockers T, 1999, CLIN ORAL IMPLAN RES, V10, P487, DOI 10.1034/j.1600-0501.1999.100607.x
   Kim M, 2008, IN VIVO, V22, P231
   Lee DW, 2009, INT J ORAL MAX IMPL, V24, P609
   Meijndert L, 2005, INT J ORAL MAX SURG, V34, P877, DOI 10.1016/j.ijom.2005.04.017
   Nevins M, 2006, INT J PERIODONT REST, V26, P19
   PIETROKOVSKI J, 1967, J PROSTHET DENT, V17, P21, DOI 10.1016/0022-3913(67)90046-7
   Schropp L, 2003, INT J PERIODONT REST, V23, P313
   Skoglund A, 1997, INT J ORAL MAX IMPL, V12, P194
NR 30
TC 19
Z9 25
U1 0
U2 15
PU QUINTESSENCE PUBLISHING CO INC
PI HANOVER PARK
PA 4350 CHANDLER DRIVE, HANOVER PARK, IL 60133 USA
SN 0198-7569
J9 INT J PERIODONT REST
JI Int. J. Periodontics Restor. Dent.
PD AUG
PY 2012
VL 32
IS 4
BP 459
EP 466
PG 8
WC Dentistry, Oral Surgery & Medicine
SC Dentistry, Oral Surgery & Medicine
GA 009NE
UT WOS:000309031700011
PM 22577652
DA 2018-10-19
ER

PT J
AU Lopez, MSP
   Lopez-Cabarcos, E
   Lopez-Ruiz, B
AF Sanchez-Paniagua Lopez, M.
   Lopez-Cabarcos, E.
   Lopez-Ruiz, B.
TI Influence of the host matrix of the enzyme in the performance of
   amperometric biosensors
SO SENSORS AND ACTUATORS B-CHEMICAL
LA English
DT Article
DE Tyrosinase biosensor; Polymeric microparticles; Laponite; Brushite
ID PHENOLIC-COMPOUNDS; POLYACRYLAMIDE MICROGELS; GLUCOSE-OXIDASE;
   TYROSINASE; FLAVONOIDS; ELECTRODES; FOODS
AB In this work we present a comparative study of four amperometric biosensors of phenol prepared by means of immobilization of tyrosinase in organic and inorganic matrices. The immobilization within organic matrices consisted on enzyme entrapped in both polyacrylamide microgels, and polyvinylimidazole microparticles. On the other hand, two inorganic matrices were investigated: a laponite clay and the calcium phosphate cement, brushite. The enzyme was absorbed on these inorganic matrices and subsequently was cross-linked by glutaraldehyde. The detection of phenolic compounds was performed in aqueous and organic media by direct electrochemical reduction of the enzymatic product, o-quinone, at -0.1 V versus SCE. The large differences found in biosensors performance are attributed to the environment surrounding the enzyme, or the biomaterial layers used in the fabrication of the biosensor. Sensors based on inorganic matrices provided the best results in detection of monophenols and catechol in aqueous solution, being the biosensor of brushite the most sensitive device (S = 46 AM(-1) cm(-2)) with the lowest detection limit (DL = 3 nM). On organic media (acetonitrile, dioxane, and ethanol), the optimum catechol detection was achieved with both, biosensors based on brushite (S = 3.3 A M-1 cm(-2), DL = 40 nM) and also with biosensors prepared with polyvinylimidazole microparticles (S = 12.5 mA M-1 cm(-2), DL = 8 mu M). (C) 2012 Elsevier B.V. All rights reserved.
C1 [Sanchez-Paniagua Lopez, M.; Lopez-Ruiz, B.] Univ Complutense Madrid, Fac Farm, Secc Dept Quim Analit, E-28040 Madrid, Spain.
   [Lopez-Cabarcos, E.] Univ Complutense Madrid, Fac Farm, Dept Fis Quim Farmaceut, E-28040 Madrid, Spain.
RP Lopez-Ruiz, B (reprint author), Univ Complutense Madrid, Fac Farm, Secc Dept Quim Analit, E-28040 Madrid, Spain.
EM bealopru@farm.ucm.es
RI Lopez Cabarcos, Enrique/L-5802-2014
OI Lopez Cabarcos, Enrique/0000-0003-2939-4130
FU Program "UCM Consolidation of Research Groups" [CCG07-UCM/MAT-2681 (Gp
   950247), GR35/10-A-911033]; Spanish Science and Innovation Ministry
   [MAT2010-15349]; COST Action [CM1101]
FX The authors acknowledge financial support from the CCG07-UCM/MAT-2681
   (Gp 950247) and GR35/10-A-911033 grants of the Program "UCM
   Consolidation of Research Groups", the Spanish Science and Innovation
   Ministry (grant MAT2010-15349), and the COST Action CM1101.
CR BROWN RS, 1994, ANAL BIOCHEM, V222, P131, DOI 10.1006/abio.1994.1464
   Coche-Guerente L, 1999, J ELECTROANAL CHEM, V470, P53, DOI 10.1016/S0022-0728(99)00217-X
   Cristea C, 2005, ELECTROCHIM ACTA, V50, P3713, DOI 10.1016/j.electacta.2005.01.017
   Cummings EA, 2001, TALANTA, V55, P1015, DOI 10.1016/S0039-9140(01)00532-X
   Cushnie TPT, 2005, INT J ANTIMICROB AG, V26, P343, DOI 10.1016/j.ijantimicag.2005.09.002
   Duarte N, 2010, PLANTA MED, V76, P975, DOI 10.1055/s-0029-1240892
   Harnly JM, 2007, ANAL BIOANAL CHEM, V389, P47, DOI 10.1007/s00216-007-1424-7
   HENNION MC, 1994, TRAC-TREND ANAL CHEM, V13, P361, DOI 10.1016/0165-9936(94)85007-0
   Perez JPH, 2006, BIOSENS BIOELECTRON, V22, P429, DOI 10.1016/j.bios.2006.05.015
   HORWITZ W, 1982, ANAL CHEM, V54, pA67, DOI 10.1021/ac00238a002
   Hosseini SH, 2005, PROCESS BIOCHEM, V40, P1027, DOI 10.1016/j.procbio.2004.05.002
   Huang M. T., 1992, ACS S SERIES
   Ikeata K., 2000, BIORESOURCE TECHNOL, V74, P191
   Jiang Fan, 2003, Current Vascular Pharmacology, V1, P135, DOI 10.2174/1570161033476736
   LAANE C, 1987, BIOTECHNOL BIOENG, V30, P81, DOI 10.1002/bit.260300112
   Lopez MSP, 2009, BIOSENS BIOELECTRON, V24, P2574, DOI 10.1016/j.bios.2009.01.002
   Mousty C, 2007, ELECTROANAL, V19, P253, DOI 10.1002/elan.200603718
   Mousty C, 2010, ANAL BIOANAL CHEM, V396, P315, DOI 10.1007/s00216-009-3274-y
   OMALLEY JJ, 1972, BIOCHEMISTRY-US, V11, P3527, DOI 10.1021/bi00769a006
   Ozoner S.K., 2011, ENV BIOSENSORS, P319
   Retama JR, 2005, BIOSENS BIOELECTRON, V20, P2268, DOI 10.1016/j.bios.2004.10.011
   Retama JR, 2003, BIOMATERIALS, V24, P2965, DOI 10.1016/S0142-9612(03)00095-4
   RiceEvans CA, 1997, TRENDS PLANT SCI, V2, P152, DOI 10.1016/S1360-1385(97)01018-2
   Sanchez Ferrer A, 1995, BIOCHIM BIOPHYS ACTA, V1247, P1
   Lopez MSP, 2007, ELECTROANAL, V19, P370, DOI 10.1002/elan.200603742
   Lopez MSP, 2006, BIOMOL ENG, V23, P135, DOI 10.1016/j.bioeng.2006.04.001
   Lopez MSP, 2009, ELECTROANAL, V21, P512, DOI 10.1002/elan.200804436
   SODERHALL K, 1985, PLANT PHYSIOL, V78, P730, DOI 10.1104/pp.78.4.730
   Stalikas CD, 2007, J SEP SCI, V30, P3268, DOI 10.1002/jssc.200700261
   Tortet L, 1997, SOLID STATE IONICS, V97, P253, DOI 10.1016/S0167-2738(97)00047-7
   TURKEY J. W., 1977, EXPLORATORY DATA ANA
   Yu JH, 2004, ELECTROANAL, V16, P1305, DOI 10.1002/elan.200302951
NR 32
TC 3
Z9 3
U1 2
U2 29
PU ELSEVIER SCIENCE SA
PI LAUSANNE
PA PO BOX 564, 1001 LAUSANNE, SWITZERLAND
SN 0925-4005
J9 SENSOR ACTUAT B-CHEM
JI Sens. Actuator B-Chem.
PD AUG-SEP
PY 2012
VL 171
BP 387
EP 397
DI 10.1016/j.snb.2012.04.074
PG 11
WC Chemistry, Analytical; Electrochemistry; Instruments & Instrumentation
SC Chemistry; Electrochemistry; Instruments & Instrumentation
GA 002XQ
UT WOS:000308572700048
DA 2018-10-19
ER

PT J
AU Kim, DM
   Nevins, M
   Camelo, M
   Nevins, ML
   Schupbach, P
   Rodrigues, VS
   Fiorellini, JP
AF Kim, David M.
   Nevins, Myron
   Camelo, Marcelo
   Nevins, Marc L.
   Schupbach, Peter
   Rodrigues, Vinicius S.
   Fiorellini, Joseph P.
TI Human Histologic Evaluation of the Use of the Dental Putty for Bone
   Formation in the Maxillary Sinus: Case Series
SO JOURNAL OF ORAL IMPLANTOLOGY
LA English
DT Article
DE humans; maxillary sinus; complications; microscopy
ID ANORGANIC BOVINE BONE; FLOOR ELEVATION; AUGMENTATION; COMPLICATIONS;
   SURVIVAL; GRAFT
AB A proof-of-principle study was conducted to assess the safety and efficacy of dental putty as an alternative sinus augmentation biomaterial. Six healthy patients requiring a total of 10 sinus augmentations received sinus augmentations. All patients volunteered and signed an informed consent based on the Helsinki declaration of 1975, as revised in 2000. The sinus augmentation was performed under local anesthesia with a mucoperiosteal flap elevated to expose the buccal wall of the maxillary sinus. The space was then filled with the dental putty in several increments, and the window was covered with an absorbable collagen membrane. Biopsies were harvested from all 10 treated sinuses using a 3-mm trephine bur at the time of implant placement at either 6 or at 9 months after sinus augmentation. All patients completed the study without complications, except for 1 patient who reported fistulas at 1 and 2 months after the surgery. Clinical reentry revealed that regenerated bone on the osteotomy site was soft and immature. The ground sections of the biopsied cores revealed minimum amounts of trabeculation surrounded by an abundant array of irregular-shaped residual alloplastic particles embedded in loose connective tissue. The present study's findings revealed inadequate bone formation, although the material appears to be bioinert as there is no elicitation of inflammatory response.
C1 [Kim, David M.; Nevins, Myron; Nevins, Marc L.; Rodrigues, Vinicius S.] Harvard Univ, Sch Dent Med, Div Periodontol, Dept Oral Med Infect & Immun, Cambridge, MA 02138 USA.
   [Camelo, Marcelo] Inst Adv Dent Studies, Belo Horizonte, MG, Brazil.
   [Schupbach, Peter] PSchupbach Histol, Res Lab Implants & Biomat, Horgen, Switzerland.
   [Fiorellini, Joseph P.] Univ Penn, Sch Dent Med, Dept Periodont, Philadelphia, PA 19104 USA.
RP Kim, DM (reprint author), Harvard Univ, Sch Dent Med, Div Periodontol, Dept Oral Med Infect & Immun, Cambridge, MA 02138 USA.
EM dkim@hsdm.harvard.edu
FU Sunstar Americas, Inc.
FX This study was sponsored by a grant from Sunstar Americas, Inc. The
   authors report no conflicts of interest related to this study.
CR Anavi Y, 2008, ORAL SURG ORAL MED O, V106, P34, DOI 10.1016/j.tripleo.2007.09.021
   Barone A, 2006, INT J ORAL MAX IMPL, V21, P81
   Boyne P J, 1997, Int J Periodontics Restorative Dent, V17, P11
   Cammack GV, 2005, INT J PERIODONT REST, V25, P231
   Chappard D, 2010, MICRON, V41, P321, DOI 10.1016/j.micron.2009.12.005
   Chiapasco M, 2009, INT J ORAL MAX IMPL, V24, P237
   Del Fabbro M, 2004, INT J PERIODONT REST, V24, P565
   Ferreira CEA, 2009, J PERIODONTOL, V80, P1920, DOI 10.1902/jop.2009.090263
   Frenken JWFH, 2010, CLIN ORAL IMPLAN RES, V21, P201, DOI 10.1111/j.1600-0501.2009.01821.x
   Jensen OT, 1998, INT J ORAL MAX IMPL, V13, P11
   Kim DM, 2009, INT J PERIODONT REST, V29, P415
   Nevins M, 1996, Int J Periodontics Restorative Dent, V16, P8
   Nevins M, 2009, INT J PERIODONT REST, V29, P583
   Novabone, NOV DENT PUTT
   Pjetursson BE, 2008, J CLIN PERIODONTOL, V35, P216, DOI 10.1111/j.1600-051X.2008.01272.x
   Schwartz-Arad D, 2004, J PERIODONTOL, V75, P511, DOI 10.1902/jop.2004.75.4.511
   Triplett RG, 2009, J ORAL MAXIL SURG, V67, P1947, DOI 10.1016/j.joms.2009.04.085
   Wallace Stephen S, 2003, Ann Periodontol, V8, P328, DOI 10.1902/annals.2003.8.1.328
   Wallace Stephen S, 2006, Compend Contin Educ Dent, V27, P662
NR 19
TC 1
Z9 1
U1 0
U2 5
PU ALLEN PRESS INC
PI LAWRENCE
PA 810 E 10TH ST, LAWRENCE, KS 66044 USA
SN 0160-6972
J9 J ORAL IMPLANTOL
JI J. Oral Implant.
PD AUG
PY 2012
VL 38
IS 4
BP 391
EP 398
DI 10.1563/AAID-JOI-D-11-00069
PG 8
WC Dentistry, Oral Surgery & Medicine
SC Dentistry, Oral Surgery & Medicine
GA 998ZJ
UT WOS:000308278600009
PM 21767203
DA 2018-10-19
ER

PT J
AU Elias, PZ
   Spector, M
AF Elias, Paul Z.
   Spector, Myron
TI Viscoelastic characterization of rat cerebral cortex and type I collagen
   scaffolds for central nervous system tissue engineering
SO JOURNAL OF THE MECHANICAL BEHAVIOR OF BIOMEDICAL MATERIALS
LA English
DT Article
DE Rat brain; Collagen; Scaffold; Viscoelastic; Mechanical properties
ID BRAIN-INJURY; CROSS-LINKING; GAG SCAFFOLDS; CELL THERAPY; VIVO;
   MATRICES; MODEL; LEVEL; VITRO; BIOMECHANICS
AB In the field of tissue engineering and regenerative medicine for the central nervous system, therapeutic strategies may involve implantation of biomaterial scaffolds into the brain. An understanding of the relationship between the brain and the scaffold mechanical properties can help in the selection of a safe and effective biomaterial. This research demonstrates the use of indentation testing along with viscoelastic modeling to characterize and compare mechanical properties of in situ rat cerebral cortex and collagen scaffolds of varying collagen concentration. The stress-relaxation solution for indentation of a viscoelastic material was derived based on a five-element Maxwell model and use of the correspondence principle. Applying the model to experimental stress-relaxation data, the brain was characterized by three shear moduli G(1) = 1.6 +/- 0.10 kPa, G(2) = 2.0 +/- 0.15 kPa, G(3) = 1.8 +/- 0.20 kPa, and two viscosities eta(2) = 11.0 +/- 0.44 kPa.s, eta(3) = 148.7 +/- 6.70 kPa.s, with corresponding relaxation time constants tau(1) = 5.7 +/- 0.3 s and tau(2) = 88.4 +/- 7.6 s. The brain showed average relaxation of 74% from its peak force during loading to an approximately asymptotic force over a 5 minute hold at constant displacement. Collagen scaffolds generally showed increasing trends in the shear moduli, viscosities, and percentage relaxation with increasing collagen concentration. While the brain had similar stiffness to the 1.0% collagen scaffold during the loading phase, the brain's relaxation behavior was distinct from all of the scaffolds. Similarities and differences between the mechanical behavior of the brain and collagen scaffolds of varying collagen concentration are discussed in relation to application of biomaterials for regenerative medicine. (C) 2012 Elsevier Ltd. All rights reserved.
C1 [Elias, Paul Z.; Spector, Myron] VA Boston Healthcare Syst, Tissue Engn Labs, Boston, MA 02130 USA.
   [Elias, Paul Z.] MIT, Harvard Mit Div Hlth Sci & Technol, Cambridge, MA 02139 USA.
   [Spector, Myron] Harvard Univ, Sch Med, Brigham & Womens Hosp, Dept Orthoped Surg, Boston, MA 02115 USA.
RP Elias, PZ (reprint author), VA Boston Healthcare Syst, Tissue Engn Labs, Mail Stop 151 Res,Room D1-151,150 S Huntington Av, Boston, MA 02130 USA.
EM pzelias@alum.mit.edu
OI Spector, Myron/0000-0003-3328-4858
FU U.S. Department of Veterans Affairs, Veterans Health Administration,
   Rehabilitation Research and Development Service
FX The research reported here was supported by the U.S. Department of
   Veterans Affairs, Veterans Health Administration, Rehabilitation
   Research and Development Service. We thank Dr. Simona Socrate and Dr.
   Thibault Prevost (MIT Department of Mechanical Engineering) for
   assistance with the mechanical testing.
CR Bain AC, 2000, J BIOMECH ENG-T ASME, V122, P615, DOI 10.1115/1.1324667
   Balgude AP, 2001, BIOMATERIALS, V22, P1077, DOI 10.1016/S0142-9612(00)00350-1
   Bolliet C, 2008, TISSUE ENG PT C-METH, V14, P207, DOI 10.1089/ten.tec.2008.0168
   Cheng L, 2000, J POLYM SCI POL PHYS, V38, P10, DOI 10.1002/(SICI)1099-0488(20000101)38:1<10::AID-POLB2>3.0.CO;2-6
   Cheng L, 2005, MECH MATER, V37, P213, DOI 10.1016/j.mechmat.2004.03.002
   Cholas RH, 2012, BIOMATERIALS, V33, P2050, DOI 10.1016/j.biomaterials.2011.11.028
   Compton CC, 1998, J INVEST DERMATOL, V110, P908, DOI 10.1046/j.1523-1747.1998.00200.x
   Damink LHHO, 1996, BIOMATERIALS, V17, P765, DOI 10.1016/0142-9612(96)81413-X
   Delcroix GJR, 2010, BIOMATERIALS, V31, P2105, DOI 10.1016/j.biomaterials.2009.11.084
   Engler AJ, 2006, CELL, V126, P677, DOI 10.1016/j.cell.2006.06.044
   Fitch MT, 1999, J NEUROSCI, V19, P8182
   Flanagan LA, 2002, NEUROREPORT, V13, P2411, DOI 10.1097/01.wnr.0000048003.96487.97
   Fountoulakis M, 2001, EXP NEUROL, V167, P86, DOI 10.1006/exnr.2000.7529
   Freyman TM, 2001, BIOMATERIALS, V22, P2883, DOI 10.1016/S0142-9612(01)00034-5
   Gefen A, 2003, J NEUROTRAUM, V20, P1163, DOI 10.1089/089771503770802853
   Gefen A, 2004, J BIOMECH, V37, P1339, DOI 10.1016/j.jbiomech.2003.12.032
   Georges PC, 2006, BIOPHYS J, V90, P3012, DOI 10.1529/biophysj.105.073114
   Gibson LJ, 2005, J BIOMECH, V38, P377, DOI 10.1016/j.jbiomech.2004.09.027
   Harley BA, 2004, CELLS TISSUES ORGANS, V176, P153, DOI 10.1159/000075035
   Harley BA, 2007, ACTA BIOMATER, V3, P463, DOI 10.1016/j.aetbio.2006.12.009
   Hsu WC, 2000, INVEST OPHTH VIS SCI, V41, P2404
   HUANG C, 1977, J BIOMED MATER RES, V11, P137, DOI 10.1002/jbm.820110113
   Kaster T, 2011, J BIOMECH, V44, P1158, DOI 10.1016/j.jbiomech.2011.01.019
   Kyriacou SK, 2002, BIOMECH MODEL MECHAN, V1, P151, DOI 10.1007/s10237-002-0013-0
   Lee E.H., 1960, J APPL MECH, V27, P438, DOI DOI 10.1115/1.3644020
   Madaghiele M, 2008, J BIOMED MATER RES A, V85A, P757, DOI 10.1002/jbm.a.31517
   Miller K, 2005, J BIOMECH, V38, P153, DOI 10.1016/j.jbiomech.2004.03.004
   Miller K, 2000, J BIOMECH, V33, P1369, DOI 10.1016/S0021-9290(00)00120-2
   O'Brien FJ, 2004, BIOMATERIALS, V25, P1077, DOI 10.1016/S0142-9612(03)00630-6
   Orive G, 2009, NAT REV NEUROSCI, V10, P682, DOI 10.1038/nrn2685
   Pataquiva-Mateus AY, 2012, J BIOMED MATER RES B, V100B, P862, DOI 10.1002/jbm.b.32650
   Pena A, 2005, ACT NEUR S, V95, P333
   Pieper JS, 1999, BIOMATERIALS, V20, P847, DOI 10.1016/S0142-9612(98)00240-3
   Prange MT, 2002, J BIOMECH ENG-T ASME, V124, P244, DOI 10.1115/1.1449907
   Saha K, 2008, BIOPHYS J, V95, P4426, DOI 10.1529/biophysj.108.132217
   SCHETTINI A, 1988, AM J PHYSIOL, V255, pR799
   Shear DA, 2010, J NEUROTRAUM, V27, P1911, DOI 10.1089/neu.2010.1399
   Spilker MH, 2001, RESTOR NEUROL NEUROS, V18, P23
   Tang SQ, 2007, J BIOMED MATER RES A, V82A, P323, DOI 10.1002/jbm.a.30974
   Thibault KL, 1998, J BIOMECH, V31, P1119, DOI 10.1016/S0021-9290(98)00122-5
   van Dommelen JAW, 2010, J MECH BEHAV BIOMED, V3, P158, DOI 10.1016/j.jmbbm.2009.09.001
   Vickers SM, 2006, TISSUE ENG, V12, P1345, DOI 10.1089/ten.2006.12.1345
   Walker PA, 2009, STEM CELL REV REP, V5, P283, DOI 10.1007/s12015-009-9081-1
   Wang TW, 2009, ACTA BIOMATER, V5, P2371, DOI 10.1016/j.actbio.2009.03.033
   Williams AJ, 2005, J NEUROTRAUM, V22, P313, DOI 10.1089/neu.2005.22.313
   Williams AJ, 2006, NEUROSCI LETT, V408, P183, DOI 10.1016/j.neulet.2006.08.086
   Williams AJ, 2006, J NEUROTRAUM, V23, P1828, DOI 10.1089/neu.2006.23.1828
   Zacharaki EI, 2008, IEEE T BIO-MED ENG, V55, P1233, DOI 10.1109/TBME.2007.905484
NR 48
TC 15
Z9 15
U1 0
U2 25
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 1751-6161
J9 J MECH BEHAV BIOMED
JI J. Mech. Behav. Biomed. Mater.
PD AUG
PY 2012
VL 12
BP 63
EP 73
DI 10.1016/j.jmbbm.2012.03.014
PG 11
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 003QL
UT WOS:000308626300007
PM 22659367
DA 2018-10-19
ER

PT J
AU Butler, MJ
   Sefton, MV
AF Butler, Mark J.
   Sefton, Michael V.
TI Cotransplantation of Adipose-Derived Mesenchymal Stromal Cells and
   Endothelial Cells in a Modular Construct Drives Vascularization in
   SCID/bg Mice
SO TISSUE ENGINEERING PART A
LA English
DT Article
ID STEM-CELLS; IN-VIVO; IMMUNODEFICIENT MICE; NETWORK FORMATION; PROGENITOR
   CELLS; HEART-FAILURE; BLOOD-VESSELS; TISSUE; TRANSPLANTATION;
   DIFFERENTIATION
AB A modular approach to adipose tissue engineering was explored by embedding adipose-derived mesenchymal stromal cells (adMSC) in sub-mm-sized collagen rods or "modules" and coating with human microvascular endothelial cells (HMEC). After subcutaneous injection into a SCID/Bg mouse, HMEC on modules containing embedded adMSC appeared to detach from the modules to form vessels as early as day 3, as confirmed by the human EC-specific UEA-1 lectin stain, and these vessels persisted for up to 90 days. Vessel numbers decreased over 14 days, but vessel size increased suggesting a maturing of the vasculature. Vessel perfusion with the host was confirmed at 21 days by microCT. HMEC on modules without embedded adMSC remained attached to the module surface at day 3 and UEA-1 staining disappeared over 14 days suggesting cell death. It appeared that cotransplantation with adMSC had an anti-apoptotic and proangiogenic effect on HMEC. The early revascularization strategy may be successful in supporting adMSC viability and differentiation, as a preliminary study suggests progressive fat accumulation in the HMEC + adMSC implants: similar to 60% of the implant area stained positive for Oil Red O by day 90. adMSC-embedded modules without HMEC surface coating did not show similar levels of Oil Red O staining. All implant volumes decreased over the time course of the experiment, yet HMEC+ adMSC module implants were larger than adMSC-only implants at day 90. Collagen gel is mechanically weak and contracts in vivo making it unsuitable as a biomaterial for adipose tissue engineering where volume maintenance is critical. When combined with an appropriate biomaterial, the modular approach to adipose tissue engineering may represent a successful strategy to engineer soft tissue substitutes of clinical relevance.
C1 [Butler, Mark J.; Sefton, Michael V.] Univ Toronto, Inst Biomat & Biomed Engn, 164 Coll St,Suite 407, Toronto, ON M5S 3G9, Canada.
   [Butler, Mark J.; Sefton, Michael V.] Univ Toronto, Dept Chem Engn & Appl Chem, Toronto, ON M5S 3G9, Canada.
RP Sefton, MV (reprint author), Univ Toronto, Inst Biomat & Biomed Engn, 164 Coll St,Suite 407, Toronto, ON M5S 3G9, Canada.
EM michael.sefton@utoronto.ca
FU U.S. National Institutes of Health [EB006903]; Canadian Institutes of
   Health Research [MOP-89864]; Natural Sciences and Engineering Research
   Council of Canada (NSERC); Advanced Regenerative Tissue Engineering
   Centre (ARTEC)
FX The authors acknowledge the financial support of the U.S. National
   Institutes of Health (EB006903) and the Canadian Institutes of Health
   Research (MOP-89864). MJB thanks the Natural Sciences and Engineering
   Research Council of Canada (NSERC) and the Advanced Regenerative Tissue
   Engineering Centre (ARTEC) for fellowship support. We are grateful to
   Dr. John Semple and Women's College Hospital for the donations of
   adipose tissue, to Chuen Lo for his technical expertise in animal
   surgeries, and to Kim Woodhouse for her guidance and support. Also, we
   thank Lisa Yu (Dr. R. M. Henkelman) for microCT imaging and Toronto
   General Hospital's Pathology research group for all histology and
   immunostaining services.
CR Assmus B, 2002, CIRCULATION, V106, P3009, DOI 10.1161/01.CIR.0000043246.74879.CD
   Bhang SH, 2011, BIOMATERIALS, V32, P2734, DOI 10.1016/j.biomaterials.2010.12.035
   Borges J, 2003, TISSUE ENG, V9, P1263, DOI 10.1089/10763270360728170
   Cai XX, 2011, BIOL CELL, V103, P435, DOI 10.1042/BC20110033
   Chamberlain M Dean, 2010, J Vis Exp, DOI 10.3791/2177
   Chamberlain MD, 2012, TISSUE ENG PT A, V18, P285, DOI [10.1089/ten.TEA.2011.0393, 10.1089/ten.tea.2011.0393]
   Chamberlain MD, 2011, TISSUE ENG PT A, V17, P151, DOI 10.1089/ten.TEA.2010.0293
   Chen XF, 2009, TISSUE ENG PT A, V15, P1363, DOI 10.1089/ten.tea.2008.0314
   Cho SW, 2006, BIOCHEM BIOPH RES CO, V345, P588, DOI 10.1016/j.bbrc.2006.04.089
   Cho SW, 2005, BIOMATERIALS, V26, P3577, DOI 10.1016/j.biomaterials.2004.09.013
   Cooper TP, 2011, ACTA BIOMATER, V7, P1072, DOI 10.1016/j.actbio.2010.11.008
   Enis DR, 2005, P NATL ACAD SCI USA, V102, P425, DOI 10.1073/pnas.0408357102
   ERSEK RA, 1991, PLAST RECONSTR SURG, V87, P219, DOI 10.1097/00006534-199102000-00001
   Fischbach C, 2004, EXP CELL RES, V300, P54, DOI 10.1016/j.yexcr.2004.05.036
   Flynn L, 2009, J BIOMED MATER RES A, V89A, P929, DOI 10.1002/jbm.a.32044
   Flynn L, 2006, J BIOMED MATER RES A, V79A, P359, DOI 10.1002/jbm.a.30762
   Fukumura D, 2003, CIRC RES, V93, pE88, DOI 10.1161/01.RES.0000099243.20096.FA
   Gupta R, 2009, TISSUE ENG PT A, V15, P2875, DOI [10.1089/ten.tea.2008.0494, 10.1089/ten.TEA.2008.0494]
   Gupta R, 2011, TISSUE ENG PT A, V17, P2005, DOI [10.1089/ten.tea.2010.0542, 10.1089/ten.TEA.2010.0542]
   Halbleib M, 2003, BIOMATERIALS, V24, P3125, DOI 10.1016/S0142-9612(03)00156-X
   Hong SJ, 2010, CURR OPIN ORGAN TRAN, V15, P86, DOI 10.1097/MOT.0b013e328334f074
   Hutley LJ, 2001, AM J PHYSIOL-ENDOC M, V281, pE1037
   Katz AJ, 1999, CLIN PLAST SURG, V26, P587
   Khan OF, 2012, TISSUE ENG PT A, V18, P744, DOI [10.1089/ten.tea.2011.0058, 10.1089/ten.TEA.2011.0058]
   Kloeters O, 2011, ARCH ORTHOP TRAUM SU, V131, P1459, DOI 10.1007/s00402-011-1306-5
   Koike N, 2004, NATURE, V428, P138, DOI 10.1038/428138a
   Kondo K, 2009, ARTERIOSCL THROM VAS, V29, P61, DOI 10.1161/ATVBAHA.108.166496
   Kral JG, 1999, PLAST RECONSTR SURG, V104, P1732, DOI 10.1097/00006534-199911000-00018
   Lin CS, 2010, HISTOL HISTOPATHOL, V25, P807, DOI 10.14670/HH-25.807
   Madonna R, 2010, J CARDIOVASC MED, V11, P71, DOI 10.2459/JCM.0b013e328330e9be
   Marxen M, 2004, MED PHYS, V31, P305, DOI 10.1118/1.1637971
   Mcguigan AP, 2007, TISSUE ENG, V13, P1069, DOI 10.1089/ten.2006.0253
   Menasche P, 2001, LANCET, V357, P279, DOI 10.1016/S0140-6736(00)03617-5
   Merfeld-Clauss S, 2010, TISSUE ENG PT A, V16, P2953, DOI [10.1089/ten.tea.2009.0635, 10.1089/ten.TEA.2009.0635]
   Miranville A, 2004, CIRCULATION, V110, P349, DOI 10.1161/01.CIR.0000135466.16823.D0
   NIECHAJEV I, 1994, PLAST RECONSTR SURG, V94, P496, DOI 10.1097/00006534-199409000-00012
   Nor JE, 2001, LAB INVEST, V81, P453
   Nor JE, 1999, AM J PATHOL, V154, P375, DOI 10.1016/S0002-9440(10)65284-4
   Ohmura Y, 2010, TRANSPLANTATION, V90, P1366, DOI 10.1097/TP.0b013e3181ffba31
   Orban JM, 2004, J BIOMED MATER RES A, V68A, P756, DOI 10.1002/jbm.a.20110
   Patrick CW, 1999, TISSUE ENG, V5, P139, DOI 10.1089/ten.1999.5.139
   Patrick CW, 2002, TISSUE ENG, V8, P283, DOI 10.1089/107632702753725049
   Phillips MI, 2008, FUTUR CARDIOL, V4, P285, DOI 10.2217/14796678.4.3.285
   Planat-Benard V, 2004, CIRCULATION, V109, P656, DOI 10.1161/01.CIR.0000114522.38265.61
   Rehman J, 2004, CIRCULATION, V109, P1292, DOI 10.1161/01.CIR.0000121425.42966.F1
   Saunders WB, 2006, J CELL BIOL, V175, P179, DOI 10.1083/jcb.200603176
   Schechner JS, 2000, P NATL ACAD SCI USA, V97, P9191, DOI 10.1073/pnas.150242297
   Skovseth DK, 2002, AM J PATHOL, V160, P1629, DOI 10.1016/S0002-9440(10)61110-8
   Traktuev DO, 2008, CIRC RES, V102, P77, DOI 10.1161/CIRCRESAHA.107.159475
   Traktuev DO, 2009, CIRC RES, V104, P1410, DOI 10.1161/CIRCRESAHA.108.190926
   Tremblay PL, 2005, AM J TRANSPLANT, V5, P1002, DOI 10.1111/j.1600-6143.2005.00790.x
   VARZANEH FE, 1994, METABOLISM, V43, P906, DOI 10.1016/0026-0495(94)90275-5
   von Heimburg D, 2001, BIOMATERIALS, V22, P429, DOI 10.1016/S0142-9612(00)00186-1
   Yu G, 2010, CYTOTHERAPY, V12, P538, DOI 10.3109/14653241003649528
   Zhu M, 2010, ANN PLAS SURG, V64, P222, DOI 10.1097/SAP.0b013e31819ae05c
NR 55
TC 26
Z9 26
U1 0
U2 10
PU MARY ANN LIEBERT, INC
PI NEW ROCHELLE
PA 140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA
SN 1937-3341
EI 1937-335X
J9 TISSUE ENG PT A
JI Tissue Eng. Part A
PD AUG
PY 2012
VL 18
IS 15-16
BP 1628
EP 1641
DI 10.1089/ten.tea.2011.0467
PG 14
WC Cell & Tissue Engineering; Biotechnology & Applied Microbiology; Cell
   Biology
SC Cell Biology; Biotechnology & Applied Microbiology
GA 995HP
UT WOS:000307999100010
PM 22655687
OA Green Published
DA 2018-10-19
ER

PT J
AU Shchukarev, A
   Mladenovic, Z
   Ransjo, M
AF Shchukarev, A.
   Mladenovic, Z.
   Ransjo, M.
TI Surface characterization of bone graft substitute materials conditioned
   in cell culture medium. 2. Protein adsorption
SO SURFACE AND INTERFACE ANALYSIS
LA English
DT Article
DE cryogenic XPS; solid-liquid interface; bone graft substitute;
   biomaterial; Bio-Oss; Algipore; Bioglass 45S5; serum; protein adsorption
ID XPS
AB Three bone graft substitute materials (Bioglass 45S5, Bio-Oss (R) and Algipore (R)) were conditioned in a-minimum essential medium (alpha-MEM), with the addition of 10% fetal bovine serum (FBS), for 1 and 7?days. The chemistry of their solid-solution interface was monitored by X-ray photoelectron spectroscopy, using fast-frozen sample technique, and compared to that reported for original alpha-MEM. FBS added to the biological medium causes significant changes in the interface after only 1day of conditioning. Interfacial chemical composition and N 1s spectra show immediate adsorption of proteins at the surface of all three biomaterials, independent of their surface charge and chemical composition. However, the atomic ratio C/N and the C 1s spectra indicate a different orientation of adsorbed serum proteins, which is dependent on the particle's surface charge. Moreover, the adsorption of serum proteins at the surface of Bio-Oss causes a charge reversal at the interface, as evidenced by the change in the atomic ratio of Na/Cl. In addition to the particle's surface charge, the formation of the protein interfacial layer at the surface of the biomaterial seems to be the second major phenomenon important for subsequent cell recognition and the initiation of biomineralization. Copyright (c) 2012 John Wiley & Sons, Ltd.
C1 [Shchukarev, A.] Umea Univ, Dept Chem, S-90187 Umea, Sweden.
   [Mladenovic, Z.; Ransjo, M.] Umea Univ, Dept Odontol, S-90187 Umea, Sweden.
RP Shchukarev, A (reprint author), Umea Univ, Dept Chem, S-90187 Umea, Sweden.
EM andrei.shchukarev@chem.umu.se
FU Swedish Dental Society
FX This work was supported by grants from the Swedish Dental Society.
CR Bohner M, 2009, BIOMATERIALS, V30, P2175, DOI 10.1016/j.biomaterials.2009.01.008
   Castner DG, 2002, SURF SCI, V500, P28, DOI 10.1016/S0039-6028(01)01587-4
   Hartvig RA, 2011, LANGMUIR, V27, P2634, DOI 10.1021/la104720n
   Hughes F. J., 1997, METHODS BONE BIOL, P1
   Lee JTY, 2011, ACTA BIOMATER, V7, P2615, DOI 10.1016/j.actbio.2011.02.034
   Leone L, 2006, SURF INTERFACE ANAL, V38, P202, DOI 10.1002/sia.2184
   Meyer U, 2005, Eur Cell Mater, V9, P39
   Mladenovic Z, 2010, SURF INTERFACE ANAL, V42, P452, DOI 10.1002/sia.3337
   Ramstedt M, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.209536
   Shchukarev A, 2006, ADV COLLOID INTERFAC, V122, P149, DOI 10.1016/j.cis.2006.06.015
   Shchukarev A., 2011, BIOMATERIALS, P287
   Shchukarev A, 2007, J PHYS CHEM C, V111, P18307, DOI 10.1021/jp075321c
   Siebers MC, 2005, BIOMATERIALS, V26, P137, DOI 10.1016/j.biomaterials.2004.02.021
   Smith IO, 2004, J BIOMED MATER RES A, V70A, P436, DOI 10.1002/jbm.a.30098
   Wilson CJ, 2005, TISSUE ENG, V11, P1, DOI 10.1089/ten.2005.11.1
NR 15
TC 5
Z9 5
U1 4
U2 24
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0142-2421
J9 SURF INTERFACE ANAL
JI Surf. Interface Anal.
PD AUG
PY 2012
VL 44
IS 8
SI SI
BP 919
EP 923
DI 10.1002/sia.5012
PG 5
WC Chemistry, Physical
SC Chemistry
GA 977LM
UT WOS:000306662600009
DA 2018-10-19
ER

PT J
AU Hu, WW
   Syu, WJ
   Chen, WY
   Ruaan, RC
   Cheng, YC
   Chien, CC
   Li, C
   Chung, CA
   Tsao, CW
AF Hu, Wei-Wen
   Syu, Wun-Jheng
   Chen, Wen-Yih
   Ruaan, Ruoh-Chyu
   Cheng, Yu-Che
   Chien, Chih-Cheng
   Li, Chuan
   Chung, Chih-Ang
   Tsao, Chia-Wen
TI Use of Biotinylated Chitosan for Substrate-Mediated Gene Delivery
SO BIOCONJUGATE CHEMISTRY
LA English
DT Article
ID DNA DELIVERY; TRANSFECTION EFFICIENCY; MOLECULAR-WEIGHT; IN-VIVO;
   POLYELECTROLYTE COMPLEXES; NUCLEIC-ACIDS; NANOPARTICLES; THERAPY;
   VECTOR; CARRIERS
AB To improve transfection efficiency of nonviral vectors, biotinylated chitosan was applied to complex with DNA in different N/P ratios. The morphologies and the sizes of formed nanoparticles were suitable for cell uptake. The biotinylation decreased the surface charges of nanoparticles and hence reduced the cytotoxicity. The loading capacities of chitosan were slightly decreased with the increase of biotinylation, but most of the DNA molecules were still complexed. Using different avidin-coated surfaces, the interaction between biotinylated nanoparticles to the substrate may be manipulated. The in vitro transfection results demonstrated that biotinylated nanoparticles may be bound to avidin coated surfaces, and the transfection efficiencies were thus increased. Through regulating the N/P ratio, biotinylation levels, and surface avidin, the gene delivery can be optimized. Compared to the nonmodified chitosan, biotinylated nanoparticles on biomaterial surfaces can increase their chances to contact adhered cells. This spatially controlled gene delivery improved the gene transfer efficiency of nonviral vectors and could be broadly applied to different biomaterial scaffolds for tissue engineering applications.
C1 [Hu, Wei-Wen; Syu, Wun-Jheng; Chen, Wen-Yih; Ruaan, Ruoh-Chyu] Natl Cent Univ, Dept Chem & Mat Engn, Jhongli, Taiwan.
   [Chen, Wen-Yih] Natl Cent Univ, Ctr Dynam Biomarkers & Translat Med, Jhongli, Taiwan.
   [Ruaan, Ruoh-Chyu; Cheng, Yu-Che; Chien, Chih-Cheng] Natl Cent Univ, Inst Biomed Engn, Jhongli, Taiwan.
   [Li, Chuan; Chung, Chih-Ang; Tsao, Chia-Wen] Natl Cent Univ, Dept Mech Engn, Jhongli, Taiwan.
   [Cheng, Yu-Che; Chien, Chih-Cheng] Cathay Gen Hosp, Dept Med Res, Taipei, Taiwan.
   [Chien, Chih-Cheng] Fu Jen Catholic Univ, Sch Med, Taipei, Taiwan.
   [Chien, Chih-Cheng] Sijhih Cathay Gen Hosp, Dept Anesthesiol, Taipei, Taiwan.
RP Hu, WW (reprint author), Natl Cent Univ, Dept Chem & Mat Engn, Jhongli, Taiwan.
EM huweiwen@cc.ncu.edu.tw
RI Chung, Chih-Ang/J-3045-2016
OI Chung, Chih-Ang/0000-0001-9406-1864
FU National Science Council of Taiwan [NSC 98-2218-E-008-009]; National
   Central University [99CGH-NCU-A2]; Cathy General Hospital Joint Research
   Center
FX This research was supported by the grant of NSC 98-2218-E-008-009 from
   the National Science Council of Taiwan, and 99CGH-NCU-A2 from the
   National Central University and Cathy General Hospital Joint Research
   Center.
CR Alatorre-Meda M, 2011, COLLOID SURFACE B, V82, P54, DOI 10.1016/j.colsurfb.2010.08.013
   Bengali Z, 2005, BIOTECHNOL BIOENG, V90, P290, DOI 10.1002/bit.20393
   Boeckle S, 2004, J GENE MED, V6, P1102, DOI 10.1002/jgm.598
   Chan P, 2007, BIOMATERIALS, V28, P540, DOI 10.1016/j.biomaterials.2006.08.046
   Chang KL, 2010, BIOCONJUGATE CHEM, V21, P1087, DOI 10.1021/bc1000609
   Chung Y. C., 2010, BIOMED MATER, V5, P1
   Denuziere A, 1996, CARBOHYD POLYM, V29, P317, DOI 10.1016/S0144-8617(96)00035-5
   Douglas KL, 2006, J CONTROL RELEASE, V115, P354, DOI 10.1016/j.jconrel.2006.08.021
   Erbacher P, 1998, PHARMACEUT RES, V15, P1332, DOI 10.1023/A:1011981000671
   Franceschi RT, 2000, J CELL BIOCHEM, V78, P476, DOI 10.1002/1097-4644(20000901)78:3<476::AID-JCB12>3.0.CO;2-5
   Ghosn B, 2008, CURR TOP MED CHEM, V8, P331
   GREEN NM, 1963, BIOCHEM J, V89, P585, DOI 10.1042/bj0890585
   Herweijer H, 2003, GENE THER, V10, P453, DOI 10.1038/sj.gt.3301983
   Hu WW, 2007, GENE THER, V14, P891, DOI 10.1038/sj.gt.3302940
   Hu WW, 2008, J GENE MED, V10, P1102, DOI 10.1002/jgm.1233
   Hu WW, 2009, BIOMATERIALS, V30, P5785, DOI 10.1016/j.biomaterials.2009.06.041
   Hu WW, 2009, J CONTROL RELEASE, V135, P250, DOI 10.1016/j.jconrel.2009.01.020
   Hu Y, 2009, BIOMATERIALS, V30, P3626, DOI 10.1016/j.biomaterials.2009.03.037
   Huang M, 2005, J CONTROL RELEASE, V106, P391, DOI 10.1016/j.cornel.2005.05.004
   Hunter AC, 2010, BBA-BIOENERGETICS, V1797, P1203, DOI 10.1016/j.bbabio.2010.03.026
   Illum L, 1998, PHARMACEUT RES, V15, P1326
   Izumrudov VA, 1999, BIOPOLYMERS, V52, P94, DOI 10.1002/1097-0282(1999)52:2<94::AID-BIP3>3.0.CO;2-O
   Jiang HL, 2011, EUR J PHARM BIOPHARM, V77, P36, DOI 10.1016/j.ejpb.2010.09.014
   Jullig M, 2004, ANZ J SURG, V74, P46, DOI 10.1046/j.1445-1433.2003.documendoc.doc.x
   Kai E, 2004, PHARM RES, V21, P838, DOI 10.1023/B:PHAM.0000026437.32238.6f
   Katas H, 2006, J CONTROL RELEASE, V115, P216, DOI 10.1016/j.jconrel.2006.07.021
   Kichler A, 2001, J GENE MED, V3, P135, DOI 10.1002/jgm.173
   Lai WF, 2009, J CONTROL RELEASE, V134, P158, DOI 10.1016/j.jconrel.2008.11.021
   Lavertu M, 2006, BIOMATERIALS, V27, P4815, DOI 10.1016/j.biomaterials.2006.04.029
   Lee M, 2001, PHARMACEUT RES, V18, P427, DOI 10.1023/A:1011037807261
   LEPECQ JB, 1967, J MOL BIOL, V27, P87, DOI 10.1016/0022-2836(67)90353-1
   Li ZT, 2010, CARBOHYD POLYM, V80, P254, DOI 10.1016/j.carbpol.2009.11.021
   Lin QK, 2009, COLLOID SURFACE B, V74, P298, DOI 10.1016/j.colsurfb.2009.07.036
   LIVNAH O, 1993, FEBS LETT, V328, P165, DOI 10.1016/0014-5793(93)80986-5
   MacLaughlin FC, 1998, J CONTROL RELEASE, V56, P259, DOI 10.1016/S0168-3659(98)00097-2
   Mao HQ, 2001, J CONTROL RELEASE, V70, P399, DOI 10.1016/S0168-3659(00)00361-8
   Mao SR, 2010, ADV DRUG DELIVER REV, V62, P12, DOI 10.1016/j.addr.2009.08.004
   Nimesh S, 2010, MOL BIOTECHNOL, V46, P182, DOI 10.1007/s12033-010-9286-1
   Opanasopit P, 2009, INT J PHARMACEUT, V382, P291, DOI 10.1016/j.ijpharm.2009.08.029
   Oungbho K, 1997, INT J PHARM, V156, P229, DOI 10.1016/S0378-5173(97)00201-9
   Pannier AK, 2004, MOL THER, V10, P19, DOI 10.1016/j.ymthe.2004.03.020
   Parker AL, 2002, ANAL BIOCHEM, V302, P75, DOI 10.1006/abio.2001.5507
   Pfeifer A, 2001, ANNU REV GENOM HUM G, V2, P177, DOI 10.1146/annurev.genom.2.1.177
   Rao SB, 1997, J BIOMED MATER RES, V34, P21, DOI 10.1002/(SICI)1097-4636(199701)34:1<21::AID-JBM4>3.0.CO;2-P
   Rejman J, 2004, BIOCHEM J, V377, P159, DOI 10.1042/BJ20031253
   Sarkar K, 2011, J APPL POLYM SCI, V121, P2239, DOI 10.1002/app.33832
   Segura T, 2003, J CONTROL RELEASE, V93, P69, DOI 10.1016/j.jconrel.2003.08.003
   Strand SP, 2010, BIOMATERIALS, V31, P975, DOI 10.1016/j.biomaterials.2009.09.102
   Thibault M, 2011, BIOMATERIALS, V32, P4639, DOI 10.1016/j.biomaterials.2011.03.010
   WAGNER E, 1991, P NATL ACAD SCI USA, V88, P4255, DOI 10.1073/pnas.88.10.4255
   Wang CHK, 2011, TRENDS BIOTECHNOL, V29, P119, DOI 10.1016/j.tibtech.2010.11.005
   Wang JW, 2011, J APPL POLYM SCI, V121, P3531, DOI 10.1002/app.34140
   Wang X, 2010, PHARMAZIE, V65, P572, DOI 10.1691/ph.2010.9422
   Yang SJ, 2010, J GENE MED, V12, P168, DOI 10.1002/jgm.1418
   Yu HJ, 2011, MACROMOL BIOSCI, V11, P352, DOI 10.1002/mabi.201000283
   Zeng X, 2009, PHARM RES-DORDR, V26, P1931, DOI 10.1007/s11095-009-9920-4
   Zhai XY, 2011, J APPL POLYM SCI, V121, P3569, DOI 10.1002/app.34156
   Zhang HL, 2011, J BIOMED MATER RES A, V98A, P296, DOI 10.1002/jbm.a.33115
   Zhao RL, 2011, INT J PHARMACEUT, V413, P254, DOI 10.1016/j.ijpharm.2011.04.039
   Zhao XL, 2011, J NANOPART RES, V13, P693, DOI 10.1007/s11051-010-0067-3
   Zhu DW, 2010, INT J NANOMED, V5, P1095, DOI 10.2147/IJN.S14358
NR 61
TC 14
Z9 15
U1 2
U2 30
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 1043-1802
J9 BIOCONJUGATE CHEM
JI Bioconjugate Chem.
PD AUG
PY 2012
VL 23
IS 8
BP 1587
EP 1599
DI 10.1021/bc300121y
PG 13
WC Biochemical Research Methods; Biochemistry & Molecular Biology;
   Chemistry, Multidisciplinary; Chemistry, Organic
SC Biochemistry & Molecular Biology; Chemistry
GA 988JU
UT WOS:000307487300010
PM 22768969
DA 2018-10-19
ER

PT J
AU Dey, A
   van den Hoogen, CJ
   Rosso, M
   Lousberg, N
   Hendrix, MMRM
   Friedrich, H
   Ramirez-Rico, J
   Zuilhof, H
   de With, G
   Sommerdijk, NAJM
AF Dey, Archan
   van den Hoogen, Chris. J.
   Rosso, Michel
   Lousberg, Niek
   Hendrix, Marco M. R. M.
   Friedrich, Heiner
   Ramirez-Rico, Joaquin
   Zuilhof, Han
   de With, Gijsbertus
   Sommerdijk, Nico A. J. M.
TI Biomimetic Mineralization of Calcium Phosphate on a Functionalized
   Porous Silicon Carbide Biomaterial
SO CHEMPLUSCHEM
LA English
DT Article
DE biomineralization; ceramics; electron microscopy; hybrid materials;
   surface modification
ID OCTACALCIUM PHOSPHATE; BIOMEDICAL APPLICATIONS; BIOACTIVE GLASS;
   IN-VITRO; HYDROXYAPATITE; BONE; TRANSFORMATION; CERAMICS;
   CRYSTALLIZATION; INTERFACES
AB Porous biomorphic silicon carbide (bioSiC) is a structurally realistic, high-strength, and biocompatible material which is promising for application in load-bearing implants. The deposition of an osteoconductive coating is essential for further improvement of its integration with the surrounding tissue. A new strategy towards biomimetic calcium phosphate coatings on bioSiC is described. X-ray photoelectron spectroscopy (XPS) analysis shows that using 10-undecenoic acid methyl ester a covalently bound monolayer can be synthesized on the surface of the bioSiC. After hydrolysis it exposes carboxylic acid groups that promote the selective nucleation and growth of a very well-defined crystalline layer of calcium phosphate. The resulting calcium phosphate coating is characterized by X-ray diffraction and electron microscopy techniques. Further, ion beam imaging is employed to quantify the mineral deposition meanwhile, three-dimensional dual-beam imaging (FIB/SEM) is used to visualize the bioSiC/mineral interface. The monolayer is show to actively induce the nucleation of a well-defined and highly crystalline mixed octacalcium phosphate/hydroxyapatite (OCP/HAP) coating on implantable bioSiC substrates with complex geometry. The mild biomimetic procedure, in principle, allows for the inclusion of bioactive compounds that aid in tissue regeneration. Moreover, the mixed OCP/HAP phase will have a higher solubility compared to HAP, which, in combination with its porous structure, is expected to render the coating more reabsorbable than standard HAP coatings.
C1 [Dey, Archan; van den Hoogen, Chris. J.; Lousberg, Niek; Hendrix, Marco M. R. M.; Friedrich, Heiner; de With, Gijsbertus; Sommerdijk, Nico A. J. M.] Eindhoven Univ Technol, Lab Mat & Interface Chem, NL-5600 MB Eindhoven, Netherlands.
   [Rosso, Michel; Zuilhof, Han] Wageningen Univ, Organ Chem Lab, NL-6703 HB Wageningen, Netherlands.
   [Ramirez-Rico, Joaquin] Univ Seville, Dpto Fis Mat Condensada, ICMS, CSIC, Seville 41080, Spain.
RP Sommerdijk, NAJM (reprint author), Eindhoven Univ Technol, Lab Mat & Interface Chem, POB 513, NL-5600 MB Eindhoven, Netherlands.
EM N.Sommerdijk@tue.nl
RI Sommerdijk, Nico/B-7239-2013; de With, Gijsbertus/E-3235-2014; Dey,
   Archan/G-8023-2011; Ramirez-Rico, Joaquin/A-7006-2009; Friedrich,
   Heiner/F-7981-2010
OI Sommerdijk, Nico/0000-0002-8956-195X; Ramirez-Rico,
   Joaquin/0000-0002-1184-0756; Friedrich, Heiner/0000-0003-4582-0064
FU European Community [NMP4-CT-2006-033277]; MicroNed, a national program;
   Dutch Ministry of Economic Affairs [6163510395]; Netherlands
   Organization for Scientific Research (NWO)
FX The research was supported by the European Community (project code
   NMP4-CT-2006-033277), MicroNed, a national program funded by the Dutch
   Ministry of Economic Affairs (project no. 6163510395), and the
   Netherlands Organization for Scientific Research (NWO). We thank P. H.
   H. Bomans for help with HRTEM imaging and L. Mouton for the FIB-SEM data
   processing.
CR Adrien A., 2006, ACTA OCEANOLOG BELG, V72, P734
   Alves NM, 2010, J MATER CHEM, V20, P2911, DOI 10.1039/b910960a
   Arellano-Lopez A.R., 2004, INT J APPL CERAM TEC, V1, P56
   Bocking T, 2008, ADV FUNCT MATER, V18, P3827, DOI 10.1002/adfm.200800640
   Bodier-Houlle P, 1998, ACTA CRYSTALLOGR D, V54, P1377, DOI 10.1107/S0907444998005769
   BUNKER BC, 1994, SCIENCE, V264, P48, DOI 10.1126/science.264.5155.48
   de Carlos A, 2006, J MATER SCI-MATER M, V17, P523, DOI 10.1007/s10856-006-8935-1
   Dey A, 2010, NAT MATER, V9, P1010, DOI 10.1038/NMAT2900
   Dorozhkin SV, 2002, ANGEW CHEM INT EDIT, V41, P3130, DOI 10.1002/1521-3773(20020902)41:17<3130::AID-ANIE3130>3.0.CO;2-1
   Dorozhkin SV, 2002, ANGEW CHEM, V114, P3260
   Erickson D., 1991, SCI AM           AUG, P86
   GEESINK RGT, 1988, J BONE JOINT SURG BR, V70, P17
   Giannuzzi LA, 2007, J ORAL MAXIL SURG, V65, P737, DOI 10.1016/j.joms.2006.10.025
   Goldstein J., 2003, SCANNING ELECT MICRO
   Gonzalez P, 2003, BIOMATERIALS, V24, P4827, DOI 10.1016/S0142-9612(03)00405-8
   Green D, 2002, BONE, V30, P810, DOI 10.1016/S8756-3282(02)00727-5
   Hench LL, 2002, SCIENCE, V295, P1014, DOI 10.1126/science.1067404
   Hench LL, 1998, J AM CERAM SOC, V81, P1705
   Horvathova R, 2008, MAT SCI ENG C-BIO S, V28, P1414, DOI 10.1016/j.msec.2008.03.010
   IIJIMA M, 1992, J CRYST GROWTH, V116, P319, DOI 10.1016/0022-0248(92)90639-Z
   Kamakura S, 2002, J BIOMED MATER RES, V59, P29, DOI 10.1002/jbm.1213.abs
   KLEIN CPAT, 1994, J BIOMED MATER RES, V28, P961, DOI 10.1002/jbm.820280815
   LeGeros RZ, 2008, CHEM REV, V108, P4742, DOI 10.1021/cr800427g
   Mao CB, 1998, J MATER CHEM, V8, P2795, DOI 10.1039/a801384e
   Mitchell DRG, 2008, MICROSC RES TECHNIQ, V71, P588, DOI 10.1002/jemt.20591
   Oliveros A., 2010, MATER RES SOC S P, V1235
   Olszta MJ, 2007, MAT SCI ENG R, V58, P77, DOI 10.1016/j.mser.2007.05.001
   Rosso M, 2008, LANGMUIR, V24, P4007, DOI 10.1021/la704002y
   Ryu J, 2010, ADV FUNCT MATER, V20, P2132, DOI 10.1002/adfm.200902347
   Spoerke ED, 2009, ADV MATER, V21, P425, DOI 10.1002/adma.200802242
   Surmenev RA, 2011, SURF COAT TECH, V205, P3600, DOI 10.1016/j.surfcoat.2010.12.039
   Suzuki O, 2010, ACTA BIOMATER, V6, P3379, DOI 10.1016/j.actbio.2010.04.002
   Tampieri A, 2009, J MATER CHEM, V19, P4973, DOI 10.1039/b900333a
   Tseng YH, 2006, J AM CHEM SOC, V128, P6909, DOI 10.1021/ja060336u
   Vallet-Regi M, 2006, DALTON T, P5211, DOI 10.1039/b610219k
   Wang XJ, 2010, TISSUE ENG PT A, V16, P309, DOI [10.1089/ten.tea.2009.0074, 10.1089/ten.TEA.2009.0074]
   Zhan JH, 2005, ADV FUNCT MATER, V15, P2005, DOI 10.1002/adfm.200500274
   ZOU X, 2007, ADV EXP MED BIOL, V585, P197
NR 38
TC 4
Z9 4
U1 1
U2 47
PU WILEY-V C H VERLAG GMBH
PI WEINHEIM
PA BOSCHSTRASSE 12, D-69469 WEINHEIM, GERMANY
SN 2192-6506
J9 CHEMPLUSCHEM
JI ChemPlusChem
PD AUG
PY 2012
VL 77
IS 8
SI SI
BP 694
EP 699
DI 10.1002/cplu.201200118
PG 6
WC Chemistry, Multidisciplinary
SC Chemistry
GA 987FG
UT WOS:000307401800011
DA 2018-10-19
ER

PT J
AU Muser, SE
   Paukstelis, PJ
AF Muser, Stephanie E.
   Paukstelis, Paul J.
TI Three-Dimensional DNA Crystals with pH-Responsive Noncanonical Junctions
SO JOURNAL OF THE AMERICAN CHEMICAL SOCIETY
LA English
DT Article
ID HOMO BASE-PAIRS; STRANDED-DNA; MACROMOLECULAR STRUCTURES; NANOSCALE
   SHAPES; FOLDING DNA; DESIGN; DUPLEX; ARRAYS; NANOPARTICLES; QUADRUPLEX
AB Three-dimensional (3D) DNA crystals have been envisioned as programmable biomaterial scaffolds for creating ordered arrays of biological and nonbiological molecules. Despite having excellent programmable properties, the linearity of the Watson-Crick B-form duplex imposes limitations on 3D crystal design. Predictable noncanonical base pairing motifs have the potential to serve as junctions to connect linear DNA segments into complex 3D lattices. Here, we designed crystals based on a template structure with parallel-stranded noncanonical base pairs. Depending on pH, the structures we determined contained all but one or two of the designed secondary structure interactions. Surprisingly, a conformational change of the designed Watson Crick duplex region resulted in crystal packing differences between the predicted and observed structures. However, the designed noncanonical motif was virtually identical to the template when crystals were grown at pH 5.5, highlighting the motifs predictability. At pH 7.0 we observed a structurally similar variation on this motif that contains a previously unobserved C-G.G-C quadruple base pair. We demonstrate that these two variants can interconvert in aystallo in response to pH perturbations. This study spotlights several important considerations in DNA crystal design, describes the first 3D DNA lattice composed of A-DNA helical sheets, and reveals a noncanonical DNA motif that has adaptive features that may be useful for designing dynamic crystals or biomaterial assemblies.
C1 [Muser, Stephanie E.; Paukstelis, Paul J.] Univ Maryland, Dept Chem & Biochem, Ctr Biomol Struct & Org, Maryland NanoCtr, College Pk, MD 20742 USA.
RP Paukstelis, PJ (reprint author), Univ Maryland, Dept Chem & Biochem, Ctr Biomol Struct & Org, Maryland NanoCtr, College Pk, MD 20742 USA.
EM paukstel@umd.edu
FU NSF [1149665]
FX This work was supported by an NSF CAREER award to P.J.P. (1149665).
   Coordinates and structure factors have been deposited in the Protein
   Data Bank with IDs 4F8G and 4F8I.
CR Adams PD, 2011, METHODS, V55, P94, DOI 10.1016/j.ymeth.2011.07.005
   Alberti P, 2003, P NATL ACAD SCI USA, V100, P1569, DOI 10.1073/pnas.0335459100
   Andersen ES, 2009, NATURE, V459, P73, DOI 10.1038/nature07971
   Ariga K, 2008, MACROMOL BIOSCI, V8, P981, DOI 10.1002/mabi.200800102
   Barish RD, 2005, NANO LETT, V5, P2586, DOI [10.1021/nl052038l, 10.1021/nl0520381]
   Bauer C, 1997, J INORG BIOCHEM, V68, P129, DOI 10.1016/S0162-0134(97)00083-4
   Bindewald E, 2008, J MOL GRAPH MODEL, V27, P299, DOI 10.1016/j.jmgm.2008.05.004
   Bindewald E, 2008, NUCLEIC ACIDS RES, V36, pD392, DOI 10.1093/nar/gkm842
   BRAUNLIN WH, 1992, BIOPOLYMERS, V32, P1703, DOI 10.1002/bip.360321212
   CHEN Y, 2004, ANGEW CHEM, V116, P5449
   Chhabra R, 2007, ADV EXP MED BIOL, V620, P107
   Costa D, 2010, ADV COLLOID INTERFAC, V158, P21, DOI 10.1016/j.cis.2009.10.002
   Dietz H, 2009, SCIENCE, V325, P725, DOI 10.1126/science.1174251
   Ding BQ, 2004, J AM CHEM SOC, V126, P10230, DOI 10.1021/ja047486u
   Douglas SM, 2009, NATURE, V459, P414, DOI 10.1038/nature08016
   Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493
   Endo M, 2009, J AM CHEM SOC, V131, P15570, DOI 10.1021/ja904252e
   FRANKLIN RE, 1953, NATURE, V171, P740, DOI 10.1038/171740a0
   Han DR, 2011, SCIENCE, V332, P342, DOI 10.1126/science.1202998
   He Y, 2005, J AM CHEM SOC, V127, P12202, DOI 10.1021/ja0541938
   Ke YG, 2009, J AM CHEM SOC, V131, P15903, DOI 10.1021/ja906381y
   Kettani A, 1999, STRUCTURE, V7, P803, DOI 10.1016/S0969-2126(99)80104-X
   Kobuna Tomonori, 2002, Nucleic Acids Res Suppl, P179
   Liedl T, 2010, NAT NANOTECHNOL, V5, P520, DOI [10.1038/NNANO.2010.107, 10.1038/nnano.2010.107]
   Lin CX, 2006, CHEMPHYSCHEM, V7, P1641, DOI 10.1002/cphc.200600260
   Liu HP, 2006, ANGEW CHEM INT EDIT, V45, P1942, DOI 10.1002/anie.200504022
   Liu Y, 2005, J AM CHEM SOC, V127, P17140, DOI 10.1021/ja055614o
   Lu XJ, 2008, NAT PROTOC, V3, P1213, DOI 10.1038/nprot.2008.104
   Mao CD, 2000, NATURE, V407, P493, DOI 10.1038/35035038
   Mitchell JC, 2004, J AM CHEM SOC, V126, P16342, DOI 10.1021/ja043890h
   Mitra D, 2004, ANGEW CHEM INT EDIT, V43, P5804, DOI 10.1002/anie.200460255
   Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255
   Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X
   Paukstelis PJ, 2006, J AM CHEM SOC, V128, P6794, DOI 10.1021/ja061322r
   Paukstelis PJ, 2004, CHEM BIOL, V11, P1119, DOI 10.1016/j.chembiol.2004.05.021
   ROBINSON H, 1992, BIOCHEMISTRY-US, V31, P10510, DOI 10.1021/bi00158a014
   Robinson H, 1996, NUCLEIC ACIDS RES, V24, P676, DOI 10.1093/nar/24.4.676
   ROBINSON H, 1993, P NATL ACAD SCI USA, V90, P5224, DOI 10.1073/pnas.90.11.5224
   Rothemund PWK, 2006, NATURE, V440, P297, DOI 10.1038/nature04586
   Rothemund PWK, 2004, PLOS BIOL, V2, P2041, DOI 10.1371/journal.pbio.0020424
   Saha S, 2012, CHEM COMMUN, V48, P2513, DOI 10.1039/c2cc16347k
   Seeman N. C., 2002, Natural Computing, V1, P53, DOI 10.1023/A:1015055810719
   SEEMAN NC, 1982, J THEOR BIOL, V99, P237, DOI 10.1016/0022-5193(82)90002-9
   Seeman NC, 2003, NATURE, V421, P427, DOI 10.1038/nature01406
   Seeman NC, 1998, ANNU REV BIOPH BIOM, V27, P225, DOI 10.1146/annurev.biophys.27.1.225
   Sharma J, 2006, ANGEW CHEM INT EDIT, V45, P730, DOI 10.1002/anie.200503208
   Shih WM, 2004, NATURE, V427, P618, DOI 10.1038/nature02307
   Siddiqui-Jain A, 2002, P NATL ACAD SCI USA, V99, P11593, DOI 10.1073/pnas.182256799
   Stearns LA, 2009, ANGEW CHEM INT EDIT, V48, P8494, DOI 10.1002/anie.200903319
   Stuart MAC, 2010, NAT MATER, V9, P101, DOI [10.1038/NMAT2614, 10.1038/nmat2614]
   Sun TL, 2011, ADV MATER, V23, pH57, DOI 10.1002/adma.201004326
   Sunami T, 2002, NUCLEIC ACIDS RES, V30, P5253, DOI 10.1093/nar/gkf639
   SUNDQUIST WI, 1989, NATURE, V342, P825, DOI 10.1038/342825a0
   Surana S, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1340
   Westhof E, 2000, STRUCT FOLD DES, V8, pR55, DOI 10.1016/S0969-2126(00)00112-X
   Winfree E, 1998, NATURE, V394, P539, DOI 10.1038/28998
   XU QW, 1993, BIOPHYS J, V65, P1039, DOI 10.1016/S0006-3495(93)81163-9
   Yan H, 2003, J AM CHEM SOC, V125, P14246, DOI 10.1021/ja036676m
   Yan H, 2003, SCIENCE, V301, P1882, DOI 10.1126/science.1089389
   Yingling YG, 2007, NANO LETT, V7, P2328, DOI 10.1021/nl070984r
   You Jin-Oh, 2010, J Biol Eng, V4, P15, DOI 10.1186/1754-1611-4-15
   Zheng JP, 2009, NATURE, V461, P74, DOI 10.1038/nature08274
NR 62
TC 10
Z9 10
U1 2
U2 32
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 0002-7863
J9 J AM CHEM SOC
JI J. Am. Chem. Soc.
PD AUG 1
PY 2012
VL 134
IS 30
BP 12557
EP 12564
DI 10.1021/ja3025033
PG 8
WC Chemistry, Multidisciplinary
SC Chemistry
GA 981CH
UT WOS:000306942600049
PM 22768973
DA 2018-10-19
ER

PT J
AU McNamara, K
   Tofail, SAM
   Conroy, D
   Butler, J
   Gandhi, AA
   Redington, W
AF McNamara, Karrina
   Tofail, Syed A. M.
   Conroy, Derek
   Butler, James
   Gandhi, Abbasi A.
   Redington, Wynette
TI X-ray analyses of thermally grown and reactively sputtered tantalum
   oxide films on NiTi alloy
SO NUCLEAR INSTRUMENTS & METHODS IN PHYSICS RESEARCH SECTION B-BEAM
   INTERACTIONS WITH MATERIALS AND ATOMS
LA English
DT Article
DE X-ray diffraction; X-ray photoelectron spectroscopy; NiTi; Ta-coating;
   Reactive sputtering; Oxidation of metals
ID MEDICAL APPLICATIONS; SURFACE; BIOCOMPATIBILITY; CORROSION; NICKEL
AB Sputter deposition of tantalum (Ta) on the surface of NiTi alloy is expected to improve the alloy's corrosion resistance and biocompatibility. Tantalum is a well-known biomaterial which is not affected by body fluids and is not irritating to human tissue. Here we compare the oxidation chemistry crystal structure evolution of tantalum oxide films grown on NiTi by reactive O-2 sputtering and by thermal oxidation of sputter deposited Ta films. The effect of sputtering parameters and post-sputtering treatments on the morphology, oxidation state and crystal structure of the tantalum oxide layer have been investigated by field-emission scanning electron microscopy (FE-SEM), X-ray photoelectron spectroscopy (XPS) and X-ray diffraction (XRD). The study has found that it may be better to avoid oxidation at and above 600 degrees C. The study establishes that reactive sputtering in presence of low oxygen mixture yields thicker film with better control of the film quality except that the surface oxidation state of Ta is slightly lower. (C) 2011 Elsevier B.V. All rights reserved.
C1 [McNamara, Karrina; Tofail, Syed A. M.; Conroy, Derek; Butler, James; Gandhi, Abbasi A.; Redington, Wynette] Univ Limerick, Mat & Surface Sci Inst, Limerick, Ireland.
RP Tofail, SAM (reprint author), Univ Limerick, Mat & Surface Sci Inst, Limerick, Ireland.
EM Tofail.Syed@ul.ie
RI Gandhi, Abbasi/K-4633-2013
OI McNamara, Karrina/0000-0003-0635-2536
CR Cheng Y, 2006, J MATER SCI, V41, P4961, DOI 10.1007/s10853-006-0096-6
   Cheng Y, 2004, SURF COAT TECH, V186, P346, DOI 10.1016/j.surfcoat.2004.01.012
   CULLITY BD, 2001, ELEMENTS XRAY DIFFRA, P177
   Duerig T, 1999, MAT SCI ENG A-STRUCT, V273, P149, DOI 10.1016/S0921-5093(99)00294-4
   Hoffman S., 1990, AUGER XRAY PHOTOELEC, V1
   Hollands E, 1968, J MATER SCI, V3, P544, DOI 10.1007/BF00549739
   Nolan M., 2010, PHYS CHEM CHEM PHYS, V12, P33
   Nolan M., 2010, BIOMATERIALS, V31, P13
   Shabalovskaya S, 2008, ACTA BIOMATER, V4, P447, DOI 10.1016/j.actbio.2008.01.013
   Shabalovskaya S., 2008, SHAPE MEMORY ALLOYS
   Shabalovskaya SA, 2002, BIO-MED MATER ENG, V12, P69
   Shabalovskaya SA, 2009, BIOMATERIALS, V30, P468, DOI 10.1016/j.biomaterials.2008.10.014
   Wever DJ, 1998, BIOMATERIALS, V19, P761, DOI 10.1016/S0142-9612(97)00210-X
   Zein S., 2005, ELECTROCHEMISTRY COM, V7, P9
NR 14
TC 4
Z9 4
U1 0
U2 27
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0168-583X
J9 NUCL INSTRUM METH B
JI Nucl. Instrum. Methods Phys. Res. Sect. B-Beam Interact. Mater. Atoms
PD AUG 1
PY 2012
VL 284
BP 49
EP 52
DI 10.1016/j.nimb.2011.07.106
PG 4
WC Instruments & Instrumentation; Nuclear Science & Technology; Physics,
   Atomic, Molecular & Chemical; Physics, Nuclear
SC Instruments & Instrumentation; Nuclear Science & Technology; Physics
GA 980EC
UT WOS:000306875400012
DA 2018-10-19
ER

PT J
AU Li, F
   Chen, YZ
   Miao, ZN
   Zheng, SY
   Jin, J
AF Li, Fang
   Chen, Yong-Zhen
   Miao, Zong-Ning
   Zheng, Shi-ying
   Jin, Jun
TI Human Placenta-Derived Mesenchymal Stem Cells with Silk Fibroin
   Biomaterial in the Repair of Articular Cartilage Defects
SO CELLULAR REPROGRAMMING
LA English
DT Article
ID TISSUE; THERAPY; IDENTIFICATION; DIFFERENTIATE; MICROVESICLES;
   REGENERATION; BLOOD
AB Cartilage tissue engineering requires a porous biodegradable scaffold and nonimmunogenic cells with chondrogenic potential. In this study, the ability of the placenta-derived mesenchymal stem cells (PMSCs) to grow on silk fibroin (SF) biomaterial was determined, and the potential of a SF biomaterial serving as a delivery vehicle for human PMSCs in a rabbit articular cartilage defects model was evaluated. Human PMSCs were maintained in vitro in an allogeneic mixed lymphocyte reactions (MLR) system to investigate the suppressive effects on T cell proliferation. A total of 12 healthy adult New Zealand rabbits were implanted with a PMSC/SF biomaterial complex after articular cartilage defects of the femoral condyle in the knee were established. The repair of the articular cartilage defects was observed after 4 weeks, 8 weeks, and 12 weeks. Results from the MLR indicated that human PMSCs inhibited rabbit T cell responses. Knee damage was repaired by the newly formed hyaline cartilage, and within 12 weeks there was neither degeneration nor infiltration with lymphocytes or leukocytes, and no silk fibroin biomaterial residue was detected. In conclusion, the silk fibroin biomaterial can be applied as a new scaffold for cartilage tissue engineering, and implantation of human PMSCs on the cartilage can enhance repair of articular cartilage defects in a rabbit model.
C1 [Zheng, Shi-ying] Soochow Univ, Dept Cardiothorac Surg, Affiliated Hosp 1, Suzhou 215006, Peoples R China.
   [Li, Fang; Chen, Yong-Zhen] Soochow Univ, Dept Human Anat Histol & Embryol, Sch Biol & Basic Med Sci, Suzhou 215007, Peoples R China.
   [Miao, Zong-Ning] Wuxi 3 Peoples Hosp, Stem Cell Res Lab, Wuxi 214041, Peoples R China.
   [Jin, Jun] Soochow Univ, Dept Emergency, Affiliated Hosp 1, Suzhou 215006, Peoples R China.
RP Zheng, SY (reprint author), Soochow Univ, Dept Cardiothorac Surg, Affiliated Hosp 1, Suzhou 215006, Peoples R China.
EM zhengshicn@yeah.net; junjin88@sina.com
CR Altman GH, 2003, BIOMATERIALS, V24, P401, DOI 10.1016/S0142-9612(02)00353-8
   De Coppi P, 2007, NAT BIOTECHNOL, V25, P100, DOI 10.1038/nbt1274
   Di Nicola M, 2002, BLOOD, V99, P3838, DOI 10.1182/blood.V99.10.3838
   Etienne O, 2009, J PERIODONTOL, V80, P1852, DOI 10.1902/jop.2009.090231
   Guang Y.L., 2007, J BIOL CHEM, V282, P20407
   Herrera MB, 2010, J CELL MOL MED, V14, P1605, DOI 10.1111/j.1582-4934.2009.00860.x
   Kelly S. S., 2011, AM J RESP CRIT CARE, V183, P215
   Kim HJ, 2005, BIOMATERIALS, V26, P4442, DOI 10.1016/j.biomaterials.2004.11.013
   Kulig KM, 2004, TRANSPL IMMUNOL, V12, P303, DOI 10.1016/j.trim.2003.12.005
   Le Blanc K, 2007, J INTERN MED, V262, P509, DOI 10.1111/j.1365-2796.2007.01844.x
   Lee KBL, 2007, STEM CELLS, V25, P2964, DOI 10.1634/stemcells.2006-0311
   Maria C.D, 2010, HISTOL HISTOPATHOL, V25, P397
   Mauck RL, 2003, TISSUE ENG, V9, P597, DOI 10.1089/107632703768247304
   Miao ZN, 2006, CELL BIOL INT, V30, P681, DOI 10.1016/j.cellbi.2006.03.009
   O'Donoghue K, 2003, MOL HUM REPROD, V9, P497, DOI 10.1093/molehr/gag063
   Parolini O, 2008, STEM CELLS, V26, P300, DOI 10.1634/stemcells.2007-0594
   Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143
   Pountos I, 2007, INJURY, V38, P23, DOI DOI 10.1016/S0020-1383(08)70006-8
   Ratajczak J, 2006, LEUKEMIA, V20, P1487, DOI 10.1038/sj.leu.2404296
   Ratajczak MZ, 2012, LEUKEMIA, V26, P1166, DOI 10.1038/leu.2011.389
   Ringden O, 2006, TRANSPLANTATION, V81, P1390, DOI 10.1097/01.tp.0000214462.63943.14
   Sarugaser R, 2005, STEM CELLS, V23, P220, DOI 10.1634/stemcells.2004-0166
   Schuh EM, 2009, AM J VET RES, V70, P1526, DOI 10.2460/ajvr.70.12.1526
   Temenoff JS, 2000, BIOMATERIALS, V21, P431, DOI 10.1016/S0142-9612(99)00213-6
   Toma C, 2002, CIRCULATION, V105, P93, DOI 10.1161/hc0102.101442
   Woodbury D, 2000, J NEUROSCI RES, V61, P364, DOI 10.1002/1097-4547(20000815)61:4<364::AID-JNR2>3.3.CO;2-3
   Xue Q, 2010, STEM CELLS DEV, V19, P27, DOI 10.1089/scd.2009.0076
   Zuk PA, 2001, TISSUE ENG, V7, P211, DOI 10.1089/107632701300062859
NR 28
TC 16
Z9 18
U1 1
U2 19
PU MARY ANN LIEBERT INC
PI NEW ROCHELLE
PA 140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA
SN 2152-4971
J9 CELL REPROGRAM
JI Cell. Reprogramm.
PD AUG
PY 2012
VL 14
IS 4
BP 334
EP 341
DI 10.1089/cell.2012.0002
PG 8
WC Cell & Tissue Engineering; Biotechnology & Applied Microbiology;
   Genetics & Heredity
SC Cell Biology; Biotechnology & Applied Microbiology; Genetics & Heredity
GA 985TH
UT WOS:000307292500006
PM 22816556
DA 2018-10-19
ER

PT J
AU Rodriguez, IA
   Lopez-Lopez, MT
   Oliveira, ACX
   Sanchez-Quevedo, MC
   Campos, A
   Alaminos, M
   Duran, JDG
AF Rodriguez, I. A.
   Lopez-Lopez, M. T.
   Oliveira, A. C. X.
   Sanchez-Quevedo, M. C.
   Campos, A.
   Alaminos, M.
   Duran, J. D. G.
TI Rheological characterization of human fibrin and fibrin-agarose oral
   mucosa substitutes generated by tissue engineering
SO JOURNAL OF TISSUE ENGINEERING AND REGENERATIVE MEDICINE
LA English
DT Article
DE oral mucosa; fibrin; fibrin-agarose; rheology; viscoelasticity; yield
   stress; viscoelastic moduli
ID IN-VITRO; RECONSTRUCTION; EXPRESSION; PATTERNS; SCAFFOLD; PALATE; GRAFT
AB In regenerative medicine, the generation of biocompatible substitutes of tissues by in vitro tissue engineering must fulfil certain requirements. In the case of human oral mucosa, the rheological properties of tissues deserve special attention because of their influence in the acoustics and biomechanics of voice production. This work is devoted to the rheological characterization of substitutes of the connective tissue of the human oral mucosa. Two substitutes, composed of fibrin and fibrinagarose, were prepared in cell culture for periods in the range 121?days. The time evolution of the rheological properties of both substitutes was studied by two different experimental procedures: steady-state and oscillatory measurements. The former allows the plastic behaviour of the substitutes to be characterized by estimating their yield stress; the latter is employed to quantify their viscoelastic responses by obtaining the elastic (G') and viscous (G'') moduli. The results demonstrate that both substitutes are characterized by a predominant elastic response, in which G' (order 100?Pa) is roughly one order of magnitude larger than G'' (order 10?Pa). But the most relevant insight is the stability, throughout the 21?days of culture time, of the rheological quantities in the case of fibrinagarose, whereas the fibrin substitute shows a significant hardening. This result provides evidence that the addition to fibrin of a small amount of agarose allows the rheological stability of the oral mucosa substitute to be maintained. This feature, together with its viscoelastic similitude with native tissues, makes this biomaterial appropriate for potential use as a scaffold in regenerative therapies of human oral mucosa. Copyright (c) 2011 John Wiley & Sons, Ltd.
C1 [Duran, J. D. G.] Univ Granada, Fac Sci, Dept Appl Phys, E-18071 Granada, Spain.
   [Rodriguez, I. A.] Natl Univ Cordoba, Sch Dent, Dept Histol B, Cordoba, Argentina.
   [Oliveira, A. C. X.; Sanchez-Quevedo, M. C.; Campos, A.; Alaminos, M.] Univ Granada, Dept Histol, Tissue Engn Grp, E-18071 Granada, Spain.
RP Duran, JDG (reprint author), Univ Granada, Fac Sci, Dept Appl Phys, Campus Fuentenueva, E-18071 Granada, Spain.
EM jdgarcia@ugr.es
RI Lopez-Duran, Juan de Dios/M-2774-2014; Lopez-Lopez, Modesto
   T/K-7327-2012; ALAMINOS, MIGUEL/N-9960-2016
OI Lopez-Duran, Juan de Dios/0000-0002-5586-1276; Lopez-Lopez, Modesto
   T/0000-0002-9068-7795; ALAMINOS, MIGUEL/0000-0003-4876-2672
FU National Ministry of Science and Innovation; MCINN; Instituto de Salud
   Carlos III, Spain [FIS PI 08/0615, FIS2009-07321]; Junta de Andalucia,
   Spain [P08-FQM-3993, P09-FQM-4787]; University of Granada, Spain
FX This study was supported by the National Ministry of Science and
   Innovation, MCINN, Instituto de Salud Carlos III, Spain (Grant Nos FIS
   PI 08/0615 and FIS2009-07321) and the Junta de Andalucia, Spain (Grant
   Nos P08-FQM-3993 and P09-FQM-4787). M.T.L.-L. also acknowledges
   financial support by the University of Granada, Spain.
CR Alaminos M, 2007, J TISSUE ENG REGEN M, V1, P350, DOI 10.1002/term.38
   Alaminos M, 2006, INVEST OPHTH VIS SCI, V47, P3311, DOI 10.1167/iovs.05-1647
   Barnes H. A., 1993, INTRO RHEOLOGY
   BARNES HA, 1995, J NON-NEWTON FLUID, V56, P221, DOI 10.1016/0377-0257(94)01282-M
   Birch MJ, 2009, CLEFT PALATE-CRAN J, V46, P268, DOI 10.1597/08-012.1
   Chan RW, 1999, J ACOUST SOC AM, V106, P2008, DOI 10.1121/1.427947
   CLARK RAF, 2000, PRINCIPLES TISSUE EN, P857
   de Souza Sergio Luis Scombatti, 2008, J Int Acad Periodontol, V10, P87
   Fujioka M, 1997, CLEFT PALATE-CRAN J, V34, P297, DOI 10.1597/1545-1569(1997)034<0297:MGFAIO>2.3.CO;2
   Garzon I, 2009, J PERIODONTAL RES, V44, P588, DOI 10.1111/j.1600-0765.2008.01159.x
   Garzon I, 2009, INT J ARTIF ORGANS, V32, P711
   Grayson WL, 2009, SEMIN CELL DEV BIOL, V20, P665, DOI 10.1016/j.semcdb.2008.12.008
   Inoue K, 1985, Dent Mater J, V4, P47
   Kassab Moawia M, 2010, Dent Clin North Am, V54, P129, DOI 10.1016/j.cden.2009.08.009
   Kutty JK, 2009, TISSUE ENG PART B-RE, V15, P249, DOI 10.1089/ten.TEB.2008.0588
   Langer B, 1985, J PERIODONTOL, V48, P151
   Lauer G, 2001, J ORAL MAXIL SURG, V59, P169, DOI 10.1053/joms.2001.20489
   MacNeil S, 2011, METHODS MOL BIOL, V695, P129, DOI 10.1007/978-1-60761-984-0_9
   Macosko CW, 1994, RHEOLOGY PRINCIPLES
   Novaes AB, 2007, J PERIODONTOL, V78, P296, DOI 10.1902/jop.2007.060060
   Paolantonio M, 2002, J PERIODONTOL, V73, P1299, DOI 10.1902/jop.2002.73.11.1299
   Pena I, 2010, J PERIODONTAL RES, V45, P375, DOI 10.1111/j.1600-0765.2009.01248.x
   Pretuzzelli GJ, 1992, ANN PLAST SURG, V47, P293
   ROODENBURG JLN, 1990, INT J ORAL MAX SURG, V19, P181, DOI 10.1016/S0901-5027(05)80141-9
   Rosenthal E, 2004, HEAD NECK-J SCI SPEC, V26, P930, DOI 10.1002/hed.20076
   Rouabhia M, 2010, BIOMATERIALS, V31, P5798, DOI 10.1016/j.biomaterials.2010.04.004
   Sanchez-Quevedo MC, 2007, HISTOL HISTOPATHOL, V22, P631, DOI 10.14670/HH-22.631
   Schultze-Mosgau S, 2004, INT J ORAL MAX SURG, V33, P476, DOI 10.1016/j.ijom.2003.12.005
   Tamerler C, 2009, PHILOS T R SOC A, V367, P1705, DOI 10.1098/rsta.2009.0018
   Urken ML, 1995, ATLAS REGIONAL FREE, P261
   Yatabe M, 1991, Kokubyo Gakkai Zasshi, V58, P74
NR 31
TC 13
Z9 14
U1 2
U2 24
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1932-6254
EI 1932-7005
J9 J TISSUE ENG REGEN M
JI J. Tissue Eng. Regen. Med.
PD AUG
PY 2012
VL 6
IS 8
BP 636
EP 644
DI 10.1002/term.466
PG 9
WC Cell & Tissue Engineering; Biotechnology & Applied Microbiology; Cell
   Biology; Engineering, Biomedical
SC Cell Biology; Biotechnology & Applied Microbiology; Engineering
GA 980TO
UT WOS:000306916600005
PM 21916018
DA 2018-10-19
ER

PT J
AU Miyahara, T
   Nyan, M
   Shimoda, A
   Yamamoto, Y
   Kuroda, S
   Shiota, M
   Akiyoshi, K
   Kasugai, S
AF Miyahara, Takayuki
   Nyan, Myat
   Shimoda, Asako
   Yamamoto, Yuka
   Kuroda, Shinji
   Shiota, Makoto
   Akiyoshi, Kazunari
   Kasugai, Shohei
TI Exploitation of a novel polysaccharide nanogel cross-linking membrane
   for guided bone regeneration (GBR)
SO JOURNAL OF TISSUE ENGINEERING AND REGENERATIVE MEDICINE
LA English
DT Article
DE guided bone regeneration; biomaterials; bone regeneration; acryloyl
   group-modified cholesterol-bearing pullulan (CHPOA); morphometric
   analysis; radiology; membrane; animal experiments
ID OSSEOINTEGRATED TITANIUM IMPLANTS; CHOLESTEROL-BEARING PULLULAN;
   GROWTH-FACTOR; TISSUE REGENERATION; FOLLOW-UP; PROSPECTIVE MULTICENTER;
   HYDROGEL NANOPARTICLE; BOVINE COLLAGEN; ITI-IMPLANTS; STABILIZATION
AB Cholesterol-bearing pullulan (CHP) nanogel is a synthetic degradable biomaterial for drug delivery with high biocompatibility. Guided bone regeneration (GBR) is a bone augmentation technique in which a membrane is used to create and keep a secluded regenerative space. The purpose of the present study was to evaluate the effects of the novel CHP nanogel membrane in GBR. Thirty-six adult Wistar rats were used and bilaterally symmetrical full-thickness parietal bone defects of 5?mm diameter were created with a bone trephine burr. Each defect was covered with the collagen membrane or the CHP nanogel membrane or untreated without any membrane. The animals were sacrificed at 2, 4 and 8?weeks and analysed radiologically and histologically. Furthermore, after incubating human serum with CHP nanogel or collagen, the amount of PDGF in the serum was measured using ELISA. New bone formation in terms of bone volume was higher in the nanogel group than in the control or collagen groups at 2 and 4?weeks. At 8?weeks, both membrane groups showed higher bone volumes than the control group. Notably, the newly-formed bone in the bone defect in the nanogel group was uniform and histologically indistinguishable from the original bone, whereas in the collagen group the new bone showed an irregular structure that was completely different from the original bone. After incubating with CHP nanogel, the amount of PDGF in the serum decreased significantly. CHP nanogel GBR membrane favourably stimulated bone regeneration, in which a unique characteristic of CHP nanogel, the storage of endogenous growth factors, was likely implicated. Copyright (c) 2011 John Wiley & Sons, Ltd.
C1 [Miyahara, Takayuki] Tokyo Med & Dent Univ, Bunkyo Ku, Tokyo 1138549, Japan.
   [Shimoda, Asako; Yamamoto, Yuka; Akiyoshi, Kazunari] Tokyo Med & Dent Univ, Organ Biomat Inst Biomat & Bioengn, Tokyo 1138549, Japan.
   [Akiyoshi, Kazunari] Kyoto Univ, Grad Sch Engn, Dept Polymer Chem, Kyoto 6068501, Japan.
   [Miyahara, Takayuki; Nyan, Myat; Shimoda, Asako; Akiyoshi, Kazunari; Kasugai, Shohei] Tokyo Med & Dent Univ, Global Ctr Excellence GCOE Programme, Int Res Ctr Mol Sci Tooth & Bone Dis, Tokyo 1138549, Japan.
RP Miyahara, T (reprint author), Tokyo Med & Dent Univ, Bunkyo Ku, 1-5-45 Yushima, Tokyo 1138549, Japan.
EM miyahara.irm@tmd.ac.jp
FU Ministry of Education, Culture, Sports, Science and Technology, Japan
   [22791925, 22659355]
FX We greatly appreciate the help of Dr Tomoko Nagayama, Dr Jia Hao, Dr
   Reena Rodriguez, Dr Warunee Pluemsakunthai and Dr Hisham Rojbani with
   animal experiments and Dr Toshimitsu Yamamoto with histomorphometric
   analysis. This work was supported by Grants-in-Aid for GCOE Research and
   for Exploratory Research from the Ministry of Education, Culture,
   Sports, Science and Technology, Japan (Grant Nos 22791925, 22659355).
CR Akiyoshi K, 1999, BIOCONJUGATE CHEM, V10, P321, DOI 10.1021/bc9801272
   Akiyoshi K, 1996, EUR J PHARM BIOPHARM, V42, P286
   Akiyoshi K, 2002, BIOMACROMOLECULES, V3, P280, DOI 10.1021/bm010144l
   Akiyoshi K, 1998, J CONTROL RELEASE, V54, P313, DOI 10.1016/S0168-3659(98)00017-0
   Akiyoshi Kazunari, 2006, Nihon Rinsho, V64, P215
   Albrektsson T, 1986, Int J Oral Maxillofac Implants, V1, P11
   ALBREKTSSON T, 1981, ACTA ORTHOP SCAND, V52, P155, DOI 10.3109/17453678108991776
   Arvidson K, 1998, CLIN ORAL IMPLAN RES, V9, P225, DOI 10.1034/j.1600-0501.1998.090403.x
   Brocard D, 2000, INT J ORAL MAX IMPL, V15, P691
   Bunyaratavej P, 2001, J PERIODONTOL, V72, P215, DOI 10.1902/jop.2001.72.2.215
   Buser D, 1997, CLIN ORAL IMPLAN RES, V8, P161, DOI 10.1034/j.1600-0501.1997.080302.x
   Buser D, 1993, Int J Periodontics Restorative Dent, V13, P29
   CHARRIERE G, 1989, J AM ACAD DERMATOL, V21, P1203, DOI 10.1016/S0190-9622(89)70330-3
   Dahlin C, 1989, Int J Oral Maxillofac Implants, V4, P19
   DAHLIN C, 1988, PLAST RECONSTR SURG, V81, P672, DOI 10.1097/00006534-198805000-00004
   Hadjidakis DJ, 2006, ANN NY ACAD SCI, V1092, P385, DOI 10.1196/annals.1365.035
   HAMMERLE CHF, 1995, J PERIODONTOL, V66, P303
   Hayashi C, 2009, J CELL PHYSIOL, V220, P1, DOI 10.1002/jcp.21760
   Hsieh SC, 1998, J CELL BIOCHEM, V69, P169, DOI 10.1002/(SICI)1097-4644(19980501)69:2<169::AID-JCB7>3.0.CO;2-Q
   Kageyama S, 2008, CANCER SCI, V99, P601, DOI 10.1111/j.1349-7006.2007.00705.x
   Kamolratanakul P, 2011, ARTHRITIS RHEUM-US, V63, P1021, DOI 10.1002/art.30151
   KEEFE J, 1992, Clinical Materials, V9, P155, DOI 10.1016/0267-6605(92)90095-B
   Kobayashi H, 2009, J BIOMED MATER RES B, V91B, P55, DOI 10.1002/jbm.b.31373
   KOSTOPOULOS L, 1994, CLIN ORAL IMPLAN RES, V5, P245, DOI 10.1034/j.1600-0501.1994.050408.x
   Lee EJ, 2009, BIOMATERIALS, V30, P743, DOI 10.1016/j.biomaterials.2008.10.025
   Lekholm U, 1999, INT J ORAL MAX IMPL, V14, P639
   Leonhardt A, 2002, CLIN ORAL IMPLAN RES, V13, P127, DOI 10.1034/j.1600-0501.2002.130202.x
   Lindquist LW, 1996, CLIN ORAL IMPLAN RES, V7, P329, DOI 10.1034/j.1600-0501.1996.070405.x
   Lyn AK, 2004, J BIOMED MATER RES B, V71, P343
   Nevins M, 2009, INT J PERIODONT REST, V29, P583
   NYMAN S, 1982, J CLIN PERIODONTOL, V9, P290, DOI 10.1111/j.1600-051X.1982.tb02095.x
   NYMAN S, 1990, International Journal of Oral and Maxillofacial Implants, V5, P9
   Shimizu T, 2008, BIOCHEM BIOPH RES CO, V367, P330, DOI 10.1016/j.bbrc.2007.12.112
   Simion M, 1996, Int J Oral Maxillofac Implants, V11, P735
   Urban IA, 2009, INT J ORAL MAX IMPL, V24, P502
   van Steenberghe D, 1990, Int J Oral Maxillofac Implants, V5, P272
   VANSTEENBERGHE D, 1989, J PROSTHET DENT, V61, P217, DOI 10.1016/0022-3913(89)90378-8
   Zhang ZM, 1998, BIOCHEM BIOPH RES CO, V251, P190, DOI 10.1006/bbrc.1998.9412
NR 38
TC 12
Z9 14
U1 0
U2 31
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1932-6254
J9 J TISSUE ENG REGEN M
JI J. Tissue Eng. Regen. Med.
PD AUG
PY 2012
VL 6
IS 8
BP 666
EP 672
DI 10.1002/term.475
PG 7
WC Cell & Tissue Engineering; Biotechnology & Applied Microbiology; Cell
   Biology; Engineering, Biomedical
SC Cell Biology; Biotechnology & Applied Microbiology; Engineering
GA 980TO
UT WOS:000306916600008
PM 22095663
DA 2018-10-19
ER

PT J
AU Brochhausen, C
   Schmitt, VH
   Rajab, TK
   Planck, CNE
   Kramer, B
   Tapprich, C
   Wallwiener, M
   Hierlemann, H
   Planck, H
   Kirkpatrick, CJ
AF Brochhausen, Christoph
   Schmitt, Volker H.
   Rajab, Taufiek K.
   Planck, Constanze N. E.
   Kraemer, Bernhard
   Tapprich, Christine
   Wallwiener, Markus
   Hierlemann, Helmut
   Planck, Heinrich
   Kirkpatrick, C. James
TI Mesothelial morphology and organisation after peritoneal treatment with
   solid and liquid adhesion barriers-a scanning electron microscopical
   study
SO JOURNAL OF MATERIALS SCIENCE-MATERIALS IN MEDICINE
LA English
DT Article
ID UTERINE HORN MODEL; ABDOMINAL ADHESIONS; HOSPITAL READMISSIONS;
   UNITED-STATES; CELLS; PREVENTION; DIALYSIS; EXPRESSION; ICODEXTRIN;
   SURGERY
AB Separation of traumatized tissue represents the only promising strategy in postoperative adhesion prevention, a relevant clinical problem after surgical intervention. In the present study scanning electron microscopy (SEM) and subsequent morphometry were used to analyse the tissue response to five commercial adhesion barriers. Standardised peritoneal lesions in Wistar rats were covered with solid and viscous barrier materials and semiquantitatively analysed 14 days postoperatively. Striking morphological differences in lesion surface organisation between the barrier groups became apparent with colonisation of the barrier by mesothelial cells to different degrees. Furthermore, the mesothelial cells showed either a normal or activated phenotype depending on the underlying biomaterial. These experiments demonstrate that the examination by SEM gives useful insights into the performance of barrier materials and the cellular processes of adhesion prevention, since mesothelial cells play an active role in the pathogenesis of adhesion formation.
C1 [Brochhausen, Christoph; Schmitt, Volker H.; Tapprich, Christine; Kirkpatrick, C. James] Johannes Gutenberg Univ Mainz, Inst Pathol, REPAIR Lab, Univ Med Ctr, D-6500 Mainz, Germany.
   [Rajab, Taufiek K.] Harvard Univ, Brigham & Womens Hosp, Sch Med, Dept Surg, Boston, MA 02115 USA.
   [Planck, Constanze N. E.; Kraemer, Bernhard] Univ Tubingen, Dept Gynecol & Obstet, Tubingen, Germany.
   [Planck, Constanze N. E.; Hierlemann, Helmut; Planck, Heinrich] German Ctr Biomat & Artificial Organs eV, Denkendorf, Germany.
   [Wallwiener, Markus] Univ Heidelberg, Womens Hosp, Heidelberg, Germany.
   [Hierlemann, Helmut; Planck, Heinrich] Inst Text Technol & Proc Engn, Denkendorf, Germany.
RP Brochhausen, C (reprint author), Johannes Gutenberg Univ Mainz, Inst Pathol, REPAIR Lab, Univ Med Ctr, D-6500 Mainz, Germany.
EM brochhausen@pathologie.klinik.uni-mainz.de
CR Almeida O D Jr, 1997, J Am Assoc Gynecol Laparosc, V4, P587, DOI 10.1016/S1074-3804(05)80093-3
   BEAVIS J, 1994, PERITON DIALYSIS INT, V14, P348
   Bender TO, 2007, INT J ARTIF ORGANS, V30, P1075
   Bittinger F, 1997, EXP CELL RES, V236, P155, DOI 10.1006/excr.1997.3724
   Bittinger F, 1999, J SURG RES, V82, P28, DOI 10.1006/jsre.1998.5449
   Bittinger F, 1998, J PATHOL, V186, P422, DOI 10.1002/(SICI)1096-9896(199812)186:4<422::AID-PATH209>3.0.CO;2-7
   Bittinger F, 1996, PATHOBIOLOGY, V64, P320, DOI 10.1159/000164067
   Boland GM, 2006, J SURG RES, V132, P3, DOI 10.1016/j.jss.2005.12.002
   Boulanger E, 2004, NEPHROL DIAL TRANSPL, V19, P2208, DOI 10.1093/ndt/gfh277
   Brochhausen C, 2002, EXPRESSION KINETIK Z
   Brochhausen C, 2009, BIOMATERIALIEN, V10, P7
   Brochhausen C, 2012, J GASTROINTEST SURG, V16, P1256, DOI 10.1007/s11605-011-1819-9
   Brochhausen C, 2011, J BIOMED MATER RES A, V98A, P143, DOI 10.1002/jbm.a.33083
   BRUNSCHWIG A, 1953, J Int Chir, V13, P265
   BRUNSCHWIG A, 1954, 15 C SOC INT CHIR LI, P756
   Cheong YC, 2001, HUM REPROD UPDATE, V7, P556, DOI 10.1093/humupd/7.6.556
   Coleman MG, 2000, DIS COLON RECTUM, V43, P1297, DOI 10.1007/BF02237441
   Corona R, 2011, FERTIL STERIL, V95, P1224, DOI 10.1016/j.fertnstert.2011.01.004
   Dizerega GS, 2007, J BIOMED MATER RES B, V81B, P239, DOI 10.1002/jbm.b.30659
   DIZEREGA GS, 1990, PERITONEUM
   DOBBIE JW, 1988, AM J KIDNEY DIS, V12, P31, DOI 10.1016/S0272-6386(88)80068-4
   ELLIS H, 1965, BRIT J SURG, V52, P471, DOI 10.1002/bjs.1800520616
   Ellis H, 1999, LANCET, V353, P1476, DOI 10.1016/S0140-6736(98)09337-4
   Gotloib L, 2003, FREE RADICAL BIO MED, V34, P419, DOI 10.1016/S0891-5849(02)01296-0
   Gotloib L, 2002, NEPHRON, V92, P142, DOI 10.1159/000064482
   Gotloib Lazaro, 2009, Adv Perit Dial, V25, P6
   Gotloib L, 2009, CONTRIB NEPHROL, V163, P35, DOI 10.1159/000223778
   Ha H, 2000, PERITON DIALYSIS INT, V20, pS10
   Hellebrekers BWJ, 2011, BRIT J SURG, V98, P1503, DOI 10.1002/bjs.7657
   Howard FM, 2000, OBSTET GYNECOL, V96, P934, DOI 10.1016/S0029-7844(00)01056-5
   JOHNSON FR, 1962, BRIT J SURG, V49, P653, DOI 10.1002/bjs.18004921819
   Klein CL, 1995, PATHOBIOLOGY, V63, P204, DOI 10.1159/000163953
   Lower AM, 2000, BRIT J OBSTET GYNAEC, V107, P855, DOI 10.1111/j.1471-0528.2000.tb11083.x
   Lucas PA, 1996, J SURG RES, V65, P135, DOI 10.1006/jsre.1996.0355
   Lucas PA, 1996, J SURG RES, V62, P229, DOI 10.1006/jsre.1996.0200
   Maciver AH, 2011, SURGERY, V150, P907, DOI 10.1016/j.surg.2011.06.022
   Marana R, 2000, PERITONEAL SURG, P329
   MERLO G, 1980, EUR SURG RES, V12, P433, DOI 10.1159/000128151
   Mutsaers SE, 2002, RESPIROLOGY, V7, P171, DOI 10.1046/j.1440-1843.2002.00404.x
   Planck CNE, 2010, BIOMATERIALIEN, V11, P24
   RAFTERY AT, 1973, J ANAT, V115, P375
   Rajab TK, 2010, J SURG RES, V161, P246, DOI 10.1016/j.jss.2008.11.839
   Rajab TK, 2009, WORLD J SURG, V33, P748, DOI 10.1007/s00268-008-9917-x
   Rajab TK, 2009, SURGERY, V145, P196, DOI 10.1016/j.surg.2008.08.019
   Ray NF, 1998, J AM COLL SURGEONS, V186, P1, DOI 10.1016/S1072-7515(97)00127-0
   RAY NF, 1993, SURG GYNECOL OBSTET, V176, P271
   Sheldon HK, 2012, J GASTROINTEST SURG, V16, P325, DOI 10.1007/s11605-011-1709-1
   van der Krabben AA, 2000, BRIT J SURG, V87, P467, DOI 10.1046/j.1365-2168.2000.01394.x
   VANHINSBERGH VWM, 1990, BLOOD, V75, P1490
   Wallwiener CW, 2010, FERTIL STERIL, V93, P1040, DOI 10.1016/j.fertnstert.2008.12.002
   Wallwiener M, 2006, FERTIL STERIL, V86, P1266, DOI 10.1016/j.fertnstert.2006.05.023
   Yang B, 2011, J BIOMED MATER RES B, V96B, P57, DOI 10.1002/jbm.b.31739
   Yao V, 2003, BRIT J SURG, V90, P1187, DOI 10.1002/bjs.4373
   Zhong J H, 2000, Adv Perit Dial, V16, P36
NR 54
TC 7
Z9 7
U1 1
U2 10
PU SPRINGER
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 0957-4530
J9 J MATER SCI-MATER M
JI J. Mater. Sci.-Mater. Med.
PD AUG
PY 2012
VL 23
IS 8
BP 1931
EP 1939
DI 10.1007/s10856-012-4659-6
PG 9
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 976LT
UT WOS:000306586900010
PM 22573064
DA 2018-10-19
ER

PT J
AU McCanless, JD
   Jennings, LK
   Bumgardner, JD
   Cole, JA
   Haggard, WO
AF McCanless, Jonathan D.
   Jennings, Lisa K.
   Bumgardner, Joel D.
   Cole, Judith A.
   Haggard, Warren O.
TI Hematoma-inspired alginate/platelet releasate/CaPO4 composite:
   initiation of the inflammatory-mediated response associated with
   fracture repair in vitro and ex vivo injection delivery
SO JOURNAL OF MATERIALS SCIENCE-MATERIALS IN MEDICINE
LA English
DT Article
ID MESENCHYMAL STEM-CELLS; TRICALCIUM PHOSPHATE; GROWTH-FACTORS;
   BONE-MARROW; PLATELETS; BIOCOMPATIBILITY; DIFFERENTIATION; EXPRESSION;
   ACTIVATION; PROTEIN
AB A clinical need continues for consistent bone remodeling within problematic sites such as those of fracture nonunion, avascular necrosis, or irregular bone formations. In attempt to address such needs, a biomaterial system is proposed to induce early inflammatory responses after implantation and to provide later osteoconductive scaffolding for bone regeneration. Biomaterial-induced inflammation would parallel the early stage of hematoma-induced fracture repair and allow scaffold-promoted remodeling of osseous tissue to a healthy state. Initiation of the wound healing cascade by two human concentrated platelet releasate-containing alginate/beta-tricalcium phosphate biocomposites has been studied in vitro using the TIB-71 (TM) RAW264.7 mouse monocyte cell line. Inflammatory responses inherent to the base material were found and could be modulated through incorporation of platelet releasate. Differences in hydrogel wt% (2 vs. 8 %) and/or calcium phosphate granule vol.% (20 vs. 10 %) allowed for tuning the response associated with platelet releasate-associated growth factor elution. Tunability from completely suppressing the inflammatory response to augmenting the response was observed through varied elution profiles of both releasate-derived bioagents and impurities inherent to alginate. A 2.5-fold upregulation of inducible-nitric oxide synthase gene expression followed by a tenfold increase in nitrite media levels was induced by inclusion of releasate within the 8 wt%/10 vol.% formulation and was comparable to an endotoxin positive control. Whereas, near complete elimination of inflammation was seen when releasate was included within the 2 wt%/20 vol.% formulation. These in vitro results suggested tunable interactions between the multiple platelet releasate-derived bioagents and the biocomposites for enhancing hematoma-like fracture repair. Additionally, minimally invasive delivery for in situ curing of the implant system via injection was demonstrated in rat tail vertebrae using microcomputed tomography.
C1 [McCanless, Jonathan D.; Bumgardner, Joel D.; Haggard, Warren O.] Univ Memphis, Dept Biomed Engn, Herff Coll Engn, Memphis, TN 38152 USA.
   [Jennings, Lisa K.] Univ Tennessee, Hlth Sci Ctr, Coll Med, Dept Internal Med, Memphis, TN 38163 USA.
   [Jennings, Lisa K.] Univ Tennessee, Hlth Sci Ctr, Vasc Biol Ctr Excellence, Memphis, TN 38163 USA.
   [Cole, Judith A.] Univ Memphis, Dept Biol Sci, Coll Arts & Sci, Memphis, TN 38152 USA.
RP McCanless, JD (reprint author), Univ Memphis, Dept Biomed Engn, Herff Coll Engn, 330 Engn Technol Bldg,3815 Cent Ave, Memphis, TN 38152 USA.
EM jonathan_mccanless@excite.com
CR Aslam R, 2006, BLOOD, V107, P637, DOI 10.1182/blood-2005-06-2202
   Bauer TW, 2007, ARCH PATHOL LAB MED, V131, P217
   Beamer Brandon, 2010, HSS J, V6, P85, DOI 10.1007/s11420-009-9129-4
   Boyle WJ, 2003, NATURE, V423, P337, DOI 10.1038/nature01658
   Brass L, 2010, HEMATOL-AM SOC HEMAT, P387, DOI 10.1182/asheducation-2010.1.387
   Burg KJL, 2000, BIOMATERIALS, V21, P2347, DOI 10.1016/S0142-9612(00)00102-2
   Cuetara BLV, 2006, IN VITRO CELL DEV-AN, V42, P182
   Dimitriou R, 2011, BMC MED, V9, DOI 10.1186/1741-7015-9-66
   dos Santos EA, 2008, J MATER SCI-MATER M, V19, P2307, DOI 10.1007/s10856-007-3347-4
   El-Sharkawy H, 2007, J PERIODONTOL, V78, P661, DOI 10.1902/jop.2007.060302
   Goldring SR, 2008, RHEUM DIS CLIN N AM, V34, P561, DOI 10.1016/j.rdc.2008.07.001
   Gordon S, 2005, NAT REV IMMUNOL, V5, P953, DOI 10.1038/nri1733
   Gruber R, 2002, BONE, V30, P726, DOI 10.1016/S8756-3282(02)00697-X
   Gurevitch O, 2009, FOLIA BIOL-PRAGUE, V55, P27
   Haselmayer P, 2007, BLOOD, V110, P1029, DOI 10.1182/blood-2007-01-069195
   Janicki P, 2011, INJURY, V42, pS77, DOI 10.1016/j.injury.2011.06.014
   Kalfas IH, 2001, NEUROSURG FOCUS, V10, P1, DOI DOI 10.3171/FOC.2001.10.4.2
   Kolar P, 2010, TISSUE ENG PART B-RE, V16, P427, DOI 10.1089/ten.TEB.2009.0687
   Kolk A, 2012, J CRANIOMAXILLOFAC S
   Kong H, 2005, POLYSACCHARIDES, P817
   Leslie M, 2010, SCIENCE, V328, P562, DOI 10.1126/science.328.5978.562
   Lock EF, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-386
   Ma PX, 2006, SCAFFOLDING TISSUE E, P13
   McCanless J, 2012, 58 ANN M ORTH RES SO
   McCanless JD, 2012, J BIOMED MATER RES A, V100A, P1107, DOI 10.1002/jbm.a.34038
   McCanless JD, 2012, J BIOMED MATER RES A, V100A, P220, DOI 10.1002/jbm.a.33256
   Mehta S, 2008, J ORTHOP TRAUMA, V22, P433, DOI 10.1097/BOT.0b013e31817e793f
   Mitani T, 2005, NITRIC OXIDE-BIOL CH, V13, P78, DOI 10.1016/j.niox.2005.05.001
   Mora R, 2006, NONUNION LONG BONES
   Motamedi K, 2011, RADIOL CLIN N AM, V49, P1115, DOI 10.1016/j.rcl.2011.07.002
   Muguruma Y, 2006, BLOOD, V107, P1878, DOI 10.1182/blood-2005-06-2211
   Nicolin V, 2005, ANAT REC PART A, V286A, P945, DOI 10.1002/ar.a.20239
   Nunamaker EA, 2007, J BIOMED MATER RES A, V83A, P1128, DOI 10.1002/jbm.a.31275
   Schmidhammer R, 2006, J TRAUMA, V61, P199, DOI 10.1097/01.ta.0000195987.57939.7e
   Semple JW, 2011, NAT REV IMMUNOL, V11, P264, DOI 10.1038/nri2956
   Shiraki R, 2004, THROMB RES, V113, P379, DOI 10.1016/j.thromres.2004.03.023
   Sun Y, 2010, INT ORTHOP, V34, P589, DOI 10.1007/s00264-009-0793-2
   Tanaka T, 2010, J BIOMED MATER RES A, V93A, P469, DOI 10.1002/jbm.a.32560
   Wang ML, 2007, SPINE J, V7, P466, DOI 10.1016/j.spinee.2006.06.400
   Washington AV, 2009, J CLIN INVEST, V119, P1489, DOI 10.1172/JCI36175
   Whitelaw M. A., 1999, V69, P99
   Williams DF, 2008, BIOMATERIALS, V29, P2941, DOI 10.1016/j.biomaterials.2008.04.023
NR 42
TC 3
Z9 3
U1 0
U2 19
PU SPRINGER
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 0957-4530
EI 1573-4838
J9 J MATER SCI-MATER M
JI J. Mater. Sci.-Mater. Med.
PD AUG
PY 2012
VL 23
IS 8
BP 1971
EP 1981
DI 10.1007/s10856-012-4672-9
PG 11
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 976LT
UT WOS:000306586900014
PM 22588505
DA 2018-10-19
ER

PT J
AU Janardhanan, S
   Wang, MO
   Fisher, JP
AF Janardhanan, Sathyanarayana
   Wang, Martha O.
   Fisher, John P.
TI Coculture Strategies in Bone Tissue Engineering: The Impact of Culture
   Conditions on Pluripotent Stem Cell Populations
SO TISSUE ENGINEERING PART B-REVIEWS
LA English
DT Review
ID CHONDROGENIC DIFFERENTIATION; OSTEOGENIC DIFFERENTIATION; IN-VITRO;
   GENE-EXPRESSION; ARTICULAR CHONDROCYTES; STROMAL CELLS; ENDOCHONDRAL
   OSSIFICATION; MORPHOGENETIC SIGNALS; 3-DIMENSIONAL CULTURE; FLOW
   PERFUSION
AB The use of pluripotent stem cell populations for bone tissue regeneration provides many opportunities and challenges within the bone tissue engineering field. For example, coculture strategies have been utilized to mimic embryological development of bone tissue, and particularly the critical intercellular signaling pathways. While research in bone biology over the last 20 years has expanded our understanding of these intercellular signaling pathways, we still do not fully understand the impact of the system's physical characteristics (orientation, geometry, and morphology). This review of coculture literature delineates the various forms of coculture systems and their respective outcomes when applied to bone tissue engineering. To understand fully the key differences between the different coculture methods, we must appreciate the underlying paradigms of physiological interactions. Recent advances have enabled us to extrapolate these techniques to larger dimensions and higher geometric resolutions. Finally, the contributions of bioreactors, micropatterned biomaterials, and biomaterial interaction platforms are evaluated to give a sense of the sophistication established by a combination of these concepts with coculture systems.
C1 [Wang, Martha O.; Fisher, John P.] Univ Maryland, Fischell Dept Bioengn, College Pk, MD 20742 USA.
   [Janardhanan, Sathyanarayana; Fisher, John P.] Univ Maryland, Dept Chem & Biomol Engn, College Pk, MD 20742 USA.
RP Fisher, JP (reprint author), Univ Maryland, Fischell Dept Bioengn, 3238 Jeong H Kim Engn Bldg 225, College Pk, MD 20742 USA.
EM jpfisher@umd.edu
FU National Institutes of Health [R01 AR061460]
FX This research was supported by the National Institutes of Health (R01
   AR061460).
CR Ahmed Nazish, 2007, Cell Physiol Biochem, V20, P665, DOI 10.1159/000107728
   Asnaghi MA, 2009, BIOMATERIALS, V30, P5260, DOI 10.1016/j.biomaterials.2009.07.018
   Barry F, 2001, EXP CELL RES, V268, P189, DOI 10.1006/excr.2001.5278
   Bhatia SN, 1999, FASEB J, V13, P1883
   Bidwell JP, 1998, J BONE MINER RES, V13, P155, DOI 10.1359/jbmr.1998.13.2.155
   Boskey AL, 2000, J CELL BIOCHEM, V79, P89, DOI 10.1002/1097-4644(2000)79:1<89::AID-JCB90>3.0.CO;2-A
   Botchwey EA, 2001, J BIOMED MATER RES, V55, P242
   Cancedda R, 2000, INT J DEV BIOL, V44, P707
   CHEN U, 1993, DEV DYNAM, V197, P217, DOI 10.1002/aja.1001970306
   Chen X, 2006, STEM CELLS, V24, P2052, DOI 10.1634/stemcells.2005-0591
   Coates EE, 2010, ANN BIOMED ENG, V38, P3371, DOI 10.1007/s10439-010-0096-1
   Colnot C, 2005, J CELL BIOCHEM, V95, P688, DOI 10.1002/jcb.20449
   Colnot CI, 2001, MECH DEVELOP, V100, P245, DOI 10.1016/S0925-4773(00)00532-3
   Duffy GP, 2009, TISSUE ENG PT A, V15, P2459, DOI [10.1089/ten.tea.2008.0341, 10.1089/ten.TEA.2008.0341]
   Franceschi RT, 2007, ANN NY ACAD SCI, V1116, P196, DOI 10.1196/annals.1402.081
   Gerstenfeld LC, 2003, CONNECT TISSUE RES, V44, P85, DOI 10.1080/03008200390152142
   Gerstenfeld LC, 2002, J BONE MINER RES, V17, P221, DOI 10.1359/jbmr.2002.17.2.221
   Ghosh P, 2010, ARTHRITIS RES THER, V12, DOI 10.1186/ar2935
   Giovannini S, 2010, EUR CELLS MATER, V20, P245
   Goldring MB, 2006, J CELL BIOCHEM, V97, P33, DOI 10.1002/jcb.20652
   Goldstein AS, 2001, BIOMATERIALS, V22, P1279, DOI 10.1016/S0142-9612(00)00280-5
   Gomes ME, 2003, J BIOMED MATER RES A, V67A, P87, DOI 10.1002/jbm.a.10075
   Grassel S, 2010, RHEUMATOLOGY, V49, P218, DOI 10.1093/rheumatology/kep326
   Granchi D, 2010, TISSUE ENG PART C-ME, V16, P511, DOI [10.1089/ten.tec.2009.0405, 10.1089/ten.TEC.2009.0405]
   Grassel S, 2007, FRONT BIOSCI, V12, P4946, DOI 10.2741/2440
   Grellier M, 2009, TRENDS BIOTECHNOL, V27, P562, DOI 10.1016/j.tibtech.2009.07.001
   Handschel Jorg G K, 2007, Head Face Med, V3, P4, DOI 10.1186/1746-160X-3-4
   Hendriks J, 2007, J TISSUE ENG REGEN M, V1, P170, DOI 10.1002/term.19
   Heng BC, 2004, STEM CELLS, V22, P1152, DOI 10.1634/stemcells.2004-0062
   Hoemann CD, 2009, PATHOL BIOL, V57, P318, DOI 10.1016/j.patbio.2008.06.004
   Holtorf HL, 2005, J BIOMED MATER RES A, V72A, P326, DOI 10.1002/jbm.a.30251
   Hwang NS, 2007, J CELL PHYSIOL, V212, P281, DOI 10.1002/jcp.21052
   Hwang NS, 2006, STEM CELLS, V24, P284, DOI 10.1634/stemcells.2005-0024
   Ilmer M, 2009, TISSUE ENG PT A, V15, P2397, DOI 10.1089/ten.tea.2008.0427
   Inanc B, 2006, TISSUE ENG, V12, P257, DOI 10.1089/ten.2006.12.257
   James CG, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008693
   Jiang J, 2005, BIOCHEM BIOPH RES CO, V338, P762, DOI 10.1016/j.bbrc.2005.10.025
   Jin QM, 2003, J BIOMED MATER RES A, V67A, P54, DOI 10.1002/jbm.a.10058
   Jing DH, 2010, HAEMATOL-HEMATOL J, V95, P542, DOI 10.3324/haematol.2009.010736
   Kim K., 2010, ACTA BIOMATER, V7, P1249
   Kim K, 2010, TISSUE ENG PART B-RE, V16, P523, DOI [10.1089/ten.teb.2010.0171, 10.1089/ten.TEB.2010.0171]
   Kozhevnikova M N, 2008, Izv Akad Nauk Ser Biol, P261
   Kumar D, 2009, MOL CELL BIOL, V29, P4262, DOI 10.1128/MCB.01779-08
   LACOMBEGLEIZE S, 1995, IN VITRO CELL DEV-AN, V31, P649
   Lee JY, 2009, LANGMUIR, V25, P3880, DOI [10.1021/la803635r, 10.1021/1a803635r]
   Lettry V, 2010, JPN J VET RES, V58, P5
   Lichtenberg A, 2005, BIOMATERIALS, V26, P555, DOI 10.1016/j.biomaterials.2004.02.063
   Liu X, 2010, BIOMATERIALS, V31, P9406, DOI 10.1016/j.biomaterials.2010.08.052
   Moon JJ, 2009, TISSUE ENG PT A, V15, P579, DOI 10.1089/ten.tea.2008.0196
   Nakaoka R, 2006, TISSUE ENG, V12, P2425, DOI 10.1089/ten.2006.12.2425
   Ortega N, 2004, TRENDS CELL BIOL, V14, P86, DOI 10.1016/j.tcb.2003.12.003
   Phillips JE, 2007, TISSUE ENG, V13, P2029, DOI 10.1089/ten.2006.0041
   Rai MF, 2009, RES VET SCI, V87, P399, DOI 10.1016/j.rvsc.2009.04.008
   Rubin J, 2006, GENE, V367, P1, DOI 10.1016/j.gene.2005.10.028
   Sanchez C, 2005, OSTEOARTHR CARTILAGE, V13, P988, DOI 10.1016/j.joca.2005.07.012
   Sikavitsas VI, 2001, BIOMATERIALS, V22, P2581, DOI 10.1016/S0142-9612(01)00002-3
   Spalazzi JP, 2003, IEEE ENG MED BIOL, V22, P27, DOI 10.1109/MEMB.2003.1256269
   Stanton LA, 2004, BIOCHEM J, V378, P53, DOI 10.1042/BJ20030874
   Steinert A, 2003, J ORTHOPAED RES, V21, P1090, DOI 10.1016/S0736-0266(03)00100-1
   Stiehler M, 2009, J BIOMED MATER RES A, V89A, P96, DOI 10.1002/jbm.a.31967
   Takagi M, 2008, BIOTECHNOL LETT, V30, P1189, DOI 10.1007/s10529-008-9683-8
   Takahashi S, 2009, J BIOSCI BIOENG, V108, P544, DOI 10.1016/j.jbiosc.2009.06.013
   Thompson AD, 2009, TISSUE ENG PT A, V15, P1181, DOI 10.1089/ten.tea.2007.0275
   Trkov S, 2010, J TISSUE ENG REGEN M, V4, P205, DOI 10.1002/term.231
   Tsuchiya K, 2004, MAT SCI ENG C-BIO S, V24, P391, DOI 10.1016/j.msec.2003.12.014
   Wei AQ, 2009, TISSUE ENG PT A, V15, P2581, DOI [10.1089/ten.tea.2008.0458, 10.1089/ten.TEA.2008.0458]
   Williams C, 2005, ANN BIOMED ENG, V33, P920, DOI 10.1007/s10439-005-3238-0
   Woods A, 2006, J BIOL CHEM, V281, P13134, DOI 10.1074/jbc.M509433200
   Yoon D.M., 2007, TISSUE ENG, V585, P67
   Yoon DM, 2007, BIOMATERIALS, V28, P299, DOI 10.1016/j.biomaterials.2006.08.039
   Yu XJ, 2004, P NATL ACAD SCI USA, V101, P11203, DOI 10.1073/pnas.0402532101
   Zaucke F, 2001, BIOCHEM J, V358, P17, DOI 10.1042/0264-6021:3580017
   Zeng Y, 2008, J BIOMECH ENG-T ASME, V130, DOI 10.1115/1.2913231
NR 73
TC 8
Z9 9
U1 1
U2 27
PU MARY ANN LIEBERT, INC
PI NEW ROCHELLE
PA 140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA
SN 1937-3368
J9 TISSUE ENG PART B-RE
JI Tissue Eng. Part B-Rev.
PD AUG
PY 2012
VL 18
IS 4
BP 312
EP 321
DI 10.1089/ten.teb.2011.0681
PG 10
WC Cell & Tissue Engineering; Biotechnology & Applied Microbiology; Cell
   Biology
SC Cell Biology; Biotechnology & Applied Microbiology
GA 979IK
UT WOS:000306810500007
PM 22655979
OA Green Published
DA 2018-10-19
ER

PT J
AU Bal, BS
   Rahaman, MN
AF Bal, B. S.
   Rahaman, M. N.
TI Orthopedic applications of silicon nitride ceramics
SO ACTA BIOMATERIALIA
LA English
DT Review
DE Silicon nitride; Biomaterials; Ceramics; Hip and knee replacement
ID TOTAL HIP-ARTHROPLASTY; CROSS-LINKED POLYETHYLENE; TOTAL KNEE
   ARTHROPLASTY; ZIRCONIA FEMORAL-HEAD; IMPROVED OXIDATION RESISTANCE;
   RANDOMIZED CONTROLLED-TRIAL; LOW-FRICTION ARTHROPLASTY; IN-VITRO;
   FOLLOW-UP; MECHANICAL-PROPERTIES
AB Silicon nitride (Si3N4) is a ceramic material developed for industrial applications that demand high strength and fracture resistance under extreme operating conditions. Recently, Si3N4 has been used as an orthopedic biomaterial, to promote bone fusion in spinal surgery and to develop bearings that can improve the wear and longevity of prosthetic hip and knee joints. Si3N4 has been implanted in human patients for over 3 years now, and clinical trials with Si3N4 femoral heads in prosthetic hip replacement are contemplated. This review will provide background information and data relating to Si3N4 ceramics that will be of interest to engineering and medical professionals. (c) 2012 Acta Materialia Inc. Published by Elsevier Ltd. All rights reserved.
C1 [Bal, B. S.] Univ Missouri, Sch Med, Dept Orthopaed Surg, Columbia, MO 65211 USA.
   [Rahaman, M. N.] Missouri Univ Sci & Technol, Dept Mat Sci & Engn, Rolla, MO 65409 USA.
RP Bal, BS (reprint author), Univ Missouri, Sch Med, Dept Orthopaed Surg, Columbia, MO 65211 USA.
EM balb@health.missouri.edu
OI Bal, B. Sonny/0000-0002-9615-8632
CR Affatato S, 2006, J BIOMED MATER RES B, V78B, P76, DOI 10.1002/jbm.b.30462
   Akagi M, 2000, J BONE JOINT SURG AM, V82A, P1626, DOI 10.2106/00004623-200011000-00017
   Anderson MC, 2010, J BIOMED MATER RES A, V92A, P1598, DOI 10.1002/jbm.a.32498
   Bal BS, 2008, J BIOMED MATER RES B, V87B, P447, DOI 10.1002/jbm.b.31123
   Bal B Sonny, 2008, Instr Course Lect, V57, P223
   Bal B Sonny, 2006, J Knee Surg, V19, P89
   Bal BS, 2009, J ARTHROPLASTY, V24, P110, DOI 10.1016/j.arth.2008.01.300
   Bal SB, 2006, SEMIN ARTHROPLASTY, V17, P94
   Barrack RL, 2004, CLIN ORTHOP RELAT R, P73, DOI 10.1097/01.blo.0000150132.11142.d2
   Bascarevic Z, 2010, INT ORTHOP, V34, P1129, DOI 10.1007/s00264-009-0899-6
   Becher PF, 1998, J AM CERAM SOC, V81, P2821
   BECHER PF, 1991, J AM CERAM SOC, V74, P255, DOI 10.1111/j.1151-2916.1991.tb06872.x
   Blewis ME, 2007, EUR CELLS MATER, V13, P26, DOI 10.22203/eCM.v013a03
   Blumenfeld TJ, 2010, KNEE, V17, P412, DOI 10.1016/j.knee.2009.11.008
   Bozic KJ, 2009, J BONE JOINT SURG AM, V91A, P1614, DOI 10.2106/JBJS.H.01220
   Brook R., 1991, CONCISE ENCY ADV CER
   Burnett R Stephen J, 2009, Iowa Orthop J, V29, P28
   Capello WN, 2011, CLIN ORTHOP RELAT R, V469, P825, DOI 10.1007/s11999-010-1556-5
   Cappi B, 2010, J BIOMED MATER RES A, V93A, P67, DOI 10.1002/jbm.a.32527
   CHARNLEY J, 1995, CLIN ORTHOP RELAT R, P4
   Chen FC, 2000, MATER RES INNOV, V3, P250, DOI 10.1007/PL00010875
   Cheong YS, 2000, J AM CERAM SOC, V83, P154, DOI 10.1111/j.1151-2916.2000.tb01164.x
   Cheong YS, 2000, J AM CERAM SOC, V83, P161, DOI 10.1111/j.1151-2916.2000.tb01165.x
   Chowdhury S, 2007, J BIOMED MATER RES B, V81B, P486, DOI 10.1002/jbm.b.30688
   Clarke IC, 2003, J BONE JOINT SURG AM, V85A, P73, DOI 10.2106/00004623-200300004-00009
   Cooper HJ, 2010, CLIN ORTHOP RELAT R, V468, P3278, DOI 10.1007/s11999-010-1361-1
   Corradi M, 2011, CLIN ORTHOP RELAT R, V469, P1651, DOI 10.1007/s11999-010-1682-0
   Davda K, 2011, J BONE JOINT SURG BR, V93B, P738, DOI 10.1302/0301-620X.93B6.25804
   Davis DH, 2002, BIOMATERIALS, V23, P4019, DOI 10.1016/S0142-9612(02)00152-7
   Fernandez-Fairen M, 2007, CLIN ORTHOP RELAT R, P122, DOI 10.1097/BLO.0b013eb4c3
   FISCHER TE, 1985, WEAR, V105, P29, DOI 10.1016/0043-1648(85)90004-3
   Fukui K, 2011, J ARTHROPLASTY, V26, P45, DOI 10.1016/j.arth.2009.11.005
   Garino JP, 2000, CLIN ORTHOP RELAT R, P41
   Garvin KL, 2009, CLIN ORTHOP RELAT R, V467, P141, DOI 10.1007/s11999-008-0544-5
   Good V, 2003, J BONE JOINT SURG AM, V85A, P105, DOI 10.2106/00004623-200300004-00013
   Griffith MJ, 2006, CLIN ORTHOP RELAT R, P3, DOI 10.1097/01.blo.0000224009.27422.7d
   Silva CCGE, 2008, MATER CHARACT, V59, P1339, DOI 10.1016/j.matchar.2007.11.007
   Guedes e Silva CC, 2008, J BIOMED MATER RES A, V84A, P337, DOI 10.1002/jbm.a.31363
   Hah SR, 1999, J ELECTROCHEM SOC, V146, P1505, DOI 10.1149/1.1391795
   Hamadouche M, 2002, J BONE JOINT SURG AM, V84A, P69, DOI 10.2106/00004623-200201000-00011
   Hannouche D, 2011, INT ORTHOP, V35, P207, DOI 10.1007/s00264-010-1187-1
   Hayaishi Y, 2008, MOD RHEUMATOL, V18, P647, DOI 10.1007/s10165-008-0108-2
   Herrmann M, 2006, J CERAM SOC JPN, V114, P1069, DOI 10.2109/jcersj.114.1069
   HOWLETT CR, 1989, CLIN ORTHOP RELAT R, P293
   Hui C, 2011, J BONE JOINT SURG AM, V93A, P624, DOI 10.2106/JBJS.I.01753
   Iliev C, 2010, IND LUBR TRIBOL, V62, P32, DOI 10.1108/00368791011012443
   Innocenti M, 2010, CLIN ORTHOP RELAT R, V468, P1258, DOI 10.1007/s11999-009-1109-y
   INSALL JN, 1983, J BONE JOINT SURG AM, V65, P619, DOI 10.2106/00004623-198365050-00006
   INSALL JN, 1985, CLIN ORTHOP RELAT R, P13
   ISHIGAKI H, 1988, WEAR, V121, P107, DOI 10.1016/0043-1648(88)90034-8
   Iwakiri K, 2008, CLIN ORTHOP RELAT R, V466, P1186, DOI 10.1007/s11999-008-0168-9
   Jahanmir S, 2004, TRIBOL LETT, V17, P409, DOI 10.1023/B:TRIL.0000044489.44053.be
   Jahanmir S, 2002, P I MECH ENG J-J ENG, V216, P371, DOI 10.1243/135065002762355307
   Kim YH, 2011, J ARTHROPLASTY, V26, P218, DOI 10.1016/j.arth.2010.03.010
   Koshino T, 2002, J ARTHROPLASTY, V17, P1009, DOI 10.1054/arth.2002.35826
   Kotzar G, 2002, BIOMATERIALS, V23, P2737, DOI 10.1016/S0142-9612(02)00007-8
   Kowalczewski Jacek B, 2005, Chir Narzadow Ruchu Ortop Pol, V70, P401
   Kristensen BW, 2001, BRAIN RES, V896, P1, DOI 10.1016/S0006-8993(00)03304-7
   Kue R, 1999, BIOMATERIALS, V20, P1195, DOI 10.1016/S0142-9612(99)00007-1
   Kusaka J, 1999, WEAR, V225, P734, DOI 10.1016/S0043-1648(98)00386-X
   Lachiewicz PF, 2011, J AM ACAD ORTHOP SUR, V19, P143, DOI 10.5435/00124635-201103000-00003
   Lee KH, 1989, MAT SCI ENG A-STRUCT, V186, P185
   Lewis PM, 2010, J ARTHROPLASTY, V25, P392, DOI 10.1016/j.arth.2009.01.013
   Li C.-W., 1989, CERAM ENG SCI P, V105, P632
   Lombardi AV, 2010, CLIN ORTHOP RELAT R, V468, P367, DOI 10.1007/s11999-009-1143-9
   Lubbeke A, 2011, J BONE JOINT SURG BR, V93B, P456, DOI 10.1302/0301-620X.93B4.25868
   Luo M, 2009, MAT SCI ENG C-BIO S, V29, P1422, DOI 10.1016/j.msec.2008.11.012
   Maccauro G, 2004, J BONE JOINT SURG BR, V86B, P1192, DOI 10.1302/0301-620X.86B8.15012
   Maccauro G, 2009, INT J IMMUNOPATH PH, V22, P773, DOI 10.1177/039463200902200323
   Marshall A, 2008, J AM ACAD ORTHOP SUR, V16, pS1, DOI 10.5435/00124635-200800001-00003
   Masonis JL, 2004, J ARTHROPLASTY, V19, P898, DOI 10.1016/j.arth.2004.02.045
   Masson B, 2009, INT ORTHOP, V33, P359, DOI 10.1007/s00264-007-0484-9
   Maw W, 2002, J APPL PHYS, V92, P5103, DOI 10.1063/1.1510595
   Mazzocchi M, 2008, J MATER SCI-MATER M, V19, P2881, DOI 10.1007/s10856-008-3417-2
   Mazzocchi M, 2008, J MATER SCI-MATER M, V19, P2889, DOI 10.1007/s10856-008-3437-y
   Mazzucco D, 2004, CLIN ORTHOP RELAT R, P17, DOI 10.1097/01.blo.0000150315.47697.b9
   Nakahara I, 2010, J ARTHROPLASTY, V25, P1182, DOI 10.1016/j.arth.2009.09.006
   Neumann A, 2006, OTOLARYNG HEAD NECK, V134, P923, DOI 10.1016/j.otohns.2006.01.022
   Neumann A, 2006, HNO, V54, P937, DOI 10.1007/s00106-006-1397-4
   Neumann A, 2004, LARYNGO RHINO OTOL, V83, P845, DOI 10.1055/s-2004-825739
   Neumann A, 2004, J MATER SCI-MATER M, V15, P1135, DOI 10.1023/B:JMSM.0000046396.14073.92
   Nizard R, 2005, J BONE JOINT SURG BR, V87B, P755, DOI 10.1302/0301-620X.87B6
   Oduwole KO, 2010, KNEE SURG SPORT TR A, V18, P945, DOI 10.1007/s00167-010-1074-8
   Ong KL, 2006, CLIN ORTHOP RELAT R, P22, DOI 10.1097/01.blo.0000214439.95268.59
   Oonishi H, 2005, J BIOMED MATER RES B, V74B, P754, DOI 10.1002/jbm.b.30273
   Oonishi H, 1984, ORTHOPAEDIC CERAMIC, V4, P297
   Oonishi H, 2001, KEY ENG MATER, V192-195, P999
   Otten Renee, 2010, Ned Tijdschr Geneeskd, V154, pA1534
   PARK DS, 1992, J AM CERAM SOC, V75, P3033, DOI 10.1111/j.1151-2916.1992.tb04383.x
   Pezzotti G, 2008, J AM CERAM SOC, V91, P1199, DOI 10.1111/j.1551-2916.2007.01507.x
   Pezzotti G, 2011, J AM CERAM SOC, V94, P945, DOI 10.1111/j.1551-2916.2010.04181.x
   Pezzotti G, 2009, J AM CERAM SOC, V92, P1817, DOI 10.1111/j.1551-2916.2009.03114.x
   Rahaman MN, 2007, J AM CERAM SOC, V90, P1965, DOI 10.1111/j.1551-2916.2007.01725.x
   Rani DA, 2005, J AM CERAM SOC, V88, P1655, DOI 10.1111/j.1551-2916.2005.00274.x
   Rhoads DP, 2008, J ARTHROPLASTY, V23
   Riley FL, 2000, J AM CERAM SOC, V83, P245
   Saito T, 1997, WEAR, V205, P153, DOI 10.1016/S0043-1648(96)07287-0
   Salgueiredo E, 2008, DIAM RELAT MATER, V17, P878, DOI 10.1016/j.diamond.2007.08.019
   Sariali E, 2010, J ORTHOP RES, V28, P979, DOI 10.1002/jor.21100
   SASAKI S, 1989, WEAR, V134, P185, DOI 10.1016/0043-1648(89)90068-9
   Shi F, 2005, KEY ENG MAT, V280-283, P1211, DOI 10.4028/www.scientific.net/KEM.280-283.1211
   Silva CCG, 2004, MAT SCI ENG C-BIO S, V24, P643, DOI 10.1016/j.msec.2004.08.007
   Smith LK, 2010, CLIN ORTHOP RELAT R, V468, P3077, DOI 10.1007/s11999-010-1377-6
   Sorrell C. C., 2004, P 7 WORLD BIOM C, V7, P1872
   Supancic P, 2009, KEY ENG MATER, V409, P193, DOI 10.4028/www.scientific.net/KEM.409.193
   Takadoum J, 1998, J EUR CERAM SOC, V18, P553, DOI 10.1016/S0955-2219(97)00157-X
   Taylor R. M., 2010, J BONE JOINT SURG BR, V92, P133
   Thomas GER, 2011, J BONE JOINT SURG AM, V93A, P716, DOI 10.2106/JBJS.J.00287
   Tsarenko I, 2003, J AM CERAM SOC, V86, P1622, DOI 10.1111/j.1151-2916.2003.tb03528.x
   Tsukamoto R, 2006, ACTA ORTHOP, V77, P505, DOI 10.1080/17453670610046479
   Vavrik P, 2008, ACTA CHIR ORTHOP TR, V75, P436
   Wang L, 2000, WEAR, V246, P159, DOI 10.1016/S0043-1648(00)00504-4
   Wang W, 2009, CERAM INT, V35, P3339, DOI 10.1016/j.ceramint.2009.05.034
   Willert HG, 2005, J BONE JOINT SURG AM, V87A, P28, DOI 10.2106/JBJS.A.02039pp
   Wynn-Jones H, 2011, ACTA ORTHOP, V82, P301, DOI 10.3109/17453674.2011.579518
   Xu JG, 2000, WEAR, V245, P61, DOI 10.1016/S0043-1648(00)00466-X
   Zhang W, 2010, J MATER SCI-MATER M, V21, P3049, DOI 10.1007/s10856-010-4144-z
   Zhou YS, 1997, WEAR, V210, P171, DOI 10.1016/S0043-1648(97)00066-5
   Zywiel MG, 2011, CLIN ORTHOP RELAT R, V469, P1536, DOI 10.1007/s11999-010-1658-0
NR 119
TC 87
Z9 89
U1 7
U2 100
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1742-7061
EI 1878-7568
J9 ACTA BIOMATER
JI Acta Biomater.
PD AUG
PY 2012
VL 8
IS 8
BP 2889
EP 2898
DI 10.1016/j.actbio.2012.04.031
PG 10
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 977BK
UT WOS:000306631100002
PM 22542731
DA 2018-10-19
ER

PT J
AU Barradas, AMC
   Lachmann, K
   Hlawacek, G
   Frielink, C
   Truckenmoller, R
   Boerman, OC
   van Gastel, R
   Garritsen, H
   Thomas, M
   Moroni, L
   van Blitterswijk, C
   de Boer, J
AF Barradas, Ana M. C.
   Lachmann, Kristina
   Hlawacek, Gregor
   Frielink, Cathelijne
   Truckenmoller, Roman
   Boerman, Otto C.
   van Gastel, Raoul
   Garritsen, Henk
   Thomas, Michael
   Moroni, Lorenzo
   van Blitterswijk, Clemens
   de Boer, Jan
TI Surface modifications by gas plasma control osteogenic differentiation
   of MC3T3-E1 cells
SO ACTA BIOMATERIALIA
LA English
DT Article
DE Biomaterials; Surface characterization; Protein adsorption; Cell
   adhesion; Osteogenic differentiation
ID MESENCHYMAL STEM-CELLS; IN-VITRO; BONE-FORMATION; BIODEGRADABLE
   POLYMERS; PROTEIN ADSORPTION; INTEGRIN BINDING; BIOMATERIALS; PHENOTYPE;
   CHEMISTRY; SPECIFICITY
AB Numerous studies have shown that the physicochemical properties of biomaterials can control cell activity. Cell adhesion, proliferation, differentiation as well as tissue formation in vivo can be tuned by properties such as the porosity, surface micro- and nanoscale topography and chemical composition of biomaterials. This concept is very appealing for tissue engineering since instructive properties in bioactive materials can be more economical and time efficient than traditional strategies of cell pre-differentiation in vitro prior to implantation. The biomaterial surface, which is easy to modify due to its accessibility, may provide the necessary signals to elicit a certain cellular behavior. Here, we used gas plasma technology at atmospheric pressure to modify the physicochemical properties of polylactic acid and analyzed how this influenced pre-osteoblast proliferation and differentiation. Tetramethylsilane and 3-aminopropyl-trimethoxysilane with helium as a carrier gas or a mixture of nitrogen and hydrogen were discharged to polylactic acid discs to create different surface chemical compositions, hydrophobicity and microscale topographies. Such modifications influenced protein adsorption and pre-osteoblast cell adhesion, proliferation and osteogenic differentiation. Furthermore polylactic acid treated with tetramethylsilane enhanced osteogenic differentiation compared to the other surfaces. This promising surface modification could be further explored for potential development of bone graft substitutes. (c) 2012 Acta Materialia Inc. Published by Elsevier Ltd. All rights reserved.
C1 [Barradas, Ana M. C.; Truckenmoller, Roman; Moroni, Lorenzo; van Blitterswijk, Clemens; de Boer, Jan] Univ Twente, MIRA Inst Biomed Res & Tech Med, Dept Tissue Regenerat, NL-7500 AE Enschede, Netherlands.
   [Lachmann, Kristina; Thomas, Michael] Fraunhofer Inst Surface Engn & Thin Films IST, D-38108 Braunschweig, Germany.
   [Hlawacek, Gregor; van Gastel, Raoul] Univ Twente, MESA Inst Nanotechnol, NL-7500 AE Enschede, Netherlands.
   [Frielink, Cathelijne; Boerman, Otto C.] Radboud Univ Nijmegen, Med Ctr, Dept Nucl Med, NL-6525 GA Nijmegen, Netherlands.
   [Garritsen, Henk] Helmholtz Ctr Infect Res GmbH, D-38124 Braunschweig, Germany.
   [Garritsen, Henk] Stadt Klinikum, Dept Transfus Med, D-38114 Braunschweig, Germany.
RP de Boer, J (reprint author), Univ Twente, MIRA Inst Biomed Res & Tech Med, Dept Tissue Regenerat, POB 217, NL-7500 AE Enschede, Netherlands.
EM j.deboer@utwente.nl
RI Moroni, Lorenzo/D-2826-2014; Hlawacek, Gregor/C-7164-2008; Boerman,
   Otto/A-8112-2014; Thomas, Michael/Q-6980-2016
OI Moroni, Lorenzo/0000-0003-1298-6025; Hlawacek,
   Gregor/0000-0001-7192-716X; Boerman, Otto/0000-0001-6832-101X; van
   Blitterswijk, Clemens/0000-0003-2371-4615; Barradas,
   Ana/0000-0003-4221-8879
FU TeRM Smart Mix Program of the Netherlands Ministry of Economic Affairs;
   Netherlands Ministry of Education, Culture and Science; Dutch Technology
   Foundation STW
FX The authors gratefully acknowledge Jan Petersen for technical support
   with AFM imaging, the financial support of the TeRM Smart Mix Program of
   the Netherlands Ministry of Economic Affairs and the Netherlands
   Ministry of Education, Culture and Science (A.B.) and the Dutch
   Technology Foundation STW, which is the applied science division of NWO,
   and the Technology Programme of the Ministry of Economic Affairs (G.H.).
CR Al-Aql ZS, 2008, J DENT RES, V87, P107, DOI DOI 10.1177/154405910808700215
   Anderson DG, 2005, BIOMATERIALS, V26, P4892, DOI 10.1016/j.biomaterials.2004.11.052
   Athanasiou KA, 1998, ARTHROSCOPY, V14, P726, DOI 10.1016/S0749-8063(98)70099-4
   BALE MD, 1989, BLOOD, V74, P2698
   Briem D, 2005, J MATER SCI-MATER M, V16, P671, DOI 10.1007/s10856-005-2539-z
   Brown SA, 2011, PLAST RECONSTR SURG, V127, P1684, DOI 10.1097/PRS.0b013e318208d371
   Chim H, 2003, J BIOMED MATER RES A, V65A, P327, DOI 10.1002/jbm.a.10478
   Curran JM, 2011, BIOMATERIALS, V32, P4753, DOI 10.1016/j.biomaterials.2011.03.045
   Curran JM, 2005, BIOMATERIALS, V26, P7057, DOI 10.1016/j.biomaterials.2005.05.008
   Curran JM, 2006, BIOMATERIALS, V27, P4783, DOI 10.1016/j.biomaterials.2006.05.001
   Dalby MJ, 2007, NAT MATER, V6, P997, DOI 10.1038/nmat2013
   Denis FA, 2002, LANGMUIR, V18, P819, DOI 10.1021/la011011o
   FABRIZIUSHOMAN DJ, 1991, J BIOMAT SCI-POLYM E, V3, P27, DOI 10.1163/156856292X00060
   Fernandes H, 2009, TISSUE ENG PART A, V16, P1693
   FRAKER PJ, 1978, BIOCHEM BIOPH RES CO, V80, P849, DOI 10.1016/0006-291X(78)91322-0
   Frank O, 2002, J CELL BIOCHEM, V85, P737, DOI 10.1002/jcb.10174
   Gorski JP, 1998, CRIT REV ORAL BIOL M, V9, P201, DOI 10.1177/10454411980090020401
   GRIESSER HJ, 1994, J BIOMAT SCI-POLYM E, V5, P531, DOI 10.1163/156856294X00194
   Habibovic P, 2005, BIOMATERIALS, V26, P3565, DOI 10.1016/j.biomaterials.2004.09.056
   Hill R, 2008, PHYSCS PROC, V1, P135, DOI 10.1016/j.phpro.2008.07.088
   Jorgensen NR, 2004, STEROIDS, V69, P219, DOI 10.1016/j.steroids.2003.12.005
   Kanzler B, 1998, DEVELOPMENT, V125, P2587
   Keselowsky BG, 2005, P NATL ACAD SCI USA, V102, P5953, DOI 10.1073/pnas.0407356102
   Keselowsky BG, 2003, J BIOMED MATER RES A, V66A, P247, DOI 10.1002/jbm.a.10537
   Kim S, 2003, GENE DEV, V17, P1979, DOI 10.1101/gad.1119303
   Klages C.-P., 2000, PLASMAS POLYM, V5, P79
   Klages C. - P., 2002, VAKUUM FORSCHUNG PRA, V14, P149
   Kumar G, 2011, BIOMATERIALS, V32, P9188, DOI 10.1016/j.biomaterials.2011.08.054
   Lord MS, 2006, BIOMATERIALS, V27, P4856, DOI 10.1016/j.biomaterials.2006.05.037
   Mahmood TA, 2006, BIOMACROMOLECULES, V7, P3012, DOI 10.1021/bm060489+
   Middleton JC, 2000, BIOMATERIALS, V21, P2335, DOI 10.1016/S0142-9612(00)00101-0
   Mwale F, 2006, BIOMATERIALS, V27, P2258, DOI 10.1016/j.biomaterials.2005.11.006
   Navarro M, 2008, J R SOC INTERFACE, V5, P1137, DOI 10.1098/rsif.2008.0151
   Neuss S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023195
   Notte J, 2007, AIP CONF PROC, V931, P489
   NYGREN H, 1992, J BIOMED MATER RES, V26, P77, DOI 10.1002/jbm.820260108
   Pavlica S, 2009, BIOMATERIALS, V30, P6514, DOI 10.1016/j.biomaterials.2009.08.024
   Ripamonti U, 1999, S AFR J SCI, V95, P335
   Shah A, 2011, J TISSUE ENG REGEN M, V5, P301, DOI 10.1002/term.316
   Siddappa Ramakrishnaiah, 2007, Curr Stem Cell Res Ther, V2, P209, DOI 10.2174/157488807781696267
   Siow KS, 2006, PLASMA PROCESS POLYM, V3, P392, DOI 10.1002/ppap.200600021
   Thomas M, 2011, EURO PHYS J APPL PHY, P55
   TOMPKINS HG, 1974, APPL SPECTROSC, V28, P335, DOI 10.1366/000370274774332380
   Unadkat HV, 2011, P NATL ACAD SCI USA, V108, P16565, DOI 10.1073/pnas.1109861108
   Van der Stok J, 2011, ACTA BIOMATER, V7, P739, DOI 10.1016/j.actbio.2010.07.035
   Woodfield TBF, 2006, BIOMATERIALS, V27, P1043, DOI 10.1016/j.biomaterials.2005.07.032
   Yuan HP, 2001, J MATER SCI-MATER M, V12, P7, DOI 10.1023/A:1026792615665
NR 47
TC 19
Z9 19
U1 0
U2 21
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1742-7061
J9 ACTA BIOMATER
JI Acta Biomater.
PD AUG
PY 2012
VL 8
IS 8
BP 2969
EP 2977
DI 10.1016/j.actbio.2012.04.021
PG 9
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 977BK
UT WOS:000306631100010
PM 22522130
DA 2018-10-19
ER

PT J
AU Li, YC
   Lin, YC
   Young, TH
AF Li, Yi-Chen
   Lin, Yong-Chong
   Young, Tai-Horng
TI Combination of media, biomaterials and extracellular matrix proteins to
   enhance the differentiation of neural stem/precursor cells into neurons
SO ACTA BIOMATERIALIA
LA English
DT Article
DE Neural stem/precursor cells; Differentiation; Neurons; Serum fraction;
   Poly(ethylene-co-vinyl alcohol)
ID CENTRAL-NERVOUS-SYSTEM; EMBRYONIC STEM-CELLS; GROWTH-FACTOR; PRECURSOR
   CELLS; IN-VITRO; PROLIFERATION; SERUM; BEHAVIOR; CULTURE; NEUROGENESIS
AB The purpose of this study was to induce the differentiation of neural stem/precursor cells (NSPC) more towards neurons than glial cells by the combination of media, biomaterials and extracellular matrix (ECM) proteins. Considering the role of serum, 10% fetal bovine serum or its fractions were added to DMEM/F12 medium to examine the effect of the differentiation-promoting potential on cultured NSPC isolated from embryonic rat cerebral cortex. The NSPC were cultured for 7 days, after which differentiation was assayed using immunocytochemistry for lineage specific markers. It was demonstrated that molecules promoting neuron differentiation were present in serum with molecular weight <100 kDa, which could dominate the differentiation of NSPC principally into neurons in the presence of basic fibroblast growth factor. In contrast, NSPC were induced to differentiate predominantly into glial cell phenotypes in the presence of whole serum components. Based on medium containing serum fraction, semi-quantification showed that the MAP2-positive percentage of the immunoreactive ratio within migrated cells could be promoted over 85% by combining poly(ethylene-co-vinyl alcohol) biomaterial and fibronectin matrix protein. These results are very encouraging, since an environment favorable for neuronal differentiation should be useful in the development of strategies for controlling the behavior of NSPC in neuroscience research. (c) 2012 Acta Materialia Inc. Published by Elsevier Ltd. All rights reserved.
C1 [Young, Tai-Horng] Natl Taiwan Univ, Inst Biomed Engn, Coll Med, Taipei 100, Taiwan.
   Natl Taiwan Univ, Coll Engn, Taipei 100, Taiwan.
RP Young, TH (reprint author), Natl Taiwan Univ, Inst Biomed Engn, Coll Med, Taipei 100, Taiwan.
EM thyoung@ntu.edu.tw
FU National Science Council of Taiwan; Republic of China
FX The authors thank the National Science Council of Taiwan, the Republic
   of China, for their financial support of this research.
CR Androutsellis-Theotokis A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009414
   BOTTENSTEIN JE, 1979, P NATL ACAD SCI USA, V76, P514, DOI 10.1073/pnas.76.1.514
   Cameron HA, 1998, J NEUROBIOL, V36, P287, DOI 10.1002/(SICI)1097-4695(199808)36:2<287::AID-NEU13>3.3.CO;2-E
   CATTANEO E, 1990, NATURE, V347, P762, DOI 10.1038/347762a0
   Chen CR, 2009, ACTA BIOMATER, V5, P2610, DOI 10.1016/j.actbio.2009.03.037
   Choi KC, 2008, J KOREAN NEUROSURG S, V44, P375, DOI 10.3340/jkns.2008.44.6.375
   Cooke MJ, 2010, SOFT MATTER, V6, P4988, DOI 10.1039/c0sm00448k
   Erlandsson A, 2001, J NEUROSCI, V21, P3483, DOI 10.1523/JNEUROSCI.21-10-03483.2001
   Flanagan LA, 2006, J NEUROSCI RES, V83, P845, DOI 10.1002/jnr.20778
   Harper MM, 2010, J MOL NEUROSCI, V40, P269, DOI 10.1007/s12031-009-9211-x
   Hung CH, 2006, BIOMATERIALS, V27, P4461, DOI 10.1016/j.biomaterials.2006.04.021
   Hung CH, 2006, BIOMATERIALS, V27, P5901, DOI 10.1016/j.biomaterials.2006.08.009
   Johe KK, 1996, GENE DEV, V10, P3129, DOI 10.1101/gad.10.24.3129
   KAUFMAN LM, 1983, SCIENCE, V220, P1394, DOI 10.1126/science.6857258
   Kiryushko D, 2003, J BIOL CHEM, V278, P12325, DOI 10.1074/jbc.M211628200
   Kokuzawa J, 2003, MOL CELL NEUROSCI, V24, P190, DOI 10.1016/S1044-7431(03)00160-X
   Kuhn HG, 1997, J NEUROSCI, V17, P5820
   Leipzig ND, 2011, BIOMATERIALS, V32, P57, DOI 10.1016/j.biomaterials.2010.09.031
   Leker RR, 2009, J NEURAL TRANSM, V116, P1397, DOI 10.1007/s00702-009-0329-3
   LOEBER CP, 1990, DEV BIOL, V140, P401, DOI 10.1016/0012-1606(90)90089-2
   McKay R, 1997, SCIENCE, V276, P66, DOI 10.1126/science.276.5309.66
   MORI N, 1990, COLD SH Q B, V55, P255
   Nakajima M, 2007, BIOMATERIALS, V28, P1048, DOI 10.1016/j.biomaterials.2006.10.004
   Ohtsuka M, 2009, J NEUROSCI RES, V87, P301, DOI 10.1002/jnr.21855
   Okabe S, 1996, MECH DEVELOP, V59, P89, DOI 10.1016/0925-4773(96)00572-2
   Pachernik J, 2002, REPROD NUTR DEV, V42, P317, DOI 10.1051/rnd:2002028
   REYNOLDS BA, 1992, SCIENCE, V255, P1707, DOI 10.1126/science.1553558
   Schulz TC, 2004, STEM CELLS, V22, P1218, DOI 10.1634/stemcells.2004-0114
   Shah NM, 1997, P NATL ACAD SCI USA, V94, P11369, DOI 10.1073/pnas.94.21.11369
   Takahashi J, 1999, J NEUROBIOL, V38, P65, DOI 10.1002/(SICI)1097-4695(199901)38:1<65::AID-NEU5>3.3.CO;2-H
   Tsai RYL, 2000, J NEUROSCI, V20, P3725
   VARON S, 1979, NEUROCHEM RES, V4, P155, DOI 10.1007/BF00964141
   Wang JH, 2006, BIOMATERIALS, V27, P3441, DOI 10.1016/j.biomaterials.2006.02.002
   Willerth SM, 2007, STEM CELLS, V25, P2235, DOI 10.1634/stemcells.2007-0111
   Young TH, 2008, BIOMATERIALS, V29, P3521, DOI 10.1016/j.biomaterials.2008.05.013
   Young TH, 2009, BIOMATERIALS, V30, P5031, DOI 10.1016/j.biomaterials.2009.05.065
   Young TH, 1998, BIOMATERIALS, V19, P717, DOI 10.1016/S0142-9612(98)00187-2
   Young TH, 2005, BIOMATERIALS, V26, P4291, DOI 10.1016/j.biomaterials.2004.10.043
NR 38
TC 15
Z9 15
U1 0
U2 13
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1742-7061
J9 ACTA BIOMATER
JI Acta Biomater.
PD AUG
PY 2012
VL 8
IS 8
BP 3035
EP 3048
DI 10.1016/j.actbio.2012.04.036
PG 14
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 977BK
UT WOS:000306631100017
PM 22548842
DA 2018-10-19
ER

PT J
AU Tamimi, F
   Le Nihouannen, D
   Eimar, H
   Sheikh, Z
   Komarova, S
   Barralet, J
AF Tamimi, Faleh
   Le Nihouannen, Damien
   Eimar, Hazem
   Sheikh, Zeeshan
   Komarova, Svetlana
   Barralet, Jake
TI The effect of autoclaving on the physical and biological properties of
   dicalcium phosphate dihydrate bioceramics: Brushite vs. monetite
SO ACTA BIOMATERIALIA
LA English
DT Article
DE Brushite; Monetite; Dicalcium phosphate; Gene expression; Bone
   regeneration
ID IN-VIVO; BONE SUBSTITUTES; CEMENT; RESORPTION; SHEEP; EXPRESSION;
   SCAFFOLDS; CULTURE; IMPLANTATION; GRANULES
AB Dicalcium phosphate dihydrate (brushite) is an osteoconductive biomaterial with great potential as a bioresorbable cement for bone regeneration. Preset brushite cement can be dehydrated into dicalcium phosphate anhydrous (monetite) bioceramics by autoclaving. This heat treatment results in changes in the physical characteristics of the material, improving in vivo bioresorption. This property is a great advantage in bone regeneration: however, it is not known how autoclaving brushite preset cement might improve its capacity to regenerate bone. This study was designed to compare brushite bioceramics with monetite bioceramics in terms of physical characteristics in vitro, and in vivo performance upon bone implantation. In this study we observed that monetite bioceramics prepared by autoclaving preset brushite cements had higher porosity, interconnected porosity and specific surface area than their brushite precursors. In vitro cell culture experiments revealed that bone marrow cells expressed higher levels of osteogenic genes Runx2, Opn, and Alp when the cells were cultured on monetite ceramics rather than on brushite ones. In vivo experiments revealed that monetite bioceramics resorbed faster than brushite ones and were more infiltrated with newly formed bone. In summary, autoclaving preset brushite cements results in a material with improved properties for bone regeneration procedures. (c) 2012 Acta Materialia Inc. Published by Elsevier Ltd. All rights reserved.
C1 [Tamimi, Faleh; Eimar, Hazem; Sheikh, Zeeshan; Komarova, Svetlana; Barralet, Jake] McGill Univ, Fac Dent, Montreal, PQ, Canada.
   [Le Nihouannen, Damien] Univ Bordeaux Segalen, UFR Sci Vie, Bordeaux, France.
RP Tamimi, F (reprint author), McGill Univ, Fac Dent, Montreal, PQ, Canada.
EM faleh.tamimimarino@mcgill.ca
RI barralet, jake/A-5820-2008
OI barralet, jake/0000-0003-3543-6042
FU "COBO" MDEIE (PSR-SIIRI) grant; The Faculty of Dentistry of McGill
   University; RSBO-FODQ program; "Harry Rosen" salary award
FX The authors acknowledge financial support from a "COBO" MDEIE
   (PSR-SIIRI) grant, The Faculty of Dentistry of McGill University,
   RSBO-FODQ program, and the "Harry Rosen" salary award (F.T., the
   provision of a Canadian Research Chair (Jake Barralet)).
CR Aberg J, 2010, J BIOMED MATER RES B, V93B, P436, DOI 10.1002/jbm.b.31600
   Alkhraisat MH, 2008, BIOMATERIALS, V29, P4691, DOI 10.1016/j.biomaterials.2008.08.026
   Alshaaer M, 2011, CEMENT CONCRETE RES, V41, P30, DOI 10.1016/j.cemconres.2010.09.002
   Apelt D, 2004, BIOMATERIALS, V25, P1439, DOI 10.1016/j.biomaterials.2003.08.073
   Armstrong S, 2009, J CELL SCI, V122, P136, DOI 10.1242/jcs.031534
   Bohner M, 2008, J BIOMED MATER RES B, V84B, P375, DOI 10.1002/jbm.b.30881
   Bohner M, 2004, BIOMATERIALS, V25, P3569, DOI 10.1016/j.biomaterials.2003.10.032
   Bohner M, 2003, BIOMATERIALS, V24, P3463, DOI 10.1016/S0142-9612(03)00234-5
   Constantz BR, 1998, J BIOMED MATER RES, V43, P451, DOI 10.1002/(SICI)1097-4636(199824)43:4<451::AID-JBM13>3.0.CO;2-Q
   Frayssinet P, 1998, BIOMATERIALS, V19, P971, DOI 10.1016/S0142-9612(97)00163-4
   Galea LG, 2008, BIOMATERIALS, V29, P3400, DOI 10.1016/j.biomaterials.2008.04.041
   Gbureck U, 2007, ADV FUNCT MATER, V17, P3940, DOI 10.1002/adfm.200700019
   Giocondi JL, 2010, PHILOS T R SOC A, V368, P1937, DOI 10.1098/rsta.2010.0006
   Grossardt C, 2010, TISSUE ENG PT A, V16, P3687, DOI [10.1089/ten.tea.2010.0281, 10.1089/ten.TEA.2010.0281]
   Grover LM, 2003, BIOMATERIALS, V24, P4133, DOI 10.1016/S0142-9612(03)00293-X
   Habibovic P, 2008, BIOMATERIALS, V29, P944, DOI 10.1016/j.biomaterials.2007.10.023
   Hing KA, 2005, INT J APPL CERAM TEC, V2, P184, DOI 10.1111/j.1744-7402.2005.02020.x
   Klammert U, 2009, ACTA BIOMATER, V5, P727, DOI 10.1016/j.actbio.2008.08.019
   Kuemmerle JM, 2005, J CRANIO MAXILL SURG, V33, P37, DOI 10.1016/j.jcms.2004.09.002
   Marino FT, 2007, J BIOMED MATER RES B, V83B, P571, DOI 10.1002/jbm.b.30830
   Oberle A, 2005, SCHWEIZ ARCH TIERH, V147, P482, DOI 10.1024/0036-7281.147.11.482
   Ohura K, 1996, J BIOMED MATER RES, V30, P193, DOI 10.1002/(SICI)1097-4636(199602)30:2<193::AID-JBM9>3.0.CO;2-M
   Penel G, 1999, BONE, V25, p81S, DOI 10.1016/S8756-3282(99)00139-8
   Pfaffl M, 2001, NUCL ACIDS RES, V29
   Rochet N, 2003, BONE, V32, P602, DOI 10.1016/S8756-3282(03)00093-0
   Sun JS, 2004, BIOMATERIALS, V25, P607, DOI 10.1016/S0142-9612(03)00567-2
   Tamimi F, 2012, ACTA BIOMATER, V8, P474, DOI 10.1016/j.actbio.2011.08.005
   Tamimi F, 2010, BIOMATERIALS, V31, P2762, DOI 10.1016/j.biomaterials.2009.12.039
   Tamimi F, 2009, BIOMATERIALS, V30, P6318, DOI 10.1016/j.biomaterials.2009.07.049
   Tamimi F, 2008, J BIOMED MATER RES A, V87A, P980, DOI 10.1002/jbm.a.31842
   Tamimi FM, 2006, J CLIN PERIODONTOL, V33, P922, DOI 10.1111/j.1600-051X.2006.01004.x
   Tas AC, 2004, J AM CERAM SOC, V87, P2195, DOI 10.1111/j.1151-2916.2004.tb07490.x
   Theiss F, 2005, BIOMATERIALS, V26, P4383, DOI 10.1016/j.biomaterials.2004.11.056
   Wang CY, 2004, BIOMATERIALS, V25, P2507, DOI 10.1016/j.biomaterials.2003.09.035
   Xia ZD, 2006, BIOMATERIALS, V27, P4557, DOI 10.1016/j.biomaterials.2006.04.030
   Xu HHK, 2007, DENT MATER, V23, P433, DOI 10.1016/j.dental.2006.02.014
   Xu HHK, 2010, TISSUE ENG PT A, V16, P2743, DOI [10.1089/ten.tea.2009.0757, 10.1089/ten.TEA.2009.0757]
   Yefang Z, 2007, INT J ORAL MAX SURG, V36, P137, DOI 10.1016/j.ijom.2006.08.012
   Zhang NL, 2010, BIOMATERIALS, V31, P7653, DOI 10.1016/j.biomaterials.2010.06.043
NR 39
TC 41
Z9 42
U1 3
U2 42
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1742-7061
J9 ACTA BIOMATER
JI Acta Biomater.
PD AUG
PY 2012
VL 8
IS 8
BP 3161
EP 3169
DI 10.1016/j.actbio.2012.04.025
PG 9
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 977BK
UT WOS:000306631100030
PM 22522010
DA 2018-10-19
ER

PT J
AU Chau, DYS
   Brown, SV
   Mather, ML
   Hutter, V
   Tint, NL
   Dua, HS
   Rose, FRAJ
   Ghaemmaghami, AM
AF Chau, David Y. S.
   Brown, Sheridan V.
   Mather, Melissa L.
   Hutter, Victoria
   Tint, Naing L.
   Dua, Harminder S.
   Rose, Felicity R. A. J.
   Ghaemmaghami, Amir M.
TI Tissue transglutaminase (TG-2) modified amniotic membrane: a novel
   scaffold for biomedical applications
SO BIOMEDICAL MATERIALS
LA English
DT Article
ID OCULAR SURFACE RECONSTRUCTION; CROSS-LINKING; DENDRITIC CELLS; MICROBIAL
   TRANSGLUTAMINASE; BASEMENT-MEMBRANE; EPITHELIAL-CELLS; IN-SITU;
   COLLAGEN; GELATIN; TRANSPLANTATION
AB The amniotic membrane (AM) is considered as a natural cell culture substrate and has occasionally been exploited in regenerative medicine especially for ocular surface reconstruction and dermal wound healing applications. However, its use is limited by its relatively weak mechanical strength, difficulty during manual handling and susceptibility to proteolytic degradation in vivo. Therefore, in this study we aimed to enhance the mechanical and biological characteristics of the AM by enzymatically cross-linking it using tissue transglutaminase (TG)-a calcium-dependent enzyme capable of forming stable epsilon(gamma-glutamyl) lysine cross-linkages. Using a biological catalyst such as TG does not only prevent denaturation during sample preparation but also minimizes the potential of residual chemical cross-linking agents compared to alternative methodologies. Human AM, sourced from elective caesarean sectioning, were treated with TG, bovine serum albumin and/or a no-treatment control. Samples were then compared in terms of their physical and (scanning electron microscopy (SEM), transparency, mechanical strength, susceptibility to proteolytic degradation) biological characteristics (in vitro cell culture, activation of dendritic cells (DC)) and their in vivo biocompatibility/angiogenic capacity (chick chorioallantoic membrane assay). TG-treated AM exhibited enhanced mechanical strength and greater resistance to proteolytic/collagenase degradation compared to the control(s). SEM imaging of the TG-treated membrane summarized a significantly closer association and greater interconnectivity of individual collagen fibres yet it had no effect on the overall transparency of the AM. In vitro cell culture demonstrated no detrimental effect of TG-treatment on the AM in terms of cell attachment, spreading, proliferation and differentiation. Moreover, an 'immune response' was not elicited based on extended in vitro culture with human-monocyte-derived DC. Interestingly, the TG-treated AM still allowed angiogenesis to occur and in some instances, demonstrated an enhancement compared to the control (n = 5). We hereby demonstrate that treating the AM with the cross-linking enzyme, TG, results in a novel biomaterial with enhanced mechanical and biological characteristics. Above all, this modified membrane demonstrates greater strength, maintains in vitro cell growth, retains optical transparency and allows angiogenesis to occur without inducing an immune response. Altogether, this study demonstrates the feasibility of TG as an alternate cross-linking treatment for the production of novel biomaterials and suggests that TG-treated AM may now be more commonly exploited as a therapeutic dressing for ocular or wound applications.
C1 [Chau, David Y. S.; Brown, Sheridan V.; Ghaemmaghami, Amir M.] Univ Nottingham, Queens Med Ctr, Sch Mol Med Sci, Allergy Res Grp, Nottingham NG7 2UH, England.
   [Mather, Melissa L.] Univ Nottingham, Fac Engn, Elect Syst & Opt Res Div, Nottingham NG7 2RD, England.
   [Mather, Melissa L.] Natl Phys Lab, Div Mat, Teddington TW11 0LW, Middx, England.
   [Hutter, Victoria; Tint, Naing L.; Rose, Felicity R. A. J.] Univ Nottingham, Sch Pharm, Div Drug Delivery & Tissue Engn, Nottingham NG7 2RD, England.
   [Tint, Naing L.; Dua, Harminder S.] Univ Nottingham, Queens Med Ctr, Sch Med & Hlth Sci, Div Ophthalmol & Vis Sci, Nottingham NG7 2UH, England.
RP Ghaemmaghami, AM (reprint author), Univ Nottingham, Queens Med Ctr, Sch Mol Med Sci, Allergy Res Grp, Nottingham NG7 2UH, England.
EM amg@nottingham.ac.uk
OI Rose, Felicity/0000-0001-6640-8840; Mather, Melissa/0000-0002-5551-1321;
   Ghaemmaghami, Amir/0000-0003-3160-8759; Chau, David/0000-0001-9200-6749
FU University of Nottingham; MRC; National Physical Laboratory Strategic
   Research Fellowship
FX The authors would like to thank Nina Lane and Dr Adrian Robbins for
   their useful discussions in flow cytometry analysis and Paul Cato for
   help with DC generation. Dr Don Price is acknowledged for the kind
   donation of the Love wave device. This study was partly funded by the
   University of Nottingham. NLT is a holder of a MRC Discipline Hopper
   Grant award. MM is supported by a National Physical Laboratory Strategic
   Research Fellowship. The funders had no role in study design, data
   collection and analysis, decision to publish, or preparation of the
   manuscript.
CR Akpalo E, 2010, ACTA BIOMATER, V6, P396, DOI 10.1016/j.actbio.2009.08.001
   Bailey P, 1996, US Patent, Patent No. [WO0204739, 0204739]
   Banchereau J, 2000, ANNU REV IMMUNOL, V18, P767, DOI 10.1146/annurev.immunol.18.1.767
   Banchereau J, 1998, NATURE, V392, P245, DOI 10.1038/32588
   BENNETT JP, 1980, LANCET, V1, P1153
   BENSLIMANE S, 1988, EUR SURG RES, V20, P18
   Broderick EP, 2005, J BIOMED MATER RES B, V72B, P37, DOI 10.1002/jbm.b.30119
   CAMPBELL S, 1989, J CELL SCI, V94, P307
   Chau DYS, 2005, BIOMATERIALS, V26, P6518, DOI 10.1016/j.biomaterials.2005.04.017
   Chau DYS, 2007, TRENDS BIOMATERIALS, P143
   Chen TH, 2003, BIOMATERIALS, V24, P2831, DOI 10.1016/S0142-9612(03)00096-6
   Collighan RJ, 2009, AMINO ACIDS, V36, P659, DOI 10.1007/s00726-008-0190-y
   Connon CJ, 2010, BRIT J OPHTHALMOL, V94, P1057, DOI 10.1136/bjo.2008.153064
   Cortez J, 2005, J BIOTECHNOL, V116, P379, DOI 10.1016/j.biotec.2004.12.007
   DAVIS JW, 1910, J HOPKINS MED J, V15, P307
   Dua HS, 2004, SURV OPHTHALMOL, V49, P51, DOI 10.1016/j.survophthal.2003.10.004
   Dua HS, 1999, BRIT J OPHTHALMOL, V83, P748, DOI 10.1136/bjo.83.6.748
   DUNN MW, 1969, ARCH OPHTHALMOL-CHIC, V82, P840
   FOLK JE, 1973, ADV ENZYMOL RAMB, V38, P109
   Fortunato SJ, 2004, J PERINAT MED, V32, P122, DOI 10.1515/JPM.2004.022
   Fujisato T, 1999, J BIOMAT SCI-POLYM E, V10, P1171, DOI 10.1163/156856299X00829
   Garcia-Nieto S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010123
   GENTILE V, 1991, J BIOL CHEM, V266, P478
   GIRARD MT, 1993, J CELL SCI, V104, P1001
   GREENBERG CS, 1991, FASEB J, V5, P3071
   Griffin M, 2002, BIOCHEM J, V368, P377, DOI 10.1042/BJ20021234
   Halloran DO, 2008, BIOMATERIALS, V29, P438, DOI 10.1016/j.biomaterials.2007.10.009
   Hao YX, 2000, CORNEA, V19, P348, DOI 10.1097/00003226-200005000-00018
   Hodde J, 2002, TISSUE ENG, V8, P295, DOI 10.1089/107632702753725058
   Hopkinson A, 2006, INVEST OPHTH VIS SCI, V47, P4316, DOI 10.1167/iovs.05-1415
   Horlock C, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-3-r30
   Hu B-H, 2005, Orthod Craniofac Res, V8, P145, DOI 10.1111/j.1601-6343.2005.00330.x
   Ishii C, 1994, Europe Patent, Patent No. 0610649
   Ito A, 2003, J BIOSCI BIOENG, V95, P196, DOI 10.1016/S1389-1723(03)80129-9
   Jones RA, 1997, J CELL SCI, V110, P2461
   KIM JC, 1995, CORNEA, V14, P473
   Koizumi N, 2003, BRIT J OPHTHALMOL, V87, P1437, DOI 10.1136/bjo.87.12.1437-a
   KOVACS G, 1994, SENSOR ACTUAT A-PHYS, V43, P38, DOI 10.1016/0924-4247(93)00660-V
   Kuraishi C, 1997, J FOOD SCI, V62, P488, DOI 10.1111/j.1365-2621.1997.tb04412.x
   Lee CH, 2001, INT J PHARM, V221, P1, DOI 10.1016/S0378-5173(01)00691-3
   Lineen E, 2008, J CRANIOFAC SURG, V19, P923, DOI 10.1097/SCS.0b013e318175b5ab
   LIU BC, 1989, J BIOMED MATER RES, V23, P833, DOI 10.1002/jbm.820230803
   Lorentz KM, 2011, BIOMATERIALS, V32, P430, DOI 10.1016/j.biomaterials.2010.08.109
   Ma DHK, 2010, BIOMATERIALS, V31, P6647, DOI 10.1016/j.biomaterials.2010.05.034
   Matsuda S, 1999, J BIOMED MATER RES, V45, P20, DOI 10.1002/(SICI)1097-4636(199904)45:1<20::AID-JBM3>3.0.CO;2-6
   Matthews R N, 1982, Obstet Gynecol Annu, V11, P31
   McDermott MK, 2004, BIOMACROMOLECULES, V5, P1270, DOI 10.1021/bm034529a
   McHale MK, 2005, TISSUE ENG, V11, P1768, DOI 10.1089/ten.2005.11.1768
   MIGNATTI P, 1989, J CELL BIOL, V108, P671, DOI 10.1083/jcb.108.2.671
   Nakamura T, 2003, CORNEA, V22, P70, DOI 10.1097/00003226-200301000-00017
   Nakamura T, 2004, INVEST OPHTH VIS SCI, V45, P93, DOI 10.1167/iovs.03-0752
   Niknejad H, 2008, EUR CELLS MATER, V15, P88
   O Halloran DM, 2006, TISSUE ENG, V12, P1467, DOI 10.1089/ten.2006.12.1467
   O'Halloran DM, 2007, TISSUE ENG, V13, P1927, DOI 10.1089/ten.2005.0608
   Orban JM, 2004, J BIOMED MATER RES A, V68A, P756, DOI 10.1002/jbm.a.20110
   Parolini O, 2009, REGEN MED, V4, P275, DOI 10.2217/17460751.4.2.275
   Raghunath M, 1999, INVEST OPHTH VIS SCI, V40, P2780
   Raimbault V, 2010, SENSOR ACTUAT B-CHEM, V144, P467, DOI 10.1016/j.snb.2009.10.044
   Rasmussen L, 1996, World Patent, Patent No. [WO9413839, 9413839]
   Royer PJ, 2010, J IMMUNOL, V185, P1522, DOI 10.4049/jimmunol.1000774
   Saif J, 2010, ARTERIOSCL THROM VAS, V30, P1897, DOI 10.1161/ATVBAHA.110.207928
   Sippel KC, 2001, CURR OPIN OPHTHALMOL, V12, P269, DOI 10.1097/00055735-200108000-00006
   Toda A, 2007, J PHARMACOL SCI, V105, P215, DOI 10.1254/jphs.CP0070034
   WIESE KH, 1975, ARCH GYNAKOL, V218, P243, DOI 10.1007/BF00667385
   Wolbank S, 2009, TISSUE ENG PT A, V15, P1843, DOI 10.1089/ten.tea.2008.0205
   Yung CW, 2007, J BIOMED MATER RES A, V83A, P1039, DOI 10.1002/jbm.a.31431
   YURCHENCO PD, 1987, J CELL BIOL, V105, P2559, DOI 10.1083/jcb.105.6.2559
   Zeugois DI, 2010, J BIOMED MATER RES A, V92A, P1310, DOI 10.1002/jbm.a.32383
NR 68
TC 10
Z9 11
U1 0
U2 14
PU IOP PUBLISHING LTD
PI BRISTOL
PA TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND
SN 1748-6041
EI 1748-605X
J9 BIOMED MATER
JI Biomed. Mater.
PD AUG
PY 2012
VL 7
IS 4
AR 045011
DI 10.1088/1748-6041/7/4/045011
PG 14
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 978BD
UT WOS:000306712900011
PM 22652528
DA 2018-10-19
ER

PT J
AU Qiu, ZY
   Li, G
   Zhang, YQ
   Liu, J
   Hu, W
   Ma, J
   Zhang, SM
AF Qiu, Z. Y.
   Li, G.
   Zhang, Y. Q.
   Liu, J.
   Hu, W.
   Ma, J.
   Zhang, S. M.
TI Fine structure analysis and sintering properties of Si-doped
   hydroxyapatite
SO BIOMEDICAL MATERIALS
LA English
DT Article
ID SILICON-SUBSTITUTED HYDROXYAPATITE; PREFERRED GROWTH ORIENTATION;
   BIOMIMETIC APATITE; BONE; PHOSPHATE; CRYSTAL; BIOCERAMICS; RATS;
   CA-10(PO4)(6-X)(SIO4)(X)(OH)(2-X); REGENERATION
AB Si-doped hydroxyapatite (Si-HA) has been intensively investigated as a promising bone biomaterial because of the biomineralization and bone formation benefit from silicon addition. In the current work, Si-HA samples were synthesized by the aqueous precipitation method. The sintering property of Si-HA was studied in terms of phase composition and transition, which was influenced by the Si doping percentage and sintering temperature. The results indicate that all the as-prepared and sintered low Si doping samples (Si% <= 1.6 wt%) possess HA phases; while the high Si doping samples (Si% >= 2 wt%) present amorphous phases as prepared, and largely or even completely transform to beta-tricalcium phosphate (beta-TCP) phase after sintering at 1250 degrees C. The Rietveld refinement on x-ray diffraction patterns was conducted to determine the particle sizes, microstrain factors and anisotropic distributions. According to the refined results, the calculated anisotropic particle sizes correspond to the observations made by transmission electron microscopy. The microstrains also present anisotropic distributions in all refinements. The accurate variation in the fine structure of Si-HA has been studied by the improved refinements after considering the anisotropic distribution.
C1 [Qiu, Z. Y.; Li, G.; Zhang, Y. Q.; Liu, J.; Hu, W.; Ma, J.; Zhang, S. M.] Huazhong Univ Sci & Technol, Adv Biomat & Tissue Engn Ctr, Wuhan 430074, Peoples R China.
   [Qiu, Z. Y.] China Korea Ctr Biomat & Nano Biotechnol, Wuhan 430074, Peoples R China.
   [Zhang, S. M.] Huazhong Univ Sci & Technol, Minist Educ China, Key Lab Biomed Photon, Wuhan 430074, Peoples R China.
RP Zhang, SM (reprint author), Huazhong Univ Sci & Technol, Adv Biomat & Tissue Engn Ctr, Wuhan 430074, Peoples R China.
EM smzhang@mail.hust.edu.cn
RI Ma, Jun/K-2084-2012
OI Ma, Jun/0000-0001-5167-1750
FU National Basic Research Program [2012CB933601]; Natural Science
   Foundation of China [30870624, 81071263]; National High-Tech RD Program
   [2011AA030105]; International Science and Technology Cooperation Program
   of China [0102011DFA31430]; Research Fund for the Doctoral Program of
   Higher Education of China [20110142110034]
FX This work was supported by the grants from the National Basic Research
   Program (no 2012CB933601), the Natural Science Foundation of China (no
   30870624, no 81071263), the National High-Tech R&D Program (no
   2011AA030105) and the International Science and Technology Cooperation
   Program of China (no 0102011DFA31430) and Research Fund for the Doctoral
   Program of Higher Education of China (no 20110142110034).
CR Arcos D, 2004, CHEM MATER, V16, P2300, DOI 10.1021/cm035337
   Baeza A, 2010, ACTA BIOMATER, V6, P743, DOI 10.1016/j.actbio.2009.09.004
   Botelho CM, 2002, J MATER SCI-MATER M, V13, P1123, DOI 10.1023/A:1021177601899
   Cai YL, 2010, BIOMED MATER, V5, DOI 10.1088/1748-6041/5/5/054114
   CARLISLE EM, 1972, SCIENCE, V178, P619, DOI 10.1126/science.178.4061.619
   CARLISLE EM, 1988, SCI TOTAL ENVIRON, V73, P95, DOI 10.1016/0048-9697(88)90190-8
   CARLISLE EM, 1970, SCIENCE, V167, P279, DOI 10.1126/science.167.3916.279
   Chen C, 2011, CHEM COMMUN, V47, P11056, DOI 10.1039/c1cc13480a
   Deng XM, 2001, BIOMATERIALS, V22, P2867, DOI 10.1016/S0142-9612(01)00031-X
   Eisinger J., 1993, Magnesium Research, V6, P247
   Fidalgo A, 2001, J NON-CRYST SOLIDS, V283, P144, DOI 10.1016/S0022-3093(01)00418-5
   Gibson IR, 2002, J AM CERAM SOC, V85, P2771
   Gibson IR, 1999, J BIOMED MATER RES, V44, P422, DOI 10.1002/(SICI)1097-4636(19990315)44:4<422::AID-JBM8>3.0.CO;2-#
   Gomes S, 2012, ACTA BIOMATER, V8, P1180, DOI 10.1016/j.actbio.2011.12.003
   Gomes S, 2011, CHEM MATER, V23, P3072, DOI 10.1021/cm200537v
   Guo LH, 2003, J MATER SCI-MATER M, V14, P817, DOI 10.1023/A:1025048724330
   Hayakawa S, 2009, ACTA BIOMATER, V5, P2152, DOI 10.1016/j.actbio.2009.02.018
   HERMAN H, 1961, ARCH ORAL BIOL, V5, P137, DOI 10.1016/0003-9969(61)90007-3
   Hing KA, 2006, BIOMATERIALS, V27, P5014, DOI 10.1016/j.biomaterials.2006.05.039
   Jugdaohsingh R, 2008, BONE, V43, P596, DOI 10.1016/j.bone.2008.04.014
   Larson A. C., 2004, 86748 LAUR LOS AL NA
   Laurencin D, 2011, BIOMATERIALS, V32, P1826, DOI 10.1016/j.biomaterials.2010.11.017
   Leventouri T, 2003, BIOMATERIALS, V24, P4205, DOI 10.1016/S0142-9612(03)00333-8
   Li YF, 2010, BIOMATERIALS, V31, P9006, DOI 10.1016/j.biomaterials.2010.07.112
   Li ZY, 2007, BIOMATERIALS, V28, P1452, DOI 10.1016/j.biomaterials.2006.11.001
   Liao CJ, 1999, BIOMATERIALS, V20, P1807, DOI 10.1016/S0142-9612(99)00076-9
   Macdonald HM, 2012, BONE, V50, P681, DOI 10.1016/j.bone.2011.11.020
   Mao K, 2009, BIOMED MATER, V4, DOI 10.1088/1748-6041/4/4/045003
   Montazeri L, 2010, BIOMED MATER, V5, DOI 10.1088/1748-6041/5/4/045004
   Muller FA, 2007, J CRYST GROWTH, V304, P464, DOI 10.1016/j.jcrysgro.2007.03.014
   Muller L, 2007, BIOMOL ENG, V24, P462, DOI 10.1016/j.bioeng.2007.07.011
   Palard M, 2008, J SOLID STATE CHEM, V181, P1950, DOI 10.1016/j.jssc.2008.04.027
   Palard M, 2009, ACTA BIOMATER, V5, P1223, DOI 10.1016/j.actbio.2008.10.016
   Patterson AL, 1939, PHYS REV, V56, P978, DOI 10.1103/PhysRev.56.978
   Pek YS, 2009, BIOMATERIALS, V30, P822, DOI 10.1016/j.biomaterials.2008.10.053
   Porter AE, 2004, J BIOMED MATER RES A, V68A, P133, DOI 10.1002/jbm.a.20064
   Porter AE, 2003, BIOMATERIALS, V24, P4609, DOI 10.1016/S0142-9612(03)00355-7
   Ren F, 2010, ACTA BIOMATER, V6, P2787, DOI 10.1016/j.actbio.2009.12.044
   ROOME CM, 1995, BIOMATERIALS, V16, P691, DOI 10.1016/0142-9612(95)99696-J
   Roy M, 2011, ACTA BIOMATER, V7, P866, DOI 10.1016/j.actbio.2010.09.016
   Ryu HS, 2002, BIOMATERIALS, V23, P909, DOI 10.1016/S0142-9612(01)00201-0
   SCHWARZ K, 1972, NATURE, V239, P333, DOI 10.1038/239333a0
   Steimetz T, 2007, BONE, V40, pS8, DOI 10.1016/j.bone.2006.12.024
   SUDARSANAN K, 1969, ACTA CRYSTALL B-STRU, VB 25, P1534, DOI 10.1107/S0567740869004298
   Tang XL, 2005, MATER LETT, V59, P3841, DOI 10.1016/j.matlet.2005.06.060
   Thein-Han WW, 2009, ACTA BIOMATER, V5, P1182, DOI 10.1016/j.actbio.2008.11.025
   Tian T, 2008, MAT SCI ENG C-BIO S, V28, P57, DOI 10.1016/j.msec.2007.10.049
   Toby BH, 2006, POWDER DIFFR, V21, P67, DOI 10.1154/1.2179804
   Toraya H, 1995, RIETVELD METHOD, P254
   Vallet-Regi M, 2005, J MATER CHEM, V15, P1509, DOI 10.1039/b414143a
   Velard F, 2010, BIOMATERIALS, V31, P2001, DOI 10.1016/j.biomaterials.2009.11.066
   Zhai WY, 2012, ACTA BIOMATER, V8, P341, DOI 10.1016/j.actbio.2011.09.008
   Zhang WB, 2011, ACTA BIOMATER, V7, P800, DOI 10.1016/j.actbio.2010.08.031
   Zou S, 2005, J MATER SCI-MATER M, V16, P1143, DOI 10.1007/s10856-005-4721-8
NR 54
TC 19
Z9 20
U1 0
U2 35
PU IOP PUBLISHING LTD
PI BRISTOL
PA TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND
SN 1748-6041
EI 1748-605X
J9 BIOMED MATER
JI Biomed. Mater.
PD AUG
PY 2012
VL 7
IS 4
AR 045009
DI 10.1088/1748-6041/7/4/045009
PG 11
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 978BD
UT WOS:000306712900009
PM 22652464
DA 2018-10-19
ER

PT J
AU Niwa, D
   Fujie, T
   Lang, T
   Goda, N
   Takeoka, S
AF Niwa, Daisuke
   Fujie, Toshinori
   Lang, Thorsten
   Goda, Nobuhito
   Takeoka, Shinji
TI Heterofunctional nanosheet controlling cell adhesion properties by
   collagen coating
SO JOURNAL OF BIOMATERIALS APPLICATIONS
LA English
DT Article
DE poly-L-lactic acid; collagen; fibroblast (NIH3T3); cell adhesion; in
   vitro test; immunocytochemistry; nanosheet
ID SURFACE MODIFICATION; THIN-FILMS; ROBUST; NANOMEMBRANES; ASSEMBLIES;
   INTEGRINS; MIGRATION; IMPLANTS; MATRIX; REPAIR
AB Recently, biomaterials have been widely used in a variety of medical applications. We previously reported that a poly-l-lactic acid (PLLA) nanosheet shows anti-adhesive properties and constitutes a useful biomaterial for preventing unwanted wound adhesion in surgical operations. In this article, we examine whether the PLLA nanosheet can be specifically modified with biomacromolecules on one surface only. Such an approach would endow each side of the nanosheet with discrete functions, that is anti-adhesive and pro-healing properties. We fabricated two distinct PLLA nanosheets: (i) collagen cast on the surface of a PLLA nanosheet (Col-Cast-PLLA) and (ii) collagen spin-coated on the nanosheet (Col-Spin-PLLA). In the Col-Spin-PLLA nanosheet, the collagen layer had a thickness of 5-10 nm on the PLLA surface and displayed increased hydrophilicity compared to both PLLA and Col-Cast-PLLA nanosheets. In addition, atomic force microscopy showed disorganized collagen fibril formation on the PLLA layer when covered using the spin-coating method, while apparent bundle formations of collagen were formed in the Col-Cast-PLLA nanosheet. The Col-Spin-PLLA nanosheet provided a microenvironment for cells to adhere and spread. By contrast, the Col-Cast-PLLA nanosheet displayed reduced cell adhesion compared to the Col-Spin-PLLA nanosheet. Consistent with these findings, immunocytochemical analysis clearly showed fine networks of actin filaments in cells cultured on the Col-Spin-PLLA, but not the Col-Cast-PLLA nanosheet. Therefore, the Col-Spin-PLLA nanosheet was shown to be more suitable for acting as a scaffold. In conclusion, we have succeeded in developing a heterofunctional nanosheet comprising a collagen modified side, which has the ability to rapidly adhere cells, and an unmodified side, which acts as an adhesion barrier, by using a spin-coating technique.
C1 [Niwa, Daisuke; Fujie, Toshinori; Goda, Nobuhito; Takeoka, Shinji] Waseda Univ, Grad Sch Adv Sci & Engn, Dept Life Sci & Med Biosci, TWIns,Shinjuku Ku, Tokyo 1628480, Japan.
   [Lang, Thorsten] Univ Bonn, D-53115 Bonn, Germany.
RP Takeoka, S (reprint author), Waseda Univ, Grad Sch Adv Sci & Engn, Dept Life Sci & Med Biosci, TWIns,Shinjuku Ku, 2-2 Wakamatsu Cho, Tokyo 1628480, Japan.
EM takeoka@waseda.jp
RI Fujie, Toshinori/O-1493-2018
OI Fujie, Toshinori/0000-0003-1417-8670; Goda, Nobuhito/0000-0003-0295-4257
FU Mext, Japan [21300181]
FX This work was partially supported by GCOE 'Practical Chemical Wisdom'
   (D.N.), 'Scientific Research (B) 21300181' (S.T., N.G.), 'High-Tech
   Research Center' Project for Waseda University (S.T., N.G.): matching
   fund subsidy from Mext, Japan.
CR Aukhil I, 2000, PERIODONTOL 2000, V22, P44, DOI 10.1034/j.1600-0757.2000.2220104.x
   DAVIS GE, 1992, BIOCHEM BIOPH RES CO, V182, P1025, DOI 10.1016/0006-291X(92)91834-D
   Elliott JT, 2003, LANGMUIR, V19, P1506, DOI 10.1021/la026216r
   Elliott JT, 2005, MATRIX BIOL, V24, P489, DOI 10.1016/j.matbio.2005.07.005
   Fernandes H, 2009, J MATER CHEM, V19, P5474, DOI 10.1039/b822177d
   Fujie T, 2007, ADV MATER, V19, P3549, DOI 10.1002/adma.200700661
   Fujie T, 2010, SOFT MATTER, V6, P4672, DOI 10.1039/c0sm00527d
   Fujie T, 2009, ADV FUNCT MATER, V19, P2560, DOI 10.1002/adfm.200900103
   Heino J, 2007, BIOESSAYS, V29, P1001, DOI 10.1002/bies.20636
   Hong Y, 2005, BIOMATERIALS, V26, P6305, DOI 10.1016/j.biomaterials.2005.03.038
   Inagaki K, 2000, ONCOGENE, V19, P75, DOI 10.1038/sj.onc.1203204
   Jiang CY, 2004, ADV MATER, V16, P157, DOI 10.1002/adma.200306010
   Jin ML, 2000, INVEST OPHTH VIS SCI, V41, P4324
   Jung HJ, 2005, MACROMOL RES, V13, P446, DOI 10.1007/BF03218479
   Li X, 2008, APPL SURF SCI, V255, P459, DOI 10.1016/j.apsusc.2008.06.105
   Liang ZH, 2009, MATER LETT, V63, P927, DOI 10.1016/j.matlet.2009.01.059
   Markutsya S, 2005, ADV FUNCT MATER, V15, P771, DOI 10.1002/adfm.200400149
   Matsui J, 2004, J AM CHEM SOC, V126, P3708, DOI 10.1021/ja039871+
   Morra M, 2006, J BIOMED MATER RES A, V78A, P449, DOI 10.1002/jbm.a.30783
   Okamura Y, 2009, ADV MATER, V21, P4388, DOI 10.1002/adma.200901035
   Pilcher BK, 1998, ARCH DERMATOL RES, V290, pS37, DOI 10.1007/PL00007452
   Priolo MA, 2010, ACS APPL MATER INTER, V2, P312, DOI 10.1021/am900820k
   Rhee S, 2007, P NATL ACAD SCI USA, V104, P5425, DOI 10.1073/pnas.0608030104
   Tang ZY, 2003, NAT MATER, V2, P413, DOI 10.1038/nmat906
   Taubenberger AV, 2010, BIOMATERIALS, V31, P2827, DOI 10.1016/j.biomaterials.2009.12.051
   VANWACHEM PB, 1985, BIOMATERIALS, V6, P403, DOI 10.1016/0142-9612(85)90101-2
   Vendamme R, 2006, NAT MATER, V5, P494, DOI 10.1038/nmat1655
   YAMAMOTO M, 1995, EXP CELL RES, V219, P249, DOI 10.1006/excr.1995.1225
   Yang HS, 2007, MACROMOL RES, V15, P256, DOI 10.1007/BF03218784
   Zhang J, 2005, BIOMATERIALS, V26, P3353, DOI 10.1016/j.biomaterials.2004.08.019
NR 30
TC 10
Z9 10
U1 1
U2 29
PU SAGE PUBLICATIONS LTD
PI LONDON
PA 1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND
SN 0885-3282
J9 J BIOMATER APPL
JI J. Biomater. Appl.
PD AUG
PY 2012
VL 27
IS 2
BP 131
EP 141
DI 10.1177/0885328210394470
PG 11
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 979UG
UT WOS:000306844800003
PM 21343215
DA 2018-10-19
ER

PT J
AU Kim, SH
   Park, JK
   Hong, JH
   Jung, HS
   Hong, KS
   Lee, JH
   Park, KB
   Choi, SK
   Seo, YK
AF Kim, Sung-Hyun
   Park, Jung-Keug
   Hong, Joo-Hee
   Jung, Hyun-Suk
   Hong, Kug-Sun
   Lee, Jong-Ho
   Park, Kwang-Bum
   Choi, Seok-Kyu
   Seo, Young-Kwon
TI Increase of BM-MSC proliferation using L-DOPA on titanium surface in
   vitro
SO JOURNAL OF BIOMATERIALS APPLICATIONS
LA English
DT Article
DE dental implant; titanium; biomaterial; L-DOPA; biocompatibility
ID BONE MORPHOGENETIC PROTEIN-2; FUNCTIONAL-GROUPS; DENTAL IMPLANT;
   COATINGS; OSSEOINTEGRATION; DIFFERENTIATION; ENHANCEMENT; WETTABILITY;
   ATTACHMENT; BEHAVIOR
AB In order to increase biocompatibility, many dental implants have been studied by immobilization of biomolecules on biomaterials. We used l-3,4-dihydroxyphenylalanine (L-DOPA) as a biomolecule for surface-modified titanium. Water contact angles of nontreated titanium discs (negative control), etched titanium discs (positive control), and titanium discs treated with L-DOPA following the etching process (experimental group) were 82.4 +/- 5.7 degrees, 67.1 +/- 0.56 degrees, and 44.15 +/- 0.91 degrees, respectively. Using atomic force microscopy images, we were able to find L-DOPA, which adhered to the titanium surface. The number of human bone marrow mesenchymal stem cells (BM-MSCs) in the experimental group was much higher than that of cells in any other group. Quantification values of amine groups in the positive control and experimental groups were approximately 3 and 7.5 mu g, respectively. Therefore, findings from our research suggested the possibility of a causal link between increased L-DOPA content and cell proliferation in BM-MSCs. Moreover, coating of the discs with L-DOPA can result in greater hydrophilicity of the titanium surface and enhancement of cell adhesion and mitochondrial activity.
C1 [Seo, Young-Kwon] Dongguk Univ, Biotechnol Res Inst, Seoul 100273, South Korea.
   [Kim, Sung-Hyun; Park, Jung-Keug] Dongguk Univ, Dept Med Biotechnol, Seoul 100715, South Korea.
   [Hong, Joo-Hee] Dongguk Univ, Dept Chem & Biochem Engn, Seoul 100715, South Korea.
   [Jung, Hyun-Suk] Kookmin Univ, Dept Adv Mat Engn, Seoul 136702, South Korea.
   [Hong, Kug-Sun] Seoul Natl Univ, Dept Mat Sci & Engn, Seoul 151744, South Korea.
   [Lee, Jong-Ho] Seoul Natl Univ, Dept Oral & Maxillofacial Surg, Seoul 151744, South Korea.
   [Park, Kwang-Bum; Choi, Seok-Kyu] Megagen Implant Co Ltd, Gyongsan 712852, Gyeongbuk, South Korea.
RP Seo, YK (reprint author), Dongguk Univ, Biotechnol Res Inst, 3-27-3 Pil Dong, Seoul 100273, South Korea.
EM bioseo@dongguk.edu
RI Jung, Hyun Suk/H-3659-2015
OI Jung, Hyun Suk/0000-0002-7803-6930
FU MKE/KEIT [10033290]
FX This study was supported by the R&D Program of MKE/KEIT [10033290,
   Development of surface activation technology for best function
   magnification of implant containing bioactive materials].
CR Barber TA, 2003, J BIOMED MATER RES A, V64A, P38, DOI 10.1002/jbm.a.10321
   Choi KM, 2008, J BIOSCI BIOENG, V105, P586, DOI 10.1263/jbb.105.586
   Daculsi G, 2003, J MATER SCI-MATER M, V14, P195, DOI 10.1023/A:1022842404495
   Daugaard H, 2010, J BIOMED MATER RES A, V92A, P913, DOI 10.1002/jbm.a.32303
   de Groot K, 1998, P I MECH ENG H, V212, P137, DOI 10.1243/0954411981533917
   Elias CN, 2008, J MECH BEHAV BIOMED, V1, P234, DOI 10.1016/j.jmbbm.2007.12.002
   Engel A, 1997, CURR OPIN STRUC BIOL, V7, P279, DOI 10.1016/S0959-440X(97)80037-1
   Fan XW, 2005, J AM CHEM SOC, V127, P15843, DOI 10.1021/ja0532638
   Fawzy AS, 2009, J DENT, V37, P255
   Gutierrez-Tauste D, 2008, THIN SOLID FILMS, V516, P3831, DOI 10.1016/j.tsf.2007.06.165
   Janorkar AV, 2007, J BIOMED MATER RES B, V81B, P142, DOI 10.1002/jbm.b.30647
   Le Guehennec L, 2007, DENT MATER, V23, P844, DOI 10.1016/j.dental.2006.06.025
   Lee H, 2009, ADV MATER, V21, P431, DOI 10.1002/adma.200801222
   LEE JH, 1994, BIOMATERIALS, V15, P705, DOI 10.1016/0142-9612(94)90169-4
   Lim TY, 2009, J MATER SCI-MATER M, V20, P1, DOI 10.1007/s10856-008-3528-9
   McCracken M, 1999, J Prosthodont, V8, P40, DOI 10.1111/j.1532-849X.1999.tb00006.x
   OKUYAMA T, 1960, J BIOCHEM-TOKYO, V47, P454, DOI 10.1093/oxfordjournals.jbchem.a127083
   Park JA, 2010, J ADV PROSTHODONT, V2, P18, DOI [10.4047/jap.2010.2.1.18, 10.4047/jap.2010.2.18-24]
   Park JW, 2009, ACTA BIOMATER, V6, P1661
   Puleo DA, 2002, BIOMATERIALS, V23, P2079, DOI 10.1016/S0142-9612(01)00339-8
   Schiller A, 2004, NEUROLOGY, V63, P1524
   Shi ZL, 2009, TISSUE ENG PT A, V15, P417, DOI 10.1089/ten.tea.2007.0415
   Stadlinger B, 2009, J CLIN PERIODONTOL, V36, P698, DOI 10.1111/j.1600-051X.2009.01435.x
   Tengvall P, 2001, TITANIUM MED MAT SCI
   Waite JH, 2001, BIOCHEMISTRY-US, V40, P2887, DOI 10.1021/bi002718x
   Webb K, 1998, J BIOMED MATER RES, V41, P422, DOI 10.1002/(SICI)1097-4636(19980905)41:3<422::AID-JBM12>3.0.CO;2-K
   WONG M, 1995, J BIOMED MATER RES, V29, P1567, DOI 10.1002/jbm.820291213
   Yokoyama K, 2002, BIOMATERIALS, V23, P2459, DOI 10.1016/S0142-9612(01)00380-5
   Yu ME, 1998, MACROMOLECULES, V31, P4739, DOI 10.1021/ma980268z
   Yu ME, 1999, J AM CHEM SOC, V121, P5825, DOI 10.1021/ja990469y
NR 30
TC 6
Z9 6
U1 0
U2 13
PU SAGE PUBLICATIONS LTD
PI LONDON
PA 1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND
SN 0885-3282
J9 J BIOMATER APPL
JI J. Biomater. Appl.
PD AUG
PY 2012
VL 27
IS 2
BP 143
EP 152
DI 10.1177/0885328210397679
PG 10
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 979UG
UT WOS:000306844800004
PM 21343218
DA 2018-10-19
ER

PT J
AU Cortez, PP
   Silva, MA
   Santos, M
   Armada-da-Silva, P
   Afonso, A
   Lopes, MA
   Santos, JD
   Mauricio, AC
AF Cortez, Paulo Pegado
   Silva, Marta Alves
   Santos, Marta
   Armada-da-Silva, Paulo
   Afonso, Amrico
   Lopes, Maria A.
   Santos, Jose Domingos
   Mauricio, Ana Colette
TI A glass-reinforced hydroxyapatite and surgical-grade calcium sulfate for
   bone regeneration: In vivo biological behavior in a sheep model
SO JOURNAL OF BIOMATERIALS APPLICATIONS
LA English
DT Article
DE calcium sulfate; Bonelike (R); in vivo test; hydroxyapatite composite;
   bone graft; tricalcium phosphate
ID GRAFT SUBSTITUTES; OSTEOCLASTIC RESORPTION; MICROSTRUCTURAL
   CHARACTERIZATION; MAXILLOFACIAL SURGERY; PHOSPHATE CERAMICS; ORTHOPEDIC
   TRAUMA; MARROW-CELLS; DEFECTS; VITRO; BONELIKE(R)
AB A glass-reinforced hydroxyapatite (HA) composite (Bonelike (R)) was developed for bone grafting. This biomaterial is composed of a modified HA matrix with alpha- and beta-tricalcium phosphate secondary phases, resulting in higher solubility than single HA type of materials. Several in vitro and in vivo studies demonstrated that Bonelike (R) has a highly bioactive behavior, which was also confirmed by employing granular forms of this biomaterial in orthopedics and dental applications. However, a fast consolidation vehicle was needed to promote the fixation of Bonelike (R) granules if applied in larger defects or in unstable sites. Surgical-grade calcium sulfate (CS), which is widely recognized as a well-tolerated and inexpensive bone graft material, was the chosen vehicle to improve the handling characteristics of Bonelike (R) as it can be used in the form of a powder that is mixed with a liquid to form a paste that sets in situ. After application in non-critical monocortical defects in sheep, histological, and scanning electron microscopy evaluations demonstrated that Bonelike (R) associated to CS functioned as a very satisfactory scaffold for bone regeneration as it achieved synchronization of the ingrowing bone with biomaterial resorption and subsequent preservation of the bone graft initial volume. Therefore, our results indicate that CS is an effective vehicle for Bonelike (R) granules as it facilitates their application and does not interfere with their proven highly osteoconductive properties. In the opposite way, the incorporation of Bonelike (R) improves the bone regeneration capabilities of CS.
C1 [Cortez, Paulo Pegado; Santos, Marta; Mauricio, Ana Colette] Univ Porto, Inst Ciencias Tecnol Agr Agroalimentares ICETA, Ctr Estudos Ciencia Anim CECA, P-4485661 Vairao, Portugal.
   [Cortez, Paulo Pegado; Mauricio, Ana Colette] Univ Porto ICBAS UP, Inst Ciencias Biomed Abel Salazar, P-4099003 Oporto, Portugal.
   [Silva, Marta Alves] Univ Porto FEUP, Dept Engn Met & Mat DEMM, Fac Engn, P-4200465 Oporto, Portugal.
   [Armada-da-Silva, Paulo] Univ Tecn Lisboa UTL, Fac Motricidade Humana FMH, P-1499002 Cruz Quebrada Lisboa, Portugal.
   [Afonso, Amrico] Univ Porto FMD UP, Fac Med Dent, P-4200393 Oporto, Portugal.
   [Lopes, Maria A.; Santos, Jose Domingos] Univ Porto, Dept Engn Met & Mat DEMM, CEMUC, P-4200465 Oporto, Portugal.
RP Cortez, PP (reprint author), Univ Porto, Inst Ciencias Tecnol Agr Agroalimentares ICETA, Ctr Estudos Ciencia Anim CECA, Campus Agr Vairao,Rua Padre Armando Quintas, P-4485661 Vairao, Portugal.
EM pcortez@mail.icav.up.pt
RI Lopes, Maria A./P-4442-2014; Armada-da-Silva, Paulo/L-5675-2013; Lopes,
   Cristina/A-4241-2010
OI Lopes, Maria A./0000-0003-4105-8148; Armada-da-Silva,
   Paulo/0000-0002-3814-6879; Mauricio, Ana Colette/0000-0002-0018-9363;
   Santos, Marta/0000-0003-4244-5166; Santos, Jose
   Domingos/0000-0002-6871-9850; Silva, Marta/0000-0002-4833-3686; Cortez,
   Paulo/0000-0001-7132-6786; Afonso, Americo/0000-0001-7579-1407
FU Fundacao para a Ciencia e Tecnologia (FCT) [PTDC/CVT/64220/2006,
   SFRH/BD/31842/2006]; European Regional Development Fund through the QREN
   Project BIOMATCELL [1372]
FX This study was supported by the Fundacao para a Ciencia e Tecnologia
   (FCT) through the financing of the research project PTDC/CVT/64220/2006
   and through the PhD grant SFRH/BD/31842/2006. Financial support was also
   provided by the European Regional Development Fund, through the QREN
   Project BIOMAT&CELL No. 1372.
CR Ammann P, 2003, OSTEOPOROSIS INT, V14, pS13, DOI 10.1007/s00198-002-1345-4
   ANUSAVICE KJ, 2003, PHILLIPS SCI DENT MA, P255
   Askeland DR, 1994, SCI ENG MAT
   Augat P, 2006, AGE AGEING, V35, P27, DOI 10.1093/ageing/afl081
   BASLE MF, 1993, CALCIFIED TISSUE INT, V53, P348, DOI 10.1007/BF01351842
   Benhamou CL, 2008, OSTEOPOROS INT  0421, V19, P853
   Beuerlein MJS, 2010, J ORTHOP TRAUMA, V24, pS46, DOI 10.1097/BOT.0b013e3181cec48e
   Bodde EWH, 2007, J BIOMED MATER RES A, V82A, P711, DOI 10.1002/bjm.a.30990
   Chen QZ, 2004, BIOMATERIALS, V25, P4243, DOI 10.1016/j.biomaterials.2003.11.017
   Cook Emily A, 2009, Clin Podiatr Med Surg, V26, P589, DOI 10.1016/j.cpm.2009.07.003
   COSTANTINO PD, 1994, OTOLARYNG CLIN N AM, V27, P1037
   DACULSI G, 1990, J BIOMED MATER RES, V24, P379, DOI 10.1002/jbm.820240309
   DEMAEYER EAP, 1993, B SOC CHIM BELG, V102, P601
   Duarte F, 2004, MATER SCI FORUM, V455-456, P370, DOI 10.4028/www.scientific.net/MSF.455-456.370
   Ferraz MP, 1999, J MATER SCI-MATER M, V10, P567, DOI 10.1023/A:1008924516146
   Ferraz MP, 2001, J MATER SCI-MATER M, V12, P629, DOI 10.1023/A:1011245828046
   FROST HM, 1969, CALC TISS RES, V3, P211, DOI 10.1007/BF02058664
   Gauthier O, 1998, BIOMATERIALS, V19, P133, DOI 10.1016/S0142-9612(97)00180-4
   Glazer P A, 2001, Spine J, V1, P395, DOI 10.1016/S1529-9430(01)00108-5
   Goldberg AM, 2003, HDB LAB ANIMAL SCI, V1, P539
   GUNDERSEN HJG, 1988, APMIS, V96, P379, DOI 10.1111/j.1699-0463.1988.tb05320.x
   Gutierres M, 2008, ACTA BIOMATER, V4, P370, DOI 10.1016/j.actbio.2007.06.009
   Gutierres M, 2007, J MATER SCI-MATER M, V18, P2377, DOI 10.1007/s10856-007-3171-x
   Gutierres M, 2006, J ORTHOP RES, V24, P953, DOI 10.1002/jor.20117
   Hak DJ, 2007, J AM ACAD ORTHOP SUR, V15, P525, DOI 10.5435/00124635-200709000-00003
   HAYDEN JM, 1995, BONE, V17, pS93, DOI 10.1016/8756-3282(95)00186-H
   Helgeson Melvin D, 2009, Orthopedics, V32, P323
   Hench LL, 1971, J BIOMED MATER RES S, V2, P117, DOI DOI 10.1002/JBM.820050611
   Heymann D, 2001, HISTOL HISTOPATHOL, V16, P37, DOI 10.14670/HH-16.37
   Hing KA, 2005, INT J APPL CERAM TEC, V2, P184, DOI 10.1111/j.1744-7402.2005.02020.x
   Jha LJ, 1996, J BIOMED MATER RES, V31, P481, DOI 10.1002/(SICI)1097-4636(199608)31:4<481::AID-JBM7>3.0.CO;2-H
   Jha LJ, 1997, J MATER SCI-MATER M, V8, P185, DOI 10.1023/A:1018531505484
   Keating JF, 2001, J BONE JOINT SURG BR, V83B, P3, DOI 10.1302/0301-620X.83B1.11952
   Kelly CM, 2001, CLIN ORTHOP RELAT R, P42
   KLEIN CPAT, 1983, J BIOMED MATER RES, V17, P769, DOI 10.1002/jbm.820170505
   Kon E, 2010, J ORTHOP RES, V28, P116, DOI 10.1002/jor.20958
   Lee Gregory H, 2002, Iowa Orthop J, V22, P35
   LEGEROS RZ, 1981, PROG CRYST GROWTH CH, V4, P1
   Legeros RZ, 2003, J MATER SCI-MATER M, V14, P201, DOI 10.1023/A:1022872421333
   Lobato JV, 2005, KEY ENG MAT, V284-286, P877, DOI 10.4028/www.scientific.net/KEM.284-286.877
   Lopes MA, 2001, J BIOMED MATER RES, V54, P463, DOI 10.1002/1097-4636(20010315)54:4<463::AID-JBM10>3.0.CO;2-Y
   Lopes MA, 2000, BIOMATERIALS, V21, P1165, DOI 10.1016/S0142-9612(00)00007-7
   Lopes MA, 1998, J BIOMED MATER RES, V41, P649, DOI 10.1002/(SICI)1097-4636(19980915)41:4<649::AID-JBM17>3.0.CO;2-9
   Lu JX, 1999, J MATER SCI-MATER M, V10, P111, DOI 10.1023/A:1008973120918
   Maragos P, 2002, INT J PERIODONT REST, V22, P493
   Martin TJ, 2005, TRENDS MOL MED, V11, P76, DOI 10.1016/j.molmed.2004.12.004
   MATRAJT H, 1966, STAIN TECHNOL, V41, P97, DOI 10.3109/10520296609116287
   NELSON DGA, 1982, CALCIFIED TISSUE INT, V34, pS69
   Nilsson M, 2004, J BONE JOINT SURG BR, V86B, P120, DOI 10.1302/0301-620X.86B1.14040
   Ooms EM, 2002, J BIOMED MATER RES, V61, P9, DOI 10.1002/jbm.10029
   Orsini G, 2004, J BIOMED MATER RES B, V68B, P199, DOI 10.1002/jbm.b.20012
   Panchbhavi VK, 2008, FOOT ANKLE INT, V29, P593, DOI 10.3113/FAI.2008.0593
   Paolantonio M, 2008, J PERIODONTOL, V79, P1886, DOI 10.1902/jop.2008.080076 
   Parsons J R, 1988, Ann N Y Acad Sci, V523, P190, DOI 10.1111/j.1749-6632.1988.tb38512.x
   PELTIER LF, 1959, AM J SURG, V97, P311, DOI 10.1016/0002-9610(59)90305-8
   PELTIER LF, 1978, J BONE JOINT SURG AM, V60, P820, DOI 10.2106/00004623-197860060-00017
   Peters CL, 2006, J BIOMED MATER RES A, V76A, P456, DOI 10.1002/jbm.a.30569
   Pietrzak WS, 2000, J CRANIOFAC SURG, V11, P327, DOI 10.1097/00001665-200011040-00009
   Rauschmann M, 2010, EUR SPINE J, V19, P887, DOI 10.1007/s00586-010-1279-z
   Ricci JL, 2000, BONE ENG, P332
   Robinson D, 1999, Ann Transplant, V4, P91
   Santos JD, 1996, J MATER SCI-MATER M, V7, P181, DOI 10.1007/BF00121258
   SANTOS JD, 1994, BIOMATERIALS, V15, P5, DOI 10.1016/0142-9612(94)90188-0
   SANTOS JD, 2000, Patent No. 2000068164
   Scarano A, 2007, IMPLANT DENT, V16, P195, DOI 10.1097/ID.0b013e3180587ad8
   Schopper C, 2005, J BIOMED MATER RES B, V74B, P458, DOI 10.1002/jbm.b.30199
   Seeman E, 2003, NEW ENGL J MED, V349, P320, DOI 10.1056/NEJMp038101
   SEEMAN E, 1982, J CLIN INVEST, V69, P1302, DOI 10.1172/JCI110570
   Marques JMS, 2009, J MATER SCI-MATER M, V20, P725, DOI 10.1007/s10856-008-3628-6
   Silva PL, 1998, SURF COAT TECH, V102, P191, DOI 10.1016/S0257-8972(97)00576-8
   Slater N, 2008, CLIN ORAL IMPLAN RES, V19, P814, DOI 10.1111/j.1600-0501.2008.01550.x
   SNYDERS RV, 1993, J ORAL MAXIL SURG, V51, P517, DOI 10.1016/S0278-2391(10)80506-3
   Sousa RC, 2008, J BIOMATER APPL, V22, P373, DOI 10.1177/0885328207078260
   Stevenson S, 1999, ORTHOP CLIN N AM, V30, P543, DOI 10.1016/S0030-5898(05)70107-3
   Stubbs D, 2004, BIOMATERIALS, V25, P5037, DOI 10.1016/j.biomaterials.2004.02.014
   SUMMERS BN, 1989, J BONE JOINT SURG BR, V71, P677
   Thomas MV, 2009, J BIOMED MATER RES B, V88B, P597, DOI 10.1002/jbm.b.31269
   Turner TM, 2001, J BONE JOINT SURG AM, V83A, P8, DOI 10.2106/00004623-200100021-00003
   Uchino T, 2010, J MATER SCI-MATER M, V21, P1921, DOI 10.1007/s10856-010-4042-4
   Walsh WR, 2003, CLIN ORTHOP RELAT R, P228, DOI 10.1097/01.blo.0000030062.92399.6a
   Wenisch S, 2003, J BIOMED MATER RES A, V67A, P713, DOI 10.1002/jbm.a.10091
   Yamada S, 1997, BIOMATERIALS, V18, P1037, DOI 10.1016/S0142-9612(97)00036-7
   Yamada S, 1997, J BIOMED MATER RES, V37, P346, DOI 10.1002/(SICI)1097-4636(19971205)37:3<346::AID-JBM5>3.0.CO;2-L
   Yasukawa A, 1996, J MATER CHEM, V6, P1401, DOI 10.1039/jm9960601401
   Younger E M, 1989, J Orthop Trauma, V3, P192, DOI 10.1097/00005131-198909000-00002
   Yuan HP, 2000, BIOMATERIALS, V21, P1283, DOI 10.1016/S0142-9612(00)00016-8
   Zaidi M, 2004, BIOL REV, V79, P79, DOI 10.1017/S1464793103006262
NR 87
TC 8
Z9 8
U1 3
U2 26
PU SAGE PUBLICATIONS LTD
PI LONDON
PA 1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND
SN 0885-3282
J9 J BIOMATER APPL
JI J. Biomater. Appl.
PD AUG
PY 2012
VL 27
IS 2
BP 201
EP 217
DI 10.1177/0885328211399479
PG 17
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 979UG
UT WOS:000306844800010
PM 21602251
DA 2018-10-19
ER

PT J
AU McKenna, KA
   Gregory, KW
   Sarao, RC
   Maslen, CL
   Glanville, RW
   Hinds, MT
AF McKenna, Kathryn A.
   Gregory, Kenton W.
   Sarao, Rebecca C.
   Maslen, Cheryl L.
   Glanville, Robert W.
   Hinds, Monica T.
TI Structural and cellular characterization of electrospun recombinant
   human tropoelastin biomaterials
SO JOURNAL OF BIOMATERIALS APPLICATIONS
LA English
DT Article
DE elastin; cell adhesion; cell proliferation; vascular biomaterial; tissue
   engineering
ID SUPRAVALVULAR AORTIC-STENOSIS; TISSUE ENGINEERING APPLICATIONS;
   IN-VITRO; VASCULAR GRAFT; CROSS-LINKING; ELASTIN GENE; BINDING PROTEIN;
   BLOOD-VESSELS; COLLAGEN; SCAFFOLDS
AB An off-the-shelf vascular graft biomaterial for vascular bypass surgeries is an unmet clinical need. The vascular biomaterial must support cell growth, be non-thrombogenic, minimize intimal hyperplasia, match the structural properties of native vessels, and allow for regeneration of arterial tissue. Electrospun recombinant human tropoelastin (rTE) as a medial component of a vascular graft scaffold was investigated in this study by evaluating its structural properties, as well as its ability to support primary smooth muscle cell adhesion and growth. rTE solutions of 9, 15, and 20 wt% were electrospun into sheets with average fiber diameters of 167 +/- 32, 522 +/- 67, and 735 +/- 270 nm, and average pore sizes of 0.4 +/- 0.1, 5.8 +/- 4.3, and 4.9 +/- 2.4 mu m, respectively. Electrospun rTE fibers were cross-linked with disuccinimidyl suberate to produce an insoluble fibrous polymeric recombinant tropoelastin (prTE) biomaterial. Smooth muscle cells attached via integrin binding to the rTE coatings and proliferated on prTE biomaterials at a comparable rate to growth on prTE coated glass, glass alone, and tissue culture plastic. Electrospun tropoelastin demonstrated the cell compatibility and design flexibility required of a graft biomaterial for vascular applications.
C1 [McKenna, Kathryn A.; Hinds, Monica T.] Oregon Hlth & Sci Univ, Dept Biomed Engn, Portland, OR 97239 USA.
   [McKenna, Kathryn A.; Gregory, Kenton W.; Sarao, Rebecca C.; Glanville, Robert W.] Providence St Vincent Med Ctr, Oregon Med Laser Ctr, Portland, OR 97225 USA.
   [Maslen, Cheryl L.] Oregon Hlth & Sci Univ, Div Cardiovasc Med, Portland, OR 97239 USA.
RP Hinds, MT (reprint author), Oregon Hlth & Sci Univ, Dept Biomed Engn, 3303 SW Bond Ave,Mailcode CH13B, Portland, OR 97239 USA.
EM hindsm@ohsu.edu
FU NIH [R01-HL095474]; Department of the Army [W81XWH-04-1-0841,
   W81XWH-05-1-0586]
FX We would like to thank Dr. Jack M. McCarthy for his assistance with SEM
   and TEM imaging, Dr. Brian Kim for his assistance with cross-linking
   modalities, and Dr. Sean Kirkpatrick for his assistance in evaluating
   fiber orientation. Tropoelastin was produced with the excellent
   technical assistance of Amy Jay, Cher Hawkey, and Rose Merten. This work
   was funded in part by the NIH R01-HL095474 and Department of the Army,
   Grant Nos. W81XWH-04-1-0841 and W81XWH-05-1-0586. This work does not
   necessarily reflect the policy of the government and no official
   endorsement should be inferred.
CR Abbott WM, 2004, VASCULAR SURG PRINCI, P611
   Bax DV, 2009, J BIOL CHEM, V284, P28616, DOI 10.1074/jbc.M109.017525
   BAXTER BT, 1992, J VASC SURG, V16, P192, DOI 10.1016/0741-5214(92)90107-J
   BLOOD CH, 1988, J CELL BIOL, V107, P1987, DOI 10.1083/jcb.107.5.1987
   Boland ED, 2004, FRONT BIOSCI-LANDMRK, V9, P1422, DOI 10.2741/1313
   BREWSTER DC, 1995, VASCULAR SURG, P492
   Broekelmann TJ, 2005, J BIOL CHEM, V280, P40939, DOI 10.1074/jbc.M507309200
   Buttafoco L, 2005, J CONTROL RELEASE, V101, P322
   Buttafoco L, 2006, BIOMATERIALS, V27, P724, DOI 10.1016/j.biomaterials.2005.06.024
   CURRAN ME, 1993, CELL, V73, P159, DOI 10.1016/0092-8674(93)90168-P
   Daamen WF, 2007, BIOMATERIALS, V28, P4378, DOI 10.1016/j.biomaterials.2007.06.025
   Dardik H, 2002, J VASC SURG, V35, P64, DOI 10.1067/mva.2002.121053
   Dyksterhuis LB, 2007, MATRIX BIOL, V26, P125, DOI 10.1016/j.matbio.2006.10.002
   EWART AK, 1994, J CLIN INVEST, V93, P1071, DOI 10.1172/JCI117057
   GANDHI RH, 1994, SURGERY, V115, P617
   Gui LQ, 2009, TISSUE ENG PT A, V15, P2665, DOI [10.1089/ten.tea.2008.0526, 10.1089/ten.TEA.2008.0526]
   Heydarkhan-Hagvall S, 2008, BIOMATERIALS, V29, P2907, DOI 10.1016/j.biomaterials.2008.03.034
   HINEK A, 1988, SCIENCE, V239, P1539, DOI 10.1126/science.2832941
   HINEK A, 1993, J CLIN INVEST, V91, P1198, DOI 10.1172/JCI116280
   Karnik SK, 2003, MATRIX BIOL, V22, P409, DOI 10.1016/S0945-053X(03)00076-3
   Karnik SK, 2003, DEVELOPMENT, V130, P411, DOI 10.1242/dev.00223
   Koombhongse S, 2001, J POLYM SCI POL PHYS, V39, P2598, DOI 10.1002/polb.10015
   L'Heureux N, 2007, NAT CLIN PRACT CARD, V4, P389, DOI 10.1038/ncpcardio0930
   LANSING AI, 1952, ANAT RECORD, V114, P555, DOI 10.1002/ar.1091140404
   Lee SJ, 2007, J BIOMED MATER RES A, V83A, P999, DOI 10.1002/jbm.a.31287
   Li DY, 1997, HUM MOL GENET, V6, P1021, DOI 10.1093/hmg/6.7.1021
   Li M, 2006, J BIOMED MATER RES A, V79A, P963, DOI 10.1002/jbm.a.30833
   Li MY, 2005, BIOMATERIALS, V26, P5999, DOI 10.1016/j.biomaterials.2005.03.030
   Lloyd-Jones D, 2010, CIRCULATION, V121, pE46, DOI 10.1161/CIRCULATIONAHA.109.192667
   Lowry OH, 1941, J BIOL CHEM, V139, P795
   McAllister TN, 2009, LANCET, V373, P1440, DOI 10.1016/S0140-6736(09)60248-8
   MECHAM RP, 1989, BIOCHEMISTRY-US, V28, P3716, DOI 10.1021/bi00435a014
   Megelski S, 2002, MACROMOLECULES, V35, P8456, DOI 10.1021/ma020444a
   Mithieux SM, 2005, J STRUCT BIOL, V149, P282, DOI 10.1016/j.jsb.2004.11.005
   Mithieux SM, 2004, BIOMATERIALS, V25, P4921, DOI 10.1016/j.biomaterials.2004.01.055
   Murugan R, 2006, TISSUE ENG, V12, P435, DOI 10.1089/ten.2006.12.435
   Nivison-Smith L, 2010, ACTA BIOMATER, V6, P354, DOI 10.1016/j.actbio.2009.08.011
   Patel A, 2006, CARDIOVASC RES, V71, P40, DOI 10.1016/j.cardiores.2006.02.021
   RIZZO R J, 1989, Journal of Vascular Surgery, V10, P365, DOI 10.1067/mva.1989.13151
   Rnjak J, 2009, BIOMATERIALS, V30, P6469, DOI 10.1016/j.biomaterials.2009.08.017
   ROACH MR, 1957, CAN J BIOCHEM PHYS, V35, P681
   ROBERT L, 1989, PATHOL BIOL, V37, P736
   SAWYER PN, 1987, AM J SURG, V154, P533, DOI 10.1016/0002-9610(87)90272-8
   Smith MJ, 2008, ACTA BIOMATER, V4, P58, DOI 10.1016/j.actbio.2007.08.001
   Smith MJ, 2009, BIOMATERIALS, V30, P149, DOI 10.1016/j.biomaterials.2008.09.019
   Stegemann JP, 2003, ANN BIOMED ENG, V31, P391, DOI 10.1114/1.1558031
   Stitzel J, 2006, BIOMATERIALS, V27, P1088, DOI 10.1016/j.biomaterials.2005.07.048
   Strobel R, 1996, EUR J VASC ENDOVASC, V11, P417, DOI 10.1016/S1078-5884(96)80173-0
   Thomas V, 2007, BIOMED MATER, V2, P224, DOI 10.1088/1748-6041/2/4/004
   Urban Z, 1999, HUM GENET, V104, P135, DOI 10.1007/s004390050926
   Vartanian KB, 2008, BIOCHEM BIOPH RES CO, V371, P787, DOI 10.1016/j.bbrc.2008.04.167
   Wise SG, 2005, J STRUCT BIOL, V149, P273, DOI 10.1016/j.jsb.2004.11.006
   Zeugolis DI, 2009, J BIOMED MATER RES A, V89A, P895, DOI 10.1002/jbm.a.32031
   Zhang X, 2010, BIOMATERIALS, V31, P4376, DOI 10.1016/j.biomaterials.2010.02.017
NR 54
TC 9
Z9 9
U1 0
U2 13
PU SAGE PUBLICATIONS LTD
PI LONDON
PA 1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND
SN 0885-3282
J9 J BIOMATER APPL
JI J. Biomater. Appl.
PD AUG
PY 2012
VL 27
IS 2
BP 219
EP 230
DI 10.1177/0885328211399480
PG 12
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 979UG
UT WOS:000306844800011
PM 21586601
OA Green Accepted
DA 2018-10-19
ER

PT J
AU Suckow, MA
   Wolter, WR
   Fecteau, C
   LaBadie-Suckow, SM
   Johnson, C
AF Suckow, Mark A.
   Wolter, William R.
   Fecteau, Chris
   LaBadie-Suckow, Susan M.
   Johnson, Chad
TI Bupivacaine-enhanced small intestinal submucosa biomaterial as a hernia
   repair device
SO JOURNAL OF BIOMATERIALS APPLICATIONS
LA English
DT Article
DE bupivacaine; small intestinal submucosa; hernia repair; analgesic;
   extracellular matrix
ID POSTOPERATIVE PAIN; LOCAL-ANESTHETICS; ANIMAL-MODEL; LIDOCAINE; TRIAL;
   GRAFT; INFILTRATION; MANAGEMENT; WOUNDS
AB Management of post-surgical pain following herniorrhaphy remains a clinical challenge and novel methods to deliver analgesic compounds could be of great benefit. Because there is great interest in the use of natural biomaterials for hernia repair, we investigated the biocompatibility of a natural biomaterial, porcine small intestinal submucosa (SIS), which was impregnated with bupivacaine (SIS-B) via immersion in a solution of poly(lactic-co-glycolic acid) (PLGA). Groups of Sprague Dawley rats underwent surgical creation of a ventral abdominal wall defect with subsequent repair using either SIS or SIS-B. Analysis of serial blood samples showed peak bupivacaine levels (83 ng/mL) were achieved 16 h after implantation of SIS-B. One month after surgery, the rats were euthanized and implant sites harvested for mechanical strength testing and histological analysis. At the time of necropsy, adhesion extent and tenacity was greater in SIS-B rats, with 90% of SIS-B rats have adhesion to the implant site compared to only 75% of SIS rats. Microscopically, SIS implant sites were characterized by small amounts of residual SIS surrounded by mild-to-moderate chronic inflammation. In contrast, rats treated with SIS-B, residual SIS-B was surrounded by a ring of acute inflammatory cells and an outer ring of chronic inflammatory cells, possibly due to bupivacaine or residual PLGA. Mechanical strength testing of the harvested implant sites showed no significant (p <= 0.05) difference between SIS and SIS-B implants. In summary, bupivacaine is readily elaborated from SIS-B; and impregnation of SIS with bupivacaine does not substantially alter the biocompatibility of the biomaterial or its mechanical strength following implantation.
C1 [Suckow, Mark A.; Wolter, William R.; LaBadie-Suckow, Susan M.] Univ Notre Dame, Freimann Life Sci Ctr, Notre Dame, IN 46556 USA.
   [Fecteau, Chris; Johnson, Chad] Cook Biotech Inc, W Lafayette, IN 47906 USA.
RP Suckow, MA (reprint author), Univ Notre Dame, Freimann Life Sci Ctr, Notre Dame, IN 46556 USA.
EM suckow.1@nd.edu
RI Suckow, Mark/C-2696-2014
OI Suckow, Mark/0000-0001-7317-697X
CR Ansaloni L, 2007, Hernia, V11, P321, DOI 10.1007/s10029-007-0225-4
   Ausems ME, 2007, ANAESTHESIA, V62, P325, DOI 10.1111/j.1365-2044.2007.04991.x
   Bar-Dayan A, 2004, SURG ENDOSC, V18, P1079, DOI 10.1007/s00464-003-8214-x
   Bay-Nielsen M, 1999, BRIT J ANAESTH, V82, P280, DOI 10.1093/bja/82.2.280
   Beijani GK, 2007, J NEUROSURG, V106, P1028
   Buckenmaier CC, 1999, AM SURGEON, V65, P274
   CHVAPIL M, 1979, J SURG RES, V27, P367, DOI 10.1016/0022-4804(79)90155-0
   Cote CH, 2008, MUSCLE NERVE, V37, P754, DOI 10.1002/mus.20998
   Drucker M, 1998, WORLD J SURG, V22, P394, DOI 10.1007/s002689900403
   Edelman SD, 2001, SURG ENDOSC     1216, V15, P976
   El-Radaideh KM, 2006, ASIAN J SURG, V29, P242, DOI 10.1016/S1015-9584(09)60096-8
   Gordon SM, 2008, ANESTH ANALG, V106, P321, DOI 10.1213/01.ane.0000296474.79437.23
   Groban L, 2003, REGION ANESTH PAIN M, V28, P3, DOI 10.1053/rapm.2003.50014
   Johnson BM, 2010, J SURG RES
   Kim MS, 2007, BIOMATERIALS, V28, P5137, DOI 10.1016/j.biomaterials.2007.08.014
   Knoll LD, 2007, J UROLOGY, V178, P2474, DOI 10.1016/j.juro.2007.08.044
   Koivusalo AI, 2009, PEDIATRICS, V123, P332, DOI 10.1542/peds.2007-3752
   Massaron S, 2007, Hernia, V11, P517, DOI 10.1007/s10029-007-0267-7
   Mitchell A, 2008, J AM COLL SURGEONS, V206, P472, DOI 10.1016/j.jamcollsurg.2007.09.006
   Mostow EN, 2005, J VASC SURG, V41, P837, DOI 10.1016/j.jvs.2005.01.042
   Niezgoda Jeffrey A, 2005, Adv Skin Wound Care, V18, P258, DOI 10.1097/00129334-200506000-00012
   Oncel M, 2001, J SURG RES, V101, P52, DOI 10.1006/jsre.2001.6245
   Palminteri E, 2007, EUR UROL, V51, P1695, DOI 10.1016/j.eururo.2006.12.016
   Saber AA, 2009, INT J SURG, V7, P36, DOI 10.1016/j.ijsu.2008.09.003
   Sanchez B, 2004, AM SURGEON, V70, P1002
   Scherb Michael B, 2009, Orthopedics, V32, P26
   Ueno T, 2004, J GASTROINTEST SURG, V8, P109, DOI 10.1016/j.gassur.2003.09.025
   VASSEUR PB, 1984, AM J VET RES, V45, P2385
NR 28
TC 1
Z9 1
U1 0
U2 9
PU SAGE PUBLICATIONS LTD
PI LONDON
PA 1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND
SN 0885-3282
J9 J BIOMATER APPL
JI J. Biomater. Appl.
PD AUG
PY 2012
VL 27
IS 2
BP 231
EP 237
DI 10.1177/0885328211406298
PG 7
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 979UG
UT WOS:000306844800012
PM 21680611
DA 2018-10-19
ER

PT J
AU Shim, JH
   Lee, JS
   Kim, JY
   Cho, DW
AF Shim, Jin-Hyung
   Lee, Jung-Seob
   Kim, Jong Young
   Cho, Dong-Woo
TI Bioprinting of a mechanically enhanced three-dimensional dual cell-laden
   construct for osteochondral tissue engineering using a multi-head
   tissue/organ building system
SO JOURNAL OF MICROMECHANICS AND MICROENGINEERING
LA English
DT Article
ID FREE-FORM FABRICATION; ALGINATE; REGENERATION; SCAFFOLDS; HYDROGEL;
   MICROSTEREOLITHOGRAPHY; BIOFABRICATION; DEPOSITION; CARTILAGE; COMPLEX
AB The aim of this study was to build a mechanically enhanced three-dimensional (3D) bioprinted construct containing two different cell types for osteochondral tissue regeneration. Recently, the production of 3D cell-laden structures using various scaffold-free cell printing technologies has opened up new possibilities. However, ideal 3D complex tissues or organs have not yet been printed because gel-state hydrogels have been used as the principal material and are unable to maintain the desired 3D structure due to their poor mechanical strength. In this study, thermoplastic biomaterial polycaprolactone (PCL), which shows relatively high mechanical properties as compared with hydrogel, was used as a framework for enhancing the mechanical stability of the bioprinted construct. Two different alginate solutions were then infused into the previously prepared framework consisting of PCL to create the 3D construct for osteochondral printing. For this work, a multi-head tissue/organ building system (MtoBS), which was particularly designed to dispense thermoplastic biomaterial and hydrogel having completely different rheology properties, was newly developed and used to bioprint osteochondral tissue. It was confirmed that the line width, position and volume control of PCL and alginate solutions were adjustable in the MtoBS. Most importantly, dual cell-laden 3D constructs consisting of osteoblasts and chondrocytes were successfully fabricated. Further, the separately dispensed osteoblasts and chondrocytes not only retained their initial position and viability, but also proliferated up to 7 days after being dispensed.
C1 [Kim, Jong Young] Andong Natl Univ, Dept Mech Engn, Angong, South Korea.
EM dwcho@postech.ac.kr
FU National Research Foundation of Korea (NRF); Korea government (MEST)
   [2011-0000412]
FX This work was supported by the National Research Foundation of Korea
   (NRF) grant funded by the Korea government (MEST) (no 2011-0000412).
CR Ahn G, 2010, J BIOMECH ENG-T ASME, V132, DOI 10.1115/1.4002429
   Allan KS, 2007, TISSUE ENG, V13, P167, DOI 10.1089/ten.2006.0081
   Atala A, 2006, LANCET, V367, P1241, DOI 10.1016/S0140-6736(06)68438-9
   Augst AD, 2006, MACROMOL BIOSCI, V6, P623, DOI 10.1002/mabi.200600069
   Bhandari RNB, 2001, TISSUE ENG, V7, P345, DOI 10.1089/10763270152044206
   Boucard N, 2007, BIOMATERIALS, V28, P3478, DOI 10.1016/j.biomaterials.2007.04.021
   Buyukhatipoglu K, 2009, BIOFABRICATION, V1, DOI 10.1088/1758-5082/1/3/035003
   Cebotari S, 2006, CIRCULATION, V114, pI132, DOI 10.1161/CIRCULATIONAHA.105.001065
   Censi R, 2011, ADV FUNCT MATER, V21, P1833, DOI 10.1002/adfm.201002428
   Charuchinda A, 2003, POLYM INT, V52, P1175, DOI 10.1002/pi.1234
   Fedorovich NE, 2008, TISSUE ENG PT A, V14, P127, DOI 10.1089/ten.a.2007.0158
   Fedorovich NE, 2012, TISSUE ENG PART C-ME, V18, P33, DOI [10.1089/ten.tec.2011.0060, 10.1089/ten.TEC.2011.0060]
   Fedorovich NE, 2011, TISSUE ENG PT A, V17, P2473, DOI [10.1089/ten.tea.2011.0001, 10.1089/ten.TEA.2011.0001]
   Fedorovich NE, 2009, BIOMACROMOLECULES, V10, P1689, DOI 10.1021/bm801463q
   Gauvin R, 2011, VASC CELL, V3, DOI 10.1186/2045-824X-3-24
   Griffith LG, 2002, SCIENCE, V295, P1009, DOI 10.1126/science.1069210
   Hollister SJ, 2005, NAT MATER, V4, P518, DOI 10.1038/nmat1421
   Hong SJ, 2011, EXP CELL RES, V317, P2299, DOI 10.1016/j.yexcr.2011.07.004
   Hutmacher DW, 2004, TRENDS BIOTECHNOL, V22, P354, DOI 10.1016/j.tibtech.2004.05.006
   Jung JW, 2012, INT J PRECIS ENG MAN, V13, P445, DOI 10.1007/s12541-012-0057-8
   Kim JY, 2009, J MICROMECH MICROENG, V19, DOI 10.1088/0960-1317/19/10/105003
   Kim SW, 2009, LARYNGOSCOPE, V119, P62, DOI 10.1002/lary.20025
   Lam CXF, 2008, BIOMED MATER, V3, DOI 10.1088/1748-6041/3/3/034108
   Lee JW, 2011, BIOMATERIALS, V32, P744, DOI 10.1016/j.biomaterials.2010.09.035
   Li HP, 2011, CARBOHYD POLYM, V84, P1117, DOI 10.1016/j.carbpol.2010.12.072
   Li MG, 2009, BIOFABRICATION, V1, DOI 10.1088/1758-5082/1/3/032001
   Li MG, 2011, BIOTECHNOL PROGR, V27, P1777, DOI 10.1002/btpr.679
   Macchiarini P, 2008, LANCET, V372, P2023, DOI 10.1016/S0140-6736(08)61598-6
   Manojlovic V, 2006, J CHEM TECHNOL BIOT, V81, P505, DOI 10.1002/jctb.1465
   Matsumura G, 2003, BIOMATERIALS, V24, P2303, DOI 10.1016/S0142-9612(03)00043-7
   Max V, 2010, BIOMED MICRODEVICES, V12, P253
   Melchels FPW, 2010, BIOMATERIALS, V31, P6121, DOI 10.1016/j.biomaterials.2010.04.050
   Mummery CL, 2011, CIRC RES, V109, P828, DOI 10.1161/RES.0b013e3182349a8a
   Ohashi K, 2012, CELL TRANSPLANT, V21, P429, DOI 10.3727/096368911X605330
   Park JK, 2011, ADV FUNCT MATER, V21, P2906, DOI 10.1002/adfm.201100612
   Pokrywczynska M, 2008, TRANSPL P, V40, P1664, DOI 10.1016/j.transproceed.2008.03.135
   Rezende RA, 2009, J APPL POLYM SCI, V113, P3866, DOI 10.1002/app.30170
   Sekine H, 2006, CIRCULATION, V114, pI87, DOI 10.1161/CIRCULATIONAHA.105.000273
   Seol YJ, 2012, SOFT MATTER, V8, P1730, DOI 10.1039/c1sm06863f
   Shim JH, 2011, BIOFABRICATION, V3, DOI 10.1088/1758-5082/3/3/034102
   Shim JH, 2010, J BIOMAT SCI-POLYM E, V21, P1069, DOI 10.1163/092050609X12457428919034
   SMITH JR, 1992, AM J CLIN NUTR, V55, P1215
NR 42
TC 134
Z9 139
U1 14
U2 211
PU IOP PUBLISHING LTD
PI BRISTOL
PA TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND
SN 0960-1317
EI 1361-6439
J9 J MICROMECH MICROENG
JI J. Micromech. Microeng.
PD AUG
PY 2012
VL 22
IS 8
AR 085014
DI 10.1088/0960-1317/22/8/085014
PG 11
WC Engineering, Electrical & Electronic; Nanoscience & Nanotechnology;
   Instruments & Instrumentation; Physics, Applied
SC Engineering; Science & Technology - Other Topics; Instruments &
   Instrumentation; Physics
GA 977IC
UT WOS:000306649000014
HC Y
HP N
DA 2018-10-19
ER

PT J
AU Swindle-Reilly, KE
   Papke, JB
   Kutosky, HP
   Throm, A
   Hammer, JA
   Harkins, AB
   Willits, RK
AF Swindle-Reilly, Katelyn E.
   Papke, Jason B.
   Kutosky, Hannah P.
   Throm, Allison
   Hammer, Joshua A.
   Harkins, Amy B.
   Willits, Rebecca Kuntz
TI The impact of laminin on 3D neurite extension in collagen gels
SO JOURNAL OF NEURAL ENGINEERING
LA English
DT Article
ID PERIPHERAL-NERVE REGENERATION; EXTRACELLULAR-MATRIX PROTEINS; IN-VITRO;
   CELL-ADHESION; NEURAL TISSUE; MECHANICAL-PROPERTIES; NEUTROPHIL
   MOTILITY; AXONAL REGENERATION; CHONDROITIN SULFATE; FIBRIN MATRICES
AB The primary goal of this research was to characterize the effect of laminin on three-dimensional (3D) neurite growth. Gels were formed using type I collagen at concentrations of 0.4-2.0 mg mL(-1) supplemented with laminin at concentrations of 0, 1, 10, or 100 mu g mL(-1). When imaged with confocal microscopy, laminin was shown to follow the collagen fibers; however, the addition of laminin had minimal effect on the stiffness of the scaffolds at any concentration of collagen. Individual neurons dissociated from E9 chick dorsal root ganglia were cultured in the gels for 24 h, and neurite lengths were measured. For collagen gels without laminin, a typical bimodal response of neurite outgrowth was observed, with increased growth at lower concentrations of collagen gel. However, alteration of the chemical nature of the collagen gel by the laminin additive shifted, or completely mitigated, the bimodal neurite growth response seen in gels without laminin. Expression of integrin subunits, alpha 1, alpha 3, alpha 6 and beta 1, were confirmed by PCR and immunolabeling in the 3D scaffolds. These results provide insight into the interplay between mechanical and chemical environment to support neurite outgrowth in 3D. Understanding the relative impact of environmental factors on 3D nerve growth may improve biomaterial design for nerve cell regeneration.
C1 [Throm, Allison; Willits, Rebecca Kuntz] Univ Akron, Dept Biomed Engn, Akron, OH 44325 USA.
   [Swindle-Reilly, Katelyn E.; Kutosky, Hannah P.; Throm, Allison; Hammer, Joshua A.; Harkins, Amy B.] St Louis Univ, Dept Biomed Engn, St Louis, MO 63103 USA.
   [Papke, Jason B.; Harkins, Amy B.] St Louis Univ, Dept Pharmacol & Physiol Sci, St Louis, MO 63104 USA.
RP Willits, RK (reprint author), Univ Akron, Dept Biomed Engn, 260 S Forge St,OLRC 301, Akron, OH 44325 USA.
EM willits@uakron.edu
RI Willits, Rebecca/B-5017-2010
OI Willits, Rebecca/0000-0002-1866-6789; Swindle-Reilly,
   Katelyn/0000-0003-1739-0263
FU NSF CBET Award [0755389]; NSF EEC [0849621]; NSF [0818672]; NICHD
FX This research was funded in part by NSF CBET Award 0755389 (RKW, HK, &
   AT), NSF EEC 0849621 (JAH), NSF 0818672 (ABH). The antibody 3A10
   developed by Alan F Horwitz was obtained from the Developmental Studies
   Hybridoma Bank developed under the auspices of the NICHD and maintained
   by the Department of Biology, University of Iowa, Iowa City, IA 52242,
   USA. Some of the work was carried out while RKW was at the Department of
   Biomedical Engineering, Saint Louis University, St Louis, MO 63103, USA.
CR Baldwin SP, 1996, INT J DEV NEUROSCI, V14, P351, DOI 10.1016/0736-5748(96)00018-4
   Balgude AP, 2001, BIOMATERIALS, V22, P1077, DOI 10.1016/S0142-9612(00)00350-1
   Blewitt M, 2007, BIOMEDICAL ENG
   Blewitt MJ, 2007, ANN BIOMED ENG, V35, P2159, DOI 10.1007/s10439-007-9389-4
   Brocco MA, 1999, DEV BRAIN RES, V118, P23, DOI 10.1016/S0165-3806(99)00120-0
   CARBONETTO S, 1987, J PHYSIOL-PARIS, V82, P258
   Ceballos D, 1999, EXP NEUROL, V158, P290, DOI 10.1006/exnr.1999.7111
   Chamberlain LJ, 1998, EXP NEUROL, V154, P315, DOI 10.1006/exnr.1998.6955
   CHANDRAKASAN G, 1976, J BIOL CHEM, V251, P6062
   Chen YS, 2000, BIOMATERIALS, V21, P1541, DOI 10.1016/S0142-9612(00)00028-4
   Chung TW, 2011, BIOMATERIALS, V32, P734, DOI 10.1016/j.biomaterials.2010.09.023
   Condic ML, 1997, NATURE, V389, P852, DOI 10.1038/39878
   Cullen DK, 2007, ANN BIOMED ENG, V35, P835, DOI 10.1007/s10439-007-9292-z
   Culley B, 2001, NEUROSCI LETT, V301, P83, DOI 10.1016/S0304-3940(01)01615-9
   Deister C, 2007, J BIOMAT SCI-POLYM E, V18, P983, DOI 10.1163/156856207781494377
   di Summa PG, 2011, NEUROSCIENCE, V181, P278, DOI 10.1016/j.neuroscience.2011.02.052
   Dickson BJ, 2002, SCIENCE, V298, P1959, DOI 10.1126/science.1072165
   Dickson BJ, 2003, SCIENCE, V299, P515
   Dohm S, 2000, RESTOR NEUROL NEUROS, V16, P117
   Evans AR, 2007, DEV NEUROBIOL, V67, P1721, DOI 10.1002/dneu.20540
   Evans GRD, 2002, BIOMATERIALS, V23, P841, DOI 10.1016/S0142-9612(01)00190-9
   Gomez TM, 1996, J NEUROBIOL, V29, P18, DOI 10.1002/(SICI)1097-4695(199601)29:1<18::AID-NEU2>3.0.CO;2-A
   Guarnieri D, 2007, J MATER SCI-MATER M, V18, P245, DOI 10.1007/s10856-006-0686-5
   GUNDERSEN RW, 1987, DEV BIOL, V121, P423, DOI 10.1016/0012-1606(87)90179-5
   Hadlock T, 2000, TISSUE ENG, V6, P119, DOI 10.1089/107632700320748
   Hart A, 2011, TISSUE ENGINEERING: FROM LAB TO CLINIC, P245, DOI 10.1007/978-3-642-02824-3_13
   Hoffman-Kim D, 2010, ANNU REV BIOMED ENG, V12, P203, DOI 10.1146/annurev-bioeng-070909-105351
   Kemp SWP, 2009, TISSUE ENG PT A, V15, P1975, DOI 10.1089/ten.tea.2008.0338
   Kuntz RM, 1997, BIOPHYS J, V72, P1472, DOI 10.1016/S0006-3495(97)78793-9
   Labrador RO, 1998, EXP NEUROL, V149, P243, DOI 10.1006/exnr.1997.6650
   LAMOUREUX P, 1992, J CELL BIOL, V118, P655, DOI 10.1083/jcb.118.3.655
   LEMMON V, 1992, J NEUROSCI, V12, P818
   Mahoney MJ, 2006, BIOMATERIALS, V27, P2265, DOI 10.1016/j.biomaterials.2005.11.007
   McCulloch F, 1998, NEUROREPORT, V9, P2391, DOI 10.1097/00001756-199807130-00044
   McKerracher L, 1996, MOL NEUROBIOL, V12, P95, DOI 10.1007/BF02740648
   Miller C, 2001, TISSUE ENG, V7, P705, DOI 10.1089/107632701753337663
   O'Connor SM, 2001, NEUROSCI LETT, V304, P189, DOI 10.1016/S0304-3940(01)01769-4
   PARKHURST MR, 1992, BIOPHYS J, V61, P306, DOI 10.1016/S0006-3495(92)81838-6
   Pittier R, 2005, J NEUROBIOL, V63, P1, DOI 10.1002/neu.20116
   Rizzo JF, 2004, RESTOR NEUROL NEUROS, V22, P429
   ROGERS SL, 1983, DEV BIOL, V98, P212, DOI 10.1016/0012-1606(83)90350-0
   Schense JC, 2000, J BIOL CHEM, V275, P6813, DOI 10.1074/jbc.275.10.6813
   Scott R, 2010, J BIOMED MATER RES A, V93A, P817, DOI 10.1002/jbm.a.32775
   SILVER FH, 1980, J BIOL CHEM, V255, P9427
   SKUBITZ APN, 1991, J CELL BIOL, V115, P1137, DOI 10.1083/jcb.115.4.1137
   Stuart K, 2008, BIOPOLYMERS, V89, P841, DOI 10.1002/bip.21024
   Suter DM, 2000, J NEUROBIOL, V44, P97, DOI 10.1002/1097-4695(200008)44:2<97::AID-NEU2>3.0.CO;2-U
   TOMASELLI KJ, 1987, J CELL BIOL, V105, P2347, DOI 10.1083/jcb.105.5.2347
   TOMASELLI KJ, 1993, J NEUROSCI, V13, P4880
   Tonge D, 1998, PROG NEUROBIOL, V54, P459, DOI 10.1016/S0301-0082(97)00072-5
   Tonge DA, 2000, NEUROSCIENCE, V100, P201, DOI 10.1016/S0306-4522(00)00255-4
   Tonge DA, 1997, EXP NEUROL, V146, P81, DOI 10.1006/exnr.1997.6498
   VANDERREST M, 1991, FASEB J, V5, P2814
   Wang W, 2008, J BIOMED MATER RES A, V84A, P557, DOI 10.1002/jbm.a.31536
   WAYNER EA, 1988, J CELL BIOL, V107, P1881, DOI 10.1083/jcb.107.5.1881
   Willits RK, 2004, J BIOMAT SCI-POLYM E, V15, P1521, DOI 10.1163/1568562042459698
   Wood MD, 2009, ACTA BIOMATER, V5, P959, DOI 10.1016/j.actbio.2008.11.008
   Wood MD, 2009, J NEURAL ENG, V6, DOI 10.1088/1741-2560/6/4/046003
   Yu TT, 2005, BIOMATERIALS, V26, P1507, DOI 10.1016/j.biomaterials.2004.05.012
   Yu XJ, 2001, J NEUROSCI RES, V66, P303, DOI 10.1002/jnr.1225
   Zhang Z, 2007, ARTIF ORGANS, V31, P13, DOI 10.1111/j.1525-1594.2007.00335.x
NR 61
TC 17
Z9 17
U1 1
U2 37
PU IOP PUBLISHING LTD
PI BRISTOL
PA TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND
SN 1741-2560
J9 J NEURAL ENG
JI J. Neural Eng.
PD AUG
PY 2012
VL 9
IS 4
AR 046007
DI 10.1088/1741-2560/9/4/046007
PG 10
WC Engineering, Biomedical; Neurosciences
SC Engineering; Neurosciences & Neurology
GA 978QF
UT WOS:000306759600020
PM 22736189
DA 2018-10-19
ER

PT J
AU Olivares-Navarrete, R
   Raines, AL
   Hyzy, SL
   Park, JH
   Hutton, DL
   Cochran, DL
   Boyan, BD
   Schwartz, Z
AF Olivares-Navarrete, Rene
   Raines, Andrew L.
   Hyzy, Sharon L.
   Park, Jung Hwa
   Hutton, Daphne L.
   Cochran, David L.
   Boyan, Barbara D.
   Schwartz, Zvi
TI Osteoblast maturation and new bone formation in response to titanium
   implant surface features are reduced with age
SO JOURNAL OF BONE AND MINERAL RESEARCH
LA English
DT Article
DE OSTEOBLASTS; AGE; MICROSTRUCTURED TITANIUM; OSSEOINTEGRATION; 1;
   25-DIHYDROXYVITAMIN D3
ID CELL RESPONSE; MICRON-SCALE; ENERGY; DIFFERENTIATION; ROUGHNESS;
   OSSEOINTEGRATION; MICROSTRUCTURE; PROLIFERATION; REGENERATION;
   INTEGRATION
AB The surface properties of materials contribute to host cellular response and play a significant role in determining the overall success or failure of an implanted biomaterial. Rough titanium (Ti) surface microtopography and high surface free energy have been shown to enhance osteoblast maturation in vitro and increase bone formation in vivo. Whereas the surface properties of Ti are known to affect osteoblast response, host bone quality also plays a significant role in determining successful osseointegration. One factor affecting host bone quality is patient age. We examined both in vitro and in vivo whether response to Ti surface features was affected by animal age. Calvarial osteoblasts isolated from 1-, 3-, and 11-month-old rats all displayed a reduction in cell number and increases in alkaline phosphatasespecific activity and osteocalcin in response to increasing Ti surface microtopography and surface energy. Further, osteoblasts from the three ages examined displayed increased production of osteocalcin and local factors osteoprotegerin, vascular endothelial growth factor (VEGF)-A, and active transforming growth factor (TGF)-beta 1 in response to increasing Ti surface roughness and surface energy. Latent TGF-beta 1 only increased in cultures of osteoblasts from 1- and 3-month-old rats. Treatment with the systemic osteotropic hormone 1a,25(OH)2D3 further enhanced the response of osteoblasts to Ti surface features for all three age groups. However, osteoblasts derived from 11-month-old animals had a reduced response to 1a,25(OH)2D3 compared to osteoblasts derived from 1-or 3-month-old animals. These results were confirmed in vivo. Ti implants placed in the femoral intramedullary canal of old (9-month-old) mice yielded lower bone-to-implant contact and neovascularization in response to Ti surface roughness and energy compared to younger (2-month-old) mice. These results show that rodent osteoblast maturation in vitro as well as new bone formation in vivo is reduced with age. Whether comparable age differences exist in humans needs to be determined. (C) 2012 American Society for Bone and Mineral Research.
C1 [Boyan, Barbara D.] Georgia Inst Technol, Wallace H Coulter Dept Biomed Engn, Parker H Petit Inst Bioengn & Biosci, Atlanta, GA 30332 USA.
   [Raines, Andrew L.] St Josephs Translat Res Inst, Atlanta, GA USA.
   [Cochran, David L.; Schwartz, Zvi] Univ Texas Hlth Sci Ctr San Antonio, San Antonio, TX 78229 USA.
RP Boyan, BD (reprint author), Georgia Inst Technol, Wallace H Coulter Dept Biomed Engn, Parker H Petit Inst Bioengn & Biosci, 315 Ferst Dr NW, Atlanta, GA 30332 USA.
EM barbara.boyan@bme.gatech.edu
RI Hyzy, Sharon/C-8552-2015
OI Hyzy, Sharon/0000-0001-8359-207X; Olivares-Navarrete,
   Rene/0000-0003-1232-9164
FU NIH USPHS [AR052102]; ITI Foundation; Children's Healthcare of Atlanta;
   Cell and Tissue Engineering (CTEng) NIH Biotechnology Training Grant [TG
   GM08433]
FX This study was funded by NIH USPHS AR052102, the ITI Foundation, and
   Children's Healthcare of Atlanta. ALR was supported by funding from Cell
   and Tissue Engineering (CTEng) NIH Biotechnology Training Grant (TG
   GM08433). Implants were provided as a gift from Institut Straumann AG
   (Basel, Switzerland). We thank Ms. Sonja Bustamante for her excellent
   technical help.
CR BELLOWS CG, 1986, CALCIFIED TISSUE INT, V38, P143, DOI 10.1007/BF02556874
   Boyan B. D., 2003, European Cells & Materials, V6, P22
   Boyan BD, 2003, J ORTHOPAED RES, V21, P638, DOI 10.1016/S0736-0266(02)00261-9
   Boyan BD, 1996, BIOMATERIALS, V17, P137, DOI 10.1016/0142-9612(96)85758-9
   BUSER D, 1991, J BIOMED MATER RES, V25, P889, DOI 10.1002/jbm.820250708
   Buser D, 2004, J DENT RES, V83, P529, DOI 10.1177/154405910408300704
   Chen JX, 2010, J BIOL CHEM, V285, P37041, DOI 10.1074/jbc.M110.157115
   Cochran DL, 1998, J BIOMED MATER RES, V40, P1, DOI 10.1002/(SICI)1097-4636(199804)40:1<1::AID-JBM1>3.0.CO;2-Q
   Cochran DL, 1999, J PERIODONTOL, V70, P1523, DOI 10.1902/jop.1999.70.12.1523
   ELLINGSEN JE, 1991, BIOMATERIALS, V12, P593, DOI 10.1016/0142-9612(91)90057-H
   Ferguson SJ, 2006, J BIOMED MATER RES A, V78A, P291, DOI 10.1002/jbm.a.30678
   Fisher M, 2010, BONE, V46, P396, DOI 10.1016/j.bone.2009.09.029
   GOTFREDSEN K, 1995, J BIOMED MATER RES, V29, P1223, DOI 10.1002/jbm.820291009
   Goto T, 2004, BIO-MED MATER ENG, V14, P537
   Keselowsky BG, 2007, J BIOMED MATER RES A, V80A, P700, DOI 10.1002/jbm.a.30898
   Kieswetter K, 1996, CRIT REV ORAL BIOL M, V7, P329, DOI 10.1177/10454411960070040301
   Kumar A, 2002, INT J ORAL MAX IMPL, V17, P816
   MARTIN JY, 1995, J BIOMED MATER RES, V29, P389, DOI 10.1002/jbm.820290314
   Olivares-Navarrete R, 2008, P NATL ACAD SCI USA, V105, P15767, DOI 10.1073/pnas.0805420105
   Olivares-Navarrete R, 2012, STEM CELLS DEV
   Olivares-Navarrete R, 2011, BIOMATERIALS, V32, P6399, DOI 10.1016/j.biomaterials.2011.05.036
   Olivares-Navarrete Rene, 2010, Biol Sex Differ, V1, P4, DOI 10.1186/2042-6410-1-4
   Olivares-Navarrete R, 2010, BIOMATERIALS, V31, P2728, DOI 10.1016/j.biomaterials.2009.12.029
   Raines AL, 2011, J BIOMED MATER RES A, V96A, P575, DOI 10.1002/jbm.a.33012
   Raines AL, 2010, BIOMATERIALS, V31, P4909, DOI 10.1016/j.biomaterials.2010.02.071
   Ratner BD, 2004, BIOMATERIALS SCI INT
   Rupp F, 2006, J BIOMED MATER RES A, V76A, P323, DOI 10.1002/jbm.a.30518
   Schwartz Z, 2008, CLIN ORAL IMPLAN RES, V19, P1233, DOI 10.1111/j.1600-0501.2008.01582.x
   Schwartz Z, 2001, J BIOMED MATER RES, V56, P417, DOI 10.1002/1097-4636(20010905)56:3<417::AID-JBM1111>3.0.CO;2-K
   Schwarz F, 2009, J BIOMED MATER RES B, V88B, P544, DOI 10.1002/jbm.b.31233
   Shimpo S, 2003, EUR J ORTHODONT, V25, P1, DOI 10.1093/ejo/25.1.1
   Tucci Michelle, 2009, Biomed Sci Instrum, V45, P407
   Wang Y, 2010, J STEROID BIOCHEM, V121, P257
   Zhang XJ, 2011, J MOL MED, V89, P985, DOI 10.1007/s00109-011-0754-2
   Zhao G, 2007, BIOMATERIALS, V28, P2821, DOI 10.1016/j.biomaterials.2007.02.024
   Zhao G, 2006, CLIN ORAL IMPLAN RES, V17, P258, DOI 10.1111/j.1600-0501.2005.01195.x
   Zhao G, 2005, J BIOMED MATER RES A, V74A, P49, DOI 10.1002/jbm.a.30320
   Zinger O, 2005, BIOMATERIALS, V26, P1837, DOI 10.1016/j.biomaterials.2004.06.035
NR 38
TC 44
Z9 44
U1 0
U2 12
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0884-0431
J9 J BONE MINER RES
JI J. Bone Miner. Res.
PD AUG
PY 2012
VL 27
IS 8
BP 1773
EP 1783
DI 10.1002/jbmr.1628
PG 11
WC Endocrinology & Metabolism
SC Endocrinology & Metabolism
GA 974XQ
UT WOS:000306471300015
PM 22492532
OA Bronze, Green Accepted
DA 2018-10-19
ER

PT J
AU Bezerra, BD
   Brazao, MAM
   de Campos, MLG
   Casati, MZ
   Sallum, EA
   Sallum, AW
AF Bezerra, Beatriz de Brito
   Mendes Brazao, Mariana Amade
   Gomes de Campos, Mirella Lindoso
   Casati, Marcio Zaffalon
   Sallum, Enilson Antonio
   Sallum, Antonio Wilson
TI Association of hyaluronic acid with a collagen scaffold may improve bone
   healing in critical-size bone defects
SO CLINICAL ORAL IMPLANTS RESEARCH
LA English
DT Article
DE critical-size defect; hyaluronan; wound healing
ID AUTOGENOUS BONE; MATRIX; GRAFT; RAT; REGENERATION; GROWTH; CD44;
   DIFFERENTIATION; HYDROXYAPATITE; BIOMATERIAL
AB Objectives: To evaluate the effects of a 1% hyaluronic acid (HA) gel in combination with an absorbable collagen sponge (ACS) in the healing of critical-size calvaria defects in rats. Material and methods: Thirty-two adult Wistar rats were used. Two 5-mm-diameter critical-size defects were created and the treatments were randomly distributed as follows: (1) 1% HA; (2) 1% HA gel-soaked ACS; (3) control (blood clot); and (4) ACS. The animals were sacrificed 60 days post-surgery, when biopsies were collected and processed for histology and histometric analysis. Bone fill was measured as the difference between the initial and the final defect sizes. Non-parametric tests were used to analyze differences between treatments (a=1%) and a t-test for body weight gain in each treatment group (a=5%). Results: Histological analysis showed bone formation on the edges of the defects, although very limited, and a thin layer of connective tissue occupying the midportion of the defects in the control and the ACS groups. Defects filled with a 1% HA gel and 1% HA gel+ACS had a thicker layer of connective tissue and more new bone formed in the margins of the defects. Linear histometric measures showed no significant differences in the initial defect sizes between the groups (P>0.05). The association 1% HA gel+ACS (0.96 +/- 0.14 mm) had significantly greater bone fill than the control (0.5 +/- 0.02 mm) and ACS (0.56 +/- 0.05 mm)-treated groups (P=0.0043 and 0.0173, respectively). Treatment with a 1% HA gel (0.7 +/- 0.14 mm) showed no significant differences when compared with the other treatments. Conclusion: Within the limits of this study, a 1% HA gel associated with a collagen scaffold can improve new bone formation in critical-size defects. However, this treatment never resulted in complete closure of the defects and healing in the major portion of the defects was characterized by fibrous tissue. To cite this article:?de Brito Bezerra B, Brazao MAM, de Campos MLG, Casati MZ, Sallum EA, Sallum AW. Association of hyaluronic acid with a collagen scaffold may improve bone healing in critical-size bone defects.?Clin. Oral Impl. Res. 23, 2012; 938942?doi: 10.1111/j.1600-0501.2011.02234.x
C1 [Bezerra, Beatriz de Brito; Gomes de Campos, Mirella Lindoso; Casati, Marcio Zaffalon; Sallum, Enilson Antonio; Sallum, Antonio Wilson] Univ Estadual Campinas, Piracicaba Dent Sch, Div Periodont, Dept Prosthodont & Periodont, Sao Paulo, Brazil.
   [Mendes Brazao, Mariana Amade] Sao Leopoldo Mandic Dent Sch, Dept Endodont, Sao Paulo, Brazil.
RP Bezerra, BD (reprint author), Ave Limeira 901, BR-13414903 Sao Paulo, Brazil.
EM beatrizbb@yahoo.com
RI Sallum, Enilson/G-2097-2016; Sallum, Antonio Wilson/J-2984-2015; casati,
   marcio/G-7475-2012
OI Campos, Mirella/0000-0002-9516-6526
FU National Council for Scientific and Technological Development (CNPq),
   Brasilia, DF, Brazil
FX This study was supported by The National Council for Scientific and
   Technological Development (CNPq), Brasilia, DF, Brazil, in the forms of
   a grant to A. W. S. and a scholarship to M. A. M. B. We would like to
   thank Dr Thomas Brown III for kindly reviewing this manuscript.
CR Araujo MG, 2009, CLIN ORAL IMPLAN RES, V20, P433, DOI 10.1111/j.1600-0501.2009.01705.x
   Aslan M, 2006, J BIOMATER APPL, V20, P209, DOI 10.1177/0885328206051047
   BOSKEY AL, 1991, MATRIX, V11, P442, DOI 10.1016/S0934-8832(11)80198-8
   Cardaropoli G, 2005, J CLIN PERIODONTOL, V32, P435, DOI 10.1111/j.1600-051X.2005.00692.x
   Chan C, 2002, INT J ORAL MAX SURG, V31, P73, DOI 10.1054/ijom.2001.0143
   Deliberador TM, 2006, J PERIODONTOL, V77, P780, DOI 10.1902/jop.2006.050209
   Devlin H, 2000, CELLS TISSUES ORGANS, V167, P33, DOI 10.1159/000016764
   Donos N, 2004, CLIN ORAL IMPLAN RES, V15, P101, DOI 10.1111/j.1600-0501.2004.00986.x
   Friess W, 1999, INT J PHARM, V187, P91, DOI 10.1016/S0378-5173(99)00174-X
   Geiger M, 2003, ADV DRUG DELIVER REV, V55, P1613, DOI 10.1016/j.addr.2003.08.010
   HANDLEY CJ, 1976, BIOCHIM BIOPHYS ACTA, V444, P69, DOI 10.1016/0304-4165(76)90224-5
   Kim CS, 2005, J CLIN PERIODONTOL, V32, P583, DOI 10.1111/j.1600-051X.2005.00729.x
   KUBLER N, 1990, CLIN ORTHOP RELAT R, P279
   LESLEY J, 1992, EUR J IMMUNOL, V22, P2719, DOI 10.1002/eji.1830221036
   MacNeill SR, 1999, J CLIN PERIODONTOL, V26, P239, DOI 10.1034/j.1600-051X.1999.260407.x
   Mardas N, 2002, J CRANIOFAC SURG, V13, P453, DOI 10.1097/00001665-200205000-00017
   Mardas N, 2008, CLIN ORAL IMPLAN RES, V19, P1010, DOI 10.1111/j.1600-0501.2008.01572.x
   MARX RE, 1994, CLIN PLAST SURG, V21, P377
   Mendes BrazAo MA, 2010, BRAZILIAN J ORAL SCI, V9, P124
   Mendes RM, 2008, ARCH ORAL BIOL, V53, P1155, DOI 10.1016/j.archoralbio.2008.07.001
   Nagata MJ, 2010, J ORTHOP RES, V28, P468, DOI 10.1002/jor.21027
   NOBLE PW, 1993, J CLIN INVEST, V91, P2368, DOI 10.1172/JCI116469
   NYMAN S, 1982, J CLIN PERIODONTOL, V9, P290, DOI 10.1111/j.1600-051X.1982.tb02095.x
   Pilloni A, 1998, CELL TISSUE RES, V294, P323, DOI 10.1007/s004410051182
   SASAKI T, 1995, BONE, V16, P9, DOI 10.1016/S8756-3282(94)00001-8
   Schmitz JP, 1986, CLIN ORTHOP RELAT R, V205, P298
   Slevin M, 2002, J BIOL CHEM, V277, P41046, DOI 10.1074/jbc.M109443200
   Takahashi Y, 2005, J BIOL CHEM, V280, P24195, DOI 10.1074/jbc.M411913200
   TOOLE BP, 1971, DEV BIOL, V25, P57, DOI 10.1016/0012-1606(71)90019-4
   TURLEY EA, 1993, EXP CELL RES, V207, P277, DOI 10.1006/excr.1993.1194
   Yun JI, 2010, J CLIN PERIODONTOL, V37, P419, DOI 10.1111/j.1600-051X.2010.01547.x
NR 31
TC 17
Z9 17
U1 0
U2 10
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0905-7161
J9 CLIN ORAL IMPLAN RES
JI Clin. Oral Implant. Res.
PD AUG
PY 2012
VL 23
IS 8
BP 938
EP 942
DI 10.1111/j.1600-0501.2011.02234.x
PG 5
WC Dentistry, Oral Surgery & Medicine; Engineering, Biomedical
SC Dentistry, Oral Surgery & Medicine; Engineering
GA 972UZ
UT WOS:000306307700007
PM 21689163
DA 2018-10-19
ER

PT J
AU Kirkland, NT
AF Kirkland, N. T.
TI Magnesium biomaterials: past, present and future
SO CORROSION ENGINEERING SCIENCE AND TECHNOLOGY
LA English
DT Article
DE Magnesium; Biomaterial; In vitro; Corrosion; In vivo; Coating
ID IN-VITRO; ION-IMPLANTATION; RARE-EARTH; CORROSION-RESISTANCE; ADSORPTION
   BEHAVIOR; PURE MAGNESIUM; OPTIMAL-DESIGN; ALLOYS; BONE; CELLS
AB Following a reinvigorated interest in the late 1990s, magnesium (Mg) and its alloys have experienced increasing research attention in the realm of biomaterials. From essentially no papers on the topic several years ago, there are currently 10-15 articles published in international journals each week dealing with different aspects of Mg bioperformance. Given the dynamic nature of the topic, many works reproduce a great deal of information in a non-systematic manner and, unfortunately, also repeat the same systematic errors, which lead to many articles providing information of limited value. This review seeks to provide a succinct overview of the area, highlighting some of the most important considerations for this field and suggesting critical improvements and changes that are needed to ensure the continual and efficient development of Mg biomaterials.
C1 Nagasaki Univ, Grad Sch Engn, Dept Adv Technol & Sci Sustainable Dev, Nagasaki 852, Japan.
RP Kirkland, NT (reprint author), Nagasaki Univ, Grad Sch Engn, Dept Adv Technol & Sci Sustainable Dev, Nagasaki 852, Japan.
EM nkirkland@nagasaki-u.ac.jp
OI Kirkland, Nicholas/0000-0001-5043-3400
CR Abd El-Rahman SS, 2003, PHARMACOL RES, V47, P189, DOI 10.1016/S1043-6618(02)00336-5
   Adachi T, 2006, BIOMATERIALS, V27, P3964, DOI 10.1016/j.biomaterials.2006.02.039
   Allan B, 1999, BRIT J OPHTHALMOL, V83, P1235, DOI 10.1136/bjo.83.11.1235
   [Anonymous], 2012, P 4 S BIOD MET MAR I
   Avedesian M. M., 1999, MAGNESIUM MAGNESIUM, Vix
   Avedesian MM, 1999, ASM SPECIALTY HDB, P12
   Bach F. W., 2006, DEV BIOCOMPATIBLE MA
   Barrere F., 2002, THESIS U TWENTE ENSC, P15
   Bhagwagar Z, 2002, CLIN NEUROSCI RES, V2, P222, DOI 10.1016/S1566-2772(02)00046-4
   Blokhuis TJ, 2000, J TRAUMA, V48, P179, DOI 10.1097/00005373-200001000-00037
   Bondemark L, 1994, Br J Orthod, V21, P335
   BRUCE DW, 1963, TOXICOL APPL PHARM, V5, P750, DOI 10.1016/0041-008X(63)90067-X
   Chen XB, 2011, CORROSION-US, V67, DOI 10.5006/1.3563639
   Chen X.-B., 2012, CORROSION IN PRESS
   Chen Y, 2010, MATER LETT, V64, P1996, DOI 10.1016/j.matlet.2010.06.011
   Cui F, 2008, FRONT MAT SCI CHINA, V2, P143
   Davis KG, 1998, CLIN BIOMECH, V13, P141, DOI 10.1016/S0268-0033(97)00037-5
   DOMINGO JL, 1995, NEUROTOXICOL TERATOL, V17, P515, DOI 10.1016/0892-0362(95)00002-9
   DONOHUE VE, 1995, J APPL BIOMATER, V6, P69, DOI 10.1002/jab.770060110
   Drynda A, 2009, J BIOMED MATER RES A, V91A, P360, DOI 10.1002/jbm.a.32235
   Duygulu O, 2007, MATER SCI FORUM, V546-549, P421, DOI 10.4028/www.scientific.net/MSF.546-549.421
   Emley E.F., 1966, PRINCIPLES MAGNESIUM, P200
   Feyerabend F, 2006, TISSUE ENG, V12, P3545, DOI 10.1089/ten.2006.12.3545
   Feyerabend F, 2010, ACTA BIOMATER, V6, P1834, DOI 10.1016/j.actbio.2009.09.024
   Flaten TP, 2001, BRAIN RES BULL, V55, P187, DOI 10.1016/S0361-9230(01)00459-2
   Ganeshan S, 2009, ACTA MATER, V57, P3876, DOI 10.1016/j.actamat.2009.04.038
   Gerasimov V. V., 1957, RUSS CHEM B, V6, P1192
   Ghali E, 2004, J MATER ENG PERFORM, V13, P517, DOI 10.1361/10599490420665
   Granchi D, 1999, BIOMATERIALS, V20, P1079, DOI 10.1016/S0142-9612(99)00004-6
   Gruhl S, 2009, J ANAL ATOM SPECTROM, V24, P181, DOI 10.1039/b813734j
   Gu XN, 2009, BIOMATERIALS, V30, P484, DOI 10.1016/j.biomaterials.2008.10.021
   Hartwig A, 2001, MUTAT RES-FUND MOL M, V475, P113, DOI 10.1016/S0027-5107(01)00074-4
   Hollister SJ, 2002, BIOMATERIALS, V23, P4095, DOI 10.1016/S0142-9612(02)00148-5
   HOWLETT CR, 1994, J MATER SCI-MATER M, V5, P715, DOI 10.1007/BF00120363
   Inoue H, 2002, CORROS SCI, V44, P603, DOI 10.1016/S0010-938X(01)00092-0
   Jackson DR, 2000, LANGMUIR, V16, P5449, DOI 10.1021/la991497x
   KIM SG, 1991, MATER T JIM, V32, P875, DOI 10.2320/matertrans1989.32.875
   Kim SR, 2003, BIOMATERIALS, V24, P1389, DOI 10.1016/S0142-9612(02)00523-9
   Kirkland NT, 2012, ACTA BIOMATER, V8, P925, DOI 10.1016/j.actbio.2011.11.014
   Kirkland NT, 2010, CORROS SCI, V52, P287, DOI 10.1016/j.corsci.2009.09.033
   Kirkland NT, 2012, J MATER SCI-MATER M, V23, P283, DOI 10.1007/s10856-011-4517-y
   Kirkland NT, 2011, JOM-US, V63, P28, DOI 10.1007/s11837-011-0089-z
   Koch CF, 2007, MAT SCI ENG C-BIO S, V27, P484, DOI 10.1016/j.msec.2006.05.025
   Kuwahara H, 2001, MATER TRANS, V42, P1317, DOI 10.2320/matertrans.42.1317
   Lambotte A., 1932, B MEM SOC NAT CHIR, V28, P1325
   Leon B., 2008, THIN CALCIUM PHOSPHA
   Levesque J, 2008, ACTA BIOMATER, V4, P284, DOI 10.1016/j.actbio.2007.09.012
   Li LC, 2004, SURF COAT TECH, V185, P92, DOI 10.1016/j.surfcoat.2004.01.004
   Lopez HY, 2006, KEY ENG MAT, V309-311, P453, DOI 10.4028/www.scientific.net/KEM.309-311.453
   Lucey TD, 1977, METAL TOXICITY MAMMA
   Meyer-Lindenberg A., [No title captured], Patent No. [US 200410241036, 200410241036]
   Mudali UK, 2003, SADHANA-ACAD P ENG S, V28, P601
   Okuma T, 2001, NUTRITION, V17, P679, DOI 10.1016/S0899-9007(01)00551-2
   Omanovic S, 1999, LANGMUIR, V15, P8315, DOI 10.1021/la990474f
   Pholer O. E. M., 1986, ASM HDB FAILURE ANAL, V670
   Pietrzak W. S., 1996, BONE S1, V19, pS109
   Porter R. S., 2006, MERCK MANUAL DIAGNOS
   PULEO DA, 1995, J APPL BIOMATER, V6, P109, DOI 10.1002/jab.770060205
   RASHMIRRAVEN AM, 1995, J APPL BIOMATER, V6, P237, DOI 10.1002/jab.770060404
   Richards AM, 2010, J OSTEOPOROS, DOI 10.4061/2010/504078
   Saris NEL, 2000, CLIN CHIM ACTA, V294, P1, DOI 10.1016/S0009-8981(99)00258-2
   Schinhammer M, 2010, ACTA BIOMATER, V6, P1705, DOI 10.1016/j.actbio.2009.07.039
   Seal CK, 2009, IOP CONF SER-MAT SCI, V4, DOI 10.1088/1757-899X/4/1/012011
   Song GL, 2007, CORROS SCI, V49, P1696, DOI 10.1016/j.corsci.2007.01.001
   Staiger MP, 2006, BIOMATERIALS, V27, P1728, DOI 10.1016/j.biomaterials.2005.10.003
   The American Foundry Society Technical Department, 2006, MAGN ALL
   Tian X. B., 2005, SURF COAT TECH, V198, P454
   Timmer RT, 1999, J AM SOC NEPHROL, V10, P666
   Tsantrizos A, 2000, SPINE, V25, P1899, DOI 10.1097/00007632-200008010-00007
   Ulrich U. M., 2008, THIN CALCIUM PHOSPHA, P67
   Vadapalli S, 2006, SPINE, V31, P2189, DOI 10.1097/01.brs.0000232720.23748.ce
   Verbrugge J., 1934, PRESSE MED, V23, P460
   Vojtech D, 2006, KOVOVE MATER, V44, P211
   Vormann Juergen, 2003, Molecular Aspects of Medicine, V24, P27, DOI 10.1016/S0098-2997(02)00089-4
   Wan YZ, 2008, APPL SURF SCI, V254, P5514, DOI 10.1016/j.apsusc.2008.02.117
   Waterman J, 2011, MAGNESIUM TECHNOLOGY, P403
   Waterman J, 2011, MATER SCI ENG B-ADV, V176, P1756, DOI 10.1016/j.mseb.2011.06.021
   Waterman J., 2009, P 3 IND AUSTR C CONJ, P77
   Williams David, 2006, Med Device Technol, V17, P9
   Wintermantel E, 1998, BIOKOMPATIBLE WERKST, V2
   Witte F, 2007, J BIOMED MATER RES A, V81A, P748, DOI 10.1002/jbm.a.31170
   Witte F, 2006, BIOMATERIALS, V27, P1013, DOI 10.1016/j.biomaterials.2005.07.037
   Witte F, 2008, J BIOMED MATER RES A, V86A, P1041, DOI 10.1002/jbm.a.31713
   Witte F, 2007, BIOMATERIALS, V28, P2163, DOI 10.1016/j.biomaterials.2006.12.027
   Witte F, 2008, CURR OPIN SOLID ST M, V12, P63, DOI 10.1016/j.cossms.2009.04.001
   Wolf Federica I., 2003, Molecular Aspects of Medicine, V24, P3, DOI 10.1016/S0098-2997(02)00087-0
   Yang J. X., 2008, SURF COAT TECH, V202, P5733
   Yang L, 2009, MAT SCI ENG C-BIO S, V29, P1691, DOI 10.1016/j.msec.2009.01.014
   Yfantis C. D., 2006, WSEAS Transactions on Environment and Development, V2, P1110
   Zeng RC, 2008, ADV ENG MATER, V10, pB3, DOI 10.1002/adem.200800035
   Zhang H, 1999, 9 ANN VM GOLDSCHM C
   Zhang YP, 2011, PROCEEDINGS OF THE 18TH INTERNATIONAL CONFERENCE ON NUCLEAR ENGINEERING 2010, VOL 4 PTS A AND B, P1
NR 92
TC 56
Z9 60
U1 1
U2 51
PU TAYLOR & FRANCIS LTD
PI ABINGDON
PA 2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND
SN 1478-422X
EI 1743-2782
J9 CORROS ENG SCI TECHN
JI Corros. Eng. Sci. Technol.
PD AUG
PY 2012
VL 47
IS 5
BP 322
EP 328
DI 10.1179/1743278212Y.0000000034
PG 7
WC Materials Science, Multidisciplinary; Metallurgy & Metallurgical
   Engineering
SC Materials Science; Metallurgy & Metallurgical Engineering
GA 971VX
UT WOS:000306234100002
DA 2018-10-19
ER

PT J
AU Bohner, M
   Galea, L
   Doebelin, N
AF Bohner, Marc
   Galea, Laetitia
   Doebelin, Nicola
TI Calcium phosphate bone graft substitutes: Failures and hopes
SO JOURNAL OF THE EUROPEAN CERAMIC SOCIETY
LA English
DT Article
DE Biomaterial; Bone; Physico-chemical; Biological; Calcium phosphate
ID BETA-TRICALCIUM PHOSPHATE; PLATELET-RICH PLASMA; IN-VIVO; POLYMERIC
   BIOMATERIALS; OCTACALCIUM PHOSPHATE; EXTRACELLULAR CALCIUM; TITANIUM
   IMPLANTS; HYDRAULIC CEMENT; LOW-TEMPERATURE; ECTOPIC BONE
AB Despite 40 years of efforts, researchers have failed to provide calcium phosphate bone graft substitutes performing well enough to replace bone grafting procedures: their osteogenesis potential is limited, and calcium phosphates are too brittle. However, there is hope to solve the two aforementioned problems. First, it is now clear why nacre and bone are very tough despite a high ceramic load. Also, recent studies suggest that calcium and phosphate ions can trigger osteoinduction. The present article aims: (i) to review our current knowledge in the field of synthetic bone graft substitutes, (ii) to explain why ceramics and in particular calcium phosphates are still the most promising materials for bone graft substitution, and (iii) finally to describe the strategy to obtain osteoinductive calcium phosphate bone graft substitutes as strong as cortical bone. (c) 2012 Elsevier Ltd. All rights reserved.
C1 [Bohner, Marc; Galea, Laetitia; Doebelin, Nicola] RMS Fdn, CH-2544 Bettlach, Switzerland.
RP Bohner, M (reprint author), RMS Fdn, Bischmattstr 12, CH-2544 Bettlach, Switzerland.
EM marc.bohner@rms-foundation.ch
RI Bohner, Marc/F-3828-2011
OI Bohner, Marc/0000-0002-5079-3286
FU Mathys Ltd
FX The author would like to thank Mathys Ltd for their financial support,
   as well as Rainer Egli and Michel Descamps for Fig. 2.
CR Arrington ED, 1996, CLIN ORTHOP RELAT R, P300
   Axelrad TW, 2009, CYTOKINE GROWTH F R, V20, P481, DOI 10.1016/j.cytogfr.2009.10.003
   BANWART JC, 1995, SPINE, V20, P1055, DOI 10.1097/00007632-199505000-00012
   Barralet J, 2009, TISSUE ENG PT A, V15, P1601, DOI 10.1089/ten.tea.2007.0370
   Bashoor-Zadeh M, 2011, BIOMATERIALS, V32, P6362, DOI 10.1016/j.biomaterials.2011.05.030
   Boanini E, 2010, ACTA BIOMATER, V6, P1882, DOI 10.1016/j.actbio.2009.12.041
   Bohner M, 2004, BIOMATERIALS, V25, P3569, DOI 10.1016/j.biomaterials.2003.10.032
   Bohner M, 2011, ACTA BIOMATER, V7, P478, DOI 10.1016/j.actbio.2010.08.008
   Bohner M, 2008, WOODHEAD PUBL MATER, P95, DOI 10.1533/9781845695033.2.95
   Bohner M, 2010, EUR CELLS MATER, V20, P1
   Bohner M, 2010, MATER TODAY, V13, P24, DOI 10.1016/S1369-7021(10)70014-6
   Bohner M, 2009, ACTA BIOMATER, V5, P3524, DOI 10.1016/j.actbio.2009.05.024
   Bohner M, 2009, BIOMATERIALS, V30, P6403, DOI 10.1016/j.biomaterials.2009.08.007
   Bonderer LJ, 2008, SCIENCE, V319, P1069, DOI 10.1126/science.1148726
   Constantz BR, 1998, J BIOMED MATER RES, V43, P451, DOI 10.1002/(SICI)1097-4636(199824)43:4<451::AID-JBM13>3.0.CO;2-Q
   Currey J D, 1970, Clin Orthop Relat Res, V73, P209
   de Bruijn JD, 1999, ADV DENT RES, P74
   Deville S, 2006, SCIENCE, V311, P515, DOI 10.1126/science.1120937
   Dorozhkin SV, 2002, PROG CRYST GROWTH CH, V44, P45, DOI 10.1016/S0960-8974(02)00004-9
   Driessens F C, 1988, Ann N Y Acad Sci, V523, P131, DOI 10.1111/j.1749-6632.1988.tb38507.x
   Driessens FCM, 1988, RELATION PHYSICOCHEM
   DRISKELL TD, 1973, J DENT RES I, V52, P123
   DUCHEYNE P, 1981, J BIOMED MATER RES, V15, P441, DOI 10.1002/jbm.820150315
   EGGLI PS, 1988, CLIN ORTHOP RELAT R, P127
   Egli RJ, 2011, ADV ENG MATER, V13, pB102, DOI 10.1002/adem.201080037
   Frankenburg EP, 1998, J BONE JOINT SURG AM, V80A, P1112, DOI 10.2106/00004623-199808000-00004
   FRASER JRE, 1984, CLIN EXP PHARMACOL P, V11, P17, DOI 10.1111/j.1440-1681.1984.tb00235.x
   Gao HJ, 2003, P NATL ACAD SCI USA, V100, P5597, DOI 10.1073/pnas.0631609100
   GOGOLEWSKI S, 1993, J BIOMED MATER RES, V27, P1135, DOI 10.1002/jbm.820270904
   Habibovic P, 2005, BIOMATERIALS, V26, P3565, DOI 10.1016/j.biomaterials.2004.09.056
   Habibovic P, 2011, ACTA BIOMATER, V7, P3013, DOI 10.1016/j.actbio.2011.03.027
   Habibovic P, 2008, BIOMATERIALS, V29, P944, DOI 10.1016/j.biomaterials.2007.10.023
   Habibovic P, 2007, J TISSUE ENG REGEN M, V1, P25, DOI 10.1002/term.5
   Habibovic P, 2010, ADV MATER, V22, P1858, DOI 10.1002/adma.200902778
   Hartgerink JD, 2001, SCIENCE, V294, P1684, DOI 10.1126/science.1063187
   Hench L., 2004, J AUST CERAM SOC, V40, P1
   Hernigou P, 2005, J BONE JOINT SURG BR, V87B, P896, DOI 10.1302/0301-620X.87B7.16289
   HIRANO S, 1989, BIOMATERIALS, V10, P574, DOI 10.1016/0142-9612(89)90066-5
   HOFMANN GO, 1995, ARCH ORTHOP TRAUM SU, V114, P159, DOI 10.1007/BF00443390
   Hollister SJ, 2005, NAT MATER, V4, P518, DOI 10.1038/nmat1421
   Ignatius AA, 2001, J BIOMED MATER RES, V58, P701, DOI 10.1002/jbm.10024
   Ikenaga M, 1998, J BIOMED MATER RES, V40, P139, DOI 10.1002/(SICI)1097-4636(199804)40:1<139::AID-JBM16>3.0.CO;2-J
   Intini G, 2009, BIOMATERIALS, V30, P4956, DOI 10.1016/j.biomaterials.2009.05.055
   Ito A, 2006, BIOMED MATER, V1, P134, DOI 10.1088/1748-6041/1/3/007
   Johnson AJW, 2011, ACTA BIOMATER, V7, P16, DOI 10.1016/j.actbio.2010.07.012
   KANATANI M, 1991, BIOCHEM BIOPH RES CO, V181, P1425, DOI 10.1016/0006-291X(91)92098-5
   Karageorgiou V, 2005, BIOMATERIALS, V26, P5474, DOI 10.1016/j.biomaterials.2005.02.002
   KLAWITTER JJ, 1971, J BIOMED MATER RES S, V2, P161, DOI DOI 10.1002/JBM.820050613
   KLEIN CPAT, 1985, BIOMATERIALS, V6, P189, DOI 10.1016/0142-9612(85)90008-0
   Koerten HK, 1999, J BIOMED MATER RES, V44, P78, DOI 10.1002/(SICI)1097-4636(199901)44:1<78::AID-JBM9>3.0.CO;2-6
   Koester KJ, 2008, NAT MATER, V7, P672, DOI 10.1038/nmat2221
   KOKUBO T, 1987, J MATER SCI, V22, P4067, DOI 10.1007/BF01133359
   Komlev VS, 2010, EUR CELLS MATER, V19, P136, DOI 10.22203/eCM.v019a14
   Komlev VS, 2009, TISSUE ENG PART C-ME, V15, P425, DOI 10.1089/ten.tec.2008.0428
   Kruyt MC, 2004, J ORTHOPAED RES, V22, P544, DOI 10.1016/j.orthres.2003.10.010
   Lefort M, 2010, ANGEW CHEM INT EDIT, V49, P10110, DOI 10.1002/anie.201002729
   LeGeros RZ, 2008, CHEM REV, V108, P4742, DOI 10.1021/cr800427g
   Lindley EM, 2010, J BIOMED MATER RES B, V94B, P463, DOI 10.1002/jbm.b.31676
   Linhart W, 2004, UNFALLCHIRURG, V107, P154, DOI 10.1007/s00113-003-0707-5
   Martinez-Vazquez FJ, 2010, ACTA BIOMATER, V6, P4361, DOI 10.1016/j.actbio.2010.05.024
   Marx RE, 1998, ORAL SURG ORAL MED O, V85, P638, DOI 10.1016/S1079-2104(98)90029-4
   Meleti Z, 2000, BONE, V27, P359, DOI 10.1016/S8756-3282(00)00346-X
   Merten HA, 2001, J CRANIOFAC SURG, V12, P59, DOI 10.1097/00001665-200101000-00010
   METSGER DS, 1993, CLIN ORTHOP RELAT R, P283
   Miyamoto Y, 1999, J BIOMED MATER RES, V48, P36, DOI 10.1002/(SICI)1097-4636(1999)48:1<36::AID-JBM8>3.0.CO;2-I
   Mroz TE, 2010, SPINE, V35, pS86, DOI 10.1097/BRS.0b013e3181d81ef2
   Munch E, 2008, SCIENCE, V322, P1516, DOI 10.1126/science.1164865
   MUNTING E, 1993, J MATER SCI-MATER M, V4, P337, DOI 10.1007/BF00122290
   Nakade O, 2001, J BONE MINER METAB, V19, P13, DOI 10.1007/s007740170055
   NAKAMURA T, 1985, J BIOMED MATER RES, V19, P685, DOI 10.1002/jbm.820190608
   Ohura K, 1996, J BIOMED MATER RES, V30, P193, DOI 10.1002/(SICI)1097-4636(199602)30:2<193::AID-JBM9>3.0.CO;2-M
   Pan HB, 2009, CRYST GROWTH DES, V9, P639, DOI 10.1021/cg801118v
   PASSUTI N, 1989, CLIN ORTHOP RELAT R, P169
   Patntirapong S, 2009, BIOMATERIALS, V30, P548, DOI 10.1016/j.biomaterials.2008.09.062
   PELTIER L F, 1961, Clin Orthop, V21, P1
   Peuster M, 2006, BIOMATERIALS, V27, P4955, DOI 10.1016/j.biomaterials.2006.05.029
   Pioletti DP, 2000, BIOMATERIALS, V21, P1103, DOI 10.1016/S0142-9612(99)00250-1
   Podsiadlo P, 2007, SCIENCE, V318, P80, DOI 10.1126/science.1143176
   RABALAIS ML, 1981, J PERIODONTOL, V52, P680, DOI 10.1902/jop.1981.52.11.680
   Ripamonti U, 1999, S AFR J SCI, V95, P335
   RIPAMONTI U, 1991, J BONE JOINT SURG AM, V73A, P692, DOI 10.2106/00004623-199173050-00007
   Roshan-Ghias A, 2010, EUR CELLS MATER, V19, P41, DOI 10.22203/eCM.v019a05
   Sasano Yasuyuki, 1995, Anatomical Record, V242, P40
   Schilling AF, 2004, BIOMATERIALS, V25, P3963, DOI 10.1016/j.biomaterials.2003.10.079
   Seeherman H, 2006, J BONE JOINT SURG AM, V88A, P144, DOI 10.2106/JBJS.D.02453
   Seeherman HJ, 2006, J BONE JOINT SURG AM, V88A, P1553, DOI 10.2106/JBJS.E.01006
   Stoll T, 2004, MATERIALWISS WERKST, V35, P198, DOI 10.1002/mawe.200400738
   Suh JKF, 2000, BIOMATERIALS, V21, P2589
   Sulliyan F., 2008, EUROPEAN MARKETS BON
   Suwanprateeb J, 1998, J BIOMED MATER RES, V39, P16, DOI 10.1002/(SICI)1097-4636(199801)39:1<16::AID-JBM3>3.0.CO;2-L
   Suzuki O, 2008, CURR MED CHEM, V15, P305, DOI 10.2174/092986708783497283
   Takemoto M, 2006, BIOMATERIALS, V27, P2682, DOI 10.1016/j.biomaterials.2005.12.014
   Tamimi F, 2008, J BIOMED MATER RES A, V87A, P980, DOI 10.1002/jbm.a.31842
   Tao JH, 2008, CRYST GROWTH DES, V8, P2227, DOI 10.1021/cg700808h
   Teitelbaum SL, 2000, SCIENCE, V289, P1504, DOI 10.1126/science.289.5484.1504
   Theiss F, 2005, BIOMATERIALS, V26, P4383, DOI 10.1016/j.biomaterials.2004.11.056
   Tian XY, 2011, BONE, V48, P197, DOI 10.1016/j.bone.2010.09.009
   Vatsa A, 2006, J BONE MINER RES, V21, P1722, DOI 10.1359/JBMR.060720
   VEREECKE G, 1990, J CRYST GROWTH, V104, P820, DOI 10.1016/0022-0248(90)90108-W
   Vert M, 2007, PROG POLYM SCI, V32, P755, DOI 10.1016/j.progpolymsci.2007.05.006
   Wang D, 1999, J BONE MINER RES, V14, P893, DOI 10.1359/jbmr.1999.14.6.893
   West JL, 1999, MACROMOLECULES, V32, P241, DOI 10.1021/ma981296k
   Williams BJ, 2011, SPINE, V36, P1685, DOI 10.1097/BRS.0b013e318216d825
   WINTER GD, 1969, NATURE, V223, P88, DOI 10.1038/223088a0
   Witte F, 2006, BIOMATERIALS, V27, P1013, DOI 10.1016/j.biomaterials.2005.07.037
   Wong DA, 2008, SPINE J, V8, P1011, DOI 10.1016/j.spinee.2007.06.014
   Wu XM, 2003, BBA-MOL CELL RES, V1641, P65, DOI 10.1016/S0167-4889(03)00065-X
   Yamada S, 1997, BIOMATERIALS, V18, P1037, DOI 10.1016/S0142-9612(97)00036-7
   Yamasaki H., 1990, JPN J ORAL BIOL, V32, P190, DOI DOI 10.2330/JORALBIOSCI1965.32.190
   Yang L, 2010, BIOMATERIALS, V31, P2976, DOI 10.1016/j.biomaterials.2010.01.002
   Yaremchuk KL, 2010, LARYNGOSCOPE, V120, P1954, DOI 10.1002/lary.21096
   Yoshida K, 2006, J AM CERAM SOC, V89, P688, DOI 10.1111/j.1551-2916.2005.00727.x
   Yoshinari M, 2002, BIOMATERIALS, V23, P2879, DOI 10.1016/S0142-9612(01)00415-X
   Younger E M, 1989, J Orthop Trauma, V3, P192, DOI 10.1097/00005131-198909000-00002
   Yuan HP, 2010, P NATL ACAD SCI USA, V107, P13614, DOI 10.1073/pnas.1003600107
   ZAIDI M, 1989, BIOCHEM BIOPH RES CO, V163, P1461, DOI 10.1016/0006-291X(89)91143-1
   Zberg B, 2009, NAT MATER, V8, P887, DOI [10.1038/NMAT2542, 10.1038/nmat2542]
NR 117
TC 96
Z9 101
U1 2
U2 56
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0955-2219
EI 1873-619X
J9 J EUR CERAM SOC
JI J. Eur. Ceram. Soc.
PD AUG
PY 2012
VL 32
IS 11
SI SI
BP 2663
EP 2671
DI 10.1016/j.jeurceramsoc.2012.02.028
PG 9
WC Materials Science, Ceramics
SC Materials Science
GA 971ZV
UT WOS:000306247200013
DA 2018-10-19
ER

PT J
AU Tu, DD
   Seth, A
   Gil, ES
   Kaplan, DL
   Mauney, JR
   Estrada, CR
AF Tu, Duong D.
   Seth, Abhishek
   Gil, Eun Seok
   Kaplan, David L.
   Mauney, Joshua R.
   Estrada, Carlos R.
TI Evaluation of Biomaterials for Bladder Augmentation using Cystometric
   Analyses in Various Rodent Models
SO JOVE-JOURNAL OF VISUALIZED EXPERIMENTS
LA English
DT Article
DE Bioengineering; Issue 66; Medicine; Biomedical Engineering; Physiology;
   Silk; bladder tissue engineering; biomaterial; scaffold; matrix;
   augmentation; cystometry
AB Renal function and continence of urine are critically dependent on the proper function of the urinary bladder, which stores urine at low pressure and expels it with a precisely orchestrated contraction. A number of congenital and acquired urological anomalies including posterior urethral valves, benign prostatic hyperplasia, and neurogenic bladder secondary to spina bifida/spinal cord injury can result in pathologic tissue remodeling leading to impaired compliance and reduced capacity(1). Functional or anatomical obstruction of the urinary tract is frequently associated with these conditions, and can lead to urinary incontinence and kidney damage from increased storage and voiding pressures(2). Surgical implantation of gastrointestinal segments to expand organ capacity and reduce intravesical pressures represents the primary surgical treatment option for these disorders when medical management fails(3). However, this approach is hampered by the limitation of available donor tissue, and is associated with significant complications including chronic urinary tract infection, metabolic perturbation, urinary stone formation, and secondary malignancy(4,5).
   Current research in bladder tissue engineering is heavily focused on identifying biomaterial configurations which can support regeneration of tissues at defect sites. Conventional 3-D scaffolds derived from natural and synthetic polymers such as small intestinal submucosa and polyglycolic acid have shown some short-term success in supporting urothelial and smooth muscle regeneration as well as facilitating increased organ storage capacity in both animal models and in the clinic(6,7). However, deficiencies in scaffold mechanical integrity and biocompatibility often result in deleterious fibrosis(8), graft contracture(9), and calcification(10), thus increasing the risk of implant failure and need for secondary surgical procedures. In addition, restoration of normal voiding characteristics utilizing standard biomaterial constructs for augmentation cystoplasty has yet to be achieved, and therefore research and development of novel matrices which can fulfill this role is needed.
   In order to successfully develop and evaluate optimal biomaterials for clinical bladder augmentation, efficacy research must first be performed in standardized animal models using detailed surgical methods and functional outcome assessments. We have previously reported the use of a bladder augmentation model in mice to determine the potential of silk fibroin-based scaffolds to mediate tissue regeneration and functional voiding characteristics. (11,12) Cystometric analyses of this model have shown that variations in structural and mechanical implant properties can influence the resulting urodynamic features of the tissue engineered bladders(11,12). Positive correlations between the degree of matrix-mediated tissue regeneration determined histologically and functional compliance and capacity evaluated by cystometry were demonstrated in this model(11,12). These results therefore suggest that functional evaluations of biomaterial configurations in rodent bladder augmentation systems may be a useful format for assessing scaffold properties and establishing in vivo feasibility prior to large animal studies and clinical deployment. In the current study, we will present various surgical stages of bladder augmentation in both mice and rats using silk scaffolds and demonstrate techniques for awake and anesthetized cystometry.
C1 [Tu, Duong D.; Seth, Abhishek; Mauney, Joshua R.; Estrada, Carlos R.] Harvard Univ, Sch Med, Childrens Hosp Boston, Cambridge, MA 02138 USA.
   [Gil, Eun Seok; Kaplan, David L.] Tufts Univ, Boston, MA USA.
RP Mauney, JR (reprint author), Harvard Univ, Sch Med, Childrens Hosp Boston, Cambridge, MA 02138 USA.
EM joshua.mauney@childrens.harvard.edu;
   carlos.estrada@childrens.harvard.edu
RI Estrada, Carlos/H-2199-2015
OI Estrada, Carlos/0000-0003-0586-9832
FU Children's Hospital Boston Urology Endowment Revenue Fund; National
   Institutes of Health [NIBIB P41-EB002520, NIDDK T32-DK60442, NIDDK
   1K99-DK083616]
FX These studies were funded, in part, by the Children's Hospital Boston
   Urology Endowment Revenue Fund and the National Institutes of Health
   grants NIBIB P41-EB002520 (Kaplan); NIDDK T32-DK60442 (Freeman); NIDDK
   1K99-DK083616 (Mauney). We acknowledge Dr. Peter Zvara from the
   University of Vermont for assistance in establishing the technique for
   cystostomy tube placement and cystometry.
CR Andersson KE, 2011, NEUROUROL URODYNAM, V30, P636, DOI 10.1002/nau.21108
   Ashley RA, 2010, BJU INT, V105, P1462, DOI 10.1111/j.1464-410X.2009.08965.x
   Atala A, 2000, WORLD J UROL, V18, P364, DOI 10.1007/s003450000152
   Atala A, 2006, LANCET, V367, P1241, DOI 10.1016/S0140-6736(06)68438-9
   Cannon TW, 2001, LIFE SCI, V69, P1193
   Chung SY, 2005, J UROLOGY, V174, P353, DOI 10.1097/01.ju.0000161592.00434.c1
   Gomez P, 2011, BIOMATERIALS, V32, P7562, DOI 10.1016/j.biomaterials.2011.06.067
   Hensle Terry W, 2007, Curr Urol Rep, V8, P157, DOI 10.1007/s11934-007-0066-9
   MALMGREN A, 1987, J UROLOGY, V137, P1291, DOI 10.1016/S0022-5347(17)44485-5
   Matsuura S, 2000, NEUROUROL URODYNAM, V19, P87, DOI 10.1002/(SICI)1520-6777(2000)19:1<87::AID-NAU9>3.0.CO;2-O
   Mauney JR, 2011, BIOMATERIALS, V32, P808, DOI 10.1016/j.biomaterials.2010.09.051
   Niknejad KG, 2000, INT UROGYNECOL J, V11, P156, DOI 10.1007/s001920070043
   Pandita RK, 2000, J UROLOGY, V164, P1385, DOI 10.1016/S0022-5347(05)67204-7
   Persson K, 1998, AM J PHYSIOL-REG I, V275, pR1366
   Roehrborn CG, 2011, MED CLIN N AM, V95, P87, DOI 10.1016/j.mcna.2010.08.013
   Sharma AK, 2011, STEM CELLS, V29, P241, DOI 10.1002/stem.568
   Smith PP, 2008, NEUROUROL URODYNAM, V27, P324, DOI 10.1002/nau.20512
   Smith PP, 2010, NEUROUROL URODYNAM, V29, P1344, DOI 10.1002/nau.20850
   Soler R, 2011, NEUROUROL URODYNAM, V30, P188, DOI 10.1002/nau.20917
   Soler R, 2010, J UROLOGY, V183, P780, DOI 10.1016/j.juro.2009.09.074
   Somani BK, 2007, J UROLOGY, V177, P1793, DOI 10.1016/j.juro.2007.01.038
   Streng T, 2004, BJU INT, V94, P138, DOI 10.1111/j.1464-410X.2004.04875.x
   YAKSH TL, 1986, AM J PHYSIOL, V251, pR1177
   Zhang YY, 2006, BJU INT, V98, P1100, DOI 10.1111/j.1464-410X.2006.06447.x
NR 24
TC 5
Z9 6
U1 1
U2 1
PU JOURNAL OF VISUALIZED EXPERIMENTS
PI CAMBRIDGE
PA 1 ALEWIFE CENTER, STE 200, CAMBRIDGE, MA 02140 USA
SN 1940-087X
J9 JOVE-J VIS EXP
JI J. Vis. Exp.
PD AUG
PY 2012
IS 66
AR UNSP e3981
DI 10.3791/3981
PG 12
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA V36QC
UT WOS:000209225000019
PM 22907252
OA Green Published, Bronze
DA 2018-10-19
ER

PT J
AU Ehrmantraut, S
   Naumann, A
   Willnecker, V
   Akinyemi, S
   Korbel, C
   Scheuer, C
   Meyer-Lindenberg, A
   Menger, MD
   Laschke, MW
AF Ehrmantraut, Susanne
   Naumann, Andreas
   Willnecker, Vivienne
   Akinyemi, Stephanie
   Koerbel, Christina
   Scheuer, Claudia
   Meyer-Lindenberg, Andrea
   Menger, Michael D.
   Laschke, Matthias W.
TI Vitalization of Porous Polyethylene (Medpor (R)) with Chondrocytes
   Promotes Early Implant Vascularization and Incorporation into the Host
   Tissue
SO TISSUE ENGINEERING PART A
LA English
DT Article
ID PLATELET-RICH PLASMA; HIGH-DENSITY POLYETHYLENE; DORSAL SKINFOLD
   CHAMBER; GROWTH-FACTOR; SUBCUTANEOUS IMPLANTS; ENGINEERED CARTILAGE;
   RECONSTRUCTION; SCAFFOLDS; BIOCOMPATIBILITY; EXPRESSION
AB Porous polyethylene (Medpor (R)) is frequently used in craniofacial reconstructive surgery. The successful incorporation of this alloplastic biomaterial depends on adequate vascularization. Here, we analyzed whether the early vascularization of porous polyethylene can be accelerated by vitalization with human chondrocytes. For this purpose, small polyethylene samples were coated with platelet-rich plasma (PRP) or a suspension of PRP and human chondrocytes. Uncoated polyethylene samples served as controls. Subsequently, the samples were implanted into the dorsal skinfold chamber of CD-1 nude mice to repetitively analyze their vascularization and biocompatibility by means of intravital fluorescence microscopy. PRP-chondrocyte-coated polyethylene exhibited an accelerated and improved vascularization when compared with the other two groups. This was indicated by a significantly higher functional capillary density of the microvascular network developing around the implants. Moreover, a leukocyte-endothelial cell interaction was found in a physiological range at the implantation site of all three groups, demonstrating that the vitalization with PRP and chondrocytes did not affect the good biocompatibility of the alloplastic material. Additional histological, immunohistochemical, and in situ hybridization analyses revealed that the chondrocytes formed a bioprotective tissue layer, which prevented the accumulation of macrophages and foreign body giant cells on the polyethylene surface. These findings clearly indicate that vitalization of polyethylene with chondrocytes promotes early implant vascularization and incorporation into the host tissue and, thus, may be a promising approach that prevents postoperative complications such as implant extrusion, migration, and infection.
C1 [Ehrmantraut, Susanne; Koerbel, Christina; Scheuer, Claudia; Menger, Michael D.; Laschke, Matthias W.] Univ Saarland, Inst Clin & Expt Surg, D-66421 Homburg, Germany.
   [Ehrmantraut, Susanne; Meyer-Lindenberg, Andrea] Univ Munich, Dept Small Anim Surg, Munich, Germany.
   [Naumann, Andreas; Willnecker, Vivienne; Akinyemi, Stephanie] Univ Saarland, Dept Otorhinolaryngol Head & Neck Surg, D-66421 Homburg, Germany.
   [Naumann, Andreas] Klinikum Bremen Mitte gGmbH, Dept Otorhinolaryngol, Bremen, Germany.
RP Laschke, MW (reprint author), Univ Saarland, Inst Clin & Expt Surg, D-66421 Homburg, Germany.
EM matthias.laschke@uks.eu
FU research program of the Medical Faculty of the University of Saarland
   (HOMFOR)
FX This work was supported by the research program of the Medical Faculty
   of the University of Saarland (HOMFOR 2008).
CR BAKER M, 1974, MICROVASC RES, V7, P131, DOI 10.1016/0026-2862(74)90043-0
   Berghaus A, 2010, ADV OTO-RHINO-LARYNG, V68, P53, DOI 10.1159/000314562
   Ehrmantraut S, 2010, EUR CELLS MATER, V19, P107, DOI 10.22203/eCM.v019a11
   Eppley BL, 2006, PLAST RECONSTR SURG, V118, p147E, DOI 10.1097/01.prs.0000239606.92676.cf
   Eppley BL, 2004, PLAST RECONSTR SURG, V114, P1502, DOI 10.1097/01.PRS.0000138251.07040.51
   Kim MB, 2004, MICROCIRCULATION, V11, P55, DOI 10.1080/10739680490266199
   Kim SW, 2009, LARYNGOSCOPE, V119, P62, DOI 10.1002/lary.20025
   Laghi Pasini F., 1985, INT J TISSUE REACT, V7, P367
   Laschke MW, 2008, J BIOMED MATER RES A, V85A, P397, DOI 10.1002/jbm.a.31503
   Laschke MW, 2011, EUR CELLS MATER, V22, P147, DOI 10.22203/eCM.v022a12
   Laschke MW, 2010, ACTA BIOMATER, V6, P2020, DOI 10.1016/j.actbio.2009.12.004
   Laschke MW, 2009, ACTA BIOMATER, V5, P1991, DOI 10.1016/j.actbio.2009.02.006
   Laschke MW, 2011, TISSUE ENG PT A, V17, P841, DOI [10.1089/ten.tea.2010.0329, 10.1089/ten.TEA.2010.0329]
   Lee S, 2005, ARCH OTOLARYNGOL, V131, P446, DOI 10.1001/archotol.131.5.446
   Marx R E, 2001, Implant Dent, V10, P225
   Menger MD, 2002, EUR SURG RES, V34, P83, DOI 10.1159/000048893
   Misson P, 2004, J LEUKOCYTE BIOL, V76, P926, DOI 10.1189/jlb.0104019
   Monroy A, 2007, INT J PEDIATR OTORHI, V71, P547, DOI 10.1016/j.ijporl.2006.11.025
   Mosser DM, 2003, J LEUKOCYTE BIOL, V73, P209, DOI 10.1189/jlb.0602325
   Naik MN, 2007, OPHTHAL PLAST RECONS, V23, P463, DOI 10.1097/IOP.0b013e318158ec8e
   Nomura Y, 2009, PATHOL INT, V59, P631, DOI 10.1111/j.1440-1827.2009.02418.x
   Peled ZM, 2008, PLAST RECONSTR SURG, V121, p85E, DOI 10.1097/01.prs.0000299386.73127.a7
   Reiffel AJ, 2011, ANN PLAS SURG, V66, P24, DOI 10.1097/SAP.0b013e3181d3ef8e
   Roller J, 2008, LANGENBECK ARCH SURG, V393, P349, DOI 10.1007/s00423-008-0295-5
   Rucker M, 2006, BIOMATERIALS, V27, P5027, DOI 10.1016/j.biomaterials.2006.05.033
   Sabini P, 2000, Arch Facial Plast Surg, V2, P27, DOI 10.1001/archfaci.2.1.27
   Schagemann JC, 2010, BIOMATERIALS, V31, P2798, DOI 10.1016/j.biomaterials.2009.12.037
   Sclafani AP, 1997, ARCH OTOLARYNGOL, V123, P328
   Strieth S, 2010, J BIOMED MATER RES A, V93A, P1566, DOI 10.1002/jbm.a.32670
   Waehre T, 2004, THROMB HAEMOSTASIS, V92, P1358, DOI 10.1160/TH04-03-0146
   Weibrich G, 2002, J CRANIO MAXILL SURG, V30, P97, DOI 10.1054/jems.2002.0285
   Yonenaga K, 2010, TISSUE ENG PART C-ME, V16, P1461, DOI 10.1089/ten.TEC.2009.0597
NR 32
TC 11
Z9 11
U1 0
U2 4
PU MARY ANN LIEBERT, INC
PI NEW ROCHELLE
PA 140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA
SN 1937-3341
J9 TISSUE ENG PT A
JI Tissue Eng. Part A
PD AUG
PY 2012
VL 18
IS 15-16
BP 1562
EP 1572
DI 10.1089/ten.tea.2011.0340
PG 11
WC Cell & Tissue Engineering; Biotechnology & Applied Microbiology; Cell
   Biology
SC Cell Biology; Biotechnology & Applied Microbiology
GA 995HP
UT WOS:000307999100004
PM 22452340
DA 2018-10-19
ER

PT J
AU Xie, Y
   Liu, MF
   Zhou, J
AF Xie, Yun
   Liu, Meifeng
   Zhou, Jian
TI Molecular dynamics simulations of peptide adsorption on self-assembled
   monolayers
SO APPLIED SURFACE SCIENCE
LA English
DT Article
DE Protein adsorption; Molecular dynamics simulation; Molecular simulation;
   Biomaterial; Anti-fouling; Zwitterionic compound
ID PROTEIN-SURFACE INTERACTIONS; POLY(ETHYLENE OXIDE); NONFOULING BEHAVIOR;
   COMPUTER-SIMULATION; STRONG RESISTANCE; CHARGED SURFACES; WATER;
   ORIENTATION; POLYMERS; SYSTEM
AB All-atom molecular dynamics simulations are performed to investigate the neuromedin-B peptide adsorption on the self-assembled monolayers (SAMs) of SH(CH2)(10)N+(CH3)(2)CH2CH(OH)CH2SO3-(SBT), SH(CH2)(10)OH and SH(CH2)(10)CH3. The force-distance profiles show that the surface resistance to peptide adsorption is mainly generated by the water molecules tightly bound to surfaces via hydrogen bonds (hydration water molecules); but surfaces themselves may also set an energy barrier for the approaching peptide. For the SBT-SAM, the surface first exerts a relatively high repulsive force and then a rather week attractive force on the approaching peptide; meanwhile the hydration water molecules exert a strong repulsive force on the peptide. Therefore, SBT-SAM has an excellent performance on resisting protein adsorption. For the OH-SAM and CH3-SAM, surfaces show low or little energy barrier but strong affinity to the peptide; and the hydration water molecules apply merely a repulsive force within a much narrower range and with lower intensity compared with the case for the SBT-SAM. The analysis of structural and dynamical properties of the peptide, surface and water indicates that possible factors contributing to surface resistance include the hydrogen-bond formation capability of surfaces, mobility of water molecules near surfaces, surface packing density and chain flexibility of SAMs. There are a large number of hydrogen bonds formed between the hydration water molecules and the functional groups of the SBT-SAM, which greatly lowers the mobility of water molecules near the surface. This tightly-bound water layer effectively reduces the direct contact between the surface and the peptide. Furthermore, the SBT-SAM also has a high flexibility and a low surface packing density, which allows water molecules to penetrate into the surface to form tightly-bound networks and therefore reduces the affinity between the peptide and the surface. The results show that the protein-resistant properties of the SAMs are in the decreasing order of SBT-SAM > OH-SAM > CH3-SAM, which provide mechanistic explanation on SBT materials' excellent anti-fouling performance. (C) 2012 Elsevier B.V. All rights reserved.
C1 [Xie, Yun; Liu, Meifeng; Zhou, Jian] S China Univ Technol, Sch Chem & Chem Engn, Guangdong Prov Key Lab Green Chem Prod Technol, Guangzhou 510640, Guangdong, Peoples R China.
RP Zhou, J (reprint author), S China Univ Technol, Sch Chem & Chem Engn, Guangdong Prov Key Lab Green Chem Prod Technol, Guangzhou 510640, Guangdong, Peoples R China.
EM jianzhou@scut.edu.cn
RI Zhou, Jian/E-4504-2011; Xie, Yun/N-4746-2017
OI Zhou, Jian/0000-0002-3033-7785; Xie, Yun/0000-0002-0525-8540
FU Program for New Century Excellent Talents in University [NCET-07-0313];
   National Natural Science Foundation of China [20706019, 20876052];
   Guangdong Science Foundation [S2011010002078]
FX This work is supported by Program for New Century Excellent Talents in
   University (NCET-07-0313), National Natural Science Foundation of China
   (Nos. 20706019, 20876052) and Guangdong Science Foundation (No.
   S2011010002078). The computational resources for this project are
   provided by SCUTGrid at South China University of Technology.
CR Agashe M, 2005, LANGMUIR, V21, P1103, DOI 10.1021/la0478364
   Archambault JG, 2004, COLLOID SURFACE B, V33, P111, DOI 10.1016/j.colsurfb.2003.09.004
   BERENDSEN HJC, 1984, J CHEM PHYS, V81, P3684, DOI 10.1063/1.448118
   BROOKS BR, 1983, J COMPUT CHEM, V4, P187, DOI 10.1002/jcc.540040211
   Chang Y, 2006, LANGMUIR, V22, P2222, DOI 10.1021/la052692v
   Chapman RG, 2001, LANGMUIR, V17, P1225, DOI 10.1021/la001222d
   Chapman RG, 2000, J AM CHEM SOC, V122, P8303, DOI 10.1021/ja000774f
   Chen SF, 2005, J AM CHEM SOC, V127, P14473, DOI 10.1021/ja054169u
   Chen SF, 2006, LANGMUIR, V22, P2418, DOI 10.1021/la052851w
   Cheng G, 2009, BIOMATERIALS, V30, P5234, DOI 10.1016/j.biomaterials.2009.05.058
   Falkenhagen D, 1999, ARTIF ORGANS, V23, P81, DOI 10.1046/j.1525-1594.1999.06292.x
   Franks F., 1973, WATER COMPREHENSIVE
   Halperin A, 2000, CR ACAD SCI IV-PHYS, V1, P1171, DOI 10.1016/S1296-2147(00)01129-X
   He SM, 2010, PROG CHEM, V22, P760
   He Y, 2008, PHYS CHEM CHEM PHYS, V10, P5539, DOI 10.1039/b807129b
   He Y, 2008, LANGMUIR, V24, P10358, DOI 10.1021/la8013046
   Holmlin RE, 2001, LANGMUIR, V17, P2841, DOI 10.1021/la0015258
   Hower JC, 2008, J CHEM PHYS, V129, DOI 10.1063/1.3012563
   Ismail AE, 2007, LANGMUIR, V23, P8508, DOI 10.1021/la700829r
   JEON SI, 1991, J COLLOID INTERF SCI, V142, P149, DOI 10.1016/0021-9797(91)90043-8
   Kane RS, 2003, LANGMUIR, V19, P2388, DOI 10.1021/la020737x
   Kingshott P, 1999, CURR OPIN SOLID ST M, V4, P403, DOI 10.1016/S1359-0286(99)00018-2
   Knotts TA, 2008, BIOPHYS J, V94, P4473, DOI 10.1529/biophysj.107.123158
   Kubiak-Ossowska K, 2010, LANGMUIR, V26, P7690, DOI 10.1021/la101276v
   Ladd J, 2008, BIOMACROMOLECULES, V9, P1357, DOI 10.1021/bm701301s
   Latour RA, 2006, J BIOMED MATER RES A, V78A, P843, DOI 10.1002/jbm.a.30818
   Li D, 2011, COLLOID SURFACE B, V86, P1, DOI 10.1016/j.colsurfb.2011.04.003
   Li LY, 2007, J BIOMAT SCI-POLYM E, V18, P1415, DOI 10.1163/156856207782246795
   Li LY, 2005, J PHYS CHEM B, V109, P2934, DOI 10.1021/jp0473321
   Luk YY, 2000, LANGMUIR, V16, P9604, DOI 10.1021/la0004653
   LUZAR A, 1993, J CHEM PHYS, V98, P8160, DOI 10.1063/1.464521
   MacKerell AD, 1998, J PHYS CHEM B, V102, P3586, DOI 10.1021/jp973084f
   Manna M, 2011, LANGMUIR, V27, P3713, DOI 10.1021/la104046z
   Mark P, 2001, J PHYS CHEM A, V105, P9954, DOI 10.1021/jp003020w
   McPherson T, 1998, LANGMUIR, V14, P176, DOI 10.1021/la9706781
   Nonella M, 2010, CHEM PHYS, V378, P73, DOI 10.1016/j.chemphys.2010.10.005
   NORDE W, 1986, ADV COLLOID INTERFAC, V25, P267, DOI 10.1016/0001-8686(86)80012-4
   Ohki-Hamazaki H, 2000, PROG NEUROBIOL, V62, P297, DOI 10.1016/S0301-0082(00)00004-6
   Ostuni E, 2001, LANGMUIR, V17, P6336, DOI 10.1021/la010552a
   Ostuni E, 2001, LANGMUIR, V17, P5605, DOI 10.1021/la010384m
   Pandey LM, 2011, APPL SURF SCI, V257, P4731, DOI 10.1016/j.apsusc.2010.12.148
   Pertsin AJ, 2000, LANGMUIR, V16, P8829, DOI 10.1021/1a000340y
   Podstawka-Proniewicz E, 2011, APPL SURF SCI, V257, P8246, DOI 10.1016/j.apsusc.2011.02.012
   Ratner BD, 1996, J MOL RECOGNIT, V9, P617, DOI 10.1002/(SICI)1099-1352(199634/12)9:5/6<617::AID-JMR310>3.0.CO;2-D
   Raz SR, 2008, BIOSENS BIOELECTRON, V24, P552, DOI 10.1016/j.bios.2008.05.010
   Roach P, 2005, J AM CHEM SOC, V127, P8168, DOI 10.1021/ja042898o
   RYCKAERT JP, 1977, J COMPUT PHYS, V23, P327, DOI 10.1016/0021-9991(77)90098-5
   Sheng YB, 2011, J MOL STRUCT, V995, P142, DOI 10.1016/j.molstruc.2011.04.007
   Sheng YB, 2010, J PHYS CHEM C, V114, P454, DOI 10.1021/jp908629g
   Svec F, 1996, SCIENCE, V273, P205, DOI 10.1126/science.273.5272.205
   Vonarbourg A, 2006, BIOMATERIALS, V27, P4356, DOI 10.1016/j.biomaterials.2006.03.039
   Wei SA, 2011, J CHEM PHYS, V134, DOI 10.1063/1.3589863
   Xie Y, 2010, J CHEM PHYS, V132, DOI 10.1063/1.3305244
   Zhang AJ, 2009, PROG CHEM, V21, P1408
   Zhang Z, 2006, J PHYS CHEM B, V110, P10799, DOI 10.1021/jp057266i
   Zhang Z, 2008, BIOMACROMOLECULES, V9, P2686, DOI 10.1021/bm800407r
   Zhang Z, 2006, LANGMUIR, V22, P10072, DOI 10.1021/la062175d
   Zheng J, 2004, LANGMUIR, V20, P8931, DOI 10.1021/la036345n
   Zheng J, 2005, BIOPHYS J, V89, P158, DOI 10.1529/biophysj.105.059428
   Zheng J, 2006, J CHEM PHYS, V125, DOI 10.1063/1.2363978
   Zhou J, 2004, J PHYS CHEM B, V108, P17418, DOI 10.1021/jp038048x
   Zhou J, 2004, J CHEM PHYS, V121, P1050, DOI 10.1063/1.1757434
   Zhou J, 2003, LANGMUIR, V19, P3472, DOI 10.1021/la026871z
NR 63
TC 34
Z9 34
U1 1
U2 89
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0169-4332
J9 APPL SURF SCI
JI Appl. Surf. Sci.
PD AUG 1
PY 2012
VL 258
IS 20
BP 8153
EP 8159
DI 10.1016/j.apsusc.2012.05.013
PG 7
WC Chemistry, Physical; Materials Science, Coatings & Films; Physics,
   Applied; Physics, Condensed Matter
SC Chemistry; Materials Science; Physics
GA 967XF
UT WOS:000305940700058
DA 2018-10-19
ER

PT J
AU Yang, HJ
   Yue, Q
AF Yang, H. J.
   Yue, Q.
TI Effect of glucose addition and N sources in defined media on fibrolytic
   activity profiles of Neocallimastix sp YQ1 grown on corn stover
SO JOURNAL OF ANIMAL PHYSIOLOGY AND ANIMAL NUTRITION
LA English
DT Article
DE corn stover; Rumen; Neocallimastix sp; YQ1; ferulic acid esterase;
   acetyl esterase; volatile fatty acids
ID RUMEN ANAEROBIC FUNGUS; PLANT-CELL WALL; CAECOMYCES-COMMUNIS; FERULOYL
   ESTERASES; COUMAROYL ESTERASE; DETERGENT FIBER; ACETYL ESTERASE; DIETARY
   FIBER; FRONTALIS; ENZYMES
AB Cleavage of plant cell wall arabinoxylans occurs by the action of ferulic acid esterase (FAE) and acetyl esterase (AE), which cleave feruloyl groups substituted at the 5'-OH group of arabinosyl residues and acetyl groups substituted at O-2/O-3 of the xylan backbone, respectively. In this study, we examined the enzyme profiles of the anaerobic rumen fungus Neocallimastix sp. YQ1 for FAE, AE and polysaccharide hydrolases when grown on corn stover, a lignin-rich waste biomaterial. A 2 x 4 factorial experiment in 10-days pure cultures was used to test glucose addition (G+: glucose at 1.0 g/l, G-: no glucose) and four N sources (N1: 1.0 g/l yeast extract, 1.0 g/l tryptone and 0.5 g/l (NH4)2SO4; N2: 2.8 g/l yeast extract and 0.5 g/l (NH4)2SO4; N3: 1.6 g/l tryptone and 0.5 g/l (NH4)2SO4; N4: 1.4 g/l tryptone and 1.7 g/l yeast extract) in defined media. The optimal combinations of glucose and N sources to promote FAE and AE activity were G+ N2 and G+ N4, respectively. The peak activities of FAE and AE occurred on days 9 and 10, respectively. Addition of glucose and an increase in yeast extract and/or tryptone to a Hungates medium favoured fungal production of volatile fatty acids, which could be just a consequence of more organic matter available to digest. This suggests that enzymatic release of ferulic acid by a synergistic action of lignin hydrolytic esterase and polysaccharide hydrolases may be essential for plant cell wall biodegradation in the rumen.
C1 [Yang, H. J.; Yue, Q.] China Agr Univ, State Key Lab Anim Nutr, Coll Anim Sci & Technol, Beijing 100193, Peoples R China.
RP Yang, HJ (reprint author), China Agr Univ, State Key Lab Anim Nutr, Coll Anim Sci & Technol, Beijing 100193, Peoples R China.
EM yang_hongjian@sina.com
RI Yang, H.J./A-6816-2010
OI Yang, Hong-Jian/0000-0001-5726-5526
FU National Key Basic Research Program of China [2011CB100800]; National
   Natural Science Foundation [31072054]
FX We appreciate the support of the National Key Basic Research Program of
   China (Project No: 2011CB100800) and National Natural Science Foundation
   (Project No. 31072054).
CR AOAC, 1999, OFF METH AN
   Baqueiro-Pena I, 2010, BIORESOURCE TECHNOL, V101, P4721, DOI 10.1016/j.biortech.2010.01.086
   BARICHIEVICH EM, 1990, APPL ENVIRON MICROB, V56, P43
   BAUCHOP T, 1981, APPL ENVIRON MICROB, V42, P1103
   BORNEMAN WS, 1990, APPL MICROBIOL BIOT, V33, P345, DOI 10.1007/BF00164534
   BORNEMAN WS, 1991, APPL ENVIRON MICROB, V57, P2337
   Brookman JL, 2000, MICROBIOL-UK, V146, P393, DOI 10.1099/00221287-146-2-393
   Chen YC, 2003, FEMS MICROBIOL LETT, V221, P227, DOI 10.1016/S0378-1097(03)00207-6
   Chungool W, 2008, WORLD J MICROB BIOT, V24, P549, DOI 10.1007/s11274-007-9509-1
   Colombatto D, 2003, J ANIM SCI, V81, P2628
   Gerbi C, 1996, RES MICROBIOL, V147, P363, DOI 10.1016/0923-2508(96)84711-5
   Hodrova B, 1998, RES MICROBIOL, V149, P417, DOI 10.1016/S0923-2508(98)80324-0
   Hungate R. E., 1969, METHODS MICROBIOLO B, P117, DOI DOI 10.1016/S0580-9517(08)70503-8
   LOWE SE, 1987, APPL ENVIRON MICROB, V53, P1216
   LOWE SE, 1985, J GEN MICROBIOL, V131, P2225
   MILLER GL, 1959, ANAL CHEM, V31, P426, DOI 10.1021/ac60147a030
   MOUNTFORT DO, 1985, APPL ENVIRON MICROB, V49, P1314
   MOUNTFORT DO, 1989, APPL ENVIRON MICROB, V55, P1016
   ORPIN CG, 1986, T BRIT MYCOL SOC, V86, P178, DOI 10.1016/S0007-1536(86)80138-3
   Orskov E R, 1975, World Rev Nutr Diet, V22, P152
   Panagiotou G, 2007, J BIOTECHNOL, V130, P219, DOI 10.1016/j.jbiotec.2007.04.011
   PHILLIPS MW, 1988, BIOSYSTEMS, V21, P377, DOI 10.1016/0303-2647(88)90036-6
   Saad WZ, 2008, ANAEROBE, V14, P118, DOI 10.1016/j.anaerobe.2007.10.003
   Sancho AI, 2001, J CEREAL SCI, V34, P173, DOI 10.1006/jcrs.2001.0386
   Sarangi P.K., 2009, ASIAN J MICROBIOL BI, V11, P273
   Shin HD, 2006, ENZYME MICROB TECH, V38, P478, DOI 10.1016/j.enzmictec.2005.07.003
   Timell T. E., 1967, Wood Science and Technology, V1, P45
   Topakas E, 2007, PROCESS BIOCHEM, V42, P497, DOI 10.1016/j.procbio.2007.01.007
   Tripathi VK, 2007, ANAEROBE, V13, P36, DOI 10.1016/j.anaerobe.2006.11.001
   VANSOEST PJ, 1991, J DAIRY SCI, V74, P3583, DOI 10.3168/jds.S0022-0302(91)78551-2
   WILLIAMS AG, 1987, CAN J MICROBIOL, V33, P418, DOI 10.1139/m87-071
   Williamson G, 1998, MICROBIOL-SGM, V144, P2011, DOI 10.1099/00221287-144-8-2011
   Wolfrum EJ, 2009, CELLULOSE, V16, P577, DOI 10.1007/s10570-009-9318-9
   Yang HJ, 2010, ANIM FEED SCI TECH, V159, P110, DOI 10.1016/j.anifeedsci.2010.06.006
   Yang HJ, 2009, ANIM FEED SCI TECH, V154, P218, DOI 10.1016/j.anifeedsci.2009.09.006
   Yue Q, 2009, ANIM FEED SCI TECH, V153, P169, DOI 10.1016/j.anifeedsci.2009.06.002
   Yue Q, 2009, ANIM FEED SCI TECH, V153, P263, DOI 10.1016/j.anifeedsci.2009.06.019
NR 37
TC 2
Z9 3
U1 0
U2 14
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0931-2439
J9 J ANIM PHYSIOL AN N
JI J. Anim. Physiol. Anim. Nutr.
PD AUG
PY 2012
VL 96
IS 4
BP 554
EP 562
DI 10.1111/j.1439-0396.2011.01177.x
PG 9
WC Agriculture, Dairy & Animal Science; Veterinary Sciences
SC Agriculture; Veterinary Sciences
GA 968IF
UT WOS:000305970500002
PM 21635576
DA 2018-10-19
ER

PT J
AU Kim, HJ
   Park, SS
   Oh, SY
   Kim, H
   Kweon, OK
   Woo, HM
   Kim, WH
AF Kim, Hee Jung
   Park, Sung Su
   Oh, Sun Young
   Kim, Hyoju
   Kweon, Oh-Kyeong
   Woo, Heung Myong
   Kim, Wan Hee
TI Effect of acellular dermal matrix as a delivery carrier of
   adipose-derived mesenchymal stem cells on bone regeneration
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART B-APPLIED BIOMATERIALS
LA English
DT Article
DE bone graft; osteogenesis; scaffold; stem cells; dermal substitutes
ID CALVARIAL DEFECT MODEL; IN-VIVO; RAT; REPAIR; OSTEOGENESIS; SCAFFOLD;
   TISSUE; VITRO
AB The purpose of this study is to evaluate the effect of acellular dermal matrix (ADM) as a delivery carrier of adipose-derived mesenchymal stem cells (ASCs) on bone regeneration in athymic murine calvarial bone defect. Paired-critical size defects in nude rat skull were made. The right-side defects received ASCs/ADM or only ADM, whereas the left-side defect was not treated. In 3D images, new bone formation in the ASCs/ADM group was apparent at 4 wk, but in the ADM group at 8 wk. At 4 and 8 wk, bone mineral density and tissue volume in rats that received ASCs/ADM were significantly greater than rats that received ADM and control groups. Histological examination revealed that the defect was repaired by bone in the ASCs/ADM group, whereas only minimal bone island with fibrous connection was observed in the control group. In histomorphometric analysis, the total healing score in the ASCs/ADM group at 4 wk was significantly higher than the ADM and negative control group, whereas the score of 8 wk was similar between the ASCs/ADM and ADM group. ASCs/ADM implants promote new bone formation more rapidly than ADM only or no treatment. ADM seeded with ASCs may be potentially useful as a future biomaterial option in bone implants. (c) 2012 Wiley Periodicals, Inc. J Biomed Mater Res Part B: Appl Biomater 100B: 16451653, 2012.
C1 [Kim, Hee Jung; Park, Sung Su; Oh, Sun Young; Kim, Hyoju; Kweon, Oh-Kyeong; Kim, Wan Hee] Seoul Natl Univ, Coll Vet Med, Dept Vet Surg, Seoul, South Korea.
   [Woo, Heung Myong] Kangwon Natl Univ, Dept Vet Surg Sci, Chunchon, South Korea.
   [Woo, Heung Myong] Stem Cell Inst KNU, Sch Vet Med, Chunchon, South Korea.
RP Kim, WH (reprint author), Seoul Natl Univ, Coll Vet Med, Dept Vet Surg, Seoul, South Korea.
EM whkim@snu.ac.kr
FU Ministry of Education, Science and Technology [2010-0015586]; National
   Research Foundation of Korea (NRF)
FX This research was supported by Basic Science Research Program through
   the National Research Foundation of Korea (NRF) funded by the Ministry
   of Education, Science and Technology (2010-0015586).
CR Altman AM, 2008, AESTHET PLAST SURG, V32, P698, DOI 10.1007/s00266-008-9159-1
   Altman AM, 2008, BIOMATERIALS, V29, P1431, DOI 10.1016/j.biomaterials.2007.11.026
   BASSETT CAL, 1972, CLIN ORTHOP RELAT R, P49
   Bohnenblust ME, 2009, J CRANIOFAC SURG, V20, P340, DOI 10.1097/SCS.0b013e3181992316
   Bosch C, 1998, J CRANIOFAC SURG, V9, P310, DOI 10.1097/00001665-199807000-00004
   Cowan CM, 2007, TISSUE ENG, V13, P501, DOI 10.1089/ten.2006.0141
   Cui L, 2007, BIOMATERIALS, V28, P5477, DOI 10.1016/j.biomaterials.2007.08.042
   Fligiel SEG, 2003, J INVEST DERMATOL, V120, P842, DOI 10.1046/j.1523-1747.2003.12148.x
   Fotek PD, 2009, J PERIODONTOL, V80, P776, DOI 10.1902/jop.2009.080514
   Gupta DM, 2008, J CRANIOFAC SURG, V19, P192, DOI 10.1097/scs.0b013e31815c93b7
   Hagenmueller H, 2007, ANN BIOMED ENG, V35, P1657, DOI 10.1007/s10439-007-9338-2
   Mardas N, 2002, J CRANIOFAC SURG, V13, P453, DOI 10.1097/00001665-200205000-00017
   Mardas N, 2002, J CRANIOFAC SURG, V13, P462
   Meinel L, 2005, BONE, V37, P688, DOI 10.1016/j.bone.2005.06.010
   Melcher AH, 1963, J BONE JOINT SURG BR, V45B, P14
   MULLIKEN JB, 1980, PLAST RECONSTR SURG, V65, P553, DOI 10.1097/00006534-198005000-00001
   Park SS, 2011, J CELL PHYSIOL, V226, P3251, DOI 10.1002/jcp.22686
   PROLO DJ, 1982, CLIN ORTHOP RELAT R, P230
   Qiu QQ, 2007, J BIOMED MATER RES B, V81B, P516, DOI 10.1002/jbm.b.30692
   SCHMITZ JP, 1986, CLIN ORTHOP RELAT R, P299
   Schonmeyr B, 2009, TISSUE ENG PT A, V15, P1833, DOI 10.1089/ten.tea.2008.0446
   Sclafani A P, 2000, Arch Facial Plast Surg, V2, P130, DOI 10.1001/archfaci.2.2.130
   Terella A, 2010, ARCH FACIAL PLAST S, V12, P166, DOI 10.1001/archfacial.2010.37
   Umoh JU, 2009, PHYS MED BIOL, V54, P2147, DOI 10.1088/0031-9155/54/7/020
   Yoon E, 2007, TISSUE ENG, V13, P619, DOI 10.1089/ten.2006.0102
NR 25
TC 5
Z9 5
U1 0
U2 9
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1552-4973
J9 J BIOMED MATER RES B
JI J. Biomed. Mater. Res. Part B
PD AUG
PY 2012
VL 100B
IS 6
BP 1645
EP 1653
DI 10.1002/jbm.b.32733
PG 9
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 968IS
UT WOS:000305972800021
PM 22707031
DA 2018-10-19
ER

PT J
AU Getgood, AMJ
   Kew, SJ
   Brooks, R
   Aberman, H
   Simon, T
   Lynn, AK
   Rushton, N
AF Getgood, Alan M. J.
   Kew, Simon J.
   Brooks, Roger
   Aberman, Harold
   Simon, Timothy
   Lynn, Andrew K.
   Rushton, Neil
TI Evaluation of early-stage osteochondral defect repair using a biphasic
   scaffold based on a collagen-glycosaminoglycan biopolymer in a caprine
   model
SO KNEE
LA English
DT Article
DE Osteochondral; Biomaterial; Scaffold; Cartilage; Bone
ID AUTOLOGOUS CHONDROCYTE IMPLANTATION; FULL-THICKNESS DEFECTS;
   ARTICULAR-CARTILAGE; POSTTRAUMATIC OSTEOARTHRITIS; KNEE; DESIGN;
   MICROFRACTURE; MOSAICPLASTY; REGENERATION; DEGRADATION
AB The aim of this study was to evaluate a new collagen-GAG-calcium phosphate biphasic scaffold for the repair of surgically created osteochondral defects in goats. Comparison of morphological, histological and mechanical performance of the repair tissue was made with defects repaired using a synthetic polymer scaffold. Defects were created in the medial femoral condyle (MFC) and lateral trochlear sulcus (LTS) of Boer Cross goats and evaluated at 12 and 26 weeks. It was found that the total histology score of the collagen-GAG based biomaterial (23.8; SD 1.7) provided a significant improvement ( p<0.05) over the biphasic PLGA material (19;3) and the empty control defect (17.3;1.2) in the LTS. The overall trajectory of histological and morphological improvement between 12 and 26 weeks was found to be higher for the collagen-GAG scaffold compared to the PLGA material. The occurrence of sub-chondral bone cysts was lower for the collagen-GAG scaffold with an incidence of 17% of defects, compared to 67% for the PLGA material at 26 weeks. The cartilage repair tissue for both materials evaluated was superior after 26 weeks implantation than the empty control with 75% of the collagen-GAG-treated defects showing markedly more hyaline-like cartilage and 50% of the PLGA sites exhibiting hyaline-like appearances, compared to 17% for the empty control. These early stage data indicate biphasic scaffolds based on collagen-GAG and PLGA both provide indications of satisfactory development of a structural repair to surgically prepared osteochondral defects. Furthermore, the biomaterial composition of the collagen-GAG may provide a more favourable environment for osteochondral repair. (C) 2011 Elsevier B.V. All rights reserved.
C1 [Getgood, Alan M. J.; Brooks, Roger; Rushton, Neil] Univ Cambridge, Orthopaed Res Unit, Addenbrookes Hosp, Cambridge CB2 2QQ, England.
   [Kew, Simon J.; Lynn, Andrew K.] TiGenix Ltd, Cambridge, England.
   [Aberman, Harold; Simon, Timothy] Adv Biol Concepts, Los Alamitos, CA 90720 USA.
RP Getgood, AMJ (reprint author), Univ Cambridge, Orthopaed Res Unit, Addenbrookes Hosp, Box 180,Hills Rd, Cambridge CB2 2QQ, England.
EM agetgood@btinternet.com
RI Getgood, Alan/I-3305-2013
FU TiGenix Ltd.; UK Technology Strategy Board
FX This study formed the basis for application for CE marking of
   'Chondromimetic' as a medical device. Chondromimetic is distributed by
   Orthomimetics/TiGenix Ltd, Cambridge UK. Three of the authors (SK, AKL,
   NR) hold shares in TiGenix Ltd. Two of the authors (AG, NR) receive
   consultancy fees from TiGenix Ltd.; The authors would like to
   acknowledge the funding support from the UK Technology Strategy Board.
CR Antheunis H, 2010, BIOMACROMOLECULES, V11, P1118, DOI 10.1021/bm100125b
   Bentley G, 2003, J BONE JOINT SURG BR, V85B, P223, DOI 10.1302/0301-620X.85B2.13543
   BRITTBERG M, 1994, NEW ENGL J MED, V331, P889, DOI 10.1056/NEJM199410063311401
   Brown TD, 2006, J ORTHOP TRAUMA, V20, P739, DOI 10.1097/01.bot.0000246468.80635.ef
   Carmont MR, 2009, ARTHROSCOPY, V25, P810, DOI 10.1016/j.arthro.2009.01.023
   Chamberlain LJ, 1998, EXP NEUROL, V154, P315, DOI 10.1006/exnr.1998.6955
   Getgood A, 2009, J BONE JOINT SURG BR, V91B, P565, DOI 10.1302/0301-620X.91B5.21832
   Ghosh K, 2007, ADV DRUG DELIVER REV, V59, P1306, DOI 10.1016/j.addr.2007.08.014
   Gikas PD, 2009, J BONE JOINT SURG BR, V91B, P1172, DOI 10.1302/0301-620X.91B9.22490
   Gomoll AH, 2010, KNEE SURG SPORT TR A, V18, P434, DOI 10.1007/s00167-010-1072-x
   Hangody L, 2003, J BONE JOINT SURG AM, V85A, P25, DOI 10.2106/00004623-200300002-00004
   Harley BA, 2010, J BIOMED MATER RES A, V92A, P1078, DOI 10.1002/jbm.a.32387
   Harley BA, 2010, J BIOMED MATER RES A, V92A, P1066, DOI 10.1002/jbm.a.32361
   Heir S, 2010, AM J SPORT MED, V38, P231, DOI 10.1177/0363546509352157
   Jackson DW, 2001, J BONE JOINT SURG AM, V83A, P53, DOI 10.2106/00004623-200101000-00008
   Kerker JT, 2008, SPORTS MED ARTHROSC, V16, P208, DOI 10.1097/JSA.0b013e31818cdbaa
   Khan WS, 2010, KNEE, V17, P369, DOI 10.1016/j.knee.2009.12.003
   Knutsen G, 2004, J BONE JOINT SURG AM, V86A, P455, DOI 10.2106/00004623-200403000-00001
   Konan S, 2009, KNEE SURG SPORT TR A, V17, P293, DOI 10.1007/s00167-008-0684-x
   Lotz MK, 2010, ARTHRITIS RES THER, V12, DOI 10.1186/ar3046
   Lynn AK, 2010, J BIOMED MATER RES A, V92A, P1057, DOI 10.1002/jbm.a.32415
   Moojen DJF, 2002, TISSUE ENG, V8, P627, DOI 10.1089/107632702760240544
   Murray C. J. L, 1996, GLOBAL BURDEN DIS
   Pek YS, 2004, BIOMATERIALS, V25, P473, DOI 10.1016/S0142-9612(03)00541-6
   Roos EM, 2005, CURR OPIN RHEUMATOL, V17, P195, DOI 10.1097/01.bor.0000151406.64393.00
   Rutgers M, 2010, OSTEOARTHR CARTILAGE, V18, P12, DOI 10.1016/j.joca.2009.08.009
   Sellers RS, 1997, J BONE JOINT SURG AM, V79A, P1452, DOI 10.2106/00004623-199710000-00002
   Steadman JR, 2010, CARTILAGE, V1, P78, DOI 10.1177/1947603510365533
   Steadman JR, 2003, ARTHROSCOPY, V19, P477, DOI 10.1053/jars.2003.50112
   Williams Riley J, 2008, Instr Course Lect, V57, P563
   Yannas I., 2001, TISSUE ORGAN REGENER
   Yannas IV, 2010, PHILOS T R SOC A, V368, P2123, DOI 10.1098/rsta.2010.0015
   YANNAS IV, 1989, P NATL ACAD SCI USA, V86, P933, DOI 10.1073/pnas.86.3.933
NR 33
TC 36
Z9 39
U1 4
U2 28
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0968-0160
EI 1873-5800
J9 KNEE
JI Knee
PD AUG
PY 2012
VL 19
IS 4
BP 422
EP 430
DI 10.1016/j.knee.2011.03.011
PG 9
WC Orthopedics; Sport Sciences; Surgery
SC Orthopedics; Sport Sciences; Surgery
GA 966QK
UT WOS:000305852300037
PM 21620711
DA 2018-10-19
ER

PT J
AU Claramunt, R
   Paez, JMG
   Alvarez, L
   Ros, A
   Casado, MC
AF Claramunt, Rafael
   Garcia Paez, Jose Maria
   Alvarez, Lourdes
   Ros, Antonio
   Concepcion Casado, Maria
TI Fatigue behaviour of young ostrich pericardium
SO MATERIALS SCIENCE & ENGINEERING C-MATERIALS FOR BIOLOGICAL APPLICATIONS
LA English
DT Article
DE Pericardium; Fatigue; Mechanical properties; Cardiac valve
ID PROSTHETIC HEART-VALVES; TISSUE SELECTION SITES; BOVINE PERICARDIUM;
   HYDRODYNAMIC FUNCTION; MECHANICAL-BEHAVIOR; FIBER ARCHITECTURE; CALF
   PERICARDIUM; SUTURE; CALCIFICATION; BIOPROSTHESES
AB Young ostrich pericardia (biomaterial under study for manufacturing cardiac valve leaflets), has been subjected to biaxial tension fatigue until breakage. Supraphysiological values of pressure (1 to 6 atm) have been employed to accelerate damage and, therefore, to reduce testing time but at physiological frequency in order to avoid viscoelastic behaviour changes.
   The lifetime fatigue curves have been obtained and large scatter has been observed in the results but this can be strongly reduced with adequate material selection.
   The thickness-based selection of samples has proved to be ineffective both in reducing scatter or improving strength, but the energy-based selection aided with statistical decision techniques has been shown to be very successful. The energy loss (energy under the hysteresis loop of each load and unload cycle) appears to be a very accurate predictor of the expected fatigue lifetime of the tissue. (C) 2012 Elsevier B.V. All rights reserved.
C1 [Claramunt, Rafael; Garcia Paez, Jose Maria; Ros, Antonio] Univ Politecn Madrid, ETSI Ind, Dept Struct Mech, E-28006 Madrid, Spain.
   [Alvarez, Lourdes] Hosp Puerto de Hierro Majadahonda, Madrid 28222, Spain.
   [Concepcion Casado, Maria] Univ Alcala De Henares, Didact Dept, Guadalajara 19001, Spain.
RP Claramunt, R (reprint author), Univ Politecn Madrid, ETSI Ind, Dept Struct Mech, C Jose Gutierrez Abascal 2, E-28006 Madrid, Spain.
EM rclaramunt@etsii.upm.es
FU Ministerio de Ciencia e Innovacion (Spain) [MAT2009-10258]
FX This work has been funded by MAT2009-10258 project from Ministerio de
   Ciencia e Innovacion (Spain). The authors wish to thank Ms. Silvia
   Claramunt and Ms. Rachel Kelly for the review of the original in
   English.
CR BECK JR, 1986, ARCH PATHOL LAB MED, V110, P13
   Bernacca GM, 2002, J BIOMED MATER RES, V61, P138, DOI 10.1002/jbm.10149
   Bernacca GM, 2002, BIOMATERIALS, V23, P45, DOI 10.1016/S0142-9612(01)00077-1
   Braile DM, 1998, J HEART VALVE DIS, V7, P202
   CANNEGIETER SC, 1994, CIRCULATION, V89, P635, DOI 10.1161/01.CIR.89.2.635
   Carrera San Martin A, 1998, J Biomed Mater Res, V39, P568
   Claramunt R, 2011, J MECH BEHAV BIOMED, V4, P1929, DOI 10.1016/j.jmbbm.2011.06.009
   Ellsmere JC, 1999, BIOMATERIALS, V20, P1143, DOI 10.1016/S0142-9612(99)00013-7
   Hiester ED, 1998, J BIOMED MATER RES, V39, P215, DOI 10.1002/(SICI)1097-4636(199802)39:2<215::AID-JBM7>3.0.CO;2-S
   Hiester ED, 1998, J BIOMED MATER RES, V39, P207, DOI 10.1002/(SICI)1097-4636(199802)39:2<207::AID-JBM6>3.0.CO;2-T
   Jennings LM, 2002, ANN THORAC SURG, V74, P63, DOI 10.1016/S0003-4975(02)03617-2
   Kent PD, 1998, CARDIOVASC PATHOL, V7, P9, DOI 10.1016/S1054-8807(97)00040-9
   Paez J.M. Garcia, 2002, J BIOMATER APPL, V2, P105
   Paez J.M. Garcia, 2002, J BIOMATER APPL, V2, P85
   Paez JMG, 2000, J BIOMATER APPL, V15, P47
   Paez JMG, 2006, J BIOMED MATER RES A, V77A, P839, DOI 10.1002/jbm.a.30650
   Paez JMG, 2004, J BIOMED MATER RES B, V69B, P125, DOI 10.1002/jbm.b.20014
   Paez JMG, 2003, BIOMATERIALS, V24, P1671, DOI 10.1016/S0142-9612(02)00536-7
   Paez JMG, 2002, J BIOMED MATER RES, V62, P73, DOI 10.1002/jbm.10266
   Paez JMG, 2001, BIOMATERIALS, V22, P2731
   Sacks M S, 1994, ASAIO J, V40, pM632, DOI 10.1097/00002480-199407000-00075
   Sellaro TL, 2007, J BIOMED MATER RES A, V80A, P194, DOI 10.1002/jbm.a.30871
   SIMIONESCU D, 1993, J BIOMED MATER RES, V27, P697, DOI 10.1002/jbm.820270602
   THUBRIKAR MJ, 1983, J THORAC CARDIOV SUR, V86, P115
   Timoshenko S., 1970, RESISTENCIA MAT, VII, P398
   TYERS GFO, 1995, ANN THORAC SURG, V60, pS464
   Vesely I, 2003, CARDIOVASC PATHOL, V12, P277, DOI 10.1016/S1054-8807(03)00075-9
   Vesely I, 2001, J HEART VALVE DIS, V10, P471
   Vongpatanasin W, 1996, NEW ENGL J MED, V335, P407, DOI 10.1056/NEJM199608083350607
   Zhang G., 2005, Journal of Musculoskeletal & Neuronal Interactions, V5, P85
NR 30
TC 2
Z9 2
U1 2
U2 7
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0928-4931
J9 MAT SCI ENG C-MATER
JI Mater. Sci. Eng. C-Mater. Biol. Appl.
PD AUG 1
PY 2012
VL 32
IS 6
BP 1415
EP 1420
DI 10.1016/j.msec.2012.04.020
PG 6
WC Materials Science, Biomaterials
SC Materials Science
GA 969BO
UT WOS:000306030900014
PM 24364940
DA 2018-10-19
ER

PT J
AU Maiolo, AS
   Amado, MN
   Gonzalez, JS
   Alvarez, VA
AF Sebastian Maiolo, Adolfo
   Nicolas Amado, Matias
   Soledad Gonzalez, Jimena
   Alejandra Alvarez, Vera
TI Development and characterization of Poly (vinyl alcohol) based hydrogels
   for potential use as an articular cartilage replacement
SO MATERIALS SCIENCE & ENGINEERING C-MATERIALS FOR BIOLOGICAL APPLICATIONS
LA English
DT Article
DE Poly (vinyl alcohol); Hydroxyapatite; Hydrogel; Cartilage replacement
ID DIFFERENTIAL SCANNING CALORIMETRY; ARTIFICIAL KNEE-JOINT; POLY(VINYL
   ALCOHOL); COMPOSITE HYDROGEL; UNCONFINED COMPRESSION;
   MECHANICAL-PROPERTIES; PVA HYDROGEL; FRICTION; HYDROXYAPATITE; BEHAVIOR
AB Hydroxyapatite (HA) reinforced Poly(vinyl alcohol) (PVA) hydrogel composites has been proposed as a promising biomaterial to replace diseased or damaged articular cartilage. Here, PVA/in-situ produced HA hydrogels with 0,3 and 7.5 wt.% of HA content were obtained by freezing/thawing technique. Thermal, structural and mechanical characterizations were carried out. SEM micrographs revealed that HA was homogeneously distributed in PVA until 3 wt.% whereas partial agglomeration was observed for higher contents (7.5 wt.%). No significant changes were observed in the glass transition temperature (the average value was near to 78 degrees C +/- 3 degrees C), the melting point and structural water content whereas the gel fraction slightly increased (from 0.72 to 0.78) with the increase the content of HA. The absorbed water decreased (from 85.7% to 80.5%) as a function of HA content The stress-strain curves were really different in hydrated and non-hydrated conditions, changing from non-linear, in presence of water, to linear behavior in a dried state, being in the first case consistent with the articular cartilage. The lowest friction coefficient was obtained for samples with 3 wt % HA (0.067 +/- 0.049), which is, together with a high resistance (721 +/- 25 kPa), an important property for materials that will be used as articular replacement. The results indicate that this hydrogel could be used, after other studies, as articular cartilage replacement. (C) 2012 Published by Elsevier B.V.
C1 [Sebastian Maiolo, Adolfo; Nicolas Amado, Matias; Soledad Gonzalez, Jimena; Alejandra Alvarez, Vera] Natl Univ Mar del Plata, Fac Engn, CoMP Composite Mat Grp, Res Inst Mat Sci & Technol INTEMA, RA-4302 Mar Del Plata, Juan B Justo, Argentina.
RP Alvarez, VA (reprint author), Natl Univ Mar del Plata, Fac Engn, CoMP Composite Mat Grp, Res Inst Mat Sci & Technol INTEMA, B7608FDQ, RA-4302 Mar Del Plata, Juan B Justo, Argentina.
EM alvarezvera@fi.mdp.edu.ar
FU CONICET (National Scientific and Technical Research Council); ANPCyT
   (National Agency of Scientific and Technology Promotion); UNMdP
   (National University of Mar del Plata)
FX This study was supported by CONICET (National Scientific and Technical
   Research Council), ANPCyT (National Agency of Scientific and Technology
   Promotion) and UNMdP (National University of Mar del Plata).
CR Ahn ES, 2001, NANO LETT, V1, P149, DOI 10.1021/nl0055299
   Almarza AJ, 2004, ANN BIOMED ENG, V32, P2, DOI 10.1023/B:ABME.0000007786.37957.65
   Arnoczky S.P., 1992, GROSS VASCULAR ANATO, P1
   Auger D D, 1995, Proc Inst Mech Eng H, V209, P73, DOI 10.1243/PIME_PROC_1995_209_323_02
   Azuma C, 2007, J BIOMED MATER RES A, V81A, P373, DOI 10.1002/jbm.a.31043
   Cai YR, 2007, J MATER CHEM, V17, P3780, DOI 10.1039/b705129h
   CHA WI, 1993, MAKROMOL CHEM, V194, P2433
   Chanda A, 1997, CERAM INT, V23, P437, DOI 10.1016/S0272-8842(96)00052-1
   Chen SS, 2001, OSTEOARTHR CARTILAGE, V9, P561, DOI 10.1053/joca.2001.0424
   Cho HJ, 2004, MATER CHEM PHYS, V88, P9, DOI 10.1016/j.matchemphys.2003.10.021
   Cui WU, 2007, J BIOMED MATER RES A, V82A, P831, DOI 10.1002/jbm.a.31187
   Eyrich D, 2007, BIOMATERIALS, V28, P55, DOI 10.1016/j.biomaterials.2006.08.027
   FITHIAN DC, 1990, CLIN ORTHOP RELAT R, P19
   Grant C, 2006, BIOTECHNOL PROGR, V22, P1400, DOI 10.1021/bp060181u
   Gratz R., 2006, J BIOMECH, V39, P138
   Guha A, 2010, BIOINSPIR BIOMIM, V5, DOI 10.1088/1748-3182/5/2/024001
   Hartmut F., 2003, MAT SCI ENG C, V23, P763
   Holloway JL, 2010, ACTA BIOMATER, V6, P4716, DOI 10.1016/j.actbio.2010.06.025
   Huang CY, 2005, J BIOMECH, V38, P799, DOI 10.1016/j.jbiomech.2004.05.006
   Huang H. Y., 1997, CLIN NEUROL NEUROSUR, V99, P20
   Huang X, 2009, MATER RES INNOV, V13, P98, DOI 10.1179/143307509X435187
   Jilie K., 2008, SMART POLYM APPL BIO
   KEMPSON GE, 1979, ADULT ARTICULAR CART, P333
   Kobayashi M, 2005, BIOMATERIALS, V26, P3243, DOI 10.1016/j.biomaterials.2004.08.028
   Kokabi M, 2007, EUR POLYM J, V43, P773, DOI 10.1016/j.eurpolymj.2006.11.030
   Korhonen RK, 2010, MED ENG PHYS, V32, P155, DOI 10.1016/j.medengphy.2009.11.004
   Ma R., 2010, MAT SCI ENG C, V29, P1979
   Mallapragada SK, 1996, J POLYM SCI POL PHYS, V34, P1339, DOI 10.1002/(SICI)1099-0488(199605)34:7<1339::AID-POLB15>3.0.CO;2-B
   Mow Van C., 1997, P113
   NOGUCHI T, 1991, J APPL BIOMATER, V2, P101, DOI 10.1002/jab.770020205
   Pan YS, 2006, J CENT SOUTH UNIV T, V13, P27, DOI 10.1007/s11771-006-0101-x
   Pan YS, 2007, WEAR, V262, P1021, DOI 10.1016/j.wear.2006.10.005
   [潘育松 Pan Yusong], 2006, [摩擦学学报, Tribology], V26, P188
   Pan YS, 2007, KEY ENG MATER, V330-332, P1297, DOI 10.4028/www.scientific.net/KEM.330-332.1297
   Pan YS, 2010, J WUHAN UNIV TECHNOL, V25, P474, DOI 10.1007/s11595-010-0026-y
   Pan YS, 2009, J MATER SCI-MATER M, V20, P1291, DOI 10.1007/s10856-008-3679-8
   Pan YS, 2009, WEAR, V266, P699, DOI 10.1016/j.wear.2008.08.012
   Park S, 2004, OSTEOARTHR CARTILAGE, V12, P65, DOI 10.1016/j.joca.2003.08.005
   PEPPAS NA, 1976, J APPL POLYM SCI, V20, P1457, DOI 10.1002/app.1976.070200604
   PEPPAS NA, 1977, J BIOMED MATER RES, V11, P423, DOI 10.1002/jbm.820110309
   Gonzalez JS, 2011, THERMOCHIM ACTA, V521, P184, DOI 10.1016/j.tca.2011.04.022
   Stammen JA, 2001, BIOMATERIALS, V22, P799, DOI 10.1016/S0142-9612(00)00242-8
   Suciu AN, 2004, JSME INT J C-MECH SY, V47, P209, DOI 10.1299/jsmec.47.209
   Suciu AN, 2004, JSME INT J C-MECH SY, V47, P199, DOI 10.1299/jsmec.47.199
   Wu W, 2007, J BIOMECH, V40, P2580, DOI 10.1016/j.jbiomech.2006.11.009
   Yang CC, 2009, THIN SOLID FILMS, V517, P4735, DOI 10.1016/j.tsf.2009.03.138
   Zhang DK, 2009, J BIONIC ENG, V6, P22, DOI 10.1016/S1672-6529(08)60093-1
   Zhang DK, 2010, J BIONIC ENG, V7, P235, DOI 10.1016/S1672-6529(10)60246-6
NR 48
TC 26
Z9 31
U1 1
U2 81
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0928-4931
J9 MAT SCI ENG C-MATER
JI Mater. Sci. Eng. C-Mater. Biol. Appl.
PD AUG 1
PY 2012
VL 32
IS 6
BP 1490
EP 1495
DI 10.1016/j.msec.2012.04.030
PG 6
WC Materials Science, Biomaterials
SC Materials Science
GA 969BO
UT WOS:000306030900024
PM 24364950
DA 2018-10-19
ER

PT J
AU Cimpean, A
   Mitran, V
   Ciofrangeanu, CM
   Galateanu, B
   Bertrand, E
   Gordin, DM
   Iordachescu, D
   Gloriant, T
AF Cimpean, Anisoara
   Mitran, Valentina
   Ciofrangeanu, Cristina M.
   Galateanu, Bianca
   Bertrand, Emmanuel
   Gordin, Doina-Margareta
   Iordachescu, Dana
   Gloriant, Thierry
TI Osteoblast cell behavior on the new beta-type Ti-25Ta-25Nb alloy
SO MATERIALS SCIENCE & ENGINEERING C-MATERIALS FOR BIOLOGICAL APPLICATIONS
LA English
DT Article
DE Beta-titanium alloy; Cytocompatibility; Osteoblast; Morphology;
   Adhesion; Proliferation
ID TITANIUM-ALLOYS; BIOMEDICAL APPLICATIONS; ORTHOPEDIC IMPLANTS;
   SURFACE-TOPOGRAPHY; NUCLEAR ANTIGEN; FIBROBLASTS; PROLIFERATION;
   ADHESION; TI6AL4V; CYTOTOXICITY
AB Among metallic materials used as bone substitutes, beta titanium alloys gain an increasing importance because of their low modulus, high corrosion resistance and good biocompatibility. In this work, an investigation of the in vitro cytocompatibility of a recently new developed beta-type Ti-25Ta-25Nb alloy was carried out by evaluating the behavior of human osteoblasts. The metallic Ti-6Al-4V biomaterial, which is one of representative alpha + beta type titanium alloys for biomedical applications, and Tissue Culture Polystyrene (TCPS), were also investigated as reference Ti-based material and control substrate, respectively. Both metallic surfaces were analyzed by X-ray diffraction, atomic force microscopy and X-ray photoelectron spectroscopy. The cellular response was quantified by assessments of viability, cell attachment and spreading, cell morphology, production and extracellular organization of fibronectin and cell proliferation. Polished surfaces from both materials having an equiaxed grain microstructure and nanometre scale surface roughness elicited an essentially identical osteoblast response in terms of all analyzed cellular parameters. Thus, on both surfaces the cells displayed high survival rates, good cell adhesion and spreading, a dense and randomly dispersed fibronectin matrix and increasing cell proliferation rates over the incubation time. Furhermore, the enhanced biological performance of Ti-25Ta-25Nb was highly supported by the results obtained in comparison with TCPS. These findings, together with previously shown superelastic behavior, low Young's modulus and high corrosion resistance, recommend Ti-25Ta-25Nb as good candidate for applications in bone implantology. (c) 2012 Elsevier B.V. All rights reserved.
C1 [Cimpean, Anisoara; Mitran, Valentina; Ciofrangeanu, Cristina M.; Galateanu, Bianca; Iordachescu, Dana] Univ Bucharest, Dept Biochem & Mol Biol, Bucharest 050095, Romania.
   [Bertrand, Emmanuel; Gordin, Doina-Margareta; Gloriant, Thierry] INSA Rennes, CNRS, UMR SCR Chim Met 6226, F-35043 Rennes, France.
RP Cimpean, A (reprint author), Univ Bucharest, Dept Biochem & Mol Biol, 91-95 Spl Independentei, Bucharest 050095, Romania.
EM anisoara.cimpean@bio.unibuc.ro
RI Galateanu, Bianca/D-1632-2015; Cimpean, Anisoara/C-2101-2011
OI Galateanu, Bianca/0000-0001-8093-1750; Cimpean,
   Anisoara/0000-0002-5833-3110; Gordin, Doina
   Margareta/0000-0003-2200-9930; Mitran, Valentina/0000-0002-5192-9595;
   BERTRAND, Emmanuel/0000-0002-2478-495X
FU Eureka/MNT ERA-Net European consortium, Project "NanoBioAll" Advanced
   Metallic Biomaterials, Nano-Structured, for Implantable Medical Devices
   [MNT-7-017/2009]
FX This research was funded in the frame of a Eureka/MNT ERA-Net European
   consortium, Project "NanoBioAll" Advanced Metallic Biomaterials,
   Nano-Structured, for Implantable Medical Devices (Grant No.
   MNT-7-017/2009). The authors are grateful to Dr. P. Osiceanu from
   Institute of Physical Chemistry "Ilie Murgulescu" of Romanian Academy,
   Bucharest (Romania) for XPS analysis.
CR Banerjee R, 2005, MAT SCI ENG C-BIO S, V25, P282, DOI 10.1016/j.msec.2004.12.010
   Bertrand E, 2010, J MECH BEHAV BIOMED, V3, P559, DOI 10.1016/j.jmbbm.2010.06.007
   BRAVO R, 1987, J CELL BIOL, V105, P1549, DOI 10.1083/jcb.105.4.1549
   Cimpean A, 2011, MATER CHEM PHYS, V125, P485, DOI 10.1016/j.matchemphys.2010.10.028
   Donato TAG, 2009, MAT SCI ENG C-BIO S, V29, P1365, DOI 10.1016/j.msec.2008.10.021
   Garcia-Alonso MC, 2003, BIOMATERIALS, V24, P19, DOI 10.1016/S0142-9612(02)00237-5
   Geetha M, 2009, PROG MATER SCI, V54, P397, DOI 10.1016/j.pmatsci.2008.06.004
   Geiger B, 2001, NAT REV MOL CELL BIO, V2, P793, DOI 10.1038/35099066
   Gloriant T, 2006, ADV ENG MATER, V8, P961, DOI 10.1002/adem.200600106
   Gordin DM, 2004, J MATER SCI-MATER M, V15, P885, DOI 10.1023/B:JMSM.0000036276.32211.31
   Gordin DM, 2008, ADV ENG MATER, V10, P714, DOI 10.1002/adem.200800041
   Grinnell F, 1978, Int Rev Cytol, V53, P65
   HARRIS SA, 1995, J BONE MINER RES, V10, P178
   Kim Young-Min, 2009, J Adv Prosthodont, V1, P56, DOI 10.4047/jap.2009.1.1.56
   KURKI P, 1988, J IMMUNOL METHODS, V109, P49, DOI 10.1016/0022-1759(88)90441-3
   Lee TM, 2004, BIOMATERIALS, V25, P23, DOI 10.1016/S0142-9612(03)00465-4
   LINTER CM, 1985, BRIT J HOSP MED, V34, P361
   Loesberg WA, 2007, CELL MOTIL CYTOSKEL, V64, P174, DOI 10.1002/cm.20174
   Long M, 1998, BIOMATERIALS, V19, P1621, DOI 10.1016/S0142-9612(97)00146-4
   Luo Y, 2009, P I MECH ENG J-J ENG, V223, P311, DOI 10.1243/13506501JET488
   McCracken M, 1999, J Prosthodont, V8, P40, DOI 10.1111/j.1532-849X.1999.tb00006.x
   MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4
   Niinomi M, 2005, MAT SCI ENG C-BIO S, V25, P417, DOI 10.1016/j.msec.2005.01.024
   Niinomi M, 2003, SCI TECHNOL ADV MAT, V4, P445, DOI 10.1016/j.stam.2003.09.002
   Pankov R, 2002, J CELL SCI, V115, P3861, DOI 10.1242/jcs.00059
   Pegueroles M, 2010, ACTA BIOMATER, V6, P291, DOI 10.1016/j.actbio.2009.07.030
   Pohler OEM, 2000, INJURY, V31, pS7
   Ponsonnet L, 2002, MAT SCI ENG C-BIO S, V21, P157, DOI 10.1016/S0928-4931(02)00097-8
   Rack HJ, 2006, MAT SCI ENG C-BIO S, V26, P1269, DOI 10.1016/j.msec.2005.08.032
   Saito T, 2010, MAT SCI ENG C-MATER, V30, P1, DOI 10.1016/j.msec.2009.06.010
   SCHMALZ G, 1994, J DENT, V22, pS6, DOI 10.1016/0300-5712(94)90032-9
   Taddei EB, 2004, MAT SCI ENG C-BIO S, V24, P683, DOI 10.1016/j.msec.2004.08.011
   Takagi J, 2004, BIOCHEM SOC T, V32, P403, DOI 10.1042/BST0320403
   TAMADA Y, 1993, POLYMER, V34, P2208, DOI 10.1016/0032-3861(93)90752-V
   Tanaka Y, 2008, CORROS SCI, V50, P2111, DOI 10.1016/j.corsci.2008.06.002
   Tognarini I, 2008, BIOMATERIALS, V29, P809, DOI 10.1016/j.biomaterials.2007.10.043
   Vagaska B, 2010, PHYSIOL RES, V59, P309
   Wirth C, 2005, MAT SCI ENG C-BIO S, V25, P51, DOI 10.1016/j.msec.2004.06.001
   Zhao YK, 2006, J MATER SCI TECHNOL, V22, P205
NR 39
TC 18
Z9 18
U1 2
U2 32
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0928-4931
EI 1873-0191
J9 MAT SCI ENG C-MATER
JI Mater. Sci. Eng. C-Mater. Biol. Appl.
PD AUG 1
PY 2012
VL 32
IS 6
BP 1554
EP 1563
DI 10.1016/j.msec.2012.04.042
PG 10
WC Materials Science, Biomaterials
SC Materials Science
GA 969BO
UT WOS:000306030900034
PM 24364960
DA 2018-10-19
ER

PT J
AU Araujo, IMS
   Zampa, MF
   Moura, JB
   dos Santos, JR
   Eaton, P
   Zucolotto, V
   Veras, LMC
   de Paula, RCM
   Feitosa, JPA
   Leite, JRSA
   Eiras, C
AF Araujo, I. M. S.
   Zampa, M. F.
   Moura, J. B.
   dos Santos, J. R., Jr.
   Eaton, P.
   Zucolotto, V.
   Veras, L. M. C.
   de Paula, R. C. M.
   Feitosa, J. P. A.
   Leite, J. R. S. A.
   Eiras, C.
TI Contribution of the cashew gum (Anacardium occidentale L.) for
   development of layer-by-layer films with potential application in
   nanobiomedical devices
SO MATERIALS SCIENCE & ENGINEERING C-MATERIALS FOR BIOLOGICAL APPLICATIONS
LA English
DT Article
DE Cashew gum; Phthalocyanines; Dopamine detection; Layer-by-layer
ID POLYELECTROLYTE MULTILAYERS; EXUDATE POLYSACCHARIDE; RHEOLOGICAL
   PROPERTIES; SENSING APPLICATIONS; ADSORPTION; PHTHALOCYANINES;
   BIOSENSOR; ARRAY
AB The search for bioactive molecules to be employed as recognition elements in biosensors has stimulated researchers to pore over the rich Brazilian biodiversity. In this sense, we introduce the use of natural cashew gum (Anacardium occidentale L) as an active biomaterial to be used in the form of layer-by-layer films, in conjunction with phthalocyanines, which were tested as electrochemical sensors for dopamine detection. We investigated the effects of chemical composition of cashew gum from two different regions of Brazil (Piaui and Ceara states) on the physico-chemical characteristics of these nanostructures. The morphology of the nanostructures containing cashew gum was studied by atomic force microscopy which indicates that smooth films punctuated by globular features were formed that showed low roughness values. The results indicate that, independent of the origin, cashew gum stands out as an excellent film forming material with potential application in nanobiomedical devices as electrochemical sensors. (c) 2012 Elsevier B.V. All rights reserved.
C1 [Araujo, I. M. S.; Zampa, M. F.; Veras, L. M. C.; Leite, J. R. S. A.; Eiras, C.] Univ Fed Piaui, UFPI, Nucleo Pesquisa Biodiversidade & Biotecnol, BIOTEC, BR-64202020 Parnaiba, PI, Brazil.
   [Araujo, I. M. S.; Moura, J. B.; dos Santos, J. R., Jr.] Univ Fed Piaui, UFPI, CCN, Dept Quim, BR-64049550 Teresina, PI, Brazil.
   [Zampa, M. F.] IFPI, Inst Fed Educ Ciencia & Tecnol Piaui, BR-64210260 Parnaiba, PI, Brazil.
   [Eaton, P.] Univ Porto, Fac Ciencias, REQUIMTE, P-4169007 Oporto, Portugal.
   [Zucolotto, V.] Univ Sao Paulo, IFSC, Grp Biofis Mol Sergio Mascarenhas, BR-13566590 Sao Carlos, SP, Brazil.
   [de Paula, R. C. M.; Feitosa, J. P. A.] Univ Fed Ceara, Dept Quim Organ & Inorgan, BR-60455760 Fortaleza, Ceara, Brazil.
RP Eiras, C (reprint author), Univ Fed Piaui, UFPI, Nucleo Pesquisa Biodiversidade & Biotecnol, BIOTEC, CMRV, BR-64202020 Parnaiba, PI, Brazil.
EM carla.eiras.ufpi@gmail.com
RI Chaves, Pedro/K-1288-2013; Eiras, Carla/G-3156-2012; REQUIMTE,
   AL/H-9106-2013; REQUIMTE, FMN/M-5611-2013; Eaton, Peter/B-4906-2008; Sao
   Carlos Institute of Physics, IFSC/USP/M-2664-2016; Inomat,
   Inct/H-9989-2013; REQUIMTE, UCIBIO/N-9846-2013
OI Eiras, Carla/0000-0001-8861-774X; Eaton, Peter/0000-0003-1821-1992;
   Zucolotto, Valtencir/0000-0003-4307-3077
FU Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq,
   Brazil-"Consolidacao Novos Campi") [503495/2009-3]; Nanobiomed Network
   CAPES, Brazil; FAPEPI [20.203.0637/2008]; FAPESP; CNPq [577.355/2008-2];
   IFPI/Pro-Agrupar [16-2010]; Nanobiomed Network CAPES Brazil; IMMP/MCT;
   INCT-INOMAT
FX We are grateful to the technical support from LAPETRO, UFPI. This study
   received financial support from Conselho Nacional de Desenvolvimento
   Cientifico e Tecnologico (CNPq, Brazil-"Consolidacao Novos Campi, 2009"
   processo 503495/2009-3) and Nanobiomed Network CAPES, Brazil. AFM
   results were obtained using the equipment at the CEMUP-Centro de
   Materiais da Universidade do Porto.; This work was supported by FAPEPI
   (20.203.0637/2008), FAPESP, CNPq (577.355/2008-2), IFPI/Pro-Agrupar
   (No16-2010), Nanobiomed Network CAPES Brazil, IMMP/MCT and INCT-INOMAT.
   No conflict of interest was reported by authors of this article.
CR Ariga K, 1997, J AM CHEM SOC, V119, P2224, DOI 10.1021/ja963442c
   Arya SK, 2008, BIOSENS BIOELECTRON, V23, P1083, DOI 10.1016/j.bios.2007.10.018
   da Cunha P.L.R., 2007, J BRAZIL CHEM SOC, V18, P85
   da Cunha PLR, 2009, QUIM NOVA, V32, P649, DOI 10.1590/S0100-40422009000300009
   Dahint R, 2007, BIOSENS BIOELECTRON, V22, P3174, DOI 10.1016/j.bios.2007.02.012
   de Paula RCM, 1998, POLYM INT, V45, P27, DOI 10.1002/(SICI)1097-0126(199801)45:1<27::AID-PI900>3.0.CO;2-9
   de Paula RCM, 2001, CARBOHYD POLYM, V44, P133, DOI 10.1016/S0144-8617(00)00213-7
   DECHER G, 1991, BER BUNSEN PHYS CHEM, V95, P1430, DOI 10.1002/bbpc.19910951122
   DEPAULA RCM, 1995, CARBOHYD POLYM, V26, P177, DOI 10.1016/0144-8617(95)00006-S
   Eiras C, 2010, J BIOMAT SCI-POLYM E, V21, P1533, DOI 10.1163/092050609X12519805626077
   Feldheim DL, 1996, J AM CHEM SOC, V118, P7640, DOI 10.1021/ja9612007
   Fowler JM, 2008, ELECTROCHEM COMMUN, V10, P1020, DOI 10.1016/j.elecom.2008.05.002
   GLYPHIS JP, 1988, PHYTOCHEMISTRY, V27, P743, DOI 10.1016/0031-9422(88)84086-X
   INTINI M, 1987, International Journal of Tropical Plant Diseases, V5, P115
   IRVINE JTS, 1989, J ELECTROANAL CHEM, V271, P161, DOI 10.1016/0022-0728(89)80072-5
   Kafi AKM, 2007, J NANOSCI NANOTECHNO, V7, P4005, DOI 10.1166/jnn.2007.095
   Kern W., 1984, SEMICOND INT, V4, P94
   Ladam G, 2000, BIOMACROMOLECULES, V1, P674, DOI 10.1021/bm005572q
   Lancas F. M., 2004, VALIDACAO METODOS CR
   LEZNOFF CC, 1989, PHTHALOCYANINES PROP
   Mehta M, 2007, BIOSENS BIOELECTRON, V23, P728, DOI 10.1016/j.bios.2007.08.011
   OLIVEIRA ON, 2002, HDB POLYELECTROLYTES, P1
   Oni J, 2001, ANAL CHIM ACTA, V434, P9, DOI 10.1016/S0003-2670(01)00822-4
   Pei RJ, 2001, BIOMACROMOLECULES, V2, P463, DOI 10.1021/bm0001289
   Picart C, 2002, P NATL ACAD SCI USA, V99, P12531, DOI 10.1073/pnas.202486099
   Rick J, 2006, BIOSENS BIOELECTRON, V22, P329, DOI 10.1016/j.bios.2006.04.007
   Thevenot DR, 1999, PURE APPL CHEM, V71, P2333, DOI 10.1351/pac199971122333
   Venton B. J., 2003, ANAL CHEM, V75, p414A
   Whistler R. L., 1993, IND GUMS POLYSACCHAR
   YAMANAKA H., 2009, BIOSSENSORES ELETROQ
   Zampa MF, 2007, BIOMACROMOLECULES, V8, P3408, DOI 10.1021/bm700528u
   Zucolotto V, 2006, SENSOR ACTUAT B-CHEM, V113, P809, DOI 10.1016/j.snb.2005.03.114
NR 32
TC 15
Z9 15
U1 1
U2 42
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0928-4931
J9 MAT SCI ENG C-MATER
JI Mater. Sci. Eng. C-Mater. Biol. Appl.
PD AUG 1
PY 2012
VL 32
IS 6
BP 1588
EP 1593
DI 10.1016/j.msec.2012.04.048
PG 6
WC Materials Science, Biomaterials
SC Materials Science
GA 969BO
UT WOS:000306030900038
PM 24364964
DA 2018-10-19
ER

PT J
AU Bryers, JD
   Giachelli, CM
   Ratner, BD
AF Bryers, James D.
   Giachelli, Cecilia M.
   Ratner, Buddy D.
TI Engineering biomaterials to integrate and heal: The biocompatibility
   paradigm shifts
SO BIOTECHNOLOGY AND BIOENGINEERING
LA English
DT Review
DE tissue regeneration; foreign body response; macrophage phenotype
ID GIANT-CELL FORMATION; ACUTE INFLAMMATORY RESPONSES; IMPLANTABLE GLUCOSE
   SENSORS; FOREIGN-BODY RESPONSE; SMOOTH-MUSCLE-CELLS; IN-VITRO; PROTEIN
   ADSORPTION; MACROPHAGE ACTIVATION; EXTRACELLULAR-MATRIX; ECTOPIC
   CALCIFICATION
AB This article focuses on one of the major failure routes of implanted medical devices, the foreign body reaction (FBR)that is, the phagocytic attack and encapsulation by the body of the so-called biocompatible biomaterials comprising the devices. We then review strategies currently under development that might lead to biomaterial constructs that will harmoniously heal and integrate into the body. We discuss in detail emerging strategies to inhibit the FBR by engineering biomaterials that elicit more biologically pertinent responses. Biotechnol. Bioeng. 2012; 109:18981911. (c) 2012 Wiley Periodicals, Inc.
C1 [Bryers, James D.; Giachelli, Cecilia M.; Ratner, Buddy D.] Univ Washington, Dept Bioengn, Seattle, WA 98195 USA.
RP Bryers, JD (reprint author), Univ Washington, Dept Bioengn, N310C Foege Hall,Box 355061, Seattle, WA 98195 USA.
EM jbryers@uw.edu
FU NIBIB NIH HHS [R01 EB007575]; NIAID NIH HHS [R56 AI084856]
CR AMIJI M, 1992, J BIOMAT SCI-POLYM E, V3, P375, DOI 10.1163/156856292X00196
   Anderson JM, 2008, SEMIN IMMUNOL, V20, P86, DOI 10.1016/j.smim.2007.11.004
   Anderson JM, 2001, ANNU REV MATER RES, V31, P81, DOI 10.1146/annurev.matsci.31.1.81
   ANDERSON JM, 1990, INT J ARTIF ORGANS, V13, P375
   ANDRADE JD, 1987, ANN NY ACAD SCI, V516, P158, DOI 10.1111/j.1749-6632.1987.tb33038.x
   Atzet S, 2008, BIOMACROMOLECULES, V9, P3370, DOI 10.1021/bm800686h
   BABU M, 1989, MOL CELL BIOL, V9, P1642, DOI 10.1128/MCB.9.4.1642
   Badylak SF, 2007, BIOMATERIALS, V28, P3587, DOI 10.1016/j.biomaterials.2007.04.043
   Beckstead BL, 2009, J BIOMED MATER RES A, V91A, P436, DOI 10.1002/jbm.a.32214
   Bensaid W, 2003, BIOMATERIALS, V24, P2497, DOI 10.1016/S0142-9612(02)00618-X
   Bergman AJ, 1999, BIOMATERIALS, V20, P2235, DOI 10.1016/S0142-9612(99)00154-4
   Bota PCS, 2010, J BIOMED MATER RES A, V95A, P649, DOI 10.1002/jbm.a.32893
   Bouhadir KH, 2001, BIOTECHNOL PROGR, V17, P945, DOI 10.1021/bp010070p
   BRAUKER JH, 1995, J BIOMED MATER RES, V29, P1517, DOI 10.1002/jbm.820291208
   Brodbeck WG, 2005, J BIOMED MATER RES A, V74A, P222, DOI 10.1002/jbm.a.30313
   Bruemmer D, 2003, CIRC RES, V93, pE38, DOI 10.1161/01.RES.0000088344.15288.E6
   Cai KY, 2002, J BIOMED MATER RES, V60, P398, DOI 10.1002/jbm.10008
   Chung TW, 2002, BIOMATERIALS, V23, P2827, DOI 10.1016/S0142-9612(01)00399-4
   CHVAPIL M, 1977, J BIOMED MATER RES, V11, P721, DOI 10.1002/jbm.820110508
   COTRAN RS, 1990, J AM SOC NEPHROL, V1, P225
   Cotran RS, 1999, PATHOLOGIC BASIS DIS
   Dantzer E, 2001, BRIT J PLAST SURG, V54, P659, DOI 10.1054/bjps.2001.3684
   Dar A, 2002, BIOTECHNOL BIOENG, V80, P305, DOI 10.1002/bit.10372
   Denuziere A, 1998, BIOMATERIALS, V19, P1275, DOI 10.1016/S0142-9612(98)00036-2
   DZIUK PJ, 1966, ENDOCRINOLOGY, V78, P208, DOI 10.1210/endo-78-1-208
   Edmondson S, 2004, CHEM SOC REV, V33, P14, DOI 10.1039/b210143m
   ENGELBERG I, 1991, BIOMATERIALS, V12, P292, DOI 10.1016/0142-9612(91)90037-B
   Fukano Y, 2010, J BIOMED MATER RES A, V94A, P1172, DOI 10.1002/jbm.a.32798
   Fukano Y, 2006, WOUND REPAIR REGEN, V14, P484, DOI 10.1111/j.1743-6109.2006.00138.x
   GALLIN JI, 1999, INFLAMMATION BASIC P
   Gao JM, 1998, J BIOMED MATER RES, V42, P417, DOI 10.1002/(SICI)1097-4636(19981205)42:3<417::AID-JBM11>3.3.CO;2-N
   Geelhood SJ, 2007, J BIOMED MATER RES B, V81B, P251, DOI 10.1002/jbm.b.30660
   Giachelli CM, 1998, AM J PATHOL, V152, P353
   Gordon S, 2003, NAT REV IMMUNOL, V3, P23, DOI 10.1038/nri978
   Goreish HH, 2004, J BIOMED MATER RES A, V68A, P1, DOI 10.1002/jbm.a.10141
   Gratchev A, 2006, IMMUNOBIOLOGY, V211, P473, DOI 10.1016/j.imbio.2006.05.017
   Gunatillake Pathiraja A., 2003, European Cells & Materials, V5, P1
   HENSON PM, 1980, AM J PATHOL, V101, P494
   HENSON PM, 1971, J IMMUNOL, V107, P1535
   HENSON PM, 1987, J CLIN INVEST, V79, P669, DOI 10.1172/JCI112869
   Hoffman AS, 2002, ADV DRUG DELIVER REV, V54, P3, DOI 10.1016/S0169-409X(01)00239-3
   Hu WJ, 2001, BLOOD, V98, P1231, DOI 10.1182/blood.V98.4.1231
   Huang Y, 2005, BIOMATERIALS, V26, P7616, DOI 10.1016/j.biomaterials.2005.05.036
   Hume DA, 2002, J LEUKOCYTE BIOL, V72, P621
   Hutmacher DW, 2001, J BIOMED MATER RES, V55, P203, DOI 10.1002/1097-4636(200105)55:2<203::AID-JBM1007>3.3.CO;2-Z
   Isenhath SN, 2007, J BIOMED MATER RES A, V83A, P915, DOI 10.1002/jbm.a.31391
   Iwasaki Y, 1998, J BIOMAT SCI-POLYM E, V9, P801, DOI 10.1163/156856298X00163
   Jabs A, 2005, J VASC RES, V42, P174, DOI 10.1159/000084406
   Jay SM, 2007, AM J PATHOL, V171, P632, DOI 10.2353/ajpath.2007.061213
   Jockenhoevel S, 2001, THORAC CARDIOV SURG, V49, P287, DOI 10.1055/s-2001-17807
   JOHNSTON RB, 1988, NEW ENGL J MED, V318, P747, DOI 10.1056/NEJM198803243181205
   Jono S, 2000, J BIOL CHEM, V275, P20197, DOI 10.1074/jbc.M909174199
   Kao WYJ, 1999, BIOMATERIALS, V20, P2213, DOI 10.1016/S0142-9612(99)00152-0
   KARP RD, 1973, J NATL CANCER I, V51, P1275, DOI 10.1093/jnci/51.4.1275
   Keselowsky BG, 2007, BIOMATERIALS, V28, P3626, DOI 10.1016/j.biomaterials.2007.04.035
   Kessler PD, 1999, ANNU REV PHYSIOL, V61, P219, DOI 10.1146/annurev.physiol.61.1.219
   Kingshott P, 1999, CURR OPIN SOLID ST M, V4, P403, DOI 10.1016/S1359-0286(99)00018-2
   Knowles NG, 2005, J BIOMED MATER RES A, V74A, P482, DOI 10.1002/jbm.a.30384
   Kopecek J, 2007, BIOMATERIALS, V28, P5185, DOI 10.1016/j.biomaterials.2007.07.044
   Kudo H, 2006, BIOSENS BIOELECTRON, V22, P558, DOI 10.1016/j.bios.2006.05.006
   Kumar TRS, 2001, BIOMATERIALS, V22, P2769
   Kuwana M, 2006, STEM CELLS, V24, P2733, DOI 10.1634/stemcells.2006-0026
   Kyriakides TR, 2004, AM J PATHOL, V165, P2157, DOI 10.1016/S0002-9440(10)63265-8
   Kyriakides TR, 2001, MOL THER, V3, P842, DOI 10.1006/mthe.2001.0336
   Lahiji A, 2000, J BIOMED MATER RES, V51, P586
   Lavik Erin, 2002, Methods Mol Biol, V198, P89
   LEHRER RI, 1988, ANN INTERN MED, V109, P127, DOI 10.7326/0003-4819-109-2-127
   Liaw L, 1998, J CLIN INVEST, V101, P1468
   Lindahl U, 1998, J BIOL CHEM, V273, P24979, DOI 10.1074/jbc.273.39.24979
   Linnes MP, 2007, BIOMATERIALS, V28, P5298, DOI 10.1016/j.biomaterials.2007.08.020
   Lowry KJ, 1997, J BIOMED MATER RES, V36, P536
   Madden LR, 2010, P NATL ACAD SCI USA, V107, P15211, DOI 10.1073/pnas.1006442107
   Madihally SV, 1999, BIOMATERIALS, V20, P1133, DOI 10.1016/S0142-9612(99)00011-3
   Malafaya PB, 2007, ADV DRUG DELIVER REV, V59, P207, DOI 10.1016/j.addr.2007.03.012
   MALECH HL, 1987, NEW ENGL J MED, V317, P687, DOI 10.1056/NEJM198709103171107
   Mantovani A, 2004, TRENDS IMMUNOL, V25, P677, DOI 10.1016/j.it.2004.09.015
   Mao JS, 2003, BIOMATERIALS, V24, P1621, DOI 10.1016/S0142-9612(02)00549-5
   Marra KG, 1999, J BIOMED MATER RES, V47, P324, DOI 10.1002/(SICI)1097-4636(19991205)47:3<324::AID-JBM6>3.0.CO;2-Y
   Marshall A. J., 2004, ACS POLYM PREPR, V45, P100
   Martin P, 2005, TRENDS CELL BIOL, V15, P599, DOI 10.1016/j.tcb.2005.09.002
   Mekori YA, 2000, IMMUNOL REV, V173, P131, DOI 10.1034/j.1600-065X.2000.917305.x
   Mendelsohn JD, 2003, BIOMACROMOLECULES, V4, P96, DOI 10.1021/bm0256101
   Michel R, 2005, LANGMUIR, V21, P12327, DOI 10.1021/la051726h
   MIKOS AG, 1994, POLYMER, V35, P1068, DOI 10.1016/0032-3861(94)90953-9
   Mizuno K, 2003, J BIOMED MATER RES A, V64A, P177, DOI 10.1002/jbm.a.10396
   MOONEY D, 1992, J CELL PHYSIOL, V151, P497, DOI 10.1002/jcp.1041510308
   Mooney DJ, 1996, BIOMATERIALS, V17, P1417, DOI 10.1016/0142-9612(96)87284-X
   Mooney DT, 1996, BIOMATERIALS, V17, P115, DOI 10.1016/0142-9612(96)85756-5
   Mooney JE, 2010, AM J PATHOL, V176, P369, DOI 10.2353/ajpath.2010.090545
   Mori R, 2008, J EXP MED, V205, P43, DOI 10.1084/jem.20071412
   Morra M, 2000, J BIOMAT SCI-POLYM E, V11, P547, DOI 10.1163/156856200743869
   Mosser DM, 2008, NAT REV IMMUNOL, V8, P958, DOI 10.1038/nri2448
   Mosser DM, 2003, J LEUKOCYTE BIOL, V73, P209, DOI 10.1189/jlb.0602325
   Munder M, 1998, J IMMUNOL, V160, P5347
   Murray PJ, 2006, CURR OPIN PHARMACOL, V6, P379, DOI 10.1016/j.coph.2006.01.010
   Mytar B, 1999, BRIT J CANCER, V79, P737, DOI 10.1038/sj.bjc.6690118
   NAKAMURA T, 1989, J BIOMED MATER RES, V23, P1115, DOI 10.1002/jbm.820231003
   Nath N, 2002, ADV MATER, V14, P1243, DOI 10.1002/1521-4095(20020903)14:17<1243::AID-ADMA1243>3.0.CO;2-M
   Nayak S, 2004, ANGEW CHEM INT EDIT, V43, P6706, DOI 10.1002/anie.200461090
   Nolan CM, 2005, BIOMACROMOLECULES, V6, P2032, DOI 10.1021/bm0500087
   Oberpenning F, 1999, NAT BIOTECHNOL, V17, P149
   Ohri R, 2005, CALCIFIED TISSUE INT, V76, P307, DOI 10.1007/s00223-004-0071-7
   Ophascharoensuk V, 1999, KIDNEY INT, V56, P571, DOI 10.1046/j.1523-1755.1999.00580.x
   Orgill DP, 1999, ANN NY ACAD SCI, V888, P233, DOI 10.1111/j.1749-6632.1999.tb07959.x
   Osathanon T, 2008, BIOMATERIALS, V29, P4091, DOI 10.1016/j.biomaterials.2008.06.030
   Osathanon T, 2009, BIOMATERIALS, V30, P4513, DOI 10.1016/j.biomaterials.2009.05.022
   Ozawa T, 2002, J THORAC CARDIOV SUR, V124, P1157, DOI 10.1067/mtc.2002.127449
   Panzer U, 2001, KIDNEY INT, V59, P1762, DOI 10.1046/j.1523-1755.2001.0590051762.x
   Park JH, 2003, J BIOMED MATER RES A, V64A, P309
   Pattison MA, 2005, BIOMATERIALS, V26, P2491, DOI 10.1016/j.biomaterials.2004.07.011
   Persy VP, 2003, KIDNEY INT, V63, P543, DOI 10.1046/j.1523-1755.2003.00767.x
   Picha GJ, 1996, J BIOMED MATER RES, V30, P305
   Pieper JS, 2002, J BIOMED MATER RES, V62, P185, DOI 10.1002/jbm.10267
   POBER JS, 1990, TRANSPLANTATION, V50, P537, DOI 10.1097/00007890-199010000-00001
   Prichard HL, 2007, BIOMATERIALS, V28, P936, DOI 10.1016/j.biomaterials.2006.09.012
   PRIME KL, 1993, J AM CHEM SOC, V115, P10714, DOI 10.1021/ja00076a032
   QUINN CP, 1995, BIOMATERIALS, V16, P389, DOI 10.1016/0142-9612(95)98856-9
   Rajachar RM, 2009, CARDIOVASC PATHOL, V18, P77, DOI 10.1016/j.carpath.2007.11.004
   Ratner BD, 1996, J MOL RECOGNIT, V9, P617, DOI 10.1002/(SICI)1099-1352(199634/12)9:5/6<617::AID-JMR310>3.0.CO;2-D
   Recum A F, 1996, Tissue Eng, V2, P241, DOI 10.1089/ten.1996.2.241
   Ronneberger B, 1996, J BIOMED MATER RES, V30, P31
   Rothenburger M, 2001, THORAC CARDIOV SURG, V49, P204, DOI 10.1055/s-2001-16108
   Saul JM, 2007, BIOMATERIALS, V28, P4705, DOI 10.1016/j.biomaterials.2007.07.026
   Savill J, 1996, BIOCHEM SOC T, V24, P1065, DOI 10.1042/bst0241065
   Schwartz BR, 1999, J IMMUNOL, V162, P4842
   Sharifi BG, 2006, ARTERIOSCL THROM VAS, V26, P1273, DOI 10.1161/01.ATV.0000222017.05085.8e
   Sharkawy AA, 1997, J BIOMED MATER RES, V37, P401
   Shen MC, 2002, J BIOMAT SCI-POLYM E, V13, P367, DOI 10.1163/156856202320253910
   Singh N, 2007, BIOMACROMOLECULES, V8, P3271, DOI 10.1021/bm700516v
   Singla A, 2002, J BIOMED MATER RES, V60, P368, DOI 10.1002/jbm.10077
   Spilker MH, 2001, BIOMATERIALS, V22, P1085, DOI 10.1016/S0142-9612(00)00345-8
   STEIN M, 1992, J EXP MED, V176, P287, DOI 10.1084/jem.176.1.287
   Steitz SA, 2002, AM J PATHOL, V161, P2035, DOI 10.1016/S0002-9440(10)64482-3
   STOKES KB, 1988, PACE, V11, P1797, DOI 10.1111/j.1540-8159.1988.tb06312.x
   Szleifer I, 1997, CURR OPIN SOLID ST M, V2, P337, DOI 10.1016/S1359-0286(97)80125-8
   Szleifer I, 1997, PHYSICA A, V244, P370, DOI 10.1016/S0378-4371(97)00293-8
   Takahashi H, 2010, J CONTROL RELEASE, V147, P400, DOI 10.1016/j.jconrel.2010.08.019
   Tan W, 2001, TISSUE ENG, V7, P203, DOI 10.1089/107632701300062831
   TANG LP, 1993, J EXP MED, V178, P2147, DOI 10.1084/jem.178.6.2147
   Tang LP, 1998, P NATL ACAD SCI USA, V95, P8841, DOI 10.1073/pnas.95.15.8841
   Taylor PM, 2002, J HEART VALVE DIS, V11, P298
   Tsai AT, 2005, BIOMATERIALS, V26, P5835, DOI 10.1016/j.biomaterials.2005.03.003
   Unsworth LD, 2008, LANGMUIR, V24, P1924, DOI 10.1021/la702310t
   Unsworth LD, 2005, BIOMATERIALS, V26, P5927, DOI 10.1016/j.biomaterials.2005.03.010
   Verreck FAW, 2004, P NATL ACAD SCI USA, V101, P4560, DOI 10.1073/pnas.0400983101
   Vorotnikova E, 2010, MATRIX BIOL, V29, P690, DOI 10.1016/j.matbio.2010.08.007
   Wagner VE, 2004, J BIOMED MATER RES A, V69A, P79, DOI 10.1002/jbm.a.20115
   Wagner VE, 2004, BIOMATERIALS, V25, P2247, DOI 10.1016/j.biomaterials.2003.09.020
   Wang C, 2008, BIOMACROMOLECULES, V9, P561, DOI 10.1021/bm701102y
   Wang YC, 2004, FASEB J, V18, P525, DOI 10.1096/fj.03-0490fje
   WILLIAMS GT, 1983, J CLIN PATHOL, V36, P723, DOI 10.1136/jcp.36.7.723
   Wilson CJ, 2005, TISSUE ENG, V11, P1, DOI 10.1089/ten.2005.11.1
   Xia Z, 2006, BIOMED MATER, V1, pR1, DOI 10.1088/1748-6041/1/1/R01
   Yang J, 2002, BIOMATERIALS, V23, P471, DOI 10.1016/S0142-9612(01)00129-6
   Yang Y, 2000, BIOSENS BIOELECTRON, V15, P221, DOI 10.1016/S0956-5663(00)00082-8
   Yannas IV, 1997, ANN NY ACAD SCI, V831, P280
   YOKOYAMA M, 1986, J BIOMED MATER RES, V20, P867, DOI 10.1002/jbm.820200702
   Zaleskas JM, 2001, EXP CELL RES, V270, P21, DOI 10.1006/excr.2001.5325
   Zhang Z, 2008, BIOMATERIALS, V29, P4285, DOI 10.1016/j.biomaterials.2008.07.039
   Zhao B, 2000, PROG POLYM SCI, V25, P677, DOI 10.1016/S0079-6700(00)00012-5
   Zhu HG, 2002, J BIOMED MATER RES, V62, P532, DOI 10.1002/jbm.10313
NR 161
TC 95
Z9 96
U1 6
U2 157
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0006-3592
EI 1097-0290
J9 BIOTECHNOL BIOENG
JI Biotechnol. Bioeng.
PD AUG
PY 2012
VL 109
IS 8
BP 1898
EP 1911
DI 10.1002/bit.24559
PG 14
WC Biotechnology & Applied Microbiology
SC Biotechnology & Applied Microbiology
GA 961GE
UT WOS:000305451400003
PM 22592568
OA Green Accepted
DA 2018-10-19
ER

PT J
AU Vrana, NE
   Dupret-Bories, A
   Bach, C
   Chaubaroux, C
   Coraux, C
   Vautier, D
   Boulmedais, F
   Haikel, Y
   Debry, C
   Metz-Boutigue, MH
   Lavalle, P
AF Vrana, Nihal Engin
   Dupret-Bories, Agnes
   Bach, Charlotte
   Chaubaroux, Christophe
   Coraux, Christelle
   Vautier, Dominique
   Boulmedais, Fouzia
   Haikel, Youssef
   Debry, Christian
   Metz-Boutigue, Marie-Helene
   Lavalle, Philippe
TI Modification of macroporous titanium tracheal implants with
   biodegradable structures: Tracking in vivo integration for determination
   of optimal in situ epithelialization conditions
SO BIOTECHNOLOGY AND BIOENGINEERING
LA English
DT Article
DE titanium; trachea; implant; epithelialization; porosity; in vivo; CGA;
   collagen
ID POROUS-TITANIUM; SURVIVAL ANALYSIS; CHROMOGRANIN-A; RECONSTRUCTION;
   PROSTHESES; RABBITS; REPLACEMENT; FABRICATION; SCAFFOLDS; PROMOTES
AB Previously, we showed that macroporous titanium implants, colonized in vivo together with an epithelial graft, are viable options for tracheal replacement in sheep. To decrease the number of operating steps, biomaterial-based replacements for epithelial graft and intramuscular implantation were developed in the present study. Hybrid microporous PLLA/titanium tracheal implants were designed to decrease initial stenosis and provide a surface for epithelialization. They have been implanted in New Zealand white rabbits as tracheal substitutes and compared to intramuscular implantation samples. Moreover, a basement membrane like coating of the implant surface was also designed by Layer-by-Layer (LbL) method with collagen and alginate. The results showed that the commencement of stenosis can be prevented by the microporous PLLA. For determination of the optimum time point of epithelialization after implantation, HPLC analysis of blood samples, C-reactive protein (CRP), and Chromogranin A (CGA) analyses and histology were carried out. Following 3 weeks the implant would be ready for epithelialization with respect to the amount of tissue integration. Calcein-AM labeled epithelial cell seeding showed that after 3 weeks implant surfaces were suitable for their attachment. CRP readings were steady after an initial rise in the first week. Cross-linked collagen/alginate structures show nanofibrillarity and they form uniform films over the implant surfaces without damaging the microporosity of the PLLA body. Human respiratory epithelial cells proliferated and migrated on these surfaces which provided a better alternative to PLLA film surface. In conclusion, collagen/alginate LbL coated hybrid PLLA/titanium implants are viable options for tracheal replacement, together with in situ epithelialization. Biotechnol. Bioeng. 2012; 109:21342146. (c) 2012 Wiley Periodicals, Inc.
C1 [Vrana, Nihal Engin; Dupret-Bories, Agnes; Bach, Charlotte; Chaubaroux, Christophe; Vautier, Dominique; Haikel, Youssef; Debry, Christian; Metz-Boutigue, Marie-Helene; Lavalle, Philippe] INSERM, U977, F-67085 Strasbourg, France.
   [Dupret-Bories, Agnes; Debry, Christian] Hop Univ Strasbourg, Serv Otorhinolaryngol, F-67098 Strasbourg, France.
   [Bach, Charlotte; Vautier, Dominique; Haikel, Youssef; Metz-Boutigue, Marie-Helene; Lavalle, Philippe] Univ Strasbourg, Fac Chirurg Dent, F-67000 Strasbourg, France.
   [Coraux, Christelle] INSERM, U903, F-51092 Reims, France.
   [Boulmedais, Fouzia] CNRS, UPR 22, Inst Charles Sadron, F-67034 Strasbourg 2, France.
RP Lavalle, P (reprint author), INSERM, U977, 11 Rue Humann, F-67085 Strasbourg, France.
EM philippe.lavalle@inserm.fr
RI Lavalle, Philippe/E-6328-2016; Vrana, Nihal/A-2029-2010; Boulmedais,
   Fouzia/B-4657-2011; CORAUX, Christelle/P-5668-2016
OI Lavalle, Philippe/0000-0001-8798-912X; Vrana, Nihal/0000-0002-5398-6710;
   Boulmedais, Fouzia/0000-0002-4934-9276; CORAUX,
   Christelle/0000-0001-5345-5074; Dupret-Bories, Agnes/0000-0002-7068-3500
FU Region Alsace; PMNA (Pole Materiaux et Nanosciences d'Alsace)
FX Contract grant sponsor: Region Alsace; Contract grant sponsor: PMNA
   (Pole Materiaux et Nanosciences d'Alsace)
CR Alvarez H, 2008, J BIOMED MATER RES B, V85B, P93, DOI 10.1002/jbm.b.30921
   Bader A, 2010, J CELL MOL MED, V14, P1877, DOI 10.1111/j.1582-4934.2010.01073.x
   Colombo B, 2002, J BIOL CHEM, V277, P45911, DOI 10.1074/jbc.M202637200
   Delaere P, 2010, NEW ENGL J MED, V362, P138, DOI 10.1056/NEJMoa0810653
   Dupret-Bories A, 2011, J REHABIL RES DEV, V48, P851, DOI 10.1682/JRRD.2010.10.0194
   Fong E, 2010, P NATL ACAD SCI USA, V107, P19302, DOI 10.1073/pnas.1008291107
   Gasnier C, 2004, PROTEOMICS, V4, P1789, DOI 10.1002/pmic.200300693
   Go T, 2010, J THORAC CARDIOV SUR, V139, P437, DOI 10.1016/j.jtcvs.2009.10.002
   Goh YQ, 2008, J MATER SCI-MATER M, V19, P2445, DOI 10.1007/s10856-008-3366-9
   Grillo HC, 2002, ANN THORAC SURG, V73, P1995, DOI 10.1016/S0003-4975(02)03564-6
   Horuk R, 2001, IMMUNOL LETT, V76, P193, DOI 10.1016/S0165-2478(01)00172-9
   Hwang YJ, 2011, ACS APPL MATER INTER, V3, P2579, DOI 10.1021/am200416h
   Janssen LM, 2010, J TISSUE ENG REGEN M, V4, P395, DOI 10.1002/term.254
   Janssen LM, 2009, ARCH OTOLARYNGOL, V135, P472, DOI 10.1001/archoto.2009.29
   Kalathur M, 2010, CELL MOL LIFE SCI, V67, P4185, DOI 10.1007/s00018-010-0499-z
   LeSimple P, 2007, AM J RESP CELL MOL, V36, P296, DOI 10.1165/rcmb.2006-0270OC
   Lobler M, 2002, J BIOMED MATER RES, V61, P165, DOI 10.1002/jbm.10155
   Macchiarini P, 2008, LANCET, V372, P2023, DOI 10.1016/S0140-6736(08)61598-6
   Matschegewski C, 2010, BIOMATERIALS, V31, P5729, DOI 10.1016/j.biomaterials.2010.03.073
   Nakamura T, 2009, J THORAC CARDIOV SUR, V138, P811, DOI 10.1016/j.jtcvs.2008.07.072
   National Research Council, 2010, GUID CAR US LAB AN
   Nicole L, 2010, ADV MATER, V22, P3208, DOI 10.1002/adma.201000231
   Omori K, 2008, ANN OTO RHINOL LARYN, V117, P673, DOI 10.1177/000348940811700908
   Roomans Godfried M, 2010, Eur Cell Mater, V19, P284
   Rougier S, 2006, VET MICROBIOL, V115, P192, DOI 10.1016/j.vetmic.2006.02.003
   Ryan G, 2006, BIOMATERIALS, V27, P2651, DOI 10.1016/j.biomaterials.2005.12.002
   Sato T, 2010, J THORAC CARDIOV SUR, V139, P26, DOI 10.1016/j.jtcvs.2009.04.006
   Schultz P, 2007, EUR ARCH OTO-RHINO-L, V264, P433, DOI 10.1007/s00405-006-0195-7
   Schultz P, 2004, EUR ARCH OTO-RHINO-L, V261, P484, DOI 10.1007/s00405-003-0717-5
   Schultz P, 2002, ANN THORAC SURG, V73, P1747, DOI 10.1016/S0003-4975(02)03569-5
   Shearer H, 2006, TISSUE ENG, V12, P2717, DOI 10.1089/ten.2006.12.2717
   Shooshtarizadeh P, 2010, REGUL PEPTIDES, V165, P102, DOI 10.1016/j.regpep.2009.11.014
   Sundararaghavan HG, 2008, J BIOMED MATER RES A, V87A, P308, DOI 10.1002/jbm.a.31715
   Tatekawa Y, 2010, J SURG RES, V160, P114, DOI 10.1016/j.jss.2008.11.003
   ten Hallers EJO, 2004, BIOMATERIALS, V25, P1533, DOI 10.1016/S0142-9612(03)00500-3
   Tseng WC, 2005, ANAL CHIM ACTA, V543, P38, DOI 10.1016/j.aca.2005.04.048
   Vrana NE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020480
   Zhang D, 2009, ANN MED, V41, P38, DOI 10.1080/07853890802199791
NR 38
TC 12
Z9 12
U1 0
U2 24
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0006-3592
J9 BIOTECHNOL BIOENG
JI Biotechnol. Bioeng.
PD AUG
PY 2012
VL 109
IS 8
BP 2134
EP 2146
DI 10.1002/bit.24456
PG 13
WC Biotechnology & Applied Microbiology
SC Biotechnology & Applied Microbiology
GA 961GE
UT WOS:000305451400026
PM 22331657
DA 2018-10-19
ER

PT J
AU Karam, JP
   Muscari, C
   Montero-Menei, CN
AF Karam, Jean-Pierre
   Muscari, Claudio
   Montero-Menei, Claudia N.
TI Combining adult stem cells and polymeric devices for tissue engineering
   in infarcted myocardium
SO BIOMATERIALS
LA English
DT Review
DE Myocardial infarction; Tissue engineering; Adult stem cell; Biomimetic
   scaffolds; Pharmacologically active microcarrier
ID PHARMACOLOGICALLY ACTIVE MICROCARRIERS; NEONATAL-RAT CARDIOMYOCYTES;
   MESENCHYMAL-STROMAL CELLS; IMPROVES CARDIAC-FUNCTION; ENDOTHELIAL
   GROWTH-FACTOR; RGD MODIFIED ALGINATE; LONG-TERM SURVIVAL; IN-VIVO
   EVALUATION; PROGENITOR CELLS; HEART-FAILURE
AB An increasing number of studies in cardiac cell therapy have provided encouraging results for cardiac repair. Adult stem cells may overcome ethical and availability concerns, with the additional advantages, in some cases, to allow autologous grafts to be performed. However, the major problems of cell survival, cell fate determination and engraftment after transplantation, still remain. Tissue-engineering strategies combining scaffolds and cells have been developed and have to be adapted for each type of application to enhance stem cell function. Scaffold properties required for cardiac cell therapy are here discussed. New tissue engineering advances that may be implemented in combination with adult stem cells for myocardial infarction therapy are also presented. Biomaterials not only provide a 3D support for the cells but may also mimic the structural architecture of the heart. Using hydrogels or particulate systems, the biophysical and biochemical microenvironments of transplanted cells can also be controlled. Advances in biomaterial engineering have permitted the development of sophisticated drug-releasing materials with a biomimetic 3D support that allow a better control of the microenvironment of transplanted cells. (C) 2012 Elsevier Ltd. All rights reserved.
C1 [Montero-Menei, Claudia N.] INSERM, MINT Micro & Nanomed Biomimet, MINT Bioinspired Micro & Nanomed, U1066, F-49933 Angers, France.
   [Karam, Jean-Pierre; Montero-Menei, Claudia N.] LUNAM Univ, UMR S 1066, F-49933 Angers, France.
   [Muscari, Claudio] Univ Bologna, Dept Biochem G Moruzzi, I-40126 Bologna, Italy.
   [Muscari, Claudio] Natl Inst Cardiovasc Res INRC, I-40126 Bologna, Italy.
RP Montero-Menei, CN (reprint author), INSERM, MINT Micro & Nanomed Biomimet, MINT Bioinspired Micro & Nanomed, U1066, F-49933 Angers, France.
EM claudia.montero-menei@univ-angers.fr
RI Montero-Menei, claudia/K-5373-2015
CR Aggarwal S, 2005, BLOOD, V105, P1815, DOI 10.1182/blood-2004-04-1559
   AHUMADA GG, 1984, J HISTOCHEM CYTOCHEM, V32, P383, DOI 10.1177/32.4.6707462
   Al Kindi AH, 2011, EUR J CARDIO-THORAC, V39, P241, DOI 10.1016/j.ejcts.2010.03.066
   Alavi A, 2007, METHOD ENZYMOL, V426, P85, DOI 10.1016/S0076-6879(07)26005-7
   Amado LC, 2005, P NATL ACAD SCI USA, V102, P11474, DOI 10.1073/pnas.0504388102
   Assmus B, 2002, CIRCULATION, V106, P3009, DOI 10.1161/01.CIR.0000043246.74879.CD
   Assmus B, 2006, NEW ENGL J MED, V355, P1222, DOI 10.1056/NEJMoa051779
   Aubert-Pouessel A, 2004, J CONTROL RELEASE, V95, P463, DOI 10.1016/j.jconrel.2003.12.012
   Badie N, 2009, BIOPHYS J, V96, P3873, DOI 10.1016/j.bpj.2009.02.019
   Banquet S, 2011, CIRCULATION, V124, P1059, DOI 10.1161/CIRCULATIONAHA.110.010264
   Beamish JA, 2009, BIOMATERIALS, V30, P4127, DOI 10.1016/j.biomaterials.2009.04.038
   Bearzi C, 2007, P NATL ACAD SCI USA, V104, P14068, DOI 10.1073/pnas.0706760104
   Beitnes JO, 2011, EXPERT REV CARDIOVAS, V9, P1015, DOI [10.1586/ERC.11.108, 10.1586/erc.11.108]
   Beltrami AP, 2003, CELL, V114, P763, DOI 10.1016/S0092-8674(03)00687-1
   Bicknell KA, 2007, J MOL CELL CARDIOL, V42, P706, DOI 10.1016/j.yjmcc.2007.01.006
   BORG TK, 1982, COLLAGEN REL RES, V2, P211
   Bouffi C, 2010, BIOMATERIALS, V31, P6485, DOI 10.1016/j.biomaterials.2010.05.013
   Britten MB, 2003, CIRCULATION, V108, P2212, DOI 10.1161/01.CIR.0000095788.78169.AF
   Brodbeck WG, 2002, P NATL ACAD SCI USA, V99, P10287, DOI 10.1073/pnas.162124199
   Brown DA, 2005, J BIOMED MATER RES A, V74A, P419, DOI 10.1002/jbm.a.30344
   Brutsaert DL, 2003, PHYSIOL REV, V83, P59, DOI 10.1152/physrev.00017.2002
   Buxboim A, 2010, J PHYS-CONDENS MAT, V22, DOI 10.1088/0953-8984/22/19/194116
   Buxboim A, 2010, J CELL SCI, V123, P297, DOI 10.1242/jcs.041186
   Cai LY, 2009, STEM CELLS, V27, P230, DOI 10.1634/stemcells.2008-0273
   Caplan AI, 2006, J CELL BIOCHEM, V98, P1076, DOI 10.1002/jcb.20886
   Carr CA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025669
   Chachques JC, 2008, ANN THORAC SURG, V85, P901, DOI 10.1016/j.athoracsur.2007.10.052
   Chaudhuri T, 2010, METHODS MOL BIOL, V621, P185, DOI 10.1007/978-1-60761-063-2_13
   Chavakis E, 2008, J MOL CELL CARDIOL, V45, P514, DOI 10.1016/j.yjmcc.2008.01.004
   Chimenti I, 2010, CIRC RES, V106, P971, DOI 10.1161/CIRCRESAHA.109.210682
   Chiu LLY, 2010, BIOMATERIALS, V31, P226, DOI 10.1016/j.biomaterials.2009.09.039
   Choi YS, 2012, BIOMATERIALS, V33, P2482, DOI 10.1016/j.biomaterials.2011.12.004
   Choi YS, 2010, J CELL MOL MED, V14, P878, DOI 10.1111/j.1582-4934.2010.01009.x
   Christman KL, 2006, J AM COLL CARDIOL, V48, P907, DOI 10.1016/j.jacc.2006.06.005
   Chung HJ, 2006, PHARM RES, V23, P1835, DOI 10.1007/s11095-006-9039-9
   Cittadini A, 2011, EUR J HEART FAIL, V13, P1264, DOI 10.1093/eurjhf/hfr143
   Courtney T, 2006, BIOMATERIALS, V27, P3631, DOI 10.1016/j.biomaterials.2006.02.024
   D'Amario D, 2011, CIRC RES, V108, P1467, DOI 10.1161/CIRCRESAHA.111.240648
   Dai WD, 2005, CIRCULATION, V112, P214, DOI 10.1161/CIRCULATIONAHA.104.527937
   Delcroix GJR, 2011, BIOMATERIALS, V32, P1560, DOI 10.1016/j.biomaterials.2010.10.041
   Delcroix GJR, 2010, BIOMATERIALS, V31, P2105, DOI 10.1016/j.biomaterials.2009.11.084
   Deuse T, 2009, CIRCULATION, V120, pS247, DOI 10.1161/CIRCULATIONAHA.108.843680
   Di Nardo P, 2010, J CELL PHYSIOL, V224, P590, DOI 10.1002/jcp.22165
   Dvir T, 2009, P NATL ACAD SCI USA, V106, P14990, DOI 10.1073/pnas.0812242106
   Efe JA, 2011, NAT CELL BIOL, V13, P215, DOI 10.1038/ncb2164
   Ellison GM, 2011, J AM COLL CARDIOL, V58, P977, DOI 10.1016/j.jacc.2011.05.013
   Engler AJ, 2008, J CELL SCI, V121, P3794, DOI 10.1242/jcs.029678
   Engler AJ, 2006, CELL, V126, P677, DOI 10.1016/j.cell.2006.06.044
   Engler AJ, 2004, J CELL BIOL, V166, P877, DOI 10.1083/jcb.200405004
   Fazel S, 2005, J THORAC CARDIOV SUR, V130, P1310, DOI 10.1016/j.jtcvs.2005.07.012
   Fischer LJ, 2009, J SURG RES, V152, P157, DOI 10.1016/j.jss.2008.06.029
   Fiumana E, 2012, J SURG RES      0327
   Flaim CJ, 2008, STEM CELLS DEV, V17, P29, DOI 10.1089/scd.2007.0085
   Forte G, 2008, STEM CELLS, V26, P2093, DOI 10.1634/stemcells.2008-0061
   FROEN JF, 1995, ACTA ANAT, V152, P119
   Fujimoto KL, 2007, ANN THORAC SURG, V83, P648, DOI 10.1016/j.athoracsur.2006.06.085
   Garcia AJ, 1999, MOL BIOL CELL, V10, P785, DOI 10.1091/mbc.10.3.785
   Gaustad KG, 2004, BIOCHEM BIOPH RES CO, V314, P420, DOI 10.1016/j.bbrc.2003.12.109
   Gavira JJ, 2006, CARDIOVASC RES, V71, P744, DOI 10.1016/j.cardiores.2006.06.018
   Gimble JM, 2007, CIRC RES, V100, P1249, DOI 10.1161/01.RES.0000265074.83288.09
   Giteau A, 2008, EUR J PHARM BIOPHARM, V70, P127, DOI 10.1016/j.ejpb.2008.03.006
   Gnecchi M, 2008, CIRC RES, V103, P1204, DOI 10.1161/CIRCRESAHA.108.176826
   Godier-Furnemont AFG, 2011, P NATL ACAD SCI USA, V108, P7974, DOI 10.1073/pnas.1104619108
   Gooch Keith J., 1993, Current Opinion in Biotechnology, V4, P193, DOI 10.1016/0958-1669(93)90124-F
   Grenier G, 2005, TISSUE ENG, V11, P90, DOI 10.1089/ten.2005.11.90
   Guan JJ, 2011, BIOMATERIALS, V32, P5568, DOI 10.1016/j.biomaterials.2011.04.038
   Guo HD, 2011, TISSUE ENG PT A, V17, P45, DOI [10.1089/ten.tea.2010.0124, 10.1089/ten.TEA.2010.0124]
   Hagege AA, 2006, CIRCULATION, V114, pI108, DOI 10.1161/CIRCULATIONAHA.105.000521
   Haider HK, 2010, J CARDIOVASC TRANSL, V3, P89, DOI 10.1007/s12265-009-9161-2
   Hashimoto J, 2006, STEM CELLS, V24, P2346, DOI 10.1634/stemcells.2005-0605
   Hassink RJ, 2008, CARDIOVASC RES, V78, P18, DOI 10.1093/cvr/cvm101
   Holst J, 2010, NAT BIOTECHNOL, V28, P1123, DOI 10.1038/nbt.1687
   Hoshino K, 2006, GENE THER, V13, P1320, DOI 10.1038/sj.gt.3302793
   Huang S, 2000, EXP CELL RES, V261, P91, DOI 10.1006/excr.2000.5044
   Hubbell JA, 1999, CURR OPIN BIOTECH, V10, P123, DOI 10.1016/S0958-1669(99)80021-4
   Humphries JD, 2006, J CELL SCI, V119, P3901, DOI 10.1242/jcs.03098
   Hynes B, 2011, EUR HEART J
   Hynes RO, 2002, CELL, V110, P673, DOI 10.1016/S0092-8674(02)00971-6
   Ieda M, 2010, CELL, V142, P375, DOI 10.1016/j.cell.2010.07.002
   Ingber DE, 2006, FASEB J, V20, P811, DOI 10.1096/fj.05-5424rev
   Jiang YH, 2002, NATURE, V418, P41, DOI 10.1038/nature00870
   Johnston PV, 2009, CIRCULATION, V120, P1075, DOI 10.1161/CIRCULATIONAHA.108.816058
   Jollivet C, 2004, BIOMATERIALS, V25, P933, DOI 10.1016/S0142-9612(03)00601-X
   Jujo K, 2008, J MOL CELL CARDIOL, V45, P530, DOI 10.1016/j.yjmcc.2008.08.003
   Kai D, 2011, J BIOMED MATER RES B, V98B, P379, DOI 10.1002/jbm.b.31862
   Kajstura J, 2005, CIRC RES, V96, P127, DOI 10.1161/01.RES.0000151843.79801.60
   Kenar H, 2011, BIOMATERIALS, V32, P5320, DOI 10.1016/j.biomaterials.2011.04.025
   Keselowsky BG, 2005, P NATL ACAD SCI USA, V102, P5953, DOI 10.1073/pnas.0407356102
   KNOWLTON AA, 1992, J CLIN INVEST, V89, P1060, DOI 10.1172/JCI115685
   Kocher AA, 2001, NAT MED, V7, P430, DOI 10.1038/86498
   Kretlow JD, 2007, ADV DRUG DELIVER REV, V59, P263, DOI 10.1016/j.addr.2007.03.013
   Kuppuswamy D, 2002, CIRC RES, V90, P1240, DOI 10.1161/01.RES.0000025080.78636.23
   Laflamme MA, 2005, NAT BIOTECHNOL, V23, P845, DOI 10.1038/nbt1117
   Laflamme MA, 2007, NAT BIOTECHNOL, V25, P1015, DOI 10.1038/nbt1327
   Lee ST, 2011, J AM COLL CARDIOL, V57, P455, DOI 10.1016/j.jacc.2010.07.049
   Lee WCC, 2009, INT J CARDIOL, V133, P399, DOI 10.1016/j.ijcard.2007.11.068
   Leobon B, 2009, CARDIOVASC RES, V83, P757, DOI 10.1093/cvr/cvp167
   Li SWC, 2009, CELL BIOL INT, V33, P255, DOI 10.1016/j.cellbi.2008.11.009
   Li ZQ, 2011, EXPERT OPIN DRUG DEL, V8, P991, DOI 10.1517/17425247.2011.581656
   Lin YD, 2010, CIRCULATION, V122, pS132, DOI 10.1161/CIRCULATIONAHA.110.939512
   Lloyd-Jones DM, 2001, ARCH INTERN MED, V161, P949, DOI 10.1001/archinte.161.7.949
   Losordo DW, 2004, CIRCULATION, V109, P2692, DOI 10.1161/01.CIR.0000128596.49339.05
   LUNDGREN E, 1985, EXP CELL RES, V158, P371, DOI 10.1016/0014-4827(85)90462-8
   Lutolf MP, 2005, NAT BIOTECHNOL, V23, P47, DOI 10.1038/nbt1055
   Madonna R, 2010, BASIC RES CARDIOL, V105, P443, DOI 10.1007/s00395-010-0102-7
   Makino S, 1999, J CLIN INVEST, V103, P697, DOI 10.1172/JCI5298
   McMullen NM, 2007, CAN J PHYSIOL PHARM, V85, P1, DOI 10.1139/Y06-105
   Meliga E, 2007, CELL TRANSPLANT, V16, P963, DOI 10.3727/096368907783338190
   Menasche P, 2001, LANCET, V357, P279, DOI 10.1016/S0140-6736(00)03617-5
   Menasche P, 2008, J MOL CELL CARDIOL, V45, P545, DOI 10.1016/j.yjmcc.2007.11.009
   Menasche P, 2007, PROG CARDIOVASC DIS, V50, P7, DOI 10.1016/j.pcad.2007.02.002
   Messina E, 2004, CIRC RES, V95, P911, DOI 10.1161/01.RES.0000147315.71699.51
   Metzele R, 2011, FASEB J, V25, P830, DOI 10.1096/fj.09-153221
   Miyagi Y, 2011, BIOMATERIALS, V32, P1280, DOI 10.1016/j.biomaterials.2010.10.007
   Morishita N, 1996, JPN CIRC J, V60, P108, DOI 10.1253/jcj.60.108
   Muller-Ehmsen J, 2002, CIRCULATION, V105, P1720, DOI 10.1161/01.CIR.0000013782.76324.92
   Murry CE, 2004, NATURE, V428, P664, DOI 10.1038/nature02446
   Narmoneva DA, 2004, CIRCULATION, V110, P962, DOI 10.1161/01.CIR.0000140667.37070.07
   Niagara MI, 2007, CIRC RES, V100, P545, DOI 10.1161/01.RES.0000258460.41160.ef
   Noel D, 2008, EXP CELL RES, V314, P1575, DOI 10.1016/j.yexcr.2007.12.022
   Nunes SS, 2011, J CARDIOVASC TRANSL, V4, P592, DOI 10.1007/s12265-011-9307-x
   Oh H, 2003, P NATL ACAD SCI USA, V100, P12313, DOI 10.1073/pnas.2132126100
   Orlic D, 2001, NATURE, V410, P701, DOI 10.1038/35070587
   Oshima H, 2005, MOL THER, V12, P1130, DOI 10.1016/j.ymthe.2005.04.686
   Park H, 2005, IN VITRO CELL DEV-AN, V41, P188
   Passier R, 2008, NATURE, V453, P322, DOI 10.1038/nature07040
   Penn MS, 2002, PROG CARDIOVASC DIS, V45, P21, DOI 10.1053/pcad.2002.123466
   PEPINE CJ, 1989, AM J CARDIOL, V64, pB2, DOI 10.1016/S0002-9149(89)80002-5
   Pfister O, 2005, CIRC RES, V97, P52, DOI 10.1161/01.RES.0000173297.53793.fa
   Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143
   Planat-Benard V, 2004, CIRCULATION, V109, P656, DOI 10.1161/01.CIR.0000114522.38265.61
   Reinecke H, 2002, J MOL CELL CARDIOL, V34, P241, DOI 10.1006/jmcc.2001.1507
   Reusch P, 1996, CIRC RES, V79, P1046, DOI 10.1161/01.RES.79.5.1046
   Robinson KA, 2005, CIRCULATION, V112, pI135, DOI 10.1161/CIRCULATIONAHA.104.525436
   Rose RA, 2008, STEM CELLS, V26, P2884, DOI 10.1634/stemcells.2008-0329
   Rowlands AS, 2008, AM J PHYSIOL-CELL PH, V295, pC1037, DOI 10.1152/ajpcell.67.2008
   Ruvinov E, 2011, BIOMATERIALS, V32, P565, DOI 10.1016/j.biomaterials.2010.08.097
   Salasznyk RM, 2004, J BIOMED BIOTECHNOL, P24, DOI 10.1155/S1110724304306017
   Schenke-Layland K, 2009, J SURG RES, V153, P217, DOI 10.1016/j.jss.2008.03.019
   Segers VFM, 2011, CIRC RES, V109, P910, DOI 10.1161/CIRCRESAHA.111.249052
   Segers VFM, 2010, J CARDIOVASC TRANSL, V3, P469, DOI 10.1007/s12265-010-9207-5
   Shen DL, 2012, J CELL MOL MED, V16, P2112, DOI 10.1111/j.1582-4934.2011.01512.x
   Shi RZ, 2008, BIOCHEM BIOPH RES CO, V376, P247, DOI 10.1016/j.bbrc.2008.09.004
   Shin H, 2003, BIOMATERIALS, V24, P4353, DOI 10.1016/S0142-9612(03)00339-9
   Shin M, 2004, BIOMATERIALS, V25, P3717, DOI 10.1016/j.biomaterials.2003.10.055
   Shiota M, 2007, EXP CELL RES, V313, P1008, DOI 10.1016/j.yexcr.2006.12.017
   Silva GV, 2005, CIRCULATION, V111, P150, DOI 10.1161/01.CIR.0000151812.86142.45
   Siminiak T, 2004, AM HEART J, V148, P531, DOI 10.1016/j.ahj.2004.03.043
   Singelyn JM, 2009, BIOMATERIALS, V30, P5409, DOI 10.1016/j.biomaterials.2009.06.045
   Smith RR, 2007, CIRCULATION, V115, P896, DOI 10.1161/CIRCULATIONAHA.106.655209
   Song YH, 2007, BIOCHEM BIOPH RES CO, V354, P999, DOI 10.1016/j.bbrc.2007.01.095
   Springer ML, 2005, AM J PHYSIOL-HEART C, V289, pH1307, DOI 10.1152/ajpheart.00164.2005
   Strauer BE, 2002, CIRCULATION, V106, P1913, DOI 10.1161/01.CIR.0000034046.87607.1C
   Stupack Dwayne G, 2007, Oncology (Williston Park), V21, P6
   Sy JC, 2010, J CARDIOVASC TRANSL, V3, P461, DOI 10.1007/s12265-010-9210-x
   Tambara K, 2005, CIRCULATION, V112, pI129, DOI 10.1161/CIRCULATIONAHA.104.526293
   Tatard VM, 2004, CELL TRANSPLANT, V13, P573, DOI 10.3727/000000004783983675
   Tatard VM, 2007, BIOMATERIALS, V28, P1978, DOI 10.1016/j.biomaterials.2006.12.021
   Tatard VM, 2005, BIOMATERIALS, V26, P3727, DOI 10.1016/j.biomaterials.2004.09.042
   Terrovitis JV, 2010, CIRC RES, V106, P479, DOI 10.1161/CIRCRESAHA.109.208991
   Tomita S, 1999, CIRCULATION, V100, P247
   Tse JR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015978
   Tulloch NL, 2011, CIRC RES, V109, P47, DOI 10.1161/CIRCRESAHA.110.237206
   Urbanek K, 2005, CIRC RES, V97, P663, DOI 10.1161/01.RES.0000183733.53101.11
   van Dijk A, 2008, CELL TISSUE RES, V334, P457, DOI 10.1007/s00441-008-0713-6
   van Laake LW, 2007, STEM CELL RES, V1, P9, DOI 10.1016/j.scr.2007.06.001
   Tran VT, 2012, EUR J PHARM SCI, V45, P128, DOI 10.1016/j.ejps.2011.10.030
   VANDENBURGH HH, 1992, AM J PHYSIOL, V262, pR350
   Vidarsson H, 2010, STEM CELL REV REP, V6, P108, DOI 10.1007/s12015-010-9113-x
   Wang F, 2010, ADV DRUG DELIVER REV, V62, P784, DOI 10.1016/j.addr.2010.03.001
   Wang F, 2010, ACTA BIOMATER, V6, P1978, DOI 10.1016/j.actbio.2009.12.011
   Wang L, 2009, AM J PHYSIOL-HEART C, V297, pH1020, DOI 10.1152/ajpheart.01082.2008
   Wang N, 2009, NAT REV MOL CELL BIO, V10, P75, DOI 10.1038/nrm2594
   Wang XH, 2006, STEM CELLS, V24, P1779, DOI 10.1634/stemcells.2005-0386
   Wei HJ, 2008, BIOMATERIALS, V29, P3547, DOI 10.1016/j.biomaterials.2008.05.009
   Wells RG, 2008, HEPATOLOGY, V47, P1394, DOI 10.1002/hep.22193
   Wijelath ES, 2004, J VASC SURG, V39, P655, DOI 10.1016/j.jvs.2003.10.042
   Willems IEMG, 1996, J PATHOL, V179, P321
   Williams AR, 2011, CIRC RES, V109, P923, DOI 10.1161/CIRCRESAHA.111.243147
   Winitsky SO, 2005, PLOS BIOL, V3, P662, DOI 10.1371/journal.pbio.0030087
   Wollert KC, 2005, CIRCULATION, V112, P151, DOI 10.1161/CIRCULATIONAHA.105.551895
   Wu X, 2010, AM J PHYSIOL-HEART C, V298, pH2071, DOI 10.1152/ajpheart.01156.2009
   Yang L, 2011, STEM CELL RES THER, V2, DOI 10.1186/scrt42
   Yoshida Y, 2011, J MOL CELL CARDIOL, V50, P327, DOI 10.1016/j.yjmcc.2010.10.026
   Young JL, 2011, BIOMATERIALS, V32, P1002, DOI 10.1016/j.biomaterials.2010.10.020
   Young PP, 2007, PROG CARDIOVASC DIS, V49, P421, DOI 10.1016/j.pcad.2007.02.004
   Yu JS, 2010, BIOMATERIALS, V31, P7012, DOI 10.1016/j.biomaterials.2010.05.078
   Yu J, 2009, BIOMATERIALS, V30, P751, DOI 10.1016/j.biomaterials.2008.09.059
   Zhang JH, 2009, CIRC RES, V104, pE30, DOI 10.1161/CIRCRESAHA.108.192237
   Zhang P, 2011, STEM CELLS DEV, V20, P977, DOI 10.1089/scd.2010.0152
   Zhang SN, 2009, CLIN CARDIOL, V32, P458, DOI 10.1002/clc.20575
   Zhang XL, 2010, EXP BIOL MED, V235, P1505, DOI 10.1258/ebm.2010.010175
   Zimmermann WH, 2011, J MOL CELL CARDIOL, V50, P320, DOI 10.1016/j.yjmcc.2010.10.027
NR 193
TC 65
Z9 65
U1 7
U2 71
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
EI 1878-5905
J9 BIOMATERIALS
JI Biomaterials
PD AUG
PY 2012
VL 33
IS 23
BP 5683
EP 5695
DI 10.1016/j.biomaterials.2012.04.028
PG 13
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 963CG
UT WOS:000305597100003
PM 22594970
DA 2018-10-19
ER

PT J
AU Chen, EYT
   Wang, YC
   Mintz, A
   Richards, A
   Chen, CS
   Lu, D
   Nguyen, T
   Chin, WC
AF Chen, Eric Y. T.
   Wang, Yung-Chen
   Mintz, Alexander
   Richards, Alan
   Chen, Chi-Shuo
   Lu, David
   Thien Nguyen
   Chin, Wei-Chun
TI Activated charcoal composite biomaterial promotes human embryonic stem
   cell differentiation toward neuronal lineage
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A
LA English
DT Article
DE activated charcoal; coal; composite biomaterials; hESC differentiation;
   neuron
ID WALLED CARBON NANOTUBES; GRAPHENE OXIDE; NEURAL STEM; IN-VITRO;
   NANOFIBROUS SCAFFOLDS; SPINAL-CORD; TOXICITY; CYTOTOXICITY; MATRIX;
   PROLIFERATION
AB Transplantation of biomaterial scaffolds encasing human embryonic stem cells (hESCs) has been proposed as a clinical therapy for various neurological lesions and disorders. In light of recent developments, artificially synthesized carbon-based biomaterials such as carbon nanotubes and graphene have demonstrated feasibility in supporting stem cell attachment and differentiation. However, the applicability is significantly hampered by evidence of nanotoxic effects on multiple cell types. Thus, an emergent drive for an innovative carbonaceous biomaterial calls for a safer platform with comparable advantageous characteristics. Here, we showed for the first time, a natural coal-based activated charcoal (AC) composite biosubstrate can support and promote neuronal differentiation in hESCs. The bio-friendly AC composite biomatrices resulted in more matured neuron-like cells. Both of axonal length and density were at least twice as long and abundant, respectively, when compared with control groups. A functional assay demonstrated that the derived neuron-like cells responded to depolarization-dependent synaptic recycling and may contain active synapses. In addition, the AC composite substrate can serve to concentrate growth factors and cell adhesion proteins, further encouraging attachment and hESC differentiation. Moreover, the AC composite biomaterial can potentially be economically manufactured as implantable three-dimensional bioscaffolds, facilitating the regeneration of damaged neural and other tissues. (C) 2012 Wiley Periodicals, Inc. J Biomed Mater Res Part A, 2012.
C1 [Chen, Eric Y. T.; Wang, Yung-Chen; Mintz, Alexander; Richards, Alan; Chen, Chi-Shuo; Lu, David; Chin, Wei-Chun] Univ Calif, Bioengn Program, Merced, CA 95343 USA.
   [Thien Nguyen] Johns Hopkins Univ, Dept Neurol, Baltimore, MD 21205 USA.
RP Chin, WC (reprint author), Univ Calif, Bioengn Program, Merced, CA 95343 USA.
EM wchin2@ucmerced.edu
RI Chin, Wei-Chun/A-6068-2008
OI Chin, Wei-Chun/0000-0003-4881-9085
FU Muscular Dystrophy Association (MDA); UC Merced GRC Summer Fellowships;
   Center of Excellence on Health Disparities
FX Contract grant sponsors: Muscular Dystrophy Association (MDA), UC Merced
   GRC Summer Fellowships, Center of Excellence on Health Disparities
CR Agarwal S, 2010, LANGMUIR, V26, P2244, DOI 10.1021/la9048743
   AHMED SN, 1993, FUEL PROCESS TECHNOL, V34, P123, DOI 10.1016/0378-3820(93)90095-L
   Akhavan O, 2010, ACS NANO, V4, P5731, DOI 10.1021/nn101390x
   Baker BM, 2009, EXPERT REV MED DEVIC, V6, P515, DOI [10.1586/erd.09.39, 10.1586/ERD.09.39]
   Belyanskaya L, 2009, NEUROTOXICOLOGY, V30, P702, DOI 10.1016/j.neuro.2009.05.005
   Bhattarai N, 2006, ADV MATER, V18, P1463, DOI 10.1002/adma.200502537
   Cellot G, 2009, NAT NANOTECHNOL, V4, P126, DOI [10.1038/nnano.2008.374, 10.1038/NNANO.2008.374]
   Chang YL, 2011, TOXICOL LETT, V200, P201, DOI 10.1016/j.toxlet.2010.11.016
   Chao TI, 2009, BIOCHEM BIOPH RES CO, V384, P426, DOI 10.1016/j.bbrc.2009.04.157
   Chen YC, 2010, BIOMATERIALS, V31, P5575, DOI 10.1016/j.biomaterials.2010.03.061
   Cheng C, 2009, BIOMATERIALS, V30, P4152, DOI 10.1016/j.biomaterials.2009.04.019
   Cui DX, 2005, TOXICOL LETT, V155, P73, DOI 10.1016/j.toxlet.2004.08.015
   Santos CMD, 2010, J PAIN SYMPTOM MANAG, V39, P1065, DOI 10.1016/j.jpainsymman.2009.11.319
   Dastgheib SA, 2001, CARBON, V39, P1849, DOI 10.1016/S0008-6223(00)00315-8
   Depan D, 2011, ACTA BIOMATER, V7, P3432, DOI 10.1016/j.actbio.2011.05.019
   DeQuach JA, 2011, TISSUE ENG PT A, V17, P2583, DOI [10.1089/ten.tea.2010.0724, 10.1089/ten.TEA.2010.0724]
   Edwards SL, 2009, EXPERT REV MED DEVIC, V6, P499, DOI [10.1586/erd.09.29, 10.1586/ERD.09.29]
   Engler AJ, 2006, CELL, V126, P677, DOI 10.1016/j.cell.2006.06.044
   Flanagan LA, 2006, J NEUROSCI RES, V83, P845, DOI 10.1002/jnr.20778
   Foo KY, 2010, J HAZARD MATER, V175, P1, DOI 10.1016/j.jhazmat.2009.10.014
   Frithsen IL, 2010, AM FAM PHYSICIAN, V81, P316
   Gamby J, 2001, J POWER SOURCES, V101, P109, DOI 10.1016/S0378-7753(01)00707-8
   Gefen A, 2004, J BIOMECH, V37, P1339, DOI 10.1016/j.jbiomech.2003.12.032
   Gupta D, 2006, BIOMATERIALS, V27, P2370, DOI 10.1016/j.biomaterials.2005.11.015
   Hu WB, 2010, ACS NANO, V4, P4317, DOI 10.1021/nn101097v
   Huang Y, 2005, BIOMATERIALS, V26, P7616, DOI 10.1016/j.biomaterials.2005.05.036
   Hubert T, 2009, CELL MOL LIFE SCI, V66, P1223, DOI 10.1007/s00018-008-8561-9
   Jakubek LM, 2009, BIOMATERIALS, V30, P6351, DOI 10.1016/j.biomaterials.2009.08.009
   Kim KS, 2009, NATURE, V457, P706, DOI 10.1038/nature07719
   Langer R, 2004, NATURE, V428, P487, DOI 10.1038/nature02388
   LECHEVALLIER MW, 1984, APPL ENVIRON MICROB, V48, P918
   Lee JH, 2011, J R SOC INTERFACE, V8, P998, DOI 10.1098/rsif.2010.0613
   Lee WC, 2011, ACS NANO, V5, P7334, DOI 10.1021/nn202190c
   Liao KH, 2011, ACS APPL MATER INTER, V3, P2607, DOI 10.1021/am200428v
   Lin HJ, 2004, DEV BRAIN RES, V153, P163, DOI 10.1016/j.devbrainres.2004.08.010
   Ma W, 2008, TISSUE ENG PT A, V14, P1673, DOI 10.1089/ten.tea.2007.0357
   Ma W, 2008, BMC DEV BIOL, V8, DOI 10.1186/1471-213X-8-90
   Manna SK, 2005, NANO LETT, V5, P1676, DOI 10.1021/nl0507966
   Meng J, 2006, J BIOMED MATER RES A, V79A, P298, DOI 10.1002/jbm.a.30787
   Nayak TR, 2011, ACS NANO, V5, P4670, DOI 10.1021/nn200500h
   Novikova LN, 2003, CURR OPIN NEUROL, V16, P711, DOI 10.1097/01.wco.0000102620.38669.3e
   Olson KR, 2010, J MED TOXICOL, V6, P190, DOI 10.1007/s13181-010-0046-1
   Park KH, 2003, J BIOL CHEM, V278, P50212, DOI 10.1074/jbc.M310216200
   Prabhakaran MP, 2009, BIOMATERIALS, V30, P4996, DOI 10.1016/j.biomaterials.2009.05.057
   Ryoo SR, 2010, ACS NANO, V4, P6587, DOI 10.1021/nn1018279
   Sasidharan A, 2011, NANOSCALE, V3, P2461, DOI 10.1039/c1nr10172b
   Shvedova AA, 2003, J TOXICOL ENV HEAL A, V66, P1909, DOI 10.1080/15287390390231566
   Simon-Deckers A, 2008, TOXICOLOGY, V253, P137, DOI 10.1016/j.tox.2008.09.007
   Sridharan I, 2009, BIOCHEM BIOPH RES CO, V381, P508, DOI 10.1016/j.bbrc.2009.02.072
   Sun XM, 2008, NANO RES, V1, P203, DOI 10.1007/s12274-008-8021-8
   Tatard VM, 2005, CURR DRUG TARGETS, V6, P81, DOI 10.2174/1389450053344885
   Thomas TD, 2008, BIOTECHNOL ADV, V26, P618, DOI 10.1016/j.biotechadv.2008.08.003
   Vallabani NVS, 2011, J BIOMED NANOTECHNOL, V7, P106, DOI 10.1166/jbn.2011.1224
   Wang JY, 2011, TOXICOL IN VITRO, V25, P242, DOI 10.1016/j.tiv.2010.11.010
   Williams DR, 2008, NAT PROTOC, V3, P835, DOI 10.1038/nprot.2008.47
   Yang F, 2004, BIOMATERIALS, V25, P1891, DOI 10.1016/j.biomaterials.2003.08.062
   Yang F, 2005, BIOMATERIALS, V26, P2603, DOI 10.1016/j.biomaterials.2004.06.051
   Zhang YB, 2010, ACS NANO, V4, P3181, DOI 10.1021/nn1007176
   Zhu L, 2007, NANO LETT, V7, P3592, DOI 10.1021/nl071303v
NR 59
TC 11
Z9 12
U1 0
U2 45
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1549-3296
J9 J BIOMED MATER RES A
JI J. Biomed. Mater. Res. Part A
PD AUG
PY 2012
VL 100A
IS 8
BP 2006
EP 2017
DI 10.1002/jbm.a.34201
PG 12
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 961ZW
UT WOS:000305509700010
PM 22623371
DA 2018-10-19
ER

PT J
AU Lee, OJ
   Lee, JM
   Kim, JH
   Kim, J
   Kweon, H
   Jo, YY
   Park, CH
AF Lee, Ok Joo
   Lee, Jung Min
   Kim, Ji Heui
   Kim, Jin
   Kweon, HaeYong
   Jo, You Young
   Park, Chan Hum
TI Biodegradation behavior of silk fibroin membranes in repairing tympanic
   membrane perforations
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A
LA English
DT Article
DE silk fibroin; biomaterial; degradation; membranes
ID BOMBYX-MORI; IN-VITRO; SUTURE MATERIALS; SCAFFOLD DESIGN; STEM-CELLS;
   VIVO; BIOMATERIALS; DEGRADATION; HYDROGELS; PROTEINS
AB Silk fibroin (SF) from silkworms has been widely studied as a biomaterial. The degradation behavior of silk biomaterials is important for medical applications, but few studies have examined long-term degradation behavior in vivo. In this study, we investigated the degradation behavior of SF membranes in vitro and in vivo. For the in vitro assay, we observed degradation of silk membranes in phosphate buffered saline, culture media, and an enzyme (proteinase K) solution. In the proteinase K solution, 80% of the silk membranes degraded within 10 days. Silk membranes exhibited no cytotoxicity toward L929 cells and rat tissues. To investigate the degradation of silk membranes in vivo, they were implanted subcutaneously in rats and harvested 19 months after surgery. Scanning electron microscopy imaging and histological analysis of silk membrane explants showed that they broke into several pieces after 16 months. Results show that silk membranes are biocompatible and display excellent long-term degradation behavior when used as biomaterials. (C) 2012 Wiley Periodicals, Inc. J Biomed Mater Res Part A, 2012.
C1 [Lee, Ok Joo; Lee, Jung Min; Park, Chan Hum] Hallym Univ, Nanobio Regenerat Med Inst, Chunchon 200702, South Korea.
   [Kim, Ji Heui; Park, Chan Hum] Hallym Univ, Sch Med, Chuncheon Sacred Heart Hosp, Dept Otorhinolaryngol Head & Neck Surg, Chunchon 200702, Kangwon, South Korea.
   [Kim, Jin] Yonsei Univ, Coll Med, Dept Otorhinolaryngol, Seoul, South Korea.
   [Kweon, HaeYong; Jo, You Young] Natl Acad Agr Sci, Rural Dev Adm, Sericultural & Apicultural Mat Div, Suwon, South Korea.
RP Park, CH (reprint author), Hallym Univ, Nanobio Regenerat Med Inst, 1 Okcheon Dong, Chunchon 200702, South Korea.
EM hlpch@paran.com
RI 이, 옥주/B-8523-2016
OI Park, Chan Hum/0000-0002-9732-361X
FU Ministry for Food, Agriculture, Forestry and Fisheries, Republic of
   Korea [111100-03-1-SB010]
FX This research was supported by Bio-industry Technology Development
   Program (111100-03-1-SB010), Ministry for Food, Agriculture, Forestry
   and Fisheries, Republic of Korea.
CR Altman GH, 2003, BIOMATERIALS, V24, P401, DOI 10.1016/S0142-9612(02)00353-8
   Arai T, 2004, J APPL POLYM SCI, V91, P2383, DOI 10.1002/app.13393
   Asakura T, 2001, J MOL BIOL, V306, P291, DOI 10.1006/jmbi.2000.4394
   BUCKNALL TE, 1983, EUR SURG RES, V15, P59, DOI 10.1159/000128334
   Chen Guoding, 1996, Journal of Sericultural Science of Japan, V65, P182
   CHEN K, 1991, Journal of Sericultural Science of Japan, V60, P402
   Chen Kaili, 1996, Journal of Sericultural Science of Japan, V65, P131
   Chen X, 1997, J APPL POLYM SCI, V65, P2257, DOI 10.1002/(SICI)1097-4628(19970912)65:11<2257::AID-APP23>3.0.CO;2-Z
   Chen X, 2001, BIOPHYS CHEM, V89, P25, DOI 10.1016/S0301-4622(00)00213-1
   Chen X, 2001, POLYMER, V42, P9969, DOI 10.1016/S0032-3861(01)00541-9
   DEWAIR M, 1985, J ALLERGY CLIN IMMUN, V76, P537, DOI 10.1016/0091-6749(85)90772-9
   Drury JL, 2003, BIOMATERIALS, V24, P4337, DOI 10.1016/S0142-9612(03)00340-5
   FRANKS F, 1993, PROTEIN BIOTECHNOLOG
   FREDDI G, 1995, J APPL POLYM SCI, V56, P1537, DOI 10.1002/app.1995.070561203
   Freddi G, 1999, INT J BIOL MACROMOL, V24, P251, DOI 10.1016/S0141-8130(98)00087-7
   GREENWALD D, 1994, J SURG RES, V56, P372, DOI 10.1006/jsre.1994.1058
   Ha SW, 2003, BIOMACROMOLECULES, V4, P488, DOI 10.1021/bm0255948
   HALSTED W, 1892, ANN SURG, V16, P505
   He SJ, 1999, INT J BIOL MACROMOL, V24, P187, DOI 10.1016/S0141-8130(99)00004-5
   Horan RL, 2005, BIOMATERIALS, V26, P3385, DOI 10.1016/j.biomaterials.2004.09.020
   Hu X, 2006, MACROMOLECULES, V39, P6161, DOI 10.1021/ma0610109
   Imai Yuuki, 2008, Clin Calcium, V18, P1693, DOI CliCa081216931700
   Inoue S, 2000, J BIOL CHEM, V275, P40517, DOI 10.1074/jbc.M006897200
   Kim J, 2010, WOUND REPAIR REGEN, V18, P132, DOI 10.1111/j.1524-475X.2009.00565.x
   Kim UJ, 2004, BIOMACROMOLECULES, V5, P786, DOI 10.1021/bm0345460
   Kong XD, 2004, J CRYST GROWTH, V270, P197, DOI 10.1016/j.jcrysgro.2004.06.007
   LANGE F, 2007, MUNCHEN MED WOCHEN, V17, P834
   Lange F, 1903, VERH DTSCH ORTHOP GE, V2, P10
   Li MZ, 2002, INT J BIOL MACROMOL, V30, P89, DOI 10.1016/S0141-8130(02)00007-7
   Li MZ, 2003, BIOMATERIALS, V24, P357, DOI 10.1016/S0142-9612(02)00326-5
   Ludloff K., 1927, ZENTRALBL CHIR, V54, P3162
   Magnani A, 1991, MODERN ASPECTS PROTE, P91
   Mauney JR, 2007, BIOMATERIALS, V28, P5280, DOI 10.1016/j.biomaterials.2007.08.017
   Meinel L, 2005, BIOMATERIALS, V26, P147, DOI 10.1016/j.biomaterials.2004.02.047
   Min BM, 2004, INT J BIOL MACROMOL, V34, P281, DOI 10.1016/j.ijbiomac.2004.08.004
   MORI H, 2000, REV MOL BIOTECHNOL, V74, P95, DOI DOI 10.1016/S1389-0352(00)00004-0
   Navarro M, 2008, J R SOC INTERFACE, V5, P1137, DOI 10.1098/rsif.2008.0151
   Putthanarat S, 2002, POLYMER, V43, P3405, DOI 10.1016/S0032-3861(02)00161-1
   Ringe J, 2002, NATURWISSENSCHAFTEN, V89, P338, DOI 10.1007/s00114-002-0344-9
   ROSSITCH E, 1987, CHILD NERV SYST, V3, P375, DOI 10.1007/BF00270712
   Rossitch E Jr, 1987, N C Med J, V48, P669
   SALTHOUSE TN, 1977, AM J OPHTHALMOL, V84, P224, DOI 10.1016/0002-9394(77)90856-X
   SCHAGGER H, 1987, ANAL BIOCHEM, V166, P368, DOI 10.1016/0003-2697(87)90587-2
   SOONG HK, 1984, OPHTHALMOLOGY, V91, P479
   Tsuboi Y, 2001, APPL PHYS A-MATER, V73, P637, DOI 10.1007/s003390100984
   Tsukada M, 1996, J APPL POLYM SCI, V60, P1619, DOI 10.1002/(SICI)1097-4628(19960606)60:10<1619::AID-APP14>3.0.CO;2-#
   Uebersax L, 2006, TISSUE ENG, V12, P3417, DOI 10.1089/ten.2006.12.3417
   Um IC, 2001, INT J BIOL MACROMOL, V29, P91, DOI 10.1016/S0141-8130(01)00159-3
   Unger RE, 2004, BIOMATERIALS, V25, P1069, DOI [10.1016/S0142-9612(03)00619-7, 10.1016/S0142-9612(03)00630-6]
   Wang Y, 2008, BIOMATERIALS, V29, P3415, DOI 10.1016/j.biomaterials.2008.05.002
   Wang YZ, 2006, BIOMATERIALS, V27, P6064, DOI 10.1016/j.biomaterials.2006.07.008
NR 51
TC 21
Z9 24
U1 1
U2 26
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1549-3296
J9 J BIOMED MATER RES A
JI J. Biomed. Mater. Res. Part A
PD AUG
PY 2012
VL 100A
IS 8
BP 2018
EP 2026
DI 10.1002/jbm.a.33308
PG 9
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 961ZW
UT WOS:000305509700011
PM 22581612
DA 2018-10-19
ER

PT J
AU Ardjomandi, N
   Klein, C
   Kohler, K
   Maurer, A
   Kalbacher, H
   Niederlander, J
   Reinert, S
   Alexander, D
AF Ardjomandi, N.
   Klein, C.
   Kohler, K.
   Maurer, A.
   Kalbacher, H.
   Niederlaender, J.
   Reinert, S.
   Alexander, D.
TI Indirect coating of RGD peptides using a poly-L-lysine spacer enhances
   jaw periosteal cell adhesion, proliferation, and differentiation into
   osteogenic tissue
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A
LA English
DT Article
DE polylactic acid scaffolds; RGD peptides; jaw periosteal cells;
   integrin-mediated adhesion; proliferation; mineralization
ID BONE; MINERALIZATION; BIOMATERIALS; INTEGRINS; CAPACITY; SURFACES;
   GROWTH
AB The aim of our study was to generate a biofunctionalized, three-dimensional (3D) biomaterial to enhance jaw periosteal cell (JPC) adhesion and differentiation into osteogenic tissue. Therefore, open-cell polylactic acid (OPLA) scaffolds were coated covalently with different RGD peptides (a conserved recognition sequence of the most ECM proteinsarginine-glycine-asparagine) and different coating variants. The linear and cyclic RGD peptides were either applied directly or indirectly via a poly-L-lysine (PLL) spacer. JPCs were analyzed on coated constructs in 2D and 3D cultures and showed enhanced rates for indirectly coated scaffolds using the PLL spacer. By gene expression, we detected significantly increased levels of osteogenic marker genes, such as alkaline phosphatase, RUNX2, and AMELY in JPCs seeded onto PLL/linear RGD constructs compared to the otherwise-coated constructs. An analysis of the JPC mineralization capacity revealed the highest amounts of calciumphosphate precipitates in cells growing within the PLL/linear scaffolds. Additionally, the JPC adhesion behavior on OPLA scaffolds seems to be mediated by ITGB3, ITGB1, and ITGAV, as shown by blocking assays. We concluded that coating of OPLA constructs with linear RGD peptides via PLL represents a suitable approach for functionalizing the polymer surface and enhancing adhesion, proliferation, and mineralization of JPCs. (C) 2012 Wiley Periodicals, Inc. J Biomed Mater Res Part A, 2012.
C1 [Ardjomandi, N.; Reinert, S.; Alexander, D.] Univ Tubingen Hosp, Dept Oral & Maxillofacial Surg, Tubingen, Germany.
   [Ardjomandi, N.; Kohler, K.] Univ Tubingen Hosp, Ctr Regenerat Med & Biol, Tubingen, Germany.
   [Klein, C.] Univ Tubingen Hosp, Dept Pediat & Operat Dent Periodontol & Endodonto, Tubingen, Germany.
   [Maurer, A.; Kalbacher, H.] Univ Tubingen, Med & Nat Sci Res Ctr MNF, D-72074 Tubingen, Germany.
   [Niederlaender, J.] Univ Childrens Hosp Tubingen, Dept Congenital & Pediat Cardiac Surg, Tubingen, Germany.
RP Ardjomandi, N (reprint author), Univ Tubingen Hosp, Dept Oral & Maxillofacial Surg, Tubingen, Germany.
EM nina.ardjomandi@med.uni-tuebingen.de
RI Maurer, Andreas/A-9814-2010
OI Maurer, Andreas/0000-0003-2412-5361
FU DFG Graduate College [794]; BMBF
FX Contract grant sponsor: DFG Graduate College; contract grant number:
   794.; Contract grant sponsor: BMBF
CR Agata H, 2007, J DENT RES, V86, P79, DOI 10.1177/154405910708600113
   Alexander D, 2008, J MATER SCI-MATER M, V19, P965, DOI 10.1007/s10856-007-3351-8
   Alexander D, 2010, CELL PHYSIOL BIOCHEM, V26, P1073, DOI 10.1159/000323985
   Alexander D, 2009, CELL PHYSIOL BIOCHEM, V24, P283, DOI 10.1159/000233253
   Alvarez-Barreto JF, 2007, TISSUE ENG, V13, P1205, DOI 10.1089/ten.2006.0330
   Barczyk M, 2010, CELL TISSUE RES, V339, P269, DOI 10.1007/s00441-009-0834-6
   Bikle DD, 2002, J BONE MINER RES, V17, P1570, DOI 10.1359/jbmr.2002.17.9.1570
   Bosman FT, 2003, J PATHOL, V200, P423, DOI 10.1002/path.1437
   Chen DY, 2011, INT J MOL MED, V27, P707, DOI 10.3892/ijmm.2011.634
   De Bari C, 2006, ARTHRITIS RHEUM, V54, P1209, DOI 10.1002/art.21753
   De Bari C, 2001, ARTHRITIS RHEUM, V44, P85, DOI 10.1002/1529-0131(200101)44:1<85::AID-ANR12>3.0.CO;2-6
   Deng ZL, 2008, FRONT BIOSCI-LANDMRK, V13, P2001, DOI 10.2741/2819
   Dixon MJ, 2011, NAT REV GENET, V12, P167, DOI 10.1038/nrg2933
   Dominici M, 2006, CYTOTHERAPY, V8, P315, DOI 10.1080/14653240600855905
   Habibovic P, 2007, J TISSUE ENG REGEN M, V1, P25, DOI 10.1002/term.5
   Hamidouche Z, 2010, BMC CELL BIOL, V11, DOI 10.1186/1471-2121-11-44
   Hern DL, 1998, J BIOMED MATER RES, V39, P266, DOI 10.1002/(SICI)1097-4636(199802)39:2<266::AID-JBM14>3.0.CO;2-B
   Hersel U, 2003, BIOMATERIALS, V24, P4385, DOI 10.1016/S0142-9612(03)00343-0
   Hutmacher DW, 2003, TISSUE ENG, V9, pS45, DOI 10.1089/10763270360696978
   Irvine DJ, 2002, BIOPHYS J, V82, P120, DOI 10.1016/S0006-3495(02)75379-4
   Kantlehner M, 2000, CHEMBIOCHEM, V1, P107, DOI 10.1002/1439-7633(20000818)1:2<107::AID-CBIC107>3.3.CO;2-W
   Kantlehner M, 1999, ANGEW CHEM INT EDIT, V38, P560, DOI 10.1002/(SICI)1521-3773(19990215)38:4<560::AID-ANIE560>3.0.CO;2-F
   Kolhar P, 2010, J BIOTECHNOL, V146, P143, DOI 10.1016/j.jbiotec.2010.01.016
   Lieb E, 2005, BIOMATERIALS, V26, P2333, DOI 10.1016/j.biomaterials.2004.07.010
   Maheshwari G, 2000, J CELL SCI, V113, P1677
   MASSIA SP, 1991, J CELL BIOL, V114, P1089, DOI 10.1083/jcb.114.5.1089
   Orimo Hideo, 2010, Journal of Nippon Medical School, V77, P4
   PIERSCHBACHER MD, 1984, NATURE, V309, P30, DOI 10.1038/309030a0
   Pike DB, 2010, ADV DRUG DELIVER REV, V62, P167, DOI 10.1016/j.addr.2009.11.027
   Ringe J, 2008, J TISSUE ENG REGEN M, V2, P136, DOI 10.1002/term.75
   RUOSLAHTI E, 1987, SCIENCE, V238, P491, DOI 10.1126/science.2821619
   Schaffner P, 2003, CELL MOL LIFE SCI, V60, P119, DOI 10.1007/s000180300008
   Thumshirn G, 2003, CHEM-EUR J, V9, P2717, DOI 10.1002/chem.200204304
   van der Flier A, 2001, CELL TISSUE RES, V305, P285, DOI 10.1007/s004410100417
   Westlin WF, 2001, CANCER J, V7, pS139
   Yang XB, 2001, BONE, V29, P523, DOI 10.1016/S8756-3282(01)00617-2
   Zhu Shi-Jiang, 2006, Oral Surg Oral Med Oral Pathol Oral Radiol Endod, V101, P164, DOI 10.1016/j.tripleo.2005.04.006
NR 37
TC 9
Z9 10
U1 0
U2 19
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1549-3296
J9 J BIOMED MATER RES A
JI J. Biomed. Mater. Res. Part A
PD AUG
PY 2012
VL 100A
IS 8
BP 2034
EP 2044
DI 10.1002/jbm.a.34062
PG 11
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 961ZW
UT WOS:000305509700013
PM 22581657
DA 2018-10-19
ER

PT J
AU Jimenez-Pique, E
   Ramos, A
   Munoz-Tabares, JA
   Hatton, A
   Soldera, F
   Mucklich, F
   Anglada, M
AF Jimenez-Pique, E.
   Ramos, A.
   Munoz-Tabares, J. A.
   Hatton, A.
   Soldera, F.
   Muecklich, F.
   Anglada, M.
TI Focused ion beam tomography of zirconia degraded under hydrothermal
   conditions
SO JOURNAL OF THE EUROPEAN CERAMIC SOCIETY
LA English
DT Article
DE ZrO2; Mechanical properties; Defects; Tomography; Fracture
ID TETRAGONAL ZIRCONIA; CRACK MORPHOLOGIES; DEGRADATION; MICROSTRUCTURES;
   TRANSFORMATION; NANOINDENTATION; BIOMATERIAL; DEPENDENCE; CERAMICS;
   FUTURE
AB Three-dimensional tomography was performed on hydrothermal degraded zirconia by sequential focussed ion beam (FIB) sectioning and field emission scanning electron microscopy (FE-SEM) observation. By means of image analysis the distribution of microcracks produced under the surface was reconstructed and characterized.
   Results show a microcrack network preferentially oriented parallel to the surface, and a gradient in microcrack density from the surface, which is coherent with other measurements that reveal a decrease in monoclinic phase. The elastic properties of the reconstructed volume are simulated, showing that the deterioration of mechanical properties of degraded zirconia can be mainly attributed to microcracking, with a minor contribution of the phase transformation. (C) 2012 Elsevier Ltd. All rights reserved.
C1 [Jimenez-Pique, E.] Univ Politecn Cataluna, Ctr Res Nanoengn CRnE, E-08028 Barcelona, Spain.
   [Ramos, A.] Univ Ramon Llull, Inst Quim Sarria, Grp Engn Mat, Barcelona 08017, Spain.
   [Hatton, A.; Soldera, F.; Muecklich, F.] Univ Saarland, Dept Mat Sci, D-66123 Saarbrucken, Germany.
RP Jimenez-Pique, E (reprint author), Univ Politecn Cataluna, Ctr Res Nanoengn CRnE, Avda Diagonal 647 ETSEIB, E-08028 Barcelona, Spain.
EM emilio.jimenez@upc.edu
RI Munoz Tabares, Jose Alejandro/E-1154-2011
OI Munoz Tabares, Jose Alejandro/0000-0001-9646-9927; ANGLADA,
   MARC/0000-0003-4955-3434; Soldera, Flavio/0000-0002-5904-496X; Ramos
   Masana, Ana/0000-0003-4405-2083; Jimenez-Pique,
   Emilio/0000-0002-6950-611X
FU Ministerio de Ciencia e Innovacion (MICINN) of Spain [MAT2008-03398];
   EFRE of European Commission
FX The authors would like to acknowledge the financial support provided by
   the Ministerio de Ciencia e Innovacion (MICINN) of Spain through project
   MAT2008-03398 F. Soldera and F. Mucklich thank the EFRE Funds of the
   European Commission for support of activities within the AME-Lab
   project.
CR Casellas D, 2001, J EUR CERAM SOC, V21, P765, DOI 10.1016/S0955-2219(00)00273-9
   Cattani-Lorente M, 2011, ACTA BIOMATER, V7, P858, DOI 10.1016/j.actbio.2010.09.020
   Chevalier J, 2006, BIOMATERIALS, V27, P535, DOI 10.1016/j.biomaterials.2005.07.034
   Chevalier J, 2007, ANNU REV MATER RES, V37, P1, DOI 10.1146/annurev.matsci.37.052506.084250
   Chevalier J, 2009, J AM CERAM SOC, V92, P1901, DOI 10.1111/j.1551-2916.2009.03278.x
   Deville S, 2005, J BIOMED MATER RES B, V72B, P239, DOI 10.1002/jbm.b.30123
   Deville S, 2004, ACTA MATER, V52, P5709, DOI 10.1016/j.actamat.2004.08.036
   Elfallagh F, 2009, J EUR CERAM SOC, V29, P47, DOI 10.1016/j.jeurceramsoc.2008.05.042
   Elfallagh F, 2008, J MICROSC-OXFORD, V230, P240, DOI 10.1111/j.1365-2818.2008.01981.x
   Fischer FD, 2003, EUR J MECH A-SOLID, V22, P709, DOI 10.1016/S0997-7538(03)00081-0
   Gaillard Y, 2008, ACTA MATER, V56, P4206, DOI 10.1016/j.actamat.2008.04.050
   Gaillard Y, 2006, PHILOS MAG, V86, P5441, DOI 10.1080/14786430600778674
   Gaillard Y, 2009, J MATER RES, V24, P719, DOI 10.1557/JMR.2009.0091
   Guo X, 2001, J MATER SCI, V36, P3737, DOI 10.1023/A:1017925800904
   Jeanvoine N, 2008, ADV ENG MATER, V10, P973, DOI 10.1002/adem.200800108
   Kara A, 2004, J EUR CERAM SOC, V24, P3091, DOI [10.1016/j.jeurceramsoc.2003.11.004, 10.1016/j.jeurceramsoc.2003.10.004]
   KIM YS, 1994, J NUCL MATER, V209, P326, DOI 10.1016/0022-3115(94)90271-2
   Luo J, 1999, CERAM INT, V25, P281, DOI 10.1016/S0272-8842(98)00037-6
   Marro FG, 2009, INT J MATER RES, V100, P92, DOI 10.3139/146.101791
   Morales M, 2010, ACTA MATER, V58, P2504, DOI 10.1016/j.actamat.2009.12.036
   Mufioz-Tabares JA, 2010, J AM CERAM SOC, V936, P1790
   Munoz-Tabares JA, 2011, ACTA MATER, V59, P473, DOI 10.1016/j.actamat.2010.09.047
   Ohser J., 2000, STAT ANAL MICROSTRUC
   Piconi C, 1999, BIOMATERIALS, V20, P1, DOI 10.1016/S0142-9612(98)00010-6
   Russ John C., 2000, PRACTICAL STEREOLOGY
   Soldera FA, 2011, ADV STRUCT MAT, V10, P171, DOI 10.1007/978-3-642-17782-8_8
   Velichko A, 2008, ACTA MATER, V56, P1981, DOI 10.1016/j.actamat.2007.12.033
   Velichko A, 2009, ADV SOLID STATE PHYS, V48, P331, DOI 10.1007/978-3-540-85859-1_26
NR 28
TC 19
Z9 19
U1 1
U2 28
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0955-2219
J9 J EUR CERAM SOC
JI J. Eur. Ceram. Soc.
PD AUG
PY 2012
VL 32
IS 10
BP 2129
EP 2136
DI 10.1016/j.jeurceramsoc.2012.02.011
PG 8
WC Materials Science, Ceramics
SC Materials Science
GA 952HH
UT WOS:000304782600010
DA 2018-10-19
ER

PT J
AU Fiedler, T
   Belova, IV
   Murch, GE
   Roether, JA
   Boccaccini, AR
AF Fiedler, T.
   Belova, I. V.
   Murch, G. E.
   Roether, J. A.
   Boccaccini, A. R.
TI Tailoring elastic properties of PLGA/TiO2 biomaterials
SO COMPUTATIONAL MATERIALS SCIENCE
LA English
DT Article
DE Biomaterial; Particle reinforced composite; Elastic properties; Finite
   element analysis; Analytical analysis
ID TISSUE ENGINEERING SCAFFOLDS; BONE; NANOCOMPOSITES; BIOACTIVITY; MODULUS
AB This paper addresses the mechanical properties of titania reinforced poly(lactic-co-glycolic acid) (PLGA), a composite material being considered for applications in bone tissue engineering. Titania nano-particles are added to the PLGA matrix for the improvement of mechanical properties. By changing the fraction of reinforcement, mechanical properties can be adjusted to match values of the surrounding tissue for mechanical compatibility. Numerical finite element and theoretical analyses were conducted to obtain simple design guidelines for tailoring the mechanical properties of these promising composites. (c) 2012 Elsevier B.V. All rights reserved.
C1 [Fiedler, T.; Belova, I. V.; Murch, G. E.] Univ Newcastle, Univ Ctr Mass & Thermal Transport Engn Mat, Sch Engn, Callaghan, NSW 2308, Australia.
   [Roether, J. A.] Univ Erlangen Nurnberg, Dept Mat Sci & Engn, Inst Polymer Mat, D-91058 Erlangen, Germany.
   [Boccaccini, A. R.] Univ Erlangen Nurnberg, Inst Biomat, Dept Mat Sci & Engn, D-91058 Erlangen, Germany.
RP Fiedler, T (reprint author), Univ Newcastle, Univ Ctr Mass & Thermal Transport Engn Mat, Sch Engn, Callaghan, NSW 2308, Australia.
EM Thomas.Fiedler@newcastle.edu.au
RI Boccaccini, Aldo/C-7905-2013
OI Fiedler, Thomas/0000-0003-0256-8233
CR ASHMAN RB, 1988, J BIOMECH, V21, P177, DOI 10.1016/0021-9290(88)90167-4
   Boccaccini AR, 2010, COMPOS SCI TECHNOL, V70, P1764, DOI 10.1016/j.compscitech.2010.06.002
   Bosisio MR, 2007, J BIOMECH, V40, P2022, DOI 10.1016/j.jbiomech.2006.09.018
   ESHELBY JD, 1957, PROC R SOC LON SER-A, V241, P376, DOI 10.1098/rspa.1957.0133
   Guarino V, 2007, EXPERT REV MED DEVIC, V4, P405, DOI 10.1586/17434440.4.3.405
   Hench LL, 2002, SCIENCE, V295, P1014, DOI 10.1126/science.1067404
   Ichitsubo T, 2002, ACTA MATER, V50, P4105, DOI 10.1016/S1359-6454(02)00228-8
   Karageorgiou V, 2005, BIOMATERIALS, V26, P5474, DOI 10.1016/j.biomaterials.2005.02.002
   Luo YB, 2009, ACTA MATER, V57, P3182, DOI 10.1016/j.actamat.2009.03.022
   Milton G. W., 2002, THEORY COMPOSITES
   Novak S, 2009, J MATER SCI, V44, P1442, DOI 10.1007/s10853-008-2858-9
   O'Brien FJ, 2011, MATER TODAY, V14, P88, DOI 10.1016/S1369-7021(11)70058-X
   Odin G, 2010, MED ENG PHYS, V32, P630, DOI 10.1016/j.medengphy.2010.03.009
   Ratner BD, 2004, ANNU REV BIOMED ENG, V6, P41, DOI 10.1146/annurev.bioeng.6.040803.140027
   Shackelford J. F., 2000, CRC MAT SCI ENG HDB
   Tamjid E, 2011, MATER LETT, V65, P2530, DOI 10.1016/j.matlet.2011.05.037
   Torquato S, 2002, RANDOM HETERGENEOUS
   Torres FG, 2007, COMPOS SCI TECHNOL, V67, P1139, DOI 10.1016/j.compscitech.2006.05.018
   Wang YJ, 2010, J BIOMED MATER RES B, V93B, P84, DOI 10.1002/jbm.b.31561
NR 19
TC 6
Z9 6
U1 0
U2 22
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0927-0256
J9 COMP MATER SCI
JI Comput. Mater. Sci.
PD AUG
PY 2012
VL 61
BP 283
EP 286
DI 10.1016/j.commatsci.2012.04.043
PG 4
WC Materials Science, Multidisciplinary
SC Materials Science
GA 949FL
UT WOS:000304562000038
DA 2018-10-19
ER

PT J
AU Elias, PZ
   Spector, M
AF Elias, Paul Z.
   Spector, Myron
TI Implantation of a collagen scaffold seeded with adult rat hippocampal
   progenitors in a rat model of penetrating brain injury
SO JOURNAL OF NEUROSCIENCE METHODS
LA English
DT Article
DE Penetrating brain injury; Traumatic brain injury; Collagen scaffold;
   Brain tissue engineering; Stem cells; Adult hippocampal neural
   progenitors
ID NEURAL STEM-CELLS; MAJOR HISTOCOMPATIBILITY COMPLEX; STEM/PROGENITOR
   CELLS; IN-VITRO; PERINEURONAL OLIGODENDROCYTES; NEURONAL
   DIFFERENTIATION; FUNCTIONAL RECOVERY; PARKINSONS-DISEASE; COGNITIVE
   FUNCTION; MHC EXPRESSION
AB Penetrating brain injury (PBI) is a complex central nervous system injury in which mechanical damage to brain parenchyma results in hemorrhage, ischemia, broad areas of necrosis, and eventually cavitation. The permanent loss of brain tissue affords the possibility of treatment using a biomaterial scaffold to fill the lesion site and potentially deliver pharmacological or cellular therapeutic agents. The administration of cellular therapy may be of benefit in both mitigating the secondary injury process and promoting regeneration through replacement of certain cell populations. This study investigated the survival and differentiation of adult rat hippocampal neural progenitor cells delivered by a collagen scaffold in a rat model of PBI. The cell-scaffold construct was implanted 1 week after injury and was observed to remain intact with open pores upon analysis 4 weeks later. Implanted neural progenitors were found to have survived within the scaffold, and also to have migrated into the surrounding brain. Differentiated phenotypes included astrocytes, oligodendrocytes, vascular endothelial cells, and possibly macrophages. The demonstrated multipotency of this cell population in vivo in the context of traumatic brain injury has implications for regenerative therapies, but additional stimulation appears necessary to promote neuronal differentiation outside normally neurogenic regions. (c) 2012 Elsevier B.V. All rights reserved.
C1 [Elias, Paul Z.; Spector, Myron] VA Boston Healthcare Syst, Tissue Engn Labs, Boston, MA 02130 USA.
   [Elias, Paul Z.] MIT, Harvard Mit Div Hlth Sci & Technol, Cambridge, MA 02139 USA.
   [Spector, Myron] Harvard Univ, Sch Med, Dept Orthoped Surg, Brigham & Womens Hosp, Boston, MA 02115 USA.
RP Elias, PZ (reprint author), VA Boston Healthcare Syst, Tissue Engn Labs, Mail Stop 151,150 S Huntington Ave, Boston, MA 02130 USA.
EM pzelias@alum.mit.edu; mspector@rics.bwh.harvard.edu
OI Spector, Myron/0000-0003-3328-4858
FU U.S. Department of Veterans Affairs; Veterans Health Administration,
   Rehabilitation Research and Development Service
FX This research was supported by the U.S. Department of Veterans Affairs,
   Veterans Health Administration, Rehabilitation Research and Development
   Service.
CR Aberg MAI, 2003, MOL CELL NEUROSCI, V24, P23, DOI 10.1016/S1044-7431(03)00082-4
   Al Nimer F, 2004, NEUROREPORT, V15, P1871, DOI 10.1097/00001756-200408260-00007
   Andres RH, 2008, NEUROSURG FOCUS, V24, DOI 10.3171/FOC/2008/24/3-4/E15
   Arvidsson A, 2002, NAT MED, V8, P963, DOI 10.1038/nm747
   Astradsson A, 2008, NEUROSURG FOCUS, V24, DOI 10.3171/FOC/2008/24/3-4/E5
   Bakshi A, 2006, EUR J NEUROSCI, V23, P2119, DOI 10.1111/j.1460-9568.2006.04743.x
   Bakshi A, 2005, BRAIN RES, V1065, P8, DOI 10.1016/j.brainres.2005.09.059
   Baschong W, 2001, J HISTOCHEM CYTOCHEM, V49, P1565, DOI 10.1177/002215540104901210
   Ben-Hur T, 2008, ANN NY ACAD SCI, V1142, P218, DOI 10.1196/annals.1444.014
   Ben-Shaanan TL, 2008, MOL PSYCHIATR, V13, P222, DOI 10.1038/sj.mp.4002084
   Bifari Francesco, 2010, World J Stem Cells, V2, P50, DOI 10.4252/wjsc.v2.i3.50
   Bolliet C, 2008, TISSUE ENG PT C-METH, V14, P207, DOI 10.1089/ten.tec.2008.0168
   Bramlett HM, 2004, J CEREBR BLOOD F MET, V24, P133, DOI 10.1097/01.WCB.0000111614.19196.04
   Capetian P, 2011, SEMIN IMMUNOPATHOL, V33, P619, DOI 10.1007/s00281-011-0272-x
   Carson MJ, 2006, IMMUNOL REV, V213, P48, DOI 10.1111/j.1600-065X.2006.00441.x
   Chen ZG, 2008, HUM MOL GENET, V17, pR84, DOI 10.1093/hmg/ddn104
   Chen ZG, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014787
   Chen ZY, 2011, BRAIN RES, V1368, P71, DOI 10.1016/j.brainres.2010.10.028
   Chiba S, 2004, J NEUROL SCI, V219, P107, DOI 10.1016/j.jns.2004.01.006
   Chopp M, 2008, ACT NEUR S, V105, P79
   Clelland CD, 2008, NEUROSURG FOCUS, V24, DOI 10.3171/FOC/2008/24/3-4/E8
   Compton CC, 1998, J INVEST DERMATOL, V110, P908, DOI 10.1046/j.1523-1747.1998.00200.x
   Coras R, 2010, BRAIN, V133, P3359, DOI 10.1093/brain/awq215
   Cromey DW, 2010, SCI ENG ETHICS, V16, P639, DOI 10.1007/s11948-010-9201-y
   Dayer AG, 2007, BRAIN, V130, P2962, DOI 10.1093/brain/awm200
   Delcroix GJR, 2010, BIOMATERIALS, V31, P2105, DOI 10.1016/j.biomaterials.2009.11.084
   Dziewczapolski G, 2003, EXP NEUROL, V183, P653, DOI 10.1016/S0014-4886(03)00212-7
   Elias PZ, 2012, J MECH BEHAV BIOMED, V12, P63, DOI 10.1016/j.jmbbm.2012.03.014
   Elias PZ, 2012, J NEUROTRAU IN PRESS
   Faijerson J, 2006, J NEUROSCI RES, V84, P1415, DOI 10.1002/jnr.21044
   Freed CR, 2001, NEW ENGL J MED, V344, P710, DOI 10.1056/NEJM200103083441002
   GAGE FH, 1995, P NATL ACAD SCI USA, V92, P11879, DOI 10.1073/pnas.92.25.11879
   Gao JL, 2006, EXP NEUROL, V201, P281, DOI 10.1016/j.expneurol.2006.04.039
   Goya RL, 2011, NEUROBIOL DIS, V41, P407, DOI 10.1016/j.nbd.2010.10.008
   Guillemin GJ, 2004, J LEUKOCYTE BIOL, V75, P388, DOI 10.1189/jlb.0303114
   Hagan M, 2003, NEUROSCI LETT, V351, P149, DOI 10.1016/S0304-3940(03)00944-3
   Harley BA, 2004, CELLS TISSUES ORGANS, V176, P153, DOI 10.1159/000075035
   Harley BA, 2007, ACTA BIOMATER, V3, P463, DOI 10.1016/j.aetbio.2006.12.009
   Harting MT, 2008, NEUROSURG FOCUS, V24, DOI 10.3171/FOC/2008/24/3-4/E17
   Harting MT, 2009, J SURG RES, V153, P188, DOI 10.1016/j.jss.2008.03.037
   Hermann A, 2006, J NEUROCHEM, V98, P629, DOI 10.1111/j.1471-4159.2006.03916.x
   Hori J, 2003, STEM CELLS, V21, P405, DOI 10.1634/stemcells.21-4-405
   Hsieh J, 2004, J CELL BIOL, V164, P111, DOI 10.1083/jcb.200308101
   Hsieh J, 2004, P NATL ACAD SCI USA, V101, P16659, DOI 10.1073/pnas.0407643101
   Hsu WC, 2000, INVEST OPHTH VIS SCI, V41, P2404
   Jain KK, 2009, MOL BIOTECHNOL, V42, P367, DOI 10.1007/s12033-009-9166-8
   Jessberger S, 2008, NAT NEUROSCI, V11, P888, DOI 10.1038/nn.2148
   Johansson CB, 1999, EXP CELL RES, V253, P733, DOI 10.1006/excr.1999.4678
   Johansson S, 2008, STEM CELLS, V26, P2444, DOI 10.1634/stemcells.2008-0116
   Klassen H, 2003, VISION RES, V43, P947, DOI 10.1016/S0042-6989(03)00094-4
   Li Y, 2009, NEUROSCI LETT, V456, P120, DOI 10.1016/j.neulet.2008.03.096
   Lo EH, 2008, NAT MED, V14, P497, DOI 10.1038/nm1735
   Lu DY, 2002, CELL TRANSPLANT, V11, P275
   Lu DY, 2002, J NEUROSURG, V97, P935, DOI 10.3171/jns.2002.97.4.0935
   LUDWIN SK, 1984, NEUROPATH APPL NEURO, V10, P143, DOI 10.1111/j.1365-2990.1984.tb00345.x
   LUDWIN SK, 1979, ACTA NEUROPATHOL, V47, P49, DOI 10.1007/BF00698272
   Muir JK, 1999, J NEUROTRAUM, V16, P403, DOI 10.1089/neu.1999.16.403
   Naegele JR, 2010, NEUROPHARMACOLOGY, V58, P855, DOI 10.1016/j.neuropharm.2010.01.019
   Nakada A, 2009, CELLS TISSUES ORGANS, V190, P326, DOI 10.1159/000223233
   Nehlin JO, 2009, BIOGERONTOLOGY, V10, P339, DOI 10.1007/s10522-009-9213-7
   Odeberg J, 2005, J NEUROIMMUNOL, V161, P1, DOI 10.1016/j.jneuroim.2004.11.016
   Oishi K, 2004, J PHARMACOL SCI, V96, P208, DOI 10.1254/jphs.FP0040373
   Olanow CW, 2003, ANN NEUROL, V54, P403, DOI 10.1002/ana.10720
   Pagani L, 2008, NEUROL RES, V30, P244, DOI 10.1179/016164107X230667
   Palmer TD, 1997, MOL CELL NEUROSCI, V8, P389, DOI 10.1006/mcne.1996.0595
   Park KI, 2002, NAT BIOTECHNOL, V20, P1111, DOI 10.1038/nbt751
   Philips MF, 1999, J NEUROSURG, V90, P116, DOI 10.3171/jns.1999.90.1.0116
   Prajerova I, 2010, CELL MOL NEUROBIOL, V30, P199, DOI 10.1007/s10571-009-9443-x
   Ricci-Vitiani L, 2006, NEUROL RES, V28, P488, DOI 10.1179/016164106X115134
   Richardson RM, 2010, J NEUROSURG, V112, P1125, DOI 10.3171/2009.4.JNS081087
   Riess P, 2002, NEUROSURGERY, V51, P1043, DOI 10.1227/01.NEU.0000027826.68845.CF
   Roshal LM, 2009, B EXP BIOL MED+, V148, P140, DOI 10.1007/s10517-009-0642-8
   Ruoslahti E, 1996, GLYCOBIOLOGY, V6, P489, DOI 10.1093/glycob/6.5.489
   Sapsford W, 2003, J R Army Med Corps, V149, P5
   Shear DA, 2004, BRAIN RES, V1026, P11, DOI 10.1016/j.brainres.2004.07.087
   Shindo T, 2006, J MED INVESTIG, V53, P42, DOI 10.2152/jmi.53.42
   Sinson G, 1996, J NEUROSURG, V84, P655, DOI 10.3171/jns.1996.84.4.0655
   Spilker MH, 2001, RESTOR NEUROL NEUROS, V18, P23
   Sun JQ, 2010, DEV DYNAM, V239, P2345, DOI 10.1002/dvdy.22377
   Takahashi J, 1999, J NEUROBIOL, V38, P65, DOI 10.1002/(SICI)1097-4695(199901)38:1<65::AID-NEU5>3.3.CO;2-H
   Takasaki C, 2010, EUR J NEUROSCI, V32, P1326, DOI 10.1111/j.1460-9568.2010.07377.x
   Taniike M, 2002, J NEUROSCI, V22, P4885, DOI 10.1523/JNEUROSCI.22-12-04885.2002
   Tate CC, 2009, J TISSUE ENG REGEN M, V3, P208, DOI 10.1002/term.154
   Tate MC, 2002, CELL TRANSPLANT, V11, P283
   Teng FYH, 2009, DIFFERENTIATION, V77, P121, DOI 10.1016/j.diff.2008.09.013
   Ubiali F, 2007, INT IMMUNOL, V19, P1063, DOI 10.1093/intimm/dxm079
   Walker PA, 2010, STEM CELLS INT, DOI 10.4061/2010/369578
   Wang TW, 2009, ACTA BIOMATER, V5, P2371, DOI 10.1016/j.actbio.2009.03.033
   Williams AJ, 2005, J NEUROTRAUM, V22, P313, DOI 10.1089/neu.2005.22.313
   Williams AJ, 2007, J NEUROINFLAMM, V4, DOI 10.1186/1742-2094-4-17
   Williams AJ, 2006, NEUROSCI LETT, V408, P183, DOI 10.1016/j.neulet.2006.08.086
   Williams AJ, 2006, J NEUROTRAUM, V23, P1828, DOI 10.1089/neu.2006.23.1828
   Wong DY, 2008, J NEUROSURG, V109, P715, DOI 10.3171/JNS/2008/109/10/0715
   Wong DY, 2007, TISSUE ENG, V13, P2515, DOI 10.1089/ten.2006.0440
   Wurmser AE, 2004, NATURE, V430, P350, DOI 10.1038/nature02604
   Wurmser AE, 2002, NATURE, V416, P485, DOI 10.1038/416485a
   Yin L, 2008, STEM CELLS DEV, V17, P53, DOI 10.1089/scd.2007.0063
NR 97
TC 13
Z9 17
U1 0
U2 21
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0165-0270
EI 1872-678X
J9 J NEUROSCI METH
JI J. Neurosci. Methods
PD JUL 30
PY 2012
VL 209
IS 1
BP 199
EP 211
DI 10.1016/j.jneumeth.2012.06.003
PG 13
WC Biochemical Research Methods; Neurosciences
SC Biochemistry & Molecular Biology; Neurosciences & Neurology
GA 983QB
UT WOS:000307132700024
PM 22698665
DA 2018-10-19
ER

PT J
AU Hofstetter, M
   Howgate, J
   Schmid, M
   Schoell, S
   Sachsenhauser, M
   Adiguzel, D
   Stutzmann, M
   Sharp, ID
   Thalhammer, S
AF Hofstetter, Markus
   Howgate, John
   Schmid, Martin
   Schoell, Sebastian
   Sachsenhauser, Matthias
   Adiguezel, Denis
   Stutzmann, Martin
   Sharp, Ian D.
   Thalhammer, Stefan
TI In vitro bio-functionality of gallium nitride sensors for radiation
   biophysics
SO BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
LA English
DT Article
DE Gallium nitride; Biocompatibility; Biofunctionality; Biomaterial; DNA
   double strand breaks; Ionizing radiation
ID FIELD-EFFECT TRANSISTORS; MICROELECTRODE ARRAY; ELECTROGENIC CELLS;
   STRAND BREAKS; DNA-DAMAGE; SURFACES; GAN; REPAIR; BIOSENSORS
AB There is an increasing interest in the integration of hybrid bio-semiconductor systems for the non-invasive evaluation of physiological parameters. High quality gallium nitride and its alloys show promising characteristics to monitor cellular parameters. Nevertheless, such applications not only request appropriate sensing capabilities but also the biocompatibility and especially the biofunctionality of materials. Here we show extensive biocompatibility studies of gallium nitride and, for the first time, a biofunctionality assay using ionizing radiation. Analytical sensor devices are used in medical settings, as well as for cell-and tissue engineering. Within these fields, semiconductor devices have increasingly been applied for online biosensing on a cellular and tissue level. Integration of advanced materials such as gallium nitride into these systems has the potential to increase the range of applicability for a multitude of test devices and greatly enhance sensitivity and functionality. However, for such applications it is necessary to optimize cell-surface interactions and to verify the biocompatibility of the semiconductor. In this work, we present studies of mouse fibroblast cell activity grown on gallium nitride surfaces after applying external noxa. Cell-semiconductor hybrids were irradiated with X-rays at air kerma doses up to 250 mGy and the DNA repair dynamics, cell proliferation, and cell growth dynamics of adherent cells were compared to control samples. The impact of ionizing radiation on DNA, along with the associated cellular repair mechanisms, is well characterized and serves as a reference tool for evaluation of substrate effects. The results indicate that gallium nitride does not require specific surface treatments to ensure biocompatibility and suggest that cell signaling is not affected by micro-environmental alterations arising from gallium nitride-cell interactions. The observation that gallium nitride provides no bio-functional influence on the cellular environment confirms that this material is well suited for future biosensing applications without the need for additional chemical surface modification.
C1 [Hofstetter, Markus; Schmid, Martin; Adiguezel, Denis; Thalhammer, Stefan] German Res Ctr Environm Hlth, Helmholtz Zentrum Munchen, D-85764 Neuherberg, Germany.
   [Howgate, John; Schoell, Sebastian; Sachsenhauser, Matthias; Stutzmann, Martin; Sharp, Ian D.] Tech Univ Munich, Walter Schottky Inst, D-85748 Garching, Germany.
RP Thalhammer, S (reprint author), German Res Ctr Environm Hlth, Helmholtz Zentrum Munchen, Ingolstadter Landstr 1, D-85764 Neuherberg, Germany.
EM stefan.thalhammer@helmholtz-muenchen.de
RI Sharp, Ian/I-6163-2015; Thalhammer, Stefan/C-1031-2011; Stutzmann,
   Martin/B-1480-2012
OI Sharp, Ian/0000-0001-5238-7487; Stutzmann, Martin/0000-0002-0068-3505
FU German Excellence Initiative via the Nanosystems Initiative Munich
   (NIM); Technische Universitat Munchen - Institute for Advanced Study;
   German Excellence Initiative
FX This work was supported by the German Excellence Initiative via the
   Nanosystems Initiative Munich (NIM) and the Technische Universitat
   Munchen - Institute for Advanced Study, funded by the German Excellence
   Initiative. We thank Sabine Konzack, Robin Materlik, and Terry R.
   Heidmann for experimental work.
CR Anderson L, 2001, MOL CELL BIOL, V21, P1719, DOI 10.1128/MCB.21.5.1719-1729.2001
   Aylon Y, 2004, DNA REPAIR, V3, P797, DOI 10.1016/j.dnarep.2004.04.013
   Baur B, 2005, APPL PHYS LETT, V87, DOI 10.1063/1.2150280
   Berdat D, 2006, SENSOR ACTUAT B-CHEM, V118, P53, DOI 10.1016/j.snb.2006.04.064
   BERGVELD P, 1976, IEEE T BIO-MED ENG, V23, P136, DOI 10.1109/TBME.1976.324574
   Bousse L, 1996, SENSOR ACTUAT B-CHEM, V34, P270, DOI 10.1016/S0925-4005(96)01906-5
   Cimalla I, 2007, SENSOR ACTUAT B-CHEM, V123, P740, DOI 10.1016/j.snb.2006.10.030
   COLLINS AR, 1995, MUTAT RES-DNA REPAIR, V336, P69, DOI 10.1016/0921-8777(94)00043-6
   CONNOLLY P, 1990, BIOSENS BIOELECTRON, V5, P223, DOI 10.1016/0956-5663(90)80011-2
   Estephan E, 2008, J PHYS CHEM B, V112, P8799, DOI 10.1021/jp804112y
   Guemouri L, 2000, J CHEM PHYS, V113, P8183, DOI 10.1063/1.1314861
   Heer F, 2004, BIOSENS BIOELECTRON, V20, P358, DOI 10.1016/j.bios.2004.02.006
   Hofstetter M, 2011, PHYS MED BIOL, V56, P3215, DOI 10.1088/0031-9155/56/11/004
   Hofstetter M, 2010, APPL PHYS LETT, V96, DOI 10.1063/1.3334682
   Howgate J, 2010, ADV MATER, V22, P2632, DOI 10.1002/adma.200903756
   Kloss FR, 2007, J NANOSCI NANOTECHNO, V7, P4581, DOI 10.1166/jnn.2007.004
   Mahmoodi M, 2011, PROPERTIES AND APPLICATIONS OF SILICON CARBIDE, P297
   Reichert W.M., 2000, HDB BIOMATERIALS EVA, V28
   Richards R.G., 1996, INJURY, V23, P38
   Rothkamm K, 2003, P NATL ACAD SCI USA, V100, P5057, DOI 10.1073/pnas.0830918100
   Schoell SJ, 2008, APPL PHYS LETT, V92, DOI 10.1063/1.2908871
   Steinhoff G, 2005, APPL PHYS LETT, V86, DOI [10.1063/1.1853531, 10.1063/1.185331]
   Steinhoff G, 2003, ADV FUNCT MATER, V13, P841, DOI 10.1002/adfm.200304397
   Steinhoff G, 2003, APPL PHYS LETT, V83, P177, DOI 10.1063/1.1589188
   THOMAS CA, 1972, EXP CELL RES, V74, P61, DOI 10.1016/0014-4827(72)90481-8
   WARD JF, 1990, INT J RADIAT BIOL, V57, P1141, DOI 10.1080/09553009014551251
   Yu JJ, 2007, BIOSENS BIOELECTRON, V23, P513, DOI 10.1016/j.bios.2007.06.014
NR 27
TC 14
Z9 14
U1 0
U2 30
PU ACADEMIC PRESS INC ELSEVIER SCIENCE
PI SAN DIEGO
PA 525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA
SN 0006-291X
J9 BIOCHEM BIOPH RES CO
JI Biochem. Biophys. Res. Commun.
PD JUL 27
PY 2012
VL 424
IS 2
BP 348
EP 353
DI 10.1016/j.bbrc.2012.06.142
PG 6
WC Biochemistry & Molecular Biology; Biophysics
SC Biochemistry & Molecular Biology; Biophysics
GA 986TS
UT WOS:000307369100026
PM 22771805
DA 2018-10-19
ER

PT J
AU Lee, HM
   Kim, JK
   Cho, TS
AF Lee, Hyun Mee
   Kim, Jong-Ki
   Cho, Tae-Sub
TI Applications of ophthalmic biomaterials embedded with fucoidan
SO JOURNAL OF INDUSTRIAL AND ENGINEERING CHEMISTRY
LA English
DT Review
DE Hydrogel; Poly(2-hydroxyethyl methacylate); Methacrylic acid;
   Biomaterial; Antibacterial; Protein adsorption; Polymer
ID HYDROGEL CONTACT-LENSES; CONTROLLED DRUG-RELEASE; SULFATED
   POLYSACCHARIDE; BACTERIAL ADHESION; PSEUDOMONAS-AERUGINOSA; POLY(HEMA)
   HYDROGELS; LAMINARIA-JAPONICA; PROTEIN ADSORPTION; VIRUS-INFECTION;
   CHARGED GROUPS
AB Hydrogel biofilms of a biocompatible polymer, poly(2-hydroxyethyl methacylate) (pHEMA), containing fucoidan and/or methacrylic acid (MAA) were synthesized and tested for suitability of biomedical application. Films' water contents, antimicrobial effects and protein adsorption in the presence of various concentrations of fucoidan were measured. Protein adsorption in various MAA concentrations at fixed fucoidan concentration was also studied. The adsorption of bovine serum albumin was found to be independent of the concentrations of fucoidan and MAA. In the absence of MAA, lysozyme adsorption was not affected by the concentration of fucoidan. The presence of MAA increased the amount of adsorbed lysozyme. The antibacterial activity of fucoidan had little effect in the absence of MAA. However, in the presence of MAA, the antibacterial effect of fucoidan increased with increasing MAA concentration. (c) 2012 The Korean Society of Industrial and Engineering Chemistry. Published by Elsevier B.V. All rights reserved.
C1 [Cho, Tae-Sub] Yeungnam Univ Daedong, Dept Chem, Coll Sci, Gyongsan 712749, Gyeongbuk, South Korea.
   [Lee, Hyun Mee] Catholic Univ Daegu, Dept Optometry & Vis Sci, Coll Hlth & Med Sci, Gyongsan 712702, Gyeongbuk, South Korea.
   [Kim, Jong-Ki] Catholic Univ Daegu, Dept Biomed Engn, Sch Med, Taegu 705034, South Korea.
RP Cho, TS (reprint author), Yeungnam Univ Daedong, Dept Chem, Coll Sci, Gyongsan 712749, Gyeongbuk, South Korea.
EM tscho@yu.ac.kr
FU Basic Science Research Program though the National Research Foundation
   of Korea (NRF); Ministry of Education, Science and Technology
   [2011-0014794]; Yeungnam University
FX This research was supported by Basic Science Research Program though the
   National Research Foundation of Korea (NRF) funded by the Ministry of
   Education, Science and Technology (No. 2011-0014794) and an internal
   research grant of Yeungnam University.
CR Ahanotu Ejem N., 2001, CLAO Journal, V27, P89
   Anderson JM, 2008, SEMIN IMMUNOL, V20, P86, DOI 10.1016/j.smim.2007.11.004
   Beyer M, 2006, BIOMATERIALS, V27, P3505, DOI 10.1016/j.biomaterials.2006.01.046
   BOHNERT JL, 1988, INVEST OPHTH VIS SCI, V29, P362
   Chan GYN, 2006, BIOMATERIALS, V27, P1287, DOI 10.1016/j.biomaterials.2005.08.005
   Cook A D, 1993, J Biomater Appl, V8, P72, DOI 10.1177/088532829300800105
   COOK AD, 1993, J BIOMED MATER RES, V27, P119, DOI 10.1002/jbm.820270115
   Cowell BA, 1998, J APPL MICROBIOL, V84, P950
   Dumitriu S., 2002, POLYM BIOMATERIALS
   Fleiszig SMJ, 1996, OPTOMETRY VISION SCI, V73, P590, DOI 10.1097/00006324-199609000-00005
   FLEISZIG SMJ, 1992, J CLIN MICROBIOL, V30, P1156
   Gao BJ, 2010, COLLOID SURFACE B, V77, P206, DOI 10.1016/j.colsurfb.2010.01.025
   Garrett Q, 1998, BIOMATERIALS, V19, P2175, DOI 10.1016/S0142-9612(98)00125-2
   Garrett Q., 2006, BIOMATERIALS, V27, P1341
   Gatta La, 2009, J BIOMED MATER RES A, V90, P292
   Hayashi K, 2008, INT IMMUNOPHARMACOL, V8, P109, DOI 10.1016/j.intimp.2007.10.017
   He HY, 2004, J CONTROL RELEASE, V95, P391, DOI 10.1016/j.jconrel.2003.12.004
   Houghton PJ, 2005, J ETHNOPHARMACOL, V100, P100, DOI 10.1016/j.jep.2005.07.001
   Hu MX, 2006, J MEMBRANE SCI, V285, P196, DOI 10.1016/j.memsci.2006.08.023
   Jeong E.-S., 2009, FISH AQUA SCI, V12, P194
   Lee HM, 2011, B KOREAN CHEM SOC, V32, P4239, DOI 10.5012/bkcs.2011.32.12.4239
   Lord MS, 2006, BIOMATERIALS, V27, P567, DOI 10.1016/jbiomaterials.2005.06.010
   Luensmann Doerte, 2008, Cont Lens Anterior Eye, V31, P179, DOI 10.1016/j.clae.2008.05.004
   Mabilleau G, 2006, J BIOMED MATER RES A, V77A, P35, DOI 10.1002/jbm.a.30618
   Magnusson KE, 1982, SCAND J INFECT DIS S, V33, P32
   Makarenkova I. D., 2010, Voprosy Virusologii, V55, P41
   Martineau L, 2006, BURNS, V32, P172, DOI 10.1016/j.burns.2005.08.012
   PANJWANI N, 1990, INVEST OPHTH VIS SCI, V31, P696
   PASCUAL A, 1986, EUR J CLIN MICROBIOL, V5, P518, DOI 10.1007/BF02017694
   PATTI JM, 1992, J BIOL CHEM, V267, P4766
   Piras A.M., 2008, INT J PHARMACEUT, V357, P250
   PORTOLES M, 1994, ADV EXP MED BIOL, V350, P421
   QUINN KJ, 1985, BIOMATERIALS, V6, P369, DOI 10.1016/0142-9612(85)90095-X
   Refojo M.F., 1991, CONTACT LENSES CLAO, V9, P1
   Ruther P., 1980, MICROBIAL ADHESION S, P79
   Santin M, 1996, BIOMATERIALS, V17, P1459, DOI 10.1016/0142-9612(96)89769-9
   Santos J.-F.R., 2010, ACTA BIOMATER
   Sariri R, 2004, J Appl Biomater Biomech, V2, P1
   Schiraldi C, 2004, BIOMATERIALS, V25, P3645, DOI 10.1016/j.biomaterials.2003.10.059
   Schneider GB, 2004, BIOMATERIALS, V25, P3023, DOI 10.1016/j.biomaterials.2003.09.084
   Senni K, 2006, ARCH BIOCHEM BIOPHYS, V445, P56, DOI 10.1016/j.abb.2005.11.001
   Shi BJ, 2007, CARBOHYD POLYM, V68, P687, DOI 10.1016/j.carbpol.2006.08.003
   Sokker HH, 2009, CARBOHYD POLYM, V75, P222, DOI 10.1016/j.carbpol.2008.06.015
   Solomon O.D., 1999, CORNEA, V11, P47
   Taylor RL, 1998, OPTOMETRY VISION SCI, V75, P23, DOI 10.1097/00006324-199801000-00021
   Tighe B., 2009, CONTACT LENS MAT CON, P59
   Tissot B, 2003, BBA-PROTEINS PROTEOM, V1651, P5, DOI 10.1016/S1570-9639(03)00230-9
   Tranoudis Ioannis, 2004, Cont Lens Anterior Eye, V27, P115, DOI 10.1016/j.clae.2004.03.001
   von Eiff C, 2005, DRUGS, V65, P179, DOI 10.2165/00003495-200565020-00003
   Wang J, 2008, INT J BIOL MACROMOL, V42, P127, DOI 10.1016/j.ijbiomac.2007.10.003
   WICHTERLE O, 1960, NATURE, V185, P117, DOI 10.1038/185117a0
   Wilhelmus K R, 1988, Infect Dis Clin North Am, V2, P99
   Xinming Li, 2008, Cont Lens Anterior Eye, V31, P57, DOI 10.1016/j.clae.2007.09.002
   Xiong MP, 2007, BIOMATERIALS, V28, P4889, DOI 10.1016/j.biomaterials.2007.07.043
   Yu BZ, 2008, BIOSENS BIOELECTRON, V23, P1278, DOI 10.1016/j.bios.2007.11.010
   Zapopozhets T S, 1995, Antibiot Khimioter, V40, P9
NR 56
TC 8
Z9 8
U1 3
U2 38
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 1226-086X
J9 J IND ENG CHEM
JI J. Ind. Eng. Chem.
PD JUL 25
PY 2012
VL 18
IS 4
BP 1197
EP 1201
DI 10.1016/j.jiec.2012.01.030
PG 5
WC Chemistry, Multidisciplinary; Engineering, Chemical
SC Chemistry; Engineering
GA 970XA
UT WOS:000306164400001
DA 2018-10-19
ER

PT J
AU Zhang, JE
   Pritchard, E
   Hu, X
   Valentin, T
   Panilaitis, B
   Omenetto, FG
   Kaplan, DL
AF Zhang, Jeney
   Pritchard, Eleanor
   Hu, Xiao
   Valentin, Thomas
   Panilaitis, Bruce
   Omenetto, Fiorenzo G.
   Kaplan, David L.
TI RETRACTED: Stabilization of vaccines and antibiotics in silk and
   eliminating the cold chain (Retracted article. See vol. 109, pg. 11981,
   2012)
SO PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF
   AMERICA
LA English
DT Article; Retracted Publication
DE measles; mumps; rubella; penicillin
ID RELEASE DRUG-DELIVERY; STABILITY; VIRUS; BIOMATERIALS; RESPONSES;
   MEASLES; FIBROIN; MUMPS; CHALLENGES; STORAGE
AB Sensitive biological compounds, such as vaccines and antibiotics, traditionally require a time-dependent "cold chain" to maximize therapeutic activity. This flawed process results in billions of dollars worth of viable drug loss during shipping and storage, and severely limits distribution to developing nations with limited infrastructure. To address these major limitations, we demonstrate self-standing silk protein biomaterial matrices capable of stabilizing labile vaccines and antibiotics, even at temperatures up to 60 degrees C over more than 6 months. Initial insight into the mechanistic basis for these findings is provided. Importantly, these findings suggest a transformative approach to the cold chain to revolutionize the way many labile therapeutic drugs are stored and utilized throughout the world.
C1 [Zhang, Jeney; Pritchard, Eleanor; Hu, Xiao; Valentin, Thomas; Panilaitis, Bruce; Omenetto, Fiorenzo G.; Kaplan, David L.] Tufts Univ, Dept Biomed Engn, Medford, MA 02155 USA.
   [Zhang, Jeney] Tufts Univ, Dept Chem & Biol Engn, Medford, MA 02155 USA.
RP Kaplan, DL (reprint author), Tufts Univ, Dept Biomed Engn, Medford, MA 02155 USA.
EM david.kaplan@tufts.edu
RI Hu, Xiao/F-2403-2012
OI Hu, Xiao/0000-0002-2579-2820
FU NIH (P41 Tissue Engineering Resource Center) [EB002520]; AFOSR
   [9550-10-1-0172zsAJMn];  [EY020856];  [DE017207-01];  [EB003210]
FX The technical assistance or advice of Nicholas Guziewicz, Michael
   Lovett, Nikola Kojic and Reid McCabe is gratefully acknowledged. We
   thank the NIH (P41 Tissue Engineering Resource Center EB002520) and
   EY020856, DE017207-01, EB003210 and AFOSR 9550-10-1-0172zsAJMn for
   support of this work.
CR Adu FD, 1996, PUBLIC HEALTH, V110, P325
   Altman GH, 2003, BIOMATERIALS, V24, P401, DOI 10.1016/S0142-9612(02)00353-8
   Arya SC, 2001, VACCINE, V19, P595
   Ausar SF, 2006, J BIOL CHEM, V281, P19478, DOI 10.1074/jbc.M603313200
   BENEDICT RG, 1945, J BACTERIOL, V49, P85
   BISHAI DM, 1992, PEDIATRICS, V89, P193
   BOYLE VJ, 1973, ANTIMICROB AGENTS CH, V3, P418, DOI 10.1128/AAC.3.3.418
   Brandau DT, 2003, J PHARM SCI-US, V92, P218, DOI 10.1002/jps.10296
   Chen DX, 2009, EXPERT REV VACCINES, V8, P547, DOI 10.1586/ERV.09.20
   Chen X, 2011, J CONTROL RELEASE, V152, P349, DOI 10.1016/j.jconrel.2011.02.026
   CHERIYAN E, 1993, ARCH DIS CHILD, V69, P600, DOI 10.1136/adc.69.5.600
   CHEYNE J, 1989, REV INFECT DIS, V11, pS617
   COLINET G, 1982, J BIOL STAND, V10, P341, DOI 10.1016/S0092-1157(82)80011-5
   Das P, 2004, LANCET INFECT DIS, V4, P719, DOI 10.1016/S1473-3099(04)01222-8
   Fleming A, 1929, BRIT J EXP PATHOL, V10, P226
   Galazka A, 1998, GLOBAL PROGRAMME VAC
   Gianfreda L, 1984, ENZYME MICROB TECHNO, V7, P78
   Guziewicz N, 2011, BIOMATERIALS, V32, P2642, DOI 10.1016/j.biomaterials.2010.12.023
   HALL WW, 1973, J GEN VIROL, V19, P175, DOI 10.1099/0022-1317-19-2-175
   Hu X, 2007, THERMOCHIM ACTA, V461, P137, DOI 10.1016/j.tca.2006.12.011
   Hu ZQ, 2001, J ANTIMICROB CHEMOTH, V48, P361, DOI 10.1093/jac/48.3.361
   Jin HJ, 2003, NATURE, V424, P1057, DOI 10.1038/nature01809
   Lawrence BD, 2008, BIOMACROMOLECULES, V9, P1214, DOI 10.1021/bm701235f
   Leal-Egana A, 2010, BIOTECHNOL APPL BIOC, V55, P155, DOI 10.1042/BA20090229
   Li S, 1994, BIOTECHNOL BIOENG, V48, P490
   Lu Q, 2010, MACROMOL BIOSCI, V10, P359, DOI 10.1002/mabi.200900388
   MCALEER WJ, 1980, J BIOL STAND, V8, P281, DOI 10.1016/S0092-1157(80)80005-9
   Meinel L, 2005, BIOMATERIALS, V26, P147, DOI 10.1016/j.biomaterials.2004.02.047
   MERZ DC, 1983, VIROLOGY, V131, P328, DOI 10.1016/0042-6822(83)90501-9
   Omenetto F, 2010, SCI AM, V303, P76, DOI 10.1038/scientificamerican1110-76
   Packer L., 2002, METHODS ENZYMOLOGY, V349
   Panilaitis B, 2003, BIOMATERIALS, V24, P3079, DOI 10.1016/S0142-9612(03)00158-3
   Pritchard EM, 2012, BIOPOLYMERS, V97, P479, DOI 10.1002/bip.22026
   Pritchard EM, 2011, EXPERT OPIN DRUG DEL, V8, P797, DOI 10.1517/17425247.2011.568936
   Pritchard EM, 2010, J CONTROL RELEASE, V144, P159, DOI 10.1016/j.jconrel.2010.01.035
   Seo YK, 2009, J ORTHOP RES, V27, P495, DOI 10.1002/jor.20752
   Sun YC, 2004, ADV DRUG DELIVER REV, V56, P1481, DOI 10.1016/j.addr.2004.02.009
   Tsioris K, 2012, ADV FUNCT MATER, V22, P330, DOI 10.1002/adfm.201102012
   Vepari C, 2007, PROG POLYM SCI, V32, P991, DOI 10.1016/j.progpolymsci.2007.05.013
   Wang X, 2008, BIOMATERIALS, V29, P894, DOI 10.1016/j.biomaterials.2007.10.055
   Wang YZ, 2006, BIOMATERIALS, V27, P6064, DOI 10.1016/j.biomaterials.2006.07.008
   Waterman KC, 2005, INT J PHARM, V293, P101, DOI 10.1016/j.ijpharm.2004.12.013
   WHODavey S, 2000, KEY PROSPERITY SUCCE
   Wolfson LJ, 2008, B WORLD HEALTH ORGAN, V86, P27, DOI 10.2471/BLT.07.045096
   Worrall EE, 2000, VACCINE, V19, P834, DOI 10.1016/S0264-410X(00)00229-2
   Xuan RC, 2010, J ENVIRON SCI HEAL B, V45, P73, DOI 10.1080/03601230903404556
   Yager P, 2006, NATURE, V442, P412, DOI 10.1038/nature05064
NR 47
TC 95
Z9 98
U1 7
U2 89
PU NATL ACAD SCIENCES
PI WASHINGTON
PA 2101 CONSTITUTION AVE NW, WASHINGTON, DC 20418 USA
SN 0027-8424
J9 P NATL ACAD SCI USA
JI Proc. Natl. Acad. Sci. U. S. A.
PD JUL 24
PY 2012
VL 109
IS 30
BP 11981
EP 11986
DI 10.1073/pnas.1206210109
PG 6
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA 981TD
UT WOS:000306992700029
PM 22778443
OA Green Published, Bronze
DA 2018-10-19
ER

PT J
AU Ganesh, M
   Gross, RA
AF Ganesh, Manoj
   Gross, Richard A.
TI Embedded enzymatic biomaterial degradation: Flow conditions & relative
   humidity
SO POLYMER
LA English
DT Article
DE Embedded enzymes; Biomaterial degradation; Bioresorbable polymers
ID TISSUE-ENGINEERING APPLICATIONS; MASSIVE POLY(ALPHA-HYDROXY ACIDS);
   PHOSPHATE-BUFFERED SOLUTION; ION-PAIRED COMPLEX; IN-VITRO; BIORESORBABLE
   POLYMERS; POLY(ETHYLENE GLYCOL); EPSILON-CAPROLACTONE; BLOCK-COPOLYMER;
   POLY(EPSILON-CAPROLACTONE)
AB Enzyme-catalyzed degradation of PCL films with embedded Candida antarctica Lipase B (CALB, 1.6%-by-wt) under continuous fluid exchange (flow) conditions and in controlled humidity desiccators were determined. At 0.2 mL/min flow rate, film weight loss reached 85% in 3 d relative to bulk-no flow incubations where 70% degradation occurred in 9 days. This increase in rate under flow conditions is attributed to more efficient removal of degradation products that can act as competitive inhibitors. However, further increase in flow rate from 0.2 to 0.5 mL/min results in slower weight loss (7 days, 70%) as increased flow rate appears to negatively influence enzyme stability. Another intriguing discovery is that, by using flow in place of bulk-no flow conditions, removal of degradation products is more efficient leading to formation of a porous matrix where SEM cross sectional images show larger better defined pores. The unusual phenomenon of high porosity matrices resulting from enzyme-catalyzed hydrolysis is unique to embedded enzyme systems. Studies were also conducted where 1.6% CALB-embedded PCL films were incubated in desiccators set at 20, 75 and 95% relative humidity (RH). Water-uptake and molecular weight change at 20% RH were insignificant. However, at 75 and 95% RH, by 28 days, %-water content increased to 0.30 and 0.82, and film M-n decreased by 25% to 59,300 and 58% to 33,900, respectively. While stability under controlled low-humidity environments demonstrates options for safe storage, applications are envisioned where the unique degradation properties of enzyme-embedded bioresorbable films will be exploited for release of actives ranging from fragrances, flavors and therapeutic agents. (C) 2012 Elsevier Ltd. All rights reserved.
C1 [Ganesh, Manoj; Gross, Richard A.] Polytech Inst NYU, Ctr Biocatalysis & Bioproc Macromol, Metrotech Ctr 6, Brooklyn, NY 11201 USA.
RP Gross, RA (reprint author), Polytech Inst NYU, Ctr Biocatalysis & Bioproc Macromol, Metrotech Ctr 6, Brooklyn, NY 11201 USA.
EM rgross@poly.edu
RI Ganesh, Manoj/I-2434-2014
OI Ganesh, Manoj/0000-0001-8852-3161
FU Center for Biocatalysis and Bioprocessing at NYU-POLY (a graduated
   center of the NSF I/UCRC program)
FX The authors acknowledge the Advanced Imaging Facility, College of Staten
   Island, and Sara Guariglia, for their assistance in obtaining SEM
   images. A special thanks to Wenchun Xie for her help in GPC experiments.
   Finally, we thank the Center for Biocatalysis and Bioprocessing at
   NYU-POLY (a graduated center of the NSF I/UCRC program) for its
   financial support.
CR Agrawal CM, 2000, BIOMATERIALS, V21, P2443, DOI 10.1016/S0142-9612(00)00112-5
   Altreuter DH, 2002, ENZYME MICROB TECH, V31, P10, DOI 10.1016/S0141-0229(02)00092-3
   Armentano I, 2010, POLYM DEGRAD STABIL, V95, P2126, DOI 10.1016/j.polymdegradstab.2010.06.007
   Bancroft GN, 2003, TISSUE ENG, V9, P549, DOI 10.1089/107632703322066723
   Bankova M, 2002, MACROMOLECULES, V35, P6858, DOI 10.1021/ma0202282
   BEZWADA RS, 1995, BIOMATERIALS, V16, P1141, DOI 10.1016/0142-9612(95)93577-Z
   Bilodeau K, 2006, TISSUE ENG, V12, P2367, DOI 10.1089/ten.2006.12.2367
   Bindhu LV, 2003, BIOCHEM ENG J, V15, P47, DOI 10.1016/S1369-703X(02)00173-0
   Brahatheeswaran D., 2011, INT J POLYM SCI
   Brown M, 2008, PLAST RUBBER COMPOS, V37, P46, DOI 10.1179/174328908X283339
   Chu CC, 2005, KIRK OTHMER ENCY CHE
   Cui Z, 2011, J BIOMEDICAL MAT R A
   Ganesh M, 2009, MACROMOLECULES, V42, P6836, DOI 10.1021/ma901481h
   Hiraishi T, 2009, MINI-REV ORG CHEM, V6, P44, DOI 10.2174/157019309787316139
   Huang MH, 2004, J BIOMED MATER RES A, V69A, P417, DOI 10.1002/jbm.a.30008
   Kim SS, 2000, TISSUE ENG, V6, P39, DOI 10.1089/107632700320874
   Kulkarni A, 2008, EUR J PHARM BIOPHARM, V68, P46, DOI 10.1016/j.ejpb.2007.05.021
   LI SM, 1990, J MATER SCI-MATER M, V1, P198, DOI 10.1007/BF00701077
   Martina M, 2007, POLYM INT, V56, P145, DOI 10.1002/pi.2108
   Maxson S, 2011, TISSUE ENGINEERING: FROM LAB TO CLINIC, P179, DOI 10.1007/978-3-642-02824-3_10
   Molea S, 2000, BRIT J PLAST SURG, V53, P137
   Paradkar D, 1994, BIOTECHNOL BIOENG, V43, P529
   Pastorino L, 2004, ENZYME MICROB TECH, V35, P321, DOI 10.1016/j.enzmictec.2004.05.005
   Porter JR, 2009, BIOMATERIALS, V30, P780, DOI 10.1016/j.biomaterials.2008.10.022
   Qian HT, 2000, POLYM DEGRAD STABIL, V68, P423, DOI 10.1016/S0141-3910(00)00031-8
   RICHARD AG, 2002, SCIENCE, V297, P803
   Sabir MI, 2009, J MATER SCI, V44, P5713, DOI 10.1007/s10853-009-3770-7
   SHENGUO W, 1993, POLYM ADVAN TECHNOL, V4, P363
   Sun HF, 2006, BIOMATERIALS, V27, P1735, DOI 10.1016/j.biomaterials.2005.09.019
   THERIN M, 1992, BIOMATERIALS, V13, P594, DOI 10.1016/0142-9612(92)90027-L
   Tsuji H, 2004, BIOMATERIALS, V25, P5449, DOI 10.1016/j.biomaterials.2003.12.053
   Tsuji H, 1998, J APPL POLYM SCI, V67, P405
   Vert M, 2009, J MATER SCI-MATER M, V20, P437, DOI 10.1007/s10856-008-3581-4
   Wang YM, 2005, MACROMOL MATER ENG, V290, P792, DOI 10.1002/mame.200500003
   Wei XW, 2009, INT J PHARMACEUT, V381, P1, DOI 10.1016/j.ijpharm.2009.07.033
   Woodruff MA, 2010, PROG POLYM SCI, V35, P1217, DOI 10.1016/j.progpolymsci.2010.04.002
   Wu JC, 2006, J CHEM TECHNOL BIOT, V81, P1003, DOI 10.1002/jctb.1504
   Wuisman PIJM, 2006, EUR SPINE J, V15, P133, DOI 10.1007/s00586-005-1003-6
   Zilberman M, 2006, ANNU REV BIOMED ENG, V8, P153, DOI 10.1146/annurev.bioeng.8.013106.151418
NR 39
TC 10
Z9 10
U1 2
U2 23
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0032-3861
EI 1873-2291
J9 POLYMER
JI Polymer
PD JUL 19
PY 2012
VL 53
IS 16
BP 3454
EP 3461
DI 10.1016/j.polymer.2012.06.017
PG 8
WC Polymer Science
SC Polymer Science
GA 979MZ
UT WOS:000306825400006
DA 2018-10-19
ER

PT J
AU Bal, KE
   Bal, Y
   Cote, G
   Chagnes, A
AF Bal, K. E.
   Bal, Y.
   Cote, G.
   Chagnes, A.
TI Morphology and antimicrobial properties of Luffa cylindrica
   fibers/chitosan biomaterial as micro-reservoirs for silver delivery
SO MATERIALS LETTERS
LA English
DT Article
DE Luffa fibers; Chitosan; Electron microscopy; Biomaterials; Porous
   materials; Antimicrobial activity
ID NANOPARTICLES; FIBERS; AG
AB Micro-spongy structure of Luffa cylindrica fibers (LCF) coated with chitosan (CS). called micro-reservoir, seems to be an interesting route to promote local silver particle (Ag) delivery. In the present paper, the morphology and the antimicrobial activity of LCF-CS-Ag micro-reservoir were investigated. The LCF-chitosan material (LCF-CS) was successfully prepared by contacting LCF with hydroxide sodium solution followed by an acetic acid treatment of chitosan. Scanning electron microscopy pictures (SEM-EDX) showed that the LCF surface was strongly modified by the treatment and confirmed the growth of nanoparticles of silver (NpAg) with a size ranging from 20 to 150 nm onto and into the surface of the cell-fibers (CF). The LCF-CS and LCF-CS-Ag biomaterials exhibit antibacterial activities as bacteriostasis zone diameters range from 7 to 15 mm against Staphylococcus aureus and from 7.3 to 17 mm against Escherichia coli. Furthermore, an inhibitory effect was observed for a relatively long period (18 days). (C) 2012 Elsevier B.V. All rights reserved.
C1 [Bal, K. E.; Bal, Y.] Ctr Univ Medea, Lab Biomat & Phenomenes Transport, Quartier Ain Dheb, Medea, Algeria.
   [Bal, K. E.] Univ Saad Dahleb Blida, Lab Phys Chim Mol & Macromol, Blida, Algeria.
   [Cote, G.; Chagnes, A.] Chim ParisTech, LECIME, Ecole Natl Super Chim Paris, F-75005 Paris, France.
   [Cote, G.; Chagnes, A.] CNRS, UMR 7575, F-75005 Paris, France.
RP Bal, Y (reprint author), Ctr Univ Medea, Lab Biomat & Phenomenes Transport, Quartier Ain Dheb, Medea, Algeria.
EM bal_y@yahoo.fr; alexandre-chagnes@ens.chimie-paristech.fr
RI CHAGNES, Alexandre/A-7441-2011
OI CHAGNES, Alexandre/0000-0002-4345-6812
CR Altinisik A, 2010, J HAZARD MATER, V179, P658, DOI 10.1016/j.jhazmat.2010.03.053
   Bal KE, 2004, TEXT RES J, V74, P241, DOI 10.1177/004051750407400310
   Ganguly R, 2007, BIORESOURCE TECHNOL, V98, P1246, DOI 10.1016/j.biortech.2006.05.004
   Magudapathy P, 2001, PHYSICA B, V299, P142, DOI 10.1016/S0921-4526(00)00580-9
   Muzzarelli R.A.A., 1973, NATURAL CHELATING PO
   PIDDOCK LJV, 1990, J APPL BACTERIOL, V68, P307, DOI 10.1111/j.1365-2672.1990.tb02880.x
   Rai M, 2009, BIOTECHNOL ADV, V27, P76, DOI 10.1016/j.biotechadv.2008.09.002
   Satyanarayana KG, 2007, COMPOS PART A-APPL S, V38, P1694, DOI 10.1016/j.compositesa.2007.02.006
   Strobin G, 2006, POL CHITIN SOC MONOG, pXl
   Wei DW, 2008, COLLOID SURFACE B, V62, P136, DOI 10.1016/j.colsurfb.2007.09.030
   Wiggers D, 2004, 4 ENC PROGR REC HUM
   Xu XY, 2006, EUR POLYM J, V42, P2081, DOI 10.1016/j.eurpolymj.2006.03.032
NR 12
TC 11
Z9 12
U1 1
U2 31
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0167-577X
J9 MATER LETT
JI Mater. Lett.
PD JUL 15
PY 2012
VL 79
BP 238
EP 241
DI 10.1016/j.matlet.2012.04.036
PG 4
WC Materials Science, Multidisciplinary; Physics, Applied
SC Materials Science; Physics
GA 965KR
UT WOS:000305767200071
DA 2018-10-19
ER

PT J
AU Zavgorodniy, AV
   Mason, RS
   LeGeros, RZ
   Rohanizadeh, R
AF Zavgorodniy, Alexander V.
   Mason, Rebecca S.
   LeGeros, Racquel Z.
   Rohanizadeh, Ramin
TI Adhesion of a chemically deposited monetite coating to a Ti substrate
SO SURFACE & COATINGS TECHNOLOGY
LA English
DT Article
DE Monetite; Calcium phosphate coatings; Titanium implants
ID TITANIUM SUBSTRATE; HYDROXYAPATITE; CAHPO4; POWDER; TRANSFORMATION;
   ARTHROPLASTY; SPECTROSCOPY; GRANULES; BRUSHITE; HIP
AB Monetite is a promising biomaterial for restoring the function of the compromised skeletal structures due to its superior osteoconductive and resorption properties. However, its potential as a coating for orthopaedic implants in load bearing applications has not yet been investigated. The aim of this study was to prepare monetite coating on Ti substrate in mild conditions, which may allow incorporation of protein-based drugs during the coating deposition. Coatings were prepared using chemical deposition of monetite on Ti substrate in acidic conditions at 75 degrees C for 24 h. Coatings were characterised by scanning electron microscope (SEM), energy-dispersive X-ray spectroscopy (EDS), X-ray diffraction (XRD) and Fourier transform infrared spectroscopy (FTIR). Adhesion of the coatings to Ti substrate was measured using tensile tests. EDS confirmed the calcium phosphate nature of the coating and XRD and FTIR confirmed the monetite phase of the coatings. SEM revealed that the coatings were formed of densely packed plate-like monetite crystals, with the crystal size approximately 20 x 10 x 5 mu m. Adhesion tests showed cohesive failure of the monetite coatings and the tensile strength of the coating was in the range of 15.43 +/- 0.20 MPa. Mechanical tests showed that monetite coatings were stable and could be considered for use with Ti orthopaedic implants. (C) 2012 Elsevier B.V. All rights reserved.
C1 [Zavgorodniy, Alexander V.; Mason, Rebecca S.] Univ Sydney, Dept Physiol, Sydney, NSW 2006, Australia.
   [LeGeros, Racquel Z.] NYU, Dept Biomat & Biomimet, New York, NY 10010 USA.
RP Zavgorodniy, AV (reprint author), Univ Sydney, Dept Physiol, Pharm Bldg A15,Sci Rd, Sydney, NSW 2006, Australia.
EM alexander.zavgorodniy@sydney.edu.au
RI Rohanizadeh, Ramin/J-5719-2016
OI Rohanizadeh, Ramin/0000-0002-7967-5515
FU ARC [DP0986230]
FX The authors wish to acknowledge the facilities and technical assistance
   from staff in Australian Centre for Microscopy & Microanalysis,
   University of Sydney. This work was supported by the ARC Discovery Grant
   DP0986230.
CR [Anonymous], 2005, F114705 ASTM
   [Anonymous], 1994, GUID DOC TEST ORTH I
   Buckwalter JA, 2004, CLIN ORTHOP RELAT R, pS6, DOI 10.1097/01.blo.0000143938.30681.9d
   Christensen K, 2009, LANCET, V374, P1196, DOI 10.1016/S0140-6736(09)61460-4
   Da Silva MHP, 2001, SURF COAT TECH, V137, P270
   Desai T.R., 2008, ADV BIOCERAMICS BIOC, P61
   Djosic MS, 2009, COLLOID SURFACE A, V341, P110, DOI 10.1016/j.colsurfa.2009.03.046
   Gbureck U, 2007, ADV FUNCT MATER, V17, P3940, DOI 10.1002/adfm.200700019
   Geetha M, 2009, PROG MATER SCI, V54, P397, DOI 10.1016/j.pmatsci.2008.06.004
   Habibovic P, 2008, BIOMATERIALS, V29, P944, DOI 10.1016/j.biomaterials.2007.10.023
   Hsu YS, 1998, CERAM INT, V24, P249, DOI 10.1016/S0272-8842(96)00056-9
   Klammert U, 2009, ACTA BIOMATER, V5, P727, DOI 10.1016/j.actbio.2008.08.019
   Kokubo T, 2009, J EUR CERAM SOC, V29, P1267, DOI 10.1016/j.jeurceramsoc.2008.08.004
   Kurtz S, 2007, J BONE JOINT SURG AM, V89A, P780, DOI 10.2106/JBJS.F.00222
   Legeros R. Z., 1991, MONOGRAPHS ORAL SCI
   Legeros R.Z., 1990, HDB BIOACTIVE CERAMI, V2, P17
   LeGeros R. Z., 1991, BONE BIOMATERIAL INT
   LEGEROS RZ, 1995, CERAMIC T, V48, P173
   Ma MG, 2006, J PHYS CHEM B, V110, P14226, DOI 10.1021/jp061738r
   Pan J, 1996, ELECTROCHIM ACTA, V41, P1143, DOI 10.1016/0013-4686(95)00465-3
   Ramaswamy Y, 2009, EXPERT REV MED DEVIC, V6, P423, DOI 10.1586/ERD.09.17
   Rixrath E, 2008, J BIOMECH, V41, P1137, DOI 10.1016/j.jbiomech.2007.12.009
   Rohanizadeh R, 2005, J BIOMED MATER RES A, V72A, P428, DOI 10.1002/jbm.a.30258
   Rohanizadeh R., 2008, KEY ENG MAT
   Ruan QC, 2009, J PHYS CHEM B, V113, P1100, DOI 10.1021/jp809494f
   Schmidt J, 2009, J SOLUTION CHEM, V38, P1267, DOI 10.1007/s10953-009-9445-9
   Sun LM, 2001, J BIOMED MATER RES, V58, P570, DOI 10.1002/jbm.1056.abs
   Tamimi F, 2010, BIOMATERIALS, V31, P2762, DOI 10.1016/j.biomaterials.2009.12.039
   Tamimi F, 2009, BIOMATERIALS, V30, P6318, DOI 10.1016/j.biomaterials.2009.07.049
   Tamimi F, 2008, J BIOMED MATER RES A, V87A, P980, DOI 10.1002/jbm.a.31842
   Tokuoka Y, 2006, CHEM LETT, V35, P1220, DOI 10.1246/cl.2006.1220
   Tortet L, 1997, J SOLID STATE CHEM, V132, P6, DOI 10.1006/jssc.1997.7383
   Xu JW, 1999, SPECTROCHIM ACTA A, V55, P2801, DOI 10.1016/S1386-1425(99)00090-6
   Zavgorodniy AV, 2011, J MATER SCI-MATER M, V22, P1, DOI 10.1007/s10856-010-4179-1
NR 34
TC 8
Z9 8
U1 2
U2 18
PU ELSEVIER SCIENCE SA
PI LAUSANNE
PA PO BOX 564, 1001 LAUSANNE, SWITZERLAND
SN 0257-8972
J9 SURF COAT TECH
JI Surf. Coat. Technol.
PD JUL 15
PY 2012
VL 206
IS 21
BP 4433
EP 4438
DI 10.1016/j.surfcoat.2012.04.090
PG 6
WC Materials Science, Coatings & Films; Physics, Applied
SC Materials Science; Physics
GA 969BQ
UT WOS:000306031100016
DA 2018-10-19
ER

PT J
AU Phipps, MC
   Xu, YY
   Bellis, SL
AF Phipps, Matthew C.
   Xu, Yuanyuan
   Bellis, Susan L.
TI Delivery of Platelet-Derived Growth Factor as a Chemotactic Factor for
   Mesenchymal Stem Cells by Bone-Mimetic Electrospun Scaffolds
SO PLOS ONE
LA English
DT Article
ID TISSUE REGENERATION; PDGF-BB; NANOFIBROUS SCAFFOLDS;
   CLINICAL-APPLICATIONS; CONTROLLED-RELEASE; IN-VIVO; CHEMOKINE;
   MITOGENESIS; EXPRESSION; MIGRATION
AB The recruitment of mesenchymal stem cells (MSCs) is a vital step in the bone healing process, and hence the functionalization of osteogenic biomaterials with chemotactic factors constitutes an important effort in the tissue engineering field. Previously we determined that bone-mimetic electrospun scaffolds composed of polycaprolactone, collagen I and nanohydroxyapatite (PCL/col/HA) supported greater MSC adhesion, proliferation and activation of integrin-related signaling cascades than scaffolds composed of PCL or collagen I alone. In the current study we investigated the capacity of bone-mimetic scaffolds to serve as carriers for delivery of an MSC chemotactic factor. In initial studies, we compared MSC chemotaxis toward a variety of molecules including PDGF-AB, PDGF-BB, BMP2, and a mixture of the chemokines SDF-1 alpha, CXCL16, MIP-1 alpha, MIP-1 beta, and RANTES. Transwell migration assays indicated that, of these factors, PDGF-BB was the most effective in stimulating MSC migration. We next evaluated the capacity of PCL/col/HA scaffolds, compared with PCL scaffolds, to adsorb and release PDGF-BB. We found that significantly more PDGF- BB was adsorbed to, and subsequently released from, PCL/col/HA scaffolds, with sustained release extending over an 8-week interval. The PDGF-BB released was chemotactically active in transwell migration assays, indicating that bioactivity was not diminished by adsorption to the biomaterial. Complementing these studies, we developed a new type of migration assay in which the PDGF-BB-coated bone-mimetic substrates were placed 1.5 cm away from the cell migration front. These experiments confirmed the ability of PDGF-BB-coated PCL/col/HA scaffolds to induce significant MSC chemotaxis under more stringent conditions than standard types of migration assays. Our collective results substantiate the efficacy of PDGF-BB in stimulating MSC recruitment, and further show that the incorporation of native bone molecules, collagen I and nanoHA, into electrospun scaffolds not only enhances MSC adhesion and proliferation, but also increases the amount of PDGF-BB that can be delivered from scaffolds.
C1 [Phipps, Matthew C.; Xu, Yuanyuan; Bellis, Susan L.] Univ Alabama Birmingham, Dept Physiol & Biophys, Birmingham, AL 35294 USA.
   [Bellis, Susan L.] Univ Alabama Birmingham, Dept Biomed Engn, Birmingham, AL 35294 USA.
RP Phipps, MC (reprint author), Univ Alabama Birmingham, Dept Physiol & Biophys, Birmingham, AL 35294 USA.
EM bellis@uab.edu
FU National Institutes of Health [R01AR51539, T32EB004312]
FX This study received support from National Institutes of Health grants
   R01AR51539 (SLB), and T32EB004312 (MCP predoctoral fellowship) URL:
   www.nih.gov. The funders had no role in study design, data collection
   and analysis, decision to publish, or preparation of the manuscript.
CR Andrae J, 2008, GENE DEV, V22, P1276, DOI 10.1101/gad.1653708
   BETSHOLTZ C, 1986, P NATL ACAD SCI USA, V83, P6440, DOI 10.1073/pnas.83.17.6440
   BOWENPOPE DF, 1984, BLOOD, V64, P458
   CANALIS E, 1992, GROWTH REGULAT, V2, P151
   Chamberlain G, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002934
   Chen L, 2009, BIOMACROMOLECULES, V10, P3193, DOI 10.1021/bm900850q
   Chen RR, 2007, PHARM RES, V24, P258, DOI 10.1007/s11095-006-9173-4
   Di Martino Alberto, 2011, Musculoskelet Surg, V95, P69, DOI 10.1007/s12306-011-0097-8
   Distler JHW, 2003, Q J NUCL MED, V47, P149
   Fujii H, 1999, HISTOCHEM CELL BIOL, V112, P131, DOI 10.1007/s004180050399
   Graham S, 2009, EXPERT OPIN INV DRUG, V18, P1633, DOI 10.1517/13543780903241607
   Gruber R, 2003, J ORTHOPAED RES, V21, P941, DOI 10.1016/S0736-0266(03)00053-6
   HART CE, 1990, BIOCHEMISTRY-US, V29, P166, DOI 10.1021/bi00453a022
   Heldin CH, 1999, PHYSIOL REV, V79, P1283
   Hollinger JO, 2008, J BONE JOINT SURG AM, V90A, P48, DOI 10.2106/JBJS.G.01231
   Holzwarth JM, 2011, BIOMATERIALS, V32, P9622, DOI 10.1016/j.biomaterials.2011.09.009
   Homsi Jade, 2007, Cancer Control, V14, P285
   Jang JH, 2009, ADV DRUG DELIVER REV, V61, P1065, DOI 10.1016/j.addr.2009.07.008
   Javed F, 2011, ARCH ORAL BIOL, V56, P1476, DOI 10.1016/j.archoralbio.2011.06.020
   Jin QM, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001729
   Karp JM, 2009, CELL STEM CELL, V4, P206, DOI 10.1016/j.stem.2009.02.001
   KELLY JD, 1985, EMBO J, V4, P3399, DOI 10.1002/j.1460-2075.1985.tb04096.x
   Krattinger N, 2011, EUR CELLS MATER, V21, P46, DOI 10.22203/eCM.v021a04
   Liao IC, 2005, J CONTROL RELEASE, V104, P347, DOI 10.1016/j.jconrel.2005.02.013
   Lieberman JR, 2002, J BONE JOINT SURG AM, V84A, P1032, DOI 10.2106/00004623-200206000-00022
   Lin H, 2006, BIOMATERIALS, V27, P5708, DOI 10.1016/j.biomaterials.2006.07.023
   Lind M, 1996, BONE, V18, P53, DOI 10.1016/8756-3282(95)00423-8
   Ponte AL, 2007, STEM CELLS, V25, P1737, DOI 10.1634/stemcells.2007-0054
   Ozaki Y, 2007, STEM CELLS DEV, V16, P119, DOI 10.1089/scd.2006.0032
   Park YJ, 1998, J CONTROL RELEASE, V51, P201, DOI 10.1016/S0168-3659(97)00169-7
   Pham QP, 2006, TISSUE ENG, V12, P1197, DOI 10.1089/ten.2006.12.1197
   Phinney DG, 2007, STEM CELLS, V25, P2896, DOI 10.1634/stemcells.2007-0637
   Phipps MC, 2012, BIOMATERIALS, V33, P524, DOI 10.1016/j.biomaterials.2011.09.080
   Phipps MC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016813
   Prabhakaran MP, 2011, J NANOSCI NANOTECHNO, V11, P3039, DOI 10.1166/jnn.2011.3753
   Richardson TP, 2001, NAT BIOTECHNOL, V19, P1029, DOI 10.1038/nbt1101-1029
   Solchaga LA, 2012, J TISSUE ENG, V3, DOI 10.1177/2041731412442668
   Solchaga LA, 2012, SPINE, V37, pE461, DOI 10.1097/BRS.0b013e31823b01dc
   Trippel S B, 1997, Instr Course Lect, V46, P473
   Wei GB, 2006, J CONTROL RELEASE, V112, P103, DOI 10.1016/j.jconrel.2006.01.011
   Wilson CJ, 2005, TISSUE ENG, V11, P1, DOI 10.1089/ten.2005.11.1
   Yang LQ, 2006, CELL, V127, P139, DOI 10.1016/j.cell.2006.08.036
   Young CS, 2011, J TISSUE ENG
NR 43
TC 47
Z9 50
U1 0
U2 42
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD JUL 12
PY 2012
VL 7
IS 7
AR e40831
DI 10.1371/journal.pone.0040831
PG 9
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA 973NH
UT WOS:000306366400060
PM 22808271
OA DOAJ Gold, Green Published
DA 2018-10-19
ER

PT J
AU Wang, JJ
   Liu, F
AF Wang, Jing Jing
   Liu, Fang
TI Imparting antifouling properties of silicone hydrogels by grafting
   poly(ethylene glycol) methyl ether acrylate initiated by UV light
SO JOURNAL OF APPLIED POLYMER SCIENCE
LA English
DT Article
DE silicone hydrogel; poly(ethylene glycol) methyl ether acrylate (PEGMA);
   grafting; antifouling
ID SURFACE MODIFICATION; PROTEIN ADSORPTION; PLATELET-ADHESION;
   MEMBRANE-SURFACE; GLOW-DISCHARGE; CELL-ADHESION; POLYMERIZATION;
   PHOSPHORYLCHOLINE; POLYMERS; POLYDIMETHYLSILOXANE
AB Both hydrophilic and antifouling surfaces were prepared on silicone hydrogels with poly(ethylene glycol) methyl ether acrylate (PEGMA) grafted by UV-induced radical polymerization. The PEGMA-grafted silicone hydrogels were characterized by graft yield and static water contact angle measurements. According to the results, the graft yield reached a maximum at 8 min of UV exposure time and 20 wt% PEGMA concentration. The modified silicone hydrogels possessed hydrophilic surfaces with the lowest water contact angle of 36 degrees. The oxygen permeability and transparency of the PEGMA-grafted silicone hydrogels were as high as the unmodified silicone hydrogel. The mechanical property of silicone hydrogels was maintained at about 95% of the tensile strength and elastic modulus after the PEGMA grafting. The in vitro single protein adsorption on the PEGMA-grafted silicone hydrogels decreased by 70-80% compared to the unmodified silicone hydrogel. The PEGMA-grafted silicone hydrogel is expected to be a novel biomaterial, which possesses excellent surface hydrophilicity, antifouling property, oxygen permeability, and mechanical property. (C) 2011 Wiley Periodicals, Inc. J Appl Polym Sci, 2012
C1 [Wang, Jing Jing; Liu, Fang] Yancheng Inst Technol, Dept Polymer Mat & Engn, Sch Mat Engn, Key Lab Adv Technol Environm Protect Jiangsu Prov, Yancheng 224051, Peoples R China.
RP Wang, JJ (reprint author), Yancheng Inst Technol, Dept Polymer Mat & Engn, Sch Mat Engn, Key Lab Adv Technol Environm Protect Jiangsu Prov, Yancheng 224051, Peoples R China.
EM jjwang1@hotmail.com
FU Natural Science Fund for Colleges and Universities [11KJB430013];
   Natural Research Fund [XKR2011010]; Research Fund of Key Laboratory for
   Advanced Technology in Environmental Protection of Jiangsu Province
   [AE201069]
FX Contract grant sponsor: Natural Science Fund for Colleges and
   Universities; contract grant number: 11KJB430013.; Contract grant
   sponsor: Natural Research Fund; contract grant number: XKR2011010.;
   Contract grant sponsor: Research Fund of Key Laboratory for Advanced
   Technology in Environmental Protection of Jiangsu Province; contract
   grant number: AE201069.
CR Archambault JG, 2004, COLLOID SURFACE B, V33, P111, DOI 10.1016/j.colsurfb.2003.09.004
   Bozukova D, 2008, LANGMUIR, V24, P6649, DOI 10.1021/la7033774
   Bozukova D, 2007, BIOMACROMOLECULES, V8, P2379, DOI 10.1021/bm0701649
   Erdodi G, 2005, J POLYM SCI POL CHEM, V43, P3491, DOI 10.1002/pola.20791
   Gao Y, 2009, J POLYM RES, V16, P709, DOI 10.1007/s10965-009-9277-8
   Goda T, 2006, BIOMATERIALS, V27, P5151, DOI 10.1016/j.biomaterials.2006.05.046
   Gong X, 2000, J POLYM SCI POL PHYS, V38, P2323, DOI 10.1002/1099-0488(20000901)38:17<2323::AID-POLB120>3.0.CO;2-6
   Ishihara K, 1998, J BIOMED MATER RES, V39, P323, DOI 10.1002/(SICI)1097-4636(199802)39:2<323::AID-JBM21>3.0.CO;2-C
   Ishihara K, 2000, COLLOID SURFACE B, V18, P325, DOI 10.1016/S0927-7765(99)00158-7
   Kang JS, 2003, J APPL POLYM SCI, V88, P3188, DOI 10.1002/app.12148
   Kobayashi T, 2007, SURF COAT TECH, V201, P8039, DOI 10.1016/j.surfcoat.2006.02.056
   Lan S, 2005, BIOSENS BIOELECTRON, V20, P1697, DOI 10.1016/j.bios.2004.06.025
   Sartori S, 2008, REACT FUNCT POLYM, V68, P809, DOI 10.1016/j.reactfunctpolym.2007.12.002
   Sugiura S, 2008, COLLOID SURFACE B, V63, P301, DOI 10.1016/j.colsurfb.2007.12.013
   Sun FQ, 2010, CHINESE J POLYM SCI, V28, P547, DOI 10.1007/s10118-010-9082-1
   SUZUKI M, 1986, MACROMOLECULES, V19, P1804, DOI 10.1021/ma00161a005
   Thissen H, 2010, BIOMATERIALS, V31, P5510, DOI 10.1016/j.biomaterials.2010.03.040
   Thom V, 1998, MACROMOL CHEM PHYSIC, V199, P2723, DOI 10.1002/(SICI)1521-3935(19981201)199:12<2723::AID-MACP2723>3.0.CO;2-K
   Uyama Y, 1998, ADV POLYM SCI, V137, P1
   Watanabe T., 2003, US Patent, Patent No. [0,125,500, 0125500]
   Wavhal DS, 2003, LANGMUIR, V19, P79, DOI 10.1021/la020653o
   Willis SL, 2001, BIOMATERIALS, V22, P3261, DOI 10.1016/S0142-9612(01)00164-8
   Yao K, 2006, J BIOMED MATER RES A, V78A, P684, DOI 10.1002/jbm.a.30741
   Zhang F, 2001, J BIOMED MATER RES, V56, P324, DOI 10.1002/1097-4636(20010905)56:3<324::AID-JBM1100>3.0.CO;2-P
   Zhu GQ, 2009, FIBER POLYM, V10, P425, DOI 10.1007/s12221-009-0425-x
   Zou XP, 2002, PLASMAS POLYM, V7, P151, DOI 10.1023/A:1016243403102
NR 26
TC 5
Z9 5
U1 3
U2 63
PU WILEY-BLACKWELL
PI MALDEN
PA COMMERCE PLACE, 350 MAIN ST, MALDEN 02148, MA USA
SN 0021-8995
J9 J APPL POLYM SCI
JI J. Appl. Polym. Sci.
PD JUL 5
PY 2012
VL 125
IS 1
BP 548
EP 554
DI 10.1002/app.35687
PG 7
WC Polymer Science
SC Polymer Science
GA 919ST
UT WOS:000302349700065
DA 2018-10-19
ER

PT J
AU Reichert, JC
   Cipitria, A
   Epari, DR
   Saifzadeh, S
   Krishnakanth, P
   Berner, A
   Woodruff, MA
   Schell, H
   Mehta, M
   Schuetz, MA
   Duda, GN
   Hutmacher, DW
AF Reichert, Johannes C.
   Cipitria, Amaia
   Epari, Devakara R.
   Saifzadeh, Siamak
   Krishnakanth, Pushpanjali
   Berner, Arne
   Woodruff, Maria A.
   Schell, Hanna
   Mehta, Manav
   Schuetz, Michael A.
   Duda, Georg N.
   Hutmacher, Dietmar W.
TI A Tissue Engineering Solution for Segmental Defect Regeneration in
   Load-Bearing Long Bones
SO SCIENCE TRANSLATIONAL MEDICINE
LA English
DT Article
ID HUMAN OSTEOGENIC PROTEIN-1; MORPHOGENETIC PROTEIN-7; AUTOLOGOUS BONE;
   MARROW-CELLS; IN-VITRO; SCAFFOLD; FRACTURES; NONUNION; DIFFERENTIATION;
   DEGRADATION
AB The reconstruction of large defects (>10 mm) in humans usually relies on bone graft transplantation. Limiting factors include availability of graft material, comorbidity, and insufficient integration into the damaged bone. We compare the gold standard autograft with biodegradable composite scaffolds consisting of medical-grade polycaprolactone and tricalcium phosphate combined with autologous bone marrow-derived mesenchymal stem cells (MSCs) or recombinant human bone morphogenetic protein 7 (rhBMP-7). Critical-sized defects in sheep-a model closely resembling human bone formation and structure-were treated with autograft, rhBMP-7, or MSCs. Bridging was observed within 3 months for both the autograft and the rhBMP-7 treatment. After 12 months, biomechanical analysis and microcomputed tomography imaging showed significantly greater bone formation and superior strength for the biomaterial scaffolds loaded with rhBMP-7 compared to the autograft. Axial bone distribution was greater at the interfaces. With rhBMP-7, at 3 months, the radial bone distribution within the scaffolds was homogeneous. At 12 months, however, significantly more bone was found in the scaffold architecture, indicating bone remodeling. Scaffolds alone or with MSC inclusion did not induce levels of bone formation comparable to those of the autograft and rhBMP-7 groups. Applied clinically, this approach using rhBMP-7 could overcome autograft-associated limitations.
C1 [Reichert, Johannes C.; Epari, Devakara R.; Saifzadeh, Siamak; Krishnakanth, Pushpanjali; Berner, Arne; Woodruff, Maria A.; Schuetz, Michael A.; Hutmacher, Dietmar W.] Queensland Univ Technol, Inst Hlth & Biomed Innovat, Brisbane, Qld 4059, Australia.
   [Reichert, Johannes C.] Univ Wurzburg, Dept Trauma Hand Plast & Reconstruct Surg, D-97080 Wurzburg, Germany.
   [Cipitria, Amaia; Schell, Hanna; Mehta, Manav; Duda, Georg N.] Humboldt Univ, Charite Univ Med Berlin, Julius Wolff Inst, D-13353 Berlin, Germany.
   [Cipitria, Amaia; Schell, Hanna; Mehta, Manav; Duda, Georg N.] Humboldt Univ, Charite Univ Med Berlin, Ctr Musculoskeletal Surg, Berlin Brandenburg Ctr Regenerat Therapies, D-13353 Berlin, Germany.
   [Cipitria, Amaia; Schell, Hanna; Mehta, Manav; Duda, Georg N.] Free Univ Berlin, D-13353 Berlin, Germany.
   [Berner, Arne] Univ Regensburg, Dept Trauma Surg, D-93053 Regensburg, Germany.
RP Hutmacher, DW (reprint author), Queensland Univ Technol, Inst Hlth & Biomed Innovat, Brisbane, Qld 4059, Australia.
EM dietmar.hutmacher@qut.edu.au
RI Duda, Georg/H-2085-2016; Woodruff, Maria/J-1247-2012; Cipitria,
   Amaia/J-2010-2014; Saifzadeh, Siamak/J-1240-2012; Epari,
   Devakar/J-1204-2012
OI Duda, Georg/0000-0001-7605-3908; Cipitria, Amaia/0000-0002-9918-1512;
   Saifzadeh, Siamak/0000-0002-0295-7477; Epari,
   Devakar/0000-0002-9306-709X; Hutmacher, Dietmar
   Werner/0000-0001-5678-2134; Woodruff, Maria/0000-0002-4909-5288
FU Centro de Estudios e Investigaciones Tecnicas, Universidad de Navarra,
   Spain; Australian Research Council; Wesley Research Foundation,
   Brisbane; Berlin-Brandenburg Center for Regenerative Therapies
FX Funding: Centro de Estudios e Investigaciones Tecnicas, Universidad de
   Navarra, Spain (A. C.); the Australian Research Council and the Wesley
   Research Foundation, Brisbane; and the Berlin-Brandenburg Center for
   Regenerative Therapies.
CR Alberts KA, 1999, INJURY, V30, P519, DOI 10.1016/S0020-1383(99)00143-6
   Anitua E, 2004, THROMB HAEMOSTASIS, V91, P4, DOI 10.1160/TH03-07-0440
   ASAHINA I, 1993, J CELL BIOL, V123, P921, DOI 10.1083/jcb.123.4.921
   Bloemers FW, 2003, J BIOMED MATER RES B, V66B, P526, DOI 10.1002/jbm.b.10045
   Bostrom M, 1996, CLIN ORTHOP RELAT R, P272
   Cipitria A, 2012, J BONE MINER RES, V27, P1275, DOI 10.1002/jbmr.1589
   Darder-Garcia A, 1998, CLIN ORTHOP RELAT R, P97
   den Boer FC, 2003, J ORTHOPAED RES, V21, P521, DOI 10.1016/S0736-0266(02)00205-X
   Friedlaender GE, 2001, J BONE JOINT SURG AM, V83A, pS151
   Gao C, 2012, J ORTHOP RES, V30, P1183, DOI 10.1002/jor.22028
   Geesink RGT, 1999, J BONE JOINT SURG BR, V81B, P710, DOI 10.1302/0301-620X.81B4.9311
   Grayson WL, 2010, P NATL ACAD SCI USA, V107, P3299, DOI 10.1073/pnas.0905439106
   Guldberg RE, 2008, BIOMATERIALS, V29, P3757, DOI 10.1016/j.biomaterials.2008.06.018
   Haidar ZS, 2009, BIOTECHNOL LETT, V31, P1817, DOI 10.1007/s10529-009-0099-x
   Hollister SJ, 2011, TISSUE ENG PART B-RE, V17, P459, DOI [10.1089/ten.teb.2011.0251, 10.1089/ten.TEB.2011.0251]
   Janicki P, 2011, EUR CELLS MATER, V21, P488, DOI 10.22203/eCM.v021a37
   Kanakaris NK, 2008, INJURY, V39, pS83, DOI 10.1016/S0020-1383(08)70019-6
   Kanczler JM, 2008, EUR CELLS MATER, V15, P100, DOI 10.22203/eCM.v015a08
   Lam CXF, 2008, BIOMED MATER, V3, DOI 10.1088/1748-6041/3/3/034108
   Lam CXF, 2009, J BIOMED MATER RES A, V90A, P906, DOI 10.1002/jbm.a.32052
   LANGER R, 1993, SCIENCE, V260, P920, DOI 10.1126/science.8493529
   Moutos FT, 2007, NAT MATER, V6, P162, DOI 10.1038/nmat1822
   Muschler GF, 2010, TISSUE ENG PART B-RE, V16, P123, DOI [10.1089/ten.teb.2009.0658, 10.1089/ten.TEB.2009.0658]
   NEWMAN E, 1995, BONE, V16, pS277, DOI 10.1016/8756-3282(95)00026-A
   Obert L, 2005, INJURY, V36, P38, DOI 10.1016/j.injury.2005.07.033
   Onishi T, 1998, BONE, V22, P605, DOI 10.1016/S8756-3282(98)00056-8
   PITT CG, 1981, BIOMATERIALS, V2, P215
   Probst FA, 2010, HANDCHIR MIKROCHIR P, V42, P369, DOI 10.1055/s-0030-1248310
   Reichert JC, 2011, J TISSUE ENG REGEN M, V5, P831, DOI 10.1002/term.392
   Reichert JC, 2010, TISSUE ENG PART B-RE, V16, P93, DOI [10.1089/ten.teb.2009.0455, 10.1089/ten.TEB.2009.0455]
   Reichert JC, 2011, INT ORTHOP, V35, P1229, DOI 10.1007/s00264-010-1146-x
   Reichert JC, 2010, J TISSUE ENG REGEN M, V4, P565, DOI 10.1002/term.276
   Reichert JC, 2009, BIOMATERIALS, V30, P2149, DOI 10.1016/j.biomaterials.2008.12.050
   Ronga M, 2006, INJURY, V37, pS51, DOI 10.1016/j.injury.2006.08.024
   Sakai D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024847
   Sawyer AA, 2009, BIOMATERIALS, V30, P2479, DOI 10.1016/j.biomaterials.2008.12.055
   Schantz JT, 2002, CELL TRANSPLANT, V11, P125
   Takigami H, 2007, J ORTHOP RES, V25, P1333, DOI 10.1002/jor.20411
   ten Dijke P, 2003, J BONE JOINT SURG AM, V85A, P34
   TRIFFITT PD, 1994, ACTA ORTHOP SCAND, V65, P195, DOI 10.3109/17453679408995433
   Wei GB, 2007, BIOMATERIALS, V28, P2087, DOI 10.1016/j.biomaterials.2006.12.028
   Weibrich G, 2001, INT J ORAL MAX IMPL, V16, P693
   Weiss RJ, 2008, ACTA ORTHOP, V79, P526, DOI 10.1080/17453670710015535
   Woodruff MA, 2010, PROG POLYM SCI, V35, P1217, DOI 10.1016/j.progpolymsci.2010.04.002
NR 44
TC 94
Z9 97
U1 3
U2 55
PU AMER ASSOC ADVANCEMENT SCIENCE
PI WASHINGTON
PA 1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA
SN 1946-6234
J9 SCI TRANSL MED
JI Sci. Transl. Med.
PD JUL 4
PY 2012
VL 4
IS 141
AR 141ra93
DI 10.1126/scitranslmed.3003720
PG 11
WC Cell Biology; Medicine, Research & Experimental
SC Cell Biology; Research & Experimental Medicine
GA 970DR
UT WOS:000306108800009
PM 22764209
DA 2018-10-19
ER

PT J
AU Taraballi, F
   Wang, S
   Li, J
   Lee, FYY
   Venkatraman, SS
   Birch, WR
   Teoh, SH
   Boey, FYC
   Ng, KW
AF Taraballi, Francesca
   Wang, Shuai
   Li, Jian
   Lee, Fiona Yann Yann
   Venkatraman, Subbu S.
   Birch, William R.
   Teoh, Swee Hin
   Boey, Freddy Yin Chiang
   Ng, Kee Woei
TI Understanding the Nano-topography Changes and Cellular Influences
   Resulting from the Surface Adsorption of Human Hair Keratins
SO ADVANCED HEALTHCARE MATERIALS
LA English
DT Article
ID CELLS; BIOMATERIALS; EXPRESSION; PROLIFERATION; ATTACHMENT; SUBSTRATA;
   FOLLICLE; ADHESIVE; GUIDANCE; CATALOG
AB Recent interest in the use of human hair keratins as a biomaterial has grown, fuelled by improvements in keratin extraction methods and better understanding of keratin bioactivity. The use of keratins as a bioactive coating for in vitro cell culture studies is an attractive proposition. In this light, the surface adsorption of human hair keratins onto tissue culture polystyrene surfaces has been investigated. Keratin density, nano-topography and hydrophobicity of keratin coated surfaces were characterized. To understand the cellular influence of these coated surfaces, murine L929 fibroblasts were cultured on them and evaluated for cytotoxicity, proliferation, metabolic activity and detachment behaviors compared to collagen type 1 coated surfaces. Keratins were deposited up to a density of 650 ng/cm(2) when a coating concentration of 80 mu g/ml or higher was used. The surface features formed by adsorbed keratins also changed in a coating concentration dependent manner. These surfaces improved L929 mouse fibroblast adhesion and proliferation in comparison to uncoated and collagen type 1 coated tissue culture polystyrene. Furthermore, the expression of fibronectin was accelerated on surfaces coated with solutions of higher keratin concentrations. These results suggest that human hair keratins can be used as a viable surface coating material to enhance substrate compliance for culturing cells.
C1 [Taraballi, Francesca; Wang, Shuai; Venkatraman, Subbu S.; Boey, Freddy Yin Chiang; Ng, Kee Woei] Nanyang Technol Univ, Sch Mat Sci & Engn, Singapore 639798, Singapore.
   [Lee, Fiona Yann Yann] Nanyang Technol Univ, Sch Biol Sci, Singapore 639798, Singapore.
   [Li, Jian; Birch, William R.] ASTAR, Inst Mat Res & Engn, Singapore 117602, Singapore.
   [Teoh, Swee Hin] Nanyang Technol Univ, Div Bioengn, Sch Chem & Biomed Engn, Singapore 637459, Singapore.
RP Ng, KW (reprint author), Nanyang Technol Univ, Sch Mat Sci & Engn, 50 Nanyang Ave, Singapore 639798, Singapore.
EM kwng@ntu.edu.sg
RI Birch, William/U-8795-2017; Ng, Kee Woei/B-7242-2008; Boey, Freddy Yin
   Chiang/G-2618-2017; Venkatraman, Subramanian/A-2228-2011
OI Birch, William/0000-0001-8150-9033; Ng, Kee Woei/0000-0002-7276-3563;
   Venkatraman, Subramanian/0000-0002-8693-1070; Taraballi,
   Francesca/0000-0002-4959-1169
FU National Medical Research Council, Singapore [NMRC/NIG/1005/2009];
   National Research Foundation, Singapore
FX This research was supported by the National Medical Research Council,
   Singapore (NMRC/NIG/1005/2009) and the National Research Foundation,
   Singapore (Competitive Research Programme).
CR Arnold M, 2004, CHEMPHYSCHEM, V5, P383, DOI 10.1002/cphc.200301014
   Britland S, 1996, EXP CELL RES, V228, P313, DOI 10.1006/excr.1996.0331
   CLARK P, 1991, J CELL SCI, V99, P73
   Curtis ASG, 2004, IEEE T NANOBIOSCI, V3, P61, DOI 10.1109/TNB.2004.824276
   Dalby M J, 2004, IEE Proc Nanobiotechnol, V151, P53, DOI 10.1049/ip-nbt:20040534
   Dalby MJ, 2002, TISSUE ENG, V8, P1099, DOI 10.1089/107632702320934191
   Dalby MJ, 2004, INT J BIOCHEM CELL B, V36, P2005, DOI 10.1016/j.biocel.2004.03.001
   Dalby MJ, 2002, TISSUE ENG, V8, P453, DOI 10.1089/107632702760184718
   Denis FA, 2005, SMALL, V1, P984, DOI 10.1002/smll.200500116
   Denis FA, 2004, LANGMUIR, V20, P9335, DOI 10.1021/la049188g
   DOWLING LM, 1986, BIOCHEM J, V236, P705, DOI 10.1042/bj2360705
   Fuchs E, 1995, ANNU REV CELL DEV BI, V11, P123, DOI 10.1146/annurev.cb.11.110195.001011
   Fujii T, 2008, J MATER SCI-MATER M, V19, P2335, DOI 10.1007/s10856-007-3341-x
   Hill P, 2010, BIOMATERIALS, V31, P585, DOI 10.1016/j.biomaterials.2009.09.076
   Katoh K, 2004, BIOMATERIALS, V25, P4255, DOI 10.1016/j.biomaterials.2003.11.018
   Kirfel J, 2003, CELL MOL LIFE SCI, V60, P56, DOI 10.1007/s000180300004
   Langbein L, 1999, J BIOL CHEM, V274, P19874, DOI 10.1074/jbc.274.28.19874
   Langbein L, 2001, J BIOL CHEM, V276, P35123, DOI 10.1074/jbc.M103305200
   Li HQ, 2012, ACTA BIOMATER, V8, P531, DOI 10.1016/j.actbio.2011.09.029
   Makarem R., 1991, BIOCHEM SOC T, V19, P380
   Pallandre A, 2005, J AM CHEM SOC, V127, P4320, DOI 10.1021/ja043656r
   Reichl S, 2009, BIOMATERIALS, V30, P6854, DOI 10.1016/j.biomaterials.2009.08.051
   Richter JR, 2012, ACTA BIOMATER, V8, P274, DOI 10.1016/j.actbio.2011.08.020
   Richter JR, 2011, BIOMATERIALS, V32, P7555, DOI 10.1016/j.biomaterials.2011.06.061
   Shin H, 2003, BIOMATERIALS, V24, P4353, DOI 10.1016/S0142-9612(03)00339-9
   Sierpinski P, 2008, BIOMATERIALS, V29, P118, DOI 10.1016/j.biomaterials.2007.08.023
   STREULI CH, 1993, J CELL BIOL, V120, P253, DOI 10.1083/jcb.120.1.253
   SUTHERLAND DS, 1993, BIOMATERIALS, V14, P893, DOI 10.1016/0142-9612(93)90130-T
   Szeverenyi I, 2008, HUM MUTAT, V29, P351, DOI 10.1002/humu.20652
   Taraballi F, 2009, SOFT MATTER, V5, P660, DOI 10.1039/b809236b
   Verma V, 2008, BIOMED MATER, V3, DOI 10.1088/1748-6041/3/2/025007
   Wang S, 2012, CELL TISSUE RES, V347, P795, DOI 10.1007/s00441-011-1295-2
   WOJCIAKSTOTHARD B, 1995, CELL MOTIL CYTOSKEL, V31, P147, DOI 10.1002/cm.970310207
   Yamauchi K, 1998, J BIOMAT SCI-POLYM E, V9, P259, DOI 10.1163/156856298X00640
   Yap LYW, 2011, TISSUE ENG PART C-ME, V17, P193, DOI 10.1089/ten.TEC.2010.0328
   Zor T, 1996, ANAL BIOCHEM, V236, P302, DOI 10.1006/abio.1996.0171
NR 36
TC 20
Z9 20
U1 1
U2 26
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 2192-2640
J9 ADV HEALTHC MATER
JI Adv. Healthc. Mater.
PD JUL
PY 2012
VL 1
IS 4
BP 513
EP 519
DI 10.1002/adhm.201200043
PG 7
WC Engineering, Biomedical; Nanoscience & Nanotechnology; Materials
   Science, Biomaterials
SC Engineering; Science & Technology - Other Topics; Materials Science
GA 092IE
UT WOS:000315113100017
PM 23184785
DA 2018-10-19
ER

PT J
AU Uno, H
   Wang, ZH
   Takada, N
   Ishizuka, T
   Yawo, H
   Urisu, T
AF Uno, Hidetaka
   Wang, Zhi-hong
   Takada, Noriko
   Ishizuka, Toru
   Yawo, Hiromu
   Urisu, Tsuneo
TI Channelrhodopsin as a Noble Biomaterial Useful for the Operation and
   Performance Test of the Ionchannel Devices
SO MATERIALS TRANSACTIONS
LA English
DT Article
DE planar patch clamp biosensor; channelrhodopsin; C2Cl2; HEK293; ion
   channel current; action potential
ID PLANAR PATCH-CLAMP; ION-CHANNEL BIOSENSOR; MICROFLUIDICS; CONNECTIVITY;
   FABRICATION; PHOTOCYCLE; SUBSTRATE; NETWORKS; NEURONS; CULTURE
AB The light-gated ion-channel protein is expected to be able to improve the performance of ionchannel devices for the multi-point screening and neural network devices based on the planar patch clamp. However, no studies with light-gated ion channels on a planar patch clamp have been reported. We constructed an incubation type of planar patch clamp biosensor using silicon-on-insulator substrates with a 1-2 mu m micropore in them. Channelrhodopsin 2-expressing C2Cl2 cells and channelrhodopsin/wide receiver-expressing HEK293 cells were seeded on the surface of the sensor chip and incubated to almost complete confluence. A laser beam (473 nm wavelength) was radiated on the cells adsorbing to the sensor chip's micropore and the light-gated channel currents of the voltage clamp and action potentials of the current clamp modes were observed. Good signal to noise ratios were obtained, although the seal resistance was not so large, 10-30 M Omega. The observed pulse shape of the ion-channel currents also qualitatively resembled reported results measured with a pipette patch clamp. These results strongly suggest that the light-gated ion channel proteins are useful biomaterials for ionchannel devices. [doi:10.2320/matertrans.N-M2012814]
C1 [Uno, Hidetaka; Wang, Zhi-hong; Urisu, Tsuneo] Nagoya Univ, Res Ctr Innovat Nanobiodevices, Nagoya, Aichi 4648603, Japan.
   [Takada, Noriko] Natl Inst Nat Sci, Inst Mol Sci, Okazaki, Aichi 4448585, Japan.
   [Ishizuka, Toru; Yawo, Hiromu] Tohoku Univ, Grad Sch Life Sci, Dept Dev Biol & Neurosci, Sendai, Miyagi 9808577, Japan.
RP Uno, H (reprint author), Nagoya Univ, Res Ctr Innovat Nanobiodevices, Nagoya, Aichi 4648603, Japan.
RI Yawo, Hiromu/I-4871-2015; Ishizuka, Toru/L-8191-2017
OI Yawo, Hiromu/0000-0002-4299-3288; Ishizuka, Toru/0000-0003-4405-8792
FU Japanese Ministry of Education, Culture, Sports, Science and Technology;
   JSPS Asian Core Program; NINS Cooperation Project on Biomolecular
   Sensors; IMS special research projects; JST-CREST
FX We thank the staff of the Equipment Development Center, especially Mr.
   Mitsukazu Suzui, Mr. Masaki Aoyama, and Mr. Takuhiko Kondo for their
   help with building the devices. This work was partly supported by
   Grants-in-Aid for Scientific Research, Basic research (A) by the
   Japanese Ministry of Education, Culture, Sports, Science and Technology,
   the JSPS Asian Core Program, the NINS Cooperation Project on
   Biomolecular Sensors, IMS special research projects, and JST-CREST.
CR Asano T, 2008, T MRS JAP, V33, P767
   Bamann C, 2008, J MOL BIOL, V375, P686, DOI 10.1016/j.jmb.2007.10.072
   Chow BY, 2010, NATURE, V463, P98, DOI 10.1038/nature08652
   Erickson J, 2008, J NEUROSCI METH, V175, P1, DOI 10.1016/j.jneumeth.2008.07.023
   Fertig N, 2002, BIOPHYS J, V82, P3056, DOI 10.1016/S0006-3495(02)75646-4
   Fertig N, 2010, FUTURE MED CHEM, V2, P691, DOI [10.4155/fmc.10.183, 10.4155/FMC.10.183]
   Fujita H, 2007, EXP CELL RES, V313, P1853, DOI 10.1016/j.yexcr.2007.03.002
   Ishibashi T, 2009, BIOMED MICRODEVICES, V11, P413, DOI 10.1007/s10544-008-9247-7
   Ishizuka T, 2006, NEUROSCI RES, V54, P85, DOI 10.1016/j.neures.2005.10.009
   Kamada M, 2004, EUR J NEUROSCI, V20, P2499, DOI 10.1111/j.1460-9568.2004.03721.x
   Li XH, 2006, NANO LETT, V6, P815, DOI 10.1021/nl060165r
   Matthews B, 2006, J MICROELECTROMECH S, V15, P214, DOI 10.1109/JMEMS.2005.863606
   Nagai T, 2002, NAT BIOTECHNOL, V20, P87, DOI 10.1038/nbt0102-87
   Nagel G, 2003, P NATL ACAD SCI USA, V100, P13940, DOI 10.1073/pnas.1936192100
   Pantoja R, 2004, BIOSENS BIOELECTRON, V20, P509, DOI 10.1016/j.bios.2004.02.020
   Petreanu L, 2007, NAT NEUROSCI, V10, P663, DOI 10.1038/nn1891
   Reska A, 2008, ADV MATER, V20, P2751, DOI 10.1002/adma.200800270
   Ritter E, 2008, J BIOL CHEM, V283, P35033, DOI 10.1074/jbc.M806353200
   ROBERTS WM, 1992, METHOD ENZYMOL, V207, P155
   Schoenenberger P, 2008, BRAIN CELL BIOL, V36, P119, DOI 10.1007/s11068-008-9025-8
   Sett A, 2003, RECEPTOR CHANNEL, V9, P59
   Sordel T, 2006, J BIOTECHNOL, V125, P142, DOI 10.1016/j.jbiotec.2006.02.008
   Stehfest K, 2010, CHEMPHYSCHEM, V11, P1120, DOI 10.1002/cphc.200900980
   Tao HZW, 2000, J NEUROSCI, V20, P3233, DOI 10.1523/JNEUROSCI.20-09-03233.2000
   Taylor AM, 2010, NEURON, V66, P57, DOI 10.1016/j.neuron.2010.03.022
   Tourovskaia A, 2006, BIOPHYS J, V90, P2192, DOI 10.1529/biophysj.105.074864
   Urisu T, 2008, ANAL BIOANAL CHEM, V391, P2703, DOI 10.1007/s00216-008-1994-z
   Wang H, 2007, P NATL ACAD SCI USA, V104, P8143, DOI 10.1073/pnas.0700384104
   Wang HX, 2009, J BIOL CHEM, V284, P5685, DOI 10.1074/jbc.M807632200
   Wen L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012893
   Zhang F, 2006, NAT METHODS, V3, P785, DOI 10.1038/nmeth936
   Zhang ZL, 2008, THIN SOLID FILMS, V516, P2813, DOI 10.1016/j.tsf.2007.04.104
NR 32
TC 0
Z9 0
U1 0
U2 9
PU JAPAN INST METALS
PI SENDAI
PA 1-14-32, ICHIBANCHO, AOBA-KU, SENDAI, 980-8544, JAPAN
SN 1345-9678
EI 1347-5320
J9 MATER TRANS
JI Mater. Trans.
PD JUL
PY 2012
VL 53
IS 7
BP 1305
EP 1309
DI 10.2320/matertrans.N-M2012814
PG 5
WC Materials Science, Multidisciplinary; Metallurgy & Metallurgical
   Engineering
SC Materials Science; Metallurgy & Metallurgical Engineering
GA 999UY
UT WOS:000308341700019
OA Bronze
DA 2018-10-19
ER

PT J
AU Shiraishi, N
   Tu, R
   Uzuka, R
   Anada, T
   Narushima, T
   Goto, T
   Niinomi, M
   Sasaki, K
   Suzuki, O
AF Shiraishi, Naru
   Tu, Rong
   Uzuka, Risa
   Anada, Takahisa
   Narushima, Takayuki
   Goto, Takashi
   Niinomi, Mitsuo
   Sasaki, Keiichi
   Suzuki, Osamu
TI Biomechanical Evaluation of Amorphous Calcium Phosphate Coated TNTZ
   Implants Prepared Using a Radiofrequency Magnetron Sputtering System
SO MATERIALS TRANSACTIONS
LA English
DT Article
DE amorphous calcium phosphate; dental implant; osseointegration; push-in
   test; Ti-29Nb-13Ta-4.6Zr (TNTZ)
ID MECHANICAL-PROPERTIES; OCCLUSAL OVERLOAD; DENTAL IMPLANTS;
   TITANIUM-ALLOY; BONE; HYDROXYAPATITE; MOBILITY; FILMS; VIVO
AB Ti-29Nb-13Ta-4.6Zr alloy (TNTZ), a new beta-type Ti alloy, has excellent advantages as a biomaterial, such as low Young's modulus and cytotoxicity, and the absence of allergens. However, it is unclear whether TNTZ can achieve sufficient osseointcgration for it to be used as a dental implant. The effectiveness of surface modification of TNTZ implants by radiofrequency (RF) magnetron sputtering is also unclear. We investigated the biomechanical behaviors of TNTZ implants in vivo, using cylindrical implants of four types: pure Ti, TNTZ, and pure Ti and TNTZ coated with amorphous calcium phosphate (ACP). The implants were inserted in rat femurs, and the femurs were subjected to biomechanical analyses after various time intervals. The results suggest that TNTZ implants can achieve osseointegration similar to that of pure Ti, and that surface modification with ACP by RF magnetron sputtering improves osseointegration, especially in the later stages of healing. doi:10.2320/matertrans.M2012078]
C1 [Shiraishi, Naru] Tohoku Univ, Grad Sch Dent, Res Unit Interface Oral Hlth Sci, Sendai, Miyagi 9808577, Japan.
   [Tu, Rong; Goto, Takashi; Niinomi, Mitsuo] Tohoku Univ, Inst Mat Res, Sendai, Miyagi 9808575, Japan.
   [Uzuka, Risa; Sasaki, Keiichi] Tohoku Univ, Grad Sch Dent, Div Adv Prosthet Dent, Sendai, Miyagi 9808577, Japan.
   [Anada, Takahisa; Suzuki, Osamu] Tohoku Univ, Grad Sch Dent, Div Craniofacial Funct Engn, Sendai, Miyagi 9808577, Japan.
   [Narushima, Takayuki] Tohoku Univ, Grad Sch Engn, Dept Mat Proc, Sendai, Miyagi 9808579, Japan.
RP Shiraishi, N (reprint author), Tohoku Univ, Grad Sch Dent, Res Unit Interface Oral Hlth Sci, Sendai, Miyagi 9808577, Japan.
RI Tu, Rong/G-8983-2018; Niinomi, Mitsuo/B-5965-2011; GOTO,
   TAKASHI/C-2470-2011
OI Tu, Rong/0000-0002-5923-6793; 
FU Research and Education Funding for Inter-University Research Project
   (Highly-functional Interface Science: Innovation of Biomaterials;
   Ministry of Education, Culture, Sports, Science and Technology (MEXT),
   Japan; MEXT, Japan [22791861, 23792210]
FX This study was supported in part by Research and Education Funding for
   Inter-University Research Project (Highly-functional Interface Science:
   Innovation of Biomaterials with Highly-Functional Interface to Host and
   Parasite), Ministry of Education, Culture, Sports, Science and
   Technology (MEXT), Japan, and in part by a Grant-in-Aid for Young
   Scientist B (22791861 and 23792210) from MEXT, Japan.
CR Branemark P I, 1977, Scand J Plast Reconstr Surg Suppl, V16, P1
   Combes C, 2010, ACTA BIOMATER, V6, P3362, DOI 10.1016/j.actbio.2010.02.017
   Isidor F, 1998, INT J ORAL MAX IMPL, V13, P377
   Isidor F, 1997, CLIN ORAL IMPLAN RES, V8, P1, DOI 10.1111/j.1600-0501.1997.tb00001.x
   Kuroda D, 1998, MAT SCI ENG A-STRUCT, V243, P244, DOI 10.1016/S0921-5093(97)00808-3
   Leeuwenburgh S, 2001, J BIOMED MATER RES, V56, P208, DOI 10.1002/1097-4636(200108)56:2<208::AID-JBM1085>3.0.CO;2-R
   MEUNIER A, 1990, INT ORTHOP, V14, P67
   Miyata T, 2000, INT J ORAL MAX IMPL, V15, P425
   Nagano M, 1996, BIOMATERIALS, V17, P1771, DOI 10.1016/0142-9612(95)00357-6
   Narushima T, 2005, MATER TRANS, V46, P2246, DOI 10.2320/matertrans.46.2246
   Niinomi M, 2011, INT J BIOMATER, DOI 10.1155/2011/836587
   Niinomi M, 2003, BIOMATERIALS, V24, P2673, DOI 10.1016/S0142-9612(03)00069-3
   Niinomi M, 2002, MATER TRANS, V43, P2970, DOI 10.2320/matertrans.43.2970
   Niinomi M., 2010, B IRON STEEL I JPN, V15, P661
   Niinomi M., 2008, J MECH BEHAV BIOME 1, V3, P0
   Ogawa T, 2000, J DENT RES, V79, P1857, DOI 10.1177/00220345000790110701
   Piattelli A, 2003, J PERIODONTOL, V74, P385, DOI 10.1902/jop.2003.74.3.385
   Rangert B, 1995, Int J Oral Maxillofac Implants, V10, P326
   Seong WJ, 2011, INT J ORAL MAX IMPL, V26, P826
   SUZUKI O, 1991, TOHOKU J EXP MED, V164, P37, DOI 10.1620/tjem.164.37
   Ueda K, 2010, MATER SCI FORUM, V631-632, P211, DOI 10.4028/www.scientific.net/MSF.631-632.211
   Ueda K., 2007, MAT T, V48, P307
   Ueda K, 2007, BIOMED MATER, V2, pS160, DOI 10.1088/1748-6041/2/3/S14
   Yang YZ, 2005, BIOMATERIALS, V26, P327, DOI 10.1016/j.biomaterials.2004.02.029
NR 24
TC 3
Z9 3
U1 2
U2 16
PU JAPAN INST METALS
PI SENDAI
PA 1-14-32, ICHIBANCHO, AOBA-KU, SENDAI, 980-8544, JAPAN
SN 1345-9678
EI 1347-5320
J9 MATER TRANS
JI Mater. Trans.
PD JUL
PY 2012
VL 53
IS 7
BP 1343
EP 1348
DI 10.2320/matertrans.M2012078
PG 6
WC Materials Science, Multidisciplinary; Metallurgy & Metallurgical
   Engineering
SC Materials Science; Metallurgy & Metallurgical Engineering
GA 999UY
UT WOS:000308341700025
OA Bronze
DA 2018-10-19
ER

PT J
AU Kim, BS
   Choi, JS
   Kim, JD
   Yoon, HI
   Choi, YC
   Cho, YW
AF Kim, Beob Soo
   Choi, Ji Suk
   Kim, Jae Dong
   Yoon, Hwa In
   Choi, Young Chan
   Cho, Yong Woo
TI Human collagen isolated from adipose tissue
SO BIOTECHNOLOGY PROGRESS
LA English
DT Article
DE collagen; adipose tissue; liposuction; extracellular matrix; extraction
ID CONNECTIVE-TISSUE; EXTRACELLULAR-MATRIX; THERMAL-STABILITY; SKIN
   COLLAGEN; I COLLAGEN; PROTEINS; EXTRACTION; FISH; DIFFERENTIATION;
   DENATURATION
AB Collagen, the most abundant protein in vertebrates, is a useful biomaterial in pharmaceutical and medical industries. So far, most collagen has been extracted from animals and cadavers. Herein, we suggest human adipose tissue, which is routinely abandoned after liposuction, as a plentiful source of human collagen. In this study, human collagen was obtained from adipose tissue through two successive major steps: (i) extraction of the extracellular matrix (ECM) by pulverization, centrifugation, alkaline, and alcohol treatment; (ii) isolation of collagen from ECM by pepsin treatment in dilute acetic acid. The purified human adipose-derived collagen was characterized by Fourier transform infrared spectroscopy, polyacrylamide gel electrophoresis, amino acid analysis, and circular dichroism spectroscopy. The extracted collagen showed a typical triple helix structure, good thermal stability due to abundant imino acids, and high solubility at acidic pH. The collagen greatly facilitated the adhesion and proliferation of human adipose-derived stem cells and normal human dermal fibroblasts on polystyrene plates. These results suggest that human adipose tissue obtained by liposuction can provide human collagen for use in cosmetics, pharmaceutics, and medicine. (c) 2012 American Institute of Chemical Engineers Biotechnol. Prog., 28: 973980, 2012
C1 [Cho, Yong Woo] Hanyang Univ, Dept Chem Engn, Ansan 426791, Gyeonggi Do, South Korea.
   [Kim, Beob Soo; Choi, Ji Suk; Kim, Jae Dong; Yoon, Hwa In; Choi, Young Chan] Hanyang Univ, Dept Bionanotechnol, Ansan 426791, Gyeonggi Do, South Korea.
RP Cho, YW (reprint author), Hanyang Univ, Dept Chem Engn, Ansan 426791, Gyeonggi Do, South Korea.
EM ywcho7@hanyang.ac.kr
FU National Research Foundation of Korea (NRF) [2009-0075546,
   2011-0019774]; Korean government (MEST); Seoul RBD Program [SS110011]
FX This work was supported by the Basic Science Research Program (Grant No.
   2009-0075546), and the Bio & Medical Technology Development Program
   (Grant No. 2011-0019774) through the National Research Foundation of
   Korea (NRF) funded by the Korean government (MEST). This work was also
   supported by Seoul R&BD Program (Grant No. SS110011).
CR Calejo MT, 2009, J BIOMAT SCI-POLYM E, V20, P2073, DOI 10.1163/156856208X399125
   Chen CH, 2007, BIOMATERIALS, V28, P4643, DOI 10.1016/j.biomaterials.2007.07.015
   Choi JS, 2011, J BIOMED MATER RES A, V97A, P292, DOI 10.1002/jbm.a.33056
   DAVISON PF, 1967, J EXP MED, V126, P331, DOI 10.1084/jem.126.2.331
   Flynn LE, 2010, BIOMATERIALS, V31, P4715, DOI 10.1016/j.biomaterials.2010.02.046
   Foegeding E. A., 1996, FOOD CHEM, P879
   Friess W, 1998, EUR J PHARM BIOPHARM, V45, P113, DOI 10.1016/S0939-6411(98)00017-4
   Geutjes PJ, 2010, J VASC SURG, V52, P1330, DOI 10.1016/j.jvs.2010.05.118
   GROSS J, 1955, P NATL ACAD SCI USA, V41, P1, DOI 10.1073/pnas.41.1.1
   HARRINGTON WF, 1966, ANNU REV BIOCHEM, V35, P599, DOI 10.1146/annurev.bi.35.070166.003123
   HEIDEMANN E, 1982, ADV POLYM SCI, V43, P143
   Helcke T., 2000, INT FOOD INGREDIENTS, V1, P6
   Hickman D, 2000, J BIOTECHNOL, V79, P245, DOI 10.1016/S0168-1656(00)00241-8
   JACKSON M, 1995, BBA-MOL BASIS DIS, V1270, P1, DOI 10.1016/0925-4439(94)00056-V
   Jongjareonrak A, 2005, J SCI FOOD AGR, V85, P1203, DOI 10.1002/jsfa.2072
   Khan T, 2009, MOL CELL BIOL, V29, P1575, DOI 10.1128/MCB.01300-08
   Kim BS, 2010, J BIOMAT SCI-POLYM E, V21, P1701, DOI 10.1163/092050609X12548957288848
   KIMURA S, 1992, COMP BIOCHEM PHYS B, V102, P255, DOI 10.1016/0305-0491(92)90119-C
   KLEINMAN HK, 1982, BIOCHEMISTRY-US, V21, P6188, DOI 10.1021/bi00267a025
   KRIMM S, 1986, ADV PROTEIN CHEM, V38, P181, DOI 10.1016/S0065-3233(08)60528-8
   Kucharz E. J., 1992, COLLAGENS BIOCH PATH
   LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0
   Lee CH, 2001, INT J PHARM, V221, P1, DOI 10.1016/S0378-5173(01)00691-3
   Li D, 2008, J CHEM TECHNOL BIOT, V83, P1041, DOI 10.1002/jctb.1912
   Liu ZY, 2010, J AGR FOOD CHEM, V58, P1270, DOI 10.1021/jf9032415
   LOWRY OH, 1951, J BIOL CHEM, V193, P265
   Maraldi NM, 2009, ADV ENZYME REGUL, V49, P197, DOI 10.1016/j.advenzreg.2008.12.009
   Miura-Yokota Y, 2004, CONNECT TISSUE RES, V45, P109, DOI 10.1080/03008200490464857
   MONTERO P, 1991, J SCI FOOD AGR, V54, P137, DOI 10.1002/jsfa.2740540115
   Muraoka M, 1996, J BIOCHEM-TOKYO, V119, P167
   Nagai T, 2002, FOOD CHEM, V76, P149, DOI 10.1016/S0308-8146(01)00255-2
   Nagai T, 2000, FOOD CHEM, V68, P277, DOI 10.1016/S0308-8146(99)00188-0
   Nakajima I, 1998, DIFFERENTIATION, V63, P193, DOI 10.1046/j.1432-0436.1998.6340193.x
   NIMNI ME, 1988, COLLAGEN
   Ogawa M, 2003, J AGR FOOD CHEM, V51, P8088, DOI 10.1021/jf034350r
   PAYNE KJ, 1988, BIOPOLYMERS, V27, P1749, DOI 10.1002/bip.360271105
   Purna S K, 2000, Burns, V26, P54
   RIGBY BJ, 1968, NATURE, V219, P166, DOI 10.1038/219166a0
   RUBIN AL, 1965, BIOCHEMISTRY-US, V4, P181, DOI 10.1021/bi00878a001
   Ruszczak Z, 2003, ADV DRUG DELIVER REV, V55, P1595, DOI 10.1016/j.addr.2003.08.003
   Sato K, 2000, J BIOL CHEM, V275, P25870, DOI 10.1074/jbc.M003700200
   Shah YR, 2011, INT J DRUG DEV RES, V3, P14
   STRAWICH E, 1971, BIOCHEMISTRY-US, V10, P3905, DOI 10.1021/bi00797a017
   Swatschek D, 2002, EUR J PHARM BIOPHARM, V53, P107, DOI 10.1016/S0939-6411(01)00192-8
   Vojdani F., 1996, METHODS TESTING PROT, P11
   Wallace DG, 2003, ADV DRUG DELIVER REV, V55, P1631, DOI 10.1016/j.addr.2003.08.004
   Ward A. G., 1977, SCI TECHNOLOGY GELAT
   Wong D. W. S., 1989, MECH THEORY FOOD CHE
   Woo JW, 2008, FOOD HYDROCOLLOID, V22, P879, DOI 10.1016/j.foodhyd.2007.04.015
   Zhang Y, 2007, FOOD CHEM, V103, P906, DOI 10.1016/j.foodchem.2006.09.053
NR 50
TC 9
Z9 9
U1 1
U2 29
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 8756-7938
J9 BIOTECHNOL PROGR
JI Biotechnol. Prog.
PD JUL-AUG
PY 2012
VL 28
IS 4
BP 973
EP 980
DI 10.1002/btpr.1555
PG 8
WC Biotechnology & Applied Microbiology; Food Science & Technology
SC Biotechnology & Applied Microbiology; Food Science & Technology
GA 984VQ
UT WOS:000307220900010
PM 22549937
DA 2018-10-19
ER

PT J
AU Girgis, DO
   Karp, CL
   Miller, D
AF Girgis, Dalia O.
   Karp, Carol L.
   Miller, Darlene
TI Ocular infections caused by non-tuberculous mycobacteria: update on
   epidemiology and management
SO CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY
LA English
DT Article
DE antibiotic; bacterial disease; eye; fluoroquinolone; infection
ID IN-SITU KERATOMILEUSIS; ATYPICAL MYCOBACTERIA; CHELONAE KERATITIS;
   4TH-GENERATION FLUOROQUINOLONE; SOUTH FLORIDA; FORTUITUM; ABSCESSUS;
   LASIK; ENDOPHTHALMITIS; CONJUNCTIVITIS
AB Background: To provide an update on the frequency, distribution, risk factors and in vitro susceptibility of ocular infections caused by non-tuberculous mycobacteria. Design: Retrospective study of university clinic patients. Participants: One hundred thirty-nine patients with culture confirmed non-tuberculous mycobacteria infections seen at Bascom Palmer Eye Institute from January 1980 to July 2007. Methods: Chart review of data collected included patients' demographics, risk factors, microbiological profiles and clinical outcomes. Main Outcome Measures: Frequency, distribution, risk factors and in vitro susceptibility of ocular infections caused by non-tuberculous mycobacteria. Results: A total of 183 non-tuberculous mycobacteria isolates from 142 eyes were identified, with a fourfold increase in the number of eyes infected with non-tuberculous mycobacteria from 19801989 (13.4%) to 20002007 (56.3%). Eighty-three percent of non-tuberculous mycobacteria isolates were identified as M. abscessus/chelonae. The majority (91%) of isolates were recovered within 10 days. Common diagnoses included keratitis (36.6%), scleral buckle infections (14.8%) and socket/implant infections (14.8%). Identifiable risk factors were presence of biomaterials (63.1%), ocular surgery (24.1%) and steroid exposure (77%). The median time from diagnosis of culture positive non-tuberculous mycobacteria infection to resolution was 13 to 24 weeks. Combination therapy was used to treat 80% of infected eyes. In vitro susceptibility of non-tuberculous mycobacteria isolates were: amikacin, 81%; clarithromycin, 93%; and moxifloxacin, 21%. Conclusions: The incidence of ocular infections caused by non-tuberculous mycobacteria has increased within the last 8 years, with a high number of biomaterial associated infections among this group. Clinical diagnosis and microbiological confirmation of non-tuberculous mycobacteria infections remains challenging. Patient outcomes may be improved by early diagnosis, appropriate therapy and removal of biomaterials.
C1 [Girgis, Dalia O.; Karp, Carol L.; Miller, Darlene] Univ Miami, Bascom Palmer Eye Inst, Sch Med, Miami, FL 33136 USA.
RP Miller, D (reprint author), Univ Miami, Bascom Palmer Eye Inst, Sch Med, 900 NW 17th St, Miami, FL 33136 USA.
EM dmiller@med.miami.edu
RI Miller, Darlene/C-9053-2013
FU NIH [P30-EY14801]; Research to Prevent Blindness
FX NIH core grant: P30-EY14801, Research to Prevent Blindness.
CR Alexandrakis G, 2000, OPHTHALMOLOGY, V107, P1497, DOI 10.1016/S0161-6420(00)00179-2
   ARTENSTEIN AW, 1993, OPHTHALMOLOGY, V100, P666
   Bottone EJ, 2005, CORNEA, V24, P356, DOI 10.1097/01.ico.0000138858.95516.c5
   Brancato R, 1997, ARCH OPHTHALMOL-CHIC, V115, P1316, DOI 10.1001/archopht.1997.01100160486019
   CARSON LA, 1978, APPL ENVIRON MICROB, V36, P839
   Chang MA, 2004, SURV OPHTHALMOL, V49, P269, DOI 10.1016/j.survophthal.2004.02.007
   Covert TC, 1999, APPL ENVIRON MICROB, V65, P2492
   Daines BS, 2003, J CATARACT REFR SURG, V29, P1014, DOI 10.1016/S0886-3350(02)01613-9
   de la Cruz J, 2007, J CATARACT REFR SURG, V33, P1318, DOI 10.1016/j.jcrs.2007.03.035
   de la Cruz Jose, 2007, International Ophthalmology Clinics, V47, P73, DOI 10.1097/IIO.0b013e318037751b
   EIFERMAN RA, 1982, ARCH OPHTHALMOL-CHIC, V100, P1817, DOI 10.1001/archopht.1982.01030040797018
   Falkinham JO, 1996, CLIN MICROBIOL REV, V9, P177
   Ford JG, 1998, OPHTHALMOLOGY, V105, P1652, DOI 10.1016/S0161-6420(98)99034-0
   Freitas D, 2003, OPHTHALMOLOGY, V110, P276, DOI 10.1016/S0161-6420(02)01643-3
   Giaconi J, 2002, J CATARACT REFR SURG, V28, P887, DOI 10.1016/S0886-3350(01)01096-3
   Hamam RN, 2006, OPHTHALMOLOGY, V113, P950, DOI 10.1016/j.ophtha.2006.02.028
   HOLLAND SP, 1991, OPHTHALMOLOGY, V98, P933
   Joshi L, 2009, CLIN INFECT DIS, V48, pe73, DOI 10.1086/597298
   Karp CL, 2003, OPHTHALMOLOGY, V110, P503, DOI 10.1016/S0161-6420(02)01760-8
   KATOWITZ JA, 1987, OPHTHALMIC SURG LAS, V18, P97
   Kovoor Timmy A, 2004, Eye Contact Lens, V30, P90, DOI 10.1097/01.ICL.00000117255.97190.98
   Kuehne JJ, 2004, AM J OPHTHALMOL, V138, P547, DOI 10.1016/j.ajo.2004.04.071
   Lee SB, 2005, CAN J OPHTHALMOL, V40, P750, DOI 10.1016/S0008-4182(05)80094-8
   Margo CE, 2000, ARCH OPHTHALMOL-CHIC, V118, P1125, DOI 10.1001/archopht.118.8.1125
   Merani R, 2008, CLIN EXP OPHTHALMOL, V36, P371, DOI 10.1111/j.1442-9071.2008.01772.x
   MOORTHY RS, 1995, BRIT J OPHTHALMOL, V79, P93, DOI 10.1136/bjo.79.1.93
   Moshirfar M, 2007, J CATARACT REFR SURG, V33, P1978, DOI 10.1016/j.jcrs.2007.07.019
   MURRAY PR, 1999, MANUAL CLIN MICROBIO
   Mutyala S, 1996, RETINA-J RET VIT DIS, V16, P122, DOI 10.1097/00006982-199616020-00006
   OBrien T. P. M. A. Y, 1996, OCULAR INFECT IMMUNI, P1033
   ORMEROD LD, 1991, OPHTHALMOLOGY, V98, P159
   Palmi D, 2007, CORNEA, V26, P729
   PANWALKER AP, 1986, INFECT CONT HOSP EP, V7, P67, DOI 10.1017/S0195941700063918
   PASCHAL JF, 1992, CORNEA, V11, P493, DOI 10.1097/00003226-199211000-00001
   Petrini B, 2006, APMIS, V114, P319, DOI 10.1111/j.1600-0463.2006.apm_390.x
   Ramaswamy AA, 2000, OPHTHALMOLOGY, V107, P1283, DOI 10.1016/S0161-6420(00)00162-7
   Reviglio V, 1998, J REFRACT SURG, V14, P357
   ROBIN JB, 1986, AM J OPHTHALMOL, V102, P72, DOI 10.1016/0002-9394(86)90212-6
   ROOTMAN DS, 1989, CAN J OPHTHALMOL, V24, P221
   SCHULZEROBBECKE R, 1992, TUBERCLE LUNG DIS, V73, P141, DOI 10.1016/0962-8479(92)90147-C
   September SM, 2004, APPL ENVIRON MICROB, V70, P7571, DOI 10.1128/AEM.70.12.7571-7573.2004
   Serra C, 2007, J CLIN MICROBIOL, V45, P1663, DOI 10.1128/JCM.00119-07
   SMIDDY WE, 1991, RETINA-J RET VIT DIS, V11, P394, DOI 10.1097/00006982-199111040-00005
   SMITH RE, 1980, AM J OPHTHALMOL, V89, P139, DOI 10.1016/0002-9394(80)90241-X
   Solomon A, 2001, OPHTHALMOLOGY, V108, P2201, DOI 10.1016/S0161-6420(01)00851-X
   Solomon R, 2003, J CATARACT REFR SURG, V29, P2001, DOI 10.1016/S0886-3350(03)00512-1
   Srinivasan M., 2005, Indian Journal of Ophthalmology, V53, P67
   Tortoli E, 2003, CLIN MICROBIOL REV, V16, P319, DOI 10.1128/CMR.16.2.319-354.2003
   Wallace RJ, 2001, ANTIMICROB AGENTS CH, V45, P764, DOI 10.1128/AAC.45.3.764-767.2001
   Yakrus MA, 2001, J CLIN MICROBIOL, V39, P4103, DOI 10.1128/JCM.39.11.4103-4110.2001
NR 50
TC 24
Z9 24
U1 1
U2 7
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1442-6404
EI 1442-9071
J9 CLIN EXP OPHTHALMOL
JI Clin. Exp. Ophthalmol.
PD JUL
PY 2012
VL 40
IS 5
BP 467
EP 475
DI 10.1111/j.1442-9071.2011.02679.x
PG 9
WC Ophthalmology
SC Ophthalmology
GA 978QQ
UT WOS:000306760700008
PM 21902780
DA 2018-10-19
ER

PT J
AU Aguirre, A
   Gonzalez, A
   Navarro, M
   Castano, O
   Planell, JA
   Engel, E
AF Aguirre, Aitor
   Gonzalez, Arlyng
   Navarro, Melba
   Castano, Oscar
   Planell, Josep A.
   Engel, Elisabeth
TI CONTROL OF MICROENVIRONMENTAL CUES WITH A SMART BIOMATERIAL COMPOSITE
   PROMOTES ENDOTHELIAL PROGENITOR CELL ANGIOGENESIS
SO EUROPEAN CELLS & MATERIALS
LA English
DT Article
DE Calcium phosphate glass composite; smart biomaterial; endothelial
   progenitor cell; angiogenesis; mechanosensing; calcium-sensing receptor
ID CALCIUM-SENSING RECEPTOR; HUMAN OSTEOBLASTS; GENE-EXPRESSION; IONIC
   PRODUCTS; MYOSIN-II; IN-VITRO; BONE; GROWTH; TISSUE; VASCULARIZATION
AB Smart biomaterials play a key role when aiming at successful tissue repair by means of regenerative medicine approaches, and are expected to contain chemical as well as mechanical cues that will guide the regenerative process. Recent advances in the understanding of stem cell biology and mechanosensing have shed new light onto the importance of the local microenvironment in determining cell fate. Herein we report the biological properties of a bioactive, biodegradable calcium phosphate glass/polylactic acid composite biomaterial that promotes bone marrow-derived endothelial progenitor cell (EPC) mobilisation, differentiation and angiogenesis through the creation of a controlled bone healing-like microenvironment. The angiogenic response is triggered by biochemical and mechanical cues provided by the composite, which activate two synergistic cell signalling pathways: a biochemical one mediated by the calcium-sensing receptor and a mechanosensitive one regulated by non-muscle myosin II contraction. Together, these signals promote a synergistic response by activating EPCs-mediated VEGF and VEGFR-2 synthesis, which in turn promote progenitor cell homing, differentiation and tubulogenesis. These findings highlight the importance of controlling microenvironmental cues for stem/progenitor cell tissue engineering and offer exciting new therapeutical opportunities for biomaterialbased vascularisation approaches and clinical applications.
C1 [Engel, Elisabeth] Inst Bioengn Catalonia, Biomat Regenerat Therapies Grp, Barcelona, Spain.
   [Aguirre, Aitor; Navarro, Melba; Planell, Josep A.; Engel, Elisabeth] Tech Univ Catalonia, Barcelona, Spain.
   [Aguirre, Aitor; Gonzalez, Arlyng; Navarro, Melba; Castano, Oscar; Planell, Josep A.; Engel, Elisabeth] CIBER BBN, Zaragoza, Spain.
RP Engel, E (reprint author), Inst Bioengn Catalonia, Biomat Regenerat Therapies Grp, Baldiri Reixac 15-21, Barcelona, Spain.
EM elisabeth.engel@upc.edu
RI Gonzalez Vazquez, Arlyng/G-9653-2012; Aguirre, Aitor/A-3294-2013;
   Castano, Oscar/F-6725-2012; Engel, Elisabeth/D-4365-2014
OI Gonzalez Vazquez, Arlyng/0000-0003-0648-5590; Castano,
   Oscar/0000-0001-9212-784X; Engel, Elisabeth/0000-0003-4855-8874;
   Aguirre, Aitor/0000-0002-1383-2792
FU European Comission [NMP3-LA-2008-214402]; Spanish Ministry of Science
   and Innovation [MAT2008-06887-C03-01]; CIBER-BBN; Generalitat of
   Catalunya; Spanish MICINN
FX We are grateful to Dr. Damian Lacroix for helpful comments and data on
   scaffold stiffness. We thank the European Comission (European project
   NMP3-LA-2008-214402, ANGIOSCAFF), the Spanish Ministry of Science and
   Innovation (Project MAT2008-06887-C03-01) and the CIBER-BBN for funding.
   AA was supported by a FI-B pre-doctoral grant from the Generalitat of
   Catalunya. OC acknowledges the Spanish MICINN for a Ramon y Cajal
   contract. We wish to confirm that there are no known conflicts of
   interest associated with this publication and there has been no
   significant financial support for this work that could have influenced
   its outcome.
CR Adams GB, 2006, NATURE, V439, P599, DOI 10.1038/nature04247
   Aguirre A, 2010, BIOCHEM BIOPH RES CO, V400, P284, DOI 10.1016/j.bbrc.2010.08.073
   Aguirre A, 2010, BIOCHEM BIOPH RES CO, V393, P156, DOI 10.1016/j.bbrc.2010.01.109
   Anderson DG, 2004, SCIENCE, V305, P1923, DOI 10.1126/science.1099987
   Asahara T, 1997, SCIENCE, V275, P964, DOI 10.1126/science.275.5302.964
   Brown EM, 2001, PHYSIOL REV, V81, P239
   Byfield FJ, 2009, J BIOMECH, V42, P1114, DOI 10.1016/j.jbiomech.2009.02.012
   Chang WH, 2008, SCI SIGNAL, V1, DOI 10.1126/scisignal.1159945
   Day RM, 2005, TISSUE ENG, V11, P768, DOI 10.1089/ten.2005.11.768
   Engler AJ, 2006, CELL, V126, P677, DOI 10.1016/j.cell.2006.06.044
   Forster NA, 2011, ISLETS, V3, P271, DOI 10.4161/isl.3.5.15942
   Fuchs S, 2006, BIOMATERIALS, V27, P5399, DOI 10.1016/j.biomaterials.2006.06.015
   Goeckeler ZM, 2008, AM J PHYSIOL-CELL PH, V295, pC994, DOI 10.1152/ajpcell.00318.2008
   Hammond CM, 2007, BLOOD, V110, P3985, DOI 10.1182/blood-2007-05-088468
   Hench LL, 2002, SCIENCE, V295, P1014, DOI 10.1126/science.1067404
   Holmes K, 2007, CELL SIGNAL, V19, P2003, DOI 10.1016/j.cellsig.2007.05.013
   Ingber DE, 2008, PROG BIOPHYS MOL BIO, V97, P163, DOI 10.1016/j.pbiomolbio.2008.02.005
   Ingber DE, 2006, FASEB J, V20, P811, DOI 10.1096/fj.05-5424rev
   Kanczler JM, 2008, EUR CELLS MATER, V15, P100, DOI 10.22203/eCM.v015a08
   Kirkpatrick CJ, 2011, ADV DRUG DELIVER REV, V63, P291, DOI 10.1016/j.addr.2011.01.009
   Kneser U, 2006, TISSUE ENG, V12, P1721, DOI 10.1089/ten.2006.12.1721
   Koffler J, 2011, P NATL ACAD SCI USA, V108, P14789, DOI 10.1073/pnas.1017825108
   Larrivee B., 2007, V180, P89
   Li HY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016767
   Liu JY, 2007, CARDIOVASC RES, V75, P618, DOI 10.1016/j.cardiores.2007.04.018
   Liu ZA, 2010, BRIT J PHARMACOL, V159, P304, DOI 10.1111/j.1476-5381.2009.00477.x
   Lugus JJ, 2007, DEVELOPMENT, V134, P393, DOI 10.1242/dev.02731
   Lutolf MP, 2009, NATURE, V462, P433, DOI 10.1038/nature08602
   Mammoto A, 2009, CURR OPIN CELL BIOL, V21, P864, DOI 10.1016/j.ceb.2009.08.001
   Mammoto A, 2009, NATURE, V457, P1103, DOI 10.1038/nature07765
   Marnmoto A, 2008, CURR OPIN HEMATOL, V15, P228, DOI 10.1097/MOH.0b013e3282fa7445
   Martin D, 2009, J BIOL CHEM, V284, P6038, DOI 10.1074/jbc.C800207200
   Mentaverri R, 2006, FASEB J, V20, P2562, DOI 10.1096/fj.06-6304fje
   Mooney DJ, 2008, CELL STEM CELL, V2, P205, DOI 10.1016/j.stem.2008.02.005
   Navarro M, 2004, J MATER SCI-MATER M, V15, P419, DOI 10.1023/B:JMSM.0000021113.88702.9d
   Niggli V, 2006, BIOCHEM BIOPH RES CO, V343, P602, DOI 10.1016/j.bbrc.2006.03.022
   Nomi M, 2002, MOL ASPECTS MED, V23, P463, DOI 10.1016/S0098-2997(02)00008-0
   Rehfeldt F, 2007, ADV DRUG DELIVER REV, V59, P1329, DOI 10.1016/j.addr.2007.08.007
   Santos MI, 2010, MACROMOL BIOSCI, V10, P12, DOI 10.1002/mabi.200900107
   Sanzana ES, 2008, ACTA BIOMATER, V4, P1924, DOI 10.1016/j.actbio.2008.04.023
   SILVER IA, 1988, EXP CELL RES, V175, P266, DOI 10.1016/0014-4827(88)90191-7
   Spencer VA, 2010, J MAMMARY GLAND BIOL, V15, P65, DOI 10.1007/s10911-010-9163-3
   Takahashi T, 1999, NAT MED, V5, P434
   Tommila M, 2009, J R SOC INTERFACE, V6, P873, DOI 10.1098/rsif.2009.0020
   Wang HH, 2008, AM J PHYSIOL-HEART C, V294, pH2060, DOI 10.1152/ajpheart.00970.2007
   Xynos ID, 2000, BIOCHEM BIOPH RES CO, V276, P461, DOI 10.1006/bbrc.2000.3503
   Xynos ID, 2001, J BIOMED MATER RES, V55, P151, DOI 10.1002/1097-4636(200105)55:2<151::AID-JBM1001>3.3.CO;2-4
NR 47
TC 40
Z9 40
U1 1
U2 33
PU AO RESEARCH INSTITUTE DAVOS-ARI
PI DAVOS
PA CLAVADELERSTRASSE 8, DAVOS, CH 7270, SWITZERLAND
SN 1473-2262
J9 EUR CELLS MATER
JI Eur. Cells Mater.
PD JUL-DEC
PY 2012
VL 24
BP 90
EP 106
DI 10.22203/eCM.v024a07
PG 17
WC Cell & Tissue Engineering; Engineering, Biomedical; Materials Science,
   Biomaterials; Orthopedics
SC Cell Biology; Engineering; Materials Science; Orthopedics
GA 989JJ
UT WOS:000307555800007
PM 22828988
OA DOAJ Gold
DA 2018-10-19
ER

PT J
AU Studer, D
   Millan, C
   Ozturk, E
   Maniura-Weber, K
   Zenobi-Wong, M
AF Studer, Deborah
   Millan, Christopher
   Oeztuerk, Ece
   Maniura-Weber, Katharina
   Zenobi-Wong, Marcy
TI MOLECULAR AND BIOPHYSICAL MECHANISMS REGULATING HYPERTROPHIC
   DIFFERENTIATION IN CHONDROCYTES AND MESENCHYMAL STEM CELLS
SO EUROPEAN CELLS & MATERIALS
LA English
DT Article
DE Hypertrophy; mesenchymal stem cells; chondrogenesis; biomaterials;
   epigenetics; hypoxia; coculture
ID GROWTH-PLATE CHONDROCYTES; HUMAN ARTICULAR CHONDROCYTES; HORMONE-RELATED
   PEPTIDE; PROMOTES CHONDROGENIC DIFFERENTIATION; TRANSCRIPTION FACTOR
   RUNX2; IN-VITRO CHONDROGENESIS; REDUCED OXYGEN-TENSION; GENE-EXPRESSION;
   BONE-MARROW; PARATHYROID-HORMONE
AB Chondrocyte hypertrophy is one of the key physiological processes involved in the longitudinal growth of long bones, yet regulation of hypertrophy is becoming increasingly relevant for clinical application of mesenchymal stem cells (MSCs) and screening for drugs to treat hypertrophic osteoarthritis. The extraordinary cell volume increase during hypertrophy is accompanied by an up-regulation of collagen X, matrix metalloproteinases (MMPs), and vascular endothelial growth factor (VEGF), all which are targets of the runt-related transcription factor 2 (Runx2). Many pathways, including parathyroid hormone-related protein (PTHrP)/Indian Hedgehog, Wingless/Int (Wnt)/beta-catenin, and transforming growth factor beta (TGF-beta)/Sma and Mad Related Family (Smad) pathways, can regulate hypertrophy, but factors as diverse as hypoxia, co-culture, epigenetics and biomaterial composition can also potently affect Runx2 expression. Control of hypertrophic differentiation can be exploited both for cartilage repair, where a stable phenotype is desired, but also in bone regeneration, where hypertrophic cartilage could act as a template for endochondral bone formation. We hope this review will motivate the design of novel engineered microenvironments for skeletal regeneration applications.
C1 [Studer, Deborah; Millan, Christopher; Oeztuerk, Ece; Zenobi-Wong, Marcy] ETH, Cartilage Engn Regenerat Lab, Dept Hlth Sci & Technol, CH-8092 Zurich, Switzerland.
   [Studer, Deborah; Maniura-Weber, Katharina] Empa, Lab Mat Biol Interact, Swiss Fed Labs Mat Testing & Res, St Gallen, Switzerland.
RP Zenobi-Wong, M (reprint author), ETH, Cartilage Engn Regenerat Lab, Dept Hlth Sci & Technol, Gloriastr 35,ETZ F84, CH-8092 Zurich, Switzerland.
EM zmarcy@ethz.ch
RI Zenobi-Wong, Marcy/J-5398-2013
OI Zenobi-Wong, Marcy/0000-0002-8522-9909; Maniura,
   Katharina/0000-0001-7895-3563
FU Swiss National Science Foundation [CR23I2-130678/1]; European Union
   [NMP4-SL-2009-229292]
FX This study was supported by the Swiss National Science Foundation
   (CR23I2-130678/1) to MZW and KMW and the European Union Seventh
   Framework Programme (FP7/2007-2013) under grant agreement no
   NMP4-SL-2009-229292 (Find&Bind). We acknowledge Markus Rottmar for
   carefully reviewing the manuscript.
CR Acharya C, 2012, J CELL PHYSIOL, V227, P88, DOI 10.1002/jcp.22706
   Amano M, 1997, SCIENCE, V275, P1308, DOI 10.1126/science.275.5304.1308
   Amling M, 1997, J CELL BIOL, V136, P205, DOI 10.1083/jcb.136.1.205
   Anderson H Clarke, 2003, Curr Rheumatol Rep, V5, P222, DOI 10.1007/s11926-003-0071-z
   Angers S, 2009, NAT REV MOL CELL BIO, V10, P468, DOI 10.1038/nrm2717
   Arnold MA, 2007, DEV CELL, V12, P377, DOI 10.1016/j.devcel.2007.02.004
   Awad HA, 2004, BIOMATERIALS, V25, P3211, DOI 10.1016/j.biomaterials.2003.10.045
   Backs J, 2008, MOL CELL BIOL, V28, P3437, DOI 10.1128/MCB.01611-07
   Backs J, 2006, J CLIN INVEST, V116, P1853, DOI 10.1172/JCI27438
   Balcerzak M, 2003, ACTA BIOCHIM POL, V50, P1019
   Barry F, 2001, EXP CELL RES, V268, P189, DOI 10.1006/excr.2001.5278
   Barter MJ, 2012, OSTEOARTHR CARTILAGE, V20, P339, DOI 10.1016/j.joca.2011.12.012
   Bassik MC, 2004, EMBO J, V23, P1207, DOI 10.1038/sj.emboj.7600104
   BAWDEN JW, 1989, ANAT REC, V224, P226, DOI 10.1002/ar.1092240212
   Benton G, 2009, FASEB J, V23, P3884, DOI 10.1096/fj.08-128702
   BENYA PD, 1982, CELL, V30, P215, DOI 10.1016/0092-8674(82)90027-7
   Beris AE, 2005, INJURY, V36, pS14, DOI 10.1016/j.injury.2005.10.007
   Betre H, 2006, BIOMATERIALS, V27, P91, DOI 10.1016/j.biomaterials.2005.05.071
   Bian L, 2011, TISSUE ENG PT A, V17, P1137, DOI [10.1089/ten.tea.2010.0531, 10.1089/ten.TEA.2010.0531]
   Bian LM, 2011, BIOMATERIALS, V32, P6425, DOI 10.1016/j.biomaterials.2011.05.033
   Bohrnsen F, 2009, BMC CELL BIOL, V10, DOI 10.1186/1471-2121-10-92
   BONEN DK, 1991, J CELL BIOL, V115, P1171, DOI 10.1083/jcb.115.4.1171
   Bradley EW, 2010, MOL ENDOCRINOL, V24, P1581, DOI 10.1210/me.2010-0037
   BUCKWALTER JA, 1986, J BONE JOINT SURG AM, V68A, P243, DOI 10.2106/00004623-198668020-00010
   Bush PG, 2008, J CELL PHYSIOL, V214, P621, DOI 10.1002/jcp.21249
   Bush PG, 2010, J BONE MINER RES, V25, P1594, DOI 10.1002/jbmr.47
   Caporali E, 2011, VET CLIN MED
   Chang Wenhan, 1999, Endocrinology, V140, P5883, DOI 10.1210/en.140.12.5883
   Chao PHG, 2006, AM J PHYSIOL-CELL PH, V291, pC718, DOI 10.1152/ajpcell.00127.2005
   Chen ZX, 2011, J BIOL CHEM, V286, P18347, DOI 10.1074/jbc.R110.205286
   Cheung KSC, 2009, RHEUMATOL INT, V29, P525, DOI 10.1007/s00296-008-0744-z
   Choi KH, 2010, BIOMATERIALS, V31, P5355, DOI 10.1016/j.biomaterials.2010.03.053
   Choi SW, 2012, BIOCHEM J, V443, P789, DOI 10.1042/BJ20112062
   Clark AL, 2010, ARTHRITIS RHEUM-US, V62, P2973, DOI 10.1002/art.27624
   Connelly JT, 2008, J CELL PHYSIOL, V217, P145, DOI 10.1002/jcp.21484
   Cooke ME, 2011, OSTEOARTHR CARTILAGE, V19, P1210, DOI 10.1016/j.joca.2011.07.005
   Crapo PM, 2011, BIOMATERIALS, V32, P3233, DOI 10.1016/j.biomaterials.2011.01.057
   Curran JM, 2005, BIOMATERIALS, V26, P7057, DOI 10.1016/j.biomaterials.2005.05.008
   D'Andrea P, 2000, BIORHEOLOGY, V37, P75
   D'Ippolito G, 2006, BONE, V39, P513, DOI 10.1016/j.bone.2006.02.061
   Dioum EM, 2009, SCIENCE, V324, P1289, DOI 10.1126/science.1169956
   Dong YF, 2006, J CELL PHYSIOL, V208, P77, DOI 10.1002/jcp.20656
   Dudek KA, 2010, J BIOL CHEM, V285, P24381, DOI 10.1074/jbc.M110.111328
   Dy P, 2012, DEV CELL, V22, P597, DOI 10.1016/j.devcel.2011.12.024
   El-Serafi AT, 2011, DIFFERENTIATION, V81, P35, DOI 10.1016/j.diff.2010.09.183
   Elvenes J, 2009, J ORTHOP SCI, V14, P410, DOI 10.1007/s00776-009-1349-4
   Ezura Y, 2009, ARTHRITIS RHEUM, V60, P1416, DOI 10.1002/art.24472
   Farnum CE, 2002, BONE, V30, P574, DOI 10.1016/S8756-3282(01)00710-4
   Finan JD, 2009, ANN BIOMED ENG, V37, P477, DOI 10.1007/s10439-008-9618-5
   Fischer J, 2010, ARTHRITIS RHEUM-US, V62, P2696, DOI 10.1002/art.27565
   Fosang AJ, 1996, FEBS LETT, V380, P17, DOI 10.1016/0014-5793(95)01539-6
   Freed LE, 2006, TISSUE ENG, V12, P3285, DOI 10.1089/ten.2006.12.3285
   Furumatsu T, 2005, J BIOL CHEM, V280, P8343, DOI 10.1074/jbc.M413913200
   Furumatsu T, 2010, ACTA MED OKAYAMA, V64, P155
   Gao L, 2010, STEM CELLS, V28, P564, DOI 10.1002/stem.308
   Giannoni P, 2009, J APPL BIOMATER BIOM, V7, P1
   GRANDOLFO M, 1992, BIOCHEM BIOPH RES CO, V182, P1429, DOI 10.1016/0006-291X(92)91893-U
   Grayson WL, 2006, J CELL PHYSIOL, V207, P331, DOI 10.1002/jcp.20571
   Guan YJ, 2011, FASEB J, V25, P4457, DOI 10.1096/fj.11-185132
   Guilak F, 1999, J ORTHOPAED RES, V17, P421, DOI 10.1002/jor.1100170319
   Guo J, 2002, DEV CELL, V3, P183, DOI 10.1016/S1534-5807(02)00218-6
   Hall BK, 2000, BIOESSAYS, V22, P138, DOI 10.1002/(SICI)1521-1878(200002)22:2<138::AID-BIES5>3.0.CO;2-4
   Han JW, 2010, INT J MOL MED, V25, P377, DOI 10.3892/ijmm_00000355
   Haudenschild DR, 2010, ARTHRITIS RHEUM-US, V62, P191, DOI 10.1002/art.25051
   He HL, 1997, J CELL BIOL, V138, P1219, DOI 10.1083/jcb.138.6.1219
   Hellingman CA, 2011, TISSUE ENG PT A, V17, P1157, DOI [10.1089/ten.tea.2010.0043, 10.1089/ten.TEA.2010.0043]
   Hendy GN, 2009, PROG MOL BIOL TRANSL, V89, P31, DOI 10.1016/S1877-1173(09)89003-0
   Hirao M, 2006, J BIOL CHEM, V281, P31079, DOI 10.1074/jbc.M602296200
   Hirsch MS, 1997, DEV DYNAM, V210, P249, DOI 10.1002/(SICI)1097-0177(199711)210:3<249::AID-AJA6>3.3.CO;2-3
   Hoffmann A, 2002, J CELL SCI, V115, P769
   HOLTZER H, 1964, BIOPHYS J, V4, P239, DOI 10.1016/S0006-3495(64)86941-1
   Hoshiba T, 2010, EXPERT OPIN BIOL TH, V10, P1717, DOI 10.1517/14712598.2010.534079
   Huang J, 2010, STEM CELLS, V28, P357, DOI 10.1002/stem.288
   Huang WD, 2000, MOL CELL BIOL, V20, P7838, DOI 10.1128/MCB.20.20.7838-7838.2000
   Hunziker EB, 1999, HISTOCHEM CELL BIOL, V112, P115, DOI 10.1007/s004180050397
   Hutmacher DW, 2000, BIOMATERIALS, V21, P2529, DOI 10.1016/S0142-9612(00)00121-6
   IANNOTTI JP, 1989, J ORTHOPAED RES, V7, P511, DOI 10.1002/jor.1100070408
   IANNOTTI JP, 1994, CLIN ORTHOP RELAT R, P222
   Im GI, 2011, BIOTECHNOL LETT, V33, P1061, DOI 10.1007/s10529-010-0514-3
   Inada M, 2004, P NATL ACAD SCI USA, V101, P17192, DOI 10.1073/pnas.0407788101
   Jensen ED, 2009, J BIOL CHEM, V284, P2225, DOI 10.1074/jbc.M800586200
   Johnson KA, 2008, J CELL SCI, V121, P2256, DOI 10.1242/jcs.011262
   Johnstone B, 1998, EXP CELL RES, V238, P265, DOI 10.1006/excr.1997.3858
   Kafienah W, 2007, ARTHRITIS RHEUM, V56, P177, DOI 10.1002/art.22285
   Kang JS, 2005, EMBO J, V24, P2543, DOI 10.1038/sj.emboj.7600729
   Kanichai M, 2008, J CELL PHYSIOL, V216, P708, DOI 10.1002/jcp.21446
   Kawato Y, 2011, BIOCHEM BIOPH RES CO, V416, P205, DOI 10.1016/j.bbrc.2011.11.026
   Kim YJ, 2008, BIOCHEM BIOPH RES CO, V376, P241, DOI 10.1016/j.bbrc.2008.08.133
   Kirsch T, 2003, MOL B INT U, P172
   Kobayashi T, 2002, DEVELOPMENT, V129, P2977
   Kozhemyakina E, 2009, MOL CELL BIOL, V29, P5751, DOI 10.1128/MCB.00415-09
   Kronenberg HM, 2006, ANN NY ACAD SCI, V1068, P1, DOI 10.1196/annals.1346.002
   Kuo CK, 2006, CURR OPIN RHEUMATOL, V18, P64, DOI 10.1097/01.bor.0000198005.88568.df
   Kwon HJ, 2010, ACTA BIOMATER, V6, P494, DOI 10.1016/j.actbio.2009.07.033
   Kwon TG, 2011, J CELL BIOCHEM, V112, P3582, DOI 10.1002/jcb.23289
   Lafont JE, 2007, ARTHRITIS RHEUM, V56, P3297, DOI 10.1002/art.22878
   Lamprecht SA, 2003, NAT REV CANCER, V3, P601, DOI 10.1038/nrc1144
   Lanske B, 1996, SCIENCE, V273, P663, DOI 10.1126/science.273.5275.663
   Lee JM, 2012, BIOCHEM BIOPH RES CO, V421, P819, DOI 10.1016/j.bbrc.2012.04.096
   Lengner CJ, 2005, J BIOL CHEM, V280, P15872, DOI 10.1074/jbc.M411144200
   Lennon DP, 2001, J CELL PHYSIOL, V187, P345, DOI 10.1002/jcp.1081
   Li TF, 2004, EXP CELL RES, V299, P128, DOI 10.1016/j.yexcr.2004.05.025
   Li WJ, 2005, BIOMATERIALS, V26, P5158, DOI 10.1016/j.biomaterials.2005.01.002
   Li Y, 2011, BIOPHYS J, V100, P1902, DOI 10.1016/j.bpj.2011.03.008
   Li YW, 2011, DEVELOPMENT, V138, P359, DOI 10.1242/dev.052324
   Lin EA, 2009, J BIOL CHEM, V284, P11326, DOI 10.1074/jbc.M807709200
   Liu SQ, 2010, BIOMATERIALS, V31, P7298, DOI 10.1016/j.biomaterials.2010.06.001
   LOESER RF, 1995, EXP CELL RES, V217, P248, DOI 10.1006/excr.1995.1084
   Loeser RF, 2000, OSTEOARTHR CARTILAGE, V8, P96, DOI 10.1053/joca.1999.0277
   Lu ZF, 2008, BIOCHEM BIOPH RES CO, V372, P547, DOI 10.1016/j.bbrc.2008.05.063
   Luckman SP, 2003, BIOCHEM J, V372, P485, DOI 10.1042/BJ20021572
   Mackay AM, 1998, TISSUE ENG, V4, P415, DOI 10.1089/ten.1998.4.415
   Mackie EJ, 2011, J ENDOCRINOL, V211, P109, DOI 10.1530/JOE-11-0048
   MacRae VE, 2010, BONE, V46, P1146, DOI 10.1016/j.bone.2009.12.018
   Mak KK, 2008, DEVELOPMENT, V135, P1947, DOI 10.1242/dev.018044
   Maruyama T, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2000727
   Mauck RL, 2006, OSTEOARTHR CARTILAGE, V14, P179, DOI 10.1016/j.joca.2005.09.002
   Mauck RL, 2011, TISSUE ENGINEERING: FROM LAB TO CLINIC, P493, DOI 10.1007/978-3-642-02824-3_23
   Mello MA, 1999, IN VITRO CELL DEV-AN, V35, P262
   Merceron C, 2012, STEM CELLS, V30, P471, DOI 10.1002/stem.1686
   Millward-Sadler SJ, 2004, ANN BIOMED ENG, V32, P435, DOI 10.1023/B:ABME.0000017538.72511.48
   Miyaki S, 2010, GENE DEV, V24, P1173, DOI 10.1101/gad.1915510
   Mo XT, 2009, BONE, V45, P42, DOI 10.1016/j.bone.2008.07.240
   Mohyeldin A, 2010, CELL STEM CELL, V7, P150, DOI 10.1016/j.stem.2010.07.007
   Mrugala D, 2009, CLONING STEM CELLS, V11, P61, DOI 10.1089/clo.2008.0070
   Mueller MB, 2008, ARTHRITIS RHEUM-US, V58, P1377, DOI 10.1002/art.23370
   Murphy CL, 2010, CELL RES, V20, P977, DOI 10.1038/cr.2010.99
   Murphy CL, 2001, TISSUE ENG, V7, P791, DOI 10.1089/107632701753337735
   Murphy CL, 2004, J CELL PHYSIOL, V199, P451, DOI 10.1002/jcp.10481
   Mwale F, 2006, TISSUE ENG, V12, P2639, DOI 10.1089/ten.2006.12.2639
   Narcisi R, 2012, J CELL PHYSIOL, V227, P3282, DOI 10.1002/jcp.24024
   Negoro K, 2008, CLIN EXP RHEUMATOL, V26, P534
   Nesic D, 2006, ADV DRUG DELIVER REV, V58, P300, DOI 10.1016/j.addr.2006.01.012
   Nguyen LH, 2010, BIOMATERIALS, V32, P1327
   Orimo Hideo, 2010, Journal of Nippon Medical School, V77, P4
   Ortega N, 2004, TRENDS CELL BIOL, V14, P86, DOI 10.1016/j.tcb.2003.12.003
   Park SH, 2011, TISSUE ENG PT A, V17, P1277, DOI [10.1089/ten.tea.2010.0337, 10.1089/ten.TEA.2010.0337]
   Pei M, 2009, DIFFERENTIATION, V78, P260, DOI 10.1016/j.diff.2009.08.001
   Pelttari K, 2006, ARTHRITIS RHEUM-US, V54, P3254, DOI 10.1002/art.22136
   Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143
   Provot S, 2006, DEVELOPMENT, V133, P651, DOI 10.1242/dev.02258
   Quintana L., 2008, TISSUE ENG PART B-RE, V15, P29
   Re'em T., 2011, BIOMATERIALS, V33, P751
   Reddi AH, 2000, TISSUE ENG, V6, P351, DOI 10.1089/107632700418074
   Richter K, 2007, J CELL SCI, V120, P1673, DOI 10.1242/jcs.03440
   Roach HI, 2005, ARTHRITIS RHEUM-US, V52, P3110, DOI 10.1002/art.21300
   Robins JC, 2005, BONE, V37, P313, DOI 10.1016/j.bone.2005.04.040
   Rodriguez L, 2005, ENDOCRINOLOGY, V146, P4597, DOI 10.1210/en.2005-0437
   Ronziere MC, 2010, BIO-MED MATER ENG, V20, P145, DOI 10.3233/BME-2010-0626
   Saito T, 2010, NAT MED, V16, P678, DOI 10.1038/nm.2146
   Sekiya I, 2002, P NATL ACAD SCI USA, V99, P4397, DOI 10.1073/pnas.052716199
   Shapiro Irving M., 2005, Birth Defects Research, V75, P330, DOI 10.1002/bdrc.20057
   Sheehy EJ, 2012, BIOCHEM BIOPH RES CO, V417, P305, DOI 10.1016/j.bbrc.2011.11.105
   Shen G, 2005, Orthod Craniofac Res, V8, P11, DOI 10.1111/j.1601-6343.2004.00308.x
   Shimizu E, 2010, J BIOL CHEM, V285, P9616, DOI 10.1074/jbc.M109.094862
   SOLURSH M, 1975, DEV BIOL, V44, P278, DOI 10.1016/0012-1606(75)90398-X
   Song JJ, 2011, TRENDS MOL MED, V17, P424, DOI 10.1016/j.molmed.2011.03.005
   Srinivas V, 2009, CELLS TISSUES ORGANS, V189, P88, DOI 10.1159/000151428
   Stanton LA, 2004, BIOCHEM J, V378, P53, DOI 10.1042/BJ20030874
   Strobel S, 2010, ARTHRITIS RES THER, V12, DOI 10.1186/ar2942
   Suomi S, 2008, GENE REGUL SYST BIO, V2, P177
   Swieszkowski W, 2007, BIOMOL ENG, V24, P489, DOI 10.1016/j.bioeng.2007.07.014
   Swingler TE, 2011, ARTHRITIS RHEUM, V64, P1909
   Takeda S, 2001, GENE DEV, V15, P467, DOI 10.1101/gad.845101
   Tamiya H, 2008, GENE, V416, P53, DOI 10.1016/j.gene.2008.03.003
   Tanaka K, 2007, MATRIX BIOL, V26, P409, DOI 10.1016/j.matbio.2007.04.005
   Thirunavukkarasu K, 2007, MOL BIOL REP, V34, P1, DOI 10.1007/s11033-006-9001-2
   Tomita M, 2002, J BIOL CHEM, V277, P42214, DOI 10.1074/jbc.C200504200
   Topol LL, 2009, J BIOL CHEM, V284, P3323, DOI 10.1074/jbc.M808048200
   Tuddenham L, 2006, FEBS LETT, V580, P4214, DOI 10.1016/j.febslet.2006.06.080
   van der Kraan PM, 2009, OSTEOARTHR CARTILAGE, V17, P1539, DOI 10.1016/j.joca.2009.06.008
   van der Windt AE, 2012, ARTHRITIS RHEUM-US, V64, P1929, DOI 10.1002/art.34369
   van Donkelaar CC, 2007, BIOMECH MODEL MECHAN, V6, P55, DOI 10.1007/s10237-006-0035-0
   Varghese S, 2008, MATRIX BIOL, V27, P12, DOI 10.1016/j.matbio.2007.07.002
   Vega RB, 2004, CELL, V119, P555, DOI 10.1016/j.cell.2004.10.024
   Verzi MP, 2007, DEV CELL, V12, P645, DOI 10.1016/j.devcel.2007.03.007
   Vinatier C, 2009, CURR STEM CELL RES T, V4, P318, DOI 10.2174/157488809789649205
   Vortkamp A, 1996, SCIENCE, V273, P613, DOI 10.1126/science.273.5275.613
   Wang AH, 1999, MOL CELL BIOL, V19, P7816
   Wang F, 2011, J ORTHOP SCI, V16, P304, DOI 10.1007/s00776-011-0055-1
   Wang GY, 2005, J BONE MINER RES, V20, P1022, DOI 10.1359/JBMR.050113
   Wang GY, 2004, J BIOL CHEM, V279, P13205, DOI 10.1074/jbc.M311427200
   Weiss S, 2010, J CELL PHYSIOL, V223, P84, DOI 10.1002/jcp.22013
   Wienholds E, 2005, FEBS LETT, V579, P5911, DOI 10.1016/j.febslet.2005.07.070
   Williams R, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013246
   Woodfield TBF, 2006, BIOMATERIALS, V27, P1043, DOI 10.1016/j.biomaterials.2005.07.032
   Woods A, 2006, J BIOL CHEM, V281, P13134, DOI 10.1074/jbc.M509433200
   Wu SF, 2004, FASEB J, V18, P143, DOI 10.1096/fj.03-0294fje
   Xu Y, 2007, TISSUE ENG, V13, P2981, DOI 10.1089/ten.2007.0050
   Yamashita S, 2009, EXP CELL RES, V315, P2231, DOI 10.1016/j.yexcr.2009.03.008
   Yang B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021679
   Yang S, 2010, NAT MED, V16, P687, DOI 10.1038/nm.2153
   Yang X, 2001, J CELL BIOL, V153, P35, DOI 10.1083/jcb.153.1.35
   Yoon BS, 2006, DEVELOPMENT, V133, P4667, DOI 10.1242/dev.02680
   Yoshida CA, 2004, GENE DEV, V18, P952, DOI 10.1101/gad.1174704
   Zhang Y, 2011, P NATL ACAD SCI USA, V108, P9863, DOI 10.1073/pnas.1018493108
   Zhen XC, 2001, J BIOL CHEM, V276, P4879, DOI 10.1074/jbc.M004990200
   Zhou G, 2006, P NATL ACAD SCI USA, V103, P19004, DOI 10.1073/pnas.0605170103
   Zimmermann P, 2008, ARTHRITIS RHEUM, V58, P2743, DOI 10.1002/art.23736
   Zscharnack M, 2009, CELLS TISSUES ORGANS, V190, P81, DOI 10.1159/000178024
   Zuscik MJ, 2002, EXP CELL RES, V276, P310, DOI 10.1006/excr.2002.5527
NR 201
TC 94
Z9 106
U1 0
U2 64
PU AO RESEARCH INSTITUTE DAVOS-ARI
PI DAVOS
PA CLAVADELERSTRASSE 8, DAVOS, CH 7270, SWITZERLAND
SN 1473-2262
J9 EUR CELLS MATER
JI Eur. Cells Mater.
PD JUL-DEC
PY 2012
VL 24
BP 118
EP 135
DI 10.22203/eCM.v024a09
PG 18
WC Cell & Tissue Engineering; Engineering, Biomedical; Materials Science,
   Biomaterials; Orthopedics
SC Cell Biology; Engineering; Materials Science; Orthopedics
GA 989JJ
UT WOS:000307555800009
PM 22828990
OA DOAJ Gold
DA 2018-10-19
ER

PT J
AU Oliveira, MI
   Santos, SG
   Oliveira, MJ
   Torres, AL
   Barbosa, MA
AF Oliveira, Marta I.
   Santos, Susana G.
   Oliveira, Maria J.
   Torres, Ana L.
   Barbosa, Mario A.
TI CHITOSAN DRIVES ANTI-INFLAMMATORY MACROPHAGE POLARISATION AND
   PRO-INFLAMMATORY DENDRITIC CELL STIMULATION
SO EUROPEAN CELLS & MATERIALS
LA English
DT Article
DE Macrophage; dendritic cell; chitosan; polarisation; cell activation;
   immunomodulation; inflammation; immune response
ID FOREIGN-BODY REACTION; MIXED LYMPHOCYTE-REACTION; SCAVENGER RECEPTOR
   CD163; IN-VITRO; MANNOSE RECEPTOR; MATRIX METALLOPROTEINASES;
   COSTIMULATORY MOLECULES; POLYSACCHARIDE CHITOSAN; MEDIATED STIMULATION;
   DEACETYLATED CHITIN
AB Macrophages and dendritic cells (DC) share the same precursor and play key roles in immunity. Modulation of their behaviour to achieve an optimal host response towards an implanted device is still a challenge. Here we compare the differentiation process and polarisation of these related cell populations and show that they exhibit different responses to chitosan (Ch), with human monocyte-derived macrophages polarising towards an anti-inflammatory phenotype while their DC counterparts display pro-inflammatory features. Macrophages and DC, whose interactions with biomaterials are frequently analysed using fully differentiated cells, were cultured directly on Ch films, rather than exposed to the polymer after complete differentiation. Ch was the sole stimulating factor and activated both macrophages and DC, without leading to significant T cell proliferation. After 10 d on Ch, macrophages significantly down-regulated expression of pro-inflammatory markers, CD86 and MHCII. Production of pro-inflammatory cytokines, particularly TNF-alpha, decreased with time for cells cultured on Ch, while anti-inflammatory IL-10 and TGF-beta 1, significantly increased. Altogether, these results suggest an M2c polarisation. Also, macrophage matrix metalloproteinase activity was augmented and cell motility was stimulated by Ch. Conversely, DC significantly enhanced CD86 expression, reduced IL-10 secretion and increased TNF-alpha and IL-1 beta levels. Our findings indicate that cells with a common precursor may display different responses, when challenged by the same biomaterial. Moreover, they help to further comprehend macrophage/DC interactions with Ch and the balance between pro-and anti-inflammatory signals associated with implant biomaterials. We propose that an overall pro-inflammatory reaction may hide the expression of anti-inflammatory cytokines, likely relevant for tissue repair/regeneration.
C1 [Oliveira, Marta I.; Santos, Susana G.; Oliveira, Maria J.; Torres, Ana L.; Barbosa, Mario A.] Univ Porto, Inst Biomed Engn, P-4150180 Oporto, Portugal.
   [Oliveira, Maria J.] Univ Porto, Fac Med, P-4150180 Oporto, Portugal.
   [Torres, Ana L.] Univ Porto, Fac Engn, P-4150180 Oporto, Portugal.
   [Barbosa, Mario A.] Univ Porto, Inst Ciencias Biomed Abel Salazar, P-4150180 Oporto, Portugal.
RP Barbosa, MA (reprint author), Univ Porto, Inst Biomed Engn, Rua Campo Alegre 823, P-4150180 Oporto, Portugal.
EM mbarbosa@ineb.up.pt
RI Barbosa, Mario/F-5964-2011; Torres, Ana Luisa/D-3983-2014; Santos,
   Susana/L-9351-2013; Oliveira, Marta/M-9386-2013
OI Barbosa, Mario/0000-0003-3568-7482; Torres, Ana
   Luisa/0000-0003-1338-8625; Santos, Susana/0000-0002-8604-2978; Oliveira,
   Marta/0000-0002-0578-9202; Oliveira, Maria Jose/0000-0002-0724-0272
FU POPH/QREN; Fundacao para a Ciencia e a Tecnologia (FCT)
   [PTDC/SAU-BEB/099954/2008]; FCT-POPH [SFRH/BPD/37090/2007]; FCT-POPH-FSE
   (Ciencia)
FX The authors would like to thank Instituto Portugues do Sangue (IPS) for
   kindly donating the buffy coats. This work was supported by POPH/QREN
   2007-2013 and the Fundacao para a Ciencia e a Tecnologia (FCT) ((Project
   PTDC/SAU-BEB/099954/2008). MIO is recipient of a post-doctoral
   fellowship from FCT-POPH (SFRH/BPD/37090/2007). SGS and MJO have
   research positions funded by FCT-POPH-FSE (Ciencia 2007). We wish to
   confirm that there are no known conflicts of interest associated with
   this publication and there has been no significant financial support for
   this work that could have influenced its outcome.
CR Abensee JEB, 2008, SEMIN IMMUNOL, V20, P101, DOI 10.1016/j.smim.2007.10.013
   Anderson JM, 2008, SEMIN IMMUNOL, V20, P86, DOI 10.1016/j.smim.2007.11.004
   Anderson JM, 2007, BIOMATERIALS, V28, P5114, DOI [10.1016/j.biomaterials.2007.07.010, 10.1016/j.biornaterials.2007.07.010]
   Arca HC, 2009, EXPERT REV VACCINES, V8, P937, DOI 10.1586/ERV.09.47
   Ariganello MB, 2011, BIOMATERIALS, V32, P439, DOI 10.1016/j.biomaterials.2010.09.004
   Azab AK, 2007, J BIOMED MATER RES A, V83A, P414, DOI 10.1002/jbm.a.31256
   Babensee JE, 1998, ADV DRUG DELIVER REV, V33, P111, DOI 10.1016/S0169-409X(98)00023-4
   Babensee JE, 2005, J BIOMED MATER RES A, V74A, P503, DOI 10.1002/jbm.a.30429
   Baldrick P, 2010, REGUL TOXICOL PHARM, V56, P290, DOI 10.1016/j.yrtph.2009.09.015
   Banchereau J, 2000, ANNU REV IMMUNOL, V18, P767, DOI 10.1146/annurev.immunol.18.1.767
   Barbosa JN, 2010, J BIOMED MATER RES A, V93A, P20, DOI 10.1002/jbm.a.32499
   Brodbeck WG, 2005, J BIOMED MATER RES A, V74A, P222, DOI 10.1002/jbm.a.30313
   Brodbeck WG, 2003, J BIOMED MATER RES A, V64A, P320, DOI 10.1002/jbm.a.10425
   Brodbeck WG, 2002, CYTOKINE, V18, P311, DOI 10.1006/cyto.2002.1048
   Chang DT, 2009, J BIOMED MATER RES A, V89A, P490, DOI 10.1002/jbm.a.31981
   Chapuis F, 1997, EUR J IMMUNOL, V27, P431, DOI 10.1002/eji.1830270213
   Crompton KE, 2006, J MATER SCI-MATER M, V17, P633, DOI 10.1007/s10856-006-9226-6
   Dash M, 2011, PROG POLYM SCI, V36, P981, DOI 10.1016/j.progpolymsci.2011.02.001
   DeFife KM, 1999, J HISTOCHEM CYTOCHEM, V47, P65, DOI 10.1177/002215549904700107
   Dinnes DLM, 2008, DIFFERENTIATION, V76, P232, DOI 10.1111/j.1432-0436.2007.00221.x
   Fabriek BO, 2007, J NEUROIMMUNOL, V187, P179, DOI 10.1016/j.jneuroim.2007.04.016
   Fainaru O, 2007, GENES IMMUN, V8, P239, DOI 10.1038/sj.gene.6364380
   Feng J, 2004, BIOCHEM BIOPH RES CO, V317, P414, DOI 10.1016/j.bbrc.2004.03.048
   Fiani ML, 1998, J LEUKOCYTE BIOL, V64, P85
   Goetzl EJ, 1996, J IMMUNOL, V156, P1
   Gordon S, 2003, NAT REV IMMUNOL, V3, P23, DOI 10.1038/nri978
   Gretzer C, 2003, BIOMATERIALS, V24, P2843, DOI 10.1016/S0142-9612(03)00097-8
   Guzman-Morales J, 2011, BIOCHEM BIOPH RES CO, V405, P538, DOI 10.1016/j.bbrc.2011.01.063
   Han YP, 2005, INT IMMUNOPHARMACOL, V5, P1533, DOI 10.1016/j.intimp.2005.04.015
   Hidaka Y, 1999, J BIOMED MATER RES, V46, P418, DOI 10.1002/(SICI)1097-4636(19990905)46:3<418::AID-JBM15>3.0.CO;2-T
   Higgins DM, 2009, AM J PATHOL, V175, P161, DOI 10.2353/ajpath.2009.080962
   Huber S, 2010, BLOOD, V116, P3311, DOI 10.1182/blood-2010-02-271981
   Jones JA, 2008, J BIOMED MATER RES A, V84A, P158, DOI 10.1002/jbm.a.31220
   Jones JA, 2007, J BIOMED MATER RES A, V83A, P585, DOI 10.1002/jbm.a.31221
   Kang ML, 2009, BIOTECHNOL ADV, V27, P857, DOI 10.1016/j.biotechadv.2009.06.007
   Kim H, 2011, J BIOMED MATER RES A, V97A, P395, DOI 10.1002/jbm.a.33070
   Kim IY, 2008, BIOTECHNOL ADV, V26, P1, DOI 10.1016/j.biotechadv.2007.07.009
   Kou PM, 2011, J BIOMED MATER RES A, V96A, P239, DOI 10.1002/jbm.a.32971
   LARSEN CP, 1994, J IMMUNOL, V152, P5208
   Leon B, 2005, SEMIN IMMUNOL, V17, P313, DOI 10.1016/j.smim.2005.05.013
   Lolmede K, 2009, J LEUKOCYTE BIOL, V85, P779, DOI 10.1189/jlb.0908579
   MANGI RJ, 1975, YALE J BIOL MED, V48, P217
   Mantovani A, 2005, IMMUNITY, V23, P344, DOI 10.1016/j.immuni.2005.10.001
   Mantovani A, 2004, TRENDS IMMUNOL, V25, P677, DOI 10.1016/j.it.2004.09.015
   Martinez FO, 2008, FRONT BIOSCI-LANDMRK, V13, P453, DOI 10.2741/2692
   Martinez-Pomares L, 1998, J BIOL CHEM, V273, P23376, DOI 10.1074/jbc.273.36.23376
   Mesure L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012949
   Mori T, 1997, BIOMATERIALS, V18, P947, DOI 10.1016/S0142-9612(97)00017-3
   Mori T, 2005, J VET MED SCI, V67, P51, DOI 10.1292/jvms.67.51
   Muzzarelli RAA, 2010, MAR DRUGS, V8, P292, DOI 10.3390/md8020292
   Muzzarelli RAA, 2009, CARBOHYD POLYM, V76, P167, DOI 10.1016/j.carbpol.2008.11.002
   NISHIMURA K, 1986, VACCINE, V4, P151, DOI 10.1016/0264-410X(86)90002-2
   Oppmann B, 2000, IMMUNITY, V13, P715, DOI 10.1016/S1074-7613(00)00070-4
   PELUSO G, 1994, BIOMATERIALS, V15, P1215, DOI 10.1016/0142-9612(94)90272-0
   Pioli PA, 2004, J LEUKOCYTE BIOL, V76, P500, DOI 10.1189/jlb.1203617
   Porcheray F, 2005, CLIN EXP IMMUNOL, V142, P481, DOI 10.1111/j.1365-2249.2005.02934.x
   Porporatto C, 2005, J LEUKOCYTE BIOL, V78, P62, DOI 10.1189/jlb.0904541
   Porporatto C, 2003, BIOCHEM BIOPH RES CO, V304, P266, DOI 10.1016/S0006-291X(03)00579-5
   Porporatto C, 2009, CLIN EXP IMMUNOL, V155, P79, DOI 10.1111/j.1365-2249.2008.03777.x
   Rodriguez A, 2009, J BIOMED MATER RES A, V89A, P152, DOI 10.1002/jbm.a.31939
   Rogers TH, 2011, BIOMATERIALS, V32, P1270, DOI 10.1016/j.biomaterials.2010.10.014
   SALLUSTO F, 1994, J EXP MED, V179, P1109, DOI 10.1084/jem.179.4.1109
   Santos SG, 2008, ARTHRITIS RES THER, V10, DOI 10.1186/ar2492
   Scheinecker C, 1998, J IMMUNOL, V161, P3966
   Schutte RJ, 2009, J BIOMED MATER RES A, V88A, P128, DOI 10.1002/jbm.a.31863
   Schutte RJ, 2009, BIOMATERIALS, V30, P160, DOI 10.1016/j.biomaterials.2008.09.026
   Slutter B, 2010, J CONTROL RELEASE, V143, P207, DOI 10.1016/j.jconrel.2010.01.007
   STEINBACH F, 1994, J IMMUNOL METHODS, V174, P109, DOI 10.1016/0022-1759(94)90015-9
   Tomihata K, 1997, BIOMATERIALS, V18, P567, DOI 10.1016/S0142-9612(96)00167-6
   Ueno H, 2001, ADV DRUG DELIVER REV, V52, P105, DOI 10.1016/S0169-409X(01)00189-2
   Ueno H, 2001, BIOMATERIALS, V22, P2125, DOI 10.1016/S0142-9612(00)00401-4
   Ueno H, 2001, BIOMATERIALS, V22, P1667, DOI 10.1016/S0142-9612(00)00328-8
   van der Lubben IM, 2001, ADV DRUG DELIVER REV, V52, P139, DOI 10.1016/S0169-409X(01)00197-1
   VandeVord PJ, 2002, J BIOMED MATER RES, V59, P585, DOI 10.1002/jbm.1270
   Verhasselt V, 1997, J IMMUNOL, V158, P2919
   Walschus U, 2012, J MATER SCI-MATER M, V23, P1299, DOI 10.1007/s10856-012-4600-z
   Webster NL, 2006, J LEUKOCYTE BIOL, V80, P1052, DOI 10.1189/jlb0306152
   Wei XL, 2009, FOOD AGR IMMUNOL, V20, P269, DOI 10.1080/09540100903168157
   Xia Z, 2006, BIOMED MATER, V1, pR1, DOI 10.1088/1748-6041/1/1/R01
   Yussof SJM, 2011, MAT SCI, V2011
NR 80
TC 56
Z9 57
U1 4
U2 37
PU AO RESEARCH INSTITUTE DAVOS-ARI
PI DAVOS
PA CLAVADELERSTRASSE 8, DAVOS, CH 7270, SWITZERLAND
SN 1473-2262
J9 EUR CELLS MATER
JI Eur. Cells Mater.
PD JUL-DEC
PY 2012
VL 24
BP 136
EP 153
DI 10.22203/eCM.v024a10
PG 18
WC Cell & Tissue Engineering; Engineering, Biomedical; Materials Science,
   Biomaterials; Orthopedics
SC Cell Biology; Engineering; Materials Science; Orthopedics
GA 989JJ
UT WOS:000307555800010
PM 22828991
OA DOAJ Gold
DA 2018-10-19
ER

PT J
AU Vaquero-Aguilar, C
   Jimenez-Melendo, M
   Torres-Lagares, D
   Llena-Blasco, O
   Bruguera, A
   Llena-Blasco, J
   Garcia-Calderon, M
   Velazquez-Cayon, R
   Gutierrez-Perez, JL
AF Vaquero-Aguilar, Cristina
   Jimenez-Melendo, Manuel
   Torres-Lagares, Daniel
   Llena-Blasco, Oriol
   Bruguera, August
   Llena-Blasco, Jaime
   Garcia-Calderon, Manuel
   Velazquez-Cayon, Rocio
   Gutierrez-Perez, Jose-Luis
TI Zirconia Implant Abutments: Microstructural Analysis
SO INTERNATIONAL JOURNAL OF ORAL & MAXILLOFACIAL IMPLANTS
LA English
DT Article
DE ceramics; dental implants; microstructure; zirconia
ID TETRAGONAL ZIRCONIA; STABILIZED ZIRCONIA; SYSTEM; BIOMATERIAL; CERAMICS;
   WATER
AB Purpose: Yttria-stabilized zirconia (ZrO2-Y2O3) ceramics have received increasing attention in recent years because of their stress-induced tetragonal-to-monoclinic (martensitic) transformation. This unique process acts as a toughening mechanism, imparting strength and toughness to the ceramic alloy. This property, along with well-documented biocompatibility, is now being exploited in an increasing number of medical applications, including implant dentistry. To prevent clinical problems and predict their behavior and physical limitations, a characterization of the ceramic elements used in dental restorations is essential. The aim of the present study is to characterize the crystal structure, elemental composition, and microstructure of as-received ZiReal Post (Biomet 3i) zirconium oxide abutments, as well as specimens coated with a first layer of a low-fusing fluoroapatite ceramic. Materials and Methods: Zirconium oxide abutments, both as-received and porcelain-coated, were studied using the following techniques: x-ray diffraction, x-ray fluorescence, energy dispersive x-ray spectroscopy, optical microscopy, and scanning and transmission electron microscopy Results: X-ray analyses detected only the presence of Zr, O, Y, and hafnium (Hf), in an amount of 3% to 4% molecular weight Y2O3-ZrO2. X-ray diffraction measurements showed that the ceramic abutment crystallizes mainly in the tetragonal phase, with some residual monoclinic phase. The microstructure is characterized by a rather homogenous grain distribution, formed by equiaxed and fine grains with a mean size of 0.30 mu m. Conclusions: Compositional and diffraction results are consistent with polycrystalline yttria-stabilized tetragonal zirconia. The material is susceptible to undergoing the stress-induced transformation toughening mechanism because of the very fine grain size. Except for machining ring marks, the surfaces exhibit an excellent finishing quality. No structural modifications were observed in the fluoroapatite ceramic-coated abutments because of the relatively low temperatures used for ceramization compared with the phase-transformation temperatures used for zirconia. INT J ORAL MAXILLOFAC IMPLANTS 2012;27:785-791.
C1 [Vaquero-Aguilar, Cristina; Jimenez-Melendo, Manuel] Univ Seville, Dept Condensed Matter Phys, Seville, Spain.
   [Torres-Lagares, Daniel; Garcia-Calderon, Manuel; Velazquez-Cayon, Rocio; Gutierrez-Perez, Jose-Luis] Univ Seville, Dept Stomatol, Seville, Spain.
   [Gutierrez-Perez, Jose-Luis] Virgen del Rocio Hosp, Clin Management Unit UGC, Seville, Spain.
RP Torres-Lagares, D (reprint author), Fac Odontol Sevilla, C Avicena S-N, Seville 41009, Spain.
EM danieltl@us.es
OI Gutierrez Perez, Jose Luis/0000-0003-2624-1454
FU Ministerio de Ciencia e Innovacion, Spain [MAT2009-13979-C03-01]
FX The authors wish to thank Biomet 3i for supplying the abutments used in
   this study. Partial financial support from the Ministerio de Ciencia e
   Innovacion, Spain (project no. MAT2009-13979-C03-01), is also
   acknowledged.
CR Al-Amleh B, 2010, J ORAL REHABIL, V37, P641, DOI 10.1111/j.1365-2842.2010.02094.x
   BINON PP, 2000, QUINTESSENCE DENT TE, V23, P91
   Bravo-Leon A, 2002, ACTA MATER, V50, P4555, DOI 10.1016/S1359-6454(02)00283-5
   Brodbeck Urs, 2003, J Esthet Restor Dent, V15, P10, DOI 10.1111/j.1708-8240.2003.tb00278.x
   Butz F, 2005, J ORAL REHABIL, V32, P838, DOI 10.1111/j.1365-2842.2005.01515.x
   Chevalier J, 2006, BIOMATERIALS, V27, P535, DOI 10.1016/j.biomaterials.2005.07.034
   Chevalier J, 1999, J AM CERAM SOC, V82, P2150
   CLAUSSEN N, 1984, ADV CERAMICS, V12
   Denry I, 2008, DENT MATER, V24, P299, DOI 10.1016/j.dental.2007.05.007
   GARVIE RC, 1975, NATURE, V258, P703, DOI 10.1038/258703a0
   Green D. J., 1989, TRANSFORMATION TOUGH
   Guo X, 2004, CHEM MATER, V16, P3988, DOI 10.1021/cm040167h
   Helmer JD, 1969, S US CER SURG IMPL
   Jimenez-Melendo M, 1998, J AM CERAM SOC, V81, P2761
   Kelly JR, 2008, DENT MATER, V24, P289, DOI 10.1016/j.dental.2007.05.005
   Kim JW, 2010, J DENT RES, V89, P91, DOI 10.1177/0022034509354193
   KURTZ SK, 1980, J APPL PHYS, V51, P5725, DOI 10.1063/1.327580
   LANGE FF, 1982, J MATER SCI, V17, P240, DOI 10.1007/BF00809059
   Lughi V, 2010, DENT MATER, V26, P807, DOI 10.1016/j.dental.2010.04.006
   MARTINEZFERNANDEZ J, 1995, ACTA METALL MATER, V43, P593, DOI 10.1016/0956-7151(94)00268-M
   Piconi C, 1999, BIOMATERIALS, V20, P1, DOI 10.1016/S0142-9612(98)00010-6
   SCOTT HG, 1975, J MATER SCI, V10, P1527, DOI 10.1007/BF01031853
   SOMIYA S, 1988, ADV CERAMICS, V24
   Stanford C., 2006, INT J ORAL MAXILLOF, V21, P841
   Studart AR, 2007, DENT MATER, V23, P106, DOI 10.1016/j.dental.2005.12.008
   TORAYA H, 1984, J AM CERAM SOC, V67, pC119
   Wohlwend A, 1996, QUINTESSENZ ZAHNTECH, V22, P364
   Wu NL, 2001, J MATER RES, V16, P1
NR 28
TC 5
Z9 5
U1 0
U2 10
PU QUINTESSENCE PUBLISHING CO INC
PI HANOVER PARK
PA 4350 CHANDLER DRIVE, HANOVER PARK, IL 60133 USA
SN 0882-2786
J9 INT J ORAL MAX IMPL
JI Int. J. Oral Maxillofac. Implants
PD JUL-AUG
PY 2012
VL 27
IS 4
BP 785
EP 791
PG 7
WC Dentistry, Oral Surgery & Medicine
SC Dentistry, Oral Surgery & Medicine
GA 988XV
UT WOS:000307525700007
PM 22848879
DA 2018-10-19
ER

PT J
AU Finnemore, A
   Cunha, P
   Shean, T
   Vignolini, S
   Guldin, S
   Oyen, M
   Steiner, U
AF Finnemore, Alexander
   Cunha, Pedro
   Shean, Tamaryn
   Vignolini, Silvia
   Guldin, Stefan
   Oyen, Michelle
   Steiner, Ullrich
TI Biomimetic layer-by-layer assembly of artificial nacre
SO NATURE COMMUNICATIONS
LA English
DT Article
ID AMORPHOUS CALCIUM-CARBONATE; PRECURSOR PILP PROCESS; SINGLE-CRYSTALS;
   HYBRID MATERIALS; SPONGE SPICULES; SHELL FORMATION; ABALONE NACRE;
   POLYMER-FILMS; THIN-FILMS; BIOMINERALIZATION
AB Nacre is a technologically remarkable organic-inorganic composite biomaterial. It consists of an ordered multilayer structure of crystalline calcium carbonate platelets separated by porous organic layers. This microstructure exhibits both optical iridescence and mechanical toughness, which transcend those of its constituent components. Replication of nacre is essential for understanding this complex biomineral, and paves the way for tough coatings fabricated from cheap abundant materials. Fabricating a calcitic nacre imitation with biologically similar optical and mechanical properties will likely require following all steps taken in biogenic nacre synthesis. Here we present a route to artificial nacre that mimics the natural layer-by-layer approach to fabricate a hierarchical crystalline multilayer material. Its structure-function relationship was confirmed by nacre-like mechanical properties and striking optical iridescence. Our biomimetic route uses the interplay of polymer-mediated mineral growth, combined with layer-by-layer deposition of porous organic films. This is the first successful attempt to replicate nacre, using CaCO3.
C1 [Finnemore, Alexander; Cunha, Pedro; Vignolini, Silvia; Guldin, Stefan; Steiner, Ullrich] Univ Cambridge, Dept Phys, Cavendish Lab, Cambridge CB3 0HE, England.
   [Shean, Tamaryn; Oyen, Michelle] Univ Cambridge, Dept Engn, Cambridge CB2 1PZ, England.
RP Steiner, U (reprint author), Univ Cambridge, Dept Phys, Cavendish Lab, JJ Thomson Ave, Cambridge CB3 0HE, England.
EM u.steiner@phy.cam.ac.uk
RI Vignolini, Silvia/A-5196-2009; Vignolini, Silvia/O-5604-2016; Steiner,
   Ullrich/K-4777-2013; Guldin, Stefan/A-7209-2011
OI Vignolini, Silvia/0000-0003-0664-1418; Vignolini,
   Silvia/0000-0003-0664-1418; Steiner, Ullrich/0000-0001-5936-339X;
   Guldin, Stefan/0000-0002-4413-5527; Oyen, Michelle/0000-0002-3428-748X
FU EPSRC
FX We thank J.J. Baumberg and J.T. Hugall for help with simulations and
   J.J. Rickard for TEM. We acknowledge the EPSRC for funding.
CR Addadi L, 2006, CHEM-EUR J, V12, P981, DOI 10.1002/chem.200500980
   ADDADI L, 1987, P NATL ACAD SCI USA, V84, P2732, DOI 10.1073/pnas.84.9.2732
   Aizenberg J, 2003, SCIENCE, V299, P1205, DOI 10.1126/science.1079204
   Aksay IA, 1996, SCIENCE, V273, P892, DOI 10.1126/science.273.5277.892
   Bonderer LJ, 2008, SCIENCE, V319, P1069, DOI 10.1126/science.1148726
   Burghard Z, 2009, NANO LETT, V9, P4103, DOI 10.1021/nl902324x
   Burtovyy R, 2008, LANGMUIR, V24, P5903, DOI 10.1021/la703545t
   Cartwright JHE, 2007, J R SOC INTERFACE, V4, P491, DOI 10.1098/rsif.2006.0188
   Cheng XG, 2007, J CRYST GROWTH, V307, P395, DOI 10.1016/j.jcrysgro.2007.07.006
   Currey JD, 1999, J EXP BIOL, V202, P3285
   DECHER G, 1992, THIN SOLID FILMS, V210, P831, DOI 10.1016/0040-6090(92)90417-A
   Finnemore AS, 2009, ADV MATER, V21, P3928, DOI 10.1002/adma.200900615
   Fu Y, 2002, MACROMOLECULES, V35, P9451, DOI 10.1021/ma0207881
   Gehrke N, 2005, CHEM MATER, V17, P6514, DOI 10.1021/cm052150k
   Gilbert PUPA, 2008, J AM CHEM SOC, V130, P17519, DOI 10.1021/ja8065495
   Gong HF, 2010, COLLOID SURFACE A, V354, P279, DOI 10.1016/j.colsurfa.2009.08.002
   Gower LB, 2000, J CRYST GROWTH, V210, P719, DOI 10.1016/S0022-0248(99)00749-6
   JACKSON AP, 1988, PROC R SOC SER B-BIO, V234, P415, DOI 10.1098/rspb.1988.0056
   Kato T, 2000, ADV MATER, V12, P1543, DOI 10.1002/1521-4095(200010)12:20<1543::AID-ADMA1543>3.0.CO;2-P
   Ludwigs S, 2006, ADV MATER, V18, P2270, DOI 10.1002/adma.200600091
   Munch E, 2008, SCIENCE, V322, P1516, DOI 10.1126/science.1164865
   OLIVER WC, 1992, J MATER RES, V7, P1564, DOI 10.1557/JMR.1992.1564
   Politi Y, 2008, P NATL ACAD SCI USA, V105, P17362, DOI 10.1073/pnas.0806604105
   Rousseau M, 2005, BIOMATERIALS, V26, P6254, DOI 10.1016/j.biomaterials.2005.03.028
   Schaffer TE, 1997, CHEM MATER, V9, P1731, DOI 10.1021/cm960429i
   Sethmann I, 2006, J INORG BIOCHEM, V100, P88, DOI 10.1016/j.jinorgbio.2005.10.005
   Sethmann I, 2008, MICRON, V39, P209, DOI 10.1016/j.micron.2007.01.006
   Smith BL, 1999, NATURE, V399, P761, DOI 10.1038/21607
   Song F, 2003, BIOMATERIALS, V24, P3623, DOI 10.1016/S0142-9612(03)00215-1
   Tang ZY, 2003, NAT MATER, V2, P413, DOI 10.1038/nmat906
   Wei H, 2007, CHEM MATER, V19, P1974, DOI 10.1021/cm062898i
   Weiner S, 2008, J STRUCT BIOL, V163, P229, DOI 10.1016/j.jsb.2008.02.001
   Weiss IM, 2002, J EXP ZOOL, V293, P478, DOI 10.1002/jez.90004
   Wilt FH, 1999, J STRUCT BIOL, V126, P216, DOI 10.1006/jsbi.1999.4105
   Wucher B, 2007, CHEM MATER, V19, P1111, DOI 10.1021/cm0620640
   Xu X, 2006, J PHYS CHEM B, V110, P2764, DOI 10.1021/jp055712w
   Yao HB, 2010, ANGEW CHEM INT EDIT, V49, P10127, DOI 10.1002/anie.201004748
   Zaremba C, 1994, P ROY SOC LOND B BIO, V256, P17
   Zhan JH, 2003, ADV MATER, V15, P621, DOI 10.1002/adma.200304600
NR 39
TC 140
Z9 144
U1 9
U2 391
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 2041-1723
J9 NAT COMMUN
JI Nat. Commun.
PD JUL
PY 2012
VL 3
AR 966
DI 10.1038/ncomms1970
PG 6
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA 981UA
UT WOS:000306995000038
PM 22828626
OA DOAJ Gold
DA 2018-10-19
ER

PT J
AU Griffith, M
   Polisetti, N
   Kuffova, L
   Gallar, J
   Forrester, J
   Vemuganti, GK
   Fuchsluger, TA
AF Griffith, May
   Polisetti, Naresh
   Kuffova, Lucia
   Gallar, Juana
   Forrester, John
   Vemuganti, Geeta K.
   Fuchsluger, Thomas Armin
TI Regenerative Approaches as Alternatives to Donor Allografting for
   Restoration of Corneal Function
SO OCULAR SURFACE
LA English
DT Article
DE biomaterial scaffolds; corneal transplantation; keratoprostheses; stem
   cells; regeneration
ID LIMBAL EPITHELIAL-CELLS; OCULAR SURFACE DISEASE; AMNIOTIC MEMBRANE
   TRANSPLANTATION; IMMOBILIZED POLY(VINYL ALCOHOL); PENETRATING
   KERATOPLASTY; ENDOTHELIAL-CELLS; STEM-CELLS; IN-VITRO; CULTURED LIMBAL;
   BIOENGINEERED CORNEAS
AB A range of alternatives to human donor tissue for corneal transplantation are being developed to address the shortfall of good quality tissues as well as the clinical conditions for which allografting is contraindicated. Classical keratoprostheses, commonly referred to as artificial corneas, are being used clinically to replace minimal corneal function. However, they are used only as last resorts, as they are associated with significant complications, such as extrusion/rejection, glaucoma, and retinal detachment. The past few years have seen significant developments in technologies designed to replace part or the full thickness of damaged or diseased corneas with materials that encourage regeneration to different extents. This review describes selected examples of these corneal substitutes, which range from cell-based regenerative strategies to keratoprostheses with regenerative capabilities via tissue-engineered scaffolds pre-seeded with stem cells. It is unlikely that one corneal substitute will be best for all indications, but taken together, the various approaches may soon be able to supplement the supply of human donor corneas for transplantation or allow restoration of diseased or damaged corneas that cannot be treated by currently available techniques.
C1 [Griffith, May; Polisetti, Naresh] Linkoping Univ, Dept Clin & Expt Med, Integrat Regenerat Med IGEN Ctr, S-58185 Linkoping, Sweden.
   [Kuffova, Lucia] Univ Aberdeen, Div Appl Med, Sect Infect & Immun, Aberdeen AB9 1FX, Scotland.
   [Gallar, Juana] Univ Miguel Hernandez, Inst Neurociencias, Alicante, Spain.
   [Forrester, John] Univ Aberdeen, Dept Ophthalmol, Aberdeen AB9 1FX, Scotland.
   [Vemuganti, Geeta K.; Fuchsluger, Thomas Armin] Univ Hyderabad, Sch Med Sci, Hyderabad 500134, Andhra Pradesh, India.
   [Fuchsluger, Thomas Armin] Univ Dusseldorf, Dept Ophthalmol, D-40225 Dusseldorf, Germany.
RP Griffith, M (reprint author), Linkoping Univ, Dept Clin & Expt Med, Integrat Regenerat Med IGEN Ctr, Cell Biol Bldg,Level 10, S-58185 Linkoping, Sweden.
EM May.Griffith@liu.se
RI Gallar, Juana/B-4563-2011
OI Gallar, Juana/0000-0002-3559-3649; Griffith, May/0000-0003-1222-6720
FU Swedish Research Council, County Council of Ostergotland, Sweden;
   Canadian Stem Cell Network; NSERC Canada [SAF2011-22500]; Spanish
   Ministerio de Economia y Competitividad
FX Financial support for clinical research reported on biosynthetic corneas
   for regenerative application are from research grants from the Swedish
   Research Council, County Council of Ostergotland, Sweden and the
   Canadian Stem Cell Network. Other research data generated from authors
   were supported by research grants from their own countries, including
   NSERC Canada (MG) and grant SAF2011-22500 from the Spanish Ministerio de
   Economia y Competitividad (JG).
CR Ambrose WM, 2009, J BIOMED MATER RES B, V90B, P818, DOI 10.1002/jbm.b.31351
   AMIS EJ, 1985, INT J BIOL MACROMOL, V7, P130, DOI 10.1016/0141-8130(85)90014-5
   Arnalich-Montiel F, 2008, STEM CELLS, V26, P570, DOI 10.1634/stemcells.2007-0653
   Aucoin L, 2002, J BIOMAT SCI-POLYM E, V13, P447, DOI 10.1163/156856202320253956
   Bareiss B, 2010, OPEN TISSUE ENG REGE, V3, P10
   Belmonte C, 2004, EXP EYE RES, V78, P513, DOI 10.1016/j.exer.2003.09.023
   Belmonte C, 2009, INVEST OPHTHALMOL VI, V50
   Belmonte C, 2007, J REFRACT SURG, V23, P598
   Black JA, 2002, EXP EYE RES, V75, P193, DOI 10.1006/exer.2002.2014
   Bonini S, 2002, ADV EXP MED BIOL, V506, P531
   Bruining MJ, 2002, BIOMATERIALS, V23, P1213, DOI 10.1016/S0142-9612(01)00237-X
   Carlsson David J, 2003, Curr Opin Ophthalmol, V14, P192, DOI 10.1097/00055735-200308000-00004
   Carrier P, 2008, INVEST OPHTH VIS SCI, V49, P1376, DOI 10.1167/iovs.07-0904
   Chirila TV, 2008, TISSUE ENG PT A, V14, P1203, DOI [10.1089/ten.tea.2007.0224, 10.1089/tea.2007.0224]
   Choi JS, 2010, BIOMATERIALS, V31, P6738, DOI 10.1016/j.biomaterials.2010.05.020
   Claesson M, 2002, BRIT J OPHTHALMOL, V86, P174, DOI 10.1136/bjo.86.2.174
   Cosar CB, 2002, CORNEA, V21, P148, DOI 10.1097/00003226-200203000-00003
   Dada T, 1999, CORNEA, V18, P296, DOI 10.1097/00003226-199905000-00009
   Darwish T, 2007, CORNEA, V26, P935, DOI 10.1097/ICO.0b013e3180de493f
   Daya SM, 2005, OPHTHALMOLOGY, V112, P470, DOI 10.1016/j.ophtha.2004.09.023
   de Rotth A, 1940, ARCH OPHTHALMOL-CHIC, V23, P522
   Deshpande P, 2009, TISSUE ENG PT A, V15, P2889, DOI [10.1089/ten.tea.2008.0528, 10.1089/ten.TEA.2008.0528]
   Di Girolamo N, 2009, TRANSPLANTATION, V87, P1571, DOI 10.1097/TP.0b013e3181a4bbf2
   Dravida S, 2008, J TISSUE ENG REGEN M, V2, P263, DOI 10.1002/term.91
   Du YQ, 2009, STEM CELLS, V27, P1635, DOI 10.1002/stem.91
   Dua HS, 2004, SURV OPHTHALMOL, V49, P51, DOI 10.1016/j.survophthal.2003.10.004
   Duan X, 2006, BIOMATERIALS, V27, P4608, DOI 10.1016/j.biomaterials.2006.04.022
   Duan X, 2005, J BIOMED MATER RES A, V75A, P510, DOI 10.1002/jbm.a.30475
   DUFFY P, 1974, NEW ENGL J MED, V290, P692
   Edwards M, 2002, CORNEA, V21, P152, DOI 10.1097/00003226-200203000-00004
   Espana EM, 2003, BRIT J OPHTHALMOL, V87, P1509, DOI 10.1136/bjo.87.12.1509
   Fagerholm P., 2010, SCI TRANSL MED, V2, P1
   Fagerholm P, 2009, CTS-CLIN TRANSL SCI, V2, P162, DOI 10.1111/j.1752-8062.2008.00083.x
   Forrester JV, 2008, MUCOSAL IMMUNOL, V1, P372, DOI 10.1038/mi.2008.27
   Francis D, 2009, EXP EYE RES, V88, P339, DOI 10.1016/j.exer.2008.06.016
   Fuchsluger TA, 2011, GENE THER, V18, P778, DOI 10.1038/gt.2011.20
   Fuchsluger TA, 2011, KLIN MONATSBL AUGENH, V228, P498, DOI 10.1055/s-0031-1273399
   Fuchsluger TA, 2011, HUM GENE THER, V22, P549, DOI 10.1089/hum.2010.079
   George A, 2002, BIOMATERIALS, V23, P1369, DOI 10.1016/S0142-9612(01)00257-5
   Gomaa A, 2010, CLIN EXP OPHTHALMOL, V38, P211, DOI 10.1111/j.1442-9071.2010.02231.x
   Gomes Jose A P, 2005, Curr Opin Ophthalmol, V16, P233, DOI 10.1097/01.icu.0000172827.31985.3a
   Gonzalez-Andrades M, 2011, INVEST OPHTH VIS SCI, V52, P215, DOI 10.1167/iovs.09-4773
   Guo XQ, 2007, INVEST OPHTH VIS SCI, V48, P4050, DOI 10.1167/iovs.06-1216
   Gupta Vishali, 2001, Indian Journal of Ophthalmology, V49, P53
   Guthoff RF, 2005, CORNEA, V24, P608, DOI 10.1097/01.ico.0000154384.05614.8f
   Hackett JM, 2011, INVEST OPHTH VIS SCI, V52, P651, DOI 10.1167/iovs.10-5224
   Han B, 2002, CORNEA, V21, P505, DOI 10.1097/01.ICO.0000016343.19018.1D
   Hao YX, 2000, CORNEA, V19, P348, DOI 10.1097/00003226-200005000-00018
   Hashimoto Y, 2010, BIOMATERIALS, V31, P3941, DOI 10.1016/j.biomaterials.2010.01.122
   Heinz C, 2004, CORNEA, V23, P524, DOI 10.1097/01.ico.0000114128.63670.e2
   Higa K, 2007, INVEST OPHTH VIS SCI, V48, P597, DOI 10.1167/iovs.06-0664
   Hoffman AS, 2002, ADV DRUG DELIVER REV, V54, P3, DOI 10.1016/S0169-409X(01)00239-3
   Hori J, 2001, INVEST OPHTH VIS SCI, V42, P1820
   HOUFF SA, 1979, NEW ENGL J MED, V300, P603, DOI 10.1056/NEJM197903153001105
   Hu J, 2012, ACTA BIOMATER, V8, P1156, DOI 10.1016/j.actbio.2011.09.013
   Hu XJ, 2005, TISSUE ENG, V11, P1710, DOI 10.1089/ten.2005.11.1710
   Ignacio TS, 2005, AM J OPHTHALMOL, V139, P325, DOI 10.1016/j.ajo.2004.09.068
   Inatomi T, 2006, AM J OPHTHALMOL, V142, P757, DOI 10.1016/j.ajo.2006.06.004
   Jacob JT, 2005, J BIOMED MATER RES B, V72B, P198, DOI 10.1002/jbm.b.30131
   Javaloy J, 2000, ARCH SOC ESP OFTALMO, V75, P595
   Johnson G, 2000, J BIOMED MATER RES, V51, P612, DOI 10.1002/1097-4636(20000915)51:4<612::AID-JBM9>3.3.CO;2-Q
   Joyce NC, 2003, PROG RETIN EYE RES, V22, P359, DOI 10.1016/S1350-9462(02)00065-4
   Kaminski SL, 2002, J REFRACT SURG, V18, P731
   KENYON KR, 1989, OPHTHALMOLOGY, V96, P709
   Kenyon KR, 1989, OPHTHALMOLOGY, V96, P722
   KIM JC, 1995, CORNEA, V14, P473
   Kim MK, 2001, J CATARACT REFR SURG, V27, P766, DOI 10.1016/S0886-3350(00)00701-X
   Klenkler BJ, 2005, BIOMATERIALS, V26, P7286, DOI 10.1016/j.biomaterials.2005.05.045
   Knickelbein JE, 2009, SURV OPHTHALMOL, V54, P226, DOI 10.1016/j.survophthal.2008.12.004
   KOBAYASHI H, 1991, BIOMATERIALS, V12, P747, DOI 10.1016/0142-9612(91)90024-5
   Koizumi N, 2000, CURR EYE RES, V20, P173, DOI 10.1076/0271-3683(200003)20:3;1-9;FT173
   Kruse FE, 1999, OPHTHALMOLOGY, V106, P1504, DOI 10.1016/S0161-6420(99)90444-X
   Lawrence BD, 2008, BIOMACROMOLECULES, V9, P1214, DOI 10.1021/bm701235f
   Lee KY, 2001, CHEM REV, V101, P1869, DOI 10.1021/cr000108x
   Lee SH, 2011, J KOREAN OPHTHALMOL, V52, P86
   Legeais JM, 1998, BIOMATERIALS, V19, P1517, DOI 10.1016/S0142-9612(98)00069-6
   Lencova A, 2011, TRANSPL IMMUNOL, V24, P189, DOI 10.1016/j.trim.2010.11.005
   Li F, 2005, BIOMATERIALS, V26, P3093, DOI 10.1016/j.biomaterials.2004.07.063
   Li FF, 2003, P NATL ACAD SCI USA, V100, P15346, DOI 10.1073/pnas.2536767100
   Liu HS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010707
   Liu L, 2007, BIOMATERIALS, V28, P3807, DOI 10.1016/j.biomaterials.2007.04.025
   Liu WG, 2009, BIOMATERIALS, V30, P1551, DOI 10.1016/j.biomaterials.2008.11.022
   McLaughlin CR, 2010, BIOMATERIALS, V31, P2770, DOI 10.1016/j.biomaterials.2009.12.031
   McLaughlin CR, 2009, FRONT BIOSCI-LANDMRK, V14, P3326, DOI 10.2741/3455
   Merrett K, 2003, J BIOMED MATER RES A, V67A, P981, DOI 10.1002/jbm.a.10165
   Merrett K, 2001, J BIOMAT SCI-POLYM E, V12, P647, DOI 10.1163/156856201316883467
   Meyer-Blazejewska EA, 2010, INVEST OPHTH VIS SCI, V51, P765, DOI 10.1167/iovs.09-4109
   Miyashita H, 2006, J BIOMED MATER RES B, V76B, P56, DOI 10.1002/jbm.b.30332
   Muller LJ, 2003, EXP EYE RES, V76, P521, DOI 10.1016/S0014-4835(03)00050-2
   Muraine MC, 2002, ARCH OPHTHALMOL-CHIC, V120, P812
   Myung D, 2008, BIOTECHNOL PROGR, V24, P735, DOI 10.1021/bp070476n
   Myung D, 2007, BIOMED MICRODEVICES, V9, P911, DOI 10.1007/s10544-006-9040-4
   Myung D, 2009, J BIOMED MATER RES A, V90A, P70, DOI 10.1002/jbm.a.32056
   Nakamura T, 2004, ACTA OPHTHALMOL SCAN, V82, P468, DOI 10.1111/j.1600-0420.2004.00285.x
   Nishida K, 2004, NEW ENGL J MED, V351, P1187, DOI 10.1056/NEJMoa040455
   Notara M, 2007, J MATER SCI-MATER M, V18, P329, DOI 10.1007/s10856-006-0697-2
   Okumura N, 2011, CORNEA, V30, pS54, DOI 10.1097/ICO.0b013e3182281ee1
   Okumura N, 2009, INVEST OPHTH VIS SCI, V50, P3680, DOI 10.1167/iovs.08-2634
   Patel SV, 2007, ARCH OPHTHALMOL-CHIC, V125, P1693, DOI 10.1001/archopht.125.12.1693
   Pauklin M, 2010, DEV OPHTHALMOL, V45, P57, DOI 10.1159/000315020
   Peh GSL, 2011, TRANSPLANTATION, V91, P811, DOI 10.1097/TP.0b013e3182111f01
   Pellegrini G, 1997, LANCET, V349, P990, DOI 10.1016/S0140-6736(96)11188-0
   PIERSCHBACHER MD, 1987, J BIOL CHEM, V262, P17294
   Plskova J, 2002, BRIT J OPHTHALMOL, V86, P108, DOI 10.1136/bjo.86.1.108
   Marquez SP, 2009, ACTA BIOMATER, V5, P1839, DOI 10.1016/j.actbio.2009.02.011
   Proulx S, 2010, MOL VIS, V16, P2192
   Rafat MA, ENCY EYE
   Rama P, 2001, TRANSPLANTATION, V72, P1478, DOI 10.1097/00007890-200111150-00002
   RAO GN, 1985, OPHTHALMOLOGY, V92, P1408
   ROZSA AJ, 1983, INVEST OPHTH VIS SCI, V24, P1033
   Ruberti JW, 2008, PROG RETIN EYE RES, V27, P549, DOI 10.1016/j.preteyeres.2008.08.001
   Sangwan VS, 2003, CORNEA, V22, P478, DOI 10.1097/00003226-200307000-00016
   Schwab IR, 2000, CORNEA, V19, P421, DOI 10.1097/00003226-200007000-00003
   Shimmura S, 2003, CORNEA, V22, pS81, DOI 10.1097/00003226-200310001-00012
   Shortt AJ, 2007, SURV OPHTHALMOL, V52, P483, DOI 10.1016/j.survophthal.2007.06.013
   Shortt AJ, 2009, BIOMATERIALS, V30, P1056, DOI 10.1016/j.biomaterials.2008.10.048
   Stachs O, 2010, J REFRACT SURG, V26, P159, DOI 10.3928/1081597X-20100224-01
   Tervo T, 2003, PROG RETIN EYE RES, V22, P339, DOI 10.1016/S1350-9462(02)00064-2
   Tosi GM, 2005, J CELL PHYSIOL, V202, P849, DOI 10.1002/jcp.20181
   Touhami A, 2002, INVEST OPHTH VIS SCI, V43, P987
   TRELFORD JD, 1979, AM J OBSTET GYNECOL, V134, P833, DOI 10.1016/0002-9378(79)90957-8
   Tsai RJ, 2000, NEW ENGL J MED, V343, P86, DOI 10.1056/NEJM200007133430202
   TSAI RJF, 1994, CORNEA, V13, P389, DOI 10.1097/00003226-199409000-00003
   Tseng SCG, 1999, J CELL PHYSIOL, V179, P325, DOI 10.1002/(SICI)1097-4652(199906)179:3<325::AID-JCP10>3.3.CO;2-O
   Uchino Y, 2007, J BIOMED MATER RES B, V81B, P201, DOI 10.1002/jbm.b.30654
   Wallace C, 2005, J BIOMED MATER RES A, V72A, P19, DOI 10.1002/jbm.a.30199
   Whitcher JP, 2001, B WORLD HEALTH ORGAN, V79, P214
   WILHELMUS KR, 1995, ARCH OPHTHALMOL-CHIC, V113, P1497, DOI 10.1001/archopht.1995.01100120027002
   Williams KA, 2006, TRANSPLANTATION, V81, P896, DOI 10.1097/01.tp.0000185197.37824.35
   Yu CQ, 2007, INVEST OPHTH VIS SCI, V48, P1535, DOI 10.1167/iovs.06-1192
   Zhu C, 2004, INVEST OPHTH VIS SCI, V45, P1743, DOI 10.1167/iovs-030814
NR 131
TC 18
Z9 21
U1 0
U2 25
PU ETHIS COMMUNICATINS, INC
PI NEW YORK
PA 75 MAIDEN LANE, STE 408, NEW YORK, NY 10038 USA
SN 1542-0124
J9 OCUL SURF
JI Ocul. Surf.
PD JUL
PY 2012
VL 10
IS 3
BP 170
EP 183
DI 10.1016/j.jtos.2012.04.004
PG 14
WC Ophthalmology
SC Ophthalmology
GA 985KD
UT WOS:000307262200005
PM 22814644
DA 2018-10-19
ER

PT J
AU Tang, ACL
   Chang, MY
   Tang, ZCW
   Li, HJ
   Hwang, GL
   Hsieh, PCH
AF Tang, Alan C. L.
   Chang, Ming-Yao
   Tang, Zack C. W.
   Li, Hui-Jing
   Hwang, Gan-Lin
   Hsieh, Patrick C. H.
TI Treatment of Acute Thromboembolism in Mice Using Heparin-Conjugated
   Carbon Nanocapsules
SO ACS NANO
LA English
DT Article
DE anticoagulant; drug delivery; heparin; nanoparticle; surface analysis;
   thrombogenicity
ID PLASMINOGEN-ACTIVATOR INHIBITOR-1; IN-VIVO; DRUG-DELIVERY; ARTERIAL
   THROMBOSIS; UNFRACTIONATED HEPARIN; TIO2 NANOPARTICLES; GRAPHENE OXIDE;
   TISSUE FACTOR; NANOTUBES; FULLERENE
AB The unsurpassed properties in electrical conductivity, thermal conductivity, strength, and surface area-to-volume ratio allow for many potential applications of carbon nanomaterials in various fields. Recently, studies have characterized the potential of using carbon nanotubes (CNTs) as a biomaterial for biomedical applications and as a drug carrier via intravenous injection. However, most studies show that unmodified CNTs possess a high degree of toxicity and cause inflammation, mechanical obstruction from high organ retention, and other biocompatibility issues following in vivo delivery. In contrast, carbon nanocapsules (CNCs) have a lower aspect ratio compared with CNTs and have a higher dispersion rate. To investigate the possibility of using CNCs as an alternative to CNTs for drug delivery, heparin-conjugated CNCs (CNC-H) were studied in a mouse model of acute hindlimb thromboembolism. Our results showed that CNC-H not only displayed superior antithrombotic activity in vitro and in vivo but they also had the ability to extend the thrombus formation time far longer than an injection of heparin or CNCs alone. Therefore, the present study showed for the first time that functionalized CNCs can act as nanocarriers to deliver thrombolytic therapeutics.
C1 [Tang, Alan C. L.; Tang, Zack C. W.; Li, Hui-Jing; Hsieh, Patrick C. H.] Natl Cheng Kung Univ & Hosp, Inst Clin Med, Tainan 70428, Taiwan.
   [Chang, Ming-Yao; Hsieh, Patrick C. H.] Natl Cheng Kung Univ & Hosp, Dept Biomed Engn, Tainan 70428, Taiwan.
   [Hwang, Gan-Lin] Ind Technol Res Inst, Nanopowder & Thin Film Technol Ctr, Tainan 709, Taiwan.
   [Hsieh, Patrick C. H.] Acad Sinica, Inst Biomed Sci, Taipei 115, Taiwan.
RP Hsieh, PCH (reprint author), Natl Cheng Kung Univ & Hosp, Inst Clin Med, Tainan 70428, Taiwan.
EM phsieh@mail.ncku.edu.tw
RI Hsieh, Patrick Ching-Ho/H-5108-2015
OI Hsieh, Patrick C.H./0000-0002-8910-3596
FU Taiwan National Science Council [99-3112-B-006-008, 99-2627-M-006-009,
   100-2325-B-006-002]; Taiwan National Health Research Institutes
   [EX-9722SI]; Taiwan Department of Health, Executive Yuan
   [DOH100-TD-PB-111-TM018]; Center for Micro/Nano Science and Technology
   of NCKU [99C028]
FX This work was supported by the Taiwan National Science Council
   (99-3112-B-006-008, 99-2627-M-006-009, 100-2325-B-006-002), the Taiwan
   National Health Research Institutes (EX-9722SI), the Taiwan Department
   of Health, Executive Yuan (DOH100-TD-PB-111-TM018), and the Center for
   Micro/Nano Science and Technology of NCKU (99C028).
CR Aillon KL, 2009, ADV DRUG DELIVER REV, V61, P457, DOI 10.1016/j.addr.2009.03.010
   Baati T, 2012, BIOMATERIALS, V33, P4936, DOI 10.1016/j.biomaterials.2012.03.036
   Baker GL, 2008, TOXICOL SCI, V101, P122, DOI 10.1093/toxsci/kfm243
   Baughman RH, 2002, SCIENCE, V297, P787, DOI 10.1126/science.1060928
   Bhirde AA, 2009, ACS NANO, V3, P307, DOI 10.1021/nn800551s
   Burke AR, 2011, BIOMATERIALS, V32, P5970, DOI 10.1016/j.biomaterials.2011.04.059
   Chan AKC, 2008, THROMB RES, V122, P135, DOI 10.1016/j.thromres.2007.09.007
   Chang W., 2010, ADV DRUG DELIVERY RE, V62, P633
   Chong W.H., 2004, J LIGHTWAVE TECHNOL, P22
   Chu CC, 2005, ADV MATER, V17, P2707, DOI 10.1002/adma.200500757
   Chuang YJ, 2001, J BIOL CHEM, V276, P14961, DOI 10.1074/jbc.M011550200
   Crawley JTB, 2008, ARTERIOSCL THROM VAS, V28, P233, DOI 10.1161/ATVBAHA.107.141606
   Deng X, 2007, CARBON, V45, P1419, DOI 10.1016/j.carbon.2007.03.035
   Dobrovolskaia MA, 2007, NAT NANOTECHNOL, V2, P469, DOI 10.1038/nnano.2007.223
   Dobrovolskaia MA, 2009, NAT NANOTECHNOL, V4, P411, DOI [10.1038/NNANO.2009.175, 10.1038/nnano.2009.175]
   Erdely A, 2009, NANO LETT, V9, P36, DOI 10.1021/nl801828z
   Harrison BS, 2007, BIOMATERIALS, V28, P344, DOI 10.1016/j.biomaterials.2006.07.044
   Hirsh J, 2001, ARTERIOSCL THROM VAS, V21, P1094, DOI 10.1161/hq0701.093686
   Hong H, 2012, BIOMATERIALS, V33, P4147, DOI 10.1016/j.biomaterials.2012.02.031
   Huang HC, 2006, THIN SOLID FILMS, V511, P203, DOI 10.1016/j.tsf.2005.12.127
   Huang HC, 2006, THIN SOLID FILMS, V515, P1033, DOI 10.1016/j.tsf.2006.07.071
   Hwang G. L, U. S. Patent, Patent No. 7156958
   Hwang GL, 2003, CHEM MATER, V15, P1353, DOI 10.1021/cm020747j
   Jeon O, 2007, BIOMATERIALS, V28, P2763, DOI 10.1016/j.biomaterials.2007.02.023
   Jia G, 2005, ENVIRON SCI TECHNOL, V39, P1378, DOI 10.1021/es048729l
   Johnston HJ, 2010, TOXICOL SCI, V114, P162, DOI 10.1093/toxsci/kfp265
   Kim S, 2010, MATER CHEM PHYS, V122, P164, DOI 10.1016/j.matchemphys.2010.02.054
   Kim S, 2008, CARBON, V46, P1523, DOI 10.1016/j.carbon.2008.05.027
   Konstantinides S, 2001, CIRCULATION, V103, P576, DOI 10.1161/01.CIR.103.4.576
   Kostarelos K, 2009, NAT NANOTECHNOL, V4, P627, DOI 10.1038/nnano.2009.241
   Kostarelos K, 2008, NAT BIOTECHNOL, V26, P774, DOI 10.1038/nbt0708-774
   Labhasetwar V, 1997, ADV DRUG DELIVER REV, V24, P63, DOI 10.1016/S0169-409X(96)00483-8
   Lacerda L, 2006, ADV DRUG DELIVER REV, V58, P1460, DOI 10.1016/j.addr.2006.09.015
   Lassalle V, 2007, MACROMOL BIOSCI, V7, P767, DOI 10.1002/mabi.200700022
   LaVan DA, 2003, NAT BIOTECHNOL, V21, P1184, DOI 10.1038/nbt876
   Li C, 2007, J MATER CHEM, V17, P2406, DOI [10.1039/b618518e, 10.1039/b618548e]
   Liu Z, 2007, ACS NANO, V1, P50, DOI 10.1021/nn700040t
   Matsubara S, 2010, J OBSTET GYNAECOL RE, V36, P58, DOI 10.1111/j.1447-0756.2009.01107.x
   Muller J, 2008, CHEM RES TOXICOL, V21, P1698, DOI 10.1021/tx800101p
   Murugesan S, 2006, LANGMUIR, V22, P3461, DOI 10.1021/la0534468
   Nemmar A, 2007, J THROMB HAEMOST, V5, P1217, DOI 10.1111/j.1538-7836.2007.02557.x
   Owens AP, 2011, J THROMB HAEMOST, V9, P1862, DOI 10.1111/j.1538-7836.2011.04287.x
   Park TJ, 2012, PROCESS BIOCHEM, V47, P113, DOI 10.1016/j.procbio.2011.10.017
   Podesta JE, 2009, SMALL, V5, P1176, DOI 10.1002/smll.200801572
   Poland CA, 2008, NAT NANOTECHNOL, V3, P423, DOI 10.1038/nnano.2008.111
   Radomski A, 2005, BRIT J PHARMACOL, V146, P882, DOI 10.1038/sj.bjp.0706386
   Ryman-Rasmussen JP, 2009, NAT NANOTECHNOL, V4, P747, DOI [10.1038/NNANO.2009.305, 10.1038/nnano.2009.305]
   Saito N, 2009, CHEM SOC REV, V38, P1897, DOI 10.1039/b804822n
   Si PZ, 2003, CARBON, V41, P247, DOI 10.1016/S0008-6223(02)00280-4
   Singh SK, 2012, ACS NANO, V6, P2731, DOI 10.1021/nn300172t
   Singh SK, 2011, ACS NANO, V5, P4987, DOI 10.1021/nn201092p
   Su FK, 2006, J APPL POLYM SCI, V100, P3784, DOI 10.1002/app.23785
   Su T. T, 2006, IEEE C EM TECHN NAN, P25
   Tang A.C., 2012, PLOS ONE, P7
   Tseng MT, 2006, THROMB RES, V118, P275, DOI 10.1016/j.thromres.2005.09.004
   Wang C, 2008, POLYMER, V49, P5564, DOI 10.1016/j.polymer.2008.09.057
   Wang L, 2009, BLOOD, V113, P705, DOI 10.1182/blood-2007-05-090944
   Wang XK, 2005, THROMB RES, V115, P95, DOI 10.1016/j.thromres.2004.07.009
   Wu KK, 1996, J INTERN MED, V239, P17, DOI 10.1046/j.1365-2796.1996.331661000.x
   Xu JY, 2007, CARBON, V45, P1865, DOI 10.1016/j.carbon.2007.04.030
   Yang K, 2011, ACS NANO, V5, P516, DOI 10.1021/nn1024303
   Yang K, 2010, NANO LETT, V10, P3318, DOI 10.1021/nl100996u
   Zhang Y, 2010, DRUG DISCOV TODAY, V15, P428, DOI 10.1016/j.drudis.2010.04.005
   Zhu YH, 1999, CIRCULATION, V99, P3050, DOI 10.1161/01.CIR.99.23.3050
   Zolnik BS, 2010, ENDOCRINOLOGY, V151, P458, DOI 10.1210/en.2009-1082
NR 65
TC 5
Z9 6
U1 1
U2 56
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 1936-0851
J9 ACS NANO
JI ACS Nano
PD JUL
PY 2012
VL 6
IS 7
BP 6099
EP 6107
DI 10.1021/nn301198r
PG 9
WC Chemistry, Multidisciplinary; Chemistry, Physical; Nanoscience &
   Nanotechnology; Materials Science, Multidisciplinary
SC Chemistry; Science & Technology - Other Topics; Materials Science
GA 977OL
UT WOS:000306673800040
PM 22713482
DA 2018-10-19
ER

PT J
AU Lee, DS
   Lee, I
AF Lee, Dong Sub
   Lee, Inhyung
TI Development of Monacolin K-Enriched Ganghwayakssuk (Artemisia princeps
   Pamp.) by Fermentation with Monascus pilosus
SO JOURNAL OF MICROBIOLOGY AND BIOTECHNOLOGY
LA English
DT Article
DE Gangwhayakssuk (Artemisia princeps Pamp.); response surface methodology;
   Monascus pilosus; monacolin K
ID LOVASTATIN; CITRININ; RUBER; RICE; PRODUCTS; ACID
AB Monacolin K-enriched ganghwayakssuk (Artemisia princeps Pamp.) was developed by fermentation with Monascus sp. Among the 15 Monascus spp. isolated previously from Monascus fermentation products, Monascus pilosus KMU108 produced 2,219 mg/kg of monacolin K during ganghwayakssuk fermentation with no detectable citrinin. The optimum concentrations of ganghwayakssuk and glucose determined from the response surface methodology (RSM) design were 2.2% and 3.8%, respectively. By applying these conditions, the monacolin K productivity was increased to 3,007 mg/kg after 15 days of fermentation. On the other hand, other characteristics such as the total content of flavonoids and phenolic compounds, and the antioxidant activity were relatively unchanged. Therefore, Monascus-fermented ganghwayakssuk is an excellent biomaterial for the development of functional foods because of its high level of monacolin K, known to lower cholesterol levels.
C1 [Lee, Inhyung] Kookmin Univ, Dept Adv Fermentat Fus Sci & Technol, Seoul 136702, South Korea.
   [Lee, Dong Sub] Kookmin Univ, Dept Foods & Nutr, Seoul 136702, South Korea.
RP Lee, I (reprint author), Kookmin Univ, Dept Adv Fermentat Fus Sci & Technol, Seoul 136702, South Korea.
EM leei@kookmin.ac.kr
FU Kookmin University in Korea; Seoul (Korea) RBD Program [10580]
FX This study was supported by the Research Program 2012 of Kookmin
   University in Korea and by the Seoul (Korea) R&BD Program (10580).
CR Ahn BY, 1992, KOR J FOOD HYGINE, V7, P157
   Bensky D, 1990, CHINESE HERBAL MED F
   BLANC PJ, 1995, BIOTECHNOL LETT, V17, P291, DOI 10.1007/BF01190639
   Chang YN, 2002, ENZYME MICROB TECH, V30, P889, DOI 10.1016/S0141-0229(02)00037-6
   Cho H.Y., 2006, KOREAN J BIOTECHNOL, V21, P129
   Cho Y.H., 2001, KOR J INT AGR, V13, P313
   Choi Y. M., 2006, KOREAN J CROP SCI, V50, P209
   ENDO A, 1985, J ANTIBIOT, V38, P420, DOI 10.7164/antibiotics.38.420
   ENDO A, 1979, J ANTIBIOT, V32, P852, DOI 10.7164/antibiotics.32.852
   ERDOGRUL L, 2004, TURK ELECT J BIOTECH, V2, P37
   Folin O., 1912, J BIOL CHEM, V12, P230
   Hong J.H., 2007, J KOREAN SOC FOOD SC, V36, P657
   Hong SY, 2011, BIOSCI BIOTECH BIOCH, V75, P1490, DOI 10.1271/bbb.110195
   Hwang KE, 2011, FOOD SCI BIOTECHNOL, V20, P1381, DOI 10.1007/s10068-011-0190-7
   Jung Hyuck-Jun, 2004, [Korean Journal of Microbiology, 미생물학회지], V40, P160
   Kim HJ, 2007, FOOD SCI BIOTECHNOL, V16, P142
   Kim JY, 2010, FOOD SCI BIOTECHNOL, V19, P1151, DOI 10.1007/s10068-010-0164-1
   Kjeldahl J., 1883, FRESEN Z ANAL CHEM, V22, P366, DOI DOI 10.1007/BF01338151
   Kowapradit S., 2007, J AGR TECHNOLOGY, V3, P129
   Kwon M., 2007, KOREAN J MED CROP SC, V15, P233
   KYSILKA R, 1993, J CHROMATOGR, V630, P415, DOI 10.1016/0021-9673(93)80480-V
   Lee CL, 2006, J AOAC INT, V89, P669
   Lee S.-J., 1999, KOREAN J FOOD SCI TE, V31, P815
   Lin YL, 2008, APPL MICROBIOL BIOT, V77, P965, DOI 10.1007/s00253-007-1256-6
   Moreno MIN, 2000, J ETHNOPHARMACOL, V71, P109, DOI 10.1016/S0378-8741(99)00189-0
   Ryu S.-N., 2008, KOREAN J INT AGR, V20, P40
   RYU SN, 2005, KOREAN J CROP SCI, V50, P204
   Schwanninger M, 2002, HOLZ ROH WERKST, V60, P343, DOI 10.1007/s00107-002-0312-2
   TANAKA T, 1976, TANAKAS CYCLOPEDIA E
   Wild D, 2002, J AGR FOOD CHEM, V50, P3999, DOI 10.1021/jf020023s
   Xu BJ, 2005, BIOTECHNOL BIOPROC E, V10, P78, DOI 10.1007/BF02931187
   Yoo H. J., 2002, KOREAN J MICROBIOL, V38, P230
   Yoon S. J., 2007, KOREAN J BIOTECHNOL, V22, P288
   Yoshikawa M, 1996, CHEM PHARM BULL, V44, P1656
NR 34
TC 3
Z9 4
U1 1
U2 14
PU KOREAN SOC MICROBIOLOGY & BIOTECHNOLOGY
PI SEOUL
PA KOREA SCI TECHNOL CENTER #507,  635-4 YEOGSAM-DONG, KANGNAM-GU, SEOUL
   135-703, SOUTH KOREA
SN 1017-7825
J9 J MICROBIOL BIOTECHN
JI J. Microbiol. Biotechnol.
PD JUL
PY 2012
VL 22
IS 7
BP 975
EP 980
DI 10.4014/jmb.1201.01016
PG 6
WC Biotechnology & Applied Microbiology; Microbiology
SC Biotechnology & Applied Microbiology; Microbiology
GA 981BY
UT WOS:000306941700013
PM 22580317
DA 2018-10-19
ER

PT J
AU Elias, PZ
   Spector, M
AF Elias, Paul Z.
   Spector, Myron
TI Characterization of a Bilateral Penetrating Brain Injury in Rats and
   Evaluation of a Collagen Biomaterial for Potential Treatment
SO JOURNAL OF NEUROTRAUMA
LA English
DT Article
DE collagen; penetrating brain injury; rat brain; scaffold; traumatic brain
   injury
ID CENTRAL-NERVOUS-SYSTEM; CRANIOCEREBRAL GUNSHOT WOUNDS; MESENCHYMAL
   STEM-CELLS; SPINAL-CORD; HEAD-INJURY; INTRACRANIAL-PRESSURE; TISSUE
   REGENERATION; GAG SCAFFOLDS; ADULT MICE; IN-VITRO
AB Penetrating brain injury (PBI) encountered in both the military and civilian sectors results in high morbidity and mortality due to the absence of effective treatment options for survivors of the initial trauma. Developing therapies for such injuries requires a better understanding of the complex pathology involved when projectiles enter the skull and disrupt the brain parenchyma. This study presents a histological characterization of bilateral PBI using a relatively new injury model in the rat, and also investigates the implantation of a collagen scaffold into the PBI lesion as a potential treatment option. At 1 week post-PBI, the lesion was characterized by dense macrophage infiltration, evolving astrogliosis, hypervascularity, and an absence of viable neurons, oligodendrocytes, and myelinated axons. Histomorphometric analysis revealed that the PBI lesion volume expanded by 29% between 1 week and 5 weeks post-injury, resulting in formation of a large acellular cavity. Immunohistochemistry showed a decrease in the presence of CD68-positive macrophages from 1 to 5 weeks post-PBI as the necrotic tissue in the lesion was cleared, while persistent glial scarring remained in the form of upregulated GFAP expression surrounding the PBI cavity. Implanted type I collagen scaffolds remained intact with open pores after time periods of 1 week and 4 weeks in vivo, and were found to be sparsely infiltrated with macrophages, astrocytes, and endothelial cells. Collagen scaffolds appear to be an appropriate delivery vehicle for cellular and pharmacological therapeutic agents in future studies of PBI.
C1 [Elias, Paul Z.; Spector, Myron] VA Boston Healthcare Syst, Tissue Engn Labs, Boston, MA 02130 USA.
   [Elias, Paul Z.] MIT, Harvard MIT Div Hlth Sci & Technol, Cambridge, MA 02139 USA.
   [Spector, Myron] Harvard Univ, Brigham & Womens Hosp, Sch Med, Dept Orthoped Surg, Boston, MA 02115 USA.
RP Elias, PZ (reprint author), VA Boston Healthcare Syst, Tissue Engn Labs, Mail Stop 151,Room D1-151,150 S Huntington Ave, Boston, MA 02130 USA.
EM pzelias@alum.mit.edu
OI Spector, Myron/0000-0003-3328-4858
FU U.S. Department of Veterans Affairs, Veterans Health Administration,
   Rehabilitation Research and Development Service
FX The research reported here was supported by the U.S. Department of
   Veterans Affairs, Veterans Health Administration, Rehabilitation
   Research and Development Service. M. S. is a VA Research Career
   Scientist.
CR ALLEN IV, 1983, ACTA NEUROPATHOL, V59, P277, DOI 10.1007/BF00691493
   ALLEN IV, 1982, INJURY, V14, P183, DOI 10.1016/0020-1383(82)90057-2
   Arvidsson A, 2002, NAT MED, V8, P963, DOI 10.1038/nm747
   Bell RS, 2010, NEUROSURG FOCUS, V28, DOI 10.3171/2010.2.FOCUS1022
   Bolliet C, 2008, TISSUE ENG PT C-METH, V14, P207, DOI 10.1089/ten.tec.2008.0168
   CAREY ME, 1989, J NEUROSURG, V71, P754, DOI 10.3171/jns.1989.71.5.0754
   Chamberlain LJ, 2000, J NEUROSCI RES, V60, P666, DOI 10.1002/(SICI)1097-4547(20000601)60:5<666::AID-JNR12>3.0.CO;2-0
   Chang YC, 2007, CELL TRANSPLANT, V16, P171
   Chen ZY, 2011, BRAIN RES, V1368, P71, DOI 10.1016/j.brainres.2010.10.028
   Cholas RH, 2012, BIOMATERIALS, V33, P2050, DOI 10.1016/j.biomaterials.2011.11.028
   Cromey DW, 2010, SCI ENG ETHICS, V16, P639, DOI 10.1007/s11948-010-9201-y
   Deguchi K, 2006, J CEREBR BLOOD F MET, V26, P1263, DOI 10.1038/sj.jcbfm.9600275
   Elias PZ, 2012, J MECH BEHAV BIOMED, V12, P63, DOI 10.1016/j.jmbbm.2012.03.014
   Fitch MT, 2008, EXP NEUROL, V209, P294, DOI 10.1016/j.expneurol.2007.05.014
   Galtrey CM, 2007, BRAIN RES REV, V54, P1, DOI 10.1016/j.brainresrev.2006.09.006
   Goings GE, 2004, BRAIN RES, V996, P213, DOI 10.1016/j.brainres.2003.10.034
   Harley BA, 2004, CELLS TISSUES ORGANS, V176, P153, DOI 10.1159/000075035
   Harley BA, 2007, ACTA BIOMATER, V3, P463, DOI 10.1016/j.aetbio.2006.12.009
   Hou SP, 2005, J NEUROSCI METH, V148, P60, DOI 10.1016/j.jneumeth.2005.04.016
   HUNT TK, 1984, SURGERY, V96, P48
   Izci Y, 2005, EMERG MED J, V22, P409, DOI 10.1136/emj.2004.014704
   Izci Y, 2003, TOHOKU J EXP MED, V201, P39, DOI 10.1620/tjem.201.39
   Jain KK, 2008, DRUG DISCOV TODAY, V13, P1082, DOI 10.1016/j.drudis.2008.09.006
   Jankovic S, 2000, ACTA NEUROCHIR, V142, P101, DOI 10.1007/s007010050014
   KARGER B, 1995, INT J LEGAL MED, V108, P53, DOI 10.1007/BF01369905
   KAUFMAN HH, 1995, NEUROSURG CLIN N AM, V6, P701
   Kigerl KA, 2009, J NEUROSCI, V29, P13435, DOI 10.1523/JNEUROSCI.3257-09.2009
   Kim TW, 2007, J TRAUMA, V62, P1446, DOI 10.1097/01.ta.0000222909.31666.db
   KNOWLSON GT, 1974, J NEUROL NEUROSUR PS, V37, P971, DOI 10.1136/jnnp.37.8.971
   Lee DHS, 2003, NAT REV DRUG DISCOV, V2, P872, DOI 10.1038/nrd1228
   Lu XCM, 2011, J NEUROTRAUM, V28, P71, DOI 10.1089/neu.2010.1471
   Lu XCM, 2009, J NEUROTRAUM, V26, P141, DOI 10.1089/neu.2008.0629
   Madaghiele M, 2008, J BIOMED MATER RES A, V85A, P757, DOI 10.1002/jbm.a.31517
   Martins RS, 2003, SURG NEUROL, V60, P98, DOI 10.1016/S0090-3019(03)00302-1
   Murano T, 2005, AM SURGEON, V71, P1009
   Nakada A, 2009, CELLS TISSUES ORGANS, V190, P326, DOI 10.1159/000223233
   Novozhilova A P, 1997, Neurosci Behav Physiol, V27, P183, DOI 10.1007/BF02461951
   O'Brien FJ, 2004, BIOMATERIALS, V25, P1077, DOI 10.1016/S0142-9612(03)00630-6
   Pabuscu Y, 2003, COMPUT MED IMAG GRAP, V27, P397, DOI 10.1016/S0895-6111(03)00015-6
   Parent JM, 2002, ANN NEUROL, V52, P802, DOI 10.1002/ana.10393
   Pataquiva-Mateus A.Y., 2012, J BIOMED MAT RES B
   Pek YS, 2004, BIOMATERIALS, V25, P473, DOI 10.1016/S0142-9612(03)00541-6
   Picard-Riera N, 2004, J NEUROSCI RES, V76, P223, DOI 10.1002/jnr.20040
   Plant GW, 1997, EXP NEUROL, V143, P287, DOI 10.1006/exnr.1997.6407
   Pruitt B, 2001, J TRAUMA, V51, pS44
   Ramaswamy S, 2005, BRAIN RES, V1053, P38, DOI 10.1016/j.brainres.2005.06.042
   Richardson RM, 2007, NEUROSURG CLIN N AM, V18, P169, DOI 10.1016/j.nec.2006.10.007
   Rosenfeld JV, 2002, J CLIN NEUROSCI, V9, P9, DOI 10.1054/jocn.2001.0949
   Salman H, 2004, J NEUROTRAUM, V21, P283, DOI 10.1089/089771504322972077
   Sapsford W, 2003, J R Army Med Corps, V149, P5
   Shear DA, 2010, J NEUROTRAUM, V27, P1911, DOI 10.1089/neu.2010.1399
   SOBLOSKY JS, 1992, J NEUROSURG, V76, P119, DOI 10.3171/jns.1992.76.1.0119
   Spilker MH, 1997, TISSUE ENG, V3, P309, DOI 10.1089/ten.1997.3.309
   Sun LX, 2004, J CLIN INVEST, V113, P1364, DOI 10.1172/JCI200420001
   Sun XD, 2009, BIOMATERIALS, V30, P1222, DOI 10.1016/j.biomaterials.2008.10.020
   Tang SQ, 2007, J BIOMED MATER RES A, V82A, P323, DOI 10.1002/jbm.a.30974
   Tian WM, 2009, BIOMED MATER, V4, DOI 10.1088/1748-6041/4/1/015010
   Tian WM, 2005, TISSUE ENG, V11, P513, DOI 10.1089/ten.2005.11.513
   Vargas ME, 2007, ANNU REV NEUROSCI, V30, P153, DOI 10.1146/annurev.neuro.30.051606.094354
   Vickers SM, 2006, TISSUE ENG, V12, P1345, DOI 10.1089/ten.2006.12.1345
   Wang TW, 2009, ACTA BIOMATER, V5, P2371, DOI 10.1016/j.actbio.2009.03.033
   Wei G, 2010, J NEUROTRAUM, V27, P1635, DOI 10.1089/neu.2010.1378
   Wei HH, 2009, J NEUROINFLAMM, V6, DOI 10.1186/1742-2094-6-19
   Williams AJ, 2005, J NEUROTRAUM, V22, P313, DOI 10.1089/neu.2005.22.313
   Williams AJ, 2007, J NEUROINFLAMM, V4, DOI 10.1186/1742-2094-4-17
   Williams AJ, 2006, NEUROSCI LETT, V408, P183, DOI 10.1016/j.neulet.2006.08.086
   Williams AJ, 2006, J NEUROTRAUM, V23, P1828, DOI 10.1089/neu.2006.23.1828
   WOERLY S, 1992, J NEURAL TRANSP PLAS, V3, P21, DOI 10.1155/NP.1992.21
   Woerly S, 1999, TISSUE ENG, V5, P467, DOI 10.1089/ten.1999.5.467
   Wong DY, 2008, J NEUROSURG, V109, P715, DOI 10.3171/JNS/2008/109/10/0715
   Wong DY, 2007, TISSUE ENG, V13, P2515, DOI 10.1089/ten.2006.0440
   Yamashita T, 2006, J NEUROSCI, V26, P6627, DOI 10.1523/JNEUROSCI.0149-06.2006
   Yannas IV, 2005, J R SOC INTERFACE, V2, P403, DOI 10.1098/rsif.2005.0062
   Zhang C, 2005, J NEUROTRAUM, V22, P1456, DOI 10.1089/neu.2005.22.1456
   Zhang HZ, 2007, BRAIN RES, V1132, P29, DOI 10.1016/j.brainres.2006.09.117
   Zhang JY, 2007, J BIOMECH, V40, P2341, DOI 10.1016/j.jbiomech.2006.10.021
   Zhang JY, 2005, J NEUROTRAUM, V22, P1335, DOI 10.1089/neu.2005.22.1335
NR 77
TC 6
Z9 6
U1 0
U2 6
PU MARY ANN LIEBERT INC
PI NEW ROCHELLE
PA 140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA
SN 0897-7151
J9 J NEUROTRAUM
JI J. Neurotrauma
PD JUL
PY 2012
VL 29
IS 11
BP 2086
EP 2102
DI 10.1089/neu.2011.2181
PG 17
WC Critical Care Medicine; Clinical Neurology; Neurosciences
SC General & Internal Medicine; Neurosciences & Neurology
GA 983CX
UT WOS:000307095800009
PM 22519932
DA 2018-10-19
ER

PT J
AU Matschegewski, C
   Staehlke, S
   Birkholz, H
   Lange, R
   Beck, U
   Engel, K
   Nebe, JB
AF Matschegewski, Claudia
   Staehlke, Susanne
   Birkholz, Harald
   Lange, Regina
   Beck, Ulrich
   Engel, Konrad
   Nebe, J. Barbara
TI Automatic Actin Filament Quantification of Osteoblasts and Their
   Morphometric Analysis on Microtextured Silicon-Titanium Arrays
SO MATERIALS
LA English
DT Article
DE actin cytoskeleton; MG-63 osteoblasts; microtexturing; ridge detection;
   image processing
ID PHYSICOCHEMICAL CHARACTERISTICS; QUANTITATIVE-ANALYSIS;
   EXTRACELLULAR-MATRIX; REGULAR GEOMETRY; CELLS; SURFACES; ADHESION;
   TOPOGRAPHY; ATTACHMENT; ORGANIZATION
AB Microtexturing of implant surfaces is of major relevance in the endeavor to improve biorelevant implant designs. In order to elucidate the role of biomaterial's topography on cell physiology, obtaining quantitative correlations between cellular behavior and distinct microarchitectural properties is in great demand. Until now, the microscopically observed reorganization of the cytoskeleton on structured biomaterials has been difficult to convert into data. We used geometrically microtextured silicon-titanium arrays as a model system. Samples were prepared by deep reactive-ion etching of silicon wafers, resulting in rectangular grooves (width and height: 2 mu m) and cubic pillars (pillar dimensions: 2 x 2 x 5 and 5 x 5 x 5 mu m); finally sputter-coated with 100 nm titanium. We focused on the morphometric analysis of MG-63 osteoblasts, including a quantification of the actin cytoskeleton. By means of our novel software FilaQuant, especially developed for automatic actin filament recognition, we were first able to quantify the alterations of the actin network dependent on the microtexture of a material surface. The cells' actin fibers were significantly reduced in length on the pillared surfaces versus the grooved array (4-5 fold) and completely reorganized on the micropillars, but without altering the orientation of cells. Our morpho-functional approach opens new possibilities for the data correlation of cell-material interactions.
C1 [Matschegewski, Claudia; Staehlke, Susanne; Nebe, J. Barbara] Univ Rostock, Biomed Res Ctr, Dept Cell Biol, D-18057 Rostock, Germany.
   [Birkholz, Harald; Engel, Konrad] Univ Rostock, Inst Math, D-18057 Rostock, Germany.
   [Lange, Regina; Beck, Ulrich] Univ Rostock, Dept Elect Engn & Informat, D-18059 Rostock, Germany.
RP Nebe, JB (reprint author), Univ Rostock, Biomed Res Ctr, Dept Cell Biol, Schillingallee 69, D-18057 Rostock, Germany.
EM claudia.matschegewski@uni-rostock.de; susanne.staehlke@uni-rostock.de;
   harald.birkholz@uni-rostock.de; regina.lange@uni-rostock.de;
   ulrich.beck@uni-rostock.de; konrad.engel@uni-rostock.de;
   barbara.nebe@med.uni-rostock.de
RI Nebe, Barbara/C-3577-2015
OI Nebe, Barbara/0000-0003-2662-0905
FU German Research Foundation (DFG) [NE 560/7-2, BE 2362/2-2]; DFG
   graduated school welisa [1505/1]
FX We appreciate the financial support of CM, SS and RL of the German
   Research Foundation (DFG) (NE 560/7-2, BE 2362/2-2) as well as of the
   DFG graduated school welisa (1505/1).
CR Anselme K, 2006, BIOMATERIALS, V27, P1187, DOI 10.1016/j.biomaterials.2005.10.009
   Anselme K, 2002, J BIOMED MATER RES, V60, P529, DOI 10.1002/jbm.10101
   Beil M, 2005, J MICROSC-OXFORD, V220, P84, DOI 10.1111/j.1365-2818.2005.01505.x
   Biggs MJP, 2007, J MATER SCI-MATER M, V18, P399, DOI 10.1007/s10856-006-0705-6
   Birkholz H, 2010, IFMBE PROC, V25, P1932
   Birkholz H., 2011, P SPIE
   Birkholz H, 2011, J COMPUT APPL MATH, V235, P2502, DOI 10.1016/j.cam.2010.11.003
   CLARK EA, 1995, SCIENCE, V268, P233, DOI 10.1126/science.7716514
   Curtis ASG, 2006, J R SOC INTERFACE, V3, P393, DOI 10.1098/rsif.2005.0104
   Curtis ASG, 1998, J BIOMAT SCI-POLYM E, V9, P1313, DOI 10.1163/156856298X00415
   Eberly D., 1994, J MATH IMAGING VIS, V4, P351
   Giljean S, 2010, J BIOMED MATER RES A, V94A, P1111, DOI 10.1002/jbm.a.32793
   Gonzalez RC, 2008, DIGITAL IMAGE PROCES
   Hayes JS, 2010, EUR CELLS MATER, V20, P98
   HUNTER A, 1995, BIOMATERIALS, V16, P287, DOI 10.1016/0142-9612(95)93256-D
   Ismail FSM, 2007, J MATER SCI-MATER M, V18, P705, DOI 10.1007/s10856-006-0012-2
   Jager M, 2007, J BIOMED BIOTECHNOL, DOI 10.1155/2007/69036
   Kharitonova M.A., 2003, J CELL SCI, V117, P1955
   Krzysiek-Maczka G, 2010, FOLIA BIOL-KRAKOW, V58, P21, DOI 10.3409/fb58_1-2.21-27
   LAERMER F, 1994, Patent No. 4241045C1
   Lange R, 2010, SURF INTERFACE ANAL, V42, P497, DOI 10.1002/sia.3320
   Lange R, 2002, BIOMOL ENG, V19, P255, DOI 10.1016/S1389-0344(02)00047-3
   Lu X, 2003, J BIOMED MATER RES A, V66A, P677, DOI 10.1002/jbm.a.10022
   Luthen F, 2005, BIOMATERIALS, V26, P2423, DOI 10.1016/j.biomaterials.2004.07.054
   Marquez JP, 2006, INT J SOLIDS STRUCT, V43, P6413, DOI 10.1016/j.ijsolstr.2005.11.003
   Matschegewski C, 2010, BIOMATERIALS, V31, P5729, DOI 10.1016/j.biomaterials.2010.03.073
   MOONEY DJ, 1995, J CELL SCI, V108, P2311
   Nebe JGB, 2007, MACROMOL BIOSCI, V7, P567, DOI 10.1002/mabi.200600293
   Passeri G, 2010, CLIN ORAL IMPLAN RES, V21, P756, DOI 10.1111/j.1600-0501.2009.01906.x
   Senju Y, 2009, J BIOCHEM, V145, P137, DOI 10.1093/jb/mvn151
   Sjostrom T, 2011, APPL SURF SCI, V257, P4552, DOI 10.1016/j.apsusc.2010.11.064
   Stricker J, 2010, J BIOMECH, V43, P9, DOI 10.1016/j.jbiomech.2009.09.003
   Uggeri J, 2010, MICRON, V41, P210, DOI 10.1016/j.micron.2009.10.013
   Walboomers XF, 1999, J BIOMED MATER RES, V46, P212, DOI 10.1002/(SICI)1097-4636(199908)46:2<212::AID-JBM10>3.0.CO;2-Y
   Yang JY, 2009, J BIOMED MATER RES A, V90A, P629, DOI 10.1002/jbm.a.32130
   Zhao G, 2006, CLIN ORAL IMPLAN RES, V17, P258, DOI 10.1111/j.1600-0501.2005.01195.x
   Zinger O, 2005, BIOMATERIALS, V26, P1837, DOI 10.1016/j.biomaterials.2004.06.035
NR 37
TC 19
Z9 19
U1 0
U2 19
PU MDPI AG
PI BASEL
PA POSTFACH, CH-4005 BASEL, SWITZERLAND
SN 1996-1944
J9 MATERIALS
JI Materials
PD JUL
PY 2012
VL 5
IS 7
BP 1176
EP 1195
DI 10.3390/ma5071176
PG 20
WC Materials Science, Multidisciplinary
SC Materials Science
GA 978NQ
UT WOS:000306750400001
OA DOAJ Gold, Green Published
DA 2018-10-19
ER

PT J
AU Wattamwar, PP
   Biswal, D
   Cochran, DB
   Lyvers, AC
   Eitel, RE
   Anderson, KW
   Hilt, JZ
   Dziubla, TD
AF Wattamwar, Paritosh P.
   Biswal, Dipti
   Cochran, David B.
   Lyvers, Adam C.
   Eitel, Richard E.
   Anderson, Kimberly W.
   Hilt, J. Zach
   Dziubla, Thomas D.
TI Synthesis and characterization of poly(antioxidant beta-amino esters)
   for controlled release of polyphenolic antioxidants
SO ACTA BIOMATERIALIA
LA English
DT Article
DE Antioxidant polymers; Polyphenols; Oxidative stress; Curcumin;
   Biocompatibility
ID ENDOTHELIAL-CELLS; OXIDATIVE STRESS; IN-VIVO; POLYMERS; FLAVONOIDS;
   DELIVERY; 2',7'-DICHLOROFLUORESCIN; CYTOTOXICITY; ENVIRONMENT; APOPTOSIS
AB Attenuation of cellular oxidative stress, which plays a central role in biomaterial-induced inflammation, provides an exciting opportunity to control the host tissue response to biomaterials. In the case of biodegradable polymers, biomaterial-induced inflammation is often a result of local accumulation of polymer degradation products, hence there is a need for new biomaterials that can inhibit this response. Antioxidant polymers, which have antioxidants incorporated into the polymer backbone, are a class of biomaterials that, upon degradation, release active antioxidants, which can scavenge free radicals and attenuate oxidative stress, resulting in improved material biocompatibility. In this work, we have synthesized poly(antioxidant beta-amino ester) (PA beta AE) biodegradable hydrogels of two polyphenolic antioxidants, quercetin and curcumin. The degradation characteristics of PA beta AE hydrogels and the antioxidant activity of PA beta AE degradation products were studied. Treatment of endothelial cells with PA beta AE degradation products protected cells from hydrogen-peroxide-induced oxidative stress. (C) 2012 Acta Materialia Inc. Published by Elsevier Ltd. All rights reserved.
C1 [Wattamwar, Paritosh P.; Biswal, Dipti; Cochran, David B.; Lyvers, Adam C.; Eitel, Richard E.; Anderson, Kimberly W.; Hilt, J. Zach; Dziubla, Thomas D.] Univ Kentucky, Dept Chem & Mat Engn, Lexington, KY 40506 USA.
RP Dziubla, TD (reprint author), Univ Kentucky, Dept Chem & Mat Engn, 177 FP Anderson Tower, Lexington, KY 40506 USA.
EM dziubla@engr.uky.edu
RI Eitel, Richard/E-2889-2010
OI Eitel, Richard/0000-0002-5090-2075
FU Office of Naval Research (ONR DEPSCoR)
FX We gratefully acknowledge Dr. James. W. Geddes for access to the
   fluorescent spectrophotometer and Ranjana Singh for her help with the
   instrument. We are also grateful to the Department of Chemistry NMR
   facility. This work was supported by the Office of Naval Research (ONR
   DEPSCoR).
CR Aggarwal BB, 2009, TRENDS PHARMACOL SCI, V30, P85, DOI 10.1016/j.tips.2008.11.002
   Anderson DG, 2006, ADV MATER, V18, P2614, DOI 10.1002/adma.200600529
   Anderson DG, 2003, ANGEW CHEM INT EDIT, V42, P3153, DOI 10.1002/anie.200351244
   Badylak SF, 2008, TISSUE ENG PT A, V14, P1835, DOI 10.1089/ten.tea.2007.0264
   Bat E, 2010, J BIOMED MATER RES A, V95A, P940, DOI 10.1002/jbm.a.32921
   Biswal D, 2011, POLYMER, V52, P5985, DOI 10.1016/j.polymer.2011.10.058
   Boudreaux CJ, 1996, J CONTROL RELEASE, V40, P223, DOI 10.1016/0168-3659(95)00189-1
   Choi YJ, 2005, J NUTR, V135, P707
   Choi YJ, 2003, J NUTR, V133, P985
   Fleming C, 2005, NAT CHEM BIOL, V1, P270, DOI 10.1038/nchembio730
   Fu K, 2000, PHARMACEUT RES, V17, P100, DOI 10.1023/A:1007582911958
   Jiang WW, 2007, J BIOMED MATER RES A, V82A, P492, DOI 10.1002/jbm.a.31175
   KAPLAN SS, 1992, J BIOMED MATER RES, V26, P1039, DOI 10.1002/jbm.820260806
   LEBEL CP, 1992, CHEM RES TOXICOL, V5, P227, DOI 10.1021/tx00026a012
   Leonarduzzi G, 2010, CURR MED CHEM, V17, P74, DOI 10.2174/092986710789957760
   Li N, 2008, J AGR FOOD CHEM, V56, P3876, DOI 10.1021/jf073520n
   Liu WE, 2011, BIOMATERIALS, V32, P1796, DOI 10.1016/j.biomaterials.2010.11.029
   Matsuo M, 2005, BIOL PHARM BULL, V28, P253, DOI 10.1248/bpb.28.253
   Rota C, 1999, J BIOL CHEM, V274, P28161, DOI 10.1074/jbc.274.40.28161
   ROYALL JA, 1993, ARCH BIOCHEM BIOPHYS, V302, P348, DOI 10.1006/abbi.1993.1222
   Schmidt DR, 2007, J BIOMED MATER RES A, V83A, P617, DOI 10.1002/jbm.a.31270
   Spizzirri UG, 2009, BIOMACROMOLECULES, V10, P1923, DOI 10.1021/bm900325t
   Udipi K, 2000, J BIOMED MATER RES, V51, P549, DOI 10.1002/1097-4636(20000915)51:4<549::AID-JBM2>3.0.CO;2-Z
   Wachsberger PR, 2003, INT J HYPERTHER, V19, P507, DOI 10.1080/0265673031000078697
   Wang B, 2007, ANESTH ANALG, V105, P1027, DOI 10.1213/01.ane.0000281046.77228.91
   Wang YZ, 2006, BIOMATERIALS, V27, P3265, DOI 10.1016/j.biomaterials.2006.01.036
   Wattamwar PP, 2011, J BIOMED MATER RES A, V99A, P184, DOI 10.1002/jbm.a.33174
   Wattamwar PP, 2010, ADV FUNCT MATER, V20, P147, DOI 10.1002/adfm.200900839
   Williams SR, 2009, BIOMACROMOLECULES, V10, P155, DOI 10.1021/bm801058j
   Woo HB, 2005, BIOORG MED CHEM LETT, V15, P3782, DOI 10.1016/j.bmcl.2005.05.064
   Wrona M, 2008, FREE RADICAL BIO MED, V44, P56, DOI 10.1016/j.freeradbiomed.2007.09.005
NR 31
TC 31
Z9 31
U1 4
U2 30
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1742-7061
J9 ACTA BIOMATER
JI Acta Biomater.
PD JUL
PY 2012
VL 8
IS 7
BP 2529
EP 2537
DI 10.1016/j.actbio.2012.03.022
PG 9
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 974NK
UT WOS:000306442400011
PM 22426289
DA 2018-10-19
ER

PT J
AU Soman, P
   Lee, JW
   Phadke, A
   Varghese, S
   Chen, SC
AF Soman, Pranav
   Lee, Jin Woo
   Phadke, Ameya
   Varghese, Shyni
   Chen, Shaochen
TI Spatial tuning of negative and positive Poisson's ratio in a multi-layer
   scaffold
SO ACTA BIOMATERIALIA
LA English
DT Article
DE Poisson's ratio; Biomaterials; Tissue engineering; Porous scaffolds;
   Poly(ethylene) glycol
ID CELLULAR MATERIALS; MICROPOROUS MATERIALS; NONLINEAR PROPERTIES;
   MATERIALS SCIENCE; AUXETIC BEHAVIOR; DESIGN; MICROSTRUCTURE;
   DEFORMATIONS; FABRICATION; HONEYCOMBS
AB While elastic modulus is tunable in tissue engineering scaffolds, it is substantially more challenging to tune the Poisson's ratio of scaffolds. In certain biological applications, scaffolds with a tunable Poisson's ratio may be more suitable for emulating the behavior of native tissue mechanics. Here, we design and fabricate a scaffold, which exhibits simultaneous negative and positive Poisson's ratio behavior. Custom-made digital micro-mirror device stereolithography was used to fabricate single- and multiple-layer scaffolds using polyethylene glycol-based biomaterial. These scaffolds are composed of pore structures having special geometries, and deformation mechanisms, which can be tuned to exhibit both negative Poisson's ratio (NPR) and positive Poisson's ratio (PPR) behavior in a side-to-side or top-to-bottom configuration. Strain measurement results demonstrate that analytical deformation models and simulations accurately predict the Poisson's ratios of both the NPR and PPR regions. This hybrid Poisson's ratio property can be imparted to any photocurable material, and potentially be applicable in a variety of biomedical applications. (C) 2012 Acta Materialia Inc. Published by Elsevier Ltd. All rights reserved.
C1 [Soman, Pranav; Lee, Jin Woo; Chen, Shaochen] Univ Calif San Diego, Dept NanoEngn, La Jolla, CA 92093 USA.
   [Phadke, Ameya; Varghese, Shyni] Univ Calif San Diego, Dept Bioengn, La Jolla, CA 92093 USA.
RP Chen, SC (reprint author), Univ Calif San Diego, Dept NanoEngn, 9500 Gilman Dr,Atkinson Hall,MC 0448, La Jolla, CA 92093 USA.
EM chen168@ucsd.edu
FU National Institute of Biomedical Imaging and Bioengineering
   [R01EB012597]; National Science Foundation [CMMI-1130894]
FX The project described was supported by Award Number R01EB012597 from the
   National Institute of Biomedical Imaging and Bioengineering and a Grant
   (CMMI-1130894) from the National Science Foundation. We thank Intel's
   High Education Program for the computer support.
CR ALDERSON KL, 1992, POLYMER, V33, P4435, DOI 10.1016/0032-3861(92)90294-7
   ALMGREN RF, 1985, J ELASTICITY, V15, P427
   Baughman RH, 1998, SCIENCE, V279, P1522, DOI 10.1126/science.279.5356.1522
   Baughman RH, 2000, SCIENCE, V288, P2018, DOI 10.1126/science.288.5473.2018
   Baughman RH, 1998, NATURE, V392, P362, DOI 10.1038/32842
   BAUGHMAN RH, 1993, NATURE, V365, P735, DOI 10.1038/365735a0
   Blitterswijk C. V., 2008, TISSUE ENG
   BURNS S, 1987, SCIENCE, V238, P551, DOI 10.1126/science.238.4826.551
   Burriesci GP, 2007, ANNULOPLASTY PROSTHE
   CADDOCK BD, 1989, J PHYS D APPL PHYS, V22, P1877, DOI 10.1088/0022-3727/22/12/012
   Chen XG, 2009, J MECH BEHAV BIOMED, V2, P494, DOI 10.1016/j.jmbbm.2008.12.004
   CHOI JB, 1992, J MATER SCI, V27, P4678, DOI 10.1007/BF01166005
   CHOI JB, 1995, J COMPOS MATER, V29, P113, DOI 10.1177/002199839502900106
   CHOI JB, 1992, J MATER SCI, V27, P5375, DOI 10.1007/BF00553421
   Eisenstadt MM, 1971, INTRO MECH PROPERTIE
   Engler AJ, 2006, CELL, V126, P677, DOI 10.1016/j.cell.2006.06.044
   Evans KE, 2000, ADV MATER, V12, P617, DOI 10.1002/(SICI)1521-4095(200005)12:9<617::AID-ADMA617>3.0.CO;2-3
   EVANS KE, 1989, J PHYS D APPL PHYS, V22, P1883, DOI 10.1088/0022-3727/22/12/013
   EVANS KE, 1991, NATURE, V353, P124, DOI 10.1038/353124a0
   Fozdar DY, 2011, ADV FUNCT MATER, V21, P2712, DOI 10.1002/adfm.201002022
   GARDNER GB, 1995, NATURE, V374, P792, DOI 10.1038/374792a0
   Gaspar N, 2005, ACTA MATER, V53, P2439, DOI 10.1016/j.actamat.2005.02.006
   Gibson L. G., 1997, CELLULAR SOLIDS STRU
   GIBSON LJ, 1982, P ROY SOC LOND A MAT, V382, P25, DOI 10.1098/rspa.1982.0087
   GUNTON DJ, 1972, J MATER SCI, V7, P1061, DOI 10.1007/BF00550070
   Hall LJ, 2008, SCIENCE, V320, P504, DOI 10.1126/science.1149815
   Hwang YS, 2011, REGEN MED, V6, P505, DOI [10.2217/RME.11.38, 10.2217/rme.11.38]
   Jackman RJ, 1998, SCIENCE, V280, P2089, DOI 10.1126/science.280.5372.2089
   Jawad H, 2008, BRIT MED BULL, V87, P31, DOI 10.1093/bmb/ldn026
   KESKAR NR, 1992, NATURE, V358, P222, DOI 10.1038/358222a0
   Khademhosseini A, 2007, BIOMATERIALS, V28, P5087, DOI 10.1016/j.biomaterials.2007.07.021
   Lakes R, 2000, SCIENCE, V288, P1976, DOI 10.1126/science.288.5473.1976
   Lakes R, 2001, NATURE, V414, P503, DOI 10.1038/35107190
   LAKES R, 1987, SCIENCE, V235, P1038, DOI 10.1126/science.235.4792.1038
   Lin CY, 2004, J BIOMECH, V37, P623, DOI 10.1016/j.jbiomech.2003.09.029
   Masters IG, 1996, COMPOS STRUCT, V35, P403, DOI 10.1016/S0263-8223(96)00054-2
   MILTON GW, 1992, J MECH PHYS SOLIDS, V40, P1105, DOI 10.1016/0022-5096(92)90063-8
   ROTHENBURG L, 1991, NATURE, V354, P470, DOI 10.1038/354470a0
   Smith CW, 2000, ACTA MATER, V48, P4349, DOI 10.1016/S1359-6454(00)00269-X
   Teng CJ, 2006, J THORAC CARDIOV SUR, V132, P628, DOI 10.1016/j.jtcvs.2006.05.034
   Timmins LH, 2010, AM J PHYSIOL-HEART C, V298, pH1537, DOI 10.1152/ajpheart.00891.2009
   VERONDA DR, 1970, J BIOMECH, V3, P111, DOI 10.1016/0021-9290(70)90055-2
   Veronda DR, 1970, J BIOMECH, V3, P124
   Veronda DR, 1970, J BIOMECH, V3
   WILLIAMS JL, 1982, J BIOMECH ENG-T ASME, V104, P50, DOI 10.1115/1.3138303
NR 45
TC 28
Z9 28
U1 1
U2 44
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1742-7061
J9 ACTA BIOMATER
JI Acta Biomater.
PD JUL
PY 2012
VL 8
IS 7
BP 2587
EP 2594
DI 10.1016/j.actbio.2012.03.035
PG 8
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 974NK
UT WOS:000306442400017
PM 22465577
OA Green Accepted
DA 2018-10-19
ER

PT J
AU Lozano, D
   Feito, MJ
   Portal-Nunez, S
   Lozano, RM
   Matesanz, MC
   Serrano, MC
   Vallet-Regi, M
   Portoles, MT
   Esbrit, P
AF Lozano, Daniel
   Feito, Maria Jose
   Portal-Nunez, Sergio
   Lozano, Rosa Maria
   Matesanz, Maria Concepcion
   Serrano, Maria Concepcion
   Vallet-Regi, Maria
   Portoles, Maria Teresa
   Esbrit, Pedro
TI Osteostatin improves the osteogenic activity of fibroblast growth
   factor-2 immobilized in Si-doped hydroxyapatite in osteoblastic cells
SO ACTA BIOMATERIALIA
LA English
DT Article
DE Osteostatin; Fibroblast growth factor-2; Osteoblastic function;
   Parathyroid hormone-related protein; Si-based hydroxyapatite
ID HORMONE-RELATED PROTEIN; INHIBITS BONE-RESORPTION; PTHRP 107-139;
   SIGNALING PATHWAYS; ENDOTHELIAL-CELLS; IN-VITRO; DIFFERENTIATION;
   PROLIFERATION; ANGIOGENESIS; FGF-2
AB Si-doped hydroxyapatite (Si-HA) is a suitable ceramic for the controlled release of agents to improve bone repair. We recently showed that parathyroid hormone-related protein (PTHrP) (107-111) (osteostatin) has remarkable osteogenic features in various in vitro and in vivo systems. Fibroblast growth factor (FGF)-2 modulates osteoblastic function and induces angiogenesis, and can promote osteoblast adhesion and proliferation after immobilization on Si-HA. In the present study we examined whether osteostatin might improve the biological efficacy of FGF-2-coated Si-HA in osteoblastic MC3T3-E1 cells in vitro. We found that Si-HA/FGF-2 in the presence or absence of osteostatin (100 nM) similarly increased cell growth (by about 50%). However, addition of the latter peptide to Si-HA/FGF-2 significantly enhanced gene expression of Runx2, osteocalcin, vascular endothelial growth factor (VEGF) and the VEGF receptors 1 and 2, without significantly affecting that of FGF receptors in these cells. Moreover, secreted VEGF in the MC3T3-E1 cell conditioned medium, which induced the proliferation of pig endothelial-like cells, was also enhanced by these combined factors. The synergistic action of osteostatin and Si-HA/FGF-2 on the VEGF system was abrogated by a mitogen-activated protein kinase inhibitor (U0126) and by the calcium antagonist verapamil. This action was related to an enhancement of alkaline phosphatase activity and matrix mineralization in MC3T3-E1 cells, and also in primary human osteoblastic cells. These in vitro data show that osteostatin increases the osteogenic efficacy of a Si-HA/FGF-2 biomaterial by a mechanism involving mitogen-activated protein kinases and intracellular Ca2+. These findings provide an attractive strategy for bone tissue engineering. (C) 2012 Acta Materialia Inc. Published by Elsevier Ltd. All rights reserved.
C1 [Lozano, Daniel; Portal-Nunez, Sergio; Esbrit, Pedro] Inst Invest Sanitaria Fundac Jimenez Diaz, Lab Metab Mineral Oseo, Madrid, Spain.
   [Lozano, Daniel; Portal-Nunez, Sergio; Esbrit, Pedro] Inst Salud Carlos III RETICEF, Madrid, Spain.
   [Feito, Maria Jose; Matesanz, Maria Concepcion; Portoles, Maria Teresa] Univ Complutense, Dept Bioquim & Biol Mol I, E-28040 Madrid, Spain.
   [Lozano, Rosa Maria] CSIC, Ctr Invest Biol, Madrid, Spain.
   [Lozano, Rosa Maria] CSIC, Ctr Invest Biol, Dept Biol Quim Fis, Madrid, Spain.
   [Serrano, Maria Concepcion] CSIC, Inst Ciencia Mat, Grp Mat Bioinspirados, Madrid, Spain.
   [Vallet-Regi, Maria] Dept Quim Inorgan & Bioinorgan, Madrid, Spain.
RP Lozano, D (reprint author), Inst Invest Sanitaria Fundac Jimenez Diaz, Lab Metab Mineral Oseo, Madrid, Spain.
EM dlozano@fjd.es
RI Serrano, Maria Concepcion/D-7442-2014; Lozano, Daniel/B-5081-2017;
   Vallet-Regi, Maria/M-3378-2014; Portoles, Maria Teresa/U-1678-2017;
   Portal-Nunez, Sergio/L-7391-2014
OI Serrano, Maria Concepcion/0000-0002-5010-644X; Lozano,
   Daniel/0000-0001-5902-9201; Vallet-Regi, Maria/0000-0002-6104-4889;
   Portoles, Maria Teresa/0000-0002-9681-0184; Portal-Nunez,
   Sergio/0000-0003-0659-1545
FU Spanish Ministerio de Ciencia e Innovacion [PI080922, PI11/00449,
   RETICEF RD06/0013/1002, MAT2008-00736, MAT2008-06719-C03-02]; Fundacion
   de Investigacion Medica Mutua Madrilena; Comunidad Autonoma de Madrid
   [S2009 MAT-1472]
FX We are indebted to Dr. Laura Saldana (IdiPaz, Madrid) for providing
   primary hOB cells. This investigation was supported by grants from the
   Spanish Ministerio de Ciencia e Innovacion (PI080922, PI11/00449,
   RETICEF RD06/0013/1002, MAT2008-00736, and MAT2008-06719-C03-02),
   Fundacion de Investigacion Medica Mutua Madrilena, and Comunidad
   Autonoma de Madrid (S2009 MAT-1472).
CR Alonso V, 2008, J CELL PHYSIOL, V217, P717, DOI 10.1002/jcp.21547
   Arcos D, 2004, CHEM MATER, V16, P2300, DOI 10.1021/cm035337
   Bisello A, 2004, ENDOCRINOLOGY, V145, P3551, DOI 10.1210/en.2004-0509
   Bohner M, 2009, BIOMATERIALS, V30, P6403, DOI 10.1016/j.biomaterials.2009.08.007
   Boileau G, 2001, BIOCHEM J, V355, P707, DOI 10.1042/bj3550707
   Chau JFL, 2009, HISTOL HISTOPATHOL, V24, P1593, DOI 10.14670/HH-24.1593
   Chen FM, 2010, BIOMATERIALS, V31, P6279, DOI 10.1016/j.biomaterials.2010.04.053
   Cornish J, 1999, J BONE MINER RES, V14, P915, DOI 10.1359/jbmr.1999.14.6.915
   Cornish J, 1997, ENDOCRINOLOGY, V138, P1299, DOI 10.1210/en.138.3.1299
   Cuthbertson RM, 1999, BBA-PROTEIN STRUCT M, V1432, P64, DOI 10.1016/S0167-4838(99)00078-3
   Dailey L, 2005, CYTOKINE GROWTH F R, V16, P233, DOI 10.1016/j.cytogfr.2005.01.007
   de Gortazar AR, 2006, CALCIFIED TISSUE INT, V79, P360, DOI 10.1007/s00223-006-0099-y
   Matesanz MD, 2012, MACROMOL BIOSCI, V12, P446, DOI 10.1002/mabi.201100456
   Esbrit P, 2000, J AM SOC NEPHROL, V11, P1085
   Fei YR, 2011, J BIOL CHEM, V286, P40575, DOI 10.1074/jbc.M111.274910
   FENTON AJ, 1991, ENDOCRINOLOGY, V129, P1762, DOI 10.1210/endo-129-4-1762
   de Castro LF, 2012, J CELL PHYSIOL, V227, P1752, DOI 10.1002/jcp.22902
   Grellier M, 2009, J CELL BIOCHEM, V106, P390, DOI 10.1002/jcb.22018
   Haupt LM, 2009, J CELL PHYSIOL, V220, P780, DOI 10.1002/jcp.21825
   Hughes-Fulford M, 2011, J ORTHOP SURG RES, V6, DOI 10.1186/1749-799X-6-8
   Jacobsen KA, 2008, J BONE MINER RES, V23, P596, DOI 10.1359/JBMR.080103
   Feito MJ, 2011, J MATER SCI-MATER M, V22, P405, DOI 10.1007/s10856-010-4193-3
   Kyono A, 2012, J BONE MINER METAB, V30, P19, DOI 10.1007/s00774-011-0288-2
   Lazarous DF, 2001, CURR INTERV CARDIOL, V3, P213
   Lozano D, 2011, BRIT J PHARMACOL, V162, P1424, DOI 10.1111/j.1476-5381.2010.01155.x
   Lozano D, 2010, ACTA BIOMATER, V6, P797, DOI 10.1016/j.actbio.2009.08.033
   Luong LN, 2012, BIOMATERIALS, V33, P283, DOI 10.1016/j.biomaterials.2011.09.052
   Mabilleau G, 2008, BIOMATERIALS, V29, P1593, DOI 10.1016/j.biomaterials.2007.12.01
   Manzano M, 2011, ACTA BIOMATER, V7, P3555, DOI 10.1016/j.actbio.2011.06.004
   Marie PJ, 2003, GENE, V316, P23, DOI 10.1016/S0378-1119(03)00748-0
   Mayer H, 2005, J CELL BIOCHEM, V95, P827, DOI 10.1002/jcb.20462
   Nillesen STM, 2006, J CONTROL RELEASE, V116, pE88, DOI 10.1016/j.jconrel.2006.09.065
   Nillesen STM, 2007, BIOMATERIALS, V28, P1123, DOI 10.1016/j.biomaterials.2006.10.029
   Presta M, 2005, CYTOKINE GROWTH F R, V16, P159, DOI 10.1016/j.cytogfr.2005.01.004
   Serrano MC, 2008, J BIOMED MATER RES A, V87A, P964, DOI 10.1002/jbm.a.31728
   Shalhoub V, 2011, CALCIFIED TISSUE INT, V89, P140, DOI 10.1007/s00223-011-9501-5
   Towler DA, 2007, J CLIN INVEST, V117, P1477, DOI 10.1172/JCI32518
   Trejo CG, 2010, BIOMATERIALS, V31, P8564, DOI 10.1016/j.biomaterials.2010.07.103
   Valin A, 2001, ENDOCRINOLOGY, V142, P2752, DOI 10.1210/en.142.7.2752
   Vallet-Regi M, 2005, J MATER CHEM, V15, P1509, DOI 10.1039/b414143a
   Walenta K, 2005, BIOCHEM BIOPH RES CO, V333, P476, DOI 10.1016/j.bbrc.2005.05.153
   Wieghaus KA, 2006, TISSUE ENG, V12, P1903, DOI 10.1089/ten.2006.12.1903
   Xiao GZ, 2002, J BIOL CHEM, V277, P36181, DOI 10.1074/JBC.m206057200
NR 43
TC 27
Z9 29
U1 11
U2 38
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1742-7061
J9 ACTA BIOMATER
JI Acta Biomater.
PD JUL
PY 2012
VL 8
IS 7
BP 2770
EP 2777
DI 10.1016/j.actbio.2012.04.002
PG 8
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 974NK
UT WOS:000306442400036
PM 22487933
DA 2018-10-19
ER

PT J
AU Wenisch, S
   Cavalcanti-Adam, EA
   Tryankowski, E
   Raabe, O
   Kilian, O
   Heiss, C
   Alt, V
   Arnhold, S
   Schnettler, R
AF Wenisch, Sabine
   Cavalcanti-Adam, E. Ada
   Tryankowski, Eva
   Raabe, Oksana
   Kilian, Olaf
   Heiss, Christian
   Alt, Volker
   Arnhold, Stefan
   Schnettler, Reinhard
TI Light- and transmission-electron-microscopic investigations on
   distribution of CD44, connexin 43 and actin cytoskeleton during the
   foreign body reaction to a nanoparticular hydroxyapatite in mini-pigs
SO ACTA BIOMATERIALIA
LA English
DT Article
DE Biodegradation; Foreign body giant cells; Hydroxyapatite; Macrophage;
   TEM
ID MULTINUCLEATED GIANT-CELLS; GAP JUNCTION PROTEIN; OSTEOCLAST FUNCTION;
   MACROPHAGE FUSION; COMMUNICATION; EXPRESSION; DYNAMICS; BONE;
   PHOSPHORYLATION; MOLECULES
AB Foreign body giant cells (FBGCs) are formed by fusion of mononucleated macrophages during the foreign body response to a nanoparticulate hydroxyapatite (HA) implanted in defects of mini-pig femura. The molecular mechanisms underlying the formation of FBGCs are still largely obscure. Here we propose connexin 43 (cx43) and CD44 as candidate molecules involved in the fusion process. Immunohistochemistry and ultrastructural immunogold labeling indicated that cx43 is present within the ruffled border of FBGCs and is the main component of gap junctions formed between fusing macrophages. CD44 was strongly expressed during clustering and fusion of mononucleated macrophages. FBGCs adhering apically at the implanted HA showed CD44 reactivity only along the basolateral aspects of the plasma membranes, while podosome formation was observed within the sealing zone and ruffled border. Taken together, these findings demonstrate that cx43 and CD44 are part of the fusion machinery responsible for the formation of FBGCs. Furthermore, the results of microfilament and cx43 labeling suggest a functional role for podosomes and hemi-channels in biomaterial degradation. (C) 2012 Acta Materialia Inc. Published by Elsevier Ltd. All rights reserved.
C1 [Wenisch, Sabine; Tryankowski, Eva; Raabe, Oksana; Arnhold, Stefan] Univ Giessen, Inst Vet Anat, D-35392 Giessen, Germany.
   [Cavalcanti-Adam, E. Ada] Univ Heidelberg, Dept Biophys Chem, D-69120 Heidelberg, Germany.
   [Kilian, Olaf; Heiss, Christian; Alt, Volker; Schnettler, Reinhard] Univ Giessen, D-35394 Giessen, Germany.
   [Heiss, Christian; Alt, Volker; Schnettler, Reinhard] Univ Giessen, Dept Trauma Surg, D-35385 Giessen, Germany.
RP Wenisch, S (reprint author), Univ Giessen, Inst Vet Anat, D-35392 Giessen, Germany.
EM sabine.wenisch@vetmed.uni-giessen.de
OI Cavalcanti-Adam, Elisabetta/0000-0003-0243-1552
FU DFG (Collaborative Research Center) [TR79]
FX We thank Anne Hild for excellent technical assistance, and Dr. Katja
   Hose for helpful discussion on connexin 43. This work was supported by a
   grant from the DFG (Collaborative Research Center TR79).
CR Akisaka T, 2003, J ELECTRON MICROSC, V52, P535, DOI 10.1093/jmicro/52.6.535
   Akisaka T, 2008, CELL TISSUE RES, V331, P625, DOI 10.1007/s00441-007-0552-x
   Anderson JM, 2008, SEMIN IMMUNOL, V20, P86, DOI 10.1016/j.smim.2007.11.004
   Anderson JM, 2001, ANNU REV MATER RES, V31, P81, DOI 10.1146/annurev.matsci.31.1.81
   Anderson JM, 2000, CURR OPIN HEMATOL, V7, P40, DOI 10.1097/00062752-200001000-00008
   Bonnema H, 2003, J BIOMED MATER RES A, V64A, P502, DOI 10.1002/jbm.a.10404
   Chabadel A, 2007, MOL BIOL CELL, V18, P4899, DOI 10.1091/mbc.E07-04-0378
   Cui WG, 2006, BLOOD, V107, P796, DOI 10.1182/blood-2005-05-1902
   Eugenin EA, 2003, J IMMUNOL, V170, P1320, DOI 10.4049/jimmunol.170.3.1320
   Evans JG, 2006, EUR J CELL BIOL, V85, P145, DOI 10.1016/j.ejcb.2005.08.006
   FALK MM, 1994, J CELL BIOL, V127, P343, DOI 10.1083/jcb.127.2.343
   Fuller K, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012837
   Herde K, 2007, BIOMATERIALS, V28, P4912, DOI 10.1016/j.biomaterials.2007.07.027
   Ilvesaro J, 2003, CRIT REV EUKAR GENE, V13, P133
   Ilvesaro J, 2000, J BONE MINER RES, V15, P919, DOI 10.1359/jbmr.2000.15.5.919
   Ilvesaro J, 2001, BMC MUSCULOSKEL DIS, P2
   Ishii M, 2008, MOD RHEUMATOL, V18, P220, DOI 10.1007/s10165-008-0051-2
   Jiang JX, 2007, FRONT BIOSCI-LANDMRK, V12, P1450, DOI 10.2741/2159
   Jordan K, 2001, J CELL SCI, V114, P763
   Jurdic P, 2006, EUR J CELL BIOL, V85, P195, DOI 10.1016/j.ejcb.2005.09.008
   Kjenseth A, 2010, CELL SIGNAL, V22, P1267, DOI 10.1016/j.cellsig.2010.03.005
   LAIRD DW, 1991, BIOCHEM J, V273, P67, DOI 10.1042/bj2730067
   Leithe E, 2006, BIOCHEM J, V393, P59, DOI 10.1042/BJ20050674
   Luxenburg C, 2006, EUR J CELL BIOL, V85, P203, DOI 10.1016/j.ejcb.2005.11.002
   Luxenburg C, 2007, PLOS ONE, V31, pe179
   Matemba SF, 2006, J CELL BIOCHEM, V99, P528, DOI 10.1002/jcb.20866
   Most J, 1997, BLOOD, V89, P662
   MUSIL LS, 1990, J CELL BIOL, V111, P2077, DOI 10.1083/jcb.111.5.2077
   MUSIL LS, 1993, CELL, V74, P1065, DOI 10.1016/0092-8674(93)90728-9
   Ponta H, 2003, NAT REV MOL CELL BIO, V4, P33, DOI 10.1038/nrm1004
   Saltel F, 2008, EUR J CELL BIOL, V87, P459, DOI 10.1016/j.ejcb.2008.01.001
   Samanna V, 2007, J CELL PHYSIOL, V213, P710, DOI 10.1002/jcp.21137
   Stains JP, 2005, BBA-BIOMEMBRANES, V1719, P69, DOI 10.1016/j.bbamem.2005.10.012
   Sterling H, 1998, J CELL BIOL, V143, P837, DOI 10.1083/jcb.143.3.837
   Tadic D, 2004, BIOMATERIALS, V25, P987, DOI 10.1016/S0142-9612(03)00621-5
   Tadic D, 2002, BIOMATERIALS, V23, P2553, DOI 10.1016/S0142-9612(01)00390-8
   Vignery A, 2005, J EXP MED, V202, P337, DOI 10.1084/jem.20051123
   Vignery A, 2000, INT J EXP PATHOL, V81, P291, DOI 10.1046/j.1365-2613.2000.00164.x
   Yeager M, 1998, CURR OPIN STRUC BIOL, V8, P517, DOI 10.1016/S0959-440X(98)80131-0
NR 39
TC 2
Z9 2
U1 0
U2 10
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1742-7061
J9 ACTA BIOMATER
JI Acta Biomater.
PD JUL
PY 2012
VL 8
IS 7
BP 2807
EP 2814
DI 10.1016/j.actbio.2012.03.039
PG 8
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 974NK
UT WOS:000306442400040
PM 22470101
DA 2018-10-19
ER

PT J
AU Swierczewska, M
   Choi, KY
   Mertz, EL
   Huang, XL
   Zhang, F
   Zhu, L
   Yoon, HY
   Park, JH
   Bhirde, A
   Lee, S
   Chen, XY
AF Swierczewska, Magdalena
   Choi, Ki Young
   Mertz, Edward L.
   Huang, Xinglu
   Zhang, Fan
   Zhu, Lei
   Yoon, Hong Yeol
   Park, Jae Hyung
   Bhirde, Ashwinkumar
   Lee, Seulki
   Chen, Xiaoyuan
TI A Facile, One-Step Nanocarbon Functionalization for Biomedical
   Applications
SO NANO LETTERS
LA English
DT Article
DE Carbon nanomaterials; one-step functionalization; hyaluronic acid;
   nanotubes; molecular imaging
ID WALLED CARBON NANOTUBES; RAMAN-SPECTROSCOPY; HYALURONIC-ACID; LIVING
   MICE; BIOSENSORS; MOLECULE; AGENTS; CD44
AB Despite their immense potential in biomedicine, carbon nanomaterials suffer from inefficient dispersion and biological activity in vivo. Here we utilize a single, yet multifunctional, hyaluronic acid-based biosurfactant to simultaneously disperse nanocarbons and target single-walled carbon nanotubes (SWCNTs) to CD44 receptor positive tumor cells with prompt uptake. Cellular uptake was monitored by intracellular enzyme-activated fluorescence, and localization of SWCNTs within cells was further confirmed by Raman mapping. In vivo photoacoustic, fluorescence, and positron emission tomography imaging of coated SWCNTs display high tumor targeting capability while providing long-term, fluorescence molecular imaging of targeted enzyme events. By utilizing a single biomaterial surfactant for SWCNT dispersion without additional bioconjugation, we designed a facile technique that brings nanocarbons closer to their biomedical potential.
C1 [Swierczewska, Magdalena; Choi, Ki Young; Huang, Xinglu; Zhang, Fan; Zhu, Lei; Bhirde, Ashwinkumar; Lee, Seulki; Chen, Xiaoyuan] NIBIB, LOMIN, NIH, Bethesda, MD 20892 USA.
   [Swierczewska, Magdalena] SUNY Stony Brook, Dept Biomed Engn, Stony Brook, NY 11794 USA.
   [Mertz, Edward L.] Eunice Kennedy Shriver Natl Inst Child Hlth & Hum, Sect Phys Biochem, Off Sci Director, NIH, Bethesda, MD 20892 USA.
   [Zhu, Lei] Xiamen Univ, Sch Publ Hlth, Ctr Mol Imaging & Translat Med, Xiamen 361000, Peoples R China.
   [Yoon, Hong Yeol; Park, Jae Hyung] Sungkyunkwan Univ, Dept Polymer Sci & Engn, Suwon, South Korea.
RP Lee, S (reprint author), NIBIB, LOMIN, NIH, Bethesda, MD 20892 USA.
EM seulki.lee@nih.gov; shawn.chen@nih.gov
RI CHOI, KI YOUNG/Q-7177-2016; byun, jaehyun/G-5584-2014; Zhu,
   Lei/P-9786-2016; Yoon, Hong Yeol/A-2413-2016; Yoon, Hong
   Yeol/D-4005-2017; Park, Jae Hyung/B-5967-2018
OI CHOI, KI YOUNG/0000-0002-4207-2665; Zhu, Lei/0000-0002-1820-4795; Yoon,
   Hong Yeol/0000-0003-3242-3633; 
FU National Institute of Biomedical Imaging and Bioengineering (NIBIB);
   National Institute of Child Health and Human Development (NICHD);
   National Institutes of Health (NIH); National Science Foundation of
   China (NSFC) [81028009]; Chinese Academy of Sciences [2011T2J06]; Henry
   M. Jackson Foundation; NIH [K99/R00]
FX This work was supported by the Intramural Research Program (IRP) of the
   National Institute of Biomedical Imaging and Bioengineering (NIBIB) and
   of the National Institute of Child Health and Human Development (NICHD),
   National Institutes of Health (NIH), the International Cooperative
   Program of the National Science Foundation of China (NSFC) (81028009),
   Chinese Academy of Sciences professorship for Senior International
   Scientists (2011T2J06), Henry M. Jackson Foundation, and partially
   supported by an NIH Pathway to Independence (K99/R00) Award. The authors
   thank the input of Dr. Albert Jin for his AFM work, Dr. Guofeng Zhang
   for his TEM expertise, Dr. John Sun of VisualSonics for his great effort
   with photoacoustic imaging, and Ms. Myung Sun Lee for illustrations.
CR Alivisatos P, 2004, NAT BIOTECHNOL, V22, P47, DOI 10.1038/nbt927
   Baughman RH, 2002, SCIENCE, V297, P787, DOI 10.1126/science.1060928
   Besteman K, 2003, NANO LETT, V3, P727, DOI 10.1021/nl034139u
   Chen RJ, 2003, P NATL ACAD SCI USA, V100, P4984, DOI 10.1073/pnas.0837064100
   Choi KY, 2012, COLLOID SURFACE B, V99, P82, DOI 10.1016/j.colsurfb.2011.10.029
   Choi KY, 2011, ACS NANO, V5, P8591, DOI 10.1021/nn202070n
   Choi KY, 2010, BIOMATERIALS, V31, P106, DOI 10.1016/j.biomaterials.2009.09.030
   Correa-Duarte MA, 2004, NANO LETT, V4, P2233, DOI 10.1021/nl048574f
   Dai HJ, 2002, SURF SCI, V500, P218, DOI 10.1016/S0039-6028(01)01558-8
   De La Zerda A, 2008, NAT NANOTECHNOL, V3, P557, DOI 10.1038/nnano.2008.231
   Harrison BS, 2007, BIOMATERIALS, V28, P344, DOI 10.1016/j.biomaterials.2006.07.044
   Heller DA, 2005, ADV MATER, V17, P2793, DOI 10.1002/adma.200500477
   Kam NWS, 2005, P NATL ACAD SCI USA, V102, P11600, DOI 10.1073/pnas.0502680102
   Karousis N, 2010, CHEM REV, V110, P5366, DOI 10.1021/cr100018g
   Keren S, 2008, P NATL ACAD SCI USA, V105, P5844, DOI 10.1073/pnas.0710575105
   Liu G., 2012, ANGEW CHEM INT EDIT, V51, P558
   Liu Z, 2008, CANCER RES, V68, P6652, DOI 10.1158/0008-5472.CAN-08-1468
   Liu Z, 2008, P NATL ACAD SCI USA, V105, P1410, DOI 10.1073/pnas.0707654105
   Liu Z, 2007, NAT NANOTECHNOL, V2, P47, DOI 10.1038/nnano.2006.170
   Liu Z, 2009, NAT PROTOC, V4, P1372, DOI 10.1038/nprot.2009.146
   Moulton SE, 2007, J AM CHEM SOC, V129, P9452, DOI 10.1021/ja072160h
   Ponta H, 2003, NAT REV MOL CELL BIO, V4, P33, DOI 10.1038/nrm1004
   Razal JM, 2008, ADV FUNCT MATER, V18, P61, DOI 10.1002/adfm.200700822
   Tasis D, 2006, CHEM REV, V106, P1105, DOI 10.1021/cr050569o
   Yang ST, 2012, THERANOSTICS, V2, P271, DOI 10.7150/thno.3618
   Zavaleta C, 2008, NANO LETT, V8, P2800, DOI 10.1021/nl801362a
   Zoller M, 2011, NAT REV CANCER, V11, P254, DOI 10.1038/nrc3023
NR 27
TC 51
Z9 53
U1 5
U2 87
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 1530-6984
J9 NANO LETT
JI Nano Lett.
PD JUL
PY 2012
VL 12
IS 7
BP 3613
EP 3620
DI 10.1021/nl301309g
PG 8
WC Chemistry, Multidisciplinary; Chemistry, Physical; Nanoscience &
   Nanotechnology; Materials Science, Multidisciplinary; Physics, Applied;
   Physics, Condensed Matter
SC Chemistry; Science & Technology - Other Topics; Materials Science;
   Physics
GA 972QY
UT WOS:000306296200044
PM 22694219
OA Green Accepted
DA 2018-10-19
ER

PT J
AU Biswas, N
   Dey, A
   Mukhopadhyay, AK
AF Biswas, N.
   Dey, A.
   Mukhopadhyay, A. K.
TI Loading rate effect on nanohardness of human enamel
SO INDIAN JOURNAL OF PHYSICS
LA English
DT Article
DE Nanoindentation; Nanohardness; Loading rate; Enamel
ID LIME-SILICA GLASS; BULK METALLIC GLASSES; MECHANICAL-PROPERTIES;
   PLASTIC-DEFORMATION; SINGLE-CRYSTAL; THIN-FILMS; POP-IN;
   NANOINDENTATION; BEHAVIOR; INDENTATION
AB In the present work, nanoindentation technique has been utilised to study the physics of deformation at the scale of micro/nano-structure of tooth enamel which is basically the hardest natural biomaterial in the human body comprising of a hybrid combination of hydroxypatite ceramic nano-crystal and organic-protein matrix. We have observed about 8 % increase in the nanohardness of human enamel with the increase in loading rate from similar to 1 x 10(3) mu N s(-1) to 3 x 10(5) mu N s(-1). The results have been explained in terms of the maximum shear stress generated underneath the nanoindenter.
C1 [Biswas, N.; Mukhopadhyay, A. K.] CSIR, Cent Glass & Ceram Res Inst, Mech Property Evaluat Sect, Kolkata 700032, India.
   [Dey, A.] ISRO, Satellite Ctr, Thermal Syst Grp, Bangalore 560017, Karnataka, India.
RP Mukhopadhyay, AK (reprint author), CSIR, Cent Glass & Ceram Res Inst, Mech Property Evaluat Sect, Kolkata 700032, India.
EM anoopmukherjee@cgcri.res.in
OI Dey, Arjun/0000-0003-3727-3056
FU CSIR [NWP 0027]
FX Permission of Director, CSIR-CGCRI, Kolkata to publish this work and
   financial supports of CSIR (Project No. NWP 0027) are gratefully
   acknowledged. The author AD also acknowledges the constant encouragement
   from Director, ISAC, Bangalore.
CR Ang SF, 2010, BIOMATERIALS, V31, P1955, DOI 10.1016/j.biomaterials.2009.11.045
   Barnoush A, 2010, SCRIPTA MATER, V63, P465, DOI 10.1016/j.scriptamat.2010.04.048
   Berke PZ, 2012, TRIBOL INT, V47, P167, DOI 10.1016/j.triboint.2011.10.020
   Bhaskar S N, 1997, ORBANS ORAL HISTOLOG
   Bradby J E, 2002, APPL PHYS LETT, V80, P3
   Chakraborty R, 2010, PHYS CHEM GLASSES-B, V51, P293
   Chakraborty R, 2010, METALL MATER TRANS A, V41A, P1301, DOI 10.1007/s11661-010-0176-8
   Chang L, 2009, MAT SCI ENG A-STRUCT, V506, P125, DOI 10.1016/j.msea.2008.11.021
   Choi I C, 2012, SCR MAT
   Cuy JL, 2002, ARCH ORAL BIOL, V47, P281, DOI 10.1016/S0003-9969(02)00006-7
   de la R Fox N, 2007, J EUR CERAM SOC, V27, P3311
   Devi S, 2010, INDIAN J PHYS, V84, P1561, DOI 10.1007/s12648-010-0142-8
   Dey A, 2011, INT J APPL GLASS SCI, V2, P155
   Dey A, 2011, J NON-CRYST SOLIDS, V357, P2934, DOI 10.1016/j.jnoncrysol.2011.03.036
   Ge J, 2005, BIOMATERIALS, V26, P3333, DOI 10.1016/j.biomaterials.2004.07.059
   Gerberich WW, 1996, ACTA MATER, V44, P3585, DOI 10.1016/1359-6454(96)00010-9
   Golovin YI, 2002, PHILOS MAG A, V82, P1857, DOI 10.1080/01418610210133496
   Gouldstone A, 2000, ACTA MATER, V48, P2277, DOI 10.1016/S1359-6454(00)00009-4
   Guicciardi S, 2010, J EUR CERAM SOC, V30, P1027, DOI 10.1016/j.jeurceramsoc.2009.10.014
   He JY, 2012, EXPRESS POLYM LETT, V6, P198, DOI 10.3144/expresspolymlett.2012.22
   Huang J, 2011, APPL PHYS LETT, V98, DOI 10.1063/1.3593381
   Jose F, 2011, MAT SCI ENG A-STRUCT, V528, P6438, DOI 10.1016/j.msea.2011.04.068
   Kalhor D, 2010, INDIAN J PHYS, V84, P539, DOI 10.1007/s12648-010-0040-0
   Kuan SY, 2011, SURF COAT TECH, V206, P1116, DOI 10.1016/j.surfcoat.2011.07.093
   Kucheyev SO, 2002, APPL PHYS LETT, V80, P956, DOI 10.1063/1.1448175
   Lippert F, 2004, EUR J ORAL SCI, V112, P61, DOI 10.1111/j.0909-8836.2004.00095.x
   Lucca DA, 2010, CIRP ANN-MANUF TECHN, V59, P803, DOI 10.1016/j.cirp.2010.05.009
   Luz GM, 2010, COMPOS SCI TECHNOL, V70, P1777, DOI 10.1016/j.compscitech.2010.05.013
   Mandal G, 2011, INDIAN J PHYS, V85, P1229, DOI 10.1007/s12648-011-0149-9
   Mann A. B., 1994, MATER RES SOC S P, V356, P271
   Mao WG, 2011, J EUR CERAM SOC, V31, P1865, DOI 10.1016/j.jeurceramsoc.2011.04.012
   Mao WG, 2011, SCRIPTA MATER, V65, P127, DOI 10.1016/j.scriptamat.2011.03.022
   Marwan S, 2009, INT J THEOR APPL MUL, V1, P1
   Meyers MA, 2008, PROG MATER SCI, V53, P1, DOI 10.1016/j.pmatsci.2007.05.002
   Mitra S, 2011, INDIAN J PHYS, V85, P649, DOI 10.1007/s12648-011-0067-x
   Mukhopadhyay NK, 2007, MAT SCI ENG A-STRUCT, V449, P954, DOI 10.1016/j.msea.2006.02.258
   Mukhopadhyay NK, 2006, INT MATER REV, V51, P209, DOI 10.1179/174328006X102475
   Nowak R, 1996, PHILOS MAG A, V74, P171, DOI 10.1080/01418619608239696
   OLIVER WC, 1992, J MATER RES, V7, P1564, DOI 10.1557/JMR.1992.1564
   Packard CE, 2007, ACTA MATER, V55, P5348, DOI 10.1016/j.actamat.2007.05.054
   Park E G, 2005, J BIOMED NANOTECHNOL, V1, p[18, 2005]
   Park S, 2008, J MATER SCI-MATER M, V19, P2317, DOI 10.1007/s10856-007-3340-y
   Poolthong S, 1998, J DENT MAT, V77, P1120
   Rabkin E, 2010, ACTA MATER, V58, P1589, DOI 10.1016/j.actamat.2009.11.002
   Richter A, 2009, MICRON, V40, P94, DOI 10.1016/j.micron.2008.01.002
   Roa JJ, 2011, THIN SOLID FILMS, V519, P2470, DOI 10.1016/j.tsf.2010.12.101
   Sajan D, 2011, INDIAN J PHYS, V85, P477, DOI 10.1007/s12648-011-0054-2
   SAMANDARI SS, 2009, ACTA BIOMATER, V5, P2206
   Sarmah S, 2011, INDIAN J PHYS, V85, P713, DOI 10.1007/s12648-011-0071-1
   Sarmah S, 2010, INDIAN J PHYS, V84, P1211, DOI 10.1007/s12648-010-0109-9
   Schuh CA, 2003, ACTA MATER, V51, P87, DOI 10.1016/S1359-6454(02)00303-8
   Schuh CA, 2006, MATER TODAY, V9, P32, DOI 10.1016/S1369-7021(06)71495-X
   Shang HX, 2006, J MATER RES, V21, P632, DOI 10.1557/JMR.2006.0097
   Ubale AU, 2010, INDIAN J PHYS, V84, P1497, DOI 10.1007/s12648-010-0140-x
   Viswanath B, 2007, SCRIPTA MATER, V57, P361, DOI 10.1016/j.scriptamat.2007.04.027
   Wolf B, 2001, MAT SCI ENG A-STRUCT, V298, P284, DOI 10.1016/S0921-5093(00)01287-9
   Zamiri A, 2011, J MECH BEHAV BIOMED, V4, P146, DOI 10.1016/j.jmbbm.2010.11.001
   Zhang L, 2011, SCRIPTA MATER, V64, P919, DOI 10.1016/j.scriptamat.2011.01.037
   Zhao L, 2011, MAT SCI ENG A-STRUCT, V530, P196, DOI 10.1016/j.msea.2011.09.074
   Zhou JK, 2006, APPL PHYS LETT, V89, DOI 10.1063/1.2245439
   Zhou J, 2007, J BIOMED MATER RES A, V81A, P66, DOI 10.1002/jbm.a.31012
NR 61
TC 7
Z9 7
U1 0
U2 11
PU INDIAN ASSOC CULTIVATION SCIENCE
PI KOLKATA
PA INDIAN J PHYSICS, JADAVPUR, KOLKATA 700 032, INDIA
SN 0973-1458
EI 0974-9845
J9 INDIAN J PHYS
JI Indian J. Phys.
PD JUL
PY 2012
VL 86
IS 7
BP 569
EP 574
DI 10.1007/s12648-012-0088-0
PG 6
WC Physics, Multidisciplinary
SC Physics
GA 970JM
UT WOS:000306124200003
DA 2018-10-19
ER

PT J
AU Tran, NQ
   Joung, YK
   Choi, JH
   Park, KM
   Park, KD
AF Tran, Ngoc Q.
   Joung, Yoon K.
   Choi, Jong H.
   Park, Kyung M.
   Park, Ki D.
TI In situ-forming quercetin-conjugated heparin hydrogels for blood
   compatible and antiproliferative metal coating
SO JOURNAL OF BIOACTIVE AND COMPATIBLE POLYMERS
LA English
DT Article
DE Heparin; quercetin; hydrogel; blood compatibility; antiproliferation
   effect; coated metal surface; platlet adhesion; quercetin release;
   quercetin conjugated heparin; enzymatic preparation
ID IN-VITRO; ADHESION; STENT; RELEASE; POLYMER; POLYPHENOLS; ADSORPTION;
   RESTENOSIS; SURFACE; CELLS
AB In this study, in situ-forming quercetin-conjugated heparin hydrogels to be used to coat metal surfaces for blood compatibility were developed and characterized. Four units of quercetin and poly(ethylene glycol)-tyramine were conjugated per heparin for blood compatibility and hydrogel formation, respectively. The product, quercetin-conjugated heparin-poly(ethylene glycol)-tyramine, was cross-linked in situ via an enzymatic reaction using horseradish peroxidase and hydrogen peroxide to form a hydrogel. The physicochemical properties, such as the gelation time and swelling/degradation time as well as the release kinetics of quercetin, were controlled by changing the catalytic concentrations. The quercetin-conjugated heparin hydrogel, when adhered to a metal surface, enhanced blood compatibility and reduced platelet adhesion by 77%. The release of quercetin inhibited the proliferation of smooth muscle cells. The quercetin-conjugated heparin-poly(ethylene glycol)-tyramine hydrogel is a promising biomaterial with a stable-coated metal surface, with enhanced blood compatibility and antiproliferation effects.
C1 [Tran, Ngoc Q.; Joung, Yoon K.; Choi, Jong H.; Park, Kyung M.; Park, Ki D.] Ajou Univ, Grad Sch, Dept Mol Sci & Technol, Suwon 443749, South Korea.
   [Joung, Yoon K.] Korea Inst Sci & Technol, Ctr Biomat, Seoul, South Korea.
RP Park, KD (reprint author), Ajou Univ, Grad Sch, Dept Mol Sci & Technol, San 5, Suwon 443749, South Korea.
EM kdp@ajou.ac.kr
OI joung, yoon ki/0000-0001-8661-481X
FU Fundamental R&D Program for Core Technology of Materials; Ministry of
   Knowledge Economy, Republic of Korea [K0006028]; Ministry of Science &
   Technology, Republic of Korea [B020214]
FX This study was supported by a grant from the Fundamental R&D Program for
   Core Technology of Materials funded by the Ministry of Knowledge
   Economy, Republic of Korea (K0006028) and Nano-Biotechnology Project
   (Regenomics), Ministry of Science & Technology, Republic of Korea
   (B020214).
CR Aksoy EA, 2008, J BIOACT COMPAT POL, V23, P505, DOI 10.1177/0883911508097422
   Alcocer F, 2002, SURGERY, V131, P198, DOI 10.1067/msy.2002.119190
   Bayram C, 2010, BIOMED MATER, V5, DOI 10.1088/1748-6041/5/5/055007
   Boots AW, 2003, BIOCHEM BIOPH RES CO, V308, P560, DOI 10.1016/S0006-291X(03)01438-4
   Burke SA, 2007, BIOMED MATER, V2, P203, DOI 10.1088/1748-6041/2/4/001
   Chen YK, 2010, MATER SCI FORUM, V658, P511, DOI 10.4028/www.scientific.net/MSF.658.511
   Choi J, 2009, BIOMATERIALS, V30, P5201, DOI 10.1016/j.biomaterials.2009.06.003
   Clark TWI, 2009, CARDIOVASC INTER RAD, V32, P703, DOI 10.1007/s00270-009-9608-5
   Dugas TR, 2010, US Patent, Patent No. 331965
   Erlund I, 2004, NUTR RES, V24, P851, DOI 10.1016/j.nutres.2004.07.005
   Fan PS, 2001, ACTA PHARMACOL SIN, V22, P857
   Formica JV, 1995, FOOD CHEM TOXICOL, V33, P1061, DOI 10.1016/0278-6915(95)00077-1
   Goda T, 2007, COLLOID SURFACE B, V54, P67, DOI 10.1016/j.colsurfb.2006.09.006
   Grech JMR, 2008, J BIOACT COMPAT POL, V23, P367, DOI 10.1177/0883911508093389
   Guerrero JA, 2005, J THROMB HAEMOST, V3, P369, DOI 10.1111/j.1538-7836.2004.01099.x
   GUGLER R, 1975, EUR J CLIN PHARMACOL, V9, P229, DOI 10.1007/BF00614022
   Hayek T, 1997, ARTERIOSCL THROM VAS, V17, P2744, DOI 10.1161/01.ATV.17.11.2744
   Huang YY, 2010, BIOMATERIALS, V31, P4382, DOI 10.1016/j.biomaterials.2010.01.147
   Indolfi L, 2009, J MATER SCI-MATER M, V20, P1541, DOI 10.1007/s10856-009-3699-z
   Joung YK, 2012, COLLOID SURF B
   Kazmierska Katarzyna A., 2009, Recent Patents on Biomedical Engineering, V2, P1, DOI 10.2174/1874764710902010001
   Lee YK, 2007, BIOMATERIALS, V28, P1523, DOI 10.1016/j.biomaterials.2006.11.020
   Lih E, 2008, J BIOACT COMPAT POL, V23, P444, DOI 10.1177/0883911508095245
   Lipke EA, 2005, ACTA BIOMATER, V1, P597, DOI 10.1016/j.actbio.2005.07.010
   Mehran R, 2003, CIRCULATION, V108, P1078, DOI 10.1161/01.CIR.0000086347.31341.F9
   Moon SK, 2003, BIOCHEM BIOPH RES CO, V301, P1069, DOI 10.1016/S0006-291X(03)00091-3
   Park K, 2004, LANGMUIR, V20, P11726, DOI 10.1021/la048646i
   Park K, 2006, J CONTROL RELEASE, V114, P300, DOI 10.1016/j.jconrel.2006.05.017
   Peshkova S, 2003, J BIOTECHNOL, V102, P199, DOI 10.1016/S0168-1656(03)00026-9
   Silvestri D, 2009, J BIOMATER APPL, V24, P353, DOI 10.1177/0885328208095198
   Tran NQ, 2010, BIOMACROMOLECULES, V11, P617, DOI 10.1021/bm100047y
   van der Veen M, 2007, COLLOID SURFACE B, V54, P136, DOI 10.1016/j.colsurfb.2006.08.017
   Vreeland V, 1998, J PHYCOL, V34, P1, DOI 10.1046/j.1529-8817.1998.340001.x
   Welt FGP, 2002, ARTERIOSCL THROM VAS, V22, P1769, DOI 10.1161/01.ATV.0000037100.44766.5B
   Zilberman M, 2009, J BIOMATER APPL, V23, P385, DOI 10.1177/0885328207088261
NR 35
TC 3
Z9 3
U1 4
U2 23
PU SAGE PUBLICATIONS LTD
PI LONDON
PA 1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND
SN 0883-9115
J9 J BIOACT COMPAT POL
JI J. Bioact. Compat. Polym.
PD JUL
PY 2012
VL 27
IS 4
BP 313
EP 326
DI 10.1177/0883911512448246
PG 14
WC Biotechnology & Applied Microbiology; Materials Science, Biomaterials;
   Polymer Science
SC Biotechnology & Applied Microbiology; Materials Science; Polymer Science
GA 970NH
UT WOS:000306137300002
DA 2018-10-19
ER

PT J
AU Xiao, WQ
   Liu, WL
   Sun, J
   Dan, XL
   Wei, D
   Fan, HS
AF Xiao, Wenqian
   Liu, Wenlong
   Sun, Jing
   Dan, Xiuli
   Wei, Dan
   Fan, Hongsong
TI Ultrasonication and Genipin Cross-Linking to Prepare Novel Silk
   Fibroin-Gelatin Composite Hydrogel
SO JOURNAL OF BIOACTIVE AND COMPATIBLE POLYMERS
LA English
DT Article
DE Gelatin; hydrogels; silk; tissue engineering; ultrasonication; genipin
ID FIBROBLAST CELLS; HYBRID SCAFFOLD; HYALURONIC-ACID; PORE-SIZE; TISSUE;
   DELIVERY; POROSITY; GROWTH; DIFFERENTIATION; ENCAPSULATION
AB Hydrogels are highly desirable tissue engineering scaffolds due to their high water content and structural similarity to a natural extra cellular matrix. However, the extensive use of hydrogels is limited by their low strength and facile degradation. By combining mechanical integrity and slow degradation of silk fibroin with excellent bioactivity of gelatin, a novel biocompatible protein-based composite hydrogel of silk fibroin and gelatin was developed. The gelation of silk fibroin aqueous solution was accelerated by ultrasonication, and gelatin derived from porcine skin was immobilized into the hydrogel network by the silk fibroin beta-sheets. After that, genipin was used to post-cross-link the hydrogel to form a compact and stable hydrogel network. This hydrogel composite was a mechanically robust biomaterial with predictable long-term degradation characteristics. MG63 cells readily attached, spread, and proliferated on the surface of the hydrogels as demonstrated by fluorescein diacetate/propidium iodide staining and mitochondrial activity (3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl tetrazolium bromide) assay. Furthermore, the physicochemical and biological properties of hydrogel were fine-tunable by altering the ratio of silk fibroin and gelatin. The silk fibroin/gelatin composite hydrogels are anticipated to have the potential as cartilage or non-load-bearing bone tissue engineering and regeneration.
C1 [Xiao, Wenqian; Liu, Wenlong; Sun, Jing; Dan, Xiuli; Wei, Dan; Fan, Hongsong] Sichuan Univ, Natl Engn Res Ctr Biomat, Chengdu 610064, Sichuan, Peoples R China.
RP Fan, HS (reprint author), Sichuan Univ, Natl Engn Res Ctr Biomat, Chengdu 610064, Sichuan, Peoples R China.
EM hsfan@scu.edu.cn
OI Liu, Wenlong/0000-0002-8514-6812
FU National Natural Science Foundation of China [81071272]; National Basic
   Research Program of China [2011CB606201]
FX This study was supported by the National Natural Science Foundation of
   China (contract grant no. 81071272) and National Basic Research Program
   of China (contract grant no. 2011CB606201).
CR Anseth KS, 1996, BIOMATERIALS, V17, P1647, DOI 10.1016/0142-9612(96)87644-7
   Benton JA, 2009, TISSUE ENG PT A, V15, P3221, DOI [10.1089/ten.tea.2008.0545, 10.1089/ten.TEA.2008.0545]
   Drury JL, 2003, BIOMATERIALS, V24, P4337, DOI 10.1016/S0142-9612(03)00340-5
   Durmaz S, 2000, POLYMER, V41, P3693, DOI 10.1016/S0032-3861(99)00558-3
   Fan HB, 2008, BIOMATERIALS, V29, P1017, DOI 10.1016/j.biomaterials.2007.10.048
   Gil ES, 2006, BIOMACROMOLECULES, V7, P728, DOI 10.1021/bm050622i
   Gotoh Y, 1998, J BIOMED MATER RES, V39, P351, DOI 10.1002/(SICI)1097-4636(19980305)39:3<351::AID-JBM2>3.0.CO;2-I
   Griffith LG, 2002, SCIENCE, V295, P1009, DOI 10.1126/science.1069210
   Guziewicz N, 2011, BIOMATERIALS, V32, P2642, DOI 10.1016/j.biomaterials.2010.12.023
   Ha SW, 2005, BIOMACROMOLECULES, V6, P1722, DOI 10.1021/bm050010y
   Hoffman AS, 2002, ADV DRUG DELIVER REV, V54, P3, DOI 10.1016/S0169-409X(01)00239-3
   Horan RL, 2005, BIOMATERIALS, V26, P3385, DOI 10.1016/j.biomaterials.2004.09.020
   Hu K, 2007, J BIOACT COMPAT POL, V22, P395, DOI 10.1177/0883911507079893
   Hu XA, 2010, BIOMACROMOLECULES, V11, P3178, DOI 10.1021/bm1010504
   Jia XQ, 2009, MACROMOL BIOSCI, V9, P140, DOI 10.1002/mabi.200800284
   Karageorgiou V, 2005, BIOMATERIALS, V26, P5474, DOI 10.1016/j.biomaterials.2005.02.002
   Khademhosseini A, 2009, SCI AM, V300, P64, DOI 10.1038/scientificamerican0509-64
   Kim NR, 2009, ORAL SURG ORAL MED O, V107, pE54, DOI 10.1016/j.tripleo.2009.01.047
   Kim UJ, 2004, BIOMACROMOLECULES, V5, P786, DOI 10.1021/bm0345460
   LANGER R, 1993, SCIENCE, V260, P920, DOI 10.1126/science.8493529
   Lee KY, 2001, CHEM REV, V101, P1869, DOI 10.1021/cr000108x
   Leisk GG, 2010, ADV MATER, V22, P711, DOI 10.1002/adma.200902643
   Levental I, 2007, SOFT MATTER, V3, P299, DOI 10.1039/b610522j
   Li MZ, 2003, BIOMATERIALS, V24, P357, DOI 10.1016/S0142-9612(02)00326-5
   MINOURA N, 1995, BIOCHEM BIOPH RES CO, V208, P511, DOI 10.1006/bbrc.1995.1368
   Mohamadnia Z, 2007, J BIOACT COMPAT POL, V22, P342, DOI 10.1177/0883911507078519
   Motta A, 2011, J BIOACT COMPAT POL, V26, P130, DOI 10.1177/0883911511400251
   Nagarkar S, 2010, PHYS CHEM CHEM PHYS, V12, P3834, DOI 10.1039/b916319k
   Nichol JW, 2010, BIOMATERIALS, V31, P5536, DOI 10.1016/j.biomaterials.2010.03.064
   Payne RG, 2002, BIOMATERIALS, V23, P4359, DOI 10.1016/S0142-9612(02)00184-9
   Peppas NA, 2006, ADV MATER, V18, P1345, DOI 10.1002/adma.200501612
   Rnjak-Kovacina J, 2011, BIOMATERIALS, V32, P6729, DOI 10.1016/j.biomaterials.2011.05.065
   Shin H, 2003, BIOMATERIALS, V24, P4353, DOI 10.1016/S0142-9612(03)00339-9
   Silva SS, 2008, BIOMACROMOLECULES, V9, P2764, DOI 10.1021/bm800874q
   Silva SS, 2008, MACROMOL BIOSCI, V8, P766, DOI 10.1002/mabi.200700300
   Solorio L, 2010, J TISSUE ENG REGEN M, V4, P514, DOI 10.1002/term.267
   Tamada Y, 2005, BIOMACROMOLECULES, V6, P3100, DOI 10.1021/bm050431f
   Venkataraman R, 2007, MAT SCI ENG A-STRUCT, V445, P269, DOI 10.1016/j.msea.2006.09.042
   Vepari C, 2007, PROG POLYM SCI, V32, P991, DOI 10.1016/j.progpolymsci.2007.05.013
   Vunjak-Novakovic Gordana, 2003, Novartis Found Symp, V249, P34
   Wang XQ, 2008, BIOMATERIALS, V29, P1054, DOI 10.1016/j.biomaterials.2007.11.003
   Wang XQ, 2011, MACROMOL BIOSCI, V11, P100, DOI 10.1002/mabi.201000173
   Wang YZ, 2006, BIOMATERIALS, V27, P6064, DOI 10.1016/j.biomaterials.2006.07.008
   Wu SC, 2011, J BIOACT COMPAT POL, V26, P565, DOI 10.1177/0883911511423563
   Xiao WQ, 2011, ACTA BIOMATER, V7, P2384, DOI 10.1016/j.actbio.2011.01.016
   Xuejun X, 2004, J BIOACT COMPAT POL, V19, P5, DOI 10.1177/0883911504041608
   Yuan Y, 2007, CARBOHYD POLYM, V68, P561, DOI 10.1016/j.carbpol.2006.10.023
   Yucel T, 2009, BIOPHYS J, V97, P2044, DOI 10.1016/j.bpj.2009.07.028
   Zhang WJ, 2011, BIOMATERIALS, V32, P9415, DOI 10.1016/j.biomaterials.2011.08.047
NR 49
TC 20
Z9 23
U1 6
U2 77
PU SAGE PUBLICATIONS LTD
PI LONDON
PA 1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND
SN 0883-9115
J9 J BIOACT COMPAT POL
JI J. Bioact. Compat. Polym.
PD JUL
PY 2012
VL 27
IS 4
BP 327
EP 341
DI 10.1177/0883911512448692
PG 15
WC Biotechnology & Applied Microbiology; Materials Science, Biomaterials;
   Polymer Science
SC Biotechnology & Applied Microbiology; Materials Science; Polymer Science
GA 970NH
UT WOS:000306137300003
DA 2018-10-19
ER

PT J
AU Amini, AA
   Nair, LS
AF Amini, Ashley A.
   Nair, Lakshmi S.
TI Enzymatically cross-linked injectable gelatin gel as osteoblast delivery
   vehicle
SO JOURNAL OF BIOACTIVE AND COMPATIBLE POLYMERS
LA English
DT Article
DE Gelatin; hydrogels; injectable biomaterial; cell delivery; tissue
   engineering; intercellular signaling; osteogenic function; encapsulated
   cells; enzymatic cross-linking; injectable gelatin
ID TYRAMINE HYDROGEL SYSTEM; BIOMEDICAL APPLICATIONS; REGENERATIVE
   MEDICINE; ELECTROSPUN MEMBRANES; PHOTOCURABLE GELATIN; DIFFERENTIATION;
   LINKING; COLLAGEN; RELEASE; SCAFFOLDS
AB Injectable and degradable hydrogels are potential candidates as cell delivery vehicles for the regeneration of osseous defects. We evaluated the potential of injectable enzymatically cross-linked gelatin gel as an osteoblast delivery vehicle using murine preosteoblast MC3T3-E1 cells. Injectable hydrogels were prepared by enzymatic cross-linking of the phenol derivatives of gelatin (tyramine-modified) in the presence of hydrogen peroxide (H2O2) and horseradish peroxidase. The effect of gelatin concentration on gel morphology and in supporting the adhesion and spreading of encapsulated MC3T3-E1 cells, activation of intercellular signaling in MC3T3-E1 cells by extracellular signal-regulated kinase phosphorylation, beta-catenin and Runx2 was evaluated. Both tyramine-modified and unmodified gelatins as well as gelatin gels did not activate intercellular signaling pathways in MC3T3-E1 cells. The encapsulated cells in gelatin gel showed extracellular signal-regulated kinase phosphorylation and active beta-catenin expression in the presence of inductive molecules such as insulin and LiCl. The gelatin gels formed from 10 to 25 mg/mL tyramine-modified gelatin supported the adhesion, spreading, and three-dimensional growth of MC3T3-E1 cells. However, the lack of activation of intercellular signaling in the gelatin gel indicates the need to add exogenous bioactive molecules to modulate the osteogenic functions of the encapsulated cells.
C1 [Nair, Lakshmi S.] Univ Connecticut, Ctr Hlth, Inst Regenerat Engn, Dept Orthopaed Surg, Farmington, CT 06030 USA.
   [Amini, Ashley A.] Univ Connecticut, Ctr Hlth, Sch Dent Med, Farmington, CT 06030 USA.
   [Nair, Lakshmi S.] Univ Connecticut, Biomed Engn Program, Inst Mat Sci, Dept Chem Mat & Biomol Engn, Farmington, CT 06030 USA.
RP Nair, LS (reprint author), Univ Connecticut, Ctr Hlth, Inst Regenerat Engn, Dept Orthopaed Surg, Farmington, CT 06030 USA.
EM nair@uchc.edu
FU Department of Defense [W81XWH-10-1-0947]; UConn Center for Science and
   Technology Commercialization (CSTC)
FX This work was supported by the Department of Defense (W81XWH-10-1-0947)
   and UConn Center for Science and Technology Commercialization (CSTC).
CR Alvarez-Perez MA, 2010, BIOMACROMOLECULES, V11, P2238, DOI 10.1021/bm100221h
   Annabi N, 2010, TISSUE ENG PART B-RE, V16, P371, DOI [10.1089/ten.teb.2009.0639, 10.1089/ten.TEB.2009.0639]
   ATKINSON SJ, 1992, BIOCHEM J, V288, P605, DOI 10.1042/bj2880605
   Attia J, 2011, J BIOACT COMPAT POL, V26, P71, DOI 10.1177/0883911510391445
   Balakrishnan B, 2005, BIOMATERIALS, V26, P3941, DOI 10.1016/j.biomaterials.2004.10.005
   Benoit DSW, 2007, BIOMATERIALS, V28, P66, DOI 10.1016/j.biomaterials.2006.08.033
   Betz MW, 2010, BIOMACROMOLECULES, V11, P1160, DOI 10.1021/bm100061z
   Buhus G, 2009, J BIOACT COMPAT POL, V24, P525, DOI 10.1177/0883911509349687
   Choi JY, 1996, J CELL BIOCHEM, V61, P609, DOI 10.1002/(SICI)1097-4644(19960616)61:4<609::AID-JCB15>3.0.CO;2-A
   COBBETT WG, 1962, BIOCHEM J, V84, P468, DOI 10.1042/bj0840468
   Darr A, 2009, J MATER SCI-MATER M, V20, P33, DOI 10.1007/s10856-008-3540-0
   Davis NE, 2010, BIOMATERIALS, V31, P7288, DOI 10.1016/j.biomaterials.2010.06.003
   Dreesmann L, 2007, BIOMATERIALS, V28, P5536, DOI 10.1016/j.biomaterials.2007.08.040
   Fukaya C, 2009, J BIOMED MATER RES B, V91B, P329, DOI 10.1002/jbm.b.31406
   Ge CX, 2007, J CELL BIOL, V176, P709, DOI 10.1083/jcb.200610046
   Guarino V, 2011, J BIOACT COMPAT POL, V26, P144, DOI 10.1177/0883911511399410
   Hennink WE, 2002, ADV DRUG DELIVER REV, V54, P13, DOI 10.1016/S0169-409X(01)00240-X
   Hoshikawa A, 2006, TISSUE ENG, V12, P2333, DOI 10.1089/ten.2006.12.2333
   Hu M, 2009, BIOMATERIALS, V30, P3523, DOI 10.1016/j.biomaterials.2009.03.004
   Hwang CM, 2010, BIOFABRICATION, V2, DOI 10.1088/1758-5082/2/3/035003
   Jiang T, 2008, CURR TOP MED CHEM, V8, P354
   Kawazoe N, 2009, J BIOACT COMPAT POL, V24, P25, DOI 10.1177/0883911508099439
   Kim K, 2010, TISSUE ENG PART B-RE, V16, P523, DOI [10.1089/ten.teb.2010.0171, 10.1089/ten.TEB.2010.0171]
   Kopecek J, 2009, ACTA BIOMATER, V5, P805, DOI 10.1016/j.actbio.2008.10.001
   Kuijpers AJ, 2000, J BIOMAT SCI-POLYM E, V11, P225, DOI 10.1163/156856200743670
   Kuwahara K, 2010, TISSUE ENG PART C-ME, V16, P609, DOI [10.1089/ten.tec.2009.0406, 10.1089/ten.TEC.2009.0406]
   Kwon YJ, 2002, BIOTECHNIQUES, V33, P212, DOI 10.2144/02331dd05
   Lee F, 2008, SOFT MATTER, V4, P880, DOI 10.1039/b719557e
   Lee F, 2009, J CONTROL RELEASE, V134, P186, DOI 10.1016/j.jconrel.2008.11.028
   Lee YH, 2010, APPL SURF SCI, V256, P5882, DOI 10.1016/j.apsusc.2010.03.069
   Liu X, 2009, BIOMATERIALS, V30, P2252, DOI 10.1016/j.biomaterials.2008.12.068
   Minh KN, 2010, MACROMOL BIOSCI, V10, P563, DOI 10.1002/mabi.200900402
   MUSSO H, 1963, ANGEW CHEM INT EDIT, V2, P723, DOI DOI 10.1002/ANIE.196307231
   Nair LS, 2007, BIOMACROMOLECULES, V8, P3779, DOI 10.1021/bm7006967
   Nicodemus GD, 2008, TISSUE ENG PT B-REV, V14, P149, DOI 10.1089/ten.teb.2007.0332
   Okino H, 2002, J BIOMED MATER RES, V59, P233, DOI 10.1002/jbm.1237
   Olsen D, 2003, ADV DRUG DELIVER REV, V55, P1547, DOI 10.1016/j.addr.2003.08.008
   Park KM, 2011, J MATER CHEM, V21, P13180, DOI 10.1039/c1jm12527c
   Peng S, 2011, CELL BIOL INT, V35, P587, DOI 10.1042/CBI20100452
   Rydholm AE, 2005, BIOMATERIALS, V26, P4495, DOI 10.1016/j.biomaterials.2004.11.046
   Sakai S, 2009, J MATER CHEM, V19, P230, DOI 10.1039/b812086b
   Sakai S, 2009, BIOMATERIALS, V30, P3371, DOI 10.1016/j.biomaterials.2009.03.030
   Shimokawa K, 2002, MOL HUM REPROD, V8, P32, DOI 10.1093/molehr/8.1.32
   Slaughter BV, 2009, ADV MATER, V21, P3307, DOI 10.1002/adma.200802106
   Spotnitz WD, 2008, TRANSFUSION, V48, P1502, DOI 10.1111/j.1537-2995.2008.01703.x
   STEIN GS, 1990, FASEB J, V4, P3111
   SUDO H, 1983, J CELL BIOL, V96, P191, DOI 10.1083/jcb.96.1.191
   Sutter M, 2007, J CONTROL RELEASE, V119, P301, DOI 10.1016/j.jconrel.2007.03.003
   Terao K, 2003, J BIOMAT SCI-POLYM E, V14, P1197, DOI 10.1163/156856203322553437
   Wang CM, 2010, ADV DRUG DELIVER REV, V62, P699, DOI 10.1016/j.addr.2010.02.001
   Yamamoto M, 1999, J BIOACT COMPAT POL, V14, P474, DOI 10.1177/088391159901400603
   Yu L, 2008, CHEM SOC REV, V37, P1473, DOI 10.1039/b713009k
   Yung CW, 2010, J BIOMED MATER RES A, V95A, P25, DOI 10.1002/jbm.a.32740
   Zhao XH, 2011, P NATL ACAD SCI USA, V108, P67, DOI 10.1073/pnas.1007862108
NR 54
TC 19
Z9 19
U1 0
U2 38
PU SAGE PUBLICATIONS LTD
PI LONDON
PA 1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND
SN 0883-9115
EI 1530-8030
J9 J BIOACT COMPAT POL
JI J. Bioact. Compat. Polym.
PD JUL
PY 2012
VL 27
IS 4
BP 342
EP 355
DI 10.1177/0883911512444713
PG 14
WC Biotechnology & Applied Microbiology; Materials Science, Biomaterials;
   Polymer Science
SC Biotechnology & Applied Microbiology; Materials Science; Polymer Science
GA 970NH
UT WOS:000306137300004
DA 2018-10-19
ER

PT J
AU Nath, S
   Dubey, AK
   Basu, B
AF Nath, Shekhar
   Dubey, Ashutosh Kumar
   Basu, Bikramjit
TI Mechanical properties of novel calcium phosphate-mullite biocomposites
SO JOURNAL OF BIOMATERIALS APPLICATIONS
LA English
DT Article
DE calcium phosphate; mullite; hardness; fracture toughness; strength
ID HYDROXYAPATITE-ZIRCONIA COMPOSITES; CERAMIC-MATRIX COMPOSITE; BIOMEDICAL
   APPLICATIONS; PHASE-STABILITY; MICROSTRUCTURE DEVELOPMENT; REINFORCED
   HYDROXYAPATITE; FRACTURE-TOUGHNESS; ALUMINA; HARDNESS; FABRICATION
AB Herein, the results of systematic mechanical property measurements of pressureless sintered calcium phosphate (CaP)-mullite composites are discussed. Our experimental results demonstrated how the mullite addition (upto 30 wt%) influenced hardness, elastic modulus, strength and toughness properties of the composites. In assessing each of these fundamental material properties, either a range of load or a number of complimentary techniques were used to obtain reliable measure of mechanical properties. Importantly, the results of single edge V notch beam measurements revealed that a reliable toughness value of similar to 1.5 MPa m(0.5) could be obtained in composites containing 20 or 30 wt% mullite. Our results clearly illustrated that a combination of elastic modulus (similar to 80 GPa), compressive strength of more than 350 MPa, three-point flexural strength of 70-80 MPa, hardness of 4-5 GPa were achievable with the investigated composites. Such a combination of material properties, in addition to modest toughness property appeared to indicate that CaP-mullite composites could be used as a biomaterial for hard tissue replacement.
C1 [Nath, Shekhar; Dubey, Ashutosh Kumar; Basu, Bikramjit] Indian Inst Technol, Lab Biomat, Dept Mat Sci & Engn, Kanpur 208016, Uttar Pradesh, India.
RP Basu, B (reprint author), Indian Inst Technol, Lab Biomat, Dept Mat Sci & Engn, Kanpur 208016, Uttar Pradesh, India.
EM bikram@iitk.ac.in
RI BASU, BIKRAMJIT/A-9967-2013
OI Nath, Shekhar/0000-0003-1153-1213
FU Department of Biotechnology, Government of India
FX The authors wish to thank Dr U Ramamurthy of IISc Bangalore, India, for
   extending access to instrumented indentation measurements. Thanks are
   due to Dr Krishanu Biswas of IIT Kanpur, India, for his help in TEM
   analysis. They also wish to acknowledge the financial support provided
   by the Department of Biotechnology, Government of India.
CR Annaz B, 2004, J MICROSC-OXFORD, V215, P100, DOI 10.1111/j.0022-2720.2004.01354.x
   [Anonymous], 1995, C125995 ASTM, VC1259-95, P375
   Anstis G R, 1981, J AM CERAM SOC, V64, P553
   AWAJI H, 1990, J AM CERAM SOC, V73, P3522, DOI 10.1111/j.1151-2916.1990.tb06490.x
   Bodhak S, 2009, J BIOMATER APPL, V23, P407, DOI 10.1177/0885328208090012
   Chen BQ, 2008, MAT SCI ENG C-BIO S, V28, P1052, DOI 10.1016/j.msec.2007.04.034
   Chen B, 2008, CERAM INT, V34, P359, DOI 10.1016/j.ceramint.2006.10.021
   Choi SR, 2005, CERAM INT, V31, P39, DOI 10.1016/j.ceramint.2004.03.032
   Fernandez C, 2003, J EUR CERAM SOC, V23, P1031, DOI 10.1016/S0955-2219(02)00264-9
   Gautier S, 1997, J EUR CERAM SOC, V17, P1361, DOI 10.1016/S0955-2219(97)89403-4
   Gogotsi AG, 2003, CERAM INT, V29, P777
   Goller G, 2003, CERAM INT, V29, P721, DOI 10.1016/S0272-8842(02)00223-7
   Hornez JC, 2007, BIOMOL ENG, V24, P505, DOI 10.1016/j.bioeng.2007.08.015
   Ivanov B, 2003, APPL SURF SCI, V208, P77, DOI 10.1016/S0169-4332(02)01339-9
   Jia D, 2003, J AM CERAM SOC, V90, P2766
   Kanzakai S, 1985, J AM CERAM SOC, V68, pC
   Kim HW, 2003, MAT SCI ENG C-BIO S, V23, P515, DOI 10.1016/S0928-4931(02)00355-7
   Kim HW, 2002, J AM CERAM SOC, V85, P1634, DOI 10.1111/j.1151-2916.2002.tb00328.x
   Kmita AR, 2006, J EUR CERAM SOC, V26, P1481
   LI J, 1995, BIOMATERIALS, V16, P417, DOI 10.1016/0142-9612(95)98860-G
   METCALFE BL, 1975, BRIT CERAM TRANS J, V74, P193
   Mizuno M, 1995, J AM CERAM SOC, V78, P1795
   Mrudiyasni KS, 1972, J AM CERAM SOC, V55, P548
   Nath S, 2008, THESIS IIT KANPUR IN
   Nath S, 2008, SCRIPTA MATER, V58, P1054, DOI 10.1016/j.scriptamat.2008.01.045
   Nath S, 2010, J AM CERAM SOC, V93, P1639, DOI 10.1111/j.1551-2916.2010.03662.x
   Nath S, 2008, J KOREAN CERAM SOC, V45, P1, DOI 10.4191/kcers.2008.45.1.001
   Nath S, 2009, J BIOMED MATER RES B, V90B, P547, DOI 10.1002/jbm.b.31316
   Nath S, 2009, MAT SCI ENG C-BIO S, V29, P97, DOI 10.1016/j.msec.2008.05.019
   Nath S, 2009, J BIOMED MATER RES B, V88B, P1, DOI 10.1002/jbm.b.31050
   NIIHARA K, 1982, J MATER SCI LETT, V1, P13, DOI 10.1007/BF00724706
   NISHIDA T, 1994, J AM CERAM SOC, V77, P606, DOI 10.1111/j.1151-2916.1994.tb07038.x
   OLIVER WC, 1992, J MATER RES, V7, P1564, DOI 10.1557/JMR.1992.1564
   Rao RR, 2002, MAT SCI ENG C-BIO S, V20, P187
   Rathje W., 1939, BODENK PFLERNAH, V12, P121
   Reis RL, 2005, BIODEGRADABLE SYSTEM
   Santos Maria Helena, 2004, Mat. Res., V7, P625, DOI 10.1590/S1516-14392004000400017
   Silva VV, 2001, COMPOS SCI TECHNOL, V61, P301, DOI 10.1016/S0266-3538(00)00222-0
   Slosarczyk A, 1998, J MATER SCI-MATER M, V9, P103, DOI 10.1023/A:1008803232685
   Strecker Kurt, 2005, Mat. Res., V8, P121, DOI 10.1590/S1516-14392005000200004
   Suchanek W, 1997, J AM CERAM SOC, V80, P2805, DOI 10.1111/j.1151-2916.1997.tb03197.x
   Suchanek W, 1996, BIOMATERIALS, V17, P1715, DOI 10.1016/0142-9612(96)87652-6
   Sung YM, 2007, NANOTECHNOLOGY, V18
   TAYA M, 1990, J AM CERAM SOC, V73, P1382, DOI 10.1111/j.1151-2916.1990.tb05209.x
   Volceanov A, 2006, J OPTOELECTRON ADV M, V8, P585
   Wang CX, 2004, MATER CHARACT, V52, P301, DOI 10.1016/j.matchar.2004.06.007
   WITEK SR, 1989, J AM CERAM SOC, V72, P469, DOI 10.1111/j.1151-2916.1989.tb06155.x
   Zhang XH, 2008, MATER LETT, V62, P1058, DOI 10.1016/j.matlet.2007.07.044
NR 48
TC 9
Z9 9
U1 0
U2 9
PU SAGE PUBLICATIONS LTD
PI LONDON
PA 1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND
SN 0885-3282
J9 J BIOMATER APPL
JI J. Biomater. Appl.
PD JUL
PY 2012
VL 27
IS 1
BP 67
EP 78
DI 10.1177/0885328210393292
PG 12
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 970NE
UT WOS:000306136900007
PM 21343213
DA 2018-10-19
ER

PT J
AU Alghazzawi, TF
   Lemons, J
   Liu, PR
   Essig, ME
   Bartolucci, AA
   Janowski, GM
AF Alghazzawi, Tariq F.
   Lemons, Jack
   Liu, Perng-Ru
   Essig, Milton E.
   Bartolucci, Alfred A.
   Janowski, Gregg M.
TI Influence of Low-Temperature Environmental Exposure on the Mechanical
   Properties and Structural Stability of Dental Zirconia
SO JOURNAL OF PROSTHODONTICS-IMPLANT ESTHETIC AND RECONSTRUCTIVE DENTISTRY
LA English
DT Article
DE Low-temperature degradation; zirconia; transformation
ID Y-TZP; FLEXURAL STRENGTH; CE-TZP/AL2O3 NANOCOMPOSITE; SURFACE-STRUCTURE;
   FEMORAL HEADS; CERAMICS; TRANSFORMATION; DEGRADATION; BIOMATERIAL;
   ROUGHNESS
AB Purpose: The effect of dental fabrication procedures of zirconia monolithic restorations and changes in properties during low-temperature exposure in the oral environment is not completely understood. The purpose of this study was to investigate the effect of procedures for fabrication of dental restorations by low-temperature simulation and relative changes of flexural strength, nanoindentation hardness, Young's modulus, surface roughness, and structural stability of yttria-stabilized zirconia. Materials and Methods: A total of 64 zirconia specimens were prepared to simulate dental practice. The specimens were divided into the control group and the accelerated aging group. The simulated group followed the same procedure as the control group except for the aging treatment. Atomic force microscopy was used to measure surface roughness. The degree of tetragonal-to-monoclinic transformation was determined using X-ray diffraction. Nanoindentation hardness and modulus measurements were carried out on the surface of the zirconia specimens using a nanoindenter XP/G200 system. The yttria levels for nonaged and aged specimens were measured using energy dispersive spectroscopy. Flexural strength was determined using the piston-on-three-ball test. The t-test was used to determine statistical significance. Results: Means and standard deviations were calculated using all observations for each condition and evaluated using a group t-test (p < 0.05). The LTD treatment resulted in increased surface roughness (from 12.23 nm to 21.56 nm for Ra and 15.06 nm to 27.45 nm for RMS) and monoclinic phase fractions (from 2% to 21%), with a concomitant decrease in hardness (from 16.56 GPa to 15.14 GPa) and modulus (from 275.68 GPa to 256.56 GPa). Yttria content (from 4.43% to 4.46%) and flexural strength (from 586 MPa to 578 MPa) were not significantly altered, supporting longer term in vivo function without biomechanical fracture. Conclusion: The LTD treatment induced the tetragonal-to-monoclinic transformation with surface roughening in zirconia prepared using dental procedures.
C1 [Alghazzawi, Tariq F.] Taibah Univ Madina, Dept Prosthet Dent Sci, Coll Dent, Madinah, Saudi Arabia.
   [Lemons, Jack; Liu, Perng-Ru] Univ Alabama Birmingham, Dept Prosthodont, Birmingham, AL USA.
   [Essig, Milton E.] Univ Alabama Birmingham, Dept Gen Dent Sci, Birmingham, AL USA.
   [Bartolucci, Alfred A.] Univ Alabama Birmingham, Dept Biostat, Birmingham, AL 35294 USA.
   [Janowski, Gregg M.] Univ Alabama Birmingham, Dept Mat Sci & Engn, Birmingham, AL 35294 USA.
RP Alghazzawi, TF (reprint author), BEC 254,1530 3rd Ave S, Birmingham, AL 35294 USA.
EM tariq@uab.edu
OI Janowski, Gregg/0000-0001-8384-4820
FU American College of Prosthodontists Education Foundation (ACPEF)
FX This project was supported by the American College of Prosthodontists
   Education Foundation (ACPEF) Research Fellowship Award on November 28,
   2008.
CR Addison O, 2003, DENT MATER, V19, P291, DOI 10.1016/S0109-5641(02)00046-5
   [Anonymous], 2000, 4287 BS EN ISO
   Ardlin BI, 2002, DENT MATER, V18, P590, DOI 10.1016/S0109-5641(01)00095-1
   Ban S, 2008, J BIOMED MATER RES B, V87B, P492, DOI 10.1002/jbm.b.31131
   Bollen CML, 1997, DENT MATER, V13, P258, DOI 10.1016/S0109-5641(97)80038-3
   Catledge SA, 2003, J MATER SCI-MATER M, V14, P863, DOI 10.1023/A:1025678525474
   Chevalier J, 2006, BIOMATERIALS, V27, P535, DOI 10.1016/j.biomaterials.2005.07.034
   Chevalier J, 2009, J AM CERAM SOC, V92, P1901, DOI 10.1111/j.1551-2916.2009.03278.x
   Chowdhury S, 2007, J BIOMED MATER RES B, V81B, P486, DOI 10.1002/jbm.b.30688
   Curtis AR, 2006, J DENT, V34, P195, DOI 10.1016/j.jdent.2005.06.006
   Denry IL, 2010, J BIOMED MATER RES B, V93B, P236, DOI 10.1002/jbm.b.31580
   Denry IL, 2006, J BIOMED MATER RES B, V76B, P440, DOI 10.1002/jbm.b.30382
   Denry I, 2008, DENT MATER, V24, P299, DOI 10.1016/j.dental.2007.05.007
   Deville S, 2005, J BIOMED MATER RES B, V72B, P239, DOI 10.1002/jbm.b.30123
   Fleming GJP, 2004, J DENT, V32, P67, DOI 10.1016/j.jdent.2003.08.004
   GARVIE RC, 1972, J AM CERAM SOC, V55, P303, DOI 10.1111/j.1151-2916.1972.tb11290.x
   Guo X, 1999, J PHYS CHEM SOLIDS, V60, P539, DOI 10.1016/S0022-3697(98)00301-1
   Hernigou P, 2003, J BONE JOINT SURG BR, V85B, P504, DOI 10.1302/0301-620X.85B4.13397
   Huang C.W., 2011, DENT MATER, V27, P117
   ISO, 2008, 6872 ISO
   Jevnikar P, 2000, MAGNET RESON MED, V44, P686, DOI 10.1002/1522-2594(200011)44:5<686::AID-MRM5>3.0.CO;2-5
   Jones CS, 2004, BRIT DENT J, V196, P42, DOI 10.1038/sj.bdj.4810881
   KOBAYASHI K, 1981, SOLID STATE IONICS, V3-4, P489, DOI 10.1016/0167-2738(81)90138-7
   Kosmac T, 2008, J EUR CERAM SOC, V28, P1085, DOI 10.1016/j.jeurceramsoc.2007.09.013
   LANGE FF, 1986, J AM CERAM SOC, V69, P237, DOI 10.1111/j.1151-2916.1986.tb07415.x
   Papanagiotou HP, 2006, J PROSTHET DENT, V96, P154, DOI 10.1016/j.prosdent.2006.08.004
   Piconi C, 1999, BIOMATERIALS, V20, P1, DOI 10.1016/S0142-9612(98)00010-6
   Pittayachawan P, 2007, DENT MATER, V23, P1018, DOI 10.1016/j.dental.2006.09.003
   Santos EM, 2004, J ARTHROPLASTY, V19, P30, DOI 10.1016/j.arth.2004.06.017
   Sato T., 1985, J MATER SCI, V20, P3899
   Tanaka K, 2003, J BIOMED MATER RES A, V67A, P200, DOI 10.1002/jbm.a.10006
   Wang H, 2008, DENT MATER, V24, P633, DOI 10.1016/j.dental.2007.06.030
   YOSHIMURA M, 1987, J MATER SCI LETT, V6, P465, DOI 10.1007/BF01756800
NR 33
TC 35
Z9 40
U1 2
U2 25
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1059-941X
J9 J PROSTHODONT
JI J. Prosthodont.
PD JUL
PY 2012
VL 21
IS 5
BP 363
EP 369
DI 10.1111/j.1532-849X.2011.00838.x
PG 7
WC Dentistry, Oral Surgery & Medicine
SC Dentistry, Oral Surgery & Medicine
GA 972KS
UT WOS:000306276600005
PM 22372432
DA 2018-10-19
ER

PT J
AU Gupta, N
   Kushwaha, AK
   Chattopadhyaya, MC
AF Gupta, Neha
   Kushwaha, Atul Kumar
   Chattopadhyaya, M. C.
TI Adsorption studies of cationic dyes onto Ashoka (Saraca asoca) leaf
   powder
SO JOURNAL OF THE TAIWAN INSTITUTE OF CHEMICAL ENGINEERS
LA English
DT Article
DE Adsorption; Methylene blue; Malachite green; Rhodamine B; Brilliant
   green; Saraca asoca
ID METHYLENE-BLUE ADSORPTION; BRILLIANT GREEN-DYE; AQUEOUS-SOLUTION;
   MALACHITE-GREEN; RHODAMINE-B; ACTIVATED CARBON; EQUILIBRIUM ISOTHERM;
   REMOVAL; WASTE; KINETICS
AB In present study, batch adsorption experiments were carried out using ashoka leaf powder (ALP), a low cost, locally available biomaterial as an adsorbent for the removal of cationic dyes such as methylene blue, malachite green, rhodamine B and brilliant green from aqueous solution. The ALP was characterized by Fourier transform infrared (FTIR) spectroscopy and scanning electron microscope (SEM). Effect of various physico-chemical parameters such as pH, ionic strength, adsorbent dose, contact time, initial dye concentration and temperature were investigated and optimal experimental conditions were ascertained. Available models like Lagergren's pseudo-first order kinetics, Ho's pseudo-second order kinetics and intraparticle diffusion were used to evaluate the kinetics and the mechanism of the adsorption. The Langmuir, Freundlich, Temkin and Scatchard isotherm models were tested to represent the equilibrium data and the constants of the isotherms were determined by using the experimental data. Thermodynamic parameters such as change in Gibb's free energy (Delta G degrees), change in enthalpy (Delta H degrees) and change in entropy (Delta S degrees) were calculated to predict the nature of adsorption process. (C) 2012 Taiwan Institute of Chemical Engineers. Published by Elsevier B.V. All rights reserved.
C1 [Gupta, Neha; Kushwaha, Atul Kumar; Chattopadhyaya, M. C.] Univ Allahabad, Dept Chem, Environm Chem Res Lab, Allahabad 211002, Uttar Pradesh, India.
RP Chattopadhyaya, MC (reprint author), Univ Allahabad, Dept Chem, Environm Chem Res Lab, Allahabad 211002, Uttar Pradesh, India.
EM neha.evs07@gmail.com; atulkk2008@gmail.com; mcc46@rediffmail.com
RI Chattopadhyaya, Mahesh/K-4729-2015
FU Council of Scientific and Industrial Research (CSIR), New Delhi, India
FX Authors are thankful to the NCEMP, Allahabad University for recording
   SEM and Council of Scientific and Industrial Research (CSIR), New Delhi,
   India, for the financial support.
CR Ahmad R, 2010, J ENVIRON MANAGE, V91, P1032, DOI 10.1016/j.jenvman.2009.12.016
   Ali M, 2008, PHARMACOGNOSY, P668
   Anjaneyulu Y., 2005, Reviews in Environmental Science and Bio/Technology, V4, P245, DOI 10.1007/s11157-005-1246-z
   ANLIKER R, 1977, ECOTOX ENVIRON SAFE, V1, P211, DOI 10.1016/0147-6513(77)90037-9
   Barka N, 2011, J TAIWAN INST CHEM E, V42, P320, DOI 10.1016/j.jtice.2010.07.004
   Belala Z, 2011, DESALINATION, V271, P80, DOI 10.1016/j.desal.2010.12.009
   BHANDARY MJ, 1995, J ETHNOPHARMACOL, V47, P149, DOI 10.1016/0378-8741(95)01274-H
   Bhatnagar A, 2010, BIOCHEM ENG J, V48, P181, DOI 10.1016/j.bej.2009.10.005
   Bhattacharyya KG, 2005, DYES PIGMENTS, V65, P51, DOI 10.1016/j.dyepig.2004.06.016
   BROWN MA, 1993, CRIT REV ENV SCI TEC, V23, P249, DOI 10.1080/10643380490434119
   Crini G, 2008, DYES PIGMENTS, V77, P415, DOI 10.1016/j.dyepig.2007.07.001
   Daneshvar N, 2007, BIORESOURCE TECHNOL, V98, P1176, DOI 10.1016/j.biortech.2006.05.025
   Brito SMD, 2010, J HAZARD MATER, V174, P84, DOI 10.1016/j.jhazmat.2009.09.020
   Dutta S, 2011, DESALINATION, V275, P26, DOI 10.1016/j.desal.2011.02.057
   El Qada EN, 2006, CHEM ENG J, V124, P103, DOI 10.1016/j.cej.2006.08.015
   Fu F., 2010, J ENVIRON MANAGE, V92, P407, DOI DOI 10.1016/J.JENVMAN.2010.11.011
   Gad HMH, 2009, J HAZARD MATER, V168, P1070, DOI 10.1016/j.jhazmat.2009.02.155
   Gurses A, 2006, J HAZARD MATER, V131, P217, DOI 10.1016/j.jhazmat.2005.09.036
   Hamdaoui O, 2008, CHEM ENG J, V143, P73, DOI 10.1016/j.cej.2007.12.018
   Hameed BH, 2009, J HAZARD MATER, V166, P233, DOI 10.1016/j.jhazmat.2008.11.019
   Hameed BH, 2009, J HAZARD MATER, V164, P870, DOI 10.1016/j.jhazmat.2008.08.084
   Han RP, 2010, CARBOHYD POLYM, V79, P1140, DOI 10.1016/j.carbpol.2009.10.054
   Ho YS, 1999, PROCESS BIOCHEM, V34, P451, DOI 10.1016/S0032-9592(98)00112-5
   Kadirvelu K, 2005, CHEMOSPHERE, V60, P1009, DOI 10.1016/j.chemosphere.2005.01.047
   Khattri SD, 2009, J HAZARD MATER, V167, P1089, DOI 10.1016/j.jhazmat.2009.01.101
   Kumar KV, 2006, DYES PIGMENTS, V69, P102, DOI 10.1016/j.dyepig.2005.02.005
   Kumar PS, 2009, J ENG SCI TECHNOL, V4, P381
   Lagergren S, 1898, KUNGLIGA SVENSKA VET, V24, P1, DOI DOI 10.1007/BF01501332
   Mahmoodi NM, 2011, DESALINATION, V272, P187, DOI 10.1016/j.desal.2011.01.023
   Mane VS, 2007, J ENVIRON MANAGE, V84, P390, DOI 10.1016/j.jenvman.2006.06.024
   Manohar D.M., 2006, APPL CLAY SCI, V31, P194, DOI DOI 10.1016/J.CLAY.2005.08.008
   Nandi BK, 2009, J HAZARD MATER, V161, P387, DOI 10.1016/j.jhazmat.2008.03.110
   Neha Gupta, 2011, Journal of Chemical and Pharmaceutical Research, V3, P284
   Noonpui S, 2010, CHEM ENG J, V162, P503, DOI 10.1016/j.cej.2010.05.051
   Panda GC, 2009, J HAZARD MATER, V164, P374, DOI 10.1016/j.jhazmat.2008.08.015
   Pavan FA, 2008, J HAZARD MATER, V150, P703, DOI 10.1016/j.jhazmat.2007.05.023
   Pehlivan E, 2008, BIORESOURCE TECHNOL, V99, P3520, DOI 10.1016/j.biortech.2007.07.052
   Ponnusami V, 2008, J HAZARD MATER, V152, P276, DOI 10.1016/j.jhazmat.2007.06.107
   Ponnusami V, 2009, J HAZARD MATER, V169, P119, DOI 10.1016/j.jhazmat.2009.03.066
   Selvam PP, 2008, J HAZARD MATER, V155, P39, DOI 10.1016/j.jhazmat.2007.11.025
   Srinivasan A, 2010, J ENVIRON MANAGE, V91, P1915, DOI 10.1016/j.jenvman.2010.05.003
   Sureshkumar MV, 2008, COLLOID SURFACE A, V317, P277, DOI 10.1016/j.colsurfa.2007.10.026
   Temkin M, 1940, ACTA PHYSICOCHIM URS, V12, P327
   Uddin MT, 2009, J HAZARD MATER, V164, P53, DOI 10.1016/j.jhazmat.2008.07.131
   Weber W, 1963, J SANITARY ENGINEERI, V89, P31, DOI DOI 10.1016/J.DESAL.2010.08.036
   Yu JX, 2009, BIOCHEM ENG J, V45, P145, DOI 10.1016/j.bej.2009.03.007
   Zhang J, 2008, J HAZARD MATER, V150, P774, DOI 10.1016/j.jhazmat.2007.05.036
NR 47
TC 56
Z9 56
U1 0
U2 13
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 1876-1070
J9 J TAIWAN INST CHEM E
JI J. Taiwan Inst. Chem. Eng.
PD JUL
PY 2012
VL 43
IS 4
BP 604
EP 613
DI 10.1016/j.jtice.2012.01.008
PG 10
WC Engineering, Chemical
SC Engineering
GA 972GM
UT WOS:000306265300017
DA 2018-10-19
ER

PT J
AU Antunes, RA
   de Oliveira, MCL
   Costa, I
AF Antunes, R. A.
   de Oliveira, M. C. L.
   Costa, I.
TI Study of the correlation between corrosion resistance and
   semi-conducting properties of the passive film of AISI 316L stainless
   steel in physiological solution
SO MATERIALS AND CORROSION-WERKSTOFFE UND KORROSION
LA English
DT Article
DE 316L; biomaterial; EIS; Mott-Schottky
ID IN-VITRO CORROSION; ELECTROCHEMICAL IMPEDANCE SPECTROSCOPY; BORATE
   BUFFER SOLUTION; SEMICONDUCTING PROPERTIES; ELECTRONIC-PROPERTIES;
   CHEMICAL-COMPOSITION; METALLIC IMPLANTS; THIN-FILMS; BEHAVIOR; COATINGS
AB In this work the corrosion resistance of AISI 316L biomedical stainless steel was assessed through electrochemical impedance spectroscopy (EIS) measurements in Hanks' solution at 37?degrees C. Specimens were immersed in the electrolyte during 21 days. Semi-conducting properties of the passive film naturally formed on the surface of the metallic material during the test were evaluated through the MottSchottky approach. The aim was to investigate the correlation between corrosion resistance and semi-conducting properties in the physiological solution. The corrosion resistance was found to decrease with the immersion time. The density of defects in the passive film increased accordingly as indicated by the MottSchottky plots. The passive film presented a semi-conducting behavior with a duplex character. Above the flat band potential the behavior was typical of an n-type semiconductor whilst below such value it was typical of a p-type semiconductor. The results from EIS measurements and MottSchottky were in good agreement, suggesting that the corrosion resistance of biomedical stainless steels may be associated with the semi-conducting properties of the passive films formed during immersion in physiological medium.
C1 [Antunes, R. A.] Fed Univ ABC UFABC, Engn Modeling & Appl Social Sci Ctr CECS, BR-09210170 Santo Andre, SP, Brazil.
   [de Oliveira, M. C. L.] Ctr Inovacao Empreendedorismo & Tecnol CIETEC, Electrocell Ind Com Equip Eletricos LTDA, BR-05508000 Sao Paulo, Brazil.
   [Costa, I.] Inst Pesquisas Energeticas & Nucl IPEN USP, CCTM, BR-05508000 Sao Paulo, Brazil.
RP Antunes, RA (reprint author), Fed Univ ABC UFABC, Engn Modeling & Appl Social Sci Ctr CECS, BR-09210170 Santo Andre, SP, Brazil.
EM renato.antunes@ufabc.edu.br
RI Lopes de Oliveira, Mara Cristina/J-6029-2018; Antunes,
   Renato/K-4738-2015
OI Lopes de Oliveira, Mara Cristina/0000-0003-1971-636X; Antunes,
   Renato/0000-0003-1540-6495
FU CNPq ( National Council of Scientific and Technological Development)
FX The authors are thankful to CNPq ( National Council of Scientific and
   Technological Development) for the financial support to this work.
CR Ahn SJ, 2004, ELECTROCHIM ACTA, V49, P3347, DOI 10.1016/j.electacta.2004.02.043
   Amri J, 2008, CORROS SCI, V50, P431, DOI 10.1016/j.corsci.2007.08.013
   Antunes RA, 2010, SURF COAT TECH, V205, P2074, DOI 10.1016/j.surfcoat.2010.08.101
   Antunes Renato Altobelli, 2009, Critical Reviews in Biomedical Engineering, V37, P425
   Assis SL, 2005, J BIOMED MATER RES B, V73B, P109, DOI 10.1002/jbm.b.30205
   Azar V, 2010, SURF COAT TECH, V204, P3546, DOI 10.1016/j.surfcoat.2010.04.015
   Azzi M, 2010, SURF COAT TECH, V204, P3986, DOI 10.1016/j.surfcoat.2010.05.004
   Azzi M, 2009, WEAR, V267, P860, DOI 10.1016/j.wear.2009.02.006
   Balamurugan A, 2008, MATER CORROS, V59, P855, DOI 10.1002/maco.200804173
   Ballarre J, 2010, ACTA BIOMATER, V6, P1601, DOI 10.1016/j.actbio.2009.10.015
   Belo MD, 1998, CORROS SCI, V40, P447, DOI 10.1016/S0010-938X(97)00158-3
   Belo MD, 1998, CORROS SCI, V40, P481, DOI 10.1016/S0010-938X(98)00016-X
   BRUG GJ, 1984, J ELECTROANAL CHEM, V176, P275, DOI 10.1016/S0022-0728(84)80324-1
   Cai M, 1996, J ELECTROCHEM SOC, V143, P3895, DOI 10.1149/1.1837313
   Carmezim MJ, 2005, CORROS SCI, V47, P581, DOI 10.1016/j.corsci.2004.07.002
   Cieslik M, 2011, CORROS SCI, V53, P296, DOI 10.1016/j.corsci.2010.09.034
   Ding MH, 2010, APPL SURF SCI, V257, P696, DOI 10.1016/j.apsusc.2010.07.026
   Ding MH, 2010, SURF COAT TECH, V204, P2519, DOI 10.1016/j.surfcoat.2010.01.028
   Fattah-alhosseini A, 2010, CORROS SCI, V52, P205, DOI 10.1016/j.corsci.2009.09.003
   Feng ZC, 2010, CORROS SCI, V52, P3646, DOI 10.1016/j.corsci.2010.07.013
   Ge HH, 2003, APPL SURF SCI, V211, P321, DOI 10.1016/S0169-4332(03)00355-6
   HAKIKI NE, 1995, CORROS SCI, V37, P1809, DOI 10.1016/0010-938X(95)00084-W
   Hakiki NE, 1998, J ELECTROCHEM SOC, V145, P3821, DOI 10.1149/1.1838880
   Hernandez RPB, 2010, CORROS SCI, V52, P826, DOI 10.1016/j.corsci.2009.11.003
   Javidi M, 2009, MATER CORROS, V60, P336, DOI 10.1002/maco.200805117
   Khelfaoui Y, 2006, SURF COAT TECH, V200, P4523, DOI 10.1016/j.surfcoat.2005.03.043
   Kocijan A, 2011, CORROS SCI, V53, P776, DOI 10.1016/j.corsci.2010.11.010
   Lee JB, 2010, MATER CHEM PHYS, V122, P194, DOI 10.1016/j.matchemphys.2010.02.033
   Lei MK, 2001, BIOMATERIALS, V22, P641, DOI 10.1016/S0142-9612(00)00226-X
   LOVRECEK B, 1972, ELECTROCHIM ACTA, V17, P1151, DOI 10.1016/0013-4686(72)90031-X
   Marcus P, 1998, ELECTROCHIM ACTA, V43, P109, DOI 10.1016/S0013-4686(97)00239-9
   Martini EMA, 2000, CORROS SCI, V42, P443, DOI 10.1016/S0010-938X(99)00064-5
   Montemor MF, 2000, CORROS SCI, V42, P1635, DOI 10.1016/S0010-938X(00)00012-3
   Nicic I, 2008, J NUCL MATER, V379, P54, DOI 10.1016/j.jnucmat.2008.06.014
   Ningshen S, 2007, CORROS SCI, V49, P481, DOI 10.1016/j.corsci.2006.05.041
   Ningshen S, 2009, ELECTROCHIM ACTA, V54, P6374, DOI 10.1016/j.electacta.2009.06.003
   Pan J, 1997, J BIOMED MATER RES, V35, P309, DOI 10.1002/(SICI)1097-4636(19970605)35:3<309::AID-JBM5>3.3.CO;2-N
   Perez FJ, 2002, SURF COAT TECH, V155, P250
   Rocha LA, 2004, SURF COAT TECH, V180, P158, DOI 10.1016/j.surfcoat.2003.10.059
   Rondelli G, 2005, BIOMATERIALS, V26, P739, DOI 10.1016/j.biomaterials.2004.03.012
   Sahoo S, 2010, SURF COAT TECH, V204, P2817, DOI 10.1016/j.surfcoat.2010.02.058
   SCHMUKI P, 1992, J ELECTROCHEM SOC, V139, P1908, DOI 10.1149/1.2069520
   Shahryari A, 2008, MAT SCI ENG C-BIO S, V28, P94, DOI 10.1016/j.msec.2007.09.002
   Sikora E, 1996, ELECTROCHIM ACTA, V41, P783, DOI 10.1016/0013-4686(95)00312-6
   SUNSERI C, 1990, J ELECTROCHEM SOC, V137, P2411, DOI 10.1149/1.2086952
   Taveira LV, 2010, CORROS SCI, V52, P2813, DOI 10.1016/j.corsci.2010.04.021
   Terada M., 2010, MATER CORROS, V61, P1
   Torabi M, 2011, MATER CORROS, V62, P252, DOI 10.1002/maco.200905399
   Wang L, 2010, SURF COAT TECH, V205, P1599, DOI 10.1016/j.surfcoat.2010.07.111
   Wijesinghe TLSL, 2008, CORROS SCI, V50, P23, DOI 10.1016/j.corsci.2007.06.009
   Yan Y, 2006, TRIBOL INT, V39, P1509, DOI 10.1016/j.triboint.2006.01.016
   Yashiro H, 1998, CORROS SCI, V40, P781, DOI 10.1016/S0010-938X(97)00178-9
NR 52
TC 13
Z9 13
U1 1
U2 33
PU WILEY-V C H VERLAG GMBH
PI WEINHEIM
PA BOSCHSTRASSE 12, D-69469 WEINHEIM, GERMANY
SN 0947-5117
EI 1521-4176
J9 MATER CORROS
JI Mater. Corros.
PD JUL
PY 2012
VL 63
IS 7
BP 586
EP 592
DI 10.1002/maco.201006052
PG 7
WC Materials Science, Multidisciplinary; Metallurgy & Metallurgical
   Engineering
SC Materials Science; Metallurgy & Metallurgical Engineering
GA 970NG
UT WOS:000306137200005
DA 2018-10-19
ER

PT J
AU Shirakata, Y
   Taniyama, K
   Yoshimoto, T
   Takeuchi, N
   Noguchi, K
AF Shirakata, Yoshinori
   Taniyama, Katsuyoshi
   Yoshimoto, Takehiko
   Takeuchi, Naoshi
   Noguchi, Kazuyuki
TI Effect of bone swaging with calcium phosphate bone cement on periodontal
   regeneration in dogs
SO ORAL SURGERY ORAL MEDICINE ORAL PATHOLOGY ORAL RADIOLOGY
LA English
DT Article
ID CONTIGUOUS AUTOGENOUS TRANSPLANT; GUIDED TISSUE REGENERATION; INTRABONY
   DEFECTS; GRAFTS; REPAIR; WALL; AUGMENTATION; BIOMATERIAL; MEMBRANE;
   FIXATION
AB Objectives. The present study evaluated the effects of bone swaging (BS) with injectable calcium phosphate bone cement (CPC) on periodontal healing in 1-wall intrabony defects in dogs.
   Study Design. Surgically created 1-wall intrabony defects were treated with BS, CPC, BS with CPC (BS/CPC), or open-flap debridement (OFD). The animals were humanely killed for histologic evaluation at 8 weeks.
   Results. New bone formation occurred from the host bone toward the coronal region of the defects in the BS/CPC group. The height of new bone formation was significantly higher in the BS/CPC group than in the other groups (P < .05). New cementum formation was most notable in the BS/CPC group, where it was significantly greater than in the OFD and CPC groups (P < .05).
   Conclusions. Within the limitations of the present study, it was concluded that BS/CPC treatment effectively promoted new bone and cementum formation in 1-wall intrabony defects in dogs. (Oral Surg Oral Med Oral Pathol Oral Radiol 2012;114:35-42)
C1 [Shirakata, Yoshinori; Taniyama, Katsuyoshi; Yoshimoto, Takehiko; Takeuchi, Naoshi; Noguchi, Kazuyuki] Kagoshima Univ, Dept Periodontol, Grad Sch Med & Dent Sci, Kagoshima 8908544, Japan.
   Kagoshima Univ, Dept Periodontol, Grad Sch Med & Dent Sci, Kagoshima 8908544, Japan.
RP Shirakata, Y (reprint author), Kagoshima Univ, Dept Periodontol, Grad Sch Med & Dent Sci, 8-35-1 Sakuragaoka, Kagoshima 8908544, Japan.
EM syoshi@dent.kagoshima-u.ac.jp
FU Ministry of Education, Science, Sports and Culture, Japan [20791472]
FX This study was supported by a Grant-in-Aid for Encouragement of Young
   Scientists B (No. 20791472 to Dr. Y. Shirakata) from the Ministry of
   Education, Science, Sports and Culture, Japan.
CR ALBERIUS P, 1992, J ORAL MAXIL SURG, V50, P829, DOI 10.1016/0278-2391(92)90274-4
   Araujo MG, 2002, J CLIN PERIODONTOL, V29, P1122, DOI 10.1034/j.1600-051X.2002.291213.x
   Baker DL, 2005, J CLIN PERIODONTOL, V32, P561, DOI 10.1111/j.1600-051X.2005.00714.x
   BLOCK MS, 1985, J ORAL MAXIL SURG, V43, P3, DOI 10.1016/S0278-2391(85)80005-7
   BURNETTE EW, 1967, J PERIODONTOL, V38, P148, DOI 10.1902/jop.1967.38.2.148
   CONSTANTZ BR, 1995, SCIENCE, V267, P1796, DOI 10.1126/science.7892603
   Donos N, 2005, CLIN ORAL IMPLAN RES, V16, P133, DOI 10.1111/j.1600-0501.2004.01104.x
   Donos N, 2002, CLIN ORAL IMPLAN RES, V13, P192, DOI 10.1034/j.1600-0501.2002.130210.x
   Ersanli S, 2004, J PERIODONTOL, V75, P750, DOI 10.1902/jop.2004.75.5.750
   EWEN SJ, 1965, J PERIODONTOL, V36, P57, DOI 10.1902/jop.1965.36.1.57
   HANEY JM, 1993, J PERIODONTOL, V64, P883, DOI 10.1902/jop.1993.64.9.883
   Hayashi C, 2006, J PERIODONTOL, V77, P940, DOI 10.1902/jop.2006.050283
   HIATT WH, 1978, J PERIODONTOL, V49, P495, DOI 10.1902/jop.1978.49.10.495
   Kim CS, 2005, J CLIN PERIODONTOL, V32, P583, DOI 10.1111/j.1600-051X.2005.00729.x
   LIN KY, 1990, PLAST RECONSTR SURG, V86, P449, DOI 10.1097/00006534-199009000-00010
   Nevins ML, 2003, INT J PERIODONT REST, V23, P9
   PHILLIPS JH, 1988, PLAST RECONSTR SURG, V82, P872, DOI 10.1097/00006534-198811000-00023
   Rosen PS, 2000, PERIODONTOL 2000, V22, P88, DOI 10.1034/j.1600-0757.2000.2220107.x
   ROSS SE, 1966, PERIODONTICS, V4, P246
   Sakata J, 2006, INT J PERIODONT REST, V26, P161
   Sculean A, 2004, Clin Oral Investig, V8, P70
   Shirakata Y, 2002, J PERIODONTOL, V73, P1043, DOI 10.1902/jop.2002.73.9.1043
   Shirakata Y, 2007, J PERIODONTOL, V78, P889, DOI 10.1902/jop.2007.060353
   Sigurdsson T J, 1996, Int J Periodontics Restorative Dent, V16, P524
   Trombelli L, 1999, J CLIN PERIODONTOL, V26, P381, DOI 10.1034/j.1600-051X.1999.260608.x
   Walsh WR, 2008, BIOMATERIALS, V29, P266, DOI 10.1016/j.biomaterials.2007.09.035
   Wikesjo U M, 1995, J Calif Dent Assoc, V23, P30
   ZUBERY Y, 1993, J PERIODONTOL, V64, P66, DOI 10.1902/jop.1993.64.1.66
NR 28
TC 4
Z9 4
U1 0
U2 1
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 2212-4403
J9 OR SURG OR MED OR PA
JI Oral Surg. Oral Med. Oral Pathol. Oral Radiol.
PD JUL
PY 2012
VL 114
IS 1
BP 35
EP 42
DI 10.1016/j.tripleo.2011.05.028
PG 8
WC Dentistry, Oral Surgery & Medicine
SC Dentistry, Oral Surgery & Medicine
GA 972OL
UT WOS:000306286300020
PM 22732847
DA 2018-10-19
ER

PT J
AU Nunes, J
   Santos, RJ
   Loureiro, V
   Piedade, AP
AF Nunes, Jorge
   Santos, Rita J.
   Loureiro, Vera
   Piedade, Ana P.
TI Nanocomposite Thin Films with Hybrid Inorganic/Organic Matrix for the
   Modification of Silicon-Based Implants
SO PLASMA PROCESSES AND POLYMERS
LA English
DT Article
DE contact angles hysteresis; hybrid inorganic; organic thin films;
   nanocomposites; neural implants; sputtering
ID MICROELECTRODE ARRAYS; NEURAL RECORDINGS; STAINLESS-STEEL; BRAIN-TISSUE;
   ELECTRODE; RELEASE; DEXAMETHASONE; BIOMATERIALS; INTERFACE; POLYIMIDE
AB Thin nanocomposite hybrid films were deposited by r.f. magnetron sputtering. These were composed of of SiO2, poly(propylene) (PP) and SiO2/PP, with Ag contents varying from 0 to 30?at.-%. The influence of metal concentration on the properties of the deposited surfaces was evaluated. The chemical composition, chemical structure, morphology, dynamic wettability behavior, and microstructure were studied. The overall properties of the inorganic/organic system are more influenced by those of the ceramic fraction than by the polymeric one. The hysteresis of the contact angle shows that all the surfaces interact with water and that the presence of the metallic element increases reactivity in an aqueous medium. These results show promising applications in the biomedical field particularly in those that use silicon as a biomaterial for implants.
C1 [Nunes, Jorge; Santos, Rita J.; Loureiro, Vera; Piedade, Ana P.] CEMUC Dept Engn Mecan, P-3030788 Coimbra, Portugal.
RP Piedade, AP (reprint author), CEMUC Dept Engn Mecan, Rua Luis Reis Silva, P-3030788 Coimbra, Portugal.
EM ana.piedade@dem.uc.pt
RI Piedade, Ana/K-8637-2012
OI Piedade, Ana/0000-0002-1588-0640; Santos, Rita Joana/0000-0002-1349-5685
FU Portuguese Foundation for Science and Technology (FCT)
   [SFRH/BD/47586/2008]
FX The authors acknowledge the financial support from the Portuguese
   Foundation for Science and Technology (FCT) for the PhD grant of JN
   (SFRH/BD/47586/2008).
CR Abidian MR, 2006, ADV MATER, V18, P405, DOI 10.1002/adma.200501726
   Armelao L, 2009, CHEMPHYSCHEM, V10, P3249, DOI 10.1002/cphc.200900571
   Biran R, 2005, EXP NEUROL, V195, P115, DOI 10.1016/j.expneurol.2005.04.020
   CAMPBELL PK, 1991, IEEE T BIO-MED ENG, V38, P758, DOI 10.1109/10.83588
   Coates J., 2000, ENCY ANAL CHEM, V12, P10815, DOI DOI 10.1002/9780470027318.A5606
   Drabik M, 2007, VACUUM, V81, P920, DOI 10.1016/j.vacuum.2006.10.013
   Drabik M, 2007, PLASMA PROCESS POLYM, V4, P654, DOI 10.1002/ppap.200700006
   EDELL DJ, 1992, IEEE T BIO-MED ENG, V39, P635, DOI 10.1109/10.141202
   Erbil HY, 2006, SURFACE CHEM SOLID L
   Gao LC, 2006, LANGMUIR, V22, P6234, DOI 10.1021/la060254j
   GLOCKER DA, 1995, HDB THIN FILM PROCES
   Green RA, 2010, BIOMATERIALS, V31, P886, DOI 10.1016/j.biomaterials.2009.09.099
   He W, 2006, J NEURAL ENG, V3, P316, DOI 10.1088/1741-2560/3/4/009
   Kim CS, 2008, J SOL-GEL SCI TECHN, V47, P7, DOI 10.1007/s10971-008-1739-7
   Kim DH, 2010, ACTA BIOMATER, V6, P57, DOI 10.1016/j.actbio.2009.07.034
   Leung BK, 2008, BIOMATERIALS, V29, P3289, DOI 10.1016/j.biomaterials.2008.03.045
   Ludwig KA, 2006, J NEURAL ENG, V3, P59, DOI 10.1088/1741-2560/3/1/007
   Moxon KA, 2007, J BIOMAT SCI-POLYM E, V18, P1263, DOI 10.1163/156856207782177882
   Normann RA, 1999, VISION RES, V39, P2577, DOI 10.1016/S0042-6989(99)00040-1
   Nunes J, 2008, MICROSC MICROANAL, V14, P35, DOI 10.1017/S1431927608089307
   Pal S, 2007, APPL ENVIRON MICROB, V73, P1712, DOI 10.1128/AEM.02218-06
   Palumbo F, 2011, PLASMA PROCESS POLYM, V8, P118, DOI 10.1002/ppap.201000098
   Piedade AP, 2008, ACTA BIOMATER, V4, P1073, DOI 10.1016/j.actbio.2008.02.023
   Piedade AP, 2009, J NANOSCI NANOTECHNO, V9, P3792, DOI 10.1166/jnn.2009.NS69
   Piedade A. P., 2001, THESIS U COIMBRA
   Pierce AL, 2009, J NEUROSCI METH, V180, P106, DOI 10.1016/j.jneumeth.2009.02.008
   Polikov VS, 2005, J NEUROSCI METH, V148, P1, DOI 10.1016/j.jneumeth.2005.08.015
   Rak K, 2011, J BIOMED MATER RES A, V97A, P158, DOI 10.1002/jbm.a.33042
   REICHELT K, 1990, THIN SOLID FILMS, V191, P91, DOI 10.1016/0040-6090(90)90277-K
   Roach P, 2010, SURF SCI REP, V65, P145, DOI 10.1016/j.surfrep.2010.07.001
   Rousche PJ, 2001, IEEE T BIO-MED ENG, V48, P361, DOI 10.1109/10.914800
   Spataro L, 2005, EXP NEUROL, V194, P289, DOI 10.1016/j.expneurol.2004.08.037
   Stelmashuk V, 2004, VACUUM, V75, P207, DOI 10.1016/j.vacuum.2004.02.007
   Stieglitz T, 2004, BIOMED TECH, V49, P72, DOI 10.1515/BMT.2004.015
   Szarowski DH, 2003, BRAIN RES, V983, P23, DOI 10.1016/S0006-8993(03)03023-3
   Wadhwa R, 2006, J CONTROL RELEASE, V110, P531, DOI 10.1016/j.jconrel.2005.10.027
   Yang ZL, 2011, PLASMA PROCESS POLYM, V8, P208, DOI 10.1002/ppap.201000111
   Zhong YH, 2008, J R SOC INTERFACE, V5, P957, DOI 10.1098/rsif.2008.0071
NR 38
TC 2
Z9 2
U1 3
U2 26
PU WILEY-V C H VERLAG GMBH
PI WEINHEIM
PA BOSCHSTRASSE 12, D-69469 WEINHEIM, GERMANY
SN 1612-8850
J9 PLASMA PROCESS POLYM
JI Plasma Process. Polym.
PD JUL
PY 2012
VL 9
IS 7
BP 709
EP 717
DI 10.1002/ppap.201100089
PG 9
WC Physics, Applied; Physics, Fluids & Plasmas; Physics, Condensed Matter;
   Polymer Science
SC Physics; Polymer Science
GA 972LV
UT WOS:000306279500008
DA 2018-10-19
ER

PT J
AU Sandhya, S
   Sureshbabu, S
   Varma, HK
   Komath, M
AF Sandhya, S.
   Sureshbabu, S.
   Varma, H. K.
   Komath, Manoj
TI Nucleation kinetics of the formation of low dimensional calcium sulfate
   dihydrate crystals in isopropyl alcohol medium
SO CRYSTAL RESEARCH AND TECHNOLOGY
LA English
DT Article
DE calcium sulfate; gypsum; crystal growth; induction time; classical
   nucleation theory; nucleation kinetics
ID SULFURIC-ACID; GYPSUM; CRYSTALLIZATION; HEMIHYDRATE; MORPHOLOGY;
   PRECIPITATION; NANOPARTICLES; NANOWIRES; RATES
AB Calcium sulfate dihydrate, constituted as uniform crystals of low dimensions, is a potential biomaterial for clinical applications like bone graft substitution and drug delivery. In this work, isopropyl alcohol has been used as a solvent to obtain low dimensional calcium sulfate dihydrate crystals from calcium nitrate - sulfuric acid system. Reactants in 0.5 molar concentration at ambient conditions generated uniform rod-shaped crystals of length 35 mu m. Analysis using X-ray Diffractometry and Fourier Transform Infrared Spectrometry showed the material to be well crystallized, phase-pure calcium sulfate dihydrate. The nucleation kinetics has been studied by observing the induction time of phase formation in solutions of millimolar concentrations through turbidimetry at 300 K. The data have been analysed using classical nucleation theory to deduce parameters like interfacial tension (or surface free energy), nucleation rate and critical radius. The surface free energy obtained (5.6 mJ/m2) is comparatively lower than that reported for aqueous precipitation, which could be attributed to the presence of isopropyl alcohol. On escalating the supersaturation ratio, the nucleation rate drastically increased and the critical radius decreased exponentially. Particles formed at supersaturation 1.39 showed a monomodal distribution centered at 8.2 nm in Dynamic Light Scattering analysis. Comparable particle sizes were obtained in Transmission Electron Microscopy.
C1 [Sandhya, S.; Sureshbabu, S.; Varma, H. K.; Komath, Manoj] Sree Chitra Tirunal Inst Med Sci & Technol, Biomed Technol Wing, Trivandrum 695012, Kerala, India.
RP Komath, M (reprint author), Sree Chitra Tirunal Inst Med Sci & Technol, Biomed Technol Wing, Trivandrum 695012, Kerala, India.
EM manoj@sctimst.ac.in
OI Komath, Manoj/0000-0003-2336-5785
FU Department of Science and Technology (Science and Engineering Research
   Council), Government of India
FX The authors would like to express their gratitude to Department of
   Science and Technology (Science and Engineering Research Council),
   Government of India, for the financial support to this work.
CR Alimi F, 2004, DESALINATION, V166, P427, DOI 10.1016/j.desal.2004.06.097
   Beckmann W., 1991, J CRYST GROWTH, V198/991, P7031
   Chen Y, 2007, EUR J INORG CHEM, P4906, DOI 10.1002/ejic.200700196
   Datta S, 2005, CRYST RES TECHNOL, V40, P233, DOI 10.1002/crat.200410331
   De Meer S, 2000, J GEOL SOC LONDON, V157, P269
   De Yoreo JJ, 2003, REV MINERAL GEOCHEM, V54, P57, DOI 10.2113/0540057
   Dixit NM, 2002, PHYS REV E, V66, DOI 10.1103/PhysRevE.66.051602
   Dixit NM, 2001, COLLOID SURFACE A, V190, P47, DOI 10.1016/S0927-7757(01)00664-1
   EDINGER SE, 1973, J CRYST GROWTH, V18, P217, DOI 10.1016/0022-0248(73)90164-4
   El-Shall H, 2002, CRYST RES TECHNOL, V37, P1264, DOI 10.1002/crat.200290001
   Eun HT, 2003, J IND ENG CHEM, V9, P614
   Guan BH, 2010, IND ENG CHEM RES, V49, P5569, DOI 10.1021/ie902022b
   Horsch M, 2008, PHYS REV E, V78, DOI 10.1103/PhysRevE.78.011603
   Kats J. L., 1992, PURE APPL CHEM, V11, P1661
   Knittle E, 2001, PHYS CHEM MINER, V28, P630, DOI 10.1007/s002690100187
   Liao JC, 2009, INT ORTHOP, V33, P1669, DOI 10.1007/s00264-008-0677-x
   Ling YB, 2005, IND ENG CHEM RES, V44, P715, DOI 10.1021/ie049316w
   Mahmoud MHH, 2004, J COLLOID INTERF SCI, V270, P99, DOI 10.1016/j.jcis.2003.09.023
   McCartney E. R, 1958, J COLLOID SCI, V13, P383, DOI 10.1016/0095-8522(58)90047-3
   Mirzayan R, 2001, J BONE JOINT SURG AM, V83A, P355, DOI 10.2106/00004623-200103000-00006
   MOLINABOLIVAR JA, 2004, COLLOIDAL BIOMOLECUL, P53
   Moroni D, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.235703
   Mullin J.W, 1972, CRYSTALLISATION
   Murray CB, 2000, ANNU REV MATER SCI, V30, P545, DOI 10.1146/annurev.matsci.30.1.545
   Myerson A. S., 1993, SERIES CHEM ENG
   Osterwalder N, 2007, J NANOPART RES, V9, P275, DOI 10.1007/s11051-006-9149-7
   Pecora G, 1997, ORAL SURG ORAL MED O, V84, P424, DOI 10.1016/S1079-2104(97)90043-3
   Peltier L. F., 1961, J CLIN ORTHOP, V21, P1
   Prisciandaro M, 2006, IND ENG CHEM RES, V45, P2070, DOI 10.1021/ie050615a
   Prisciandaro M, 2003, IND ENG CHEM RES, V42, P6647, DOI 10.1021/ie020996h
   Rashad MM, 2004, J CRYST GROWTH, V267, P372, DOI 10.1016/j.jcrysgro.2004.03.060
   Rees GD, 1999, LANGMUIR, V15, P1993, DOI 10.1021/la981026v
   Ricci J. L., 1992, T 4 WORLD BIOM C BER
   SIDQUI M, 1995, BIOMATERIALS, V16, P1327, DOI 10.1016/0142-9612(95)91048-4
   SOHNEL O, 1988, J COLLOID INTERF SCI, V123, P43, DOI 10.1016/0021-9797(88)90219-6
   Song XF, 2011, CRYST RES TECHNOL, V46, P166, DOI 10.1002/crat.201000420
   Thomas MV, 2009, J BIOMED MATER RES B, V88B, P597, DOI 10.1002/jbm.b.31269
   Wang FL, 2010, IND ENG CHEM RES, V49, P11344, DOI 10.1021/ie100309b
   Wang P, 2008, J AM CERAM SOC, V91, P2039, DOI 10.1111/j.1551-2916.2008.02358.x
   Yang L., 2001, B MATER SCI, V34, P233
   Yu BQ, 2009, INT ORTHOP, V33, P1127, DOI 10.1007/s00264-008-0611-2
NR 41
TC 14
Z9 15
U1 0
U2 24
PU WILEY-V C H VERLAG GMBH
PI WEINHEIM
PA BOSCHSTRASSE 12, D-69469 WEINHEIM, GERMANY
SN 0232-1300
J9 CRYST RES TECHNOL
JI Cryst. Res. Technol.
PD JUL
PY 2012
VL 47
IS 7
BP 780
EP 792
DI 10.1002/crat.201200098
PG 13
WC Crystallography
SC Crystallography
GA 967YC
UT WOS:000305943100015
DA 2018-10-19
ER

PT J
AU Atala, A
AF Atala, Anthony
TI Tissue engineering of reproductive tissues and organs
SO FERTILITY AND STERILITY
LA English
DT Article
DE Amniotic fluid stem cell; biomaterial; penis; testes; uterus; urethra;
   vagina
ID EMBRYONIC STEM-CELLS; ACELLULAR MATRIX GRAFT; IN-VITRO;
   ENDOTHELIAL-CELLS; COLLAGEN MATRIX; NUCLEAR TRANSPLANTATION; URETHRAL
   RECONSTRUCTION; FUNCTIONAL-PROPERTIES; CORPORAL TISSUE; SMOOTH-MUSCLE
AB Regenerative medicine and tissue engineering technology may soon offer new hope for patients with serious injuries and end-stage reproductive organ failure. Scientists are now applying the principles of cell transplantation, material science, and bioengineering to construct biological substitutes that can restore and maintain normal function in diseased and injured reproductive tissues. In addition, the stem cell field is advancing, and new discoveries in this field will lead to new therapeutic strategies. For example, newly discovered types of stem cells have been retrieved from uterine tissues such as amniotic fluid and placental stem cells. The process of therapeutic cloning and the creation of induced pluripotent cells provide still other potential sources of stem cells for cell-based tissue engineering applications. Although stem cells are still in the research phase, some therapies arising from tissue engineering endeavors that make use of autologous adult cells have already entered the clinic. This article discusses these tissue engineering strategies for various organs in the male and female reproductive tract. (Fertil Steril (R) 2012; 98: 21-9. (C) 2012 by American Society for Reproductive Medicine.)
C1 Wake Forest Univ, Sch Med, Wake Forest Inst Regenerat Med, Dept Urol, Winston Salem, NC 27157 USA.
RP Atala, A (reprint author), Wake Forest Univ, Sch Med, Wake Forest Inst Regenerat Med, Dept Urol, Med Ctr Blvd, Winston Salem, NC 27157 USA.
EM aatala@wfubmc.edu
OI Atala, Anthony/0000-0001-8186-2160
CR Amiel GE, 1999, UROL CLIN N AM, V26, P235, DOI 10.1016/S0094-0143(99)80019-6
   Amiel GE, 2006, TISSUE ENG, V12, P2355, DOI 10.1089/ten.2006.12.2355
   Assady S, 2001, DIABETES, V50, P1691, DOI 10.2337/diabetes.50.8.1691
   Atala A, 1998, J UROLOGY, V159, P2, DOI 10.1016/S0022-5347(01)63994-6
   Atala A, 2006, LANCET, V367, P1241, DOI 10.1016/S0140-6736(06)68438-9
   Atala A, 1999, J UROLOGY, V162, P1148, DOI 10.1016/S0022-5347(01)68105-9
   ATALA A, 1992, J UROLOGY, V148, P658, DOI 10.1016/S0022-5347(17)36685-5
   Atala A, 2001, BJU INT, V88, P765, DOI 10.1046/j.1464-4096.2001.atala.2467.x
   Atala A, 1999, ADV EXP MED BIOL, V462, P31
   BAZEED MA, 1983, UROLOGY, V21, P53, DOI 10.1016/0090-4295(83)90123-1
   BERGSMA JE, 1995, BIOMATERIALS, V16, P267, DOI 10.1016/0142-9612(95)93253-A
   Brivanlou AH, 2003, SCIENCE, V300, P913, DOI 10.1126/science.1082940
   Campbell GR, 2008, J TISSUE ENG REGEN M, V2, P50, DOI 10.1002/term.66
   Chen F, 1999, UROLOGY, V54, P407, DOI 10.1016/S0090-4295(99)00179-X
   Chen KL, 2010, P NATL ACAD SCI USA, V107, P3346, DOI 10.1073/pnas.0909367106
   CILENTO BG, 1994, J UROLOGY, V152, P665, DOI 10.1016/S0022-5347(17)32676-9
   Dahms SE, 1998, BRIT J UROL, V82, P411
   De Coppi P, 2007, NAT BIOTECHNOL, V25, P100, DOI 10.1038/nbt1274
   de Filippo RE, 2003, TISSUE ENG, V9, P301, DOI 10.1089/107632703764664765
   De Filippo RE, 2002, J UROLOGY, V168, P1789, DOI 10.1097/01.ju.0000027662.69103.72
   Dinnyes Andras, 2002, Cloning and Stem Cells, V4, P81, DOI 10.1089/153623002753632075
   El Kassaby A, 2008, J UROLOGY, V179, P1432, DOI 10.1016/j.juro.2007.11.101
   El-Kassaby AW, 2003, J UROLOGY, V169, P170, DOI 10.1016/S0022-5347(05)64060-8
   Falke G, 2003, TISSUE ENG, V9, P871, DOI 10.1089/107632703322495529
   GILDING DK, 1981, BIOCOMPATIBILITY CLI, P209
   Harris LD, 1998, J BIOMED MATER RES, V42, P396, DOI 10.1002/(SICI)1097-4636(19981205)42:3<396::AID-JBM7>3.0.CO;2-E
   Hochedlinger K, 2004, HEMATOL J, V5, pS114, DOI 10.1038/sj.thj.6200435
   Hochedlinger K, 2002, CURR OPIN CELL BIOL, V14, P741, DOI 10.1016/S0955-0674(02)00380-0
   House M, 2010, TISSUE ENG PT A, V16, P2101, DOI [10.1089/ten.tea.2009.0457, 10.1089/ten.TEA.2009.0457]
   HYNES RO, 1992, CELL, V69, P11, DOI 10.1016/0092-8674(92)90115-S
   Itskovitz-Eldor J, 2000, MOL MED, V6, P88, DOI 10.1007/BF03401776
   Kaufman DS, 2001, P NATL ACAD SCI USA, V98, P10716, DOI 10.1073/pnas.191362598
   Kehat I, 2001, J CLIN INVEST, V108, P407, DOI 10.1172/JCI12131
   Kershen RT, 2002, TISSUE ENG, V8, P515, DOI 10.1089/107632702760184754
   Kim BS, 1998, TRENDS BIOTECHNOL, V16, P224, DOI 10.1016/S0167-7799(98)01191-3
   Kwon TG, 2002, J UROLOGY, V168, P1754, DOI 10.1097/01.ju.0000030103.53181.7d
   Le Roux PJ, 2005, J UROLOGY, V173, P140, DOI 10.1097/01.ju.0000146554.79487.7f
   Lee SJ, 2008, BIOMATERIALS, V29, P2891, DOI 10.1016/j.biomaterials.2008.03.032
   Lee SJ, 2008, BIOMATERIALS, V29, P1422, DOI 10.1016/j.biomaterials.2007.11.024
   Levenberg S, 2002, P NATL ACAD SCI USA, V99, P4391, DOI 10.1073/pnas.032074999
   LI ST, 1995, BIOMEDICAL ENG HDB, P627
   Li XA, 2011, BIOMATERIALS, V32, P8172, DOI 10.1016/j.biomaterials.2011.07.050
   Liebert M, 1997, DIFFERENTIATION, V61, P177, DOI 10.1046/j.1432-0436.1997.6130177.x
   Liebert M, 1991, Semin Urol, V9, P124
   MACHLUF M, 1998, GRAFT, V1, P31
   Meissner A, 2007, NAT BIOTECHNOL, V25, P1177, DOI 10.1038/nbt1335
   MIKOS AG, 1994, BIOMATERIALS, V15, P55, DOI 10.1016/0142-9612(94)90197-X
   Nguyen HT, 1999, IN VITRO CELL DEV-AN, V35, P371
   Oberpenning F, 1999, NAT BIOTECHNOL, V17, P149
   Okita K, 2007, NATURE, V448, P313, DOI 10.1038/nature05934
   OLSEN L, 1992, SCAND J UROL NEPHROL, V26, P323, DOI 10.3109/00365599209181220
   Park HJ, 1999, J UROLOGY, V162, P1106, DOI 10.1016/S0022-5347(01)68084-4
   PEPPAS NA, 1994, SCIENCE, V263, P1715, DOI 10.1126/science.8134835
   Piechota HJ, 1998, J UROLOGY, V159, P1717, DOI 10.1097/00005392-199805000-00100
   Puthenveettil JA, 1999, ADV EXP MED BIOL, V462, P83
   Raya-Rivera AM, 2008, WORLD J UROL, V26, P307
   Raya-Rivera A, 2011, LANCET, V377, P1175, DOI 10.1016/S0140-6736(10)62354-9
   Reubinoff BE, 2001, NAT BIOTECHNOL, V19, P1134, DOI 10.1038/nbt1201-1134
   Rideout WM, 2001, SCIENCE, V293, P1093, DOI 10.1126/science.1063206
   SAMS AE, 1995, OSTEOARTHR CARTILAGE, V3, P47, DOI 10.1016/S1063-4584(05)80037-8
   Schuldiner M, 2000, P NATL ACAD SCI USA, V97, P11307, DOI 10.1073/pnas.97.21.11307
   Schuldiner M, 2001, BRAIN RES, V913, P201, DOI 10.1016/S0006-8993(01)02776-7
   Scriven SD, 1997, J UROLOGY, V158, P1147, DOI 10.1016/S0022-5347(01)64407-0
   Sievert KD, 2000, J UROLOGY, V163, P1958, DOI 10.1016/S0022-5347(05)67610-0
   SILVER FH, 1992, J LONG-TERM EFF MED, V2, P67
   Solter D, 2000, NAT REV GENET, V1, P199, DOI 10.1038/35042066
   Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019
   Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024
   Wang T, 2003, CREATION ENG UTERUS
   Wernig M, 2007, NATURE, V448, P318, DOI 10.1038/nature05944
   Yoo JJ, 1998, UROLOGY, V51, P221, DOI 10.1016/S0090-4295(97)00644-4
   Yoo JJ, 1999, J UROLOGY, V162, P1119, DOI 10.1016/S0022-5347(01)68090-X
   Yu JY, 2007, SCIENCE, V318, P1917, DOI 10.1126/science.1151526
   Zhang SC, 2001, NAT BIOTECHNOL, V19, P1129, DOI 10.1038/nbt1201-1129
NR 74
TC 31
Z9 32
U1 1
U2 36
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0015-0282
J9 FERTIL STERIL
JI Fertil. Steril.
PD JUL
PY 2012
VL 98
IS 1
DI 10.1016/j.fertnstert.2012.05.038
PG 9
WC Obstetrics & Gynecology; Reproductive Biology
SC Obstetrics & Gynecology; Reproductive Biology
GA 968AU
UT WOS:000305950200011
PM 22748231
DA 2018-10-19
ER

PT J
AU Moharamzadeh, K
   Colley, H
   Murdoch, C
   Hearnden, V
   Chai, WL
   Brook, IM
   Thornhill, MH
   MacNeil, S
AF Moharamzadeh, K.
   Colley, H.
   Murdoch, C.
   Hearnden, V.
   Chai, W. L.
   Brook, I. M.
   Thornhill, M. H.
   MacNeil, S.
TI Tissue-engineered Oral Mucosa
SO JOURNAL OF DENTAL RESEARCH
LA English
DT Review
DE fibroblast; keratinocyte; biocompatibility; biomaterial; regeneration;
   gingiva
ID BILAYERED CELL THERAPY; IN-VITRO MODEL; CANDIDA-ALBICANS; EQUIVALENTS
   CHARACTERIZATION; BUCCAL MUCOSA; ATHYMIC MICE; SKIN; CULTURE;
   KERATINOCYTES; DIFFERENTIATION
AB Advances in tissue engineering have permitted the three-dimensional (3D) reconstruction of human oral mucosa for various in vivo and in vitro applications. Tissue-engineered oral mucosa have been further optimized in recent years for clinical applications as a suitable graft material for intra-oral and extra-oral repair and treatment of soft-tissue defects. Novel 3D in vitro models of oral diseases such as cancer, Candida, and bacterial invasion have been developed as alternatives to animal models for investigation of disease phenomena, their progression, and treatment, including evaluation of drug delivery systems. The introduction of 3D oral mucosal reconstructs has had a significant impact on the approaches to biocompatibility evaluation of dental materials and oral healthcare products as well as the study of implant-soft tissue interfaces. This review article discusses the recent advances in tissue engineering and applications of tissue-engineered human oral mucosa.
C1 [Moharamzadeh, K.; Colley, H.; Murdoch, C.; Hearnden, V.; Brook, I. M.; Thornhill, M. H.] Univ Sheffield, Sch Clin Dent, Sheffield S10 2TA, S Yorkshire, England.
   [Chai, W. L.] Univ Malaya, Dept Gen Dent Practice & Oral & Maxillofacial Ima, Kuala Lumpur, Malaya, Malaysia.
   [Hearnden, V.; MacNeil, S.] Univ Sheffield, Kroto Res Inst, Sheffield S10 2TA, S Yorkshire, England.
RP Moharamzadeh, K (reprint author), Univ Sheffield, Sch Clin Dent, Sheffield S10 2TA, S Yorkshire, England.
EM k.moharamzadeh@sheffield.ac.uk
RI Chai, Wen Lin/B-3582-2010
OI Chai, Wen Lin/0000-0002-0945-1807; Thornhill,
   Martin/0000-0003-0681-4083; Hearnden, Vanessa/0000-0003-0838-7783;
   Murdoch, Craig/0000-0001-9724-122X; Moharamzadeh,
   Keyvan/0000-0002-8842-4638
CR Barbagli Guido, 2007, Int. braz j urol., V33, P461, DOI 10.1590/S1677-55382007000400002
   Bhargava S, 2008, EUR UROL, V53, P1263, DOI 10.1016/j.eururo.2008.01.061
   Chai WL, 2010, J PERIODONTOL, V81, P1187, DOI 10.1902/jop.2010.090648
   Chai WL, 2011, J BIOMED A IN PRESS
   Colley HE, 2011, BRIT J CANCER, V105, P1582, DOI 10.1038/bjc.2011.403
   Costea DE, 2005, DIFFERENTIATION, V73, P134, DOI 10.1111/j.1432-0436.2005.00017.x
   Dongari-Bagtzoglou A, 2006, NAT PROTOC, V1, P2012, DOI 10.1038/nprot.2006.323
   Dwivedi P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016218
   EAGLSTEIN WH, 1995, DERMATOL SURG, V21, P839, DOI 10.1111/j.1524-4725.1995.tb00709.x
   Gaballah K, 2008, J PATHOL, V215, P280, DOI 10.1002/path.2360
   Gaggioli C, 2007, NAT CELL BIOL, V9, P1392, DOI 10.1038/ncb1658
   Gursoy UK, 2010, J PERIODONTOL, V81, P1084, DOI 10.1902/jop.2010.090664
   Hearnden V, 2011, ADV DRUG DE IN PRESS
   Hearnden V, 2009, PHARM RES-DORDR, V26, P1718, DOI 10.1007/s11095-009-9882-6
   Hsieh PC, 2010, J CLIN PERIODONTOL, V37, P705, DOI 10.1111/j.1600-051X.2010.01542.x
   Jin GR, 2011, ACTA BIOMATER, V7, P3113, DOI 10.1016/j.actbio.2011.04.017
   KIM JP, 1994, LAB INVEST, V71, P401
   Kinikoglu B, 2009, BIOMATERIALS, V30, P6418, DOI 10.1016/j.biomaterials.2009.08.010
   Koschier F, 2011, FOOD CHEM TOXICOL, V49, P2524, DOI 10.1016/j.fct.2011.06.018
   Kulasekara KK, 2009, ARCH ORAL BIOL, V54, P924, DOI 10.1016/j.archoralbio.2009.07.004
   Lambros MP, 2011, BIOCHEM BIOPH RES CO, V405, P102, DOI 10.1016/j.bbrc.2010.12.135
   Lee KH, 2000, YONSEI MED J, V41, P774, DOI 10.3349/ymj.2000.41.6.774
   Lohmeyer JA, 2011, LANGENBECK ARCH SURG, V396, P543, DOI 10.1007/s00423-011-0761-3
   Luitaud C, 2007, J BIOMED MATER RES B, V83B, P554, DOI 10.1002/jbm.b.30828
   MacNeil S, 2007, NATURE, V445, P874, DOI 10.1038/nature05664
   Marsh D, 2011, J PATHOL, V223, P470, DOI 10.1002/path.2830
   McGuire MK, 2008, J PERIODONTOL, V79, P1847, DOI [10.1902/jop.2008.080017, 10.1902/jop.2008.080017 ]
   Mohammadi M, 2007, J PERIODONTOL, V78, P1897, DOI 10.1902/jop.2007.070083
   Mohammadi Mohammad, 2011, Acta Med Iran, V49, P319
   Moharamzadeh K, 2008, J MATER SCI-MATER M, V19, P1793, DOI 10.1007/s10856-007-3321-1
   Moharamzadeh K, 2007, J DENT RES, V86, P115, DOI 10.1177/154405910708600203
   Moharamzadeh K, 2008, J DENT, V36, P331, DOI 10.1016/j.jdent.2008.01.019
   Moharamzadeh K, 2009, J PERIODONTOL, V80, P769, DOI 10.1902/jop.2009.080610
   Mostefaoui Y, 2004, CYTOKINE, V25, P162, DOI 10.1016/j.cyto.2003.11.015
   Moyes DL, 2010, CELL HOST MICROBE, V8, P225, DOI 10.1016/j.chom.2010.08.002
   Nevins ML, 2010, INT J PERIODONT REST, V30, P31
   Ophof R, 2008, EUR J ORTHODONT, V30, P1, DOI 10.1093/ejo/cjm082
   Ouwehand K, 2011, J LEUKOCYTE BIOL, V90, P1027, DOI 10.1189/jlb.0610374
   Patterson JM, 2011, EUR UROL, V60, P856, DOI 10.1016/j.eururo.2011.07.045
   Pena I, 2011, J PERIODONTAL RES, V46, P214, DOI 10.1111/j.1600-0765.2010.01330.x
   Pena I, 2010, J PERIODONTAL RES, V45, P375, DOI 10.1111/j.1600-0765.2009.01248.x
   Pendegrass CJ, 2008, J BONE JOINT SURG BR, V90B, P114, DOI 10.1302/0301-620X.90B1.19580
   Perez-Amodio S, 2011, TISSUE ENG PT A, V17, P1583, DOI 10.1089/ten.tea.2010.0429
   PURDUE GF, 1997, J BURN CARE REHABIL, V18, P13
   Rouabhia M, 2011, MED MYCOL, V49, P458, DOI 10.3109/13693786.2010.535031
   Rouabhia M, 2010, BIOMATERIALS, V31, P5798, DOI 10.1016/j.biomaterials.2010.04.004
   Schaller M, 2006, NAT PROTOC, V1, P2767, DOI 10.1038/nprot.2006.474
   Selim M, 2011, BJU INT, V107, P296, DOI 10.1111/j.1464-410X.2010.09310.x
   Smith LE, 2011, J BIOMED OPT, V16, DOI 10.1117/1.3652708
   Sun JN, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001181
   Sun T, 2006, J BIOTECHNOL, V122, P372, DOI 10.1016/j.jbiotec.2006.12.021
   Takagi R, 2010, GASTROINTEST ENDOSC, V72, P1253, DOI 10.1016/j.gie.2010.08.007
   Tobita T, 2010, INT J ORAL MAX SURG, V39, P364, DOI 10.1016/j.ijom.2009.12.020
   Trombetta D, 2005, TOXICOL LETT, V159, P219, DOI 10.1016/j.toxlet.2005.05.019
   Vande Vannet B., 2007, EUR J ORTHODONT, V29, P60
   Vande Vannet BM, 2007, ANGLE ORTHOD, V77, P716
   Villar CC, 2007, INFECT IMMUN, V75, P2126, DOI 10.1128/IAI.00054-07
   Stone Anthony R, 2008, Eur Urol, V53, P1270, DOI [10.1016/j.eururo.2008.01.063, 10.1016/j.eururo.2008.01.062]
   Winterroth F, 2011, ULTRASOUND MED BIOL, V37, P1734, DOI 10.1016/j.ultrasmedbio.2011.06.010
   Wolf K, 2009, SEMIN CELL DEV BIOL, V20, P931, DOI 10.1016/j.semcdb.2009.08.005
   Xiong XP, 2010, J BIOMED MATER RES B, V94B, P165, DOI 10.1002/jbm.b.31637
   Xu Q, 2009, J ORAL MAXIL SURG, V67, P1256, DOI 10.1016/j.joms.2009.02.003
   Yadev NR, 2011, MICROB PATHOGENESIS, V50, P278, DOI 10.1016/j.micpath.2010.11.009
   Yang GP, 2007, GUT, V56, P313, DOI 10.1136/gut.2006.100073
   Yoshizawa M, 2011, J ORAL MAXI IN PRESS
NR 65
TC 51
Z9 52
U1 3
U2 64
PU SAGE PUBLICATIONS INC
PI THOUSAND OAKS
PA 2455 TELLER RD, THOUSAND OAKS, CA 91320 USA
SN 0022-0345
J9 J DENT RES
JI J. Dent. Res.
PD JUL
PY 2012
VL 91
IS 7
BP 642
EP 650
DI 10.1177/0022034511435702
PG 9
WC Dentistry, Oral Surgery & Medicine
SC Dentistry, Oral Surgery & Medicine
GA 964PM
UT WOS:000305708600003
PM 22266525
DA 2018-10-19
ER

PT J
AU Pereira, CL
   Antunes, JC
   Goncalves, RM
   Ferreira-da-Silva, F
   Barbosa, MA
AF Pereira, Catarina Leite
   Antunes, Joana Costa
   Goncalves, Raquel Madeira
   Ferreira-da-Silva, Frederico
   Barbosa, Mario Adolfo
TI Biosynthesis of highly pure poly-gamma-glutamic acid for biomedical
   applications
SO JOURNAL OF MATERIALS SCIENCE-MATERIALS IN MEDICINE
LA English
DT Article
ID BACILLUS-SUBTILIS; POLY(GAMMA-GLUTAMIC ACID); NANOPARTICLES; CHITOSAN;
   DELIVERY; MICROORGANISMS; LICHENIFORMIS; BIOPOLYMER; CELLS
AB The remarkable properties of poly-aminoacids, mainly their biocompatibility and biodegradability, have prompted an increasing interest in these polymers for biomedical applications. Poly-gamma-glutamic acid (gamma-PGA) is one of the most interesting poly-aminoacids with potential applications as a biomaterial. Here we describe the production and characterization of gamma-PGA by Bacillus subtilis natto. The gamma-PGA was produced with low molecular weight (10-50 kDa), high purity grade (> 99 %) and a d-/l-glutamate ratio of 50-60/50-40 %. To evaluate the feasibility of using this gamma-PGA as a biomaterial, chitosan (Ch)/gamma-PGA nanoparticles were prepared by the coacervation method at pH ranging from 3.0 to 5.0, with dimensions in the interval 214-221 nm with a poly-dispersion index of ca. 0.2. The high purity of gamma-PGA produced by this method, which is firstly described here, renders this biopolymer suitable for biomedical applications. Moreover, the Ch/gamma-PGA nanocomplexes developed in this investigation can be combined with biologically active substances for their delivery in the organism. The fact that the assembly between Ch and gamma-PGA relies on electrostatic interactions enables addition of other molecules that can be released into the medium through changes from acidic to physiological pH, without loss in biological activity.
C1 [Pereira, Catarina Leite; Antunes, Joana Costa; Goncalves, Raquel Madeira; Barbosa, Mario Adolfo] Univ Porto, INEB Inst Engn Biomed, P-4150180 Oporto, Portugal.
   [Antunes, Joana Costa] Univ Porto, Fac Engn, P-4200465 Oporto, Portugal.
   [Ferreira-da-Silva, Frederico] IBMC Inst Biol Mol & Celular, P-4150180 Oporto, Portugal.
   [Barbosa, Mario Adolfo] Univ Porto, Inst Ciencias Biomed Abel Salazar, P-4099003 Oporto, Portugal.
RP Pereira, CL (reprint author), Univ Porto, INEB Inst Engn Biomed, Rua Campo Alegre 823, P-4150180 Oporto, Portugal.
EM Catarina.pereira@ineb.up.pt
RI Goncalves, Raquel/C-5940-2012; Silva, Frederico/K-3820-2013; Barbosa,
   Mario/F-5964-2011
OI Goncalves, Raquel/0000-0003-2841-0485; Silva,
   Frederico/0000-0002-8890-4228; Barbosa, Mario/0000-0003-3568-7482; Leite
   Pereira, Catarina/0000-0001-8703-1245
FU DISC Regeneration project [NMP3-LA-2008-213904 (FP7)]
FX This work was supported by DISC Regeneration project, with the grant
   agreement No NMP3-LA-2008-213904 (FP7). The authors would like to thank
   to Dr. Ana Azevedo and Professor Joao Costa Pessoa from Instituto
   Superior Tecnico-Universidade Tecnica de Lisboa, for providing access to
   Circular Dichroism technique and for assistance in interpretation of
   data.
CR Antunes JC, 2011, BIOMACROMOLECULES, V12, P4183, DOI 10.1021/bm2008235
   Ashiuchi M, 1999, BIOCHEM BIOPH RES CO, V263, P6, DOI 10.1006/bbrc.1999.1298
   Ashiuchi M, 2004, APPL ENVIRON MICROB, V70, P4249, DOI 10.1128/AEM.70.7.4249-4255.2004
   Ashiuchi M, 2002, APPL MICROBIOL BIOT, V59, P9, DOI 10.1007/s00253-002-0984-x
   Berger J, 2004, EUR J PHARM BIOPHARM, V57, P35, DOI 10.1016/s0939-6411(03)00160-7
   BIRRER GA, 1994, INT J BIOL MACROMOL, V16, P265, DOI 10.1016/0141-8130(94)90032-9
   Buescher JM, 2007, CRIT REV BIOTECHNOL, V27, P1, DOI 10.1080/07388550601166458
   Calvo P, 1997, J APPL POLYM SCI, V63, P125, DOI 10.1002/(SICI)1097-4628(19970103)63:1<125::AID-APP13>3.0.CO;2-4
   EDDE B, 1990, SCIENCE, V247, P83, DOI 10.1126/science.1967194
   Georgiou CD, 2008, ANAL BIOANAL CHEM, V391, P391, DOI 10.1007/s00216-008-1996-x
   GOTO A, 1992, BIOSCI BIOTECH BIOCH, V56, P1031, DOI 10.1271/bbb.56.1031
   Hajdu I, 2008, COLLOID POLYM SCI, V286, P343, DOI 10.1007/s00396-007-1785-7
   Hsieh CY, 2005, BIOMATERIALS, V26, P5617, DOI 10.1016/j.biomaterials.2005.02.012
   Kang HS, 2007, J APPL POLYM SCI, V103, P386, DOI 10.1002/app.24623
   Keresztessy Z, 2009, COLLOID POLYM SCI, V287, P759, DOI 10.1007/s00396-009-2022-3
   KUBOTA H, 1993, BIOSCI BIOTECH BIOCH, V57, P1212, DOI 10.1271/bbb.57.1212
   Kunioka M, 1997, APPL MICROBIOL BIOT, V47, P469, DOI 10.1007/s002530050958
   KUNIOKA M, 1994, APPL MICROBIOL BIOT, V40, P867, DOI 10.1007/s002530050082
   Lee PW, 2008, BIOMATERIALS, V29, P742, DOI 10.1016/j.biomaterials.2007.10.034
   Lin YH, 2005, BIOMACROMOLECULES, V6, P1104, DOI 10.1021/bm049312a
   Lin YH, 2007, BIOMACROMOLECULES, V8, P146, DOI 10.1021/bm0607776
   Nelson DL, 2005, LEHNINGER PRINCIPLES, P78
   Park C, 2005, J MOL CATAL B-ENZYM, V35, P128, DOI 10.1016/j.molcatb.2005.06.007
   Peng SF, 2009, BIOMATERIALS, V30, P1797, DOI 10.1016/j.biomaterials.2008.12.019
   Prodhomme EJF, 2003, BIOCONJUGATE CHEM, V14, P1148, DOI 10.1021/bc020019m
   Ratner BD, 2004, NATURAL MAT BIOMATER
   Richard A, 2003, BIOTECHNOL BIOENG, V82, P299, DOI 10.1002/bit.10568
   Sanda F, 2001, J POLYM SCI POL CHEM, V39, P732, DOI 10.1002/1099-0518(20010301)39:5<732::AID-POLA1045>3.0.CO;2-P
   Schneerson R, 2003, P NATL ACAD SCI USA, V100, P8945, DOI 10.1073/pnas.1633512100
   Shih IL, 2001, BIORESOURCE TECHNOL, V79, P207, DOI 10.1016/S0960-8524(01)00074-8
   Socrates G., 2001, INFRARED RAMAN CHARA
   Sung MH, 2005, CHEM REC, V5, P352, DOI 10.1002/tcr.20061
   Yamaguchi F, 1996, BIOSCI BIOTECH BIOCH, V60, P255, DOI 10.1271/bbb.60.255
NR 33
TC 15
Z9 15
U1 3
U2 33
PU SPRINGER
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 0957-4530
J9 J MATER SCI-MATER M
JI J. Mater. Sci.-Mater. Med.
PD JUL
PY 2012
VL 23
IS 7
BP 1583
EP 1591
DI 10.1007/s10856-012-4639-x
PG 9
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 964MC
UT WOS:000305698500003
PM 22532096
DA 2018-10-19
ER

PT J
AU Fatimi, A
   Tassin, JF
   Bosco, J
   Deterre, R
   Axelos, MAV
   Weiss, P
AF Fatimi, Ahmed
   Tassin, Jean-Francois
   Bosco, Julia
   Deterre, Remi
   Axelos, Monique A. V.
   Weiss, Pierre
TI Injection of calcium phosphate pastes: prediction of injection force and
   comparison with experiments
SO JOURNAL OF MATERIALS SCIENCE-MATERIALS IN MEDICINE
LA English
DT Article
ID INJECTABLE BONE SUBSTITUTE; RHEOLOGICAL PROPERTIES; CEMENT;
   HYDROXYPROPYLMETHYLCELLULOSE; METHYLCELLULOSE; THERMOGELATION;
   SUSPENSIONS; CERAMICS; SYSTEMS; ACID
AB Calcium phosphate ceramics suspensions (ICPCS) are used in bone and dental surgery as injectable bone substitutes. This ICPCS biomaterial associates biphasic calcium phosphate (BCP) granules with hydroxypropylmethylcellulose (HPMC) polymer. Different ICPCS were prepared and their rheological properties were evaluated in parallel disks geometry as a function of the BCP weight ratio (35, 40, 45 and 50 %). The suspensions show a strongly increased viscosity as compared to the suspending fluid and the high shear rate part of the flow curve can be fitted with a power law model (Ostwald-de Waele model). The fitting parameters depend on the composition of the suspension. A simple device has been used to characterize extrusion of the paste using a disposable syringe fitted with a needle. The injection pressure of four ICPCS formulations was studied under various conditions (needle length and radius and volumetric flow rate), yielding an important set of data. A theoretical approach based on the capillary flow of non-Newtonian fluids was used to predict the necessary pressure for injection, on the basis of flow curves and extrusion conditions. The extrusion pressure calculated from rheological data shows a quantitative agreement with the experimental one for model fluids (Newtonian and HPMC solution) but also for the suspension, when needles with sufficiently large diameters as compared to the size of particles, are used. Depletion and possibly wall slip is encountered in the suspensions when narrower diameters are used, so that the injection pressure is less than that anticipated. However a constant proportionality factor exists between theory and injection experiments. The approach developed in this study can be used to correlate the rheological parameters to the necessary pressure for injection and defines the pertinent experimental conditions to obtain a quantitative agreement between theory and experiments.
C1 [Fatimi, Ahmed; Bosco, Julia; Weiss, Pierre] INSERM, U791, LIOAD, F-44042 Nantes 1, France.
   [Fatimi, Ahmed; Bosco, Julia; Weiss, Pierre] LUNAM Univ, LIOAD, F-44042 Nantes 1, France.
   [Tassin, Jean-Francois] Univ Maine, CNRS, UMR 6120, LPCI, F-72085 Le Mans 9, France.
   [Deterre, Remi] LUNAM Univ, IUT Nantes, OPERP ERT1086, GEPEA,CNRS,UMR 6144, F-44475 Carquefou, France.
   [Axelos, Monique A. V.] INRA, Biopolymeres Interact Assemblages BIA UR1268, F-44316 Nantes 3, France.
RP Weiss, P (reprint author), INSERM, U791, LIOAD, 1 Pl Alexis Ricordeau, F-44042 Nantes 1, France.
EM ahmed.fatimi@crchum.qc.ca; pierre.weiss@univ-nantes.fr
RI Weiss, Pierre/P-1372-2014
OI Weiss, Pierre/0000-0002-6159-8590
FU regional program BIOREGOS (Region Pays de la Loire, France)
FX This study was supported by the regional program BIOREGOS (Region Pays
   de la Loire, France). Authors extend their sincere thanks to Colorcon
   (R) for the supply of the polymer Methocel (TM) E4M. The help of Paul
   Pilet for the image observations and Jean-Michel Bouler for the BCP
   preparations is acknowledged with gratitude.
CR BAGLEY EB, 1957, J APPL PHYS, V28, P624, DOI 10.1063/1.1722814
   Barralet JE, 2004, BIOMATERIALS, V25, P2197, DOI 10.1016/j.biomaterials.2003.09.085
   Bohner M, 2005, BIOMATERIALS, V26, P1553, DOI 10.1016/j.biomaterials.2004.05.010
   Bosco J, 2007, KEY ENG MATER, V330-332, P847, DOI 10.4028/www.scientific.net/KEM.330-332.847
   Bouler JM, 2000, J BIOMED MATER RES, V51, P680, DOI 10.1002/1097-4636(20000915)51:4<680::AID-JBM16>3.0.CO;2-#
   BUJAKE JE, 1965, J PHARM SCI, V54, P1599, DOI 10.1002/jps.2600541109
   CHANG CY, 1994, J RHEOL, V38, P85, DOI 10.1122/1.550497
   CROSS MM, 1965, J COLL SCI IMP U TOK, V20, P417, DOI 10.1016/0095-8522(65)90022-X
   DACULSI G, 1989, J BIOMED MATER RES, V23, P883, DOI 10.1002/jbm.820230806
   Daculsi G, 1998, BIOMATERIALS, V19, P1473, DOI 10.1016/S0142-9612(98)00061-1
   Daculsi G., 2008, KEY ENG MATER, V361-363, P17
   Dorozhkin SV, 2001, J BIOMED MATER RES, V54, P247, DOI 10.1002/1097-4636(200102)54:2<247::AID-JBM12>3.0.CO;2-G
   Fatimi A, 2008, KEY ENG MATER, V361-363, P365, DOI 10.4028/www.scientific.net/KEM.361-363.365
   Fatimi A, 2008, BIOMATERIALS, V29, P533, DOI 10.1016/j.biomaterials.2007.10.032
   Fatimi A, 2010, J MATER SCI-MATER M, V21, P1799, DOI 10.1007/s10856-010-4047-z
   Fatimi A, 2009, ACTA BIOMATER, V5, P3423, DOI 10.1016/j.actbio.2009.05.030
   Fellah BH, 2008, BIOMATERIALS, V29, P1177, DOI 10.1016/j.biomaterials.2007.11.034
   GEIGER K, 1989, KAUT GUMMI KUNSTST, V42, P273
   Habib M, 2008, ACTA BIOMATER, V4, P1465, DOI 10.1016/j.actbio.2008.03.004
   HAQUE A, 1993, CARBOHYD POLYM, V22, P175, DOI 10.1016/0144-8617(93)90138-T
   HAQUE A, 1993, CARBOHYD POLYM, V22, P161, DOI 10.1016/0144-8617(93)90137-S
   Hirrien M, 1998, POLYMER, V39, P6251, DOI 10.1016/S0032-3861(98)00142-6
   Jegoux F, 2010, ARCH OTOLARYNGOL, V136, P971, DOI 10.1001/archoto.2010.173
   Khairoun I, 1998, J MATER SCI-MATER M, V9, P425, DOI 10.1023/A:1008811215655
   Khairoun I, 1999, BIOMATERIALS, V20, P393, DOI 10.1016/S0142-9612(98)00202-6
   Leroux L, 1999, BONE, V25, p31S, DOI 10.1016/S8756-3282(99)00130-1
   Macosko CW, 1994, RHEOLOGY PRINCIPLES
   Mooney M., 1931, J RHEOL, V2, P210, DOI DOI 10.1122/1.2116364
   Qi XP, 2009, MAT SCI ENG C-MATER, V29, P1901, DOI 10.1016/j.msec.2009.02.021
   Rabinowitsch B, 1929, Z PHYS CHEM A-CHEM T, V145, P1
   Ratier A, 2004, INT J PHARM, V274, P261, DOI 10.1016/j.ijpharm.2004.01.021
   Sarda S, 2001, J MATER SCI-MATER M, V12, P905, DOI 10.1023/A:1012832325957
   SARKAR N, 1995, CARBOHYD POLYM, V27, P177, DOI 10.1016/0144-8617(95)00061-B
   Wang H, 2005, KEY ENG MATER, V288-289, P557, DOI 10.4028/www.scientific.net/KEM.288-289.557
   Wang XP, 2007, J BIOMED MATER RES B, V81B, P410, DOI 10.1002/jbm.b.30678
   Wang XP, 2006, J BIOMED MATER RES B, V78B, P259, DOI 10.1002/jbm.b.30481
   Weiss P, 1998, J BIOMED MATER RES, V41, P167, DOI 10.1002/(SICI)1097-4636(199807)41:1<167::AID-JBM20>3.0.CO;2-J
   Weiss P, 1999, BONE, V25, p67S, DOI 10.1016/S8756-3282(99)00146-5
   Weiss P, 2007, BIOMATERIALS, V28, P3295, DOI 10.1016/j.biomaterials.2007.04.006
NR 39
TC 8
Z9 8
U1 2
U2 35
PU SPRINGER
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 0957-4530
J9 J MATER SCI-MATER M
JI J. Mater. Sci.-Mater. Med.
PD JUL
PY 2012
VL 23
IS 7
BP 1593
EP 1603
DI 10.1007/s10856-012-4640-4
PG 11
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 964MC
UT WOS:000305698500004
PM 22528073
DA 2018-10-19
ER

PT J
AU Domanski, M
   Winnubst, L
   Luttge, R
   Lamers, E
   Walboomers, XF
   Jansen, J
   Gardeniers, H
AF Domanski, Maciej
   Winnubst, Louis
   Luttge, Regina
   Lamers, Edwin
   Walboomers, X. Frank
   Jansen, John
   Gardeniers, Han
TI Production and characterization of miro- and nano-features in biomedical
   alumina and zirconia ceramics using a tape casting route
SO JOURNAL OF MATERIALS SCIENCE-MATERIALS IN MEDICINE
LA English
DT Article
ID ADHESION; FIBROBLASTS; LITHOGRAPHY; TOPOGRAPHY; MORPHOLOGY; MEMBRANES;
   SURFACES; TITANIUM; JOINT
AB A process of micromolding, delivering micro- and nanopatterned ceramic surfaces for biomaterial applications is described in this work. To create the desired structures, tape casting of ceramic slurries on microfabricated silicon mold was used. Several tape casting slurry compositions were tested to evaluate the feasibility of transferring micro- and nano-features from silicon molds. Used ceramics were alumina (alpha-Al2O3) and yttria stabilized zirconia. Three types of polymeric binders for the green tape (PVB, PES, and PVP) were investigated using three different solvents (ethanol, n-methyl-pyrrolidone, water). Well-defined features in shapes of wells with diameters down to 2.4 mu m and a depth of 10 mu m and pillars with diameters down to 1.7 mu m and a height of 3 mu m were obtained. Morphology, grain size and porosity of the sintered bodies were characterized. Finally fibroblast cells were cultured on the surfaces in order to observe their morphology under influence of the microstructured surfaces.
C1 [Domanski, Maciej; Winnubst, Louis; Luttge, Regina; Gardeniers, Han] Univ Twente, MESA Inst Nanotechnol, NL-7500 AE Enschede, Netherlands.
   [Lamers, Edwin; Walboomers, X. Frank; Jansen, John] Radboud Univ Nijmegen, Med Ctr, Dept Biomat, NL-6500 HB Nijmegen, Netherlands.
RP Domanski, M (reprint author), Univ Twente, MESA Inst Nanotechnol, POB 217, NL-7500 AE Enschede, Netherlands.
EM maciejmd@gmail.com
RI Jansen, John/H-8055-2014; Gardeniers, Johannes/B-6309-2013; Walboomers,
   X.Frank/B-3692-2013
OI Gardeniers, Johannes/0000-0003-0581-2668; 
FU Dutch Technology Foundation [STW NTH.7621]
FX This project was sponsored by the Dutch Technology Foundation (STW
   NTH.7621).
CR Balasundaram G, 2006, BIOMATERIALS, V27, P2798, DOI 10.1016/j.biomaterials.2005.12.008
   Best SM, 2008, J EUR CERAM SOC, V28, P1319, DOI 10.1016/j.jeurceramsoc.2007.12.001
   Dalby MJ, 2004, EXP CELL RES, V295, P387, DOI 10.1016/j.yexcr.2004.02.004
   Eisenbarth E, 1996, BIOMATERIALS, V17, P1399, DOI 10.1016/0142-9612(96)87281-4
   Freshney R.I., 1999, FRESHNEYS CULTURE AN
   Heydarkhan-Hagvall S, 2007, CELL COMMUN ADHES, V14, P181, DOI 10.1080/15419060701755594
   Hu JM, 1997, APPL PHYS LETT, V71, P2020, DOI 10.1063/1.119774
   Kusaka J, 1999, WEAR, V225, P734, DOI 10.1016/S0043-1648(98)00386-X
   Kwan YBP, 2002, J MATER SCI, V37, P2557, DOI 10.1023/A:1015460127828
   Larry L. H., 1991, J AM CERAM SOC, V74, P1487
   LIN YS, 1991, J AM CERAM SOC, V74, P219, DOI 10.1111/j.1151-2916.1991.tb07320.x
   Liu Y, 2006, DESALINATION, V199, P360, DOI 10.1016/j.desal.2006.03.216
   Loesberg WA, 2007, BIOMATERIALS, V28, P3944, DOI 10.1016/j.biomaterials.2007.05.030
   MENDELSON MI, 1969, J AM CERAM SOC, V52, P443, DOI 10.1111/j.1151-2916.1969.tb11975.x
   Mustafa K, 2005, BIOMATERIALS, V26, P373, DOI 10.1016/j.biomaterials.2004.02.037
   Parker JATC, 2002, BIOMATERIALS, V23, P3887, DOI 10.1016/S0142-9612(02)00134-5
   Pfeiffer F, 2003, MICROELECTRON ENG, V67-8, P913, DOI 10.1016/S0167-9317(03)00154-0
   Puckett S, 2008, INT J NANOMED, V3, P229
   Rieu J., 1993, Clinical Materials, V12, P227, DOI 10.1016/0267-6605(93)90077-K
   Schonholzer UP, 2002, J AM CERAM SOC, V85, P1885
   Treccani L, 2009, ADV ENG MATER, V11, pB61, DOI 10.1002/adem.200800372
   Xu ZL, 2004, J MEMBRANE SCI, V233, P101, DOI 10.1016/j.memsci.2004.01.005
   YOUNG AC, 1993, MATER CHEM PHYS, V34, P147, DOI 10.1016/0254-0584(93)90204-Y
   Zhou YS, 1997, WEAR, V210, P171, DOI 10.1016/S0043-1648(97)00066-5
NR 24
TC 10
Z9 10
U1 0
U2 29
PU SPRINGER
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 0957-4530
J9 J MATER SCI-MATER M
JI J. Mater. Sci.-Mater. Med.
PD JUL
PY 2012
VL 23
IS 7
BP 1637
EP 1644
DI 10.1007/s10856-012-4635-1
PG 8
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 964MC
UT WOS:000305698500008
PM 22528070
OA Green Published, Other Gold
DA 2018-10-19
ER

PT J
AU Koop, HS
   Da-Lozzo, EJ
   de Freitas, RA
   Franco, CRC
   Mitchell, DA
   Silveira, JLM
AF Koop, Heidegrid S.
   Da-Lozzo, Eneida J.
   de Freitas, Rilton A.
   Franco, Celia R. C.
   Mitchell, David A.
   Silveira, Joana L. M.
TI Rheological Characterization of a Xanthan-Galactomannan Hydrogel Loaded
   with Lipophilic Substances
SO JOURNAL OF PHARMACEUTICAL SCIENCES
LA English
DT Article
DE hydrogel; rheology; drug delivery system; cryo-scanning electronic
   microscopy; transdermal drug delivery; interaction; microemulsions;
   polymeric biomaterial
ID LOCUST BEAN GUM; PHOSPHOLIPID MICROEMULSIONS; BACTERIAL POLYSACCHARIDE;
   ISOPROPYL MYRISTATE; CREEP MEASUREMENTS; SKIN PERMEATION; CARBOPOL GELS;
   CURCUMIN; SYSTEMS; SPECTROSCOPY
AB We compared the structures and rheology of xanthan-galactomannan (X:G) hydrogels with the addition of curcumin in microemulsion (X:GMC) and ethanol (X:GEC). X:GMC hydrogels have gel characteristics and exhibited a significantly higher elastic response than the X:GEC and X:G hydrogels at room temperature, but after heating, an increase in the elastic modulus was observed for the last two systems. The visualization of the hydrogel microstructures by cryo-scanning electronic microscopy revealed pores within the lamellar structure only for X:GMC. In vitro skin permeation tests showed a more pronounced lag time for X:GMC; however, a more efficient permeation from X:GMC than from X:GEC. This study demonstrates that the X:G system is an alternative to traditional gels for the topical applications of hydrophobic drugs. (C) 2012 Wiley Periodicals, Inc. and the American Pharmacists Association J Pharm Sci 101:2457-2467, 2012
C1 [Koop, Heidegrid S.; Da-Lozzo, Eneida J.; Mitchell, David A.; Silveira, Joana L. M.] Univ Fed Parana, Dept Biochem & Mol Biol, BR-81531980 Curitiba, Parana, Brazil.
   [de Freitas, Rilton A.] Univ Fed Parana, Dept Chem, BR-81531980 Curitiba, Parana, Brazil.
   [Franco, Celia R. C.] Univ Fed Parana, Dept Cellular Biol, BR-81531980 Curitiba, Parana, Brazil.
RP Silveira, JLM (reprint author), Univ Fed Parana, Dept Biochem & Mol Biol, BP 19046, BR-81531980 Curitiba, Parana, Brazil.
EM jlms12@yahoo.com
RI de Freitas, Rilton/D-5410-2012; Mitchell, David/A-8935-2008
OI de Freitas, Rilton/0000-0002-7424-2999; Mitchell,
   David/0000-0001-9355-5520; Koop, Heidegrid/0000-0002-4261-8031
FU Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES);
   Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq);
   Nanoglicobiotech/CNPq; Fundacao Araucaria-PRONEX; Federal University of
   Parana
FX This work was financially supported by the Coordenacao de
   Aperfeicoamento de Pessoal de Nivel Superior (CAPES), Conselho Nacional
   de Desenvolvimento Cientifico e Tecnologico (CNPq),
   Nanoglicobiotech/CNPq, Fundacao Araucaria-PRONEX, and Federal University
   of Parana. The authors wish to thank Dr. M. Rinaudo for valuable
   discussion regarding rheology and Grupo O Boticario for the analysis
   using the Franz-type glass diffusion cells. Jim Hesson of
   AcademicEnglishSolutions.com revised the English.
CR ABOOFAZELI R, 1993, INT J PHARM, V93, P161, DOI 10.1016/0378-5173(93)90174-E
   Amnuaikit C, 2005, INT J PHARM, V289, P167, DOI 10.1016/j.ijpharm.2004.11.007
   Arellano A, 1999, EUR J PHARM SCI, V7, P129, DOI 10.1016/S0928-0987(98)00010-4
   Asai A, 2000, LIFE SCI, V67, P2785, DOI 10.1016/S0024-3205(00)00868-7
   Bayerlein F., 1993, P191, DOI 10.1533/9781845698430.4.191
   Bonacucina G, 2006, INT J PHARM, V307, P129, DOI 10.1016/j.ijpharm.2005.09.034
   Bonacucina G, 2004, INT J PHARM, V282, P115, DOI 10.1016/j.ijpharm.2004.06.012
   Bonacucina G, 2008, AAPS J, V10, P84, DOI 10.1208/s12248-008-9008-9
   Bresolin TMB, 1999, INT J BIOL MACROMOL, V26, P225, DOI 10.1016/S0141-8130(99)00087-2
   Bresolin TMB, 1998, INT J BIOL MACROMOL, V23, P263, DOI 10.1016/S0141-8130(98)00061-0
   Clark AH, 1987, ADV POLYM SCI, V83, P82
   Dea I. C. M., 1975, Advances in Carbohydrate Chemistry and Biochemistry, V31, P241
   Dorai T, 2004, CANCER LETT, V215, P129, DOI 10.1016/j.canlet.2004.07.013
   El-Kattan AF, 2001, INT J PHARMACEUT, V289, P167
   FRANZ TJ, 1975, J INVEST DERMATOL, V64, P190, DOI 10.1111/1523-1747.ep12533356
   Fu X, 2007, J POLYM RES, V14, P297, DOI 10.1007/s10965-007-9110-1
   GANTER JLMS, 1993, J CARBOHYD CHEM, V12, P753, DOI 10.1080/07328309308019005
   Goncalves MP, 2004, RHEOL ACTA, V34, P184
   Heng MCY, 2000, BRIT J DERMATOL, V143, P937, DOI 10.1046/j.1365-2133.2000.03767.x
   Heng PWS, 2005, PHARM RES, V22, P677
   HERMANSSON AM, 1981, J COLLOID INTERF SCI, V81, P519, DOI 10.1016/0021-9797(81)90433-1
   Iwunze MO, 2004, J MOL LIQ, V111, P161, DOI 10.1016/j.molliq.2003.12.013
   Kang L, 2005, J CONTROL RELEASE, V106, P88, DOI 10.1016/j.jconrel.2005.04.017
   Koop HS, 2009, MAT SCI ENG C-BIO S, V29, P559, DOI 10.1016/j.msec.2008.10.004
   Madison KC, 2003, J INVEST DERMATOL, V121, P231, DOI 10.1046/j.1523-1747.2003.12359.x
   Maiti K, 2007, INT J PHARMACEUT, V330, P155, DOI 10.1016/j.ijpharm.2006.09.025
   MANNION RO, 1992, CARBOHYD POLYM, V19, P91, DOI 10.1016/0144-8617(92)90118-A
   Mao CF, 2006, POLYMER, V47, P7980, DOI 10.1016/j.polymer.2006.09.032
   MILAS M, 1979, CARBOHYD RES, V76, P189, DOI 10.1016/0008-6215(79)80017-8
   Miquel J, 2002, ARCH GERONTOL GERIAT, V34, P37, DOI 10.1016/S0167-4943(01)00194-7
   MORRIS ER, 1977, J MOL BIOL, V110, P1, DOI 10.1016/S0022-2836(77)80095-8
   Morris ER, 1990, MIXED POLYM GELS FOO, P192
   Normand V, 1997, RHEOL ACTA, V36, P610, DOI 10.1007/BF00367356
   Organisation for Economic Co-operation and Development (OECD), 2004, SKIN ABS VITR METH O
   Paradossi G, 2002, BIOMACROMOLECULES, V3, P498, DOI 10.1021/bm010163v
   Patel NA, 2009, PHARM DEV TECHNOL, V14, P80, DOI 10.1080/10837450802409438
   Peppas NA, 2000, EUR J PHARM BIOPHARM, V50, P27, DOI 10.1016/S0939-6411(00)00090-4
   PROVENCHER SW, 1982, COMPUT PHYS COMMUN, V27, P229, DOI 10.1016/0010-4655(82)90174-6
   PROVENCHER SW, 1979, MAKROMOL CHEM, V180, P201
   Rayment P, 1998, CARBOHYD POLYM, V35, P55, DOI 10.1016/S0144-8617(97)00231-2
   Richter S, 2005, MACROMOL RAPID COMM, V26, P548, DOI 10.1002/marc.200400631
   SAINTRUTH H, 1995, INT J PHARM, V116, P253, DOI 10.1016/0378-5173(94)00316-W
   Sandolo C, 2010, CARBOHYD POLYM, V82, P733, DOI 10.1016/j.carbpol.2010.05.044
   Sandur SK, 2007, FREE RADICAL BIO MED, V43, P568, DOI 10.1016/j.freeradbiomed.2007.05.009
   Schramm G., 2006, REOLOGIA REOMETRIA F
   Shakibaei M, 2007, BIOCHEM PHARMACOL, V73, P1434, DOI 10.1016/j.bcp.2007.01.005
   Sharma RA, 2005, EUR J CANCER, V41, P1955, DOI 10.1016/j.ejca.2005.05.009
   TAKO M, 1984, AGR BIOL CHEM TOKYO, V48, P2995, DOI 10.1080/00021369.1984.10866638
   TAKO M, 1986, FEBS LETT, V204, P33, DOI 10.1016/0014-5793(86)81382-5
   Tamburic S, 1995, PHARM SCI, V1, P107, DOI DOI 10.1111/J.2042-7158.1995.TB00403.X
   TINLAND B, 1988, MAKROMOL CHEM-RAPID, V9, P69
   Tiyaboonchai W, 2007, INT J PHARM, V337, P299, DOI 10.1016/j.ijpharm.2006.12.043
   Tonnesen HH, 2002, INT J PHARM, V244, P127, DOI 10.1016/S0378-5173(02)00323-X
   Wolfrom M. L., 1963, METHODS CARBOHYD CHE, P211
NR 54
TC 10
Z9 10
U1 0
U2 32
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0022-3549
J9 J PHARM SCI-US
JI J. Pharm. Sci.
PD JUL
PY 2012
VL 101
IS 7
BP 2457
EP 2467
DI 10.1002/jps.23178
PG 11
WC Chemistry, Medicinal; Chemistry, Multidisciplinary; Pharmacology &
   Pharmacy
SC Pharmacology & Pharmacy; Chemistry
GA 965JI
UT WOS:000305763500020
PM 22549766
DA 2018-10-19
ER

PT J
AU Duan, CH
   Wang, JX
   Zhou, SB
   Feng, B
   Lu, X
   Weng, J
AF Duan, Caihong
   Wang, Jianxin
   Zhou, Shaobing
   Feng, Bo
   Lu, Xiong
   Weng, Jie
TI Study on phase transformation and controllable synthesis of calcium
   phosphate using a sol-gel approach
SO JOURNAL OF SOL-GEL SCIENCE AND TECHNOLOGY
LA English
DT Article
DE Biomaterial; Sol-gel; Calcium phosphate; Phase transformation
ID CARBONATED HYDROXYAPATITE; APATITES; CERAMICS; TEMPERATURE; IONS;
   SUBSTITUTION; IMPLANTS; CELLS
AB It is always difficult to achieve pure hydroxyapatite (HA) and tricalcium phosphate (TCP) at high temperatures by using non-alkoxide-based sol-gel techniques and other related techniques, which have limited their application. In this paper, our study brought to light that the reason for that was a non-uniform mixing of the reactants at molecular-level, which led to different Ca/P ratios and hence to the occurrence of three high temperature stable phases of HA, TCP and CaO at high temperatures. A series of experiments were designed to demonstrate this proposed hypothesis. Our study firstly revealed that by introducing ethylene glycol into the sol-gel system, the uniform mixing of the reactants at molecular-level could be obtained and then pure HA and TCP phases were achieved at high temperatures.
C1 [Duan, Caihong; Wang, Jianxin; Zhou, Shaobing; Feng, Bo; Lu, Xiong; Weng, Jie] SW Jiaotong Univ, Sch Mat Sci & Engn, Minist Educ, Key Lab Adv Technol Mat, Chengdu 610031, Peoples R China.
RP Wang, JX (reprint author), SW Jiaotong Univ, Sch Mat Sci & Engn, Minist Educ, Key Lab Adv Technol Mat, Chengdu 610031, Peoples R China.
EM j.wang63@gmail.com
RI Weng, Jie/B-3005-2010; Feng, Bo/B-3498-2010; LU, xiong/B-3092-2010
OI LU, xiong/0000-0001-6367-430X
FU National Natural Science Foundation of China [51072167]; National Basic
   Research Program of China (973 program) [2012CB933602]
FX This work was supported by the National Natural Science Foundation of
   China (No.51072167) and the National Basic Research Program of China
   (973 program, 2012CB933602).
CR Aoki H, 1994, MED APPL HYDROXYAPAT
   APFELBAUM F, 1992, J INORG BIOCHEM, V45, P277, DOI 10.1016/0162-0134(92)84016-G
   Barinov SM, 2006, J MATER SCI-MATER M, V17, P597, DOI 10.1007/s10856-006-9221-y
   Barralet J, 1998, J BIOMED MATER RES, V41, P79, DOI 10.1002/(SICI)1097-4636(199807)41:1<79::AID-JBM10>3.0.CO;2-C
   Bigi A, 2004, J SOLID STATE CHEM, V177, P3092, DOI 10.1016/j.jssc.2004.05.018
   Blakeslee KC, 1970, SOC R SCI LIEGE MEM, V20, P121
   Bleach NC, 2002, BIOMATERIALS, V23, P1579, DOI 10.1016/S0142-9612(01)00283-6
   BONEL G, 1972, ANN CHIM FRANCE, V7, P65
   BUCHOLZ RW, 1987, ORTHOP CLIN N AM, V18, P323
   DELANGE GL, 1989, J DENT RES, V68, P509, DOI 10.1177/00220345890680031601
   Dong JA, 2002, BIOMATERIALS, V23, P4493, DOI 10.1016/S0142-9612(02)00193-X
   ELLIOTT JC, 1985, CALCIFIED TISSUE INT, V37, P372, DOI 10.1007/BF02553704
   Elliott JC, 1994, STRUCTURE CHEM APATI
   Fathi MH, 2007, MATER LETT, V61, P3978, DOI 10.1016/j.matlet.2007.01.028
   FEATHERSTONE JDB, 1980, AUST J CHEM, V33, P2363, DOI 10.1071/CH9802363
   Ghomi H, 2011, J SOL-GEL SCI TECHN, V58, P642, DOI 10.1007/s10971-011-2439-2
   HENCH LL, 1993, INTRO BIOCERAMICS
   JARCHO M, 1981, CLIN ORTHOP RELAT R, P259
   JARCHO M, 1986, DENT CLIN N AM, V30, P25
   Jillavenkatesa A, 1998, J MATER SCI, V33, P4111, DOI 10.1023/A:1004436732282
   KLEE WE, 1970, Z KRISTALLOGR KRIST, V131, P95, DOI 10.1524/zkri.1970.131.1-6.95
   Lafon JP, 2008, J EUR CERAM SOC, V28, P139, DOI 10.1016/j.jeurceramsoc.2007.06.009
   LEGROS R, 1986, J CHEM RES SYNOP, V77, P2313
   Liu DM, 2001, BIOMATERIALS, V22, P1721, DOI 10.1016/S0142-9612(00)00332-X
   Liu DM, 2002, BIOMATERIALS, V23, P1679, DOI 10.1016/S0142-9612(01)00295-2
   Murugan R, 2006, ACTA BIOMATER, V2, P201, DOI 10.1016/j.actbio.2005.09.005
   OKAZAKI M, 1991, BIOMATERIALS, V12, P831, DOI 10.1016/0142-9612(91)90070-Q
   Penel G, 1998, CALCIFIED TISSUE INT, V63, P475, DOI 10.1007/s002239900561
   REY C, 1989, CALCIFIED TISSUE INT, V45, P157, DOI 10.1007/BF02556059
   Ryu HS, 2004, BIOMATERIALS, V25, P393, DOI 10.1016/S0142-9612(03)00538-6
   Suchanek W, 1998, J MATER RES, V13, P94, DOI 10.1557/JMR.1998.0015
   Suchanek WL, 2002, BIOMATERIALS, V23, P699, DOI 10.1016/S0142-9612(01)00158-2
   TONSUAADU K, 1995, THERMOCHIM ACTA, V256, P55, DOI 10.1016/0040-6031(94)02169-O
   Tromel G, 1932, EISENFORSCHUNG DUSSE, V14, P25
   Uemura T, 2003, BIOMATERIALS, V24, P2277, DOI 10.1016/S0142-9612(03)00039-5
   Wang F, 2005, MATER LETT, V59, P916, DOI 10.1016/j.matlet.2004.08.041
   Wang JX, 1998, BIOMATERIALS, V19, P1387, DOI 10.1016/S0142-9612(98)00014-3
   Welch JH, 1959, J CHEM SOC, P4442
   Wilson RM, 2004, BIOMATERIALS, V25, P2205, DOI 10.1016/j.biomaterials.2003.08.057
   WINAND L, 1961, ANN CHIM FRANCE, V6, P941
   WINTER M, 1981, BIOMATERIALS, V2, P159, DOI 10.1016/0142-9612(81)90043-0
NR 41
TC 1
Z9 1
U1 2
U2 24
PU SPRINGER
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 0928-0707
J9 J SOL-GEL SCI TECHN
JI J. Sol-Gel Sci. Technol.
PD JUL
PY 2012
VL 63
IS 1
BP 126
EP 134
DI 10.1007/s10971-012-2774-y
PG 9
WC Materials Science, Ceramics
SC Materials Science
GA 964HF
UT WOS:000305684000016
DA 2018-10-19
ER

PT J
AU Baraniak, PR
   Cooke, MT
   Saeed, R
   Kinney, MA
   Fridley, KM
   McDevitt, TC
AF Baraniak, Priya R.
   Cooke, Marissa T.
   Saeed, Rabbia
   Kinney, Melissa A.
   Fridley, Krista M.
   McDevitt, Todd C.
TI Stiffening of human mesenchymal stem cell spheroid microenvironments
   induced by incorporation of gelatin microparticles
SO JOURNAL OF THE MECHANICAL BEHAVIOR OF BIOMEDICAL MATERIALS
LA English
DT Article; Proceedings Paper
CT Symposium on the Mechanical Behaviour of Cells, Scaffolds and Engineered
   Tissues/TERMIS-EU Meeting
CY JUN, 2011
CL Granada, SPAIN
SP Elsevier, Journal Mech Behav Biomed Mat
DE Stem cells; Mesenchymal stem cells; Biomaterials; Polymers;
   Microparticles; Tissue engineering
ID MECHANICAL REGULATION; TISSUE REGENERATION; TUMOR SPHEROIDS; STROMAL
   CELLS; BONE-MARROW; DIFFERENTIATION; ELASTICITY; GENERATION; SUBSTRATE;
   STIFFNESS
AB Culturing multipotent adult mesenchymal stem cells as 3D aggregates augments their differentiation potential and paracrine activity. One caveat of stem cell spheroids, though, can be the limited diffusional transport barriers posed by the inherent 3D structure of the multicellular aggregates. In order to circumvent such limitations, polymeric microparticles have been incorporated into stem cell aggregates as a means to locally control the biochemical and physical properties of the 3D microenvironment. However, the introduction of biomaterials to the 3D stem cell microenvironment could alter the mechanical forces sensed by cells within aggregates, which in turn could impact various cell behaviors and overall spheroid mechanics. Therefore, the objective of this study was to determine the acute effects of biomaterial incorporation within mesenchymal stem cell spheroids on aggregate structure and mechanical properties. The results of this study demonstrate that although gelatin microparticle incorporation results in similar multicellular organization within human mesenchymal stem cell spheroids, the introduction of gelatin materials significantly impacts spheroid mechanical properties. The marked differences in spheroid mechanics induced by microparticle incorporation may hold major implications for in vitro directed differentiation strategies and offer a novel route to engineer the mechanical properties of tissue constructs ex vivo. (C) 2012 Elsevier Ltd. All rights reserved.
C1 [Baraniak, Priya R.; Cooke, Marissa T.; Saeed, Rabbia; Kinney, Melissa A.; Fridley, Krista M.; McDevitt, Todd C.] Georgia Inst Technol, Wallace H Coulter Dept Biomed Engn, Atlanta, GA 30332 USA.
   [Baraniak, Priya R.; Cooke, Marissa T.; Saeed, Rabbia; Kinney, Melissa A.; Fridley, Krista M.; McDevitt, Todd C.] Emory Univ, Atlanta, GA 30332 USA.
   [McDevitt, Todd C.] Georgia Inst Technol, Parker H Petit Inst Bioengn & Biosci, Atlanta, GA 30332 USA.
RP McDevitt, TC (reprint author), Georgia Inst Technol, Wallace H Coulter Dept Biomed Engn, 313 Ferst Dr, Atlanta, GA 30332 USA.
EM priya.r.baraniak@gatech.edu; marissa.cooke@bme.gatech.edu;
   rsaeed@gatech.edu; mkinney@gatech.edu; kfridley3@mail.gatech.edu;
   todd.mcdevitt@bme.gatech.edu
FU NIBIB NIH HHS [R01 EB010061]; NIGMS NIH HHS [R01 GM088291]
CR Baraniak P. R., 2011, CELL TISSUE RES
   Baraniak PR, 2010, REGEN MED, V5, P121, DOI 10.2217/RME.09.74
   Bartosh TJ, 2010, P NATL ACAD SCI USA, V107, P13724, DOI 10.1073/pnas.1008117107
   Boerckel JD, 2011, P NATL ACAD SCI USA, V108, pE674, DOI 10.1073/pnas.1107019108
   Bratt-Leal AM, 2011, BIOMATERIALS, V32, P48, DOI 10.1016/j.biomaterials.2010.08.113
   Bratt-Leal AM, 2009, BIOTECHNOL PROGR, V25, P43, DOI [10.1021/bp.139, 10.1002/btpr.139]
   Carpenedo R. L., 2007, STEM CELLS
   Carpenedo RL, 2010, J BIOMED MATER RES A, V94A, P466, DOI 10.1002/jbm.a.32710
   Carpenedo RL, 2009, BIOMATERIALS, V30, P2507, DOI 10.1016/j.biomaterials.2009.01.007
   Davidson LA, 2011, CURR TOP DEV BIOL, V95, P215, DOI 10.1016/B978-0-12-385065-2.00007-4
   De Santis G, 2011, EUR CELLS MATER, V22, P202, DOI 10.22203/eCM.v022a16
   Dominici M, 2006, CYTOTHERAPY, V8, P315, DOI 10.1080/14653240600855905
   Engler A. J., 2007, Journal of Musculoskeletal & Neuronal Interactions, V7, P335
   Engler AJ, 2006, CELL, V126, P677, DOI 10.1016/j.cell.2006.06.044
   Erices A, 2000, BRIT J HAEMATOL, V109, P235, DOI 10.1046/j.1365-2141.2000.01986.x
   Evans N. D., 2009, EUR CELLS MATER, V18, P13
   Evans ND, 2009, EUR CELLS MATER, V18, P1
   Frith JE, 2010, TISSUE ENG PART C-ME, V16, P735, DOI [10.1089/ten.tec.2009.0432, 10.1089/ten.TEC.2009.0432]
   Fu JP, 2010, NAT METHODS, V7, P733, DOI 10.1038/nmeth.1487
   Gao L, 2010, STEM CELLS, V28, P564, DOI 10.1002/stem.308
   Gomez EW, 2010, J CELL BIOCHEM, V110, P44, DOI 10.1002/jcb.22545
   Hayashi K, 2011, ACTA BIOMATER, V7, P2797, DOI 10.1016/j.actbio.2011.04.013
   Hussain A., 2011, TISSUE ENG A
   Ivascu A, 2006, J BIOMOL SCREEN, V11, P922, DOI 10.1177/1087057106292763
   Kurosawa H, 2007, J BIOSCI BIOENG, V103, P389, DOI 10.1263/jbb.103.389
   Levental I, 2007, SOFT MATTER, V3, P299, DOI 10.1039/b610522j
   Marrero B, 2009, IN VITRO CELL DEV-AN, V45, P523, DOI 10.1007/s11626-009-9217-2
   Mohajeri S, 2010, TISSUE ENG PT A, V16, P3821, DOI 10.1089/ten.TEA.2009.0520
   Nam J, 2011, ACTA BIOMATER, V7, P1516, DOI 10.1016/j.actbio.2010.11.022
   Neuss S, 2004, STEM CELLS, V22, P405, DOI 10.1634/stemcells.22-3-405
   Ong SM, 2010, BIOMATERIALS, V31, P1180, DOI 10.1016/j.biomaterials.2009.10.049
   Pittenger Mark F., 2008, V449, P27, DOI 10.1007/978-1-60327-169-1_2
   Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143
   Purpura KA, 2012, BIOMATERIALS, V33, P1271, DOI 10.1016/j.biomaterials.2011.10.051
   Quapp KM, 1998, J BIOMECH ENG-T ASME, V120, P757, DOI 10.1115/1.2834890
   Ravindran S, 2012, TISSUE ENG PT A, V18, P295, DOI [10.1089/ten.TEA.2011.0136, 10.1089/ten.tea.2011.0136]
   Rowlands AS, 2008, AM J PHYSIOL-CELL PH, V295, pC1037, DOI 10.1152/ajpcell.67.2008
   Sachlos E, 2008, BIOMATERIALS, V29, P4471, DOI 10.1016/j.biomaterials.2008.08.012
   Saha K, 2008, BIOPHYS J, V95, P4426, DOI 10.1529/biophysj.108.132217
   Serpooshan V, 2010, ACTA BIOMATER, V6, P3978, DOI 10.1016/j.actbio.2010.04.028
   Timmins Nicholas E., 2007, V140, P141
   Treiser MD, 2010, P NATL ACAD SCI USA, V107, P610, DOI 10.1073/pnas.0909597107
   Ungrin MD, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001565
   Wang Y, 2011, STEM CELLS DEV
   Winer JP, 2009, TISSUE ENG PT A, V15, P147, DOI 10.1089/ten.tea.2007.0388
   Yamamoto E, 1999, J BIOMECH ENG-T ASME, V121, P124, DOI 10.1115/1.2798033
   Yang MT, 2011, NAT PROTOC, V6, P187, DOI 10.1038/nprot.2010.189
   Zuk PA, 2001, TISSUE ENG, V7, P211, DOI 10.1089/107632701300062859
NR 48
TC 34
Z9 35
U1 2
U2 30
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 1751-6161
J9 J MECH BEHAV BIOMED
JI J. Mech. Behav. Biomed. Mater.
PD JUL
PY 2012
VL 11
SI SI
BP 63
EP 71
DI 10.1016/j.jmbbm.2012.02.018
PG 9
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 964XK
UT WOS:000305729800007
PM 22658155
OA Green Accepted
DA 2018-10-19
ER

PT J
AU Diab, T
   Pritchard, EM
   Uhrig, BA
   Boerckel, JD
   Kaplan, DL
   Guldberg, RE
AF Diab, Tamim
   Pritchard, Eleanor M.
   Uhrig, Brent A.
   Boerckel, Joel D.
   Kaplan, David L.
   Guldberg, Robert E.
TI A silk hydrogel-based delivery system of bone morphogenetic protein for
   the treatment of large bone defects
SO JOURNAL OF THE MECHANICAL BEHAVIOR OF BIOMEDICAL MATERIALS
LA English
DT Article; Proceedings Paper
CT Symposium on the Mechanical Behaviour of Cells, Scaffolds and Engineered
   Tissues/TERMIS-EU Meeting
CY JUN, 2011
CL Granada, SPAIN
SP Elsevier, Journal Mech Behav Biomed Mat
DE Bone regeneration; Silk; Biomaterials; Growth factor carrier
ID IN-VITRO; FUNCTIONAL REPAIR; FIBROIN; SCAFFOLDS; FILMS; BIOMATERIALS;
   RELEASE; VIVO; DIFFERENTIATION; STABILIZATION
AB The use of tissue grafting for the repair of large bone defects has numerous limitations including donor site morbidity and the risk of disease transmission. These limitations have prompted research efforts to investigate the effects of combining biomaterial scaffolds with biochemical cues to augment bone repair. The goal of this study was to use a critically-sized rat femoral segmental defect model to investigate the efficacy of a delivery system consisting of an electrospun polycaprolactone (PCL) nanofiber mesh tube with a silk fibroin hydrogel for local recombinant bone morphogenetic protein 2 (BMP-2) delivery. Bilateral 8 mm segmental femoral defects were formed in 13-week-old Sprague Dawley rats. Perforated electrospun PCL nanofiber mesh tubes were fitted into the adjacent native bone such that the lumen of the tubes contained the defect (Kolambkar et al., 2011b). Silk hydrogels with or without BMP-2 were injected into the defect. Bone regeneration was longitudinally assessed using 2D X-ray radiography and 3D microcomputed topography (mu CT). Following sacrifice at 12 weeks after surgery, the extracted femurs were either subjected to biomechanical testing or assigned for histology. The results demonstrated that silk was an effective carrier for BMP-2. Compared to the delivery system without BMP-2, the delivery system that contained BMP-2 resulted in more bone formation (p < 0.05) at 4, 8, 12 weeks after surgery. Biomechanical properties were also significantly improved in the presence of BMP-2 (p < 0.05) and were comparable to age-matched intact femurs. Histological evaluation of the defect region indicated that the silk hydrogel has been completely degraded by the end of the study. Based on these results, we conclude that a BMP-2 delivery system consisting of an electrospun PCL nanofiber mesh tube with a silk hydrogel presents an effective strategy for functional repair of large bone defects. (C) 2011 Elsevier Ltd. All rights reserved.
C1 [Guldberg, Robert E.] Georgia Inst Technol, Inst Bioengn & Biosci, George W Woodruff Sch Mech Engn, Atlanta, GA 30332 USA.
   [Diab, Tamim; Uhrig, Brent A.; Boerckel, Joel D.; Guldberg, Robert E.] Georgia Inst Technol, Parker H Petit Inst Bioengn & Biosci, Atlanta, GA 30332 USA.
   [Pritchard, Eleanor M.; Kaplan, David L.] Tufts Univ, Dept Biomed Engn, Medford, MA 02155 USA.
RP Guldberg, RE (reprint author), Georgia Inst Technol, Inst Bioengn & Biosci, George W Woodruff Sch Mech Engn, 315 Ferst Dr, Atlanta, GA 30332 USA.
EM tdiab@gatech.edu; eleanor.pritchard@tufts.edu; brent.uhrig@gatech.edu;
   joel.boerckel@gatech.edu; david.kaplan@tufts.edu;
   robert.guldberg@me.gatech.edu
RI Boerckel, Joel/A-7223-2015
FU NIBIB NIH HHS [R01 EB003210, EB002520, P41 EB002520, EB003210]; NIAMS
   NIH HHS [AR056694, R01 AR056694, R01 AR051336, R01 AR051336-04]
CR Acharya C, 2008, J MATER SCI-MATER M, V19, P2827, DOI 10.1007/s10856-008-3408-3
   Benoit DSW, 2005, ACTA BIOMATER, V1, P461, DOI 10.1016/j.actbio.2005.03.002
   Bessa PC, 2010, J TISSUE ENG REGEN M, V4, P349, DOI 10.1002/term.245
   Bessa PC, 2010, TISSUE ENG PART C-ME, V16, P937, DOI [10.1089/ten.tec.2009.0486, 10.1089/ten.TEC.2009.0486]
   Boerckel JD, 2011, BIOMATERIALS, V32, P5241, DOI 10.1016/j.biomaterials.2011.03.063
   Carragee EJ, 2011, SPINE J, V11, P471, DOI 10.1016/j.spinee.2011.04.023
   Chen B, 2007, BIOMATERIALS, V28, P1027, DOI 10.1016/j.biomaterials.2006.10.013
   Dupont K.M., 2011, CELL TISSUE RES
   Fini M, 2005, BIOMATERIALS, V26, P3527, DOI 10.1016/j.biomaterials.2004.09.040
   Glassman SD, 2007, SPINE J, V7, P44, DOI 10.1016/j.spinee.2006.06.381
   Guziewicz N, 2011, BIOMATERIALS, V32, P2642, DOI 10.1016/j.biomaterials.2010.12.023
   Horan RL, 2005, BIOMATERIALS, V26, P3385, DOI 10.1016/j.biomaterials.2004.09.020
   Jiang XQ, 2009, BIOMATERIALS, V30, P4522, DOI 10.1016/j.biomaterials.2009.05.021
   Karageorgiou V, 2004, J BIOMED MATER RES A, V71A, P528, DOI 10.1002/jbm.a.30186
   Kirker-Head C, 2007, BONE, V41, P247, DOI 10.1016/j.bone.2007.04.186
   Kluge JA, 2010, J MECH BEHAV BIOMED, V3, P278, DOI 10.1016/j.jmbbm.2009.12.001
   Kolambkar YM, 2011, BONE, V49, P485, DOI 10.1016/j.bone.2011.05.010
   Kolambkar YM, 2011, BIOMATERIALS, V32, P65, DOI 10.1016/j.biomaterials.2010.08.074
   Kundu B, 2010, PROG POLYM SCI, V35, P1116, DOI 10.1016/j.progpolymsci.2010.04.004
   Lawrence BD, 2008, BIOMACROMOLECULES, V9, P1214, DOI 10.1021/bm701235f
   Leal-Egana A, 2010, BIOTECHNOL APPL BIOC, V55, P155, DOI 10.1042/BA20090229
   Li CM, 2006, BIOMATERIALS, V27, P3115, DOI 10.1016/j.biomaterials.2006.01.022
   Lu Q, 2010, MACROMOL BIOSCI, V10, P359, DOI 10.1002/mabi.200900388
   Lu SZ, 2009, BIOMACROMOLECULES, V10, P1032, DOI 10.1021/bm800956n
   Luginbuehl V, 2004, EUR J PHARM BIOPHARM, V58, P197, DOI 10.1016/j.ejpb.2004.03.004
   Meinel L, 2005, BIOMATERIALS, V26, P147, DOI 10.1016/j.biomaterials.2004.02.047
   Meinel L, 2006, BIOMATERIALS, V27, P4993, DOI 10.1016/j.biomaterials.2006.05.021
   Numata K, 2010, ADV DRUG DELIVER REV, V62, P1497, DOI 10.1016/j.addr.2010.03.009
   Oest ME, 2007, J ORTHOP RES, V25, P941, DOI 10.1002/jor.20372
   Panilaitis B, 2003, BIOMATERIALS, V24, P3079, DOI 10.1016/S0142-9612(03)00158-3
   Seo YK, 2009, J ORTHOP RES, V27, P495, DOI 10.1002/jor.20752
   Sofia S, 2001, J BIOMED MATER RES, V54, P139, DOI 10.1002/1097-4636(200101)54:1<139::AID-JBM17>3.0.CO;2-7
   Suh DY, 2002, SPINE, V27, P353, DOI 10.1097/00007632-200202150-00006
   Vepari C, 2007, PROG POLYM SCI, V32, P991, DOI 10.1016/j.progpolymsci.2007.05.013
   Wang XQ, 2008, BIOMATERIALS, V29, P1054, DOI 10.1016/j.biomaterials.2007.11.003
   Wang XQ, 2009, J CONTROL RELEASE, V134, P81, DOI 10.1016/j.jconrel.2008.10.021
   Wang Y, 2008, BIOMATERIALS, V29, P3415, DOI 10.1016/j.biomaterials.2008.05.002
   Wang YZ, 2006, BIOMATERIALS, V27, P6064, DOI 10.1016/j.biomaterials.2006.07.008
   Wenk E, 2010, BIOMATERIALS, V31, P1403, DOI 10.1016/j.biomaterials.2009.11.006
   Wongpanit P, 2010, J BIOMAT SCI-POLYM E, V21, P1403, DOI 10.1163/092050609X12517858243706
   Wray L.S., 2011, J BIOMED MAT RES B
   Zheng Wenzhong, 2011, Wuhan Daxue Xuebao (Yixue Ban), V32, P32
NR 42
TC 50
Z9 56
U1 3
U2 40
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 1751-6161
J9 J MECH BEHAV BIOMED
JI J. Mech. Behav. Biomed. Mater.
PD JUL
PY 2012
VL 11
SI SI
BP 123
EP 131
DI 10.1016/j.jmbbm.2011.11.007
PG 9
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 964XK
UT WOS:000305729800013
PM 22658161
OA Green Accepted
DA 2018-10-19
ER

PT J
AU Zhang, Y
   Liu, Y
   Ji, XB
   Banks, CE
   Zhang, W
AF Zhang, Ying
   Liu, Yong
   Ji, Xiaobo
   Banks, Craig E.
   Zhang, Wei
TI Conversion of natural egg-shell to 3D flower-like hydroxyapatite
   agglomerates for highly sensitive detection of As3+ ions
SO MATERIALS LETTERS
LA English
DT Article
DE Biomaterials; Hydroxyapatite; Eggshell; Crystal growth; Arsenic; Sensors
ID STRIPPING VOLTAMMETRIC DETERMINATION; ELECTRODE; ARSENIC(III);
   SPECIATION; FILM; SPECTROMETRY; SEAWATER; METALS; WATER
AB Inorganic arsenic ions such as As3+ in the environment have become one of the potential risks for human health. In this work, 3D flower-like hydroxyapatite agglomerates were converted from natural egg-shell powder under mild conditions and applied on the detection of As3+. The effect of conversion time on the determination capability was investigated. This biomaterial has been demonstrated to be highly sensitive to trace As' with a limit of detection down to 0.034 ppb. (C) 2012 Elsevier B.V. All rights reserved.
C1 [Zhang, Ying; Liu, Yong] Cent S Univ, State Key Lab Powder Met, Changsha 410083, Peoples R China.
   [Ji, Xiaobo; Banks, Craig E.] Cent S Univ, Sch Chem & Chem Engn, Changsha 410083, Peoples R China.
   [Banks, Craig E.] Manchester Metropolitan Univ, Div Chem & Environm Sci, Sch Sci & Environm, Fac Sci & Engn, Manchester M1 5GD, Lancs, England.
   [Zhang, Wei] China Shipbldg Ind Corp, Res Inst 712, Wuhan 430064, Peoples R China.
RP Liu, Y (reprint author), Cent S Univ, State Key Lab Powder Met, 932 Lushan S Rd, Changsha 410083, Peoples R China.
EM yonliu11@yahoo.com.cn
RI banks, craig/A-8889-2013
OI banks, craig/0000-0002-0756-9764
FU National Natural Science Foundation of China [50823006]; Ministry of
   Education [1343-76140000003]
FX This work was financially supported by the National Natural Science
   Foundation of China (No. 50823006) and Young Scholarship Award for
   Excellent Doctoral Candidates from the Ministry of Education
   (1343-76140000003).
CR Anezaki K, 1999, ANAL SCI, V15, P829, DOI 10.2116/analsci.15.829
   Dai XA, 2006, ANAL SCI, V22, P567, DOI 10.2116/analsci.22.567
   El Mhanunedi MA, 2007, ELECTROANAL, V19, P1727, DOI 10.1002/elan.200703927
   Feeney S., 2000, ANAL CHEM, V72, P2222
   Feng L, 1998, ANAL CHIM ACTA, V375, P167
   Gibbon-Walsh K, 2010, ANAL CHIM ACTA, V662, P1, DOI 10.1016/j.aca.2009.12.038
   Laschi S, 2007, ANAL LETT, V40, P3002, DOI 10.1080/00032710701645703
   Lee SJ, 2003, MATER LETT, V57, P4570, DOI 10.1016/S0167-577X903)00363-X
   Lei Y, 2010, ANAL BIOCHEM, V398, P191
   Liu L, 2011, LANGMUIR, V27, P7199, DOI 10.1021/la200738n
   Mandal BK, 2002, TALANTA, V58, P201, DOI 10.1016/S0039-9140(02)00268-0
   Munoz E, 2005, TALANTA, V65, P613, DOI 10.1016/j.talanta.2004.07.034
   Pan DW, 2009, ANAL CHEM, V81, P5088, DOI 10.1021/ac900417e
   Rivera EM, 1999, MATER LETT, V41, P128, DOI 10.1016/S0167-577X(99)00118-4
   SADANA RS, 1983, ANAL CHEM, V55, P304, DOI 10.1021/ac00253a028
   Salaun P, 2007, ANAL CHIM ACTA, V585, P312, DOI 10.1016/j.aca.2006.12.048
   Salimi M, 2004, ANALYST, V129, P9
   Simm AO, 2005, ELECTROANAL, V17, P1727, DOI 10.1002/elan.200503299
   Simm AO, 2005, ELECTROANAL, V17, P335, DOI 10.1002/elan.200403110
   Simm AO, 2004, ANAL CHEM, V76, P5051, DOI 10.1021/ac049331a
   Simm C, 2005, ANAL BIOANAL CHEM, V381, P979
   Sun YC, 1997, TALANTA, V44, P1379, DOI 10.1016/S0039-9140(96)02197-2
   THOMAS P, 1995, J ANAL ATOM SPECTROM, V10, P615, DOI 10.1039/ja9951000615
   Wang B, 2009, BIOSENS BIOELECTRON, V24, P1141, DOI 10.1016/j.bios.2008.06.053
   Yokel RA, 2006, J TOXICOL ENV HEAL B, V9, P63, DOI 10.1080/15287390500196230
   Zhang Y, 2011, J MATER CHEM, V21, P14428, DOI 10.1039/c1jm12544c
   Zhang Y, 2011, J MATER CHEM, V21, P7552, DOI 10.1039/c1jm10949a
   Zhang Y, 2011, CHEM COMMUN, V47, P4126, DOI 10.1039/c1cc10489f
NR 28
TC 9
Z9 9
U1 1
U2 55
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0167-577X
J9 MATER LETT
JI Mater. Lett.
PD JUL 1
PY 2012
VL 78
SI SI
BP 120
EP 123
DI 10.1016/j.matlet.2012.03.055
PG 4
WC Materials Science, Multidisciplinary; Physics, Applied
SC Materials Science; Physics
GA 965PN
UT WOS:000305779800037
DA 2018-10-19
ER

PT J
AU Aktas, C
   Dorrschuck, E
   Schuh, C
   Miro, MM
   Lee, J
   Putz, N
   Wennemuth, G
   Metzger, W
   Oberringer, M
   Veith, M
   Abdul-Khaliq, H
AF Aktas, Cenk
   Doerrschuck, Eva
   Schuh, Cathrin
   Miro, Marina Martinez
   Lee, Juseok
   Puetz, Norbert
   Wennemuth, Gunther
   Metzger, Wolfgang
   Oberringer, Martin
   Veith, Michael
   Abdul-Khaliq, Hashim
TI Micro- and nanostructured Al2O3 surfaces for controlled vascular
   endothelial and smooth muscle cell adhesion and proliferation
SO MATERIALS SCIENCE & ENGINEERING C-MATERIALS FOR BIOLOGICAL APPLICATIONS
LA English
DT Article
DE Nanowires; CVD; Cells; Biomaterial
ID MORPHOLOGY; NANOWIRES; COATINGS; STENTS
AB The effect of the micro- and nanotopography on vascular cell-surface interaction is investigated using nano- and microstructured Al2O3 as model substrate. Two different nanostructured Al2O3 surfaces composed of low density (LD) and high density (HD) nanowires (NWs) were synthesized by chemical vapour deposition (CVD) and commercially available microstructured Al2O3 plates were used for comparison. A clear diverging response of human umbilical vein endothelial cells (HUVEC) and human umbilical vein smooth muscle cells (HUVSMC) was observed on these nano- and microstructured surfaces. LD Al2O3 NWs seem to enhance the proliferation of HUVECs selectively. This selective control of the cell-surface interaction by topography may represent a key issue for the future stent material design. (C) 2012 Elsevier B.V. All rights reserved.
C1 [Aktas, Cenk; Miro, Marina Martinez; Lee, Juseok; Veith, Michael] INM Leibniz Inst New Mat, CVD Biosurfaces Div, D-66123 Saarbrucken, Germany.
   [Doerrschuck, Eva; Schuh, Cathrin; Abdul-Khaliq, Hashim] Univ Saarland, Clin Paediat Cardiol, D-66424 Homburg, Germany.
   [Puetz, Norbert; Wennemuth, Gunther] Univ Saarland, Dept Anat & Cell Biol, D-66424 Homburg, Germany.
   [Metzger, Wolfgang; Oberringer, Martin] Univ Saarland, Dept Trauma Hand & Reconstruct Surg, D-66424 Homburg, Germany.
   [Veith, Michael] Univ Saarland, Dept Inorgan Chem, D-66123 Saarbrucken, Germany.
RP Aktas, C (reprint author), INM Leibniz Inst New Mat, CVD Biosurfaces Div, D-66123 Saarbrucken, Germany.
EM cenk.aktas@inm-gmbh.de
OI Wennemuth, Gunther/0000-0003-3313-2475
FU HOMFOR (Homburger Forschungs-forderungsprogramm) [T201000560]
FX We thank Ina Marsollek and Ayman Haidar for the cell density analysis.
   This work is funded by HOMFOR (Homburger Forschungs-forderungsprogramm)
   (fond-no. T201000560). Eva Dorrschuck thanks Kay-Martin Hanschmann for
   his expert assistance with the statistical analysis.
CR Aktas C, 2011, ADV MATER RES-SWITZ, V324, P105, DOI 10.4028/www.scientific.net/AMR.324.105
   Aktas O.C., 2010, THESIS U SAARLANDES
   Ball MD, 2004, J MATER SCI-MATER M, V15, P447, DOI 10.1023/B:JMSM.0000021118.85955.4a
   Choubey A., 2010, J MATER SCI-MATER M, V10, P2105
   Chu CL, 2006, MAT SCI ENG A-STRUCT, V417, P104, DOI 10.1016/j.msea.2005.11.010
   Curtis A, 1997, BIOMATERIALS, V18, P1573, DOI 10.1016/S0142-9612(97)00144-0
   Dalby M J, 2005, Eur Cell Mater, V9, P1
   Dalby MJ, 2004, BIOMATERIALS, V25, P5415, DOI 10.1016/j.biomaterials.2003.12.049
   Dearnaley G, 2005, SURF COAT TECH, V200, P2518, DOI 10.1016/j.surfcoat.2005.07.077
   Fine E, 2009, INT J NANOMED, V4, P91
   Lee JY, 2008, BIOMATERIALS, V29, P3743, DOI 10.1016/j.biomaterials.2008.05.029
   Lipski AM, 2008, BIOMATERIALS, V29, P3836, DOI 10.1016/j.biomaterials.2008.06.002
   Mirzadeh H, 2011, J BIOMED MATER RES A, V98A, P63, DOI 10.1002/jbm.a.33097
   Morales AM, 1998, SCIENCE, V279, P208, DOI 10.1126/science.279.5348.208
   PALMAZ JC, 1993, AM J ROENTGENOL, V160, P613, DOI 10.2214/ajr.160.3.8430566
   Puskas JE, 2009, WIRES NANOMED NANOBI, V1, P451, DOI 10.1002/wnan.038
   Ran CB, 2008, LANGMUIR, V24, P9952, DOI 10.1021/la801461j
   Ranella A, 2010, ACTA BIOMATER, V6, P2711, DOI 10.1016/j.actbio.2010.01.016
   Rebollar E, 2008, BIOMATERIALS, V29, P1796, DOI 10.1016/j.biomaterials.2007.12.039
   Schmehl JM, 2008, CARDIOVASC REVASCULA, V9, P255, DOI 10.1016/j.carrev.2008.03.004
   Shen Y, 2009, ACTA BIOMATER, V5, P3593, DOI 10.1016/j.actbio.2009.05.021
   Sherlock RJ, 2003, P SOC PHOTO-OPT INS, V4876, P11, DOI 10.1117/12.463640
   Stoeckel D, 2002, MINIM INVASIV THER, V11, P137, DOI 10.1080/136457002760273340
   Stover M, 2006, J MATER SCI, V41, P5569, DOI 10.1007/s10853-006-0257-7
   van Oeveren W., 2001, PROG BIOMED RES, V6, P195
   Veith M, 1996, J MATER SCI, V31, P2009, DOI 10.1007/BF00356620
   Veith M., 2010, BIOFABRICATION, V2
   Veith M, 2008, EUR J INORG CHEM, P5181, DOI 10.1002/ejic.200800890
   Wentzel J.J., 2008, EUROINTERVENTION SC, V4, P27
   Wieneke H., 2001, PROG BIOMED RES, V6, P215
NR 30
TC 13
Z9 14
U1 1
U2 17
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0928-4931
J9 MAT SCI ENG C-MATER
JI Mater. Sci. Eng. C-Mater. Biol. Appl.
PD JUL 1
PY 2012
VL 32
IS 5
BP 1017
EP 1024
DI 10.1016/j.msec.2012.02.032
PG 8
WC Materials Science, Biomaterials
SC Materials Science
GA 964SF
UT WOS:000305716300001
DA 2018-10-19
ER

PT J
AU He, TT
   Yang, ZL
   Chen, R
   Wang, J
   Leng, YX
   Sun, H
   Huang, N
AF He, Tingting
   Yang, Zhilu
   Chen, Rui
   Wang, Jin
   Leng, Yongxiang
   Sun, Hong
   Huang, Nan
TI Enhanced endothelialization guided by fibronectin functionalized plasma
   polymerized acrylic acid film
SO MATERIALS SCIENCE & ENGINEERING C-MATERIALS FOR BIOLOGICAL APPLICATIONS
LA English
DT Article
DE Acrylic acid; Plasma polymerization; Fibronectin immobilization;
   Endothelialization
ID CELL-ADHESION; COVALENT IMMOBILIZATION; STAINLESS-STEEL; RGD PEPTIDES;
   SURFACES; ATTACHMENT; STENT; BIOCOMPATIBILITY; BIOMATERIAL; SPECIFICITY
AB The plasma polymerized acrylic acid (PPAA) films with high carboxyl concentration were fabricated by low temperature plasma polymerization technology. Vacuum thermal treatment was used to modify the PPAA films. The stability of the PPAA film was evidenced by scanning electron microscopy (SEM). The result of toluidine blue-O (TBO) method showed that the -COOH concentration on the surface of the PPAA films decreased from 20.73 nM to17.90 nM after vacuum thermal treatment. Fibronectin (Fn) was successfully covalently immobilized onto the modified surface PPAA via a covalent bond reacted with carboxyl groups. Diffuse reflectance Fourier infrared transform spectroscopy (DRFTIR) and X-ray photoelectron spectroscopy (XPS) were utilized to characterize the layer-by-layer PPAA surface modification. From the evaluation of immunostaining for actin and Cell Counting Kit-8 (CCK-8), the surface of Fn-immobilized thermal treated PPAA films could be used to enhance the adhesion and proliferation of human umbilical vein endothelial cells (HUVECs). Especially, the exposure of RGD domain existing in the immobilized Fn was ascertained by ELISA, which was one of main improvement factors of HUVEC's adhesion and proliferation. This study demonstrated a promising surface modification used for vascular devices. (C) 2012 Published by Elsevier B.V.
C1 [He, Tingting; Yang, Zhilu; Chen, Rui; Wang, Jin; Leng, Yongxiang; Sun, Hong; Huang, Nan] SW Jiaotong Univ, Educ Minist, Key Lab Adv Technol Mat, Chengdu 610031, Peoples R China.
RP Wang, J (reprint author), SW Jiaotong Univ, Educ Minist, Key Lab Adv Technol Mat, Chengdu 610031, Peoples R China.
EM jinxxwang@263.net
OI Leng, Y.X./0000-0001-6823-1233
FU National Natural Science Foundation of China [50673081]; Ministry of
   Scientific and Technical Project of China [2011CB606204]; program for
   Sichuan Youthful Science and Technology Foundation [2010JQ0081]
FX This work was supported by Project 50673081 supported by National
   Natural Science Foundation of China, Key Basic Research Project No.
   2011CB606204 supported by Ministry of Scientific and Technical Project
   of China and program for Sichuan Youthful Science and Technology
   Foundation 2010JQ0081.
CR Amaral F., 2009, BIOMATERIALS, V30, P5465
   Barbucci R, 2005, BIOMACROMOLECULES, V6, P638, DOI 10.1021/bm049642v
   Barranco V, 2004, ELECTROCHIM ACTA, V49, P1999, DOI 10.1016/j.electacta.2003.12.030
   Chen JL, 2010, J BIOMED MATER RES A, V95A, P341, DOI 10.1002/jbm.a.32847
   Chollet C, 2007, BIOMOL ENG, V24, P477, DOI 10.1016/j.bioeng.2007.07.012
   Chollet C, 2009, BIOMATERIALS, V30, P711, DOI 10.1016/j.biomaterials.2008.10.033
   Chong MSK, 2009, BIOMATERIALS, V30, P2241, DOI 10.1016/j.biomaterials.2008.12.056
   CORINNE RW, 2007, BIOMATERIALS OXFORD, V28, P851
   Davis DH, 2002, BIOMATERIALS, V23, P4019, DOI 10.1016/S0142-9612(02)00152-7
   Futakawa S, 2009, ANAL CHIM ACTA, V631, P116, DOI 10.1016/j.aca.2008.10.028
   He Y, 2010, AM J CARDIOL, V105, P1272, DOI 10.1016/j.amjcard.2009.12.042
   Ito Y, 1997, BIOMATERIALS, V18, P197, DOI 10.1016/S0142-9612(96)00119-6
   Jia C.F., 2005, PLASMA PROCESS POLYM, V2, P127
   Keselowsky BG, 2003, J BIOMED MATER RES A, V66A, P247, DOI 10.1002/jbm.a.10537
   Lee MH, 2006, BIOMATERIALS, V27, P1907, DOI 10.1016/j.biomaterials.2005.11.003
   Li GC, 2010, COLLOID SURFACE B, V81, P255, DOI 10.1016/j.colsurfb.2010.07.016
   Lin QK, 2010, BIOMATERIALS, V31, P4017, DOI 10.1016/j.biomaterials.2010.01.092
   Liu S, 2005, LANGMUIR, V21, P8572, DOI 10.1021/la051449e
   Lopez LC, 2005, SURF COAT TECH, V200, P1000, DOI 10.1016/j.surfcoat.2005.02.003
   Mani G, 2010, BIOMATERIALS, V31, P5372, DOI 10.1016/j.biomaterials.2010.03.043
   Menem G., 2002, BIOMATERIALS, V23, P3927
   Meng S, 2009, BIOMATERIALS, V30, P2276, DOI 10.1016/j.biomaterials.2008.12.075
   Patricia R., 2010, COLLOID SURFACE B, V78, P310
   Petrie TA, 2006, BIOMATERIALS, V27, P5459, DOI 10.1016/j.biomaterials.2006.06.027
   Sumpio BE, 2002, INT J BIOCHEM CELL B, V34, P1508, DOI 10.1016/S1357-2725(02)00075-4
   Tada N, 2010, CIRC-CARDIOVASC INTE, V3, P174, DOI 10.1161/CIRCINTERVENTIONS.109.877522
   Walter M., 2005, BIOMATERIALS, V26, P2813
   Williamson MR, 2007, BIOMATERIALS, V28, P5307, DOI 10.1016/j.biomaterials.2007.08.019
   Xue XQ, 2010, APPL SURF SCI, V256, P3866, DOI 10.1016/j.apsusc.2010.01.042
   Yang ZL, 2010, BIOMATERIALS, V31, P2072, DOI 10.1016/j.biomaterials.2009.11.091
   Yang ZL, 2009, PLASMA PROCESS POLYM, V6, P498, DOI 10.1002/ppap.200800195
   Yin YB, 2009, BIOMATERIALS, V30, P1675, DOI 10.1016/j.biomaterials.2008.11.009
   Yuan Y, 2008, J MATER SCI-MATER M, V19, P2187, DOI 10.1007/s10856-007-3319-8
   Zhang P., 2005, BIOMATERIALS, V26, P47
   Zhang Y, 2007, MAT SCI ENG C-BIO S, V27, P213, DOI 10.1016/j.msec.2006.03.013
NR 35
TC 10
Z9 10
U1 1
U2 34
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0928-4931
J9 MAT SCI ENG C-MATER
JI Mater. Sci. Eng. C-Mater. Biol. Appl.
PD JUL 1
PY 2012
VL 32
IS 5
BP 1025
EP 1031
DI 10.1016/j.msec.2012.02.028
PG 7
WC Materials Science, Biomaterials
SC Materials Science
GA 964SF
UT WOS:000305716300002
DA 2018-10-19
ER

PT J
AU Floroian, L
   Florescu, M
   Sima, F
   Popescu-Pelin, G
   Ristoscu, C
   Mihailescu, IN
AF Floroian, L.
   Florescu, M.
   Sima, F.
   Popescu-Pelin, G.
   Ristoscu, C.
   Mihailescu, I. N.
TI Synthesis of biomaterial thin films by pulsed laser technologies:
   Electrochemical evaluation of bioactive glass-based nanocomposite
   coatings for biomedical applications
SO MATERIALS SCIENCE & ENGINEERING C-MATERIALS FOR BIOLOGICAL APPLICATIONS
LA English
DT Article
DE Bioactive and anticorrosive coatings; Composite bioactive glass-polymer
   thin layers; Electrochemical impedance spectroscopy
ID TITANIUM IMPLANT; BIOGLASS; DEPOSITION; ELECTRODES; ADSORPTION; ALLOYS;
   TESTS; BONE; PMMA
AB The surface of biomedical titanium implants has been covered with thin films of bioactive glass and bioactive glass + poly(methyl methacrylate nanocomposite) in order to increase the resistance to corrosion and improve the bioactivity of their area in contact with bone tissue. To this purpose Pulsed Laser Deposition and Matrix Assisted Pulsed Laser Evaporation with an excimer laser source have been applied.
   The layer assessments under conditions that simulate their biological interaction with the human body fluids and resistance to degradation have been studied by electrochemical polarization and electrochemical impedance spectroscopy. The poly(methyl methacrylate) addition to bioglass has reduced the bone ability to bond but resulted in a significant increase of the shielding efficiency against corrosion of the applied coatings. The obtained results support the application of bioactive glass and composite bioactive glass + poly(methyl methacrylate) coatings for the development of advanced highly stable implants and prostheses that cannot be affected by corrosion. (C) 2012 Elsevier B.V. All rights reserved.
C1 [Sima, F.; Popescu-Pelin, G.; Ristoscu, C.; Mihailescu, I. N.] Natl Inst Laser Plasma & Radiat Phys, Laser Surface Plasma Interact Lab, Lasers Dept, RO-77125 Magurele, Ilfov, Romania.
   [Floroian, L.; Florescu, M.] Transilvania Univ Brasov, Dept Phys, Brasov 500036, Romania.
RP Mihailescu, IN (reprint author), Natl Inst Laser Plasma & Radiat Phys, Laser Surface Plasma Interact Lab, Lasers Dept, POB MG 54, RO-77125 Magurele, Ilfov, Romania.
EM lauraf@unitbv.ro; florescum@unitbv.ro; felix.sima@inflpr.ro;
   gianina.popescu@inflpr.ro; carmen.ristoscu@inflpr.ro;
   ion.mihailescu@inflpr.ro
RI Mihailescu, Ion/A-5403-2011; Ristoscu, Carmen/B-8628-2011; SIMA, Felix
   Nicolae/C-2734-2011; Florescu, Monica/B-5022-2008
OI Ristoscu, Carmen/0000-0002-8433-9217; Florescu,
   Monica/0000-0002-1467-3113; Floroian, Laura/0000-0002-3289-8025
FU European Social Fund POSDRU [POSDRU/89/1.5/S/60746]
FX F. S., G. P.-P., C. R. and I. N. M. acknowledge the European Social Fund
   POSDRU 2007-2013 through the contract POSDRU/89/1.5/S/60746.
CR Andersson O.H., 1999, J NONCRYST SOLIDS, V246, P9
   Berbecaru C, 2009, APPL SURF SCI, V255, P5476, DOI 10.1016/j.apsusc.2008.08.020
   Bianco PD, 1996, J BIOMED MATER RES, V31, P227
   Boger A, 2008, J BIOMAT SCI-POLYM E, V19, P1125, DOI 10.1163/156856208785540154
   BRETT CMA, 1994, J ELECTROANAL CHEM, V366, P225, DOI 10.1016/0022-0728(93)02994-S
   Bruens ML, 2003, J CRANIOFAC SURG, V14, P63, DOI 10.1097/00001665-200301000-00011
   Brunette D. M., 2001, TITANIUM MED MAT SCI
   Cristescu R, 2004, THIN SOLID FILMS, V453, P262, DOI 10.1016/j.tsf.2003.11.145
   Floroian L, 2007, DIG J NANOMATER BIOS, V2, P285
   Floroian L, 2008, APPL SURF SCI, V255, P3056, DOI 10.1016/j.apsusc.2008.08.105
   Floroian L, 2011, METAL CERAMIC POLYM, P393
   Frazer Robert Q, 2005, J Long Term Eff Med Implants, V15, P629
   Gomez-Vega JM, 1999, J BIOMED MATER RES, V46, P549, DOI 10.1002/(SICI)1097-4636(19990915)46:4<549::AID-JBM13>3.0.CO;2-M
   Gross UM, 2009, THIN CALCIUM PHOSPHA, P67, DOI DOI 10.1007/978-0-387-77718-4.CH4
   Hench L.L., 1993, BIOACTIVE GLASS COAT
   HENCH LL, 1982, BIOMATERIALS INTERFA
   Jacobs JJ, 1999, CLIN ORTHOP RELAT R, P173
   KARTHEGA M, 2006, TRENDS BIOMATER ARTI, V20, P31
   KOKUBO T, 1990, J BIOMED MATER RES, V24, P721, DOI 10.1002/jbm.820240607
   Layrolle P., 2009, THIN CALCIUM PHOSPHA, P9
   Leon B, 2009, THIN CALCIUM PHOSPHA, P101
   Liu XY, 2004, MAT SCI ENG R, V47, P49, DOI 10.1016/j.mser.2004.11.001
   OGINO M, 1980, J BIOMED MATER RES, V14, P55, DOI 10.1002/jbm.820140107
   OHURA K, 1992, J MATER SCI-MATER M, V3, P95, DOI 10.1007/BF00705275
   Oliveira-Brett AM, 2002, LANGMUIR, V18, P2326, DOI 10.1021/la010980g
   Passy S., 2003, INT J COSMETIC SURG, V5, P193
   PAZO A, 1998, CERAMIC MICROSTRUCTU, P543
   Perez N., 2004, ELECTROCHEMISTRY COR
   Pique A., 2007, PULSED LASER DEPOSIT, P63
   Popa MV, 2007, MATER CORROS, V58, P667, DOI 10.1002/maco.200704053
   Popescu AC, 2009, APPL SURF SCI, V255, P5486, DOI 10.1016/j.apsusc.2008.10.031
   Sima F, 2009, J OPTOELECTRON ADV M, V11, P1170
   Tanaskovic D, 2007, APPL SURF SCI, V254, P1279, DOI 10.1016/j.apsusc.2007.08.009
NR 33
TC 16
Z9 16
U1 3
U2 39
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0928-4931
J9 MAT SCI ENG C-MATER
JI Mater. Sci. Eng. C-Mater. Biol. Appl.
PD JUL 1
PY 2012
VL 32
IS 5
BP 1152
EP 1157
DI 10.1016/j.msec.2012.03.001
PG 6
WC Materials Science, Biomaterials
SC Materials Science
GA 964SF
UT WOS:000305716300020
DA 2018-10-19
ER

PT J
AU Green, JJ
AF Green, Jordan J.
TI 2011 Rita Schaffer Lecture: Nanoparticles for Intracellular Nucleic Acid
   Delivery
SO ANNALS OF BIOMEDICAL ENGINEERING
LA English
DT Article
DE Biomaterials; Gene delivery; Nanoparticle; DNA; siRNA
ID NONVIRAL GENE DELIVERY; HUMAN ENDOTHELIAL-CELLS; PLURIPOTENT STEM-CELLS;
   POLY(AMIDO AMINE)S; POLY(BETA-AMINO ESTERS); POLYMER NANOPARTICLES;
   CATIONIC POLYMERS; IN-VITRO; THERAPY; DNA
AB Nanoparticles are a promising technology for delivery of new types of therapeutics. A polymer library approach has allowed engineering of polymeric particles that are particularly effective for the delivery of DNA and siRNA to human cells. Certain chemical structural motifs, degradable linkages, hydrophobicity, and biophysical properties are key for successful intracellular delivery. Small differences to biomaterial structure, and especially the type of degradable linkage in the polymers, can be critical for successful delivery of siRNA vs. DNA. Furthermore, subtle changes to biomaterial structure can facilitate cell-type gene delivery specificity between human brain cancer cells and healthy cells as well as between human retinal endothelial cells and epithelial cells. These polymeric nanoparticles are effective for nucleic acid delivery in a broad range of human cell types and have applications to regenerative medicine, ophthalmology, and cancer among many other biomedical research areas.
C1 [Green, Jordan J.] Johns Hopkins Univ, Sch Med, Dept Biomed Engn, Wilmer Eye Inst,Inst Nanobiotechnol, Baltimore, MD 21231 USA.
   [Green, Jordan J.] Johns Hopkins Univ, Sch Med, Translat Tissue Engn Ctr, Baltimore, MD 21231 USA.
RP Green, JJ (reprint author), Johns Hopkins Univ, Sch Med, Dept Biomed Engn, Wilmer Eye Inst,Inst Nanobiotechnol, 400 N Broadway,Smith 5017, Baltimore, MD 21231 USA.
EM green@jhu.edu
FU Maryland Technology Development Corporation Maryland Stem Cell Research
   Fund [2009-MSCRFE-0098-00]; National Institutes of Health [R21CA152473];
   Institute for Nanobiotechnology at the Johns Hopkins University
FX Finally, I would like to thank the institutions that funded this
   research. This work was funded in part by the following sources: the
   Maryland Technology Development Corporation Maryland Stem Cell Research
   Fund (2009-MSCRFE-0098-00), the National Institutes of Health
   (R21CA152473), and the Institute for Nanobiotechnology at the Johns
   Hopkins University.
CR Acharya S, 2011, ADV DRUG DELIVER REV, V63, P170, DOI 10.1016/j.addr.2010.10.008
   American Cancer Society, CANC FACTS AND FIG
   Anderson DG, 2003, ANGEW CHEM INT EDIT, V42, P3153, DOI 10.1002/anie.200351244
   [Anonymous], 2012, J GENE MED
   Arote RB, 2011, EXPERT OPIN DRUG DEL, V8, P1237, DOI 10.1517/17425247.2011.586333
   Austin CD, 2005, P NATL ACAD SCI USA, V102, P17987, DOI 10.1073/pnas.0509035102
   Bhise NS, 2012, SMALL, V8, P367, DOI 10.1002/smll.201101718
   Bhise NS, 2010, BIOMATERIALS, V31, P8088, DOI 10.1016/j.biomaterials.2010.07.023
   BOUSSIF O, 1995, P NATL ACAD SCI USA, V92, P7297, DOI 10.1073/pnas.92.16.7297
   Buckner JC, 2003, SEMIN ONCOL, V30, P10, DOI 10.1053/j.seminoncol.2003.11.031
   Check E, 2005, NATURE, V433, P561, DOI 10.1038/433561a
   Consortium W.T.C.C., 2007, NATURE, V447, P661, DOI DOI 10.1038/NATURE05911
   Dean DA, 2005, GENE THER, V12, P881, DOI 10.1038/sj.gt.3302534
   Fire A, 1998, NATURE, V391, P806, DOI 10.1038/35888
   Gabrielson NP, 2012, ANGEW CHEM INT EDIT, V51, P1143, DOI 10.1002/anie.201104262
   Green JJ, 2008, NANO LETT, V8, P3126, DOI 10.1021/nl8012665
   Green JJ, 2008, ACCOUNTS CHEM RES, V41, P749, DOI 10.1021/ar7002336
   Green JJ, 2007, ADV MATER, V19, P2836, DOI 10.1002/adma.200700371
   Green JJ, 2006, BIOCONJUGATE CHEM, V17, P1162, DOI 10.1021/bc0600968
   Griffith OW, 1999, FREE RADICAL BIO MED, V27, P922, DOI 10.1016/S0891-5849(99)00176-8
   Harris TJ, 2010, BIOMATERIALS, V31, P998, DOI 10.1016/j.biomaterials.2009.10.012
   Hollon T, 2000, NAT MED, V6, P6, DOI 10.1038/71545
   Huang YH, 2009, CANCER RES, V69, P6184, DOI 10.1158/0008-5472.CAN-09-0061
   Khalil IA, 2006, PHARMACOL REV, V58, P32, DOI 10.1124/pr.58.1.8
   Lai SK, 2007, BIOMATERIALS, V28, P2876, DOI 10.1016/j.biomaterials.2007.02.021
   Lee JS, 2009, NANO LETT, V9, P2402, DOI 10.1021/nl9009793
   Lin C, 2006, J CONTROL RELEASE, V116, P130, DOI 10.1016/j.jconrel.2006.09.009
   Lin C, 2008, J CONTROL RELEASE, V132, P267, DOI 10.1016/j.jconrel.2008.06.022
   Lynn DM, 2000, J AM CHEM SOC, V122, P10761, DOI 10.1021/ja0015388
   Mahato RI, 2005, ADV DRUG DELIVER REV, V57, P699, DOI 10.1016/j.addr.2004.12.005
   Mao HQ, 2001, J CONTROL RELEASE, V70, P399, DOI 10.1016/S0168-3659(00)00361-8
   McGirt MJ, 2009, J NEUROSURG, V110, P583, DOI 10.3171/2008.5.17557
   McGirt MJ, 2009, J NEUROSURG, V110, P156, DOI 10.3171/2008.4.17536
   Merdan T, 2002, ADV DRUG DELIVER REV, V54, P715, DOI 10.1016/S0169-409X(02)00046-7
   Nguyen DN, 2009, ADV MATER, V21, P847, DOI 10.1002/adma.200801478
   Ogris M, 2003, J CONTROL RELEASE, V91, P173, DOI 10.1016/S0168-3659(03)00230-X
   Partridge KA, 2004, TISSUE ENG, V10, P295, DOI 10.1089/107632704322791934
   Pun SH, 2002, BIOCONJUGATE CHEM, V13, P630, DOI 10.1021/bc0155768
   Putnam D, 2006, NAT MATER, V5, P439, DOI 10.1038/nmat1645
   Read ML, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni085
   Richardson SCW, 2001, BIOMACROMOLECULES, V2, P1023, DOI 10.1021/bm010079f
   Schaffer DV, 2000, BIOTECHNOL BIOENG, V67, P598, DOI 10.1002/(SICI)1097-0290(20000305)67:5<598::AID-BIT10>3.0.CO;2-G
   Segura T, 2001, ANNU REV MATER RES, V31, P25, DOI 10.1146/annurev.matsci.31.1.25
   Shmueli RB, 2012, NANOMED-NANOTECHNOL, V8, P1200, DOI 10.1016/j.nano.2012.01.006
   Shmueli RB, 2010, EXPERT OPIN DRUG DEL, V7, P535, DOI 10.1517/17425241003603653
   Showalter SL, 2008, CANCER BIOL THER, V7, P1584, DOI 10.4161/cbt.7.10.6562
   Sonawane ND, 2003, J BIOL CHEM, V278, P44826, DOI 10.1074/jbc.M308643200
   Sunshine J., 2009, C P IEEE ENG MED BIO, V1, P2412
   Sunshine J, 2009, ADV MATER, V21, P4947, DOI 10.1002/adma.200901718
   Sunshine JC, 2011, THER DELIV, V2, P493, DOI 10.4155/TDE.11.14
   Sunshine JC, 2011, BIOMACROMOLECULES, V12, P3592, DOI 10.1021/bm200807s
   Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019
   Thomas CE, 2003, NAT REV GENET, V4, P346, DOI 10.1038/nrg1066
   Tzeng SY, 2011, INT J NANOMED, V6, P3309, DOI 10.2147/IJN.S27269
   Tzeng SY, 2011, BIOMATERIALS, V32, P5402, DOI 10.1016/j.biomaterials.2011.04.016
   Verma IM, 1997, NATURE, V389, P239, DOI 10.1038/38410
   von Gersdorff K, 2006, MOL THER, V14, P745, DOI 10.1016/j.ymthe.2006.07.006
   WATSON JD, 1953, NATURE, V171, P737, DOI 10.1038/171737a0
   Yang F, 2010, P NATL ACAD SCI USA, V107, P3317, DOI 10.1073/pnas.0905432106
   Yu JY, 2009, SCIENCE, V324, P797, DOI 10.1126/science.1172482
   Zhou JB, 2012, NAT MATER, V11, P82, DOI [10.1038/NMAT3187, 10.1038/nmat3187]
NR 61
TC 11
Z9 11
U1 0
U2 15
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 0090-6964
J9 ANN BIOMED ENG
JI Ann. Biomed. Eng.
PD JUL
PY 2012
VL 40
IS 7
BP 1408
EP 1418
DI 10.1007/s10439-012-0550-3
PG 11
WC Engineering, Biomedical
SC Engineering
GA 959WL
UT WOS:000305348500002
PM 22451256
OA Green Accepted, Bronze
DA 2018-10-19
ER

PT J
AU Devi, AS
   Ogawa, Y
   Shimoji, Y
   Balakumar, S
   Ponnuraj, K
AF Devi, Aribam Swarmistha
   Ogawa, Yohsuke
   Shimoji, Yoshihiro
   Balakumar, Subramanian
   Ponnuraj, Karthe
TI Collagen adhesin-nanoparticle interaction impairs adhesin's ligand
   binding mechanism
SO BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS
LA English
DT Article
DE Rhusiopathiae surface protein B (RspB); Crystal structure; Collagen Hug
   model; Silver nanoparticle; Biomaterial; Antiadhesive property
ID SURFACE-PROPERTIES DETERMINE; STAPHYLOCOCCUS-AUREUS; SILVER
   NANOPARTICLES; ERYSIPELOTHRIX-RHUSIOPATHIAE; ENTEROCOCCUS-FAECALIS;
   CRYSTAL-STRUCTURE; BIOFILM FORMATION; PROTEIN CORONA; HUG MODEL; MSCRAMM
AB Background: Pathogenic bacteria specifically recognize extracellular matrix (ECM) molecules of the host (e.g. collagen, fibrinogen and fibronectin) through their surface proteins known as MSCRAMMs (Microbial Surface Components Recognizing Adhesive Matrix Molecules) and initiate colonization. On implantation, biomaterials easily get coated with these ECM molecules and the MSCRAMMs mediate bacterial adherence to biomaterials. With the rapid rise in antibiotic resistance, designing alternative strategies to reduce/eliminate bacterial colonization is absolutely essential.
   Methods: The Rhusiopathiae surface protein B (RspB) is a collagen-binding MSCRAMM of Erysipelothrix rhusiopathiae. It also binds to abiotic surfaces. The crystal structure of the collagen-binding region of RspB (rRspB(31-348)) reported here revealed that RspB also binds collagen by a unique ligand binding mechanism called "Collagen Hug" which is a common theme for collagen-binding MSCRAMMs of many Gram-positive bacteria. Here, we report the interaction studies between rRspB(31-348) and silver nanoparticles using methods like gel shift assay, gel permeation chromatography and circular dichroism spectroscopy.
   Results: The "Collagen Hug" mechanism was inhibited in the presence of silver nanoparticles as rRspB(31-348) was unable to bind to collagen. The total loss of binding was likely because of rRspB(31-348) and silver nanoparticle protein corona formation and not due to the loss of the structural integrity of rRspB(31-348) on binding with nanoparticles as observed from circular dichroism experiments.
   General significance: Interaction of rRspB(31-348) with silver nanoparticle impaired its ligand binding mechanism. Details of this inhibition mechanism may be useful for the development of antimicrobial materials and antiadhesion drugs. (C) 2012 Elsevier B.V. All rights reserved.
C1 [Devi, Aribam Swarmistha; Ponnuraj, Karthe] Univ Madras, Ctr Adv Study Crystallog & Biophys, Madras 600025, Tamil Nadu, India.
   [Ogawa, Yohsuke; Shimoji, Yoshihiro] Natl Inst Anim Hlth, Tsukuba, Ibaraki 3050856, Japan.
   [Balakumar, Subramanian] Univ Madras, Natl Ctr Nanosci & Nanotechnol, Madras 600025, Tamil Nadu, India.
RP Ponnuraj, K (reprint author), Univ Madras, Ctr Adv Study Crystallog & Biophys, Guindy Campus, Madras 600025, Tamil Nadu, India.
EM pkarthe@hotmail.com
FU Department of Science and Technology (DST), Government of India; DST;
   Ministry of Foreign Affairs/Sincrotrone Trieste, Italy; Department of
   Biotechnology (DBT), Government of India; National Center for
   Nanoscience and Nanotechnology, University of Madras
FX We gratefully acknowledge the Department of Science and Technology
   (DST), Government of India, for the financial support provided to carry
   out the work. K.P. thanks DST and the Ministry of Foreign
   Affairs/Sincrotrone Trieste, Italy, for the financial support to visit
   Elettra synchrotron facility for data collection. K.P. also thanks the
   Department of Biotechnology (DBT), Government of India for the financial
   assistance to visit ESRF BM14, Grenoble, France for data collection.
   K.P. and S.B. thank the National Center for Nanoscience and
   Nanotechnology, University of Madras for the financial support. We thank
   Dr. Arulandu Arockiasamy from the International Centre for Genetic
   Engineering and Biotechnology (ICGEB), India for the help rendered while
   preparing the selenomethionine protein, Dr. Aruna Dhathathreyan from the
   Central Leather Research Institute (CLRI), Chennai, India for providing
   the CD spectroscopy facility and Maheshkumar Jaganathan (CLRI) for the
   help with the CD measurement.
CR Allaker RP, 2010, J DENT RES, V89, P1175, DOI 10.1177/0022034510377794
   Arciola CR, 2005, FEMS MICROBIOL LETT, V246, P81, DOI 10.1016/j.femsle.2005.03.035
   BAIER RE, 1984, J BIOMED MATER RES, V18, P337, DOI 10.1002/jbm.820180404
   Bowden MG, 2008, J BIOL CHEM, V283, P638, DOI 10.1074/jbc.M706252200
   Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254
   Cedervall T, 2007, P NATL ACAD SCI USA, V104, P2050, DOI 10.1073/pnas.0608582104
   Deivanayagam CCS, 2002, EMBO J, V21, P6660, DOI 10.1093/emboj/cdf619
   Devi AS, 2010, ACTA CRYSTALLOGR F, V66, P156, DOI 10.1107/S1744309109035581
   ELECHIGUERRA JL, 2005, J NANOBIOTECHNOL, V3
   Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158
   Esmay PA, 2003, INFECT IMMUN, V71, P4368, DOI 10.1128/IAI.71.8.4368-4374.2003
   Furno F, 2004, J ANTIMICROB CHEMOTH, V54, P1019, DOI 10.1093/jac/dkh478
   Gordon O, 2010, ANTIMICROB AGENTS CH, V54, P4208, DOI 10.1128/AAC.01830-09
   Lackner P, 2008, NEUROCRIT CARE, V8, P360, DOI 10.1007/s12028-008-9071-1
   Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404
   Leslie A.G.W., JOINT CCP4 ESF EAMCB
   Li LW, 2010, ANALYST, V135, P1519, DOI 10.1039/c0an00075b
   Liao J., 2010, INT J NANOMED, V13, P337
   Liu Q, 2007, J BIOL CHEM, V282, P19629, DOI 10.1074/jbc.M611137200
   Lundqvist M, 2008, P NATL ACAD SCI USA, V105, P14265, DOI 10.1073/pnas.0805135105
   Lynch I, 2008, NANO TODAY, V3, P40, DOI 10.1016/S1748-0132(08)70014-8
   Montanaro L, 1999, BIOMATERIALS, V20, P1945, DOI 10.1016/S0142-9612(99)00099-X
   Morones JR, 2005, NANOTECHNOLOGY, V16, P2346, DOI 10.1088/0957-4484/16/10/059
   Nerad J.L., 1998, INFECT DIS, P1755
   Panjikar S, 2005, ACTA CRYSTALLOGR D, V61, P449, DOI 10.1107/S0907444905001307
   PATTI JM, 1994, ANNU REV MICROBIOL, V48, P585, DOI 10.1146/annurev.mi.48.100194.003101
   Pei L, 2001, MICROB PATHOGENESIS, V31, P185, DOI 10.1006/mpat.2001.0462
   Pei L, 2001, J INFECT DIS, V184, P52, DOI 10.1086/321003
   Ponnuraj K, 2003, CELL, V115, P217, DOI 10.1016/S0092-8674(03)00809-2
   Rich RL, 1999, J BIOL CHEM, V274, P26939, DOI 10.1074/jbc.274.38.26939
   Roe D., 2004, J ANTIMICROB CHEMOTH, V6, P869
   SAMBROOK J, 1989, MOL CLONING LAB MANU, V3, P3
   Schwarz-Linek U, 2003, NATURE, V423, P177, DOI 10.1038/nature0189
   Shimoji Y, 2003, J BACTERIOL, V185, P2739, DOI 10.1128/JB.185.9.2739-2748.2003
   Stobie N, 2008, BIOMATERIALS, V29, P963, DOI 10.1016/j.biomaterials.2007.10.057
   Tovchigrechko A, 2006, NUCLEIC ACIDS RES, V34, pW310, DOI 10.1093/nar/gkl206
   Wood RL, 1999, DIS SWINE, P419
   Zong YN, 2005, EMBO J, V24, P4224, DOI 10.1038/sj.emboj.7600888
NR 38
TC 3
Z9 3
U1 2
U2 26
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0304-4165
J9 BBA-GEN SUBJECTS
JI Biochim. Biophys. Acta-Gen. Subj.
PD JUL
PY 2012
VL 1820
IS 7
BP 819
EP 828
DI 10.1016/j.bbagen.2012.04.006
PG 10
WC Biochemistry & Molecular Biology; Biophysics
SC Biochemistry & Molecular Biology; Biophysics
GA 960CR
UT WOS:000305366100004
PM 22538248
DA 2018-10-19
ER

PT J
AU Jao, WC
   Yang, MC
   Lin, CH
   Hsu, CC
AF Jao, Win-Chun
   Yang, Ming-Chien
   Lin, Chien-Hong
   Hsu, Chi-Chuan
TI Fabrication and characterization of electrospun silk fibroin/TiO2
   nanofibrous mats for wound dressings
SO POLYMERS FOR ADVANCED TECHNOLOGIES
LA English
DT Article
DE electrospinning; silk fibroin; TiO2; hemocompatibility;
   cytocompatibility; antibacterial activity; wound dressing
ID BOMBYX-MORI SILK; COMPOSITE FILMS; FORMIC-ACID; THIN-FILMS; TIO2;
   SCAFFOLDS; POLYMER; NANOCOMPOSITE; COAGULATION; BIOMATERIAL
AB Silk fibroin (SF) nanofibrous mats were fabricated via electrospinning process. These fibers were blended with TiO2 nanoparticles (TiO2 NPs). The influence of TiO2 NPs on the nanofibrous matrices was investigated by scanning electron microscopy (SEM), transmission electron microscopy, energy-dispersive X-ray, and thermogravimetric analysis. The SEM images revealed that the average diameter of the SF/TiO2 fibers was 385 +/- 63?nm when the concentration of SF was up to 10% (w/v). Infrared spectra showed that the beta-sheet structure of the silk fibroin increased after acetone treatment. These SF/TiO2 nanofibrous mats exhibited higher equilibrium water content and water vapor transmission rate than hydrocolloid dressing. The hemocompatibility and cytocompatibility of SF/TiO2 nanofibrous mats were evaluated by complete blood count, cell attachment, and the spreading of L929 fibroblasts. These SF/TiO2 nanofibrous mats exhibited antibacterial activity against Escherichia coli under UV irradiation. Thus, these novel nanocomposite mats may be used for biomedical applications such as wound dressing. Copyright (c) 2011 John Wiley & Sons, Ltd.
C1 [Yang, Ming-Chien; Lin, Chien-Hong; Hsu, Chi-Chuan] Natl Taiwan Univ Sci & Technol, Dept Mat Sci & Engn, Taipei 10607, Taiwan.
   [Jao, Win-Chun] China Univ Sci & Technol, Dept Biol Sci & Technol, Taipei 11581, Taiwan.
RP Yang, MC (reprint author), Natl Taiwan Univ Sci & Technol, Dept Mat Sci & Engn, Taipei 10607, Taiwan.
EM myang@mail.ntust.edu.tw
FU National Science Council of the Republic of China [NSC
   99-2218-E-157-001]
FX This work was supported by the National Science Council of the Republic
   of China under Grant NSC 99-2218-E-157-001.
CR Ahn YC, 2006, CURR APPL PHYS, V6, P1030, DOI 10.1016/j.cap.2005.07.013
   Baram N, 2009, ELECTROCHIM ACTA, V54, P3381, DOI 10.1016/j.electacta.2008.12.033
   Bhardwaj N, 2010, BIOTECHNOL ADV, V28, P325, DOI 10.1016/j.biotechadv.2010.01.004
   Chen C, 2006, POLYMER, V47, P6322, DOI 10.1016/j.polymer.2006.07.009
   Chen HC, 2009, POLYM ADVAN TECHNOL, V20, P98, DOI 10.1002/pat.1244
   Chen X, 2001, BIOPHYS CHEM, V89, P25, DOI 10.1016/S0301-4622(00)00213-1
   Damodar R. A., 2010, J HAZARD MATER, V172, P1321
   Du CL, 2009, MAT SCI ENG C-BIO S, V29, P62, DOI 10.1016/j.msec.2008.05.010
   Feng XX, 2007, INT J BIOL MACROMOL, V40, P105, DOI 10.1016/j.ijbiomac.2006.06.011
   Gao Z, 2008, MAT SCI ENG C-BIO S, V28, P1227, DOI 10.1016/j.msec.2007.11.003
   GOLDSTEIN BD, 1988, OCCUP MED, V3, P541
   Gu SY, 2009, MAT SCI ENG C-MATER, V29, P1822, DOI 10.1016/j.msec.2009.02.010
   Huang MH, 2010, POLYM ADVAN TECHNOL, V21, P561, DOI 10.1002/pat.1466
   Huang ZM, 2003, COMPOS SCI TECHNOL, V63, P2223, DOI 10.1016/S0266-3538(03)00178-7
   Kangwansupamonkon W, 2010, POLYM DEGRAD STABIL, V95, P1894, DOI 10.1016/j.polymdegradstab.2010.04.019
   Kangwansupamonkon W, 2009, NANOMED-NANOTECHNOL, V5, P240, DOI 10.1016/j.nano.2008.09.004
   Kim UJ, 2005, BIOMATERIALS, V26, P2775, DOI 10.1016/j.biomaterials.2004.07.044
   Kong XD, 2004, J CRYST GROWTH, V270, P197, DOI 10.1016/j.jcrysgro.2004.06.007
   Lannutti J, 2007, MAT SCI ENG C-BIO S, V27, P504, DOI 10.1016/j.msec.2006.05.019
   Liang D, 2007, ADV DRUG DELIVER REV, V59, P1392, DOI 10.1016/j.addr.2007.04.021
   Liu TY, 2005, BIOMATERIALS, V26, P1437, DOI 10.1016/j.biomaterials.2004.04.039
   Liu Y, 2008, MICROPOR MESOPOR MAT, V114, P431, DOI 10.1016/j.micromeso.2008.01.032
   Lu ZX, 2003, LANGMUIR, V19, P8765, DOI 10.1021/la034807r
   Marciano FR, 2009, J COLLOID INTERF SCI, V340, P87, DOI 10.1016/j.jcis.2009.08.024
   Mihailovic D, 2010, CARBOHYD POLYM, V79, P526, DOI 10.1016/j.carbpol.2009.08.036
   Min BM, 2004, BIOMATERIALS, V25, P1289, DOI 10.1016/j.biomaterials.2003.08.045
   Ovington LG, 2007, CLIN DERMATOL, V25, P33, DOI 10.1016/j.clindermatol.2006.09.003
   Pant H. R., 2010, J HAZARD MATER, V185, P124
   Park KE, 2006, INT J BIOL MACROMOL, V38, P165, DOI 10.1016/j.ijbiomac.2006.03.003
   Schneider A, 2009, ACTA BIOMATER, V5, P2570, DOI 10.1016/j.actbio.2008.12.013
   Sill TJ, 2008, BIOMATERIALS, V29, P1989, DOI 10.1016/j.biomaterials.2008.01.011
   Skorb EV, 2008, APPL CATAL B-ENVIRON, V84, P94, DOI 10.1016/j.apcatb.2008.03.007
   Sukigara S, 2003, POLYMER, V44, P5721, DOI 10.1016/S0032-3861(03)00532-9
   Sunada K, 2003, J PHOTOCH PHOTOBIO A, V156, P227, DOI 10.1016/S1010-6030(02)00434-3
   Takahashi O, 2000, FOOD CHEM TOXICOL, V38, P203, DOI 10.1016/S0278-6915(99)00155-6
   Trapalis CC, 2003, THIN SOLID FILMS, V433, P186, DOI 10.1016/S0040-6090(03)00331-6
   Um IC, 2004, INT J BIOL MACROMOL, V34, P89, DOI 10.1016/j.ijbiomac.2004.03.007
   Um IC, 2003, INT J BIOL MACROMOL, V33, P203, DOI 10.1016/j.ijbiomac.2003.08.004
   Um IC, 2001, INT J BIOL MACROMOL, V29, P91, DOI 10.1016/S0141-8130(01)00159-3
   Unger RE, 2004, BIOMATERIALS, V25, P1069, DOI [10.1016/S0142-9612(03)00619-7, 10.1016/S0142-9612(03)00630-6]
   Vepari C, 2007, PROG POLYM SCI, V32, P991, DOI 10.1016/j.progpolymsci.2007.05.013
   Wadbua P, 2010, INT J BIOL MACROMOL, V46, P493, DOI 10.1016/j.ijbiomac.2010.03.007
   Wang HY, 2010, CHINESE CHEM LETT, V21, P1119, DOI 10.1016/j.cclet.2010.03.009
   Wang SD, 2010, MAT SCI ENG C-MATER, V30, P670, DOI 10.1016/j.msec.2010.02.021
   Wang YH, 2004, J POLYM SCI POL CHEM, V42, P4289, DOI 10.1002/pola.20271
   Wu H., 2008, MATER LETT, V26, P828
   Wu N, 2009, J APPL POLYM SCI, V112, P1481, DOI 10.1002/app.29535
   Zhang XH, 2009, ADV DRUG DELIVER REV, V61, P988, DOI 10.1016/j.addr.2009.07.005
   Zhang Z. H., 2008, BIOMATERIALS, V29, P2217
NR 49
TC 16
Z9 20
U1 2
U2 86
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1042-7147
EI 1099-1581
J9 POLYM ADVAN TECHNOL
JI Polym. Adv. Technol.
PD JUL
PY 2012
VL 23
IS 7
BP 1066
EP 1076
DI 10.1002/pat.2014
PG 11
WC Polymer Science
SC Polymer Science
GA 962UH
UT WOS:000305570600006
DA 2018-10-19
ER

PT J
AU Bazaka, K
   Jacob, MV
   Crawford, RJ
   Ivanova, EP
AF Bazaka, Kateryna
   Jacob, Mohan V.
   Crawford, Russell J.
   Ivanova, Elena P.
TI Efficient surface modification of biomaterial to prevent biofilm
   formation and the attachment of microorganisms
SO APPLIED MICROBIOLOGY AND BIOTECHNOLOGY
LA English
DT Review
DE Biomaterials; Surface treatment; Biofilm; Bacterial attachment
ID TISSUE ENGINEERING APPLICATIONS; REDUCE BACTERIAL ADHESION;
   PSEUDOMONAS-AERUGINOSA; BIOMEDICAL APPLICATIONS; STAPHYLOCOCCUS-AUREUS;
   ESCHERICHIA-COLI; SILVER NANOPARTICLES; NANOSCALE ROUGHNESS; TITANIUM
   SURFACES; NANOCOMPOSITE COATINGS
AB Biomaterials play a fundamental role in disease management and the improvement of health care. In recent years, there has been a significant growth in the diversity, function, and number of biomaterials used worldwide. Yet, attachment of pathogenic microorganisms onto biomaterial surfaces remains a significant challenge that substantially undermines their clinical applicability, limiting the advancement of these systems. The emergence and escalating pervasiveness of antibiotic-resistant bacterial strains makes the management of biomaterial-associated nosocomial infections increasingly difficult. The conventional post-operative treatment of implant-caused infections using systemic antibiotics is often marginally effective, further accelerating the extent of antimicrobial resistance. Methods by which the initial stages of bacterial attachment and biofilm formation can be restricted or prevented are therefore sought. The surface modification of biomaterials has the potential to alleviate pathogenic biofouling, therefore preventing the need for conventional antibiotics to be applied.
C1 [Jacob, Mohan V.; Crawford, Russell J.; Ivanova, Elena P.] Swinburne Univ Technol, Fac Life & Social Sci, Hawthorn, Vic 3122, Australia.
   [Bazaka, Kateryna] James Cook Univ, Sch Engn, Elect Mat Res Lab, Townsville, Qld 4811, Australia.
RP Crawford, RJ (reprint author), Swinburne Univ Technol, Fac Life & Social Sci, POB 218, Hawthorn, Vic 3122, Australia.
EM RCrawford@swin.edu.au; EIvanova@swin.edu.au
RI Jacob, Mohan/B-9097-2009
OI Jacob, Mohan/0000-0002-2598-7193; Crawford, Russell/0000-0003-1054-5285;
   Bazaka, Kateryna/0000-0003-2032-6377
FU Australian Research Council (ARC); Advanced Manufacturing CRC;
   Australian Postgraduate Award (APA); Australian Institute of Nuclear
   Science and Engineering (AINSE)
FX This study was supported in part by Australian Research Council (ARC)
   and Advanced Manufacturing CRC.K. B. is a recipient of an Australian
   Postgraduate Award (APA) and an Australian Institute of Nuclear Science
   and Engineering Postgraduate Research Award (AINSE PGRA).
CR Agarwal A, 2010, BIOMATERIALS, V31, P680, DOI 10.1016/j.biomaterials.2009.09.092
   AHEARN DG, 1995, J IND MICROBIOL, V15, P372, DOI 10.1007/BF01569993
   An YH, 1995, J MICROBIOL METH, V24, P29, DOI 10.1016/0167-7012(95)00051-8
   Andersson DI, 2011, FEMS MICROBIOL REV, V35, P901, DOI 10.1111/j.1574-6976.2011.00289.x
   Andrews SS, 2009, PHYS BIOL, V6, DOI 10.1088/1478-3975/6/4/046015
   Ansari SA, 2012, BIOTECHNOL ADV, V30, P512, DOI 10.1016/j.biotechadv.2011.09.005
   Anselme K, 2010, ACTA BIOMATER, V6, P3824, DOI 10.1016/j.actbio.2010.04.001
   Ardehali R, 2002, ARTIF ORGANS, V26, P512, DOI 10.1046/j.1525-1594.2002.06923.x
   Baum C, 2002, MAR BIOL, V140, P653, DOI 10.1007/s00227-001-0710-8
   Bazaka K, 2011, BIOTECHNOL J, V6, P1103, DOI 10.1002/biot.201100027
   Bazaka K, 2011, ADV EXP MED BIOL, V715, P213, DOI 10.1007/978-94-007-0940-9_13
   Bazaka K, 2011, POLYMERS-BASEL, V3, P388, DOI 10.3390/polym3010388
   Bazaka K, 2011, ACTA BIOMATER, V7, P2015, DOI 10.1016/j.actbio.2010.12.024
   Bazaka K, 2010, BIOMACROMOLECULES, V11, P2016, DOI 10.1021/bm100369n
   Bendrea AD, 2011, J BIOMATER APPL, V26, P3, DOI 10.1177/0885328211402704
   Bhushan B, 2008, SOFT MATTER, V4, P1799, DOI 10.1039/b808146h
   Biederman H, 2011, SURF COAT TECH, V205, pS10, DOI 10.1016/j.surfcoat.2011.03.115
   Birla SS, 2009, LETT APPL MICROBIOL, V48, P173, DOI 10.1111/j.1472-765X.2008.02510.x
   Bjelland AM, 2012, INFECT IMMUN, V80, P1681, DOI 10.1128/IAI.06038-11
   Bordi C, 2011, ANN INTENSIVE CARE, V1, DOI 10.1186/2110-5820-1-19
   Bos R, 1999, FEMS MICROBIOL REV, V23, P179, DOI 10.1016/S0168-6445(99)00004-2
   BoulangePetermann L, 1997, BIOFOULING, V11, P201, DOI 10.1080/08927019709378331
   Brunetti V, 2010, P NATL ACAD SCI USA, V107, P6264, DOI 10.1073/pnas.0914456107
   Busscher HJ, 2010, CURR OPIN COLLOID IN, V15, P510, DOI 10.1016/j.cocis.2010.05.014
   Cappella B, 1999, SURF SCI REP, V34, P1, DOI 10.1016/S0167-5729(99)00003-5
   Cardoso MV, 2011, AUST DENT J, V56, P31, DOI 10.1111/j.1834-7819.2011.01294.x
   Chen W, 2006, BIOMATERIALS, V27, P5512, DOI 10.1016/j.biomaterials.2006.07.003
   Cho M, 2005, APPL ENVIRON MICROB, V71, P270, DOI 10.1128/AEM.71.1.270-275.2005
   Chung KK, 2007, BIOINTERPHASES, V2, P89, DOI 10.1116/1.2751405
   Colon G, 2006, J BIOMED MATER RES A, V78A, P595, DOI 10.1002/jbm.a.30789
   Colvin KM, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001264
   Costerton JW, 1999, SCIENCE, V284, P1318, DOI 10.1126/science.284.5418.1318
   DAVIES DG, 1995, APPL ENVIRON MICROB, V61, P860
   Decho AW, 2000, CONT SHELF RES, V20, P1257, DOI 10.1016/S0278-4343(00)00022-4
   Desmet T, 2009, BIOMACROMOLECULES, V10, P2351, DOI 10.1021/bm900186s
   Diaz C, 2007, LANGMUIR, V23, P11206, DOI 10.1021/la700650q
   Díaz Carolina, 2007, Mat. Res., V10, P11, DOI 10.1590/S1516-14392007000100004
   Dibrov P, 2002, ANTIMICROB AGENTS CH, V46, P2668, DOI 10.1128/AAC.46.8.2668-2670.2002
   Ditta IB, 2008, APPL MICROBIOL BIOT, V79, P127, DOI 10.1007/s00253-008-1411-8
   Dobrzynski M, 2011, RESULTS PROBL CELL D, V53, P11, DOI 10.1007/978-3-642-19065-0_2
   Dodiuk H, 2007, POLYM ADVAN TECHNOL, V18, P746, DOI 10.1002/pat.957
   Doring G, 2011, FEMS MICROBIOL REV, V35, P124, DOI 10.1111/j.1574-6976.2010.00237.x
   Donlan RM, 2002, EMERG INFECT DIS, V8, P881, DOI 10.3201/eid0809.020063
   Dorobantu LS, 2009, LANGMUIR, V25, P6968, DOI 10.1021/la9001237
   Dorozhkin S.V., 2011, BIOMATTER, V1, P1, DOI DOI 10.5618/BI0.2011.V1.N1.1
   Dowling DP, 2001, THIN SOLID FILMS, V398, P602, DOI 10.1016/S0040-6090(01)01326-8
   Edwards KJ, 2001, CHEM GEOL, V180, P19, DOI 10.1016/S0009-2541(01)00303-5
   Elbert DL, 2011, ACTA BIOMATER, V7, P31, DOI 10.1016/j.actbio.2010.07.028
   Estrin Y, 2009, J BIOMED MATER RES A, V90A, P1239, DOI 10.1002/jbm.a.32174
   Ewald A, 2006, BIOMED ENG ONLINE, V5, DOI 10.1186/1475-925X-5-22
   Fadeeva E, 2011, LANGMUIR, V27, P3012, DOI 10.1021/la104607g
   Fadeeva E, 2009, PHYS STATUS SOLIDI A, V206, P1348, DOI 10.1002/pssa.200881063
   Favia P., 2000, PLASMAS POLYM, DOI [10.1023/A:1009517408368, DOI 10.1023/A:1009517408368]
   Fernandez ICS, 2011, BIOMATERIALS, V32, P979, DOI 10.1016/j.biomaterials.2010.10.011
   Flemming HC, 2007, J BACTERIOL, V189, P7945, DOI 10.1128/JB.00858-07
   Flemming HC, 2010, NAT REV MICROBIOL, V8, P623, DOI 10.1038/nrmicro2415
   Freire-Moran L, 2011, DRUG RESIST UPDATE, V14, P118, DOI 10.1016/j.drup.2011.02.003
   Fu JH, 2005, BIOMATERIALS, V26, P6684, DOI 10.1016/j.biomaterials.2005.04.034
   Fu RH, 2011, CELL TRANSPLANT, V20, P37, DOI 10.3727/096368910X532756
   Gabriel GJ, 2007, MAT SCI ENG R, V57, P28, DOI 10.1016/j.mser.2007.03.002
   Gioe TJ, 2011, CLIN ORTHOP RELAT R, V469, P48, DOI 10.1007/s11999-010-1436-z
   Gogniat G, 2006, FEMS MICROBIOL LETT, V258, P18, DOI 10.1111/j.1574-6968.2006.00190.x
   Gottenbos B, 2001, J ANTIMICROB CHEMOTH, V48, P7, DOI 10.1093/jac/48.1.7
   Hanssen AD, 2002, J ARTHROPLASTY, V17, P98, DOI 10.1054/arth.2002.32458
   Harris LG, 2004, BIOMATERIALS, V25, P4135, DOI 10.1016/j.biomaterials.2003.11.033
   Hashimoto K, 2005, JPN J APPL PHYS 1, V44, P8269, DOI 10.1143/JJAP.44.8269
   Hochbaum AI, 2010, NANO LETT, V10, P3717, DOI 10.1021/nl102290k
   Holt KB, 2005, BIOCHEMISTRY-US, V44, P13214, DOI 10.1021/bi0508542
   Hoppe A, 2011, BIOMATERIALS, V32, P2757, DOI 10.1016/j.biomaterials.2011.01.004
   Hu C, 2007, APPL CATAL B-ENVIRON, V73, P345, DOI 10.1016/j.apcatb.2007.01.006
   Ivanova EP, 2008, MICRON, V39, P1197, DOI 10.1016/j.micron.2008.04.009
   Ivanova EP, 2011, APPL MICROBIOL BIOT, V91, P1149, DOI 10.1007/s00253-011-3195-5
   Ivanova EP, 2010, LANGMUIR, V26, P1973, DOI 10.1021/la902623c
   Jiao YQ, 2010, APPL ENVIRON MICROB, V76, P2916, DOI 10.1128/AEM.02289-09
   Johnson AJW, 2011, ACTA BIOMATER, V7, P16, DOI 10.1016/j.actbio.2010.07.012
   Karatan E, 2009, MICROBIOL MOL BIOL R, V73, P310, DOI 10.1128/MMBR.00041-08
   Katsikogianni M, 2004, Eur Cell Mater, V8, P37
   Kelly PJ, 2009, SURF COAT TECH, V204, P1137, DOI 10.1016/j.surfcoat.2009.05.012
   Khan OF, 2011, TRENDS BIOTECHNOL, V29, P379, DOI 10.1016/j.tibtech.2011.03.004
   Kitao T, 2011, ARTIF ORGANS, V35, P543, DOI [10.1111/j.1525-1594.2010.01192.x, 10.1111/j.1525-1594.2011.01321.x]
   Korner E, 2011, SURF COAT TECH, V205, P2978, DOI 10.1016/j.surfcoat.2010.11.001
   Korner E, 2010, PLASMA PROCESS POLYM, V7, P619, DOI 10.1002/ppap.200900163
   Kumar R, 2005, BIOMATERIALS, V26, P2081, DOI 10.1016/j.biomaterials.2004.05.030
   Laue H, 2006, MICROBIOL-SGM, V152, P2909, DOI 10.1099/mic.0.28875-0
   Lee B, 2011, APMIS, V119, P263, DOI 10.1111/j.1600-0463.2011.02726.x
   Lele UN, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014516
   Lewis G, 2011, J BIOMED MATER RES B, V98B, P171, DOI 10.1002/jbm.b.31835
   Li WR, 2011, BIOMETALS, V24, P135, DOI 10.1007/s10534-010-9381-6
   Liu XY, 2004, MAT SCI ENG R, V47, P49, DOI 10.1016/j.mser.2004.11.001
   Liu Y, 2011, J PHARM ANA, V1, P175, DOI 10.1016/j.jpha.2011.06.001
   Livermore DM, 2005, LANCET INFECT DIS, V5, P450, DOI 10.1016/S1473-3099(05)70166-3
   Lok CN, 2007, J BIOL INORG CHEM, V12, P527, DOI 10.1007/s00775-007-0208-z
   Low WL, 2011, INT J ANTIMICROB AG, V37, P162, DOI 10.1016/j.ijantimicag.2010.10.015
   Ma L, 2006, J BACTERIOL, V188, P8213, DOI 10.1128/JB.01202-06
   Madkour AE, 2008, POLYM INT, V57, P6, DOI 10.1002/pi.2399
   Malkin AJ, 2010, SCANNING PROBE MICROSCOPY OF FUNCTIONAL MATERIALS: NANOSCALE IMAGING AND SPECTROSCOPY, P39, DOI 10.1007/978-1-4419-7167-8_2
   Marambio-Jones C, 2010, J NANOPART RES, V12, P1531, DOI 10.1007/s11051-010-9900-y
   Marini M, 2007, BIOMACROMOLECULES, V8, P1246, DOI 10.1021/bm060721b
   Medilanski E, 2002, BIOFOULING, V18, P193, DOI 10.1080/08927010290011370
   Mitik-Dineva N, 2010, BIOFOULING, V26, P461, DOI 10.1080/08927011003753399
   Mitik-Dineva N, 2009, CURR MICROBIOL, V58, P268, DOI 10.1007/s00284-008-9320-8
   Mitik-Dineva Natasa, 2008, Biotechnology Journal, V3, P536, DOI 10.1002/biot.200700244
   Montanaro L, 2007, BIOMATERIALS, V28, P5155, DOI 10.1016/j.biomaterials.2007.08.003
   Morent R, 2011, PLASMA PROCESS POLYM, V8, P171, DOI 10.1002/ppap.201000153
   Nablo BJ, 2001, J AM CHEM SOC, V123, P9712, DOI 10.1021/ja0165077
   Naderi H, 2011, J BIOMATER APPL, V26, P383, DOI 10.1177/0885328211408946
   Norowski PA, 2009, J BIOMED MATER RES B, V88B, P530, DOI 10.1002/jbm.b.31152
   Parreira P, 2011, J BIOMED MATER RES A, V99A, P344, DOI 10.1002/jbm.a.33178
   Pavithra D, 2008, BIOMED MATER, V3, DOI 10.1088/1748-6041/3/3/034003
   Petrova OE, 2012, J BACTERIOL, V194, P2413, DOI 10.1128/JB.00003-12
   Petrova OE, 2011, J BACTERIOL, V193, P6614, DOI 10.1128/JB.00305-11
   Ploux L, 2009, LANGMUIR, V25, P8161, DOI 10.1021/la900457f
   Ploux L, 2010, J ADHES SCI TECHNOL, V24, P2165, DOI 10.1163/016942410X511079
   Poulter N, 2009, CHEM COMMUN, P7312, DOI 10.1039/b915467a
   Price JS, 1996, J BIOMED MATER RES, V30, P281, DOI 10.1002/(SICI)1097-4636(199603)30:3<281::AID-JBM2>3.0.CO;2-M
   Rai M, 2009, BIOTECHNOL ADV, V27, P76, DOI 10.1016/j.biotechadv.2008.09.002
   Raynor JE, 2009, BIOINTERPHASES, V4, pFA3, DOI 10.1116/1.3089252
   Rios PF, 2007, J ADHES SCI TECHNOL, V21, P399, DOI 10.1163/156856107780474975
   Rios PF, 2006, J ADHES SCI TECHNOL, V20, P563, DOI 10.1163/156856106777213302
   Rojas IA, 2000, J CONTROL RELEASE, V63, P175, DOI 10.1016/S0168-3659(99)00195-9
   Rowan B, 2002, LANGMUIR, V18, P9914, DOI 10.1021/la020664h
   Rozhok S, 2006, LANGMUIR, V22, P11251, DOI 10.1012/la0609726
   Saito N, 2011, CHEM SOC REV, V40, P3824, DOI 10.1039/c0cs00120a
   Sardella E, 2006, PLASMA PROCESS POLYM, V3, P456, DOI 10.1002/ppap.200600041
   Scheuerman TR, 1998, J COLLOID INTERF SCI, V208, P23, DOI 10.1006/jcis.1998.5717
   Shadanbaz S, 2012, ACTA BIOMATER, V8, P20, DOI 10.1016/j.actbio.2011.10.016
   Shanks RMQ, 2005, INFECT IMMUN, V73, P4596, DOI 10.1128/IAI.73.8.4596-4606.2005
   Shao W, 2010, COLLOID SURFACE B, V76, P98, DOI 10.1016/j.colsurfb.2009.10.018
   Shao W, 2010, SURF COAT TECH, V204, P1288, DOI 10.1016/j.surfcoat.2009.10.015
   Sheng GP, 2010, BIOTECHNOL ADV, V28, P882, DOI 10.1016/j.biotechadv.2010.08.001
   Shukla A, 2010, BIOMATERIALS, V31, P2348, DOI 10.1016/j.biomaterials.2009.11.082
   Silver S, 2003, FEMS MICROBIOL REV, V27, P341, DOI 10.1016/S0168-6445(03)00047-0
   Solouk A, 2011, BIOTECHNOL APPL BIOC, V58, P311, DOI 10.1002/bab.50
   Stigter M, 2004, J CONTROL RELEASE, V99, P127, DOI 10.1016/j.jconrel.2004.06.011
   Stobie N, 2008, BIOMATERIALS, V29, P963, DOI 10.1016/j.biomaterials.2007.10.057
   Subbiahdoss G, 2009, ACTA BIOMATER, V5, P1399, DOI 10.1016/j.actbio.2008.12.011
   Sun HL, 2011, BIOMACROMOLECULES, V12, P1937, DOI 10.1021/bm200043u
   Tan A, 2011, NANOMEDICINE-UK, V6, P1101, DOI [10.2217/NNM.11.64, 10.2217/nnm.11.64]
   Tarquinio KM, 2010, INT J NANOMED, V5, P177
   Truong VK, 2010, BIOMATERIALS, V31, P3674, DOI 10.1016/j.biomaterials.2010.01.071
   Truong VK, 2009, APPL MICROBIOL BIOT, V83, P925, DOI 10.1007/s00253-009-1944-5
   Valiev RZ, 2008, ADV ENG MATER, V10, pB15, DOI 10.1002/adem.200800026
   Van Vlierberghe S, 2011, BIOMACROMOLECULES, V12, P1387, DOI 10.1021/bm200083n
   Vasilev K, 2011, PLASMA PROCESS POLYM, V8, P1010, DOI 10.1002/ppap.201100097
   Vasilev K, 2010, NANOTECHNOLOGY, V21, DOI 10.1088/0957-4484/21/21/215102
   Vasilev K, 2010, NANO LETT, V10, P202, DOI 10.1021/nl903274q
   Vi Khanh Truong, 2010, 2010 International Conference on Nanoscience and Nanotechnology, P253, DOI 10.1109/ICONN.2010.6045205
   Truong VK, 2010, PROG COLL POL SCI S, V137, P41, DOI 10.1007/978-3-642-13461-6_9
   Vilain S, 2009, APPL ENVIRON MICROB, V75, P2861, DOI 10.1128/AEM.01317-08
   Webb HK, 2011, CURR MED CHEM, V18, P3367
   WENZEL RN, 1949, J PHYS COLLOID CHEM, V53, P1466, DOI 10.1021/j150474a015
   Whitchurch CB, 2002, SCIENCE, V295, P1487, DOI 10.1126/science.295.5559.1487
   Whitehead KA, 2005, COLLOID SURFACE B, V41, P129, DOI 10.1016/j.colsurfb.2004.10.010
   Whitehead K, 2010, J VAC SCI TECHNOL B, V28, P180, DOI 10.1116/1.3293232
   Whitehead KA, 2006, COLLOID SURFACE B, V51, P44, DOI 10.1016/j.colsurfb.2006.05.003
   Wu SL, 2011, ACS APPL MATER INTER, V3, P2851, DOI 10.1021/am2003944
   Wu Y, 2011, BIOMATERIALS, V32, P951, DOI 10.1016/j.biomaterials.2010.10.001
   Yang L, 2007, MICROBIOL-SGM, V153, P1318, DOI 10.1099/mic.0.2006/004911-0
   Yates HM, 2008, J PHOTOCH PHOTOBIO A, V197, P197, DOI 10.1016/j.jphotochem.2007.12.023
   Zaporojtchenko V, 2006, NANOTECHNOLOGY, V17, P4904, DOI 10.1088/0957-4484/17/19/020
   Zhao HM, 2011, INT ORTHOP, V35, P1751, DOI 10.1007/s00264-011-1339-y
   Zilberman M, 2008, J CONTROL RELEASE, V130, P202, DOI 10.1016/j.jconrel.2008.05.020
NR 162
TC 79
Z9 80
U1 4
U2 183
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 0175-7598
EI 1432-0614
J9 APPL MICROBIOL BIOT
JI Appl. Microbiol. Biotechnol.
PD JUL
PY 2012
VL 95
IS 2
BP 299
EP 311
DI 10.1007/s00253-012-4144-7
PG 13
WC Biotechnology & Applied Microbiology
SC Biotechnology & Applied Microbiology
GA 958HL
UT WOS:000305227100003
PM 22618687
DA 2018-10-19
ER

PT J
AU Asai, D
   Xu, DH
   Liu, WG
   Quiroz, FG
   Callahan, DJ
   Zalutsky, MR
   Craig, SL
   Chilkoti, A
AF Asai, Daisuke
   Xu, Donghua
   Liu, Wenge
   Quiroz, Felipe Garcia
   Callahan, Daniel J.
   Zalutsky, Michael R.
   Craig, Stephen L.
   Chilkoti, Ashutosh
TI Protein polymer hydrogels by in situ, rapid and reversible self-gelation
SO BIOMATERIALS
LA English
DT Article
DE Hydrogel; Thermally responsive material; Cross-linking; Drug delivery
ID ELASTIN-LIKE POLYPEPTIDE; RECURSIVE DIRECTIONAL LIGATION; CARTILAGINOUS
   TISSUE-REPAIR; DRUG-DELIVERY SYSTEMS; BIOMEDICAL APPLICATIONS;
   CROSS-LINKING; PEROXIDE
AB Protein-based biomaterials are an important class of materials for applications in biotechnology and medicine. The exquisite control of their composition, stereochemistry, and chain length offers unique opportunities to engineer biofunctionality, biocompatibility, and biodegradability into these materials. Here, we report the synthesis of a thermally responsive peptide polymer-based hydrogel composed of a recombinant elastin-like polypeptide (ELP) that rapidly forms a reversibly cross-linked hydrogel by the formation of intermolecular disulfide cross-links. To do so, we designed and synthesized ELPs that incorporate periodic cysteine residues (cELPs), and show that cELPs are thermally responsive protein polymers that display rapid gelation under physiologically relevant, mild oxidative conditions. Gelation of cELPs, at concentrations as low as 2.5 wt%, occurs in similar to 2.5 min upon addition a low concentration of hydrogen peroxide (0.3 wt%). We show the utility of these hydrogels for the sustained release of a model protein in vitro, and demonstrate the ability of this injectable biomaterial to pervade tumors to maximize tumor coverage and retention time upon intratumoral injection. cELPs represent a new class of injectable reversibly cross-linked hydrogels with properties intermediate between ELP coacervates and chemically cross-linked ELP hydrogels that will find useful applications in drug delivery and tissue engineering. (C) 2012 Elsevier Ltd. All rights reserved.
C1 [Asai, Daisuke; Liu, Wenge; Quiroz, Felipe Garcia; Callahan, Daniel J.; Chilkoti, Ashutosh] Duke Univ, Dept Biomed Engn, Durham, NC 27708 USA.
   [Asai, Daisuke] St Marianna Univ, Sch Med, Dept Microbiol, Kawasaki, Kanagawa 2168511, Japan.
   [Xu, Donghua; Craig, Stephen L.] Duke Univ, Dept Chem, Durham, NC 27708 USA.
   [Zalutsky, Michael R.] Duke Univ, Dept Radiol, Durham, NC 27710 USA.
RP Chilkoti, A (reprint author), Duke Univ, Dept Biomed Engn, Durham, NC 27708 USA.
EM chilkoti@duke.edu
RI Craig, Stephen/D-3484-2011; Xu, Donghua/K-2095-2012
OI Craig, Stephen/0000-0002-8810-0369; Asai, Daisuke/0000-0003-4015-6694;
   Liu, Wenge/0000-0002-0688-1879
FU NIH [R01-GM-061232, R01-EB-000188, R01-CA-138784, R01-EB-001037]; NSF
   [CHE-0646670]; Science and Technology Foundation of Japan
FX This work was financially supported by NIH grant R01-GM-061232 and
   R01-EB-000188 to A.C., NIH grant R01-CA-138784 to W.L., and NIH grant
   R01-EB-001037 and NSF grant CHE-0646670 to S.L.C. D.A. acknowledges a
   grant from the Science and Technology Foundation of Japan. We thank Dr.
   Takeshi Mori, Dr. Xinghai Li, Dr. Ganesan Vaidyanathan, and Mr. Jonathan
   R. McDaniel for useful discussions.
CR Anumolu SS, 2011, BIOMATERIALS, V32, P1204, DOI 10.1016/j.biomaterials.2010.08.117
   Betre H, 2006, BIOMATERIALS, V27, P91, DOI 10.1016/j.biomaterials.2005.05.071
   Betre H, 2002, BIOMACROMOLECULES, V3, P910, DOI 10.1021/bm0255037
   Betre H, 2006, J CONTROL RELEASE, V115, P175, DOI 10.1016/j.jconrel.2006.07.022
   Goth Laszlo, 2006, Orvosi Hetilap, V147, P887
   Halliwell B, 2000, FEBS LETT, V486, P10, DOI 10.1016/S0014-5793(00)02197-9
   Hatefi A, 2002, J CONTROL RELEASE, V80, P9, DOI 10.1016/S0168-3659(02)00008-1
   Hoffman AS, 2002, ADV DRUG DELIVER REV, V54, P3, DOI 10.1016/S0169-409X(01)00239-3
   Jin R, 2007, BIOMATERIALS, V28, P2791, DOI 10.1016/j.biomaterials.2007.02.032
   Koo H, 2009, INT J PHARMACEUT, V374, P58, DOI 10.1016/j.ijpharm.2009.03.010
   Kopecek J, 2007, BIOMATERIALS, V28, P5185, DOI 10.1016/j.biomaterials.2007.07.044
   Kretlow JD, 2007, ADV DRUG DELIVER REV, V59, P263, DOI 10.1016/j.addr.2007.03.013
   Lee J, 2001, MACROMOLECULES, V34, P5968, DOI 10.1021/ma0017844
   Lim DW, 2008, BIOMACROMOLECULES, V9, P222, DOI 10.1021/bm7007982
   Lim DW, 2007, BIOMACROMOLECULES, V8, P1463, DOI 10.1021/bm061059m
   Liu W, 2006, J CONTROL RELEASE, V114, P184, DOI 10.1016/j.jcornel.2006.06.001
   Liu WG, 2010, J CONTROL RELEASE, V144, P2, DOI 10.1016/j.jconrel.2010.01.032
   McDaniel JR, 2010, BIOMACROMOLECULES, V11, P944, DOI 10.1021/bm901387t
   McHale MK, 2005, TISSUE ENG, V11, P1768, DOI 10.1089/ten.2005.11.1768
   Meyer DE, 2002, BIOMACROMOLECULES, V3, P357, DOI 10.1021/bm015630n
   Meyer DE, 1999, NAT BIOTECHNOL, V17, P1112, DOI 10.1038/15100
   Minh KN, 2010, MACROMOL BIOSCI, V10, P563, DOI 10.1002/mabi.200900402
   Nagapudi K, 2002, MACROMOLECULES, V35, P1730, DOI 10.1021/ma011429t
   Nishinari K, 2009, PROG COLL POL SCI S, V136, P87, DOI 10.1007/2882_2009_12
   Packhaeuser CB, 2004, EUR J PHARM BIOPHARM, V58, P445, DOI 10.1016/uj.ejpb.2004.03.003
   Sakloetsakun D, 2009, BIOMATERIALS, V30, P6151, DOI 10.1016/j.biomaterials.2009.07.060
   Shu XZ, 2002, BIOMACROMOLECULES, V3, P1304, DOI 10.1021/bm025603c
   Tan JT, 2004, CHEMBIOCHEM, V5, P1479, DOI 10.1002/cbic.200400036
   Unak T, 2001, APPL RADIAT ISOTOPES, V54, P749, DOI 10.1016/S0969-8043(00)00337-7
   Van Tomme SR, 2008, INT J PHARM, V355, P1, DOI 10.1016/j.ijpharm.2008.01.057
   Wright ER, 2002, ADV DRUG DELIVER REV, V54, P1057, DOI 10.1016/S0169-409X(02)00059-5
   Wu ZM, 2009, EUR J PHARM SCI, V37, P198, DOI 10.1016/j.ejps.2009.01.010
   Yu L, 2008, CHEM SOC REV, V37, P1473, DOI 10.1039/b713009k
NR 33
TC 42
Z9 43
U1 4
U2 148
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
EI 1878-5905
J9 BIOMATERIALS
JI Biomaterials
PD JUL
PY 2012
VL 33
IS 21
BP 5451
EP 5458
DI 10.1016/j.biomaterials.2012.03.083
PG 8
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 956QY
UT WOS:000305105400028
PM 22538198
OA Green Accepted
DA 2018-10-19
ER

PT J
AU Fan, ZX
   Lu, Y
   Deng, L
   Li, XQ
   Zhi, W
   Li-Ling, J
   Yang, ZM
   Xie, HQ
AF Fan, Zhao-Xin
   Lu, Yao
   Deng, Li
   Li, Xiu-Qun
   Zhi, Wei
   Li-Ling, Jesse
   Yang, Zhi-Ming
   Xie, Hui-Qi
TI Placenta- versus bone-marrow-derived mesenchymal cells for the repair of
   segmental bone defects in a rabbit model
SO FEBS JOURNAL
LA English
DT Article
DE bone defect; bone marrow; mesenchymal stem cells; placenta; tissue
   engineering
ID CRITICAL-SIZED DEFECTS; STEM-CELLS; IN-VITRO; MORPHOGENETIC PROTEIN;
   MULTIPOTENT CELLS; STROMAL CELLS; TISSUE; SCAFFOLDS; BLOOD;
   DIFFERENTIATION
AB Tissue-engineered bones (TEBs) constructed with bone-marrow-derived mesenchymal stem cells (BMSCs) seeded on biomaterial scaffolds have achieved good results for bone defect repair in both animal experiments and clinical trials. This has been limited, however, by the source and quantity of BMSCs. We here explored TEBs constructed by placenta-derived mesenchymal stem cells (PMSCs) and compared their effect for the repair of critical-sized segmental osteoperiosteal defects with TEBs constructed with BMSCs. PMSCs were isolated from rabbit placenta by gradient centrifugation and in vitro monolayer culturing, and BMSCs were isolated from the hindlimb bone marrow of newborn rabbit. Primary cultured PMSCs and BMSCs were uniformly in a spindle shape. Immunocytochemistry indicated that both types of cells are positive for CD44 and CD105, and negative for CD34 and CD40L, confirming that they are mesenchymal stem cells. BrdU-labeled PMSCs and BMSCs were respectively co-cultured with bio-derived bone materials to construct TEBs in vitro. Critical-sized segmental osteoperiosteal defects of radii were created in 24 rabbits by surgery. The defects were repaired with TEBs constructed with PMSCs and BMSCs. The results showed that TEBs constructed by both PMSCs and BMSCs could repair the osteoperiosteal defects in a multipoint manner. Measurement of radiography, histology, immunohistochemistry, alkaline phosphatase activity, osteocalcin assaying and biomechanical properties have found no significant difference between the two groups at 2, 4, 8 and 12 weeks after the transplantation (P > 0.05). Taken together, our results indicate that PMSCs have similar biological characteristics and osteogenic capacity to BMSCs and can be used as a new source of seeding cells for TEBs.
C1 [Fan, Zhao-Xin; Lu, Yao; Deng, Li; Li, Xiu-Qun; Zhi, Wei; Yang, Zhi-Ming; Xie, Hui-Qi] Sichuan Univ, W China Hosp, State Key Lab Biotherapy & Regenerat Med, Lab Stem Cell & Tissue Engn,Res Ctr, Chengdu 610041, Peoples R China.
   [Lu, Yao] Subei Peoples Hosp, Dept Orthoped, Yangzhou, Peoples R China.
   [Li-Ling, Jesse] Sichuan Univ, Inst Med Genet, Sch Life Sci, Minist Educ, Chengdu 610041, Peoples R China.
   [Li-Ling, Jesse] Sichuan Univ, Minist Educ, Key Lab Bioresources & Ecoenvironm, Chengdu 610041, Peoples R China.
   [Li-Ling, Jesse; Xie, Hui-Qi] Northeastern Univ, Sino Dutch Biomed & Informat Engn Sch, Shenyang, Peoples R China.
RP Xie, HQ (reprint author), Sichuan Univ, W China Hosp, State Key Lab Biotherapy & Regenerat Med, Lab Stem Cell & Tissue Engn,Res Ctr, Chengdu 610041, Peoples R China.
EM xiehuiqi@scu.edu.cn
FU National High Technology Research and Development Program of China
   [2012AA020503, Esophagus 2009AA02Z106]; Funding for New Century
   Excellent Talents in Universities [NCET070575]; Fundamental Research
   Funds for the Central Universities [N110804002]; Ministry of Education
   and State Administration of Foreign Experts Affairs [MS2011DBDX021]
FX This work was jointly supported by the National High Technology Research
   and Development Program of China (2012AA020503 and Esophagus
   2009AA02Z106), the Funding for New Century Excellent Talents in
   Universities (NCET070575), the Fundamental Research Funds for the
   Central Universities (N110804002) and the Overseas Teacher Project of
   the Ministry of Education and State Administration of Foreign Experts
   Affairs (MS2011DBDX021).
CR Arinzeh TL, 2003, J BONE JOINT SURG AM, V85A, P1927, DOI 10.2106/00004623-200310000-00010
   Barry FP, 2004, INT J BIOCHEM CELL B, V36, P568, DOI 10.1016/j.biocel.2003.11.001
   Caplan AI, 2005, TISSUE ENG, V11, P1198, DOI 10.1089/ten.2005.11.1198
   Chang CM, 2007, BIOCHEM BIOPH RES CO, V357, P414, DOI 10.1016/j.bbrc.2007.03.157
   Chien CC, 2006, STEM CELLS, V24, P1759, DOI 10.1634/stemcells.2005-0521
   Clokie CML, 2002, J CRANIOFAC SURG, V13, P111, DOI 10.1097/00001665-200201000-00026
   COOK SD, 1995, J BONE JOINT SURG AM, V77A, P734, DOI 10.2106/00004623-199505000-00010
   Cowan CM, 2005, CURR TOP DEV BIOL, V66, P239, DOI 10.1016/S0070-2153(05)66008-5
   DeCoster TA, 2004, J AM ACAD ORTHOP SUR, V12, P28, DOI 10.5435/00124635-200401000-00005
   Delloye C, 2003, Acta Orthop Belg, V69, P1
   Fehrer C, 2005, EXP GERONTOL, V40, P926, DOI 10.1016/j.exger.2005.07.006
   Fu YS, 2006, STEM CELLS, V24, P115, DOI 10.1634/stemcells.2005-0053
   Fukuchi Y, 2004, STEM CELLS, V22, P649, DOI 10.1634/stemcells.22-5-649
   HAYNESWORTH SE, 1992, BONE, V13, P81, DOI 10.1016/8756-3282(92)90364-3
   Huang YC, 2009, STEM CELL REV REP, V5, P247, DOI 10.1007/s12015-009-9069-x
   in't Anker PS, 2004, STEM CELLS, V22, P1338, DOI 10.1634/stemcells.2004-0058
   Javazon EH, 2004, EXP HEMATOL, V32, P414, DOI 10.1016/j.exphem.2004.02.004
   JOHNSON EE, 1989, CLIN ORTHOP RELAT R, P254
   Karageorgiou V, 2005, BIOMATERIALS, V26, P5474, DOI 10.1016/j.biomaterials.2005.02.002
   Khan SN, 2005, J AM ACAD ORTHOP SUR, V13, P77, DOI 10.5435/00124635-200501000-00010
   LANE JM, 1987, ORTHOP CLIN N AM, V18, P213
   Lee OK, 2004, BLOOD, V103, P1669, DOI 10.1182/blood-2003-05-1670
   Mauney JR, 2005, BIOMATERIALS, V26, P3173, DOI 10.1016/j.biomaterials.2004.08.020
   Mauney JR, 2005, TISSUE ENG, V11, P787, DOI 10.1089/ten.2005.11.787
   Mauney JR, 2004, TISSUE ENG, V10, P81, DOI 10.1089/107632704322791727
   Miao ZN, 2006, CELL BIOL INT, V30, P681, DOI 10.1016/j.cellbi.2006.03.009
   Mistry AS, 2005, ADV BIOCHEM ENG BIOT, V94, P1, DOI 10.1007/b99997
   Mitchell KE, 2003, STEM CELLS, V21, P50, DOI 10.1634/stemcells.21-1-50
   Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143
   Salgado AJ, 2004, MACROMOL BIOSCI, V4, P743, DOI 10.1002/mabi.200400026
   Seeherman HJ, 2006, J BONE JOINT SURG AM, V88A, P1553, DOI 10.2106/JBJS.E.01006
   Shih DTB, 2005, STEM CELLS, V23, P1012, DOI 10.1634/stemcells.2004-0125
   Sundelacruz S, 2009, SEMIN CELL DEV BIOL, V20, P646, DOI 10.1016/j.semcdb.2009.03.017
   Suvorova EI, 2007, SCANNING, V29, P162, DOI 10.1002/sca.20058
   Toma C, 2002, CIRCULATION, V105, P93, DOI 10.1161/hc0102.101442
   Trubiani O, 2005, INT J IMMUNOPATH PH, V18, P213, DOI 10.1177/039463200501800204
   Vogelin E, 2005, J BONE JOINT SURG AM, V87A, P1323, DOI 10.2106/JBJS.C.00913
   Winn SR, 1999, J BIOMED MATER RES, V45, P414, DOI 10.1002/(SICI)1097-4636(19990615)45:4<414::AID-JBM17>3.0.CO;2-Z
   Xie HQ, 2007, BIOMATERIALS, V28, P3314, DOI 10.1016/j.biomaterials.2007.04.001
   Yen BL, 2005, STEM CELLS, V23, P3, DOI 10.1634/stemcells.2004-0098
   Zuk PA, 2001, TISSUE ENG, V7, P211, DOI 10.1089/107632701300062859
   Zvaifler NJ, 2000, ARTHRITIS RES, V2, P477, DOI 10.1186/ar130
NR 42
TC 18
Z9 19
U1 1
U2 17
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1742-464X
J9 FEBS J
JI FEBS J.
PD JUL
PY 2012
VL 279
IS 13
BP 2455
EP 2465
DI 10.1111/j.1742-4658.2012.08625.x
PG 11
WC Biochemistry & Molecular Biology
SC Biochemistry & Molecular Biology
GA 958ZM
UT WOS:000305279500017
PM 22564891
DA 2018-10-19
ER

PT J
AU Jamesh, M
   Kumar, S
   Narayanan, TSNS
AF Jamesh, M.
   Kumar, Satendra
   Narayanan, T. S. N. Sankara
TI Electrodeposition of hydroxyapatite coating on magnesium for biomedical
   applications
SO JOURNAL OF COATINGS TECHNOLOGY AND RESEARCH
LA English
DT Article
DE Magnesium; Degradable biomaterial; Corrosion; Hydroxyapatite;
   Electrodeposition
ID AC-IMPEDANCE SPECTROSCOPY; SIMULATED BODY-FLUID; CORROSION BEHAVIOR;
   ELECTROCHEMICAL-BEHAVIOR; IMPLANT APPLICATIONS; ANODIC FILM; IN-VITRO;
   ALLOYS; SURFACE; TITANIUM
AB The effectiveness of hydroxyapatite (HA) coating prepared by electrodeposition technique in improving the corrosion resistance of commercially pure magnesium (CP-Mg) in simulated body fluid (SBF) is addressed. The coating formed in as-deposited condition is identified as dicalcium phosphate dehydrate (DCPD) (Brushite), which is converted to HA after immersion in 1 M NaOH at 80A degrees C for 2 h. The XRD patterns and FTIR spectra confirm the formation of DCPD and HA. During electrodeposition, the H2PO4 (-) ion is reduced and the reaction between Ca2+ ions and the reduced phosphate ions leads to the formation of DCPD, which is converted to HA following treatment in NaOH. The deposition of HA coating enables a threefold increase in the corrosion resistance of CP-Mg. The ability to offer a significant improvement in corrosion resistance coupled with the bioactive characteristics of the HA coating establish that electrodeposition of HA is a viable approach to engineer the surface of CP-Mg in the development of Mg-based degradable implant materials.
C1 [Jamesh, M.; Kumar, Satendra; Narayanan, T. S. N. Sankara] Madras Ctr, Natl Met Lab, Madras 600113, Tamil Nadu, India.
RP Narayanan, TSNS (reprint author), Madras Ctr, Natl Met Lab, CSIR Madras Complex, Madras 600113, Tamil Nadu, India.
EM tsnsn@rediffmail.com
RI Sahu, Anjani/E-7590-2015
OI MOHAMMED IBRAHIM, Jamesh/0000-0001-7756-5657
CR Abd El-Rahman SS, 2003, PHARMACOL RES, V47, P189, DOI 10.1016/S1043-6618(02)00336-5
   Aksakal B, 2004, J MATER ENG PERFORM, V19, P894
   Baltat-Bazia A, 1992, MATER SCI FORUM, V111-112, P359
   Ban S, 2002, BIOMATERIALS, V23, P2965, DOI 10.1016/S0142-9612(02)00025-X
   Bard A. J., 2001, ELECTROCHEMICAL METH
   BARDWELL JA, 1991, ELECTROCHIM ACTA, V36, P647, DOI 10.1016/0013-4686(91)85153-X
   Baril G, 2001, J ELECTROCHEM SOC, V148, pB489, DOI 10.1149/1.1415722
   BOSTMAN OM, 1991, J BONE JOINT SURG BR, V73, P679
   BOUKAMP BA, 1989, EQUIVALENT CIRCUIT M
   Burg KJL, 2000, BIOMATERIALS, V21, P2347, DOI 10.1016/S0142-9612(00)00102-2
   Chehroudi B, 1997, J BIOMED MATER RES, V34, P279
   Cook S D, 1987, Int J Oral Maxillofac Implants, V2, P15
   Dearnley PA, 2005, SURF COAT TECH, V198, P483, DOI 10.1016/j.surfcoat.2004.10.067
   Elliott JC, 1994, STRUCTURE CHEM APATI
   Erne P, 2006, CARDIOVASC INTER RAD, V29, P11, DOI 10.1007/s00270-004-0341-9
   Hamid Huda, 2007, Mcgill J Med, V10, P105
   HELLER J, 1990, BIODEGRADABLE POLYM, P121
   Heublein B, 2003, HEART, V89, P651, DOI 10.1136/heart.89.6.651
   Hiromoto S, 2009, ELECTROCHIM ACTA, V54, P7085, DOI 10.1016/j.electacta.2009.07.033
   Hsu HC, 2009, J MATER SCI-MATER M, V20, P615, DOI 10.1007/s10856-008-3603-2
   Hu HB, 2002, MAT SCI ENG C-BIO S, V20, P209, DOI 10.1016/S0928-4931(02)00035-8
   Hu J, 2010, MATER CHEM PHYS, V119, P294, DOI 10.1016/j.matchemphys.2009.08.066
   Ionita D, 2007, J OPTOELECTRON ADV M, V9, P3316
   Jamesh M, 2012, J MATER ENG PERFORM, V21, P900, DOI 10.1007/s11665-011-9970-8
   Jamesh M, 2011, CORROS SCI, V53, P645, DOI 10.1016/j.corsci.2010.10.011
   JORIS SJ, 1971, J PHYS CHEM-US, V75, P3172, DOI 10.1021/j100689a025
   Kar A, 2006, SURF COAT TECH, V201, P3723, DOI 10.1016/j.surfcoat.2006.09.008
   KASEMO B, 1986, CRIT REV BIOCOMPAT, V2, P335
   Kokubo T, 2006, BIOMATERIALS, V27, P2907, DOI 10.1016/j.biomaterials.2006.01.017
   Kumar S, 2008, J DENT, V36, P500, DOI 10.1016/j.jdent.2008.03.007
   Kumar S, 2010, MATER CHEM PHYS, V119, P337, DOI 10.1016/j.matchemphys.2009.09.007
   Kumar S, 2009, J ALLOY COMPD, V479, P699, DOI 10.1016/j.jallcom.2009.01.036
   Kuo MC, 2002, MAT SCI ENG C-BIO S, V20, P153, DOI 10.1016/S0928-4931(02)00026-7
   Kuwahara H, 2001, MATER TRANS, V42, P1317, DOI 10.2320/matertrans.42.1317
   LEGEROS RZ, 1975, ARCH ORAL BIOL, V20, P63, DOI 10.1016/0003-9969(75)90154-5
   Levesque J, 2004, ADV MATER PROCESS, V162, P45
   Li LC, 2004, SURF COAT TECH, V185, P92, DOI 10.1016/j.surfcoat.2004.01.004
   Liu XY, 2004, MAT SCI ENG R, V47, P49, DOI 10.1016/j.mser.2004.11.001
   Man HC, 2009, THIN SOLID FILMS, V517, P5496, DOI 10.1016/j.tsf.2009.03.208
   Mansfeld F, 1993, ANAL INTERPRETATION
   Meng EC, 2011, APPL SURF SCI, V257, P4811, DOI 10.1016/j.apsusc.2010.12.073
   Meyer-Lindenberg A, 2004, medical implant for the human or animal body: US, Patent No. [US 20040241036 A1, 20040241036]
   Morlidge JR, 1999, ELECTROCHIM ACTA, V44, P2423, DOI 10.1016/S0013-4686(98)00363-6
   Nagels J, 2003, J SHOULDER ELB SURG, V12, P35, DOI 10.1067/mse.2003.22
   Nakamura Y, 1997, FUND APPL TOXICOL, V37, P106, DOI 10.1006/faat.1997.2322
   Narayanan R, 2007, SCRIPTA MATER, V56, P229, DOI 10.1016/j.scriptamat.2006.10.004
   Paital SR, 2009, MAT SCI ENG R, V66, P1, DOI 10.1016/j.mser.2009.05.001
   Peeters P, 2005, J ENDOVASC THER, V12, P1, DOI 10.1583/04-1349R.1
   Peuster M, 2006, CARDIOL YOUNG, V16, P107, DOI 10.1017/S1047951106000011
   Pilliar R M, 1998, Implant Dent, V7, P305, DOI 10.1097/00008505-199807040-00009
   Rehman I, 1997, J MATER SCI-MATER M, V8, P1, DOI 10.1023/A:1018570213546
   Saris NEL, 2000, CLIN CHIM ACTA, V294, P1, DOI 10.1016/S0009-8981(99)00258-2
   Serre CM, 1998, J BIOMED MATER RES, V42, P626
   Sobieszczyk S, 2010, ADV MATER SCI, V10, P19, DOI 10.2478/v10077-010-0002-4
   Song GL, 2007, CORROS SCI, V49, P1696, DOI 10.1016/j.corsci.2007.01.001
   Song Y, 2010, ACTA BIOMATER, V6, P1736, DOI 10.1016/j.actbio.2009.12.020
   Song YW, 2009, MAT SCI ENG C-BIO S, V29, P1039, DOI 10.1016/j.msec.2008.08.026
   Souto RM, 2004, J BIOMED MATER RES A, V70A, P59, DOI 10.1002/jbm.a.30061
   Souto RM, 2003, BIOMATERIALS, V24, P4213, DOI 10.1016/S0142-9612(03)00362-4
   Staiger MP, 2006, BIOMATERIALS, V27, P1728, DOI 10.1016/j.biomaterials.2005.10.003
   Svehla M, 2000, J BIOMED MATER RES, V51, P15, DOI 10.1002/(SICI)1097-4636(200007)51:1<15::AID-JBM3>3.0.CO;2-9
   THOMPSON I, 1994, CORROS SCI, V36, P187, DOI 10.1016/0010-938X(94)90119-8
   Upadhyay D, 2006, MAT SCI ENG A-STRUCT, V432, P1, DOI 10.1016/j.msea.2006.05.003
   Vormann Juergen, 2003, Molecular Aspects of Medicine, V24, P27, DOI 10.1016/S0098-2997(02)00089-4
   Wilkinson CDW, 1998, J VAC SCI TECHNOL B, V16, P3132, DOI 10.1116/1.590451
   Witte F, 2006, BIOMATERIALS, V27, P1013, DOI 10.1016/j.biomaterials.2005.07.037
   Xin YC, 2008, J MATER RES, V23, P312, DOI [10.1557/jmr.2008.0040, 10.1557/JMR.2008.0040]
   Xin YC, 2009, SURF COAT TECH, V203, P2554, DOI 10.1016/j.surfcoat.2009.02.074
   Xu JW, 1999, SPECTROCHIM ACTA A, V55, P2801, DOI 10.1016/S1386-1425(99)00090-6
   Xue-Nan Gu, 2010, Frontiers of Materials Science in China, V4, P111, DOI 10.1007/s11706-010-0024-1
   Yamaguchi T, 2006, NUCL INSTRUM METH B, V249, P723, DOI 10.1016/j.nimb.2006.03.126
   Yang WD, 2006, J RARE EARTH, V24, P369, DOI 10.1016/S1002-0721(06)60126-9
   Yousefpour M, 2007, MAT SCI ENG C-BIO S, V27, P1482, DOI 10.1016/j.msec.2006.07.003
   Zartner P, 2007, CATHETER CARDIO INTE, V69, P443, DOI 10.1002/ccd.20828
   Zeng RC, 2008, ADV ENG MATER, V10, pB3, DOI 10.1002/adem.200800035
   Zhang YJ, 2005, CORROS SCI, V47, P2816, DOI 10.1016/j.corsci.2005.01.010
   Zreiqat H, 2002, J BIOMED MATER RES, V62, P175, DOI 10.1002/jbm.10270
NR 77
TC 54
Z9 56
U1 4
U2 61
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 1945-9645
EI 1935-3804
J9 J COAT TECHNOL RES
JI J. Coat. Technol. Res.
PD JUL
PY 2012
VL 9
IS 4
BP 495
EP 502
DI 10.1007/s11998-011-9382-6
PG 8
WC Chemistry, Applied; Materials Science, Coatings & Films
SC Chemistry; Materials Science
GA 958IZ
UT WOS:000305231400012
DA 2018-10-19
ER

PT J
AU Ma, J
   Qi, Y
AF Ma, J.
   Qi, Y.
TI Preparation and characterisation of TiO2-SnO2 binary oxide nanotubes
SO MATERIALS TECHNOLOGY
LA English
DT Article
DE TiO2; SnO2; Composite nanotubes
ID FERRITE COMPOSITE NANOPARTICLES; PHOTOCATALYTIC SHELL; BIOMATERIAL
   SYSTEM; ROOM-TEMPERATURE; MAGNETIC CORE; ANTIMICROBIAL ACTIVITY;
   TEMPLATE; PROPERTY; NANORODS; GROWTH
AB The nanotubular architectures of metal oxides have emerged as a fascinating class of nanomaterials because of their superior performance in numerous applications, such as gas sensing, drug delivery and electronic and optoelectronic device. One of the most powerful and now extensively synthesising methods for nanotube (NT) structures relies on solid state templates and sol-gel to control the diameter and length of nanostructures. Among the metal oxides, TiO2 and SnO2 are the functional semiconductor oxides for their wide applications in nanodevice. It is meaningful to prepare the TiO2 oxide NT compositing the SnO2 component. In this work, the synthesis of nanotubular architectured composite materials consisting of TiO2 and SnO2 by the combination of the sol-gel chemical method and the anodic aluminium oxide templating method is reported. The method can control the diameter and tube end morphology, and the as obtained products were characterised by X-ray diffractometry, scanning electron microscopy, transmission electron microscopy and energy dispersive X-ray spectrometry. The diameter of the composite NT is similar to 150 nm with open tube end. The composite NTs are composed of mixed oxides of Sn, O and Ti. The mechanisms of formation of NTs have been elucidated. The reported results are expected to have a significant impact on synthesising other binary oxide NTs.
C1 [Qi, Y.] Taiyuan Univ Technol, Coll Environm Sci & Engn, Taiyuan 030024, Peoples R China.
   [Ma, J.] Taiyuan Univ Technol, Inst Measuring & Controlling Technol, Taiyuan 030024, Peoples R China.
RP Qi, Y (reprint author), Taiyuan Univ Technol, Coll Environm Sci & Engn, Taiyuan 030024, Peoples R China.
EM qiyutyut@163.com
CR Feng X, 2010, MATER TECHNOL, V25, P35, DOI 10.1179/106678509X12519031979876
   Hou LR, 2007, J HAZARD MATER, V139, P310, DOI 10.1016/j.jhazmat.2006.06.035
   Jung JH, 2002, CHEM MATER, V14, P1445, DOI [10.1021/cm011625e, 10.1021/cmOI1625]
   Kanamadi CM, 2009, J NANOSCI NANOTECHNO, V9, P4942, DOI 10.1166/jnn.2009.1271
   Lim SH, 2005, INORG CHEM, V44, P4124, DOI 10.1021/ic0501723
   Liu ZY, 2007, NANO LETT, V7, P1081, DOI 10.1021/nl061898e
   Mao YB, 2004, J AM CHEM SOC, V126, P15245, DOI 10.1021/ja046331j
   Nguyen VD, 2008, PHYSICA E, V41, P258, DOI 10.1016/j.physe.2008.07.007
   Oliveira M. M., 2003, CHEM MATER, V15, P19039
   Rana S, 2006, ACTA BIOMATER, V2, P421, DOI 10.1016/j.actbio.2006.03.005
   Rana S, 2005, ACTA BIOMATER, V1, P691, DOI 10.1016/j.actbio.2005.07.007
   Rana S, 2005, MAT SCI ENG B-SOLID, V119, P144, DOI 10.1016/j.mseb.2005.02.043
   Rawat J, 2007, MATER SCI TECH-LOND, V23, P97, DOI 10.1179/174328407X158488
   Rawat J, 2007, MAT SCI ENG C-BIO S, V27, P540, DOI 10.1016/j.msec.2006.05.021
   Rorvik PM, 2009, J EUR CERAM SOC, V29, P2575, DOI 10.1016/j.jeurceramsoc.2009.02.004
   Shah J, 2011, ADV ENG MATER, V13, pB234, DOI 10.1002/adem.201080130
   Shah JS, 2011, ADV ENG MATER, V13, pB41, DOI 10.1002/adem.201080051
   Sunkara BK, 2008, ACTA BIOMATER, V4, P273, DOI 10.1016/j.actbio.2007.07.002
   Tada H, 2000, J PHYS CHEM B, V104, P4585, DOI 10.1021/jp000049r
   Venkatasubramanian R, 2008, MATER SCI TECH-LOND, V24, P589, DOI 10.1179/174328408X282065
   Wang Y, 2005, CHEM MATER, V17, P3899, DOI 10.1021/cm050724f
   Wen Z, 2010, PHYSICA B, V405, P1345, DOI 10.1016/j.physb.2009.11.086
   Wu XD, 2011, J HAZARD MATER, V187, P283, DOI 10.1016/j.jhazmat.2011.01.010
   Yu HD, 2005, J AM CHEM SOC, V127, P2378, DOI 10.1021/ja043121y
   Zeng W, 2010, MATER TRANS, V51, P243, DOI 10.2320/matertrans.MC200904
   Zhao QA, 2011, NANOTECHNOLOGY, V22, DOI 10.1088/0957-4484/22/12/125603
NR 26
TC 3
Z9 3
U1 1
U2 34
PU MANEY PUBLISHING
PI LEEDS
PA STE 1C, JOSEPHS WELL, HANOVER WALK, LEEDS LS3 1AB, W YORKS, ENGLAND
SN 1066-7857
J9 MATER TECHNOL
JI Mater. Technol.
PD JUL
PY 2012
VL 27
IS 3
BP 239
EP 242
DI 10.1179/1753555712Y.0000000007
PG 4
WC Materials Science, Multidisciplinary
SC Materials Science
GA 958XH
UT WOS:000305273800006
DA 2018-10-19
ER

PT J
AU Sonmezoglu, S
   Cankaya, G
   Serin, N
AF Sonmezoglu, S.
   Cankaya, G.
   Serin, N.
TI Influence of annealing temperature on structural, morphological and
   optical properties of nanostructured TiO2 thin films
SO MATERIALS TECHNOLOGY
LA English
DT Article
DE X-ray diffraction; Thin film structure and morphology; Optical
   properties of thin films; Nanoparticles
ID FERRITE COMPOSITE NANOPARTICLES; SOL-GEL PROCESS; NICKEL FERRITE;
   PHOTOCATALYTIC SHELL; BIOMATERIAL SYSTEM; MAGNETIC CORE; ANTIMICROBIAL
   ACTIVITY; TITANIUM-DIOXIDE; HEAT-MIRROR; DEPOSITION
AB Thermal annealing is widely used to improve crystal quality, which affects electrical and structural properties by reducing study defects in materials. Therefore, enormous research efforts were focused on the control of material surface nanostructure through annealing processes, which is of interest for various technologies. However, no work providing a detailed explanation for the structural, morphological and optical parameters of nanostructured TiO2 thin films deposited on glass at temperature above 500 degrees C by the sol-gel dip coating method has been presented to date. In this work, we have grown nanostructured TiO2 thin films by sol-gel dip coating method on glass substrates at room temperature and studied the effects of annealing temperature from 200 to 700 degrees C on optical performance, microstructural changes and surface morphology evolution. The results of this work may be summarised as follows: the X-ray diffraction results show that annealed TiO2 thin films have anatase crystal structure, and the intensities of the peaks of the crystalline phase increased with the increase in annealing temperature; from atomic force microscopy images, distinct variations in morphology of the thin films were also observed; and optical results show that TiO2 films exhibit high visible transmittance, and it has a maximum transmittance of similar to 93.61% at 500 degrees C annealing temperature. The optical band gap of the as grown thin films decreases from 3.68 to 3.31 eV with the increase in annealing temperatures. The TiO2 thin film annealed at 500 degrees C has the best optical property. The change in structural, morphological and optical properties with annealing temperature demonstrates that this material has a potential to be used as a novel technology such as nanoelectronics and possibly nano-optoelectronic devices based on nanomaterial for insulating, semiconducting and electron and/or hole blocking layer, etc.
C1 [Sonmezoglu, S.] Karamanoglu Mehmetbey Univ, Fac Engn, Dept Mat Sci & Engn, TR-70100 Karaman, Turkey.
   [Cankaya, G.] Yildirim Beyazit Univ, Fac Engn & Nat Sci, Dept Mat Engn, Ankara, Turkey.
   [Serin, N.] Ankara Univ, Fac Engn, Dept Engn Phys, TR-06100 Ankara, Turkey.
RP Sonmezoglu, S (reprint author), Karamanoglu Mehmetbey Univ, Fac Engn, Dept Mat Sci & Engn, TR-70100 Karaman, Turkey.
EM svssonmezoglu@kmu.edu.tr
RI Cankaya, Guven/J-9048-2017; SONMEZOGLU, Savas/K-9362-2016
OI Cankaya, Guven/0000-0003-2932-1695; SONMEZOGLU,
   Savas/0000-0002-6011-3504
CR Cullity B.D., 1978, ELEMENTS XRAY DIFFRA
   Diebold U, 2003, SURF SCI REP, V48, P53, DOI 10.1016/S0167-5729(02)00100-0
   Euvananont C, 2008, CERAM INT, V34, P1067, DOI 10.1016/j.ceramint.2007.09.043
   Goossens A, 1998, CHEM VAPOR DEPOS, V4, P109, DOI 10.1002/(SICI)1521-3862(199805)04:03<109::AID-CVDE109>3.0.CO;2-U
   Gubbala S, 2006, MATER SCI TECH-LOND, V22, P845, DOI 10.1179/174328406X91096
   Hasan MM, 2010, OPT MATER, V32, P690, DOI 10.1016/j.optmat.2009.07.011
   Hou Y.-Q., 2003, APPL SURF SCI, V218, P98
   Kawasaki H, 2008, J PHYS CONF SER, V100, DOI 10.1088/1742-6596/100/1/012038
   Kim HS, 1997, IEEE ELECTR DEVICE L, V18, P465, DOI 10.1109/55.624911
   Legrand-Buscema C, 2002, THIN SOLID FILMS, V418, P79, DOI 10.1016/S0040-6090(02)00714-9
   Mikhelashvili V, 2001, J APPL PHYS, V89, P3256, DOI 10.1063/1.1349860
   Mohammadi MR, 2010, MATER CHEM PHYS, V122, P512, DOI 10.1016/j.matchemphys.2010.03.036
   Okada M, 2006, VACUUM, V80, P732, DOI 10.1016/j.vacuum.2005.11.014
   OREGAN B, 1991, NATURE, V353, P737, DOI 10.1038/353737a0
   Park J, 2009, NANOTECHNOLOGY, V20, DOI 10.1088/0957-4484/20/10/105608
   Philippe K., 2004, NANOSTRUCTURED MAT S
   Pulker H. K., 1999, COATINGS ON GLASS
   Raffi M, 2006, MATER CHEM PHYS, V99, P405, DOI 10.1016/j.matchemphys.2005.11.012
   Rana S, 2007, ACTA BIOMATER, V3, P233, DOI 10.1016/j.actbio.2006.10.006
   Rana S, 2006, ACTA BIOMATER, V2, P421, DOI 10.1016/j.actbio.2006.03.005
   Rana S, 2005, ACTA BIOMATER, V1, P691, DOI 10.1016/j.actbio.2005.07.007
   Rana S, 2005, MAT SCI ENG B-SOLID, V119, P144, DOI 10.1016/j.mseb.2005.02.043
   RAO KN, 1989, THIN SOLID FILMS, V176, P181, DOI 10.1016/0040-6090(89)90091-6
   Rawat J, 2007, MATER SCI TECH-LOND, V23, P97, DOI 10.1179/174328407X158488
   Rawat J, 2007, MAT SCI ENG C-BIO S, V27, P540, DOI 10.1016/j.msec.2006.05.021
   Ray S, 2007, J PHYS D APPL PHYS, V40, P2445, DOI 10.1088/0022-3727/40/8/006
   Shah J, 2011, ADV ENG MATER, V13, pB234, DOI 10.1002/adem.201080130
   Shah JS, 2011, ADV ENG MATER, V13, pB41, DOI 10.1002/adem.201080051
   Sunkara BK, 2008, ACTA BIOMATER, V4, P273, DOI 10.1016/j.actbio.2007.07.002
   SWANEPOEL R, 1983, J PHYS E SCI INSTRUM, V16, P1214, DOI 10.1088/0022-3735/16/12/023
   TAUC J, 1970, MATER RES BULL, V5, P721, DOI 10.1016/0025-5408(70)90112-1
   Tavares CJ, 2007, MAT SCI ENG B-SOLID, V138, P139, DOI 10.1016/j.mseb.2005.11.043
   Venkatasubramanian R, 2008, MATER SCI TECH-LOND, V24, P589, DOI 10.1179/174328408X282065
   Wang ZG, 2005, APPL SURF SCI, V239, P262, DOI 10.1016/j.apsusc.2004.06.011
   Zhang J, 2007, ACTA BIOMATER, V3, P838, DOI 10.1016/j.actbio.2007.05.011
   Zhang JL, 2007, LANGMUIR, V23, P6342, DOI 10.1021/la0636199
   Zhou XS, 2006, J PHYS D APPL PHYS, V39, P558, DOI 10.1088/0022-3727/39/3/021
NR 37
TC 16
Z9 16
U1 1
U2 35
PU MANEY PUBLISHING
PI LEEDS
PA STE 1C, JOSEPHS WELL, HANOVER WALK, LEEDS LS3 1AB, W YORKS, ENGLAND
SN 1066-7857
EI 1753-5557
J9 MATER TECHNOL
JI Mater. Technol.
PD JUL
PY 2012
VL 27
IS 3
BP 251
EP 256
DI 10.1179/1753555712Y.0000000008
PG 6
WC Materials Science, Multidisciplinary
SC Materials Science
GA 958XH
UT WOS:000305273800008
DA 2018-10-19
ER

PT J
AU Esfahani, H
   Javadi, AH
   Farahmandnejad, MA
   Nourpour, P
   Shabani, K
AF Esfahani, H.
   Javadi, A. H.
   Farahmandnejad, M. A.
   Nourpour, P.
   Shabani, K.
TI Study on kinetic of UV and solar assisted photocatalytic degradation of
   rhodamine B by TiO2 nanostructure layer
SO MATERIALS TECHNOLOGY
LA English
DT Article
DE Photocatalyst; Rhodamine B; Slurry method; Solar; TiO2; UV
ID FERRITE COMPOSITE NANOPARTICLES; THIN-FILMS; BIOMATERIAL SYSTEM;
   WATER-TREATMENT; ACTIVATED CARBON; MAGNETIC CORE; DEPOSITION; REACTOR;
   SHELL; GLASS
AB Water and energy crisis are two problems that need to attend in the next decay. Lack of adequate fresh water throughout the world special in regions with scarcity of water will affect the social manner. This paper discusses on the life cycle assessment for retrofitting the photocatalytic technology as an alternative waste water treatment. The effect and kinetic of UV and solar irradiation on photocatalytic dynamic reactor using TiO2-P25 (Degussa) were investigated for removal of rhodamine B (RhB) dye chosen as organic pollutant. The degradation kinetic of RhB is discussed in terms of Longmire model. The results showed that UV irradiation was more efficient than solar irradiation to degrade the RhB dye. The effect of temperature on performance of photo reactor was monitored in 15, 25 and 50 degrees C. The photocatalytic reactor degraded the RhB in warm conditions better than the cool conditions.
C1 [Esfahani, H.] MERC, Karaj, Iran.
   [Javadi, A. H.; Farahmandnejad, M. A.; Nourpour, P.; Shabani, K.] Engn Res Inst, Tehran, Iran.
RP Esfahani, H (reprint author), MERC, Karaj, Iran.
EM h-esfahani@merc.ac.ir
OI Esfahani, Hamid/0000-0003-1246-733X
FU Engineering Research Institute
FX The authors wish to acknowledge the Engineering Research Institute for
   the financial support through the project 'Waste water purification by
   nano TiO<INF>2</INF> photocatalyst'.
CR Abou-Helal MO, 2002, APPL SURF SCI, V195, P53, DOI 10.1016/S0169-4332(02)00533-0
   Al-Rasheed R, 2003, CHEMOSPHERE, V51, P925, DOI 10.1016/S0045-6535(03)00097-3
   Aloisi GG, 2006, J PHYS CHEM SOLIDS, V67, P909, DOI 10.1016/j.jpcs.2006.01.003
   Anandkumar J, 2011, J HAZARD MATER, V186, P1088, DOI 10.1016/j.jhazmat.2010.11.104
   Arin M., 2001, J EUR CERAM SOC, V31, P1067
   Balamurugan A, 2005, MATER LETT, V59, P3138, DOI 10.1016/j.matlet.2005.05.036
   Brezova V, 2009, J PHOTOCH PHOTOBIO A, V206, P177, DOI 10.1016/j.jphotochem.2009.06.006
   Carp O, 2004, PROG SOLID STATE CH, V32, P33, DOI 10.1016/j.progsolidstchem.2004.08.001
   Cheremisinoff N. P., 2002, HDB WATER WASTE WATE, P62
   Chong M. N., 2001, WATER RES, V44, P2997
   Faur C, 2008, CHEM ENG J, V145, P7, DOI 10.1016/j.cej.2008.02.015
   Guan ZS, 2006, J COLLOID INTERF SCI, V302, P113, DOI 10.1016/j.jcis.2006.05.063
   Gutierrez D., 2008, THESIS U AUTONOMA BA
   He HY, 2008, MATER TECHNOL, V23, P110, DOI 10.1179/175355508X266980
   Herbig B, 2004, J PHOTOCH PHOTOBIO A, V163, P359, DOI 10.1016/j.jphotochem.2004.01.005
   Iliescu C, 2005, SURF COAT TECH, V198, P314, DOI 10.1016/j.surfcoat.2004.10.094
   Kang BC, 2000, SURF COAT TECH, V131, P88, DOI 10.1016/S0257-8972(00)00765-9
   Konieczny K, 2002, DESALINATION, V147, P109, DOI 10.1016/S0011-9164(02)00584-2
   Li J, 2009, MATER TECHNOL, V24, P231, DOI 10.1179/175355509X447212
   Lin CF, 2006, WASTE MANAGE, V26, P970, DOI 10.1016/j.wasman.2005.09.014
   Ma Y., 2001, J APPL SURF SCI, V257, P5046
   Ma Z, 2008, MATER TECHNOL, V23, P81, DOI 10.1179/175355508X310106
   Mansilla HD, 2007, APPL CATAL B-ENVIRON, V76, P57, DOI 10.1016/j.apcatb.2007.04.025
   Matilainen A, 2010, ADV COLLOID INTERFAC, V159, P189, DOI 10.1016/j.cis.2010.06.007
   Meng FM, 2009, VACUUM, V83, P1147, DOI 10.1016/j.vacuum.2009.02.009
   Rana S, 2006, ACTA BIOMATER, V2, P421, DOI 10.1016/j.actbio.2006.03.005
   Rana S, 2005, ACTA BIOMATER, V1, P691, DOI 10.1016/j.actbio.2005.07.007
   Rawat J, 2007, MAT SCI ENG C-BIO S, V27, P540, DOI 10.1016/j.msec.2006.05.021
   Shivaprasad M, 2011, MATER TECHNOL, V26, P168, DOI 10.1179/175355511X13109965351239
   Skoog DA, 1998, PRINCIPLE INSTRUMENT
   Sunkara BK, 2008, ACTA BIOMATER, V4, P273, DOI 10.1016/j.actbio.2007.07.002
   Sutherland J, 2004, WATER RES, V38, P193, DOI 10.1016/j.watres.2003.09.008
   Tang YW, 2005, MATER LETT, V59, P434, DOI 10.1016/j.matlet.2004.09.040
   Tran T, 2007, WATER RES, V41, P3915, DOI 10.1016/j.watres.2007.06.008
   Wang D., 2001, J HAZARD MATER, V192, P150
   Wang RC, 2009, J HAZARD MATER, V169, P926, DOI 10.1016/j.jhazmat.2009.04.036
   Weerasinghe HC, 2009, J PHOTOCH PHOTOBIO A, V206, P64, DOI 10.1016/j.jphotochem.2009.05.013
   Xu YL, 2009, CHEM ENG J, V150, P302, DOI 10.1016/j.cej.2009.01.002
   Yang J, 2010, MATER TECHNOL, V25, P39, DOI 10.1179/175355509X12608871787915
   Yang XH, 2011, MATER TECHNOL, V26, P229, DOI 10.1179/175355511X13110717549116
   Zhang LF, 2003, SEP PURIF TECHNOL, V31, P105, DOI 10.1016/S1383-5866(02)00157-0
   Zheng HJ, 2009, MATER TECHNOL, V24, P221, DOI 10.1179/106678509X12519032988271
NR 42
TC 5
Z9 5
U1 2
U2 15
PU MANEY PUBLISHING
PI LEEDS
PA STE 1C, JOSEPHS WELL, HANOVER WALK, LEEDS LS3 1AB, W YORKS, ENGLAND
SN 1066-7857
J9 MATER TECHNOL
JI Mater. Technol.
PD JUL
PY 2012
VL 27
IS 3
BP 261
EP 266
DI 10.1179/1066785712Z.00000000073
PG 6
WC Materials Science, Multidisciplinary
SC Materials Science
GA 958XH
UT WOS:000305273800010
DA 2018-10-19
ER

PT J
AU Liu, ZF
   Liu, ZC
   Wang, Y
   Li, YB
   Qu, L
   E, L
   Ya, J
   Huang, PY
AF Liu, Z. F.
   Liu, Z. C.
   Wang, Y.
   Li, Y. B.
   Qu, L.
   E, L.
   Ya, J.
   Huang, P. Y.
TI Photocatalysis of TiO2 nanoparticles supported on natural zeolite
SO MATERIALS TECHNOLOGY
LA English
DT Article
DE TiO2; Natural zeolite; Photocatalytic; Sol-gel; Support
ID COMPOSITE NANOPARTICLES; VISIBLE-LIGHT; ANTIMICROBIAL ACTIVITY;
   BIOMATERIAL SYSTEM; ACTIVATED CARBON; METHYLENE-BLUE; MAGNETIC CORE;
   WATER; DEGRADATION; CATALYSTS
AB In order to achieve rapid and efficient decomposition of organic pollutants and put it to wastewater treatment, the composite materials of nanoTiO(2) powder immobilised on zeolite were synthesised. Moreover, the effects of technology parameters, such as TiO2 loading content, calcining temperature and ultrasonic treatment, on photocatalytic reactivity were examined. The proposed research investigates the following aspects, which are important in understanding the preparation and application of TiO2/zeolite composite photocatalysts: nanosize TiO2 particles were supported on natural zeolite by a simple sol-gel method in order to maximise the photocatalytic performance of the nanosize TiO2 as well as reduce the preparation cost; and the effects of TiO2 loading content, calcining temperature and ultrasonic treatment on photocatalytic reactivity were researched. The novel aspect of the proposed photocatalysts is the combination of nanosize TiO2 particles and natural zeolite by a simple sol-gel method. The product of the research can be used in wastewater treatment resolving the difficulties of TiO2 recovery and surface contact based photocatalytic reaction.
C1 [Liu, Z. F.; Liu, Z. C.; Wang, Y.; Li, Y. B.; Qu, L.; E, L.; Ya, J.; Huang, P. Y.] Tianjin Inst Urban Construct, Dept Mat Sci & Engn, Tianjin 300384, Peoples R China.
RP Liu, ZF (reprint author), Tianjin Inst Urban Construct, Dept Mat Sci & Engn, Tianjin 300384, Peoples R China.
EM tjulzf@163.com
FU Natural Science Foundation of Tianjin [11JCYBJC27000]; Technology
   Development Foundation Plan Project of Tianjin Colleges [20100316]
FX The authors gratefully acknowledge the financial support from the
   Natural Science Foundation of Tianjin (grant no. 11JCYBJC27000) and the
   Technology Development Foundation Plan Project of Tianjin Colleges
   (grant no. 20100316).
CR Abellan MN, 2009, J PHOTOCH PHOTOBIO A, V202, P164, DOI 10.1016/j.jphotochem.2008.11.020
   Bhattacharyya A, 2004, CATAL TODAY, V98, P431, DOI 10.1016/j.cattod.2004.08.010
   Caputo D, 2007, MICROPOR MESOPOR MAT, V105, P260, DOI 10.1016/j.micromeso.2007.04.018
   Colella C, 2007, MICROPOR MESOPOR MAT, V105, P213, DOI 10.1016/j.micromeso.2007.04.056
   Devi LG, 2009, J HAZARD MATER, V162, P899, DOI 10.1016/j.jhazmat.2008.05.116
   Dubey N, 2007, CATAL TODAY, V129, P428, DOI 10.1016/j.cattod.2006.09.041
   Lin KF, 2008, J CATAL, V254, P64, DOI 10.1016/j.jcat.2007.11.017
   Liu SX, 2007, J CHEM TECHNOL BIOT, V82, P453, DOI 10.1002/jetb.1688
   Liu ZF, 2006, J SOL-GEL SCI TECHN, V38, P73, DOI 10.1007/s10971-006-5035-0
   Liu ZF, 2010, MATER CHEM PHYS, V120, P277, DOI 10.1016/j.matchemphys.2009.11.008
   Mahalakshmi M, 2009, J HAZARD MATER, V161, P336, DOI 10.1016/j.jhazmat.2008.03.098
   Paramasivam I, 2009, NANOTECHNOLOGY, V20, DOI 10.1088/0957-4484/20/22/225607
   Petkowicz DI, 2009, APPL CATAL A-GEN, V357, P125, DOI 10.1016/j.apcata.2008.12.040
   Rana S, 2007, ACTA BIOMATER, V3, P233, DOI 10.1016/j.actbio.2006.10.006
   Rana S, 2005, ACTA BIOMATER, V1, P691, DOI 10.1016/j.actbio.2005.07.007
   Rana S., 2005, MAT SCI ENG C, VC119, P114
   Rawat J, 2007, MATER SCI TECH-LOND, V23, P97, DOI 10.1179/174328407X158488
   Rawat J, 2007, MAT SCI ENG C-BIO S, V27, P540, DOI 10.1016/j.msec.2006.05.021
   Shen Q, 2010, CHEM ENG J, V165, P301, DOI 10.1016/j.cej.2010.08.057
   Sunkara BK, 2008, ACTA BIOMATER, V4, P273, DOI 10.1016/j.actbio.2007.07.002
   Takeuchi M, 2007, J CATAL, V246, P235, DOI 10.1016/j.jcat.2006.12.010
   Tayade RJ, 2007, IND ENG CHEM RES, V46, P369, DOI 10.1021/ie060641o
   Xu JJ, 2008, J PHYS CHEM SOLIDS, V69, P2366, DOI 10.1016/j.jpcs.2008.03.017
   Yahiro H, 2007, CATAL TODAY, V120, P158, DOI 10.1016/j.cattod.2006.07.039
   Yang J, 2006, J HAZARD MATER, V137, P952, DOI 10.1016/j.jhazmat.2006.03.017
   Zainudin NF, 2010, J HAZARD MATER, V174, P299, DOI 10.1016/j.jhazmat.2009.09.051
   Zhu B., 2009, J ADV OXID TECHNOL, V12, P1
   Zou LD, 2008, J PHOTOCH PHOTOBIO A, V196, P24, DOI 10.1016/j.jphotochem.2007.11.008
NR 28
TC 14
Z9 14
U1 3
U2 37
PU MANEY PUBLISHING
PI LEEDS
PA STE 1C, JOSEPHS WELL, HANOVER WALK, LEEDS LS3 1AB, W YORKS, ENGLAND
SN 1066-7857
J9 MATER TECHNOL
JI Mater. Technol.
PD JUL
PY 2012
VL 27
IS 3
BP 267
EP 271
DI 10.1179/1753555712Y.0000000011
PG 5
WC Materials Science, Multidisciplinary
SC Materials Science
GA 958XH
UT WOS:000305273800011
DA 2018-10-19
ER

PT J
AU Cirillo, G
   Puoci, F
   Iemma, F
   Curcio, M
   Parisi, OI
   Spizzirri, UG
   Altimari, I
   Picci, N
AF Cirillo, Giuseppe
   Puoci, Francesco
   Iemma, Francesca
   Curcio, Manuela
   Parisi, Ortensia Ilaria
   Spizzirri, Umile Gianfranco
   Altimari, Ilaria
   Picci, Nevio
TI Starch-quercetin conjugate by radical grafting: synthesis and biological
   characterization
SO PHARMACEUTICAL DEVELOPMENT AND TECHNOLOGY
LA English
DT Article
DE Antioxidant; biomaterial; enzyme; polymer functionalization; starch
ID ANTIOXIDANT PROPERTIES; FERULIC ACID; VITAMIN-E; CAPACITY; POLYMERS;
   POLYMERIZATION; INHIBITORS; CHITOSAN; EXTRACT; SYSTEM
AB A novel flavonoid-polysaccharide conjugate was synthesized by free radical grafting of quercetin on starch. The covalent insertion of quercetin in the polymeric chain was confirmed by FT-IR, DSC and fluorescence analyses, while an estimation of the amount of quercetin bound per g of polymer was obtained by the Folin-Ciocalteu assay. The conjugate shows improved UV stability and retains the antioxidant properties of free quercetin, such as scavenging activity towards free radicals (DPPH and peroxynitrite); inhibition of the free radical formation (peroxidation of linoleic acid) and total antioxidant activity. The conjugate also prevented drug degradation and shows potential health functionality in the treatment of Alzheimer disease, diabetes and as skin-whitening agent.
C1 [Cirillo, Giuseppe; Puoci, Francesco; Iemma, Francesca; Curcio, Manuela; Parisi, Ortensia Ilaria; Spizzirri, Umile Gianfranco; Altimari, Ilaria; Picci, Nevio] Univ Calabria, Dipartimento Sci Farmaceut, I-87036 Arcavacata Di Rende, CS, Italy.
RP Cirillo, G (reprint author), Univ Calabria, Dipartimento Sci Farmaceut, Edificio Polifunz, I-87036 Arcavacata Di Rende, CS, Italy.
EM giuseppe.cirillo@unical.it
RI Cirillo, Giuseppe/C-4262-2014
OI Cirillo, Giuseppe/0000-0002-9592-1333; Iemma,
   Francesca/0000-0001-9548-0446; Picci, Nevio/0000-0003-1985-2724; Curcio,
   Manuela/0000-0003-2026-0152; Parisi, Ortensia
   Ilaria/0000-0002-2556-9864; Puoci, Francesco/0000-0002-5963-6762
FU MIUR; University of Calabria
FX This work was financially supported by MIUR (Programma di ricerca di
   rilevante interesse nazionale 2008) and University of Calabria funds.
   The authors report no declarations of interest.
CR ALMALAIKA S, 1995, POLYM DEGRAD STABIL, V49, P77, DOI 10.1016/0141-3910(95)00114-2
   Amin Ismail, 2004, Food Chemistry, V87, P581, DOI 10.1016/j.foodchem.2004.01.010
   Ardestani A, 2007, FOOD CHEM, V104, P21, DOI 10.1016/j.foodchem.2006.10.066
   ATKINSON D, 1992, EUR POLYM J, V28, P1569, DOI 10.1016/0014-3057(92)90153-S
   Bao YM, 2008, J PHARMACEUT BIOMED, V48, P664, DOI 10.1016/j.jpba.2008.06.013
   Careri M, 2003, J AGR FOOD CHEM, V51, P5226, DOI 10.1021/jf034149g
   Casas M, 2010, CARBOHYD POLYM, V80, P71, DOI 10.1016/j.carbpol.2009.10.065
   Cirillo G, 2010, BIOMACROMOLECULES, V11, P3909
   Cirillo G, 2010, J PHARM PHARMACOL, V62, P577, DOI [10.1211/jpp.62.05.0003, 10.1211/jpp/62.05.0003]
   Cummings JH, 2007, EUR J CLIN NUTR, V61, pS5, DOI 10.1038/sj.ejcn.1602936
   Duenas M, 2010, J PHARMACEUT BIOMED, V51, P443, DOI 10.1016/j.jpba.2009.04.007
   Fred-Jaiyesimi A, 2009, FOOD CHEM, V116, P285, DOI 10.1016/j.foodchem.2009.02.047
   Hou WL, 2009, PHYTOTHER RES, V23, P614, DOI 10.1002/ptr.2661
   Huang DJ, 2005, J AGR FOOD CHEM, V53, P1841, DOI 10.1021/jf030723c
   Iemma F, 2007, J PHARM PHARMACOL, V59, P597, DOI 10.1211/jpp.59.4.0016
   Iemma F, 2010, J APPL POLYM SCI, V115, P784, DOI 10.1002/app.31067
   Jung M, 2007, MOLECULES, V12, P2130, DOI 10.3390/12092130
   Katalinic V, 2010, FOOD CHEM, V119, P715, DOI 10.1016/j.foodchem.2009.07.019
   Kitagawa M, 2006, CARBOHYD POLYM, V64, P218, DOI 10.1016/j.carbpol.2005.11.029
   Kodali Vidya Prabhakar, 2008, Biotechnol J, V3, P245, DOI 10.1002/biot.200700208
   Kwon YI, 2008, BIORESOURCE TECHNOL, V99, P2981, DOI 10.1016/j.biortech.2007.06.035
   Lemieux M, 2009, INT J PHARMACEUT, V382, P172, DOI 10.1016/j.ijpharm.2009.08.030
   Ma XF, 2008, BIOMACROMOLECULES, V9, P3314, DOI 10.1021/bm800987c
   Melo R, 2009, J HAZARD MATER, V172, P1185, DOI 10.1016/j.jhazmat.2009.07.122
   Moon JK, 2009, J AGR FOOD CHEM, V57, P1655, DOI 10.1021/jf803537k
   Morell MK, 2005, CURR OPIN PLANT BIOL, V8, P204, DOI 10.1016/j.pbi.2005.01.009
   Nakamatsu J, 2006, BIOMACROMOLECULES, V7, P3345, DOI 10.1021/bm0605311
   Ortiz C, 1999, J BIOMED MATER RES, V45, P184, DOI 10.1002/(SICI)1097-4636(19990605)45:3<184::AID-JBM4>3.0.CO;2-8
   Pan YM, 2007, FOOD CHEM, V103, P913, DOI 10.1016/j.foodchem.2006.09.044
   Prieto P, 1999, ANAL BIOCHEM, V269, P337, DOI 10.1006/abio.1999.4019
   Puoci F, 2008, J AGR FOOD CHEM, V56, P10646, DOI 10.1021/jf802302k
   Quici N, 2009, PHOTOCH PHOTOBIO SCI, V8, P975, DOI 10.1039/b901904a
   Ramassamy C, 2006, EUR J PHARMACOL, V545, P51, DOI 10.1016/j.ejphar.2006.06.025
   Rangkadilok N, 2007, FOOD CHEM TOXICOL, V45, P328, DOI 10.1016/j.fct.2006.08.022
   Ratnam DV, 2006, J CONTROL RELEASE, V113, P189, DOI 10.1016/j.jconrel.2006.04.015
   Robaszkiewicz A, 2010, TALANTA, V80, P2196, DOI 10.1016/j.talanta.2009.11.004
   Rudi H, 2006, ANIM FEED SCI TECH, V130, P55, DOI 10.1016/j.anifeedsci.2006.01.017
   Santander-Ortega MJ, 2010, J CONTROL RELEASE, V141, P85, DOI 10.1016/j.jconrel.2009.08.012
   Schinella G, 2009, FOOD RES INT, V42, P1403, DOI 10.1016/j.foodres.2009.07.004
   Singh B, 2010, TOXICOL APPL PHARM, V247, P83, DOI 10.1016/j.taap.2010.06.011
   Spizzirri UG, 2010, CARBOHYD POLYM, V79, P333, DOI 10.1016/j.carbpol.2009.08.010
   Tseng TW, 1997, POLYM DEGRAD STABIL, V58, P241, DOI 10.1016/S0141-3910(97)00041-4
   Wang HF, 2000, FOOD CHEM, V68, P115, DOI 10.1016/S0308-8146(99)00179-X
   Waterman KC, 2002, PHARM DEV TECHNOL, V7, P1, DOI 10.1081/PDT-120002237
   Zhang YY, 2008, J APPL POLYM SCI, V107, P891, DOI 10.1002/app.26402
   Zhao Y, 2007, EUR POLYM J, V43, P4541, DOI 10.1016/j.eurpolymj.2007.07.029
NR 46
TC 18
Z9 18
U1 3
U2 26
PU INFORMA HEALTHCARE
PI LONDON
PA TELEPHONE HOUSE, 69-77 PAUL STREET, LONDON EC2A 4LQ, ENGLAND
SN 1083-7450
J9 PHARM DEV TECHNOL
JI Pharm. Dev. Technol.
PD JUL-AUG
PY 2012
VL 17
IS 4
BP 466
EP 476
DI 10.3109/10837450.2010.546413
PG 11
WC Pharmacology & Pharmacy
SC Pharmacology & Pharmacy
GA 958NX
UT WOS:000305247300009
PM 21226550
DA 2018-10-19
ER

PT J
AU Kuraitis, D
   Ebadi, D
   Zhang, P
   Rizzuto, E
   Vulesevic, B
   Padavan, DT
   Al Madhoun, A
   McEwan, KA
   Sofrenovic, T
   Nicholson, K
   Whitman, SC
   Mesana, TG
   Skerjanc, IS
   Musaro, A
   Ruel, M
   Suuronen, EJ
AF Kuraitis, D.
   Ebadi, D.
   Zhang, P.
   Rizzuto, E.
   Vulesevic, B.
   Padavan, D. T.
   Al Madhoun, A.
   McEwan, K. A.
   Sofrenovic, T.
   Nicholson, K.
   Whitman, S. C.
   Mesana, T. G.
   Skerjanc, I. S.
   Musaro, A.
   Ruel, M.
   Suuronen, E. J.
TI INJECTED MATRIX STIMULATES MYOGENESIS AND REGENERATION OF MOUSE SKELETAL
   MUSCLE AFTER ISCHAEMIC INJURY
SO EUROPEAN CELLS & MATERIALS
LA English
DT Article
DE Hydrogel; injectable; muscle; neovascularisation; regenerative medicine;
   tissue-material interactions
AB Biomaterial-guided regeneration represents a novel approach for the treatment of myopathies. Revascularisation and the intramuscular extracellular matrix are important factors in stimulating myogenesis and regenerating muscle damaged by ischaemia. In this study, we used an injectable collagen matrix, enhanced with sialyl Lewis(X) (sLe(X)), to guide skeletal muscle differentiation and regeneration. The elastic properties of collagen and sLe(X)-collagen matrices were similar to those of skeletal muscle, and culture of pluripotent mESCs on the matrices promoted their differentiation into myocyte-like cells expressing Pax3, MHC3, myogenin and Myf5. The regenerative properties of matrices were evaluated in ischaemic mouse hind-limbs. Treatment with the sLe(X)-matrix augmented the production of myogenic-mediated factors insulin-like growth factor (IGF)-1, and IGF binding protein-2 and -5 after 3 days. This was followed by muscle regeneration, including a greater number of regenerating myofibres and increased transcription of Six1, M-cadherin, myogenin and Myf5 after 10 days. Simultaneously, the sLe(X)-matrix promoted increased mobilisation and engraftment of bone marrow-derived progenitor cells, the development of larger arterioles and the restoration of tissue perfusion. Both matrix treatments tended to reduce maximal forces of ischaemic solei muscles, but sLe(X)-matrix lessened this loss of force and also prevented muscle fatigue. Only sLe(X)-matrix treatment improved mobility of mice on a treadmill. Together, these results suggest a novel approach for regenerative myogenesis, whereby treatment only with a matrix, which possesses an inherent ability to guide myogenic differentiation of pluripotent stem cells, can enhance the endogenous vascular and myogenic regeneration of skeletal muscle, thus holding promise for future clinical use.
C1 [Kuraitis, D.; Zhang, P.; Vulesevic, B.; Padavan, D. T.; McEwan, K. A.; Sofrenovic, T.; Nicholson, K.; Mesana, T. G.; Ruel, M.; Suuronen, E. J.] Univ Ottawa, Inst Heart, Div Cardiac Surg, Ottawa, ON K1Y 4W7, Canada.
   [Kuraitis, D.; Vulesevic, B.; Sofrenovic, T.; Ruel, M.; Suuronen, E. J.] Univ Ottawa, Dept Cellular & Mol Med, Ottawa, ON K1H 8M5, Canada.
   [Rizzuto, E.; Musaro, A.] Univ Roma La Sapienza, IIM, DAHFMO Unit Histol & Med Embryol, Inst Pasteur Cenci Bolognetti, I-00181 Rome, Italy.
   [Ebadi, D.; Al Madhoun, A.; Skerjanc, I. S.] Univ Ottawa, Dept Biochem Microbiol & Immunol, Ottawa, ON K1H 8M5, Canada.
   [McEwan, K. A.] Univ Ottawa, Fac Engn, Ottawa, ON K1N 6N5, Canada.
   [Whitman, S. C.] Univ Ottawa, Inst Heart, Vasc Biol Lab, Ottawa, ON K1Y 4W7, Canada.
RP Suuronen, EJ (reprint author), Univ Ottawa, Inst Heart, Div Cardiac Surg, 40 Ruskin St, Ottawa, ON K1Y 4W7, Canada.
EM esuuronen@ottawaheart.ca
RI Rizzuto, Emanuele/K-9437-2016; Musaro, Antonio/K-9598-2016
OI Rizzuto, Emanuele/0000-0003-2314-6128; Musaro,
   Antonio/0000-0002-2944-9739; RUEL, MARC/0000-0002-0487-1319
FU Heart & Stroke Foundation of Ontario [T-6793]; 7FP-Myoage; Fondazione
   Roma; AFM; Canadian Institutes of Health Research [84458]; National
   Sciences and Engineering Research Council; Lawrence Soloway Research
   Fellowship award; University of Ottawa; Ontario Graduate Scholarship;
   Heart and Stroke Foundation of Ontario
FX The authors would like to thank Carmine Nicoletti, Elaine Wong and
   Suzanne Crowe for their technical assistance, and Dr. Wankei Wan for the
   use of his mechanical testing facilities at the Fordham Centre for
   Biomedical Engineering, University of Western Ontario, Canada. This work
   was supported by grant-in-aid #T-6793 from the Heart & Stroke Foundation
   of Ontario (to EJS), by grants from the 7FP-Myoage, Fondazione Roma, and
   AFM (to AM) and by operating grant #84458 from the Canadian Institutes
   of Health Research (to ISS). DK was supported by a Canadian Institutes
   of Health Research Canadian Graduate Scholarship, DE was supported by a
   National Sciences and Engineering Research Council Alexander Graham Bell
   Award, PZ was supported by the Lawrence Soloway Research Fellowship
   award, DTP was supported by a University of Ottawa Cardiology Research
   Endowment Fellowship, KM was supported by an Ontario Graduate
   Scholarship, and DK and TS were supported by Heart and Stroke Foundation
   of Ontario Master's Awards.
CR Abdel-Latif A, 2007, ARCH INTERN MED, V167, P989, DOI 10.1001/archinte.167.10.989
   Bayol S, 2000, BIOCHEM BIOPH RES CO, V273, P282, DOI 10.1006/bbrc.2000.2667
   Bernal A, 2011, CELL DEATH DIFFER, V19, P345, DOI DOI 10.1038/CDD.2011.110
   Biancone L, 2004, J IMMUNOL, V173, P5268, DOI 10.4049/jimmunol.173.8.5268
   Birch HL, 2007, INT J EXP PATHOL, V88, P241, DOI 10.1111/j.1365-2613.2007.00552.x
   Boodhwani M, 2008, EUR J CARDIO-THORAC, V33, P645, DOI 10.1016/j.ejcts.2007.12.016
   Borselli C, 2010, P NATL ACAD SCI USA, V107, P3287, DOI 10.1073/pnas.0903875106
   Carosio S, 2011, AGEING RES REV, V10, P35, DOI 10.1016/j.arr.2009.08.001
   Chen FM, 2010, BIOMATERIALS, V31, P6279, DOI 10.1016/j.biomaterials.2010.04.053
   Corti S, 2010, BRAIN, V133, P465, DOI 10.1093/brain/awp318
   Deasy BM, 2009, MOL THER, V17, P1788, DOI 10.1038/mt.2009.136
   Del Prete Z, 2008, ANN BIOMED ENG, V36, P1281, DOI 10.1007/s10439-008-9496-x
   Deng C, 2010, TISSUE ENG PT A, V16, P3099, DOI 10.1089/ten.tea.2009.0504
   Derkaoui SM, 2010, ACTA BIOMATER, V6, P3506, DOI 10.1016/j.actbio.2010.03.043
   Di Santo S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005643
   DONALIES M, 1991, P NATL ACAD SCI USA, V88, P8024, DOI 10.1073/pnas.88.18.8024
   Duan CM, 2010, GEN COMP ENDOCR, V167, P344, DOI 10.1016/j.ygcen.2010.04.009
   Elliott JT, 2007, BIOMATERIALS, V28, P576, DOI 10.1016/j.biomaterials.2006.09.023
   Engler AJ, 2006, CELL, V126, P677, DOI 10.1016/j.cell.2006.06.044
   Engler AJ, 2004, J CELL BIOL, V166, P877, DOI 10.1083/jcb.200405004
   Esposito A, 2007, J APPL PHYSIOL, V102, P1640, DOI 10.1152/japplphysiol.01397.2006
   Ewton DZ, 1998, J CELL PHYSIOL, V177, P47, DOI 10.1002/(SICI)1097-4652(199810)177:1<47::AID-JCP5>3.0.CO;2-E
   Ferreira JCB, 2008, AM J PHYSIOL-REG I, V294, pR26, DOI 10.1152/ajpregu.00424.2007
   Frangogiannis NG, 2000, J IMMUNOL, V165, P2798, DOI 10.4049/jimmunol.165.5.2798
   Gayraud-Morel B, 2007, DEV BIOL, V312, P13, DOI 10.1016/j.ydbio.2007.08.059
   Grounds Miranda D., 2008, V3, P269
   Guan K, 1999, CYTOTECHNOLOGY, V30, P211, DOI 10.1023/A:1008041420166
   Hayward R, 1997, EUR J PHARMACOL, V334, P157, DOI 10.1016/S0014-2999(97)01149-7
   Kennedy KAM, 2009, BMC BIOL, V7, DOI 10.1186/1741-7007-7-67
   Kimura Y, 2010, J BIOMAT SCI-POLYM E, V21, P37, DOI 10.1163/156856209X410193
   Kjaer M, 2004, PHYSIOL REV, V84, P649, DOI 10.1152/physrev.00031.2003
   Klein D, 2010, HISTOL HISTOPATHOL, V25, P681, DOI 10.14670/HH-25.681
   Ko HCH, 2007, EUR CELLS MATER, V14, P1
   Koffler J, 2011, P NATL ACAD SCI USA, V108, P14789, DOI 10.1073/pnas.1017825108
   Koike T, 2003, J GERONTOL A-BIOL, V58, P798
   Kovanen V, 2002, EXERC SPORT SCI REV, V30, P20, DOI 10.1097/00003677-200201000-00005
   Kroehne V, 2008, J CELL MOL MED, V12, P1640, DOI 10.1111/j.1582-4934.2008.00238.x
   Kuang SH, 2007, CELL, V129, P999, DOI 10.1016/j.cell.2007.03.044
   Kuraitis D, 2011, EUR CELLS MATER, V22, P109, DOI 10.22203/eCM.v022a09
   Kuraitis D, 2012, BIOMATERIALS, V33, P428, DOI 10.1016/j.biomaterials.2011.09.078
   Kuraitis D, 2011, J MOL CELL CARDIOL, V51, P187, DOI 10.1016/j.yjmcc.2011.04.011
   Li Z, 2011, CYTOTHERAPY, V13, P69, DOI 10.3109/14653249.2010.510502
   Limbourg A, 2009, NAT PROTOC, V4, P1737, DOI 10.1038/nprot.2009.185
   Liu YB, 2010, NUCLEIC ACIDS RES, V38, P6857, DOI 10.1093/nar/gkq585
   Martin TA, 2005, HISTOPATHOLOGY, V46, P422, DOI 10.1111/j.1365-2559.2005.02104.x
   MCGEACHIE JK, 1987, CELL TISSUE RES, V248, P125, DOI 10.1007/BF01239972
   Millon LE, 2009, J BIOMED MATER RES B, V90B, P922, DOI 10.1002/jbm.b.31364
   Montarras D, 2005, SCIENCE, V309, P2064, DOI 10.1126/science.1114758
   Musaro A, 1999, MOL CELL BIOL, V19, P3115
   NABESHIMA Y, 1993, NATURE, V364, P532, DOI 10.1038/364532a0
   Ning Y, 2006, MOL ENDOCRINOL, V20, P2173, DOI 10.1210/me.2005-0196
   Parise G, 2006, APPL PHYSIOL NUTR ME, V31, P773, DOI 10.1139/H06-055
   Pelosi L, 2007, FASEB J, V21, P1393, DOI 10.1096/fj.06-7690comd
   Ridgeway AG, 2001, J BIOL CHEM, V276, P19033, DOI 10.1074/jbc.M011491200
   Rossi CA, 2010, ORGANOGENESIS, V6, P167, DOI 10.4161/org.6.3.12419
   Roy S, 2006, PHYSIOL GENOMICS, V25, P364, DOI 10.1152/physiolgenomics.00013.2006
   RUDNICKI MA, 1993, CELL, V75, P1351, DOI 10.1016/0092-8674(93)90621-V
   Ruvinov E, 2011, BIOMATERIALS, V32, P565, DOI 10.1016/j.biomaterials.2010.08.097
   Sabourin LA, 2000, CLIN GENET, V57, P16, DOI 10.1034/j.1399-0004.2000.570103.x
   Saif J, 2010, ARTERIOSCL THROM VAS, V30, P1897, DOI 10.1161/ATVBAHA.110.207928
   San Antonio JD, 2006, ENCY MICROVASCULATUR, P127
   Savage J, 2009, STEM CELLS, V27, P1231, DOI 10.1002/stem.57
   Seale P, 2004, PLOS BIOL, V2, P664, DOI 10.1371/journal.pbio.0020130
   Seeger FH, 2009, ARTERIOSCL THROM VAS, V29, P1802, DOI 10.1161/ATVBAHA.109.194688
   Shi M, 2009, STEM CELLS, V27, P949, DOI 10.1002/stem.4
   Sun DX, 2009, FASEB J, V23, P382, DOI 10.1096/fj.07-095901
   Suuronen EJ, 2008, SEMIN THORAC CARDIOV, V20, P110, DOI 10.1053/j.semtcvs.2008.03.005
   Suuronen EJ, 2009, FASEB J, V23, P1447, DOI 10.1096/fj.08-111054
   Vignaud A, 2010, J BIOMED BIOTECHNOL, DOI 10.1155/2010/724914
   Villalta SA, 2011, HUM MOL GENET, V20, P790, DOI 10.1093/hmg/ddq523
   Wang JS, 2011, CHINESE MED J-PEKING, V124, P1075, DOI 10.3760/cma.j.issn.0366-6999.2011.07.023
   Whitman SC, 2004, ARTERIOSCL THROM VAS, V24, P1049, DOI 10.1161/01.ATV.0000124923.95545.2c
NR 72
TC 17
Z9 18
U1 0
U2 5
PU AO RESEARCH INSTITUTE DAVOS-ARI
PI DAVOS
PA CLAVADELERSTRASSE 8, DAVOS, CH 7270, SWITZERLAND
SN 1473-2262
J9 EUR CELLS MATER
JI Eur. Cells Mater.
PD JUL-DEC
PY 2012
VL 24
BP 175
EP 196
DI 10.22203/eCM.v024a13
PG 22
WC Cell & Tissue Engineering; Engineering, Biomedical; Materials Science,
   Biomaterials; Orthopedics
SC Cell Biology; Engineering; Materials Science; Orthopedics
GA V30XB
UT WOS:000208847600001
PM 22972509
OA DOAJ Gold
DA 2018-10-19
ER

PT J
AU Bryan, N
   Ahswin, H
   Smart, N
   Bayon, Y
   Wohlert, S
   Hunt, JA
AF Bryan, Nicholas
   Ahswin, Helen
   Smart, Neil
   Bayon, Yves
   Wohlert, Stephen
   Hunt, John A.
TI REACTIVE OXYGEN SPECIES (ROS) - A FAMILY OF FATE DECIDING MOLECULES
   PIVOTAL IN CONSTRUCTIVE INFLAMMATION AND WOUND HEALING
SO EUROPEAN CELLS & MATERIALS
LA English
DT Article
DE Reactive oxygen species; inflammation; wound healing; leukocytes;
   pattern recognition receptors; cell signalling; biomaterials
AB Wound healing requires a fine balance between the positive and deleterious effects of reactive oxygen species (ROS); a group of extremely potent molecules, rate limiting in successful tissue regeneration. A balanced ROS response will debride and disinfect a tissue and stimulate healthy tissue turnover; suppressed ROS will result in infection and an elevation in ROS will destroy otherwise healthy stromal tissue. Understanding and anticipating the ROS niche within a tissue will greatly enhance the potential to exogenously augment and manipulate healing.
   Tissue engineering solutions to augment successful healing and remodelling of wounded or diseased tissue rely on a controlled balance between the constructive and destructive capacity of the leukocyte secretome, including ROS.
   This review comprehensively considers leukocyte derived ROS in tissue repair with particular interest in surgical intervention with inclusion of a biomaterial. The article considers ROS fundamental chemistry, formation, stimulation and clearance before applying this to discuss the implications of ROS in healing tissue with and without a biomaterial. We also systematically discuss ROS in leukocyte signalling and compare and contrast experimental means of measuring ROS.
C1 [Bryan, Nicholas; Hunt, John A.] Univ Liverpool, Inst Ageing & Chron Dis, UKBioTEC, UKCTE, Liverpool L69 3GA, Merseyside, England.
   [Ahswin, Helen; Bayon, Yves; Wohlert, Stephen] Covidien Sofradim Prod, F-01600 Trevoux, France.
   [Smart, Neil] Royal Devon & Exeter Hosp, Exeter EX2 5DW, Devon, England.
RP Bryan, N (reprint author), Univ Liverpool, Sch Clin Sci, UK Ctr Tissue Engn Ground Floor, Duncan Bldg,Daulby St, Liverpool L69 3GA, Merseyside, England.
EM n.bryan@liv.ac.uk
RI Smart, Neil/F-8837-2014; Hunt, John/G-6366-2012
OI Smart, Neil/0000-0002-3043-8324; Hunt, John/0000-0002-5168-4778
CR Abram CL, 2009, ANNU REV IMMUNOL, V27, P339, DOI 10.1146/annurev.immunol.021908.132554
   Afonso V, 2007, JOINT BONE SPINE, V74, P324, DOI 10.1016/j.jbspin.2007.02.002
   Aliyev E, 2004, BIOMATERIALS, V25, P4633, DOI 10.1016/j.biomaterials.2003.12.004
   Alleva R, 2005, BIOCHEM BIOPH RES CO, V333, P404, DOI 10.1016/j.bbrc.2005.05.119
   Anderson JM, 2008, SEMIN IMMUNOL, V20, P86, DOI 10.1016/j.smim.2007.11.004
   Arana L, 2012, EXP CELL RES, V318, P350, DOI 10.1016/j.yexcr.2011.11.013
   Babensee JE, 1998, ADV DRUG DELIVER REV, V33, P111, DOI 10.1016/S0169-409X(98)00023-4
   Basoni C, 2006, BIOCHEM BIOPH RES CO, V343, P609, DOI 10.1016/j.bbrc.2006.03.003
   Bokoch GM, 2006, ANTIOXID REDOX SIGN, V8, P1533, DOI 10.1089/ars.2006.8.1533
   Bose M, 1995, IMMUNOL LETT, V48, P59, DOI 10.1016/0165-2478(95)02444-1
   Brechard S, 2005, CELL CALCIUM, V37, P531, DOI 10.1016/j.ceca.2005.01.019
   Brown DI, 2009, FREE RADICAL BIO MED, V47, P1239, DOI 10.1016/j.freeradbiomed.2009.07.023
   Bryan N, 2012, CLIN BIOCHEM, V45, P672, DOI 10.1016/j.clinbiochem.2012.02.026
   Bryan N, 2012, BIOMATERIALS, V33, P6380, DOI 10.1016/j.biomaterials.2012.05.058
   Buonocore G, 2010, SEMIN FETAL NEONAT M, V15, P186, DOI 10.1016/j.siny.2010.04.003
   Carriere A, 2009, ARTERIOSCL THROM VAS, V29, P1093, DOI 10.1161/ATVBAHA.109.188318
   Chang HH, 2005, BIOMATERIALS, V26, P745, DOI 10.1016/j.biomaterials.2004.03.021
   Chaves MM, 2009, MECH AGEING DEV, V130, P588, DOI 10.1016/j.mad.2009.07.001
   Cheung CY, 2008, ADV FUNCT MATER, V18, P3119, DOI 10.1002/adfm.200800566
   Clark RA, 2004, MECH AGEING DEV, V125, P799, DOI 10.1016/j.mad.2004.08.009
   Cooper AM, 2000, INFECT IMMUN, V68, P1231, DOI 10.1128/IAI.68.3.1231-1234.2000
   Dahlgren C, 1999, J IMMUNOL METHODS, V232, P3, DOI 10.1016/S0022-1759(99)00146-5
   Daly KA, 2012, BIOMATERIALS, V33, P91, DOI 10.1016/j.biomaterials.2011.09.040
   de Haan JB, 2004, FREE RADICAL BIO MED, V36, P53, DOI 10.1016/j.freeradbiomed.2003.10.020
   De Oliveira Marques V, 2007, J IMMUNOL, V178, P3893
   Defranco DL, 2007, IMMUNITY IMMUNE RESP, P74
   Demirci M, 2008, DENT MATER, V24, P632
   DEVEREUX DF, 1991, AM J SURG, V162, P243, DOI 10.1016/0002-9610(91)90078-R
   Dewas C, 2003, J IMMUNOL, V171, P4392, DOI 10.4049/jimmunol.171.8.4392
   Di Virgilio F, 2001, BLOOD, V97, P587, DOI 10.1182/blood.V97.3.587
   Diebold BA, 2001, NAT IMMUNOL, V2, P211, DOI 10.1038/85259
   EHRENGRUBER MU, 1994, FEBS LETT, V346, P181, DOI 10.1016/0014-5793(94)00463-3
   Eming SA, 2009, SEMIN CELL DEV BIOL, V20, P517, DOI 10.1016/j.semcdb.2009.04.009
   Fan J, 2011, BIOMATERIALS, V32, P1611, DOI 10.1016/j.biomaterials.2010.11.004
   Fattman CL, 2003, FREE RADICAL BIO MED, V35, P236, DOI 10.1016/S0891-5849(03)00275-2
   FAULKNER K, 1993, FREE RADICAL BIO MED, V15, P447, DOI 10.1016/0891-5849(93)90044-U
   Ferguson LR, 2005, MUTAT RES-FUND MOL M, V591, P3, DOI 10.1016/j.mrfmmm.2005.05.017
   Fialkow L, 2007, FREE RADICAL BIO MED, V42, P153, DOI 10.1016/j.freeadbiomed.2006.09.030
   Foo NP, 2011, TOXICOLOGY, V282, P39, DOI 10.1016/j.tox.2011.01.009
   Franz S, 2011, BIOMATERIALS, V32, P6692, DOI 10.1016/j.biomaterials.2011.05.078
   Glebska J, 2005, FREE RADICAL BIO MED, V38, P1014, DOI 10.1016/j.freeadbiomed.2004.12.028
   Gomes A, 2005, J BIOCHEM BIOPH METH, V65, P45, DOI 10.1016/j.jbbm.2005.10.003
   Gordillo GM, 2003, AM J SURG, V186, P259, DOI 10.1016/S0002-9610(03)00211-3
   Gozal E, 2001, FREE RADICAL BIO MED, V31, P679, DOI 10.1016/S0891-5849(01)00630-X
   Groemping Y, 2003, CELL, V113, P343, DOI 10.1016/S0092-8674(03)00314-3
   Gupta S, 2011, ADV PARASIT, V76, P153, DOI 10.1016/B978-0-12-385895-5.00007-4
   GUTTERIDGE JMC, 1981, BIOCHEM J, V199, P259, DOI 10.1042/bj1990259
   HADJUR C, 1995, J PHOTOCH PHOTOBIO B, V29, P147, DOI 10.1016/1011-1344(95)07123-J
   Henderson LM, 1996, BBA-BIOENERGETICS, V1273, P87, DOI 10.1016/0005-2728(95)00140-9
   Herre J, 2004, MOL IMMUNOL, V40, P869, DOI 10.1016/j.molimm.2003.10.007
   Higurashi S, 2012, BIOCHEM BIOPH RES CO, V417, P794, DOI 10.1016/j.bbrc.2011.12.038
   Hubbard AK., 2000, FREE RADIC BIOL MED, V28
   Huo YA, 2009, EXP EYE RES, V89, P876, DOI 10.1016/j.exer.2009.07.012
   INDIK ZK, 1995, BLOOD, V86, P4389
   Jamali AE, 2010, FREE RADIC BIOL MED, V48, P798
   Jang YY, 2007, BLOOD, V110, P3056, DOI 10.1182/blood-2007-05-087759
   Jann NJ, 2011, IMMUNOL LETT, V135, P17, DOI 10.1016/j.imlet.2010.09.007
   Janssen-Heininger Y, 2005, AM J PATHOL, V166, P649, DOI 10.1016/S0002-9440(10)62286-9
   Jeannin P, 2008, CURR OPIN IMMUNOL, V20, P530, DOI 10.1016/j.coi.2008.04.013
   Johnson Felicity, 2005, Molecular Aspects of Medicine, V26, P340, DOI 10.1016/j.mam.2005.07.006
   Jose GS, 2009, FREE RADICAL BIO MED, V46, P1058, DOI 10.1016/j.freeradbiomed.2009.01.009
   Kader KN, 2007, J BIOMED MATER RES B, V83B, P138, DOI 10.1002/jbm.b.30777
   Kalyanaraman B, 2012, FREE RADICAL BIO MED, V52, P1, DOI 10.1016/j.freeradbiomed.2011.09.030
   Kanda Y, 2011, LIFE SCI, V89, P250, DOI 10.1016/j.lfs.2011.06.007
   Kasahara E, 2011, FEBS LETT, V585, P2263, DOI 10.1016/j.febslet.2011.05.049
   Kawai T, 2007, SEMIN IMMUNOL, V19, P24, DOI 10.1016/j.smim.2006.12.004
   Khan N, 2006, BLOOD, V107, P1513, DOI 10.1182/blood-2005-04-1707
   Khodr B, 2001, FREE RADICAL BIO MED, V30, P1, DOI 10.1016/S0891-5849(00)00378-6
   Kim JH, 2011, STEM CELLS DEV, V20, P1753, DOI 10.1089/scd.2010.0469
   Kim JS, 2011, EXP GERONTOL, V46, P500, DOI 10.1016/j.exger.2011.02.012
   KLEGERIS A, 1994, EUR J PHARMACOL, V260, P273, DOI 10.1016/0014-2999(94)90351-4
   Klink M, 2009, IMMUNOBIOLOGY, V214, P692, DOI 10.1016/j.imbio.2008.12.001
   Klyubin IV, 1996, EUR J CELL BIOL, V70, P347
   Knapp LT, 2000, J BIOL CHEM, V275, P24136, DOI 10.1074/jbc.M002043200
   Knight J, 1996, BR J RHEUMATOL S2, V35
   Knight J, 1997, IMMUNOL NEWS, V4, P26
   Kondo Y, 2008, BIOCHEM BIOPH RES CO, V377, P291, DOI 10.1016/j.bbrc.2008.09.132
   Kono K, 1996, EUR J IMMUNOL, V26, P1308, DOI 10.1002/eji.1830260620
   Kraaij MD, 2010, P NATL ACAD SCI USA, V107, P17686, DOI 10.1073/pnas.1012016107
   Kumagai Y, 2010, J ALLERGY CLIN IMMUN, V125, P985, DOI 10.1016/j.jaci.2010.01.058
   Kumar V, 2010, INT IMMUNOPHARMACOL, V10, P1325, DOI 10.1016/j.intimp.2010.08.012
   Lam GY, 2010, SEMIN IMMUNOPATHOL, V32, P415, DOI 10.1007/s00281-010-0221-0
   Lambeth JD, 2007, FREE RADICAL BIO MED, V43, P332, DOI 10.1016/j.freeradbiomed.2007.03.027
   Lambeth JD, 2007, FREE RADICAL BIO MED, V43, P319, DOI 10.1016/j.freeradbiomed.2007.03.028
   Leslie RGQ, 2001, ENCY LIFE SCI, P1, DOI 10.1038/npg.els,0000512
   Lim Y, 2006, J NUTR BIOCHEM, V17, P328, DOI 10.1016/j.jnutbio.2005.08.004
   Limon-Pacheco J, 2009, MUTAT RES-GEN TOX EN, V674, P137, DOI 10.1016/j.mrgentox.2008.09.015
   Liu WE, 2011, BIOMATERIALS, V32, P1796, DOI 10.1016/j.biomaterials.2010.11.029
   Loo AEK, 2011, FREE RADICAL BIO MED, V51, P884, DOI 10.1016/j.freeradbiomed.2011.06.001
   Maher J, 2010, TOXICOL APPL PHARM, V244, P4, DOI 10.1016/j.taap.2010.01.011
   Markovic Z, 2008, BIOMATERIALS, V29, P3561, DOI 10.1016/j.biomaterials.2008.05.005
   Matsue H, 2003, J IMMUNOL, V171, P3010, DOI 10.4049/jimmunol.171.6.3010
   McGreal EP, 2005, CURR OPIN IMMUNOL, V17, P18, DOI 10.1016/j.coi.2004.12.001
   Millar TM, 2007, FREE RADICAL BIO MED, V42, P1165, DOI 10.1016/j.freeradbiomed.2007.01.015
   Mizuki K, 2005, ARCH BIOCHEM BIOPHYS, V444, P185, DOI 10.1016/j.abb.2005.10.012
   Moseley R, 2003, BIOMATERIALS, V24, P1549, DOI 10.1016/S0142-9612(02)00540-9
   Mouche S, 2007, BBA-MOL CELL RES, V1773, P1015, DOI 10.1016/j.bbamcr.2007.03.003
   MULLER T, 1989, J BIOLUM CHEMILUM, V3, P105, DOI 10.1002/bio.1170030304
   Myhre O, 2003, BIOCHEM PHARMACOL, V65, P1575, DOI 10.1016/S0006-2952(03)00083-2
   Naik E, 2011, J EXP MED, V31, P519
   Nakamura H, 2001, P NATL ACAD SCI USA, V98, P15143, DOI 10.1073/pnas.191498798
   Nathan C, 2006, NAT REV IMMUNOL, V6, P173, DOI 10.1038/nri1785
   Nathan C, 2000, P NATL ACAD SCI USA, V97, P8841, DOI 10.1073/pnas.97.16.8841
   Nimmerjahn F, 2008, NAT REV IMMUNOL, V8, P34, DOI 10.1038/nri2206
   Nishikawa M, 2009, ADV DRUG DELIVER REV, V61, P319, DOI 10.1016/j.addr.2009.01.001
   Nogueira-Machado JA, 2003, DIABETES METAB, V29, P533, DOI 10.1016/S1262-3636(07)70068-X
   Nygren H, 2001, COLLOID SURFACE B, V22, P87, DOI 10.1016/S0927-7765(00)00216-2
   Ohashi T, 2002, FEBS LETT, V511, P21, DOI 10.1016/S0014-5793(01)03262-8
   Okutomi T, 1997, FEMS IMMUNOL MED MIC, V18, P105, DOI 10.1016/S0928-8244(97)00027-8
   Osorio F, 2011, IMMUNITY, V34, P651, DOI 10.1016/j.immuni.2011.05.001
   Park JE, 2004, AM J SURG, V187, p11S, DOI 10.1016/S0002-9610(03)00296-4
   Pham CTN, 2008, INT J BIOCHEM CELL B, V40, P1317, DOI 10.1016/j.biocel.2007.11.008
   Philpott DJ, 2010, CURR OPIN IMMUNOL, V22, P428, DOI 10.1016/j.coi.2010.04.010
   Poli Giuseppe, 2000, Molecular Aspects of Medicine, V21, P49, DOI 10.1016/S0098-2997(00)00004-2
   Pricop L, 1999, J IMMUNOL, V162, P7041
   RATHAKRISHNAN C, 1993, FREE RADICAL BIO MED, V15, P143, DOI 10.1016/0891-5849(93)90053-W
   Reichl S, 2001, FREE RADICAL RES, V35, P723, DOI 10.1080/10715760100301231
   Reichl S, 2000, FREE RADICAL BIO MED, V28, P1555, DOI 10.1016/S0891-5849(00)00268-9
   Rinaldi M, 2007, VET IMMUNOL IMMUNOP, V115, P107, DOI 10.1016/j.vetimm.2006.09.009
   Rutault K, 1999, FREE RADICAL BIO MED, V26, P232, DOI 10.1016/S0891-5849(98)00194-4
   SAMUNI A, 1991, FREE RADICAL BIO MED, V10, P305, DOI 10.1016/0891-5849(91)90037-4
   SANDERS SP, 1994, FREE RADICAL BIO MED, V16, P753, DOI 10.1016/0891-5849(94)90190-2
   Santos TC, 2007, J BIOTECHNOL, V132, P218, DOI 10.1016/j.jbiotec.2007.07.497
   SAVILL J, 1993, IMMUNOL TODAY, V14, P131, DOI 10.1016/0167-5699(93)90215-7
   Schafer M, 2008, PHARMACOL RES, V58, P165, DOI 10.1016/j.phrs.2008.06.004
   Schilder AM, 2010, AUTOIMMUN REV, V9, P483, DOI 10.1016/j.autrev.2010.02.006
   Schmielau J, 2001, CANCER RES, V61, P4756
   Schonfelder U, 2005, BIOMATERIALS, V26, P6664, DOI 10.1016/j.biomaterials.2005.04.030
   Sen CK, 2008, BBA-GEN SUBJECTS, V1780, P1348, DOI 10.1016/j.bbagen.2008.01.006
   Shen WL, 2006, BIOCHEM BIOPH RES CO, V339, P337, DOI 10.1016/j.bbrc.2005.10.207
   Shields AM, 2011, CLIN EXP IMMUNOL, V165, P292, DOI 10.1111/j.1365-2249.2011.04433.x
   Song WH, 2010, TOXICOL LETT, V199, P389, DOI 10.1016/j.toxlet.2010.10.003
   Steiling H, 1999, EXP CELL RES, V247, P484, DOI 10.1006/excr.1998.4366
   Storz P, 2005, FRONT BIOSCI-LANDMRK, V10, P1881, DOI 10.2741/1667
   SUTHERLAND K, 1993, J CLIN INVEST, V92, P2360, DOI 10.1172/JCI116841
   Swarnakar NK, 2011, BIOMATERIALS, V32, P6860, DOI 10.1016/j.biomaterials.2011.05.079
   Szpaderska AM, 2005, SURGERY, V137, P571, DOI 10.1016/j.surg.2005.01.006
   Tarr JM, 2012, CELL SIGNAL, V24, P873, DOI 10.1016/j.cellsig.2011.12.003
   Taylor EL, 2003, CELL DEATH DIFFER, V10, P418, DOI 10.1038/sj.cdd.4401152
   Taylor GC, 1996, BIOMATERIALS, V17, P1313, DOI 10.1016/0142-9612(96)88677-7
   Tlili A, 2011, FREE RADICAL BIO MED, V50, P438, DOI 10.1016/j.freeradbiomed.2010.11.024
   Toppo S, 2009, BBA-GEN SUBJECTS, V1790, P1486, DOI 10.1016/j.bbagen.2009.04.007
   Tsirogianni AK, 2006, INJURY, V37, pS5, DOI 10.1016/j.injury.2006.02.035
   Valle-Prieto A, 2010, STEM CELLS DEV, V19, P1885, DOI 10.1089/scd.2010.0093
   van der Vliet A, 2008, FREE RADICAL BIO MED, V44, P938, DOI 10.1016/j.freeradbiomed.2007.11.016
   Vautier S, 2012, CYTOKINE, V58, P89, DOI 10.1016/j.cyto.2011.08.031
   VILIM V, 1989, FREE RADICAL BIO MED, V6, P623, DOI 10.1016/0891-5849(89)90070-1
   Ward C, 2000, BIOCHEM PHARMACOL, V59, P305, DOI 10.1016/S0006-2952(99)00329-9
   Ward RA, 2000, J BIOL CHEM, V275, P36713, DOI 10.1074/jbc.M003017200
   Wilgus TA, 2008, PHARMACOL RES, V58, P112, DOI 10.1016/j.phrs.2008.07.009
   Witko-Sarsat V, 2000, LAB INVEST, V80, P617, DOI 10.1038/labinvest.3780067
   Wood ZA, 2003, TRENDS BIOCHEM SCI, V28, P32, DOI 10.1016/S0968-0004(02)00003-8
   Wu Y, 2006, TRENDS CELL BIOL, V16, P189, DOI 10.1016/j.tcb.2006.02.003
   Yano K, 2003, VET IMMUNOL IMMUNOP, V93, P1, DOI 10.1016/S0165-2427(03)00046-1
   Yin JJ, 2009, BIOMATERIALS, V30, P611, DOI 10.1016/j.biomaterials.2008.09.061
   Yoo SK, 2011, NATURE, V480, P109, DOI 10.1038/nature10632
   Yoo SK, 2009, CURR BIOL, V19, pR553, DOI 10.1016/j.cub.2009.06.025
   Yoshitomi T, 2012, ACTA BIOMATER, V8, P1323, DOI 10.1016/j.actbio.2011.11.029
   Yoshitomi T, 2011, BIOMATERIALS, V32, P8021, DOI 10.1016/j.biomaterials.2011.07.014
   Zelko IN, 2002, FREE RADICAL BIO MED, V33, P337, DOI 10.1016/S0891-5849(02)00905-X
   Zhang WJ, 2009, FREE RADICAL BIO MED, V46, P791, DOI 10.1016/j.freeradbiomed.2008.12.003
NR 161
TC 81
Z9 86
U1 2
U2 17
PU AO RESEARCH INSTITUTE DAVOS-ARI
PI DAVOS
PA CLAVADELERSTRASSE 8, DAVOS, CH 7270, SWITZERLAND
SN 1473-2262
J9 EUR CELLS MATER
JI Eur. Cells Mater.
PD JUL-DEC
PY 2012
VL 24
BP 249
EP 265
DI 10.22203/eCM.v024a18
PG 17
WC Cell & Tissue Engineering; Engineering, Biomedical; Materials Science,
   Biomaterials; Orthopedics
SC Cell Biology; Engineering; Materials Science; Orthopedics
GA V30XB
UT WOS:000208847600006
PM 23007910
OA DOAJ Gold
DA 2018-10-19
ER

PT J
AU Foka, A
   Katsikogianni, MG
   Anastassiou, ED
   Spiliopoulou, I
   Missirlis, YF
AF Foka, Antigoni
   Katsikogianni, Maria G.
   Anastassiou, Evangelos D.
   Spiliopoulou, Iris
   Missirlis, Yannis F.
TI THE COMBINED EFFECT OF SURFACE CHEMISTRY AND FLOW CONDITIONS ON
   STAPHYLOCOCCUS EPIDERMIDIS ADHESION AND ica OPERON EXPRESSION
SO EUROPEAN CELLS & MATERIALS
LA English
DT Article
DE Bacterial adhesion; biomaterials; gene expression; surface chemistry;
   self-assembly; surface analysis; shear
AB The assessment of biomaterial susceptibility to infection relies mainly on the analysis of macroscopic bacterial responses to material interactions, usually under static conditions. However, new technologies permit a more profound understanding of the molecular basis of bacteria-biomaterial interactions. In this study, we combine both conventional phenotypic analysis - using confocal microscopy - and genotypic analysis - using the relative reverse transcription polymerase chain reaction (RT-PCR) - to examine the interaction of bacteria with OH- and CH3-terminated glass surfaces, under dynamic flow conditions. Bacterial adhesion, as well as slime production and biofilm formation, was much higher on the CH3-terminated than on the OH-terminated glass - for four Staphylococcus epidermidis strains. This was in agreement with the icaA and icaD gene expression results that showed increased expression for the bacteria adhering to the CH3-terminated substrate, especially under the higher shear rate. Therefore, the combined effect of the surface chemistry and shear significantly influence the adhesion and phenotype of interacting bacterial cells, while there are putative links between phenotypic responses to bacteria-material interactions and gene-expression profile alterations. This indicates that analysis of gene expression not only can greatly refine our knowledge of bacteria-material interactions, but also yield novel biomarkers for potential use in biocompatibility assessment.
C1 [Foka, Antigoni; Anastassiou, Evangelos D.; Spiliopoulou, Iris] Univ Patras, Sch Med, Dept Microbiol, Patras 26504, Greece.
   [Katsikogianni, Maria G.; Missirlis, Yannis F.] Univ Patras, Dept Mech Engn & Aeronaut, Lab Biomech & Biomed Engn, Patras 26504, Greece.
RP Missirlis, YF (reprint author), Univ Patras, Dept Mech Engn & Aeronaut, Lab Biomech & Biomed Engn, Patras 26504, Greece.
EM yfmissirlis@gmail.com
OI Katsikogianni, Maria/0000-0002-1560-3993
FU programme: INTERREG IIIA: GREECE - ITALY "Establishment of a
   Multidisciplinary Scientific Network for the development and application
   of Advanced Biomaterials"
FX This project was partially funded by the programme: INTERREG IIIA:
   GREECE - ITALY "Establishment of a Multidisciplinary Scientific Network
   for the development and application of Advanced Biomaterials" 2006-2008.
CR Alhede M, 2012, FEMS IMMUNOL MED MIC, V65, P335, DOI 10.1111/j.1574-695X.2012.00956.x
   An YH, 1997, J MICROBIOL METH, V30, P141, DOI 10.1016/S0167-7012(97)00058-4
   Arciola CR, 2002, BIOMATERIALS, V23, P4233, DOI 10.1016/S0142-9612(02)00171-0
   Baca-DeLancey RR, 1999, P NATL ACAD SCI USA, V96, P4610, DOI 10.1073/pnas.96.8.4610
   Balazs DJ, 2003, SURF INTERFACE ANAL, V35, P301, DOI 10.1002/sia.1533
   Bayoudh S, 2005, COLLOID SURFACE A, V266, P160, DOI 10.1016/j.colsurfa.2005.06.025
   Becker P, 2001, APPL ENVIRON MICROB, V67, P2958, DOI 10.1128/AEM.67.7.2958-2965.2001
   Boks NP, 2008, MICROBIOL-SGM, V154, P3122, DOI 10.1099/mic.0.2008/018622-0
   Boks NP, 2008, COLLOID SURFACE B, V67, P276, DOI 10.1016/j.colsurfb.2008.08.021
   Campoccia D, 2010, BIOMATERIALS, V31, P6363, DOI 10.1016/j.biomaterials.2010.05.005
   Cerca N, 2005, RES MICROBIOL, V156, P506, DOI 10.1016/j.resmic.2005.01.007
   Chini V, 2007, LETT APPL MICROBIOL, V45, P479, DOI 10.1111/j.1472-765X.2007.02208.x
   Costerton JW, 1999, SCIENCE, V284, P1318, DOI 10.1126/science.284.5418.1318
   Cowan MM, 1999, CLIN MICROBIOL REV, V12, P564
   DAVIES DG, 1995, APPL ENVIRON MICROB, V61, P860
   Faucheux N, 2004, BIOMATERIALS, V25, P2721, DOI 10.1016/j.biomaterials.2003.09.069
   Finlay JA, 2002, INTEGR COMP BIOL, V42, P1116, DOI 10.1093/icb/42.6.1116
   Fitzpatrick F, 2002, J HOSP INFECT, V52, P212, DOI 10.1053/jhin.2002.1309
   Fluckiger U, 2005, INFECT IMMUN, V73, P1811, DOI 10.1128/IAI.73.3.1811-1819.2005
   Gerke C, 1998, J BIOL CHEM, V273, P18586, DOI 10.1074/jbc.273.29.18586
   GOLDSMITH HL, 1986, THROMB HAEMOSTASIS, V55, P415
   Heilmann C, 1996, MOL MICROBIOL, V20, P1083, DOI 10.1111/j.1365-2958.1996.tb02548.x
   ISHAK MA, 1985, J CLIN MICROBIOL, V22, P1025
   Ishibashi K, 2010, APPL ENVIRON MICROB, V76, P751, DOI 10.1128/AEM.02230-09
   Jacobs CR, 1998, J BIOMECH, V31, P969, DOI 10.1016/S0021-9290(98)00114-6
   Kajiyama S, 2009, J ORTHOP SCI, V14, P769, DOI 10.1007/s00776-009-1405-0
   Katsikogianni M, 2008, COLLOID SURFACE B, V65, P257, DOI 10.1016/j.colsurfb.2008.04.017
   Katsikogianni M, 2006, J MATER SCI-MATER M, V17, P679, DOI 10.1007/s10856-006-9678-8
   Katsikogianni MG, 2010, ACTA BIOMATER, V6, P1107, DOI 10.1016/j.actbio.2009.08.006
   Khalichi P, 2009, BIOMATERIALS, V30, P452, DOI 10.1016/j.biomaterials.2008.09.053
   Kim DH, 2009, ANNU REV BIOMED ENG, V11, P203, DOI 10.1146/annurev-bioeng-061008-124915
   Kontos F, 2003, J MICROBIOL METH, V55, P465, DOI 10.1016/S0167-7012(03)00173-8
   Liu Y, 2002, WATER RES, V36, P1653, DOI 10.1016/S0043-1354(01)00379-7
   Liu Y, 2001, J APPL MICROBIOL, V90, P337, DOI 10.1046/j.1365-2672.2001.01244.x
   Liu YT, 2007, LANGMUIR, V23, P7134, DOI 10.1021/la700575u
   Mack D, 2007, ANAL BIOANAL CHEM, V387, P399, DOI 10.1007/s00216-006-0745-2
   Meiders JM, 1995, J COLLOID INTERF SCI, V176, P329
   Morra M, 1996, J BIOMED MATER RES, V31, P149
   Mrksich M, 1997, CURR OPIN COLLOID IN, V2, P83, DOI 10.1016/S1359-0294(97)80012-X
   Nejadnik MR, 2008, APPL ENVIRON MICROB, V74, P916, DOI 10.1128/AEM.01557-07
   Nuryastuti T, 2011, J BIOMED MATER RES A, V96A, P365, DOI 10.1002/jbm.a.32984
   O'Gara JP, 2007, FEMS MICROBIOL LETT, V270, P179, DOI 10.1111/j.1574-6968.2007.00688.x
   Otto M, 2012, SEMIN IMMUNOPATHOL, V34, P201, DOI 10.1007/s00281-011-0296-2
   Pfaffl M., 2004, A Z QUANTITATIVE PCR, P87, DOI 10.1007/s10551-011-0963-1
   Popat KC, 2007, BIOMATERIALS, V28, P4880, DOI 10.1016/j.biomaterials.2007.07.037
   Prigent-Combaret C, 1999, J BACTERIOL, V181, P5993
   Razatos A, 1998, P NATL ACAD SCI USA, V95, P11059, DOI 10.1073/pnas.95.19.11059
   Rohde H, 2010, EUR J CELL BIOL, V89, P103, DOI 10.1016/j.ejcb.2009.10.005
   SAMBROOK J, 1989, MOL CLONING, V1, P7
   Scheuerman TR, 1998, J COLLOID INTERF SCI, V208, P23, DOI 10.1006/jcis.1998.5717
   Seddon JRT, 2011, J PHYS CONDENS MATT, V23
   Sharp JM, 2005, LANGMUIR, V21, P8198, DOI 10.1021/la046765s
   Shive MS, 2000, P NATL ACAD SCI USA, V97, P6710, DOI 10.1073/pnas.110463197
   Silver JH, 1999, BIOMATERIALS, V20, P1533, DOI 10.1016/S0142-9612(98)00173-2
   Sokurenko EV, 2008, CELL HOST MICROBE, V4, P314, DOI 10.1016/j.chom.2008.09.005
   Stavridi M, 2003, MAT SCI ENG C-BIO S, V23, P359, DOI 10.1016/S0928-4931(02)00287-4
   Strathmann M, 2002, J MICROBIOL METH, V50, P237, DOI 10.1016/S0167-7012(02)00032-5
   Sugimura H, 2002, SURF INTERFACE ANAL, V34, P550, DOI 10.1002/sia.1358
   Thomas WE, 2002, CELL, V109, P913, DOI 10.1016/S0092-8674(02)00796-1
   Truong VK, 2010, BIOMATERIALS, V31, P3674, DOI 10.1016/j.biomaterials.2010.01.071
   TYLER BJ, 1992, J BIOMED MATER RES, V26, P273, DOI 10.1002/jbm.820260302
   Vandecasteele SJ, 2004, J BACTERIOL, V186, P2236, DOI 10.1128/JB.186.8.2236-2239.2004
   Vandecasteele SJ, 2003, J INFECT DIS, V188, P730, DOI 10.1086/377452
   VANOSS CJ, 1986, J COLLOID INTERF SCI, V111, P378, DOI 10.1016/0021-9797(86)90041-X
   Vogel V, 2006, NAT REV MOL CELL BIO, V7, P265, DOI 10.1038/nrm1890
   Vuong C, 2004, J BIOL CHEM, V279, P54881, DOI 10.1074/jbc.M411374200
   WANG IW, 1995, J BIOMED MATER RES, V29, P485, DOI 10.1002/jbm.820290408
   WASSERMAN SR, 1989, LANGMUIR, V5, P1074, DOI 10.1021/la00088a035
   WIENCEK KM, 1995, J BACTERIOL, V177, P1959, DOI 10.1128/jb.177.8.1959-1966.1995
   Wilson JW, 2007, P NATL ACAD SCI USA, V104, P16299, DOI 10.1073/pnas.0707155104
   Yamamoto K, 2005, AM J PHYSIOL-HEART C, V288, pH1915, DOI 10.1152/ajpheart.00956.2004
   Zhang YQ, 2003, MOL MICROBIOL, V49, P1577, DOI 10.1046/j.1365-2958.2003.03671.x
NR 72
TC 12
Z9 12
U1 0
U2 7
PU AO RESEARCH INSTITUTE DAVOS-ARI
PI DAVOS
PA CLAVADELERSTRASSE 8, DAVOS, CH 7270, SWITZERLAND
SN 1473-2262
J9 EUR CELLS MATER
JI Eur. Cells Mater.
PD JUL-DEC
PY 2012
VL 24
BP 386
EP 402
DI 10.22203/eCM.v024a28
PG 17
WC Cell & Tissue Engineering; Engineering, Biomedical; Materials Science,
   Biomaterials; Orthopedics
SC Cell Biology; Engineering; Materials Science; Orthopedics
GA V30XB
UT WOS:000208847600016
PM 23160991
OA DOAJ Gold
DA 2018-10-19
ER

PT J
AU Lin, HS
   Wang, HS
   Yang, RS
   Huang, TH
AF Lin, Hsin-Shih
   Wang, Ho-Seng
   Yang, Rong-Sen
   Huang, Tsang-Hai
TI Landing Produced Different Adaptation Behaviors On Bone Biomaterial
   Between Fore-limb And Hind-limb In Rats
SO JOURNAL OF GENERAL INTERNAL MEDICINE
LA English
DT Meeting Abstract
C1 [Lin, Hsin-Shih; Wang, Ho-Seng] Natl Taiwan Normal Univ, Taipei, Taiwan.
   [Yang, Rong-Sen] Natl Taiwan Univ Hosp, Taipei, Taiwan.
   [Huang, Tsang-Hai] Natl Cheng Kung Univ, Tainan 70101, Taiwan.
EM 897300180@ntnu.edu.tw
NR 0
TC 0
Z9 0
U1 0
U2 0
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 0884-8734
EI 1525-1497
J9 J GEN INTERN MED
JI J. Gen. Intern. Med.
PD JUL
PY 2012
VL 27
SU 2
MA 1268
BP 245
EP 245
PG 1
WC Health Care Sciences & Services; Medicine, General & Internal
SC Health Care Sciences & Services; General & Internal Medicine
GA V35IG
UT WOS:000209142901025
DA 2018-10-19
ER

PT J
AU Guo, LT
   Lin, HS
   Hsieh, SYS
   Chang, MS
   Yang, RS
   Huang, TH
AF Guo, Liang-Tong
   Lin, Hsin-Shih
   Hsieh, Shen-Yu Sandy
   Chang, Ming-Shi
   Yang, Rong-Sen
   Huang, Tsang-Hai
TI Effects of Endurance Exercise Training and Zoledronic Acid Treatment on
   Biomaterial Properties of Femora in Ovariectomized Rats
SO JOURNAL OF GENERAL INTERNAL MEDICINE
LA English
DT Meeting Abstract
C1 [Guo, Liang-Tong; Chang, Ming-Shi; Huang, Tsang-Hai] Natl Cheng Kung Univ, Tainan 70101, Taiwan.
   [Lin, Hsin-Shih; Hsieh, Shen-Yu Sandy] Natl Taiwan Normal Univ, Taipei, Taiwan.
   [Yang, Rong-Sen] Natl Taiwan Univ Hosp, Taipei, Taiwan.
EM yanshishn@yahoo.com.tw
NR 0
TC 0
Z9 0
U1 0
U2 0
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 0884-8734
EI 1525-1497
J9 J GEN INTERN MED
JI J. Gen. Intern. Med.
PD JUL
PY 2012
VL 27
SU 2
MA 1272
BP 246
EP 246
PG 1
WC Health Care Sciences & Services; Medicine, General & Internal
SC Health Care Sciences & Services; General & Internal Medicine
GA V35IG
UT WOS:000209142901029
DA 2018-10-19
ER

PT J
AU Kolski-Andreaco, A
   Chao, W
AF Kolski-Andreaco, Aaron
   Chao, Wendy
TI July 2012: This Month in JoVE
SO JOVE-JOURNAL OF VISUALIZED EXPERIMENTS
LA English
DT Article
DE This Month in JoVE; Issue 65
AB Historically, JoVE, The Journal of Visualized Experiments, has focused primarily on biomedical research and has developed subsections for Bioengineering, Clinical and Translational Medicine, Immunology and Infection, and Neuroscience. This July, JoVE launches its Applied Physics section, which includes a range of content from Plasma Physics to Materials Science. We begin the new section with a notable article from Purdue University, where researchers in the Center for Laser-Based Manufacturing are studying.
   Matter exists in three familiar states: solid, liquid, and gas. If a gas is hit with enough energy, atoms can lose electrons, or become ionized, to form a fourth state called plasma. Plasma is the most abundant form of matter; occupying about 99.999% of the visible universe. Using ultrashort laser pulses of 100 femtoseconds, or 100 quadrillionths of a second, our authors demonstrate a technique called pump probe shadowgraphy, which allows the early plasma to be visualized as it evolves from metal surfaces. By constructing a simulation model, these investigators are able to examine early plasma dynamics, enabling a better understanding of how matter becomes ionized.
   For the materials science subcategory of applied physics, JoVE materializes at the University of Michigan, where researchers are developing new methods in microfabrication. Our authors demonstrate a method for growing complex, three-dimensional microstructures out of carbon nanotubes, which can be used as master molds to cast replicas out of polymers or biological materials. Scanning electron microscopy reveals that the carbon nanotube master molds are reproduced with high fidelity in microscale shape and nanoscale texture in the polymer replicas made from these molds. Microfabrication technology allows laboratory operations to be performed on small scales - essentially putting a lab on a chip.
   Shifting from Applied Physics to cardiac physiology, JoVE visits The George Washington University to capture a modified Langendorff preparation. JoVE has published several articles that demonstrate this physiological prep, which allows the heart to beat in isolation for hours at a time. The approach involves retrograde perfusion of the heart, via the aorta, which shuts the aortic valve and forces oxygenated perfusate through the coronary circulation, in order to sustain cardiac tissue.
   Our authors present a modification to this preparation that involves cannulating the left atrial appendage, the inferior vena cava, and the pulmonary artery. In this state all four chambers of the heart are cannulated, thereby providing physiological load pressures to both ventricles, and eliminating the need to retrogradely-pefuse the heart through the aorta. Therefore, perfusion of the heart is in the normal direction, and the heart provides its own pressure for coronary perfusion.
   Once this biventricular working heart model is achieved, our authors proceed to set up imaging of nictonamide adenine dinucleoutide, or NADH, fluorescence. This coenzyme, which is found in mitochondria, emits fluorescence in its reduced state and provides a readout for local oxygen concentration, and therefore heart metabolism. These investigators demonstrate measurements of NADH fluorescence during different pacing rates and thereby illustrate the potential of this physiologically-relevant model to provide insight into cardiac pathologies.
   In our Bioengineering section, JoVE visits the University of the Pacific for an article dealing with synthetic spider silk production. Back in 2010, JoVE published an article from the Vierra lab, which demonstrated microdissection techniques to isolate the 12 silk producing glands from the Black Widow spider. Isolation of these glands allows for analytical techniques to be performed, in order to identify specific spider silk proteins. Because spiders are venomous and cannibalistic, rearing them for large scale production of spider silk is unrealistic. Therefore, the Vierra lab transforms bacteria with silk protein-containing plasmids and expresses recombinant spider silk proteins in bacteria.
   This July in JoVE, the Vierra group takes us through a method for isolating and purifying spider silk protein from these bacteria. They then show us how purified protein is spun into fibers and demonstrate methods for collecting these fibers, as well as assessing their strength. Spider silk is of great interest to biomaterial scientists, because of its biocompatibility and mechanical properties, which make it stronger than tensile steel. The Vierra lab has shown us laboratory-scale production of spider silk that can potentially be extended to a large scale manufacturing process. This brief summary synopsizes four of the fifty articles that JoVE will release this July. Other noteworthy publications include demonstrations of ex ovo electroporation in late stage chicken embryos, production of secreted proteins from human cells, and the ex vivo culturing of fruit fly brains.
C1 [Kolski-Andreaco, Aaron] Massachusetts Eye & Ear, Dept Ophthalmol, Boston, MA USA.
OI Chao, Wendy/0000-0002-9418-8723
NR 0
TC 0
Z9 0
U1 2
U2 8
PU JOURNAL OF VISUALIZED EXPERIMENTS
PI CAMBRIDGE
PA 1 ALEWIFE CENTER, STE 200, CAMBRIDGE, MA 02140 USA
SN 1940-087X
J9 JOVE-J VIS EXP
JI J. Vis. Exp.
PD JUL
PY 2012
IS 65
AR UNSP e5010
DI 10.3791/5010
PG 3
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA V36PJ
UT WOS:000209223200052
OA Bronze
DA 2018-10-19
ER

PT J
AU Subbiandoss, G
   Sharifi, S
   Grijpma, DW
   Laurent, S
   van der Mei, HC
   Mahmoudi, M
   Busscher, HJ
AF Subbiandoss, Guruprakash
   Sharifi, Shahriar
   Grijpma, Dirk W.
   Laurent, Sophie
   van der Mei, Henny C.
   Mahmoudi, Morteza
   Busscher, Henk J.
TI Magnetic targeting of surface-modified superparamagnetic iron oxide
   nanoparticles yields antibacterial efficacy against biofilms of
   gentamicin-resistant staphylococci
SO ACTA BIOMATERIALIA
LA English
DT Article
DE Superparamagnetic iron oxide nanoparticles; Magnetism; Surface
   functionalities; Biofilm
ID SILVER NANOPARTICLES; PARTICLES; ADHESION; AGENTS; CELLS
AB Biofilms on biomaterial implants are hard to eradicate with antibiotics due to the protection offered by the biofilm mode of growth, especially when caused by antibiotic-resistant strains. Superparamagnetic iron oxide nanoparticles (SPIONs) are widely used in various biomedical applications, such as targeted drug delivery and magnetic resonance imaging. Here, we evaluate the hypothesis that SPIONs can be effective in the treatment of biomaterial-associated infection. SPIONs can be targeted to the infection site using an external magnetic field, causing deep penetration in a biofilm and possibly effectiveness against antibiotic-resistant strains. We report that carboxyl-grafted SPIONs, magnetically concentrated in a biofilm, cause an approximately 8-fold higher percentage of dead staphylococci than does gentamicin for a gentamicin-resistant strain in a developing biofilm. Moreover, magnetically concentrated carboxyl-grafted SPIONs cause bacterial killing in an established biofilm. Thus magnetic targeting of SPIONs constitutes a promising alternative for the treatment of costly and recalcitrant biomaterial-associated infections by antibiotic-resistant strains. (C) 2012 Acta Materialia Inc. Published by Elsevier Ltd. All rights reserved.
C1 [Subbiandoss, Guruprakash; Sharifi, Shahriar; Grijpma, Dirk W.; van der Mei, Henny C.; Busscher, Henk J.] Univ Med Ctr Groningen, WJ Kolff Inst, Dept Biomed Engn, NL-9713 AV Groningen, Netherlands.
   [Subbiandoss, Guruprakash; Sharifi, Shahriar; Grijpma, Dirk W.; van der Mei, Henny C.; Busscher, Henk J.] Univ Groningen, NL-9713 AV Groningen, Netherlands.
   [Grijpma, Dirk W.] Univ Twente, Dept Biomat Sci & Technol, NL-7500 AE Enschede, Netherlands.
   [Laurent, Sophie] Univ Mons, NMR & Mol Imaging Lab, Dept Gen Organ & Biomed Chem, B-7000 Mons, Belgium.
   [Mahmoudi, Morteza] Pasteur Inst Iran, Natl Cell Bank, Tehran 13164, Iran.
   [Mahmoudi, Morteza] Univ Tehran Med Sci, Fac Pharm, Nanotechnol Res Ctr, Tehran, Iran.
RP van der Mei, HC (reprint author), Univ Med Ctr Groningen, WJ Kolff Inst, Dept Biomed Engn, Antonius Deusinglaan 1, NL-9713 AV Groningen, Netherlands.
EM h.c.van.der.mei@umcg.nl
RI Mahmoudi, Morteza/L-5332-2017; Sharifi, Shahriar/E-1188-2012
OI Mahmoudi, Morteza/0000-0002-2575-9684; Sharifi,
   Shahriar/0000-0002-3853-5428; Subbiahdoss,
   Guruprakash/0000-0002-6684-7322
FU University Medical Center Groningen, Groningen, The Netherlands
FX This research was funded by the University Medical Center Groningen,
   Groningen, The Netherlands.
CR Allaker RP, 2010, J DENT RES, V89, P1175, DOI 10.1177/0022034510377794
   Amiri H, 2011, NANOSCALE, V3, P1022, DOI 10.1039/c0nr00603c
   Bock N, 2010, ACTA BIOMATER, V6, P786, DOI 10.1016/j.actbio.2009.09.017
   Bruce IJ, 2004, J MAGN MAGN MATER, V284, P145, DOI 10.1016/j.jmmm.2004.06.032
   Corbin A, 2011, ANTIMICROB AGENTS CH, V55, P3338, DOI 10.1128/AAC.00206-11
   Costerton JW, 1999, INT J ANTIMICROB AG, V11, P217, DOI 10.1016/S0924-8579(99)00018-7
   Das M, 2008, NANOTECHNOLOGY, V19, DOI 10.1088/0957-4484/19/41/415101
   de Kraker MEA, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001104
   El Badawy AM, 2011, ENVIRON SCI TECHNOL, V45, P283, DOI 10.1021/es1034188
   Forge D, 2008, J PHYS CHEM C, V112, P19178, DOI 10.1021/jp803832k
   GRISTINA AG, 1987, SCIENCE, V237, P1588, DOI 10.1126/science.3629258
   Horak D, 2007, J SEP SCI, V30, P1751, DOI 10.1002/jssc.200700088
   Ishida H, 1998, ANTIMICROB AGENTS CH, V42, P1641, DOI 10.1128/AAC.42.7.1641
   Ito A, 2004, TISSUE ENG, V10, P833, DOI 10.1089/1076327041348301
   Jordan A, 1999, J MAGN MAGN MATER, V201, P413, DOI 10.1016/S0304-8853(99)00088-8
   Khalil H, 2007, MICROBES INFECT, V9, P460, DOI 10.1016/j.micinf.2007.01.002
   Kim JS, 2007, NANOMED-NANOTECHNOL, V3, P95, DOI 10.1016/j.nano.2006.12.001
   Laurent S, 2008, CHEM REV, V108, P2064, DOI 10.1021/cr068445e
   Lee C, 2008, ENVIRON SCI TECHNOL, V42, P4927, DOI 10.1021/es800408u
   Li BK, 2004, COLLOID SURFACE B, V36, P81, DOI 10.1016/j.colsurfb.2004.05.006
   Mahmoudi Morteza, 2010, International Journal of Biomedical Nanoscience and Nanotechnology, V1, P164, DOI 10.1504/IJBNN.2010.034651
   Mahmoudi M, 2010, J IRAN CHEM SOC, V7, pS1, DOI 10.1007/BF03246181
   Mahmoudi M, 2009, J COLLOID INTERF SCI, V336, P510, DOI 10.1016/j.jcis.2009.04.046
   Mahmoudi M, 2011, CHEM REV, V111, P5610, DOI 10.1021/cr100440g
   Mahmoudi M, 2011, ADV DRUG DELIVER REV, V63, P24, DOI 10.1016/j.addr.2010.05.006
   Mahmoudi M, 2011, CHEM REV, V111, P253, DOI 10.1021/cr1001832
   Morones JR, 2005, NANOTECHNOLOGY, V16, P2346, DOI 10.1088/0957-4484/16/10/059
   Nel AE, 2009, NAT MATER, V8, P543, DOI [10.1038/nmat2442, 10.1038/NMAT2442]
   Stoimenov PK, 2002, LANGMUIR, V18, P6679, DOI 10.1021/la0202374
   Taylor EN, 2009, INT J NANOMED, V4, P145
   Verma A, 2010, SMALL, V6, P12, DOI 10.1002/smll.200901158
   Wang LY, 2006, CHEM-EUR J, V12, P6341, DOI 10.1002/chem.200501334
   Xu ZH, 1997, APPL SURF SCI, V120, P269, DOI 10.1016/S0169-4332(97)00234-1
NR 33
TC 62
Z9 63
U1 2
U2 43
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1742-7061
J9 ACTA BIOMATER
JI Acta Biomater.
PD JUL
PY 2012
VL 8
IS 6
BP 2047
EP 2055
DI 10.1016/j.actbio.2012.03.002
PG 9
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 955QN
UT WOS:000305036100004
PM 22406508
DA 2018-10-19
ER

PT J
AU Steward, AJ
   Thorpe, SD
   Vinardell, T
   Buckley, CT
   Wagner, DR
   Kelly, DJ
AF Steward, A. J.
   Thorpe, S. D.
   Vinardell, T.
   Buckley, C. T.
   Wagner, D. R.
   Kelly, D. J.
TI Cell-matrix interactions regulate mesenchymal stem cell response to
   hydrostatic pressure
SO ACTA BIOMATERIALIA
LA English
DT Article
DE Fibrin; Agarose; Hydrostatic pressure; Stem cell; Chondrogenesis
ID IN-VITRO CHONDROGENESIS; DYNAMIC COMPRESSION; STROMAL CELLS;
   DIFFERENTIATION; CHONDROCYTES; FIBRINOGEN; CALCIFICATION; TRANSDUCTION;
   EXPRESSION; INTEGRINS
AB Both hydrostatic pressure (HP) and cell-matrix interactions have independently been shown to regulate the chondrogenic differentiation of mesenchymal stem cells (MSCs). The objective of this study was to test the hypothesis that the response of MSCs to hydrostatic pressure will depend on the biomaterial within which the cells are encapsulated. Bone-marrow-derived MSCs were seeded into either agarose or fibrin hydrogels and exposed to 10 MPa of cyclic HP (1 Hz, 4 h per day, 5 days per week for 3 weeks) in the presence of either 1 or 10 ng ml(-1) of TGF-beta 3. Agarose hydrogels were found to support a spherical cellular morphology, while MSCs seeded into fibrin hydrogels attached and spread, with clear stress fiber formation. Hydrogel contraction was also observed in MSC-fibrin constructs. While agarose hydrogels better supported chondrogenesis of MSCs, HP only enhanced sulfated glycosaminoglycan (sGAG) accumulation in fibrin hydrogels, which correlated with a reduction in fibrin contraction. HP also reduced alkaline phosphatase activity in the media for both agarose and fibrin constructs, suggesting that this stimulus plays a role in the maintenance of the chondrogenic phenotype. This study demonstrates that a complex relationship exists between cell-matrix interactions and hydrostatic pressure, which plays a key role in regulating the chondrogenic differentiation of MSCs. (C) 2012 Acta Materialia Inc. Published by Elsevier Ltd. All rights reserved.
C1 [Steward, A. J.; Thorpe, S. D.; Vinardell, T.; Buckley, C. T.; Kelly, D. J.] Trinity Coll Dublin, Sch Engn, Trinity Ctr Bioengn, Dublin 2, Ireland.
   [Steward, A. J.; Wagner, D. R.] Univ Notre Dame, Dept Mech Engn, Notre Dame, IN 46556 USA.
RP Kelly, DJ (reprint author), Trinity Coll Dublin, Sch Engn, Trinity Ctr Bioengn, Dublin 2, Ireland.
EM kellyd9@tcd.ie
RI Buckley, Conor/C-3575-2014
OI Buckley, Conor/0000-0001-7452-4534; Thorpe, Stephen/0000-0002-4707-7756;
   Kelly, Daniel/0000-0003-4091-0992
FU Science Foundation Ireland [08/Y15/B1336]; European Research Council
   [258463]; Naughton Graduate Fellowship
FX This study was supported by a President of Ireland Young Researcher
   Award from Science Foundation Ireland (08/Y15/B1336), funding from a
   European Research Council Starter Grant (No. 258463) and a Naughton
   Graduate Fellowship.
CR Angele P, 2003, J ORTHOPAED RES, V21, P451, DOI 10.1016/S0736-0266(02)00230-9
   Arnsdorf EJ, 2009, J CELL SCI, V122, P546, DOI 10.1242/jcs.036293
   BENYA PD, 1982, CELL, V30, P215, DOI 10.1016/0092-8674(82)90027-7
   CHERESH DA, 1989, CELL, V58, P945, DOI 10.1016/0092-8674(89)90946-X
   Connelly JT, 2008, J CELL PHYSIOL, V217, P145, DOI 10.1002/jcp.21484
   Connelly JT, 2007, BIOMATERIALS, V28, P1071, DOI 10.1016/j.biomaterials.2006.10.006
   Dickhut A, 2009, J CELL PHYSIOL, V219, P219, DOI 10.1002/jcp.21673
   Elder BD, 2009, TISSUE ENG PART B-RE, V15, P43, DOI 10.1089/ten.teb.2008.0435
   Elder SH, 2006, J ORTHOP RES, V24, P740, DOI 10.1002/jor.20086
   Finger AR, 2007, TISSUE ENG, V13, P1151, DOI 10.1089/ten.2006.0290
   Giancotti FG, 1999, SCIENCE, V285, P1028, DOI 10.1126/science.285.5430.1028
   Gorodetsky R, 2003, EXP CELL RES, V287, P116, DOI 10.1016/S0014-4827(03)00120-4
   Ho W, 2006, TISSUE ENG, V12, P1587, DOI 10.1089/ten.2006.12.1587
   Ignat'eva NY, 2007, J ANAL CHEM+, V62, P51, DOI 10.1134/S106193480701011X
   Kafienah Wa'el, 2004, Methods Mol Biol, V238, P217
   Kelly DJ, 2010, BIRTH DEFECTS RES C, V90, P75, DOI 10.1002/bdrc.20173
   KIM YJ, 1988, ANAL BIOCHEM, V174, P168, DOI 10.1016/0003-2697(88)90532-5
   Lennon DP, 2006, EXP HEMATOL, V34, P1604, DOI 10.1016/j.exphem.2006.07.014
   Li Z, 2010, J CELL MOL MED, V14, P1338, DOI 10.1111/j.1582-4934.2009.00780.x
   Luo ZJ, 2007, P I MECH ENG H, V221, P499, DOI 10.1243/09544119JEIM199
   Meyer EG, 2011, J MECH BEHAV BIOMED, V4, P1257, DOI 10.1016/j.jmbbm.2011.04.012
   Miyanishi K, 2006, TISSUE ENG, V12, P2253, DOI 10.1089/ten.2006.12.2253
   Miyanishi K, 2006, TISSUE ENG, V12, P1419, DOI 10.1089/ten.2006.12.1419
   Ogawa R, 2009, TISSUE ENG PT A, V15, P2937, DOI [10.1089/ten.tea.2008.0672, 10.1089/ten.TEA.2008.0672]
   PARKKINEN JJ, 1995, J ORTHOPAED RES, V13, P495, DOI 10.1002/jor.1100130404
   Pelttari K, 2006, ARTHRITIS RHEUM-US, V54, P3254, DOI 10.1002/art.22136
   Schwartz MA, 1995, ANNU REV CELL DEV BI, V11, P549, DOI 10.1146/annurev.cb.11.110195.003001
   Sheehy EJ, 2012, BIOCHEM BIOPH RES CO, V417, P305, DOI 10.1016/j.bbrc.2011.11.105
   Steward AJ, 2011, JOM-US, V63, P74, DOI 10.1007/s11837-011-0062-x
   Thorpe SD, 2008, BIOCHEM BIOPH RES CO, V377, P458, DOI 10.1016/j.bbrc.2008.09.154
   Thorpe SD, 2010, ANN BIOMED ENG, V38, P2896, DOI 10.1007/s10439-010-0059-6
   Vinardell T, 2012, TISSUE ENG
   Vinardell T, 2012, EUR CELLS MATER, V23, P121, DOI 10.22203/eCM.v023a09
   Wagner DR, 2008, ANN BIOMED ENG, V36, P813, DOI 10.1007/s10439-008-9448-5
   WANG N, 1993, SCIENCE, V260, P1124, DOI 10.1126/science.7684161
   Wong M, 2003, BONE, V33, P685, DOI 10.1016/S8756-3282(03)00242-4
   Zeiter S, 2009, BIORHEOLOGY, V46, P45, DOI 10.3233/BIR-2009-0520
NR 37
TC 39
Z9 39
U1 0
U2 16
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1742-7061
J9 ACTA BIOMATER
JI Acta Biomater.
PD JUL
PY 2012
VL 8
IS 6
BP 2153
EP 2159
DI 10.1016/j.actbio.2012.03.016
PG 7
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 955QN
UT WOS:000305036100015
PM 22426136
DA 2018-10-19
ER

PT J
AU Hovland, A
   Hardersen, R
   Nielsen, EW
   Enebakk, T
   Christiansen, D
   Ludviksen, JK
   Mollnes, TE
   Lappegard, KT
AF Hovland, Anders
   Hardersen, Randolf
   Nielsen, Erik Waage
   Enebakk, Terje
   Christiansen, Dorte
   Ludviksen, Judith Krey
   Mollnes, Tom Eirik
   Lappegard, Knut Tore
TI Complement profile and activation mechanisms by different LDL apheresis
   systems
SO ACTA BIOMATERIALIA
LA English
DT Article
DE Extracorporeal circulation; Lipid; Complement; Biocompatibility
ID ALTERNATIVE PATHWAY; BIOCOMPATIBILITY; ATHEROSCLEROSIS; HEMODIALYSIS;
   PLASMA; INFLAMMATION; MEMBRANES; RECEPTOR; COLUMNS; SURFACE
AB Extracorporeal removal of low-density lipoprotein (LDL) cholesterol by means of selective LDL apheresis is indicated in otherwise uncontrolled familial hypercholesterolemia. During blood-biomaterial interaction other constituents than the LDL particles are affected, including the complement system. We set up an ex vivo model in which human whole blood was passed through an LDL apheresis system with one of three different apheresis columns: whole blood adsorption, plasma adsorption and plasma filtration. The concentrations of complement activation products revealed distinctly different patterns of activation and adsorption by the different systems. Evaluated as the final common terminal complement complex (TCC) the whole blood system was inert, in contrast to the plasma systems, which generated substantial and equal amounts of TCC. Initial classical pathway activation was revealed equally for both plasma systems as increases in the C1rs-C1inh complex and C4d. Alternative pathway activation (Bb) was most pronounced for the plasma adsorption system. Although the anaphylatoxins (C3a and C5a) were equally generated by the two plasma separation systems, they were efficiently adsorbed to the plasma adsorption column before the "outlet", whereas they were left free in the plasma in the filtration system. Consequently, during blood-biomaterial interaction in LDL apheresis the complement system is modulated in different manners depending on the device composition. (C) 2012 Acta Materialia Inc. Published by Elsevier Ltd. All rights reserved.
C1 [Hovland, Anders; Lappegard, Knut Tore] Nordland Hosp, Div Internal Med, Coronary Care Unit, Bodo, Norway.
   [Hovland, Anders; Nielsen, Erik Waage; Lappegard, Knut Tore] Univ Tromso, Inst Clin Med, N-9001 Tromso, Norway.
   [Hardersen, Randolf; Enebakk, Terje] Nordland Hosp, Div Internal Med, Dialysis Unit, Bodo, Norway.
   [Nielsen, Erik Waage] Nordland Hosp, Dept Anesthesia, Bodo, Norway.
   [Christiansen, Dorte; Ludviksen, Judith Krey; Mollnes, Tom Eirik] Nordland Hosp, Somat Res Lab, Bodo, Norway.
   [Mollnes, Tom Eirik] Univ Tromso, Inst Med Biol, N-9001 Tromso, Norway.
RP Hovland, A (reprint author), Nordland Hosp, Div Internal Med, Coronary Care Unit, Bodo, Norway.
EM anders.w.hovland@gmail.com
FU Raagholt Foundation; Odd Fellow Foundation
FX We have received unrestricted research grants from the Raagholt and the
   Odd Fellow Foundations. Gambro Norway generously supplied the columns
   and tubes used in the study.
CR Andersson J, 2005, BIOMATERIALS, V26, P1477, DOI 10.1016/j.biomaterials.2004.05.011
   Andersson J, 2002, J IMMUNOL, V168, P5786, DOI 10.4049/jimmunol.168.11.5786
   Clark WR, 1999, KIDNEY INT, V56, P2005, DOI 10.1046/j.1523-1755.1999.00784.x
   Ebo DG, 2006, ALLERGY, V61, P211, DOI 10.1111/j.1398-9995.2006.00982.x
   Fadul JEM, 1998, J CLIN APHERESIS, V13, P167, DOI 10.1002/(SICI)1098-1101(1998)13:4<167::AID-JCA5>3.0.CO;2-N
   Ferraz N, 2008, J BIOMED MATER RES A, V87A, P575, DOI 10.1002/jbm.a.31818
   Fure H, 1997, SCAND J IMMUNOL, V46, P553, DOI 10.1046/j.1365-3083.1997.d01-168.x
   Harboe M, 2008, J CELL MOL MED, V12, P1074, DOI 10.1111/j.1582-4934.2008.00350.x
   Harboe M, 2011, ADV DRUG DELIVER REV, V63, P976, DOI 10.1016/j.addr.2011.05.010
   Haskard DO, 2008, CURR OPIN LIPIDOL, V19, P478, DOI 10.1097/MOL.0b013e32830f4a06
   Horl WH, 2002, J AM SOC NEPHROL, V13, pS62
   Hovland A, 2010, J CLIN APHERESIS, V25, P294, DOI 10.1002/jca.20256
   Hovland A, 2009, J CLIN APHERESIS, V24, P247, DOI 10.1002/jca.20223
   Koziolek MJ, 2010, THER APHER DIAL, V14, P143, DOI 10.1111/j.1744-9987.2009.00747.x
   Malik TH, 2010, CIRCULATION, V122, P1948, DOI 10.1161/CIRCULATIONAHA.110.981365
   MOLLNES TE, 1985, SCAND J IMMUNOL, V22, P183, DOI 10.1111/j.1365-3083.1985.tb01870.x
   Mollnes TE, 2002, BLOOD, V100, P1869
   Neil HAW, 1999, ATHEROSCLEROSIS, V142, P105
   Nilsson B, 2007, MOL IMMUNOL, V44, P82, DOI 10.1016/j.molimm.2006.06.020
   Speidl WS, 2011, J THROMB HAEMOST, V9, P428, DOI 10.1111/j.1538-7836.2010.04172.x
   Speidl WS, 2011, FASEB J, V25, P35, DOI 10.1096/fj.10-156083
   Subramanian S, 2002, KIDNEY INT, V62, P1819, DOI 10.1046/j.1523-1755.2002.00608.x
   Takeda Y, 2010, ARTIF ORGANS, V34, P1144, DOI 10.1111/j.1525-1594.2009.00995.x
   Thompson GR, 2008, ATHEROSCLEROSIS, V198, P247, DOI 10.1016/j.atherosclerosis.2008.02.009
   VANBEAUMONT W, 1972, J APPL PHYSIOL, V32, P712
   Williams DF, 2008, BIOMATERIALS, V29, P2941, DOI 10.1016/j.biomaterials.2008.04.023
   Williams DF, 1986, P CONS C EUR SOC BIO
   Wu GX, 2009, CIRC RES, V104, P550, DOI 10.1161/CIRCRESAHA.108.191361
   WURZNER R, 1991, EUR J CLIN INVEST, V21, P288, DOI 10.1111/j.1365-2362.1991.tb01372.x
NR 29
TC 8
Z9 8
U1 2
U2 14
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1742-7061
J9 ACTA BIOMATER
JI Acta Biomater.
PD JUL
PY 2012
VL 8
IS 6
BP 2288
EP 2296
DI 10.1016/j.actbio.2012.02.017
PG 9
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 955QN
UT WOS:000305036100030
PM 22373816
DA 2018-10-19
ER

PT J
AU Yin, KF
   Wang, ZF
   Fan, X
   Bian, YY
   Guo, J
   Lan, J
AF Yin, Kaifeng
   Wang, Zhifeng
   Fan, Xin
   Bian, Yuanyuan
   Guo, Jing
   Lan, Jing
TI The experimental research on two-generation BLB dental implants - Part
   I: surface modification and osseointegration
SO CLINICAL ORAL IMPLANTS RESEARCH
LA English
DT Article
DE BLB dental implant; electrophoresis deposition; micro-arc oxidation;
   osseointegration; plasma spraying
ID MICRO-ARC OXIDATION; COMMERCIALLY PURE TITANIUM; HYDROXYAPATITE
   COATINGS; APATITE INDUCTION; SPECIAL EMPHASIS; BONE RESPONSE; ROUGHNESS;
   CELLS; PERFORMANCE; TOPOGRAPHY
AB Objective: The study was designed to evaluate the comparative effect of osseointegration induced by the dental implants of Beijing Leiden Biomaterial (BLB) and BLBIII. Materials and methods: The surface properties ofBLBI and BLBIII were studied through thermal field-scanning electron microscopy, energy-dispersive X-ray spectroscopy (EDS) and optical profilometer. A total of 36 BLBI and BLBIII implants, with each of the two groups possessing 18, were randomly implanted into the extraction fossa of the mandibular premolar areas of six Beagles. The animals were then executed 2, 4 and 8 weeks after the surgery, which was followed by macroscopic examination and histomorphometric analysis. Results: Typical cloud-form microstructure was found on the surface of BLBI implant, which was distributed widely yet in an irregular way. The surface of BLBIII implant was mainly featured by a highly porous layer. The EDS spectra of BLBI indicated the peaks of calcium (Ca) and phosphorous (P) compatible with apatite phase, while the peaks of Ca, P, oxygen and titanium were incorporated in the BLBIII group. The ratio of Ca and K showed no significant differences in the surface chemical composition of BLBI and BLBIII. Surface microtopographic analysis showed a statistical difference (P<0.01) in the roughness between BLBI (Ra) and BLBIII. In the healing period, a larger amount of osteoid and bone tissues were observed in the areas surrounding the BLBIII group than those of the BLBII group. After 2 and 4 weeks of the surgery, the boneimplant contact (BIC) of BLBIII group presented higher value of statistical significance (P<0.05) than that of BLBI. However, after the 8-week healing period, the BIC difference between the two groups proved to be of no statistical significance (P>0.05). Conclusion: Micro-arc oxidation (MAO) and electrophoresis deposition (EPD) are able to produce a highly porous layer on the surface of BLBIII, which is characterized by a relatively stable Ca/P ratio similar to that of the hydroxyapatite layer. Therefore, superior and early osseointegration potential was demonstrated in the threaded implants treated by MAO coupling with EPD, rather than the merely cylindrical-shaped ones with plasma-sprayed HA coating layer. To cite this article:?Yin K, Wang Z, Fan X, Bian Y, Guo J, Lan J. The experimental research on two-generation BLB dental implants. Part I: surface modification and osseointegration.?Clin. Oral Impl. Res. 23, 2012; 846852.?doi: 10.1111/j.1600-0501.2011.02209.x
C1 [Fan, Xin; Bian, Yuanyuan; Lan, Jing] Shandong Univ, Dept Prosthodont, Sch Dent, Jinan 250012, Shangdong, Peoples R China.
   [Guo, Jing] Shandong Univ, Dept Endodont, Sch Dent, Jinan 250012, Shangdong, Peoples R China.
   [Wang, Zhifeng] Shandong Univ, Dept Pedodont, Sch Dent, Jinan 250012, Shangdong, Peoples R China.
   [Yin, Kaifeng] Shandong Univ, Dept Orthodont, Sch Dent, Jinan 250012, Shangdong, Peoples R China.
RP Lan, J (reprint author), Shandong Univ, Dept Prosthodont, Sch Dent, 44-1 Wenhua Xi Rd, Jinan 250012, Shangdong, Peoples R China.
EM lanjing_rainbow@yahoo.com.cn
FU National Natural Science Foundation of China [30801308]; Department of
   Science and Technology of Shandong province (China) [2007BS03053,
   Q2008C10, 2010G0020237]
FX The research was supported by National Natural Science Foundation of
   China (30801308) and the Department of Science and Technology of
   Shandong province (China) (2007BS03053, Q2008C10, 2010G0020237).
CR Albrektsson T, 1998, J ORAL MAXIL SURG, V56, P1312, DOI 10.1016/S0278-2391(98)90616-4
   Albrektsson T, 2004, INT J PROSTHODONT, V17, P544
   Albrektsson T, 2004, INT J PROSTHODONT, V17, P536
   Aoki H, 2006, BIO-MED MATER ENG, V16, P157
   Bigi A, 2005, BIOMATERIALS, V26, P4085, DOI 10.1016/j.biomaterials.2004.10.034
   Curtis A, 1997, BIOMATERIALS, V18, P1573, DOI 10.1016/S0142-9612(97)00144-0
   Diniz MG, 2002, J MATER SCI-MATER M, V13, P421, DOI 10.1023/A:1014357122284
   Frauchiger VM, 2004, BIOMATERIALS, V25, P593, DOI 10.1016/S0142-9612(03)00560-X
   Guo Q, 2005, HEBEI MED, V11, P989
   Han Y, 2009, J BIOMED MATER RES A, V88A, P117, DOI 10.1002/jbm.a.31859
   Huang HL, 2010, COMPUT BIOL MED, V40, P525, DOI 10.1016/j.compbiomed.2010.03.008
   Huang Y, 2007, BIOMED MATER, V2, P196, DOI 10.1088/1748-6041/2/3/005
   Kim DY, 2009, ACTA BIOMATER, V5, P2196, DOI 10.1016/j.actbio.2009.02.021
   Lan Jing, 2003, Shanghai Kou Qiang Yi Xue, V12, P419
   LeGeros RZ, 2002, CLIN ORTHOP RELAT R, P81
   Li LH, 2004, BIOMATERIALS, V25, P2867, DOI 10.1016/j.biomaterials.2003.09.048
   Liao X., 2007, CHINESE J ORAL IMPLA, V2, P73
   Lincks J, 1998, BIOMATERIALS, V19, P2219, DOI 10.1016/S0142-9612(98)00144-6
   Luo C., 2005, BEIJING J STOMATOLOG, V13, P47
   Matykina E, 2009, ACTA BIOMATER, V5, P1356, DOI 10.1016/j.actbio.2008.10.007
   Misch Carl E, 2004, Implant Dent, V13, P207, DOI 10.1097/01.id.0000140461.25451.31
   Mustafa K, 2001, CLIN ORAL IMPLAN RES, V12, P515, DOI 10.1034/j.1600-0501.2001.120513.x
   Nie X, 2001, J BIOMED MATER RES, V57, P612, DOI 10.1002/1097-4636(20011215)57:4<612::AID-JBM1208>3.0.CO;2-H
   Nogueras-Bayona Joaquim, 2004, Implant Dent, V13, P185
   Ong J L, 2000, Crit Rev Biomed Eng, V28, P667
   Park YS, 2005, INT J ORAL MAX IMPL, V20, P31
   Ryu HS, 2008, SURF COAT TECH, V202, P1853, DOI 10.1016/j.surfcoat.2007.08.003
   Shalabi MM, 2006, J DENT RES, V85, P496, DOI 10.1177/154405910608500603
   Song WH, 2005, J AM CERAM SOC, V88, P2642, DOI 10.1111/j.1551-2916.2005.00476.x
   STEFLIK DE, 1994, J ORAL IMPLANTOL, V20, P198
   Strnad Z, 2000, INT J ORAL MAX IMPL, V15, P483
   Sul YT, 2005, BIOMATERIALS, V26, P6720, DOI 10.1016/j.biomaterials.2005.04.058
   Sul YT, 2003, BIOMATERIALS, V24, P3893, DOI 10.1016/S0142-9612(03)00261-8
   Sun LM, 2001, J BIOMED MATER RES, V58, P570, DOI 10.1002/jbm.1056.abs
   Wang YM, 2006, SURF COAT TECH, V201, P82, DOI 10.1016/j.surfcoat.2005.10.044
   Wennerberg A, 1996, BIOMATERIALS, V17, P15, DOI 10.1016/0142-9612(96)80750-2
   Yang W. Q., 1997, J BIOMED MATER RES, V37, P267
   Yao ZQ, 2010, ACTA BIOMATER, V6, P2816, DOI 10.1016/j.actbio.2009.12.053
NR 38
TC 6
Z9 7
U1 2
U2 14
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0905-7161
J9 CLIN ORAL IMPLAN RES
JI Clin. Oral Implant. Res.
PD JUL
PY 2012
VL 23
IS 7
BP 846
EP 852
DI 10.1111/j.1600-0501.2011.02209.x
PG 7
WC Dentistry, Oral Surgery & Medicine; Engineering, Biomedical
SC Dentistry, Oral Surgery & Medicine; Engineering
GA 955BQ
UT WOS:000304992500011
PM 21564304
DA 2018-10-19
ER

PT J
AU Teigen, K
   Jokstad, A
AF Teigen, Kyrre
   Jokstad, Asbjorn
TI Dental implant suprastructures using cobalt-chromium alloy compared with
   gold alloy framework veneered with ceramic or acrylic resin: a
   retrospective cohort study up to 18 years
SO CLINICAL ORAL IMPLANTS RESEARCH
LA English
DT Article
DE cobalt-chromium; dental implant; gold alloy; suprastructure; veneering
   material
ID FIXED PARTIAL DENTURES; LEAST 5 YEARS; COMPLICATION RATES; OBSERVATION
   PERIOD; CLINICAL-TRIALS; FOLLOW-UP; SURVIVAL; BIOCOMPATIBILITY;
   MULTICENTER; PROSTHESES
AB Background: An association between the long-term success and survival of implant-supported prostheses as a function of biomaterial combinations has not been established. The use of cast cobaltchromium for the suprastructure framework may be an alternative to the conventional approach of using type 3 gold alloys. Materials and methods: A retrospective chart audit of all patients who had received implant-supported fixed dental prostheses (FDP) before 1996 was identified in a private practice clinic. Data were recorded for FDPs made from four combinations of alloy frameworks and veneering material, i.e. type 3 gold and cobaltchromium with ceramic or prefabricated acrylic teeth. The extracted data from the charts were subjected to explorative statistical tests including KaplanMeier survival analyses. Results: Patients (n=198) with 270 short and extensive FDPs supported entirely by 1117 implants were identified. The average follow-up observation periods varied between 4 and 220 months, with an average of 120 months. The success and survival, as well as event rates and types of biological and technical complications, were similar for implant-supported FDPs using cobaltchromium and type 3 gold alloy frameworks veneered with ceramics or prefabricated acrylic teeth. An influence of the suprastructure biomaterial combination on the clinical performance of the individual supporting implants could not be established. Conclusions: Implant-supported FDPs made from type 3 gold or cobaltchromium frameworks and veneered with ceramic or prefabricated acrylic teeth demonstrate comparable clinical performance. The biomaterial combinations do not appear to influence the success or survival of the individual implants. To cite this article:?Teigen K, Jokstad A. Dental implant suprastructures using cobaltchromium alloy compared with gold alloy framework veneered with ceramic or acrylic resin: a retrospective cohort study up to 18 years.?Clin. Oral Impl. Res. 23, 2012; 853860.?doi: 10.1111/j.1600-0501.2011.02211.x
C1 [Jokstad, Asbjorn] Univ Toronto, Fac Dent Prosthodont, Toronto, ON, Canada.
RP Teigen, K (reprint author), Arken Tannlegesenter, N-5116 Ulset, Norway.
EM kyrre.teigen@arkentannlege.no
RI jokstad, asbjorn/B-1446-2008; Jokstad, Asbjorn/M-7136-2014
OI Jokstad, Asbjorn/0000-0002-5902-4520
FU Ole Smith-Housken's fund
FX Financial support: Ole Smith-Housken's fund. The study was conducted
   during post-graduate training in prosthetic dentistry at the Faculty of
   Dentistry, University of Oslo.
CR ADELL R, 1981, INT J ORAL MAXILLOF, V10, P387, DOI 10.1016/S0300-9785(81)80077-4
   ANDERSON RJ, 1993, J PROSTHET DENT, V69, P1, DOI 10.1016/0022-3913(93)90230-L
   BERGENDAL T, 1995, CLIN ORAL IMPLAN RES, V6, P246, DOI 10.1034/j.1600-0501.1995.060408.x
   Branemark P I, 1977, Scand J Plast Reconstr Surg Suppl, V16, P1
   BRANEMARK PI, 1985, TISSUE INTEGRATED PR
   BRUNSKI J B, 1992, Clinical Materials, V10, P153, DOI 10.1016/0267-6605(92)90049-Y
   Bryant SR, 2007, INT J ORAL MAX IMPL, V22, P117
   Chao Y., 1988, CLIN MAT, V3, P309
   Chuang SK, 2002, J DENT RES, V81, P572, DOI 10.1177/154405910208100814
   Cox J, 1985, Swed Dent J Suppl, V28, P71
   Fleming TR, 2000, BIOMETRICS, V56, P971, DOI 10.1111/j.0006-341X.2000.0971.x
   Geis-Gerstorfer J, 1989, Int J Oral Maxillofac Implants, V4, P119
   Geurtsen W, 2002, CRIT REV ORAL BIOL M, V13, P71, DOI 10.1177/154411130201300108
   GJERDET NR, 1980, ACTA ODONTOL SCAND, V38, P273, DOI 10.3109/00016358009033593
   GLANTZ PO, 1984, J BIOL BUCCALE, V12, P3
   Glantz PO, 1985, TISSUE INTEGRATED PR, P329
   Herrmann I, 1999, INT J PROSTHODONT, V12, P160
   Herrmann I, 2007, CLIN IMPLANT DENT R, V9, P6, DOI 10.1111/j.1708-8208.2006.00026.x
   Jemt T, 1992, Int J Periodontics Restorative Dent, V12, P177
   Lemons J E, 1988, Int J Oral Implantol, V5, P41
   Marklund S, 2003, INT J PROSTHODONT, V16, P70
   Nilner K, 1985, Swed Dent J Suppl, V28, P85
   Ortorp A, 2000, Clin Implant Dent Relat Res, V2, P2, DOI 10.1111/j.1708-8208.2000.tb00101.x
   Owall B E, 1991, Int J Prosthodont, V4, P24
   PETO R, 1977, BRIT J CANCER, V35, P1, DOI 10.1038/bjc.1977.1
   Pjetursson BE, 2004, CLIN ORAL IMPLAN RES, V15, P667, DOI 10.1111/j.1600-0501.2004.01120.x
   Roach M, 2007, DENT CLIN N AM, V51, pvi
   Roach Michael, 2007, Dent Clin North Am, V51, P603, DOI 10.1016/j.cden.2007.04.001
   Sahin S, 2001, Implant Dent, V10, P85
   Sailer I, 2007, INT J PROSTHODONT, V20, P383
   Sailer I, 2009, INT J PROSTHODONT, V22, P553
   SMEDBERG J-I, 1991, International Journal of Oral and Maxillofacial Implants, V6, P154
   Tan K, 2004, CLIN ORAL IMPLAN RES, V15, P654, DOI 10.1111/j.1600-0501.2004.01119.x
   Walter M, 1999, J ORAL REHABIL, V26, P91, DOI 10.1046/j.1365-2842.1999.00373.x
   ZARB GA, 1983, J PROSTHET DENT, V50, P271, DOI 10.1016/0022-3913(83)90029-X
   ZARB GA, 1985, TISSUE INTEGRATED PR, P241
NR 36
TC 11
Z9 12
U1 0
U2 8
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0905-7161
J9 CLIN ORAL IMPLAN RES
JI Clin. Oral Implant. Res.
PD JUL
PY 2012
VL 23
IS 7
BP 853
EP 860
DI 10.1111/j.1600-0501.2011.02211.x
PG 8
WC Dentistry, Oral Surgery & Medicine; Engineering, Biomedical
SC Dentistry, Oral Surgery & Medicine; Engineering
GA 955BQ
UT WOS:000304992500012
PM 21692856
DA 2018-10-19
ER

PT J
AU Bottino, MC
   Thomas, V
   Schmidt, G
   Vohra, YK
   Chu, TMG
   Kowolik, MJ
   Janowski, GM
AF Bottino, Marco C.
   Thomas, Vinoy
   Schmidt, Gudrun
   Vohra, Yogesh K.
   Chu, Tien-Min Gabriel
   Kowolik, Michael J.
   Janowski, Gregg M.
TI Recent advances in the development of GTR/GBR membranes for periodontal
   regeneration-A materials perspective
SO DENTAL MATERIALS
LA English
DT Review
DE Periodontitis; Periodontal regeneration; Scaffolds; Electrospinning;
   Hydrogels; Hydroxyapatite; Drug delivery; Membranes; Guided tissue
   regeneration
ID GUIDED BONE REGENERATION; TISSUE ENGINEERING APPLICATIONS; DERMAL MATRIX
   GRAFT; HYDROXYAPATITE/COLLAGEN/PLGA COMPOSITE MEMBRANE; NANOFIBROUS
   NANOCOMPOSITE SCAFFOLDS; COLLAGEN BARRIER MEMBRANES; BETA-TRICALCIUM
   PHOSPHATE; CROSS-LINKING AGENT; MECHANICAL-PROPERTIES; GINGIVAL
   RECESSION
AB Periodontitis is a major chronic inflammatory disorder that can lead to the destruction of the periodontal tissues and, ultimately, tooth loss. To date, flap debridement and/or flap curettage and periodontal regenerative therapy with membranes and bone grafting materials have been employed with distinct levels of clinical success. Current resorbable and non-resorbable membranes act as a physical barrier to avoid connective and epithelial tissue down-growth into the defect, favoring the regeneration of periodontal tissues. These conventional membranes possess many structural, mechanical, and bio-functional limitations and the "ideal" membrane for use in periodontal regenerative therapy has yet to be developed. Based on a graded-biomaterials approach, we have hypothesized that the next-generation of guided tissue and guided bone regeneration (GTR/GBR) membranes for periodontal tissue engineering will be a biologically active, spatially designed and functionally graded nanofibrous biomaterial that closely mimics the native extra-cellular matrix (ECM).
   Objective. This review is presented in three major parts, including (1) a brief overview of the periodontium and its pathological conditions, (2) currently employed therapeutics used to regenerate the distinct periodontal tissues, and (3) a review of commercially available GTR/GBR membranes as well as the recent advances on the processing and characterization of GTR/GBR membranes from a materials perspective.
   Significance. Studies of spatially designed and functionally graded membranes (FGM) and in vitro antibacterial/cell-related research are addressed. Finally, as a future outlook, the use of hydrogels in combination with scaffold materials is highlighted as a promising approach for periodontal tissue engineering. (C) 2012 Academy of Dental Materials. Published by Elsevier Ltd. All rights reserved.
C1 [Bottino, Marco C.; Chu, Tien-Min Gabriel] Indiana Univ Sch Dent, Dept Restorat Dent, Div Dent Biomat, Indianapolis, IN 46202 USA.
   [Thomas, Vinoy; Vohra, Yogesh K.] Univ Alabama Birmingham, CNMB, Birmingham, AL 35294 USA.
   [Schmidt, Gudrun] Purdue Univ, Weldon Sch Biomed Engn, W Lafayette, IN 47907 USA.
   [Kowolik, Michael J.] Indiana Univ Sch Dent, Dept Periodont, Indianapolis, IN 46202 USA.
   [Kowolik, Michael J.] Indiana Univ Sch Dent, Allied Dent Programs, Indianapolis, IN 46202 USA.
   [Janowski, Gregg M.] Univ Alabama Birmingham, Dept Mat Sci & Engn, Birmingham, AL 35294 USA.
RP Bottino, MC (reprint author), Indiana Univ Sch Dent, Dept Restorat Dent, Div Dent Biomat, 1121 W Michigan St, Indianapolis, IN 46202 USA.
EM mbottino@iupui.edu
OI Janowski, Gregg/0000-0001-8384-4820; Chu, Tien-Min
   Gabriel/0000-0002-7190-837X; Bottino, Marco C./0000-0001-8740-2464
CR Agarwal S, 2009, ADV FUNCT MATER, V19, P2863, DOI 10.1002/adfm.200900591
   Al-Hamdan K, 2003, J PERIODONTOL, V74, P1520, DOI 10.1902/jop.2003.74.10.1520
   Al-Mubarak S A, 2000, J Int Acad Periodontol, V2, P64
   Ayres CE, 2010, WIRES NANOMED NANOBI, V2, P20, DOI 10.1002/wnan.55
   Baker BM, 2008, BIOMATERIALS, V29, P2348, DOI 10.1016/j.biomaterials.2008.01.032
   Bakota EL, 2011, BIOMACROMOLECULES, V12, P82, DOI 10.1021/bm1010195
   Behring J, 2008, ODONTOLOGY, V96, P1, DOI 10.1007/s10266-008-0087-y
   Bhrany AD, 2008, J TISSUE ENG REGEN M, V2, P365, DOI 10.1002/term.105
   Bishop A, 2006, POLYM ADVAN TECHNOL, V17, P902, DOI 10.1002/pat.787
   Bottino MC, 2011, ACTA BIOMATER, V7, P216, DOI 10.1016/j.actbio.2010.08.019
   Bottino MC, 2010, J BIOMED MATER RES B, V95B, P276, DOI 10.1002/jbm.b.31711
   Bottino MC, 2009, DENT MATER, V25, P1109, DOI 10.1016/j.dental.2009.03.007
   Bunyaratavej P, 2001, J PERIODONTOL, V72, P215, DOI 10.1902/jop.2001.72.2.215
   Chen FM, 2010, TISSUE ENG PART B-RE, V16, P219, DOI [10.1089/ten.teb.2009.0562, 10.1089/ten.TEB.2009.0562]
   Chen FM, 2011, BIOMATERIALS, V32, P3189, DOI 10.1016/j.biomaterials.2010.12.032
   Chen FM, 2011, J CONTROL RELEASE, V149, P92, DOI 10.1016/j.jconrel.2010.10.021
   Chen FM, 2010, BIOMATERIALS, V31, P7892, DOI 10.1016/j.biomaterials.2010.07.019
   Chen FM, 2009, MED RES REV, V29, P472, DOI 10.1002/med.20144
   Chen YT, 1997, J PERIODONTOL, V68, P172, DOI 10.1902/jop.1997.68.2.172
   Chou AHK, 2007, IMPLANT DENT, V16, P89, DOI 10.1097/ID.0b013e318031224a
   Coic M, 2010, REV STOMATOL CHIR, V111, P286, DOI 10.1016/j.stomax.2010.10.006
   Coonts BA, 1998, J BIOMED MATER RES, V42, P303, DOI 10.1002/(SICI)1097-4636(199811)42:2<303::AID-JBM16>3.3.CO;2-Z
   Davis KA, 2002, CRIT REV THER DRUG, V19, P385, DOI 10.1615/CritRevTherDrugCarrierSyst.v19.i45.30
   Deng XL, 2007, J BIOMAT SCI-POLYM E, V18, P117, DOI 10.1163/156856207779146123
   Dong YX, 2009, TISSUE ENG PART B-RE, V15, P333, DOI [10.1089/ten.teb.2008.0619, 10.1089/ten.TEB.2008.0619]
   Dong ZX, 2011, J POWER SOURCES, V196, P4886, DOI 10.1016/j.jpowsour.2011.01.090
   Donos N, 2002, CLIN ORAL IMPLAN RES, V13, P203, DOI 10.1034/j.1600-0501.2002.130211.x
   Eichhorn SJ, 2005, J ROY SOC INTERFACE, V2, P309, DOI 10.1098/rsif.2005.0039
   El-Ghannam A, 2005, EXPERT REV MED DEVIC, V2, P87, DOI 10.1586/17434440.2.1-87
   El-Kamel AH, 2007, AAPS PHARMSCITECH, V8
   Erisken C, 2008, BIOMATERIALS, V29, P4065, DOI 10.1016/j.biomaterials.2008.06.022
   Felipe MEMC, 2007, J PERIODONTOL, V78, P1209, DOI 10.1902/jop.2007.060356
   Fisher OZ, 2010, ACCOUNTS CHEM RES, V43, P419, DOI 10.1021/ar900226q
   Freeman CD, 1997, DRUGS, V54, P679, DOI 10.2165/00003495-199754050-00003
   Fu YC, 2008, BIOTECHNOL BIOENG, V99, P996, DOI 10.1002/bit.21648
   Fujihara K, 2005, BIOMATERIALS, V26, P4139, DOI 10.1016/j.biomaterials.2004.09.014
   Gaharwar AK, 2011, BIOMACROMOLECULES, V12, P1641, DOI 10.1021/bm200027z
   Galler KM, 2011, REGEN MED, V6, P191, DOI 10.2217/RME.11.3
   Gentile P, 2011, BIOTECHNOL J, V6, P1187, DOI 10.1002/biot.201100294
   Geurs NC, 2008, J PERIODONTOL, V79, P1133, DOI 10.1902/jop.2008.070595 
   Giannobile William V, 2003, Ann Periodontol, V8, P193, DOI 10.1902/annals.2003.8.1.193
   Gielkens PFM, 2008, J DENT RES, V87, P1048, DOI 10.1177/154405910808701107
   GILLETT IR, 1990, J CLIN PERIODONTOL, V17, P673, DOI 10.1111/j.1600-051X.1990.tb01053.x
   Gouk SS, 2008, J BIOMED MATER RES B, V84B, P205, DOI 10.1002/jbm.b.30862
   Grandin H, 2011, TISSUE ENG B
   Gupta D, 2009, BIOMATERIALS, V30, P2085, DOI 10.1016/j.biomaterials.2008.12.079
   Haffajee A D, 1994, Periodontol 2000, V5, P78, DOI 10.1111/j.1600-0757.1994.tb00020.x
   He CL, 2009, J BIOMED MATER RES A, V89A, P80, DOI 10.1002/jbm.a.32004
   Hosokawa R, 2000, CLIN ORAL IMPLAN RES, V11, P345, DOI 10.1034/j.1600-0501.2000.011004345.x
   Hou LT, 2004, J CLIN PERIODONTOL, V31, P68, DOI 10.1111/j.0303-6979.2004.00436.x
   Hyun YT, 2007, KEY ENG MATER, V342-343, P109, DOI 10.4028/www.scientific.net/KEM.342-343.109
   Jeong SI, 2007, BIOMATERIALS, V28, P1115, DOI 10.1016/j.biomaterials.2006.10.025
   Jose MV, 2010, MACROMOL BIOSCI, V10, P433, DOI 10.1002/mabi.200900287
   Jose MV, 2009, ACTA BIOMATER, V5, P305, DOI 10.1016/j.actbio.2008.07.019
   JOVANOVIC SA, 1995, INT J PERIODONT REST, V15, P57
   Jung RE, 2003, CLIN ORAL IMPLAN RES, V14, P556, DOI 10.1034/j.1600-0501.2003.00921.x
   Karring T, 2000, J Int Acad Periodontol, V2, P101
   Karring T, 1993, Periodontol 2000, V1, P26, DOI 10.1111/j.1600-0757.1993.tb00204.x
   Karsenty G, 1999, GENE DEV, V13, P3037, DOI 10.1101/gad.13.23.3037
   Kasaj Adrian, 2008, Head Face Med, V4, P22, DOI 10.1186/1746-160X-4-22
   Kassab MM, 2003, J AM DENT ASSOC, V134, P220, DOI 10.14219/jada.archive.2003.0137
   Kenawy ER, 2002, J CONTROL RELEASE, V81, P57, DOI 10.1016/S0168-3659(02)00041-X
   Kikuchi M, 2004, BIOMATERIALS, V25, P5979, DOI 10.1016/j.biomaterials.2004.02.001
   Kirker-Head CA, 2007, JAVMA-J AM VET MED A, V231, P1039, DOI 10.2460/javma.231.7.1039
   Kitamura M, 2011, J DENT RES, V90, P35, DOI 10.1177/0022034510384616
   Klinge U, 1999, EUR J SURG, V165, P665
   LANGER R, 1993, SCIENCE, V260, P920, DOI 10.1126/science.8493529
   Laurell L, 1998, INT DENT J, V48, P386, DOI 10.1111/j.1875-595X.1998.tb00701.x
   Li JD, 2009, J MATER SCI-MATER M, V20, P1031, DOI 10.1007/s10856-008-3664-2
   Li WJ, 2006, ACTA BIOMATER, V2, P377, DOI 10.1016/j.actbio.2006.02.005
   Li WJ, 2002, J BIOMED MATER RES, V60, P613, DOI 10.1002/jbm.10167
   Liao S, 2005, BIOMATERIALS, V26, P7564, DOI 10.1016/j.biomaterials.2005.05.050
   Liao S, 2007, DENT MATER, V23, P1120, DOI 10.1016/j.dental.2006.06.045
   Lin CC, 2009, PHARM RES-DORD, V26, P631, DOI 10.1007/s11095-008-9801-2
   LINDE A, 1993, J PERIODONTOL, V64, P1116, DOI 10.1902/jop.1993.64.11s.1116
   LIVESEY SA, 1995, TRANSPLANTATION, V60, P1, DOI 10.1097/00007890-199507150-00001
   Lutolf MP, 2003, P NATL ACAD SCI USA, V100, P5413, DOI 10.1073/pnas.0737381100
   MAGNUSSON I, 1988, J PERIODONTOL, V59, P1, DOI 10.1902/jop.1988.59.1.1
   Martins A, 2008, INT MATER REV, V53, P257, DOI 10.1179/174328008X353547
   Martins A, 2007, NANOMEDICINE-UK, V2, P929, DOI 10.2217/17435889.2.6.929
   McClain PK, 2000, PERIODONTOL 2000, V22, P190, DOI 10.1034/j.1600-0757.2000.2220112.x
   McClure MJ, 2010, ACTA BIOMATER, V6, P2422, DOI 10.1016/j.actbio.2009.12.029
   Milella E, 2001, J BIOMED MATER RES, V58, P427, DOI 10.1002/jbm.1038
   Milella E, 2001, J BIOMED MATER RES, V57, P248, DOI 10.1002/1097-4636(200111)57:2<248::AID-JBM1165>3.0.CO;2-X
   Murphy Kevin G, 2003, Ann Periodontol, V8, P266, DOI 10.1902/annals.2003.8.1.266
   Murugan R, 2006, TISSUE ENG, V12, P435, DOI 10.1089/ten.2006.12.435
   Nakahara Taka, 2006, Dent Clin North Am, V50, P265, DOI 10.1016/j.cden.2005.11.004
   Nakashima M, 2003, NAT BIOTECHNOL, V21, P1025, DOI 10.1038/nbt864
   Nam J, 2007, TISSUE ENG, V13, P2249, DOI 10.1089/ten.2006.0306
   Nanci A, 2006, PERIODONTOL 2000, V40, P11, DOI 10.1111/j.1600-0757.2005.00141.x
   Needleman IG, 2006, COCHRANE DB SYST REV, V2, P29
   Nevins M, 2005, J PERIODONTOL, V76, P2205, DOI 10.1902/jop.2005.76.12.2205
   Ngiam M, 2009, BONE, V45, P4, DOI 10.1016/j.bone.2009.03.674
   Nie H, 2008, BIOTECHNOL BIOENG, V99, P223, DOI 10.1002/bit.21517
   Nishimura F, 2007, PERIODONTOL 2000, V43, P245, DOI 10.1111/j.1600-0757.2006.00171.x
   NYMAN S, 1982, J CLIN PERIODONTOL, V9, P257, DOI 10.1111/j.1600-051X.1982.tb02065.x
   NYMAN S, 1982, J CLIN PERIODONTOL, V9, P290, DOI 10.1111/j.1600-051X.1982.tb02095.x
   NYMAN S, 1987, J PERIODONTAL RES, V22, P252, DOI 10.1111/j.1600-0765.1987.tb01581.x
   Owens K W, 2001, Implant Dent, V10, P49
   Park JK, 2009, ACTA BIOMATER, V5, P3394, DOI 10.1016/j.actbio.2009.05.019
   Park YJ, 2000, J BIOMED MATER RES, V51, P391, DOI 10.1002/1097-4636(20000905)51:3<391::AID-JBM13>3.0.CO;2-9
   Pham QP, 2006, TISSUE ENG, V12, P1197, DOI 10.1089/ten.2006.12.1197
   Phipps MC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016813
   Piattelli A, 1996, BIOMATERIALS, V17, P791, DOI 10.1016/0142-9612(96)81416-5
   Pihlstrom BL, 2005, LANCET, V366, P1809, DOI 10.1016/S0140-6736(05)67728-8
   Polimeni G, 2006, PERIODONTOL 2000, V41, P30, DOI 10.1111/j.1600-0757.2006.00157.x
   Polimeni G, 2005, J CLIN PERIODONTOL, V32, P951, DOI 10.1111/j.1600-051X.2005.00763.x
   Polimeni G, 2008, CLIN IMPLANT DENT R, V10, P99, DOI 10.1111/j.1708-8208.2007.00067.x
   Prabhakaran MP, 2009, ACTA BIOMATER, V5, P2884, DOI 10.1016/j.actbio.2009.05.007
   Raeber GP, 2005, BIOPHYS J, V89, P1374, DOI 10.1529/biophysj.104.050682
   Rathe F, 2009, TISSUE ENG PART B-RE, V15, P215, DOI 10.1089/ten.teb.2008.0065
   Reneker DH, 2008, POLYMER, V49, P2387, DOI 10.1016/j.polymer.2008.02.002
   Retzepi M, 2010, CLIN ORAL IMPLAN RES, V21, P567, DOI 10.1111/j.1600-0501.2010.01922.x
   Ripamonti U, 2007, TISSUE ENG, V13, P51, DOI 10.1089/ten.2006.0167
   Santos A, 2005, J PERIODONTOL, V76, P1982, DOI 10.1902/jop.2005.76.11.1982
   SAWHNEY AS, 1994, J BIOMED MATER RES, V28, P831, DOI 10.1002/jbm.820280710
   Sculean A, 2008, J CLIN PERIODONTOL, V35, P106, DOI 10.1111/j.1600-051X.2008.01263.x
   Sell S, 2007, POLYM INT, V56, P1349, DOI 10.1002/pi.2344
   Sell SA, 2009, ADV DRUG DELIVER REV, V61, P1007, DOI 10.1016/j.addr.2009.07.012
   Shin SY, 2005, J PERIODONTOL, V76, P1778, DOI 10.1902/jop.2005.76.10.1778
   Shoichet MS, 2010, MACROMOLECULES, V43, P581, DOI 10.1021/ma901530r
   Sill TJ, 2008, BIOMATERIALS, V29, P1989, DOI 10.1016/j.biomaterials.2008.01.011
   Slots J, 1999, PERIODONTOL 2000, V19, P164, DOI 10.1111/j.1600-0757.1999.tb00154.x
   Soletti L, 2010, ACTA BIOMATER, V6, P110, DOI 10.1016/j.actbio.2009.06.026
   Southerland JH, 2006, PERIODONTOL 2000, V40, P130, DOI 10.1111/j.1600-0757.2005.00138.x
   Srouji S, 2011, TISSUE ENG PT A, V17, P269, DOI [10.1089/ten.tea.2010.0250, 10.1089/ten.TEA.2010.0250]
   Sundararaghavan HG, 2008, J BIOMED MATER RES A, V87A, P308, DOI 10.1002/jbm.a.31715
   Sung HW, 1999, J BIOMAT SCI-POLYM E, V10, P63, DOI 10.1163/156856299X00289
   Sung HW, 1999, BIOMATERIALS, V20, P1759, DOI 10.1016/S0142-9612(99)00069-1
   Sung HW, 1999, J BIOMED MATER RES, V47, P116, DOI 10.1002/(SICI)1097-4636(199911)47:2<116::AID-JBM2>3.0.CO;2-J
   Taba M Jr, 2005, Orthod Craniofac Res, V8, P292
   Takata T, 2001, J PERIODONTAL RES, V36, P322, DOI 10.1034/j.1600-0765.2001.360508.x
   Tal H, 2008, CLIN ORAL IMPLAN RES, V19, P760, DOI 10.1111/j.1600-0501.2008.01546.x
   Tatakis DN, 2000, J PERIODONTOL, V71, P299, DOI 10.1902/jop.2000.71.2.299
   Teng SH, 2008, J BIOMED MATER RES B, V87B, P132, DOI 10.1002/jbm.b.31082
   Teng SH, 2009, J BIOMED MATER RES A, V88A, P569, DOI 10.1002/jbm.a.31897
   Tessmar J, 2006, SALT LEACHING POLYM
   Thoma DS, 2011, J CLIN PERIODONTOL, V38, P253, DOI 10.1111/j.1600-051X.2010.01656.x
   Thomas V, 2006, J NANOSCI NANOTECHNO, V6, P487, DOI 10.1166/jnn.2006.097
   Thomas V, 2007, BIOMED MATER, V2, P224, DOI 10.1088/1748-6041/2/4/004
   Thomas V, 2006, CURR NANOSCI, V2, P155
   Thomas V, 2007, BIOMACROMOLECULES, V8, P631, DOI 10.1021/bm060879w
   Thomas V, 2011, ACTA BIOMATER, V7, P2070, DOI 10.1016/j.actbio.2011.01.008
   Thomas V, 2009, BIOTECHNOL BIOENG, V104, P1025, DOI 10.1002/bit.22467
   Trombelli L, 2005, PERIODONTOL 2000, V37, P88, DOI 10.1111/j.1600-0757.2004.03798.x
   Tugnait A, 2001, J DENT, V29, P381, DOI 10.1016/S0300-5712(01)00035-5
   Venezia E, 2004, CRIT REV ORAL BIOL M, V15, P382, DOI 10.1177/154411130401500605
   Venugopal J, 2008, J MATER SCI-MATER M, V19, P2039, DOI 10.1007/s10856-007-3289-x
   Venugopal J, 2008, J BIOMED MATER RES B, V84B, P34, DOI 10.1002/jbm.b.30841
   Wang C, 2002, MATER LETT, V57, P99, DOI 10.1016/S0167-577X(02)00706-1
   Wang HL, 2005, J PERIODONTOL, V76, P1601
   Wennstrom J L, 1996, Ann Periodontol, V1, P671, DOI 10.1902/annals.1996.1.1.671
   Wikesjo U M, 1995, J Calif Dent Assoc, V23, P30
   Wu CJ, 2011, MACROMOLECULES, V44, P8215, DOI 10.1021/ma200562k
   Wutticharoenmongkol P, 2006, MACROMOL BIOSCI, V6, P70, DOI 10.1002/mabi.200500150
   Yamada M, 2011, CLIN ORAL IMPLAN RES, V22, P165, DOI 10.1111/j.1600-0501.2010.01975.x
   Yang F, 2009, ACTA BIOMATER, V5, P3295, DOI 10.1016/j.actbio.2009.05.023
   Zamani M, 2010, EUR J PHARM BIOPHARM, V75, P179, DOI 10.1016/j.ejpb.2010.02.002
   Zhang JC, 2010, CLIN ORAL IMPLAN RES, V21, P392, DOI 10.1111/j.1600-0501.2009.01857.x
   Zhang X, 2009, J BIOMED MATER RES B, V89B, P135, DOI 10.1002/jbm.b.31196
   Zhu JM, 2010, BIOMATERIALS, V31, P4639, DOI 10.1016/j.biomaterials.2010.02.044
   Zilberman M, 2008, J CONTROL RELEASE, V130, P202, DOI 10.1016/j.jconrel.2008.05.020
NR 162
TC 167
Z9 171
U1 30
U2 190
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0109-5641
EI 1879-0097
J9 DENT MATER
JI Dent. Mater.
PD JUL
PY 2012
VL 28
IS 7
BP 703
EP 721
DI 10.1016/j.dental.2012.04.022
PG 19
WC Dentistry, Oral Surgery & Medicine; Materials Science, Biomaterials
SC Dentistry, Oral Surgery & Medicine; Materials Science
GA 952PY
UT WOS:000304805800005
PM 22592164
HC Y
HP N
DA 2018-10-19
ER

PT J
AU Bajpai, I
   Saha, N
   Basu, B
AF Bajpai, Indu
   Saha, Naresh
   Basu, Bikramjit
TI Moderate intensity static magnetic field has bactericidal effect on E.
   coli and S. epidermidis on sintered hydroxyapatite
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART B-APPLIED BIOMATERIALS
LA English
DT Article
DE antibacterial; static magnetic field; bacterial adhesion; hydroxyapatite
ID ESCHERICHIA-COLI; ELECTROMAGNETIC-FIELDS; STAPHYLOCOCCUS-EPIDERMIDIS;
   MEMBRANE DAMAGE; KILLS BACTERIA; CELL-WALL; ADHESION; MECHANISM;
   SURFACES; ANTIBACTERIAL
AB The application of electromagnetic field in the context of bacteria associated infections on biomaterial surfaces has not been extensively explored. In this work, we applied a moderate intensity static magnetic field (100 mT) to understand the adhesion and growth behavior of both gram positive (S. epidermidis) and gram negative bacteria (E. coli) and also to investigate bactericidal/bacteriostatic property of the applied electromagnetic field. An in-house built magnetometer was used to apply static homogeneous magnetic field during a planned set of in vitro experiments. Both the sintered hydroxyapatite (HA) and the control samples seeded with bacteria were exposed to the magnetic field (100 mT) for different timescale during their log phase growth. Quantitative analysis of the SEM images confirms the effect of electromagnetic field on suppressing bacterial growth. Furthermore, cell integrity and inner membrane permeabilization assays were performed to understand the origin of such effect. The results of these assays were statistically analyzed to reveal the bactericidal effect of magnetic field, indicating cell membrane damage. Under the investigated culture conditions, the bactericidal effect was found to be less effective for S. Epidermidis than E. coli. (c) 2012 Wiley Periodicals, Inc. J Biomed Mater Res Part B: Appl Biomater 2012:100B:12061217, 2012.
C1 [Basu, Bikramjit] Indian Inst Sci, Mat Res Ctr, Bangalore 560012, Karnataka, India.
   [Bajpai, Indu; Saha, Naresh] Indian Inst Technol, Dept Mat Sci & Engn, Lab Biomat, Kanpur 208016, Uttar Pradesh, India.
RP Basu, B (reprint author), Indian Inst Sci, Mat Res Ctr, Bangalore 560012, Karnataka, India.
EM bikram@mrc.iisc.ernet.in
RI BASU, BIKRAMJIT/A-9967-2013
FU Department of Science and Technology; Department of Biotechnology,
   Government of India
FX Contract grant sponsors: Department of Science and Technology and
   Department of Biotechnology, Government of India
CR Albertini MC, 2003, BIOCHIMIE, V85, P963, DOI 10.1016/j.biochi.2003.09.017
   An YH, 1998, J BIOMED MATER RES, V43, P338, DOI 10.1002/(SICI)1097-4636(199823)43:3<338::AID-JBM16>3.0.CO;2-B
   Becker RO, 1963, ELECT BIOL ENG, V1, P293
   Binhi VN, 2001, BIOELECTROMAGNETICS, V22, P79, DOI 10.1002/1521-186X(200102)22:2<79::AID-BEM1009>3.0.CO;2-7
   Bowden MG, 2005, MICROBIOL-SGM, V151, P1453, DOI 10.1099/mic.0.27534-0
   Chen W, 2006, BIOMATERIALS, V27, P5512, DOI 10.1016/j.biomaterials.2006.07.003
   Costerton JW, 1999, SCIENCE, V284, P1318, DOI 10.1126/science.284.5418.1318
   Dini L, 2005, MICRON, V36, P195, DOI 10.1016/j.micron.2004.12.009
   Fanelli C, 1999, FASEB J, V13, P95
   Fojt L, 2004, BIOELECTROCHEMISTRY, V63, P337, DOI 10.1016/j.bioelechem.2003.11.010
   Garrett TR, 2008, PROG NAT SCI, V18, P1049, DOI 10.1016/j.pnsc.2008.04.001
   Gartzke J, 2002, AM J PHYSIOL-CELL PH, V283, pC1333, DOI 10.1152/ajpcell.00167.2002
   Gollwitzer H, 2003, J ANTIMICROB CHEMOTH, V51, P585, DOI 10.1093/jac/dkg105
   Harris LG, 2006, INJURY, V37, P3, DOI 10.1016/j.injury.2006.04.003
   HOGT AH, 1985, J GEN MICROBIOL, V131, P2485
   HONG FT, 1995, BIOSYSTEMS, V36, P187, DOI 10.1016/0303-2647(95)01555-Y
   Hori K, 2010, BIOCHEM ENG J, V48, P424, DOI 10.1016/j.bej.2009.11.014
   Ibrahim HR, 2000, BBA-GEN SUBJECTS, V1523, P196, DOI 10.1016/S0304-4165(00)00122-7
   Je JY, 2006, J AGR FOOD CHEM, V54, P6629, DOI 10.1021/jf061310p
   Ji WJ, 2009, MICRON, V40, P894, DOI 10.1016/j.micron.2009.05.010
   KELLENBERGER E, 1958, J BIOPHYS BIOCHEM CY, V4, P323, DOI 10.1083/jcb.4.3.323
   Kohno, 2000, Pathophysiology, V7, P143, DOI 10.1016/S0928-4680(00)00042-0
   Kroupova J, 2007, BIOELECTROCHEMISTRY, V70, P96, DOI 10.1016/j.bioelechem.2006.03.034
   Kuijer R, 2007, BIOMATERIALS, V28, P5148, DOI 10.1016/j.biomaterials.2007.06.003
   Liu H, 2004, INT J FOOD MICROBIOL, V95, P147, DOI 10.1016/j.ijfoodmicro.2004.01.022
   Liu Y, 2005, BIOPHYS CHEM, V117, P39, DOI 10.1016/j.bpc.2005.04.015
   Luka S, 2009, MICRON, V40, P918
   Martin M.F San, 2001, INNOV FOOD SCI EMERG, V2, P273
   Mittenzwey R, 1996, BIOELECTROCH BIOENER, V40, P21, DOI 10.1016/0302-4598(95)00504-8
   Miyakoshi J, 2005, PROG BIOPHYS MOL BIO, V87, P213, DOI 10.1016/j.pbiomolbio.2004.08.008
   NAFZIGER J, 1993, BIOELECTROCH BIOENER, V30, P133, DOI 10.1016/0302-4598(93)80071-2
   Nath S, 2010, J MATER SCI-MATER M, V21, P1273, DOI 10.1007/s10856-009-3939-2
   NIKAIDO H, 1994, SCIENCE, V264, P382, DOI 10.1126/science.8153625
   Otto K, 2008, RES MICROBIOL, V159, P415, DOI 10.1016/j.resmic.2008.04.007
   Panagopoulos DJ, 2002, BIOCHEM BIOPH RES CO, V298, P95, DOI 10.1016/S0006-291X(02)02393-8
   RIJNAARTS HHM, 1995, COLLOID SURFACE B, V4, P5, DOI DOI 10.1016/0927-7765(94)01146-V
   Saha N., 2011, J BIOMED MATER RES B, V100B, P256
   Saha N, 2010, J BIOMED MATER RES B, V95B, P430, DOI 10.1002/jbm.b.31734
   Santos Maria Helena, 2004, Mat. Res., V7, P625, DOI 10.1590/S1516-14392004000400017
   Schierholz JM, 2001, J HOSP INFECT, V49, P87, DOI 10.1053/jhin.2001.1052
   Schulz GE, 2002, BBA-BIOMEMBRANES, V1565, P308, DOI 10.1016/S0005-2736(02)00577-1
   Strasak L, 2002, BIOELECTROCHEMISTRY, V55, P161, DOI 10.1016/S1567-5394(01)00152-9
   Todar K., TODARS ONLINE TXB BA
   Triampo W, 2004, J BIOSCI BIOENG, V98, P182
   Tsuchiya K, 1996, J FERMENT BIOENG, V81, P343, DOI 10.1016/0922-338X(96)80588-5
NR 45
TC 14
Z9 15
U1 1
U2 24
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1552-4973
J9 J BIOMED MATER RES B
JI J. Biomed. Mater. Res. Part B
PD JUL
PY 2012
VL 100B
IS 5
BP 1206
EP 1217
DI 10.1002/jbm.b.32685
PG 12
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 953JX
UT WOS:000304864500004
PM 22576793
DA 2018-10-19
ER

PT J
AU Cheng, NC
   Chang, HH
   Tu, YK
   Young, TH
AF Cheng, Nai-Chen
   Chang, Hsu-Hsien
   Tu, Yuan-Kun
   Young, Tai-Horng
TI Efficient transfer of human adipose-derived stem cells by
   chitosan/gelatin blend films
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART B-APPLIED BIOMATERIALS
LA English
DT Article
DE adipose-derived stem cell; chitosan; gelatin; cell therapy; wound
   dressings
ID IN-VITRO; CHONDROGENIC DIFFERENTIATION; BIOMEDICAL APPLICATIONS; GELATIN
   SCAFFOLDS; COATED SURFACE; TISSUE; CHONDROCYTES; SPHEROIDS; HYDROGEL;
   ALGINATE
AB Adipose-derived stem cells (ASCs) are a potential source of abundant mesenchymal stem cells and represent a promising cell-based therapy for tissue damage or degeneration conditions. Previous investigations have demonstrated enhanced therapeutic effects of ASCs in a three-dimensional spheroid culture formulation. In this study, we hypothesize that a composite membrane made of chitosan/gelatin (C/G) is beneficial to facilitate transfer of human ASCs in spheroids. Increasing chitosan content within the blends enhanced the mechanical properties of the sample, including tensile strength and elongation-at-break ratio. Although ASC spheroids developed shortly after seeding on pure chitosan films, increasing gelatin proportion in the C/G blends promoted cell adhesion onto the membranes. We also found that ASCs did not proliferate on chitosan films, but C/G blends of different ratios supported ASC proliferation in the first 4 days of culture. However, ASCs on all C/G blends started to detach from the films to form spheroids after day 4, while ASCs on pure gelatin films remained attached and continued to grow. Gradual gelatin release from the C/G blend films, leading to enriched chitosan content in the blends, probably encouraged ASC detachment and spheroid formation. We placed porous collagen matrix on ASC-seeded C/G blends to simulate the application of ASC-seeded C/G films onto injured tissue and found that a C/G film composed of 75% chitosan could facilitate significantly more cell transfer into the overlying collagen sponge. Therefore, a blend film containing 75% chitosan and 25% gelatin showed promising results to serve as a biomaterial for human ASC-based cell therapy. (c) 2012 Wiley Periodicals, Inc. J Biomed Mater Res Part B:, 2012.
C1 [Cheng, Nai-Chen; Chang, Hsu-Hsien; Young, Tai-Horng] Natl Taiwan Univ, Inst Biomed Engn, Coll Med, Taipei 100, Taiwan.
   [Cheng, Nai-Chen; Chang, Hsu-Hsien; Young, Tai-Horng] Natl Taiwan Univ, Coll Engn, Taipei 100, Taiwan.
   [Cheng, Nai-Chen] Natl Taiwan Univ Hosp, Dept Surg, Taipei 100, Taiwan.
   [Cheng, Nai-Chen; Young, Tai-Horng] Natl Taiwan Univ, Res Ctr Dev Biol & Regenerat Med, Taipei 100, Taiwan.
   [Tu, Yuan-Kun] I Shou Univ, Dept Orthoped, E Da Hosp, Kaohsiung, Taiwan.
RP Young, TH (reprint author), Natl Taiwan Univ, Inst Biomed Engn, Coll Med, Taipei 100, Taiwan.
EM thyoung@ntu.edu.tw
OI Cheng, Naichen/0000-0003-4071-5628
FU National Science Council, Taiwan [NSC 100-2320-B-002-108]; National
   Taiwan University Hospital [100-M1690]; E-Da Hospital-National Taiwan
   University Hospital [100-EDN09]
FX Contract grant sponsor: National Science Council, Taiwan; contract grant
   number: NSC 100-2320-B-002-108; Contract grant sponsor: National Taiwan
   University Hospital; contract grant number: 100-M1690; Contract grant
   sponsor: E-Da Hospital-National Taiwan University Hospital Joint
   Research Program; contract grant number: 100-EDN09
CR AHMED SA, 1994, J IMMUNOL METHODS, V170, P211
   Aust L, 2004, CYTOTHERAPY, V6, P7, DOI 10.1080/14653240310004539
   Awad HA, 2004, BIOMATERIALS, V25, P3211, DOI 10.1016/j.biomaterials.2003.10.045
   Badylak SE, 2008, SEMIN IMMUNOL, V20, P109, DOI 10.1016/j.smim.2007.11.003
   Chatelet C, 2001, BIOMATERIALS, V22, P261, DOI 10.1016/S0142-9612(00)00183-6
   Chen YH, 2009, TISSUE ENG PT A, V15, P2001, DOI 10.1089/ten.tea.2008.0251
   Cheng MY, 2003, BIOMATERIALS, V24, P2871, DOI 10.1016/S0142-9612(03)00117-0
   Cheng NC, 2012, BIOMATERIALS, V33, P1748, DOI 10.1016/j.biomaterials.2011.11.049
   Cheng NC, 2009, TISSUE ENG PT A, V15, P231, DOI 10.1089/ten.tea.2008.0253
   Cheng YH, 2011, BIOMATERIALS, V32, P6953, DOI 10.1016/j.biomaterials.2011.03.065
   Chiono V, 2008, J MATER SCI-MATER M, V19, P889, DOI 10.1007/s10856-007-3212-5
   Cui YL, 2003, BIOMATERIALS, V24, P3859, DOI 10.1016/S0142-9612(03)00209-6
   Dhandayuthapani B, 2010, J BIOMED MATER RES B, V94B, P264, DOI 10.1002/jbm.b.31651
   Di Martino A, 2005, BIOMATERIALS, V26, P5983, DOI 10.1016/j.biomaterials.2005.03.016
   Dominici M, 2006, CYTOTHERAPY, V8, P315, DOI 10.1080/14653240600855905
   Estes RT, 2006, J CELL PHYSIOL, V209, P987, DOI 10.1002/jcp.20808
   Franco RA, 2011, J MATER SCI-MATER M, V22, P2207, DOI 10.1007/s10856-011-4402-8
   Fraser JK, 2006, TRENDS BIOTECHNOL, V24, P150, DOI 10.1016/j.tibtech.2006.01.010
   Gimble Jeffrey M, 2011, Front Biosci (Schol Ed), V3, P69, DOI 10.2741/s133
   Gimble JM, 2003, CURR TOP DEV BIOL, V58, P137, DOI 10.1016/S0070-2153(03)58005-X
   Guilak F, 2006, J CELL PHYSIOL, V206, P229, DOI 10.1002/jcp.20463
   Han YS, 2009, GERONTOLOGY, V55, P592, DOI 10.1159/000235547
   Huang Y, 2005, BIOMATERIALS, V26, P7616, DOI 10.1016/j.biomaterials.2005.05.036
   Kim S, 2005, J BIOMED MATER RES B, V75B, P442, DOI 10.1002/jbm.b.30324
   Lee WY, 2009, BIOMATERIALS, V30, P5505, DOI 10.1016/j.biomaterials.2009.07.006
   Li JJ, 2010, J BIOMED MATER RES B, V95B, P308, DOI 10.1002/jbm.b.31715
   Lin SJ, 2005, BIOMATERIALS, V26, P1413, DOI 10.1016/j.biomaterials.2004.05.002
   Lu Z, 2010, TISSUE ENG PT A, V16, P81, DOI [10.1089/ten.tea.2009.0222, 10.1089/ten.TEA.2009.0222]
   Mao JS, 2004, BIOMATERIALS, V25, P3973, DOI 10.1016/j.biomaterials.2003.10.080
   Pulieri E, 2008, J BIOMED MATER RES A, V86A, P311, DOI 10.1002/jbm.a.31492
   Risbud M, 2001, CELL TRANSPLANT, V10, P755, DOI 10.3727/000000001783986224
   Ryan PL, 2001, P NATL ACAD SCI USA, V98, P4323, DOI 10.1073/pnas.071615398
   Sechriest VF, 2000, J BIOMED MATER RES, V49, P534, DOI 10.1002/(SICI)1097-4636(20000315)49:4<534::AID-JBM12>3.0.CO;2-#
   Shao HJ, 2010, J BIOMED MATER RES A, V93A, P1297, DOI 10.1002/jbm.a.32629
   Shi CM, 2006, J SURG RES, V133, P185, DOI 10.1016/j.jss.2005.12.013
   Tigli RS, 2009, J TISSUE ENG REGEN M, V3, P348, DOI 10.1002/term.169
   Tsai T, 2011, ANTIMICROB AGENTS CH, V55, P1883, DOI 10.1128/AAC.00550-10
   Tuzlakoglu K, 2004, MACROMOL BIOSCI, V4, P811, DOI 10.1002/mabi.200300100
   Vickers SM, 2006, TISSUE ENG, V12, P1345, DOI 10.1089/ten.2006.12.1345
   Yang TL, 2009, BIOCHEM BIOPH RES CO, V381, P466, DOI 10.1016/j.bbrc.2008.10.116
   Yeh LK, 2009, J BIOMED MATER RES A, V90A, P18, DOI 10.1002/jbm.a.32077
   Yu J, 2009, BIOMATERIALS, V30, P751, DOI 10.1016/j.biomaterials.2008.09.059
NR 42
TC 8
Z9 10
U1 2
U2 28
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1552-4973
EI 1552-4981
J9 J BIOMED MATER RES B
JI J. Biomed. Mater. Res. Part B
PD JUL
PY 2012
VL 100B
IS 5
BP 1369
EP 1377
DI 10.1002/jbm.b.32706
PG 9
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 953JX
UT WOS:000304864500022
PM 22566407
DA 2018-10-19
ER

PT J
AU Baiguera, S
   Macchiarini, P
   Ribatti, D
AF Baiguera, Silvia
   Macchiarini, Paolo
   Ribatti, Domenico
TI Chorioallantoic membrane for in vivo investigation of tissue-engineered
   construct biocompatibility
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART B-APPLIED BIOMATERIALS
LA English
DT Review
DE biocompatibility; chorioallantoic membrane (CAM); tissue-engineered
   construct; tissue regeneration
ID ENDOTHELIAL GROWTH-FACTOR; CHICK-EMBRYO; COLLAGEN MATRICES; COVALENT
   INCORPORATION; ANGIOGENESIS ASSAYS; MODEL; BIOMATERIALS; SCAFFOLDS;
   RESPONSES; HEPARIN
AB In tissue engineering approach, the scaffold plays a key role for a suitable outcome of cell-scaffold interactions and for the success of tissue healing and regeneration. As a consequence, the characterization of scaffold properties and the in vivo evaluation of tissue responses and effects result to be essential in the development of suitable implantable device. Among the in vivo methods, the chick embryo chorioallantoic membrane (CAM) assay represents a rather simple and cost-effective procedure to study the biocompatibility responses of graft materials. CAM is indeed characterized by low experiment costs, simplicity, relative speed in obtaining the expected results, limited ethical concern, no need of high-level technical skill, and the absence of a mature immune system, resulting in an inexpensive, simple, and practical method to evaluate and characterize tissue-engineered constructs. The results till now obtained suggest that CAM assay can be used as a pre-screening assay, before in vivo animal studies, to determine whether the scaffold is liable to cause an adverse reaction and to evaluate its future enhancement of existing materials for tissue engineering. A review of the more recent results related to the use of CAM for in vivo biomaterial property evaluation is herein reported. (c) 2012 Wiley Periodicals, Inc. J Biomed Mater Res Part B: Appl Biomater, 2012.
C1 [Baiguera, Silvia; Macchiarini, Paolo] Univ Hosp Careggi, European Ctr Thorac Res CERT, BIOAIRLab, Florence, Italy.
   [Ribatti, Domenico] Univ Bari, Sch Med, Dept Basic Med Sci, Bari, Italy.
RP Baiguera, S (reprint author), Univ Hosp Careggi, European Ctr Thorac Res CERT, BIOAIRLab, Florence, Italy.
EM sbaiguer@libero.it
RI Macchiarini, Paolo/E-6878-2013; Yin, ming/F-3737-2012
FU Associazione Italiana per la Ricerca sul Cancro (AIRC); Investigator
   Grant and Special Program Molecular Clinical Oncology [pd 239-
   28/04/2009, delibera GRT 1210/08]
FX Contract grant sponsors: Associazione Italiana per la Ricerca sul Cancro
   (AIRC); Investigator Grant and Special Program Molecular Clinical
   Oncology 5 per mille n. 9965, Milan, Italy; Grant (pd 239- 28/04/2009,
   delibera GRT 1210/08) issued on the 28 December 2008 by the region
   Tuscany (Italy) entitled "Clinical laboratory for complex thoracic
   respiratory and vascular diseases and alternatives to pulmonary
   transplantation''
CR Anderson JM, 1999, J CONTROL RELEASE, V57, P107, DOI 10.1016/S0168-3659(98)00178-3
   AUERBACH R, 1974, DEV BIOL, V41, P391, DOI 10.1016/0012-1606(74)90316-9
   Azzarello J, 2007, BIOMED MATER, V2, P55, DOI 10.1088/1748-6041/2/2/001
   Baiguera S, 2011, BIOMATERIALS, V32, P4433, DOI 10.1016/j.biomaterials.2011.02.055
   Baiguera S, 2010, BIOMATERIALS, V31, P8931, DOI 10.1016/j.biomaterials.2010.08.005
   Borges J, 2003, TISSUE ENG, V9, P441, DOI 10.1089/107632703322066624
   Brown BN, 2010, BIOMATERIALS, V31, P428, DOI 10.1016/j.biomaterials.2009.09.061
   Buschmann J, 2011, TISSUE ENG PT A, V17, P291, DOI [10.1089/ten.tea.2010.0278, 10.1089/ten.TEA.2010.0278]
   Carmeliet P, 2005, NATURE, V438, P932, DOI 10.1038/nature04478
   Chiba A, 2010, ARCH HISTOL CYTOL, V73, P45, DOI 10.1679/aohc.73.45
   Conconi MT, 2005, J ANAT, V207, P79, DOI 10.1111/j.1469-7580.2005.00427.x
   Conconi MT, 2004, ANAT REC PART A, V281A, P1303, DOI 10.1002/ar.a.20137
   Cortiella J, 2010, TISSUE ENG PT A, V16, P2565, DOI 10.1089/ten.tea.2009.0730
   CRUM R, 1985, SCIENCE, V230, P1375, DOI 10.1126/science.2416056
   DEFOUW DO, 1989, MICROVASC RES, V38, P136, DOI 10.1016/0026-2862(89)90022-8
   Dreesmann L, 2007, BIOMATERIALS, V28, P5536, DOI 10.1016/j.biomaterials.2007.08.040
   Falkner E, 2004, ATLA-ALTERN LAB ANIM, V32, P573
   Fisher AB, 2001, AM J PHYSIOL-LUNG C, V281, pL529
   Gilbert TW, 2006, BIOMATERIALS, V27, P3675, DOI 10.1016/j.biomaterials.2006.02.014
   Guedez L, 2003, AM J PATHOL, V162, P1431, DOI 10.1016/S0002-9440(10)64276-9
   Haag J, 2012, BIOMATERIALS, V33, P780, DOI 10.1016/j.biomaterials.2011.10.008
   Hasan Jurjees, 2004, Angiogenesis, V7, P1, DOI 10.1023/B:AGEN.0000037338.51851.d1
   Holzmann P, 2010, ALTEX-ALTERN ANIM EX, V27, P97
   Jain RK, 1997, NAT MED, V3, P1203, DOI 10.1038/nm1197-1203
   JANSE EM, 1991, IMMUNOBIOLOGY, V182, P472
   Katoh M, 2001, CELLS TISSUES ORGANS, V169, P125, DOI 10.1159/000047870
   Kauvar AS, 2010, J PERIODONTOL, V81, P1196, DOI 10.1902/jop.2010.090441
   Klueh U, 2003, J BIOMED MATER RES A, V67A, P838, DOI 10.1002/jbm.a.10059
   Koch S, 2006, J MATER SCI-MATER M, V17, P735, DOI 10.1007/s10856-006-9684-x
   Li S, 2005, J CELL BIOCHEM, V96, P1110, DOI 10.1002/jcb.20614
   Macchiarini P, 2008, LANCET, V372, P2023, DOI 10.1016/S0140-6736(08)61598-6
   Murphy JB, 1913, J EXP MED, V17, P482, DOI 10.1084/jem.17.4.482
   NGUYEN M, 1994, MICROVASC RES, V47, P31, DOI 10.1006/mvre.1994.1003
   Oates M, 2007, BIOMATERIALS, V28, P3679, DOI 10.1016/j.biomaterials.2007.04.042
   Ott HC, 2008, NAT MED, V14, P213, DOI 10.1038/nm1684
   Petersen TH, 2010, SCIENCE, V329, P538, DOI 10.1126/science.1189345
   Ribatti D, 2003, BRAIN RES, V989, P9, DOI 10.1016/S0006-8993(03)03225-6
   Ribatti D, 2001, ANAT REC, V264, P317, DOI 10.1002/ar.10021
   Ribatti D, 1996, INT J DEV BIOL, V40, P1189
   Ribatti D, 2010, INT REV CEL MOL BIO, V270, P181
   Ribatti D, 2010, CHICK EMBRYO CHORIOA, P1
   Rosengren A, 2003, J BIOMED MATER RES A, V67A, P918, DOI 10.1002/jbm.a.10509
   Schoen F. J., 2004, BIOMATERIALS SCI INT, P293
   Smith JD, 2007, MICROVASC RES, V73, P84, DOI 10.1016/j.mvr.2006.10.007
   Soker S, 2000, WORLD J UROL, V18, P10, DOI 10.1007/PL00007070
   Staton CA, 2009, INT J EXP PATHOL, V90, P195, DOI 10.1111/j.1365-2613.2008.00633.x
   Steffens GCM, 2004, TISSUE ENG, V10, P1502, DOI 10.1089/ten.2004.10.1502
   Storgard Chris, 2005, Methods Mol Biol, V294, P123
   Tan Q, 2007, EUR J CARDIO-THORAC, V31, P806, DOI 10.1016/j.ejcts.2007.01.045
   Uygun BE, 2010, NAT MED, V16, P814, DOI 10.1038/nm.2170
   Valdes TI, 2002, J BIOMED MATER RES, V62, P273, DOI 10.1002/jbm.10152
   Vargas GE, 2009, ACTA BIOMATER, V5, P374, DOI 10.1016/j.actbio.2008.07.016
   Wainwright JM, 2010, TISSUE ENG PART C-ME, V16, P525, DOI [10.1089/ten.tec.2009.0392, 10.1089/ten.TEC.2009.0392]
   Yang XBB, 2004, TISSUE ENG, V10, P1037, DOI 10.1089/1076327041887718
   Yao C, 2008, BIOMATERIALS, V29, P66, DOI 10.1016/j.biomaterials.2007.08.049
   Zwadlo-Klarwasser G, 2001, J MATER SCI-MATER M, V12, P195, DOI 10.1023/A:1008950713001
NR 56
TC 28
Z9 29
U1 0
U2 20
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1552-4973
EI 1552-4981
J9 J BIOMED MATER RES B
JI J. Biomed. Mater. Res. Part B
PD JUL
PY 2012
VL 100B
IS 5
BP 1425
EP 1434
DI 10.1002/jbm.b.32653
PG 10
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 953JX
UT WOS:000304864500029
PM 22279003
DA 2018-10-19
ER

PT J
AU Ortiz, J
   Chou, LL
AF Ortiz, Jan
   Chou, Laisheng Lee
TI Calcium upregulated survivin expression and associated osteogenesis of
   normal human osteoblasts
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A
LA English
DT Article
DE osteoblasts; survivin; apoptosis; calcium; biomaterial induced
ID HUMAN-BONE-CELLS; GENE-EXPRESSION; PROGRESSIVE DEVELOPMENT;
   EXTRACELLULAR CALCIUM; MOLECULAR-MECHANISMS; APOPTOSIS PROTEIN;
   CARCINOMA-CELLS; PROLIFERATION; DIFFERENTIATION; CANCER
AB Survivin is an antiapoptotic protein expressed in all phases of the normal cell cycle but is at its highest level during the G2/M interphase. This protein has been recently identified in normal human osteoblasts and has raised questions about the regulation of its expression. This study intends to verify if survivin expression could be manipulated by external factors such as calcium ions. Normal human alveolar bone explants recovered from six healthy donors were cultured to 2nd passage. Cells were cultured with essential medium as a control and with medium containing supplemental calcium ions at a concentration of 30 parts per million as a study group. Vitamin D3 was added to all culture groups at the 5th and 18th days to promote differentiation. Differentiation markers were confirmed by performing mineralization, alkaline phosphatase (ALP), and osteocalcin assays at 7 and 21 days. Cell attachment was measured at 16 h and used as a reference for cell proliferation at 7 days and 21 days. Survivin levels were measured at 16 h, 7 and 21 days. Compared with the control group, the study group presented a significant increase of survivin expression at 16 h (p < 0.01), at 7 days (p < 0.01), and at 21 days (p < 0.05), a significant increase of cell proliferation, ALP activity and mineralization at 7 days (p < 0.05) and 21 days (p < 0.05), and a significant increase in osteocalcin expression only at 21 days (p < 0.01). This study demonstrated that survivin expression could be significantly upregulated by calcium-enhanced normal human osteoblast cultures, which might correlate to subsequent upregulation of cell proliferation and differentiation. (C) 2012 Wiley Periodicals, Inc. J Biomed Mater Res Part A, 2012.
C1 [Chou, Laisheng Lee] Boston Univ, Dept Restorat Sci Biomat, Henry M Goldman Sch Dent Med, Boston, MA 02118 USA.
   [Chou, Laisheng Lee] Boston Univ, Div Oral Med, Henry M Goldman Sch Dent Med, Boston, MA 02118 USA.
   [Ortiz, Jan] Boston Univ, Dept Restorat Sci Orthodont, Henry M Goldman Sch Dent Med, Boston, MA 02118 USA.
RP Chou, LL (reprint author), Boston Univ, Dept Restorat Sci Biomat, Henry M Goldman Sch Dent Med, Boston, MA 02118 USA.
EM lchou@bu.edu
CR Altieri DC, 1999, LAB INVEST, V79, P1543
   Altieri DC, 1999, LAB INVEST, V79, P1327
   Altznauer F, 2004, J EXP MED, V199, P1343, DOI 10.1084/jem.20032003
   Ambrosini G, 1997, NAT MED, V3, P917, DOI 10.1038/nm0897-917
   AUFMKOLK B, 1985, CALCIFIED TISSUE INT, V37, P228, DOI 10.1007/BF02554868
   BARER MR, 1986, HISTOCHEM J, V18, P122, DOI 10.1007/BF01675366
   Berardi JM, 2008, J INT SOC SPORT NUTR, V5, DOI 10.1186/1550-2783-5-20
   Blanc-Brude OP, 2003, CLIN CANCER RES, V9, P2683
   Bluteau G, 2006, BIOMATERIALS, V27, P2934, DOI 10.1016/j.biomaterials.2006.01.004
   Chang YL, 2000, J BIOMED MATER RES, V52, P270, DOI 10.1002/1097-4636(200011)52:2<270::AID-JBM5>3.0.CO;2-1
   Chen Y, 2000, THESIS BOSTON U
   Delhalle S, 2003, ANN NY ACAD SCI, V1010, P1, DOI 10.1196/annals.1299.001
   Deveraux QL, 1999, GENE DEV, V13, P239, DOI 10.1101/gad.13.3.239
   Eapen A, 2010, J BIOL CHEM, V285, P36339, DOI 10.1074/jbc.M110.145607
   Freshney RI, 1994, CULTURE ANIMAL CELLS, P227
   Fukuda S, 2004, BLOOD, V103, P120, DOI 10.1182/blood-2003-05-1756
   Fukuda S, 2002, BLOOD, V100, P2463, DOI 10.1182/blood.V100.7.2463
   Fukuda S, 2001, BLOOD, V98, P2019
   GILLIES RJ, 1986, ANAL BIOCHEM, V159, P109, DOI 10.1016/0003-2697(86)90314-3
   Gurbuxani S, 2005, P NATL ACAD SCI USA, V102, P11480, DOI 10.1073/pnas.0500303102
   Hofmann A, 2008, J TRAUMA, V65, P1402, DOI 10.1097/TA.0b013e318173e7c2
   Ikeguchi M, 2002, DIAGN MOL PATHOL, V11, P33, DOI 10.1097/00019606-200203000-00007
   Johnson ME, 2004, VET PATHOL, V41, P599, DOI 10.1354/vp.41-6-599
   KANATANI M, 1991, BIOCHEM BIOPH RES CO, V181, P1425, DOI 10.1016/0006-291X(91)92098-5
   KERR JFR, 1972, BRIT J CANCER, V26, P239, DOI 10.1038/bjc.1972.33
   Khan Z, 2010, RADIOTHER ONCOL, V96, P267, DOI 10.1016/j.radonc.2010.06.005
   Kostenuik PJ, 1997, AM J PHYSIOL-ENDOC M, V273, pE1133
   KUENG W, 1989, ANAL BIOCHEM, V182, P16, DOI 10.1016/0003-2697(89)90710-0
   Li FZ, 1998, NATURE, V396, P580, DOI 10.1038/25141
   LI PJ, 1993, BIOMATERIALS, V14, P963, DOI 10.1016/0142-9612(93)90186-6
   Liang XJ, 2009, CELL BIOL INT, V33, P119, DOI 10.1016/j.cellbi.2008.10.013
   Liu GM, 2009, MOL CARCINOGEN, V48, P202, DOI 10.1002/mc.20470
   Lu J, 2011, VIROLOGY, V410, P64, DOI 10.1016/j.virol.2010.10.029
   Mailland M, 1997, ENDOCRINOLOGY, V138, P3601, DOI 10.1210/en.138.9.3601
   MANOLAGAS SC, 1981, J BIOL CHEM, V256, P7115
   Martinez A, 2004, AM J PATHOL, V164, P501, DOI 10.1016/S0002-9440(10)63140-9
   Matsuoka H, 1999, J BIOMED MATER RES, V47, P176, DOI 10.1002/(SICI)1097-4636(199911)47:2<176::AID-JBM7>3.0.CO;2-Z
   McMurtry MS, 2005, J CLIN INVEST, V115, P1479, DOI 10.1172/JCI23203
   Mesri M, 2001, AM J PATHOL, V158, P1757, DOI 10.1016/S0002-9440(10)64131-4
   Mita AC, 2008, CLIN CANCER RES, V14, P5000, DOI 10.1158/1078-0432.CCR-08-0746
   Moriai R, 2001, ANTICANCER RES, V21, P595
   Muzio L. Lo, 2003, Journal of Dental Research, V82, P923
   Nabilsi NH, 2010, J ENDOCRINOL, V207, P237, DOI 10.1677/JOE-10-0128
   Nakade O, 2001, J BONE MINER METAB, V19, P13, DOI 10.1007/s007740170055
   NIJWEIDE PJ, 1986, PHYSIOL REV, V66, P855
   Okada H, 2004, J EXP MED, V199, P399, DOI 10.1084/jem.20032092
   Ortiz J, 2010, CHIN J ORAL MAXILLOF, V8, P241
   OWEN TA, 1990, J CELL PHYSIOL, V143, P420, DOI 10.1002/jcp.1041430304
   OWEN TA, 1991, ENDOCRINOLOGY, V128, P1496, DOI 10.1210/endo-128-3-1496
   Palmieri Annalisa, 2009, Indian J Dent Res, V20, P52
   Reed JC, 2000, AM J PATHOL, V157, P1415, DOI 10.1016/S0002-9440(10)64779-7
   Reed JC, 1999, J CLIN ONCOL, V17, P2941, DOI 10.1200/JCO.1999.17.9.2941
   ROBEY PG, 1985, CALCIFIED TISSUE INT, V37, P453, DOI 10.1007/BF02557826
   Rosa J, 2006, MOL BIOL CELL, V17, P1483
   Salvesen GS, 1997, CELL, V91, P443, DOI 10.1016/S0092-8674(00)80430-4
   SODEK J, 1987, METHOD ENZYMOL, V145, P303
   STEIN GS, 1993, ENDOCR REV, V14, P424, DOI 10.1210/er.14.4.424
   SUGIMOTO T, 1994, AM J PHYSIOL, V266, pE709
   Sun JY, 2009, ACTA BIOMATER, V5, P1284, DOI 10.1016/j.actbio.2008.10.011
   Tamm I, 1998, CANCER RES, V58, P5315
   Tanaka K, 2000, CLIN CANCER RES, V6, P127
   Thornberry NA, 1998, SCIENCE, V281, P1312, DOI 10.1126/science.281.5381.1312
   Tsai SW, 2009, J BIOMED MATER RES A, V91A, P985, DOI 10.1002/jbm.a.32324
   Wolanin Kamila, 2007, Postepy Biochem, V53, P10
   Wu YF, 2010, NEOPLASMA, V57, P501, DOI 10.4149/neo_2010_06_501
   Xing Z, 2004, J EXP MED, V199, P69, DOI 10.1084/jem.20031588
   Yang D, 2004, P NATL ACAD SCI USA, V101, P15100, DOI 10.1073/pnas.0406665101
   Zou J, 2010, ARCH MED RES, V41, P162, DOI 10.1016/j.arcmed.2010.04.006
NR 68
TC 11
Z9 12
U1 0
U2 5
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1549-3296
J9 J BIOMED MATER RES A
JI J. Biomed. Mater. Res. Part A
PD JUL
PY 2012
VL 100A
IS 7
BP 1770
EP 1776
DI 10.1002/jbm.a.34103
PG 7
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 946ZN
UT WOS:000304396500015
PM 22488949
DA 2018-10-19
ER

PT J
AU Greenawalt, KE
   Corazzini, RL
   Colt, MJ
   Holmdahl, L
AF Greenawalt, Keith E.
   Corazzini, Rubina L.
   Colt, M. Jude
   Holmdahl, Lena
TI Adhesion formation to hemostatic agents and its reduction with a sodium
   hyaluronate/carboxymethylcellulose adhesion barrier
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A
LA English
DT Article
DE hemostatic agents; adhesions; adhesion prevention; sodium hyaluronate;
   carboxymethylcellulose membrane; seprafilm
ID ENDOSCOPIC SINUS SURGERY; SMALL-BOWEL OBSTRUCTION; ABDOMINAL ADHESIONS;
   POLYPROPYLENE MESH; PREVENTION; FLOSEAL; AVITENE; GRANULOMAS; CELLULOSE;
   MODEL
AB The impact of hemostatic agents on postoperative adhesion formation has not been well studied. We hypothesized that hemostatic agents would be a significant nidus for adhesion formation and that a resorbable barrier would effectively reduce adhesions to hemostatic agents. Four commercial hemostatic agents, each composed of a different biomaterial matrix, were implanted in female SpragueDawley rats, and adhesion formation was examined 7 days after surgery. In separate studies, the effects of serosal trauma (via cecal abrasion), added blood, and the presence of chemically modified sodium hyaluronate/carboxymethylcellulose (HA/CMC) barrier on adhesion formation to hemostatic agents were studied. Significant adhesions formed to hemostatic agents even in the absence of traumatized tissue. When applied after cecal abrasion, the incidence of adhesions to the hemostatic agents increased. Addition of blood to this model increased adhesion formation even further, causing adhesions in every animal in the study. An HA/CMC adhesion barrier reduced adhesions to hemostatic agents in the presence of serosal trauma and maintained effectiveness even in the presence of blood. In conclusion, hemostatic agents potentiated adhesion formation at the site of application in a model without trauma. In more challenging models, their adhesiogenic contribution was overwhelmed by trauma and blood. HA/CMC adhesion barrier applied over hemostatic agents at the time of surgery provided significant protection against postoperative adhesions in these preclinical models. (C) 2012 Wiley Periodicals, Inc. J Biomed Mater Res Part A, 2012.
C1 [Greenawalt, Keith E.; Corazzini, Rubina L.; Colt, M. Jude; Holmdahl, Lena] Genzyme Corp, Biomat Sci, Framingham, MA 01701 USA.
RP Greenawalt, KE (reprint author), Genzyme Corp, Biomat Sci, Framingham, MA 01701 USA.
EM keith.greenawalt@genzyme.com
CR [Anonymous], 1989, FERTIL STERIL, V51, P933
   Baakdah Hanadi, 2005, Surg Technol Int, V14, P185
   Baptista ML, 2000, J AM COLL SURGEONS, V190, P271, DOI 10.1016/S1072-7515(99)00277-X
   Baptista ML, 2000, SURGERY, V128, P86, DOI 10.1067/msy.2000.106810
   Barbolt TA, 2001, NEUROL RES, V23, P537, DOI 10.1179/016164101101198794
   Becker JM, 1996, J AM COLL SURGEONS, V183, P297
   Burns JM, 1995, J SURG RES, V59, P644, DOI 10.1006/jsre.1995.1218
   Burns JW, 1997, EUR J SURG, V163, P40
   Chandra RK, 2005, AM J RHINOL, V19, P240, DOI 10.1177/194589240501900304
   Dinsmore RC, 2000, J AM COLL SURGEONS, V191, P131, DOI 10.1016/S1072-7515(00)00337-9
   Divilio LT, 2005, INT SURG, V90, pS6
   Fazio VW, 2006, DIS COLON RECTUM, V49, P1, DOI 10.1007/s10350-005-0268-5
   Hobday CD, 2009, J MINIM INVAS GYN, V16, P224, DOI 10.1016/j.jmig.2008.12.002
   Hoffmann NE, 2009, J SURG RES, V155, P77, DOI 10.1016/j.jss.2008.08.008
   Jameson M, 2006, AM J OTOLARYNG, V27, P86, DOI 10.1016/j.amjoto.2005.07.011
   Kudesia R, 2010, J GYNECOL SURG, V26, P197, DOI 10.1089/gyn.2009.0076
   MCGREGOR DH, 1986, ANN CLIN LAB SCI, V16, P296
   Menzies D, 1992, Surg Annu, V24 Pt 1, P27
   Miyamoto K, 2006, SPINE, V31, pE91, DOI 10.1097/01.brs.0000199902.80607.ce
   Nagamatsu M, 1997, J NEUROL SCI, V146, P97, DOI 10.1016/S0022-510X(96)00295-X
   Nakajima M, 1995, ARCH PATHOL LAB MED, V119, P1161
   PARK SA, 1981, OBSTET GYNECOL, V58, P664
   Parker M C, 2004, Colorectal Dis, V6, P506, DOI 10.1111/j.1463-1318.2004.00709.x
   Shrime MG, 2007, AM J RHINOL, V21, P174, DOI 10.2500/ajr.2007.21.2986
   Suzuki Y, 2010, J MINIM INVAS GYN, V17, P641, DOI 10.1016/j.jmig.2010.03.024
   Thomas PJ, 2009, AM J OBSTET GYNECOL, V200, DOI 10.1016/j.ajog.2008.10.052
   Wiseman DM, 1999, J INVEST SURG, V12, P141
NR 27
TC 4
Z9 4
U1 4
U2 25
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1549-3296
EI 1552-4965
J9 J BIOMED MATER RES A
JI J. Biomed. Mater. Res. Part A
PD JUL
PY 2012
VL 100A
IS 7
BP 1777
EP 1782
DI 10.1002/jbm.a.34124
PG 6
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 946ZN
UT WOS:000304396500016
PM 22488970
DA 2018-10-19
ER

PT J
AU Laverty, G
   Gorman, SP
   Gilmore, BF
AF Laverty, Garry
   Gorman, Sean P.
   Gilmore, Brendan F.
TI Antimicrobial peptide incorporated poly(2-hydroxyethyl methacrylate)
   hydrogels for the prevention of Staphylococcus epidermidis-associated
   biomaterial infections
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A
LA English
DT Article
DE antimicrobial; biofilm; hydrogel; biomaterials
ID DRUG-RELEASE; IN-VITRO; 2-HYDROXYETHYL METHACRYLATE; BACTERIAL BIOFILMS;
   COPOLYMER GELS; VANCOMYCIN; ADHERENCE; DEVICE; ANTIBIOTICS; MODULATION
AB The effectiveness of the antimicrobial peptide maximin-4, the ultrashort peptide H-Orn-Orn-Trp-Trp-NH2, and the lipopeptide C12-Orn-Orn-Trp-Trp-NH2 in preventing adherence of pathogens to a candidate biomaterial were tested utilizing both matrix- and immersion-loaded poly(2-hydroxyethyl methacrylate) (poly(HEMA)) hydrogels. Antiadherent properties correlated to both the concentration released and the relative antimicrobial concentrations of each compound against Staphylococcus epidermidis ATCC 35984, at each time point. Immersion-loaded samples containing C12-Orn-Orn-Trp-Trp-NH2 exhibited the lowest adherence profile for all peptides studied over 1, 4, and 24 h. The results outlined in this article show that antimicrobial peptides have the potential to serve as an important weapon against biomaterial associated infections. (C) 2012 Wiley Periodicals, Inc. J Biomed Mater Res Part A, 2012.
C1 [Laverty, Garry; Gorman, Sean P.; Gilmore, Brendan F.] Queens Univ Belfast, Sch Pharm, Biomat Res Grp, Ctr Med Biol, Belfast BT9 7BL, Antrim, North Ireland.
RP Gilmore, BF (reprint author), Queens Univ Belfast, Sch Pharm, Biomat Res Grp, Ctr Med Biol, 97 Lisburn Rd, Belfast BT9 7BL, Antrim, North Ireland.
EM b.gilmore@qub.ac.uk
OI Laverty, Garry/0000-0002-1435-2942
CR Andrews JM, 2001, J ANTIMICROB CHEMOTH, V48, P5, DOI 10.1093/jac/48.suppl_1.5
   ANTONSEN KP, 1993, BIOMAT ARTIF CELL IM, V21, P1
   Baddour LM, 2001, AM J MED SCI, V322, P209, DOI 10.1097/00000441-200110000-00011
   Bisht GS, 2007, BIOORG MED CHEM LETT, V17, P4343, DOI 10.1016/j.bmcl.2007.05.015
   Brogden KA, 2005, NAT REV MICROBIOL, V3, P238, DOI 10.1038/nrmicro1098
   Brown KL, 2006, CURR OPIN IMMUNOL, V18, P24, DOI 10.1016/j.coi.2005.11.004
   Caramia G, 2008, CLIN DERMATOL, V26, P4, DOI [10.1016/j.clindermatol.2007.10.008, 10.1016/j.clindennatol.2007.10.008]
   Ceri H, 1999, J CLIN MICROBIOL, V37, P1771
   Coates Anthony R M, 2006, Drugs R D, V7, P133, DOI 10.2165/00126839-200607030-00001
   Costa P, 2001, EUR J PHARM SCI, V13, P123, DOI 10.1016/S0928-0987(01)00095-1
   Costerton JW, 1999, SCIENCE, V284, P1318, DOI 10.1126/science.284.5418.1318
   Cramton SE, 1999, INFECT IMMUN, V67, P5427
   Curtin J, 2003, ANTIMICROB AGENTS CH, V47, P3145, DOI 10.1128/AAC.47.10.3145-3148.2003
   Darouiche RO, 2004, NEW ENGL J MED, V350, P1422, DOI 10.1056/NEJMra035415
   DAVIS SS, 1984, COLLOID SURFACE, V12, P203, DOI 10.1016/0166-6622(84)80100-6
   Donlan RM, 2002, EMERG INFECT DIS, V8, P881, DOI 10.3201/eid0809.020063
   Falagas ME, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000011
   Giuliani A, 2007, CENT EUR J BIOL, V2, P1, DOI 10.2478/s11535-007-0010-5
   GUY RH, 1981, J PHARM SCI, V70, P1243, DOI 10.1002/jps.2600701115
   HANCOCK R, 1964, J BACTERIOL, V87, P1044
   Hwang PM, 1998, BIOCHEM CELL BIOL, V76, P235, DOI 10.1139/bcb-76-2-3-235
   Jones DS, 1997, BIOMATERIALS, V18, P503, DOI 10.1016/S0142-9612(96)00170-6
   Jones DS, 2005, J PHARM PHARMACOL, V57, P1251, DOI 10.1211/jpp.57.10.0003
   Jones DS, 2001, J MATER SCI-MATER M, V12, P399, DOI 10.1023/A:1011240818338
   Jones DS, 2005, BIOMATERIALS, V26, P2013, DOI 10.1016/j.biomaterials.2004.06.001
   Kajiyama S, 2009, J ORTHOP SCI, V14, P769, DOI 10.1007/s00776-009-1405-0
   Keren I, 2004, FEMS MICROBIOL LETT, V230, P13, DOI 10.1016/S0378-1097(03)00856-5
   KHARE AR, 1995, BIOMATERIALS, V16, P559, DOI 10.1016/0142-9612(95)91130-Q
   Kim H, 1997, J PHARM SCI, V86, P323, DOI 10.1021/js960307p
   Kodjikian L, 2005, J CATARACT REFR SURG, V31, P1050, DOI 10.1016/j.jcrs.2004.07.026
   Lai R, 2002, PEPTIDES, V23, P427, DOI 10.1016/S0196-9781(01)00641-6
   Lappe R, 2009, J FOOD ENG, V91, P223, DOI 10.1016/j.jfoodeng.2008.08.025
   Laverty G, 2010, CHEM BIOL DRUG DES, V75, P563, DOI 10.1111/j.1747-0285.2010.00973.x
   Lin CC, 2006, ADV DRUG DELIVER REV, V58, P1379, DOI 10.1016/j.addr.2006.09.004
   Mah TFC, 2001, TRENDS MICROBIOL, V9, P34, DOI 10.1016/S0966-842X(00)01913-2
   Makovitzki A, 2008, BIOCHEMISTRY-US, V47, P10630, DOI 10.1021/bi8011675
   McCann MT, 2008, J PHARM PHARMACOL, V60, P1551, DOI 10.1211/jpp/60.12.0001
   Mccoy CP, 2009, J PHARM PHARMACOL, V61, P1163, DOI 10.1211/jpp/61.09.0005
   Mermel LA, 2001, CLIN INFECT DIS, V32, P1249, DOI 10.1086/320001
   Okajima Y, 2006, INVEST OPHTH VIS SCI, V47, P2971, DOI 10.1167/iovs.05-1172
   Olson ME, 2002, CAN J VET RES, V66, P86
   Parsons C, 2009, BIOMATERIALS, V30, P597, DOI 10.1016/j.biomaterials.2008.10.015
   PEPPAS NA, 1985, PHARM ACTA HELV, V60, P110
   Pillay V, 1999, J CONTROL RELEASE, V59, P243, DOI 10.1016/S0168-3659(98)00197-7
   Powers JPS, 2003, PEPTIDES, V24, P1681, DOI 10.1016/j.peptides.2003.08.023
   RATNER BD, 1973, J BIOMED MATER RES, V7, P353, DOI 10.1002/jbm.820070407
   Reddy KVR, 2004, INT J ANTIMICROB AG, V24, P536, DOI 10.1016/j.ijantimicag.2004.09.005
   REFOJO MF, 1965, J APPL POLYM SCI, V9, P2425, DOI 10.1002/app.1965.070090707
   Rinaki E, 2003, INT J PHARM, V255, P199, DOI 10.1016/S0378-5173(03)00079-6
   RITGER P L, 1987, Journal of Controlled Release, V5, P23, DOI 10.1016/0168-3659(87)90034-4
   Siepmann J, 2001, ADV DRUG DELIVER REV, V48, P139, DOI 10.1016/S0169-409X(01)00112-0
   SINGH J, 1992, J BIOMED MATER RES, V26, P1253, DOI 10.1002/jbm.820260914
   Strom MB, 2003, J MED CHEM, V46, P1567, DOI 10.1021/jm0340039
   Wang XY, 2007, J CONTROL RELEASE, V121, P190, DOI 10.1016/j.jconrel.2007.06.006
   Zuleger S, 2001, INT J PHARM, V217, P139, DOI 10.1016/S0378-5173(01)00596-8
NR 55
TC 25
Z9 25
U1 0
U2 42
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1549-3296
J9 J BIOMED MATER RES A
JI J. Biomed. Mater. Res. Part A
PD JUL
PY 2012
VL 100A
IS 7
BP 1803
EP 1814
DI 10.1002/jbm.a.34132
PG 12
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 946ZN
UT WOS:000304396500019
PM 22489028
OA Green Published
DA 2018-10-19
ER

PT J
AU Banche, G
   Bracco, P
   Bistolfi, A
   Allizond, V
   Boffano, M
   Costa, L
   Cimino, A
   Cuffini, AM
   del Prever, EMB
AF Banche, Giuliana
   Bracco, Pierangiola
   Bistolfi, Alessandro
   Allizond, Valeria
   Boffano, Michele
   Costa, Luigi
   Cimino, Andrea
   Cuffini, Anna Maria
   del Prever, Elena Maria Brach
TI Bacterial adherence to vitamin E UHMWPE. Considerations about in vitro
   studies Reply
SO JOURNAL OF ORTHOPAEDIC RESEARCH
LA English
DT Letter
ID STAPHYLOCOCCUS-EPIDERMIDIS BIOFILM; BIOMATERIAL SURFACE-CHEMISTRY
C1 [Banche, Giuliana; Allizond, Valeria; Cuffini, Anna Maria] Univ Turin, Dept Publ Hlth & Microbiol, I-10126 Turin, Italy.
   [Bracco, Pierangiola; Costa, Luigi] Univ Turin, Dept IFM Chem, I-10125 Turin, Italy.
   [Bracco, Pierangiola; Costa, Luigi] Univ Turin, NIS Ctr Excellence, I-10125 Turin, Italy.
   [Bistolfi, Alessandro; Boffano, Michele; Cimino, Andrea; del Prever, Elena Maria Brach] Univ Turin, Dept Traumatol Orthopaed & Occupat Hlth AO CTO Ma, I-10126 Turin, Italy.
RP Banche, G (reprint author), Univ Turin, Dept Publ Hlth & Microbiol, Via Santena 9, I-10126 Turin, Italy.
RI Bracco, Pierangiola/G-8522-2011
OI Bracco, Pierangiola/0000-0003-0477-2086; Cuffini, Anna
   Maria/0000-0002-2698-164X; Banche, Giuliana/0000-0003-2219-0223;
   bistolfi, alessandro/0000-0002-4396-6222; Allizond,
   Valeria/0000-0003-0585-9247
CR Kajiyama S, 2009, J ORTHOP SCI, V14, P769, DOI 10.1007/s00776-009-1405-0
   Kinnari TJ, 2010, CLIN MICROBIOL INFEC, V16, P1036, DOI 10.1111/j.1469-0691.2009.02995.x
   MacKintosh EE, 2006, J BIOMED MATER RES A, V78A, P836, DOI 10.1002/jbm.a.30905
   Patel JD, 2007, J BIOMED MATER RES A, V80A, P742, DOI 10.1002/jbm.a.31103
   Rohde H, 2010, EUR J CELL BIOL, V89, P103, DOI 10.1016/j.ejcb.2009.10.005
   Subbiahdoss G, 2010, J BIOMED MATER RES A, V94A, P533, DOI 10.1002/jbm.a.32731
   Vandecasteele SJ, 2003, J INFECT DIS, V188, P730, DOI 10.1086/377452
NR 7
TC 1
Z9 1
U1 0
U2 6
PU WILEY-BLACKWELL
PI MALDEN
PA COMMERCE PLACE, 350 MAIN ST, MALDEN 02148, MA USA
SN 0736-0266
J9 J ORTHOP RES
JI J. Orthop. Res.
PD JUL
PY 2012
VL 30
IS 7
BP 1181
EP 1182
DI 10.1002/jor.22053
PG 2
WC Orthopedics
SC Orthopedics
GA 939KT
UT WOS:000303810000026
OA Bronze
DA 2018-10-19
ER

PT J
AU Esteban, J
   Molina-Manso, D
   Gomez-Barrena, E
AF Esteban, Jaime
   Molina-Manso, Diana
   Gomez-Barrena, Enrique
TI Bacterial Adherence to Vitamin E UHMWPE. Considerations about In Vitro
   Studies
SO JOURNAL OF ORTHOPAEDIC RESEARCH
LA English
DT Letter
ID STAPHYLOCOCCUS-EPIDERMIDIS BIOFILM; BIOMATERIAL SURFACE-CHEMISTRY
C1 [Esteban, Jaime; Molina-Manso, Diana] IIS Fdn Jimenez Diaz, Dept Clin Microbiol, Madrid, Spain.
   [Gomez-Barrena, Enrique] Univ Autonoma Madrid, Dept Orthopaed, Hosp La Paz, Madrid, Spain.
RP Esteban, J (reprint author), IIS Fdn Jimenez Diaz, Dept Clin Microbiol, Madrid, Spain.
RI Esteban, Jaime/S-6554-2018; GOMEZ-BARRENA, ENRIQUE/A-2799-2008
OI Esteban, Jaime/0000-0002-8971-3167; GOMEZ-BARRENA,
   ENRIQUE/0000-0003-1065-6137
CR Kajiyama S, 2009, J ORTHOP SCI, V14, P769, DOI 10.1007/s00776-009-1405-0
   Kinnari TJ, 2010, CLIN MICROBIOL INFEC, V16, P1036, DOI 10.1111/j.1469-0691.2009.02995.x
   MacKintosh EE, 2006, J BIOMED MATER RES A, V78A, P836, DOI 10.1002/jbm.a.30905
   Patel JD, 2007, J BIOMED MATER RES A, V80A, P742, DOI 10.1002/jbm.a.31103
   Rohde H, 2010, EUR J CELL BIOL, V89, P103, DOI 10.1016/j.ejcb.2009.10.005
   Subbiahdoss G, 2010, J BIOMED MATER RES A, V94A, P533, DOI 10.1002/jbm.a.32731
   Vandecasteele SJ, 2003, J INFECT DIS, V188, P730, DOI 10.1086/377452
NR 7
TC 3
Z9 3
U1 0
U2 8
PU WILEY-BLACKWELL
PI MALDEN
PA COMMERCE PLACE, 350 MAIN ST, MALDEN 02148, MA USA
SN 0736-0266
J9 J ORTHOP RES
JI J. Orthop. Res.
PD JUL
PY 2012
VL 30
IS 7
BP 1181
EP 1181
DI 10.1002/jor.22024
PG 1
WC Orthopedics
SC Orthopedics
GA 939KT
UT WOS:000303810000025
PM 22170101
DA 2018-10-19
ER

PT J
AU Glew, D
   Stringer, LC
   Acquaye, AA
   McQueen-Mason, S
AF Glew, David
   Stringer, Lindsay C.
   Acquaye, Adolf A.
   McQueen-Mason, Simon
TI How do end of life scenarios influence the environmental impact of
   product supply chains? comparing biomaterial and petrochemical products
SO JOURNAL OF CLEANER PRODUCTION
LA English
DT Article
DE Life cycle assessment (LCA); Greenhouse gasses (GHG); Waste; Recycle;
   Mattresses
ID CYCLE INVENTORY; GREENHOUSE-GAS; ENERGY; ETHANOL; EMISSIONS; UK
AB In this research natural fibre (biomaterial) pocket spring mattresses are shown to emit marginally less greenhouse gasses (GHG) than foam (petrochemical) pocket spring mattresses. However, when end of life scenarios are considered, the results suggest much larger GHG emission reductions for natural fibre than foam mattresses. Refurbishing natural fibre mattresses and reusing the springs, coupled with recycling the waste components, can reduce GHG emissions by 90% compared to sending the mattresses to landfill. Incinerating mattresses via combined heat and power plants for electricity production and converting the waste textiles to ethanol are also shown to reduce GHG emissions, though to a lesser extent than refurbishment and recycling. Mattresses are normally disposed of via landfill however designing for reuse and recycling, coupled with supportive policy and legislation, may encourage more natural fibre mattresses and recycling. Such changes could save between 210 and 2092 thousand tCO(2)-eq in the European Union annually. (C) 2012 Elsevier Ltd. All rights reserved.
C1 [Glew, David; McQueen-Mason, Simon] Univ York, Ctr Novel Agr Prod, York YO10 5DD, N Yorkshire, England.
   [Stringer, Lindsay C.] Univ Leeds, Sch Earth & Environm, Sustainabil Res Inst, Leeds LS2 9JT, W Yorkshire, England.
   [Acquaye, Adolf A.] Univ Sheffield, Sch Management, Ctr Energy Environm & Sustainabil, Sheffield S1 4DT, S Yorkshire, England.
RP Glew, D (reprint author), Univ York, Ctr Novel Agr Prod, York YO10 5DD, N Yorkshire, England.
EM dwg501@york.ac.uk
OI Stringer, Lindsay/0000-0003-0017-1654
FU Yorkshire White Rose Consortium of Universities; Biotechnology and
   Biological Sciences Research Council [BB/G016178/1]
FX Many thanks to Harrison Spinks Ltd for providing data with openness and
   a keen interest. The authors are indebted to the Stockholm Institute at
   York for sharing 10 tables and providing guidance on the Hybrid LCA
   methodology. Advice from Dr Nigel Mortimer (North Energy Associates) was
   gratefully received. This research was funded with thanks by the
   Yorkshire White Rose Consortium of Universities.
CR Acquaye A.A., 2011, ENV SCI TECHNOLOGY
   Acquaye AA, 2010, BUILD ENVIRON, V45, P784, DOI 10.1016/j.buildenv.2009.08.022
   AFNOR, 2006, REV COMM ECO LAB CRI
   British Standards Institution, 2000, EN 1957 2000 DOM FUR
   BSI Group, 2008, GUID PAS 2050 ASS CA
   [Centre for industrial studies CSIL], 2010, WORLD MATTR IND
   Cherubini F, 2010, APPL ENERG, V87, P47, DOI 10.1016/j.apenergy.2009.08.024
   Cherubini F, 2009, RESOUR CONSERV RECY, V53, P434, DOI 10.1016/j.resconrec.2009.03.013
   Chiaramonti D, 2010, BIOMASS BIOENERG, V34, P787, DOI 10.1016/j.biombioe.2010.01.022
   Crawford RH, 2008, J ENVIRON MANAGE, V88, P496, DOI 10.1016/j.jenvman.2007.03.024
   Deliege E., 2010, BED MATTRESSES LCA C
   Department of energy and climate change, 2011, CARB BUDG
   European Commission, 2001, WAST MAN OPT CLIM CH
   Fand S., 2011, CROPPING BIOENERGY B
   Finnveden G, 2009, J ENVIRON MANAGE, V91, P1, DOI 10.1016/j.jenvman.2009.06.018
   Geoghegan-Quinn M., 2010, C KNOWLEDGE BASED BI
   Gonzalez-Garcia S, 2010, RENEW SUST ENERG REV, V14, P2077, DOI 10.1016/j.rser.2010.03.035
   Hakkinen T, 2010, J CLEAN PROD, V18, P1458, DOI 10.1016/j.jclepro.2010.05.005
   Heijungs R, 2006, J IND ECOL, V10, P147, DOI 10.1162/jiec.2006.10.3.147
   Hendrickson C., 1998, ENVIRON SCI TECHNOL, V32, P184, DOI DOI 10.1021/ES983471I
   Jeihanipour A, 2010, WASTE MANAGE, V30, P2504, DOI 10.1016/j.wasman.2010.06.026
   Joshi S., 1999, J IND ECOL, V3, P95, DOI DOI 10.1162/108819899569449
   Macedo IC, 2008, BIOMASS BIOENERG, V32, P582, DOI 10.1016/j.biombioe.2007.12.006
   Miller R. E., 1985, INPUT OUTPUT ANAL FD
   Panels G.N.R., 2010, GFK CONS SCOP BEDS M
   Robert KH, 2002, J CLEAN PROD, V10, P197, DOI 10.1016/S0959-6526(01)00061-0
   Scarlat N, 2011, ENERG POLICY, V39, P1630, DOI 10.1016/j.enpol.2010.12.039
   Searchinger T, 2008, SCIENCE, V319, P1238, DOI 10.1126/science.1151861
   Suh S, 2005, J CLEAN PROD, V13, P687, DOI 10.1016/j.jclepro.2003.04.001
   ten Raa Th, 2007, ECON SYST RES, V19, P453
   Tilman D, 2009, SCIENCE, V325, P270, DOI 10.1126/science.1177970
   von Blottnitz H, 2007, J CLEAN PROD, V15, P607, DOI 10.1016/j.jclepro.2006.03.002
   Wiedmann T, 2010, ECON SYST RES, V22, P19, DOI 10.1080/09535311003612591
   Wiedmann TO, 2011, ENVIRON SCI TECHNOL, V45, P5900, DOI 10.1021/es2007287
NR 34
TC 20
Z9 21
U1 2
U2 28
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0959-6526
J9 J CLEAN PROD
JI J. Clean Prod.
PD JUL
PY 2012
VL 29-30
BP 122
EP 131
DI 10.1016/j.jclepro.2012.02.005
PG 10
WC GREEN & SUSTAINABLE SCIENCE & TECHNOLOGY; Engineering, Environmental;
   Environmental Sciences
SC Science & Technology - Other Topics; Engineering; Environmental Sciences
   & Ecology
GA 932QM
UT WOS:000303305600014
DA 2018-10-19
ER

PT J
AU Douillard, T
   Chevalier, J
   Descamps-Mandine, A
   Warner, I
   Galais, Y
   Whitaker, P
   Wu, JJ
   Wang, QQ
AF Douillard, T.
   Chevalier, J.
   Descamps-Mandine, A.
   Warner, I.
   Galais, Y.
   Whitaker, P.
   Wu, J. J.
   Wang, Q. Q.
TI Comparative ageing behaviour of commercial, unworn and worn 3Y-TZP and
   zirconia-toughened alumina hip joint heads
SO JOURNAL OF THE EUROPEAN CERAMIC SOCIETY
LA English
DT Article
DE Lifetime; Al2O3; ZrO2; Biomedical applications; Composites
ID BIOMEDICAL IMPLANTS; CERAMICS; BIOMATERIAL; SENSITIVITY; FUTURE
AB There is a trend today to develop zirconia toughened alumina (ZTA) composites for orthopaedic applications. So far, there is limited data concerning their sensitivity to ageing, especially considering tests performed on implants produced on an industrial scale. Here, complementary tools were used to assess the ageing resistance of ZTA femoral heads. The results were compared to femoral heads processed under the same industrial process with monolithic 3Y-TZP. As expected, monolithic 3Y-TZP implants exhibited significant ageing. In contrast ZTA femoral head showed no sign of degradation even over a period equivalent to that of a human life. The potential impact of coupling effects between wear and ageing is assessed. Monolithic zirconia and ZTA femoral heads were thus first worn in a hip joint simulator, and then aged in autoclave. The kinetics of transformation of the worn monolithic zirconia implants is accelerated while that of worn ZTA femoral heads remains almost unchanged. (C) 2012 Elsevier Ltd. All rights reserved.
C1 [Douillard, T.; Chevalier, J.] INSA Lyon, MATEIS, CNRS, UMR 5510, F-69621 Villeurbanne, France.
   [Descamps-Mandine, A.] INSA Lyon, INL, CNRS, UMR 5270, F-69621 Villeurbanne, France.
   [Wu, J. J.; Wang, Q. Q.] Univ Durham, Sch Engn & Comp Sci, Durham DH1 3LE, England.
RP Chevalier, J (reprint author), INSA Lyon, MATEIS, CNRS, UMR 5510, F-69621 Villeurbanne, France.
EM jeromechevalier@me.com
RI Douillard, Thierry/G-9808-2014
OI Douillard, Thierry/0000-0001-7113-889X
FU INSA; MORGAN; Engineering and Physical Sciences Research Council
   [EP/E028039/1]
FX This project was covered by a contract between INSA and MORGAN, and in
   part by the French National Agency under the name 'Bioceramics for long
   lasting implants' (OPT HIP, ANR-07-MAPR-0014-01).
CR Chevalier J, 2006, BIOMATERIALS, V27, P535, DOI 10.1016/j.biomaterials.2005.07.034
   Chevalier J, 1999, J AM CERAM SOC, V82, P2150
   Chevalier J, 2009, J EUR CERAM SOC, V29, P1245, DOI 10.1016/j.jeurceramsoc.2008.08.025
   Chevalier J, 2007, ANNU REV MATER RES, V37, P1, DOI 10.1146/annurev.matsci.37.052506.084250
   Chevalier J, 2009, BIOMATERIALS, V30, P5279, DOI 10.1016/j.biomaterials.2009.06.022
   Chevalier J, 2009, J AM CERAM SOC, V92, P1901, DOI 10.1111/j.1551-2916.2009.03278.x
   Deville S, 2006, BIOMATERIALS, V27, P2186, DOI 10.1016/j.biomaterials.2005.11.021
   Deville S, 2005, J BIOMED MATER RES B, V72B, P239, DOI 10.1002/jbm.b.30123
   Deville S, 2003, J EUR CERAM SOC, V23, P2975, DOI 10.1016/S0955-2219(03)00313-3
   Gutknecht D, 2004, J EUR CERAM SOC, V24, P3483
   Kuntz M, 2006, SEMIN ARTHROPLASTY, V17, P141
   Piconi C, 1999, BIOMATERIALS, V20, P1, DOI 10.1016/S0142-9612(98)00010-6
   Rahaman MN, 2007, J AM CERAM SOC, V90, P1965, DOI 10.1111/j.1551-2916.2007.01725.x
   Schneider J, 2008, J AM CERAM SOC, V91, P3613, DOI 10.1111/j.1551-2916.2008.02700.x
   Toraya H., 1984, J AM CERAM SOC, V67, P119
NR 15
TC 24
Z9 24
U1 0
U2 35
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0955-2219
J9 J EUR CERAM SOC
JI J. Eur. Ceram. Soc.
PD JUL
PY 2012
VL 32
IS 8
BP 1529
EP 1540
DI 10.1016/j.jeurceramsoc.2012.01.003
PG 12
WC Materials Science, Ceramics
SC Materials Science
GA 932GX
UT WOS:000303279600008
DA 2018-10-19
ER

PT J
AU Jeong, SI
   Lee, SE
   Yang, H
   Park, CS
   Jin, YH
   Park, YS
AF Jeong, Seong Il
   Lee, Seung Eun
   Yang, Hana
   Park, Cheung-Seog
   Jin, Young-Ho
   Park, Yong Seek
TI Effect of alpha,beta-unsaturated aldehydes on endothelial cell growth in
   bacterial cellulose for vascular tissue engineering
SO MOLECULAR & CELLULAR TOXICOLOGY
LA English
DT Article
DE Bacterial cellulose; alpha,beta-unsaturated aldehydes; Cardiovascular
   disease; Vascular grafts material
ID MECHANICAL-PROPERTIES; BLOOD-VESSELS; EXPRESSION; SCAFFOLDS; ACROLEIN;
   CROTONALDEHYDE; CARTILAGE; ADDUCTS; PECAM-1; BIOLOGY
AB Cardiovascular disease is the leading global cause of death. Cigarette smoking is a major risk factor for cardiovascular disease. And alpha,beta-unsaturated aldehydes such as acrolein and crotonaldehyde are major component of cigarette smoke. Use of replacement grafts materials is one of the cardiovascular disease treatments. However, currently available synthetic materials generally produce poor outcomes including hyperplasia and thrombogenicity. Recently, bacterial synthesized cellulose has received interest as a new functional vascular graft biomaterial owing to its bio-compatibility. However, the association of a bacterial cellulose-based scaffold and cigarette smoke is not known. The present study investigated the alteration of function of human umbilical vein endothelial cells (HUVECs) treated with alpha,beta-unsaturated aldehyde on bacterial cellulose-based material. The data suggest that alpha,beta-unsaturated aldehydes in cigarette smoke induce altered endothelial cell functions including morphology, adhesion, proliferation, viability and growth on bacterial cellulose. These results may provide the view that cigarette smoking of cardiovascular disease patients applied to bacterial cellulose-based vascular grafts is risk.
C1 [Jeong, Seong Il; Lee, Seung Eun; Yang, Hana; Park, Cheung-Seog; Park, Yong Seek] Kyung Hee Univ, Sch Med, Dept Microbiol, Seoul 130701, South Korea.
   [Jin, Young-Ho] Kyung Hee Univ, Sch Med, Dept Physiol, Seoul 130701, South Korea.
RP Park, YS (reprint author), Kyung Hee Univ, Sch Med, Dept Microbiol, Seoul 130701, South Korea.
EM yongseek@khu.ac.kr
FU National Research Foundation of Korea (NRF); Ministry of Education,
   Science and Technology [2011-0011748]
FX This work was supported Basic Science Research Program through the
   National Research Foundation of Korea (NRF) funded by the Ministry of
   Education, Science and Technology (No. 2011-0011748).
CR Andersson J, 2010, J BIOMED MATER RES A, V94A, P1124, DOI 10.1002/jbm.a.32784
   Andrade FK, 2010, ACTA BIOMATER, V6, P4034, DOI 10.1016/j.actbio.2010.04.023
   Andre E, 2008, J CLIN INVEST, V118, P2574, DOI 10.1172/JCI34886
   Backdahl H, 2006, BIOMATERIALS, V27, P2141, DOI 10.1016/j.biomaterials.2005.10.026
   Backdahl H, 2008, J TISSUE ENG REGEN M, V2, P320, DOI 10.1002/term.97
   Cai Z, 2010, CELLULOSE, V17, P83, DOI 10.1007/s10570-009-9362-5
   Carter CA, 2009, TOXICOLOGY, V261, P89, DOI 10.1016/j.tox.2009.04.039
   Czaja W, 2006, BIOMATERIALS, V27, P145, DOI 10.1016/j.biomaterials.2005.07.035
   Dalle-Donne I, 2007, FREE RADICAL BIO MED, V42, P583, DOI 10.1016/j.freeradbiomed.2006.11.026
   Facchinetti F, 2007, AM J RESP CELL MOL, V37, P617, DOI 10.1165/rcmb.2007-01300C
   Fernandes PH, 2005, ENVIRON MOL MUTAGEN, V45, P455, DOI 10.1002/em.20117
   Frachon S, 2001, J HEPATOL, V34, P850, DOI 10.1016/S0168-8278(01)00049-6
   Guney N, 2008, MED ONCOL, V25, P194, DOI 10.1007/s12032-007-9026-y
   HESTRIN S, 1954, BIOCHEM J, V58, P345, DOI 10.1042/bj0580345
   Jeong S. I, 2011, MOL CELL TOXICOL, V7, P129
   Jeong SI, 2010, MOL CELL TOXICOL, V6, P373, DOI 10.1007/s13273-010-0049-7
   Klemm D, 2001, PROG POLYM SCI, V26, P1561, DOI 10.1016/S0079-6700(01)00021-1
   Ladoux B, 2010, BIOPHYS J, V98, P534, DOI 10.1016/j.bpj.2009.10.044
   Lee SE, 2010, BIOCHIP J, V4, P264, DOI 10.1007/s13206-010-4402-7
   Li ZS, 2005, J BIOMED MATER RES A, V75A, P485, DOI 10.1002/jbm.a.30449
   Ma ZW, 2005, BIOMATERIALS, V26, P2527, DOI 10.1016/j.biomaterials.2004.07.026
   Minko IG, 2009, CHEM RES TOXICOL, V22, P759, DOI 10.1021/tx9000489
   Muller AM, 2002, EXP MOL PATHOL, V72, P221, DOI 10.1006/exmp.2002.2424
   NEWMAN PJ, 1994, ANN NY ACAD SCI, V714, P165, DOI 10.1111/j.1749-6632.1994.tb12041.x
   Nge TT, 2010, CELLULOSE, V17, P349, DOI 10.1007/s10570-009-9394-x
   Pankajakshan D, 2010, CAN J PHYSIOL PHARM, V88, P855, DOI [10.1139/y10-073, 10.1139/Y10-073]
   Park YS, 2007, ARTERIOSCL THROM VAS, V27, P1319, DOI 10.1161/ATVBAHA.106.132837
   Pusztaszeri MP, 2006, J HISTOCHEM CYTOCHEM, V54, P385, DOI 10.1369/jhc.4A6514.2005
   Rambo CR, 2008, MAT SCI ENG C-BIO S, V28, P549, DOI 10.1016/j.msec.2007.11.011
   Svensson A, 2005, BIOMATERIALS, V26, P419, DOI 10.1016/j.biomaterials.2004.02.049
   Wiegand C, 2006, CELLULOSE, V13, P485, DOI 10.1007/s10570-005-9022-3
   Zahedmanesh H, 2011, J BIOMED MATER RES B, V97B, P105, DOI 10.1002/jbm.b.31791
NR 32
TC 11
Z9 11
U1 0
U2 40
PU KOREAN SOCIETY TOXICOGENOMICS & TOXICOPROTEOMICS-KSTT
PI GYEONGGI-DO
PA HANYANG UNIV, SCI & TECHNOL BLDG 1, RM 423, SA-DONG, SANGROK-GU, ANSAN,
   GYEONGGI-DO, 426 791, SOUTH KOREA
SN 1738-642X
J9 MOL CELL TOXICOL
JI Mol. Cell. Toxicol.
PD JUN 30
PY 2012
VL 8
IS 2
BP 119
EP 126
DI 10.1007/s13273-012-0015-7
PG 8
WC Biochemistry & Molecular Biology; Toxicology
SC Biochemistry & Molecular Biology; Toxicology
GA 966US
UT WOS:000305863500002
DA 2018-10-19
ER

PT J
AU Cartwright, JHE
   Checa, AG
   Escribano, B
   Sainz-Diaz, CI
AF Cartwright, Julyan H. E.
   Checa, Antonio G.
   Escribano, Bruno
   Ignacio Sainz-Diaz, C.
TI Crystal growth as an excitable medium
SO PHILOSOPHICAL TRANSACTIONS OF THE ROYAL SOCIETY A-MATHEMATICAL PHYSICAL
   AND ENGINEERING SCIENCES
LA English
DT Article
DE crystal morphology; defects; growth models; nucleation
ID DYNAMICS
AB Crystal growth has been widely studied for many years, and, since the pioneering work of Burton, Cabrera and Frank, spirals and target patterns on the crystal surface have been understood as forms of tangential crystal growth mediated by defects and by two-dimensional nucleation. Similar spirals and target patterns are ubiquitous in physical systems describable as excitable media. Here, we demonstrate that this is not merely a superficial resemblance, that the physics of crystal growth can be set within the framework of an excitable medium, and that appreciating this correspondence may prove useful to both fields. Apart from solid crystals, we discuss how our model applies to the biomaterial nacre, formed by layer growth of a biological liquid crystal.
C1 [Escribano, Bruno] Basque Ctr Appl Math, Bilbao 48009, Spain.
   [Cartwright, Julyan H. E.; Ignacio Sainz-Diaz, C.] Univ Granada, CSIC, Inst Andaluz Ciencias Tierra, E-18071 Granada, Spain.
   [Checa, Antonio G.] Univ Granada, Fac Ciencias, Dept Estratig & Paleontol, E-18071 Granada, Spain.
RP Escribano, B (reprint author), Basque Ctr Appl Math, Alameda Mazarredo 14, Bilbao 48009, Spain.
EM bescribano@bcamath.org
RI Checa, Antonio/A-6157-2008; Cartwright, Julyan/C-1387-2016
OI Checa, Antonio/0000-0001-7873-7545; Cartwright,
   Julyan/0000-0001-7392-0957
CR Aranson IS, 1998, PHYS REV LETT, V80, P1770, DOI 10.1103/PhysRevLett.80.1770
   Ball P., 2001, SELF MADE TAPESTRY P
   Burgers JM, 1940, P PHYS SOC, V52, P23, DOI 10.1088/0959-5309/52/1/304
   BURTON WK, 1951, PHILOS T R SOC S-A, V243, P299, DOI 10.1098/rsta.1951.0006
   Cartwright JHE, 2000, PHYS REV E, V62, P1149, DOI 10.1103/PhysRevE.62.1149
   Cartwright JHE, 1997, PHYS REV LETT, V79, P527, DOI 10.1103/PhysRevLett.79.527
   Cartwright JHE, 1999, INT J BIFURCAT CHAOS, V9, P2197, DOI 10.1142/S0218127499001620
   Cartwright JHE, 2007, J R SOC INTERFACE, V4, P491, DOI 10.1098/rsif.2006.0188
   Cartwright JHE, 2009, P NATL ACAD SCI USA, V106, P10499, DOI 10.1073/pnas.0900867106
   Chen CC, 2009, J CRYST GROWTH, V311, P702, DOI 10.1016/j.jcrysgro.2008.09.077
   Chernov AA, 2004, J CRYST GROWTH, V264, P499, DOI 10.1016/j.jcrysgro.2003.12.076
   Chernov AA, 2003, J STRUCT BIOL, V142, P3, DOI 10.1016/S1047-8477(03)00034-0
   FALO F, 1991, PHYS REV B, V43, P8081, DOI 10.1103/PhysRevB.43.8081
   Faraday M., 1834, PHIL T, V124, P55, DOI DOI 10.1098/RSTL.1834.0007
   FEINGOLD M, 1988, PHYS REV A, V37, P4060, DOI 10.1103/PhysRevA.37.4060
   FRANK FC, 1950, PHYS REV, V79, P722, DOI 10.1103/PhysRev.79.722
   Mackay A. L., 1976, Physics Bulletin, V27, P495
   MARKUS M, 1990, NATURE, V347, P56, DOI 10.1038/347056a0
   McPherson A, 2003, J STRUCT BIOL, V142, P32, DOI 10.1016/S1047-8477(03)00036-4
   MERON E, 1992, PHYS REP, V218, P1, DOI 10.1016/0370-1573(92)90098-K
   Misbah C, 2010, REV MOD PHYS, V82, P981, DOI 10.1103/RevModPhys.82.981
   Pimpinelli A., 1998, PHYS CRYSTAL GROWTH
   Pina CM, 2009, SURF SCI, V603, P2708, DOI 10.1016/j.susc.2009.07.007
   Shapere Alfred, 1989, GEOMETRIC PHASES PHY
   Smereka P, 2000, PHYSICA D, V138, P282, DOI 10.1016/S0167-2789(99)00216-X
   TYSON JJ, 1988, PHYSICA D, V32, P327, DOI 10.1016/0167-2789(88)90062-0
   Uehara T, 2003, J CRYST GROWTH, V254, P251, DOI 10.1016/S0022-0248(03)01120-5
NR 27
TC 5
Z9 5
U1 0
U2 17
PU ROYAL SOC
PI LONDON
PA 6-9 CARLTON HOUSE TERRACE, LONDON SW1Y 5AG, ENGLAND
SN 1364-503X
J9 PHILOS T R SOC A
JI Philos. Trans. R. Soc. A-Math. Phys. Eng. Sci.
PD JUN 28
PY 2012
VL 370
IS 1969
SI SI
BP 2866
EP 2876
DI 10.1098/rsta.2011.0600
PG 11
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA 946KQ
UT WOS:000304350900005
PM 22615465
OA Bronze
DA 2018-10-19
ER

PT J
AU Zhao, MZ
   An, MR
   Wang, QS
   Liu, XC
   Lai, WJ
   Zhao, XY
   Wei, SC
   Ji, JG
AF Zhao, Minzhi
   An, Mingrui
   Wang, Qingsong
   Liu, Xiaochen
   Lai, Wenjia
   Zhao, Xuyang
   Wei, Shicheng
   Ji, Jianguo
TI Quantitative proteomic analysis of human osteoblast-like MG-63 cells in
   response to bioinert implant material titanium and polyetheretherketone
SO JOURNAL OF PROTEOMICS
LA English
DT Article
DE Biomaterial; Biocompatibility; SILAC; Polyetheretherketone (PEEK);
   Titanium; Proteomics
ID MICROARRAY DATA; PROTEIN; BIOMATERIAL; GENE
AB Commercially pure titanium (cpTi) and polyetheretherketone (PEEK) are widely used surface-modified implant materials in orthopedics and dental therapeutics. However, there still has not been comprehensive biocompatibility evaluation of them at molecular level. By employing stable isotope labeling with amino acids in cell culture (SILAC), we profiled the dynamic protein expression changes in human osteoblast-like MG-63 cells cultured on cpTi and PEEK, respectively. About 2000 proteins were quantified and 400 proteins showed substantial alterations in expression levels upon each material treatment Notably, the extent of alterations diminished as the contact prolonged, which suggested adaptive response to the bioinert materials. Similar patterns of expression changes were observed for both cpTi and PEEK. The representative pathways reflected the regulation of biosynthesis, metabolism and cell adhesion in the adaptive process. In addition, PEEK showed stronger inhibition on mRNA processing, which explained the lower proliferation rate of the cells cultured on PEEK. Our results indicated that the widely used bioinert materials cpTi and PEEK could individually induce a cooperative response involving a wide panel of proteins and pathways. This study has established a basis for better understanding the biocompatibility of surface-modified implant biomaterials at molecular level. (c) 2012 Elsevier B.V. All rights reserved.
C1 [Wei, Shicheng] Peking Univ, Sch Stomatol, Ctr Biomat & Med Devices, Beijing 100081, Peoples R China.
   [Zhao, Minzhi; Liu, Xiaochen; Wei, Shicheng; Ji, Jianguo] Peking Univ, Acad Adv Interdisciplinary Studies, Ctr Biomed Mat & Tissue Engn, Beijing 100871, Peoples R China.
   [An, Mingrui; Wang, Qingsong; Lai, Wenjia; Zhao, Xuyang; Ji, Jianguo] Peking Univ, Coll Life Sci, State Key Lab Prot & Plant Gene Res, Beijing 100871, Peoples R China.
RP Wei, SC (reprint author), Peking Univ, Sch Stomatol, Ctr Biomat & Med Devices, Beijing 100081, Peoples R China.
EM xgt1986627@163.com; an5137991@126.com; wangqingsong@gmail.com;
   lxc200107@yahoo.com.cn; wenjia@pku.edu.cn; zhao-xu-yang@163.com;
   sc-wei@pku.edu.cn; jijg@pku.edu.cn
FU National Key Basic Research Program of China [2007CB936103,
   2010CB912203, 2011CB915504]; National Natural Science Foundation of
   China [90919023, 30970652]; Fundamental Research Funds for the Central
   Universities
FX This work was supported by grants from the National Key Basic Research
   Program of China (No. 2007CB936103, 2010CB912203 and 2011CB915504), the
   National Natural Science Foundation of China (No. 90919023 and 30970652)
   and the Fundamental Research Funds for the Central Universities.
CR Bhole D, 2003, CRIT CARE MED, V31, P97
   Carmona-Saez P, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-1-r3
   CHU ML, 1989, EMBO J, V8, P1939, DOI 10.1002/j.1460-2075.1989.tb03598.x
   Comi GP, 2001, ANN NEUROL, V50, P202, DOI 10.1002/ana.1095
   Cox J, 2009, NAT PROTOC, V4, P698, DOI 10.1038/nprot.2009.36
   Cox J, 2008, NAT BIOTECHNOL, V26, P1367, DOI 10.1038/nbt.1511
   Dahlquist KD, 2002, NAT GENET, V31, P19, DOI 10.1038/ng0502-19
   Hallab Nadim James, 2009, SAS J, V3, P143, DOI 10.1016/j.esas.2009.11.005
   Han CM, 2010, BIOMATERIALS, V31, P3465, DOI 10.1016/j.biomaterials.2009.12.030
   Harris HE, 2004, EUR J IMMUNOL, V34, P1503
   Ito Y, 2003, CANCER RES, V63, P6651
   Karring H, 2007, MOL VIS, V13, P997
   Kovacevic Z, 2006, CARCINOGENESIS, V27, P2355, DOI 10.1093/carcin/bg1146
   Kurtz SM, 2007, BIOMATERIALS, V28, P4845, DOI 10.1016/j.biomaterials.2007.07.013
   Lautenschlager E P, 1993, Int Dent J, V43, P245
   Niiro H, 2002, NAT REV IMMUNOL, V2, P945, DOI 10.1038/nri955
   Nogales-Cadenas R, 2009, NUCLEIC ACIDS RES, V37, pW317, DOI 10.1093/nar/gkp416
   Norris LA, 2003, BEST PRACT RES CL OB, V17, P369, DOI 10.1053/S1521-6934(03)00014-2
   Oike Y, 2005, NAT MED, V11, P400, DOI 10.1038/nm1214
   Ong SE, 2005, NAT CHEM BIOL, V1, P252, DOI 10.1038/nchembio736
   Pan CP, 2009, MOL CELL PROTEOMICS, V8, P443, DOI 10.1074/mcp.M800258-MCP200
   Power KA, 2010, BIOMATERIALS, V31, P6667, DOI 10.1016/j.biomaterials.2010.05.029
   Ritchie DB, 2009, BBA-GENE REGUL MECH, V1789, P624, DOI 10.1016/j.bbagrm.2009.08.010
   Ruddell RG, 2009, HEPATOLOGY, V49, P887, DOI 10.1002/hep.22716
   Sagomonyants KB, 2008, BIOMATERIALS, V29, P1563, DOI 10.1016/j.biomaterials.2007.12.001
   Sturn A, 2002, BIOINFORMATICS, V18, P207, DOI 10.1093/bioinformatics/18.1.207
   Toth JM, 2006, BIOMATERIALS, V27, P324, DOI 10.1016/j.biomaterials.2005.07.011
   Vandamme K, 2011, BIOMATERIALS, V32, P3547, DOI 10.1016/j.biomaterials.2011.01.056
   Witzmann FA, 2006, NANOMED-NANOTECHNOL, V2, P158, DOI 10.1016/j.nano.2006.07.005
   Xu JL, 2009, BIOMATERIALS, V30, P5385, DOI 10.1016/j.biomaterials.2009.07.002
   Yang SH, 2003, GENE, V320, P3, DOI 10.1016/S0378-1119(03)00816-3
NR 31
TC 22
Z9 22
U1 2
U2 35
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 1874-3919
J9 J PROTEOMICS
JI J. Proteomics
PD JUN 27
PY 2012
VL 75
IS 12
BP 3560
EP 3573
DI 10.1016/j.jprot.2012.03.033
PG 14
WC Biochemical Research Methods
SC Biochemistry & Molecular Biology
GA 982ZU
UT WOS:000307086500014
PM 22504627
DA 2018-10-19
ER

PT J
AU Taraban, MB
   Feng, Y
   Hammouda, B
   Hyland, LL
   Yu, YB
AF Taraban, Marc B.
   Feng, Yue
   Hammouda, Boualem
   Hyland, Laura L.
   Yu, Y. Bruce
TI Chirality-Mediated Mechanical and Structural Properties of Oligopeptide
   Hydrogels
SO CHEMISTRY OF MATERIALS
LA English
DT Article
DE hydrogels; mechanical properties; homochirality; heterochirality;
   dynamic rheometry; NMR spectroscopy; small-angle X-ray scattering;
   small-angle neutron scattering
ID SMALL-ANGLE SCATTERING; BIODEGRADABLE HYDROGELS; STEREOCOMPLEX
   FORMATION; ALZHEIMERS-DISEASE; PEPTIDE ASSEMBLIES; SYMMETRY-BREAKING;
   AQUEOUS-SOLUTIONS; BLOCK-COPOLYMERS; SHEAR MODULUS; AMINO-ACIDS
AB The origin and the effects of homochirality in the biological world continuously stimulate numerous hypotheses and much debate. This work attempts to look at the biohomochirality issue from a different angle-the mechanical properties of the bulk biomaterial and their relation to nanoscale structures. Using a pair of oppositely charged peptides that co-assemble into hydrogels, we systematically investigated the effect of chirality on the mechanical properties of these hydrogels through different combinations of syndiotactic and isotactic peptides. It was found that homochirality confers mechanical advantage, resulting in a higher elastic modulus and strain yield value. Yet, heterochirality confers kinetic advantage, resulting in faster gelation. Structurally, both homochiral and heterochiral hydrogels are made of fibers interconnected by lappet-like webs, but the homochiral peptide fibers are thicker and denser. These results highlight the possible role of biohomochirality in the evolution and/or natural selection of biomaterials.
C1 [Taraban, Marc B.; Hyland, Laura L.; Yu, Y. Bruce] Univ Maryland, Fischell Dept Bioengn, College Pk, MD 20742 USA.
   [Hammouda, Boualem] NIST, NIST Ctr Neutron Res, Gaithersburg, MD 20899 USA.
   [Feng, Yue; Yu, Y. Bruce] Univ Maryland, Sch Pharm, Dept Pharmaceut Sci, Baltimore, MD 21201 USA.
RP Yu, YB (reprint author), Univ Maryland, Fischell Dept Bioengn, College Pk, MD 20742 USA.
EM byu@rx.umaryland.edu
RI Feng, Yue/H-1578-2012
FU NIH [EB004416]; U.S. DOE [DE-AC02-06CH11357]; National Science
   Foundation [DMR-0944772]
FX Financial support provided by the NIH (EB004416) is gratefully
   acknowledged. Use of the Advanced Photon Source, an Office of Science
   User Facility operated for the U.S. Department of Energy (DOE) Office of
   Science by Argonne National Laboratory, was supported by the U.S. DOE
   under Contract No. DE-AC02-06CH11357. Beamtime was awarded through the
   program of General User Proposals to GUP-24524. We also thank Drs. J.
   Ilavsky and Xiaobing Zuo (ANL) for assistance. The identification of
   commercial products does not imply endorsement by the National Institute
   of Standards and Technology nor does it imply that these are the best
   for the purpose. This work is based upon activities supported in part by
   the National Science Foundation under Agreement No. DMR-0944772.
CR Anil B, 2004, J AM CHEM SOC, V126, P13194, DOI 10.1021/ja047119i
   Avetisov V, 1996, P NATL ACAD SCI USA, V93, P11435, DOI 10.1073/pnas.93.21.11435
   Bao G, 2003, NAT MATER, V2, P715, DOI 10.1038/nmat1001
   Becerril J, 2005, EUR J ORG CHEM, P481, DOI 10.1002/ejoc.200400629
   Bernstein SL, 2009, NAT CHEM, V1, P326, DOI [10.1038/nchem.247, 10.1038/NCHEM.247]
   Blackmond DG, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a002147
   Brizard A., 2005, TOP CURR CHEM, V256, P814
   Chalifour RJ, 2003, J BIOL CHEM, V278, P34874, DOI 10.1074/jbc.M212694200
   Chan W. C., 2000, FMOC SOLID PHASE PEP, P1
   Clark TD, 1998, J AM CHEM SOC, V120, P8949, DOI 10.1021/ja981485i
   de Jong SJ, 2000, MACROMOLECULES, V33, P3680, DOI 10.1021/ma992067g
   de Jong SJ, 2001, J CONTROL RELEASE, V72, P47, DOI 10.1016/S0168-3659(01)00261-9
   Durani S, 2008, ACCOUNTS CHEM RES, V41, P1301, DOI 10.1021/ar700265t
   Dzolic Z, 2006, NEW J CHEM, V30, P1411, DOI 10.1039/b609642e
   Dzwolak W, 2004, J AM CHEM SOC, V126, P3762, DOI 10.1021/ja039138i
   Esler WP, 1999, BIOPOLYMERS, V49, P505, DOI 10.1002/(SICI)1097-0282(199905)49:6<505::AID-BIP8>3.3.CO;2-9
   Feng Y, 2011, SOFT MATTER, V7, P9890, DOI 10.1039/c1sm06389h
   Fitz D., 2007, CURR CHEM BIOL, V1, P41
   Friggeri A, 2005, CHEM-EUR J, V11, P5353, DOI 10.1002/chem.200500007
   Frkanec L, 2010, CHEM COMMUN, V46, P522, DOI 10.1039/b920353m
   FUHRHOP JH, 1987, ANGEW CHEM INT EDIT, V26, P699, DOI 10.1002/anie.198706991
   GILL SC, 1989, ANAL BIOCHEM, V182, P319, DOI 10.1016/0003-2697(89)90602-7
   Glatter O, 1982, SMALL ANGLE XRAY SCA
   Glinka CJ, 1998, J APPL CRYSTALLOGR, V31, P430, DOI 10.1107/S0021889897017020
   Green MM, 2010, ORIGINS LIFE EVOL B, V40, P111, DOI 10.1007/s11084-009-9180-7
   Grillo-Bosch D, 2009, CHEMMEDCHEM, V4, P1488, DOI 10.1002/cmdc.200900191
   Guinier A., 1939, Annales de Physique, V12, P161
   Haack T, 1997, LETT PEPT SCI, V4, P377, DOI 10.1023/A:1008825727500
   Hiemstra C, 2005, MACROMOL SYMP, V224, P119, DOI 10.1002/masy.200550611
   Hiemstra C, 2007, J AM CHEM SOC, V129, P9918, DOI 10.1021/ja072113p
   Hiemstra C, 2006, BIOMACROMOLECULES, V7, P2790, DOI 10.1021/bm060630e
   Hirst AR, 2007, CHEM-EUR J, V13, P2180, DOI 10.1002/chem.200601665
   Hirst AR, 2004, CHEM-EUR J, V10, P5901, DOI 10.1002/chem.200400502
   Hyland LL, 2012, BIOPOLYMERS, V97, P177, DOI 10.1002/bip.21722
   JOYCE GF, 1984, NATURE, V310, P602, DOI 10.1038/310602a0
   Kline SR, 2006, J APPL CRYSTALLOGR, V39, P895, DOI 10.1107/S0021889806035059
   Konarev PV, 2003, J APPL CRYSTALLOGR, V36, P1277, DOI 10.1107/S0021889803012779
   Kozin MB, 2001, J APPL CRYSTALLOGR, V34, P33, DOI 10.1107/S0021889800014126
   Kuhn H, 2008, CURR OPIN COLLOID IN, V13, P3, DOI 10.1016/j.cocis.2007.08.008
   Kumar A, 2009, J PHYS CHEM B, V113, P16435, DOI 10.1021/jp906811k
   Ladik JJ, 2006, J MOL MODEL, V12, P462, DOI 10.1007/s00894-005-0073-z
   Luo XH, 2001, CHEM COMMUN, P1556, DOI 10.1039/b104428c
   MACKINTOSH FC, 1995, PHYS REV LETT, V75, P4425, DOI 10.1103/PhysRevLett.75.4425
   Makarevic J, 2010, BEILSTEIN J ORG CHEM, V6, P945, DOI 10.3762/bjoc.6.106
   MILTON RCD, 1992, SCIENCE, V256, P1445, DOI 10.1126/science.1604320
   Nagy KJ, 2011, J AM CHEM SOC, V133, P14975, DOI 10.1021/ja206742m
   Nanda V, 2007, PROTEIN SCI, V16, P1667, DOI 10.1110/ps.072867007
   Paradossi G, 2001, MACROMOLECULES, V34, P8179, DOI 10.1021/ma010418x
   Paradossi G, 1999, BIOPOLYMERS, V50, P201, DOI 10.1002/(SICI)1097-0282(199908)50:2<201::AID-BIP9>3.3.CO;2-P
   POROD G, 1951, KOLLOID Z Z POLYM, V124, P83, DOI 10.1007/BF01512792
   Ramachandran S, 2005, BIOMACROMOLECULES, V6, P1316, DOI 10.1021/bm049284w
   Reich Z, 1996, J AM CHEM SOC, V118, P6345, DOI 10.1021/ja9600237
   Saghatelian A, 2001, NATURE, V409, P797, DOI 10.1038/35057238
   Slager J, 2003, MACROMOLECULES, V36, P2999, DOI 10.1021/ma025753f
   Slager J, 2002, BIOMATERIALS, V23, P4389, DOI 10.1016/S0142-9612(02)00179-5
   Slager J, 2003, ADV DRUG DELIVER REV, V55, P549, DOI 10.1016/S0169-409X(03)00042-5
   Svergun DI, 1999, BIOPHYS J, V76, P2879, DOI 10.1016/S0006-3495(99)77443-6
   SVERGUN DI, 1992, J APPL CRYSTALLOGR, V25, P495, DOI 10.1107/S0021889892001663
   Trevors JT, 2011, CR BIOL, V334, P269, DOI 10.1016/j.crvi.2011.02.010
   Trevors JT, 2005, PROG BIOPHYS MOL BIO, V89, P1, DOI 10.1016/j.pbiomolbio.2004.07.003
   URATA H, 1991, J AM CHEM SOC, V113, P8174, DOI 10.1021/ja00021a057
   Volkov VV, 2003, J APPL CRYSTALLOGR, V36, P860, DOI 10.1107/S0021889803000268
   Wadai H, 2005, BIOCHEMISTRY-US, V44, P157, DOI 10.1021/bi0485880
   Weissbuch I, 2009, ACCOUNTS CHEM RES, V42, P1128, DOI 10.1021/ar900033k
   Whitten AE, 2009, METHODS MOL BIOL, V544, P307, DOI 10.1007/978-1-59745-483-4_20
   Whitten AE, 2008, P NATL ACAD SCI USA, V105, P18360, DOI 10.1073/pnas.0808903105
   WU DH, 1995, J MAGN RESON SER A, V115, P260, DOI 10.1006/jmra.1995.1176
NR 67
TC 13
Z9 13
U1 0
U2 37
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 0897-4756
J9 CHEM MATER
JI Chem. Mat.
PD JUN 26
PY 2012
VL 24
IS 12
BP 2299
EP 2310
DI 10.1021/cm300422q
PG 12
WC Chemistry, Physical; Materials Science, Multidisciplinary
SC Chemistry; Materials Science
GA 963YX
UT WOS:000305662000009
PM 23641124
OA Green Accepted
DA 2018-10-19
ER

PT J
AU McCreedy, DA
   Sakiyama-Elbert, SE
AF McCreedy, Dylan A.
   Sakiyama-Elbert, Shelly E.
TI Combination therapies in the CNS: Engineering the environment
SO NEUROSCIENCE LETTERS
LA English
DT Review
DE Spinal cord injury; Traumatic brain injury; Cell transplantation;
   Biomaterials; Chondroitin sulfate proteoglycans; Myelin-associated
   inhibitors
ID SPINAL-CORD-INJURY; NEURAL STEM-CELLS; TRAUMATIC BRAIN-INJURY;
   CENTRAL-NERVOUS-SYSTEM; AXONAL REGENERATION; FUNCTIONAL RECOVERY;
   SCHWANN-CELL; NOGO-66 RECEPTOR; NEUROTROPHIC FACTOR; POLYMER SCAFFOLDS
AB The inhibitory extracellular environment that develops in response to traumatic brain injury and spinal cord injury hinders axon growth thereby limiting restoration of function. Several strategies have been developed to engineer a more permissive central nervous system (CNS) environment to promote regeneration and functional recovery. The multi-faced inhibitory nature of the CNS lesion suggests that therapies used in combination may be more effective. In this mini-review we summarize the most recent attempts to engineer the CNS extracellular environment after injury using combinatorial strategies. The advantages and limits of various combination therapies utilizing neurotrophin delivery, cell transplantation, and biomaterial scaffolds are discussed. Treatments that reduce the inhibition by chondroitin sulfate proteoglycans, myelin-associated inhibitors, and other barriers to axon regeneration are also reviewed. Based on the current state of the field, future directions are suggested for research on combination therapies in the CNS. (C) 2012 Elsevier Ireland Ltd. All rights reserved.
C1 [McCreedy, Dylan A.; Sakiyama-Elbert, Shelly E.] Washington Univ, Dept Biomed Engn, St Louis, MO 63130 USA.
RP Sakiyama-Elbert, SE (reprint author), Washington Univ, Dept Biomed Engn, 1 Brookings Dr,Box 1097, St Louis, MO 63130 USA.
EM sakiyama@wustl.edu
RI Sakiyama-Elbert, Shelly/A-6753-2008
OI Sakiyama-Elbert, Shelly/0000-0003-4832-5851
FU NINDS NIH HHS [R01 NS051454, R01 NS051454-07]
CR BAIN G, 1995, DEV BIOL, V168, P342, DOI 10.1006/dbio.1995.1085
   Blesch A, 2003, J COMP NEUROL, V467, P403, DOI 10.1002/cne.10934
   Blesch A, 2002, BRAIN RES BULL, V57, P833, DOI 10.1016/S0361-9230(01)00774-2
   Bradbury EJ, 1999, EUR J NEUROSCI, V11, P3873, DOI 10.1046/j.1460-9568.1999.00809.x
   Bradbury EJ, 2002, NATURE, V416, P636, DOI 10.1038/416636a
   Bradbury EJ, 2011, BRAIN RES BULL, V84, P306, DOI 10.1016/j.brainresbull.2010.06.015
   Bretzner F, 2010, J NEUROSCI RES, V88, P2833, DOI 10.1002/jnr.22440
   Cao QL, 2010, J NEUROSCI, V30, P2989, DOI 10.1523/JNEUROSCI.3174-09.2010
   Carlson SL, 1998, EXP NEUROL, V151, P77, DOI 10.1006/exnr.1998.6785
   CATTANEO E, 1990, NATURE, V347, P762, DOI 10.1038/347762a0
   Chen BKK, 2011, BIOMATERIALS, V32, P8077, DOI 10.1016/j.biomaterials.2011.07.029
   Chen X., 2011, J MAT SCI MAT MED
   Crowe MJ, 1997, NAT MED, V3, P73, DOI 10.1038/nm0197-73
   DAVID S, 1981, SCIENCE, V214, P931, DOI 10.1126/science.6171034
   Deng LX, 2011, EXP NEUROL, V229, P238, DOI 10.1016/j.expneurol.2011.02.001
   Fan JA, 2011, J BIOMED MATER RES B, V97B, P271, DOI 10.1002/jbm.b.31810
   Fleming JC, 2006, BRAIN, V129, P3249, DOI 10.1093/brain/awl296
   Fouad K, 2005, J NEUROSCI, V25, P1169, DOI 10.1523/JNEUROSCI.3562-04.2005
   Galtrey CM, 2007, BRAIN RES REV, V54, P1, DOI 10.1016/j.brainresrev.2006.09.006
   Golden KL, 2007, EXP NEUROL, V207, P203, DOI 10.1016/j.expneurol.2007.06.023
   Grill R, 1997, J NEUROSCI, V17, P5560
   Guo JS, 2007, SPINAL CORD, V45, P15, DOI 10.1038/sj.sc.3101943
   Han QQ, 2009, TISSUE ENG PT A, V15, P2927, DOI [10.1089/ten.tea.2008.0506, 10.1089/ten.TEA.2008.0506]
   Hannila SS, 2008, EXP NEUROL, V209, P321, DOI 10.1016/j.expneurol.2007.06.020
   Hofstetter CP, 2002, P NATL ACAD SCI USA, V99, P2199, DOI 10.1073/pnas.042678299
   Hooshmand MJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005871
   Houle JD, 2006, J NEUROSCI, V26, P7405, DOI 10.1523/JNEUROSCI.1166-06.2006
   Hwang D.H., 2010, CELL TRANSPLANT
   Iannotti CA, 2011, EXP NEUROL, V230, P3, DOI 10.1016/j.expneurol.2010.03.010
   Jain A, 2006, BIOMATERIALS, V27, P497, DOI 10.1016/j.biomaterials.2005.07.008
   Ji BX, 2005, EUR J NEUROSCI, V22, P587, DOI 10.1111/j.1460-9568.2005.04241.x
   Johnson PJ, 2010, SOFT MATTER, V6, P5127, DOI 10.1039/c0sm00173b
   Johnson PJ, 2009, BIOTECHNOL BIOENG, V104, P1207, DOI 10.1002/bit.22476
   Kakulas B A, 1999, J Spinal Cord Med, V22, P119
   Karimi-Abdolrezaee S, 2006, J NEUROSCI, V26, P3377, DOI 10.1523/JNEUROSCI.4184-05.2006
   Keirstead HS, 2005, J NEUROSCI, V25, P4694, DOI 10.1523/JNEUROSCI.0311-05.2005
   Kim H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021744
   Kim HM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004987
   KLEINMAN HK, 1982, BIOCHEMISTRY-US, V21, P6188, DOI 10.1021/bi00267a025
   KLEINMAN HK, 1986, BIOCHEMISTRY-US, V25, P312, DOI 10.1021/bi00350a005
   Koda M, 2007, EUR SPINE J, V16, P2206, DOI 10.1007/s00586-007-0499-3
   KREIDER BQ, 1981, BRAIN RES, V207, P433, DOI 10.1016/0006-8993(81)90375-9
   Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001
   Lee H, 2010, P NATL ACAD SCI USA, V107, P3340, DOI 10.1073/pnas.0905437106
   Li SX, 2003, J NEUROSCI, V23, P4219
   Lu D., 2007, NEUROSURGERY, V61, P602
   Lu DY, 2007, NEUROSURGERY, V61, P596, DOI 10.1227/01.NEU.000028004/.85651.4F
   Lu P, 2008, EXP NEUROL, V209, P313, DOI 10.1016/j.expneurol.2007.08.004
   McGee AW, 2003, TRENDS NEUROSCI, V26, P193, DOI 10.1016/S0166-2236(03)00062-6
   Menei P, 1998, EUR J NEUROSCI, V10, P607, DOI 10.1046/j.1460-9568.1998.00071.x
   Moore MJ, 2006, BIOMATERIALS, V27, P419, DOI 10.1016/j.biomaterials.2005.07.045
   National Spinal Cord Injury Statistical Center, 2010, J Spinal Cord Med, V33, P439
   Nomura H, 2008, TISSUE ENG PT A, V14, P649, DOI 10.1089/tea.2007.0180
   Olson HE, 2009, TISSUE ENG PT A, V15, P1797, DOI 10.1089/ten.tea.2008.0364
   Oudega M, 2006, J NEUROTRAUM, V23, P453, DOI 10.1089/neu.2006.23.453
   Patel V, 2010, J NEUROTRAUM, V27, P789, DOI 10.1089/neu.2008.0809
   Pritchard CD, 2010, J NEUROSCI METH, V188, P258, DOI 10.1016/j.jneumeth.2010.02.019
   Qiu J, 2002, NEURON, V34, P895, DOI 10.1016/S0896-6273(02)00730-4
   Ramer MS, 2003, EUR J NEUROSCI, V18, P2713, DOI 10.1046/j.1460-9568.2003.03012.x
   Rauch MF, 2009, EUR J NEUROSCI, V29, P132, DOI 10.1111/j.1460-9568.2008.06567.x
   Rooney GE, 2011, TISSUE ENG PT A, V17, P1287, DOI [10.1089/ten.tea.2010.0396, 10.1089/ten.TEA.2010.0396]
   SCHNELL L, 1990, NATURE, V343, P269, DOI 10.1038/343269a0
   Stokols S, 2006, TISSUE ENG, V12, P2777, DOI 10.1089/ten.2006.12.2777
   Takami T, 2002, J NEUROSCI, V22, P6670
   Tate CC, 2009, J TISSUE ENG REGEN M, V3, P208, DOI 10.1002/term.154
   Teng YD, 2002, P NATL ACAD SCI USA, V99, P3024, DOI 10.1073/pnas.052678899
   Thuret S, 2006, NAT REV NEUROSCI, V7, P628, DOI 10.1038/nrn1955
   Tohda C, 2011, PHARMACOL THERAPEUT, V132, P57, DOI 10.1016/j.pharmthera.2011.05.006
   Tom VJ, 2009, J NEUROSCI, V29, P14881, DOI 10.1523/JNEUROSCI.3641-09.2009
   TUSZYNSKI MH, 1994, EXP NEUROL, V126, P1, DOI 10.1006/exnr.1994.1037
   Vavrek R, 2007, J NEUROTRAUM, V24, P1667, DOI 10.1089/neu.2007.0290
   Vroemen M, 2003, EUR J NEUROSCI, V18, P743, DOI 10.1046/j.1460-9568.2003.02804.x
   Wei YT, 2010, J BIOMED MATER RES B, V95B, P110, DOI 10.1002/jbm.b.31689
   Willerth SM, 2007, ADV DRUG DELIVER REV, V59, P325, DOI 10.1016/j.addr.2007.03.014
   Xu CJ, 2011, NEUROPATH APPL NEURO, V37, P135, DOI 10.1111/j.1365-2990.2010.01117.x
   XU XM, 1995, J COMP NEUROL, V351, P145, DOI 10.1002/cne.903510113
   YAMAGATA T, 1968, J BIOL CHEM, V243, P1523
   Ye JH, 1997, EXP NEUROL, V143, P70, DOI 10.1006/exnr.1996.6353
NR 78
TC 33
Z9 35
U1 2
U2 40
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND
SN 0304-3940
J9 NEUROSCI LETT
JI Neurosci. Lett.
PD JUN 25
PY 2012
VL 519
IS 2
SI SI
BP 115
EP 121
DI 10.1016/j.neulet.2012.02.025
PG 7
WC Neurosciences
SC Neurosciences & Neurology
GA 970QG
UT WOS:000306146800005
PM 22343313
OA Green Accepted
DA 2018-10-19
ER

PT J
AU Lampe, KJ
   Heilshorn, SC
AF Lampe, Kyle J.
   Heilshorn, Sarah C.
TI Building stem cell niches from the molecule up through engineered
   peptide materials
SO NEUROSCIENCE LETTERS
LA English
DT Review
DE Engineered peptide; Engineered protein; Tissue engineering; Neural stem
   cell; Stem cell niche; Extracellular matrix
ID SPINAL-CORD-INJURY; SELF-ASSEMBLING NANOFIBERS; NEURAL PROGENITOR CELLS;
   IN-VITRO; AMPHIPHILE NANOFIBERS; MECHANICAL-PROPERTIES;
   EXTRACELLULAR-MATRIX; FACTOR DELIVERY; HYDROGELS; SCAFFOLD
AB The native stem cell niche is a dynamic and complex microenvironment. Recapitulating this niche is a critical focus within the fields of stem cell biology, tissue engineering, and regenerative medicine and requires the development of well-defined, tunable materials. Recent biomaterial design strategies seek to create engineered matrices that interact with cells at the molecular scale and allow on-demand, cell-triggered matrix modifications. Peptide and protein engineering can accomplish these goals through the molecular-level design of bioinductive and bioresponsive materials. This brief review focuses on engineered peptide and protein materials suitable for use as in vitro neural stem cell niche mimics and in vivo central nervous system repair. A key hallmark of these materials is the immense design freedom to specify the exact amino acid sequence leading to multi-functional bulk materials with tunable properties. These advanced materials are engineered using rational design strategies to recapitulate key aspects of the native neural stem cell niche. The resulting materials often combine the advantages of biological matrices with the engineering control of synthetic polymers. Future design strategies are expected to endow these materials with multiple layers of bi-directional feedback between the cell and the matrix, which will lead to more advanced mimics of the highly dynamic neural stem cell niche. (C) 2012 Elsevier Ireland Ltd. All rights reserved.
C1 [Lampe, Kyle J.; Heilshorn, Sarah C.] Stanford Univ, Stanford, CA 94305 USA.
RP Heilshorn, SC (reprint author), Stanford Univ, 476 Lomita Mall, Stanford, CA 94305 USA.
EM klampe@stanford.edu; heilshorn@stanford.edu
FU Ruth L. Kirschstein NRSA Postdoctoral Fellowship; CIRM [RT2-01938]; NIH
   [DP2-OD-006477]; NSF [DMR-0846363]
FX KJL was supported by a Ruth L. Kirschstein NRSA Postdoctoral Fellowship.
   The authors acknowledge funding from CIRM RT2-01938, NIH DP2-OD-006477,
   and NSF DMR-0846363. Special thanks to Widya Mulyasasmita for editing
   assistance.
CR Bakshi A, 2005, BRAIN RES, V1065, P8, DOI 10.1016/j.brainres.2005.09.059
   Banerjee A, 2009, BIOMATERIALS, V30, P4695, DOI 10.1016/j.biomaterials.2009.05.050
   Berlemann U, 2009, EUR SPINE J, V18, P1706, DOI 10.1007/s00586-009-1136-0
   Bini E, 2006, BIOMACROMOLECULES, V7, P3139, DOI 10.1021/bm0607877
   Boyd LM, 2006, EUR SPINE J, V15, pS414, DOI 10.1007/s00586-006-0172-2
   Bracalello A, 2011, BIOMACROMOLECULES, V12, P2957, DOI 10.1021/bm2005388
   Branco MC, 2010, BIOMATERIALS, V31, P9527, DOI 10.1016/j.biomaterials.2010.08.047
   Branco MC, 2009, BIOMATERIALS, V30, P1339, DOI 10.1016/j.biomaterials.2008.11.019
   Burns TC, 2011, EXPERT OPIN BIOL TH, V11, P447, DOI 10.1517/14712598.2011.552883
   CAPPELLO J, 1990, BIOTECHNOL PROGR, V6, P198, DOI 10.1021/bp00003a006
   Cappello J, 1998, J CONTROL RELEASE, V53, P105, DOI 10.1016/S0168-3659(97)00243-5
   Carrico IS, 2007, J AM CHEM SOC, V129, P4874, DOI 10.1021/ja070200b
   Charati MB, 2009, SOFT MATTER, V5, P3412, DOI 10.1039/b910980c
   Cigognini D., 2011, PLOS ONE, V6
   Cukierman E, 2001, SCIENCE, V294, P1708, DOI 10.1126/science.1064829
   Dahlin RL, 2011, TISSUE ENG PART B-RE, V17, P349, DOI [10.1089/ten.teb.2011.0238, 10.1089/ten.TEB.2011.0238]
   DeForest CA, 2009, NAT MATER, V8, P659, DOI [10.1038/NMAT2473, 10.1038/nmat2473]
   Di Zio K, 2003, MACROMOLECULES, V36, P1553, DOI 10.1021/ma0256587
   Doetsch F, 1999, CELL, V97, P703, DOI 10.1016/S0092-8674(00)80783-7
   Doetsch F, 2003, CURR OPIN GENET DEV, V13, P543, DOI 10.1016/j.gde.2003.08.012
   Ellis-Behnke RG, 2006, P NATL ACAD SCI USA, V103, P5054, DOI 10.1073/pnas.0600559103
   Elvin CM, 2005, NATURE, V437, P999, DOI 10.1038/nature04085
   Fagerholm P., 2010, SCI TRANSL MED, V2, P1
   Fagerholm P, 2009, CTS-CLIN TRANSL SCI, V2, P162, DOI 10.1111/j.1752-8062.2008.00083.x
   Foo CTSWP, 2009, P NATL ACAD SCI USA, V106, P22067, DOI 10.1073/pnas.0904851106
   Frisen J, 2001, BIOESSAYS, V23, P3, DOI 10.1002/1521-1878(200101)23:1<3::AID-BIES1001>3.0.CO;2-F
   Gage FH, 1998, J NEUROBIOL, V36, P249, DOI 10.1002/(SICI)1097-4695(199808)36:2<249::AID-NEU11>3.0.CO;2-9
   Gelain F., 2006, PLOS ONE, V1
   Gelain F, 2011, ACS NANO, V5, P227, DOI 10.1021/nn102461w
   Guo J, 2007, NANOMED-NANOTECHNOL, V3, P311, DOI 10.1016/j.nano.2007.09.003
   Guo JS, 2009, NANOMED-NANOTECHNOL, V5, P345, DOI 10.1016/j.nano.2008.12.001
   Haines-Butterick L, 2007, P NATL ACAD SCI USA, V104, P7791, DOI 10.1073/pnas.0701980104
   Haines-Butterick LA, 2008, BIOMATERIALS, V29, P4164, DOI 10.1016/j.biomaterials.2008.07.009
   Hakkinen KM, 2011, TISSUE ENG PT A, V17, P713, DOI [10.1089/ten.tea.2010.0273, 10.1089/ten.TEA.2010.0273]
   Hartgerink JD, 2001, SCIENCE, V294, P1684, DOI 10.1126/science.1063187
   Hartgerink JD, 2002, P NATL ACAD SCI USA, V99, P5133, DOI 10.1073/pnas.072699999
   Hern DL, 1998, J BIOMED MATER RES, V39, P266, DOI 10.1002/(SICI)1097-4636(199802)39:2<266::AID-JBM14>3.0.CO;2-B
   HIGUCHI M, 1995, COLLOID POLYM SCI, V273, P1022, DOI 10.1007/BF00657668
   Hoffmann JC, 2010, SOFT MATTER, V6, P5056, DOI 10.1039/c0sm00140f
   Holmes TC, 2000, P NATL ACAD SCI USA, V97, P6728, DOI 10.1073/pnas.97.12.6728
   Hu XA, 2010, BIOMATERIALS, V31, P8121, DOI 10.1016/j.biomaterials.2010.07.044
   Huang J, 2007, POLYM REV, V47, P29, DOI 10.1080/15583720601109560
   Klotzsch E, 2009, P NATL ACAD SCI USA, V106, P18267, DOI 10.1073/pnas.0907518106
   Kloxin AM, 2009, SCIENCE, V324, P59, DOI 10.1126/science.1169494
   Kretsinger JK, 2005, BIOMATERIALS, V26, P5177, DOI 10.1016/j.biomaterials.2005.01.029
   Lammel A, 2011, BIOMATERIALS, V32, P2233, DOI 10.1016/j.biomaterials.2010.11.060
   Lampe KJ, 2010, TISSUE ENG PT A, V16, P1857, DOI [10.1089/ten.tea.2009.0509, 10.1089/ten.TEA.2009.0509]
   Lampe KJ, 2010, J BIOMED MATER RES A, V94A, P1162, DOI 10.1002/jbm.a.32787
   Lampe KJ, 2009, BIOTECHNOL BIOENG, V103, P1214, DOI 10.1002/bit.22352
   Liu CY, 2003, NEUROSURGERY, V52, P1154, DOI 10.1227/01.NEU.0000057747.93237.8F
   Lutolf MP, 2009, NATURE, V462, P433, DOI 10.1038/nature08602
   Lutolf MP, 2005, NAT BIOTECHNOL, V23, P47, DOI 10.1038/nbt1055
   MacKay JA, 2009, NAT MATER, V8, P993, DOI [10.1038/NMAT2569, 10.1038/nmat2569]
   Megeed Z, 2004, J CONTROL RELEASE, V94, P433, DOI 10.1016/j.jconrel.2003.10.027
   Miller JS, 2010, BIOMATERIALS, V31, P3736, DOI 10.1016/j.biomaterials.2010.01.058
   Morrison SJ, 2000, CELL, V101, P499, DOI 10.1016/S0092-8674(00)80860-0
   Nagai Y, 2006, J CONTROL RELEASE, V115, P18, DOI 10.1016/j.jconrel.2006.06.031
   Noble M., 2003, ANN NEW YORK ACAD SC
   Nowak AP, 2002, NATURE, V417, P424, DOI 10.1038/417424a
   Piantino J, 2006, EXP NEUROL, V201, P359, DOI 10.1016/j.expneurol.2006.04.020
   Qiu WG, 2010, BIOMACROMOLECULES, V11, P3219, DOI 10.1021/bm100469w
   Ribeiro A., 2011, TISSUE ENG A
   Rughani RV, 2010, MACROMOLECULES, V43, P7924, DOI 10.1021/ma1014808
   Saha K, 2008, BIOPHYS J, V95, P4426, DOI 10.1529/biophysj.108.132217
   Sakiyama-Elbert SE, 2001, FASEB J, V15, P1300
   Salinas CN, 2008, BIOMATERIALS, V29, P2370, DOI 10.1016/j.biomaterials.2008.01.035
   Schedin P., 2011, COLD SPRING HARBOR P, V3
   Schense JC, 2000, NAT BIOTECHNOL, V18, P415
   Semino CE, 2004, TISSUE ENG, V10, P643, DOI 10.1089/107632704323061997
   Sestan N, 1999, SCIENCE, V286, P741, DOI 10.1126/science.286.5440.741
   Shen Q, 2004, SCIENCE, V304, P1338, DOI 10.1126/science.1095505
   Shen W, 2007, SOFT MATTER, V3, P99, DOI 10.1039/b610986a
   Silva GA, 2004, SCIENCE, V303, P1352, DOI 10.1126/science.1093783
   Song Hongjun, 2002, Nature (London), V417, P39, DOI 10.1038/417039a
   Sortwell CE, 2003, FRONT BIOSCI, V8, pS522, DOI 10.2741/1096
   Stendahl JC, 2008, TRANSPLANTATION, V86, P478, DOI 10.1097/TP.0b013e3181806d9d
   Straley KS, 2009, ADV MATER, V21, P4148, DOI 10.1002/adma.200901865
   Straley KS, 2009, SOFT MATTER, V5, P114, DOI 10.1039/b808504h
   Taraballi Francesca, 2010, Front Neuroeng, V3, P1, DOI 10.3389/neuro.16.001.2010
   Tate CC, 2009, J TISSUE ENG REGEN M, V3, P208, DOI 10.1002/term.154
   Teles H, 2010, J CONTROL RELEASE, V147, P298, DOI 10.1016/j.jconrel.2010.07.098
   Teng YD, 2002, P NATL ACAD SCI USA, V99, P3024, DOI 10.1073/pnas.052678899
   Thonhoff JR, 2008, BRAIN RES, V1187, P42, DOI 10.1016/j.brainres.2007.10.046
   Topp S, 2006, J AM CHEM SOC, V128, P13994, DOI 10.1021/ja064546i
   Tysseling-Mattiace VM, 2008, J NEUROSCI, V28, P3814, DOI 10.1523/JNEUROSCI.0143-08.2008
   Webber MJ, 2011, P NATL ACAD SCI USA, V108, P13438, DOI 10.1073/pnas.1016546108
   Williams AJ, 2001, J POLYM SCI POL PHYS, V39, P2759, DOI 10.1002/polb.10032
   Wipff PJ, 2007, J CELL BIOL, V179, P1311, DOI 10.1083/jcb.200704042
   Wosnick JH, 2008, CHEM MATER, V20, P55, DOI 10.1021/cm071158m
   Wurmser AE, 2004, SCIENCE, V304, P1253, DOI 10.1126/science.1099344
   Xia XX, 2010, P NATL ACAD SCI USA, V107, P14059, DOI 10.1073/pnas.1003366107
   Yang CY, 2009, BIOMATERIALS, V30, P2881, DOI 10.1016/j.biomaterials.2009.01.056
   Yang CL, 2004, BIODRUGS, V18, P103, DOI 10.2165/00063030-200418020-00004
   ZHANG SG, 1993, P NATL ACAD SCI USA, V90, P3334, DOI 10.1073/pnas.90.8.3334
   Zhang SM, 2010, NAT MATER, V9, P594, DOI [10.1038/nmat2778, 10.1038/NMAT2778]
   Zhang ZX, 2010, BIOTECHNOL BIOPROC E, V15, P545, DOI 10.1007/s12257-009-3076-2
   Zhong CL, 1998, J CELL BIOL, V141, P539, DOI 10.1083/jcb.141.2.539
   Zhong J, 2010, NEUROREHAB NEURAL RE, V24, P636, DOI 10.1177/1545968310361958
NR 98
TC 34
Z9 34
U1 0
U2 43
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND
SN 0304-3940
EI 1872-7972
J9 NEUROSCI LETT
JI Neurosci. Lett.
PD JUN 25
PY 2012
VL 519
IS 2
SI SI
BP 138
EP 146
DI 10.1016/j.neulet.2012.01.042
PG 9
WC Neurosciences
SC Neurosciences & Neurology
GA 970QG
UT WOS:000306146800009
PM 22322073
OA Green Accepted, Other Gold
DA 2018-10-19
ER

PT J
AU Kubota, H
   Endo, H
   Noma, M
   Tsuchiya, H
   Yoshimoto, A
   Takahashi, Y
   Inaba, Y
   Matsukura, M
   Sudo, K
AF Kubota, Hiroshi
   Endo, Hidehito
   Noma, Mio
   Tsuchiya, Hiroshi
   Yoshimoto, Akihiro
   Takahashi, Yu
   Inaba, Yusuke
   Matsukura, Mitsuru
   Sudo, Kenichi
TI Equine pericardial roll graft replacement of infected pseudoaneurysm of
   the ascending aorta
SO JOURNAL OF CARDIOTHORACIC SURGERY
LA English
DT Article
DE Equine pericardium; Biomaterial; Infection; Aortic aneurysm; Surgery;
   Pseudoaneurysm
ID RECONSTRUCTION; ANEURYSMS
AB The standard procedure for treating infected aortic aneurysms is to resect the infected aorta, debridement of the surrounding tissue, in situ graft replacement, and omentopexy. However, the question of which graft material is optimal is still a matter of controversy. We recently treated a patient with an infected ascending aortic aneurysm. Because of previous abdominal surgery, the omentum was unavailable. The ascending aorta was replaced in situ with equine pericardial roll grafts. The patient is alive and well 29 months after the operation.
C1 [Kubota, Hiroshi; Endo, Hidehito; Noma, Mio; Tsuchiya, Hiroshi; Yoshimoto, Akihiro; Takahashi, Yu; Inaba, Yusuke; Matsukura, Mitsuru; Sudo, Kenichi] Kyorin Univ, Dept Cardiovasc Surg, Tokyo, Japan.
RP Kubota, H (reprint author), Kyorin Univ, Dept Cardiovasc Surg, Tokyo, Japan.
EM kub@ks.kyorin-u.ac.jp
CR Czerny M, 2011, ANN THORAC SURG, V92, P1657, DOI 10.1016/j.athoracsur.2011.06.073
   Gupta AK, 1996, J VASC SURG, V24, P472, DOI 10.1016/S0741-5214(96)70204-5
   Kubota H, 2012, J CARDIOTHORAC SURG, V7, DOI 10.1186/1749-8090-7-45
   Miyamoto Shinji, 2004, Ann Thorac Cardiovasc Surg, V10, P252
   Salles CA, 1998, J HEART VALVE DIS, V7, P305
   VOGT P, 1995, J THORAC CARDIOV SUR, V109, P589, DOI 10.1016/S0022-5223(95)70294-6
   VOGT PR, 1995, EUR J CARDIO-THORAC, V9, P502, DOI 10.1016/S1010-7940(95)80050-6
   Yamamoto H, 2011, INTERACT CARDIOV TH, V12, P866, DOI 10.1510/icvts.2010.262667
   Yamamoto H, 2009, GEN THORAC CARDIOVAS, V57, P413, DOI 10.1007/s11748-008-0388-7
   Yamamoto H, 2009, J VASC SURG, V49, P1041, DOI 10.1016/j.jvs.2008.11.053
NR 10
TC 3
Z9 3
U1 0
U2 0
PU BIOMED CENTRAL LTD
PI LONDON
PA 236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND
SN 1749-8090
J9 J CARDIOTHORAC SURG
JI J. Cardiothorac. Surg.
PD JUN 14
PY 2012
VL 7
AR 54
DI 10.1186/1749-8090-7-54
PG 4
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA 029AW
UT WOS:000310468200001
PM 22697377
OA DOAJ Gold, Green Published
DA 2018-10-19
ER

PT J
AU Wang, PSP
   Craig, CJ
   Schepartz, A
AF Wang, Pam Shou-Ping
   Craig, Cody J.
   Schepartz, Alanna
TI Relationship between side-chain branching and stoichiometry in
   beta(3)-peptide bundles
SO TETRAHEDRON
LA English
DT Article
DE Biomaterial; Protein design; Protein folding; Self-assembly
ID BETA-PEPTIDE BUNDLE; COILED COILS; PROTEIN; STABILITY; DESIGN; WATER
AB The stability and stoichiometry of beta(3)-peptide bundles is influenced by side-chain identity. Previously reported beta(3)-peptides containing beta(3)-homoleucine on one helical face assemble into octamers, whereas those containing beta(3)-homovaline form tetramers. The side chains of beta(3)-homoleucine and beta(3)-homovaline differ in terms of both side-chain length and gamma-carbon branching. To evaluate the extent to which these two parameters control beta(3)-peptide bundle stoichiometry, we synthesized the beta(3)-peptide Acid-3Y, which contains beta(3)-homoisoleucine in place of beta(3)-homoleucine or beta(3)-homovaline on one helical face. Acid-3Y assembles into a stable tetramer whose stability resembles that of the previously characterized Acid-VY tetramer. These results suggest that beta(3)-peptide bundle stoichiometry can be modulated by the presence or absence of gamma-carbon branching on core side chains. (C) 2012 Elsevier Ltd. All rights reserved.
C1 [Wang, Pam Shou-Ping; Craig, Cody J.; Schepartz, Alanna] Yale Univ, Dept Chem, New Haven, CT 06520 USA.
   [Schepartz, Alanna] Yale Univ, Dept Mol Cellular & Dev Biol, New Haven, CT 06520 USA.
RP Schepartz, A (reprint author), Yale Univ, Dept Chem, 275 Prospect St, New Haven, CT 06520 USA.
EM alanna.schepartz@yale.edu
FU NIH [GM 74756]; NSF [CHE-0848098]
FX This work was supported by the NIH (GM 74756) and the NSF (CHE-0848098).
CR COHEN C, 1990, PROTEINS, V7, P1, DOI 10.1002/prot.340070102
   Craig CJ, 2011, CHEMBIOCHEM, V12, P1035, DOI 10.1002/cbic.201000753
   Daniels DS, 2007, J AM CHEM SOC, V129, P1532, DOI 10.1021/ja068678n
   DEGRADO WF, 1985, J AM CHEM SOC, V107, P7684, DOI 10.1021/ja00311a076
   DURCHSCHLAG H, 1994, PROG COLL POL SCI S, V94, P20
   Goodman JL, 2008, CHEMBIOCHEM, V9, P1576, DOI 10.1002/cbic.200800039
   Goodman JL, 2007, J AM CHEM SOC, V129, P14746, DOI 10.1021/ja0754002
   HARBURY PB, 1993, SCIENCE, V262, P1401, DOI 10.1126/science.8248779
   Kritzer JA, 2005, J AM CHEM SOC, V127, P167, DOI 10.1021/ja0459375
   Matulis D, 1999, BIOPOLYMERS, V49, P451, DOI 10.1002/(SICI)1097-0282(199905)49:6<451::AID-BIP3>3.0.CO;2-6
   Molski MA, 2010, J AM CHEM SOC, V132, P3658, DOI 10.1021/ja910903c
   Monera OD, 1995, J PEPT SCI, V1, P319, DOI 10.1002/psc.310010507
   NEUBERG M, 1989, NATURE, V338, P589, DOI 10.1038/338589a0
   Oakley MG, 2001, CURR OPIN STRUC BIOL, V11, P450, DOI 10.1016/S0959-440X(00)00232-3
   Petersson EJ, 2007, J AM CHEM SOC, V129, P5344, DOI 10.1021/ja070567g
   Seebach D, 1996, HELV CHIM ACTA, V79, P913, DOI 10.1002/hlca.19960790402
   SEMISOTNOV GV, 1991, BIOPOLYMERS, V31, P119, DOI 10.1002/bip.360310111
   Shandler SJ, 2010, J AM CHEM SOC, V132, P7312, DOI 10.1021/ja906700x
NR 18
TC 4
Z9 4
U1 1
U2 13
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0040-4020
J9 TETRAHEDRON
JI Tetrahedron
PD JUN 10
PY 2012
VL 68
IS 23
BP 4342
EP 4345
DI 10.1016/j.tet.2012.03.079
PG 4
WC Chemistry, Organic
SC Chemistry
GA 949IN
UT WOS:000304570000002
PM 22822272
OA Green Accepted
DA 2018-10-19
ER

PT J
AU Zhang, H
   Li, LL
   Dai, FY
   Zhang, HH
   Ni, B
   Zhou, W
   Yang, X
   Wu, YZ
AF Zhang, Hao
   Li, Ling-ling
   Dai, Fang-yin
   Zhang, Hao-hao
   Ni, Bing
   Zhou, Wei
   Yang, Xia
   Wu, Yu-zhang
TI Preparation and characterization of silk fibroin as a biomaterial with
   potential for drug delivery
SO JOURNAL OF TRANSLATIONAL MEDICINE
LA English
DT Article
DE Silk fibroin; Calcium-alcohol solutions; Crystalline structure; Drug
   delivery; Biomaterial
ID BOMBYX-MORI; L-ASPARAGINASE; STRUCTURAL-CHARACTERIZATION; I STRUCTURE;
   FILMS; DISSOLUTION; PROTEIN; FIBER; MODEL; REGENERATION
AB Background: Degummed silk fibroin from Bombyx mori (silkworm) has potential carrier capabilities for drug delivery in humans; however, the processing methods have yet to be comparatively analyzed to determine the differential effects on the silk protein properties, including crystalline structure and activity.
   Methods: In this study, we treated degummed silk with four kinds of calcium-alcohol solutions, and performed secondary structure measurements and enzyme activity test to distinguish the differences between the regenerated fibroins and degummed silk fibroin.
   Results: Gel electrophoresis analysis revealed that Ca(NO3)(2)-methanol, Ca(NO3)(2)-ethanol, or CaCl2-methanol treatments produced more lower molecular weights of silk fibroin than CaCl2-ethanol. X-ray diffraction and Fourier-transform infrared spectroscopy showed that CaCl2-ethanol produced a crystalline structure with more silk I (a-form, type II beta-turn), while the other treatments produced more silk II (beta-form, anti-parallel beta-pleated sheet). Solid-State C-13 cross polarization and magic angle spinning-nuclear magnetic resonance measurements suggested that regenerated fibroins from CaCl2-ethanol were nearly identical to degummed silk fibroin, while the other treatments produced fibroins with significantly different chemical shifts. Finally, enzyme activity test indicated that silk fibroins from CaCl2-ethanol had higher activity when linked to a known chemotherapeutic drug, L-asparaginase, than the fibroins from other treatments.
   Conclusions: Collectively, these results suggest that the CaCl2-ethanol processing method produces silk fibroin with biomaterial properties that are appropriate for drug delivery.
C1 [Zhang, Hao; Zhang, Hao-hao; Ni, Bing; Zhou, Wei; Yang, Xia; Wu, Yu-zhang] Third Mil Med Univ, Inst Immunol, Chongqing 400038, Peoples R China.
   [Li, Ling-ling] Chongqing Ind & Trade Polytech, Dept Biochem Engn, Chongqing 408000, Peoples R China.
   [Dai, Fang-yin] Southwest Univ, State Key Lab Silkworm Genome Biol, Chongqing 400715, Peoples R China.
RP Yang, X (reprint author), Third Mil Med Univ, Inst Immunol, Chongqing 400038, Peoples R China.
EM oceanyangx@gmail.com; wuyuzhang20006@sohu.com
OI Ni, Bing/0000-0002-4297-5346
CR Ali Mir Mahdi, 2011, J Ayurveda Integr Med, V2, P72, DOI 10.4103/0975-9476.82527
   Altman GH, 2003, BIOMATERIALS, V24, P401, DOI 10.1016/S0142-9612(02)00353-8
   Chatterjee S, 2009, APPL BIOCHEM BIOTECH, V157, P593, DOI 10.1007/s12010-008-8405-y
   Chuan Xin Liang KH, 1992, J APPL POLYM SCI, V45, P1937
   FRASER RDB, 1966, J MOL BIOL, V19, P580, DOI 10.1016/S0022-2836(66)80026-8
   Freddi G, 1999, INT J BIOL MACROMOL, V24, P251, DOI 10.1016/S0141-8130(98)00087-7
   Greish K, 2010, J GENE MED, V12, P572, DOI 10.1002/jgm.1469
   Ha SW, 2005, BIOMACROMOLECULES, V6, P1722, DOI 10.1021/bm050010y
   Ha SW, 2003, BIOMACROMOLECULES, V4, P488, DOI 10.1021/bm0255948
   He SJ, 1999, INT J BIOL MACROMOL, V24, P187, DOI 10.1016/S0141-8130(99)00004-5
   Huang J, 2007, BIOMATERIALS, V28, P2358, DOI 10.1016/j.biomaterials.2006.11.021
   INOUE S, 1986, BIOCHEM BIOPH RES CO, V141, P165, DOI 10.1016/S0006-291X(86)80349-7
   KILLANDER D, 1976, CANCER, V37, P220, DOI 10.1002/1097-0142(197601)37:1<220::AID-CNCR2820370132>3.0.CO;2-W
   LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0
   Leal-Egana A, 2010, BIOTECHNOL APPL BIOC, V55, P155, DOI 10.1042/BA20090229
   LOTZ B, 1979, BIOCHIMIE, V61, P205, DOI 10.1016/S0300-9084(79)80067-X
   Lovett M, 2010, ORGANOGENESIS, V6, P217, DOI [10.4161/org.6.4.13407, 10.4161/org6.4.13407]
   Lu Q, 2010, ACTA BIOMATER, V6, P1380, DOI 10.1016/j.actbio.2009.10.041
   Lu SZ, 2009, BIOMACROMOLECULES, V10, P1032, DOI 10.1021/bm800956n
   Mandal BB, 2010, ACTA BIOMATER, V6, P360, DOI 10.1016/j.actbio.2009.08.035
   Mathur AB, 1997, BIOPOLYMERS, V42, P61, DOI 10.1002/(SICI)1097-0282(199707)42:1<61::AID-BIP6>3.0.CO;2-#
   Mauney JR, 2011, BIOMATERIALS, V32, P808, DOI 10.1016/j.biomaterials.2010.09.051
   Meinel L, 2005, BIOMATERIALS, V26, P147, DOI 10.1016/j.biomaterials.2004.02.047
   Omenetto FG, 2010, SCIENCE, V329, P528, DOI 10.1126/science.1188936
   Tanaka K, 1999, INSECT BIOCHEM MOLEC, V29, P269, DOI 10.1016/S0965-1748(98)00135-0
   Tang Y, 2006, BIOMED MATER, V1, P242, DOI 10.1088/1748-6041/1/4/010
   Teramoto H, 2005, BIOMACROMOLECULES, V6, P2049, DOI 10.1021/bm0500547
   Wilson D, 2000, BIOPHYS J, V78, P2690, DOI 10.1016/S0006-3495(00)76813-5
   Yao JM, 2003, J BIOCHEM, V133, P147, DOI 10.1093/jb/mvg014
   Zhang KH, 2011, J BIOMAT SCI-POLYM E, V22, P1069, DOI 10.1163/092050610X498204
   Zhang YQ, 2005, J BIOTECHNOL, V120, P315, DOI 10.1016/j.jbiotec.2005.06.027
   Zhang YQ, 2004, BIOMATERIALS, V25, P3751, DOI 10.1016/j.biomaterials.2003.10.019
   Zhang YQ, 2006, J BIOMED MATER RES B, V79B, P275, DOI 10.1002/jbm.b.30539
   Zhao CH, 2003, BIOPOLYMERS, V69, P253, DOI 10.1002/bip.10350
   Zhu ZH, 2008, EXPRESS POLYM LETT, V2, P885, DOI 10.3144/expresspolymlett.2008.103
   Zhu ZH, 2010, J BIOMAT SCI-POLYM E, V21, P395, DOI 10.1163/156856209X423126
NR 36
TC 17
Z9 19
U1 7
U2 64
PU BIOMED CENTRAL LTD
PI LONDON
PA 236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND
SN 1479-5876
J9 J TRANSL MED
JI J. Transl. Med.
PD JUN 7
PY 2012
VL 10
AR 117
DI 10.1186/1479-5876-10-117
PG 9
WC Medicine, Research & Experimental
SC Research & Experimental Medicine
GA 074SZ
UT WOS:000313835100001
PM 22676291
OA DOAJ Gold, Green Published
DA 2018-10-19
ER

PT J
AU Wang, XM
   He, J
   Wang, Y
   Cui, FZ
AF Wang, Xiumei
   He, Jin
   Wang, Ying
   Cui, Fu-Zhai
TI Hyaluronic acid-based scaffold for central neural tissue engineering
SO INTERFACE FOCUS
LA English
DT Review
DE central neural tissue engineering; hyaluronic acid; central nervous
   system; regeneration; scaffold
ID SPINAL-CORD-INJURY; MYELIN-ASSOCIATED GLYCOPROTEIN; NOGO-66 RECEPTOR
   ANTIBODY; STEM-CELL DIFFERENTIATION; TRAUMATIC BRAIN-INJURY; NERVE
   GROWTH-FACTOR; NEURITE OUTGROWTH; AXONAL REGENERATION;
   CONTROLLED-RELEASE; ELECTROSPUN NANOFIBERS
AB Central nervous system (CNS) regeneration with central neuronal connections and restoration of synaptic connections has been a long-standing worldwide problem and, to date, no effective clinical therapies are widely accepted for CNS injuries. The limited regenerative capacity of the CNS results from the growth-inhibitory environment that impedes the regrowth of axons. Central neural tissue engineering has attracted extensive attention from multi-disciplinary scientists in recent years, and many studies have been carried out to develop cell-and regeneration-activating biomaterial scaffolds that create an artificial micro-environment suitable for axonal regeneration. Among all the biomaterials, hyaluronic acid (HA) is a promising candidate for central neural tissue engineering because of its unique physico-chemical and biological properties. This review attempts to outline current biomaterials-based strategies for CNS regeneration from a tissue engineering point of view and discusses the main progresses in research of HA-based scaffolds for central neural tissue engineering in detail.
C1 [Wang, Xiumei; He, Jin; Wang, Ying; Cui, Fu-Zhai] Tsinghua Univ, Inst Regenerat Med & Biomimet Mat, State Key Lab New Ceram & Fine Proc, Dept Mat Sci & Engn, Beijing 100084, Peoples R China.
RP Wang, XM (reprint author), Tsinghua Univ, Inst Regenerat Med & Biomimet Mat, State Key Lab New Ceram & Fine Proc, Dept Mat Sci & Engn, Beijing 100084, Peoples R China.
EM wxm@mail.tsinghua.edu.cn
FU 973 programme [2011CB606205]; National Natural Science Foundation of
   China [50973052, 50803031]
FX This work was supported by 973 programme (grant no. 2011CB606205) and
   the National Natural Science Foundation of China (grant nos. 50973052
   and 50803031).
CR Barralet JE, 2005, J MATER SCI-MATER M, V16, P515, DOI 10.1007/s10856-005-0526-z
   Beattie MS, 2002, PROG BRAIN RES, V137, P37
   Borkenhagen M, 1998, J BIOMED MATER RES, V40, P392, DOI 10.1002/(SICI)1097-4636(19980603)40:3<392::AID-JBM8>3.0.CO;2-C
   Brannvall K, 2007, J NEUROSCI RES, V85, P2138, DOI 10.1002/jnr.21358
   Burdick JA, 2006, BIOMATERIALS, V27, P452, DOI 10.1016/j.biomaterials.2005.06.034
   Campo GM, 2010, BIOCHIMIE, V92, P204, DOI 10.1016/j.biochi.2009.10.006
   Carlberg B, 2009, BIOMED MATER, V4, DOI 10.1088/1748-6041/4/4/045004
   Chen MS, 2000, NATURE, V403, P434, DOI 10.1038/35000219
   Chen WYJ, 1999, WOUND REPAIR REGEN, V7, P79, DOI 10.1046/j.1524-475X.1999.00079.x
   Christopherson GT, 2009, BIOMATERIALS, V30, P556, DOI 10.1016/j.biomaterials.2008.10.004
   Chvatal SA, 2008, BIOMATERIALS, V29, P1967, DOI 10.1016/j.biomaterials.2008.01.002
   Cooper A, 2011, CARBOHYD POLYM, V85, P149, DOI 10.1016/j.carbpol.2011.02.008
   Corey JM, 2007, J BIOMED MATER RES A, V83A, P636, DOI 10.1002/jbm.a.31285
   Costa C, 2007, J CHEM NEUROANAT, V33, P111, DOI 10.1016/j.jchemneu.2007.01.006
   Cui FZ, 2006, J MATER SCI-MATER M, V17, P1393, DOI 10.1007/s10856-006-0615-7
   Davies SJA, 1999, J NEUROSCI, V19, P5810, DOI 10.1523/JNEUROSCI.19-14-05810.1999
   Domeniconi M, 2002, NEURON, V35, P283, DOI 10.1016/S0896-6273(02)00770-5
   Duan WM, 2000, NEUROSCIENCE, V100, P521, DOI 10.1016/S0306-4522(00)00299-2
   Engler AJ, 2006, CELL, V126, P677, DOI 10.1016/j.cell.2006.06.044
   Flynn L, 2003, BIOMATERIALS, V24, P4265, DOI 10.1016/S0142-9612(03)00334-X
   Ford MC, 2006, P NATL ACAD SCI USA, V103, P2512, DOI 10.1073/pnas.0506020102
   Fournier AE, 2001, NATURE, V409, P341, DOI 10.1038/35053072
   Frampton JP, 2011, BIOMED MATER, V6, DOI 10.1088/1748-6041/6/1/015002
   Freudenberg U, 2009, BIOMATERIALS, V30, P5049, DOI 10.1016/j.biomaterials.2009.06.002
   Georges PC, 2006, BIOPHYS J, V90, P3012, DOI 10.1529/biophysj.105.073114
   GrandPre T, 2000, NATURE, V403, P439, DOI 10.1038/35000226
   Gumera C, 2011, J MATER CHEM, V21, P7033, DOI 10.1039/c0jm04335d
   Guo J, 2007, NANOMED-NANOTECHNOL, V3, P311, DOI 10.1016/j.nano.2007.09.003
   Hashemi SM, 2011, BIOMATERIALS, V32, P7363, DOI 10.1016/j.biomaterials.2011.06.048
   Hejcl A, 2010, STEM CELLS DEV, V19, P1535, DOI 10.1089/scd.2009.0378
   Hench LL, 2002, SCIENCE, V295, P1014, DOI 10.1126/science.1067404
   Hou S, 2006, NEUROSCIENCE, V137, P519, DOI 10.1016/j.neuroscience.2005.09.029
   Hou SP, 2005, J NEUROSCI METH, V148, P60, DOI 10.1016/j.jneumeth.2005.04.016
   Huber AB, 2002, J NEUROSCI, V22, P3553
   Hulsebosch CE, 2002, ADV PHYSIOL EDUC, V26, P238, DOI 10.1152/advan.00039.2002
   Hurtado A, 2011, BIOMATERIALS, V32, P6068, DOI 10.1016/j.biomaterials.2011.05.006
   Hynes SR, 2009, J BIOMED MATER RES A, V89A, P499, DOI 10.1002/jbm.a.31987
   Iannotti C, 2003, EXP NEUROL, V183, P379, DOI 10.1016/S0014-4886(03)00188-2
   Il Cho Y, 2010, ACTA BIOMATER, V6, P4725, DOI 10.1016/j.actbio.2010.06.019
   Jain A, 2006, BIOMATERIALS, V27, P497, DOI 10.1016/j.biomaterials.2005.07.008
   Jin GZ, 2011, NEUROSCI LETT, V501, P10, DOI 10.1016/j.neulet.2011.06.023
   Johnson PJ, 2010, CELL TRANSPLANT, V19, P89, DOI 10.3727/096368909X477273
   Kadoya K, 2009, NEURON, V64, P165, DOI 10.1016/j.neuron.2009.09.016
   Khaing ZZ, 2011, J NEURAL ENG, V8, DOI 10.1088/1741-2560/8/4/046033
   King VR, 2010, NEUROSCIENCE, V168, P523, DOI 10.1016/j.neuroscience.2010.03.040
   Koh HS, 2008, BIOMATERIALS, V29, P3574, DOI 10.1016/j.biomaterials.2008.05.014
   KREWSON CE, 1995, BRAIN RES, V680, P196, DOI 10.1016/0006-8993(95)00261-N
   LaPlaca MC, 2007, PROG BRAIN RES, V161, P13, DOI 10.1016/S0079-6123(06)61002-9
   Laurent Torvard C., 1996, Immunology and Cell Biology, V74, pA1, DOI 10.1038/icb.1996.32
   Lee JY, 2009, BIOMATERIALS, V30, P4325, DOI 10.1016/j.biomaterials.2009.04.042
   Leipzig ND, 2009, BIOMATERIALS, V30, P6867, DOI 10.1016/j.biomaterials.2009.09.002
   Li XG, 2009, BIOMATERIALS, V30, P4978, DOI 10.1016/j.biomaterials.2009.05.047
   Li XG, 2009, BIOMATERIALS, V30, P1121, DOI 10.1016/j.biomaterials.2008.10.063
   Lin CM, 2009, SURG NEUROL, V72, P50, DOI 10.1016/j.wneu.2009.09.004
   Liu T, 2010, J BIOMED MATER RES A, V95A, P276, DOI 10.1002/jbm.a.32831
   Lu DY, 2007, NEUROSURGERY, V61, P596, DOI 10.1227/01.NEU.000028004/.85651.4F
   Ma J, 2007, BIOMED MATER, V2, P233, DOI 10.1088/1748-6041/2/4/005
   MACKINNON SE, 1990, PLAST RECONSTR SURG, V85, P419, DOI 10.1097/00006534-199003000-00015
   Mahmood A, 2011, J NEUROTRAUM, V28, P1199, DOI 10.1089/neu.2010.1694
   Manuskiatti W, 1996, INT J DERMATOL, V35, P539, DOI 10.1111/j.1365-4362.1996.tb03650.x
   MCKERRACHER L, 1994, NEURON, V13, P805, DOI 10.1016/0896-6273(94)90247-X
   Meek MF, 1999, MICROSURG, V19, P247, DOI 10.1002/(SICI)1098-2752(1999)19:5<247::AID-MICR7>3.0.CO;2-E
   Mo LH, 2010, BIOMATERIALS, V31, P2184, DOI 10.1016/j.biomaterials.2009.11.078
   Mori M, 2004, ACTA HISTOCHEM CYTOC, V37, P1, DOI 10.1267/ahc.37.1
   Mukhatyar VJ, 2011, BIOMATERIALS, V32, P3958, DOI 10.1016/j.biomaterials.2011.02.015
   Namba RM, 2009, ACTA BIOMATER, V5, P1884, DOI 10.1016/j.actbio.2009.01.036
   Novikova LN, 2006, J BIOMED MATER RES A, V77A, P242, DOI 10.1002/jbm.a.30603
   Ozgenel GY, 2003, MICROSURG, V23, P575, DOI 10.1002/micr.10209
   Pan LJ, 2009, J NEUROSCI RES, V87, P3207, DOI 10.1002/jnr.22142
   Park J, 2010, J BIOMED MATER RES A, V93A, P1091, DOI 10.1002/jbm.a.32519
   Piantino J, 2006, EXP NEUROL, V201, P359, DOI 10.1016/j.expneurol.2006.04.020
   Platt CI, 2003, J NEUROSCI RES, V74, P417, DOI 10.1002/jnr.10783
   Prabhakaran MP, 2009, BIOMATERIALS, V30, P4996, DOI 10.1016/j.biomaterials.2009.05.057
   Prinjha R, 2000, NATURE, V403, P383, DOI 10.1038/35000287
   Rahman N, 2010, BIOMATERIALS, V31, P8262, DOI 10.1016/j.biomaterials.2010.07.040
   Rauch MF, 2009, EUR J NEUROSCI, V29, P132, DOI 10.1111/j.1460-9568.2008.06567.x
   Sakiyama-Elbert SE, 2000, J CONTROL RELEASE, V65, P389, DOI 10.1016/S0168-3659(99)00221-7
   Schense JC, 2000, NAT BIOTECHNOL, V18, P415
   Schnell E, 2007, BIOMATERIALS, V28, P3012, DOI 10.1016/j.biomaterials.2007.03.009
   Scott JB, 2011, BIOMATERIALS, V32, P4830, DOI 10.1016/j.biomaterials.2011.03.037
   Seidlits SK, 2010, BIOMATERIALS, V31, P3930, DOI 10.1016/j.biomaterials.2010.01.125
   Shen YH, 2008, ACTA BIOMATER, V4, P477, DOI 10.1016/j.actbio.2007.12.011
   Shen YX, 2010, CELL TRANSPLANT, V19, P147, DOI 10.3727/096368910X492616
   Silver J, 2004, NAT REV NEUROSCI, V5, P146, DOI 10.1038/nrn1326
   Smith LA, 2004, COLLOID SURFACE B, V39, P125, DOI [10.1016/j.colsurfb.2003.12.004, 10.1016/j.colsurfb.2003.l2.004]
   Stokols S, 2006, BIOMATERIALS, V27, P443, DOI 10.1016/j.biomaterials.2005.06.039
   Stokols S, 2004, BIOMATERIALS, V25, P5839, DOI 10.1016/j.biomaterials.2004.01.041
   Stokols S, 2006, TISSUE ENG, V12, P2777, DOI 10.1089/ten.2006.12.2777
   Suzuki M, 2003, J NEUROSCI RES, V72, P646, DOI 10.1002/jnr.10589
   Taylor SJ, 2004, J CONTROL RELEASE, V98, P281, DOI 10.1016/j.jconrel.2004.05.003
   Tian WM, 2005, TISSUE ENG, V11, P513, DOI 10.1089/ten.2005.11.513
   Tian WM, 2005, J CONTROL RELEASE, V102, P13, DOI 10.1016/j.jconrel.2004.09.025
   Vinson M, 2001, J BIOL CHEM, V276, P20280, DOI 10.1074/jbc.M100345200
   Wang KC, 2002, NATURE, V417, P941, DOI 10.1038/nature00867
   Wang TW, 2009, ACTA BIOMATER, V5, P2371, DOI 10.1016/j.actbio.2009.03.033
   Wang XX, 2002, J NEUROSCI, V22, P5505
   Wang Y, 2011, PHARM RES-DORDR, V28, P1406, DOI 10.1007/s11095-011-0452-3
   Wang YC, 2008, BIOMATERIALS, V29, P4546, DOI 10.1016/j.biomaterials.2008.07.050
   Wei YT, 2007, BIOMED MATER, V2, pS142, DOI 10.1088/1748-6041/2/3/S11
   Wei YT, 2010, J BIOMED MATER RES B, V95B, P110, DOI 10.1002/jbm.b.31689
   Wei YT, 2009, J BIOACT COMPAT POL, V24, P205, DOI 10.1177/0883911509102266
   Willerth SM, 2007, J BIOMED MATER RES A, V80A, P13, DOI 10.1002/jbm.a.30844
   Wong DY, 2008, J NEUROTRAUM, V25, P1027, DOI 10.1089/neu.2007.0473
   Xie JW, 2009, ACS NANO, V3, P1151, DOI 10.1021/nn900070z
   Xie JW, 2009, BIOMATERIALS, V30, P354, DOI 10.1016/j.biomaterials.2008.09.046
   Xiong Y, 2009, BRAIN RES, V1263, P183, DOI 10.1016/j.brainres.2009.01.032
   Xu T, 2009, BIOMATERIALS, V30, P4377, DOI 10.1016/j.biomaterials.2009.04.047
   Yang F, 2005, BIOMATERIALS, V26, P2603, DOI 10.1016/j.biomaterials.2004.06.051
   YAVIN E, 1974, J CELL BIOL, V62, P540, DOI 10.1083/jcb.62.2.540
   Yiu G, 2006, NAT REV NEUROSCI, V7, P617, DOI 10.1038/nrn1956
   Yu HW, 2010, ANAT REC, V293, P911, DOI 10.1002/ar.20941
   Yu LMY, 2008, J NEUROSCI METH, V171, P253, DOI 10.1016/j.jneumeth.2008.03.023
   Zhao LR, 2005, BRAIN RES, V1054, P1, DOI 10.1016/j.brainres.2005.04.056
   Zhao XB, 2010, CHEM SOC REV, V39, P3480, DOI 10.1039/b915923c
NR 114
TC 36
Z9 36
U1 0
U2 56
PU ROYAL SOC
PI LONDON
PA 6-9 CARLTON HOUSE TERRACE, LONDON SW1Y 5AG, ENGLAND
SN 2042-8898
EI 2042-8901
J9 INTERFACE FOCUS
JI Interface Focus
PD JUN 6
PY 2012
VL 2
IS 3
BP 278
EP 291
DI 10.1098/rsfs.2012.0016
PG 14
WC Biology
SC Life Sciences & Biomedicine - Other Topics
GA 930AI
UT WOS:000303107300003
PM 23741606
OA Bronze, Green Published
DA 2018-10-19
ER

PT J
AU Lu, T
   Qiao, YQ
   Liu, XY
AF Lu, Tao
   Qiao, Yuqin
   Liu, Xuanyong
TI Surface modification of biomaterials using plasma immersion ion
   implantation and deposition
SO INTERFACE FOCUS
LA English
DT Review
DE plasma immersion ion implantation and deposition; surface modification;
   physico-chemical characteristics; bioactivity; haemocompatibility;
   antibacterial activity
ID DIAMOND-LIKE CARBON; SHAPE-MEMORY ALLOYS; C-H FILMS; BLOOD
   COMPATIBILITY; NITI ALLOYS; ANTIBACTERIAL PROPERTIES; BIOMEDICAL
   APPLICATIONS; MECHANICAL-PROPERTIES; CORROSION BEHAVIOR; WEAR-RESISTANCE
AB Although remarkable progress has been made on biomaterial research, the ideal biomaterial that satisfies all the technical requirements and biological functions is not available up to now. Surface modification seems to be a more economic and efficient way to adjust existing conventional biomaterials to meet the current and ever-evolving clinical needs. From an industrial perspective, plasma immersion ion implantation and deposition (PIII&D) is an attractive method for biomaterials owing to its capability of treating objects with irregular shapes, as well as the control of coating composition. It is well acknowledged that the physico-chemical characteristics of biomaterials are the decisive factors greatly affecting the biological responses of biomaterials including bioactivity, haemocompatibility and antibacterial activity. Here, we mainly review the recent advances in surface modification of biomaterials via PIII&D technology, especially titanium alloys and polymers used for orthopaedic, dental and cardiovascular implants. Moreover, the variations of biological performances depending on the physico-chemical properties of modified biomaterials will be discussed.
C1 [Lu, Tao; Qiao, Yuqin; Liu, Xuanyong] Chinese Acad Sci, Shanghai Inst Ceram, State Key Lab High Performance Ceram & Superfine, Shanghai 200050, Peoples R China.
RP Liu, XY (reprint author), Chinese Acad Sci, Shanghai Inst Ceram, State Key Lab High Performance Ceram & Superfine, Shanghai 200050, Peoples R China.
EM xyliu@mail.sic.ac.cn
RI Liu, Xuanyong/J-2609-2018
FU National Basic Research Programme of China (973 Programme)
   [2012CB933601]; National Natural Science Foundation of China [31100675,
   51071168]; State Key Laboratory of High Performance Ceramics Superfine
   Microstructure
FX This work was jointly supported by the National Basic Research Programme
   of China (973 Programme, 2012CB933601), National Natural Science
   Foundation of China (31100675 and 51071168) and the Young Scholar
   Project of State Key Laboratory of High Performance Ceramics Superfine
   Microstructure.
CR Alonso F, 1997, SURF COAT TECH, V93, P305, DOI 10.1016/S0257-8972(97)00065-0
   Anders A, 2004, SURF COAT TECH, V183, P301, DOI 10.1016/j.surfcoat.2003.09.049
   Anders A, 1997, SURF COAT TECH, V93, P158, DOI 10.1016/S0257-8972(97)00037-6
   Anders A, 2002, VACUUM, V67, P673, DOI 10.1016/S0042-207X(02)00260-9
   Anders A, 2002, SURF COAT TECH, V156, P3, DOI 10.1016/S0257-8972(02)00066-X
   Armitage DA, 2007, APPL SURF SCI, V253, P4085, DOI 10.1016/j.apsusc.2006.09.006
   Berry C W, 1992, Implant Dent, V1, P59, DOI 10.1097/00008505-199200110-00006
   Cao HL, 2011, BIOMATERIALS, V32, P693, DOI 10.1016/j.biomaterials.2010.09.066
   Chen JY, 2002, SURF COAT TECH, V156, P289, DOI 10.1016/S0257-8972(02)00089-0
   Chen JY, 2002, BIOMATERIALS, V23, P2545, DOI 10.1016/S0142-9612(01)00389-1
   Chu PK, 2007, SURF COAT TECH, V201, P5601, DOI 10.1016/j.surfcoat.2006.07.003
   Chu PK, 2010, SURF COAT TECH, V204, P2853, DOI 10.1016/j.surfcoat.2010.01.045
   Chu PK, 2009, SURF COAT TECH, V203, P2793, DOI 10.1016/j.surfcoat.2009.02.131
   Chu PK, 2006, NUCL INSTRUM METH B, V242, P1, DOI 10.1016/j.nimb.2005.08.015
   Chu PK, 2001, SURF COAT TECH, V136, P151, DOI 10.1016/S0257-8972(00)01046-X
   Cui FZ, 2000, SURF COAT TECH, V131, P481, DOI 10.1016/S0257-8972(00)00809-4
   Daley B, 2004, J BONE JOINT SURG BR, V86B, P598, DOI 10.1302/0301-620X.86B4.14368
   Drees P, 2007, NAT CLIN PRACT RHEUM, V3, P165, DOI 10.1038/ncprheum0428
   Farshi MS, 1997, NUCL INSTRUM METH B, V127, P787, DOI 10.1016/S0168-583X(97)00008-6
   Garcia JA, 2011, VACUUM, V85, P1125, DOI 10.1016/j.vacuum.2010.12.024
   Gittens RA, 2011, BIOMATERIALS, V32, P3395, DOI 10.1016/j.biomaterials.2011.01.029
   Griffith LG, 2002, SCIENCE, V295, P1009, DOI 10.1126/science.1069210
   Grill A, 2003, DIAM RELAT MATER, V12, P166, DOI 10.1016/S0925-9635(03)00018-9
   Hauert R, 2003, DIAM RELAT MATER, V12, P583, DOI 10.1016/S0925-9635(03)00081-5
   Hench LL, 2002, SCIENCE, V295, P1014, DOI 10.1126/science.1067404
   HENCH LL, 1984, SCIENCE, V226, P630, DOI 10.1126/science.6093253
   HENCH LL, 1980, SCIENCE, V208, P826, DOI 10.1126/science.6246576
   Hetrick EM, 2006, CHEM SOC REV, V35, P780, DOI 10.1039/b515219b
   Huang N, 1998, BIOMATERIALS, V19, P771, DOI 10.1016/S0142-9612(98)00212-9
   Huang N, 1994, J Biomater Appl, V8, P404, DOI 10.1177/088532829400800406
   INMAN RD, 1984, AM J MED, V77, P47, DOI 10.1016/0002-9343(84)90434-0
   Jonasova L, 2004, BIOMATERIALS, V25, P1187, DOI 10.1016/j.biomaterials.2003.08.009
   Kim S, 2009, ACTA BIOMATER, V5, P144, DOI 10.1016/j.actbio.2008.07.033
   Kokubo T, 2003, BIOMATERIALS, V24, P2161, DOI 10.1016/S0142-9612(03)00044-9
   Kou PM, 2011, ACTA BIOMATER, V7, P1354, DOI 10.1016/j.actbio.2010.10.020
   Krischok S, 2007, SURF SCI, V601, P3856, DOI 10.1016/j.susc.2007.04.060
   Kwok SCH, 2006, DIAM RELAT MATER, V15, P893, DOI 10.1016/j.diamond.2005.10.062
   Kwok SCH, 2005, DIAM RELAT MATER, V14, P78, DOI 10.1016/j.diamond.2004.07.019
   Lee JH, 2005, BIOMATERIALS, V26, P3249, DOI 10.1016/j.biomaterials.2004.08.033
   Leng YX, 2002, SURF COAT TECH, V156, P295, DOI 10.1016/S0257-8972(02)00092-0
   Leng YX, 2000, THIN SOLID FILMS, V377, P573, DOI 10.1016/S0040-6090(00)01306-7
   Leng YX, 2001, SURF COAT TECH, V138, P296, DOI 10.1016/S0257-8972(00)01172-5
   Leyland A, 2000, WEAR, V246, P1, DOI 10.1016/S0043-1648(00)00488-9
   Liang H, 2007, APPL SURF SCI, V253, P3326, DOI 10.1016/j.apsusc.2006.07.038
   Liao Y, 2011, SCIENCE, V334, P1687, DOI 10.1126/science.1213902
   Lim JY, 2008, BIOMATERIALS, V29, P1776, DOI 10.1016/j.biomaterials.2007.12.026
   Liu B, 2011, ACTA BIOMATER, V7, P1407, DOI 10.1016/j.actbio.2010.11.001
   Liu XM, 2008, SURF COAT TECH, V202, P2463, DOI 10.1016/j.surfcoat.2007.08.017
   Liu XY, 2004, MAT SCI ENG R, V47, P49, DOI 10.1016/j.mser.2004.11.001
   Liu XY, 2005, BIOMATERIALS, V26, P6143, DOI 10.1016/j.biomaterials.2005.04.035
   Liu XY, 2005, SURF COAT TECH, V191, P43, DOI 10.1016/j.surfcoat.2004.08.118
   Macnair R, 1998, P I MECH ENG H, V212, P465, DOI 10.1243/0954411981534222
   Maendl S., 2002, Biomolecular Engineering, V19, P129
   Maitz MF, 2005, BIOMATERIALS, V26, P5465, DOI 10.1016/j.biomaterials.2005.02.006
   Mikulewicz M, 2011, BIOL TRACE ELEM RES, V142, P865, DOI 10.1007/s12011-010-8798-7
   Narayan RJ, 2010, PHILOS T R SOC A, V368, P1831, DOI 10.1098/rsta.2010.0001
   Okabe Y, 2005, SURF COAT TECH, V196, P303, DOI 10.1016/j.surfcoat.2004.08.190
   Palacios C, 2006, CRIT REV FOOD SCI, V46, P621, DOI 10.1080/10408390500466174
   Park JW, 2012, CLIN ORAL IMPLAN RES, V23, P294, DOI 10.1111/j.1600-0501.2010.02144.x
   Poon RWY, 2005, NUCL INSTRUM METH B, V237, P411, DOI 10.1016/j.nimb.2005.05.030
   Poon RWY, 2005, BIOMATERIALS, V26, P2265, DOI 10.1016/j.biomaterials.2004.07.056
   Poon RWY, 2005, MAT SCI ENG A-STRUCT, V390, P444, DOI 10.1016/j.msea.2004.08.061
   Poon RWY, 2005, THIN SOLID FILMS, V488, P20, DOI 10.1016/j.tsf.2005.04.002
   Powles RC, 2005, DIAM RELAT MATER, V14, P1577, DOI 10.1016/j.diamond.2005.02.013
   Rani VVD, 2012, ACTA BIOMATER, V8, P1976, DOI 10.1016/j.actbio.2012.01.021
   Regan EM, 2010, BIOMATERIALS, V31, P207, DOI 10.1016/j.biomaterials.2009.09.042
   Roach P, 2007, J MATER SCI-MATER M, V18, P1263, DOI 10.1007/s10856-006-0064-3
   Shi W, 2001, WEAR, V250, P544, DOI 10.1016/S0043-1648(01)00636-6
   Sui JH, 2006, DIAM RELAT MATER, V15, P1720, DOI 10.1016/j.diamond.2006.03.004
   Sui JH, 2009, NUCL INSTRUM METH B, V267, P2475, DOI 10.1016/j.nimb.2009.05.049
   Tang BY, 1998, SURF COAT TECH, V104, P248, DOI 10.1016/S0257-8972(98)00403-4
   Taubes G, 2008, SCIENCE, V321, P356, DOI 10.1126/science.321.5887.356
   Thevenot P, 2008, CURR TOP MED CHEM, V8, P270
   Thorwarth G, 2007, PLASMA PROCESS POLYM, V4, pS364, DOI 10.1002/ppap.200731001
   Tian XB, 2004, SURF COAT TECH, V186, P190, DOI 10.1016/j.surfcoat.2004.04.049
   Vandamme K, 2011, BIOMATERIALS, V32, P3547, DOI 10.1016/j.biomaterials.2011.01.056
   Wan GJ, 2004, SURF COAT TECH, V186, P136, DOI 10.1016/j.surfcoat.2004.04.037
   Wang HY, 2010, BIOMATERIALS, V31, P8181, DOI 10.1016/j.biomaterials.2010.07.054
   Wang HY, 2010, BIOMATERIALS, V31, P413, DOI 10.1016/j.biomaterials.2009.09.066
   Wang HY, 2009, ACTA BIOMATER, V5, P279, DOI 10.1016/j.actbio.2008.07.017
   Wang J, 2004, SURF COAT TECH, V186, P299, DOI 10.1016/j.surfcoat.2004.02.046
   Xie YT, 2005, BIOMATERIALS, V26, P6129, DOI 10.1016/j.biomaterials.2005.03.032
   Yang P, 2004, SURF COAT TECH, V177, P747, DOI 10.1016/j.surfcoat.2003.08.016
   Yang P, 2003, BIOMATERIALS, V24, P2821, DOI 10.1016/S0142-9612(03)00091-7
   Yang P, 2002, SURF COAT TECH, V156, P284, DOI 10.1016/S0257-8972(02)00087-7
   Zhang W, 2007, APPL SURF SCI, V253, P8981, DOI 10.1016/j.apsusc.2007.05.019
   Zhang W, 2006, APPL SURF SCI, V252, P7884, DOI 10.1016/j.apsusc.2005.09.057
   Zhang W, 2008, ACTA BIOMATER, V4, P2028, DOI 10.1016/j.actbio.2008.05.012
   Zhang W, 2008, SURF COAT TECH, V203, P909, DOI 10.1016/j.surfcoat.2008.08.023
NR 89
TC 43
Z9 46
U1 7
U2 114
PU ROYAL SOC
PI LONDON
PA 6-9 CARLTON HOUSE TERRACE, LONDON SW1Y 5AG, ENGLAND
SN 2042-8898
J9 INTERFACE FOCUS
JI Interface Focus
PD JUN 6
PY 2012
VL 2
IS 3
BP 325
EP 336
DI 10.1098/rsfs.2012.0003
PG 12
WC Biology
SC Life Sciences & Biomedicine - Other Topics
GA 930AI
UT WOS:000303107300006
PM 23741609
OA Green Published, Bronze
DA 2018-10-19
ER

PT J
AU Xiao, R
   Chu, BF
   Zhang, L
   Cao, JK
AF Xiao Rui
   Chu Bing-feng
   Zhang Lan
   Cao Jun-kai
TI Aging performances for resisting low-temperature of three dental
   yttria-stabilized zirconia ceramic core materials
SO CHINESE MEDICAL JOURNAL
LA English
DT Article
DE ceramic; Yttria-stabilized tetragonal zirconia; X-ray diffraction
ID FLEXURAL STRENGTH; MECHANICAL-PROPERTIES; TOUGHENED ZIRCONIA;
   SURFACE-STRUCTURE; IMPLANTS; BIOMATERIAL; BEHAVIOR
AB Background The low-temperature resistance aging performance of Yttria-stabilized tetragonal zirconia polycrystal (Y-TZP) is the key effective factor that influences the long-term success rate of prosthesis. The objective of this study was to test and compare the aging performances for resisting low temperature of Lava Frame, Cercon Smart, and Upcera Yttria-stabilized zirconia core materials, via analyzing the micro and the crystal phases of the materials, and measure the three-point bending strength and the fracture toughness.
   Methods The three zirconia green bodies were prepared as 60 test samples for three-point bending strength and as 60 test samples for fracture toughness. The test samples for three-point bending strength and fracture toughness were assigned to five groups and were treated respectively for 0, 5, 10, 15, and 20 hours to observe the micro and the crystal phases of the test samples. Then the three-point bending strength and fracture toughness were tested by X-ray diffraction (XRD).
   Results The m phase content of Lava Frame was raised from 7.70% to 13.01%; the m phase content of Cercon Smart was raised from 4.95% to 8.53%; and Lava Frame is raised from 10.84% to 35.18%. The three-point bending strengths of the three zirconia core materials were higher than 1100 MPa and the fracture toughness was higher than 3 MPa.m(1/2). The three-point bending strength and the fracture toughness of Upera zirconia decreased the most, followed by Lava Frame, and then by Cercon Smart.
   Conclusion The aging resistance sequences of the three zirconia core materials are, from strong to weak, Cercon Smart, Lava Frame, and Upcera. Chin Med J 2012;125(11):1999-2003
C1 [Xiao Rui; Chu Bing-feng; Cao Jun-kai] Peoples Liberat Army Gen Hosp, Inst Stomatol, Beijing 100853, Peoples R China.
   [Chu Bing-feng] Hainan Branch Peoples Liberat Army Gen Hosp, Dept Stomatol, Sanya 572000, Hainan, Peoples R China.
RP Cao, JK (reprint author), Peoples Liberat Army Gen Hosp, Inst Stomatol, Beijing 100853, Peoples R China.
EM caojk@hotmail.com
CR Ardlin BI, 2002, DENT MATER, V18, P590, DOI 10.1016/S0109-5641(01)00095-1
   Bocanegra-Bernal MH, 2002, J MATER SCI, V37, P4947, DOI 10.1023/A:1021099308957
   Chevalier J, 2006, BIOMATERIALS, V27, P535, DOI 10.1016/j.biomaterials.2005.07.034
   Chevalier J, 2007, ANNU REV MATER RES, V37, P1, DOI 10.1146/annurev.matsci.37.052506.084250
   Chowdhury S, 2007, J BIOMED MATER RES B, V81B, P486, DOI 10.1002/jbm.b.30688
   Clarke IC, 2003, J BONE JOINT SURG AM, V85A, P73, DOI 10.2106/00004623-200300004-00009
   Denry I, 2008, DENT MATER, V24, P299, DOI 10.1016/j.dental.2007.05.007
   Hisbergues M, 2009, J BIOMED MATER RES B, V88B, P519, DOI 10.1002/jbm.b.31147
   Kim Hyung-Tae, 2009, J Adv Prosthodont, V1, P113, DOI 10.4047/jap.2009.1.3.113
   Liu Q, 2010, ADV MATER RES-SWITZ, V105-106, P49, DOI 10.4028/www.scientific.net/AMR.105-106.49
   Lughi V, 2010, DENT MATER, V26, P807, DOI 10.1016/j.dental.2010.04.006
   Papanagiotou HP, 2006, J PROSTHET DENT, V96, P154, DOI 10.1016/j.prosdent.2006.08.004
   Qi Liu, 2012, Key Engineering Materials, V492, P71, DOI 10.4028/www.scientific.net/KEM.492.71
   Richter EJ, 2008, QJDT, V6, P184
   Marocho SMS, 2010, DENT MATER, V26, P483, DOI 10.1016/j.dental.2010.01.007
   Schneider J, 2008, J AM CERAM SOC, V91, P3613, DOI 10.1111/j.1551-2916.2008.02700.x
   TSUBAKINO H, 1993, J MATER SCI LETT, V12, P196, DOI 10.1007/BF00819957
   Vagkopoulou T, 2009, INT J ESTHET DENT, V4, P130
   Yi YF, 2009, RARE METAL MAT ENG, V38, P870
   Yoshimura M, 1987, J MATER SCI LETT, V6, P456
NR 20
TC 4
Z9 4
U1 0
U2 7
PU MEDKNOW PUBLICATIONS & MEDIA PVT LTD
PI MUMBAI
PA B-9, KANARA BUSINESS CENTRE, OFF LINK RD, GHAKTOPAR-E, MUMBAI, 400075,
   INDIA
SN 0366-6999
J9 CHINESE MED J-PEKING
JI Chin. Med. J.
PD JUN 5
PY 2012
VL 125
IS 11
BP 1999
EP 2003
DI 10.3760/cmaj.issn.0366-6999.2012.11.029
PG 5
WC Medicine, General & Internal
SC General & Internal Medicine
GA 958RZ
UT WOS:000305259700030
PM 22884068
OA DOAJ Gold
DA 2018-10-19
ER

PT J
AU Cado, G
   Kerdjoudj, H
   Chassepot, A
   Lefort, M
   Benmlih, K
   Hemmerle, J
   Voegel, JC
   Jierry, L
   Schaaf, P
   Frere, Y
   Boulmedais, F
AF Cado, G.
   Kerdjoudj, H.
   Chassepot, A.
   Lefort, M.
   Benmlih, K.
   Hemmerle, J.
   Voegel, J. -C.
   Jierry, L.
   Schaaf, P.
   Frere, Y.
   Boulmedais, F.
TI Polysaccharide Films Built by Simultaneous or Alternate Spray: A Rapid
   Way to Engineer Biomaterial Surfaces
SO LANGMUIR
LA English
DT Article
ID LAYER-BY-LAYER; POLYELECTROLYTE MULTILAYER FILMS; ADHESION PROPERTIES;
   HYALURONIC-ACID; IONIC-STRENGTH; CELL-ADHESION; CROSS-LINKING; CHITOSAN;
   HEPARIN; COATINGS
AB We investigated polysaccharide films obtained by simultaneous and alternate spraying of a chitosan (CHI) solution as polycation and hyaluronic acid (HA), alginate (ALG), and chondroitin sulfate (CS) solutions as polyanions. For simultaneous spraying, the film thickness increases linearly with the cumulative spraying time and passes through a maximum for polyanion/CHI molar charge ratios lying between 0.6 and 1.2. The size of polyanion/CHI complexes formed in solution was compared with the simultaneously sprayed film growth rate as a function of the polyanion/CHI molar charge ratio. A good correlation was found. This suggests the importance of polyanion/polycation complexation in the simultaneous spraying process. Depending on the system, the film topography is either liquid-like or granular. Film biocompatibility was evaluated using human gingival fibroblasts. A small or no difference is observed in cell viability and adhesion between the two deposition processes. The CHI/HA system appears to be the best for cell adhesion inducing the clustering of CD44, a cell surface HA receptor, at the membrane of cells. Simultaneous or alternate spraying of CHI/HA appears thus to be a convenient and fast procedure for biomaterial surface modifications.
C1 [Cado, G.; Lefort, M.; Jierry, L.; Schaaf, P.; Frere, Y.; Boulmedais, F.] Ctr Natl Rech Sci, Inst Charles Sadron, UPR 22, F-67034 Strasbourg, France.
   [Kerdjoudj, H.] Univ Reims, UFR Odontol, EA 4691, SFR Cap Sante, F-51095 Reims, France.
   [Chassepot, A.; Benmlih, K.; Hemmerle, J.; Voegel, J. -C.] INSERM, UMR 977, F-67085 Strasbourg, France.
   [Chassepot, A.; Benmlih, K.; Hemmerle, J.; Voegel, J. -C.] Univ Strasbourg, Fac Chirurg Dent, F-67000 Strasbourg, France.
   [Jierry, L.; Schaaf, P.] Univ Strasbourg, Ecole Europeenne Chim Polymeres & Mat, F-67087 Strasbourg, France.
   [Jierry, L.; Schaaf, P.; Boulmedais, F.] Int Ctr Frontier Res Chem, F-67083 Strasbourg, France.
RP Boulmedais, F (reprint author), Ctr Natl Rech Sci, Inst Charles Sadron, UPR 22, 23 Rue Loess, F-67034 Strasbourg, France.
EM fouzia.boulmedais@ics-cnrs.unistra.fr
RI Boulmedais, Fouzia/B-4657-2011; SCHAAF, Pierre/J-2751-2016
OI Boulmedais, Fouzia/0000-0002-4934-9276; SCHAAF,
   Pierre/0000-0001-7423-5492; JIERRY, Loic/0000-0002-7541-1360
FU "BDI" of the Centre National de la Recherche Scientifique; Region
   Alsace; Jeunes Chercheurs du PMNA
FX Bernard Senger is acknowledged for his help in statistical analysis. G.
   C. was supported by a "BDI" doctoral fellowship of the Centre National
   de la Recherche Scientifique and the Region Alsace. "Jeunes Chercheurs
   du PMNA 2009" is acknowledged for financial support.
CR Almodovar J, 2011, BIOMACROMOLECULES, V12, P2755, DOI 10.1021/bm200519y
   Almodovar J, 2010, BIOMACROMOLECULES, V11, P2629, DOI 10.1021/bm1005799
   Boddohi S, 2008, BIOMACROMOLECULES, V9, P2021, DOI 10.1021/bm8002573
   Boddohi S, 2010, ADV MATER, V22, P2998, DOI 10.1002/adma.200903790
   Boulmedais F, 2004, BIOMATERIALS, V25, P2003, DOI 10.1016/j.biomaterials.2003.08.039
   Bratskaya S, 2007, BIOMACROMOLECULES, V8, P2960, DOI 10.1021/bm700620j
   Burke SE, 2003, BIOMACROMOLECULES, V4, P1773, DOI 10.1021/bm034184w
   Chassepot A, 2012, CHEM MATER, V24, P930, DOI 10.1021/cm2024982
   Chua PH, 2008, BIOMATERIALS, V29, P1412, DOI 10.1016/j.biomaterials.2007.12.019
   Cooper S. L., 1982, BIOMATERIALS INTERFA, P539
   Crouzier T, 2010, SMALL, V6, P651, DOI 10.1002/smll.200901728
   DECHER G, 1992, THIN SOLID FILMS, V210, P831, DOI 10.1016/0040-6090(92)90417-A
   Ferrer MCC, 2010, LANGMUIR, V26, P14126, DOI 10.1021/la102315j
   Fu JH, 2005, BIOMATERIALS, V26, P6684, DOI 10.1016/j.biomaterials.2005.04.034
   GOMBOTZ WR, 1987, CRIT REV BIOCOMPAT, V4, P1
   Hillberg AL, 2009, BIOMATERIALS, V30, P4463, DOI 10.1016/j.biomaterials.2009.05.026
   Holmes CA, 2012, J BIOMED MATER RES A, V100A, P518, DOI 10.1002/jbm.a.33305
   Krogman KC, 2009, NAT MATER, V8, P512, DOI [10.1038/NMAT2430, 10.1038/nmat2430]
   Kujawa P, 2005, J AM CHEM SOC, V127, P9224, DOI 10.1021/ja044385n
   Larkin AL, 2010, BIOMACROMOLECULES, V11, P2788, DOI 10.1021/bm100867h
   Lefort M, 2011, LANGMUIR, V27, P4653, DOI 10.1021/la104809z
   Lefort M, 2010, ANGEW CHEM INT EDIT, V49, P10110, DOI 10.1002/anie.201002729
   Liu M, 2007, LANGMUIR, V23, P9378, DOI 10.1021/la7002996
   Liu YX, 2005, COLLOID SURFACE B, V46, P117, DOI 10.1016/j.colsurfb.2005.09.005
   Liu ZM, 2010, MACROMOL BIOSCI, V10, P1043, DOI 10.1002/mabi.202000086
   Lundin M, 2011, LANGMUIR, V27, P7537, DOI 10.1021/la200441u
   Lundin M, 2010, LANGMUIR, V26, P3242, DOI 10.1021/la902968h
   Marken E, 2008, THIN SOLID FILMS, V516, P7770, DOI 10.1016/j.tsf.2008.05.054
   Martins GV, 2010, MACROMOL BIOSCI, V10, P1444, DOI 10.1002/mabi.201000193
   Morra M, 2005, BIOMACROMOLECULES, V6, P1205, DOI 10.1021/bm049346i
   PAGE B, 1993, INT J ONCOL, V3, P473
   Porcel CH, 2005, LANGMUIR, V21, P800, DOI 10.1021/la047570n
   Pure E, 2009, CELL SIGNAL, V21, P651, DOI 10.1016/j.cellsig.2009.01.024
   RATNER BD, 1993, J BIOMED MATER RES, V27, P837, DOI 10.1002/jbm.820270702
   Ratner BD, 1990, PLASMA DEPOSITION TR, P463
   RATNER BD, 1989, COMPREHENSIVE POLYM, P201
   Richert L, 2004, LANGMUIR, V20, P448, DOI 10.1021/la035415n
   Richert L, 2004, BIOMACROMOLECULES, V5, P284, DOI 10.1021/bm0342281
   Schaaf P, 2012, ADV MATER, V24, P1001, DOI 10.1002/adma.201104227
   Schlenoff JB, 2000, LANGMUIR, V16, P9968, DOI 10.1021/la001312i
   Schneider A, 2006, LANGMUIR, V22, P1193, DOI 10.1021/la0521802
   Schneider A, 2007, BIOMED MATER, V2, pS45, DOI 10.1088/1748-6041/2/1/S07
   Thierry B, 2003, BIOMACROMOLECULES, V4, P1564, DOI 10.1021/bm0341834
   Vasconcellos FC, 2010, BIOMACROMOLECULES, V11, P2407, DOI 10.1021/bm100570r
   Voytik-Harbin SL, 1998, IN VITRO CELL DEV-AN, V34, P239
   Zhou J, 2010, J COLLOID INTERF SCI, V345, P241, DOI 10.1016/j.jcis.2010.02.004
NR 46
TC 19
Z9 19
U1 2
U2 71
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 0743-7463
J9 LANGMUIR
JI Langmuir
PD JUN 5
PY 2012
VL 28
IS 22
BP 8470
EP 8478
DI 10.1021/la300563s
PG 9
WC Chemistry, Multidisciplinary; Chemistry, Physical; Materials Science,
   Multidisciplinary
SC Chemistry; Materials Science
GA 952HM
UT WOS:000304783300023
PM 22554108
DA 2018-10-19
ER

PT J
AU Tao, H
   Kaplan, DL
   Omenetto, FG
AF Tao, Hu
   Kaplan, David L.
   Omenetto, Fiorenzo G.
TI Silk Materials - A Road to Sustainable High Technology
SO ADVANCED MATERIALS
LA English
DT Review
DE silk; photonics; electronics; sustainable materials; materials
   manufacturing; biopolymers; nanotechnology; biomedical devices; sensing
ID MESENCHYMAL STEM-CELLS; MARROW STROMAL CELLS; FIBROIN FILMS; SPIDER
   SILK; BOMBYX-MORI; IN-VITRO; BIOMATERIAL COATINGS; BIOMEDICAL
   APPLICATIONS; MECHANICAL-PROPERTIES; PROTEIN MONOLAYERS
AB This review addresses the use of silk protein as a sustainable material in optics and photonics, electronics and optoelectronic applications. These options represent additional developments for this technology platform that compound the broad utility and impact of this material for medical needs that have been recently described in the literature. The favorable properties of the material certainly make a favorable case for the use of silk, yet serve as a broad inspiration to further develop biological foundries for both the synthesis and processing of Nature's materials for technological applications.
C1 [Omenetto, Fiorenzo G.] Tufts Univ, Dept Biomed Engn, Dept Phys, Medford, MA 02155 USA.
RP Omenetto, FG (reprint author), Tufts Univ, Dept Biomed Engn, Dept Phys, 4 Colby St, Medford, MA 02155 USA.
EM fiorenzo.omenetto@tufts.edu
RI Tao, Hu/C-1528-2013
FU DARPA; AFOSR; NSF; NIH; J. Simon Guggenheim Memorial Foundation
FX We acknowledge the invaluable contributions of multiple colleagues and
   collaborators across numerous institutions that have directly
   participated in many aspects of this research. We gratefully acknowledge
   DARPA, the AFOSR, NSF and NIH for support of the various phases of the
   work reviewed herein. FGO gratefully acknowledges support from the J.
   Simon Guggenheim Memorial Foundation.
CR Adato R, 2009, P NATL ACAD SCI USA, V106, P19227, DOI 10.1073/pnas.0907459106
   Agarwal N, 1997, J APPL POLYM SCI, V63, P401
   Aizenberg J, 2004, ADV MATER, V16, P1295, DOI 10.1002/adma.200400759
   Aizenberg J, 2001, NATURE, V412, P819, DOI 10.1038/35090573
   Altman GH, 2003, BIOMATERIALS, V24, P401, DOI 10.1016/S0142-9612(02)00353-8
   Altman GH, 2002, BIOMATERIALS, V23, P4131, DOI 10.1016/S0142-9612(02)00156-4
   Amsden JJ, 2010, ADV MATER, V22, P1746, DOI 10.1002/adma.200903166
   Amsden JJ, 2009, OPT EXPRESS, V17, P21271, DOI 10.1364/OE.17.021271
   Arockiados T, 2008, MATER CHEM PHYS, V111, P517, DOI 10.1016/j.matchemphys.2008.05.016
   Barber J, 2005, J PHYS CHEM A, V109, P3501, DOI 10.1021/jp044384h
   Barrett CJ, 2007, SOFT MATTER, V3, P1249, DOI 10.1039/b705619b
   Baryshev AV, 2009, J MATER SCI-MATER EL, V20, P416, DOI 10.1007/s10854-008-9659-4
   Bettinger CJ, 2007, ADV MATER, V19, P2847, DOI 10.1002/adma.200602487
   Boriskina SV, 2010, OPT EXPRESS, V18, P14568, DOI 10.1364/OE.18.014568
   Braun FN, 2003, INT J BIOL MACROMOL, V32, P59, DOI 10.1016/S0141-8130(03)00038-2
   Brigo L, 2008, SENSOR ACTUAT B-CHEM, V130, P477, DOI 10.1016/j.snb.2007.09.020
   Brookes VL, 2008, J MATER SCI, V43, P3728, DOI 10.1007/s10853-008-2597-y
   Capelli R, 2011, ORG ELECTRON, V12, P1146, DOI 10.1016/j.orgel.2011.04.005
   Carofiglio T, 2006, TETRAHEDRON, V62, P1502, DOI 10.1016/j.tet.2005.11.016
   Chen X, 2006, SOFT MATTER, V2, P448, DOI 10.1039/b601286h
   Domachuk P., 2009, APPL PHYS LETT, P95
   ELACHI C, 1976, P IEEE, V64, P1666, DOI 10.1109/PROC.1976.10409
   ENGELBERG I, 1991, BIOMATERIALS, V12, P292, DOI 10.1016/0142-9612(91)90037-B
   Etienne O, 2009, J PERIODONTOL, V80, P1852, DOI 10.1902/jop.2009.090231
   Foo CWP, 2006, P NATL ACAD SCI USA, V103, P9428, DOI 10.1073/pnas.0601096103
   Ghosh S, 2009, BIOMATERIALS, V30, P6530, DOI 10.1016/j.biomaterials.2009.08.019
   Gil ES, 2010, LANGMUIR, V26, P15614, DOI 10.1021/la102509a
   Goldsmith MR, 2005, ANNU REV ENTOMOL, V50, P71, DOI 10.1146/annurev.ento.50.071803.130456
   Gouda MD, 2003, J BIOL CHEM, V278, P24324, DOI 10.1074/jbc.M208711200
   Hofmann S, 2006, J CONTROL RELEASE, V111, P219, DOI 10.1016/j.jconrel.205.12.009
   Hooper IR, 2006, OPT EXPRESS, V14, P4891, DOI 10.1364/OE.14.004891
   Hu X, 2006, MACROMOLECULES, V39, P6161, DOI 10.1021/ma0610109
   Hu X, 2011, BIOMACROMOLECULES, V12, P1686, DOI 10.1021/bm200062a
   Irimia-Vladu M, 2011, J MATER CHEM, V21, P1350, DOI 10.1039/c0jm02444a
   Jiang XQ, 2009, BIOMATERIALS, V30, P4522, DOI 10.1016/j.biomaterials.2009.05.021
   Jin HJ, 2005, ADV FUNCT MATER, V15, P1241, DOI 10.1002/adfm.200400405
   Karageorgiou V, 2004, J BIOMED MATER RES A, V71A, P528, DOI 10.1002/jbm.a.30186
   Karageorgiou V, 2006, J BIOMED MATER RES A, V78A, P324, DOI 10.1002/jbm.a.30728
   Khire TS, 2010, SOFT MATTER, V6, P2066, DOI 10.1039/b924530h
   Kim D. Y., 2009, APPL PHYS LETT, P95
   Kim DH, 2010, NAT MATER, V9, P511, DOI [10.1038/nmat2745, 10.1038/NMAT2745]
   Kim HJ, 2005, BIOMATERIALS, V26, P4442, DOI 10.1016/j.biomaterials.2004.11.013
   Kino R, 2006, J APPL POLYM SCI, V99, P2822, DOI 10.1002/app.22910
   Kluge JA, 2008, TRENDS BIOTECHNOL, V26, P244, DOI 10.1016/j.tibtech.2008.02.006
   Kundu SC, 2008, PROG POLYM SCI, V33, P998, DOI 10.1016/j.progpolymsci.2008.08.002
   Lawrence BD, 2008, BIOMACROMOLECULES, V9, P1214, DOI 10.1021/bm701235f
   Lawrence BD, 2009, BIOMATERIALS, V30, P1299, DOI 10.1016/j.biomaterials.2008.11.018
   Lee SY, 2010, P NATL ACAD SCI USA, V107, P12086, DOI 10.1073/pnas.1002849107
   Legnani C, 2008, THIN SOLID FILMS, V517, P1016, DOI 10.1016/j.tsf.2008.06.011
   Li CM, 2006, BIOMATERIALS, V27, P3115, DOI 10.1016/j.biomaterials.2006.01.022
   Liu L, 2008, J BIOMAT SCI-POLYM E, V19, P325, DOI 10.1163/156856208783721010
   Liu Y, 2008, BIOMACROMOLECULES, V9, P1782, DOI 10.1021/bm7014174
   Lovett M, 2007, BIOMATERIALS, V28, P5271, DOI 10.1016/j.biomterials.2007.08.008
   Lu Q, 2010, MACROMOL BIOSCI, V10, P359, DOI 10.1002/mabi.200900388
   Lu SZ, 2009, BIOMACROMOLECULES, V10, P1032, DOI 10.1021/bm800956n
   Lv Q, 2005, J APPL POLYM SCI, V96, P2168, DOI 10.1002/app.21682
   Mallick H, 2000, B MATER SCI, V23, P319, DOI 10.1007/BF02720090
   Marolt D, 2006, BIOMATERIALS, V27, P6138, DOI 10.1016/j.biomaterials.2006.07.015
   Meinel L, 2006, BONE, V39, P922, DOI 10.1016/j.bone.2006.04.019
   Meinel L, 2005, BONE, V37, P688, DOI 10.1016/j.bone.2005.06.010
   Meinel L, 2005, BIOMATERIALS, V26, P147, DOI 10.1016/j.biomaterials.2004.02.047
   Meinel L, 2004, ANN BIOMED ENG, V32, P112, DOI 10.1023/B:ABME.0000007796.48329.b4
   Meinel L, 2006, BIOMATERIALS, V27, P4993, DOI 10.1016/j.biomaterials.2006.05.021
   Meyer WL, 2009, BIOMACROMOLECULES, V10, P858, DOI 10.1021/bm801364h
   Mills CA, 2006, J BIOMED MATER RES A, V76A, P781, DOI 10.1002/jbm.a.30539
   Min BM, 2006, MACROMOL BIOSCI, V6, P285, DOI 10.1002/mabi.200500246
   Mondia JP, 2010, ADV MATER, V22, P4596, DOI 10.1002/adma.201001238
   Moreau JE, 2008, TISSUE ENG PT A, V14, P1161, DOI [10.1089/ten.tea.2007.0147, 10.1089/tea.2007.0147]
   Mori H, 2000, J Biotechnol, V74, P95
   Motta A, 2002, J BIOACT COMPAT POL, V17, P23, DOI 10.1106/088391102023195
   Muller C, 2011, ADV MATER, V23, P898, DOI 10.1002/adma.201003601
   Murphy AR, 2008, BIOMATERIALS, V29, P4260, DOI 10.1016/j.biomaterials.2008.07.019
   O'Hara JF, 2008, OPT EXPRESS, V16, P1786, DOI 10.1364/OE.16.001786
   Oksman K, 2009, PLAST RUBBER COMPOS, V38, P396, DOI 10.1179/146580109X12540995045723
   Omenetto FG, 2008, NAT PHOTONICS, V2, P641, DOI 10.1038/nphoton.2008.207
   Park I., 2007, APPL PHYS LETT, P90
   Parker ST, 2009, ADV MATER, V21, P2411, DOI 10.1002/adma.200801580
   Pendry JB, 1999, IEEE T MICROW THEORY, V47, P2075, DOI 10.1109/22.798002
   Perez-Rigueiro J, 2000, J APPL POLYM SCI, V75, P1270, DOI 10.1002/(SICI)1097-4628(20000307)75:10<1270::AID-APP8>3.3.CO;2-3
   Perry H, 2008, ADV MATER, V20, P3070, DOI 10.1002/adma.200800011
   Pins GD, 1997, BIOPHYS J, V73, P2164, DOI 10.1016/S0006-3495(97)78247-X
   Porter D, 2009, ADV MATER, V21, P487, DOI 10.1002/adma.200801332
   Pritchard EM, 2010, J CONTROL RELEASE, V144, P159, DOI 10.1016/j.jconrel.2010.01.035
   Pritchard EM, 2009, 2009 35TH ANNUAL NORTHEAST BIOENGINEERING CONFERENCE, P282
   Psaltis D, 1998, COMPUTER, V31, P52, DOI 10.1109/2.652917
   Rajkhowa R, 2010, MACROMOL BIOSCI, V10, P599, DOI 10.1002/mabi.200900358
   Rockwood DN, 2011, NAT PROTOC, V6, P1612, DOI 10.1038/nprot.2011.379
   Santin M, 1999, J BIOMED MATER RES, V46, P382, DOI 10.1002/(SICI)1097-4636(19990905)46:3<382::AID-JBM11>3.0.CO;2-R
   Scheibel T, 2005, CURR OPIN BIOTECH, V16, P427, DOI 10.1016/j.copbio.2005.05.005
   Schneider A, 2009, ACTA BIOMATER, V5, P2570, DOI 10.1016/j.actbio.2008.12.013
   Shao ZZ, 2003, MACROMOLECULES, V36, P1157, DOI 10.1021/ma0214660
   Singh TB, 2010, ADV POLYM SCI, V223, P189, DOI 10.1007/12_2009_6
   Soffer L, 2008, J BIOMAT SCI-POLYM E, V19, P653, DOI 10.1163/156856208784089607
   Sofia S, 2001, J BIOMED MATER RES, V54, P139, DOI 10.1002/1097-4636(200101)54:1<139::AID-JBM17>3.0.CO;2-7
   Steckl AJ, 2007, NAT PHOTONICS, V1, P3, DOI 10.1038/nphoton.2006.56
   Steckl J., 2006, APPL PHYS LETT, P88
   Sugihara A, 2000, P SOC EXP BIOL MED, V225, P58, DOI 10.1046/j.1525-1373.2000.22507.x
   Sundar VC, 2003, NATURE, V424, P899, DOI 10.1038/424899a
   Szybala C, 2009, EXP NEUROL, V219, P126, DOI 10.1016/j.expneurol.2009.05.018
   Tansil NC, 2011, ADV MATER, V23, P1463, DOI 10.1002/adma.201003860
   Tao H., 2010, APPL PHYS LETT, P97
   Tao H, 2010, ADV MATER, V22, P3527, DOI 10.1002/adma.201000412
   Tsioris K, 2011, ADV MATER, V23, P2015, DOI 10.1002/adma.201004771
   Tsioris K, 2010, ADV FUNCT MATER, V20, P1083, DOI 10.1002/adfm.200902050
   Valluzzi R, 2002, PHILOS T ROY SOC B, V357, P165, DOI 10.1098/rstb.2001.1032
   Vepari C, 2007, PROG POLYM SCI, V32, P991, DOI 10.1016/j.progpolymsci.2007.05.013
   Vollrath F, 2001, NATURE, V410, P541, DOI 10.1038/35069000
   Vukusic P, 2009, J R SOC INTERFACE, V6, pS193, DOI 10.1098/rsif.2008.0345.focus
   Vukusic P, 2000, NATURE, V404, P457, DOI 10.1038/35006561
   Vukusic P, 1999, P ROY SOC B-BIOL SCI, V266, P1403, DOI 10.1098/rspb.1999.0794
   Wang CH, 2011, ADV MATER, V23, P1630, DOI 10.1002/adma.201004071
   Wang H, 1998, J CHROMATOGR A, V828, P121, DOI 10.1016/S0021-9673(98)00832-2
   Wang X, 2008, BIOMATERIALS, V29, P894, DOI 10.1016/j.biomaterials.2007.10.055
   Wang XY, 2007, J CONTROL RELEASE, V121, P190, DOI 10.1016/j.jconrel.2007.06.006
   Wang XQ, 2010, BIOMATERIALS, V31, P1025, DOI 10.1016/j.biomaterials.2009.11.002
   Wang XY, 2005, LANGMUIR, V21, P11335, DOI 10.1021/la051862m
   Wang YZ, 2006, BIOMATERIALS, V27, P6064, DOI 10.1016/j.biomaterials.2006.07.008
   Wen JC, 2011, ACTA POLYM SIN, P12, DOI 10.3724/SP.J.1105.2011.10247
   Wilz A, 2008, BIOMATERIALS, V29, P3609, DOI 10.1016/j.biomaterials.2008.05.010
   Xu T, 2007, MAT SCI ENG C-BIO S, V27, P579, DOI 10.1016/j.msec.2006.05.029
   Yang Y, 2005, ADV MATER, V17, P84, DOI 10.1002/adma.200400344
   Yao JM, 2010, ADV MATER, V22, P1102, DOI 10.1002/adma.200904097
   Yeo JH, 2000, BIOL PHARM BULL, V23, P1220
   Yi HM, 2005, BIOMACROMOLECULES, V6, P2881, DOI 10.1021/bm0504101
   Yu Z, 2007, APPL OPTICS, V46, P1507, DOI 10.1364/AO.46.001507
   Zhao J, 2009, BONE, V45, P517, DOI 10.1016/j.bone.2009.05.026
   Zhou GQ, 2009, ADV MATER, V21, P366, DOI 10.1002/adma.200800582
NR 127
TC 212
Z9 214
U1 18
U2 301
PU WILEY-V C H VERLAG GMBH
PI WEINHEIM
PA BOSCHSTRASSE 12, D-69469 WEINHEIM, GERMANY
SN 0935-9648
J9 ADV MATER
JI Adv. Mater.
PD JUN 5
PY 2012
VL 24
IS 21
BP 2824
EP 2837
DI 10.1002/adma.201104477
PG 14
WC Chemistry, Multidisciplinary; Chemistry, Physical; Nanoscience &
   Nanotechnology; Materials Science, Multidisciplinary; Physics, Applied;
   Physics, Condensed Matter
SC Chemistry; Science & Technology - Other Topics; Materials Science;
   Physics
GA 949SH
UT WOS:000304595700002
PM 22553118
HC Y
HP N
DA 2018-10-19
ER

PT J
AU Zhang, X
   Gao, XH
   Jiang, L
   Qin, JH
AF Zhang, Xu
   Gao, Xinghua
   Jiang, Lei
   Qin, Jianhua
TI Flexible Generation of Gradient Electrospinning Nanofibers Using a
   Microfluidic Assisted Approach
SO LANGMUIR
LA English
DT Article
ID MESENCHYMAL STEM-CELLS; BONE DEFECTS; SCAFFOLDS; FIBERS; TISSUE;
   PROMOTION
AB The nanofiber surface modified with physical or chemical gradients is very useful in a wide range of areas including tissue engineering, regenerative medicine, drug screening, and biomaterial chemistry. In this work, we presented a novel and straightforward microfluidic assisted approach to produce electrospinning nanofibers containing gradients in different compositions, nanoparticles and biomolecule concentrations. The series of gradient nanofibers were mainly produced by using a two inlet microfluidic device in combination with an electrospinning nozzle on a 3-D controllable platform, which exhibited different functions and properties. The controlled nanofibers with incorporated biomolecule gradient were used for guiding the spatial differentiation in mesenchymal stem cells (MSCs). This established approach is very simple, and flexible to operate, which might find enormous potential for biology and tissue engineering applications.
C1 [Zhang, Xu; Gao, Xinghua; Jiang, Lei; Qin, Jianhua] Chinese Acad Sci, Dalian Inst Chem Phys, Dalian 116023, Peoples R China.
   [Zhang, Xu; Gao, Xinghua] Chinese Acad Sci, Grad Sch, Beijing, Peoples R China.
RP Qin, JH (reprint author), Chinese Acad Sci, Dalian Inst Chem Phys, 457 Zhongshan Rd, Dalian 116023, Peoples R China.
EM jhqin@dicp.ac.cn
RI Jiang, Lei/B-1066-2011; Jiang, Lei/D-5654-2011
FU NSFC-RGC [11161160522]; Chinese Academy of Sciences [KJCX2-YW-H18,
   YZ200908]
FX This work was supported by Joint Research Fund of NSFC-RGC
   (11161160522), Knowledge Innovation Program of the Chinese Academy of
   Sciences (KJCX2-YW-H18), and Instrument Research and Development Program
   of the Chinese Academy of Sciences (YZ200908).
CR Engler AJ, 2006, CELL, V126, P677, DOI 10.1016/j.cell.2006.06.044
   Fu SZ, 2010, J PHYS CHEM C, V114, P18372, DOI 10.1021/jp106488t
   Gao JA, 2010, J GENET GENOMICS, V37, P475, DOI 10.1016/S1673-8527(09)60067-9
   Gao XH, 2011, ELECTROPHORESIS, V32, P3431, DOI 10.1002/elps.201100237
   Gulfam M, 2011, LANGMUIR, V27, P10993, DOI 10.1021/la201253z
   Gupta D, 2009, BIOMATERIALS, V30, P2085, DOI 10.1016/j.biomaterials.2008.12.079
   Hashemi SM, 2011, BIOMATERIALS, V32, P7363, DOI 10.1016/j.biomaterials.2011.06.048
   Hashi CK, 2007, P NATL ACAD SCI USA, V104, P11915, DOI 10.1073/pnas.0704581104
   Ignatious F, 2010, PHARM RES-DORDR, V27, P576, DOI 10.1007/s11095-010-0061-6
   K-hasuwan PR, 2011, LANGMUIR, V27, P10938, DOI [10.1021/la20255w, 10.1021/la202255w]
   Lewkowitz-Shpuntoff HM, 2009, BIOMATERIALS, V30, P8, DOI 10.1016/j.biomaterials.2008.09.015
   Li XR, 2009, NANO LETT, V9, P2763, DOI 10.1021/nl901582f
   Li XR, 2008, LANGMUIR, V24, P14145, DOI 10.1021/la802984a
   Lo CM, 2000, BIOPHYS J, V79, P144, DOI 10.1016/S0006-3495(00)76279-5
   Nandakumar A, 2010, LANGMUIR, V26, P7380, DOI 10.1021/la904406b
   Nie HM, 2007, J CONTROL RELEASE, V120, P111, DOI 10.1016/j.jconrel.2007.03.018
   Nie H, 2009, BIOMATERIALS, V30, P892, DOI 10.1016/j.biomaterials.2008.10.029
   Orlova Y, 2011, BIOMATERIALS, V32, P5615, DOI 10.1016/j.biomaterials.2011.04.042
   Piskin E, 2009, J BIOMED MATER RES A, V90A, P1137, DOI 10.1002/jbm.a.32157
   Shi J, 2010, ACS APPL MATER INTER, V2, P1025, DOI 10.1021/am9007962
   Tiwari SK, 2010, INT J PHARMACEUT, V392, P209, DOI 10.1016/j.ijpharm.2010.03.021
   Tse JR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015978
   Ulrich TA, 2010, BIOMATERIALS, V31, P1875, DOI 10.1016/j.biomaterials.2009.10.047
   Xie JW, 2010, NANOSCALE, V2, P35, DOI 10.1039/b9nr00243j
   Xing SY, 2011, LAB CHIP, V11, P3642, DOI 10.1039/c1lc20390h
   Yang X.C., 2009, TISS ENG, V15, P1945
   Yang Y, 2011, BIOMATERIALS, V32, P4243, DOI 10.1016/j.biomaterials.2011.02.042
NR 27
TC 26
Z9 26
U1 2
U2 97
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 0743-7463
J9 LANGMUIR
JI Langmuir
PD JUN 3
PY 2012
VL 28
IS 26
BP 10026
EP 10032
DI 10.1021/la300821r
PG 7
WC Chemistry, Multidisciplinary; Chemistry, Physical; Materials Science,
   Multidisciplinary
SC Chemistry; Materials Science
GA 966XA
UT WOS:000305869500016
PM 22607039
OA Green Published
DA 2018-10-19
ER

PT J
AU Tong, ZX
   Jia, XQ
AF Tong, Zhixiang
   Jia, Xinqiao
TI Biomaterial-based strategies for the engineering of mechanically active
   soft tissues
SO MRS COMMUNICATIONS
LA English
DT Article
ID VOCAL FOLD MUCOSA; CELLULAR MECHANOTRANSDUCTION; BIODEGRADABLE
   ELASTOMERS; DRUG-DELIVERY; HYDROGELS; PEPTIDE; CARTILAGE; NETWORKS;
   POLYMERS; MINERALIZATION
AB Load-bearing, mechanically active tissues are routinely subjected to nonlinear mechanical deformations. Consequently, these tissues exhibit complex mechanical properties and unique tissue organizations. Successful engineering of mechanically active tissues relies on the integration of the mechanical sensing mechanism found in the native tissues into polymeric scaffolds. Intelligent biomaterials that closely mimic the structural organizations and multi-scale responsiveness of the natural extracellular matrices, when strategically combined with multipotent cells and dynamic culture devices that generate physiologically relevant physical forces, will lead to the creation of artificial tissues that are mechanically robust and biologically functional.
C1 [Tong, Zhixiang; Jia, Xinqiao] Univ Delaware, Dept Mat Sci & Engn, Biomed Engn Program, Delaware Biotechnol Inst, Newark, DE 19716 USA.
RP Jia, XQ (reprint author), Univ Delaware, Dept Mat Sci & Engn, Biomed Engn Program, Delaware Biotechnol Inst, Newark, DE 19716 USA.
EM xjia@udel.edu
RI Tong, Zhixiang/G-5685-2016
FU National Institutes of Health [R01 DC008965, P20 RR017716]; National
   Science Foundation (Biomaterials Program) [DMR 0643226]; DuPont Company;
   University of Delaware Research Foundation
FX Work in the authors' laboratory has been funded by grants from the
   National Institutes of Health (R01 DC008965 and P20 RR017716), the
   National Science Foundation (Biomaterials Program, DMR 0643226), the
   DuPont Company and the University of Delaware Research Foundation. We
   thank Dr. Alexandra Farran and Dr. Robert Witt for providing the vocal
   fold video stroboscopic image in Fig. 4.
CR Alberts B, 2002, MOL BIOL CELL
   Almine JF, 2010, CHEM SOC REV, V39, P3371, DOI 10.1039/b919452p
   Amsden B, 2007, SOFT MATTER, V3, P1335, DOI 10.1039/b707472g
   Atala A, 2006, LANCET, V367, P1241, DOI 10.1016/S0140-6736(06)68438-9
   Becker N, 2003, NAT MATER, V2, P278, DOI 10.1038/nmat858
   Bellingham CM, 2003, BIOPOLYMERS, V70, P445, DOI 10.1002/bip.10512
   Burdick JA, 2011, BIOMATERIALS FOR TISSUE ENGINEERING APPLICATIONS: A REVIEW OF THE PAST AND FUTURE TRENDS, P1, DOI 10.1007/978-3-7091-0385-2_1
   Casper CL, 2007, BIOMACROMOLECULES, V8, P1116, DOI 10.1021/bm061003s
   Chen HC, 2006, BIOTECHNOL LETT, V28, P1415, DOI 10.1007/s10529-006-9111-x
   Chicurel ME, 1998, CURR OPIN CELL BIOL, V10, P232, DOI 10.1016/S0955-0674(98)80145-2
   Chiquet M, 1999, MATRIX BIOL, V18, P417, DOI 10.1016/S0945-053X(99)00039-6
   Cohen NP, 1998, J ORTHOP SPORT PHYS, V28, P203, DOI 10.2519/jospt.1998.28.4.203
   Cordier P, 2008, NATURE, V451, P977, DOI 10.1038/nature06669
   Crapo PM, 2011, BIOMATERIALS, V32, P3233, DOI 10.1016/j.biomaterials.2011.01.057
   Dankers PYW, 2005, NAT MATER, V4, P568, DOI 10.1038/nmat1418
   Davisson T, 2002, J ORTHOPAED RES, V20, P842, DOI 10.1016/S0736-0266(01)00160-7
   Debelle L, 1999, INT J BIOCHEM CELL B, V31, P261, DOI 10.1016/S1357-2725(98)00098-3
   Doroski DM, 2010, TISSUE ENG PT A, V16, P3457, DOI 10.1089/ten.tea.2010.0233
   Elvin CM, 2005, NATURE, V437, P999, DOI 10.1038/nature04085
   Engelmayr GC, 2008, NAT MATER, V7, P1003, DOI 10.1038/nmat2316
   Fantner GE, 2005, NAT MATER, V4, P612, DOI 10.1038/nmat1428
   Farach-Carson MC, 2007, GLYCOBIOLOGY, V17, P897, DOI 10.1093/glycob/cwm043
   Farach-Carson MC, 2005, CRIT REV EUKAR GENE, V15, P29, DOI 10.1615/CritRevEukaryotGeneExpr.v15.i1.30
   Farran AJE, 2013, J TISSUE ENG REGEN M, V7, P213, DOI 10.1002/term.514
   Fletcher DA, 2010, NATURE, V463, P485, DOI 10.1038/nature08908
   Fratzl P, 2007, J R SOC INTERFACE, V4, P637, DOI 10.1098/rsif.2007.0218
   Gkioni K, 2010, TISSUE ENG PART B-RE, V16, P577, DOI [10.1089/ten.teb.2010.0462, 10.1089/ten.TEB.2010.0462]
   Gong JP, 2010, SOFT MATTER, V6, P2583, DOI 10.1039/b924290b
   Gray SD, 2000, OTOLARYNG CLIN N AM, V33, P679, DOI 10.1016/S0030-6665(05)70237-1
   Greef TFA, 2008, NATURE, V453, P171, DOI [DOI 10.1038/453171A, 10.1038/453171a]
   Grieshaber S.E., 2012, BIOMACROMOLECU UNPUB
   Grieshaber SE, 2011, BIOMATERIALS FOR TISSUE ENGINEERING APPLICATIONS: A REVIEW OF THE PAST AND FUTURE TRENDS, P9, DOI 10.1007/978-3-7091-0385-2_2
   Grieshaber SE, 2009, MACROMOLECULES, V42, P2532, DOI 10.1021/ma802791z
   Haraguchi K, 2003, MACROMOLECULES, V36, P5732, DOI 10.1021/ma034366i
   Hartgerink JD, 2001, SCIENCE, V294, P1684, DOI 10.1126/science.1063187
   Hartnick CJ, 2005, LARYNGOSCOPE, V115, P4, DOI 10.1097/01.mlg.0000150685.54893.e9
   Hirano M., 1981, ASHA REP, V11, P11
   Hoffman BD, 2011, NATURE, V475, P316, DOI 10.1038/nature10316
   Holmes JW, 2005, ANNU REV BIOMED ENG, V7, P223, DOI 10.1146/annurev.bioeng.7.060804.100453
   Ingber DE, 2008, PROG BIOPHYS MOL BIO, V97, P163, DOI 10.1016/j.pbiomolbio.2008.02.005
   Ingber DE, 2006, FASEB J, V20, P811, DOI 10.1096/fj.05-5424rev
   Jha AK, 2011, BIOMATERIALS, V32, P2466, DOI 10.1016/j.biomaterials.2010.12.024
   Jha AK, 2010, SOFT MATTER, V6, P5045, DOI 10.1039/c0sm00101e
   Jha AK, 2009, BIOMATERIALS, V30, P6964, DOI 10.1016/j.biomaterials.2009.09.009
   Jha AK, 2009, MACROMOLECULES, V42, P537, DOI 10.1021/ma8019442
   Jia X., 2010, U.S. Patent, Patent No. [12/781,305, 12781305]
   Jia XQ, 2009, MACROMOL BIOSCI, V9, P140, DOI 10.1002/mabi.200800284
   Jia XQ, 2006, BIOMACROMOLECULES, V7, P3336, DOI 10.1021/bm0604956
   Kakisis JD, 2005, J VASC SURG, V41, P349, DOI 10.1016/j.jvs.2004.12.026
   Kloxin CJ, 2010, MACROMOLECULES, V43, P2643, DOI 10.1021/ma902596s
   Kopecek J, 2009, J POLYM SCI POL CHEM, V47, P5929, DOI 10.1002/pola.23607
   Kresh JY, 2011, PFLUG ARCH EUR J PHY, V462, P75, DOI 10.1007/s00424-011-0954-1
   Krishna OD, 2011, BIOMATERIALS, V32, P6412, DOI 10.1016/j.biomaterials.2011.05.034
   Kung C, 2005, NATURE, V436, P647, DOI 10.1038/nature03896
   Kushner AM, 2007, J AM CHEM SOC, V129, P14110, DOI 10.1021/ja0742176
   Kushner AM, 2011, ANGEW CHEM INT EDIT, V50, P9026, DOI 10.1002/anie.201006496
   Kutty JK, 2010, J TISSUE ENG REGEN M, V4, P62, DOI 10.1002/term.219
   LAL J, 1986, ADV ELASTOMERS RUBBE
   Langer R, 2004, NATURE, V428, P487, DOI 10.1038/nature02388
   LANGER R, 1993, SCIENCE, V260, P920, DOI 10.1126/science.8493529
   Lee KY, 2000, NATURE, V408, P998
   Li LQ, 2011, BIOMACROMOLECULES, V12, P2302, DOI 10.1021/bm200373p
   Lutolf MP, 2005, NAT BIOTECHNOL, V23, P47, DOI 10.1038/nbt1055
   Lv S, 2010, NATURE, V465, P69, DOI 10.1038/nature09024
   Macchiarini P, 2008, LANCET, V372, P2023, DOI 10.1016/S0140-6736(08)61598-6
   Megeed Z, 2002, ADV DRUG DELIVER REV, V54, P1075, DOI 10.1016/S0169-409X(02)00063-7
   Montarnal D, 2011, SCIENCE, V334, P965, DOI 10.1126/science.1212648
   Moutos FT, 2007, NAT MATER, V6, P162, DOI 10.1038/nmat1822
   Nerurkar NL, 2009, NAT MATER, V8, P986, DOI [10.1038/NMAT2558, 10.1038/nmat2558]
   Niklason LE, 1999, SCIENCE, V284, P489, DOI 10.1126/science.284.5413.489
   Orbach R, 2009, BIOMACROMOLECULES, V10, P2646, DOI 10.1021/bm900584m
   Ozerdem OR, 2003, J CRANIOFAC SURG, V14, P517, DOI 10.1097/00001665-200307000-00023
   Qin GK, 2011, BIOMATERIALS, V32, P9231, DOI 10.1016/j.biomaterials.2011.06.010
   Ramachandran S, 2005, BIOMACROMOLECULES, V6, P1316, DOI 10.1021/bm049284w
   Sato K, 2002, ANN OTO RHINOL LARYN, V111, P15, DOI 10.1177/000348940211100103
   Sato K, 2001, ANN OTO RHINOL LARYN, V110, P417, DOI 10.1177/000348940111000505
   Sato K, 2008, ACTA OTO-LARYNGOL, V128, P694, DOI 10.1080/00016480701675643
   Schneider JP, 2002, J AM CHEM SOC, V124, P15030, DOI 10.1021/ja027993g
   Serrano MC, 2010, ADV FUNCT MATER, V20, P192, DOI 10.1002/adfm.200901040
   Shen W, 2006, NAT MATER, V5, P153, DOI 10.1038/nmat1573
   Sijbesma RP, 1997, SCIENCE, V278, P1601, DOI 10.1126/science.278.5343.1601
   Stevens MM, 2005, SCIENCE, V310, P1135, DOI 10.1126/science.1106587
   Titze IR, 2004, J BIOMECH, V37, P1521, DOI 10.1016/j.jbiomech.2004.01.007
   TITZE IR, 1994, J VOICE, V8, P99, DOI 10.1016/S0892-1997(05)80302-9
   Torrent-Guasp F, 2005, EUR J CARDIO-THORAC, V27, P191, DOI 10.1016/j.ejects.2004.11.026
   Tschumperlin DJ, 2004, NATURE, V429, P83, DOI 10.1038/nature02543
   Ulijn RV, 2008, CHEM SOC REV, V37, P664, DOI 10.1039/b609047h
   Venugopal JR, 2012, J R SOC INTERFACE, V9, P1, DOI 10.1098/rsif.2011.0301
   Wisse E, 2006, MACROMOLECULES, V39, P7425, DOI 10.1021/ma060986i
   Xiao L.X., 2011, SOFT MATTER UNPUB
   Xiao LX, 2010, SOFT MATTER, V6, P5293, DOI 10.1039/c0sm00511h
   Xu X, 2012, SOFT MATTER, V8, P3280, DOI 10.1039/c2sm06463d
   Xu X, 2011, ACTA BIOMATER, V7, P3050, DOI 10.1016/j.actbio.2011.04.018
   Yan CQ, 2010, SOFT MATTER, V6, P5143, DOI 10.1039/c0sm00642d
   Zhang C, 2009, SOFT MATTER, V5, P3831, DOI 10.1039/b912102a
   Zhang SG, 2002, BIOTECHNOL ADV, V20, P321, DOI 10.1016/S0734-9750(02)00026-5
   Zheng PW, 2012, J AM CHEM SOC, V134, P2024, DOI 10.1021/ja2113257
NR 97
TC 10
Z9 10
U1 0
U2 36
PU CAMBRIDGE UNIV PRESS
PI NEW YORK
PA 32 AVENUE OF THE AMERICAS, NEW YORK, NY 10013-2473 USA
SN 2159-6859
J9 MRS COMMUN
JI MRS Commun.
PD JUN
PY 2012
VL 2
IS 2
BP 31
EP 39
DI 10.1557/mrc.2012.4
PG 9
WC Materials Science, Multidisciplinary
SC Materials Science
GA 085DA
UT WOS:000314591500001
PM 25250199
OA Green Accepted, Bronze
DA 2018-10-19
ER

PT J
AU Astachov, L
   Nevo, Z
   Vago, R
AF Astachov, Liliana
   Nevo, Zvi
   Vago, Razi
TI Calcite Biohybrids as Microenvironment for Stem Cells
SO POLYMERS
LA English
DT Article
DE calcium carbonate; mesenchymal stem cells (MSCs); chondrogenesity;
   hyaluronic acid (HA)
ID TISSUE ENGINEERING SCAFFOLDS; PHOTOCROSSLINKED HYALURONIC-ACID;
   SPINAL-CORD-INJURY; OF-THE-ART; NATURAL CORAL; STROMAL CELLS;
   BONE-GRAFT; IN-VITRO; DIFFERENTIATION; CARTILAGE
AB A new type of composite 3D biomaterial that provides extracellular cues that govern the differentiation processes of mesenchymal stem cells (MSCs) has been developed. In the present study, we evaluated the chondrogenecity of a biohybrid composed of a calcium carbonate scaffold in its calcite polymorph and hyaluronic acid (HA). The source of the calcite scaffolding is an exoskeleton of a sea barnacle Tetraclita rifotincta (T. rifotincta), Pilsbry (1916). The combination of a calcium carbonate-based bioactive scaffold with a natural polymeric hydrogel is designed to mimic the organic-mineral composite of developing bone by providing a fine-tuned microenvironment. The results indicate that the calcite-HA interface creates a suitable microenvironment for the chondrogenic differentiation of MSCs, and therefore, the biohybrid may provide a tool for tissue-engineered cartilage.
C1 [Astachov, Liliana; Vago, Razi] Ben Gurion Univ Negev, Avram & Stella Goldstein Goren Dept Biotechnol En, IL-84105 Beer Sheva, Israel.
   [Nevo, Zvi] Tel Aviv Univ, Dept Human Mol Genet & Biochem, Sackler Fac Med, IL-69978 Tel Aviv, Israel.
RP Vago, R (reprint author), Ben Gurion Univ Negev, Avram & Stella Goldstein Goren Dept Biotechnol En, IL-84105 Beer Sheva, Israel.
EM eliliana@bgu.ac.il; zvinevo@post.tau.ac.il; rvago@bgu.ac.il
CR Abramovitch-Gottlib L, 2006, TISSUE ENG, V12, P729, DOI 10.1089/ten.2006.12.729
   Aigner J, 1998, J BIOMED MATER RES, V42, P172, DOI 10.1002/(SICI)1097-4636(199811)42:2<172::AID-JBM2>3.0.CO;2-M
   Angele P, 2009, J BIOMED MATER RES A, V91A, P416, DOI 10.1002/jbm.a.32236
   Astachov L, 2011, FRONT BIOSCI-LANDMRK, V16, P458, DOI 10.2741/3698
   Astachov L, 2011, FRONT BIOSCI-LANDMRK, V16, P261, DOI 10.2741/3687
   Bakos D, 1999, BIOMATERIALS, V20, P191, DOI 10.1016/S0142-9612(98)00163-X
   Baumann MD, 2010, BIOMATERIALS, V31, P7631, DOI 10.1016/j.biomaterials.2010.07.004
   Bianco P, 2001, STEM CELLS, V19, P180, DOI 10.1634/stemcells.19-3-180
   Boccaccini AR, 2005, EXPERT REV MED DEVIC, V2, P303, DOI 10.1586/17434440.2.3.303
   Butler DL, 2000, J BIOMECH ENG-T ASME, V122, P570, DOI 10.1115/1.1318906
   Camenisch TD, 2000, AM J RESP CELL MOL, V23, P431, DOI 10.1165/ajrcmb.23.4.f201
   Chan CK, 2007, NEUROREPORT, V18, P1533, DOI 10.1097/WNR.0b013e3282efa065
   Chen FL, 2004, BRIT J ORAL MAX SURG, V42, P532, DOI 10.1016/j.bjoms.2004.08.007
   Cristino S, 2005, J BIOMED MATER RES A, V73A, P275, DOI 10.1002/jbm.a.30261
   Daculsi G, 2003, J MATER SCI-MATER M, V14, P195, DOI 10.1023/A:1022842404495
   Demers C, 2002, BIO-MED MATER ENG, V12, P15
   Fricain JC, 1998, J BIOMED MATER RES, V42, P96, DOI 10.1002/(SICI)1097-4636(199810)42:1<96::AID-JBM12>3.0.CO;2-M
   FUJITA Y, 1991, J BIOMED MATER RES, V25, P991, DOI 10.1002/jbm.820250806
   Galle J, 2010, CURR MED CHEM, V17, P2274, DOI 10.2174/092986710791331095
   Gao Jizong, 2002, Tissue Engineering, V8, P827, DOI 10.1089/10763270260424187
   Gao JZ, 2001, TISSUE ENG, V7, P363, DOI 10.1089/10763270152436427
   Gross-Aviv T., 2009, BIOMIMETIC SUPRAMOLE, P207
   Hench LL, 2002, SCIENCE, V295, P1014, DOI 10.1126/science.1067404
   Horn EM, 2007, J NEUROSURG-SPINE, V6, P133, DOI 10.3171/spi.2007.6.2.133
   Huang L, 2003, J BIOMED MATER RES A, V66A, P880, DOI 10.1002/jbm.a.10535
   Javed A, 2009, CELLS TISSUES ORGANS, V189, P133, DOI 10.1159/000151719
   Kito H, 1996, J BIOMED MATER RES, V30, P321
   KNUDSON CB, 1985, DEV BIOL, V112, P308, DOI 10.1016/0012-1606(85)90401-4
   Lakes R., 2000, BIOMEDICAL ENG HDB, P208
   Lange C, 2005, STEM CELLS DEV, V14, P70, DOI 10.1089/scd.2005.14.70
   LANGER R, 1993, SCIENCE, V260, P920, DOI 10.1126/science.8493529
   Leach JB, 2003, BIOTECHNOL BIOENG, V82, P578, DOI 10.1002/bit.10605
   Lefebvre V, 2001, OSTEOARTHR CARTILAGE, V9, pS69, DOI 10.1053/joca.2001.0447
   Lesley J, 2000, EUR J IMMUNOL, V30, P245, DOI 10.1002/1521-4141(200001)30:1<245::AID-IMMU245>3.0.CO;2-X
   Lisignoli G, 2005, BIOMATERIALS, V26, P5677, DOI 10.1016/j.biomaterials.2005.02.031
   Liu CM, 2008, CELL TISSUE RES, V334, P435, DOI 10.1007/s00441-008-0699-0
   Meszar Z., 2000, BRAIN RES B, V75, P414
   Milella E, 2002, BIOMATERIALS, V23, P1053, DOI 10.1016/S0142-9612(01)00217-4
   Murakami S, 2000, P NATL ACAD SCI USA, V97, P1113, DOI 10.1073/pnas.97.3.1113
   Ng LJ, 1997, DEV BIOL, V183, P108, DOI 10.1006/dbio.1996.8487
   Palumbo FS, 2006, CARBOHYD POLYM, V66, P379, DOI 10.1016/j.carbpol.2006.03.023
   Pilloni A, 1998, CELL TISSUE RES, V294, P323, DOI 10.1007/s004410051182
   Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143
   Ponta H, 2003, NAT REV MOL CELL BIO, V4, P33, DOI 10.1038/nrm1004
   Pure E, 2009, CELL SIGNAL, V21, P651, DOI 10.1016/j.cellsig.2009.01.024
   Radice M, 2000, J BIOMED MATER RES, V50, P101, DOI 10.1002/(SICI)1097-4636(200005)50:2<101::AID-JBM2>3.0.CO;2-M
   Raghunath J, 2007, BIOTECHNOL APPL BIOC, V46, P73, DOI 10.1042/BA20060134
   Sakai Y, 2007, BIO-MED MATER ENG, V17, P191
   Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73
   Solchaga LA, 2000, J ORTHOP RES, V18, P773, DOI 10.1002/jor.1100180515
   Stockwell RA., 1979, BIOL CARTILAGE CELLS
   Takeda M, 2006, J BIOL CHEM, V281, P40089, DOI 10.1074/jbc.M608425200
   Toole B P, 1977, Soc Gen Physiol Ser, V32, P139
   Toole BP, 2004, NAT REV CANCER, V4, P528, DOI 10.1038/nrc1391
   Turley EA, 2002, J BIOL CHEM, V277, P4589, DOI 10.1074/jbc.R100038200
   Vago R, 2008, MAR BIOTECHNOL, V10, P343, DOI 10.1007/s10126-008-9103-z
   Vago Razi, 2008, Organogenesis, V4, P18
   Woodfield TBF, 2005, TISSUE ENG, V11, P1297, DOI 10.1089/ten.2005.11.1297
   WRIGHT E, 1995, NAT GENET, V9, P15, DOI 10.1038/ng0195-15
   Zavan B, 2008, NEUROL RES, V30, P190, DOI 10.1179/174313208X281082
   Zou XN, 2004, BIOMATERIALS, V25, P5375, DOI 10.1016/j.biomaterials.2003.12.041
NR 61
TC 0
Z9 0
U1 0
U2 28
PU MDPI AG
PI BASEL
PA POSTFACH, CH-4005 BASEL, SWITZERLAND
SN 2073-4360
J9 POLYMERS-BASEL
JI Polymers
PD JUN
PY 2012
VL 4
IS 2
BP 1065
EP 1083
DI 10.3390/polym4021065
PG 19
WC Polymer Science
SC Polymer Science
GA 068HH
UT WOS:000313356500010
OA DOAJ Gold
DA 2018-10-19
ER

PT J
AU Palmquist, A
   Engqvist, H
   Lausmaa, J
   Thomsen, P
AF Palmquist, Anders
   Engqvist, Hakan
   Lausmaa, Jukka
   Thomsen, Peter
TI Commercially Available Dental Implants: Review of Their Surface
   Characteristics
SO JOURNAL OF BIOMATERIALS AND TISSUE ENGINEERING
LA English
DT Review
DE Osseointegration; Dental Implants; Surface Topography; Surface
   Chemistry; Surface Phase Composition
ID FOCUSED ION-BEAM; TRANSMISSION ELECTRON-MICROSCOPY; TITANIUM-ALLOY
   IMPLANTS; PURE TITANIUM; SPECTROSCOPIC CHARACTERIZATION; BONE RESPONSE;
   TIO2 COATINGS; OXIDE-FILMS; BACKSCATTER DIFFRACTION; BIOMATERIAL
   SURFACES
AB Titanium is widely used as an implant material in dentistry with excellent clinical results. The clinical success of the implants is often coupled to the surface properties of the implants. This review focuses on the available literature describing the surface characteristics of the most widely used commercial dental implants. The current commercially available dental implants all show differences in their surface characteristics, for example with regard to surface roughness, surface energy, and surface phase composition. Some surfaces lack published data while the characteristics of others are well described in the literature. However, more analysis by standardized techniques must be performed in order to fully understand which specific parameters are important for osseointegration and clinical success.
C1 [Palmquist, Anders; Thomsen, Peter] Univ Gothenburg, Sahlgrenska Acad, Dept Biomat, S-40530 Gothenburg, Sweden.
   [Engqvist, Hakan] Uppsala Univ, Angstrom Lab, Dept Engn Sci, S-75121 Uppsala, Sweden.
   [Lausmaa, Jukka] SP Tech Res Inst Sweden, Dept Chem & Mat Technol, S-50115 Boras, Sweden.
   [Palmquist, Anders; Engqvist, Hakan; Lausmaa, Jukka; Thomsen, Peter] BIOMATCELL Vinn Excellence Ctr Biomat & Cell Ther, S-40530 Gothenburg, Sweden.
RP Palmquist, A (reprint author), Univ Gothenburg, Sahlgrenska Acad, Dept Biomat, S-40530 Gothenburg, Sweden.
RI Palmquist, Anders/D-2171-2014
OI Engqvist, Hakan/0000-0001-9529-650X; Thomsen, Peter/0000-0003-3910-6665
FU Swedish Research Council [K2012-52X-09495-25-3]; BIOMATCELL VINN
   Excellence Center of Biornaterials and Cell Therapy; VINNOVA VinnVaxt
   Program Biomedical Development in Western Sweden; LUA/ALF
FX The financial support from the Swedish Research Council (grant
   K2012-52X-09495-25-3), BIOMATCELL VINN Excellence Center of
   Biornaterials and Cell Therapy, VINNOVA VinnVaxt Program Biomedical
   Development in Western Sweden, LUA/ALF grant, Dr. Felix Neuberghs
   Stiftelse, Magnus Bergvalls Stiftelse, is gratefully acknowledged. No
   financial support from the marketing companies was obtained. All
   implants examined were purchased from the respective company with
   exception of Biohelix and Fixture Original which were provided free of
   charge from Branemark Integration. JL and PT were co-inventors of
   TiUnite and Biohelix, respectively.
CR ADELL R, 1981, INT J ORAL MAXILLOF, V10, P387, DOI 10.1016/S0300-9785(81)80077-4
   Albrektsson T, 2004, INT J PROSTHODONT, V17, P544
   Albrektsson T, 2004, INT J PROSTHODONT, V17, P536
   [Anonymous], 2008, NOBELACTIVE TECHNICA
   [Anonymous], 2008, IMPLANTAT FRAN BRANE
   Aronsson BO, 2001, J BIOMED MATER RES, V54, P20, DOI 10.1002/1097-4636(200101)54:1<20::AID-JBM3>3.0.CO;2-Z
   ASK M, 1990, J MATER RES, V5, P1662, DOI 10.1557/JMR.1990.1662
   ASK M, 1989, APPL SURF SCI, V35, P283, DOI 10.1016/0169-4332(89)90013-5
   Astra Tech Dental, 2008, ASTRA TECH DENTAL PR
   Berglundh T, 2007, CLIN ORAL IMPLAN RES, V18, P655, DOI 10.1111/j.1600-0501.2007.01397.x
   Bhattacharyya A, 2009, SCANNING, V31, P114, DOI 10.1002/sca.20150
   Biomet 3i, 2008, PROD CAT REV F 02 08
   Boyan BD, 1998, J BIOMED MATER RES, V39, P77, DOI 10.1002/(SICI)1097-4636(199801)39:1<77::AID-JBM10>3.0.CO;2-L
   Branemark P I, 1977, Scand J Plast Reconstr Surg Suppl, V16, P1
   Branemark R, 2011, NANOMED-NANOTECHNOL, V7, P220, DOI 10.1016/j.nano.2010.10.006
   Buser D, 1999, J BIOMED MATER RES, V45, P75, DOI 10.1002/(SICI)1097-4636(199905)45:2<75::AID-JBM1>3.0.CO;2-P
   Buser D, 2004, J DENT RES, V83, P529, DOI 10.1177/154405910408300704
   Carr AB, 2001, J PROSTHET DENT, V85, P276, DOI 10.1067/mpr.2001.114821
   Conforto E, 2004, PHILOS MAG, V84, P631, DOI 10.1080/14786430310001627386
   Cooper LF, 2006, BIOMATERIALS, V27, P926, DOI 10.1016/j.biomaterials.2005.07.009
   Davies JE, 2007, BIOMATERIALS, V28, P5058, DOI 10.1016/j.biomaterials.2007.07.049
   Ellingsen J. E., 2006, APPL OSSEOINTEGRATIO, V5, P18
   Ellingsen JE, 2006, PERIODONTOL 2000, V41, P136, DOI 10.1111/j.1600-0757.2006.00175.x
   Ellingsen JE, 2004, INT J ORAL MAX IMPL, V19, P659
   Ellingsen JE, 1998, PERIODONTOL 2000, V17, P36, DOI 10.1111/j.1600-0757.1998.tb00121.x
   ELLINGSEN JE, 2000, BONE ENG, P183
   Esposito M, 2005, INT J ORAL MAX IMPL, V20, P557
   Esposito Marco, 2005, Eur J Prosthodont Restor Dent, V13, P15
   Fandridis J, 2008, IMPLANT DENT, V17, P91, DOI [10.1097/ID.0b013e318166d9ac, 10.1097/lD.0b013e318166d9ac]
   Feng B, 2002, J MATER SCI-MATER M, V13, P457, DOI 10.1023/A:1014737831371
   Forsgren J, 2007, ACTA BIOMATER, V3, P980, DOI 10.1016/j.actbio.2007.03.006
   Freese H. L., 2001, BIOL RESPONSES MED A, V1019
   Galli C, 2005, J PERIODONTOL, V76, P364, DOI 10.1902/jop.2005.76.3.364
   Giannuzzi LA, 2005, MICROSC MICROANAL S2, V11, P998
   Giannuzzi LA, 2007, J ORAL MAXIL SURG, V65, P737, DOI 10.1016/j.joms.2006.10.025
   Goransson A, 2006, CLIN IMPLANT DENT R, V8, P210, DOI 10.1111/j.1708-8208.2006.00021.x
   Gubbi P., 2007, HYDROPHOBIC HYDROPHI
   Gubbi P., 2007, QUALITATIVE QUANITIT
   Guilherme AS, 2005, J PROSTHET DENT, V93, P378, DOI 10.1016/j.prosdent.2005.01.010
   Hall J, 2000, APPL OSSEOINTEGRATIO, V1, P5
   Han CH, 1998, CLIN ORAL IMPLAN RES, V9, P1, DOI 10.1034/j.1600-0501.1998.090101.x
   Jarmar T, 2008, CLIN IMPLANT DENT R, V10, P11, DOI 10.1111/j.1708-8208.2007.00056.x
   Jarmar T, 2008, J BIOMED MATER RES A, V87A, P1003, DOI 10.1002/jbm.a.31856
   JOHANSSON C, 1989, J BIOMED ENG, V11, P3, DOI 10.1016/0141-5425(89)90158-1
   JOHANSSON C B, 1991, International Journal of Oral and Maxillofacial Implants, V6, P437
   Johansson CB, 1998, INT J ORAL MAX IMPL, V13, P315
   JOHANSSON CB, 1993, J MATER SCI-MATER M, V4, P132, DOI 10.1007/BF00120382
   JOHANSSON CB, 1992, J MATER SCI-MATER M, V3, P126, DOI 10.1007/BF00705280
   Johansson CB, 1992, EUR J EXP MUSCULOSKE, V1, P161
   Kang BS, 2009, ACTA BIOMATER, V5, P2222, DOI 10.1016/j.actbio.2009.01.049
   Kasemo B, 1988, Int J Oral Maxillofac Implants, V3, P247
   Kokubo T, 2006, BIOMATERIALS, V27, P2907, DOI 10.1016/j.biomaterials.2006.01.017
   Lausmaa J, 1996, J ELECTRON SPECTROSC, V81, P343, DOI 10.1016/0368-2048(95)02530-8
   LAUSMAA J, 1988, BIOMATERIALS, V9, P277, DOI 10.1016/0142-9612(88)90098-1
   LAUSMAA J, 1990, APPL SURF SCI, V44, P133, DOI 10.1016/0169-4332(90)90100-E
   Le Guehennec L, 2008, ACTA BIOMATER, V4, P535, DOI 10.1016/j.actbio.2007.12.002
   Lewandowska M, 2007, BIOMOL ENG, V24, P438, DOI 10.1016/j.bioeng.2007.07.002
   Lin CW, 2005, BIOMATERIALS, V26, P2899, DOI 10.1016/j.biomaterials.2004.09.007
   Lindberg F, 2008, BIOMATERIALS, V29, P3317, DOI 10.1016/j.biomaterials.2008.04.034
   Lindsay MJ, 2007, ELECTROCHIM ACTA, V52, P6401, DOI 10.1016/j.electacta.2007.04.027
   Masaki C, 2005, CLIN ORAL IMPLAN RES, V16, P650, DOI 10.1111/j.1600-0501.2005.01170.x
   Massaro C, 2002, J MATER SCI-MATER M, V13, P535, DOI 10.1023/A:1015170625506
   Mendes V. C., 2008, J BIOMED MAT RES A
   Mendes VC, 2007, BIOMATERIALS, V28, P4748, DOI 10.1016/j.biomaterials.2007.07.020
   Moritz N, 2005, BIOMATERIALS, V26, P4460, DOI 10.1016/j.biomaterials.2004.11.020
   Moritz N, 2003, J BIOMED MATER RES A, V65A, P9, DOI 10.1002/jbm.a.10434
   PALMQUIST A, 2009, J BIOMED MATER RES A, V92, P1476
   PALMQUIST A, 2011, APPL BIOMATERIALS, V97, P289, DOI DOI 10.1002/JBM.B.31814
   Palmquist A, 2011, CLIN IMPLANT DENT RE, DOI 10.1111/j.1708-8208.2011.00361.x
   Palmquist A., 2008, NOVEL TECHNIQUE PREP
   Park JY, 2001, BIOMATERIALS, V22, P2671, DOI 10.1016/S0142-9612(01)00009-6
   Perrin D, 2002, CLIN ORAL IMPLAN RES, V13, P465, DOI 10.1034/j.1600-0501.2002.130504.x
   Qu Z, 2007, J BIOMED MATER RES A, V82A, P658, DOI 10.1002/bjm.a.31023
   RADEGRAN G, 1991, J ELECTRON MICR TECH, V19, P99, DOI 10.1002/jemt.1060190110
   Rossi S, 2007, J BIOMED MATER RES A, V82A, P965, DOI 10.1002/jbm.a.31245
   Rupp F, 2004, BIOMATERIALS, V25, P1429, DOI 10.1016/j.biomaterials.2003.08.015
   Rupp F, 2006, J BIOMED MATER RES A, V76A, P323, DOI 10.1002/jbm.a.30518
   Sawase T, 2008, CLIN ORAL IMPLAN RES, V19, P491, DOI 10.1111/j.1600-0501.2007.01509.x
   Sawase T, 2007, CLIN ORAL IMPLAN RES, V18, P680, DOI 10.1111/j.1600-0501.2007.01404.x
   Schupbach P, 2005, CLIN IMPLANT DENT R, V7, pS36, DOI 10.1111/j.1708-8208.2005.tb00073.x
   Schwarz F, 2007, CLIN ORAL INVEST, V11, P245, DOI 10.1007/s00784-007-0110-7
   Schwarz F, 2007, ORAL MAXILLOFAC SURG, V11, P11, DOI 10.1007/s10006-006-0045-1
   Sul YT, 2006, INT J PROSTHODONT, V19, P319
   Sul YT, 2002, BIOMATERIALS, V23, P491, DOI 10.1016/S0142-9612(01)00131-4
   Suttin Z., 2006, ADHESION SHEAR STREN
   Suttin Z., 2006, SURFACE AREA INCREAS
   Szmukler-Moncler S, 2004, J BIOMED MATER RES B, V69B, P46, DOI 10.1002/jbm.b.20021
   Szmukler-Moncler S, 2004, J BIOMED MATER RES B, V68B, P149, DOI 10.1002/jbm.b.20003
   Szmukler-Moncler S, 2010, CLIN ORAL IMPLAN RES, V21, P944, DOI 10.1111/j.1600-0501.2010.01938.x
   Thomsson M, 2008, EUR J ORAL IMPLANTOL, V1, P229
   Trager-Cowan C, 2002, J MICROSC-OXFORD, V205, P226, DOI 10.1046/j.1365-2818.2002.00996.x
   Vosos J., 2001, TITANIUM MED MAT SCI
   Wennerberg A, 1996, MED ENG PHYS, V18, P548, DOI 10.1016/1350-4533(95)00005-4
   Wennerberg A, 2006, APPL OSSEOINTEGRATIO, V5, P40
   Yang BC, 2004, BIOMATERIALS, V25, P1003, DOI 10.1016/S0142-9612(03)00626-4
   Zhao G, 2005, J BIOMED MATER RES A, V74A, P49, DOI 10.1002/jbm.a.30320
NR 96
TC 11
Z9 11
U1 1
U2 53
PU AMER SCIENTIFIC PUBLISHERS
PI VALENCIA
PA 26650 THE OLD RD, STE 208, VALENCIA, CA 91381-0751 USA
SN 2157-9083
J9 J BIOMATER TISS ENG
JI J. Biomater. Tissue Eng.
PD JUN
PY 2012
VL 2
IS 2
BP 112
EP 124
DI 10.1166/jbt.2012.1033
PG 13
WC Cell & Tissue Engineering
SC Cell Biology
GA 057NR
UT WOS:000312570800003
DA 2018-10-19
ER

PT J
AU Xiao, WD
   Zhong, ZM
   Tang, YZ
   Xu, ZX
   Xu, Z
   Chen, JT
AF Xiao, Wen-De
   Zhong, Zhao-Ming
   Tang, Yong-Zhi
   Xu, Zi-Xing
   Xu, Zhun
   Chen, Jian-Ting
TI Repair of critical size bone defects with porous poly(D,L-lactide)/nacre
   nanocomposite hollow scaffold
SO SAUDI MEDICAL JOURNAL
LA English
DT Article
ID PINCTADA-FUCATA; MATRIX PROTEIN; IN-VITRO; NACRE; MINERALIZATION;
   HYDROXYAPATITE; OSTEOBLASTS; COMPOSITES; CELLS
AB Objectives: To generate a novel porous poly(D,L-lactide)/nacre nanocomposite hollow scaffold.
   Methods: This study was performed in the Department of Spine Surgery, Southern Medical University, Guangzhou, China from September 2010 to September 2011. Nacre nanoparticles were prepared using a physical process and identified by x-ray diffraction and transmission electron microscopy, to generate a novel scaffold though the salt leaching processing technique. The morphology and structure properties of this scaffold were further investigated under scanning electron microscope and mechanical property testing. Additionally, the biological characteristics were evaluated by cell culture experiments in vitro. Thirty-six rabbits were randomly divided into 3 groups. The defects were implanted with/without poly(D,L-lactide)/nacre scaffold or poly(D,L-lactide) scaffold. The results were assessed by radiographs and bone mineral density to monitor bone repairing.
   Results: The nacre nanoparticles were spherical in shape, with a diameter range from 45-95 nm. The scaffolds possessed an interconnected porous structure with an average pore size of 322.5 +/- 50.8 mu m, and exhibited a high porosity (82.5 +/- 0.8%), as well as good compressive strength of 4.5 +/- 0.25 Mpa. Primary biocompatibility experiments in vitro showed that cells adhered and proliferated well on the scaffolds. The animal study further demonstrated that the scaffolds could repair the critical size segmental bone defects in 12 weeks.
   Conclusion: Newly established scaffolds may serve as a promising biomaterial for bone tissue engineering.
C1 [Xiao, Wen-De; Zhong, Zhao-Ming; Tang, Yong-Zhi; Xu, Zi-Xing; Xu, Zhun; Chen, Jian-Ting] So Med Univ, Nanfang Hosp, Dept Spine Surg, Guangzhou 510515, Guangdong, Peoples R China.
   [Xiao, Wen-De] Gannan Med Univ, Affiliated Hosp 1, Dept Orthoped, Ganzhou, Jiangxi, Peoples R China.
RP Chen, JT (reprint author), So Med Univ, Nanfang Hosp, Dept Spine Surg, Guangzhou 510515, Guangdong, Peoples R China.
EM chenjt.99@tom.com
FU Guangdong Science & Technology Committee, Guangdong, China
   [2007B031003005]
FX This work was supported by Guangdong Science & Technology Committee,
   Guangdong, China (No. 2007B031003005).
CR Bahar H, 2003, J PERIODONTOL, V74, P366, DOI 10.1902/jop.2003.74.3.366
   Christenson EM, 2007, J ORTHOP RES, V25, P11, DOI 10.1002/jor.20305
   Deliloglu-Gurhan I, 2006, SAUDI MED J, V27, P305
   Guan LM, 2004, J BIOMED MATER RES A, V71A, P480, DOI 10.1002/jbm.a.30173
   Kasuga T, 2003, BIOMATERIALS, V24, P3247, DOI 10.1016/S0142-9612(03)00190-X
   Kucukkolbasi H, 2009, SAUDI MED J, V30, P329
   Lamghari M, 2001, BIOMATERIALS, V22, P555, DOI 10.1016/S0142-9612(00)00213-1
   Lao YX, 2007, COMP BIOCHEM PHYS B, V148, P201, DOI 10.1016/j.cbpb.2007.05.010
   Liao S, 2008, J MECH BEHAV BIOMED, V1, P252, DOI 10.1016/j.jmbbm.2008.01.007
   Liu Y, 2009, BIOMATERIALS, V30, P6276, DOI 10.1016/j.biomaterials.2009.08.003
   Luz GM, 2009, PHILOS T R SOC A, V367, P1587, DOI 10.1098/rsta.2009.0007
   Meijer GJ, 2007, PLOS MED, V4, P260, DOI 10.1371/journal.pmed.0040009
   Murphy CM, 2010, BIOMATERIALS, V31, P461, DOI 10.1016/j.biomaterials.2009.09.063
   Oh SH, 2007, BIOMATERIALS, V28, P1664, DOI 10.1016/j.biomaterials.2006.11.024
   Ossendorf C, 2007, SAUDI MED J, V28, P1251
   Peng Q, 2010, J BIOMED MATER RES A, V93A, P920, DOI 10.1002/jbm.a.32408
   Ramay HRR, 2004, BIOMATERIALS, V25, P5171, DOI 10.1016/j.biomaterials.2003.12.023
   Rousseau M, 2003, COMP BIOCHEM PHYS B, V135, P1, DOI 10.1016/S1096-4959(03)00032-0
   Rousseau M, 2008, J BIOMED MATER RES A, V85A, P487, DOI 10.1002/jbm.a.31553
   Sreckovic T, 2008, J MICROSC-OXFORD, V232, P639, DOI 10.1111/j.1365-2818.2008.02131.x
   Suzuki M, 2009, SCIENCE, V325, P1388, DOI 10.1126/science.1173793
   Wang XJ, 2010, MED ENG PHYS, V32, P391, DOI 10.1016/j.medengphy.2010.02.002
   Wu H, 2010, J BIOMED MATER RES A, V92A, P238, DOI 10.1002/jbm.a.32376
   Zhang C, 2006, MAR BIOTECHNOL, V8, P624, DOI 10.1007/s10126-006-6037-1
NR 24
TC 3
Z9 6
U1 0
U2 7
PU SAUDI MED J
PI RIYADH
PA ARMED FORCES HOSPITAL, PO BOX 7897,, RIYADH 11159, SAUDI ARABIA
SN 0379-5284
J9 SAUDI MED J
JI Saudi Med. J.
PD JUN
PY 2012
VL 33
IS 6
BP 601
EP 607
PG 7
WC Medicine, General & Internal
SC General & Internal Medicine
GA 036GM
UT WOS:000311014400002
PM 22729113
OA DOAJ Gold
DA 2018-10-19
ER

PT J
AU Brochhausen, C
   Turial, S
   Muller, FKP
   Schmitt, VH
   Coerdt, W
   Wihlm, JM
   Schier, F
   Kirkpatrick, CJ
AF Brochhausen, Christoph
   Turial, Salmai
   Mueller, Felix K. P.
   Schmitt, Volker H.
   Coerdt, Wiltrud
   Wihlm, Jean-Marie
   Schier, Felix
   Kirkpatrick, C. James
TI Pectus excavatum: history, hypotheses and treatment options
SO INTERACTIVE CARDIOVASCULAR AND THORACIC SURGERY
LA English
DT Article
DE Pectus excavatum; Funnel chest; History; Hypotheses; Development; Chest
   wall deformity
ID CHEST-WALL DEFORMITIES; MINIMALLY INVASIVE REPAIR; SURGICAL REPAIR; NUSS
   PROCEDURE; COSTAL CARTILAGES; CARDIAC-FUNCTION; METAANALYSIS;
   EXPERIENCE; RAVITCH; STERNOCHONDROPLASTY
AB Pectus excavatum and pectus carinatum represent the most frequent chest wall deformations. However, the pathogenesis is still poorly understood and research results remain inconsistent. To focus on the recent state of knowledge, we summarize and critically discuss the pathological concepts based on the history of these entities, beginning with the first description in the sixteenth century. Based on the early clinical descriptions, we review and discuss the different pathogenetic hypotheses. To open new perspectives for the potential pathomechanisms, the embryonic and foetal development of the ribs and the sternum is highlighted following the understanding that the origin of these deformities is given by the disruption in the maturation of the parasternal region. In the second, different therapeutical techniques are highlighted and based on the pathogenetic hypotheses and the embryological knowledge potential new biomaterial-based perspectives with interesting insights for tissue engineering-based treatment options are presented.
C1 [Brochhausen, Christoph; Mueller, Felix K. P.; Schmitt, Volker H.; Coerdt, Wiltrud; Kirkpatrick, C. James] Univ Med Ctr Mainz, REPAIRlab, Inst Pathol, D-55131 Mainz, Germany.
   [Turial, Salmai; Schier, Felix] Univ Med Ctr Mainz, Dept Paediat Surg, D-55131 Mainz, Germany.
   [Wihlm, Jean-Marie] Hop Univ, Dept Thorac Surg, NHC, Strasbourg, France.
RP Brochhausen, C (reprint author), Univ Med Ctr Mainz, REPAIR Lab, Inst Pathol, Langenbeckstr 1, D-55131 Mainz, Germany.
EM brochhausen@pathologie.klinik.uni-mainz.de
CR Antonoff MB, 2009, J PEDIATR SURG, V44, P1113, DOI 10.1016/j.jpedsurg.2009.02.017
   Antonoff MB, 2009, J PEDIATR SURG, V44
   Aronson DC, 2007, WORLD J SURG, V31, P1518, DOI 10.1007/s00268-007-9081-8
   Bauhinus J, 1609, JOHANNES OBSERVATORI, V1609, P322
   BEISER GD, 1972, NEW ENGL J MED, V287, P267, DOI 10.1056/NEJM197208102870602
   Brown AL, 1939, J THORACIC SURG, V9, P164
   CHEN JM, 1952, J ANAT, V86, P387
   Coelho MD, 2009, ANN THORAC SURG, V88, P1773, DOI 10.1016/j.athoracsur.2009.07.051
   Coln E, 2006, J PEDIATR SURG, V41, P683, DOI 10.1016/j.jpedsurg.2005.12.009
   Colombani PM, 2009, SEMIN THORAC CARDIOV, V21, P58, DOI 10.1053/j.semtcvs.2009.04.003
   Eggel, 1870, VIRCHOWS ARCH PATH A, V49, P230
   Feng JX, 2001, J PEDIATR SURG, V36, P1770, DOI 10.1053/jpsu.2001.28820
   Flesch M., 1873, VIRCHOWS ARCH, V75, P289
   Fokin AA, 2008, INTERACT CARDIOV TH, V7, P56
   Fonkalsrud EW, 2000, ANN SURG, V231, P443, DOI 10.1097/00000658-200003000-00019
   Geisbe H, 1967, Langenbecks Arch Chir, V319, P536, DOI 10.1007/BF02659333
   Guntheroth WG, 2007, AM J CARDIOL, V99, P1762, DOI 10.1016/j.amjcard.2007.01.064
   Gurkok S, 2001, EUR J CARDIO-THORAC, V19, P711, DOI 10.1016/S1010-7940(01)00661-3
   Haecker FM, 2011, PEDIATR SURG INT, V27, P623, DOI 10.1007/s00383-010-2843-7
   Hagmann, 1888, JB KINDERHEILKUNDE, V15, P455
   Harrison MR, 2007, J PEDIATR SURG, V42, P81, DOI 10.1016/j.jpedsurg.2006.09.042
   Harrison MR, 2007, J PEDIATR SURG, V42, P85
   Johnson JN, 2008, J PEDIATR-US, V153, P359, DOI 10.1016/j.jpeds.2008.03.037
   Kelly RE, 2005, J PEDIATR SURG, V40, P1275, DOI 10.1016/j.jpedsurg.2005.05.010
   Kelly RE, 2007, J AM COLL SURGEONS, V205, P205, DOI 10.1016/j.jamcollsurg.2007.03.027
   Kelly RE, 2008, PEDIATRICS, V122, P1218, DOI 10.1542/peds.2007-2723
   Kotzot D, 2009, J PEDIATR SURG, V44, P2004, DOI 10.1016/j.jpedsurg.2009.07.029
   Kubiak R, 2007, EUR J PEDIATR SURG, V17, P255, DOI 10.1055/s-2007-965060
   Lacquet LK, 1998, J CARDIOVASC SURG, V39, P683
   LACQUET LK, 1982, ACTA CHIR BELG, V82, P541
   Lam MWC, 2008, J PEDIATR SURG, V43, P819, DOI 10.1016/j.jpedsurg.2007.12.020
   Langer E., 1880, HERRN JW WIENER MED, V49, P515
   Lansman S, 2002, J PEDIATR SURG, V37, P1281, DOI 10.1053/jpsu.2002.34983
   Luzzi L, 2004, BRIT J PLAST SURG, V57, P733, DOI 10.1016/j.bjps.2004.05.019
   Malek MH, 2006, EUR J CARDIO-THORAC, V30, P637, DOI 10.1016/j.ejcts.2006.07.004
   Malek MH, 2006, CHEST, V130, P506, DOI 10.1378/chest.130.2.506
   MEYER L, 1911, BERL KLIN WSCHR, V48, P1563
   Nakaoka T, 2009, J PEDIATR SURG, V44, P1333, DOI 10.1016/j.jpedsurg.2008.09.023
   Nasr A, 2010, J PEDIATR SURG, V45, P880, DOI 10.1016/j.jpedsurg.2010.02.012
   Nuss D, 1998, J PEDIATR SURG, V33, P545, DOI 10.1016/S0022-3468(98)90314-1
   Ohno K, 2009, J PEDIATR SURG, V44, P2426, DOI 10.1016/j.jpedsurg.2009.09.006
   Pilegaard HK, 2009, EUR J CARDIO-THORAC, V35, P561, DOI 10.1016/j.ejcts.2008.10.049
   RAVITCH MM, 1949, ANN SURG, V129, P429, DOI 10.1097/00000658-194904000-00002
   RAVITCH MM, 1977, ANN THORAC SURG, V23, P301, DOI 10.1016/S0003-4975(10)64129-X
   REHBEIN F, 1957, ARCH DIS CHILD, V32, P5, DOI 10.1136/adc.32.161.5
   Robicsek F, 2009, SEMIN THORAC CARDIOV, V21, P64, DOI 10.1053/j.semtcvs.2009.03.002
   RUPPRECHT H, 1987, Z KINDERCHIR, V42, P228
   Schier F, 2005, J PEDIATR SURG, V40, P496, DOI 10.1016/j.jpedsurg.2004.11.033
   Stefani A, 1998, EUR J CARDIO-THORAC, V14, P434, DOI 10.1016/S1010-7940(98)00190-0
   Sweet RH, 1944, ANN SURG, V119, P922
   Torre M, 2008, EUR J PEDIATR SURG, V18, P407, DOI 10.1055/s-2008-1039176
   Von Luschka H, 1863, ANATOMIE MENSCHEN RU, P23
   Weber PG, 2006, J THORAC CARDIOV SUR, V132, P1369, DOI 10.1016/j.jtcvs.2006.08.023
   Wihlm JM, 2007, INTERACT CARDIOV TH, V6, P273
   WILLIAMS CT, 1872, T PATHOL SOC LOND, V24, P50
   Woillez, 1860, CAS DEFORMITEE THORA, P3
NR 56
TC 44
Z9 50
U1 0
U2 14
PU OXFORD UNIV PRESS
PI OXFORD
PA GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND
SN 1569-9293
J9 INTERACT CARDIOV TH
JI Interact Cardiovasc. Thorac. Surg.
PD JUN
PY 2012
VL 14
IS 6
BP 801
EP 806
DI 10.1093/icvts/ivs045
PG 6
WC Cardiac & Cardiovascular Systems; Respiratory System; Surgery
SC Cardiovascular System & Cardiology; Respiratory System; Surgery
GA 025GK
UT WOS:000310175300034
PM 22394989
OA Green Published, Bronze
DA 2018-10-19
ER

PT J
AU Ju, CQ
   Gao, L
   Wu, XY
   Pang, KP
AF Ju, Chengqun
   Gao, Li
   Wu, Xinyi
   Pang, Kunpeng
TI A human corneal endothelium equivalent constructed with acellular
   porcine corneal matrix
SO INDIAN JOURNAL OF MEDICAL RESEARCH
LA English
DT Article
DE Biomaterial; corneal endothelium; decellularized carrier; organ culture
ID CELL TRANSPLANTATION; DESCEMETS-MEMBRANE; EPITHELIAL-CELLS; CARRIER;
   SCAFFOLD; RABBIT; MODEL
AB Background & objectives: Artificial corneal endothelium equivalents can not only be used as in vitro model for biomedical research including toxicological screening of drugs and investigation of pathological corneal endothelium conditions, but also as potential sources of grafts for corneal keratoplasty. This study was aimed to demonstrate the feasibility of constructing human corneal endothelium equivalents using human corneal endothelial cells and acellular porcine corneal matrix.
   Methods: Porcine corneas were decellularized with sodium dodecyl sulphate (SOS) solution. Human corneal endothelial cells B4G12 were cultured with leaching liquid extracted from the acellular porcine corneal matrix, and then cell proliferative ability was evaluated by MTT assay. B4G12 cells were transplanted to a rat corneal endothelial deficiency model to analyze their in vivo bio-safety and pump function, and then seeded and cultured on acellular porcine corneal matrix for two wk. Corneal endothelium equivalents were analyzed using HE staining, trypan blue and alizarin red S co-staining, immunofluorescence and corneal swelling assay.
   Results: The leaching liquid from acellular porcine corneal matrix had little influence on the proliferation ability of B4G12 cells. Animal transplantation of B4G12 cells showed that these cells had similar function to the native cells without causing a detectable immunological reaction and neoplasm in vivo. These formed a monolayer covering the surface of the acellular porcine corneal matrix. Trypan blue and alizarin red S co-staining showed that B4G12 cells were alive after two wk in organ culture and cell boundaries were clearly delineated. Proper localizations of ZO-1 and Na+/K+ ATPase were detected by immunofluorescence assay. Functional experiments were conducted to show that the Na+/K+ ATPase inhibitor ouabain could block the ionic-pumping function of this protein, leading to persistent swelling of 51.7 per cent as compared to the control.
   Interpretation & conclusions: Our findings showed that B4G12 cells served as a good model for native corneal endothelial cells in vivo. Corneal endothelium equivalents had properties similar to those of native corneal endothelium and could serve as a good model for in vitro study of human corneal endothelium.
C1 [Ju, Chengqun; Wu, Xinyi; Pang, Kunpeng] Shandong Univ, Qilu Hosp, Dept Ophthalmol, Jinan 250012, Peoples R China.
   [Ju, Chengqun; Pang, Kunpeng] Shandong Univ, Chinese Minist Educ, Key Lab Cardiovasc Remodeling & Funct Res, Jinan 250012, Peoples R China.
   [Ju, Chengqun; Pang, Kunpeng] Shandong Univ, Qilu Hosp, Chinese Minist Hlth, Jinan 250012, Peoples R China.
   [Gao, Li] Shandong Univ, Qilu Hosp, Div Sci Res, Jinan 250012, Peoples R China.
RP Wu, XY (reprint author), Shandong Univ, Qilu Hosp, Dept Ophthalmol, 107 Wenhua Xi Rd, Jinan 250012, Peoples R China.
EM xywu8868@163.com
CR Bednarz J, 2001, BRIT J OPHTHALMOL, V85, P1416, DOI 10.1136/bjo.85.12.1416
   Bednarz J, 2000, ACTA OPHTHALMOL SCAN, V78, P130, DOI 10.1034/j.1600-0420.2000.078002130.x
   Ben-Eliahu S, 2011, OPHTHAL SURG LAS IM, V42, P152, DOI 10.3928/15428877-20110125-01
   Bhrany AD, 2006, TISSUE ENG, V12, P319, DOI 10.1089/ten.2006.12.319
   Bolland F, 2007, BIOMATERIALS, V28, P1061, DOI 10.1016/j.biomaterials.2006.10.005
   Choi JS, 2010, BIOMATERIALS, V31, P6738, DOI 10.1016/j.biomaterials.2010.05.020
   Daniel J, 2005, ASAIO J, V51, P252, DOI 10.1097/01.MAT.0000160872.41871.7E
   Du LQ, 2011, ARTIF ORGANS, V35, P691, DOI 10.1111/j.1525-1594.2010.01174.x
   Du LQ, 2011, BRIT J OPHTHALMOL, V95, P410, DOI 10.1136/bjo.2008.142539
   Eye Bank Association of America, 1999, EY BANK STAT REP
   Flynn L, 2006, J BIOMED MATER RES A, V79A, P359, DOI 10.1002/jbm.a.30762
   Fu Y, 2010, CELLS TISSUES ORGANS, V191, P193, DOI 10.1159/000235680
   Gao XS, 2008, J MATER SCI-MATER M, V19, P3611, DOI 10.1007/s10856-008-3508-0
   Gotze T, 2008, GRAEF ARCH CLIN EXP, V246, P1575, DOI 10.1007/s00417-008-0904-6
   Hempel B, 2001, GRAEF ARCH CLIN EXP, V239, P801, DOI 10.1007/s004170100364
   Ishino Y, 2004, INVEST OPHTH VIS SCI, V45, P800, DOI 10.1167/iovs.03-0016
   Jee DH, 2010, JPN J OPHTHALMOL, V54, P602, DOI 10.1007/s10384-010-0884-z
   Kampmeier J, 2000, CORNEA, V19, P355, DOI 10.1097/00003226-200005000-00020
   Koizumi N, 2007, INVEST OPHTH VIS SCI, V48, P4519, DOI 10.1167/iovs.07-0567
   Landry H, 2011, INVEST OPHTH VIS SCI, V52, P2279, DOI 10.1167/iovs.10-6187
   LANGE TM, 1993, J CATARACT REFR SURG, V19, P232, DOI 10.1016/S0886-3350(13)80947-9
   Madden PW, 2011, BIOMATERIALS, V32, P4076, DOI 10.1016/j.biomaterials.2010.12.034
   McFetridge PS, 2004, ASAIO J, V50, P591, DOI 10.1097/01.MAT.0000144365.22025.9B
   MINKOWSKI JS, 1984, INVEST OPHTH VIS SCI, V25, P1416
   Pang KP, 2010, BIOMATERIALS, V31, P7257, DOI 10.1016/j.biomaterials.2010.05.066
   Proulx S, 2009, TISSUE ENG PT A, V15, P1709, DOI 10.1089/ten.tea.2008.0208
   Shimmura S, 2005, BRIT J OPHTHALMOL, V89, P134, DOI 10.1136/bjo.2004.050591
   STERN ME, 1981, INVEST OPHTH VIS SCI, V20, P497
   TAYLOR MJ, 1981, BRIT J OPHTHALMOL, V65, P815, DOI 10.1136/bjo.65.12.815
   Valtink M, 2008, CELLS TISSUES ORGANS, V187, P286, DOI 10.1159/000113406
   VANHORN DL, 1977, INVEST OPHTH VIS SCI, V16, P597
   Wu WC, 2007, CURR EYE RES, V32, P199, DOI 10.1080/02713680601174165
   Zhu C, 2004, INVEST OPHTH VIS SCI, V45, P1743, DOI 10.1167/iovs-030814
NR 33
TC 11
Z9 12
U1 2
U2 9
PU MEDKNOW PUBLICATIONS & MEDIA PVT LTD
PI MUMBAI
PA B-9, KANARA BUSINESS CENTRE, OFF LINK RD, GHAKTOPAR-E, MUMBAI, 400075,
   INDIA
SN 0971-5916
J9 INDIAN J MED RES
JI Indian J. Med. Res.
PD JUN
PY 2012
VL 135
IS 6
BP 887
EP 894
PG 8
WC Immunology; Medicine, General & Internal; Medicine, Research &
   Experimental
SC Immunology; General & Internal Medicine; Research & Experimental
   Medicine
GA 998XZ
UT WOS:000308275000013
PM 22825608
OA DOAJ Gold
DA 2018-10-19
ER

PT J
AU Hu, YP
   Cao, LJ
   Gu, L
   Li, QH
   Shen, HX
   Zheng, T
AF Hu Yao-ping
   Cao Lei-jian
   Gu Li
   Li Qing-hua
   Shen Hong-xia
   Zheng Tao
TI Preparation and biocompatibility evaluation of poly(D,
   L-lactide-co-glycine)
SO JOURNAL OF CENTRAL SOUTH UNIVERSITY
LA English
DT Article
DE morpholine-2,5-dione; lactide; amino acid; biocompatibility
AB D,L-lactide was prepared from D, L-lactic acid by means of polymerization and depolymerization at low vacuum level. Morpholine-2,5-dione (MD) was synthesized from the cyclization of chloroacetyl glycine which was made from chloroacetyl chloride and glycine in the basic condition. A novel copolymer (PLAMD) with D, L-lactide (D, L-LA) and morpholine-2,5-dione (MD) was synthesized using stannous octoate as initiator, and characterized with FT-IR and (HNMR)-H-1. The biocompatibility of PLAMD and PLA was investigated by MTT and microscope. The results show that amino acid is introduced into PDLLA main chain. PLAMD has better cell affinity than PLA, so it is a promising biomaterial.
C1 [Gu Li; Shen Hong-xia; Zheng Tao] Jiaxing Univ, Inst Polymer Mat Engn, Jiaxing 314001, Peoples R China.
   [Hu Yao-ping; Cao Lei-jian; Li Qing-hua] Changzhou Univ, Sch Mat Sci & Engn, Changzhou 213164, Peoples R China.
RP Gu, L (reprint author), Jiaxing Univ, Inst Polymer Mat Engn, Jiaxing 314001, Peoples R China.
EM guli@mail.zjxu.edu.cn
FU National Natural Science Foundation of China [21107032]; Natural Science
   Foundation of Zhejiang Province, China [Y406469, Y4110606]; Science
   Foundation of Jiaxing Science and Technology Bureau, China [2008AY2018,
   2011AY1048-5, 2011AY1030]; Science and Technology Department of Zhejiang
   Province, China [Science Foundation of Jiaxing Science and Technology
   Bureau, China; Project(2009C21003]
FX Project(21107032) supported by the National Natural Science Foundation
   of China; Projects(Y406469, Y4110606) supported by the Natural Science
   Foundation of Zhejiang Province, China; Projects(2008AY2018,
   2011AY1048-5, 2011AY1030) supported by the Science Foundation of Jiaxing
   Science and Technology Bureau, China; Project(2009C21003) supported by
   the Science and Technology Department of Zhejiang Province, China
CR [曹雪波 Cao Xuebo], 2002, [高分子材料科学与工程, Polymer Materials Science & Engineering], V18, P115
   CIAPETTI G, 1993, BIOMATERIALS, V14, P359, DOI 10.1016/0142-9612(93)90055-7
   CUI Guo-zhen, 2009, CHEM BIOENGINEERING, V26, P41
   Gu L, 2008, J CENT SOUTH UNIV T, V15, P469, DOI 10.1007/s11771-008-0088-6
   [侯晓娜 HOU Xiao-Na], 2009, [应用化学, Chinese Journal of Applied Chemistry], V26, P273
   [侯晓娜 HOU Xiaona], 2009, [材料导报, Materials Review], V23, P36
   Katsikari A, 2009, MATER SCI ENG B-ADV, V165, P160, DOI 10.1016/j.mseb.2009.09.007
   Li GU, 2003, J JIAXING U, V15, P18
   [罗彦凤 Luo Yanfeng], 2005, [高分子材料科学与工程, Polymer Materials Science & Engineering], V21, P139
   Nair LS, 2007, PROG POLYM SCI, V32, P762, DOI 10.1016/j.progpolymsci.2007.05.017
   Nelson TD, 2004, TETRAHEDRON LETT, V45, P8917, DOI 10.1016/j.tetlet.2004.09.185
   Peng YL, 2010, POLYMER, V51, P4329, DOI 10.1016/j.polymer.2010.07.016
   Rasal RM, 2010, PROG POLYM SCI, V35, P338, DOI 10.1016/j.progpolymsci.2009.12.003
   Rezwan K, 2006, BIOMATERIALS, V27, P3413, DOI 10.1016/j.biomaterials.2006.01.039
   Ruan G, 2003, BIOMATERIALS, V24, P5037, DOI 10.1016/S0142-9612(03)00419-8
   SHEN Zheng-rong, 1999, CHEM REAGENT, V1, P311
   SU Ai-hua, 2004, CHINESE J CLIN REHAB, V8, P866
   [唐智荣 Tang Zhirong], 2002, [华东理工大学学报. 自然科学版, Journal of East China University of Science and Technoloy.Natural Sciences Edition], V28, P618
   WILLIAMS D F., 1981, SYSTEMATIC ASPECTS B, V2, P45
   Yan Qiong-jiao, 2008, Journal of Central South University (Science and Technology), V39, P1190
   YANG Li-chuan, 2010, MATER SCI ENG, V26, P129
   YE Rui-rong, 2010, MAT REV, V24, P94
   [叶瑞荣 Ye Ruirong], 2010, [化学研究与应用, Chemical Research and Application], V22, P1126
NR 23
TC 0
Z9 0
U1 3
U2 20
PU JOURNAL OF CENTRAL SOUTH UNIV TECHNOLOGY
PI HUNAN
PA EDITORIAL OFFICE, CHANGSHA, HUNAN 410083, PEOPLES R CHINA
SN 2095-2899
J9 J CENT SOUTH UNIV
JI J. Cent. South Univ.
PD JUN
PY 2012
VL 19
IS 6
BP 1517
EP 1521
DI 10.1007/s11771-012-1170-7
PG 5
WC Metallurgy & Metallurgical Engineering
SC Metallurgy & Metallurgical Engineering
GA 985GI
UT WOS:000307251000007
DA 2018-10-19
ER

PT J
AU McHenry, MP
AF McHenry, Mark P.
TI Australian carbon biosequestration and bioenergy policy co-evolution:
   mechanisms, mitigation and convergence
SO AUSTRALIAN FORESTRY
LA English
DT Article
DE forestry; carbon; policy; climatic change; legislation; international
   agreements; Australia
ID KYOTO PROTOCOL; CLIMATE-CHANGE
AB The intricacies of international land-use change and forestry policy reflect the temporal, technical and political difficulty of integrating biological systems and climate change mitigation. The plethora of co-existing policies with varied technical rules, accreditation requirements, accounting methods, market registries, etc., disguise the unequal efficacies of each mechanism. This work explores the co-evolution and convergence of Australian voluntary and mandatory climate-related policies at the biosequestration-bioenergy interface. Currently, there are temporal differences between the fast-evolving and precise climate-change mechanisms, and the long-term 'permanence' sought from land use changes encouraged by biosequestration instruments. Policy convergence that favours the most efficient, appropriate and scientifically substantiated policy mechanisms is required. These policies must recognise the fundamental biological foundation of biosequestration, bioenergy, biomaterial industrial development and other areas such as food security and environmental concerns. Policy mechanisms that provide administrative simplicity, project longevity and market certainty are necessary for rural and regional Australians to cost-effectively harness the considerable climate change mitigation potential of biological systems.
C1 Murdoch Univ, Sch Engn & Energy, Murdoch, WA 6150, Australia.
RP McHenry, MP (reprint author), Murdoch Univ, Sch Engn & Energy, Murdoch, WA 6150, Australia.
EM mpmchenry@gmail.com
CR AGO (Australian Greenhouse Office), 2006, GREENH FRIENDL GUID
   Babiker M.H., 2002, ENVIRON SCI POLICY, V5, P195
   CAPOOR K, 2008, STATE TRENDS CARBON
   Capoor K., 2009, STATE TRENDS CARBON
   Chicago Climate Exchange, 2008, CCX ADV 2008 01
   Crowley K., 2007, AUSTR GREENH CHALL P
   DCC, 2009, TRACK KYOT 2020 AUST
   DCC (Department of Climate Change), 2009, REV FISC IMP CARB PO
   DCC (Department of Climate Change), 2009, GREENH FRIENDL
   DCC (Department of Climate Change), 2008, CARB POLL RED SCHEM, V1
   DCC (Department of Climate Change), 2009, GREENH FRIENDL CARB
   DCC (Department of Climate Change), 2008, CARB POLL RED SCHEM, V2
   DCC (Department of Climate Change), 2009, AUSTR NAT GUID PROC
   DCCEE (Department of Climate Change and Energy Efficiency), 2011, CARB FARM IN PREL ES
   Department of Climate Change (DCC), 2008, CARB POLL RED SCHEM
   Dumanski J, 2004, CLIMATIC CHANGE, V65, P255, DOI 10.1023/B:CLIM.0000038210.66057.61
   Fry I., 2007, REV EUR COMP INT ENV, V16, P341
   GreenPower, 2009, OUR ACCR STAND
   GreenPower, 2009, GREENPOWER WORKS
   Hamilton C., 1999, ENVIRON SCI POLICY, V2, P145
   Hepburn C, 2007, ANNU REV ENV RESOUR, V32, P375, DOI 10.1146/annurev.energy.32.053006.141203
   Hohne N, 2007, ENVIRON SCI POLICY, V10, P353, DOI 10.1016/j.envsci.2007.02.001
   Howard J., 1997, SAFEGUARDING FUTURE
   IEA, 2006, CARR STICKS TAX SUBS
   Illum K, 2004, ENERG POLICY, V32, P1013, DOI 10.1016/S0301-4215(03)00058-2
   IPART, 2008, COMPL OP NSW GREENH
   IPART (Independent Pricing and Regulatory Tribunal), 2009, COMPL OP NSW GREENH
   Kent A, 2006, ENERG POLICY, V34, P1046, DOI 10.1016/j.enpol.2004.10.009
   Kossoy A., 2010, STATE TRENDS CARBON
   Linacre N., 2011, STATE TRENDS CARBON
   MacGill A., 2006, ENERG POLICY, V34, P11
   McDonald M, 2005, AUST J POLIT HIST, V51, P216, DOI 10.1111/j.1467-8497.2005.00371.x
   McHenry M.P., 2009, NO TILL FARMING EFFE, P93
   McKinsey and Company, 2009, PATHW LOW CARB EC VE
   NSW Department of Water and Energy, 2009, NAT GREENPOWER ACCR
   NSW Government, 2008, TRANS ARR NSW GREENH
   NSW Government, 2008, CGAS NEWSLETTER  SEP
   ORER (Office of the Renewable Energy Regulator), 2003, MAND REN EN TARG REV
   Parliament of the Commonwealth of Australia, 2000, HEAT IS AUSTR GREENH
   Prins G, 2007, NATURE, V449, P973, DOI 10.1038/449973a
   TAPLIN R, 1995, AUST GEOGR, V26, P16, DOI 10.1080/00049189508703125
   UN and UNFCCC (United Nations and United Nations Framework Convention on Climate Change), 2002, C PART ITS 7 SESS
   URS Australia Pty Ltd, 2008, NAT GREENPOWER ACCR
   Wilkins Roger, 2008, STRATEGIC REV AUSTR
NR 44
TC 1
Z9 1
U1 0
U2 11
PU INST FORESTERS AUSTRALIA
PI YARRALUMLA
PA P O BOX 2, YARRALUMLA, ACT 2600, AUSTRALIA
SN 0004-9158
J9 AUST FORESTRY
JI Austral. For.
PD JUN
PY 2012
VL 75
IS 2
BP 82
EP 94
DI 10.1080/00049158.2012.10676389
PG 13
WC Forestry
SC Forestry
GA 977SJ
UT WOS:000306684500003
DA 2018-10-19
ER

PT J
AU Hwang, JH
   Kim, OY
   Kim, AR
   Bae, JY
   Jeong, SM
   Shim, JB
   Yoon, KH
   Lee, D
   Khang, G
AF Hwang, Ji Hye
   Kim, On You
   Kim, A. Ram
   Bae, Ji Yeon
   Jeong, Su Mi
   Shim, Jung Bo
   Yoon, Kun Ho
   Lee, Dongwon
   Khang, Gilson
TI EFFECT OF PURIFIED ALGINATE MICROCAPSULES ON THE REGENERATION OF
   CHONDROCYTES
SO BIOMEDICAL ENGINEERING-APPLICATIONS BASIS COMMUNICATIONS
LA English
DT Article
DE Alginate; Purification; Modified Korbutt Method; Chondrocytes;
   Biocompatibility
ID CHONDROGENIC DIFFERENTIATION; TISSUE; CHITOSAN; CULTURE; MATRIX;
   TRANSPLANTATION; PURIFICATION; FABRICATION; COMPOSITE; SCAFFOLDS
AB Adult articular cartilage tissue has poor capability of self-repair. Therefore, a variety of tissue engineering approaches are motivated by the clinical need for articular repair. Alginate has been used as a biomaterial for cartilage regeneration. The alginate is a natural polymer that is extracted from seaweeds and purification. However, the main drawback is the immune rejection in vivo. To overcome this problem, we have developed the biocompability of alginate using modified Korbutt method. After alginate was purified, purified alginate microcapsules were used in cartilage regeneration. Chondrocytes were seeded in purified and nonpurified alginate microcapsules, and then cell viability, proliferation and phenotype were analyzed by 3-(4,5-dimethylthiazol-2-yl)-2,5 diphenyltetrazolium bromide (MTT) assay. Reverse transcriptase-polymerase chain reaction (RT-PCR) was conducted to confirm mRNA expression on collagen type I and collagen type II for chondrocytes phenotype. Hematoxylin and eosin (H&E) and Safranin-O histological staining showed tissue growth at the interface during the first 10 days. In this study, chondrocytes in purified alginate microcapsules had higher cell viability, proliferation and more phenotype expression than those in nonpurified alginate microcapsules. The results suggest that the purified alginate microcapsule is useful for cartilage regeneration.
C1 [Hwang, Ji Hye; Kim, On You; Kim, A. Ram; Bae, Ji Yeon; Jeong, Su Mi; Shim, Jung Bo; Lee, Dongwon; Khang, Gilson] Chonbuk Natl Univ, Dept BIN Fus Technol, Polymer Fus Res Ctr, Jeonju 561756, South Korea.
   [Hwang, Ji Hye; Kim, On You; Kim, A. Ram; Bae, Ji Yeon; Jeong, Su Mi; Shim, Jung Bo; Lee, Dongwon; Khang, Gilson] Chonbuk Natl Univ, Dept PolymerNano Sci Technol, Jeonju 561756, South Korea.
   [Yoon, Kun Ho] Catholic Univ Korea, Coll Med, Dept Internal Med, Div Endocrinol & Metab, Seoul 137701, South Korea.
RP Khang, G (reprint author), Chonbuk Natl Univ, Dept BIN Fus Technol, Polymer Fus Res Ctr, 567 Baekje Daero, Jeonju 561756, South Korea.
EM dlee@jbnu.ac.kr; gskhang@jbnu.ac.kr
RI Khang, Gilson/B-2109-2013
FU WCU [R31-20029]; XRD [A040004]; MBC [0405-B001-0204-0006]
FX This research was supported by WCU (R31-20029), XRD (A040004) and MBC
   (0405-B001-0204-0006).
CR Aaron GM, 2009, TISSUE ENG PART A, V15, P1301
   Carracedo AG, 2008, EUR J PHARM BIOPHARM, V69, P675
   CIMA LG, 1991, J BIOMECH ENG-T ASME, V113, P143, DOI 10.1115/1.2891228
   Cooper JA, 2005, BIOMATERIALS, V26, P1523, DOI 10.1016/j.biomaterials.2004.05.014
   Gaserod O, 1999, BIOMATERIALS, V20, P773, DOI 10.1016/S0142-9612(98)00230-0
   Gombotz WR, 1998, ADV DRUG DELIVER REV, V31, P267, DOI 10.1016/S0169-409X(97)00124-5
   Jork A, 2000, APPL MICROBIOL BIOT, V53, P224, DOI 10.1007/s002530050012
   Khang G, 2003, ADV EXP MED BIOL, V534, P235
   Khattak SF, 2006, BIOTECHNOL LETT, V28, P1361, DOI 10.1007/s10529-006-9104-9
   Kim I, 2003, POLYM-KOREA, V27, P195
   Kim O. Y., 2011, INT J TISSUE REG, V2, P13
   Kim TH, 2011, INT J TISSUE REGEN, V2, P1
   KLOCK G, 1994, APPL MICROBIOL BIOT, V40, P638
   Langer R, 2004, NATURE, V428, P487, DOI 10.1038/nature02388
   Lee DA, 2003, ACTA ORTHOP SCAND, V74, P6, DOI 10.1080/00016470310013581
   Lee JH, 2010, INT J TISSUE REGEN, V1, P1, DOI DOI 10.1371/J0URNAL.P0NE.0015394
   Lee KJ, 2005, SPINE J S, V5, P217
   Lei J, 2008, MACROMOL RES, V16, P45, DOI 10.1007/BF03218959
   Lemoine D, 1998, INT J PHARMACEUT, V179, P9
   Liew CV, 2006, INT J PHARM, V309, P25, DOI 10.1016/ijpharm.2005.10.040
   Masuda K, 2003, J ORTHOPAED RES, V21, P139, DOI 10.1016/S0736-0266(02)00109-2
   McConell K, 2004, FOOD BIOPROD PROCESS, V82, P126, DOI 10.1205/0960308041614873
   Mizuno S, 1996, BIOMATERIALS, V17, P1819, DOI 10.1016/0142-9612(96)00041-5
   Munirah S, 2008, J BIOMAT SCI-POLYM E, V19, P1219
   NOGAMI H, 1974, J CELL BIOL, V62, P510, DOI 10.1083/jcb.62.2.510
   Park HY, 1997, J KOREAN IND CHEM EN, V35, P264
   Park K, 2008, BIOMATERIALS, V29, P2490, DOI 10.1016/j.biomaterials.2008.02.017
   Prokop A, 1997, ANN NY ACAD SCI, V831, P223
   Roh IJ, 2002, J BIOMAT SCI-POLYM E, V13, P769, DOI 10.1163/156856202760197401
   Shipa A, 2003, J MACROMOL SCI POL C, VC43, P187
   Tam SK, 2006, BIOMATERIALS, V27, P1296, DOI 10.1016/j.biomaterials.2005.08.027
   Tonnesen HH, 2002, DRUG DEV IND PHARM, V28, P621, DOI 10.1081/DDC-120003853
   Wandrey C, 2001, ANN NY ACAD SCI, V944, P187
   Wu YN, 2007, BIOMATERIALS, V28, P4056, DOI 10.1016/j.biomaterials.2007.05.039
   Xia WY, 2004, J BIOMED MATER RES B, V71B, P373, DOI 10.1002/jbm.b.30087
NR 35
TC 2
Z9 2
U1 0
U2 16
PU WORLD SCIENTIFIC PUBL CO PTE LTD
PI SINGAPORE
PA 5 TOH TUCK LINK, SINGAPORE 596224, SINGAPORE
SN 1016-2372
J9 BIOMED ENG-APP BAS C
JI Biomed. Eng.-Appl. Basis Commun.
PD JUN
PY 2012
VL 24
IS 3
BP 185
EP 195
DI 10.4015/S1016237212500019
PG 11
WC Engineering, Biomedical
SC Engineering
GA 970ZE
UT WOS:000306170300001
DA 2018-10-19
ER

PT J
AU Liu, JB
   Lawrence, BD
   Liu, AH
   Schwab, IR
   Oliveira, LA
   Rosenblatt, MI
AF Liu, Jingbo
   Lawrence, Brian D.
   Liu, Aihong
   Schwab, Ivan R.
   Oliveira, Lauro A.
   Rosenblatt, Mark I.
TI Silk Fibroin as a Biomaterial Substrate for Corneal Epithelial Cell
   Sheet Generation
SO INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE
LA English
DT Article
ID HUMAN AMNIOTIC MEMBRANE; STEM-CELLS; EX-VIVO; ARTICULAR-CARTILAGE;
   CULTURE SURFACE; IN-VIVO; DIFFERENTIATION; SCAFFOLDS; TRANSPLANTATION;
   PROTEIN
AB PURPOSE. To evaluate a silk fibroin (SF) biomaterial as a substrate for corneal epithelial cell proliferation, differentiation, and stratification in vitro compared with denuded human amniotic membrane (AM).
   METHODS. Primary human and rabbit corneal epithelial cells and immortalized human corneal limbal epithelial cells were cultured on the SF and denuded AM, respectively. The biological cell behavior, including the morphology, proliferation, differentiation, and stratification, on the two substrates was compared and analyzed.
   RESULTS. Corneal epithelial cells can adhere and proliferate on the SF and denuded AM with a cobblestone appearance, abundant microvilli on the surface, and wide connection with the adjacent cells. MTT assay showed that cell proliferation on denuded AM was statistically higher than that on SF at 24 and 72 hours after plating (P = 0.001 and 0.0005, respectively). Expression of Delta Np63a and keratin 3/12 was detected in primary cell cultures on the two substrates with no statistical difference. When cultured at the air-liquid interface for 7 days, cells on SF could form a comparable stratified graft with a 2- to 3-cell layering, which compared similarly to AM cultures.
   CONCLUSIONS. SF, a novel biomaterial, could support corneal epithelial cells to proliferate, differentiate, and stratify, retaining the normal characteristic epithelium phenotype. Compared with AM, its unique features, including the transparency, ease of handling, and transfer, and inherent freedom from disease transmission, make it a promising substrate for corneal wound repair and tissue-engineering purposes. (Invest Ophthalmol Vis Sci. 2012;53:4130-4138) DOI:10.1167/iovs.12-9876
C1 [Liu, Jingbo; Lawrence, Brian D.; Liu, Aihong; Rosenblatt, Mark I.] Weill Cornell Med Coll, New York, NY USA.
   [Schwab, Ivan R.] Univ Calif Davis, Davis, CA 95616 USA.
   [Oliveira, Lauro A.] Univ Fed Sao Paulo, Sao Paulo, Brazil.
RP Rosenblatt, MI (reprint author), 1300 York Ave,LC 305, New York, NY 10065 USA.
EM mar2058@med.cornell.edu
FU National Institutes of Health [K08EY015829, R21EY019561, R24EY015656];
   National Natural Science Foundation of China [30801262]; Research to
   Prevent Blindness Career Development Award; Tri-Institutional Stem Cell
   Initiative
FX Supported by National Institutes of Health Grants K08EY015829,
   R21EY019561, and R24EY015656; National Natural Science Foundation of
   China Grant 30801262; a Research to Prevent Blindness Career Development
   Award; and a Tri-Institutional Stem Cell Initiative.
CR Acharya C, 2008, J MATER SCI-MATER M, V19, P2827, DOI 10.1007/s10856-008-3408-3
   Braet F, 1997, J MICROSC-OXFORD, V186, P84, DOI 10.1046/j.1365-2818.1997.1940755.x
   Bray LJ, 2011, BIOMATERIALS, V32, P5086, DOI 10.1016/j.biomaterials.2011.03.068
   Chen B, 2010, TISSUE ENG PT A, V16, P2721, DOI 10.1089/ten.tea.2009.0711
   Etienne O, 2009, J PERIODONTOL, V80, P1852, DOI 10.1902/jop.2009.090231
   Fu Y, 2009, CELLS TISSUES ORGANS, V191, P193, DOI [10.1159/000235680, DOI 10.1159/000235680]
   Fukuda K, 1999, CORNEA, V18, P73, DOI 10.1097/00003226-199901000-00013
   Gimeno FL, 2007, J CATARACT REFR SURG, V33, P1958, DOI 10.1016/j.jcrs.2007.07.020
   Grueterich M, 2003, SURV OPHTHALMOL, V48, P631, DOI 10.1016/j.survophthal.2003.08.003
   Hayashida Y, 2005, INVEST OPHTH VIS SCI, V46, P1632, DOI 10.1167/iovs.04-0813
   Higa K, 2007, INVEST OPHTH VIS SCI, V48, P597, DOI 10.1167/iovs.06-0664
   Higa K, 2011, J BIOMAT SCI-POLYM E, V22, P2261, DOI 10.1163/092050610X538218
   Hopkinson A, 2008, TISSUE ENG PART C-ME, V14, P371, DOI 10.1089/ten.tec.2008.0315
   Jin HJ, 2005, ADV FUNCT MATER, V15, P1241, DOI 10.1002/adfm.200400405
   Karageorgiou V, 2004, J BIOMED MATER RES A, V71A, P528, DOI 10.1002/jbm.a.30186
   Koizumi N, 2000, CURR EYE RES, V20, P173, DOI 10.1076/0271-3683(200003)20:3;1-9;FT173
   Lawrence BD, 2008, BIOMACROMOLECULES, V9, P1214, DOI 10.1021/bm701235f
   Lawrence BD, 2009, BIOMATERIALS, V30, P1299, DOI 10.1016/j.biomaterials.2008.11.018
   Liu J, 2011, EXPERT REV OPHTHALMO, V5, P645
   Liu JB, 2011, AM J OPHTHALMOL, V152, P739, DOI 10.1016/j.ajo.2011.03.037
   Ma DHK, 2002, CORNEA, V21, P275, DOI 10.1097/00003226-200204000-00008
   Meinel L, 2005, BONE, V37, P688, DOI 10.1016/j.bone.2005.06.010
   MINOURA N, 1995, BIOCHEM BIOPH RES CO, V208, P511, DOI 10.1006/bbrc.1995.1368
   Morita Y, 2002, BIO-MED MATER ENG, V12, P291
   Nazarov R, 2004, BIOMACROMOLECULES, V5, P718, DOI 10.1021/bm034327e
   Nishida K, 2004, TRANSPLANTATION, V77, P379, DOI 10.1097/01.TP.0000110320.45678.30
   Oyen ML, 2004, J MATER SCI-MATER M, V15, P651, DOI 10.1023/B:JMSM.0000030205.62668.90
   Pang KP, 2010, BIOMATERIALS, V31, P7257, DOI 10.1016/j.biomaterials.2010.05.066
   Pellegrini G, 1997, LANCET, V349, P990, DOI 10.1016/S0140-6736(96)11188-0
   Pellegrini G, 2001, P NATL ACAD SCI USA, V98, P3156, DOI 10.1073/pnas.061032098
   Sahoo S, 2010, J BIOMED MATER RES B, V95B, P19, DOI 10.1002/jbm.b.31678
   SCHERMER A, 1986, J CELL BIOL, V103, P49, DOI 10.1083/jcb.103.1.49
   Sofia S, 2001, J BIOMED MATER RES, V54, P139, DOI 10.1002/1097-4636(200101)54:1<139::AID-JBM17>3.0.CO;2-7
   Spoerl E, 2004, OPHTHAL RES, V36, P71, DOI 10.1159/000076884
   Sudha B, 2008, INDIAN J MED RES, V128, P149
   Talukdar S, 2011, BIOMATERIALS, V32, P8927, DOI 10.1016/j.biomaterials.2011.08.027
   Tsai RJ, 2000, NEW ENGL J MED, V343, P86, DOI 10.1056/NEJM200007133430202
   Tseng Scheffer C G, 2004, Ocul Surf, V2, P177
   Wang XY, 2005, LANGMUIR, V21, P11335, DOI 10.1021/la051862m
   Wang Y, 2008, BIOMATERIALS, V29, P3415, DOI 10.1016/j.biomaterials.2008.05.002
   Yan LP, 2012, ACTA BIOMATER, V8, P289, DOI 10.1016/j.actbio.2011.09.037
   Zakaria N, 2009, TISSUE ENG PART C-ME, V16, P921
NR 42
TC 46
Z9 50
U1 1
U2 30
PU ASSOC RESEARCH VISION OPHTHALMOLOGY INC
PI ROCKVILLE
PA 12300 TWINBROOK PARKWAY, ROCKVILLE, MD 20852-1606 USA
SN 0146-0404
J9 INVEST OPHTH VIS SCI
JI Invest. Ophthalmol. Vis. Sci.
PD JUN
PY 2012
VL 53
IS 7
BP 4130
EP 4138
DI 10.1167/iovs.12-9876
PG 9
WC Ophthalmology
SC Ophthalmology
GA 971CM
UT WOS:000306181200100
PM 22661480
OA Green Published, Bronze
DA 2018-10-19
ER

PT J
AU Liu, ZB
   Xiao, LD
   Xu, BJ
   Zhang, Y
   Mak, AFT
   Li, Y
   Man, WY
   Yang, M
AF Liu, Zongbin
   Xiao, Lidan
   Xu, Baojian
   Zhang, Yu
   Mak, Arthur F. T.
   Li, Yi
   Man, Wing-yin
   Yang, Mo
TI Covalently immobilized biomolecule gradient on hydrogel surface using a
   gradient generating microfluidic device for a quantitative mesenchymal
   stem cell study
SO BIOMICROFLUIDICS
LA English
DT Article
ID MARROW STROMAL CELLS; TISSUE-ENGINEERING APPLICATIONS; OSTEOGENIC
   DIFFERENTIATION; PEG HYDROGELS; RGD PEPTIDES; IN-VITRO; BONE; SUBSTRATE;
   PROTEINS; MODULATION
AB Precisely controlling the spatial distribution of biomolecules on biomaterial surface is important for directing cellular activities in the controlled cell microenvironment. This paper describes a polydimethylsiloxane (PDMS) gradient-generating microfluidic device to immobilize the gradient of cellular adhesive Arg-Gly-Asp (RGD) peptide on poly (ethylene glycol) (PEG) hydrogel. Hydrogels are formed by exposing the mixture of PEG diacrylate (PEGDA), acryloyl-PEG-RGD, and photo-initiator with ultraviolet light. The microfluidic chip was simulated by a fluid dynamic model for the biomolecule diffusion process and gradient generation. PEG hydrogel covalently immobilized with RGD peptide gradient was fabricated in this microfluidic device by photo-polymerization. Bone marrow derived rat mesenchymal stem cells (MSCs) were then cultured on the surface of RGD gradient PEG hydrogel. Cell adhesion of rat MSCs on PEG hydrogel with various RGD gradients were then qualitatively and quantitatively analyzed by immunostaining method. MSCs cultured on PEG hydrogel surface with RGD gradient showed a grated fashion for cell adhesion and spreading that was proportional to RGD concentration. It was also found that 0.107-0.143mM was the critical RGD concentration range for MSCs maximum adhesion on PEG hydrogel. (C) 2012 American Institute of Physics. [http://dx.doi.org/10.1063/1.4704522]
C1 [Liu, Zongbin; Xiao, Lidan; Mak, Arthur F. T.; Yang, Mo] Hong Kong Polytech Univ, Fac Engn, Interdisciplinary Div Biomed Engn, Hong Kong, Hong Kong, Peoples R China.
   [Liu, Zongbin] Chinese Acad Sci, Shenzhen Inst Adv Technol, Beijing 100864, Peoples R China.
   [Xu, Baojian] Shanghai Inst Microsyst & Informat Technol, Shanghai, Peoples R China.
   [Zhang, Yu; Li, Yi] Hong Kong Polytech Univ, Inst Text & Clothing, Hong Kong, Hong Kong, Peoples R China.
   [Man, Wing-yin] Hong Kong Polytech Univ, Dept Appl Biol & Chem Technol, Hong Kong, Hong Kong, Peoples R China.
RP Yang, M (reprint author), Hong Kong Polytech Univ, Fac Engn, Interdisciplinary Div Biomed Engn, Hong Kong, Hong Kong, Peoples R China.
EM htmems@polyu.edu.hk
RI Yang, Mo/K-1274-2012; LI, YI/G-4421-2012; Zhang, Yu/J-9587-2012
OI Yang, Mo/0000-0002-3863-8187; LI, YI/0000-0002-2092-4505; Zhang,
   Yu/0000-0001-6751-9294
FU Hong Kong Polytechnic University [G-YX5G]
FX This work was partially supported by the postdoctoral fellowship fund of
   the Hong Kong Polytechnic University (G-YX5G).
CR Benoit DSW, 2008, NAT MATER, V7, P816, DOI 10.1038/nmat2269
   Benoit DSW, 2007, BIOMATERIALS, V28, P66, DOI 10.1016/j.biomaterials.2006.08.033
   BOYDEN S, 1962, J EXP MED, V115, P453, DOI 10.1084/jem.115.3.453
   Bruder SP, 1998, J ORTHOPAED RES, V16, P155, DOI 10.1002/jor.1100160202
   Calplan A. I., 2005, TISSUE ENG, V11, P1198
   Cavalcanti-Adam EA, 2002, J BONE MINER RES, V17, P2130, DOI 10.1359/jbmr.2002.17.12.2130
   Chung BG, 2006, LAB CHIP, V6, P764, DOI 10.1039/b512667c
   Curran JM, 2006, BIOMATERIALS, V27, P4783, DOI 10.1016/j.biomaterials.2006.05.001
   Delamarche E, 1998, J AM CHEM SOC, V120, P500, DOI 10.1021/ja973071f
   Dertinger SKW, 2001, ANAL CHEM, V73, P1240, DOI 10.1021/ac001132d
   Discher DE, 2005, SCIENCE, V310, P1139, DOI 10.1126/science.1116995
   Fosser KA, 2003, ANAL CHEM, V75, P5775, DOI 10.1021/ac034634a
   Frith J. E., 2012, J CELL SCI, V125, P1
   Gaarcia A. J., 2005, BIOMATERIALS, V26, P7525
   Geiger B, 2002, CELL, V110, P139, DOI 10.1016/S0092-8674(02)00831-0
   Georgescu W, 2008, LAB CHIP, V8, P238, DOI 10.1039/b716203k
   Gunawan RC, 2005, LANGMUIR, V21, P3061, DOI 10.1021/la048303k
   Huang Y, 2011, BIOMICROFLUIDICS, V5, DOI 10.1063/1.3555195
   Jackson L, 2007, J POSTGRAD MED, V53, P121
   Jeon NL, 2000, LANGMUIR, V16, P8311, DOI 10.1021/la000600b
   Jeon NL, 2002, NAT BIOTECHNOL, V20, P826, DOI 10.1038/nbt712
   Krampera M, 2006, BONE, V39, P678, DOI 10.1016/j.bone.2006.04.020
   LOHOF AM, 1992, J NEUROSCI, V12, P1253
   Lutolf MP, 2009, NATURE, V462, P433, DOI 10.1038/nature08602
   MURUGAIAH V, 1992, ANAL CHEM, V64, P2130, DOI 10.1021/ac00042a018
   Nguyen KT, 2002, BIOMATERIALS, V23, P4307, DOI 10.1016/S0142-9612(02)00175-8
   Nuttelman CR, 2004, J BIOMED MATER RES A, V68A, P773, DOI 10.1002/jbm.a.20112
   Peppas NA, 2000, ANNU REV BIOMED ENG, V2, P9, DOI 10.1146/annurev.bioeng.2.1.9
   Sawyer AA, 2005, BIOMATERIALS, V26, P1467, DOI 10.1016/j.biomaterials.2004.05.008
   Shin H, 2005, BIOMATERIALS, V26, P3645, DOI 10.1016/j.biomaterials.2004.09.050
   Shin H, 2004, J BIOMED MATER RES A, V69A, P535, DOI 10.1002/jbm.a.30027
   Shu XZ, 2004, J BIOMED MATER RES A, V68A, P365, DOI 10.1002/jbm.a.20002
   Tessmar JK, 2007, MACROMOL BIOSCI, V7, P23, DOI 10.1002/mabi.200600096
   Waggoner R. A., 1995, MACROMOLECULES, V28, P2568
   Yang F, 2005, BIOMATERIALS, V26, P5991, DOI 10.1016/j.biomaterials.2005.03.018
   ZHENG JQ, 1994, NATURE, V368, P140, DOI 10.1038/368140a0
NR 36
TC 13
Z9 13
U1 6
U2 64
PU AMER INST PHYSICS
PI MELVILLE
PA CIRCULATION & FULFILLMENT DIV, 2 HUNTINGTON QUADRANGLE, STE 1 N O 1,
   MELVILLE, NY 11747-4501 USA
SN 1932-1058
J9 BIOMICROFLUIDICS
JI Biomicrofluidics
PD JUN
PY 2012
VL 6
IS 2
AR 024111
DI 10.1063/1.4704522
PG 12
WC Biochemical Research Methods; Biophysics; Nanoscience & Nanotechnology;
   Physics, Fluids & Plasmas
SC Biochemistry & Molecular Biology; Biophysics; Science & Technology -
   Other Topics; Physics
GA 966LS
UT WOS:000305839800022
PM 22550556
OA Green Published
DA 2018-10-19
ER

PT J
AU Testori, T
   Iezzi, G
   Manzon, L
   Fratto, G
   Piattelli, A
   Weinstein, RL
AF Testori, Tiziano
   Iezzi, Giovanna
   Manzon, Licia
   Fratto, Giovanni
   Piattelli, Adriano
   Weinstein, Roberto L.
TI High Temperature-Treated Bovine Porous Hydroxyapatite in Sinus
   Augmentation Procedures: A Case Report
SO INTERNATIONAL JOURNAL OF PERIODONTICS & RESTORATIVE DENTISTRY
LA English
DT Article
ID CALCIUM-PHOSPHATE CERAMICS; BONE INGROWTH; CORALLINE HYDROXYAPATITE;
   IMPLANTS; MACROPOROSITY; SUBSTITUTION; DENSITY; RABBITS; INVIVO
AB Among the graft materials that can be used clinically xenografts are the most common. Xenografts are of bovine, porcine, or equine origin and require the complete removal of proteins to avoid immunologic problems and the risk of transmission of prions, viruses, etc. Protein destruction can be achieved by a chemical procedure using organic solvents and heat treatment. After this process, a carbonated hydroxyapatite similar to human bone remains. The aim of this case report is to investigate the bone formation in a sinus augmentation procedure using a high temperature-treated bovine porous hydroxyapatite. A 58-year-old woman underwent bilateral sinus augmentation using this biomaterial. After 9 months, during stage-two surgery, two core biopsy specimens were retrieved and treated to obtain thin ground undecalcified sections. Microscopically newly formed bone was present at the interface with most particles. The major portion of the particles appeared to be completely lined and surrounded by bone. No obvious signs of resorption were present on the biomaterial surface. No gaps or connective tissue were present at the bone-biomaterial interface. No inflammatory infiltrate or fibrous encapsulation of the particles was present. Histomorphometry showed that the percentages of newly formed bone, residual grafted particles, and marrow spaces were 25.1% +/- 2.3%, 37.3% +/- 1.1%, and 38.5% +/- 3.1%, respectively. The excellent properties demonstrated by Endobon are probably a result of its particular hydroxyapatite porous microstructure with a high percentage of interconnected micropores that promote the ingrowth of osteogenic cells and vessels, making graft integration easier and faster. (Int J Periodontics Restorative Dent 2012;32:295-301.)
C1 [Testori, Tiziano] Univ Milan, IRCCS, Sect Implant Dent & Oral Rehabil, Dept Odontol,Galeazzi Inst, I-20161 Milan, Italy.
   [Iezzi, Giovanna; Piattelli, Adriano] Univ G dAnnunzio, Sch Dent, Chieti, Italy.
   [Manzon, Licia; Fratto, Giovanni] Univ Roma La Sapienza, Sch Dent, Rome, Italy.
RP Testori, T (reprint author), Univ Milan, IRCCS, Sect Implant Dent & Oral Rehabil, Dept Odontol,Galeazzi Inst, Via Riccardo Galeazzi 4, I-20161 Milan, Italy.
EM info@tiziano-testori.it
OI MANZON, Licia/0000-0002-7727-7652; FRATTO, Giovanni/0000-0002-0114-2145
CR Baer W, 2002, J HAND SURG-BRIT EUR, V27B, P101, DOI 10.1054/jhsb.2001.0686
   Bareille R, 2000, BIOMATERIALS, V21, P1345, DOI 10.1016/S0142-9612(00)00015-6
   DACULSI G, 1990, BIOMATERIALS, V11, P86
   EGGLI PS, 1988, CLIN ORTHOP RELAT R, P127
   Gauthier O, 1998, BIOMATERIALS, V19, P133, DOI 10.1016/S0142-9612(97)00180-4
   Gierse H, 1999, ARCH ORTHOP TRAUM SU, V119, P349, DOI 10.1007/s004020050426
   Grimm J, 2001, ARCH ORTHOP TRAUM SU, V121, P158, DOI 10.1007/s004020000194
   Gunther KP, 1998, ORTHOPADE, V27, P105
   Hing KA, 2004, J BIOMED MATER RES A, V68A, P187, DOI 10.1002/jbm.a.10050
   Hing KA, 1999, J MATER SCI-MATER M, V10, P663, DOI 10.1023/A:1008900127475
   Hing KA, 1997, J MATER SCI-MATER M, V8, P731, DOI 10.1023/A:1018500309969
   Hing KA, 1999, J MATER SCI-MATER M, V10, P135, DOI 10.1023/A:1008929305897
   HOLMES R, 1984, CLIN ORTHOP RELAT R, P252
   Isaksson S, 1992, Swed Dent J Suppl, V84, P1
   Karageorgiou V, 2005, BIOMATERIALS, V26, P5474, DOI 10.1016/j.biomaterials.2005.02.002
   Kehr P, 2000, EUR J ORTHOP SURG TR, V10, P217
   Khodadadyan-Klostermann C, 2002, Acta Chir Orthop Traumatol Cech, V69, P16
   KLAWITTER JJ, 1976, J BIOMED MATER RES, V10, P311, DOI 10.1002/jbm.820100212
   KUHNE JH, 1994, ACTA ORTHOP SCAND, V65, P246, DOI 10.3109/17453679408995448
   Le Guehennec L, 2004, Eur Cell Mater, V8, P1
   Merkx MAW, 1999, BIOMATERIALS, V20, P2029, DOI 10.1016/S0142-9612(99)00105-2
   NAKAHARA H, 1992, CLIN ORTHOP RELAT R, P291
   Piattelli M, 1999, INT J ORAL MAX IMPL, V14, P835
   RENOOIJ W, 1985, CLIN ORTHOP RELAT R, P272
   Schnettler R, 2009, J BIOMED MATER RES B, V90B, P75, DOI 10.1002/jbm.b.31255
   Valentini P, 1998, CLIN ORAL IMPLAN RES, V9, P59, DOI 10.1034/j.1600-0501.1998.090108.x
   Werber KD, 2000, J HAND SURG-AM, V25A, P833, DOI 10.1053/jhsu.2000.16354
NR 27
TC 7
Z9 7
U1 0
U2 5
PU QUINTESSENCE PUBLISHING CO INC
PI HANOVER PARK
PA 4350 CHANDLER DRIVE, HANOVER PARK, IL 60133 USA
SN 0198-7569
J9 INT J PERIODONT REST
JI Int. J. Periodontics Restor. Dent.
PD JUN
PY 2012
VL 32
IS 3
BP 295
EP 301
PG 7
WC Dentistry, Oral Surgery & Medicine
SC Dentistry, Oral Surgery & Medicine
GA 966SC
UT WOS:000305856700006
PM 22408774
DA 2018-10-19
ER

PT J
AU Amini, F
   Rakhshan, V
   Pousti, M
   Rahimi, H
   Shariati, M
   Aghamohamadi, B
AF Amini, Fariborz
   Rakhshan, Vahid
   Pousti, Maryam
   Rahimi, Hajir
   Shariati, Mahsa
   Aghamohamadi, Bahareh
TI Variations in surface roughness of seven orthodontic archwires: an
   SEM-profilometry study
SO KOREAN JOURNAL OF ORTHODONTICS
LA English
DT Article
DE Physical property; Wire; Scanning electron microscopy; Biomaterial
   science
ID ORAL-MUCOSA CELLS; IN-VIVO; MECHANICAL-PROPERTIES; STAINLESS-STEEL; ION
   RELEASE; WIRES; APPLIANCES; CORROSION; RESISTANCE; SYSTEMS
AB Objective: The purpose of this study was to evaluate the surface roughness (SR) of 2 types of orthodontic archwires made by 4 different manufacturers. Methods: This in vitro experimental study was conducted on 35 specimens of 7 different orthodontic archwires, namely, 1 nickel-titanium (NiTi) archwire each from the manufacturers American Orthodontics, OrthoTechnology, All-Star Orthodontics, and Smart Technology, and 1 stainless steel (SS) archwire each from the manufacturers American Orthodontics, OrthoTechnology, and All-Star Orthodontics. After analyzing the composition of each wire by energy-dispersive X-ray analysis, the SR of each wire was determined by scanning electron microscopy (SEM) and surface profilometry. Data were analyzed using the Kruskal-Wallis and Mann-Whitney U tests (alpha < 0.05). Results: The average SR of NiTi wires manufactured by Smart Technology, American Orthodontics, OrthoTechnology, and All-Star Orthodontics were 1,289 +/- 915 A degrees, 1,378 +/- 372 A degrees, 2,444 +/- 369 A degrees, and 5,242 +/- 2,832 A degrees, respectively. The average SR of SS wires manufactured by All-Star Orthodontics, OrthoTechnology, and American Orthodontics were 710 +/- 210 A degrees, 1,831 +/- 1,156 A degrees, and 4,018 +/- 2,214 A', respectively. Similar to the results of profilometry, the SEM images showed more defects and cracks on the SS wire made by American Orthodontics and the NiTi wire made by All-Star Orthodontics than others. Conclusions: The NiTi wire manufactured by All-Star Orthodontics and the SS wire made by American Orthodontics were the roughest wires. [Korean J Orthod 2012;42(3):129-137]
C1 [Amini, Fariborz; Pousti, Maryam; Rahimi, Hajir; Shariati, Mahsa; Aghamohamadi, Bahareh] Islamic Azad Univ, Dept Orthodont & Dentofacial Orthoped, Dent Branch, Tehran 19465, Iran.
   [Rakhshan, Vahid] Islamic Azad Univ, Dept Dent Anat & Morphol, Dent Branch, Tehran 19465, Iran.
RP Amini, F (reprint author), Islamic Azad Univ, Dept Orthodont & Dentofacial Orthoped, Dent Branch, 4,10th Neyestan,Pasdaran Ave, Tehran 19465, Iran.
EM aminiorhod@yahoo.com
RI aghamohammadi, bahareh/H-2289-2018
CR Amini F, 2008, ORTHOD CRANIOFAC RES, V11, P51, DOI 10.1111/j.1601-6343.2008.00414.x
   Amini F, 2012, EUR J ORTHODONT, V34, P126, DOI 10.1093/ejo/cjq181
   Baccetti T, 2009, ANGLE ORTHOD, V79, P533, DOI 10.2319/050508-249.1
   BISHARA SE, 1995, AM J ORTHOD DENTOFAC, V108, P115, DOI 10.1016/S0889-5406(95)70073-0
   Bourauel C, 1998, EUR J ORTHODONT, V20, P79, DOI 10.1093/ejo/20.1.79
   BRANTLEY WA, 2001, ORTHODONTIC MAT SCI, P77
   Daems J, 2009, EUR J ORTHODONT, V31, P260, DOI 10.1093/ejo/cjn104
   Elayyan F, 2008, EUR J ORTHODONT, V30, P661, DOI 10.1093/ejo/cjn057
   Faccioni F, 2003, AM J ORTHOD DENTOFAC, V124, P687, DOI 10.1016/j.ajodo.2003.09.010
   Huang HH, 2007, DENT MATER, V23, P24, DOI 10.1016/j.dental.2005.11.042
   Huang HH, 2005, ANGLE ORTHOD, V75, P661
   JACKSON CM, 1972, NASA SP, V5110
   KAPILA S, 1989, AM J ORTHOD DENTOFAC, V96, P100, DOI 10.1016/0889-5406(89)90251-5
   Khosravanifard B, 2011, ORTHOD WAVES, V70, P27, DOI 10.1016/j.odw.2010.08.003
   KUSY RP, 1990, J BIOMECH, V23, P913, DOI 10.1016/0021-9290(90)90356-8
   KUSY RP, 1988, ANGLE ORTHOD, V58, P33
   Mohlin B, 1991, Eur J Orthod, V13, P386
   Neumann P, 2002, J MATER SCI-MATER M, V13, P141, DOI 10.1023/A:1013831011241
   OSHIDA Y, 1992, Bio-Medical Materials and Engineering, V2, P51
   Pernier C, 2005, EUR J ORTHODONT, V27, P72, DOI 10.1093/ejo/cjh076
   PROSOSKI RR, 1991, AM J ORTHOD DENTOFAC, V100, P341, DOI 10.1016/0889-5406(91)70072-5
   Rapiejko C, 2009, WEAR, V266, P850, DOI 10.1016/j.wear.2008.12.013
   Shin Ji-Soo, 2003, Aust Orthod J, V19, P13
   Staffolani N, 1999, J DENT, V27, P449, DOI 10.1016/S0300-5712(98)00073-6
   Verstrynge A, 2006, AM J ORTHOD DENTOFAC, V130, P460, DOI 10.1016/j.ajodo.2004.12.030
   Widu F, 1999, J MATER SCI-MATER M, V10, P275, DOI 10.1023/A:1008953412622
NR 26
TC 8
Z9 8
U1 1
U2 5
PU KOREAN ASSOC ORTHODONTISTS
PI SEOUL
PA 603 TRAPALACE II, 1327 SEOCHO-DONG, SEOCHO-GU, SEOUL, 137-070, SOUTH
   KOREA
SN 2234-7518
J9 KOREAN J ORTHOD
JI Korean J. Orthod.
PD JUN
PY 2012
VL 42
IS 3
BP 129
EP 137
DI 10.4041/kjod.2012.42.3.129
PG 9
WC Dentistry, Oral Surgery & Medicine
SC Dentistry, Oral Surgery & Medicine
GA 969JC
UT WOS:000306050500005
PM 23112943
OA Other Gold, Green Published
DA 2018-10-19
ER

PT J
AU Moreau, ALD
   Janissen, R
   Santos, CA
   Peroni, LA
   Stach-Machado, DR
   de Souza, AA
   de Souza, AP
   Cotta, MA
AF Moreau, Alberto L. D.
   Janissen, Richard
   Santos, Clelton A.
   Peroni, Luis A.
   Stach-Machado, Dagmar R.
   de Souza, Alessandra A.
   de Souza, Anete P.
   Cotta, Monica A.
TI Highly-sensitive and label-free indium phosphide biosensor for early
   phytopathogen diagnosis
SO BIOSENSORS & BIOELECTRONICS
LA English
DT Article
DE Immunosensor; Field-effect transistor; Chemical functionalization;
   Citrus Tristeza Virus; Xylella fastidiosa; Phytopathogen
ID AMINO PROPYL TRIETHOXYSILANE; E-GLASS SURFACE; INP; DNA; FILMS;
   IMMOBILIZATION; ALKANETHIOLS; ATTACHMENT; ANTIBODIES; PATHOGEN
AB The development of highly-sensitive and label-free operating semiconductor-based, biomaterial detecting sensors has important applications in areas such as environmental science, biomedical research and medical diagnostics. In the present study, we developed an Indium Phosphide (InP) semiconductor-based resistive biosensor using the change of its electronic properties upon biomaterial adsorption as sensing element. To detect biomaterial at low concentrations, the procedure of functionalization and covalent biomolecule immobilization was also optimized to guarantee high molecule density and high reproducibility which are prerequisite for reliable results. The characterization, such as biomolecular conjugation efficiency, detection concentration limits, recepton:ligand specificity and concentration detection range was analyzed by using three different biological systems: i) synthetic dsDNA and two phytopathogenic diseases, ii) the severe CB-form of Citrus Tristeza Virus (CIV) and iii) Xylella fastidiosa, both causing great economic loss worldwide. The experimental results show a sensitivity of 1 pM for specific ssDNA detection and about 2 nM for the specific detection of surface proteins of CTV and X fastidiosa phytopathogens. A brief comparison with other semiconductor based biosensors and other methodological approaches is discussed and confirms the high sensitivity and reproducibility of our InP based biosensor which could be suitable for reliable early infection diagnosis in environmental and life sciences. (C) 2012 Elsevier B.V. All rights reserved.
C1 [Moreau, Alberto L. D.; Janissen, Richard; Cotta, Monica A.] Univ Estadual Campinas, Inst Fis Gleb Wataghin, BR-13083859 Campinas, SP, Brazil.
   [Santos, Clelton A.; de Souza, Anete P.] Univ Estadual Campinas, Ctr Biol Mol & Engn Genet, BR-13083875 Campinas, SP, Brazil.
   [Peroni, Luis A.; Stach-Machado, Dagmar R.] Univ Estadual Campinas, Inst Biol, BR-13083862 Campinas, SP, Brazil.
   [de Souza, Alessandra A.] Inst Agron, Ctr APTA Citros Sylvio Moreira, BR-13469970 Cordeiropolis, SP, Brazil.
RP Moreau, ALD (reprint author), Univ Estadual Campinas, Inst Fis Gleb Wataghin, BR-13083859 Campinas, SP, Brazil.
EM amoreau@ifi.unicamp.br
RI Inst. of Physics, Gleb Wataghin/A-9780-2017; Bioetanol,
   Inct/I-1068-2013; Citros, Inct/I-2442-2013; Cotta, Monica/H-3505-2012;
   Santos, Clelton/I-2202-2012; 2, INCT/G-6506-2013; Janissen,
   Richard/I-5612-2014; de Souza, Anete/B-8663-2012
OI Santos, Clelton/0000-0002-6725-8925; Janissen,
   Richard/0000-0003-0901-3433; de Souza, Anete/0000-0003-3831-9829
FU FAPESP (Fundacao de Amparo a Pesquisa do Estado de Sao Paulo); CNPq
   (Conselho Nacional de Desenvolvimento Cientifico e Tecnologico); CNPq;
   FAPESP
FX This work was financially supported by FAPESP (Fundacao de Amparo a
   Pesquisa do Estado de Sao Paulo) and CNPq (Conselho Nacional de
   Desenvolvimento Cientifico e Tecnologico). A.L.D.M. and R.J. acknowledge
   scholarships from CNPq and FAPESP, respectively.
CR Albrecht C, 2003, SCIENCE, V301, P367, DOI 10.1126/science.1084713
   Blank K, 2003, P NATL ACAD SCI USA, V100, P11356, DOI 10.1073/pnas.1934928100
   Bortoleto JRR, 2002, SURF SCI, V515, P117, DOI 10.1016/S0039-6028(02)01822-8
   Chatterjee S, 2008, ANNU REV PHYTOPATHOL, V46, P243, DOI 10.1146/annurev.phyto.45.062806.094342
   Chattopadhyay S, 2009, CRIT REV SOLID STATE, V34, P224, DOI 10.1080/10408430903352082
   COTTA MA, 1995, APPL PHYS LETT, V66, P2358, DOI 10.1063/1.113982
   COTTA MA, 1995, APPL PHYS LETT, V67, P1122, DOI 10.1063/1.114981
   Draper NR, 1998, APPL REGRESSION ANAL
   Ebner A, 2007, ULTRAMICROSCOPY, V107, P922, DOI 10.1016/j.ultramic.2007.02.035
   Galup-Montoro C., 2007, MOSFET MODELING CIRC
   Goncalves D, 2008, BIOSENS BIOELECTRON, V24, P545, DOI 10.1016/j.bios.2008.05.006
   Hinterdorfer P, 2002, COLLOID SURFACE B, V23, P115, DOI 10.1016/S0927-7765(01)00256-9
   Jane A, 2009, TRENDS BIOTECHNOL, V27, P230, DOI 10.1016/j.tibtech.2008.12.004
   Janissen R, 2009, COLLOID SURFACE B, V71, P200, DOI 10.1016/j.colsurfb.2009.02.011
   Kamruzzahan ASM, 2006, BIOCONJUGATE CHEM, V17, P1473, DOI 10.1021/bc060252a
   Khoodoo MHR, 2005, EUR J PLANT PATHOL, V112, P379, DOI 10.1007/s10658-005-7062-z
   Kimura T, 2006, JPN J APPL PHYS 1, V45, P3414, DOI 10.1143/JJAP.45.3414
   Krautbauer R, 2003, NANO LETT, V3, P493, DOI 10.1021/nl034049p
   Lazcka O, 2007, BIOSENS BIOELECTRON, V22, P1205, DOI 10.1016/j.bios.2006.06.036
   Lei Y, 2005, ENVIRON SCI TECHNOL, V39, P8853, DOI 10.1021/es050720b
   Lenci S, 2010, MAT SCI ENG C-MATER, V30, P1221, DOI 10.1016/j.msec.2010.07.002
   Lindroos K, 2001, Nucleic Acids Res, V29, pE69, DOI 10.1093/nar/29.13.e69
   Logatcheva A, 2008, COLLOID SURFACE A, V315, P156, DOI 10.1016/j.colsurfa.2007.07.033
   Nicu L, 2008, J APPL PHYS, V104
   Park HH, 2007, J PHYS CHEM C, V111, P3710, DOI 10.1021/jp066109w
   Peroni LA, 2009, VIRUS RES, V145, P18, DOI 10.1016/j.virusres.2009.05.014
   Sato T., 2010, J ELECTROCHEMICAL SO, V157, P165
   Seker F, 2000, CHEM REV, V100, P2505, DOI 10.1021/cr980093r
   Sturzenegger M, 1999, J PHYS CHEM B, V103, P10838, DOI 10.1021/jp992290f
   Su LA, 2011, BIOSENS BIOELECTRON, V26, P1788, DOI 10.1016/j.bios.2010.09.005
   Sze S. M., 2007, PHYS SEMICONDUCTOR D
   Talazac L, 2001, SENSOR ACTUAT B-CHEM, V76, P258, DOI 10.1016/S0925-4005(01)00579-2
   VANDENBERG ET, 1991, J COLLOID INTERF SCI, V147, P103, DOI 10.1016/0021-9797(91)90139-Y
   Walsh MK, 2001, J BIOCHEM BIOPH METH, V47, P221, DOI 10.1016/S0165-022X(00)00146-9
   WANG D, 1992, J MATER SCI, V27, P36, DOI 10.1007/BF02403641
   WANG D, 1993, J MATER SCI, V28, P2481, DOI 10.1007/BF01151683
   Wierzbowska K, 2008, SENSOR ACTUAT A-PHYS, V142, P237, DOI 10.1016/j.sna.2007.02.021
   Xue QN, 2011, SENSOR ACTUAT A-PHYS, V169, P282, DOI 10.1016/j.sna.2011.01.017
   Yong-Mei X., 2007, J CHEM TECHNOLOGY BI, V82, P33
   Zerulla D, 2009, J ELECTRON SPECTROSC, V172, P78, DOI 10.1016/j.elspec.2009.03.017
NR 40
TC 7
Z9 7
U1 5
U2 39
PU ELSEVIER ADVANCED TECHNOLOGY
PI OXFORD
PA OXFORD FULFILLMENT CENTRE THE BOULEVARD, LANGFORD LANE, KIDLINGTON,
   OXFORD OX5 1GB, OXON, ENGLAND
SN 0956-5663
J9 BIOSENS BIOELECTRON
JI Biosens. Bioelectron.
PD JUN-JUL
PY 2012
VL 36
IS 1
BP 62
EP 68
DI 10.1016/j.bios.2012.03.038
PG 7
WC Biophysics; Biotechnology & Applied Microbiology; Chemistry, Analytical;
   Electrochemistry; Nanoscience & Nanotechnology
SC Biophysics; Biotechnology & Applied Microbiology; Chemistry;
   Electrochemistry; Science & Technology - Other Topics
GA 964BC
UT WOS:000305667700011
PM 22538056
DA 2018-10-19
ER

PT J
AU Solin, N
   Inganas, O
AF Solin, Niclas
   Inganas, Olle
TI Protein Nanofibrils Balance Colours in Organic White-Light-Emitting
   Diodes
SO ISRAEL JOURNAL OF CHEMISTRY
LA English
DT Review
DE proteins; self-assembly; organic light-emitting diodes; polymers;
   phosphorescence
ID AMYLOID FIBRILS; CONJUGATED POLYMERS; ENERGY-TRANSFER;
   ELECTROLUMINESCENT DEVICES; EXCITATION-ENERGY; HIGH-EFFICIENCY;
   EMISSION; COMPLEX; WATER; MECHANOCHEMISTRY
AB In this review we discuss our efforts in using protein nanowires (amyloid fibrils) as structural templates for use in organic electronics applications, mainly focusing on organic light-emitting diodes (OLEDs). We discuss different ways of functionalising amyloid fibrils. In one method, the amyloid fibril is used to organise luminescent polymers. We also discuss an alternative preparative method, resulting in amyloid-like materials functionalised with phosphorescent organometallic complexes. We discuss the incorporation of such materials in organic electronics devices, such as OLEDs. When amyloid fibrils are integrated into the OLED active layer, consisting of an electroluminescent blue-emitting polyfluorene, the efficiency of the device increases by a factor of 10. Furthermore, when amyloid fibrils incorporating phosphorescent metal complexes are used, the phosphorescent guest functions more efficiently than in the corresponding case where naked metal complexes are used. By preparing amyloid fibrils incorporating green- and red-emitting phosphorescent complexes, and combining these with blue-emitting polyfluorene, we can fabricate devices for white-light emission. The origin of the effects of the biomaterial on device performance is discussed.
C1 [Solin, Niclas; Inganas, Olle] Linkoping Univ, Dept Phys Chem & Biol IFM, SE-58183 Linkoping, Sweden.
RP Solin, N (reprint author), Linkoping Univ, Dept Phys Chem & Biol IFM, SE-58183 Linkoping, Sweden.
EM nicso@ifm.liu.se
RI Solin, Niclas/L-6639-2015
OI Inganas, Olle/0000-0002-6243-1450
FU Swedish Research Council (V.R.); Royal Swedish Academy of Science
   (K.V.A.); Knut and Alice Wallenberg foundation
FX We acknowledge funding from the Swedish Research Council (V.R.), and
   thank all co-workers, whose names appear in the references, for their
   contributions to the work described. Prof. Mats R. Andersson is
   acknowledged for supply of polymers. N. S. acknowledges funding from the
   Royal Swedish Academy of Science (K.V.A.). O. I. is a Wallenberg
   Scholar, and the Knut and Alice Wallenberg foundation is gratefully
   acknowledged for this grant and for instrument grants.
CR Baldo MA, 2000, NATURE, V403, P750
   Baldo MA, 1998, NATURE, V395, P151
   Barber J, 2009, CHEM SOC REV, V38, P185, DOI 10.1039/b802262n
   Barrau S, 2008, APPL PHYS LETT, V93, DOI 10.1063/1.2949073
   BERGGREN M, 1994, NATURE, V372, P444, DOI 10.1038/372444a0
   BERNANOSE A, 1955, BRIT J APPL PHYS, pS54, DOI 10.1088/0508-3443/6/S4/319
   Bettinger CJ, 2010, POLYM INT, V59, P563, DOI 10.1002/pi.2827
   Braga D, 2004, ANGEW CHEM INT EDIT, V43, P4002, DOI 10.1002/anie.200301721
   BRAUN D, 1991, APPL PHYS LETT, V58, P1982, DOI 10.1063/1.105039
   Burn PL, 2007, ADV MATER, V19, P1675, DOI 10.1002/adma.200601592
   BURROUGHES JH, 1990, NATURE, V347, P539, DOI 10.1038/347539a0
   Channon K, 2008, SOFT MATTER, V4, P647, DOI 10.1039/b713013a
   Channon KJ, 2008, J AM CHEM SOC, V130, P5487, DOI 10.1021/ja710310c
   Channon KJ, 2009, J AM CHEM SOC, V131, P12520, DOI 10.1021/ja902825j
   Chen YH, 2011, APPL PHYS LETT, V98, DOI 10.1063/1.3599557
   Cherny I, 2008, ANGEW CHEM INT EDIT, V47, P4062, DOI 10.1002/anie.200703133
   Chiti F, 2006, ANNU REV BIOCHEM, V75, P333, DOI 10.1146/annurev.biochem.75.101304.123901
   Dobson CM, 1999, TRENDS BIOCHEM SCI, V24, P329, DOI 10.1016/S0968-0004(99)01445-0
   Facchetti A, 2011, CHEM MATER, V23, P733, DOI 10.1021/cm102419z
   Fernandez-Bertran JF, 1999, PURE APPL CHEM, V71, P581, DOI 10.1351/pac199971040581
   Gao HF, 2010, NANO LETT, V10, P1440, DOI 10.1021/nl100347p
   Gilat SL, 1999, ANGEW CHEM INT EDIT, V38, P1422, DOI 10.1002/(SICI)1521-3773(19990517)38:10<1422::AID-ANIE1422>3.0.CO;2-V
   Gong X, 2003, ADV MATER, V15, P45, DOI 10.1002/adma.200390007
   Hagen JA, 2006, APPL PHYS LETT, V88, DOI 10.1063/1.2197973
   Hamedi M, 2008, NANO LETT, V8, P1736, DOI 10.1021/nl0808233
   Hamedi M, 2009, NANO LETT, V9, P631, DOI 10.1021/nl802919w
   Hatwar T.K., 2008, LUMINESCENT MAT APPL, P111
   Heeger AJ, 2010, CHEM SOC REV, V39, P2354, DOI 10.1039/b914956m
   Heimel G, 2011, CHEM MATER, V23, P359, DOI 10.1021/cm1021257
   Heldt CL, 2011, PROTEINS, V79, P92, DOI 10.1002/prot.22861
   HELFRICH W, 1965, PHYS REV LETT, V14, P229, DOI 10.1103/PhysRevLett.14.229
   Herland A, 2005, ADV MATER, V17, P1466, DOI 10.1002/adma.200500183
   Herland A, 2008, J MATER CHEM, V18, P126, DOI 10.1039/b712829k
   Herland A, 2007, SMALL, V3, P318, DOI 10.1002/smll.200600377
   Hilsum C, 2010, PHILOS T R SOC A, V368, P1027, DOI 10.1098/rsta.2009.0247
   Hoeben FJM, 2005, CHEM REV, V105, P1491, DOI 10.1021/cr030070z
   Inganas O, 2009, ACCOUNTS CHEM RES, V42, P1731, DOI 10.1021/ar900073s
   Irimia-Vladu M, 2011, J MATER CHEM, V21, P1350, DOI 10.1039/c0jm02444a
   James SL, 2012, CHEM SOC REV, V41, P413, DOI 10.1039/c1cs15171a
   Jansen R, 2005, BIOPHYS J, V88, P1344, DOI 10.1529/biophysj.104.048843
   Jiang CY, 2004, ADV MATER, V16, P537, DOI 10.1002/adma.200306331
   Karlsson RH, 2009, CHEM MATER, V21, P1815, DOI 10.1021/cm801512r
   Kelley TW, 2004, CHEM MATER, V16, P4413, DOI 10.1021/cm049614j
   Kim FS, 2011, CHEM MATER, V23, P682, DOI 10.1021/cm102772x
   Knowles TPJ, 2011, NAT NANOTECHNOL, V6, P469, DOI [10.1038/nnano.2011.102, 10.1038/NNANO.2011.102]
   Kobayashi N, 2001, J MATER CHEM, V11, P1766, DOI 10.1039/b102882k
   Krebs MRH, 2005, J STRUCT BIOL, V149, P30, DOI 10.1016/j.jsb.2004.08.002
   Kulkarni AP, 2003, MACROMOLECULES, V36, P5285, DOI 10.1021/ma0344700
   Laquai F, 2009, MACROMOL RAPID COMM, V30, P1203, DOI 10.1002/marc.200900309
   Leclere P, 2006, MAT SCI ENG R, V55, P1, DOI 10.1016/j.mser.2006.12.001
   Lindstrom UM, 2002, CHEM REV, V102, P2751, DOI 10.1021/cr010122p
   Luisi PL, 2006, EMERGENCE OF LIFE: FROM CHEMICAL ORIGINS TO SYNTHETIC BIOLOGY, P1
   Lv J, 2008, PURE APPL CHEM, V80, P639, DOI 10.1351/pac200880030639
   Ma DG, 2002, APPL PHYS LETT, V81, P2285, DOI 10.1063/1.1507826
   Mottier P., 2009, LEDS LIGHTING APPL
   Muller C, 2011, ADV MATER, V23, P898, DOI 10.1002/adma.201003601
   Nakamura E, 2011, NAT MATER, V10, P158, DOI 10.1038/nmat2969
   Nakamura K, 2010, APPL PHYS LETT, V97, DOI 10.1063/1.3512861
   PARTRIDGE RH, 1983, POLYMER, V24, P748, DOI 10.1016/0032-3861(83)90014-9
   Pron A, 2010, CHEM SOC REV, V39, P2577, DOI 10.1039/b907999h
   Rizzo A, 2010, NANO LETT, V10, P2225, DOI 10.1021/nl1012008
   Rizzo A, 2010, CHEM-EUR J, V16, P4190, DOI 10.1002/chem.201000146
   SARICIFTCI NS, 1992, SCIENCE, V258, P1474, DOI 10.1126/science.258.5087.1474
   Scheibel T, 2003, P NATL ACAD SCI USA, V100, P4527, DOI 10.1073/pnas.0431081100
   Schwartz G, 2009, ADV FUNCT MATER, V19, P1319, DOI 10.1002/adfm.200801503
   Serin JM, 2002, CHEM COMMUN, P2605, DOI 10.1039/b207905d
   Sipe JD, 2000, J STRUCT BIOL, V130, P88, DOI 10.1006/jsbi.2000.4221
   Spanggaard H, 2004, SOL ENERG MAT SOL C, V83, P125, DOI 10.1016/j.solmat.2004.02.021
   Steed J. W., 2009, SUPRAMOLECULAR CHEM
   Tanaka H, 2008, NANO LETT, V8, P2858, DOI 10.1021/nl801510z
   TANG CW, 1987, APPL PHYS LETT, V51, P913, DOI 10.1063/1.98799
   TANG CW, 1986, APPL PHYS LETT, V48, P183, DOI 10.1063/1.96937
   Wang Q, 2010, CHEM SOC REV, V39, P2387, DOI 10.1039/b909057f
   WAUGH DF, 1946, J AM CHEM SOC, V68, P247, DOI 10.1021/ja01206a030
   Weil T, 2002, ANGEW CHEM INT EDIT, V41, P1900, DOI 10.1002/1521-3773(20020603)41:11<1900::AID-ANIE1900>3.0.CO;2-8
   Weissermel K., 2003, IND ORGANIC CHEM
   Williamson A, 2011, PHOTOSYNTH RES, V107, P71, DOI 10.1007/s11120-010-9559-3
   Woolfson DN, 2010, CHEM SOC REV, V39, P3464, DOI 10.1039/c0cs00032a
   Zhao XG, 2011, CHEM SOC REV, V40, P3728, DOI 10.1039/c0cs00194e
   Zhuang DQ, 2010, MACROMOLECULES, V43, P8170, DOI 10.1021/ma100525k
NR 80
TC 13
Z9 13
U1 3
U2 62
PU WILEY-V C H VERLAG GMBH
PI WEINHEIM
PA POSTFACH 101161, 69451 WEINHEIM, GERMANY
SN 0021-2148
EI 1869-5868
J9 ISR J CHEM
JI Isr. J. Chem.
PD JUN
PY 2012
VL 52
IS 6
SI SI
BP 529
EP 539
DI 10.1002/ijch.201100113
PG 11
WC Chemistry, Multidisciplinary
SC Chemistry
GA 961ZS
UT WOS:000305509300006
DA 2018-10-19
ER

PT J
AU Lee, JS
   Cho, SW
AF Lee, Jung Seung
   Cho, Seung-Woo
TI Liver tissue engineering: Recent advances in the development of a
   bio-artificial liver
SO BIOTECHNOLOGY AND BIOPROCESS ENGINEERING
LA English
DT Review
DE liver tissue engineering; biomaterials; scaffolds; hepatocytes; stem
   cells; growth factor delivery
ID MESENCHYMAL STEM-CELLS; FIBROBLAST-GROWTH-FACTOR; BIODEGRADABLE POLYMER
   SCAFFOLD; ASSEMBLING PEPTIDE HYDROGEL; MARROW-DERIVED CELLS; FETAL
   LIVER; RAT-LIVER; IN-VIVO; HEPATOCYTE TRANSPLANTATION; ANGIOGENIC
   EFFICACY
AB Orthotopic liver transplantation is the most common treatment for patients with end-stage liver failure. However, liver transplantation is greatly limited by a donor shortage. Liver tissue engineering may offer a promising strategy to solve this problem by providing transplantable, bioartificial livers. Diverse types of cells, biomaterials, and growth factor delivery systems have been tested for efficient regeneration of liver tissues that possess hepatic functions comparable to native livers. This article reviews recent advances in liver tissue engineering and describes cell sources, biomaterial scaffolds, and growth factor delivery systems that are currently being used to improve the regenerative potential of tissue-engineered livers.
C1 [Lee, Jung Seung; Cho, Seung-Woo] Yonsei Univ, Dept Biotechnol, Seoul 120749, South Korea.
RP Lee, JS (reprint author), Yonsei Univ, Dept Biotechnol, Seoul 120749, South Korea.
EM seungwoocho@yonsei.ac.kr
FU National Research Foundation (NRF) of Korea, Republic of Korea
   [2010-0025982, 2010-0020409]
FX This work was supported by grants (2010-0025982 and 2010-0020409) funded
   by the National Research Foundation (NRF) of Korea, Republic of Korea.
CR Aurich H, 2009, GUT, V58, P570, DOI 10.1136/gut.2008.154880
   Aurich I, 2007, GUT, V56, P405, DOI 10.1136/gut.2005.090050
   Baptista PM, 2011, HEPATOLOGY, V53, P604, DOI 10.1002/hep.24067
   Basma H, 2009, GASTROENTEROLOGY, V136, P990, DOI 10.1053/j.gastro.2008.10.047
   Bhang SH, 2009, STEM CELLS, V27, P1976, DOI 10.1002/stem.115
   Cai J, 2007, HEPATOLOGY, V45, P1229, DOI 10.1002/hep.21582
   Chen AA, 2011, P NATL ACAD SCI USA, V108, P11842, DOI 10.1073/pnas.1101791108
   Cho SW, 2007, EUR J HEART FAIL, V9, P974, DOI 10.1016/j.ejheart.2007.06.012
   Cho SW, 2007, CELL TRANSPLANT, V16, P421, DOI 10.3727/000000007783464795
   Cho SW, 2006, J VASC SURG, V44, P1329, DOI 10.1016/j.jvs.2006.07.032
   Cho SW, 2006, TISSUE ENG, V12, P1651, DOI 10.1089/ten.2006.12.1651
   Cho SW, 2009, TISSUE ENG PT A, V15, P901, DOI 10.1089/ten.tea.2008.0172
   Cho SW, 2006, J BIOMED MATER RES A, V76A, P252, DOI 10.1002/jbm.a.30535
   Cho SW, 2005, ANN SURG, V241, P506, DOI 10.1097/01.sla.0000154268.12239.ed
   Cho SW, 2005, BIOMATERIALS, V26, P3577, DOI 10.1016/j.biomaterials.2004.09.013
   Dvir-Ginzberg M, 2003, TISSUE ENG, V9, P757, DOI 10.1089/107632703768247430
   Dvir-Ginzberg M, 2008, FASEB J, V22, P1440, DOI 10.1096/fj.07-9277com
   Espejel S, 2010, J CLIN INVEST, V120, P3120, DOI 10.1172/JCI43267
   Farzaneh Z, 2010, STEM CELL REV REP, V6, P601, DOI 10.1007/s12015-010-9179-5
   Feng ZQ, 2009, BIOMATERIALS, V30, P2753, DOI 10.1016/j.biomaterials.2009.01.053
   FROST SJ, 1990, BIOCHEMISTRY-US, V29, P10425, DOI 10.1021/bi00497a019
   Genove E, 2009, J CELL MOL MED, V13, P3387, DOI 10.1111/j.1582-4934.2009.00970.x
   HABIBULLAH CM, 1994, TRANSPLANTATION, V58, P951, DOI 10.1097/00007890-199410270-00016
   Hanna JH, 2010, CELL, V143, P508, DOI 10.1016/j.cell.2010.10.008
   Hashemi SM, 2009, CELLS TISSUES ORGANS, V190, P135, DOI 10.1159/000187716
   Hasirci V, 2001, TISSUE ENG, V7, P385, DOI 10.1089/10763270152436445
   Hawkins JA, 2003, J THORAC CARDIOV SUR, V126, P247, DOI 10.1016/S0022-5223(03)00116-8
   Hou YT, 2011, J BIOSCI BIOENG, V112, P265, DOI 10.1016/j.jbiosc.2011.05.003
   Hou YT, 2010, J BIOSCI BIOENG, V110, P208, DOI 10.1016/j.jbiosc.2010.01.016
   Huang HY, 2006, CELL TRANSPLANT, V15, P799, DOI 10.3727/000000006783981486
   Itle LJ, 2005, BIOTECHNOL PROGR, V21, P926, DOI 10.1021/bp049681i
   Jeon O, 2006, BIOMATERIALS, V27, P1598, DOI 10.1016/j.biomaterials.2005.08.030
   Jeon O, 2005, J CONTROL RELEASE, V105, P249, DOI 10.1016/j.jconrel.2005.03.023
   Katsuda T, 2010, J BIOCHEM, V148, P281, DOI 10.1093/jb/mvq063
   Kazemnejad S, 2009, J GASTROEN HEPATOL, V24, P278, DOI 10.1111/j.1440-1746.2008.05530.x
   Kedem A, 2005, TISSUE ENG, V11, P715, DOI 10.1089/ten.2005.11.715
   Khan AA, 2010, CELL TRANSPLANT, V19, P409, DOI 10.3727/096368910X498241
   Kim BS, 1998, TRENDS BIOTECHNOL, V16, P224, DOI 10.1016/S0167-7799(98)01191-3
   Kim M, 2010, BIOMATERIALS, V31, P3596, DOI 10.1016/j.biomaterials.2010.01.068
   Kim SS, 1998, ANN SURG, V228, P8, DOI 10.1097/00000658-199807000-00002
   Kisseleva T, 2010, CURR OPIN GASTROEN, V26, P395, DOI 10.1097/MOG.0b013e32833a6bec
   Kobayashi N, 2000, Hum Cell, V13, P7
   Lang R, 2011, BIOMATERIALS, V32, P7042, DOI 10.1016/j.biomaterials.2011.06.005
   Lee H, 2002, TRANSPLANTATION, V73, P1589, DOI 10.1097/00007890-200205270-00011
   Lee KY, 2001, CHEM REV, V101, P1869, DOI 10.1021/cr000108x
   Lee NK, 2009, BIOTECHNOL BIOPROC E, V14, P180, DOI 10.1007/s12257-008-0208-z
   LEMIRE JM, 1991, AM J PATHOL, V139, P535
   Li JL, 2003, BIOMATERIALS, V24, P2317, DOI 10.1016/S0142-9612(03)00048-6
   Li TZ, 2010, TISSUE ENG PT A, V16, P2649, DOI [10.1089/ten.tea.2009.0814, 10.1089/ten.TEA.2009.0814]
   Li TZ, 2008, BIOTECHNOL BIOPROC E, V13, P659, DOI 10.1007/s12257-008-0080-x
   Lin N, 2010, CELL PROLIFERAT, V43, P427, DOI 10.1111/j.1365-2184.2010.00692.x
   LIU H, 2011, SCI TRANSL MED, V3, P82
   Liu T, 2010, TISSUE ENG PT A, V16, P1115, DOI [10.1089/ten.tea.2009.0391, 10.1089/ten.TEA.2009.0391]
   LOBLEY GE, 1995, BRIT J NUTR, V73, P667, DOI 10.1079/BJN19950072
   LUNDQUIST F, 1962, J CLIN INVEST, V41, P955, DOI 10.1172/JCI104574
   Macchiarini P, 2008, LANCET, V372, P2023, DOI 10.1016/S0140-6736(08)61598-6
   Michalopoulos GK, 2010, AM J PATHOL, V176, P2, DOI 10.2353/ajpath.2010.090675
   MITO M, 1992, TRANSPLANT P, V24, P3052
   MOSHAGE HJ, 1987, J CLIN INVEST, V79, P1635, DOI 10.1172/JCI113000
   Oertel M, 2008, GASTROENTEROLOGY, V134, P823, DOI 10.1053/j.gastro.2008.01.007
   Ott HC, 2008, NAT MED, V14, P213, DOI 10.1038/nm1684
   Pi LY, 2005, GASTROENTEROLOGY, V128, P2077, DOI 10.1053/j.gastro.2005.03.081
   Piryaei A, 2011, STEM CELL REV REP, V7, P103, DOI 10.1007/s12015-010-9126-5
   Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143
   Sandhu JS, 2001, AM J PATHOL, V159, P1323, DOI 10.1016/S0002-9440(10)62519-9
   Schmidt CE, 2000, BIOMATERIALS, V21, P2215, DOI 10.1016/S0142-9612(00)00148-4
   SCHWANDER JC, 1983, ENDOCRINOLOGY, V113, P297, DOI 10.1210/endo-113-1-297
   Seo YK, 2010, BIOTECHNOL BIOPROC E, V15, P552, DOI 10.1007/s12257-009-3082-4
   Sgroi A, 2009, TRANSPLANTATION, V87, P457, DOI 10.1097/TP.0b013e3181963ad3
   Si-Tayeb K, 2010, HEPATOLOGY, V51, P297, DOI 10.1002/hep.23354
   Soto-Gutierrez A, 2011, TISSUE ENG PART C-ME, V17, P677, DOI 10.1089/ten.tec.2010.0698
   Stock P, 2010, NAT PROTOC, V5, P617, DOI 10.1038/nprot.2010.7
   Strom SC, 1997, TRANSPLANTATION, V63, P559, DOI 10.1097/00007890-199702270-00014
   Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019
   Tamura N, 2003, INT J ARTIF ORGANS, V26, P783
   Terry C, 2005, CELL TRANSPLANT, V14, P585, DOI 10.3727/000000005783982765
   Terry Claire, 2009, V481, P25, DOI 10.1007/978-1-59745-201-4_3
   Thomson JA, 1998, SCIENCE, V282, P1145, DOI 10.1126/science.282.5391.1145
   Tibbitt MW, 2009, BIOTECHNOL BIOENG, V103, P655, DOI 10.1002/bit.22361
   Underhill GH, 2007, BIOMATERIALS, V28, P256, DOI 10.1016/j.biomaterials.2006.08.043
   Uygun BE, 2010, NAT MED, V16, P814, DOI 10.1038/nm.2170
   Wang S, 2008, TISSUE ENG PT A, V14, P227, DOI 10.1089/tea.2007.0143
   Wang X, 2003, P NATL ACAD SCI USA, V100, P11881, DOI 10.1073/pnas.1734199100
   Wang YF, 2011, HEPATOLOGY, V53, P293, DOI 10.1002/hep.24012
   Yoo JJ, 1998, UROLOGY, V51, P221, DOI 10.1016/S0090-4295(97)00644-4
   Yovchev MI, 2008, HEPATOLOGY, V47, P636, DOI 10.1002/hep.22047
   Zavan B, 2005, BIOMATERIALS, V26, P7038, DOI 10.1016/j.biomaterials.2005.04.067
   Zhang WX, 2010, ADV DRUG DELIVER REV, V62, P814, DOI 10.1016/j.addr.2010.02.005
   Zheng XF, 2011, BIOTECHNOL BIOPROC E, V16, P593, DOI [10.1007/s12257-010-0348-9, 10.1007/S12257-010-0348-9]
NR 89
TC 7
Z9 7
U1 4
U2 68
PU KOREAN SOC BIOTECHNOLOGY & BIOENGINEERING
PI SEOUL
PA KOREAN SCIENCE TECHNOLOGY CENTER, #704 YEOGSAM-DONG, KANGNAM-KU, SEOUL
   135-703, SOUTH KOREA
SN 1226-8372
J9 BIOTECHNOL BIOPROC E
JI Biotechnol. Bioprocess Eng.
PD JUN
PY 2012
VL 17
IS 3
BP 427
EP 438
DI 10.1007/s12257-012-0047-9
PG 12
WC Biotechnology & Applied Microbiology
SC Biotechnology & Applied Microbiology
GA 953LK
UT WOS:000304868700001
DA 2018-10-19
ER

PT J
AU Kim, BS
   Choi, JS
   Kim, JD
   Choi, YC
   Cho, YW
AF Kim, Beob Soo
   Choi, Ji Suk
   Kim, Jae Dong
   Choi, Young Chan
   Cho, Yong Woo
TI Recellularization of decellularized human adipose-tissue-derived
   extracellular matrix sheets with other human cell types
SO CELL AND TISSUE RESEARCH
LA English
DT Article
DE Decellularization; Recellularization; Extracellular matrix; Adipose
   tissue; Tissue engineering
ID SMALL-INTESTINAL SUBMUCOSA; POLY(L-LACTIC ACID) FOAMS; IN-VITRO; DERMAL
   FIBROBLASTS; HEART-VALVES; SCAFFOLDS; BLADDER; GROWTH; BIOMATERIALS;
   REGENERATION
AB Decellularized human extracellular matrices (ECMs) are an extremely appealing biomaterial for tissue engineering and regenerative medicine. In this study, we decellularized human adipose tissue, fabricated a thin ECM sheet and explored the potential of this human adipose-derived ECM sheet as a substrate to support the formation of tissues other than adipose tissue. Acellular ECM sheets were fabricated from human adipose tissue through successive physical and chemical treatments: homogenization, centrifugation, casting, freeze-drying and sodium dodecyl sulfate treatment. The ECM sheets exhibited good mechanical properties, despite their porous structure. They degraded quickly in the presence of collagenase and the degradation rate increased with the collagenase concentration in phosphate-buffered saline. Five different human cell types, covering a broad range of cells and applications (normal human dermal fibroblasts, human aortic smooth muscle cells, human chondrocytes, human umbilical vein endothelial cells and human adipose-derived stem cells), were seeded onto the ECM sheets. All the human cell types spread well, proliferated and were successfully integrated into the decellularized ECM sheet. Overall, the results suggest that recellularized ECM sheets are a promising substitute for defective or damaged human tissues.
C1 [Kim, Beob Soo; Choi, Ji Suk; Kim, Jae Dong; Choi, Young Chan; Cho, Yong Woo] Hanyang Univ, Dept Chem Engn, Ansan 426791, Gyeonggi Do, South Korea.
   [Kim, Beob Soo; Choi, Ji Suk; Kim, Jae Dong; Choi, Young Chan; Cho, Yong Woo] Hanyang Univ, Dept Bionanotechnol, Ansan 426791, Gyeonggi Do, South Korea.
RP Cho, YW (reprint author), Hanyang Univ, Dept Chem Engn, 1271 Sa 3 Dong, Ansan 426791, Gyeonggi Do, South Korea.
EM ywcho7@hanyang.ac.kr
FU Basic Science Research Program [2009-0075546]; National Research
   Foundation of Korea (NRF) [2011-0019774]; Korean government (MEST);
   Business for Academic-Industrial Cooperative Establishments [00046001];
   Korea Small and Medium Business Administration
FX This work was supported by the Basic Science Research Program (grant no.
   2009-0075546) and the Bio & Medical Technology Development Program
   (grant no. 2011-0019774) of the National Research Foundation of Korea
   (NRF) funded by the Korean government (MEST). Our research (grant no.
   00046001) was also supported by Business for Academic-Industrial
   Cooperative Establishments funded by the Korea Small and Medium Business
   Administration in 2011.
CR Badylak SF, 2009, ACTA BIOMATER, V5, P1, DOI 10.1016/j.actbio.2008.09.013
   Beatty MW, 2002, TISSUE ENG, V8, P955, DOI 10.1089/107632702320934056
   Borschel GH, 2004, PLAST RECONSTR SURG, V113, P595, DOI 10.1097/01.PRS.0000101064.62289.2F
   Boyce ST, 2001, BURNS, V27, P523, DOI 10.1016/S0305-4179(01)00019-5
   Choi JS, 2010, TISSUE ENG PART C-ME, V16, P387, DOI [10.1089/ten.tec.2009.0276, 10.1089/ten.TEC.2009.0276]
   Choi JS, 2011, J BIOMED MATER RES A, V97A, P292, DOI 10.1002/jbm.a.33056
   Choi JS, 2009, J CONTROL RELEASE, V139, P2, DOI 10.1016/j.jconrel.2009.05.034
   Cimini M, 2005, J BIOMED MATER RES A, V75A, P895, DOI 10.1002/jbm.a.30493
   CUONO C, 1986, LANCET, V1, P1123
   Dahms SE, 1998, BRIT J UROL, V82, P411
   De Cock LJ, 2010, BIOMACROMOLECULES, V11, P1002, DOI 10.1021/bm9014649
   Du C, 1999, J BIOMED MATER RES, V44, P407, DOI 10.1002/(SICI)1097-4636(19990315)44:4<407::AID-JBM6>3.0.CO;2-T
   Ellis MJ, 2008, BIOTECHNOL BIOENG, V101, P369, DOI 10.1002/bit.21902
   Finne-Wistrand A, 2008, MACROMOL BIOSCI, V8, P951, DOI 10.1002/mabi.200700328
   Hashizume H, 2002, ARCH HISTOL CYTOL, V65, P347, DOI 10.1679/aohc.65.347
   Hutmacher DW, 2001, J BIOMAT SCI-POLYM E, V12, P107, DOI 10.1163/156856201744489
   Ingram JH, 2007, TISSUE ENG, V13, P1561, DOI 10.1089/ten.2006.0362
   Kim BS, 2010, J BIOMAT SCI-POLYM E, V21, P1701, DOI 10.1163/092050609X12548957288848
   Kuo YC, 2008, BIOMACROMOLECULES, V9, P2662, DOI 10.1021/bm800651r
   Kuroyanagi Y, 2001, ARTIF ORGANS, V25, P180, DOI 10.1046/j.1525-1594.2001.025003180.x
   Lo H, 1996, J BIOMED MATER RES, V30, P475, DOI 10.1002/(SICI)1097-4636(199604)30:4<475::AID-JBM5>3.0.CO;2-M
   Malcarney HL, 2005, AM J SPORT MED, V33, P907, DOI 10.1177/0363546504271500
   MIKOS AG, 1994, POLYMER, V35, P1068, DOI 10.1016/0032-3861(94)90953-9
   Mirsadraee S, 2006, TISSUE ENG, V12, P763, DOI 10.1089/ten.2006.12.763
   Misseri R, 2005, J UROLOGY, V174, P1680, DOI 10.1097/01.ju.0000176421.95997.6f
   MOHAN D, 1982, J BIOMECH, V15, P887, DOI 10.1016/0021-9290(82)90055-0
   Nishimura T, 2010, TISSUE ENG PT A, V16, P1761, DOI [10.1089/ten.tea.2009.0485, 10.1089/ten.TEA.2009.0485]
   Oiwa Y, 2004, NEUROL MED-CHIR, V44, P94, DOI 10.2176/nmc.44.94
   Piechota HJ, 1999, UROL RES, V27, P206, DOI 10.1007/s002400050111
   Place ES, 2009, NAT MATER, V8, P457, DOI [10.1038/NMAT2441, 10.1038/nmat2441]
   Rasad MSBA, 2010, CARBOHYD POLYM, V79, P1094, DOI 10.1016/j.carbpol.2009.10.048
   Schopka S, 2009, J BIOMED MATER RES B, V88B, P130, DOI 10.1002/jbm.b.31159
   Shoichet MS, 2010, MACROMOLECULES, V43, P581, DOI 10.1021/ma901530r
   Sodian R, 2000, ANN THORAC SURG, V70, P140, DOI 10.1016/S0003-4975(00)01255-8
   Tsukihara H, 2006, ANN THORAC SURG, V81, P650, DOI 10.1016/j.athoracsur.2005.07.022
   Tu QF, 2008, APPL SURF SCI, V255, P282, DOI 10.1016/j.apsusc.2008.06.161
   van Tienen TG, 2002, BIOMATERIALS, V23, P1731, DOI 10.1016/S0142-9612(01)00280-0
   Voytik-Harbin SL, 1998, TISSUE ENG, V4, P157, DOI 10.1089/ten.1998.4.157
   WAKE MC, 1994, CELL TRANSPLANT, V3, P339, DOI 10.1177/096368979400300411
   WHANG K, 1995, POLYMER, V36, P837, DOI 10.1016/0032-3861(95)93115-3
   White JK, 2005, ANN THORAC SURG, V80, P704, DOI 10.1016/j.athoracsur.2004.08.063
   Yokoya S, 2008, AM J SPORT MED, V36, P1298, DOI 10.1177/0363546508314416
   Zehr KJ, 2005, J THORAC CARDIOV SUR, V130, P1010, DOI 10.1016/j.jtcvs.2005.03.044
   Zhong SP, 2005, BIOMACROMOLECULES, V6, P2998, DOI 10.1021/bm050318p
NR 44
TC 28
Z9 31
U1 3
U2 28
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 0302-766X
J9 CELL TISSUE RES
JI Cell Tissue Res.
PD JUN
PY 2012
VL 348
IS 3
BP 559
EP 567
DI 10.1007/s00441-012-1391-y
PG 9
WC Cell Biology
SC Cell Biology
GA 952TE
UT WOS:000304814500018
PM 22447167
DA 2018-10-19
ER

PT J
AU Wang, YP
   He, YH
   Zhu, ZJ
   Jiang, Y
   Zhang, J
   Niu, JL
   Mao, L
   Yuan, GY
AF Wang YongPing
   He YaoHua
   Zhu ZhaoJin
   Jiang Yao
   Zhang Jian
   Niu JiaLin
   Mao Lin
   Yuan GuangYin
TI In vitro degradation and biocompatibility of Mg-Nd-Zn-Zr alloy
SO CHINESE SCIENCE BULLETIN
LA English
DT Article
DE magnesium alloy; degradation; biocompatibility; in vitro
ID BIODEGRADABLE MAGNESIUM SCAFFOLDS; BONE IMPLANT APPLICATION; CORROSION
   BEHAVIOR; BIOMATERIALS; METAL
AB In this study, in vitro degradation and biocompatibility of Mg-Nd-Zn-Zr (NZK) alloy were investigated to determine its suitability as a degradable medical biomaterial. Its corrosion properties were evaluated by static immersion test, electrochemical corrosion test, scanning electron microscopy (SEM), and energy dispersive spectroscopic (EDS) analysis, and in vitro biocompatibilities were assessed by hemolysis and cytotoxicity tests. Pure magnesium was used as control. The results of static immersion test and electrochemical corrosion test in simulated body fluid (SBF) demonstrated that the addition of alloying elements could improve the corrosion resistance. The hemolysis test found that the hemolysis rate of calcium phosphate coated NZK alloy was 4.8%, which was lower than the safe value of 5%. The cytotoxicity test indicated that NZK alloy extracts did not significantly reduce MC3T3-E-1 cell viability. Hemolysis test and cytotoxicity test display excellent hemocompatibility and cytocompatibility of NZK alloy in vitro. Our data indicate that NZK alloy has excellent biocompatibility and thus can be considered as a potential degradable medical biomaterial for orthopedic applications.
C1 [Wang YongPing; He YaoHua; Zhu ZhaoJin; Jiang Yao] Shanghai Jiao Tong Univ, Peoples Hosp 6, Dept Orthopaed, Shanghai 200233, Peoples R China.
   [Zhang Jian; Niu JiaLin; Mao Lin; Yuan GuangYin] Shanghai Jiao Tong Univ, Sch Mat Sci & Engn, Natl Engn Res Ctr Light Alloys Net Forming, Shanghai 200240, Peoples R China.
RP Jiang, Y (reprint author), Shanghai Jiao Tong Univ, Peoples Hosp 6, Dept Orthopaed, Shanghai 200233, Peoples R China.
EM jiangyao195106@163.com; gyyuan@sjtu.edu.cn
FU National Natural Science Foundation of China [81071452, 30772182]
FX This work was supported by the National Natural Science Foundation of
   China (81071452 and 30772182).
CR ASTM, 2004, ANN BOOK ASTM STAND
   Babkin V.M., 2004, MET SCI HEAT TREAT, V5, P543
   Gu XN, 2010, BIOMATERIALS, V31, P1093, DOI 10.1016/j.biomaterials.2009.11.015
   Gu XN, 2009, BIOMATERIALS, V30, P484, DOI 10.1016/j.biomaterials.2008.10.021
   He YH, 2009, CHINESE SCI BULL, V54, P484, DOI 10.1007/s11434-009-0080-z
   Huan ZG, 2010, J MATER SCI-MATER M, V21, P2623, DOI 10.1007/s10856-010-4111-8
   International Organization for Standardization (ISO), 2002, 10993 ISO
   ISO, 1999, 10993 ISO
   Lambotte A., 1932, B MEM SOC NAT CHIR, V28, P1325
   Levesque J, 2008, ACTA BIOMATER, V4, P284, DOI 10.1016/j.actbio.2007.09.012
   Li ZJ, 2008, BIOMATERIALS, V29, P1329, DOI 10.1016/j.biomaterials.2007.12.021
   McBride ED, 1938, J AMER MED ASSOC, V111, P2464, DOI 10.1001/jama.1938.02790530018007
   Rondelli G, 2005, BIOMATERIALS, V26, P739, DOI 10.1016/j.biomaterials.2004.03.012
   Song G.L., 2002, J LIGHT MET, V1, P1
   Staiger MP, 2006, BIOMATERIALS, V27, P1728, DOI 10.1016/j.biomaterials.2005.10.003
   Williams David, 2006, Med Device Technol, V17, P9
   Witte F, 2007, J BIOMED MATER RES A, V81A, P757, DOI 10.1002/jbm.a.31293
   Witte F, 2007, J BIOMED MATER RES A, V81A, P748, DOI 10.1002/jbm.a.31170
   Witte F, 2006, BIOMATERIALS, V27, P1013, DOI 10.1016/j.biomaterials.2005.07.037
   Witte F., 2005, BIOMATERIALS, V26, P3357
   Witte F, 2007, BIOMATERIALS, V28, P2163, DOI 10.1016/j.biomaterials.2006.12.027
   Witte F, 2010, ACTA BIOMATER, V6, P1680, DOI 10.1016/j.actbio.2010.02.028
   Witte F, 2008, CURR OPIN SOLID ST M, V12, P63, DOI 10.1016/j.cossms.2009.04.001
   Xin Y, 2011, ACTA BIOMATER, V7, P1452, DOI 10.1016/j.actbio.2010.12.004
   Xu LP, 2008, J MATER SCI-MATER M, V19, P1017, DOI 10.1007/s10856-007-3219-y
   Xu LP, 2007, J BIOMED MATER RES A, V83A, P703, DOI 10.1002/jbm.a.31273
   Xu LP, 2009, BIOMATERIALS, V30, P1512, DOI 10.1016/j.biomaterials.2008.12.001
   Yuan GY, PRC Patent, Patent No. [ZL 201010252357.0, 2010102523570]
   Zberg B, 2009, NAT MATER, V8, P887, DOI [10.1038/NMAT2542, 10.1038/nmat2542]
   Zhang SX, 2010, ACTA BIOMATER, V6, P626, DOI 10.1016/j.actbio.2009.06.028
NR 30
TC 12
Z9 14
U1 2
U2 44
PU SCIENCE PRESS
PI BEIJING
PA 16 DONGHUANGCHENGGEN NORTH ST, BEIJING 100717, PEOPLES R CHINA
SN 1001-6538
J9 CHINESE SCI BULL
JI Chin. Sci. Bull.
PD JUN
PY 2012
VL 57
IS 17
BP 2163
EP 2170
DI 10.1007/s11434-012-5066-6
PG 8
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA 953FU
UT WOS:000304853100017
OA Bronze
DA 2018-10-19
ER

PT J
AU Gregorutti, RW
   Grau, JE
   Elsner, CI
AF Gregorutti, R. W.
   Grau, J. E.
   Elsner, C. I.
TI Microstructural, mechanical and electrochemical characterisation of
   biomaterial ASTM F745 cast by vacuum
SO MATERIALS SCIENCE AND TECHNOLOGY
LA English
DT Article
DE Biomaterials; Austenitic steel; Vacuum casting; Mechanical properties;
   Corrosion
ID STEEL ORTHOPEDIC IMPLANT; PITTING CORROSION; FATIGUE
AB Countergravity low pressure casting (CLA) was performed to enhance the properties of ASTM F745 stainless steel (SS), which is usually used as biomaterial. The macro- and microstructures were compared with those obtained by the conventional process of investment casting (IC). The SS cast by CLA (SSCLA) exhibited a smaller size of solidification cell and finer dendritic microstructure. The average of its dendritic primary spacing was 110.4 mu m, while for the same steel cast by IC (SSIC), it was 186.7 mu m. The density of non-metallic inclusions delta(1) in the SSCLA was 717 I mm(-2), being the majority of them smaller than 1.5 mu m. In the case of SSIC, delta(1) was 852 I mm(-2), with a size distribution of up to 8 mu m. The SSCLA showed a higher breakdown potential than the SSIC, the values being 0.300 and 0.210 V(saturated calomel electrode) respectively, which means a higher resistance to suffer localised corrosion. Finely, the CLA process also allowed obtaining better mechanical properties.
C1 [Gregorutti, R. W.; Grau, J. E.] Lab Entrenamiento Multidisciplinario Invest Tecno, La Plata, Buenos Aires, Argentina.
   [Elsner, C. I.] Ctr Invest & Desarrollo Tecnol Pinturas CIDEPINT, La Plata, Buenos Aires, Argentina.
   [Elsner, C. I.] UNLP, Fac Ingn, La Plata, Buenos Aires, Argentina.
RP Gregorutti, RW (reprint author), Lab Entrenamiento Multidisciplinario Invest Tecno, Av 52 S-N,E-121 & 122,B1900AYB, La Plata, Buenos Aires, Argentina.
EM metalurgia@lemit.gov.ar
FU Comision de Investigaciones Cientificas de la Provincia de Buenos Aires
   (CICPBA); Consejo Nacional de Investigaciones Cientificas y Tecnicas
   (CONICET); Universidad Nacional de La Plata of Argentina
FX The authors thank the Comision de Investigaciones Cientificas de la
   Provincia de Buenos Aires (CICPBA), the Consejo Nacional de
   Investigaciones Cientificas y Tecnicas (CONICET) and the Universidad
   Nacional de La Plata of Argentina for the financial support to carry out
   the present research paper.
CR [Anonymous], 2007, F74507 ASTM INT, P302
   ASM International, 1988, MET HDB, V15, P696
   ASM International, 1988, MET HDB, V9, P141
   Brunski J. B., 2004, BIOMATERIALS SCI INT, P137
   Demian C, 2009, J OPTOELECTRON BIOME, V1, P172
   Flemings M. C., 1974, MAT SCI ENG SERIES, P146
   Ha HY, 2007, CORROS SCI, V49, P1266, DOI 10.1016/j.corsci.2006.08.017
   Kurz W., 1992, FUNDAMENTALS SOLIDIF, P63
   Manivasagam G., 2010, CORROS SCI, V2, P40
   Matsuura H, 2002, J NEUROSURG, V97, P1472, DOI 10.3171/jns.2002.97.6.1472
   Mudali UK, 2003, SADHANA-ACAD P ENG S, V28, P601
   Proverbio E., 2001, J FAIL ANAL PREV, V4, P33
   Sawyer-Glover M., 2000, J MAGN RESON IMAGING, V12, P92
   SIVAKUMAR M, 1995, J MATER SCI LETT, V14, P148, DOI 10.1007/BF00456573
   Sudhakar KV, 2005, ENG FAIL ANAL, V12, P249, DOI 10.1016/j.engfai;anal.2004.05.004
   Teoh SH, 2000, INT J FATIGUE, V22, P825, DOI 10.1016/S0142-1123(00)00052-9
   Zhang KM, 2006, SURF COAT TECH, V201, P1393, DOI 10.1016/j.surfcoat.2006.02.008
NR 17
TC 2
Z9 3
U1 1
U2 3
PU MANEY PUBLISHING
PI LEEDS
PA STE 1C, JOSEPHS WELL, HANOVER WALK, LEEDS LS3 1AB, W YORKS, ENGLAND
SN 0267-0836
J9 MATER SCI TECH-LOND
JI Mater. Sci. Technol.
PD JUN
PY 2012
VL 28
IS 6
BP 742
EP 747
DI 10.1179/1743284712Y.0000000003
PG 6
WC Materials Science, Multidisciplinary; Metallurgy & Metallurgical
   Engineering
SC Materials Science; Metallurgy & Metallurgical Engineering
GA 952WE
UT WOS:000304824100015
DA 2018-10-19
ER

PT J
AU Pavcnik, D
   Tekulve, K
   Uchida, BT
   Luo, ZH
   Jeromel, M
   Van Alstine, WG
   Keller, FS
   Rosch, J
AF Pavcnik, Dusan
   Tekulve, Kurt
   Uchida, Barry T.
   Luo, Zhong-Huo
   Jeromel, Miran
   Van Alstine, William G.
   Keller, Frederick S.
   Roesch, Josef
TI Double BioDisk: a new bioprosthetic device for transcatheter closure of
   atrial septal defects - a feasibility study in adult sheep
SO RADIOLOGY AND ONCOLOGY
LA English
DT Article
DE atrial septal defect; transcatheter closure; small intestinal submucosa;
   biomaterial; embolism; heart septal defects
ID BIOSTAR-DEVICE; MATRIX
AB Background. To evaluate the long-term effectiveness and safety of a new Double BioDisk (DBD) device for closure of atrial septal defect (ASD).
   Materials and methods. ASD was created with transeptal needle (TS) followed by balloon dilatation in 12 sheep weighing 40.1 to 64 kg (mean 55.2 +/- 7.1). The ASD diameters were measured after creation and two weeks later before DBD implantation. The DBDs consists of two nitinol rings 18 to 28 mm in diameter connected with small cannulas and covered with a porcine small intestinal submucosa (SIS). They were implanted via a 10 Fr sheath. DBD effectiveness was evaluated by angiocardiography and by intra-cardiac echogram (ICE) with Doppler studies. Two animals were acute, two were followed for 6 weeks, three for 3 months, three for 6 months and two for 12 months.
   Results. TS punctures were successful in 10 sheep. In two sheep ASD was created by existing PFO dilation. The ASD size ranged from 13-15 mm (mean 14.1 +/- 0.73 mm) after initial balloon dilation and from 9-13 mm (mean 10.06 +/- 1.37 mm) after two weeks. In all animals none of the successfully implanted DBDs spontaneously embolized on release or on follow up. ICE demonstrated no shunting around the DBDs during follows ups. Macroscopic and histologic evaluation of the 6, 12, 24 and 52 weeks animals showed that DBDs were well incorporated in the atrial septum with complete shunt closure. The SIS showed progressive remodeling with the host cells, including endothelization of the DBD devices.
   Conclusions. ASD closure with the Double BioDisk is safe and effective in adult sheep.
C1 [Pavcnik, Dusan; Uchida, Barry T.; Luo, Zhong-Huo; Jeromel, Miran; Keller, Frederick S.; Roesch, Josef] Oregon Hlth & Sci Univ, Dotter Intervent Inst, Portland, OR 97201 USA.
   [Tekulve, Kurt] Cook Med Inc, Bloomington, IN USA.
   [Van Alstine, William G.] Purdue Univ, Sch Vet Med, W Lafayette, IN 47907 USA.
   [Jeromel, Miran] Univ Clin Ctr, Inst Radiol, Ljubljana, Slovenia.
RP Pavcnik, D (reprint author), Oregon Hlth & Sci Univ, Dotter Intervent Inst, L342,3181 SW Sam Jackson Pk Rd, Portland, OR 97201 USA.
EM pavcnikd@ohsu.edu
FU Cook Medical; Cook Medical, Bloomington, Indiana
FX D.P. reports receiving research grants from Cook Medical. K. T. is Cook
   Medical employee. W. G. V. A. reports receiving consulting fees from
   Cook Medical.; This study was sponsored by Cook Medical, Bloomington,
   Indiana. The authors thank William E. Schoenlein and the team from
   Purdue University, West Lafayette, Indiana and Garry Pressler and the
   team from MED Institute, Inc., West Lafayette, Indiana for their
   assistance with the animal experiments and the histology. The authors
   thank Sheri Imai-Swiggart for her assistance.
CR Badylak SF, 2007, BIOMATERIALS, V28, P3587, DOI 10.1016/j.biomaterials.2007.04.043
   Hoehn R, 2010, CATHETER CARDIO INTE, V75, P72, DOI 10.1002/ccd.22233
   Jeromel P, 2010, RADIOL ONCOL, V44, P149
   Jux C, 2006, J AM COLL CARDIOL, V48, P161, DOI 10.1016/j.jacc.2006.02.057
   Kim Michael S, 2007, J Interv Cardiol, V20, P524, DOI 10.1111/j.1540-8183.2007.00304.x
   KING TD, 1974, SURGERY, V75, P383
   Kranokpiraksa P, 2010, RADIOL ONCOL, V44, P86, DOI 10.2478/v10019-010-0021-0
   Majunke Nicolas, 2007, J Interv Cardiol, V20, P517, DOI 10.1111/j.1540-8183.2007.00303.x
   Morgan G, 2010, CATHETER CARDIO INTE, V76, P241, DOI 10.1002/ccd.22517
   Mullen MJ, 2006, CIRCULATION, V114, P1962, DOI 10.1161/CIRCULATIONAHA.106.664672
   Narayanaswamy M, 2000, J VASC INTERV RADIOL, V11, P5, DOI 10.1016/S1051-0443(07)61271-8
   Ni RF, 2009, CARDIOVASC INTER RAD, V32, P313, DOI 10.1007/s00270-008-9426-1
   PAVCNIK D, 1993, CARDIOVASC INTER RAD, V16, P308, DOI 10.1007/BF02629163
   Pavcnik D, 2008, RADIOL ONCOL, V42, P59
   Pavcnik D, 2010, CATHETER CARDIO INTE, V75, P861, DOI 10.1002/ccd.22429
   Rao PS, 2003, CATHETER BASED DEVIC, P3
   Uchida BT, 2011, CARDIOVASC INTER RAD, V34, P620, DOI 10.1007/s00270-010-9948-1
NR 17
TC 2
Z9 2
U1 0
U2 4
PU ASSOC RADIOLOGY & ONCOLOGY
PI LJUBLJANA
PA INST ONCOLOGY, ZALOSKA CESTA 2, LJUBLJANA, 1000, SLOVENIA
SN 1318-2099
J9 RADIOL ONCOL
JI Radiol. Oncol.
PD JUN
PY 2012
VL 46
IS 2
BP 89
EP 96
DI 10.2478/v10019-012-0029-8
PG 8
WC Oncology; Radiology, Nuclear Medicine & Medical Imaging
SC Oncology; Radiology, Nuclear Medicine & Medical Imaging
GA 952CT
UT WOS:000304768200001
PM 23077444
OA DOAJ Gold, Green Published
DA 2018-10-19
ER

PT J
AU Cui, XF
   Breitenkamp, K
   Finn, MG
   Lotz, M
   D'Lima, DD
AF Cui, Xiaofeng
   Breitenkamp, Kurt
   Finn, M. G.
   Lotz, Martin
   D'Lima, Darryl D.
TI Direct Human Cartilage Repair Using Three-Dimensional Bioprinting
   Technology
SO TISSUE ENGINEERING PART A
LA English
DT Article
ID POLY(ETHYLENE GLYCOL) HYDROGELS; TISSUE-ENGINEERED CARTILAGE; HUMAN
   ARTICULAR-CARTILAGE; ZONAL ORGANIZATION; IN-VITRO; CHONDROCYTES; KNEE;
   PRINTHEAD; DEFECTS; CULTURE
AB Current cartilage tissue engineering strategies cannot as yet fabricate new tissue that is indistinguishable from native cartilage with respect to zonal organization, extracellular matrix composition, and mechanical properties. Integration of implants with surrounding native tissues is crucial for long-term stability and enhanced functionality. In this study, we developed a bioprinting system with simultaneous photopolymerization capable for three-dimensional (3D) cartilage tissue engineering. Poly(ethylene glycol) dimethacrylate (PEGDMA) with human chondrocytes were printed to repair defects in osteochondral plugs (3D biopaper) in layer-by-layer assembly. Compressive modulus of printed PEGDMA was 395.73+/-80.40 kPa, which was close to the range of the properties of native human articular cartilage. Printed human chondrocytes maintained the initially deposited positions due to simultaneous photopolymerization of surrounded biomaterial scaffold, which is ideal in precise cell distribution for anatomic cartilage engineering. Viability of printed human chondrocytes increased 26% in simultaneous polymerization than polymerized after printing. Printed cartilage implant attached firmly with surrounding tissue and greater proteoglycan deposition was observed at the interface of implant and native cartilage in Safranin-O staining. This is consistent with the enhanced interface failure strength during the culture assessed by push-out testing. Printed cartilage in 3D biopaper had elevated glycosaminoglycan (GAG) content comparing to that without biopaper when normalized to DNA. These observations were consistent with gene expression results. This study indicates the importance of direct cartilage repair and promising anatomic cartilage engineering using 3D bioprinting technology.
C1 [Cui, Xiaofeng; Lotz, Martin; D'Lima, Darryl D.] Scripps Res Inst, Dept Mol & Expt Med, La Jolla, CA 92037 USA.
   [Cui, Xiaofeng; D'Lima, Darryl D.] Scripps Clin, Shiley Ctr Orthopaed Res & Educ, La Jolla, CA 92037 USA.
   [Breitenkamp, Kurt; Finn, M. G.] Scripps Res Inst, Dept Chem, La Jolla, CA 92037 USA.
   [Breitenkamp, Kurt; Finn, M. G.] Scripps Res Inst, Skaggs Inst Chem Biol, La Jolla, CA 92037 USA.
RP D'Lima, DD (reprint author), Scripps Res Inst, Dept Mol & Expt Med, 10550 N Torrey Pines Rd, La Jolla, CA 92037 USA.
EM ddlima@scripps.edu
RI Cui, Xiaofeng/A-7208-2012
OI Cui, Xiaofeng/0000-0003-2761-3934; D'Lima, Darryl/0000-0002-8707-1455
FU NIH [AG007996]; CIRM [TR1-01216]; STSI [UL1 RR025774]; NSF [1011796]
FX The authors would like to acknowledge Melissa Szeto for harvesting human
   chondrocytes; Jonathan Netter and Nick Steklov for assisting with
   mechanical testing; William Hui, Margaret Chadwell, and Lilo Creighton
   for helping with histology; and Chien-Chi Lin, Shawn Grogan, Noboru
   Taniguchi, Stuart Duffy, Sujata Sovani, Chantal Pauli, Marissa Chen,
   Diana Brinson, and Olee Tsaiwei for constructive suggestions and other
   technical support. This work was funded by the NIH (AG007996), CIRM
   (TR1-01216), STSI (UL1 RR025774), and NSF (grant no. 1011796).
CR ARMSTRONG CG, 1982, J BONE JOINT SURG AM, V64, P88, DOI 10.2106/00004623-198264010-00013
   BENYA PD, 1978, CELL, V15, P1313, DOI 10.1016/0092-8674(78)90056-9
   BLANCO FJ, 1995, AM J PATHOL, V146, P75
   Boland Thomas, 2006, Biotechnology Journal, V1, P910, DOI 10.1002/biot.200600081
   BRITTBERG M, 1994, NEW ENGL J MED, V331, P889, DOI 10.1056/NEJM199410063311401
   Bryant SJ, 2000, J BIOMAT SCI-POLYM E, V11, P439, DOI 10.1163/156856200743805
   Bryant SJ, 2004, ANN BIOMED ENG, V32, P407, DOI 10.1023/B:ABME.0000017535.00602.ca
   Bryant SJ, 2002, J BIOMED MATER RES, V59, P63, DOI 10.1002/jbm.1217
   BUSKIRK WA, 1988, HEWLETT-PACKARD J, V39, P55
   Canfield B., 1997, U. S. Patent, Patent No. [5,673,069, 5673069]
   Cohen DL, 2010, BIOFABRICATION, V2, DOI 10.1088/1758-5082/2/3/035004
   Cui XF, 2010, BIOTECHNOL BIOENG, V106, P963, DOI 10.1002/bit.22762
   Cui XF, 2009, BIOMATERIALS, V30, P6221, DOI 10.1016/j.biomaterials.2009.07.056
   Deitch S., 2008, MATER RES SOC S P, V1094, P52
   Elisseeff J, 2000, J BIOMED MATER RES, V51, P164, DOI 10.1002/(SICI)1097-4636(200008)51:2<164::AID-JBM4>3.0.CO;2-W
   Elisseeff J, 1999, PLAST RECONSTR SURG, V104, P1014, DOI 10.1097/00006534-199909040-00017
   FARNDALE RW, 1986, BIOCHIM BIOPHYS ACTA, V883, P173, DOI 10.1016/0304-4165(86)90306-5
   HARMON JP, 1988, HEWLETT-PACKARD J, V39, P62
   Hock S. W., 1996, Patent No. [5,521,622, 5521622, US5521622]
   Hoenig E, 2011, TISSUE ENG PT A, V17, P1401, DOI [10.1089/ten.TEA.2010.0395, 10.1089/ten.tea.2010.0395]
   Hudson K. R., 2000, US Patent, Patent No. [6,042,211, 6042211]
   Hunziker EB, 2002, OSTEOARTHR CARTILAGE, V10, P432, DOI 10.1053/joca.2002.0801
   Hunziker EB, 2002, OSTEOARTHR CARTILAGE, V10, P564, DOI 10.1053/joca.2002.0814
   Kalson NS, 2010, INT J CLIN PRACT, V64, P1444, DOI 10.1111/j.1742-1241.2010.02420.x
   Kim TK, 2003, OSTEOARTHR CARTILAGE, V11, P653, DOI 10.1016/S1063-4584(03)00120-1
   Lin-Gibson S, 2004, BIOMACROMOLECULES, V5, P1280, DOI 10.1021/bm0498777
   MAIER R, 1993, J BIOL CHEM, V268, P21527
   Mohebi MM, 2002, J COMB CHEM, V4, P267, DOI 10.1021/cc010075e
   Mow V., 1997, BASIC ORTHOPAEDIC BI
   MUIR H, 1995, BIOESSAYS, V17, P1039, DOI 10.1002/bies.950171208
   Rasanen P, 2007, ACTA ORTHOP, V78, P108, DOI 10.1080/17453670610013501
   Schmitt B, 2003, DIFFERENTIATION, V71, P567, DOI 10.1111/j.1432-0436.2003.07109003.x
   SHAPIRO F, 1993, J BONE JOINT SURG AM, V75A, P532, DOI 10.2106/00004623-199304000-00009
   Sharma B, 2007, TISSUE ENG, V13, P405, DOI 10.1089/ten.2006.0068
   Tam HK, 2007, J ORTHOP RES, V25, P1136, DOI 10.1002/jor.20428
   Wang DA, 2007, NAT MATER, V6, P385, DOI 10.1038/nmat1890
   Xu T, 2006, BIOMATERIALS, V27, P3580, DOI 10.1016/j.biomaterials.2006.01.048
NR 37
TC 212
Z9 223
U1 18
U2 253
PU MARY ANN LIEBERT, INC
PI NEW ROCHELLE
PA 140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA
SN 1937-3341
J9 TISSUE ENG PT A
JI Tissue Eng. Part A
PD JUN
PY 2012
VL 18
IS 11-12
BP 1304
EP 1312
DI 10.1089/ten.tea.2011.0543
PG 9
WC Cell & Tissue Engineering; Biotechnology & Applied Microbiology; Cell
   Biology
SC Cell Biology; Biotechnology & Applied Microbiology
GA 952GK
UT WOS:000304779400020
PM 22394017
OA Green Published
DA 2018-10-19
ER

PT J
AU Santos, E
   Hernandez, RM
   Pedraz, JL
   Orive, G
AF Santos, Edorta
   Hernandez, Rosa M.
   Luis Pedraz, Jose
   Orive, Gorka
TI Novel advances in the design of three-dimensional bio-scaffolds to
   control cell fate: translation from 2D to 3D
SO TRENDS IN BIOTECHNOLOGY
LA English
DT Review
DE biomaterial; 3D scaffolds; cell encapsulation; artificial ECM; tissue
   engineering; regenerative medicine
ID PEPTIDE-AMPHIPHILE NANOFIBERS; EXTRACELLULAR-MATRIX;
   MECHANICAL-PROPERTIES; BIOACTIVE HYDROGELS; ALGINATE HYDROGELS; POLYMER
   SCAFFOLDS; PEG HYDROGELS; BIOMATERIALS; MICROENVIRONMENT; MINERALIZATION
AB Recreating the most critical aspects of the native extracellular matrix (ECM) is fundamental to understand and control the processes regulating cell fate and cell function. From the ill-defined complexity to the controlled simplicity, we discuss the different strategies that are being carried out by scientists worldwide to achieve the latest advances in the sophistication of three-dimensional (3D) scaffolds, stressing their impact on cell biology, tissue engineering and regenerative medicine. Synthetic and naturally derived polymers like polyethylene glycol, alginate, agarose, etc., together with micro- and nano-fabrication techniques are allowing the creation of 3D models where biophysical and biochemical variables can be modified with high precision, orthogonality and even in real-time.
C1 [Santos, Edorta; Hernandez, Rosa M.; Luis Pedraz, Jose; Orive, Gorka] Univ Basque Country, Sch Pharm, NanoBioCel Grp, Lab Pharmaceut, Vitoria, Spain.
   [Santos, Edorta; Hernandez, Rosa M.; Luis Pedraz, Jose; Orive, Gorka] Biomed Res Networking Ctr Bioengn Biomat & Nanome, Vitoria, Spain.
RP Orive, G (reprint author), Univ Basque Country, Sch Pharm, NanoBioCel Grp, Lab Pharmaceut, Vitoria, Spain.
EM gorka.orive@ehu.es
RI SANTOS VIZCAINO, EDORTA/L-2796-2017; Hernandez, Rosa Maria/S-6332-2017
OI SANTOS VIZCAINO, EDORTA/0000-0001-7064-4563; Hernandez, Rosa
   Maria/0000-0002-3947-409X; PEDRAZ MUNOZ, JOSE LUIS/0000-0002-3938-2267
FU Basque Government (Department of Education, Universities and Research)
FX E.S. thanks the Basque Government (Department of Education, Universities
   and Research) for the fellowship grant.
CR Aizawa Y, 2010, ADV MATER, V22, P4831, DOI 10.1002/adma.201001855
   Anderson SB, 2011, BIOMATERIALS, V32, P3564, DOI 10.1016/j.biomaterials.2011.01.064
   Ashe HL, 2006, DEVELOPMENT, V133, P385, DOI 10.1242/dev.02238
   Ayres CE, 2010, WIRES NANOMED NANOBI, V2, P20, DOI 10.1002/wnan.55
   Bauer AL, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000445
   Benoit DSW, 2008, NAT MATER, V7, P816, DOI 10.1038/nmat2269
   Bettinger CJ, 2009, ANGEW CHEM INT EDIT, V48, P5406, DOI 10.1002/anie.200805179
   Bhardwaj N, 2010, BIOTECHNOL ADV, V28, P325, DOI 10.1016/j.biotechadv.2010.01.004
   Bian LM, 2011, BIOMATERIALS, V32, P6425, DOI 10.1016/j.biomaterials.2011.05.033
   Bongio M, 2011, Eur Cell Mater, V22, P359
   Bryant SJ, 2004, BIOTECHNOL BIOENG, V86, P747, DOI 10.1002/bit.20160
   Bryant SJ, 2003, J BIOMED MATER RES A, V64A, P70, DOI 10.1002/jbm.a.10319
   Chan G, 2008, TRENDS BIOTECHNOL, V26, P382, DOI 10.1016/j.tibtech.2008.03.011
   Choi NW, 2007, NAT MATER, V6, P908, DOI 10.1038/nmat2022
   Cohen ED, 2009, J CLIN INVEST, V119, P2538, DOI 10.1172/JCI38079
   Comisar WA, 2007, BIOMATERIALS, V28, P4409, DOI 10.1016/j.biomaterials.2007.06.018
   Cukierman E, 2010, SEMIN CANCER BIOL, V20, P139, DOI 10.1016/j.semcancer.2010.04.004
   David F.W., 2011, BIOMATERIALS, V32, P4195
   DeForest CA, 2011, NAT CHEM, V3, P925, DOI [10.1038/nchem.1174, 10.1038/NCHEM.1174]
   DeForest CA, 2009, NAT MATER, V8, P659, DOI [10.1038/NMAT2473, 10.1038/nmat2473]
   Discher DE, 2009, SCIENCE, V324, P1673, DOI 10.1126/science.1171643
   Dong B, 2009, SMALL, V5, P1508, DOI 10.1002/smll.200801750
   Dvir T, 2011, NAT NANOTECHNOL, V6, P13, DOI [10.1038/nnano.2010.246, 10.1038/NNANO.2010.246]
   Engler AJ, 2006, CELL, V126, P677, DOI 10.1016/j.cell.2006.06.044
   Fisher OZ, 2010, ACCOUNTS CHEM RES, V43, P419, DOI 10.1021/ar900226q
   Freeman I, 2008, BIOMATERIALS, V29, P3260, DOI 10.1016/j.biomaterials.2008.04.025
   Friedland JC, 2009, SCIENCE, V323, P642, DOI 10.1126/science.1168441
   Gelain F, 2007, MACROMOL BIOSCI, V7, P544, DOI 10.1002/mabi.200700033
   Griffith LG, 2006, NAT REV MOL CELL BIO, V7, P211, DOI 10.1038/nrm1858
   Guilak F, 2009, CELL STEM CELL, V5, P17, DOI 10.1016/j.stem.2009.06.016
   Hartgerink JD, 2001, SCIENCE, V294, P1684, DOI 10.1126/science.1063187
   Heino J, 2009, CURR PHARM DESIGN, V15, P1309, DOI 10.2174/138161209787846720
   Huebsch N, 2010, NAT MATER, V9, P518, DOI [10.1038/NMAT2732, 10.1038/nmat2732]
   Huebsch N, 2009, NATURE, V462, P426, DOI 10.1038/nature08601
   Hutmacher DW, 2010, TRENDS BIOTECHNOL, V28, P125, DOI 10.1016/j.tibtech.2009.12.001
   Ionescu LC, 2010, BIOMATERIALS, V31, P4113, DOI 10.1016/j.biomaterials.2010.01.098
   Isenberg BC, 2009, BIOPHYS J, V97, P1313, DOI 10.1016/j.bpj.2009.06.021
   Jeon O, 2012, BIOMATERIALS, V33, P3503, DOI 10.1016/j.biomaterials.2012.01.041
   Keskar V, 2009, TISSUE ENG PT A, V15, P1695, DOI 10.1089/ten.tea.2008.0238
   Kim H, 2012, TRENDS BIOTECHNOL, V30, P55, DOI 10.1016/j.tibtech.2011.07.002
   Kloxin AM, 2010, ADV MATER, V22, P3484, DOI 10.1002/adma.200904179
   Kloxin AM, 2010, ADV MATER, V22, P61, DOI 10.1002/adma.200900917
   Kloxin AM, 2010, BIOMATERIALS, V31, P1, DOI 10.1016/j.biomaterials.2009.09.025
   Kloxin AM, 2009, SCIENCE, V324, P59, DOI 10.1126/science.1169494
   Kolambkar YM, 2011, BONE, V49, P485, DOI 10.1016/j.bone.2011.05.010
   Kolambkar YM, 2011, BIOMATERIALS, V32, P65, DOI 10.1016/j.biomaterials.2010.08.074
   Kong HJ, 2007, NAT REV DRUG DISCOV, V6, P455, DOI 10.1038/nrd2309
   Kshitiz, 2011, TRENDS BIOTECHNOL, V29, P399, DOI 10.1016/j.tibtech.2011.03.006
   Lee KY, 2012, PROG POLYM SCI, V37, P106, DOI 10.1016/j.progpolymsci.2011.06.003
   Lee SC, 2012, P NATL ACAD SCI USA, V109, P3299, DOI 10.1073/pnas.1113193109
   Lee SH, 2008, BIOMATERIALS, V29, P2962, DOI 10.1016/j.biomaterials.2008.04.004
   Lee W, 2010, P NATL ACAD SCI USA, V107, P20709, DOI 10.1073/pnas.1005211107
   Levental KR, 2009, CELL, V139, P891, DOI 10.1016/j.cell.2009.10.027
   Lin CC, 2011, P NATL ACAD SCI USA, V108, P6380, DOI 10.1073/pnas.1014026108
   Lo CM, 2000, BIOPHYS J, V79, P144, DOI 10.1016/S0006-3495(00)76279-5
   Lutolf MP, 2009, NATURE, V462, P433, DOI 10.1038/nature08602
   Lutolf MP, 2009, NAT MATER, V8, P451, DOI 10.1038/nmat2458
   Lutolf MP, 2009, INTEGR BIOL, V1, P235, DOI 10.1039/b902243k
   Mei Y, 2010, BIOMATERIALS, V31, P8989, DOI 10.1016/j.biomaterials.2010.08.029
   Metters AT, 2000, POLYMER, V41, P3993, DOI 10.1016/S0032-3861(99)00629-1
   Moon JJ, 2010, BIOMATERIALS, V31, P3840, DOI 10.1016/j.biomaterials.2010.01.104
   Mooney DJ, 2008, CELL STEM CELL, V2, P205, DOI 10.1016/j.stem.2008.02.005
   Nuttelman CR, 2006, ADV EXP MED BIOL, V585, P135
   Odedra D, 2011, ACTA BIOMATER, V7, P3027, DOI 10.1016/j.actbio.2011.05.002
   Orive G, 2009, J CONTROL RELEASE, V135, P203, DOI 10.1016/j.jconrel.2009.01.005
   Patterson J, 2010, BIOMATERIALS, V31, P6772, DOI 10.1016/j.biomaterials.2010.05.047
   Peters A, 2009, TISSUE ENG PART B-RE, V15, P225, DOI [10.1089/ten.teb.2009.0049, 10.1089/ten.TEB.2009.0049]
   Place ES, 2009, NAT MATER, V8, P457, DOI [10.1038/NMAT2441, 10.1038/nmat2441]
   Rexeisen EL, 2010, LANGMUIR, V26, P1953, DOI 10.1021/la902571q
   Riddle K.W., 2004, FOCUS BIOTECHNOLOG A, V8A, P1
   Rozario T, 2010, DEV BIOL, V341, P126, DOI 10.1016/j.ydbio.2009.10.026
   Salinas CN, 2008, MACROMOLECULES, V41, P6019, DOI 10.1021/ma800621h
   Sands RW, 2007, CURR OPIN BIOTECH, V18, P448, DOI 10.1016/j.copbio.2007.10.004
   Shah RN, 2010, P NATL ACAD SCI USA, V107, P3293, DOI 10.1073/pnas.0906501107
   Shen YH, 2008, ACTA BIOMATER, V4, P477, DOI 10.1016/j.actbio.2007.12.011
   Shoichet MS, 2010, MACROMOLECULES, V43, P581, DOI 10.1021/ma901530r
   Silva GA, 2004, SCIENCE, V303, P1352, DOI 10.1126/science.1093783
   Stachowiak AN, 2005, ADV MATER, V17, P399, DOI 10.1002/adma.200400507
   Sun QH, 2010, PHARM RES-DORD, V27, P264, DOI 10.1007/s11095-009-0014-0
   Sur S, 2012, BIOMATERIALS, V33, P545, DOI 10.1016/j.biomaterials.2011.09.093
   Tayalia P, 2008, ADV MATER, V20, P4494, DOI 10.1002/adma.200801319
   Thierry D., 2012, CARBOHYD POLYM, V87, P1013
   Tibbitt MW, 2009, BIOTECHNOL BIOENG, V103, P655, DOI 10.1002/bit.22361
   Toh WS, 2012, BIOMATERIALS, V33, P3835, DOI 10.1016/j.biomaterials.2012.01.065
   Webber MJ, 2011, P NATL ACAD SCI USA, V108, P13438, DOI 10.1073/pnas.1016546108
   Wosnick JH, 2008, CHEM MATER, V20, P55, DOI 10.1021/cm071158m
   Wylie RG, 2011, NAT MATER, V10, P799, DOI [10.1038/nmat3101, 10.1038/NMAT3101]
   Wylie RG, 2011, BIOMACROMOLECULES, V12, P3789, DOI 10.1021/bm201037j
   Zhang SG, 2003, NAT BIOTECHNOL, V21, P1171, DOI 10.1038/nbt874
   Zhou XM, 2008, GENE DEV, V22, P1231, DOI 10.1101/gad.1643308
NR 90
TC 67
Z9 69
U1 1
U2 100
PU ELSEVIER SCIENCE LONDON
PI LONDON
PA 84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND
SN 0167-7799
J9 TRENDS BIOTECHNOL
JI Trends Biotechnol.
PD JUN
PY 2012
VL 30
IS 6
BP 331
EP 341
DI 10.1016/j.tibtech.2012.03.005
PG 11
WC Biotechnology & Applied Microbiology
SC Biotechnology & Applied Microbiology
GA 953FG
UT WOS:000304851700005
PM 22560988
DA 2018-10-19
ER

PT J
AU Kim, HN
   Kang, DH
   Kim, MS
   Jiao, A
   Kim, DH
   Suh, KY
AF Kim, Hong Nam
   Kang, Do-Hyun
   Kim, Min Sung
   Jiao, Alex
   Kim, Deok-Ho
   Suh, Kahp-Yang
TI Patterning Methods for Polymers in Cell and Tissue Engineering
SO ANNALS OF BIOMEDICAL ENGINEERING
LA English
DT Article
DE Patterning; Biocompatible polymers; Topography; Rigidity;
   Cell-biomaterial interface
ID EMBRYONIC STEM-CELLS; CONDUCTING-POLYMER; SOFT LITHOGRAPHY;
   ELASTIC-MODULUS; HYDROGEL MICROSTRUCTURES; NANOIMPRINT LITHOGRAPHY;
   MECHANICAL-PROPERTIES; POLYETHYLENE-GLYCOL; YOUNGS MODULUS; IN-VIVO
AB Polymers provide a versatile platform for mimicking various aspects of physiological extracellular matrix properties such as chemical composition, rigidity, and topography for use in cell and tissue engineering applications. In this review, we provide a brief overview of patterning methods of various polymers with a particular focus on biocompatibility and processability. The materials highlighted here are widely used polymers including thermally curable polydimethyl siloxane, ultraviolet-curable polyurethane acrylate and polyethylene glycol, thermo-sensitive poly(N-isopropylacrylamide) and thermoplastic and conductive polymers. We also discuss how micro- and nanofabricated polymeric substrates of tunable elastic modulus can be used to engineer cell and tissue structure and function. Such synergistic effect of topography and rigidity of polymers may be able to contribute to constructing more physiologically relevant microenvironment.
C1 [Kim, Hong Nam; Kang, Do-Hyun; Kim, Min Sung; Suh, Kahp-Yang] Seoul Natl Univ, Sch Mech & Aerosp Engn, Seoul 151742, South Korea.
   [Jiao, Alex; Kim, Deok-Ho] Univ Washington, Dept Bioengn, Seattle, WA 98195 USA.
RP Suh, KY (reprint author), Seoul Natl Univ, Sch Mech & Aerosp Engn, Seoul 151742, South Korea.
EM sky4u@snu.ac.kr
OI Kim, Deok-Ho/0000-0002-6989-6074
FU National Research Foundation; Korean Government [NRF-2011-220-D00035];
   WCU (World Class University) [R31-2008-000-10083-0]; Basic Science
   Research Program [2010-0027955]; Department of Bioengineering at the
   University of Washington; Perkins Coie Award for Discovery; NIH
   [T32-EB001650-07]
FX This work was supported by National Research Foundation Grant funded by
   the Korean Government (NRF-2011-220-D00035), WCU (World Class
   University) program (R31-2008-000-10083-0) and Basic Science Research
   Program (2010-0027955). D. H. Kim thanks Department of Bioengineering at
   the University of Washington for the new faculty startup fund. D. H. Kim
   is also supported by a Perkins Coie Award for Discovery. A. Jiao was
   supported by NIH training Grant T32-EB001650-07.
CR Abe H., 1996, DATA BOOK MECH PROPE
   AGRAWAL CM, 1992, BIOMATERIALS, V13, P176, DOI 10.1016/0142-9612(92)90068-Y
   Almany L, 2005, BIOMATERIALS, V26, P2467, DOI 10.1016/j.biomaterials.2004.06.047
   [Anonymous], NORL PROD CORP DAT
   Armani D, 1999, PROC IEEE MICR ELECT, P222, DOI 10.1109/MEMSYS.1999.746817
   Ashby MF, 2011, MAT SELECTION MECH D
   ASM International, 2009, MAT COAT MED DEV CAR
   Bean BP, 2007, NAT REV NEUROSCI, V8, P451, DOI 10.1038/nrn2148
   Beaupre GS, 2000, J REHABIL RES DEV, V37, P145
   Belanger MC, 2001, J BIOMED MATER RES, V58, P467, DOI 10.1002/jbm.1043
   Bikram M, 2007, ANN BIOMED ENG, V35, P796, DOI 10.1007/s10439-007-9263-4
   Bratlie KM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010032
   Camelliti P, 2005, CARDIOVASC RES, V65, P40, DOI 10.1016/j.cardiores.2004.08.020
   Campbell BH, 2003, J BIOMECH, V36, P137, DOI 10.1016/S0021-9290(02)00325-1
   Chandra D, 2008, SOFT MATTER, V4, P979, DOI 10.1039/b717711a
   Chen CC, 2009, MATER LETT, V63, P1872, DOI 10.1016/j.matlet.2009.05.073
   Choi KM, 2003, J AM CHEM SOC, V125, P4060, DOI 10.1021/ja029973k
   Choi SJ, 2011, J MATER CHEM, V21, P14325, DOI 10.1039/c1jm12201k
   Choi SJ, 2004, J AM CHEM SOC, V126, P7744, DOI 10.1021/ja048972k
   Collier JH, 2000, J BIOMED MATER RES, V50, P574, DOI 10.1002/(SICI)1097-4636(20000615)50:4<574::AID-JBM13>3.0.CO;2-I
   Cooperstein MA, 2010, LANGMUIR, V26, P7695, DOI 10.1021/la902587p
   Cui XY, 2003, SENSOR ACTUAT B-CHEM, V89, P92, DOI 10.1016/S0925-4005(02)00448-3
   Dal Zilio S, 2009, MICROELECTRON ENG, V86, P1150, DOI 10.1016/j.mee.2009.02.006
   Dalby MJ, 2007, NAT MATER, V6, P997, DOI 10.1038/nmat2013
   Dolatshahi-Pirouz Alireza, 2011, J Funct Biomater, V2, P88, DOI 10.3390/jfb2030088
   Domke J, 1998, LANGMUIR, V14, P3320, DOI 10.1021/la9713006
   Dong B, 2006, ADV FUNCT MATER, V16, P1937, DOI 10.1002/adfm.200600225
   Emelianov SY, 1998, ULTRASON, P1753, DOI 10.1109/ULTSYM.1998.765288
   Engler AJ, 2006, CELL, V126, P677, DOI 10.1016/j.cell.2006.06.044
   Fisher OZ, 2010, ACCOUNTS CHEM RES, V43, P419, DOI 10.1021/ar900226q
   Flanagan LA, 2002, NEUROREPORT, V13, P2411, DOI 10.1097/01.wnr.0000048003.96487.97
   FREED LE, 1994, BIO-TECHNOL, V12, P689, DOI 10.1038/nbt0794-689
   Fu JP, 2010, NAT METHODS, V7, P733, DOI 10.1038/nmeth.1487
   Gajendran P, 2008, PURE APPL CHEM, V80, P2377, DOI 10.1351/pac200880112377
   Gates BD, 2004, ANNU REV MATER RES, V34, P339, DOI 10.1146/annurev.matsci.34.052803.091100
   Gefen A, 2004, J BIOMECH, V37, P1339, DOI 10.1016/j.jbiomech.2003.12.032
   Genzer J, 2006, SOFT MATTER, V2, P310, DOI 10.1039/b516741h
   GHISTA DN, 1975, MED BIOL ENG, V13, P151, DOI 10.1007/BF02477722
   Gilmore KJ, 2009, BIOMATERIALS, V30, P5292, DOI 10.1016/j.biomaterials.2009.06.059
   Goldenberg LM, 2010, J OPTICS-UK, V12, DOI 10.1088/2040-8978/12/1/015103
   Gordan OD, 2008, LANGMUIR, V24, P6636, DOI 10.1021/la800728x
   Green RA, 2008, BIOMATERIALS, V29, P3393, DOI 10.1016/j.biomaterials.2008.04.047
   Greiner A, 2007, ANGEW CHEM INT EDIT, V46, P5670, DOI 10.1002/anie.200604646
   Gunatillake Pathiraja A., 2003, European Cells & Materials, V5, P1
   Guo LJ, 2007, ADV MATER, V19, P495, DOI 10.1002/adma.200600882
   Hahn MS, 2006, BIOMATERIALS, V27, P2519, DOI 10.1016/j.biomaterials.2005.11.045
   Hall TJ, 1997, IEEE T ULTRASON FERR, V44, P1355, DOI 10.1109/58.656639
   Heo YJ, 2011, P NATL ACAD SCI USA, V108, P13399, DOI 10.1073/pnas.1104954108
   Hirose M, 2000, BIOMACROMOLECULES, V1, P377, DOI 10.1021/bm0002961
   Hsiue GH, 2003, BIOMATERIALS, V24, P2423, DOI 10.1016/S0142-9612(03)00035-8
   Huang CY, 2009, SMALL, V5, P583, DOI 10.1002/smll.200801197
   Huh D, 2007, NAT MATER, V6, P424, DOI 10.1038/nmat1907
   Idota N, 2009, BIOMATERIALS, V30, P2095, DOI 10.1016/j.biomaterials.2008.12.058
   Im SG, 2007, ADV MATER, V19, P2863, DOI 10.1002/adma.200701170
   Ishiyama C, 2002, J POLYM SCI POL PHYS, V40, P460, DOI 10.1002/polb.10107
   Jang JH, 2007, ANGEW CHEM INT EDIT, V46, P9027, DOI 10.1002/anie.200703525
   Jang KJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015966
   Janmey PA, 2007, ANNU REV BIOMED ENG, V9, P1, DOI 10.1146/annurev.bioeng.9.060906.151927
   Jeong HE, 2009, P NATL ACAD SCI USA, V106, P5639, DOI 10.1073/pnas.0900323106
   Jeong HE, 2008, LAB CHIP, V8, P1787, DOI 10.1039/b810348h
   Jones BF, 2005, J BIOMECH, V38, P1653, DOI 10.1016/j.jbiomech.2004.07.027
   KADLER KE, 1990, ANN NY ACAD SCI, V580, P214, DOI 10.1111/j.1749-6632.1990.tb17930.x
   Khademhosseini A, 2006, P NATL ACAD SCI USA, V103, P2480, DOI 10.1073/pnas.0507681102
   Khademhosseini A, 2003, ADV MATER, V15, P1995, DOI 10.1002/adma.200305433
   Kim DH, 2010, ADV MATER, V22, P4551, DOI 10.1002/adma.201000468
   Kim DH, 2010, P NATL ACAD SCI USA, V107, P565, DOI 10.1073/pnas.0906504107
   Kim DH, 2009, ANNU REV BIOMED ENG, V11, P203, DOI 10.1146/annurev-bioeng-061008-124915
   Kim DH, 2009, BIOMATERIALS, V30, P5433, DOI 10.1016/j.biomaterials.2009.06.042
   Kim DH, 2009, ADV FUNCT MATER, V19, P1579, DOI 10.1002/adfm.200801174
   Kim HN, 2011, LAB CHIP, V11, P717, DOI 10.1039/c0lc00277a
   Kim KH, 2008, SPRINGER PROC PHYS, V124, P229
   Kim P, 2006, LAB CHIP, V6, P1432, DOI 10.1039/b610503c
   Kim P, 2010, ADV MATER, V22, P2426, DOI 10.1002/adma.200903440
   Kim P, 2009, LAB CHIP, V9, P3255, DOI 10.1039/b911271e
   Kim YS, 2003, NANOTECHNOLOGY, V14, P1140, DOI 10.1088/0957-4484/14/10/312
   Kotov NA, 2009, ADV MATER, V21, P3970, DOI 10.1002/adma.200801984
   Kotwal A, 2001, BIOMATERIALS, V22, P1055, DOI 10.1016/S0142-9612(00)00344-6
   Krouskop TA, 1998, ULTRASONIC IMAGING, V20, P260, DOI 10.1177/016173469802000403
   Kwak MK, 2011, ADV MATER, V23, P3949, DOI 10.1002/adma.201101694
   Kwon KW, 2007, LAB CHIP, V7, P1461, DOI 10.1039/b710054j
   Lang U, 2009, SYNTHETIC MET, V159, P473, DOI 10.1016/j.synthmet.2008.11.005
   Leach JB, 2007, J NEURAL ENG, V4, P26, DOI 10.1088/1741-2560/4/2/003
   Lee H, 2005, J NEURAL ENG, V2, P81, DOI 10.1088/1741-2560/2/4/003
   Lee JY, 2009, BIOMATERIALS, V30, P4325, DOI 10.1016/j.biomaterials.2009.04.042
   Lee JY, 2009, LANGMUIR, V25, P3880, DOI [10.1021/la803635r, 10.1021/1a803635r]
   Lee MR, 2010, BIOMATERIALS, V31, P4360, DOI 10.1016/j.biomaterials.2010.02.012
   Lee SH, 2010, LAB CHIP, V10, P3300, DOI 10.1039/c0lc00127a
   Lee SH, 2008, ADV MATER, V20, P788, DOI 10.1002/adma.200701475
   Lee SH, 2009, LANGMUIR, V25, P12024, DOI 10.1021/la903236d
   Legant WR, 2010, NAT METHODS, V7, P969, DOI 10.1038/NMETH.1531
   Li G, 2007, J MATER CHEM, V17, P3126, DOI 10.1039/b703075b
   Li MY, 2006, BIOMATERIALS, V27, P2705, DOI 10.1016/j.biomaterials.2005.11.037
   LI SL, 1993, SCIENCE, V259, P957, DOI 10.1126/science.259.5097.957
   Li ZW, 2009, NANO LETT, V9, P2306, DOI 10.1021/nl9004892
   Li ZZ, 2004, AM J SPORT MED, V32, P435, DOI 10.1177/0095399703258680
   Liliensiek SJ, 2010, BIOMATERIALS, V31, P5418, DOI 10.1016/j.biomaterials.2010.03.045
   Lim SH, 2009, ADV DRUG DELIVER REV, V61, P1084, DOI 10.1016/j.addr.2009.07.011
   Liu WE, 2011, BIOMATERIALS, V32, P1796, DOI 10.1016/j.biomaterials.2010.11.029
   Lloyd AW, 2001, BIOMATERIALS, V22, P769, DOI 10.1016/S0142-9612(00)00237-4
   Luna JI, 2011, TISSUE ENG PART C-ME, V17, P579, DOI [10.1089/ten.TEC.2010.0410, 10.1089/ten.tec.2010.0410]
   Marencic AP, 2010, ANNU REV CHEM BIOMOL, V1, P277, DOI 10.1146/annurev-chembioeng-073009-101007
   Markovitz-Bishitz Y, 2010, BIOMATERIALS, V31, P8436, DOI 10.1016/j.biomaterials.2010.07.050
   Mathews M B, 1975, Mol Biol Biochem Biophys, P1
   Matsumaru Y, 1996, J BIOMAT SCI-POLYM E, V7, P795, DOI 10.1163/156856296X00138
   Meng J, 2009, J BIOMED MATER RES A, V88A, P105, DOI 10.1002/jbm.a.31862
   MENTE PL, 1989, J ORTHOPAED RES, V7, P456, DOI 10.1002/jor.1100070320
   Middleton JC, 2000, BIOMATERIALS, V21, P2335, DOI 10.1016/S0142-9612(00)00101-0
   MIH JD, 2008, P AM THORAC SOC, V5, P364
   Mills KL, 2008, J MATER RES, V23, P37, DOI 10.1557/JMR.2008.0029
   Mills KL, 2010, LAB CHIP, V10, P1627, DOI 10.1039/c000863j
   Mohr JC, 2006, BIOMATERIALS, V27, P6032, DOI 10.1016/j.biomaterials.2006.07.012
   Mohr JC, 2010, BIOMATERIALS, V31, P1885, DOI 10.1016/j.biomaterials.2009.11.033
   Murray P, 1997, SYNTHETIC MET, V84, P847, DOI 10.1016/S0379-6779(96)04177-X
   Nahum A. M, 2002, ACCIDENTAL INJURY BI
   Nemir S, 2010, ANN BIOMED ENG, V38, P2, DOI 10.1007/s10439-009-9811-1
   Ochsner M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009445
   Odom TW, 2002, LANGMUIR, V18, P5314, DOI 10.1021/la020169l
   Ohya Shoji, 2004, J Artif Organs, V7, P181
   OMMAYA A K, 1968, Journal of Biomechanics, V1, P127, DOI 10.1016/0021-9290(68)90015-8
   Park J, 2012, IEEE T NANOBIOSCI, V11, P28, DOI 10.1109/TNB.2011.2165728
   Park MC, 2006, LAB CHIP, V6, P988, DOI 10.1039/b602961b
   Park MC, 2011, LAB CHIP, V11, P79, DOI [10.1039/c0lc00114g, 10.1039/c01c00114g]
   Pascual M, 1997, ANNU REV MED, V48, P467, DOI 10.1146/annurev.med.48.1.467
   Patel S, 2007, NANO LETT, V7, P2122, DOI 10.1021/nl071182z
   Pedrotty DM, 2005, AM J PHYSIOL-HEART C, V288, pH1620, DOI 10.1152/ajpheart.00610.2003
   Peng R, 2011, BIOMATERIALS, V32, P8048, DOI 10.1016/j.biomaterials.2011.07.035
   Piruska A, 2005, LAB CHIP, V5, P1348, DOI 10.1039/b508288a
   Qin D, 2010, NAT PROTOC, V5, P491, DOI 10.1038/nprot.2009.234
   Razal JM, 2009, ADV FUNCT MATER, V19, P3381, DOI 10.1002/adfm.200900464
   Revzin A, 2001, LANGMUIR, V17, P5440, DOI 10.1021/la010075w
   RHO JY, 1993, J BIOMECH, V26, P111, DOI 10.1016/0021-9290(93)90042-D
   Rogers J. A, 2009, UNCONVENTIONAL NANOP
   Saha K, 2008, BIOPHYS J, V95, P4426, DOI 10.1529/biophysj.108.132217
   Samani A, 2007, PHYS MED BIOL, V52, P1565, DOI 10.1088/0031-9155/52/6/002
   Sanghvi AB, 2005, NAT MATER, V4, P496, DOI 10.1038/nmat1397
   Schiffman JD, 2008, POLYM REV, V48, P317, DOI 10.1080/15583720802022182
   SCHILD HG, 1992, PROG POLYM SCI, V17, P163, DOI 10.1016/0079-6700(92)90023-R
   Schmid H, 2000, MACROMOLECULES, V33, P3042, DOI 10.1021/ma982034l
   Schmidt CE, 1997, P NATL ACAD SCI USA, V94, P8948, DOI 10.1073/pnas.94.17.8948
   SCHMIEGEL WW, 1979, ANGEW MAKROMOL CHEM, V76-7, P39, DOI 10.1002/apmc.1979.050760103
   Shimizu T, 2002, J BIOMED MATER RES, V60, P110, DOI 10.1002/jbm.1284
   Silva JR, 2009, P NATL ACAD SCI USA, V106, P11102, DOI 10.1073/pnas.0904505106
   SILVER FH, 1992, J LONG-TERM EFF MED, V2, P165
   Sitti M, 2003, J ADHES SCI TECHNOL, V17, P1055, DOI 10.1163/156856103322113788
   Sochol RD, 2011, SOFT MATTER, V7, P4606, DOI 10.1039/c1sm05163f
   Suh KY, 2009, ADV FUNCT MATER, V19, P2699, DOI 10.1002/adfm.200900771
   Suh KY, 2001, ADV MATER, V13, P1386, DOI 10.1002/1521-4095(200109)13:18<1386::AID-ADMA1386>3.0.CO;2-X
   Sung JH, 2011, LAB CHIP, V11, P389, DOI [10.1039/c0lc00273a, 10.1039/c01c00273a]
   Tabesh H, 2009, NEUROCHEM INT, V54, P73, DOI 10.1016/j.neuint.2008.11.002
   Takigawa T, 1997, POLYM GELS NETW, V5, P585, DOI 10.1016/S0966-7822(97)00028-2
   Taylor Z, 2004, J BIOMECH, V37, P1263, DOI 10.1016/j.jbiomech.2003.11.027
   Tekin H, 2011, J AM CHEM SOC, V133, P12944, DOI 10.1021/ja204266a
   Tekin H, 2010, LAB CHIP, V10, P2411, DOI 10.1039/c004732e
   Teo WE, 2006, NANOTECHNOLOGY, V17, pR89, DOI 10.1088/0957-4484/17/14/R01
   THUBRIKAR M, 1980, CIRC RES, V47, P792, DOI 10.1161/01.RES.47.5.792
   Tsai IY, 2004, J BIOMED MATER RES A, V71A, P462, DOI 10.1002/jbm.a.30183
   Tsai IY, 2004, LANGMUIR, V20, P5952, DOI 10.1021/la049957w
   Tzvetkova-Chevolleau T, 2008, BIOMATERIALS, V29, P1541, DOI 10.1016/j.biomaterials.2007.12.016
   Vasita R, 2006, INT J NANOMED, V1, P15, DOI 10.2147/nano.2006.1.1.15
   Veronese FM, 2005, DRUG DISCOV TODAY, V10, P1451, DOI 10.1016/S1359-6446(05)03575-0
   Vihola H, 2005, BIOMATERIALS, V26, P3055, DOI 10.1016/j.biomaterials.2004.09.008
   Wang HC, 1996, J BIOMECH, V29, P1633, DOI 10.1016/0021-9290(96)00080-2
   Wang JHC, 2005, ANN BIOMED ENG, V33, P337, DOI 10.1007/s10439-005-1736-8
   Wu W, 2008, NANO LETT, V8, P3865, DOI 10.1021/nl802295n
   Xia YN, 1998, ANNU REV MATER SCI, V28, P153, DOI 10.1146/annurev.matsci.28.1.153
   Yamato M, 2002, BIOMATERIALS, V23, P561, DOI 10.1016/S0142-9612(01)00138-7
   Yamato M, 2001, J BIOMED MATER RES, V55, P137, DOI 10.1002/1097-4636(200104)55:1<137::AID-JBM180>3.0.CO;2-L
   Yang F, 2005, BIOMATERIALS, V26, P2603, DOI 10.1016/j.biomaterials.2004.06.051
   Yang S, 2010, ADV FUNCT MATER, V20, P2550, DOI 10.1002/adfm.201000034
   Yang Y, 2010, WIRES NANOMED NANOBI, V2, P478, DOI 10.1002/wnan.74
   Yeh WC, 2001, ULTRASON, P1233, DOI 10.1109/ULTSYM.2001.991942
   Yeh WC, 2002, ULTRASOUND MED BIOL, V28, P467, DOI 10.1016/S0301-5629(02)00489-1
   Yim EKF, 2010, BIOMATERIALS, V31, P1299, DOI 10.1016/j.biomaterials.2009.10.037
   Yoo PJ, 2004, CHEM MATER, V16, P5000, DOI 10.1021/cm049068u
   You MH, 2010, BIOMACROMOLECULES, V11, P1856, DOI 10.1021/bm100374n
   Young R. J, 1981, INTRO POLYM
   Zhu XY, 2005, NAT MATER, V4, P403, DOI 10.1038/nmat1365
NR 177
TC 68
Z9 68
U1 6
U2 101
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 0090-6964
EI 1573-9686
J9 ANN BIOMED ENG
JI Ann. Biomed. Eng.
PD JUN
PY 2012
VL 40
IS 6
SI SI
BP 1339
EP 1355
DI 10.1007/s10439-012-0510-y
PG 17
WC Engineering, Biomedical
SC Engineering
GA 949WX
UT WOS:000304609000012
PM 22258887
OA Green Accepted
DA 2018-10-19
ER

PT J
AU Salbach, J
   Rachner, TD
   Rauner, M
   Hempel, U
   Anderegg, U
   Franz, S
   Simon, JC
   Hofbauer, LC
AF Salbach, Juliane
   Rachner, Tilman D.
   Rauner, Martina
   Hempel, Ute
   Anderegg, Ulf
   Franz, Sandra
   Simon, Jan-Christoph
   Hofbauer, Lorenz C.
TI Regenerative potential of glycosaminoglycans for skin and bone
SO JOURNAL OF MOLECULAR MEDICINE-JMM
LA English
DT Review
DE Glycosaminoglycans; Extracellular matrix; Biomaterial design; Skin;
   Bone; Wound healing
ID MESENCHYMAL STEM-CELLS; KAPPA-B LIGAND; WEIGHT HYALURONIC-ACID;
   CHONDROITIN SULFATE-E; TOLL-LIKE RECEPTOR-4; HEPARAN-SULFATE; IN-VITRO;
   HYDROXYAPATITE/COLLAGEN COMPOSITES; OSTEOCLASTIC DIFFERENTIATION;
   EXTRACELLULAR-MATRIX
AB To meet the growing need for tissue replacement materials for our aging population, the development of new adaptive biomaterials is essential. The tissues with the highest demand for implant materials are skin and bone. These tissues share various similarities, including signaling pathways and extracellular matrix composition. Glycosaminoglycans such as hyaluronan and chondroitin sulfate are the major organic extracellular matrix components. They modulate the attraction of skin and bone precursor cells and their subsequent differentiation and gene expression and regulate the action of proteins essential to bone and skin regeneration. The precise action of glycosaminoglycans varies according to their structural composition mainly in respect to the degree of sulfation and polymer length. Changes in the glycosaminoglycan composition are frequently seen in physiological and pathological remodeling processes, such as bone formation or scaring. Here, we review the current state of knowledge of how the most common glycosaminoglycan, chondroitin sulfate and hyaluronan, interact with bone and skin cells, and summarize their potential in tissue engineering for skeletal and skin diseases.
C1 [Salbach, Juliane; Rachner, Tilman D.; Rauner, Martina; Hofbauer, Lorenz C.] Tech Univ Dresden, Div Endocrinol Diabet & Metab Bone Dis, Dept Med 3, Med Ctr, D-01307 Dresden, Germany.
   [Hempel, Ute] Tech Univ Dresden, Inst Physiol Chem, D-01307 Dresden, Germany.
   [Anderegg, Ulf; Franz, Sandra; Simon, Jan-Christoph] Univ Leipzig, Dept Dermatol Venerol & Allergol, Leipzig, Germany.
   [Hofbauer, Lorenz C.] Ctr Regenerat Therapies Dresden, Dresden, Germany.
RP Hofbauer, LC (reprint author), Tech Univ Dresden, Div Endocrinol Diabet & Metab Bone Dis, Dept Med 3, Med Ctr, Fetscherstr 74, D-01307 Dresden, Germany.
EM lorenz.hofbauer@uniklinikum-dresden.de
RI Hofbauer, Lorenz/G-2490-2010; Salbach-Hirsch, Juliane/H-9409-2013;
   Rauner, Martina/A-1665-2015
OI Hofbauer, Lorenz/0000-0002-8691-8423; Salbach-Hirsch,
   Juliane/0000-0001-7097-9953; Franz, Sandra/0000-0002-3449-2723
FU Deutsche Forschungsgemeinschaft [Transregio 67]
FX This study is supported by grants from Deutsche Forschungsgemeinschaft
   Transregio 67 (projects B1, B2, B3, and B4).
CR AKIMOTO S, 1992, BRIT J DERMATOL, V126, P29, DOI 10.1111/j.1365-2133.1992.tb08399.x
   Alliston Tamara, 2010, J Pediatr Rehabil Med, V3, P129, DOI 10.3233/PRM-2010-0117
   Ariyoshi W, 2005, J BIOL CHEM, V280, P18967, DOI 10.1074/jbc.M412740200
   Ariyoshi W, 2008, J CELL BIOCHEM, V103, P1707, DOI 10.1002/jcb.21559
   Augello A, 2010, EUR CELLS MATER, V20, P121
   Averbeck M, 2007, J INVEST DERMATOL, V127, P687, DOI 10.1038/sj.jid.5700614
   Baldwin AD, 2010, BIOPOLYMERS, V94, P128, DOI 10.1002/bip.21334
   Bastow ER, 2008, CELL MOL LIFE SCI, V65, P395, DOI 10.1007/s00018-007-7360-z
   Baud'huin M, 2010, EUR J CELL BIOL, V90, P49
   Becker D, 2002, J BIOMED MATER RES, V59, P516, DOI 10.1002/jbm.1265
   Bernstein EF, 1996, BRIT J DERMATOL, V135, P255, DOI 10.1111/j.1365-2133.1996.tb01156.x
   Bierbaum S, 2006, J BIOMED MATER RES A, V77A, P551, DOI 10.1002/jbm.a.30572
   Bierbaum S., 2010, ARTIFICIAL EXTRACELL
   Boyle WJ, 2003, NATURE, V423, P337, DOI 10.1038/nature01658
   CATINI C, 1990, Archivio Italiano di Anatomia e di Embriologia, V95, P237
   Chabadel A, 2007, MOL BIOL CELL, V18, P4899, DOI 10.1091/mbc.E07-04-0378
   Chang EJ, 2007, J CELL SCI, V120, P166, DOI 10.1242/jcs.03310
   CHEN CC, 1985, CALCIFIED TISSUE INT, V37, P395, DOI 10.1007/BF02553709
   Chen WYJ, 1999, WOUND REPAIR REGEN, V7, P79, DOI 10.1046/j.1524-475X.1999.00079.x
   Chen XD, 2010, BIRTH DEFECTS RES C, V90, P45, DOI 10.1002/bdrc.20171
   Cui WG, 2006, BLOOD, V107, P796, DOI 10.1182/blood-2005-05-1902
   Day AJ, 2005, TRENDS IMMUNOL, V26, P637, DOI 10.1016/j.it.2005.09.009
   Del Fattore A, 2008, ARCH BIOCHEM BIOPHYS, V473, P147, DOI 10.1016/j.abb.2008.01.011
   Dieckmann C, 2010, EXP DERMATOL, V19, P697, DOI 10.1111/j.1600-0625.2010.01087.x
   DOCHERTY R, 1989, J CELL SCI, V92, P263
   Dombrowski C, 2009, STEM CELLS DEV, V18, P661, DOI 10.1089/scd.2008.0157
   Douglas T, 2007, BIOMOL ENG, V24, P455, DOI 10.1016/j.bioeng.2007.07.008
   Douglas T, 2008, J MATER SCI-MATER M, V19, P1653, DOI 10.1007/S10856-007-3250-Z
   Douglas T, 2008, J BIOMED MATER RES A, V84A, P805, DOI 10.1002/jbm.a.31501
   Douglas T, 2007, BIOMACROMOLECULES, V8, P1085, DOI 10.1021/bm0609644
   Ellis I, 1997, DEVELOPMENT, V124, P1593
   Ellis IR, 2007, EXP CELL RES, V313, P732, DOI 10.1016/j.yexcr.2006.11.016
   Esko J.D., 2009, ESSENTIALS GLYCOBIOL
   Farrell E, 2006, TISSUE ENG, V12, P459, DOI 10.1089/ten.2006.12.459
   Fini M, 2004, BIOMED PHARMACOTHER, V58, P487, DOI 10.1016/j.biopha.2004.08.016
   FOSCHI D, 1990, INT J TISSUE REACT, V12, P333
   Franz S, 2011, BIOMATERIALS, V32, P6692, DOI 10.1016/j.biomaterials.2011.05.078
   Freyman TM, 2001, PROG MATER SCI, V46, P273, DOI 10.1016/S0079-6425(00)00018-9
   Gama CI, 2005, CURR OPIN CHEM BIOL, V9, P609, DOI 10.1016/j.cbpa.2005.10.003
   Gama CI, 2006, NAT CHEM BIOL, V2, P467, DOI 10.1038/nchembio810
   Gama CristalI, 2007, CHONDROITIN SULFATE
   Gandhi NS, 2008, CHEM BIOL DRUG DES, V72, P455, DOI 10.1111/j.1747-0285.2008.00741.x
   Gariboldi S, 2008, J IMMUNOL, V181, P2103, DOI 10.4049/jimmunol.181.3.2103
   Gebhardt C, 2010, J INVEST DERMATOL, V130, P141, DOI 10.1038/jid.2009.210
   Grzesik WJ, 2002, J BIOL CHEM, V277, P43638, DOI 10.1074/jbc.M202124200
   Gu H, 2010, EXP DERMATOL, V19, pE336, DOI 10.1111/j.1600-0625.2009.01052.x
   Hadjidakis DJ, 2006, ANN NY ACAD SCI, V1092, P385, DOI 10.1196/annals.1365.035
   Hascall V., 2009, ESSENTIALS GLYCOBIOL
   Haupt LM, 2009, J CELL PHYSIOL, V220, P780, DOI 10.1002/jcp.21825
   Hintze V, 2009, BIOMACROMOLECULES, V10, P3290, DOI 10.1021/bm9008827
   Holick MF, 2007, NEW ENGL J MED, V357, P266, DOI 10.1056/NEJMra070553
   Hoshiba T, 2009, J BIOL CHEM, V284, P31164, DOI 10.1074/jbc.M109.054676
   Hsu FY, 2010, ACTA BIOMATER, V6, P2140, DOI 10.1016/j.actbio.2009.12.023
   Hubbell JA, 2003, CURR OPIN BIOTECH, V14, P551, DOI 10.1016/j.copbio.2003.09.004
   Irie A, 2007, BONE, V41, P165, DOI 10.1016/j.bone.2007.04.190
   Jackson RA, 2007, J CELL PHYSIOL, V210, P38, DOI 10.1002/jcp.20813
   Jahoda CAB, 2003, EXP DERMATOL, V12, P849, DOI 10.1111/j.0906-6705.2003.00161.x
   Jiang DH, 2005, NAT MED, V11, P1173, DOI 10.1038/nm1315
   Jokela TA, 2008, CONNECT TISSUE RES, V49, P115, DOI 10.1080/03008200802148439
   Khosla S, 2001, ENDOCRINOLOGY, V142, P5050, DOI 10.1210/en.142.12.5050
   Khosla S, 2008, J CLIN INVEST, V118, P421, DOI 10.1172/JC133612
   Kirschfink M, 1997, J IMMUNOL, V158, P1324
   Klim JR, 2010, NAT METHODS, V7, P989, DOI 10.1038/NMETH.1532
   Kobayashi H, 1997, AM J PHYSIOL-CELL PH, V273, pC1151
   Kunze R, 2009, GLYCOCONJ J, V27, P151
   Lako M, 2002, J CELL SCI, V115, P3967, DOI 10.1242/jcs.00060
   Lam PK, 1999, J TRAUMA, V47, P918, DOI 10.1097/00005373-199911000-00017
   Lamari FN, 2006, STRUCTURE CHONDROITI
   Lamoureux F, 2007, BIOESSAYS, V29, P758, DOI 10.1002/bies.20612
   Lamoureux F, 2009, CANCER RES, V69, P526, DOI 10.1158/0008-5472.CAN-08-2648
   Lawrence DA, 1996, EUR CYTOKINE NETW, V7, P363
   Li ZQ, 2002, J BIOL CHEM, V277, P28669, DOI 10.1074/jbc.M204004200
   Lian JB, 2004, CRIT REV EUKAR GENE, V14, P1
   Ling L, 2010, J CELL BIOCHEM, V109, P1222, DOI 10.1002/jcb.22506
   Lion JM, 2009, BIOCHEM PHARMACOL, V78, P1448, DOI 10.1016/j.bcp.2009.07.014
   Lokeshwar VB, 2000, J BIOL CHEM, V275, P27641
   LORENZ HP, 1995, PLAST RECONSTR SURG, V96, P1251, DOI 10.1097/00006534-199511000-00001
   Loser K, 2006, NAT MED, V12, P1372, DOI 10.1038/nm1518
   LUBEN RA, 1974, ENDOCRINOLOGY, V94, P737, DOI 10.1210/endo-94-3-737
   Luong-Van E, 2007, J MOL HISTOL, V38, P459, DOI 10.1007/s10735-007-9129-y
   Lynch MP, 1998, J CELL BIOCHEM, V68, P31
   Maccari F, 2008, INT J DERMATOL, V47, P1024, DOI 10.1111/j.1365-4632.2008.03762.x
   Mack JA, 2011, J INVEST DE IN PRESS
   Mania VM, 2009, IUBMB LIFE, V61, P447, DOI 10.1002/iub.167
   Mathieu LM, 2006, BIOMATERIALS, V27, P905, DOI 10.1016/j.biomaterials.2005.07.015
   Meran S, 2010, J BIOL CHEM, V286, P17618
   Miyazaki T, 2008, J CELL PHYSIOL, V217, P769, DOI 10.1002/jcp.21557
   Miyazaki T, 2010, DENT MATER J, V29, P403, DOI 10.4012/dmj.2009-132
   Monslow J, 2009, J INVEST DERMATOL, V129, P2046, DOI 10.1038/jid.2009.9
   Moseley R, 2004, WOUND REPAIR REGEN, V12, P419, DOI 10.1111/j.1067-1927.2004.12406.x
   Mutsaers SE, 1997, INT J BIOCHEM CELL B, V29, P5, DOI 10.1016/S1357-2725(96)00115-X
   Nagahata M, 2004, BIOCHEM BIOPH RES CO, V315, P603, DOI 10.1016/j.bbrc.2004.01.098
   Nagahata M, 2005, BIOMATERIALS, V26, P5138, DOI 10.1016/j.biomaterials.2005.01.041
   NEMETHCSOKA M, 1977, CONNECT TISSUE RES, V5, P1, DOI 10.3109/03008207709152605
   Nikitovic D, 2005, ANTICANCER RES, V25, P2851
   Olczyk P, 2008, POSTEP HIG MED DOSW, V62, P651
   Orlandi RR, 2007, LARYNGOSCOPE, V117, P1288, DOI 10.1097/MLG.0b013e318058a083
   Pieper JS, 1999, BIOMATERIALS, V20, P847, DOI 10.1016/S0142-9612(98)00240-3
   Pieper JS, 2000, BIOMATERIALS, V21, P1689, DOI 10.1016/S0142-9612(00)00052-1
   Pittenger Mark F., 2008, V449, P27, DOI 10.1007/978-1-60327-169-1_2
   Pivetta E, 2011, J CELL PHYSIOL, V226, P769, DOI 10.1002/jcp.22398
   Ponta H, 2003, NAT REV MOL CELL BIO, V4, P33, DOI 10.1038/nrm1004
   Prestwich Glenn D, 2008, Organogenesis, V4, P42
   Prince CW, 2004, BMC MUSCULOSKEL DIS, V5, DOI 10.1186/1471-2474-5-12
   PRINCE CW, 1983, J NUTR, V113, P1576
   Rammelt S, 2007, J ORTHOP RES, V25, P1052, DOI 10.1002/jor.20403
   Rider CC, 2006, BIOCHEM SOC T, V34, P458, DOI 10.1042/BST0340458
   Robey PG, 2009, PRIMER METABOLIC BON
   Ross FP, 2006, J CLIN INVEST, V116, P1140, DOI 10.1172/JCI28605
   Roughley PJ, 2006, EUR CELLS MATER, V12, P92, DOI 10.22203/eCM.v012a11
   Ruffell B, 2005, BIOCHEM BIOPH RES CO, V334, P306, DOI 10.1016/j.bbrc.2005.06.108
   Ruffell B, 2011, J BIOL CHEM, V286, P19179, DOI 10.1074/jbc.M110.200790
   Ruggiero Florence, 2005, Journal de la Societe de Biologie, V199, P301, DOI 10.1051/jbio:2005031
   Saito A, 2004, ELECTROPHORESIS, V25, P2452, DOI 10.1002/elps.200305997
   Saltel F, 2008, EUR J CELL BIOL, V87, P459, DOI 10.1016/j.ejcb.2008.01.001
   Sasisekharan R, 2006, ANNU REV BIOMED ENG, V8, P181, DOI 10.1146/annurev.bioeng.8.061505.095745
   SAVAGE K, 1985, J INVEST DERMATOL, V84, P521, DOI 10.1111/1523-1747.ep12273514
   Scharnweber D, 2009, RES SIGNPOST
   Schneiders W, 2009, J ORTHOP RES, V27, P15, DOI 10.1002/jor.20719
   Schneiders W, 2008, J BIOMED MATER RES A, V85A, P638, DOI 10.1002/jbm.a.31611
   Schoppet M, 2002, ARTERIOSCL THROM VAS, V22, P549, DOI 10.1161/01.ATV.0000012303.37971.DA
   Scuderi N, 2009, IN VIVO, V23, P991
   Shinmyouzu K, 2007, BIOCHEM BIOPH RES CO, V354, P447, DOI 10.1016/j.bbrc.2006.12.221
   Silbert JE, 2002, IUBMB LIFE, V54, P177, DOI 10.1080/15216540290114450
   Simonaro CM, 2008, AM J PATHOL, V172, P112, DOI 10.2353/ajpath.2008.070564
   Sorokin L, 2010, NAT REV IMMUNOL, V10, P712, DOI 10.1038/nri2852
   Souza-Fernandes AB, 2006, CRIT CARE, V10, DOI 10.1186/cc5069
   Stadlinger B, 2008, INT J ORAL MAX SURG, V37, P54, DOI 10.1016/j.ijom.2007.05.024
   Sterling H, 1998, J CELL BIOL, V143, P837, DOI 10.1083/jcb.143.3.837
   SWANN DA, 1985, J INVEST DERMATOL, V84, P527, DOI 10.1111/1523-1747.ep12273517
   TAMMI R, 1988, J INVEST DERMATOL, V90, P412, DOI 10.1111/1523-1747.ep12456530
   Termeer C, 2002, J EXP MED, V195, P99, DOI 10.1084/jem.20001858
   Theoleyre S, 2006, BIOCHEM BIOPH RES CO, V347, P460, DOI 10.1016/j.bbrc.2006.06.120
   Tierney CM, 2009, J BIOMED MATER RES A, V91A, P92, DOI 10.1002/jbm.a.32207
   Trouvin AP, 2010, CLIN INTERV AGING, V5, P345, DOI 10.2147/CIA.S10153
   TURLEY EA, 1991, J CELL BIOL, V112, P1041, DOI 10.1083/jcb.112.5.1041
   TURLEY EA, 1982, BIOCHEM BIOPH RES CO, V108, P1016, DOI 10.1016/0006-291X(82)92101-5
   Vallieres M, 2010, OSTEOARTHR CARTILAGE, V18, pS1, DOI 10.1016/j.joca.2010.02.017
   van der Harst MR, 2004, OSTEOARTHR CARTILAGE, V12, P752, DOI 10.1016/j.joca.2004.05.004
   Van Vlierberghe S, 2011, BIOMACROMOLECULES, V12, P1387, DOI 10.1021/bm200083n
   VEJLENS L, 1971, CALC TISS RES, V7, P175, DOI 10.1007/BF02062605
   Velasco CR, 2010, DRUG DISCOV TODAY, V15, P553, DOI 10.1016/j.drudis.2010.05.009
   Waddington RJ, 1998, MATRIX BIOL, V17, P255, DOI 10.1016/S0945-053X(98)90079-8
   WADDINGTON RJ, 1989, ARCH ORAL BIOL, V34, P587, DOI 10.1016/0003-9969(89)90100-3
   Wagner DO, 2011, ACTA ORTHOP, V82, P393, DOI 10.3109/17453674.2011.588861
   Wang TW, 2006, BIOMATERIALS, V27, P5689, DOI 10.1016/j.biomaterials.2006.07.024
   West DC, 1997, INT J BIOCHEM CELL B, V29, P201, DOI 10.1016/S1357-2725(96)00133-1
   Wiegand C, 2010, ARCH DERMATOL RES, V302, P419, DOI 10.1007/s00403-009-1011-1
   WILLEN MD, 1991, J INVEST DERMATOL, V96, P968, DOI 10.1111/1523-1747.ep12476335
   WITT DP, 1994, CURR BIOL, V4, P394, DOI 10.1016/S0960-9822(00)00088-9
   Yamawaki H, 2009, GLYCOBIOLOGY, V19, P83, DOI 10.1093/glycob/cwn109
   Zhang LJ, 2010, PROG MOL BIOL TRANSL, V93, P1, DOI 10.1016/S1877-1173(10)93001-9
   Zhu W, 2008, OSTEOPOROSIS, VOLS I AND II, 3RD EDITION, P191
   Zimmerman E, 2002, BIOPHYS J, V82, P1848, DOI 10.1016/S0006-3495(02)75535-5
NR 154
TC 76
Z9 76
U1 6
U2 79
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 0946-2716
J9 J MOL MED
JI J. Mol. Med.
PD JUN
PY 2012
VL 90
IS 6
BP 625
EP 635
DI 10.1007/s00109-011-0843-2
PG 11
WC Genetics & Heredity; Medicine, Research & Experimental
SC Genetics & Heredity; Research & Experimental Medicine
GA 950AY
UT WOS:000304622300003
PM 22187113
DA 2018-10-19
ER

PT J
AU Wu, I
   Nahas, Z
   Kimmerling, KA
   Rosson, GD
   Elisseeff, JH
AF Wu, Iwen
   Nahas, Zayna
   Kimmerling, Kelly A.
   Rosson, Gedge D.
   Elisseeff, Jennifer H.
TI An Injectable Adipose Matrix for Soft-Tissue Reconstruction
SO PLASTIC AND RECONSTRUCTIVE SURGERY
LA English
DT Article; Proceedings Paper
CT Annual Meeting of the
   Tissue-Engineering-and-Regenerative-Medicine-International-Society
CY DEC 05-08, 2010
CL Orlando, FL
SP Tissue Engn & Regenerat Med Int Soc
ID FIBROBLAST-GROWTH-FACTOR; MESENCHYMAL STEM-CELLS; POSTMASTECTOMY BREAST
   RECONSTRUCTION; DE-NOVO ADIPOGENESIS; IN-VITRO; EXTRACELLULAR-MATRIX;
   CROSS-LINKING; GELATIN MICROSPHERES; HUMAN PREADIPOCYTES;
   BASEMENT-MEMBRANE
AB Background: Soft-tissue repair is currently limited by the availability of autologous tissue sources and the absence of an ideal soft-tissue replacement comparable to native adipose tissue. Extracellular matrix-based biomaterials have demonstrated great potential as instructive scaffolds for regenerative medicine, mechanically and biochemically defined by the tissue of origin. As such, the distinctive high lipid content of adipose tissue requires unique processing conditions to generate a biocompatible scaffold for soft-tissue repair.
   Methods: Human adipose tissue was decellularized to obtain a matrix devoid of lipids and cells while preserving extracellular matrix architecture and bioactivity. To control degradation and volume persistence, the scaffold was cross-linked using hexamethylene diisocyanate and 1-ethyl-3-(3-dimethylaminopropyl) carbodiimide. In vitro studies with human adipose-derived stem cells were used to assess cell viability and adipogenic differentiation on the biomaterial. In vivo biocompatibility and volume persistence were evaluated by subcutaneous implantation over 12 weeks in a small-animal model.
   Results: The scaffold provided a biocompatible matrix supporting the growth and differentiation of adipose-derived stem cells in vitro. Cross-linking the matrix increased its resistance to enzymatic degradation. Subcutaneous implantation of the acellular adipose matrix in Sprague-Dawley rats showed minimal inflammatory reaction. Adipose tissue development and vascularization were observed in the implant, with host cells migrating into the matrix indicating the instructive potential of the matrix for guiding tissue remodeling and regeneration.
   Conclusions: With its unique biological and mechanical properties, decellularized adipose extracellular matrix is a promising biomaterial scaffold that can potentially be used allogenically for the correction of soft-tissue defects. (Plast. Reconstr. Surg. 129: 1247, 2012.)
C1 [Elisseeff, Jennifer H.] Johns Hopkins Univ, Sch Med, Dept Biomed Engn, Baltimore, MD 21287 USA.
   Johns Hopkins Univ, Sch Med, Dept Otolaryngol, Baltimore, MD 21287 USA.
   Johns Hopkins Univ, Sch Med, Dept Plast Surg, Baltimore, MD 21287 USA.
RP Elisseeff, JH (reprint author), Johns Hopkins Univ, Sch Med, Dept Biomed Engn, Smith 5035,400 N Broadway, Baltimore, MD 21287 USA.
EM jhe@jhu.edu
RI Rosson, Gedge/I-5918-2013
OI Rosson, Gedge/0000-0003-1817-9443
FU NIDCR NIH HHS [5R01DE016887-04, R01 DE016887]
CR Abberton KM, 2008, CELLS TISSUES ORGANS, V188, P347, DOI 10.1159/000121575
   Alderman AK, 2002, PLAST RECONSTR SURG, V109, P2265, DOI 10.1097/00006534-200206000-00015
   Alhadlaq A, 2005, TISSUE ENG, V11, P556, DOI 10.1089/ten.2005.11.556
   ALLEN RJ, 1994, ANN PLAS SURG, V32, P32, DOI 10.1097/00000637-199401000-00007
   Atisha D, 2009, ANN PLAS SURG, V63, P222, DOI 10.1097/SAP.0b013e31818c4a9e
   Badylak SF, 2009, ACTA BIOMATER, V5, P1, DOI 10.1016/j.actbio.2008.09.013
   Bauer-Kreisel P, 2010, ADV DRUG DELIVER REV, V62, P798, DOI 10.1016/j.addr.2010.04.003
   Brennan EP, 2008, J TISSUE ENG REGEN M, V2, P491, DOI 10.1002/term.123
   Brown BN, 2011, TISSUE ENG PART C-ME, V17, P411, DOI [10.1089/ten.tec.2010.0342, 10.1089/ten.TEC.2010.0342]
   Cheng MH, 2010, J BIOMED MATER RES A, V92A, P852, DOI 10.1002/jbm.a.32410
   Cho SW, 2005, BIOMATERIALS, V26, P3577, DOI 10.1016/j.biomaterials.2004.09.013
   Choi JH, 2010, TISSUE ENG PART B-RE, V16, P413, DOI [10.1089/ten.teb.2009.0544, 10.1089/ten.TEB.2009.0544]
   Choi JS, 2009, J CONTROL RELEASE, V139, P2, DOI 10.1016/j.jconrel.2009.05.034
   Choi YS, 2005, BIOMATERIALS, V26, P5855, DOI 10.1016/j.biomaterials.2005.02.022
   Chung HJ, 2009, TISSUE ENG PT A, V15, P1391, DOI 10.1089/ten.tea.2008.0344
   Cordeiro PG, 2008, NEW ENGL J MED, V359, P1590, DOI 10.1056/NEJMct0802899
   Damink LHHO, 1996, BIOMATERIALS, V17, P765, DOI 10.1016/0142-9612(96)81413-X
   DAMINK LHHO, 1995, J MATER SCI-MATER M, V6, P429
   Fischbach C, 2004, TISSUE ENG, V10, P215, DOI 10.1089/107632704322791862
   Flynn L, 2009, J BIOMED MATER RES A, V89A, P929, DOI 10.1002/jbm.a.32044
   Flynn L, 2006, J BIOMED MATER RES A, V79A, P359, DOI 10.1002/jbm.a.30762
   Forthomme B, 2010, CLIN PHYSIOL FUNCT I, V30, P406, DOI 10.1111/j.1475-097X.2010.00956.x
   Gilbert TW, 2006, BIOMATERIALS, V27, P3675, DOI 10.1016/j.biomaterials.2006.02.014
   Hemmrich K, 2005, BIOMATERIALS, V26, P7025, DOI 10.1016/j.biomaterials.2005.04.065
   Hemmrich K, 2008, J SURG RES, V144, P82, DOI 10.1016/j.jss.2007.03.017
   Hillel AT, 2009, TISSUE ENG PT A, V15, P479, DOI 10.1089/ten.tea.2007.0352
   Hiraoka Y, 2006, TISSUE ENG, V12, P1475, DOI 10.1089/ten.2006.12.1475
   HORL HW, 1991, ANN PLAS SURG, V26, P248
   Jing W, 2007, CELL TISSUE RES, V330, P567, DOI 10.1007/s00441-007-0493-4
   Katz RD, 2010, MICROSURG, V30, P593, DOI 10.1002/micr.20794
   Kawaguchi N, 1998, P NATL ACAD SCI USA, V95, P1062, DOI 10.1073/pnas.95.3.1062
   KIM YJ, 1988, ANAL BIOCHEM, V174, P168, DOI 10.1016/0003-2697(88)90532-5
   Kimura Y, 2002, TISSUE ENG, V8, P603, DOI 10.1089/107632702760240526
   Kimura Y, 2003, BIOMATERIALS, V24, P2513, DOI 10.1016/S0142-9612(03)00049-8
   Kroll SS, 2000, PLAST RECONSTR SURG, V106, P576, DOI 10.1097/00006534-200009030-00008
   Massey MF, 2009, PLAST RECONSTR SURG, V124, P737, DOI 10.1097/PRS.0b013e3181b17a56
   Mauney JR, 2007, BIOMATERIALS, V28, P5280, DOI 10.1016/j.biomaterials.2007.08.017
   Morgan SM, 2009, BIOMATERIALS, V30, P1910, DOI 10.1016/j.biomaterials.2008.12.033
   NAIMARK WA, 1995, J MATER SCI-MATER M, V6, P235, DOI 10.1007/BF00146862
   Neubauer M, 2005, TISSUE ENG, V11, P1840, DOI 10.1089/ten.2005.11.1840
   Patrick CW, 2002, TISSUE ENG, V8, P283, DOI 10.1089/107632702753725049
   Pulagam SR, 2006, BREAST J, V12, P63, DOI 10.1111/j.1075-122X.2006.00188.x
   Rad AN, 2010, MICROSURG, V30, P339, DOI 10.1002/micr.20753
   Rault I, 1996, J MATER SCI-MATER M, V7, P215, DOI 10.1007/BF00119733
   Reing JE, 2009, TISSUE ENG PT A, V15, P605, DOI 10.1089/ten.tea.2007.0425
   Rosson GD, 2007, MICROSURG, V27, P641, DOI 10.1002/micr.20423
   Rosson GD, 2010, ANN SURG ONCOL, V17, P1890, DOI 10.1245/s10434-010-0913-7
   Shanti RM, 2008, ANN PLAS SURG, V61, P566, DOI 10.1097/SAP.0b013e31816d9579
   Spear SL, 2000, PLAST RECONSTR SURG, V106, P1300, DOI 10.1097/00006534-200011000-00010
   Stillaert F, 2007, TISSUE ENG, V13, P2291, DOI 10.1089/ten.2006.0382
   Torio-Padron N, 2007, AESTHET PLAST SURG, V31, P285, DOI 10.1007/s00266-006-0221-6
   Tottey S, 2010, TISSUE ENG PART A, V17, P37
   Uriel S, 2008, BIOMATERIALS, V29, P3712, DOI 10.1016/j.biomaterials.2008.05.028
   Vermette M, 2007, BIOMATERIALS, V28, P2850, DOI 10.1016/j.biomaterials.2007.02.030
   von Heimburg D., 2003, International Journal of Artificial Organs, V26, P1064
   Wan DC, 2009, J CRANIOFAC SURG, V20, P273, DOI 10.1097/SCS.0b013e31819921d3
   WOESSNER JF, 1961, ARCH BIOCHEM BIOPHYS, V93, P440, DOI 10.1016/0003-9861(61)90291-0
NR 57
TC 46
Z9 48
U1 0
U2 27
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA 530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA
SN 0032-1052
J9 PLAST RECONSTR SURG
JI Plast. Reconstr. Surg.
PD JUN
PY 2012
VL 129
IS 6
BP 1247
EP 1257
DI 10.1097/PRS.0b013e31824ec3dc
PG 11
WC Surgery
SC Surgery
GA 950KQ
UT WOS:000304648500037
PM 22327888
OA Green Accepted
DA 2018-10-19
ER

PT J
AU Pettinicchio, M
   Sammons, R
   Caputi, S
   Piattelli, A
   Traini, T
AF Pettinicchio, M.
   Sammons, R.
   Caputi, S.
   Piattelli, A.
   Traini, T.
TI Bone regeneration in sinus augmentation procedures with calcium
   sulphate. Microstructure and microanaytical investigations
SO AUSTRALIAN DENTAL JOURNAL
LA English
DT Article
DE Biomaterials; calcium sulphate; calcium phosphate; scanning electron
   microscopy; fluorescence microscopy; polarized light microscopy
ID PERIODONTAL DEFECTS; INTRABONY DEFECTS; GRAFT SUBSTITUTE; MAXILLARY
   SINUS; SULFATE BARRIER; FURCATION DEFECTS; CLINICAL REPORT;
   COMPACT-BONE; IMPLANT; PLASTER
AB Background: The aim of this study was a histological and ultrastructural evaluation of the bone formed in human sinus augmentation procedures with calcium sulphate (CaS). Methods: Scanning electron microscopy (SEM) and energy dispersive X-ray spectroscopy (EDS) were used to evaluate the relationship between CaS and newly-formed bone, while birefringence was used to evaluate the bone structure around the CaS particles by polarized light microscopy. Unstained sections were studied with an Axiovert 200 M using the fluorescence in reflected UV light to evaluate the interface between CaS and newly-formed bone. Twenty specimens retrieved from the sinus after a healing period of six months were studied. Results: EDS analysis of six specimens showed that little sulphur remained and residual particles appeared to have transformed to calcium phosphate. Under polarized light a few biomaterial remnants were present in some areas and covered by mature bone. The relationship between residual particles and bone due to the different photon emission under UV light stimulation was observed under fluorescence microscopy. Conclusions: The present results confirm the high biocompatibility and rapid resorption rate of CaS. The mechanism of transformation of CaS to calcium phosphate, already demonstrated in animal studies, has been confirmed in the present human study.
C1 [Pettinicchio, M.; Caputi, S.; Piattelli, A.] Univ G dAnnunzio, Dept Oral Sci Nano & Biotechnol, Chieti, Italy.
   [Sammons, R.] Univ Birmingham, Sch Dent, Birmingham B15 2TT, W Midlands, England.
   [Traini, T.] EIS Int Educ Soc, San Benedetto Tronto, Italy.
RP Traini, T (reprint author), Via Vestini 31, I-66100 Chieti, Italy.
EM t.traini@unich.it
OI Sammons, Rachel/0000-0002-4787-048X; Traini, Tonino/0000-0002-0265-8709
FU EIS-International Educational Society, San Benedetto del Tronto, Italy
FX This work was partially supported by the EIS-International Educational
   Society, San Benedetto del Tronto, Italy.
CR Al Ruhaimi KA, 2001, INT J ORAL MAX SURG, V30, P228, DOI 10.1054/ijom.2001.0048
   Al Ruhaimi KA, 2000, INT J ORAL MAX IMPL, V15, P859
   Al Ruhaimi KA, 2001, J ORAL MAXIL SURG, V59, P1319, DOI 10.1053/joms.2001.27526
   ALDERMAN NE, 1969, J PERIODONTOL, V40, P11, DOI 10.1902/jop.1969.40.1.11
   Alexander DI, 2001, CAN J SURG, V44, P262
   AMLER MH, 1987, J PERIODONTOL, V58, P758, DOI 10.1902/jop.1987.58.11.758
   Andreana S, 1998, J PERIODONTOL, V69, P601, DOI 10.1902/jop.1998.69.5.601
   BAHN SL, 1966, ORAL SURG ORAL MED O, V21, P672, DOI 10.1016/0030-4220(66)90045-4
   BELL WILLIAM H., 1964, ORAL SURG ORAL MED ORAL PATHOL, V17, P650, DOI 10.1016/0030-4220(64)90372-X
   Bier S J, 1999, Compend Contin Educ Dent, V20, P655
   BOYDE A, 1990, BONE, V11, P35, DOI 10.1016/8756-3282(90)90069-B
   BOYDE A, 1984, METAB BONE DIS RELAT, V5, P299, DOI 10.1016/0221-8747(84)90017-1
   COETZEE AS, 1980, ARCH OTOLARYNGOL, V106, P405
   DAMIEN CJ, 1994, CALCIFIED TISSUE INT, V55, P151, DOI 10.1007/BF00297191
   De Leonardis D, 1999, INT J ORAL MAX IMPL, V14, P869
   De Leonardis D, 2000, J PERIODONTOL, V71, P940
   DIBATTISTA P, 1995, J PERIODONTOL, V66, P673, DOI 10.1902/jop.1995.66.8.673
   EDBERG E, 1930, ACTA CHIR SCAND, V67, P313
   Gitelis S, 2001, ORTHOPEDICS, V24, P162
   Guarnieri R, 2002, INT J PERIODONT REST, V22, P503
   Hadjipavlou AG, 2000, SPINE, V25, P10, DOI 10.1097/00007632-200001010-00004
   Kelly CM, 2001, CLIN ORTHOP RELAT R, P42
   Kim CK, 1998, J PERIODONTOL, V69, P982, DOI 10.1902/jop.1998.69.9.982
   Kim CK, 1998, J PERIODONTOL, V69, P1317, DOI 10.1902/jop.1998.69.12.1317
   Kim CK, 1998, INT DENT J, V48, P330, DOI 10.1111/j.1875-595X.1998.tb00725.x
   MacNeill SR, 1999, J CLIN PERIODONTOL, V26, P239, DOI 10.1034/j.1600-051X.1999.260407.x
   Maragos P, 2002, INT J PERIODONT REST, V22, P493
   Nystrom C, 1928, ACTA CHIR SCAND, V63, P296
   Orsini G, 2004, J BIOMED MATER RES B, V68B, P199, DOI 10.1002/jbm.b.20012
   Orsini M, 2001, J PERIODONTOL, V72, P296, DOI 10.1902/jop.2001.72.3.296
   Payne JM, 1996, J PERIODONTOL, V67, P236, DOI 10.1902/jop.1996.67.3.236
   Pecora G, 2001, INT ENDOD J, V34, P189, DOI 10.1046/j.1365-2591.2001.00369.x
   Pecora G, 1997, Dent Clin North Am, V41, P585
   Pecora G, 1997, ORAL SURG ORAL MED O, V84, P424, DOI 10.1016/S1079-2104(97)90043-3
   Pecora GE, 1998, INT J ORAL MAX IMPL, V13, P866
   PELTIER L F, 1961, Clin Orthop, V21, P1
   PEPELASSI EM, 1991, J PERIODONTOL, V62, P106, DOI 10.1902/jop.1991.62.2.106
   Piattelli A, 1997, BIOMATERIALS, V18, P577, DOI 10.1016/S0142-9612(96)00177-9
   Pietrzak WS, 2000, J CRANIOFAC SURG, V11, P327, DOI 10.1097/00001665-200011040-00009
   Randetz WH, 1965, J PERIODONTOL, V36, P357
   Ricci JL, 2000, BONE ENG, P332
   Rosen PS, 1999, J PERIODONTOL, V70, P554, DOI 10.1902/jop.1999.70.5.554
   Setya A B, 1999, Periodontal Clin Investig, V21, P5
   SHAFFER CD, 1971, J PERIODONTOL, V42, P685, DOI 10.1902/jop.1971.42.11.685
   Sottosanti J, 1992, Compendium, V13, P226
   Sottosanti J S, 1995, Periodontal Clin Investig, V17, P10
   Strocchi Rita, 2002, J Oral Implantol, V28, P273, DOI 10.1563/1548-1336(2002)028<0273:BRWCSE>2.3.CO;2
   Tay BKB, 1999, ORTHOP CLIN N AM, V30, P615, DOI 10.1016/S0030-5898(05)70114-0
   Walsh WR, 2003, CLIN ORTHOP RELAT R, P228, DOI 10.1097/01.blo.0000030062.92399.6a
   YAMAZAKI Y, 1988, CLIN ORTHOP RELAT R, P240
   Yoshikawa G, 2002, INT ENDOD J, V35, P255, DOI 10.1046/j.1365-2591.2002.00473.x
NR 51
TC 6
Z9 6
U1 0
U2 3
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0045-0421
J9 AUST DENT J
JI Aust. Dent. J.
PD JUN
PY 2012
VL 57
IS 2
BP 200
EP 206
DI 10.1111/j.1834-7819.2012.01684.x
PG 7
WC Dentistry, Oral Surgery & Medicine
SC Dentistry, Oral Surgery & Medicine
GA 947OC
UT WOS:000304438300015
PM 22624762
DA 2018-10-19
ER

PT J
AU Gorlero, F
   Glorio, M
   Lorenzi, P
   Bruno-Franco, M
   Mazzei, C
AF Gorlero, Franco
   Glorio, Matilde
   Lorenzi, Paola
   Bruno-Franco, Massimiliano
   Mazzei, Clemente
TI New approach in vaginal prolapse repair: mini-invasive surgery
   associated with application of platelet-rich fibrin
SO INTERNATIONAL UROGYNECOLOGY JOURNAL
LA English
DT Article
DE Dyspareunia; Pelvic organ prolapse (POP); Platelet-rich fibrin (PRF);
   Quality of life; Recurrence; Site-specific repair
ID RECONSTRUCTIVE SURGERY; GENITAL PROLAPSE; RISK-FACTORS; MESH;
   METABOLISM; VIVOSTAT; WOMEN
AB Platelet-rich fibrin (PRF) matrix is an autologous leukocyte and PRF biomaterial. PRF is a fibrin matrix polymerized in a tetramolecular structure with the incorporation of platelets, leukocytes, cytokines, and circulating stem cells. The three-dimensional structure of PRF is optimal for migration of endothelial cells and fibroblasts. It permits rapid angiogenesis and easier remodeling of fibrin in a more resistant connective matrix. In vaginal surgery, PRF may act as a graft material with better healing and better functional outcome.
   We performed a prospective observational study on ten consecutive women requiring surgery for prolapse recurrence (stage II or higher). These women had high risks for recurrence, erosion with graft materials, and intraoperative and postoperative complications with traditional pelvic reconstructive surgical procedures. ICS score and P-QoL Questionnaire results were assessed preoperatively and postoperatively. Surgery consisted of anterior, posterior, or apical repair plus PRF. Follow-up was performed at 1, 6, 12, 18, and 24 months.
   Anatomically, the success rate was 80%. Prolapse symptoms improved by 100%. Sexual activity increased by 20% without dyspareunia. The surgical time was satisfactory (mean, 38.5 min). There were no intraoperative or postoperative complications.
   The use of PRF for site-specific prolapse repair is associated with a good functional outcome because of the healing and mechanical properties of PRF.
C1 [Glorio, Matilde] ASL 1 Imperiese, Gynecol & Obstet Unit, I-18100 Imperia, Italy.
   [Gorlero, Franco; Glorio, Matilde; Lorenzi, Paola] ASL 1, Imperia Hosp, Gynecol & Obstet Unit, Liguria, Italy.
   [Bruno-Franco, Massimiliano; Mazzei, Clemente] ASL 1, Blood Bank Imperia Hosp, Immunohematol & Transfus Med Unit, Liguria, Italy.
RP Glorio, M (reprint author), ASL 1 Imperiese, Gynecol & Obstet Unit, Via St Agata 10, I-18100 Imperia, Italy.
EM matiglori@libero.it
CR Abed H, 2011, INT UROGYNECOL J, V22, P789, DOI 10.1007/s00192-011-1384-5
   Anitua E, 2007, BIOMATERIALS, V28, P4551, DOI 10.1016/j.biomaterials.2007.06.037
   Baessler K, 2006, CURR OPIN OBSTET GYN, V18, P560, DOI 10.1097/01.gco.0000242961.48114.b0
   Bako A, 2009, INT UROGYNECOL J, V20, P103, DOI 10.1007/s00192-008-0717-5
   Belcher E, 2010, J THORAC CARDIOV SUR, V140, P32, DOI 10.1016/j.jtcvs.2009.11.064
   Bhanot Sumeet, 2002, Facial Plast Surg, V18, P27, DOI 10.1055/s-2002-19824
   Cervigni M, 2001, Curr Opin Urol, V11, P429, DOI 10.1097/00042307-200107000-00016
   Choukroun J, 2006, ORAL SURG ORAL MED O, V101, P299, DOI 10.1016/j.tripleo.2005.07.012
   Collinet P, 2006, INT UROGYNECOL J, V17, P315, DOI 10.1007/s00192-005-0003-8
   Digesu GA, 2003, EUR J OBSTET GYN R B, V106, P184, DOI 10.1016/S0301-2115(02)00229-4
   Dohan David M, 2006, Oral Surg Oral Med Oral Pathol Oral Radiol Endod, V101, pe37, DOI 10.1016/j.tripleo.2005.07.008
   Dohan David M, 2006, Oral Surg Oral Med Oral Pathol Oral Radiol Endod, V101, pe51, DOI 10.1016/j.tripleo.2005.07.010
   Dohan David M, 2006, Oral Surg Oral Med Oral Pathol Oral Radiol Endod, V101, pe45, DOI 10.1016/j.tripleo.2005.07.009
   Falconer C, 2001, INT UROGYNECOL J PEL, V12, pS19, DOI 10.1007/s001920170007
   Haylen BT, 2010, INT UROGYNECOL J, V21, P5, DOI 10.1007/s00192-009-0976-9
   Jackson SR, 1996, LANCET, V347, P1658, DOI 10.1016/S0140-6736(96)91489-0
   Kjaergard HK, 1998, ANN THORAC SURG, V66, P482, DOI 10.1016/S0003-4975(98)00470-6
   LILES WC, 1995, J INFECT DIS, V172, P1573, DOI 10.1093/infdis/172.6.1573
   Nedelec B, 2000, J BURN CARE REHABIL, V21, P205, DOI 10.1097/00004630-200021030-00005
   Olsen AL, 1997, OBSTET GYNECOL, V89, P501, DOI 10.1016/S0029-7844(97)00058-6
   Porter WE, 1999, AM J OBSTET GYNECOL, V181, P1353, DOI 10.1016/S0002-9378(99)70376-5
   Rardin CR, 2009, J MINIM INVAS GYN, V16, P360, DOI 10.1016/j.jmig.2009.01.004
   Ridgeway B, 2008, CLIN OBSTET GYNECOL, V51, P136, DOI 10.1097/GRF.0b013e318161e6c6
   Rinne KM, 1999, EUR J OBSTET GYN R B, V84, P23, DOI 10.1016/S0301-2115(99)00002-0
   Salvatore S, 2010, CURR OPIN OBSTET GYN, V22, P420, DOI 10.1097/GCO.0b013e32833e4974
   SILVER FH, 1995, BIOMATERIALS, V16, P891, DOI 10.1016/0142-9612(95)93113-R
   Spotnitz WD, 2010, WORLD J SURG, V34, P632, DOI 10.1007/s00268-009-0252-7
   van Dam JH, 2000, DIS COLON RECTUM, V43, P1556, DOI 10.1007/BF02236738
   van Hinsbergh VWM, 2001, ANN NY ACAD SCI, V936, P426
NR 29
TC 8
Z9 8
U1 0
U2 4
PU SPRINGER LONDON LTD
PI LONDON
PA 236 GRAYS INN RD, 6TH FLOOR, LONDON WC1X 8HL, ENGLAND
SN 0937-3462
EI 1433-3023
J9 INT UROGYNECOL J
JI Int. Urogynecol. J.
PD JUN
PY 2012
VL 23
IS 6
BP 715
EP 722
DI 10.1007/s00192-012-1667-5
PG 8
WC Obstetrics & Gynecology; Urology & Nephrology
SC Obstetrics & Gynecology; Urology & Nephrology
GA 945XF
UT WOS:000304309100011
PM 22273814
DA 2018-10-19
ER

PT J
AU Hagn, F
AF Hagn, Franz
TI A structural view on spider silk proteins and their role in fiber
   assembly
SO JOURNAL OF PEPTIDE SCIENCE
LA English
DT Review
DE biomaterials; NMR spectroscopy; spider silk; structure
ID C-TERMINAL DOMAIN; DRAGLINE SILK; MECHANISM; SEQUENCE
AB Spider silk is the toughest known biomaterial and even outrivals modern synthetic high-performance materials. The question of understanding fiber formation is how the spider can prevent premature and fatal aggregation processes inside its own body and how the chemical and mechanical stimuli used to induce the fiber formation process translate into structural changes of the silk material, finally leading to controlled and irreversible aggregation. Here, the focus will be on the structure and function of the highly conserved N-domains and C-terminal domains of spider dragline silk which, unlike the very long repetitive sequence elements, adopt a folded conformation in solution and are therefore able to control intermolecular interactions and aggregation between other spider silk molecules. The structures of these domains add valuable details for the construction of a molecular picture of the complicated and highly optimized silk assembly process that might be beneficial for large-scale in vitro fiber formation attempts with recombinant silk material. Copyright (c) 2012 European Peptide Society and John Wiley & Sons, Ltd.
C1 Harvard Univ, Sch Med, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA.
RP Hagn, F (reprint author), Harvard Univ, Sch Med, Dept Biol Chem & Mol Pharmacol, 240 Longwood Ave, Boston, MA 02115 USA.
EM franz_hagn@hms.harvard.edu
RI Hagn, Franz/N-9553-2016
OI Hagn, Franz/0000-0002-1315-459X
FU Technische Universitat Munchen; Andreas Bausch and Georg Abstreiter (TU
   Munchen); EMBO [ALTF-265-2010]; Human Frontier Science Program
   [LT000297/2011-L]
FX All experiments were performed in the lab of Horst Kessler at the
   Technische Universitat Munchen. I want to thank him for continuous
   support and guidance as well as for proofreading of the manuscript.
   Thomas Scheibel, Lukas Eisoldt, Christopher Thamm, and John Hardy are
   gratefully acknowledged for collaboration in the spider silk field and
   the kind gift of plasmids used for initial work. I want to thank the
   Elitenetzwerk Bayem and the elite graduate program CompInt managed by
   Andreas Bausch and Georg Abstreiter (TU Munchen) for their support. I
   also want to thank Katie Edmonds (Harvard Medical School) for
   proofreading of the manuscript. The Bavarian NMR Centre is gratefully
   acknowledged for NMR time. The chemical shift assignments and structural
   coordinates are deposited at the BMRB (16249 and 17131) and the RCSB
   database (2khm. pdb), respectively. Postdoctoral funding by EMBO
   (ALTF-265-2010) and Human Frontier Science Program (LT000297/2011-L)
   long-term fellowships is gratefully acknowledged.
CR Askarieh G, 2010, NATURE, V465, P236, DOI 10.1038/nature08962
   Exler JH, 2007, ANGEW CHEM INT EDIT, V46, P3559, DOI 10.1002/anie.200604718
   Gaines WA, 2010, J BIOL CHEM, V285, P40745, DOI 10.1074/jbc.M110.163121
   GEMMECKER G, 1993, J AM CHEM SOC, V115, P11620, DOI 10.1021/ja00077a080
   GOSLINE JM, 1986, ENDEAVOUR, V10, P37, DOI 10.1016/0160-9327(86)90049-9
   Gosline JM, 1999, J EXP BIOL, V202, P3295
   Gouet P, 2003, NUCLEIC ACIDS RES, V31, P3320, DOI 10.1093/nar/gkg556
   Hagn F, 2011, ANGEW CHEM INT EDIT, V50, P310, DOI 10.1002/anie.201003795
   Hagn F, 2010, NATURE, V465, P239, DOI 10.1038/nature08936
   Heim M, 2009, ANGEW CHEM INT EDIT, V48, P3584, DOI 10.1002/anie.200803341
   Hummerich D, 2004, BIOCHEMISTRY-US, V43, P13604
   Ittah S, 2006, BIOMACROMOLECULES, V7, P1790, DOI 10.1021/bm060120k
   Ittah S, 2007, BIOMACROMOLECULES, V8, P2768, DOI 10.1021/bm7004559
   Jin HJ, 2003, NATURE, V424, P1057, DOI 10.1038/nature01809
   Knight DP, 1999, P ROY SOC B-BIOL SCI, V266, P519, DOI 10.1098/rspb.1999.0667
   Knight DP, 2001, NATURWISSENSCHAFTEN, V88, P179, DOI 10.1007/s001140100220
   Knight DP, 2000, INT J BIOL MACROMOL, V27, P205, DOI 10.1016/S0141-8130(00)00124-0
   KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0
   Landreh M, 2010, J MOL BIOL, V404, P328, DOI 10.1016/j.jmb.2010.09.054
   Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404
   Lefevre T, 2008, BIOMACROMOLECULES, V9, P2399, DOI 10.1021/bm800390j
   Lewis RV, 2006, CHEM REV, V106, P3762, DOI 10.1021/cr010194g
   Lin Z, 2009, P NATL ACAD SCI USA, V106, P8906, DOI 10.1073/pnas.0813255106
   Motriuk-Smith D, 2005, BIOMACROMOLECULES, V6, P3152, DOI 10.1021/bm050472b
   Rammensee S, 2008, P NATL ACAD SCI USA, V105, P6590, DOI 10.1073/pnas.0709246105
   Rising A, 2006, BIOMACROMOLECULES, V7, P3120, DOI 10.1021/bm060693x
   Romer L, 2008, PRION, V2, P154
   Sattler M, 1999, PROG NUCL MAG RES SP, V34, P93, DOI 10.1016/S0079-6565(98)00025-9
   Slotta U, 2007, MACROMOL BIOSCI, V7, P183, DOI 10.1002/mabi.200600201
   Sponner A, 2005, BIOCHEM BIOPH RES CO, V338, P897, DOI 10.1016/j.bbrc.2005.10.048
   Tugarinov V, 2003, J AM CHEM SOC, V125, P13868, DOI 10.1021/ja030345s
   van Beek JD, 2002, P NATL ACAD SCI USA, V99, P10266, DOI 10.1073/pnas.152162299
   Vendrely C, 2007, MACROMOL BIOSCI, V7, P401, DOI 10.1002/mabi.200600255
   VOLLRATH F, 1992, SCI AM, V266, P70, DOI 10.1038/scientificamerican0392-70
   Vollrath F, 2001, NATURE, V410, P541, DOI 10.1038/35069000
   WISHART DS, 1994, J BIOMOL NMR, V4, P171
NR 36
TC 12
Z9 15
U1 3
U2 71
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1075-2617
J9 J PEPT SCI
JI J. Pept. Sci.
PD JUN
PY 2012
VL 18
IS 6
BP 357
EP 365
DI 10.1002/psc.2417
PG 9
WC Biochemistry & Molecular Biology; Chemistry, Analytical
SC Biochemistry & Molecular Biology; Chemistry
GA 944IV
UT WOS:000304194000001
PM 22570231
DA 2018-10-19
ER

PT J
AU Lin, H
   Yang, G
   Tan, J
   Tuan, RS
AF Lin, Hang
   Yang, Guang
   Tan, Jian
   Tuan, Rocky S.
TI Influence of decellularized matrix derived from human mesenchymal stem
   cells on their proliferation, migration and multi-lineage
   differentiation potential
SO BIOMATERIALS
LA English
DT Article
DE Decellularized matrix; Adult stem cells; Cell migration;
   Differentiation; Cell-matrix interaction
ID MEMBRANE EXTRACELLULAR-MATRIX; OSTEOGENIC DIFFERENTIATION; STROMAL
   CELLS; GROWTH; INTEGRIN; CULTURE; REGENERATION; VITRONECTIN; ADHESION;
   STRESS
AB Developing biomaterials to promote stem cell proliferation and differentiation is a critical requirement in tissue engineering and regeneration. Extracellular matrix (ECM) derived from mesenchymal stem cells (MSCs) has recently been shown to be able to maintain the differentiation potential of MSCs during culture expansion and to restore the activities of aging MSCs, suggesting that MSC ECM (MECM) may be a suitable culture substrate to enhance the bioactivity of biomaterial scaffolds for MSCs. This investigation aims to characterize the biological nature and specificity of the influence of the MECM on MSCs. Native ECM produced by human MSC in vitro was extracted in urea, and the residual pellet was further processed with pepsin digestion (denoted as U-MECM and HP-MECM, respectively). The MECM products were then coated as a substrate on standard tissue culture plastic, and the behavior of MSCs seeded on the coated surfaces was studied. Our results showed that U-MECM coating dramatically accelerated MSC proliferation, attachment, spread, migration and multi-lineage differentiation (i.e., osteogenesis and adipogenesis), compared to collagen type I and HP-MECM coating. Non-collagenous proteins are likely the bioactive components in U-MECM, as MSCs cultured on collagen type I and HP-MECM showed similar biological activities, and collagen type I appeared to be the major protein components remaining in HP-MECM based on SDS-PAGE. These findings support the biological utility of MECM in the formulation of biomaterial scaffolds to enhance MSC bioactivities, including proliferation, migration and multi-lineage differentiation, for tissue regeneration applications. (C) 2012 Elsevier Ltd. All rights reserved.
C1 [Lin, Hang; Yang, Guang; Tan, Jian; Tuan, Rocky S.] Univ Pittsburgh, Sch Med, Ctr Cellular & Mol Engn, Dept Orthopaed Surg, Pittsburgh, PA 15219 USA.
RP Tuan, RS (reprint author), Univ Pittsburgh, Sch Med, Ctr Cellular & Mol Engn, Dept Orthopaed Surg, 450 Technol Dr,Room 221, Pittsburgh, PA 15219 USA.
EM rst13@pitt.edu
RI Lin, Hang/D-3003-2012
OI Lin, Hang/0000-0002-0781-6630
FU Commonwealth of Pennsylvania Department of Health
FX The authors gratefully acknowledge Dr. Paul Manner, University of
   Washington, for providing human tissue samples, and Dr. Juan M.Taboas,
   University of Pittsburgh, for real-time PCR technical instructions and
   helpful discussions regarding this work. Supported in part by a grant
   from the Commonwealth of Pennsylvania Department of Health.
CR Agrawal V, 2011, TISSUE ENG PT A, V17, P2435, DOI [10.1089/ten.TEA.2011.0036, 10.1089/ten.tea.2011.0036]
   Aizman I, 2009, J NEUROSCI RES, V87, P3198, DOI 10.1002/jnr.22146
   Ando W, 2008, TISSUE ENG PT A, V14, P2041, DOI 10.1089/ten.tea.2008.0015
   Angstmann M, 2011, CYTOTHERAPY, V13, P1074, DOI 10.3109/14653249.2011.584863
   Chen FH, 2008, ARTHRITIS RES THER, V10, DOI 10.1186/ar2514
   Chen XD, 2010, BIRTH DEFECTS RES C, V90, P45, DOI 10.1002/bdrc.20171
   Decaris ML, 2010, ANN BIOMED ENG, V39, P1174
   Discher DE, 2009, SCIENCE, V324, P1673, DOI 10.1126/science.1171643
   Doran MR, 2010, BIOMATERIALS, V31, P5137, DOI 10.1016/j.biomaterials.2010.03.015
   Engler AJ, 2006, CELL, V126, P677, DOI 10.1016/j.cell.2006.06.044
   Freytes DO, 2008, BIOMATERIALS, V29, P1630, DOI 10.1016/j.biomaterials.2007.12.014
   Fu RH, 2011, CELL TRANSPLANT, V20, P37, DOI 10.3727/096368910X532756
   Garcia-Gomez I, 2010, EXPERT OPIN BIOL TH, V10, P1453, DOI 10.1517/14712598.2010.519333
   Guilak F, 2009, CELL STEM CELL, V5, P17, DOI 10.1016/j.stem.2009.06.016
   Ho M, 2006, BIOMATERIALS, V27, P4333, DOI 10.1016/j.biomaterials.2006.03.037
   Huang NF, 2010, ACTA BIOMATER, V6, P4614, DOI 10.1016/j.actbio.2010.06.033
   Hynes RO, 2009, SCIENCE, V326, P1216, DOI 10.1126/science.1176009
   Kim SH, 2011, J ENDOCRINOL, V209, P139, DOI 10.1530/JOE-10-0377
   Kuhn NZ, 2010, J CELL PHYSIOL, V222, P268, DOI 10.1002/jcp.21940
   Kundu AK, 2009, TISSUE ENG PT A, V15, P273, DOI 10.1089/ten.tea.2008.0055
   Lai YL, 2010, STEM CELLS DEV, V19, P1095, DOI 10.1089/scd.2009.0217
   Lindner U, 2010, CYTOTHERAPY, V12, P992, DOI 10.3109/14653249.2010.510503
   Matsubara T, 2004, BIOCHEM BIOPH RES CO, V313, P503, DOI 10.1016/j.bbrc.2003.11.143
   Mizuno M, 2000, J CELL PHYSIOL, V184, P207, DOI 10.1002/1097-4652(200008)184:2<207::AID-JCP8>3.3.CO;2-L
   Mruthyunjaya S, 2011, FEBS LETT, V585, P1915, DOI 10.1016/j.febslet.2011.04.072
   Mruthyunjaya S, 2010, BIOCHEM BIOPH RES CO, V391, P43, DOI 10.1016/j.bbrc.2009.10.158
   Noth U, 2010, ADV DRUG DELIVER REV, V62, P765, DOI 10.1016/j.addr.2010.04.004
   Ode A, 2010, J BIOMED MATER RES A, V95A, P1114, DOI 10.1002/jbm.a.32909
   Park JS, 2010, BIOMATERIALS, V31, P6239, DOI 10.1016/j.biomaterials.2010.05.002
   Parsons JT, 2010, NAT REV MOL CELL BIO, V11, P633, DOI 10.1038/nrm2957
   Prowse ABJ, 2011, STEM CELL RES, V6, P1, DOI 10.1016/j.scr.2010.09.005
   Qian LC, 2004, BIOMATERIALS, V25, P1331, DOI 10.1016/j.biomaterials.2003.08.013
   Salasznyk RM, 2004, J BIOMED BIOTECHNOL, P24, DOI 10.1155/S1110724304306017
   Santiago JA, 2009, TISSUE ENG PT A, V15, P3911, DOI 10.1089/ten.tea.2008.0603
   Schafer M, 2008, PHARMACOL RES, V58, P165, DOI 10.1016/j.phrs.2008.06.004
   Schofer MD, 2009, J MATER SCI-MATER M, V20, P1535, DOI 10.1007/s10856-009-3719-z
   Shi CY, 2011, BIOMATERIALS, V32, P2508, DOI 10.1016/j.biomaterials.2010.12.026
   Stern MM, 2009, BIOMATERIALS, V30, P2393, DOI 10.1016/j.biomaterials.2008.12.069
   Sun Y, 2011, FASEB J, V25, P1474, DOI 10.1096/fj.10-161497
   Thibault MM, 2007, STEM CELLS DEV, V16, P489, DOI 10.1089/scd.2006.0100
   Uriel S, 2009, TISSUE ENG PART C-ME, V15, P309, DOI 10.1089/ten.tec.2008.0309
   Wei H, 2010, J CELL BIOCHEM, V111, P967, DOI 10.1002/jcb.22785
NR 42
TC 59
Z9 60
U1 1
U2 49
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD JUN
PY 2012
VL 33
IS 18
BP 4480
EP 4489
DI 10.1016/j.biomaterials.2012.03.012
PG 10
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 941GZ
UT WOS:000303953000005
PM 22459197
DA 2018-10-19
ER

PT J
AU Skardal, A
   Smith, L
   Bharadwaj, S
   Atala, A
   Soker, S
   Zhang, YY
AF Skardal, Aleksander
   Smith, Leona
   Bharadwaj, Shantaram
   Atala, Anthony
   Soker, Shay
   Zhang, Yuanyuan
TI Tissue specific synthetic ECM hydrogels for 3-D in vitro maintenance of
   hepatocyte function
SO BIOMATERIALS
LA English
DT Article
DE Hyaluronic acid; Heparin; Hepatocyte; Extracellular matrix; Growth
   factors
ID HYALURONAN HYDROGELS; STEM-CELL; EXTRACELLULAR MATRICES; GROWTH-FACTOR;
   SCAFFOLDS; DIFFERENTIATION; TOXICOLOGY; TOXICITY; RELEASE; CULTURE
AB Despite recent advances in biomaterial science, there is yet no culture system that supports long-term culture expansion of human adult hepatocytes, while preserving continued function. Previous studies suggested that acellular liver extracellular matrix (ECM), employed as a substrate, improved proliferation and function of liver cells. Here we investigated whether extracts prepared from acellular liver ECM (liver ECM extract, LEE), or from whole (fresh) liver tissue (liver tissue extract, LIE), could be combined with collagen Type I, hyaluronic acid (HA), or heparin-conjugated HA (HP) hydrogels to enhance survival and functional output of primary human hepatocytes. The liver-specific semi-synthetic ECMs (sECMs) were prepared by incorporating LEE or LIE into the gel matrices. Subsequently, primary human hepatocytes were maintained in sandwich-style hydrogel cultures for 4 weeks. Progressive increase in hepatocyte metabolism was observed in all HA and HP groups. Hepatocytes cultured in HA and HP hydrogels containing LEE or LTE synthesized and secreted steady levels of albumin and urea and sustained cytochrome p450-dependent drug metabolism of ethoxycoumarin. Collectively, these results indicate that customized HA hydrogels with liver-specific ECM components may be an efficient method for expansion human hepatocytes in vitro for cell therapy and drug and toxicology screening purposes. (C) 2012 Elsevier Ltd. All rights reserved.
C1 [Skardal, Aleksander; Smith, Leona; Bharadwaj, Shantaram; Atala, Anthony; Soker, Shay; Zhang, Yuanyuan] Wake Forest Inst Regenerat Med, Winston Salem, NC 27101 USA.
RP Soker, S (reprint author), Wake Forest Inst Regenerat Med, 391 Technol Way, Winston Salem, NC 27101 USA.
EM ssoker@wfubmc.edu; yzhang@wakehealth.edu
OI Atala, Anthony/0000-0001-8186-2160
FU Telemedicine and Advanced Technology Research Center (TATRC) at the U.S.
   Army Medical Research and Material Command (USAMRMC) [W81XWH-07-1-0718]
FX We thank Disher Packing, Inc. for providing porcine livers. We also
   thank Pedro Baptista for his contributions to parts of this project.
   This study was supported, in part, by the Telemedicine and Advanced
   Technology Research Center (TATRC) at the U.S. Army Medical Research and
   Material Command (USAMRMC) through award W81XWH-07-1-0718.
CR Ananthanarayanan A, 2011, TRENDS BIOTECHNOL, V29, P110, DOI 10.1016/j.tibtech.2010.10.006
   Badylak SF, 2007, BIOMATERIALS, V28, P3587, DOI 10.1016/j.biomaterials.2007.04.043
   Bierwolf J, 2011, BIOTECHNOL BIOENG, V108, P141, DOI 10.1002/bit.22924
   Burdick JA, 2011, ADV MATER, V23, pH41, DOI 10.1002/adma.201003963
   Elia R, 2010, BIOMATERIALS, V31, P4630, DOI 10.1016/j.biomaterials.2010.02.043
   Erickson IE, 2009, TISSUE ENG PT A, V15, P1041, DOI 10.1089/ten.tea.2008.0099
   Fan JY, 2010, J MATER SCI-MATER M, V21, P319, DOI 10.1007/s10856-009-3833-y
   Feng ZQ, 2009, BIOMATERIALS, V30, P2753, DOI 10.1016/j.biomaterials.2009.01.053
   Freytes DO, 2008, BIOMATERIALS, V29, P1630, DOI 10.1016/j.biomaterials.2007.12.014
   Fukuda J, 2011, BIOMICROFLUIDICS, V5, DOI 10.1063/1.3576905
   Gerecht S, 2007, P NATL ACAD SCI USA, V104, P11298, DOI 10.1073/pnas.0703723104
   Greenhough S, 2010, TOXICOLOGY, V278, P250, DOI 10.1016/j.tox.2010.07.012
   Guo L, 2011, DRUG METAB DISPOS, V39, P528, DOI 10.1124/dmd.110.035873
   Gomez-Lechon MJ, 2010, METHODS MOL BIOL, V640, P389, DOI 10.1007/978-1-60761-688-7_21
   Kim M, 2010, BIOMATERIALS, V31, P3596, DOI 10.1016/j.biomaterials.2010.01.068
   Lang R, 2011, BIOMATERIALS, V32, P7042, DOI 10.1016/j.biomaterials.2011.06.005
   Leach JB, 2004, J BIOMED MATER RES A, V70A, P74, DOI 10.1002/jbm.a.30063
   Li J, 2010, STEM CELLS DEV, V19, P1427, DOI 10.1089/scd.2009.0415
   Liu YC, 2007, WOUND REPAIR REGEN, V15, P245, DOI 10.1111/j.1524-475X.2007.00211.x
   Liu YC, 2007, TISSUE ENG, V13, P1091, DOI 10.1089/ten.2006.0297
   Lu YP, 2004, BIOMATERIALS, V25, P4393, DOI [10.1016/j.biomaterials.2003.10.092, 10.1016/j.biomaterials.2003.08.014]
   Mazzitelli S, 2011, ACTA BIOMATER, V7, P1050, DOI 10.1016/j.actbio.2010.10.005
   Miki D, 2002, CORNEA, V21, P393, DOI 10.1097/00003226-200205000-00012
   Pike DB, 2006, BIOMATERIALS, V27, P5242, DOI 10.1016/j.biomaterials.2006.05.018
   Prestwich GD, 2008, ACCOUNTS CHEM RES, V41, P139, DOI 10.1021/ar7000827
   Serban Monica A, 2008, Curr Protoc Cell Biol, VChapter 10, DOI 10.1002/0471143030.cb1014s40
   Shu XZ, 2006, J BIOMED MATER RES A, V79A, P902, DOI 10.1002/jbm.a.30831
   Skardal A, 2010, ADV MATER, V22, P4736, DOI 10.1002/adma.201001436
   Skardal A, 2010, BIOMATERIALS, V31, P6173, DOI 10.1016/j.biomaterials.2010.04.045
   Williams CM, 2011, TISSUE ENG PT A, V17, P1055, DOI [10.1089/ten.tea.2010.0398, 10.1089/ten.TEA.2010.0398]
NR 30
TC 65
Z9 69
U1 3
U2 59
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD JUN
PY 2012
VL 33
IS 18
BP 4565
EP 4575
DI 10.1016/j.biomaterials.2012.03.034
PG 11
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 941GZ
UT WOS:000303953000014
PM 22475531
OA Green Accepted
DA 2018-10-19
ER

PT J
AU Zakhem, E
   Raghavan, S
   Gilmont, RR
   Bitar, KN
AF Zakhem, Elie
   Raghavan, Shreya
   Gilmont, Robert R.
   Bitar, Khalil N.
TI Chitosan-based scaffolds for the support of smooth muscle constructs in
   intestinal tissue engineering
SO BIOMATERIALS
LA English
DT Article
DE Rabbit circular smooth muscle (RCSM) constructs; Chitosan; Force
   generation; Scaffold; Concentric
ID SMALL-BOWEL RESECTION; IN-VITRO; CELLS; COLLAGEN; RELAXATION;
   OVERWEIGHT; WEIGHT; MODEL
AB Intestinal tissue engineering is an emerging field due to a growing demand for intestinal lengthening and replacement procedures secondary to massive resections of the bowel. Here, we demonstrate the potential use of a chitosan/collagen scaffold as a 3D matrix to support the bioengineered circular muscle constructs maintain their physiological functionality. We investigated the biocompatibility of chitosan by growing rabbit colonic circular smooth muscle cells (RCSMCs) on chitosan-coated plates. The cells maintained their spindle-like morphology and preserved their smooth muscle phenotypic markers. We manufactured tubular scaffolds with central openings composed of chitosan and collagen in a 1:1 ratio. Concentrically aligned 3D circular muscle constructs were bioengineered using fibrin-based hydrogel seeded with RCSMCs. The constructs were placed around the scaffold for 2 weeks, after which they were taken off and tested for their physiological functionality. The muscle constructs contracted in response to acetylcholine (Ach) and potassium chloride (KCl) and they relaxed in response to vasoactive intestinal peptide (VIP). These results demonstrate that chitosan is a biomaterial possibly suitable for intestinal tissue engineering applications. (c) 2012 Elsevier Ltd. All rights reserved.
C1 [Zakhem, Elie; Raghavan, Shreya; Gilmont, Robert R.; Bitar, Khalil N.] Wake Forest Sch Med, Wake Forest Inst Regenerat Med, Winston Salem, NC 27101 USA.
RP Bitar, KN (reprint author), Wake Forest Sch Med, Wake Forest Inst Regenerat Med, 391 Technol Way, Winston Salem, NC 27101 USA.
EM kbitar@wakehealth.edu
OI Raghavan, Shreya/0000-0002-4631-7762
FU National Institutes of Health [RO1 DK-042876, RO1 DK-071614]
FX The authors would like to thank Sita Somara and Saranyaraajan
   Varadarajan for their assistance with this study and the colleagues at
   Wake Forest Institute for Regenerative Medicine for providing assistance
   with the microscopy. The authors gratefully acknowledge the funding
   support provided by National Institutes of Health RO1 DK-042876 and RO1
   DK-071614.
CR An JY, 2002, BRIT J PHARMACOL, V137, P1001, DOI 10.1038/sj.bjp.0704954
   COSNES J, 1978, DIGESTION, V18, P329, DOI 10.1159/000198220
   de Toledo OMS, 2002, IUBMB LIFE, V54, P19, DOI 10.1080/15216540290106431
   Di Martino A, 2005, BIOMATERIALS, V26, P5983, DOI 10.1016/j.biomaterials.2005.03.016
   GALEA MH, 1992, J PEDIATR SURG, V27, P592, DOI 10.1016/0022-3468(92)90455-G
   Gillian B., 1998, NUTRITION, V14, P813
   Grikscheit TC, 2004, ANN SURG, V240, P748, DOI 10.1097/01.sla.0000143246.07277.73
   Grikscheit TC, 2003, ANN SURG, V238, P35, DOI 10.1097/01.SLA.0000074964.77367.4a
   Gupta A, 2009, BIOTECHNOL APPL BIOC, V54, P221, DOI 10.1042/BA20090214
   Hecker L, 2005, AM J PHYSIOL-GASTR L, V289, pG188, DOI 10.1152/ajpgi.00335.2004
   Hori Y, 2002, J SURG RES, V102, P156, DOI 10.1006/jsre.2001.6294
   Hori Y, 2001, INT J ARTIF ORGANS, V24, P50
   HOSEY MM, 1992, FASEB J, V6, P845
   Hu XY, 2009, TISSUE ENG PT A, V15, P3297, DOI 10.1089/ten.TEA.2009.0017
   Janson Douglas D, 2002, Nutr Clin Pract, V17, P361, DOI 10.1177/0115426502017006361
   Kato T, 2002, WORLD J SURG, V26, P226
   Kim IY, 2008, BIOTECHNOL ADV, V26, P1, DOI 10.1016/j.biotechadv.2007.07.009
   Krupnick A S, 2000, Semin Gastrointest Dis, V11, P41
   L'Heureux N, 2001, FASEB J, V15, P515, DOI 10.1096/fj.00-0283com
   Lee M, 2008, TISSUE ENG PT A, V14, P1395, DOI 10.1089/ten.tea.2007.0232
   Ma L, 2003, BIOMATERIALS, V24, P4833, DOI 10.1016/S0142-9612(03)00374-0
   Madihally SV, 1999, BIOMATERIALS, V20, P1133, DOI 10.1016/S0142-9612(99)00011-3
   Mhurchu CN, 2005, OBES REV, V6, P35, DOI 10.1111/j.1467-789X.2005.00158.x
   Mhurchu CN, 2004, INT J OBESITY, V28, P1149, DOI 10.1038/sj.ijo.0802693
   MURTHY KS, 1995, AM J PHYSIOL-CELL PH, V268, pC171
   Muzzarelli RAA, 1996, CARBOHYD POLYM, V29, P309, DOI 10.1016/S0144-8617(96)00033-1
   Nakase Y, 2006, TISSUE ENG, V12, P403, DOI 10.1089/ten.2006.12.403
   Neff LP, 2011, J VASC SURG, V53, P426, DOI 10.1016/j.jvs.2010.07.054
   Raghavan S, 2010, TISSUE ENG PART C-ME, V16, P999, DOI 10.1089/ten.TEC.2009.0394
   Sachlos E, 2006, TISSUE ENG, V12, P2479, DOI 10.1089/ten.2006.12.2479
   Sarkar S, 2005, ACTA BIOMATER, V1, P93, DOI 10.1016/j.actbio.2004.08.003
   Schmidt T, 1996, GUT, V38, P859, DOI 10.1136/gut.38.6.859
   Somara S, 2010, AM J PHYSIOL-GASTR L, V299, pG1164, DOI 10.1152/ajpgi.00479.2009
   Somara S, 2009, GASTROENTEROLOGY, V137, P53, DOI 10.1053/j.gastro.2009.03.036
   Suh JKF, 2000, BIOMATERIALS, V21, P2589
   Taravel MN, 1996, BIOMATERIALS, V17, P451, DOI 10.1016/0142-9612(96)89663-3
   Uygun BE, 2009, TISSUE ENG PT A, V15, P3499, DOI 10.1089/ten.TEA.2008.0405
   Van Geldre LA, 2004, CURR PHARM DESIGN, V10, P2483
   VandeVord PJ, 2002, J BIOMED MATER RES, V59, P585, DOI 10.1002/jbm.1270
   Xu CY, 2004, BIOMATERIALS, V25, P877, DOI 10.1016/S0142-9612(03)00593-3
NR 40
TC 47
Z9 48
U1 0
U2 33
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD JUN
PY 2012
VL 33
IS 19
BP 4810
EP 4817
DI 10.1016/j.biomaterials.2012.03.051
PG 8
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 941MA
UT WOS:000303966100004
PM 22483012
OA Green Accepted
DA 2018-10-19
ER

PT J
AU Zhang, ZP
   Tan, SW
   Feng, SS
AF Zhang, Zhiping
   Tan, Songwei
   Feng, Si-Shen
TI Vitamin E TPGS as a molecular biomaterial for drug delivery
SO BIOMATERIALS
LA English
DT Review
DE Cancer nanotechnology; Biodegradable polymers; Liposomes; Micelles;
   Nanoparticles; Prodrugs
ID POLYETHYLENE-GLYCOL SUCCINATE; BIODEGRADABLE COPOLYMER BLEND;
   SUPERPARAMAGNETIC IRON-OXIDE; SOLID LIPID NANOPARTICLES; ENHANCED
   CELLULAR UPTAKE; NEW-CONCEPT CHEMOTHERAPY; DOUBLE EMULSION PROCESS;
   BLOOD-BRAIN-BARRIER; BREAST-CANCER CELLS; IN-VITRO EVALUATION
AB D-alpha-tocopheryl polyethylene glycol succinate (Vitamin E TPGS, or simply TPGS) is a water-soluble derivative of natural Vitamin E, which is formed by esterification of Vitamin E succinate with polyethylene glycol (PEG). As such, it has advantages of PEG and Vitamin E in application of various nanocarriers for drug delivery, including extending the half-life of the drug in plasma and enhancing the cellular uptake of the drug. TPGS has an amphiphilic structure of lipophilic alkyl tail and hydrophilic polar head with a hydrophile/lipophile balance (HLB) value of 13.2 and a relatively low critical micelle concentration (CMC) of 0.02% w/w, which make it to be an ideal molecular biomaterial in developing various drug delivery systems, including prodrugs, micelles, liposomes and nanoparticles, which would be able to realize sustained, controlled and targeted drug delivery as well as to overcome multidrug resistance (MDR) and to promote oral drug delivery as an inhibitor of P-glycoprotein (P-gp). In this review, we briefly discuss its physicochemical and pharmaceutical properties and its wide applications in composition of the various nanocarriers for drug delivery, which we call TPGS-based drug delivery systems. (c) 2012 Elsevier Ltd. All rights reserved.
C1 [Feng, Si-Shen] Natl Univ Singapore, Dept Chem & Biomol Engn, Singapore 117576, Singapore.
   [Zhang, Zhiping; Tan, Songwei] Huazhong Univ Sci & Technol, Tongji Sch Pharm, Wuhan 430030, Peoples R China.
   [Zhang, Zhiping; Tan, Songwei] Huazhong Univ Sci & Technol, Natl Engn Res Ctr Nanomed, Wuhan 430030, Peoples R China.
   [Feng, Si-Shen] Natl Univ Singapore, Dept Bioengn, Singapore 117576, Singapore.
   [Feng, Si-Shen] Natl Univ Singapore, Nanosci & Nanoengn Initiat NUSNNI, Singapore 117576, Singapore.
RP Feng, SS (reprint author), Natl Univ Singapore, Dept Chem & Biomol Engn, Block E5,02-11,4 Engn Dr 4, Singapore 117576, Singapore.
EM chefss@nus.edu.sg
RI Tan, Song-wei/H-1789-2011; zhang, zhiping/H-1786-2011
OI Tan, Song-wei/0000-0002-2986-8968; 
FU National Basic Research Program of China (973 Program) [2012CB932500];
   Singapore-China Collaborative Grant, A*STAR, Singapore
   [R-398-000-077-305]; NUS FRC [R-397-000-136-731]
FX The work was financially supported jointly by National Basic Research
   Program of China (973 Program, 2012CB932500) and the Singapore-China
   Collaborative Grant, A*STAR, Singapore (R-398-000-077-305. PI: SS Feng)
   and NUS FRC R-397-000-136-731 (Co-PI: SS Feng).
CR Anbharasi V, 2010, J BIOMED MATER RES A, V94A, P730, DOI 10.1002/jbm.a.32734
   Cao N, 2008, BIOMATERIALS, V29, P3856, DOI 10.1016/j.biomaterials.2008.05.016
   Chandran T, 2010, INT J PHARMACEUT, V392, P170, DOI 10.1016/j.ijpharm.2010.03.056
   Chandrasekharan P, 2011, BIOMATERIALS, V32, P5663, DOI 10.1016/j.biomaterials.2011.04.037
   Chen HB, 2011, NANOSCALE RES LETT, V6, DOI 10.1007/s11671-010-9741-8
   Cheow WS, 2011, COLLOID SURFACE B, V85, P214, DOI 10.1016/j.colsurfb.2011.02.033
   Cho KY, 2001, J CONTROL RELEASE, V76, P275, DOI 10.1016/S0168-3659(01)00442-4
   Chytil P, 2006, J CONTROL RELEASE, V115, P26, DOI 10.1016/j.jconrel.2006.06.028
   Collnot EM, 2010, MOL PHARMACEUT, V7, P642, DOI 10.1021/mp900191s
   Conover CD, 1998, CANCER CHEMOTH PHARM, V42, P407, DOI 10.1007/s002800050837
   Constantinides PP, 2006, PHARM RES, V23, P243, DOI 10.1007/s11095-005-9262-9
   Dabholkar RD, 2006, INT J PHARM, V315, P148, DOI 10.1016/j.ijpharm.2006.02.018
   Dai WG, 2008, INT J PHARM, V355, P31, DOI 10.1016/j.ijpharm.2007.12.015
   Dinarvand R, 2011, INT J NANOMED, V6, P877, DOI 10.2147/IJN.S18905
   Dintaman JM, 1999, PHARMACEUT RES, V16, P1550, DOI 10.1023/A:1015000503629
   Dong XW, 2009, EUR J PHARM BIOPHARM, V72, P9, DOI 10.1016/j.ejpb.2008.11.012
   Dong YC, 2004, BIOMATERIALS, V25, P2843, DOI 10.1016/j.biomaterials.2003.09.055
   Duncan R, 2003, NAT REV DRUG DISCOV, V2, P347, DOI 10.1038/nrd1088
   Esmaeili F, 2007, J EXP NANOSCI, V2, P183, DOI 10.1080/17458080701393137
   Feng SS, 2008, BIOMATERIALS, V29, P4146
   Feng SS, 2007, CHEM ENG SCI, V62, P6641, DOI 10.1016/j.ces.2007.08.006
   Feng SS, 2007, NANOMEDICINE-UK, V2, P333, DOI 10.2217/17435889.2.3.333
   Feng SS, 2006, NANOMEDICINE-UK, V1, P297, DOI 10.2217/17435889.1.3.297
   Feng SS, 2009, BIOMATERIALS, V30, P3297, DOI 10.1016/j.biomaterials.2009.02.045
   Feng SS, 2004, CURR MED CHEM, V11, P413, DOI 10.2174/0929867043455909
   Feng SS, 2004, EXPERT REV MED DEVIC, V1, P115, DOI 10.1586/17434440.1.1.115
   Feng SS, 2003, CHEM ENG SCI, V58, P4087, DOI 10.1016/S0009-2509(03)00234-3
   Feng X, 2002, BIOORG MED CHEM LETT, V12, P3301, DOI 10.1016/S0960-894X(02)00694-7
   Gan CW, 2010, BIOMATERIALS, V31, P7748, DOI 10.1016/j.biomaterials.2010.06.053
   Gan CW, 2010, CURR PHARM DESIGN, V16, P2308
   Gao Y, 2008, COLLOID SURFACE B, V64, P194, DOI 10.1016/j.colsurfb.2008.01.021
   Greenwald RB, 2003, ADV DRUG DELIVER REV, V55, P217, DOI 10.1016/S0169-409X(02)00180-1
   Greenwald RB, 2001, J CONTROL RELEASE, V74, P159, DOI 10.1016/S0168-3659(01)00331-5
   Greenwald RB, 2000, CRIT REV THER DRUG, V17, P101
   Ha PT, 2010, ADV NAT SCI NANOSCI, V1, P15
   Huang LQ, 2011, INTEGR BIOL-UK, V3, P993, DOI 10.1039/c1ib00026h
   Huang W, 2011, CHEM J CHINESE U, V32, P416
   Italia JL, 2009, PHARM RES-DORDR, V26, P1324, DOI 10.1007/s11095-009-9841-2
   Jung GY, 2009, ARCH PHARM RES, V32, P359, DOI 10.1007/s12272-009-1308-9
   Katragadda U, 2011, INT J PHARMACEUT, V419, P281, DOI 10.1016/j.ijpharm.2011.07.033
   Kim MS, 2005, INT J PHARMACEUT, V304, P165, DOI 10.1016/j.ijpharm.2005.08.004
   Kopecek J, 2001, J CONTROL RELEASE, V74, P147, DOI 10.1016/S0168-3659(01)00330-3
   Kopecek J, 2000, EUR J PHARM BIOPHARM, V50, P61, DOI 10.1016/S0939-6411(00)00075-8
   KRASAVAGE WJ, 1977, J AGR FOOD CHEM, V25, P273, DOI 10.1021/jf60210a002
   Kulkarni SA, 2011, NANOMEDICINE-UK, V6, P377, DOI 10.2217/NNM.10.131
   Lee P.FengSS, 2005, AACR M, P337
   Lee SH, 2007, BIOMATERIALS, V28, P2041, DOI 10.1016/j.biomaterials.2007.01.003
   Li C, 1999, CLIN CANCER RES, V5, P891
   Li PY, 2009, 2009 INTERNATIONAL CONFERENCE ON BIOMEDICAL AND PHARMACEUTICAL ENGINEERING, P239
   Li PY, 2010, BIOMACROMOLECULES, V11, P2576, DOI 10.1021/bm1005195
   Liu YT, 2010, NANOMEDICINE-UK, V5, P687, DOI 10.2217/nnm.10.47
   Ma P, 2009, J BIOMED NANOTECHNOL, V5, P151, DOI 10.1166/jbn.2009.1021
   Ma YD, 2010, POLYMER, V51, P5952, DOI 10.1016/j.polymer.2010.10.029
   Ma YD, 2010, NANOSCALE RES LETT, V5, P1161, DOI 10.1007/s11671-010-9620-3
   Maupas C, 2011, INT J PHARMACEUT, V411, P136, DOI 10.1016/j.ijpharm.2011.03.056
   Meena AK, 2008, LIPIDS, V43, P231, DOI 10.1007/s11745-007-3142-5
   Mi Y, 2011, BIOMATERIALS, V32, P4058, DOI 10.1016/j.biomaterials.2011.02.022
   Mu L, 2006, COLLOID SURFACE B, V47, P90, DOI 10.1016/j.colsurfb.2005.08.016
   Mu L, 2005, INT J PHARM, V306, P142, DOI 10.1016/j.ijpharm.2005.08.026
   Mu L, 2003, J CONTROL RELEASE, V86, P33, DOI 10.1016/S0168-3659(02)00320-6
   Mu L, 2003, PHARM RES, V20, P1864, DOI 10.1023/B:PHAM.0000003387.15428.42
   Mu L, 2005, J CONTROL RELEASE, V103, P565, DOI 10.1016/j.conrel.2004.12.023
   Mu L, 2004, COLLOID POLYM SCI, V283, P58, DOI 10.1007/s00396-004-1090-7
   Mu L, 2002, J CONTROL RELEASE, V80, P129, DOI 10.1016/S0168-3659(02)00025-1
   Muthu MS, 2011, INT J PHARMACEUT, V421, P332, DOI 10.1016/j.ijpharm.2011.09.045
   Pan J, 2008, BIOTECHNOL BIOENG, V101, P622, DOI 10.1002/bit.21924
   Pan J, 2008, BIOMATERIALS, V29, P2663, DOI 10.1016/j.biomaterials.2008.02.020
   Pan J, 2010, NANOMEDICINE-UK, V5, P347, DOI 10.2217/NNM.10.13
   Pan J, 2009, BIOMATERIALS, V30, P1176, DOI 10.1016/j.biomaterials.2008.10.039
   Parhi P, 2011, ACTA BIOMATER, V7, P3656, DOI 10.1016/j.actbio.2011.06.015
   Parmentier J, 2011, INT J PHARMACEUT, V405, P210, DOI 10.1016/j.ijpharm.2010.12.005
   Parmentier J, 2010, EUR J PHARM BIOPHARM, V76, P394, DOI 10.1016/j.ejpb.2010.09.002
   Prashant C, 2010, J APPL PHYS, V107, P301
   Prashant C, 2010, BIOMATERIALS, V31, P5588, DOI 10.1016/j.biomaterials.2010.03.070
   Ren FZ, 2009, J DISPER SCI TECHNOL, V30, P1129, DOI 10.1080/01932690802701507
   Ruan G, 2004, J MICROENCAPSUL, V21, P399, DOI 10.1080/02652040410001729214
   Ruan G, 2002, J CONTROL RELEASE, V84, P151, DOI 10.1016/S0168-3659(02)00292-4
   Sadoqi M, 2009, J COLLOID INTERF SCI, V333, P585, DOI 10.1016/j.jcis.2009.01.048
   Shah AR, 2011, COLLOID SURFACE B, V85, P116, DOI 10.1016/j.colsurfb.2011.01.021
   Shieh MJ, 2011, J CONTROL RELEASE, V152, P418, DOI 10.1016/j.jconrel.2011.03.017
   Somavarapul S, 2005, INT J PHARM, V298, P344, DOI 10.1016/i.ijpharm.2005.03.029
   Song N, 2011, COLLOID SURFACE B, V87, P454, DOI 10.1016/j.colsurfb.2011.06.009
   Sun BF, 2009, ADV SCI TECH, P160
   Sun B, 2009, NANOMEDICINE-UK, V4, P431, DOI [10.2217/nnm.09.17, 10.2217/NNM.09.17]
   Sutthanut K, 2009, J BIOMED NANOTECHNOL, V5, P224, DOI 10.1166/jbn.2009.1026
   Tan YF, 2011, BIOMATERIALS, V32, P2969, DOI 10.1016/j.biomaterials.2010.12.055
   van der Ende AE, 2010, POLYM CHEM-UK, V1, P93, DOI 10.1039/b9py00272c
   Vandoolaeghe P, 2009, LANGMUIR, V25, P3999, DOI 10.1021/la802768q
   Varma MVS, 2005, EUR J PHARM SCI, V25, P445, DOI 10.1016/j.ejps.2005.04.003
   Veronese FM, 2005, BIOCONJUGATE CHEM, V16, P775, DOI 10.1021/bc040241m
   Wacher VJ, 2002, J PHARMACOL EXP THER, V303, P308, DOI 10.1124/jpet.102.036541
   Wang J, 2003, J MICROENCAPSUL, V20, P317, DOI 10.1080/0265204021000058401
   Wang JF, 2011, BIOMACROMOLECULES, V12, P228, DOI 10.1021/bm101206g
   Wang JL, 2009, J COLLOID INTERF SCI, V336, P808, DOI 10.1016/j.jcis.2009.04.080
   Weecharangsan W, 2010, ANTICANCER RES, V30, P31
   Weecharangsan W, 2009, MOL PHARMACEUT, V6, P1848, DOI 10.1021/mp900150g
   Win KY, 2006, BIOMATERIALS, V27, P2285, DOI 10.1016/j.biomaterials.2005.11.008
   Win KY, 2005, BIOMATERIALS, V26, P2713, DOI 10.1016/j.biomaterials.2004.07.050
   Wu SH, 1999, PHARM TECHNOL, V23, P52
   Xie JW, 2010, CURR PHARM DESIGN, V16, P2331, DOI 10.2174/138161210791920432
   Xie JW, 2005, PHARM RES, V22, P2079, DOI 10.1007/s11095-005-7782-y
   Xiong XY, 2011, J BIOMAT SCI-POLYM E, V22, P1607, DOI 10.1163/092050610X519444
   Xu H, 2010, ADV POWDER TECHNOL, V21, P551, DOI 10.1016/j.apt.2010.02.011
   Yan A, 2007, CARBON, V45, P2463, DOI 10.1016/j.carbon.2007.08.035
   Yang XJ, 2011, MOL PHARMACEUT, V8, P709, DOI 10.1021/mp100272k
   Yeung E, 2009, J MICROENCAPSUL, V26, P9, DOI 10.1080/02652040802094402
   Yu L, 1999, PHARMACEUT RES, V16, P1812, DOI 10.1023/A:1018939006780
   Zhai GX, 2008, ANTICANCER RES, V28, P2801
   Zhang ZP, 2008, PHARM RES-DORDR, V25, P1925, DOI 10.1007/s11095-008-9611-6
   Zhang ZP, 2007, BIOMATERIALS, V28, P1889, DOI 10.1016/j.biomaterials.2006.12.018
   Zhang Z, 2006, INT J PHARM, V324, P191, DOI 10.1016/j.ijpharm.2006.06.013
   Zhang ZP, 2011, NANOMEDICINE-UK, V6, P583, DOI [10.2217/nnm.11.66, 10.2217/NNM.11.66]
   Zhang ZP, 2006, BIOMATERIALS, V27, P4025, DOI 10.1016/j.biomaterials.2006.03.006
   Zhang ZP, 2006, BIOMACROMOLECULES, V7, P1139, DOI 10.1021/bm050953v
   Zhang ZP, 2006, BIOMATERIALS, V27, P262, DOI 10.1016/j.biomaterials.2005.05.104
   Zhao HZ, 2008, J BIOMED MATER RES A, V84A, P954, DOI 10.1002/jbm.a.31402
   Zhao HZ, 2009, J BIOMED MATER RES A, V91A, P505, DOI 10.1002/jbm.a.32220
   Zhao J, 2012, BIOMATERIALS, V33, P1948, DOI 10.1016/j.biomaterials.2011.11.051
   Zhao LY, 2010, J PHARM SCI-US, V99, P3552, DOI 10.1002/jps.22113
   Zhao LY, 2011, J BIOMED NANOTECHNOL, V7, P358, DOI 10.1166/jbn.2011.1298
   Zheng Y, 2010, INT J PHARMACEUT, V390, P234, DOI 10.1016/j.ijpharm.2010.02.008
NR 121
TC 259
Z9 271
U1 29
U2 289
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD JUN
PY 2012
VL 33
IS 19
BP 4889
EP 4906
DI 10.1016/j.biomaterials.2012.03.046
PG 18
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 941MA
UT WOS:000303966100013
PM 22498300
HC Y
HP N
DA 2018-10-19
ER

PT J
AU Sundar, SS
   Sangeetha, D
AF Sundar, Saravanabhavan Shanmuga
   Sangeetha, Dharmalingam
TI Fabrication and evaluation of electrospun collagen/poly(N-isopropyl
   acrylamide)/chitosan mat as blood-contacting biomaterials for drug
   delivery
SO JOURNAL OF MATERIALS SCIENCE-MATERIALS IN MEDICINE
LA English
DT Article
ID SOLID LIPID NANOPARTICLES; CROSS-LINKING; DNA DELIVERY; CHITOSAN;
   RELEASE; COLLAGEN; COMPATIBILITY; HYDROGELS; PROTEINS; IMPLANTS
AB The recent advances in electrospinning have resulted in technologies facilitating easy drug entrapment, obtaining high surface area and thereby higher drug loading and release efficacy, burst control as well as the specific morphology which could be controlled according to the desired requirement. The present study focused on the fabrication of collagen/poly(-isopropyl acrylamide)/chitosan complex with incorporated 5-fluorouracil, an anticancer drug by the method of electrospinning. The effect of chitosan on the fiber morphology and release kinetics was analyzed by varying its concentration. The release kinetics showed that the increase in chitosan concentration delayed the release of the drug from the fiber network. Nano hydroxyapatite was added to the fiber matrix in order to impart bioactivity, which was confirmed by studies in simulated body fluid. The addition of poly(-isopropyl acrylamide) increased the blood compatibility of the prepared model. Thus, the model prepared to can find potential application in the field of cancer therapy as a drug-delivery agent in post-surgical treatment of cancer and as blood contacting biomaterial.
C1 [Sundar, Saravanabhavan Shanmuga; Sangeetha, Dharmalingam] Anna Univ, Dept Chem, Madras 600025, Tamil Nadu, India.
RP Sangeetha, D (reprint author), Anna Univ, Dept Chem, Madras 600025, Tamil Nadu, India.
EM sangeetha@annauniv.edu
OI Saravanabhavan, Shanmuga Sundar/0000-0003-0598-4187
FU Council of Scientific and Industrial Research (CSIR), New Delhi, India
   (CSIR) [172.5.2]
FX Authors would like to acknowledge for the financial support from the
   Council of Scientific and Industrial Research (CSIR), New Delhi, India
   (CSIR Lr. No. 172.5.2, Dated: 26-11-2009).
CR BEENA MS, 1995, ARTIF CELL BLOOD SUB, V23, P175, DOI 10.3109/10731199509117937
   Berkland C, 2002, J CONTROL RELEASE, V82, P137, DOI 10.1016/S0168-3659(02)00136-0
   Cai LL, 2011, INT J PHARMACEUT, V408, P173, DOI 10.1016/j.ijpharm.2011.01.042
   Chen X, 2011, J MATER SCI-MATER M, V22, P2347, DOI 10.1007/s10856-011-4401-9
   Chew SY, 2005, BIOMACROMOLECULES, V6, P2017, DOI 10.1021/bm0501149
   El-Ghannam A, 2010, J MATER SCI-MATER M, V21, P2701, DOI 10.1007/s10856-010-4121-6
   Enea D, 2011, J MATER SCI-MATER M, V22, P1569, DOI 10.1007/s10856-011-4336-1
   Franco RA, 2011, J MATER SCI-MATER M, V22, P2207, DOI 10.1007/s10856-011-4402-8
   Friess W, 1998, EUR J PHARM BIOPHARM, V45, P113, DOI 10.1016/S0939-6411(98)00017-4
   Gopal VS, 2011, J MATER SCI-MATER M, V22, P865, DOI DOI 10.1007/S10856-011-4274-Y
   Goppert TM, 2005, INT J PHARMACEUT, V302, P172, DOI 10.1016/j.ijpharm.2005.06.025
   He Q, 2011, J MATER SCI-MATER M, V22, P2791, DOI 10.1007/s10856-011-4444-y
   Jain SK, 2008, J MICROENCAPSUL, V25, P289, DOI [10.1080/02652040701799598, 10.1080/02652040701799598 ]
   Kakinoki S, 2007, EUR J PHARM BIOPHARM, V66, P383, DOI 10.1016/j.ejpb.2006.11.022
   Kenawy ER, 2002, J CONTROL RELEASE, V81, P57, DOI 10.1016/S0168-3659(02)00041-X
   Khor E, 1997, BIOMATERIALS, V18, P95, DOI 10.1016/S0142-9612(96)00106-8
   Kong L, 2006, EUR POLYM J, V42, P31771
   Kumari A, 2010, COLLOID SURFACE B, V75, P1, DOI 10.1016/j.colsurfb.2009.09.001
   Lee SB, 2004, J APPL POLYM SCI, V92, P2612, DOI 10.1002/app.20265
   Li WJ, 2002, J BIOMED MATER RES, V60, P613, DOI 10.1002/jbm.10167
   Luu YK, 2003, J CONTROL RELEASE, V89, P341, DOI 10.1016/S0168-3659(03)00097-X
   Manconi M, 2010, INT J PHARMACEUT, V392, P92, DOI 10.1016/j.ijpharm.2010.03.038
   Matthews JA, 2003, J BIOACT COMPAT POL, V18, P125, DOI 10.1177/088391103033856
   Mi FL, 2001, BIOMATERIALS, V22, P165, DOI 10.1016/S0142-9612(00)00167-8
   OLIVER RF, 1980, BRIT J EXP PATHOL, V61, P544
   PHILLIPS TA, 1980, J PHARM SCI, V69, P1428, DOI 10.1002/jps.2600691220
   STEMBERGER A, 1990, HAMOSTASEOLOGIE, V10, P164
   Sumanta KS, 2010, J MATER SCI-MATER M, V21, P1587, DOI [10.1007/s10856-010-3998-4, DOI 10.1007/S10856-010-3998-4]
   Toshkova R, 2010, INT J PHARMACEUT, V400, P221, DOI 10.1016/j.ijpharm.2010.08.039
   Wang Q, 2010, CARBOHYD POLYM, V82, P842, DOI 10.1016/j.carbpol.2010.06.004
   Wu HJ, 2010, J MATER SCI-MATER M, V21, P3207, DOI 10.1007/s10856-010-4164-8
   Xu JQ, 2011, MATER LETT, V65, P2800, DOI 10.1016/j.matlet.2011.06.018
   Zahedi P, 2009, INT J PHARMACEUT, V377, P76, DOI 10.1016/j.ijpharm.2009.05.003
   Zeng J, 2005, J CONTROL RELEASE, V105, P43, DOI 10.1016/j.j.conrel.2005.02.024
   Zeng Jing, 2003, Journal of Controlled Release, V92, P227, DOI 10.1016/S0168-3659(03)00372-9
   Zeng P, 2011, INT J PHARMACEUT, V415, P259, DOI 10.1016/j.ijpharm.2011.05.053
   Zhao JH, 2012, J MATER SCI-MATER M, V23, P517, DOI 10.1007/s10856-011-4468-3
NR 37
TC 10
Z9 11
U1 2
U2 56
PU SPRINGER
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 0957-4530
J9 J MATER SCI-MATER M
JI J. Mater. Sci.-Mater. Med.
PD JUN
PY 2012
VL 23
IS 6
BP 1421
EP 1430
DI 10.1007/s10856-012-4610-x
PG 10
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 943WD
UT WOS:000304155500008
PM 22476650
DA 2018-10-19
ER

PT J
AU Matsumoto, MA
   Caviquioli, G
   Biguetti, CC
   Holgado, LD
   Saraiva, PP
   Renno, ACM
   Kawakami, RY
AF Matsumoto, Mariza Akemi
   Caviquioli, Gustavo
   Biguetti, Claudia Cristina
   Holgado, Leandro de Andrade
   Saraiva, Patricia Pinto
   Muniz Renno, Ana Claudia
   Kawakami, Roberto Yoshio
TI A novel bioactive vitroceramic presents similar biological responses as
   autogenous bone grafts
SO JOURNAL OF MATERIALS SCIENCE-MATERIALS IN MEDICINE
LA English
DT Article
ID SINUS FLOOR AUGMENTATION; DENTAL IMPLANTS; ILIAC CREST; ALVEOLAR RIDGES;
   OSSEOINTEGRATION; BIOSILICATE(R); REGENERATION; PLACEMENT; CALVARIAL;
   MORBIDITY
AB Bioactive glasses represent an interesting class of bone substitute's biomaterials. The present study investigated the repair of bone defects filled with a novel bioactive vitroceramic (Biosilicate(A (R))), alone or in association with particulate autogenous bone grafts in calvaria defects of rabbits. After 7, 14, and 30 days the specimens were retrieved for histological, histomorphometric and immunohistochemistry analysis. Satisfactory bone formation was observed in all groups, and direct bone-biomaterial surface was noted. Histomorphometric assessment did not show statistically significant differences in bone formation among the groups and periods, except for BG group at day 14. Immunoexpression of Runx-2 was similar among the groups containing the graft and the biomaterial, being more intense than in control group. Similar result was observed for VEGF expression, especially in the last experimental period. These results revealed that Biosilicate(A (R)) presented a favorable behavior, comparable to autogenous bone graft.
C1 [Matsumoto, Mariza Akemi] Univ Sagrado Coracao, Dept Hlth Sci, Discipline Oral & Maxillofacial Surg, BR-17013070 Bauru, SP, Brazil.
   [Caviquioli, Gustavo; Biguetti, Claudia Cristina] Univ Sagrado Coracao, Sch Dent, BR-17011160 Bauru, SP, Brazil.
   [Holgado, Leandro de Andrade; Kawakami, Roberto Yoshio] Univ Sagrado Coracao, Dept Hlth Sci, Discipline Oral & Maxillofacial Surg, BR-17011160 Bauru, SP, Brazil.
   [Saraiva, Patricia Pinto] Univ Sagrado Coracao, Dept Hlth Sci, Discipline Periodontol, BR-17011160 Bauru, SP, Brazil.
   [Muniz Renno, Ana Claudia] Univ Fed Sao Paulo, Dept Biosci, BR-11060001 Santos, SP, Brazil.
RP Matsumoto, MA (reprint author), Univ Sagrado Coracao, Dept Hlth Sci, Discipline Oral & Maxillofacial Surg, Rua Luiz Bagnol 1-26, BR-17013070 Bauru, SP, Brazil.
EM vicmak.blv@terra.com.br
RI Renno, Ana Claudia/C-1266-2015; Biguetti, Claudia Cristina/F-5118-2012;
   Matsumoto, Mariza/C-5183-2012
OI Saraiva, Patricia/0000-0002-2454-3996
FU Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP/SP)
   [2008/11485-8, 2009/17294-1]
FX The authors are grateful to Maira Cristina Rondina Couto for histology
   and imunohistochemical assistance, Wilson Aparecido Oscini for
   histomorphometry assistance, and Dr. Solange Braga Franzolin for the
   statistical assessment. This work was supported by Fundacao de Amparo a
   Pesquisa do Estado de Sao Paulo (FAPESP/SP), Grant numbers 2008/11485-8;
   2009/17294-1.
CR Afzal F, 2004, J PATHOL, V202, P503, DOI 10.1002/path.1536
   Araujo MG, 2010, CLIN ORAL IMPLAN RES, V21, P445, DOI 10.1111/j.1600-0501.2009.01876.x
   Azenha Marcelo Rodrigues, 2010, Braz. Dent. J., V21, P383, DOI 10.1590/S0103-64402010000500001
   Barone A, 2009, J ORAL MAXIL SURG, V67, P1300, DOI 10.1016/j.joms.2008.12.043
   Block MS, 1997, J ORAL MAXIL SURG, V55, P1281, DOI 10.1016/S0278-2391(97)90185-3
   Cordioli G, 2001, CLIN ORAL IMPLAN RES, V12, P270, DOI 10.1034/j.1600-0501.2001.012003270.x
   Crespi R, 2007, INT J ORAL MAX IMPL, V22, P527
   De Santis E, 2011, CLIN ORAL IMPLAN RES, V22, P430, DOI 10.1111/j.1600-0501.2010.02122.x
   Gerressen M, 2009, CLIN ORAL IMPLAN RES, V20, P109, DOI 10.1111/j.1600-0501.2008.01619.x
   Martins CHG, 2011, J MATER SCI-MATER M, V22, P1439, DOI 10.1007/s10856-011-4330-7
   Granito RN, 2011, J BIOMED MATER RES B, V97B, P139, DOI 10.1002/jbm.b.31795
   Hallman M, 2001, Clin Implant Dent Relat Res, V3, P87, DOI 10.1111/j.1708-8208.2001.tb00236.x
   Hatano N, 2004, CLIN ORAL IMPLAN RES, V15, P339, DOI 10.1111/j.1600-0501.2004.00996.x
   Hench LL, 2002, SCIENCE, V295, P1014, DOI 10.1126/science.1067404
   HENCH LL, 1973, J BIOMED MATER RES, V7, P25, DOI 10.1002/jbm.820070304
   Herford AS, 2011, ORAL MAXIL SURG CLIN, V23, P433, DOI 10.1016/j.coms.2011.04.004
   JAMES PF, 1995, J NON-CRYST SOLIDS, V181, P1, DOI 10.1016/0022-3093(94)00515-X
   Kohgo T, 2011, INT J PERIODONT REST, V31, pE9
   MERWIN GE, 1986, ARCH OTOLARYNGOL, V112, P280
   Misch CM, 2011, ORAL MAXIL SURG CLIN, V23, P229, DOI 10.1016/j.coms.2011.01.003
   NETO JM, 2007, J BIOMED MATER RES, V82, P545
   Nunes LSD, 2010, CLIN ORAL IMPLAN RES, V21, P584, DOI 10.1111/j.1600-0501.2009.01858.x
   Palmer W, 2008, W INDIAN MED J, V57, P490
   Pedrosa WF, 2009, CLIN ORAL IMPLAN RES, V20, P1254, DOI 10.1111/j.1600-0501.2009.01747.x
   Raghoebar GM, 2007, INT J ORAL MAX IMPL, V22, P359
   Rana M, 2011, HEAD NECK ONCOL, V28, P3
   Rogers GF, 2011, PLAST RECONSTR SURG, V127, P1631, DOI 10.1097/PRS.0b013e31821084f0
   Roriz VM, 2010, CLIN ORAL IMPLAN RES, V21, P148, DOI 10.1111/j.1600-0501.2009.01812.x
   Sbordone L, 2009, INT J ORAL MAX IMPL, V24, P316
   Tan YY, 2010, ORTHOD CRANIOFAC RES, V13, P223, DOI 10.1111/j.1601-6343.2010.01498.x
   Tsigkou O, 2009, BIOMATERIALS, V30, P3542, DOI 10.1016/j.biomaterials.2009.03.019
   Varanasi VG, 2011, J BIOMED MATER RES A, V98A, P177, DOI 10.1002/jbm.a.33102
   Xu CX, 2011, BIOMATERIALS, V32, P1051, DOI 10.1016/j.biomaterials.2010.09.068
   ZANOTTO ED, 2004, Patent No. 2004074199
NR 34
TC 16
Z9 16
U1 0
U2 14
PU SPRINGER
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 0957-4530
J9 J MATER SCI-MATER M
JI J. Mater. Sci.-Mater. Med.
PD JUN
PY 2012
VL 23
IS 6
BP 1447
EP 1456
DI 10.1007/s10856-012-4612-8
PG 10
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 943WD
UT WOS:000304155500010
PM 22426745
DA 2018-10-19
ER

PT J
AU Kokkinos, PA
   Koutsoukos, PG
   Deligianni, DD
AF Kokkinos, Petros A.
   Koutsoukos, Petros G.
   Deligianni, Despina D.
TI Detachment strength of human osteoblasts cultured on hydroxyapatite with
   various surface roughness. Contribution of integrin subunits
SO JOURNAL OF MATERIALS SCIENCE-MATERIALS IN MEDICINE
LA English
DT Article
ID BONE-MARROW-CELLS; BIOMATERIAL SURFACES; GENE-EXPRESSION; SHEAR
   STRESSES; ADHESION; TITANIUM; DIFFERENTIATION; FIBRONECTIN;
   PROLIFERATION; DEVICE
AB Hydroxyapatite (HA) has been widely used as a bone substitute in dental, maxillofacial and orthopaedic surgery and as osteoconductive bone substitute or precoating of pedicle screws and cages in spine surgery. The aim of the present study was to investigate the osteoblastic adhesion strength on HA substrata with different surface topography and biochemistry (pre-adsorption of fibronectin) after blocking of specific integrin subunits with monoclonal antibodies. Stoichiometric HA was prepared by precipitation followed by ageing and characterized by SEM, EDX, powder XRD, Raman spectroscopy, TGA, and specific surface area analysis. Human bone marrow derived osteoblasts were cultured on HA disc-shaped substrata which were sintered and polished resulting in two surface roughness grades. For attachment evaluation, cells were incubated with monoclonal antibodies and seeded for 2 h on the substrata. Cell detachment strength was determined using a rotating disc device. Cell detachment strength was surface roughness, fibronectin preadsorption and intergin subunit sensitive.
C1 [Kokkinos, Petros A.; Deligianni, Despina D.] Univ Patras, Dept Mech Engn & Aeronaut, Lab Biomech & Biomed Engn, Patras 26500, Greece.
   [Koutsoukos, Petros G.] Univ Patras, Dept Chem Engn, Patras 26500, Greece.
   [Koutsoukos, Petros G.] Univ Patras, FORTH ICE HT, Patras 26500, Greece.
RP Deligianni, DD (reprint author), Univ Patras, Dept Mech Engn & Aeronaut, Lab Biomech & Biomed Engn, Patras 26500, Greece.
EM deligian@mech.upatras.gr
FU NICHD; Research Committee of the University of Patras [2992]
FX The monoclonal antibodies used in the present study were obtained from
   the Developmental Studies Hybridoma Bank developed under the auspices of
   the NICHD and maintained by The University of Iowa, Department of
   Biology, Iowa City, IA 52242. This project was financially supported by
   the project, "K. Karatheodori" (2992) of the Research Committee of the
   University of Patras. The authors wish to express their gratitude to Dr.
   P. Korovessis, for providing bone marrow.
CR Athanassiou G, 2001, J MATER SCI-MATER M, V12, P965, DOI 10.1023/A:1012809115479
   Borsari V, 2005, J BIOMED MATER RES B, V75B, P359, DOI 10.1002/jbm.b.30313
   Bundy KJ, 2001, CELL BIOL INT, V25, P289, DOI 10.1006/cbir.2000.0648
   Castoldi M, 1997, CELL BIOL INT, V21, P7, DOI 10.1006/cbir.1996.0110
   De Ruijter JE, 2001, TISSUE ENG, V7, P279, DOI 10.1089/10763270152044143
   Deligianni D, 2005, J SPINAL DISORD TECH, V18, P257
   Deligianni DD, 2001, BIOMATERIALS, V22, P87, DOI 10.1016/S0142-9612(00)00174-5
   Garcia AJ, 1999, MOL BIOL CELL, V10, P785, DOI 10.1091/mbc.10.3.785
   Garcia AJ, 1997, BIOMATERIALS, V18, P1091, DOI 10.1016/S0142-9612(97)00042-2
   Garcia AJ, 1998, J BIOMED MATER RES, V40, P48, DOI 10.1002/(SICI)1097-4636(199804)40:1<48::AID-JBM6>3.0.CO;2-R
   Huang J, 2010, ACTA BIOMATER, V6, P241, DOI 10.1016/j.actbio.2009.06.032
   Keselowsky BG, 2005, BIOMATERIALS, V26, P413, DOI 10.1016/j.biomaterials.2004.02.050
   Kilpadi KL, 2005, J BIOMED MATER RES A, V73A, P254, DOI 10.1002/jbm.a.30290
   Kokkinos PA, 2009, J MATER SCI-MATER M, V20, P655, DOI 10.1007/s10856-008-3602-3
   Korovessis PG, 2002, J SPINAL DISORD TECH, V15, P175, DOI 10.1097/00024720-200204000-00015
   Letechipia JE, 2010, MED HYPOTHESES, V75, P196, DOI 10.1016/j.mehy.2010.02.021
   Matsuura T, 2000, BIOMATERIALS, V21, P1121, DOI 10.1016/S0142-9612(99)00264-1
   Olivares-Navarrete R, 2008, P NATL ACAD SCI USA, V105, P15767, DOI 10.1073/pnas.0805420105
   Raz P, 2004, J BIOMED MATER RES A, V71A, P217, DOI 10.1002/jbm.a.30134
   REUTELINGSPERGER CPM, 1994, J MATER SCI-MATER M, V5, P361, DOI 10.1007/BF00058964
   Reyes CD, 2003, J BIOMED MATER RES A, V67A, P328, DOI 10.1002/jbm.a.10122
   Rezania A, 1999, J ORTHOPAED RES, V17, P615, DOI 10.1002/jor.1100170423
   Rosa AL, 2003, DENT MATER, V19, P768, DOI 10.1016/S0109-5641(03)00024-1
   Rouahi M, 2006, BIOMATERIALS, V27, P2829, DOI 10.1016/j.biomaterials.2006.01.001
   Schneider GB, 1999, BONE, V24, P321, DOI 10.1016/S8756-3282(99)00007-1
   Siebers MC, 2008, J MATER SCI-MATER M, V19, P861, DOI 10.1007/s10856-007-0166-6
   Taite LJ, 2006, ANN BIOMED ENG, V34, P1705, DOI 10.1007/s10439-006-9173-x
   Tang Q, 2010, J MATER SCI-MATER M, V21, P173, DOI 10.1007/s10856-009-3841-y
   Teixeira S, 2008, J MATER SCI-MATER M, V19, P855, DOI 10.1007/s10856-007-3005-x
   Vohra S, 2008, J MATER SCI-MATER M, V19, P3657
NR 30
TC 11
Z9 11
U1 0
U2 34
PU SPRINGER
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 0957-4530
J9 J MATER SCI-MATER M
JI J. Mater. Sci.-Mater. Med.
PD JUN
PY 2012
VL 23
IS 6
BP 1489
EP 1498
DI 10.1007/s10856-012-4628-0
PG 10
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 943WD
UT WOS:000304155500014
PM 22484862
DA 2018-10-19
ER

PT J
AU Krishnan, R
   Rajeswari, R
   Venugopal, J
   Sundarrajan, S
   Sridhar, R
   Shayanti, M
   Ramakrishna, S
AF Krishnan, R.
   Rajeswari, R.
   Venugopal, J.
   Sundarrajan, S.
   Sridhar, R.
   Shayanti, M.
   Ramakrishna, S.
TI Polysaccharide nanofibrous scaffolds as a model for in vitro skin tissue
   regeneration
SO JOURNAL OF MATERIALS SCIENCE-MATERIALS IN MEDICINE
LA English
DT Article
ID MEMBRANE
AB Tissue engineering and nanotechnology have advanced a general strategy combining the cellular elements of living tissue with sophisticated functional biocomposites to produce living structures of sufficient size and function at a low cost for clinical relevance. Xylan, a natural polysaccharide was electrospun along with polyvinyl alcohol (PVA) to produce Xylan/PVA nanofibers for skin tissue engineering. The Xylan/PVA glutaraldehyde (Glu) vapor cross-linked nanofibers were characterized by SEM, FT-IR, tensile testing and water contact angle measurements to analyze the morphology, functional groups, mechanical properties and wettability of the fibers for skin tissue regeneration. The cell-biomaterial interactions were studied by culturing human foreskin fibroblasts on Xylan/PVA Glu vapor cross-linked and Xylan/PVA/Glu blend nanofibrous scaffolds. The observed results showed that the mechanical properties (72 %) and fibroblast proliferation significantly increased up to 23 % ( < 0.05) in 48 h Glu vapor cross-linked nanofibers compared to 24 h Glu vapor cross-linked Xylan/PVA nanofibers. The present study may prove that the natural biodegradable Xylan/PVA nanofibrous scaffolds have good potential for fibroblast adhesion, proliferation and cell matrix interactions relevant for skin tissue regeneration.
C1 [Krishnan, R.; Rajeswari, R.; Venugopal, J.; Sundarrajan, S.; Sridhar, R.; Shayanti, M.; Ramakrishna, S.] Natl Univ Singapore, Fac Engn, NUSNNI, Ctr Nanofibers & Nanotechnol, Singapore 117548, Singapore.
   [Krishnan, R.; Rajeswari, R.; Sundarrajan, S.; Sridhar, R.; Ramakrishna, S.] Natl Univ Singapore, Dept Mech Engn, Singapore 117576, Singapore.
RP Venugopal, J (reprint author), Natl Univ Singapore, Fac Engn, NUSNNI, Ctr Nanofibers & Nanotechnol, Singapore 117548, Singapore.
EM nnijrv@nus.edu.sg
RI Radhakrishnan, Sridhar/B-7439-2013; Subramanian, Sundarrajan/E-8022-2011
OI Radhakrishnan, Sridhar/0000-0002-5068-3175; Jayarama Reddy,
   Venugopal/0000-0001-5867-8007
FU Ministry of Education [R-265-000-318-112]; NRF-Technion
   [R-398-001-065-592]; NUSNNI, National University of Singapore, Singapore
FX This study was supported by the Ministry of Education
   (R-265-000-318-112), NRF-Technion (R-398-001-065-592), and NUSNNI,
   National University of Singapore, Singapore.
CR BARNES MJ, 1976, BIOCHEM J, V157, P263, DOI 10.1042/bj1570263
   Bhattarai SR, 2004, BIOMATERIALS, V25, P2595, DOI 10.1016/j.biomaterials.2003.09.043
   Chandrasekaran AR, 2011, BIOMED MATER, V6, DOI 10.1088/1748-6041/6/1/015001
   CIMA LG, 1991, J BIOMECH ENG-T ASME, V113, P143, DOI 10.1115/1.2891228
   Dinand E, 2001, CARBOHYD RES, V330, P285, DOI 10.1016/S0008-6215(00)00273-1
   Ebringerova A, 2000, CARBOHYD POLYM, V42, P123, DOI 10.1016/S0144-8617(99)00150-2
   Habibi Y, 2002, CARBOHYD RES, V337, P1593, DOI 10.1016/S0008-6215(02)00186-6
   Jeong L, 2009, INT J BIOL MACROMOL, V44, P222, DOI 10.1016/j.ijbiomac.2008.12.008
   Kacurakova M, 2000, CARBOHYD POLYM, V43, P195, DOI 10.1016/S0144-8617(00)00151-X
   Khil MS, 2003, J BIOMED MATER RES B, V67B, P675, DOI 10.1002/jbm.b.10058
   Lerman OZ, 2003, AM J PATHOL, V162, P303, DOI 10.1016/S0002-9440(10)63821-7
   MacNeil S, 2008, MATER TODAY, V11, P26, DOI 10.1016/S1369-7021(08)70087-7
   Parenteau-Bareil R, 2010, ACTA BIOMATER, V7, P3757
   Ravichandran R., 2010, TISSUE ENG PART A, V17, P1363
   Ravichandran Rajeswari, 2009, World J Stem Cells, V1, P55, DOI 10.4252/wjsc.v1.i1.55
   Supp DM, 2005, CLIN DERMATOL, V23, P403, DOI 10.1016/j.clindermatol.2004.07.023
   Unlu CH, 2009, CARBOHYD POLYM, V76, P585, DOI 10.1016/j.carbpol.2008.11.029
   Venugopal J, 2005, TISSUE ENG, V11, P847, DOI 10.1089/ten.2005.11.847
   Venugopal J., 2006, ARTIF ORGANS, V30, P438
   Venugopal JR, 2008, ARTIF ORGANS, V32, P388, DOI 10.1111/j.1525-1594.2008.00557.x
   YANNAS IV, 1982, SCIENCE, V215, P174, DOI 10.1126/science.7031899
NR 21
TC 20
Z9 21
U1 1
U2 32
PU SPRINGER
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 0957-4530
J9 J MATER SCI-MATER M
JI J. Mater. Sci.-Mater. Med.
PD JUN
PY 2012
VL 23
IS 6
BP 1511
EP 1519
DI 10.1007/s10856-012-4630-6
PG 9
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 943WD
UT WOS:000304155500016
PM 22491895
DA 2018-10-19
ER

PT J
AU Peng, QM
   Li, XJ
   Ma, N
   Liu, RP
   Zhang, HJ
AF Peng, Qiuming
   Li, Xuejun
   Ma, Ning
   Liu, Riping
   Zhang, Hongjie
TI Effects of backward extrusion on mechanical and degradation properties
   of Mg-Zn biomaterial
SO JOURNAL OF THE MECHANICAL BEHAVIOR OF BIOMEDICAL MATERIALS
LA English
DT Article
DE Magnesium alloys; Biomaterial; Microstructure; Mechanical properties;
   Corrosion properties
ID SIMULATED BODY-FLUID; MAGNESIUM ALLOYS; RARE-EARTH; CORROSION;
   BEHAVIORS; EVOLUTION; ELEMENTS; CELLS
AB Backward extrusion was used to improve the properties of Mg-based biomaterials. The microstructures, mechanical performance and corrosion properties of as-cast and backward extruded Mg-xZn (x = 0.5, 1, 1.5, 2, wt.%) alloys were investigated. The secondary dendrite arm spacing of as-cast Mg-xZn alloys and the grain size of backward extruded Mg-xZn alloys were decreased with the increment of Zn content. Meanwhile, both strength and elongation were improved by backward extruded treatment. With increasing Zn addition, the corrosion properties of both as-cast and backward extruded Mg-xZn alloys were decreased. However, the corrosion performance of backward extruded sample was improved obviously compared to the corresponding as-cast one. More importantly, the degradation rate of the backward extruded alloy was stable, which was mainly associated with the fine second precipitates and the homogeneous microstructure. It was demonstrated that backward extrusion was an effective approach to manufacture high performance Mg-based biomaterials. (C) 2012 Elsevier Ltd. All rights reserved.
C1 [Peng, Qiuming; Li, Xuejun; Ma, Ning; Liu, Riping] Yanshan Univ, State Key Lab Metastable Mat Sci & Technol, Qinhuangdao 066004, Peoples R China.
   [Zhang, Hongjie] Chinese Acad Sci, Changchun Inst Appl Chem, State Key Lab Rare Earth Resource Utilizat, Changchun 130022, Peoples R China.
RP Peng, QM (reprint author), Yanshan Univ, State Key Lab Metastable Mat Sci & Technol, Qinhuangdao 066004, Peoples R China.
EM pengqiuming@gmail.com
OI Li, Xiaojing/0000-0002-9435-0866
FU National Natural Science Foundation of China [51101142, 51121061]
FX This research is financially supported by the National Natural Science
   Foundation of China (Grant Nos 51101142 and 51121061).
CR Acharya G, 2006, ADV DRUG DELIVER REV, V58, P387, DOI 10.1016/j.addr.2006.01.016
   ARSENAULT RJ, 1989, METALL TRANS A, V20, P1411, DOI 10.1007/BF02665498
   Beals RS, 2007, JOM-US, V59, P39, DOI 10.1007/s11837-007-0102-8
   Bender S, 2007, MATER CORROS, V58, P977, DOI 10.1002/maco.200704091
   Berman E, 1980, TOXIC METALS THEIR A
   Ferreira ME, 2003, J TRACE ELEM MED BIO, V17, P45, DOI 10.1016/S0946-672X(03)80045-7
   Feyerabend F, 2010, ACTA BIOMATER, V6, P1834, DOI 10.1016/j.actbio.2009.09.024
   Friedman LH, 1998, PHYS REV LETT, V81, P2715, DOI 10.1103/PhysRevLett.81.2715
   Friedrich H. E., 2006, MAGNESIUM TECHNOLOGY
   Ganeshan S, 2009, ACTA MATER, V57, P3876, DOI 10.1016/j.actamat.2009.04.038
   Gao X, 2007, SCRIPTA MATER, V56, P645, DOI 10.1016/j.scriptamat.2007.01.006
   GHOSH S, 1990, MUTAT RES, V243, P29, DOI 10.1016/0165-7992(90)90119-5
   Gu XN, 2011, ACTA BIOMATER, V7, P1880, DOI 10.1016/j.actbio.2010.11.034
   Gu XN, 2010, ACTA BIOMATER, V6, P4605, DOI 10.1016/j.actbio.2010.07.026
   Hort N, 2010, ACTA BIOMATER, V6, P1714, DOI 10.1016/j.actbio.2009.09.010
   Hou XL, 2009, MAT SCI ENG A-STRUCT, V520, P162, DOI 10.1016/j.msea.2009.05.034
   Liang SJ, 2009, J ALLOY COMPD, V472, P127, DOI 10.1016/j.jallcom.2008.04.093
   Liu K, 2009, MAT SCI ENG A-STRUCT, V505, P13, DOI 10.1016/j.msea.2008.12.023
   Luo AA, 2002, JOM-J MIN MET MAT S, V54, P42, DOI 10.1007/BF02701073
   Milazzo G., 1978, TABLES STANDARD ELEC
   Peng QM, 2010, BIOMATERIALS, V31, P398, DOI 10.1016/j.biomaterials.2009.09.065
   Shaw CA, 2009, J INORG BIOCHEM, V103, P1555, DOI 10.1016/j.jinorgbio.2009.05.019
   Song GL, 2005, ADV ENG MATER, V7, P563, DOI 10.1002/adem.200500013
   Song GL, 2003, ADV ENG MATER, V5, P837, DOI 10.1002/adem.200310405
   Song JM, 2006, J ELECTRON MATER, V35, P2154, DOI 10.1007/s11664-006-0326-3
   Song YW, 2009, MAT SCI ENG C-BIO S, V29, P1039, DOI 10.1016/j.msec.2008.08.026
   Witte F, 2008, SCRIPTA MATER, V58, P453, DOI 10.1016/j.scriptamat.2007.10.039
   Witte F, 2006, BIOMATERIALS, V27, P1013, DOI 10.1016/j.biomaterials.2005.07.037
   Witte F, 2010, ACTA BIOMATER, V6, P1792, DOI 10.1016/j.actbio.2009.10.012
   Yamasaki M, 2007, CORROS SCI, V49, P255, DOI 10.1016/j.corsci.2006.05.017
   Zberg B, 2009, NAT MATER, V8, P887, DOI [10.1038/NMAT2542, 10.1038/nmat2542]
   ZENG Rong-chang, 2008, ADV ENG MAT B, V10, P3
   Zhang SX, 2010, ACTA BIOMATER, V6, P626, DOI 10.1016/j.actbio.2009.06.028
   Zhao MC, 2008, CORROS SCI, V50, P3168, DOI 10.1016/j.corsci.2008.08.023
NR 34
TC 32
Z9 32
U1 1
U2 41
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 1751-6161
J9 J MECH BEHAV BIOMED
JI J. Mech. Behav. Biomed. Mater.
PD JUN
PY 2012
VL 10
BP 128
EP 137
DI 10.1016/j.jmbbm.2012.02.024
PG 10
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 944TU
UT WOS:000304227500012
PM 22520425
DA 2018-10-19
ER

PT J
AU Yilmazer, H
   Niinomi, M
   Nakai, M
   Hieda, J
   Todaka, Y
   Akahori, T
   Miyazaki, T
AF Yilmazer, H.
   Niinomi, M.
   Nakai, M.
   Hieda, J.
   Todaka, Y.
   Akahori, T.
   Miyazaki, T.
TI Heterogeneous structure and mechanical hardness of biomedical beta-type
   Ti-29Nb-13Ta-4.6Zr subjected to high-pressure torsion
SO JOURNAL OF THE MECHANICAL BEHAVIOR OF BIOMEDICAL MATERIALS
LA English
DT Article
DE Ti-29Nb-13Ta-4.6Zr; Metallic biomaterial; High-pressure torsion;
   Microstructure; Mechanical hardness
ID SEVERE PLASTIC-DEFORMATION; X-RAY-DIFFRACTION; MICROSTRUCTURAL
   EVOLUTION; TITANIUM-ALLOY; GRAIN-SIZE; CORROSION CHARACTERISTICS;
   THERMAL-STABILITY; PARAMETERS; FATIGUE; SUPERPLASTICITY
AB A novel beta-type titanium alloy, Ti-29Nb-13Ta-4.6Zr (TNTZ), has been developed as a candidate for biomedical applications. TNTZ exhibits non-toxicity and a low Young's modulus close to that of bone (10-30 GPa). Such a low Young's modulus of this alloy is achieved by comprising a single metastable beta phase. Greater mechanical biocompatibility, which implies higher mechanical strength and hardness while maintaining a low Young's modulus, has been aimed for TNTZ. Therefore, strengthening by grain refinement and increasing dislocation density is expected to provide TNTZ high mechanical strength while keeping a low Young's modulus because they keep the original beta phase. In this case, high-pressure torsion (HPT) processing is one of the effective ways to obtain these properties simultaneously in TNTZ. Thus, in this study, the effect of HPT processing on the microstructure and mechanical hardness of TNTZ was systematically investigated at rotation numbers (N) of 1 to 20 under a pressure of around 1.25 GPa at room temperature.
   On the cross sections of TNTZ subjected to HPT processing (TNTZ(HPT)) after cold rolling (TNTZ(CR)) at any rotation number, a heterogeneous microstructure consisting of a matrix and a non-etched band, which is not corroded by etching solution, can be observed. The thickness of non-etched band increases as rotation number and distance from specimen center increase. Both matrix and non-etched band comprise a single beta phase, but their grain geometries are different each other. Equiaxed grains and elongated grains are observed in the matrix and the non-etched band, respectively. The equiaxed grain diameter, which is ranged from 155 nm to 44 nm, in the matrix decreases with increasing rotation number. Contrastingly, the elongated grains with a length of around 300 nm and a width of 30 nm, which are nearly constant with rotation number, are observed in the non-etched band.
   The mechanical hardness of TNTZ(HPT) is consistently much higher than that of TNTZ(CR). The mechanical hardness distribution on the surface of TNTZ(HPT) is heterogeneous in the radial and depth directions, while that of TNTZ(CR) is homogeneous; the mechanical hardness is higher in the peripheral region than in the central region on the surfaces of TNTZ(HPT) at all N. Further, the mechanical hardness distribution on the cross sections of TNTZ(HPT) at all N is also heterogeneous in depth direction; the mechanical hardness is higher in the peripheral region than in the central region. The heterogeneous mechanical hardness distribution depending on the position on the surface and cross section of TNTZ(HPT) is considered to be related to grain refinement and imposed strain due to HPT processing. (C) 2012 Elsevier Ltd. All rights reserved.
C1 [Niinomi, M.; Nakai, M.; Hieda, J.] Tohoku Univ, Inst Mat Res, Sendai, Miyagi 9808577, Japan.
   [Todaka, Y.] Toyohashi Univ Technol, Dept Prod Syst Engn, Toyohashi, Aichi 4418580, Japan.
   [Akahori, T.] Meijo Univ, Fac Mat Sci & Technol, Dept Mat Sci & Engn, Nagoya, Aichi 4688502, Japan.
   [Miyazaki, T.] Tohoku Univ, Instrumental Anal Grp, Grad Sch Engn, Sendai, Miyagi 9808579, Japan.
RP Niinomi, M (reprint author), Tohoku Univ, Inst Mat Res, Sendai, Miyagi 9808577, Japan.
EM niinomi@imr.tohoku.ac.jp
RI Nakai, Masaaki/C-1919-2009; Yilmazer, Hakan/C-2911-2011; Todaka,
   Yoshikazu/D-3809-2015; Niinomi, Mitsuo/B-5965-2011
OI Yilmazer, Hakan/0000-0001-5602-4966; 
FU Ministry of Education, Culture, Sports, Science and Technology (MEXT),
   Japan; Japan Society for the Promotion of Science and Technology Agency
   (JST), Japan
FX This work was supported in part by Global COE Program "Materials
   Integration (International Centre of Education and Research), Tohoku
   University", the Ministry of Education, Culture, Sports, Science and
   Technology (MEXT), Japan, the Inter-University Cooperative Research
   Program "Highly-Functional Interface Science: Innovation of Biomaterials
   with Highly Functional Interface to the Host and Parasite, Tohoku
   University and Kyushu University", MEXT, Japan, the Grants-in-Aid for
   Young Scientists (B), the Japan Society for the Promotion of Science and
   Technology Agency (JST), Japan.
CR Akahori T, 2005, MAT SCI ENG C-BIO S, V25, P248, DOI 10.1016/j.msec.2004.12.007
   Akahori T, 2004, MATER TRANS, V45, P1540, DOI 10.2320/matertrans.45.1540
   Edalati K, 2011, ACTA MATER, V59, P6831, DOI 10.1016/j.actamat.2011.07.046
   Estrin Y, 2008, J MECH PHYS SOLIDS, V56, P1186, DOI 10.1016/j.jmps.2007.10.004
   Geng F, 2011, MAT SCI ENG A-STRUCT, V528, P5435, DOI 10.1016/j.msea.2011.03.064
   Hamdy AS, 2006, INT J ELECTROCHEM SC, V1, P171
   Hao YL, 2005, APPL PHYS LETT, V87, DOI 10.1063/1.2037192
   Holand T. J. B., 1997, J APPL CRYSTALLOGR, V30, P84
   Horita Z, 2005, MAT SCI ENG A-STRUCT, V410, P422, DOI 10.1016/j.msea.2005.08.133
   Horita Z, 1996, J MATER RES, V11, P1880, DOI 10.1557/JMR.1996.0239
   Islamgaliev RK, 2008, MAT SCI ENG A-STRUCT, V493, P190, DOI 10.1016/j.msea.2007.08.084
   Ito Y, 2009, MAT SCI ENG A-STRUCT, V503, P32, DOI 10.1016/j.msea.2008.03.055
   Iwahashi Y, 1997, ACTA MATER, V45, P4733, DOI 10.1016/S1359-6454(97)00100-6
   Jiang HG, 2000, MAT SCI ENG A-STRUCT, V290, P128, DOI 10.1016/S0921-5093(00)00919-9
   Kent D, 2011, J MECH BEHAV BIOMED, V4, P405, DOI 10.1016/j.jmbbm.2010.11.013
   Korznikov AV, 2001, ACTA MATER, V49, P663, DOI 10.1016/S1359-6454(00)00345-1
   Kwok CT, 2006, MATER LETT, V60, P2419, DOI 10.1016/j.matlet.2006.01.053
   Li L, 2009, ACTA MATER, V57, P4988, DOI 10.1016/j.actamat.2009.07.002
   Li SJ, 2008, MAT SCI ENG A-STRUCT, V480, P101, DOI 10.1016/j.msea.2007.06.070
   Mishra RS, 2001, MAT SCI ENG A-STRUCT, V298, P44, DOI 10.1016/S0921-5093(00)01338-1
   Nakai M, 2012, METALL MATER TRANS A, V43A, P294, DOI 10.1007/s11661-011-0860-3
   Niinomi M, 1998, MAT SCI ENG A-STRUCT, V243, P231, DOI 10.1016/S0921-5093(97)00806-X
   Niinomi M, 2008, J MECH BEHAV BIOMED, V1, P30, DOI 10.1016/j.jmbbm.2007.07.001
   Orlov D, 2009, MAT SCI ENG A-STRUCT, V499, P427, DOI 10.1016/j.msea.2008.09.036
   Saito Y, 1999, ACTA MATER, V47, P579, DOI 10.1016/S1359-6454(98)00365-6
   Semenova IP, 2009, MAT SCI ENG A-STRUCT, V503, P92, DOI 10.1016/j.msea.2008.07.075
   Song X, 2011, MAT SCI ENG A-STRUCT, V528, P5600, DOI 10.1016/j.msea.2011.03.108
   Stolyarov VV, 1999, NANOSTRUCT MATER, V11, P947, DOI 10.1016/S0965-9773(99)00384-0
   Surgueeva A.V., 2000, SCRIPTA METALL, V43, P819
   Todaka Y, 2008, MATER TRANS, V49, P47, DOI 10.2320/matertrans.ME200714
   Ungar T, 1998, ACTA MATER, V46, P3693, DOI 10.1016/S1359-6454(98)00001-9
   Ungar T, 2004, SCRIPTA MATER, V51, P777, DOI 10.1016/j.scriptamat.2004.05.007
   Valiev RZ, 2000, PROG MATER SCI, V45, P103, DOI 10.1016/S0079-6425(99)00007-9
   Vorhauer A, 2004, SCRIPTA MATER, V51, P921, DOI 10.1016/j.scriptamat.2004.04.025
   Williams K.G., 1953, ACTA METALL, V1, P22
   Xiao MJ, 2011, J MATER SCI TECHNOL, V27, P1099, DOI 10.1016/S1005-0302(12)60003-6
   Xu W, 2009, SCRIPTA MATER, V60, P1012, DOI 10.1016/j.scriptamat.2009.02.043
   Yilmazer H., INT J MICRO IN PRESS
   Zhao YS, 2008, J APPL CRYSTALLOGR, V41, P1095, DOI 10.1107/S0021889808031762
   Zhilyaev AP, 2008, PROG MATER SCI, V53, P893, DOI 10.1016/j.pmatsci.2008.03.002
   Zhilyaev AP, 2003, ACTA MATER, V51, P753, DOI 10.1016/S1359-6454(02)00466-4
NR 41
TC 20
Z9 22
U1 4
U2 35
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 1751-6161
J9 J MECH BEHAV BIOMED
JI J. Mech. Behav. Biomed. Mater.
PD JUN
PY 2012
VL 10
BP 235
EP 245
DI 10.1016/j.jmbbm.2012.02.022
PG 11
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 944TU
UT WOS:000304227500022
PM 22520435
DA 2018-10-19
ER

PT J
AU Thomas, G
   Unger, K
   Krznaric, M
   Galpine, A
   Bethel, J
   Tomlinson, C
   Woodbridge, M
   Butcher, S
AF Thomas, Geraldine
   Unger, Kristian
   Krznaric, Marko
   Galpine, Angela
   Bethel, Jackie
   Tomlinson, Christopher
   Woodbridge, Mark
   Butcher, Sarah
TI The Chernobyl Tissue Bank - A Repository for Biomaterial and Data Used
   in Integrative and Systems Biology Modeling the Human Response to
   Radiation
SO GENES
LA English
DT Article
DE Chernobyl; Tissue Bank; systems biology
AB The only unequivocal radiological effect of the Chernobyl accident on human health is the increase in thyroid cancer in those exposed in childhood or early adolescence. In response to the scientific interest in studying the molecular biology of thyroid cancer post Chernobyl, the Chernobyl Tissue Bank (CTB: www.chernobyltissuebank.com) was established in 1998. Thus far it is has collected biological samples from 3,861 individuals, and provided 27 research projects with 11,254 samples. The CTB was designed from its outset as a resource to promote the integration of research and clinical data to facilitate a systems biology approach to radiation related thyroid cancer. The project has therefore developed as a multidisciplinary collaboration between clinicians, dosimetrists, molecular biologists and bioinformaticians and serves as a paradigm for tissue banking in the omics era.
C1 [Thomas, Geraldine; Unger, Kristian; Krznaric, Marko; Galpine, Angela; Bethel, Jackie] Univ London Imperial Coll Sci Technol & Med, Hammersmith Hosp, Dept Surg & Canc, London W12 0HS, England.
   [Tomlinson, Christopher; Woodbridge, Mark; Butcher, Sarah] Univ London Imperial Coll Sci Technol & Med, Bioinformat Support Serv, Div Mol Biosci, London SW7 2AZ, England.
RP Thomas, G (reprint author), Univ London Imperial Coll Sci Technol & Med, Hammersmith Hosp, Dept Surg & Canc, Du Cane Rd, London W12 0HS, England.
EM gerry.thomas@imperial.ac.uk; k.unger@imperial.ac.uk;
   m.krznaric@imperial.ac.uk; a.galpine@imperial.ac.uk;
   j.bethel@imperial.ac.uk; chris.tomlinson@imperial.ac.uk;
   m.woodbridge@imperial.ac.uk; s.butcher@imperial.ac.uk
OI Unger, Kristian/0000-0002-0374-2320; Woodbridge,
   Mark/0000-0002-0650-9751
FU European Commission [ERB15CT97 1100, FIR1200120123, FP7 211712];
   National Cancer Institute of the USA [5U24CA082102]; Sasakawa Memorial
   Health Foundation of Japan; World Health Organisation; Biotechnology and
   Biological Sciences Research Council [BB/C519670/1]
FX The authors gratefully acknowledge the financial support provided by the
   following bodies since 1998: The European Commission (Grant numbers
   ERB15CT97 1100, FIR1200120123, FP7 211712), the National Cancer
   Institute of the USA (grant number 5U24CA082102), the Sasakawa Memorial
   Health Foundation of Japan and the World Health Organisation. We also
   acknowledge the commitment of our colleagues at the Institute of
   Endocrinology and Metabolism in Ukraine, in particular Academician MD
   Tronko, Professor TI Bogdanova and their clinical and scientific staff,
   and at the Federal State Institution "Medical Radiological Research
   Centre" of the Russian Ministry of Health and Social Development, in
   Obninsk, Russia, particularly Academician AF Tsyb, Professors EF
   Lushnikov, and A Abrosimov and their clinical and scientific staff. The
   support of the other members, past and present, of the various panels
   that oversee the CTB is also gratefully acknowledged, as is the
   generosity of the patients that have donated their samples to the CTB.
   We also gratefully acknowledge the Biotechnology and Biological Sciences
   Research Council [BB/C519670/1] for funding previous work by Woodbridge
   and Tomlinson on which various aspects of the portal, integrative and
   research databases build.
CR [Anonymous], 2000, EXP EFF CHERN ACC, V2
   [Anonymous], 2008, UNSCEAR REPORT 2008
   Barden CB, 2003, CLIN CANCER RES, V9, P1792
   BAVERSTOCK K, 1992, NATURE, V359, P21, DOI 10.1038/359021b0
   Braverman L.E., 1991, THYROID FUNDAMENTAL
   Chevillard S, 2004, CLIN CANCER RES, V10, P6586, DOI 10.1158/1078-0432.CCR-04-0053
   Committee to Assess Health Risks from Exposure to Low Levels of Ionizing Radiation, 2006, HLTH RISKS EXP LOW L
   Detours V, 2007, BRIT J CANCER, V97, P818, DOI 10.1038/sj.bjc.6603938
   Detours V, 2005, BRIT J CANCER, V92, P1545, DOI 10.1038/sj.bjc.6602521
   Faratian D, 2009, NAT REV CLIN ONCOL, V6, P455, DOI 10.1038/nrclinonc.2009.102
   Hess J, 2011, P NATL ACAD SCI USA, V108, P9595, DOI 10.1073/pnas.1017137108
   Huang Y, 2001, P NATL ACAD SCI USA, V98, P15044, DOI 10.1073/pnas.251547398
   Jarzab B, 2005, CANCER RES, V65, P1587, DOI 10.1158/0008-5472.CAN-04-3078
   KAZAKOV VS, 1992, NATURE, V359, P21, DOI 10.1038/359021a0
   Kimmel RR, 2006, RADIAT RES, V166, P519, DOI 10.1667/RR0547.1
   LiVolsi VA, 2011, CLIN ONCOL-UK, V23, P261, DOI 10.1016/j.clon.2011.01.160
   Maenhaut C, 2011, CLIN ONCOL-UK, V23, P282, DOI 10.1016/j.clon.2011.01.509
   Mazzanti C, 2004, CANCER RES, V64, P2898, DOI 10.1158/0008-5472.CAN-03-3811
   Richter H, 2004, THYROID, V14, P1061, DOI 10.1089/thy.2004.14.1061
   RON E, 1995, RADIAT RES, V141, P259, DOI 10.2307/3579003
   Santoro M, 2000, BRIT J CANCER, V82, P315
   Stein L, 2010, THYROID, V20, P475, DOI 10.1089/thy.2009.0008
   Suchy B, 1998, BRIT J CANCER, V77, P952, DOI 10.1038/bjc.1998.157
   Thomas GA, 2011, CLIN ONCOL-UK, V23, P229, DOI 10.1016/j.clon.2011.02.001
   Thomas GA, 2011, CLIN ONCOL-UK, V23, P276, DOI 10.1016/j.clon.2011.01.503
   Thomas G.A., 2001, FI4CCT980017 EC
   THOMPSON DE, 1994, RADIAT RES, V137, pS17, DOI 10.2307/3578892
   Tuttle RM, 2011, CLIN ONCOL-UK, V23, P268, DOI 10.1016/j.clon.2011.01.178
   Williams ED, 2008, THYROID, V18, P847, DOI 10.1089/thy.2008.0039
   Williams ED, 2000, INT J SURG PATHOL, V8, P181, DOI 10.1177/106689690000800304
   Williams ED, 2004, BRIT J CANCER, V90, P2219, DOI 10.1038/sj.bjc.6601860
   Zablotska LB, 2008, AM J EPIDEMIOL, V167, P305, DOI 10.1093/aje/kwm301
NR 32
TC 4
Z9 4
U1 0
U2 1
PU MDPI AG
PI BASEL
PA POSTFACH, CH-4005 BASEL, SWITZERLAND
SN 2073-4425
J9 GENES-BASEL
JI Genes
PD JUN
PY 2012
VL 3
IS 2
BP 278
EP 290
DI 10.3390/genes3020278
PG 13
WC Genetics & Heredity
SC Genetics & Heredity
GA V36YD
UT WOS:000209242600005
PM 24704918
OA DOAJ Gold, Green Published
DA 2018-10-19
ER

PT J
AU Zamora, DO
   Natesan, S
   Christy, RJ
AF Zamora, David O.
   Natesan, Shanmugasundaram
   Christy, Robert J.
TI Constructing a Collagen Hydrogel for the Delivery of Stem Cell-loaded
   Chitosan Microspheres
SO JOVE-JOURNAL OF VISUALIZED EXPERIMENTS
LA English
DT Article
DE Bioengineering; Issue 64; Biomedical Engineering; Tissue Engineering;
   chitosan; microspheres; collagen; hydrogel; cell delivery;
   adipose-derived stem cells; ASC; CSM
AB Multipotent stem cells have been shown to be extremely useful in the field of regenerative medicine(1-3). However, in order to use these cells effectively for tissue regeneration, a number of variables must be taken into account. These variables include: the total volume and surface area of the implantation site, the mechanical properties of the tissue and the tissue microenvironment, which includes the amount of vascularization and the components of the extracellular matrix. Therefore, the materials being used to deliver these cells must be biocompatible with a defined chemical composition while maintaining a mechanical strength that mimics the host tissue. These materials must also be permeable to oxygen and nutrients to provide a favorable microenvironment for cells to attach and proliferate. Chitosan, a cationic polysaccharide with excellent biocompatibility, can be easily chemically modified and has a high affinity to bind with in vivo macromolecules(4-5). Chitosan mimics the glycosaminoglycan portion of the extracellular matrix, enabling it to function as a substrate for cell adhesion, migration and proliferation. In this study we utilize chitosan in the form of microspheres to deliver adipose-derived stem cells (ASC) into a collagen based three-dimensional scaffold(6). An ideal cell-to-microsphere ratio was determined with respect to incubation time and cell density to achieve maximum number of cells that could be loaded. Once ASC are seeded onto the chitosan microspheres (CSM), they are embedded in a collagen scaffold and can be maintained in culture for extended periods. In summary, this study provides a method to precisely deliver stem cells within a three dimensional biomaterial scaffold.
C1 [Zamora, David O.; Natesan, Shanmugasundaram; Christy, Robert J.] US Army Inst Surg Res, Dept Regenerat Med, Ft Sam Houston, TX 78234 USA.
RP Christy, RJ (reprint author), US Army Inst Surg Res, Dept Regenerat Med, Ft Sam Houston, TX 78234 USA.
EM Robert.Christy@us.army.mil
OI Natesan, Shanmugasundaram/0000-0003-4213-3111; Zamora,
   David/0000-0002-7003-5933
FU Geneva Foundation; Pittsburgh Tissue Engineering Initiative
FX D.O.Z. is supported by a grant awarded from The Geneva Foundation. S.N.
   was supported by a Postdoctoral Fellowship Grant from the Pittsburgh
   Tissue Engineering Initiative.
CR Altman AM, 2010, ACTA BIOMATER, V6, P1388, DOI 10.1016/j.actbio.2009.10.034
   Altman AM, 2009, STEM CELLS, V27, P250, DOI 10.1634/stemcells.2008-0178
   Alves da Silva M.L., 2010, J TISSUE ENG REGEN M
   Baruch L, 2006, BIOPOLYMERS, V82, P570, DOI 10.1002/bip.20509
   Benoit DSW, 2007, J BIOMED MATER RES A, V81A, P259, DOI 10.1002/jbm.a.31292
   BORNSTEIN MB, 1958, LAB INVEST, V7, P134
   Bozkurt G, 2010, NEUROSURGERY, V67, P1733, DOI 10.1227/NEU.0b013e3181f9af35
   BUBNIS WA, 1992, ANAL BIOCHEM, V207, P129, DOI 10.1016/0003-2697(92)90513-7
   Girandon L, 2011, FOLIA BIOL-PRAGUE, V57, P47
   Goren A, 2010, FASEB J, V24, P22, DOI 10.1096/fj.09-131888
   Haque T, 2005, INT J ARTIF ORGANS, V28, P631
   Kang YM, 2010, INT J MOL SCI, V11, P4140, DOI 10.3390/ijms11104140
   Kim IY, 2008, BIOTECHNOL ADV, V26, P1, DOI 10.1016/j.biotechadv.2007.07.009
   Krampera M, 2006, BONE, V39, P678, DOI 10.1016/j.bone.2006.04.020
   Leipzig ND, 2011, BIOMATERIALS, V32, P57, DOI 10.1016/j.biomaterials.2010.09.031
   Machado CB, 2007, BIOMED MATER, V2, P124, DOI 10.1088/1748-6041/2/2/010
   Natesan S, 2010, TISSUE ENG PT A, V16, P1369, DOI [10.1089/ten.tea.2009.0404, 10.1089/ten.TEA.2009.0404]
   Nuttelman CR, 2005, MATRIX BIOL, V24, P208, DOI 10.1016/j.matbio.2005.03.004
   Patrick CW, 2001, ANAT RECORD, V263, P361, DOI 10.1002/ar.1113
   Pountos Ippokratis, 2005, Injury, V36 Suppl 3, pS8, DOI 10.1016/j.injury.2005.07.028
   Shanmuganathan S, 2008, CARBOHYD POLYM, V73, P201, DOI 10.1016/j.carbpol.2007.11.039
   Shi CM, 2006, J SURG RES, V133, P185, DOI 10.1016/j.jss.2005.12.013
   Wang Q, 2011, J BIOMED MATER RES A, V96A, P520, DOI 10.1002/jbm.a.33000
   Wei Y., 2011, J MAT SCI MAT MED
   ZIELINSKI BA, 1994, BIOMATERIALS, V15, P1049
NR 25
TC 1
Z9 1
U1 0
U2 14
PU JOURNAL OF VISUALIZED EXPERIMENTS
PI CAMBRIDGE
PA 1 ALEWIFE CENTER, STE 200, CAMBRIDGE, MA 02140 USA
SN 1940-087X
J9 JOVE-J VIS EXP
JI J. Vis. Exp.
PD JUN
PY 2012
IS 64
AR UNSP e3624
DI 10.3791/3624
PG 7
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA V36PI
UT WOS:000209223100006
PM 22688576
OA Green Published
DA 2018-10-19
ER

PT J
AU Inpanya, P
   Faikrua, A
   Ounaroon, A
   Sittichokechaiwut, A
   Viyoch, J
AF Inpanya, Paichit
   Faikrua, Atchariya
   Ounaroon, Anan
   Sittichokechaiwut, Anuphan
   Viyoch, Jarupa
TI Effects of the blended fibroin/aloe gel film on wound healing in
   streptozotocin-induced diabetic rats
SO BIOMEDICAL MATERIALS
LA English
DT Article
ID ALOE-VERA GEL; IN-VITRO DEGRADATION; GROWTH-FACTOR BFGF; SILK FIBROIN;
   DERMAL WOUNDS; SCAFFOLDS; SKIN; BIOMATERIAL; FIBROBLASTS; COLLAGEN
AB Delayed healing remains a major clinical problem and here we have sought to develop an improved dressing film comprising 1.95% w/v fibroin and 0.05% w/v aloe gel extract. The tensile strength of dry film was 21.1 +/- 0.5 MPa and broke at 1.1 +/- 0.2% elongation; corresponding values for wet film were 18.3 +/- 1.3 MPa and 1.9 +/- 0.1%. The film maintained its shape upon water immersion and the swelling ratio of the dry film was 0.8 +/- 0.1 while the water uptake was 43.7 +/- 2.6%. After 28 days of incubation in phosphate buffered saline (1 M, pH 7.4, 37 degrees C), the weight of film was reduced by 6.7 +/- 1.1% and the tensile strength and elongation at breaking point (dry state) were 15.4 +/- 0.6 MPa and 1.5 +/- 0.2%, respectively. Compared to aloe-free fibroin film (2.0% fibroin extract only), the blended film enhanced the attachment and proliferation of skin fibroblasts. The bFGF immunofluorescence of fibroblasts cultured on the blended film appeared greater than those cultured on tissue culture plate or on aloe-free fibroin film while alpha-smooth muscle actin was maintained. In streptozotocin-induced diabetic rats, the wounds dressed with the blended film were smaller (p < 0.05) by day 7 after wounding, compared to untreated diabetic wounds. Histology of repaired diabetic wounds showed the fibroblast distribution and collagen fiber organization to be similar to wounds in normal rats, and this was matched by enhanced hydroxyproline content. Thus, such accelerated wound healing by the blended fibroin/aloe gel films may find application in treatment of diabetic non-healing skin ulcers.
C1 [Inpanya, Paichit; Viyoch, Jarupa] Naresuan Univ, Fac Pharmaceut Sci, Dept Pharmaceut Technol, Phitsanulok 65000, Thailand.
   [Inpanya, Paichit; Ounaroon, Anan; Viyoch, Jarupa] Naresuan Univ, Ctr Excellence Innovat Chem, Phitsanulok 65000, Thailand.
   [Faikrua, Atchariya] Univ Phayao, Sch Med Sci, Phayao 56000, Thailand.
   [Ounaroon, Anan] Naresuan Univ, Fac Pharmaceut Sci, Dept Pharmaceut Chem & Pharmacognosy, Phitsanulok 65000, Thailand.
   [Sittichokechaiwut, Anuphan] Naresuan Univ, Dept Prevent Dent, Fac Dent, Phitsanulok 65000, Thailand.
RP Inpanya, P (reprint author), Naresuan Univ, Fac Pharmaceut Sci, Dept Pharmaceut Technol, Phitsanulok 65000, Thailand.
EM jarupav@nu.ac
FU Thailand Research Fund (TRF); Center of Excellence for Innovation in
   Chemistry (PERCH-CIC), Office of the Higher Education Commission,
   Thailand
FX Financial support for this study came from Thailand Research Fund (TRF),
   and a grant for a graduate student from the Center of Excellence for
   Innovation in Chemistry (PERCH-CIC), Office of the Higher Education
   Commission, Thailand. The authors would like to acknowledge the Faculty
   of Pharmaceutical Sciences, Naresuan University for their facility
   support. In addition, we also thank Dr C Norman Scholfield for useful
   discussions.
CR Abdullah KM, 2003, J ALTERN COMPLEM MED, V9, P711, DOI 10.1089/107555303322524553
   Akbarzadeh A, 2007, INDIAN J CLIN BIOCHE, V22, P60, DOI 10.1007/BF02913315
   Altman GH, 2003, BIOMATERIALS, V24, P401, DOI 10.1016/S0142-9612(02)00353-8
   Aramwit P, 2007, BIOSCI BIOTECH BIOCH, V71, P2473, DOI 10.1271/bbb.70243
   Bagheri M, 2011, J SURG RES, V169, pE101, DOI 10.1016/j.jss.2011.02.039
   Bautista-Perez R, 2004, J ETHNOPHARMACOL, V93, P89, DOI 10.1016/j.jep.2004.03.030
   Blakytny R, 2006, DIABETIC MED, V23, P594, DOI 10.1111/j.1464-5491.2006.01773.x
   Chang XL, 2011, J TAIWAN INST CHEM E, V42, P197, DOI 10.1016/j.jtice.2010.07.007
   Chen G, 2004, J MATER SCI-MATER M, V15, P671, DOI 10.1023/B:JMSM.0000030208.89523.2a
   Chithra P, 1998, J ETHNOPHARMACOL, V59, P195, DOI 10.1016/S0378-8741(97)00124-4
   Chithra P, 1998, MOL CELL BIOCHEM, V181, P71, DOI 10.1023/A:1006813510959
   Davis RH, 1998, J AM PODIAT MED ASSN, V78, P60
   DELAPP NW, 1990, J INVEST DERMATOL, V94, P777, DOI 10.1111/1523-1747.ep12874637
   Desta T, 2010, J DENT RES, V89, P609, DOI 10.1177/0022034510362960
   Faikrua A, 2009, SCIENCEASIA, V35, P247, DOI 10.2306/scienceasia1513-1874.2009.35.247
   FERREIRA SH, 1993, AGENTS ACTIONS, V38, pC7, DOI 10.1007/BF01991120
   Grazul-Bilska AT, 2003, DRUGS TODAY, V39, P787, DOI 10.1358/dot.2003.39.10.799472
   Habeeb F, 2007, METHODS, V42, P315, DOI 10.1016/j.ymeth.2007.03.004
   Hakvoort TE, 2000, EUR CYTOKINE NETW, V11, P233
   Horan RL, 2005, BIOMATERIALS, V26, P3385, DOI 10.1016/j.biomaterials.2004.09.020
   Hu K, 2006, J BIOACT COMPAT POL, V21, P23, DOI 10.1177/0883911506060455
   Jao WC, 2012, POLYM ADVAN TECHNOL, V23, P1066, DOI 10.1002/pat.2014
   Jin HJ, 2004, BIOMACROMOLECULES, V5, P711, DOI 10.1021/bm0343287
   Kearns V, 2008, TOPICS TISSUE ENG, V4, P1
   Khan TA, 2000, J PHARM PHARM SCI, V3, P303
   Kim UJ, 2005, BIOMATERIALS, V26, P2775, DOI 10.1016/j.biomaterials.2004.07.044
   Kino R, 2007, J BIOSCI BIOENG, V103, P514, DOI 10.1263/jbb.103.514
   Komesu Marilena Chinali, 2004, Pathophysiology, V11, P63, DOI 10.1016/j.pathophys.2004.02.002
   Liu TL, 2010, J ZHEJIANG UNIV-SC B, V11, P10, DOI 10.1631/jzus.B0900163
   Loots MAM, 1998, J INVEST DERMATOL, V111, P850, DOI 10.1046/j.1523-1747.1998.00381.x
   Lu Q, 2007, BIOMATERIALS, V28, P2306, DOI 10.1016/j.biomaterials.2007.01.031
   Ma L, 2004, J BIOMED MATER RES A, V71A, P334, DOI 10.1002/jbm.a.30170
   Ma L, 2003, BIOMATERIALS, V24, P4833, DOI 10.1016/S0142-9612(03)00374-0
   Malay O, 2008, J THERM ANAL CALORIM, V94, P749, DOI 10.1007/s10973-008-9368-5
   Mandal BB, 2009, BIOMATERIALS, V30, P2956, DOI 10.1016/j.biomaterials.2009.02.006
   McAnulty RJ, 2007, INT J BIOCHEM CELL B, V39, P666, DOI 10.1016/j.biocel.2006.11.005
   Menke NB, 2007, CLIN DERMATOL, V25, P19, DOI 10.1016/j.clindermatol.2006.12.005
   Min BM, 2004, INT J BIOL MACROMOL, V34, P281, DOI 10.1016/j.ijbiomac.2004.08.004
   Min SJ, 2012, J BIOMAT SCI-POLYM E, V23, P97, DOI 10.1163/092050610X543609
   MINOURA N, 1995, BIOCHEM BIOPH RES CO, V208, P511, DOI 10.1006/bbrc.1995.1368
   Miyaguchi Y, 2005, FOOD SCI TECHNOL RES, V11, P37, DOI 10.3136/fstr.11.37
   Miyoshi M, 2005, J BIOMAT SCI-POLYM E, V16, P893, DOI 10.1163/1568562054255709
   Noh HK, 2006, BIOMATERIALS, V27, P3934, DOI 10.1016/j.biomaterials.2006.03.016
   Pae HO, 2003, J ETHNOPHARMACOL, V88, P287, DOI 10.1016/S0378-8741(03)00228-9
   Phetdee M., 2008, International Journal of Cosmetic Science, V30, P285, DOI 10.1111/j.1468-2494.2008.00447.x
   Prasad SK, 2010, PHARM BIOL, V48, P1397, DOI 10.3109/13880209.2010.486837
   Rajasekaran S, 2005, PHARMACOL REP, V57, P90
   Rajasekaran S, 2004, J MED FOOD, V7, P61, DOI 10.1089/109662004322984725
   Reuter J, 2008, SKIN PHARMACOL PHYS, V21, P106, DOI 10.1159/000114871
   Rice WL, 2008, BIOMATERIALS, V29, P2015, DOI 10.1016/j.biomaterials.2007.12.049
   She ZD, 2008, POLYM DEGRAD STABIL, V93, P1316, DOI 10.1016/j.polymdegradstab.2008.04.001
   Shukla A, 1999, J ETHNOPHARMACOL, V65, P1, DOI 10.1016/S0378-8741(98)00141-X
   Talukdar S, 2011, BIOMATERIALS, V32, P2149, DOI 10.1016/j.biomaterials.2010.11.052
   Vaithanomsat P., 2006, KASETSART J NAT SCI, V40, P152
   Vasconcelos A, 2008, BIOMACROMOLECULES, V9, P1299, DOI 10.1021/bm7012789
   Vepari C, 2007, PROG POLYM SCI, V32, P991, DOI 10.1016/j.progpolymsci.2007.05.013
   Viyoch J., 2003, International Journal of Cosmetic Science, V25, P113, DOI 10.1046/j.1467-2494.2003.00177.x
   Wang YZ, 2006, BIOMATERIALS, V27, P6064, DOI 10.1016/j.biomaterials.2006.07.008
   Yamada H, 2001, MAT SCI ENG C-BIO S, V14, P41, DOI 10.1016/S0928-4931(01)00207-7
   Yang YM, 2007, BIOMATERIALS, V28, P1643, DOI 10.1016/j.biomaterials.2006.12.004
   Yu A, 2012, J BIOMAT SCI-POLYM E, V23, P1315, DOI 10.1163/092050611X580463
   Zhang YQ, 2005, J BIOTECHNOL, V120, P315, DOI 10.1016/j.jbiotec.2005.06.027
NR 62
TC 38
Z9 40
U1 2
U2 34
PU IOP PUBLISHING LTD
PI BRISTOL
PA TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND
SN 1748-6041
EI 1748-605X
J9 BIOMED MATER
JI Biomed. Mater.
PD JUN
PY 2012
VL 7
IS 3
AR 035008
DI 10.1088/1748-6041/7/3/035008
PG 13
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 937OK
UT WOS:000303667600008
PM 22418946
DA 2018-10-19
ER

PT J
AU Chang, PC
   Lim, LP
   Chong, LY
   Dovban, ASM
   Chien, LY
   Chung, MC
   Lei, C
   Kao, MJ
   Chen, CH
   Chiang, HC
   Kuo, YP
   Wang, CH
AF Chang, P. -C.
   Lim, L. P.
   Chong, L. Y.
   Dovban, A. S. M.
   Chien, L. -Y.
   Chung, M. -C.
   Lei, C.
   Kao, M. -J.
   Chen, C. -H.
   Chiang, H. -C.
   Kuo, Y. -P.
   Wang, C. -H.
TI PDGF-Simvastatin Delivery Stimulates Osteogenesis in Heat-induced
   Osteonecrosis
SO JOURNAL OF DENTAL RESEARCH
LA English
DT Article
DE growth factor(s); biomaterial(s); bone biology; bone
   remodeling/regeneration; biocompatibility; tissue engineering
ID BONE-FORMATION; THERAPY; MATRIX; REGENERATION; IRRIGATION; DEFECTS;
   REPAIR
AB Heat generated during implant osteotomy might lead to osteonecrosis and delayed bone repair, thus resulting in impaired early osseointegration and fixation of bone-anchoring devices. In this study, we proposed to overcome heat-induced injury to bone by fabricating core-shell polymeric biodegradable microspheres encapsulating a mitogenic factor, platelet-derived growth factor (PDGF), and a differentiation factor, simvastatin, in a simultaneous or sequential release profile. Microspheres encapsulating bovine serum albumin (BSA), PDGF, simvastatin, PDGF-in-core with simvastatin-in-shell, and simvastatin-in-core with PDGF-in-shell were delivered to fill standardized osteotomy sites on edentulous ridges of rat maxillae under irrigated or non-irrigated conditions. In the absence of irrigation, significant reduction of cell viability and increase in inflammation and sequestrum formation without evidence of osteogenesis were observed. Both PDGF and simvastatin deliveries facilitated cell viability and reduced osteonecrosis. Localized osteogenesis was seen under simvastatin treatment, while generalized but primitive osteogenesis was noted in PDGF-treated osteotomy sites. In addition, sequential PDGF-simvastatin delivery further augmented osteogenesis and promoted bone maturation. The results suggested that sequential PDGF-simvastatin delivery was an effective modality to prevent heat-induced complications and facilitate bone apposition after implant osteotomy, potentially favoring the early fixation of bone-anchoring devices and oral implant osseointegration.
C1 [Chang, P. -C.; Lim, L. P.; Chong, L. Y.; Dovban, A. S. M.; Chien, L. -Y.; Chung, M. -C.; Kao, M. -J.] Natl Univ Singapore, Fac Dent, Singapore 119083, Singapore.
   [Lei, C.; Wang, C. -H.] Natl Univ Singapore, Dept Chem & Biomol Engn, Singapore 119083, Singapore.
   [Chen, C. -H.; Chiang, H. -C.; Kuo, Y. -P.] Natl Taiwan Univ, Sch Dent, Taipei 10764, Taiwan.
RP Chang, PC (reprint author), Natl Univ Singapore, Fac Dent, 11 Lower Kent Ridge Rd, Singapore 119083, Singapore.
EM dencpc@nus.edu.sg
OI CHANG, PO-CHUN/0000-0002-4493-6922
FU NUS; National Medical Research Council of Singapore [R-221-000-034-133,
   R-221-000-028-275]
FX This study was supported by NUS and National Medical Research Council of
   Singapore under research grants R-221-000-034-133 and R-221-000-028-275.
   The authors declare no potential conflicts of interest with respect to
   the authorship and/or publication of this article.
CR Barone CM, 1997, J CRANIOFAC SURG, V8, P466, DOI 10.1097/00001665-199711000-00007
   Berglundh T, 2003, CLIN ORAL IMPLAN RES, V14, P251, DOI 10.1034/j.1600-0501.2003.00972.x
   Burghardt AJ, 2008, CALCIFIED TISSUE INT, V83, P129, DOI 10.1007/s00223-008-9158-x
   Chang PC, 2010, GENE THER, V17, P95, DOI 10.1038/gt.2009.117
   Chang PC, 2012, J BIOMED A IN PRESS
   Dunn CA, 2005, MOL THER, V11, P294, DOI 10.1016/j.ymthe.2004.10.005
   ERIKSSON RA, 1984, J ORAL MAXIL SURG, V42, P705, DOI 10.1016/0278-2391(84)90417-8
   Flanagan D, 2010, IMPLANT DENT, V19, P241, DOI 10.1097/ID.0b013e3181dc9852
   Hsieh SC, 1998, J CELL BIOCHEM, V69, P169, DOI 10.1002/(SICI)1097-4644(19980501)69:2<169::AID-JCB7>3.0.CO;2-Q
   Jin QM, 2004, MOL THER, V9, P519, DOI 10.1016/j.ymthe.2004.01.016
   Kieswetter K, 1997, ENDOCRINE, V6, P257, DOI 10.1007/BF02820501
   Kolambkar YM, 2011, BIOMATERIALS, V32, P65, DOI 10.1016/j.biomaterials.2010.08.074
   Kumar A, 2010, TISSUE ENG PT A, V16, P983, DOI [10.1089/ten.tea.2009.0230, 10.1089/ten.TEA.2009.0230]
   Lee YJ, 2008, BIOMATERIALS, V29, P1940, DOI 10.1016/j.biomaterials.2007.12.045
   Mulder G, 2009, WOUND REPAIR REGEN, V17, P772, DOI 10.1111/j.1524-475X.2009.00541.x
   Neves JS, 2009, ARCH ORAL BIOL, V54, P651, DOI 10.1016/j.archoralbio.2009.04.001
   Nie HM, 2010, J BIOMED MATER RES A, V95A, P709, DOI 10.1002/jbm.a.32867
   Pape HC, 2007, J BONE JOINT SURG BR, V89B, P1421, DOI 10.1302/0301-620X.89B11.19570
   Ranganath SH, 2010, BIOMATERIALS, V31, P5199, DOI 10.1016/j.biomaterials.2010.03.002
   Schroeder JE, 2010, INJURY, V41, P235, DOI 10.1016/j.injury.2009.09.041
   Seiberling KA, 2011, INT FORUM ALLERGY RH, V1, P351, DOI 10.1002/alr.20075
   Sener BC, 2009, CLIN ORAL IMPLAN RES, V20, P294, DOI 10.1111/j.1600-0501.2008.01643.x
   Vandermeer JS, 2011, J BONE JOINT SURG AM, V93A, P905, DOI 10.2106/JBJS.J.00716
   Wikesjo UME, 2003, J CLIN PERIODONTOL, V30, P705, DOI 10.1034/j.1600-051X.2003.00363.x
   Yoshida K, 2009, CLIN ORAL IMPLAN RES, V20, P782, DOI 10.1111/j.1600-0501.2008.01654.x
NR 25
TC 9
Z9 9
U1 0
U2 7
PU SAGE PUBLICATIONS INC
PI THOUSAND OAKS
PA 2455 TELLER RD, THOUSAND OAKS, CA 91320 USA
SN 0022-0345
J9 J DENT RES
JI J. Dent. Res.
PD JUN
PY 2012
VL 91
IS 6
BP 618
EP 624
DI 10.1177/0022034512445194
PG 7
WC Dentistry, Oral Surgery & Medicine
SC Dentistry, Oral Surgery & Medicine
GA 939KL
UT WOS:000303809000016
PM 22496127
DA 2018-10-19
ER

PT J
AU Ding, M
   Danielsen, CC
   Overgaard, S
AF Ding, Ming
   Danielsen, Carl Christian
   Overgaard, Soren
TI The effects of glucocorticoid on microarchitecture, collagen, mineral
   and mechanical properties of sheep femur cortical bone
SO JOURNAL OF TISSUE ENGINEERING AND REGENERATIVE MEDICINE
LA English
DT Article
DE glucocorticoid-induced osteoporosis; microarchitecture; mechanical
   property; collagen and mineral; sheep cortical bone; tissue engineering
ID LARGE ANIMAL-MODEL; CANCELLOUS BONE; INDUCED OSTEOPOROSIS; TRABECULAR
   BONE; AGE; MICROSTRUCTURE; OVARIECTOMY; VALIDATION
AB In this study, 18 female skeletally mature sheep were randomly allocated into three groups of six each. Group 1 (glucocorticoid-1) received prednisolone treatment (0.60 mg/kg/day, five times weekly) for 7 months. Group 2 (glucocorticoid-2) received the same treatment regime followed by observation of 3 months without treatment. Group 3 was left untreated and served as controls. All sheep received a restricted diet with low calcium and phosphorus. At sacrifice, cortical bone samples from the femur midshaft of each sheep were harvested, micro-CT scanned and subjected to three-point bending and tensile strength testing. Bone collagen and mineral were determined. Cortical porosity was significantly increased in the glucocorticoid-2 compared with the glucocorticoid-1 and control groups. Apparent density was significantly decreased in the glucocorticoid-2 compared with the glucocorticoid-1 group. Collagen content was significantly increased in the glucocorticoid-2 compared with the glucocorticoid-1 and control groups. Bone mineral content did not differ between the groups. Neither the three-point bending mechanical properties nor the tensile mechanical properties differed significantly between the groups, while there was a trend towards decreasing bending mechanical properties in the glucocorticoid-2 group. In conclusion, 7 months of glucocorticoid treatment with malnutrition had a significant impact on the cortical microarchitecture of the sheep femur midshaft. These observed changes occurred 3 months after glucocorticoid cessation, suggesting a delayed effect of glucocorticoid on cortical bone. Thus, changes in cortical bone beyond cancellous bone might further increase fracture risk in patients treated with glucocorticoids. This model might be used as a glucocorticoid-induced osteoporotic model for orthopaedic biomaterial, joint prosthesis and medical device researches. Copyright (c) 2011 John Wiley & Sons, Ltd.
C1 [Ding, Ming; Overgaard, Soren] Univ So Denmark, Orthopaed Res Lab, Dept Orthopaed & Traumatol, Odense Univ Hosp,Inst Clin Res, DK-5000 Odense C, Denmark.
   [Danielsen, Carl Christian] Univ Aarhus, Dept Connect Tissue Biol, Inst Anat, DK-8000 Aarhus C, Denmark.
RP Ding, M (reprint author), Univ So Denmark, Orthopaed Res Lab, Dept Orthopaed & Traumatol, Odense Univ Hosp,Inst Clin Res, JB Winsloewsvej 15,3rd Floor, DK-5000 Odense C, Denmark.
EM ming.ding@ouh.regionsyddanmark.dk
OI Overgaard, Soren/0000-0001-6829-4787; Ding, Ming/0000-0002-6610-8079
FU Danish Research Agency [SSVF-22-04-0705]
FX This study was kindly supported by the Danish Research Agency (Grant No.
   SSVF-22-04-0705). We thank Eva K. Mikkelsen, Gitte Dybmose, Birthe
   Faurskov and Dorte Brorsen for their skilful technical assistance and
   the animal care staff at the Biomedicine Laboratory for their care of
   the animals.
CR Augat P, 2003, J BIOMED MATER RES A, V66A, P457, DOI 10.1002/jbm.a.10601
   Augat P, 2006, AGE AGEING, V35, P27, DOI 10.1093/ageing/afl081
   Civitelli R, 2008, J Endocrinol Invest, V31, P2
   DANIELSEN CC, 1988, J BIOMECH, V21, P207, DOI 10.1016/0021-9290(88)90171-6
   DANIELSEN CC, 1986, CALCIFIED TISSUE INT, V39, P69, DOI 10.1007/BF02553293
   Ding M, 2006, CALCIFIED TISSUE INT, V78, P113, DOI 10.1007/s00223-005-0028-5
   Ding M, 1997, J BONE JOINT SURG BR, V79B, P995, DOI 10.1302/0301-620X.79B6.7538
   Ding M, 1999, J BIOMECH, V32, P323, DOI 10.1016/S0021-9290(98)00176-6
   Ding M, 2002, J ORTHOPAED RES, V20, P615, DOI 10.1016/S0736-0266(01)00132-2
   Ding M, 2010, ACTA ORTHOP, V81, P5, DOI 10.3109/17453671003619037
   Ding M, 2010, SPINE, V35, P363, DOI 10.1097/BRS.0b013e3181b8e0ff
   Kanis JA, 2002, LANCET, V359, P1929, DOI 10.1016/S0140-6736(02)08761-5
   Kim HJ, 2006, J CLIN INVEST, V116, P2152, DOI 10.1172/JCI28084
   Lill CA, 2002, OSTEOPOROSIS INT, V13, P480, DOI 10.1007/s001980200058
   Lill CA, 2002, OSTEOPOROSIS INT, V13, P407, DOI 10.1007/s001980200047
   Manolagas SC, 2000, J BONE MINER RES, V15, P1001, DOI 10.1359/jbmr.2000.15.6.1001
   Manolagas SC, 1999, J BONE MINER RES, V14, P1061, DOI 10.1359/jbmr.1999.14.7.1061
   Mazziotti G, 2010, AM J MED, V123, P877, DOI 10.1016/j.amjmed.2010.02.028
   Schorlemmer S, 2005, BONE, V37, P491, DOI 10.1016/j.bone.2005.05.002
   Schorlemmer S, 2003, J BONE MINER RES, V18, P2010, DOI 10.1359/jbmr.2003.18.11.2010
   Sigrist IM, 2007, J BONE MINER METAB, V25, P28, DOI 10.1007/s00774-006-0724-x
   Thorndike E. A., 1998, FRONT BIOSCI, V3, P17
   Zarrinkalam MR, 2009, EUR SPINE J, V18, P244, DOI 10.1007/s00586-008-0813-8
   Zioupos P, 1999, J BIOMED MATER RES, V45, P108, DOI 10.1002/(SICI)1097-4636(199905)45:2<108::AID-JBM5>3.0.CO;2-A
NR 24
TC 4
Z9 6
U1 0
U2 7
PU WILEY-BLACKWELL
PI MALDEN
PA COMMERCE PLACE, 350 MAIN ST, MALDEN 02148, MA USA
SN 1932-6254
J9 J TISSUE ENG REGEN M
JI J. Tissue Eng. Regen. Med.
PD JUN
PY 2012
VL 6
IS 6
BP 443
EP 450
DI 10.1002/term.448
PG 8
WC Cell & Tissue Engineering; Biotechnology & Applied Microbiology; Cell
   Biology; Engineering, Biomedical
SC Cell Biology; Biotechnology & Applied Microbiology; Engineering
GA 938VR
UT WOS:000303762000003
PM 21751424
DA 2018-10-19
ER

PT J
AU Pavlica, S
   Schmitmeier, S
   Gloeckner, P
   Piscioneri, A
   Peinemann, F
   Krohn, K
   Siegmund-Schulz, M
   Laera, S
   Favia, P
   De Bartolo, L
   Bader, A
AF Pavlica, Sanja
   Schmitmeier, Stephanie
   Gloeckner, Pia
   Piscioneri, Antonella
   Peinemann, Frank
   Krohn, Knut
   Siegmund-Schulz, Michaela
   Laera, Stefania
   Favia, Pietro
   De Bartolo, Loredana
   Bader, Augustinus
TI Effect of native and NH3 plasma-functionalized polymeric membranes on
   the gene expression profiles of primary hepatocytes
SO JOURNAL OF TISSUE ENGINEERING AND REGENERATIVE MEDICINE
LA English
DT Article
DE primary rat hepatocytes; gene expression; PEEK-WC-PU membranes; plasma
   processing; membrane bioreactor; collagen sandwich
ID PRIMARY RAT HEPATOCYTES; SMALL-SCALE BIOREACTOR; SURFACE MODIFICATION;
   HEPATOCELLULAR-CARCINOMA; CELLS; LIVER; DIFFERENTIATION; IMMOBILIZATION;
   BIOMATERIAL; REGUCALCIN
AB Little is known about how cells respond to different biomaterials at the molecular level. Biomaterials could stimulate specific cellular responses at the molecular level, such as activation of signalling pathways that control gene activity involved in the maintenance, growth and functional regeneration of liver tissue in vitro. This aspect is an important step in liver tissue engineering. Currently, there are no data available concerning the modulation of cellular genomic response by using synthetic membranes in a bioartificial system. For the first time we investigated gene expression profiles of primary hepatocytes cultured on different substrates: collagen sandwich, native and NH3 plasma-grafted PEEKWCPU membranes. Gene expression in cell suspension prepared after cell isolation was used as a control. Generally, microarray data revealed that the expression of the majority of genes remained unchanged compared to the control. Among 31 000 genes, 52 were significantly changed: 20 were upregulated and 32 downregulated. There were similar changes in gene expression of hepatocytes cultured in the membranes and collagen sandwich. However, some genes involved in the cell proliferation and functional metabolic pathways are more expressed in cells cultured on the membranes and especially on the functionalized ones. Both membranes sustained liver functions at the molecular level, demonstrating their suitability for the reconstruction of liver and as a toxicogenomic tool to predict the liver response to novel drugs. Copyright (c) 2011 John Wiley & Sons, Ltd.
C1 [Pavlica, Sanja; Schmitmeier, Stephanie; Gloeckner, Pia; Peinemann, Frank; Bader, Augustinus] Univ Leipzig, Ctr Biotechnol & Biomed, BBZ, D-04103 Leipzig, Germany.
   [Piscioneri, Antonella; De Bartolo, Loredana] Univ Calabria, Inst Membrane Technol, Natl Res Council Italy, ITM CNR, I-87036 Arcavacata Di Rende, CS, Italy.
   [Laera, Stefania; Favia, Pietro] Univ Bari, Dept Chem, I-70121 Bari, Italy.
   [Krohn, Knut] Univ Leipzig, IZKF, Core Unit DNA Technol, D-04103 Leipzig, Germany.
   [Siegmund-Schulz, Michaela] Univ Leipzig, Dept Pharmaceut Technol, D-04103 Leipzig, Germany.
RP Pavlica, S (reprint author), Univ Leipzig, Dept Cell Tech & Appl Stem Cell Biol, Biotechnol Biomed Ctr, Deutsch Pl 5, D-04103 Leipzig, Germany.
EM sanja.pavlica@bbz.uni-leipzig.de
RI De Bartolo, Loredana/E-5074-2015; Piscioneri, Antonella/N-6910-2018
OI De Bartolo, Loredana/0000-0003-3774-9114; Piscioneri,
   Antonella/0000-0002-1052-1550
FU EU [NMP3-CT-013653]
FX This study was funded by the EU through the project LIVE-BIOMAT
   NMP3-CT-013653. Microarray analysis was conducted at the IZKF Leipzig at
   the Faculty of Medicine of the University Leipzig (Projekt Z03). We
   thank Dr Eva Schmelzer for her help in analysing microarray data.
CR ALLEN SL, 1977, BIOCHEM BIOPH RES CO, V75, P111, DOI 10.1016/0006-291X(77)91296-7
   Bader A, 1998, XENOBIOTICA, V28, P815, DOI 10.1080/004982598239074
   Beigel J, 2008, TOXICOL IN VITRO, V22, P171, DOI 10.1016/j.tiv.2007.06.019
   Cukierman E, 2001, SCIENCE, V294, P1708, DOI 10.1126/science.1064829
   De Bartolo L, 2005, BIOMATERIALS, V26, P6625, DOI 10.1016/j.biomaterials.2005.04.021
   De Bartolo L, 2002, BIOMATERIALS, V23, P2485, DOI 10.1016/S0142-9612(01)00383-0
   De Bartolo L, 2007, BIOMOL ENG, V24, P23, DOI 10.1016/j.bioeng.2006.07.001
   De Bartolo L, 2009, BIOMATERIALS, V30, P2531, DOI 10.1016/j.biomaterials.2009.01.011
   Diekmann S, 2007, INT J ARTIF ORGANS, V30, P192
   DUNN JCY, 1992, J CELL BIOL, V116, P1043, DOI 10.1083/jcb.116.4.1043
   Favia P, 2008, NATO SCI PEACE SEC A, P203
   Favia P., 2005, PLASMA PROCESS POLYM, P271
   Favre C, 1998, J HEPATOL, V28, P700, DOI 10.1016/S0168-8278(98)80295-X
   Gerritsen ME, 2003, MICROCIRCULATION, V10, P63, DOI 10.1038/sj.mn.7800170
   Guengerich FP., 1989, PHARMACOL REV, V40, P243
   Kakizaki S, 2007, LIVER INT, V27, P109, DOI 10.1111/j.1478-3231.2006.01384.x
   KAZMAIER M, 1985, EMBO J, V4, P1261, DOI 10.1002/j.1460-2075.1985.tb03770.x
   Keselowsky BG, 2005, P NATL ACAD SCI USA, V102, P5953, DOI 10.1073/pnas.0407356102
   Kidambi S, 2007, TISSUE ENG, V13, P2105, DOI 10.1089/ten.2006.0151
   Laera S, 2009, PLASMA PROCESS POLYM, V6, pS81, DOI 10.1002/ppap.200930307
   Lalazar A, 1997, GENE, V195, P235, DOI 10.1016/S0378-1119(97)00159-5
   Lam K, 2001, J CELL PHYSIOL, V189, P79, DOI 10.1002/jcp.1142
   LII CK, 1994, ARCH BIOCHEM BIOPHYS, V308, P231, DOI 10.1006/abbi.1994.1033
   Liu YF, 2007, ONCOL REP, V18, P943
   Lopez LC, 2005, SURF COAT TECH, V200, P1000, DOI 10.1016/j.surfcoat.2005.02.003
   Lopez LC, 2006, ADV FUNCT MATER, V16, P1417, DOI 10.1002/adfm.200500502
   Ma ZW, 2007, COLLOID SURFACE B, V60, P137, DOI 10.1016/j.colsurfb.2007.06.019
   Memoli B, 2007, BIOMATERIALS, V28, P4836, DOI 10.1016/j.biomaterials.2007.05.043
   Miele L, 2008, GASTROENTEROLOGY, V135, P2282
   Mwale F, 2007, BIOMED ENG ONLINE, V6, DOI 10.1186/1475-925X-6-33
   Park J, 2008, BIOTECHNOL BIOENG, V99, P455, DOI 10.1002/bit.21572
   Pavlica S, 2009, BIOMATERIALS, V30, P6514, DOI 10.1016/j.biomaterials.2009.08.024
   Ratziu V, 1998, P NATL ACAD SCI USA, V95, P9500, DOI 10.1073/pnas.95.16.9500
   Robbi M, 2000, MAMM GENOME, V11, P1034, DOI 10.1007/s003350010189
   Salerno S, 2009, BIOMATERIALS, V30, P4348, DOI 10.1016/j.biomaterials.2009.04.052
   Sardella E, 2006, PLASMA PROCESS POLYM, V3, P456, DOI 10.1002/ppap.200600041
   Schmitmeier S, 2006, BIOTECHNOL BIOENG, V95, P1198, DOI 10.1002/bit.21089
   Seglen P O, 1976, Methods Cell Biol, V13, P29, DOI 10.1016/S0091-679X(08)61797-5
   Sibilla P, 2006, J DENT RES, V85, P354, DOI 10.1177/154405910608500414
   Sirach E, 2007, CELL DEATH DIFFER, V14, P1202, DOI 10.1038/sj.cdd.4402114
   Starkel P, 2000, LIVER, V20, P405, DOI 10.1034/j.1600-0676.2000.020005405.x
   TAKAHASHI H, 1993, MOL CELL BIOCHEM, V124, P169, DOI 10.1007/BF00929209
   Tuschl G, 2006, TOXICOLOGY, V218, P205, DOI 10.1016/j.tox.2005.10.017
   YAMAGUCHI M, 1992, MOL CELL BIOCHEM, V110, P25, DOI 10.1007/BF02385002
   Zhang H.C., 1987, Chin. Pat., Patent No. [85108751, CN 85,108 751]
NR 45
TC 4
Z9 4
U1 0
U2 11
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1932-6254
J9 J TISSUE ENG REGEN M
JI J. Tissue Eng. Regen. Med.
PD JUN
PY 2012
VL 6
IS 6
BP 486
EP 496
DI 10.1002/term.453
PG 11
WC Cell & Tissue Engineering; Biotechnology & Applied Microbiology; Cell
   Biology; Engineering, Biomedical
SC Cell Biology; Biotechnology & Applied Microbiology; Engineering
GA 938VR
UT WOS:000303762000007
PM 21751426
DA 2018-10-19
ER

PT J
AU Nikpour, MR
   Rabiee, SM
   Jahanshahi, M
AF Nikpour, M. R.
   Rabiee, S. M.
   Jahanshahi, M.
TI Synthesis and characterization of hydroxyapatite/chitosan nanocomposite
   materials for medical engineering applications
SO COMPOSITES PART B-ENGINEERING
LA English
DT Article
DE Nano-structures; Polymer-matrix composites; Mechanical properties;
   Electron microscopy
ID COMPOSITE SCAFFOLDS; CHITOSAN; DELIVERY; CHITIN; DNA
AB Incorporation of hydroxyapatite (HA) with organic polymer in favor of composites would be used in biomaterial engineering. According to prior researches, because of its chemical similarity to natural bone and dental, this product could improve bioactivity and bone bonding ability. In this research, nano-hydroxyapatite/chitosan composite material was prepared via in situ Hybridization route. The surface chemical characterization on the nanocomposite was evaluated by Fourier transformed infrared (FTIR) and X-ray diffraction (XRD). Surface topography, roughness and morphology of the samples were observed by atomic force microscopy (AFM) and scanning electron microscopy (SEM). The characterization results confirmed homogeneity, interaction and integration between the HA and chitosan matrix. It was indicated that composite samples consist of homogeneous aggregations around 40-100 nm, in which many HA nanocrystals align along the chitosan molecules. HA grain gradually decreased in size when amount of chitosan increased from 0 to 6 g into 100 cc solution. It can be seen that by increasing chitosan, the aggregation of nanoparticles enhance and subsequently, improve the expected compatibility among HA filler and chitosan matrix. Furthermore, the mechanical compressive testing indicated that the synthesized composites have acceptable mechanical behavior for tissue substitution. The mechanistic of the biodegradable nanocomposite systems, their preparation and characterization for medical usage are strongly discussed. (C) 2012 Elsevier Ltd. All rights reserved.
C1 [Nikpour, M. R.; Rabiee, S. M.; Jahanshahi, M.] Babol Univ Technol, Nanotechnol Res Inst, Babol Sar, Iran.
   [Nikpour, M. R.; Jahanshahi, M.] Babol Univ Technol, Fac Chem Engn, Babol Sar, Iran.
   [Rabiee, S. M.] Babol Univ Technol, Fac Mech Engn, Babol Sar, Iran.
RP Jahanshahi, M (reprint author), Babol Univ Technol, Nanotechnol Res Inst, POB 484, Babol Sar, Iran.
EM mmohse@yahoo.com
CR Alatorre-Meda M, 2011, COLLOID SURFACE B, V82, P54, DOI 10.1016/j.colsurfb.2010.08.013
   Albano C, 2011, J MECH BEHAV BIOMED, V4, P467, DOI 10.1016/j.jmbbm.2010.12.008
   da Silva MLA, 2010, ACTA BIOMATER, V6, P1149, DOI 10.1016/j.actbio.2009.09.006
   Falini G, 2004, TISSUE ENG, V10, P1, DOI 10.1089/107632704322791646
   Griffon DJ, 2006, ACTA BIOMATER, V2, P313, DOI 10.1016/j.actbio.2005.12.007
   Gu RL, 2010, BIOMATERIALS, V31, P1270, DOI 10.1016/j.biomaterials.2009.10.023
   Hench LL, 1998, J AM CERAM SOC, V81, P1705
   Hu QL, 2004, BIOMATERIALS, V25, P779, DOI 10.1016/S0142-9612(03)00582-9
   Jiang T, 2006, BIOMATERIALS, V27, P4894, DOI 10.1016/j.biomaterials.2006.05.025
   Johnson JW, 2011, ACTA BIOMATER, V7, P16
   Khanna R., 2010, INT J POLYM SCI, V10, P12
   Khor E, 2003, BIOMATERIALS, V24, P2339, DOI 10.1016/S0142-9612(03)00026-7
   Oliveira JM, 2006, BIOMATERIALS, V27, P6123, DOI 10.1016/j.biomaterials.2006.07.034
   Park JH, 2010, ADV DRUG DELIVER REV, V62, P28, DOI 10.1016/j.addr.2009.10.003
   Pena J, 2006, J EUR CERAM SOC, V26, P3631, DOI 10.1016/j.jeurceramsoc.2005.12.028
   Peter M, 2010, CARBOHYD POLYM, V79, P284, DOI 10.1016/j.carbpol.2009.08.001
   Puppi D, 2010, PROG POLYM SCI, V35, P403, DOI 10.1016/j.progpolymsci.2010.01.006
   Rabiee SM, 2008, BIOTECHNOL BIOPROC E, V13, P204, DOI [10.1007/s12257-007-0163-0, 10.1007/S12257-007-0163-0]
   Rae Hull J, 2008, MATER SCI ENG, V28, P434
   Ragetly G, 2010, ACTA BIOMATER, V6, P3988, DOI 10.1016/j.actbio.2010.05.016
   Senturk SB, 2011, CARBOHYD POLYM, V84, P141, DOI 10.1016/j.carbpol.2010.11.015
   Suh FJK, 2000, BIOMATERIALS, V21, P2589
   Thein-Han WW, 2009, ACTA BIOMATER, V5, P1182, DOI 10.1016/j.actbio.2008.11.025
   Wang XH, 2002, BIOMATERIALS, V23, P4167, DOI 10.1016/S0142-9612(02)00153-9
   Yilgor P, 2009, BIOMATERIALS, V30, P3551, DOI 10.1016/j.biomaterials.2009.03.024
   Zhang Y, 2001, J BIOMED MATER RES, V55, P304, DOI 10.1002/1097-4636(20010605)55:3<304::AID-JBM1018>3.0.CO;2-J
   Zhang YZ, 2008, BIOMATERIALS, V29, P4314, DOI 10.1016/j.biomaterials.2008.07.038
   Zhang YF, 2006, BIOCHEM BIOPH RES CO, V344, P362, DOI 10.1016/j.bbrc.2006.03.106
   Zhou CJ, 2011, COLLOID SURFACE B, V84, P155, DOI 10.1016/j.colsurfb.2010.12.030
NR 29
TC 72
Z9 75
U1 3
U2 74
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1359-8368
J9 COMPOS PART B-ENG
JI Compos. Pt. B-Eng.
PD JUN
PY 2012
VL 43
IS 4
BP 1881
EP 1886
DI 10.1016/j.compositesb.2012.01.056
PG 6
WC Engineering, Multidisciplinary; Materials Science, Composites
SC Engineering; Materials Science
GA 932KW
UT WOS:000303291000024
DA 2018-10-19
ER

PT J
AU Fallon, A
   Goodchild, T
   Wang, RY
   Matheny, RG
AF Fallon, Anna
   Goodchild, Traci
   Wang, Ruoya
   Matheny, Robert G.
TI Remodeling of Extracellular Matrix Patch used for Carotid Artery Repair
SO JOURNAL OF SURGICAL RESEARCH
LA English
DT Article
DE endarterectomy; extracellular matrix; biomaterial; carotid artery;
   small-intestinal submucosa
ID SMALL-INTESTINAL SUBMUCOSA; VALVE LEAFLET SUBSTITUTE; VEIN PATCH;
   ENDARTERECTOMY; RECONSTRUCTION; SCAFFOLDS; RUPTURE; GRAFTS; MODEL; TRIAL
AB Background. We evaluated the in vitro strength and in vivo arterial-wall response to an extracellular-matrix-based patch material in a sheep model of carotid artery repair.
   Materials and Methods. A six-ply sheet of acellular, porcine extracellular matrix (ECM) was subjected to in vitro material strength testing and implanted in 15 sheep for 30, 90, and 180 d. Bovine pericardium was used as a control in some animals. In vivo graft patency was assessed by angiography. Explanted grafts were evaluated by histopathology and burst-strength testing.
   Results. Mean (SD) in vitro suture retention force of the ECM sheet was 14.5 (3.06) N; tensile strength was 29.7 (6.11) N; and probe burst strength was 185 (22.6) N. In vivo, mild stenosis was observed at 30 d for all patches; stenosis was absent at 90 d in the ECM-repaired arteries but not bovine pericardium controls. Pseudoaneurysm was not observed in any animal. Histopathology showed progressive graft degradation, collagen deposition, formation of neocapillaries and fibrocellular neointima, and endothelialization, but no calcification. Mean (SD) burst pressure for unrepaired arteries was 2608 (858) mmHg and 1473 (694) mmHg for ECM-repaired vessels. Mean change in diameter from unloaded state to burst pressure was 29% (9.7) for unrepaired vessels and 24% (13.4) for ECM-repaired vessels.
   Conclusions. The six-ply ECM sheet can withstand the forces encountered after carotid artery repair. In sheep, it shows evidence of progressive, constructive remodeling as early as 30 d post-implantation with rapid deposition of endothelium. ECM shows promise as a patch material for CEA repair. (C) 2012 Elsevier Inc. All rights reserved.
C1 [Fallon, Anna; Matheny, Robert G.] CorMatrix Cardiovasc Inc, Alpharetta, GA 30009 USA.
   [Goodchild, Traci] St Josephs Translat Res Inst, Atlanta, GA USA.
   [Wang, Ruoya] Georgia Inst Technol, Inst Bioengn & Biosci, Vasc Biomech Lab, Atlanta, GA 30332 USA.
RP Fallon, A (reprint author), CorMatrix Cardiovasc Inc, 286 S Main St,Suite 200, Alpharetta, GA 30009 USA.
EM afallon@cormatrix.com
FU CorMatrix Cardiovascular, Inc.
FX The study was sponsored by CorMatrix Cardiovascular, Inc. AF is an
   employee of CorMatrix Cardiovascular, Inc. TG is a senior
   scientist/study director at Saint Joseph's Translational Research
   Institute. The services provided by SJTRI, overseen by TG, were paid for
   by CorMatrix Cardiovascular, Inc. RW performed the mechanical burst
   pressure testing, which was funded by CorMatrix Cardiovascular, Inc. RGM
   is an employee of CorMatrix Cardiovascular, Inc. The authors thank
   Jeanne McAdara-Berkowitz, Ph.D. for professional assistance with the
   preparation of the manuscript.
CR Arquizan C, 2011, STROKE, V42, P1015, DOI 10.1161/STROKEAHA.110.589309
   Badylak S, 2003, HEART SURG FORUM, V6, pE20
   Badylak SE, 2002, SEMIN CELL DEV BIOL, V13, P377, DOI 10.1016/S1084-9521(02)00094-0
   BADYLAK SF, 1989, J SURG RES, V47, P74, DOI 10.1016/0022-4804(89)90050-4
   Beattie AJ, 2009, TISSUE ENG PT A, V15, P1119, DOI 10.1089/ten.tea.2008.0162
   Bonati LH, 2009, LANCET NEUROL, V8, P908, DOI 10.1016/S1474-4422(09)70227-3
   Boyd WD, 2010, HEART SURG FORUM, V13, pE311, DOI 10.1532/HSF98.20091184
   Brennan EP, 2006, TISSUE ENG, V12, P2949, DOI 10.1089/ten.2006.12.2949
   Eckstein HH, 2008, LANCET NEUROL, V7, P893, DOI 10.1016/S1474-4422(08)70196-0
   Ederle J, 2010, LANCET, V375, P985, DOI 10.1016/S0140-6736(10)60239-5
   Gerdisch MW, 2010, INNOVATIONS, V5, P60, DOI 10.1097/IMI.0b013e3181cbb421
   Gleason RL, 2007, J BIOMECH, V40, P766, DOI 10.1016/j.jbiomech.2006.03.018
   Hutter R, 2004, CIRCULATION, V110, P2430, DOI 10.1161/01.CIR.0000145120.37891.8A
   Lantz G C, 1990, J Invest Surg, V3, P217, DOI 10.3109/08941939009140351
   LANTZ GC, 1992, J SURG RES, V53, P175, DOI 10.1016/0022-4804(92)90031-T
   Li X, 2011, ANN VASC SURG, V25, P561, DOI 10.1016/j.avsg.2010.11.007
   Matheny RG, 2000, J HEART VALVE DIS, V9, P769
   McCready RA, 2005, J VASC SURG, V41, P782, DOI 10.1016/j.jvs.2005.02.035
   MCCREADY RA, 1992, J VASC SURG, V15, P661, DOI 10.1016/0741-5214(92)90012-W
   Mirensky TL, 2009, J PEDIATR SURG, V44, P1127, DOI 10.1016/j.jpedsurg.2009.02.035
   Mirensky TL, 2009, J PEDIATR SURG, V44, P1132
   Neuhauser B, 2003, CARDIOVASC SURG, V11, P465, DOI 10.1016/S0967-2109(03)00109-1
   OHARA PJ, 1992, J VASC SURG, V15, P504, DOI 10.1016/0741-5214(92)90189-F
   RILES TS, 1990, SURGERY, V107, P10
   Rizzo A, 2000, J VASC SURG, V32, P602, DOI 10.1067/mva.2000.107567
   Robinson KA, 2005, CIRCULATION, V112, pI135, DOI 10.1161/CIRCULATIONAHA.104.525436
   SANDUSKY GE, 1992, AM J PATHOL, V140, P317
   Yacoub M, 2000, J HEART VALVE DIS, V9, P774
NR 28
TC 22
Z9 22
U1 0
U2 11
PU ACADEMIC PRESS INC ELSEVIER SCIENCE
PI SAN DIEGO
PA 525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA
SN 0022-4804
J9 J SURG RES
JI J. Surg. Res.
PD JUN 1
PY 2012
VL 175
IS 1
BP E25
EP E34
DI 10.1016/j.jss.2011.11.001
PG 10
WC Surgery
SC Surgery
GA 934UP
UT WOS:000303472500004
PM 22316677
DA 2018-10-19
ER

PT J
AU Chai, YC
   Kerckhofs, G
   Roberts, SJ
   Van Bael, S
   Schepers, E
   Vleugels, J
   Luyten, FP
   Schrooten, J
AF Chai, Yoke Chin
   Kerckhofs, Greet
   Roberts, Scott J.
   Van Bael, Simon
   Schepers, Evert
   Vleugels, Jozef
   Luyten, Frank P.
   Schrooten, Jan
TI Ectopic bone formation by 3D porous calcium phosphate-Ti6Al4V hybrids
   produced by perfusion electrodeposition
SO BIOMATERIALS
LA English
DT Article
DE Bone formation; Calcium phosphate; Osteoinduction; Electrodeposition;
   Titanium scaffolds
ID DIAMOND CONCEPT; TITANIUM-ALLOY; CELLS; DIFFERENTIATION; COATINGS;
   HYDROXYAPATITE; OSTEOINDUCTION; BIOMATERIALS; CERAMICS
AB Successful clinical repair of non-healing skeletal defects requires the use of bone substitutes with robust bone inductivity and excellent biomechanical stability. Thus, three-dimensionally functionalised porous calcium phosphate-Ti6Al4V (Cap-Ti) hybrids were produced by perfusion electrodeposition, and the in vitro and in vivo biological performances were evaluated using human periosteum derived cells (hPDCs). By applying various current densities at the optimised deposition conditions, CaP coatings with sub-micrometer to nano-scale porous crystalline structures and different ion dissolution kinetics were deposited on the porous Ti6Al4V scaffolds. These distinctive physicochemical properties caused a significant impact on in vitro proliferation, osteogenic differentiation, and matrix mineralisation of hPDCs. This includes a potential role of hPDCs in mediating osteoclastogenesis for the resorption of CaP coatings, as indicated by a significant down-regulation of osteoprotegerin (OPG) gene expression and by the histological observation of abundant multi-nucleated giant cells near to the coatings. By subcutaneous implantation, the produced hybrids induced ectopic bone formation, which was highly dependent on the physicochemical properties of the CaP coating (including the Ca2+ dissolution kinetics and coating surface topography), in a cell density-dependent manner. This study provided further insight on stem cell-Cap biomaterial interactions, and the feasibility to produced bone reparative units that are predictively osteoinductive in vivo by perfusion electrodeposition technology. (c) 2012 Elsevier Ltd. All rights reserved.
C1 [Kerckhofs, Greet; Vleugels, Jozef; Schrooten, Jan] Katholieke Univ Leuven, Dept Met & Mat Engn, B-3001 Louvain, Belgium.
   [Chai, Yoke Chin; Roberts, Scott J.; Luyten, Frank P.] Katholieke Univ Leuven, Lab Skeletal Dev & Joint Disorders, B-3000 Louvain, Belgium.
   [Chai, Yoke Chin] Univ Malaya, Fac Engn, Dept Biomed Engn, Kuala Lumpur 50603, Malaysia.
   [Chai, Yoke Chin; Kerckhofs, Greet; Roberts, Scott J.; Van Bael, Simon; Schepers, Evert; Luyten, Frank P.; Schrooten, Jan] Katholieke Univ Leuven, Div Skeletal Tissue, B-3001 Louvain, Belgium.
   [Van Bael, Simon] Katholieke Univ Leuven, Div Biomech & Engn Design, B-3001 Heverlee, Belgium.
   [Van Bael, Simon] Katholieke Univ Leuven, Div Prod Engn Machine Design & Automat, Dept Mech Engn, B-3001 Louvain, Belgium.
   [Schepers, Evert] Katholieke Univ Leuven, Dept Prosthet Dent, B-3000 Louvain, Belgium.
RP Schrooten, J (reprint author), Katholieke Univ Leuven, Dept Met & Mat Engn, Kasteelpk Arenberg 44,Bus 2450, B-3001 Louvain, Belgium.
EM yokechin.chai@med.kuleuven.be; greet.kerckhofs@mtm.kuleuven.be;
   Scott.Roberts@med.kuleuven.be; Simon.VanBael@mech.kuleuven.be;
   evert.schepers@med.kuleuven.be; jozef.vleugels@mtm.kuleuven.be;
   Frank.Luyten@uz.kuleuven.be; Jan.Schrooten@mtm.kuleuven.be
RI Kerckhofs, Greet/J-5006-2016; Vleugels, Jozef/C-8262-2017
OI Kerckhofs, Greet/0000-0002-1750-8324; Vleugels,
   Jozef/0000-0003-4432-4675
FU KU Leuven IDO - QuEST [05/009]; Stem Cell Institute of Leuven - KU
   Leuven; Agency for Innovation by Science and Technology in Flanders
   [IWT/OZM/090655]; Prometheus; Leuven Research & Development Division of
   Skeletal Tissue Engineering of the KU Leuven
FX The authors thank Carla Geeroms, Joop Van Deursen and Ing. Johan
   Vanhulst for the excellent technical assistances on microcomputer
   tomography analysis of bone formation and the development of the
   six-channel perfusion electrodeposition system. This work is funded by
   the KU Leuven IDO project 05/009 - QuEST, the Stem Cell Institute of
   Leuven - KU Leuven, the Agency for Innovation by Science and Technology
   in Flanders: IWT/OZM/090655, and is part of Prometheus, the Leuven
   Research & Development Division of Skeletal Tissue Engineering of the KU
   Leuven: www.kuleuven.be/prometheus.
CR Lopez-Heredia MA, 2007, J MATER SCI-MATER M, V18, P381, DOI 10.1007/s10856-006-0703-8
   Barbosa MA, 2004, KEY ENG MATER, V254-256, P713
   Barradas AMC, 2011, EUR CELLS MATER, V21, P407, DOI 10.22203/eCM.v021a31
   Barralet J, 2009, TISSUE ENG PT A, V15, P1601, DOI 10.1089/ten.tea.2007.0370
   Beaman FD, 2006, RADIOL CLIN N AM, V44, P451, DOI 10.1016/j.rcl.2006.01.001
   Beck GR, 2003, J CELL BIOCHEM, V90, P234, DOI 10.1002/jcb.10266
   Calori GM, 2011, INJURY, V42, P1191, DOI 10.1016/j.injury.2011.04.016
   Chai YC, 2011, TISSUE ENG PT A, V17, P1083, DOI [10.1089/ten.TEA.2010.0160, 10.1089/ten.tea.2010.0160]
   Chai YC, 2012, TISSUE ENG PART C-ME, V18, P90, DOI [10.1089/ten.tec.2011.0248, 10.1089/ten.TEC.2011.0248]
   Chai YC, 2012, BIOMATERIALS, V33, P3127, DOI 10.1016/j.biomaterials.2012.01.015
   Chai YC, 2011, ACTA BIOMATER, V7, P2310, DOI 10.1016/j.actbio.2010.12.032
   Chang YL, 2000, J BIOMED MATER RES, V52, P270, DOI 10.1002/1097-4636(200011)52:2<270::AID-JBM5>3.0.CO;2-1
   Detsch R, 2008, ACTA BIOMATER, V4, P139, DOI 10.1016/j.actbio.2007.03.014
   Eyckmans J, 2010, J CELL MOL MED, V14, P1845, DOI 10.1111/j.1582-4934.2009.00807.x
   Giannoudis PV, 2007, INJURY, V38, pS3, DOI 10.1016/S0020-1383(08)70003-2
   Habibovic P, 2006, J BIOMED MATER RES A, V77A, P747, DOI 10.1002/jbm.a.30712
   Habibovic P, 2006, J ORTHOP RES, V24, P867, DOI 10.1002/jor.20115
   Habibovic P, 2005, BIOMATERIALS, V26, P23, DOI 10.1016/j.biomaterials.2004.02.026
   Leon Betty, 2009, THIN CALCIUM PHOSPHA
   Lopez-Heredia MA, 2008, BIOMATERIALS, V29, P2608, DOI 10.1016/j.biomaterials.2008.02.021
   Miao SD, 2009, J MATER SCI-MATER M, V20, P131, DOI 10.1007/s10856-008-3552-9
   Nakamura S, 2010, TISSUE ENG PT A, V16, P2467, DOI [10.1089/ten.tea.2009.0337, 10.1089/ten.TEA.2009.0337]
   Richard D, 2006, J BIOMED MATER RES B, V79B, P108, DOI 10.1002/jbm.b.30519
   Roberts SJ, 2011, BIOMATERIALS, V32, P4393, DOI 10.1016/j.biomaterials.2011.02.047
   Roy ME, 2002, BONE, V31, P296, DOI 10.1016/S8756-3282(02)00821-9
   Sharma S, 2009, J MATER SCI-MATER M, V20, P93, DOI 10.1007/s10856-008-3490-6
   Tsang EJ, 2011, ANN BIOMED ENG, V39, P1186, DOI 10.1007/s10439-010-0245-6
   Van Bael S, 2011, MAT SCI ENG A-STRUCT, V528, P7423, DOI 10.1016/j.msea.2011.06.045
   Wang J, 2008, J DENT RES, V87, P650, DOI 10.1177/154405910808700713
   Wang J, 2004, J DENT RES, V83, P296, DOI 10.1177/154405910408300405
   Yuan HP, 2010, P NATL ACAD SCI USA, V107, P13614, DOI 10.1073/pnas.1003600107
NR 31
TC 37
Z9 38
U1 3
U2 46
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
EI 1878-5905
J9 BIOMATERIALS
JI Biomaterials
PD JUN
PY 2012
VL 33
IS 16
BP 4044
EP 4058
DI 10.1016/j.biomaterials.2012.02.026
PG 15
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 929WL
UT WOS:000303096300004
PM 22381474
DA 2018-10-19
ER

PT J
AU Yamada, Y
   Hozumi, K
   Aso, A
   Hotta, A
   Toma, K
   Katagiri, F
   Kikkawa, Y
   Nomizu, M
AF Yamada, Yuji
   Hozumi, Kentaro
   Aso, Akihiro
   Hotta, Atsushi
   Toma, Kazunori
   Katagiri, Fumihiko
   Kikkawa, Yamato
   Nomizu, Motoyoshi
TI Laminin active peptide/agarose matrices as multifunctional biomaterials
   for tissue engineering
SO BIOMATERIALS
LA English
DT Article
DE ECM (extracellular matrix); Laminin; Peptide; Polysaccharide; Cell
   culture
ID CELL-BINDING SEQUENCES; ALPHA-1 CHAIN; EXTRACELLULAR-MATRIX; SYNTHETIC
   PEPTIDES; G-DOMAIN; BIOLOGICAL-ACTIVITY; BASEMENT-MEMBRANE; SCAFFOLD
   MATERIAL; GLOBULAR DOMAIN; 3 DIMENSIONS
AB Cell adhesive peptides derived from extracellular matrix components are potential candidates to afford bio-adhesiveness to cell culture scaffolds for tissue engineering. Previously, we covalently conjugated bioactive laminin peptides to polysaccharides, such as chitosan and alginate, and demonstrated their advantages as biomaterials. Here, we prepared functional polysaccharide matrices by mixing laminin active peptides and agarose gel. Several laminin peptide/agarose matrices showed cell attachment activity. In particular, peptide AG73 (RKRLQVQLSIRT)/agarose matrices promoted strong cell attachment and the cell behavior depended on the stiffness of agarose matrices. Fibroblasts formed spheroid structures on the soft AG73/agarose matrices while the cells formed a monolayer with elongated morphologies on the stiff matrices. On the stiff AG73/agarose matrices, neuronal cells extended neuritic processes and endothelial cells formed capillary-like networks. In addition, salivary gland cells formed acini-like structures on the soft matrices. These results suggest that the peptide/agarose matrices are useful for both two- and three-dimensional cell culture systems as a multifunctional biomaterial for tissue engineering. (c) 2012 Elsevier Ltd. All rights reserved.
C1 [Yamada, Yuji; Hozumi, Kentaro; Katagiri, Fumihiko; Kikkawa, Yamato; Nomizu, Motoyoshi] Tokyo Univ Pharm & Life Sci, Sch Pharm, Lab Clin Biochem, Hachioji, Tokyo 1920392, Japan.
   [Aso, Akihiro; Hotta, Atsushi] Keio Univ, Dept Mech Engn, Kohoku Ku, Yokohama, Kanagawa 2238522, Japan.
   [Toma, Kazunori] Asahi Kasei Corp, Fuji, Shizuoka 4168501, Japan.
RP Nomizu, M (reprint author), Tokyo Univ Pharm & Life Sci, Sch Pharm, Lab Clin Biochem, 1432-1 Horinouchi, Hachioji, Tokyo 1920392, Japan.
EM nomizu@toyaku.ac.jp
RI Hotta, Atsushi/E-9302-2014; Kikkawa, Yamato/D-1503-2010
OI Hotta, Atsushi/0000-0001-9516-2739; 
FU Ministry of Education, Cultures, Sports, Science and Technology of Japan
   [22390017]
FX This work was supported by Grants-in-Aid for Scientific Research from
   the Ministry of Education, Cultures, Sports, Science and Technology of
   Japan (22390017).
CR Ahearne M, 2005, J R SOC INTERFACE, V2, P455, DOI 10.1098/rsif.2005.0065
   Badylak SF, 2007, BIOMATERIALS, V28, P3587, DOI 10.1016/j.biomaterials.2007.04.043
   Badylak SF, 2009, ACTA BIOMATER, V5, P1, DOI 10.1016/j.actbio.2008.09.013
   BELLAMKONDA R, 1995, J BIOMED MATER RES, V29, P663, DOI 10.1002/jbm.820290514
   Frantz C, 2010, J CELL SCI, V123, P4195, DOI 10.1242/jcs.023820
   Fujii T, 2000, BIOSCI BIOTECH BIOCH, V64, P1618, DOI 10.1271/bbb.64.1618
   Hoffman MP, 1998, J BIOL CHEM, V273, P28633, DOI 10.1074/jbc.273.44.28633
   Hoffman MP, 2001, J BIOL CHEM, V276, P22077, DOI 10.1074/jbc.M100774200
   Hozumi K, 2010, ARCH BIOCHEM BIOPHYS, V503, P213, DOI 10.1016/j.abb.2010.08.012
   Ikemoto S, 2006, J BIOMED MATER RES A, V79A, P716, DOI 10.1002/jbm.a.30804
   Kang HG, 2007, CANCER RES, V67, P3094, DOI 10.1158/0008-5472.CAN-06-3259
   Kasai S, 2007, BIOCHEMISTRY-US, V46, P3966, DOI 10.1021/bi062097t
   Kikkawa Y, 2011, J BIOMED MATER RES A, V99A, P203, DOI 10.1002/jbm.a.33176
   Kleinman HK, 2005, SEMIN CANCER BIOL, V15, P378, DOI 10.1016/j.semcancer.2005.05.004
   Kruegel J, 2010, CELL MOL LIFE SCI, V67, P2879, DOI 10.1007/s00018-010-0367-x
   Kuo CK, 2001, BIOMATERIALS, V22, P511, DOI 10.1016/S0142-9612(00)00201-5
   Lin Ruei-Zhen, 2008, Biotechnology Journal, V3, P1172, DOI 10.1002/biot.200700228
   Mauck RL, 2006, OSTEOARTHR CARTILAGE, V14, P179, DOI 10.1016/j.joca.2005.09.002
   Miner JH, 2004, ANNU REV CELL DEV BI, V20, P255, DOI 10.1146/annurev.cellbio.20.010403.094555
   Mochizuki M, 2003, FASEB J, V17, P875, DOI 10.1096/fj.02-0564fje
   Mochizuki M, 2007, ARCH BIOCHEM BIOPHYS, V459, P249, DOI 10.1016/j.abb.2006.12.026
   Nomizu M, 1997, J BIOL CHEM, V272, P32198, DOI 10.1074/jbc.272.51.32198
   Nomizu M, 1998, J BIOL CHEM, V273, P32491, DOI 10.1074/jbc.273.49.32491
   NOMIZU M, 1995, J BIOL CHEM, V270, P20583, DOI 10.1074/jbc.270.35.20583
   Nomizu M, 2000, ARCH BIOCHEM BIOPHYS, V378, P311, DOI 10.1006/abbi.2000.1828
   OCONNELL KA, 1990, J IMMUNOL, V144, P521
   Owen SC, 2010, J BIOMED MATER RES A, V94A, P1321, DOI 10.1002/jbm.a.32834
   Pelham J.R., 1997, P NATL ACAD SCI USA, V94, P13661
   Prestwich GD, 2008, ACCOUNTS CHEM RES, V41, P139, DOI 10.1021/ar7000827
   Richard BL, 1996, EXP CELL RES, V228, P98, DOI 10.1006/excr.1996.0304
   Schmeichel KL, 2003, J CELL SCI, V116, P2377, DOI 10.1242/jcs.00503
   SHIRASUNA K, 1981, CANCER, V48, P745, DOI 10.1002/1097-0142(19810801)48:3<745::AID-CNCR2820480314>3.0.CO;2-7
   Smith IO, 2009, WIRES NANOMED NANOBI, V1, P226, DOI 10.1002/wnan.026
   Suzuki N, 2005, CONNECT TISSUE RES, V46, P142, DOI 10.1080/03008200591008527
   Suzuki N, 2003, J BIOL CHEM, V278, P45697, DOI 10.1074/jbc.M304667200
   Takei R, 2005, BIOTECHNOL LETT, V27, P1149, DOI 10.1007/s10529-005-8652-8
   Tibbitt MW, 2009, BIOTECHNOL BIOENG, V103, P655, DOI 10.1002/bit.22361
   Weeks BS, 1998, EXP CELL RES, V243, P375, DOI 10.1006/excr.1998.4157
   Wells RG, 2008, HEPATOLOGY, V47, P1394, DOI 10.1002/hep.22193
   Yamada M, 2002, FEBS LETT, V530, P48, DOI 10.1016/S0014-5793(02)03393-8
   Yamada Y, 2011, CHEM-EUR J, V17, P10500, DOI 10.1002/chem.201101064
   Yamada Y, 2010, BIOPOLYMERS, V94, P711, DOI 10.1002/bip.21429
   Zhu JM, 2010, BIOMATERIALS, V31, P4639, DOI 10.1016/j.biomaterials.2010.02.044
NR 43
TC 25
Z9 27
U1 3
U2 36
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD JUN
PY 2012
VL 33
IS 16
BP 4118
EP 4125
DI 10.1016/j.biomaterials.2012.02.044
PG 8
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 929WL
UT WOS:000303096300011
PM 22410171
DA 2018-10-19
ER

PT J
AU Bartneck, M
   Heffels, KH
   Pan, Y
   Bovi, M
   Zwadlo-Klarwasser, G
   Groll, J
AF Bartneck, Matthias
   Heffels, Karl-Heinz
   Pan, Yu
   Bovi, Manfred
   Zwadlo-Klarwasser, Gabriele
   Groll, Juergen
TI Inducing healing-like human primary macrophage phenotypes by 3D hydrogel
   coated nanofibres
SO BIOMATERIALS
LA English
DT Article
DE Monocyte; Macrophage; Cytokine; Angiogenesis; SEM
ID SCAVENGER RECEPTOR; HUMAN-MONOCYTES; EXTRACELLULAR-MATRIX; PROTEIN
   ADSORPTION; SURFACE-CHEMISTRY; IN-VITRO; ACTIVATION; DEGRADATION;
   FIBERS; CELL
AB Immune cells are present in the blood and in resident tissues, and the nature of their reaction towards biomaterials is decisive for materials success or failure. Macrophages may for example be classically activated to trigger inflammation (M1), or alternatively activated which supports healing and vascularisation (M2). Here, we have generated 3D nanofibrous meshes in different porosities and precisely controlled surface chemistries comprising PLGA, hydrogel-coated protein repellant and protein repellant endowed with the bioactive peptide sequences GRGDS or GLF. We also prepared 2D substrates with corresponding surface chemistry for a systematic evaluation of primary human macrophage adhesion, migration, transcriptome expression, cytokine release and surface marker expression. Our data show that material morphology is a powerful means in biomaterial design to influence immune cell response. Flat substrates lead to an increased number of M2 classified CD163(+) macrophages. However, these M2 cells released large amounts of pro-inflammatory cytokines. In contrast, 3D nanofibres with corresponding surface chemistry yielded M1 classified 27E10(+) macrophages with a significantly increased release of pro-angiogenic chemokines and angiogenesis related molecules and a strong decrease of pro-inflammatory cytokines. We thus suggest that, for macrophages in contact with biomaterials, cytokine release is taken as main criterion instead of surface-markers for macrophage classifications. (c) 2012 Elsevier Ltd. All rights reserved.
C1 [Bartneck, Matthias; Zwadlo-Klarwasser, Gabriele] Rhein Westfal TH Aachen, Interdisciplinary Ctr Clin Res, Fac Med, D-52074 Aachen, Germany.
   [Heffels, Karl-Heinz] Rhein Westfal TH Aachen, DWI eV, D-52056 Aachen, Germany.
   [Heffels, Karl-Heinz] Rhein Westfal TH Aachen, Inst Tech & Macromol Chem, D-52056 Aachen, Germany.
   [Heffels, Karl-Heinz; Groll, Juergen] Univ Hosp Wurzburg, Dept Funct Mat Med & Dent, D-97070 Wurzburg, Germany.
   [Pan, Yu] Rhein Westfal TH Aachen, Biointerface Lab, D-52074 Aachen, Germany.
   [Bovi, Manfred] Rhein Westfal TH Aachen, Fac Med, Electron Microscop Facil, D-52074 Aachen, Germany.
   [Zwadlo-Klarwasser, Gabriele] Rhein Westfal TH Aachen, Dept Dermatol, Fac Med, D-52074 Aachen, Germany.
RP Bartneck, M (reprint author), Rhein Westfal TH Aachen, Interdisciplinary Ctr Clin Res, Fac Med, Pauwelsstr 30, D-52074 Aachen, Germany.
EM mbartneck@ukaachen.de
RI Groll, Jurgen/F-4202-2012
OI Groll, Jurgen/0000-0003-3167-8466
FU DFG research training group "Biointerface" [GRK1035]; Interdisciplinary
   Centre for Clinical Research (IZKF Aachen) within the faculty of
   medicine at the RWTH Aachen
FX This study was supported by the DFG research training group
   "Biointerface" (GRK1035) and the Interdisciplinary Centre for Clinical
   Research (IZKF Aachen) within the faculty of medicine at the RWTH
   Aachen.
CR [Anonymous], 2012, MEDWATCH SAF AL HUM
   Arredouani MS, 2007, J IMMUNOL, V178, P5912, DOI 10.4049/jimmunol.178.9.5912
   Badylak SF, 2008, TISSUE ENG PT A, V14, P1835, DOI 10.1089/ten.tea.2007.0264
   Bartneck M, 2010, ACTA BIOMATER, V6, P3864, DOI 10.1016/j.actbio.2010.04.025
   Brodbeck WG, 2003, J BIOMED MATER RES A, V64A, P320, DOI 10.1002/jbm.a.10425
   Deng M, 2002, J MATER SCI-MATER M, V13, P1091, DOI 10.1023/A:1020361109859
   Dennis Glynn Jr, 2003, Genome Biol, V4, pP3, DOI 10.1186/gb-2003-4-5-p3
   Eichhorn SJ, 2005, J ROY SOC INTERFACE, V2, P309, DOI 10.1098/rsif.2005.0039
   Fu Q, 2010, CLIN CHEM, V56, P314, DOI 10.1373/clinchem.2009.135087
   Fuentes-Duculan J, 2010, J INVEST DERMATOL, V130, P2412, DOI 10.1038/jid.2010.165
   GAI WP, 1993, BRAIN RES, V618, P135, DOI 10.1016/0006-8993(93)90436-Q
   Grafahrend D, 2008, BIOTECHNOL BIOENG, V101, P609, DOI 10.1002/bit.21928
   Grafahrend D, 2011, NAT MATER, V10, P67, DOI [10.1038/nmat2904, 10.1038/NMAT2904]
   Gratchev A, 2005, SCAND J IMMUNOL, V61, P10, DOI 10.1111/j.0300-9475.2005.01524.x
   Green DM, 1998, J IMMUNOL, V161, P2481
   Greiner A, 2007, ANGEW CHEM INT EDIT, V46, P5670, DOI 10.1002/anie.200604646
   Hogger P, 1998, J IMMUNOL, V161, P1883
   Huang ZM, 2003, COMPOS SCI TECHNOL, V63, P2223, DOI 10.1016/S0266-3538(03)00178-7
   Katsuda Shogo, 2003, J Atheroscler Thromb, V10, P267
   KESKIOJA J, 1976, CELL, V9, P29, DOI 10.1016/0092-8674(76)90049-0
   Kleinman HK, 2003, CURR OPIN BIOTECH, V14, P526, DOI 10.1016/j.copbio.2003.08.002
   Kzhyshkowska J, 2006, J CELL MOL MED, V10, P635, DOI 10.2755/jcmm010.003.08
   Leidi M, 2009, J IMMUNOL, V182, P4415, DOI 10.4049/jimmunol.0713732
   Li J, 2010, STEM CELLS DEV, V19, P1427, DOI 10.1089/scd.2009.0415
   Liu J, 2007, APPL MICROBIOL BIOT, V74, P263, DOI 10.1007/s00253-006-0722-x
   Martin D, 2009, J BIOL CHEM, V284, P6038, DOI 10.1074/jbc.C800207200
   Martinez FO, 2008, FRONT BIOSCI-LANDMRK, V13, P453, DOI 10.2741/2692
   Mitola S, 2010, BLOOD, V116, P3677, DOI 10.1182/blood-2010-06-291930
   Mori T, 2005, J VET MED SCI, V67, P51, DOI 10.1292/jvms.67.51
   Mullarky IK, 2006, INFECT IMMUN, V74, P1181, DOI 10.1128/IAI.74.2.1181-1188.2006
   Onofre Gabriela, 2009, Acta Medica (Hradec Kralove), V52, P57, DOI 10.14712/18059694.2016.105
   Palecanda A, 1999, J EXP MED, V189, P1497, DOI 10.1084/jem.189.9.1497
   PARK TG, 1995, BIOMATERIALS, V16, P1123, DOI 10.1016/0142-9612(95)93575-X
   Paula NE, 2008, BIOMATERIALS, V29, P4056, DOI 10.1016/j.biomaterials.2008.07.010
   Pechkovsky DV, 2010, CLIN IMMUNOL, V137, P89, DOI 10.1016/j.clim.2010.06.017
   Pettersen JS, 2011, J INVEST DERMATOL, V131, P1322, DOI [10.1038/jid.2011.9, 10.103/jid.2011.9]
   Roca H, 2009, J BIOL CHEM, V284, P34342, DOI 10.1074/jbc.M109.042671
   Rosenkilde MM, 2004, APMIS, V112, P481, DOI 10.1111/j.1600-0463.2004.apm11207-0808.x
   Sahin H, HEPATOLOGY IN PRESS, DOI [10.1002/hep.25545, DOI 10.1002/HEP.25545]
   Schmidt DR, 2007, J BIOMED MATER RES A, V83A, P617, DOI 10.1002/jbm.a.31270
   Schwarzer E, 1999, MOL BIOCHEM PARASIT, V100, P61, DOI 10.1016/S0166-6851(99)00031-6
   Seifert O, 2008, WOUND REPAIR REGEN, V16, P254, DOI 10.1111/j.1524-475X.2007.00343.x
   Sturn A, 2002, BIOINFORMATICS, V18, P207, DOI 10.1093/bioinformatics/18.1.207
   Su SH, 2005, J BIOMAT SCI-POLYM E, V16, P353, DOI 10.1163/1568562053654077
   TRABER MG, 1980, P NATL ACAD SCI-BIOL, V77, P5466, DOI 10.1073/pnas.77.9.5466
   van Apeldoorn AA, 2004, J AM CHEM SOC, V126, P13226, DOI 10.1021/ja0459936
   Wang B, 2007, AM J PHYSIOL-CELL PH, V292, pC1523, DOI 10.1152/ajpcell.00409.2006
   Williams DF, 2011, BIOMATERIALS, V32, P4195, DOI 10.1016/j.biomaterials.2011.02.025
   Zbinden S, 2010, ARTERIOSCL THROM VAS, V30, P477, DOI 10.1161/ATVBAHA.109.200949
   Zimmermann HW, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011049
   ZWADLO G, 1986, J IMMUNOL, V137, P512
NR 51
TC 50
Z9 50
U1 3
U2 38
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
EI 1878-5905
J9 BIOMATERIALS
JI Biomaterials
PD JUN
PY 2012
VL 33
IS 16
BP 4136
EP 4146
DI 10.1016/j.biomaterials.2012.02.050
PG 11
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 929WL
UT WOS:000303096300013
PM 22417617
DA 2018-10-19
ER

PT J
AU Hozumi, K
   Sasaki, A
   Yamada, Y
   Otagiri, D
   Kobayashi, K
   Fujimori, C
   Katagiri, F
   Kikkawa, Y
   Nomizu, M
AF Hozumi, Kentaro
   Sasaki, Ayano
   Yamada, Yuji
   Otagiri, Dai
   Kobayashi, Kazuki
   Fujimori, Chikara
   Katagiri, Fumihiko
   Kikkawa, Yamato
   Nomizu, Motoyoshi
TI Reconstitution of laminin-111 biological activity using multiple peptide
   coupled to chitosan scaffolds
SO BIOMATERIALS
LA English
DT Article
DE Cell adhesion; Chitin/chitosan; ECM (extracellular matrix); Integrin;
   Peptide; Scaffold
ID CELL-BINDING SEQUENCES; CHAIN G DOMAIN; ALPHA-1 CHAIN; SYNTHETIC
   PEPTIDES; EXTRACELLULAR-MATRIX; BASEMENT-MEMBRANE; GLOBULAR DOMAIN;
   TISSUE; RKRLQVQLSIRT; IDENTIFICATION
AB Laminin-111, a multifunctional matrix protein, has diverse biological functions. Previously, we have identified various biologically active sequences in laminin-111 by a systematic peptide screening. We also demonstrated that peptide-conjugated chitosan matrices enhance the biological functions of the active sequences and are useful as a scaffold. Here, we conjugated sixty biologically active laminin-111 peptides onto chitosan matrices. The twenty-nine peptide-chitosan matrices promoted various biological activities, including cell attachment, spreading, and neurite outgrowth. The biological activities of peptide-chitosan matrices depend on the peptide. These peptide-chitosan matrices are categorized into six groups depending on their biological activities. Next, we conjugated five active peptides, which showed strong cell attachment activity in the each group, onto a single chitosan matrix to mimic the multiple activities of laminin-111. The mixed peptides-chitosan matrix significantly promoted cell attachment and cell spreading over that observed with the individual peptides. We also demonstrated that a mixed peptides-chitosan matrix, using four neurite outgrowth-promoting peptides each from a different group, enhanced the activity. These data suggest that the mixed peptides synergistically induce laminin-like biological activities on a chitosan matrix. The active peptides-chitosan matrices described here have potential for use as biomaterial for tissue engineering and regeneration. (C) 2012 Elsevier Ltd. All rights reserved.
C1 [Hozumi, Kentaro; Sasaki, Ayano; Yamada, Yuji; Otagiri, Dai; Kobayashi, Kazuki; Fujimori, Chikara; Katagiri, Fumihiko; Kikkawa, Yamato; Nomizu, Motoyoshi] Tokyo Univ Pharm & Life Sci, Sch Pharm, Lab Clin Biochem, Hachioji, Tokyo 1920392, Japan.
RP Nomizu, M (reprint author), Tokyo Univ Pharm & Life Sci, Sch Pharm, Lab Clin Biochem, 1432-1 Horinouchi, Hachioji, Tokyo 1920392, Japan.
EM nomizu@toyaku.ac.jp
RI Kikkawa, Yamato/D-1503-2010
FU Ministry of Education, Cultures, Sports, Science and Technology of Japan
   [MN 22390017]
FX This work was supported by Grants-in-Aid for Scientific Research from
   the Ministry of Education, Cultures, Sports, Science and Technology of
   Japan (MN 22390017).
CR Arnaoutova I, 2010, INT J CANC
   Aumailley M, 2005, MATRIX BIOL, V24, P326, DOI 10.1016/j.matbio.2005.05.006
   Badylak SF, 2009, ACTA BIOMATER, V5, P1, DOI 10.1016/j.actbio.2008.09.013
   Castell Jose V., 2009, V481, P35, DOI 10.1007/978-1-59745-201-4_4
   Di Martino A, 2005, BIOMATERIALS, V26, P5983, DOI 10.1016/j.biomaterials.2005.03.016
   Durbeej M, 2010, CELL TISSUE RES, V339, P259, DOI 10.1007/s00441-009-0838-2
   GRANT DS, 1991, IN VITRO CELL DEV B, V27, P327
   GREENE LA, 1976, P NATL ACAD SCI USA, V73, P2424, DOI 10.1073/pnas.73.7.2424
   Hayashi K, 2002, J INVEST DERMATOL, V118, P712, DOI 10.1046/j.1523-1747.2002.01730.x
   Hoffman MP, 1998, J BIOL CHEM, V273, P28633, DOI 10.1074/jbc.273.44.28633
   Hoffman MP, 2001, J BIOL CHEM, V276, P22077, DOI 10.1074/jbc.M100774200
   Hozumi K, 2010, ARCH BIOCHEM BIOPHYS, V503, P213, DOI 10.1016/j.abb.2010.08.012
   Hozumi K, 2010, BIOMATERIALS, V31, P3237, DOI 10.1016/j.biomaterials.2010.01.043
   Hozumi K, 2009, BIOMATERIALS, V30, P1596, DOI 10.1016/j.biomaterials.2008.12.011
   Ikemoto S, 2006, J BIOMED MATER RES A, V79A, P716, DOI 10.1002/jbm.a.30804
   Khvorostov I., 2008, J VIS EXP
   Kikkawa Y, 2009, BIOMATERIALS, V30, P6888, DOI 10.1016/j.biomaterials.2009.09.011
   Lutolf MP, 2005, NAT BIOTECHNOL, V23, P47, DOI 10.1038/nbt1055
   Maria OM, 2011, INT J BIOCHEM CELL B, V43, P622, DOI 10.1016/j.biocel.2011.01.001
   Masuda R, 2009, WOUND REPAIR REGEN, V17, P127, DOI 10.1111/j.1524-475X.2008.00450.x
   Miner JH, 2008, MICROSC RES TECHNIQ, V71, P349, DOI 10.1002/jemt.20563
   Miner JH, 2004, ANNU REV CELL DEV BI, V20, P255, DOI 10.1146/annurev.cellbio.20.010403.094555
   Mochizuki M, 2003, FASEB J, V17, P875, DOI 10.1096/fj.02-0564fje
   Mochizuki M, 2007, BIOPOLYMERS, V88, P122, DOI 10.1002/bip.20684
   Mochizuki M, 2007, ARCH BIOCHEM BIOPHYS, V459, P249, DOI 10.1016/j.abb.2006.12.026
   Nomizu M, 1997, J BIOL CHEM, V272, P32198, DOI 10.1074/jbc.272.51.32198
   Nomizu M, 1998, J BIOL CHEM, V273, P32491, DOI 10.1074/jbc.273.49.32491
   NOMIZU M, 1995, J BIOL CHEM, V270, P20583, DOI 10.1074/jbc.270.35.20583
   Nomizu M, 2000, ARCH BIOCHEM BIOPHYS, V378, P311, DOI 10.1006/abbi.2000.1828
   Philip D, 2005, STEM CELLS, V23, P288, DOI 10.1634/stemcells.2002.0109
   Ponce ML, 2003, CANCER RES, V63, P5060
   Rosso F, 2004, J CELL PHYSIOL, V199, P174, DOI 10.1002/jcp.10471
   Rozario T, 2010, DEV BIOL, V341, P126, DOI 10.1016/j.ydbio.2009.10.026
   Sato N, 2004, NAT MED, V10, P55, DOI 10.1038/nm979
   Scheele S, 2007, J MOL MED-JMM, V85, P825, DOI 10.1007/s00109-007-0182-5
   Suzuki N, 2003, BIOCHEMISTRY-US, V42, P12625, DOI 10.1021/bi030014s
   Suzuki N, 2003, J BIOL CHEM, V278, P45697, DOI 10.1074/jbc.M304667200
   Weeks BS, 1998, EXP CELL RES, V243, P375, DOI 10.1006/excr.1998.4157
   Wiradjaja F, 2010, BIRTH DEFECTS RES C, V90, P8, DOI 10.1002/bdrc.20172
   Yamada M, 2002, FEBS LETT, V530, P48, DOI 10.1016/S0014-5793(02)03393-8
   Yamada Y, 2011, CHEM-EUR J, V17, P10500, DOI 10.1002/chem.201101064
   Zhang J, 2008, J VIS EXP
NR 42
TC 12
Z9 12
U1 1
U2 13
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD JUN
PY 2012
VL 33
IS 17
BP 4241
EP 4250
DI 10.1016/j.biomaterials.2012.02.055
PG 10
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 930YT
UT WOS:000303181500001
PM 22436803
DA 2018-10-19
ER

PT J
AU Li, Q
   Tao, L
   Chen, B
   Ren, HZ
   Hou, XL
   Zhou, SQ
   Zhou, JX
   Sun, XT
   Dai, JW
   Ding, YT
AF Li, Qiang
   Tao, Liang
   Chen, Bing
   Ren, Haozhen
   Hou, Xianglin
   Zhou, Siqiao
   Zhou, Jianxin
   Sun, Xitai
   Dai, Jianwu
   Ding, Yitao
TI Extrahepatic bile duct regeneration in pigs using collagen scaffolds
   loaded with human collagen-binding bFGF
SO BIOMATERIALS
LA English
DT Article
DE Collagen; Basic fibroblast growth factor; Extrahepatic bile duct
   regeneration; Tissue engineering
ID FIBROBLAST-GROWTH-FACTOR; SMALL-INTESTINAL SUBMUCOSA; BILIARY-TRACT
   REGENERATION; INJURY; REPAIR; TISSUE; VASCULARIZATION; CONTRACTION;
   BIOSCAFFOLD; FACTOR-2
AB Extrahepatic bile duct defects and their complications are benign lesions but with malignant outcomes. Extrahepatic bile duct regeneration at the injury site could be important for the repair. In our previous work, a human basic fibroblast growth factor (bFGF) fused with a collagen-binding domain (CBD) was produced to activate the collagen membrane to obtain targeted tissue regeneration. This collagen/growth factor functional biomaterial could promote the regeneration of skin, bladder and full-thickness abdominal wall by accelerating vascularization and cellularization of autologous tissues. We speculate that the functional biomaterial could also provide the repairing effect on extrahepatic bile duct injuries. Using a pig extrahepatic bile duct injury model, we found that the collagen/CBD-bFGF composite biomaterial could significantly promote the extrahepatic bile duct regeneration at the injury site without causing structure deformation or hepatic dysfunction during both short- and long-time observations. (C) 2012 Elsevier Ltd. All rights reserved.
C1 [Chen, Bing; Dai, Jianwu] Chinese Acad Sci, Inst Genet & Dev Biol, State Key Lab Mol Dev Biol, Beijing 100190, Peoples R China.
   [Li, Qiang; Tao, Liang; Ren, Haozhen; Zhou, Siqiao; Zhou, Jianxin; Sun, Xitai; Ding, Yitao] Nanjing Univ, Sch Med, Affiliated Drum Tower Hosp, Dept Hepatobiliary Surg, Nanjing 210008, Peoples R China.
   [Hou, Xianglin] Yantai Zhenghai Biotechnol Inc, Yantai 264006, Shandong, Peoples R China.
RP Dai, JW (reprint author), Chinese Acad Sci, Inst Genet & Dev Biol, State Key Lab Mol Dev Biol, 3 Nanyitiao, Beijing 100190, Peoples R China.
EM jwdai@genentics.ac.cn; yitaoding@hotmail.com
FU Chinese Academy of Sciences [XDA01030401]
FX This work is supported by a grant from the "Strategic Priority Research
   Program" of the Chinese Academy of Sciences (Grant No. XDA01030401).
CR Aikawa M, 2010, SURGERY, V147, P575, DOI 10.1016/j.surg.2009.10.049
   Aikawa Masayasu, 2007, Journal of Smooth Muscle Research, V43, P211, DOI 10.1540/jsmr.43.211
   Andersson R, 2008, HPB, V10, P416, DOI 10.1080/13651820802140745
   BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3
   Chen W, 2010, J UROLOGY, V183, P2432, DOI 10.1016/j.juro.2010.02.042
   DARBY I, 1990, LAB INVEST, V63, P21
   DESMOULIERE A, 1995, AM J PATHOL, V146, P56
   DESOUZA SJ, 1992, J BIOL CHEM, V267, P13763
   Di Lullo GA, 2002, J BIOL CHEM, V277, P4223, DOI 10.1074/jbc.M110709200
   El-Assmy A, 2004, J UROLOGY, V171, P1939, DOI 10.1097/01.ju.0000121437.94629.ef
   Gomez NA, 2004, SURGERY, V135, P460, DOI 10.1016/j.surg.2003.06.004
   Gomez NA, 2002, J GASTROINTEST SURG, V6, P116, DOI 10.1016/S1091-255X(01)00038-5
   Hogan AM, 2009, ANN SURG, V249, P292, DOI 10.1097/SLA.0b013e318195c50c
   Kim BS, 2000, WORLD J UROL, V18, P2, DOI 10.1007/s003450050002
   KLAGSBRUN M, 1989, ARTERIOSCLEROSIS, V9, P269, DOI 10.1161/01.ATV.9.3.269
   Lau WY, 2007, HEPATOB PANCREAT DIS, V6, P459
   Lynn AK, 2004, J BIOMED MATER RES B, V71B, P343, DOI 10.1002/jbm.b.30096
   MENDELOWITZ DS, 1982, AM J SURG, V143, P221, DOI 10.1016/0002-9610(82)90073-3
   Miyazawa M, 2005, AM J TRANSPLANT, V5, P1541, DOI 10.1111/j.1600-6143.2005.00845.x
   Nagase T, 2007, J PLAST RECONSTR AES, V60, P327, DOI 10.1016/j.bjps.2005.12.056
   Nakamura S, 2008, J BIOMED MATER RES A, V85A, P619, DOI 10.1002/jbm.a.31563
   Nakashima S, 2007, INT J ARTIF ORGANS, V30, P75
   Nakashima S., 2007, INFLAMM REGEN, V27, P579
   Nedelec B, 2000, HAND CLIN, V16, P289
   Panpimanmas S, 2008, HEPATO-GASTROENTEROL, V55, P1962
   RIFKIN DB, 1989, J CELL BIOL, V109, P1, DOI 10.1083/jcb.109.1.1
   Rosen M, 2002, SURGERY, V132, P480, DOI 10.1067/msy.2002.126505
   Shi CY, 2011, BIOMATERIALS, V32, P753, DOI 10.1016/j.biomaterials.2010.09.038
   SHIMONO K, 1995, ARTIF ORGANS, V19, P115, DOI 10.1111/j.1525-1594.1995.tb02299.x
   SQUIRES CH, 1988, J BIOL CHEM, V263, P16297
   Tabata Y, 1999, BIOMATERIALS, V20, P2169, DOI 10.1016/S0142-9612(99)00121-0
   Thomson BNJ, 2006, BRIT J SURG, V93, P216, DOI 10.1002/bjs.5194
   Tocchi A, 2001, ANN SURG, V234, P210, DOI 10.1097/00000658-200108000-00011
   Virag JAI, 2007, AM J PATHOL, V171, P1431, DOI 10.2353/ajpat.2007.070003
   VoytikHarbin SL, 1997, J CELL BIOCHEM, V67, P478, DOI 10.1002/(SICI)1097-4644(19971215)67:4<478::AID-JCB6>3.0.CO;2-P
   Zhao WX, 2008, J MOL MED, V86, P1127, DOI 10.1007/s00109-008-0372-9
   Zhao WX, 2007, J BIOMED MATER RES A, V82A, P630, DOI 10.1002/bjm.a.31179
NR 37
TC 23
Z9 29
U1 1
U2 29
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD JUN
PY 2012
VL 33
IS 17
BP 4298
EP 4308
DI 10.1016/j.biomaterials.2012.03.003
PG 11
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 930YT
UT WOS:000303181500006
PM 22429981
DA 2018-10-19
ER

PT J
AU Seyednejad, H
   Gawlitta, D
   Kuiper, RV
   de Bruin, A
   van Nostrum, CF
   Vermonden, T
   Dhert, WJA
   Hennink, WE
AF Seyednejad, Hajar
   Gawlitta, Debby
   Kuiper, Raoul V.
   de Bruin, Alain
   van Nostrum, Cornelus F.
   Vermonden, Tina
   Dhert, Wouter J. A.
   Hennink, Wim E.
TI In vivo biocompatibility and biodegradation of 3D-printed porous
   scaffolds based on a hydroxyl-functionalized poly(epsilon-caprolactone)
SO BIOMATERIALS
LA English
DT Article
DE Functionalized polyester; Polycaprolactone; Biocompatibility;
   Biodegradation
ID ENZYMATIC DEGRADATION; TISSUE-RESPONSE; ALIPHATIC POLYESTERS;
   BIOMATERIALS; REGENERATION; FABRICATION; HYDROLYSIS; CONSTRUCTS;
   MECHANISM; ADHESION
AB The aim of this study was to evaluate the in vivo biodegradation and biocompatibility of three-dimensional (3D) scaffolds based on a hydroxyl-functionalized polyester (poly( hydroxymethylglycolide-co-epsilon-caprolactone), PHMGCL), which has enhanced hydrophilicity, increased degradation rate, and improved cell material interactions as compared to its counterpart poly(epsilon-caprolactone), PCL In this study, 3D scaffolds based on this polymer (PHMGCL, HMG:CL 8:92) were prepared by means of fiber deposition (melt-plotting). The biodegradation and tissue biocompatibility of PHMGCL and PCL scaffolds after subcutaneous implantation in Balb/c mice were investigated. At 4 and 12 weeks post implantation, the scaffolds were retrieved and evaluated for extent of degradation by measuring the residual weight of the scaffolds, thermal properties (DSC), and morphology (SEM) whereas the polymer was analyzed for both its composition (H-1 NMR) and molecular weight (GPC). The scaffolds with infiltrated tissues were harvested, fixed, stained and histologically analyzed. The in vitro enzymatic degradation of these scaffolds was also investigated in lipase solutions. It was shown that PHMGCL 3D-scaffolds lost more than 60% of their weight within 3 months of implantation while PCL scaffolds showed no weight loss in this time frame. The molecular weight (M-w) of PHMGCL decreased from 46.9 kDa before implantation to 23.2 kDa after 3 months of implantation, while the molecular weight of PCL was unchanged in this period. H-1 NMR analysis showed that the degradation of PHMGCL was characterized by a loss of HMG units. In vitro enzymatic degradation showed that PHMGCL scaffolds were degraded within 50 h, while the degradation time for PCL scaffolds of similar structure was 72 h. A normal foreign body response to both scaffold types characterized by the presence of macrophages, lymphocytes, and fibrosis was observed with a more rapid onset in PHMGCL scaffolds. The extent of tissue-scaffold interactions as well as vascularization was shown to be higher for PHMGCL scaffolds compared to PCL ones. Therefore, the fast degradable PHMGCL which showed good biocompatibility is a promising biomaterial for tissue engineering applications. (C) 2012 Elsevier Ltd. All rights reserved.
C1 [Seyednejad, Hajar; van Nostrum, Cornelus F.; Vermonden, Tina; Hennink, Wim E.] Univ Utrecht, Fac Sci, UIPS, Dept Pharmaceut, NL-3508 TB Utrecht, Netherlands.
   [Gawlitta, Debby; Dhert, Wouter J. A.] Univ Med Ctr Utrecht, Dept Orthopaed, NL-3508 GA Utrecht, Netherlands.
   [Kuiper, Raoul V.; de Bruin, Alain] Univ Utrecht, Fac Vet Med, Dept Pathobiol, Dutch Mol Pathol Ctr, NL-3508 TB Utrecht, Netherlands.
RP Hennink, WE (reprint author), Univ Utrecht, Fac Sci, UIPS, Dept Pharmaceut, POB 80082, NL-3508 TB Utrecht, Netherlands.
EM W.E.Hennink@uu.nl
RI Seyednejad, Hajar/G-1166-2012; Vermonden, Tina/I-9491-2016; van Nostrum,
   Cornelus/I-9445-2016
OI Kuiper, Raoul/0000-0001-5645-2389; Vermonden, Tina/0000-0002-6047-5900
CR Achim G, 1996, BIOMATERIALS, V17, P103
   Ahola S, 2008, LANGMUIR, V24, P11592, DOI 10.1021/la801550j
   Alves CM, 2010, J R SOC INTERFACE, V7, P1367, DOI 10.1098/rsif.2010.0022
   Anderson JM, 2008, SEMIN IMMUNOL, V20, P86, DOI 10.1016/j.smim.2007.11.004
   Assas M, 2011, COMPUT AIDED DESIGN, V8, P37
   Burugapalli K, 2007, BIOMACROMOLECULES, V8, P3439, DOI 10.1021/bm700560k
   Byers BA, 2006, J BIOMED MATER RES A, V76A, P646, DOI 10.1002/jbm.a.30549
   Causa F, 2007, BIOMATERIALS, V28, P5093, DOI 10.1016/j.biomaterials.2007.07.030
   Censi R, 2011, J BIOMED MATER RES A, V97A, P219, DOI 10.1002/jbm.a.33048
   Chen SL, 2010, BIOMATERIALS, V31, P3479, DOI 10.1016/j.biomaterials.2010.01.074
   Cunliffe D, 1999, APPL ENVIRON MICROB, V65, P4995
   Estelles JM, 2008, J MATER SCI-MATER M, V19, P189, DOI 10.1007/s10856-006-0101-2
   Fedorovich NE, 2011, TRENDS BIOTECHNOL, V29, P601, DOI 10.1016/j.tibtech.2011.07.001
   Franz S, 2011, BIOMATERIALS, V32, P6692, DOI 10.1016/j.biomaterials.2011.05.078
   Gan ZH, 1999, POLYMER, V40, P2859, DOI 10.1016/S0032-3861(98)00549-7
   GOPFERICH A, 1993, J POLYM SCI POL CHEM, V31, P2445, DOI 10.1002/pola.1993.080311004
   Hallab NJ, 2001, TISSUE ENG, V7, P55, DOI 10.1089/107632700300003297
   Herzog K, 2006, POLYM DEGRAD STABIL, V91, P2486, DOI 10.1016/j.polymdegradstab.2006.03.005
   Hoque M.E., 2009, TISSUE ENG PART A, V15, P3013
   HULBERT S F, 1970, Journal of Biomedical Materials Research, V4, P433, DOI 10.1002/jbm.820040309
   Ji W, 2011, ACTA BIOMATER, V6, P4199
   Jones AC, 2009, BIOMATERIALS, V30, P1440, DOI 10.1016/j.biomaterials.2008.10.056
   Karageorgiou V, 2005, BIOMATERIALS, V26, P5474, DOI 10.1016/j.biomaterials.2005.02.002
   Kulkarni A, 2008, EUR J PHARM BIOPHARM, V68, P46, DOI 10.1016/j.ejpb.2007.05.021
   Lam CXF, 2009, J BIOMED MATER RES A, V90A, P906, DOI 10.1002/jbm.a.32052
   Leemhuis M, 2006, MACROMOLECULES, V39, P3500, DOI 10.1021/ma052128c
   Leemhuis M, 2003, EUR J ORG CHEM, P3344, DOI 10.1002/ejoc.200300181
   Li SM, 2003, BIOMACROMOLECULES, V4, P372, DOI 10.1021/bm025748j
   Mochizuki M, 1997, POLYM ADVAN TECHNOL, V8, P203
   Park SA, 2011, POLYM ENG SCI, V51, P1883, DOI 10.1002/pen.21982
   Park SA, 2011, BIOPROC BIOSYST ENG, V34, P505, DOI 10.1007/s00449-010-0499-2
   Pieper JS, 2000, BIOMATERIALS, V21, P1689, DOI 10.1016/S0142-9612(00)00052-1
   PITT CG, 1981, J APPL POLYM SCI, V26, P3779, DOI 10.1002/app.1981.070261124
   Schantz JT, 2002, MAT SCI ENG C-BIO S, V20, P9, DOI 10.1016/S0928-4931(02)00007-3
   Seyednejad H, 2011, MACROMOL BIOSCI, V11, P1684, DOI 10.1002/mabi.201100229
   Seyednejad H, 2011, ACTA BIOMATER, V7, P1999, DOI 10.1016/j.actbio.2011.01.018
   Seyednejad H, 2009, BIOMACROMOLECULES, V10, P3048, DOI 10.1021/bm900693p
   Shoichet MS, 2009, MACROMOLECULES, V43, P581
   Sivalingam G, 2003, CHEM ENG SCI, V58, P2911, DOI 10.1016/S0009-2509(03)00155-6
   Sobral JM, 2011, ACTA BIOMATER, V7, P1009, DOI 10.1016/j.actbio.2010.11.003
   Sun HF, 2006, BIOMATERIALS, V27, P1735, DOI 10.1016/j.biomaterials.2005.09.019
   TAKEMURA R, 1984, AM J PHYSIOL, V246, pC1
   Williams DF, 2008, BIOMATERIALS, V29, P2941, DOI 10.1016/j.biomaterials.2008.04.023
   Woodruff MA, 2010, PROG POLYM SCI, V35, P1217, DOI 10.1016/j.progpolymsci.2010.04.002
   Xia Z, 2006, BIOMED MATER, V1, pR1, DOI 10.1088/1748-6041/1/1/R01
   Yeong WY, 2004, TRENDS BIOTECHNOL, V22, P643, DOI 10.1016/j.tibtech.2004.10.004
   Yoon H, 2010, J BIOMAT SCI-POLYM E, V21, P159, DOI 10.1163/156856209X410292
   Zeng J, 2004, MACROMOL BIOSCI, V4, P1118, DOI 10.1002/mabi.200400092
NR 48
TC 95
Z9 99
U1 11
U2 245
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD JUN
PY 2012
VL 33
IS 17
BP 4309
EP 4318
DI 10.1016/j.biomaterials.2012.03.002
PG 10
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 930YT
UT WOS:000303181500007
PM 22436798
DA 2018-10-19
ER

PT J
AU Freilich, M
   Wen, B
   Shafer, D
   Schleier, P
   Dard, M
   Pendrys, D
   Ortiz, D
   Kuhn, L
AF Freilich, Martin
   Wen, Bo
   Shafer, David
   Schleier, Peter
   Dard, Michel
   Pendrys, David
   Ortiz, Denise
   Kuhn, Liisa
TI Implant-guided vertical bone growth in the mini-pig
SO CLINICAL ORAL IMPLANTS RESEARCH
LA English
DT Article
DE biomaterial scaffold; ng; rhBMP-2; scaffold retainer; vertical
   supracrestal bone growth
ID ALVEOLAR RIDGE AUGMENTATION; POSTEROLATERAL LUMBAR FUSION; MORPHOGENETIC
   PROTEIN-2; TITANIUM IMPLANTS; REGENERATION; MATRIX; MODEL; ENHANCEMENT;
   FACTOR-5; DEFECTS
AB Objective: To attain and describe guided vertical bone regeneration around titanium (Ti) and titanium zirconium (TiZr) dental implants utilizing non-glycosylated recombinant human bone morphogenetic protein-2 (ng/rhBMP-2), biomaterial scaffolds and a scaffold retainer. Materials and methods: Thirty-two modified Straumann TE implants were partially embedded in the mandibles of eight adult mini-pigs. Pre-shaped resorbable scaffolds were placed around the implant and shielded and stabilized with a newly developed Ti custom scaffold retainer (umbrella) or wide-neck (WN) healing caps to stabilize the scaffold. Ng/rhBMP-2 (50 mu g) was applied to the supracrestal portion of the implant or incorporated within the scaffold. At 9 weeks, soft tissue healing was assessed. Vertical bone regeneration outcomes including bone height, bone-to-implant contact (BIC) and bone volume were assessed by micro-computed tomography and histology. Results: Soft tissue healing at the test sites (+ng/rhBMP-2/+scaffold) appeared to be substantially better than the control sites (-ng/rhBMP-2/-scaffold). Bone height, BIC percentage and bone volume were all similar regardless of whether WN healing caps or umbrella scaffold stabilization was used for all biomaterial scaffolds tested. WN healing cap test sites showed greater new bone height and BIC as compared with aggregate data from the control sites (P=0.05). Comparison of aggregate data from the umbrella test sites showed greater BIC and new bone volume as compared with aggregate data from the control sites(P=0.05). Conclusion: Vertical bone regeneration was successfully attained utilizing ng/rhBMP-2, biomaterial scaffolds and a scaffold retainer.
C1 [Freilich, Martin; Wen, Bo; Ortiz, Denise; Kuhn, Liisa] Univ Connecticut, Sch Dent Med, Dept Reconstruct Sci, Ctr Biomat, Farmington, CT 06032 USA.
   [Shafer, David] Univ Connecticut, Sch Dent Med, Div Oral & Maxillofacial Surg, Dept Craniofacial Sci, Farmington, CT 06032 USA.
   [Schleier, Peter] Clin Special Med, Oralfacial Surg Sect, Stavanger, Norway.
   [Dard, Michel] Inst Straumann, Basel, Switzerland.
RP Freilich, M (reprint author), Univ Connecticut, Sch Dent Med, Dept Reconstruct Sci, Ctr Biomat, 263 Farmington Ave, Farmington, CT 06032 USA.
EM freilich@nso2.uchc.edu
FU Institut Straumann AG, Basel, Switzerland
FX This study was supported by Institut Straumann AG, Basel, Switzerland,
   which included the manufacture of custom experimental titanium implants
   and components. We appreciate the gift of ng/rhBMP-2 provided by Dr
   Peter Hortschansky of the Hans Knoll Institute, Jena, Germany, and the
   excellent micro-CT imaging performed by Dr Martin Stauber at b-cube AG,
   Zurich, Switzerland. We also thank Dr Antoine Alves (NAMSA) for
   histological and histomorphometric analysis. Finally, we are highly
   indebted to Mr Marcel Obrecht at Institut Straumann for his careful
   organization of all activities during surgical implantation and
   important contributions to this manuscript.
CR Cochran DL, 1996, CLIN ORAL IMPLAN RES, V7, P240, DOI 10.1034/j.1600-0501.1996.070306.x
   Dard M, 2008, BRIT J SURG, V95, P10
   DONATH K, 1982, J ORAL PATHOL MED, V11, P318, DOI 10.1111/j.1600-0714.1982.tb00172.x
   Feichtinger M, 2007, CLEFT PALATE-CRAN J, V44, P142, DOI 10.1597/06-047.1
   Freilich M, 2008, BONE, V43, P781, DOI 10.1016/j.bone.2008.05.021
   Freilich M, 2009, CLIN ORAL IMPLAN RES, V20, P201, DOI 10.1111/j.1600-0501.2008.01615.x
   Hall SL, 2007, MOL THER, V15, P1881, DOI 10.1038/sj.mt.6300258
   Jahng TA, 2004, NEUROSURGERY, V54, P171, DOI 10.1227/01.NEU.0000097516.00961.EB
   Jovanovic S A, 1995, Int J Oral Maxillofac Implants, V10, P23
   Jung RE, 2008, J CLIN PERIODONTOL, V35, P255, DOI 10.1111/j.1600-051X.2008.01270.x
   Kieswetter K, 1996, J BIOMED MATER RES, V32, P55, DOI 10.1002/(SICI)1097-4636(199609)32:1<55::AID-JBM7>3.0.CO;2-O
   Leknes KN, 2008, CLIN ORAL IMPLAN RES, V19, P1027, DOI 10.1111/j.1600-0501.2008.01567.x
   LINDHOLM TC, 1988, CLIN ORTHOP RELAT R, P265
   Lutolf MP, 2003, P NATL ACAD SCI USA, V100, P5413, DOI 10.1073/pnas.0737381100
   Magit DP, 2006, SPINE, V31, P2180, DOI 10.1097/01.brs.0000232823.82106.0a
   Miranda DAO, 2005, J PERIODONTOL, V76, P210, DOI 10.1902/jop.2005.76.2.210
   Neen D, 2006, SPINE, V31, pE636, DOI 10.1097/01.brs.0000232028.97590.12
   Polimeni G, 2005, J CLIN PERIODONTOL, V32, P951, DOI 10.1111/j.1600-051X.2005.00763.x
   Poynton AR, 2002, SPINE, V27, pS40, DOI 10.1097/01.BRS.0000020734.34957.6A
   Renvert S, 1996, CLIN ORAL IMPLAN RES, V7, P360, DOI 10.1034/j.1600-0501.1996.070409.x
   Roos-Jansaker AM, 2002, CLIN ORAL IMPLAN RES, V13, P455, DOI 10.1034/j.1600-0501.2002.130502.x
   Sachse A, 2005, BONE, V37, P699, DOI 10.1016/j.bone.2005.06.011
   SAMPATH TK, 1990, J BIOL CHEM, V265, P13198
   Schmoekel H, 2004, J ORTHOPAED RES, V22, P376, DOI 10.1016/S0736-0266(03)00188-8
   Schmoekel HG, 2005, J SMALL ANIM PRACT, V46, P17, DOI 10.1111/j.1748-5827.2005.tb00269.x
   Sigurdsson TJ, 1997, CLIN ORAL IMPLAN RES, V8, P367, DOI 10.1034/j.1600-0501.1997.080503.x
   Simion M, 2007, INT J PERIODONT REST, V27, P109
   Tinti C, 1997, Int J Periodontics Restorative Dent, V17, P53
   URIST MR, 1971, J DENT RES, V50, P1392, DOI 10.1177/00220345710500060601
   URIST MR, 1965, SCIENCE, V150, P893, DOI 10.1126/science.150.3698.893
   Wikesjo UME, 2008, J CLIN PERIODONTOL, V35, P1001, DOI 10.1111/j.1600-051X.2008.01321.x
   Woo BH, 2001, PHARMACEUT RES, V18, P1747, DOI 10.1023/A:1013382832091
NR 32
TC 11
Z9 11
U1 0
U2 7
PU WILEY-BLACKWELL
PI MALDEN
PA COMMERCE PLACE, 350 MAIN ST, MALDEN 02148, MA USA
SN 0905-7161
J9 CLIN ORAL IMPLAN RES
JI Clin. Oral Implant. Res.
PD JUN
PY 2012
VL 23
IS 6
BP 751
EP 757
DI 10.1111/j.1600-0501.2011.02199.x
PG 7
WC Dentistry, Oral Surgery & Medicine; Engineering, Biomedical
SC Dentistry, Oral Surgery & Medicine; Engineering
GA 930EC
UT WOS:000303119000015
PM 21810121
DA 2018-10-19
ER

PT J
AU Karimi, S
   Nickchi, T
   Alfantazi, AM
AF Karimi, Shima
   Nickchi, Tirdad
   Alfantazi, Akram M.
TI Long-term corrosion investigation of AISI 316L, Co-28Cr-6Mo, and
   Ti-6Al-4V alloys in simulated body solutions
SO APPLIED SURFACE SCIENCE
LA English
DT Article
DE Biomaterial; Oxide film; Immersion test; Protein; Ion release; Surface
   concentration
ID BOVINE SERUM-ALBUMIN; SURFACE OXIDE-FILM; MO IMPLANT ALLOY;
   STAINLESS-STEEL; ORTHOPEDIC IMPLANTS; MACROPHAGE CELLS; IN-VITRO;
   BIOLOGICAL ENVIRONMENTS; PROTEIN SOLUTIONS; ION RELEASE
AB The long-term weight loss, ion release and surface composition of AISI 316L, the Co-28Cr-6Mo and Ti-6Al-4V alloys were investigated in phosphate buffered solutions (PBS) with various bovine serum albumin (BSA) concentrations. All the samples lost weight up to 14 weeks and then started to gain weight. This can be explained by precipitation of dissolved ions on the surface after 14 weeks of immersion. The quantities of the dissolved ions were measured in immersed solution for 8, 14 and 22 weeks by induced coupled plasma-optical emission spectrometer (ICP-OES). The amounts of Fe released from 316L, and Co and Mo released from the Co-28Cr-6Mo alloy decreased after 14 weeks of immersion in PBS and BSA solutions. This observation coincides with the weight change of the samples. The oxide layer composition and concentration of the specimens exposed to solutions for 22 weeks were identified by X-ray photoelectron spectroscopy (XPS) analysis. The XPS results revealed that chromium is the main component of the 316L and Co-28Cr-6Mo alloy. The high Cr concentration of the 316L and Co-Cr-Mo oxide layer corresponds with the slow dissolution rate of Cr compared to other alloying elements of the 316L and Co-28Cr-6Mo alloy. Crown Copyright (C) 2012 Published by Elsevier B. V. All rights reserved.
C1 [Karimi, Shima; Nickchi, Tirdad; Alfantazi, Akram M.] Univ British Columbia, Dept Mat Engn, Vancouver, BC V6T 1Z4, Canada.
RP Karimi, S (reprint author), Univ British Columbia, Dept Mat Engn, Vancouver, BC V6T 1Z4, Canada.
EM shimak80@gmail.com
OI alfantazi, akram/0000-0002-4039-5110
FU Natural Science and Engineering Research Council of Canada (NSERC)
FX We would like to acknowledge financial support of the Natural Science
   and Engineering Research Council of Canada (NSERC).
CR [Anonymous], 2001, F212908 ASTM, DOI [10.1520/F2129-08, DOI 10.1520/F2129-08]
   [Anonymous], 2004, G3172 ASTM INT, DOI [10.1520/G0031-72R04, DOI 10.1520/G0031-72R04]
   [Anonymous], 2005, D5245 ASTM, DOI [10.1520/D5245-92R05, DOI 10.1520/D5245-92R05]
   Ardlin BI, 2005, EUR J ORAL SCI, V113, P83, DOI 10.1111/j.1600-0722.2005.00187.x
   Bastidas JM, 2002, CORROS SCI, V44, P625, DOI 10.1016/S0010-938X(01)00072-5
   Beddoes J, 1999, J MATER SCI-MATER M, V10, P389, DOI 10.1023/A:1008918929036
   BLACK J, 1983, BIOMATERIALS, V4, P160, DOI 10.1016/0142-9612(83)90003-0
   Cahoon J., 2004, J BIOMED MATER RES, V2, P1
   Contu F, 2002, J BIOMED MATER RES, V62, P412, DOI 10.1002/jbm.10329
   Frateur I, 2006, ELECTROCHIM ACTA, V51, P1550, DOI 10.1016/j.electacta.2005.02.116
   Hanawa T, 2001, APPL SURF SCI, V183, P68, DOI 10.1016/S0169-4332(01)00551-7
   HANSEN DC, 1994, J COLLOID INTERF SCI, V168, P206, DOI 10.1006/jcis.1994.1410
   HEALY KE, 1992, BIOMATERIALS, V13, P553, DOI 10.1016/0142-9612(92)90108-Z
   Hiromoto S, 2005, BIOMATERIALS, V26, P4912, DOI 10.1016/j.biomaterials.2005.01.028
   Hiromoto S, 2004, BIOMATERIALS, V25, P979, DOI 10.1016/S0142-9612(03)00620-3
   Hodgson AWE, 2004, ELECTROCHIM ACTA, V49, P2167, DOI 10.1016/j.electacta.2003.12.043
   Huang HH, 2003, BIOMATERIALS, V24, P3585, DOI 10.1016/S0142-9612(03)00188-1
   Karimi S, 2011, CORROS SCI, V53, P3262, DOI 10.1016/j.corsci.2011.06.009
   KASEMO B, 1994, ENVIRON HEALTH PERSP, V102, P41, DOI 10.2307/3432057
   Khan MA, 1999, BIOMATERIALS, V20, P631, DOI 10.1016/S0142-9612(98)00217-8
   Kim YJ, 2005, SPINE, V30, P923, DOI 10.1097/01.brs.0000158872.42802.be
   Koike M, 2001, BIOMATERIALS, V22, P2931, DOI 10.1016/S0142-9612(01)00040-0
   Koike M, 2001, J ORAL REHABIL, V28, P540, DOI 10.1046/j.1365-2842.2001.00690.x
   Lewis AC, 2005, J BIOMED MATER RES A, V73A, P456, DOI 10.1002/jbm.a.30368
   Lin HY, 2004, J ORTHOP RES, V22, P1231, DOI 10.1016/j.orthres.2004.04.005
   Lin HY, 2004, APPL SURF SCI, V225, P21, DOI 10.1016/j.apsusc.2003.09.027
   Lin HY, 2004, BIOMATERIALS, V25, P1233, DOI 10.1016/j.biomaterials.2003.08.016
   MERRITT K, 1983, BIOMATER ARTIF CELL, V11, P115, DOI 10.3109/10731198309118800
   MERRITT K, 1988, J BIOMED MATER RES, V22, P111, DOI 10.1002/jbm.820220204
   Milosev I, 2000, BIOMATERIALS, V21, P2103, DOI 10.1016/S0142-9612(00)00145-9
   Okazaki Y, 2005, BIOMATERIALS, V26, P11, DOI 10.1016/j.biomaterials.2004.02.005
   Olsson COA, 2003, ELECTROCHIM ACTA, V48, P1093, DOI 10.1016/S0013-4686(02)00841-1
   Omanovic S, 1999, LANGMUIR, V15, P8315, DOI 10.1021/la990474f
   Qiu HJ, 2006, BIOMATERIALS, V27, P5845, DOI 10.1016/j.biomaterials.2006.07.042
   RUDEE ML, 1985, J BIOMED MATER RES, V19, P57, DOI 10.1002/jbm.820190106
   Shih CC, 2004, CORROS SCI, V46, P427, DOI 10.1016/S0010-938X(03)00148-3
   Silva-Bermudez P, 2011, APPL SURF SCI, V258, P1711, DOI 10.1016/j.apsusc.2011.10.020
   Sleigh C, 1996, J ELECTRON SPECTROSC, V77, P41, DOI 10.1016/0368-2048(95)02392-5
   SOUSA SR, 1991, J MATER SCI-MATER M, V2, P19, DOI 10.1007/BF00701683
   Speight J. G., 2005, LANGES HDB CHEM
   Takemoto S, 2005, BIOMATERIALS, V26, P829, DOI 10.1016/j.biomaterials.2004.03.025
   Vidal CV, 2008, CORROS SCI, V50, P1954, DOI 10.1016/j.corsci.2008.04.002
NR 42
TC 42
Z9 44
U1 1
U2 31
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0169-4332
J9 APPL SURF SCI
JI Appl. Surf. Sci.
PD JUN 1
PY 2012
VL 258
IS 16
BP 6087
EP 6096
DI 10.1016/j.apsusc.2012.03.008
PG 10
WC Chemistry, Physical; Materials Science, Coatings & Films; Physics,
   Applied; Physics, Condensed Matter
SC Chemistry; Materials Science; Physics
GA 925TK
UT WOS:000302784200028
DA 2018-10-19
ER

PT J
AU Zanina, N
   Haddad, S
   Othmane, A
   Jouenne, T
   Vaudry, D
   Souiri, M
   Mora, L
AF Zanina, Nahla
   Haddad, Soumaya
   Othmane, Ali
   Jouenne, Thierry
   Vaudry, David
   Souiri, Mina
   Mora, Laurence
TI Endothelial cell adhesion on polyelectrolyte multilayer films
   functionalised with fibronectin and collagen
SO CHEMICAL PAPERS
LA English
DT Article
DE polyelectrolyte multilayers; endothelial cells; cell adhesion;
   proliferation; atomic force microscopy; wettability; electrochemical
   impedance spectroscopy
ID CONTACT-ANGLE MEASUREMENTS; SURFACE; GROWTH; ANTITHROMBIN; WETTABILITY;
   MECHANISM; MEMBRANES; PROTEINS; TITANIUM; PEPTIDE
AB The seeding of endothelial cells on biomaterial surfaces has become a major challenge to achieve better haemocompatibility of these surfaces. Multilayers of polyelectrolytes formed by the layer-by-layer method are promising in this respect. In this study, the interactions of endothelial cells with multilayered polyelectrolytes films were investigated. The build-ups were prepared by self-assembled alternatively adsorbed polyanions and polycations functionalised with fibronectin and collagen. Anionic poly(sodium 4-styrenesulfonate) and cationic poly(allylamine hydrochloride) polyelectrolytes were chosen as a model system. Elaborated surfaces were characterised by electrochemical impedance spectroscopy and cyclic voltammetry. The modified electrode showed good reversible electrochemical properties and high stability in an electrolyte solution. The film ohmic resistance was highest when the film was coated with fibronectin; the parameters so determined were correlated with atomic force microscopy images. Cell colorimetric assay (WST-1) and immunofluorescence were used to quantify the cell viability and evaluate the adhesion properties. When cultured on a surface where proteins were deposited, cells adhered and proliferated better with fibronectin than with collagen. In addition, a high surface free energy was favourable to adhesion and proliferation (48.8 mJ m(-2) for fibronectin and 39.7 mJ m(-2) for collagen, respectively). Endothelial cells seeded on functionalised-polyelectrolyte multilayer films showed a good morphology and adhesion necessary for the development of a new endothelium. (C) 2012 Institute of Chemistry, Slovak Academy of Sciences
C1 [Zanina, Nahla; Haddad, Soumaya; Othmane, Ali; Souiri, Mina] Univ Monastir, Biophys Lab, Fac Med, Monastir 5019, Tunisia.
   [Zanina, Nahla; Haddad, Soumaya; Mora, Laurence] Univ Paris 13, INSERM, U698, Dept Bioengn,Inst Galilee, F-93430 Villetaneuse, France.
   [Jouenne, Thierry] Univ Rouen, CNRS, UMR 6270, F-76821 Rouen, France.
   [Jouenne, Thierry] Univ Rouen, Prote Platform FR 3038, European Inst Peptide Res IFRMP23, F-76821 Rouen, France.
   [Jouenne, Thierry; Vaudry, David] Univ Rouen, INSERM, U413, Lab Cellular & Mol Neuroendocrinol, F-76821 Rouen, France.
RP Othmane, A (reprint author), Univ Monastir, Biophys Lab, Fac Med, Monastir 5019, Tunisia.
EM Ali.Othmane@fmm.rnu.tn
RI VAUDRY, David/M-1454-2018
OI jouenne, thierry/0000-0003-0994-9944
FU CMCU (PAI) [05S0812]
FX The authors would like to thank CMCU (PAI Project No. 05S0812) for their
   financial support.
CR ALBELDA SM, 1993, LAB INVEST, V68, P4
   Bery M. N., 1995, BIOELECTROCHEMISTRY, P134
   Borghol N, 2011, J BIOTECHNOL, V151, P114, DOI 10.1016/j.jbiotec.2010.11.014
   Bouafsoun A, 2006, MAT SCI ENG C-BIO S, V26, P260, DOI 10.1016/j.msec.2005.10.051
   Bouafsoun A, 2007, MAT SCI ENG C-BIO S, V27, P709, DOI 10.1016/j.msec.2006.06.038
   Boura C, 2005, BIOMATERIALS, V26, P4568, DOI 10.1016/j.biomaterials.2004.11.036
   Boura C, 2003, BIOMATERIALS, V24, P3521, DOI 10.1016/S0142-9612(03)00214-X
   Bowlin GL, 1997, CELL TRANSPLANT, V6, P623, DOI 10.1016/S0963-6897(97)00096-1
   Chluba J, 2001, BIOMACROMOLECULES, V2, P800, DOI 10.1021/bm015529i
   Gammoudi I, 2010, BIOSENS BIOELECTRON, V26, P1723, DOI 10.1016/j.bios.2010.07.118
   Haddad S, 2011, ELECTROCHIM ACTA, V56, P7303, DOI 10.1016/j.electacta.2011.06.048
   Haddad S, 2011, TALANTA, V85, P927, DOI 10.1016/j.talanta.2011.04.079
   Ladam G, 2000, BIOMACROMOLECULES, V1, P674, DOI 10.1021/bm005572q
   Muller M, 2001, MACROMOL RAPID COMM, V22, P390, DOI 10.1002/1521-3927(20010301)22:6<390::AID-MARC390>3.0.CO;2-B
   Nonner W, 2000, J MOL LIQ, V87, P149, DOI 10.1016/S0167-7322(00)00118-5
   Picart C, 2001, LANGMUIR, V17, P7414, DOI 10.1021/la010848g
   Picart C, 2007, COLLOID SURFACE A, V303, P30, DOI 10.1016/j.colsurfa.2007.02.015
   Ponsonnet L, 2003, MAT SCI ENG C-BIO S, V23, P551, DOI 10.1016/S0928-4931(03)00033-X
   Ponsonnet L, 2002, MAT SCI ENG C-BIO S, V21, P157, DOI 10.1016/S0928-4931(02)00097-8
   Schultz P, 2005, BIOMATERIALS, V26, P2621, DOI 10.1016/j.biomaterials.2004.06.049
   Seifalian AM, 2002, ARTIF ORGANS, V26, P307, DOI 10.1046/j.1525-1594.2002.06841.x
   Senel M, 2010, CHEM PAP, V64, P1, DOI 10.2478/s11696-009-0103-x
   Tryoen-Toth P, 2002, J BIOMED MATER RES, V60, P657, DOI 10.1002/jbm.10110
   TURNER MR, 1992, EXP PHYSIOL, V77, P741, DOI 10.1113/expphysiol.1992.sp003640
   van Oss C.J., 1995, INTERFACIAL FORCES A
   VANLOOSDRECHT MCM, 1990, MICROBIOL REV, V54, P75
   VANOSS CJ, 1989, J COLLOID INTERF SCI, V128, P313, DOI 10.1016/0021-9797(89)90345-7
   vanOss CJ, 1997, CURR OPIN COLLOID IN, V2, P503, DOI 10.1016/S1359-0294(97)80099-4
   VANOSS CJ, 1989, SEPAR SCI TECHNOL, V24, P15, DOI 10.1080/01496398908049748
   Vautier D, 2002, J BIOMAT SCI-POLYM E, V13, P712, DOI DOI 10.1163/156856202320269175
   Velzenberger E, 2009, COLLOID SURFACE B, V68, P238, DOI 10.1016/j.colsurfb.2008.10.022
   Vodouhe C, 2005, BIOMATERIALS, V26, P545, DOI 10.1016/j.biomaterials.2004.02.057
   Vuori K, 1998, J MEMBRANE BIOL, V165, P191, DOI 10.1007/s002329900433
   Waldeck H, 2008, ACTA BIOMATER, V4, P1172, DOI 10.1016/j.actbio.2008.03.020
   Wang CH, 2011, J ALLOY COMPD, V509, P691, DOI 10.1016/j.jallcom.2010.06.071
   Xi FN, 2011, J ELECTROANAL CHEM, V656, P252, DOI 10.1016/j.jelechem.2010.10.025
   Zhang P, 2008, J MEMBRANE SCI, V320, P73, DOI 10.1016/j.memsci.2008.03.055
   Zhu YB, 2004, COLLOID SURFACE B, V36, P49, DOI 10.1016/j.colsurfb.2004.04.008
NR 38
TC 7
Z9 7
U1 1
U2 31
PU VERSITA
PI WARSAW
PA SOLIPSKA 14A-1, 02-482 WARSAW, POLAND
SN 0366-6352
J9 CHEM PAP
JI Chem. Pap.
PD JUN
PY 2012
VL 66
IS 5
BP 532
EP 542
DI 10.2478/s11696-012-0141-7
PG 11
WC Chemistry, Multidisciplinary
SC Chemistry
GA 923VA
UT WOS:000302646800016
DA 2018-10-19
ER

PT J
AU Holland, C
   O'Neil, K
   Vollrath, F
   Dicko, C
AF Holland, Chris
   O'Neil, Kathy
   Vollrath, Fritz
   Dicko, Cedric
TI Distinct structural and optical regimes in natural silk spinning
SO BIOPOLYMERS
LA English
DT Article
DE birefringence; spider; dragline; silk; mechanical testing
ID SPIDER DRAGLINE SILK; MECHANICAL-PROPERTIES; RAMAN-SPECTROSCOPY; FIBERS;
   ORIENTATION; BEHAVIOR
AB This study investigates the relationship between birefringence and mechanical properties in the dragline silk of the gold orb weaving spider Nephila edulis. Using a custom birefringence-tensile testing device, we probed the orientation and water-induced swelling of fibers spun at variety of drawing rates ranging from 0.003 to 400 mm s-1. Our results indicate that based upon drawing rate, silk fibers fall into three distinct regimes each with characteristic orientation and swelling properties. Further investigation using in situ tensile testing reveals interactions between a fiber's drawing speed, mechanical properties, and orientation that support previous model predictions. We propose that simultaneous birefringence-tensile testing provides a unique and readily accessible insight into the structural behavior of this interesting and important biomaterial. (C) 2011 Wiley Periodicals, Inc. Biopolymers 97: 368373, 2012.
C1 [Holland, Chris; O'Neil, Kathy; Vollrath, Fritz; Dicko, Cedric] Univ Oxford, Dept Zool, Oxford OX1 3PS, England.
RP Dicko, C (reprint author), Lund Univ, Pure & Appl Biochem Dept, S-22100 Lund, Sweden.
EM cedric.dicko@tbiokem.lth.se
RI Holland, Chris/E-5491-2011
OI Holland, Chris/0000-0003-0913-2221
FU AFSOR [F49620-03-1-0111, FA9550-09-1-0111]; European Commission
   [G5RD-CT-2002-00738, EC-MTKD-CT-2004-014533]; ERC [SP2-GA-2008-233409];
   EPSRC [EP/E039715/1]; Magdalen College, St Edmund Hall Oxford
FX Contract grant sponsor: AFSOR; Contract grant numbers: F49620-03-1-0111,
   FA9550-09-1-0111; Contract grant sponsor: European Commission; Contract
   grant numbers: G5RD-CT-2002-00738, EC-MTKD-CT-2004-014533; Contract
   grant sponsor: ERC; Contract grant number: SP2-GA-2008-233409; Contract
   grant sponsor: EPSRC Life Sciences Interface Fellowship; Contract grant
   number: EP/E039715/1; Contract grant sponsors: Magdalen College, St
   Edmund Hall Oxford
CR Beek J., 2002, P NATL ACAD SCI USA, V99, P10266
   BURSTEIN EA, 1976, INTRINSIC PROTEIN FL
   Carmichael S, 1999, INT J BIOL MACROMOL, V24, P219, DOI 10.1016/S0141-8130(99)00008-2
   Carmichael S, 1999, J APPL POLYM SCI, V72, P895
   Crawford S., 1953, P PHYS SOC B, V65, P884
   Dicko C, 2005, INT J BIOL MACROMOL, V36, P215, DOI 10.1016/j.ijbiomac.2005.06.004
   Dicko C., 2010, FUNCTIONAL AMYLOID A, P51
   Elices M, 2004, J APPL POLYM SCI, V92, P3537, DOI 10.1002/app.20383
   Ene R, 2009, SOFT MATTER, V5, P4568, DOI 10.1039/b911159j
   Geday MA, 2000, J MICROSC-OXFORD, V198, P1
   Glisovic A, 2008, MACROMOLECULES, V41, P390, DOI 10.1021/ma070528p
   Grubb DT, 1999, INT J BIOL MACROMOL, V24, P203, DOI 10.1016/S0141-8130(98)00086-5
   Grubb DT, 1997, MACROMOLECULES, V30, P2860, DOI 10.1021/ma961293c
   KERKAM K, 1991, NATURE, V349, P596, DOI 10.1038/349596a0
   Kuznetsova IM, 2004, J PROTEOME RES, V3, P485, DOI 10.1021/pr034094y
   Liu Y, 2005, NAT MATER, V4, P901, DOI 10.1038/nmet1534
   Liu Y, 2008, BIOMACROMOLECULES, V9, P116, DOI 10.1021/bm700877g
   LONG SD, 1991, J APPL POLYM SCI, V42, P1911, DOI 10.1002/app.1991.070420714
   Madsen B, 1999, INT J BIOL MACROMOL, V24, P301, DOI 10.1016/S0141-8130(98)00094-4
   Riekel C, 2000, BIOMACROMOLECULES, V1, P622, DOI 10.1021/bm000047c
   Rousseau ME, 2004, BIOMACROMOLECULES, V5, P2247, DOI 10.1021/bm049717V
   Sapede D, 2005, MACROMOLECULES, V38, P8447, DOI 10.1021/ma0507995
   Shao ZZ, 1999, INT J BIOL MACROMOL, V24, P295, DOI 10.1016/S0141-8130(98)00093-2
   Sirichaisit J, 2003, BIOMACROMOLECULES, V4, P387, DOI 10.1021/bm0256956
   Vollrath F, 2009, WOODHEAD PUBL TEXT, V88B, P146, DOI 10.1533/9781845697310.1.146
   Vollrath F, 2001, NATURE, V410, P541, DOI 10.1038/35069000
   Ward I. M., 1997, STRUCTURE PROPERTIES
   WORK RW, 1977, TEXT RES J, V47, P650, DOI 10.1177/004051757704701003
NR 28
TC 10
Z9 10
U1 0
U2 32
PU WILEY-BLACKWELL
PI MALDEN
PA COMMERCE PLACE, 350 MAIN ST, MALDEN 02148, MA USA
SN 0006-3525
J9 BIOPOLYMERS
JI Biopolymers
PD JUN
PY 2012
VL 97
IS 6
SI SI
BP 368
EP 373
DI 10.1002/bip.22022
PG 6
WC Biochemistry & Molecular Biology; Biophysics
SC Biochemistry & Molecular Biology; Biophysics
GA 911GW
UT WOS:000301706300008
PM 22240893
DA 2018-10-19
ER

PT J
AU Kundu, SC
   Kundu, B
   Talukdar, S
   Bano, S
   Nayak, S
   Kundu, J
   Mandal, BB
   Bhardwaj, N
   Botlagunta, M
   Dash, BC
   Acharya, C
   Ghosh, AK
AF Kundu, S. C.
   Kundu, Banani
   Talukdar, Sarmistha
   Bano, Subia
   Nayak, Sunita
   Kundu, Joydip
   Mandal, Biman B.
   Bhardwaj, Nandana
   Botlagunta, Mahendran
   Dash, Biraja C.
   Acharya, Chitrangada
   Ghosh, Ananta K.
TI Invited review nonmulberry silk biopolymers
SO BIOPOLYMERS
LA English
DT Review
DE nonmulberry silk; fibroin; sericin; biomaterial; tissue engineering;
   regenerative medicine
ID TROPICAL TASAR SILKWORM; TISSUE ENGINEERING APPLICATIONS;
   NECROSIS-FACTOR-ALPHA; SAMIA-CYNTHIA-RICINI; ANTHERAEA-MYLITTA;
   NON-MULBERRY; BOMBYX-MORI; IN-VITRO; MECHANICAL-PROPERTIES; FIBROIN
   PROTEIN
AB The silk produced by silkworms are biopolymers and can be classified into two typesmulberry and nonmulberry. Mulberry silk of silkworm Bombyx mori has been extensively explored and used for century old textiles and sutures. But for the last few decades it is being extensively exploited for biomedical applications. However, the transformation of nonmulberry silk from being a textile commodity to biomaterials is relatively new. Within a very short period of time, the combination of load bearing capability and tensile strength of nonmulberry silk has been equally envisioned for bone, cartilage, adipose, and other tissue regeneration. Adding to its advantage is its diverse morphology, including macro to nano architectures with controllable degradation and biocompatibility yields novel natural material systems in vitro. Its follow on applications involve sustained release of model compounds and anticancer drugs. Its 3D cancer models provide compatible microenvironment systems for better understanding of the cancer progression mechanism and screening of anticancer compounds. Diversely designed nonmulberry matrices thus provide an array of new cutting age technologies, which is unattainable with the current synthetic materials that lack biodegradability and biocompatibility. Scientific exploration of nonmulberry silk in tissue engineering, regenerative medicine, and biotechnological applications promises advancement of sericulture industries in India and China, largest nonmulberry silk producers of the world. This review discusses the prospective biomedical applications of nonmulberry silk proteins as natural biomaterials. (C) 2011 Wiley Periodicals, Inc. Biopolymers 97: 455467, 2012.
C1 [Kundu, S. C.; Kundu, Banani; Talukdar, Sarmistha; Bano, Subia; Nayak, Sunita; Kundu, Joydip; Mandal, Biman B.; Bhardwaj, Nandana; Botlagunta, Mahendran; Dash, Biraja C.; Acharya, Chitrangada; Ghosh, Ananta K.] Indian Inst Technol, Dept Biotechnol, Kharagpur 721302, W Bengal, India.
RP Kundu, SC (reprint author), Indian Inst Technol, Dept Biotechnol, Kharagpur 721302, W Bengal, India.
EM kundu@hijli.iitkgp.ernet.in
RI Kundu, Banani/O-9320-2016; Botlagunta, Mahendran/R-5140-2018; Kundu,
   Subhas/P-1989-2016
OI Kundu, Banani/0000-0003-1251-700X; Botlagunta,
   Mahendran/0000-0002-0490-2832; Kundu, Subhas/0000-0002-7170-2291;
   Bhardwaj, Dr. Nandana/0000-0002-7747-3661
FU Department of Biotechnology; Indo-Australia Biotechnology Fund; Council
   of Scientific Industrial Research; Department of Science and Technology;
   Indo-Russian and Indo-Austria Biotechnology Programme; Government of
   India; Indo-US Scientific and Technology Forum, New Delhi
FX Contract grant sponsors: Department of Biotechnology and its
   Bioinformatics facility, Indo-Australia Biotechnology Fund, Council of
   Scientific Industrial Research, Department of Science and Technology,
   Indo-Russian and Indo-Austria Biotechnology Programme, Government of
   India, Indo-US Scientific and Technology Forum, New Delhi
CR Acharya C, 2008, J MATER SCI-MATER M, V19, P2827, DOI 10.1007/s10856-008-3408-3
   Acharya C, 2009, J BIOMATER APPL, V23, P497, DOI 10.1177/0885328208094261
   Acharya C, 2008, BIOMATERIALS, V29, P4665, DOI 10.1016/j.biomaterials.2008.08.033
   Acharya P. K., 1992, ROLE SERICULTURE ERA, P6
   Ahmad R, 2004, DNA CELL BIOL, V23, P149, DOI 10.1089/104454904322964742
   Akai H., 1998, 3 INT C WILD SILK MO, P255
   Altman GH, 2003, BIOMATERIALS, V24, P401, DOI 10.1016/S0142-9612(02)00353-8
   Aramwit P, 2007, BIOSCI BIOTECH BIOCH, V71, P2473, DOI 10.1271/bbb.70243
   Aramwit P, 2010, BIOTECHNOL APPL BIOC, V55, P91, DOI 10.1042/BA20090186
   Asakura T, 2004, BIOMATERIALS, V25, P617, DOI 10.1016/S0142-9612(03)00570-2
   Bhardwaj N, 2011, CARBOHYD POLYM, V85, P325, DOI 10.1016/j.carbpol.2011.02.027
   Chen JS, 2003, J BIOMED MATER RES A, V67A, P559, DOI 10.1002/jbm.a.10120
   Chowdhury S. N., 1970, ERICULTURE MUGACULTU, P1
   Cukierman E, 2001, SCIENCE, V294, P1708, DOI 10.1126/science.1064829
   Dash BC, 2009, J BIOTECHNOL, V144, P321, DOI 10.1016/j.jbiotec.2009.09.019
   Dash R, 2006, INT J BIOL MACROMOL, V38, P255, DOI 10.1016/j.ijbiomac.2006.03.001
   Dash R, 2008, MOL CELL BIOCHEM, V311, P111, DOI 10.1007/s11010-008-9702-z
   Dash R, 2007, COMP BIOCHEM PHYS B, V147, P129, DOI 10.1016/j.cbpb.2007.01.009
   Datta A, 2001, COMP BIOCHEM PHYS B, V129, P197, DOI 10.1016/S1096-4959(01)00377-3
   Datta A, 2001, INSECT BIOCHEM MOLEC, V31, P1013, DOI 10.1016/S0965-1748(01)00049-2
   Fang Q, 2009, MAT SCI ENG C-BIO S, V29, P1527, DOI 10.1016/j.msec.2008.12.007
   Fu CJ, 2009, CHEM COMMUN, P6515, DOI 10.1039/b911049f
   Fuchs S, 2009, BIOMATERIALS, V30, P1329, DOI 10.1016/j.biomaterials.2008.11.028
   Furuzono T, 2000, BIOMATERIALS, V21, P327, DOI 10.1016/S0142-9612(99)00177-5
   GAMO T, 1977, INSECT BIOCHEM, V7, P285, DOI 10.1016/0020-1790(77)90026-9
   GROVES RW, 1995, BRIT J DERMATOL, V132, P345, DOI 10.1111/j.1365-2133.1995.tb08666.x
   Hakimi O, 2007, COMPOS PART B-ENG, V38, P324, DOI 10.1016/j.compositesb.2006.06.012
   Hakimi O, 2010, J BIOMED MATER RES A, V92A, P1366, DOI 10.1002/jbm.a.32462
   Hardy JG, 2008, POLYMER, V49, P4309, DOI 10.1016/j.polymer.2008.08.006
   Hardy JG, 2010, PROG POLYM SCI, V35, P1093, DOI 10.1016/j.progpolymsci.2010.04.005
   Hartland-Rowe Richard, 1992, Botswana Notes and Records, V24, P123
   Hayashi CY, 1999, INT J BIOL MACROMOL, V24, P271, DOI 10.1016/S0141-8130(98)00089-0
   Janzen D.H., 1984, Oxford Surveys in Evolutionary Biology, V1, P85
   Jin HJ, 2003, NATURE, V424, P1057, DOI 10.1038/nature01809
   Jolly M S, 1979, FAO AGR SERV B, V4, P1
   Jolly M. S., 1974, TASAR CULTURE
   Kakati LN, 2009, TROP ECOL, V50, P137
   Kardestuncer T, 2006, CLIN ORTHOP RELAT R, P234, DOI 10.1097/01.blo.0000205879.50834.fe
   Kasoju N, 2010, ADV ENG MATER, V12, pB139, DOI 10.1002/adem.200980055
   Kasoju N, 2009, J TISSUE ENG REGEN M, V3, P539, DOI 10.1002/term.196
   Kato N., 1998, BIOSCI BIOTECH BIOCH, V62, P45
   Khire TS, 2010, SOFT MATTER, V6, P2066, DOI 10.1039/b924530h
   Kundu B, 2010, PROG POLYM SCI, V35, P1116, DOI 10.1016/j.progpolymsci.2010.04.004
   Kundu J, 2010, INT J PHARMACEUT, V388, P242, DOI 10.1016/j.ijpharm.2009.12.052
   Kundu J, 2008, MAT SCI ENG C-BIO S, V28, P1376, DOI 10.1016/j.msec.2008.03.004
   Kundu SC, 2008, PROG POLYM SCI, V33, P998, DOI 10.1016/j.progpolymsci.2008.08.002
   Lee EH, 2010, ORAL SURG ORAL MED O, V109, pE33, DOI 10.1016/j.tripleo.2009.12.043
   Lee KG, 2011, INT J BIOL MACROMOL, V48, P223, DOI 10.1016/j.ijbiomac.2010.09.020
   Luan XY, 2006, BIOMED MATER, V1, P181, DOI 10.1088/1748-6041/1/4/001
   Luan XY, 2009, CELL BIOL INT, V33, P1127, DOI 10.1016/j.cellbi.2009.07.005
   Lundmark K, 2005, P NATL ACAD SCI USA, V102, P6098, DOI 10.1073/pnas.0501814102
   Mahendran B, 2006, GENE, V370, P51, DOI 10.1016/j.gene.2005.11.010
   Mahendran B, 2006, J BIOCHEM MOL BIOL, V39, P522
   Mai-ngam K, 2011, J BIOMAT SCI-POLYM E, V22, P2001, DOI 10.1163/092050610X530964
   Mandal BB, 2008, MACROMOL BIOSCI, V8, P807, DOI 10.1002/mabi.200800113
   Mandal BB, 2008, BIOTECHNOL BIOENG, V100, P1237, DOI 10.1002/bit.21835
   Mandal BB, 2008, BIOTECHNOL BIOENG, V99, P1482, DOI 10.1002/bit.21699
   Mandal BB, 2011, INT J BIOL MACROMOL, V49, P125, DOI 10.1016/j.ijbiomac.2011.03.015
   Mandal BB, 2010, ACTA BIOMATER, V6, P360, DOI 10.1016/j.actbio.2009.08.035
   Mandal BB, 2009, ACTA BIOMATER, V5, P2579, DOI 10.1016/j.actbio.2009.02.033
   Mandal BB, 2009, BIOMATERIALS, V30, P5170, DOI 10.1016/j.biomaterials.2009.05.072
   Mandal BB, 2009, BIOMATERIALS, V30, P5019, DOI 10.1016/j.biomaterials.2009.05.064
   Mandal BB, 2009, ACTA BIOMATER, V5, P3007, DOI 10.1016/j.actbio.2009.03.026
   Mandal BB, 2009, NANOTECHNOLOGY, V20, DOI 10.1088/0957-4484/20/35/355101
   Mandal BB, 2009, BIOMED MICRODEVICES, V11, P467, DOI 10.1007/s10544-008-9252-x
   MINOURA N, 1995, BIOCHEM BIOPH RES CO, V208, P511, DOI 10.1006/bbrc.1995.1368
   Momotani E, 1998, J VET MED SCI, V60, P519, DOI 10.1292/jvms.60.519
   Mori H., 2000, REV MOL BIOTECHNOL, V7, P95
   Nagai N, 2009, BIOL PHARM BULL, V32, P933, DOI 10.1248/bpb.32.933
   Nishida A, 2011, INT J PHARMACEUT, V407, P44, DOI 10.1016/j.ijpharm.2011.01.006
   Omenetto FG, 2010, SCIENCE, V329, P528, DOI 10.1126/science.1188936
   Packard A. S., 1914, MEM NATL ACAD SCI  3
   Padamwar MN, 2004, J SCI IND RES INDIA, V63, P323
   Panilaitis B, 2003, BIOMATERIALS, V24, P3079, DOI 10.1016/S0142-9612(03)00158-3
   Perez-Rigueiro J, 2000, POLYMER, V41, P8433, DOI 10.1016/S0032-3861(00)00179-8
   Poza P, 2002, ENG FRACT MECH, V69, P1035, DOI 10.1016/S0013-7944(01)00120-5
   Qanungo KR, 2002, J GEN VIROL, V83, P1483, DOI 10.1099/0022-1317-83-6-1483
   Rajkhowa R, 2000, J APPL POLYM SCI, V77, P2418, DOI 10.1002/1097-4628(20000912)77:11<2418::AID-APP10>3.3.CO;2-H
   Rajkhowa R., 2011, TERMISAP P, P158
   Robson R, 1998, HDB FIBRE CHEM, P415
   ROSSITCH E, 1987, CHILD NERV SYST, V3, P375, DOI 10.1007/BF00270712
   RUOSLAHTI E, 1987, SCIENCE, V238, P491, DOI 10.1126/science.2821619
   Saha M, 2008, J ECON ENTOMOL, V101, P1176, DOI 10.1603/0022-0493(2008)101[1176:DORAPD]2.0.CO;2
   Saha M, 2006, BIOCHEM GENET, V44, P72, DOI 10.1007/s10528-006-9007-4
   Santin M, 1999, J BIOMED MATER RES, V46, P382, DOI 10.1002/(SICI)1097-4636(19990905)46:3<382::AID-JBM11>3.0.CO;2-R
   Sehnal F, 2004, BIOMACROMOLECULES, V5, P666, DOI 10.1021/bm0344046
   Sen K, 2004, J APPL POLYM SCI, V92, P1098, DOI 10.1002/app.13610
   Sen K, 2004, J APPL POLYM SCI, V92, P1080, DOI 10.1002/app.13609
   Shao ZZ, 2002, NATURE, V418, P741, DOI 10.1038/418741a
   Sonwalker T. N., 1991, HDB SILK TECHNOLOGY, P58
   SOONG HK, 1984, OPHTHALMOLOGY, V91, P479
   Taddei P, 2006, BIOMACROMOLECULES, V7, P259, DOI 10.1021/bm0506290
   Takasu Y, 2002, BIOSCI BIOTECH BIOCH, V66, P2715, DOI 10.1271/bbb.66.2715
   Talukdar S, 2011, BIOMATERIALS, V32, P8927, DOI 10.1016/j.biomaterials.2011.08.027
   Talukdar S, 2011, BIOMATERIALS, V32, P2149, DOI 10.1016/j.biomaterials.2010.11.052
   Tamada Y, 2004, J BIOMAT SCI-POLYM E, V15, P971, DOI 10.1163/1568562041526469
   Tanaka K, 1999, INSECT BIOCHEM MOLEC, V29, P269, DOI 10.1016/S0965-1748(98)00135-0
   Tao W, 2007, INT J BIOL MACROMOL, V40, P472, DOI 10.1016/j.ijbiomac.2006.11.006
   TOKUTAKE S, 1980, BIOCHEM J, V187, P413, DOI 10.1042/bj1870413
   TSUKADA M, 1994, J POLYM SCI POL PHYS, V32, P961, DOI 10.1002/polb.1994.090320519
   Tsukada M., 1996, POLYMERIC MAT ENCYLO, P7728
   Tuskes P.M., 1996, WILD SILK MOTHS N AM
   Vepari C, 2007, PROG POLYM SCI, V32, P991, DOI 10.1016/j.progpolymsci.2007.05.013
   Wang Y, 2008, BIOMATERIALS, V29, P3415, DOI 10.1016/j.biomaterials.2008.05.002
   Wen ZM, 1996, J INVEST ALLERG CLIN, V6, P237
   Wu Linlin, 2011, Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi, V25, P181
   YAMAGUCHI K, 1989, J MOL BIOL, V210, P127, DOI 10.1016/0022-2836(89)90295-7
   Zhang Q, 2009, MATERIALS, V2, P2276, DOI 10.3390/ma2042276
   Zhang YP, 2010, J BIOMED BIOTECHNOL, P1, DOI 10.1155/2010/683962
   Zhang YQ, 2006, J CHEM TECHNOL BIOT, V81, P136, DOI 10.1002/jctb.1370
   Zhang YQ, 2006, J CONTROL RELEASE, V115, P307, DOI 10.1016/j.jconrel.2006.08.019
   Zhao CX, 2011, INT J BIOL MACROMOL, V48, P249, DOI 10.1016/j.ijbiomac.2010.11.004
   Zhao HP, 2005, POLYMER, V46, P9192, DOI 10.1016/j.polymer.2005.07.004
   Zhaorigetu S, 2003, J PHOTOCH PHOTOBIO B, V71, P11, DOI 10.1016/S1011-1344(03)00092-7
   Zhou JA, 2010, POLYM DEGRAD STABIL, V95, P1679, DOI 10.1016/j.polymdegradstab.2010.05.025
NR 115
TC 88
Z9 89
U1 3
U2 89
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0006-3525
EI 1097-0282
J9 BIOPOLYMERS
JI Biopolymers
PD JUN
PY 2012
VL 97
IS 6
SI SI
BP 455
EP 467
DI 10.1002/bip.22024
PG 13
WC Biochemistry & Molecular Biology; Biophysics
SC Biochemistry & Molecular Biology; Biophysics
GA 911GW
UT WOS:000301706300015
PM 22241173
DA 2018-10-19
ER

PT J
AU Widhe, M
   Johansson, J
   Hedhammar, M
   Rising, A
AF Widhe, Mona
   Johansson, Jan
   Hedhammar, My
   Rising, Anna
TI Invited Review Current Progress and Limitations of Spider Silk for
   Biomedical Applications
SO BIOPOLYMERS
LA English
DT Review
DE spider silk; biocompatibility; cell culture
ID 3-DIMENSIONAL CELL-CULTURE; TERM SELF-RENEWAL; DRAGLINE SILK;
   MECHANICAL-PROPERTIES; IN-VIVO; WETTABILITY GRADIENT; RECOMBINANT
   PROTEINS; NEURITE EXTENSION; BACILLUS-SUBTILIS; ESCHERICHIA-COLI
AB Spider silk is a fascinating material combining remarkable mechanical properties with low density and biodegradability. Because of these properties and historical descriptions of medical applications, spider silk has been proposed to be the ideal biomaterial. However, overcoming the obstacles to produce spider silk in sufficient quantities and in a manner that meets regulatory demands has proven to be a difficult task. Also, there are relatively few studies of spider silk in biomedical applications available, and the methods and materials used vary a lot. Herein we summarize cell culture- and in vivo implantation studies of natural and synthetic spider silk, and also review the current status and future challenges in the quest for a large scale production of spider silk for medical applications. (C) 2011 Wiley Periodicals, Inc. Biopolymers 97: 468478, 2012.
C1 [Widhe, Mona; Johansson, Jan; Hedhammar, My; Rising, Anna] Swedish Univ Agr Sci, Dept Anat Physiol & Biochem, Uppsala, Sweden.
   [Widhe, Mona; Rising, Anna] Spiber Technol AB, S-75651 Uppsala, Sweden.
   [Johansson, Jan; Hedhammar, My; Rising, Anna] Karolinska Inst, Dept Neurobiol Care Sci & Soc, Stockholm, Sweden.
RP Hedhammar, M (reprint author), Swedish Univ Agr Sci, Dept Anat Physiol & Biochem, Uppsala, Sweden.
EM my.hedhammar@slu.se
OI Rising, Anna/0000-0002-1872-1207
FU Swedish Research Council; Formas; Vinnova
FX Contract grant sponsor: Swedish Research Council, Formas, and Vinnova
CR Agapov II, 2009, DOKL BIOCHEM BIOPHYS, V426, P127, DOI 10.1134/S1607672909030016
   Allmeling C, 2008, CELL PROLIFERAT, V41, P408, DOI 10.1111/j.1365-2184.2008.00534.x
   Allmeling C, 2006, J CELL MOL MED, V10, P770, DOI 10.2755/jcmm010.003.18
   Anderson JM, 2008, SEMIN IMMUNOL, V20, P86, DOI 10.1016/j.smim.2007.11.004
   Arcidiacono S, 2002, MACROMOLECULES, V35, P1262, DOI 10.1021/ma011471o
   Arcidiacono S, 1998, APPL MICROBIOL BIOT, V49, P31, DOI 10.1007/s002530051133
   Aydin HM, 2009, J TISSUE ENG REGEN M, V3, P470, DOI 10.1002/term.187
   Ayoub NA, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000514
   Bini E, 2006, BIOMACROMOLECULES, V7, P3139, DOI 10.1021/bm0607877
   Blackshaw SE, 1997, P ROY SOC B-BIOL SCI, V264, P657, DOI 10.1098/rspb.1997.0093
   Bryson CJ, 2010, BIODRUGS, V24, P1, DOI 10.2165/11318560-000000000-00000
   Carletti E, 2011, METHODS MOL BIOL, V695, P17, DOI 10.1007/978-1-60761-984-0_2
   Dickinson LE, 2011, MACROMOL BIOSCI, V11, P36, DOI 10.1002/mabi.201000245
   Doran PM, 2000, CURR OPIN BIOTECH, V11, P199, DOI 10.1016/S0958-1669(00)00086-0
   Dutta RC, 2009, BIOTECHNOL ADV, V27, P334, DOI 10.1016/j.biotechadv.2009.02.002
   Dvir-Ginzberg M, 2008, FASEB J, V22, P1440, DOI 10.1096/fj.07-9277com
   Engler AJ, 2006, CELL, V126, P677, DOI 10.1016/j.cell.2006.06.044
   Exler JH, 2007, ANGEW CHEM INT EDIT, V46, P3559, DOI 10.1002/anie.200604718
   Fahnestock SR, 1997, APPL MICROBIOL BIOT, V47, P23, DOI 10.1007/s002530050883
   Fahnestock SR, 1997, APPL MICROBIOL BIOT, V47, P33, DOI 10.1007/s002530050884
   FAHNESTOCK SR, 1987, APPL ENVIRON MICROB, V53, P379
   Fisher JP, 2004, J BIOMED MATER RES A, V71A, P268, DOI 10.1002/jbm.a.30148
   Foo CWP, 2006, P NATL ACAD SCI USA, V103, P9428, DOI 10.1073/pnas.0601096103
   Fredriksson C, 2009, MATERIALS, V2, P1908, DOI 10.3390/ma2041908
   Fukushima Y, 1998, BIOPOLYMERS, V45, P269, DOI 10.1002/(SICI)1097-0282(19980405)45:4<269::AID-BIP1>3.0.CO;2-J
   Gellynck K, 2008, J MATER SCI-MATER M, V19, P3399, DOI 10.1007/s10856-008-3474-6
   Gosline JM, 1999, J EXP BIOL, V202, P3295
   Grip S, 2009, PROTEIN SCI, V18, P1012, DOI 10.1002/pro.111
   Hagn F, 2010, NATURE, V465, P239, DOI 10.1038/nature08936
   HANSSON M, 1992, J BACTERIOL, V174, P4239
   Hedhammar M, 2010, BIOMACROMOLECULES, V11, P953, DOI 10.1021/bm9014039
   Hermanson KD, 2007, PHYS CHEM CHEM PHYS, V9, P6442, DOI 10.1039/b709808a
   Hezi-Yamit A, 2009, J BIOMED MATER RES A, V90A, P133, DOI 10.1002/jbm.a.32057
   Huang J, 2007, BIOMATERIALS, V28, P2358, DOI 10.1016/j.biomaterials.2006.11.021
   Huemmerich D, 2006, APPL PHYS A-MATER, V82, P219, DOI 10.1007/s00339-005-3428-5
   Janmey PA, 2007, ANNU REV BIOMED ENG, V9, P1, DOI 10.1146/annurev.bioeng.9.060906.151927
   Jenkins N, 1996, NAT BIOTECHNOL, V14, P975, DOI 10.1038/nbt0896-975
   Junghans F, 2006, APPL PHYS A-MATER, V82, P253, DOI 10.1007/s00339-005-3432-9
   Kluge JA, 2008, TRENDS BIOTECHNOL, V26, P244, DOI 10.1016/j.tibtech.2008.02.006
   Knight E, 2011, METHODS MOL BIOL, V695, P323, DOI 10.1007/978-1-60761-984-0_20
   Kong HJ, 2005, P NATL ACAD SCI USA, V102, P4300, DOI 10.1073/pnas.0405873102
   Kou PM, 2011, J BIOMED MATER RES A, V96A, P239, DOI 10.1002/jbm.a.32971
   Kuhbier JW, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012032
   Lammel A, 2008, CHEMSUSCHEM, V1, P413, DOI 10.1002/cssc.200800030
   Lazaris A, 2002, SCIENCE, V295, P472, DOI 10.1126/science.1065780
   Lee JH, 1998, J COLLOID INTERF SCI, V205, P323, DOI 10.1006/jcis.1998.5688
   Lee J, 2008, TISSUE ENG PT B-REV, V14, P61, DOI 10.1089/teb.2007.0150
   Liebmann B, 2008, COLLOID SURFACE A, V331, P126, DOI 10.1016/j.colsurfa.2008.04.005
   Lu BY, 2010, BURNS, V36, P891, DOI 10.1016/j.burns.2009.12.001
   Luna SM, 2011, J BIOMATER APPL, V26, P101, DOI 10.1177/0885328210362924
   Ma JKC, 2003, NAT REV GENET, V4, P794, DOI 10.1038/nrg1177
   Malmsten M, 2003, BIOPOLYMERS INTERFAC
   Maltman DJ, 2010, BIOCHEM SOC T, V38, P1072, DOI 10.1042/BST0381072
   Melkoumian Z, 2010, NAT BIOTECHNOL, V28, P606, DOI 10.1038/nbt.1629
   Metwalli E, 2007, APPL PHYS A-MATER, V89, P655, DOI 10.1007/s00339-007-4265-5
   Michal CA, 1996, BIOPHYS J, V70, P489, DOI 10.1016/S0006-3495(96)79594-2
   Mieszawska AJ, 2010, CHEM MATER, V22, P5780, DOI 10.1021/cm101940u
   Moisenovich MM, 2011, J BIOMED MATER RES A, V96A, P125, DOI 10.1002/jbm.a.32968
   Morais JM, 2010, AAPS J, V12, P188, DOI 10.1208/s12248-010-9175-3
   Morgan AW, 2008, BIOMATERIALS, V29, P2556, DOI 10.1016/j.biomaterials.2008.02.007
   Muller C, 2011, J MATER CHEM, V21, P2909, DOI 10.1039/c0jm03270k
   Nemir S, 2010, ANN BIOMED ENG, V38, P2, DOI 10.1007/s10439-009-9811-1
   Park Y, 2005, OSTEOARTHR CARTILAGE, V13, P527, DOI 10.1016/j.joca.2005.02.006
   Petroll WM, 2003, CELL MOTIL CYTOSKEL, V55, P254, DOI 10.1002/cm.10126
   PRINCE JT, 1995, BIOCHEMISTRY-US, V34, P10879, DOI 10.1021/bi00034a022
   Radtke C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016990
   Rammensee S, 2008, P NATL ACAD SCI USA, V105, P6590, DOI 10.1073/pnas.0709246105
   Ratner BD, 2004, BIOMATERIALS SCI INT
   Rising A, 2006, BIOMACROMOLECULES, V7, P3120, DOI 10.1021/bm060693x
   Rising A, 2011, CELL MOL LIFE SCI, V68, P169, DOI 10.1007/s00018-010-0462-z
   Rodin S, 2010, NAT BIOTECHNOL, V28, P611, DOI 10.1038/nbt.1620
   Ruardy TG, 1997, J COLLOID INTERF SCI, V188, P209, DOI 10.1006/jcis.1997.4769
   Sakiyama SE, 1999, FASEB J, V13, P2214
   Salerno A, 2009, J MATER SCI-MATER M, V20, P2043, DOI 10.1007/s10856-009-3767-4
   Sandkvist M, 1996, CURR OPIN BIOTECH, V7, P505, DOI 10.1016/S0958-1669(96)80053-X
   Scheller J, 2004, TRANSGENIC RES, V13, P51, DOI 10.1023/B:TRAG.0000017175.78809.7a
   Scheller J, 2001, NAT BIOTECHNOL, V19, P573, DOI 10.1038/89335
   Schmeichel KL, 2003, J CELL SCI, V116, P2377, DOI 10.1242/jcs.00503
   Slotta U, 2006, SUPRAMOL CHEM, V18, P465, DOI 10.1080/10610270600832042
   Slotta UK, 2008, ANGEW CHEM INT EDIT, V47, P4592, DOI 10.1002/anie.200800683
   Spiess K, 2010, MACROMOL BIOSCI, V10, P998, DOI 10.1002/mabi.201000071
   Stark M, 2007, BIOMACROMOLECULES, V8, P1695, DOI 10.1021/bm070049y
   Stephens JS, 2005, BIOMACROMOLECULES, V6, P1405, DOI 10.1021/bm049296h
   Szela S, 2000, BIOMACROMOLECULES, V1, P534, DOI 10.1021/bm0055697
   Teule F, 2009, NAT PROTOC, V4, P341, DOI 10.1038/nprot.2008.250
   Valluzzi R, 1999, J PHYS CHEM B, V103, P11382, DOI 10.1021/jp991363s
   Vehoff T, 2007, BIOPHYS J, V93, P4425, DOI 10.1529/biophysj.106.099309
   Vendrely C, 2007, MACROMOL BIOSCI, V7, P401, DOI 10.1002/mabi.200600255
   Vert M, 2011, INT J ARTIF ORGANS, V34, P76, DOI 10.5301/IJAO.2011.6400
   VLODAVSKY I, 1981, NATURE, V289, P304, DOI 10.1038/289304a0
   Vollrath F, 2002, IN VIVO, V16, P229
   Walsh G., 2002, PROTEINS BIOTECHNOLO
   Wang SD, 2009, BIOMACROMOLECULES, V10, P2240, DOI 10.1021/bm900416b
   Werten MWT, 2008, BIOMACROMOLECULES, V9, P1705, DOI 10.1021/bm701111z
   Widhe M, 2010, BIOMATERIALS, V31, P9575, DOI 10.1016/j.biomaterials.2010.08.061
   Williams David, 2003, Med Device Technol, V14, P9
   Winkler S, 2000, BIOCHEMISTRY-US, V39, P14002, DOI 10.1021/bi005119z
   Winkler S, 1999, INT J BIOL MACROMOL, V24, P265, DOI 10.1016/S0141-8130(98)00088-9
   WONG SL, 1995, CURR OPIN BIOTECH, V6, P517, DOI 10.1016/0958-1669(95)80085-9
   Xiang P, 2011, INT J BIOL MACROMOL, V49, P281, DOI 10.1016/j.ijbiomac.2011.05.004
   Xu HT, 2007, ANIM BIOTECHNOL, V18, P1, DOI 10.1080/10495390601091024
   Xu LC, 2007, BIOMATERIALS, V28, P3273, DOI 10.1016/j.biomaterials.2007.03.032
   YAMADA KM, 1978, NATURE, V275, P179, DOI 10.1038/275179a0
   Yang LA, 2010, BIOMED MATER, V5, DOI 10.1088/1748-6041/5/4/045002
   Yu XJ, 1999, TISSUE ENG, V5, P291, DOI 10.1089/ten.1999.5.291
   Yuan Y, 2011, INT J LAB HEMATOL, V33, P516, DOI 10.1111/j.1751-553X.2011.01324.x
NR 106
TC 36
Z9 44
U1 3
U2 101
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0006-3525
EI 1097-0282
J9 BIOPOLYMERS
JI Biopolymers
PD JUN
PY 2012
VL 97
IS 6
SI SI
BP 468
EP 478
DI 10.1002/bip.21715
PG 11
WC Biochemistry & Molecular Biology; Biophysics
SC Biochemistry & Molecular Biology; Biophysics
GA 911GW
UT WOS:000301706300016
PM 21898363
DA 2018-10-19
ER

PT J
AU Pritchard, EM
   Dennis, PB
   Omenetto, F
   Naik, RR
   Kaplan, DL
AF Pritchard, Eleanor M.
   Dennis, Patrick B.
   Omenetto, Fiorenzo
   Naik, Rajesh R.
   Kaplan, David L.
TI Physical and chemical aspects of stabilization of compounds in silk
SO BIOPOLYMERS
LA English
DT Review
DE silk fibroin; immobilization; stabilization; drug delivery; tissue
   engineering
ID FIBROBLAST-GROWTH-FACTOR; BONE MORPHOGENETIC PROTEIN-2; CONTROLLED
   DRUG-DELIVERY; CONTROLLED-RELEASE; FIBROIN MEMBRANE; IN-VIVO;
   GLUCOSE-OXIDASE; ENZYME IMMOBILIZATION; ADENOSINE RELEASE; SCAFFOLDS
AB The challenge of stabilization of small molecules and proteins has received considerable interest. The biological activity of small molecules can be lost as a consequence of chemical modifications, while protein activity may be lost due to chemical or structural degradation, such as a change in macromolecular conformation or aggregation. In these cases, stabilization is required to preserve therapeutic and bioactivity efficacy and safety. In addition to use in therapeutic applications, strategies to stabilize small molecules and proteins also have applications in industrial processes, diagnostics, and consumer products like food and cosmetics. Traditionally, therapeutic drug formulation efforts have focused on maintaining stability during product preparation and storage. However, with growing interest in the fields of encapsulation, tissue engineering, and controlled release drug delivery systems, new stabilization challenges are being addressed; the compounds or protein of interest must be stabilized during: (1) fabrication of the protein or small molecule-loaded carrier, (2) device storage, and (3) for the duration of intended release needs in vitro or in vivo. We review common mechanisms of compound degradation for small molecules and proteins during biomaterial preparation (including tissue engineering scaffolds and drug delivery systems), storage, and in vivo implantation. We also review the physical and chemical aspects of polymer-based stabilization approaches, with a particular focus on the stabilizing properties of silk fibroin biomaterials. (C) 2011 Wiley Periodicals, Inc. Biopolymers 97: 479498, 2012.
C1 [Pritchard, Eleanor M.; Omenetto, Fiorenzo; Kaplan, David L.] Tufts Univ, Dept Biomed Engn, Medford, MA 02155 USA.
   [Dennis, Patrick B.; Naik, Rajesh R.] Mat & Mfg Directorate, Wright Patterson AFB, OH 45433 USA.
RP Kaplan, DL (reprint author), Tufts Univ, Dept Biomed Engn, Medford, MA 02155 USA.
EM david.kaplan@tufts.edu
FU NSF; NIH; AFOSR
FX Contract grant sponsors The NSF, The NIH and The AFOSR
CR Acharya Chitrangada, 2008, Biotechnol J, V3, P226, DOI 10.1002/biot.200700120
   Altman GH, 2003, BIOMATERIALS, V24, P401, DOI 10.1016/S0142-9612(02)00353-8
   Baycin D, 2007, J AGR FOOD CHEM, V55, P1227, DOI 10.1021/jf062829o
   Benoit DSW, 2005, ACTA BIOMATER, V1, P461, DOI 10.1016/j.actbio.2005.03.002
   Bessa PC, 2010, TISSUE ENG PART C-ME, V16, P937, DOI [10.1089/ten.tec.2009.0486, 10.1089/ten.TEC.2009.0486]
   Bilati U, 2005, EUR J PHARM BIOPHARM, V59, P375, DOI 10.1016/j.ejpb.2004.10.006
   Biondi M, 2008, ADV DRUG DELIVER REV, V60, P229, DOI 10.1016/j.addr.2007.08.038
   Brisaert M, 1996, PHARM WORLD SCI, V18, P182, DOI 10.1007/BF00820730
   Chatterjee S, 2009, APPL BIOCHEM BIOTECH, V157, P593, DOI 10.1007/s12010-008-8405-y
   Chen B., BIOMASS BIO IN PRESS
   Chen B, 2007, BIOMATERIALS, V28, P1027, DOI 10.1016/j.biomaterials.2006.10.013
   Chen FM, 2010, BIOMATERIALS, V31, P6279, DOI 10.1016/j.biomaterials.2010.04.053
   Choi HM, 2004, TEXT RES J, V74, P333, DOI 10.1177/004051750407400409
   CORDIER D, 1982, ENZYME MICROB TECH, V4, P249, DOI 10.1016/0141-0229(82)90040-0
   DEMURA M, 1989, BIOSENSORS, V4, P361, DOI 10.1016/0265-928X(89)80002-1
   DEMURA M, 1989, BIOTECHNOL BIOENG, V33, P598, DOI 10.1002/bit.260330513
   DEMURA M, 1991, J MEMBRANE SCI, V59, P39, DOI 10.1016/S0376-7388(00)81220-X
   DEMURA M, 1989, J BIOTECHNOL, V10, P113, DOI 10.1016/0168-1656(89)90033-3
   Dennis P.B., UNPUB
   Diab T., J MECH BEHA IN PRESS
   Fu K, 2000, NAT BIOTECHNOL, V18, P24, DOI 10.1038/71875
   GRASSET L, 1983, BIOTECHNOL BIOENG, V25, P1423, DOI 10.1002/bit.260250520
   Gupta V, 2009, INT J NANOMED, V4, P115
   Guziewicz N, 2011, BIOMATERIALS, V32, P2642, DOI 10.1016/j.biomaterials.2010.12.023
   Hofmann S, 2006, J CONTROL RELEASE, V111, P219, DOI 10.1016/j.jconrel.205.12.009
   Horan RL, 2005, BIOMATERIALS, V26, P3385, DOI 10.1016/j.biomaterials.2004.09.020
   INOUE S, 1986, BIOCHEM BIOPH RES CO, V141, P165, DOI 10.1016/S0006-291X(86)80349-7
   ISHII A, 1995, DYES PIGMENTS, V27, P211, DOI 10.1016/0143-7208(94)00053-5
   Kaltenbach M, 2011, AM J HEALTH-SYST PH, V68, P1533, DOI 10.2146/ajhp100573
   Karageorgiou V, 2004, J BIOMED MATER RES A, V71A, P528, DOI 10.1002/jbm.a.30186
   Karageorgiou V, 2006, J BIOMED MATER RES A, V78A, P324, DOI 10.1002/jbm.a.30728
   Kikuchi J, 1999, BIOMATERIALS, V20, P647, DOI 10.1016/S0142-9612(98)00220-8
   Kim D.H., 2009, APPL PHYS LETT, V95
   Kim DH, 2010, NAT MATER, V9, P511, DOI [10.1038/nmat2745, 10.1038/NMAT2745]
   Kirker-Head C, 2007, BONE, V41, P247, DOI 10.1016/j.bone.2007.04.186
   KLIBANOV AM, 1979, ANAL BIOCHEM, V93, P1
   KUZUHARA A, 1987, J BIOTECHNOL, V5, P199, DOI 10.1016/0168-1656(87)90016-2
   LANGER R, 1980, CHEM ENG COMMUN, V6, P1, DOI 10.1080/00986448008912519
   Lawrence BD, 2008, BIOMACROMOLECULES, V9, P1214, DOI 10.1021/bm701235f
   Leal-Egana A, 2010, BIOTECHNOL APPL BIOC, V55, P155, DOI 10.1042/BA20090229
   Li CM, 2006, BIOMATERIALS, V27, P3115, DOI 10.1016/j.biomaterials.2006.01.022
   Liu YC, 1996, J BIOTECHNOL, V46, P131, DOI 10.1016/0168-1656(95)00182-4
   Lu Q, 2011, ACTA BIOMATER, V7, P2782, DOI 10.1016/j.actbio.2011.03.001
   Lu Q, 2010, MACROMOL BIOSCI, V10, P359, DOI 10.1002/mabi.200900388
   Lu S.Z., 2009, FRONT MAT SCI CHINA, V3, P367
   Madduri S, 2010, BIOMATERIALS, V31, P2323, DOI 10.1016/j.biomaterials.2009.11.073
   Mateo C, 2007, ENZYME MICROB TECH, V40, P1451, DOI 10.1016/j.enzmictec.2007.01.018
   Mehta SK, 2011, COLLOID SURFACE A, V375, P219, DOI 10.1016/j.colsurfa.2010.12.014
   Meinel L, 2005, BIOMATERIALS, V26, P147, DOI 10.1016/j.biomaterials.2004.02.047
   MIYAIRI S, 1978, AGR BIOL CHEM TOKYO, V42, P1661, DOI 10.1080/00021369.1978.10863228
   Murphy AR, 2009, J MATER CHEM, V19, P6443, DOI 10.1039/b905802h
   Numata K, 2010, ADV DRUG DELIVER REV, V62, P1497, DOI 10.1016/j.addr.2010.03.009
   Omenetto FG, 2008, NAT PHOTONICS, V2, P641, DOI 10.1038/nphoton.2008.207
   Omenetto FG, 2010, SCIENCE, V329, P528, DOI 10.1126/science.1188936
   Panilaitis B, 2003, BIOMATERIALS, V24, P3079, DOI 10.1016/S0142-9612(03)00158-3
   Pritchard E.M., UNPUB
   Pritchard EM, 2011, EXPERT OPIN DRUG DEL, V8, P797, DOI 10.1517/17425247.2011.568936
   Putthanarat S, 2004, POLYMER, V45, P8451, DOI 10.1016/j.polymer.2004.10.014
   Qian JH, 1997, BIOSENS BIOELECTRON, V12, P1213, DOI 10.1016/S0956-5663(97)00056-0
   Qian JH, 1996, ANAL BIOCHEM, V236, P208, DOI 10.1006/abio.1996.0158
   SAKSELA O, 1988, J CELL BIOL, V107, P743, DOI 10.1083/jcb.107.2.743
   Saxena U, 2010, APPL BIOCHEM BIOTECH, V162, P1122, DOI 10.1007/s12010-010-8923-2
   Singh BK, 2006, FEMS MICROBIOL REV, V30, P428, DOI 10.1111/j.1574-6976.2006.00018.x
   Sofia S, 2001, J BIOMED MATER RES, V54, P139, DOI 10.1002/1097-4636(200101)54:1<139::AID-JBM17>3.0.CO;2-7
   Szybala C, 2009, EXP NEUROL, V219, P126, DOI 10.1016/j.expneurol.2009.05.018
   Tao H., UNPUB
   Tsioris K, 2012, ADV FUNCT MATER, V22, P330, DOI 10.1002/adfm.201102012
   Tsioris K, 2010, ADV FUNCT MATER, V20, P1083, DOI 10.1002/adfm.200902050
   Turos E, 2007, BIOORG MED CHEM LETT, V17, P3468, DOI 10.1016/j.bmcl.2007.03.077
   Uebersax L, 2008, J CONTROL RELEASE, V127, P12, DOI 10.1016/j.jconrel.2007.11.006
   Uebersax L, 2007, BIOMATERIALS, V28, P4449, DOI 10.1016/j.biomaterials.2007.06.034
   Varde NK, 2007, J CONTROL RELEASE, V124, P172, DOI 10.1016/j.jconrel.2007.09.005
   Vepari C, 2007, PROG POLYM SCI, V32, P991, DOI 10.1016/j.progpolymsci.2007.05.013
   Vepari CP, 2006, BIOTECHNOL BIOENG, V93, P1130, DOI 10.1002/bit.20833
   VLODAVSKY I, 1991, J CELL BIOCHEM, V45, P167, DOI 10.1002/jcb.240450208
   Wang XQ, 2008, BIOMATERIALS, V29, P1054, DOI 10.1016/j.biomaterials.2007.11.003
   Wang XQ, 2007, J CONTROL RELEASE, V117, P360, DOI 10.1016/j.jconrel.2006.11.021
   Wang XQ, 2011, MACROMOL BIOSCI, V11, P100, DOI 10.1002/mabi.201000173
   Wang XQ, 2009, J CONTROL RELEASE, V134, P81, DOI 10.1016/j.jconrel.2008.10.021
   Wang Y, 2008, BIOMATERIALS, V29, P3415, DOI 10.1016/j.biomaterials.2008.05.002
   Wang YZ, 2006, BIOMATERIALS, V27, P6064, DOI 10.1016/j.biomaterials.2006.07.008
   Wenk E, 2008, J CONTROL RELEASE, V132, P26, DOI 10.1016/j.jconrel.2008.08.005
   Wenk E, 2011, J CONTROL RELEASE, V150, P128, DOI 10.1016/j.jconrel.2010.11.007
   Wenk E, 2010, BIOMATERIALS, V31, P1403, DOI 10.1016/j.biomaterials.2009.11.006
   Whitelock JM, 1996, J BIOL CHEM, V271, P10079, DOI 10.1074/jbc.271.17.10079
   Wilz A, 2008, BIOMATERIALS, V29, P3609, DOI 10.1016/j.biomaterials.2008.05.010
   Wongpanit P, 2010, J BIOMAT SCI-POLYM E, V21, P1403, DOI 10.1163/092050609X12517858243706
   Wu YH, 2006, ANAL CHIM ACTA, V558, P179, DOI 10.1016/j.aca.2005.11.031
   YOSHIMIZU H, 1990, J APPL POLYM SCI, V40, P127, DOI 10.1002/app.1990.070400111
   Zhang WJ, 2011, BIOMATERIALS, V32, P9415, DOI 10.1016/j.biomaterials.2011.08.047
   Zhang YQ, 1998, ANAL CHIM ACTA, V369, P123, DOI 10.1016/S0003-2670(98)00236-0
   Zhang YQ, 2005, J BIOTECHNOL, V120, P315, DOI 10.1016/j.jbiotec.2005.06.027
   Zhang YQ, 1998, APPL BIOCHEM BIOTECH, V75, P215, DOI 10.1007/BF02787776
   Zhang YQ, 1998, BIOTECHNOL ADV, V16, P961, DOI 10.1016/S0734-9750(98)00012-3
   Zhang YQ, 2006, J BIOMED MATER RES B, V79B, P275, DOI 10.1002/jbm.b.30539
   Zhu GZ, 2000, NAT BIOTECHNOL, V18, P52
NR 96
TC 77
Z9 79
U1 5
U2 135
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0006-3525
EI 1097-0282
J9 BIOPOLYMERS
JI Biopolymers
PD JUN
PY 2012
VL 97
IS 6
SI SI
BP 479
EP 498
DI 10.1002/bip.22026
PG 20
WC Biochemistry & Molecular Biology; Biophysics
SC Biochemistry & Molecular Biology; Biophysics
GA 911GW
UT WOS:000301706300017
PM 22270942
OA Green Accepted
DA 2018-10-19
ER

PT J
AU Loganathan, R
   Potetz, BR
   Rongish, BJ
   Little, CD
AF Loganathan, Rajprasad
   Potetz, Brian R.
   Rongish, Brenda J.
   Little, Charles D.
TI Spatial Anisotropies and Temporal Fluctuations in Extracellular Matrix
   Network Texture during Early Embryogenesis
SO PLOS ONE
LA English
DT Article
ID CELL-SHAPE CHANGES; MOVEMENT; EMBRYO; TISSUE; MORPHOGENESIS;
   FIBRONECTIN; GASTRULATION; ORGANIZATION; INFLAMMATION; SUBSTRATE
AB Early stages of vertebrate embryogenesis are characterized by a remarkable series of shape changes. The resulting morphological complexity is driven by molecular, cellular, and tissue-scale biophysical alterations. Operating at the cellular level, extracellular matrix (ECM) networks facilitate cell motility. At the tissue level, ECM networks provide material properties required to accommodate the large-scale deformations and forces that shape amniote embryos. In other words, the primordial biomaterial from which reptilian, avian, and mammalian embryos are molded is a dynamic composite comprised of cells and ECM. Despite its central importance during early morphogenesis we know little about the intrinsic micrometer-scale surface properties of primordial ECM networks. Here we computed, using avian embryos, five textural properties of fluorescently tagged ECM networks - (a) inertia, (b) correlation, (c) uniformity, (d) homogeneity, and (e) entropy. We analyzed fibronectin and fibrillin-2 as examples of fibrous ECM constituents. Our quantitative data demonstrated differences in the surface texture between the fibronectin and fibrillin-2 network in Day 1 (gastrulating) embryos, with the fibronectin network being relatively coarse compared to the fibrillin-2 network. Stage-specific regional anisotropy in fibronectin texture was also discovered. Relatively smooth fibronectin texture was exhibited in medial regions adjoining the primitive streak (PS) compared with the fibronectin network investing the lateral plate mesoderm (LPM), at embryonic stage 5. However, the texture differences had changed by embryonic stage 6, with the LPM fibronectin network exhibiting a relatively smooth texture compared with the medial PS-oriented network. Our data identify, and partially characterize, stage-specific regional anisotropy of fibronectin texture within tissues of a warm-blooded embryo. The data suggest that changes in ECM textural properties reflect orderly time-dependent rearrangements of a primordial biomaterial. We conclude that the ECM microenvironment changes markedly in time and space during the most important period of amniote morphogenesis-as determined by fluctuating textural properties.
C1 [Loganathan, Rajprasad; Rongish, Brenda J.; Little, Charles D.] Univ Kansas, Med Ctr, Dept Anat & Cell Biol, Kansas City, KS 66103 USA.
   [Loganathan, Rajprasad; Potetz, Brian R.] Univ Kansas, Dept Elect Engn & Comp Sci, Lawrence, KS 66045 USA.
RP Loganathan, R (reprint author), Johns Hopkins Univ, Sch Med, Dept Cell Biol, Baltimore, MD 21218 USA.
EM rlogana2@jhmi.edu
RI Rongish, Brenda/G-7637-2016
OI Rongish, Brenda/0000-0002-1559-2876
FU National Institutes of Health [HL068855, HL085694, GM76692]; G Harold &
   Leila Y Mathers Charitable Foundation
FX This work was supported by the National Institutes of Health RO1 grants
   HL068855 (CDL), HL085694 (BJR), GM76692 (CDL, PI is James A. Glazier,
   Indiana University); and the G Harold & Leila Y Mathers Charitable
   Foundation (CDL and BJR). The funders had no role in study design, data
   collection and analysis, decision to publish, or preparation of the
   manuscript.
CR Adair-Kirk TL, 2008, INT J BIOCHEM CELL B, V40, P1101, DOI 10.1016/j.biocel.2007.12.005
   Alberts B, 2002, MOL BIOL CELL
   Arroyo AG, 2010, CARDIOVASC RES, V86, P226, DOI 10.1093/cvr/cvq049
   Bae E, 2004, J BIOL CHEM, V279, P35749, DOI 10.1074/jbc.M406283200
   Bokel C, 2002, DEV CELL, V3, P311, DOI 10.1016/S1534-5807(02)00265-4
   Butusov OB, 2006, THEOR FOUND CHEM EN+, V40, P291, DOI 10.1134/S0040579506030109
   CARTER SB, 1965, NATURE, V208, P1183, DOI 10.1038/2081183a0
   CARTER SB, 1967, NATURE, V213, P256, DOI 10.1038/213256a0
   Chapman SC, 2001, DEV DYNAM, V220, P284, DOI 10.1002/1097-0177(20010301)220:3<284::AID-DVDY1102>3.3.CO;2-X
   Czirok A, 2006, J CELL PHYSIOL, V207, P97, DOI 10.1002/jcp.20573
   Davidson L, 2009, INT J BIOCHEM CELL B, V41, P2147, DOI 10.1016/j.biocel.2009.04.015
   Davidson LA, 2011, CURR TOP DEV BIOL, V95, P215, DOI 10.1016/B978-0-12-385065-2.00007-4
   Dobaczewski M, 2010, J MOL CELL CARDIOL, V48, P504, DOI 10.1016/j.yjmcc.2009.07.015
   Fleury Vincent, 2007, Organogenesis, V3, P49
   GALLAGHER BC, 1993, DEV DYNAM, V196, P70, DOI 10.1002/aja.1001960109
   GEORGE EL, 1993, DEVELOPMENT, V119, P1079
   Gjorevski N, 2009, CYTOKINE GROWTH F R, V20, P459, DOI 10.1016/j.cytogfr.2009.10.013
   Gonzalez RC, 2002, DIGITAL IMAGE PROCES, P643
   HAMBURGER V, 1992, DEV DYNAM, V195, P231, DOI 10.1002/dvdy.1001950404
   HARALICK RM, 1979, P IEEE, V67, P786, DOI 10.1109/PROC.1979.11328
   HARALICK RM, 1973, IEEE T SYST MAN CYB, VSMC3, P610, DOI 10.1109/TSMC.1973.4309314
   Hohenester E, 2002, MATRIX BIOL, V21, P115, DOI 10.1016/S0945-053X(01)00191-3
   Koppen M, 2006, DEVELOPMENT, V133, P2671, DOI 10.1242/dev.02439
   Krafts KP, 2010, ORGANOGENESIS, V6, P225, DOI 10.4161/org.6.4.12555
   Kurpios NA, 2008, P NATL ACAD SCI USA, V105, P8499, DOI 10.1073/pnas.0803578105
   Little CD, 2000, METH MOL B, V135, P183
   Lo CM, 2000, BIOPHYS J, V79, P144, DOI 10.1016/S0006-3495(00)76279-5
   MOILLIET JL, 1967, NATURE, V213, P260, DOI 10.1038/213260a0
   NEW DAT, 1955, J EMBRYOL EXP MORPH, V3, P320
   Paluch E, 2009, CURR BIOL, V19, pR790, DOI 10.1016/j.cub.2009.07.029
   Pilot F, 2005, DEV DYNAM, V232, P685, DOI 10.1002/dvdy.20334
   POOLE TJ, 1982, DEV BIOL, V92, P144, DOI 10.1016/0012-1606(82)90159-2
   Ramos JW, 1996, DEVELOPMENT, V122, P2873
   Rongish BJ, 1998, DEV DYNAM, V212, P461
   Rosenfield A, 1970, VISUAL TEXTURE ANAL, P70
   Rozario T, 2010, DEV BIOL, V341, P126, DOI 10.1016/j.ydbio.2009.10.026
   Rozario T, 2009, DEV BIOL, V327, P386, DOI 10.1016/j.ydbio.2008.12.025
   Skoglund P, 2007, DEV BIOL, V301, P404, DOI 10.1016/j.ydbio.2006.09.005
   Stern CD, 2004, GASTRULATION CELLS E, P219
   Szabo A, 2011, PHYS BIOL, V8, DOI 10.1088/1478-3975/8/4/045006
   Thiery JP, 1989, BIOL EXTRACELLULAR M, P181
   Tomita F, 1990, COMPUTER ANAL VISUAL
   Tsuda T, 1996, DEV BIOL, V173, P39, DOI 10.1006/dbio.1996.0005
   Tuceryan M, HDB PATTERN RECOGNIT, P207
   Vakonakis L, 2007, CURR OPIN CELL BIOL, V19, P578, DOI 10.1016/j.ceb.2007.09.005
   WUNSCH AM, 1994, DEV BIOL, V165, P585, DOI 10.1006/dbio.1994.1278
   Zamir EA, 2006, P NATL ACAD SCI USA, V103, P19806, DOI 10.1073/pnas.0606100103
   Zamir EA, 2008, PLOS BIOL, V6, P2163, DOI 10.1371/journal.pbio.0060247
NR 48
TC 5
Z9 5
U1 0
U2 6
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD MAY 31
PY 2012
VL 7
IS 5
AR e38266
DI 10.1371/journal.pone.0038266
PG 14
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA 959TY
UT WOS:000305338500120
PM 22693609
OA DOAJ Gold, Green Published
DA 2018-10-19
ER

PT J
AU Kirubaharan, CJ
   Kalpana, D
   Lee, YS
   Kim, AR
   Yoo, DJ
   Nahm, KS
   Kumar, GG
AF Kirubaharan, C. Joseph
   Kalpana, D.
   Lee, Yang Soo
   Kim, A. R.
   Yoo, Don Jin
   Nahm, Kee Suk
   Kumar, G. Gnana
TI Biomediated Silver Nanoparticles for the Highly Selective Copper(II) Ion
   Sensor Applications
SO INDUSTRIAL & ENGINEERING CHEMISTRY RESEARCH
LA English
DT Article
ID METAL-IONS; WATER
AB Nanoparticles synthesis is an evergreen research field of 21st century in which the connotation of the biomediated experimental process is highly imperative. Biomediated silver nanoparticles were synthesized with the aid of an eco-friendly biomaterial, namely, aqueous Azadirachta indica extract. The effect of pH and temperature on the formation of silver nanoparticles was analyzed. Formation of the silver nanoparticles was verified by surface plasmon spectra using a UV-vis spectrophotometer. Morphology and crystalline structure of the prepared silver nanoparticles were characterized by TEM and XRD techniques, respectively. Furthermore, the biomediated silver nanoparticles without any surface modification were used for the heavy metal ion sensors in aqueous media. The prepared silver nanoparticles were successful in detecting even the minimal amount of heavy metal copper(II) ion and exhibited excellent specific metal ion selectivity.
C1 [Kim, A. R.; Yoo, Don Jin; Nahm, Kee Suk] Chonbuk Natl Univ, Dept Hydrogen & Fuel Cells Engn, Specialized Grad Sch, Jeonju 561756, South Korea.
   [Kirubaharan, C. Joseph; Kumar, G. Gnana] Madurai Kamaraj Univ, Dept Phys Chem, Madurai 625021, Tamil Nadu, India.
   [Kalpana, D.; Lee, Yang Soo] Chonbuk Natl Univ, Dept Forest Sci & Technol, Inst Agr Sci & Technol, Jeonju 561756, South Korea.
RP Nahm, KS (reprint author), Chonbuk Natl Univ, Dept Hydrogen & Fuel Cells Engn, Specialized Grad Sch, Jeonju 561756, South Korea.
EM nahmks@chonbuk.ac.kr; kumarg2006@gmail.com
RI yoo, dongjin/D-8037-2017
FU Department of Science and Technology-SERC, New Delhi
   [SR/FT/CS-113/2010(G)]; Human Resources Development of the Korea
   Institute of Energy Technology Evaluation and Planning (KETEP); Korea
   Government Ministry of Knowledge Economy [20114030200060]
FX C.J.K. and G.G.K. were supported by Department of Science and
   Technology-SERC, New Delhi, Fast Track Project for Young Scientist Grant
   No. SR/FT/CS-113/2010(G). K.S.N. was supported by the Human Resources
   Development of the Korea Institute of Energy Technology Evaluation and
   Planning (KETEP) grant funded by the Korea Government Ministry of
   Knowledge Economy (No. 20114030200060).
CR Arthur Nozik J., 2010, NANO LETT, V10, P2735
   Dahl AJ, 2007, CHEM REV, V107, P2228
   Durgadas CV, 2011, ANALYST, V136, P933, DOI 10.1039/c0an00424c
   Forzani ES, 2005, ENVIRON SCI TECHNOL, V39, P1257, DOI 10.1021/es049234z
   Hajizadeh S, 2011, ANAL METHODS-UK, V3, P2599, DOI 10.1039/c1ay05567d
   He HR, 2003, J AM CHEM SOC, V125, P1468, DOI 10.1021/ja0284761
   Kohler JM, 2001, SENSOR ACTUAT B-CHEM, V76, P166, DOI 10.1016/S0925-4005(01)00619-0
   Kozlowski H, 2006, METALLOCHEMISTRY OF NEURODEGENERATION: BIOLOGICAL, CHEMICAL AND GENETIC ASPECTS, pV, DOI 10.1039/9781847555311-FP005
   Kumar GG, 2011, J MATER CHEM, V21, P17382, DOI 10.1039/c1jm11528f
   Lu Y, 2003, BIOSENS BIOELECTRON, V18, P529, DOI 10.1016/S0956-5663(03)00013-7
   Mahendra N, 2002, SENSOR ACTUAT B-CHEM, V81, P196, DOI 10.1016/S0925-4005(01)00952-2
   Malcik N, 2000, QUIM ANAL, V19, P94
   Mayr T, 2002, ANALYST, V127, P248, DOI 10.1039/b106298k
   OEHME I, 1994, FRESEN J ANAL CHEM, V350, P563, DOI 10.1007/BF00321805
   Preininger C, 1996, BIOSENS BIOELECTRON, V11, P981, DOI 10.1016/0956-5663(96)87657-3
   Qi LF, 2006, BIOORG MED CHEM LETT, V16, P4243, DOI 10.1016/j.bmcl.2006.05.078
   Shankar SS, 2004, J COLLOID INTERF SCI, V275, P496, DOI 10.1016/j.jcis.2004.03.003
   Shirai Y, 2006, CHEM SOC REV, V35, P1043, DOI 10.1039/b514700j
   Silva AMB, 2007, J PHYS CHEM SOLIDS, V68, P729, DOI 10.1016/j.jpcs.2007.03.052
   Tripathy A, 2010, J NANOPART RES, V12, P237, DOI 10.1007/s11051-009-9602-5
   Wen XG, 2006, LANGMUIR, V22, P4836, DOI 10.1021/la060267x
   Xu H, 2011, ACS APPL MATER INTER, V3, P22, DOI 10.1021/am100781n
   Yang X, 2010, J NANOPART RES, V12, P1589, DOI 10.1007/s11051-009-9675-1
   Yogev D., 1990, J PHYS CHEM-US, V94, P753
NR 24
TC 57
Z9 58
U1 1
U2 19
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 0888-5885
J9 IND ENG CHEM RES
JI Ind. Eng. Chem. Res.
PD MAY 30
PY 2012
VL 51
IS 21
BP 7441
EP 7446
DI 10.1021/ie3003232
PG 6
WC Engineering, Chemical
SC Engineering
GA 949JV
UT WOS:000304573400033
DA 2018-10-19
ER

PT J
AU Schricker, SR
   Palacio, MLB
   Bhushan, B
AF Schricker, Scott R.
   Palacio, Manuel L. B.
   Bhushan, Bharat
TI Designing nanostructured block copolymer surfaces to control protein
   adhesion
SO PHILOSOPHICAL TRANSACTIONS OF THE ROYAL SOCIETY A-MATHEMATICAL PHYSICAL
   AND ENGINEERING SCIENCES
LA English
DT Review
DE block copolymers; adhesion; protein conformation; atomic force
   microscopy
ID SELF-ASSEMBLED MONOLAYERS; HUMAN BLOOD-PLASMA; FRAGMENTATION CHAIN
   TRANSFER; ELECTRON-BEAM LITHOGRAPHY; ATOMIC-FORCE MICROSCOPE;
   SILICON-BASED SURFACES; CONTROL CELL-ADHESION; CLICK CHEMISTRY; RADICAL
   POLYMERIZATION; DRUG-DELIVERY
AB The profile and conformation of proteins that are adsorbed onto a polymeric biomaterial surface have a profound effect on its in vivo performance. Cells and tissue recognize the protein layer rather than directly interact with the surface. The chemistry and morphology of a polymer surface will govern the protein behaviour. So, by controlling the polymer surface, the biocompatibility can be regulated. Nanoscale surface features are known to affect the protein behaviour, and in this overview the nanostructure of self-assembled block copolymers will be harnessed to control protein behaviour. The nanostructure of a block copolymer can be controlled by manipulating the chemistry and arrangement of the blocks. Random, A-B and A-B-A block copolymers composed of methyl methacrylate copolymerized with either acrylic acid or 2-hydroxyethyl methacrylate will be explored. Using atomic force microscopy (AFM), the surface morphology of these block copolymers will be characterized. Further, AFM tips functionalized with proteins will measure the adhesion of that particular protein to polymer surfaces. In this manner, the influence of block copolymer morphology on protein adhesion can be measured. AFM tips functionalized with antibodies to fibronectin will determine how the surfaces will affect the conformation of fibronectin, an important parameter in evaluating surface biocompatibility.
C1 [Schricker, Scott R.] Ohio State Univ, Coll Dent, Restorat & Prosthet Dent Sect, Columbus, OH 43210 USA.
   [Palacio, Manuel L. B.; Bhushan, Bharat] Ohio State Univ, Nanoprobe Lab Bio & Nanotechnol & Biomimet, Columbus, OH 43210 USA.
RP Schricker, SR (reprint author), Ohio State Univ, Coll Dent, Restorat & Prosthet Dent Sect, Columbus, OH 43210 USA.
EM schricker.1@osu.edu
RI Bhushan, Bharat/A-9684-2013; Schricker, Scott/A-3957-2008
OI Bhushan, Bharat/0000-0001-7161-6601; Schricker,
   Scott/0000-0003-1982-1282
FU NCRR NIH HHS [UL1 RR025755]
CR Adams ML, 2003, J PHARM SCI, V92, P1343, DOI 10.1002/jps.10397
   Allison DP, 2002, CURR OPIN BIOTECH, V13, P47, DOI 10.1016/S0958-1669(02)00283-5
   Awsiuk K, 2010, COLLOID SURFACE B, V80, P63, DOI 10.1016/j.colsurfb.2010.05.033
   Aydin D, 2010, LANGMUIR, V26, P15472, DOI 10.1021/la103065x
   Barner-Kowollik C, 2003, J POLYM SCI POL CHEM, V41, P365, DOI 10.1002/pola.10567
   Barrias CC, 2009, BIOMATERIALS, V30, P307, DOI 10.1016/j.biomaterials.2008.09.048
   Barz M, 2010, MACROMOL RAPID COMM, V31, P1492, DOI 10.1002/marc.201000090
   Baum BJ, 2000, J AM DENT ASSOC, V131, P309, DOI 10.14219/jada.archive.2000.0174
   Bhushan B, 2005, ACTA BIOMATER, V1, P327, DOI 10.1016/j.actbio.2005.01.002
   Bhushan B, 2006, ACTA BIOMATER, V2, P39, DOI 10.1016/j.actbio.2005.08.010
   Bhushan B., 2011, NANOTRIBOLOGY NANOME
   Bhushan B., 2010, SPRINGER HDB NANOTEC
   Blattler T, 2006, J NANOSCI NANOTECHNO, V6, P2237, DOI 10.1166/jnn.2006.501
   Boukari A, 2006, J BIOMED MATER RES A, V78A, P466, DOI 10.1002/jbm.a.30778
   Browne MM, 2004, SURF SCI, V553, P155, DOI 10.1016/j.susc.2004.01.046
   Burton Z, 2005, NANO LETT, V5, P1607, DOI 10.1021/nl050861b
   Cao B, 2011, MACROMOL BIOSCI, V11, P970, DOI 10.1002/mabi.201100010
   Chen GJ, 2009, LANGMUIR, V25, P2860, DOI 10.1021/la803523b
   Cheng CX, 2005, LANGMUIR, V21, P6576, DOI 10.1021/la050187d
   Cheung JWC, 2008, LANGMUIR, V24, P13842, DOI 10.1021/la802452v
   Chiefari J, 1998, MACROMOLECULES, V31, P5559, DOI 10.1021/ma9804951
   CHO CS, 1993, J BIOMED MATER RES, V27, P199, DOI 10.1002/jbm.820270209
   Chong YK, 1999, MACROMOLECULES, V32, P2071, DOI 10.1021/ma981472p
   Christian DA, 2009, NAT MATER, V8, P843, DOI [10.1038/nmat2512, 10.1038/NMAT2512]
   Collier TO, 2002, J BIOMED MATER RES, V60, P487, DOI 10.1002/jbm.10043
   Dalby MJ, 2008, J BIOMED MATER RES A, V84A, P973, DOI 10.1002/jbm.a.31409
   DEKKER A, 1991, BIOMATERIALS, V12, P130, DOI 10.1016/0142-9612(91)90191-C
   Ebner A, 2007, BIOCONJUGATE CHEM, V18, P1176, DOI 10.1021/bc070030s
   Engel E, 2008, TRENDS BIOTECHNOL, V26, P39, DOI 10.1016/j.tibtech.2007.10.005
   Feng W, 2011, ACTA BIOMATER, V7, P3692, DOI 10.1016/j.actbio.2011.06.007
   Fiten MWM, 2005, J POLYM SCI POL CHEM, V43, P3831, DOI 10.1002/pola.20868
   Gadt T, 2009, NAT MATER, V8, P144, DOI [10.1038/NMAT2356, 10.1038/nmat2356]
   Garcia AJ, 1999, MOL BIOL CELL, V10, P785, DOI 10.1091/mbc.10.3.785
   George PA, 2010, BIOMATERIALS, V31, P641, DOI 10.1016/j.biomaterials.2009.09.094
   George PA, 2009, BIOMATERIALS, V30, P4732, DOI 10.1016/j.biomaterials.2009.05.039
   George PA, 2009, BIOMATERIALS, V30, P2449, DOI 10.1016/j.biomaterials.2009.01.012
   Gondi SR, 2007, MACROMOLECULES, V40, P474, DOI 10.1021/ma061959v
   Gopferich A, 1999, J BIOMED MATER RES, V46, P390
   Grafahrend D, 2008, J MATER SCI-MATER M, V19, P1479, DOI 10.1007/s10856-007-3299-8
   Greenfield MA, 2009, J AM CHEM SOC, V131, P12030, DOI 10.1021/ja903546y
   Guvendiren M, 2008, BIOMACROMOLECULES, V9, P122, DOI 10.1021/bm700886b
   HANNAN GN, 1988, EXP CELL RES, V178, P343, DOI 10.1016/0014-4827(88)90404-1
   Hart A, 2007, J MATER SCI-MATER M, V18, P1211, DOI 10.1007/s10856-007-0157-7
   Hauser J, 2009, J MATER SCI-MATER M, V20, P2541, DOI 10.1007/s10856-009-3826-x
   HAYMAN EG, 1985, EXP CELL RES, V160, P245, DOI 10.1016/0014-4827(85)90173-9
   Heijink A, 2008, CLIN ORTHOP RELAT R, V466, P977, DOI 10.1007/s11999-008-0117-7
   Hein CD, 2008, PHARM RES-DORDR, V25, P2216, DOI 10.1007/s11095-008-9616-1
   Jeong JH, 2000, COLLOID SURFACE B, V18, P371, DOI 10.1016/S0927-7765(99)00162-9
   Jung SY, 2003, J AM CHEM SOC, V125, P12782, DOI 10.1021/ja037263o
   Kantawong F, 2009, J R SOC INTERFACE, V6, P1075, DOI 10.1098/rsif.2008.0447
   Kennedy JE, 2011, MAT SCI ENG C-MATER, V31, P246, DOI 10.1016/j.msec.2010.09.004
   Keselowsky BG, 2003, J BIOMED MATER RES A, V66A, P247, DOI 10.1002/jbm.a.10537
   Keselowsky BG, 2004, BIOMATERIALS, V25, P5947, DOI 10.1016/j.biomaterials.2004.01.062
   Khang D, 2008, BIOMED MICRODEVICES, V12, P575
   Khang D, 2008, BIOMATERIALS, V29, P970, DOI 10.1016/j.biomaterials.2007.11.009
   Khang D, 2009, ACTA BIOMATER, V5, P1425, DOI 10.1016/j.actbio.2009.01.031
   Kim EJ, 2009, J BIOMED MATER RES A, V90A, P1198, DOI 10.1002/jbm.a.32160
   Kim TG, 2006, TISSUE ENG, V12, P221, DOI 10.1089/ten.2006.12.221
   Kowalczynska HM, 2005, J BIOMED MATER RES A, V72A, P228, DOI 10.1002/jbm.a.30238
   Krishnan A, 2004, LANGMUIR, V20, P5071, DOI 10.1021/la036218r
   Krishnan A, 2006, BIOMATERIALS, V27, P3187, DOI 10.1016/j.biomaterials.2005.12.032
   Kubies D, 2000, BIOMATERIALS, V21, P529, DOI 10.1016/S0142-9612(99)00219-7
   Kumar N, 2005, LANGMUIR, V21, P6652, DOI 10.1021/la050331v
   Kumar N, 2007, J PHYS CHEM B, V111, P4581, DOI 10.1021/jp068509p
   KWON GS, 1995, ADV DRUG DELIVER REV, V16, P295, DOI 10.1016/0169-409X(95)00031-2
   Lai JT, 2002, MACROMOLECULES, V35, P6754, DOI 10.1021/ma020362m
   Lan MA, 2005, BIOMATERIALS, V26, P4523, DOI 10.1016/j.biomaterials.2004.11.028
   Lazos D, 2005, LANGMUIR, V21, P8774, DOI 10.1021/la051049r
   Lian XM, 2010, ACS APPL MATER INTER, V2, P2261, DOI 10.1021/am1003156
   Lin JC, 1996, J COLLOID INTERF SCI, V182, P315, DOI 10.1006/jcis.1996.0470
   Liu D, 2009, LANGMUIR, V25, P4526, DOI 10.1021/la8038957
   Liu XM, 2009, J NANOSCI NANOTECHNO, V9, P3449, DOI 10.1166/jnn.2009.NS15
   Liu XY, 2005, BIOMATERIALS, V26, P6143, DOI 10.1016/j.biomaterials.2005.04.035
   Lord MS, 2006, BIOMATERIALS, V27, P4856, DOI 10.1016/j.biomaterials.2006.05.037
   Martinelli E, 2008, LANGMUIR, V24, P13138, DOI 10.1021/la801991k
   Mayadunne RTA, 2000, MACROMOLECULES, V33, P243, DOI 10.1021/ma991451a
   Meldal M, 2008, CHEM REV, V108, P2952, DOI 10.1021/cr0783479
   Mele Elisa, 2009, V47, P341, DOI 10.1007/978-3-540-88552-8_15
   Moses JE, 2007, CHEM SOC REV, V36, P1249, DOI 10.1039/b613014n
   Nelson GW, 2010, COLLOID SURFACE B, V78, P61, DOI 10.1016/j.colsurfb.2010.02.012
   Nicolay R, 2008, MACROMOLECULES, V41, P4585, DOI 10.1021/ma800539v
   NIMERI G, 1994, J BIOMAT SCI-POLYM E, V6, P573, DOI 10.1163/156856294X00527
   Noh H, 2007, BIOMATERIALS, V28, P405, DOI 10.1016/j.biomaterials.2006.09.006
   NOJIRI C, 1990, J BIOMED MATER RES, V24, P1151, DOI 10.1002/jbm.820240903
   Nuttelman CR, 2001, J BIOMED MATER RES, V57, P217, DOI 10.1002/1097-4636(200111)57:2<217::AID-JBM1161>3.0.CO;2-I
   OKANO T, 1986, J BIOMED MATER RES, V20, P919, DOI 10.1002/jbm.820200707
   OKANO T, 1986, J BIOMED MATER RES, V20, P1035, DOI 10.1002/jbm.820200716
   Palacio M, 2010, J MICROSC-OXFORD, V240, P239, DOI 10.1111/j.1365-2818.2010.03420.x
   Palacio MLB, 2012, J BIOMED MATER RES A, V100A, P978, DOI 10.1002/jbm.a.34033
   Palacio MLB, 2012, J BIOMED MATER RES A, V100A, P18, DOI 10.1002/jbm.a.33219
   Palacio MLB, 2011, J R SOC INTERFACE, V8, P630, DOI 10.1098/rsif.2010.0557
   Pareta RA, 2010, J BIOMED MATER RES A, V92A, P1190, DOI 10.1002/jbm.a.32433
   Pei J, 2011, BIOMATERIALS, V32, P8968, DOI 10.1016/j.biomaterials.2011.08.034
   Peterca M, 2010, J AM CHEM SOC, V132, P11288, DOI 10.1021/ja104432d
   Qian JS, 2010, TRENDS BIOTECHNOL, V28, P84, DOI 10.1016/j.tibtech.2009.11.003
   Qin D, 2010, NAT PROTOC, V5, P491, DOI 10.1038/nprot.2009.234
   Quemener D, 2006, CHEM COMMUN, P5051, DOI 10.1039/b611224b
   Ranade SV, 2005, ACTA BIOMATER, V1, P137, DOI 10.1016/j.actbio.2004.09.004
   Raynor JE, 2009, BIOINTERPHASES, V4, pFA3, DOI 10.1116/1.3089252
   Ren TB, 2008, J BIOMED MATER RES A, V86A, P209, DOI 10.1002/jbm.a.31508
   ROSE L.F., 2004, PERIODONTICS MED SUR
   Rosler A, 2001, ADV DRUG DELIVER REV, V53, P95, DOI 10.1016/S0169-409X(01)00222-8
   Rostovtsev VV, 2002, ANGEW CHEM INT EDIT, V41, P2596, DOI 10.1002/1521-3773(20020715)41:14<2596::AID-ANIE2596>3.0.CO;2-4
   Ruzette AV, 2005, NAT MATER, V4, P19, DOI 10.1038/nmat1295
   Sargeant TD, 2008, BIOMATERIALS, V29, P1085, DOI 10.1016/j.biomaterials.2007.11.002
   Schricker S, 2010, ULTRAMICROSCOPY, V110, P639, DOI 10.1016/j.ultramic.2010.02.025
   Schricker SR, 2011, COLLOID POLYM SCI, V289, P219, DOI 10.1007/s00396-010-2352-1
   Tang J, 2007, J MOL RECOGNIT, V20, P483, DOI 10.1002/jmr.828
   Tosatti S, 2003, BIOMATERIALS, V24, P4949, DOI 10.1016/S0142-9612(03)00420-4
   Turbill P, 1996, BIOMATERIALS, V17, P1279, DOI 10.1016/0142-9612(96)88673-X
   VandeVondele S, 2003, BIOTECHNOL BIOENG, V82, P784, DOI 10.1002/bit.10625
   VROMAN L, 1962, NATURE, V196, P476, DOI 10.1038/196476a0
   Wilson CJ, 2005, TISSUE ENG, V11, P1, DOI 10.1089/ten.2005.11.1
   Xu LC, 2007, BIOMATERIALS, V28, P3273, DOI 10.1016/j.biomaterials.2007.03.032
   Xu LC, 2010, J BIOMED MATER RES A, V92A, P126, DOI 10.1002/jbm.a.32340
   Yang DJ, 2007, J BIOMED MATER RES A, V82A, P680, DOI 10.1002/bjm.a.31099
   Yang XZ, 2009, BIOMACROMOLECULES, V10, P2213, DOI 10.1021/bm900390k
   Yu H. F., 2007, MOL CRYST LIQ CRYST, V478, P271, DOI DOI 10.1080/15421400701680812
   Zhu J, 2007, POLYMER, V48, P6992, DOI 10.1016/j.polymer.2007.10.004
NR 119
TC 6
Z9 6
U1 2
U2 51
PU ROYAL SOC
PI LONDON
PA 6-9 CARLTON HOUSE TERRACE, LONDON SW1Y 5AG, ENGLAND
SN 1364-503X
J9 PHILOS T R SOC A
JI Philos. Trans. R. Soc. A-Math. Phys. Eng. Sci.
PD MAY 28
PY 2012
VL 370
IS 1967
SI SI
BP 2348
EP 2380
DI 10.1098/rsta.2011.0484
PG 33
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA 927UT
UT WOS:000302936400005
PM 22509062
OA Bronze
DA 2018-10-19
ER

PT J
AU Hryniewicz, T
   Konarski, P
   Rokicki, R
   Valicek, J
AF Hryniewicz, Tadeusz
   Konarski, Piotr
   Rokicki, Ryszard
   Valicek, Jan
TI SIMS studies of titanium biomaterial hydrogenation after
   magnetoelectropolishing
SO SURFACE & COATINGS TECHNOLOGY
LA English
DT Article
DE Titanium biomaterial; Magnetoelectropolishing (MEP); Hydrogenation; SIMS
   depth profile analysis
ID ENDODONTIC INSTRUMENTS; ROTARY INSTRUMENTS; CYCLIC FATIGUE; RESISTANCE;
   CORROSION; FRACTURE
AB Hydrogenation of the commercial purity (99%) CP Titanium Grade 2 biomaterial was investigated using the secondary ion mass spectrometry (SIMS) after two finishing electrochemical operations: standard electropolishing (EP), and magnetoelectropolishing (MEP). The SIMS depth profile analyses were carried out right after electropolishing, and again one month later. The mass spectrograms of secondary positive and negative ions were recorded. SIMS spectra reveal higher emission of positive O+, Ti+ and TiO+ secondary ions which corresponds to higher oxidation of MEP sample. Negative spectra show higher concentration of compounds containing carbon on MEP sample than those of EP sample. Lower content of hydrogen in the near-surface layers in the MEP sample right after the process was revealed. It was found that the concentrations of oxygen and hydrogen alter in time. One month of storage in air causes the contents of hydrogen in EP and MEP samples to be equalized. The SIMS studies performed after a one month period show that the differences in hydrogen contents between EP and MEP samples are not significant. (c) 2012 Elsevier B.V. All rights reserved.
C1 [Hryniewicz, Tadeusz] Politech Koszalinska, Surface Electrochem Div, PL-75620 Koszalin, Poland.
   [Konarski, Piotr] Tele & Radio Res Inst, Vacuum Measurement Lab, PL-03450 Warsaw, Poland.
   [Rokicki, Ryszard] Electrobright, Macungie, PA USA.
   [Valicek, Jan] VSB TU Ostrava, Dept Phys, Ostrava, Czech Republic.
RP Hryniewicz, T (reprint author), Politech Koszalinska, Surface Electrochem Div, Raclawicka 15-17, PL-75620 Koszalin, Poland.
EM Tadeusz.Hryniewicz@tu.koszalin.pl
RI Konarski, Piotr/E-7804-2010
OI Konarski, Piotr/0000-0003-0655-6336
FU Operational Programme 'Research and Development for Innovations';
   Structural Funds of the European Union, state budget of the Czech
   Republic; ICT project [CZ.1.05/2.1.00/03.0082]
FX The work has been partly supported by Operational Programme 'Research
   and Development for Innovations' funded by Structural Funds of the
   European Union, state budget of the Czech Republic and the ICT project
   No. CZ.1.05/2.1.00/03.0082.
CR Anderson ME, 2007, J ENDODONT, V33, P1212, DOI 10.1016/j.joen.2007.07.007
   Bui TB, 2008, J ENDODONT, V34, P190, DOI 10.1016/j.joen.2007.10.007
   Cheung GSP, 2007, INT ENDOD J, V40, P626, DOI 10.1111/j.1365-2591.2007.01257.x
   Chuang LC, 2011, APPL SURF SCI, V258, P297, DOI 10.1016/j.apsusc.2011.08.055
   Cisse O, 2002, J BIOMED MATER RES, V61, P339, DOI 10.1002/jbm.10114
   Fahidy T. Z., 2002, MOD ASPECT ELECTROC, P333
   Gambarini G, 2001, INT ENDOD J, V34, P386, DOI 10.1046/j.1365-2591.2001.00259.x
   Hinds G, 2001, J PHYS CHEM B, V105, P9487, DOI 10.1021/jp010581u
   Hryniewicz T, 2007, Metal Finishing, V104, P26, DOI 10.1016/S0026-0576(06)80361-2
   Hryniewicz Tadeusz, 2009, Pomiary Automatyka Kontrola, V55, P247
   Hryniewicz T, 2009, SURF COAT TECH, V203, P1508, DOI 10.1016/j.surfcoat.2008.11.028
   Hryniewicz T., 2009, MAT RES SOC S P E, V1244E, P21, DOI DOI 10.1557/PROC-1244-3
   Hryniewicz T, 2011, BIOMATERIALS SCIENCE AND ENGINEERING, P227
   Hryniewicz T, 2011, SURF COAT TECH, V205, P4228, DOI 10.1016/j.surfcoat.2011.03.024
   Konarski P, 2003, APPL SURF SCI, V203, P354, DOI 10.1016/S0169-4332(02)00675-X
   Konarski P, 1996, VACUUM, V47, P1111, DOI 10.1016/0042-207X(96)00134-0
   Kuhn G, 2001, J ENDODONT, V27, P516, DOI 10.1097/00004770-200108000-00005
   Kuhn V.A., 2004, GALVANOTECHNIK, V102, p[8, 1851]
   Linsuwanont P, 2004, INT ENDOD J, V37, P19, DOI 10.1111/j.1365-2591.2004.00747.x
   Oliver WC, 2004, J MATER RES, V19, P3, DOI 10.1557/jmr.2004.19.1.3
   Parashos P, 2006, J ENDODONT, V32, P1031, DOI 10.1016/j.joen.2006.06.008
   Praisarnti C, 2010, J ENDODONT, V36, P1354, DOI 10.1016/j.joen.2010.02.025
   Pruett JP, 1997, J ENDODONT, V23, P77, DOI 10.1016/S0099-2399(97)80250-6
   Rokicki R, 2008, T I MET FINISH, V86, P280, DOI 10.1179/174591908X345040
   Rokicki R., 1990, MET FINISH, V88, P65
   Rokicki R., 2009, US Patent, Patent No. 7632390
   Schmidt Anelise Marlene, 2006, Mat. Res., V9, P387, DOI 10.1590/S1516-14392006000400008
   Seah MP, 2012, SURF INTERFACE ANAL, V44, P208, DOI 10.1002/sia.3798
   Tajima K, 2008, DENT MATER J, V27, P258, DOI 10.4012/dmj.27.258
   Tripi TR, 2006, ORAL SURG ORAL MED O, V102, P106
   Weldon LM, 2005, J MATER SCI-MATER M, V16, P107, DOI 10.1007/s10856-005-5922-x
   Yamamoto I, 1996, SCI REP RES TOHOKU A, V42, P309
NR 32
TC 15
Z9 15
U1 1
U2 17
PU ELSEVIER SCIENCE SA
PI LAUSANNE
PA PO BOX 564, 1001 LAUSANNE, SWITZERLAND
SN 0257-8972
J9 SURF COAT TECH
JI Surf. Coat. Technol.
PD MAY 25
PY 2012
VL 206
IS 19-20
BP 4027
EP 4031
DI 10.1016/j.surfcoat.2012.03.083
PG 5
WC Materials Science, Coatings & Films; Physics, Applied
SC Materials Science; Physics
GA 963ZB
UT WOS:000305662400029
DA 2018-10-19
ER

PT J
AU Hallmann, L
   Ulmer, P
   Reusser, E
   Hammerle, CHF
AF Hallmann, Lubica
   Ulmer, Peter
   Reusser, Eric
   Haemmerle, Christoph H. F.
TI Effect of blasting pressure, abrasive particle size and grade on phase
   transformation and morphological change of dental zirconia surface
SO SURFACE & COATINGS TECHNOLOGY
LA English
DT Article
DE Air abrasion; Dental zirconia (Y-TZP); Phase transformation
ID FLEXURAL STRENGTH; BOND STRENGTH; FATIGUE LIFE; CERAMICS; BIOMATERIAL;
   CEMENTS
AB This study aimed to evaluate the effect of different blasting pressures and airborne particle composition and size on phase transformation and surface morphological change of yttria-stabilized tetragonal polycrystalline zirconia (Y-TZP). Specimens sintered at 1350 degrees C for 2 h were abraded with 50 and 110 mu m alumina and 30 and 110 mu m silica-coated alumina particle at pressures of 1, 1.5, 2, 2.5, 3 and 3.5 bar. It was found that air abrasion changes the morphology of the Y-TZP ceramic surface. Flaws, microcracks, plastic deformations, pits, embedding of airborne particle on the ceramic surface, cluster of loosely nano-silica particle, melting of ceramic surface, coating of surface with non-uniform loosely nano-silica particle and t-m phase transformation were observed after air abrasion process. The extent of morphological change and t-m phase transformation of abraded surface depended on the pressures and size of abrasive particle. Higher pressure and larger size resulted in more extensive morphological change and more frequent t-m phase transformation. Conclusion: The extent of morphological change of ceramic surface depends on the blasting pressures and grain size of airborne particle. Nano-silica particle loosely covered the ceramic surface after air abrasion. The abrasion of the ceramic surface with 50 or 110 mu m alumina airborne particle at pressures of 2.5 or 1.5 bar, respectively, was regarded as the optimum blasting condition. (c) 2012 Elsevier B.V. All rights reserved.
C1 [Hallmann, Lubica; Haemmerle, Christoph H. F.] Univ Zurich, Ctr Dent Med, Clin Fixed & Removable Prosthodont & Dent Mat Sci, CH-8032 Zurich, Switzerland.
   [Ulmer, Peter; Reusser, Eric] ETH, Inst Geochem & Petrol, Zurich, Switzerland.
RP Hallmann, L (reprint author), Univ Zurich, Ctr Dent Med, Clin Fixed & Removable Prosthodont & Dent Mat Sci, Plattenstr 11, CH-8032 Zurich, Switzerland.
EM lubica.hallmann@zzm.uzh
RI Ulmer, Peter/G-4694-2018
OI Ulmer, Peter/0000-0001-9131-0669
CR Aboushelib N., 2007, J PROSTHET DENT, V98, P379
   Blatz B.M., 2003, J ESTHET RESTOR DENT, V15, P362
   Blixt M, 2000, INT J PROSTHODONT, V13, P221
   Burke P.D., 1997, J MATER SCI LETT, V16, P883
   Casucci A, 2009, J DENT, V37, P891, DOI 10.1016/j.jdent.2009.06.013
   Cavalcanti N.A., 2009, OPER DENT, V34-3, P280
   Denry I, 2008, DENT MATER, V24, P299, DOI 10.1016/j.dental.2007.05.007
   Denry L.I., 2006, J BIOMED MATER RES B, V76B, P440
   Guazzato M, 2005, J DENT, V33, P9, DOI 10.1016/j.jdent.2004.07.001
   Guazzato M, 2004, BIOMATERIALS, V25, P2153, DOI 10.1016/j.biomaterials.2003.08.056
   Harris F., 1999, INT J ADHES ADHES, V19, P445
   Heikkinen TT, 2007, ACTA ODONTOL SCAND, V65, P241, DOI 10.1080/00016350701459753
   Hisbergues M, 2009, J BIOMED MATER RES B, V88B, P519, DOI 10.1002/jbm.b.31147
   Holmberg K, 2000, CERAM INT, V26, P787, DOI 10.1016/S0272-8842(00)00015-8
   Kern M, 2009, J ADHES SCI TECHNOL, V23, P1097, DOI 10.1163/156856109X432721
   Kim K.B., 2005, J PROSTHET DENT, V94, P357
   Kosmac T, 1999, DENT MATER, V15, P426, DOI 10.1016/S0109-5641(99)00070-6
   Kosmac T, 2008, J EUR CERAM SOC, V28, P1085, DOI 10.1016/j.jeurceramsoc.2007.09.013
   Lohbauer U, 2008, J BIOMED MATER RES B, V87B, P461, DOI 10.1002/jbm.b.31126
   Lorente C.M., 2010, DENT MATER, V26, P5
   Lung KYC, 2010, APPL SURF SCI, V257, P1228
   Magne P, 2010, DENT MATER, V26, P345, DOI 10.1016/j.dental.2009.12.005
   Nothdurft P.F., 2009, CLIN ORAL INVEST, V13, P9
   Phark H.J., 2009, J PROSTHET DENT, V101, P29
   Piconi C, 1999, BIOMATERIALS, V20, P1, DOI 10.1016/S0142-9612(98)00010-6
   Pittayachawan P, 2009, J BIOMED MATER RES B, V88B, P366, DOI 10.1002/jbm.b.31064
   Tanaka R, 2008, J DENT RES, V87, P666, DOI 10.1177/154405910808700705
   Wolfart M, 2007, DENT MATER, V23, P45, DOI 10.1016/j.dental.2005.11.040
   Yang B, 2007, J DENT RES, V86, P749, DOI 10.1177/154405910708600812
   Yang B, 2010, DENT MATER, V26, P44, DOI 10.1016/j.dental.2009.08.008
   Zhang Y, 2004, J BIOMED MATER RES B, V71B, P381, DOI 10.1002/jbm.b.30097
   Zhang Y, 2006, INT J PROSTHODONT, V19, P442
NR 32
TC 17
Z9 17
U1 1
U2 8
PU ELSEVIER SCIENCE SA
PI LAUSANNE
PA PO BOX 564, 1001 LAUSANNE, SWITZERLAND
SN 0257-8972
J9 SURF COAT TECH
JI Surf. Coat. Technol.
PD MAY 25
PY 2012
VL 206
IS 19-20
BP 4293
EP 4302
DI 10.1016/j.surfcoat.2012.04.043
PG 10
WC Materials Science, Coatings & Films; Physics, Applied
SC Materials Science; Physics
GA 963ZB
UT WOS:000305662400065
DA 2018-10-19
ER

PT J
AU Spiliopoulou, AI
   Krevvata, MI
   Kolonitsiou, F
   Harris, LG
   Wilkinson, TS
   Davies, AP
   Dimitracopoulos, GO
   Karamanos, NK
   Mack, D
   Anastassiou, ED
AF Spiliopoulou, Anastasia I.
   Krevvata, Maria I.
   Kolonitsiou, Fevronia
   Harris, Llinos G.
   Wilkinson, Thomas S.
   Davies, Angharad P.
   Dimitracopoulos, Georgios O.
   Karamanos, Nikos K.
   Mack, Dietrich
   Anastassiou, Evangelos D.
TI An extracellular Staphylococcus epidermidis polysaccharide: relation to
   Polysaccharide Intercellular Adhesin and its implication in phagocytosis
SO BMC MICROBIOLOGY
LA English
DT Article
ID COAGULASE-NEGATIVE STAPHYLOCOCCI; BIOFILM FORMATION; SURFACE
   POLYSACCHARIDE; ENZYME-IMMUNOASSAY; PASTEURELLA-MULTOCIDA; TRANSPOSON
   MUTANTS; CONJUGATE VACCINES; SLIME PRODUCTION; TN917 INSERTION; PHASE
   VARIATION
AB Background: The skin commensal and opportunistic pathogen Staphylococcus epidermidis is a leading cause of hospital-acquired and biomaterial-associated infections. The polysaccharide intercellular adhesin (PIA), a homoglycan composed of beta-1,6-linked N-acetylglucosamine residues, synthesized by enzymes encoded in icaADBC is a major functional factor in biofilm accumulation, promoting virulence in experimental biomaterial-associated S. epidermidis infection. Extracellular mucous layer extracts of S. epidermidis contain another major polysaccharide, referred to as 20-kDa polysaccharide (20-kDaPS), composed mainly out of glucose, N-acetylglucosamine, and being partially sulfated. 20-kDaPS antiserum prevents adhesion of S. epidermidis on endothelial cells and development of experimental keratitis in rabbits. Here we provide experimental evidence that 20-kDaPS and PIA represent distinct molecules and that 20-kDaPS is implicated in endocytosis of S. epidermidis bacterial cells by human monocyte-derived macrophages.
   Results: Analysis of 75 clinical coagulase-negative staphylococci from blood-cultures and central venous catheter tips indicated that 20-kDaPS is expressed exclusively in S. epidermidis but not in other coagulase-negative staphylococcal species. Tn917-insertion in various locations in icaADBC in mutants M10, M22, M23, and M24 of S. epidermidis 1457 are abolished for PIA synthesis, while 20-kDaPS expression appears unaltered as compared to wild-type strains using specific anti-PIA and anti-20-kDaPS antisera. While periodate oxidation and dispersin B treatments abolish immuno-reactivity and intercellular adhesive properties of PIA, no abrogative activity is exerted towards 20-kDaPS immunochemical reactivity following these treatments. PIA polysaccharide I-containing fractions eluting from Q-Sepharose were devoid of detectable 20-kDaPS using specific ELISA. Preincubation of non-20-kDaPS-producing clinical strain with increasing amounts of 20-kDaPS inhibits endocytosis by human macrophages, whereas, preincubation of 20-kDaPS-producing strain ATCC35983 with 20-kDaPS antiserum enhances bacterial endocytosis by human macrophages.
   Conclusions: In conclusion, icaADBC is not involved in 20-kDaPS synthesis, while the chemical and chromatographic properties of PIA and 20-kDaPS are distinct. 20-kDaPS exhibits anti-phagocytic properties, whereas, 20-kDaPS antiserum may have a beneficial effect on combating infection by 20-kDaPS-producing S. epidermidis.
C1 [Spiliopoulou, Anastasia I.; Harris, Llinos G.; Wilkinson, Thomas S.; Davies, Angharad P.; Mack, Dietrich] Swansea Univ, Coll Med, Inst Life Sci, Swansea, W Glam, Wales.
   [Spiliopoulou, Anastasia I.; Krevvata, Maria I.; Kolonitsiou, Fevronia; Dimitracopoulos, Georgios O.; Anastassiou, Evangelos D.] Univ Patras, Sch Med, Dept Microbiol, GR-26110 Patras, Greece.
   [Karamanos, Nikos K.] Univ Patras, Dept Chem, Biochem Lab, Patras, Greece.
RP Mack, D (reprint author), Swansea Univ, Coll Med, Inst Life Sci, Swansea, W Glam, Wales.
EM D.Mack@swansea.ac.uk; edanastassiou@med.upatras.gr
RI Krevvata, Maria/O-6178-2014; Wilkinson, Thomas/C-5237-2013; Karamanos,
   Nikos/A-3616-2008
OI Krevvata, Maria/0000-0001-9283-3656; Wilkinson,
   Thomas/0000-0003-0397-6079; Karamanos, Nikos/0000-0003-3618-0288;
   Harris, Llinos/0000-0002-0295-3038; Davies, Angharad/0000-0003-4190-8894
FU ESCMID; Medical Research Council [G0801929]
FX Part of this work was supported by an ESCMID 2009 Training Fellowship
   given to AS. Part of this work was presented at the 5th Panhellenic
   Congress of Clinical Microbiology and Hospital Infections, February 2011
   and awarded as the best oral presentation by the Organizing Committee.
   We thank Dr. Jeffrey B. Kaplan, New Jersey Dental School, Newark, USA,
   for the kind gift of recombinant DspB.
CR Aderem A, 1999, ANNU REV IMMUNOL, V17, P593, DOI 10.1146/annurev.immunol.17.1.593
   Albanyan EA, 2000, INFECT IMMUN, V68, P2053, DOI 10.1128/IAI.68.4.2053-2060.2000
   Allen LAH, 2000, J EXP MED, V191, P115, DOI 10.1084/jem.191.1.115
   Arciola CR, 2001, J CLIN MICROBIOL, V39, P2151, DOI 10.1128/JCM.39.6.2151-2156.2001
   ARVANITI A, 1994, ARCH BIOCHEM BIOPHYS, V308, P432, DOI 10.1006/abbi.1994.1061
   Baldassarri L, 1996, INFECT IMMUN, V64, P3410
   Broekhuizen CAN, 2009, BIOMATERIALS, V30, P6444, DOI 10.1016/j.biomaterials.2009.08.018
   Chokr A, 2006, INT J MED MICROBIOL, V296, P381, DOI 10.1016/j.ijmm.2006.02.018
   CHRISTENSEN GD, 1990, INFECT IMMUN, V58, P2906
   Christner M, 2010, MOL MICROBIOL, V75, P187, DOI 10.1111/j.1365-2958.2009.06981.x
   de Silva GDI, 2002, J CLIN MICROBIOL, V40, P382, DOI [10.1128/JCM.40.02.382-388.2002, 10.1128/JCM.40.2.382-388.2002]
   DeLoid GM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006209
   Dobinsky S, 2002, PLASMID, V47, P10, DOI 10.1006/plas.2001.1554
   Ernst JD, 2000, CELL MICROBIOL, V2, P379, DOI 10.1046/j.1462-5822.2000.00075.x
   Gening ML, 2010, INFECT IMMUN, V78, P764, DOI 10.1128/IAI.01093-09
   Georgakopoulos CD, 2006, CURR EYE RES, V31, P137, DOI 10.1080/02713680500516540
   Georgakopoulos CD, 2002, J PHARMACEUT BIOMED, V29, P255, DOI 10.1016/S0731-7085(02)00056-0
   Gerke C, 1998, J BIOL CHEM, V273, P18586, DOI 10.1074/jbc.273.29.18586
   Gotz F, 2002, MOL MICROBIOL, V43, P1367, DOI 10.1046/j.1365-2958.2002.02827.x
   Harro JM, 2010, FEMS IMMUNOL MED MIC, V59, P306, DOI 10.1111/j.1574-695X.2010.00708.x
   Heilmann C, 1996, INFECT IMMUN, V64, P277
   Heilmann C, 1996, MOL MICROBIOL, V20, P1083, DOI 10.1111/j.1365-2958.1996.tb02548.x
   Kaplan JB, 2004, ANTIMICROB AGENTS CH, V48, P2633, DOI 10.1128/AAC.48.7.2633-2636.2004
   KARAMANOS NK, 1995, BIOCHIMIE, V77, P217, DOI 10.1016/0300-9084(96)88127-2
   Karamanos NK, 1997, ARCH BIOCHEM BIOPHYS, V342, P389, DOI 10.1006/abbi.1997.0107
   Kolonitsiou F, 2001, J PHARMACEUT BIOMED, V24, P429, DOI 10.1016/S0731-7085(00)00449-0
   Krevvata MI, 2011, CONNECT TISSUE RES, V52, P183, DOI 10.3109/03008207.2010.505309
   Krevvata MI, 2010, BIOMED CHROMATOGR, V25, P531
   Kristian SA, 2008, J INFECT DIS, V197, P1028, DOI 10.1086/528992
   Laine RA, 2002, GLYCOSCIENCES STATUS, P7
   Lamari F, 2000, J PHARMACEUT BIOMED, V23, P363, DOI 10.1016/S0731-7085(00)00299-5
   Lamari FN, 2004, J PHARMACEUT BIOMED, V34, P803, DOI 10.1016/S0731-7085(03)00564-8
   Mack D, 1996, J INFECT DIS, V174, P881, DOI 10.1093/infdis/174.4.881
   MACK D, 1994, INFECT IMMUN, V62, P3244
   Mack D, 1996, J BACTERIOL, V178, P175, DOI 10.1128/jb.178.1.175-183.1996
   Mack D, 1999, INFECT IMMUN, V67, P1004
   MACK D, 1992, INFECT IMMUN, V60, P2048
   Mack D, 2001, METHOD ENZYMOL, V336, P215, DOI 10.1016/S0076-6879(01)36592-8
   Mack D, 2000, INFECT IMMUN, V68, P3799, DOI 10.1128/IAI.68.7.3799-3807.2000
   Mack D, 2009, TOP CURR CHEM, V288, P57
   Mack D, 2007, ANAL BIOANAL CHEM, V387, P399, DOI 10.1007/s00216-006-0745-2
   Maira-Litran T, 2005, INFECT IMMUN, V73, P6752, DOI 10.1128/IAI.73.10.6752-6762.2005
   Maira-Litran T, 2004, VACCINE, V22, P872, DOI 10.1016/j.vaccine.2003.11.033
   Maira-Litran T, 2002, INFECT IMMUN, V70, P4433, DOI 10.1128/IAI.70.8.4433-4440.2002
   Mckenney D, 2000, J BIOTECHNOL, V83, P37, DOI 10.1016/S0168-1656(00)00296-0
   McKenney D, 1999, SCIENCE, V284, P1523, DOI 10.1126/science.284.5419.1523
   McKenney D, 1998, INFECT IMMUN, V66, P4711
   Nilsdotter-Augustinsson A, 2007, EUR J CLIN MICROBIOL, V26, P255, DOI 10.1007/s10096-007-0281-9
   Ohlsen K, 2010, INT J MED MICROBIOL, V300, P402, DOI 10.1016/j.ijmm.2010.04.015
   Otto M, 2009, NAT REV MICROBIOL, V7, P555, DOI 10.1038/nrmicro2182
   Perez MM, 2009, VACCINE, V27, P2379, DOI 10.1016/j.vaccine.2009.02.005
   Petropoulos IK, 2006, GRAEF ARCH CLIN EXP, V244, P1322, DOI 10.1007/s00417-006-0261-2
   Pruimboom IM, 1999, INFECT IMMUN, V67, P1292
   Pruimboom IM, 1996, AVIAN DIS, V40, P887, DOI 10.2307/1592313
   Rennermalm A, 2004, INFECT IMMUN, V72, P3081, DOI 10.1128/IAI.72.5.3081-3083.2004
   Rohde H, 2004, J CLIN MICROBIOL, V42, P5614, DOI 10.1128/JCM.42.12.5614-5619.2004
   Rohde H, 2001, MED MICROBIOL IMMUN, V190, P105, DOI 10.1007/s00430-001-0099-5
   Rohde H, 2005, MOL MICROBIOL, V55, P1883, DOI 10.1111/j.1365-2958.04515.x
   Rohde H, 2007, BIOMATERIALS, V28, P1711, DOI 10.1016/j.biomaterials.2006.11.046
   Rohde H, 2010, EUR J CELL BIOL, V89, P103, DOI 10.1016/j.ejcb.2009.10.005
   Rupp ME, 1999, INFECT IMMUN, V67, P2656
   Sadovskaya I, 2005, INFECT IMMUN, V73, P3007, DOI 10.1128/IAI.73.5.3007-3017.2005
   Spellberg B, 2010, HUM VACCINES, V6, P857, DOI 10.4161/hv.6.10.12469
   TOJO M, 1988, J INFECT DIS, V157, P713, DOI 10.1093/infdis/157.4.713
   von Eiff C, 2002, LANCET INFECT DIS, V2, P677, DOI 10.1016/S1473-3099(02)00438-3
   Vuong C, 2004, CELL MICROBIOL, V6, P269, DOI 10.1111/j.1462-5822.2004.00367.x
   Vuong C, 2002, MICROBES INFECT, V4, P481, DOI 10.1016/S1286-4579(02)01563-0
   Weisman LE, 2009, INT IMMUNOPHARMACOL, V9, P639, DOI 10.1016/j.intimp.2009.02.008
   Ziebuhr W, 1999, MOL MICROBIOL, V32, P345, DOI 10.1046/j.1365-2958.1999.01353.x
   Ziebuhr W, 1997, INFECT IMMUN, V65, P890
NR 70
TC 15
Z9 15
U1 2
U2 26
PU BIOMED CENTRAL LTD
PI LONDON
PA 236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND
SN 1471-2180
J9 BMC MICROBIOL
JI BMC Microbiol.
PD MAY 17
PY 2012
VL 12
AR 76
DI 10.1186/1471-2180-12-76
PG 14
WC Microbiology
SC Microbiology
GA 000RZ
UT WOS:000308407100001
PM 22594478
OA DOAJ Gold, Green Published
DA 2018-10-19
ER

PT J
AU Jeon, SD
   Lee, JE
   Kim, SJ
   Kim, SW
   Han, SO
AF Jeon, Sang Duck
   Lee, Ji Eun
   Kim, Su Jung
   Kim, Seung Wook
   Han, Sung Ok
TI Analysis of selective, high protein-protein binding interaction of
   cohesin-dockerin complex using biosensing methods
SO BIOSENSORS & BIOELECTRONICS
LA English
DT Article
DE Protein-protein interaction; Biomarker; Fluorescence; Optical biosensor;
   Surface plasmon resonance
ID CLOSTRIDIUM-CELLULOVORANS CELLULOSOME; DIFFERENT CARBON-SOURCES;
   CRYSTALLINE CELLULOSE; CELLULOLYTICUM; THERMOCELLUM; DEGRADATION;
   CELLULASES; EXPRESSION; PURIFICATION; SUBUNITS
AB Optical biosensors that use fluorescence are promising tools for the analysis of target materials such as protein, DNA and other biomaterial. To analyze the binding properties of a protein-protein interaction, we constructed fluorescent biomarkers based on the cohesin-dockerin interaction, which coordinates the assembly of cellulolytic enzymes and scaffolding proteins to produce a cell surface multiprotein complex known as the "cellulosome" in some anaerobic bacteria. Our 2D-PAGE results displayed diverse binding profiles to the dockerin containing cellulosomal proteins produced by Clostridium cellulovorans grown on different carbon sources, such as Avicel, xylan and AXP (Avicel:xylan:pectin (3:1:1)). Fluorescence intensity analysis indicated that EngE and EngH bound more efficiently to Coh6 than to Coh2 or Coh9 (2-fold to 6-fold and 1.5-fold to 5-fold, respectively), while others cellulosomal proteins displayed similar results. In addition, both an enzyme-linked interaction assay (ELIA) and surface plasmon resonance (SPR) analyses demonstrated that both EngE and EngH preferentially bound cohesin6 versus the other two cohesin molecules. This work demonstrated the analysis of the binding patterns between interacting proteins using fluorescent biomarkers. We also illustrated the potential of this sensitive approach to quantify specific target analytical materials via the example of the cohesin-dockerin interaction. (C) 2012 Elsevier B.V. All rights reserved.
C1 [Jeon, Sang Duck; Lee, Ji Eun; Kim, Su Jung; Han, Sung Ok] Korea Univ, Sch Life Sci & Biotechnol, Seoul 136701, South Korea.
   [Kim, Seung Wook] Korea Univ, Dept Chem & Biol Engn, Seoul 136701, South Korea.
RP Han, SO (reprint author), Korea Univ, Sch Life Sci & Biotechnol, Seoul 136701, South Korea.
EM samhan@korea.ac.kr
RI shin, sang kyu/F-2615-2013; Kim, Seung Wook/F-6955-2013; Choi,
   Han/F-7096-2013
OI Kim, Seung Wook/0000-0002-2137-4736
FU Ministry for Agriculture, Forestry and Fisheries, Republic of Korea
   [309016-5]; Korea Institute of Energy Technology Evaluation and Planning
   (KETEP); Korea government Ministry of Knowledge Economy [2011T100200066]
FX This study was supported by the Technology Development Program for
   Agriculture and Forestry, Ministry for Agriculture, Forestry and
   Fisheries, Republic of Korea (no. 309016-5) and the New & Renewable
   Energy Technology Development Program of the Korea Institute of Energy
   Technology Evaluation and Planning (KETEP) grant funded by the Korea
   government Ministry of Knowledge Economy (no. 2011T100200066). The
   surface plasmon resonance analysis was performed at Korea Basic Science
   Institute (Seoul, Korea).
CR Arai T, 2006, APPL MICROBIOL BIOT, V71, P654, DOI 10.1007/s00253-005-0249-6
   BAYER EA, 1985, J BACTERIOL, V163, P552
   BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3
   BYFIELD MP, 1994, BIOSENS BIOELECTRON, V9, P373, DOI 10.1016/0956-5663(94)80038-3
   Cho W, 2010, J BIOTECHNOL, V145, P233, DOI 10.1016/j.jbiotec.2009.11.020
   Demishtein A, 2010, J MOL RECOGNIT, V23, P525, DOI 10.1002/jmr.1029
   DOI RH, 1994, CRIT REV MICROBIOL, V20, P87, DOI 10.3109/10408419409113548
   Doi RH, 2003, J BACTERIOL, V185, P5907, DOI 10.1128/JB.185.20.5907-5914.2003
   Doi RH, 2008, ANN NY ACAD SCI, V1125, P267, DOI 10.1196/annals.1419.002
   Fendri I, 2009, FEBS J, V276, P3076, DOI 10.1111/j.1742-4658.2009.07025.x
   Fierobe HP, 1999, BIOCHEMISTRY-US, V38, P12822, DOI 10.1021/bi9911740
   Han SO, 2005, MICROBIOL-SGM, V151, P1491, DOI 10.1099/mic.0.27605-0
   Han SO, 2004, J BACTERIOL, V186, P8347, DOI 10.1128/JB.186.24.8347-8355.2004
   Han SO, 2004, J BACTERIOL, V186, P4218, DOI 10.1128/JB.186.13.4218-4227.2004
   Jean S.D., 2011, APPL MICROBIOL BIOT, V90, P565
   Jeon S.D., 2011, N BIOTECHNOL, V29, P365
   Jindou S, 2004, J BIOL CHEM, V279, P9867, DOI 10.1074/jbc.M308673200
   Kakiuchi M, 1998, J BACTERIOL, V180, P4303
   Kosugi A, 2002, J BACTERIOL, V184, P6859, DOI 10.1128/JB.184.24.6859-6865.2002
   Murashima K, 2002, J BACTERIOL, V184, P5088, DOI 10.1128/JB.184.18.5088-5095.2002
   Pages S, 1996, J BACTERIOL, V178, P2279, DOI 10.1128/jb.178.8.2279-2286.1996
   Park JS, 2001, J BACTERIOL, V183, P5431, DOI 10.1128/JB.183.18.5431-5435.2001
   Sakka K., 2010, FEMS MICROBIOL LETT, V314, P75
   Sakka K, 2011, FEMS MICROBIOL LETT, V314, P75, DOI 10.1111/j.1574-6968.2010.02146.x
   Sakka K, 2009, FEMS MICROBIOL LETT, V300, P249, DOI 10.1111/j.1574-6968.2009.01788.x
   SHOSEYOV O, 1990, P NATL ACAD SCI USA, V87, P2192, DOI 10.1073/pnas.87.6.2192
   SLEAT R, 1984, APPL ENVIRON MICROB, V48, P88
   Steenbakkers PJM, 2008, MYCOL RES, V112, P999, DOI 10.1016/j.mycres.2008.01.021
   Su LA, 2011, BIOSENS BIOELECTRON, V26, P1788, DOI 10.1016/j.bios.2010.09.005
   Wang R, 2011, BIOSENS BIOELECTRON, V28, P304, DOI 10.1016/j.bios.2011.07.036
   Wilson GS, 2005, BIOSENS BIOELECTRON, V20, P2388, DOI 10.1016/j.bios.2004.12.003
   YARON S, 1995, FEBS LETT, V360, P121, DOI 10.1016/0014-5793(95)00074-J
NR 32
TC 15
Z9 15
U1 1
U2 19
PU ELSEVIER ADVANCED TECHNOLOGY
PI OXFORD
PA OXFORD FULFILLMENT CENTRE THE BOULEVARD, LANGFORD LANE, KIDLINGTON,
   OXFORD OX5 1GB, OXON, ENGLAND
SN 0956-5663
J9 BIOSENS BIOELECTRON
JI Biosens. Bioelectron.
PD MAY 15
PY 2012
VL 35
IS 1
BP 382
EP 389
DI 10.1016/j.bios.2012.03.023
PG 8
WC Biophysics; Biotechnology & Applied Microbiology; Chemistry, Analytical;
   Electrochemistry; Nanoscience & Nanotechnology
SC Biophysics; Biotechnology & Applied Microbiology; Chemistry;
   Electrochemistry; Science & Technology - Other Topics
GA 955QM
UT WOS:000305036000058
PM 22480778
DA 2018-10-19
ER

PT J
AU Elayaraja, K
   Rajesh, P
   Joshy, MIA
   Chandra, VS
   Suganthi, RV
   Kennedy, J
   Kulriya, PK
   Sulania, I
   Asokan, K
   Kanjilal, D
   Avasthi, DK
   Varma, HK
   Kalkura, SN
AF Elayaraja, K.
   Rajesh, P.
   Joshy, M. I. Ahymah
   Chandra, V. Sarath
   Suganthi, R. V.
   Kennedy, J.
   Kulriya, P. K.
   Sulania, I.
   Asokan, K.
   Kanjilal, D.
   Avasthi, D. K.
   Varma, H. K.
   Kalkura, S. Narayana
TI Enhancement of wettability and antibiotic loading/release of
   hydroxyapatite thin film modified by 100 MeV Ag7+ ion irradiation
SO MATERIALS CHEMISTRY AND PHYSICS
LA English
DT Article
DE Biomaterial; Coatings; Ion beam analysis; Irradiation effects
ID SIMULATED BODY-FLUID; BONE CELL-MATERIALS; HIGH-ENERGY;
   RAMAN-SPECTROSCOPY; PHOSPHATE-GLASSES; STAINLESS-STEEL; PART I;
   TITANIUM; BIOACTIVITY; COATINGS
AB The effect of swift heavy 100 MeV Ag7+ ions irradiation was studied on hydroxyapatite (HAp) thin film prepared by pulsed laser deposition technique (PLD). The GIXRD analysis confirmed the absence of any phase in the HAp phase due to irradiation. In addition, there was a considerable decrease in crystallinity and crystallite size on irradiation. There was no significant variation in the stoichiometry of the irradiated films. Irradiation seemed to decrease the optical band gap energy of HAp thin films. The surface roughness, wettability and bioactivity were improved on irradiation of the samples. Amount of amoxicillin loading/release increased (10%) in ion beam irradiated (1 x 10(12) ions cm(-2)) sample. Irradiated sample showed fast rate of amoxicillin (AMX) release than the pristine. Bactericidal effect was found to increase on irradiation. Surface modified and antibiotics incorporated HAP coated titanium implants may be used to prevent post-surgical infections and to promote bone-bonding of orthopedic devices. (C) 2012 Elsevier B.V. All rights reserved.
C1 [Elayaraja, K.; Joshy, M. I. Ahymah; Chandra, V. Sarath; Suganthi, R. V.; Kalkura, S. Narayana] Anna Univ, Ctr Crystal Growth, Madras 600025, Tamil Nadu, India.
   [Rajesh, P.; Varma, H. K.] Sree Chitra Tirunal Inst Med Sci & Technol, Biomed Technol Wing, Trivandrum 695012, Kerala, India.
   [Kennedy, J.] GNS Sci, Natl Isotope Ctr, Lower Hutt, New Zealand.
   [Kulriya, P. K.; Sulania, I.; Asokan, K.; Kanjilal, D.; Avasthi, D. K.] Interuniv Accelerator Ctr, New Delhi 110067, India.
RP Kalkura, SN (reprint author), Anna Univ, Ctr Crystal Growth, Madras 600025, Tamil Nadu, India.
EM kalkurasn@annauniv.edu
RI Kolanthai, Elayaraja/D-3041-2015; Avasthi, Devesh/D-4712-2013;
   Palangadan, Rajesh/F-7743-2013; Kandasami, Asokan/A-6035-2009; Kennedy,
   John/B-6054-2009; Kanjilal, Dinakar/D-4731-2013
OI Kolanthai, Elayaraja/0000-0003-2615-6866; Palangadan,
   Rajesh/0000-0001-9328-0862; Kandasami, Asokan/0000-0002-0613-219X;
   Kanjilal, Dinakar/0000-0001-9728-3147; Sulania,
   Indra/0000-0002-4833-1656; Kandasami, Asokan/0000-0002-1602-765X;
   Kennedy, John V/0000-0002-9126-4997
FU CSIR, India [09/468(0413)/2009-EMR-I]; IUAC, New Delhi [UFUP 31317]
FX One of the authors K. Elayaraja acknowledges CSIR, India for the award
   of SRF fellowship (File No.: 09/468(0413)/2009-EMR-I). The authors thank
   the Department of Biotechnology (BT/PR11799/MED/32/103/2009), India and
   IUAC, New Delhi through research project UFUP 31317. We thank Ganga
   Baskar, Ganesh Venkatraman, SRMC, Chennai for their help in study of
   cell viability.
CR Abo-Naf SM, 2008, OPT MATER, V30, P900, DOI 10.1016/j.optmat.2007.03.013
   Anee TK, 2003, MATER CHEM PHYS, V80, P725, DOI 10.1016/S0254-0584(03)00116-0
   Aronov D, 2006, PROCESS BIOCHEM, V41, P2367, DOI 10.1016/j.procbio.2006.06.006
   Aronov D, 2007, J APPL PHYS, V101, DOI 10.1063/1.2433702
   Ball MD, 2001, BIOMATERIALS, V22, P337, DOI 10.1016/S0142-9612(00)00189-7
   Bodhak S, 2009, ACTA BIOMATER, V5, P2178, DOI 10.1016/j.actbio.2009.02.023
   Capello WN, 2009, CLIN ORTHOP RELAT R, V467, P155, DOI 10.1007/s11999-008-0550-7
   Cusco R, 1998, J EUR CERAM SOC, V18, P1301, DOI 10.1016/S0955-2219(98)00057-0
   Das K, 2008, J BIOMED MATER RES B, V87B, P455, DOI 10.1002/jbm.b.31125
   de Araujo TS, 2007, J MATER SCI, V42, P2236, DOI 10.1007/s10853-006-0536-3
   DOOLITTLE LR, 1985, NUCL INSTRUM METH B, V9, P344, DOI 10.1016/0168-583X(85)90762-1
   El-Batal FH, 2009, INDIAN J PURE AP PHY, V47, P631
   Elayaraja K, 2011, APPL SURF SCI, V257, P2134, DOI 10.1016/j.apsusc.2010.09.062
   FLEISCHE.RL, 1965, J APPL PHYS, V36, P3645, DOI 10.1063/1.1703059
   Girija EK, 2008, J CERAM SOC JPN, V116, P320, DOI 10.2109/jcersj2.116.320
   Hao L., 2006, SURF COAT TECH, V200, P5581, DOI [DOI 10.1016/j.surfcoat.2005.07.107, DOI 10.1016/J.SURFCOAT.2005.07.107]
   Hemon S., 1997, NUCL INSTRUM METH B, V122, P5260
   HENCH LL, 1991, J AM CERAM SOC, V74, P1487, DOI 10.1111/j.1151-2916.1991.tb07132.x
   Kim HM, 2005, BIOMATERIALS, V26, P4366, DOI 10.1016/j.biomaterials.2004.11.022
   Kokubo T, 2006, BIOMATERIALS, V27, P2907, DOI 10.1016/j.biomaterials.2006.01.017
   Kumar V, 1999, OPT MATER, V12, P115, DOI 10.1016/S0925-3467(98)00052-4
   Lee IS, 2002, BIOMATERIALS, V23, P609, DOI 10.1016/S0142-9612(01)00147-8
   Lin FH, 2004, MATER CHEM PHYS, V87, P24, DOI 10.1016/j.matchemphys.2004.03.030
   Link KC, 1996, CHEM ENG TECHNOL, V19, P432, DOI 10.1002/ceat.270190508
   Liu DM, 2002, BIOMATERIALS, V23, P691, DOI 10.1016/S0142-9612(01)00157-0
   Liu J, 2008, APPL PHYS A-MATER, V91, P17, DOI 10.1007/s00339-008-4402-9
   Lombardi AV, 2009, CLIN ORTHOP RELAT R, V467, P146, DOI 10.1007/s11999-008-0568-x
   Lopatin CM, 1998, NUCL INSTRUM METH B, V145, P522, DOI 10.1016/S0168-583X(98)80557-0
   Mene RU, 2011, VACUUM, V86, P66, DOI 10.1016/j.vacuum.2011.04.015
   Mene RU, 2011, RADIAT PHYS CHEM, V80, P682, DOI 10.1016/j.radphyschem.2011.02.002
   Miro S, 2005, NUCL INSTRUM METH B, V227, P306, DOI 10.1016/j.nimb.2004.08.025
   Miro S., 2011, J RAMAN SPECTROSC, DOI 101002/jrs.2955
   Parthiban SP, 2008, NUCL INSTRUM METH B, V266, P911, DOI 10.1016/j.nimb.2008.02.026
   Pelletier H, 2004, NUCL INSTRUM METH B, V216, P269, DOI 10.1016/j.nimb.2003.11.045
   Pichugin VF, 2008, SURF COAT TECH, V202, P3913, DOI 10.1016/j.surfcoat.2008.01.038
   Pramatarova L, 2007, J MATER SCI-MATER M, V18, P435, DOI 10.1007/s10856-007-2002-4
   Rajesh P, 2011, J MATER SCI-MATER M, V22, P1671, DOI 10.1007/s10856-011-4342-3
   Rajesh P, 2011, J MATER SCI-MATER M, V22, P497, DOI 10.1007/s10856-011-4230-x
   Ronald H.J., 2003, BIOMATERIALS, V24, P4559
   Rosenman G, 2007, J LUMIN, V122, P936, DOI 10.1016/j.jlumin.2006.01.331
   Rusu VM, 2005, BIOMATERIALS, V26, P5414, DOI 10.1016/j.biomaterials.2005.01.051
   Sagari ARA, 2008, NUCL INSTRUM METH B, V266, P2515, DOI 10.1016/j.nimb.2008.03.069
   Sioshansi P, 1996, SURF COAT TECH, V83, P175, DOI 10.1016/0257-8972(95)02838-2
   Spirak J.M., 1990, J BIOMED MATER RES, V24, P1121
   Suganthi RV, 2009, J MATER SCI-MATER M, V20, P271, DOI 10.1007/s10856-008-3652-6
   Vellet-Regi M., 2006, CHEM-EUR J, V12, P5934
   Weikusat C, 2011, PHYS CHEM MINER, V38, P293, DOI 10.1007/s00269-010-0403-2
   Yang PP, 2008, BIOMATERIALS, V29, P4341, DOI 10.1016/j.biomaterials.2008.07.042
   Yen SK, 2003, MATER CHEM PHYS, V77, P70, DOI 10.1016/S0254-0584(01)00562-4
   YOSHINARI M, 1994, BIOMATERIALS, V15, P529, DOI 10.1016/0142-9612(94)90019-1
   Ziegler J. F., 1985, STOPPING RANGE IONS
NR 51
TC 13
Z9 13
U1 1
U2 18
PU ELSEVIER SCIENCE SA
PI LAUSANNE
PA PO BOX 564, 1001 LAUSANNE, SWITZERLAND
SN 0254-0584
J9 MATER CHEM PHYS
JI Mater. Chem. Phys.
PD MAY 15
PY 2012
VL 134
IS 1
BP 464
EP 477
DI 10.1016/j.matchemphys.2012.03.018
PG 14
WC Materials Science, Multidisciplinary
SC Materials Science
GA 949MW
UT WOS:000304581300072
DA 2018-10-19
ER

PT J
AU Frisz, JF
   Choi, JS
   Wilson, RL
   Harley, BAC
   Kraft, ML
AF Frisz, Jessica F.
   Choi, Ji Sun
   Wilson, Robert L.
   Harley, Brendan A. C.
   Kraft, Mary L.
TI Identifying Differentiation Stage of Individual Primary Hematopoietic
   Cells from Mouse Bone Marrow by Multivariate Analysis of TOF-Secondary
   Ion Mass Spectrometry Data
SO ANALYTICAL CHEMISTRY
LA English
DT Article
ID RAY PHOTOELECTRON-SPECTROSCOPY; PRINCIPAL COMPONENT ANALYSIS;
   PLURIPOTENT STEM-CELLS; ADSORBED PROTEIN FILMS; PROGENITOR CELLS; SIMS
   DATA; NICHES; IDENTIFICATION; MEMBRANES; DISCRIMINATE
AB The ability to self-renew and differentiate into multiple types of blood and immune cells renders hematopoietic stem and progenitor cells (HSPCs) valuable for clinical treatment of hematopoietic pathologies and as models of stem cell differentiation for tissue engineering applications. To study directed hematopoietic stem cell (HSC) differentiation and identify the conditions that recreate the native bone marrow environment, combinatorial biomaterials that exhibit lateral variations in chemical and mechanical properties are employed. New experimental approaches are needed to facilitate correlating cell differentiation stage with location in the culture system. We demonstrate that multivariate analysis of time-of-flight secondary ion mass spectrometry (TOF-SIMS) data can be used to identify the differentiation state of individual hematopoietic cells (HCs) isolated from mouse bone marrow. Here, we identify primary HCs from three distinct stages of B cell lymphopoiesis at the single cell level: HSPCs, common lymphoid progenitors, and mature B cells. The differentiation state of individual HCs in a test set could be identified with a partial least-squares discriminant analysis (PLS-DA) model that was constructed with calibration spectra from HCs of known differentiation status. The lowest error of identification was obtained when the intrapopulation spectral variation between the cells in the calibration and test sets was minimized. This approach complements the traditional methods that are used to identify HC differentiation stage. Further, the ability to gather mass spectrometry data from single HSCs cultured on graded biomaterial substrates may provide significant new insight into how HSPCs respond to extrinsic cues as well as the molecular changes that occur during cell differentiation.
C1 [Frisz, Jessica F.; Wilson, Robert L.; Kraft, Mary L.] Univ Illinois, Dept Chem, Urbana, IL 61801 USA.
   [Choi, Ji Sun; Harley, Brendan A. C.; Kraft, Mary L.] Univ Illinois, Dept Chem & Biomol Engn, Urbana, IL 61801 USA.
   [Harley, Brendan A. C.] Univ Illinois, Inst Genom Biol, Urbana, IL 61801 USA.
RP Kraft, ML (reprint author), Univ Illinois, Dept Chem, Urbana, IL 61801 USA.
EM mlkraft@illinois.edu
OI Choi, Ji Sun/0000-0001-9302-7840; Harley, Brendan/0000-0001-5458-154X
FU U.S. Department of Energy (DOE) [DEFG02-07ER46453, DE-FG02-07ER46471];
   American Cancer Society, Illinois Division, Inc (BACH) [160673, 189782]
FX Portions of this work were carried out in the Frederick Seitz Materials
   Research Laboratory Central Facilities, Univ. of Illinois, which is
   partially supported by the U.S. Department of Energy (DOE) under grants
   DEFG02-07ER46453 and DE-FG02-07ER46471. M.L.K. holds a Career Award at
   the Scientific Interface from the Burroughs Wellcome Fund. This work was
   partially supported by Grants #160673 and #189782 from the American
   Cancer Society, Illinois Division, Inc (BACH). The authors thank Barbara
   Pilas and Ben Montez from the Flow Cytometry Facility, UIUC, and Mr.
   Bhushan Mahadik (ChBE, UIUC) for assistance with flow cytometry sorting
   and analysis.
CR Adolfsson J, 2001, IMMUNITY, V15, P659, DOI 10.1016/S1074-7613(01)00220-5
   Adolfsson J, 2005, CELL, V121, P295, DOI 10.1016/j.cell.2005.02.013
   Anderton CR, 2012, SURF INTERFACE ANAL, V44, P322, DOI 10.1002/sia.3806
   Baker MJ, 2008, ANALYST, V133, P175, DOI 10.1039/b712853c
   Barnes CA, 2012, ANAL CHEM, V84, P893, DOI 10.1021/ac201179t
   Basaiawmoit RV, 2010, METHODS MOL BIOL, V648, P107, DOI 10.1007/978-1-60761-756-3_7
   Berman ESF, 2006, ANAL CHEM, V78, P6497, DOI 10.1021/ac060865g
   Berman ESF, 2009, SURF INTERFACE ANAL, V41, P97, DOI 10.1002/sia.2953
   BROWN J, 1991, INT IMMUNOL, V3, P175, DOI 10.1093/intimm/3.2.175
   Calvi LM, 2003, NATURE, V425, P841, DOI 10.1038/nature02040
   Cariappa A, 2002, CURR OPIN IMMUNOL, V14, P241, DOI 10.1016/S0952-7915(02)00328-X
   Chambers SM, 2007, PLOS BIOL, V5, P1750, DOI 10.1371/journal.pbio.0050201
   CHEN YW, 1992, INT IMMUNOL, V4, P1293, DOI 10.1093/intimm/4.11.1293
   Chong IG, 2005, CHEMOMETR INTELL LAB, V78, P103, DOI 10.1016/j.chemolab.2004.12.011
   Daley GQ, 2008, CELL, V132, P544, DOI 10.1016/j.cell.2008.02.009
   das Neves RP, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000560
   Freshney RI, 2010, CULTURE ANIMAL CELLS, P1
   Graham DJ, 2006, APPL SURF SCI, V252, P6860, DOI 10.1016/j.apsusc.2006.02.149
   Hardy RR, 2001, ANNU REV IMMUNOL, V19, P595, DOI 10.1146/annurev.immunol.19.1.595
   Holst J, 2010, NAT BIOTECHNOL, V28, P1123, DOI 10.1038/nbt.1687
   Houtkooper RH, 2011, SCI REP-UK, V1, DOI 10.1038/srep00134
   Iwasaki H, 2007, ONCOGENE, V26, P6687, DOI 10.1038/sj.onc.1210754
   Jungnickel H, 2005, ANAL CHEM, V77, P1740, DOI 10.1021/ac048792t
   Kiel MJ, 2005, CELL, V121, P1109, DOI 10.1016/j.cell.2005.05.026
   Kulp KS, 2006, ANAL CHEM, V78, P3651, DOI 10.1021/ac060054c
   Kurczy ME, 2010, P NATL ACAD SCI USA, V107, P2751, DOI 10.1073/pnas.0908101107
   Lhoest JB, 2001, J BIOMED MATER RES, V57, P432, DOI 10.1002/1097-4636(20011205)57:3<432::AID-JBM1186>3.0.CO;2-G
   Luo W, 2011, J AM CHEM SOC, V133, P10780, DOI 10.1021/ja204893w
   Lutolf MP, 2009, INTEGR BIOL, V1, P59, DOI 10.1039/b815718a
   Magnusson YK, 2008, OBESITY, V16, P2745, DOI 10.1038/oby.2008.424
   Martin TA, 2011, BIOMATERIALS, V32, P3949, DOI 10.1016/j.biomaterials.2011.02.018
   May CJ, 2004, ANAL CHEM, V76, P1114, DOI 10.1021/ac034874q
   Mayack SR, 2010, NATURE, V463, P495, DOI 10.1038/nature08749
   Mei Y, 2010, NAT MATER, V9, P768, DOI [10.1038/NMAT2812, 10.1038/nmat2812]
   Musumarra G, 2004, J CHEMOMETR, V18, P125, DOI 10.1002/cem.846
   Oran U, 2004, APPL SURF SCI, V227, P318, DOI 10.1016/j.apsusc.2003.12.008
   Ostrowski SG, 2004, SCIENCE, V305, P71, DOI 10.1126/science.1099791
   Passegue E, 2003, P NATL ACAD SCI USA, V100, P11842, DOI 10.1073/pnas.2034201100
   Rieger MA, 2008, CELLS TISSUES ORGANS, V188, P139, DOI 10.1159/000114540
   Schroeder T, 2010, CELL STEM CELL, V6, P203, DOI 10.1016/j.stem.2010.02.006
   Tang C, 2011, NAT BIOTECHNOL, V29, P829, DOI 10.1038/nbt.1947
   Thompson CE, 2006, APPL SURF SCI, V252, P6719, DOI 10.1016/j.apsusc.2006.02.237
   Thompson CE, 2004, APPL SURF SCI, V231, P420, DOI 10.1016/j.apsusc.2004.03.154
   Tokoyoda K, 2004, IMMUNITY, V20, P707, DOI 10.1016/j.immuni.2004.05.001
   Touboul D, 2005, J AM SOC MASS SPECTR, V16, P1608, DOI 10.1016/j.jasms.2005.06.005
   Vaezian B, 2010, ANAL CHEM, V82, P10006, DOI 10.1021/ac101640c
   Wagner MS, 2001, LANGMUIR, V17, P4649, DOI 10.1021/la001209t
   Warren LA, 2009, MECH AGEING DEV, V130, P46, DOI 10.1016/j.mad.2008.03.010
   Weissman IL, 2000, CELL, V100, P157, DOI 10.1016/S0092-8674(00)81692-X
   Wilson A, 2006, NAT REV IMMUNOL, V6, P93, DOI 10.1038/nri1779
   Yang LP, 2005, BLOOD, V105, P2717, DOI 10.1182/blood-2004-06-2159
   Yilmaz OH, 2006, BLOOD, V107, P924, DOI 10.1182/blood-2005-05-2140
   Yin T, 2006, J CLIN INVEST, V116, P1195, DOI 10.1172/JCI28568
NR 53
TC 16
Z9 15
U1 0
U2 38
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 0003-2700
EI 1520-6882
J9 ANAL CHEM
JI Anal. Chem.
PD MAY 15
PY 2012
VL 84
IS 10
BP 4307
EP 4313
DI 10.1021/ac203329j
PG 7
WC Chemistry, Analytical
SC Chemistry
GA 941LU
UT WOS:000303965500012
PM 22507202
OA Green Accepted
DA 2018-10-19
ER

PT J
AU Kubota, H
   Endo, H
   Noma, M
   Tsuchiya, H
   Yoshimoto, A
   Matsukura, M
   Takahashi, Y
   Inaba, Y
   Sudo, K
AF Kubota, Hiroshi
   Endo, Hidehito
   Noma, Mio
   Tsuchiya, Hiroshi
   Yoshimoto, Akihiro
   Matsukura, Mitsuru
   Takahashi, Yu
   Inaba, Yusuke
   Sudo, Kenichi
TI Equine pericardial roll graft replacement of infected pseudoaneurysm of
   the aortic arch
SO JOURNAL OF CARDIOTHORACIC SURGERY
LA English
DT Article
DE Equine pericardium; Biomaterial; Infection; Aortic aneurysm; Surgery
ID ANEURYSMS
AB Resection of the infected aorta, debridement of the surrounding tissue, in situ graft replacement, and omentopexy is the standard procedure for treating infected aortic aneurysms, but the question of which graft material is optimal is still a matter of controversy. We recently treated a patient with an infected thoracic aortic aneurysm. The aneurysm was located in the proximal aortic arch. Because the patients had previously undergone abdominal surgery, the aortic arch were replaced in situ with a branched equine pericardial roll grafts. The patient is alive and well 23 months after the operation.
C1 [Kubota, Hiroshi; Endo, Hidehito; Noma, Mio; Tsuchiya, Hiroshi; Yoshimoto, Akihiro; Matsukura, Mitsuru; Takahashi, Yu; Inaba, Yusuke; Sudo, Kenichi] Kyorin Univ, Dept Cardiovasc Surg, Mitaka, Tokyo 1818611, Japan.
RP Kubota, H (reprint author), Kyorin Univ, Dept Cardiovasc Surg, 6-20-2 Shinkawa, Mitaka, Tokyo 1818611, Japan.
EM kub@ks.kyorin-u.ac.jp
CR Czerny M, 2011, ANN THORAC SURG, V92, P1657, DOI 10.1016/j.athoracsur.2011.06.073
   Gupta AK, 1996, J VASC SURG, V24, P472, DOI 10.1016/S0741-5214(96)70204-5
   Kubota H, 2010, ANN THORAC SURG, V90, P1340, DOI 10.1016/j.athoracsur.2010.03.024
   VOGT P, 1995, J THORAC CARDIOV SUR, V109, P589, DOI 10.1016/S0022-5223(95)70294-6
   VOGT PR, 1995, EUR J CARDIO-THORAC, V9, P502, DOI 10.1016/S1010-7940(95)80050-6
   Yamamoto H, 2011, INTERACT CARDIOV TH, V12, P866, DOI 10.1510/icvts.2010.262667
   Yamamoto H, 2009, GEN THORAC CARDIOVAS, V57, P413, DOI 10.1007/s11748-008-0388-7
   Yamamoto H, 2009, J VASC SURG, V49, P1041, DOI 10.1016/j.jvs.2008.11.053
NR 8
TC 5
Z9 5
U1 0
U2 1
PU BIOMED CENTRAL LTD
PI LONDON
PA 236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND
SN 1749-8090
J9 J CARDIOTHORAC SURG
JI J. Cardiothorac. Surg.
PD MAY 14
PY 2012
VL 7
AR 45
DI 10.1186/1749-8090-7-45
PG 5
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA 993RM
UT WOS:000307877300001
PM 22583570
OA DOAJ Gold, Green Published
DA 2018-10-19
ER

PT J
AU Yang, WJ
   Yang, CS
   Huang, CJ
   Chen, KS
   Lin, SF
AF Yang, Wen-Jen
   Yang, Chih-Sheng
   Huang, Chen-Ji
   Chen, Ko-Shao
   Lin, Shuen-Fuh
TI Bostrycin, a novel coupling agent for protein immobilization and
   prevention of biomaterial-centered infection produced by Nigrospora sp
   No. 407
SO ENZYME AND MICROBIAL TECHNOLOGY
LA English
DT Article
DE Bostrycin; Coupling agent; Surface modification; Protein immobilization;
   Bacteriostasis
ID ALTERNARIA-SOLANI; DACTYLARIA-LUTEA; METABOLITES;
   TETRAHYDROANTHRAQUINONES; OXIDASE; STRAIN
AB Bostrycin, a red antibacterial agent with tetrahydroanthraquinone structure, has been isolated from Nigrospora sp. No. 407. This study investigated the potential antibacterial and multifunctional properties of matrixes through immobilization of bostrycin on their surface for immobilization of protein and prevention of bacterial growth. Bostrycin was immobilized on nonwoven polypropylene (PP) fabric by a technique using glutaraldehyde and polyethyleneimine for the activation of the surface. Glucose oxidase immobilized on bostrycin-treated nonwoven PP fabric showed high activity. The immobilization process improved thermal stability of the enzymes. During repeated assay for 30 cycles, the enzyme activity dropped to only 70% of the initial activity. Both bostrycin-treated nonwoven PP fabric sample and subsequently immobilized glucose oxidase sample on the surface also still exhibited a bacteriostatic effect. This is the first study to show that bostrycin is a promising coupling agent for surface modification on matrix and its potential applications in protein immobilization and biomaterial-centered infection. Crown Copyright (C) 2012 Published by Elsevier Inc. All rights reserved.
C1 [Lin, Shuen-Fuh] Natl Univ Kaohsiung, Dept Life Sci, Kaohsiung 811, Taiwan.
   [Yang, Wen-Jen; Yang, Chih-Sheng] Natl Univ Kaohsiung, Inst Biotechnol, Kaohsiung 811, Taiwan.
   [Huang, Chen-Ji] Natl Chiao Tung Univ, Dept Biol Sci & Technol, Hsinchu 30010, Taiwan.
   [Chen, Ko-Shao] Tatung Univ, Dept Mat Engn, Taipei 104, Taiwan.
RP Lin, SF (reprint author), Natl Univ Kaohsiung, Dept Life Sci, 700 Kaohsiung Univ Rd, Kaohsiung 811, Taiwan.
EM sflin@nuk.edu.tw
FU National Science Council [NSC98-2221-E-390-010]
FX The authors are thankful for the financial supports provided by the
   National Science Council through the grant NSC98-2221-E-390-010. The
   authors also thank the laboratory staffs of Kaohsiung Veteran General
   Hospital and Institute of Preventive Medicine, National Defense Medical
   Center (Taipei) for their assistance with the antibacterial assay of
   bostrycin against the pathogenic strains.
CR ALLAIN CC, 1974, CLIN CHEM, V20, P470
   Alvi KA, 2004, J IND MICROBIOL BIOT, V31, P11, DOI 10.1007/s10295-003-0106-5
   ASSANTE G, 1987, PHYTOCHEMISTRY, V26, P703, DOI 10.1016/S0031-9422(00)84768-8
   Barry A I., 1980, ANTIBIOTICS LAB MED, P10
   BEAGLEY B, 1989, J CHEM SOC CHEM COMM, P17, DOI 10.1039/c39890000017
   BECKER AM, 1978, J ANTIBIOT, V31, P324, DOI 10.7164/antibiotics.31.324
   BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3
   BURNS CJ, 1991, AUST J CHEM, V44, P1729, DOI 10.1071/CH9911729
   CHARUDATTAN R, 1982, APPL ENVIRON MICROB, V43, P846
   Eijk G.W.V., 1975, EXPERIENTIA, V31, P783
   Furuya K., 1969, SANKYO KENKYUSHO NEM, V21, P165
   Garcia JL, 1990, BIOTECHNOL TECH, P425
   Gerberding JL, 1999, CURR CLIN TOPICS INF, V19, P83
   Gottenbos B, 2002, J MATER SCI-MATER M, V13, P717, DOI 10.1023/A:1016175502756
   GRISTINA AG, 1987, SCIENCE, V237, P1588, DOI 10.1126/science.3629258
   He MZ, 2005, SHANGHAI TEXT SCI TE, V33, P62
   Ivanova VB, 2002, J ANTIBIOT, V55, P914, DOI 10.7164/antibiotics.55.914
   Kang GD, 2004, FIBER POLYM, V5, P234, DOI 10.1007/BF02903006
   KELLY TR, 1985, J ORG CHEM, V50, P3679, DOI 10.1021/jo00220a001
   KETTNER M, 1973, J ANTIBIOT, V26, P692, DOI 10.7164/antibiotics.26.692
   Li DX, 2007, BIOCHEM BIOPH RES CO, V355, P488, DOI 10.1016/j.bbrc.2007.01.183
   Lin SF, 1996, BIOTECHNOL TECH, V10, P63, DOI 10.1007/BF00161086
   Namikoshi M, 2003, J ANTIBIOT, V56, P755, DOI 10.7164/antibiotics.56.755
   NODA T, 1970, TETRAHEDRON, V26, P1339, DOI 10.1016/S0040-4020(01)93004-2
   Noda T, 1968, TETRAHEDRON LETT, V9, P6087
   OKAMURA N, 1993, PHYTOCHEMISTRY, V34, P1005, DOI 10.1016/S0031-9422(00)90703-9
   RUSIN KM, 1992, BIOSENS BIOELECTRON, V7, P367, DOI 10.1016/0956-5663(92)85033-7
   STOESSL A, 1983, CAN J CHEM, V61, P378, DOI 10.1139/v83-068
   SUEMITSU R, 1990, PHYTOCHEMISTRY, V29, P1509, DOI 10.1016/0031-9422(90)80110-3
   Wheeler MM, 1975, PLANTA MED, V14, P288
   YAGI A, 1993, PHYTOCHEMISTRY, V33, P87, DOI 10.1016/0031-9422(93)85401-C
NR 31
TC 5
Z9 6
U1 0
U2 19
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0141-0229
J9 ENZYME MICROB TECH
JI Enzyme Microb. Technol.
PD MAY 10
PY 2012
VL 50
IS 6-7
BP 287
EP 292
DI 10.1016/j.enzmictec.2012.02.002
PG 6
WC Biotechnology & Applied Microbiology
SC Biotechnology & Applied Microbiology
GA 941IA
UT WOS:000303955700003
PM 22500894
DA 2018-10-19
ER

PT J
AU Benfenati, V
   Stahl, K
   Gomis-Perez, C
   Toffanin, S
   Sagnella, A
   Torp, R
   Kaplan, DL
   Ruani, G
   Omenetto, FG
   Zamboni, R
   Muccini, M
AF Benfenati, Valentina
   Stahl, Katja
   Gomis-Perez, Carolina
   Toffanin, Stefano
   Sagnella, Anna
   Torp, Reidun
   Kaplan, David L.
   Ruani, Giampiero
   Omenetto, Fiorenzo G.
   Zamboni, Roberto
   Muccini, Michele
TI Biofunctional Silk/Neuron Interfaces
SO ADVANCED FUNCTIONAL MATERIALS
LA English
DT Article
DE silk films; biofunctional interfaces; neuron electrophysiology
ID PERIPHERAL-NERVE REGENERATION; ROOT GANGLION NEURONS; THIN-FILM
   TRANSISTORS; RAT SENSORY NEURONS; GROWTH-FACTOR NGF; SILK FIBROIN;
   IN-VITRO; DRG NEURONS; NEUROPATHIC PAIN; SCIATIC-NERVE
AB Silk fibroin (SF) is a biocompatible and slowly biodegradable material with excellent mechanical properties and huge potential for use as biofunctional interface in electronic devices that aim to stimulate and control neural network activity and peripheral nerve repair. It is shown that SF films act as material interfaces that support the adherence and neurite outgrowth of dorsal root ganglion (DRG) neurons and preserve neuronal functions. Silk films preserve the capability of neuronal cells to fire and DRG neurons on silk films retain the intracellular free Ca2+ concentration ([Ca2+]i) response to capsaicin, a typical noxious stimulus for this neuronal culture model. It is also demonstrated that nerve growth factor (NGF)-functionalized silk films promote neurite outgrowth and modulate functional properties of DRG neurons. The results show that silk preserves DRG neuronal physiology and is a promising biomaterial platform for the future development of devices with goals including functional recovery of injured neurons, neurite functional outgrowth in vitro, or functional electrostimulation in vivo.
C1 [Benfenati, Valentina; Toffanin, Stefano; Ruani, Giampiero; Muccini, Michele] ISMN, CNR, I-40129 Bologna, Italy.
   [Stahl, Katja; Torp, Reidun] Univ Oslo, Ctr Mol Biol & Neurosci, NO-0317 Oslo, Norway.
   [Gomis-Perez, Carolina] Univ Bologna, Dept Human & Gen Physiol, I-40127 Bologna, Italy.
   [Sagnella, Anna; Zamboni, Roberto] ISOF, CNR, I-40129 Bologna, Italy.
   [Kaplan, David L.; Omenetto, Fiorenzo G.] Tufts Univ, Dept Biomed Engn, Medford, MA 02155 USA.
RP Benfenati, V (reprint author), ISMN, CNR, Via Gobetti 101, I-40129 Bologna, Italy.
EM v.benfenati@bo.ismn.cnr.it; M.Muccini@bo.ismn.cnr.it
RI Muccini, Michele/D-6935-2018; Ruani, Giampiero/B-2990-2010; Zamboni,
   Roberto/P-3610-2015; Gomis-Perez, Carolina/J-6472-2012; Toffanin,
   Stefano/N-7651-2015; Benfenati, Valentina/D-4579-2016
OI Muccini, Michele/0000-0003-0489-8316; Ruani,
   Giampiero/0000-0001-9326-0490; Zamboni, Roberto/0000-0003-3739-2207;
   Gomis-Perez, Carolina/0000-0002-6818-4403; Toffanin,
   Stefano/0000-0003-4099-8664; Benfenati, Valentina/0000-0002-2858-8497
FU EU [FP7-ICT- 248052]; Consorzio MIST E-R [I.1.1]; Italian MIUR
   [FIRB-RBPR05JH2]; NIH P41 Tissue Engineering Resource Center [P41
   EB002520]
FX V.B. and K.S. conbributed equally to this work. This work was supported
   by EU project FP7-ICT- 248052 (PHOTO-FET), by Consorzio MIST E-R through
   Programma Operativo FESR 2007-2013 della Regione Emilia-Romagna-Attivita
   I.1.1, and by Italian MIUR project FIRB-RBPR05JH2 (ITALNANONET). The
   authors also thank the NIH P41 Tissue Engineering Resource Center (P41
   EB002520) for partial financial support. The authors gratefully
   acknowledge the skillfull technical support of Marco Caprini and Alessia
   Minardi, Dept. of Human and General Physiology, University of Bologna,
   for DRG cell culture preparation and maintenance.
CR ACEVEDO LD, 1995, BRAIN RES, V701, P89, DOI 10.1016/0006-8993(95)00979-6
   AGUAYO LG, 1992, BRAIN RES, V570, P61, DOI 10.1016/0006-8993(92)90564-P
   Alluin O, 2009, BIOMATERIALS, V30, P363, DOI 10.1016/j.biomaterials.2008.09.043
   Altman GH, 2003, BIOMATERIALS, V24, P401, DOI 10.1016/S0142-9612(02)00353-8
   Aurilio C, 2008, J CELL PHYSIOL, V215, P8, DOI 10.1002/jcp.21280
   Baron Ralf, 2009, Handb Exp Pharmacol, P3, DOI 10.1007/978-3-540-79090-7_1
   Belkas JS, 2004, NEUROL RES, V26, P151, DOI 10.1179/016164104225013798
   Bellamkonda RV, 2006, BIOMATERIALS, V27, P3515, DOI 10.1016/j.biomaterials.2006.02.030
   Benfenati V, 2010, BIOMATERIALS, V31, P7883, DOI 10.1016/j.biomaterials.2010.07.013
   Bettinger CJ, 2010, ADV MATER, V22, P651, DOI 10.1002/adma.200902322
   BEVAN S, 1995, J NEUROSCI, V15, P4918
   BIRCH BD, 1992, P NATL ACAD SCI USA, V89, P7978, DOI 10.1073/pnas.89.17.7978
   Burkey TH, 2004, METH MOLEC MED, P189
   Capelli R, 2011, ORG ELECTRON, V12, P1146, DOI 10.1016/j.orgel.2011.04.005
   Caterina MJ, 2000, SCIENCE, V288, P306, DOI 10.1126/science.288.5464.306
   Cesare P, 1996, P NATL ACAD SCI USA, V93, P15435, DOI 10.1073/pnas.93.26.15435
   Cummins TR, 2009, NAT PROTOC, V4, P1103, DOI 10.1038/nprot.2009.91
   Cummins TR, 2000, J NEUROSCI, V20, P8754
   Cunha S., 2011, NANOMEDICINE, V7, P50
   Di Giovanni S, 2005, J BIOL CHEM, V280, P2084, DOI 10.1074/jbc.M411975200
   Doolabh VB, 1996, REV NEUROSCIENCE, V7, P47
   Fromherz P, 2003, NANOELECTRONICS INFO, P781
   Greve F, 2007, BIOMATERIALS, V28, P5246, DOI 10.1016/j.biomaterials.2007.08.010
   GRYNKIEWICZ G, 1985, J BIOL CHEM, V260, P3440
   Horan RL, 2005, BIOMATERIALS, V26, P3385, DOI 10.1016/j.biomaterials.2004.09.020
   Hudson LJ, 2001, EUR J NEUROSCI, V13, P2105, DOI 10.1046/j.0953-816x.2001.01591.x
   Irimia-Vladu M, 2010, ADV FUNCT MATER, V20, P4069, DOI 10.1002/adfm.201001031
   Johnson MA, 2007, J NEUROSCI, V27, P3069, DOI 10.1523/JNEUROSCI.4562-06.2007
   Kharlampieva E, 2010, ACS NANO, V4, P7053, DOI 10.1021/nn102456w
   Kim DH, 2010, NAT MATER, V9, P511, DOI [10.1038/nmat2745, 10.1038/NMAT2745]
   Kim DH, 2009, APPL PHYS LETT, V95, DOI 10.1063/1.3238552
   Klusakova I, 2009, ANN ANAT, V191, P248, DOI 10.1016/j.aanat.2009.02.007
   Lankford KL, 1998, J COMP NEUROL, V391, P11, DOI 10.1002/(SICI)1096-9861(19980202)391:1<11::AID-CNE2>3.0.CO;2-U
   Lawrence BD, 2008, J MATER SCI, V43, P6967, DOI 10.1007/s10853-008-2961-y
   Lu QA, 2011, BIOMACROMOLECULES, V12, P1080, DOI 10.1021/bm101422j
   Madduri S, 2010, BIOMATERIALS, V31, P2323, DOI 10.1016/j.biomaterials.2009.11.073
   Melli G, 2009, EXPERT OPIN DRUG DIS, V4, P1035, DOI 10.1517/17460440903266829
   Palazzo E, 2010, MOL PAIN, V6, DOI 10.1186/1744-8069-6-66
   Pazyra-Murphy MF, 2008, JOVE-J VIS EXP, V20, P951
   Perry H, 2008, ADV MATER, V20, P3070, DOI 10.1002/adma.200800011
   Pfister LA, 2007, J PERIPHER NERV SYST, V12, P65, DOI 10.1111/j.1529-8027.2007.00125.x
   Poghossian A, 2009, SEMIN CELL DEV BIOL, V20, P41, DOI 10.1016/j.semcdb.2009.01.014
   Premkumar LS, 2008, CURR NEUROPHARMACOL, V6, P151, DOI 10.2174/157015908784533888
   Schmidt CE, 1997, P NATL ACAD SCI USA, V94, P8948, DOI 10.1073/pnas.94.17.8948
   Sculptoreanu A, 2007, EXP NEUROL, V205, P92, DOI 10.1016/j.expneurol.2007.01.038
   Singh RP, 2009, CELL TRANSPLANT, V18, P55, DOI 10.3727/096368909788237177
   Sinis N, 2009, J BRACHIAL PLEX PERI, V4, DOI 10.1186/1749-7221-4-19
   Stucky CL, 1999, J NEUROSCI, V19, P6497
   Tang X, 2009, J BIOMED MATER RES A, V91A, P166, DOI 10.1002/jbm.a.32212
   Tripathi PK, 2006, NEUROSCIENCE, V143, P923, DOI 10.1016/j.neuroscience.2006.08.052
   Uebersax L, 2007, BIOMATERIALS, V28, P4449, DOI 10.1016/j.biomaterials.2007.06.034
   Ueda H, 2006, PHARMACOL THERAPEUT, V109, P57, DOI 10.1016/j.pharmthera.2005.06.003
   VANDERZEE CEEM, 1989, J NEUROSCI, V9, P3505
   Vellani V, 2001, J PHYSIOL-LONDON, V534, P813, DOI 10.1111/j.1469-7793.2001.00813.x
   Vepari C, 2007, PROG POLYM SCI, V32, P991, DOI 10.1016/j.progpolymsci.2007.05.013
   Volterra A, 2005, NAT REV NEUROSCI, V6, P626, DOI 10.1038/nrn1722
   Voskerician G, 2003, BIOMATERIALS, V24, P1959, DOI 10.1016/S0142-9612(02)00565-3
   Wang CH, 2011, ADV MATER, V23, P1630, DOI 10.1002/adma.201004071
   Wang Wei, 2010, Phys Med Rehabil Clin N Am, V21, P157, DOI 10.1016/j.pmr.2009.07.003
   Yang Y, 2007, BIOMATERIALS, V28, P5526, DOI 10.1016/j.biomaterials.2007.09.001
   Yang YM, 2007, BIOMATERIALS, V28, P1643, DOI 10.1016/j.biomaterials.2006.12.004
   Zencirci SG, 2010, J NEUROSCI METH, V191, P277, DOI 10.1016/j.jneumeth.2010.07.008
   Zhang XF, 2004, BRAIN RES, V1009, P147, DOI 10.1016/j.brainres.2004.02.057
   Zhang XF, 2003, NEUROSCIENCE, V122, P1003, DOI 10.1016/j.neuroscience.2003.08.035
NR 64
TC 28
Z9 28
U1 2
U2 89
PU WILEY-V C H VERLAG GMBH
PI WEINHEIM
PA POSTFACH 101161, 69451 WEINHEIM, GERMANY
SN 1616-301X
EI 1616-3028
J9 ADV FUNCT MATER
JI Adv. Funct. Mater.
PD MAY 9
PY 2012
VL 22
IS 9
BP 1871
EP 1884
DI 10.1002/adfm.201102310
PG 14
WC Chemistry, Multidisciplinary; Chemistry, Physical; Nanoscience &
   Nanotechnology; Materials Science, Multidisciplinary; Physics, Applied;
   Physics, Condensed Matter
SC Chemistry; Science & Technology - Other Topics; Materials Science;
   Physics
GA 934HK
UT WOS:000303434600010
DA 2018-10-19
ER

PT J
AU Ko, YG
   Yu, SM
   Park, SJ
   Chun, HJ
   Kim, CH
AF Ko, Young Gun
   Yu, Seong Mi
   Park, Sang Joon
   Chun, Heung Jae
   Kim, Chun-Ho
TI Characterization of Surface Properties and Cytocompatibility of
   Ion-etched Chitosan Films
SO LANGMUIR
LA English
DT Article
ID CELL-ADHESION; POLYMER SURFACES; NITROGEN PLASMA; DERMAL SCAFFOLD;
   STEM-CELLS; IN-VITRO; FT-IR; BIOMATERIALS; BIOCOMPATIBILITY; WETTABILITY
AB Surface modification of biomaterials has been highlighted by biomedical engineers as a facile method for improving cell-biomaterial interactions without the expense and time required to develop new materials. In the present study, we investigated the influence of ion-etching on the surface characteristics of chitosan films using XPS and ATR FT-IR. The physiological behavior of human dermal fibroblasts (hDFs) grown on such surfaces was studied by evaluating adhesive and proliferative properties, and by examining surface morphologies of hDFs using AFM. hDFs displayed different shapes depending on the ion-etching time. hDFs grown on chitosan films ion-etched for 5 min displayed better development of lamellipodia and filopodia around the hDF periphery than did cells grown on nonmodified chitosan film, whereas hDFs did not spread well on films ion-etched for 20 min. Films ion-etched for 5 min or less had higher NH2 and COOH contents, leading to enhanced hDF adhesion and proliferation.
C1 [Ko, Young Gun; Yu, Seong Mi; Park, Sang Joon; Kim, Chun-Ho] Korea Inst Radiol & Med Sci, Lab Tissue Engn, Seoul 139706, South Korea.
   [Ko, Young Gun] Korea Inst Sci & Technol, Energy Mech Ctr, Seoul 136791, South Korea.
   [Chun, Heung Jae] Catholic Univ Korea, Coll Med, Dept Biomed Engn, Seoul 137701, South Korea.
RP Kim, CH (reprint author), Korea Inst Radiol & Med Sci, Lab Tissue Engn, 75 Nowon Gil, Seoul 139706, South Korea.
EM chkim@kcch.re.kr
RI Ko, Young Gun/A-1299-2007
OI Ko, Young Gun/0000-0002-1277-9555
FU Industrial Strategic Technology Development Program [10035291]; Korea
   Science and Engineering Foundation (KOSEF); Ministry of Education,
   Science and Technology (MEST, Korea)
FX This study was supported by Industrial Strategic Technology Development
   Program (10035291, Multifunctional medical fiber complex technology)
   founded by the Ministry of Knowledge Economy (MICE, Korea) and by
   Nuclear Research Development Program of the Korea Science and
   Engineering Foundation (KOSEF) grant funded by Ministry of Education,
   Science and Technology (MEST, Korea).
CR Amaral IF, 2005, J BIOMAT SCI-POLYM E, V16, P1575, DOI 10.1163/156856205774576736
   Anders A, 2005, SURF COAT TECH, V200, P1893, DOI 10.1016/j.surfcoat.2005.08.018
   Bordenave N, 2008, BIOMACROMOLECULES, V9, P2377, DOI 10.1021/bm800375v
   Cai L, 2010, BIOMATERIALS, V31, P4457, DOI 10.1016/j.biomaterials.2010.02.020
   Chan C.-M, 1994, POLYM SURFACE MODIFI, P37
   Chan C.-M, 1994, POLYM SURFACE MODIFI, P7
   Chatelet C, 2001, BIOMATERIALS, V22, P261, DOI 10.1016/S0142-9612(00)00183-6
   Cho S.J., 2011, INT J TISSUE REGEN, V2011, p[2, 52]
   Chung TW, 2011, CARBOHYD POLYM, V85, P726, DOI 10.1016/j.carbpol.2011.03.025
   Colthup N. B., 1964, INTRO INFRARED RAMAN
   Cooke F.W., 1996, BIOMATERIALS SCI, P11
   Dalby MJ, 2007, NAT MATER, V6, P997, DOI 10.1038/nmat2013
   DAVENAS J, 1990, ADV MATER, V2, P521, DOI 10.1002/adma.19900021103
   De Geyter N, 2008, SURF INTERFACE ANAL, V40, P608, DOI 10.1002/sia.2611
   Discher DE, 2005, SCIENCE, V310, P1139, DOI 10.1126/science.1116995
   Faucheux N, 2004, BIOMATERIALS, V25, P2721, DOI 10.1016/j.biomaterials.2003.09.069
   Freier T, 2005, BIOMATERIALS, V26, P5872, DOI 10.1016/j.biomaterials.2005.02.033
   Geiger B, 2001, NAT REV MOL CELL BIO, V2, P793, DOI 10.1038/35099066
   Geiger B, 2009, NAT REV MOL CELL BIO, V10, P21, DOI 10.1038/nrm2593
   Howling GI, 2001, BIOMATERIALS, V22, P2959, DOI 10.1016/S0142-9612(01)00042-4
   Jiang QR, 2009, SURF COAT TECH, V203, P1604, DOI 10.1016/j.surfcoat.2008.12.010
   Joshi RS, 2009, EUR PHYS J D, V54, P249, DOI 10.1140/epjd/e2009-00088-6
   Kane J. B., 1996, BIOMATERIALS SCI INT, P360
   Kim CH, 2004, MACROMOL RES, V12, P367, DOI 10.1007/BF03218413
   Kim H.L, 2010, INT J TISSUE REGEN, V1, P81
   Ko YG, 2001, BIOMATERIALS, V22, P2115, DOI 10.1016/S0142-9612(00)00400-2
   Ko YG, 2009, J COLLOID INTERF SCI, V330, P77, DOI 10.1016/j.jcis.2008.10.015
   Kumar MNVR, 2004, CHEM REV, V104, P6017, DOI 10.1021/cr030441b
   Lee JH, 1998, J COLLOID INTERF SCI, V205, P323, DOI 10.1006/jcis.1998.5688
   Liu XM, 2009, J NANOSCI NANOTECHNO, V9, P3449, DOI 10.1166/jnn.2009.NS15
   Lopez-Perez PM, 2007, J MATER CHEM, V17, P4064, DOI 10.1039/b707326g
   Lutolf MP, 2005, NAT BIOTECHNOL, V23, P47, DOI 10.1038/nbt1055
   Ma PX, 2008, ADV DRUG DELIVER REV, V60, P184, DOI 10.1016/j.addr.2007.08.041
   Ma PX, 2004, MATER TODAY, V7, P30, DOI 10.1016/S1369-7021(04)00233-0
   Matienzo LJ, 2002, MACROMOL MATER ENG, V287, P871, DOI 10.1002/mame.200290022
   Minagawa M, 1997, J APPL POLYM SCI, V63, P1625
   Mrksich M, 2000, CHEM SOC REV, V29, P267, DOI 10.1039/a705397e
   Oh SH, 2003, BIOMATERIALS, V24, P4011, DOI 10.1016/S0142-9612(03)00284-9
   Park HS, 2004, TISSUE ENG, V10, P343, DOI 10.1089/107632704323061708
   PEARSON FG, 1960, J POLYM SCI, V43, P101, DOI 10.1002/pol.1960.1204314109
   Price R, 2008, ACAD PR SER BIOM ENG, P507, DOI 10.1016/B978-0-12-370869-4.00017-3
   Ranjan A., 2009, NANOTECHNOLOGY, V20
   Shimahara K, 1996, ADV CHITIN CHITOSAN, P364
   Silva SS, 2008, MACROMOL BIOSCI, V8, P568, DOI 10.1002/mabi.200700264
   Silva SS, 2005, J MATER SCI-MATER M, V16, P575, DOI 10.1007/s10856-005-0534-z
   Sionkowska A, 2011, PROG POLYM SCI, V36, P1254, DOI 10.1016/j.progpolymsci.2011.05.003
   Sioshansi P, 1996, SURF COAT TECH, V83, P175, DOI 10.1016/0257-8972(95)02838-2
   Van de Velde K, 2004, CARBOHYD POLYM, V58, P409, DOI 10.1016/j.carbpol.2004.08.004
   Vesel A, 2008, SURF INTERFACE ANAL, V40, P661, DOI 10.1002/sia.2691
   Wagner C.D., 2007, NIST XRAY PHOTOELECT
   Wang Y., 2009, BIOMED MATER, V4
   Wang YC, 2003, BIOMACROMOLECULES, V4, P224, DOI 10.1021/bm0256294
   Wei JH, 2007, J BIOMED MATER RES B, V81B, P66, DOI 10.1002/jbm.b.30638
   Youn YH, 2007, KEY ENG MATER, V342-343, P185, DOI 10.4028/www.scientific.net/KEM.342-343.185
   Zhang Y, 2009, MAT SCI ENG C-BIO S, V29, P908, DOI 10.1016/j.msec.2008.07.040
   Zheng JN, 2010, LANGMUIR, V26, P17156, DOI 10.1021/la1030203
NR 56
TC 6
Z9 6
U1 0
U2 18
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 0743-7463
J9 LANGMUIR
JI Langmuir
PD MAY 8
PY 2012
VL 28
IS 18
BP 7223
EP 7232
DI 10.1021/la204176j
PG 10
WC Chemistry, Multidisciplinary; Chemistry, Physical; Materials Science,
   Multidisciplinary
SC Chemistry; Materials Science
GA 936ZK
UT WOS:000303628600018
PM 22537110
DA 2018-10-19
ER

PT J
AU Weidner, C
   de Groot, JC
   Prasad, A
   Freiwald, A
   Quedenau, C
   Kliem, M
   Witzke, A
   Kodelja, V
   Han, CT
   Giegold, S
   Baumann, M
   Klebl, B
   Siems, K
   Muller-Kuhrt, L
   Schurmann, A
   Schuler, R
   Pfeiffer, AFH
   Schroeder, FC
   Bussow, K
   Sauer, S
AF Weidner, Christopher
   de Groot, Jens C.
   Prasad, Aman
   Freiwald, Anja
   Quedenau, Claudia
   Kliem, Magdalena
   Witzke, Annabell
   Kodelja, Vitam
   Han, Chung-Ting
   Giegold, Sascha
   Baumann, Matthias
   Klebl, Bert
   Siems, Karsten
   Mueller-Kuhrt, Lutz
   Schuermann, Annette
   Schueler, Rita
   Pfeiffer, Andreas F. H.
   Schroeder, Frank C.
   Buessow, Konrad
   Sauer, Sascha
TI Amorfrutins are potent antidiabetic dietary natural products
SO PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF
   AMERICA
LA English
DT Article
DE nuclear receptors; nutrition; compound screening; organic synthesis;
   x-ray structure
ID ACTIVATED-RECEPTOR-GAMMA; AMELIORATES GLUCOSE-TOLERANCE; OBESITY-RELATED
   INFLAMMATION; PPAR-GAMMA; INSULIN-RESISTANCE; METABOLIC SYNDROME;
   NUCLEAR RECEPTORS; GENE-EXPRESSION; LIGAND-BINDING; DISCOVERY
AB Given worldwide increases in the incidence of obesity and type 2 diabetes, new strategies for preventing and treating metabolic diseases are needed. The nuclear receptor PPAR. (peroxisome proliferator-activated receptor gamma) plays a central role in lipid and glucose metabolism; however, current PPAR.-targeting drugs are characterized by undesirable side effects. Natural products from edible biomaterial provide a structurally diverse resource to alleviate complex disorders via tailored nutritional intervention. We identified a family of natural products, the amorfrutins, from edible parts of two legumes, Glycyrrhiza foetida and Amorpha fruticosa, as structurally new and powerful antidiabetics with unprecedented effects for a dietary molecule. Amorfrutins bind to and activate PPAR., which results in selective gene expression and physiological profiles markedly different from activation by current synthetic PPAR. drugs. In diet-induced obese and db/db mice, amorfrutin treatment strongly improves insulin resistance and other metabolic and inflammatory parameters without concomitant increase of fat storage or other unwanted side effects such as hepatoxicity. These results show that selective PPAR.-activation by diet-derived ligands may constitute a promising approach to combat metabolic disease.
C1 [Weidner, Christopher; Freiwald, Anja; Quedenau, Claudia; Kliem, Magdalena; Witzke, Annabell; Kodelja, Vitam; Han, Chung-Ting; Sauer, Sascha] Max Planck Inst Mol Genet, Otto Warburg Lab, D-14195 Berlin, Germany.
   [Weidner, Christopher] Free Univ Berlin, Dept Biol Chem & Pharm, D-14195 Berlin, Germany.
   [de Groot, Jens C.; Buessow, Konrad] Helmholtz Ctr Infect Res, Div Struct Biol, D-38124 Braunschweig, Germany.
   [Prasad, Aman; Schroeder, Frank C.] Cornell Univ, Dept Chem & Chem Biol, Ithaca, NY 14853 USA.
   [Prasad, Aman; Schroeder, Frank C.] Cornell Univ, Boyce Thompson Inst, Ithaca, NY 14853 USA.
   [Giegold, Sascha; Baumann, Matthias; Klebl, Bert] Lead Discovery Ctr GmbH, D-44227 Dortmund, Germany.
   [Siems, Karsten; Mueller-Kuhrt, Lutz] AnalytiCon Discovery GmbH, D-14473 Potsdam, Germany.
   [Schuermann, Annette; Schueler, Rita; Pfeiffer, Andreas F. H.] German Inst Human Nutr, D-14558 Nuthetal, Germany.
RP Sauer, S (reprint author), Max Planck Inst Mol Genet, Otto Warburg Lab, Ihnestr 63-73, D-14195 Berlin, Germany.
EM sauer@molgen.mpg.de
RI Schroeder, Frank/H-5026-2012
OI Pfeiffer, Andreas F. H./0000-0002-6887-0016; Han,
   Chung-Ting/0000-0003-1916-0314; Schroeder, Frank/0000-0002-4420-0237
FU German Ministry for Education and Research (BMBF) [0315082]; National
   Genome Research Net (NGFN) [01 GS 0828]; European Union
   [HEALTH-F4-2008-201418, 262055]; TRIAD foundation; Max Planck Society
FX We thank A. Schoop and M. Ristow for fruitful discussions, suggestions,
   and material provided. We are deeply grateful to K. Hansen, U. Schroder,
   and L. Hartmann for technical assistance during the animal studies. We
   thank R. Feldmann for critical reading of the manuscript. This work is
   part of the Ph.D. theses of C.W. and J.C.d.G. Our work is supported by
   the German Ministry for Education and Research (BMBF, grant number
   0315082), the National Genome Research Net (NGFN, grant number 01 GS
   0828), the European Union [FP7/2007-2013, under grant agreement number
   [HEALTH-F4-2008-201418], entitled READNA, and [FP7/2007-2011], under
   grant agreement no 262055 (ESGI)], the TRIAD foundation (to F.C.S.), and
   the Max Planck Society.
CR ALEGRET M, 1994, BRIT J PHARMACOL, V112, P551, DOI 10.1111/j.1476-5381.1994.tb13109.x
   [Anonymous], 2010, NAT REV DRUG DISCOV, V9, P828, DOI 10.1038/nrd3317
   Argmann CA, 2005, EUR J CLIN INVEST, V35, P82, DOI 10.1111/j.1365-2362.2005.01456.x
   Argmann CA, 2005, EUR J CLIN INVEST, V35, P80, DOI [10.1111/j.1365-2362.2005.01456.x, DOI 10.1111/J.1365-2362.2005.01456.X]
   Argmann C, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000752
   Artis DR, 2009, P NATL ACAD SCI USA, V106, P262, DOI 10.1073/pnas.0811325106
   Berger JP, 2003, MOL ENDOCRINOL, V17, P662, DOI 10.1210/me.2002.0217
   Bruning JB, 2007, STRUCTURE, V15, P1258, DOI 10.1016/j.str.2007.07.014
   Cho N, 2008, CURR TOP MED CHEM, V8, P1483, DOI 10.2174/156802608786413474
   Choi JH, 2010, NATURE, V466, P451, DOI 10.1038/nature09291
   Cock TA, 2004, EMBO REP, V5, P142, DOI 10.1038/sj.embor.7400082
   Cronet P, 2001, STRUCTURE, V9, P699, DOI 10.1016/S0969-2126(01)00634-7
   Dat NT, 2008, J NAT PROD, V71, P1696, DOI 10.1021/np800383q
   Doshi LS, 2010, EXPERT OPIN INV DRUG, V19, P489, DOI 10.1517/13543781003640169
   Fischer JJ, 2011, J PROTEOMICS, V10, P160
   Gronemeyer H, 2004, NAT REV DRUG DISCOV, V3, P950, DOI 10.1038/nrd1551
   Guri AJ, 2007, CLIN NUTR, V26, P107, DOI 10.1016/j.clnu.2006.07.008
   Hontecillas R, 2009, J AM COLL NUTR, V28, P184, DOI 10.1080/07315724.2009.10719770
   HOTAMISLIGIL GS, 1993, SCIENCE, V259, P87, DOI 10.1126/science.7678183
   Huang THW, 2005, BASIC CLIN PHARMACOL, V96, P3, DOI 10.1111/j.1742-7843.2005.pto960102.x
   Jones D, 2010, NAT REV DRUG DISCOV, V9, P668, DOI 10.1038/nrd3271
   Kahn SE, 2006, NATURE, V444, P840, DOI 10.1038/nature05482
   Kuda O, 2009, J PHYSIOL PHARMACOL, V60, P135
   Kulozik P, 2011, CELL METAB, V13, P389, DOI 10.1016/j.cmet.2011.02.011
   Lamb J, 2006, SCIENCE, V313, P1929, DOI 10.1126/science.1132939
   Larsen PJ, 2003, DIABETES, V52, P2249, DOI 10.2337/diabetes.52.9.2249
   Lehrke M, 2005, CELL, V123, P993, DOI 10.1016/j.cell.2005.11.026
   Li JWH, 2009, SCIENCE, V325, P161, DOI 10.1126/science.1168243
   Li PP, 2011, CELL, V147, P815, DOI 10.1016/j.cell.2011.09.050
   Lu M, 2011, NAT MED, V17, P618, DOI 10.1038/nm.2332
   Marchesini G, 2001, DIABETES, V50, P1844, DOI 10.2337/diabetes.50.8.1844
   Muller M, 2003, NAT REV GENET, V4, P315, DOI 10.1038/nrg1047
   Nolte RT, 1998, NATURE, V395, P137
   Ong SE, 2009, P NATL ACAD SCI USA, V106, P4617, DOI 10.1073/pnas.0900191106
   Rizzo G, 2006, CURR OPIN PHARMACOL, V6, P421, DOI 10.1016/j.coph.2006.03.012
   Rosen CJ, 2010, NEW ENGL J MED, V363, P803, DOI 10.1056/NEJMp1008233
   Ryan KK, 2011, NAT MED, V17, P623, DOI 10.1038/nm.2349
   Schupp M, 2005, DIABETES, V54, P3442, DOI 10.2337/diabetes.54.12.3442
   Smyth S, 2006, NAT MED, V12, P75, DOI 10.1038/nm0106-75
   SPIEGELMAN BM, 1983, J BIOL CHEM, V258, P83
NR 40
TC 91
Z9 96
U1 1
U2 41
PU NATL ACAD SCIENCES
PI WASHINGTON
PA 2101 CONSTITUTION AVE NW, WASHINGTON, DC 20418 USA
SN 0027-8424
J9 P NATL ACAD SCI USA
JI Proc. Natl. Acad. Sci. U. S. A.
PD MAY 8
PY 2012
VL 109
IS 19
BP 7257
EP 7262
DI 10.1073/pnas.1116971109
PG 6
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA 942ZQ
UT WOS:000304090600034
PM 22509006
OA Green Published, Bronze
DA 2018-10-19
ER

PT J
AU Yang, TI
   Su, TL
   Lin, PL
   Tseng, IH
   Chang, CH
   Fang, HW
AF Yang, Ta-I
   Su, Tai-Lun
   Lin, Po-Liang
   Tseng, I-Hsiang
   Chang, Chih-Hung
   Fang, Hsu-Wei
TI Fabrication of porous polylactic acid films assisted by dip-coating and
   template leaching techniques
SO JOURNAL OF APPLIED POLYMER SCIENCE
LA English
DT Article
DE polylactic acid; porous thin film; dip coating; template leaching;
   biomaterial
ID PHASE INVERSION; SCAFFOLDS; SOLUBILITY; SEPARATION
AB A new simple method was developed to fabricate porous polylactic acid (PLA) films coated directly on substrates. The PLA films with a controllable thickness were realized using a dip-coating technique. The pore structure of the resulting porous PLA films was tailored by utilizing phase inversion process and template leaching techniques. The experimental results show that the resulting PLA films became thicker when using the coating solution with a higher viscosity or applying a faster withdrawal speed. The porous structures (pore size and void density) of the resulting PLA films are significantly influenced by the polymer concentration, the nonsolvents, and the addition of poly(ethylene glycol) templates. The analyses of solubility parameters was utilized to explain the porous structures of the resulting PLA films in details. (C) 2011 Wiley Periodicals, Inc. J Appl Polym Sci, 2012
C1 [Yang, Ta-I; Su, Tai-Lun; Lin, Po-Liang; Fang, Hsu-Wei] Natl Taipei Univ Technol, Dept Chem Engn & Biotechnol, Taipei, Taiwan.
   [Tseng, I-Hsiang] Natl Chin Yi Univ Technol, Dept Chem & Mat Engn, Taichung, Taiwan.
   [Chang, Chih-Hung] Far Eastern Mem Hosp, Dept Surg, Div Orthoped, New Taipei City, Taipei, Taiwan.
   [Chang, Chih-Hung] Yuan Ze Univ, Grad Sch Biotechnol & Bioengn, Tao Yuan, Taiwan.
   [Fang, Hsu-Wei] Natl Hlth Res Inst, Div Med Engn Res, Miaoli, Taiwan.
RP Fang, HW (reprint author), Natl Taipei Univ Technol, Dept Chem Engn & Biotechnol, Taipei, Taiwan.
EM hwfang@ntut.edu.tw
RI Tseng, I-Hsiang/R-8505-2017
OI Tseng, I-Hsiang/0000-0003-4690-9968
FU Ministry of Education, Taiwan [0990045921D]; Far Eastern Memorial
   Hospital [FEMH-96-C-001]; National Science Council of Taiwan
   [NSC-94-2622-E-027-011-CC3]
FX Contract grant sponsor: Ministry of Education, Taiwan; contract grant
   number: 0990045921D.; Contract grant sponsor: Far Eastern Memorial
   Hospital; contract grant number: FEMH-96-C-001.; Contract grant sponsor:
   National Science Council of Taiwan; contract grant number:
   NSC-94-2622-E-027-011-CC3.
CR Aegerter M. A., 2004, SOL GEL TECHNOLOGIES
   Barroca N, 2010, ACTA BIOMATER, V6, P3611, DOI 10.1016/j.actbio.2010.03.032
   Ghosh S, 2008, ACTA BIOMATER, V4, P887, DOI 10.1016/j.actbio.2008.03.001
   Gupta B, 2007, PROG POLYM SCI, V32, P455, DOI 10.1016/j.progpolymsci.2007.01.005
   Hou XH, 2008, SURF COAT TECH, V202, P5175, DOI 10.1016/j.surfcoat.2008.05.055
   Kim YD, 2001, J MEMBRANE SCI, V190, P69, DOI 10.1016/S0376-7388(01)00420-3
   Miao XG, 2010, MATERIALS, V3, P26, DOI 10.3390/ma3010026
   Ozdemir C, 2007, EUR POLYM J, V43, P3068, DOI 10.1016/j.eurpolymj.2007.02.022
   Papenburg BJ, 2010, ACTA BIOMATER, V6, P2477, DOI 10.1016/j.actbio.2009.12.051
   PINNAU I, 1991, J APPL POLYM SCI, V43, P1491, DOI 10.1002/app.1991.070430811
   Rissanen M, 2008, J APPL POLYM SCI, V110, P2399, DOI 10.1002/app.28769
   Wei GB, 2009, BIOMATERIALS, V30, P6426, DOI 10.1016/j.biomaterials.2009.08.012
   Wu H, 2008, ACTA BIOMATER, V4, P76, DOI 10.1016/j.actbio.2007.06.010
   Yimsiri P, 2006, CHEM ENG SCI, V61, P3496, DOI 10.1016/j.ces.2005.12.018
NR 14
TC 8
Z9 8
U1 4
U2 19
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0021-8995
EI 1097-4628
J9 J APPL POLYM SCI
JI J. Appl. Polym. Sci.
PD MAY 5
PY 2012
VL 124
IS 3
BP 2333
EP 2339
DI 10.1002/app.35277
PG 7
WC Polymer Science
SC Polymer Science
GA 886DL
UT WOS:000299831900065
DA 2018-10-19
ER

PT J
AU Zhou, XY
   Yuan, XX
   Shi, ZY
   Meng, DC
   Jiang, WJ
   Wu, LP
   Chen, JC
   Chen, GQ
AF Zhou, Xiao-Yun
   Yuan, Xiao-Xi
   Shi, Zhen-Yu
   Meng, De-Chuang
   Jiang, Wen-Jun
   Wu, Lin-Ping
   Chen, Jin-Chun
   Chen, Guo-Qiang
TI Hyperproduction of poly(4-hydroxybutyrate) from glucose by recombinant
   Escherichia coli
SO MICROBIAL CELL FACTORIES
LA English
DT Article
DE Poly(4HB); PHB; Polyhydroxyalkanoates; PhaP; 4-hydroxybutyrate;
   Escherichia coli; Metabolic engineering; Synthetic biology
ID RALSTONIA-EUTROPHA H16; PSEUDOMONAS-PUTIDA KT2442;
   ALCALIGENES-EUTROPHUS; COMAMONAS-ACIDOVORANS; MEDICAL APPLICATIONS;
   MICROBIAL SYNTHESIS; PROTEIN PHAR; POLYHYDROXYALKANOATES;
   POLY(3-HYDROXYBUTYRATE-CO-4-HYDROXYBUTYRATE); DEGRADATION
AB Background: Poly(4-hydroxybutyrate) [poly(4HB)] is a strong thermoplastic biomaterial with remarkable mechanical properties, biocompatibility and biodegradability. However, it is generally synthesized when 4-hydroxybutyrate (4HB) structurally related substrates such as gamma-butyrolactone, 4-hydroxybutyrate or 1,4-butanediol (1,4-BD) are provided as precursor which are much more expensive than glucose. At present, high production cost is a big obstacle for large scale production of poly(4HB).
   Results: Recombinant Escherichia coli strain was constructed to achieve hyperproduction of poly(4-hydroxybutyrate) [poly(4HB)] using glucose as a sole carbon source. An engineering pathway was established in E. coli containing genes encoding succinate degradation of Clostridium kluyveri and PHB synthase of Ralstonia eutropha. Native succinate semialdehyde dehydrogenase genes sad and gabD in E. coli were both inactivated to enhance the carbon flux to poly (4HB) biosynthesis. Four PHA binding proteins (PhaP or phasins) including PhaP1, PhaP2, PhaP3 and PhaP4 from R. eutropha were heterologously expressed in the recombinant E. coli, respectively, leading to different levels of improvement in poly(4HB) production. Among them PhaP1 exhibited the highest capability for enhanced polymer synthesis. The recombinant E. coli produced 5.5 g L-1 cell dry weight containing 35.4% poly(4HB) using glucose as a sole carbon source in a 48 h shake flask growth. In a 6-L fermentor study, 11.5 g L-1 cell dry weight containing 68.2% poly (4HB) was obtained after 52 h of cultivation. This was the highest poly(4HB) yield using glucose as a sole carbon source reported so far. Poly(4HB) was structurally confirmed by gas chromatographic (GC) as well as H-1 and C-13 NMR studies.
   Conclusions: Significant level of poly(4HB) biosynthesis from glucose can be achieved in sad and gabD genes deficient strain of E. coli JM109 harboring an engineering pathway encoding succinate degradation genes and PHB synthase gene, together with expression of four PHA binding proteins PhaP or phasins, respectively. Over 68% poly(4HB) was produced in a fed-batch fermentation process, demonstrating the feasibility for enhanced poly(4HB) production using the recombinant strain for future cost effective commercial development.
C1 [Zhou, Xiao-Yun; Yuan, Xiao-Xi; Meng, De-Chuang; Jiang, Wen-Jun; Chen, Jin-Chun; Chen, Guo-Qiang] Tsinghua Univ, Sch Life Sci, Tsinghua Peking Ctr Life Sci,Dept Biol Sci & Biot, MOE Key Lab Bioinformat & Syst Biol, Beijing 100084, Peoples R China.
   [Shi, Zhen-Yu] Univ Melbourne, Dept Chem, Parkville, Vic 3052, Australia.
   [Wu, Lin-Ping] Univ Copenhagen, Fac Pharmaceut Sci, Dept Pharmaceut & Analyt Chem, Copenhagen, Denmark.
   [Chen, Guo-Qiang] Tsinghua Univ, Ctr Nano & Micro Mech, Beijing 100084, Peoples R China.
RP Chen, JC (reprint author), Tsinghua Univ, Sch Life Sci, Tsinghua Peking Ctr Life Sci,Dept Biol Sci & Biot, MOE Key Lab Bioinformat & Syst Biol, Beijing 100084, Peoples R China.
EM chenjc@mail.tsinghua.edu.cn; chengq@mail.tsinghua.edu.cn
RI WU, LinPing/E-4343-2012
OI WU, Linping/0000-0001-7579-2987
FU Basic Science Foundation 973 [2012CB725200, 2012CB725201, 2011CBA00807];
   National Natural Science Foundation of China [31170099, 30570024]
FX We are grateful to Professor Alexander Steinbuchel of the University of
   Munster in Germany for the generous donation of Ralstonia eutropha H16.
   We are also very grateful to Professor Shui-Shan Song of Biology
   Institute of Hebei Province in Shijiazhuang/China for the kind donation
   of plasmid pKSSE5.3. This research was supported by the State Basic
   Science Foundation 973 (Grant No. 2012CB725200, 2012CB725201 and
   2011CBA00807). Grants from National Natural Science Foundation of China
   (Grant No. 31170099 and 30570024) also contributed to this project.
CR ANDERSON AJ, 1990, MICROBIOL REV, V54, P450
   Cai L, 2011, MICROB CELL FACT, V10, DOI 10.1186/1475-2859-10-88
   Chen GQ, 2005, BIOMATERIALS, V26, P6565, DOI 10.1016/j.biomaterials.2005.04.036
   Chen GQ, 2005, APPL MICROBIOL BIOT, V67, P592, DOI 10.1007/s00253-005-1917-2
   Chen GQ, 2012, CHEM REV, V112, P2082, DOI 10.1021/cr200162d
   Chen GQ, 2009, CHEM SOC REV, V38, P2434, DOI 10.1039/b812677c
   Chen JY, 2004, FEMS MICROBIOL LETT, V234, P231, DOI 10.1016/j.femsle.2004.03.029
   Cheng S, 2006, BIOMATERIALS, V27, P3758, DOI 10.1016/j.biomaterials.2006.02.046
   Choi MH, 1999, APPL ENVIRON MICROB, V65, P1570
   Dennis D, 2003, FEMS MICROBIOL LETT, V226, P113, DOI 10.1016/S0378-1097(03)00610-4
   Gao X, 2011, CURR OPIN BIOTECH, V22, P768, DOI 10.1016/j.copbio.2011.06.005
   Gao Y, 2006, EUR POLYM J, V42, P764, DOI 10.1016/j.eurpolymj.2005.09.028
   Hazer B, 2007, APPL MICROBIOL BIOT, V74, P1, DOI 10.1007/s00253-006-0732-8
   Hein S, 1997, FEMS MICROBIOL LETT, V153, P411, DOI 10.1016/S0378-1097(97)00282-6
   Kato M, 1996, APPL MICROBIOL BIOT, V45, P363, DOI 10.1007/s002530050697
   KUNIOKA M, 1989, APPL MICROBIOL BIOT, V30, P569
   KUNIOKA M, 1988, POLYM COMMUN, V29, P174
   Lee WH, 2004, POLYM DEGRAD STABIL, V84, P129, DOI 10.1016/j.polymdegradstab.2003.10.003
   Li ZJ, 2010, METAB ENG, V12, P352, DOI 10.1016/j.ymben.2010.03.003
   Luo RC, 2006, BIOCHEM ENG J, V32, P218, DOI 10.1016/j.bej.2006.10.005
   Lux G, 1996, Z GASTROENTEROL, V34, P542
   Madison LL, 1999, MICROBIOL MOL BIOL R, V63, P21
   Martin DP, 2003, BIOCHEM ENG J, V16, P97, DOI 10.1016/S1369-703X(03)00040-8
   MERGAERT J, 1993, APPL ENVIRON MICROB, V59, P3233
   Mitomo H, 2001, POLYMER, V42, P3455, DOI 10.1016/S0032-3861(00)00678-9
   NAKAMURA S, 1992, MACROMOLECULES, V25, P4237, DOI 10.1021/ma00043a001
   Neumann L, 2008, J BACTERIOL, V190, P2911, DOI 10.1128/JB.01486-07
   Ouyang SP, 2007, BIOMACROMOLECULES, V8, P2504, DOI 10.1021/bm0702307
   Pohlmann A, 2006, NAT BIOTECHNOL, V24, P1257, DOI 10.1038/nbt1244
   Potter M, 2005, MICROBIOL-SGM, V151, P825, DOI 10.1099/mic.0.27613-0
   Potter M, 2005, BIOMACROMOLECULES, V6, P552, DOI 10.1021/bm049401n
   Potter M, 2004, MICROBIOL-SGM, V150, P2301, DOI 10.1099/mic.0.26970-0
   Saito Y, 1996, POLYM INT, V39, P169
   Singh M, 2009, MICROB CELL FACT, V8, DOI 10.1186/1475-2859-8-38
   Sohling B, 1996, J BACTERIOL, V178, P871
   Song Shui-shan, 2005, Weishengwu Xuebao, V45, P382
   Song SS, 1999, BIOTECHNOL LETT, V21, P193, DOI 10.1023/A:1005451810844
   SPYROS A, 1995, MACROMOLECULES, V28, P6108, DOI 10.1021/ma00122a017
   STEINBUCHEL A, 1995, FEMS MICROBIOL LETT, V128, P219, DOI 10.1016/0378-1097(95)00125-O
   Steinbuechel Alexander, 1994, Journal of Environmental Polymer Degradation, V2, P67, DOI 10.1007/BF02074775
   Sudesh K, 1999, INT J BIOL MACROMOL, V25, P79, DOI 10.1016/S0141-8130(99)00018-5
   Sun J, 2007, BIOMATERIALS, V28, P3896, DOI 10.1016/j.biomaterials.2007.05.011
   Tripathi L, 2012, MICROB CELL FACT, V11, DOI 10.1186/1475-2859-11-44
   Valentin HE, 1997, J BIOTECHNOL, V58, P33, DOI 10.1016/S0168-1656(97)00127-2
   VALENTIN HE, 1995, EUR J BIOCHEM, V227, P43, DOI 10.1111/j.1432-1033.1995.tb20358.x
   Wang ZH, 2011, MICROB CELL FACT, V10, DOI 10.1186/1475-2859-10-21
   WIECZOREK R, 1995, J BACTERIOL, V177, P2425, DOI 10.1128/jb.177.9.2425-2435.1995
   Zhang S, 2010, MICROB CELL FACT, V9, DOI 10.1186/1475-2859-9-28
NR 48
TC 23
Z9 25
U1 1
U2 52
PU BIOMED CENTRAL LTD
PI LONDON
PA 236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND
SN 1475-2859
J9 MICROB CELL FACT
JI Microb. Cell. Fact.
PD MAY 2
PY 2012
VL 11
AR 54
DI 10.1186/1475-2859-11-54
PG 8
WC Biotechnology & Applied Microbiology
SC Biotechnology & Applied Microbiology
GA 067ZG
UT WOS:000313333600001
PM 22550959
OA DOAJ Gold, Green Published
DA 2018-10-19
ER

PT J
AU Bratlie, KM
   York, RL
   Invernale, MA
   Langer, R
   Anderson, DG
AF Bratlie, Kaitlin M.
   York, Roger L.
   Invernale, Michael A.
   Langer, Robert
   Anderson, Daniel G.
TI Materials for Diabetes Therapeutics
SO ADVANCED HEALTHCARE MATERIALS
LA English
DT Article
ID LOOP INSULIN DELIVERY; TRANSDERMAL DRUG-DELIVERY; GLUCOSE-SENSING
   MOIETY; RESPONSIVE POLYMER GEL; CRITICAL SOLUTION TEMPERATURE; WALLED
   CARBON NANOTUBES; CONTROLLED-RELEASE; PHYSIOLOGICAL PH; IN-VIVO;
   POLY(VINYL ALCOHOL)
AB This review is focused on the materials and methods used to fabricate closed-loop systems for type 1 diabetes therapy. Herein, we give a brief overview of current methods used for patient care and discuss two types of possible treatments and the materials used for these therapies-(i) artificial pancreases, comprised of insulin producing cells embedded in a polymeric biomaterial, and (ii) totally synthetic pancreases formulated by integrating continuous glucose monitors with controlled insulin release through degradable polymers and glucose-responsive polymer systems. Both the artificial and the completely synthetic pancreas have two major design requirements: the device must be both biocompatible and be permeable to small molecules and proteins, such as insulin. Several polymers and fabrication methods of artificial pancreases are discussed: microencapsulation, conformal coatings, and planar sheets. We also review the two components of a completely synthetic pancreas. Several types of glucose sensing systems (including materials used for electrochemical, optical, and chemical sensing platforms) are discussed, in addition to various polymer-based release systems (including ethylene-vinyl acetate, polyanhydrides, and phenylboronic acid containing hydrogels).
C1 [Bratlie, Kaitlin M.; York, Roger L.; Invernale, Michael A.; Langer, Robert; Anderson, Daniel G.] MIT, Koch Inst Integrat Canc Res, Cambridge, MA 02142 USA.
   [Bratlie, Kaitlin M.; York, Roger L.; Invernale, Michael A.; Langer, Robert; Anderson, Daniel G.] Childrens Hosp, Dept Anesthesiol, Boston, MA 02115 USA.
   [Bratlie, Kaitlin M.; Langer, Robert; Anderson, Daniel G.] MIT, Dept Chem Engn, Cambridge, MA 02139 USA.
   [Langer, Robert; Anderson, Daniel G.] MIT, Harvard Mit Div Hlth Sci & Technol, Cambridge, MA 02142 USA.
RP Anderson, DG (reprint author), MIT, Koch Inst Integrat Canc Res, 32 Vassar St, Cambridge, MA 02142 USA.
EM dgander@mit.edu
RI York, Roger/C-6547-2008
OI York, Roger/0000-0002-5105-6800
FU Juvenile Diabetes Research Foundation [17-2007-1063]; Leona M. and Harry
   B. Helmsley Charitable Trust [09PG-T1D027]; National Institutes of
   Health [F32 EB011580-01]
FX This work was supported by grant 17-2007-1063 from the Juvenile Diabetes
   Research Foundation, grant 09PG-T1D027 from the Leona M. and Harry B.
   Helmsley Charitable Trust, and a generous gift from Parviz Tayebati. K.
   M. B. is grateful to the support from the National Institutes of Health
   postdoctoral fellowship F32 EB011580-01.
CR Aiedeh K, 1997, J MICROENCAPSUL, V14, P567, DOI 10.3109/02652049709006810
   American Diabetes Association, 2012, DIAB STAT
   Ansari A. A., 2010, BIOSENSORS, P302
   Aoki T, 1996, POLYM J, V28, P371, DOI 10.1295/polymj.28.371
   Arai G, 2006, J ELECTROANAL CHEM, V591, P1, DOI 10.1016/j.jelechem.2005.02.025
   Barman I, 2010, ANAL CHEM, V82, P6104, DOI 10.1021/ac100810e
   Barone PW, 2006, ANGEW CHEM INT EDIT, V45, P8138, DOI 10.1002/anie.200603138
   Barone PW, 2005, NAT MATER, V4, P86, DOI 10.1038/nmat1276
   Binyamin G, 1999, J ELECTROCHEM SOC, V146, P2965, DOI 10.1149/1.1392036
   Bratlie KM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010032
   BROUSSOLLE C, 1994, LANCET, V343, P514, DOI 10.1016/S0140-6736(94)91462-1
   BROWN L, 1986, DIABETES, V35, P684, DOI 10.2337/diabetes.35.6.684
   Brown LR, 1996, J PHARM SCI, V85, P1341, DOI 10.1021/js9600686
   Cabric S, 2007, DIABETES, V56, P2008, DOI 10.2337/db07-0358
   Calafiore R, 1999, ANN NY ACAD SCI, V875, P219, DOI 10.1111/j.1749-6632.1999.tb08506.x
   Cass A. E. G., 1987, ANAL CHEM, V4, P667
   Chaudhri BP, 2010, J MICROMECH MICROENG, V20, DOI 10.1088/0960-1317/20/6/064006
   Chen J, 1995, CARBOHYD POLYM, V28, P69, DOI 10.1016/0144-8617(95)00080-1
   Cheng JJ, 2006, PHARM RES, V23, P557, DOI 10.1007/s11095-005-9444-5
   Choi SO, 2010, BIOMED MICRODEVICES, V12, P263, DOI 10.1007/s10544-009-9381-x
   Choi WS, 2001, P NATL ACAD SCI USA, V98, P11103, DOI 10.1073/pnas.201413798
   COLTON CK, 1995, CELL TRANSPLANT, V4, P415, DOI 10.1016/0963-6897(95)00025-S
   Cordes DB, 2005, ORG BIOMOL CHEM, V3, P1708, DOI 10.1039/b418953a
   Costantino HR, 1997, ACS SYM SER, V675, P29
   Costantino HR, 1998, BIOCHEMISTRY-MOSCOW+, V63, P357
   COULTHARD CE, 1945, BIOCHEM J, V39, P24, DOI 10.1042/bj0390024
   CREQUE HM, 1980, DIABETES, V29, P37, DOI 10.2337/diabetes.29.1.37
   Daneman D, 2006, LANCET, V367, P847, DOI 10.1016/S0140-6736(06)68341-4
   Dang TT, 2009, BIOMATERIALS, V30, P6896, DOI 10.1016/j.biomaterials.2009.09.012
   Desai NP, 2000, J MICROENCAPSUL, V17, P677
   Duvivier-Kali VF, 2001, DIABETES, V50, P1698, DOI 10.2337/diabetes.50.8.1698
   Edelman ER, 1996, J PHARM SCI-US, V85, P1271, DOI 10.1021/js9601694
   Edwards DA, 1997, SCIENCE, V276, P1868, DOI 10.1126/science.276.5320.1868
   El-Khatib FH, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3000619
   Elliott RB, 2005, TRANSPL P, V37, P3505, DOI 10.1016/j.transproceed.2005.09.038
   Elliott RB, 2007, XENOTRANSPLANTATION, V14, P157, DOI 10.1111/j.1399-3089.2007.00384.x
   Farmer TG, 2008, J PHARM PHARMACOL, V60, P1, DOI 10.1211/jpp.60.1.0001
   Freeman R., 2009, CHEM COMMUN, V7, P764
   GOPFERICH A, 1994, ACS SYM SER, V567, P242
   Gough DA, 2010, SCI TRANSL MED, V2, P42
   GRIMSHAW PE, 1989, CHEM ENG SCI, V44, P827, DOI 10.1016/0009-2509(89)85256-X
   Gupta J, 2009, DIABETES TECHNOL THE, V11, P329, DOI 10.1089/dia.2008.0103
   Gupta S, 2010, P NATL ACAD SCI USA, V107, P13246, DOI 10.1073/pnas.1005704107
   Hall KK, 2011, ACTA BIOMATER, V7, P614, DOI 10.1016/j.actbio.2010.07.016
   Haller J, 2008, J APPL PHYSIOL, V104, P795, DOI 10.1152/japplphysiol.00959.2007
   HANAIREBROUTIN H, 1995, DIABETES CARE, V18, P388, DOI 10.2337/diacare.18.3.388
   Hari PR, 1996, J MICROENCAPSUL, V13, P319, DOI 10.3109/02652049609026019
   HEISE HM, 1989, ANAL CHEM, V61, P2009, DOI 10.1021/ac00193a004
   Heller A, 2008, CHEM REV, V108, P2482, DOI 10.1021/cr068069y
   Heller A, 2010, ACCOUNTS CHEM RES, V43, P963, DOI 10.1021/ar9002015
   Hermanides J, 2011, DIABETES CARE, V34, pS197, DOI 10.2337/dc11-s219
   Hisamitsu I, 1997, PHARMACEUT RES, V14, P289, DOI 10.1023/A:1012033718302
   Honda M, 2009, LANGMUIR, V25, P8349, DOI 10.1021/la804262b
   Hovorka R, 2006, DIABETIC MED, V23, P1, DOI 10.1111/j.1464-5491.2005.01672.x
   Hovorka R, 2011, NAT REV ENDOCRINOL, V7, P385, DOI 10.1038/nrendo.2011.32
   ISHIHARA K, 1984, POLYM J, V16, P625, DOI 10.1295/polymj.16.625
   Jaffari S. A., 1996, BIOSENS BIOELECTRON, V12, P1
   JAMES DE, 1981, DIABETOLOGIA, V21, P554
   Kanekiyo Y, 2005, MACROMOL RAPID COMM, V26, P1542, DOI 10.1002/marc.200500423
   Karachevtsev VA, 2007, CHEM PHYS LETT, V435, P104, DOI 10.1016/j.cplett.2006.12.052
   KATAOKA K, 1994, MACROMOLECULES, V27, P1061, DOI 10.1021/ma00082a028
   Kataoka K, 1998, J AM CHEM SOC, V120, P12694, DOI 10.1021/ja982975d
   KATAOKA K, 1995, J BIOCHEM-TOKYO, V117, P1145, DOI 10.1093/oxfordjournals.jbchem.a124835
   KEILIN D, 1948, BIOCHEM J, V42, P221, DOI 10.1042/bj0420221
   Kikuchi A, 1996, ANAL CHEM, V68, P823, DOI 10.1021/ac950748d
   Kitano S., 1991, MACROMOL RAPID COMM, V233, P227
   KLOCK G, 1994, APPL MICROBIOL BIOT, V40, P638
   Klonoff DC, 2005, DIABETES CARE, V28, P1231, DOI 10.2337/diacare.28.5.1231
   Koschwanez HE, 2007, BIOMATERIALS, V28, P3687, DOI 10.1016/j.biomaterials.2007.03.034
   Kost J, 2001, ADV DRUG DELIVER REV, V46, P125, DOI 10.1016/S0169-409X(00)00136-8
   KOST J, 1987, J BIOMED MATER RES, V21, P1367, DOI 10.1002/jbm.820211202
   KOST J, 1989, P NATL ACAD SCI USA, V86, P7663, DOI 10.1073/pnas.86.20.7663
   KOST J, 1992, TRENDS BIOTECHNOL, V10, P127, DOI 10.1016/0167-7799(92)90194-Z
   Kuenzi S., 2010, SENSOR ACTUAT B-CHEM, V147, P1
   Kuenzi S, 2010, SENSOR ACTUAT B-CHEM, V146, P1, DOI 10.1016/j.snb.2009.12.029
   Kulseng B, 1997, CELL TRANSPLANT, V6, P387, DOI 10.1016/S0963-6897(97)00002-X
   Kumar V., 2010, ROBBINS COTRAN PATHO
   Kuo CY, 2011, DIABETES TECHNOL THE, V13, P596, DOI 10.1089/dia.2010.0223
   Kvist PH, 2006, DIABETES TECHNOL THE, V8, P463, DOI 10.1089/dia.2006.8.463
   LANGER R, 1993, ACCOUNTS CHEM RES, V26, P537, DOI 10.1021/ar00034a004
   LANGER R, 1991, ANN NY ACAD SCI, V618, P330, DOI 10.1111/j.1749-6632.1991.tb27252.x
   Lee DY, 2006, AM J TRANSPLANT, V6, P1820, DOI 10.1111/j.1600-6143.2006.01414.x
   Lee DY, 2007, BIOMATERIALS, V28, P1957, DOI 10.1016/j.biomaterials.2006.12.015
   Lei M, 2006, DIABETES TECHNOL THE, V8, P112, DOI 10.1089/dia.2006.8.112
   LEVY D, 1989, J CLIN INVEST, V83, P2074, DOI 10.1172/JCI114119
   LIM F, 1980, SCIENCE, V210, P908, DOI 10.1126/science.6776628
   Liu WE, 2011, BIOMATERIALS, V32, P1796, DOI 10.1016/j.biomaterials.2010.11.029
   Ma ML, 2011, ADV MATER, V23, pH189, DOI 10.1002/adma.201100513
   Mader HS, 2008, MICROCHIM ACTA, V162, P1, DOI 10.1007/s00604-008-0947-8
   Mano N, 2005, J ELECTROANAL CHEM, V574, P347, DOI 10.1016/j.jelechem.2004.08.014
   Mao F, 2003, J AM CHEM SOC, V125, P4951, DOI 10.1021/ja029510e
   Marieb E. N., 1998, HUMAN ANATOMY PHYSL
   Marques RG, 2004, PANCREAS, V29, P231, DOI 10.1097/00006676-200410000-00009
   Martanto W, 2004, PHARM RES, V21, P947, DOI 10.1023/B:PHAM.0000029282.44140.2e
   Matsumoto A, 2004, BIOMACROMOLECULES, V5, P1038, DOI 10.1021/bm0345413
   Matsumoto A, 2004, MACROMOLECULES, V37, P1502, DOI 10.1021/ma035382i
   Matsumoto A, 2003, BIOMACROMOLECULES, V4, P1410, DOI 10.1021/bm034139o
   Matsumoto A, 2010, CHEM COMMUN, V46, P2203, DOI 10.1039/b920319b
   McAllister DV, 2003, P NATL ACAD SCI USA, V100, P13755, DOI 10.1073/pnas.2331316100
   Mermut O, 2006, J AM CHEM SOC, V128, P3598, DOI 10.1021/ja056031h
   Miller PR, 2011, BIOMICROFLUIDICS, V5, DOI 10.1063/1.3569945
   MITRAGOTRI S, 1995, SCIENCE, V269, P850, DOI 10.1126/science.7638603
   Mitragotri S, 2000, J APPL PHYSIOL, V89, P961
   Mitragotri S, 2000, J CONTROL RELEASE, V63, P41, DOI 10.1016/S0168-3659(99)00178-9
   MOE ST, 1993, MACROMOLECULES, V26, P3589, DOI 10.1021/ma00066a017
   Morissette SL, 2003, P NATL ACAD SCI USA, V100, P2180, DOI 10.1073/pnas.0437744100
   NAKAMURA S, 1976, BIOCHIM BIOPHYS ACTA, V445, P294, DOI 10.1016/0005-2744(76)90084-X
   Nakayama D, 2003, ANGEW CHEM INT EDIT, V42, P4197, DOI 10.1002/anie.200351746
   NELSON JD, 1983, DIABETES CARE, V6, P262, DOI 10.2337/diacare.6.3.262
   O'Sullivan ES, 2010, DIABETOLOGIA, V53, P937, DOI 10.1007/s00125-009-1653-8
   O'Sullivan ES, 2011, ENDOCR REV, V32, P827, DOI 10.1210/er.2010-0026
   Orive G, 2003, NAT MED, V9, P104, DOI 10.1038/nm0103-104
   Park S, 2006, ANAL CHIM ACTA, V556, P46, DOI 10.1016/j.aca.2005.05.080
   Park TG, 1999, BIOMATERIALS, V20, P517, DOI 10.1016/S0142-9612(98)00197-5
   Peterson K, 2009, BIOMED PAP, V153, P47, DOI 10.5507/bp.2009.008
   Phillips NB, 2010, J BIOL CHEM, V285, P11755, DOI 10.1074/jbc.C110.105825
   Pickup JC, 2005, BIOSENS BIOELECTRON, V20, P1897, DOI 10.1016/j.bios.2004.08.016
   Pollok J. M., 2010, TRANSPL P, V<IT>33 </IT>, P1713
   Porter RM, 2007, TISSUE ENG, V13, P1333, DOI 10.1089/ten.2006.0345
   Prausnitz MR, 2008, NAT BIOTECHNOL, V26, P1261, DOI 10.1038/nbt.1504
   Qi M, 2004, BIOMATERIALS, V25, P5885, DOI 10.1016/j.biomaterials.2004.01.050
   Qiu C, 2007, ADV MATER, V19, P1603, DOI 10.1002/adma.200602574
   Rahman MM, 2010, SENSORS-BASEL, V10, P4855, DOI 10.3390/s100504855
   Ramkissoon-Ganorkar C, 1999, J CONTROL RELEASE, V59, P287, DOI 10.1016/S0168-3659(99)00006-1
   Rasmussen T, 2010, PHARM RES-DORDR, V27, P1337, DOI 10.1007/s11095-010-0116-8
   Ravaine V, 2008, J CONTROL RELEASE, V132, P2, DOI 10.1016/j.jconrel.2008.08.009
   Renard E, 2006, DIABETES METAB, V32, P497, DOI 10.1016/S1262-3636(06)72802-6
   Renard E, 1996, DIABETES CARE, V19, P812, DOI 10.2337/diacare.19.8.812
   Renard E, 2010, DIABETES CARE, V33, P121, DOI 10.2337/dc09-1080
   RON E, 1993, P NATL ACAD SCI USA, V90, P4176, DOI 10.1073/pnas.90.9.4176
   Sandler S, 1997, TRANSPLANTATION, V63, P1712, DOI 10.1097/00007890-199706270-00002
   Santini JT, 2000, ANGEW CHEM INT EDIT, V39, P2397
   SAWHNEY AS, 1992, BIOMATERIALS, V13, P863, DOI 10.1016/0142-9612(92)90180-V
   Scaramuzza AE, 2011, DIABETES TECHNOL THE, V13, P99, DOI 10.1089/dia.2010.0119
   Schoemaker Michael, 2003, Diabetes Technol Ther, V5, P599, DOI 10.1089/152091503322250613
   Sershen S, 2002, ADV DRUG DELIVER REV, V54, P1225, DOI 10.1016/S0169-409X(02)00090-X
   Shapiro AMJ, 2006, NEW ENGL J MED, V355, P1318, DOI 10.1056/NEJMoa061267
   SHIINO D, 1994, BIOMATERIALS, V15, P121, DOI 10.1016/0142-9612(94)90261-5
   SHIINO D, 1994, J CONTROL RELEASE, V28, P317, DOI 10.1016/0168-3659(94)90196-1
   Shiino D, 1995, J CONTROL RELEASE, V37, P269, DOI 10.1016/0168-3659(95)00084-4
   Shoji E, 2001, J AM CHEM SOC, V123, P3383, DOI 10.1021/ja005906j
   Siegel RA, 2004, MACROMOL SYMP, V207, P249, DOI 10.1002/masy.200450322
   Siegel RA, 2010, J CONTROL RELEASE, V141, P303, DOI 10.1016/j.jconrel.2009.12.012
   SLUZKY V, 1992, BIOTECHNOL BIOENG, V40, P895, DOI 10.1002/bit.260400805
   SLUZKY V, 1991, P NATL ACAD SCI USA, V88, P9377, DOI 10.1073/pnas.88.21.9377
   Sparacino G, 2007, IEEE T BIO-MED ENG, V54, P931, DOI 10.1109/TBME.2006.889774
   Staples M, 2006, PHARM RES, V23, P847, DOI 10.1007/s11095-006-9906-4
   Steiner DF, 1997, SCIENCE, V277, P531, DOI 10.1126/science.277.5325.531
   Storrs R, 2001, ANN NY ACAD SCI, V944, P252
   Stuart DA, 2006, ANAL CHEM, V78, P7211, DOI 10.1021/ac061238u
   Sun YP, 2001, ANAL CHEM, V73, P1599, DOI 10.1021/ac0015117
   Swain S, 2011, CURR DRUG DELIV, V8, P456, DOI 10.2174/156720111795767979
   Tang H, 2002, PHARMACEUT RES, V19, P1160, DOI 10.1023/A:1019898109793
   Teply BA, 2008, BIOMATERIALS, V29, P1216, DOI 10.1016/j.biomaterials.2007.11.018
   Teramura Y, 2007, BIOMATERIALS, V28, P4818, DOI 10.1016/j.biomaterials.2007.07.050
   Teramura Y, 2010, ADV DRUG DELIVER REV, V62, P827, DOI 10.1016/j.addr.2010.01.005
   Teramura Y, 2010, SOFT MATTER, V6, P1081, DOI 10.1039/b913621e
   Thomas J, 2007, BIOCONJUGATE CHEM, V18, P1841, DOI 10.1021/bc700146r
   Thompson BC, 2010, MACROMOL RAPID COMM, V31, P1293, DOI 10.1002/marc.201000064
   Thoniyot P, 2006, DIABETES TECHNOL THE, V8, P279, DOI 10.1089/dia.2006.8.279
   Totani T, 2008, BIOMATERIALS, V29, P2878, DOI 10.1016/j.biomaterials.2008.03.024
   Uludag H, 2000, ADV DRUG DELIVER REV, V42, P29, DOI 10.1016/S0169-409X(00)00053-3
   Valente AXCN, 2003, BIODRUGS, V17, P9, DOI 10.2165/00063030-200317010-00002
   Vanbever R, 1999, DRUG DEVELOP RES, V48, P178, DOI 10.1002/(SICI)1098-2299(199912)48:4<178::AID-DDR5>3.3.CO;2-9
   Vos P. D., 1998, TRANSPL P, V30, P496
   Vos PD, 1997, BIOMATERIALS, V18, P273, DOI [10.1016/S0142-9612(96)00135-4, DOI 10.1016/S0142-9612(96)00135-4]
   Waugh DF, 1944, J AM CHEM SOC, V66, P663, DOI 10.1021/ja01232a516
   WAUGH DF, 1953, J AM CHEM SOC, V75, P2592, DOI 10.1021/ja01107a013
   WILSON R, 1992, BIOSENS BIOELECTRON, V7, P165, DOI 10.1016/0956-5663(92)87013-F
   Windmiller JR, 2011, ANALYST, V136, P1846, DOI 10.1039/c1an00012h
   Yehezkeli O, 2009, CHEM-EUR J, V15, P2674, DOI 10.1002/chem.200801609
   Yin RX, 2010, COLLOID SURFACE B, V76, P483, DOI 10.1016/j.colsurfb.2009.12.008
   Yonzon CR, 2004, ANAL CHEM, V76, P78, DOI 10.1021/ac035134k
   Youssef J. E., 2009, ALGORITHMS, V<IT>2</IT>, P518
   Yu BZ, 2007, DIABETES TECHNOL THE, V9, P265, DOI 10.1089/dia.2006.0020
   Zahn Jeffrey D, 2005, Diabetes Technol Ther, V7, P536, DOI 10.1089/dia.2005.7.536
   Zayats M, 2002, J AM CHEM SOC, V124, P2120, DOI 10.1021/ja025503e
   ZEKORN T, 1992, ACTA DIABETOL, V29, P41, DOI 10.1007/BF00572829
   Zenkl G, 2009, MICROCHIM ACTA, V166, P123, DOI 10.1007/s00604-009-0172-0
   Zentner GM, 2001, J CONTROL RELEASE, V72, P203, DOI 10.1016/S0168-3659(01)00276-0
   Ziaie B, 2004, ADV DRUG DELIVER REV, V56, P145, DOI 10.1016/j.addr.2003.09.001
   Zimmermann S., 2003, TRANSDUCERS 03 12 IN, V1, P99
NR 182
TC 67
Z9 68
U1 9
U2 124
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 2192-2640
J9 ADV HEALTHC MATER
JI Adv. Healthc. Mater.
PD MAY
PY 2012
VL 1
IS 3
BP 267
EP 284
DI 10.1002/adhm.201200037
PG 18
WC Engineering, Biomedical; Nanoscience & Nanotechnology; Materials
   Science, Biomaterials
SC Engineering; Science & Technology - Other Topics; Materials Science
GA 092HV
UT WOS:000315112200002
PM 23184741
OA Green Accepted
DA 2018-10-19
ER

PT J
AU Wang, K
   Cai, L
   Zhang, L
   Dong, JY
   Wang, SF
AF Wang, Kan
   Cai, Lei
   Zhang, Li
   Dong, Jingyan
   Wang, Shanfeng
TI Biodegradable Photo-Crosslinked Polymer Substrates with Concentric
   Microgrooves for Regulating MC3T3-E1 Cell Behavior
SO ADVANCED HEALTHCARE MATERIALS
LA English
DT Article
ID OSTEOBLAST-LIKE CELLS; POLY(EPSILON-CAPROLACTONE FUMARATE) NETWORKS;
   EMBRYONIC STEM-CELLS; POLY(PROPYLENE FUMARATE); IN-VITRO;
   MECHANICAL-PROPERTIES; CONTACT GUIDANCE; GROWTH-BEHAVIOR; BONE-MARROW;
   SURFACES
AB Both intrinsic material properties and topographical features are critical in influencing cell-biomaterial interactions. We present a systematic investigation of regulating mouse pre-osteoblastic MC3T3-E1 cell behavior on biodegradable polymer substrates with distinct mechanical properties and concentric microgrooves. The precursors for fabricating substrates used here were two poly(epsilon-caprolactone) triacrylates (PCLTAs) synthesized from poly(epsilon-caprolactone) triols with molecular weights of similar to 7000 and similar to 10000 g mol(-1). These two PCLTAs were photo-crosslinked into PCL networks with distinct thermal, rheological, and mechanical properties at physiological temperature because of their different crystallinities and melting temperatures. Microgrooved substrates with four groove widths of 7.5, 16.1, 44.2, and 91.2 mu m and three groove depths of 0.2, 1, and 10 mu m were prepared through replica molding, i.e., photo-crosslinking PCLTA on micro-fabricated silicon wafers with pre-designed concentric groove patterns. MC3T3-E1 cell attachment and proliferation could be better supported by the stiffer substrates while not significantly influenced by the microgrooves. Microgroove dimensions could regulate MC3T3-E1 cell alignment, nuclear shape and distribution, mineralization, and gene expression. Among the microgrooves with a fixed depth of 10 mu m, the smallest width of 7.5 mu m could align and elongate the cytoskeleton and nuclei most efficiently. Strikingly, higher mineral deposition and upregulation of osteocalcin gene expression were found in the narrower microgrooves when the groove depth was 10 mu m.
C1 [Wang, Kan; Cai, Lei; Wang, Shanfeng] Univ Tennessee, Dept Mat Sci & Engn, Knoxville, TN 37996 USA.
   [Wang, Shanfeng] Oak Ridge Natl Lab, Biosci Div, Oak Ridge, TN 37831 USA.
   [Zhang, Li; Dong, Jingyan] N Carolina State Univ, Edward P Fitts Dept Ind & Syst Engn, Raleigh, NC 27695 USA.
RP Wang, SF (reprint author), Univ Tennessee, Dept Mat Sci & Engn, Knoxville, TN 37996 USA.
EM swang16@utk.edu
RI Cai, Lei/D-1589-2013; Dong, Jingyan/B-3665-2010
OI Dong, Jingyan/0000-0003-2224-9168
FU Start-up Research Fund from the University of Tennessee; Professional
   Development Award from the University of Tennessee; National Science
   Foundation [DMR-11-06142]; North Carolina State University
FX This work was majorly supported by the Start-up Research Fund and
   Professional Development Award from the University of Tennessee, and
   National Science Foundation (DMR-11-06142; to S. W.). Fabrication of
   silicon molds was performed in Dr. Dong's laboratory with the help of
   the start-up fund from North Carolina State University.
CR Anselme K, 2002, J BIOMED MATER RES, V60, P529, DOI 10.1002/jbm.10101
   Bettinger CJ, 2009, ANGEW CHEM INT EDIT, V48, P5406, DOI 10.1002/anie.200805179
   Bettinger CJ, 2006, BIOMATERIALS, V27, P2558, DOI 10.1016/j.biomaterials.2005.11.029
   Brandrup J., 1989, POLYM HDB
   Bruinink A, 2001, BIOMATERIALS, V22, P2465, DOI 10.1016/S0142-9612(00)00434-8
   Cai L, 2010, BIOMATERIALS, V31, P7423, DOI 10.1016/j.biomaterials.2010.06.028
   Cai L, 2010, BIOMATERIALS, V31, P4457, DOI 10.1016/j.biomaterials.2010.02.020
   Cai L, 2010, POLYMER, V51, P164, DOI 10.1016/j.polymer.2009.11.042
   Cai L, 2010, BIOMACROMOLECULES, V11, P304, DOI 10.1021/bm901237t
   CHEHROUDI B, 1992, CELL MATER, V2, P89
   Crouch AS, 2009, BIOMATERIALS, V30, P1560, DOI 10.1016/j.biomaterials.2008.11.041
   Curtis A, 1997, BIOMATERIALS, V18, P1573, DOI 10.1016/S0142-9612(97)00144-0
   Curtis ASG, 1998, J BIOMAT SCI-POLYM E, V9, P1313, DOI 10.1163/156856298X00415
   Dalby MJ, 2003, EXP CELL RES, V284, P274, DOI 10.1016/S0014-4827(02)00053-8
   Davidson PM, 2009, ADV MATER, V21, P3586, DOI 10.1002/adma.200900582
   Discher DE, 2005, SCIENCE, V310, P1139, DOI 10.1126/science.1116995
   Flemming RG, 1999, BIOMATERIALS, V20, P573, DOI 10.1016/S0142-9612(98)00209-9
   Gerecht S, 2007, BIOMATERIALS, V28, P4068, DOI 10.1016/j.biomaterials.2007.05.027
   HARBERS GM, 2006, INTRO BIOMATERIALS, P15
   Ishaug SL, 1996, BIOTECHNOL BIOENG, V50, P443, DOI 10.1002/(SICI)1097-0290(19960520)50:4<443::AID-BIT12>3.0.CO;2-K
   Kenar H, 2006, BIOMATERIALS, V27, P885, DOI 10.1016/j.biomaterials.2005.07.001
   Khatiwala CB, 2006, AM J PHYSIOL-CELL PH, V290, pC1640, DOI 10.1152/ajpcell.00455.2005
   Lamers E, 2010, BIOMATERIALS, V31, P3307, DOI 10.1016/j.biomaterials.2010.01.034
   Lee MR, 2010, BIOMATERIALS, V31, P4360, DOI 10.1016/j.biomaterials.2010.02.012
   Lenhert S, 2005, BIOMATERIALS, V26, P563, DOI 10.1016/j.biomaterials.2004.02.068
   Li F, 2008, CELL MOTIL CYTOSKEL, V65, P332, DOI 10.1002/cm.20263
   Lim JY, 2007, TISSUE ENG, V13, P1879, DOI 10.1089/ten.2006.0154
   Matsuzaka K, 2004, J BIOMED MATER RES A, V68A, P227, DOI 10.1002/jbm.a.10158
   Matsuzaka K, 2003, BIOMATERIALS, V24, P2711, DOI 10.1016/S0142-9612(03)00085-1
   Matsuzaka K, 1999, BIOMATERIALS, V20, P1293, DOI 10.1016/S0142-9612(99)00029-0
   Matsuzaka K, 2000, CLIN ORAL IMPLAN RES, V11, P325, DOI 10.1034/j.1600-0501.2000.011004325.x
   Moriguchi T, 2003, J COLLOID INTERF SCI, V260, P19, DOI 10.1016/S0021-9797(02)00157-1
   NEMIR S, 2009, ANN BIOMED ENG, V38, P2
   OAKLEY C, 1993, J CELL SCI, V106, P343
   Tang J, 2010, BIOMATERIALS, V31, P2470, DOI 10.1016/j.biomaterials.2009.12.006
   Thomas CH, 2002, P NATL ACAD SCI USA, V99, P1972, DOI 10.1073/pnas.032668799
   Tsai WB, 2009, J MATER SCI-MATER M, V20, P1367, DOI 10.1007/s10856-008-3687-8
   Walboomers XF, 1998, BIOMATERIALS, V19, P1861, DOI 10.1016/S0142-9612(98)00093-3
   Wang JHC, 2000, J BIOMECH, V33, P729, DOI 10.1016/S0021-9290(00)00013-0
   Wang JHC, 2003, J BIOMECH, V36, P97, DOI 10.1016/S0021-9290(02)00233-6
   Wang K, 2012, LANGMUIR, V28, P4382, DOI 10.1021/la205162d
   Wang K, 2011, POLYMER, V52, P2827, DOI 10.1016/j.polymer.2011.04.048
   Wang K, 2010, BIOMACROMOLECULES, V11, P2748, DOI 10.1021/bm1008102
   Wang SF, 2008, BIOMACROMOLECULES, V9, P1229, DOI 10.1021/bm7012313
   Wang SF, 2009, ACTA BIOMATER, V5, P1531, DOI 10.1016/j.actbio.2008.12.015
   Wang SF, 2008, POLYMER, V49, P5692, DOI 10.1016/j.polymer.2008.10.021
   Yang JY, 2009, J BIOMED MATER RES A, V90A, P629, DOI 10.1002/jbm.a.32130
   Yim EKF, 2007, EXP CELL RES, V313, P1820, DOI 10.1016/j.yexcr.2007.02.031
   Zhu BS, 2005, TISSUE ENG, V11, P825, DOI 10.1089/ten.2005.11.825
NR 49
TC 28
Z9 28
U1 0
U2 37
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 2192-2640
J9 ADV HEALTHC MATER
JI Adv. Healthc. Mater.
PD MAY
PY 2012
VL 1
IS 3
BP 292
EP 301
DI 10.1002/adhm.201200030
PG 10
WC Engineering, Biomedical; Nanoscience & Nanotechnology; Materials
   Science, Biomaterials
SC Engineering; Science & Technology - Other Topics; Materials Science
GA 092HV
UT WOS:000315112200004
PM 23184743
DA 2018-10-19
ER

PT J
AU Kimura, Y
   Matsuzaka, K
   Yoshinari, M
   Inoue, T
AF Kimura, Yutaka
   Matsuzaka, Kenichi
   Yoshinari, Masao
   Inoue, Takashi
TI Initial attachment of human oral keratinocytes cultured on zirconia or
   titanium
SO DENTAL MATERIALS JOURNAL
LA English
DT Article
DE Zirconia; Titanium; Oral keratinocyte; Initial attachment; Laminin
   gamma(2)
ID EPITHELIAL-CELLS; SUBSEQUENT BEHAVIOR; DENTAL IMPLANT; PURE TITANIUM;
   EXPRESSION; SURFACES; ADHESION; LAMININ; DIFFERENTIATION; BIOMATERIAL
AB Initial attachment of human oral keratinocytes (HOKs) cultured on mirror-surfaced commercially pure titanium (Ti) or yttria-stabilized tetragonal zirconia polycrystals (TZP) was investigated. Numbers of viable attached HOKs, their mRNAs and proteins expression of laminin gamma(2) and integrin beta(4) were evaluated using the WST-1 assay, quantitative real-time PCR and enzyme-linked immunosorbent assay, respectively. Localization of laminin gamma(2) and integrin beta(4) was observed using immunofluorescent staining. Cell spreading was evaluated by measuring the perimeter of actin on fluorescent stained images, and cell morphology was examined using scanning electron microscopy. At 1 h TZP elicited less of initial attachment than Ti in terms of mRNAs expression and proteins expression of laminin gamma(2) and integrin beta(4) (p<0.05). However, at 48 h MP was showed similar initial attachment in comparison to Ti. Therefore, it was suggested that TZP has a potential to form epithelial attachment like Ti.
C1 [Kimura, Yutaka; Matsuzaka, Kenichi; Yoshinari, Masao; Inoue, Takashi] Tokyo Dent Coll, Oral Hlth Sci Ctr, Mihama Ku, Chiba 2618502, Japan.
   [Kimura, Yutaka; Matsuzaka, Kenichi; Inoue, Takashi] Tokyo Dent Coll, Dept Clin Pathophysiol, Mihama Ku, Chiba 2618502, Japan.
RP Matsuzaka, K (reprint author), Tokyo Dent Coll, Oral Hlth Sci Ctr, Mihama Ku, 1-2-2 Masago, Chiba 2618502, Japan.
EM matsuzak@tdc.ac.jp
CR Atsuta I, 2005, BIOMATERIALS, V26, P6280, DOI 10.1016/j.biomaterials.2005.03.046
   BRUNETTE DM, 1986, EXP CELL RES, V167, P203, DOI 10.1016/0014-4827(86)90217-X
   Clainche C. L. E., 2008, PHYSIOL REV, V88, P489
   Cochran David, 1994, Int J Oral Maxillofac Implants, V9, P289
   Daike LE, 1988, P NATL ACAD SCI USA, V85, P6792
   Degidi M, 2006, J PERIODONTOL, V77, P73, DOI 10.1902/jop.2006.77.1.73
   Depprich Rita, 2008, Head Face Med, V4, P29, DOI 10.1186/1746-160X-4-29
   Dutta PK, 2004, J COLLOID INTERF SCI, V278, P270, DOI 10.1016/j.jcis.2004.06.015
   Eilingsen JE, 1991, BIOMATERIALS, V12, P593
   Feng J, 2003, BIOMATERIALS, V24, P4663
   Goldfinger LE, 1999, J CELL SCI, V112, P2615
   Gordon DJ, 2010, J BIOMED MATER RES A, V94A, P586, DOI 10.1002/jbm.a.32735
   Hisbergues M, 2009, J BIOMED MATER RES B, V88B, P519, DOI 10.1002/jbm.b.31147
   Kim JB, 2007, BONE, V41, P39, DOI 10.1016/j.bone.2007.01.024
   Ko HC, 2007, DENT MATER, V23, P1349, DOI 10.1016/j.dental.2006.11.023
   Kohal RJ, 2004, J PERIODONTOL, V75, P1262, DOI 10.1902/jop.2004.75.9.1262
   Masaoka T, 2008, J PERIODONTAL RES, V44, P489
   Muller K, 2006, NEUROENDOCRINOL LETT, V27, P31
   Okumura A, 2001, BIOMATERIALS, V22, P2263, DOI 10.1016/S0142-9612(00)00415-4
   Pae A, 2009, BIOMED MATER, V4, DOI 10.1088/1748-6041/4/2/025005
   Pasakova V, 2007, J MATER SCI-MATER M, V18, P465
   Raisanen L, 2000, J BIOMED MATER RES, V49, P79
   Ryan MC, 1999, J CELL BIOL, V145, P1309, DOI 10.1083/jcb.145.6.1309
   Scarano A, 2004, J PERIODONTOL, V75, P292, DOI 10.1902/jop.2004.75.2.292
   Scarano Antonio, 2003, J Oral Implantol, V29, P8, DOI 10.1563/1548-1336(2003)029<0008:BRTZCI>2.3.CO;2
   Sennerby L, 2005, CLIN IMPLANT DENT R, V7, pS13, DOI 10.1111/j.1708-8208.2005.tb00070.x
   Shiraiwa M, 2002, J PERIODONTOL, V73, P852, DOI 10.1902/jop.2002.73.8.852
   Sicilia A, 2008, CLIN ORAL IMPLAN RES, V19, P823, DOI 10.1111/j.1600-0501.2008.01544.x
   Sugisawa M, 2010, J PERIODONTAL RES, V45, P284, DOI 10.1111/j.1600-0765.2009.01231.x
   Tanno M, 2006, J PERIODONTAL RES, V41, P5
   Wei JH, 2007, J BIOMED MATER RES B, V81B, P66, DOI 10.1002/jbm.b.30638
   Wei WCJ, 1999, J AM CERAM SOC, V82, P3385
   Werner S, 2009, BIOMATERIALS, V30, P2291, DOI 10.1016/j.biomaterials.2009.01.004
   Yamashita D, 2009, DENT MATER J, V28, P461, DOI 10.4012/dmj.28.461
   Yoshinari M, 2011, JPN DENT SCI REV, V47, P89, DOI 10.1016/j.jdsr.2011.03.001
   Zile MA, 2011, J BIOMED MATER RES A, V97A, P59, DOI 10.1002/jbm.a.33028
NR 36
TC 13
Z9 13
U1 0
U2 8
PU JAPANESE SOC DENTAL MATERIALS DEVICES
PI TOKYO
PA C/O KOKU HOKEN KYOKAI, 1-43-9 KOMAGOME TS BDG, KOMAGOME, TOSHIMA-KU,
   TOKYO, 170-0003, JAPAN
SN 0287-4547
J9 DENT MATER J
JI Dent. Mater. J.
PD MAY
PY 2012
VL 31
IS 3
BP 346
EP 353
DI 10.4012/dmj.2011-189
PG 8
WC Dentistry, Oral Surgery & Medicine; Materials Science, Biomaterials
SC Dentistry, Oral Surgery & Medicine; Materials Science
GA 985JG
UT WOS:000307259800003
PM 22673460
OA Bronze
DA 2018-10-19
ER

PT J
AU Cengiz, S
   Tanrikulu, F
   Aksu, S
AF Cengiz, Sevilay
   Tanrikulu, Fatmagul
   Aksu, Sevil
TI An alternative source of adsorbent for the removal of dyes from textile
   waters: Posidonia oceanica (L.)
SO CHEMICAL ENGINEERING JOURNAL
LA English
DT Article
DE Posidonia oceanica (L.); Dye adsorption; Wastewater treatment; Astrazon
   Red
ID BASIC RED 46; MACROALGA CAULERPA-LENTILLIFERA; METAL-COMPLEXED DYE;
   FIXED-BED COLUMN; AQUEOUS-SOLUTION; METHYLENE-BLUE;
   ADSORPTION-ISOTHERMS; ACTIVATED CARBON; BIOSORPTION; EQUILIBRIUM
AB The dead leaves of Posidonia oceanica (Linnaeus) Delile which is an endemic species in the Mediterranean sea were used as an alternative and low cost biomaterial for removal of Astrazon Red from wastewaters. Experiments were performed to investigate the impact of some parameters such as contact time, pH, adsorbent dosage, etc. on the adsorption of Astrazon Red. Kinetic experiments revealed that the adsorption of Astrazon Red onto P. oceanica can be described with pseudo second-order model and the equilibrium isotherm data were well described by the Langmuir model. The maximum adsorption capacity of the biomass was found to be 68.97 mg/g at 25 degrees C. The results presented, that this waste material accumulated seasonally on the beaches may be a suitable adsorbent for decolorization of industrial effluents due to its low cost and sufficient adsorption capacity. (C) 2012 Elsevier B.V. All rights reserved.
C1 [Cengiz, Sevilay; Tanrikulu, Fatmagul; Aksu, Sevil] Akdeniz Univ, Fac Sci, Dept Chem, TR-07058 Antalya, Turkey.
RP Cengiz, S (reprint author), Akdeniz Univ, Fac Sci, Dept Chem, TR-07058 Antalya, Turkey.
EM sevilay_cengiz@yahoo.com
RI Cengiz, Sevilay/D-8050-2017; Aksu, Sevil/C-2510-2016
CR Ahmad R, 2009, J HAZARD MATER, V171, P767, DOI 10.1016/j.jhazmat.2009.06.060
   Akbal F, 2005, J COLLOID INTERF SCI, V286, P455, DOI 10.1016/j.jcis.2005.01.036
   Ali H., 2008, J ENV SCI TECHNOL, V1, P143, DOI DOI 10.3923/JEST.2008.143.150
   Annadurai G, 2002, J HAZARD MATER, V92, P263, DOI 10.1016/S0304-3894(02)00017-1
   Atar N, 2011, J CHEM ENG DATA, V56, P508, DOI 10.1021/je100993m
   Benhammou A, 2005, J COLLOID INTERF SCI, V282, P320, DOI 10.1016/j.jcis.2004.08.168
   Cavas L, 2011, CHEM ENG J, V171, P557, DOI 10.1016/j.cej.2011.04.030
   Cengiz S, 2008, BIORESOURCE TECHNOL, V99, P2357, DOI 10.1016/j.biortech.2007.05.011
   Cengiz S, 2010, MAR BIOTECHNOL, V12, P728, DOI 10.1007/s10126-010-9260-8
   Crini G, 2008, PROG POLYM SCI, V33, P399, DOI 10.1016/j.progpolymsci.2007.11.001
   Deniz F, 2011, CHEM ENG J, V170, P67, DOI 10.1016/j.cej.2011.03.029
   Deniz F, 2011, DESALINATION, V268, P6, DOI 10.1016/j.desal.2010.09.043
   Dogan M, 2003, CHEMOSPHERE, V50, P517, DOI 10.1016/S0045-6535(02)00629-X
   Dogan M, 2007, DYES PIGMENTS, V75, P701, DOI 10.1016/j.dyepig.2006.07.023
   Dubinin M.M., 1947, P ACAD SCI USSR PHYS, V55, P331
   Dural U., 2011, CHEM ENG J, V168, P77
   Freundlich H M F, 1906, J PHYS CHEM, V57, P385
   Gong RM, 2005, J HAZARD MATER, V121, P247, DOI 10.1016/j.jhazmat.2005.01.029
   Gregg S. L., 1982, ADSORPTION SURFACE A
   Guezguez I, 2009, IND CROP PROD, V29, P197, DOI 10.1016/j.indcrop.2008.05.002
   Gupta VK, 2011, J HAZARD MATER, V186, P891, DOI 10.1016/j.jhazmat.2010.11.091
   Hameed BH, 2009, J HAZARD MATER, V162, P939, DOI 10.1016/j.jhazmat.2008.05.120
   Hao GP, 2010, CARBON, V48, P3330, DOI 10.1016/j.carbon.2010.05.011
   Hasany SM, 1996, APPL RADIAT ISOTOPES, V47, P467, DOI 10.1016/0969-8043(95)00310-X
   Ho YS, 1999, PROCESS BIOCHEM, V34, P451, DOI 10.1016/S0032-9592(98)00112-5
   HOBSON JP, 1969, J PHYS CHEM-US, V73, P2720, DOI 10.1021/j100842a045
   Jaikumar V., 2009, INT J CHEM, V1, P2
   Jain R, 2010, J HAZARD MATER, V182, P749, DOI 10.1016/j.jhazmat.2010.06.098
   Jain S, 2010, DESALINATION, V250, P921, DOI 10.1016/j.desal.2009.04.005
   Jellali S, 2011, DESALINATION, V270, P40, DOI 10.1016/j.desal.2010.11.018
   Kadirvelu K, 2003, ADV ENVIRON RES, V7, P471, DOI 10.1016/S1093-0191(02)00018-7
   Karim AB, 2009, J HAZARD MATER, V168, P304, DOI 10.1016/j.jhazmat.2009.02.028
   Kumar KV, 2005, PROCESS BIOCHEM, V40, P2865, DOI 10.1016/j.procbio.2005.01.007
   Kumar R, 2011, DESALINATION, V265, P112, DOI 10.1016/j.desal.2010.07.040
   Lagergren S, 1898, KUNGLIGA SVENSKA VET, V24, P1, DOI DOI 10.1007/BF01501332
   Langmuir I, 1916, J AM CHEM SOC, V38, P2221, DOI 10.1021/ja02268a002
   Liu RC, 2011, DESALINATION, V268, P111, DOI 10.1016/j.desal.2010.10.006
   Mahmoodi NM, 2010, DESALINATION, V264, P134, DOI 10.1016/j.desal.2010.07.017
   Markovska L, 2001, KOREAN J CHEM ENG, V18, P190, DOI 10.1007/BF02698458
   Marungrueng K, 2006, J ENVIRON MANAGE, V78, P268, DOI 10.1016/j.jenvman.2005.04.022
   Marungrueng K, 2007, BIORESOURCE TECHNOL, V98, P1567, DOI 10.1016/j.biortech.2006.06.010
   McKay G, 1999, WATER AIR SOIL POLL, V114, P423, DOI 10.1023/A:1005197308228
   MEYER V, 1992, WATER SCI TECHNOL, V26, P1205
   Mittal A, 2010, J COLLOID INTERF SCI, V343, P463, DOI 10.1016/j.jcis.2009.11.060
   Mona S, 2011, INT BIODETER BIODEGR, V65, P513, DOI 10.1016/j.ibiod.2011.02.002
   Namasivayam C, 1998, BIORESOURCE TECHNOL, V64, P77, DOI 10.1016/S0960-8524(97)86722-3
   Ncibi MC, 2009, DESALINATION, V243, P109, DOI 10.1016/j.desal.2008.04.018
   Ncibi MC, 2008, BIORESOURCE TECHNOL, V99, P5582, DOI 10.1016/j.biortech.2007.10.040
   Ncibi MC, 2006, ADSORPT SCI TECHNOL, V24, P461, DOI 10.1260/026361706780154383
   Ncibi MC, 2007, J HAZARD MATER, V139, P280, DOI 10.1016/j.jhazmat.2006.06.029
   Olgun A, 2009, J HAZARD MATER, V161, P148, DOI 10.1016/j.jhazmat.2008.03.064
   Patil Satish, 2011, International Journal of Environmental Sciences, V1, P1116
   Pavasant P, 2006, BIORESOURCE TECHNOL, V97, P2321, DOI 10.1016/j.biortech.2005.10.032
   Saeed A, 2005, SEP PURIF TECHNOL, V45, P25, DOI 10.1016/j.seppur.2005.02.004
   Saeed A, 2010, J HAZARD MATER, V179, P564, DOI 10.1016/j.jhazmat.2010.03.041
   Santos SCR, 2008, APPL CLAY SCI, V42, P137, DOI 10.1016/j.clay.2008.01.002
   Song JY, 2011, DESALINATION, V265, P119, DOI 10.1016/j.desal.2010.07.041
   Sulochana R, 2009, WORLD APPL SCI J, V5, P114
   Tan IAW, 2009, J HAZARD MATER, V164, P473, DOI 10.1016/j.jhazmat.2008.08.025
   Uddin MT, 2009, J ENVIRON MANAGE, V90, P3443, DOI 10.1016/j.jenvman.2009.05.030
   US Environmental Protection Agency (US EPA), 1996, EPA625R96004
   Wahab MA, 2010, BIORESOURCE TECHNOL, V101, P8606, DOI 10.1016/j.biortech.2010.06.099
   Wu FC, 2005, J COLLOID INTERF SCI, V283, P49, DOI 10.1016/j.jcis.2004.08.037
NR 63
TC 39
Z9 39
U1 1
U2 28
PU ELSEVIER SCIENCE SA
PI LAUSANNE
PA PO BOX 564, 1001 LAUSANNE, SWITZERLAND
SN 1385-8947
J9 CHEM ENG J
JI Chem. Eng. J.
PD MAY 1
PY 2012
VL 189
BP 32
EP 40
DI 10.1016/j.cej.2012.02.015
PG 9
WC Engineering, Environmental; Engineering, Chemical
SC Engineering
GA 937DN
UT WOS:000303639300005
DA 2018-10-19
ER

PT J
AU Jin, XD
   Ni, QQ
   Fu, YQ
   Zhang, L
   Natsuki, T
AF Jin, Xudong
   Ni, Qing-Qing
   Fu, Yaqin
   Zhang, Li
   Natsuki, Toshiaki
TI Hydrothermal Synthesis of Carbon Nanotube/Nickel Ferrite Nanocomposites
SO SEN-I GAKKAISHI
LA English
DT Article
ID NICKEL FERRITE; MAGNETIC-PROPERTIES; COMPOSITE NANOPARTICLES; CATION
   DISTRIBUTION; BIOMATERIAL SYSTEM; MFE2O4 M; NIFE2O4; CO; SEPARATION; NI
AB We report a simple hydrothermal synthesis of carbon nanotube/nickel ferrite (CNT/NiFe2O4) nanocomposites. The CNTs used in this work were pretreated with nitric acid. The evolution of the synthesis of the CNT/NiFe2O4 nanocomposites was studied using X-ray photoelectron spectroscopy, X-ray diffraction, energy-dispersive X-ray spectroscopy, and transmission electron microscopy. The results suggest that NiFe2O4 nanoparticles were synthesized in situ on the CNT surface. Vibrating-sample magnetometer measurements showed that the CNT/NiFe2O4 nanocomposites exhibit typical soft ferromagnetic behavior with saturation magnetization (Ms) of about 24 emu/g.
C1 [Jin, Xudong] Shinshu Univ, Interdisciplinary Grad Sch Sci & Technol, Ueda, Nagano 3868567, Japan.
   [Ni, Qing-Qing; Fu, Yaqin] Zhejiang Sci Tech Univ, Minist Educ, Key Lab Adv Text Mat & Mfg Technol, Hangzhou 310018, Peoples R China.
   [Ni, Qing-Qing; Natsuki, Toshiaki] Shinshu Univ, Dept Funct Machinery & Mech, Ueda, Nagano 3868567, Japan.
   [Zhang, Li] Shinshu Univ, Fac Engn, Ueda, Nagano 3868567, Japan.
RP Jin, XD (reprint author), Shinshu Univ, Interdisciplinary Grad Sch Sci & Technol, Ueda, Nagano 3868567, Japan.
FU Ministry of Education, Culture, Sports, Science and Technology, Japan
FX This work was supported by a Grant-in-Aid Global COE Program from the
   Ministry of Education, Culture, Sports, Science and Technology, Japan.
CR Baby TT, 2010, TALANTA, V80, P2016, DOI 10.1016/j.talanta.2009.11.010
   Cao XH, 2011, SOLID STATE COMMUN, V151, P678, DOI 10.1016/j.ssc.2011.02.022
   Chen DH, 2001, MATER RES BULL, V36, P1369, DOI 10.1016/S0025-5408(01)00620-1
   Cheng Y, 2005, J SOLID STATE CHEM, V178, P2394, DOI 10.1016/j.jssc.2005.05.006
   Deng YH, 2005, CHEM COMMUN, P5548, DOI 10.1039/b511683j
   George M, 2006, J MAGN MAGN MATER, V302, P190, DOI 10.1016/j.jmmm.2005.08.029
   Haetge J, 2010, INORG CHEM, V49, P11619, DOI 10.1021/ic102052r
   Hankare PP, 2011, APPL CATAL B-ENVIRON, V107, P333, DOI 10.1016/j.apcatb.2011.07.033
   Komarneni S, 1998, J AM CERAM SOC, V81, P3041
   Lavela P, 2007, J POWER SOURCES, V172, P379, DOI 10.1016/j.jpowsour.2007.07.055
   Li SH, 2008, J SOLID STATE CHEM, V181, P1650, DOI 10.1016/j.jssc.2008.05.021
   Li Y, 2011, PARTICUOLOGY, V9, P475, DOI 10.1016/j.partic.2011.04.005
   Liu JJ, 2001, MATER RES BULL, V36, P2357, DOI 10.1016/S0025-5408(01)00722-X
   Maaz K, 2009, J MAGN MAGN MATER, V321, P1838, DOI 10.1016/j.jmmm.2008.11.098
   Mittal VK, 2006, SOLID STATE COMMUN, V137, P6, DOI 10.1016/j.ssc.2005.10.019
   Mu SX, 2010, ACS APPL MATER INTER, V2, P111, DOI 10.1021/am900620u
   Nam JH, 2009, J MAGN MAGN MATER, V321, P1389, DOI 10.1016/j.jmmm.2009.02.044
   Naseri MG, 2011, POWDER TECHNOL, V212, P80, DOI 10.1016/j.powtec.2011.04.033
   Nawale AB, 2011, J ALLOY COMPD, V509, P4404, DOI 10.1016/j.jallcom.2011.01.057
   Prabhakaran T, 2011, J ALLOY COMPD, V509, P7071, DOI 10.1016/j.jallcom.2011.03.176
   Pyrzynska K, 2010, TRAC-TREND ANAL CHEM, V29, P718, DOI 10.1016/j.trac.2010.03.013
   Rana S, 2006, ACTA BIOMATER, V2, P421, DOI 10.1016/j.actbio.2006.03.005
   Rawat J, 2007, MAT SCI ENG C-BIO S, V27, P540, DOI 10.1016/j.msec.2006.05.021
   Sepelak V, 2007, J PHYS CHEM C, V111, P5026, DOI 10.1021/jp067620s
   Shi Y, 1999, J MAGN MAGN MATER, V205, P249, DOI 10.1016/S0304-8853(99)00504-1
   Sunkara BK, 2008, ACTA BIOMATER, V4, P273, DOI 10.1016/j.actbio.2007.07.002
   Sunny V, 2010, J ALLOY COMPD, V489, P297, DOI 10.1016/j.jallcom.2009.09.077
   Thostenson ET, 2001, COMPOS SCI TECHNOL, V61, P1899, DOI 10.1016/S0266-3538(01)00094-X
   Tyagi S, 2011, CERAM INT, V37, P2631, DOI 10.1016/j.ceramint.2011.04.012
   Wang J, 2006, MAT SCI ENG B-SOLID, V127, P81, DOI 10.1016/j.mseb.2005.09.003
   Wang ZL, 2008, J PHYS CHEM B, V112, P11292, DOI 10.1021/jp804178w
   Wepasnick KA, 2011, CARBON, V49, P24, DOI 10.1016/j.carbon.2010.08.034
   Wu HX, 2011, ACTA BIOMATER, V7, P3496, DOI 10.1016/j.actbio.2011.05.031
   Xu SH, 2007, APPL CATAL B-ENVIRON, V71, P177, DOI 10.1016/j.apcatb.2006.09.004
   Zhang JL, 2009, J SOLID STATE CHEM, V182, P2135, DOI 10.1016/j.jssc.2009.05.032
   Zhang Q, 2009, MATER CHEM PHYS, V116, P658, DOI 10.1016/j.matchemphys.2009.05.029
   Zhou J, 2005, J AM CERAM SOC, V88, P3535, DOI 10.1111/j.1551-2916.2005.00629.x
NR 37
TC 0
Z9 0
U1 1
U2 12
PU SOC FIBER SCIENCE TECHNOLOGY
PI TOKYO
PA KAMIOSAKI 3-3-9-208, SHINAGAWA-KU, TOKYO, 141-0025, JAPAN
SN 0037-9875
J9 SEN-I GAKKAISHI
JI Sen-I Gakkaishi
PD MAY
PY 2012
VL 68
IS 5
BP 112
EP 117
DI 10.2115/fiber.68.112
PG 6
WC Materials Science, Textiles; Polymer Science
SC Materials Science; Polymer Science
GA 982IZ
UT WOS:000307038000010
OA Bronze
DA 2018-10-19
ER

PT J
AU Grobelski, B
   Walczak, DA
   Pawelczak, D
   Kolodziejczyk, M
   Bielecki, S
   Taran, K
   Pasieka, Z
AF Grobelski, B.
   Walczak, D. A.
   Pawelczak, D.
   Kolodziejczyk, M.
   Bielecki, S.
   Taran, K.
   Pasieka, Z.
TI Artificial small arteries substitute created from novel biomaterial
SO VASCULAR PHARMACOLOGY
LA English
DT Meeting Abstract
CT 6th European Meeting on Vascular Biology and Medicine (EMVBM)
CY SEP 21-24, 2011
CL Krakow, POLAND
C1 [Grobelski, B.] Med Univ Lodz, Dept Haemostasis & Haemostat Disorders, Lodz, Poland.
   [Walczak, D. A.; Pawelczak, D.; Pasieka, Z.] Med Univ Lodz, Dept Expt Surg, Lodz, Poland.
   [Kolodziejczyk, M.; Bielecki, S.] Tech Univ Lodz, Inst Tech Biochem, PL-90924 Lodz, Poland.
   [Taran, K.] Med Univ Lodz, Dept Pathol, Lodz, Poland.
EM bartlomiej.grobelski@umed.lodz.pl
NR 0
TC 0
Z9 0
U1 0
U2 4
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 1537-1891
J9 VASC PHARMACOL
JI Vasc. Pharmacol.
PD MAY-JUN
PY 2012
VL 56
IS 5-6
SI SI
BP 346
EP 346
DI 10.1016/j.vph.2011.08.114
PG 1
WC Pharmacology & Pharmacy
SC Pharmacology & Pharmacy
GA 980JM
UT WOS:000306889400126
DA 2018-10-19
ER

PT J
AU Kumar, S
   Koh, J
AF Kumar, Santosh
   Koh, Joonseok
TI Physiochemical, Optical and Biological Activity of Chitosan-Chromone
   Derivative for Biomedical Applications
SO INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
LA English
DT Article
DE chitosan; chitosan-chromone derivative; characterization; biomaterial
ID INHIBITORY-ACTIVITY; CONTROLLED-RELEASE; ANALOGS; AGENTS; DRUG;
   ACTIVATION; FLAVONOIDS; MOLECULES; SCAFFOLDS; PROPERTY
AB This paper describes the physiochemical, optical and biological activity of chitosan-chromone derivative. The chitosan-chromone derivative gels were prepared by reacting chitosan with chromone-3-carbaldehyde, followed by solvent exchange, filtration and drying by evaporation. The identity of Schiff base was confirmed by UV-Vis absorption spectroscopy and Fourier-transform infrared (FTIR) spectroscopy. The chitosan-chromone derivative was evaluated by X-ray diffraction (XRD), thermogravimetric analysis (TGA), differential scanning calorimetry (DSC), scanning electron microscopy (SEM), photoluminescence (PL) and circular dichroism (CD). The CD spectrum showed the chitosan-chromone derivative had a secondary helical structure. Microbiological screening results demonstrated the chitosan-chromone derivative had antimicrobial activity against Escherichia coli bacteria. The chitosan-chromone derivative did not have any adverse effect on the cellular proliferation of mouse embryonic fibroblasts (MEF) and did not lead to cellular toxicity in MEFs. These results suggest that the chitosan-chromone derivative gels may open a new perspective in biomedical applications.
C1 [Kumar, Santosh; Koh, Joonseok] Konkuk Univ, Dept Text Engn, Seoul 143701, South Korea.
RP Koh, J (reprint author), Konkuk Univ, Dept Text Engn, Seoul 143701, South Korea.
EM santoshics@rediffmail.com; ccdjko@konkuk.ac.kr
OI Kumar, Santosh/0000-0002-1457-5804; KOH, JOONSEOK/0000-0001-6542-0493
FU Konkuk University, Seoul, South Korea
FX This research was supported by the 2011 KU Brain Pool Program of Konkuk
   University, Seoul, South Korea. We gratefully acknowledge M. K. Gupta,
   the Department of Animal Biotechnology, Konkuk University, Seoul, for
   the biological activity test.
CR Anitha A, 2009, CARBOHYD POLYM, V78, P672, DOI 10.1016/j.carbpol.2009.05.028
   Badawy M. E. I., 2008, POLYM INT, V57, P254
   Cornelissen JJLM, 2002, PURE APPL CHEM, V74, P2021, DOI 10.1351/pac200274112021
   Deng YH, 2000, J NAT PROD, V63, P1082, DOI 10.1021/np000054m
   Depan D, 2011, MAT SCI ENG C-MATER, V31, P1305, DOI 10.1016/j.msec.2011.04.010
   Depan D, 2011, ACTA BIOMATER, V7, P3432, DOI 10.1016/j.actbio.2011.05.019
   Depan D, 2011, ACTA BIOMATER, V7, P2163, DOI 10.1016/j.actbio.2011.01.029
   FRADET G, 1986, CHITIN NATURE TECHNO, P443
   Groweiss A, 2000, J NAT PROD, V63, P1537, DOI 10.1021/np000175m
   Hirano S, 1999, CARBOHYD POLYM, V38, P293, DOI 10.1016/S0144-8617(98)00126-X
   Jayakumar R, 2010, CARBOHYD POLYM, V82, P227, DOI 10.1016/j.carbpol.2010.04.074
   Jayakumar R., 2010, BIOTECHNOL ADV, V79, P142
   Khan IA, 2000, J NAT PROD, V63, P1414, DOI 10.1021/np000010d
   Khor E, 2003, BIOMATERIALS, V24, P2339, DOI 10.1016/S0142-9612(03)00026-7
   Kumar S., 2010, CARBOHYD POLYM, V80, P564
   Kumar S, 2012, INT J BIOL MACROMOL, V50, P493, DOI 10.1016/j.ijbiomac.2012.01.015
   Kumar S, 2011, INT J BIOL MACROMOL, V49, P356, DOI 10.1016/j.ijbiomac.2011.05.017
   Kumar S, 2010, J APPL POLYM SCI, V115, P3056, DOI 10.1002/app.31385
   Kumar S, 2009, J MACROMOL SCI A, V46, P1095, DOI 10.1080/10601320903256539
   Kumar S, 2009, INT J BIOL MACROMOL, V45, P330, DOI 10.1016/j.ijbiomac.2009.08.002
   Kumar S, 2007, BIOORGAN MED CHEM, V15, P2952, DOI 10.1016/j.bmc.2007.02.004
   Larget R, 2000, BIOORG MED CHEM LETT, V10, P835, DOI 10.1016/S0960-894X(00)00110-4
   Lin LC, 2000, J NAT PROD, V63, P627, DOI 10.1021/np990538m
   Lord MS, 2011, BIOMATERIALS, V32, P6655, DOI 10.1016/j.biomaterials.2011.05.062
   Ma WG, 1996, PHYTOCHEMISTRY, V43, P1339
   Maganti N, 2011, ADV ENG MATER, V13, pB108, DOI 10.1002/adem.201080094
   Mali S, 2009, MAT SCI ENG C-MATER, V29, P2417, DOI 10.1016/j.msec.2009.07.003
   Misra R.D.K., 2008, MAT SCI TECHNOL, V34, P1062
   Mooney DJ, 1996, BIOMATERIALS, V17, P1417, DOI 10.1016/0142-9612(96)87284-X
   MUZZARELLI RAA, 1994, BIOMATERIALS, V15, P1075, DOI 10.1016/0142-9612(94)90093-0
   Muzzarelli RAA, 1999, EXS, V87, P251
   Nam DH, 2010, EUR J MED CHEM, V45, P4288, DOI 10.1016/j.ejmech.2010.06.030
   Park HR, 2011, BIOORG MED CHEM LETT, V21, P3202, DOI 10.1016/j.bmcl.2011.04.055
   Pietta PG, 2000, J NAT PROD, V63, P1035, DOI 10.1021/np9904509
   Rejinold NS, 2012, CARBOHYD POLYM, V87, P943, DOI 10.1016/j.carbpol.2011.08.044
   Santos J.E., 2005, CARBOHYD POLYM, V60, P227
   Shaw AY, 2009, EUR J MED CHEM, V44, P2552, DOI 10.1016/j.ejmech.2009.01.034
   Shi BY, 2012, BIOMACROMOLECULES, V13, P146, DOI 10.1021/bm201380e
   Shi YQ, 2001, J NAT PROD, V64, P181, DOI 10.1021/np000317c
   Thanigaimalai P, 2010, BIOORGAN MED CHEM, V18, P4625, DOI 10.1016/j.bmc.2010.05.028
   Thanigaimalai P, 2010, EUR J MED CHEM, V45, P2531, DOI 10.1016/j.ejmech.2010.02.041
   Thein-Han WW, 2009, ACTA BIOMATER, V5, P3453, DOI 10.1016/j.actbio.2009.05.012
   Thein-Han WW, 2009, ACTA BIOMATER, V5, P1182, DOI 10.1016/j.actbio.2008.11.025
   Valenti P, 2000, BIOORGAN MED CHEM, V8, P239, DOI 10.1016/S0968-0896(99)00282-5
   Van Beijnen J.M., 1983, MACROMOLECULES, V16, P1679
   Xiao Y, 2008, REACT FUNCT POLYM, V68, P1281, DOI 10.1016/j.reactfunctpolym.2008.06.015
   Yuan Q, 2008, ACTA BIOMATER, V4, P1024, DOI 10.1016/j.actbio.2008.02.002
   Yuan Q, 2010, ACTA BIOMATER, V6, P1140, DOI 10.1016/j.actbio.2009.08.027
   Zhang YL, 2011, BIOMACROMOLECULES, V12, P2894, DOI 10.1021/bm200423f
   Zhou T, 2010, BIOORGAN MED CHEM, V18, P6678, DOI 10.1016/j.bmc.2010.07.065
NR 50
TC 41
Z9 41
U1 1
U2 19
PU MDPI AG
PI BASEL
PA POSTFACH, CH-4005 BASEL, SWITZERLAND
SN 1661-6596
J9 INT J MOL SCI
JI Int. J. Mol. Sci.
PD MAY
PY 2012
VL 13
IS 5
BP 6102
EP 6116
DI 10.3390/ijms13056102
PG 15
WC Biochemistry & Molecular Biology; Chemistry, Multidisciplinary
SC Biochemistry & Molecular Biology; Chemistry
GA 971EJ
UT WOS:000306186200056
PM 22754352
OA DOAJ Gold, Green Published
DA 2018-10-19
ER

PT J
AU Milinkovic, I
   Rudolf, R
   Raic, KT
   Aleksic, Z
   Lazic, V
   Todorovic, A
   Stamenkovic, D
AF Milinkovic, Iva
   Rudolf, Rebeka
   Raic, Karlo T.
   Aleksic, Zoran
   Lazic, Vojkan
   Todorovic, Aleksandar
   Stamenkovic, Dragoslav
TI ASPECTS OF TITANIUM-IMPLANT SURFACE MODIFICATION AT THE MICRO AND NANO
   LEVELS
SO MATERIALI IN TEHNOLOGIJE
LA English
DT Article
DE Ti implant; surface modification; microlevel; Au nanoparticles
ID BIOMEDICAL APPLICATIONS
AB The shape and chemical composition, as well as the macro- and microtopography, of an implant surface have been studied widely as the major factors that positively influence implant osseointegration. Titanium and titanium alloys have been used extensively over the past 20 years as biomedical materials in orthopedic and dental surgery because of their good mechanical properties, corrosion resistance, no cell toxicity, and very poor inflammatory response in pen-implant tissue, which confirms their high biocompatibility. Their favorable biological performance is attributed to a thin native oxide film that forms spontaneously on the titanium surface. It is well established that surface roughness plays an important role in implant fixation. Accordingly, some authors have indicated the existence of an optimal range of surface roughness.
   The titanium surface can be either chemically or physically modified, or both, in order to improve biomaterial tissue integration. Different treatments are used to modify the titanium surface. Hydroxyapatite coatings, preceded or not by acid etching, are used to create a rough, potentially bioactive surface. Oxide blasting treatments, either with or without chemical etching, are used to develop rough surfaces. Thick oxide films obtained by anodic or thermal oxidation have been used to accelerate the osseointegration process. The ideal microtopography of the surface is still unknown, however, because it is very difficult to associate surface properties with clinical results.
   As more accurate knowledge is required, several Ti surfaces have been analyzed and the endosseous implant surface modified on the micro level has been thoroughly studied. Additionally, the production of gold (Au) nanoparticles to be added to the micron-scale modified surface has been performed. In this respect, an appropriate overview of our results is given.
C1 [Milinkovic, Iva; Aleksic, Zoran; Lazic, Vojkan; Todorovic, Aleksandar; Stamenkovic, Dragoslav] Univ Belgrade, Sch Dent Med, Belgrade, Serbia.
   [Rudolf, Rebeka] Univ Maribor, Fac Mech Engn, Maribor 2000, Slovenia.
   [Raic, Karlo T.] Univ Belgrade, Fac Technol & Met, Belgrade 11000, Serbia.
RP Milinkovic, I (reprint author), Univ Belgrade, Sch Dent Med, Dr Subotica 8, Belgrade, Serbia.
EM karlo@tmf.bg.ac.rs
FU Eureka project [E! 5831]
FX This paper is part of the Eureka project E! 5831 Cell - Ti. The authors
   gratefully acknowledge the Ministry of Higher Education, Science and
   Technology of the Republic of Slovenia and the Ministry of Science and
   Technological Development of the Republic of Serbia.
CR BRANEMARK PI, 1983, J PROSTHET DENT, V50, P399, DOI 10.1016/S0022-3913(83)80101-2
   BUSER D, 1991, J BIOMED MATER RES, V25, P889, DOI 10.1002/jbm.820250708
   Chu PK, 2002, MAT SCI ENG R, V36, P143, DOI 10.1016/S0927-796X(02)00004-9
   Fasasi AY, 2009, MAT SCI ENG C-BIO S, V29, P5, DOI 10.1016/j.msec.2008.05.002
   Gehrke Peter, 2003, Dent Implantol Update, V14, P57
   Liu XY, 2004, MAT SCI ENG R, V47, P49, DOI 10.1016/j.mser.2004.11.001
   Mendonca G., 2008, BIOMATERIALS, V28, P3822
   Raic KT, 2009, MATER TEHNOL, V43, P3
   Stopic S., 2011, METALL, V65, P147
   Stopic S., 2010, METALL, V64, P474
   Wennerberg A, 1998, CLIN ORAL IMPLAN RES, V9, P11, DOI 10.1034/j.1600-0501.1998.090102.x
   Wennerberg A., 2010, INT J ORAL MAXILLOF, V25, P6
NR 12
TC 4
Z9 4
U1 0
U2 22
PU INST ZA KOVINSKE MATERIALE I IN TEHNOLOGIE
PI LJUBJANA
PA LEPI POT 11, LJUBJANA, 10000, SLOVENIA
SN 1580-2949
J9 MATER TEHNOL
JI Mater. Tehnol.
PD MAY-JUN
PY 2012
VL 46
IS 3
BP 251
EP 256
PG 6
WC Materials Science, Multidisciplinary
SC Materials Science
GA 963XA
UT WOS:000305657100011
OA DOAJ Gold
DA 2018-10-19
ER

PT J
AU Bandeira, LC
   Ciuffi, KJ
   Calefi, PS
   Nassar, EJ
   Silva, JVL
   Oliveira, M
   Maia, IA
   Salvado, IM
   Fernandes, MHV
AF Bandeira, Lucimara C.
   Ciuffi, Katia J.
   Calefi, Paulo S.
   Nassar, Eduardo J.
   Silva, Jorge V. L.
   Oliveira, Marcelo
   Maia, Izaque A.
   Salvado, Isabel M.
   Fernandes, Maria Helena V.
TI Effect of Calcium Phosphate Coating on Polyamide Substrate for
   Biomaterial Applications
SO JOURNAL OF THE BRAZILIAN CHEMICAL SOCIETY
LA English
DT Article
DE sol-gel; dip-coating; rapid prototyping; polyamide coated with calcium
   phosphate; biomaterial
ID IN-VITRO; APATITE; FILMS; GLASS; BIOCOMPATIBILITY; BIOCOMPOSITES;
   COMPOSITE
AB A new type of material from polyamide coated with calcium phosphate was developed aiming to have potential application as biomaterial. Coating was obtained by the sol-gel method and calcium phosphate was obtained after contact with body fluid solution. The coated polyamide (before and after contact with body fluid solution) was characterized by thermogravimetric and differential thermal (TGA/DTA) analyses, differential scanning calorimetry (DSC), scanning electron microscopy (SEM) and attenuated total reflectance Fourier transform infrared spectroscopy (ATR-FTIR). These characterizations revealed that the calcium phosphate coating has a thickness of less than 3 mu m, which resulted in an increase in the melting point and improved the thermal stability of polyamide. After contact with body fluid, the interactions between the coating and the substrate remained, and there was formation of crystalline and amorphous phosphates on polyamide surface.
C1 [Bandeira, Lucimara C.; Ciuffi, Katia J.; Calefi, Paulo S.; Nassar, Eduardo J.] Univ Franca, BR-14404600 Franca, SP, Brazil.
   [Silva, Jorge V. L.; Oliveira, Marcelo; Maia, Izaque A.] Ctr Tecnol Informacao Renato Archer CTI, BR-13069901 Campinas, SP, Brazil.
   [Salvado, Isabel M.; Fernandes, Maria Helena V.] Univ Aveiro, Dept Engn Ceram & Vidro, CICECO, P-3810 Aveiro, Portugal.
RP Nassar, EJ (reprint author), Univ Franca, Av Dr Armando Salles Oliveira 201, BR-14404600 Franca, SP, Brazil.
EM ejnassar@unifran.br
RI ciuffi, Katia/B-8788-2012; Sergio Calefi, Paulo/D-1704-2013; Ciuffi,
   katia/D-5980-2015; Nassar, Eduardo/H-7354-2013
OI Ciuffi, katia/0000-0001-8270-0286; Oliveira,
   Marcelo/0000-0003-0695-6188; Salvado, Isabel/0000-0003-0265-4553; V
   Fernandes, Maria Helena/0000-0002-1240-2512
FU Brazilian research funding agency Fundacao de Amparo a Pesquisa do
   Estado de Sao Paulo (FAPESP); Brazilian research funding agency Conselho
   Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq); Brazilian
   research funding agency Coordenacao de Aperfeicoamento de Pessoal de
   Nivel Superior (CAPES)
FX The authors acknowledge Fundacao de Amparo a Pesquisa do Estado de Sao
   Paulo (FAPESP), Conselho Nacional de Desenvolvimento Cientifico e
   Tecnologico (CNPq) and Coordenacao de Aperfeicoamento de Pessoal de
   Nivel Superior (CAPES) (Brazilian research funding agencies) for
   supporting this work.
CR Aegerter M. A., 2004, SOL GEL TECHNOLOGIES
   Arcos D, 2010, ACTA BIOMATER, V6, P2874, DOI 10.1016/j.actbio.2010.02.012
   Bandeira L. C., 2011, Cerâmica, V57, P166, DOI 10.1590/S0366-69132011000200006
   Bandeira L. C., 2010, ADV BIOSCI BIOTECHNO, V1, P200
   Bandeira LC, 2009, J THERM ANAL CALORIM, V97, P67, DOI 10.1007/s10973-008-9689-4
   BUENO WA, 1989, MANUAL ESPECTROSCOPI
   Cestari A, 2009, J ALLOY COMPD, V472, P299, DOI 10.1016/j.jallcom.2008.04.053
   Colthup N. B., 1990, INTRO INFRARED RAMAN
   de Campos BM, 2011, VIRTUAL PHYS PROTOTY, V6, P33, DOI 10.1080/17452759.2010.491938
   Hench L. L., 1998, SOL GEL SILICA PROPE
   Jie W, 2005, J MATER SCI, V40, P793, DOI 10.1007/s10853-005-6326-5
   Jie W, 2004, EUR POLYM J, V40, P509, DOI 10.1016/j.eurpolymj.2003.10.028
   Kawai T, 2004, BIOMATERIALS, V25, P4529, DOI 10.1016/j.biomaterials.2003.11.039
   Kawai T, 2007, J MATER SCI-MATER M, V18, P1037, DOI 10.1007/s10856-006-0081-2
   KOKUBO T, 1990, J BIOMED MATER RES, V24, P721, DOI 10.1002/jbm.820240607
   Leeuwenburgh SCG, 2008, BIOMATERIALS, V29, P3047, DOI 10.1016/j.biomaterials.2008.04.032
   Meurer MI, 2005, Virtual Modeling and Rapid Manufacturing, P167
   Nassar EJ, 2007, QUIM NOVA, V30, P1567, DOI 10.1590/S0100-40422007000700013
   Nassar EJ, 2007, J SOL-GEL SCI TECHN, V43, P21, DOI 10.1007/s10971-007-1546-6
   Nassar EJ, 2003, QUIM NOVA, V26, P674, DOI 10.1590/S0100-40422003000500010
   Peitl O, 2001, J NON-CRYST SOLIDS, V292, P115, DOI 10.1016/S0022-3093(01)00822-5
   Rocha LA, 2007, MATER CHEM PHYS, V101, P238, DOI 10.1016/j.matchemphys.2006.04.002
   Salmoria GV, 2009, POLYM TEST, V28, P746, DOI 10.1016/j.polymertesting.2009.06.010
   Shen J, 2009, J BIOMED MATER RES B, V91B, P897, DOI 10.1002/jbm.b.31472
   Takadama H, 2001, CHEM MATER, V13, P1108, DOI 10.1021/cm0008718
   Volpato N., 2007, PROTOTIPAGEM RAPIDA
   Wang HN, 2007, BIOMATERIALS, V28, P3338, DOI 10.1016/j.biomaterials.2007.04.014
   Wright J. D., 2001, SOL GEL MAT CHEM APP, V4
   Yi Z, 2007, MAT SCI ENG A-STRUCT, V452-453, P512
   Zhang X, 2007, COMPOS PART A-APPL S, V38, P843, DOI 10.1016/j.compositesa.2006.08.002
   Zhang Y, 2009, J BIOMED MATER RES A, V91A, P1018, DOI 10.1002/jbm.a.32298
NR 31
TC 7
Z9 7
U1 0
U2 14
PU SOC BRASILEIRA QUIMICA
PI SAO PAULO
PA CAIXA POSTAL 26037, 05599-970 SAO PAULO, BRAZIL
SN 0103-5053
J9 J BRAZIL CHEM SOC
JI J. Braz. Chem. Soc.
PD MAY
PY 2012
VL 23
IS 5
BP 810
EP 817
PG 8
WC Chemistry, Multidisciplinary
SC Chemistry
GA 953FR
UT WOS:000304852800004
OA DOAJ Gold
DA 2018-10-19
ER

PT J
AU Song, Y
   Margolles-Clark, E
   Fraker, CA
   Weaver, JD
   Ricordi, C
   Pileggi, A
   Stabler, CL
   Buchwald, P
AF Song, Y.
   Margolles-Clark, E.
   Fraker, C. A.
   Weaver, J. D.
   Ricordi, C.
   Pileggi, A.
   Stabler, C. L.
   Buchwald, P.
TI Feasibility of localized immunosuppression: 3. Preliminary evaluation of
   organosilicone constructs designed for sustained drug release in a cell
   transplant environment using dexamethasone
SO PHARMAZIE
LA English
DT Article; Proceedings Paper
CT 8th Conference on Retrometabolism Based Drug Design and Targeting
CY JUN 02-04, 2011
CL Graz, AUSTRIA
ID CLINICAL ISLET TRANSPLANTATION; INDUCED INSULIN-RESISTANCE; IMMUNE
   PRIVILEGE; IN-VITRO; FLUOCINOLONE ACETONIDE; BIOARTIFICIAL PANCREAS;
   INHALED TACROLIMUS; GRAFT-REJECTION; ALLOGRAFT MODEL; RAT ISLETS
AB As part of our ongoing effort to develop biohybrid devices for pancreatic islet transplantation, we are interested in establishing the feasibility of a localized immune-suppressive approach to avoid or minimize the undesirable side effects of existing systemic treatments. Since biohybrid devices can also incorporate biocompatible scaffold constructs to provide a support environment for the transplanted cells that enhances their engraftment and long-term function, we are particularly interested in an approach that would use the same three-dimensional construct, or part of the same construct, to also provide sustained release of therapeutic agents to modulate the inflammatory and immune responses locally. Within this framework, here, we report preliminary results obtained during the investigation of the suitability of organosilicone constructs for providing sustained localized drug release using small, matrix-type polydimethylsiloxane (PDMS) disks and dexamethasone as a model hydrophobic drug. Following a short burst, long-term steady sustained release was observed under in vitro conditions at levels of 0.1-0.5 mu g/day/disk with a profile in excellent agreement with that predicted by the Higuchi equation. To verify that therapeutic levels can be achieved, suppression of LPS-induced activation has been shown in THP-1 cells with disks that have been pre-soaked for up to 28 days. These preliminary results prove the feasibility of this approach where an integral part of the biomaterial construct used to enhance cell engraftment and long-term function also serves to provide sustained local drug release.
C1 [Song, Y.; Fraker, C. A.; Weaver, J. D.; Ricordi, C.; Pileggi, A.; Stabler, C. L.; Buchwald, P.] Univ Miami, Diabet Res Inst, Miller Sch Med, Miami, FL 33136 USA.
   [Margolles-Clark, E.; Ricordi, C.; Pileggi, A.; Stabler, C. L.] Univ Miami, DeWitt Daughtry Dept Surg, Miller Sch Med, Miami, FL 33136 USA.
RP Buchwald, P (reprint author), Univ Miami, Diabet Res Inst, Miller Sch Med, 1450 NW 10 Ave,R-134, Miami, FL 33136 USA.
EM pbuchwald@med.miami.edu
RI Pileggi, Antonello/A-2394-2008; Stabler, Cherie/E-8227-2011
OI Pileggi, Antonello/0000-0001-7819-2813; Fraker,
   Christopher/0000-0002-2010-0573; Ricordi, Camillo/0000-0001-8092-7153;
   Buchwald, Peter/0000-0003-2732-8180
CR Arck PC, 2008, CURR OPIN PHARMACOL, V8, P480, DOI 10.1016/j.coph.2008.06.003
   Association of Reproductive Health Professionals, 2008, SINGL ROD CONTR IMPL, P20
   Bocca N, 2008, PHARMAZIE, V63, P226, DOI 10.1691/ph.2008.7774
   Bocca N., 2009, BIOARTIFICIAL PANCRE, P309
   Bocca N, 2010, AM J TRANSPLANT, V10, P149
   Brady AC, 2010, AM J TRANSPLANT, V10, P551
   Buchwald P, 2010, PHARMAZIE, V65, P421, DOI 10.1691/ph.2010.0525R
   Buchwald P, 2008, STEROIDS, V73, P193, DOI 10.1016/j.steroids.2007.10.001
   Croxatto HB, 2002, CONTRACEPTION, V65, P15, DOI 10.1016/S0010-7824(01)00294-3
   del Amo EM, 2008, DRUG DISCOV TODAY, V13, P135, DOI 10.1016/j.drudis.2007.11.002
   Deuse T, 2010, AM J RESP CELL MOL, V43, P403, DOI 10.1165/rcmb.2009-0208OC
   Fort A, 2008, CELL TRANSPLANT, V17, P997, DOI 10.3727/096368908786991498
   FREISE CE, 1991, TRANSPLANTATION, V52, P318
   Furtado A, 2000, TRANSPLANT P, V32, P1206, DOI 10.1016/S0041-1345(00)01187-8
   Galletti PM, 2006, BIOMEDICAL ENG HDB, P711
   Gibly RF, 2011, DIABETOLOGIA, V54, P2494, DOI 10.1007/s00125-011-2243-0
   HIGUCHI T, 1961, J PHARM SCI, V50, P874, DOI 10.1002/jps.2600501018
   Holan V, 2011, J CONTROL RELEASE, V156, P406, DOI 10.1016/j.jconrel.2011.07.022
   Hult M, 2009, MOL CELL ENDOCRINOL, V301, P109, DOI 10.1016/j.mce.2008.09.038
   INCEOGLU S, 1994, ANN PLAS SURG, V33, P57, DOI 10.1097/00000637-199407000-00011
   Jaffe GJ, 2005, OPHTHALMOLOGY, V112, P1192, DOI 10.1016/j.ophtha.2005.03.013
   Kim J, 2008, BIOMATERIALS, V29, P2259, DOI 10.1016/j.biomaterials.2008.01.030
   Kim J, 2010, J CONTROL RELEASE, V148, P110, DOI 10.1016/j.jconrel.2010.07.119
   Kizilel Seda, 2005, Diabetes Technol Ther, V7, P968, DOI 10.1089/dia.2005.7.968
   KNISELY TL, 1994, INVEST OPHTH VIS SCI, V35, P3711
   Lambillotte C, 1997, J CLIN INVEST, V99, P414, DOI 10.1172/JCI119175
   LANGER R, 1983, PHARMACOL THERAPEUT, V21, P35, DOI 10.1016/0163-7258(83)90066-9
   Lee PI, 2011, INT J PHARMACEUT, V418, P18, DOI 10.1016/j.ijpharm.2011.01.019
   Liu P, 2006, DESIGN CONTROLLED RE, P107
   Malcolm K, 2003, J CONTROL RELEASE, V90, P217, DOI 10.1016/S0168-3659(03)00178-0
   Margolles-Clark E, 2010, CHEM BIOL DRUG DES, V76, P305, DOI 10.1111/j.1747-0285.2010.01014.x
   Margolles-Clark E, 2009, J MOL MED, V87, P1133, DOI 10.1007/s00109-009-0519-3
   Mellor AL, 2008, NAT REV IMMUNOL, V8, P74, DOI 10.1038/nri2233
   Mineo D, 2009, DIABETES CARE, V32, P1563, DOI 10.2337/dc09-0490
   Miyazawa M, 2008, J TOXICOL SCI, V33, P71, DOI 10.2131/jts.33.71
   Moussy Y, 2006, BIOTECHNOL PROGR, V22, P819, DOI 10.1021/bp060031j
   MULLER DWM, 1994, CORONARY ARTERY DIS, V5, P435, DOI 10.1097/00019501-199405000-00010
   Narang AS, 2006, PHARMACOL REV, V58, P194, DOI 10.1124/pr.58.2.6
   Niederkorn JY, 2006, NAT IMMUNOL, V7, P354, DOI 10.1038/ni1328
   Ozcay N, 1997, TRANSPLANTATION, V63, P1220, DOI 10.1097/00007890-199705150-00006
   PAGANO G, 1983, J CLIN INVEST, V72, P1814, DOI 10.1172/JCI111141
   Patil SD, 2007, J CONTROL RELEASE, V117, P68, DOI 10.1016/j.jconrel.2006.10.013
   Pedraza E, 2009, IFMBE P, V24, P233
   PIERLUISSI J, 1986, DIABETOLOGIA, V29, P119, DOI 10.1007/BF00456122
   Pileggi A, 2006, ANN NY ACAD SCI, V1079, P383, DOI 10.1196/annals.1375.059
   Pileggi A, 2006, TRANSPLANTATION, V81, P1318, DOI 10.1097/01.tp.0000203858.41105.88
   Pinto E, 2010, PHARMAZIE, V65, P429, DOI 10.1691/ph.2010.0033R
   Qi D, 2007, AM J PHYSIOL-ENDOC M, V292, pE654, DOI 10.1152/ajpendo.00453.2006
   Rafacho A, 2010, ENDOCRINOLOGY, V151, P85, DOI 10.1210/en.2009-0704
   Ricordi C, 2005, TRANSPLANTATION, V79, P1298, DOI 10.1097/01.TP.0000157275.64874.84
   RILO HLR, 1994, TRANSPLANTATION, V57, P181
   RUERS TJM, 1986, TRANSPLANTATION, V41, P156, DOI 10.1097/00007890-198602000-00004
   RUERS TJM, 1988, TRANSPLANTATION, V46, P820, DOI 10.1097/00007890-198812000-00006
   Sakoda H, 2000, DIABETES, V49, P1700, DOI 10.2337/diabetes.49.10.1700
   Saltzman WM, 2002, NAT REV DRUG DISCOV, V1, P177, DOI 10.1038/nrd744
   Schrepfer S, 2007, AM J TRANSPLANT, V7, P1733, DOI 10.1111/j.1600-6143.2007.01858.x
   Shirbacheh MV, 1998, TRANSPLANT P, V30, P2739, DOI 10.1016/S0041-1345(98)00800-8
   Siepmann J, 2011, INT J PHARMACEUT, V418, P6, DOI 10.1016/j.ijpharm.2011.03.051
   Silva AI, 2006, MED RES REV, V26, P181, DOI 10.1002/med.20047
   Sivin I., 2002, JADELLE LEVONORGESTR, P48
   Skyler JS, 2011, DIABETES, V60, P1, DOI 10.2337/db10-1114
   Solari MG, 2009, PLAST RECONSTR SURG, V123, p17S, DOI 10.1097/PRS.0b013e318191bcbd
   WANG X, 1995, TRANSPLANT INT, V8, P268, DOI 10.1007/BF00346879
   Ward WK, 2010, J BIOMED MATER RES A, V94A, P280, DOI 10.1002/jbm.a.32651
   Weber T, 1997, TRANSPLANTATION, V64, P705, DOI 10.1097/00007890-199709150-00007
   Zawalich WS, 2006, METABOLISM, V55, P35, DOI 10.1016/j.metabol.2005.06.023
NR 66
TC 5
Z9 5
U1 1
U2 9
PU GOVI-VERLAG  PHARMAZEUTISCHER VERLAG GMBH
PI ESCHBORN
PA PHARMAZEUTISCCARL MANNICH STR 26, D-65760 ESCHBORN, GERMANY
SN 0031-7144
J9 PHARMAZIE
JI Pharmazie
PD MAY
PY 2012
VL 67
IS 5
BP 394
EP 399
DI 10.1691/ph.2012.1697
PG 6
WC Chemistry, Medicinal; Chemistry, Multidisciplinary; Pharmacology &
   Pharmacy
SC Pharmacology & Pharmacy; Chemistry
GA 954WF
UT WOS:000304978000007
PM 22764570
DA 2018-10-19
ER

PT J
AU Owen, K
   Wilshaw, SP
   Homer-Vanniasinkam, S
   Bojar, RA
   Berry, H
   Ingham, E
AF Owen, K.
   Wilshaw, S. -P
   Homer-Vanniasinkam, S.
   Bojar, R. A.
   Berry, H.
   Ingham, E.
TI Assessment of the Antimicrobial Activity of Acellular Vascular Grafts
SO EUROPEAN JOURNAL OF VASCULAR AND ENDOVASCULAR SURGERY
LA English
DT Article
DE Vascular graft infections; Decellularisation; Biofilm formation;
   Antimicrobial activity
ID INTESTINAL SUBMUCOSA; SAPHENOUS-VEIN; BYPASS; POLYTETRAFLUOROETHYLENE;
   MANAGEMENT; PROSTHESES; INFECTION; MATRIX
AB Several studies have reported biological vascular grafts to be more resistant to microbial infection than synthetic counterparts in vivo. Indeed, small intestinal submucosa (SIS) materials have previously been reported to be antimicrobial. The aim of this study was to assess the antimicrobial activity and the ability to resist biofilm formation of a novel acellular vascular graft and compare it to commercially available alternatives using a range of organisms: MRSA, MSSA, Staphylococcus epidermidis, Enterococcus faecalis, Escherichia coli, Klebsiella pneumonia, Pseudomonas aeruginosa and Candida albicans. This was achieved using a modified disk diffusion assay and extraction of the materials into solution followed by minimum inhibitory concentration assays. To assess resistance to biofilm formation a novel biofilm assay was developed which compared the total colony forming units (CFU) recovered from each material and identification of the percentage of CFU which were loosely attached, residing within the biofilm or attached to the biomaterial. The results indicated a lack of antimicrobial activity for all materials tested, including SIS. The biological materials were more resistant to the formation of a biofilm compared to Dacron. (C) 2012 European Society for Vascular Surgery. Published by Elsevier Ltd. All rights reserved.
C1 [Owen, K.; Wilshaw, S. -P; Ingham, E.] Univ Leeds, Fac Biol Sci, Inst Med & Biol Engn, Leeds LS2 9JT, W Yorkshire, England.
   [Homer-Vanniasinkam, S.] Leeds Gen Infirm, Vasc Inst, Leeds LS1 3EX, W Yorkshire, England.
   [Bojar, R. A.] Evocutis, Wetherby LS22 7TW, W Yorkshire, England.
   [Berry, H.] Tissue Regenix Ltd, Bioctr, York YO10 5NY, N Yorkshire, England.
RP Owen, K (reprint author), Univ Leeds, Fac Biol Sci, Inst Med & Biol Engn, Leeds LS2 9JT, W Yorkshire, England.
EM jhs5kno@leeds.ac.uk
OI Wilshaw, Stacy-Paul/0000-0002-7599-8165; Berry,
   Helen/0000-0003-2426-1881
FU Tissue Regenix Group Plc; Biotechnology and Biological Sciences research
   council (BBSRC); Tissue Regenix Plc; WELMEC, a Centre of Excellence in
   Medical Engineering; Wellcome Trust; EPSRC [WT 088908/Z/09/Z];
   Biotechnology and Biological Sciences Research Council [BB/C510767/1]
FX Tissue Regenix Group Plc contributed to the funding of this work. Also
   Prof E. Ingham is a share holder and advisor of the company.; The
   authors would like to thank the Biotechnology and Biological Sciences
   research council (BBSRC), Tissue Regenix Plc and WELMEC, a Centre of
   Excellence in Medical Engineering funded by the Wellcome Trust and
   EPSRC, under grant number WT 088908/Z/09/Z, for funding the current
   study. Dr H. Berry acted as a representative of Tissue Regenix Plc as an
   author and as such contributed to both drafting the manuscript and gave
   final approval for publication on their behalf. The authors would also
   like to thank Dr J Sandoe of the Leeds Teaching Hospitals Trust for his
   clinical microbiology contributions.
CR Andrews JM, 2009, J ANTIMICROB CHEMOTH, V64, P454, DOI 10.1093/jac/dkp244
   BADYLAK SF, 1994, J VASC SURG, V19, P465, DOI 10.1016/S0741-5214(94)70073-7
   Booth C, 2002, J HEART VALVE DIS, V11, P457
   Bose S, 2011, J CLIN DIAGN RES, V5, P127
   Brennan EP, 2006, TISSUE ENG, V12, P2949, DOI 10.1089/ten.2006.12.2949
   CALLIGARO KD, 1992, J VASC SURG, V16, P337, DOI 10.1016/0741-5214(92)90366-G
   CHERRY KJ, 1992, J VASC SURG, V15, P295, DOI 10.1016/0741-5214(92)90251-3
   Darouiche RO, 2004, ANN VASC SURG, V18, P497, DOI 10.1007/s10016-004-0062-1
   Fisher J, 2008, United States patent, Patent No. 7354749
   Fisher John, 2010, GB patent, Patent No. [GB1020846.0, 10208460]
   Hirsch AT, 2006, CIRCULATION, V113, pE463, DOI 10.1161/CIRCULATIONAHA.106.174526
   Javerliat I, 2007, J VASC SURG, V46, P1026, DOI 10.1016/j.jvs.2007.06.023
   Jernigan TW, 2004, ANN SURG, V239, P733, DOI 10.1097/01.sla.0000124447.30808.c7
   Johnson WC, 2000, J VASC SURG, V32, P268, DOI 10.1067/mva.2000.106944
   Klinkert P, 2004, EUR J VASC ENDOVASC, V27, P357, DOI 10.1016/j.ejvs.2003.12.027
   Mathews CHK, 2005, BIOCHEMISTRY
   MERTENS RA, 1995, J VASC SURG, V21, P782, DOI 10.1016/S0741-5214(05)80009-6
   Sarikaya A, 2002, TISSUE ENG, V8, P63, DOI 10.1089/107632702753503063
   Sawer PN, 1987, MODERN VASCULAR GRAF
   SCHMITT DD, 1986, J VASC SURG, V3, P732, DOI 10.1067/mva.1986.avs0030732
   Sokal R. R., 2001, BIOMETRY
   Wilshaw SP, 2006, TISSUE ENG, V12, P2117, DOI 10.1089/ten.2006.12.2117
NR 22
TC 3
Z9 3
U1 0
U2 7
PU W B SAUNDERS CO LTD
PI LONDON
PA 32 JAMESTOWN RD, LONDON NW1 7BY, ENGLAND
SN 1078-5884
EI 1532-2165
J9 EUR J VASC ENDOVASC
JI Eur. J. Vasc. Endovasc. Surg.
PD MAY
PY 2012
VL 43
IS 5
BP 573
EP 581
DI 10.1016/j.ejvs.2012.01.027
PG 9
WC Surgery; Peripheral Vascular Disease
SC Surgery; Cardiovascular System & Cardiology
GA 949NN
UT WOS:000304583000017
PM 22340962
OA Bronze
DA 2018-10-19
ER

PT J
AU Li, CC
   Hsiang, CY
   Wu, SL
   Ho, TY
AF Li, Chia-Cheng
   Hsiang, Chien-Yun
   Wu, Shih-Lu
   Ho, Tin-Yun
TI Identification of novel mechanisms of silymarin on the carbon
   tetrachloride-induced liver fibrosis in mice by nuclear factor-kappa B
   bioluminescent imaging-guided transcriptomic analysis
SO FOOD AND CHEMICAL TOXICOLOGY
LA English
DT Article
DE Liver fibrosis; Silymarin; Nuclear factor-kappa B; Bioluminescent
   imaging; DNA microarray; Cytochrome c oxidase
ID STELLATE CELL ACTIVATION; HOST-BIOMATERIAL INTERACTION; IN-VIVO;
   GENE-EXPRESSION; HEPATIC-FIBROSIS; DRUG DEVELOPMENT; RAT-LIVER; MODEL;
   HEPATOTOXICITY; MOLECULES
AB In this study, we applied bioluminescent imaging-guided transcriptomic analysis to evaluate and identify the therapeutic potentials and novel mechanisms of silymarin on carbon tetrachloride (CCl4)-induced liver fibrosis. Transgenic mice, carrying the luciferase genes driven by nuclear factor-kappa B (NF-kappa B), were given with CCl4 and/or silymarin. In vivo NF-kappa B activity was evaluated by bioluminescent imaging, liver fibrosis was judged by Sirius red staining and immunohistochemistry, and gene expression profiles of silymarin-treated livers were analyzed by DNA microarray. CCl4 enhanced the NF-kappa B-dependent hepatic luminescence and induced hepatic fibrosis, while silymarin reduced the CCl4-induced hepatic luminescence and improved CCl4-induced liver fibrosis. Microarray analysis showed that silymarin altered the transforming growth factor-beta-mediated pathways, which play pivotal roles in the progression of liver fibrosis. Moreover, we newly identified that silymarin downregulated the expression levels of cytoskeleton organization genes and mitochondrion electron-transfer chain genes, such as cytochrome c oxidase Cox6a2, Cox7a1, and Cox8b genes. In conclusion, the correlation of NF-kappa B-dependent luminescence and liver fibrosis suggested the feasibility of NF-kappa B bioluminescent imaging for the evaluation of liver fibrosis progression and therapeutic potentials. Moreover, our findings suggested that silymarin might exhibit anti-fibrotic effects in vivo via altering the expression of genes involved in cytoskeleton organization and mitochondrion electron-transfer chain. (C) 2012 Elsevier Ltd. All rights reserved.
C1 [Li, Chia-Cheng; Ho, Tin-Yun] China Med Univ, Grad Inst Chinese Med, Taichung 40402, Taiwan.
   [Hsiang, Chien-Yun] China Med Univ, Dept Microbiol, Taichung 40402, Taiwan.
   [Wu, Shih-Lu] China Med Univ, Dept Biochem, Taichung 40402, Taiwan.
   [Ho, Tin-Yun] China Med Univ Hosp, Dept Nucl Med, Taichung 40447, Taiwan.
RP Ho, TY (reprint author), China Med Univ, Grad Inst Chinese Med, 91 Hsueh Shih Rd, Taichung 40402, Taiwan.
EM cyhsiang@mail.cmu.edu.tw
RI Ho, Tin-Yun/O-3889-2015; Hsiang, Chien-Yun/O-3853-2015
FU National Science Council; Committee on Chinese Medicine and Pharmacy at
   Department of Health [CCMP100-RD-048]; China Medical University
   [CMU100-S-16, CMU100-S-34, CMU100-TS-14]
FX This work was supported by grants from National Science Council,
   Committee on Chinese Medicine and Pharmacy at Department of Health
   (CCMP100-RD-048), and China Medical University (CMU100-S-16,
   CMU100-S-34, and CMU100-TS-14).
CR Abenavoli L, 2010, PHYTOTHER RES, V24, P1423, DOI 10.1002/ptr.3207
   Ai W, 2010, J CELL BIOCHEM, V110, P1111, DOI 10.1002/jcb.22623
   Baeuerle PA, 1997, ADV IMMUNOL, V65, P111, DOI 10.1016/S0065-2776(08)60742-7
   Baldwin AS, 1996, ANNU REV IMMUNOL, V14, P649, DOI 10.1146/annurev.immunol.14.1.649
   Basiglio CL, 2009, CHEM-BIOL INTERACT, V179, P297, DOI 10.1016/j.cbi.2008.12.008
   Bataller R, 2005, J CLIN INVEST, V115, P209, DOI 10.1172/JCI200524282
   Baur JA, 2006, NATURE, V444, P337, DOI 10.1038/nature05354
   Bonizzi G, 2004, TRENDS IMMUNOL, V25, P280, DOI 10.1016/j.it.2004.03.008
   Boyer PD, 1997, ANNU REV BIOCHEM, V66, P717, DOI 10.1146/annurev.biochem.66.1.717
   Chandan BK, 2008, J ETHNOPHARMACOL, V119, P218, DOI 10.1016/j.jep.2008.06.020
   Chang CT, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023682
   CHAVEZ E, 1988, LIFE SCI, V43, P975, DOI 10.1016/0024-3205(88)90542-5
   Cheng HM, 2010, J ETHNOPHARMACOL, V132, P429, DOI 10.1016/j.jep.2010.08.022
   Comporti M, 2009, HISTOL HISTOPATHOL, V24, P893, DOI 10.14670/HH-24.893
   Contag CH, 2002, ANNU REV BIOMED ENG, V4, P235, DOI 10.1146/annurev.bioeng.4.111901.093336
   De Minicis S, 2007, GASTROENTEROLOGY, V132, P1937, DOI 10.1053/j.gastro.2007.02.033
   Dothager RS, 2009, CURR OPIN BIOTECH, V20, P45, DOI 10.1016/j.copbio.2009.01.007
   Hellerbrand C, 1999, J HEPATOL, V30, P77, DOI 10.1016/S0168-8278(99)80010-5
   Ho TY, 2007, BIOMATERIALS, V28, P4370, DOI 10.1016/j.biomaterials.2007.07.005
   Hseu Y.C., 2011, FOOD CHEM TOXICOL, V48, P2319
   Hsiang CY, 2009, BIOMATERIALS, V30, P3042, DOI 10.1016/j.biomaterials.2009.02.016
   Jia JD, 2001, J HEPATOL, V35, P392, DOI 10.1016/S0168-8278(01)00148-9
   JIMENEZ W, 1985, HEPATOLOGY, V5, P815, DOI 10.1002/hep.1840050517
   Karin M, 2000, ANNU REV IMMUNOL, V18, P621, DOI 10.1146/annurev.immunol.18.1.621
   Krahenbuhl S, 1992, Scand J Gastroenterol Suppl, V193, P90
   Lamb J, 2006, SCIENCE, V313, P1929, DOI 10.1126/science.1132939
   LOPEZDELEON A, 1985, J HISTOCHEM CYTOCHEM, V33, P737, DOI 10.1177/33.8.2410480
   Lotersztajn S, 2005, ANNU REV PHARMACOL, V45, P605, DOI 10.1146/annurev.pharmtox.45.120403.095906
   Luedde T, 2011, NAT REV GASTRO HEPAT, V8, P108, DOI 10.1038/nrgastro.2010.213
   Montaner D, 2006, NUCLEIC ACIDS RES, V34, pW486, DOI 10.1093/nar/gkl197
   Nanji AA, 2001, J PHARMACOL EXP THER, V299, P638
   Ottobrini L, 2005, Q J NUCL MED MOL IM, V49, P361
   Pietrangelo A, 2002, J BIOENERG BIOMEMBR, V34, P67, DOI 10.1023/A:1013874804911
   Polyak SJ, 2007, GASTROENTEROLOGY, V132, P1925, DOI 10.1053/j.gastro.2007.02.038
   Pradhan SC, 2006, INDIAN J MED RES, V124, P491
   Sakaida I, 2004, HEPATOLOGY, V40, P1304, DOI 10.1002/hep.20452
   Saller R, 2001, DRUGS, V61, P2035, DOI 10.2165/00003495-200161140-00003
   Sarraf-Yazdi S, 2004, J SURG RES, V120, P249, DOI 10.1016/j.jss.2004.02.013
   Shaker E, 2010, FOOD CHEM TOXICOL, V48, P803, DOI 10.1016/j.fct.2009.12.011
   Shiryaeva A, 2008, J BIOENERG BIOMEMBR, V40, P27, DOI 10.1007/s10863-008-9125-2
   SIEBENLIST U, 1994, ANNU REV CELL BIOL, V10, P405, DOI 10.1146/annurev.cellbio.10.1.405
   Sun H, 2010, EUR J PHARMACOL, V631, P53, DOI 10.1016/j.ejphar.2010.01.002
   Suter L, 2004, CHEM BIOL, V11, P161, DOI 10.1016/j.chembiol.2004.02.003
   Tacke F, 2005, J HEPATOL, V42, P666, DOI 10.1016/j.jhep.2004.12.024
   TANAKA A, 1987, LIFE SCI, V41, P741, DOI 10.1016/0024-3205(87)90454-1
   Upadhyay G, 2010, FOOD CHEM TOXICOL, V48, P1660, DOI 10.1016/j.fct.2010.03.041
   Weber LWD, 2003, CRIT REV TOXICOL, V33, P105, DOI 10.1080/713611034
   Weiler-Normann C, 2007, Z GASTROENTEROL, V45, P43, DOI 10.1055/s-2006-927387
   Wells RG, 2005, J CLIN GASTROENTEROL, V39, pS158, DOI 10.1097/01.mcg.0000155516.02468.0f
   Wu SL, 2009, J PHARMACOL EXP THER, V330, P370, DOI 10.1124/jpet.109.152835
   Xiong YQ, 2005, ANTIMICROB AGENTS CH, V49, P380, DOI 10.1128/AAC.49.1.380-387.2005
NR 51
TC 23
Z9 23
U1 2
U2 10
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0278-6915
J9 FOOD CHEM TOXICOL
JI Food Chem. Toxicol.
PD MAY
PY 2012
VL 50
IS 5
BP 1568
EP 1575
DI 10.1016/j.fct.2012.02.025
PG 8
WC Food Science & Technology; Toxicology
SC Food Science & Technology; Toxicology
GA 949JH
UT WOS:000304572000051
PM 22386810
DA 2018-10-19
ER

PT J
AU Tieghi, R
   Consorti, G
   Clauser, LC
AF Tieghi, Riccardo
   Consorti, Giuseppe
   Clauser, Luigi C.
TI Contouring of the Forehead Irregularities (Washboard Effect) With Bone
   Biomaterial
SO JOURNAL OF CRANIOFACIAL SURGERY
LA English
DT Article
DE Forehead deformity; washboard effect; biomaterials; bone grafting;
   craniofacial trauma; craniofacial surgery; frontal sinus
ID HYDROXYAPATITE CEMENT; RECONSTRUCTION; DEFECTS
AB Calvarial vault defects may be repaired with autologous bone or alloplastic materials, such as methyl methacrylate, hydroxyapatite, titanium, or porous polyethylene. The criterion standard for repairing small cranial defects is autogenous bone from iliac crest or split calvarial grafts. However, autogenous grafts may result in donor-site morbidity, increased operative time, reabsorption, blood loss, and additional time for recovery. An alloplastic material should have some ideal properties, including easy adaptation, biocompatibility, which permit ingrowth of new tissue, stability of shape, and low rate of reabsorption. An implant in this area should be easily shaped and positioned, allowing an easy tissue in growth.
   The authors report the case of a 50-year-old man with a deformity of the frontal region as a result of a frontonaso-orbitoethmoidal fracture after reduction and fixation of the fractures and right frontal sinus cranialization with frontal craniotomy via coronal approach. The deformity caused the typical aspect (washboard effect). Correction and reconstruction were performed by using Cerament (Bonesupport AB, Lund, Sweden), alloplastic biphasic material, composed of 60% alpha-hemihydrate of calcium sulfate and 40% hydroxyapatite. Four years after the surgery, the patient had recovered with satisfactory morphology of the forehead as well as disappearance of the frowning look in the frontal region.
C1 [Tieghi, Riccardo; Consorti, Giuseppe; Clauser, Luigi C.] St Anna Hosp & Univ, Ctr Craniofacial Deform & Orbital Surg, Unit Cranio Maxillo Facial Surg, I-44100 Ferrara, Italy.
RP Clauser, LC (reprint author), St Anna Hosp & Univ, Ctr Craniofacial Deform & Orbital Surg, Unit Cranio Maxillo Facial Surg, Corso Giovecca 203, I-44100 Ferrara, Italy.
EM csr@unife.it
CR David L, 2005, J CRANIOFAC SURG, V16, P129, DOI 10.1097/00001665-200501000-00026
   Duman H, 1999, J CRANIO MAXILL SURG, V27, P298, DOI 10.1054/jcms.1999.0902
   Friedman C D, 2000, Arch Facial Plast Surg, V2, P124, DOI 10.1001/archfaci.2.2.124
   Greene AK, 2008, J CRANIO MAXILL SURG, V36, P138, DOI 10.1016/j.jcms.2007.05.008
   Lykins CL, 1998, ARCH OTOLARYNGOL, V124, P153, DOI 10.1001/archotol.124.2.153
   Taghizadeh F, 2006, ARCH FACIAL PLAST S, V8, P416, DOI 10.1001/archfaci.8.6.416
   Weissman JL, 1996, AM J NEURORADIOL, V17, P1569
NR 7
TC 6
Z9 6
U1 0
U2 2
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA 530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA
SN 1049-2275
J9 J CRANIOFAC SURG
JI J. Craniofac. Surg.
PD MAY
PY 2012
VL 23
IS 3
BP 932
EP 934
DI 10.1097/SCS.0b013e3182505593
PG 3
WC Surgery
SC Surgery
GA 948BW
UT WOS:000304479600115
PM 22627408
DA 2018-10-19
ER

PT J
AU Margonar, R
   Queiroz, TP
   Luvizuto, ER
   Marcantonio, E
   Lia, RCC
   Holzhausen, M
   Marcantonio, E
AF Margonar, Rogerio
   Queiroz, Thallita P.
   Luvizuto, Eloa R.
   Marcantonio, Elcio
   Comelli Lia, Raphael Carlos
   Holzhausen, Marinela
   Marcantonio-Junior, Elcio
TI Bioactive Glass for Alveolar Ridge Augmentation
SO JOURNAL OF CRANIOFACIAL SURGERY
LA English
DT Article
DE Bioactive glass; alveolar socket; bone; alveolar healing process;
   implants; biomaterial
ID BONE; BIOMATERIALS; DEFECTS
AB The restoration and recovery of the alveolar healing process are a challenge to dental surgeons to achieve satisfactory results at the osseointegration of implants and implant rehabilitation. Different operative technique and biomaterials are being used to reconstruct the framework of the alveolar process. One of the biomaterials used for this purpose is the bioactive glass. The aim of this study was to report clinical and histologic final results of 7 clinical reports of alveolar ridge augmentation using bioactive glass. Clinically, bioglass was able to maintain bone architecture of the alveolar bone and repaired satisfactory. Biopsy was performed on the histologic samples and showed bone formation in intimate contact to the particles of the biomaterial.
C1 [Margonar, Rogerio; Queiroz, Thallita P.; Marcantonio, Elcio] Univ Ctr Araraquara UNIARA, Sch Dent, Dept Hlth Sci, Implantol Post Graduat Course, Araraquara, SP, Brazil.
   [Luvizuto, Eloa R.] UNESP Univ Estadual Paulista, Aracatuba Dent Sch, Dept Surg, Sao Paulo, Brazil.
   [Luvizuto, Eloa R.] UNESP Univ Estadual Paulista, Aracatuba Dent Sch, Integrated Clin, Sao Paulo, Brazil.
   [Comelli Lia, Raphael Carlos] Univ Ctr Araraquara UNIARA, Sch Dent, Dept Pathol, Araraquara, SP, Brazil.
   [Comelli Lia, Raphael Carlos] Univ Ctr Araraquara UNIARA, Sch Dent, Dept Oral Diag, Araraquara, SP, Brazil.
   [Holzhausen, Marinela] Sao Paulo Univ USP, Sch Dent, Dept Stomatol, Div Periodontol, Sao Paulo, Brazil.
   [Marcantonio-Junior, Elcio] UNESP Univ Estadual Paulista, Araraquara Dent Sch, Discipline Periodontol, Dept Oral Diag, Sao Paulo, Brazil.
RP Luvizuto, ER (reprint author), Rua Jose Bonifacio 1193, BR-16015050 Sao Paulo, Brazil.
EM eloa@foa.unesp.br
RI Holzhausen, Marinella/G-2886-2012; Queiroz, Thallita/C-5085-2012;
   Holzhausen, Marinella/J-4298-2014; Marcantonio, Elcio/A-4784-2008
OI Queiroz, Thallita/0000-0002-2464-8181; Holzhausen,
   Marinella/0000-0001-9413-5253; Marcantonio, Elcio/0000-0003-1294-2305;
   Marcantonio Junior, Elcio/0000-0002-9660-4524
CR Furosawa T, 1997, IMPLANT DENT, V6, P93
   HENCH LL, 1974, J BIOMED MATER RES, V8, P49, DOI 10.1002/jbm.820080307
   HENCH LL, 1973, J BIOMED MATER RES, V7, P25, DOI 10.1002/jbm.820070304
   HENCH LL, 1980, SCIENCE, V208, P826, DOI 10.1126/science.6246576
   Hoppe A, 2011, BIOMATERIALS, V32, P2757, DOI 10.1016/j.biomaterials.2011.01.004
   Kokubo T, 2006, BIOMATERIALS, V27, P2907, DOI 10.1016/j.biomaterials.2006.01.017
   KOKUBO T, 1990, J BIOMED MATER RES, V24, P721, DOI 10.1002/jbm.820240607
   Luvizuto ER, 2011, ARCH ORAL BIOL, V56, P984, DOI 10.1016/j.archoralbio.2011.03.015
   Luvizuto ER, 2011, BIOMATERIALS, V32, P3855, DOI 10.1016/j.biomaterials.2011.01.076
   Luvizuto ER, 2010, BONE, V46, P1021, DOI 10.1016/j.bone.2009.12.016
   Luvizuto ER, 2010, ARCH ORAL BIOL, V55, P52, DOI 10.1016/j.archoralbio.2009.11.001
   Rahaman MN, 2011, ACTA BIOMATER, V7, P2355, DOI 10.1016/j.actbio.2011.03.016
   SCHEPERS E, 1991, J ORAL REHABIL, V18, P439, DOI 10.1111/j.1365-2842.1991.tb01689.x
   Schepers E J, 1993, Implant Dent, V2, P151, DOI 10.1097/00008505-199309000-00002
   Schepers EJG, 1997, J ORAL REHABIL, V24, P171
   Wheeler DL, 1997, J BIOMED MATER RES, V35, P249, DOI 10.1002/(SICI)1097-4636(199705)35:2<249::AID-JBM12>3.0.CO;2-C
NR 16
TC 5
Z9 5
U1 0
U2 6
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA 530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA
SN 1049-2275
J9 J CRANIOFAC SURG
JI J. Craniofac. Surg.
PD MAY
PY 2012
VL 23
IS 3
BP E220
EP E222
DI 10.1097/SCS.0b013e31824de5a4
PG 4
WC Surgery
SC Surgery
GA 948BW
UT WOS:000304479600019
PM 22627439
DA 2018-10-19
ER

PT J
AU Coad, BR
   Scholz, T
   Vasilev, K
   Hayball, JD
   Short, RD
   Griesser, HJ
AF Coad, Bryan R.
   Scholz, Tanja
   Vasilev, Krasimir
   Hayball, John D.
   Short, Robert D.
   Griesser, Hans J.
TI Functionality of Proteins Bound to Plasma Polymer Surfaces
SO ACS APPLIED MATERIALS & INTERFACES
LA English
DT Article
DE biomaterial interface engineering; plasma polymerization;
   bioconjugation; ethanol plasma polymer; propionaldehyde plasma polymer;
   aldehyde surface; biointerfaces; biomaterial surfaces; protein
   adsorption
ID ENDOTHELIAL-CELL GROWTH; OXYGEN-CONTAINING FILMS; HUMAN SERUM-ALBUMIN;
   ALLYL ALCOHOL; IMMUNOGLOBULIN-G; ACRYLIC-ACID; BINDING; ADSORPTION;
   POLYSTYRENE; ATTACHMENT
AB The deposition of a thin film layer by plasma polymerization enables the surface functionalization of a wide range of substrate materials for biointerfacial interactions. Plasma polymers can surface-bind proteins specifically via covalent linkages or nonspecifically through other irreversible adsorption mechanisms; key questions are whether covalent chemisorption has indeed occurred, and whether the protein retains functionality. Here the mode of surface binding of streptavidin and the biotin binding functionality of the bound streptavidin layer are studied on plasma polymer (pp) surfaces deposited using propionaldehyde and ethanol that were plasma polymerized at different powers (P) to investigate possible mechanisms for protein binding to a range of different surface chemistries. As expected, with pp surfaces composed principally of aldehyde groups, protein conjugation appears to be specific (chemisorption) allowing the immobilization of streptavidin (SAV) molecules retaining the ability to bind biotinylated probes. To contrast with this, we present the first study of protein adsorption to ethanol pp surfaces prepared at different P. This provides an investigation into retention of the hydroxyl functionality in the pp at low P and its effect on protein adsorption. Adsorption of human serum albumin (HSA) to ethanol pp was similar to that on propionaldehyde pp except at low P (5 W) where hydroxyl group retention and hydration presumably has a role in reducing protein adsorption. Although we observed SAV adsorption to ethanol pp surfaces at all P, interestingly, the protein lost its ability to bind biotinylated probes. Thus we suggest that irreversible, nonspecific adsorption of protein on ethanol pp surfaces results in apparent protein denaturation despite the hydrophilic nature of the ethanol pp surface. We conclude by making inferences between the pp structure as measured by X-ray photoelectron spectroscopy (XPS) and the related protein adsorption mechanisms.
C1 [Coad, Bryan R.; Scholz, Tanja; Griesser, Hans J.] Univ S Australia, Ian Wark Res Inst, Mawson Lakes, SA 5095, Australia.
   [Coad, Bryan R.; Vasilev, Krasimir; Short, Robert D.] Univ S Australia, Mawson Inst, Mawson Lakes, SA 5095, Australia.
   [Hayball, John D.] Royal Adelaide Hosp, Expt Therapeut Lab, Hanson Inst, Adelaide, SA 5000, Australia.
   [Hayball, John D.] Univ S Australia, Sansom Inst, Adelaide, SA 5000, Australia.
   [Hayball, John D.] Univ Adelaide, Sch Med, Adelaide, SA 5000, Australia.
RP Coad, BR (reprint author), Univ S Australia, Ian Wark Res Inst, Mawson Lakes, SA 5095, Australia.
EM Bryan.Coad@unisa.edu.au
RI Coad, Bryan/B-4505-2009; Griesser, Hans/E-5628-2011; Short,
   Robert/D-4580-2009; Hayball, John/F-4137-2013
OI Coad, Bryan/0000-0003-3297-3977; Griesser, Hans/0000-0003-1072-7863;
   Hayball, John/0000-0002-3089-4506
FU National Health and Medical Research Council, Australia [631931]
FX We acknowledge funding from the National Health and Medical Research
   Council, Australia, under Grant ID 631931.
CR Arneen A.P., 1994, POLYMER, V35, P4382
   Bhattacharya AA, 2000, J MOL BIOL, V303, P721, DOI 10.1006/jmbi.2000.4158
   Blattler TM, 2006, LANGMUIR, V22, P5760, DOI 10.1021/la0602766
   Bullett NA, 2003, J MATER CHEM, V13, P1546, DOI 10.1039/b302176a
   BUTLER JE, 1992, J IMMUNOL METHODS, V150, P77, DOI 10.1016/0022-1759(92)90066-3
   Christo SN, 2012, AUST J CHEM, V65, P45, DOI 10.1071/CH11311
   Coad BR, 2012, LANGMUIR, V28, P2710, DOI 10.1021/la204714p
   Coad BR, 2012, ACTA BIOMATER, V8, P608, DOI 10.1016/j.actbio.2011.10.006
   Crowther J. R, 1995, ELISA THEORY PRACTIC, V42, P223
   CURTIS ASG, 1986, J CELL SCI, V86, P9
   Daw R, 1998, BIOMATERIALS, V19, P1717, DOI 10.1016/S0142-9612(98)00080-5
   Diener KR, 2012, ACTA BIOMATER, V8, P99, DOI 10.1016/j.actbio.2011.09.001
   ERTEL SI, 1990, J BIOMED MATER RES, V24, P1637, DOI 10.1002/jbm.820241207
   ERTEL SI, 1991, J BIOMAT SCI-POLYM E, V3, P163, DOI 10.1163/156856291X00269
   Fally F, 1996, J APPL POLYM SCI, V59, P1569, DOI 10.1002/(SICI)1097-4628(19960307)59:10<1569::AID-APP10>3.3.CO;2-Z
   France RM, 1998, CHEM MATER, V10, P1176, DOI 10.1021/cm970761+
   Freitag S, 1997, PROTEIN SCI, V6, P1157, DOI 10.1002/pro.5560060604
   GRIESSER HJ, 1989, VACUUM, V39, P485, DOI 10.1016/0042-207X(89)90272-8
   GRIESSER HJ, 1990, J APPL POLYM SCI APP, V46, P361
   Guerin DC, 2002, LANGMUIR, V18, P4118, DOI 10.1021/la011566j
   Hermanson G. T., 2008, BIOCONJUGATE TECHNIQ, P1202
   Kim MS, 2008, PROG POLYM SCI, V33, P138, DOI 10.1016/j.progpolymsci.2007.06.001
   Kingshott P, 2002, BIOMATERIALS, V23, P2043, DOI 10.1016/S0142-9612(01)00334-9
   Malik AF, 2011, P NATL ACAD SCI USA, V108, P20095, DOI 10.1073/pnas.1105152108
   Mitchell SA, 2004, SURF SCI, V561, P110, DOI 10.1016/j.susc.2004.05.001
   OTOOLE L, 1995, J CHEM SOC FARADAY T, V91, P3907, DOI 10.1039/ft9959103907
   OToole L, 1997, J CHEM SOC FARADAY T, V93, P1141, DOI 10.1039/a607397b
   OToole L, 1997, J CHEM SOC FARADAY T, V93, P1961, DOI 10.1039/a608412e
   Ratner BD, 2004, ANNU REV BIOMED ENG, V6, P41, DOI 10.1146/annurev.bioeng.6.040803.140027
   Siow KS, 2006, PLASMA PROCESS POLYM, V3, P392, DOI 10.1002/ppap.200600021
   Su XD, 2005, LANGMUIR, V21, P348, DOI 10.1021/la047997u
   Tayyab S, 1999, INT J BIOL MACROMOL, V26, P173, DOI 10.1016/S0141-8130(99)00074-4
   Vermette P, 2003, J COLLOID INTERF SCI, V259, P13, DOI 10.1016/S0021-9797(02)00185-6
   Whittle JD, 2002, J MATER CHEM, V12, P2726, DOI 10.1039/b201471h
   Zhang Z, 2003, LANGMUIR, V19, P4765, DOI 10.1021/la026980d
NR 35
TC 32
Z9 32
U1 1
U2 46
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 1944-8244
J9 ACS APPL MATER INTER
JI ACS Appl. Mater. Interfaces
PD MAY
PY 2012
VL 4
IS 5
BP 2455
EP 2463
DI 10.1021/am300128n
PG 9
WC Nanoscience & Nanotechnology; Materials Science, Multidisciplinary
SC Science & Technology - Other Topics; Materials Science
GA 945OF
UT WOS:000304285200022
PM 22489739
DA 2018-10-19
ER

PT J
AU Wang, QC
   Uzunoglu, E
   Wu, Y
   Libera, M
AF Wang, Qichen
   Uzunoglu, Emel
   Wu, Yong
   Libera, Matthew
TI Self-Assembled Poly(ethylene glycol)-co-Acrylic Acid Microgels to
   Inhibit Bacterial Colonization of Synthetic Surfaces
SO ACS APPLIED MATERIALS & INTERFACES
LA English
DT Article
DE microgels; PEG; self-assembly; patterning; antifouling; bacteria;
   biofilms; infection
ID ANTIMICROBIAL PROPERTIES; STAPHYLOCOCCUS-AUREUS; STATISTICAL-MECHANICS;
   SILVER NANOPARTICLES; POLYMER MULTILAYERS; PROTEIN ADSORPTION; GLYCOL)
   HYDROGELS; MAMMALIAN-CELLS; ADHESION; OXIDE)
AB We explored the use of self-assembled microgels to inhibit the bacterial colonization of synthetic surfaces both by modulating surface cell adhesiveness at length scales comparable to bacterial dimensions (similar to 1 mu m) and by locally storing/releasing an antimicrobial. Poly(ethylene glycol) [PEG] and poly(ethylene glycol)-co-acrylic acid [PEG-AA] microgels were synthesized by suspension photopolymerization. Consistent with macroscopic gels, a pH dependence of both zeta potential and hydrodynamic diameter was observed in AA-containing microgels but not in pure PEG microgels. The microgels were electrostatically deposited onto poly(L-lysine) (PLL) primed silicon to form submonolayer surface coatings. The microgel surface density could be controlled via the deposition time and the microgel concentration in the parent suspension. In addition to their intrinsic antifouling properties, after deposition, the microgels could be loaded with a cationic antimicrobial peptide (L5) because of favorable electrostatic interactions. Loading was significantly higher in PEG-AA microgels than in pure PEG microgels. The modification of PLL-primed Si by unloaded PEG-AA microgels reduced the short-term (6 h) S. epidermidis surface colonization by a factor of 2, and the degree of inhibition increased when the average spacing between microgels was reduced. Postdeposition L5 peptide loading into microgels further reduced bacterial colonization to the extent that, after 10 h of S. epidermidis culture in tryptic soy broth, the colonization of L5-loaded PEG-AA microgel-modified Si was comparable to the very small level of colonization observed on macroscopic PEG gel controls. The fact that these microgels can be deposited by a nonline-of-sight self-assembly process and hinder bacterial colonization opens the possibility of modifying the surfaces of topographically complex biomedical devices and reduces the rate of biomaterial-associated infection.
C1 [Wang, Qichen; Uzunoglu, Emel; Wu, Yong; Libera, Matthew] Stevens Inst Technol, Dept Chem Engn & Mat Sci, Hoboken, NJ 07030 USA.
   [Uzunoglu, Emel] Ankara Univ, Dept Med Microbiol, TR-06100 Ankara, Turkey.
RP Libera, M (reprint author), Stevens Inst Technol, Dept Chem Engn & Mat Sci, Hoboken, NJ 07030 USA.
EM mlibera@stevens.edu
RI Wang, Qichen/B-4198-2015
FU National Science Foundation [CBET-0708379, DMR-0922522]
FX The authors thank Prof. Jeff Kaplan of the New Jersey Dental School for
   providing the NJ9709 strain of S. epidermidis as well as Svetlana
   Pavlukhina and Prof. Svetlana Sukhishvili of Stevens for helpful
   conversations. This research project has been supported by the National
   Science Foundation through Grant #CBET-0708379 and used microscope
   resources partially funded by the National Science Foundation through
   NSF Grant DMR-0922522.
CR Cao XL, 2010, J MATER SCI-MATER M, V21, P2861, DOI 10.1007/s10856-010-4133-2
   Chapman RG, 2001, LANGMUIR, V17, P1225, DOI 10.1021/la001222d
   Chen RX, 2009, BIOFOULING, V25, P517, DOI 10.1080/08927010902954207
   Chen W, 2006, BIOMATERIALS, V27, P5512, DOI 10.1016/j.biomaterials.2006.07.003
   Choi J, 2005, MACROMOLECULES, V38, P116, DOI 10.1021/ma048596o
   CHOU PY, 1978, ANNU REV BIOCHEM, V47, P251, DOI 10.1146/annurev.bi.47.070178.001343
   CLSI, 2009, M07A8 CLSI
   Crank J, 1975, MATH DIFFUSION, pviii
   DESAI NP, 1992, BIOMATERIALS, V13, P417, DOI 10.1016/0142-9612(92)90160-P
   Dvoracek CM, 2009, LANGMUIR, V25, P10322, DOI 10.1021/la901161z
   Elbert DL, 1996, ANNU REV MATER SCI, V26, P365, DOI 10.1146/annurev.ms.26.080196.002053
   Erol M, 2006, LANGMUIR, V22, P11329, DOI 10.1021/la061790e
   Flory P. J, 1953, PRINCIPLES POLYM CHE
   Flory PJ, 1943, J CHEM PHYS, V11, P521, DOI 10.1063/1.1723792
   Flory PJ, 1943, J CHEM PHYS, V11, P512, DOI 10.1063/1.1723791
   Glinel K, 2009, BIOCONJUGATE CHEM, V20, P71, DOI 10.1021/bc800280u
   GOMBOTZ WR, 1991, J BIOMED MATER RES, V25, P1547, DOI 10.1002/jbm.820251211
   Gong X, 2000, J POLYM SCI POL PHYS, V38, P2323, DOI 10.1002/1099-0488(20000901)38:17<2323::AID-POLB120>3.0.CO;2-6
   Grunlan JC, 2005, BIOMACROMOLECULES, V6, P1149, DOI 10.1021/bm049528c
   Habash MB, 2000, COLLOID SURFACE B, V19, P13, DOI 10.1016/S0927-7765(00)00131-4
   Hamm SC, 2012, ACS APPL MATER INTER, V4, P178, DOI 10.1021/am2012273
   HARPAZ Y, 1994, STRUCTURE, V2, P641, DOI 10.1016/S0969-2126(00)00065-4
   Harris LG, 2006, J BIOMED MATER RES A, V78A, P50, DOI 10.1002/jbm.a.30611
   Hiemenz P.C., 2007, POLYM CHEM, pxvii
   Hucknall A, 2009, ADV MATER, V21, P2441, DOI 10.1002/adma.200900383
   HUMPHRIES M, 1987, FEMS MICROBIOL ECOL, V45, P297, DOI 10.1111/j.1574-6968.1987.tb02380.x
   Israelachvili J, 1997, P NATL ACAD SCI USA, V94, P8378, DOI 10.1073/pnas.94.16.8378
   Kaplan JB, 2004, ANTIMICROB AGENTS CH, V48, P2633, DOI 10.1128/AAC.48.7.2633-2636.2004
   Kazemzadeh-Narbat M, 2010, BIOMATERIALS, V31, P9519, DOI 10.1016/j.biomaterials.2010.08.035
   Khoo X, 2010, BIOMATERIALS, V31, P9285, DOI 10.1016/j.biomaterials.2010.08.031
   Khoo XJ, 2009, J AM CHEM SOC, V131, P10992, DOI 10.1021/ja9020827
   Kingshott P, 2003, LANGMUIR, V19, P6912, DOI 10.1021/la034032m
   Kofinas P, 1996, BIOMATERIALS, V17, P1547, DOI 10.1016/0142-9612(96)89781-X
   Koh WG, 2003, BIOMED MICRODEVICES, V5, P11, DOI 10.1023/A:1024455114745
   Kostenko V, 2010, ANTIMICROB AGENTS CH, V54, P5120, DOI 10.1128/AAC.00825-10
   Krsko P, 2003, LANGMUIR, V19, P5618, DOI 10.1021/la034157r
   Krsko P, 2009, ACTA BIOMATER, V5, P589, DOI 10.1016/j.actbio.2008.08.025
   Lawson MC, 2007, CLIN ORTHOP RELAT R, P96, DOI 10.1097/BLO.0b013e3180986706
   Li BY, 2009, BIOMATERIALS, V30, P2552, DOI 10.1016/j.biomaterials.2009.01.042
   LUSTIG SR, 1988, J APPL POLYM SCI, V36, P735, DOI 10.1002/app.1988.070360401
   Malmsten M, 1998, J COLLOID INTERF SCI, V202, P507, DOI 10.1006/jcis.1998.5513
   Mellott MB, 2001, BIOMATERIALS, V22, P929, DOI 10.1016/S0142-9612(00)00258-1
   MERRILL EW, 1993, BIOMATERIALS, V14, P1117, DOI 10.1016/0142-9612(93)90154-T
   Monteiro DR, 2009, INT J ANTIMICROB AG, V34, P103, DOI 10.1016/j.ijantimicag.2009.01.017
   Moskowitz JS, 2010, BIOMATERIALS, V31, P6019, DOI 10.1016/j.biomaterials.2010.04.011
   Murata H, 2007, BIOMATERIALS, V28, P4870, DOI 10.1016/j.biomaterials.2007.06.012
   Ostuni E, 2001, LANGMUIR, V17, P6336, DOI 10.1021/la010552a
   Patel JD, 2007, J BIOMED MATER RES A, V80A, P742, DOI 10.1002/jbm.a.31103
   Pavlukhina S, 2010, BIOMACROMOLECULES, V11, P3448, DOI 10.1021/bm100975w
   Podsiadlo P, 2005, LANGMUIR, V21, P11915, DOI 10.1021/la051284+
   PRIME KL, 1993, J AM CHEM SOC, V115, P10714, DOI 10.1021/ja00076a032
   PRIME KL, 1991, SCIENCE, V252, P1164, DOI 10.1126/science.252.5009.1164
   Qiu HW, 2006, J AM CERAM SOC, V89, P1180, DOI 10.1111/j.1551-2916.2005.00847.x
   Rasband W. S, 1997, IAMGEJ
   Revzin A, 2004, LANGMUIR, V20, P2999, DOI 10.1021/la035827w
   Roosjen A, 2005, J BIOMED MATER RES B, V73B, P347, DOI 10.1002/jbm.b.30227
   Roosjen A, 2004, LANGMUIR, V20, P10949, DOI 10.1021/la0484691
   Rosin P., 1933, Journal of the Institute of Fuel, V7, P29
   Schmidt M, 2002, J PHYS-CONDENS MAT, V14, P12119, DOI 10.1088/0953-8984/14/46/316
   Schmidt S, 2008, LANGMUIR, V24, P12595, DOI 10.1021/la801770n
   Slaughter BV, 2009, ADV MATER, V21, P3307, DOI 10.1002/adma.200802106
   South AB, 2009, ACS APPL MATER INTER, V1, P2747, DOI 10.1021/am9005435
   Sukhishvili SA, 2002, MACROMOLECULES, V35, P301, DOI 10.1021/ma011346c
   Tiller JC, 2001, P NATL ACAD SCI USA, V98, P5981, DOI 10.1073/pnas.111143098
   Toppazzini M, 2011, CARBOHYD POLYM, V83, P578, DOI 10.1016/j.carbpol.2010.08.020
   Tu ZG, 2009, PEPTIDES, V30, P1523, DOI 10.1016/j.peptides.2009.05.009
   Wagner VE, 2004, BIOMATERIALS, V25, P2247, DOI 10.1016/j.biomaterials.2003.09.020
   Wang Y, 2011, ADV FUNCT MATER, V21, P3916, DOI 10.1002/adfm.201100659
   Weaver L, 2010, J APPL MICROBIOL, V109, P2200, DOI 10.1111/j.1365-2672.2010.04852.x
   Wei Y, 2008, LANGMUIR, V24, P6721, DOI 10.1021/la8005772
   Wilson WW, 2001, J MICROBIOL METH, V43, P153, DOI 10.1016/S0167-7012(00)00224-4
   Zhao LZ, 2009, J BIOMED MATER RES B, V91B, P470, DOI 10.1002/jbm.b.31463
NR 72
TC 26
Z9 26
U1 4
U2 102
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 1944-8244
J9 ACS APPL MATER INTER
JI ACS Appl. Mater. Interfaces
PD MAY
PY 2012
VL 4
IS 5
BP 2498
EP 2506
DI 10.1021/am300197m
PG 9
WC Nanoscience & Nanotechnology; Materials Science, Multidisciplinary
SC Science & Technology - Other Topics; Materials Science
GA 945OF
UT WOS:000304285200027
PM 22519439
DA 2018-10-19
ER

PT J
AU Coad, BR
   Lu, Y
   Glattauer, V
   Meagher, L
AF Coad, Bryan R.
   Lu, Yi
   Glattauer, Veronica
   Meagher, Laurence
TI Substrate-Independent Method for Growing and Modulating the Density of
   Polymer Brushes from Surfaces by ATRP
SO ACS APPLIED MATERIALS & INTERFACES
LA English
DT Article
DE biomaterial interface engineering; surface-initiated ATRP; polymer
   brush; colloid probe microscopy; plasma polymerization; biomaterial
   surfaces
ID TRANSFER RADICAL POLYMERIZATION; ATOMIC-FORCE MICROSCOPY; PROTEIN
   ADSORPTION; CHAIN-LENGTH; INITIATED POLYMERIZATION; METHACRYLATE)
   BRUSHES; CELL-ADHESION; GRAFT DENSITY; AQUEOUS ATRP; LAYERS
AB We describe a method for grafting PEG-based polymer chains of variable surface density using a substrate independent approach, allowing grafting from virtually any material substrate. The approach relies upon initial coupling of a macroinitiator to plasma polymer treated surfaces. The macroinitiator is a novel random terpolymer containing ATRP initiator residues, strongly negatively charged groups, and carboxylic acid moieties that facilitate covalent surface anchoring. Surface-initiated ATRP (SI-ATRP) using polyethylene glycol methyl ether methacrylate (PEGMA) at different concentrations led to grafted surfaces of controlled thickness in either the "brush" or "mushroom" morphology, which was controlled by the abundance of initiator residues in the macroinitiator. Grafted polymer layer structure was investigated via direct interaction force measurements using colloid probe atomic force microscopy (AFM). Equilibrium, hydrated graft layer thicknesses inferred from the highly repulsive AFM force data suggest that the polymer brush graft layer contained polymer chains which were fully stretched. Since the degree of stretching resulted in layer thicknesses approaching the polymer contour length, the polymer brushes studied must be very close to maximum graft density. Grafted layers where the polymer molecules were in the mushroom regime resulted in much thinner layers but the chains had greater chain entropic freedom as indicated by strongly attractive bridging interactions between tethered chains and the silica colloid probe. Use of this experimental methodology would be suitable for preparing grafted polymer layers of a preferred density free from substrate-specific linking chemistries.
C1 [Coad, Bryan R.; Lu, Yi; Glattauer, Veronica; Meagher, Laurence] CSIRO Mat Sci & Engn, Clayton, Vic, Australia.
   [Coad, Bryan R.; Glattauer, Veronica; Meagher, Laurence] Cooperat Res Ctr Polymers, Notting Hill, Vic, Australia.
   [Coad, Bryan R.] Univ S Australia, Ian Wark Res Inst, Mawson Lakes, SA, Australia.
   [Coad, Bryan R.] Univ S Australia, Mawson Inst, Mawson Lakes, SA, Australia.
RP Coad, BR (reprint author), CSIRO Mat Sci & Engn, Clayton, Vic, Australia.
EM Bryan.Coad@unisa.edu.au
RI Coad, Bryan/B-4505-2009; Glattauer, veronica/A-9435-2018; Meagher,
   Laurence/G-1412-2012
OI Coad, Bryan/0000-0003-3297-3977; Meagher, Laurence/0000-0002-2055-6159
FU Cooperative Research Centre for Polymers
FX We acknowledge the Cooperative Research Centre for Polymers for funding
   (BRC). We are grateful to Dr. Jo Cosgriff and Dr. Roger Mulder for
   assistance with NMR and to Mr. Kelly Tsang for assistance with the cell
   culture studies.
CR Bao ZY, 2006, MACROMOLECULES, V39, P5251, DOI 10.1021/ma060095a
   Barbey R, 2009, CHEM REV, V109, P5437, DOI 10.1021/cr900045a
   Bergenudd H, 2009, MACROMOLECULES, V42, P3302, DOI 10.1021/ma8028425
   Bruening ML, 2008, LANGMUIR, V24, P7663, DOI 10.1021/la800179z
   CLEVELAND JP, 1993, REV SCI INSTRUM, V64, P403, DOI 10.1063/1.1144209
   Coad BR, 2007, LANGMUIR, V23, P11791, DOI 10.1021/la7001703c
   Coad BR, 2007, BIOTECHNOL BIOENG, V97, P574, DOI 10.1002/bit.21283
   Coad BR, 2012, ACTA BIOMATER, V8, P608, DOI 10.1016/j.actbio.2011.10.006
   de Vos WM, 2011, MACROMOLECULES, V44, P2334, DOI 10.1021/ma1028642
   DEGENNES PG, 1980, MACROMOLECULES, V13, P1069, DOI 10.1021/ma60077a009
   Edmondson S, 2004, CHEM SOC REV, V33, P14, DOI 10.1039/b210143m
   Edmondson S, 2009, POLYM INT, V58, P307, DOI 10.1002/pi.2529
   Feng W, 2005, MACROMOL RAPID COMM, V26, P1383, DOI 10.1002/marc.200500335
   Fristrup CJ, 2009, SOFT MATTER, V5, P4623, DOI 10.1039/b821815c
   Gautrot JE, 2010, BIOMATERIALS, V31, P5030, DOI 10.1016/j.biomaterials.2010.02.066
   Goodman D, 2004, LANGMUIR, V20, P6238, DOI 10.1021/la030692y
   Goodman D, 2004, LANGMUIR, V20, P2333, DOI 10.1021/la035843t
   GRIESSER HJ, 1989, VACUUM, V39, P485, DOI 10.1016/0042-207X(89)90272-8
   Hamilton-Brown P, 2009, LANGMUIR, V25, P9149, DOI 10.1021/la900703e
   Hucknall A, 2009, ADV MATER, V21, P2441, DOI 10.1002/adma.200900383
   Hucknall A, 2009, BIOINTERPHASES, V4, pFA50, DOI 10.1116/1.3151968
   Janzen J, 2004, J BIOMAT SCI-POLYM E, V15, P1121, DOI 10.1163/1568562041753043
   Jayachandran KN, 2002, MACROMOLECULES, V35, P4247, DOI 10.1021/ma011651y
   Jiang DW, 2010, MACROMOLECULES, V43, P71, DOI 10.1021/ma9018262
   Jiang XW, 2008, ADV FUNCT MATER, V18, P27, DOI 10.1002/adfm.200700789
   Kingshott P, 2002, BIOMATERIALS, V23, P2043, DOI 10.1016/S0142-9612(01)00334-9
   Kizhakkedathu JN, 2009, LANGMUIR, V25, P3794, DOI 10.1021/la803690q
   Kizhakkedathu JN, 2003, MACROMOLECULES, V36, P591, DOI 10.1021/ma021337j
   Kizhakkedathu JN, 2004, MACROMOLECULES, V37, P734, DOI 10.1021/ma034934u
   Lai BFL, 2010, BIOMATERIALS, V31, P6710, DOI 10.1016/j.biomaterials.2010.05.052
   Liu Y, 2004, LANGMUIR, V20, P6710, DOI 10.1021/la049465j
   Ma HW, 2010, ACS APPL MATER INTER, V2, P3223, DOI 10.1021/am1006832
   Meagher L., 2008, Patent No. [US2008045686-A1, 2008045686]
   Meagher L., 2008, Patent No. [CN101528876-A, 101528876]
   Meagher L., 2008, Patent No. [JP2010501028-W, 2010501028]
   Meagher L., 2008, Patent No. [AU2007284002-A1, 2007284002]
   Meagher L., 2008, Polymeric coatings and methods for forming them, Patent No. [WO2008019450-A1, 2008019450]
   Meagher L., 2008, Patent No. [EP2052045-A1, 2052045]
   MILNER ST, 1991, SCIENCE, V251, P905, DOI 10.1126/science.251.4996.905
   Mittal V, 2008, MACROMOL REACT ENG, V2, P215, DOI 10.1002/mren.200700052
   Nagase K, 2008, LANGMUIR, V24, P511, DOI 10.1021/la701839s
   Ohno K, 2010, MACROMOLECULES, V43, P5569, DOI 10.1021/ma10013258
   PYUN J, 2004, POLYM BRUSHES, P51
   Raynor JE, 2009, BIOINTERPHASES, V4, pFA3, DOI 10.1116/1.3089252
   Riachi C, 2009, MACROMOLECULES, V42, P8076, DOI 10.1021/ma901537x
   Schuwer N, 2011, MACROMOLECULES, V44, P6868, DOI 10.1021/ma201069d
   Tan SB, 2011, MACROMOLECULES, V44, P7911, DOI 10.1021/ma201942z
   Tugulu S, 2008, BIOMACROMOLECULES, V9, P906, DOI 10.1021/bm7012939
   Vermette P, 2002, LANGMUIR, V18, P10137, DOI 10.1021/la0202834
   Wang SQ, 2009, LANGMUIR, V25, P13448, DOI 10.1021/la901785t
   Wang XJ, 2006, LANGMUIR, V22, P817, DOI 10.1021/la052741p
   Wu T, 2002, J AM CHEM SOC, V124, P9394, DOI 10.1021/ja027412n
   Xu FJ, 2009, PROG POLYM SCI, V34, P719, DOI 10.1016/j.progpolymsci.2009.04.005
   Yamamoto S, 2000, MACROMOLECULES, V33, P5608, DOI 10.1021/ma991988o
   Yamamoto S, 2000, MACROMOLECULES, V33, P5602, DOI 10.1021/ma991733a
   Zhao C, 2011, LANGMUIR, V27, P4906, DOI 10.1021/la200061h
   Zou YQ, 2010, BIOMACROMOLECULES, V11, P284, DOI 10.1021/bm901159d
   Zou YQ, 2009, MACROMOLECULES, V42, P3258, DOI 10.1021/ma8025699
NR 58
TC 26
Z9 26
U1 1
U2 66
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 1944-8244
J9 ACS APPL MATER INTER
JI ACS Appl. Mater. Interfaces
PD MAY
PY 2012
VL 4
IS 5
BP 2811
EP 2823
DI 10.1021/am300463q
PG 13
WC Nanoscience & Nanotechnology; Materials Science, Multidisciplinary
SC Science & Technology - Other Topics; Materials Science
GA 945OF
UT WOS:000304285200068
PM 22512463
DA 2018-10-19
ER

PT J
AU Lullove, E
AF Lullove, Eric
TI Acellular Fetal Bovine Dermal Matrix in the Treatment of Nonhealing
   Wounds in Patients with Complex Comorbidities
SO JOURNAL OF THE AMERICAN PODIATRIC MEDICAL ASSOCIATION
LA English
DT Article
ID DIABETIC FOOT ULCERS; REGENERATIVE TISSUE MATRIX; HUMAN SKIN EQUIVALENT;
   RANDOMIZED-TRIAL; CLINICAL-TRIAL; MANAGEMENT; MULTICENTER; DERMAGRAFT;
   APLIGRAF; THERAPY
AB Background: In contrast to the narrow indications for living skin equivalents, extracellular matrix biomaterials are clinically used in a wide range of wound-healing applications. Given the breadth of possible uses, the goal of this study was to retrospectively compile and analyze the clinical application and effectiveness of an extracellular matrix biomaterial derived from fetal bovine dermis (PriMatrix; TEI Biosciences, Boston, Massachusetts) in patients treated by a single physician and monitored postsurgically in an outpatient wound care center.
   Methods: A retrospective medical record review was conducted of consecutive patients treated from January 2007 through January 2009 with meshed PriMatrix after sharp/surgical debridement and coverage with standard moist wound therapy dressings.
   Results: Twenty-nine patients and 34 wounds were compiled. All of the wounds were unresponsive to conservative treatment owing to complications, including infection, exposed bone or tendon, and other comorbidities known to delay healing. Wounds included 11 diabetic ulcers, 8 venous stasis ulcers, 10 nonhealing traumatic wounds, and 5 other chronic wounds. Thirty of 34 wounds healed, with four patients lost to follow-up. Mean time to healing for diabetic foot ulcers was 105 days with an average of 2.6 PriMatrix applications. Mean time to healing for venous, traumatic, and other chronic wounds was 74 to 82 days with an average of 1.2 to 1.4 PriMatrix applications.
   Conclusions: In patients with comorbidities known to delay healing, the implantation of PriMatrix promoted the healing and, ultimately, full reepithelialization of otherwise unresponsive wounds of varied etiology, including those with complications of infection or exposed bone or tendon. (J Am Podiatr Med Assoc 102(3): 233-239, 2012)
RP Lullove, E (reprint author), 7301 W Palmetto Pk Rd,Suite 201-C, Boca Raton, FL 33433 USA.
EM drericlullove@happyhealthyfeet.com
FU TEI Biosciences
FX Financial support was provided by TEI Biosciences.
CR ADVANCED BIOHEALING INC, 2007, DERM HUM FIBR DER DE
   ADZICK NS, 1985, J PEDIATR SURG, V20, P315
   [Anonymous], 2010, APL PRESCR INF
   Apelqvist J, 2008, AM J SURG, V195, P782, DOI 10.1016/j.amjsurg.2007.06.023
   Bello Y M, 2001, Am J Clin Dermatol, V2, P305, DOI 10.2165/00128071-200102050-00005
   BOLTON LL, 1996, NURS MANAGE, V30, P32
   Brem H, 2000, ARCH SURG-CHICAGO, V135, P627, DOI 10.1001/archsurg.135.6.627
   Brigido SA, 2004, ORTHOPEDICS, V27, pS145
   Brigido Stephen A, 2006, Int Wound J, V3, P181, DOI 10.1111/j.1742-481X.2006.00209.x
   Bullard KM, 2003, WORLD J SURG, V27, P54, DOI 10.1007/s00268-002-6737-2
   Cook JL, 2008, AM J VET RES, V69, P148, DOI 10.2460/ajvr.69.1.148
   Cornwell Kevin G, 2009, Clin Podiatr Med Surg, V26, P507, DOI 10.1016/j.cpm.2009.08.001
   Driver VR, 2008, J MANAG CARE MED, V11, P13
   Dunckel AP, 2009, OSTOMY WOUND MANAG, V55, P44
   Edmonds M, 2009, INT J LOW EXTR WOUND, V8, P11, DOI 10.1177/1534734609331597
   Falanga V, 1999, WOUND REPAIR REGEN, V7, P201, DOI 10.1046/j.1524-475X.1999.00201.x
   Frykberg RG, 2006, J FOOT ANKLE SURG S, V45, pS1
   Gentzkow GD, 1996, DIABETES CARE, V19, P350, DOI 10.2337/diacare.19.4.350
   HEALTHPOINT LTD/COOK BIOTECH INC, 2006, OASIS WOUND MATR INS
   HIGC S WR, 2010, WOUND CARE HYPERBARI, V1, P8
   HIGGS WR, 2010, WOUND CARE HYPERBARI, V1, P9
   Karr JC, 2011, ADV SKIN WOUND CARE, V24, P119, DOI 10.1097/01.ASW.0000395038.28398.88
   Larson BJ, 2010, PLAST RECONSTR SURG, V126, P1172, DOI 10.1097/PRS.0b013e3181eae781
   Longaker Michael T., 1994, Wound Repair and Regeneration, V2, P104, DOI 10.1046/j.1524-475X.1994.20204.x
   Margolis DJ, 1999, DIABETES CARE, V22, P692, DOI 10.2337/diacare.22.5.692
   Marston WA, 2003, DIABETES CARE, V26, P1701, DOI 10.2337/diacare.26.6.1701
   Martin Billy R, 2005, Int Wound J, V2, P161, DOI 10.1111/j.1742-4801.2005.00099.x
   Mostow EN, 2005, J VASC SURG, V41, P837, DOI 10.1016/j.jvs.2005.01.042
   NEII J, 2011, ANN SCI C SE SOC PLA
   Niezgoda Jeffrey A, 2005, Adv Skin Wound Care, V18, P258, DOI 10.1097/00129334-200506000-00012
   Redekop WK, 2003, PHARMACOECONOMICS, V21, P1171, DOI 10.2165/00019053-200321160-00003
   Reyzelman A, 2009, INT WOUND J, V6, P196, DOI 10.1111/j.1742-481X.2009.00585.x
   Romanelli M, 2010, ADV SKIN WOUND CARE, V23, P34, DOI 10.1097/01.ASW.0000363485.17224.26
   Ruszczak Z, 2003, ADV DRUG DELIVER REV, V55, P1595, DOI 10.1016/j.addr.2003.08.003
   Stockl K, 2004, DIABETES CARE, V27, P2129, DOI 10.2337/diacare.27.9.2129
   Valentin JE, 2006, J BONE JOINT SURG AM, V88A, P2673, DOI 10.2106/JBJS.E.01008
   Veves A, 2001, DIABETES CARE, V24, P290, DOI 10.2337/diacare.24.2.290
   Winitphakdeedecha R, 2008, J DRUGS DERMATOL, V7, P781
   WRIGHT MEDICAL TECHNOLOGY INC/LIFECELL CORP, 2009, GRAFT JACKET REG TIS
NR 39
TC 13
Z9 13
U1 0
U2 16
PU AMER PODIATRIC MED ASSOC
PI BETHESDA
PA 9312 OLD GEORGETOWN ROAD, BETHESDA, MD 20814-1621 USA
SN 8750-7315
EI 1930-8264
J9 J AM PODIAT MED ASSN
JI J. Am. Podiatr. Med. Assoc.
PD MAY-JUN
PY 2012
VL 102
IS 3
BP 233
EP 239
DI 10.7547/1020233
PG 7
WC Orthopedics
SC Orthopedics
GA 945OW
UT WOS:000304286900008
PM 22659766
DA 2018-10-19
ER

PT J
AU Baez, JE
   Marcos-Fernandez, A
AF Baez, Jose E.
   Marcos-Fernandez, Angel
TI Degradable poly(ester-ether urethane)s derived of AB(2) miktoarm star
   copolymer poly(ethylene glycol-(epsilon-caprolactone)(2)) diol:
   Synthesis, characterization and degradation
SO REACTIVE & FUNCTIONAL POLYMERS
LA English
DT Article
DE Miktoarm star copolymer; Ring-opening polymerization;
   Poly(epsilon-caprolactone); Poly(ethylene glycol); Poly(ester-ether
   urethane)
ID TYROSINE-BASED POLYURETHANES; EPSILON-CAPROLACTONE; BIODEGRADABLE
   POLYURETHANES; BIOMATERIAL APPLICATIONS; POLY(EPSILON-CAPROLACTONE);
   GLYCOL); OLIGOMERS
AB Four different miktoarm star copolymers poly(ethylene glycol-(epsilon-caprolactone)(2)) diol [PEG-PCL2] were obtained using alpha-diol-omega-methoxy poly(ethylene glycol) [MPEG-(OH)(2)] as macroinitiator/chain transfer wagent in the ring opening polymerization (ROP) of epsilon-caprolactone (CL) catalyzed by tin(II) 2-ethylhexanoate [Sn(Oct)(2)]. PEG-PCL2 and 1,6-hexamethylene diisocyanate (HDI) were used as precursors of a new family of poly(ester-ether urethane)s PEUs. PEUs films were characterized by FT-IR, DSC, mechanical properties, water absorption, hydrolytic degradation and SEM. (C) 2012 Elsevier Ltd. All rights reserved.
C1 [Baez, Jose E.; Marcos-Fernandez, Angel] CSIC, Inst Ciencia & Tecnol Polimeros, Dept Quim & Tecnol Elastomeros, Madrid 28006, Spain.
RP Baez, JE (reprint author), CSIC, Inst Ciencia & Tecnol Polimeros, Dept Quim & Tecnol Elastomeros, C Juan de la Cierva 3, Madrid 28006, Spain.
EM jebaez14@yahoo.com.mx
RI Marcos Fernandez, Angel/D-9910-2012
OI Marcos-Fernandez, Angel/0000-0001-9004-9868
FU Spanish Ministry of Science and Innovation (MICINN) [MAT2008-00619/MAT,
   MAT2010-20668/MAT]; Consejo Nacional de Ciencia y Tecnologia (CONACYT)
   from Mexico [94112]
FX We are indebted to the Spanish Ministry of Science and Innovation
   (MICINN) for the economic support of this work (Grants MAT2008-00619/MAT
   and MAT2010-20668/MAT). J.E.B thanks to Consejo Nacional de Ciencia y
   Tecnologia (CONACYT) from Mexico for the postdoctoral fellowship (No.
   94112) and Instituto de Ciencia y Tecnologia de Polimeros (CSIC). J.E.B
   thanks to Dr. David Gomez-Varga for the SEM micrographs and Dr. Alberto
   Fernandez-Torrez for the accessing to DSC. Finally, J.E.B. wishes to
   thank Mrs. Irene Caso Neira and MA Jennifer Lee O'Donnell (Coffee &
   Sock) for her valuable help and consideration.
CR Abraham GA, 2006, J BIOMED MATER RES A, V76A, P729, DOI 10.1002/jbm.a.30540
   Baez JE, 2006, POLYMER, V47, P8420, DOI 10.1016/j.polymer.2006.10.023
   Baez JE, 2011, INT J POLYM ANAL CH, V16, P377, DOI 10.1080/1023666X.2011.596264
   Baez JE, 2011, POLYM-PLAST TECHNOL, V50, P839, DOI 10.1080/03602559.2011.551976
   Choi CY, 2005, B KOR CHEM SOC, V26, P523
   Cometa S, 2010, POLYM DEGRAD STABIL, V95, P2013, DOI 10.1016/j.polymdegradstab.2010.07.007
   CRESCENZI V, 1972, EUR POLYM J, V8, P449, DOI 10.1016/0014-3057(72)90109-7
   Gong CY, 2009, J APPL POLYM SCI, V113, P1111, DOI 10.1002/app.29946
   Loh XJ, 2008, BIOMATERIALS, V29, P3185, DOI 10.1016/j.biomaterials.2008.04.015
   Miura Y, 2005, MACROMOL CHEM PHYSIC, V206, P504, DOI 10.1002/macp.200400353
   Naguib HF, 2011, J POLYM RES, V18, P1217, DOI 10.1007/s10965-010-9525-y
   Rahman MS, 2008, MACROMOLECULES, V41, P7029, DOI 10.1021/ma801384u
   Sarkar D, 2008, J APPL POLYM SCI, V108, P2345, DOI 10.1002/app.27637
   Sarkar D, 2009, J BIOMED MATER RES A, V90A, P263, DOI 10.1002/jbm.a.32095
   Sivakumar PM, 2012, CARBOHYD POLYM, V87, P353, DOI 10.1016/j.carbpol.2011.07.061
   Van Butsele K, 2006, MACROMOLECULES, V39, P5652, DOI 10.1021/ma0606859
   You JH, 2008, MACROMOL RES, V16, P609, DOI 10.1007/BF03218568
   Zhou LJ, 2012, BIOMATERIALS, V33, P2734, DOI 10.1016/j.biomaterials.2011.11.009
NR 18
TC 3
Z9 3
U1 5
U2 20
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 1381-5148
EI 1873-166X
J9 REACT FUNCT POLYM
JI React. Funct. Polym.
PD MAY
PY 2012
VL 72
IS 5
BP 349
EP 357
DI 10.1016/j.reactfunctpolym.2012.03.004
PG 9
WC Chemistry, Applied; Engineering, Chemical; Polymer Science
SC Chemistry; Engineering; Polymer Science
GA 944VD
UT WOS:000304231000009
DA 2018-10-19
ER

PT J
AU Chen, XY
   Cai, KY
   Lai, M
   Zhao, L
   Tang, LL
AF Chen, Xiuyong
   Cai, Kaiyong
   Lai, Min
   Zhao, Li
   Tang, Liling
TI Mesenchymal Stem Cells Differentiation on Hierarchically
   Micro/Nano-Structured Titanium Substrates
SO ADVANCED ENGINEERING MATERIALS
LA English
DT Article
ID OSTEOBLAST-LIKE CELLS; IN-VITRO; POLY(D,L-LACTIC ACID); TIO2 NANOTUBES;
   SURFACE; BIOMATERIALS; INTERFACE; IMPLANTS; ADHESION; CULTURE
AB Surface topography of a biomaterial plays an essential role in the regulation of cell adhesion, proliferation, and differentiation. To investigate the influence of hierarchically micro/nano-structured substrates on the differentiation of mesenchymal stem cells (MSCs), a series of micro-, nano-, and micro/nano-structured titanium substrates were fabricated via dual acid etching and/or anodic oxidation. The morphologies of titanium substrates were characterized by field emission scanning electron microscopy (FE-SEM) and contact angle measurement, respectively. The differentiation of MSCs adhered to different substrates was investigated in vitro. Compared to native titanium, micro/nano-structured titanium substrates improved the alkaline phosphatase (ALP) production and mineralization of MSCs. More importantly, micro/nano-structured titanium substrates demonstrated great potential to induce the differentiation of MSCs, which was revealed by the expressions of osteocalcin (OCN) and osteopontin (OPN). The study provides a potential alternative to generate hierarchically micro/nano-structured titanium-based implant for enhanced osseointegration.
C1 [Chen, Xiuyong; Cai, Kaiyong; Lai, Min; Tang, Liling] Chongqing Univ, Coll Bioengn, Key Lab Biorheol Sci & Technol, Minist Educ, Chongqing 400044, Peoples R China.
   [Zhao, Li] China Natl Ctr Biotechnol Dev, Beijing 100036, Peoples R China.
RP Chen, XY (reprint author), Chongqing Univ, Coll Bioengn, Key Lab Biorheol Sci & Technol, Minist Educ, Chongqing 400044, Peoples R China.
EM Kaiyong_cai@cqu.edu.cn
RI Cai, Kaiyong/B-3061-2012; Chen, Xiuyong/R-6928-2017; 蔡, 开勇/G-1233-2011
OI Chen, Xiuyong/0000-0001-5027-8631; 
FU China Ministry of Science and Technology [2009CB930000]; Natural Science
   Foundation of China [11032012, 51173216]; Fok Ying Tung Education
   Foundation [121035]; Natural Science Foundation of Chongqing Municipal
   Government (CSTC) [2010AB5116, 2008AB5129]; 111 project [B06023];
   Fundamental Research Funds for the Central Universities [CDJXS10 23 22
   11]
FX This work was financially supported by China Ministry of Science and
   Technology (973 Project No. 2009CB930000), Natural Science Foundation of
   China (11032012 and 51173216), Fok Ying Tung Education Foundation
   (121035), Natural Science Foundation of Chongqing Municipal Government
   (CSTC, 2010AB5116, and 2008AB5129), "111 project" (B06023) and
   Fundamental Research Funds for the Central Universities (Project No.
   CDJXS10 23 22 11).
CR Ayukawa Y, 1998, J BIOMED MATER RES, V41, P111
   Balaur E, 2005, ELECTROCHEM COMMUN, V7, P1066, DOI 10.1016/j.elecom.2005.07.014
   Bianco P, 2001, STEM CELLS, V19, P180, DOI 10.1634/stemcells.19-3-180
   Brammer KS, 2009, ACTA BIOMATER, V5, P3215, DOI 10.1016/j.actbio.2009.05.008
   Brunski JB, 2000, INT J ORAL MAX IMPL, V15, P15
   Cai KY, 2002, J BIOMED MATER RES, V60, P398, DOI 10.1002/jbm.10008
   Cai KY, 2002, BIOMATERIALS, V23, P1153, DOI 10.1016/S0142-9612(01)00230-7
   Cancedda R, 2003, STEM CELLS, V21, P610, DOI 10.1634/stemcells.21-5-610
   Castner DG, 2002, SURF SCI, V500, P28, DOI 10.1016/S0039-6028(01)01587-4
   Gao L, 2009, J BIOMED MATER RES B, V89B, P335, DOI 10.1002/jbm.b.31221
   Grigoriou V, 2005, J BIOL CHEM, V280, P1733, DOI 10.1074/jbc.M402550200
   Guo J, 2007, BIOMATERIALS, V28, P5418, DOI 10.1016/j.biomaterials.2007.08.032
   Hu Y, 2009, BIOMATERIALS, V30, P3626, DOI 10.1016/j.biomaterials.2009.03.037
   Hubbell JA, 2008, NAT MATER, V7, P609, DOI 10.1038/nmat2238
   Humphries JD, 2007, J CELL BIOL, V179, P1043, DOI 10.1083/jcb.200703036
   Kim MJ, 2006, J BIOMED MATER RES A, V79A, P1023, DOI 10.1002/jbm.a.31040
   Kubo K, 2009, BIOMATERIALS, V30, P5319, DOI 10.1016/j.biomaterials.2009.06.021
   Lutolf MP, 2005, NAT BIOTECHNOL, V23, P47, DOI 10.1038/nbt1055
   Macak JM, 2008, J ELECTROANAL CHEM, V621, P254, DOI 10.1016/j.jelechem.2008.01.005
   Oh S, 2006, J BIOMED MATER RES A, V78A, P97, DOI 10.1002/jbm.a.30722
   Oh S, 2009, P NATL ACAD SCI USA, V106, P2130, DOI 10.1073/pnas.0813200106
   Olivares-Navarrete R, 2008, P NATL ACAD SCI USA, V105, P15767, DOI 10.1073/pnas.0805420105
   Park J, 2007, NANO LETT, V7, P1686, DOI 10.1021/nl070678d
   Park J, 2009, SMALL, V5, P666, DOI 10.1002/smll.200801476
   Petite H, 2000, NAT BIOTECHNOL, V18, P959, DOI 10.1038/79449
   Popat KC, 2007, BIOMATERIALS, V28, P3188, DOI 10.1016/j.biomaterials.2007.03.020
   Pountos I, 2007, INJURY, V38, pS23, DOI 10.1016/S0020-1383(08)70006-8
   STEIN GS, 1993, ENDOCR REV, V14, P424, DOI 10.1210/er.14.4.424
   Stevens MM, 2005, SCIENCE, V310, P1135, DOI 10.1126/science.1106587
   Wen KK, 2009, J BIOL CHEM, V284, P30463, DOI 10.1074/jbc.M109.021295
   WLODARSKI KH, 1986, CALCIFIED TISSUE INT, V39, P382, DOI 10.1007/BF02555175
   Yamamoto Y, 2003, J DENT RES, V82, P962, DOI 10.1177/154405910308201205
   Zhao LZ, 2010, BIOMATERIALS, V31, P5072, DOI 10.1016/j.biomaterials.2010.03.014
   Zwilling V, 1999, SURF INTERFACE ANAL, V27, P629, DOI 10.1002/(SICI)1096-9918(199907)27:7<629::AID-SIA551>3.0.CO;2-0
NR 34
TC 21
Z9 22
U1 1
U2 60
PU WILEY-V C H VERLAG GMBH
PI WEINHEIM
PA PO BOX 10 11 61, D-69451 WEINHEIM, GERMANY
SN 1438-1656
J9 ADV ENG MATER
JI Adv. Eng. Mater.
PD MAY
PY 2012
VL 14
IS 5
BP B216
EP B223
DI 10.1002/adem.201180073
PG 8
WC Materials Science, Multidisciplinary
SC Materials Science
GA 940TP
UT WOS:000303916300004
DA 2018-10-19
ER

PT J
AU Travan, A
   Marsich, E
   Donati, I
   Foulc, MP
   Moritz, N
   Aro, HT
   Paoletti, S
AF Travan, Andrea
   Marsich, Eleonora
   Donati, Ivan
   Foulc, Marie-Pierre
   Moritz, Niko
   Aro, Hannu T.
   Paoletti, Sergio
TI Polysaccharide-Coated Thermosets for Orthopedic Applications: From
   Material Characterization to In Vivo Tests
SO BIOMACROMOLECULES
LA English
DT Article
ID FIBER-REINFORCED COMPOSITE; LACTOSE-MODIFIED CHITOSAN; SURFACE
   MODIFICATION; CELL BEHAVIOR; CONTACT-ANGLE; TITANIUM; BONE; IMPLANT;
   LAYER; BIOMATERIALS
AB The long-term stability and success of orthopedic implants depend on the osseointegration process, which is strongly influenced by the biomaterial surface. A promising approach to enhance implant integration involves the modification of the surface of the implant by means of polymers that mimic the natural components of the extracellular matrix, for example, polysaccharides. In this study, methacrylate thermosets (bisphenol A glycidylmethacrylate/triethyleneglycol dimethacrylate), a widely used composition for orthopedic and dental applications, have been coated by electrostatic deposition of a bioactive chitosan-derivative. This polysaccharide was shown to induce osteoblasts aggregation in vitro, to stimulate cell proliferation and to enhance alkaline phosphatase activity. The coating deposition was studied by analyzing the effect of pH and ionic strength on the grafting of the polysaccharide. Contact angle studies show that the functionalizecl material displays a higher hydrophilic character owing to the increase of surface polar groups. The mechanical properties of the coating were evaluated by nanoindentation studies which point to higher values of indentation hardness and modulus (E) of the polysaccharide surface layer, while the influence of cyclic stress on the construct was assessed by fatigue tests. Finally, in vivo tests in minipigs showed that the polysaccharide-based implant showed a good biocompatibility and an ability for osseointegration at least similar to that of the titanium Ti6Al4V alloy with roughened surface.
C1 [Travan, Andrea; Marsich, Eleonora; Donati, Ivan; Paoletti, Sergio] Univ Trieste, Dept Life Sci, I-34127 Trieste, Italy.
   [Foulc, Marie-Pierre] Rescoll, Soc Rech, F-33615 Pessac, France.
   [Moritz, Niko; Aro, Hannu T.] Univ Turku, Dept Orthopaed Surg & Traumatol, Orthopaed Res Unit, FIN-20520 Turku, Finland.
RP Travan, A (reprint author), Univ Trieste, Dept Life Sci, Via Giorgieri 1, I-34127 Trieste, Italy.
EM atravan@units.it
RI Donati, Ivan/C-3725-2017
OI Paoletti, Sergio/0000-0001-5944-8182; TRAVAN,
   Andrea/0000-0002-7454-6415; Aro, Hannu/0000-0003-3118-9144; MARSICH,
   ELEONORA/0000-0002-0700-4464
FU EU [026279-2]; COST action [MP0701]; University of Trieste through the
   InterDepartment Center for Molecular Medicine - CIMM
FX This study was supported by the EU-FP6 Project "NEW-BONE" (Contract No.
   026279-2) and by the COST action MP0701. The financial support of the
   University of Trieste to I.D. (through the InterDepartment Center for
   Molecular Medicine - CIMM) and to A.T. (through the Post-Doc Fellowship
   Programme) is gratefully acknowledged. The authors would like to thank
   Mrs. Suzanne Cann for proofreading.
CR Abdulmajeed AA, 2011, DENT MATER, V27, P313, DOI 10.1016/j.dental.2010.11.007
   ANDRADE J D, 1991, Journal of Biomaterials Science Polymer Edition, V2, P161
   Avila G, 2009, IMPLANT DENT, V18, P17, DOI 10.1097/ID.0b013e318192cb7d
   Baldwin AD, 2010, BIOPOLYMERS, V94, P128, DOI 10.1002/bip.21334
   Beutner R, 2010, J R SOC INTERFACE, V7, pS93, DOI 10.1098/rsif.2009.0418.focus
   Bumgardner JD, 2003, J BIOMAT SCI-POLYM E, V14, P1401, DOI 10.1163/156856203322599734
   Bumgardner JD, 2007, IMPLANT DENT, V16, P66, DOI 10.1097/ID.0b013e3180312011
   Cai KY, 2005, BIOMATERIALS, V26, P5960, DOI 10.1016/j.biomaterials.2005.03.020
   Carneiro-Da-Cunha MG, 2010, CARBOHYD POLYM, V82, P153, DOI 10.1016/j.carbpol.2010.04.043
   Donati I, 2005, BIOMATERIALS, V26, P987, DOI 10.1016/j.biomaterials.2004.04.015
   DRAUGHN RA, 1979, J DENT RES, V58, P1093, DOI 10.1177/00220345790580031101
   Drummond JL, 2003, DENT MATER, V19, P226, DOI 10.1016/S0109-5641(02)00034-9
   Garcia AJ, 2006, ADV POLYM SCI, P171, DOI 10.1007/12_071
   Hu XF, 2010, BIOMATERIALS, V31, P8854, DOI 10.1016/j.biomaterials.2010.08.006
   Jansen J A, 1994, J Invest Surg, V7, P123, DOI 10.3109/08941939409015356
   Kwok DY, 1999, ADV COLLOID INTERFAC, V81, P167, DOI 10.1016/S0001-8686(98)00087-6
   Marcon P, 2005, BIOMATERIALS, V26, P4975, DOI 10.1016/j.biomaterials.2005.01.044
   Martin HJ, 2008, THIN SOLID FILMS, V516, P6277, DOI 10.1016/j.tsf.2007.12.001
   Mattila RH, 2009, ACTA BIOMATER, V5, P1639, DOI 10.1016/j.actbio.2009.01.020
   Navarro M, 2008, J R SOC INTERFACE, V5, P1137, DOI 10.1098/rsif.2008.0151
   Nganga S, 2011, J MECH BEHAV BIOMED, V4, P1797, DOI 10.1016/j.jmbbm.2011.05.037
   OLIVER WC, 1992, J MATER RES, V7, P1564, DOI 10.1557/JMR.1992.1564
   Pasqui D, 2007, BIOMACROMOLECULES, V8, P3965, DOI 10.1021/bm701033u
   Porter JR, 2009, BIOTECHNOL PROGR, V25, P1539, DOI 10.1002/btpr.246
   Rotta J, 2009, MAT SCI ENG C-BIO S, V29, P619, DOI 10.1016/j.msec.2008.10.032
   Silva SS, 2007, CARBOHYD POLYM, V70, P25, DOI 10.1016/j.carbpol.2007.02.023
   Thull R, 2002, BIOMOL ENG, V19, P43, DOI 10.1016/S1389-0344(02)00009-6
   Tommeraas K, 2002, CARBOHYD RES, V337, P2455, DOI 10.1016/S0008-6215(02)00334-8
   Travan A, 2011, ACTA BIOMATER, V7, P337, DOI 10.1016/j.actbio.2010.07.024
   Travan A, 2010, BIOMACROMOLECULES, V11, P583, DOI 10.1021/bm9011419
   Tuusa SMR, 2008, J BIOMED MATER RES B, V84B, P510, DOI 10.1002/jbm.b.30898
   Vallittu PK, 1999, J ORAL REHABIL, V26, P208, DOI 10.1046/j.1365-2842.1999.00360.x
   VANOSS CJ, 1988, CHEM REV, V88, P927, DOI 10.1021/cr00088a006
   Wanichapichart P, 2009, SURF COAT TECH, V203, P2531, DOI 10.1016/j.surfcoat.2009.02.069
   Xu JP, 2008, APPL SURF SCI, V255, P538, DOI 10.1016/j.apsusc.2008.06.098
   Yakup A.M., 2004, J MEMBRANE SCI, V240, P167
   Yatabe M, 2001, J ORAL REHABIL, V28, P180, DOI 10.1046/j.1365-2842.2001.00634.x
NR 37
TC 28
Z9 28
U1 0
U2 29
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 1525-7797
J9 BIOMACROMOLECULES
JI Biomacromolecules
PD MAY
PY 2012
VL 13
IS 5
BP 1564
EP 1572
DI 10.1021/bm3002683
PG 9
WC Biochemistry & Molecular Biology; Chemistry, Organic; Polymer Science
SC Biochemistry & Molecular Biology; Chemistry; Polymer Science
GA 941GL
UT WOS:000303951600038
PM 22509800
DA 2018-10-19
ER

PT J
AU Alves, A
   Duarte, ARC
   Mano, JF
   Sousa, RA
   Reis, RL
AF Alves, Anabela
   Duarte, Ana Rita C.
   Mano, Joao F.
   Sousa, Rui A.
   Reis, Rui L.
TI PDLLA enriched with ulvan particles as a novel 3D porous scaffold
   targeted for bone engineering
SO JOURNAL OF SUPERCRITICAL FLUIDS
LA English
DT Article
DE Ulvan; Poly-D,L-lactic acid; Subcritical sintering; Scaffold; Tissue
   engineering
ID FIBER-MESH SCAFFOLDS; DRUG-DELIVERY; ACID) FIBER; IN-VITRO; POLYMERS;
   SYSTEMS; CELLS; DIFFERENTIATION; DEGRADATION; FABRICATION
AB A marine derived polysaccharide, ulvan, extracted from green algae, was combined with poly-D, L- lactic acid (PDLLA) in order to produce a novel scaffold for bone tissue engineering applications. Three dimensional (3D) scaffolds of PDLLA loaded with ulvan particles were originally prepared by subcritical fluid sintering with carbon dioxide at 40 degrees C and 50 bar. Prepared matrixes were characterized in order to validate their suitability to be used as scaffolds for bone tissue regeneration. Characterization included micro-computed tomography, mechanical compression testing, water uptake and degradation testing, and cytotoxicity assays. In addition, ulvan particles loaded with dexamethasone, were also dispersed within the PDLLA matrix and the respective release profile from the samples was evaluated. Prepared PDLLA scaffolds enriched with ulvan particles demonstrated appropriate physicochemical and cytocompatible features to be used for the envisaged applications. On the other hand, the release of dexamethasone from ulvan particles embedded within the PDLLA matrix revealed that the designed systems can be potentially suitable for localized drug delivery. These results further contribute to the establishment of ulvan as a potential novel biomaterial. (c) 2012 Elsevier B.V. All rights reserved.
C1 [Alves, Anabela; Duarte, Ana Rita C.; Mano, Joao F.; Sousa, Rui A.; Reis, Rui L.] Univ Minho, Res Grp Biomat Biodegradables & Biomimet 3Bs, Headquarters European Inst Excellence Tissue Engn, P-4806909 Taipas, Guimaraes, Portugal.
RP Alves, A (reprint author), Univ Minho, Res Grp Biomat Biodegradables & Biomimet 3Bs, Headquarters European Inst Excellence Tissue Engn, AvePk, P-4806909 Caldas Das Taipas, Guimaraes, Portugal.
EM anabela.pinto@dep.uminho.pt
RI Mano, Joao/A-4418-2009; Duarte, Ana Rita/B-9640-2011; Alves,
   Anabela/C-2729-2011; Reis, Rui L./A-8938-2008; Group, 3Bs/E-4374-2012
OI Mano, Joao/0000-0002-2342-3765; Duarte, Ana Rita/0000-0003-0800-0112;
   Alves, Anabela/0000-0002-6878-0766; Reis, Rui L./0000-0002-4295-6129;
   Group, 3Bs/0000-0002-5195-3456; Sousa, Rui/0000-0003-0362-7418
FU Fundacao para a Ciencia e Tecnologia [SFRH/BD/39359/2007]; IBERO-MARE;
   European Regional Development Fund (ERDF); POCTEP
FX Anabela Alves is grateful for financial support from Fundacao para a
   Ciencia e Tecnologia through the SFRH/BD/39359/2007 grant. This work was
   partially supported by the project IBERO-MARE approved by Operational
   Programme for Cross-border Cooperation: Spain Portugal, 2007-2013
   (POCTEP), with funding contribution through the European Regional
   Development Fund (ERDF co-funding) and POCTEP.
CR Alves A., PROCESSING DEG UNPUB
   Alves A, 2012, INT J PHARMACEUT, V426, P76, DOI 10.1016/j.ijpharm.2012.01.021
   Alves A, 2010, CARBOHYD RES, V345, P2194, DOI 10.1016/j.carres.2010.07.039
   [Anonymous], 2009, 109935 ISO
   Atala A, 2007, J TISSUE ENG REGEN M, V1, P83, DOI 10.1002/term.18
   Balmayor ER, 2008, J MATER SCI-MATER M, V19, P1617, DOI 10.1007/s10856-008-3378-5
   Correlo VM, 2010, MACROMOL BIOSCI, V10, P1495, DOI 10.1002/mabi.201000011
   Costa C, 2012, CARBOHYD POLYM, V88, P537, DOI 10.1016/j.carbpol.2011.12.041
   Davies OR, 2008, ADV DRUG DELIVER REV, V60, P373, DOI 10.1016/j.addr.2006.12.001
   Dawes GJS, 2009, J MATER SCI-MATER M, V20, P1089, DOI 10.1007/s10856-008-3666-0
   Duarte ARC, 2009, ACTA BIOMATER, V5, P2054, DOI 10.1016/j.actbio.2009.01.047
   Gaalen S.M.v., 2008, TISSUE ENG, P555
   Gibson LJ, 2005, J BIOMECH, V38, P377, DOI 10.1016/j.jbiomech.2004.09.027
   Gomes ME, 2008, J TISSUE ENG REGEN M, V2, P243, DOI 10.1002/term.89
   Gupta B, 2007, PROG POLYM SCI, V32, P455, DOI 10.1016/j.progpolymsci.2007.01.005
   Harris LD, 1998, J BIOMED MATER RES, V42, P396, DOI 10.1002/(SICI)1097-4636(19981205)42:3<396::AID-JBM7>3.0.CO;2-E
   Hickey T, 2002, BIOMATERIALS, V23, P1649, DOI 10.1016/S0142-9612(01)00291-5
   Jaiswal N, 1997, J CELL BIOCHEM, V64, P295, DOI 10.1002/(SICI)1097-4644(199702)64:2<295::AID-JCB12>3.0.CO;2-I
   Karageorgiou V, 2005, BIOMATERIALS, V26, P5474, DOI 10.1016/j.biomaterials.2005.02.002
   Kim BS, 1998, TRENDS BIOTECHNOL, V16, P224, DOI 10.1016/S0167-7799(98)01191-3
   KRUSKAL WILLIAM H., 1952, JOUR AMER STATIST ASSOC, V47, P583, DOI 10.2307/2280779
   Liu XH, 2004, ANN BIOMED ENG, V32, P477, DOI 10.1023/B:ABME.0000017544.36001.8e
   Malafaya PB, 2008, BIOMATERIALS, V29, P3914, DOI 10.1016/j.biomaterials.2008.06.023
   Malafaya PB, 2007, ADV DRUG DELIVER REV, V59, P207, DOI 10.1016/j.addr.2007.03.012
   MANIATOPOULOS C, 1988, CELL TISSUE RES, V254, P317
   MANN HB, 1947, ANN MATH STAT, V18, P50, DOI 10.1214/aoms/1177730491
   Mano JF, 2007, J R SOC INTERFACE, V4, P999, DOI 10.1098/rsif.2007.0220
   Mano JF, 2004, COMPOS SCI TECHNOL, V64, P789, DOI 10.1016/j.compscitech.2003.09.001
   Mathieu LM, 2006, BIOMATERIALS, V27, P905, DOI 10.1016/j.biomaterials.2005.07.015
   Mooney DJ, 1996, BIOMATERIALS, V17, P1417, DOI 10.1016/0142-9612(96)87284-X
   MULLER R, 2003, OSTEOPOROS INT S5, V14, P89
   Nair LS, 2007, PROG POLYM SCI, V32, P762, DOI 10.1016/j.progpolymsci.2007.05.017
   Nie HM, 2007, J CONTROL RELEASE, V120, P111, DOI 10.1016/j.jconrel.2007.03.018
   Puppi D, 2010, PROG POLYM SCI, V35, P403, DOI 10.1016/j.progpolymsci.2010.01.006
   Santo VE, 2010, J SUPERCRIT FLUID, V54, P320, DOI 10.1016/j.supflu.2010.05.021
   Sanz-Herrera JA, 2009, ACTA BIOMATER, V5, P219, DOI 10.1016/j.actbio.2008.06.021
   Shoichet MS, 2009, MACROMOLECULES, V43, P581
   Siepmann J, 2001, ADV DRUG DELIVER REV, V48, P139, DOI 10.1016/S0169-409X(01)00112-0
   Siepmann J, 2008, INT J PHARMACEUT, V364, P328, DOI 10.1016/j.ijpharm.2008.09.004
   Signini R, 1999, POLYM BULL, V42, P159, DOI 10.1007/s002890050448
   Singh L, 2004, BIOMATERIALS, V25, P2611, DOI 10.1016/j.biomaterials.2003.09.040
   Singh M, 2010, ACTA BIOMATER, V6, P137, DOI 10.1016/j.actbio.2009.07.042
   Tai HY, 2007, EUR CELLS MATER, V14, P64, DOI 10.22203/eCM.v014a07
   Teng XR, 2007, J BIOMED MATER RES B, V81B, P185, DOI 10.1002/jbm.b.30652
   Vasiliu S, 2005, EUR POLYM J, V41, P923, DOI 10.1016/j.eurpolymj.2004.11.017
   Yang SF, 2001, TISSUE ENG, V7, P679, DOI 10.1089/107632701753337645
   Zhang XF, 2007, POLYMER, V48, P1005, DOI 10.1016/j.polymer.2006.12.028
NR 47
TC 21
Z9 22
U1 1
U2 25
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0896-8446
EI 1872-8162
J9 J SUPERCRIT FLUID
JI J. Supercrit. Fluids
PD MAY
PY 2012
VL 65
BP 32
EP 38
DI 10.1016/j.supflu.2012.02.023
PG 7
WC Chemistry, Physical; Engineering, Chemical
SC Chemistry; Engineering
GA 942CT
UT WOS:000304020600005
DA 2018-10-19
ER

PT J
AU Amoozgar, Z
   Park, JY
   Lin, QN
   Yeo, Y
AF Amoozgar, Zohreh
   Park, Joonyoung
   Lin, Qingnuo
   Yeo, Yoon
TI Low Molecular-Weight Chitosan as a pH-Sensitive Stealth Coating for
   Tumor-Specific Drug Delivery
SO MOLECULAR PHARMACEUTICS
LA English
DT Article
DE pH-sensitive; stealth; nanoparticles; low molecular-weight chitosans;
   tumor-specific drug delivery
ID GENE DELIVERY; MUCOADHESIVE PROPERTIES; INTRACELLULAR DRUG; IN-VIVO;
   NANOPARTICLES; BIODISTRIBUTION; EXPLOITATION; EFFICACY
AB When a nanoparticle is developed for systemic application, its surface is typically protected by poly(ethylene glycol) (PEG) to help prolonged circulation and evasion of immune clearance. On the other hand, PEG can interfere with interactions between nanocarriers and target cells and negatively influence the therapeutic outcomes. To overcome this challenge, we propose low molecular-weight chitosan (LMWC) as an alternative surface coating, which can protect the nanomedicine in neutral pH but allow cellular interactions in the weakly acidic pH of tumors. LMWCs with a molecular weight of 2-4 kDa, 4-6.5 kDa, and 11-22 kDa were produced by hydrogen peroxide digestion and covalently conjugated with poly(lactic-co-glycolic acid) (PLGA). Nanoparticles created with PLGA-LMWC conjugates showed pH-sensitive cell interactions, which enabled specific drug delivery to cells in a weakly acidic environment. The hydrophilic LMWC layer reduced opsonization and phagocytic uptake. These properties qualify LMWCs as a promising biomaterial for pH-sensitive stealth coating.
C1 [Amoozgar, Zohreh; Park, Joonyoung; Lin, Qingnuo; Yeo, Yoon] Purdue Univ, Dept Ind & Phys Pharm, W Lafayette, IN 47907 USA.
   [Yeo, Yoon] Purdue Univ, Weldon Sch Biomed Engn, W Lafayette, IN 47907 USA.
RP Yeo, Y (reprint author), Purdue Univ, Dept Ind & Phys Pharm, 575 Stadium Mall Dr G22, W Lafayette, IN 47907 USA.
EM yyeo@purdue.edu
FU NIH [R21 CA135130]; NSF [DMR-1056997]; Lilly Endowment, Inc.; Ronald W.
   Dollens Graduate Scholarship; Bilsland Dissertation Fellowship
FX This work was supported by NIH R21 CA135130, NSF DMR-1056997, and a
   grant from the Lilly Endowment, Inc. to the College of Pharmacy. The
   authors appreciate the support of the Ronald W. Dollens Graduate
   Scholarship and the Bilsland Dissertation Fellowship for Zohreh
   Amoozgar. The authors also thank Drs. David Thompson and Seok-Hee Hyun
   for the help with GPC, and Ms. Debra Sherman for SEM.
CR Bartlett DW, 2007, P NATL ACAD SCI USA, V104, P15549, DOI 10.1073/pnas.0707461104
   CARSTENSEN H, 1992, CLIN NUTR, V11, P289, DOI 10.1016/0261-5614(92)90006-C
   Cheng R, 2011, J CONTROL RELEASE, V152, P2, DOI 10.1016/j.jconrel.2011.01.030
   Chung YI, 2010, J CONTROL RELEASE, V143, P374, DOI 10.1016/j.jconrel.2010.01.017
   Gerweck LE, 1996, CANCER RES, V56, P1194
   Hatakeyama H, 2011, ADV DRUG DELIVER REV, V63, P152, DOI 10.1016/j.addr.2010.09.001
   He P, 1998, INT J PHARMACEUT, V166, P75, DOI 10.1016/S0378-5173(98)00027-1
   Henning T, 2004, ANTI-CANCER DRUG, V15, P7, DOI 10.1097/01.cad.0000109801.38926.d8
   Hong RL, 1999, CLIN CANCER RES, V5, P3645
   Huang C, 2010, J MATER CHEM, V20, P8512, DOI 10.1039/c0jm01526a
   Kim BS, 2008, ARCH PHARM RES, V31, P1050, DOI 10.1007/s12272-001-1267-5
   Kirpotin DB, 2006, CANCER RES, V66, P6732, DOI 10.1158/0008-5472.CAN-05-4199
   Leane MM, 2004, INT J PHARM, V271, P241, DOI 10.1016/j.ijpharm.2003.11.023
   LEHR CM, 1992, INT J PHARM, V78, P43, DOI 10.1016/0378-5173(92)90353-4
   Mamot C, 2005, CANCER RES, V65, P11631, DOI 10.1158/0008-5472.CAN-05-1093
   Mishra S, 2004, EUR J CELL BIOL, V83, P97, DOI 10.1078/0171-9335-00363
   Moreno D, 2010, EUR J PHARM BIOPHARM, V74, P265, DOI 10.1016/j.ejpb.2009.10.005
   Muzzarelli R.A.A., 1997, CHITIN HDB, P457
   Nie Y, 2011, BIOMATERIALS, V32, P858, DOI 10.1016/j.biomaterials.2010.09.032
   Otsuka H, 2003, ADV DRUG DELIVER REV, V55, P403, DOI 10.1016/S0169-409X(02)00226-0
   Owens DE, 2006, INT J PHARM, V307, P93, DOI 10.1016/j.ijpharm.2005.10.010
   Romberg B, 2008, PHARM RES, V25, P55, DOI 10.1007/s11095-007-9348-7
   Sarmento B, 2011, CARBOHYD POLYM, V84, P919, DOI 10.1016/j.carbpol.2010.12.042
   Sawant RM, 2006, BIOCONJUGATE CHEM, V17, P943, DOI 10.1021/bc060080h
   Sethuraman VA, 2007, J CONTROL RELEASE, V118, P216, DOI 10.1016/j.jconrel.2006.12.008
   Tahara K, 2009, INT J PHARMACEUT, V382, P198, DOI 10.1016/j.ijpharm.2009.07.023
   TANNOCK IF, 1989, CANCER RES, V49, P4373
   Tian F, 2004, CARBOHYD POLYM, V57, P31, DOI 10.1016/j.carbpol.2004.03.016
   Xu PS, 2009, MOL PHARMACEUT, V6, P190, DOI 10.1021/mp800137z
   Zhang L, 2008, CLIN PHARMACOL THER, V83, P761, DOI 10.1038/sj.clpt.6100400
   Zhou J, 2010, J COLLOID INTERF SCI, V345, P241, DOI 10.1016/j.jcis.2010.02.004
NR 31
TC 79
Z9 82
U1 6
U2 72
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 1543-8384
J9 MOL PHARMACEUT
JI Mol. Pharm.
PD MAY
PY 2012
VL 9
IS 5
BP 1262
EP 1270
DI 10.1021/mp2005615
PG 9
WC Medicine, Research & Experimental; Pharmacology & Pharmacy
SC Research & Experimental Medicine; Pharmacology & Pharmacy
GA 941KC
UT WOS:000303961100021
PM 22489704
OA Green Accepted
DA 2018-10-19
ER

PT J
AU Draenert, FG
   Kammerer, PW
   Palarie, V
   Wagner, W
AF Draenert, Florian G.
   Kaemmerer, Peer W.
   Palarie, Victor
   Wagner, Wilfried
TI Vertical Bone Augmentation with Simultaneous Dental Implantation Using
   Crestal Biomaterial Rings: A Rabbit Animal Study
SO CLINICAL IMPLANT DENTISTRY AND RELATED RESEARCH
LA English
DT Article
DE biomaterials; rabbit; vertical bone augmentation
ID ALVEOLAR RIDGE AUGMENTATION; GUIDED TISSUE REGENERATION; DISTRACTION
   OSTEOGENESIS; SINUS FLOOR; FOLLOW-UP; PLACEMENT; RECONSTRUCTION;
   CYLINDERS; TREPHINE; SURGERY
AB Background: Ceramic biomaterial blocks like hydroxyl apatite are too brittle for simple simultaneous vertical augmentation and dental implant placement. Biological scaffolds of xenogenic or allogenic origin are known to be advantageous. Purpose: The aim of this study was the proof of principle for combined vertical bone augmentation and dental implantation with marginal cuffs made of biological scaffolds with interconnecting porous system and titanium dental implants. Materials and Methods: Cylindrical porcine biomaterial rings (processed, mineralized bone matrix) were placed in combination with titanium dental implants in the tibia model using six chinchilla bastard rabbits (n = 12 samples). Histological examination included undecalcified histological examination with toluidine blue staining and fluorescence microscopy. Animals were sacrificed after 30 days. Results: The results showed bony healing in the scaffolds with immature bone tissue ingrowth following the trabecular structure, showing lamellar cancellous bone healing. Fluorescence microscope showed analogous results. Conclusion: The biological scaffold proved a biocompatibility in a xenogenic setting. The vertical bone augmentation with simultaneous implantation was successful and proved the feasibility of the concept.
C1 [Draenert, Florian G.; Wagner, Wilfried] Johannes Gutenberg Univ Mainz, Clin Oral & Maxillofacial Surg, Mainz, Germany.
   [Kaemmerer, Peer W.; Palarie, Victor] State Med & Pharmaceut Univ Nicolae Testemitanu, Clin Oral & Maxillofacial Surg, Kishinev, Moldova.
RP Draenert, FG (reprint author), Augustuspl 2, D-55131 Mainz, Germany.
EM draenert@floriandraenert.com
OI Kammerer, Peer Wolfgang/0000-0002-1671-3764; Palarie,
   Victor/0000-0003-1420-7523
CR Buser D, 1999, PERIODONTOL 2000, V19, P151, DOI 10.1111/j.1600-0757.1999.tb00153.x
   Calvo-Guirado JL, 2012, CLIN ORAL IMPLAN RES, V23, P667, DOI 10.1111/j.1600-0501.2011.02193.x
   Cawood JI, 2007, INT J ORAL MAX SURG, V36, P377, DOI 10.1016/j.ijom.2007.01.024
   Cordioli G, 2003, CLIN ORAL IMPLAN RES, V14, P750, DOI 10.1046/j..2003.00956.x
   DAHLIN C, 1988, PLAST RECONSTR SURG, V81, P672, DOI 10.1097/00006534-198805000-00004
   DONATH K, 1982, J ORAL PATHOL MED, V11, P318, DOI 10.1111/j.1600-0714.1982.tb00172.x
   Draenert FG, 2011, CLIN IMPLANT DENT R, V13, P238, DOI 10.1111/j.1708-8208.2009.00199.x
   Draenert GF, 2007, J CRANIO MAXILL SURG, V35, P201, DOI 10.1016/j.jcms.2007.02.005
   Draenert GF, 2007, BIOMATERIALS, V28, P1531, DOI 10.1016/j.biomaterials.2006.11.029
   Draenert GF, 2009, GROWTH FACTORS, V27, P419, DOI 10.3109/08977190903231075
   Draenert G F, 2007, Mund Kiefer Gesichtschir, V11, P43, DOI 10.1007/s10006-006-0042-4
   Esposito M, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003607.pub3
   Felice P, 2009, CLIN ORAL IMPLAN RES, V20, P1386, DOI 10.1111/j.1600-0501.2009.01765.x
   Fontana F, 2011, CLIN ORAL IMPLAN RES, V22, P760, DOI 10.1111/j.1600-0501.2010.02056.x
   Giesenhagen B, 2008, Z ZAHNARZTL IMPLANTO, V24, P43
   Joosten U, 2005, BIOMATERIALS, V26, P5251, DOI 10.1016/j.biomaterials.2005.01.001
   Khoury F, 1999, INT J ORAL MAX IMPL, V14, P557
   Khoury F, 2001, J PERIODONTOL, V72, P1498, DOI 10.1902/jop.2001.72.11.1498
   Khoury F, 2006, BONE AUGMENTATION OR
   Klesper B, 2002, J CRANIO MAXILL SURG, V30, P280, DOI 10.1054/jcms.2002.0315
   Liljensten E L, 2000, Clin Implant Dent Relat Res, V2, P50, DOI 10.1111/j.1708-8208.2000.tb00106.x
   McAllister BS, 2003, PERIODONTOL 2000, V33, P54, DOI 10.1046/j.0906-6713.2002.03305.x
   Nunamaker DM, 1998, CLIN ORTHOP RELAT R, pS56
   Raghoebar GM, 2001, CLIN ORAL IMPLAN RES, V12, P279, DOI 10.1034/j.1600-0501.2001.012003279.x
   Rocchietta I, 2008, J CLIN PERIODONTOL, V35, P203, DOI 10.1111/j.1600-051X.2008.01271.x
   Roccuzzo M, 2007, CLIN ORAL IMPLAN RES, V18, P286, DOI 10.1111/j.1600-0501.2006.01301.x
   Sandor GKB, 2003, ORAL SURG ORAL MED O, V95, P150, DOI 10.1067/moe.2003.42
   Sandor GKB, 2003, J ORAL MAXIL SURG, V61, P164, DOI 10.1053/joms.2003.50042
   SCHETTLER D, 1977, J MAXILLOFAC SURG, V5, P199, DOI 10.1016/S0301-0503(77)80106-9
   Simion M, 2001, CLIN ORAL IMPLAN RES, V12, P35, DOI 10.1034/j.1600-0501.2001.012001035.x
   Simion M, 2009, INT J PERIODONT REST, V29, P245
   Steinhauser E, 1967, Trans Int Conf Oral Surg, P203
   Stetzer K, 2002, J ORAL MAXIL SURG, V60, P427, DOI 10.1053/joms.2002.31232
   Stetzer K, 2002, J ORAL MAXILLOFAC SU, V60, P436
   Tinti C, 1996, INT J PERIODONT REST, V16, P221
   Tonetti MS, 2008, J CLIN PERIODONTOL, V35, P168, DOI 10.1111/j.1600-051X.2008.01268.x
   Urban IA, 2009, INT J ORAL MAX IMPL, V24, P502
   Wagner W, 1981, Dtsch Zahnarztl Z, V36, P82
NR 38
TC 10
Z9 10
U1 0
U2 5
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1523-0899
EI 1708-8208
J9 CLIN IMPLANT DENT R
JI Clin. Implant Dent. Relat. Res.
PD MAY
PY 2012
VL 14
SU 1
SI SI
BP e169
EP e174
DI 10.1111/j.1708-8208.2011.00401.x
PG 6
WC Dentistry, Oral Surgery & Medicine
SC Dentistry, Oral Surgery & Medicine
GA 939YP
UT WOS:000303857300019
PM 22145692
DA 2018-10-19
ER

PT J
AU Liu, QY
   Jiang, L
   Shi, R
   Zhang, LQ
AF Liu, Quanyong
   Jiang, Lei
   Shi, Rui
   Zhang, Liqun
TI Synthesis, preparation, in vitro degradation, and application of novel
   degradable bioelastomers-A review
SO PROGRESS IN POLYMER SCIENCE
LA English
DT Review
DE Bioelastomer; Biomaterial; Biodegradation; Tissue engineering; Drug
   delivery; Review
ID BIODEGRADABLE POLYESTER ELASTOMER; POLY GLYCEROL-SEBACATE; TISSUE
   ENGINEERING APPLICATIONS; CONTROLLED DRUG-DELIVERY; POLYLACTIDE
   THERMOPLASTIC ELASTOMERS; RING-OPENING POLYMERIZATION; CARBONATE
   BUILDING-BLOCKS; BLOOD-VESSEL CONSTRUCTS; CROSS-LINKED ELASTOMERS;
   CO-CYCLIC CARBONATE)S
AB Degradable bioelastomers are novel polymer biomaterials mainly applied in soft tissue engineering and drug delivery. Synthetic degradable bioelastomers present four remarkable features: three-dimensional crosslinking network structure similar to that of natural elastins, high flexibility and elasticity capable of providing mechanical stimuli for tissue engineering constructs, matched mechanical properties especially with soft body tissues, and broad biodegradability that can be adjusted directly by crosslink density. In this review, degradable bioelastomers are divided into chemically and physically crosslinked bioelastomers. In view of the influence of crosslinking structures on the properties of bioelastomers, chemically crosslinked bioelastomers are further classified into thermo-cured and photo-cured bioelastomers, and physically crosslinked bioelastomers correspond to thermoplastic bioelastomers. In this contribution, after a discussion on the definition of and design strategies for degradable bioelastomers is delivered, the recent advances in the synthesis, properties (especially the in vitro degradation), and potential biomedical applications of these materials are described. Simultaneously, some insights on degradable bioelastomers have also been illuminated. Degradable bioelastomers are sure to play an increasingly significant role in the future developments of polymer biomaterials. (C) 2011 Elsevier Ltd. All rights reserved.
C1 [Liu, Quanyong; Zhang, Liqun] Beijing Univ Chem Technol, State Key Lab Organ Inorgan Composites, Beijing 100029, Peoples R China.
   [Liu, Quanyong; Jiang, Lei] Beihang Univ, Sch Chem & Environm, Minist Educ, Key Lab Bioinspired Smart Interfacial Sci & Techn, Beijing 100191, Peoples R China.
   [Shi, Rui] Peking Univ, Clin Med Coll 4, Beijing Res Inst Traumatol & Orthopaed, Lab Bone Tissue Engn, Beijing 100035, Peoples R China.
RP Zhang, LQ (reprint author), Beijing Univ Chem Technol, State Key Lab Organ Inorgan Composites, Beisanhuan E Rd, Beijing 100029, Peoples R China.
EM zhanglq@mail.buct.edu.cn
RI zhang, liqun/S-7337-2016
OI zhang, liqun/0000-0003-0291-4351
FU National Science Foundation for Young Scientists of China [51003003];
   Natural Science Foundation of China [50933001]; Outstanding Young
   Scientists Foundation of NSF of China [50725310]; National 973 programs
   [2010CB934700]; Beijing Natural Science Foundation [2061002, 2102020]
FX This work is supported by the Project of National Science Foundation for
   Young Scientists of China (Grant No. 51003003), Key Project of Natural
   Science Foundation of China (Grant No. 50933001), Outstanding Young
   Scientists Foundation of NSF of China (Grant No. 50725310), National 973
   programs (Grant No. 2010CB934700), Key Project of Beijing Natural
   Science Foundation (Grant No. 2061002), and Beijing Natural Science
   Foundation (Grant No. 2102020). We would like to thank Prof. Tung W.
   Chan and Dr. Will Mars for proofreading the manuscript.
CR Albertsson AC, 2003, BIOMACROMOLECULES, V4, P1466, DOI 10.1021/bm034247a
   Amsden B, 2004, BIOMACROMOLECULES, V5, P1399, DOI 10.1021/bm034538j
   AMSDEN B, 1995, J CONTROL RELEASE, V33, P99, DOI 10.1016/0168-3659(94)00073-4
   Amsden BG, 2006, BIOMACROMOLECULES, V7, P365, DOI 10.1021/bm050731x
   Amsden BG, 2004, BIOMACROMOLECULES, V5, P2479, DOI 10.1021/bm049578h
   Amsden B, 2007, SOFT MATTER, V3, P1335, DOI 10.1039/b707472g
   Amsden BG, 2008, EXPERT OPIN DRUG DEL, V5, P175, DOI 10.1517/17425247.5.2.175
   ARABULI N, 1994, MACROMOL CHEM PHYSIC, V195, P2279, DOI 10.1002/macp.1994.021950633
   Arcos D, 2009, J MATER SCI-MATER M, V20, P447, DOI 10.1007/s10856-008-3616-x
   Ba CY, 2003, BIOMACROMOLECULES, V4, P1827, DOI 10.1021/bm034235p
   BAKKUM EA, 1995, J MATER SCI-MATER M, V6, P41, DOI 10.1007/BF00121246
   Balguid A, 2007, TISSUE ENG, V13, P1501, DOI 10.1089/ten.2006.0279
   Barrett DG, 2008, MACROMOLECULES, V41, P6347, DOI 10.1021/ma8009728
   Barrett DG, 2008, BIOMACROMOLECULES, V9, P2029, DOI 10.1021/bm800271f
   Barrett DG, 2010, POLYM CHEM-UK, V1, P296, DOI 10.1039/b9py00226j
   Bat E, 2011, ACTA BIOMATER, V7, P1939, DOI 10.1016/j.actbio.2011.01.010
   Bat E, 2010, BIOMACROMOLECULES, V11, P2692, DOI 10.1021/bm1007234
   Bat E, 2010, BIOMATERIALS, V31, P8696, DOI 10.1016/j.biomaterials.2010.07.102
   BERGSMA JE, 1995, BIOMATERIALS, V16, P25, DOI 10.1016/0142-9612(95)91092-D
   Bettinger CJ, 2008, BIOMATERIALS, V29, P2315, DOI 10.1016/j.biomaterials.2008.01.029
   Bettinger CJ, 2009, PURE APPL CHEM, V81, P2183, DOI 10.1351/PAC-CON-09-07-10
   Bettinger CJ, 2006, BIOMATERIALS, V27, P2558, DOI 10.1016/j.biomaterials.2005.11.029
   Bettinger CJ, 2006, ADV MATER, V18, P165, DOI 10.1002/adma.200500438
   BEUMER GJ, 1994, J BIOMED MATER RES, V28, P545, DOI 10.1002/jbm.820280504
   Bezemer JM, 2000, J CONTROL RELEASE, V64, P179, DOI 10.1016/S0168-3659(99)00127-3
   Bezemer JM, 2000, J BIOMED MATER RES, V51, P8
   Bruggeman JP, 2008, BIOMATERIALS, V29, P4726, DOI 10.1016/j.biomaterials.2008.08.037
   Bruggeman JP, 2008, ADV MATER, V20, P1922, DOI 10.1002/adma.200702377
   Bruggeman JP, 2010, J BIOMED MATER RES A, V95A, P92, DOI 10.1002/jbm.a.32733
   Butler DL, 2000, J BIOMECH ENG-T ASME, V122, P570, DOI 10.1115/1.1318906
   Buttafoco L, 2006, BIOMATERIALS, V27, P724, DOI 10.1016/j.biomaterials.2005.06.024
   Cha DS, 2004, CRIT REV FOOD SCI, V44, P223, DOI 10.1080/10408690490464276
   Chapanian R, 2010, J CONTROL RELEASE, V143, P53, DOI 10.1016/j.jconrel.2009.11.025
   Chapanian R, 2010, EUR J PHARM BIOPHARM, V74, P172, DOI 10.1016/j.ejpb.2009.11.012
   Chapanian R, 2010, J BIOMED MATER RES A, V92A, P830, DOI 10.1002/jbm.a.32422
   Chapanian R, 2009, BIOMATERIALS, V30, P295, DOI 10.1016/j.biomaterials.2008.09.038
   Chen JP, 2011, ACTA BIOMATER, V7, P234, DOI 10.1016/j.actbio.2010.08.015
   Chen QZ, 2008, BIOMATERIALS, V29, P47, DOI 10.1016/j.biomaterials.2007.09.010
   Chen R, 2006, BIOMATERIALS, V27, P4453, DOI 10.1016/j.biomaterials.2006.04.011
   Chung EJ, 2011, J BIOMED MATER RES A, V96A, P29, DOI 10.1002/jbm.a.32953
   Cohn D, 2005, POLYMER, V46, P2068, DOI 10.1016/j.polymer.2005.01.012
   Cohn D, 2005, BIOMATERIALS, V26, P2297, DOI 10.1016/j.biomaterials.2004.07.052
   Cooke M, 2003, ARCH ORAL BIOL, V48, P323, DOI 10.1016/S0003-9969(03)00015-3
   Crapo PM, 2008, J BIOMED MATER RES A, V86A, P354, DOI 10.1002/jbm.a.31598
   Dechy-Cabaret O, 2004, CHEM REV, V104, P6147, DOI 10.1021/cr040002s
   DEKONING GJM, 1994, POLYMER, V35, P2090, DOI 10.1016/0032-3861(94)90233-X
   Deng MX, 2009, BIOMACROMOLECULES, V10, P3037, DOI 10.1021/bm9006437
   Dey J, 2010, J BIOMED MATER RES A, V95A, P361, DOI 10.1002/jbm.a.32846
   Dey J, 2008, BIOMATERIALS, V29, P4637, DOI 10.1016/j.biomaterials.2008.08.020
   DI MA, 2005, BIOMATERIALS, V26, P5983
   Ding MM, 2010, SOFT MATTER, V6, P2087, DOI 10.1039/b926689e
   Ding MM, 2009, BIOMACROMOLECULES, V10, P2857, DOI 10.1021/bm9006826
   Ding T, 2006, POLYM DEGRAD STABIL, V91, P733, DOI 10.1016/j.polymdegradstab.2005.06.007
   Ding T, 2010, J APPL POLYM SCI, V118, P2442, DOI 10.1002/app.32300
   Djordjevic I, 2011, POLYM INT, V60, P333, DOI 10.1002/pi.2996
   Djordjevic I, 2010, J BIOMAT SCI-POLYM E, V21, P1039, DOI 10.1163/156856209X463708
   Djordjevic I, 2010, J BIOMAT SCI-POLYM E, V21, P237, DOI 10.1163/156856209X415558
   Djordjevic I, 2009, POLYMER, V50, P1682, DOI 10.1016/j.polymer.2009.01.045
   Drotleff S, 2004, EUR J PHARM BIOPHARM, V58, P385, DOI 10.1016/j.ejpb.2004.03.018
   Emadi R, 2010, MATER LETT, V64, P1528, DOI 10.1016/j.matlet.2010.04.011
   Engelmayr GC, 2008, NAT MATER, V7, P1003, DOI 10.1038/nmat2316
   Eubeler JP, 2009, TRAC-TREND ANAL CHEM, V28, P1057, DOI 10.1016/j.trac.2009.06.007
   FAKIROV S, 1992, POLYMER, V33, P3818, DOI 10.1016/0032-3861(92)90368-7
   FAKIROV S, 1991, POLYMER, V32, P1173, DOI 10.1016/0032-3861(91)90218-8
   FAKIROV S, 1990, MAKROMOL CHEM, V191, P603
   Feng J, 2007, TISSUE ENG, V13, P1003, DOI 10.1089/ten.2006.0223
   Fong H, 1999, J POLYM SCI POL PHYS, V37, P3488, DOI 10.1002/(SICI)1099-0488(19991215)37:24<3488::AID-POLB9>3.0.CO;2-M
   Frick EM, 2003, BIOMACROMOLECULES, V4, P216, DOI 10.1021/bm025628b
   Frick EM, 2000, MACROMOL RAPID COMM, V21, P1317, DOI 10.1002/1521-3927(20001201)21:18<1317::AID-MARC1317>3.0.CO;2-B
   Fu J, 2002, BIOMATERIALS, V23, P4425, DOI 10.1016/S0142-9612(02)00182-5
   Gao J, 2008, J BIOMED MATER RES A, V85A, P1120, DOI 10.1002/jbm.a.32028
   Gao J, 2007, J BIOMED MATER RES A, V83A, P1070, DOI 10.1002/jbm.a.31434
   Gautrot JE, 2006, ANGEW CHEM INT EDIT, V45, P6872, DOI 10.1002/anie.200602096
   Gautrot JE, 2009, MACROMOLECULES, V42, P7324, DOI 10.1021/ma901090r
   Gautrot JE, 2009, J MATER CHEM, V19, P5705, DOI 10.1039/b821340b
   Geetha M, 2009, PROG POLYM SCI, V34, P397
   Ghosh F, 2011, TISSUE ENG PT A, V17, P1675, DOI [10.1089/ten.tea.2008.0450, 10.1089/ten.TEA.2008.0450]
   Gopferich A, 1996, BIOMATERIALS, V17, P103, DOI 10.1016/0142-9612(96)85755-3
   GOSLINE JM, 1984, NATURE, V309, P551, DOI 10.1038/309551a0
   GREGO AV, 1995, CLIN NUTR, V14, P143, DOI 10.1016/S0261-5614(95)80011-5
   Gu F, 2005, J CONTROL RELEASE, V102, P607, DOI 10.1016/j.jconrel.2004.10.020
   Gu F, 2007, EUR J PHARM BIOPHARM, V66, P21, DOI 10.1016/j.ejpb.2006.08.006
   Gu F, 2007, J CONTROL RELEASE, V117, P80, DOI 10.1016/j.jconrel.2006.09.077
   Guan HL, 2005, J POLYM SCI POL CHEM, V43, P1144, DOI 10.1002/pola.20590
   Guan J, 2007, J CONTROL RELEASE, V120, P70, DOI 10.1016/j.jconrel.2007.04.002
   Guan JJ, 2005, BIOMACROMOLECULES, V6, P2833, DOI 10.1021/bm0503322
   Guan JJ, 2004, BIOMATERIALS, V25, P85, DOI 10.1016/S0142-9612(03)00476-9
   Guan JJ, 2002, J BIOMED MATER RES, V61, P493, DOI 10.1002/jbm.10204
   Guelcher SA, 2008, TISSUE ENG PT B-REV, V14, P3, DOI 10.1089/teb.2007.0133
   Guo K, 2010, J APPL POLYM SCI, V117, P3386, DOI 10.1002/app.32080
   Gupta BS, 1997, J BIOMED MATER RES, V34, P341
   Gyawali D, 2010, J BIOMAT SCI-POLYM E, V21, P1761, DOI 10.1163/092050609X12567178204169
   Hassan MK, 2006, J POLYM SCI POL CHEM, V44, P2990, DOI 10.1002/pola.21373
   Hayen H, 2004, J CHROMATOGR A, V1029, P29, DOI 10.1016/j.chroma.2003.12.056
   Hazer B, 2010, J POLYM RES, V17, P567, DOI 10.1007/s10965-009-9345-0
   Hazer DB, 2009, BIOMED MATER, V4, DOI 10.1088/1748-6041/4/3/035011
   Heijkants RGJC, 2008, J BIOMED MATER RES A, V87A, P921, DOI 10.1002/jbm.a.31829
   Heijkants RGJC, 2005, BIOMATERIALS, V26, P4219, DOI 10.1016/j.biomaterials.2004.11.005
   Helminen AO, 2002, MACROMOL CHEM PHYSIC, V203, P2630, DOI 10.1002/macp.200290039
   Hemmrich K, 2008, J MATER SCI-MATER M, V19, P257, DOI 10.1007/s10856-006-0048-3
   Hidalgo-Bastida LA, 2007, ACTA BIOMATER, V3, P457, DOI 10.1016/j.actbio.2006.12.006
   Hiki S, 2000, POLYMER, V41, P7369, DOI 10.1016/S0032-3861(00)00086-0
   Hollister SJ, 2009, ADV MATER, V21, P3330, DOI 10.1002/adma.200802977
   Hong Y, 2010, BIOMATERIALS, V31, P4249, DOI 10.1016/j.biomaterials.2010.02.005
   Hou QP, 2009, ACTA BIOMATER, V5, P1543, DOI 10.1016/j.actbio.2008.12.012
   Huang X, 2009, POLYM INT, V58, P893, DOI 10.1002/pi.2609
   Ifkovits JL, 2007, TISSUE ENG, V13, P2369, DOI 10.1089/ten.2007.0093
   Ifkovits JL, 2009, ACS APPL MATER INTER, V1, P1878, DOI 10.1021/am900403k
   Ifkovits JL, 2008, BIOMED MATER, V3, DOI 10.1088/1748-6041/3/3/034104
   Ikada Y, 2000, MACROMOL RAPID COMM, V21, P117, DOI 10.1002/(SICI)1521-3927(20000201)21:3<117::AID-MARC117>3.0.CO;2-X
   Ilagan BG, 2010, J BIOMED MATER RES A, V93A, P211, DOI 10.1002/jbm.a.32482
   Ilagan BG, 2009, ACTA BIOMATER, V5, P2429, DOI 10.1016/j.actbio.2009.03.023
   Janout V, 2005, J AM CHEM SOC, V127, P22, DOI 10.1021/ja044257z
   Jeon O, 2003, MACROMOLECULES, V36, P5585, DOI 10.1021/ma034006v
   Jia L, 2005, MACROMOL BIOSCI, V5, P526, DOI 10.1002/mabi.200400227
   Jiao YP, 2007, BIOMED MATER, V2, pR24, DOI 10.1088/1748-6041/2/4/R02
   Jing Y, 2004, BIOMACROMOLECULES, V5, P2258, DOI 10.1021/bm049705+
   Johnston APR, 2008, SMALL, V4, P612, DOI 10.1002/smll.200700813
   Kang Y, 2006, J BIOMED MATER RES A, V77A, P331, DOI 10.1002/jbm.a.30607
   Katti DS, 2002, ADV DRUG DELIVER REV, V54, P933, DOI 10.1016/S0169-409X(02)00052-2
   Kavlock KD, 2007, ACTA BIOMATER, V3, P475, DOI 10.1016/j.actbio.2007.02.001
   Kim BS, 2000, J BIOMECH ENG-T ASME, V122, P210, DOI 10.1115/1.429651
   Kim JH, 2002, POLYM J, V34, P203, DOI 10.1295/polymj.34.203
   Kluge JA, 2008, TRENDS BIOTECHNOL, V26, P244, DOI 10.1016/j.tibtech.2008.02.006
   Kumara PHS, 2008, J APPL POLYM SCI, V109, P3321, DOI 10.1002/app.28402
   Langer R, 2003, AICHE J, V49, P2990, DOI 10.1002/aic.690491202
   LANGER R, 1990, BIOMATERIALS, V11, P738, DOI 10.1016/0142-9612(90)90038-R
   LANGER RS, 1981, BIOMATERIALS, V2, P201, DOI 10.1016/0142-9612(81)90059-4
   Latere JP, 2002, MACROMOLECULES, V35, P7857, DOI 10.1021/ma020441y
   LEE JM, 1985, CIRC RES, V57, P475, DOI 10.1161/01.RES.57.3.475
   Lee JW, 2001, MACROMOLECULES, V34, P3928, DOI 10.1021/ma0022351
   Lee LY, 2009, EUR POLYM J, V45, P3247, DOI 10.1016/j.eurpolymj.2009.07.016
   Lei LJ, 2007, POLYM DEGRAD STABIL, V92, P389, DOI 10.1016/j.polymdegradstab.2006.12.004
   Lei LJ, 2009, POLYM DEGRAD STABIL, V94, P1494, DOI 10.1016/j.polymdegradstab.2009.04.034
   Li MX, 2002, J POLYM SCI POL CHEM, V40, P4550, DOI 10.1002/pola.10547
   Liang SL, 2010, BIOMATERIALS, V31, P8516, DOI 10.1016/j.biomaterials.2010.07.105
   Lipik VT, 2010, ACTA BIOMATER, V6, P4261, DOI 10.1016/j.actbio.2010.05.027
   Liu BS, 2008, J BIOMED MATER RES A, V87A, P1092, DOI 10.1002/jbm.a.31916
   Liu QY, 2010, CHEM J CHINESE U, V31, P1065
   Liu QY, 2009, J BIOMAT SCI-POLYM E, V20, P1567, DOI 10.1163/092050609X12464345064325
   Liu QY, 2007, J APPL POLYM SCI, V103, P1412, DOI 10.1002/app.24394
   Liu QY, 2007, J APPL POLYM SCI, V104, P1131, DOI 10.1002/app.25606
   [刘全勇 Liu Quanyong], 2011, [复合材料学报, Acta Materiae Compositae Sinica], V28, P1
   Liu QY, 2009, POLYM DEGRAD STABIL, V94, P1427, DOI 10.1016/j.polymdegradstab.2009.05.023
   Liu QY, 2009, BIOMED MATER, V4, DOI 10.1088/1748-6041/4/2/025015
   Liu QY, 2005, J APPL POLYM SCI, V98, P2033, DOI 10.1002/app.22397
   Lucas N, 2008, CHEMOSPHERE, V73, P429, DOI 10.1016/j.chemosphere.2008.06.064
   Mahdavi A, 2008, P NATL ACAD SCI USA, V105, P2307, DOI 10.1073/pnas.0712117105
   Manno M, 2001, BIOPOLYMERS, V59, P51, DOI 10.1002/1097-0282(200107)59:1<51::AID-BIP1005>3.0.CO;2-8
   Martina M, 2007, POLYM INT, V56, P145, DOI 10.1002/pi.2108
   Matsumura G, 2003, BIOMATERIALS, V24, P2303, DOI 10.1016/S0142-9612(03)00043-7
   Migneco F, 2009, BIOMATERIALS, V30, P6479, DOI 10.1016/j.biomaterials.2009.08.021
   Miserez A, 2009, NAT MATER, V8, P910, DOI [10.1038/NMAT2547, 10.1038/nmat2547]
   Monson KL, 2003, J BIOMECH ENG-T ASME, V125, P288, DOI 10.1115/1.1554412
   MORTENSEN PB, 1981, BIOCHIM BIOPHYS ACTA, V664, P349, DOI 10.1016/0005-2760(81)90057-6
   Motlagh D, 2006, BIOMATERIALS, V27, P4315, DOI 10.1016/j.biomaterials.2006.04.010
   Motlagh D, 2007, J BIOMED MATER RES A, V82A, P907, DOI 10.1002/jbm.a.31211
   Nagata M, 2006, MACROMOL BIOSCI, V6, P333, DOI 10.1002/mabi.200600058
   Nagata M, 2004, POLYMER, V45, P87, DOI 10.1016/j.polymer.2003.11.003
   Nagata M, 2008, POLYMER, V49, P1506, DOI 10.1016/j.polymer.2008.01.062
   Nair LS, 2007, PROG POLYM SCI, V32, P762, DOI 10.1016/j.progpolymsci.2007.05.017
   Neeley WL, 2008, BIOMATERIALS, V29, P418, DOI 10.1016/j.biomaterials.2007.10.007
   Nijst CLE, 2007, BIOMACROMOLECULES, V8, P3067, DOI 10.1021/bm070423u
   Okada M, 2002, PROG POLYM SCI, V27, P87, DOI 10.1016/S0079-6700(01)00039-9
   Olson DA, 2006, J AM CHEM SOC, V128, P13625, DOI 10.1021/ja063092m
   Park JH, 2004, J CONTROL RELEASE, V95, P579, DOI 10.1016/j.jconrel.2003.12.020
   Pego AP, 2003, J CONTROL RELEASE, V87, P69, DOI 10.1016/S0168-3659(02)00351-6
   Pego AP, 2003, POLYMER, V44, P6495, DOI 10.1016/S0032-3861(03)00668-2
   Pomerantseva I, 2009, J BIOMED MATER RES A, V91A, P1038, DOI 10.1002/jbm.a.32327
   Puppi D, 2010, PROG POLYM SCI, V35, P403, DOI 10.1016/j.progpolymsci.2010.01.006
   Puskas JE, 2004, BIOMACROMOLECULES, V5, P1141, DOI 10.1021/bm034513k
   Qiu HJ, 2006, BIOMATERIALS, V27, P5845, DOI 10.1016/j.biomaterials.2006.07.042
   Radder AM, 1996, J BIOMED MATER RES, V30, P341
   RADDER AM, 1995, BIOMATERIALS, V16, P507, DOI 10.1016/0142-9612(95)91122-F
   Redenti S, 2009, BIOMATERIALS, V30, P3405, DOI 10.1016/j.biomaterials.2009.02.046
   Saad GR, 2001, MACROMOL BIOSCI, V1, P91, DOI 10.1002/1616-5195(20010301)1:3<91::AID-MABI91>3.0.CO;2-8
   Sakkers RJB, 2000, J BIOMED MATER RES, V49, P312, DOI 10.1002/(SICI)1097-4636(20000305)49:3<312::AID-JBM3>3.3.CO;2-5
   Santerre JP, 2005, BIOMATERIALS, V26, P7457, DOI 10.1016/j.biomaterials.2005.05.079
   Santos MI, 2009, J MATER CHEM, V19, P4091, DOI 10.1039/b819089e
   Schiffman JD, 2008, POLYM REV, V48, P317, DOI 10.1080/15583720802022182
   SCHIRRER R, 1992, J MATER SCI, V27, P3424, DOI 10.1007/BF01151816
   Seliktar D, 2003, TISSUE ENG, V9, P657, DOI 10.1089/107632703768247359
   Shen JY, 2007, BIOMACROMOLECULES, V8, P376, DOI 10.1021/bm060766c
   Shepherd DET, 1999, RHEUMATOLOGY, V38, P124, DOI 10.1093/rheumatology/38.2.124
   Shi R, 2006, POLYM DEGRAD STABIL, V91, P3289, DOI 10.1016/j.polymdegradstab.2006.06.007
   Shi R, 2007, J APPL POLYM SCI, V103, P574, DOI 10.1002/app.25193
   Shi R, 2009, INT J MOL SCI, V10, P4223, DOI 10.3390/ijms10104223
   Shin H, 2003, BIOMATERIALS, V24, P4353, DOI 10.1016/S0142-9612(03)00339-9
   Shin'oka T, 2005, J THORAC CARDIOV SUR, V129, P1330, DOI 10.1016/j.jtcvs.2004.12.047
   Simionescua DT, 2006, BIOMATERIALS, V27, P702, DOI 10.1016/j.biomaterials.2005.06.013
   Skarja GA, 1998, J BIOMAT SCI-POLYM E, V9, P271, DOI 10.1163/156856298X00659
   Soletti L, 2011, J BIOMED MATER RES A, V96A, P436, DOI 10.1002/jbm.a.32997
   Son JS, 2009, TISSUE ENG REGEN MED, V6, P427
   Song Y, 2010, ACTA BIOMATER, V6, P1269, DOI 10.1016/j.actbio.2009.10.002
   Stankus JJ, 2006, BIOMATERIALS, V27, P735, DOI 10.1016/j.biomaterials.2005.06.020
   Stankus JJ, 2004, J BIOMED MATER RES A, V70A, P603, DOI 10.1002/jbm.a.30122
   Stankus JJ, 2007, BIOMATERIALS, V28, P2738, DOI 10.1016/j.biomaterials.2007.02.012
   STOREY RF, 1994, POLYMER, V35, P830, DOI 10.1016/0032-3861(94)90882-6
   Sun ZJ, 2008, APPL SURF SCI, V255, P350, DOI 10.1016/j.apsusc.2008.06.157
   Sun ZJ, 2009, BIOMATERIALS, V30, P5209, DOI 10.1016/j.biomaterials.2009.06.007
   Sun ZJ, 2009, MAT SCI ENG C-BIO S, V29, P178, DOI 10.1016/j.msec.2008.06.010
   Sundback CA, 2005, BIOMATERIALS, V26, P5454, DOI 10.1016/j.biomaterials.2005.02.004
   TABOR CW, 1984, ANNU REV BIOCHEM, V53, P749, DOI 10.1146/annurev.bi.53.070184.003533
   Tang DL, 2011, J POLYM SCI POL CHEM, V49, P2959, DOI 10.1002/pola.24732
   Tatai L, 2007, BIOMATERIALS, V28, P5407, DOI 10.1016/j.biomaterials.2007.08.035
   Tatham AS, 2000, TRENDS BIOCHEM SCI, V25, P567, DOI 10.1016/S0968-0004(00)01670-4
   Thambyah A, 2006, OSTEOARTHR CARTILAGE, V14, P580, DOI 10.1016/j.joca.2006.01.015
   Therien-Aubin H, 2010, POLYMER, V51, P22, DOI 10.1016/j.polymer.2009.11.027
   Tian M, 2011, MATER LETT, V65, P3076, DOI 10.1016/j.matlet.2011.06.089
   Tienen TG, 2006, J BIOMED MATER RES B, V76B, P389, DOI 10.1002/jbm.b.30406
   Til HP, 1997, FOOD CHEM TOXICOL, V35, P337, DOI 10.1016/S0278-6915(97)00121-X
   Timbart L, 2008, J POLYM SCI POL CHEM, V46, P8191, DOI 10.1002/pola.23117
   Tobias IS, 2010, J CONTROL RELEASE, V146, P356, DOI 10.1016/j.jconrel.2010.05.036
   Tran RT, 2010, SOFT MATTER, V6, P2449, DOI 10.1039/c001605e
   Urry DW, 2002, PHILOS T R SOC B, V357, P169, DOI 10.1098/rstb.2001.1023
   Valappil SP, 2006, EXPERT REV MED DEVIC, V3, P853, DOI 10.1586/17434440.3.6.853
   Venhoven BAM, 1996, BIOMATERIALS, V17, P2313, DOI 10.1016/S0142-9612(96)00074-9
   VERT M, 1992, J MATER SCI-MATER M, V3, P432, DOI 10.1007/BF00701240
   Viseras C, 2008, MATER SCI TECH-LOND, V24, P1020, DOI 10.1179/174328408X341708
   Wanamaker CL, 2007, BIOMACROMOLECULES, V8, P3634, DOI 10.1021/bm700699g
   Wanamaker CL, 2009, BIOMACROMOLECULES, V10, P2904, DOI 10.1021/bm900721p
   Wanamaker CL, 2009, MACROMOL SYMP, V283-84, P130, DOI 10.1002/masy.200950917
   Wanamaker CL, 2009, BIOMACROMOLECULES, V10, P443, DOI 10.1021/bm801292v
   Wang LS, 2011, J POLYM RES, V18, P329, DOI 10.1007/s10965-010-9422-4
   Wang LS, 2010, J POLYM RES, V17, P77, DOI 10.1007/s10965-009-9292-9
   Wang LY, 2008, J APPL POLYM SCI, V109, P1310, DOI 10.1002/app.28103
   Wang S, 2001, BIOMATERIALS, V22, P1157, DOI 10.1016/S0142-9612(00)00356-2
   Wang WS, 2006, J POLYM SCI POL CHEM, V44, P5505, DOI 10.1002/pola.21643
   Wang YD, 2003, J BIOMED MATER RES A, V66A, P192, DOI 10.1002/jbm.a.10534
   Wang YD, 2002, NAT BIOTECHNOL, V20, P602, DOI 10.1038/nbt0602-602
   Webb AR, 2004, EXPERT OPIN BIOL TH, V4, P801, DOI 10.1517/14712598.4.6.801
   WEISFOGH T, 1960, J EXP BIOL, V37, P889
   WILLIAMS D. F., 1987, DEFINITIONS BIOMATER, P49
   Williams DF, 2008, BIOMATERIALS, V29, P2941, DOI 10.1016/j.biomaterials.2008.04.023
   Williams DF, 2009, BIOMATERIALS, V30, P5897, DOI 10.1016/j.biomaterials.2009.07.027
   Woodruff MA, 2010, PROG POLYM SCI, V35, P1217, DOI 10.1016/j.progpolymsci.2010.04.002
   Wu LB, 2011, BIOMACROMOLECULES, V12, P235, DOI 10.1021/bm1012162
   Yamanouchi D, 2008, BIOMATERIALS, V29, P3269, DOI 10.1016/j.biomaterials.2008.04.026
   Yang J, 2004, ADV MATER, V16, P511, DOI 10.1002/adma.200306264
   Yang J, 2006, ADV MATER, V18, P1493, DOI 10.1002/adma.200600230
   Yang J, 2006, BIOMATERIALS, V27, P1889, DOI 10.1016/j.biomaterials.2005.05.106
   Yang J, 2004, BIOMACROMOLECULES, V5, P209, DOI 10.1021/bm0343242
   Yang XH, 2009, J ADHESION, V85, P576, DOI 10.1080/00218460902996788
   Yoda R, 1998, J BIOMAT SCI-POLYM E, V9, P561, DOI 10.1163/156856298X00046
   Younes HM, 2004, BIOMATERIALS, V25, P5261, DOI 10.1016/j.biomaterials.2003.12.024
   Zhang DH, 2005, BIOMACROMOLECULES, V6, P2091, DOI 10.1021/bm050076t
   Zhang JH, 2009, MAT SCI ENG C-BIO S, V29, P889, DOI 10.1016/j.msec.2008.08.002
   Zhang JY, 2002, TISSUE ENG, V8, P771, DOI 10.1089/10763270260424132
   Zhang XQ, 2009, BIOMATERIALS, V30, P2632, DOI 10.1016/j.biomaterials.2009.01.021
   Zhang Z, 2006, BIOMATERIALS, V27, P1741, DOI 10.1016/j.biomaterials.2005.09.017
   Zhang Z, 2004, MACROMOL CHEM PHYSIC, V205, P867, DOI 10.1002/macp.200300184
   Zhao HC, 2009, J APPL POLYM SCI, V114, P1464, DOI 10.1002/app.30735
   Zhao Z, 2003, ADV DRUG DELIVER REV, V55, P483, DOI 10.1016/S0169-409X(03)00040-1
   Zheng YM, 2010, NATURE, V463, P640, DOI 10.1038/nature08729
   Zhong Q, 2011, POLYM ENG SCI, V51, P908, DOI 10.1002/pen.21911
NR 255
TC 95
Z9 100
U1 19
U2 327
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0079-6700
J9 PROG POLYM SCI
JI Prog. Polym. Sci.
PD MAY
PY 2012
VL 37
IS 5
BP 715
EP 765
DI 10.1016/j.progpolymsci.2011.11.001
PG 51
WC Polymer Science
SC Polymer Science
GA 939UT
UT WOS:000303845100004
DA 2018-10-19
ER

PT J
AU Sharp, KG
   Dickson, AR
   Marchenko, SA
   Yee, KM
   Emery, PN
   Laidmae, I
   Uibo, R
   Sawyer, ES
   Steward, O
   Flanagan, LA
AF Sharp, Kelli G.
   Dickson, Amanda R.
   Marchenko, Steve A.
   Yee, Kelly M.
   Emery, Pauline N.
   Laidmae, Ivo
   Uibo, Raivo
   Sawyer, Evelyn S.
   Steward, Oswald
   Flanagan, Lisa A.
TI Salmon fibrin treatment of spinal cord injury promotes functional
   recovery and density of serotonergic innervation
SO EXPERIMENTAL NEUROLOGY
LA English
DT Article
DE Dorsal hemisection; Three-dimensional; Biomaterial; Axon; BBB score;
   Bladder; Serotonin
ID AXONAL REGENERATION; ADULT-RAT; GUIDANCE CHANNELS; NERVOUS-SYSTEM;
   SCHWANN-CELL; NEURAL STEM; REACTIVE ASTROCYTES; CHITOSAN CHANNELS; SCAR
   FORMATION; GLIAL SCAR
AB The neural degeneration caused by spinal cord injury leaves a cavity at the injury site that greatly inhibits repair. One approach to promoting repair is to fill the cavity with a scaffold to limit further damage and encourage regrowth. Injectable materials are advantageous scaffolds because they can be placed as a liquid in the lesion site then form a solid in vivo that precisely matches the contours of the lesion. Fibrin is one type of injectable scaffold, but risk of infection from blood borne pathogens has limited its use. We investigated the potential utility of salmon fibrin as an injectable scaffold to treat spinal cord injury since it lacks mammalian infectious agents and encourages greater neuronal extension in vitro than mammalian fibrin or Matrigel, another injectable material. Female rats received a T9 dorsal hemisection injury and were treated with either salmon or human fibrin at the time of injury while a third group served as untreated controls. Locomotor function was assessed using the BBB scale, bladder function was analyzed by measuring residual urine, and sensory responses were tested by mechanical stimulation (von Frey hairs). Histological analyses quantified the glial scar, lesion volume, and serotonergic fiber density. Rats that received salmon fibrin exhibited significantly improved recovery of both locomotor and bladder function and a greater density of serotonergic innervation caudal to the lesion site without exacerbation of pain. Rats treated with salmon fibrin also exhibited less autophagia than those treated with human fibrin, potentially pointing to amelioration of sensory dysfunction. Glial scar formation and lesion size did not differ significantly among groups. The pattern and timing of salmon fibrin's effects suggest that it acts on neuronal populations but not by stimulating long tract regeneration. Salmon fibrin clearly has properties distinct from those of mammalian fibrin and is a beneficial injectable scaffold for treatment of spinal cord injury. (C) 2012 Elsevier Inc. All rights reserved.
C1 [Dickson, Amanda R.; Marchenko, Steve A.; Flanagan, Lisa A.] Univ Calif Irvine, Sch Med, Sue & Bill Gross Stem Cell Res Ctr, Dept Neurol, Irvine, CA 92697 USA.
   [Sharp, Kelli G.; Yee, Kelly M.; Steward, Oswald] Univ Calif Irvine, Reeve Irvine Res Ctr, Irvine, CA 92697 USA.
   [Sharp, Kelli G.; Yee, Kelly M.; Steward, Oswald] Univ Calif Irvine, Dept Anat & Neurobiol, Irvine, CA 92697 USA.
   [Emery, Pauline N.; Sawyer, Evelyn S.] Sea Run Holdings Inc, Freeport, ME USA.
   [Laidmae, Ivo; Uibo, Raivo] Immunotron Ltd, Tartu, Estonia.
RP Flanagan, LA (reprint author), Univ Calif Irvine, Sch Med, Sue & Bill Gross Stem Cell Res Ctr, Dept Neurol, 3030 Gross Hall,845 Hlth Sci Rd, Irvine, CA 92697 USA.
EM lflanaga@uci.edu
RI Uibo, Raivo/G-8940-2015
OI Steward, Oswald/0000-0001-7069-8756
FU Roman Reed Spinal Cord Injury Research Fund of California; NIH
   [R44-NS048734, AG23583]
FX The authors gratefully acknowledge the assistance provided by the Roman
   Reed Spinal Cord Injury Core Laboratory at University of California,
   Irvine, which is supported by the Roman Reed Spinal Cord Injury Research
   Fund of California and private donations to the Reeve-Irvine Research
   Center. This study was supported in part by NIH R44-NS048734 and NIH
   AG23583.
CR Adams RA, 2007, J EXP MED, V204, P571, DOI 10.1084/jem.20061931
   Akassoglou K, 2003, NEUROSCI LETT, V338, P185, DOI 10.1016/S0304-3940(02)01387-3
   Anderson KD, 2004, J NEUROTRAUM, V21, P1371, DOI 10.1089/neu.2004.21.1371
   Balgude AP, 2001, BIOMATERIALS, V22, P1077, DOI 10.1016/S0142-9612(00)00350-1
   BARBEAU H, 1991, BRAIN RES, V546, P250, DOI 10.1016/0006-8993(91)91489-N
   Basso DM, 2004, J NEUROTRAUM, V21, P395, DOI 10.1089/089771504323004548
   BASSO DM, 1995, J NEUROTRAUM, V12, P1, DOI 10.1089/neu.1995.12.1
   Beattie MS, 2000, J NEUROTRAUM, V17, P915, DOI 10.1089/neu.2000.17.915
   Bensaid W, 2003, BIOMATERIALS, V24, P2497, DOI 10.1016/S0142-9612(02)00618-X
   CHAPLAN SR, 1994, J NEUROSCI METH, V53, P55, DOI 10.1016/0165-0270(94)90144-9
   Coumans JV, 2001, J NEUROSCI, V21, P9334, DOI 10.1523/JNEUROSCI.21-23-09334.2001
   DAS GD, 1989, BRAIN RES BULL, V22, P33, DOI 10.1016/0361-9230(89)90124-X
   de Groat WC, 2006, PROG BRAIN RES, V152, P59, DOI 10.1016/S0079-6123(05)52005-3
   Elkin BS, 2007, J NEUROTRAUM, V24, P812, DOI 10.1089/neu.2006.0169
   Estores IM, 2003, J REHABIL RES DEV, V40, P93, DOI 10.1682/JRRD.2003.08.0093
   Faulkner JR, 2004, J NEUROSCI, V24, P2143, DOI 10.1523/JNEUROSCI.3547-03.2004
   Feraboli-Lohnherr D, 1999, J NEUROSCI RES, V55, P87, DOI 10.1002/(SICI)1097-4547(19990101)55:1<87::AID-JNR10>3.0.CO;2-#
   Fischer MB, 2000, NATURE, V408, P479, DOI 10.1038/35044100
   Flanagan LA, 2002, NEUROREPORT, V13, P2411, DOI 10.1097/01.wnr.0000048003.96487.97
   Hofstetter CP, 2005, NAT NEUROSCI, V8, P346, DOI 10.1038/nn1405
   Iwaya K, 1999, NEUROSURGERY, V44, P589, DOI 10.1097/00006123-199903000-00085
   Iwaya K., 1999, NEUROSURGERY, V44, P595
   Johnson PJ, 2010, SOFT MATTER, V6, P5127, DOI 10.1039/c0sm00173b
   Johnson PJ, 2009, BIOTECHNOL BIOENG, V104, P1207, DOI 10.1002/bit.22476
   Johnson PJ, 2010, J BIOMED MATER RES A, V92A, P152, DOI 10.1002/jbm.a.32343
   Ju YE, 2007, BIOMATERIALS, V28, P2097, DOI 10.1016/j.biomaterials.2007.01.008
   Kim JE, 2004, NEURON, V44, P439, DOI 10.1016/j.neuron.2004.10.015
   Laidmae I, 2006, BIOMATERIALS, V27, P5771, DOI 10.1016/j.biomaterials.2006.07.035
   Laidmae I, 2010, J BIOMED MATER RES A, V93A, P29, DOI 10.1002/jbm.a.32505
   Lankhorst AJ, 2001, J NEUROTRAUM, V18, P203, DOI 10.1089/08977150150502622
   Li SX, 2004, J NEUROSCI, V24, P10511, DOI 10.1523/JNEUROSCI.2828-04.2004
   Menezes K, 2010, FASEB J, V24, P4513, DOI 10.1096/fj.10-157628
   Michaud SE, 2002, THROMB RES, V107, P245, DOI 10.1016/S0049-3848(02)00333-X
   Mosesson MW, 2005, J THROMB HAEMOST, V3, P1894, DOI 10.1111/j.1538-7836.2005.01365.x
   Nomura H, 2008, NEUROSURGERY, V63, P127, DOI 10.1227/01.NEU.0000316.143.88403.16
   Nomura H, 2008, TISSUE ENG PT A, V14, P649, DOI 10.1089/tea.2007.0180
   Nomura H, 2006, NEUROSURGERY, V59, P183, DOI 10.1227/NEU.0000219859.35349.EF
   Novikova LN, 2003, CURR OPIN NEUROL, V16, P711, DOI 10.1097/01.wco.0000102620.38669.3e
   Oudega M, 2001, BIOMATERIALS, V22, P1125, DOI 10.1016/S0142-9612(00)00346-X
   PARK TG, 1995, J CONTROL RELEASE, V33, P211, DOI 10.1016/0168-3659(94)00084-8
   Patist CM, 2004, BIOMATERIALS, V25, P1569, DOI 10.1016/S0142-9612(03)00503-9
   Piantino J, 2006, EXP NEUROL, V201, P359, DOI 10.1016/j.expneurol.2006.04.020
   Popovich PG, 1999, EXP NEUROL, V158, P351, DOI 10.1006/exnr.1999.7118
   Powers RK, 2001, REV PHYSIOL BIOCH P, V143, P137, DOI 10.1007/BFb0115594
   Prange MT, 2002, J BIOMECH ENG-T ASME, V124, P244, DOI 10.1115/1.1449907
   Rauch MF, 2009, EUR J NEUROSCI, V29, P132, DOI 10.1111/j.1460-9568.2008.06567.x
   Reynolds LF, 2008, SPINAL CORD, V46, P58, DOI 10.1038/sj.sc.3102063
   Ribotta MGY, 2000, J NEUROSCI, V20, P5144
   Rothwell SW, 2010, BIOLOGICALS, V38, P619, DOI 10.1016/j.biologicals.2010.07.001
   Rothwell SW, 2009, J MATER SCI-MATER M, V20, P2155, DOI 10.1007/s10856-009-3769-2
   Rothwell SW, 2005, J TRAUMA, V59, P143, DOI 10.1097/01.TA.0000171528.43746.53
   Ryu JK, 2009, J THROMB HAEMOST, V7, P151, DOI 10.1111/j.1538-7836.2009.03438.x
   Saruhashi Y, 1996, EXP NEUROL, V139, P203, DOI 10.1006/exnr.1996.0094
   Schachtrup C, 2007, P NATL ACAD SCI USA, V104, P11814, DOI 10.1073/pnas.0704045104
   Schachtrup C, 2010, J NEUROSCI, V30, P5843, DOI 10.1523/JNEUROSCI.0137-10.2010
   Schmidt BJ, 2000, BRAIN RES BULL, V53, P689, DOI 10.1016/S0361-9230(00)00402-0
   Sieminski AL, 2004, J BIOMAT SCI-POLYM E, V15, P237, DOI 10.1163/156856204322793610
   Silver J, 2004, NAT REV NEUROSCI, V5, P146, DOI 10.1038/nrn1326
   Steward O, 2008, EXP NEUROL, V209, P446, DOI 10.1016/j.expneurol.2007.12.010
   Stokols S, 2006, TISSUE ENG, V12, P2777, DOI 10.1089/ten.2006.12.2777
   Straley KS, 2010, J NEUROTRAUM, V27, P1, DOI 10.1089/neu.2009.0948
   Stupack DG, 2002, J CELL SCI, V115, P3729, DOI 10.1242/jcs.00071
   Takami T, 2002, J NEUROSCI, V22, P6670
   TATOR CH, 1991, J NEUROSURG, V75, P15, DOI 10.3171/jns.1991.75.1.0015
   Taylor SJ, 2006, J CONTROL RELEASE, V113, P226, DOI 10.1016/j.jconrel.2006.05.005
   Teng YD, 2002, P NATL ACAD SCI USA, V99, P3024, DOI 10.1073/pnas.052678899
   Tobias CA, 2003, EXP NEUROL, V184, P97, DOI 10.1016/S0014-4886(03)00394-7
   Tsai EC, 2006, BIOMATERIALS, V27, P519, DOI 10.1016/j.biomaterials.2005.07.025
   Tsai EC, 2004, J NEUROTRAUM, V21, P789, DOI 10.1089/0897715041269687
   Tysseling VM, 2010, J NEUROSCI RES, V88, P3161, DOI 10.1002/jnr.22472
   Tysseling-Mattiace VM, 2008, J NEUROSCI, V28, P3814, DOI 10.1523/JNEUROSCI.0143-08.2008
   Uibo R, 2009, BBA-MOL CELL RES, V1793, P924, DOI 10.1016/j.bbamcr.2009.01.007
   Wang LZ, 2000, THROMB RES, V100, P537, DOI 10.1016/S0049-3848(00)00362-5
   WILLIAMS LR, 1987, NEUROCHEM RES, V12, P851, DOI 10.1007/BF00966306
   WOLF K, 1988, FISH VIRUSES FISH VI
   Yang Y, 2009, TISSUE ENG PT A, V15, P3283, DOI [10.1089/ten.tea.2009.0081, 10.1089/ten.TEA.2009.0081]
NR 76
TC 25
Z9 27
U1 0
U2 16
PU ACADEMIC PRESS INC ELSEVIER SCIENCE
PI SAN DIEGO
PA 525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA
SN 0014-4886
J9 EXP NEUROL
JI Exp. Neurol.
PD MAY
PY 2012
VL 235
IS 1
BP 345
EP 356
DI 10.1016/j.expneurol.2012.02.016
PG 12
WC Neurosciences
SC Neurosciences & Neurology
GA 934FZ
UT WOS:000303430400036
PM 22414309
OA Green Accepted
DA 2018-10-19
ER

PT J
AU Gualandi, C
   Soccio, M
   Govoni, M
   Valente, S
   Lotti, N
   Munari, A
   Giordano, E
   Pasquinelli, G
   Focarete, ML
AF Gualandi, Chiara
   Soccio, Michelina
   Govoni, Marco
   Valente, Sabrina
   Lotti, Nadia
   Munari, Andrea
   Giordano, Emanuele
   Pasquinelli, Gianandrea
   Focarete, Maria Letizia
TI Poly(butylene/diethylene glycol succinate) multiblock copolyester as a
   candidate biomaterial for soft tissue engineering: Solid-state
   properties, degradability, and biocompatibility
SO JOURNAL OF BIOACTIVE AND COMPATIBLE POLYMERS
LA English
DT Article
DE electrospinning; hydrolytic degradation; reactive blending; multiblock
   copolyester; soft tissue engineering
ID IN-VITRO DEGRADATION; REGENERATIVE MEDICINE; HYDROLYTIC DEGRADATION;
   ALIPHATIC POLYESTERS; BIODEGRADABLE ELASTOMERS; ELECTROSPUN SCAFFOLDS;
   NERVE REGENERATION; CARDIAC GRAFTS; DRUG-DELIVERY; FIBERS
AB A multiblock bioresorbable copolyester, poly(butylene/diethylene glycol succinate), was synthesized by reactive blending, and it was used, together with the corresponding poly(butylene succinate) homopolymer, to form films and to fabricate biomimetic electrospun scaffolds. The poly(butylene/diethylene glycol succinate) scaffold had a more pronounced elastomeric behavior than poly(butylene succinate). It also underwent hydrolytic degradation faster than poly(butylene succinate) since the incorporated diethylene glycol succinate units rendered the copolymer more hydrophilic than poly(butylene succinate). The films degraded faster than electrospun samples due to the autocatalytic effect of carboxylic end-groups. The biodegradable poly(butylene/diethylene glycol succinate) scaffold supported the growth and preserved the cardiac phenotype markers of H9c2 cells, demonstrating its potential utility in soft tissue engineering applications.
C1 [Gualandi, Chiara; Focarete, Maria Letizia] Univ Bologna, Dept Chem G Ciamician, I-40126 Bologna, Italy.
   [Gualandi, Chiara; Focarete, Maria Letizia] Univ Bologna, Natl Consortium Mat Sci & Technol, INSTM, RU Bologna, I-40126 Bologna, Italy.
   [Gualandi, Chiara] Univ Bologna, Adv Applicat Mech Engn & Mat Technol Interdept Ct, I-40126 Bologna, Italy.
   [Soccio, Michelina; Lotti, Nadia; Munari, Andrea] Univ Bologna, Dept Civil Environm & Mat Engn DICAM, I-40126 Bologna, Italy.
   [Govoni, Marco; Giordano, Emanuele] Univ Bologna, Dept Biochem G Moruzzi, Lab Cellular & Mol Engn, Cesena, Italy.
   [Govoni, Marco; Giordano, Emanuele] Univ Bologna, Natl Inst Cardiovasc Res, Cesena, Italy.
   [Pasquinelli, Gianandrea] Univ Bologna, Clin Dept Radiol & Histocytomorphol Sci, I-40126 Bologna, Italy.
RP Focarete, ML (reprint author), Univ Bologna, Dept Chem G Ciamician, Via Selmi 2, I-40126 Bologna, Italy.
EM marialetizia.focarete@unibo.it
RI Focarete, Maria Letizia/B-2369-2009; Pasquinelli,
   Gianandrea/I-7088-2012; gualandi, chiara/A-5935-2015
OI Focarete, Maria Letizia/0000-0002-0458-7836; Pasquinelli,
   Gianandrea/0000-0003-1506-1829; gualandi, chiara/0000-0002-2020-1892;
   SOCCIO, MICHELINA/0000-0003-3646-9612; Govoni,
   Marco/0000-0002-1876-8101; LOTTI, NADIA/0000-0002-7976-2934
FU Regione Emilia Romagna (Programma di Ricerca Regione Universita, Area 1b
   "Medicina rigenerativa"); Spinner Consortium of Regione Emilia Romagna;
   Istituto Nazionale per le Ricerche Cardiovascolari (INRC)
FX This research was carried out with the financial support of Regione
   Emilia Romagna (Programma di Ricerca Regione Universita 2007-2009, Area
   1b "Medicina rigenerativa"). C.G. is the recipient of a fellowship
   awarded from the Spinner Consortium of Regione Emilia Romagna. The
   postdoctoral position filled by M.G. was open with the financial support
   of the Istituto Nazionale per le Ricerche Cardiovascolari (INRC) to E.G.
CR Amsden B, 2007, SOFT MATTER, V3, P1335, DOI 10.1039/b707472g
   Black J., 1998, HDB BIOMATERIAL PROP
   Blackwood KA, 2008, BIOMATERIALS, V29, P3091, DOI 10.1016/j.biomaterials.2008.03.037
   Bosworth LA, 2010, POLYM DEGRAD STABIL, V95, P2269, DOI 10.1016/j.polymdegradstab.2010.09.007
   Bruggeman JP, 2008, BIOMATERIALS, V29, P4726, DOI 10.1016/j.biomaterials.2008.08.037
   CHEN MS, 1990, J APPL POLYM SCI, V40, P1053, DOI 10.1002/app.1990.070400537
   Chew SY, 2007, ADV FUNCT MATER, V17, P1288, DOI 10.1002/adfm.200600441
   Cui WG, 2006, BIOMACROMOLECULES, V7, P1623, DOI 10.1021/bm060057z
   Deitzel JM, 2001, POLYMER, V42, P8163, DOI 10.1016/S0032-3861(01)00336-6
   Focarete ML, 2010, J BIOMAT SCI-POLYM E, V21, P1283, DOI 10.1163/092050609X12517190417597
   Foroni L, 2010, TISSUE ENG PART C-ME, V16, P751, DOI 10.1089/ten.TEC.2009.0316
   Fujimaki T, 1998, POLYM DEGRAD STABIL, V59, P209, DOI 10.1016/S0141-3910(97)00220-6
   Gopferich A, 1996, BIOMATERIALS, V17, P103, DOI 10.1016/0142-9612(96)85755-3
   GRIZZI I, 1995, BIOMATERIALS, V16, P305, DOI 10.1016/0142-9612(95)93258-F
   Guarino V, 2011, J BIOACT COMPAT POL, V26, P144, DOI 10.1177/0883911511399410
   Guelcher SA, 2008, TISSUE ENG PT B-REV, V14, P3, DOI 10.1089/teb.2007.0133
   Han XX, 2011, ACTA BIOMATER, V7, P538, DOI 10.1016/j.actbio.2010.09.005
   HESCHELER J, 1991, CIRC RES, V69, P1476, DOI 10.1161/01.RES.69.6.1476
   Huang ZM, 2004, POLYMER, V45, P5361, DOI 10.1016/j.polymer.2004.04.005
   Inoguchi H, 2006, BIOMATERIALS, V27, P1470, DOI 10.1016/j.biomaterials.2005.08.029
   Jawad H, 2007, J TISSUE ENG REGEN M, V1, P327, DOI 10.1002/term.46
   Jiang GJ, 2010, POLYM ENG SCI, V50, P2273, DOI 10.1002/pen.21686
   Khonakdar HA, 2009, MACROMOL MATER ENG, V294, P272, DOI 10.1002/mame.200800298
   Koh HS, 2008, BIOMATERIALS, V29, P3574, DOI 10.1016/j.biomaterials.2008.05.014
   Kumbar SG, 2008, BIOMED MATER, V3, DOI 10.1088/1748-6041/3/3/034002
   Li HY, 2005, MACROMOL BIOSCI, V5, P433, DOI 10.1002/mabi.200400183
   Li SM, 1999, J BIOMED MATER RES, V48, P342, DOI 10.1002/(SICI)1097-4636(1999)48:3<342::AID-JBM20>3.0.CO;2-7
   Lu H, 2009, J BIOACT COMPAT POL, V24, P158, DOI 10.1177/0883911509103559
   Lu L, 1999, J BIOMED MATER RES, V46, P236, DOI 10.1002/(SICI)1097-4636(199908)46:2<236::AID-JBM13>3.0.CO;2-F
   Marchese P, 2004, J POLYM SCI POL PHYS, V42, P2821, DOI 10.1002/polb.20156
   Marchese P, 2002, MACROMOL CHEM PHYSIC, V203, P695, DOI 10.1002/1521-3935(20020301)203:4<695::AID-MACP695>3.0.CO;2-C
   Oliveira JT, 2008, TISSUE ENG PT A, V14, P1651, DOI 10.1089/ten.tea.2007.0307
   Ozawa T, 2002, CIRCULATION, V106, pI176, DOI 10.1161/01.cir.0000032901.55215.cc
   Pego AP, 2003, TISSUE ENG, V9, P981, DOI 10.1089/107632703322495628
   Puppi D, 2011, J BIOACT COMPAT POL, V26, P20, DOI 10.1177/0883911510392007
   Rehfeldt F, 2007, ADV DRUG DELIVER REV, V59, P1329, DOI 10.1016/j.addr.2007.08.007
   Serrano MC, 2010, ADV FUNCT MATER, V20, P192, DOI 10.1002/adfm.200901040
   Shin M, 2004, BIOMATERIALS, V25, P3717, DOI 10.1016/j.biomaterials.2003.10.055
   Soccio M, 2008, EUR POLYM J, V44, P1722, DOI 10.1016/j.eurpolymj.2008.03.022
   Soccio M, 2009, EUR POLYM J, V45, P3234, DOI 10.1016/j.eurpolymj.2009.07.017
   Stitzel J, 2006, BIOMATERIALS, V27, P1088, DOI 10.1016/j.biomaterials.2005.07.048
   Vert M, 1997, ANGEW MAKROMOL CHEM, V247, P239, DOI 10.1002/apmc.1997.052470116
   von Burkersroda F, 2002, BIOMATERIALS, V23, P4221, DOI 10.1016/S0142-9612(02)00170-9
   Xu J, 2010, BIOTECHNOL J, V5, P1149, DOI 10.1002/biot.201000136
   Yin DZ, 2007, J BIOACT COMPAT POL, V22, P143, DOI 10.1177/0883911506076063
   Zahedi P, 2010, POLYM ADVAN TECHNOL, V21, P77, DOI 10.1002/pat.1625
   Zhong X, 2003, POLYMER, V44, P4959
   Zong XH, 2005, BIOMATERIALS, V26, P5330, DOI 10.1016/j.biomaterials.2005.01.052
   Zong XH, 2003, BIOMACROMOLECULES, V4, P416, DOI 10.1021/bm025717o
NR 49
TC 24
Z9 24
U1 1
U2 35
PU SAGE PUBLICATIONS LTD
PI LONDON
PA 1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND
SN 0883-9115
J9 J BIOACT COMPAT POL
JI J. Bioact. Compat. Polym.
PD MAY
PY 2012
VL 27
IS 3
BP 244
EP 264
DI 10.1177/0883911512440536
PG 21
WC Biotechnology & Applied Microbiology; Materials Science, Biomaterials;
   Polymer Science
SC Biotechnology & Applied Microbiology; Materials Science; Polymer Science
GA 935EI
UT WOS:000303501400005
DA 2018-10-19
ER

PT J
AU Janis, AD
   Johnson, CC
   Ernst, DM
   Brightman, AO
AF Janis, Abram Daved
   Johnson, Chad C.
   Ernst, David M.
   Brightman, Andrew O.
TI Structural Characteristics of Small Intestinal Submucosa Constructs
   Dictate In Vivo Incorporation and Angiogenic Response
SO JOURNAL OF BIOMATERIALS APPLICATIONS
LA English
DT Article
DE biomaterial; extracellular matrix; angiogenesis; degradable; small
   intestinal submucosa
ID ACELLULAR BOVINE PERICARDIA; ENDOTHELIAL-CELL ADHERENCE;
   EXTRACELLULAR-MATRIX; CROSS-LINKING; PORE-SIZE; MECHANICAL-PROPERTIES;
   BIOLOGICAL TISSUE; POROUS STRUCTURES; ARTIFICIAL SKIN; SCAR FORMATION
AB The rate of angiogenesis and cellular infiltration into degradable biomaterials determines scaffold persistence in vivo. The ability to tune the degradation properties of naturally derived biomaterials has been a popular goal in tissue engineering, yet has often depended on chemical crosslinking. Small intestinal submucosa (SIS) is a naturally derived, collagen-based, bioactive scaffold that has broad clinical success in many therapeutic applications. Two methods for producing multilayer, non-crosslinked SIS constructs were compared in vitro and in vivo. Traditional and cryo SEM, mercury intrusion porosimetry, and a novel enzymatic degradation assay determined that lyophilization produced an open, porous scaffold, in contrast to the collapsed, denser structure of SIS constructs produced using a vacuum press process. The angiogenic responses to lyophilized and vacuum-pressed SIS constructs were evaluated in vivo using a subcutaneous implant assay in mice. Explanted samples were compared after 7 and 21 days using fluorescence microangiography and light microscopy. Capacity of the implant neovasculature was also determined. These experiments revealed that the lyophilized SIS was infiltrated and vascularized more rapidly than the vacuum pressed. These data demonstrate the tunable incorporation of a non-crosslinked ECM-based biomaterial, which may have implications for the persistence of this degradable scaffold in tissue engineering.
C1 [Janis, Abram Daved; Johnson, Chad C.; Ernst, David M.] Cook Biotech Inc, W Lafayette, IN 47906 USA.
   [Brightman, Andrew O.] Purdue Univ, Weldon Sch Biomed Engn, W Lafayette, IN 47907 USA.
RP Johnson, CC (reprint author), Cook Biotech Inc, 1425 Innovat Pl, W Lafayette, IN 47906 USA.
EM johnson@cookbiotech.com
FU Cook Biotech Incorporated
FX The authors like thank Melissa Bible and Amy Peterson at the Department
   of Biomedical Engineering, Purdue University for their assistance with
   the animal studies, as well as Debby Sherman at the Purdue Life Science
   Microscopy Facility for her assistance with scanning electron
   microscopy. This study was funded by Cook Biotech Incorporated.
CR Angele P, 2004, BIOMATERIALS, V25, P2831, DOI 10.1016/j.biomaterials.2003.09.066
   Badylak S, 2001, J SURG RES, V99, P282, DOI 10.1006/jsre.2001.6176
   Badylak S, 1999, BIOMATERIALS, V20, P2257, DOI 10.1016/S0142-9612(99)00156-8
   Barry JJA, 2004, BIOMATERIALS, V25, P3559, DOI 10.1016/j.biomaterials.2003.10.023
   BELLON JM, 1995, BIOMATERIALS, V16, P381, DOI 10.1016/0142-9612(95)98855-8
   Binzen E, 2004, CLIN HEMORHEOL MICRO, V30, P283
   Binzen E, 2003, CLIN HEMORHEOL MICRO, V28, P183
   Burugapalli K, 2004, J BIOMED MATER RES A, V68A, P210, DOI 10.1002/jbm.a.10117
   Carmeliet P, 2000, NAT MED, V6, P389, DOI 10.1038/74651
   Chang Y, 2004, TISSUE ENG, V10, P881, DOI 10.1089/1076327041348509
   COTE MF, 1992, BIOMATERIALS, V13, P612, DOI 10.1016/0142-9612(92)90029-N
   Courtman DW, 2001, J BIOMED MATER RES, V55, P576, DOI 10.1002/1097-4636(20010615)55:4<576::AID-JBM1051>3.0.CO;2-9
   Cox S, 2004, TISSUE ENG, V10, P942, DOI 10.1089/1076327041348392
   DAGALAKIS N, 1980, J BIOMED MATER RES, V14, P511, DOI 10.1002/jbm.820140417
   De Aza PN, 2003, BIOMATERIALS, V24, P1437, DOI 10.1016/S0142-9612(02)00530-6
   Dejardin LM, 1999, J BIOMED MATER RES, V46, P203, DOI 10.1002/(SICI)1097-4636(199908)46:2<203::AID-JBM9>3.0.CO;2-4
   Demirbilek S, 2003, PEDIATR SURG INT, V19, P588, DOI 10.1007/s00383-003-1025-2
   FERRAND BK, 1993, J BIOMED MATER RES, V27, P1235, DOI 10.1002/jbm.820271004
   Franklin M E Jr, 2004, Hernia, V8, P186
   Freytes DO, 2004, BIOMATERIALS, V25, P2353, DOI 10.1016/j.biomaterials.2003.09.015
   Hench LL, 2002, SCIENCE, V295, P1014, DOI 10.1126/science.1067404
   Hodde J, 2002, TISSUE ENG, V8, P295, DOI 10.1089/107632702753725058
   Hodde J P, 1996, Tissue Eng, V2, P209, DOI 10.1089/ten.1996.2.209
   Hodde JP, 2002, TISSUE ENG, V8, P225, DOI 10.1089/107632702753724996
   Hodde JP, 2001, ENDOTHELIUM-NEW YORK, V8, P11, DOI 10.3109/10623320109063154
   Hodde JP, 2001, WOUNDS, V13, P195
   Iivanainen E, 2003, MICROSC RES TECHNIQ, V60, P13, DOI 10.1002/jemt.10238
   Johnson C, 2004, CIRC RES, V94, P262, DOI 10.1161/01.RES.0000111527.42357.62
   Kim SH, 2000, J BIOMED MATER RES, V53, P258, DOI 10.1002/(SICI)1097-4636(2000)53:3<258::AID-JBM11>3.3.CO;2-F
   Klinge U, 2002, J SURG RES, V103, P208, DOI 10.1006/jsre.2002.6358
   Lee JE, 2001, YONSEI MED J, V42, P172, DOI 10.3349/ymj.2001.42.2.172
   Lee SJ, 2004, J BIOMAT SCI-POLYM E, V15, P1003, DOI 10.1163/1568562041526487
   Liang HC, 2004, BIOMATERIALS, V25, P3541, DOI 10.1016/j.biomaterials.2003.09.109
   Linn T, 2003, CELL TRANSPLANT, V12, P769, DOI 10.3727/000000003108747244
   Ma L, 2004, BIOMATERIALS, V25, P2997, DOI 10.1016/j.biomaterials.2003.09.092
   Marneros AG, 2001, MATRIX BIOL, V20, P337, DOI 10.1016/S0945-053X(01)00151-2
   McDevitt CA, 2003, J BIOMED MATER RES A, V67A, P637, DOI 10.1002/jbm.a.10144
   Mostow EN, 2005, J VASC SURG, V41, P837, DOI 10.1016/j.jvs.2005.01.042
   Murphy WL, 2004, J DENT RES, V83, P204, DOI 10.1177/154405910408300304
   Nehls V, 1996, MICROVASC RES, V51, P347, DOI 10.1006/mvre.1996.0032
   NIMNI ME, 1987, J BIOMED MATER RES, V21, P741, DOI 10.1002/jbm.820210606
   O'Brien FJ, 2005, BIOMATERIALS, V26, P433, DOI 10.1016/j.biomaterials.2004.02.052
   Pierres A., 2002, European Cells & Materials, V3, P31
   Ratner BD, 2004, ANNU REV BIOMED ENG, V6, P41, DOI 10.1146/annurev.bioeng.6.040803.140027
   Rutner AB, 2003, UROLOGY, V62, P805, DOI 10.1016/S0090-4295(03)00664-2
   Sachlos E., 2003, European Cells & Materials, V5, P29
   Sachlos E, 2003, EUR CELLS MATER, V5, P39
   Sacks MS, 1999, J BIOMED MATER RES, V46, P1, DOI 10.1002/(SICI)1097-4636(199907)46:1<1::AID-JBM1>3.0.CO;2-7
   Salem AK, 2002, J BIOMED MATER RES, V61, P212, DOI 10.1002/jbm.10195
   Salzmann DL, 1997, J BIOMED MATER RES, V34, P463, DOI 10.1002/(SICI)1097-4636(19970315)34:4<463::AID-JBM7>3.0.CO;2-I
   Sung HJ, 2004, BIOMATERIALS, V25, P5735, DOI 10.1016/j.biomaterials.2004.01.066
   Sung HW, 2001, J BIOMED MATER RES, V55, P538, DOI 10.1002/1097-4636(20010615)55:4<538::AID-JBM1047>3.3.CO;2-U
   Tomanek RJ, 2000, ANAT REC, V261, P126, DOI 10.1002/1097-0185(20000615)261:3<126::AID-AR7>3.0.CO;2-4
   Urech L, 2005, BIOMATERIALS, V26, P1369, DOI 10.1016/j.biomaterials.2004.04.045
   Ward WK, 2002, BIOMATERIALS, V23, P4185, DOI 10.1016/S0142-9612(02)00160-6
   Washburn EW, 1921, P NATL ACAD SCI USA, V7, P115, DOI 10.1073/pnas.7.4.115
   Wei HJ, 2005, BIOMATERIALS, V26, P1905, DOI 10.1016/j.biomaterials.2004.06.014
   WESOLOWSKI SA, 1961, SURGERY, V50, P91
   Whitson BA, 1998, J BIOMED MATER RES, V43, P277, DOI 10.1002/(SICI)1097-4636(199823)43:3<277::AID-JBM8>3.3.CO;2-M
   YANNAS IV, 1980, J BIOMED MATER RES, V14, P65, DOI 10.1002/jbm.820140108
   Yuan ZH, 2004, BIOMATERIALS, V25, P2161, DOI 10.1016/j.biomaterials.2003.08.060
   Zhang F, 2003, ANN PLAS SURG, V51, P488, DOI 10.1097/01.SAP.0000070648.65942.E6
   Zhang Z, 2004, BIOMATERIALS, V25, P177, DOI 10.1016/S0142-9612(03)00478-2
NR 63
TC 6
Z9 6
U1 7
U2 19
PU SAGE PUBLICATIONS LTD
PI LONDON
PA 1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND
SN 0885-3282
J9 J BIOMATER APPL
JI J. Biomater. Appl.
PD MAY
PY 2012
VL 26
IS 8
BP 1013
EP 1033
DI 10.1177/0885328210391688
PG 21
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 937HN
UT WOS:000303649700006
PM 21273257
DA 2018-10-19
ER

PT J
AU Kawano, PR
   Fugita, OEH
   Yamamoto, HA
   Quitzan, JG
   Padovani, C
   Amaro, JL
AF Kawano, Paulo Roberto
   Hidetoshi Fugita, Oscar Eduardo
   Yamamoto, Hamilto Akihissa
   Quitzan, Juliany Gomes
   Padovani, Carlos
   Amaro, Joao Luiz
TI Comparative Study Between Porcine Small Intestinal Submucosa and Buccal
   Mucosa in a Partial Urethra Substitution in Rabbits
SO JOURNAL OF ENDOUROLOGY
LA English
DT Article
ID HYPOSPADIAS REPAIR; BLADDER AUGMENTATION; COLLAGEN MATRIX;
   URINARY-TRACT; RECONSTRUCTION; REPLACEMENT; REGENERATION; STRICTURES;
   GRAFTS; MODEL
AB Purpose: Several urethral conditions may require tissue substitution. One collagen-base biomaterial that recently emerged as an option is small intestinal submucosa (SIS). The aim of this study was to compare the results of SIS and buccal mucosa for urethral substitution in rabbits.
   Materials and Methods: Thirty-six North Folk male rabbits were randomized into three groups. In all animals, a 10 x 5 mm urethral segment was excised, and the urethral defect was repaired using a one-layer SIS patch (group I [GI]); four-layer SIS (group II [GII]); or buccal mucosa (group III [GIII]). Urethrography was performed preoperatively and after 12 weeks. After sacrifice, graft retraction was objectively measured using Scion Image (R) computer analysis and by calculation of ellipse area. The grade of fibrosis, inflammatory reaction, vascular/epithelial regeneration, and collagen III/I ratio were analyzed by hematoxylin/eosin and Picrosirius red staining.
   Results: Urethrography confirmed a wide urethral caliber without any signs of strictures after surgery. Urethral fistulae was diagnosed in 8.3% of cases (1 animal each group). Average graft shrinkage was 55.2% in GI; 44.2% in GII; and 57.2% in GIII (p < 0.05). The intensity of chronic inflammation, fibrosis, epithelium regeneration, and neovascularization was similar in all groups (p > 0.05). Collagen III/I ratio was higher in GII (GI: 119.6; GII: 257.2 and GIII: 115.0); p < 0.01.
   Conclusions: The four-layer SIS is more advantageous than the one-layer SIS and buccal mucosa for urethral substitution in rabbits.
C1 [Kawano, Paulo Roberto; Hidetoshi Fugita, Oscar Eduardo; Yamamoto, Hamilto Akihissa; Quitzan, Juliany Gomes; Amaro, Joao Luiz] Sao Paulo State Univ UNESP, Dept Urol, Botucatu, SP, Brazil.
   [Padovani, Carlos] Sao Paulo State Univ UNESP, Dept Bioestat, Botucatu, SP, Brazil.
RP Kawano, PR (reprint author), Univ Estadual Paulista UNESP, Dept Urol, Campus & Botucatu,Dist Rubiao JR S-N, BR-18618970 Botucatu, SP, Brazil.
EM kawano@fmb.unesp.br
RI Amaro, Joao/D-8881-2012; Quitzan, Juliany/I-7867-2014; Padovani, Carlos
   Roberto/A-3656-2013
OI Padovani, Carlos Roberto/0000-0002-7719-9682; Amaro,
   Joao/0000-0003-3745-0761
CR ANWAR H, 1984, UROLOGY, V24, P583, DOI 10.1016/0090-4295(84)90107-9
   Atala A, 1999, J UROLOGY, V162, P1148, DOI 10.1016/S0022-5347(01)68105-9
   BASKIN LS, 1994, J UROLOGY, V151, P191, DOI 10.1016/S0022-5347(17)34915-7
   Bhargava S, 2004, BJU INT, V93, P1191, DOI 10.1111/j.1464-410X.2004.04860.x
   Chen F, 1999, UROLOGY, V54, P407, DOI 10.1016/S0090-4295(99)00179-X
   Chen F, 2000, WORLD J UROL, V18, P67, DOI 10.1007/s003450050012
   Cheng EY, 2000, WORLD J UROL, V18, P26, DOI 10.1007/PL00007071
   DESSANTI A, 1992, J UROLOGY, V147, P1081, DOI 10.1016/S0022-5347(17)37478-5
   DUCKETT JW, 1981, UROL CLIN N AM, V8, P503
   DUCKETT JW, 1995, J UROLOGY, V153, P1660, DOI 10.1016/S0022-5347(01)67497-4
   EHRLICH RM, 1989, J UROLOGY, V142, P626, DOI 10.1016/S0022-5347(17)38837-7
   El Kassaby A, 2008, J UROLOGY, V179, P1432, DOI 10.1016/j.juro.2007.11.101
   EWALT DH, 1992, J UROLOGY, V148, P544, DOI 10.1016/S0022-5347(17)36650-8
   Goepel M, 1996, EUR UROL, V29, P63
   Grossklaus DJ, 2001, J UROLOGY, V166, P636, DOI 10.1016/S0022-5347(05)66033-8
   Hafez AT, 2004, J UROLOGY, V171, P2489, DOI 10.1097/01.ju.0000125298.26997.84
   HAKKY SI, 1976, LANCET, V2, P1192
   Italiano G, 1997, UROL RES, V25, P137, DOI 10.1007/BF01037930
   Johanson B, 1953, ACTA CHIR SCAND, V176, P100
   Kropp B P, 1995, Urology, V46, P396, DOI 10.1016/S0090-4295(99)80227-1
   Kropp BP, 1998, UROLOGY, V52, P138, DOI 10.1016/S0090-4295(98)00114-9
   Kropp BP, 1998, WORLD J UROL, V16, P262, DOI 10.1007/s003450050064
   Kropp BP, 1996, J UROLOGY, V155, P2098, DOI 10.1016/S0022-5347(01)66117-2
   Liatsikos EN, 2001, J UROLOGY, V165, P1719, DOI 10.1016/S0022-5347(05)66401-4
   MCANINCH JW, 1993, J UROLOGY, V149, P488, DOI 10.1016/S0022-5347(17)36125-6
   Merguerian PA, 2000, BJU INT, V85, P894, DOI 10.1046/j.1464-410x.2000.00513.x
   Nuininga JE, 2003, EUR UROL, V44, P266, DOI 10.1016/S0302-2838(03)00249-5
   OLSEN L, 1992, SCAND J UROL NEPHROL, V26, P323, DOI 10.3109/00365599209181220
   RANSLEY PG, 1987, J UROLOGY, V138, P1096, DOI 10.1016/S0022-5347(17)43512-9
   Shalhav AL, 1999, J ENDOUROL, V13, P241, DOI 10.1089/end.1999.13.241
   Sievert K, 1999, 3 WORLD C UR RES PAR
   Sievert KD, 2000, WORLD J UROL, V18, P19, DOI 10.1007/s003450050004
   Soergel TM, 2003, J UROLOGY, V170, P1577, DOI 10.1097/01.ju.0000083802.87337.af
   Sofer M, 2002, J ENDOUROL, V16, P27, DOI 10.1089/089277902753483682
   Sorber M, 1997, EUR UROL, V32, P475
   TAGUCHI H, 1977, J UROLOGY, V118, P752, DOI 10.1016/S0022-5347(17)58181-1
   TSUJI I, 1967, J UROLOGY, V98, P91, DOI 10.1016/S0022-5347(17)62828-3
   TURNERWARWICK R, 1968, J UROLOGY, V100, P303, DOI 10.1016/S0022-5347(17)62525-4
   Yao LY, 1996, J UROLOGY, V156, P565
NR 39
TC 4
Z9 4
U1 0
U2 5
PU MARY ANN LIEBERT INC
PI NEW ROCHELLE
PA 140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA
SN 0892-7790
J9 J ENDOUROL
JI J. Endourol.
PD MAY
PY 2012
VL 26
IS 5
BP 427
EP 432
DI 10.1089/end.2011.0174
PG 6
WC Urology & Nephrology
SC Urology & Nephrology
GA 933YQ
UT WOS:000303403600001
PM 22191704
DA 2018-10-19
ER

PT J
AU Rosalbino, F
   Delsante, S
   Borzone, G
   Scavino, G
AF Rosalbino, F.
   Delsante, S.
   Borzone, G.
   Scavino, G.
TI Influence of noble metals alloying additions on the corrosion behaviour
   of titanium in a fluoride-containing environment
SO JOURNAL OF MATERIALS SCIENCE-MATERIALS IN MEDICINE
LA English
DT Article
ID ELECTROCHEMICAL IMPEDANCE SPECTROSCOPY; DENTAL IMPLANT APPLICATIONS;
   TI-TA ALLOYS; COMMERCIALLY PURE TITANIUM; LONG-TERM IMMERSION;
   BIOMEDICAL APPLICATIONS; MECHANICAL-PROPERTIES; ARTIFICIAL SALIVA;
   MEDICAL IMPLANTS; TI-6AL-7NB ALLOY
AB Titanium alloys exhibit excellent corrosion resistance in most aqueous media due to the formation of a stable oxide film, and some of these alloys (particularly Ti-6Al-7Nb) have been chosen for surgical and odontological implants for their resistance and biocompatibility. Treatment with fluorides (F-) is known to be the main method for preventing plaque formation and dental caries. Toothpastes, mouthwashes, and prophylactic gels can contain from 200 to 20,000 ppm F- and can affect the corrosion behaviour of titanium alloy devices present in the oral cavity. In this work, the electrochemical corrosion behaviour of Ti-1M alloys (M = Ag, Au, Pd, Pt) was assessed in artificial saliva of pH = 3.0 containing 910 ppm F- (0.05 M NaF) through open circuit potential, E-OC, and electrochemical impedance spectroscopy (EIS) measurements. The corrosion behaviour of the Ti-6Al-7Nb commercial alloy was also evaluated for comparison. E (OC) measurements show an active behaviour for all the titanium alloys in fluoridated acidified saliva due to the presence of significant concentrations of HF and HF2 (-) species that dissolve the spontaneous air-formed oxide film giving rise to surface activation. However, an increase in stability of the passive oxide layer and consequently a decrease in surface activation is observed for the Ti-1M alloys. This behaviour is confirmed by EIS measurements. In fact, the Ti-6Al-7Nb alloy exhibits lower impedance values as compared with Ti-1M alloys, the highest values being measured for the Ti-1Au alloy. The experimental results show that the corrosion resistance of the studied Ti-1M alloys is similar to or better than that of Ti-6Al-7Nb alloy currently used as biomaterial, suggesting their potential for dental applications.
C1 [Rosalbino, F.; Scavino, G.] Politecn Torino, Dipartimento Sci Mat & Ingn Chim DICHI, I-10129 Turin, Italy.
   [Delsante, S.; Borzone, G.] Univ Genoa, DCCI, Consorzio INSTM, UdR Genova, I-16146 Genoa, Italy.
RP Rosalbino, F (reprint author), Politecn Torino, Dipartimento Sci Mat & Ingn Chim DICHI, Duca Abruzzi 24, I-10129 Turin, Italy.
EM francesco.rosalbino@polito.it
OI scavino, giorgio/0000-0002-7832-1117
CR AITCHISON I, 1972, CORROSION-US, V28, P83, DOI 10.5006/0010-9312-28.3.83
   Al-Mayouf AM, 2004, MATER CORROS, V55, P524, DOI 10.1002/maco.200303770
   Al-Mayouf AM, 2004, MATER CORROS, V55, P88, DOI 10.1002/maco.200303697
   ASM International, 1993, ASM HDB, V2
   Assis SL, 2007, MATER CORROS, V58, P329, DOI 10.1002/maco.200604027
   Assis S.L.d., 2006, ELECTROCHIM ACTA, V51, P1815, DOI DOI 10.1016/J.ELECTACTA.2005.02.121
   Aziz-Kerrzo M, 2001, BIOMATERIALS, V22, P1531, DOI 10.1016/S0142-9612(00)00309-4
   Azumi K, 2000, CORROS SCI, V42, P885, DOI 10.1016/S0010-938X(99)00096-7
   Bombac D, 2007, RMZ MAT GEOENVIRON, V54, P471
   Braemer W, 2001, ADV ENG MATER, V3, P753, DOI 10.1002/1527-2648(200110)3:10<753::AID-ADEM753>3.0.CO;2-G
   Cattarin S, 2002, J ELECTROCHEM SOC, V149, P457
   Cui CY, 2008, J ALLOY COMPD, V471, P248
   DAVIDSON JA, 1994, BIO-MED MATER ENG, V4, P231
   de Mele MFL, 2000, J APPL ELECTROCHEM, V30, P95
   Dillon C.P., 1998, MATER PERFORMANCE, V7, P69
   Eisenbarth E, 2004, BIOMATERIALS, V25, P5705, DOI 10.1016/j.biomaterials.2004.01.021
   ELAGLI K, 1993, ELECTROCHIM ACTA, V38, P1769, DOI 10.1016/0013-4686(93)85075-A
   Fischer J, 2000, J BIOMED MATER RES, V52, P678, DOI 10.1002/1097-4636(20001215)52:4<678::AID-JBM12>3.0.CO;2-P
   Fovet Y, 2001, TALANTA, V53, P1053, DOI 10.1016/S0039-9140(00)00592-0
   Frateur I, 2000, J ELECTROANAL CHEM, V482, P202, DOI 10.1016/S0022-0728(00)00050-4
   Gluszek J, 1997, BIOMATERIALS, V18, P789
   Godley R, 2006, J MATER SCI-MATER M, V17, P63, DOI 10.1007/s10856-006-6330-6
   Gonzalez JEG, 1999, J ELECTROANAL CHEM, V471, P109, DOI 10.1016/S0022-0728(99)00260-0
   Gudic S, 2002, ELECTROCHIM ACTA, V47, P3009, DOI 10.1016/S0013-4686(02)00246-3
   Hanawa T, 2006, MATER SCI FORUM, V512, P243, DOI 10.4028/www.scientific.net/MSF.512.243
   Ho WF, 2008, J MATER SCI-MATER M, V19, P3179, DOI 10.1007/s10856-008-3454-x
   Huang HH, 2002, ELECTROCHIM ACTA, V47, P2311, DOI 10.1016/S0013-4686(02)00079-8
   Ibris N, 2002, J ELECTROANAL CHEM, V526, P53, DOI 10.1016/S0022-0728(02)00814-8
   Ikeda M, 2002, METALL MATER TRANS A, V33, P487, DOI 10.1007/s11661-002-0110-9
   Jablokov V.R., 2005, J ASTM INT, V2, P491
   Khan MA, 1999, BIOMATERIALS, V20, P631, DOI 10.1016/S0142-9612(98)00217-8
   Kikuchi M, 2006, DENT MATER, V22, P641, DOI 10.1016/j.dental.2005.05.015
   Kim TI, 1997, BIO-MED MATER ENG, V7, P253
   Kobayashi E, 1998, J MATER SCI-MATER M, V9, P567, DOI 10.1023/A:1008909408948
   Kondo R, 2010, MAT SCI ENG C, V31, P900
   KONONEN MHO, 1995, DENT MATER, V11, P269, DOI 10.1016/0109-5641(95)80061-1
   Kumar S, 2008, J DENT, V36, P500, DOI 10.1016/j.jdent.2008.03.007
   Kuroda D, 1998, MAT SCI ENG A-STRUCT, V243, P244, DOI 10.1016/S0921-5093(97)00808-3
   Lavos-Valereto IC, 2004, J MATER SCI-MATER M, V15, P55, DOI 10.1023/B:JMSM.0000010097.86245.74
   Leyens C, 1999, TITANIUM TITANIUM AL
   Long M, 1998, BIOMATERIALS, V19, P1621, DOI 10.1016/S0142-9612(97)00146-4
   Mabilleau G, 2006, ACTA BIOMATER, V2, P121, DOI 10.1016/j.actbio.2005.09.004
   Matono Y., 2008, PROSTHODONT RES PRAC, V7, P34
   Nakagawa M, 2005, BIOMATERIALS, V26, P2239, DOI 10.1016/j.biomaterials.2004.07.022
   Nakagawa M, 2001, Dent Mater J, V20, P305
   Nakagawa M, 1999, J DENT RES, V78, P1568, DOI 10.1177/00220345990780091201
   Niinomi M, 2008, J MECH BEHAV BIOMED, V1, P30, DOI 10.1016/j.jmbbm.2007.07.001
   Noguchi T, 2008, DENT MATER J, V27, P117, DOI 10.4012/dmj.27.117
   Okazaki Y, 1996, MAT SCI ENG A-STRUCT, V213, P138, DOI 10.1016/0921-5093(96)10247-1
   Okazaki Y, 2005, BIOMATERIALS, V26, P11, DOI 10.1016/j.biomaterials.2004.02.005
   Oliveira NTC, 2008, CORROS SCI, V50, P938, DOI 10.1016/j.corsci.2007.09.009
   Oliveira NTC, 2009, ACTA BIOMATER, V5, P399, DOI 10.1016/j.actbio.2008.07.010
   Osorio WR, 2007, ELECTROCHIM ACTA, V52, P3265, DOI 10.1016/j.electacta.2006.10.004
   Pan J, 1996, ELECTROCHIM ACTA, V41, P1143, DOI 10.1016/0013-4686(95)00465-3
   Popa MV, 2004, ELECTROCHIM ACTA, V49, P2113, DOI 10.1016/j.electacta.2003.12.036
   Pourbaix M, 1966, ATLAS ELECTROCHEMICA
   Qiang Y, 2007, T NONFERR METAL SOC, V17, P1417, DOI 10.1016/S1003-6326(07)60287-8
   Rao S, 1997, MAT SCI ENG C-BIO S, V4, P311, DOI 10.1016/S0928-4931(97)00016-7
   Reclaru L, 1998, BIOMATERIALS, V19, P85, DOI 10.1016/S0142-9612(97)00179-8
   Robert GC, 1992, DENT MAT PROPERTIES
   Robin A, 2007, MATER CORROS, V58, P173, DOI 10.1002/maco.200604004
   Rosifini Alves Rezende MC, 2007, J MATER SCI-MATER M, V18, P149
   Schiff N, 2002, BIOMATERIALS, V23, P1995, DOI 10.1016/S0142-9612(01)00328-3
   Shim HM, 2005, J BIOMED MATER RES B, V73B, P252, DOI 10.1002/jbm.b.30206
   Shukla AK, 2005, INTERMETALLICS, V13, P631, DOI 10.1016/j.intermet.2004.10.001
   Sittig C, 1999, J MATER SCI-MATER M, V10, P191, DOI 10.1023/A:1008997726370
   Souza MEP, 2007, SURF COAT TECH, V201, P7775, DOI 10.1016/j.surfcoat.2007.03.005
   SPURRIER J, 1972, CORROSION, V28, P453, DOI 10.5006/0010-9312-28.12.453
   Takahashi M, 2005, INT C SER, V1284, P326
   Takemoto S, 2005, BIOMATERIALS, V26, P829, DOI 10.1016/j.biomaterials.2004.03.025
   ToumelinChemla F, 1996, J DENT, V24, P109, DOI 10.1016/0300-5712(95)00033-X
   Trillo EA, 2001, J MATER SCI-MATER M, V12, P283, DOI 10.1023/A:1011210101895
   Wagner C, 1938, Z ELKTROCHEM ANGEW P, V44, P391
   Williams DF, 2008, BIOMATERIALS, V29, P2941, DOI 10.1016/j.biomaterials.2008.04.023
   Yamazoe J, 2007, DENT MATER J, V26, P260, DOI 10.4012/dmj.26.260
   Zhou YL, 2008, J ALLOY COMPD, V466, P535, DOI 10.1016/j.jallcom.2007.11.090
   Zhou YL, 2008, MAT SCI ENG A-STRUCT, V483-84, P153, DOI 10.1016/j.msea.2006.09.173
   Zhou YL, 2009, MAT SCI ENG C-BIO S, V29, P1061, DOI 10.1016/j.msec.2008.09.012
   Zhou YL, 2005, MATER SCI FORUM, V475-479, P2309, DOI 10.4028/www.scientific.net/MSF.475-479.2309
   Zhou YL, 2005, MAT SCI ENG A-STRUCT, V398, P28, DOI 10.1016/j.msea.2005.03.032
   Zhou YL, 2004, MAT SCI ENG A-STRUCT, V371, P283, DOI 10.1016/j.msea.2003.12.011
NR 81
TC 18
Z9 18
U1 1
U2 26
PU SPRINGER
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 0957-4530
EI 1573-4838
J9 J MATER SCI-MATER M
JI J. Mater. Sci.-Mater. Med.
PD MAY
PY 2012
VL 23
IS 5
BP 1129
EP 1137
DI 10.1007/s10856-012-4591-9
PG 9
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 933JS
UT WOS:000303357600001
PM 22382735
DA 2018-10-19
ER

PT J
AU Yang, XY
   Zhang, L
   Chen, XY
   Sun, XL
   Yang, GJ
   Guo, XZ
   Yang, H
   Gao, CY
   Gou, ZR
AF Yang, Xianyan
   Zhang, Lei
   Chen, Xiaoyi
   Sun, Xiaoliang
   Yang, Guojing
   Guo, Xingzhong
   Yang, Hui
   Gao, Changyou
   Gou, Zhongru
TI Incorporation of B2O3 in CaO-SiO2-P2O5 bioactive glass system for
   improving strength of low-temperature co-fired porous glass ceramics
SO JOURNAL OF NON-CRYSTALLINE SOLIDS
LA English
DT Article
DE Boron doping; Low melting temperature; Degradation rate; Bioactive glass
   ceramics; Sol-gel
ID LIME-PHOSPHOSILICATE GLASSES; IN-VIVO; BONE; APATITE; 45S5; LAYER;
   CRYSTALLIZATION; DEGRADABILITY; BEHAVIOR; PHASE
AB Bioactive glass ceramics (BGCs) have different rates of biodegradation and mechanical properties depending on their chemical compositions and sintering temperatures. The present study was aimed to develop the boron-rich, phosphorus-low CaO-SiO2-P2O5-B2O3 bioactive glasses (BG-B-x, X = 0, 10, 20) potentially for improving the mechanical properties of BGCs via low-temperature co-fired process. The B2O3-free BG-B-0 shrunk well at similar to 726 degrees C and melted at over 1050 degrees C, while the onset shrinking and melting temperatures of the 20 mol% B2O3-doped BG-B-20 was lowered to similar to 648 degrees C and similar to 952 degrees C, respectively. The BG-B-20 thermally treated at 850-950 degrees C was transformed into wollastonite and calcium borate, and crystallization decreased the kinetics but did not inhibit the development of hydroxyapatite on their powder and disc surface when immersed in simulated body fluid. The in vitro degradation in Tris buffer confirmed that the degradation rate markedly increased with increasing boron content in BG-B-x. The compressive strength and flexural strength of the 10% BG-B-20-reinforced 4555 porous BGC sintered at 850 degrees C was nearly four times than that of 4555 porous constructs. These studies suggest that the boron-rich, phosphorus-low CaO-SiO2-P2O5-B2O3 system is a promising biomaterial and potential low temperature co-fired aid for improving the mechanical and biological properties of porous BGCs. (C) 2012 Elsevier B.V. All rights reserved.
C1 [Yang, Xianyan; Chen, Xiaoyi; Guo, Xingzhong; Yang, Hui; Gao, Changyou; Gou, Zhongru] Zhejiang Univ, Zhejiang California Int NanoSyst Inst, Hangzhou 310029, Zhejiang, Peoples R China.
   [Zhang, Lei; Sun, Xiaoliang; Yang, Guojing] Ruian Peoples Hosp, Ruian 325200, Peoples R China.
   [Zhang, Lei; Sun, Xiaoliang; Yang, Guojing] Wenzhou Med Coll, Hosp 3, Ruian 325200, Peoples R China.
RP Gou, ZR (reprint author), Zhejiang Univ, Zhejiang California Int NanoSyst Inst, Hangzhou 310029, Zhejiang, Peoples R China.
EM zhrgou@zju.edu.cn
OI Gao, Changyou/0000-0001-5084-7208
FU Zhejiang Provincial Natural Science Foundation of China [Y2090009];
   Health Bureau of Zhejiang Province Foundation [2010SSA005, 2011C33049];
   Science and Technology Bureau of Wenzhou City [H20080039, H20100076]
FX The authors would like to acknowledge the Zhejiang Provincial Natural
   Science Foundation of China (No. Y2090009), the Health Bureau of
   Zhejiang Province Foundation (2010SSA005 and 2011C33049) and the Science
   and Technology Bureau of Wenzhou City (H20080039 and H20100076).
CR ANDERSSON OH, 1990, J MATER SCI-MATER M, V1, P219, DOI 10.1007/BF00701080
   Arstila H, 2007, J EUR CERAM SOC, V27, P1543, DOI 10.1016/j.jeurceramsoc.2006.04.017
   Brink M, 1997, J BIOMED MATER RES, V36, P109, DOI 10.1002/(SICI)1097-4636(199707)36:1<109::AID-JBM13>3.3.CO;2-Q
   Cannillo V, 2009, J EUR CERAM SOC, V29, P611, DOI 10.1016/j.jeurceramsoc.2008.06.034
   Carlson ET, 1932, BUR STAND J RES, V9, P825
   Chen GH, 2009, J ALLOY COMPD, V478, P858, DOI 10.1016/j.jallcom.2008.11.163
   Chen QZ, 2011, ACTA BIOMATER, V7, P3616, DOI 10.1016/j.actbio.2011.06.005
   Chiang CC, 2008, J ALLOY COMPD, V461, P612, DOI 10.1016/j.jallcom.2007.07.073
   Clupper DC, 2004, J EUR CERAM SOC, V24, P2929, DOI 10.1016/S0955-2219(03)00363-7
   Dzondo-Gadet M, 2002, BIOL TRACE ELEM RES, V85, P23, DOI 10.1385/BTER:85:1:23
   Hakki SS, 2010, J TRACE ELEM MED BIO, V24, P243, DOI 10.1016/j.jtemb.2010.03.003
   Hamadouche M, 2001, J BIOMED MATER RES, V54, P560, DOI 10.1002/1097-4636(20010315)54:4<560::AID-JBM130>3.3.CO;2-A
   HENCH LL, 1991, J AM CERAM SOC, V74, P1487, DOI 10.1111/j.1151-2916.1991.tb07132.x
   Hoppe A, 2011, BIOMATERIALS, V32, P2757, DOI 10.1016/j.biomaterials.2011.01.004
   Huang WH, 2006, J MATER SCI-MATER M, V17, P583, DOI 10.1007/s10856-006-9220-z
   JEAN JH, 1992, J MATER SCI, V27, P1575, DOI 10.1007/BF00542920
   Karageorgiou V, 2005, BIOMATERIALS, V26, P5474, DOI 10.1016/j.biomaterials.2005.02.002
   KITSUGI T, 1986, J BIOMED MATER RES, V20, P1295, DOI 10.1002/jbm.820200906
   KITSUGI T, 1987, J BIOMED MATER RES, V21, P1255, DOI 10.1002/jbm.820211008
   KOKUBO T, 1990, J BIOMED MATER RES, V24, P721, DOI 10.1002/jbm.820240607
   Lee JH, 2011, J ORTHOP SCI, V16, P291, DOI 10.1007/s00776-011-0047-1
   Lee JH, 2010, DRUG CHEM TOXICOL, V33, P38, DOI 10.3109/01480540903373647
   Lee JH, 2006, J BIOMED MATER RES A, V77A, P362, DOI 10.1002/jbm.a.30594
   LI P, 1992, J MATER SCI-MATER M, V3, P452, DOI 10.1007/BF00701242
   Lucas-Girot A, 2011, J NON-CRYST SOLIDS, V357, P3322, DOI 10.1016/j.jnoncrysol.2011.06.002
   Ma J, 2010, COLLOID SURFACE B, V81, P87, DOI 10.1016/j.colsurfb.2010.06.022
   Ma J, 2010, CERAM INT, V36, P1911, DOI 10.1016/j.ceramint.2010.03.017
   Manupriya, 2007, J AM CERAM SOC, V90, P467, DOI 10.1111/j.1551-2916.2006.01449.x
   Mozafari M, 2010, J NON-CRYST SOLIDS, V356, P1470, DOI 10.1016/j.jnoncrysol.2010.04.040
   O'Donnell MD, 2008, J NON-CRYST SOLIDS, V354, P3554, DOI 10.1016/j.jnoncrysol.2008.03.034
   O'Donnell MD, 2010, ACTA BIOMATER, V6, P2382, DOI 10.1016/j.actbio.2010.01.006
   O'Donnell MD, 2009, J MATER SCI-MATER M, V20, P1611, DOI 10.1007/s10856-009-3732-2
   Peitl O, 1996, J BIOMED MATER RES, V30, P509
   Ryu HS, 2004, J BIOMED MATER RES A, V68A, P79, DOI 10.1002/jbm.a.20029
   Saranti A, 2006, J NON-CRYST SOLIDS, V352, P390, DOI 10.1016/j.jnoncrysol.2006.01.042
   Saravanapavan P, 2003, J BIOMED MATER RES A, V66A, P110, DOI 10.1002/jbm.a.10532
   Sepulveda P., 2001, J BIOMED MATER RES, V59, P40
   Shu C, 2010, MAT SCI ENG C-MATER, V30, P105, DOI 10.1016/j.msec.2009.09.006
   Sponer P, 2009, ARCH ORTHOP TRAUM SU, V129, P1353, DOI 10.1007/s00402-009-0839-3
   Valimaki VV, 2006, SCAND J SURG, V95, P95
   Vallet-Regi M, 1999, J MATER CHEM, V9, P515, DOI 10.1039/a808679f
   Vedel E., 2008, EUR J GLASS SCI TE A, V50, P9
   Xu S, 2008, BIOMATERIALS, V29, P2588, DOI 10.1016/j.biomaterials.2008.03.013
   Zhang D., 2008, GLASS TECHN EURO J A, V50, P1
NR 44
TC 45
Z9 47
U1 4
U2 52
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0022-3093
EI 1873-4812
J9 J NON-CRYST SOLIDS
JI J. Non-Cryst. Solids
PD MAY 1
PY 2012
VL 358
IS 9
BP 1171
EP 1179
DI 10.1016/j.jnoncrysol.2012.02.005
PG 9
WC Materials Science, Ceramics; Materials Science, Multidisciplinary
SC Materials Science
GA 935AV
UT WOS:000303490300002
DA 2018-10-19
ER

PT J
AU Li, GH
   Liu, H
   Li, TD
   Wang, JY
AF Li, Guohong
   Liu, Hong
   Li, TianDuo
   Wang, Jiyang
TI Surface modification and functionalization of silk fibroin fibers/fabric
   toward high performance applications
SO MATERIALS SCIENCE & ENGINEERING C-MATERIALS FOR BIOLOGICAL APPLICATIONS
LA English
DT Review
DE Silk; Modification; Functionalization; Improved properties
ID BOMBYX-MORI SILK; INDUCED ARGON PLASMA; SCALED HYDROXYAPATITE/POLYMER
   COMPOSITE; VUV EXCIMER LAMP; METHYL-METHACRYLATE; CHEMICAL-MODIFICATION;
   ATMOSPHERIC-PRESSURE; MULBERRY SILK; SF6 PLASMA; 2-METHACRYLOYLOXYETHYL
   PHOSPHORYLCHOLINE
AB Silk from silkworms is composed of fibrous proteins with remarkable properties that have resulted in wide usage in the textile industry and as a biomaterial in the medical field. However, for some advanced applications, silk still has the disadvantages of wrinkling, photo-induced aging, deformation and even degradation caused by microorganism, biocompatibility problems. Based on sufficient supply of raw materials around the world and encouraged by the market demands for natural and smart materials, numerous attempts have been made in the surface modification and functionalization of silk fibroin fibers (SFFs) and silk fibroin fabric (SFF) using a wide range of functional materials and technology during last decade. Successful modification of silk may not only overcome its intrinsic shortcomings, but also enhance end-use performance. In this review, we summarize the recent progress of basic ideas, methodologies, and treatment techniques for surface modification and functionalization of SFF/SFFs with consideration of their enhanced properties and potential applications. Encouraged by achievements from experimental studies, the authors believe that such successes give silk products a promising future in both textile and biomaterial applications. (c) 2011 Elsevier B.V. All rights reserved.
C1 [Liu, Hong; Wang, Jiyang] Shandong Univ, State Key Lab Crystal Mat, Ctr Bio & Micro Nano Funct Mat, Jinan 250100, Peoples R China.
   [Li, Guohong; Li, TianDuo] Shandong Polytech Univ, Sch Chem & Pharmaceut Engn, Jinan 250353, Peoples R China.
RP Liu, H (reprint author), Shandong Univ, State Key Lab Crystal Mat, Ctr Bio & Micro Nano Funct Mat, 27 Shandanan Rd, Jinan 250100, Peoples R China.
EM hongliu@sdu.edu.cn
FU NSFC [50872070, 60974117, NSFDYS: 50925205, 50990303, IRG:50721002];
   Independent Innovation Foundation of Shandong University [2009JC011];
   Program of Introducing Talents of Discipline to Universities in China
   (111 program) [b06015]
FX This work was supported by the NSFC (50872070, 60974117, NSFDYS:
   50925205, Grant: 50990303, IRG:50721002), Independent Innovation
   Foundation of Shandong University (2009JC011), and the Program of
   Introducing Talents of Discipline to Universities in China (111 program
   No. b06015). The author wishes to express his gratitude to Bryan Baker
   for his valuable revision.
CR Altman GH, 2003, BIOMATERIALS, V24, P401, DOI 10.1016/S0142-9612(02)00353-8
   Altman GH, 2002, BIOMATERIALS, V23, P4131, DOI 10.1016/S0142-9612(02)00156-4
   Arai T, 2003, J APPL POLYM SCI, V89, P324, DOI 10.1002/app.12081
   Arai T, 2001, J APPL POLYM SCI, V82, P2832, DOI 10.1002/app.2137.abs
   Arai T, 2001, J APPL POLYM SCI, V79, P1756
   Arami M, 2007, J APPL POLYM SCI, V106, P267, DOI 10.1002/app.26492
   Baltova S, 1998, POLYM DEGRAD STABIL, V60, P53, DOI 10.1016/S0141-3910(97)00016-5
   Baltova S, 1998, POLYM DEGRAD STABIL, V60, P61, DOI 10.1016/S0141-3910(98)80027-X
   BERGONZO P, 1992, APPL SURF SCI, V54, P424, DOI 10.1016/0169-4332(92)90081-8
   Borcia G, 2006, SURF COAT TECH, V201, P3074, DOI 10.1016/j.surfcoat.2006.06.021
   Cai ZS, 2001, COLOR TECHNOL, V117, P161
   Chaivan P, 2005, SURF COAT TECH, V193, P356, DOI 10.1016/j.surfcoat.2004.08.144
   Chang SQ, 2008, MATER LETT, V62, P3447, DOI 10.1016/j.matlet.2008.02.074
   Chen GQ, 2006, J APPL POLYM SCI, V102, P424, DOI 10.1002/app.24064
   Chen JS, 2003, J BIOMED MATER RES A, V67A, P559, DOI 10.1002/jbm.a.10120
   Chen X, 2008, BIOMATERIALS, V29, P3683, DOI 10.1016/j.biomaterials.2008.05.017
   Chopra S, 1996, J TEXT I, V87, P542, DOI 10.1080/00405009608631356
   Colomban P, 2008, J RAMAN SPECTROSC, V39, P1749, DOI 10.1002/jrs.2031
   Das A, 2001, J APPL POLYM SCI, V81, P2633, DOI 10.1002/app.1707
   Das AM, 2009, IND ENG CHEM RES, V48, P9338, DOI 10.1021/ie9004755
   Davarpanah S, 2009, APPL SURF SCI, V255, P4171, DOI 10.1016/j.apsusc.2008.11.001
   Dong Q, 2005, J PHYS CHEM B, V109, P17429, DOI 10.1021/jp052826z
   Dubas ST, 2006, COLLOID SURFACE A, V289, P105, DOI 10.1016/j.colsurfa.2006.04.012
   Elsner C, 2006, APPL SURF SCI, V252, P3616, DOI 10.1016/j.apsusc.2005.05.071
   Fang KJ, 2008, J APPL POLYM SCI, V107, P2949, DOI 10.1002/app.27498
   Freddi G, 1996, J SOC DYERS COLOUR, V112, P191
   Freddi G, 2003, J BIOTECHNOL, V106, P101, DOI 10.1016/j.jbiotec.2003.09.006
   Freddi G, 1999, INT J BIOL MACROMOL, V24, P251, DOI 10.1016/S0141-8130(98)00087-7
   Furuzono T, 2004, J MATER SCI-MATER M, V15, P19, DOI 10.1023/B:JMSM.0000010093.39298.5a
   Furuzono T, 1999, J APPL POLYM SCI, V73, P2541, DOI 10.1002/(SICI)1097-4628(19990919)73:12<2541::AID-APP23>3.0.CO;2-5
   Furuzono T, 2000, BIOMATERIALS, V21, P327, DOI 10.1016/S0142-9612(99)00177-5
   Furuzono T, 2000, J BIOMED MATER RES, V50, P344, DOI 10.1002/(SICI)1097-4636(20000605)50:3<344::AID-JBM8>3.0.CO;2-D
   Gao X., 2008, B SERICULTURE, V39, P14
   Grath K.M., 1997, PROTEIN BASED MAT
   Guan JP, 2008, FIBER POLYM, V9, P438, DOI 10.1007/s12221-008-0070-9
   Guan JP, 2009, POLYM DEGRAD STABIL, V94, P450, DOI 10.1016/j.polymdegradstab.2008.10.024
   Gulrajani ML, 2008, J APPL POLYM SCI, V108, P614, DOI 10.1002/app.27584
   Gulrajani ML, 2000, INDIAN J FIBRE TEXT, V25, P69
   Han J, 2010, J NANOPART RES, V12, P347, DOI 10.1007/s11051-009-9622-1
   He JH, 2004, CHEM MATER, V16, P2656, DOI [10.1021/cm049548l, 10.1021/cm0495481]
   Hodak SK, 2008, APPL SURF SCI, V254, P4744, DOI 10.1016/j.apsusc.2008.01.110
   Inagaki N., 1996, PLASMA SURFACE MODIF
   Inoue S, 2000, J BIOL CHEM, V275, P40517, DOI 10.1074/jbc.M006897200
   Inouye K, 1998, J BIOCHEM BIOPH METH, V37, P159, DOI 10.1016/S0165-022X(98)00024-4
   Iriyama Y, 2002, J PHOTOPOLYM SCI TEC, V15, P299, DOI 10.2494/photopolymer.15.299
   Jiang S.X., 2009, FIBER POLYM, V106, P791
   Kameda T, 2006, MACROMOL MATER ENG, V291, P877, DOI 10.1002/mame.200600081
   Kaneko A, 2009, SEN-I GAKKAISHI, V65, P97
   Kardestuncer T, 2006, CLIN ORTHOP RELAT R, P234, DOI 10.1097/01.blo.0000205879.50834.fe
   Kato H., 1968, SILK PROCESSING TECH, P18
   Khan F, 2002, ADV POLYM TECH, V21, P132, DOI 10.1002/adv.10016
   Khan MMR, 2010, BIORESOURCE TECHNOL, V101, P8439, DOI 10.1016/j.biortech.2010.05.100
   Korematsu A, 2005, J MATER SCI-MATER M, V16, P67, DOI 10.1007/s10856-005-6448-y
   Kundu SC, 2008, PROG POLYM SCI, V33, P998, DOI 10.1016/j.progpolymsci.2008.08.002
   Lee KY, 2005, SURF COAT TECH, V193, P35, DOI 10.1016/j.surfcoat.2004.07.034
   Lee MS, 2006, J APPL POLYM SCI, V101, P3487, DOI 10.1002/app.24520
   Leon N. H., 1975, TEXT PROG, V7, P1
   Lewin M, 2007, HDB FIBER CHEM
   Li GH, 2011, J COLLOID INTERF SCI, V358, P307, DOI 10.1016/j.jcis.2011.02.053
   [李永强 LI Yongqiang], 2006, [纺织学报, Journal of Textile Research], V27, P8
   Liu HF, 2007, J BIOMED MATER RES B, V82B, P129, DOI 10.1002/jbm.b.30714
   Long JJ, 2008, PLASMA CHEM PLASMA P, V28, P701, DOI 10.1007/s11090-008-9153-z
   LOTZ B, 1979, BIOCHIMIE, V61, P205, DOI 10.1016/S0300-9084(79)80067-X
   Lu YH, 2007, FIBER POLYM, V8, P1, DOI 10.1007/BF02908152
   Lucas F., 1958, ADV PROTEIN CHEM SIL
   MACLAREN JA, 1981, WOOL SCI CHEM REACTI
   Maji TK, 2002, J APPL POLYM SCI, V84, P969, DOI 10.1002/app.10202
   MARSH RE, 1955, BIOCHIM BIOPHYS ACTA, V16, P1, DOI 10.1016/0006-3002(55)90178-5
   Meinel L, 2004, J BIOMED MATER RES A, V71A, P25, DOI 10.1002/jbm.a.30117
   Molina R, 2005, APPL SURF SCI, V252, P1417, DOI 10.1016/j.apsusc.2005.02.147
   Motta A., 1998, MISC PUBL NATL I SER, V23, P21
   MOY RL, 1991, AM FAM PHYSICIAN, V44, P2123
   Nimmanpipug P, 2008, MACROMOL SYMP, V264, P107, DOI 10.1002/masy.200850417
   Ojah R, 2007, J APPL POLYM SCI, V105, P2164, DOI 10.1002/app.25986
   Otterburn M.S., 1977, CHEM NATURAL PROTEIN
   Park BJ, 2007, SURF COAT TECH, V201, P5733, DOI 10.1016/j.surfcoat.2006.07.092
   Park DJ, 2008, SURF COAT TECH, V202, P5773, DOI 10.1016/j.surfcoat.2008.06.039
   Peng Q, 2006, J APPL POLYM SCI, V100, P1299, DOI 10.1002/app.23408
   Peng X.H., 2005, NEWSL SERICULT TEA, V121, P12
   Perez-Rigueiro J, 2000, POLYMER, V41, P8433, DOI 10.1016/S0032-3861(00)00179-8
   Periyasamy S, 2007, SURF COAT TECH, V201, P7286, DOI 10.1016/j.surfcoat.2007.01.038
   Periyasamy S, 2007, J APPL POLYM SCI, V103, P4102, DOI 10.1002/app.25558
   Periyasamy S., 2007, EUR POLYM J, V43, P4573, DOI DOI 10.1016/J.EURPOLYMJ.2007.07.014
   Poll HU, 2001, SURF COAT TECH, V142, P489, DOI 10.1016/S0257-8972(01)01055-6
   Potiyaraj P, 2007, MATER LETT, V61, P2464, DOI 10.1016/j.matlet.2006.09.039
   Prachayawarakorn J, 2007, J APPL POLYM SCI, V106, P1526, DOI 10.1002/app.26586
   Prachayawarakorn J, 2006, J APPL POLYM SCI, V100, P1169, DOI 10.1002/app.23216
   Rajkhowa R, 2011, J APPL POLYM SCI, V119, P1339, DOI 10.1002/app.31981
   Sargunamani D, 2006, POLYM DEGRAD STABIL, V91, P2644, DOI 10.1016/j.polymdegradstab.2006.05.001
   Selli E, 2001, MACROMOL CHEM PHYS, V202, P1672, DOI 10.1002/1521-3935(20010601)202:9<1672::AID-MACP1672>3.0.CO;2-W
   Seves A, 1998, INT BIODETER BIODEGR, V42, P203, DOI 10.1016/S0964-8305(98)00050-X
   Shang SM, 2009, FIBER POLYM, V10, P807, DOI 10.1007/s12221-009-0807-0
   Shao ZZ, 2002, NATURE, V418, P741, DOI 10.1038/418741a
   Shen L, 2007, APPL SURF SCI, V253, P5051, DOI 10.1016/j.apsusc.2006.11.027
   Su H. L., 2008, NANOTECHNOLOGY, V19, P1
   Suanpoot P, 2008, SURF COAT TECH, V202, P5543, DOI 10.1016/j.surfcoat.2008.06.086
   Svilokos Bianchi A, 1992, MELLIAND TEXTILBERIC, V73, P68
   Taddei P, 2003, J MOL STRUCT, V651, P433, DOI 10.1016/S0022-2860(02)00663-4
   Tanaka K, 1999, INSECT BIOCHEM MOLEC, V29, P269, DOI 10.1016/S0965-1748(98)00135-0
   Tao W, 2007, INT J BIOL MACROMOL, V40, P472, DOI 10.1016/j.ijbiomac.2006.11.006
   Tsukada M, 2003, J APPL POLYM SCI, V89, P638, DOI 10.1002/app.11911
   Tsukada M, 2001, J APPL POLYM SCI, V79, P1764, DOI 10.1002/1097-4628(20010307)79:10<1764::AID-APP40>3.0.CO;2-E
   Tsukada M., 1981, B SCI I TEXT FR, V10, P141
   Tsukada M., 2003, J APPL POLYM SCI, V78, P382
   Vankar PS, 2007, J CLEAN PROD, V15, P1441, DOI 10.1016/j.jclepro.2006.05.004
   Vepari C, 2007, PROG POLYM SCI, V32, P991, DOI 10.1016/j.progpolymsci.2007.05.013
   Wang CX, 2007, FIBER POLYM, V8, P225, DOI 10.1007/BF02875796
   Wang YZ, 2006, BIOMATERIALS, V27, P4434, DOI 10.1016/j.biomaterials.2006.03.050
   Wilding M. A., 1996, POLYM MAT ENCY, V11, P8307
   Xiang W, 2008, J APPL POLYM SCI, V108, P1005, DOI 10.1002/app.26990
   Yu T.Y., 2003, J FUDAN U NAT SCI, V44, P828
   ZHANG JY, 1993, APPL SURF SCI, V69, P299
   Zhao X., 2007, DYESTUFFS COLOR, V44, P23
   Zhou CZ, 2001, PROTEINS, V44, P119, DOI 10.1002/prot.1078
NR 114
TC 52
Z9 54
U1 7
U2 189
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0928-4931
J9 MAT SCI ENG C-MATER
JI Mater. Sci. Eng. C-Mater. Biol. Appl.
PD MAY 1
PY 2012
VL 32
IS 4
BP 627
EP 636
DI 10.1016/j.msec.2011.12.013
PG 10
WC Materials Science, Biomaterials
SC Materials Science
GA 932OB
UT WOS:000303299300001
DA 2018-10-19
ER

PT J
AU Jiang, LL
   Lu, X
   Leng, Y
   Qu, SX
   Feng, B
   Weng, J
   Watari, F
AF Jiang, Lili
   Lu, Xiong
   Leng, Yang
   Qu, Shuxin
   Feng, Bo
   Weng, Jie
   Watari, Fumio
TI Osteoblast behavior on TiO2 microgrooves prepared by soft-lithography
   and sol-gel methods
SO MATERIALS SCIENCE & ENGINEERING C-MATERIALS FOR BIOLOGICAL APPLICATIONS
LA English
DT Article
DE TiO2; Micropatterns; Osteoblasts; Surface energy
ID SUBSTRATUM SURFACE CHARACTERISTICS; DEFINED BIOMATERIAL SURFACES;
   CONNECTIVE-TISSUE RESPONSES; BONE-MARROW-CELLS; IN-VITRO;
   QUANTITATIVE-ANALYSIS; TITANIUM SUBSTRATA; DIFFERENT DIMENSIONS; GROOVED
   SUBSTRATA; TERM ADHESION
AB This study focused on the effects of microgrooved TiO2 surfaces on osteoblast behavior. Microgrooved TiO2 surfaces with different widths (12 mu m and 40 mu m) and flat surfaces were fabricated on glass substrates based on the combination of a sol-gel technique and soft-lithography. Osteoblasts (MC3T3-E1) were cultured on the as-prepared microgrooved and flat TiO2 surfaces. Optical microscopy and scanning electron microscopy were used to analyze the adherent cell behavior by examining the cell morphology. Orientation angle analysis indicated that the cells tended to align along the microgrooves. This tendency was stronger on the microgrooves with smaller widths and became weak with increasing width. Alamar Blue assay indicated that the microgrooves restricted cell proliferation and the alkaline phosphatase assay revealed that the microgrooves limited the differentiation rate. This restriction increased with decreasing microgroove width. The surface energy of the TiO2 surfaces was size-dependent and followed the order gamma (12 mu m) < gamma (40 mu m) < gamma (flat surfaces). Osteoblast proliferation and differentiation on the surface with high surface energy exhibited high proliferation and differentiation rates. These results indicated that surface energy appeared to be a dominant factor for cell activity. Thus, surface energy would be a valuable index for the cell compatibility of a micropatterned surface. (c) 2012 Elsevier B.V. All rights reserved.
C1 [Jiang, Lili; Lu, Xiong; Qu, Shuxin; Feng, Bo; Weng, Jie] SW Jiaotong Univ, Key Lab Adv Technol Mat, Minist Educ, Sch Mat Sci & Engn, Chengdu 610031, Sichuan, Peoples R China.
   [Leng, Yang] Hong Kong Univ Sci & Technol, Dept Mech Engn, Kowloon, Hong Kong, Peoples R China.
   [Lu, Xiong; Watari, Fumio] Hokkaido Univ, Grad Sch Dent Med, Dept Oral Hlth Sci, Sapporo, Hokkaido 0608586, Japan.
RP Lu, X (reprint author), SW Jiaotong Univ, Key Lab Adv Technol Mat, Minist Educ, Sch Mat Sci & Engn, Chengdu 610031, Sichuan, Peoples R China.
EM luxiong_2004@163.com
RI LU, xiong/B-3092-2010; Feng, Bo/B-3498-2010; Weng, Jie/B-3005-2010;
   Leng, Yang/B-3187-2010
OI LU, xiong/0000-0001-6367-430X; 
FU NSFC [31070851]; Program for New Century Excellent Talents in University
   [NCET-10-0704]; Sichuan Youth Science-Technology Foundation
   [2011JQ0010]; Fundamental Research Funds for the Central Universities
   [SWJTU11CX150]; National Basic Research Program of China (973 Program)
   [2012CB933602]
FX This project was financially supported by the NSFC (31070851), Program
   for New Century Excellent Talents in University (NCET-10-0704), Sichuan
   Youth Science-Technology Foundation (2011JQ0010), Fundamental Research
   Funds for the Central Universities (SWJTU11CX150), and National Basic
   Research Program of China (973 Program, 2012CB933602).
CR Advincula MC, 2006, BIOMATERIALS, V27, P2201, DOI 10.1016/j.biomaterials.2005.11.014
   Anselme K, 2000, BIOMATERIALS, V21, P667, DOI 10.1016/S0142-9612(99)00242-2
   Anselme K, 2006, J MATER SCI-MATER M, V17, P471, DOI 10.1007/s10856-006-8475-8
   Anselme K, 2005, ACTA BIOMATER, V1, P211, DOI 10.1016/j.actbio.2004.11.009
   Anselme K, 2010, J ADHES SCI TECHNOL, V24, P831, DOI 10.1163/016942409X12598231568186
   Ber S, 2005, BIOMATERIALS, V26, P1977, DOI 10.1016/j.biomaterials.2004.07.007
   BRUNETTE DM, 1986, EXP CELL RES, V164, P11, DOI 10.1016/0014-4827(86)90450-7
   BRUNETTE DM, 1986, EXP CELL RES, V167, P203, DOI 10.1016/0014-4827(86)90217-X
   Brunette DM, 1999, J BIOMECH ENG-T ASME, V121, P49, DOI 10.1115/1.2798042
   CHEHROUDI B, 1990, J BIOMED MATER RES, V24, P1203, DOI 10.1002/jbm.820240906
   CHEHROUDI B, 1992, J BIOMED MATER RES, V26, P493, DOI 10.1002/jbm.820260407
   Chen X, 2007, CHEM REV, V107, P2891, DOI 10.1021/cr0500535
   Cheng YT, 2005, APPL PHYS LETT, V87, DOI 10.1063/1.2130392
   CLARK P, 1991, J CELL SCI, V99, P73
   Curtis A, 1997, BIOMATERIALS, V18, P1573, DOI 10.1016/S0142-9612(97)00144-0
   denBraber ET, 1996, BIOMATERIALS, V17, P1093, DOI 10.1016/0142-9612(96)85910-2
   denBraber ET, 1996, BIOMATERIALS, V17, P2037, DOI 10.1016/0142-9612(96)00032-4
   DENBRABER ET, 1995, J BIOMED MATER RES, V29, P511, DOI 10.1002/jbm.820290411
   Falconnet D, 2006, BIOMATERIALS, V27, P3044, DOI 10.1016/j.biomaterials.2005.12.024
   Fu G, 2009, MAT SCI ENG C-MATER, V29, P2011, DOI 10.1016/j.msec.2009.03.017
   Geissler M, 2004, ADV MATER, V16, P1249, DOI 10.1002/adma.200400835
   Grew JC, 2008, J BIOMED MATER RES A, V85A, P326, DOI 10.1002/jbm.a.31378
   Hallab NJ, 2001, TISSUE ENG, V7, P55, DOI 10.1089/107632700300003297
   Huang HH, 2004, BIOMOL ENG, V21, P93, DOI 10.1016/j.bioeng.2004.05.001
   Ito Y, 1999, BIOMATERIALS, V20, P2333, DOI 10.1016/S0142-9612(99)00162-3
   Jiang LL, 2009, MAT SCI ENG C-MATER, V29, P2355, DOI 10.1016/j.msec.2009.06.005
   Kassem M, 2008, ARCH BIOCHEM BIOPHYS, V473, P183, DOI 10.1016/j.abb.2008.03.028
   Kenar H, 2008, J BIOMED MATER RES A, V85A, P1001, DOI 10.1002/jbm.a.31638
   Kenar H, 2006, BIOMATERIALS, V27, P885, DOI 10.1016/j.biomaterials.2005.07.001
   Khakbaznejad A, 2004, J BIOMED MATER RES A, V70A, P206, DOI 10.1002/jbm.a.30058
   KILPADI DV, 1994, J BIOMED MATER RES, V28, P1419, DOI 10.1002/jbm.820281206
   Kokubo T, 2007, J EUR CERAM SOC, V27, P1553, DOI 10.1016/j.jeurceramsoc.2006.04.015
   Kokubo T., 2009, J EUR CERAM SOC, P1267
   Lai HC, 2010, J BIOMED MATER RES A, V93A, P289, DOI 10.1002/jbm.a.32542
   Lee MH, 2010, BIOMATERIALS, V31, P3804, DOI 10.1016/j.biomaterials.2010.01.117
   Lee SW, 2009, CLIN ORAL IMPLAN RES, V20, P56, DOI 10.1111/j.1600-0501.2008.01597.x
   Lenhert S, 2005, BIOMATERIALS, V26, P563, DOI 10.1016/j.biomaterials.2004.02.068
   Liao HH, 2003, BIOMATERIALS, V24, P649, DOI 10.1016/S0142-9612(02)00379-4
   Lim JY, 2008, BIOMATERIALS, V29, P1776, DOI 10.1016/j.biomaterials.2007.12.026
   Lim JY, 2005, TISSUE ENG, V11, P19, DOI 10.1089/ten.2005.11.19
   Lim JY, 2004, J BIOMED MATER RES A, V68A, P504, DOI 10.1002/jbm.a.20087
   Liu XM, 2007, BIOMATERIALS, V28, P4535, DOI 10.1016/j.biomaterials.2007.06.016
   Liu YR, 2007, J ETHNOPHARMACOL, V111, P573, DOI 10.1016/j.jep.2007.01.005
   Lu X, 2003, J BIOMED MATER RES A, V66A, P677, DOI 10.1002/jbm.a.10022
   Lu X, 2008, J BIOMED MATER RES A, V84A, P523, DOI 10.1002/jbm.a.31471
   Lu X, 2009, J BIOMED MATER RES B, V90B, P438, DOI 10.1002/jbm.b.31304
   Magdon-Ismail F.S., 2007, J MATER SCI-MATER M, V18, P705
   Matsuzaka K, 1999, BIOMATERIALS, V20, P1293, DOI 10.1016/S0142-9612(99)00029-0
   Matsuzaka K, 2000, CLIN ORAL IMPLAN RES, V11, P325, DOI 10.1034/j.1600-0501.2000.011004325.x
   Matsuzaka K., 2003, BIOMATERIALS, V24, P711
   Perizzolo D, 2001, J BIOMED MATER RES, V56, P494, DOI 10.1002/1097-4636(20010915)56:4<494::AID-JBM1121>3.0.CO;2-X
   Ponsonnet L, 2003, MAT SCI ENG C-BIO S, V23, P551, DOI 10.1016/S0928-4931(03)00033-X
   Qu J, 1996, Oral Dis, V2, P102
   Ricci JL, 2008, J BIOMED MATER RES A, V85A, P313, DOI 10.1002/jbm.a.31379
   Rohanizadeh R, 2004, J BIOMED MATER RES A, V71A, P343, DOI 10.1002/jbm.a.30171
   SABOKBAR A, 1994, BONE MINER, V27, P57, DOI 10.1016/S0169-6009(08)80187-0
   Tan J, 2004, BIOMATERIALS, V25, P3593, DOI 10.1016/j.biomaterials.2003.10.034
   Wang CC, 1999, CHEM MATER, V11, P3113, DOI 10.1021/cm990180f
   Wang JHC, 2000, J BIOMECH, V33, P729, DOI 10.1016/S0021-9290(00)00013-0
   Wieland M, 2005, BIOMATERIALS, V26, P1119, DOI 10.1016/j.biomaterials.2004.04.020
   Xia YN, 1998, ANNU REV MATER SCI, V28, P153, DOI 10.1146/annurev.matsci.28.1.153
   Zhao G, 2005, J BIOMED MATER RES A, V74A, P49, DOI 10.1002/jbm.a.30320
   Zinger O, 2005, BIOMATERIALS, V26, P1837, DOI 10.1016/j.biomaterials.2004.06.035
NR 63
TC 8
Z9 9
U1 1
U2 33
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0928-4931
J9 MAT SCI ENG C-MATER
JI Mater. Sci. Eng. C-Mater. Biol. Appl.
PD MAY 1
PY 2012
VL 32
IS 4
BP 742
EP 748
DI 10.1016/j.msec.2012.01.017
PG 7
WC Materials Science, Biomaterials
SC Materials Science
GA 932OB
UT WOS:000303299300018
DA 2018-10-19
ER

PT J
AU Chen, FJ
   Porter, D
   Vollrath, F
AF Chen, Fujia
   Porter, David
   Vollrath, Fritz
TI Morphology and structure of silkworm cocoons
SO MATERIALS SCIENCE & ENGINEERING C-MATERIALS FOR BIOLOGICAL APPLICATIONS
LA English
DT Article
DE Silk; Cocoon; Biomaterial; Biological composites; Biomimetic
ID CODING NUCLEAR GENES; MECHANICAL-PROPERTIES; LEPIDOPTERA; SATURNIIDAE;
   COMPOSITE
AB Silkworm cocoons are natural polymer fibre composites made from silk fibres and sericin binder. While silk is an interesting natural material per se, an understanding of the role of silk within one of its main functional applications in silkworm cocoons will provide inspiration and tools for the design of new artificial silk composites. Here, we describe in some detail the structure and morphology of the cocoons of 27 different species of silkworm. While cocoon morphology can be described very broadly as a nonwoven fibre composite, we demonstrate a diversity of structural features such as: the number and connectivity of layers through the cocoon wall thickness, the amount and distribution of sericin binder, the diameter and packing density of the silk fibres, the degree of orientation of the nonwoven structure, the distribution of larger holes within that structure, and the presence of calcium oxalate crystals. (c) 2012 Elsevier B.V. All rights reserved.
C1 [Chen, Fujia; Porter, David; Vollrath, Fritz] Univ Oxford, Dept Zool, Oxford OX1 3PS, England.
RP Chen, FJ (reprint author), Univ Oxford, Dept Zool, S Parks Rd, Oxford OX1 3PS, England.
EM fujia.chen@zoo.ox.ac.uk
FU AFSOR, USA [F49620-03-1-0111]; European Research Council
   [SP2-GA-2008-233409]
FX We are grateful for Ms Juan Guan and Dr Chris Holland for help on
   compressive tests, Mr Maxime Boulet-Audet and Ms Imke Greving for
   instruction of FTIR tests, Mr Xiafu Shi and Mr Gwilym Davies for helping
   with the cocoon photographs. We particularly thank Prof Richard S.
   Peigler for checking the silkmoth species spelling. This project is
   funded by AFSOR (Grant No. F49620-03-1-0111), USA and European Research
   Council (SP2-GA-2008-233409).
CR ASTM, 1975, STAND METH MEAS TH D, V0-1777, P477
   Blossman-Myer B, 2010, COMP BIOCHEM PHYS A, V155, P259, DOI 10.1016/j.cbpa.2009.11.007
   Chen F, 2010, J MAT SCI ENG, V4, P28
   Chen F, 2010, PHYS REV E, V82, DOI 10.1103/PhysRevE.82.041911
   Danks HV, 2004, EUR J ENTOMOL, V101, P433, DOI 10.14411/eje.2004.062
   FREDDI G, 1994, J APPL POLYM SCI, V52, P775, DOI 10.1002/app.1994.070520608
   Hardy JG, 2010, PROG POLYM SCI, V35, P1093, DOI 10.1016/j.progpolymsci.2010.04.005
   Li Y, 2001, BIOMATERIALS, V22, P609, DOI 10.1016/S0142-9612(00)00224-6
   LOUNIBOS LP, 1975, ANIM BEHAV, V23, P843, DOI 10.1016/0003-3472(75)90109-8
   Porter D, 2009, ADV MATER, V21, P487, DOI 10.1002/adma.200801332
   Reddy N, 2010, J MATER SCI, V45, P4414, DOI 10.1007/s10853-010-4523-3
   Regier JC, 2002, INSECT SYST EVOL, V33, P9, DOI 10.1163/187631202X00028
   Regier JC, 2008, SYST ENTOMOL, V33, P219, DOI 10.1111/j.1365-3113.2007.00416.x
   Regier JC, 2008, SYST ENTOMOL, V33, P175, DOI 10.1111/j.1365-3113.2007.00409.x
   Rockwood DN, 2010, ACTA BIOMATER, V7, P144, DOI 10.1016/j.actbio.2010.07.020
   Silverstein R., 2005, INFRARED SPECTROMETR, P72
   Trouvelot L., 1867, AM NAT, P30
   Trouvelot L., 1867, AM NAT, P85
   Trouvelot L., 1867, AM NAT, P145
   Tuskes P.M., 1996, WILD SILK MOTHS N AM
   Van Der Kloot W.G., 1954, BEHAVIOUR, P233
   VANDERKLOOT WG, 1953, BEHAVIOUR, V5, P157, DOI 10.1163/156853953X00096
   VANDERKLOOT WG, 1953, BEHAVIOUR, V5, P141, DOI 10.1163/156853953X00087
   Vollrath F, 2009, POLYMER, V50, P5623, DOI 10.1016/j.polymer.2009.09.068
   Wang L, 2007, CARBOHYD POLYM, V68, P740, DOI 10.1016/j.carbpol.2006.08.010
   Weisman S, 2008, BIOMACROMOLECULES, V9, P3065, DOI 10.1021/bm8005853
   Wink W.A., 1983, SOLUTIONS BURLINGTON, P66
   Yagi N., 1926, J EXP ZOOL, P46
   Yuan QQ, 2010, POLYMER, V51, P4843, DOI 10.1016/j.polymer.2010.08.042
   Zhao HP, 2007, ENG FRACT MECH, V74, P1953, DOI 10.1016/j.engfracmech.2006.06.010
   Zhao HP, 2007, MAT SCI ENG C-BIO S, V27, P675, DOI 10.1016/j.msec.2006.06.031
   Zhao HP, 2005, POLYMER, V46, P9192, DOI 10.1016/j.polymer.2005.07.004
NR 32
TC 42
Z9 43
U1 4
U2 55
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0928-4931
J9 MAT SCI ENG C-MATER
JI Mater. Sci. Eng. C-Mater. Biol. Appl.
PD MAY 1
PY 2012
VL 32
IS 4
BP 772
EP 778
DI 10.1016/j.msec.2012.01.023
PG 7
WC Materials Science, Biomaterials
SC Materials Science
GA 932OB
UT WOS:000303299300022
DA 2018-10-19
ER

PT J
AU Zhu, HL
   Liu, N
   Feng, XX
   Chen, JY
AF Zhu, Hailin
   Liu, Na
   Feng, Xinxing
   Chen, Jianyong
TI Fabrication and characterization of silk fibroin/bioactive glass
   composite films
SO MATERIALS SCIENCE & ENGINEERING C-MATERIALS FOR BIOLOGICAL APPLICATIONS
LA English
DT Article
DE Nano bioactive glass; Silk fibroin; Composite film; Bioactivity
ID IN-VITRO; BIOACTIVE-GLASSES; GEL GLASSES; SCAFFOLDS; FIBROIN;
   ADSORPTION; SURFACE; GROWTH; POLYCAPROLACTONE; BIOMATERIALS
AB Composite films of silk fibroin (SF) with nano bioactive glass (NBG) were prepared by the solvent casting method, and the structures and properties of the composite films were characterized. Fourier transform infrared (FT-IR) spectroscopy analysis shows that the random coil and beta-sheet structure co-exist in the SF films. Results of field emission scanning electron microscope (FESEM) indicate that the NBG particles are uniformly dispersed in the SF films. The measurements of the water contact angles suggest that the incorporation of NBG into SF can improve the hydrophilicity of the composites. The bioactivity of the composite films was evaluated by soaking in 1.5 times simulated body fluid (1.5 x SBF), and formation of a hydroxycarbonate apatite (HCA) layer was determined by XRD and FESEM. The results show that the SF/NBG composite film is bioactive as it induces the formation of HCA on the surface of the composite film after soaking in 1.5 x SBF for 7 days. In vitro osteoblasts attachment and proliferation tests show that the composite film is a good matrix for the growth of osteoblasts. Consequently, the incorporation of NBG into the SF film can enhance both the bioactivity and biocompatibility of the film, which suggests that the SF/NBG composite film may be a potential biomaterial for bone tissue engineering. (c) 2012 Elsevier B.V. All rights reserved.
C1 [Zhu, Hailin; Liu, Na; Feng, Xinxing; Chen, Jianyong] Zhejiang Sci Tech Univ, Engn Res Ctr Ecodyeing & Finishing Text, Minist Educ, Hangzhou 310018, Peoples R China.
   [Zhu, Hailin] Zhejiang Sci Tech Univ, Dept Chem, Hangzhou 310018, Peoples R China.
RP Chen, JY (reprint author), Zhejiang Sci Tech Univ, Engn Res Ctr Ecodyeing & Finishing Text, Minist Educ, Hangzhou 310018, Peoples R China.
EM cjy@zstu.edu.cn
FU National Natural Science Foundation of China [50903073, 50973096,
   31070867]; Zhejiang Provincial Top Academic Discipline of Applied
   Chemistry and Eco-Dyeing & Finishing Engineering [ZYG2010015]; Science
   Foundation of Zhejiang Sci-Tech University [1113808-Y]
FX We gratefully thank the National Natural Science Foundation of China
   (grant nos. 50903073, 50973096, 31070867), Zhejiang Provincial Top
   Academic Discipline of Applied Chemistry and Eco-Dyeing & Finishing
   Engineering (ZYG2010015) and the Science Foundation of Zhejiang Sci-Tech
   University (grant nos. 1113808-Y) for support of this program.
CR Anselme K, 2000, BIOMATERIALS, V21, P667, DOI 10.1016/S0142-9612(99)00242-2
   ASAKURA T, 1985, MACROMOLECULES, V18, P1841, DOI 10.1021/ma00152a009
   Bigi A, 2000, BIOMACROMOLECULES, V1, P752, DOI 10.1021/bm0055854
   Cannillo V, 2010, COMPOS STRUCT, V92, P1823, DOI 10.1016/j.compstruct.2010.01.017
   Chen QZZ, 2006, BIOMATERIALS, V27, P2414, DOI 10.1016/j.biomaterials.2005.11.025
   Chen X, 2001, POLYMER, V42, P9969, DOI 10.1016/S0032-3861(01)00541-9
   Chittur KK, 1998, BIOMATERIALS, V19, P357, DOI 10.1016/S0142-9612(97)00223-8
   Derhami K, 2000, J BIOMED MATER RES, V52, P315, DOI 10.1002/1097-4636(200011)52:2<315::AID-JBM10>3.0.CO;2-2
   El-Ghannam AR, 2004, J BIOMED MATER RES A, V69A, P490, DOI 10.1002/jbm.a.30022
   Gough JE, 2004, J BIOMED MATER RES A, V68A, P640, DOI 10.1002/jbm.a.20075
   Ha SW, 2005, BIOMACROMOLECULES, V6, P1722, DOI 10.1021/bm050010y
   Hench LL, 1998, J AM CERAM SOC, V81, P1705
   ISHAUG SL, 1994, J BIOMED MATER RES, V28, P1445, DOI 10.1002/jbm.820281210
   Lobel KD, 1998, J BIOMED MATER RES, V39, P575, DOI 10.1002/(SICI)1097-4636(19980315)39:4<575::AID-JBM11>3.0.CO;2-6
   LOWRY OH, 1954, J BIOL CHEM, V207, P19
   Ma ZW, 2005, BIOMATERIALS, V26, P1253, DOI 10.1016/j.biomaterials.2004.04.031
   MacIntosh AC, 2008, J TISSUE ENG REGEN M, V2, P71, DOI 10.1002/term.68
   MESSING RA, 1969, J AM CHEM SOC, V91, P2370, DOI 10.1021/ja01037a030
   Middleton JC, 2000, BIOMATERIALS, V21, P2335, DOI 10.1016/S0142-9612(00)00101-0
   MILTHORPE BK, 1994, BIOMATERIALS, V15, P745, DOI 10.1016/0142-9612(94)90027-2
   Mondrinos MJ, 2006, BIOMATERIALS, V27, P4399, DOI 10.1016/j.biomaterials.2006.03.049
   MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4
   Oliveira SM, 2010, J BIOMED MATER RES A, V94A, P371, DOI 10.1002/jbm.a.32694
   PEREIRA MM, 1994, J BIOMED MATER RES, V28, P693, DOI 10.1002/jbm.820280606
   Rodrigo O., 2007, J BIOMED MATER RES A, V80, P565
   Salinas AJ, 2002, J BIOMED MATER RES, V61, P524, DOI 10.1002/jbm.10229
   Salinas AJ, 2001, J SOL-GEL SCI TECHN, V21, P13, DOI 10.1023/A:1011249330581
   Thomas CH, 1997, J BIOMED MATER RES, V37, P81, DOI 10.1002/(SICI)1097-4636(199710)37:1<81::AID-JBM10>3.0.CO;2-T
   Vallet-Regi M, 1999, J BIOMED MATER RES, V46, P560
   Vance RJ, 2004, BIOMATERIALS, V25, P2095, DOI 10.1016/j.biomaterials.2003.08.064
   Wilson D, 2000, BIOPHYS J, V78, P2690, DOI 10.1016/S0006-3495(00)76813-5
   Wu CT, 2008, ACTA BIOMATER, V4, P343, DOI 10.1016/j.actbio.2007.08.010
   Wu CT, 2006, J BIOMED MATER RES A, V76A, P73, DOI 10.1002/jbm.a.30496
   Xia W, 2007, MATER LETT, V61, P3251, DOI 10.1016/j.matlet.2006.11.048
   Xia WY, 2004, J BIOMED MATER RES B, V71B, P373, DOI 10.1002/jbm.b.30087
   Yusuke A., 2007, BIOMATERIALS, V28, P3074
   Zhang K, 2004, BIOMATERIALS, V25, P2489, DOI 10.1016/j.biomaterials.2003.09.033
   Zhang KH, 2010, J BIOMED MATER RES A, V93A, P976, DOI 10.1002/jbm.a.32497
   Zhao J, 2009, BONE, V45, P517, DOI 10.1016/j.bone.2009.05.026
NR 39
TC 9
Z9 10
U1 1
U2 32
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0928-4931
EI 1873-0191
J9 MAT SCI ENG C-MATER
JI Mater. Sci. Eng. C-Mater. Biol. Appl.
PD MAY 1
PY 2012
VL 32
IS 4
BP 822
EP 829
DI 10.1016/j.msec.2012.01.033
PG 8
WC Materials Science, Biomaterials
SC Materials Science
GA 932OB
UT WOS:000303299300030
DA 2018-10-19
ER

PT J
AU Brunger, JM
   Moutos, FT
   Perez-Pinera, P
   Lennon, DP
   Caplan, AI
   Guilak, F
   Gersbach, CA
AF Brunger, Jonathan M.
   Moutos, Franklin T.
   Perez-Pinera, Pablo
   Lennon, Donald P.
   Caplan, Arnold I.
   Guilak, Farshid
   Gersbach, Charles A.
TI Biomaterial-Mediated Gene Delivery for Tissue Engineering of Articular
   Cartilage
SO MOLECULAR THERAPY
LA English
DT Meeting Abstract
CT 15th Annual Meeting of the American-Society-of-Gene-and-Cell-Therapy
   (ASGCT)
CY MAY 16-19, 2012
CL Philadelphia, PA
SP Amer Soc Gene & Cell Therapy (ASGCT)
C1 [Brunger, Jonathan M.; Moutos, Franklin T.; Perez-Pinera, Pablo; Guilak, Farshid; Gersbach, Charles A.] Duke Univ, Durham, NC USA.
   [Lennon, Donald P.; Caplan, Arnold I.] Case Western Reserve Univ, Cleveland, OH 44106 USA.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU NATURE PUBLISHING GROUP
PI NEW YORK
PA 75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA
SN 1525-0016
J9 MOL THER
JI Mol. Ther.
PD MAY
PY 2012
VL 20
SU 1
MA 438
BP S170
EP S170
PG 1
WC Biotechnology & Applied Microbiology; Genetics & Heredity; Medicine,
   Research & Experimental
SC Biotechnology & Applied Microbiology; Genetics & Heredity; Research &
   Experimental Medicine
GA 934YU
UT WOS:000303484600439
DA 2018-10-19
ER

PT J
AU Niu, BL
   Huang, YJ
   Zhang, S
   Wang, DD
   Xu, HJ
   Kong, DL
   Qiao, MQ
AF Niu, Baolong
   Huang, Yujian
   Zhang, Suai
   Wang, Dandan
   Xu, Haijin
   Kong, Deling
   Qiao, Mingqiang
TI Expression and characterization of hydrophobin HGFI fused with the
   cell-specific peptide TPS in Pichia pastoris
SO PROTEIN EXPRESSION AND PURIFICATION
LA English
DT Article
DE Hydrophobin; TPS; Fusion expression; Self-assembly; Cell adhesion
ID HFBII HYDROPHOBIN; PROTEINS; SURFACE; ADHESION; SCAFFOLD; SC3
AB The cell-specific peptide TPS (TPSLEQRTVYAK) has been proposed as a potential candidate for fabricating tissue engineering scaffolds based on its ability of binding to human endothelial progenitor cells (EPC) with high affinity and specificity.
   In this study, the class I hydrophobin hgfI gene from Grifola frondosa and the tps were fused and cloned into pPIC9. The fusion gene was expressed in Pichia pastoris under the control of alcohol oxidase 1 promoter. Tricine-SDS-PAGE and Western blotting confirmed that the fusion protein TPS-linker-HGFI (TLH) was successfully secreted into the culture medium. The fusion protein TLH was purified by ultrafiltration and reverse-phase high performance liquid chromatography (RP-HPLC). Water contact angle (WCA) demonstrated that similar to recombinant HGFI (rHGFI), the purified TLH could convert the surface wettability of polystyrene and mica. X-ray photoelectron spectroscopy (XPS) measurements indicated that the purified TLH could form stable films on the hydrophobic siliconized glass surface.
   The cell adhesion examination showed that the TLH modified poly(epsilon-caprolactone) (PCL) could specially facilitate the EPC (particularly EPC derived from human) binding, while rHGFI modified PCL could nonselectively enhance cells adhesion. To the best of our knowledge, this is the first report that demonstrates that the TPS peptide was immobilized on biomaterial-PCL surface by fusion with hydrophobin. The potential application of this finding in combination with biomedical devices for EPC culture, will facilitate the current techniques used for cell-based therapies. (C) 2012 Elsevier Inc. All rights reserved.
C1 [Niu, Baolong; Huang, Yujian; Zhang, Suai; Wang, Dandan; Xu, Haijin; Kong, Deling; Qiao, Mingqiang] Nankai Univ, Coll Life Sci, State Key Lab Med Chem Biol, Tianjin 300071, Peoples R China.
   [Niu, Baolong; Huang, Yujian; Zhang, Suai; Wang, Dandan; Xu, Haijin; Kong, Deling; Qiao, Mingqiang] Nankai Univ, Coll Life Sci, Dept Microbiol, Tianjin 300071, Peoples R China.
RP Kong, DL (reprint author), Nankai Univ, Coll Life Sci, State Key Lab Med Chem Biol, 94 Weijin Rd, Tianjin 300071, Peoples R China.
EM delingkong@126.com; Mingqiangqiao@live.com
RI Huang, Yujian/B-2085-2016
OI Huang, Yujian/0000-0001-8543-0269
FU National Natural Science Foundation of China [31170066]; 973 Program of
   China [2011CBA00802]
FX This research was financially supported by the National Natural Science
   Foundation of China (Grant #31170066), 973 Program of China (Grant
   #2011CBA00802).
CR Amato I, 2007, BIOMATERIALS, V28, P3668, DOI 10.1016/j.biomaterials.2007.04.038
   Basheva ES, 2011, LANGMUIR, V27, P4481, DOI 10.1021/la2001943
   Chong EJ, 2007, ACTA BIOMATER, V3, P321, DOI 10.1016/j.actbio.2007.01.002
   De Vocht ML, 2002, PROTEIN SCI, V11, P1199, DOI 10.1110/ps.4540102
   Hakanpaa J, 2004, J BIOL CHEM, V279, P534, DOI 10.1074/jbc.M309650200
   Hou S, 2009, BIOFABRICATION, V1, DOI 10.1088/1758-5082/1/3/035004
   Lee SJ, 2008, BIOMATERIALS, V29, P1422, DOI 10.1016/j.biomaterials.2007.11.024
   Linder M, 2002, PROTEIN SCI, V11, P2257, DOI 10.1110/ps.0207902
   Linder MB, 2009, CURR OPIN COLLOID IN, V14, P356, DOI 10.1016/j.cocis.2009.04.001
   Linder MB, 2005, FEMS MICROBIOL REV, V29, P877, DOI 10.1016/j.femsre.2005.01.004
   Linder MB, 2004, BIOCHEMISTRY-US, V43, P11873, DOI 10.1021/bi0488202
   Niu B., 2011, AMINO ACIDS
   Palomo JM, 2003, BIOMACROMOLECULES, V4, P204, DOI 10.1021/bm020071l
   Qin M, 2007, LANGMUIR, V23, P4465, DOI 10.1021/la062744h
   Stroud PA, 2003, BIOMACROMOLECULES, V4, P956, DOI 10.1021/bm034045e
   Sunde M, 2008, MICRON, V39, P773, DOI 10.1016/j.micron.2007.08.003
   Valo HK, 2010, ACS NANO, V4, P1750, DOI 10.1021/nn9017558
   Veleva AN, 2008, BIOMATERIALS, V29, P3656, DOI 10.1016/j.biomaterials.2008.05.022
   Veleva AN, 2007, BIOTECHNOL BIOENG, V98, P306, DOI 10.1002/bit.21420
   Walther A, 2008, SOFT MATTER, V4, P663, DOI 10.1039/b718131k
   Wang ZF, 2010, PROTEIN EXPRES PURIF, V72, P19, DOI 10.1016/j.pep.2010.03.017
   Wessels JGH, 1997, ADV MICROB PHYSIOL, V38, P1
   Wohlleben W, 2010, EUR BIOPHYS J BIOPHY, V39, P457, DOI 10.1007/s00249-009-0430-4
   Wosten HAB, 2000, MICROBIOL-UK, V146, P767
   Wosten HAB, 2001, ANNU REV MICROBIOL, V55, P625, DOI 10.1146/annurev.micro.55.1.625
   Yoshimoto H, 2003, BIOMATERIALS, V24, P2077, DOI 10.1016/S0142-9612(02)00635-X
   Yu L, 2008, MICROBIOL-SGM, V154, P1677, DOI 10.1099/mic.0.2007/015263-0
NR 27
TC 12
Z9 12
U1 3
U2 26
PU ACADEMIC PRESS INC ELSEVIER SCIENCE
PI SAN DIEGO
PA 525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA
SN 1046-5928
EI 1096-0279
J9 PROTEIN EXPRES PURIF
JI Protein Expr. Purif.
PD MAY
PY 2012
VL 83
IS 1
BP 92
EP 97
DI 10.1016/j.pep.2012.03.004
PG 6
WC Biochemical Research Methods; Biochemistry & Molecular Biology;
   Biotechnology & Applied Microbiology
SC Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology
GA 934FH
UT WOS:000303428500013
PM 22440542
DA 2018-10-19
ER

PT J
AU Sinclair, SK
   Konz, GJ
   Dawson, JM
   Epperson, RT
   Bloebaum, RD
AF Sinclair, Sarina K.
   Konz, Gina J.
   Dawson, John M.
   Epperson, Richard T.
   Bloebaum, Roy D.
TI Host Bone Response to Polyetheretherketone Versus Porous Tantalum
   Implants for Cervical Spinal Fusion in a Goat Model
SO SPINE
LA English
DT Article
DE cervical spine; interbody fusion; PEEK; tantalum; ACDF
ID CALCIFIED FIBROCARTILAGE; MECHANICAL-PROPERTIES; INTERBODY IMPLANTS;
   RETRIEVAL ANALYSIS; COATED IMPLANTS; INGROWTH; COMPONENTS; TITANIUM;
   HIP; BIOMATERIAL
AB Study Design. In vivo assessment of polyetheretherketone (PEEK) and porous tantalum (TM) cervical interbody fusion devices in a goat model.
   Objective. Directly compare host bone response to PEEK and TM devices used for cervical interbody fusion.
   Summary of Background Data. PEEK devices are widely used for anterior cervical discectomy and fusion but are nonporous and have limited surface area for bone attachment.
   Methods. Twenty-five goats underwent single-level anterior cervical discectomy and fusion and were alternately implanted with TM (n = 13) or PEEK devices (n = 12) for 6, 12, and 26 weeks. Both devices contained a center graft hole (GH), filled with autograft bone from the animal's own iliac crest. The percentage of bone tissue around the implant, percentage of the implant surface in direct apposition with the host bone, and evidence of bone bridging through the implant GH were assessed by using backscattered electron imaging. Bone matrix mineral apposition rate was determined through fluorochrome double labeling, and sections were stained for histological analysis.
   Results. The TM-implanted animals had significantly greater volumes of bone tissue at the implant interface than the PEEK animals at all-time points. The TM animals also had a significantly greater average mineral apposition rate in the GH region at 6 and 12 weeks than the PEEK animals. No difference was observed at 26 weeks. A greater number of TM-implanted animals demonstrated connection between the autograft bone and both vertebrae compared with the PEEK implants. Histological staining also showed that the TM devices elicited improved host bone attachment over the PEEK implants.
   Conclusion. The TM implants supported bone growth into and around the implant margins better than the PEEK devices. TM's open cell porous structure facilitated host bone ingrowth and bone bridging through the device, which could be beneficial for long-term mechanical attachment and support in clinical applications.
C1 [Sinclair, Sarina K.; Epperson, Richard T.; Bloebaum, Roy D.] Bone & Joint Res Lab, Salt Lake City, UT USA.
   [Sinclair, Sarina K.; Epperson, Richard T.; Bloebaum, Roy D.] Univ Utah, Dept Orthopaed, Salt Lake City, UT USA.
   [Konz, Gina J.; Dawson, John M.] Zimmer Spine Inc, Minneapolis, MN USA.
RP Sinclair, SK (reprint author), 500 Foothill Blvd 151F, Salt Lake City, UT 84148 USA.
EM sarina.sinclair@hsc.utah.edu
FU Office of RD; Rehab RD; DVA; SLC; HCS; Albert & Margaret Hofmann Chair;
   Department of Orthopaedics, University of Utah School of Medicine, Salt
   Lake City, Utah; Zimmer Spine, Inc.
FX The authors thank the following for research and institutional support:
   The Office of R&D, Rehab R&D, DVA, SLC, HCS, the Albert & Margaret
   Hofmann Chair, the Department of Orthopaedics, University of Utah School
   of Medicine, Salt Lake City, Utah, and Zimmer Spine, Inc. This study was
   approved by the American Preclinical Services Institutional Animal Care
   and Use Committee.
CR Benjamin M, 1998, J ANAT, V193, P481, DOI 10.1046/j.1469-7580.1998.19340481.x
   Bloebaum RD, 2007, J BIOMED MATER RES A, V81A, P505, DOI 10.1002/jbm.a.31087
   Bloebaum R D, 1990, J Biomater Appl, V5, P56
   Bloebaum RD, 1997, J ARTHROPLASTY, V12, P920, DOI 10.1016/S0883-5403(97)90162-5
   Bloebaum RD, 1998, J BONE JOINT SURG AM, V80A, P518, DOI 10.2106/00004623-199804000-00008
   Bloebaum RD, 2004, ANAT REC PART A, V279A, P736, DOI 10.1002/ar.a.20066
   BLOEBAUM RD, 1991, CLIN ORTHOP RELAT R, P97
   Bobyn JD, 1999, J BONE JOINT SURG BR, V81B, P907, DOI 10.1302/0301-620X.81B5.9283
   Bobyn JD, 2004, J BONE JOINT SURG AM, V86A, P123, DOI 10.2106/00004623-200412002-00017
   Bridwell KH, 2007, J BONE JOINT SURG AM, V92, P2017
   Cook SD, 2004, SPINE, V29, P1118, DOI 10.1097/00007632-200405150-00013
   D'Angelo F, 2008, INDIAN J ORTHOP, V42, P275, DOI 10.4103/0019-5413.39553
   Dufour T, 2010, BRIT J NEUROSURG, V24, P633, DOI 10.3109/02688691003793029
   Ellingsen JE, 1998, PERIODONTOL 2000, V17, P36, DOI 10.1111/j.1600-0757.1998.tb00121.x
   EMMANUAL J, 1987, STAIN TECHNOL, V62, P401, DOI 10.3109/10520298709108030
   Fernandez-Fairen M, 2008, SPINE, V33, P465, DOI 10.1097/BRS.0b013e3181657f49
   FROST H. M., 1961, JOUR NEW DRUGS, V1, P206, DOI 10.1177/009127006100100503
   FROST HM, 1969, CALC TISS RES, V3, P211, DOI 10.1007/BF02058664
   Gotfredsen K, 2001, CLIN ORAL IMPLAN RES, V12, P196, DOI 10.1034/j.1600-0501.2001.012003196.x
   Gotfredsen K, 2000, Clin Implant Dent Relat Res, V2, P120, DOI 10.1111/j.1708-8208.2000.tb00002.x
   Hee HT, 2010, SPINE J, V10, P66, DOI 10.1016/j.spinee.2009.10.014
   Hofmann AA, 1997, ACTA ORTHOP SCAND, V68, P161, DOI 10.3109/17453679709004000
   HULBERT SF, 1972, J BIOMED MATER RES, V6, P347, DOI 10.1002/jbm.820060505
   Kalita SJ, 2003, MAT SCI ENG C-BIO S, V23, P611, DOI 10.1016/S0928-4931(03)00052-3
   Levi AD, 1998, SPINE, P23
   Levi ADO, 1998, SPINE, V23, P1245, DOI 10.1097/00007632-199806010-00014
   Levine BR, 2006, BIOMATERIALS, V27, P4671, DOI 10.1016/j.biomaterials.2006.04.041
   Meunier P, 1977, BONE HISTOMORPHOMETR, P249
   Park HW, 2009, SPINE, V34, pE591, DOI 10.1097/BRS.0b013e3181ab8b9a
   Pechlivanis I, 2011, SPINE, V36, P15, DOI 10.1097/BRS.0b013e3181cbf870
   PILLIAR RM, 1986, CLIN ORTHOP RELAT R, P108
   RHODES DM, 1989, CLIN RES, V37, pA224
   SANDERSON C, 1994, J HISTOTECHNOL, V17, P343, DOI 10.1179/his.1994.17.4.343
   Sanderson C, 1997, J HISTOTECHNOL, V20, P119
   Shea JE, 2002, ANAT REC, V266, P177, DOI 10.1002/ar.10051
   Shea JE, 2001, J ANAT, V198, P153, DOI 10.1046/j.1469-7580.2001.19820153.x
   Shimko DA, 2005, J BIOMED MATER RES B, V73B, P315, DOI 10.1002/jbm.b.30229
   Sidhu K S, 2001, Spine J, V1, P331, DOI 10.1016/S1529-9430(01)00113-9
   Sinclair KD, 2011, ANAT REC, V294, P831, DOI 10.1002/ar.21374
   SOBALLE K, 1992, J ORTHOPAED RES, V10, P285, DOI 10.1002/jor.1100100216
   Vicario C, 2006, NEUROCIRUGIA, V17, P132
   Vicario C, 2006, NEUROCIRUGIA ASTUR, P17
   Wang JC, 1998, SPINE, V23, P1684, DOI 10.1097/00007632-199808010-00014
   Wigfield C, 2003, BRIT J NEUROSURG, V17, P418, DOI 10.1080/02688690310001611206
   Willie BM, 2004, J BIOMED MATER RES A, V69A, P567, DOI 10.1002/jbm.a.30038
   Zardiackas LD, 2001, J BIOMED MATER RES, V58, P180, DOI 10.1002/1097-4636(2001)58:2<180::AID-JBM1005>3.0.CO;2-5
NR 46
TC 17
Z9 19
U1 3
U2 24
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA 530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA
SN 0362-2436
J9 SPINE
JI SPINE
PD MAY 1
PY 2012
VL 37
IS 10
BP E571
EP E580
DI 10.1097/BRS.0b013e318240f981
PG 10
WC Clinical Neurology; Orthopedics
SC Neurosciences & Neurology; Orthopedics
GA 935DP
UT WOS:000303499400001
PM 22146277
DA 2018-10-19
ER

PT J
AU Krishnan, R
   Arora, R
   Lamb, M
   White, SM
   Storrs, R
   Foster, C
   Botvinick, E
   Dorian, R
   Choi, B
   Lakey, JRT
AF Krishnan, R.
   Arora, R.
   Lamb, M.
   White, S. M.
   Storrs, R.
   Foster, C.
   Botvinick, E.
   Dorian, R.
   Choi, B.
   Lakey, J. R. T.
TI Vascular Remodeling in a Subcutaneous Site Secondary to Islet
   Transplantation and Biomaterial Implantation
SO AMERICAN JOURNAL OF TRANSPLANTATION
LA English
DT Meeting Abstract
CT American Transplant Congress
CY MAY, 2012
CL Boston, MA
C1 [Krishnan, R.; Lamb, M.; Foster, C.; Lakey, J. R. T.] Univ Calif Irvine, Orange, CA 92668 USA.
   [Arora, R.; White, S. M.; Botvinick, E.; Choi, B.] Univ Calif Irvine, Irvine, CA USA.
   [Storrs, R.; Dorian, R.] Islet Sheet Med LLC, San Francisco, CA USA.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU WILEY-BLACKWELL
PI MALDEN
PA COMMERCE PLACE, 350 MAIN ST, MALDEN 02148, MA USA
SN 1600-6135
J9 AM J TRANSPLANT
JI Am. J. Transplant.
PD MAY
PY 2012
VL 12
SU 3
SI SI
MA LB10
BP 359
EP 359
PG 1
WC Surgery; Transplantation
SC Surgery; Transplantation
GA 931QX
UT WOS:000303235503025
DA 2018-10-19
ER

PT J
AU Lakey, JRT
   Krishnan, R
   Arora, R
   Lamb, M
   Liang, O
   White, S
   Moy, A
   Storrs, R
   Dorian, R
   King, S
   Foster, C
   Botvinivk, E
   Choi, B
AF Lakey, J. R. T.
   Krishnan, R.
   Arora, R.
   Lamb, M.
   Liang, O.
   White, S.
   Moy, A.
   Storrs, R.
   Dorian, R.
   King, S.
   Foster, C.
   Botvinivk, E.
   Choi, B.
TI Vascular Response to Islet Xenotransplantation and Biomaterial Implants
   Using In-Vivo Optical Imaging.
SO AMERICAN JOURNAL OF TRANSPLANTATION
LA English
DT Meeting Abstract
CT American Transplant Congress
CY MAY, 2012
CL Boston, MA
C1 [Lakey, J. R. T.; Krishnan, R.; Lamb, M.; Liang, O.; Foster, C.; Botvinivk, E.] Univ Calif Irvine, Orange, CA 92668 USA.
   [Lakey, J. R. T.; Arora, R.; White, S.; Moy, A.; Botvinivk, E.; Choi, B.] Univ Calif Irvine, Beckman Laser Inst, Irvine, CA USA.
   [Storrs, R.; Dorian, R.; King, S.] Islet Sheet Med, San Francisco, CA USA.
NR 0
TC 0
Z9 0
U1 0
U2 1
PU WILEY-BLACKWELL
PI MALDEN
PA COMMERCE PLACE, 350 MAIN ST, MALDEN 02148, MA USA
SN 1600-6135
J9 AM J TRANSPLANT
JI Am. J. Transplant.
PD MAY
PY 2012
VL 12
SU 3
SI SI
MA 1541
BP 480
EP 481
PG 2
WC Surgery; Transplantation
SC Surgery; Transplantation
GA 931QX
UT WOS:000303235504131
DA 2018-10-19
ER

PT J
AU Fullenkamp, DE
   Rivera, JG
   Gong, YK
   Lau, KHA
   He, LH
   Varshney, R
   Messersmith, PB
AF Fullenkamp, Dominic E.
   Rivera, Jose G.
   Gong, Yong-kuan
   Lau, K. H. Aaron
   He, Lihong
   Varshney, Rahul
   Messersmith, Phillip B.
TI Mussel-inspired silver-releasing antibacterial hydrogels
SO BIOMATERIALS
LA English
DT Article
DE Polyethylene oxide; Silver; Hydrogel; Antibacterial; Biomimetic
   material; Nanoparticle
ID ADHESIVE PROTEINS; MEDICINE; BIOLOGY; MIMICS; BURNS; DOPA
AB A silver-releasing antibacterial hydrogel was developed that simultaneously allowed for silver nanoparticle formation and gel curing. Water-soluble polyethylene glycol (PEG) polymers were synthesized that contain reactive catechol moieties, inspired by mussel adhesive proteins, where the catechol containing amino acid 3,4-dihydroxyphenylalanine (DOPA) plays an important role in the ability of the mussel to adhere to almost any surface in an aqueous environment. We utilized silver nitrate to oxidize polymer catechols, leading to covalent cross-linking and hydrogel formation with simultaneous reduction of Ag(I). Silver release was sustained for periods of at least two weeks in PBS solution. Hydrogels were found to inhibit bacterial growth, consistent with the well-known antibacterial properties of silver, while not significantly affecting mammalian cell viability. In addition, thin hydrogel films were found to resist bacterial and mammalian cell attachment, consistent with the antifouling properties of PEG. We believe these materials have a strong potential for antibacterial biomaterial coatings and tissue adhesives, due to the material-independent adhesive properties of catechols. (C) 2012 Elsevier Ltd. All rights reserved.
C1 [Fullenkamp, Dominic E.; Rivera, Jose G.; Lau, K. H. Aaron; He, Lihong; Varshney, Rahul; Messersmith, Phillip B.] Northwestern Univ, Dept Biomed Engn, Evanston, IL 60208 USA.
   [Fullenkamp, Dominic E.; Rivera, Jose G.; Lau, K. H. Aaron; He, Lihong; Varshney, Rahul; Messersmith, Phillip B.] Northwestern Univ, Chem Life Proc Inst, Evanston, IL 60208 USA.
   [Gong, Yong-kuan] NW Univ Xian, Coll Chem & Mat Sci, Minist Educ, Key Lab Synthet & Nat Funct Mol Chem, Xian 710069, Peoples R China.
   [Varshney, Rahul; Messersmith, Phillip B.] Northwestern Univ, Chem & Biol Engn Dept, Evanston, IL 60208 USA.
   [Messersmith, Phillip B.] Northwestern Univ, Mat Sci & Engn Dept, Evanston, IL 60208 USA.
   [Messersmith, Phillip B.] Northwestern Univ, Inst Bionanotechnol Med, Evanston, IL 60208 USA.
   [Messersmith, Phillip B.] Northwestern Univ, Robert H Lurie Comprehens Canc Ctr, Evanston, IL 60208 USA.
RP Messersmith, PB (reprint author), Northwestern Univ, Dept Biomed Engn, 2145 Sheridan Rd, Evanston, IL 60208 USA.
EM philm@northwestern.edu
RI Lau, King Hang Aaron/D-2061-2010; Messersmith, Phil/B-6695-2009;
   Messersmith, Phillip/F-3433-2013
OI Lau, King Hang Aaron/0000-0003-3676-9228; Messersmith,
   Phillip/0000-0002-1197-333X
FU NIH NRSA [F30 HL096292]; NIH [R01 EB005772-02S1, R37 DE014193, R01
   EB005772]
FX The authors would like to acknowledge Brian Jao for his assistance with
   the MIS assays and Devin Barrett for helpful suggestions in the
   preparation of this manuscript. DEF was supported by NIH NRSA F30
   HL096292. JGR was supported by NIH grant R01 EB005772-02S1. This
   research was supported by NIH grants R37 DE014193 and R01 EB005772. The
   following Northwestern Univ. facilities were used for data collection:
   IMSERC (NMR and MS), KECK Biophysics (UV-Vis, GPC), QBIC (ICP-MS) and
   NUANCE (TEM).
CR Alt V, 2004, BIOMATERIALS, V25, P4383, DOI 10.1016/j.biomaterials.2003.10.078
   Baudisch O, 1933, J BIOL CHEM, V99, P485
   Black KCL, 2011, CHEM MATER, V23, P1130, DOI 10.1021/cm1024487
   Brubaker CE, 2011, BIOMACROMOLECULES, V12, P4326, DOI 10.1021/bm201261d
   Brubaker CE, 2010, BIOMATERIALS, V31, P420, DOI 10.1016/j.biomaterials.2009.09.062
   Deming TJ, 1999, CURR OPIN CHEM BIOL, V3, P100, DOI 10.1016/S1367-5931(99)80018-0
   Goldmann DA, 1996, JAMA-J AM MED ASSOC, V275, P234, DOI 10.1001/jama.275.3.234
   HACKMAN RH, 1953, BIOCHEM J, V55, P631, DOI 10.1042/bj0550631
   He LH, 2011, CHEM COMMUN, V47, P7497, DOI 10.1039/c1cc11928a
   Klasen HJ, 2000, BURNS, V26, P131, DOI 10.1016/S0305-4179(99)00116-3
   Klasen HJ, 2000, BURNS, V26, P117, DOI 10.1016/S0305-4179(99)00108-4
   Leaper David J, 2006, Int Wound J, V3, P282, DOI 10.1111/j.1742-481X.2006.00265.x
   Lee BP, 2002, BIOMACROMOLECULES, V3, P1038, DOI 10.1021/bm025546n
   Lee BP, 2011, ANNU REV MATER RES, V41, P99, DOI 10.1146/annurev-matsci-062910-100429
   Mohan YM, 2010, J COLLOID INTERF SCI, V342, P73, DOI 10.1016/j.jcis.2009.10.008
   Peppas NA, 2006, ADV MATER, V18, P1345, DOI 10.1002/adma.200501612
   Peppas NA, 2000, ANNU REV BIOMED ENG, V2, P9, DOI 10.1146/annurev.bioeng.2.1.9
   Russell A D, 1994, Prog Med Chem, V31, P351
   Schumm K, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004013.pub3
   Shao H, 2009, MACROMOL BIOSCI, V9, P464, DOI 10.1002/mabi.200800252
   Storm-Versloot MN, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006478.pub2
   Travan A, 2009, BIOMACROMOLECULES, V10, P1429, DOI 10.1021/bm900039x
   Varaprasad K, 2010, J APPL POLYM SCI, V115, P1199, DOI 10.1002/app.31249
   Vermeulen H, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005486.pub2
   WAITE JH, 1981, SCIENCE, V212, P1038, DOI 10.1126/science.212.4498.1038
   WAITE JH, 1976, ANAL BIOCHEM, V75, P211, DOI 10.1016/0003-2697(76)90072-5
   WAITE JH, 1987, INT J ADHES ADHES, V7, P9, DOI 10.1016/0143-7496(87)90048-0
   Westwood G, 2007, MACROMOLECULES, V40, P3960, DOI 10.1021/ma0703002
   Wright JB, 2002, WOUND REPAIR REGEN, V10, P141, DOI 10.1046/j.1524-475X.2002.10308.x
   Yu ME, 1998, MACROMOLECULES, V31, P4739, DOI 10.1021/ma980268z
   Yu ME, 1999, J AM CHEM SOC, V121, P5825, DOI 10.1021/ja990469y
   Zan XJ, 2010, BIOMACROMOLECULES, V11, P1082, DOI 10.1021/bm100048q
NR 32
TC 111
Z9 113
U1 15
U2 345
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
EI 1878-5905
J9 BIOMATERIALS
JI Biomaterials
PD MAY
PY 2012
VL 33
IS 15
BP 3783
EP 3791
DI 10.1016/j.biomaterials.2012.02.027
PG 9
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 932EM
UT WOS:000303273200001
PM 22374454
OA Green Accepted
DA 2018-10-19
ER

PT J
AU Tiwari-Pandey, R
   Toeg, H
   Sellke, FW
   Ruel, M
AF Tiwari-Pandey, Rashmi
   Toeg, Hadi
   Sellke, Frank W.
   Ruel, Marc
TI Clinically Relevant Extracellular-Matrix Scaffolds for Cell
   Transplantation and Vascular Repair
SO CURRENT VASCULAR PHARMACOLOGY
LA English
DT Article
DE Tissue engineering; biomaterials; cell therapy; myocardial repair;
   vascular repair; extracellular matrix
ID CIRCULATING PROGENITOR CELLS; OF-THE-ART; MYOCARDIAL-INFARCTION;
   HEART-FAILURE; CHITOSAN MICROSPHERES; CARDIAC-FUNCTION; FIBRIN GEL;
   TISSUE; COLLAGEN; BIOMATERIALS
AB Due to the very limited ability of cardiac tissue to self-regenerate, the replacement of damaged cardiomyocytes and the repair of damaged extracellular matrix (ECM) are highly sought-after therapeutic strategies. Cell transplantation in ECM scaffolds has been shown to improve retention, phenotype, and function in vascular and muscle repair. In addition to cellular patches that involve the use of biomaterial scaffolds in combination with cells, acellular patches may have a role in intrinsically recruiting cells to damaged areas. This review focuses on the clinically relevant ECM scaffolds, their interactions with cells to stimulate functions such as adhesion, migration, proliferation, and differentiation, and their intrinsic role in ECM remodeling leading to vascular and possibly myocardial repair.
C1 [Tiwari-Pandey, Rashmi; Toeg, Hadi; Ruel, Marc] Univ Ottawa, Inst Heart, Div Cardiac Surg, Ottawa, ON K1Y 4W7, Canada.
   [Sellke, Frank W.] Brown Univ, Alpert Med Sch, Div Cardiothorac Surg, Providence, RI 02912 USA.
RP Ruel, M (reprint author), Univ Ottawa, Inst Heart, Div Cardiac Surg, 40 Ruskin St, Ottawa, ON K1Y 4W7, Canada.
EM mruel@ottawaheart.ca
OI RUEL, MARC/0000-0002-0487-1319
FU NHLBI NIH HHS [R01 HL069024, T32 HL076130, R01 HL085647]
CR ADAMS JC, 1993, DEVELOPMENT, V117, P1183
   Badylak S, 2003, HEART SURG FORUM, V6, pE20
   Badylak SF, 2001, EXP HEMATOL, V29, P1310, DOI 10.1016/S0301-472X(01)00729-9
   Barnes CA, 2011, BIOMATERIALS, V32, P137, DOI 10.1016/j.biomaterials.2010.09.007
   BELL E, 1979, P NATL ACAD SCI USA, V76, P1274, DOI 10.1073/pnas.76.3.1274
   Berglund JD, 2003, BRIT J PHARMACOL, V140, P627, DOI 10.1038/sj.bjp.0705457
   Bhatia SK, 2010, BIOTECHNOL J, V5, P1309, DOI 10.1002/biot.201000230
   Braunwald E, 2000, CIRCULATION, V102, P14
   BROWN RE, 1994, CONNECT TISSUE RES, V30, P295, DOI 10.3109/03008209409015044
   Chen FM, 2011, BIOMATERIALS, V32, P3189, DOI 10.1016/j.biomaterials.2010.12.032
   Christman KL, 2006, J AM COLL CARDIOL, V48, P907, DOI 10.1016/j.jacc.2006.06.005
   Christman KL, 2004, J AM COLL CARDIOL, V44, P654, DOI 10.1016/j.jacc.2004.04.040
   Christman KL, 2004, TISSUE ENG, V10, P403, DOI 10.1089/107632704323061762
   Couet F, 2007, MACROMOL BIOSCI, V7, P701, DOI 10.1002/mabi.200700002
   Dai WD, 2005, J AM COLL CARDIOL, V46, P714, DOI 10.1016/j.jacc.2005.04.056
   Davis ME, 2005, CIRC RES, V97, P8, DOI 10.1161/01.RES.0000173376.39447.01
   Davis ME, 2005, CIRCULATION, V111, P442, DOI 10.1161/01.CIR.0000153847.47301.80
   Deng C, 2010, TISSUE ENG PT A, V16, P3099, DOI 10.1089/ten.tea.2009.0504
   Dhawan S, 2004, AAPS PHARMSCITECH, V5
   Duffy GP, 2011, EUR CELLS MATER, V21, P15, DOI 10.22203/eCM.v021a02
   Forrester JS, 2009, JACC-CARDIOVASC INTE, V2, P1, DOI 10.1016/j.jcin.2008.10.010
   Fukushima S, 2007, CIRCULATION, V115, P2254, DOI 10.1161/CIRCULATIONAHA.106.662577
   Gilbert TW, 2006, BIOMATERIALS, V27, P3675, DOI 10.1016/j.biomaterials.2006.02.014
   Giraud MN, 2007, TISSUE ENG, V13, P1825, DOI 10.1089/ten.2006.0110
   Giraud MN, 2008, ARTIF ORGANS, V32, P692, DOI 10.1111/j.1525-1594.2008.00595.x
   Godier-Furnemont AFG, 2011, P NATL ACAD SCI USA, V108, P7974, DOI 10.1073/pnas.1104619108
   Haycock JW, 2011, METHODS MOL BIOL, V695, P1, DOI 10.1007/978-1-60761-984-0_1
   Hutmacher DW, 2001, J BIOMED MATER RES, V55, P203, DOI 10.1002/1097-4636(200105)55:2<203::AID-JBM1007>3.3.CO;2-Z
   Hutmacher DW, 2001, J BIOMAT SCI-POLYM E, V12, P107, DOI 10.1163/156856201744489
   Ifkovits JL, 2010, P NATL ACAD SCI USA, V107, P11507, DOI 10.1073/pnas.1004097107
   Kellar RS, 2001, CIRCULATION, V104, P2063, DOI 10.1161/hc4201.097192
   KOH GY, 1993, AM J PHYSIOL, V264, pH1727
   Krupnick AS, 2002, J HEART LUNG TRANSPL, V21, P233, DOI 10.1016/S1053-2498(01)00349-7
   Kuraitis D, 2011, J MOL CELL CARDIOL, V51, P187, DOI 10.1016/j.yjmcc.2011.04.011
   Kuraitis D, 2010, CURR OPIN CARDIOL, V25, P575, DOI 10.1097/HCO.0b013e32833f0318
   Leor J, 2005, PHARMACOL THERAPEUT, V105, P151, DOI 10.1016/j.pharmthera.2004.10.003
   Leor Jonathan, 2006, Expert Rev Cardiovasc Ther, V4, P239, DOI 10.1586/14779072.4.2.239
   MainilVarlet P, 1997, BIOMATERIALS, V18, P257, DOI 10.1016/S0142-9612(96)00126-3
   Mi FL, 2002, BIOMATERIALS, V23, P181, DOI 10.1016/S0142-9612(01)00094-1
   Middleton JC, 2000, BIOMATERIALS, V21, P2335, DOI 10.1016/S0142-9612(00)00101-0
   Mol A, 2005, BIOMATERIALS, V26, P3113, DOI 10.1016/j.biomaterials.2004.08.007
   Murry CE, 2005, CIRCULATION, V112, P3174, DOI 10.1161/CIRCULATIONAHA.105.546218
   Nelson DM, 2011, PHARM RES-DORDR, V28, P1282, DOI 10.1007/s11095-011-0391-z
   Nelson DM, 2011, ACTA BIOMATER, V7, P1, DOI 10.1016/j.actbio.2010.06.039
   Tran NQ, 2011, MACROMOL RES, V19, P300, DOI 10.1007/s13233-011-0309-y
   Nugent HM, 2003, CIRC RES, V92, P1068, DOI 10.1161/01.RES.0000073844.41372.38
   Okada M, 2010, BIOMATERIALS, V31, P7678, DOI 10.1016/j.biomaterials.2010.06.056
   Ott HC, 2008, NAT MED, V14, P213, DOI 10.1038/nm1684
   Prestwich GD, 2011, J CONTROL RELEASE, V155, P193, DOI 10.1016/j.jconrel.2011.04.007
   Radisic M, 2007, PHILOS T R SOC B, V362, P1357, DOI 10.1098/rstb.2007.2121
   Robinson KA, 2005, CIRCULATION, V112, pI135
   Ross JJ, 2003, MATRIX BIOL, V22, P477, DOI 10.1016/S0945-053X(03)00078-7
   Ruel MA, 2003, ANN THORAC SURG, V75, P1443, DOI 10.1016/S0003-4975(02)04708-2
   Ryu JH, 2005, BIOMATERIALS, V26, P319, DOI 10.1016/j.biomaterials.2004.02.058
   SAETERSDAL T, 1992, HISTOCHEMISTRY, V98, P73, DOI 10.1007/BF00716997
   Scholl FG, 2010, WORLD J PEDIATR CONG, V1, P132, DOI 10.1177/2150135110362092
   Schussler O, 2009, NAT CLIN PRACT CARD, V6, P240, DOI 10.1038/ncpcardio1451
   Schussler Olivier, 2010, Asian Cardiovasc Thorac Ann, V18, P188, DOI 10.1177/0218492310361531
   Singelyn JM, 2010, J CARDIOVASC TRANSL, V3, P478, DOI 10.1007/s12265-010-9202-x
   Singelyn JM, 2009, BIOMATERIALS, V30, P5409, DOI 10.1016/j.biomaterials.2009.06.045
   Sinha VR, 2004, INT J PHARM, V274, P1, DOI 10.1016/j.ijpharm.2003.12.026
   SOONPAA MH, 1994, SCIENCE, V264, P98, DOI 10.1126/science.8140423
   Spotnitz W. D., 1996, SURG ADHESIVES SEALA, P3
   Stegemann JP, 2007, TISSUE ENG, V13, P2601, DOI 10.1089/ten.2007.0196
   Suuronen EJ, 2006, CIRCULATION, V114, pI138
   Suuronen EJ, 2009, FASEB J, V23, P1447, DOI 10.1096/fj.08-111054
   Tabata Y, 2009, J R SOC INTERFACE, V6, P4
   Teng CJ, 2006, J THORAC CARDIOV SUR, V132, P628, DOI 10.1016/j.jtcvs.2006.05.034
   Turer AT, 2010, AM J CARDIOL, V106, P360, DOI 10.1016/j.amjcard.2010.03.032
   Ulrich MMW, 1997, J MOL CELL CARDIOL, V29, P2533, DOI 10.1006/jmcc.1997.0486
   Van Lieshout M, 2006, TISSUE ENG, V12, P481, DOI 10.1089/ten.2006.12.481
   Van Vlierberghe S, 2011, BIOMACROMOLECULES, V12, P1387, DOI 10.1021/bm200083n
   World Health Organization, 2008, GLOB BURD DIS
   Ye Q, 2000, EUR J CARDIO-THORAC, V17, P587, DOI 10.1016/S1010-7940(00)00373-0
   Zhang G, 2006, TISSUE ENG, V12, P9, DOI 10.1089/ten.2006.12.9
   Zhang Ming, 2008, Cardiovascular & Hematological Disorders - Drug Targets, V8, P161, DOI 10.2174/187152908785849116
   Zhang Y, 2008, CIRC-CARDIOVASC IMAG, V1, P197, DOI 10.1161/CIRCIMAGING.108.781120
   Zhao HG, 2008, BIOMED MATER, V3, DOI 10.1088/1748-6041/3/1/015001
   Zhao TM, 2009, AM J PHYSIOL-HEART C, V296, pH976, DOI 10.1152/ajpheart.01134.2008
   Zhao ZQ, 2010, J AM COLL CARDIOL, V55, P1250, DOI 10.1016/j.jacc.2009.10.049
   Zimmermann WH, 2006, NAT MED, V12, P452, DOI 10.1038/nm1394
NR 81
TC 0
Z9 0
U1 0
U2 11
PU BENTHAM SCIENCE PUBL LTD
PI SHARJAH
PA EXECUTIVE STE Y-2, PO BOX 7917, SAIF ZONE, 1200 BR SHARJAH, U ARAB
   EMIRATES
SN 1570-1611
J9 CURR VASC PHARMACOL
JI Current Vascular Pharmacology
PD MAY
PY 2012
VL 10
IS 3
BP 322
EP 330
DI 10.2174/157016112799959332
PG 9
WC Pharmacology & Pharmacy; Peripheral Vascular Disease
SC Pharmacology & Pharmacy; Cardiovascular System & Cardiology
GA 931ZQ
UT WOS:000303258600007
PM 22239634
DA 2018-10-19
ER

PT J
AU Saik, JE
   McHale, MK
   West, JL
AF Saik, Jennifer E.
   McHale, Melissa K.
   West, Jennifer L.
TI Biofunctional Materials for Directing Vascular Development
SO CURRENT VASCULAR PHARMACOLOGY
LA English
DT Article
DE Angiogenesis; biomaterials; blood vessels; endothelial cells; growth
   factors; tissue engineering
ID ENDOTHELIAL GROWTH-FACTOR; EMBRYONIC STEM-CELLS; GLYCOL) DIACRYLATE
   HYDROGELS; BLOOD-VESSEL DEVELOPMENT; THERAPEUTIC ANGIOGENESIS; IN-VITRO;
   HINDLIMB ISCHEMIA; FRACTAL ANALYSIS; DRUG-DELIVERY; COVALENT
   INCORPORATION
AB Engineered tissue constructs are inherently limited by their lack of microvascularization. Evidence suggests that combining a scaffold material with cells and their cell-secreted signals instigates tubule formation, and various strategies can be employed to tailor the vascular response. This review focuses on rationally designed materials capable of supporting functional neovessel formation and stabilization. Biomaterial scaffolds and their use as growth factor delivery systems are discussed, as well as other functional enhancement strategies to direct cellular responses for effective formation of a mature vascular network.
C1 [Saik, Jennifer E.; McHale, Melissa K.; West, Jennifer L.] Rice Univ, Dept Bioengn, Houston, TX 77005 USA.
RP West, JL (reprint author), Rice Univ, Dept Bioengn, 6100 Main St, Houston, TX 77005 USA.
EM jwest@rice.edu
RI West, Jennifer/A-4582-2008
OI West, Jennifer/0000-0001-8550-2875
FU NSF [0940902]
FX JES was supported by NSF graduate fellowship # 0940902.
CR Allen KD, 2006, TISSUE ENG, V12, P1183, DOI 10.1089/ten.2006.12.1183
   Atala A, 2006, LANCET, V367, P1241, DOI 10.1016/S0140-6736(06)68438-9
   Au Patrick, 2007, V140, P183
   Avakian A, 2002, CURR EYE RES, V24, P274, DOI 10.1076/ceyr.24.4.274.8411
   Baish JW, 1996, MICROVASC RES, V51, P327, DOI 10.1006/mvre.1996.0031
   BAR RS, 1989, ENDOCRINOLOGY, V124, P1841, DOI 10.1210/endo-124-4-1841
   Bassingthwaighte J. B., 1994, FRACTAL PHYSL
   Baumgartner I, 2000, ANN INTERN MED, V132, P880, DOI 10.7326/0003-4819-132-11-200006060-00005
   Betsholtz C, 2005, EXP SUPPL, V94, P115
   Bianchi F, 2007, J BIOMED MATER RES B, V81B, P462, DOI 10.1002/jbm.b.30685
   Bikfalvi A, 1997, ENDOCR REV, V18, P26, DOI 10.1210/er.18.1.26
   Bui A, 2009, MED BIOL ENG COMPUT, V47, P763, DOI 10.1007/s11517-009-0492-6
   Cao RH, 2003, NAT MED, V9, P604, DOI 10.1038/nm848
   Cao YH, 2008, J MOL MED, V86, P785, DOI 10.1007/s00109-008-0337-z
   Carmeliet P, 1996, NATURE, V380, P435, DOI 10.1038/380435a0
   Chen RR, 2007, PHARM RES, V24, P258, DOI 10.1007/s11095-006-9173-4
   Chen XF, 2010, TISSUE ENG PT A, V16, P585, DOI [10.1089/ten.tea.2009.0491, 10.1089/ten.TEA.2009.0491]
   Chen XF, 2009, TISSUE ENG PT A, V15, P1363, DOI 10.1089/ten.tea.2008.0314
   Chinen N, 2003, J BIOMED MATER RES A, V67A, P61, DOI 10.1002/jbm.a.10061
   Cho SW, 2007, CIRCULATION, V116, P2409, DOI 10.1161/CIRCULATIONAHA.106.687038
   De Coppi P, 2005, TISSUE ENG, V11, P1034, DOI 10.1089/ten.2005.11.1034
   DeLong SA, 2005, BIOMATERIALS, V26, P3227, DOI 10.1016/j.biomaterials.2004.09.021
   Doubal FN, 2010, NEUROLOGY, V74, P1102, DOI 10.1212/WNL.0b013e3181d7d8b4
   Drury JL, 2003, BIOMATERIALS, V24, P4337, DOI 10.1016/S0142-9612(03)00340-5
   Edelman DA, 2006, J SURG RES, V135, P305, DOI 10.1016/j.jss.2006.06.010
   Ehrbar M, 2008, BIOMATERIALS, V29, P1720, DOI 10.1016/j.biomaterials.2007.12.002
   Ennett AB, 2006, J BIOMED MATER RES A, V79A, P176, DOI 10.1002/jbm.a.30771
   Epstein SE, 2001, CIRCULATION, V104, P115, DOI 10.1161/01.CIR.104.1.115
   Falanga V, 1999, WOUND REPAIR REGEN, V7, P201, DOI 10.1046/j.1524-475X.1999.00201.x
   Frerich B, 2001, INT J ORAL MAX SURG, V30, P414, DOI 10.1054/ijom.2001.0130
   Frontini MJ, 2011, NAT BIOTECHNOL, V29, P421, DOI 10.1038/nbt.1845
   Fujita M, 2007, WOUND REPAIR REGEN, V15, P58, DOI 10.1111/j.1524-475X.2006.00185.x
   Gazit Y, 1997, MICROCIRCULATION-LON, V4, P395, DOI 10.3109/10739689709146803
   Gould DJ, 2011, MICROCIRCULATION, V18, P136, DOI 10.1111/j.1549-8719.2010.00075.x
   Grauslund J, 2010, OPHTHALMOLOGY, V117, P1400, DOI 10.1016/j.ophtha.2009.10.047
   Greenberg JI, 2008, NATURE, V456, P809, DOI 10.1038/nature07424
   Guidolin D, 2004, MICROVASC RES, V67, P117, DOI 10.1016/j.mvr.2003.11.002
   Gunn JW, 2005, J BIOMED MATER RES A, V72A, P91, DOI 10.1002/jbm.a.30203
   Hahn MS, 2007, ANN BIOMED ENG, V35, P190, DOI 10.1007/s10439-006-9099-3
   Herman P, 2001, J CEREBR BLOOD F MET, V21, P741, DOI 10.1097/00004647-200106000-00012
   Hern DL, 1998, J BIOMED MATER RES, V39, P266, DOI 10.1002/(SICI)1097-4636(199802)39:2<266::AID-JBM14>3.0.CO;2-B
   Hirschi KK, 1998, J CELL BIOL, V141, P805, DOI 10.1083/jcb.141.3.805
   Hudon V, 2003, BRIT J DERMATOL, V148, P1094, DOI 10.1046/j.1365-2133.2003.05298.x
   Ikeda Y, 2004, HYPERTENS RES, V27, P119, DOI 10.1291/hypres.27.119
   JACKSON CL, 1993, AM J PATHOL, V143, P1024
   Jain RK, 2005, NAT BIOTECHNOL, V23, P821, DOI 10.1038/nbt0705-821
   Jain RK, 2003, NAT MED, V9, P685, DOI 10.1038/nm0603-685
   Jain RK, 1997, NAT MED, V3, P1203, DOI 10.1038/nm1197-1203
   Jin QM, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001729
   Kano MR, 2005, J CELL SCI, V118, P3759, DOI 10.1242/jcs.02483
   Koch S, 2006, J MATER SCI-MATER M, V17, P735, DOI 10.1007/s10856-006-9684-x
   Koga M, 2009, TISSUE ENG PT A, V15, P2727, DOI [10.1089/ten.tea.2008.0417, 10.1089/ten.TEA.2008.0417]
   Koike N, 2004, NATURE, V428, P138, DOI 10.1038/428138a
   LANDINI G, 1995, INVEST OPHTH VIS SCI, V36, P2749
   LANGER R, 1993, SCIENCE, V260, P920, DOI 10.1126/science.8493529
   Laschke MW, 2006, TISSUE ENG, V12, P2093, DOI 10.1089/ten.2006.12.2093
   Lee KY, 2003, J CONTROL RELEASE, V87, P49, DOI 10.1016/S0168-3659(02)00349-8
   Lee KY, 2000, NATURE, V408, P998
   Leslie-Barbick JE, 2011, BIOMATERIALS, V32, P5782, DOI 10.1016/j.biomaterials.2011.04.060
   Leslie-Barbick JE, 2009, J BIOMAT SCI-POLYM E, V20, P1763, DOI 10.1163/156856208X386381
   Levenberg S, 2002, P NATL ACAD SCI USA, V99, P4391, DOI 10.1073/pnas.032074999
   Lindahl P, 1997, SCIENCE, V277, P242, DOI 10.1126/science.277.5323.242
   Liu D, 2009, CURR EYE RES, V34, P945, DOI 10.3109/02713680903230079
   Madeddu P, 2005, EXP PHYSIOL, V90, P315, DOI 10.1113/expphysiol.2004.028571
   MAHADEVAN V, 1989, CANCER RES, V49, P415
   Mandelbrot BB, 1982, FRACTAL GEOMETRY NAT
   Marti HH, 2005, EXP SUPPL, V94, P163
   Masters B, 1989, BIOPHYS J, V55
   Maynard HD, 2005, ACTA BIOMATER, V1, P451, DOI 10.1016/j.actbio.2005.04.004
   Mittermayr R, 2008, WOUND REPAIR REGEN, V16, P542, DOI 10.1111/j.1524-475X.2008.00391.x
   Miyoshi M, 2005, J BIOMAT SCI-POLYM E, V16, P893, DOI 10.1163/1568562054255709
   Moioli EK, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003922
   Moon JJ, 2008, CURR TOP MED CHEM, V8, P300
   Moon JJ, 2007, BIOMACROMOLECULES, V8, P42, DOI 10.1021/bm060452p
   Moon JJ, 2010, BIOMATERIALS, V31, P3840, DOI 10.1016/j.biomaterials.2010.01.104
   Nillesen STM, 2006, J CONTROL RELEASE, V116, pE88, DOI 10.1016/j.jconrel.2006.09.065
   Nomi Masashi, 2006, Curr Stem Cell Res Ther, V1, P333
   Nor JE, 2001, LAB INVEST, V81, P453
   PARK JE, 1993, MOL BIOL CELL, V4, P1317
   Patel ZS, 2004, J BIOMAT SCI-POLYM E, V15, P701, DOI 10.1163/156856204774196117
   Peters MC, 2002, J BIOMED MATER RES, V60, P668, DOI 10.1002/jbm.10134
   Pieper JS, 2002, J BIOMED MATER RES, V62, P185, DOI 10.1002/jbm.10267
   Plotnick RE, 1996, PHYS REV E, V53, P5461, DOI 10.1103/PhysRevE.53.5461
   Poche R. A., 2010, COLD SPRING HARB PRO
   Poche RA, 2009, DEV DYNAM, V238, P2318, DOI 10.1002/dvdy.21886
   Richardson TP, 2001, NAT BIOTECHNOL, V19, P1029, DOI 10.1038/nbt1101-1029
   Rinsch C, 2001, GENE THER, V8, P523, DOI 10.1038/sj.gt.3301436
   Rogers MS, 2007, NAT PROTOC, V2, P2545, DOI 10.1038/nprot.2007.368
   Sabo E, 2001, CLIN CANCER RES, V7, P533
   Saik JE, 2011, BIOMACROMOLECULES, V12, P2715, DOI 10.1021/bm200492h
   Sandau K, 1997, J MICROSC-OXFORD, V186, P164, DOI 10.1046/j.1365-2818.1997.1270685.x
   Sanders JE, 2003, TISSUE ENG, V9, P1271, DOI 10.1089/10763270360728189
   Seifalian AM, 2002, ARTIF ORGANS, V26, P307, DOI 10.1046/j.1525-1594.2002.06841.x
   Semenza GL, 2006, CIRC RES, V98, P1115, DOI 10.1161/01.RES.0000223485.43020.9e
   Sng CCA, 2010, NEPHROL DIAL TRANSPL, V25, P2252, DOI 10.1093/ndt/gfq007
   Steffens GCM, 2004, TISSUE ENG, V10, P1502, DOI 10.1089/ten.2004.10.1502
   Stosich MS, 2007, TISSUE ENG, V13, P2881, DOI 10.1089/ten.2007.0078
   Sun Hengyun, 2011, Front Med, V5, P61, DOI 10.1007/s11684-011-0122-1
   Tolle CR, 2008, PHYSICA D, V237, P306, DOI 10.1016/j.physd.2007.09.017
   Tremblay PL, 2005, AM J TRANSPLANT, V5, P1002, DOI 10.1111/j.1600-6143.2005.00790.x
   Tsuda Y, 2007, BIOMATERIALS, V28, P4939, DOI 10.1016/j.biomaterials.2007.08.002
   Unger RE, 2007, BIOMATERIALS, V28, P3965, DOI 10.1016/j.biomaterials.2007.05.032
   Unger RE, 2010, BIOMATERIALS, V31, P6959, DOI 10.1016/j.biomaterials.2010.05.057
   Vargas A, 2007, ADV DRUG DELIVER REV, V59, P1162, DOI 10.1016/j.addr.2007.04.019
   Wang ZZ, 2007, NAT BIOTECHNOL, V25, P317, DOI 10.1038/nbt1287
   West JL, 1999, MACROMOLECULES, V32, P241, DOI 10.1021/ma981296k
   Wong C, 2003, THROMB HAEMOSTASIS, V89, P573
   Yamashita J, 2000, NATURE, V408, P92, DOI 10.1038/35040568
NR 108
TC 6
Z9 6
U1 1
U2 21
PU BENTHAM SCIENCE PUBL LTD
PI SHARJAH
PA EXECUTIVE STE Y-2, PO BOX 7917, SAIF ZONE, 1200 BR SHARJAH, U ARAB
   EMIRATES
SN 1570-1611
EI 1875-6212
J9 CURR VASC PHARMACOL
JI Current Vascular Pharmacology
PD MAY
PY 2012
VL 10
IS 3
BP 331
EP 341
PG 11
WC Pharmacology & Pharmacy; Peripheral Vascular Disease
SC Pharmacology & Pharmacy; Cardiovascular System & Cardiology
GA 931ZQ
UT WOS:000303258600008
PM 22239635
DA 2018-10-19
ER

PT J
AU McBane, JE
   Sharifpoor, S
   Labow, RS
   Ruel, M
   Suuronen, EJ
   Santerre, JP
AF McBane, Joanne E.
   Sharifpoor, Soroor
   Labow, Rosalind S.
   Ruel, Marc
   Suuronen, Erik J.
   Santerre, J. Paul
TI Tissue Engineering a Small Diameter Vessel Substitute: Engineering
   Constructs with Select Biomaterials and Cells
SO CURRENT VASCULAR PHARMACOLOGY
LA English
DT Article
DE Extracellular matrix proteins; monocytes; natural biomaterials;
   progenitor cells; small caliber vessel; stem cells; synthetic
   biomaterials; vascular tissue engineering
ID SMOOTH-MUSCLE-CELLS; CIRCULATING PROGENITOR CELLS; PLURIPOTENT
   STEM-CELLS; HUMAN PERIPHERAL-BLOOD; OUTGROWTH ENDOTHELIAL-CELLS; ADULT
   ARTERIAL REVASCULARIZATION; COLONY-STIMULATING FACTOR; BIOTUBE VASCULAR
   GRAFTS; SELF-ASSEMBLY APPROACH; IN-VITRO
AB Cardiovascular disease (CVD) is a leading cause of death and hospitalization worldwide. The need for small caliber vessels (< 6mm) to treat CVD patients has grown; however the availability of autologous vessels in cardiac and peripheral bypass candidates is limited. The search for an alternative vessel source is widespread with both natural and synthetic tissue engineered materials being investigated as scaffolds. Despite decades of exhaustive studies with decellularized extracellular matrices (ECM) and synthetic graft materials, the field remains in search of a commercially viable biomaterial construct substitute. While the previous materials have been assessed by evaluating their compatibility with fibroblasts, smooth muscle cells and endothelial cells, current materials are being conceived based on their interactions with stem cells, progenitor cells and monocytes, as the latter may hold the key to repair and regeneration. The graft's ability to recruit and maintain these cells has become a major research focus. The successful tissue engineering of a small caliber vessel graft requires the use of optimal material chemistry and biological function to promote cell recruitment into the graft while maintaining each functional phenotype during vessel tissue maturation. The discussion of these significant research challenges constitutes the focus of this review.
C1 [McBane, Joanne E.; Sharifpoor, Soroor; Santerre, J. Paul] Univ Toronto, Fac Dent, Toronto, ON M5G 1G6, Canada.
   [McBane, Joanne E.; Sharifpoor, Soroor; Santerre, J. Paul] Univ Toronto, Inst Biomat & Biomed Engn, Toronto, ON M5S 3G9, Canada.
   [McBane, Joanne E.; Labow, Rosalind S.; Ruel, Marc; Suuronen, Erik J.] Univ Ottawa, Inst Heart, Div Cardiac Surg, Ottawa, ON K1Y 4W7, Canada.
   [McBane, Joanne E.; Ruel, Marc; Suuronen, Erik J.] Univ Ottawa, Dept Cellular & Mol Med, Ottawa, ON K1N 6N5, Canada.
   [Labow, Rosalind S.] Univ Ottawa, Dept Biochem Microbiol & Immunol, Ottawa, ON K1N 6N5, Canada.
RP Santerre, JP (reprint author), Univ Toronto, Fac Dent, Room 460, Toronto, ON M5G 1G6, Canada.
EM paul.santerre@dentistry.utoronto.ca
OI RUEL, MARC/0000-0002-0487-1319
FU NSERC/CIHR [337246/83459]; Canadian Heart & Stroke Foundation; CIHR;
   Ontario graduate scholarship in science and technology (OGSST)
FX This research was funded by an NSERC/CIHR collaborative grant #
   337246/83459 (J.P. Santerre, R.S. Labow). J.E. McBane was funded by a
   Canadian Heart & Stroke Foundation Focus on Stroke post-doctoral
   fellowship. S. Sharifpoor was partially funded by CIHR strategic
   training program (Cell signaling in mucosal inflammation and repair) and
   an Ontario graduate scholarship in science and technology (OGSST).
CR Abilez O, 2006, J SURG RES, V132, P170, DOI 10.1016/j.jss.2006.2.017
   ABSHER M, 1989, IN VITRO CELL DEV B, V25, P183
   Alberts B, 2002, MOL BIOL CELL, P1279
   Allen J, 2008, TISSUE ENG PT A, V14, P183, DOI 10.1089/ten.a.2007.0265
   Allen JB, 2010, STEM CELLS, V28, P318, DOI 10.1002/stem.275
   Alobaid N, 2006, EUR J VASC ENDOVASC, V32, P76, DOI 10.1016/j.ejvs.2005.11.034
   Alobaid N, 2005, ENDOTHELIUM-J ENDOTH, V12, P243, DOI 10.1080/10623320500476617
   Amabile G, 2009, TRENDS MOL MED, V15, P59, DOI 10.1016/j.molmed.2008.12.003
   Amabile PG, 2002, J VASC INTERV RADIOL, V13, P709, DOI 10.1016/S1051-0443(07)61848-X
   Amiel GE, 2006, TISSUE ENG, V12, P2355, DOI 10.1089/ten.2006.12.2355
   Anderson JM, 2008, SEMIN IMMUNOL, V20, P86, DOI 10.1016/j.smim.2007.11.004
   Andrews KD, 2008, J MATER SCI-MATER M, V19, P1601, DOI 10.1007/s10856-008-3377-6
   Andrews KD, 2008, J SURG RES, V149, P39, DOI 10.1016/j.jss.2007.08.030
   [Anonymous], 1998, EC BURD ILLN CAN
   Aper T, 2004, EUR J VASC ENDOVASC, V28, P296, DOI 10.1016/j.ejvs.2004.05.016
   Barlis P, 2010, EUR HEART J, V31, P165, DOI 10.1093/eurheartj/ehp480
   Batten P, 2006, TISSUE ENG, V12, P2263, DOI 10.1089/ten.2006.12.2263
   Bhattacharya V, 2000, J VASC SURG, V32, P116, DOI 10.1067/mva.2000.107308
   Borschel GH, 2005, TISSUE ENG, V11, P778, DOI 10.1089/ten.2005.11.778
   Boyer M, 2000, J VASC SURG, V31, P181, DOI 10.1016/S0741-5214(00)70080-2
   Brown BN, 2009, BIOMATERIALS, V30, P1482, DOI 10.1016/j.biomaterials.2008.11.040
   Chlupac J, 2009, PHYSIOL RES, V58, pS119
   Cho SW, 2006, J BIOMED MATER RES A, V76A, P252, DOI 10.1002/jbm.a.30535
   Conklin BS, 2004, ARTIF ORGANS, V28, P668, DOI 10.1111/j.1525-1594.2004.00062.x
   Conklin BS, 2002, MED ENG PHYS, V24, P173, DOI 10.1016/S1350-4533(02)00010-3
   D'Amore A, 2010, BIOMATERIALS, V31, P5345, DOI 10.1016/j.biomaterials.2010.03.052
   Daniel J, 2005, ASAIO J, V51, P252, DOI 10.1097/01.MAT.0000160872.41871.7E
   DAVIES PF, 1995, PHYSIOL REV, V75, P519
   dela Paz NG, 2009, CELL TISSUE RES, V335, P5, DOI 10.1007/s00441-008-0706-5
   Derham C, 2008, TISSUE ENG PT A, V14, P1871, DOI 10.1089/ten.tea.2007.0103
   DiMuzio P, 2007, J VASC SURG, V45, p99A, DOI 10.1016/j.jvs.2007.02.046
   Ehrbar M, 2005, J CONTROL RELEASE, V101, P93, DOI 10.1016/j.jconrel.2004.07.018
   FORSTERMANN U, 1988, CIRC RES, V63, P306, DOI 10.1161/01.RES.63.2.306
   Fuchs S, 2007, TISSUE ENG, V13, P2577, DOI 10.1089/ten.2007.0022
   Fuchs S, 2006, BIOMATERIALS, V27, P5399, DOI 10.1016/j.biomaterials.2006.06.015
   Fuchs S, 2009, BIOMATERIALS, V30, P526, DOI 10.1016/j.biomaterials.2008.09.058
   Fussell GW, 2004, J BIOMED MATER RES A, V70A, P265, DOI 10.1002/jbm.a.30074
   Gao J, 2008, J BIOMED MATER RES A, V85A, P1120, DOI 10.1002/jbm.a.32028
   Gauvin R, 2010, TISSUE ENG PT A, V16, P1737, DOI [10.1089/ten.tea.2009.0313, 10.1089/ten.TEA.2009.0313]
   Giavaresi G, 2006, J BIOMAT SCI-POLYM E, V17, P1405, DOI 10.1163/156856206778937226
   Gilbert TW, 2006, BIOMATERIALS, V27, P3675, DOI 10.1016/j.biomaterials.2006.02.014
   Girton TS, 2000, J BIOMECH ENG-T ASME, V122, P216, DOI 10.1115/1.429652
   Gladish JC, 2005, ANN BIOMED ENG, V33, P323, DOI 10.1007/s10439-005-1734-x
   Gonda K, 2008, PLAST RECONSTR SURG, V121, P401, DOI 10.1097/01.prs.0000298322.70032.bc
   Grenier G, 2005, TISSUE ENG, V11, P90, DOI 10.1089/ten.2005.11.90
   GRENIER G, 2003, IN VITRO CELL DEV-AN, V39, P131, DOI DOI 10.1007/S11626-003-0007-Y
   Grenier G, 2006, TISSUE ENG, V12, P3159, DOI 10.1089/ten.2006.12.3159
   Grenier S, 2007, J BIOMED MATER RES A, V82A, P802, DOI 10.1002/jbm.a.31194
   Guan J, 2008, PHARM RES-DORDR, V25, P2400, DOI 10.1007/s11095-008-9628-x
   Guan JJ, 2005, BIOMATERIALS, V26, P3961, DOI 10.1016/j.biomaterials.2004.10.018
   Guan JJ, 2005, BIOMACROMOLECULES, V6, P2833, DOI 10.1021/bm0503322
   Guan JJ, 2002, J BIOMED MATER RES, V61, P493, DOI 10.1002/jbm.10204
   Harris DT, 2008, STEM CELL REV, V4, P269, DOI 10.1007/s12015-008-9039-8
   HASEGAWA N, 1988, MECH AGEING DEV, V46, P111, DOI 10.1016/0047-6374(88)90119-4
   Hashi CK, 2007, P NATL ACAD SCI USA, V104, P11915, DOI 10.1073/pnas.0704581104
   Havelka GE, 2011, VASC ENDOVASC SURG, V45, P381, DOI 10.1177/1538574411407698
   He W, 2005, BIOMATERIALS, V26, P7606, DOI 10.1016/j.biomaterials.2005.05.049
   He W, 2010, BIOMATERIALS, V31, P8235, DOI 10.1016/j.biomaterials.2010.07.034
   Hibbert B, 2009, CARDIOVASC RES, V83, P16, DOI 10.1093/cvr/cvp156
   Hoffmann J, 2008, J BIOMED MATER RES A, V84A, P614, DOI 10.1002/jbm.a.31309
   Hong Y, 2010, BIOMATERIALS, V31, P4249, DOI 10.1016/j.biomaterials.2010.02.005
   Hsu SH, 1999, ARTIF ORGANS, V23, P958
   Hsu SH, 2005, MED ENG PHYS, V27, P267, DOI 10.1016/j.medengphy.2004.10.008
   Hsu SH, 2003, ARTIF ORGANS, V27, P1068, DOI 10.1111/j.1525-1594.2003.07141.x
   HUBBELL JA, 1992, ANN NY ACAD SCI, V665, P253, DOI 10.1111/j.1749-6632.1992.tb42589.x
   Isenberg BC, 2006, CIRC RES, V98, P25, DOI 10.1161/01.RES.0000196867.12470.84
   Ishii Y, 2008, J THORAC CARDIOVASC, V135, P45
   Ishii Y, 2008, J THORAC CARDIOV SUR, V135, P1237, DOI 10.1016/j.jtcvs.2007.09.077
   Iwasaki K, 2008, CIRCULATION, V118, pS52, DOI 10.1161/CIRCULATIONAHA.107.757369
   Jankowski RJ, 1999, CLIN PLAST SURG, V26, P605
   Jay SM, 2008, FASEB J, V22, P2949, DOI 10.1096/fj.08-108803
   Jeong SI, 2007, BIOMATERIALS, V28, P1115, DOI 10.1016/j.biomaterials.2006.10.025
   Jun HW, 2005, TISSUE ENG, V11, P1133, DOI 10.1089/ten.2005.11.1133
   Jun HW, 2004, J BIOMAT SCI-POLYM E, V15, P73, DOI 10.1163/156856204322752246
   Kakisis JD, 2005, J VASC SURG, V41, P349, DOI 10.1016/j.jvs.2004.12.026
   Kannan RY, 2005, J BIOMED MATER RES B, V74B, P570, DOI 10.1002/jbm.b.30247
   Ketchedjian A, 2005, J THORAC CARDIOV SUR, V129, P159, DOI 10.1016/j.jtcvs.2004.06.017
   Kidane AG, 2006, J BIOMED MATER RES A, V79A, P606, DOI 10.1002/jbm.a.30817
   Kim WS, 2007, INT J ARTIF ORGANS, V30, P44
   KNOX G, 1957, ANN SURG, V145, P59, DOI 10.1097/00000658-195701000-00005
   Konig G, 2009, BIOMATERIALS, V30, P1542, DOI 10.1016/j.biomaterials.2008.11.011
   Kou PM, 2011, J BIOMED MATER RES A, V96A, P239, DOI 10.1002/jbm.a.32971
   Krenning G, 2009, J CELL MOL MED, V13, P2521, DOI 10.1111/j.1582-4934.2008.00479.x
   Krenning G, 2007, BIOMATERIALS, V28, P1470, DOI 10.1016/j.biomaterials.2006.11.017
   Krijgsman B, 2002, TISSUE ENG, V8, P673, DOI 10.1089/107632702760240580
   Kumar TRS, 2002, J MATER SCI-MATER M, V13, P751, DOI 10.1023/A:1016162706391
   Kuraitis D, 2011, J MOL CELL CARDIOL, V51, P187, DOI 10.1016/j.yjmcc.2011.04.011
   Kuwana M, 2006, STEM CELLS, V24, P2733, DOI 10.1634/stemcells.2006-0026
   L'Heureux N, 1998, FASEB J, V12, P47
   L'Heureux N, 2006, NAT MED, V12, P361, DOI 10.1038/nm1364
   L'Heureux N, 2001, FASEB J, V15, P515, DOI 10.1096/fj.00-0283com
   L'Heureux N, 1999, SCIENCE, V284, P1621
   L'Heureux N, 2007, NEW ENGL J MED, V357, P1451, DOI 10.1056/NEJMc071536
   L'Heureux N, 2007, NAT CLIN PRACT CARD, V4, P389, DOI 10.1038/ncpcardio0930
   Laflamme K, 2005, CIRCULATION, V111, P459, DOI 10.1161/01.CIR.0000153850.53419.50
   Laflamme K, 2006, FASEB J, V20, P1245, DOI 10.1096/fj.05-4702fje
   Laflamme K, 2006, TISSUE ENG, V12, P2275, DOI 10.1089/ten.2006.12.2275
   Lee KW, 2011, P NATL ACAD SCI USA, V108, P2705, DOI 10.1073/pnas.1017834108
   Lee SH, 2003, J BIOMED MATER RES A, V66A, P29, DOI 10.1002/jbm.a.10497
   Lee SH, 2008, BIOMATERIALS, V29, P2962, DOI 10.1016/j.biomaterials.2008.04.004
   Lee SH, 2007, BIOMATERIALS, V28, P3163, DOI 10.1016/j.biomaterials.2007.03.004
   Lepidi S, 2006, EUR J VASC ENDOVASC, V32, P411, DOI 10.1016/j.ejvs.2006.02.012
   Lester EA, 2003, J BIOMED MATER RES A, V64A, P397, DOI 10.1002/jbm.a.10378
   Liu H, 2006, BIOMATERIALS, V27, P6004, DOI 10.1016/j.biomaterials.2006.06.016
   Ma XL, 2010, CARDIOVASC RES, V86, P338, DOI 10.1093/cvr/cvq047
   Ma ZW, 2005, TISSUE ENG, V11, P1149, DOI 10.1089/ten.2005.11.1149
   MARTINPADURA I, 1995, J PATHOL, V175, P51, DOI 10.1002/path.1711750109
   McAllister TN, 2009, LANCET, V373, P1440, DOI 10.1016/S0140-6736(09)60248-8
   McBane JE, 2011, BIOMATERIALS, V32, P6034, DOI 10.1016/j.biomaterials.2011.04.048
   McBane JE, 2011, BIOMATERIALS, V32, P3584, DOI 10.1016/j.biomaterials.2011.01.069
   McBane JE, 2009, BIOMATERIALS, V30, P5497, DOI 10.1016/j.biomaterials.2009.07.010
   McCloskey KE, 2005, TISSUE ENG, V11, P497, DOI 10.1089/ten.2005.11.497
   Miller DC, 2004, BIOMATERIALS, V25, P53, DOI 10.1016/S0142-9612(03)00471-X
   Mironov V, 2008, TRENDS BIOTECHNOL, V26, P338, DOI 10.1016/j.tibtech.2008.03.001
   Mitchell SL, 2003, CARDIOVASC PATHOL, V12, P59, DOI 10.1016/S1054-8807(02)00183-7
   Nakagawa M, 2008, NAT BIOTECHNOL, V26, P101, DOI 10.1038/nbt1374
   Nakayama Y, 2004, CELL TRANSPLANT, V13, P439, DOI 10.3727/000000004783983828
   Narazaki G, 2008, CIRCULATION, V118, P498, DOI 10.1161/CIRCULATIONAHA.108.769562
   Narita Y, 2008, J ARTIF ORGANS, V11, P91, DOI 10.1007/s10047-008-0407-6
   Narita Y, 2008, CELL TISSUE RES, V333, P449, DOI 10.1007/s00441-008-0654-0
   Nelson DM, 2011, PHARM RES-DORDR, V28, P1282, DOI 10.1007/s11095-011-0391-z
   Nieponice A, 2008, BIOMATERIALS, V29, P825, DOI 10.1016/j.biomaterials.2007.10.044
   Nieponice A, 2010, TISSUE ENG PT A, V16, P1215, DOI 10.1089/ten.TEA.2009.0427
   Niklason LE, 1999, SCIENCE, V284, P489, DOI 10.1126/science.284.5413.489
   Nishlbe T, 2007, VASCULAR, V15, P356, DOI 10.2310/6670.2007.00053
   Noah EM, 2002, BIOMATERIALS, V23, P2855, DOI 10.1016/S0142-9612(01)00412-4
   NORTON L, 1975, SURGERY, V77, P280
   Pankajakshan D, 2010, CAN J PHYSIOL PHARM, V88, P855, DOI [10.1139/y10-073, 10.1139/Y10-073]
   Peichev M, 2000, BLOOD, V95, P952
   Riha GM, 2005, TISSUE ENG, V11, P1535, DOI 10.1089/ten.2005.11.1535
   Roh JD, 2010, P NATL ACAD SCI USA, V107, P4669, DOI 10.1073/pnas.0911465107
   Rosamond W, 2007, CIRCULATION, V115, pE69, DOI 10.1161/CIRCULATIONAHA.106.179918
   Rotmans JI, 2003, J SURG RES, V113, P161, DOI 10.1016/S0022-4804(03)00228-2
   ROVNER AS, 1986, J BIOL CHEM, V261, P4740
   Ruel M, 2005, J THORAC CARDIOV SUR, V130, P633, DOI 10.1016/j.jtcvs.2005.01.013
   Santerre JP, 2005, BIOMATERIALS, V26, P7457, DOI 10.1016/j.biomaterials.2005.05.079
   Sarkar S, 2006, EUR J VASC ENDOVASC, V31, P627, DOI 10.1016/j.ejvs.2006.01.006
   Sarkar S, 2008, J BIOMAT SCI-POLYM E, V19, P1347, DOI 10.1163/156856208786052371
   Schaner PJ, 2004, J VASC SURG, V40, P146, DOI 10.1016/j.jvs.2004.03.033
   Schutte RJ, 2009, J BIOMED MATER RES A, V88A, P128, DOI 10.1002/jbm.a.31863
   Schutte RJ, 2009, BIOMATERIALS, V30, P160, DOI 10.1016/j.biomaterials.2008.09.026
   Seliktar D, 2000, ANN BIOMED ENG, V28, P351, DOI 10.1114/1.275
   Serrano MC, 2008, J BIOMED MATER RES A, V87A, P964, DOI 10.1002/jbm.a.31728
   Seta Noriyuki, 2007, Keio Journal of Medicine, V56, P41, DOI 10.2302/kjm.56.41
   Sharifpoor S, 2011, BIOMATERIALS, V32, P4816, DOI 10.1016/j.biomaterials.2011.03.034
   Sharifpoor S, 2010, ACTA BIOMATER, V6, P4218, DOI 10.1016/j.actbio.2010.06.018
   Sharifpoor S, 2009, BIOMACROMOLECULES, V10, P2729, DOI 10.1021/bm9004194
   Shen G, 2003, CELL RES, V13, P335, DOI 10.1038/sj.cr.7290178
   Shirota T, 2003, TISSUE ENG, V9, P127, DOI 10.1089/107632703762687609
   Siepe M, 2008, EUR J CARDIO-THORAC, V34, P242, DOI 10.1016/j.ejcts.2008.03.067
   Soletti L, 2006, BIOMATERIALS, V27, P4863, DOI 10.1016/j.biomaterials.2006.04.042
   Soletti L, 2010, ACTA BIOMATER, V6, P110, DOI 10.1016/j.actbio.2009.06.026
   SOYER T, 1972, SURGERY, V72, P864
   Sreerekha PR, 2006, ARTIF ORGANS, V30, P242, DOI 10.1111/j.1525-1594.2006.00211.x
   Statistics Canada, 2004, CAUS DEATH
   Stitzel J, 2006, BIOMATERIALS, V27, P1088, DOI 10.1016/j.biomaterials.2005.07.048
   Suuronen EJ, 2006, CIRCULATION, V114, pI138, DOI 10.1161/CIRCULATIONAHA.105.001081
   Suuronen EJ, 2006, CARDIOVASC RES, V70, P126, DOI 10.1016/j.cardiores.2006.01.014
   Suuronen EJ, 2009, FASEB J, V23, P1447, DOI 10.1096/fj.08-111054
   Suzuki T, 2009, MICROVASC RES, V77, P143, DOI 10.1016/j.mvr.2008.08.006
   Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019
   Takaku M, 1999, ARTERIOSCL THROM VAS, V19, P2330, DOI 10.1161/01.ATV.19.10.2330
   Tang XJ, 2006, J MATER SCI-MATER M, V17, P627, DOI 10.1007/s10856-006-9225-7
   Teebken OE, 2000, EUR J VASC ENDOVASC, V19, P381, DOI 10.1053/ejvs.1999.1004
   Thebaud NB, 2007, J MATER SCI-MATER M, V18, P339, DOI 10.1007/s10856-006-0698-1
   Tieu BC, 2011, J VASC RES, V48, P261, DOI 10.1159/000320358
   van Andel CJ, 2003, ANN THORAC SURG, V76, P58, DOI 10.1016/S0003-4975(03)00263-7
   Venugopal J, 2005, CELL BIOL INT, V29, P861, DOI 10.1016/j.cellbi.2005.03.026
   VOYTA JC, 1984, J CELL BIOL, V99, P2034, DOI 10.1083/jcb.99.6.2034
   WAGNER DD, 1982, J CELL BIOL, V95, P355, DOI 10.1083/jcb.95.1.355
   Walles T, 2003, BIOMATERIALS, V24, P1233, DOI 10.1016/S0142-9612(02)00490-8
   Wang CR, 2002, J BIOMED MATER RES, V62, P315, DOI 10.1002/jbm.10137
   Wang F, 2009, ACTA BIOMATER, V5, P2901, DOI 10.1016/j.actbio.2009.04.016
   Watanabe T, 2007, J ARTIF ORGANS, V10, P10, DOI 10.1007/s10047-006-0361-0
   Watanabe T, 2010, J BIOMED MATER RES B, V92B, P236, DOI 10.1002/jbm.b.31510
   WEINBERG CB, 1986, SCIENCE, V231, P397, DOI 10.1126/science.2934816
   Weissberg P L, 1995, Blood Press Suppl, V2, P68
   [温绍君 Wen Shaojun], 2005, [中华医学杂志, National Medical Journal of China], V85, P816
   Williamson MR, 2006, BIOMATERIALS, V27, P3608, DOI 10.1016/j.biomaterials.2006.02.025
   Wu KH, 2007, J CELL BIOCHEM, V100, P608, DOI 10.1002/jcb.21078
   Wykrzykowska JJ, 2009, EXPERT OPIN DRUG DEL, V6, P113, DOI [10.1517/17425240802668495 , 10.1517/17425240802668495]
   Xie CQ, 2009, STEM CELLS DEV, V18, P741, DOI 10.1089/scd.2008.0179
   Zeltinger J, 2001, TISSUE ENG, V7, P557, DOI 10.1089/107632701753213183
   Zhang J, 2006, ARTIF ORGANS, V30, P898, DOI 10.1111/j.1525-1594.2006.00322.x
   Zhang L, 2006, J BIOMED MATER RES A, V77A, P277, DOI 10.1002/jbm.a.30614
   Zhang L, 2008, BIOTECHNOL BIOENG, V99, P1007, DOI 10.1002/bit.21629
   Zhang P, 2008, TISSUE ENG ROLES MAT, P67
   Zuba-Surma EK, 2009, CYTOM PART A, V75A, P4, DOI 10.1002/cyto.a.20665
NR 188
TC 12
Z9 12
U1 4
U2 53
PU BENTHAM SCIENCE PUBL LTD
PI SHARJAH
PA EXECUTIVE STE Y-2, PO BOX 7917, SAIF ZONE, 1200 BR SHARJAH, U ARAB
   EMIRATES
SN 1570-1611
EI 1875-6212
J9 CURR VASC PHARMACOL
JI Current Vascular Pharmacology
PD MAY
PY 2012
VL 10
IS 3
BP 347
EP 360
PG 14
WC Pharmacology & Pharmacy; Peripheral Vascular Disease
SC Pharmacology & Pharmacy; Cardiovascular System & Cardiology
GA 931ZQ
UT WOS:000303258600010
PM 22239637
DA 2018-10-19
ER

PT J
AU Silva, ES
   Sousa, RC
   Jorge, AM
   Balancin, O
AF Silva, E. S.
   Sousa, R. C.
   Jorge, A. M., Jr.
   Balancin, O.
TI Hot deformation behavior of an Nb- and N-bearing austenitic stainless
   steel biomaterial
SO MATERIALS SCIENCE AND ENGINEERING A-STRUCTURAL MATERIALS PROPERTIES
   MICROSTRUCTURE AND PROCESSING
LA English
DT Article
DE Biomaterial; Stainless steel; Workability; Processing map
ID HIGH-TEMPERATURES; PROCESSING MAPS; WORKABILITY; STRAIN; MICROSTRUCTURE;
   OPTIMIZATION; COMPRESSION; WORKING; ALLOY
AB An austenitic stainless steel (ISO 5832-9) with an intermediate level of stacking fault energy (SFE) was torsion-deformed at temperatures ranging from 900 to 1200 degrees C and at strain rates ranging from 0.01 to 10 s(-1). The hot deformation behavior was analyzed based on variations in the shape of flow stress curves, a constitutive equation, processing maps and the final microstructures. In large deformations, a region of instability in the temperature-strain rate space was observed at low temperature and high strain rates, and domains of easy processing were determined at high and intermediate temperatures and low strain rates. The final microstructure was analyzed based on the evolution of the internal structure over time in response to hardening and softening mechanisms such as work hardening, recovery and recrystallization. (C) 2012 Elsevier B.V. All rights reserved.
C1 [Silva, E. S.; Jorge, A. M., Jr.; Balancin, O.] Fed Univ Sao Carlos UFSCar, Sao Carlos, SP, Brazil.
   [Sousa, R. C.] Fed Univ Maranhao UFMA, Sao Luis, MA, Brazil.
RP Jorge, AM (reprint author), Fed Univ Sao Carlos UFSCar, Sao Carlos, SP, Brazil.
EM moreira@dema.ufscar.br
RI Jorge Junior, Alberto/B-2566-2012
OI Jorge Junior, Alberto/0000-0002-8121-9834
FU CAPES (Brazil)
FX The authors thank CAPES (Brazil) for its financial support of this work.
CR ADEVA P, 1995, MAT SCI ENG A-STRUCT, V194, P17, DOI 10.1016/0921-5093(94)09654-6
   Balancin O, 2000, METALL MATER TRANS A, V31, P1353, DOI 10.1007/s11661-000-0254-4
   Cai DY, 2007, MATER CHARACT, V58, P941, DOI 10.1016/j.matchar.2006.09.004
   Giordani EJ, 2006, SCRIPTA MATER, V55, P743, DOI 10.1016/j.scriptamat.2006.05.015
   Giordani EJ, 2005, MATER SCI FORUM, V500-501, P179, DOI 10.4028/www.scientific.net/MSF.500-501.179
   Giordani EJ, 2004, INT J FATIGUE, V26, P1129, DOI 10.1016/j.ijfatigue.2004.03.002
   Jorge Junior Alberto Moreira, 2005, Mat. Res., V8, P309, DOI 10.1590/S1516-14392005000300015
   LAASRAOUI A, 1991, METALL TRANS A, V22, P1545, DOI 10.1007/BF02667368
   Lin YC, 2009, MAT SCI ENG A-STRUCT, V523, P139, DOI 10.1016/j.msea.2009.05.056
   McQueen HJ, 2002, MAT SCI ENG A-STRUCT, V322, P43, DOI 10.1016/S0921-5093(01)01117-0
   Ornhagen C, 1996, J BIOMED MATER RES, V31, P97, DOI 10.1002/(SICI)1097-4636(199605)31:1<97::AID-JBM12>3.0.CO;2-J
   Prasad Y. V. R. K., 1997, HOT WORKING GUIDE CO
   Prasad YVRK, 1998, INT MATER REV, V43, P243, DOI 10.1179/imr.1998.43.6.243
   SCHRAMM RE, 1975, METALL TRANS A, V6, P1345, DOI 10.1007/BF02641927
   Sui FL, 2011, J MATER PROCESS TECH, V211, P433, DOI 10.1016/j.jmatprotec.2010.10.015
   Tan SP, 2009, MAT SCI ENG A-STRUCT, V517, P312, DOI 10.1016/j.msea.2009.04.028
   UVIRA JL, 1968, T METALL SOC AIME, V242, P1619
   VENUGOPAL S, 1992, METALL TRANS A, V23, P3093, DOI 10.1007/BF02646128
   Venugopal S, 1995, J NUCL MATER, V227, P1, DOI 10.1016/0022-3115(95)00154-9
   Wenhui Z., 2011, MATER DESIGN, V32, P4173
NR 20
TC 12
Z9 12
U1 2
U2 7
PU ELSEVIER SCIENCE SA
PI LAUSANNE
PA PO BOX 564, 1001 LAUSANNE, SWITZERLAND
SN 0921-5093
J9 MAT SCI ENG A-STRUCT
JI Mater. Sci. Eng. A-Struct. Mater. Prop. Microstruct. Process.
PD MAY 1
PY 2012
VL 543
BP 69
EP 75
DI 10.1016/j.msea.2012.02.048
PG 7
WC Nanoscience & Nanotechnology; Materials Science, Multidisciplinary;
   Metallurgy & Metallurgical Engineering
SC Science & Technology - Other Topics; Materials Science; Metallurgy &
   Metallurgical Engineering
GA 932NS
UT WOS:000303298400009
DA 2018-10-19
ER

PT J
AU Kundu, J
   Poole-Warren, LA
   Martens, P
   Kundu, SC
AF Kundu, Joydip
   Poole-Warren, Laura A.
   Martens, Penny
   Kundu, Subhas C.
TI Silk fibroin/poly(vinyl alcohol) photocrosslinked hydrogels for delivery
   of macromolecular drugs
SO ACTA BIOMATERIALIA
LA English
DT Article
DE Silk fibroin; Poly(vinyl alcohol); Photocrosslinking; Hydrogel; Drug
   delivery
ID MODIFIED POLY(VINYL ALCOHOL); INTERPENETRATING POLYMER NETWORK;
   METHACRYLATE HYDROGELS; FIBROIN; MACROMERS; RELEASE; ENCAPSULATION;
   BIOMATERIAL; POLOXAMER; MEDICINE
AB Hydrogels are three-dimensional polymer networks widely used in biomedical applications as drug delivery and tissue engineered scaffolds to effectively repair or replace damaged tissue. In this paper we demonstrate a newly synthesized cytocompatible and drug releasing photo-crosslinked hydrogel based on poly(vinyl alcohol) methacrylate and silk fibroin which possesses tailorable structural and biological properties. The initial silk fibroin content was 0%, 10%, 20%, 30%, 40% and 50% with respect to the weight of poly(vinyl alcohol) methacrylate. The prepared hydrogels were characterized with respect to morphology, crystallinity, stability, swelling, mass loss and cytotoxicity. FITC-dextrans of different molecular weights were chosen as model drugs molecules for release studies from the hydrogels. The hydrogels containing different silk fibroin percentages showed differences in pore size and distribution. X-ray diffraction analysis revealed that amorphous silk fibroin in poly(vinyl alcohol) methacrylate is crystallized to beta-sheet secondary structure upon gelation. The sol fraction increased with increasing fibroin concentration in the co-polymer gel (from 18% to 45%), although the hydrogel extracts were non-cytotoxic. Similarly, the addition of silk fibroin increased water uptake by the gels (from 7% to 21%). FITC-dextran release from the hydrogels was dependent on the silk fibroin content and the molecular weight of encapsulated molecules. The study outlines a newer type of photo-crosslinked interpenetrating polymer network hydrogel that possess immense potential in drug delivery applications. (C) 2012 Acta Materialia Inc. Published by Elsevier Ltd. All rights reserved.
C1 [Kundu, Joydip; Kundu, Subhas C.] Indian Inst Technol, Dept Biotechnol, Kharagpur 721302, W Bengal, India.
   [Poole-Warren, Laura A.; Martens, Penny] Univ New S Wales, Grad Sch Biomed Engn, Sydney, NSW 2052, Australia.
RP Kundu, SC (reprint author), Indian Inst Technol, Dept Biotechnol, Kharagpur 721302, W Bengal, India.
EM kundu@hijli.iitkgp.ernet.in
RI Martens, Penny/B-4274-2011
OI Martens, Penny/0000-0003-3098-1420; Poole-Warren,
   Laura/0000-0002-4414-022X; Kundu, Subhas C./0000-0002-7170-2291
FU Indian Government [BT/PR9552/747ICD/16/ 755/ 2006, BF010049]; Australian
   Government [BT/PR9552/747ICD/16/ 755/ 2006, BF010049]; Department of
   Biotechnology, Government of India, New Delhi; Department of Science and
   Technology, Government of India, New Delhi
FX This work was financially supported by the Indian and Australian
   Governments under the Australia-India Strategic Research Fund,
   Indo-Australia Biotechnology Fund (BT/PR9552/747ICD/16/ 755/ 2006 and
   BF010049), Department of Biotechnology, and Department of Science and
   Technology, Government of India, New Delhi.
CR Altman GH, 2003, BIOMATERIALS, V24, P401, DOI 10.1016/S0142-9612(02)00353-8
   Anseth KS, 2002, J CONTROL RELEASE, V78, P199, DOI 10.1016/S0168-3659(01)00500-4
   BANGA AK, 1993, PHARMACEUT RES, V10, P697, DOI 10.1023/A:1018955631835
   Beamish JA, 2010, J BIOMED MATER RES A, V92A, P441, DOI 10.1002/jbm.a.32353
   Bryant SJ, 2004, MACROMOLECULES, V37, P6726, DOI 10.1021/ma0499324
   Bryant SJ, 2003, J BIOMED MATER RES A, V64A, P70, DOI 10.1002/jbm.a.10319
   Chen X, 1997, J APPL POLYM SCI, V65, P2257, DOI 10.1002/(SICI)1097-4628(19970912)65:11<2257::AID-APP23>3.0.CO;2-Z
   Dash S, 2010, ACTA POL PHARM, V67, P217
   de Vos P, 2009, BIOMATERIALS, V30, P2559, DOI 10.1016/j.biomaterials.2009.01.014
   Fang Jia-You, 2006, Chem Pharm Bull (Tokyo), V54, P156, DOI 10.1248/cpb.54.156
   Gil ES, 2005, MACROMOL BIOSCI, V5, P702, DOI 10.1002/mabi.200500076
   Gil ES, 2007, BIOMACROMOLECULES, V8, P258, DOI 10.1021/bm060543m
   GUPTA N, 1994, POLYM INT, V35, P109, DOI 10.1002/pi.1994.210350201
   Kang GD, 2000, MACROMOL RAPID COMM, V21, P788, DOI 10.1002/1521-3927(20000701)21:11<788::AID-MARC788>3.3.CO;2-O
   Kim SH, 2000, J BIOMED MATER RES, V49, P517, DOI 10.1002/(SICI)1097-4636(20000315)49:4<517::AID-JBM10>3.0.CO;2-8
   Kundu J, 2008, J MATER SCI-MATER M, V19, P2679, DOI 10.1007/s10856-008-3398-1
   Kundu J, 2010, INT J PHARMACEUT, V388, P242, DOI 10.1016/j.ijpharm.2009.12.052
   Li MZ, 2001, MACROMOL MATER ENG, V286, P529
   Liu YX, 2010, BIOMATERIALS, V31, P1158, DOI 10.1016/j.biomaterials.2009.10.040
   Lu Q, 2008, J BIOMED MATER RES A, V1, P198
   Malafaya PB, 2007, ADV DRUG DELIVER REV, V59, P207, DOI 10.1016/j.addr.2007.03.012
   Mandal BB, 2009, BIOMATERIALS, V30, P2826, DOI 10.1016/j.biomaterials.2009.01.040
   Mann BK, 2001, BIOMATERIALS, V22, P3045, DOI 10.1016/S0142-9612(01)00051-5
   Martens P, 2000, POLYMER, V41, P7715, DOI 10.1016/S0032-3861(00)00123-3
   Martens P, 2002, POLYMER, V43, P6093, DOI 10.1016/S0032-3861(02)00561-X
   Martens P, 2007, CHEM MATER, V19, P2641, DOI 10.1021/cm0626381
   Mathews DT, 2007, J BIOMED MATER RES B, V84, P531
   Matsumoto A, 2006, J PHYS CHEM B, V110, P21630, DOI 10.1021/jp056350v
   Mawad D, 2009, INT J PHARM, V366, P31, DOI 10.1016/j.ijpharm.2008.08.038
   Mawad D, 2008, BIOMACROMOLECULES, V9, P263, DOI 10.1021/bm700754m
   Mosmann T, 1993, J IMMUNOL METHODS, V95, P55
   Muhlebach A, 1997, J POLYM SCI POL CHEM, V35, P3603
   Murphy AR, 2009, J MATER CHEM, V19, P6443, DOI 10.1039/b905802h
   Myung D, 2008, POLYM ADVAN TECHNOL, V19, P647, DOI 10.1002/pat.1134
   Nguyen KT, 2002, BIOMATERIALS, V23, P4337
   Nichol JW, 2010, BIOMATERIALS, V31, P5536, DOI 10.1016/j.biomaterials.2010.03.064
   Nilasaroya A, 2008, BIOMATERIALS, V29, P4658, DOI 10.1016/j.biomaterials.2008.08.011
   Noomrio MH, 2005, BIOTECHNOL LETT, V27, P1587, DOI 10.1007/s10529-005-1801-2
   Omenetto FG, 2010, SCIENCE, V329, P528, DOI 10.1126/science.1188936
   Peppas NA, 2000, EUR J PHARM BIOPHARM, V50, P27, DOI 10.1016/S0939-6411(00)00090-4
   Sashina ES, 2006, RUSS J APPL CHEM+, V79, P869, DOI 10.1134/S1070427206060012
   Slaughter BV, 2009, ADV MATER, V21, P3307, DOI 10.1002/adma.200802106
   Ta HT, 2008, J CONTROL RELEASE, V126, P205, DOI 10.1016/j.jconrel.2007.11.018
   Um IC, 2001, INT J BIOL MACROMOL, V29, P91, DOI 10.1016/S0141-8130(01)00159-3
   Vepari C, 2007, PROG POLYM SCI, V32, P991, DOI 10.1016/j.progpolymsci.2007.05.013
   Wang XQ, 2008, BIOMATERIALS, V29, P1054, DOI 10.1016/j.biomaterials.2007.11.003
   Wang XQ, 2010, BIOMATERIALS, V31, P1025, DOI 10.1016/j.biomaterials.2009.11.002
   WEST JL, 1995, REACT POLYM, V25, P139, DOI 10.1016/0923-1137(94)00096-N
   Yoo MK, 2004, INT J BIOL MACROMOL, V34, P263, DOI 10.1016/j.ijbiomac.2004.06.002
NR 49
TC 63
Z9 70
U1 18
U2 131
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1742-7061
J9 ACTA BIOMATER
JI Acta Biomater.
PD MAY
PY 2012
VL 8
IS 5
BP 1720
EP 1729
DI 10.1016/j.actbio.2012.01.004
PG 10
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 928NL
UT WOS:000302989700007
PM 22285428
DA 2018-10-19
ER

PT J
AU Tayton, E
   Purcell, M
   Aarvold, A
   Smith, JO
   Kalra, S
   Briscoe, A
   Shakesheff, K
   Howdle, SM
   Dunlop, DG
   Oreffo, ROC
AF Tayton, Edward
   Purcell, M.
   Aarvold, A.
   Smith, J. O.
   Kalra, S.
   Briscoe, A.
   Shakesheff, K.
   Howdle, S. M.
   Dunlop, D. G.
   Oreffo, R. O. C.
TI Supercritical CO2 fluid-foaming of polymers to increase porosity: A
   method to improve the mechanical and biocompatibility characteristics
   for use as a potential alternative to allografts in impaction bone
   grafting?
SO ACTA BIOMATERIALIA
LA English
DT Article
DE Bone tissue engineering; Biocompatibility; Mesenchymal stem cell;
   Porosity; Scaffold
ID MESENCHYMAL STEM-CELLS; MARROW STROMAL CELLS; HIP REPLACEMENTS;
   PORE-SIZE; REVISION; SCAFFOLDS; SUBSTITUTE; ACETABULUM; ADHESION
AB Disease transmission, availability and cost of allografts have resulted in significant efforts to find an alternative for use in impaction bone grafting (IBG). Recent studies identified two polymers with both structural strength and biocompatibility characteristics as potential replacements. The aim of this study was to assess whether increasing the polymer porosity further enhanced the mechanical and cellular compatibility characteristics for use as an osteogenic biomaterial alternative to allografts in IBG. Solid and porous poly(DL-lactide) (P(DL)LA) and poly(DL-lactide-co-glycolide) (P(DL)LGA) scaffolds were produced via melt processing and supercritical CO2 foaming, and the differences characterized using scanning electron microscopy (SEM). Mechanical testing included milling and impaction, with comparisons made using a shear testing rig as well as a novel agitation test for cohesion. Cellular compatibility tests for cell number, viability, and osteogenic differentiation using WST-1 assays, fluorostaining, and ALP assays were determined following 14 day culture with skeletal stem cells. SEM showed excellent porosity throughout both of the supercritical-foam-produced polymer scaffolds, with pores between 50 and 200 mu m. Shear testing showed that the porous polymers exceeded the shear strength of allograft controls (P < 0.001). Agitation testing showed greater cohesion between the particles of the porous polymers (P < 0.05). Cellular studies showed increased cell number, viability, and osteogenic differentiation on the porous polymers compared to solid block polymers (P < 0.05). The use of supercritical CO2 to generate porous polymeric biodegradable scaffolds significantly improves the cellular compatibility and cohesion observed compared to non-porous counterparts, without substantial loss of mechanical shear strength. These improved characteristics are critical for clinical translation as a potential osteogenic composite for use in IBG. (C) 2012 Acta Materialia Inc. Published by Elsevier Ltd. All rights reserved.
C1 [Tayton, Edward; Aarvold, A.; Smith, J. O.; Kalra, S.; Briscoe, A.; Dunlop, D. G.; Oreffo, R. O. C.] Univ Southampton, Sch Med, Bone & Joint Res Grp, Southampton SO16 6YD, Hants, England.
   [Purcell, M.; Howdle, S. M.] Univ Nottingham, Sch Chem, Nottingham NG7 2RD, England.
   [Shakesheff, K.] Univ Nottingham, Sch Pharm, Nottingham NG7 2RD, England.
RP Tayton, E (reprint author), Univ Southampton, Sch Med, Bone & Joint Res Grp, Southampton SO16 6YD, Hants, England.
EM E.R.TAYTON@SOTON.AC.UK
RI Shakesheff, Kevin/O-6371-2018; Howdle, Steven/A-2954-2010; Oreffo,
   Richard/A-4615-2011
OI Shakesheff, Kevin/0000-0003-3236-2439; Howdle,
   Steven/0000-0001-5901-8342; Oreffo, Richard/0000-0001-5995-6726
FU Medical Research Council (MRC) [DPFS G0802397]; Engineering and Physical
   Sciences Research Council [TS/G001650/1, EP/H01506X/1, EP/H028277/1];
   Medical Research Council [G0802397]
FX This was a Medical Research Council (MRC) funded project (DPFS
   G0802397). The MRC played no role in study design; in the collection,
   analysis and interpretation of data; in the writing of the report; and
   in the decision to submit the paper for publication.
CR Agrawal CM, 2001, J BIOMED MATER RES, V55, P141, DOI 10.1002/1097-4636(200105)55:2<141::AID-JBM1000>3.0.CO;2-J
   [Anonymous], 2011, 8 NAT JOINT REG ENGL
   [Anonymous], 2000, D216600 ASTM
   [Anonymous], 2011, OFF NAT STAT 2011 PO
   Blom AW, 2009, ACTA ORTHOP, V80, P150, DOI 10.3109/17453670902884767
   Blom AW, 2005, J BONE JOINT SURG BR, V87B, P421, DOI 10.1302/0301-620X.87B3
   Bolland BJRF, 2008, BIOMATERIALS, V29, P3221, DOI 10.1016/j.biomaterials.2008.04.017
   Bolland BJRF, 2006, REGEN MED, V1, P457, DOI 10.2217/17460751.1.4.457
   Brewster NT, 1999, J BONE JOINT SURG BR, V81B, P118, DOI 10.1302/0301-620X.81B1.8480
   Chang Z, 2000, FASEB J, V14, P137
   Cukierman E, 2001, SCIENCE, V294, P1708, DOI 10.1126/science.1064829
   Dunlop DG, 2003, J BONE JOINT SURG AM, V85A, P639, DOI 10.2106/00004623-200304000-00009
   Galea G, 1998, J BONE JOINT SURG BR, V80B, P595, DOI 10.1302/0301-620X.80B4.8240
   Halliday BR, 2003, J BONE JOINT SURG BR, V85B, P809, DOI 10.1302/0301-620X.85B6.13806
   Hubbell JA, 2003, CURR OPIN BIOTECH, V14, P551, DOI 10.1016/j.copbio.2003.09.004
   Huo M H, 1992, J Arthroplasty, V7, P109, DOI 10.1016/0883-5403(92)90003-9
   Jones AMH, 2009, EUR CELLS MATER, V18, P26
   Korda M, 2006, TISSUE ENG, V12, P625, DOI 10.1089/ten.2006.12.625
   Korda M, 2008, J ORTHOP RES, V26, P880, DOI 10.1002/jor.20598
   Marois Y, 1999, ASAIO J, V45, P272, DOI 10.1097/00002480-199907000-00005
   McNamara I, 2010, J BONE JOINT SURG BR, V92B, P617, DOI 10.1302/0301-620X.92B5.23044
   Miot S, 2005, BIOMATERIALS, V26, P2479, DOI 10.1016/j.biomaterials.2004.06.048
   O'Brien FJ, 2005, BIOMATERIALS, V26, P433, DOI 10.1016/j.biomaterials.2004.02.052
   Oakley J, 2006, J BONE JOINT SURG BR, V88B, P828, DOI 10.1302/0301-620X.88B6
   Schreurs BW, 2009, J BONE JOINT SURG BR, V91B, P1148, DOI 10.1302/0301-620X.91B9.21750
   SIMONDS RJ, 1992, NEW ENGL J MED, V326, P726, DOI 10.1056/NEJM199203123261102
   Tai HY, 2007, EUR CELLS MATER, V14, P64, DOI 10.22203/eCM.v014a07
   Tayton ER, 2011, J BONE JOIN IN PRESS
   Tillman J, 2006, BIOMATERIALS, V27, P5618, DOI 10.1016/j.biomaterials.2006.07.006
   VandeVondele S, 2003, BIOTECHNOL BIOENG, V82, P784, DOI 10.1002/bit.10625
NR 30
TC 19
Z9 22
U1 2
U2 33
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1742-7061
J9 ACTA BIOMATER
JI Acta Biomater.
PD MAY
PY 2012
VL 8
IS 5
BP 1918
EP 1927
DI 10.1016/j.actbio.2012.01.024
PG 10
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 928NL
UT WOS:000302989700026
PM 22307029
DA 2018-10-19
ER

PT J
AU Park, JH
   Olivares-Navarrete, R
   Baier, RE
   Meyer, AE
   Tannenbaum, R
   Boyan, BD
   Schwartz, Z
AF Park, Jung Hwa
   Olivares-Navarrete, Rene
   Baier, Robert E.
   Meyer, Anne E.
   Tannenbaum, Rina
   Boyan, Barbara D.
   Schwartz, Zvi
TI Effect of cleaning and sterilization on titanium implant surface
   properties and cellular response
SO ACTA BIOMATERIALIA
LA English
DT Article
DE Titanium; Sterilization; Roughness; Hydrophilicity; MG63 cells
ID SPECTROSCOPIC CHARACTERIZATION; PREPARATIVE PROCEDURES; GLOW-DISCHARGE;
   ENERGY; BIOMATERIAL; TOPOGRAPHY; PLASMA; BONE; DIFFERENTIATION;
   CONTAMINATION
AB Titanium (Ti) has been widely used as an implant material due to the excellent biocompatibility and corrosion resistance of its oxide surface. Biomaterials must be sterile before implantation, but the effects of sterilization on their surface properties have been less well studied. The effects of cleaning and sterilization on surface characteristics were bio-determined using contaminated and pure Ti substrata first manufactured to present two different surface structures: pretreated titanium (PT, Ra = 0.4 mu m) (i.e. surfaces that were not modified by sandblasting and/or acid etching); (SLA, Ra = 3.4 mu m). Previously cultured cells and associated extracellular matrix were removed from all bio-contaminated specimens by cleaning in a sonicator bath with a sequential acetone-isopropanol-ethanol-distilled water protocol. Cleaned specimens were sterilized with autoclave, gamma irradiation, oxygen plasma, or ultraviolet light. X-ray photoelectron spectroscopy (XPS), contact angle measurements, profilometry, and scanning electron microscopy were used to examine surface chemical components, hydrophilicity, roughness, and morphology, respectively. Small organic molecules present on contaminated Ti surfaces were removed with cleaning. XPS analysis confirmed that surface chemistry was altered by both cleaning and sterilization. Cleaning and sterilization affected hydrophobicity and roughness. These modified surface properties affected osteogenic differentiation of human MG63 osteoblast-like cells. Specifically, autoclaved SLA surfaces lost the characteristic increase in osteoblast differentiation seen on starting SLA surfaces, which was correlated with altered surface wettability and roughness. These data indicated that recleaned and resterilized Ti implant surfaces cannot be considered the same as the first surfaces in terms of surface properties and cell responses. Therefore, the reuse of Ti implants after resterilization may not result in the same tissue responses as found with never-before-implanted specimens. (C) 2011 Acta Materialia Inc. Published by Elsevier Ltd. All rights reserved.
C1 [Olivares-Navarrete, Rene; Boyan, Barbara D.] Georgia Inst Technol, Dept Biomed Engn, Atlanta, GA 30332 USA.
   [Park, Jung Hwa; Boyan, Barbara D.] Georgia Inst Technol, Sch Mat Sci & Engn, Atlanta, GA 30332 USA.
   [Baier, Robert E.; Meyer, Anne E.] SUNY Buffalo, Dept Oral Diagnost Sci, Buffalo, NY 14260 USA.
   [Tannenbaum, Rina] Boston Univ, Dept Mech Engn, Boston, MA 02215 USA.
   [Tannenbaum, Rina] Boston Univ, Dept Biomed Engn, Boston, MA 02215 USA.
   [Schwartz, Zvi] Univ Texas Hlth Sci Ctr San Antonio, Dept Periodont, San Antonio, TX 78229 USA.
RP Boyan, BD (reprint author), Georgia Inst Technol, Dept Biomed Engn, Atlanta, GA 30332 USA.
EM barbara.boyan@bme.gatech.edu
OI Olivares-Navarrete, Rene/0000-0003-1232-9164
FU USPHS [AR052102]; Paper Science and Engineering (PSE) program; Institute
   of Paper Science and Technology (IPST) at Georgia Tech
FX This work was supported by an USPHS Grant AR052102. A graduate
   fellowship (to J.H.P.) was awarded by the Paper Science and Engineering
   (PSE) program and funded through the Institute of Paper Science and
   Technology (IPST) at Georgia Tech. The PT and SLA disks were provided by
   Institut Straumann AG.
CR BAIER RE, 1982, BIOMATERIALS, V3, P241, DOI 10.1016/0142-9612(82)90027-8
   Boyan B. D., 2003, European Cells & Materials, V6, P22
   Boyan BD, 1996, BIOMATERIALS, V17, P137, DOI 10.1016/0142-9612(96)85758-9
   DOUNDOULAKIS JH, 1987, J PROSTHET DENT, V58, P471, DOI 10.1016/0022-3913(87)90279-4
   Esposito M, 1999, J BIOMED MATER RES, V48, P559, DOI 10.1002/(SICI)1097-4636(1999)48:4<559::AID-JBM23>3.0.CO;2-M
   Fleith S, 2005, COLLOID SURFACE B, V44, P15, DOI 10.1016/j.colsurfb.2005.05.009
   GENGENBACH TR, 1994, J POLYM SCI POL CHEM, V32, P1399, DOI 10.1002/pola.1994.080320801
   Holyoak G. R., 1995, Theriogenology, V43, P237, DOI 10.1016/0093-691X(95)92391-L
   KASEMO B, 1988, J BIOMED MATER RES-A, V22, P145, DOI 10.1002/jbm.820221307
   KELLER J C, 1990, International Journal of Oral and Maxillofacial Implants, V5, P360
   Kieswetter K, 1996, J BIOMED MATER RES, V32, P55, DOI 10.1002/(SICI)1097-4636(199609)32:1<55::AID-JBM7>3.0.CO;2-O
   Kilpadi DV, 1998, COLLOID SURFACE A, V135, P89, DOI 10.1016/S0927-7757(97)00237-9
   Lausmaa J, 1996, J ELECTRON SPECTROSC, V81, P343, DOI 10.1016/0368-2048(95)02530-8
   LAUSMAA J, 1985, BIOMATERIALS, V6, P23, DOI 10.1016/0142-9612(85)90033-X
   LAUSMAA J, 1990, APPL SURF SCI, V44, P133, DOI 10.1016/0169-4332(90)90100-E
   Machnee C H, 1993, Int J Oral Maxillofac Implants, V8, P529
   Martin JY, 1996, CLIN ORAL IMPLAN RES, V7, P27, DOI 10.1034/j.1600-0501.1996.070104.x
   Mavrogenis AF, 2009, J MUSCULOSKEL NEURON, V9, P61
   Olivares-Navarrete R, 2010, BIOMATERIALS, V31, P2728, DOI 10.1016/j.biomaterials.2009.12.029
   Pandiyaraj KN, 2009, CURR APPL PHYS, V9, P1032, DOI 10.1016/j.cap.2008.11.005
   Pegueroles M, 2008, SURF COAT TECH, V202, P3470, DOI 10.1016/j.surfcoat.2007.12.021
   Ponter AB, 2002, CONTACT ANGLE WETTAB, V2, P331
   Premnath V, 1996, BIOMATERIALS, V17, P1741, DOI 10.1016/0142-9612(95)00349-5
   Qiu QQ, 2008, J BIOMED MATER RES A, V87A, P373, DOI 10.1002/jbm.a.31790
   Rossi F, 2009, NEW J PHYS, V11, P115017
   Roth S, 2010, J APPL MICROBIOL, V108, P521, DOI 10.1111/j.1365-2672.2009.04453.x
   Rupp F, 2006, J BIOMED MATER RES A, V76A, P323, DOI 10.1002/jbm.a.30518
   SCHWARTZ Z, 1994, J CELL BIOCHEM, V56, P340, DOI 10.1002/jcb.240560310
   Schwarz F, 2009, J BIOMED MATER RES B, V88B, P544, DOI 10.1002/jbm.b.31233
   Serro AP, 2003, BIOMATERIALS, V24, P4749, DOI 10.1016/S0142-9612(03)00372-7
   Singh S, 1989, Int J Oral Maxillofac Implants, V4, P139
   SMITH DC, 1991, J BIOMED MATER RES, V25, P1045, DOI 10.1002/jbm.820250902
   SMITH DC, 1991, J BIOMED MATER RES, V25, P1069, DOI 10.1002/jbm.820250903
   STANFORD CM, 1994, J DENT RES, V73, P1061, DOI 10.1177/00220345940730050801
   Suzuki T, 2009, TISSUE ENG PT A, V15, P3679, DOI 10.1089/ten.TEA.2008.0568
   Yang LQ, 2009, APPL SURF SCI, V255, P8960, DOI 10.1016/j.apsusc.2009.03.026
   Zhao G, 2007, BIOMATERIALS, V28, P2821, DOI 10.1016/j.biomaterials.2007.02.024
   Zhao G, 2005, J BIOMED MATER RES A, V74A, P49, DOI 10.1002/jbm.a.30320
NR 38
TC 75
Z9 77
U1 1
U2 66
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1742-7061
J9 ACTA BIOMATER
JI Acta Biomater.
PD MAY
PY 2012
VL 8
IS 5
BP 1966
EP 1975
DI 10.1016/j.actbio.2011.11.026
PG 10
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 928NL
UT WOS:000302989700032
PM 22154860
OA Green Accepted
DA 2018-10-19
ER

PT J
AU Previtera, ML
   Trout, KL
   Verma, D
   Chippada, U
   Schloss, RS
   Langrana, NA
AF Previtera, Michelle L.
   Trout, Kevin L.
   Verma, Devendra
   Chippada, Uday
   Schloss, Rene S.
   Langrana, Noshir A.
TI Fibroblast Morphology on Dynamic Softening of Hydrogels
SO ANNALS OF BIOMEDICAL ENGINEERING
LA English
DT Article
DE Stress; Strain; ECM; Compliance; Stiffness; DNA gel; Wound healing
ID CROSS-LINKED GELS; EXTRACELLULAR-MATRIX; MECHANICAL-PROPERTIES;
   SUBSTRATE STIFFNESS; TRACTION FORCES; CELL-MIGRATION; ADHESION; STRESS;
   GROWTH; TISSUE
AB Despite cellular environments having dynamic characteristics, many laboratories utilized static polyacrylamide hydrogels to study the ECM-cell relationship. To attain a more in vivo like environment, we have developed a dynamic, DNA-crosslinked hydrogel (DNA gel). Through the controlled delivery of DNA, we can temporally decrease or increase gel stiffness while expanding or contracting the gel, respectively. These dual mechanical changes make DNA gels a cell-ECM model for studying dynamic mechano-regulated processes, such as wound healing. Here, we characterized DNA gels on a mechanical and cellular level. In contrast to our previous publication, in which we examined the increasing stiffness effects on fibroblast morphology, we examined the effects of decreased matrix stiffness on fibroblast morphology. In addition, we quantified the bulk and/or local stress and strain properties of dynamic gels. Gels generated about 0.5 Pa stress and about 6-11% strain upon softening to generate larger and more circular fibroblasts. These results complemented our previous study, where dynamic gels contracted upon stiffening to generate smaller and longer fibroblasts. In conclusion, we developed a biomaterial that increases and decreases in stiffness while contracting and expanding, respectively. We found that the dynamic deformation directionality of the matrix determined the fibroblast morphology and possibly influences function.
C1 [Chippada, Uday; Langrana, Noshir A.] Rutgers State Univ, Dept Mech Engn & Aerosp, Piscataway, NJ 08854 USA.
   [Previtera, Michelle L.; Verma, Devendra; Schloss, Rene S.; Langrana, Noshir A.] Rutgers State Univ, Dept Biomed Engn, Piscataway, NJ 08854 USA.
   [Trout, Kevin L.] Coll St Scholast, Dept Chem & Biochem, Duluth, MN 55811 USA.
RP Langrana, NA (reprint author), Rutgers State Univ, Dept Mech Engn & Aerosp, 599 Taylor Rd, Piscataway, NJ 08854 USA.
EM Langrana@rutgers.edu
RI Verma, Devendra/J-3122-2012; Chippada, Uday/A-5732-2013
OI Verma, Devendra/0000-0002-7492-1246
FU NJSCR [08-3080-SCR-E-0]; Rutgers RiSE; Rutgers REU-CB [NSF EEC-0851831];
   College of St. Scholastica
FX This work was supported by NJSCR #08-3080-SCR-E-0. K. T. supported by
   Rutgers RiSE summer program, Rutgers REU-CB (NSF EEC-0851831), and The
   College of St. Scholastica Ronald E. McNair Postbaccalaureate
   Achievement Program. We would like to thank Christopher Liu for analysis
   of cell density and editing of this manuscript. We would like to thank
   Dr. David I. Shreiber for the GFP fibroblasts. Lastly, we would like to
   thank Namrata Kulkarni and Vikas Shah for editing this manuscript.
CR Aarabi S, 2007, FASEB J, V21, P3250, DOI 10.1096/fj.07-8218com
   Balaban NQ, 2001, NAT CELL BIOL, V3, P466, DOI 10.1038/35074532
   Banerjee I, 2006, ANN NY ACAD SCI, V1080, P76, DOI 10.1196/annals.1380.007
   Brown XQ, 2005, BIOMATERIALS, V26, P3123, DOI 10.1016/j.biomaterials.2004.08.009
   Chippada U, 2010, THESIS RUTGERS U ELE
   Chippada U, 2010, J MATER RES, V25, P545, DOI 10.1557/JMR.2010.0067
   Cukierman E, 2001, SCIENCE, V294, P1708, DOI 10.1126/science.1064829
   Dembo M, 1999, BIOPHYS J, V76, P2307, DOI 10.1016/S0006-3495(99)77386-8
   Eastwood M, 1998, P I MECH ENG H, V212, P85, DOI 10.1243/0954411981533854
   Engler A, 2004, BIOPHYS J, V86, P617, DOI 10.1016/S0006-3495(04)74140-5
   Flanagan LA, 2002, NEUROREPORT, V13, P2411, DOI 10.1097/01.wnr.0000048003.96487.97
   FRANK C, 1995, J ORTHOP RES, V13, P157, DOI 10.1002/jor.1100130203
   Friedland JC, 2009, SCIENCE, V323, P642, DOI 10.1126/science.1168441
   Gabbiani G, 2003, J PATHOL, V200, P500, DOI 10.1002/path.1427
   Galbraith CG, 1998, CURR OPIN CELL BIOL, V10, P566, DOI 10.1016/S0955-0674(98)80030-6
   Galbraith CG, 1997, P NATL ACAD SCI USA, V94, P9114, DOI 10.1073/pnas.94.17.9114
   Galbraith CG, 1998, CELL MOTIL CYTOSKEL, V40, P317, DOI 10.1002/(SICI)1097-0169(1998)40:4<317::AID-CM1>3.0.CO;2-8
   Geiger B, 2002, CELL, V110, P139, DOI 10.1016/S0092-8674(02)00831-0
   Genes NG, 2004, ARCH BIOCHEM BIOPHYS, V422, P161, DOI 10.1016/j.abb.2003.11.023
   HASTON WS, 1983, EXP CELL RES, V146, P117, DOI 10.1016/0014-4827(83)90330-0
   Huang S, 1999, NAT CELL BIOL, V1, pE131
   Hynes RO, 1999, P NATL ACAD SCI USA, V96, P2588, DOI 10.1073/pnas.96.6.2588
   Ingber DE, 2003, P NATL ACAD SCI USA, V100, P1472, DOI 10.1073/pnas.0530201100
   Inoh H, 2002, FASEB J, V16, P405, DOI 10.1096/fj.01-0354fje
   Jean C, 2011, ONCOGENE, V30, P2697, DOI 10.1038/onc.2011.27
   Jiang FX, 2010, BIOMATERIALS, V31, P1199, DOI 10.1016/j.biomaterials.2009.10.050
   Jiang FX, 2008, ANN BIOMED ENG, V36, P1565, DOI 10.1007/s10439-008-9530-z
   Jiang FX, 2010, TISSUE ENG PT A, V16, P1873, DOI [10.1089/ten.tea.2009.0574, 10.1089/ten.TEA.2009.0574]
   JIANG X, 2007, OPEN NEUROSCI J, V1, P7
   Kano Y, 2000, CIRC RES, V86, P425, DOI 10.1161/01.RES.86.4.425
   KOLODNEY MS, 1992, J CELL BIOL, V117, P73, DOI 10.1083/jcb.117.1.73
   KUO SC, 1993, SCIENCE, V260, P232, DOI 10.1126/science.8469975
   Lauffenburger DA, 1996, CELL, V84, P359, DOI 10.1016/S0092-8674(00)81280-5
   LETOURNEAU PC, 1994, J NEUROSCI, V14, P915
   Li LL, 2011, BIOMATERIALS, V32, P4489, DOI 10.1016/j.biomaterials.2011.03.019
   Lin DC, 2005, J BIOMECH ENG-T ASME, V127, P571, DOI 10.1115/1.1933981
   Lin DC, 2005, J MATER RES, V20, P1456, DOI 10.1557/JMR.2005.0186
   Lin DC, 2004, J BIOMECH ENG-T ASME, V126, P104, DOI 10.1115/1.1645529
   Lo CM, 2000, BIOPHYS J, V79, P144, DOI 10.1016/S0006-3495(00)76279-5
   MacKenna D, 2000, CARDIOVASC RES, V46, P257, DOI 10.1016/S0008-6363(00)00030-4
   Neidlinger-Wilke C, 2001, J ORTHOP RES, V19, P286, DOI 10.1016/S0736-0266(00)00029-2
   Pelham RJ, 1997, P NATL ACAD SCI USA, V94, P13661, DOI 10.1073/pnas.94.25.13661
   Polio SR, 2012, ACTA BIOMATER, V8, P82, DOI 10.1016/j.actbio.2011.08.013
   Previtera ML, 2010, ANN BIOMED ENG, V38, P3733, DOI 10.1007/s10439-010-0112-5
   Previtera ML, 2010, J BIOSCI BIOENG, V110, P459, DOI 10.1016/j.jbiosc.2010.04.004
   RAGHOW R, 1994, FASEB J, V8, P823
   Sheetz MP, 1998, TRENDS CELL BIOL, V8, P51, DOI 10.1016/S0962-8924(98)80005-6
   Singer AJ, 1999, NEW ENGL J MED, V341, P738, DOI 10.1056/NEJM199909023411006
   Skutek M, 2001, EUR J APPL PHYSIOL, V86, P48, DOI 10.1007/s004210100502
   Solon J, 2007, BIOPHYS J, V93, P4453, DOI 10.1529/biophysj.106.101386
   Sundararaghavan HG, 2009, BIOTECHNOL BIOENG, V102, P632, DOI 10.1002/bit.22074
   Thibeault SL, 2002, J VOICE, V16, P96, DOI 10.1016/S0892-1997(02)00078-4
   Tomasek JJ, 2002, NAT REV MOL CELL BIO, V3, P349, DOI 10.1038/nrm809
   Wakatsuki T, 2000, BIOPHYS J, V79, P2353, DOI 10.1016/S0006-3495(00)76481-2
   Wang HB, 2001, P NATL ACAD SCI USA, V98, P11295, DOI 10.1073/pnas.201201198
   WANG N, 1993, SCIENCE, V260, P1124, DOI 10.1126/science.7684161
   Yeung T, 2005, CELL MOTIL CYTOSKEL, V60, P24, DOI 10.1002/cm.20041
   Zaman MH, 2006, P NATL ACAD SCI USA, V103, P10889, DOI 10.1073/pnas.0604460103
NR 58
TC 9
Z9 10
U1 1
U2 21
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 0090-6964
J9 ANN BIOMED ENG
JI Ann. Biomed. Eng.
PD MAY
PY 2012
VL 40
IS 5
BP 1061
EP 1072
DI 10.1007/s10439-011-0483-2
PG 12
WC Engineering, Biomedical
SC Engineering
GA 926DZ
UT WOS:000302812800008
PM 22160600
DA 2018-10-19
ER

PT J
AU Hume, PS
   He, J
   Haskins, K
   Anseth, KS
AF Hume, Patrick S.
   He, Jing
   Haskins, Kathryn
   Anseth, Kristi S.
TI Strategies to reduce dendritic cell activation through functional
   biomaterial design
SO BIOMATERIALS
LA English
DT Article
DE Immunomodulation; Hydrogel; Surface modification; Adhesion molecule;
   Photopolymerization
ID POLY(ETHYLENE GLYCOL) HYDROGELS; IN-VITRO; ANTIGEN; MATURATION; PEPTIDE;
   MICE; PHOTOPOLYMERIZATIONS; INDUCTION; TOLERANCE; CYTOKINES
AB Dendritic cells play a key role in determining adaptive immunity, and there is growing interest in characterizing and manipulating the interactions between dendritic cells and biomaterial surfaces. Contact with several common biomaterials can induce the maturation of immature dendritic cells, but substrates that reduce dendritic cell maturation are of particular interest within the field of cell-based therapeutics where the goal is to reduce the immune response to cell-laden material carriers. In this study, we use a materials-based strategy to functionalize poly(ethylene glycol) hydrogels with immobilized immunosuppressive factors (TGF-beta 1 and IL-10) to reduce the maturation of immature dendritic cells. TGF-beta 1 and IL-10 are commonly employed as soluble factors to program dendritic cells in vitro, and we demonstrate that these proteins retain bioactivity towards dendritic cells when immobilized on hydrogel surfaces. Following stimulation with lipopolysaccharide (LPS) and/or cytokines, a dendritic cell line interacting with the surfaces of immunosuppressive hydrogels expressed reduced markers of maturation, including IL-12 and MHCII. The bioactivity of these immunomodulatory hydrogels was further confirmed with primary bone marrow-derived dendritic cells (BMDCs) isolated from non-obese diabetic (NOD) mice, as quantified by a decrease in activation markers and a significantly reduced capacity to activate T cells. Furthermore, by introducing a second signal to promote BMDC-material interactions combined with the presentation of tolerizing signals, the multifunctional PEG hydrogels were found to further increase signaling towards BMDCs, as evidenced by greater reductions in maturation markers. (C) 2012 Elsevier Ltd. All rights reserved.
C1 [Hume, Patrick S.; Anseth, Kristi S.] Univ Colorado, Dept Chem & Biol Engn, Boulder, CO 80309 USA.
   [He, Jing] Univ Colorado, Denver Sch Med, Integrated Dept Immunol, Denver, CO 80206 USA.
   [He, Jing] Natl Jewish Hlth, Denver, CO 80206 USA.
   [Haskins, Kathryn; Anseth, Kristi S.] Univ Colorado, Howard Hughes Med Inst, Boulder, CO 80309 USA.
RP Anseth, KS (reprint author), Univ Colorado, Dept Chem & Biol Engn, 424 UCB, Boulder, CO 80309 USA.
EM Kristi.Anseth@Colorado.edu
FU National Institute of Health [R01DK076084]; Howard Hughes Medical
   Institute; Department of Education
FX The authors wish to acknowledge Dr. Charles Cheung and Dr. Chien-Chi Lin
   for initial guidance, technical assistance and helpful discussions.
   Additionally, we would like to thank Kristina Fuerst for her assistance
   with various experiments, Joshua McCall for his expertise with TGF-beta
   and the reporter cell assay, Huan (Sharon) Wang for her assistance with
   JAWSII flow cytometry, and Dr. Xue-dong Liu for providing PE-25 cells.
   Finally, we gratefully acknowledge financial support from the National
   Institute of Health (R01DK076084), the Howard Hughes Medical Institute,
   and the Department of Education's Graduate Assistance in Areas of
   National Need fellowship to P.S.H.
CR Acharya AP, 2008, BIOMATERIALS, V29, P4736, DOI 10.1016/j.biomaterials.2008.08.040
   Acharya AP, 2011, ACTA BIOMATER, V7, P180, DOI 10.1016/j.actbio.2010.08.026
   Babensee JE, 2005, J BIOMED MATER RES A, V74A, P503, DOI 10.1002/jbm.a.30429
   Banchereau J, 1998, NATURE, V392, P245, DOI 10.1038/32588
   BERGMAN B, 1994, DIABETES, V43, P197, DOI 10.2337/diabetes.43.2.197
   Cheung CY, 2006, BIOCONJUGATE CHEM, V17, P1036, DOI 10.1021/bc060023o
   Clarke DC, 2009, MOL CELL BIOL, V29, P2443, DOI 10.1128/MCB.01443-08
   Cruise GM, 1998, BIOMATERIALS, V19, P1287, DOI 10.1016/S0142-9612(98)00025-8
   Hackstein H, 2004, NAT REV IMMUNOL, V4, P24, DOI 10.1038/nri1256
   HASKINS K, 1989, P NATL ACAD SCI USA, V86, P8000, DOI 10.1073/pnas.86.20.8000
   HASKINS K, 1988, DIABETES, V37, P1444, DOI 10.2337/diabetes.37.10.1444
   Hirano Y, 2004, ADV MATER, V16, P17, DOI 10.1002/adma.200300383
   Hubbell JA, 2009, NATURE, V462, P449, DOI 10.1038/nature08604
   Hume PS, 2011, BIOMATERIALS, V32, P6204, DOI 10.1016/j.biomaterials.2011.04.049
   Hume PS, 2010, BIOMATERIALS, V31, P3166, DOI 10.1016/j.biomaterials.2010.01.035
   Ito Y, 1999, BIOMATERIALS, V20, P2333, DOI 10.1016/S0142-9612(99)00162-3
   Jenney CR, 2000, J BIOMED MATER RES, V49, P435
   Jiang XZ, 2008, INFECT IMMUN, V76, P2392, DOI 10.1128/IAI.01584-07
   Jorgensen TN, 2002, SCAND J IMMUNOL, V56, P492, DOI 10.1046/j.1365-3083.2002.01166.x
   Kosiewicz MM, 2004, IMMUNOL RES, V30, P155, DOI 10.1385/IR:30:2:155
   Kou PM, 2011, J BIOMED MATER RES A, V96A, P239, DOI 10.1002/jbm.a.32971
   LANGMUIR PB, 1993, INT IMMUNOL, V5, P169, DOI 10.1093/intimm/5.2.169
   Leclerc C, 2008, J BIOMED MATER RES A, V86A, P1033, DOI 10.1002/jbm.a.31751
   Lin CC, 2009, ADV FUNCT MATER, V19, P2325, DOI 10.1002/adfm.200900107
   Mann BK, 2001, BIOMATERIALS, V22, P439, DOI 10.1016/S0142-9612(00)00196-4
   Mant A, 2006, BIOMATERIALS, V27, P5299, DOI 10.1016/j.biomaterials.2006.04.040
   Matzinger P, 1998, SEMIN IMMUNOL, V10, P399, DOI 10.1006/smim.1998.0143
   Morelli AE, 2007, NAT REV IMMUNOL, V7, P610, DOI 10.1038/nri2132
   Norton LW, 2010, J CONTROL RELEASE, V146, P341, DOI 10.1016/j.jconrel.2010.05.032
   Otsu S, 2006, INFECT IMMUN, V74, P984, DOI 10.1128/IAI.74.2.984-993.2006
   Peng RH, 2003, ANN NY ACAD SCI, V1005, P184, DOI 10.1196/annals.1288.023
   Pinchuk LM, 2007, TOXICOL APPL PHARM, V223, P206, DOI 10.1016/j.taap.2007.06.004
   Rogers TH, 2011, BIOMATERIALS, V32, P1270, DOI 10.1016/j.biomaterials.2010.10.014
   Salinas CN, 2008, MACROMOLECULES, V41, P6019, DOI 10.1021/ma800621h
   Sato K, 1999, J IMMUNOL, V162, P3865
   Sefton MV, 2008, SEMIN IMMUNOL, V20, P83, DOI 10.1016/j.smim.2007.12.008
   Steinbrink K, 1997, J IMMUNOL, V159, P4772
   Torres-Aguilar H, 2010, J IMMUNOL, V184, P1765, DOI 10.4049/jimmunol.0902133
   TRAUT RR, 1973, BIOCHEMISTRY-US, V12, P3266, DOI 10.1021/bi00741a019
   van Kooten C, 2011, TRANSPLANTATION, V91, P2, DOI 10.1097/TP.0b013e31820263b3
   Wang GX, 2006, ARTIF CELL BLOOD SUB, V34, P11, DOI 10.1080/10731190500428283
   Zhu JM, 2010, BIOMATERIALS, V31, P4639, DOI 10.1016/j.biomaterials.2010.02.044
NR 42
TC 29
Z9 29
U1 0
U2 38
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
EI 1878-5905
J9 BIOMATERIALS
JI Biomaterials
PD MAY
PY 2012
VL 33
IS 14
BP 3615
EP 3625
DI 10.1016/j.biomaterials.2012.02.009
PG 11
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 920RQ
UT WOS:000302425400001
PM 22361099
OA Green Accepted
DA 2018-10-19
ER

PT J
AU Tah, T
   Bernards, MT
AF Tah, Tapashree
   Bernards, Matthew T.
TI Z Nonfouling polyampholyte polymer brushes with protein conjugation
   capacity
SO COLLOIDS AND SURFACES B-BIOINTERFACES
LA English
DT Article
DE Polyampholytes; Nonfouling; Protein conjugation; Dual functional
ID TRANSFER RADICAL POLYMERIZATION; SELF-ASSEMBLED MONOLAYERS; MOLECULAR
   SIMULATION; GRAFTED SURFACES; FILM THICKNESS; BLOOD-PLASMA; ADSORPTION;
   RESISTANCE; GLYCOL); PHOSPHORYLCHOLINE
AB The elimination of nonspecific protein adsorption is an important challenge in many biomaterial applications. To address this issue, numerous nonfouling chemistries have been investigated. This work reports on the dual functional properties of a polyampholyte copolymer composed of positively charged (2-(acryloyloxy) ethyl) trimethyl ammonium chloride (TMA) and negatively charged 2-carboxy ethyl acrylate (CAA) monomers. TMA:CAA copolymers have previously been shown to have nonfouling properties, but the optimal conditions for nonfouling have not been determined. To accomplish this, the thickness of the polymer brush coating was varied by manipulating the surface-initiated atom transfer radical polymerization conditions. The nonspecific adsorption of fibrinogen and lysozyme was measured as a function of the copolymer brush thickness using a surface plasmon resonance biosensor. At the optimal thickness for nonfouling, nonspecific adsorption from 10% and 100% fetal bovine serum (FBS) was determined. The results indicate that at the optimal copolymer brush thickness, TMA:CAA polyampholyte materials have ultralow fouling characteristics even upon exposure to 100% FBS. The dual functional properties of TMA:CAA copolymers were demonstrated by conjugating fibrinogen to the copolymer brush over a range of brush thicknesses. The conjugation experiments clearly demonstrate that TMA:CAA copolymers have the capacity for protein conjugation at the optimal thickness for nonfouling. However, the conformational state of the copolymer brush chains impacts the overall conjugation capacity of the system. The results of this investigation indicate that TMA:CAA polyampholyte surfaces show promise for biosensor and biomaterial applications where their dual functional properties would be beneficial. (c) 2012 Elsevier B.V. All rights reserved.
C1 [Tah, Tapashree; Bernards, Matthew T.] Univ Missouri, Dept Chem Engn, Columbia, MO 65211 USA.
   [Bernards, Matthew T.] Univ Missouri, Dept Biol Engn, Columbia, MO 65211 USA.
RP Bernards, MT (reprint author), Univ Missouri, Dept Chem Engn, Columbia, MO 65211 USA.
EM bernardsm@missouri.edu
OI Bernards, Matthew/0000-0002-5234-1910
FU College of Engineering
FX The optical profilometry, gold coating, and photolithography procedures
   were conducted at the Micro/Nano MEMS Semiconductor Utilization Facility
   with the assistance of Cherian Mathai and Dr. Venu Korampally. Financial
   support for this work was provided by the College of Engineering.
CR Azzaroni O, 2006, ANGEW CHEM INT EDIT, V45, P1770, DOI 10.1002/anie.200503264
   Bernards MT, 2008, MACROMOLECULES, V41, P4216, DOI 10.1021/ma800185y
   Chang Y, 2006, LANGMUIR, V22, P2222, DOI 10.1021/la052692v
   Chang Y, 2007, BIOMACROMOLECULES, V8, P122, DOI 10.1021/bm060739m
   Chang Y, 2011, ACS APPL MATER INTER, V3, P1228, DOI 10.1021/am200055k
   Chen SF, 2006, LANGMUIR, V22, P8186, DOI 10.1021/la061012m
   Cheng N, 2006, MACROMOL RAPID COMM, V27, P1632, DOI 10.1002/marc.200600467
   Feldman K, 1999, J AM CHEM SOC, V121, P10134, DOI 10.1021/ja991049b
   Feng W, 2006, BIOMATERIALS, V27, P847, DOI 10.1016/j.biomaterials.2005.07.006
   Feng W, 2005, LANGMUIR, V21, P5980, DOI 10.1021/la050277i
   Feng W, 2004, J POLYM SCI POL CHEM, V42, P2931, DOI 10.1002/pola.20095
   He Y, 2008, LANGMUIR, V24, P10358, DOI 10.1021/la8013046
   HEROLD DA, 1989, BIOCHEM PHARMACOL, V38, P73, DOI 10.1016/0006-2952(89)90151-2
   Hoffman AS, 1999, J BIOMAT SCI-POLYM E, V10, P1011, DOI 10.1163/156856299X00658
   Holmlin RE, 2001, LANGMUIR, V17, P2841, DOI 10.1021/la0015258
   Homola J, 2006, SPRINGER SER CHEM SE, V4, P1, DOI 10.1007/b100321
   Homola J, 2008, CHEM REV, V108, P462, DOI 10.1021/cr068107d
   Horbett Thomas A., 1996, P133
   Hucknall A, 2009, ADV MATER, V21, P2441, DOI 10.1002/adma.200900383
   Ishihara K, 1998, J BIOMED MATER RES, V39, P323, DOI 10.1002/(SICI)1097-4636(199802)39:2<323::AID-JBM21>3.0.CO;2-C
   Ladd J, 2008, BIOMACROMOLECULES, V9, P1357, DOI 10.1021/bm701301s
   Lewis AL, 2000, COLLOID SURFACE B, V18, P261, DOI 10.1016/S0927-7765(99)00152-6
   Li LY, 2007, J BIOMAT SCI-POLYM E, V18, P1415, DOI 10.1163/156856207782246795
   Li LY, 2005, J PHYS CHEM B, V109, P2934, DOI 10.1021/jp0473321
   Ma HW, 2006, ADV FUNCT MATER, V16, P640, DOI 10.1002/adfm.200500426
   Ma HW, 2004, ADV MATER, V16, P338, DOI 10.1002/adma.200305830
   Matyjaszewski K, 2001, CHEM REV, V101, P2921, DOI 10.1021/cr940534g
   Mi L, 2010, BIOMATERIALS, V31, P2919, DOI 10.1016/j.biomaterials.2009.12.038
   Ostuni E, 2001, LANGMUIR, V17, P5605, DOI 10.1021/la010384m
   Ratner BD, 2004, ANNU REV BIOMED ENG, V6, P41, DOI 10.1146/annurev.bioeng.6.040803.140027
   Rubinstein M, 1999, CURR OPIN COLLOID IN, V4, P83, DOI 10.1016/S1359-0294(99)00013-8
   Schwendel D, 2001, LANGMUIR, V17, P5717, DOI 10.1021/la010576h
   Singh N, 2007, BIOMATERIALS, V28, P763, DOI 10.1016/j.biomaterials.2006.09.036
   Skoda MWA, 2009, LANGMUIR, V25, P4056, DOI 10.1021/la8028534
   Tugulu S, 2008, BIOMACROMOLECULES, V9, P906, DOI 10.1021/bm7012939
   Vaisocherova H, 2008, ANAL CHEM, V80, P7894, DOI 10.1021/ac8015888
   Vaisocherova H, 2009, BIOSENS BIOELECTRON, V24, P1924, DOI 10.1016/j.bios.2008.09.035
   Yang W, 2008, LANGMUIR, V24, P9211, DOI 10.1021/la801487f
   Yang W, 2009, LANGMUIR, V25, P11911, DOI 10.1021/la9015788
   Zhang Z, 2006, J PHYS CHEM B, V110, P10799, DOI 10.1021/jp057266i
   Zhang Z, 2008, BIOMACROMOLECULES, V9, P2686, DOI 10.1021/bm800407r
   Zhao C, 2011, LANGMUIR, V27, P4906, DOI 10.1021/la200061h
   Zheng J, 2005, BIOPHYS J, V89, P158, DOI 10.1529/biophysj.105.059428
NR 43
TC 27
Z9 27
U1 4
U2 50
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0927-7765
J9 COLLOID SURFACE B
JI Colloid Surf. B-Biointerfaces
PD MAY 1
PY 2012
VL 93
BP 195
EP 201
DI 10.1016/j.colsurfb.2012.01.004
PG 7
WC Biophysics; Chemistry, Physical; Materials Science, Biomaterials
SC Biophysics; Chemistry; Materials Science
GA 920TX
UT WOS:000302431900028
PM 22277745
DA 2018-10-19
ER

PT J
AU Scott, GR
   Poulson, SR
AF Scott, G. Richard
   Poulson, Simon R.
TI Stable carbon and nitrogen isotopes of human dental calculus: a
   potentially new non-destructive proxy for paleodietary analysis
SO JOURNAL OF ARCHAEOLOGICAL SCIENCE
LA English
DT Article
DE Dental calculus; Stable isotopes; Carbon; Nitrogen; Paleodiet
ID DIET; MICROFOSSILS; INDIVIDUALS; POPULATIONS; CEMETERIES; UKRAINE;
   MIDDLE
AB Fifty-eight dental calculus samples from medieval and post-medieval skeletons from Vitoria, Spain, and a single sample from an Alaskan Inuit were tested for stable carbon and nitrogen isotope compositions. There was sufficient carbon and nitrogen concentrations to obtain delta C-13 and delta N-15 values, and the samples from Spain produced results that were replicable and comparable to European isotope values based on bone collagen collected from literature sources. The Alaskan Inuit calculus sample yielded a delta N-15 value of +17.5 parts per thousand, well beyond the range of the Spanish samples, but consistent with literature data for modern Greenlandic Inuit consuming a diet rich in marine food. There are several potential sources for carbon and nitrogen in calculus. The results of this study yield stable isotope values consistent with those obtained from other biomaterials used as isotope proxies for paleodietary research, including bone collagen, hair, and fingernails, although further work is necessary to verify the fidelity of calculus as an isotope proxy. Many studies in bioarchaeology are precluded by curatorial concerns regarding the destructive analysis of primary biomaterials. However, calculus is an "add-on", or secondary biomaterial, that is not an integral part of the dental or skeletal system. Hence, its consumption during analysis is technically not destructive. Therefore, isotope analysis of dental calculus may provide a potential new avenue for paleodietary analysis where the use of other primary biomaterials is precluded. (C) 2011 Published by Elsevier Ltd.
C1 [Scott, G. Richard] Univ Nevada, Dept Anthropol, Reno, NV 89557 USA.
   [Poulson, Simon R.] Univ Nevada, Dept Geol Sci & Engn, Reno, NV 89557 USA.
RP Scott, GR (reprint author), Univ Nevada, Dept Anthropol, MS0096, Reno, NV 89557 USA.
EM grcott@unr.edu; poulson@mines.unr.edu
CR Blatt S.H., 2010, INT J OSTEOARCHAEOL, DOI [10.1002/oa.1173, DOI 10.1002/OA.1173.WWW.INTERSCIENCE.WILEY.COM]
   Boyadjian CHC, 2007, J ARCHAEOL SCI, V34, P1622, DOI 10.1016/j.jas.2006.12.012
   Buchardt B, 2007, CHEM GEOL, V244, P316, DOI 10.1016/j.chemgeo.2007.06.022
   Flandrin J., 2006, HIST ALIMENTACION SP
   Garcia-Guixe E, 2009, J ARCHAEOL SCI, V36, P1018, DOI 10.1016/j.jas.2008.12.001
   Hardy K, 2009, J ARCHAEOL SCI, V36, P248, DOI 10.1016/j.jas.2008.09.015
   Hayashizaki J, 2008, ARCH ORAL BIOL, V53, P168, DOI 10.1016/j.archoralbio.2007.09.003
   Henry AG, 2008, J ARCHAEOL SCI, V35, P1943, DOI 10.1016/j.jas.2007.12.005
   Herrscher E, 2010, AM J PHYS ANTHROPOL, V141, P259, DOI 10.1002/ajpa.21141
   HILLSON S, 1986, TEETH
   HILLSON SW, 1979, WORLD ARCHAEOL, V11, P147, DOI 10.1080/00438243.1979.9979758
   Hollund HI, 2010, J ARCHAEOL SCI, V37, P2971, DOI 10.1016/j.jas.2010.08.009
   Honch NV, 2006, J ARCHAEOL SCI, V33, P1493, DOI 10.1016/j.jas.2006.02.002
   Lalueza C, 1996, AM J PHYS ANTHROPOL, V101, P101
   Lieverse AR, 1999, INT J OSTEOARCHAEOL, V9, P219, DOI 10.1002/(SICI)1099-1212(199907/08)9:4<219::AID-OA475>3.0.CO;2-V
   Lillie M, 2003, J ARCHAEOL SCI, V30, P743, DOI 10.1016/S0305-4403(02)00249-2
   Lillie M, 2011, J ARCHAEOL SCI, V38, P57, DOI 10.1016/j.jas.2010.08.010
   Linderholm A, 2008, ANTIQUITY, V82, P446, DOI 10.1017/S0003598X00096939
   Llopis M.M., 2007, HIST GASTRONOMIA ESP
   Muldner G, 2007, AM J PHYS ANTHROPOL, V134, P162, DOI 10.1002/ajpa.20647
   Muldner G, 2009, ANTIQUITY, V83, P1119
   Muldner G, 2005, J ARCHAEOL SCI, V32, P39, DOI 10.1016/j.jas.2004.05.007
   O'Connell TC, 2001, J ARCHAEOL SCI, V28, P1247, DOI 10.1006/jasc.2001.0698
   Preus HR, 2011, J ARCHAEOL SCI, V38, P1827, DOI 10.1016/j.jas.2011.03.020
   Schoeninger M. J., 2010, COMPANION BIOL ANTHR, P445, DOI DOI 10.1002/9781444320039.CH25
   Schoeninger MJ, 2009, CURR ANTHROPOL, V50, P633, DOI 10.1086/605111
   SCHWARCZ HP, 1991, YEARB PHYS ANTHROPOL, V34, P283
   Triantaphyllou S, 2008, J ARCHAEOL SCI, V35, P3028, DOI 10.1016/j.jas.2008.06.018
   Werner RA, 1999, RAPID COMMUN MASS SP, V13, P1237, DOI 10.1002/(SICI)1097-0231(19990715)13:13<1237::AID-RCM633>3.0.CO;2-C
   Wesolowski V, 2010, J ARCHAEOL SCI, V37, P1326, DOI 10.1016/j.jas.2009.12.037
   White DJ, 1997, EUR J ORAL SCI, V105, P508, DOI 10.1111/j.1600-0722.1997.tb00238.x
NR 31
TC 17
Z9 17
U1 1
U2 20
PU ACADEMIC PRESS LTD- ELSEVIER SCIENCE LTD
PI LONDON
PA 24-28 OVAL RD, LONDON NW1 7DX, ENGLAND
SN 0305-4403
EI 1095-9238
J9 J ARCHAEOL SCI
JI J. Archaeol. Sci.
PD MAY
PY 2012
VL 39
IS 5
BP 1388
EP 1393
DI 10.1016/j.jas.2011.09.029
PG 6
WC Anthropology; Archaeology; Geosciences, Multidisciplinary
SC Anthropology; Archaeology; Geology
GA 910EV
UT WOS:000301620900019
DA 2018-10-19
ER

PT J
AU Crepy, L
   Monchau, F
   Chai, F
   Raoul, G
   Hivart, P
   Hildebrand, HF
   Martin, P
   Joly, N
AF Crepy, Lucie
   Monchau, Francine
   Chai, Feng
   Raoul, Gwenael
   Hivart, Philippe
   Hildebrand, Hartmut F.
   Martin, Patrick
   Joly, Nicolas
TI Evaluation of a bio-based hydrophobic cellulose laurate film as
   biomaterialuStudy on biodegradation and cytocompatibility
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART B-APPLIED BIOMATERIALS
LA English
DT Article
DE cellulose laurate; bio-based film; cytotoxicity; cytocompatibilty;
   degradation
ID MECHANICAL-PROPERTIES; TISSUE; BIOCOMPATIBILITY; DERIVATIVES; SCAFFOLDS;
   POLYMERS; RAT; ESTERIFICATION; IRRADIATION; MEMBRANES
AB The study aims to validate an original bio-based material, obtained by grafting fatty chains, and more especially lauric chains (C12) onto cellulose, for medical applications. The mechanical properties of the synthesized cellulose laurate (C12) are close to those of petrochemical ones such as low density polyethylene. This cellulose-based polymer is transparent, flexible, and hydrophobic. To evaluate the stability of the cellulosic films in biological fluids the samples are soaked in simulated body fluid or blood plasma for a few hours to 6 months, and then submitted to mechanical and chemical analyses. The simultaneously performed cytocompatibility tests were the colony-forming viability, the vitality and cell proliferation tests using NIH 3T3 fibroblasts and MC 3T3 osteoblast-like cells. The results show the stability, the biocompatibility, and the noncytotoxicity of the synthesized cellulose laurate films. This biomaterial may so be considered for surgical applications. (c) 2012 Wiley Periodicals, Inc. J Biomed Mater Res Part B: Appl Biomater, 2012.
C1 [Crepy, Lucie; Monchau, Francine; Chai, Feng; Raoul, Gwenael; Hivart, Philippe; Hildebrand, Hartmut F.; Martin, Patrick; Joly, Nicolas] Univ Lille Nord France, F-59000 Lille, France.
   [Monchau, Francine; Martin, Patrick; Joly, Nicolas] UCCS, CNRS, UMR 8181, F-59650 Villeneuve Dascq, France.
   [Crepy, Lucie; Martin, Patrick; Joly, Nicolas] UCCS, UArtois, IUT Bethune, Bethune, France.
   [Monchau, Francine; Hivart, Philippe] Univ Artois, Lab Genie Civil & Geo Environm LGCgE EA 4515, IUT GMP, F-62408 Bethune, France.
   [Chai, Feng; Raoul, Gwenael; Hildebrand, Hartmut F.] Univ Lille 2, Fac Med Pole Rech, Grp Rech Biomat, INSERM,U1008, F-59045 Lille, France.
   [Raoul, Gwenael] CHU Lille, Hop Roger Salengro, Serv Chirurg Maxillofaciale, F-59037 Lille, France.
RP Joly, N (reprint author), Univ Lille Nord France, F-59000 Lille, France.
EM nicolas.joly@univ-artois.fr
RI Joly, Nicolas/O-5749-2016
OI Joly, Nicolas/0000-0003-0516-2466
CR Azzopardi MJ, 1999, US Pat, Patent No. 9918168
   Chandra R, 1998, PROG POLYM SCI, V23, P1273, DOI 10.1016/S0079-6700(97)00039-7
   Chauvelon G, 2000, CARBOHYD POLYM, V42, P385, DOI 10.1016/S0144-8617(99)00187-3
   Crepy L, 2011, CARBOHYD POLYM, V83, P1812, DOI 10.1016/j.carbpol.2010.10.045
   Crepy L, 2009, CHEMSUSCHEM, V2, P165, DOI 10.1002/cssc.200800171
   DAWSEY TR, 1990, J MACROMOL SCI R M C, VC30, P405, DOI 10.1080/07366579008050914
   De Olyveira G. M., 2011, J BIOMATER NANOBIOTE, V2, P239
   Dias GJ, 2003, J MATER SCI-MATER M, V14, P739, DOI 10.1023/A:1025076002948
   Entcheva E, 2004, BIOMATERIALS, V25, P5753, DOI 10.1016/j.biomaterials.2004.01.024
   Fischbach C, 2001, SURF SCI, V491, P333, DOI 10.1016/S0039-6028(01)01297-3
   Frazier M. E, 1979, TRACE METALS HLTH DI, P71
   Fricain JC, 2002, BIOMATERIALS, V23, P971, DOI 10.1016/S0142-9612(01)00152-1
   Gallagher KM, 2000, J CONTROL RELEASE, V69, P261, DOI 10.1016/S0168-3659(00)00305-9
   Gomes M, 2008, ACAD PR SER BIOM ENG, P145, DOI 10.1016/B978-0-12-370869-4.00006-9
   Grooteman M P, 1995, ASAIO J, V41, P215
   Hirano S, 1996, Biotechnol Annu Rev, V2, P237, DOI 10.1016/S1387-2656(08)70012-7
   Hofmann I, 2006, SURF COAT TECH, V201, P2392, DOI 10.1016/j.surfcoat.2006.04.007
   Hornez JC, 2007, BIOMOL ENG, V24, P505, DOI 10.1016/j.bioeng.2007.08.015
   Hornez JC, 2002, BIOMOL ENG, V19, P103, DOI 10.1016/S1389-0344(02)00017-5
   Jagur-Grodzinski J, 1999, REACT FUNCT POLYM, V39, P99, DOI 10.1016/S1381-5148(98)00054-6
   Joly N, 2005, J APPL POLYM SCI, V97, P1266, DOI 10.1002/app.21783
   JOLY N, 2006, E-POLYMERS, V70, P1
   Kim BS, 2000, WORLD J UROL, V18, P2, DOI 10.1007/s003450050002
   Kim MC, 2009, REACT FUNCT POLYM, V69, P287, DOI 10.1016/j.reactfunctpolym.2009.01.013
   Kokubo T, 2006, BIOMATERIALS, V27, P2907, DOI 10.1016/j.biomaterials.2006.01.017
   Kosaka PM, 2007, J COLLOID INTERF SCI, V316, P671, DOI 10.1016/j.jcis.2007.07.058
   Lee CG, 2008, CURR OPIN IMMUNOL, V20, P684, DOI 10.1016/j.coi.2008.10.002
   Li J, 2009, MAT SCI ENG C-BIO S, V29, P1635, DOI 10.1016/j.msec.2009.01.006
   Ma WJ, 2008, CARBOHYD POLYM, V72, P75, DOI 10.1016/j.carbpol.2007.07.033
   Martson M, 1998, EUR SURG RES, V30, P419, DOI 10.1159/000008608
   Martson M, 1999, BIOMATERIALS, V20, P1989, DOI 10.1016/S0142-9612(99)00094-0
   MIYAMOTO T, 1989, J BIOMED MATER RES, V23, P125, DOI 10.1002/jbm.820230110
   Monchi M, 2008, MANUEL EPURATION EXT, P41
   Muller FA, 2006, BIOMATERIALS, V27, P3955, DOI 10.1016/j.biomaterials.2006.02.031
   Nieddu E, 2009, REACT FUNCT POLYM, V69, P371, DOI 10.1016/j.reactfunctpolym.2009.03.002
   Rotter N, 2005, TISSUE ENG, V11, P192, DOI 10.1089/ten.2005.11.192
   Rotter N, 1998, J BIOMED MATER RES, V42, P347, DOI 10.1002/(SICI)1097-4636(19981205)42:3<347::AID-JBM2>3.0.CO;2-J
   Rudd GE, 1992, HDB PLASTICS ELASTOM, p[49, 627]
   Satge C, 2002, CARBOHYD POLYM, V49, P373, DOI 10.1016/S0144-8617(02)00004-8
   Smith A, 2008, CARBOHYD RES, V343, P2557, DOI 10.1016/j.carres.2008.07.012
   Thanki PN, 2006, APPL SURF SCI, V253, P2758, DOI DOI 10.1016/J.APSUSC.2006.05.047
   Thiebaud S, 1997, BIORESOURCE TECHNOL, V59, P103, DOI 10.1016/S0960-8524(96)00160-5
   VANWACHEM PB, 1985, BIOMATERIALS, V6, P403, DOI 10.1016/0142-9612(85)90101-2
   von Woedtke T, 2003, BIOSENS BIOELECTRON, V19, P269, DOI 10.1016/S0956-5663(03)00217-3
   Wang FJ, 2002, MAT SCI ENG C-BIO S, V20, P93, DOI 10.1016/S0928-4931(02)00018-8
   WENZEL DG, 1978, TOXICOLOGY, V11, P109, DOI 10.1016/S0300-483X(78)90789-8
NR 46
TC 7
Z9 7
U1 0
U2 7
PU WILEY-BLACKWELL
PI MALDEN
PA COMMERCE PLACE, 350 MAIN ST, MALDEN 02148, MA USA
SN 1552-4973
J9 J BIOMED MATER RES B
JI J. Biomed. Mater. Res. Part B
PD MAY
PY 2012
VL 100B
IS 4
BP 1000
EP 1008
DI 10.1002/jbm.b.32665
PG 9
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 920KH
UT WOS:000302402700014
PM 22323390
DA 2018-10-19
ER

PT J
AU Lin, M
   Xu, P
   Zhong, W
AF Lin, Mei
   Xu, Peng
   Zhong, Wei
TI Preparation, characterization, and release behavior of aspirin-loaded
   poly(2-hydroxyethyl acrylate)/silica hydrogels
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART B-APPLIED BIOMATERIALS
LA English
DT Article
DE poly(2-hydroxyethyl acrylate); silica; drug delivery; hydrogel
ID SOL-GEL REACTION; DRUG-RELEASE; 2-HYDROXYETHYL ACRYLATE; DELIVERY
   SYSTEMS; COLORIMETRIC ASSAY; SILICA; DIFFUSION; HYBRID; 2-HYDROXYPROPYL;
   NANOCOMPOSITES
AB Poly(2-hydroxyethyl acrylate) (PHEA) is a polymer hydrogel that can be used as a biomaterial. In this study, PHEA/silica composites containing aspirin as a model drug were prepared, and their drug release behaviors were tested. 2-Hydroxyethyl acrylate (HEA) was first copolymerized with 3-(trimethoxysilyl) propyl methacrylate (MSMA) in the presence of ammonium persulphate and then condensed with silicic acid oligomer. The composites were characterized with Fourier transform infrared spectroscopy (FTIR) and scanning electron microscopy (SEM). In addition, water uptake and matrix erosion of PHEA/silica of different weight ratios were also investigated. The results indicated that the silica particles were well dispersed in PHEA hydrogels. The in vitro drug release test revealed that the release rate of aspirin decreased with the increasing content of silica. The drug release behaviors were analyzed by employing the power law, which showed that the release profiles were governed either by Case II diffusion or by anomalous diffusion. The 3-(4, 5-dimethylthiazol-2-yl)-2, 5-diphenyl tetrazolium bromide (MTT) assay of rabbit chondrocytes revealed that adding silica can improve the biocompatibility of PHEA to some extent. (c) 2012 Wiley Periodicals, Inc. J Biomed Mater Res Part B: Appl Biomater, 2012.
C1 [Lin, Mei] Fujian Med Univ, Dept Med Chem, Sch Pharm, Fuzhou 350004, Fujian, Peoples R China.
   [Xu, Peng] Fudan Univ, Dept Macromol Sci, Shanghai 200433, Peoples R China.
   [Xu, Peng] Fudan Univ, Key Lab Mol Engn Polymers, Shanghai 200433, Peoples R China.
   [Zhong, Wei] Shanghai Ctr Biomed Engn, Shanghai 201201, Peoples R China.
RP Lin, M (reprint author), Fujian Med Univ, Dept Med Chem, Sch Pharm, Fuzhou 350004, Fujian, Peoples R China.
EM linmeichem@126.com
FU Fujian Provincial Science and Technology Foundation [2008F3049]; Science
   and Technology Commission of Shanghai Municipality [11nm0504900];
   Ministry of Science and Technology of China [2009CB930000]
FX Contract grant sponsor: Fujian Provincial Science and Technology
   Foundation; contract grant number: 2008F3049; Contract grant sponsor:
   Science and Technology Commission of Shanghai Municipality; contract
   grant number: 11nm0504900; Contract grant sponsor: Ministry of Science
   and Technology of China, 973 Project; contract grant number: No.
   2009CB930000
CR Arun A, 2005, J BIOMED MATER RES B, V73B, P291, DOI 10.1002/jbm.b.30214
   Chang CC, 2002, CHEM MATER, V14, P4242, DOI 10.1021/cm0202310
   Chang CM, 1997, J PHARM SCI-US, V86, P747, DOI 10.1021/js960256w
   Fragiadakis D, 2005, POLYMER, V46, P6001, DOI 10.1016/j.polymer.2005.05.080
   Gao Y, 2001, CHEM MATER, V13, P3644, DOI 10.1021/cm010179s
   Gulsen D, 2005, INT J PHARMACEUT, V292, P95, DOI 10.1016/j.ijpharm.2004.11.033
   Gulsen D, 2006, J MEMBRANE SCI, V269, P35, DOI 10.1016/j.memsci.2005.06.024
   Hoogenboom R, 2009, MACROMOL RAPID COMM, V30, P2042, DOI 10.1002/marc.200900507
   Jo H, 1999, CHEM MATER, V11, P2548, DOI 10.1021/cm9902570
   Kobayashi M, 2005, BIOMATERIALS, V26, P3243, DOI 10.1016/j.biomaterials.2004.08.028
   Kost J, 2001, ADV DRUG DELIVER REV, V46, P125, DOI 10.1016/S0169-409X(00)00136-8
   Liazawa T, 2004, POLYMER, V45, P5077
   Lin M, 2007, J PHARM SCI-US, V96, P1518, DOI 10.1002/jps.20809
   Masaro L, 1999, PROG POLYM SCI, V24, P731, DOI 10.1016/S0079-6700(99)00016-7
   MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4
   Pradas MM, 2001, POLYMER, V42, P4667
   Ragel CV, 2000, J BIOMED MATER RES, V51, P424, DOI 10.1002/1097-4636(20000905)51:3<424::AID-JBM17>3.0.CO;2-E
   Saiano F, 2005, MACROMOL BIOSCI, V5, P653, DOI 10.1002/mabi.200400223
   Saravanan BC, 2003, VET PARASITOL, V113, P211, DOI 10.1016/S0304-4017(03)00062-1
   Schiraldi C, 2004, BIOMATERIALS, V25, P3645, DOI 10.1016/j.biomaterials.2003.10.059
   Siepmann J, 2001, ADV DRUG DELIVER REV, V48, P139, DOI 10.1016/S0169-409X(01)00112-0
   Sun DH, 2005, MACROMOLECULES, V38, P5617, DOI 10.1021/ma047314h
   Teoli D, 2006, J CONTROL RELEASE, V116, P295, DOI 10.1016/j.jconrel.2006.09.010
   Vargun E, 2005, J POLYM SCI POL CHEM, V43, P3957, DOI 10.1002/pola.20867
   Varshosaz J, 2004, DRUG DELIV, V11, P53, DOI 10.1080/10717540490265298
   Wagh PB, 1998, MATER CHEM PHYS, V53, P41, DOI 10.1016/S0254-0584(97)02055-5
   Wang HT, 2005, COMPOS PART A-APPL S, V36, P909, DOI 10.1016/j.compositesa.2004.12.008
   Xu P, 2006, POLYM DEGRAD STABIL, V91, P1522, DOI 10.1016/j.polymdegradstab.2005.10.006
NR 28
TC 6
Z9 6
U1 1
U2 39
PU WILEY-BLACKWELL
PI MALDEN
PA COMMERCE PLACE, 350 MAIN ST, MALDEN 02148, MA USA
SN 1552-4973
J9 J BIOMED MATER RES B
JI J. Biomed. Mater. Res. Part B
PD MAY
PY 2012
VL 100B
IS 4
BP 1114
EP 1120
DI 10.1002/jbm.b.32678
PG 7
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 920KH
UT WOS:000302402700026
PM 22447532
DA 2018-10-19
ER

PT J
AU Williams, DL
   Costerton, JW
AF Williams, Dustin L.
   Costerton, J. William
TI Using biofilms as initial inocula in animal models of biofilm-related
   infections
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART B-APPLIED BIOMATERIALS
LA English
DT Review
DE initial inocula; planktonic; biofilm; future research; animal model
ID STAPHYLOCOCCUS-AUREUS; RABBIT MODEL; IN-VIVO; OPEN FRACTURES; HUMAN
   SKIN; AEROBIC-BACTERIA; CHRONIC WOUNDS; MIDDLE-EAR; OSTEOMYELITIS;
   EFFICACY
AB One of the most practical strategies that has been undertaken to fight biofilm implant-related infections has been the development of coatings on biomaterial devices that can elute antimicrobials into regions of patients' tissues. To date, the majority of animal studies that have been developed to model infections that accompany the use of these materials have primarily involved an initial inoculum of planktonic bacterial cells from batch cultures. Although valuable, data that have been derived from these experiments may not provide important clinical insight into how bacteria in well-established, mature biofilms impact device-related and other clinical infections when they contaminate a patient site or implanted device. In this review, a discussion is presented on the impact that a shift in biofilm research may have if initial inocula of well-established, mature biofilms are used to model biomaterial device-related infections in animal models. (c) 2011 Wiley Periodicals, Inc. J Biomed Mater Res Part B: Appl Biomater, 2011.
C1 [Williams, Dustin L.] George E Wahlen Dept Vet Affairs Med Ctr, Salt Lake City, UT 84148 USA.
   [Williams, Dustin L.] Univ Utah, Dept Bioengn, Salt Lake City, UT 84112 USA.
   [Williams, Dustin L.] Univ Utah, Dept Orthopaed, Salt Lake City, UT USA.
   [Costerton, J. William] Allegheny Singer Res Inst, Ctr Genom Sci, Pittsburgh, PA 15212 USA.
RP Williams, DL (reprint author), George E Wahlen Dept Vet Affairs Med Ctr, Salt Lake City, UT 84148 USA.
EM dustin.williams@utah.edu
FU National Institute of Arthritis and Musculoskeletal and Skin Diseases
   [R01AR057185]; Office of Research and Development, Rehabilitation RD
   Service; George E. Wahlen Department of Veterans Affairs, Salt Lake
   City, UT
FX Contract grant sponsor: National Institute of Arthritis and
   Musculoskeletal and Skin Diseases; contract grant number: R01AR057185;
   Contract grant sponsor: Office of Research and Development,
   Rehabilitation R&D Service; Contract grant sponsor: George E. Wahlen
   Department of Veterans Affairs, Salt Lake City, UT
CR BAKKEN LR, 1985, APPL ENVIRON MICROB, V49, P1482
   Bowler Philip G, 2003, Ostomy Wound Manage, V49, P44
   Brandt C, 2008, ANN SURG, V248, P695, DOI 10.1097/SLA.0b013e31818b757d
   Brin YS, 2008, J CONTROL RELEASE, V131, P121, DOI 10.1016/j.jconrel.2008.07.022
   BURET A, 1991, J BIOMED MATER RES, V25, P865, DOI 10.1002/jbm.820250706
   Cerca N, 2006, INFECT IMMUN, V74, P4849, DOI 10.1128/IAI.00230-06
   Ceri H., 2006, BIOFILMS INFECT ANTI, P257
   Chiu B, 1999, AM HEART J, V138, pS534, DOI 10.1016/S0002-8703(99)70294-2
   Chou TGR, 2010, J BIOMED MATER RES A, V92A, P942, DOI 10.1002/jbm.a.32413
   Cirioni O, 2010, EUR J VASC ENDOVASC, V40, P817, DOI 10.1016/j.ejvs.2010.08.009
   Connell JL, 2010, MBIO, V1, DOI 10.1128/mBio.00202-10
   COSTERTON JW, 1978, SCI AM, V238, P86, DOI 10.1038/scientificamerican0178-86
   Costerton JW, 2001, TRENDS MICROBIOL, V9, P50, DOI 10.1016/S0966-842X(00)01918-1
   Costerton JW, 2007, BIOFILM PRIMER, P5
   Costerton JW., 2007, BIOFILM PRIMER, P107
   Darouiche RO, 2007, J BONE JOINT SURG AM, V89A, P792, DOI 10.2106/JBJS.F.00414
   Darouiche RO, 2009, J ANTIMICROB CHEMOTH, V64, P88, DOI 10.1093/jac/dkp158
   Darouiche RO, 2005, J INFECTION, V50, P206, DOI 10.1016/j.jinf.2004.05.006
   Darouiche RO, 1998, J BONE JOINT SURG AM, V80A, P1336, DOI 10.2106/00004623-199809000-00013
   Davis SC, 2008, WOUND REPAIR REGEN, V16, P23, DOI 10.1111/j.1524-475X.2007.00303.x
   Del Pozo JL, 2009, NEW ENGL J MED, V361, P787, DOI 10.1056/NEJMcp0905029
   Dohar JE, 2005, LARYNGOSCOPE, V115, P1469, DOI 10.1097/01.mlg.0000172036.82897.d4
   Donlan R.M., 2003, MED BIOFILMS, P29
   Dowd SE, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-43
   Edwards R, 2004, CURR OPIN INFECT DIS, V17, P91, DOI 10.1097/00001432-200404000-00004
   Elasri MO, 2002, BONE, V30, P275, DOI 10.1016/S8756-3282(01)00632-9
   Feazel LM, 2009, P NATL ACAD SCI USA, V106, P16393, DOI 10.1073/pnas.0908446106
   Fernandez-Hidalgo N, 2010, J ANTIMICROB CHEMOTH, V65, P525, DOI 10.1093/jac/dkp499
   Fry Donald E, 2007, AORN J, V86, P801, DOI 10.1016/j.aorn.2007.06.022
   Gaudin A, 2011, LETT APPL MICROBIOL, V52, P253, DOI 10.1111/j.1472-765X.2010.02992.x
   GEESEY GG, 1977, CAN J MICROBIOL, V23, P1733, DOI 10.1139/m77-249
   Grice EA, 2008, GENOME RES, V18, P1043, DOI 10.1101/gr.075549.107
   Gristina AG, 1984, INFECT SURG, V3, P655
   Guarner F, 2003, LANCET, V361, P512, DOI 10.1016/S0140-6736(03)12489-0
   GUSTILO RB, 1984, J TRAUMA, V24, P742, DOI 10.1097/00005373-198408000-00009
   GUSTILO RB, 1990, J BONE JOINT SURG AM, V72A, P299, DOI 10.2106/00004623-199072020-00023
   Hansen LK, 2010, INT J ARTIF ORGANS, V33, P627
   Hart E, 2010, J ANTIMICROB CHEMOTH, V65, P974, DOI 10.1093/jac/dkq057
   HENDLEY JO, 1991, ANTIMICROB AGENTS CH, V35, P627, DOI 10.1128/AAC.35.4.627
   James G, 2009, ROLE BIOFILMS DEVICE, P11
   James GA, 2008, WOUND REPAIR REGEN, V16, P37, DOI 10.1111/j.1524-475X.2007.00321.x
   Johnson EN, 2007, CLIN INFECT DIS, V45, P409, DOI 10.1086/520029
   Kaltsas DS, 2004, ANN ROY COLL SURG, V86, P267, DOI 10.1308/147870804579
   Keeling WB, 2009, J SURG RES, V157, P223, DOI 10.1016/j.jss.2008.06.050
   KLOOS WE, 1975, APPL MICROBIOL, V30, P381
   Krasko MY, 2007, J CONTROL RELEASE, V117, P90, DOI 10.1016/j.jconrel.2006.10.010
   Krizek TJ, 1967, SURG FORUM, V18, P518
   LAMBE DW, 1991, CLIN ORTHOP RELAT R, P285
   Lambert EW, 2003, J ORTHOP TRAUMA, V17, P436, DOI 10.1097/00005131-200307000-00008
   LAWRENCE JR, 1991, J BACTERIOL, V173, P6558, DOI 10.1128/jb.173.20.6558-6567.1991
   Leid JG, 2005, J IMMUNOL, V175, P7512, DOI 10.4049/jimmunol.175.11.7512
   Li B, 2010, J CONTROL RELEASE, V145, P221, DOI 10.1016/j.jconrel.2010.04.002
   Lucke M, 2003, BONE, V32, P521, DOI 10.1016/S8756-3282(03)00050-4
   MARRIE TJ, 1982, CIRCULATION, V66, P1339, DOI 10.1161/01.CIR.66.6.1339
   MAYBERRYCARSON KJ, 1984, INFECT IMMUN, V43, P825
   Melchior MB, 2006, J VET MED B, V53, P326, DOI 10.1111/j.1439-0450.2006.00962.x
   Mertz PM, 2003, WOUNDS, V15, P129
   MURPHY RC, 1986, J SURG RES, V41, P75, DOI 10.1016/0022-4804(86)90011-9
   Murray CK, 2008, J TRAUMA, V64, pS232, DOI 10.1097/TA.0b013e318163c3f5
   NICKEL JC, 1985, ANTIMICROB AGENTS CH, V27, P619, DOI 10.1128/AAC.27.4.619
   Okuda K, 2001, J CLIN MICROBIOL, V39, P1114, DOI 10.1128/JCM.39.3.1114-1117.2001
   Owens BD, 2007, J ORTHOP TRAUMA, V21, P254, DOI 10.1097/BOT.0b013e31802f78fb
   Percival SL, 2004, WOUNDS, V16, P234
   Reid SD, 2009, J INFECT DIS, V199, P786, DOI 10.1086/597042
   ROBSON MC, 1969, MIL MED, V134, P19
   Serralta VW, 2001, WOUNDS, V13, P29
   SIMON GL, 1984, GASTROENTEROLOGY, V86, P174
   Sponseller PD, 2010, CLIN ORTHOP RELAT R, V468, P711, DOI 10.1007/s11999-009-0933-4
   STEPHEN AM, 1980, J MED MICROBIOL, V13, P45, DOI 10.1099/00222615-13-1-45
   Tate A, 2010, CURR OPIN OBSTET GYN, V22, P408, DOI 10.1097/GCO.0b013e32833e49c3
   Thomas JG, 2006, J AM DENT ASSOC, V137, p10S, DOI 10.14219/jada.archive.2006.0409
   TORSVIK V, 1990, APPL ENVIRON MICROB, V56, P782
   Williams DL, 2011, RES J MICROBIOL, V6, P425, DOI DOI 10.3923/JM.2011.425.429
   Williams D, 2008, J BIOMED MATER RES A, V85A, P366, DOI 10.1002/jbm.a.31485
   Williams DL, 2011, CURR MICROBIOL, V62, P1657, DOI 10.1007/s00284-011-9908-2
   Wimpenny J, 2000, FEMS MICROBIOL REV, V24, P661, DOI 10.1111/j.1574-6976.2000.tb00565.x
   Wolcott RD, 2010, J WOUND CARE, V19, P320, DOI 10.12968/jowc.2010.19.8.77709
   Xie ZP, 2009, J CONTROL RELEASE, V139, P118, DOI 10.1016/j.jconrel.2009.06.012
   Zalavras CG, 2007, J BONE JOINT SURG AM, V89A, P884, DOI 10.2106/00004623-200704000-00027
   Zimmerli W, 2006, BEST PRACT RES CL RH, V20, P1045, DOI 10.1016/j.berh.2006.08.003
   Zobell CE, 1943, J BACTERIOL, V46, P39
   Zou GY, 2009, J INT MED RES, V37, P1115, DOI 10.1177/147323000903700416
NR 82
TC 17
Z9 17
U1 1
U2 14
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1552-4973
EI 1552-4981
J9 J BIOMED MATER RES B
JI J. Biomed. Mater. Res. Part B
PD MAY
PY 2012
VL 100B
IS 4
BP 1163
EP 1169
DI 10.1002/jbm.b.31979
PG 7
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 920KH
UT WOS:000302402700031
PM 22120924
DA 2018-10-19
ER

PT J
AU Rolin, G
   Placet, V
   Jacquet, E
   Tauzin, H
   Robin, S
   Pazart, L
   Viennet, C
   Saas, P
   Muret, P
   Binda, D
   Humbert, P
AF Rolin, Gwenael
   Placet, Vincent
   Jacquet, Emmanuelle
   Tauzin, Helene
   Robin, Sophie
   Pazart, Lionel
   Viennet, Celine
   Saas, Philippe
   Muret, Patrice
   Binda, Delphine
   Humbert, Philippe
TI Development and characterization of a human dermal equivalent with
   physiological mechanical properties
SO SKIN RESEARCH AND TECHNOLOGY
LA English
DT Article
DE biomaterial; dermal equivalent; myofibroblasts; rigidity
ID SKIN IN-VIVO; STRESSED COLLAGEN LATTICES; TISSUE-ENGINEERED SKIN;
   INDENTATION; FIBROBLASTS; MODEL; BEHAVIOR; TENSION; INVIVO; TESTS
AB Background/aims: Different models of reconstructed skin are available, either to provide skin wound healing when this process is deficient, or to be used as an in vitro model. Nevertheless, few studies have focused on the mechanical properties of skin equivalent. Indeed, human skin is naturally under tension. Taking into account these features, the purpose of this work was to obtain a cellularized dermal equivalent (CDE), composed of collagen and dermal fibroblasts. Methods: To counteract the natural retraction of CDE and to maintain it under tension, different biomaterials were tested. Selection criteria were biocompatibility, bioadhesion properties, ability to induce differentiation of fibroblasts into myofibroblasts and mechanical characterization, considering that of skin in vivo. These assays led to the selection of honeycomb of polyester. CDE constructed on this biomaterial was further characterized mechanically using tensile tests. Results: The results showed that mechanical features of the obtained dermal equivalent, including myofibroblasts, were similar to skin in vivo. Conclusion: The original model of dermal equivalent presented herein may be a useful tool for clinical use and as an in vitro model for toxicological/pharmacological research.
C1 [Humbert, Philippe] Univ Hosp Besancon, Dept Dermatol, F-25030 Besancon, France.
   [Rolin, Gwenael; Tauzin, Helene; Viennet, Celine; Saas, Philippe; Muret, Patrice; Binda, Delphine; Humbert, Philippe] INSERM, UMR Engn & Cutaneous Biol Team 645, Besancon, France.
   [Rolin, Gwenael; Placet, Vincent; Jacquet, Emmanuelle; Tauzin, Helene; Viennet, Celine; Saas, Philippe; Humbert, Philippe] Univ Franche Comte, F-25030 Besancon, France.
   [Placet, Vincent; Jacquet, Emmanuelle] CNRS, FEMTO ST Inst, Dept Appl Mech, UMR 6174, Besancon, France.
   [Robin, Sophie] Bioexigence, Besancon, France.
   [Rolin, Gwenael; Saas, Philippe; Binda, Delphine] Univ Hosp Besancon, Clin Investigat Ctr CIC BT 506, F-25030 Besancon, France.
   [Rolin, Gwenael; Saas, Philippe; Binda, Delphine] Univ Hosp Besancon, CIC IT 808, F-25030 Besancon, France.
   [Saas, Philippe] EFS Bourgogne Franche Comte, Besancon, France.
RP Humbert, P (reprint author), Univ Hosp Besancon, Dept Dermatol, 2 Pl St Jacques, F-25030 Besancon, France.
EM philippe.humbert@univ-fcomte.fr
RI SAAS, Philippe/M-3550-2015
OI SAAS, Philippe/0000-0002-8857-9939
FU Transplantation Foundation; OSEO; Regional Council of the Franche-Comte
   Region
FX This work was supported by the Transplantation Foundation, the OSEO and
   the Regional Council of the Franche-Comte Region. We are also very
   grateful to Serge Piranda from Statice Sante for supplying us with
   biomaterials, to Sophie Launay and Virgine Mouget for technical
   assistance with flow cytometry and confocal microscopy experiments, and
   to Frances Sheppard for her linguistic assistance.
CR Agache P., 2004, MEASURING SKIN, P429
   [Anonymous], 1992, 109935 INT ORG STAND
   BELL E, 1979, P NATL ACAD SCI USA, V76, P1274, DOI 10.1073/pnas.76.3.1274
   Bride J, 2004, ARCH DERMATOL RES, V295, P312, DOI 10.1007/s00403-003-0438-z
   Clark RAF, 1996, MOL CELLULAR BIOL WO, P14
   Clark RAF, 2007, J INVEST DERMATOL, V127, P1018, DOI 10.1038/sj.jid.5700715
   Dallon JC, 2008, WOUND REPAIR REGEN, V16, P472, DOI 10.1111/j.1524-475X.2008.00392.x
   DALY CH, 1979, J INVEST DERMATOL, V73, P84, DOI 10.1111/1523-1747.ep12532770
   Delalleau A, 2006, J BIOMECH, V39, P1603, DOI 10.1016/j.jbiomech.2005.05.001
   Elsner P, 2002, BIOENGINEERING SKIN
   Jachowicz J, 2007, SKIN RES TECHNOL, V13, P299, DOI 10.1111/j.1600-0846.2007.00229.x
   Jacquet E, 2008, SKIN RES TECHNOL, V14, P1, DOI 10.1111/j.1600-0846.2007.00259.x
   Junker JPE, 2008, BURNS, V34, P942, DOI 10.1016/j.burns.2008.01.010
   Kessler D, 2001, J BIOL CHEM, V276, P36575, DOI 10.1074/jbc.M101602200
   Khatyr F, 2006, SKIN RES TECHNOL, V12, P24, DOI 10.1111/j.0909-725X.2006.00126.x
   Khatyr F, 2004, SKIN RES TECHNOL, V10, P96, DOI 10.1111/j.1600-0846.2004.00057.x
   Liang X, 2010, IEEE T BIO-MED ENG, V57, P953, DOI 10.1109/TBME.2009.2033464
   MacNeil S, 2007, NATURE, V445, P874, DOI 10.1038/nature05664
   MANSCHOT JFM, 1986, J BIOMECH, V19, P517, DOI 10.1016/0021-9290(86)90125-9
   MANSCHOT JFM, 1986, J BIOMECH, V19, P511, DOI 10.1016/0021-9290(86)90124-7
   Pailler-Mattei C, 2008, MED ENG PHYS, V30, P599, DOI 10.1016/j.medengphy.2007.06.011
   Pailler-Mattei C, 2004, J ADHES SCI TECHNOL, V18, P1739, DOI 10.1163/1568561042708368
   Parsons M, 1999, EXP CELL RES, V252, P319, DOI 10.1006/excr.1999.4618
   Retel V, 2001, SKIN RES TECHNOL, V7, P152, DOI 10.1034/j.1600-0846.2001.70302.x
   Salter D C, 1993, Int J Cosmet Sci, V15, P200, DOI 10.1111/j.1467-2494.1993.tb00075.x
   Schappacher M, 2010, MACROMOL BIOSCI, V10, P60, DOI 10.1002/mabi.200900184
   Shevchenko RV, 2010, J R SOC INTERFACE, V7, P229, DOI 10.1098/rsif.2009.0403
   Silver FH, 2003, SKIN RES TECHNOL, V9, P3, DOI 10.1034/j.1600-0846.2003.00358.x
   Tran H. V., 2007, Computer Methods in Biomechanics and Biomedical Engineering, V10, P401, DOI 10.1080/10255840701550287
   WIJN PFF, 1981, BIOENGINEERING SKIN, P135
   Zahouani H, 2009, SKIN RES TECHNOL, V15, P68, DOI 10.1111/j.1600-0846.2008.00329.x
NR 31
TC 5
Z9 5
U1 1
U2 14
PU WILEY-BLACKWELL
PI MALDEN
PA COMMERCE PLACE, 350 MAIN ST, MALDEN 02148, MA USA
SN 0909-752X
J9 SKIN RES TECHNOL
JI Skin Res. Technol.
PD MAY
PY 2012
VL 18
IS 2
BP 251
EP 258
DI 10.1111/j.1600-0846.2011.00564.x
PG 8
WC Dermatology
SC Dermatology
GA 921JA
UT WOS:000302472700019
PM 22093093
DA 2018-10-19
ER

PT J
AU Lopez, M
   Bassi, MA
   Confalone, L
   Fanali, S
   Candotto, V
   Cura, F
   Carinci, F
AF Lopez, M.
   Bassi, M. Andreasi
   Confalone, L.
   Fanali, S.
   Candotto, V.
   Cura, F.
   Carinci, F.
TI GENE EXPRESSION STUDY IN DENTAL PULP STEM CELLS CULTIVATED ON TITANIUM
   ALLOYS
SO EUROPEAN JOURNAL OF INFLAMMATION
LA English
DT Article
DE titanium alloys; gene expression; stem cells; osteodifferentiation
AB Nowadays, research on orthopedic and dental implants is focused on titanium alloys due to their appropriated mechanical properties and corrosion resistance in the body environment. Another important aspect to be investigated is their surface topography, which is very important to osseointegration. The aim of this study was to assess dental pulp stem cells response to different titanium surface topography modified. Mesenchymal stem cell marker ENG was significantly decreased in stem cells cultivated in modified titanium surface respect to machined titanium surface, indicating the differentiation effect of this biomaterial on stem cells. The obtained results can be relevant to better understand the molecular mechanism of bone regeneration and as a model for comparing other materials with similar clinical effects.
C1 [Fanali, S.] Univ G DAnnunzio, Dept Oral Sci Nano & Biotechnol, Chieti, Italy.
   [Candotto, V.; Carinci, F.] Univ Ferrara, Sect Maxillofacial & Plast Surg, Dept DMCCC, I-44100 Ferrara, Italy.
   [Cura, F.] Univ Bologna, Dept Histol Embryol & Appl Biol, Bologna, Italy.
RP Carinci, F (reprint author), Univ Ferrara, Sect Maxillofacial & Plast Surg, Dept DMCCC, Corso Giovecca 203, I-44100 Ferrara, Italy.
EM crc@unife.it
FU FMD (Rome, Italy)
FX This research was supported by FMD (Rome, Italy). Gratitude is expressed
   to Mr. Roberto Falappa, Mr. Sergio Falappa and Mr. Marco Falappa for the
   realization of the titanium samples.
CR Barry FP, 1999, BIOCHEM BIOPH RES CO, V265, P134, DOI 10.1006/bbrc.1999.1620
   Bathomarco RV, 2004, APPL SURF SCI, V233, P29, DOI 10.1016/j.apsusc.2004.04.007
   Jakob M, 2001, J CELL BIOCHEM, V81, P368, DOI 10.1002/1097-4644(20010501)81:2<368::AID-JCB1051>3.0.CO;2-J
   Jin HJ, 2009, BIOCHEM BIOPH RES CO, V381, P676, DOI 10.1016/j.bbrc.2009.02.118
   Kim HJ, 2005, J BIOMED MATER RES A, V74A, P366, DOI 10.1002/jbm.a.30327
   Oliveira NTC, 2009, ACTA BIOMATER, V5, P399, DOI 10.1016/j.actbio.2008.07.010
   Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143
   Sollazzo V, 2011, EUR J INFLAMM, V9, P125
   Sollazzo V, 2011, INT J IMMUNOPATH S1, V9, P51
   Traini T, 2008, DENT MATER, V24, P1525, DOI 10.1016/j.dental.2008.03.029
   Zhang H, 2003, BIOMATERIALS, V24, P2013, DOI 10.1016/S0142-9612(02)00616-6
NR 11
TC 0
Z9 0
U1 1
U2 1
PU SAGE PUBLICATIONS INC
PI THOUSAND OAKS
PA 2455 TELLER RD, THOUSAND OAKS, CA 91320 USA
SN 1721-727X
J9 EUR J INFLAMM
JI Eur. J. Inflamm.
PD MAY-AUG
PY 2012
VL 10
IS 2
SU S
BP 49
EP 53
DI 10.1177/1721727X120100S210
PG 5
WC Immunology
SC Immunology
GA V37BO
UT WOS:000209251500010
OA Bronze
DA 2018-10-19
ER

PT J
AU Beloti, MM
   Sicchieri, LG
   de Oliveira, PT
   Rosa, AL
AF Beloti, Marcio M.
   Sicchieri, Luciana G.
   de Oliveira, Paulo T.
   Rosa, Adalberto Luiz
TI The Influence of Osteoblast Differentiation Stage on Bone Formation in
   Autogenously Implanted Cell-Based Poly(Lactide-Co-Glycolide) and Calcium
   Phosphate Constructs
SO TISSUE ENGINEERING PART A
LA English
DT Article
ID MARROW STROMAL CELLS; TISSUE-ENGINEERED CONSTRUCTS; ENDOTHELIAL
   GROWTH-FACTOR; IN-VIVO EVALUATION; SIZE DEFECT MODEL; SCAFFOLD DESIGN;
   VITRO; REPAIR; REGENERATION; PHENOTYPE
AB We tested the hypothesis that the osteoblast differentiation status of bone marrow stem cells (BMSCs) combined with a three-dimensional (3D) structure modulates bone formation when autogenously implanted. Rat BMSCs were aspirated, expanded, and seeded into a 3D composite of poly(lactide-co-glycolide) and calcium phosphate (PLGA/CaP) to produce a hybrid biomaterial. Calvarial defects were implanted with (1) scaffold without cells (SC/NC), (2) scaffold and BMSCs (SC + BMSC), (3) scaffold and osteoblasts differentiated for 7 days (SC + OB7), and (4) for 14 days (SC + OB14). After 4 weeks, there was more bone formation in groups combining scaffold and cells, SC + BMSC and SC + OB7. A nonsignificant higher amount of bone formation was observed on SC + OB14 compared with SC/NC. Additionally, more blood vessels were counted within all hybrid biomaterials, without differences among them, than into SC/NC. These findings provide evidences that the cell differentiation status affects in vivo bone formation in autogenously implanted cell-based constructs. Undifferentiated BMSCs or osteoblasts in early stage of differentiation combined with PLGA/CaP scaffold favored bone formation compared with plain scaffold and that one associated with more mature osteoblasts.
C1 [Beloti, Marcio M.; Sicchieri, Luciana G.; de Oliveira, Paulo T.; Rosa, Adalberto Luiz] Univ Sao Paulo, Sch Dent Ribeirao Preto, Cell Culture Lab, Sao Paulo, Brazil.
RP Rosa, AL (reprint author), Univ Sao Paulo, Sch Dent Ribeirao Preto, Cell Culture Lab, Av Cafe S-N, BR-14040904 Ribeirao Preto, Brazil.
EM adalrosa@forp.usp.br
RI Rosa, Adalberto/A-6314-2008; Beloti, Marcio/E-7473-2012; Tambasco de
   Oliveira, Paulo/F-9749-2010
OI Rosa, Adalberto/0000-0002-6495-2778; Beloti, Marcio/0000-0003-0149-7189;
   Tambasco de Oliveira, Paulo/0000-0002-6662-0486
FU Sao Paulo Research Foundation (FAPESP, Brazil); National Council for
   Scientific and Technological Development (CNPq, Brazil)
FX This research was supported by grants from the Sao Paulo Research
   Foundation (FAPESP, Brazil) and the National Council for Scientific and
   Technological Development (CNPq, Brazil). The authors thank Fabiola
   Singaretti de Oliveira, Roger Rodrigo Fernandes, Junia Ramos, and
   Adriana Luisa Goncalves de Almeida for technical assistance.
CR Abbah SA, 2011, TISSUE ENG PT A, V17, P809, DOI [10.1089/ten.tea.2010.0255, 10.1089/ten.TEA.2010.0255]
   Beloti MM, 2009, J BIOMATER APPL, V23, P481, DOI 10.1177/0885328208094082
   CRANE GM, 1995, NAT MED, V1, P1322, DOI 10.1038/nm1295-1322
   Davies JE, 2010, ORGANOGENESIS, V6, P161, DOI 10.4161/org.6.3.12392
   de Gorter DJJ, 2011, J BONE MINER RES, V26, P1178, DOI 10.1002/jbmr.313
   DELEU J, 1965, J Bone Joint Surg Br, V47, P319
   Diaz-Flores L, 2009, HISTOL HISTOPATHOL, V24, P909, DOI 10.14670/HH-24.909
   Dumas A, 2009, J BIOMED MATER RES A, V90A, P1218, DOI 10.1002/jbm.a.32176
   Eghbali-Fatourechi GZ, 2005, NEW ENGL J MED, V352, P1959, DOI 10.1056/NEJMoa044264
   Gallego L, 2010, TISSUE ENG PT A, V16, P1179, DOI [10.1089/ten.tea.2009.0517, 10.1089/ten.TEA.2009.0517]
   Griffin M, 2011, J BONE JOINT SURG BR, V93B, P427, DOI 10.1302/0301-620X.93B4.25249
   Guan LM, 2004, J BIOMED MATER RES A, V71A, P480, DOI 10.1002/jbm.a.30173
   Holy CE, 2003, J BIOMED MATER RES A, V65A, P447, DOI 10.1002/jbm.a.10453
   Kruyt MC, 2007, BIOMATERIALS, V28, P1798, DOI 10.1016/j.biomaterials.2006.11.038
   Li GH, 2009, TISSUE ENG PT A, V15, P2123, DOI 10.1089/ten.tea.2008.0214
   Lickorish D, 2007, BIOMATERIALS, V28, P1495, DOI 10.1016/j.biomaterials.2006.11.025
   Mauney JR, 2005, BIOMATERIALS, V26, P3173, DOI 10.1016/j.biomaterials.2004.08.020
   Moroni L, 2008, J BIOMAT SCI-POLYM E, V19, P543, DOI 10.1163/156856208784089571
   Prockop DJ, 1997, SCIENCE, V276, P71, DOI 10.1126/science.276.5309.71
   Rath SN, 2011, J MATER SCI-MATER M, V22, P1279, DOI 10.1007/s10856-011-4300-0
   Ren TB, 2005, J BIOMED MATER RES A, V74A, P562, DOI 10.1002/jbm.a.30324
   Rosa AL, 2008, EXPERT REV MED DEVIC, V5, P719, DOI 10.1586/17434440.5.6.719
   Sicchieri LG, 2012, J TISSUE ENG REGEN M, V6, P155, DOI 10.1002/term.422
   Sikavitsas VI, 2003, J BIOMED MATER RES A, V67A, P944, DOI 10.1002/jbm.a.10126
   STEIN GS, 1993, ENDOCR REV, V14, P424, DOI 10.1210/er.14.4.424
   Tsigkou O, 2010, P NATL ACAD SCI USA, V107, P3311, DOI 10.1073/pnas.0905445107
   Uebersax L, 2006, TISSUE ENG, V12, P3417, DOI 10.1089/ten.2006.12.3417
   VACANTI CA, 1994, OTOLARYNG CLIN N AM, V27, P263
   Villars F, 2000, J CELL BIOCHEM, V79, P672, DOI 10.1002/1097-4644(20001215)79:4<672::AID-JCB150>3.0.CO;2-2
   Young S, 2009, TISSUE ENG PT A, V15, P2347, DOI 10.1089/ten.tea.2008.0510
   Yu XJ, 2004, P NATL ACAD SCI USA, V101, P11203, DOI 10.1073/pnas.0402532101
   Yuan J, 2010, TISSUE ENG PT A, V16, P1385, DOI [10.1089/ten.tea.2009.0472, 10.1089/ten.TEA.2009.0472]
NR 32
TC 10
Z9 11
U1 1
U2 2
PU MARY ANN LIEBERT, INC
PI NEW ROCHELLE
PA 140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA
SN 1937-3341
J9 TISSUE ENG PT A
JI Tissue Eng. Part A
PD MAY
PY 2012
VL 18
IS 9-10
BP 999
EP 1005
DI 10.1089/ten.tea.2011.0405
PG 7
WC Cell & Tissue Engineering; Biotechnology & Applied Microbiology; Cell
   Biology
SC Cell Biology; Biotechnology & Applied Microbiology
GA 935SJ
UT WOS:000303540400011
PM 22150110
DA 2018-10-19
ER

PT J
AU Chhikara, S
   Dutta, I
   Paulose, B
   Jaiwal, PK
   Dhankher, OP
AF Chhikara, Sudesh
   Dutta, Indrajit
   Paulose, Bibin
   Jaiwal, Pawan K.
   Dhankher, Om Parkash
TI Development of an Agrobacterium-mediated stable transformation method
   for industrial oilseed crop Crambe abyssinica 'BelAnn'
SO INDUSTRIAL CROPS AND PRODUCTS
LA English
DT Article
DE Crambe abyssinica; Agrobacterium-mediated transformation;
   beta-Glucoronidase (GUS); Arsenate reductase (ArsC);
   gamma-Glutamylcysteine synthetase (gamma-ECS)
ID T-DNA TRANSFER; SHOOT REGENERATION; SIGNAL MOLECULES; IN-VITRO;
   EXPRESSION; PLANTS; TUMEFACIENS; EXPLANTS; GENES; IDENTIFICATION
AB Crambe abyssinica is a fast growing non-food high biomass crop with significant potential for biofuel production and for phytoremediation of heavy metal contaminated soils and sediments. We have developed an efficient Agrobacterium-mediated transformation system for C. abyssinica 'BelAnn' using beta-glucuronidase (gus), bacterial arsenate reductase (ArsC), and gamma-glutamylcysteine synthetase (gamma-ECS) genes. Pre-cultured hypocotyl explants were infected with Agrobacterium tumefaciens strain LBA4404 harboring binary vector pCAMBIA1300 containing gus, ArsC, and gamma-ECS genes under the control of CaMV35S, leaf-specific SRS1p, and constitutive Act2p promoters, respectively. Following co-cultivation and selection, regenerated shoot buds were sub-cultured on MS medium containing GA(3) for shoot elongation. Elongated shoots were transferred to root induction medium for 1 week. Semi-quantitative RT-PCR analysis confirmed the expression of mRNA transcripts for gus. ArsC and gamma-ECS genes in To generation transgenic plants. Histochemical assays showed the gus expression in both vegetative and reproductive tissues of stably transformed T-1 generation plants. Germinating seeds from T-1 transgenic plants grown on MS medium containing hygromycin revealed a 3:1 Mendelian inheritance pattern for each transgene. Immunoblotting assays further confirmed the stable transformation and expression of the ArsC and gamma-ECS proteins in T-2 generation plants using anti-ArsC and gamma-ECS antibodies. This method achieved an overall frequency of 50-70% regeneration and 6.7-8.3% transformation with three different gene constructs. The method showed higher transformation efficiency than the previously reported methods and will be useful for gene manipulation in crambe to enable biomaterial and biofuel production, as well as for potential oil content modification and heavy metal phytoremediation. Published by Elsevier B.V.
C1 [Chhikara, Sudesh; Dutta, Indrajit; Paulose, Bibin; Dhankher, Om Parkash] Univ Massachusetts, Dept Plant Soil & Insect Sci, Amherst, MA 01003 USA.
   [Jaiwal, Pawan K.] Maharshi Dayanand Univ, Adv Ctr Biotechnol, Rohtak, Haryana, India.
RP Dhankher, OP (reprint author), Univ Massachusetts, Dept Plant Soil & Insect Sci, Amherst, MA 01003 USA.
EM parkash@psis.umass.edu
RI Dhankher, Om Parkash/P-1880-2016
FU Consortium of Plant Biotechnology Research (CPBR) under DOE [GO12026,
   DE-FG36-02 GO12026]
FX Authors are highly thankful to Dr. Jason White for his critical reading
   and editing of this manuscript. We thank Profs Richard B. Meagher and
   Barry P. Rosen for providing gamma-ECS and ArsC antibodies,
   respectively. Authors also thank to Dr. Magdalena Bezanilla and her lab
   members for their help and permission to use their microscopy facility.
   This work was supported by the Consortium of Plant Biotechnology
   Research (CPBR) via an award #GO12026 (under DOE prime agreement:
   DE-FG36-02 GO12026).
CR ANDERSON MD, 1992, J ECON ENTOMOL, V85, P594, DOI 10.1093/jee/85.2.594
   Anderson V.L, 1993, DEHULLED CRAMBE MEAL, V16, P22
   [Anonymous], 1993, BIOOPTIONS NEWSLETTE, P1
   Artus NN, 2006, J PLANT NUTR, V29, P667, DOI 10.1080/01904160600564444
   BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3
   Carlson K. D., 1996, Progress in new crops: Proceedings of the Third National Symposium Indianapolis, Indiana, 22-25 October, 1996., P306
   CARLSON KD, 1985, J AM OIL CHEM SOC, V62, P897, DOI 10.1007/BF02541754
   CARLSON KD, 1983, J AM OIL CHEM SOC, V60, P1979, DOI 10.1007/BF02669969
   CHI GL, 1989, PLANT SCI, V64, P243, DOI 10.1016/0168-9452(89)90030-7
   DePalma A, 2003, BIOPHARM INT, V16, P24
   Dhankher OP, 2002, NAT BIOTECHNOL, V20, P1140, DOI 10.1038/nbt747
   Eapen S, 1997, PLANT CELL TISS ORG, V51, P229, DOI 10.1023/A:1005926108586
   European Commission, 2010, EUR EC, P1, DOI DOI 10.2791/49877
   Fahey JW, 2001, PHYTOCHEMISTRY, V56, P5, DOI 10.1016/S0031-9422(00)00316-2
   Gao H.B., 1998, HEREDITAS BEIJING S, V20, P50
   Golz T., 1993, ALTERNATIVE AGR SERI, V4
   Gong HB, 2004, PLANT SCI, V167, P1191, DOI 10.1016/j.plantsci.2004.04.032
   JACQ B, 1993, PLANT CELL REP, V12, P621, DOI 10.1007/BF00232811
   Jagannath A, 2001, MOL BREEDING, V8, P11, DOI 10.1023/A:1011916216191
   JEFFERSON RA, 1987, EMBO J, V6, P3901
   Johnson R.G., 1994, 3 INT C NEW IND CROP
   Kmec P, 1998, CROP SCI, V38, P108, DOI 10.2135/cropsci1998.0011183X003800010019x
   Lazzeri L, 1994, IND CROP PROD, V3, P103, DOI 10.1016/0926-6690(94)90083-3
   LEPPIK EE, 1975, EUPHYTICA, V24, P681, DOI 10.1007/BF00132906
   Li XY, 2011, IND CROP PROD, V33, P170, DOI 10.1016/j.indcrop.2010.10.004
   Li XY, 2010, PLANT CELL TISS ORG, V100, P149, DOI 10.1007/s11240-009-9630-y
   McKay K.R., 1992, INFLUENCE PLANTING D, V49, P23
   Mett V, 2008, BIOLOGICALS, V36, P354, DOI 10.1016/j.biologicals.2008.09.001
   MURASHIGE T, 1962, PHYSIOL PLANTARUM, V15, P473, DOI 10.1111/j.1399-3054.1962.tb08052.x
   OWENS LD, 1988, PLANT PHYSIOL, V88, P570, DOI 10.1104/pp.88.3.570
   Papathanasiou GA.., 1966, PURDUE U AGR EXPT RE, P819
   Paulose B, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-108
   Sambrook J, 1989, MOL CLONING LAB MANU
   SHEIKHOLESLAM SN, 1987, PLANT MOL BIOL, V8, P291, DOI 10.1007/BF00021308
   SHIMODA N, 1990, P NATL ACAD SCI USA, V87, P6684, DOI 10.1073/pnas.87.17.6684
   STACHEL SE, 1985, NATURE, V318, P624, DOI 10.1038/318624a0
   STEG A, 1994, ANIM FEED SCI TECH, V50, P87, DOI 10.1016/0377-8401(94)90011-6
   Sunilkumar G, 1999, PLANT SCI, V141, P51, DOI 10.1016/S0168-9452(98)00228-3
   Vaine E., 2010, THESIS U MASSACHUSET
   Villemont E, 1997, PLANTA, V201, P160, DOI 10.1007/BF01007700
   Wang YP, 2000, IND CROP PROD, V12, P47, DOI 10.1016/S0926-6690(99)00066-7
   Zhang YuXiu, 2006, Plant Molecular Biology Reporter, V24, P255
NR 42
TC 11
Z9 11
U1 1
U2 21
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0926-6690
J9 IND CROP PROD
JI Ind. Crop. Prod.
PD MAY
PY 2012
VL 37
IS 1
BP 457
EP 465
DI 10.1016/j.indcrop.2011.07.021
PG 9
WC Agricultural Engineering; Agronomy
SC Agriculture
GA 913VS
UT WOS:000301906100067
DA 2018-10-19
ER

PT J
AU McCanless, JD
   Jennings, LK
   Cole, JA
   Bumgardner, JD
   Haggard, WO
AF McCanless, Jonathan D.
   Jennings, Lisa K.
   Cole, Judith A.
   Bumgardner, Joel D.
   Haggard, Warren O.
TI Induction of the early inflammatory-mediated cellular responses of
   fracture healing in vitro using platelet releasate-containing
   alginate/CaPO4 biomaterials for early osteoarthritis prevention
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A
LA English
DT Article
DE monocyte; human umbilical vein endothelial cells; alginate; tricalcium
   phosphate; platelet releasate
ID APPROPRIATE CONSERVATIVE TREATMENT; STANDING-COMMITTEE; GROWTH-FACTORS;
   STEM-CELLS; TASK-FORCE; CALCIUM; MANAGEMENT; HYDROGELS; ANGIOGENESIS;
   COMPOSITE
AB A significant gap exists in our understanding of subchondral and cancellous bone changes that may regulate osteoarthritis progression. Herein, we complement our prior osteochondrogenesis work with growth factor elution and monocyte and endothelial cell activation using two biomaterial formulations. The design of these biomaterials was inspired by the roles of a fracture hematoma, more specifically, the potential of significant cross-talk among cells and cellular factors that affect bone remodeling. Biomaterials, referred to herein as F1+ and F2+, are human concentrated platelet releasate-containing alginate/beta-tricalcium phosphate composites. F1+ has a higher calcium phosphate volume percentage and lower alginate polymer weight percent hydrogel versus F2+. The majority of releasate-derived platelet-derived growth factor eluted over 24 h for F1+ and 48 h for F2+, suggesting sustained release with an increase in alginate weight percentage. Simple monocyte and endothelial cell migration studies demonstrated 650% and 900% increases with F1+ eluate over medium alone, respectively. Induction of endothelial cell invasion over supplemented medium positive control was also shown for F2+ eluate (p = 0.03) with F1+ eluate being similar to the control. Monocyte transendothelial migration was increased over 300% and 400% for F1+ and F2+ eluates compared with medium alone, respectively. In addition, F1+ and F2+ eluates induced spontaneous endothelial tube formations similar to supplemented medium, demonstrating a well-formed network of capillary-like structures. This work demonstrated our biomaterial formulations ability to induce characteristics in vitro that parallel the in vivo behavior of fracture hematomas and potential to induce bone remodeling for the early treatment of osteoarthritic joints. (C) 2012 Wiley Periodicals, Inc. J Biomed Mater Res Part A, 2012.
C1 [McCanless, Jonathan D.; Bumgardner, Joel D.; Haggard, Warren O.] Univ Memphis, Herff Coll Engn, Dept Biomed Engn, Memphis, TN 38152 USA.
   [Jennings, Lisa K.] Univ Tennessee, Hlth Sci Ctr, Coll Med, Dept Internal Med, Memphis, TN 38163 USA.
   [Jennings, Lisa K.] Univ Tennessee, Hlth Sci Ctr, Vasc Biol Ctr Excellence, Memphis, TN 38163 USA.
   [Cole, Judith A.] Univ Memphis, Coll Arts & Sci, Dept Biol Sci, Memphis, TN 38152 USA.
   [Bumgardner, Joel D.] Univ Tennessee, Hlth Sci Ctr, Sch Dent, Memphis, TN 38163 USA.
   [Bumgardner, Joel D.] Univ Tennessee, Hlth Sci Ctr, Sch Med, Dept Plast Surg, Memphis, TN 38163 USA.
RP Haggard, WO (reprint author), Univ Memphis, Herff Coll Engn, Dept Biomed Engn, Memphis, TN 38152 USA.
EM whaggrd1@memphis.edu
CR Anitua E, 2005, J ORTHOP RES, V23, P281, DOI 10.1016/j.orthres.2004.08.015
   Buckwalter JA, 2006, ADV DRUG DELIVER REV, V58, P150, DOI 10.1016/j.addr.2006.01.006
   Coppinger Judith, 2007, Methods Mol Biol, V357, P307
   El-Sharkawy H, 2007, J PERIODONTOL, V78, P661, DOI 10.1902/jop.2007.060302
   Findlay DM, 2007, RHEUMATOLOGY, V46, P1763, DOI 10.1093/rheumatology/kem191
   Goldring SR, 2008, RHEUM DIS CLIN N AM, V34, P561, DOI 10.1016/j.rdc.2008.07.001
   Hunter DJ, 2008, RHEUM DIS CLIN N AM, V34, P689, DOI 10.1016/j.rdc.2008.05.008
   Hunter DJ, 2009, MED CLIN N AM, V93, P127, DOI 10.1016/j.mcna.2008.07.009
   Jeon O, 2011, J CONTROL RELEASE, V154, P258, DOI 10.1016/j.jconrel.2011.06.027
   Jordan KM, 2003, ANN RHEUM DIS, V62, P1145, DOI 10.1136/ard.2003.011742
   Kalfas I H, 2001, Neurosurg Focus, V10, pE1
   KOHN EC, 1995, P NATL ACAD SCI USA, V92, P1307, DOI 10.1073/pnas.92.5.1307
   Kolar P, 2010, TISSUE ENG PART B-RE, V16, P427, DOI 10.1089/ten.TEB.2009.0687
   Kong H, 2005, POLYSACCHARIDES, P817
   Lee KY, 2001, CHEM REV, V101, P1869, DOI 10.1021/cr000108x
   Ma PX, 2006, SCAFFOLDING TISSUE E, P13
   McCanless JD, HEMATOMA IN IN PRESS
   McCanless JD, 2012, J BIOMED MATER RES A, V100A, P220, DOI 10.1002/jbm.a.33256
   Mehta S, 2008, J ORTHOP TRAUMA, V22, P433, DOI 10.1097/BOT.0b013e31817e793f
   Mouline CC, 2010, EUR CELLS MATER, V20, P379
   Munaron L, 2006, RECENT PAT ANTI-CANC, V1, P105, DOI 10.2174/157489206775246502
   Nunamaker EA, 2007, J BIOMED MATER RES A, V83A, P1128, DOI 10.1002/jbm.a.31275
   Patton AM, 2003, CURR PHARM DESIGN, V9, P543, DOI 10.2174/1381612033391559
   SMETANA K, 1993, BIOMATERIALS, V14, P1046, DOI 10.1016/0142-9612(93)90203-E
   Stoppel WL, 2011, ACTA BIOMATER, V7, P3988, DOI 10.1016/j.actbio.2011.07.009
   Tan RW, 2010, POLYM DEGRAD STABIL, V95, P1736, DOI 10.1016/j.polymdegradstab.2010.05.015
   Whitelaw M. A., 1999, V69, P99
   Yang D, 2009, J BIOMED MATER RES A, V90A, P411, DOI 10.1002/jbm.a.32096
   Zhang W, 2005, ANN RHEUM DIS, V64, P669, DOI 10.1136/ard.2004.028886
   Zhou HZ, 2011, BIOMATERIALS, V32, P7503, DOI 10.1016/j.biomaterials.2011.06.045
NR 30
TC 2
Z9 2
U1 0
U2 5
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1549-3296
EI 1552-4965
J9 J BIOMED MATER RES A
JI J. Biomed. Mater. Res. Part A
PD MAY
PY 2012
VL 100A
IS 5
BP 1107
EP 1114
DI 10.1002/jbm.a.34038
PG 8
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 915IN
UT WOS:000302017800002
PM 22337563
DA 2018-10-19
ER

PT J
AU Fleckman, P
   Usui, M
   Zhao, G
   Underwood, R
   Maginness, M
   Marshall, A
   Glaister, C
   Ratner, B
   Olerud, J
AF Fleckman, Philip
   Usui, Marcia
   Zhao, Ge
   Underwood, Robert
   Maginness, Max
   Marshall, Andrew
   Glaister, Christine
   Ratner, Buddy
   Olerud, John
TI Cutaneous and inflammatory response to long-term percutaneous implants
   of sphere-templated porous/solid poly(HEMA) and silicone in mice
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A
LA English
DT Article
DE percutaneous; biomaterial; porous; skin incorporation; biointegration
ID GENETICALLY DIABETIC MOUSE; NERVE GROWTH-FACTOR; WOUND REPAIR;
   PORE-SIZE; SKIN; MODEL; INTERFACE; MECHANISMS; CELLS; BIOMATERIALS
AB This study investigates mouse cutaneous responses to long-term percutaneously implanted rods surrounded by sphere-templated porous biomaterials engineered to mimic medical devices surrounded by a porous cuff. We hypothesized that keratinocytes would migrate through the pores and stop, permigrate, or marsupialize along the porous/solid interface. Porous/solid-core poly(2-hydroxyethyl methacrylate) [poly(HEMA)] and silicone rods were implanted in mice for 14 days, and for 1, 3, and 6 months. Implants with surrounding tissue were analyzed (immuno)histochemically by light microscopy. Poly(HEMA)/skin implants yielded better morphologic data than silicone implants. Keratinocytes at the poly(HEMA) interface migrated in two different directions. Ventral keratinocytes contiguous with the dermal-epidermal junction migrated into the outermost pores, forming an integrated collar surrounding the rods. Dorsal keratinocytes appearing to emanate from the differentiated epithelial layer, extended upward along and into the exterior portion of the rod, forming an integrated sheath. Leukocytes persisted in poly(HEMA) and silicone pores for the duration of the study. Vascular and collagen networks within the poly(HEMA) pores matured as a function of time up to 3-months implantation. Nerves were not observed within the pores. Poly(HEMA) underwent morphological changes by 6 months of implantation. Marsupialization, foreign body encapsulation, and infection were not observed in any implants. (C) 2012 Wiley Periodicals, Inc. J Biomed Mater Res Part A:, 2012.
C1 [Fleckman, Philip; Usui, Marcia; Zhao, Ge; Underwood, Robert; Olerud, John] Univ Washington, Dept Med Dermatol, Seattle, WA 98195 USA.
   [Maginness, Max; Marshall, Andrew; Glaister, Christine] Healionics Corp, Technol, Redmond, WA USA.
   [Ratner, Buddy] Univ Washington, Dept Bioengn, Seattle, WA 98195 USA.
   [Ratner, Buddy] Univ Washington, Dept Chem Engn, Seattle, WA 98195 USA.
   [Ratner, Buddy] Univ Washington, Dept Chem Engn, Seattle, WA 98195 USA.
RP Fleckman, P (reprint author), Univ Washington, Dept Med Dermatol, Seattle, WA 98195 USA.
EM fleck@u.washington.edu
FU NIH [NIBIB R01 EB004422]; NSF [EEC 9529161]; Washington Technology
   Center RTD; Healionics Corporation; George F. Odland Endowed Research
   Fund
FX Contract grant sponsor: NIH; contract grant number: NIBIB R01 EB004422;
   Contract grant sponsor: NSF; contract grant number: EEC 9529161;
   Contract grant sponsors: Washington Technology Center RTD; Healionics
   Corporation; George F. Odland Endowed Research Fund
CR Akasaka Y, 2010, J PATHOL, V221, P285, DOI 10.1002/path.2710
   Delavary BM, 2011, IMMUNOBIOLOGY, V216, P753, DOI 10.1016/j.imbio.2011.01.001
   Dovi JV, 2004, THROMB HAEMOSTASIS, V92, P275, DOI 10.1160/TH03-11-0720
   Dovi JV, 2003, J LEUKOCYTE BIOL, V73, P448, DOI 10.1189/jlb.0802406
   Faryniarz DA, 1996, J ORTHOP RES, V14, P228, DOI 10.1002/jor.1100140210
   Fleckman P, 2008, BIOMED MATER, V3, DOI 10.1088/1748-6041/3/3/034006
   Fukano Y, 2010, J BIOMED MATER RES A, V94A, P1172, DOI 10.1002/jbm.a.32798
   Fukano Y, 2006, WOUND REPAIR REGEN, V14, P484, DOI 10.1111/j.1743-6109.2006.00138.x
   Gibran NS, 2003, SHOCK, V19, P127, DOI 10.1097/01.SHK.0000054742.29581.5e
   GREENHALGH DG, 1990, AM J PATHOL, V136, P1235
   HALL CW, 1975, T AM SOC ART INT ORG, V21, P281
   Humason G.L., 1962, ANIMAL TISSUE TECHNI
   Isenhath SN, 2007, J BIOMED MATER RES A, V83A, P915, DOI 10.1002/jbm.a.31391
   KARNOVSKY MJ, 1965, J CELL BIOL, V27, P137
   Knowles NG, 2005, J BIOMED MATER RES A, V74A, P482, DOI 10.1002/jbm.a.30384
   LEON A, 1994, P NATL ACAD SCI USA, V91, P3739, DOI 10.1073/pnas.91.9.3739
   Makela M, 1999, EXP CELL RES, V251, P67, DOI 10.1006/excr.1999.4564
   MARSHALL AJ, 2004, POLYM PREPRINTS, V45, P100
   Martin P, 2005, TRENDS CELL BIOL, V15, P599, DOI 10.1016/j.tcb.2005.09.002
   Martinez FO, 2009, ANNU REV IMMUNOL, V27, P451, DOI 10.1146/annurev.immunol.021908.132532
   Moodley YP, 2004, J PATHOL, V202, P486, DOI 10.1002/path.1531
   O'Brien FJ, 2005, BIOMATERIALS, V26, P433, DOI 10.1016/j.biomaterials.2004.02.052
   RICHARDSON KC, 1960, STAIN TECHNOL, V35, P313, DOI 10.3109/10520296009114754
   Singer AJ, 1999, NEW ENGL J MED, V341, P738, DOI 10.1056/NEJM199909023411006
   Spenny ML, 2002, WOUND REPAIR REGEN, V10, P295, DOI 10.1046/j.1524-475X.2002.10504.x
   Sullivan SR, 2004, PLAST RECONSTR SURG, V113, P953, DOI 10.1097/01.PRS.0000105044.03230.F4
   Sullivan SR, 2007, J DERMATOL SCI, V48, P177, DOI 10.1016/j.jdermsci.2007.07.002
   Tavakkol Z, 2010, J AM ASSOC LAB ANIM, V49, P588
   Underwood RA, 2011, J BIOMED MATER RES A, V98A, P499, DOI 10.1002/jbm.a.33125
   VONRECUM AF, 1984, J BIOMED MATER RES, V18, P323, DOI 10.1002/jbm.820180403
   Wetzler C, 2000, J INVEST DERMATOL, V115, P245, DOI 10.1046/j.1523-1747.2000.00029.x
   WINTER GD, 1974, J BIOMED MATER RES, V8, P99, DOI 10.1002/jbm.820080311
   Zhao G, 2010, WOUND REPAIR REGEN, V18, P467, DOI 10.1111/j.1524-475X.2010.00608.x
NR 33
TC 13
Z9 13
U1 0
U2 24
PU WILEY-BLACKWELL
PI MALDEN
PA COMMERCE PLACE, 350 MAIN ST, MALDEN 02148, MA USA
SN 1549-3296
J9 J BIOMED MATER RES A
JI J. Biomed. Mater. Res. Part A
PD MAY
PY 2012
VL 100A
IS 5
BP 1256
EP 1268
DI 10.1002/jbm.a.34012
PG 13
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 915IN
UT WOS:000302017800019
PM 22359383
OA Green Accepted
DA 2018-10-19
ER

PT J
AU Douglas, TEL
   Gassling, V
   Declercq, HA
   Purcz, N
   Pamula, E
   Haugen, HJ
   Chasan, S
   de Mulder, ELW
   Jansen, JA
   Leeuwenburgh, SCG
AF Douglas, Timothy E. L.
   Gassling, Volker
   Declercq, Heidi A.
   Purcz, Nicolai
   Pamula, Elzbieta
   Haugen, Havard J.
   Chasan, Safak
   de Mulder, Eric L. W.
   Jansen, John A.
   Leeuwenburgh, Sander C. G.
TI Enzymatically induced mineralization of platelet-rich fibrin
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A
LA English
DT Article
DE alkaline phosphatase; mineralization; hydrogel; bone tissue engineering;
   platelet-rich fibrin
ID CALCIUM-PHOSPHATE GRANULES; VIVO BIOLOGICAL PERFORMANCE; MESENCHYMAL
   STEM-CELLS; ALKALINE-PHOSPHATASE; IN-VITRO; GROWTH-FACTOR; SINUS LIFT;
   BONE; DIFFERENTIATION; COLLAGEN
AB Membranes of the autologous blood-derived biomaterial platelet-rich fibrin (PRF) were functionalized by incorporation of alkaline phosphatase (ALP), an enzyme involved in mineralization of bone, and subsequently incubated in calcium glycerophosphate (CaGP) solution to induce PRFs mineralization with calcium phosphate (CaP) to improve PRFs suitability as a material for bone replacement. Incorporated ALP retained its bioactivity and induced formation of CaP material within PRF membranes, as confirmed by SEM, EDS, FTIR, and von Kossa staining. The mass percentage attributable to CaP was quantified by lyophilization and measurement of the remaining mass fraction as well as by TGA. Cytocompatibility tests (LDH, MTT, and WST) with SAOS-2 cells showed that mineralized PRF did not release substances detrimental to cell vitality. Live/dead staining and SEM showed that mineralized PRF was colonized by cells. The results show that hydrogel biomaterials such as PRF can be mineralized through functionalization with ALP. (C) 2012 Wiley Periodicals, Inc. J Biomed Mater Res Part A: 2012.
C1 [Douglas, Timothy E. L.; Jansen, John A.; Leeuwenburgh, Sander C. G.] Radboud Univ Nijmegen Med Ctr, Dept Biomat, NL-6500 HB Nijmegen, Netherlands.
   [Douglas, Timothy E. L.] Univ Ghent, Polymer Chem & Biomat PBM Grp, Dept Organ Chem, B-9000 Ghent, Belgium.
   [Gassling, Volker; Purcz, Nicolai] Univ Hosp Schleswig Holstein, Clin Oral & Maxillofacial Surg, D-24105 Kiel, Germany.
   [Declercq, Heidi A.] Univ Ghent, Dept Basic Med Sci Histol Grp, B-9000 Ghent, Belgium.
   [Pamula, Elzbieta] AGH Univ Sci & Technol, Dept Biomat, Fac Mat Sci & Ceram, PL-30059 Krakow, Poland.
   [Haugen, Havard J.] Univ Oslo, Dept Biomat, Inst Clin Dent, NO-0317 Oslo, Norway.
   [Chasan, Safak] Middle E Tech Univ, Dept Mol Biol & Genet, TR-06531 Ankara, Turkey.
   [de Mulder, Eric L. W.] Radboud Univ Nijmegen Med Ctr, Dept Orthoped, NL-6500 HB Nijmegen, Netherlands.
RP Leeuwenburgh, SCG (reprint author), Radboud Univ Nijmegen Med Ctr, Dept Biomat, POB 9101, NL-6500 HB Nijmegen, Netherlands.
EM s.leeuwenburgh@dent.umcn.nl
RI Leeuwenburgh, S.C.G./L-4483-2015; Jansen, John/H-8055-2014; Gassling,
   Volker/E-4671-2016; Haugen, Havard Jostein/H-3551-2014
OI Leeuwenburgh, S.C.G./0000-0003-1471-6133; Gassling,
   Volker/0000-0002-0096-6142; Haugen, Havard Jostein/0000-0002-6690-7233;
   Douglas, Timothy/0000-0002-6661-3120
FU Dutch organization Agentschap NL [SHM08717]; Research Foundation
   Flanders (FWO); Ghent University
FX Contract grant sponsor: Dutch organization Agentschap NL in the
   framework of the IOP program "Self Healing Materials"; contract grant
   number: SHM08717 (Self-healing composites for bone substitution);
   Contract grant sponsors: T.E.L. Douglas - Postdoctoral Fellowship of
   Research Foundation Flanders (FWO): H.A. Declercq - Postdoctoral
   BOF-Mandate (Ghent University).
CR Anh DJ, 2001, CLIN CHIM ACTA, V311, P137, DOI 10.1016/S0009-8981(01)00584-8
   ANTONIADES HN, 1981, P NATL ACAD SCI-BIOL, V78, P7314, DOI 10.1073/pnas.78.12.7314
   BANKS E, 1977, SCIENCE, V198, P1164, DOI 10.1126/science.929194
   BEERTSEN W, 1992, J CLIN INVEST, V89, P1974, DOI 10.1172/JCI115805
   Berendsen AD, 2007, BIOMATERIALS, V28, P3530, DOI 10.1016/j.biomaterials.2007.04.031
   Boyan B. D., 2003, European Cells & Materials, V6, P22
   Braccini F, 2009, Rev Laryngol Otol Rhinol (Bord), V130, P175
   Brandl FP, 2010, BIOMATERIALS, V31, P3957, DOI 10.1016/j.biomaterials.2010.01.128
   BRUDER SP, 1990, BONE, V11, P133, DOI 10.1016/8756-3282(90)90061-3
   Charrier J B, 2008, Rev Laryngol Otol Rhinol (Bord), V129, P313
   Choukroun J, 2006, ORAL SURG ORAL MED O, V101, P299, DOI 10.1016/j.tripleo.2005.07.012
   Choukroun J I, 2007, Rev Laryngol Otol Rhinol (Bord), V128, P27
   de Jonge LT, 2009, ACTA BIOMATER, V5, P2773, DOI 10.1016/j.actbio.2009.03.019
   Dohan David M, 2006, Oral Surg Oral Med Oral Pathol Oral Radiol Endod, V101, pe37, DOI 10.1016/j.tripleo.2005.07.008
   Doi Y, 1996, J BIOMED MATER RES, V31, P43, DOI 10.1002/(SICI)1097-4636(199605)31:1<43::AID-JBM6>3.0.CO;2-Q
   Douglas T, 2010, CLIN ORAL IMPLAN RES, V21, P262, DOI 10.1111/j.1600-0501.2009.01818.x
   Douglas T, 2009, J MATER SCI-MATER M, V20, P1909, DOI 10.1007/s10856-009-3756-7
   Durand B, 1997, EMBO J, V16, P306, DOI 10.1093/emboj/16.2.306
   Ehrenfest DMD, 2010, ARCH ORAL BIOL, V55, P185, DOI 10.1016/j.archoralbio.2010.01.004
   Ehrenfest DMD, 2009, ORAL SURG ORAL MED O, V108, P341, DOI 10.1016/j.tripleo.2009.04.020
   Ehrenfest DMD, 2009, GROWTH FACTORS, V27, P63, DOI 10.1080/08977190802636713
   Evans ND, 2009, EUR CELLS MATER, V18, P1
   Feng CF, 2000, MATER LETT, V46, P229, DOI 10.1016/S0167-577X(00)00176-2
   Filmon R, 2002, BONE, V30, P152, DOI 10.1016/S8756-3282(01)00634-2
   Filmon R, 2000, J BIOMAT SCI-POLYM E, V11, P849, DOI 10.1163/156856200744057
   Filmon R, 2000, MORPHOLOGIE, V84, P3
   Galing VLW, 2009, ORAL SURG ORAL MED O, V108, P48, DOI 10.1016/j.tripleo.2009.02.007
   Gassling V, 2010, CLIN ORAL IMPLAN RES, V21, P543, DOI 10.1111/j.1600-0501.2009.01900.x
   He L, 2009, ORAL SURG ORAL MED O, V108, P707, DOI 10.1016/j.tripleo.2009.06.044
   Jang ES, 2010, ORAL SURG ORAL MED O, V109, P831, DOI 10.1016/j.tripleo.2009.10.038
   Jegoux F, 2005, ARCH ORTHOP TRAUM SU, V125, P153, DOI 10.1007/s00402-004-0748-4
   Kang YH, 2011, TISSUE ENG PT A, V17, P349, DOI [10.1089/ten.tea.2010.0327, 10.1089/ten.TEA.2010.0327]
   Koutsopoulos S, 2002, J BIOMED MATER RES, V62, P600, DOI 10.1002/jbm.10280
   Le Guehennec L, 2005, J MATER SCI-MATER M, V16, P29, DOI 10.1007/s10856-005-6443-3
   Le Guehennec L, 2004, EUROPEAN CELLS MAT, V8, p[1, 10], DOI DOI 10.22203/ECM.V008A01
   Le Guehennec L, 2004, EUR CELLS MATER, V8, P10
   Le Guehennec L, 2007, J MATER SCI-MATER M, V18, P1489, DOI 10.1007/s10856-006-0086-x
   Le Nihouannen D, 2006, BIOMATERIALS, V27, P2716, DOI 10.1016/j.biomaterials.2005.11.038
   Le Nihouannen D, 2008, J MATER SCI-MATER M, V19, P667, DOI 10.1007/s10856-007-3206-3
   Mazor Z, 2009, J PERIODONTOL, V80, P2056, DOI 10.1902/jop.2009.090252
   Orimo Hideo, 2010, Journal of Nippon Medical School, V77, P4
   Osathanon T, 2009, BIOMATERIALS, V30, P4513, DOI 10.1016/j.biomaterials.2009.05.022
   Park H, 2009, BIOMACROMOLECULES, V10, P541, DOI 10.1021/bm801197m
   PFEILSCHIFTER J, 1990, J BONE MINER RES, V5, P49, DOI 10.1002/jbmr.5650050109
   Rowlands AS, 2008, AM J PHYSIOL-CELL PH, V295, pC1037, DOI 10.1152/ajpcell.67.2008
   Saffarzadeh A, 2009, CLIN ORAL IMPLAN RES, V20, P1133, DOI 10.1111/j.1600-0501.2009.01738.x
   Schouten C, 2009, BIOMATERIALS, V30, P6407, DOI 10.1016/j.biomaterials.2009.08.001
   Simonpieri A, 2009, IMPLANT DENT, V18, P220, DOI 10.1097/ID.0b013e31819b5e3f
   Simonpieri A, 2009, IMPLANT DENT, V18, P102, DOI 10.1097/ID.0b013e318198cf00
   Spoerke ED, 2009, ADV MATER, V21, P425, DOI 10.1002/adma.200802242
   Su CY, 2009, ORAL SURG ORAL MED O, V108, P56, DOI 10.1016/j.tripleo.2009.02.004
   TISCHER E, 1989, BIOCHEM BIOPH RES CO, V165, P1198, DOI 10.1016/0006-291X(89)92729-0
   VALENZUELA GJ, 1987, CLIN CHEM, V33, P1801
   Van den Vreken NMF, 2010, ACTA BIOMATER, V6, P617, DOI 10.1016/j.actbio.2009.07.038
   Warnke PH, 2009, CLIN ORAL IMPLAN RES, V20, P761, DOI 10.1111/j.1600-0501.2009.01709.x
   Warnke PH, 2009, TISSUE ENG PART C-ME, V15, P115, DOI 10.1089/ten.tec.2008.0288
   Yamauchi K, 2004, BIOMATERIALS, V25, P5481, DOI 10.1016/j.biomaterials.2003.12.057
NR 57
TC 14
Z9 14
U1 1
U2 24
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1549-3296
EI 1552-4965
J9 J BIOMED MATER RES A
JI J. Biomed. Mater. Res. Part A
PD MAY
PY 2012
VL 100A
IS 5
BP 1335
EP 1346
DI 10.1002/jbm.a.34073
PG 12
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 915IN
UT WOS:000302017800026
PM 22374736
DA 2018-10-19
ER

PT J
AU Robinson, KG
   Nie, T
   Baldwin, AD
   Yang, EC
   Kiick, KL
   Akins, RE
AF Robinson, Karyn G.
   Nie, Ting
   Baldwin, Aaron D.
   Yang, Elaine C.
   Kiick, Kristi L.
   Akins, Robert E., Jr.
TI Differential effects of substrate modulus on human vascular endothelial,
   smooth muscle, and fibroblastic cells
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A
LA English
DT Review
DE PEG hydrogels; vascular cells; modulus; cell proliferation; gene
   expression
ID POLY(ETHYLENE GLYCOL) HYDROGELS; TISSUE ENGINEERING APPLICATIONS;
   GROWTH-FACTOR; EXTRACELLULAR-MATRIX; PEG HYDROGELS;
   MECHANICAL-PROPERTIES; CONTROLLED-RELEASE; ADHESION PEPTIDES;
   GENE-EXPRESSION; STAR COPOLYMER
AB Regenerative medicine approaches offer attractive alternatives to standard vascular reconstruction; however, the biomaterials to be used must have optimal biochemical and mechanical properties. To evaluate the effects of biomaterial properties on vascular cells, heparinized poly(ethylene glycol) (PEG)-based hydrogels of three different moduli, 13.7, 5.2, and 0.3 kPa, containing fibronectin and growth factor were utilized to support the growth of three human vascular cell types. The cell types exhibited differences in attachment, proliferation, and gene expression profiles associated with the hydrogel modulus. Human vascular smooth muscle cells demonstrated preferential attachment on the highest-modulus hydrogel, adventitial fibroblasts demonstrated preferential growth on the highest-modulus hydrogel, and human umbilical vein endothelial cells demonstrated preferential growth on the lowest-modulus hydrogel investigated. Our studies suggest that the growth of multiple vascular cell types can be supported by PEG hydrogels and that different populations can be controlled by altering the mechanical properties of biomaterials. (C) 2012 Wiley Periodicals, Inc. J Biomed Mater Res Part A: 2012.
C1 [Robinson, Karyn G.; Yang, Elaine C.; Akins, Robert E., Jr.] Alfred I duPont Hosp Children, Tissue Engn & Regenerat Med Lab, Wilmington, DE 19803 USA.
   [Nie, Ting; Baldwin, Aaron D.; Kiick, Kristi L.] Univ Delaware, Dept Mat Sci & Engn, Newark, DE 19716 USA.
   [Kiick, Kristi L.] Delaware Biotechnol Inst, Newark, DE 19716 USA.
RP Akins, RE (reprint author), Alfred I duPont Hosp Children, Tissue Engn & Regenerat Med Lab, Wilmington, DE 19803 USA.
EM kiick@udel.edu; rakins@nemours.org
OI Akins, Robert/0000-0001-9706-0752
FU Nemours Foundation; National Institutes of Health [COBRE P20-RR020173,
   INBRE P20-RR016472, COBRE P20-RR017716]; National Science Foundation
   [DGE-0221651]
FX Contract grant sponsor: Nemours Foundation; Contract grant sponsor:
   National Institutes of Health; contract grant numbers: COBRE
   P20-RR020173, INBRE P20-RR016472, COBRE P20-RR020173, COBRE
   P20-RR017716; Contract grant sponsor: National Science Foundation;
   contract grant number: DGE-0221651
CR Agrawal D, 2002, J NATL CANCER I, V94, P513
   Almany L, 2005, BIOMATERIALS, V26, P2467, DOI 10.1016/j.biomaterials.2004.06.047
   Banerjee A, 2009, BIOMATERIALS, V30, P4695, DOI 10.1016/j.biomaterials.2009.05.050
   Benoit DSW, 2005, ACTA BIOMATER, V1, P461, DOI 10.1016/j.actbio.2005.03.002
   Boontheekul T, 2003, CURR OPIN BIOTECH, V14, P559, DOI 10.1016/j.copbio.2003.08.004
   Bornstein P, 2009, J CELL COMMUN SIGNAL, V3, P189, DOI 10.1007/s12079-009-0060-8
   Bray I, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007850
   Breen EC, 2007, J CELL BIOCHEM, V102, P1358, DOI 10.1002/jcb.21579
   Broderick EP, 2005, J BIOMED MATER RES B, V72B, P37, DOI 10.1002/jbm.b.30119
   Bryant SJ, 2002, J BIOMED MATER RES, V59, P63, DOI 10.1002/jbm.1217
   Bryant SJ, 2003, J BIOMED MATER RES A, V64A, P70, DOI 10.1002/jbm.a.10319
   Burdick JA, 2002, BIOMATERIALS, V23, P4315, DOI 10.1016/S0142-9612(02)00176-X
   Cai SS, 2005, BIOMATERIALS, V26, P6054, DOI 10.1016/j.biomaterials.2005.03.012
   Chaudhuri S, 2007, RNA, V13, P2224, DOI 10.1261/rna.694007
   Chien S, 1998, HYPERTENSION, V31, P162, DOI 10.1161/01.HYP.31.1.162
   Collinsworth AM, 2002, AM J PHYSIOL-CELL PH, V283, pC1219, DOI 10.1152/ajpcell.00502.2001
   Dahl SLM, 2007, ANN BIOMED ENG, V35, P348, DOI 10.1007/s10439-006-9226-1
   Dallon JC, 2008, WOUND REPAIR REGEN, V16, P472, DOI 10.1111/j.1524-475X.2008.00392.x
   DeLong SA, 2005, BIOMATERIALS, V26, P3227, DOI 10.1016/j.biomaterials.2004.09.021
   Dzau VJ, 2002, NAT MED, V8, P1249, DOI 10.1038/nm1102-1249
   Elisseeff J, 1999, P NATL ACAD SCI USA, V96, P3104, DOI 10.1073/pnas.96.6.3104
   Engler AJ, 2004, J CELL BIOL, V166, P877, DOI 10.1083/jcb.200405004
   FitzGibbon GM, 1996, J AM COLL CARDIOL, V28, P616, DOI 10.1016/0735-1097(96)00206-9
   Flanagan LA, 2002, NEUROREPORT, V13, P2411, DOI 10.1097/01.wnr.0000048003.96487.97
   Ghosh K, 2006, TISSUE ENG, V12, P601, DOI 10.1089/ten.2006.12.601
   Ghosh K, 2007, BIOMATERIALS, V28, P671, DOI 10.1016/j.biomaterials.2006.09.038
   Gobin AS, 2003, J BIOMED MATER RES A, V67A, P255, DOI 10.1002/jbm.a.10110
   Goldie Lauren C, 2008, Organogenesis, V4, P257
   Gonzalez-Navarro H, 2008, ARTERIOSCL THROM VAS, V28, P2187, DOI 10.1161/ATVBAHA.108.175299
   Goumans MJ, 2003, TRENDS CARDIOVAS MED, V13, P301, DOI 10.1016/S1050-1738(03)00142-7
   Hasegawa T, 1999, ANGIOLOGY, V50, P487, DOI 10.1177/000331979905000607
   Hern DL, 1998, J BIOMED MATER RES, V39, P266, DOI 10.1002/(SICI)1097-4636(199802)39:2<266::AID-JBM14>3.0.CO;2-B
   Holderfield MT, 2008, CIRC RES, V102, P637, DOI 10.1161/CIRCRESAHA.107.167171
   Hughes GC, 2004, ANN THORAC SURG, V77, P812, DOI 10.1016/j.athorasur.2003.09.060
   Ji Y, 2006, MACROMOL BIOSCI, V6, P811, DOI 10.1002/mabi.200600132
   Jiang ZH, 2007, AM J PHYSIOL-HEART C, V293, pH482, DOI 10.1152/ajpheart.01372.2006
   Jin W, 2001, NAT GENET, V29, P389, DOI 10.1038/ng766
   Jung JP, 2008, BIOMATERIALS, V29, P2143, DOI 10.1016/j.biomaterials.2008.01.008
   Kendziorski C, 2005, P NATL ACAD SCI USA, V102, P4252, DOI 10.1073/pnas.0500607102
   Kim BS, 1999, NAT BIOTECHNOL, V17, P979, DOI 10.1038/13671
   Kim HY, 2008, HYPERTENS RES, V31, P515, DOI 10.1291/hypres.31.515
   Kleinman HK, 2003, CURR OPIN BIOTECH, V14, P526, DOI 10.1016/j.copbio.2003.08.002
   Kurihara H, 2005, J BIOSCI BIOENG, V100, P82, DOI 10.1263/jbb.100.82
   Levental Ilya, 2006, SOFT MATTER, V2, P1
   Linnes MP, 2007, BIOMATERIALS, V28, P5298, DOI 10.1016/j.biomaterials.2007.08.020
   Losordo DW, 2002, CIRCULATION, V105, P2012, DOI 10.1161/01.CIR.0000015982.70785.B7
   Lutolf MP, 2005, NAT BIOTECHNOL, V23, P47, DOI 10.1038/nbt1055
   Mammoto A, 2009, NATURE, V457, P1103, DOI 10.1038/nature07765
   Mann BK, 2001, BIOMATERIALS, V22, P3045, DOI 10.1016/S0142-9612(01)00051-5
   Mann BK, 2002, J BIOMED MATER RES, V60, P86, DOI 10.1002/jbm.10042
   Mazumder B, 2003, CELL, V115, P187, DOI 10.1016/S0092-8674(03)00773-6
   MCDONALD JA, 1980, J BIOL CHEM, V255, P8848
   MIQIN Z, 1998, BIOMATERIALS, V19, P953
   Motwani JG, 1998, CIRCULATION, V97, P916, DOI 10.1161/01.CIR.97.9.916
   Munoz-Pinto DJ, 2009, J BIOMED MATER RES A, V90A, P303, DOI 10.1002/jbm.a.32492
   Nguyen KT, 2002, BIOMATERIALS, V23, P4307, DOI 10.1016/S0142-9612(02)00175-8
   Nie T, 2007, J CONTROL RELEASE, V122, P287, DOI 10.1016/j.jconrel.2007.04.019
   Nie T, 2009, ACTA BIOMATER, V5, P865, DOI 10.1016/j.actbio.2008.12.004
   Nuttelman CR, 2001, J BIOMED MATER RES, V57, P217, DOI 10.1002/1097-4636(200111)57:2<217::AID-JBM1161>3.0.CO;2-I
   Okumura M, 1996, BIOL PHARM BULL, V19, P530
   OSOL G, 1995, J VASC RES, V32, P275, DOI 10.1159/000159102
   Padua D, 2008, CELL, V133, P66, DOI 10.1016/j.cell.2008.01.046
   Petrovic N, 2003, J BIOL CHEM, V278, P49358, DOI 10.1074/jbc.M308071200
   Peyton SR, 2008, BIOMATERIALS, V29, P2597, DOI 10.1016/j.biomaterials.2008.02.005
   Peyton SR, 2006, BIOMATERIALS, V27, P4881, DOI 10.1016/j.biomaterials.2006.05.012
   Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45
   Pratt AB, 2004, BIOTECHNOL BIOENG, V86, P27, DOI 10.1002/bit.10897
   Qian SX, 2005, OLIGONUCLEOTIDES, V15, P1, DOI 10.1089/oli.2005.15.1
   Quackenbush J, 2002, NAT GENET, V32, P496, DOI 10.1038/ng1032
   Raeber GP, 2005, BIOPHYS J, V89, P1374, DOI 10.1529/biophysj.104.050682
   Ruel M, 2002, J THORAC CARDIOV SUR, V124, P28, DOI 10.1067/mtc.2002.121974
   Rutledge RG, 2008, BMC BIOTECHNOL, V8, DOI 10.1186/1472-6750-8-47
   Saban MR, 2001, PHYSIOL GENOMICS, V5, P147
   Saha K, 2008, BIOPHYS J, V95, P4426, DOI 10.1529/biophysj.108.132217
   Sakiyama-Elbert SE, 2000, J CONTROL RELEASE, V65, P389, DOI 10.1016/S0168-3659(99)00221-7
   Sakurai D, 2004, J IMMUNOL, V173, P5801, DOI 10.4049/jimmunol.173.9.5801
   Sartore S, 2001, CIRC RES, V89, P1111, DOI 10.1161/hh2401.100844
   Schultz KM, 2009, MACROMOLECULES, V42, P5310, DOI 10.1021/ma900766u
   Schultz KM, 2009, SOFT MATTER, V5, P740, DOI 10.1039/b818178k
   Shinoka Toshiharu, 2008, Yale Journal of Biology and Medicine, V81, P161
   Sieminski AL, 2007, CELL BIOCHEM BIOPHYS, V49, P73, DOI 10.1007/s12013-007-0046-1
   Stegemann JP, 2005, J APPL PHYSIOL, V98, P2321, DOI 10.1152/japplphysiol.01114.2004
   Stetler-Stevenson WG, 2008, SCI SIGNAL, V1, DOI 10.1126/scisignal.127re6
   Subramanian A, 2005, J BIOMED MATER RES A, V75A, P742, DOI 10.1002/jbm.a.30489
   Tae G, 2006, J BIOMAT SCI-POLYM E, V17, P187, DOI 10.1163/156856206774879090
   Taylor Z, 2004, J BIOMECH, V37, P1263, DOI 10.1016/j.jbiomech.2003.11.027
   Tieu BC, 2009, J CLIN INVEST, V119, P3637, DOI 10.1172/JCI38308
   Volpert OV, 1998, P NATL ACAD SCI USA, V95, P6343, DOI 10.1073/pnas.95.11.6343
   WAGNER DD, 1979, J BIOL CHEM, V254, P6746
   Wang DZ, 2002, BIOCHEMISTRY-US, V41, P7100, DOI 10.1021/bi025902m
   Wang ZB, 2001, FEBS LETT, V508, P360, DOI 10.1016/S0014-5793(01)03109-X
   Weber DS, 2008, CIRC RES, V102, P1448, DOI 10.1161/CIRCRESAHA.108.179044
   Wilcke I, 2007, LANGENBECK ARCH SURG, V392, P305, DOI 10.1007/s00423-007-0194-1
   Williams B, 1998, J HYPERTENS, V16, P1921, DOI 10.1097/00004872-199816121-00011
   Yamaguchi N, 2005, BIOMACROMOLECULES, V6, P1931, DOI 10.1021/bm0500042
   Yamaguchi N, 2005, BIOMACROMOLECULES, V6, P1921, DOI 10.1021/bm050003+
   Yamaguchi N, 2007, J AM CHEM SOC, V129, P3040, DOI 10.1021/ja0680358
   Yan H, 2006, BIOMACROMOLECULES, V7, P2776, DOI 10.1021/bm0605560
   Yang YH, 2008, ARTERIOSCL THROM VAS, V28, P835, DOI 10.1161/ATVBAHA.107.157776
   Zhang WJ, 2007, J CELL MOL MED, V11, P945, DOI 10.1111/j.1582-4934.2007.00099.x
NR 100
TC 26
Z9 27
U1 4
U2 50
PU WILEY-BLACKWELL
PI MALDEN
PA COMMERCE PLACE, 350 MAIN ST, MALDEN 02148, MA USA
SN 1549-3296
J9 J BIOMED MATER RES A
JI J. Biomed. Mater. Res. Part A
PD MAY
PY 2012
VL 100A
IS 5
BP 1356
EP 1367
DI 10.1002/jbm.a.34075
PG 12
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 915IN
UT WOS:000302017800028
PM 22374788
OA Green Accepted
DA 2018-10-19
ER

PT J
AU Baimark, Y
AF Baimark, Yodthong
TI Morphology and thermal stability of cross-linked silk fibroin
   microparticles prepared by the water-in-oil emulsion solvent diffusion
   method
SO ASIA-PACIFIC JOURNAL OF CHEMICAL ENGINEERING
LA English
DT Article
DE silk fibroin; genipin; cross-linking; microparticles; morphology;
   porosity
ID CONTROLLED-RELEASE; DRUG-DELIVERY; MICROSPHERES; BIOMATERIAL; SCAFFOLDS;
   MEMBRANE; POWDER; VITRO; FILMS
AB In this work, the water-in-oil emulsion solvent diffusion method was developed as an alternative method for preparing cross-linked silk fibroin (SF) microparticles. Aqueous SF solution and ethyl acetate were used as water and oil phases, respectively. Influence of cross-linking on morphology and thermal stability of the SF microparticles were investigated. Genipin was used as a cross-linker. The SF microparticles had spherical shape with smooth surface when Span80 was used as the oil-soluble emulsifier. The SF in aqueous solution was cross-linked with genipin before microparticle formation. Internal morphology of the SF microparticles observed on broken microparticles showed as sponge. The cross-linking induced SF conformational changes from random coil to beta-sheet form. Porosity of the SF microparticle matrices decreased and thermal stability increased when the SF was cross-linked and the degree of cross-linking was increased. (c) 2011 Curtin University of Technology and John Wiley & Sons, Ltd.
C1 [Baimark, Yodthong] Mahasarakham Univ, Dept Chem, Fac Sci, Maha Sarakham 44150, Thailand.
   [Baimark, Yodthong] Mahasarakham Univ, Ctr Excellence Innovat Chem, Fac Sci, Maha Sarakham 44150, Thailand.
RP Baimark, Y (reprint author), Mahasarakham Univ, Dept Chem, Fac Sci, Maha Sarakham 44150, Thailand.
EM yodthong.b@msu.ac.th
FU Mahasarakham University; Center of Excellence for Innovation in
   Chemistry (PERCH-CIC), Commission on Higher Education, Ministry of
   Education, Thailand
FX This work was supported by the Mahasarakham University Development Fund
   and the Center of Excellence for Innovation in Chemistry (PERCH-CIC),
   Commission on Higher Education, Ministry of Education, Thailand.
CR Abubakr N, 2010, ASIA-PAC J CHEM ENG, V5, P804, DOI 10.1002/apj.398
   Arifin DY, 2006, ADV DRUG DELIVER REV, V58, P1274, DOI 10.1016/j.addr.2006.09.007
   Ehtezazi T, 2000, J CONTROL RELEASE, V68, P361, DOI 10.1016/S0168-3659(00)00270-4
   Hino T, 2003, J COLLOID INTERF SCI, V266, P68, DOI 10.1016/S0021-9797(03)00584-8
   Hofmann S, 2006, J CONTROL RELEASE, V111, P219, DOI 10.1016/j.jconrel.205.12.009
   Imsombut T, 2010, POWDER TECHNOL, V203, P603, DOI 10.1016/j.powtec.2010.06.027
   Jin HJ, 2004, BIOMACROMOLECULES, V5, P711, DOI 10.1021/bm0343287
   Kim KH, 2005, J BIOTECHNOL, V120, P327, DOI 10.1016/j.jbiotec.2005.06.033
   Klose D, 2006, INT J PHARMACEUT, V314, P198, DOI 10.1016/j.ijpharm.2005.07.031
   Li CM, 2006, BIOMATERIALS, V27, P3115, DOI 10.1016/j.biomaterials.2006.01.022
   Liu YC, 1996, J MACROMOL SCI PURE, VA33, P209, DOI 10.1080/10601329608010864
   Meinel L, 2005, BIOMATERIALS, V26, P147, DOI 10.1016/j.biomaterials.2004.02.047
   Moonsri P, 2008, J APPL POLYM SCI, V108, P1402, DOI 10.1002/app.27528
   Muzzarelli RAA, 2009, CARBOHYD POLYM, V77, P1, DOI 10.1016/j.carbpol.2009.01.016
   Nakamatsu J, 2006, BIOMACROMOLECULES, V7, P3345, DOI 10.1021/bm0605311
   NISHI C, 1995, J BIOMED MATER RES, V29, P829, DOI 10.1002/jbm.820290707
   Rajkhowa R, 2008, POWDER TECHNOL, V185, P87, DOI 10.1016/j.powtec.2008.01.005
   Rajkhowa R, 2009, POWDER TECHNOL, V191, P155, DOI 10.1016/j.powtec.2008.10.004
   Sashina ES, 2007, J THERM ANAL CALORIM, V89, P887, DOI 10.1007/s10973-006-7676-1
   Silva SS, 2008, BIOMACROMOLECULES, V9, P2764, DOI 10.1021/bm800874q
   Srisuwan Y, 2009, J MACROMOL SCI A, V46, P521, DOI 10.1080/10601320902797780
   Um IC, 2001, INT J BIOL MACROMOL, V29, P91, DOI 10.1016/S0141-8130(01)00159-3
   Vepari C, 2007, PROG POLYM SCI, V32, P991, DOI 10.1016/j.progpolymsci.2007.05.013
   Wang M, 2004, MACROMOLECULES, V37, P6856, DOI 10.1021/ma048988v
   Wang XQ, 2007, J CONTROL RELEASE, V117, P360, DOI 10.1016/j.jconrel.2006.11.021
   Yeo JH, 2003, EUR POLYM J, V39, P1195, DOI 10.1016/S0014-3057(02)00359-2
   Zhang YQ, 2007, J NANOPART RES, V9, P885, DOI 10.1007/s11051-006-9162-x
   Zhu ZH, 2008, EXPRESS POLYM LETT, V2, P885, DOI 10.3144/expresspolymlett.2008.103
NR 28
TC 4
Z9 5
U1 5
U2 42
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1932-2135
EI 1932-2143
J9 ASIA-PAC J CHEM ENG
JI Asia-Pac. J. Chem. Eng.
PD MAY
PY 2012
VL 7
SU 1
SI SI
BP S112
EP S117
DI 10.1002/apj.658
PG 6
WC Engineering, Chemical
SC Engineering
GA 912DA
UT WOS:000301773700016
DA 2018-10-19
ER

PT J
AU Shichor, I
   Shomron, N
   Lawlor, MW
   Bae, SA
   Zoldan, J
   Langer, R
   Kohane, DS
AF Shichor, Iris
   Shomron, Noam
   Lawlor, Michael W.
   Bae, Seul A.
   Zoldan, Janet
   Langer, Robert
   Kohane, Daniel S.
TI Toxicogenomic analysis of a sustained release local anesthetic delivery
   system
SO BIOMATERIALS
LA English
DT Article
DE Toxicogenomics; Drug delivery; Biocompatibility; Prolonged duration
   local anesthesia; Neurotoxicity; Nerve injury
ID PERIPHERAL-NERVE INJURY; PROTEIN-SUGAR PARTICLES; DORSAL-ROOT GANGLION;
   GENE-EXPRESSION; IN-VIVO; BLOCKADE; RAT; BUPIVACAINE; MICROSPHERES;
   DURATION
AB Concerns over neurotoxicity have impeded the development of sustained release formulations providing prolonged duration local anesthesia (PDLA) from a single injection, for which there is an urgent clinical need. Here, we have used toxicogenomics to investigate whether nerve injury occurred during week-long continuous sciatic nerve blockade by microspheres containing bupivacaine, tetrodotoxin, and dexamethasone (TBD). Animals treated with amitriptyline solution (our positive control for local anesthetic-associated nerve injury) developed irreversible nerve blockade, had severely abnormal nerve histology, and the expression of hundreds of genes was altered in the dorsal root ganglia at 4 and 7 days after injection. In marked contrast, TBD-treated nerves reverted to normal function, were normal histologically and there were changes in the expression of a small number of genes. Toxicogenomic studies have great potential in delineating patterns of gene expression associated with specific patterns of tissue injury (e.g. amitriptyline neurotoxicity), and in identifying related changes in gene expression upon exposure to a drug, biomaterial, or drug delivery system. (C) 2012 Elsevier Ltd. All rights reserved.
C1 [Shichor, Iris; Kohane, Daniel S.] Harvard Univ, Sch Med, Lab Biomat & Drug Delivery, Dept Anesthesiol,Div Crit Care Med,Childrens Hosp, Boston, MA 02115 USA.
   [Shichor, Iris; Langer, Robert] Harvard Massachusetts Inst Technol, Div Hlth Sci & Technol, Cambridge, MA 02139 USA.
   [Shomron, Noam] Tel Aviv Univ, Dept Cell & Dev Biol, Sackler Fac Med, Tel Aviv, Israel.
   [Lawlor, Michael W.] Harvard Univ, Sch Med, Program Genom, Div Genet,Childrens Hosp, Boston, MA 02115 USA.
   [Bae, Seul A.; Zoldan, Janet; Langer, Robert] MIT, David H Koch Inst Integrat Canc Res, Cambridge, MA 02139 USA.
RP Kohane, DS (reprint author), Harvard Univ, Sch Med, Lab Biomat & Drug Delivery, Dept Anesthesiol,Div Crit Care Med,Childrens Hosp, 300 Longwood Ave, Boston, MA 02115 USA.
EM Daniel.Kohane@childrens.harvard.edu
FU NIH [GM073626]
FX This work was funded by NIH GM073626 (to DSK).
CR ADAMS HJ, 1976, ANESTH ANALG, V55, P568
   ANDERSON JM, 1994, EUR J PHARM BIOPHARM, V40, P1
   Averill S, 2002, J NEUROSCI, V22, P7493
   Barnet CS, 2005, ANESTH ANALG, V101, P1838
   Befort K, 2003, EUR J NEUROSCI, V18, P911, DOI 10.1046/j.1460.9568.2003.02827.x
   Cai DM, 2002, NEURON, V35, P711, DOI 10.1016/S0896-6273(02)00826-7
   Castillo J, 1996, ANESTHESIOLOGY, V85, P1157, DOI 10.1097/00000542-199611000-00025
   Costigan M, 2002, BMC NEUROSCI, V3, DOI 10.1186/1471-2202-3-16
   Dai MH, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni179
   Drager C, 1998, ANESTHESIOLOGY, V89, P969, DOI 10.1097/00000542-199810000-00022
   Epstein-Barash H, 2009, P NATL ACAD SCI USA, V106, P7125, DOI 10.1073/pnas.0900598106
   Fielden MR, 2006, CURR OPIN DRUG DISC, V9, P84
   Foster WR, 2007, TOXICOL PATHOL, V35, P621, DOI 10.1080/01926230701419063
   Gerner P, 2003, ANESTHESIOLOGY, V98, P1484, DOI 10.1097/00000542-200306000-00028
   Gerner P, 2010, ANESTH ANALG, V111, P221, DOI 10.1213/ANE.0b013e3181dd2690
   Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211
   Jia XQ, 2004, BIOMATERIALS, V25, P4797, DOI 10.1016/j.biomaterials.2003.12.012
   KALICHMAN MW, 1988, ACTA NEUROPATHOL, V75, P583, DOI 10.1007/BF00686203
   Kohane DS, 2010, CHEM SCI, V1, P441, DOI 10.1039/c0sc00203h
   Kohane DS, 2003, PAIN, V104, P415, DOI 10.1016/S0304-3959(03)00049-6
   Kohane DS, 1998, ANESTHESIOLOGY, V89, P119, DOI 10.1097/00000542-199807000-00019
   Kohane DS, 2002, J BIOMED MATER RES, V59, P450, DOI 10.1002/jbm.1261
   Kohane DS, 2000, PHARMACEUT RES, V17, P1243, DOI 10.1023/A:1026470831256
   Lallemend F, 2005, J CELL SCI, V118, P4511, DOI 10.1242/jcs.02572
   Mechaly I, 2006, MOL CELL NEUROSCI, V32, P217, DOI 10.1016/j.mcn.2006.04.004
   Miksys S, 2004, DRUG METAB REV, V36, P313, DOI 10.1081/DMR-120034149
   Padera R, 2008, ANESTHESIOLOGY, V108, P921, DOI 10.1097/ALN.0b013e31816c8a48
   Padera RF, 2006, MUSCLE NERVE, V34, P747, DOI 10.1002/mus.20618
   Purdue Pharma LP, DUR STER POWD BUP DE
   Rose JS, 2005, REGION ANESTH PAIN M, V30, P275, DOI 10.1016/j.rapm.2005.01.004
   Ryan TP, 2008, CURR OPIN PHARMACOL, V8, P654, DOI 10.1016/j.coph.2008.07.011
   Sakura S, 2005, ANESTH ANALG, V101, P541, DOI 10.1213/01.ANE.0000155960.61157.12
   SAKURA S, 1995, ANESTH ANALG, V81, P338, DOI 10.1097/00000539-199508000-00023
   Scholz J, 2005, J NEUROSCI, V25, P7317, DOI 10.1523/JNEUROSCI.1526-05.2005
   Seijffers R, 2007, J NEUROSCI, V27, P7911, DOI 10.1523/JNEUROSCI.5313-06.2007
   Sesti C, 2003, J PHARMACOL EXP THER, V306, P238, DOI 10.1124/jpet.103.049874
   THALHAMMER JG, 1995, ANESTHESIOLOGY, V82, P1013, DOI 10.1097/00000542-199504000-00026
   Tobe M, 2010, ANESTHESIOLOGY, V112, P1473, DOI 10.1097/ALN.0b013e3181d4f66f
   Tsai YJ, 2009, J NEUROTRAUM, V26, P1609, DOI 10.1089/neu.2008.0642
   Tsujino H, 2000, MOL CELL NEUROSCI, V15, P170, DOI 10.1006/mcne.1999.0814
   Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498
   Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034
   Vogelaar CF, 2003, EUR J PHARMACOL, V480, P233, DOI 10.1016/j.ejphar.2003.08.110
   WAKIYAMA N, 1981, CHEM PHARM BULL, V29, P3363
   Wang CF, 2009, ANESTH ANALG, V108, P1027, DOI 10.1213/ane.0b013e318193596a
   Xiao HS, 2002, P NATL ACAD SCI USA, V99, P8360, DOI 10.1073/pnas.122231899
   ZIMMERMANN M, 1983, PAIN, V16, P109, DOI 10.1016/0304-3959(83)90201-4
NR 47
TC 5
Z9 5
U1 1
U2 8
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
EI 1878-5905
J9 BIOMATERIALS
JI Biomaterials
PD MAY
PY 2012
VL 33
IS 13
BP 3586
EP 3593
DI 10.1016/j.biomaterials.2012.01.043
PG 8
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 913XD
UT WOS:000301909800009
PM 22341215
OA Green Accepted
DA 2018-10-19
ER

PT J
AU Crispim, EG
   Piai, JF
   Fajardo, AR
   Ramos, ERF
   Nakamura, TU
   Nakamura, CV
   Rubira, AF
   Muniz, EC
AF Crispim, E. G.
   Piai, J. F.
   Fajardo, A. R.
   Ramos, E. R. F.
   Nakamura, T. U.
   Nakamura, C. V.
   Rubira, A. F.
   Muniz, E. C.
TI Hydrogels based on chemically modified poly(vinyl alcohol) (PVA-GMA) and
   PVA-GMA/chondroitin sulfate: Preparation and characterization
SO EXPRESS POLYMER LETTERS
LA English
DT Article
DE polymer gels; poly(vinyl alcohol); chondroitin sulfate; hydrogels; drug
   delivery
ID POLYVINYL-ALCOHOL; GLYCIDYL METHACRYLATE; CROSS-LINKING; RELEASE;
   MEMBRANES; MECHANISM; NETWORKS; TOXICITY; DELIVERY; BLENDS
AB This work reports the preparation of hydrogels based on PVA-GMA, PVA-GMA is poly(vinyl alcohol) (PVA) functionalized with vinyl groups from glycidyl methacrylate (GMA), and on PVA-GMA with different content of chondroitin sulfate (CS). The degrees of swelling of PVA-GMA and PVA-GMA/CS hydrogels were evaluated in distilled water and the swelling kinetics was performed in simulated gastric and intestinal fluids (SGF and SIF). PVA-GMA and PVA-GMA/CS hydrogels demonstrated to be resistant on SGF and SIF fluids. The elastic modulus, E, of swollen-hydrogels were determined through compressive tests and, according to the obtained results, the hydrogels presented good mechanical properties. At last, the presence of CS enhances the hydrogel cell compatibility as gathered by cytotoxicity assays. It was concluded that the hydrogels prepared through this work presented characteristics that allow them to be used as biomaterial, as a carrier in drug delivery system or to act as scaffolds in tissue engineering as well.
C1 [Crispim, E. G.; Piai, J. F.; Fajardo, A. R.; Rubira, A. F.; Muniz, E. C.] Univ Estadual Maringa, GMPC, Dept Quim, BR-87020900 Maringa, Parana, Brazil.
   [Ramos, E. R. F.; Nakamura, T. U.; Nakamura, C. V.] Univ Estadual Maringa, Lab Microbiol Aplicada Aos Prod Nat & Sintet, Dept Anal Clin, BR-87020900 Maringa, Parana, Brazil.
RP Muniz, EC (reprint author), Univ Estadual Maringa, GMPC, Dept Quim, Av Colombo 5790, BR-87020900 Maringa, Parana, Brazil.
EM ecmuniz@uem.br
RI Inomat, Inct/H-9989-2013; Fajardo, Andre/H-1783-2012
OI Fajardo, Andre/0000-0001-5362-6478; Muniz, Edvani/0000-0001-6685-1519
FU CNPq/Capes, Brazil [308611/2006-3]
FX The authors thank Dep. de Ciencia e Tecnologia de Alimentos (UEL,
   Londrina, Brazil) for the use of (TA.TXT2 Stable Micro System). The
   authors also thank to CNPq/Capes, Brazil, by the fellowships and
   financial support [Proc. 308611/2006-3].
CR [Anonymous], 1995, 23NF18 USP
   [Anonymous], 2005, ASTMF81301
   Avci FY, 2003, CARBOHYD RES, V338, P2101, DOI 10.1016/S0008-6215(03)00348-3
   Barthus RC, 2008, J BRAZIL CHEM SOC, V19, P630, DOI 10.1590/S0103-50532008000400004
   Byrne E.M., 2002, ADV DRUG DELIVERY RE, V54, P149, DOI [10.1016/S0169-409X(01)00246-0, DOI 10.1016/S0169-409X(01)00246-0]
   Cascone MG, 2001, J BIOMAT SCI-POLYM E, V12, P267, DOI 10.1163/156856201750180807
   Chiellini E, 2004, MACROMOL BIOSCI, V4, P218, DOI 10.1002/mabi.200300126
   Crispim E.G., 2006, E POLYM
   Crispim EG, 2006, POLYM TEST, V25, P377, DOI 10.1016/j.polymertesting.2005.12.003
   DeMerlis CC, 2003, FOOD CHEM TOXICOL, V41, P319, DOI 10.1016/S0278-6915(02)00258-2
   Eastman SA, 2010, MACROMOLECULES, V43, P4584, DOI 10.1021/ma100458v
   Elias H.G., 1983, MACROMOLECULES STRUC
   Fajardo AR, 2010, CARBOHYD POLYM, V80, P934, DOI 10.1016/j.carbpol.2010.01.009
   Gao BJ, 2009, J APPL POLYM SCI, V114, P3487, DOI 10.1002/app.30892
   Ghugare SV, 2009, BIOMACROMOLECULES, V10, P1589, DOI 10.1021/bm900185u
   GUTOWSKA A, 1994, MACROMOLECULES, V27, P4167, DOI 10.1021/ma00093a018
   Hoffman AS, 2002, ADV DRUG DELIVER REV, V54, P3, DOI 10.1016/S0169-409X(01)00239-3
   Iwafune M, 2004, ANAL BIOCHEM, V325, P35, DOI 10.1016/S0003-2697(03)00391-9
   Kartal F, 2009, J MOL CATAL B-ENZYM, V57, P55, DOI 10.1016/j.molcatb.2008.06.016
   Kelly CM, 2003, FOOD CHEM TOXICOL, V41, P719, DOI 10.1016/S0278-6915(03)00003-6
   Krupa I, 2010, J SOL-GEL SCI TECHN, V53, P107, DOI 10.1007/s10971-009-2064-5
   Kudo S, 2010, J POLYM SCI POL PHYS, V48, P1978, DOI 10.1002/polb.22076
   Lee CT, 2005, CARBOHYD POLYM, V61, P348, DOI 10.1016/j.carbpol.2005.06.018
   Li Y, 2010, MATER RES INNOV, V14, P252, DOI 10.1179/143307510X12719005364828
   Lin CC, 2006, ADV DRUG DELIVER REV, V58, P1379, DOI 10.1016/j.addr.2006.09.004
   Malmonge SM, 1999, REV BRAS ENG BIOMED, V15, P49
   Maris B, 2001, INT J PHARM, V213, P143, DOI 10.1016/S0378-5173(00)00654-2
   Martens P, 2000, POLYMER, V41, P7715, DOI 10.1016/S0032-3861(00)00123-3
   Moura MR, 2005, EUR POLYM J, V41, P2845, DOI DOI 10.1016/J.EURPOLYMJ.2005.06.007
   Oliveira JT, 2010, J BIOMED MATER RES A, V93A, P852, DOI 10.1002/jbm.a.32574
   Paradossi G., 1999, J POLYM SCI POL LETT, V37, P1225, DOI [10.1002/(SICI)1099-0488(19990615)37:12<1225::AID-POLB4>3.0.CO;2-P, DOI 10.1002/(SICI)1099-0488(19990615)37:12<1225]
   PEPPAS NA, 1977, J APPL POLYM SCI, V21, P1763, DOI 10.1002/app.1977.070210704
   Pitarresi G, 2003, BIOMATERIALS, V24, P4301, DOI 10.1016/S0142-9612(03)00332-6
   Qiu Y, 2001, ADV DRUG DELIVER REV, V53, P321, DOI 10.1016/S0169-409X(01)00203-4
   Reis AV, 2009, J ORG CHEM, V74, P3750, DOI 10.1021/jo900033c
   Reis AV, 2009, PHARM RES-DORD, V26, P438, DOI 10.1007/s11095-008-9732-y
   RITGER P L, 1987, Journal of Controlled Release, V5, P37, DOI 10.1016/0168-3659(87)90035-6
   Shaheen M.S., 2000, J CONTROL RELEASE, V81, P367, DOI [10.1016/S0168-3659(02)00085-8, DOI 10.1016/S0168-3659(02)00085-8]
   Sperling LH, 2006, INTRODUCTION TO PHYSICAL POLYMER SCIENCE, 4TH EDITION, P1
   Valente AJM, 2010, EXPRESS POLYM LETT, V4, P480, DOI 10.3144/expresspolymlett.2010.61
   Wang YH, 2010, J APPL POLYM SCI, V116, P3249, DOI 10.1002/app.31750
   Yoshinari E, 2005, POLYMER, V46, P7741, DOI 10.1016/j.polymer.2005.01.100
   You JO, 2010, LANGMUIR, V26, P4607, DOI 10.1021/la100294p
   Zhang L, 2007, J MEMBRANE SCI, V306, P93, DOI 10.1016/j.memsci.2007.08.036
   Zhao L, 2010, POLYM ADVAN TECHNOL, V21, P483, DOI 10.1002/pat.1456
NR 45
TC 28
Z9 29
U1 2
U2 61
PU BUDAPEST UNIV TECHNOL & ECON
PI BUDAPEST
PA DEPT POLYMER ENG, MUEGYETEM RKP 3, BUDAPEST, H-1111, HUNGARY
SN 1788-618X
J9 EXPRESS POLYM LETT
JI Express Polym. Lett.
PD MAY
PY 2012
VL 6
IS 5
BP 383
EP 395
DI 10.3144/expresspolymlett.2012.41
PG 13
WC Polymer Science
SC Polymer Science
GA 904IL
UT WOS:000301188000005
OA DOAJ Gold
DA 2018-10-19
ER

PT J
AU Ribeiro, AJS
   Tottey, S
   Taylor, RWE
   Bise, R
   Kanade, T
   Badylak, SF
   Dahl, KN
AF Ribeiro, Alexandre J. S.
   Tottey, Steven
   Taylor, Richard W. E.
   Bise, Ryoma
   Kanade, Takeo
   Badylak, Stephen F.
   Dahl, Kris Noel
TI Mechanical characterization of adult stem cells from bone marrow and
   perivascular niches
SO JOURNAL OF BIOMECHANICS
LA English
DT Article
DE Regenerative medicine; Stern cells; Viscoelasticity; Injection;
   Cytoskeleton; Nucleoskeleton
ID MYOCARDIAL-INFARCTION; PROGENITOR CELLS; DIFFERENTIATION; SUBSTRATE;
   REPAIR; REGENERATION; DEFORMATION; PLASTICITY; RHEOLOGY; TENSION
AB Therapies using adult stem cells often require mechanical manipulation such as injection or incorporation into scaffolds. However, force-induced rupture and mechanosensitivity of cells during manipulation is largely ignored. Here, we image cell mechanical structures and perform a biophysical characterization of three different types of human adult stem cells: bone marrow CD34+ hematopoietic, bone marrow mesenchymal and perivascular mesenchymal stem cells. We use micropipette aspiration to characterize cell mechanics and quantify deformation of subcellular structures under force and its contribution to global cell deformation. Our results suggest that CD34+ cells are mechanically suitable for injection systems since cells transition from solid- to fluid-like at constant aspiration pressure, probably due to a poorly developed actin cytoskeleton. Conversely, mesenchymal stem cells from the bone marrow and perivascular niches are more suitable for seeding into biomaterial scaffolds since they are mechanically robust and have developed cytoskeletal structures that may allow cellular stable attachment and motility through solid porous environments. Among these, perivascular stem cells cultured in 6% oxygen show a developed cytoskeleton but a more compliant nucleus, which can facilitate the penetration into pores of tissues or scaffolds. We confirm the relevance of our measurements using cell motility and migration assays and measure survival of injected cells. Since different types of adult stem cells can be used for similar applications, we suggest considering mechanical properties of stem cells to match optimal mechanical characteristics of therapies. (C) 2012 Elsevier Ltd. All rights reserved.
C1 [Dahl, Kris Noel] Carnegie Mellon Univ, Dept Chem Engn, 5000 Forbes Ave, Pittsburgh, PA 15213 USA.
   [Ribeiro, Alexandre J. S.; Taylor, Richard W. E.; Dahl, Kris Noel] Carnegie Mellon Univ, Dept Biomed Engn, Pittsburgh, PA 15213 USA.
   [Tottey, Steven; Badylak, Stephen F.] Univ Pittsburgh, McGowan Inst Regenerat Med, Pittsburgh, PA 15260 USA.
   [Bise, Ryoma; Kanade, Takeo] Carnegie Mellon Univ, Inst Robot, Pittsburgh, PA 15213 USA.
   [Badylak, Stephen F.] Univ Pittsburgh, Dept Surg, Pittsburgh, PA 15260 USA.
RP Dahl, KN (reprint author), Carnegie Mellon Univ, Dept Chem Engn, 5000 Forbes Ave, Pittsburgh, PA 15213 USA.
EM krisdahl@cmu.edu
OI Dahl, Kris/0000-0002-3874-1547; Badylak, Stephen/0000-0003-3555-0689
FU Portuguese Government-Ministry of Science and Higher Education [44299
   FCT]; NSF [CBET 0954421]; NIH [5R01 AR054940]; Portuguese
   Government-Ministry of Science and Higher Education [44299 FCT]; NSF
   [CBET 0954421]; NIH [5R01 AR054940]
FX We gratefully acknowledge funding from the Portuguese
   Government-Ministry of Science and Higher Education (44299 FCT to A.R.),
   the NSF (CBET 0954421 to K.D.) and the NIH (5R01 AR054940 to S.B.).
CR Assmus B, 2006, NEW ENGL J MED, V355, P1222, DOI 10.1056/NEJMoa051779
   BAUM CM, 1992, P NATL ACAD SCI USA, V89, P2804, DOI 10.1073/pnas.89.7.2804
   Ben-David D, 2011, J CRANIO MAXILL SURG, V39, P364, DOI 10.1016/j.jcms.2010.09.001
   Charras GT, 2004, BIOPHYS J, V87, P2870, DOI 10.1529/biophysj.104.040436
   Chowdhury F, 2010, NAT MATER, V9, P82, DOI [10.1038/nmat2563, 10.1038/NMAT2563]
   Cleland J.G., 2006, EUROPEAN J HEART FAI, P105
   Crisan M, 2008, CELL STEM CELL, V3, P301, DOI 10.1016/j.stem.2008.07.003
   Crisan M, 2009, ANN NY ACAD SCI, V1176, P118, DOI 10.1111/j.1749-6632.2009.04967.x
   Dahl KDC, 2005, MOL BIOL CELL, V16, P1901
   Dahl KN, 2005, BIOPHYS J, V89, P2855, DOI 10.1529/biophysj.105.062554
   Dahl KN, 2008, CIRC RES, V102, P1307, DOI 10.1161/CIRCRESAHA.108.173989
   Dahl KN, 2010, MICROCIRCULATION, V17, P179, DOI 10.1111/j.1549-8719.2009.00016.x
   Darling EM, 2008, J BIOMECH, V41, P454, DOI 10.1016/j.jbiomech.2007.06.019
   Dembo M, 1999, BIOPHYS J, V76, P2307, DOI 10.1016/S0006-3495(99)77386-8
   Dimmeler S, 2005, J CLIN INVEST, V115, P572, DOI 10.1172/JCI200524283
   Discher DE, 2005, SCIENCE, V310, P1139, DOI 10.1126/science.1116995
   Engler AJ, 2006, CELL, V126, P677, DOI 10.1016/j.cell.2006.06.044
   EVANS E, 1984, BLOOD, V64, P1028
   Ferrari G, 1998, SCIENCE, V279, P1528, DOI 10.1126/science.279.5356.1528
   Fletcher DA, 2010, NATURE, V463, P485, DOI 10.1038/nature08908
   Friedl P, 2011, CURR OPIN CELL BIOL, V23, P55, DOI 10.1016/j.ceb.2010.10.015
   Ghodsizad A, 2009, HEART, V95, P27, DOI 10.1136/hrt.2007.139329
   Graf T, 2002, BLOOD, V99, P3089, DOI 10.1182/blood.V99.9.3089
   Grogaard HK, 2010, SCAND CARDIOVASC J, V44, P267, DOI 10.3109/14017431.2010.490949
   Hao Y, 2011, TRANSPL P, V43, P2755, DOI 10.1016/j.transproceed.2011.06.026
   Haque F, 2010, J BIOL CHEM, V285, P3487, DOI 10.1074/jbc.M109.071910
   Hess DA, 2011, METHODS MOL BIOL, V750, P25, DOI 10.1007/978-1-61779-145-1_2
   Hochmuth RM, 2000, J BIOMECH, V33, P15, DOI 10.1016/S0021-9290(99)00175-X
   Hoffman BD, 2006, P NATL ACAD SCI USA, V103, P10259, DOI 10.1073/pnas.0510348103
   Houben F, 2007, BBA-MOL CELL RES, V1773, P675, DOI 10.1016/j.bbamcr.2006.09.018
   Jandial R, 2011, NEUROSURGERY, V69, pN13, DOI 10.1227/01.neu.0000405591.47966.a1
   Jeltsch KS, 2011, CYTOTHERAPY, V13, P357, DOI 10.3109/14653249.2010.523076
   Jing DH, 2012, HAEMATOL-HEMATOL J, V97, P331, DOI 10.3324/haematol.2011.050815
   Kasza KE, 2007, CURR OPIN CELL BIOL, V19, P101, DOI 10.1016/j.ceb.2006.12.002
   Kline J, 2008, BONE MARROW TRANSPL, V41, P505, DOI 10.1038/sj.bmt.1705931
   Lekli I, 2009, CAN J PHYSIOL PHARM, V87, P989, DOI 10.1139/Y09-102
   Li SWC, 2009, CELL BIOL INT, V33, P255, DOI 10.1016/j.cellbi.2008.11.009
   Liang CC, 2007, NAT PROTOC, V2, P329, DOI 10.1038/nprot.2007.30
   Lo CM, 2000, BIOPHYS J, V79, P144, DOI 10.1016/S0006-3495(00)76279-5
   LoCascio SA, 2011, CURR STEM CELL RES T, V6, P29
   Malliaras K, 2011, BRIT MED BULL, V98, P161, DOI 10.1093/bmb/ldr018
   Maloney JM, 2010, BIOPHYS J, V99, P2479, DOI 10.1016/j.bpj.2010.08.052
   Mansbridge J, 1998, TISSUE ENG, V4, P403, DOI 10.1089/ten.1998.4.403
   Mansour S, 2006, J AM COLL CARDIOL, V47, P1727, DOI 10.1016/j.jacc.2006.01.039
   Mazumder A, 2010, J R SOC INTERFACE, V7, pS321, DOI 10.1098/rsif.2010.0039.focus
   McBeath R, 2004, DEV CELL, V6, P483, DOI 10.1016/S1534-5807(04)00075-9
   Meshorer E, 2006, NAT REV MOL CELL BIO, V7, P540, DOI 10.1038/nrm1938
   Meyer GP, 2006, CIRCULATION, V113, P1287, DOI 10.1161/CIRCULATIONAHA.105.575118
   Nakayama K, 2009, J BIOCHEM, V146, P757, DOI 10.1093/jb/mvp167
   Noth U, 2010, ADV DRUG DELIVER REV, V62, P765, DOI 10.1016/j.addr.2010.04.004
   Pajerowski JD, 2007, P NATL ACAD SCI USA, V104, P15619, DOI 10.1073/pnas.0702576104
   Piccoli Claudia, 2007, Ital J Biochem, V56, P295
   Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143
   Roca-Cusachs P, 2009, P NATL ACAD SCI USA, V106, P16245, DOI 10.1073/pnas.0902818106
   Schachinger V, 2006, NEW ENGL J MED, V355, P1210, DOI 10.1056/NEJMoa060186
   Semenza GL, 2003, NAT REV CANCER, V3, P721, DOI 10.1038/nrc1187
   Sykova E, 2006, CELL MOL NEUROBIOL, V26, P1113, DOI 10.1007/s10571-006-9007-2
   Szablowska-Gadomska I, 2011, ACTA NEUROBIOL EXP, V71, P86
   Tan SCW, 2008, BMC CELL BIOL, V9, DOI 10.1186/1471-2121-9-40
   Teo AKK, 2010, BIOCHEM J, V428, P11, DOI 10.1042/BJ20100102
   Titushkin I, 2006, BIOPHYS J, V90, P2582, DOI 10.1529/biophysj.105.073775
   Tottey S., 2010, TISSUE ENG PART A, P37
   Van Citters KM, 2006, BIOPHYS J, V91, P3946, DOI 10.1529/biophysj.106.091264
   Watt FM, 2010, PHILOS T R SOC B, V365, P155, DOI 10.1098/rstb.2009.0149
   Xu S, 2009, BONE MARROW TRANSPL, V44, P427, DOI 10.1038/bmt.2009.52
   Yu HY, 2010, BIOCHEM BIOPH RES CO, V393, P150, DOI 10.1016/j.bbrc.2010.01.107
NR 66
TC 12
Z9 12
U1 0
U2 31
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0021-9290
EI 1873-2380
J9 J BIOMECH
JI J. Biomech.
PD APR 30
PY 2012
VL 45
IS 7
BP 1280
EP 1287
DI 10.1016/j.jbiomech.2012.01.032
PG 8
WC Biophysics; Engineering, Biomedical
SC Biophysics; Engineering
GA 936YZ
UT WOS:000303627500024
PM 22349118
OA Green Accepted
DA 2018-10-19
ER

PT J
AU Areco, MM
   Hanela, S
   Duran, J
   Afonso, MD
AF Mar Areco, Maria
   Hanela, Sergio
   Duran, Jorge
   dos Santos Afonso, Maria
TI Biosorption of Cu(II), Zn(II), Cd(II) and Pb(II) by dead biomasses of
   green alga Ulva lactuca and the development of a sustainable matrix for
   adsorption implementation
SO JOURNAL OF HAZARDOUS MATERIALS
LA English
DT Article
DE Biosorption; Adsorption matrix; Metal removal; Ulva lactuca
ID HEAVY-METAL REMOVAL; AQUEOUS-SOLUTIONS; WASTE BIOMASS; SARGASSUM SP;
   FIXED-BED; IONS; LEAD; KINETICS; SORPTION; SLUDGE
AB Many industries have high heavy metals concentrations in their effluents that should be treated before disposal in drains or natural watercourses. When adsorption process is evaluated to generate and implement an efficient, economical and sustainable method suitable for heavy metals removal from contaminated effluents, it is necessary to develop an experimental setup that contains the adsorbent.
   Ulva lactuca, a marine green alga, was studied as a natural biosorbent for heavy metals at acid pH conditions. Adsorption experiments were carried out in glass columns and in batch where the alga was suspended or fixed in an agar matrix.
   Langmuir and Freundlich models were applied to the experimental results. Langmuir model best describes the adsorption isotherms in all analyzed cases. The adsorption capacity increases with pH. Kinetic studies demonstrate that, in most studied cases, the adsorption follows a pseudo second order kinetics model.
   Removal efficiencies of the biomaterial supported in agar or fixed in columns were: fixed in columns > suspended in batch mode > fixed in agar.
   Finally, the effect of the presence of two sorbates, Cd and Pb. in the solution was measured and results demonstrate that adsorption of both metals are diminished by co/adsorption. (C) 2012 Elsevier B.V. All rights reserved.
C1 [Mar Areco, Maria; dos Santos Afonso, Maria] Univ Buenos Aires, Fac Ciencias Exactas & Nat, INQUIMAE, Buenos Aires, DF, Argentina.
   [Mar Areco, Maria; dos Santos Afonso, Maria] Univ Buenos Aires, Fac Ciencias Exactas & Nat, Dept Quim Inorgan Analit & Quim Fis, Buenos Aires, DF, Argentina.
   [Hanela, Sergio; Duran, Jorge] Inst Nacl Agua, Programa Tecnol Tratamiento, Ctr Tecnol Uso Agua, RA-1304 Buenos Aires, DF, Argentina.
RP Afonso, MD (reprint author), Univ Buenos Aires, Fac Ciencias Exactas & Nat, INQUIMAE, Ciudad Univ,Pabellon 2 3Er Piso,C1428EHA, Buenos Aires, DF, Argentina.
EM dosantos@qi.fcen.uba.ar
FU Universidad de Buenos Aires; Secretaria de Ciencia y Tecnica [UBACyT
   X043]; SECyT FONCyT-ANCyP [BID 1728 OC-AR PICT 13-08893]; Centro de
   Tecnologia del Uso del Agua, Instituto Nacional del Agua
FX The authors acknowledge Universidad de Buenos Aires, Secretaria de
   Ciencia y Tecnica through Project UBACyT X043, SECyT FONCyT-ANCyP
   through Project BID 1728 OC-AR PICT 13-08893 for financial support, and
   to the authorities of the Centro de Tecnologia del Uso del Agua,
   Instituto Nacional del Agua for encourage and support the project
   related with this work.
CR Ahmady-Asbchin S, 2009, ENVIRON TECHNOL, V30, P755, DOI 10.1080/09593330902919401
   Akhtar M., 2009, COLLOID SURFACE B, V75, P149
   Aksu Z, 2004, PROCESS BIOCHEM, V39, P599, DOI 10.1016/S0032-9592(03)00132-8
   Ariff AB, 1999, WORLD J MICROB BIOT, V15, P291, DOI 10.1023/A:1008995026987
   Davis TA, 2000, WATER RES, V34, P4270, DOI 10.1016/S0043-1354(00)00177-9
   Donghee P., 2007, CHEMOSPHERE, V66, P939
   Esposito A, 2002, CHEM ENG SCI, V57, P307, DOI 10.1016/S0009-2509(01)00399-2
   Esteves AJP, 2000, BIOTECHNOL LETT, V22, P499, DOI 10.1023/A:1005608701510
   Fagundes-Klen MR, 2010, WATER AIR SOIL POLL, V213, P15, DOI 10.1007/s11270-010-0363-7
   Falasca S., 1997, Z PFLANZ BODENKUNDE, V160, P223
   Ferraz AI, 2004, CHEM ENG J, V105, P11, DOI 10.1016/j.cej.2004.07.009
   Gong RM, 2005, CHEMOSPHERE, V58, P125, DOI 10.1016/j.chemosphere.2004.08.055
   Guo XY, 2008, J HAZARD MATER, V151, P134, DOI 10.1016/j.jhazmat.2007.05.065
   Gurbuz F, 2009, ADSORPT SCI TECHNOL, V27, P745, DOI 10.1260/0263-6174.27.8.745
   Harry E., 1999, TRENDS BIOTECHNOL, V17, P462
   Ho YS, 2006, J HAZARD MATER, V129, P137, DOI 10.1016/j.jhazmat.2005.08.020
   Ho YS, 2003, PROCESS BIOCHEM, V38, P1047, DOI 10.1016/S0032-9592(02)00239-X
   Homagai PL, 2010, BIORESOURCE TECHNOL, V101, P2067, DOI 10.1016/j.biortech.2009.11.073
   Huang X, 2010, J HAZARD MATER, V183, P793, DOI 10.1016/j.jhazmat.2010.07.096
   Jha B, 2009, BIODEGRADATION, V20, P1, DOI 10.1007/s10532-008-9194-2
   Kalavathy H, 2010, COLLOID SURFACE B, V78, P291, DOI 10.1016/j.colsurfb.2010.03.014
   Kalyani S, 2004, CHEMOSPHERE, V57, P1225, DOI 10.1016/j.chemosphere.2004.08.057
   Kleinubing S.J., 2009, ADV MAT RES, P589
   Li QZ, 2009, APPL SURF SCI, V255, P4298, DOI 10.1016/j.apsusc.2008.11.024
   Liu CC, 2011, DESALINATION, V267, P20, DOI 10.1016/j.desal.2010.08.040
   Areco MM, 2010, COLLOID SURFACE B, V81, P620, DOI 10.1016/j.colsurfb.2010.08.014
   Marandi R, 2008, MINE WATER AND THE ENVIRONMENT, PROCEEDINGS, P293
   Miretzky P, 2006, CHEMOSPHERE, V62, P247, DOI 10.1016/j.chemosphere.2005.05.010
   Murphy V, 2009, J HAZARD MATER, V166, P318, DOI 10.1016/j.jhazmat.2008.11.041
   ORMEROD EC, 1983, CLAY MINER, V18, P289, DOI 10.1180/claymin.1983.018.3.06
   Paradossi G, 1999, INT J BIOL MACROMOL, V25, P309, DOI 10.1016/S0141-8130(99)00049-5
   Pentari D, 2009, J HAZARD MATER, V168, P1017, DOI 10.1016/j.jhazmat.2009.02.131
   PLATTE JA, 1959, ANAL CHEM, V31, P1226, DOI 10.1021/ac60151a048
   Rao RAK, 2009, COLLOID SURFACE A, V332, P121, DOI 10.1016/j.colsurfa.2008.09.005
   Saeed A, 2005, J HAZARD MATER, V117, P65, DOI 10.1016/j.jhazmat.2004.09.008
   SANDELL EB, 1959, COLORIMETRIC DETERMI
   Sengil IA, 2009, J HAZARD MATER, V166, P1488, DOI 10.1016/j.jhazmat.2008.12.071
   Shiue A, 2011, BUILD ENVIRON, V46, P468, DOI 10.1016/j.buildenv.2010.08.010
   Solari P, 1996, SEPAR SCI TECHNOL, V31, P1075, DOI 10.1080/01496399608001335
   Stumm W., 1992, CHEM SOLID WATER INT
   Suharso, 2010, DESALINATION, V263, P64
   Sun YM, 2010, POL J MICROBIOL, V59, P37
   Valdman E, 2000, BIOPROCESS ENG, V22, P171, DOI 10.1007/s004490050027
   vanderWal A, 1997, COLLOID SURFACE B, V9, P81, DOI 10.1016/S0927-7765(96)01340-9
   Vijayaraghavan K, 2008, BIORESOURCE TECHNOL, V99, P2864, DOI 10.1016/j.biortech.2007.06.008
   Volesky B., 2003, SORPTION BIOSORPTION
NR 46
TC 66
Z9 76
U1 1
U2 67
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0304-3894
J9 J HAZARD MATER
JI J. Hazard. Mater.
PD APR 30
PY 2012
VL 213
BP 123
EP 132
DI 10.1016/j.jhazmat.2012.01.073
PG 10
WC Engineering, Environmental; Environmental Sciences
SC Engineering; Environmental Sciences & Ecology
GA 927FS
UT WOS:000302893100015
PM 22342902
DA 2018-10-19
ER

PT J
AU Kawashima, A
   Wada, T
   Ohmura, K
   Xie, GQ
   Inoue, A
AF Kawashima, Asahi
   Wada, Takeshi
   Ohmura, Kazuyo
   Xie, Guoqiang
   Inoue, Akihisa
TI A Ni- and Cu-free Zr-based bulk metallic glass with excellent resistance
   to stress corrosion cracking in simulated body fluids
SO MATERIALS SCIENCE AND ENGINEERING A-STRUCTURAL MATERIALS PROPERTIES
   MICROSTRUCTURE AND PROCESSING
LA English
DT Article
DE Bulk metallic glass; Simulated body fluid; Stress corrosion cracking;
   X-ray photoelectron spectroscopy
ID X-RAY PHOTOELECTRON; AMORPHOUS ALLOY; BEHAVIOR; OXIDES; CYTOTOXICITY;
   COBALT; STATE
AB In order to evaluate stress corrosion cracking (SCC) susceptibility of a Ni- and Cu-free Zr56Al16CO28 bulk metallic glass (BMG) for biomedical application, the SCC behaviour of the BMG in various simulated body fluids (SBFs) including Hanks', PBS(-) and 0.9% NaCl solutions open to air at 37 degrees C has been investigated using a slow strain rate technique (SSRT) at various initial tensile strain rates in the region of 5 x 10(-7) to 5 x 10(-4) s(-1). It was found that the Zr-Al-Co BMG exhibited excellent resistance to SCC in all of tested conditions. The amounts of cytotoxic cobalt ions released from the BMG disks of 5 mm in diameter were lower than those from the currently used biomaterial Co-Cr-Mo alloy. XPS analysis revealed that zirconium and aluminium ions were enriched in both air-formed and passive films. Moreover, these films were composed of double oxyhydroxide of zirconium, aluminium and cobalt. The formation of the stable and homogeneous double oxyhydroxide film enriched with zirconium and aluminium cations seems to be responsible for the high corrosion resistance and hence good SCC resistance of the Zr-Al-Co glassy alloy in SBFs. Thus, the Zr56Al16CO28 BMG can be potentially promising material for biomedical applications. (C) 2012 Elsevier B.V. All rights reserved.
C1 [Kawashima, Asahi; Wada, Takeshi; Ohmura, Kazuyo; Xie, Guoqiang] Tohoku Univ, Inst Mat Res, Sendai, Miyagi 9808577, Japan.
RP Kawashima, A (reprint author), Tohoku Univ, Inst Mat Res, Sendai, Miyagi 9808577, Japan.
EM ka.asahi@imr.tohoku.ac.jp
RI Wada, Takeshi/B-2431-2015; Xie, Guoqiang/A-8619-2011; BAI,
   JIE/D-7448-2016; Inoue, Akihisa/E-5271-2015
FU Japan Society for the Promotion of Science (JSPS) [20560644]; The
   Ministry of Education, Culture, Sports, Science and Technology (MEXT) of
   Japan
FX The authors wish to thank Dr. T. Ashino and Mr. K. Usui, Institute for
   Materials Research, Tohoku University for assistance in the measurements
   of released metal ions and for preparation of tensile specimens,
   respectively. This work was financially supported in part by
   Grant-in-Aid for Scientific Research (C) No. 20560644 from Japan Society
   for the Promotion of Science (JSPS) and by Advanced Materials
   Development and Integration of Novel Structured Metallic and Inorganic
   Materials from The Ministry of Education, Culture, Sports, Science and
   Technology (MEXT) of Japan. This work was a cooperative program of the
   ARCMG-IMR, Tohoku University.
CR ASAMI K, 1976, CORROS SCI, V16, P35, DOI 10.1016/S0010-938X(76)80005-4
   Ashino T, 2008, MATER TRANS, V49, P1342, DOI 10.2320/matertrans.MRA2007325
   Buzzi S, 2006, INTERMETALLICS, V14, P729, DOI 10.1016/j.intermet.2005.11.003
   Castleman L.S., 1981, CRC SERIES BIOCOMPAT
   Catelas S., 2001, J MATER SCI-MATER M, V12, P949
   CHUANG TJ, 1976, SURF SCI, V59, P413, DOI 10.1016/0039-6028(76)90026-1
   Hanawa T, 2007, METALS BIOMATERIALS
   He W, 2010, METALL MATER TRANS A, V41A, P1726, DOI 10.1007/s11661-009-0150-5
   Hiromoto S, 2000, CORROS SCI, V42, P1651, DOI 10.1016/S0010-938X(00)00022-6
   International Agency for Research on Cancer, 1996, MON EV CARC RISK CHE
   Kawashima A, 2001, MAT SCI ENG A-STRUCT, V304, P753, DOI 10.1016/S0921-5093(00)01587-2
   KAWASHIMA A, 1994, MAT SCI ENG A-STRUCT, V182, P1109
   Kawashima A, 2011, CORROS SCI, V53, P2778, DOI 10.1016/j.corsci.2011.05.014
   Kawashima A, 2010, CORROS SCI, V52, P2950, DOI 10.1016/j.corsci.2010.05.007
   Liu L, 2008, J BIOMED MATER RES A, V86A, P160, DOI 10.1002/jbm.a.31425
   MCINTYRE NS, 1975, ANAL CHEM, V47, P2208, DOI 10.1021/ac60363a034
   Morrison ML, 2005, J BIOMED MATER RES A, V74A, P430, DOI 10.1002/jbm.a.30361
   Moulder J. F., 1995, HDB XRAY PHOTOELECTR
   Pang SJ, 2003, J MATER RES, V18, P1652, DOI 10.1557/JMR.2003.0227
   Parkins R.N., 1979, ASTM
   Pourbaix M., 1974, ATLAS ELECTROCHEMICA
   Wada T, 2009, J MATER RES, V24, P2941, DOI 10.1557/JMR.2009.0348
   Yokoyama Y, 2002, MATER TRANS, V43, P2316, DOI 10.2320/matertrans.43.2316
   Zhang T, 2002, MATER TRANS, V43, P267, DOI 10.2320/matertrans.43.267
NR 24
TC 18
Z9 23
U1 3
U2 36
PU ELSEVIER SCIENCE SA
PI LAUSANNE
PA PO BOX 564, 1001 LAUSANNE, SWITZERLAND
SN 0921-5093
J9 MAT SCI ENG A-STRUCT
JI Mater. Sci. Eng. A-Struct. Mater. Prop. Microstruct. Process.
PD APR 30
PY 2012
VL 542
BP 140
EP 146
DI 10.1016/j.msea.2012.02.047
PG 7
WC Nanoscience & Nanotechnology; Materials Science, Multidisciplinary;
   Metallurgy & Metallurgical Engineering
SC Science & Technology - Other Topics; Materials Science; Metallurgy &
   Metallurgical Engineering
GA 926NR
UT WOS:000302838600017
DA 2018-10-19
ER

PT J
AU Desai, N
   Abdelhafez, F
   Calabro, A
   Falcone, T
AF Desai, Nina
   Abdelhafez, Faten
   Calabro, Anthony
   Falcone, Tommaso
TI Three dimensional culture of fresh and vitrified mouse pre-antral
   follicles in a hyaluronan-based hydrogel: a preliminary investigation of
   a novel biomaterial for in vitro follicle maturation
SO REPRODUCTIVE BIOLOGY AND ENDOCRINOLOGY
LA English
DT Article
DE Follicle; Hydrogel; 3D culture; Oocyte maturation; Vitrification;
   Extracellular matrix; Ovary
ID PREANTRAL GRANULOSA-CELL; EXTRACELLULAR-MATRIX; OVARIAN-FOLLICLES;
   OOCYTE GROWTH; DEVELOPMENTAL COMPETENCE; SECONDARY FOLLICLES;
   RHESUS-MONKEYS; SURVIVAL; TISSUE; SYSTEM
AB Background: Folliculogenesis within the ovary requires interaction between somatic cell components and the oocyte. Maintenance of 3-dimensional (3-D) architecture and granulosa-oocyte interaction may be critical for successful in vitro maturation of follicles. Testing of novel biomaterials for the 3-D culture of follicles may ultimately lead to a culture model that can support the longer in vitro culture intervals needed for in vitro maturation of human oocytes from ovarian tissue biopsies.
   Methods: A novel tyramine-based hyaluronan (HA) hydrogel was tested for its biocompatibility with ovarian follicles. The HA was prepared at concentrations from 2 to 5 mg/ml. HA hydrogel was also formulated and tested with matrix proteins (ECM). Enzymatically isolated pre-antral follicles from the ovaries of 10-12 day SJL pups were divided amongst control (CT) and HA treatments. The growth of both fresh and vitrified follicles was assessed after encapsulation in the hydrogel. The basal culture medium was MEM alpha supplemented with FSH, LH, ITS and 5% FBS. Maturation was triggered by addition of hCG and EGF after in vitro culture (IVC). Outcome parameters monitored were follicle morphology, survival after IVC, antrum formation, GVBD and MII formation. Differences between treatments were analyzed.
   Results: HA and ECM-HA encapsulated follicles looked healthy and maintained their 3-D architecture during IVC. In control cultures, the follicles flattened and granulosa: oocyte connections appeared fragile. Estradiol secretion per follicle was significantly higher by Day 12 in ECM-HA compared to HA or CT (4119, 703 and 1080 pg/ml, respectively). HA and ECM-HA cultured follicles had similar survival rates (62% and 54%, respectively), percent GV breakdown (96-97%), MII formation (47-48%) and oocyte diameters at the end of IVC. Control cultures differed significantly in percent GVBD (85%) and MII formation (67%). Vitrified-warmed follicles encapsulated in HA had an oocyte maturation rate to MII of 54% as compared to 57% in non-embedded follicles.
   Conclusions: Initial testing of this new and unique HA-based hydrogel was quite promising. The ease of follicle encapsulation in HA, its optical transparency and ability to be molded combined with its support of follicle growth, estradiol secretion and resumption of meiosis make this HA-hydrogel particularly attractive as model for 3-D ovarian follicle culture.
C1 [Desai, Nina; Abdelhafez, Faten; Falcone, Tommaso] Cleveland Clin Fertil Ctr, Dept OB GYN, Beachwood, OH 44122 USA.
   [Desai, Nina; Abdelhafez, Faten; Falcone, Tommaso] Cleveland Clin Fdn, Womens Hlth Inst, Beachwood, OH USA.
   [Calabro, Anthony] Cleveland Clin Fdn, Dept Biomed Engn, Lerner Res Inst, Cleveland, OH USA.
RP Desai, N (reprint author), Cleveland Clin Fertil Ctr, Dept OB GYN, Beachwood, OH 44122 USA.
EM desain@ccf.org
CR Adam AAG, 2004, J REPROD DEVELOP, V50, P579, DOI 10.1262/jrd.50.579
   Amorim CA, 2009, HUM REPROD, V24, P92, DOI 10.1093/humrep/den343
   Berkholtz CB, 2006, SEMIN REPROD MED, V24, P262, DOI 10.1055/s-2006-948575
   Bissell MJ, 2003, CURR OPIN CELL BIOL, V15, P753, DOI 10.1016/j.ceb.2003.10.016
   Carabatsos MJ, 2000, DEV BIOL, V226, P167, DOI 10.1006/dbio.2000.9863
   Chan J, 2005, AM J COSMET SURG, V22, P105
   Chin LK, 2011, J MATER SCI-MATER M, V22, P1465, DOI 10.1007/s10856-011-4325-4
   Cortvrindt R, 1996, HUM REPROD, V11, P2656
   Darr A, 2009, J MATER SCI-MATER M, V20, P33, DOI 10.1007/s10856-008-3540-0
   Desai N, 2011, J OBSTET GYNAECOL RE, V37, P1, DOI 10.1111/j.1447-0756.2010.01215.x
   Desai N, 2010, REPROD BIOL ENDOCRIN, V8, DOI 10.1186/1477-7827-8-119
   Diaz FJ, 2007, DEV BIOL, V305, P300, DOI 10.1016/j.ydbio.2007.02.019
   Diaz FJ, 2006, DEV BIOL, V299, P91, DOI 10.1016/j.ydbio.2006.07.012
   EPPIG JJ, 1993, DEV BIOL, V158, P400, DOI 10.1006/dbio.1993.1198
   Eppig JJ, 2005, BIOL REPROD, V73, P351, DOI 10.1095/biolreprod.105.041798
   EPPIG JJ, 1989, BIOL REPROD, V41, P268, DOI 10.1095/biolreprod41.2.268
   FIGUEIREDO JR, 1995, THERIOGENOLOGY, V43, P845, DOI 10.1016/0093-691X(95)00036-8
   Gomes JE, 1999, MOL REPROD DEV, V54, P163, DOI 10.1002/(SICI)1098-2795(199910)54:2<163::AID-MRD8>3.0.CO;2-4
   Heise M, 2005, REPROD BIOL ENDOCRIN, V3, DOI 10.1186/1477-7827-3-47
   HERLANDS RL, 1984, J EXP ZOOL, V229, P317, DOI 10.1002/jez.1402290217
   HIRSHFIELD AN, 1991, INT REV CYTOL, V124, P43
   Hovatta O, 1997, HUM REPROD, V12, P1032
   Kawashima I, 2008, REPRODUCTION, V136, P9, DOI 10.1530/REP-08-0074
   Kimura N, 2007, Soc Reprod Fertil Suppl, V63, P327
   Kreeger PK, 2006, BIOMATERIALS, V27, P714, DOI 10.1016/j.biomaterials.2005.06.016
   Kreeger PK, 2005, BIOL REPROD, V73, P942, DOI 10.1095/biolreprod.105.042390
   Kreeger PK, 2003, MOL CELL ENDOCRINOL, V205, P1, DOI 10.1016/S0303-7207(03)00209-0
   Kurisawa M, 2005, CHEM COMMUN, P4312, DOI 10.1039/b506989k
   Mainigi MA, 2011, BIOL REPROD, V85, P269, DOI 10.1095/biolreprod.111.091124
   Modina S, 2001, MARC MALPIG SYMP SER, V8, P241
   Mousset-Simeon N, 2005, ZYGOTE, V13, P167, DOI 10.1017/S0967199405003151
   Nation A, 2009, REPRODUCTION, V138, P247, DOI 10.1530/REP-09-0028
   Oktem O, 2007, REPROD SCI, V14, P358, DOI 10.1177/1933719107303397
   Pangas SA, 2003, TISSUE ENG, V9, P1013, DOI 10.1089/107632703322495655
   Redding GP, 2007, REPRODUCTION, V133, P1095, DOI 10.1530/REP-06-0171
   Shikanov A, 2011, JOVE-J VIS EXP, DOI 10.3791/2695
   Shikanov A, 2009, BIOMATERIALS, V30, P5476, DOI 10.1016/j.biomaterials.2009.06.054
   Su YQ, 2009, SEMIN REPROD MED, V27, P32, DOI 10.1055/s-0028-1108008
   Telfer EE, 2007, REPROD BIOMED ONLINE, V15, P288, DOI 10.1016/S1472-6483(10)60341-0
   West ER, 2007, BIOMATERIALS, V28, P4439, DOI 10.1016/j.biomaterials.2007.07.001
   West ER, 2007, SEMIN REPROD MED, V25, P287, DOI 10.1055/s-2007-980222
   West-Farrell ER, 2009, BIOL REPROD, V80, P432, DOI 10.1095/biolreprod.108.071142
   Xu J, 2011, HUM REPROD, V26, P1061, DOI 10.1093/humrep/der049
   Xu J, 2010, REPRODUCTION, V140, P685, DOI 10.1530/REP-10-0284
   Xu M, 2006, TISSUE ENG, V12, P2739, DOI 10.1089/ten.2006.12.2739
   Xu M, 2006, BIOL REPROD, V75, P916, DOI 10.1095/biolreprod.106.054833
   Xu M, 2009, BIOL REPROD, V81, P587, DOI 10.1095/biolreprod.108.074732
   Xu M, 2009, HUM REPROD, V24, P2531, DOI 10.1093/humrep/dep228
   Xu Min, 2007, V138, P75
NR 49
TC 24
Z9 26
U1 0
U2 19
PU BIOMED CENTRAL LTD
PI LONDON
PA 236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND
SN 1477-7827
J9 REPROD BIOL ENDOCRIN
JI Reprod. Biol. Endocrinol.
PD APR 18
PY 2012
VL 10
AR 29
DI 10.1186/1477-7827-10-29
PG 12
WC Endocrinology & Metabolism; Reproductive Biology
SC Endocrinology & Metabolism; Reproductive Biology
GA 959CT
UT WOS:000305289700001
PM 22513305
OA DOAJ Gold, Green Published
DA 2018-10-19
ER

PT J
AU Martins, JRS
   Grandini, CR
AF Severino Martins, Jose Roberto, Jr.
   Grandini, Carlos Roberto
TI Structural characterization of Ti-15Mo alloy used as biomaterial by
   Rietveld method
SO JOURNAL OF APPLIED PHYSICS
LA English
DT Article
ID TI-MO ALLOYS; TITANIUM-ALLOYS; BEHAVIOR
AB The biochemical and mechanical behavior of titanium alloys has been studied extensively for a variety of applications in the aerospace and biomedical fields. In the literature, there are studies that relate the microstructure and the phases of the material with its properties; however, there is little information that quantifies each phase and relates this to its properties. In addition, little has been done to analyze the effects of oxygen and heat treatment on the alloy's structure. In this paper, the effect of doping with oxygen and the effect of heat treatments on structural properties of Ti-15Mo alloy used as biomaterials is examined using scanning electron microscopy, x-ray diffraction, and diffractogram analysis using the Rietveld method. (C) 2012 American Institute of Physics. [http://dx.doi.org/10.1063/1.4707920]
C1 [Severino Martins, Jose Roberto, Jr.; Grandini, Carlos Roberto] UNESP Univ Estadual Paulista, Lab Anelasticidade & Biomat, BR-17033360 Bauru, SP, Brazil.
RP Grandini, CR (reprint author), UNESP Univ Estadual Paulista, Lab Anelasticidade & Biomat, BR-17033360 Bauru, SP, Brazil.
EM betog@fc.unesp.br
RI Martins Junior, Jose Roberto/E-2190-2014; Grandini, Carlos
   Roberto/A-3790-2008
OI Grandini, Carlos Roberto/0000-0002-3336-309X
FU CNPq [307.471/2007-1]; FAPESP [2008/07.588-5, 2009/00.042-0]
FX The authors thank the Brazilian Agencies CNPq (Grant No.
   #307.471/2007-1) and FAPESP (Grant Nos. #2008/07.588-5 and
   #2009/00.042-0) for their financial support.
CR [Anonymous], 2008, F206608 ASTM
   Bania P. J., 1993, TITANIUM ALLOYS 1990
   Banumathy S., 2009, J APPL PHYS, V106, P093518
   Cullity B. D., 2001, ELEMENTS XRAY DIFFRA
   Geetha M, 2009, PROG MATER SCI, V54, P397, DOI 10.1016/j.pmatsci.2008.06.004
   Guo H, 2006, SCRIPTA MATER, V54, P1409, DOI 10.1016/j.scriptamat.2005.11.053
   HILL RJ, 1987, J APPL CRYSTALLOGR, V20, P467, DOI 10.1107/S0021889887086199
   Ho WF, 2008, J ALLOY COMPD, V464, P580, DOI 10.1016/j.jallcom.2007.10.054
   Ho WF, 1999, BIOMATERIALS, V20, P2115, DOI 10.1016/S0142-9612(99)00114-3
   Larson A. C., 2004, 86748 LAUR LOS AL NA
   Lide D. R., 2004, CRC HDB CHEM PHYS RE
   Long M, 1998, BIOMATERIALS, V19, P1621, DOI 10.1016/S0142-9612(97)00146-4
   Mclachlan D.R.C., 1983, BIOL ASPECTS METALS
   Niinomi M, 1998, MAT SCI ENG A-STRUCT, V243, P231, DOI 10.1016/S0921-5093(97)00806-X
   Nogueira RA, 2008, J MATER SCI, V43, P5977, DOI 10.1007/s10853-008-2706-y
   Oliveira NTC, 2008, CORROS SCI, V50, P938, DOI 10.1016/j.corsci.2007.09.009
   Oliveira NTC, 2007, MAT SCI ENG A-STRUCT, V452, P727, DOI 10.1016/j.msea.2006.11.061
   PERL DP, 1980, SCIENCE, V208, P297, DOI 10.1126/science.7367858
   RIETVELD HM, 1969, J APPL CRYSTALLOGR, V2, P65, DOI 10.1107/S0021889869006558
   Martins JRS, 2011, MATER RES-IBERO-AM J, V14, P107, DOI 10.1590/S1516-14392011005000013
   Steinemann S., 1980, EVALUATION BIOMATERI
   Sugano M, 1998, MAT SCI ENG A-STRUCT, V243, P163, DOI 10.1016/S0921-5093(97)00795-8
   Sukedai E, 2003, MAT SCI ENG A-STRUCT, V350, P133, DOI 10.1016/S0921-5093(02)00714-1
   Wang K, 1996, MAT SCI ENG A-STRUCT, V213, P134, DOI 10.1016/0921-5093(96)10243-4
   WILLIAMSON GK, 1953, ACTA METALL MATER, V1, P22, DOI 10.1016/0001-6160(53)90006-6
NR 25
TC 8
Z9 8
U1 4
U2 24
PU AMER INST PHYSICS
PI MELVILLE
PA CIRCULATION & FULFILLMENT DIV, 2 HUNTINGTON QUADRANGLE, STE 1 N O 1,
   MELVILLE, NY 11747-4501 USA
SN 0021-8979
J9 J APPL PHYS
JI J. Appl. Phys.
PD APR 15
PY 2012
VL 111
IS 8
AR 083535
DI 10.1063/1.4707920
PG 8
WC Physics, Applied
SC Physics
GA 936OB
UT WOS:000303598800050
DA 2018-10-19
ER

PT J
AU Kodama, M
   De Velasco, MA
   Yamamoto, Y
   Shimizu, N
   Nozawa, M
   Yoshimura, K
   Yoshikawa, K
   Uemura, H
AF Kodama, Mitsuyama
   De Velasco, Marco A.
   Yamamoto, Yutaka
   Shimizu, Nobutaka
   Nozawa, Masahiro
   Yoshimura, Kazuhiro
   Yoshikawa, Kazuhiro
   Uemura, Hirotsugu
TI Use of a novel synthetic biomaterial to induce mild whole body
   hyperthermia for the treatment of cancer in a preclinical model
SO CANCER RESEARCH
LA English
DT Meeting Abstract
C1 [Kodama, Mitsuyama; De Velasco, Marco A.; Yamamoto, Yutaka; Shimizu, Nobutaka; Nozawa, Masahiro; Yoshimura, Kazuhiro; Uemura, Hirotsugu] Kinki Univ, Sch Med, Osaka 589, Japan.
   [Yoshikawa, Kazuhiro] Aichi Med Univ Hosp, Nagoya, Aichi, Japan.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU AMER ASSOC CANCER RESEARCH
PI PHILADELPHIA
PA 615 CHESTNUT ST, 17TH FLOOR, PHILADELPHIA, PA 19106-4404 USA
SN 0008-5472
EI 1538-7445
J9 CANCER RES
JI Cancer Res.
PD APR 15
PY 2012
VL 72
SU 8
MA 3517
DI 10.1158/1538-7445.AM2012-3517
PG 1
WC Oncology
SC Oncology
GA V43SQ
UT WOS:000209701500392
DA 2018-10-19
ER

PT J
AU Kucukbenli, E
   Sonkar, K
   Sinha, N
   de Gironcoli, S
AF Kuecuekbenli, Emine
   Sonkar, Kanchan
   Sinha, Neeraj
   de Gironcoli, Stefano
TI Complete C-13 NMR Chemical Shifts Assignment for Cholesterol Crystals by
   Combined CP-MAS Spectral Editing and ab Initio GIPAW Calculations with
   Dispersion Forces
SO JOURNAL OF PHYSICAL CHEMISTRY A
LA English
DT Article
ID SOLID-STATE NMR; 1ST PRINCIPLES CALCULATIONS; X-RAY-DIFFRACTION;
   1ST-PRINCIPLES CALCULATION; ANHYDROUS CHOLESTEROL; CRYSTALLOGRAPHY;
   SPECTROSCOPY; GALLSTONES; O-17; COMPUTATION
AB We report here the first fully oh initio determination of C-13 NMR spectra for several crystal structures of cholesterol, observed in various biomaterials. We combine Gauge-Including Projector Augmented Waves (GIPAW) calculations at relaxed structures, fully including dispersion forces, with Magic Angle Spinning Solid State NMR experiments and spectral editing to achieve a detailed interpretation of the complex NMR spectra of cholesterol crystals. By introducing an environment-dependent secondary referencing scheme in our calculations, not only do we reproduce the characteristic spectral features of the different crystalline polymorphs, thus clearly discriminating among them, but also closely represent the spectrum in the region of several highly overlapping peaks. This, in combination with spectral editing, allows us to provide monohydrate (ChM) and low-temperature anhydrous (ChAl) crystal polymorphs. Our results initio calculations and refined experimental techniques can be exploited for an accurate and complex systems of great interest for biomaterial studies. The method is general in nature various complex biomaterials.
C1 [Kuecuekbenli, Emine; de Gironcoli, Stefano] SISSA, I-34136 Trieste, Italy.
   [Kuecuekbenli, Emine; de Gironcoli, Stefano] IOM CNR Democritos, I-34136 Trieste, Italy.
   [Sonkar, Kanchan; Sinha, Neeraj] Ctr Biomed Magnet Resonance, Lucknow 226014, Uttar Pradesh, India.
RP Kucukbenli, E (reprint author), Ecole Polytech Fed Lausanne, CH-1015 Lausanne, Switzerland.
EM kucukben@sissa.it; kanchan@cbmr.res.in; neeraj.sinha@cbmr.res.in;
   degironc@sissa.it
RI de Gironcoli, Stefano/G-7236-2011
OI de Gironcoli, Stefano/0000-0002-2307-0998
FU CSIR; DBT, INDIA
FX We thank EU-IndiaGrid European project for supporting E.K.'s and K.S.'s
   visits to New Delhi and Trieste during the completion of this work.
   Computational facilities were provided by CINECA through the CLRgipaw
   ISCRA grant. We acknowledge the Solid State NMR facility at CBMR Lucknow
   for experimental work. K.S. and N.S. acknowledge CSIR and DBT, INDIA for
   fellowship grant.
CR Ashbrook SE, 2006, PHYS CHEM CHEM PHYS, V8, P3423, DOI 10.1039/b604520k
   Benoit M, 2005, J PHYS CHEM B, V109, P6052, DOI 10.1021/jp0492570
   Bim J, 2004, J AM CHEM SOC, V126, P8529, DOI 10.1021/ja049879z
   BLOCHL PE, 1994, PHYS REV B, V50, P17953, DOI 10.1103/PhysRevB.50.17953
   BOGREN H, 1963, BIOCHIM BIOPHYS ACTA, V75, P65, DOI 10.1016/0006-3002(63)90580-8
   Bradley JP, 2011, CRYST GROWTH DES, V11, P3463, DOI 10.1021/cg200277a
   Burns ST, 2000, J MAGN RESON, V143, P352, DOI 10.1006/jmre.1999.1996
   Cadars S, 2009, J PHYS CHEM A, V113, P902, DOI 10.1021/jp810138y
   Charpentier T, 2004, J PHYS CHEM B, V108, P4147, DOI 10.1021/jp0367225
   CRAVEN BM, 1976, NATURE, V260, P727, DOI 10.1038/260727a0
   Dion M, 2004, PHYS REV LETT, V92, DOI 10.1103/PhysRevLett.92.246401
   Dumez JN, 2009, J CHEM PHYS, V130, DOI 10.1063/1.3081630
   FACELLI JC, 1993, NATURE, V365, P325, DOI 10.1038/365325a0
   Finegold L, 1985, CHOLESTEROL MEMBRANE
   Folliet N, 2011, J AM CHEM SOC, V133, P16815, DOI 10.1021/ja201002r
   Giannozzi P, 2009, J PHYS-CONDENS MAT, V21, DOI 10.1088/0953-8984/21/39/395502
   Guo W, 1996, BIOPHYS J, V71, P2857, DOI 10.1016/S0006-3495(96)79482-1
   Harris R. K., 2009, NMR CRYSTALLOGRAPHY
   Harris RK, 2006, PHYS CHEM CHEM PHYS, V8, P137, DOI 10.1039/b513392k
   Harris RK, 2010, MAGN RESON CHEM, V48, pS103, DOI 10.1002/mrc.2636
   Heuman D., 1999, GALLSTONES SCHIFFS D, P631
   HSU LY, 1983, SCIENCE, V220, P604, DOI 10.1126/science.6836303
   Hsu LY, 2002, ACTA CRYSTALLOGR B, V58, P260, DOI 10.1107/S0108768101018729
   Jayalakshmi K, 2009, SOLID STATE NUCL MAG, V36, P60, DOI 10.1016/j.ssnmr.2009.06.001
   Pickard CJ, 2001, PHYS REV B, V63, DOI 10.1103/PhysRevB.63.245101
   Profeta M, 2003, J AM CHEM SOC, V125, P541, DOI 10.1021/ja027124r
   Roman-Perez G, 2009, PHYS REV LETT, V103, DOI 10.1103/PhysRevLett.103.096102
   RUSSELL DW, 1992, BIOCHEMISTRY-US, V31, P4737, DOI 10.1021/bi00135a001
   Salager E, 2010, J AM CHEM SOC, V132, P2564, DOI 10.1021/ja909449k
   Salager E, 2009, PHYS CHEM CHEM PHYS, V11, P2610, DOI 10.1039/b821018g
   Schoonjans K, 2000, BBA-MOL CELL BIOL L, V1529, P114, DOI 10.1016/S1388-1981(00)00141-4
   SHIEH HS, 1981, ACTA CRYSTALLOGR B, V37, P1538, DOI 10.1107/S0567740881006523
   SHIEH HS, 1977, NATURE, V267, P287, DOI 10.1038/267287a0
   SMALL DM, 1974, SCIENCE, V185, P222, DOI 10.1126/science.185.4147.222
   SUTOR DJ, 1969, GUT, V10, P681, DOI 10.1136/gut.10.8.681
   SUTOR DJ, 1972, GUT, V13, P64, DOI 10.1136/gut.13.1.64
   Webber AL, 2010, J PHYS CHEM A, V114, P10435, DOI 10.1021/jp104901j
   Weihs D, 2005, J LIPID RES, V46, P942, DOI 10.1194/jlr.M400458-JLR200
   WU XL, 1994, J MAGN RESON SER A, V111, P29, DOI 10.1006/jmra.1994.1222
   Yates JR, 2007, PHYS REV B, V76, DOI 10.1103/PhysRevB.76.024401
NR 40
TC 24
Z9 24
U1 0
U2 28
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 1089-5639
J9 J PHYS CHEM A
JI J. Phys. Chem. A
PD APR 12
PY 2012
VL 116
IS 14
BP 3765
EP 3769
DI 10.1021/jp3019974
PG 5
WC Chemistry, Physical; Physics, Atomic, Molecular & Chemical
SC Chemistry; Physics
GA 923AY
UT WOS:000302591600029
PM 22424177
DA 2018-10-19
ER

PT J
AU Prabhawathi, V
   Sivakumar, PM
   Doble, M
AF Prabhawathi, Veluchamy
   Sivakumar, Ponnurengam Malliappan
   Doble, Mukesh
TI Green Synthesis of Protein Stabilized Silver Nanoparticles Using
   Pseudomonas fluorescens, a Marine Bacterium, and Its Biomedical
   Applications When Coated on Polycaprolactam
SO INDUSTRIAL & ENGINEERING CHEMISTRY RESEARCH
LA English
DT Article
ID STAINLESS-STEEL SURFACES; ANTIBACTERIAL ACTIVITY;
   BACILLUS-LICHENIFORMIS; POLYMERIC BIOMATERIALS; ESCHERICHIA-COLI;
   BIOCOMPATIBILITY; COMPOSITE; ION; BIOSYNTHESIS; MECHANISM
AB Green synthesis of protein stabilized silver nanoparticles (AgNPs) using the supernatant of a marine isolate, Pseudomonas fluorescens PMMD3 (P.fluorescens), and its biomedical applications and biocompatibility when coated on polycaprolactam is reported here. The AgNPs are spherical and are 1-10 nm in size. AgNP-coated polycaprolactam showed 89.7% and 92.4% reduction in colony forming units (CFUs), when compared to bare polymer, against S.aureus and E.coli, respectively. In the biofilm on AgNP composite, when compared to the bare polymer, there were carbohydrate reductions by factors of 3.5 and 6.0 in S.aureus and E.coli biofilm, respectively, and protein reductions by factors of 6.5 and 3.0 in S.aureus and E.coli biofilm, respectively. Reduction in the adhesion of S.aureus, C.albicans, A.niger, and F.proliferatum were observed using scanning electron microscopy (SEM) and fluorescence microscopy. The C.albicans biofilm is 15 and 6 mu m thick on polycaprolactam and AgNP composite, respectively. We observed 84% and 80% proliferation of 3T3-L1 adipocyte cells and 85% and 97% of L929 fibroblast on the AgNP composite and bare polymer, indicating that this new material is suitable for biomaterial applications.
EM mukeshd@iitm.ac.in
OI Doble, Mukeshd/0000-0002-4335-0698; Sivakumar, Ponnurengam
   Malliappan/0000-0002-5880-9596
CR Ananth AN, 2011, COLLOID SURFACE B, V85, P138, DOI 10.1016/j.colsurfb.2011.02.012
   Cao XL, 2010, COLLOID SURFACE B, V81, P555, DOI 10.1016/j.colsurfb.2010.07.057
   Celmer D, 2008, WATER RES, V42, P3057, DOI 10.1016/j.watres.2008.02.031
   Deepak V, 2011, METAL NANOPARTICLES IN MICROBIOLOGY, P17, DOI 10.1007/978-3-642-18312-6_2
   Dong Y, 2011, ACTA BIOMATER, V7, P447, DOI 10.1016/j.actbio.2010.08.009
   Gurunathan S, 2009, COLLOID SURFACE B, V74, P328, DOI 10.1016/j.colsurfb.2009.07.048
   Hsu SH, 2011, COLLOID SURFACE B, V85, P198, DOI 10.1016/j.colsurfb.2011.02.029
   Jin X, 2010, ENVIRON SCI TECHNOL, V44, P7321, DOI 10.1021/es100854g
   Jonas T., 2010, APPL SURF SCI, V256, P2841
   Juibari MM, 2011, MATER LETT, V65, P1014, DOI 10.1016/j.matlet.2010.12.056
   Jung WK, 2008, APPL ENVIRON MICROB, V74, P2171, DOI 10.1128/AEM.02001-07
   Kalimuthu K, 2008, COLLOID SURFACE B, V65, P150, DOI 10.1016/j.colsurfb.2008.02.018
   Kalishwaralal K, 2008, MATER LETT, V62, P4411, DOI 10.1016/j.matlet.2008.06.051
   Khandwekar AP, 2011, J BIOMATER APPL, V26, P229
   Khandwekar AP, 2011, J MATER SCI-MATER M, V22, P231
   Konwarh R, 2011, COLLOID SURFACE B, V84, P338, DOI 10.1016/j.colsurfb.2011.01.024
   Kumar R, 2005, BIOMATERIALS, V26, P2081, DOI 10.1016/j.biomaterials.2004.05.030
   Luo J, 2010, INT J ANTIMICROB AG, V36, P549, DOI 10.1016/j.ijantimicag.2010.08.015
   Meng FM, 2009, APPL SURF SCI, V255, P6715, DOI 10.1016/j.apsusc.2009.02.076
   Mueller NC, 2008, ENVIRON SCI TECHNOL, V42, P4447, DOI 10.1021/es7029637
   O'Toole GA, 1998, MOL MICROBIOL, V28, P449, DOI 10.1046/j.1365-2958.1998.00797.x
   OWENS DK, 1969, J APPL POLYM SCI, V13, P1741, DOI 10.1002/app.1969.070130815
   Pal S, 2007, APPL ENVIRON MICROB, V73, P1712, DOI 10.1128/AEM.02218-06
   Paramonova E, 2007, APPL ENVIRON MICROB, V73, P7023, DOI 10.1128/AEM.00935-07
   PETIT C, 1993, J PHYS CHEM-US, V97, P12974, DOI 10.1021/j100151a054
   Prabhakar PK, 2011, COLLOID SURFACE B, V86, P146, DOI 10.1016/j.colsurfb.2011.03.033
   Prabhawathi Veluchamy, 2011, Journal of Agricultural and Food Chemistry, V59, P10869
   Rai M, 2009, BIOTECHNOL ADV, V27, P76, DOI 10.1016/j.biotechadv.2008.09.002
   Rajakumar G, 2011, ACTA TROP, V118, P196, DOI 10.1016/j.actatropica.2011.03.003
   Risbud MV, 2001, J BIOMAT SCI-POLYM E, V12, P125
   Ristorcelli E, 2008, FASEB J, V22, P3358, DOI 10.1096/fj.07-102855
   Sanpui P, 2008, INT J FOOD MICROBIOL, V124, P142, DOI 10.1016/j.ijfoodmicro.2008.03.004
   Sasidharan S, 2010, MICROSCOPY SCI TECHN, P622
   Sivakumar PM, 2010, COLLOID SURFACE B, V81, P439, DOI 10.1016/j.colsurfb.2010.07.037
   Sivakumar PM, 2010, SAR QSAR ENVIRON RES, V21, P247, DOI 10.1080/10629361003771009
   Sivakumar PM, 2010, APPL SURF SCI, V256, P6018, DOI 10.1016/j.apsusc.2010.03.112
   Sivakumar PM, 2010, CARBOHYD POLYM, V79, P717, DOI 10.1016/j.carbpol.2009.09.027
   Wang YX, 2004, PHARM RES, V21, P1362, DOI 10.1023/B:PHAM.0000036909.41843.18
   Zhao Q, 2007, APPL SURF SCI, V253, P8674, DOI 10.1016/j.apsusc.2007.04.044
NR 39
TC 14
Z9 14
U1 2
U2 20
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 0888-5885
J9 IND ENG CHEM RES
JI Ind. Eng. Chem. Res.
PD APR 11
PY 2012
VL 51
IS 14
BP 5230
EP 5239
DI 10.1021/ie2029392
PG 10
WC Engineering, Chemical
SC Engineering
GA 921VD
UT WOS:000302505300015
DA 2018-10-19
ER

PT J
AU Kao, CH
   Hsiang, CY
   Ho, TY
AF Kao, Chia-Hung
   Hsiang, Chien-Yun
   Ho, Tin-Yun
TI Assessment of Chitosan-Affected Metabolic Response by Peroxisome
   Proliferator-Activated Receptor Bioluminescent Imaging-Guided
   Transcriptomic Analysis
SO PLOS ONE
LA English
DT Article
ID HOST-BIOMATERIAL INTERACTION; MOLECULAR-WEIGHT CHITOSAN; NUCLEAR
   RECEPTORS; APOLIPOPROTEIN-B; PPAR-GAMMA; MICE; DISEASE; CHITIN;
   OLIGOSACCHARIDES; THERAPY
AB Chitosan has been widely used in food industry as a weight-loss aid and a cholesterol-lowering agent. Previous studies have shown that chitosan affects metabolic responses and contributes to anti-diabetic, hypocholesteremic, and blood glucose-lowering effects; however, the in vivo targeting sites and mechanisms of chitosan remain to be clarified. In this study, we constructed transgenic mice, which carried the luciferase genes driven by peroxisome proliferator-activated receptor (PPAR), a key regulator of fatty acid and glucose metabolism. Bioluminescent imaging of PPAR transgenic mice was applied to report the organs that chitosan acted on, and gene expression profiles of chitosan-targeted organs were further analyzed to elucidate the mechanisms of chitosan. Bioluminescent imaging showed that constitutive PPAR activities were detected in brain and gastrointestinal tract. Administration of chitosan significantly activated the PPAR activities in brain and stomach. Microarray analysis of brain and stomach showed that several pathways involved in lipid and glucose metabolism were regulated by chitosan. Moreover, the expression levels of metabolism-associated genes like apolipoprotein B (apoB) and ghrelin genes were down-regulated by chitosan. In conclusion, these findings suggested the feasibility of PPAR bioluminescent imaging-guided transcriptomic analysis on the evaluation of chitosan-affected metabolic responses in vivo. Moreover, we newly identified that downregulated expression of apoB and ghrelin genes were novel mechanisms for chitosan-affected metabolic responses in vivo.
C1 [Kao, Chia-Hung] China Med Univ Hosp, Dept Nucl Med, Taichung, Taiwan.
   [Hsiang, Chien-Yun] China Med Univ, Dept Microbiol, Taichung, Taiwan.
   [Ho, Tin-Yun] China Med Univ, Grad Inst Chinese Med, Taichung, Taiwan.
RP Ho, TY (reprint author), China Med Univ, Grad Inst Chinese Med, Taichung, Taiwan.
EM tyh@mail.cmu.edu.tw
RI Ho, Tin-Yun/O-3889-2015; Hsiang, Chien-Yun/O-3853-2015
FU National Science Council (NSC) [100-2324-B-039-001,
   NSC100-2320-B-039-020]; Committee on Chinese Medicine and Pharmacy at
   Department of Health [CCMP100-RD-048, CCMP101-RD-103]; China Medical
   University [CMU100-S-16, CMU100-S-34, CMU100-TS-14]
FX This work was supported by grants from National Science Council (NSC
   100-2324-B-039-001 and NSC100-2320-B-039-020), Committee on Chinese
   Medicine and Pharmacy at Department of Health (CCMP100-RD-048 and
   CCMP101-RD-103), and China Medical University (CMU100-S-16, CMU100-S-34,
   and CMU100-TS-14). The funders had no role in study design, data
   collection and analysis, decision to publish, or preparation of the
   manuscript.
CR Baker WL, 2009, ANN NUTR METAB, V55, P368, DOI 10.1159/000258633
   Baldrick P, 2010, REGUL TOXICOL PHARM, V56, P290, DOI 10.1016/j.yrtph.2009.09.015
   Benn M, 2009, ATHEROSCLEROSIS, V206, P17, DOI 10.1016/j.atherosclerosis.2009.01.004
   Bensinger SJ, 2008, NATURE, V454, P470, DOI 10.1038/nature07202
   Castaneda TR, 2010, FRONT NEUROENDOCRIN, V31, P44, DOI 10.1016/j.yfrne.2009.10.008
   Chang CT, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031808
   Chang CT, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023682
   Cheng WY, 2009, BRIT J PHARMACOL, V157, P746, DOI 10.1111/j.1476-5381.2009.00223.x
   Cho EJ, 2008, J MICROBIOL BIOTECHN, V18, P80
   Cho MC, 2008, PPAR RES, DOI 10.1155/2008/679137
   Ciana P, 2007, MOL ENDOCRINOL, V21, P388, DOI 10.1210/me.2006-0152
   Coll Teresa, 2009, Curr Mol Pharmacol, V2, P46
   Escher P, 2000, MUTAT RES-FUND MOL M, V448, P121, DOI 10.1016/S0027-5107(99)00231-6
   Hayashi K, 2002, BIOL PHARM BULL, V25, P188, DOI 10.1248/bpb.25.188
   Heneka MT, 2007, BBA-MOL CELL BIOL L, V1771, P1031, DOI 10.1016/j.bbalip.2007.04.016
   Ho TY, 2007, BIOMATERIALS, V28, P4370, DOI 10.1016/j.biomaterials.2007.07.005
   Hsiang CY, 2009, BIOMATERIALS, V30, P3042, DOI 10.1016/j.biomaterials.2009.02.016
   Jarmila V, 2011, CURR PHARM DESIGN, V7, P3596
   Jayakumar R, 2011, BIOTECHNOL ADV, V29, P322, DOI 10.1016/j.biotechadv.2011.01.005
   Jayakumar R, 2010, CARBOHYD POLYM, V82, P227, DOI 10.1016/j.carbpol.2010.04.074
   Jayakumar R, 2010, PROG MATER SCI, V55, P675, DOI 10.1016/j.pmatsci.2010.03.001
   Jayakumar R, 2010, BIOTECHNOL ADV, V28, P142, DOI 10.1016/j.biotechadv.2009.11.001
   Jayakumar R, 2010, CARBOHYD POLYM, V79, P1, DOI 10.1016/j.carbpol.2009.08.026
   KANAUCHI O, 1995, BIOSCI BIOTECH BIOCH, V59, P786, DOI 10.1271/bbb.59.786
   Kanehisa M, 2010, NUCLEIC ACIDS RES, V38, pD355, DOI 10.1093/nar/gkp896
   Khor E, 2003, BIOMATERIALS, V24, P2339, DOI 10.1016/S0142-9612(03)00026-7
   Kim E, 1998, J LIPID RES, V39, P703
   Kojima M, 1999, NATURE, V402, P656, DOI 10.1038/45230
   Kumar SG, 2009, PROTEOMICS, V9, P2149, DOI 10.1002/pmic.200800571
   Kummer MP, 2008, PPAR RES, DOI 10.1155/2008/403896
   LENICH C, 1988, J LIPID RES, V29, P755
   Liu SH, 2010, J AGR FOOD CHEM, V58, P5795, DOI 10.1021/jf100662r
   Lovett-Racke AE, 2004, J IMMUNOL, V172, P5790, DOI 10.4049/jimmunol.172.9.5790
   Martin H, 2010, MUTAT RES-FUND MOL M, V690, P57, DOI 10.1016/j.mrfmmm.2010.09.009
   Mhurchu CN, 2005, OBES REV, V6, P35, DOI 10.1111/j.1467-789X.2005.00158.x
   Perissi V, 2005, NAT REV MOL CELL BIO, V6, P542, DOI 10.1038/nrm1680
   Peters JM, 2008, CLIN SCI, V115, P107, DOI 10.1042/CS20080022
   Rahman MA, 2008, PROTEOMICS, V8, P569, DOI 10.1002/pmic.200700888
   Rosenson RS, 2009, ATHEROSCLEROSIS, V207, P328, DOI 10.1016/j.atherosclerosis.2009.05.020
   Schintu N, 2009, EUR J NEUROSCI, V29, P954, DOI 10.1111/j.1460-9568.2009.06657.x
   Shah A, 2010, ATHEROSCLEROSIS, V210, P35, DOI 10.1016/j.atherosclerosis.2009.11.010
   Sniderman AD, 2005, CIRCULATION, V112, P3366, DOI 10.1161/CIRCULATIONHA.105.583336
   Sumiyoshi M, 2006, J PHARM PHARMACOL, V58, P201, DOI 10.1211/jpp.58.2.0007
   Wu SL, 2009, J PHARMACOL EXP THER, V330, P370, DOI 10.1124/jpet.109.152835
   Zambelli F, 2009, NUCLEIC ACIDS RES, V37, pW247, DOI 10.1093/nar/gkp464
NR 45
TC 5
Z9 5
U1 0
U2 4
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD APR 4
PY 2012
VL 7
IS 4
AR e34969
DI 10.1371/journal.pone.0034969
PG 10
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA 953GO
UT WOS:000304855200092
PM 22496881
OA DOAJ Gold, Green Published
DA 2018-10-19
ER

PT J
AU Wagner, WD
   Argenta, LC
   Morykwas, MJ
   Levi-Polyachenko, N
AF Wagner, William D.
   Argenta, Louis C.
   Morykwas, Michael J.
   Levi-Polyachenko, Nicole
TI Production of a biodegradable electrospun biomaterial with tensile
   strength and elasticity
SO FASEB JOURNAL
LA English
DT Meeting Abstract
CT Experimental Biology Meeting
CY APR 21-25, 2012
CL San Diego, CA
C1 [Wagner, William D.; Argenta, Louis C.; Morykwas, Michael J.; Levi-Polyachenko, Nicole] Wake Forest Univ, Bowman Gray Sch Med, Winston Salem, NC USA.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU FEDERATION AMER SOC EXP BIOL
PI BETHESDA
PA 9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA
SN 0892-6638
J9 FASEB J
JI Faseb J.
PD APR
PY 2012
VL 26
PG 1
WC Biochemistry & Molecular Biology; Biology; Cell Biology
SC Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other
   Topics; Cell Biology
GA 032IZ
UT WOS:000310711305480
DA 2018-10-19
ER

PT J
AU Borgognoni, CF
   Bevilacqua, JD
   Pitombo, RND
AF Borgognoni, Camila Figueiredo
   Bevilacqua, Joyce da Silva
   de Moraes Pitombo, Ronaldo Nogueira
TI Freeze-drying microscopy in mathematical modeling of a biomaterial
   freeze-drying
SO BRAZILIAN JOURNAL OF PHARMACEUTICAL SCIENCES
LA English
DT Article
DE Freeze-drying microscopy; Bovine pericardium; Mathematical modeling
ID BOVINE PERICARDIUM; OPERATIONAL POLICIES; LYOPHILIZATION; OPTIMIZATION;
   RATES; CYCLE
AB Transplantation brings hope for many patients. A multidisciplinary approach on this field aims at creating biologically functional tissues to be used as implants and prostheses. The freeze-drying process allows the fundamental properties of these materials to be preserved, making future manipulation and storage easier. Optimizing a freeze-drying cycle is of great importance since it aims at reducing process costs while increasing product quality of this time-and-energy-consuming process. Mathematical modeling comes as a tool to help a better understanding of the process variables behavior and consequently it helps optimization studies. Freeze-drying microscopy is a technique usually applied to determine critical temperatures of liquid formulations. It has been used in this work to determine the sublimation rates of a biological tissue freeze-drying. The sublimation rates were measured from the speed of the moving interface between the dried and the frozen layer under 21.33, 42.66 and 63.99 Pa. The studied variables were used in a theoretical model to simulate various temperature profiles of the freeze-drying process. Good agreement between the experimental and the simulated results was found.
C1 [Borgognoni, Camila Figueiredo; de Moraes Pitombo, Ronaldo Nogueira] Univ Sao Paulo, Fac Pharmaceut Sci, Dept Biochem & Pharmaceut Technol, BR-05508900 Sao Paulo, Brazil.
   [Bevilacqua, Joyce da Silva] Univ Sao Paulo, Inst Math & Stat, Dept Appl Math, BR-05508900 Sao Paulo, Brazil.
RP Borgognoni, CF (reprint author), Univ Sao Paulo, Fac Ciencias Farmaceut, Dept Tecnol Bioquim Farmaceut, Av Prof Lineu Prestes 580,BL16,CP 66083, BR-05508900 Sao Paulo, Brazil.
EM caborg@usp.br
FU Foundation for Research Support of the State of Sao Paulo (FAPESP)
FX The financial support of the Foundation for Research Support of the
   State of Sao Paulo (FAPESP) is gratefully acknowledged.
CR Aimoli CG, 2007, ARTIF ORGANS, V31, P278, DOI 10.1111/j.1525-1594.2007.00376.x
   Bhattacharya A, 2003, PHYSIOL MEAS, V24, P769, DOI 10.1088/0967-3334/24/3/312
   Borgognoni CF, 2010, J APPL BIOMATER BIOM, V8, P186, DOI 10.5301/JABB.2010.6104
   Chakraborty R, 2006, SEP PURIF TECHNOL, V49, P258, DOI 10.1016/j.seppur.2005.10.008
   Chakraborty R, 2011, SEP PURIF TECHNOL, V80, P375, DOI 10.1016/j.seppur.2011.05.023
   Chouvenc P, 2004, DRY TECHNOL, V22, P1577, DOI 10.1081/DRT-200025605
   George JP, 2002, J FOOD ENG, V52, P89, DOI 10.1016/S0260-8774(01)00091-7
   Grant Y, 2009, BIOTECHNOL BIOENG, V104, P957, DOI 10.1002/bit.22448
   Leirner AA, 2009, ARTIF ORGANS, V33, P221, DOI 10.1111/j.1525-1594.2009.00712.x
   LIAPIS AI, 1979, CHEM ENG SCI, V34, P975, DOI 10.1016/0009-2509(79)85009-5
   MILLMAN MJ, 1985, AICHE J, V31, P1594, DOI 10.1002/aic.690311003
   Papavasiliou G, 2008, INT DAIRY J, V18, P247, DOI 10.1016/j.idairyj.2007.09.005
   PIKAL MJ, 1983, J PHARM SCI-US, V72, P635, DOI 10.1002/jps.2600720614
   Pisano R, 2011, IND ENG CHEM RES, V50, P7363, DOI 10.1021/ie101955a
   Sadikoglu H, 1997, DRY TECHNOL, V15, P791, DOI 10.1080/07373939708917262
   Schiesser WE, 1991, NUMERICAL METHOD LIN
   Searles JA, 2001, J PHARM SCI, V90, P872, DOI 10.1002/jps.1040
   Sheehan P, 1998, BIOTECHNOL BIOENG, V60, P712, DOI 10.1002/(SICI)1097-0290(19981220)60:6<712::AID-BIT8>3.0.CO;2-4
   Tang XL, 2004, PHARM RES, V21, P191, DOI 10.1023/B:PHAM.0000016234.73023.75
   Tattini Jr Virgilio, 2007, Mat. Res., V10, P1, DOI 10.1590/S1516-14392007000100002
   Tattini V, 2009, J THERM ANAL CALORIM, V98, P203, DOI 10.1007/s10973-009-0317-8
   Zhai S, 2003, CHEM ENG SCI, V58, P2313, DOI 10.1016/S0009-2509(03)00090-3
NR 22
TC 1
Z9 1
U1 0
U2 14
PU UNIV SAO PAULO, CONJUNTO QUIMICAS
PI SAO PAULO
PA SERVICO PUBLICACOES E CIRCULACAO, CAIXA POSTAL 66083, SAO PAULO, 00000,
   BRAZIL
SN 1984-8250
J9 BRAZ J PHARM SCI
JI Braz. J. Pharm. Sci.
PD APR-JUN
PY 2012
VL 48
IS 2
BP 203
EP 209
DI 10.1590/S1984-82502012000200003
PG 7
WC Pharmacology & Pharmacy
SC Pharmacology & Pharmacy
GA 991IA
UT WOS:000307693500003
OA DOAJ Gold
DA 2018-10-19
ER

PT J
AU Das, D
   Mukherjee, A
AF Das, Debasis
   Mukherjee, Arup
TI Biomaterial film for soluble organic sorption and anti-microbial
   activity in water environment
SO BIORESOURCE TECHNOLOGY
LA English
DT Article
DE Biopolymer; Water resistant film; Antimicrobial; Guar gum; Organic
   sorption
ID GUAR; CELLULOSE; REMOVAL
AB A cost competitive biomaterial for widespread applications in food and water technology is an urgent need. We report a new hydrophobic biomaterial film for soluble pollutant sorption and reduction of microbial load in water environment. Guar gum from the seeds of Cyamopsis tetragonolobus was hydrophobically modified following benzoyl chloride reaction in aqueous alkali. The new biopolymer derivative is insoluble in water and form castable films with a high degree of surface hydrophobicity. The film water vapor permeability was 0.233 +/- 0.029 g mm kPa(-1) h(-1) m(-2) and the tensile property was 38.65 +/- 3.66 MPa. The film surface contact angle against water was 77.36 +/- 1.09 degrees. The new biomaterial film demonstrated strong antimicrobial contact killing against both gram positive and gram negative bacteria. It also act as an efficient sorbent for a range of water soluble organic pollutants. (C) 2012 Elsevier Ltd. All rights reserved.
C1 [Das, Debasis; Mukherjee, Arup] Univ Calcutta, Dept Chem Technol, Kolkata 700009, India.
RP Mukherjee, A (reprint author), Univ Calcutta, Dept Chem Technol, 92 APC Rd, Kolkata 700009, India.
EM hdct1@yahoo.co.in
FU UGC special assistance grants under the Calcutta University Center for
   Research in Nanoscience and Nanotechnology
FX Authors intend to acknowledge the financial support extended from the
   UGC special assistance grants under the Calcutta University Center for
   Research in Nanoscience and Nanotechnology. Detailed AFM evaluations
   were conducted by Mr. Anirban Chakrabarty, University of Calcutta and
   contact angle evaluations were carried out by Dr. Bikash Mondal, City
   University of New York, USA. Their support is also appreciated.
CR Alila S, 2011, IND CROP PROD, V33, P350, DOI 10.1016/j.indcrop.2010.11.010
   Alila S, 2009, IND CROP PROD, V30, P93, DOI 10.1016/j.indcrop.2009.02.005
   Anselme K, 2010, ACTA BIOMATER, V6, P3824, DOI 10.1016/j.actbio.2010.04.001
   Bellamy L.J., 1958, INFRARED SPECTRA COM, P65
   Bordenave N, 2010, BIOMACROMOLECULES, V11, P88, DOI 10.1021/bm9009528
   Cerqueira MA, 2011, TRENDS FOOD SCI TECH, V22, P662, DOI 10.1016/j.tifs.2011.07.002
   Chen J, 2005, FOOD CHEM, V90, P461, DOI 10.1016/j.foodchem.2004.05.010
   Das D, 2011, BIORESOURCE TECHNOL, V102, P5878, DOI 10.1016/j.biortech.2011.02.034
   Han H, 2011, LANGMUIR, V27, P4010, DOI 10.1021/la1046904
   KESTING RE, 1990, J APPL POLYM SCI, V41, P2739, DOI 10.1002/app.1990.070411120
   Krishnaiah YSR, 1998, J CONTROL RELEASE, V55, P245, DOI 10.1016/S0168-3659(98)00057-1
   Mariniello L, 2007, BIOMACROMOLECULES, V8, P3008, DOI 10.1021/bm0702410
   Minekus M, 2005, BIOSCI BIOTECH BIOCH, V69, P932, DOI 10.1271/bbb.69.932
   Mothe CG, 2006, J THERM ANAL CALORIM, V85, P31, DOI 10.1007/s10973-005-7339-7
   Mukherjee A., 2007, NEW HORIZONS BIOTECH, P1
   Naoi S, 2002, J THERM ANAL CALORIM, V70, P841, DOI 10.1023/A:1022260304686
   Pereda M, 2011, FOOD HYDROCOLLOID, V25, P1372, DOI 10.1016/j.foodhyd.2011.01.001
   Qian LY, 2011, ACS APPL MATER INTER, V3, P1895, DOI 10.1021/am200094u
   RAFIQUE CM, 1950, J AM CHEM SOC, V72, P4634, DOI 10.1021/ja01166a082
   Rechendorff K, 2006, LANGMUIR, V22, P10885, DOI 10.1021/la0621923
   Rhim JW, 2007, LWT-FOOD SCI TECHNOL, V40, P232, DOI 10.1016/j.lwt.2005.10.002
   Richardson SD, 2011, ANAL CHEM, V83, P4614, DOI 10.1021/ac200915r
   Risica D, 2005, POLYMER, V46, P12247, DOI 10.1016/j.polymer.2005.10.083
   Rojo L, 2008, BIOMACROMOLECULES, V9, P2530, DOI 10.1021/bm800570u
   Song YB, 2008, BIOMACROMOLECULES, V9, P2259, DOI 10.1021/bm800429a
   Sun K, 2011, BIORESOURCE TECHNOL, V102, P5757, DOI 10.1016/j.biortech.2011.03.038
   Thire RMSM, 2003, CARBOHYD POLYM, V54, P149, DOI 10.1016/S0144-8617(03)00167-X
   Tizzotti M, 2010, MACROMOLECULES, V43, P6843, DOI 10.1021/ma101215d
   Tripathy J, 2008, CARBOHYD POLYM, V72, P462, DOI 10.1016/j.carbpol.2007.09.014
   Venkatasubramanian R, 2011, LANGMUIR, V27, P3261, DOI 10.1021/la200245m
   Vishwakarma RK, 2011, LWT-FOOD SCI TECHNOL, V44, P969, DOI 10.1016/j.lwt.2010.09.002
   Zhao YY, 2008, ENVIRON SCI TECHNOL, V42, P4857, DOI 10.1021/es7031423
NR 32
TC 4
Z9 4
U1 1
U2 15
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0960-8524
EI 1873-2976
J9 BIORESOURCE TECHNOL
JI Bioresour. Technol.
PD APR
PY 2012
VL 110
BP 412
EP 416
DI 10.1016/j.biortech.2012.01.147
PG 5
WC Agricultural Engineering; Biotechnology & Applied Microbiology; Energy &
   Fuels
SC Agriculture; Biotechnology & Applied Microbiology; Energy & Fuels
GA 966QO
UT WOS:000305852700059
PM 22357294
DA 2018-10-19
ER

PT J
AU Dai, JZ
   Cen, F
   Ji, JH
   Zhang, WW
   Xu, H
AF Dai, Jiuzhou
   Cen, Feng
   Ji, Jinhu
   Zhang, Weiwei
   Xu, Heng
TI Biosorption of Lead(II) in Aqueous Solution by Spent Mushroom Tricholoma
   lobayense
SO WATER ENVIRONMENT RESEARCH
LA English
DT Article
DE biosorption; heavy metal pollution; lead removal; mushroom Tricholoma
   lobayense
ID HEAVY-METALS; FUNGAL BIOMASS; MARINE-ALGAE; WASTE-WATER; REMOVAL;
   RECOVERY; IONS; BIOSORBENT; PB(II); PH
AB The biosorption of lead(II) ions in both simulated and real wastewater by spent mushroom Tricholoma lobayense, was studied in this work. The results show a biomass with a high potential for removing lead ions from wastewater. The optimum pH for the adsorption is 4, and the adsorption process is fast. The best sorbent mass of the biomaterial is 5 g/L with an initial lead(II) concentration of 1 mmol/L. The process follows the Langmuir isotherm model, and the biosorption capacity of lead ions reaches to 210 mg/g, which is higher than many biosorbents previously studied. The mechanism of biosorption may be mainly attributed to ion exchange. The FT-IR study identifies the functional groups responsible for this process. A scanning electron microscope showed a significant change of the sorbent surface after the biosorption process. The energy dispersive elemental analysis also confirmed the adsorption of lead(II) ions. Water Environ. Res., 84, 291 (2012).
C1 [Dai, Jiuzhou; Cen, Feng; Ji, Jinhu; Zhang, Weiwei; Xu, Heng] Sichuan Univ, Coll Life Sci, Key Lab Bioresources & Ecoenvironm Educ Minist, Chengdu 610064, Peoples R China.
RP Dai, JZ (reprint author), Sichuan Univ, Coll Life Sci, Key Lab Bioresources & Ecoenvironm Educ Minist, Chengdu 610064, Peoples R China.
EM xuheng64@sina.com
FU National 863 High Technology Research and Development Program of China
   [2006AA06Z361]; Science and Technology Supportive Project of Sichuan
   Province, China [2009SZ0204]; Chengdu Technical Project
   [10GGYB472SF-023]
FX This study was financially supported by the National 863 High Technology
   Research and Development Program of China (No. 2006AA06Z361); the
   Science and Technology Supportive Project of Sichuan Province, China
   (No. 2009SZ0204); and the Chengdu Technical Project (No.
   10GGYB472SF-023).
CR Abdel-Halim SH, 2003, WATER RES, V37, P1678, DOI 10.1016/S0043-1354(02)00554-7
   Akar T, 2005, BIOCHEM ENG J, V25, P227, DOI 10.1016/j.bcj.2005.05.006
   Akhtar N, 2004, J HAZARD MATER, V108, P85, DOI 10.1016/j.jhazmat.2004.01.002
   Chen GQ, 2006, J HAZARD MATER, V135, P249, DOI 10.1016/j.jhazmat.2005.11.060
   Chojnacka K, 2010, ENVIRON INT, V36, P299, DOI 10.1016/j.envint.2009.12.001
   FOUREST E, 1992, APPL MICROBIOL BIOT, V37, P399, DOI 10.1007/BF00211001
   General Administration of Quality Supervision Inspection and Quarantine of P. R. C., 1996, INT WAST DISCH STAND
   HALL KR, 1966, IND ENG CHEM FUND, V5, P212, DOI 10.1021/i160018a011
   Huang HY, 2009, WATER AIR SOIL POLL, V203, P53, DOI 10.1007/s11270-009-9991-1
   Jalali R, 2002, J HAZARD MATER, V92, P253, DOI 10.1016/S0304-3894(02)00021-3
   Kapoor A, 1995, BIORESOURCE TECHNOL, V53, P195, DOI 10.1016/0960-8524(95)00072-1
   Kratochvil D, 1998, TRENDS BIOTECHNOL, V16, P291, DOI 10.1016/S0167-7799(98)01218-9
   Deng LP, 2007, J HAZARD MATER, V143, P220, DOI 10.1016/j.jhazmat.2006.09.009
   Lo WH, 1999, CHEMOSPHERE, V39, P2723, DOI 10.1016/S0045-6535(99)00206-4
   Martinez M, 2006, J HAZARD MATER, V133, P203, DOI 10.1016/j.jhazmat.2005.10.030
   Matheickal JT, 1996, WATER SCI TECHNOL, V34, P1, DOI 10.1016/S0273-1223(96)00780-9
   Melgar MJ, 2007, SCI TOTAL ENVIRON, V385, P12, DOI 10.1016/j.scitotenv.2007.07.01
   MURALEEDHARAN TR, 1994, SEPAR SCI TECHNOL, V29, P1893, DOI 10.1080/01496399408002178
   Pavan FA, 2008, BIOCHEM ENG J, V40, P357, DOI 10.1016/j.bej.2008.01.004
   Qi BC, 2008, BIORESOURCE TECHNOL, V99, P5595, DOI 10.1016/j.biortech.2007.10.042
   Quek SY, 1998, WATER SA, V24, P251
   Rahman MS, 2009, CHEM ENG J, V149, P273, DOI 10.1016/j.cej.2008.11.029
   Saeed A, 2005, SEP PURIF TECHNOL, V45, P25, DOI 10.1016/j.seppur.2005.02.004
   Saeed A, 2005, J HAZARD MATER, V117, P65, DOI 10.1016/j.jhazmat.2004.09.008
   Sag Y, 1996, PROCESS BIOCHEM, V31, P573, DOI 10.1016/S0032-9592(96)00003-9
   Sangi MR, 2008, J HAZARD MATER, V155, P513, DOI 10.1016/j.jhazmat.2007.11.110
   Sari A, 2009, J HAZARD MATER, V164, P1004, DOI 10.1016/j.jhazmat.2008.09.002
   Schiewer S, 2008, J HAZARD MATER, V157, P8, DOI 10.1016/j.jhazmat.2007.12.076
   Vimala R, 2009, J HAZARD MATER, V168, P376, DOI 10.1016/j.jhazmat.2009.02.062
   WHO, 2008, GUID DRINK WAT QUAL
NR 30
TC 4
Z9 4
U1 0
U2 12
PU WATER ENVIRONMENT FEDERATION
PI ALEXANDRIA
PA 601 WYTHE ST, ALEXANDRIA, VA 22314-1994 USA
SN 1061-4303
J9 WATER ENVIRON RES
JI Water Environ. Res.
PD APR
PY 2012
VL 84
IS 4
BP 291
EP 298
DI 10.2175/106143012X13347678384404
PG 8
WC Engineering, Environmental; Environmental Sciences; Limnology; Water
   Resources
SC Engineering; Environmental Sciences & Ecology; Marine & Freshwater
   Biology; Water Resources
GA 961LY
UT WOS:000305467100001
PM 22834216
DA 2018-10-19
ER

PT J
AU Khamdahsag, P
   Pattanasiriwisawa, W
   Nanny, MA
   Grisdanurak, N
AF Khamdahsag, Pummarin
   Pattanasiriwisawa, Wanwisa
   Nanny, Mark A.
   Grisdanurak, Nurak
TI COMPARATIVE STUDY OF STICKY RICE STARCH AND POLYVINYLPYRROLIDONE AS
   TEMPLATES FOR ZnO AND Ce-ZnO SYNTHESIS
SO ENVIRONMENTAL ENGINEERING AND MANAGEMENT JOURNAL
LA English
DT Article
DE biomaterial; mechanical coating; simple chemical method; ZnO
ID OPTICAL-PROPERTIES; MAGNETIC-BEHAVIOR; TIO2; PVP; NANOPARTICLES; POWDERS
AB Sticky rice starch (S) as a bioorganic template, and polyvinylpyrrolidone (P) as a polymeric template were studied for the synthesis of ZnO and Ce-ZnO photocatalysts by the simple chemical method. Solid precursors were calcined at 550 degrees C for 3 hrs as determined from the thermal decomposition and crystallization of the photocatalysts by TGA-DTA. Based on their physicochemical properties characterized by FT-IR, FT-Raman, XRD, BET surface area, SEM, UV-Vis DRS, and zeta potential, there was no significant difference in these properties for catalysts obtained from both templates. The catalyst powder was immobilized on alumina beads via the mechanical coating technique (MCT) and applied to the photocatalytic degradation of atrazine. Under visible light irradiation, the Ce-ZnO obtained from template S showed an enhancement of the photocatalytic degradation (similar to 5.47-11.54%), which is highly dependent on the molar ratio (Ce/Zn) and pH. Sticky rice starch could be regarded as an environmental friendly alternative template for ZnO and Ce-ZnO synthesis. The catalyst addresses the entrainment in photocatalytic reactor, eliminating the need for a post filtration process.
C1 [Grisdanurak, Nurak] Thammasat Univ, Dept Chem Engn, Fac Engn, Pathum Thani 12121, Thailand.
   [Khamdahsag, Pummarin] Chulalongkorn Univ, Grad Sch, Int Postgrad Programs Environm Management, Bangkok 10330, Thailand.
   [Khamdahsag, Pummarin] Chulalongkorn Univ, Natl Ctr Excellence Environm & Hazardous Waste Ma, Bangkok 10330, Thailand.
   [Pattanasiriwisawa, Wanwisa] Synchrotron Light Res Inst, Nakhon Rachasima 30000, Thailand.
   [Nanny, Mark A.] Univ Oklahoma, Sch Civil Engn & Environm Sci, Norman, OK 73019 USA.
RP Grisdanurak, N (reprint author), Thammasat Univ, Dept Chem Engn, Fac Engn, Pathum Thani 12121, Thailand.
EM gnurak@engr.tu.ac.th
FU Office of the High Education Commission (Target Research Initiatives),
   Thailand
FX The authors would like to acknowledge the Office of the High Education
   Commission (Target Research Initiatives), Thailand for its financial
   support. We would like to sincerely thank Cyril Jose E. Bajamundi,
   Department of Chemical Engineering, University of the Philippines,
   Diliman, Philippines, for being the English editor.
CR ACROS ORGANICS BVBA, 2008, SAF DAT SHEET POL AV
   Chunming C., 2009, RARE METALS, V28, P434
   Dmitrieva IB, 2007, COLLOID SURFACE A, V300, P315, DOI 10.1016/j.colsurfa.2007.01.046
   Eskandari M, 2009, PHYSICA B, V404, P1924, DOI 10.1016/j.physb.2009.03.024
   Grisdanurak N, 2007, REACT KINET CATAL L, V92, P213, DOI 10.1007/s11144-007-5127-z
   Iwasaki M, 2004, J SOL-GEL SCI TECHN, V32, P99, DOI 10.1007/s10971-004-5772-x
   JANARDHANAN SK, 2008, TRANSIT METAL CHEM, V33, P127
   Lee MA, 2009, J ELECTROCERAM, V23, P474, DOI 10.1007/s10832-008-9499-x
   Ling QC, 2008, J PHOTOCH PHOTOBIO A, V200, P141, DOI 10.1016/j.jphotochem.2008.07.003
   Maensiri S, 2006, J MAGN MAGN MATER, V302, P448, DOI 10.1016/j.jmmm.2005.10.005
   Maensiri S, 2006, J CRYST GROWTH, V289, P102, DOI 10.1016/j.jcrysgro.2005.10.145
   Maensiri S, 2006, J MAGN MAGN MATER, V305, P381, DOI 10.1016/j.jmmm.2006.01.115
   McGlamery M.D., 1996, WEEDS, V14, P237
   Patil S, 2007, BIOMATERIALS, V28, P4600, DOI 10.1016/j.biomaterials.2007.07.029
   Phoka S, 2009, MATER CHEM PHYS, V115, P423, DOI 10.1016/j.matchemphys.2008.12.031
   Shen WZ, 2008, J HAZARD MATER, V152, P172, DOI 10.1016/j.jhazmat.2007.06.082
   Wang WJ, 2003, MATER LETT, V57, P3276, DOI 10.1016/S0167-577X(03)00047-8
   Wang XH, 2005, J AM CHEM SOC, V127, P10982, DOI 10.1021/ja051240n
   Wei SF, 2009, APPL SURF SCI, V255, P6978, DOI 10.1016/j.apsusc.2009.03.023
   Yoong LS, 2009, ENERGY, V34, P1652, DOI 10.1016/j.energy.2009.07.024
   Yoshida H, 2009, J ALLOY COMPD, V475, P383, DOI 10.1016/j.jallcom.2008.07.059
   Zheng MP, 2001, MAT SCI ENG B-SOLID, V87, P197, DOI 10.1016/S0921-5107(01)00743-7
NR 22
TC 0
Z9 0
U1 1
U2 7
PU GH ASACHI TECHNICAL UNIV IASI
PI IASI
PA 71 MANGERON BLVD, IASI, 700050, ROMANIA
SN 1582-9596
J9 ENVIRON ENG MANAG J
JI Environ. Eng. Manag. J.
PD APR
PY 2012
VL 11
IS 4
BP 759
EP 766
PG 8
WC Environmental Sciences
SC Environmental Sciences & Ecology
GA 956FP
UT WOS:000305075800009
DA 2018-10-19
ER

PT J
AU Kim, YJ
   Lee, DY
   Lee, JY
   Lim, YK
AF Kim, Yae-Jin
   Lee, Dong-Yul
   Lee, Jin-Yong
   Lim, Yong-Kyu
TI The effect of silver ion-releasing elastomers on mutans streptococci in
   dental plaque
SO KOREAN JOURNAL OF ORTHODONTICS
LA English
DT Article
DE Biomaterial science; Microbiology; Cariology
ID ANTIBACTERIAL ACTIVITY; ORTHODONTIC TREATMENT; FLUORIDE RELEASE;
   ZEOLITE; PREVALENCE
AB Objective: The purpose of this study was to investigate the antimicrobial effect of silverized elastomers on mutans streptococci in dental plaque. Methods: Forty patients undergoing orthodontic treatment were randomly placed into 1 of 2 groups. We examined the maxillary right and left central incisors and premolars, and the mandibular right and left canines of all participants. We ligated the right maxillary and left mandibular teeth of the participants in group 1 with silverized elastomers and ligated their contralateral teeth with conventional elastomers. We ligated the left maxillary teeth and right mandibular teeth of group 2 participants with silverized elastomers. Each participant visited the clinic 4 times at 3-week intervals. We applied the elastomers to the teeth on one side of each patient's mouth during their first visit. During the second visit, the elastomers were removed for microbiological analysis and replaced with steel ligatures. During the third visit, we used silverized elastomers to ligate the teeth contralateral to those treated on the first visit. The elastomers were removed during the fourth visit, and microbiological analyses were performed. We compared the quantity of bacteria on silverized and conventional elastomers at the 0.05 level of significance. Results: The percentage of mutans streptococci was not significantly different in cultures of dental plaque from the silverized and the conventional elastomers (p > 0.05). Conclusions: There was no significant difference between the antimicrobial effect of the silverized elastomers and that of the conventional elastomers. [Korean J Orthod 2012;42(2):87-93]
C1 [Lee, Dong-Yul; Lim, Yong-Kyu] Korea Univ, Coll Med, Dept Dent, Seoul 136701, South Korea.
   [Kim, Yae-Jin] Korea Univ, Grad Sch Clin Dent, Dept Orthodont, Seoul 136701, South Korea.
   [Lee, Jin-Yong] Kyung Hee Univ, Sch Dent, Dept Oral Microbiol, Seoul, South Korea.
RP Lim, YK (reprint author), Korea Univ, Coll Med, Dept Dent, 73 Inchon Ro, Seoul 136701, South Korea.
EM yonklim@hanmail.net
CR Ahn Jinsoo, 2010, [J. Korea Res. Soc. Dent. Mater., 대한치과기재학회지], V37, P297
   Ahn SJ, 2009, DENT MATER, V25, P206, DOI 10.1016/j.dental.2008.06.002
   Benson PE, 2004, AM J ORTHOD DENTOFAC, V126, P325, DOI 10.1016/j.ajodo.2003.07.007
   BERGER TJ, 1976, ANTIMICROB AGENTS CH, V10, P856, DOI 10.1128/AAC.10.5.856
   Bowden G H, 1990, J Dent Res, V69 Spec No, P653
   Breck DW, 1973, ZEOLITE MOL SIEVE ST
   Casemiro LA, 2008, GERODONTOLOGY, V25, P187, DOI 10.1111/j.1741-2358.2007.00198.x
   Magno AFF, 2008, AM J ORTHOD DENTOFAC, V133, pS104, DOI 10.1016/j.ajodo.2006.04.054
   FORSBERG C-M, 1991, European Journal of Orthodontics, V13, P416
   GREENE JC, 1964, J AM DENT ASSOC, V68, P7, DOI 10.14219/jada.archive.1964.0034
   Hotta M, 1998, J ORAL REHABIL, V25, P485, DOI 10.1046/j.1365-2842.1998.00265.x
   Im K, 1996, J ANTIBACT ANTIFUNG, V24, P269
   Kawahara K, 2000, DENT MATER, V16, P452, DOI 10.1016/S0109-5641(00)00050-6
   Kourai H., 1994, Journal of Antibacterial and Antifungal Agents, Japan, V22, P595
   Lansdown ABG, 1997, BRIT J DERMATOL, V137, P728
   Matsumura Y, 2003, APPL ENVIRON MICROB, V69, P4278, DOI 10.1128/AEM.69.7.4278-4281.2003
   Morishita M, 1998, J CLIN DENT, V9, P94
   OGAARD B, 1989, AM J ORTHOD DENTOFAC, V96, P423, DOI 10.1016/0889-5406(89)90327-2
   ROSENBLOOM RG, 1991, AM J ORTHOD DENTOFAC, V100, P35, DOI 10.1016/0889-5406(91)70046-Y
   Russell AD, 1994, PROGR MED CHEM, V31, P351, DOI DOI 10.1016/S0079-6468(08)70024-9
   SCHEIE AA, 1984, SCAND J DENT RES, V92, P211
   Schierholz JM, 1998, J HOSP INFECT, V40, P257, DOI 10.1016/S0195-6701(98)90301-2
   Shannon I L, 1974, Monogr Oral Sci, V2, P1
   Tanagawa M, 1999, CARIES RES, V33, P366, DOI 10.1159/000016535
   Uchida M, 1995, CHEM IND, V46, P48
   Uchida T, 1992, Hinyokika Kiyo, V38, P973
   Wiegand A, 2007, DENT MATER, V23, P343, DOI 10.1016/j.dental.2006.01.022
   Wiltshire WA, 1999, AM J ORTHOD DENTOFAC, V115, P288, DOI 10.1016/S0889-5406(99)70331-8
   Won YA, 2010, THESIS KOREA U
   Yamamoto K, 1996, DENT MATER, V12, P227, DOI 10.1016/S0109-5641(96)80027-3
   Yoshida K, 1999, EUR J ORAL SCI, V107, P290, DOI 10.1046/j.0909-8836.1999.eos107409.x
NR 31
TC 6
Z9 6
U1 0
U2 4
PU KOREAN ASSOC ORTHODONTISTS
PI SEOUL
PA 603 TRAPALACE II, 1327 SEOCHO-DONG, SEOCHO-GU, SEOUL, 137-070, SOUTH
   KOREA
SN 2234-7518
J9 KOREAN J ORTHOD
JI Korean J. Orthod.
PD APR
PY 2012
VL 42
IS 2
BP 87
EP 93
DI 10.4041/kjod.2012.42.2.87
PG 7
WC Dentistry, Oral Surgery & Medicine
SC Dentistry, Oral Surgery & Medicine
GA 935YN
UT WOS:000303558200006
PM 23112937
OA Green Published, Other Gold
DA 2018-10-19
ER

PT J
AU Breur, GJ
   Dickerson, CA
   Johnson, RL
   Snyder, PW
   Nauman, EA
AF Breur, G. J.
   Dickerson, C. A.
   Johnson, R. L.
   Snyder, P. W.
   Nauman, E. A.
TI OSTEOCHONDRAL DEFECT REPAIR USING A NOVEL NATURALLY DERIVED BIOMATERIAL
   SCAFFOLD
SO OSTEOARTHRITIS AND CARTILAGE
LA English
DT Meeting Abstract
CT World Congress on Osteoarthritis
CY APR 26-29, 2012
CL Barcelona, SPAIN
C1 [Breur, G. J.; Dickerson, C. A.; Johnson, R. L.; Snyder, P. W.; Nauman, E. A.] Purdue Univ, W Lafayette, IN 47907 USA.
NR 0
TC 0
Z9 0
U1 0
U2 2
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1063-4584
J9 OSTEOARTHR CARTILAGE
JI Osteoarthritis Cartilage
PD APR
PY 2012
VL 20
SU 1
BP S131
EP S131
DI 10.1016/j.joca.2012.02.173
PG 1
WC Orthopedics; Rheumatology
SC Orthopedics; Rheumatology
GA 931MF
UT WOS:000303223300281
OA Bronze
DA 2018-10-19
ER

PT J
AU Lionzo, MIZ
   Lorenzini, GC
   Tomedi, J
   Pranke, P
   Silveira, NP
AF Lionzo, Maria I. Z.
   Lorenzini, Giulia C.
   Tomedi, Joelson
   Pranke, Patricia
   Silveira, Nadya P.
TI Effects of the Composite Nanovesicles on the Physical Properties and
   Cellular Adhesion of Chitosan Films
SO JOURNAL OF BIOMEDICAL NANOTECHNOLOGY
LA English
DT Article
DE Chitosan Films; Nanovesicles; Cell Adhesion; Biomaterial; Wound
   Dressing; Cell Growth Support
ID CHONDROITIN SULFATE; CHITIN DERIVATIVES; POLYMER NETWORK; DEGRADATION;
   COMPLEXES; SCAFFOLDS
AB Chitosan films were prepared by the casting of a chitosan gel in absence and presence of composite nanovesicles. The microscopy images showed the occurrence of agglomerates on the surface and internal pores when the nanovesicles were added to the films, differently from the smooth surface of the pure chitosan films. Despite the hydrophobic character that composite nanovesicles gave to the chitosan films, as showed by the reduction of the water permeation at prolonged times, there was a reduction on the contact angle values for these samples related to the roughness of the surface. The peak of water desorption observed on calorimetric analysis of chitosan was shifted to higher values when the nanovesicles were added to the films. Furthermore, the desappearance of T-g on the films containing nanovesicles denoted their plastifier effect in the chitosan film. The swelling results showed higher water diffusion at the first times for the films containing nanovesicles because of the pores observed by microscopy. However, at prolonged times, there was a reduction on the swelling because of the lipofilic composition of the nanovesicles. Furthermore, the presence of nanovesicles led to a reduction on the water content in the chitosan films. Due to the effect on the physical properties of the chitosan films, the addition of nanovesicles on discrete concentrations contributed to the cell adhesion.
C1 [Lionzo, Maria I. Z.; Lorenzini, Giulia C.; Tomedi, Joelson; Silveira, Nadya P.] Univ Fed Rio Grande do Sul, Inst Quim, BR-91501970 Porto Alegre, RS, Brazil.
   [Pranke, Patricia] Univ Fed Rio Grande do Sul, Fac Farm, BR-90610000 Porto Alegre, RS, Brazil.
RP Silveira, NP (reprint author), Univ Fed Rio Grande do Sul, Inst Quim, Av Bento Goncalves 9500,CP 15003, BR-91501970 Porto Alegre, RS, Brazil.
RI silveira, nadya/G-9970-2016; Lionzo, Maria/D-4170-2013
OI silveira, nadya/0000-0002-1556-7304; 
CR Argin-Soysal S, 2009, FOOD HYDROCOLLOID, V23, P202, DOI 10.1016/j.foodhyd.2007.12.011
   Burg K. L. J., 2000, BIOMATERIALS PRINCIP, P164
   Cao WL, 2005, J BIOMAT SCI-POLYM E, V16, P1379, DOI 10.1163/156856205774472308
   Denuziere A, 1996, CARBOHYD POLYM, V29, P317, DOI 10.1016/S0144-8617(96)00035-5
   Dhanikula A.B., 2004, AAPS J, V6, P1
   Fajardo AR, 2010, CARBOHYD POLYM, V80, P934, DOI 10.1016/j.carbpol.2010.01.009
   Freier T, 2005, BIOMATERIALS, V26, P5872, DOI 10.1016/j.biomaterials.2005.02.033
   Gupta MK, 2007, LANGMUIR, V23, P1315, DOI 10.1021/la062047p
   Kirker KR, 2002, BIOMATERIALS, V23, P3661, DOI 10.1016/S0142-9612(02)00100-X
   Kittur FS, 2002, CARBOHYD POLYM, V49, P185, DOI 10.1016/S0144-8617(01)00320-4
   Kommireddy DS, 2006, BIOMATERIALS, V27, P4296, DOI 10.1016/j.biomaterials.2006.03.042
   Lim SM, 2007, IFMBE PROC, V15, P94
   Lionzo MIZ, 2011, NANOCOSMETICS AND NANOMEDICINES: NEW APPROACHES FOR SKIN CARE, P163
   Mertins O, 2005, CHEM PHYS LIPIDS, V138, P29, DOI 10.1016/j.chemphyslip.2005.07.004
   Murray CA, 2006, BIOMACROMOLECULES, V7, P3460, DOI 10.1021/bm060416q
   Nair LS, 2007, PROG POLYM SCI, V32, P762, DOI 10.1016/j.progpolymsci.2007.05.017
   Nel AE, 2009, NAT MATER, V8, P543, DOI [10.1038/nmat2442, 10.1038/NMAT2442]
   Neto CGT, 2005, CARBOHYD POLYM, V62, P97, DOI 10.1016/j.carbpol.2005.02.022
   Park J. B., 2000, BIOMATERIALS PRINCIP, P225
   Ratajska M, 2003, FIBRES TEXT EAST EUR, V11, P75
   RAVIKUMAR MNV, 2000, REACT FUNCT POLYM, V46, P1
   Rinaudo M, 2006, PROG POLYM SCI, V31, P603, DOI 10.1016/j.progpolymsci.2006.06.001
   Rodrigues LB, 2009, INT J PHARM, V368, P1, DOI 10.1016/j.ijpharm.2008.09.047
   Thein-Han WW, 2009, ACTA BIOMATER, V5, P3453, DOI 10.1016/j.actbio.2009.05.012
   Toffey A, 2001, CELLULOSE, V8, P35, DOI 10.1023/A:1016695522968
   Toffey A, 1996, J APPL POLYM SCI, V60, P75, DOI 10.1002/(SICI)1097-4628(19960404)60:1<75::AID-APP9>3.0.CO;2-S
   Vargas M, 2009, FOOD HYDROCOLLOID, V23, P536, DOI 10.1016/j.foodhyd.2008.02.009
   WIESMAN B, 1999, Patent No. 5929050
   Yuan NY, 2008, DESALINATION, V234, P166, DOI 10.1016/j.desal.2007.09.083
   Zhao F, 2006, BIOMATERIALS, V27, P1859, DOI 10.1016/j.biomaterials.2005.09.031
NR 30
TC 11
Z9 11
U1 1
U2 11
PU AMER SCIENTIFIC PUBLISHERS
PI VALENCIA
PA 26650 THE OLD RD, STE 208, VALENCIA, CA 91381-0751 USA
SN 1550-7033
J9 J BIOMED NANOTECHNOL
JI J. Biomed. Nanotechnol.
PD APR
PY 2012
VL 8
IS 2
BP 337
EP 344
DI 10.1166/jbn.2012.1387
PG 8
WC Nanoscience & Nanotechnology; Materials Science, Biomaterials
SC Science & Technology - Other Topics; Materials Science
GA 926JX
UT WOS:000302828400018
PM 22515086
DA 2018-10-19
ER

PT J
AU Scarparo, RK
   Dondoni, L
   Bottcher, DE
   Grecca, FS
   Figueiredo, JAP
   Batista, EL
AF Scarparo, Roberta Kochenborger
   Dondoni, Lenara
   Boettcher, Daiana Elisabeth
   Grecca, Fabiana Soares
   Figueiredo, Jose A. P.
   Batista, Eraldo L., Jr.
TI Apical Periodontium Response to Enamel Matrix Derivative as an
   Intracanal Medication in Rat Immature Teeth with Pulp Necrosis:
   Radiographic and Histologic Findings
SO JOURNAL OF ENDODONTICS
LA English
DT Article
DE Apical; enamel matrix proteins; inflammation; nonvital teeth;
   odontogenesis; periodontium
ID STEM-CELLS; IN-VITRO; PORPHYROMONAS-GINGIVALIS; REPARATIVE DENTIN;
   CALCIUM HYDROXIDE; GROWTH; GEL; REVASCULARIZATION; REGENERATION;
   EMDOGAIN(R)
AB Introduction: The aim of this study was to evaluate the enamel matrix derivative (EMD) biomaterial in nonvital immature teeth. Methods: To arrest root development, pulpectomies were performed in the lower first molars of 36 4-week-old rats; the cavities were left exposed to the oral environment for 3 weeks. Then, chemical disinfection was performed, and triple antibiotic paste (TAP) or EMD was applied in the root canals. A control group did not receive any treatment. Radiographic and histological data were evaluated after 3 and 6 weeks. Results: At 3 weeks, TAP promoted a milder inflammatory response and increased root lengths compared with the control group. At 6 weeks, root development and reduced periapical lesions could be observed in both test groups, mainly because of the deposition of a cementum-like tissue. EMD promoted narrower canals compared with TAP (P < .05). Conclusions: EMD deserves attention as a potential tool in the treatment of nonvital immature teeth. The ingrowth of cementum-like tissues into canal spaces favored dental wall thickness and may contribute to tooth resistance and support. (J Endod 2012;38:449-453)
C1 [Scarparo, Roberta Kochenborger; Dondoni, Lenara; Figueiredo, Jose A. P.; Batista, Eraldo L., Jr.] Pontificia Univ Catolic Rio Grande do Sul, Porto Alegre, RS, Brazil.
   [Boettcher, Daiana Elisabeth; Grecca, Fabiana Soares] Univ Fed Rio Grande do Sul, Porto Alegre, RS, Brazil.
RP Batista, EL (reprint author), Av Ipiranga 66131 Bld 06, BR-90619900 Porto Alegre, RS, Brazil.
EM eraldo.junior@pucrs.br
RI Figueiredo, Jose Antonio/I-4805-2012; Bottcher, Daiana/H-7993-2012
OI Figueiredo, Jose Antonio/0000-0002-8876-5993; Bottcher,
   Daiana/0000-0002-6158-8384; Batista Junior, Eraldo/0000-0003-0429-3560
FU National Council for Scientific and Technological Development of Brazil
   (CNPq) Brasilia, Distrito Federal, Brazil
FX Supported by grants of the National Council for Scientific and
   Technological Development of Brazil (CNPq) Brasilia, Distrito Federal,
   Brazil.
CR da Silva LAB, 2010, ORAL SURG ORAL MED O, V109, P779, DOI 10.1016/j.tripleo.2009.12.046
   Bose R, 2009, J ENDODONT, V35, P1343, DOI 10.1016/j.joen.2009.06.021
   Boyan BD, 2000, J PERIODONTOL, V71, P1278, DOI 10.1902/jop.2000.71.8.1278
   Chueh LH, 2009, J ENDODONT, V35, P160, DOI 10.1016/j.joen.2008.10.019
   Chueh LH, 2006, J ENDODONT, V32, P1205, DOI 10.1016/j.joen.2006.07.010
   CVEK M, 1992, ENDOD DENT TRAUMATOL, V8, P45
   Ding RY, 2009, J ENDODONT, V35, P745, DOI 10.1016/j.joen.2009.02.009
   Gronthos S, 2002, J DENT RES, V81, P531, DOI 10.1177/154405910208100806
   Guven EP, 2011, J ENDODONT, V37, P650, DOI 10.1016/j.joen.2011.02.008
   Hammarstrom L, 1997, J CLIN PERIODONTOL, V24, P658, DOI 10.1111/j.1600-051X.1997.tb00247.x
   Huang GTJ, 2008, J ENDODONT, V34, P645, DOI 10.1016/j.joen.2008.03.001
   Igarashi R, 2003, J ELECTRON MICROSC, V52, P227, DOI 10.1093/jmicro/52.2.227
   Inaba H, 2004, J PERIODONTOL, V75, P858, DOI 10.1902/jop.2004.75.6.858
   Kemoun P, 2007, CELL TISSUE RES, V329, P283, DOI 10.1007/s00441-007-0397-3
   Khedmat S, 2010, J ENDODONT, V36, P100
   Lovelace TW, 2011, J ENDODONT, V37, P133, DOI 10.1016/j.joen.2010.10.009
   Lyngstadaas SP, 2009, ORTHOD CRANIOFAC RES, V12, P243, DOI 10.1111/j.1601-6343.2009.01459.x
   Mahl CRW, 2008, DENTOMAXILLOFAC RAD, V37, P224, DOI 10.1259/dmfr/32763038
   Nakamura Y, 2002, INT ENDOD J, V35, P407, DOI 10.1046/j.1365-2591.2002.00556.x
   Olsson H, 2005, INT ENDOD J, V38, P186, DOI 10.1111/j.1365-2591.2004.00932.x
   Sato S, 2008, J PERIODONTOL, V79, P535, DOI [10.1902/jop.2008.070311, 10.1902/jop.2008.070311 ]
   Scarparo RK, 2011, J ENDODONT, V37, P1069, DOI 10.1016/j.joen.2011.05.014
   Shiba H, 1998, J CELL PHYSIOL, V174, P194
   Sonoyama W, 2007, J DENT RES, V86, P594, DOI 10.1177/154405910708600703
   Sonoyama W, 2008, J ENDODONT, V34, P166, DOI 10.1016/j.joen.2007.11.021
   Spahr A, 2002, J CLIN PERIODONTOL, V29, P62, DOI 10.1034/j.1600-051x.2002.290110.x
   Suzuki S, 2005, J DENT RES, V84, P510, DOI 10.1177/154405910508400605
   Walter C, 2006, ARCH ORAL BIOL, V51, P171, DOI 10.1016/j.archoralbio.2005.07.005
   Wang XJ, 2010, J ENDODONT, V36, P56, DOI 10.1016/j.joen.2009.09.039
   Windley W, 2005, J ENDODONT, V31, P439, DOI 10.1097/01.don.0000148143.80283.ea
NR 30
TC 9
Z9 9
U1 1
U2 13
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0099-2399
J9 J ENDODONT
JI J. Endod.
PD APR
PY 2012
VL 38
IS 4
BP 449
EP 453
DI 10.1016/j.joen.2011.12.041
PG 5
WC Dentistry, Oral Surgery & Medicine
SC Dentistry, Oral Surgery & Medicine
GA 927QX
UT WOS:000302926200007
PM 22414828
DA 2018-10-19
ER

PT J
AU Lin, LC
   Chang, SJ
   Lin, CY
   Lin, YT
   Chuang, C
   Yao, CH
   Kuo, SM
AF Lin, Li-Chun
   Chang, Shwu Jen
   Lin, Chia Yun
   Lin, Yi Ting
   Chuang, ChinWen
   Yao, Chun-Hsu
   Kuo, Shyh Ming
TI Repair of Chondral Defects With Allogenous Chondrocyte-Seeded
   Hyaluronan/Collagen II Microspheres in a Rabbit Model
SO ARTIFICIAL ORGANS
LA English
DT Article
DE Glycosaminoglycan; Collagen; Microspheres; Allogenous; High-voltage
   electrostatic field; Chondral defect; Cartilage
ID TRI-COPOLYMER SCAFFOLD; CARTILAGE REGENERATION; HYDROGEL MICROSPHERES;
   IN-VITRO; COLLAGEN; GELATIN
AB Using a recently established method to prepare hyaluronan/collagen II (HA/Col II) microspheres for a novel biomaterial to couple with living cells/tissues, this animal model study evaluated the effects on a 4-week healing process of chondral defects by the implantation of allogenous chondrocyte-seeded HA/Col II microspheres that had been cultured in vitro for 7 days prior to implantation compared with unseeded HA/Col II microspheres or an untreated wound. Four weeks postsurgery, the untreated group's defect was filled with translucent soft tissue. At the same time, the edges and demarcation lines of the healing defects that were implanted with either HA/Col II microspheres or chondrocyte-seeded HA/Col II microspheres were infused yet recognizable. Furthermore, the new tissues were well integrated into the surrounding articular cartilage. Less glycosaminoglycan (GAG) staining was observed in the defects implanted with HA/Col II microspheres, which indicated that most of the repair tissues were derived from fibrocartilage formation. Conversely, more GAG staining appeared in the defect implanted with chondrocyte-seeded HA/Col II microspheres, which demonstrated a higher level of hyaline cartilage regeneration. Due to the short healing period assigned to this study, the repaired cartilage showed limited incorporation into the surrounding host cartilage and some loose connection to the subchondral bone.
C1 [Lin, Li-Chun; Chang, Shwu Jen; Lin, Chia Yun; Lin, Yi Ting; Kuo, Shyh Ming] I Shou Univ, Dept Biomed Engn, Kaohsiung 82445, Taiwan.
   [Lin, Li-Chun; Chuang, ChinWen] I Shou Univ, Dept Elect Engn, Kaohsiung, Taiwan.
   [Yao, Chun-Hsu] China Med Univ, Dept Biomed Imaging & Radiol Sci, Taichung, Taiwan.
RP Kuo, SM (reprint author), I Shou Univ, Dept Biomed Engn, Kaohsiung 82445, Taiwan.
EM chyao@mail.cmu.edu.tw; smkuo@isu.edu.tw
CR Chang CH, 2006, BIOMATERIALS, V27, P1876, DOI 10.1016/j.biomaterials.2005.10.014
   Chang CH, 2003, BIOMATERIALS, V24, P4853, DOI 10.1016/S0142-9612(03)00383-1
   Chang SJ, 2009, ACTA BIOMATER, V5, P101, DOI 10.1016/j.actbio.2008.08.002
   Elbert DL, 2011, ACTA BIOMATER, V7, P31, DOI 10.1016/j.actbio.2010.07.028
   Gavenis K, 2007, ARTIF ORGANS, V31, P91, DOI 10.1111/j.1525-1594.2007.00347.x
   Gavenis K, 2010, ARTIF ORGANS, V34, P79, DOI 10.1111/j.1525-1594.2009.00776.x
   Hsu SH, 2006, ARTIF ORGANS, V30, P42, DOI 10.1111/j.1525-1594.2006.00179.x
   Kuo SM, 2008, J MATER SCI-MATER M, V19, P1235, DOI 10.1007/s10856-007-3205-4
   Lee CR, 2003, J ORTHOPAED RES, V21, P272, DOI 10.1016/S0736-0266(02)00153-5
   Lin LC, 2008, J APPL POLYM SCI, V108, P3210, DOI 10.1002/app.27309
   Ohyabu Y, 2010, MATER SCI ENG B-ADV, V173, P204, DOI 10.1016/j.mseb.2009.12.008
   Singh M, 2010, ACTA BIOMATER, V6, P137, DOI 10.1016/j.actbio.2009.07.042
   Solchaga LA, 2005, OSTEOARTHR CARTILAGE, V13, P297, DOI 10.1016/j.joca.2004.12.016
   Tan HP, 2009, ACTA BIOMATER, V5, P328, DOI 10.1016/j.actbio.2008.07.030
   Ungaro F, 2006, J CONTROL RELEASE, V113, P128, DOI 10.1016/j.jconrel.2006.04.011
   Weng L, 2008, BIOMATERIALS, V29, P4149, DOI 10.1016/j.biomaterials.2008.07.026
NR 16
TC 7
Z9 7
U1 0
U2 11
PU WILEY-BLACKWELL
PI MALDEN
PA COMMERCE PLACE, 350 MAIN ST, MALDEN 02148, MA USA
SN 0160-564X
J9 ARTIF ORGANS
JI Artif. Organs
PD APR
PY 2012
VL 36
IS 4
BP E102
EP E109
DI 10.1111/j.1525-1594.2011.01370.x
PG 8
WC Engineering, Biomedical; Transplantation
SC Engineering; Transplantation
GA 923EF
UT WOS:000302601400003
PM 22145763
DA 2018-10-19
ER

PT J
AU Zhao, Z
   Chen, AZ
   Li, Y
   Hu, JY
   Liu, X
   Li, JS
   Zhang, Y
   Li, G
   Zheng, ZJ
AF Zhao, Zheng
   Chen, Aizheng
   Li, Yi
   Hu, Junyan
   Liu, Xuan
   Li, Jiashen
   Zhang, Yu
   Li, Gang
   Zheng, Zijian
TI Fabrication of silk fibroin nanoparticles for controlled drug delivery
SO JOURNAL OF NANOPARTICLE RESEARCH
LA English
DT Article
DE Silk fibroin; Nanoparticles; Supercritical CO2; Indomethacin; Drug
   delivery
ID SOLUTION-ENHANCED DISPERSION; SUPERCRITICAL FLUIDS; SEDS PROCESS;
   INDOMETHACIN; CYTOTOXICITY; MICROSPHERES; BIOMATERIAL; SCAFFOLDS;
   HYDROGELS; RELEASE
AB A novel solution-enhanced dispersion by supercritical CO2 (SEDS) was employed to prepare silk fibroin (SF) nanoparticles. The resulting SF nanoparticles exhibited a good spherical shape, a smooth surface, and a narrow particle size distribution with a mean particle diameter of about 50 nm. The results of X-ray powder diffraction, thermo gravimetry-differential scanning calorimetry, and Fourier transform infrared spectroscopy analysis of the SF nanoparticles before and after ethanol treatment indicated conformation transition of SF nanoparticles from random coil to beta-sheet form and thus water insolubility. The MTS assay also suggested that the SF nanoparticles after ethanol treatment imposed no toxicity. A non-steroidal anti-inflammatory drug, indomethacin (IDMC), was chosen as the model drug and was encapsulated in SF nanoparticles by the SEDS process. The resulting IDMC-SF nanoparticles, after ethanol treatment, possessed a theoretical average drug load of 20%, an actual drug load of 2.05%, and an encapsulation efficiency of 10.23%. In vitro IDMC release from the IDMC-SF nanoparticles after ethanol treatment showed a significantly sustained release over 2 days. These studies of SF nanoparticles indicated the suitability of the SF nanoparticles prepared by the SEDS process as a biocompatible carrier to deliver drugs and also the feasibility of using the SEDS process to reach the goal of co-precipitation of drug and SF as composite nanoparticles for controlled drug delivery.
C1 [Zhao, Zheng; Chen, Aizheng; Li, Yi; Hu, Junyan; Liu, Xuan; Li, Jiashen; Zhang, Yu; Li, Gang; Zheng, Zijian] Hong Kong Polytech Univ, Inst Text & Clothing, Kowloon, Hong Kong, Peoples R China.
   [Chen, Aizheng] Huaqiao Univ, Coll Chem Engn, Xiamen 361021, Fujian, Peoples R China.
RP Li, Y (reprint author), Hong Kong Polytech Univ, Inst Text & Clothing, Kowloon, Hong Kong, Peoples R China.
EM tcliyi@polyu.edu.hk
RI HU, Junyan/J-7323-2012; Liu, Xuan/J-7367-2012; ZHENG,
   ZIJIAN/B-4012-2009; Li, Jiashen/E-8571-2015; LI, YI/G-4421-2012; Li,
   Jiashen/J-6946-2012; Zhao, Zheng/K-7150-2012; Zhang, Yu/J-9587-2012
OI ZHENG, ZIJIAN/0000-0002-6653-7594; LI, YI/0000-0002-2092-4505; Li,
   Jiashen/0000-0001-7333-5280; Zhang, Yu/0000-0001-6751-9294
FU Hong Kong Innovation and Technology Commission; Hong Kong Research
   Institute of Textile and Apparel [ITP/001/07TP, ITP/031/08TP]; Hong Kong
   Research Grant Council; Hong Kong Polytechnic University [PolyU5242/09E,
   G-YX1M, J-BB6Q, GU942]; Guangdong Provincial Department of Science and
   Technology through the Guangdong-Hong Kong International Textile
   Bioengineering Joint Research Center [2011B050300023]; Hong Kong Jockey
   Club Sports Medicine and Health Science Center
FX We would like to thank Hong Kong Innovation and Technology Commission
   and Hong Kong Research Institute of Textile and Apparel for providing
   funding support to this research through projects ITP/001/07TP,
   ITP/031/08TP, the Hong Kong Research Grant Council and the Hong Kong
   Polytechnic University through projects PolyU5242/09E, G-YX1M, J-BB6Q
   and GU942. Also, we would like to thank the support of Guangdong
   Provincial Department of Science and Technology through the
   Guangdong-Hong Kong International Textile Bioengineering Joint Research
   Center with project code 2011B050300023, as well as the sponsorship from
   Hong Kong Jockey Club Sports Medicine and Health Science Center.
CR Amiraliyan N, 2010, POLYM SCI SER A+, V52, P407, DOI 10.1134/S0965545X10040097
   Berthold A, 1996, J CONTROL RELEASE, V39, P17, DOI 10.1016/0168-3659(95)00129-8
   Blasig A, 2002, IND ENG CHEM RES, V41, P4976, DOI 10.1021/ie0201819
   Cao ZB, 2007, SOFT MATTER, V3, P910, DOI 10.1039/b703139d
   Chen AZ, 2006, MACROMOL RAPID COMM, V27, P1254, DOI 10.1002/marc.200600221
   Chen AZ, 2009, ACTA BIOMATER, V5, P2913, DOI 10.1016/j.actbio.2009.04.032
   Chen L, 2007, J NANOPART RES, V9, P777, DOI 10.1007/s11051-006-9103-8
   Chong EJ, 2007, ACTA BIOMATER, V3, P321, DOI 10.1016/j.actbio.2007.01.002
   Daamen WF, 2007, BIOMATERIALS, V28, P4378, DOI 10.1016/j.biomaterials.2007.06.025
   Grande CJ, 2009, ACTA BIOMATER, V5, P1605, DOI 10.1016/j.actbio.2009.01.022
   Jiao HS, 2009, BIOMATERIALS, V30, P5004, DOI 10.1016/j.biomaterials.2009.05.059
   Kang YQ, 2008, EUR J PHARM BIOPHARM, V70, P85, DOI 10.1016/j.ejpb.2008.03.011
   Kang YQ, 2008, J COLLOID INTERF SCI, V322, P87, DOI 10.1016/j.jcis.2008.02.031
   Kim UJ, 2005, BIOMATERIALS, V26, P2775, DOI 10.1016/j.biomaterials.2004.07.044
   Kim UJ, 2004, BIOMACROMOLECULES, V5, P786, DOI 10.1021/bm0345460
   Kundu J, 2010, INT J PHARMACEUT, V388, P242, DOI 10.1016/j.ijpharm.2009.12.052
   Kundu J, 2008, MAT SCI ENG C-BIO S, V28, P1376, DOI 10.1016/j.msec.2008.03.004
   Lewinski N, 2008, SMALL, V4, P26, DOI 10.1002/smll.200700595
   Liu LX, 2010, J NANOPART RES, V12, P1637, DOI 10.1007/s11051-009-9722-y
   Marelli B, 2010, ACTA BIOMATER, V6, P4019, DOI 10.1016/j.actbio.2010.05.008
   Marques AP, 2005, J MATER SCI-MATER M, V16, P833, DOI 10.1007/s10856-005-3580-7
   MECLEAN S, 1998, EUR J PHARM SCI, V6, P153
   Nam K, 2010, ACTA BIOMATER, V6, P403, DOI 10.1016/j.actbio.2009.06.021
   Nazarov R, 2004, BIOMACROMOLECULES, V5, P718, DOI 10.1021/bm034327e
   Panyam J, 2002, DRUG DELIV REV, V55, P329
   Pyo D, 2009, B KOREAN CHEM SOC, V30, P1215
   Rodrigues M, 2004, J SUPERCRIT FLUID, V29, P175, DOI 10.1016/S0896-8446(03)00034-2
   Rohanizadeh R, 2009, J MATER SCI-MATER M, V20, P2413, DOI 10.1007/s10856-009-3819-9
   SCHAFER V, 1992, PHARMACEUT RES, V9, P541, DOI 10.1023/A:1015852732512
   Shao ZZ, 2002, NATURE, V418, P741, DOI 10.1038/418741a
   Sundar S, 2010, SCI TECHNOL ADV MAT, V11, DOI 10.1088/1468-6996/11/1/014104
   Suo QL, 2005, POWDER TECHNOL, V154, P110, DOI 10.1016/j.powtec.2005.05.001
   Tan HP, 2009, BIOMATERIALS, V30, P2499, DOI 10.1016/j.biomaterials.2008.12.080
   Vlugt-Wensink KDF, 2007, PHARM RES, V24, P2239, DOI 10.1007/s11095-007-9433-y
   Wenk E, 2008, J CONTROL RELEASE, V132, P26, DOI 10.1016/j.jconrel.2008.08.005
   Yan HB, 2009, J NANOPART RES, V11, P1937, DOI 10.1007/s11051-008-9549-y
   Yang LQ, 2008, MACROMOL BIOSCI, V8, P279, DOI 10.1002/mabi.200700186
   Yeo SD, 2005, J SUPERCRIT FLUID, V34, P287, DOI 10.1016/j.supflu.2004.10.006
   Zhang F, 2009, J MATER SCI, V44, P5682, DOI 10.1007/s10853-009-3800-5
   Zhang JX, 2007, PHARM RES, V24, P1944, DOI 10.1007/s11095-007-9322-4
   Zhang XD, 2009, INT J NANOMED, V4, P165
   Zhang YQ, 2010, ACTA BIOMATER, V6, P2045, DOI 10.1016/j.actbio.2009.11.035
   Zhang YQ, 2007, J NANOPART RES, V9, P885, DOI 10.1007/s11051-006-9162-x
   Zhao XH, 2010, J SUPERCRIT FLUID, V51, P412, DOI 10.1016/j.supflu.2009.10.004
   Zhou CZ, 2000, NUCLEIC ACIDS RES, V28, P2413, DOI 10.1093/nar/28.12.2413
NR 45
TC 25
Z9 27
U1 1
U2 99
PU SPRINGER
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 1388-0764
J9 J NANOPART RES
JI J. Nanopart. Res.
PD APR
PY 2012
VL 14
IS 4
AR 736
DI 10.1007/s11051-012-0736-5
PG 10
WC Chemistry, Multidisciplinary; Nanoscience & Nanotechnology; Materials
   Science, Multidisciplinary
SC Chemistry; Science & Technology - Other Topics; Materials Science
GA 923TA
UT WOS:000302641000002
DA 2018-10-19
ER

PT J
AU Cui, CX
   Gao, X
   Qi, YM
   Liu, SJ
   Sun, JB
AF Cui, C. X.
   Gao, X.
   Qi, Y. M.
   Liu, S. J.
   Sun, J. B.
TI Microstructure and antibacterial property of in situ TiO2 nanotube
   layers/titanium biocomposites
SO JOURNAL OF THE MECHANICAL BEHAVIOR OF BIOMEDICAL MATERIALS
LA English
DT Article
DE Metal-matrix composites (MMCs); Surface treatments;
   Scanning/transmission electron microscopy (STEM); Chemical vapor
   deposition (CVD); Antibacterial property
ID ARRAYS
AB The TiO2 nanotube layer was in situ synthesized on the surface of pure titanium by the electrochemical anodic oxidation. The diameter of nano-TiO2 nanotubes was about 70 similar to 100 nm. The surface morphology and phase compositions of TiO2 nanotube layers were observed and analyzed using the scanning electron microscope (SEM). The important processing parameters, including anodizing voltage, reaction time, concentration of electrolyte, were optimized in more detail. The photocatalytic activity of the nano-TiO2 nanotube layers prepared with optimal conditions was evaluated via the photodegradation of methylthionine in aqueous solution. The antibacterial property of TiO2 nanotube layers prepared with optimal conditions was evaluated by inoculating Streptococcus mutans on the TiO2 nanotube layers in vitro. The results showed that TiO2 nanotube layers/Ti biocomposites had very good antibacterial activity to resist Streptococcus mutans. As a dental implant biomaterial, in situ TiO2 nanotube layer/Ti biocomposite has better and wider application prospects. (C) 2012 Elsevier Ltd. All rights reserved.
C1 [Cui, C. X.] Hebei Univ Technol, Key Lab New Types Funct Mat, Sch Mat Sci & Engn, Tianjin 300130, Peoples R China.
RP Cui, CX (reprint author), Hebei Univ Technol, Key Lab New Types Funct Mat, Sch Mat Sci & Engn, Tianjin 300130, Peoples R China.
EM hutcui@hebut.edu.cn
RI 樊, 樊亚琴/E-7242-2015
FU National Science and Technology Program International Collaborative
   Research Project [2010DFA51920]; Key Project of Foundation Research in
   Hebei Province [11965151D]; Key Project of Scientific and Technological
   Support in Tianjin [09ZCKFX03800]; Science and Technology Support
   Project in Hebei Province [09215102D]; Natural Science Foundation in
   Hebei Province [E2010000125, E2009000102]
FX The research work in this manuscript was supported by the National
   Science and Technology Program International Collaborative Research
   Project, No. 2010DFA51920, Key Project of Foundation Research in Hebei
   Province, No. 11965151D, Key Project of Scientific and Technological
   Support in Tianjin, No. 09ZCKFX03800, Science and Technology Support
   Project in Hebei Province, No. 09215102D, and Natural Science Foundation
   Project in Hebei Province, No. E2010000125 and No. E2009000102.
CR Bianco P, 2000, J CLIN INVEST, V105, P1663, DOI 10.1172/JCI10413
   Gong D, 2001, J MATER RES, V16, P3331, DOI 10.1557/JMR.2001.0457
   Ketul C P, 2007, BIOMATERIALS, V28, P4880
   Liang HC, 2009, J HAZARD MATER, V162, P1415, DOI 10.1016/j.jhazmat.2008.06.033
   Mahata S, 2009, MATER SCI-POLAND, V27, P463
   Miaoa L., 2004, APPL SURF SCI, V238, P125
   Mor G.K., 2005, ADV FUNCT MATER, V15, P1343
   Popat KC, 2005, BIOMATERIALS, V26, P4516, DOI 10.1016/j.biomaterials.2004.11.026
   Richter C, 2009, J MATER CHEM, V19, P2963, DOI 10.1039/b822501j
   Varghese O.K., 2003, J MATER RES, V18, P155
   Wang H, 2009, MATER SCI FORUM, V610-613, P288, DOI 10.4028/www.scientific.net/MSF.610-613.288
   Wang WP, 2008, KEY ENG MATER, V375-376, P353, DOI 10.4028/www.scientific.net/KEM.375-376.353
   Webster TJ, 2003, AM CERAMIC SOC B, V82, P1
NR 13
TC 8
Z9 8
U1 1
U2 39
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 1751-6161
J9 J MECH BEHAV BIOMED
JI J. Mech. Behav. Biomed. Mater.
PD APR
PY 2012
VL 8
BP 178
EP 183
DI 10.1016/j.jmbbm.2012.01.004
PG 6
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 922ZA
UT WOS:000302586300016
PM 22402164
DA 2018-10-19
ER

PT J
AU Mathieu, V
   Vayron, R
   Barthel, E
   Dalmas, D
   Soffer, E
   Anagnostou, F
   Haiat, G
AF Mathieu, Vincent
   Vayron, Romain
   Barthel, Etienne
   Dalmas, Davy
   Soffer, Emmanuel
   Anagnostou, Fani
   Haiat, Guillaume
TI Mode III cleavage of a coin-shaped titanium implant in bone: Effect of
   friction and crack propagation
SO JOURNAL OF THE MECHANICAL BEHAVIOR OF BIOMEDICAL MATERIALS
LA English
DT Article
DE Bone; Implant; Osseointegration; Mode III; Cleavage
ID INTERFACE SHEAR MODULUS; EXPERIMENTAL IN-VIVO; PUSH-OUT TEST;
   BIOMECHANICAL CHARACTERIZATION; ADHESIVE CONTACT; CORTICAL BONE;
   COMPACT-BONE; HISTOMORPHOMETRIC ANALYSIS; OSSEOINTEGRATED IMPLANTS;
   COATED IMPLANTS
AB Endosseous cementless implants are widely used in orthopaedic, maxillofacial and oral surgery. However, failures are still observed and remain difficult to anticipate as remodelling phenomena at the bone-implant interface are poorly understood. The assessment of the biomechanical strength of the bone-implant interface may improve the understanding of the osseointegration process.
   An experimental approach based on a mode III cleavage mechanical device aims at understanding the behaviour of a planar bone-implant interface submitted to torsional loading. To do so, coin-shaped titanium implants were inserted on the tibiae of a New Zealand white rabbit for seven weeks. After the sacrifice, mode III cleavage experiments were performed on bone samples. An analytical model was developed to understand the debonding process of the bone-implant interface. The model allowed to assess the values of different parameters related to bone tissue at the vicinity of the implant with the additional assumption that bone adhesion occurs over around 70% of the implant surface, which is confirmed by microscopy images. The approach allows to estimate different quantities related to the bone-implant interface such as: torsional stiffness (around 20.5 N m rad(-1)), shear modulus (around 240 MPa), maximal torsional loading (around 0.056 N.m), mode III fracture energy (around 77.5 N m(-1)) and stress intensity factor (0.27 MPa m(1/2)).
   This study paves the way for the use of mode III cleavage testing for the investigation of torsional loading strength of the bone-implant interface, which might help for the development and optimization of implant biomaterial, surface treatment and medical treatment investigations. (C) 2012 Elsevier Ltd. All rights reserved.
C1 [Vayron, Romain; Haiat, Guillaume] Univ Paris Est, CNRS, Lab Modelisat & Simulat Multiechelle, UMR 8208, F-94010 Creteil, France.
   [Mathieu, Vincent; Soffer, Emmanuel; Anagnostou, Fani] Univ Paris Diderot, CNRS, Lab Biomecan Biomat Osteo Articulaire, UMR 7052, F-75010 Paris, France.
   [Barthel, Etienne; Dalmas, Davy] CNRS, Lab Surface Verre & Interfaces, UMR 125, F-93303 Aubervilliers, France.
   [Soffer, Emmanuel; Anagnostou, Fani] Univ Paris 07, Pitie Salpetriere Hosp, AP HP, Dept Periodontol,Serv Odontol,UFR Odontol, F-75006 Paris, France.
RP Haiat, G (reprint author), Univ Paris Est, CNRS, Lab Modelisat & Simulat Multiechelle, UMR 8208, 61 Ave Gen Gaulle, F-94010 Creteil, France.
EM guillaume.haiat@univ-paris-est.fr
OI Anagnostou, Fani/0000-0002-0065-2127
FU Direction Generale de l'Armement; Centre National de la Recherche
   Scientifique; ED SIE of Universite Paris-Est; Institut des sciences de
   l'ingenierie et des systemes (INSIS) of the CNRS through a PEPS; French
   National Research Agency (ANR) through EMERGENCE [ANR-11-EMMA-039];
   Centre Francilien de l'Innovation and OSEO through the Aima Laboratoire
FX The authors acknowledge the support of the Direction Generale de
   l'Armement and of the Centre National de la Recherche Scientifique
   through the Ph.D. study of VM. The support of the ED SIE of Universite
   Paris-Est is also acknowledged. The authors acknowledge the support of
   the Institut des sciences de l'ingenierie et des systemes (INSIS) of the
   CNRS through a PEPS funding for the project "BioMatSon". This work has
   been supported by French National Research Agency (ANR) through
   EMERGENCE program (project Wave Implant n<SUP>o</SUP>ANR-11-EMMA-039)
   and by the Centre Francilien de l'Innovation and OSEO through the Aima
   Laboratoire funding.
CR ALBREKTSSON T, 1988, J PERIODONTOL, V59, P287, DOI 10.1902/jop.1988.59.5.287
   Barthel E, 1998, J COLLOID INTERF SCI, V200, P7, DOI 10.1006/jcis.1997.5309
   Basire C, 1999, EUR PHYS J-APPL PHYS, V6, P323, DOI 10.1051/epjap:1999190
   Berzins A, 1997, J BIOMED MATER RES, V34, P337
   Bhushan B, 2003, J VAC SCI TECHNOL B, V21, P2262, DOI 10.1116/1.1627336
   Bowden F.P., 2001, FRICTION LUBRIFICATI, V1
   Branemark R, 1998, J ORTHOPAED RES, V16, P61, DOI 10.1002/jor.1100160111
   Branemark R, 1998, MED ENG PHYS, V20, P216, DOI 10.1016/S1350-4533(98)00023-X
   Branemark R, 1997, BIOMATERIALS, V18, P969, DOI 10.1016/S0142-9612(97)00018-5
   Buser D, 1996, CLIN ORAL IMPLAN RES, V7, P175, DOI 10.1034/j.1600-0501.1996.070212.x
   Butz F, 2006, J DENT RES, V85, P560, DOI 10.1177/154405910608500616
   Chateauminois A., 2010, PHYS REV E, V81, P12
   COOK SD, 1995, J ARTHROPLASTY, V10, P351, DOI 10.1016/S0883-5403(05)80184-6
   de Moura MFSF, 2008, ENG FRACT MECH, V75, P3852, DOI 10.1016/j.engfracmech.2008.02.006
   Duyck J, 2006, ARCH ORAL BIOL, V51, P1, DOI 10.1016/j.archoralbio.2005.04.003
   Edwards JT, 1997, J BIOMED MATER RES, V36, P454
   Ehart RJA, 1999, WOOD SCI TECHNOL, V33, P391, DOI 10.1007/s002260050125
   Ellingsen J.E., 2000, J PERIODONTOL, V17, P36
   Franchi M, 2007, J PERIODONTOL, V78, P879, DOI 10.1902/jop.2007.060280
   Giavaresi G, 2003, BIOMATERIALS, V24, P1583, DOI 10.1016/S0142-9612(02)00548-3
   GODDENHENRICH T, 1994, REV SCI INSTRUM, V65, P2870, DOI 10.1063/1.1144630
   Goodacre CJ, 1999, J PROSTHET DENT, V81, P537, DOI 10.1016/S0022-3913(99)70208-8
   Gotfredsen K, 2001, CLIN ORAL IMPLAN RES, V12, P552, DOI 10.1034/j.1600-0501.2001.120602.x
   Haiat G, 2003, J MECH PHYS SOLIDS, V51, P69, DOI 10.1016/S0022-5096(02)00059-5
   Haiat G, 2007, LANGMUIR, V23, P11643, DOI 10.1021/la701560n
   JAGER J, 1995, ARCH APPL MECH, V65, P478, DOI 10.1007/BF00835661
   Jinno T, 1998, J BIOMED MATER RES, V42, P20, DOI 10.1002/(SICI)1097-4636(199810)42:1<20::AID-JBM4>3.0.CO;2-Q
   Johansson L, 1999, WOOD SCI TECHNOL, V33, P43, DOI 10.1007/s002260050097
   Johnson KL, 1997, J COLLOID INTERF SCI, V192, P326, DOI 10.1006/jcis.1997.4984
   Johnson KL, 1997, P ROY SOC A-MATH PHY, V453, P163, DOI 10.1098/rspa.1997.0010
   Koester KJ, 2011, J MECH BEHAV BIOMED, V4, P1504, DOI 10.1016/j.jmbbm.2011.05.020
   Laugier P, 2011, BONE QUANTITATIVE ULTRASOUND, P1, DOI 10.1007/978-94-007-0017-8
   Marin C, 2010, J MECH BEHAV BIOMED, V3, P382, DOI 10.1016/j.jmbbm.2010.02.002
   Mathieu V, ULTRASOUND IN PRESS
   Mathieu V, 2011, J ACOUST SOC AM, V129, P4062, DOI 10.1121/1.3586788
   Mathieu V, 2011, J BIOMECH ENG-T ASME, V133, DOI 10.1115/1.4003131
   Mathieu V, 2011, ULTRASOUND MED BIOL, V37, P262, DOI 10.1016/j.ultrasmedbio.2010.10.008
   MAUGIS D, 1992, J COLLOID INTERF SCI, V150, P243, DOI 10.1016/0021-9797(92)90285-T
   Maugis D, 1999, CONTACT ADHESION RUP
   Maugis D., 2000, FRICTIONLESS ELASTIC, P236
   Miller MA, 2011, J MECH BEHAV BIOMED, V4, P366, DOI 10.1016/j.jmbbm.2010.11.004
   Morais JJL, 2010, J MECH BEHAV BIOMED, V3, P446, DOI 10.1016/j.jmbbm.2010.04.001
   Muller M, 2006, J BIOMECH, V39, P2123, DOI 10.1016/j.jbiomech.2005.05.036
   NAKAMURA T, 1985, J BIOMED MATER RES, V19, P685, DOI 10.1002/jbm.820190608
   O'Brien FJ, 2003, J BIOMECH, V36, P973, DOI 10.1016/S0021-9290(03)00066-6
   O'Brien FJ, 2002, J BIOMECH, V35, P523, DOI 10.1016/S0021-9290(01)00200-7
   Ogawa T, 2000, J DENT RES, V79, P1857, DOI 10.1177/00220345000790110701
   Ogiso M, 1998, J BIOMED MATER RES, V39, P364
   Orlik J, 2003, MED ENG PHYS, V25, P825, DOI 10.1016/S1350-4533(03)00099-7
   Pattijn V, 2007, MED ENG PHYS, V29, P182, DOI 10.1016/j.medengphy.2006.02.010
   Ronold HJ, 2003, BIOMATERIALS, V24, P4559, DOI 10.1016/S0142-9612(03)00256-4
   Ronold HJ, 2003, J BIOMED MATER RES A, V67A, P524, DOI 10.1002/jbm.a.10580
   Ronold HJ, 2003, J MATER SCI-MATER M, V14, P843, DOI 10.1023/A:1025622407727
   Ronold HJ, 2002, BIOMATERIALS, V23, P2201, DOI 10.1016/S0142-9612(01)00353-2
   Ronold HJ, 2002, BIOMATERIALS, V23, P4211, DOI 10.1016/S0142-9612(02)00167-9
   ROYER D, 1996, ELASTIC WAVES SOLIDS, V1
   Schwartz Z., 2005, SURFACE MICROTOPOGRA
   Seong WJ, 2009, J PROSTHET DENT, V101, P306, DOI 10.1016/S0022-3913(09)60062-7
   Shalabi MM, 2006, J DENT RES, V85, P496, DOI 10.1177/154405910608500603
   SHIRAZIADL A, 1992, J BIOMECH ENG-T ASME, V114, P111, DOI 10.1115/1.2895434
   Skripitz R, 1999, BIOMATERIALS, V20, P351, DOI 10.1016/S0142-9612(98)00175-6
   Skripitz R, 1998, ACTA ORTHOP SCAND, V69, P315, DOI 10.3109/17453679809000938
   Soncini M, 2002, BIOMATERIALS, V23, P9, DOI 10.1016/S0142-9612(01)00073-4
   Stoppie N., 2008, J BIOMED MATER RES A, V9, P9
   Taborelli M, 1997, CLIN ORAL IMPLAN RES, V8, P208, DOI 10.1034/j.1600-0501.1997.080307.x
   Taylor D, 2003, J BIOMECH, V36, P1103, DOI 10.1016/S0021-9290(03)00104-0
   Vercaigne S, 1998, J BIOMED MATER RES, V41, P41, DOI 10.1002/(SICI)1097-4636(199807)41:1<41::AID-JBM5>3.0.CO;2-Q
   Younesi M, 2010, J MECH BEHAV BIOMED, V3, P178, DOI 10.1016/j.jmbbm.2009.08.003
   Zimmermann EA, 2010, BIOMATERIALS, V31, P5297, DOI 10.1016/j.biomaterials.2010.03.056
   Zimmermann EA, 2009, BIOMATERIALS, V30, P5877, DOI 10.1016/j.biomaterials.2009.06.017
NR 70
TC 11
Z9 11
U1 0
U2 10
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 1751-6161
J9 J MECH BEHAV BIOMED
JI J. Mech. Behav. Biomed. Mater.
PD APR
PY 2012
VL 8
BP 194
EP 203
DI 10.1016/j.jmbbm.2011.12.012
PG 10
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 922ZA
UT WOS:000302586300018
PM 22402166
DA 2018-10-19
ER

PT J
AU Bohm, I
   Strotmann, F
   Koopmans, C
   Wolf, I
   Galla, HJ
   Ritter, H
AF Boehm, Indra
   Strotmann, Falko
   Koopmans, Carsten
   Wolf, Isabel
   Galla, Hans-Joachim
   Ritter, Helmut
TI Two-Component In situ Forming Supramolecular Hydrogels as Advanced
   Biomaterials in Vitreous Body Surgery
SO MACROMOLECULAR BIOSCIENCE
LA English
DT Article
DE biocompatibility; cell morphology; cyclodextrin; host-guest hydrogel;
   membrane interaction; vitreous body
ID BEARING ADAMANTYL GROUPS; HOST-GUEST INTERACTIONS; CYCLODEXTRIN;
   POLYMERS; COPOLYMERS; SOLUBILITY; WATER
AB Polymeric beta-CD and poly{(2-acrylamido-2-methyl-1-propanesulfonic acid sodium salt)-co-[6-(acrylamido)-N-adamantylhexaneamide]} are synthesized to build in situ forming hydrogels based on host/guest interactions, so called physical hydrogels. The use of these hydrogels as a potential vitreous body substitute is discussed and recommended. Potential changes in cell morphology and cell vitality of the retinal ganglion cell line RGC-5 are determined. DSC experiments with artificial membrane structures are performed. The analyses show that beta-CD overrides the harmful effects of the highly toxic adamantyl-modified polymer. Although the final hydrogel is considered to be biocompatible, the application as a biomaterial has to be reconsidered.
C1 [Boehm, Indra; Koopmans, Carsten; Ritter, Helmut] Univ Dusseldorf, Inst Organ Chem & Macromol Chem 2, D-40225 Dusseldorf, Germany.
   [Strotmann, Falko; Wolf, Isabel; Galla, Hans-Joachim] Univ Munster, Inst Biochem, D-48149 Munster, Germany.
RP Ritter, H (reprint author), Univ Dusseldorf, Inst Organ Chem & Macromol Chem 2, Univ Str 1, D-40225 Dusseldorf, Germany.
EM H.Ritter@uni-duesseldorf.de
CR ALBERTINI G, 1990, CHEM PHYS LIPIDS, V55, P331, DOI 10.1016/0009-3084(90)90171-M
   Berridge MV, 2005, BIOTECHNOL ANN REV, V11, P127, DOI 10.1016/S1387-2656(05)11004-7
   Bihonen R. L., 1993, CHEM PHYS LIPIDS, V64, P128
   Bishop PN, 2000, PROG RETIN EYE RES, V19, P323, DOI 10.1016/S1350-9462(99)00016-6
   Chirila TV, 1998, PROG POLYM SCI, V23, P475, DOI 10.1016/S0079-6700(97)00045-2
   Choi S. W., 2004, J MACROMOL SCI CHEM, V42, P321, DOI DOI 10.1081/MA-200050463
   Dalton PD, 1995, POLYM GELS NETW, V3, P429, DOI 10.1016/0966-7822(94)00011-5
   DEMEL R A, 1976, Biochimica et Biophysica Acta, V457, P109, DOI 10.1016/0304-4157(76)90008-3
   Haag R, 2004, ANGEW CHEM INT EDIT, V43, P278, DOI 10.1002/anie.200301694
   Koopmans C, 2008, MACROMOLECULES, V41, P7418, DOI 10.1021/ma801202f
   Kopecek J, 2007, BIOMATERIALS, V28, P5185, DOI 10.1016/j.biomaterials.2007.07.044
   Kretschmann O, 2006, ANGEW CHEM INT EDIT, V45, P4361, DOI 10.1002/anie.200504539
   Kretschmann O, 2007, ANGEW CHEM INT EDIT, V46, P2708, DOI 10.1002/anie.200603753
   Krishnamoorthy RR, 2001, MOL BRAIN RES, V86, P1, DOI 10.1016/S0169-328X(00)00224-2
   Micali N, 2006, NANOTECHNOLOGY, V17, P3239, DOI 10.1088/0957-4484/17/13/027
   NAGLE JF, 1980, ANNU REV PHYS CHEM, V31, P157, DOI 10.1146/annurev.pc.31.100180.001105
   PIXTON MR, 1995, POLYMER, V36, P3165, DOI 10.1016/0032-3861(95)97880-O
   Schmitz S, 2005, ANGEW CHEM INT EDIT, V44, P5658, DOI 10.1002/anie.200501374
   Schmitz S, 2007, MACROMOL RAPID COMM, V28, P2080, DOI 10.1002/marc.200700378
   Strotmann F, 2011, ADV ENG MATER, V13, pB172, DOI 10.1002/adem.201080104
   Swindle K. E., 2007, EXP REV OPHTHALMOL, V2, P255
   Venault Antoine, 2010, International Journal of Chemical Reactor Engineering, V8
   Zidovetzki R, 2007, BBA-BIOMEMBRANES, V1768, P1311, DOI 10.1016/j.bbamen.2007.03.026
NR 23
TC 6
Z9 8
U1 3
U2 38
PU WILEY-V C H VERLAG GMBH
PI WEINHEIM
PA PO BOX 10 11 61, D-69451 WEINHEIM, GERMANY
SN 1616-5187
J9 MACROMOL BIOSCI
JI Macromol. Biosci.
PD APR
PY 2012
VL 12
IS 4
BP 432
EP 437
DI 10.1002/mabi.201100357
PG 6
WC Biochemistry & Molecular Biology; Materials Science, Biomaterials;
   Polymer Science
SC Biochemistry & Molecular Biology; Materials Science; Polymer Science
GA 923MA
UT WOS:000302622200003
PM 22323438
DA 2018-10-19
ER

PT J
AU Matesanz, MD
   Feito, MJ
   Ramirez-Santillan, C
   Lozano, RM
   Sanchez-Salcedo, S
   Arcos, D
   Vallet-Regi, M
   Portoles, MT
AF de la Concepcion Matesanz, Maria
   Jose Feito, Maria
   Ramirez-Santillan, Cecilia
   Maria Lozano, Rosa
   Sanchez-Salcedo, Sandra
   Arcos, Daniel
   Vallet-Regi, Maria
   Portoles, Maria-Teresa
TI Signaling Pathways of Immobilized FGF-2 on Silicon-Substituted
   Hydroxyapatite
SO MACROMOLECULAR BIOSCIENCE
LA English
DT Article
DE basic fibroblast growth factors; biomaterials; molecular recognition;
   osteoblasts; tissue engineering
ID FIBROBLAST-GROWTH-FACTOR; OSTEOBLAST DIFFERENTIATION; IN-VITRO;
   SCAFFOLDS; BIOCERAMICS; RESPONSES; PROTEIN; VIVO
AB Therapeutic strategies for bone regeneration involve the selection of suitable biomaterials, growth factors, and cell types to mimic the cellular microenvironment where molecular and mechanical signals control the reconstruction of bone tissue. The immobilization of basic fibroblast growth factor (FGF-2) on powdered silicon-substituted hydroxyapatite (Si-HA) allows to prepare a biofunctional biomaterial able to interact with bone cells in a very specific way. The biological activity of FGF-2/Si-HA, evaluated in Saos-2 osteoblasts and MC3T3-E1 preosteoblasts through the PLC? and MAPK/ERK signal transduction pathways, shows that FGF-2 immobilized on Si-HA provides the right signals to cells stimulating crucial intracellular mechanisms of osteoblast proliferation and differentiation.
C1 [de la Concepcion Matesanz, Maria; Jose Feito, Maria; Ramirez-Santillan, Cecilia; Portoles, Maria-Teresa] Univ Complutense, Dept Biochem & Mol Biol 1, Fac Chem, E-28040 Madrid, Spain.
   [Maria Lozano, Rosa] CSIC, Dept Phys & Chem Biol, Ctr Invest Biol, Madrid 28040, Spain.
   [Sanchez-Salcedo, Sandra; Arcos, Daniel; Vallet-Regi, Maria] Univ Complutense, Dept Inorgan & Bioinorgan Chem, Fac Pharm, E-28040 Madrid, Spain.
   [Sanchez-Salcedo, Sandra; Arcos, Daniel; Vallet-Regi, Maria] Networking Res Ctr Bioengn Biomat & Nanomed, Madrid, Spain.
RP Portoles, MT (reprint author), Univ Complutense, Dept Biochem & Mol Biol 1, Fac Chem, E-28040 Madrid, Spain.
EM portoles@quim.ucm.es
RI Vallet-Regi, Maria/M-3378-2014; SANCHEZ-SALCEDO, SANDRA/N-4501-2014;
   Arcos, Daniel/L-6167-2014; Portoles, Maria Teresa/U-1678-2017
OI Vallet-Regi, Maria/0000-0002-6104-4889; SANCHEZ-SALCEDO,
   SANDRA/0000-0002-1889-2057; Arcos, Daniel/0000-0002-5367-7272; Portoles,
   Maria Teresa/0000-0002-9681-0184
FU Comunidad de Madrid [S2009/MAT-1472]; Ministerio de Ciencia e Innovacion
   [MAT2008-06719-C03-02, MAT2008-00736, CS2010-11384-E]; Networking
   Research Center on Bioengineering, Biomaterials, and Nanomedicine
FX This study was supported by research grants from Comunidad de Madrid
   (S2009/MAT-1472) and Ministerio de Ciencia e Innovacion through the
   projects MAT2008-06719-C03-02, MAT2008-00736 and CS2010-11384-E. M. C.
   Matesanz is greatly indebted to Networking Research Center on
   Bioengineering, Biomaterials, and Nanomedicine for a fellowship. The
   authors wish to thank also to the staff of the Microscopy and Cytometry
   Center of the Universidad Complutense de Madrid (Spain) for the
   assistance in the SEM, flow cytometry, and confocal microscopy studies.
CR Alcaide M., 2009, J BIOMED MATER RES A, V8, P539
   ALESSI DR, 1995, J BIOL CHEM, V270, P27489, DOI 10.1074/jbc.270.46.27489
   Arcos D, 2004, CHEM MATER, V16, P2300, DOI 10.1021/cm035337
   Balas F, 2003, J BIOMED MATER RES A, V66A, P364, DOI 10.1002/jbm.a.10579
   Bohner M, 2009, BIOMATERIALS, V30, P6403, DOI 10.1016/j.biomaterials.2009.08.007
   Campbell PG, 2005, BIOMATERIALS, V26, P6762, DOI 10.1016/j.biomaterials.2005.04.032
   Chen FM, 2010, BIOMATERIALS, V31, P6279, DOI 10.1016/j.biomaterials.2010.04.053
   Dailey L, 2005, CYTOKINE GROWTH F R, V16, P233, DOI 10.1016/j.cytogfr.2005.01.007
   Dvorak MM, 2004, P NATL ACAD SCI USA, V101, P5140, DOI 10.1073/pnas.0306141101
   Eapen A., 2010, J BIOL CHEM, V47, P36339
   Eda H, 2008, BIOCHEM BIOPH RES CO, V366, P471, DOI 10.1016/j.bbrc.2007.11.140
   Ge CX, 2007, J CELL BIOL, V176, P709, DOI 10.1083/jcb.200610046
   Hing KA, 2006, BIOMATERIALS, V27, P5014, DOI 10.1016/j.biomaterials.2006.05.039
   Feito MJ, 2011, J MATER SCI-MATER M, V22, P405, DOI 10.1007/s10856-010-4193-3
   Kelpke SS, 2004, J BIOMED MATER RES A, V71A, P316, DOI 10.1002/jbm.a.30163
   Ker EDP, 2011, BIOMATERIALS, V32, P8097, DOI 10.1016/j.biomaterials.2011.07.025
   Kim MS, 2011, MACROMOL BIOSCI, V11, P122, DOI 10.1002/mabi.201000222
   Knights V, 2010, PHARMACOL THERAPEUT, V125, P105, DOI 10.1016/j.pharmthera.2009.10.001
   Kubota K, 2002, BONE, V31, P465, DOI 10.1016/S8756-3282(02)00852-9
   Mabilleau G, 2008, BIOMATERIALS, V29, P1593, DOI 10.1016/j.biomaterials.2007.12.01
   Manzano M, 2011, ACTA BIOMATER, V7, P3555, DOI 10.1016/j.actbio.2011.06.004
   Marie PJ, 2003, GENE, V316, P23, DOI 10.1016/S0378-1119(03)00748-0
   Miller ED, 2011, BIOMATERIALS, V32, P2775, DOI 10.1016/j.biomaterials.2010.12.005
   Pietak AM, 2007, BIOMATERIALS, V28, P4023, DOI 10.1016/j.biomaterials.2007.05.003
   Porter AE, 2004, J BIOMED MATER RES A, V68A, P133, DOI 10.1002/jbm.a.20064
   Shen H, 2008, BIOMATERIALS, V29, P2388, DOI 10.1016/j.biomaterials.2008.02.008
   Thian ES, 2006, BIOMATERIALS, V27, P2692, DOI 10.1016/j.biomaterials.2005.12.019
   Vallet-Regi M, 2005, J MATER CHEM, V15, P1509, DOI 10.1039/b414143a
   Vallet-Regi M, 2011, ADV MATER, V23, P5177, DOI 10.1002/adma.201101586
   Wenk E, 2010, BIOMATERIALS, V31, P1403, DOI 10.1016/j.biomaterials.2009.11.006
   Wieghaus KA, 2006, TISSUE ENG, V12, P1903, DOI 10.1089/ten.2006.12.1903
   Xiao GZ, 2002, J BIOL CHEM, V277, P36181, DOI 10.1074/JBC.m206057200
   Yang S, 2011, BIOMATERIALS, V32, P2851, DOI 10.1016/j.biomaterials.2011.01.015
   Zieris A, 2010, BIOMATERIALS, V31, P7985, DOI 10.1016/j.biomaterials.2010.07.021
NR 34
TC 12
Z9 12
U1 1
U2 27
PU WILEY-V C H VERLAG GMBH
PI WEINHEIM
PA BOSCHSTRASSE 12, D-69469 WEINHEIM, GERMANY
SN 1616-5187
EI 1616-5195
J9 MACROMOL BIOSCI
JI Macromol. Biosci.
PD APR
PY 2012
VL 12
IS 4
BP 446
EP 453
DI 10.1002/mabi.201100456
PG 8
WC Biochemistry & Molecular Biology; Materials Science, Biomaterials;
   Polymer Science
SC Biochemistry & Molecular Biology; Materials Science; Polymer Science
GA 923MA
UT WOS:000302622200005
PM 22389324
DA 2018-10-19
ER

PT J
AU Pierce, BF
   Tronci, G
   Rossle, M
   Neffe, AT
   Jung, F
   Lendlein, A
AF Pierce, Benjamin F.
   Tronci, Giuseppe
   Roessle, Martin
   Neffe, Axel T.
   Jung, Friedrich
   Lendlein, Andreas
TI Photocrosslinked Co-Networks from Glycidylmethacrylated Gelatin and
   Poly(ethylene glycol) Methacrylates
SO MACROMOLECULAR BIOSCIENCE
LA English
DT Article
DE biomaterials; gelatin; hydrogels; photopolymerization;
   structure-property relations
ID PHOTOCHEMICAL CROSS-LINKING; MEMORY POLYMER NETWORKS; INTERPENETRATING
   NETWORKS; RADICAL POLYMERIZATION; CLEAVAGE SITE; HYDROGELS; COLLAGEN;
   DIACRYLATE; RELEASE; PHOTOPOLYMERIZATION
AB Biopolymer-based systems with adjustable macroscopic properties that can be varied in a wide range using only small changes in chemical composition are promising candidates for biomaterial-induced autoregeneration. Glycidylmethacrylated gelatin is photopolymerized with the addition of PEG mono- or dimethacrylate to form co-networks in pH?=?7.4 PBS. The degree of swelling (Q) and water uptake (H) in PBS at 37?degrees C are tailorable for PEGDMA co-networks (Q??250650?vol%), while the storage modulus of swollen networks at 37?degrees C can be adjusted by the PEG(D)MA content (G'?=?0.7145?kPa). Indirect cytotoxicity tests on ethylene oxide sterilized films show non-toxic responses for the homonetwork and all but one PEGDMA-containing co-networks materials.
C1 [Pierce, Benjamin F.; Tronci, Giuseppe; Roessle, Martin; Neffe, Axel T.; Jung, Friedrich; Lendlein, Andreas] Helmholtz Zentrum Geesthacht, Ctr Biomat Dev & Berlin Brandenburg, Ctr Regenerat Therapies, Polymer Res Inst, D-14513 Teltow, Germany.
RP Lendlein, A (reprint author), Helmholtz Zentrum Geesthacht, Ctr Biomat Dev & Berlin Brandenburg, Ctr Regenerat Therapies, Polymer Res Inst, Kantstr 55, D-14513 Teltow, Germany.
EM andreas.lendlein@hzg.de
RI Jung, Friedrich/L-1301-2013; Lendlein, Andreas/K-9553-2013; Neffe,
   Axel/H-6997-2013
OI Jung, Friedrich/0000-0001-8098-7180; Lendlein,
   Andreas/0000-0003-4126-4670; Neffe, Axel/0000-0002-5056-3990; Tronci,
   Giuseppe/0000-0002-9426-4220
FU Deutsche Forschungsgemeinschaft (DFG) [Sonderforschungsbereich 760];
   Bundesministerium fur Bildung und Forschung [Forderkennzeichen 0315696A]
FX We thank the Deutsche Forschungsgemeinschaft (DFG) for funding of this
   project within the Sonderforschungsbereich 760 project B5 as well as the
   Bundesministerium fur Bildung und Forschung for financing through
   project Poly4BioBB (Forderkennzeichen 0315696A), and Wolfgang Albrecht,
   Ulrich Nochel, and Nico Scharnagl for technical support.
CR Ali MM, 2004, MACROMOLECULES, V37, P5219, DOI 10.1021/ma030485m
   BUBACK M, 1987, MAKROMOL CHEM-RAPID, V8, P473
   BUBNIS WA, 1992, ANAL BIOCHEM, V207, P129, DOI 10.1016/0003-2697(92)90513-7
   BURLEY SK, 1985, SCIENCE, V229, P23, DOI 10.1126/science.3892686
   Burmania JA, 2003, J BIOMED MATER RES A, V67A, P224, DOI 10.1002/jbm.a.10106
   Burmania JA, 2003, BIOMATERIALS, V24, P3921, DOI 10.1016/S0142-9612(03)00270-9
   Chan BP, 2008, ACTA BIOMATER, V4, P1627, DOI 10.1016/j.actbio.2008.06.007
   Chan BP, 2005, J BIOMED MATER RES A, V75A, P689, DOI 10.1002/jbm.a.30469
   Chan OCM, 2008, J CONTROL RELEASE, V129, P135, DOI 10.1016/j.jconrel.2008.04.011
   Choi NY, 2007, SOFT MATTER, V3, P901, DOI 10.1039/b702515g
   Choi NY, 2006, ADV ENG MATER, V8, P439, DOI 10.1002/adem.200600020
   DAMINK LHHO, 1995, J MATER SCI-MATER M, V6, P460, DOI 10.1007/BF00123371
   Draye JP, 1998, BIOMATERIALS, V19, P99, DOI 10.1016/S0142-9612(97)00164-6
   Elisseeff J, 1999, P NATL ACAD SCI USA, V96, P3104, DOI 10.1073/pnas.96.6.3104
   Engler AJ, 2006, CELL, V126, P677, DOI 10.1016/j.cell.2006.06.044
   GROSS J, 1974, BIOCHEM BIOPH RES CO, V61, P605, DOI 10.1016/0006-291X(74)91000-6
   Hu XH, 2009, MACROMOL BIOSCI, V9, P1194, DOI 10.1002/mabi.200900275
   Kelch S, 2008, ADV ENG MATER, V10, P494, DOI 10.1002/adem.200700339
   Kelch S, 2007, BIOMACROMOLECULES, V8, P1018, DOI 10.1021/bm0610370
   Leong PL, 2008, ACTA BIOMATER, V4, P1569, DOI 10.1016/j.actbio.2008.02.030
   Liu T, 2010, J BIOMED MATER RES A, V95A, P276, DOI 10.1002/jbm.a.32831
   Mateo JL, 2001, J POLYM SCI POL CHEM, V39, P2444, DOI 10.1002/pola.1221
   Neffe AT, 2011, ACTA BIOMATER, V7, P1693, DOI 10.1016/j.actbio.2010.11.025
   Neffe AT, 2010, MACROMOL RAPID COMM, V31, P1534, DOI 10.1002/marc.201000274
   Nichol JW, 2010, BIOMATERIALS, V31, P5536, DOI 10.1016/j.biomaterials.2010.03.064
   Ovsianikov A, 2011, BIOMACROMOLECULES, V12, P851, DOI 10.1021/bm1015305
   Rohanizadeh R, 2008, J MATER SCI-MATER M, V19, P1173, DOI 10.1007/s10856-007-3154-y
   Santin M, 2007, BIOMACROMOLECULES, V8, P2706, DOI 10.1021/bm0703362
   SAWHNEY AS, 1993, MACROMOLECULES, V26, P581, DOI 10.1021/ma00056a005
   SAWHNEY AS, 1994, J BIOMED MATER RES, V28, P831, DOI 10.1002/jbm.820280710
   Scherzer T, 2005, MACROMOL SYMP, V230, P173, DOI 10.1002/masy.200551157
   Schmidt CE, 2000, BIOMATERIALS, V21, P2215, DOI 10.1016/S0142-9612(00)00148-4
   Shastri VP, 2009, ADV MATER, V21, P3231, DOI 10.1002/adma.200902200
   Tronci G, 2010, J MATER CHEM, V20, P8875, DOI 10.1039/c0jm00883d
   Van den Bulcke AI, 2000, BIOMACROMOLECULES, V1, P31, DOI 10.1021/bm990017d
   Van Vlierberghe S, 2007, BIOMACROMOLECULES, V8, P331, DOI 10.1021/bm060684o
   Williams CG, 2005, BIOMATERIALS, V26, P1211, DOI 10.1016/j.biomaterials.2004.04.024
   Witte RP, 2004, J BIOMED MATER RES A, V71A, P508, DOI 10.1002/jbm.a.30179
   Xiao JX, 2010, J BIOL CHEM, V285, P34181, DOI 10.1074/jbc.M110.128355
   YAMAOKA T, 1994, J PHARM SCI, V83, P601, DOI 10.1002/jps.2600830432
   Young AM, 2009, ACTA BIOMATER, V5, P2072, DOI 10.1016/j.actbio.2009.02.022
   Zaupa A, 2011, INT J ARTIF ORGANS, V34, P139, DOI 10.5301/IJAO.2010.6083
   Zaupa A, 2011, BIOMACROMOLECULES, V12, P75, DOI 10.1021/bm101029k
   Zhu JM, 2010, BIOMATERIALS, V31, P4639, DOI 10.1016/j.biomaterials.2010.02.044
   Zohuriaan-Mehr J. M., 2009, POLYM ADVAN TECHNOL, V20, P655
NR 45
TC 23
Z9 24
U1 1
U2 31
PU WILEY-V C H VERLAG GMBH
PI WEINHEIM
PA BOSCHSTRASSE 12, D-69469 WEINHEIM, GERMANY
SN 1616-5187
EI 1616-5195
J9 MACROMOL BIOSCI
JI Macromol. Biosci.
PD APR
PY 2012
VL 12
IS 4
BP 484
EP 493
DI 10.1002/mabi.201100232
PG 10
WC Biochemistry & Molecular Biology; Materials Science, Biomaterials;
   Polymer Science
SC Biochemistry & Molecular Biology; Materials Science; Polymer Science
GA 923MA
UT WOS:000302622200009
PM 22162436
DA 2018-10-19
ER

PT J
AU Asgher, M
   Bhatti, HN
AF Asgher, Mahwish
   Bhatti, Haq Nawaz
TI Removal of reactive blue 19 and reactive blue 49 textile dyes by citrus
   waste biomass from aqueous solution: Equilibrium and kinetic study
SO CANADIAN JOURNAL OF CHEMICAL ENGINEERING
LA English
DT Article
DE Citrus sinensis; reactive anthraquinone dyes; biosorption; equilibrium
   modelling; kinetic study
ID LOW-COST ADSORBENTS; BOTTOM ASH; RHIZOPUS-ARRHIZUS; BIOSORPTION;
   ADSORPTION; WATER; SORPTION; RED; WASTEWATERS; BIOSORBENT
AB The purpose of this study was to establish the potential of inexpensive and locally available biomaterial, that is, lignocellulosic waste of Citrus sinensis as biosorbent to remove reactive anthraquinone dyes from aqueous solution. The effects of immobilisation and chemical treatment of biosorbent were also explored for the enhanced sorption of dyes. Biosorbent was chemically treated with organic and inorganic reagents of which acetic acid augmented the sorption capacities for Reactive blue 19 and Reactive blue 49 attaining equilibrium in 60?min. While immobilisation of biosorbent into calcium alginate beads reduced the sorption capacity and the time to achieve equilibrium was prolonged up to 120?min. Sorption of both reactive dyes was found to be dependent on pH of media and maximum removal was observed at pH 2. The sorption process was fast and the data followed pseudo-second-order kinetic rate equation (R2?=?0.99). The equilibrium data were also fitted to Freundlich, Langmuir and Temkin isotherms. The mechanism of sorption was found to be physiosorption. FTIR analysis and SEM imaging of biosorbent were also carried out to study functional groups involved and morphological changes at the surface of biomass. (c) 2011 Canadian Society for Chemical Engineering
C1 [Asgher, Mahwish; Bhatti, Haq Nawaz] Univ Agr Faisalabad, Dept Chem & Biochem, Environm Chem Lab, Faisalabad 38040, Pakistan.
RP Bhatti, HN (reprint author), Univ Agr Faisalabad, Dept Chem & Biochem, Environm Chem Lab, Faisalabad 38040, Pakistan.
EM hnbhatti2005@yahoo.com
RI Bhatti, Haq Nawaz/I-2069-2015; Asgher, Muhammad/G-6677-2015
OI Bhatti, Haq Nawaz/0000-0002-5445-8338
FU Higher Education Commission (HEC) of Pakistan
FX This work is a part of Ph.D. degree of Miss Mahwish Asgher. The authors
   are thankful to Higher Education Commission (HEC) of Pakistan for
   providing funds to accomplish this work. The authors are thankful to the
   Director CRL, University of Peshawar for providing technical assistance
   to the student.
CR Ahluwalia SS, 2007, BIORESOURCE TECHNOL, V98, P2243, DOI 10.1016/j.biortech.2005.12.006
   Aksu Z, 2005, PROCESS BIOCHEM, V40, P997, DOI 10.1016/j.procbio.2004.04.008
   Aksu Z, 2001, BIOCHEM ENG J, V7, P79, DOI 10.1016/S1369-703X(00)00098-X
   Aksu Z, 2000, PROCESS BIOCHEM, V36, P431, DOI 10.1016/S0032-9592(00)00233-8
   Ali I, 2006, NAT PROTOC, V1, P2661, DOI 10.1038/nprot.2006.370
   Annadurai G, 2002, J HAZARD MATER, V92, P263, DOI 10.1016/S0304-3894(02)00017-1
   Asgher M, 2010, ECOL ENG, V36, P1660, DOI 10.1016/j.ecoleng.2010.07.003
   Banat F, 2003, PROCESS BIOCHEM, V39, P193, DOI 10.1016/S0032-9592(03)00065-7
   Bhatti HN, 2010, KOREAN J CHEM ENG, V27, P218, DOI 10.2478/s11814-009-0325-1
   Bustard M, 1998, BIOPROCESS ENG, V19, P427, DOI 10.1007/PL00009028
   Calfa BA, 2008, MINER ENG, V21, P48, DOI 10.1016/j.mineng.2007.08.001
   Crini G, 2006, BIORESOURCE TECHNOL, V97, P1061, DOI 10.1016/j.biortech.2005.05.001
   Freundlich H., 1906, PHYS CHEM SOC, V40, P1361
   Fu YZ, 2002, ADV ENVIRON RES, V7, P239, DOI 10.1016/S1093-0191(01)00123-X
   Gallagher K. A., 1997, GLOBAL ENV BIOTECHNO, P27
   Guibal E, 2004, SEP PURIF TECHNOL, V38, P43, DOI 10.1016/j.seppur.2003.10.004
   Gupta VK, 2008, J COLLOID INTERF SCI, V319, P30, DOI 10.1016/j.jcis.2007.09.091
   Gupta VK, 2009, CRIT REV ENV SCI TEC, V39, P783, DOI 10.1080/10643380801977610
   Gupta VK, 2009, J ENVIRON MANAGE, V90, P2313, DOI 10.1016/j.jenvman.2008.11.017
   Gupta VK, 2009, J HAZARD MATER, V163, P396, DOI 10.1016/j.jhazmat.2008.06.104
   Gupta VK, 2008, ENVIRON SCI TECHNOL, V42, P766, DOI 10.1021/es7025032
   Gupta VK, 2006, J COLLOID INTERF SCI, V303, P80, DOI 10.1016/j.jcis.2006.07.036
   Gupta VK, 2006, J COLLOID INTERF SCI, V293, P16, DOI 10.1016/j.cis.2005.06.021
   Gupta VK, 2005, IND ENG CHEM RES, V44, P3655, DOI 10.1021/ie0500220
   Gupta VK, 2004, IND ENG CHEM RES, V43, P1740, DOI 10.1021/ie034218g
   Hanif A, 2009, ECOL ENG, V35, P1427, DOI 10.1016/j.ecoleng.2009.05.013
   Ho YS, 2005, PROCESS BIOCHEM, V40, P119, DOI 10.1016/j.procbio.2003.11.035
   Ho YS, 2003, PROCESS BIOCHEM, V38, P1047, DOI 10.1016/S0032-9592(02)00239-X
   HU TL, 1992, WATER SCI TECHNOL, V26, P357
   Jain AK, 2003, J HAZARD MATER, V101, P31, DOI 10.1016/S0304-3894(03)00146-8
   Kapoor A, 1995, BIORESOURCE TECHNOL, V53, P195, DOI 10.1016/0960-8524(95)00072-1
   Khattri SD, 1999, ADSORPT SCI TECHNOL, V17, P269, DOI 10.1177/026361749901700404
   Kiran B, 2008, BIOCHEM ENG J, V38, P47, DOI 10.1016/j.bej.2007.06.007
   Langmuir I, 1918, J AM CHEM SOC, V40, P1361, DOI 10.1021/ja02242a004
   McKay G, 1999, WATER AIR SOIL POLL, V114, P423, DOI 10.1023/A:1005197308228
   Mohan SV, 2007, J HAZARD MATER, V141, P465, DOI 10.1016/j.jhazmat.2006.07.008
   Morais LC, 1999, WATER RES, V33, P979, DOI 10.1016/S0043-1354(98)00294-2
   Murphy V, 2007, WATER RES, V41, P731, DOI 10.1016/j.watres.2006.11.032
   Namasivayam C, 1996, BIORESOURCE TECHNOL, V57, P37, DOI 10.1016/0960-8524(96)00044-2
   Nassar MM, 1997, CHEM ENG J, V66, P223, DOI 10.1016/S1385-8947(96)03193-2
   NAWAR SS, 1989, SCI TOTAL ENVIRON, V79, P271, DOI 10.1016/0048-9697(89)90342-2
   Nigam P, 2000, BIORESOURCE TECHNOL, V72, P219, DOI 10.1016/S0960-8524(99)00123-6
   Niua C. H., 2007, WATER RES, V41, P2473
   O'Mahony T, 2002, ENZYME MICROB TECH, V31, P456, DOI 10.1016/S0141-0229(02)00110-2
   Ozacar M, 2005, PROCESS BIOCHEM, V40, P565, DOI 10.1016/j.procbio.2004.01.032
   Rajeswari S., 2001, WASTE MANAGE, V21, P105
   Robinson T, 2002, ENVIRON INT, V28, P29, DOI 10.1016/S0160-4120(01)00131-3
   SILVERSTEIN RM, 1981, SPECTROMETRIC IDENTI, P107
   Tsezos M, 2001, HYDROMETALLURGY, V59, P241, DOI 10.1016/S0304-386X(99)00056-0
   Tsezos M., 1982, BIOTECHNOL BIOENG, V24, P965
   Vijayaraghavan K, 2007, CHEMOSPHERE, V68, P1838, DOI 10.1016/j.chemosphere.2007.03.030
   Volesky B, 2003, HYDROMETALLURGY, V71, P179, DOI 10.1016/S0304-386X(03)00155-5
   Yamuna R. T., 1999, THESIS BHARATHIAR U
   Zhang Y, 2006, WATER RES, V40, P788, DOI 10.1016/j.watres.2005.12.011
NR 54
TC 28
Z9 28
U1 5
U2 17
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0008-4034
EI 1939-019X
J9 CAN J CHEM ENG
JI Can. J. Chem. Eng.
PD APR
PY 2012
VL 90
IS 2
BP 412
EP 419
DI 10.1002/cjce.20531
PG 8
WC Engineering, Chemical
SC Engineering
GA 902OT
UT WOS:000301048500023
DA 2018-10-19
ER

PT J
AU Calvo-Guirado, JL
   Gomez-Moreno, G
   Guardia, J
   Ortiz-Ruiz, A
   Piatelli, A
   Barone, A
   Martinez-Gonzalez, JM
   Meseguer-Olmo, L
   Lopez-Mari, L
   Dorado, CB
AF Luis Calvo-Guirado, Jose
   Gomez-Moreno, Gerardo
   Guardia, Javier
   Ortiz-Ruiz, Antonio
   Piatelli, Adriano
   Barone, Antonio
   Maria Martinez-Gonzalez, Jose
   Meseguer-Olmo, Luis
   Lopez-Mari, Laura
   Barona Dorado, Cristina
TI Biological Response to Porcine Xenograft Implants: An Experimental Study
   in Rabbits
SO IMPLANT DENTISTRY
LA English
DT Article
DE biomaterial; porcine bone; xenografts; hydroxyapatite
ID MAXILLARY SINUS AUGMENTATION; BOVINE BONE; IN-VIVO; HYDROXYAPATITE;
   GRAFT; BIOMATERIAL; EXTRACTION; PLACEMENT; PHOSPHATE; INGROWTH
AB Purpose: The aim of this study was to evaluate the effect of a new porcine biomaterial and collagen paste in 20 New Zealand rabbits.
   Materials and Methods: Forty implants using a porcine xenograft made up of 80% corticocancellous collagenated bone particles of <= 300 mu m in size were placed in the proximal metaphyseal area of both tibiae. Four periods of time were formed: 1h, 5, 8, and 15 months. After implantation, an anteroposterior and lateral radiological study was carried out. Samples were sectioned at 5 mu m and stained using hematoxylin-eosin, Masson's trichromic, and Gordon-Switt reticulin stains.
   Results: These results confirmed the biocompatibility of this porcine biomaterial-collagen paste; only a few, occasional macrophages and scattered lymphocytes were observed. No fibrosis was observed between the implants and the bone. Moreover, the material was osteoconductive acting as a "scaffold" for bone cells, and there was a progressive increase in bone growth in and around the implants.
   Conclusion: This new porcine biomaterial-collagen paste seemed to be biocompatible, bioresorbable, and osteoconductive. (Implant Dent 2012; 21:112-117)
C1 [Luis Calvo-Guirado, Jose; Ortiz-Ruiz, Antonio; Lopez-Mari, Laura] Univ Murcia, Fac Med & Dent, Murcia, Spain.
   [Gomez-Moreno, Gerardo; Guardia, Javier] Univ Granada, Sch Dent, Granada, Spain.
   [Piatelli, Adriano] Univ G dAnnunzio, Sch Dent, Chieti, Italy.
   [Barone, Antonio] Univ Genoa, Fac Med, Genoa, Italy.
   [Maria Martinez-Gonzalez, Jose] Univ Complutense Madrid, Sch Dent, Madrid, Spain.
   [Maria Martinez-Gonzalez, Jose] Univ Hosp Madrid, Dept Oral & Dent Implant Surg, Madrid, Spain.
   [Meseguer-Olmo, Luis] Univ Murcia, Univ Hosp V Arrixaca, Unit Cell Therapy & Bone Bioengn, Murcia, Spain.
   [Barona Dorado, Cristina] Univ Complutense Madrid, Fac Dent, Madrid, Spain.
RP Calvo-Guirado, JL (reprint author), Mozart 1,1 G, E-30002 Murcia, Spain.
EM josecalvog@gmail.com
RI Barone, Antonio/O-2738-2013; Ortiz Ruiz, Antonio/M-2458-2018;
   Gomez-Moreno, Gerardo/L-8123-2014
OI Barone, Antonio/0000-0003-1226-7565; Ortiz Ruiz,
   Antonio/0000-0001-9113-8416; Gomez-Moreno, Gerardo/0000-0001-9094-4985;
   Meseguer-Olmo, Luis/0000-0003-3858-8148; calvo guirado, jose
   luis/0000-0002-4067-2253
CR Arcuri C, 2005, Minerva Stomatol, V54, P351
   Avila G, 2010, IMPLANT DENT, V19, P330, DOI 10.1097/ID.0b013e3181e59b32
   Azorit C, 2002, ANAT HISTOL EMBRYOL, V31, P224, DOI 10.1046/j.1439-0264.2002.00399.x
   Bareille R, 2000, BIOMATERIALS, V21, P1345, DOI 10.1016/S0142-9612(00)00015-6
   Barone A, 2005, INT J ORAL MAX IMPL, V20, P519
   Barone A, 2008, J PERIODONTOL, V79, P1370, DOI 10.1902/jop.2008.070628 
   Barone A, 2007, J ORAL MAXIL SURG, V65, P2039, DOI 10.1016/j.joms.2007.05.017
   Borie DC, 1998, INFECT CONT HOSP EP, V19, P355
   BURCHARDT H, 1983, CLIN ORTHOP RELAT R, P28
   Calvo-Guirado JL, 2010, MED ORAL PATOL ORAL, V15, pE366, DOI 10.4317/medoral.15.e366
   Casado PL, 2010, IMPLANT DENT, V19, P314, DOI 10.1097/ID.0b013e3181dec322
   Degidi M, 2007, IMPLANT DENT, V16, P317, DOI 10.1097/ID.0b013e3180de4c5f
   GATTI AM, 1990, BIOMATERIALS, V11, P513, DOI 10.1016/0142-9612(90)90068-2
   Hallman M, 2004, INT J ORAL MAX IMPL, V19, P222
   Hing KA, 2004, J BIOMED MATER RES A, V68A, P187, DOI 10.1002/jbm.a.10050
   Hsu FY, 2005, J MATER SCI-MATER M, V16, P341, DOI 10.1007/s10856-005-0633-x
   Kim SH, 2004, J BIOMED MATER RES B, V68B, P69, DOI 10.1002/jbm.b.10084
   Kim YK, 2011, IMPLANT DENT, V20, P267, DOI 10.1097/ID.0b013e3182166afc
   KLAWITTER JJ, 1971, J BIOMED MATER RES S, V2, P161, DOI DOI 10.1002/JBM.820050613
   LEKHOLM U, 1986, INT J ORAL MAX SURG, V15, P53, DOI 10.1016/S0300-9785(86)80011-4
   Calvo-Guirado JL, 2010, J PINEAL RES, V48, P194, DOI 10.1111/j.1600-079X.2009.00743.x
   Manso MC, 2010, IMPLANT DENT, V19, P364, DOI 10.1097/ID.0b013e3181f70ca2
   Manso MC, 2010, IMPLANT DENT, V19, P351, DOI 10.1097/ID.0b013e3181e59d03
   Marechal M, 2008, J PERIODONTOL, V79, P896, DOI [10.1902/jop.2008.070043, 10.1902/jop.2008.070043 ]
   Motomiya M, 2007, EUR SPINE J, V16, P2215, DOI 10.1007/s00586-007-0501-0
   Nannmark U, 2008, CLIN IMPLANT DENT R, V10, P264, DOI 10.1111/j.1708-8208.2007.00080.x
   Norton MR, 2003, CLIN ORAL IMPLAN RES, V14, P775, DOI 10.1046/j.0905-7161.2003.00952.x
   Orsini G, 2006, J PERIODONTOL, V77, P1984, DOI 10.1902/jop.2006.060181
   Ramirez-Fernandez MP, 2011, CLIN ORAL IMPLAN RES, V22, P767, DOI 10.1111/j.1600-0501.2010.02058.x
   Ramirez-Fernandez MP, 2011, CLIN ORAL IMPLAN RES, V22, P727, DOI 10.1111/j.1600-0501.2010.02052.x
   Santos FA, 2010, CLIN IMPLANT DENT R, V12, P18, DOI 10.1111/j.1708-8208.2008.00126.x
   Scarano A, 2007, IMPLANT DENT, V16, P195, DOI 10.1097/ID.0b013e3180587ad8
   Tamai N, 2002, J BIOMED MATER RES, V59, P110, DOI 10.1002/jbm.1222
   Urist MR, 1965, ORTHOP CLIN N AM, V150, P893
   VANBLITTERSWIJK CA, 1986, BIOMATERIALS, V7, P137, DOI 10.1016/0142-9612(86)90071-2
   Wallace S, 2010, IMPLANT DENT, V19, P272, DOI 10.1097/ID.0b013e3181e5d2a1
NR 36
TC 4
Z9 4
U1 0
U2 10
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA
SN 1056-6163
J9 IMPLANT DENT
JI Implant Dent.
PD APR
PY 2012
VL 21
IS 2
BP 112
EP 117
DI 10.1097/ID.0b013e3182425991
PG 6
WC Dentistry, Oral Surgery & Medicine
SC Dentistry, Oral Surgery & Medicine
GA 916ZC
UT WOS:000302140700008
PM 22440978
DA 2018-10-19
ER

PT J
AU Maruyama, M
   Tensho, K
   Wakabayashi, S
   Terayama, K
AF Maruyama, Masaaki
   Tensho, Keiji
   Wakabayashi, Shinji
   Terayama, Kazuo
TI Hydroxyapatite Block for Reconstruction of Severe Dysplasia or
   Acetabular Bone Defects in Total Hip Arthroplasty Operative Technique
   and Clinical Outcome
SO JOURNAL OF ARTHROPLASTY
LA English
DT Article
DE hydroxyapatite block; dysplasia; acetabular bone defect; total hip
   arthroplasty; revision; solid biomaterial
ID FEMORAL-HEAD AUTOGRAFT; DEVELOPMENTAL DYSPLASIA; CLASSIFICATION;
   MANAGEMENT
AB Fourteen hips in 14 patients (all female; average age, 64 years) with severe bone defects due to developmental dysplasia of the hip or migration of the socket were treated with hydroxyapatite block with impacted morselized bone graft in conjunction with a cemented socket. All patients were followed clinically in a prospective fashion, and radiographs were analyzed retrospectively. One initial patient had 17-year follow-up, whereas the remaining 13 patients had follow-up between 4 and 6.5 years. No acetabular components were revised, including the socket of a 17-year postoperative case that remains rigidly fixed and supported by the graft and hydroxyapatite block with only mild polyethylene wear and minor osteolysis. Osteointegration and good clinical outcome were achieved in all cases by reconstruction with this technique in total hip arthroplasty.
C1 [Maruyama, Masaaki] Shinonoi Gen Hosp, Dept Orthoped Surg, Nagano 3888004, Japan.
   [Tensho, Keiji] Shinshu Univ, Sch Med, Dept Orthoped Surg, Matsumoto, Nagano 390, Japan.
   [Wakabayashi, Shinji] Chushin Matsumoto Hosp, Matsumoto Med Ctr, Dept Orthoped Surg, Matsumoto, Nagano, Japan.
RP Maruyama, M (reprint author), Shinonoi Gen Hosp, Dept Orthoped Surg, 666-1 Ai, Nagano 3888004, Japan.
OI Tensho, Keiji/0000-0003-1146-3476
CR CROWE JF, 1979, J BONE JOINT SURG AM, V61, P15, DOI 10.2106/00004623-197961010-00004
   DANTONIO JA, 1989, CLIN ORTHOP RELAT R, P126
   DANTONIO JA, 1992, ORTHOP CLIN N AM, V23, P279
   DAUBIGNE RM, 1954, J BONE JOINT SURG AM, V36-A, P451, DOI 10.2106/00004623-195436030-00001
   HASEGAWA Y, 1992, ARCH ORTHOP TRAUM SU, V111, P187, DOI 10.1007/BF00571474
   Issack Paul S, 2009, Am J Orthop (Belle Mead NJ), V38, P509
   Ito K, 1987, KISO TO RINSHO, V212, P749
   KAMEGAYA M, 1994, J BONE JOINT SURG BR, V76B, P123
   Kobayashi S, 2003, J BONE JOINT SURG AM, V85A, P615, DOI 10.2106/00004623-200304000-00005
   Landor I, 2009, ACTA CHIR ORTHOP TR, V76, P462
   MARUYAMA M, 1995, J BONE JOINT SURG BR, V77B, P213
   Maruyama M, 1996, J BIOMED MATER RES, V32, P527, DOI 10.1002/(SICI)1097-4636(199612)32:4<527::AID-JBM5>3.0.CO;2-T
   Masui T, 2009, NAGOYA J MED SCI, V71, P145
   Pagnano MW, 1996, J BONE JOINT SURG AM, V78A, P1004, DOI 10.2106/00004623-199607000-00004
   Shinar AA, 1997, J BONE JOINT SURG AM, V79A, P159, DOI 10.2106/00004623-199702000-00001
   Spangehl MJ, 2001, J BONE JOINT SURG AM, V83A, P1484, DOI 10.2106/00004623-200110000-00004
   UCHIDA A, 1990, J BONE JOINT SURG BR, V72, P298
NR 17
TC 4
Z9 4
U1 0
U2 5
PU CHURCHILL LIVINGSTONE INC MEDICAL PUBLISHERS
PI PHILADELPHIA
PA CURTIS CENTER, INDEPENDENCE SQUARE WEST, PHILADELPHIA, PA 19106-3399 USA
SN 0883-5403
J9 J ARTHROPLASTY
JI J. Arthroplast.
PD APR
PY 2012
VL 27
IS 4
BP 591
EP 597
DI 10.1016/j.arth.2011.06.029
PG 7
WC Orthopedics
SC Orthopedics
GA 918TP
UT WOS:000302274300016
PM 21944372
DA 2018-10-19
ER

PT J
AU Hayes, JS
   Welton, JL
   Wieling, R
   Richards, RG
AF Hayes, Jessica S.
   Welton, Joanne L.
   Wieling, Ronald
   Richards, R. Geoff
TI In vivo evaluation of defined polished titanium surfaces to prevent soft
   tissue adhesion
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART B-APPLIED BIOMATERIALS
LA English
DT Article
DE soft tissue capsule; liquid filled void; in vivo; biomaterial; soft
   tissue adhesion
ID IMPLANTS; BONE; REMOVAL; INTERFACE; PLATE; MODEL; SHEEP; EASE
AB Soft tissue-implant adhesion is often required for implant integration into the body; however, in some situations, the tissue is required to glide freely over an implant. In the case of distal radius fracture treatment, current literature describes how titanium and its alloys tend to lead to more intra-tendon inflammatory reactions compared with stainless steel. This leads to tendon-implant adhesion and damage possibly causing limited palmar flexion and even tendon rupture. The goal of this study was to analyze the effect of different surface polishings of titanium and titanium molybdenum implants on soft tissue reactions in vivo, with the aim to prevent direct soft tissue adhesion. Using a nonfracture model, to allow for study of the soft-tissue-implant surface interactions only, six surface variants of the same plate design were implanted onto the tibia of 24 New Zealand white rabbits and left in situ for 12 weeks. Results indicate that paste polished commercially pure titanium and titanium molybdenum alloy had the least soft tissue adhesion, with the concomitant development of a soft tissue capsule. Surface topography did not appear influence the thickness of the connective tissue surrounding the plate. Therefore, suitable surface polishing could be applied to plates for clinical use, where free gliding of tissues is required. (c) 2012 Wiley Periodicals, Inc. J Biomed Mater Res Part B: Appl Biomater, 2012.
C1 [Hayes, Jessica S.; Welton, Joanne L.; Wieling, Ronald; Richards, R. Geoff] AO Fdn, AO Res Inst Davos, Davos, Switzerland.
RP Richards, RG (reprint author), AO Fdn, AO Res Inst Davos, Davos, Switzerland.
EM geoff.richards@aofoundation.org
RI Richards, Robert/I-8235-2015
OI Richards, Robert/0000-0002-7778-2480
CR ALBREKTSSON T, 1986, BIOMATERIALS, V7, P201, DOI 10.1016/0142-9612(86)90103-1
   BRUNET JA, 1986, CLIN ORTHOP RELAT R, P84
   BUSER D, 1991, J BIOMED MATER RES, V25, P889, DOI 10.1002/jbm.820250708
   Eschbach L, 2003, 10 FREQUENTLY ASKED
   Hayes JS, 2010, EUR CELLS MATER, V19, P117, DOI 10.22203/eCM.v019a12
   Hayes JS, 2009, EUR CELLS MATER, V18, P15, DOI 10.22203/eCM.v018a02
   Khan U, 2000, J BONE JOINT SURG BR, V82B, P1054, DOI 10.1302/0301-620X.82B7.9892
   Kloppel H, 2003, 18 EUR C BIOM OCT 1
   Lowry K J, 2000, Am J Orthop (Belle Mead NJ), V29, P789
   Meredith DO, 2007, J ORTHOP RES, V25, P1523, DOI 10.1002/jor.20430
   Parker JATC, 2002, BIOMATERIALS, V23, P3887, DOI 10.1016/S0142-9612(02)00134-5
   Pearce AI, 2008, J ORTHOP RES, V26, P1377, DOI 10.1002/jor.20665
   Richard RG, 2008, OSTEOSYNTHESIS HAND, P20
   Richards RG, 1995, CELL BIOL INT, V19, P1015, DOI 10.1006/cbir.1995.1044
   Richards RG, 2000, TRANSACTIONS, V10
   Rosengren A, 2002, IEEE T BIO-MED ENG, V49, P392, DOI 10.1109/10.991167
   Sinicropi SA, 2005, J HAND SURG-AM, V30A, P300, DOI 10.1016/j.jhsa.2004.08.004
   Ungersbock A, 1996, BIOMATERIALS, V17, P797, DOI 10.1016/0142-9612(96)81417-7
   UNGERSBOCK A, 1994, J MATER SCI-MATER M, V5, P788, DOI 10.1007/BF00213136
   Yang R, 2003, Eur Cell Mater, V6, P57
   YANG R, 2003, EUR CELLS MATER, V6, P71
NR 21
TC 7
Z9 7
U1 2
U2 11
PU WILEY-BLACKWELL
PI MALDEN
PA COMMERCE PLACE, 350 MAIN ST, MALDEN 02148, MA USA
SN 1552-4973
J9 J BIOMED MATER RES B
JI J. Biomed. Mater. Res. Part B
PD APR
PY 2012
VL 100B
IS 3
BP 611
EP 617
DI 10.1002/jbm.b.31967
PG 7
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 901RE
UT WOS:000300983700003
PM 22282225
DA 2018-10-19
ER

PT J
AU Krebs, J
   Ferguson, SJ
   Goss, B
   Stauffer, E
   Ettinger, L
   Aebli, N
AF Krebs, Joerg
   Ferguson, Stephen J.
   Goss, Ben G.
   Stauffer, Edouard
   Ettinger, Ladina
   Aebli, Nikolaus
TI Effect of vertebral cement augmentation with polymethylmethacrylate on
   intervertebral disc and bone tissue
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART B-APPLIED BIOMATERIALS
LA English
DT Article
DE cement augmentation; vertebroplasty; intervertebral disc;
   polymethylmethacrylate; degeneration; animal study; sheep; histology;
   tetracycline labeling; hematoxylin & eosin; Alcian blue-PAS;
   histomorphometry
ID FUNCTIONAL SPINAL UNIT; LARGE ANIMAL-MODEL; PERCUTANEOUS VERTEBROPLASTY;
   BIOMATERIAL RESEARCH; HISTOLOGIC-CHANGES; NUCLEUS PULPOSUS;
   FINITE-ELEMENT; LOAD-TRANSFER; IN-VITRO; DEGENERATION
AB Vertebral cement augmentation is reported to be a safe and effective technique for providing stabilization and pain relief. However, adjacent intervertebral discs may be at risk of accelerated degeneration as a result of aggravated nutritional constraints. Therefore, we investigated the effects of injecting polymethylmethacrylate (PMMA) into three adjacent lumbar vertebrae on intervertebral disc and vertebral bone tissue in 12 skeletally mature sheep. After 6 and 12 months of augmentation, the sheep were euthanized and their spines were processes for histological evaluation. Semiquantitative histomorphological analysis of discs and endplates was conducted using published criteria. Histomorphological changes in the augmented bone were assessed qualitatively. Approximately 80% of the length of the endplates was in contact with PMMA. However, there was no significant difference between the histopathological score of the discs adjacent to augmented vertebrae and the score of the control discs. Bone tissue reaction to PMMA was characterized by a thin fibrous tissue layer and occasional foreign-body reactions. New bone formation was present in all augmented vertebrae. Concerns about aggravation of disc degeneration as a result of vertebral cement augmentation seem to be unsubstantiated. Furthermore, adverse effects of PMMA cement on bone biology do not seem to be a relevant issue. (c) 2011 Wiley Periodicals, Inc. J Biomed Mater Res Part B: Appl Biomater, 2012.
C1 [Krebs, Joerg] Swiss Parapleg Ctr, Clin Trial Unit, Nottwil, Switzerland.
   [Ferguson, Stephen J.] ETH, Inst Biomech, Zurich, Switzerland.
   [Goss, Ben G.] Queensland Univ Technol, AO Spine Res Ctr, Brisbane, Qld 4001, Australia.
   [Stauffer, Edouard] Promed SA, Marly, Switzerland.
   [Ettinger, Ladina] Univ Bern, Fac Med, Inst Surg Technol & Biomech, Bern, Switzerland.
   [Aebli, Nikolaus] Swiss Parapleg Ctr, Nottwil, Switzerland.
   [Aebli, Nikolaus] Univ Basel, Fac Med, Dept Orthopaed, Basel, Switzerland.
   [Aebli, Nikolaus] Griffith Univ, Sch Med, Gold Coast, Qld, Australia.
RP Krebs, J (reprint author), Swiss Parapleg Ctr, Clin Trial Unit, Nottwil, Switzerland.
EM joerg.krebs@paranet.ch
RI Ferguson, Stephen/A-4118-2012
OI Ferguson, Stephen/0000-0003-0650-5889
FU AO Foundation, Dubendorf, Switzerland
FX Contract grant sponsor: AO Foundation, Dubendorf, Switzerland
CR Ahn Y, 2008, J NEUROSURG-SPINE, V9, P129, DOI 10.3171/SPI/2008/9/8/129
   BAKER JR, 1975, VET REC, V96, P290, DOI 10.1136/vr.96.13.290
   Baroud G, 2003, EUR SPINE J, V12, P421, DOI 10.1007/s00586-002-0512-9
   Belkoff SM, 2001, SPINE, V26, P1537, DOI 10.1097/00007632-200107150-00007
   Benneker LM, 2005, SPINE, V30, P167, DOI 10.1097/01.brs.0000150833.93248.09
   Bibby SRS, 2001, JOINT BONE SPINE, V68, P537, DOI 10.1016/S1297-319X(01)00332-3
   Boos N, 2002, SPINE, V27, P2631, DOI 10.1097/00007632-200212010-00002
   Chen JF, 2004, SURG NEUROL, V62, P494, DOI 10.1016/j.surneu.2003.10.049
   DAHL OE, 1994, ACTA ORTHOP SCAND, V65, P147, DOI 10.3109/17453679408995423
   DANILEWICZSTYSIAK Z, 1980, J PROSTHET DENT, V44, P13, DOI 10.1016/0022-3913(80)90038-4
   Deramond H, 1999, BONE, V25, p17S, DOI 10.1016/S8756-3282(99)00127-1
   Diel P, 2010, SPINE J, V10, P961, DOI 10.1016/j.spinee.2009.08.452
   Ding M, 2010, SPINE, V35, P363, DOI 10.1097/BRS.0b013e3181b8e0ff
   Fews D, 2006, VET COMP ORTHOPAED, V19, P187
   Heini PF, 2004, ORTHOPADE, V33, P22, DOI 10.1007/s00132-003-0574-3
   Horner HA, 2001, SPINE, V26, P2543, DOI 10.1097/00007632-200112010-00006
   Huang KY, 2005, SPINE, V30, pE585, DOI 10.1097/01.brs.0000182226.56498.55
   Hulme PA, 2006, SPINE, V31, P1983, DOI 10.1097/01.brs.0000229254.89952.6b
   Hutton WC, 2004, J SPINAL DISORD TECH, V17, P53, DOI 10.1097/00024720-200402000-00011
   Kaufmann TJ, 2006, AM J NEURORADIOL, V27, P1933
   Kim Choll W, 2004, Spine J, V4, P709, DOI 10.1016/j.spinee.2004.05.002
   Klazen CAH, 2010, LANCET, V376, P1085, DOI 10.1016/S0140-6736(10)60954-3
   Kobayashi N, 2005, J BIOMED MATER RES A, V75A, P123, DOI 10.1002/jbm.a.30388
   Konno S, 1994, Eur Spine J, V3, P299, DOI 10.1007/BF02200140
   Lazary A, 2008, J ORTHOP RES, V26, P601, DOI 10.1002/jor.20532
   Lin EP, 2004, AM J NEURORADIOL, V25, P175
   Luo J, 2007, BONE, V40, P1110, DOI 10.1016/j.bone.2006.11.021
   McLain Robert F, 2002, Spine (Phila Pa 1976), V27, pE200
   Melrose J, 2002, SPINE, V27, P1278, DOI 10.1097/00007632-200206150-00007
   NACHEMSON A, 1970, ACTA ORTHOP SCAND, V41, P589, DOI 10.3109/17453677008991550
   Orbell GMB, 2007, NEW ZEAL VET J, V55, P297, DOI 10.1080/00480169.2007.36784
   Pearce AI, 2007, EUR CELLS MATER, V13, P1
   Polikeit A, 2004, J BIOMECH, V37, P1061, DOI 10.1016/j.jbiomech.2003.11.018
   Polikeit A, 2003, SPINE, V28, P991, DOI 10.1097/00007632-200305150-00006
   Reid JE, 2002, CLIN BIOMECH, V17, P312, DOI 10.1016/S0268-0033(02)00009-8
   Smit TH, 2002, EUR SPINE J, V11, P137, DOI 10.1007/s005860100346
   Steens J, 2007, SPINE, V32, pE419, DOI 10.1097/BRS.0b013e318074d4b9
   Tanigawa N, 2006, CARDIOVASC INTER RAD, V29, P92, DOI 10.1007/s00270-005-0097-x
   Togawa D, 2003, SPINE, V28, P1521, DOI 10.1097/00007632-200307150-00009
   Togawa D, 2006, SPINE, V31, pE4, DOI 10.1097/01.brs.0000192637.60821.ef
   Trout AT, 2006, AM J NEURORADIOL, V27, P217
   Turner TM, 2008, SPINE J, V8, P482, DOI 10.1016/j.spinee.2006.12.007
   Uppin AA, 2003, RADIOLOGY, V226, P119, DOI 10.1148/radiol.2261011911
   Urrutia J, 2008, SPINE, V33, P877, DOI 10.1097/BRS.0b013e31816b46a5
   van der Werf M, 2007, J ANAT, V211, P769, DOI 10.1111/j.1469-7580.2007.00816.x
   Verlaan JJ, 2004, J BONE JOINT SURG AM, V86A, P1230, DOI 10.2106/00004623-200406000-00016
   Verlaan JJ, 2005, SPINE, V30, pE73, DOI 10.1097/01.brs.0000152162.64015.fb
   Wilke HJ, 1997, ANAT REC, V247, P542, DOI 10.1002/(SICI)1097-0185(199704)247:4<542::AID-AR13>3.0.CO;2-P
   Zarrinkalam MR, 2009, EUR SPINE J, V18, P244, DOI 10.1007/s00586-008-0813-8
NR 49
TC 7
Z9 8
U1 2
U2 10
PU WILEY-BLACKWELL
PI MALDEN
PA COMMERCE PLACE, 350 MAIN ST, MALDEN 02148, MA USA
SN 1552-4973
J9 J BIOMED MATER RES B
JI J. Biomed. Mater. Res. Part B
PD APR
PY 2012
VL 100B
IS 3
BP 660
EP 667
DI 10.1002/jbm.b.31990
PG 8
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 901RE
UT WOS:000300983700008
PM 22121034
DA 2018-10-19
ER

PT J
AU Kealey, CP
   Chun, YJ
   Vinuela, FE
   Mohanchandra, KP
   Carman, GP
   Vinuela, F
   Levi, DS
AF Kealey, C. P.
   Chun, Y. J.
   Vinuela, F. E.
   Mohanchandra, K. P.
   Carman, G. P.
   Vinuela, F.
   Levi, D. S.
TI In vitro and in vivo testing of a novel, hyperelastic thin film nitinol
   flow diversion stent
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART B-APPLIED BIOMATERIALS
LA English
DT Article
DE thin film nitinol; intracranial aneurysm; stent; flow-diversion
ID INTRACRANIAL ANEURYSMS; ENDOVASCULAR TREATMENT; CEREBRAL ANEURYSMS;
   SACCULAR ANEURYSMS; EXPERIENCE; ELECTROTHROMBOSIS; EMBOLIZATION
AB A flexible, low profile, flow diversion stent could replace endovascular coiling for the treatment of intracranial aneurysms. Micropatterned-thin film nitinol (TFN) is a novel biomaterial with high potential for use in next-generation endovascular devices. Recent advancements in micropatterning have allowed for fabrication of a hyperelastic thin film nitinol (HE-TFN). In this study, the authors describe in vitro and in vivo testing of novel HE-TFN based flow diverting stents. Two types of HE-TFN with expanded pores having long axes of 300 and 500 mu m were used to fabricate devices. In vitro examination of the early thrombotic response in whole blood showed a possible mechanism for the device's function, whereby HE-TFN serves as a scaffold for blood product deposition. In vivo testing in swine demonstrated rapid occlusion of model wide-neck aneurysms. Average time to occlusion for the 300-mu m device was 10.4 +/- 5.5 min. (N = 5) and 68 +/- 30 min for the 500-mu m device (N = 5). All aneurysms treated with bare metal control stents remained patent after 240 min (N = 3). SEM of acutely harvested devices supported in vitro results, demonstrating that HE-TFN serves as a scaffold for blood product deposition, potentially enhancing its flow-diverting effect. Histopathology of devices after 42 days in vivo demonstrated a healthy neointima and endothelialization of the aneurysm neck region. HE-TFN flow-diverting stents warrant further investigation as a novel treatment for intracranial aneurysms. (c) 2011 Wiley Periodicals, Inc. J Biomed Mater Res Part B: Appl Biomater, 2012.
C1 [Kealey, C. P.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Surg, Los Angeles, CA 90095 USA.
   [Chun, Y. J.] Univ Pittsburgh, Swanson Sch Engn, Dept Ind Engn, Pittsburgh, PA USA.
   [Vinuela, F. E.; Vinuela, F.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Radiol, Div Intervent Neuroradiol, Los Angeles, CA 90095 USA.
   [Mohanchandra, K. P.; Carman, G. P.] Univ Calif Los Angeles, Henry Samueli Sch Engn, Dept Mech & Aerosp Engn, Los Angeles, CA 90095 USA.
   [Levi, D. S.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Pediat, Div Pediat Cardiol, Los Angeles, CA 90095 USA.
RP Kealey, CP (reprint author), Univ Calif Los Angeles, David Geffen Sch Med, Dept Surg, Los Angeles, CA 90095 USA.
EM ckealey@mednet.ucla.edu
FU NINDS NIH HHS [R42 NS074576]
CR Chun YJ, 2010, SMART MATER STRUCT, V19, P10502
   Chun Y, 2011, SMART MATER STRUCT, V20, DOI 10.1088/0964-1726/20/5/055021
   Chun Y, 2009, MAT SCI ENG C-MATER, V29, P2436, DOI 10.1016/j.msec.2009.07.004
   Chun YJ, 2009, J BIOMECH ENG-T ASME, V131, DOI 10.1115/1.3118769
   GUGLIELMI G, 1991, J NEUROSURG, V75, P1, DOI 10.3171/jns.1991.75.1.0001
   GUGLIELMI G, 1991, J NEUROSURG, V75, P8, DOI 10.3171/jns.1991.75.1.0008
   Ho KK, 2000, THIN SOLID FILMS, V370, P18, DOI 10.1016/S0040-6090(00)00947-0
   Kealey CP, 2010, BIOMATERIALS, V31, P8864, DOI 10.1016/j.biomaterials.2010.08.014
   Levi DS, 2008, ASAIO J, V54, P221, DOI 10.1097/MAT.0b013e31816b43b0
   Lubicz B, 2010, STROKE, V41, P2247, DOI 10.1161/STROKEAHA.110.589911
   Lylyk P, 2009, NEUROSURGERY, V64, P632, DOI 10.1227/01.NEU.0000339109.98070.65
   Mawad ME, 2002, J NEUROSURG, V96, P474, DOI 10.3171/jns.2002.96.3.0474
   Murayama Y, 2003, J NEUROSURG, V98, P959, DOI 10.3171/jns.2003.98.5.0959
   Piotin M, 2010, STROKE, V41, P110, DOI 10.1161/STROKEAHA.109.558114
   Rigberg D, 2009, J VASC SURG, V50, P375, DOI 10.1016/j.jvs.2009.03.028
   Tulloch AW, 2010, J SURG RES, V4, P1
   Wong GKC, 2011, J CLIN NEUROSCI, V18, P737, DOI 10.1016/j.jocn.2010.10.011
NR 17
TC 11
Z9 11
U1 0
U2 18
PU WILEY-BLACKWELL
PI MALDEN
PA COMMERCE PLACE, 350 MAIN ST, MALDEN 02148, MA USA
SN 1552-4973
J9 J BIOMED MATER RES B
JI J. Biomed. Mater. Res. Part B
PD APR
PY 2012
VL 100B
IS 3
BP 718
EP 725
DI 10.1002/jbm.b.32504
PG 8
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 901RE
UT WOS:000300983700015
PM 22121079
DA 2018-10-19
ER

PT J
AU Xia, ZM
   Yu, XH
   Wei, M
AF Xia, Zengmin
   Yu, Xiaohua
   Wei, Mei
TI Biomimetic collagen/apatite coating formation on Ti6Al4V substrates
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART B-APPLIED BIOMATERIALS
LA English
DT Review
DE collagen; apatite composite coating; biomimetic; bonding strength;
   osteoblast activity
ID OSTEOBLAST-LIKE CELLS; TITANIUM IMPLANT SURFACES; CALCIUM-PHOSPHATE; I
   COLLAGEN; BIOLOGICAL-ACTIVITY; BONDING STRENGTH; APATITE;
   HYDROXYAPATITE; IMMOBILIZATION; ADHESION
AB Hydroxyapatite and type I collagen are two major components of natural bone. They have been used extensively to engineer biomaterial surfaces for enhanced implant-bone integrations. In this study, a collagen/apatite composite coating was successfully deposited on treated Ti6Al4V surfaces by coprecipitation of type I collagen and apatite in a collagen-containing modified simulated body fluid (m-SBF). X-ray diffraction and Fourier-transform infrared spectroscopy results indicated that the coating achieved was a composite of bone-like carbonated apatite and collagen type I, which is similar to the composition of natural bone. The coating composition and morphology could be tailored by carefully adjusting the collagen concentration in the m-SBF. In addition, both the coating thickness and bonding strength were down regulated by the collagen concentration in the m-SBF. Collagen inhibited the apatite nucleation on the metallic substrate, and thereby reduced the bonding strength of the composite coating. In addition, an in vitro cell culture study was conducted on both the apatite and the collagen-apatite coating surfaces. Addition of collagen promoted osteoblast activities, which may lead to early bone formation. (C) 2011 Wiley Periodicals, Inc. J Biomed Mater Res Part B: Appl Biomater, 2012.
C1 [Xia, Zengmin; Yu, Xiaohua; Wei, Mei] Univ Connecticut, Dept Chem Mat & Biomol Engn, Storrs, CT 06269 USA.
RP Wei, M (reprint author), Univ Connecticut, Dept Chem Mat & Biomol Engn, Storrs, CT 06269 USA.
EM m.wei@ims.uconn.edu
RI Yu, Xiaohua/J-9903-2014
FU National Science Foundation [DMI 0500269, BES 0503315]; Teleflex Medical
   Inc
FX Contract grant sponsor: National Science Foundation; contract grant
   numbers: DMI 0500269, BES 0503315; Contract grant sponsor: Teleflex
   Medical Inc
CR Abraham LC, 2008, J BIOMED MATER RES B, V87B, P264, DOI 10.1002/jbm.b.31078
   Aita H, 2009, ACTA BIOMATER, V5, P3247, DOI 10.1016/j.actbio.2009.04.022
   Att W, 2009, BIOMATERIALS, V30, P4268, DOI 10.1016/j.biomaterials.2009.04.048
   Barrere F, 2002, BIOMATERIALS, V23, P1921, DOI 10.1016/S0142-9612(01)00318-0
   Barrere F, 2004, BIOMATERIALS, V25, P2901, DOI 10.1016/j.biomaterials.2003.09.063
   Bohner M, 2009, BIOMATERIALS, V30, P2175, DOI 10.1016/j.biomaterials.2009.01.008
   Bradt JH, 1999, CHEM MATER, V11, P2694, DOI 10.1021/cm991002p
   BURRIDGE K, 1988, ANNU REV CELL BIOL, V4, P487, DOI 10.1146/annurev.cb.04.110188.002415
   Chen Y, 2008, J MATER SCI-MATER M, V19, P2261, DOI 10.1007/s10856-007-3335-8
   Chen Y, 2006, J BIOMED MATER RES B, V77B, P315, DOI 10.1002/jbm.b.30356
   Chen Y, 2008, J MATER SCI-MATER M, V19, P2563, DOI 10.1007/s10856-007-3195-2
   Cheng ZY, 2004, BIOMATERIALS, V25, P1991, DOI 10.1016/j.biomaterials.2003.08.038
   Combes C, 2002, BIOMATERIALS, V23, P2817, DOI 10.1016/S0142-9612(02)00073-X
   de Jonge LT, 2008, PHARM RES-DORDR, V25, P2357, DOI 10.1007/s11095-008-9617-0
   de Jonge LT, 2010, BIOMATERIALS, V31, P2461, DOI 10.1016/j.biomaterials.2009.11.114
   EANES ED, 1965, NATURE, V208, P365, DOI 10.1038/208365a0
   Elias CN, 2008, J MECH BEHAV BIOMED, V1, P234, DOI 10.1016/j.jmbbm.2007.12.002
   Fan YW, 2005, BIOMATERIALS, V26, P1623, DOI 10.1016/j.biomaterials.2004.06.019
   Fischer U, 2003, BIOMATERIALS, V24, P2631, DOI 10.1016/S0142-9612(03)00068-1
   Geissler U, 2000, J BIOMED MATER RES, V51, P752, DOI 10.1002/1097-4636(20000915)51:4<752::AID-JBM25>3.0.CO;2-7
   GROSS J, 1958, J BIOL CHEM, V233, P355
   Hsu YM, 2009, J BIOMED MATER RES B, V91B, P737, DOI 10.1002/jbm.b.31450
   Hu Kai, 2007, Frontiers of Materials Science in China, V1, P229, DOI 10.1007/s11706-007-0041-x
   Hu R, 2010, MATER LETT, V64, P915, DOI 10.1016/j.matlet.2010.01.057
   Kamitakahara M, 2007, BIOMED MATER, V2, pR17, DOI 10.1088/1748-6041/2/4/R01
   Kim HM, 1997, J BIOMED MATER RES, V38, P121
   Kim HM, 2001, KEY ENG MATER, V192-195, P47, DOI DOI 10.4028/WWW.SCIENTIFIC.NET/KEM.192-195.47
   Li PJ, 2003, J BIOMED MATER RES A, V66A, P79, DOI 10.1002/jbm.a.10519
   Liu XY, 2008, ACTA BIOMATER, V4, P544, DOI 10.1016/j.actbio.2008.01.011
   Liu Y, 2003, BIOMATERIALS, V24, P65, DOI 10.1016/S0142-9612(02)00252-1
   Liu YL, 2004, TISSUE ENG, V10, P101, DOI 10.1089/107632704322791745
   Liu YL, 2001, J BIOMED MATER RES, V57, P327, DOI 10.1002/1097-4636(20011205)57:3<327::AID-JBM1175>3.0.CO;2-J
   Lu X, 2005, BIOMATERIALS, V26, P1097, DOI 10.1016/j.biomaterials.2004.05.034
   Manara S, 2008, INORG CHIM ACTA, V361, P1634, DOI 10.1016/j.ica.2007.03.044
   Meyer U, 2005, Eur Cell Mater, V9, P39
   Miao SD, 2009, J MATER SCI-MATER M, V20, P131, DOI 10.1007/s10856-008-3552-9
   Mizuno M, 2000, J CELL PHYSIOL, V184, P207, DOI 10.1002/1097-4652(200008)184:2<207::AID-JCP8>3.3.CO;2-L
   Morra M, 2006, J BIOMED MATER RES A, V78A, P449, DOI 10.1002/jbm.a.30783
   Morra M, 2003, BIOMATERIALS, V24, P4639, DOI 10.1016/S0142-9612(03)00360-0
   Muller R, 2006, BIOMATERIALS, V27, P4059, DOI 10.1016/j.biomaterials.2006.03.019
   Muller R, 2005, BIOMATERIALS, V26, P6962, DOI 10.1016/j.biomaterials.2005.05.013
   Qu HB, 2008, J AM CERAM SOC, V91, P3211, DOI 10.1111/j.1551-2916.2008.02634.x
   Qu HB, 2008, J BIOMED MATER RES B, V87B, P204, DOI 10.1002/jbm.b.31096
   Qu HB, 2008, J BIOMED MATER RES B, V84B, P436, DOI 10.1002/jbm.b.30889
   Rajan N, 2006, NAT PROTOC, V1, P2753, DOI 10.1038/nprot.2006.430
   Rammelt S, 2006, BIOMATERIALS, V27, P5561, DOI 10.1016/j.biomaterials.2006.06.034
   Roehlecke C, 2001, CELLS TISSUES ORGANS, V168, P178, DOI 10.1159/000047833
   Rossler S, 1999, J MATER SCI LETT, V18, P577, DOI 10.1023/A:1006647116608
   Rupp F, 2006, J BIOMED MATER RES A, V76A, P323, DOI 10.1002/jbm.a.30518
   SABOKBAR A, 1994, BONE MINER, V27, P57, DOI 10.1016/S0169-6009(08)80187-0
   Schliephake H, 2003, J BIOMED MATER RES A, V64A, P225, DOI 10.1002/jbm.a.10363
   Shu R, 2003, J BIOMED MATER RES A, V67A, P1196, DOI 10.1002/jbm.a.20021
   Teng SH, 2008, J MATER SCI-MATER M, V19, P2453, DOI 10.1007/s10856-008-3370-0
   Ueda M, 2009, MAT SCI ENG C-MATER, V29, P2246, DOI 10.1016/j.msec.2009.05.008
   van den Dolder J, 2007, J BIOMED MATER RES A, V83A, P712, DOI 10.1002/jbm.a.31428
   Wang H, 2009, APPL SURF SCI, V255, P4074, DOI 10.1016/j.apsusc.2008.10.111
   Wu WJ, 1997, COLLOID SURFACE B, V10, P87, DOI 10.1016/S0927-7765(97)00054-4
   Yamaguchi T, 1998, BIOCHEM BIOPH RES CO, V243, P753, DOI 10.1006/bbrc.1998.8178
   Zhang L, 2008, MATER LETT, V58, P719
   Zhang YJ, 2009, J BIOMED MATER RES B, V89B, P408, DOI 10.1002/jbm.b.31228
   Zhao G, 2005, J BIOMED MATER RES A, V74A, P49, DOI 10.1002/jbm.a.30320
NR 61
TC 26
Z9 26
U1 5
U2 46
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1552-4973
EI 1552-4981
J9 J BIOMED MATER RES B
JI J. Biomed. Mater. Res. Part B
PD APR
PY 2012
VL 100B
IS 3
BP 871
EP 881
DI 10.1002/jbm.b.31970
PG 11
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 901RE
UT WOS:000300983700032
PM 22102365
DA 2018-10-19
ER

PT J
AU Gil, FJ
   Delgado, L
   Espinar, E
   Llamas, JM
AF Gil, F. J.
   Delgado, L.
   Espinar, E.
   Llamas, J. M.
TI Corrosion and corrosion-fatigue behavior of cp-Ti and Ti-6Al-4V
   laser-marked biomaterials
SO JOURNAL OF MATERIALS SCIENCE-MATERIALS IN MEDICINE
LA English
DT Article
ID DENTAL ALLOYS; TITANIUM
AB The aim of this work was to determine the influence of laser surface modification treatments on mechanical and electrochemical behavior in Ti and Ti-6Al-4V implants. For each metal, different samples were laser modified simulating the markings according to the international requirements. (It is necessary in each metallic biomaterial to mark the serial, batch and company numbers.) Microstructural changes produced by this treatment were observed: (a) the melting zone with small grain sizes and martensitic structures in above-mentioned metals and (b) the heat-affected zone (HAZ) with alpha phase in cp-Titanium with bigger grain sizes and Widmanstatten structure in Ti-6Al-4V. Positive tensile residual stress was determined by means X-ray analysis in the zones marked by laser. Furthermore, corrosion behavior was studied in a simulated body fluid at 37A degrees C. Pitting was observed in different zones near the HAZ and the results showed a decrease of the corrosion resistance in the laser treated samples. Residual stresses and the martensitic microstructures favoured the decrease of the corrosion-fatigue life around 20% of both metals under physiological conditions.
C1 [Gil, F. J.; Delgado, L.] Univ Politecn Cataluna, Dept Ciencia Mat & Ingn Met, ETSEIB, CIBER BBN, E-08028 Barcelona, Spain.
   [Espinar, E.; Llamas, J. M.] Univ Seville, Grp Invest Ortodoncia, Fac Odontol, Seville, Spain.
RP Gil, FJ (reprint author), Univ Politecn Cataluna, Dept Ciencia Mat & Ingn Met, ETSEIB, CIBER BBN, Av Diagonal 647, E-08028 Barcelona, Spain.
EM francesc.xavier.gil@upc.edu
OI Delgado, Luis Maria/0000-0001-7094-2966; Espinar Escalona,
   Eduardo/0000-0001-9120-7805
FU CICYT [MAT2009-13547]
FX The authors thank to the CICYT project MAT2009-13547 for their financial
   support.
CR BABOIAN R, 2004, ASTM STP, V576, P6
   CANAY S, 1992, J DENT RES, V23, P279
   Cortada M, 2000, J MATER SCI-MATER M, V11, P287, DOI 10.1023/A:1008905229522
   GEISGERSTORFER J, 1994, J DENT, V22, P247, DOI 10.1016/0300-5712(94)90124-4
   Lautenschlager EP, 1993, INT DENT J, V43, P253
   Lucas L C, 1992, Adv Dent Res, V6, P32
   MANSFELD F, 2003, INSTRUMENTATION CORR
   Margolin H., 1970, SCI TECHNOLOGY APPL, P795
   Rondelli G, 2002, BIOMATERIALS, V23, P639, DOI 10.1016/S0142-9612(01)00142-9
   Sevilla P, 2008, J MATER SCI-MATER M, V19, P525, DOI 10.1007/s10856-007-0164-8
   Singh R, 2006, J BIOMATER APPL, V21, P49, DOI 10.1177/0885328206055998
   Sjogen G, 1988, ACTA ODONTOL SCAND, V46, P253
   Tambasco J, 1996, J DENT TECH, V13, P31
   Zavanelli RA, 2004, J ORAL REHABIL, V31, P1029, DOI 10.1111/j.1365-2842.2004.01336.x
NR 14
TC 7
Z9 7
U1 2
U2 27
PU SPRINGER
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 0957-4530
J9 J MATER SCI-MATER M
JI J. Mater. Sci.-Mater. Med.
PD APR
PY 2012
VL 23
IS 4
BP 885
EP 890
DI 10.1007/s10856-012-4572-z
PG 6
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 919RE
UT WOS:000302345400003
PM 22350853
DA 2018-10-19
ER

PT J
AU Zhang, F
   Liu, YJ
   Xiao, XC
   Cai, XY
   Li, H
   Wang, YD
AF Zhang, F.
   Liu, Y. J.
   Xiao, X. C.
   Cai, X. Y.
   Li, H.
   Wang, Y. D.
TI Synthesis and characterisation of highly ordered mesoporous Fe2O3-SiO2
   composite and its removal properties of azo dyes from aqueous solution
SO MATERIALS TECHNOLOGY
LA English
DT Article
DE Fe2O3-SiO2 composite; Mesoporous structure; Azo dyes; Removal
   performance
ID MOLECULAR-SIEVES; MCM-41 MATERIALS; PHOTOCATALYTIC SHELL; BIOMATERIAL
   SYSTEM; MAGNETIC CORE; ANTIMICROBIAL ACTIVITY; SULFIDE NANOPARTICLES;
   CATALYTIC COMBUSTION; INFRARED-ABSORPTION; SURFACE SYNTHESIS
AB Highly ordered mesoporous material MCM-41 was synthesised from tetraethylorthosilicate as an Si source and cetyltrimethylammonium bromide as a template. Fe2O3 with 100 wt-% was introduced into the highly ordered mesoporous MCM-41 by chemical precipitation method to prepare the highly ordered mesoporous Fe2O3-SiO2 composite. The samples were characterised by X-ray diffraction, scanning electron microscopy, transmission electron microscopy, Fourier transformed infrared spectroscopy, X-ray photoelectron spectroscopy, UV-vis spectrophotometry, and nitrogen adsorption-desorption measurement respectively. The results indicate that the synthesised Fe2O3-SiO2 composite has a highly ordered mesoporous structure with a specific surface area of 593 m(2) g(-1) and a pore volume of 0.322 cm(3) g(-1). The performance of Fe2O3-SiO2 composite as a remover was further demonstrated in the removal of methyl orange (MO), Congo red, methylene blue (MB), rhodaming B (RB) under visible light irradiation respectively. A good ability to remove MB, RB and MO can be obtained. In especially, the Fe2O3-SiO2 composite shows an excellent removal performance for MB under the room temperature in short time, making them to be promising candidates for wastewater treatment.
C1 [Zhang, F.; Xiao, X. C.; Cai, X. Y.; Li, H.; Wang, Y. D.] Yunnan Univ, Dept Mat Sci & Engn, Kunming 650091, Peoples R China.
   [Liu, Y. J.] Yunnan Univ, Adv Anal & Measurement Ctr, Kunming 650091, Peoples R China.
RP Wang, YD (reprint author), Yunnan Univ, Dept Mat Sci & Engn, Kunming 650091, Peoples R China.
EM ydwang@ynu.edu.cn
FU Department of Science and Technology of Yunnan Province [2011FA001];
   Chinese Ministry of Education [210206]; National Natural Science
   Foundation of China [50662006]
FX This work was supported by the Department of Science and Technology of
   Yunnan Province via the Key Project for the Science and Technology
   (grant no. 2011FA001), the Key Project of Chinese Ministry of Education
   (grant no. 210206), and National Natural Science Foundation of China
   (grant no. 50662006).
CR Anbia M, 2010, APPL SURF SCI, V256, P3228, DOI 10.1016/j.apsusc.2009.12.010
   Anwander R, 2000, J PHYS CHEM B, V104, P3532, DOI 10.1021/jp993108d
   Araujo AS, 2000, THERMOCHIM ACTA, V345, P173, DOI 10.1016/S0040-6031(99)00374-3
   Asuha S, 2010, J HAZARD MATER, V181, P204, DOI 10.1016/j.jhazmat.2010.04.117
   BECK JS, 1992, J AM CHEM SOC, V114, P10834, DOI 10.1021/ja00053a020
   Cai Q, 1999, MICROPOR MESOPOR MAT, V32, P1, DOI 10.1016/S1387-1811(99)00082-7
   Choma J, 2002, APPL SURF SCI, V196, P216, DOI 10.1016/S0169-4332(02)00060-0
   Chuah GK, 2002, J MOL CATAL A-CHEM, V181, P25, DOI 10.1016/S1381-1169(01)00349-1
   CHUNG KT, 1992, CRIT REV MICROBIOL, V18, P175, DOI 10.3109/10408419209114557
   CHUNG KT, 1993, ENVIRON TOXICOL CHEM, V12, P2121, DOI 10.1897/1552-8618(1993)12[2121:DOADBE]2.0.CO;2
   Corma A, 1997, CHEM REV, V97, P2373, DOI 10.1021/cr960406n
   Crini G, 2006, BIORESOURCE TECHNOL, V97, P1061, DOI 10.1016/j.biortech.2005.05.001
   De Stefanis A, 2007, MICROPOR MESOPOR MAT, V99, P140, DOI 10.1016/j.micromeso.2006.08.033
   Deligeer W, 2011, APPL SURF SCI, V257, P3524, DOI 10.1016/j.apsusc.2010.11.067
   Dhas NA, 1999, CHEM MATER, V11, P806, DOI 10.1021/cm980670s
   Dhas NA, 1997, CHEM MATER, V9, P3144, DOI 10.1021/cm9704488
   Dhas NA, 1997, J PHYS CHEM B, V101, P9495, DOI 10.1021/jp971385j
   Dhas NA, 1998, APPL PHYS LETT, V72, P2514, DOI 10.1063/1.120624
   GASKELL PH, 1976, J NON-CRYST SOLIDS, V20, P153, DOI 10.1016/0022-3093(76)90130-7
   Gervasini A, 2009, J CATAL, V262, P224, DOI 10.1016/j.jcat.2008.12.016
   Gervasini A, 2008, J PHYS CHEM C, V112, P4635, DOI 10.1021/jp710742g
   Gondal MA, 2004, CHEM PHYS LETT, V385, P111, DOI 10.1016/j.cplett.2003.12.066
   Hagen A, 2002, MICROPOR MESOPOR MAT, V51, P23, DOI 10.1016/S1387-1811(01)00465-6
   Heger D, 2005, J PHYS CHEM A, V109, P6702, DOI 10.1021/jp050439j
   Herrera F, 2001, APPL CATAL B-ENVIRON, V29, P147, DOI 10.1016/S0926-3373(00)00198-3
   Hong RY, 2008, MATER CHEM PHYS, V108, P132, DOI 10.1016/j.matchemphys.2007.09.014
   Hu JS, 2008, ADV MATER, V20, P2977, DOI 10.1002/adma.200800623
   HU SM, 1980, J APPL PHYS, V51, P5945, DOI 10.1063/1.327512
   Huang PX, 2005, J PHYS CHEM B, V109, P19169, DOI 10.1021/jp052978u
   Ji PF, 2008, J PHYS CHEM C, V112, P17809, DOI 10.1021/jp8054087
   KIRK CT, 1988, PHYS REV B, V38, P1255, DOI 10.1103/PhysRevB.38.1255
   Kong Y, 2005, MICROPOR MESOPOR MAT, V86, P191, DOI 10.1016/j.micromeso.2005.07.006
   Kong Y, 2004, ADV FUNCT MATER, V14, P816, DOI 10.1002/adfm.200305111
   KRESGE CT, 1992, NATURE, V359, P710, DOI 10.1038/359710a0
   Li Y, 2004, J PHYS CHEM B, V108, P9739, DOI 10.1021/jp049824j
   Lindlar B, 2000, MICROPOR MESOPOR MAT, V38, P167, DOI 10.1016/S1387-1811(99)00291-7
   Liu HY, 2006, J AM CERAM SOC, V89, P370, DOI 10.1111/j.1551-2916.2005.00686.x
   Llusar M, 2009, J EUR CERAM SOC, V29, P3319, DOI 10.1016/j.jeurceramsoc.2009.07.018
   Lu XH, 2010, J MATER CHEM, V20, P7118, DOI 10.1039/c0jm00487a
   Okamura J, 1998, J MOL CATAL A-CHEM, V135, P133, DOI 10.1016/S1381-1169(97)00298-7
   Ortega D, 2006, J NON-CRYST SOLIDS, V352, P2801, DOI 10.1016/j.jnoncrysol.2006.03.056
   Panda N, 2011, J HAZARD MATER, V185, P359, DOI 10.1016/j.jhazmat.2010.09.042
   Parvulescu V, 2001, CATAL TODAY, V69, P315, DOI 10.1016/S0920-5861(01)00384-4
   Popa A, 2008, APPL SURF SCI, V255, P1830, DOI 10.1016/j.apsusc.2008.06.040
   Popova M, 2009, J HAZARD MATER, V168, P226, DOI 10.1016/j.jhazmat.2009.02.018
   Pradhan G. K., 2010, INT J ENG SCI TECHNO, V2, P53
   Rana S, 2006, ACTA BIOMATER, V2, P421, DOI 10.1016/j.actbio.2006.03.005
   Rana S, 2005, ACTA BIOMATER, V1, P691, DOI 10.1016/j.actbio.2005.07.007
   Rana S, 2005, MAT SCI ENG B-SOLID, V119, P144, DOI 10.1016/j.mseb.2005.02.043
   Rauf MA, 2011, DESALINATION, V276, P13, DOI 10.1016/j.desal.2011.03.071
   Rawat J, 2007, MATER SCI TECH-LOND, V23, P97, DOI 10.1179/174328407X158488
   Rawat J, 2007, MAT SCI ENG C-BIO S, V27, P540, DOI 10.1016/j.msec.2006.05.021
   Robinson T, 2001, BIORESOURCE TECHNOL, V77, P247, DOI 10.1016/S0960-8524(00)00080-8
   Rott U, 1999, WATER SCI TECHNOL, V40, P137, DOI 10.1016/S0273-1223(99)00381-9
   Run MT, 2005, CHINESE J INORG CHEM, V21, P1165
   Song XL, 2008, COLLOID SURFACE A, V313, P193, DOI 10.1016/j.colsurfa.2007.05.040
   Sorokin AB, 2000, CATAL TODAY, V57, P45, DOI 10.1016/S0920-5861(99)00312-0
   Stefanis A. D., 2007, MICROPOR MESOPOR MAT, V99, P140
   Sun K, 2008, J CATAL, V254, P383, DOI 10.1016/j.jcat.2008.01.017
   Sunkara BK, 2008, ACTA BIOMATER, V4, P273, DOI 10.1016/j.actbio.2007.07.002
   Suranjana C., 2009, CATAL TODAY, V141, P225
   Vinu A, 2004, J PHYS CHEM B, V108, P7323, DOI 10.1021/jp037303a
   Wu C, 2008, MICROPOR MESOPOR MAT, V113, P163, DOI 10.1016/j.micromeso.2007.11.013
   Wu RC, 2005, WATER RES, V39, P630, DOI 10.1016/j.watres.2004.11.005
   Wu RC, 2004, APPL CATAL B-ENVIRON, V48, P49, DOI 10.1016/j.apcatb.2003.09.006
   Ye J, 2003, J INORG MATER, V18, P677
   Zayat MZ, 2003, ADV MATER, V15, P1809, DOI 10.1002/adma.200305436
   Zhao DY, 1998, SCIENCE, V279, P548, DOI 10.1126/science.279.5350.548
   Zollinger H, 1991, COLOR CHEM SYNTHESES
NR 69
TC 6
Z9 6
U1 3
U2 49
PU MANEY PUBLISHING
PI LEEDS
PA STE 1C, JOSEPHS WELL, HANOVER WALK, LEEDS LS3 1AB, W YORKS, ENGLAND
SN 1066-7857
J9 MATER TECHNOL
JI Mater. Technol.
PD APR
PY 2012
VL 27
IS 2
BP 196
EP 204
DI 10.1179/1753555712Y.0000000003
PG 9
WC Materials Science, Multidisciplinary
SC Materials Science
GA 916TZ
UT WOS:000302127400010
DA 2018-10-19
ER

PT J
AU Parravicini, R
   Cocconcelli, F
   Verona, A
   Parravicini, V
   Giuliani, E
   Barbieri, A
AF Parravicini, Roberto
   Cocconcelli, Flavio
   Verona, Alessandro
   Parravicini, Valeriano
   Giuliani, Enrico
   Barbieri, Alberto
TI Tuna Cornea as Biomaterial for Cardiac Applications
SO TEXAS HEART INSTITUTE JOURNAL
LA English
DT Article
DE Biocompatible materials; bioprosthesis; heart valve diseases/surgery;
   heart valve prosthesis implantation/methods; models, cardiovascular;
   prosthesis design; tissue engineering/methods; transplantation,
   heterologous; tuna
ID STRUCTURAL-ANALYSIS; THUNNUS; CALCIFICATION
AB Among available biomaterials, cornea is almost completely devoid of cells and is composed only of collagen fibers oriented in an orderly pattern, which contributes to low antigenicity. Thunnus thynnus, the Atlantic bluefin tuna, is a fish with large eyes that can withstand pressures of approximately 10 MPa. We evaluated the potential of this tuna cornea in cardiac bioimplantation.
   Eyes from freshly caught Atlantic bluefin tuna were harvested and preserved in a fixative solution. Sterilized samples of corneal stroma were embedded in paraffin and stained with hematoxylin and eosin, and the histologic features were studied. Physical and mechanical resistance tests were performed in comparison with bovine pericardial strips and porcine mitral valves. Corneal material was implanted subcutaneously in 7 rats, to evaluate in vivo calcification rates. Mitral valves made from tuna corneal leaflets were implanted in 9 sheep.
   We found that the corneal tissue consisted only of parallel collagen fibers without evidence of vascular or neural structures. In tensile strength, the tuna corneal specimens were substantially similar to bovine pericardium. After 23 days, the rat-implanted samples showed no calcium or calcium salt deposition. Hydrodynamic and fatigue testing of valve prototypes yielded acceptable functional and long-term behavioral results. In the sheep, valvular performance was stable during the 180-day follow-up period, with no instrumental sign of calcification at the end of observation.
   We conclude that low antigenicity and favorable physical properties qualify tuna cornea as a potential material for durable bioimplantation. Further study is warranted. (Tex Heart Inst J 2012;39(2):179-83)
C1 [Parravicini, Roberto; Cocconcelli, Flavio; Verona, Alessandro] Univ Modena & Reggio Emilia, Dept Cardiovasc Surg, I-41124 Modena, Italy.
   [Giuliani, Enrico] Univ Modena & Reggio Emilia, Dept Surg, I-41124 Modena, Italy.
   [Barbieri, Alberto] Univ Modena & Reggio Emilia, Dept Emergency, I-41124 Modena, Italy.
   [Parravicini, Valeriano] Univ Genoa, Dept Environm Studies, I-76126 Genoa, Italy.
RP Parravicini, R (reprint author), Policlin, Via Pozzo 71, I-41124 Modena, Italy.
EM roberto.parravicini@unimore.it
RI Giuliani, Enrico/L-2158-2016; Parravicini, Valeriano/A-8539-2011;
   Barbieri, Alberto/L-1427-2016
OI Giuliani, Enrico/0000-0001-7140-7850; Barbieri,
   Alberto/0000-0002-3904-1323; Parravicini, Valeriano/0000-0002-3408-1625
CR Badylak SE, 2008, SEMIN IMMUNOL, V20, P109, DOI 10.1016/j.smim.2007.11.003
   Butany J, 2001, J Long Term Eff Med Implants, V11, P115
   Guerraty M, 2007, J INVEST MED, V55, P278, DOI 10.2310/6650.2007.00012
   Guldner NW, 2009, CIRCULATION, V119, P1653, DOI 10.1161/CIRCULATIONAHA.108.823948
   Hayward CJ, 2009, J FISH DIS, V32, P101, DOI 10.1111/j.1365-2761.2008.01010.x
   Hayward CJ, 2010, VET PARASITOL, V173, P107, DOI 10.1016/j.vetpar.2010.06.007
   Jamieson WRE, 2009, EUR J CARDIO-THORAC, V36, P818, DOI 10.1016/j.ejcts.2009.05.020
   LEE JM, 1994, AM SOC TEST MATER, V1173, P19, DOI 10.1520/STP18091S
   Morimoto K, 2004, BIOSCI BIOTECH BIOCH, V68, P861, DOI 10.1271/bbb.68.861
   Munday BL, 2003, J FISH DIS, V26, P187, DOI 10.1046/j.1365-2761.2003.00454.x
   Rao KP, 1999, J BIOMATER APPL, V13, P238, DOI 10.1177/088532829901300305
   Trabuco EC, 2007, INT UROGYNECOL J, V18, P555, DOI 10.1007/s00192-006-0288-2
NR 12
TC 1
Z9 2
U1 0
U2 10
PU TEXAS HEART INST
PI HOUSTON
PA PO BOX 20345, HOUSTON, TX 77225-0345 USA
SN 0730-2347
J9 TEX HEART I J
JI Tex. Heart Inst. J.
PD APR
PY 2012
VL 39
IS 2
BP 179
EP 183
PG 5
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA 921NS
UT WOS:000302484900004
PM 22740728
DA 2018-10-19
ER

PT J
AU Kousha, M
   Daneshvar, E
   Esmaeli, AR
   Jokar, M
   Khataee, AR
AF Kousha, M.
   Daneshvar, E.
   Esmaeli, A. R.
   Jokar, M.
   Khataee, A. R.
TI Optimization of Acid Blue 25 removal from aqueous solutions by raw,
   esterified and protonated Jania adhaerens biomass
SO INTERNATIONAL BIODETERIORATION & BIODEGRADATION
LA English
DT Article
DE Biosorption; Red algae; Experimental design; Box-Behnken; Textile dye
ID RESPONSE-SURFACE METHODOLOGY; ASPERGILLUS-NIGER; FLY-ASH;
   CHEMICAL-MODIFICATION; DYE WASTEWATERS; REACTIVE DYE; PEANUT HULL;
   BIOSORPTION; DECOLORIZATION; BIOSORBENTS
AB Box-Behnken design, which is well suited for fitting a quadratic surface and usually works well for the process optimization, was employed to optimize the removal of Acid Blue 25 (AB25) using untreated, methanol and HCl pretreated red alga, Jania adhaerens. Biomass was pretreated using hydrochloric acid 0.1 M with pure anhydrous methanol for esterification reaction and hydrochloric acid 1 M for protonation reaction. The effects of independent parameters such as biomass amount (0.2-1.4 g L-1), initial dye concentration (20-100 mg L-1) and initial pH of solution (2-6) on the AB25 biosorption were investigated through Box-Behnken design. The values of square of correlation coefficient (R-2) were 0.9946, 0.9908 and 0.9903 for untreated, methanol and HCl pretreated J. adhaerens biomass, respectively. The results showed that the maximum dye removal efficiency for untreated, methanol and HCl pretreated J. adhaerens biomass was 51.17%, 59.49%, and 85.80%, respectively. These findings revealed that pretreating biomass by HCl effectively increased AB25 removal from aqueous solution. The present work suggests that J. adhaerens biomass is a suitable biomaterial for dye removal from aqueous solutions. (C) 2012 Elsevier Ltd. All rights reserved.
C1 [Khataee, A. R.] Univ Tabriz, Fac Chem, Dept Appl Chem, Tabriz, Iran.
   [Kousha, M.; Daneshvar, E.; Esmaeli, A. R.] Isfahan Univ Technol, Fac Nat Resources, Dept Fisheries, Esfahan, Iran.
   [Jokar, M.] Isfahan Univ Technol, Fac Nat Resources, Dept Environm Sci, Esfahan, Iran.
RP Khataee, AR (reprint author), Univ Tabriz, Fac Chem, Dept Appl Chem, Tabriz, Iran.
EM a_khataee@tabrizu.ac.ir
RI Khataee, Alireza/E-2874-2015
OI Khataee, Alireza/0000-0002-4673-0223
FU Student Affairs of Isfahan University of Technology; Isfahan Water and
   Sewage Company; Isfahan Municipality
FX We thank Isfahan University of Technology students, Mohammad Salar
   Sohrabi, and Negin Koutahzadeh for their help in laboratory. We would
   like thank to Hossein Mortazavi and Adib Jaberi, the staffs of Isfahan
   Water and Sewage Company, for providing laboratory facilities and space.
   This work was financially supported by Student Affairs of Isfahan
   University of Technology, Isfahan Water and Sewage Company and Isfahan
   Municipality.
CR Amini M, 2009, CLEAN-SOIL AIR WATER, V37, P776, DOI 10.1002/clen.200900090
   Badii k., 2010, INDIAN J CHEM TECHN, V17, P77
   Bai J, 2010, J ENVIRON RADIOACTIV, V101, P969, DOI 10.1016/j.jenvrad.2010.07.003
   Bouzaida I, 2004, J PHOTOCH PHOTOBIO A, V168, P23, DOI 10.1016/j.jphotochem.2004.05.008
   Donmez GC, 1999, PROCESS BIOCHEM, V34, P885
   Enriquez S, 2009, J PHYCOL, V45, P81, DOI 10.1111/j.1529-8817.2008.00640.x
   Fereidouni M, 2009, J HAZARD MATER, V168, P1437, DOI 10.1016/j.jhazmat.2009.03.041
   Figueira MM, 1999, ENVIRON SCI TECHNOL, V33, P1840, DOI 10.1021/es981111p
   Fu YZ, 2001, AATCC REV, V1, P36
   Fu YZ, 2001, BIORESOURCE TECHNOL, V79, P251, DOI 10.1016/S0960-8524(01)00028-1
   Gong RM, 2005, DYES PIGMENTS, V67, P175, DOI 10.1016/j.dyepig.2004.12.003
   Gong RM, 2005, DYES PIGMENTS, V64, P187, DOI 10.1016/j.dyepig.2004.05.05
   Gupta V.K., 2005, IND ENG CHEM RES, V44, P1446
   Ho YS, 2003, PROCESS BIOCHEM, V38, P1047, DOI 10.1016/S0032-9592(02)00239-X
   Kao PC, 2000, J HAZARD MATER, V76, P237, DOI 10.1016/S0304-3894(00)00201-6
   Kapoor A, 1997, BIORESOURCE TECHNOL, V61, P221, DOI 10.1016/S0960-8524(97)00055-2
   Kaushik P, 2009, ENVIRON INT, V35, P127, DOI 10.1016/j.envint.2008.05.010
   Khatace A. R., 2009, Chinese Journal of Applied and Environmental Biology, V15, P110, DOI 10.3724/SP.J.1145.2009.00110
   Khataee AR, 2011, J TAIWAN INST CHEM E, V42, P26, DOI 10.1016/j.jtice.2010.03.007
   Khataee AR, 2009, J HAZARD MATER, V161, P1225, DOI 10.1016/j.jhazmat.2008.04.075
   Kousha M, 2012, INT BIODETER BIODEGR, V67, P56, DOI 10.1016/j.ibiod.2011.10.007
   Kumar KV, 2006, DYES PIGMENTS, V69, P102, DOI 10.1016/j.dyepig.2005.02.005
   Meshko V, 2001, WATER RES, V35, P3357, DOI 10.1016/S0043-1354(01)00056-2
   Nadeem R, 2008, J HAZARD MATER, V150, P335, DOI 10.1016/j.jhazmat.2007.04.110
   Pandey A, 2007, INT BIODETER BIODEGR, V59, P73, DOI 10.1016/j.ibiod.2006.08.006
   Park D, 2005, CHEMOSPHERE, V60, P1356, DOI 10.1016/j.chemosphere.2005.02.020
   Pengthamkeerati P, 2008, J HAZARD MATER, V153, P1149, DOI 10.1016/j.jhazmat.2007.09.074
   Ponnusami V, 2007, J HAZARD MATER, V142, P397, DOI 10.1016/j.jhazmat.2006.08.040
   Shukla SR, 2005, SEP PURIF TECHNOL, V43, P1, DOI 10.1016/j.seppur.2004.09.003
   Sivaraj R, 2001, WASTE MANAGE, V21, P105, DOI 10.1016/S0956-053X(00)00076-3
   Srinivasan A, 2010, J ENVIRON MANAGE, V91, P1915, DOI 10.1016/j.jenvman.2010.05.003
   Vijayaraghavan K, 2008, BIOTECHNOL ADV, V26, P266, DOI 10.1016/j.biotechadv.2008.02.002
   Vijayaraghavan K, 2007, J HAZARD MATER, V141, P45, DOI 10.1016/j.jhazmat.2006.06.081
   Wang SB, 2006, J HAZARD MATER, V136, P482, DOI 10.1016/j.jhazmat.2006.01.067
   Zhao Z., 1999, DYES PIGMENTS, V58, P179
NR 35
TC 13
Z9 13
U1 0
U2 17
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0964-8305
J9 INT BIODETER BIODEGR
JI Int. Biodeterior. Biodegrad.
PD APR
PY 2012
VL 69
BP 97
EP 105
DI 10.1016/j.ibiod.2012.01.007
PG 9
WC Biotechnology & Applied Microbiology; Environmental Sciences
SC Biotechnology & Applied Microbiology; Environmental Sciences & Ecology
GA 915TY
UT WOS:000302051500014
DA 2018-10-19
ER

PT J
AU Lamers, E
   Walboomers, XF
   Domanski, M
   Prodanov, L
   Melis, J
   Luttge, R
   Winnubst, L
   Anderson, JM
   Gardeniers, HJGE
   Jansen, JA
AF Lamers, Edwin
   Walboomers, X. Frank
   Domanski, Maciej
   Prodanov, Ljupcho
   Melis, Jacoline
   Luttge, Regina
   Winnubst, Louis
   Anderson, James M.
   Gardeniers, Han J. G. E.
   Jansen, John A.
TI In vitro and in vivo evaluation of the inflammatory response to
   nanoscale grooved substrates
SO NANOMEDICINE-NANOTECHNOLOGY BIOLOGY AND MEDICINE
LA English
DT Article
DE Inflammatory response; Nanogrooves; Mouse subcutaneous cage implant;
   Macrophages; Cytokines
ID TITANIUM SURFACE-TOPOGRAPHY; BONE MORPHOGENETIC PROTEIN-2; FOREIGN-BODY
   REACTION; TGF-BETA; OSTEOPONTIN; MACROPHAGES; OSTEOBLAST; CYTOKINES;
   DIFFERENTIATION; BIOMATERIALS
AB The immune response to an implanted biomaterial is orchestrated by macrophages. In this study various nanogrooved patterns were created by using laser interference lithography and reactive ion etching. The created nanogrooves mimic the natural extracellular matrix environment. Macrophage cell culture demonstrated that interleukin 1 beta and TNF-alpha cytokine production were upregulated on nanogrooved substrates. In vivo subcutaneous implantation in a validated mouse cage model for 14 days demonstrated that nanogrooves enhanced and guided cell adhesion, and few multinucleated cells were formed. In agreement with the in vitro results, cytokine production was found to be nanogroove dependent, as interleukin 1 beta, TNF-alpha, TGF-beta and osteopontin became upregulated. The results indicate that biomaterial surface texturing, especially at the nanometric scale, can be used to control macrophage activation to induce a wound healing response, rather than a profound inflammatory response.
C1 [Lamers, Edwin; Walboomers, X. Frank; Prodanov, Ljupcho; Melis, Jacoline; Jansen, John A.] Radboud Univ Nijmegen, Med Ctr, Dept Biomat, NL-6500 HB Nijmegen, Netherlands.
   [Domanski, Maciej; Luttge, Regina; Winnubst, Louis; Gardeniers, Han J. G. E.] Univ Twente, MESA Inst Nanotechnol, NL-7500 AE Enschede, Netherlands.
   [Anderson, James M.] Case Western Reserve Univ, Dept Pathol, Cleveland, OH 44106 USA.
RP Jansen, JA (reprint author), Radboud Univ Nijmegen, Med Ctr, Dept Biomat, 309 PB,POB 9101, NL-6500 HB Nijmegen, Netherlands.
EM j.jansen@dent.umcn.nl
RI Gardeniers, Johannes/B-6309-2013; Jansen, John/H-8055-2014; Walboomers,
   X.Frank/B-3692-2013
OI Gardeniers, Johannes/0000-0003-0581-2668; 
FU Dutch Technology Foundation STW, applied science division of NWO;
   Ministry of Economic Affairs [07621]
FX This research is supported by the Dutch Technology Foundation STW,
   applied science division of NWO and the Technology Program of the
   Ministry of Economic Affairs (project # 07621).
CR Anderson JM, 2008, SEMIN IMMUNOL, V20, P86, DOI 10.1016/j.smim.2007.11.004
   Anderson JM, 2004, BIOMATERIALS SCI INT, P296
   Atfi A, 2010, NAT CELL BIOL, V12, P205, DOI 10.1038/ncb0310-205
   Barrientos S, 2008, WOUND REPAIR REGEN, V16, P585, DOI 10.1111/j.1524-475X.2008.00410.x
   Biela SA, 2009, ACTA BIOMATER, V5, P2460, DOI 10.1016/j.actbio.2009.04.003
   Brodbeck WG, 2003, J BIOMED MATER RES A, V64A, P320, DOI 10.1002/jbm.a.10425
   Champagne CM, 2002, BONE, V30, P26, DOI 10.1016/S8756-3282(01)00638-X
   Chen SL, 2010, BIOMATERIALS, V31, P3479, DOI 10.1016/j.biomaterials.2010.01.074
   Cho HJ, 2009, CURR ATHEROSCLER REP, V11, P206, DOI 10.1007/s11883-009-0032-8
   Dalby MJ, 2007, NAT MATER, V6, P997, DOI 10.1038/nmat2013
   Dalby MJ, 2006, BIOMATERIALS, V27, P2980, DOI 10.1016/j.biomaterials.2006.01.010
   ELLIES L G, 1990, Cytokine, V2, P430, DOI 10.1016/1043-4666(90)90052-U
   Frost A, 1997, ACTA ORTHOP SCAND, V68, P91, DOI 10.3109/17453679709003987
   Gerstenfeld LC, 2001, CELLS TISSUES ORGANS, V169, P285, DOI 10.1159/000047893
   Giachelli CM, 2000, MATRIX BIOL, V19, P615, DOI 10.1016/S0945-053X(00)00108-6
   Ingram JH, 2004, BIOMATERIALS, V25, P3511, DOI 10.1016/j.biomaterials.2003.10.054
   Kubo K, 2008, J BIOMED MATER RES A, V87A, P380, DOI 10.1002/jbm.a.31791
   Kunzler TP, 2007, BIOMATERIALS, V28, P2175, DOI 10.1016/j.biomaterials.2007.01.019
   Lamers E, 2010, BIOMATERIALS, V31, P3307, DOI 10.1016/j.biomaterials.2010.01.034
   Lange J, 2010, J ORTHOP RES, V28, P778, DOI 10.1002/jor.21061
   Loesberg WA, 2007, BIOMATERIALS, V28, P3944, DOI 10.1016/j.biomaterials.2007.05.030
   Lu X, 2009, J BIOMED MATER RES B, V90B, P438, DOI 10.1002/jbm.b.31304
   Luttge R, 2007, J VAC SCI TECHNOL B, V25, P2476, DOI 10.1116/1.2800328
   Ma T, 2003, J RHEUMATOL, V30, P2547
   Margadant C, 2010, EMBO REP, V11, P97, DOI 10.1038/embor.2009.276
   McKee MD, 1996, ANAT RECORD, V245, P394, DOI 10.1002/(SICI)1097-0185(199606)245:2<394::AID-AR19>3.0.CO;2-K
   Nakai A, 2008, J HEPATO-BILIARY-PAN, V15, P615, DOI 10.1007/s00534-007-1320-8
   Olmedo ML, 1999, J ORTHOP TRAUMA, V13, P356, DOI 10.1097/00005131-199906000-00006
   OPPENHEIMER ET, 1964, CANCER RES, V24, P379
   Paula NE, 2008, BIOMATERIALS, V29, P4056, DOI 10.1016/j.biomaterials.2008.07.010
   Refai AK, 2004, J BIOMED MATER RES A, V70A, P194, DOI 10.1002/jbm.a.30075
   Rodriguez A, 2009, J BIOMED MATER RES A, V90A, P106, DOI 10.1002/jbm.a.32050
   Ross J, 1996, TRENDS GENET, V12, P171, DOI 10.1016/0168-9525(96)10016-0
   Szalay G, 2009, CIRC RES, V104, P851, DOI 10.1161/CIRCRESAHA.109.193805
   Takebe J, 2003, J BIOMED MATER RES A, V64A, P207, DOI 10.1002/jbm.a.10275
   Tan KS, 2006, BIOMATERIALS, V27, P5170, DOI 10.1016/j.biomaterials.2006.05.002
   van Soest FJ, 2005, JPN J APPL PHYS 1, V44, P6568, DOI 10.1143/JJAP.44.6568
   Walboomers XF, 1998, J BIOMED MATER RES, V42, P634, DOI 10.1002/(SICI)1097-4636(19981215)42:4<634::AID-JBM21>3.3.CO;2-F
   Wang YC, 2010, CANCER RES, V70, P4840, DOI 10.1158/0008-5472.CAN-10-0269
   Weiner S, 1998, ANNU REV MATER SCI, V28, P271, DOI 10.1146/annurev.matsci.28.1.271
   WojciakStothard B, 1996, EXP CELL RES, V223, P426, DOI 10.1006/excr.1996.0098
NR 41
TC 30
Z9 32
U1 2
U2 50
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 1549-9634
J9 NANOMED-NANOTECHNOL
JI Nanomed.-Nanotechnol. Biol. Med.
PD APR
PY 2012
VL 8
IS 3
BP 308
EP 317
DI 10.1016/j.nano.2011.06.013
PG 10
WC Nanoscience & Nanotechnology; Medicine, Research & Experimental
SC Science & Technology - Other Topics; Research & Experimental Medicine
GA 914KS
UT WOS:000301949300006
PM 21704595
DA 2018-10-19
ER

PT J
AU Adamus, A
   Wach, RA
   Olejnik, AK
   Dzierzawska, J
   Rosiak, JM
AF Adamus, Agnieszka
   Wach, Radoslaw A.
   Olejnik, Alicja K.
   Dzierzawska, Joanna
   Rosiak, Janusz M.
TI Degradation of nerve guidance channels based on a poly(L-lactic acid)
   poly(trimethylene carbonate) biomaterial
SO POLYMER DEGRADATION AND STABILITY
LA English
DT Article
DE Hydrolytic degradation; Poly(L-lactic acid); Poly(trimethylene
   carbonate); Nerve regeneration; Methyl cellulose; Radiation
   sterilization
ID IN-VITRO DEGRADATION; 1,3-TRIMETHYLENE CARBONATE; POLY(1,3-TRIMETHYLENE
   CARBONATE); HYDROLYTIC DEGRADATION; EPSILON-CAPROLACTONE; VIVO
   DEGRADATION; COPOLYMERS; REGENERATION; POLYMERS; LACTIDE
AB Poly(L-lactic acid) (PLLA) and in-house synthesized poly(trimethylene carbonate) (PTMC) were used for development of nerve guidance tubes for support of peripheral nervous system regeneration after an injury. Phase separation of a viscous solution of the polymer mixture on a rod in a non-solvent resulted in fabrication of tubular structure of large porosity. After radiation sterilization by electron beam (EB) applied to assure safety of the product, tensile properties and elasticity of manufactured tubes were sufficient for proposed application. Influence of in vitro hydrolytic degradation on molecular weight, thermal properties of the polymers, morphology and mechanical properties of the tubes was evaluated. Besides minor mass loss in the course of 12 months hydrolytic degradation, molecular weight of PLLA component decreased steadily due to hydrolysis of ester bonds. Consequently changes in thermal properties of the polymers such as change in glass transition and melting temperatures were identified. Admixture of methyl cellulose (MC) to PLLA and PTMC synthetic polymers resulted in slight change of mechanical performance of the channels after an initial two weeks of degradation since this water-soluble polymer of natural origin was extracted from the synthetic polymer matrix. Other parameters of the tube and those of synthetic polymers were not affected by the presence of MC. Based on the experimental data, it is confirmed that proposed polymeric material of PLLA/PTMC blend with and without addition of MC is suitable for further biological and in vivo study. (C) 2012 Elsevier Ltd. All rights reserved.
C1 [Adamus, Agnieszka; Wach, Radoslaw A.; Olejnik, Alicja K.; Dzierzawska, Joanna; Rosiak, Janusz M.] Tech Univ Lodz, Inst Appl Radiat Chem, PL-93590 Lodz, Poland.
RP Wach, RA (reprint author), Tech Univ Lodz, Inst Appl Radiat Chem, Wroblewskiego 15, PL-93590 Lodz, Poland.
EM wach@mitr.p.lodz.pl
FU European Commission [MIGR-CT-2007-206269]; Ministry of Science and
   Higher Education, Poland [843/7 PR UE/2008/7]
FX This work has been financed by the European Commission project
   'NerveRegeneration' MIGR-CT-2007-206269 within 7FP and by the Ministry
   of Science and Higher Education, Poland: SPB grant 843/7 PR UE/2008/7.
CR ALBERTSSON AC, 1995, J APPL POLYM SCI, V57, P87, DOI 10.1002/app.1995.070570109
   AMECKE B, 1992, Clinical Materials, V10, P47, DOI 10.1016/0267-6605(92)90084-7
   Bat E, 2009, BIOMATERIALS, V30, P3652, DOI 10.1016/j.biomaterials.2009.03.033
   Chapanian R, 2009, BIOMATERIALS, V30, P295, DOI 10.1016/j.biomaterials.2008.09.038
   Chiang HY, 2005, J NEUROPATH EXP NEUR, V64, P576, DOI 10.1097/01.jnen.0000171654.24836.bd
   Ciardelli G, 2006, MACROMOL BIOSCI, V6, P13, DOI 10.1002/mabi.200500151
   Deumens R, 2010, PROG NEUROBIOL, V92, P245, DOI 10.1016/j.pneurobio.2010.10.002
   DUBOIS P, 1994, POLYMER, V35, P4998, DOI 10.1016/0032-3861(94)90655-6
   DUDA A, 1994, MACROMOL RAPID COMM, V15, P559, DOI 10.1002/marc.1994.030150617
   ENGELBERG I, 1991, BIOMATERIALS, V12, P292, DOI 10.1016/0142-9612(91)90037-B
   FISCHER EW, 1973, KOLLOID Z Z POLYM, V251, P980, DOI 10.1007/BF01498927
   Gonzalez MF, 1999, J APPL POLYM SCI, V71, P1223, DOI 10.1002/(SICI)1097-4628(19990222)71:8<1223::AID-APP2>3.0.CO;2-I
   Gu XS, 2011, PROG NEUROBIOL, V93, P204, DOI 10.1016/j.pneurobio.2010.11.002
   Hartmann AH, 1998, BIOPOLYMERS RENEWABL
   Jiang X, 2010, EXP NEUROL, V223, P86, DOI 10.1016/j.expneurol.2009.09.009
   Jozwiakowska J, 2011, POLYM DEGRAD STABIL, V96, P1430, DOI 10.1016/j.polymdegradstab.2011.05.010
   Kowalska-Ludwicka K, ARCH MED SC IN PRESS
   Loo SCJ, 2004, POLYM DEGRAD STABIL, V83, P259, DOI 10.1016/S0141-3910(03)00271-4
   Luis AL, 2007, BIO-MED MATER ENG, V17, P39
   Lyu SP, 2009, INT J MOL SCI, V10, P4033, DOI 10.3390/ijms10094033
   MainilVarlet P, 1997, BIOMATERIALS, V18, P257, DOI 10.1016/S0142-9612(96)00126-3
   Nugroho P, 2001, POLYM DEGRAD STABIL, V72, P337, DOI 10.1016/S0141-3910(01)00030-1
   Pearson RG, 2003, TISSUE ENG, V9, P201, DOI 10.1089/107632703764664675
   Pego AP, 2003, J BIOMED MATER RES A, V67A, P1044, DOI 10.1002/jbm.a.10121
   Pego AP, 2003, J MATER SCI-MATER M, V14, P767, DOI 10.1023/A:1025084304766
   Pego AP, 2002, MACROMOL BIOSCI, V2, P411, DOI 10.1002/mabi.200290000
   PISTNER H, 1993, BIOMATERIALS, V14, P291, DOI 10.1016/0142-9612(93)90121-H
   Qin YY, 2006, J BIOMED MATER RES B, V79B, P312, DOI 10.1002/jbm.b.30544
   Rodriguez FJ, 1999, BIOMATERIALS, V20, P1489, DOI 10.1016/S0142-9612(99)00055-1
   Schlosshauer B, 2006, NEUROSURGERY, V59, P740, DOI 10.1227/01.NEU.0000235197.36789.42
   Tsuji H, 2011, MATERIALS, V4, P1384, DOI 10.3390/ma4081384
   Tyson T, 2009, BIOMACROMOLECULES, V10, P149, DOI 10.1021/bm801052m
   Wach RA, J APPL POLYM S UNPUB
   WANG H, 2003, OPERATIVE TECHNIQUES, V9, P59
   Zhang Z, 2006, BIOMATERIALS, V27, P1741, DOI 10.1016/j.biomaterials.2005.09.017
   Zhang Z, 2004, MACROMOL CHEM PHYSIC, V205, P867, DOI 10.1002/macp.200300184
   ZHU KJ, 1991, MACROMOLECULES, V24, P1736, DOI 10.1021/ma00008a008
NR 37
TC 14
Z9 14
U1 5
U2 42
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0141-3910
EI 1873-2321
J9 POLYM DEGRAD STABIL
JI Polym. Degrad. Stabil.
PD APR
PY 2012
VL 97
IS 4
BP 532
EP 540
DI 10.1016/j.polymdegradstab.2012.01.021
PG 9
WC Polymer Science
SC Polymer Science
GA 913XS
UT WOS:000301911300008
DA 2018-10-19
ER

PT J
AU Bernardino, L
   Eiriz, MF
   Santos, T
   Xapelli, S
   Grade, S
   Rosa, AI
   Cortes, L
   Ferreira, R
   Braganca, J
   Agasse, F
   Ferreira, L
   Malva, JO
AF Bernardino, Liliana
   Eiriz, Maria Francisca
   Santos, Tiago
   Xapelli, Sara
   Grade, Sofia
   Rosa, Alexandra Isabel
   Cortes, Luisa
   Ferreira, Raquel
   Braganca, Jose
   Agasse, Fabienne
   Ferreira, Lino
   Malva, Joao O.
TI Histamine Stimulates Neurogenesis in the Rodent Subventricular Zone
SO STEM CELLS
LA English
DT Article
DE Subventricular zone; Histamine; Biocompatible microparticles; Neuronal
   differentiation
ID EMBRYONIC STEM-CELLS; NECROSIS-FACTOR-ALPHA; NEURONAL DIFFERENTIATION;
   CSF HISTAMINE; PRECOLUMN DERIVATIZATION; PROMOTES NEUROGENESIS;
   TELE-METHYLHISTAMINE; CEREBROSPINAL-FLUID; PROGENITOR CELLS; BRAIN
AB Neural stem/progenitor cells present in the subventricular zone (SVZ) are a potential source of repairing cells after injury. Therefore, the identification of novel players that modulate neural stem cells differentiation can have a huge impact in stem cell-based therapies. Herein, we describe a unique role of histamine in inducing functional neuronal differentiation from cultured mouse SVZ stem/progenitor cells. This proneurogenic effect depends on histamine 1 receptor activation and involves epigenetic modifications and increased expression of Mash1, Dlx2, and Ngn1 genes. Biocompatible poly (lactic-co-glycolic acid) microparticles, engineered to release histamine in a controlled and prolonged manner, also triggered robust neuronal differentiation in vitro. Preconditioning with histamine-loaded microparticles facilitated neuronal differentiation of SVZ-GFP cells grafted in hippocampal slices and in in vivo rodent brain. We propose that neuronal commitment triggered by histamine per se or released from biomaterial-derived vehicles may represent a new tool for brain repair strategies. STEM CELLS 2012; 30:773784
C1 [Bernardino, Liliana; Malva, Joao O.] Univ Coimbra, Fac Med, Ctr Neurosci & Cell Biol, P-3004504 Coimbra, Portugal.
   [Bernardino, Liliana; Eiriz, Maria Francisca; Santos, Tiago; Xapelli, Sara; Grade, Sofia; Rosa, Alexandra Isabel; Cortes, Luisa; Ferreira, Raquel; Agasse, Fabienne; Ferreira, Lino; Malva, Joao O.] Univ Beira Interior, Ctr Neurosci & Cell Biol, Covilha, Portugal.
   [Bernardino, Liliana] Univ Beira Interior, Hlth Sci Res Ctr, Covilha, Portugal.
   [Braganca, Jose] Univ Algarve, Inst Biotechnol & Bioengn, Ctr Mol & Struct Biomed, Faro, Portugal.
RP Malva, JO (reprint author), Univ Coimbra, Fac Med, Ctr Neurosci & Cell Biol, P-3004504 Coimbra, Portugal.
EM libernardino@gmail.com; jomalva@fmed.uc.pt
RI iMed.ULisboa, iMed.ULisboa/C-6292-2014; iMed.ULisboa,
   CellFun/A-4244-2014; Grade, Sofia/Q-3967-2018; Cortes,
   Luisa/F-7349-2014; Braganca, Jose/F-4410-2012; Rosa,
   Alexandra/J-8659-2013
OI Grade, Sofia/0000-0003-1873-5550; Cortes, Luisa/0000-0001-5292-4369;
   Braganca, Jose/0000-0001-9566-400X; Rosa, Alexandra/0000-0001-6184-9911;
   Santos, Tiago/0000-0003-0237-499X; Bernardino,
   Liliana/0000-0003-3395-5973; Xapelli, Sara/0000-0001-6854-2509; Malva,
   Joao/0000-0002-5438-4447; ferreira, lino/0000-0001-8985-9302; Ferreira,
   Raquel/0000-0003-1014-0499
FU Fundacao para a Ciencia e a Tecnologia-Portugal [SFRH/BD/42848/2008,
   SFRH/BPD/34841/2007, PTDC/SAU-NEU/104415/2008, PTDC/SAU-NEU/101783/2008,
   PTDC/CTM/099659/2008]; Fundacao Calouste Gulbenkian [96542]
FX We thank Fundacao para a Ciencia e a Tecnologia-Portugal
   (SFRH/BD/42848/2008, SFRH/BPD/34841/2007, PTDC/SAU-NEU/104415/2008,
   PTDC/SAU-NEU/101783/2008, and PTDC/CTM/099659/2008), Fundacao Calouste
   Gulbenkian (96542) for funding and the MIT-Portugal Program (focus in
   Bioengineering). L.B. and M.F.E. contributed equally to this article.
CR Agasse F, 2008, STEM CELLS, V26, P1636, DOI 10.1634/stemcells.2008-0056
   Agasse F, 2008, REJUV RES, V11, P187, DOI 10.1089/rej.2007.0600
   Alvarez XA, 1996, MOL CHEM NEUROPATHOL, V29, P237, DOI 10.1007/BF02815005
   Amura CR, 2005, MOL CELL BIOL, V25, P10791, DOI 10.1128/MCB.25.24.10791-10802.2005
   Anichtchik OV, 2000, EXP NEUROL, V163, P20, DOI 10.1006/exnr.2000.7362
   Bernardino L, 2005, J NEUROSCI, V25, P6734, DOI 10.1523/JNEUROSCI.1510-05.2005
   Bernardino L, 2008, STEM CELLS, V26, P2361, DOI 10.1634/stemcells.2007-0914
   Bogoyevitch MA, 2006, MICROBIOL MOL BIOL R, V70, P1061, DOI 10.1128/MMBR.00025-06
   Bourgogne E, 2012, ANAL BIOANAL CHEM, V402, P449, DOI 10.1007/s00216-011-5224-8
   Brown RE, 2001, PROG NEUROBIOL, V63, P637, DOI 10.1016/S0301-0082(00)00039-3
   Carleton A, 2003, NAT NEUROSCI, V6, P507, DOI 10.1038/nn1048
   COELHO MH, 1991, MOL CHEM NEUROPATHOL, V14, P77, DOI 10.1007/BF03159928
   Croyal M, 2011, ANAL BIOCHEM, V409, P28, DOI 10.1016/j.ab.2010.09.045
   Ferreira L, 2008, CELL STEM CELL, V3, P136, DOI 10.1016/j.stem.2008.07.020
   Ferreira L, 2008, ADV MATER, V20, P2285, DOI 10.1002/adma.200702404
   Ferreira LS, 2007, BIOMATERIALS, V28, P2706, DOI 10.1016/j.biomaterials.2007.01.021
   Gage FH, 2000, SCIENCE, V287, P1433, DOI 10.1126/science.287.5457.1433
   Gdalyahu A, 2004, EMBO J, V23, P823, DOI 10.1038/sj.emboj.7600079
   Haas HL, 2008, PHYSIOL REV, V88, P1183, DOI 10.1152/physrev.00043.2007
   Hess DC, 2008, CELL PROLIFERAT, V41, P94, DOI 10.1111/j.1365-2184.2008.00486.x
   Jain RA, 2000, J MICROENCAPSUL, V17, P343
   Jutel M, 2002, CURR OPIN IMMUNOL, V14, P735, DOI 10.1016/S0952-7915(02)00395-3
   Kageyama R, 2005, EXP CELL RES, V306, P343, DOI 10.1016/j.yexcr.2005.03.015
   Kanbayashi T, 2009, SLEEP, V32, P181, DOI 10.1093/sleep/32.2.181
   Katoh Y, 2001, NEUROSCI LETT, V305, P181, DOI 10.1016/S0304-3940(01)01835-3
   KHANDELWAL JK, 1982, AGENTS ACTIONS, V12, P583, DOI 10.1007/BF01965064
   Kukko-Lukjanov TK, 2010, EPILEPSY RES, V90, P8, DOI 10.1016/j.eplepsyres.2010.02.012
   Kukko-Lukjanov TK, 2006, J NEUROSCI, V26, P1088, DOI 10.1523/JNEUROSCI.1369-05.2006
   Lim DA, 2009, NATURE, V458, P529, DOI 10.1038/nature07726
   Lindvall O, 2006, NATURE, V441, P1094, DOI 10.1038/nature04960
   Medina VA, 2009, FREE RADICAL BIO MED, V46, P1510, DOI 10.1016/j.freeradbiomed.2009.03.003
   Molina-Hernandez A, 2008, J NEUROCHEM, V106, P706, DOI 10.1111/j.1471-4159.2008.05424.x
   Mundargi RC, 2008, J CONTROL RELEASE, V125, P193, DOI 10.1016/j.jconrel.2007.09.013
   Nicoleau C, 2009, STEM CELLS, V27, P408, DOI 10.1634/stemcells.2008-0226
   Niimi M, 1997, J NEUROCHEM, V69, P851
   Nishino S, 2009, SLEEP, V32, P175, DOI 10.1093/sleep/32.2.175
   Oliva AA, 2006, J NEUROSCI, V26, P9462, DOI 10.1523/JNEUROSCI.2625-06.2006
   Pan GJ, 2007, CELL STEM CELL, V1, P299, DOI 10.1016/j.stem.2007.08.003
   Passani MB, 2004, TRENDS PHARMACOL SCI, V25, P618, DOI 10.1016/j.tips.10.003
   Pattyn A, 2004, NAT NEUROSCI, V7, P589, DOI 10.1038/nn1247
   Pluchino S, 2003, NATURE, V422, P688, DOI 10.1038/nature01552
   Pos Z, 2005, CANCER RES, V65, P4458, DOI 10.1158/0008-5472.CAN-05-0011
   Richardson RM, 2005, MOL CELL NEUROSCI, V28, P674, DOI 10.1016/j.mcn.2004.11.013
   Santos-Rosa H, 2002, NATURE, V419, P407, DOI 10.1038/nature01080
   Seidenfaden R, 2006, MOL CELL NEUROSCI, V32, P187, DOI 10.1016/j.mcn.2006.04.003
   Soya A, 2008, NEUROSCI LETT, V430, P224, DOI 10.1016/j.neulet.2007.11.002
   Sun Y, 2001, CELL, V104, P365, DOI 10.1016/S0092-8674(01)00224-0
   Thiriet N, 2011, J NEUROCHEM, V116, P1018, DOI 10.1111/j.1471-4159.2010.07154.x
   Tran PB, 2004, J NEUROSCI RES, V76, P20, DOI 10.1002/jnr.20001
   Wen S, 2009, PROG NEUROBIOL, V87, P98, DOI 10.1016/j.pneurobio.2008.10.002
   Wu M, 2009, J CELL BIOCHEM, V107, P264, DOI 10.1002/jcb.22122
   Yoshitake T, 2003, J NEUROSCI METH, V127, P11, DOI 10.1016/S0165-0270(03)00097-9
NR 52
TC 25
Z9 25
U1 1
U2 13
PU WILEY-BLACKWELL
PI MALDEN
PA COMMERCE PLACE, 350 MAIN ST, MALDEN 02148, MA USA
SN 1066-5099
J9 STEM CELLS
JI Stem Cells
PD APR
PY 2012
VL 30
IS 4
BP 773
EP 784
DI 10.1002/stem.1042
PG 12
WC Cell & Tissue Engineering; Biotechnology & Applied Microbiology;
   Oncology; Cell Biology; Hematology
SC Cell Biology; Biotechnology & Applied Microbiology; Oncology; Hematology
GA 915DV
UT WOS:000302005000020
PM 22893458
OA Bronze
DA 2018-10-19
ER

PT J
AU Comelekoglu, U
   Yalin, S
   Balli, E
   Berkoz, M
AF Comelekoglu, Ulku
   Yalin, Serap
   Balli, Ebru
   Berkoz, Mehmet
TI Ovariectomy decreases biomechanical quality of skin via oxidative stress
   in rat
SO TURKISH JOURNAL OF MEDICAL SCIENCES
LA English
DT Article
DE Menopause; ovariectomy; biomechanic; antioxidant; epidermis
ID AGED HUMAN SKIN; FREE-RADICALS; COLLAGEN; TISSUE; ASSAY
AB Aim: To investigate the effect of ovariectomy on the skin using bioinechanical, biochemical, and histological techniques in the ovariectomized rat model. Ovariectomy causes significant changes in the physical characteristics of the skin.
   Materials and methods: Twenty female Wistar albino rats were divided into 2 groups, with each group consisting of 10 rats: the control group and the ovariectomized group. The ovariectomized group underwent bilateral ovariectomy via ventral incision and the control group underwent a sham operation. Skin biomechanics were measured 3 months following the ovariectomy with a tensile test using a biomaterial testing machine, and tensile strength, stress, strain, and toughness were calculated. Superoxide dismutase (SOD) and catalase (CAT) activities and the levels of malondialdehyde (MDA) in the skin of the rats were also measured using the biochemical methods. Thickness of the epidermis was determined by light microscopy.
   Results: Strength, stress, strain, SOD activity, and thickness of epidermis values were significantly decreased and the MDA level was increased in the ovariectomized rats compared to the control group.
   Conclusion: Our results showed that ovariectomy decreased the biomechanical quality of skin. This result may be related to reactive oxygen species generated by the induction of ovariectomy in rat skin damaging the connective tissue components of the dermis.
C1 [Comelekoglu, Ulku] Mersin Univ, Fac Med, Dept Biophys, Mersin, Turkey.
   [Yalin, Serap] Mersin Univ, Fac Pharm, Dept Biochem, Mersin, Turkey.
   [Balli, Ebru] Mersin Univ, Fac Med, Dept Histol & Embryol, Mersin, Turkey.
   [Berkoz, Mehmet] Mersin Univ, Fac Pharm, Dept Biotechnol, Mersin, Turkey.
RP Comelekoglu, U (reprint author), Mersin Univ, Fac Med, Dept Biophys, Mersin, Turkey.
EM ucomelek@yahoo.com
RI Comelekoglu, Ulku/E-2239-2016
OI Comelekoglu, Ulku/0000-0001-8060-6333
FU Mersin University Scientific Research Foundation
FX The study was supported by the Mersin University Scientific Research
   Foundation.
CR AEBI, 1984, METHOD ENZYMOL, V105, P121, DOI DOI 10.1016/S0076-6879(84)05016-3
   Affinito P, 1999, MATURITAS, V33, P239, DOI 10.1016/S0378-5122(99)00077-8
   Ahsan H, 2003, CLIN EXP IMMUNOL, V131, P398, DOI 10.1046/j.1365-2249.2003.02104.x
   Baltaci AK, 2004, BIOL TRACE ELEM RES, V101, P231, DOI 10.1385/BTER:101:3:231
   Bird RP, 1980, J ENV HLTH, P811
   BRINCAT M, 1983, BRIT MED J, V287, P1337, DOI 10.1136/bmj.287.6402.1337
   Brown B.H., 1999, MED PHYS BIOMEDICAL
   Casari E, 1997, OSTEOPOROSIS INT, V7, P539, DOI 10.1007/BF02652559
   Del Rio D, 2005, NUTR METAB CARDIOVAS, V15, P316, DOI 10.1016/j.numecd.2005.05.003
   Fisher GJ, 2008, ARCH DERMATOL, V144, P666, DOI 10.1001/archderm.144.5.666
   Fisher GJ, 2009, AM J PATHOL, V174, P101, DOI 10.2353/ajpath.2009.080599
   Gou XE, 2000, J ORTHOPAED RES, V18, P333
   Hernandez I, 2000, AM J PHYSIOL-REG I, V279, pR1599
   Kafantari H, 2000, BONE, V26, P349, DOI 10.1016/S8756-3282(99)00279-3
   KALU DN, 1991, BONE MINER, V15, P175, DOI 10.1016/0169-6009(91)90124-I
   LOWRY OH, 1951, J BIOL CHEM, V193, P265
   Lu WW, 2000, BRIT J PLAST SURG, V53, P225, DOI 10.1054/bjps.1999.3264
   Maccarrone M, 1997, J EUR ACAD DERMATOL, V8, P185
   MICHIELS C, 1994, FREE RADICAL BIO MED, V17, P235, DOI 10.1016/0891-5849(94)90079-5
   NIGG BM, 1999, BIOMECHANICS MUSCULO, P49
   Okayama Yoshimichi, 2005, Current Drug Targets - Inflammation and Allergy, V4, P517, DOI 10.2174/1568010054526386
   Ozyazgan I, 2002, MATURITAS, V43, P65, DOI 10.1016/S0378-5122(02)00181-0
   Prediger ME, 2004, PHARMACOL BIOCHEM BE, V78, P191, DOI 10.1016/j.pbb.2004.03.009
   PROCKOP DJ, 1979, NEW ENGL J MED, V301, P77, DOI 10.1056/NEJM197907123010204
   Quan TH, 2010, J INVEST DERMATOL, V130, P415, DOI 10.1038/jid.2009.224
   Ranu S, 1991, IEEE ENG MED BIOL, V10, P55
   Silver HF, 2003, SKIN RES TECHNOL, V9, P3
   SUN Y, 1988, CLIN CHEM, V34, P497
   TAYLOR CR, 1990, J AM ACAD DERMATOL, V22, P1, DOI 10.1016/0190-9622(90)70001-X
   Weissman J, 2004, OPT EXPRESS, V12, P5760, DOI 10.1364/OPEX.12.005760
   Yagi K, 1998, Methods Mol Biol, V108, P107
NR 31
TC 7
Z9 7
U1 1
U2 11
PU TUBITAK SCIENTIFIC & TECHNICAL RESEARCH COUNCIL TURKEY
PI ANKARA
PA ATATURK BULVARI NO 221, KAVAKLIDERE, ANKARA, 00000, TURKEY
SN 1300-0144
J9 TURK J MED SCI
JI Turk. J. Med. Sci.
PD APR
PY 2012
VL 42
IS 2
BP 201
EP 209
DI 10.3906/sag-1011-1237
PG 9
WC Medicine, General & Internal
SC General & Internal Medicine
GA 914ZT
UT WOS:000301993300003
DA 2018-10-19
ER

PT J
AU Toker, SM
   Rubitschek, F
   Niendorf, T
   Canadinc, D
   Maier, HJ
AF Toker, S. M.
   Rubitschek, F.
   Niendorf, T.
   Canadinc, D.
   Maier, H. J.
TI Anisotropy of ultrafine-grained alloys under impact loading: The case of
   biomedical niobium-zirconium
SO SCRIPTA MATERIALIA
LA English
DT Article
DE Anisotropy; Impact toughness; Biomaterial; Niobium-zirconium; Implant
   material
ID MECHANICAL-PROPERTIES; ARTICULAR-CARTILAGE; BONE TISSUE; TEMPERATURE;
   CORROSION; FRACTURE; STEEL; FEMUR
AB The anisotropy-impact response relationship of a biocompatible niobium zirconium (NbZr) alloy with an ultrafine-grained microstructure was investigated. The current findings not only shed light on the micromechanisms dictating the impact response in the microstructures studied, but are also encouraging with respect to the use of NbZr in orthopedic and dental implants. (C) 2011 Acta Materialia Inc. Published by Elsevier Ltd. All rights reserved.
C1 [Toker, S. M.; Canadinc, D.] Koc Univ, Adv Mat Grp, Dept Mech Engn, TR-34450 Istanbul, Turkey.
   [Rubitschek, F.; Niendorf, T.; Maier, H. J.] Univ Gesamthsch Paderborn, Lehrstuhl Werkstoffkunde Mat Sci, D-33095 Paderborn, Germany.
RP Canadinc, D (reprint author), Koc Univ, Adv Mat Grp, Dept Mech Engn, TR-34450 Istanbul, Turkey.
EM dcanadinc@ku.edu.tr
OI Niendorf, Thomas/0000-0003-2622-5817; Maier, Hans J./0000-0003-2119-824X
FU Deutsche Forschungsgemeinschaft; Turkish Academy of Sciences (TUBA)
FX The authors thank Prof. Ibrahim Karaman for carrying out the ECAE on
   NbZr. The help of Georg Kruschinski with the experiments, and the
   financial support by Deutsche Forschungsgemeinschaft and the Turkish
   Academy of Sciences (TUBA) are acknowledged.
CR Anunmana C, 2010, DENT MATER, V26, P111, DOI 10.1016/j.dental.2009.09.003
   Barber R. E., 2008, SCRIPTA MATER, V51, P374
   Canadinc D, 2008, SCRIPTA MATER, V58, P307, DOI 10.1016/j.scriptamat.2007.09.059
   Cehreli M, 2004, J DENT, V32, P123, DOI 10.1016/j.jdent.2003.09.003
   Fukuda Y, 2000, CLIN BIOMECH, V15, P516, DOI 10.1016/S0268-0033(00)00013-9
   Gabor P., 2007, METALL MATER TRANS A, V38A, P1917
   Gupta HS, 2008, MED ENG PHYS, V30, P1209, DOI 10.1016/j.medengphy.2008.09.007
   Hallab N.J., 2006, J ASTM INT, V3
   ISO 14556:2000, 145562000 ISO
   Kannus P, 1999, BONE, V25, P229, DOI 10.1016/S8756-3282(99)00154-4
   Kim HG, 2008, J NUCL MATER, V373, P429, DOI 10.1016/j.jnucmat.2007.05.035
   Kimura Y, 2008, SCIENCE, V320, P1057, DOI 10.1126/science.1156084
   MARTIN B, 1998, SKELETAL TISSUE MECH
   Matsuno H, 2001, BIOMATERIALS, V22, P1253, DOI 10.1016/S0142-9612(00)00275-1
   Moazen M, 2011, CLIN BIOMECH, V26, P13, DOI 10.1016/j.clinbiomech.2010.09.002
   Morris JW, 2008, SCIENCE, V320, P1022, DOI 10.1126/science.1158994
   Niendorf T, 2008, SCRIPTA MATER, V58, P571, DOI 10.1016/j.scriptamat.2007.11.015
   Niendorf T, 2007, ACTA MATER, V55, P6596, DOI 10.1016/j.actamat.2007.08.015
   Niendorf T, 2010, J MATER SCI, V45, P4813, DOI 10.1007/s10853-010-4511-7
   Niendorf T., 2006, INT J MATER RES, V97, P10
   Pinilla TP, 1996, CALCIFIED TISSUE INT, V58, P231
   Rho JY, 1998, MED ENG PHYS, V20, P92, DOI 10.1016/S1350-4533(98)00007-1
   Rubitschek F, 2012, J MECH BEHAV BIOMED, V5, P181, DOI 10.1016/j.jmbbm.2011.08.023
   Segal V., 1995, U. S. Patent, Patent No. [5,400,633, 5400633]
   Song R, 2005, ACTA MATER, V53, P4881, DOI 10.1016/j.actamat.2005.07.009
   Verteramo A, 2007, J BIOMECH, V40, P3580, DOI 10.1016/j.jbiomech.2007.06.002
   Wakao N, 2009, MED ENG PHYS, V31, P1134, DOI 10.1016/j.medengphy.2009.07.010
NR 27
TC 9
Z9 9
U1 0
U2 9
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 1359-6462
J9 SCRIPTA MATER
JI Scr. Mater.
PD APR
PY 2012
VL 66
IS 7
BP 435
EP 438
DI 10.1016/j.scriptamat.2011.12.007
PG 4
WC Nanoscience & Nanotechnology; Materials Science, Multidisciplinary;
   Metallurgy & Metallurgical Engineering
SC Science & Technology - Other Topics; Materials Science; Metallurgy &
   Metallurgical Engineering
GA 909IH
UT WOS:000301557500005
DA 2018-10-19
ER

PT J
AU Touloupakis, E
   Boutopoulos, C
   Buonasera, K
   Zergioti, I
   Giardi, MT
AF Touloupakis, Eleftherios
   Boutopoulos, Christos
   Buonasera, Katia
   Zergioti, Ioanna
   Giardi, Maria Teresa
TI A photosynthetic biosensor with enhanced electron transfer generation
   realized by laser printing technology
SO ANALYTICAL AND BIOANALYTICAL CHEMISTRY
LA English
DT Article
DE Laser printing; Biosensor; Photosynthesis; Herbicides
ID PHOTOSYSTEM-II; THYLAKOID MEMBRANE; SENSOR RESPONSE; DIRECT WRITE;
   HERBICIDES; WATER; POLY(VINYLALCOHOL); IMMOBILIZATION; MICROARRAYS;
   COMPLEXES
AB One of the limits of current electrochemical biosensors is a lack of methods providing stable and highly efficient junctions between biomaterial and solid-state devices. This paper shows how laser-induced forward transfer (LIFT) can enable efficient electron transfer from photosynthetic biomaterial immobilized on screen-printed electrodes (SPE). The ideal pattern, in terms of photocurrent signal of thylakoid droplets giving a stable response signal with a current intensity of approximately 335 +/- 13 nA for a thylakoid mass of 28 +/- 4 ng, was selected. It is shown that the efficiency of energy production of a photosynthetic system can be strongly enhanced by the LIFT process, as demonstrated by use of the technique to construct an efficient and sensitive photosynthesis-based biosensor for detecting herbicides at nanomolar concentrations.
C1 [Touloupakis, Eleftherios] Biosensor Srl, I-00060 Rome, Italy.
   [Touloupakis, Eleftherios; Buonasera, Katia; Giardi, Maria Teresa] CNR, Inst Crystallog, I-00015 Rome, Italy.
   [Boutopoulos, Christos; Zergioti, Ioanna] Natl Tech Univ Athens, Dept Phys, Athens 15780, Greece.
RP Touloupakis, E (reprint author), Biosensor Srl, Via Olmetti 44, I-00060 Rome, Italy.
EM toulou_e@chemistry.uoc.gr
OI Touloupakis, Eleftherios/0000-0002-5133-0849; Boutopoulos,
   Christos/0000-0002-3892-8483; Giardi, Maria Teresa/0000-0002-7401-5905
FU European Commission [247868, 231082, 232522]
FX The work discussed in this paper used technology developed in projects
   with financial support from the European Commission (e-LIFT FP7 ICT,
   grant agreement no. 247868; BEEP-C-EN FP 7-SME-2008-01, grant agreement
   no. 231082, SENSBIOSYN FP 7-SME-2008-01, grant agreement no. 232522),
   which is gratefully acknowledged.
CR Ackerman F., 2007, INT J OCCUP ENV HEAL, V13, P441
   Avramescu A, 1999, BIOTECHNOL TECH, V13, P559, DOI 10.1023/A:1008991531206
   Barthelmebs L, 2011, METHODS MOL BIOL, V684, P247, DOI 10.1007/978-1-60761-925-3_19
   Bettazzi F, 2007, ANAL CHIM ACTA, V589, P14, DOI 10.1016/j.aca.2007.02.062
   Bhalla V, 2011, ANAL CHIM ACTA, V707, P184, DOI 10.1016/j.aca.2011.09.020
   Boutopoulos C, 2008, PHYS STATUS SOLIDI A, V205, P2505, DOI 10.1002/pssa.200780206
   Boutopoulos C, 2011, APPL PHYS LETT, V98, DOI 10.1063/1.3562297
   Boutopoulos C, 2010, APPL PHYS LETT, V96, DOI 10.1063/1.3299004
   BUCK RP, 1994, PURE APPL CHEM, V66, P2527, DOI 10.1351/pac199466122527
   Campas M, 2008, BIOTECHNOL ADV, V26, P370, DOI 10.1016/j.biotechadv.2008.04.001
   Deegan RD, 1997, NATURE, V389, P827, DOI 10.1038/39827
   Deng T, 2009, APPL PHYS LETT, V94, DOI 10.1063/1.3110054
   Duocastella M, 2008, APPL PHYS A-MATER, V93, P453, DOI 10.1007/s00339-008-4781-y
   Gantt E, 1996, PHOTOSYNTH RES, V48, P47, DOI 10.1007/BF00040995
   Giardi MT, 2005, ENVIRON SCI TECHNOL, V39, P5378, DOI 10.1021/es040511b
   Giardi MT, 2005, TRENDS BIOTECHNOL, V23, P257, DOI 10.1016/j.tibtech.2005.03.003
   Guillemot F, 2010, ACTA BIOMATER, V6, P2494, DOI 10.1016/j.actbio.2009.09.029
   Guskov A, 2009, NAT STRUCT MOL BIOL, V16, P334, DOI 10.1038/nsmb.1559
   Kaniber S, 2009, NANO LETT, V1, P133
   Karaiskou A, 2003, APPL SURF SCI, V245, P208
   Koblizek M, 2002, BIOTECHNOL BIOENG, V78, P110, DOI 10.1002/bit.10190
   Li JP, 2005, ANAL SCI, V21, P1217, DOI 10.2116/analsci.21.1217
   Luong JHT, 2008, BIOTECHNOL ADV, V26, P492, DOI 10.1016/j.biotechadv.2008.05.007
   Maly J, 2005, BIOSENS BIOELECTRON, V21, P923, DOI 10.1016/j.bios.2005.02.013
   Maly J, 2005, ANAL BIOANAL CHEM, V381, P1558, DOI 10.1007/s00216-005-3149-9
   Moreno-Garrido I, 2008, BIORESOURCE TECHNOL, V99, P3949, DOI 10.1016/j.biortech.2007.05.040
   Oettmeier W, 2003, ENCY AGROCHEMICALS, V2
   Podola B, 2003, J APPL PHYCOL, V15, P415, DOI 10.1023/A:1026051700261
   Porra RJ, 2002, PHOTOSYNTH RES, V73, P149, DOI 10.1023/A:1020470224740
   Ringeisen BR, 2002, BIOTECHNOL PROGR, V18, P1126, DOI 10.1021/bp015516g
   Rodriguez M, 2002, BIOSENS BIOELECTRON, V17, P843, DOI 10.1016/S0956-5663(02)00059-3
   Rodriguez-Mozaz S, 2006, ANAL BIOANAL CHEM, V386, P1025, DOI 10.1007/s00216-006-0574-3
   Rouillon R, 2000, J CHEM TECHNOL BIOT, V75, P1003, DOI 10.1002/1097-4660(200011)75:11<1003::AID-JCTB296>3.0.CO;2-0
   Rouillon R, 1999, ENZYME MICROB TECH, V25, P230, DOI 10.1016/S0141-0229(99)00033-2
   Serra P, 2006, J LASER MICRO NANOEN, V1, P236, DOI 10.2961/jlmn.2006.03.0017
   Shitanda I, 2005, ANAL CHIM ACTA, V530, P191, DOI 10.1016/j.aca.2004.09.073
   Shitanda I, 2009, ELECTROCHIM ACTA, V54, P4933, DOI 10.1016/j.electacta.2009.04.005
   Touloupakis E, 2005, BIOSENS BIOELECTRON, V20, P1984, DOI 10.1016/j.bios.2004.08.035
   Vittadello M, 2010, CHEMSUSCHEM, V3, P471, DOI 10.1002/cssc.200900255
   Wakabayashi K, 2002, PEST MANAG SCI, V58, P1149, DOI 10.1002/ps.560
   Wu PK, 2003, REV SCI INSTRUM, V74, P2546, DOI 10.1063/1.1544081
NR 41
TC 16
Z9 16
U1 1
U2 36
PU SPRINGER HEIDELBERG
PI HEIDELBERG
PA TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY
SN 1618-2642
J9 ANAL BIOANAL CHEM
JI Anal. Bioanal. Chem.
PD APR
PY 2012
VL 402
IS 10
BP 3237
EP 3244
DI 10.1007/s00216-012-5771-7
PG 8
WC Biochemical Research Methods; Chemistry, Analytical
SC Biochemistry & Molecular Biology; Chemistry
GA 909DK
UT WOS:000301542200018
PM 22302172
DA 2018-10-19
ER

PT J
AU Ragaseema, VM
   Unnikrishnan, S
   Krishnan, VK
   Krishnan, LK
AF Ragaseema, V. M.
   Unnikrishnan, S.
   Krishnan, V. Kalliyana
   Krishnan, Lissy K.
TI The antithrombotic and antimicrobial properties of PEG-protected silver
   nanoparticle coated surfaces
SO BIOMATERIALS
LA English
DT Article
DE Silver nanoparticles; Antimicrobial activity; Antithrombotic activity;
   Vascular tissue engineering; Biomaterial surface modification
ID DIFFERENTIATION; FIBRINOGEN; PLATELETS; MATRIX; CELLS
AB Cardiovascular implant-associated complications such as infection and thrombosis may be reduced by modification of device surfaces using antimicrobial and antithrombotic agents. Silver nanoparticles (SNPs) are well accepted for its broad-spectrum antimicrobial effect. A recent report suggested its antiplatelet effect also. So the hypothesis of this study is that polyethylene glycol (PEG) protected SNPs can be incorporated with biomaterials to attain dual properties; and by adjusting an optimum concentration, its cytotoxicity to tissues and cells can be prevented. To prove this, detailed study of PEG-SNP was done at three levels: (i) direct inhibitory effect on platelet activation, aggregation and biochemical pathways when PEG-SNP is added into platelet suspension; (ii) inhibition of platelet adhesion to PEG-SNP incorporated biological matrix and polymer scaffold and (iii) non-cytotoxic behavior of immobilized PEG-SNP in fibrin matrix. Inhibitory effects demonstrated are on: platelet function by aggregometry, exposure of activation and apoptosis markers by flow cytometry, biochemical pathway by malondealdehyde (MDA) estimation and protein phosphorylation by Western blot. Reduced platelet adhesion onto PEG-SNP incorporated scaffold is shown using scanning electron microscopy (SEM). Non-toxic behavior of endothelial cells (EC) and smooth muscle cells (SMC) grown on PEG-SNP-fibrin disc is shown by fluorescence microscopy and cell phenotype stability by real-time polymerase chain reaction (PCR). (c) 2012 Elsevier Ltd. All rights reserved.
C1 [Ragaseema, V. M.; Unnikrishnan, S.; Krishnan, Lissy K.] Sree Chitra Tirunal Inst Med Sci & Technol, Biomed Technol Wing, Thrombosis Res Unit, Trivandrum 695012, Kerala, India.
   [Krishnan, V. Kalliyana] Sree Chitra Tirunal Inst Med Sci & Technol, Biomed Technol Wing, Dent Prod Lab, Trivandrum 695012, Kerala, India.
RP Krishnan, LK (reprint author), Sree Chitra Tirunal Inst Med Sci & Technol, Biomed Technol Wing, Thrombosis Res Unit, Trivandrum 695012, Kerala, India.
EM lissykk@sctimst.ac.in
RI Sivan, Unnikrishnan/J-6308-2014
OI Sivan, Unnikrishnan/0000-0002-6074-6299
FU SCTIMST; BMT Wing, SCTIMST; CSIR, Government of India; DBT GOI
FX The authors acknowledge The Director, SCTIMST and The Head, BMT Wing,
   SCTIMST for the encouragement and support. We would like to gratefully
   acknowledge individual fellowship support from the CSIR, Government of
   India to the first author and fund support from DBT GOI, for development
   of tissue engineered small diameter vascular graft. The technical
   support obtained from Ms. Juliet Baby Saroja, and Ms. Renu Ramesh from
   Thrombosis Research Unit is acknowledged. We are thankful to Dr. Kavitha
   Raj, Microbiology Department, SCTIMST for providing us the ATCC strain
   for antimicrobial assay.
CR AshaRani PV, 2009, BMC CELL BIOL, V10, DOI 10.1186/1471-2121-10-65
   AshaRani PV, 2009, ACS NANO, V3, P279, DOI 10.1021/nn800596w
   CALVETE JJ, 1994, THROMB HAEMOSTASIS, V72, P1
   CATALANO PM, 1981, BLOOD, V57, P99
   Chennazhy KP, 2005, BIOMATERIALS, V26, P5658, DOI 10.1016/j.biomaterials.2005.02.024
   Cook BC, 2001, THROMB RES, V104, P39, DOI 10.1016/S0049-3848(01)00337-1
   Gorbet MB, 2004, BIOMATERIALS, V25, P5681, DOI 10.1016/j.biomaterials.2004.01.023
   HAWIGER J, 1982, BIOCHEMISTRY-US, V21, P1407, DOI 10.1021/bi00535a047
   Krishnan LK, 2004, BIOMATERIALS, V25, P5557, DOI 10.1016/j.biomaterials.2004.01.013
   Madhavan RV, 2011, TISSUE ENG PT A, V17, P439, DOI [10.1089/ten.tea.2009.0791, 10.1089/ten.TEA.2009.0791]
   MOUTIN MJ, 1989, BIOCHIM BIOPHYS ACTA, V984, P289, DOI 10.1016/0005-2736(89)90295-2
   Pankajakshan D, 2008, J BIOMED MATER RES B, V87B, P570, DOI 10.1002/jbm.b.31146
   Resmi KR, 2002, THROMB RES, V107, P23, DOI 10.1016/S0049-3848(02)00154-8
   SanthoshKumar TR, 2001, BIOMATERIALS, V22, P2769
   Shrivastava S, 2009, ACS NANO, V3, P1357, DOI 10.1021/nn900277t
   Sreerekha PR, 2006, CELL PROLIFERAT, V39, P301, DOI 10.1111/j.1365-2184.2006.00389.x
   Tompkins C, 2010, J AM COLL CARDIOL, V55, P2376, DOI 10.1016/j.jacc.2009.12.056
   Ware JA, 1995, WILLIAMS HEMATOLOGY, P1161
   Wen HC, 2007, J PHYS CONF SER, V61, P445, DOI 10.1088/1742-6596/61/1/089
NR 19
TC 65
Z9 68
U1 4
U2 108
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD APR
PY 2012
VL 33
IS 11
BP 3083
EP 3092
DI 10.1016/j.biomaterials.2012.01.005
PG 10
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 909JR
UT WOS:000301561300002
PM 22284585
DA 2018-10-19
ER

PT J
AU Altrock, E
   Muth, CA
   Klein, G
   Spatz, JP
   Lee-Thedieck, C
AF Altrock, Eva
   Muth, Christine A.
   Klein, Gerd
   Spatz, Joachim P.
   Lee-Thedieck, Cornelia
TI The significance of integrin ligand nanopatterning on lipid raft
   clustering in hematopoietic stem cells
SO BIOMATERIALS
LA English
DT Article
DE Substrate nanostructure; Cell adhesion; Integrin; Hematopoietic stem
   cell; Lipid raft; Cell signaling
ID PROGENITOR CELLS; IN-VIVO; FIBRONECTIN; ADHESION; NICHE;
   DIFFERENTIATION; HIBERNATION; SEGREGATION; ACTIVATION; INTERFACES
AB Hematopoietic stem cells (HSCs) are the vital, life-long source of all blood cell types. They are found in stem cell niches, specific anatomic locations that offer all the factors and signals necessary for the maintenance of the stem cell potential of HSCs. Much attention has been paid to the biochemical composition of the niches, but only little is known about the influence of physical parameters, such as ligand nanopatterns, on HSCs. To investigate the impact of nanometer-scale spacing between cell ligands on HSC adhesion, integrin distribution and signal transduction, we employed geometrically defined, nanostructured, bio-functionalized surfaces. HSCs proved to be sensitive to the lateral distance between the presented ligands with regard to adhesion and lipid raft clustering, the latter being a prerequisite for the formation of signaling complexes. Furthermore, an extensive redistribution of stem cell markers, integrins and phosphorylated proteins in HSCs was observed. In conclusion, integrin-mediated adhesion and signaling of HSCs proved to depend on the nanostructured presentation of ligands in their environment. In this work, we show that the nanostructure of the matrix is an important parameter influencing HSC behavior that should be integrated into biomaterial-based approaches aiming at HSC multiplication or differentiation. (c) 2012 Elsevier Ltd. All rights reserved.
C1 [Altrock, Eva; Muth, Christine A.; Spatz, Joachim P.; Lee-Thedieck, Cornelia] Max Planck Inst Intelligent Syst, Dept New Mat & Biosyst, D-70569 Stuttgart, Germany.
   [Altrock, Eva; Muth, Christine A.; Spatz, Joachim P.; Lee-Thedieck, Cornelia] Univ Heidelberg, Dept Biophys Chem, D-6900 Heidelberg, Germany.
   [Klein, Gerd] Univ Tubingen, Med Res Ctr, Sect Transplantat Immunol & Immunohematol, D-72072 Tubingen, Germany.
RP Lee-Thedieck, C (reprint author), Max Planck Inst Intelligent Syst, Dept New Mat & Biosyst, Heisenbergstr 3, D-70569 Stuttgart, Germany.
EM thedieck@is.mpg.de
RI Spatz, Joachim/A-1107-2017; Lee-Thedieck, Cornelia/H-2835-2013; Klein,
   Gerd/C-8499-2013
OI Spatz, Joachim/0000-0003-3419-9807; Lee-Thedieck,
   Cornelia/0000-0001-8863-5403; 
FU 'Biomaterialien/Biokompatibilitat' of the Baden-Wurttemberg Stiftung
   [P-LS-Biomat/22]; European Union [NMP4-LA-2009-229289]
FX We are indebted to Christine Mollenhauer for excellent technical
   assistance as well as to Ada Cavalcanti-Adam and Nina Grunze for
   critically revising the manuscript. The project was supported by
   contract research 'Biomaterialien/Biokompatibilitat' of the
   Baden-Wurttemberg Stiftung" (P-LS-Biomat/22). The research leading to
   these results has received funding from the European Union Senventh
   Framework Programme (FP7/2007-2013) under grant agreement no
   NMP4-LA-2009-229289 NanoII.
CR Arnold M, 2004, CHEMPHYSCHEM, V5, P383, DOI 10.1002/cphc.200301014
   Barczyk M, 2010, CELL TISSUE RES, V339, P269, DOI 10.1007/s00441-009-0834-6
   Bauer N, 2008, CELLS TISSUES ORGANS, V188, P127, DOI 10.1159/000112847
   Blummel J, 2007, BIOMATERIALS, V28, P4739, DOI 10.1016/j.biomaterials.2007.07.038
   Bullock TE, 2007, STEM CELLS, V25, P844, DOI 10.1634/stemcells.2006-0346
   Cavalcanti-Adam EA, 2006, EUR J CELL BIOL, V85, P219, DOI 10.1016/j.ejcb.2005.09.011
   Cavalcanti-Adam EA, 2008, HFSP J, V2, P276, DOI 10.2976/1.2976662
   Cavalcanti-Adam EA, 2007, BIOPHYS J, V92, P2964, DOI 10.1529/biophysj.106.089730
   Chua KN, 2006, BIOMATERIALS, V27, P6043, DOI 10.1016/j.biomaterials.2006.06.017
   del Pozo MA, 2004, SCIENCE, V303, P839, DOI 10.1126/science.1092571
   DZAMBA BJ, 1991, J CELL SCI, V100, P605
   Ehninger A, 2011, J EXP MED, V208, P421, DOI 10.1084/jem.20110132
   Forsberg EC, 2009, HAEMATOL-HEMATOL J, V94, P1477, DOI 10.3324/haematol.2009.013730
   Geiger B, 2009, NAT REV MOL CELL BIO, V10, P21, DOI 10.1038/nrm2593
   Giebel B, 2004, BLOOD, V104, P2332, DOI 10.1182/blood-2004-02-0511
   Glass R, 2003, NANOTECHNOLOGY, V14, P1153, DOI 10.1088/0957-4484/14/10/314
   Gomez-Mouton C, 2001, P NATL ACAD SCI USA, V98, P9642, DOI 10.1073/pnas.171160298
   Grote K, 2007, BLOOD, V110, P877, DOI 10.1182/blood-2006-07-036202
   Guan JL, 2004, SCIENCE, V303, P773, DOI 10.1126/science.1094376
   Hines M, 2008, J CHEM TECHNOL BIOT, V83, P421, DOI 10.1002/jctb.1856
   Hullin-Matsuda F, 2007, CELL MOL LIFE SCI, V64, P2492, DOI 10.1007/s00018-007-7281-x
   Kadler KE, 2008, CURR OPIN CELL BIOL, V20, P495, DOI 10.1016/j.ceb.2008.06.008
   Lajoie P, 2009, J CELL BIOL, V185, P381, DOI 10.1083/jcb.200811059
   Leiss M, 2008, CURR OPIN CELL BIOL, V20, P502, DOI 10.1016/j.ceb.2008.06.001
   LIESVELD JL, 1993, BLOOD, V81, P112
   Little WC, 2008, MATRIX BIOL, V27, P451, DOI 10.1016/j.matbio.2008.02.003
   Lymperi S, 2010, ANN NY ACAD SCI, V1192, P12, DOI 10.1111/j.1749-6632.2009.05223.x
   Melikova S, 2004, EXP HEMATOL, V32, P1051, DOI 10.1016/j.exphem.2004.07.018
   Oh S, 2009, P NATL ACAD SCI USA, V106, P2130, DOI 10.1073/pnas.0813200106
   Palazzo AF, 2004, SCIENCE, V303, P836, DOI 10.1126/science.1091325
   Rajendran L, 2003, P NATL ACAD SCI USA, V100, P8241, DOI 10.1073/pnas.1331629100
   Rajendran L, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008290
   Sagar BMM, 2006, BIOCHEM BIOPH RES CO, V350, P1000, DOI 10.1016/j.bbrc.2006.09.140
   SCHOFIELD R, 1978, BLOOD CELLS, V4, P7
   Simons K, 2000, NAT REV MOL CELL BIO, V1, P31, DOI 10.1038/35036052
   Spatz JP, 2000, LANGMUIR, V16, P407, DOI 10.1021/1a990070n
   Wagner W, 2005, STEM CELLS, V23, P1180, DOI 10.1634/stemcells.2005-0361
   Yamazaki S, 2006, EMBO J, V25, P3515, DOI 10.1038/sj.emboj.7601236
   Yamazaki S, 2009, BLOOD, V113, P1250, DOI 10.1182/blood-2008-04-146480
   Yim EKF, 2007, EXP CELL RES, V313, P1820, DOI 10.1016/j.yexcr.2007.02.031
   Yokota T, 1998, BLOOD, V91, P3263
NR 41
TC 40
Z9 40
U1 1
U2 44
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD APR
PY 2012
VL 33
IS 11
BP 3107
EP 3118
DI 10.1016/j.biomaterials.2012.01.002
PG 12
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 909JR
UT WOS:000301561300004
PM 22269650
DA 2018-10-19
ER

PT J
AU Chai, YC
   Roberts, SJ
   Desmet, E
   Kerckhofs, G
   van Gastel, N
   Geris, L
   Carmeliet, G
   Schrooten, J
   Luyten, FP
AF Chai, Yoke Chin
   Roberts, Scott J.
   Desmet, Eline
   Kerckhofs, Greet
   van Gastel, Nick
   Geris, Liesbet
   Carmeliet, Geert
   Schrooten, Jan
   Luyten, Frank P.
TI Mechanisms of ectopic bone formation by human osteoprogenitor cells on
   CaP biomaterial carriers
SO BIOMATERIALS
LA English
DT Article
DE Ectopic bone formation; Calcium phosphate; Stem cell-host-material
   interaction; Mesenchymal stem cells; Osteogenic differentiation
ID MESENCHYMAL STEM-CELLS; CALCIUM-PHOSPHATE; INDUCED APOPTOSIS;
   WNT/BETA-CATENIN; STROMAL CELLS; MODEL; OSTEOINDUCTION; CERAMICS;
   COLLAGEN; DIFFERENTIATION
AB Stem cell-based strategies for bone regeneration, which use calcium phosphate (CaP)-based biomaterials in combination with developmentally relevant progenitor populations, have significant potential for clinical repair of skeletal defects. However, the exact mechanism of action and the stem cell-host-material interactions are still poorly understood. We studied if pre-conditioning of human periosteum-derived cells (hPDCs) in vitro could enhance, in combination with a CaP-based biomaterial carrier, ectopic bone formation in vivo. By culturing hPDCs in a biomimetic calcium (Ca2+) and phosphate (P-i) enriched culture conditions, we observed an enhanced cell proliferation, decreased expression of mesenchymal stem cell (MSC) markers and upregulation of osteogenic genes including osterix, Runx2, osteocalcin, osteopontin, and BMP-2. However, the in vitro pre-conditioning protocols were non-predictive for in vivo ectopic bone formation. Surprisingly, culturing in the presence of Ca2+ and P-i supplements resulted in partial or complete abrogation of in vivo ectopic bone formation. Through histological, immunohistochemical and microfocus X-ray computed tomography (mu CT) analysis of the explants, we found that in situ proliferation, collagen matrix deposition and the mediation of osteoclastic activity by hPDCs are associated to their ectopic bone forming capacity. These data were validated by the multivariate analysis and partial least square regression modelling confirming the non-predictability of in vitro parameters on in vivo ectopic bone formation. Our series of experiments provided further insights on the stem cell-host-material interactions that govern in vivo ectopic bone induction driven by hPDCs on Cap-based biomaterials. (c) 2012 Elsevier Ltd. All rights reserved.
C1 [Luyten, Frank P.] Katholieke Univ Leuven, Lab Skeletal Dev & Joint Disorders, Rheumatol Sect, B-3000 Louvain, Belgium.
   [Chai, Yoke Chin] Univ Malaya, Fac Engn, Dept Biomed Engn, Kuala Lumpur 50603, Malaysia.
   [Chai, Yoke Chin; Roberts, Scott J.; Desmet, Eline; Kerckhofs, Greet; van Gastel, Nick; Geris, Liesbet; Carmeliet, Geert; Schrooten, Jan; Luyten, Frank P.] Katholieke Univ Leuven, Div Skeletal Tissue Engn, B-3000 Louvain, Belgium.
   [van Gastel, Nick; Carmeliet, Geert] Katholieke Univ Leuven, Lab Expt Med & Endocrinol, B-3000 Louvain, Belgium.
   [Geris, Liesbet] Univ Liege, Biomech Res Unit, B-4000 Liege 1, Belgium.
   [Kerckhofs, Greet; Schrooten, Jan] Katholieke Univ Leuven, Dept Met & Mat Engn, B-3001 Heverlee, Belgium.
RP Luyten, FP (reprint author), Katholieke Univ Leuven, Lab Skeletal Dev & Joint Disorders, Rheumatol Sect, O&N 1,Herestr 49,Box 7003, B-3000 Louvain, Belgium.
EM yokechin.chai@med.kuleuven.be; frank.luyten@uz.kuleuven.ac.be
RI van Gastel, Nick/P-7610-2018; Kerckhofs, Greet/J-5006-2016
OI van Gastel, Nick/0000-0002-0563-3590; Kerckhofs,
   Greet/0000-0002-1750-8324; geris, liesbet/0000-0002-8180-1445
FU K.U.Leuven IDO [05/009]; K.U.Leuven; Stem Cell Institute of Leuven -
   K.U.Leuven; Agency for Innovation by Science and Technology in Flanders
   [IWT/OZM/090655, IWT/083128]; Prometheus, the Leuven Research &
   Development Division of Skeletal Tissue Engineering of the Katholieke
   Universiteit Leuven; Scientific Research Flanders [G.0500.08, G.0982.11]
FX We are grateful to Carla Geeroms for the excellent technical assistance
   on mu CT scanning and image analysis for the quantification of bone
   formation. This work is funded by the K.U.Leuven IDO project 05/009 -
   QuEST (Y.C.C.), the Industrial Research Fund K.U.Leuven (E.D.), Stem
   Cell Institute of Leuven - K.U.Leuven (S.J.R.), the Agency for
   Innovation by Science and Technology in Flanders: IWT/OZM/090655 (G.K.),
   IWT/083128 (N.v.G.), the fund for Scientific Research Flanders:
   G.0500.08 & G.0982.11 (G.C.), and is part of Prometheus, the Leuven
   Research & Development Division of Skeletal Tissue Engineering of the
   Katholieke Universiteit Leuven: www.kuleuven.be/prometheus.
CR Alves H, 2010, J CELL MOL MED, V14, P2729, DOI 10.1111/j.1582-4934.2009.00931.x
   Baron R, 2007, ENDOCRINOLOGY, V148, P2635, DOI 10.1210/en.2007-0270
   Barrere F, 2006, INT J NANOMED, V1, P317
   BOUILLON R, 1992, CLIN CHEM, V38, P2055
   Chai YC, 2011, TISSUE ENG PT A, V17, P1083, DOI [10.1089/ten.TEA.2010.0160, 10.1089/ten.tea.2010.0160]
   Chen Jiani, 2005, Journal of Medical and Dental Sciences, V52, P27
   Cheng LJ, 2010, ACTA BIOMATER, V6, P1569, DOI 10.1016/j.actbio.2009.10.050
   De Bari C, 2008, ARTHRITIS RHEUM, V58, P240, DOI 10.1002/art.23143
   Detsch R, 2008, ACTA BIOMATER, V4, P139, DOI 10.1016/j.actbio.2007.03.014
   Eyckmans J, 2010, J CELL MOL MED, V14, P1845, DOI 10.1111/j.1582-4934.2009.00807.x
   Eyckmans J, 2006, TISSUE ENG, V12, P2203, DOI 10.1089/ten.2006.12.2203
   Farrell E, 2011, BMC MUSCULOSKEL DIS, V12, DOI 10.1186/1471-2474-12-31
   Fernandes H, 2010, TISSUE ENG PT A, V16, P1693, DOI 10.1089/ten.TEA.2009.0341
   Habibovic P, 2008, BIOMATERIALS, V29, P944, DOI 10.1016/j.biomaterials.2007.10.023
   Janes KA, 2005, SCIENCE, V310, P1646, DOI 10.1126/science.1116598
   Janes KA, 2004, J COMPUT BIOL, V11, P544, DOI 10.1089/cmb.2004.11.544
   Kruyt MC, 2003, TISSUE ENG, V9, P105, DOI 10.1089/107632703762687582
   Kuhl M, 2001, MECH DEVELOP, V106, P61, DOI 10.1016/S0925-4773(01)00416-6
   Laschke MW, 2006, TISSUE ENG, V12, P2093, DOI 10.1089/ten.2006.12.2093
   Lu ZL, 2010, TISSUE ENG PT A, V16, P3075, DOI 10.1089/ten.tea.2010.0204
   Martin I, 2002, TISSUE ENG, V8, P847, DOI 10.1089/10763270260424204
   Mbalaviele G, 1999, ENDOCRINOLOGY, V140, P3736, DOI 10.1210/en.140.8.3736
   Miller-Jensen K, 2007, NATURE, V448, P604, DOI 10.1038/nature06001
   Platt MO, 2009, STEM CELLS, V27, P2804, DOI 10.1002/stem.215
   RABAU MY, 1994, HISTOL HISTOPATHOL, V9, P525
   Riddle RC, 2009, J MOL MED-JMM, V87, P583, DOI 10.1007/s00109-009-0477-9
   Roberts SJ, 2011, BIOMATERIALS, V32, P4393, DOI 10.1016/j.biomaterials.2011.02.047
   Sawyer A, 2003, BIOTECH HISTOCHEM, V78, P271, DOI 10.1080/10520290310001646668
   Shapiro F, 2008, EUR CELLS MATER, V15, P53, DOI 10.22203/eCM.v015a05
   Tang JM, 2006, EUR J CARDIO-THORAC, V30, P353, DOI 10.1016/j.ejcts.2006.02.070
   Topol L, 2003, J CELL BIOL, V162, P899, DOI 10.1083/job.200303158
   Tortelli F, 2010, BIOMATERIALS, V31, P242, DOI 10.1016/j.biomaterials.2009.09.038
   Tullberg-Reinert H, 1999, HISTOCHEM CELL BIOL, V112, P271, DOI 10.1007/s004180050447
   VERHAEGHE J, 1989, J ENDOCRINOL, V120, P143, DOI 10.1677/joe.0.1200143
   Yuan HP, 2010, P NATL ACAD SCI USA, V107, P13614, DOI 10.1073/pnas.1003600107
NR 35
TC 59
Z9 59
U1 4
U2 27
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD APR
PY 2012
VL 33
IS 11
BP 3127
EP 3142
DI 10.1016/j.biomaterials.2012.01.015
PG 16
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 909JR
UT WOS:000301561300006
PM 22269651
DA 2018-10-19
ER

PT J
AU Lee, MH
   Kang, JH
   Lee, SW
AF Lee, Myung Hyun
   Kang, Jong Ho
   Lee, Suk Won
TI The significance of differential expression of genes and proteins in
   human primary cells caused by microgrooved biomaterial substrata
SO BIOMATERIALS
LA English
DT Article
DE Microgrooves; Acid etching; Cell proliferation; Osteoblast
   differentiation; Differential gene expression; Protein expression
ID HUMAN GINGIVAL FIBROBLASTS; MESENCHYMAL STEM-CELLS; OSTEOBLAST-LIKE
   CELLS; HUMAN PERIODONTAL-LIGAMENT; GROWTH-FACTOR; METALLOPROTEINASES-1
   TIMP-1; TISSUE INHIBITOR; TARGET GENE; IN-VITRO; TRANSLATION INITIATION
AB We demonstrate that etched microgrooves, with truncated V-shape in cross-section and subsequent acid etching, on titanium substrata alter the expression of various genes and proteins in human primary cells. Etched microgrooves with 30 or 60 mu m width and 10 mu m depth promoted human gingival fibroblast proliferation and significantly enhanced the osteoblast differentiation of human bone marrow-derived mesenchymal stem cells and human periodontal ligament cells by inducing differential expression of various genes involved in cell adhesion, migration, proliferation, mitosis, cytoskeletal reorganization, translation initiation, vesicular trafficking, proton transportation, transforming growth factor-beta signaling, mitogen-activated protein kinase signaling, simvastatin's anabolic effect on bone, inhibitory guanine nucleotide binding protein (G protein)'s action, sumoylation pathway, survival/apoptosis, mitochondrial distribution, type I collagen production, osteoblast differentiation, and bone remodeling that were verified by the differential display PCR and quantitative real-time PCR. The most influential genes on the enhancement of fibroblast proliferation or osteoblast differentiation were determined by multiple regression analysis, and the expression of relevant proteins was confirmed by western blotting and protein quantitation. (c) 2012 Elsevier Ltd. All rights reserved.
C1 [Lee, Suk Won] Kyung Hee Univ, Dept Biomat & Prosthodont, Kyung Hee Univ Hosp Gangdong, Inst Oral Biol,Sch Dent, Seoul 134727, South Korea.
   [Lee, Myung Hyun; Kang, Jong Ho] Korea Inst Ceram Engn & Technol, Green Ceram Div, Seoul 153801, South Korea.
RP Lee, SW (reprint author), Kyung Hee Univ, Dept Biomat & Prosthodont, Kyung Hee Univ Hosp Gangdong, Inst Oral Biol,Sch Dent, 892 Dongnam Ro, Seoul 134727, South Korea.
EM ysprosth@hanmail.net
FU The Industry Original Technology Development Project [10033799-2009-11];
   Ministry of Knowledge Economy, Republic of Korea
FX The authors thank Prof. Yoon Goo Kang at School of Dentistry, Kyung Hee
   University for the periodontal ligament tissues used in this study. The
   authors also thank Dr. Kyung Hee Kim and Dr. Su Hee Jung at Core
   Research Laboratory, Clinical Research Institute, Kyung Hee University
   Hospital at Gangdong for assisting cellular experiments in this study.
   This research was supported by a grant (code #: 10033799-2009-11) from
   'The Industry Original Technology Development Project' funded by the
   Ministry of Knowledge Economy, Republic of Korea.
CR ALLAN EH, 1991, J CELL PHYSIOL, V149, P34, DOI 10.1002/jcp.1041490106
   Arlt A, 2011, EUR J CELL BIOL, V90, P545, DOI 10.1016/j.ejcb.2010.10.002
   Balloni S, 2009, INT J ORAL MAX IMPL, V24, P627
   Beck M, 2002, J BIOL CHEM, V277, P30079, DOI 10.1074/jbc.M200438200
   Bergink S, 2009, NATURE, V458, P461, DOI 10.1038/nature07963
   Bertaux K, 2005, J BONE MINER METAB, V23, P114, DOI 10.1007/s00774-004-0549-4
   Biggs MJP, 2008, J R SOC INTERFACE, V5, P1231, DOI 10.1098/rsif.2008.0035
   Biggs MJP, 2009, BIOMATERIALS, V30, P5094, DOI 10.1016/j.biomaterials.2009.05.049
   Bigi A, 2005, BIOMATERIALS, V26, P2381, DOI 10.1016/j.biomaterials.2004.07.057
   Bock-Marquette I, 2004, NATURE, V432, P466, DOI 10.1038/nature03000
   Brickley K, 2011, J BIOL CHEM, V286, P18079, DOI 10.1074/jbc.M111.236018
   CHEHROUDI B, 1992, CELL MATER, V2, P89
   CHOU LS, 1995, J CELL SCI, V108, P1563
   Daci E, 1999, J BONE MINER RES, V14, P946, DOI 10.1359/jbmr.1999.14.6.946
   Dalby Matthew J, 2007, Curr Stem Cell Res Ther, V2, P129, DOI 10.2174/157488807780599220
   Dalby MJ, 2003, EXP CELL RES, V284, P274, DOI 10.1016/S0014-4827(02)00053-8
   denBraber ET, 1996, BIOMATERIALS, V17, P1093, DOI 10.1016/0142-9612(96)85910-2
   denBraber ET, 1996, BIOMATERIALS, V17, P2037, DOI 10.1016/0142-9612(96)00032-4
   Desterro JMP, 1999, J BIOL CHEM, V274, P10618, DOI 10.1074/jbc.274.15.10618
   Di Bacco A, 2006, CELL CYCLE, V5, P2310, DOI 10.4161/cc.5.20.3367
   Diwakar R, 2008, BIOCHEM BIOPH RES CO, V366, P675, DOI 10.1016/j.bbrc.2007.11.171
   Everts V, 2008, BONE, V43, P915, DOI 10.1016/j.bone.2008.07.004
   Eves EM, 2006, MOL CELL, V23, P561, DOI 10.1016/j.molcel.2006.07.015
   Fletcher CM, 1999, EMBO J, V18, P2631, DOI 10.1093/emboj/18.9.2631
   Franceschi RT, 2007, ANN NY ACAD SCI, V1116, P196, DOI 10.1196/annals.1402.081
   Frederick RL, 2007, TRAFFIC, V8, P1668, DOI 10.1111/j.1600-0854.2007.00644.x
   Geoffroy V, 2002, MOL CELL BIOL, V22, P6222, DOI 10.1128/MCB.22.17.6222-6233.2002
   Goody RS, 2005, CELL MOL LIFE SCI, V62, P1657, DOI 10.1007/s00018-005-4486-8
   Guo XK, 2006, BBA-MOL CELL RES, V1763, P296, DOI 10.1016/j.bbamcr.2006.02.012
   HAYAKAWA T, 1992, FEBS LETT, V298, P29, DOI 10.1016/0014-5793(92)80015-9
   Heo JS, 2010, MOL CELLS, V30, P449, DOI 10.1007/s10059-010-0139-3
   Heo YY, 2011, ORAL DIS, V17, P320, DOI 10.1111/j.1601-0825.2010.01728.x
   Hinkel R, 2008, CIRCULATION, V117, P2232, DOI 10.1161/CIRCULATIONAHA.107.758904
   Ho JH, 2010, J ORTHOP RES, V28, P131, DOI 10.1002/jor.20956
   Hocevar BA, 2005, J BIOL CHEM, V280, P25920, DOI 10.1074/jbc.M501150200
   Huff T, 2001, INT J BIOCHEM CELL B, V33, P205, DOI 10.1016/S1357-2725(00)00087-X
   Hwang R, 2004, J BIOL CHEM, V279, P21239, DOI 10.1074/jbc.M312771200
   Ivaska J, 2007, EXP CELL RES, V313, P2050, DOI 10.1016/j.yexcr.2007.03.040
   Jansen J A, 1999, Adv Dent Res, V13, P57
   Janssens K, 2005, ENDOCR REV, V26, P743, DOI 10.1210/er.2004-0001
   Jefferies KC, 2008, ARCH BIOCHEM BIOPHYS, V476, P33, DOI 10.1016/j.abb.2008.03.025
   Jin RX, 2002, CARCINOGENESIS, V23, P81, DOI 10.1093/carcin/23.1.81
   Johnson ES, 1997, EMBO J, V16, P5509, DOI 10.1093/emboj/16.18.5509
   Kamioka H, 2004, J BONE MINER RES, V19, P471, DOI 10.1359/JBMR.040128
   Kim SH, 2009, J PERIODONTOL, V80, P1815, DOI 10.1902/jop.2009.090249
   Kim SY, 2009, CLIN ORAL IMPLAN RES, V20, P262, DOI 10.1111/j.1600-0501.2008.01652.x
   Komori T, 2010, CELL TISSUE RES, V339, P189, DOI 10.1007/s00441-009-0832-8
   Lau KHW, 1998, J BONE MINER RES, V13, P1660, DOI 10.1359/jbmr.1998.13.11.1660
   LEBLOND CP, 1989, ANAT REC, V224, P123, DOI 10.1002/ar.1092240204
   Lee MH, 2010, BIOMATERIALS, V31, P3804, DOI 10.1016/j.biomaterials.2010.01.117
   Lee SG, 2006, P NATL ACAD SCI USA, V103, P17390, DOI 10.1073/pnas.0608386103
   Lee SW, 2009, CLIN ORAL IMPLAN RES, V20, P458, DOI 10.1111/j.1600-0501.2008.01671.x
   Lee SW, 2009, CLIN ORAL IMPLAN RES, V20, P56, DOI 10.1111/j.1600-0501.2008.01597.x
   Lesniak W, 2009, BIOCHEM BIOPH RES CO, V390, P1087, DOI 10.1016/j.bbrc.2009.10.150
   Li ZY, 2009, J BIOL CHEM, V284, P15676, DOI 10.1074/jbc.M809787200
   Lian N, 2009, J BIOL CHEM, V284, P30518, DOI 10.1074/jbc.M109.052373
   Liang ZW, 2004, BIOCHEM BIOPH RES CO, V325, P798, DOI 10.1016/j.bbrc.2004.10.124
   Lim D, 2009, CANCER LETT, V276, P109, DOI 10.1016/j.canlet.2008.10.038
   Listgarten MA, 1991, CLIN ORAL IMPLAN RES, V2, P1, DOI 10.1034/j.1600-0501.1991.020101.x
   Lorenz K, 2003, NATURE, V426, P574, DOI 10.1038/nature02158
   Lyst MJ, 2007, BIOCHEM SOC T, V35, P1389, DOI 10.1042/BST0351389
   Maeda T, 2001, BIOCHEM BIOPH RES CO, V280, P874, DOI 10.1006/bbrc.2000.4232
   Matsuura T, 2005, EUR J ORAL SCI, V113, P225, DOI 10.1111/j.1600-0722.2005.00208.x
   Mendonca DBS, 2011, BONE, V49, P463, DOI 10.1016/j.bone.2011.04.019
   Millard SM, 2011, J BONE MINER RES, V26, P822, DOI 10.1002/jbmr.273
   Moon IS, 1999, J CLIN PERIODONTOL, V26, P658, DOI 10.1034/j.1600-051X.1999.261005.x
   Nakashima A, 2006, FRONT BIOSCI, V11, P1667, DOI 10.2741/1912
   Nanda JS, 2009, J MOL BIOL, V394, P268, DOI 10.1016/j.jmb.2009.09.017
   Oakley C, 1997, EXP CELL RES, V234, P413, DOI 10.1006/excr.1997.3625
   Ogawa T, 2006, J DENT RES, V85, P566, DOI 10.1177/154405910608500617
   Osawa Y, 2003, J IMMUNOL, V170, P4053, DOI 10.4049/jimmunol.170.8.4053
   Papazisis KT, 1997, J IMMUNOL METHODS, V208, P151, DOI 10.1016/S0022-1759(97)00137-3
   Peng J, 2008, ENDOCRINOLOGY, V149, P1329, DOI 10.1210/en-2007-0235
   Perizzolo D, 2001, J BIOMED MATER RES, V56, P494, DOI 10.1002/1097-4636(20010915)56:4<494::AID-JBM1121>3.0.CO;2-X
   Pozo KBK, 2011, BBA-MOL CELL RES, V1813, P269, DOI 10.1016/j.bbamcr.2010.10.011
   Qu J, 1996, Oral Dis, V2, P102
   REITHMANN C, 1991, MOL CELL ENDOCRINOL, V82, pC215, DOI 10.1016/0303-7207(91)90022-K
   Saito A, 2011, J BIOL CHEM, V286, P4809, DOI 10.1074/jbc.M110.152900
   Schafer H, 1998, ONCOGENE, V16, P2479, DOI 10.1038/sj.onc.1201788
   Schiltz C, 2010, J CELL PHYSIOL, V222, P219, DOI 10.1002/jcp.21941
   Schwartz Z, 2001, BIOMATERIALS, V22, P731, DOI 10.1016/S0142-9612(00)00241-6
   Seeler JS, 2003, NAT REV MOL CELL BIO, V4, P690, DOI 10.1038/nrm1200
   Seo BM, 2004, LANCET, V364, P149, DOI 10.1016/S0140-6736(04)16627-0
   Sheu TJ, 2003, J BIOL CHEM, V278, P438, DOI 10.1074/jbc.M208292200
   Sosne G, 2004, EXP CELL RES, V293, P175, DOI 10.1016/j.yexcr.2003.09.022
   Studer R, 1997, BIOCHEM J, V328, P63, DOI 10.1042/bj3280063
   Sun-Wada GH, 2010, HISTOL HISTOPATHOL, V25, P1611, DOI 10.14670/HH-25.1611
   Tanaka-Kamioka K, 1998, J BONE MINER RES, V13, P1555, DOI 10.1359/jbmr.1998.13.10.1555
   Teti G, 2009, J BIOMED MATER RES A, V90A, P256, DOI 10.1002/jbm.a.32082
   TISDALE EJ, 1992, J CELL BIOL, V119, P749, DOI 10.1083/jcb.119.4.749
   Trakul N, 2005, J BIOL CHEM, V280, P24931, DOI 10.1074/jbc.M413929200
   Tu QS, 2003, J BONE MINER RES, V18, P1825, DOI 10.1359/jbmr.2003.18.10.1825
   Valencia S, 2009, INT J ORAL MAX IMPL, V24, P38
   Wang CR, 2010, J BIOL CHEM, V285, P29398, DOI 10.1074/jbc.M110.141440
   Wei JW, 2008, J CELL PHYSIOL, V217, P693, DOI 10.1002/jcp.21543
   Wek RC, 2006, BIOCHEM SOC T, V34, P7, DOI 10.1042/BST0340007
   Xiao GZ, 2005, J BIOL CHEM, V280, P30689, DOI 10.1074/jbc.M500750200
   Yang GG, 2004, J BIOMECH, V37, P1543, DOI 10.1016/j.jbiomech.2004.01.005
   Yang XG, 2004, CELL, V117, P387, DOI 10.1016/S0092-8674(04)00344-7
   Yeung K, 1999, NATURE, V401, P173
   Yoo BK, 2011, PHARMACOL THERAPEUT, V130, P1, DOI 10.1016/j.pharmthera.2011.01.008
   Yoo BK, 2009, J CLIN INVEST, V119, P465, DOI 10.1172/JCI36460
   Zhao G, 2007, BIOMATERIALS, V28, P2821, DOI 10.1016/j.biomaterials.2007.02.024
   Zhao G, 2006, CLIN ORAL IMPLAN RES, V17, P258, DOI 10.1111/j.1600-0501.2005.01195.x
   Zhao G, 2005, J BIOMED MATER RES A, V74A, P49, DOI 10.1002/jbm.a.30320
   Zhao WQ, 1998, J CELL SCI, V111, P1147
   Zhou J, 2001, J BIOL CHEM, V276, P27793, DOI 10.1074/jbc.M102803200
NR 107
TC 15
Z9 15
U1 1
U2 16
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
EI 1878-5905
J9 BIOMATERIALS
JI Biomaterials
PD APR
PY 2012
VL 33
IS 11
BP 3216
EP 3234
DI 10.1016/j.biomaterials.2012.01.034
PG 19
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 909JR
UT WOS:000301561300014
PM 22285466
DA 2018-10-19
ER

PT J
AU Moczulska, M
   Bitar, M
   Swieszkowski, W
   Bruinink, A
AF Moczulska, M.
   Bitar, M.
   Swieszkowski, W.
   Bruinink, A.
TI Biological characterization of woven fabric using two- and
   three-dimensional cell cultures
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A
LA English
DT Article
DE scaffold; textile; polyamide 6; 6; polyethylene terephthalat;
   osteoblast; fibroblast; reaggregate; 3D
ID MARROW STROMAL CELLS; FIBRO-POROUS MESHES; TISSUE-RESPONSE; BONE-MARROW;
   SCAFFOLD INTERACTIONS; SURFACE-CHARGE; IN-VITRO; 3D; DIFFERENTIATION;
   FIBROBLASTS
AB The integration and long-term functional retention of tissue implants are both strongly linked to the implant material characteristics. As a first approach, the cytocompatibility and bioactivity of such materials are evaluated using in vitro-based cell culture models. Typically, in vitro bioactivity is assessed by seeding single cells onto the test material to evaluate certain parameters such as cell adhesion, survival, proliferation, and functional differentiation. Probably, due to the reduction from three dimensional (3D) toward the two dimensional (2D) situation the data obtained from 2D culture models falls short of predicting the in vivo behavior of the biomaterial in question. In this study, a three dimensional (3D) in vitro cell culture model was applied to evaluate the bioactivity of well characterized fiber-based scaffolds using scaffold colonization as a bioactivity indicator. Cell behavior in this culture model was evaluated against a classical comparable, 2D cell culture system using polyethylene terephthalat and polyamide 6.6 fabrics. By using the 3D culture model, however, differences in cell population performance as a function of fiber diameter and mesh angle were evident. The use of 3D cell culture model clearly outperformed typical cell culture setup as means to evaluate cell populationscaffold interaction. (C) 2012 Wiley Periodicals, Inc. J Biomed Mater Res Part A:, 2012.
C1 [Moczulska, M.; Bitar, M.; Bruinink, A.] EMPA, Mat Sci & Technol, CH-9014 St Gallen, Switzerland.
   [Moczulska, M.; Swieszkowski, W.] Warsaw Univ Technol, Fac Mat Sci Engn, PL-02507 Warsaw, Poland.
RP Bruinink, A (reprint author), EMPA, Mat Sci & Technol, Lerchenfelstr 5, CH-9014 St Gallen, Switzerland.
EM arie.bruinink@empa.ch
FU EMPA; International PhD School Switzerland-Poland; Faculty of Materials
   Science and Engineering of the Warsaw University of Technology; Polish
   Ministry of Science and Higher Education
FX Contract grant sponsors: EMPA; International PhD School
   Switzerland-Poland; Faculty of Materials Science and Engineering of the
   Warsaw University of Technology; Polish Ministry of Science and Higher
   Education
CR Augsten M, 2009, P NATL ACAD SCI USA, V106, P3414, DOI 10.1073/pnas.0813144106
   Baron MJ, 2010, J BIOMECH ENG, V132
   Benigni R, 2010, J ENVIRON SCI HEAL C, V28, P272, DOI 10.1080/10590501.2010.525781
   Boyan BD, 1999, CLIN PLAST SURG, V26, P629
   Bruinink A, 2001, BIOMATERIALS, V22, P2465, DOI 10.1016/S0142-9612(00)00434-8
   Bruinink A, 2001, BIOMATERIALS, V22, P3169, DOI 10.1016/S0142-9612(01)00069-2
   Bruinink A, 1992, BRAIN BITS PIECES, P23
   Cay A, 2007, FIBRES TEXT EAST EUR, V15, P91
   Davila J C, 1968, Ann N Y Acad Sci, V146, P138, DOI 10.1111/j.1749-6632.1968.tb20278.x
   Drachev AI, 2006, HIGH ENERG CHEM+, V40, P417, DOI 10.1134/S0018143906060105
   DUNN GA, 1976, EXP CELL RES, V101, P1, DOI 10.1016/0014-4827(76)90405-5
   FELDMAN DS, 1983, BIOMATERIALS, V4, P105, DOI 10.1016/0142-9612(83)90049-2
   Fischbach C, 2009, P NATL ACAD SCI USA, V106, P399, DOI 10.1073/pnas.0808932106
   Francois S, 2008, TRENDS BIOMATER ARTI, V22, P93
   Goldstein AS, 2001, TISSUE ENG, V7, P817, DOI 10.1089/107632701753337753
   Guth K, 2010, ADV ENG MATER, V12, pB113, DOI 10.1002/adem.200980026
   Habibovic P, 2007, ADV EXP MED BIOL, V585, P327
   Hadjipanayi E, 2009, CELL MOTIL CYTOSKEL, V66, P121, DOI 10.1002/cm.20331
   Hamdan M, 2006, CLIN IMPLANT DENT R, V8, P32, DOI 10.2310/6480.2005.00028
   Hillmann G, 1999, J CELL SCI, V112, P2823
   Holtorf HL, 2005, J BIOMED MATER RES A, V74A, P171, DOI 10.1002/jbm.a.30330
   Hutmacher DW, 2000, BIOMATERIALS, V21, P2529, DOI 10.1016/S0142-9612(00)00121-6
   Hwang CM, 2009, BIOMED MICRODEVICES, V11, P739, DOI 10.1007/s10544-009-9287-7
   Ichinohe N, 2008, TISSUE ENG PT A, V14, P107, DOI 10.1089/ten.a.2007.0021
   Kaiser JP, 2006, BIOMATERIALS, V27, P5230, DOI 10.1016/j.biomaterials.2006.06.002
   Karamuk E, 2004, COMPOS SCI TECHNOL, V64, P885, DOI 10.1016/j.compscitech.2003.09.004
   Khaitan D, 2006, EXPERT OPIN DRUG DIS, V1, P663, DOI 10.1517/17460441.1.7.663
   LEE JH, 1994, BIOMATERIALS, V15, P705, DOI 10.1016/0142-9612(94)90169-4
   Ouyang A, 2007, STEM CELLS, V25, P447, DOI 10.1634/stemcells.2006-0322
   Sanders JE, 2005, J BIOMED MATER RES A, V72A, P335, DOI 10.1002/jbm.a.30259
   Sanders JE, 2005, BIOMATERIALS, V26, P813, DOI 10.1016/j.biomaterials.2004.03.030
   Sanders JE, 2002, J BIOMED MATER RES, V62, P222, DOI 10.1002/jbm.10285
   Schneider GB, 2004, BIOMATERIALS, V25, P3023, DOI 10.1016/j.biomaterials.2003.09.084
   Schuler M, 2009, J BIOMED MATER RES B, V91B, P517, DOI 10.1002/jbm.b.31425
   Sun T, 2007, J MATER SCI-MATER M, V18, P321, DOI 10.1007/s10856-006-0696-3
   Sun T, 2007, BIOTECHNOL BIOENG, V97, P1318, DOI 10.1002/bit.21309
   Sun T, 2009, J MATER SCI-MATER M, V20, P1483, DOI 10.1007/s10856-009-3703-7
   SUTHERLAND RM, 1988, SCIENCE, V240, P177, DOI 10.1126/science.2451290
   Walboomers F, 2001, PERITON DIALYSIS INT, V21, P254
   Wan H, 1997, J MATER SCI-MATER M, V8, P45, DOI 10.1023/A:1018542313236
   Wei JH, 2007, J BIOMED MATER RES B, V81B, P66, DOI 10.1002/jbm.b.30638
   Wei JH, 2009, BIOMED MATER, V4, DOI 10.1088/1748-6041/4/4/045002
   Weyhe D, 2006, WORLD J SURG, V30, P1586, DOI 10.1007/s00268-005-0601-0
   Williams D. F., 1987, DEFINITIONS BIOMATER
   Woodfield TBF, 2004, BIOMATERIALS, V25, P4149, DOI 10.1016/j.biomaterials.2003.10.056
   Yang Y, 2008, ADV MATER, V20, P2037, DOI 10.1002/adma.200702088
NR 46
TC 11
Z9 11
U1 0
U2 15
PU WILEY-BLACKWELL
PI MALDEN
PA COMMERCE PLACE, 350 MAIN ST, MALDEN 02148, MA USA
SN 1549-3296
J9 J BIOMED MATER RES A
JI J. Biomed. Mater. Res. Part A
PD APR
PY 2012
VL 100A
IS 4
BP 882
EP 893
DI 10.1002/jbm.a.34023
PG 12
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 897SU
UT WOS:000300677600009
PM 22275338
DA 2018-10-19
ER

PT J
AU Palacio, MLB
   Schricker, SR
   Bhushan, B
AF Palacio, M. L. B.
   Schricker, S. R.
   Bhushan, B.
TI Block copolymer arrangement and composition effects on protein
   conformation using atomic force microscope-based antigen-antibody
   adhesion
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A
LA English
DT Article
DE block copolymers; atomic force microscopy; protein conformation;
   fibronectin; antibody
ID CELL-ADHESION; FIBRONECTIN CONFORMATION; ADSORBED PROTEINS; INTEGRIN
   BINDING; SURFACE-FEATURES; BLOOD-PLASMA; ADSORPTION; PROLIFERATION;
   FIBRINOGEN; MORPHOLOGY
AB The conformational changes of fibronectin (FN) deposited on various block copolymers where one block is composed of poly(methyl methacrylate) (PMMA) and the other block is either poly(acrylic acid) (PAA) or poly(2-hydroxyethyl methacrylate) (PHEMA) were investigated using a functionalized atomic force microscope (AFM) tip. The tip was modified with an antibody sensitive to the exposure of the arginineglycineaspartic acid (RGD) groups in FN. By studying the adhesive interactions between the antibody and the proteins adsorbed on the block copolymer surface and phase imaging, it was found that the triblock copolymers PAA-b-PMMA-b-PAA and PMMA-b-PHEMA-b-PMMA, which both have large domain sizes, are conducive to the exposure of the FN RGD groups on the surface. On the basis of these results, it is concluded that the surface chemistry as well as the nanomorphology dictated by the block copolymer arrangement could both tune protein conformation and orientation and optimize cell adhesion to the biomaterial surface. (C) 2012 Wiley Periodicals, Inc. J Biomed Mater Res Part A:, 2012.
C1 [Schricker, S. R.] Ohio State Univ, Coll Dent, Restorat & Prosthet Dent Sect, Columbus, OH 43210 USA.
   [Palacio, M. L. B.; Bhushan, B.] Ohio State Univ, Nanoprobe Lab Bio & Nanotechnol & Biomimet, Columbus, OH 43210 USA.
RP Schricker, SR (reprint author), Ohio State Univ, Coll Dent, Restorat & Prosthet Dent Sect, Columbus, OH 43210 USA.
EM Schricker.1@osu.edu; Bhushan.2@osu.edu
RI Bhushan, Bharat/A-9684-2013; Schricker, Scott/A-3957-2008
OI Bhushan, Bharat/0000-0001-7161-6601; Schricker,
   Scott/0000-0003-1982-1282
FU NIDCR NIH HHS [K25 DE015803]; NCRR NIH HHS [UL1 RR025755]
CR Allen S, 1997, BIOCHEMISTRY-US, V36, P7457, DOI 10.1021/bi962531z
   Arnold M, 2009, SOFT MATTER, V5, P72, DOI 10.1039/b815634d
   Baugh L, 2004, J BIOMED MATER RES A, V69A, P525, DOI 10.1002/jbm.a.30026
   Bhushan B, 2008, J R SOC INTERFACE, V6, P719
   Bhushan B., 2011, NANOTRIBOLOGY NANOME
   Bhushan B., 2010, SPRINGER HDB NANOTEC
   Bhushan B, MAT TODAY IN PRESS
   Cheng CX, 2005, LANGMUIR, V21, P6576, DOI 10.1021/la050187d
   Collier TO, 2002, J BIOMED MATER RES, V60, P487, DOI 10.1002/jbm.10043
   DEKKER A, 1991, BIOMATERIALS, V12, P130, DOI 10.1016/0142-9612(91)90191-C
   DICKINSON CD, 1994, J MOL BIOL, V236, P1079, DOI 10.1016/0022-2836(94)90013-2
   Engel E, 2008, TRENDS BIOTECHNOL, V26, P39, DOI 10.1016/j.tibtech.2007.10.005
   Garcia AJ, 1999, MOL BIOL CELL, V10, P795
   Giamblanco N, 2011, LANGMUIR, V27, P312, DOI 10.1021/la104127q
   Gonzalez-Garcia C, 2010, COLLOID SURFACE B, V77, P181, DOI 10.1016/j.colsurfb.2010.01.021
   Hinterdorfer P, 1996, P NATL ACAD SCI USA, V93, P3477, DOI 10.1073/pnas.93.8.3477
   Jung SY, 2003, J AM CHEM SOC, V125, P12782, DOI 10.1021/ja037263o
   Kantawong F, 2009, J R SOC INTERFACE, V6, P1075, DOI 10.1098/rsif.2008.0447
   Keselowsky BG, 2003, J BIOMED MATER RES A, V66A, P247, DOI 10.1002/jbm.a.10537
   Keselowsky BG, 2004, BIOMATERIALS, V25, P5947, DOI 10.1016/j.biomaterials.2004.01.062
   Khang D, 2008, BIOMATERIALS, V29, P970, DOI 10.1016/j.biomaterials.2007.11.009
   Khang D, 2009, ACTA BIOMATER, V5, P1425, DOI 10.1016/j.actbio.2009.01.031
   Kienberger F, 2005, J MOL BIOL, V347, P597, DOI 10.1016/j.jmb.2005.01.042
   Kim CH, 2010, J NANOSCI NANOTECHNO, V10, P6864, DOI 10.1166/jnn.2010.2989
   Kowalczynska HM, 2005, J BIOMED MATER RES A, V72A, P228, DOI 10.1002/jbm.a.30238
   Krishnan A, 2004, LANGMUIR, V20, P5071, DOI 10.1021/la036218r
   Lan MA, 2005, BIOMATERIALS, V26, P4523, DOI 10.1016/j.biomaterials.2004.11.028
   Lee CK, 2007, MICRON, V38, P446, DOI 10.1016/j.micron.2006.06.014
   Lehnert D, 2004, J CELL SCI, V117, P41, DOI 10.1242/jcs.00836
   Little WC, 2008, MATRIX BIOL, V27, P451, DOI 10.1016/j.matbio.2008.02.003
   Lord MS, 2006, BIOMATERIALS, V27, P4856, DOI 10.1016/j.biomaterials.2006.05.037
   NIMERI G, 1994, J BIOMAT SCI-POLYM E, V6, P573, DOI 10.1163/156856294X00527
   Noh H, 2007, BIOMATERIALS, V28, P405, DOI 10.1016/j.biomaterials.2006.09.006
   Nuttelman CR, 2001, J BIOMED MATER RES, V57, P217, DOI 10.1002/1097-4636(200111)57:2<217::AID-JBM1161>3.0.CO;2-I
   Palacio M, 2010, J MICROSC-OXFORD, V240, P239, DOI 10.1111/j.1365-2818.2010.03420.x
   Palacio MLB, 2012, J BIOMED MATER RES A, V100A, P18, DOI 10.1002/jbm.a.33219
   Palacio MLB, 2011, J R SOC INTERFACE, V8, P630, DOI 10.1098/rsif.2010.0557
   Pankov R, 2002, J CELL SCI, V115, P3861, DOI 10.1242/jcs.00059
   Pareta RA, 2010, J BIOMED MATER RES A, V92A, P1190, DOI 10.1002/jbm.a.32433
   Perez-Garnes M, 2011, INT J ARTIF ORGANS, V34, P54, DOI 10.5301/IJAO.2011.6316
   Pitois O, 1999, COLLOID POLYM SCI, V277, P574, DOI 10.1007/s003960050427
   Schricker S, 2010, ULTRAMICROSCOPY, V110, P639, DOI 10.1016/j.ultramic.2010.02.025
   Stevens MM, 2002, LANGMUIR, V18, P6659, DOI 10.1021/la0202024
   Turbill P, 1996, BIOMATERIALS, V17, P1279, DOI 10.1016/0142-9612(96)88673-X
   VROMAN L, 1962, NATURE, V196, P476, DOI 10.1038/196476a0
   WIDAWSKI G, 1994, NATURE, V369, P387, DOI 10.1038/369387a0
   Wilson CJ, 2005, TISSUE ENG, V11, P1, DOI 10.1089/ten.2005.11.1
NR 47
TC 7
Z9 7
U1 1
U2 23
PU WILEY-BLACKWELL
PI MALDEN
PA COMMERCE PLACE, 350 MAIN ST, MALDEN 02148, MA USA
SN 1549-3296
J9 J BIOMED MATER RES A
JI J. Biomed. Mater. Res. Part A
PD APR
PY 2012
VL 100A
IS 4
BP 978
EP 988
DI 10.1002/jbm.a.34033
PG 11
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 897SU
UT WOS:000300677600019
PM 22278846
OA Green Accepted
DA 2018-10-19
ER

PT J
AU Xia, Y
   Mei, F
   Duan, YL
   Gao, Y
   Xiong, Z
   Zhang, T
   Zhang, HQ
AF Xia, Yang
   Mei, Fang
   Duan, Yongli
   Gao, Ying
   Xiong, Zhuo
   Zhang, Ting
   Zhang, Hongquan
TI Bone tissue engineering using bone marrow stromal cells and an
   injectable sodium alginate/gelatin scaffold
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A
LA English
DT Article
DE sodium alginate; gelatin; BMSCs; osteogenic cells; ectopic bone
   formation; calvarial critical-sized defects
ID MESENCHYMAL STEM-CELLS; CRITICAL SIZE DEFECT; FABRICATION; HYDROGELS;
   MODEL
AB To investigate the potential application of bone marrow stromal cells (BMSCs) and an injectable sodium alginate/gelatin scaffold for bone tissue engineering (BTE). The phenotype of osteogenic BMSCs was examined by mineralized nodules formation and type I collagen expression. Cell proliferation was evaluated by MTT assay. The biocompatibility of scaffold and osteogenic cells were examined by hematoxylin and eosin (H&E) staining. Ectopic bone formation as well as closure of rabbit calvarial critical-sized defects following scaffold-cell implantation were analyzed by histological examination and computed tomography (CT) scanning. Spindle-shaped osteogenic cells of high purity were derived from BMSCs. The osteogenic cells and sodium alginate/gelatin (2:3) scaffold presented fine biocompatibility following cross-linking with 0.6% of CaCl2. After implantation, the scaffold-cell construct promoted both ectopic bone formation and bone healing in the rabbit calvarial critical-sized defect model. Our data demonstrated that the sodium alginate/gelatin scaffold could be a suitable biomaterial for bone engineering, and the scaffold-osteogenic cells construct is a promising alternative approach for the bone healing process. (C) 2012 Wiley Periodicals, Inc. J Biomed Mater Res Part A:, 2012.
C1 [Xia, Yang; Mei, Fang; Zhang, Hongquan] Peking Univ, Sch Basic Med Sci, Beijing 100083, Peoples R China.
   [Xia, Yang; Duan, Yongli; Gao, Ying] Beijing Shijitan Hosp, Beijing 100038, Peoples R China.
   [Xiong, Zhuo; Zhang, Ting] Tsinghua Univ, Dept Mech Engn, Beijing 100084, Peoples R China.
RP Zhang, HQ (reprint author), Peking Univ, Sch Basic Med Sci, Beijing 100083, Peoples R China.
EM hongquan.zhang@bjmu.edu.cn
FU Beijing Natural Science Foundation [7083107]; Beijing Excellent
   Researcher Foundation [20071D0303100116]; China Postdoctoral Science
   Foundation [20090460179]; National Natural Science Foundation of China
   [30830048]; State Key Development Program of Basic Research of China
   [2010CB912203]
FX Contract grant sponsor: Beijing Natural Science Foundation; contract
   grant number: 7083107; Contract grant sponsor: Beijing Excellent
   Researcher Foundation; contract grant number: 20071D0303100116; Contract
   grant sponsor: China Postdoctoral Science Foundation; contract grant
   number: 20090460179; Contract grant sponsor: National Natural Science
   Foundation of China; contract grant number: 30830048; Contract grant
   sponsor: State Key Development Program of Basic Research of China;
   contract grant number: 2010CB912203
CR Betz RR, 2002, ORTHOPEDICS, V25, pS561
   Choi YS, 2001, J MATER SCI-MATER M, V12, P67, DOI 10.1023/A:1026765321117
   Eslaminejad MB, 2007, J TISSUE ENG REGEN M, V1, P417, DOI 10.1002/term.49
   Humber CC, 2010, ORAL SURG ORAL MED O, V109, P372, DOI 10.1016/j.tripleo.2009.10.008
   Jan Ahmed M A, 2006, Oral Surg Oral Med Oral Pathol Oral Radiol Endod, V101, P144, DOI 10.1016/j.tripleo.2005.08.032
   Kang HW, 1999, BIOMATERIALS, V20, P1339, DOI 10.1016/S0142-9612(99)00036-8
   Kaur G, 2010, BIOMATERIALS, V31, P1732, DOI 10.1016/j.biomaterials.2009.11.041
   Kisiday J, 2002, P NATL ACAD SCI USA, V99, P9996, DOI 10.1073/pnas.142309999
   Lee KY, 2001, CHEM REV, V101, P1869, DOI 10.1021/cr000108x
   Madihally SV, 1999, BIOMATERIALS, V20, P1133, DOI 10.1016/S0142-9612(99)00011-3
   Maquet V, 2004, BIOMATERIALS, V25, P4185, DOI 10.1016/j.biomaterials.2003.10.082
   Martin I, 1997, ENDOCRINOLOGY, V138, P4456, DOI 10.1210/en.138.10.4456
   Patel ZS, 2008, BONE, V43, P931, DOI 10.1016/j.bone.2008.06.019
   Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143
   Rose FRAJ, 2002, BIOCHEM BIOPH RES CO, V292, P1, DOI 10.1006/bbrc.2002.6519
   SCHMITZ JP, 1986, CLIN ORTHOP RELAT R, P299
   Tampieri A, 2005, ACTA BIOMATER, V1, P343, DOI 10.1016/j.actbio.2005.01.001
   Tan HP, 2009, BIOMATERIALS, V30, P2499, DOI 10.1016/j.biomaterials.2008.12.080
   Vacanti CA, 1999, CLIN ORTHOP RELAT R, pS375
   Zmora S, 2002, BIOMATERIALS, V23, P4087, DOI 10.1016/S0142-9612(02)00146-1
NR 20
TC 26
Z9 29
U1 2
U2 33
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1549-3296
EI 1552-4965
J9 J BIOMED MATER RES A
JI J. Biomed. Mater. Res. Part A
PD APR
PY 2012
VL 100A
IS 4
BP 1044
EP 1050
DI 10.1002/jbm.a.33232
PG 7
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 897SU
UT WOS:000300677600024
PM 22318897
DA 2018-10-19
ER

PT J
AU Hofmann, CM
   Bednar, KJ
   Anderson, JM
   Marchant, RE
AF Hofmann, Christopher M.
   Bednar, Kyle J.
   Anderson, James M.
   Marchant, Roger E.
TI Disruption of Staphylococcus epidermidis biofilm formation using a
   targeted cationic peptide
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A
LA English
DT Article
DE Staphylococcus epidermidis; biofilm; polysaccharide intercellular
   adhesin; cationic; targeting
ID POLYSACCHARIDE INTERCELLULAR ADHESIN; CATHETER-ASSOCIATED INFECTION;
   FIBRINOGEN-BINDING-PROTEIN; MOLECULAR-BASIS; RAT MODEL; PATHOGENESIS;
   IDENTIFICATION; ADHERENCE; ADHESIN/HEMAGGLUTININ; EXOPOLYSACCHARIDE
AB This study reports the use of a targeted cationic peptide with the ability to disrupt Staphylococcus epidermidis biofilm formation. Complications due to nosocomial infections of implanted medical devices pose a significant health risk to patients, with Staphylococcus epidermidis often implicated in the case of blood-contacting biomaterials. S. epidermidis virulence relies mainly on its ability to form a biofilm, the main component of which is polysaccharide intercellular adhesin (PIA). We utilized the synthetic beta 6-20 peptide, known to specifically bind S. epidermidis, in order to deliver a cationic polylysine peptide (G3K6) to the bacterial surface and disrupt the chargecharge interactions needed for PIA retention and biofilm stability. The effects of the beta 6-20-G3K6 peptide on biofilm formation were assessed using optical density, fluorescently labeled wheat germ agglutinin, nucleic acid stain (SYTO 9), and a metabolic assay (XTT, 2,3-bis(2-methoxy-4-nitro-5-sulfophenyl)-2H-tetrazolium-5-carboxanilide inner salt). Biofilms formed in the presence of beta 6-20-G3K6 peptide (100 mu M) resulted in a 37.9% reduction in PIA content and a 17.5% reduction of adherent bacteria relative to biofilms grown in the absence of peptide. These studies demonstrate the targeting ability of the beta 6-20 peptide towards biomaterial-adherent S. epidermidis, and highlight the potential for disrupting the early stages of biofilm formation. (C) 2012 Wiley Periodicals, Inc. J Biomed Mater Res Part A:, 2012.
C1 [Hofmann, Christopher M.; Bednar, Kyle J.; Anderson, James M.; Marchant, Roger E.] Case Western Reserve Univ, Dept Biomed Engn, Cleveland, OH 44106 USA.
   [Anderson, James M.] Case Western Reserve Univ, Inst Pathol, Cleveland, OH 44106 USA.
RP Marchant, RE (reprint author), Case Western Reserve Univ, Dept Biomed Engn, Cleveland, OH 44106 USA.
EM roger.marchant@case.edu
FU National Institute of Biomedical Imaging and Bioengineering
   [5R01EB000279]
FX Contract grant sponsor: National Institute of Biomedical Imaging and
   Bioengineering; contract grant number: 5R01EB000279
CR BALE MD, 1989, BLOOD, V74, P2698
   Cerca N, 2007, INFECT IMMUN, V75, P3406, DOI 10.1128/IAI.00078-07
   Ceri H, 1999, J CLIN MICROBIOL, V37, P1771
   Chaw KC, 2005, ANTIMICROB AGENTS CH, V49, P4853, DOI 10.1128/AAC.49.12.4853-4859.2005
   CHUGH TD, 1990, INFECT IMMUN, V58, P315
   Curtin JJ, 2006, ANTIMICROB AGENTS CH, V50, P1268, DOI 10.1128/AAC.50.4.1268-1275.2006
   Darouiche RO, 2004, NEW ENGL J MED, V350, P1422, DOI 10.1056/NEJMra035415
   Davis SL, 2001, J BIOL CHEM, V276, P27799, DOI 10.1074/jbc.M103873200
   DELIHAS N, 1995, FEMS MICROBIOL LETT, V132, P233, DOI 10.1016/0378-1097(95)00304-N
   FIELDS GB, 1990, INT J PEPT PROT RES, V35, P161, DOI 10.1111/j.1399-3011.1990.tb00939.x
   Heilmann C, 1996, MOL MICROBIOL, V20, P1083, DOI 10.1111/j.1365-2958.1996.tb02548.x
   Heilmann C, 1997, MOL MICROBIOL, V24, P1013, DOI 10.1046/j.1365-2958.1997.4101774.x
   Hussain M, 2001, MICROB PATHOGENESIS, V31, P261, DOI 10.1006/mpat.2001.0469
   Li DQ, 2001, CURR MICROBIOL, V42, P361, DOI 10.1007/s002840010230
   Li HL, 2005, INFECT IMMUN, V73, P3188, DOI 10.1128/IAI.73.5.3188-3191.2005
   MACK D, 1994, INFECT IMMUN, V62, P3244
   Mack D, 1996, J BACTERIOL, V178, P175, DOI 10.1128/jb.178.1.175-183.1996
   Mack D, 1999, INFECT IMMUN, V67, P1004
   MACK D, 1992, INFECT IMMUN, V60, P2048
   Nilsson M, 1998, INFECT IMMUN, V66, P2666
   O'Toole G, 2000, ANNU REV MICROBIOL, V54, P49, DOI 10.1146/annurev.micro.54.1.49
   Olson ME, 2002, CAN J VET RES, V66, P86
   Otto M, 2009, NAT REV MICROBIOL, V7, P555, DOI 10.1038/nrmicro2182
   PATTI JM, 1994, CURR OPIN CELL BIOL, V6, P752, DOI 10.1016/0955-0674(94)90104-X
   PATTI JM, 1994, ANNU REV MICROBIOL, V48, P585, DOI 10.1146/annurev.mi.48.100194.003101
   Pei L, 1999, INFECT IMMUN, V67, P4525
   Pei L, 2003, J CHROMATOGR B, V786, P319, DOI 10.1016/S1570-0232(02)00744-4
   Rogers KL, 2009, INFECT DIS CLIN N AM, V23, P73, DOI 10.1016/j.idc.2008.10.001
   Rupp ME, 2001, J INFECT DIS, V183, P1038, DOI 10.1086/319279
   Rupp ME, 1999, INFECT IMMUN, V67, P2656
   Rupp ME, 1999, INFECT IMMUN, V67, P2627
   SABATH LD, 1976, ANTIMICROB AGENTS CH, V9, P962, DOI 10.1128/AAC.9.6.962
   SHIMA S, 1984, J ANTIBIOT, V37, P1449, DOI 10.7164/antibiotics.37.1449
   Thornton J, 1996, ANAESTHESIA, V51, P1018, DOI 10.1111/j.1365-2044.1996.tb14994.x
   Trautner BW, 2004, ARCH INTERN MED, V164, P842, DOI 10.1001/archinte.164.8.842
   Uckay I, 2009, ANN MED, V41, P109, DOI 10.1080/07853890802337045
   Vuong C, 2004, J BIOL CHEM, V279, P54881, DOI 10.1074/jbc.M411374200
   Vuong C, 2004, CELL MICROBIOL, V6, P269, DOI 10.1111/j.1462-5822.2004.00367.x
   Vuong C, 2002, MICROBES INFECT, V4, P481, DOI 10.1016/S1286-4579(02)01563-0
   Watnick P, 2000, J BACTERIOL, V182, P2675, DOI 10.1128/JB.182.10.2675-2679.2000
   Williams RJ, 2002, INFECT IMMUN, V70, P6805, DOI 10.1128/IAI.70.12.6805-6810.2002
NR 41
TC 6
Z9 6
U1 2
U2 10
PU WILEY-BLACKWELL
PI MALDEN
PA COMMERCE PLACE, 350 MAIN ST, MALDEN 02148, MA USA
SN 1549-3296
J9 J BIOMED MATER RES A
JI J. Biomed. Mater. Res. Part A
PD APR
PY 2012
VL 100A
IS 4
BP 1061
EP 1067
DI 10.1002/jbm.a.33273
PG 7
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 897SU
UT WOS:000300677600026
PM 22318906
DA 2018-10-19
ER

PT J
AU Song, X
   Niinomi, M
   Nakai, M
   Tsutsumi, H
   Wang, L
AF Song, Xiu
   Niinomi, Mitsuo
   Nakai, Masaaki
   Tsutsumi, Harumi
   Wang, Lei
TI Improvement in fatigue strength while keeping low Young's modulus of a
   beta-type titanium alloy through yttrium oxide dispersion
SO MATERIALS SCIENCE & ENGINEERING C-MATERIALS FOR BIOLOGICAL APPLICATIONS
LA English
DT Article
DE Biomaterial; beta-type titanium alloy; Rare earth oxide; Fatigue
   properties; Young's modulus
ID BIOMEDICAL APPLICATIONS; MECHANICAL-PROPERTIES; TENSILE PROPERTIES;
   ELEVATED-TEMPERATURE; MICROSTRUCTURE; TI-29NB-13TA-4.6ZR;
   BIOCOMPATIBILITY; COMPOSITES; BEHAVIOR; DESIGN
AB Improvement in fatigue strength in spite of maintaining low Young's modulus was achieved in Ti-29Nb-13Ta-4.6Zr (TNTZ) by hard-particles dispersion. A certain amount of Y2O3 additions was added into TNTZ. TNTZ with 0.05-1.00mass%Y consists of a beta-phase with a small amount of Y2O3. Young's moduli of TNTZ with 0.05-1.00mass%Y are maintained low, and are almost similar to that of TNTZ without Y2O3. The tensile strength of TNTZ with 0.05-1.00mass%Y is slightly improved and the elongation does not deteriorate by Y2O3 additions. However, the 0.2% proof stress decreases with the increase in Y concentration. Although tensile properties are not changed drastically, the fatigue strength is significantly improved by Y2O3 additions. The dispersion of Y2O3 particle increases the resistance to fatigue initiation. However. Y2O3 with too large diameter at the surface of the specimen works harmfully as the fatigue initiation site. The Y2O3 diameter and volume fraction increase with the increase in Y concentration. As a result, the fatigue limit of the alloys with 0.05-1.00mass%Y firstly increases and then decreases with the increase in Y concentration. TNTZ with 0.1mass% Y exhibits the best combination of higher fatigue strength and low Young's modulus. (C) 2011 Elsevier B.V. All rights reserved.
C1 [Song, Xiu; Niinomi, Mitsuo; Nakai, Masaaki; Tsutsumi, Harumi] Tohoku Univ, Inst Mat Res, Dept Biomat Sci, Aoba Ku, Sendai, Miyagi 9808577, Japan.
   [Song, Xiu; Wang, Lei] Northeastern Univ, Minist Educ, Key Lab Anisotropy & Texture Mat, Shenyang 110004, Peoples R China.
RP Niinomi, M (reprint author), Tohoku Univ, Inst Mat Res, Dept Biomat Sci, Aoba Ku, 2-1-1 Katahira, Sendai, Miyagi 9808577, Japan.
EM niinomi@imr.tohoku.ac.jp
RI Nakai, Masaaki/C-1919-2009; Niinomi, Mitsuo/B-5965-2011
FU China Scholarship Council (CSC), China; MEXT (Tokyo, Japan) [21760549];
   Global COE (International Center of Education and Research), Tohoku
   University; R&D Institute of Metals and Composites for Future Industries
   (Tokyo, Japan); Advanced Research Center of Metallic Glasses, Institute
   for Materials Research, Tohoku University (Sendai, Japan); New Energy
   and Industrial Technology Development Organization, NEDO (Kawasaki,
   Japan); Tohoku University, MEXT (Tokyo, Japan); Kyusyu University, MEXT
   (Tokyo, Japan)
FX This work was supported in part by the China Scholarship Council (CSC),
   China; Grant-in-Aid for Young Scientists (21760549), MEXT (Tokyo,
   Japan); the Global COE Materials Integration Program (International
   Center of Education and Research), Tohoku University; R&D Institute of
   Metals and Composites for Future Industries (Tokyo, Japan);
   Interuniversity Cooperative Research Program of the Advanced Research
   Center of Metallic Glasses, Institute for Materials Research, Tohoku
   University (Sendai, Japan); The industrial Technology Research Grant
   Program in 2009 from the New Energy and Industrial Technology
   Development Organization, NEDO (Kawasaki, Japan); and the project
   between Tohoku University and Kyusyu University on "Highly-functional
   Interface Science: Innovation of Biomaterials with Highly Functional
   Interface to Host and Parasite," MEXT (Tokyo, Japan). The authors would
   like to express great thanks to Daido Steel Co., Ltd. for supplying the
   materials.
CR Akahori T, 2005, MAT SCI ENG C-BIO S, V25, P248, DOI 10.1016/j.msec.2004.12.007
   Akahori T, 2004, MATER TRANS, V45, P1540, DOI 10.2320/matertrans.45.1540
   Anuwar M, 2007, MATER LETT, V61, P1483, DOI 10.1016/j.matlet.2006.07.058
   de Castro V, 2006, MAT SCI ENG A-STRUCT, V422, P189, DOI 10.1016/j.msea.2006.02.027
   Elias LM, 2006, MAT SCI ENG A-STRUCT, V432, P108, DOI 10.1016/j.msea.2006.06.013
   Flores MS, 2004, J MATER SCI-MATER M, V15, P559, DOI 10.1023/B:JMSM.0000026100.73945.85
   Geng K, 2003, MATER DESIGN, V24, P409, DOI 10.1016/S0261-3069(03)00096-7
   Geng K, 2003, MAT SCI ENG A-STRUCT, V360, P176, DOI 10.1016/S0921-5093(03)00437-4
   Gonzalez-Carrasco JL, 2007, J BIOMED MATER RES B, V80B, P201, DOI 10.1002/jbm.b.30585
   Gonzalez-Carrasco JL, 2005, BIOMATERIALS, V26, P3861, DOI 10.1016/j.biomaterials.2004.09.058
   Hao YL, 2006, MAT SCI ENG A-STRUCT, V441, P112, DOI 10.1016/j.msea.2006.09.051
   Hao YL, 2003, METALL MATER TRANS A, V34A, P1007, DOI 10.1007/s11661-003-0230-x
   He G, 2006, MAT SCI ENG C-BIO S, V26, P14, DOI 10.1016/j.msec.2005.03.007
   Kuroda D, 1998, MAT SCI ENG A-STRUCT, V243, P244, DOI 10.1016/S0921-5093(97)00808-3
   Matsumoto H, 2005, MATER TRANS, V46, P1070, DOI 10.2320/matertrans.46.1070
   Nakai M, 2009, MATER TRANS, V50, P2716, DOI 10.2320/matertrans.MA200904
   Niinomi M, 2003, BIOMATERIALS, V24, P2673, DOI 10.1016/S0142-9612(03)00069-3
   Niinomi M, 2002, MATER TRANS, V43, P2970, DOI 10.2320/matertrans.43.2970
   Niinomi M, 2008, J MECH BEHAV BIOMED, V1, P30, DOI 10.1016/j.jmbbm.2007.07.001
   Raman V, 2006, ELECTROCHEM COMMUN, V8, P1309, DOI 10.1016/j.elecom.2006.06.004
   Sumitomo N, 2008, J MATER SCI-MATER M, V19, P1581, DOI 10.1007/s10856-008-3372-y
   Sumner DR, 1998, J BIOMECH, V31, P909, DOI 10.1016/S0021-9290(98)00096-7
   Taddei EB, 2004, MAT SCI ENG C-BIO S, V24, P683, DOI 10.1016/j.msec.2004.08.011
   Tropf W. J., 1991, HDB OPTICAL CONSTANT, V2, P1079, DOI 10.1016/B978-012544415-6.50096-0
   Wang LQ, 2009, MAT SCI ENG C-MATER, V29, P1897, DOI 10.1016/j.msec.2009.02.024
   Xu PQ, 2008, J MATER PROCESS TECH, V208, P549, DOI 10.1016/j.jmatprotec.2008.01.026
   Zheng M, 2008, KEY ENG MATER, V368-372, P1203, DOI 10.4028/www.scientific.net/KEM.368-372.1203
NR 27
TC 11
Z9 11
U1 6
U2 27
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0928-4931
J9 MAT SCI ENG C-MATER
JI Mater. Sci. Eng. C-Mater. Biol. Appl.
PD APR 1
PY 2012
VL 32
IS 3
BP 542
EP 549
DI 10.1016/j.msec.2011.12.007
PG 8
WC Materials Science, Biomaterials
SC Materials Science
GA 905MG
UT WOS:000301275700020
DA 2018-10-19
ER

PT J
AU Lawrence, BD
   Pan, Z
   Weber, MD
   Kaplan, DL
   Rosenblatt, MI
AF Lawrence, Brian D.
   Pan, Zhi
   Weber, Michael D.
   Kaplan, David L.
   Rosenblatt, Mark I.
TI Silk Film Culture System for in vitro Analysis and Biomaterial Design
SO JOVE-JOURNAL OF VISUALIZED EXPERIMENTS
LA English
DT Article
DE Bioengineering; Issue 62; silk; fibroin; film; biomaterial; surface
   patterning; in vitro; epithelium; cell culture
AB Silk films are promising protein-based biomaterials that can be fabricated with high fidelity and economically within a research laboratory environment (1,2). These materials are desirable because they possess highly controllable dimensional and material characteristics, are biocompatible and promote cell adhesion, can be modified through topographic patterning or by chemically altering the surface, and can be used as a depot for biologically active molecules for drug delivery related applications (3-8). In addition, silk films are relatively straightforward to custom design, can be designed to dissolve within minutes or degrade over years in vitro or in vivo, and are produce with the added benefit of being transparent in nature and therefore highly suitable for imaging applications (9-13). The culture system methodology presented here represents a scalable approach for rapid assessments of cell-silk film surface interactions. Of particular interest is the use of surface patterned silk films to study differences in cell proliferation and responses of cells for alignment (12,14). The seeded cultures were cultured on both micro-patterned and flat silk film substrates, and then assessed through time-lapse phase-contrast imaging, scanning electron microscopy, and biochemical assessment of metabolic activity and nucleic acid content. In summary, the silk film in vitro culture system offers a customizable experimental setup suitable to the study of cell-surface interactions on a biomaterial substrate, which can then be optimized and then translated to in vivo models. Observations using the culture system presented here are currently being used to aid in applications ranging from basic cell interactions to medical device design, and thus are relevant to a broad range of biomedical fields.
C1 [Lawrence, Brian D.; Pan, Zhi; Weber, Michael D.; Rosenblatt, Mark I.] Weill Cornell Med Coll, Margaret M Dyson Vis Res Inst, New York, NY 10065 USA.
   [Kaplan, David L.] Tufts Univ, Dept Biomed Engn, Medford, MA USA.
RP Rosenblatt, MI (reprint author), Weill Cornell Med Coll, Margaret M Dyson Vis Res Inst, New York, NY 10065 USA.
EM mar2058@med.cornell.edu
FU NIH [K08EY015829, R21EY019561, R24EY015656, P41 EB002520, R01 EY020856];
   Research to Prevent Blindness; Tri-Institutional Stem Cell Initiative
FX Funding from NIH K08EY015829, R21EY019561, R24EY015656, P41 EB002520,
   and R01 EY020856 Research to Prevent Blindness Career Development Award,
   and Tri-Institutional Stem Cell Initiative. HCLE cell line provided
   courtesy of Dr. Ilene Gipson. The authors would like to thank Dr. Aihong
   Liu at Weill Cornell Medical College for her technical assistance and
   guidance with cell culture, Anthony Labissiere at the Hospital for
   Special Surgeries for her technical assistance with SEM imaging, the
   Tissue Engineering Resource Center (TERC) at Tufts University for
   technical support with material development, and the Cornell Center for
   NanoScale Science and Technology Facility (CNF) for assistance in
   silicon wafer manufacturing.
CR Altman GH, 2003, BIOMATERIALS, V24, P401, DOI 10.1016/S0142-9612(02)00353-8
   Arai T, 2004, J APPL POLYM SCI, V91, P2383, DOI 10.1002/app.13393
   Bray LJ, 2011, BIOMATERIALS, V32, P5086, DOI 10.1016/j.biomaterials.2011.03.068
   Cebe P., 2010, BIOMATERIALS
   Chirila TV, 2008, TISSUE ENG PT A, V14, P1203, DOI [10.1089/ten.tea.2007.0224, 10.1089/tea.2007.0224]
   DEMURA M, 1989, BIOTECHNOL BIOENG, V33, P598, DOI 10.1002/bit.260330513
   Hofmann S, 2006, J CONTROL RELEASE, V111, P219, DOI 10.1016/j.jconrel.205.12.009
   Hu X, 2011, BIOMACROMOLECULES, V12, P1686, DOI 10.1021/bm200062a
   Jaalouk DE, 2009, NAT REV MOL CELL BIO, V10, P63, DOI 10.1038/nrm2597
   Jin HJ, 2005, ADV FUNCT MATER, V15, P1241, DOI 10.1002/adfm.200400405
   Lawrence BD, 2008, J MATER SCI, V43, P6967, DOI 10.1007/s10853-008-2961-y
   Lawrence BD, 2008, BIOMACROMOLECULES, V9, P1214, DOI 10.1021/bm701235f
   Lawrence BD, 2010, MACROMOL BIOSCI, V10, P393, DOI 10.1002/mabi.200900294
   Lawrence BD, 2009, BIOMATERIALS, V30, P1299, DOI 10.1016/j.biomaterials.2008.11.018
   Li MZ, 2003, BIOMATERIALS, V24, P357, DOI 10.1016/S0142-9612(02)00326-5
   Ma XL, 2006, J BIOMED MATER RES B, V78B, P89, DOI 10.1002/jbm.b.30466
   Meinel L, 2005, BIOMATERIALS, V26, P147, DOI 10.1016/j.biomaterials.2004.02.047
   Omenetto FG, 2008, NAT PHOTONICS, V2, P641, DOI 10.1038/nphoton.2008.207
   Patel A., 2010, BIOMEDICAL
   Rice WL, 2008, BIOMATERIALS, V29, P2015, DOI 10.1016/j.biomaterials.2007.12.049
   Rockwood D., 2011, NATURE PROT IN PRESS
   SHAW JTB, 1964, BIOCHEM J, V93, P45, DOI 10.1042/bj0930045
   Vepari C, 2007, PROG POLYM SCI, V32, P991, DOI 10.1016/j.progpolymsci.2007.05.013
   Wang N, 2009, NAT REV MOL CELL BIO, V10, P75, DOI 10.1038/nrm2594
   Zhang YQ, 1998, BIOTECHNOL ADV, V16, P961, DOI 10.1016/S0734-9750(98)00012-3
NR 25
TC 4
Z9 4
U1 1
U2 8
PU JOURNAL OF VISUALIZED EXPERIMENTS
PI CAMBRIDGE
PA 1 ALEWIFE CENTER, STE 200, CAMBRIDGE, MA 02140 USA
SN 1940-087X
J9 JOVE-J VIS EXP
JI J. Vis. Exp.
PD APR
PY 2012
IS 62
AR UNSP e3646
DI 10.3791/3646
PG 6
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA V36PG
UT WOS:000209222900021
PM 22565786
OA Green Published, Bronze
DA 2018-10-19
ER

PT J
AU Parkinson, LG
   Rea, SM
   Stevenson, AW
   Wood, FM
   Fear, MW
AF Parkinson, Leigh G.
   Rea, Suzanne M.
   Stevenson, Andrew W.
   Wood, Fiona M.
   Fear, Mark W.
TI The Effect of Nano-Scale Topography on Keratinocyte Phenotype and Wound
   Healing Following Burn Injury
SO TISSUE ENGINEERING PART A
LA English
DT Article
ID GROWTH-FACTOR COMPLEXES; RED DUROC PIG; COLLOIDAL LITHOGRAPHY;
   INTERACTIVE DRESSINGS; SURFACE-TOPOGRAPHY; HYPERTROPHIC SCAR; EPITHELIAL
   TISSUE; CELL-ADHESION; PORE-SIZE; MODEL
AB Topographic modulation of tissue response is an important consideration in the design and manufacture of a biomaterial. In developing new tissue therapies for skin, all levels of architecture, including the nanoscale need to be considered. Here we show that keratinocyte phenotype is affected by nanoscale changes in topography with cell morphology, proliferation, and migration influenced by the pore size in anodic aluminum oxide membranes. A membrane with a pore size of 300 nm, which enhanced cell phenotype in vitro, was used as a dressing to cover a partial thickness burn injury in the pig. Wounds dressed with the membrane showed evidence of advanced healing with significantly less organizing granulation tissue and more mature epidermal layers than control wounds dressed with a standard burns dressing. The results demonstrate the importance of nanoscale topography in modulating keratinocyte phenotype and skin wound healing.
C1 [Parkinson, Leigh G.; Rea, Suzanne M.; Stevenson, Andrew W.; Wood, Fiona M.; Fear, Mark W.] McComb Res Fdn, Perth, WA, Australia.
   [Parkinson, Leigh G.; Rea, Suzanne M.; Stevenson, Andrew W.; Wood, Fiona M.; Fear, Mark W.] Univ Western Australia, Burn Injury Repair Unit, Sch Surg, Perth, WA 6009, Australia.
   [Parkinson, Leigh G.] Murdoch Univ, Sch Engn & Energy, Perth, WA, Australia.
   [Rea, Suzanne M.; Wood, Fiona M.] Royal Perth Hosp, Perth, WA, Australia.
   [Rea, Suzanne M.; Wood, Fiona M.] Princess Margaret Hosp, Perth, WA, Australia.
   [Fear, Mark W.] Notre Dame Univ, Sch Med, Perth, WA, Australia.
RP Parkinson, LG (reprint author), Univ Western Australia, Sch Surg, Burn Injury Repair Unit, McComb Res Fdn, M318,35 Stirling Highway, Crawley, WA 6009, Australia.
EM leighgparkinson@gmail.com
RI Fear, Mark/H-9170-2014; Wood, Fiona/F-4703-2013
OI Wood, Fiona/0000-0001-5427-6588; fear, mark/0000-0003-3163-4666; Wood,
   Fiona Melanie/0000-0002-3284-6540
FU NHMRC [572734]
FX The authors wish to acknowledge Dr. Gerard Eddy Poinern for advice on
   nanoporous membrane fabrication, Dr. Griet Haitjema and Dr. Chris Quinn
   for consulting on the anesthesia for the animal work, Professor Max
   Bulsara and Dr. Hilary Wallace for statistical help and advice, Ms.
   Astrid Armitage and Mr. Andy Wilson for assistance in the animal house,
   Mrs. Kerry Parkinson for the creation of the porcine protective jackets,
   and the Marine and Freshwater Research Laboratory at Murdoch University
   for the analysis of the bloods. This work was supported by NHMRC
   development grant 572734.
CR AHN ST, 1991, ARCH SURG-CHICAGO, V126, P499
   Andersson AS, 2003, BIOMATERIALS, V24, P3427, DOI 10.1016/S0142-9612(03)00208-4
   Bloemen MCT, 2009, BURNS, V35, P463, DOI 10.1016/j.burns.2008.07.016
   Boateng JS, 2008, J PHARM SCI-US, V97, P2892, DOI 10.1002/jps.21210
   Burd A, 2005, BURNS, V31, P432, DOI 10.1016/j.burns.2005.02.016
   Burridge K, 1996, ANNU REV CELL DEV BI, V12, P463, DOI 10.1146/annurev.cellbio.12.1.463
   Chester D. L., 2004, Journal of Burn Care & Rehabilitation, V25, P266, DOI 10.1097/01.BCR.0000124749.85552.CD
   CHOU LS, 1995, J CELL SCI, V108, P1563
   CLARK P, 1991, J CELL SCI, V99, P73
   Cnaan A, 1997, STAT MED, V16, P2349, DOI 10.1002/(SICI)1097-0258(19971030)16:20<2349::AID-SIM667>3.0.CO;2-E
   Csaderova L, 2010, SMALL, V6, P2755, DOI 10.1002/smll.201000193
   Curtis A, 1997, BIOMATERIALS, V18, P1573, DOI 10.1016/S0142-9612(97)00144-0
   Cuttle L, 2008, WOUND REPAIR REGEN, V16, P626, DOI 10.1111/j.1524-475X.2008.00413.x
   Cuttle L, 2006, BURNS, V32, P806, DOI 10.1016/j.burns.2006.02.023
   Dalby M J, 2004, IEE Proc Nanobiotechnol, V151, P53, DOI 10.1049/ip-nbt:20040534
   Dalby MJ, 2002, TISSUE ENG, V8, P1099, DOI 10.1089/107632702320934191
   Dalby MJ, 2004, BIOMATERIALS, V25, P5415, DOI 10.1016/j.biomaterials.2003.12.049
   Dalby MJ, 2004, J BIOMED MATER RES A, V69A, P314, DOI 10.1002/jbm.a.20138
   Dalton BA, 2001, J BIOMED MATER RES, V56, P83, DOI 10.1002/1097-4636(200107)56:1<83::AID-JBM1071>3.0.CO;2-H
   DEITCH EA, 1983, J TRAUMA, V23, P895, DOI 10.1097/00005373-198310000-00009
   Ferguson MWJ, 2009, LANCET, V373, P1264, DOI 10.1016/S0140-6736(09)60322-6
   Flemming RG, 1999, BIOMATERIALS, V20, P573, DOI 10.1016/S0142-9612(98)00209-9
   FOLKMAN J, 1978, NATURE, V273, P345, DOI 10.1038/273345a0
   Fong J, 2006, INT J NANOMED, V1, P441, DOI 10.2147/nano.2006.1.4.441
   Gibran NS, 2007, J BURN CARE RES, V28, P577, DOI 10.1097/BCR.0B013E318093E44C
   Hamadouche M, 2002, J BONE JOINT SURG AM, V84A, P69, DOI 10.2106/00004623-200201000-00011
   Harunari N, 2006, BURNS, V32, P669, DOI 10.1016/j.burns.2006.03.015
   Hernandez F, 2000, EUR J MORPHOL, V38, P109, DOI 10.1076/0924-3860(200004)38:2;1-F;FT109
   Hoess A, 2007, ACTA BIOMATER, V3, P43, DOI 10.1016/j.actbio.2006.07.007
   Hollier B, 2005, EXP CELL RES, V305, P221, DOI 10.1016/j.yexcr.2005.01.004
   Hu W, 2010, NANOTECHNOLOGY, V21, DOI 10.1088/0957-4484/21/38/385301
   Hyde C, 2004, J INVEST DERMATOL, V122, P1198, DOI 10.1111/j.0022-202X.2004.022527.x
   Karlsson M, 2004, MICROSC RES TECHNIQ, V63, P259, DOI 10.1002/jemt.20040
   Kirker KR, 2002, BIOMATERIALS, V23, P3661, DOI 10.1016/S0142-9612(02)00100-X
   Krasteva N, 2004, BIOMATERIALS, V25, P2467, DOI 10.1016/j.biomaterials.2003.09.031
   LANGER R, 1993, SCIENCE, V260, P920, DOI 10.1126/science.8493529
   McMillan JR, 2007, TISSUE ENG, V13, P789, DOI 10.1089/ten.2006.0321
   Morin RJ, 2007, CLIN PLAST SURG, V34, P643, DOI 10.1016/j.cps.2007.07.004
   O'Brien FJ, 2005, BIOMATERIALS, V26, P433, DOI 10.1016/j.biomaterials.2004.02.052
   Park J, 2009, SMALL, V5, P666, DOI 10.1002/smll.200801476
   Parkinson LG, 2009, TISSUE ENG PT A, V15, P3753, DOI [10.1089/ten.tea.2008.0594, 10.1089/ten.TEA.2008.0594]
   Popat KC, 2007, J BIOMED MATER RES A, V80A, P955, DOI 10.1002/jbm.a.31028
   Promega, 2005, PROM TECHN B
   RASBAND W, IMAGE J 1 40G
   Schroeder JA, 2006, MICRON, V37, P577, DOI 10.1016/j.micron.2005.11.015
   Shackelford JF, 1999, MATER SCI FORUM, V293, P99, DOI 10.4028/www.scientific.net/MSF.293.99
   Steele JG, 2000, J BIOMED MATER RES, V50, P475, DOI 10.1002/(SICI)1097-4636(20000615)50:4<475::AID-JBM2>3.0.CO;2-G
   SULLIVAN T, 1990, Journal of Burn Care and Rehabilitation, V11, P256, DOI 10.1097/00004630-199005000-00014
   Swan E.E.L., 2005, WILEY PERIODICALS, V288
   Teixeira AI, 2003, J CELL SCI, V116, P1881, DOI 10.1242/jcs.00383
   Upton Z, 2008, J INVEST DERMATOL, V128, P1535, DOI 10.1038/sj.jid.5701148
   van den Bogaerdt AJ, 2004, WOUND REPAIR REGEN, V12, P225, DOI 10.1111/j.1067-1927.2004.012115.x
   Van den Kerckhove E, 2005, BURNS, V31, P696, DOI 10.1016/j.burns.2005.04.014
   Wang XQ, 2008, WOUND REPAIR REGEN, V16, P774, DOI 10.1111/j.1524-475X.2008.00428.x
   Wang XQ, 2009, BURNS, V35, P264, DOI 10.1016/j.burns.2008.05.030
   Zeltinger J, 2001, TISSUE ENG, V7, P557, DOI 10.1089/107632701753213183
   Zhu KQ, 2003, BURNS, V29, P649, DOI 10.1016/S0305-4179(03)00205-5
NR 57
TC 14
Z9 14
U1 1
U2 14
PU MARY ANN LIEBERT, INC
PI NEW ROCHELLE
PA 140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA
SN 1937-3341
J9 TISSUE ENG PT A
JI Tissue Eng. Part A
PD APR
PY 2012
VL 18
IS 7-8
BP 703
EP 714
DI 10.1089/ten.tea.2011.0307
PG 12
WC Cell & Tissue Engineering; Biotechnology & Applied Microbiology; Cell
   Biology
SC Cell Biology; Biotechnology & Applied Microbiology
GA 916XT
UT WOS:000302137200003
PM 21988618
OA Green Published
DA 2018-10-19
ER

PT J
AU Gandaglia, A
   Huerta-Cantillo, R
   Comisso, M
   Danesin, R
   Ghezzo, F
   Naso, F
   Gastaldello, A
   Schittullo, E
   Buratto, E
   Spina, M
   Gerosa, G
   Dettin, M
AF Gandaglia, Alessandro
   Huerta-Cantillo, Rocio
   Comisso, Marina
   Danesin, Roberta
   Ghezzo, Francesca
   Naso, Filippo
   Gastaldello, Alessandra
   Schittullo, Eleonora
   Buratto, Edward
   Spina, Michele
   Gerosa, Gino
   Dettin, Monica
TI Cardiomyocytes In Vitro Adhesion Is Actively Influenced by Biomimetic
   Synthetic Peptides for Cardiac Tissue Engineering
SO TISSUE ENGINEERING PART A
LA English
DT Article
ID SMOOTH-MUSCLE-CELLS; EXTRACELLULAR-MATRIX; RGD PEPTIDE; FIBRONECTIN;
   BIOMATERIALS; SURFACES; VITRONECTIN; SCAFFOLDS; VIVO; INTEGRINS
AB Scaffolds for tissue engineering must be designed to direct desired events such as cell attachment, growth, and differentiation. The incorporation of extracellular matrix-derived peptides into biomaterials has been proposed to mimic biochemical signals. In this study, three synthetic fragments of fibronectin, vitronectin, and stromal-derived factor-1 were investigated for the first time as potential adhesive sequences for cardiomyocytes (CMs) compared to smooth muscle cells. CMs are responsive to all peptides to differing degrees, demonstrating the existence of diverse adhesion mechanisms. The pretreatment of nontissue culture well surfaces with the (Arginine-Glycine-Aspartic Acid) RGD sequence anticipated the appearance of CMs' contractility compared to the control (fibronectin-coated well) and doubled the length of cell viability. Future prospects are the inclusion of these sequences into biomaterial formulation with the improvement in cell adhesion that could play an important role in cell retention during dynamic cell seeding.
C1 [Gandaglia, Alessandro; Huerta-Cantillo, Rocio; Comisso, Marina; Naso, Filippo; Gastaldello, Alessandra; Buratto, Edward; Gerosa, Gino] Univ Padua, Dept Cardiac Thorac & Vasc Sci, I-35128 Padua, Italy.
   [Danesin, Roberta; Ghezzo, Francesca; Dettin, Monica] Univ Padua, Dept Chem Proc Engn, I-35128 Padua, Italy.
   [Schittullo, Eleonora; Spina, Michele] Univ Padua, Dept Expt Biomed Sci, I-35128 Padua, Italy.
RP Gandaglia, A (reprint author), Univ Padua, Dept Cardiac Thorac & Vasc Sci, Via Giustiniani 2, I-35128 Padua, Italy.
EM alessandro.gandaglia@unipd.it
RI Gerosa, Gino/M-8106-2014
OI Gerosa, Gino/0000-0002-6261-699X; Naso, Filippo/0000-0002-8198-8799
FU Regione Veneto [RSF 286/08]; Azione Biotech III
FX This research has been supported by the Regione Veneto Grant RSF 286/08
   and Azione Biotech III.
CR Bacakova L, 2007, J MATER SCI-MATER M, V18, P1317, DOI 10.1007/s10856-006-0074-1
   Blit PH, 2010, J BIOMED MATER RES A, V94A, P1226, DOI 10.1002/jbm.a.32804
   Boateng SY, 2005, AM J PHYSIOL-CELL PH, V288, pC30, DOI 10.1152/ajpcell.00199.2004
   Carragher NO, 1999, J CELL BIOL, V147, P619, DOI 10.1083/jcb.147.3.619
   Chillakuri CR, 2010, FEBS LETT, V584, P3287, DOI 10.1016/j.febslet.2010.06.023
   Comisar WA, 2011, J THEOR BIOL, V274, P120, DOI 10.1016/j.jtbi.2011.01.007
   Conconi MT, 2010, J PEPT SCI, V16, P349, DOI 10.1002/psc.1251
   Cushing MC, 2005, J BIOMED MATER RES A, V75A, P232, DOI 10.1002/jbm.a.30412
   Dettin M, 2005, BIOMATERIALS, V26, P4507, DOI 10.1016/j.biomaterials.2004.11.023
   Dettin M, 2004, J MED CHEM, V47, P3058, DOI 10.1021/jm031067a
   Dettin M, 2006, TISSUE ENG, V12, P3509, DOI 10.1089/ten.2006.12.3509
   Dong Y, 2010, BIOMATERIALS, V31, P8921, DOI 10.1016/j.biomaterials.2010.08.001
   Gabriel M, 2006, J BIOMAT SCI-POLYM E, V17, P567, DOI 10.1163/156856206776986288
   Heldman AW, 2011, J AM COLL CARDIOL, V57, P466, DOI 10.1016/j.jacc.2010.09.028
   Hilfiker A, 2011, LANGENBECK ARCH SURG, V396, P489, DOI 10.1007/s00423-011-0762-2
   Holmes TC, 2002, TRENDS BIOTECHNOL, V20, P16, DOI 10.1016/S0167-7799(01)01840-6
   Hu XF, 2007, CIRCULATION, V116, P654, DOI 10.1161/CIRCULATIONAHA.106.672451
   Humphries MJ, 2004, BIOCHEM SOC T, V32, P822, DOI 10.1042/BST0320822
   Hynes RO, 2002, CELL, V110, P673, DOI 10.1016/S0092-8674(02)00971-6
   Ingber DE, 2006, TISSUE ENG, V12, P3265, DOI 10.1089/ten.2006.12.3265
   Iwai-Kanai E, 2008, AUTOPHAGY, V4, P322, DOI 10.4161/auto.5603
   Jeon WB, 2011, J BIOMED MATER RES A, V97A, P152, DOI 10.1002/jbm.a.33041
   Jin S., 2007, HUM CELL, V20, P11
   Kao WJ, 2001, J BIOMED MATER RES, V55, P79, DOI 10.1002/1097-4636(200104)55:1<79::AID-JBM110>3.3.CO;2-Q
   Kumar Pradeep, 2011, Recent Pat Drug Deliv Formul, V5, P24, DOI 10.2174/187221111794109510
   Kyle S, 2010, BIOMATERIALS, V31, P9395, DOI 10.1016/j.biomaterials.2010.08.051
   LANDEGREN U, 1984, J IMMUNOL METHODS, V67, P379, DOI 10.1016/0022-1759(84)90477-0
   Leiss M, 2008, CURR OPIN CELL BIOL, V20, P502, DOI 10.1016/j.ceb.2008.06.001
   Li JH, 2008, J MATER SCI-MATER M, V19, P2595, DOI 10.1007/s10856-007-3354-5
   Luchini A., 2005, THESIS U PADOVA
   Mann BK, 2001, BIOMATERIALS, V22, P3045, DOI 10.1016/S0142-9612(01)00051-5
   Mann BK, 2002, J BIOMED MATER RES, V60, P86, DOI 10.1002/jbm.10042
   MASSIA SP, 1990, ANN NY ACAD SCI, V589, P261, DOI 10.1111/j.1749-6632.1990.tb24251.x
   Michel JB, 2003, ARTERIOSCL THROM VAS, V23, P2146, DOI 10.1161/01.ATV.0000099882.52647.E4
   OAKES BW, 1982, EUR J CELL BIOL, V27, P34
   Orbach R, 2009, BIOMACROMOLECULES, V10, P2646, DOI 10.1021/bm900584m
   Petty JM, 2009, J IMMUNOL, V182, P604, DOI 10.4049/jimmunol.182.1.604
   PIERSCHBACHER MD, 1984, P NATL ACAD SCI-BIOL, V81, P5985, DOI 10.1073/pnas.81.19.5985
   PYTELA R, 1985, CELL, V40, P191, DOI 10.1016/0092-8674(85)90322-8
   Radisic M, 2007, PHILOS T R SOC B, V362, P1357, DOI 10.1098/rstb.2007.2121
   Rapuano BE, 2004, J ORTHOP RES, V22, P353, DOI 10.1016/S0736-0266(03)00180-3
   Romano NH, 2011, BBA-GEN SUBJECTS, V1810, P339, DOI 10.1016/j.bbagen.2010.07.005
   Sandeman SR, 2003, BIOMATERIALS, V24, P4729, DOI 10.1016/S0142-9612(03)00370-3
   Schvartz I, 1999, INT J BIOCHEM CELL B, V31, P539, DOI 10.1016/S1357-2725(99)00005-9
   Schwartz MA, 2002, NAT CELL BIOL, V4, pE65, DOI 10.1038/ncb0402-e65
   Sekine H, 2006, CIRCULATION, V114, pI87, DOI 10.1161/CIRCULATIONAHA.105.000273
   Shachar M., 2010, ACTA BIOMATER, V7, P152
   Shekaran A, 2011, BBA-GEN SUBJECTS, V1810, P350, DOI 10.1016/j.bbagen.2010.04.006
   Shi JJ, 2010, NANO LETT, V10, P3223, DOI 10.1021/nl102184c
   Thyberg J, 2002, J HISTOCHEM CYTOCHEM, V50, P185, DOI 10.1177/002215540205000206
   Von der Mark K., 2010, CELL TISSUE RES, V339, P1531
   Wallukat G, 2002, IN VITRO CELL DEV-AN, V38, P376
   Weikert C, 2003, CARDIOVASC RES, V59, P874, DOI 10.1016/S0008-6363(03)00508-X
NR 53
TC 7
Z9 7
U1 0
U2 13
PU MARY ANN LIEBERT, INC
PI NEW ROCHELLE
PA 140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA
SN 1937-3341
J9 TISSUE ENG PT A
JI Tissue Eng. Part A
PD APR
PY 2012
VL 18
IS 7-8
BP 725
EP 736
DI 10.1089/ten.tea.2011.0254
PG 12
WC Cell & Tissue Engineering; Biotechnology & Applied Microbiology; Cell
   Biology
SC Cell Biology; Biotechnology & Applied Microbiology
GA 916XT
UT WOS:000302137200005
PM 22011064
OA Green Published
DA 2018-10-19
ER

PT J
AU Dormer, NH
   Qiu, Y
   Lydick, AM
   Allen, ND
   Mohan, N
   Berkland, CJ
   Detamore, MS
AF Dormer, Nathan H.
   Qiu, Yue
   Lydick, Anna M.
   Allen, Nicholas D.
   Mohan, Neethu
   Berkland, Cory J.
   Detamore, Michael S.
TI Osteogenic Differentiation of Human Bone Marrow Stromal Cells in
   Hydroxyapatite-Loaded Microsphere-Based Scaffolds
SO TISSUE ENGINEERING PART A
LA English
DT Article
ID TISSUE ENGINEERING SCAFFOLDS; MESENCHYMAL STEM-CELLS; ADHESIVE RGD
   PEPTIDE; OF-THE-ART; OSTEOCHONDRAL DEFECTS; TRICALCIUM PHOSPHATE; RABBIT
   MODEL; IN-VITRO; GRADIENTS; CARTILAGE
AB Calcium-based minerals have consistently been shown to stimulate osteoblastic behavior in vitro and in vivo. Thus, use of such minerals in biomaterial applications has become an effective method to enhance bone tissue engineered constructs. In the present study, for the first time, human bone marrow stromal cells (hBMSC) were osteogenically differentiated on scaffolds consisting only of hydroxyapatite (HAp)-loaded poly(D,L-lactic acid-co-glycolic acid) (PLGA) microspheres of high monodispersity. Scaffold formulations included 0, 5, 10, and 20 wt% Hap, and the hBMSC were cultured for 6 weeks. Results demonstrated suppression of some osteogenic genes during differentiation in the HAp group, but higher end-point glycosaminoglycan and collagen content in 10% and 20% HAp samples, as evidenced by biochemical tests, histology, and immunohistochemistry. After 6 weeks of culture, constructs with 0% and 5% HAp had average compressive moduli of 0.7 +/- 0.2 and 1.5 +/- 0.9 kPa, respectively, whereas constructs with 10% and 20% HAp had higher average moduli of 17.6 +/- 4.6 and 18.9 +/- 8.1 kPa, respectively. The results of this study indicate that HAp inclusion in microsphere-based scaffolds could be implemented as a physical gradient in combination with bioactive signal gradients seen in previous iterations of these microsphere-based scaffolds to enhance osteoconduction and mechanical integrity of a healing site.
C1 [Qiu, Yue; Lydick, Anna M.; Mohan, Neethu; Berkland, Cory J.; Detamore, Michael S.] Univ Kansas, Dept Chem & Petr Engn, Lawrence, KS 66045 USA.
   [Berkland, Cory J.] Univ Kansas, Dept Pharmaceut Chem, Lawrence, KS 66045 USA.
   [Allen, Nicholas D.] Univ Kansas, Med Ctr, Kansas City, KS 66103 USA.
   [Dormer, Nathan H.; Detamore, Michael S.] Orbis Biosci, Kansas City, KS USA.
RP Detamore, MS (reprint author), Univ Kansas, Dept Chem & Petr Engn, 1530 W 15th St,4132 Learned Hall, Lawrence, KS 66045 USA.
EM detamore@ku.edu
FU National Institutes of Health (NIH) [R01 AR056347]; Pharmaceutical
   Aspects of Biotechnology Training Grant [NIH/NIGMS T32-GM008359]
FX The authors would like to acknowledge funding from the National
   Institutes of Health (NIH R01 AR056347) and from the Pharmaceutical
   Aspects of Biotechnology Training Grant (NIH/NIGMS T32-GM008359) to
   support N. H. Dormer.
CR Ahn JH, 2009, TISSUE ENG PT A, V15, P2595, DOI 10.1089/ten.TEA.2008.0511
   An Y.H., 2003, HDB HISTOLOGY METHOD
   Benoit DSW, 2005, BIOMATERIALS, V26, P5209, DOI 10.1016/j.biomaterials.2005.01.045
   Berkland C, 2001, J CONTROL RELEASE, V73, P59, DOI 10.1016/S0168-3659(01)00289-9
   BOYAN BD, 1989, J BIOL CHEM, V264, P11879
   Chan G, 2008, TRENDS BIOTECHNOL, V26, P382, DOI 10.1016/j.tibtech.2008.03.011
   Cheng L., 2009, ACTA BIOMATER, V6, P1569
   Daugaard H., 2009, J BIOMED MATER RES A, V92, P913
   Dormer NH, 2010, ANN BIOMED ENG, V38, P2121, DOI 10.1007/s10439-010-0033-3
   Dormer NH, 2010, ANN BIOMED ENG, V38, P2167, DOI 10.1007/s10439-010-0028-0
   EDWARDS CA, 1980, CLIN CHIM ACTA, V104, P161, DOI 10.1016/0009-8981(80)90192-8
   Erisken C, 2008, BIOMATERIALS, V29, P4065, DOI 10.1016/j.biomaterials.2008.06.022
   Gotterbarm T, 2006, BIOMATERIALS, V27, P3387, DOI 10.1016/j.biomaterials.2006.01.041
   Grayson WL, 2009, SEMIN CELL DEV BIOL, V20, P665, DOI 10.1016/j.semcdb.2008.12.008
   Guo X, 2010, ACTA BIOMATER, V6, P39, DOI 10.1016/j.actbio.2009.07.041
   Hersel U, 2003, BIOMATERIALS, V24, P4385, DOI 10.1016/S0142-9612(03)00343-0
   Ho MH, 2006, MACROMOL BIOSCI, V6, P90, DOI 10.1002/mabi.200500130
   Holland TA, 2005, J BIOMED MATER RES A, V75A, P156, DOI 10.1002/jbm.a.30379
   Hutmacher DW, 2007, J TISSUE ENG REGEN M, V1, P245, DOI 10.1002/term.24
   Hutmacher DW, 2000, BIOMATERIALS, V21, P2529, DOI 10.1016/S0142-9612(00)00121-6
   Im GI, 2010, TISSUE ENG PT A, V16, P1189, DOI [10.1089/ten.tea.2009.0540, 10.1089/ten.TEA.2009.0540]
   Jaiswal N, 1997, J CELL BIOCHEM, V64, P295, DOI 10.1002/(SICI)1097-4644(199702)64:2<295::AID-JCB12>3.0.CO;2-I
   Keeney M, 2009, TISSUE ENG PART B-RE, V15, P55, DOI 10.1089/ten.teb.2008.0388
   Kim K., 2010, ACTA BIOMATER, V7, P1249
   Kim TG, 2006, TISSUE ENG, V12, P221, DOI 10.1089/ten.2006.12.221
   Kon E, 2010, INJURY, V41, P693, DOI 10.1016/j.injury.2009.11.014
   Lee J, 2008, TISSUE ENG PT B-REV, V14, P61, DOI 10.1089/teb.2007.0150
   Leong KF, 2008, J MECH BEHAV BIOMED, V1, P140, DOI 10.1016/j.jmbbm.2007.11.002
   Leong Natalie L, 2006, Conf Proc IEEE Eng Med Biol Soc, V1, P2651
   Liu CZ, 2009, ACTA BIOMATER, V5, P661, DOI 10.1016/j.actbio.2008.09.022
   Liu YK, 2009, J BIOMED MATER RES A, V90A, P1083, DOI 10.1002/jbm.a.32192
   Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262
   Lu HH, 2006, ADV BIOCHEM ENG BIOT, V102, P91, DOI 10.1007/b138509
   Malafaya PB, 2009, ACTA BIOMATER, V5, P644, DOI 10.1016/j.actbio.2008.09.017
   Mano JF, 2007, J TISSUE ENG REGEN M, V1, P261, DOI 10.1002/term.37
   Martin I, 2007, J BIOMECH, V40, P750, DOI 10.1016/j.jbiomech.2006.03.008
   Martin R. B, 1998, SKELETAL TISSUE MECH
   Mikos AG, 2006, TISSUE ENG, V12, P3307, DOI 10.1089/ten.2006.12.3307
   O'Shea TM, 2008, TISSUE ENG PART B-RE, V14, P447, DOI 10.1089/ten.teb.2008.0327
   Sharma B, 2004, ANN BIOMED ENG, V32, P148, DOI 10.1023/B:ABME.0000007799.60142.78
   Shen H., 2009, ACTA BIOMATER, V6, P455
   Singh M, 2010, J BIOMED MATER RES A, V94A, P870, DOI 10.1002/jbm.a.32765
   Singh M, 2008, TISSUE ENG PART B-RE, V14, P341, DOI 10.1089/ten.teb.2008.0304
   Singh M, 2008, TISSUE ENG PART C-ME, V14, P299, DOI 10.1089/ten.tec.2008.0167
   Spalazzi JP, 2006, TISSUE ENG, V12, P3497, DOI 10.1089/ten.2006.12.3497
   Wang LM, 2009, TISSUE ENG PT A, V15, P1009, DOI 10.1089/ten.tea.2008.0012
   Wang XQ, 2009, J CONTROL RELEASE, V134, P81, DOI 10.1016/j.jconrel.2008.10.021
   Yoon JJ, 2004, BIOMATERIALS, V25, P5613, DOI 10.1016/j.biomaterials.2004.01.014
NR 48
TC 21
Z9 22
U1 1
U2 13
PU MARY ANN LIEBERT, INC
PI NEW ROCHELLE
PA 140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA
SN 1937-3341
EI 1937-335X
J9 TISSUE ENG PT A
JI Tissue Eng. Part A
PD APR
PY 2012
VL 18
IS 7-8
BP 757
EP 767
DI 10.1089/ten.tea.2011.0176
PG 11
WC Cell & Tissue Engineering; Biotechnology & Applied Microbiology; Cell
   Biology
SC Cell Biology; Biotechnology & Applied Microbiology
GA 916XT
UT WOS:000302137200008
PM 21992088
OA Green Published
DA 2018-10-19
ER

PT J
AU Guentsch, A
   Seidler, K
   Nietzsche, S
   Hefti, AF
   Preshaw, PM
   Watts, DC
   Jandt, KD
   Sigusch, BW
AF Guentsch, Arndt
   Seidler, Karin
   Nietzsche, Sandor
   Hefti, Arthur F.
   Preshaw, Philip M.
   Watts, David C.
   Jandt, Klaus D.
   Sigusch, Bernd W.
TI Biomimetic mineralization: Long-term observations in patients with
   dentin sensitivity
SO DENTAL MATERIALS
LA English
DT Article
DE Biomaterial; Dentin; Hypersensitivity; Biomimetic mineralization;
   Fluorapatite
ID CERVICAL DENTIN; HYPERSENSITIVITY; CYTOTOXICITY; EROSION;
   GLUTARALDEHYDE; DESENSITIZER; COMPOSITES; ADHESIVES; ENAMEL; PRIMER
AB Objective. Cervical tooth erosion is increasingly observed among adults and frequently associated with dentin sensitivity (DS). This study evaluated the effectiveness on DS of a biomimetic mineralization system (BIMIN) in comparison to the current standard treatment (Gluma (R) Desensitizer, Gluma).
   Methods. In this single-blind, 2-arm study, 40 patients with confirmed cervical DS were randomized to either the test group or the positive control group. A Visual-Analog-Scale (VAS) was used to assess DS following stimulation of the exposed dentin with a 2-s air blast. Assessments were made at baseline (pre-treatment), 2 days, 4, 8 and 12 weeks, and 12 months after treatment. Two-stage replicas were obtained from the treated teeth and gold sputtered at baseline, and 2 days, 3 and 12 months after treatment. Surface topography of the treated cervical lesions and occlusion of dentinal tubules were investigated using scanning electron microscopy (SEM).
   Results. Both treatments led to a statistically significant reduction (P < 0.0001) in DS that persisted over the entire 12-month observation period. Differences in DS between the treatments were not statistically significant. SEM photomicrographs demonstrated that a mineral layer concealed the dentinal tubules in the test group. In contrast, numerous dentinal tubules remained visible in cervical defects that were treated with Gluma.
   Significance. A biomimetic mineralization kit was successfully used to treat patients exhibiting DS. The effect was similar to using Gluma, and was likely the result of the deposition of an enamel-like layer on the exposed cervical dentin. (C) 2012 Academy of Dental Materials. Published by Elsevier Ltd. All rights reserved.
C1 [Guentsch, Arndt; Seidler, Karin; Sigusch, Bernd W.] Univ Jena, Jena Univ Hosp, Dept Conservat Dent, D-07743 Jena, Germany.
   [Nietzsche, Sandor] Jena Univ Hosp, Electron Microscopy Ctr, Jena, Germany.
   [Hefti, Arthur F.] Marquette Univ, Sch Dent, Milwaukee, WI 53233 USA.
   [Preshaw, Philip M.] Newcastle Univ, Sch Dent Sci, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England.
   [Preshaw, Philip M.] Newcastle Univ, Inst Cellular Med, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England.
   [Watts, David C.] Univ Manchester, Sch Dent, Manchester, Lancs, England.
   [Watts, David C.] Univ Manchester, Photon Sci Inst, Manchester, Lancs, England.
   [Watts, David C.; Jandt, Klaus D.] Univ Jena, Inst Mat Sci & Technol, D-07743 Jena, Germany.
RP Guentsch, A (reprint author), Univ Jena, Jena Univ Hosp, Dept Conservat Dent, Alten Post 4, D-07743 Jena, Germany.
EM Arndt.Guentsch@med.uni-jena.de
RI Guentsch, Arndt/N-4427-2015; Jandt, Klaus/C-8077-2016
OI Guentsch, Arndt/0000-0001-8989-1441; Jandt, Klaus/0000-0002-7537-5603;
   Watts, David/0000-0002-9105-2775
FU Heraeus Kulzer GmbH, Hanau, Germany [HKG-DT-01/2008-BIMIN]; Alexander
   von Humboldt Foundation, Bonn, Germany
FX The study was funded by a grant of Heraeus Kulzer GmbH, Hanau, Germany
   (HKG-DT-01/2008-BIMIN). DCW gratefully acknowledges the support of the
   Alexander von Humboldt Foundation, Bonn, Germany, by a Humboldt Research
   Award.
CR ABSI EG, 1989, J CLIN PERIODONTOL, V16, P190, DOI 10.1111/j.1600-051X.1989.tb01639.x
   Addy M, 2007, Int J Dent Hyg, V5, P53, DOI 10.1111/j.1601-5037.2007.00228.x
   ADDY M, 1994, ARCH ORAL BIOL, V39, pS33, DOI 10.1016/0003-9969(94)90186-4
   Arrais César Augusto Galvão, 2004, J. Appl. Oral Sci., V12, P144, DOI 10.1590/S1678-77572004000200012
   BERGENHOLTZ G, 1993, J DENT, V21, P220, DOI 10.1016/0300-5712(93)90133-B
   Beyer M, 2010, DENT MATER, V26, P831, DOI 10.1016/j.dental.2010.04.008
   Brannstrom M, 1967, Caries Res, V1, P310
   Busch S, 2003, ADV FUNCT MATER, V13, P189, DOI 10.1002/adfm.200390029
   Busch S, 2006, Induced remineralisation of human dental enamel, Patent No. [WO 2006/050966 A1, 2006050966]
   Busch S., 2004, ANGEW CHEM, V116, P1452
   dall'Orologio GD, 1999, AM J DENT, V12, P103
   DALLOROLOGIO GD, 1993, AM J DENT, V6, P283
   Demirci M, 2008, DENT MATER, V24, P362, DOI 10.1016/j.dental.2007.06.009
   Duran I, 2004, J ORAL REHABIL, V31, P351, DOI 10.1046/j.1365-2842.2003.01241.x
   Fan Y, 2009, BIOMATERIALS, V30, P478, DOI 10.1016/j.biomaterials.2008.10.019
   Ferracance J, 2011, DENT MATER, V2, P9
   Franz A, 2007, DENT MATER, V23, P1438, DOI 10.1016/j.dental.2007.05.014
   Franz A, 2009, DENT MATER, V25, P232, DOI 10.1016/j.dental.2008.07.003
   Gandolfi MPT, 2011, DENT MATER, DOI [10.1016/j.dental.2011.1007.1007, DOI 10.1016/J.DENTAL.2011.1007.1007]
   GILLAM DG, 1993, J CLIN PERIODONTOL, V20, P383
   Gillam DG, 2006, ENDOD TOPICS, V13, P13
   Guentsch A, 2010, ADV ENG MAT B, pB571
   Hannig M, 2010, NAT NANOTECHNOL, V5, P565, DOI [10.1038/NNANO.2010.83, 10.1038/nnano.2010.83]
   Heurich E, 2010, DENT MATER, V26, P326, DOI 10.1016/j.dental.2009.12.001
   Holland GR, 1997, J CLIN PERIODONTOL, V24, P808, DOI 10.1111/j.1600-051X.1997.tb01194.x
   Ide M, 2001, J CLIN PERIODONTOL, V28, P16, DOI 10.1034/j.1600-051x.2001.280103.x
   Jandt KD, 2009, DENT MATER, V25, P1001, DOI 10.1016/j.dental.2009.02.009
   Kakaboura A, 2005, AM J DENT, V18, P291
   KANAPKA JA, 1990, DENT CLIN N AM, V34, P545
   Lussi A, 2000, CARIES RES, V34, P182, DOI 10.1159/000016587
   Mozafari M, 2010, APPL SURF SCI, V257, P1740, DOI 10.1016/j.apsusc.2010.09.008
   Ning TY, 2012, J BIOMED MATER RES B, V100B, P138, DOI 10.1002/jbm.b.31931
   Ozen T, 2009, OPER DENT, V34, P392, DOI 10.2341/08-118
   Perdigao J, 2010, DENT MATER, V26, pE24, DOI 10.1016/j.dental.2009.11.149
   Polderman RN, 2007, J DENT, V35, P144, DOI 10.1016/j.jdent.2006.06.005
   Schmid-Schwap M, 2009, DENT MATER, V25, P360, DOI 10.1016/j.dental.2008.08.002
   Schmidlin P, 2004, J ADHES DENT, V1, P61
   Schupbach P, 1997, EUR J ORAL SCI, V105, P414, DOI 10.1111/j.1600-0722.1997.tb02138.x
   Sethna GD, 2011, ORAL HLTH PREV DENT, V9, P143
   Sigusch BW, 2007, DENT MATER, V23, P1342, DOI 10.1016/j.dental.2006.11.013
   Sigusch BW, 2009, DENT MATER, V25, P1446, DOI 10.1016/j.dental.2009.06.016
   von Troil B, 2002, J CLIN PERIODONTOL, V29, P173, DOI 10.1034/j.1600-051X.29.s3.10.x
   Yu X, 2010, OPER DENT, V35, P279, DOI 10.2341/09-346-C
NR 43
TC 15
Z9 17
U1 1
U2 34
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0109-5641
J9 DENT MATER
JI Dent. Mater.
PD APR
PY 2012
VL 28
IS 4
BP 457
EP 464
DI 10.1016/j.dental.2012.01.003
PG 8
WC Dentistry, Oral Surgery & Medicine; Materials Science, Biomaterials
SC Dentistry, Oral Surgery & Medicine; Materials Science
GA 905RH
UT WOS:000301289800016
PM 22305715
DA 2018-10-19
ER

PT J
AU Formosa, LM
   Mallia, B
   Camilleri, J
AF Formosa, L. M.
   Mallia, B.
   Camilleri, J.
TI The effect of curing conditions on the physical properties of tricalcium
   silicate cement for use as a dental biomaterial
SO INTERNATIONAL ENDODONTIC JOURNAL
LA English
DT Article
DE mineral trioxide aggregate; Portland cement; tricalcium silicate
ID MINERAL TRIOXIDE AGGREGATE; IN-VITRO BIOACTIVITY; SELF-SETTING
   PROPERTIES; PORTLAND-CEMENT; MECHANICAL-PROPERTIES; COMPOSITE CEMENT;
   MTA; WHITE; GRAY; RADIOPACITY
AB Aim To investigate the physical properties of tricalcium silicate (TCS) with and without the addition of a radiopacifier and compare them with that of Portland cement (PC) and radiopaque PC in an mineral trioxide aggregate-like system. Methodology Tricalcium silicate, PC and radiopacified variants containing 20% bismuth oxide were tested for radiopacity, compressive strength, setting time and dimensional stability. All the testing was performed at 37 degrees C and under different environmental conditions namely at 100% humidity or immersed in either water or Hanks balanced salt solution (HBSS). Testing was performed after both 1 and 28 days. Results The cements exhibited radiopacity values equivalent to <3 mm. Addition of 20% bismuth oxide resulted in adequate radiopacity. The strength of TCS was independent of the curing conditions. The cements without radiopacifier had improved strength characteristics when immersed in HBSS, whilst the radiopacified cements exhibited higher strengths when soaked in water. Tricalcium silicate demonstrated the shortest setting time. Addition of bismuth oxide increased the setting time of the cements while HBSS inhibited the setting of bismuth oxide-replaced cements. The PC-based materials exhibited a net contraction higher than that recorded for TCS-based cements in all curing conditions. The dimensional change exhibited by the specimens was generally greater in the first few hours of setting, but then stabilized with time. Conclusions Tricalcium silicate cement required the addition of a radiopacifying agent to make it suitable for use as a dental material. Tricalcium silicate exhibited adequate physical properties and thus was shown to be a suitable replacement for the PC component in MTA. Bismuth oxide drastically increased the setting time of the test cements in phosphate-containing solutions. Alternative radiopacifiers that do not retard the setting time need to be investigated.
C1 [Formosa, L. M.; Mallia, B.] Univ Malta, Fac Engn, Dept Met & Mat Engn, Msida, Malta.
   [Camilleri, J.] Univ Malta, Sch Med, Mater Dei Hosp, Dept Restorat Dent,Fac Dent Surg, Msida, Malta.
RP Camilleri, J (reprint author), Univ Malta, Sch Med, Mater Dei Hosp, Dept Restorat Dent,Fac Dent Surg, Msida Msd 2080, Malta.
EM josette.camilleri@um.edu.mt
RI Camilleri, Josette/N-9409-2015
OI Camilleri, Josette/0000-0003-3556-6365; Mallia,
   Bertram/0000-0002-4719-0855
CR Achternbosch M., 2003, HEAVY METALS CEMENT
   [Anonymous], 2001, 6876 ISO
   [Anonymous], 2007, 99171 ISO
   Asgary Saeed, 2004, Aust Endod J, V30, P89
   Bramante CM, 2008, ORAL SURG ORAL MED O, V106, P909, DOI 10.1016/j.tripleo.2008.07.018
   Camilleri J, 2008, INT ENDOD J, V41, P843, DOI 10.1111/j.1365-2591.2008.01435.x
   Camilleri J, 2008, INT ENDOD J, V41, P408, DOI 10.1111/j.1365-2591.2007.01370.x
   Camilleri J, 2008, INT ENDOD J, V41, P151
   Camilleri J, 2007, INT ENDOD J, V40, P462, DOI 10.1111/j.1365-2591.2007.01248.x
   Camilleri J, 2005, DENT MATER, V21, P297, DOI 10.1016/j.dental.2004.05.010
   Camilleri J, 2011, DENT MATER, V27, P836, DOI 10.1016/j.dental.2011.04.010
   Camilleri J, 2010, ADV CEM RES, V22, P115, DOI 10.1680/adcr.2010.22.2.115
   Camilleri J, 2010, INT ENDOD J, V43, P231, DOI 10.1111/j.1365-2591.2009.01670.x
   Camilleri J, 2008, INT ENDOD J, V41, P1107, DOI 10.1111/j.1365-2591.2008.01483.x
   Camilleri J, 2011, J ENDODONT, V37, P416
   Camilleri J, 2011, MATER CHARACT, V62, P70, DOI 10.1016/j.matchar.2010.10.014
   Carvalho-Junior JR, 2007, INT ENDOD J, V40, P514, DOI 10.1111/j.1365-2591.2007.01246.x
   Chang SW, 2010, ORAL SURG ORAL MED O, V109, P642, DOI 10.1016/j.tripleo.2009.12.017
   Chen CC, 2009, J ENDODONT, V35, P1554, DOI 10.1016/j.joen.2009.08.006
   Chen CC, 2009, J ENDODONT, V35, P1288, DOI 10.1016/j.joen.2009.05.036
   Chiang TY, 2010, J ENDODONT, V36, P1683, DOI 10.1016/j.joen.2010.07.003
   Chogle Sami, 2007, Gen Dent, V55, P306
   Coomaraswamy KS, 2007, J ENDODONT, V33, P295, DOI 10.1016/j.joen.2006.11.018
   De-Deus G, 2009, J ENDODONT, V35, P887, DOI 10.1016/j.joen.2009.03.003
   Ding SJ, 2009, J MATER CHEM, V19, P1183, DOI 10.1039/b819033j
   Duarte MAH, 2005, ORAL SURG ORAL MED O, V99, P648, DOI 10.1016/j.tripleo.2004.09.015
   Funteas U R, 2003, Aust Endod J, V29, P43
   Gonçalves Jorge Luis, 2010, Braz. oral res., V24, P277, DOI 10.1590/S1806-83242010000300004
   HIGGINBOTHAM TL, 1967, ORAL SURG ORAL MED O, V24, P89, DOI 10.1016/0030-4220(67)90295-2
   Huan ZG, 2008, J MATER SCI-MATER M, V19, P2913, DOI 10.1007/s10856-008-3423-4
   Matsunaga T, 2010, J ENDODONT, V36, P1988, DOI 10.1016/j.joen.2010.08.045
   Nekoofar MH, 2007, INT ENDOD J, V40, P453, DOI 10.1111/j.1365-2591.2007.01236.x
   Neville A. M, 1981, PROPERTIES CONCRETE
   Oliveira IR, 2010, INT ENDOD J, V43, P1069, DOI 10.1111/j.1365-2591.2010.01770.x
   Ramachandran VS, 1995, APPL ADMIXTURES CONC, V1st
   Schembri M, 2010, J ENDODONT, V36, P1210, DOI 10.1016/j.joen.2010.02.011
   Storm B, 2008, J ENDODONT, V34, P80, DOI 10.1016/j.joen.2007.10.006
   Tagger M, 2003, J ENDODONT, V29, P751, DOI 10.1097/00004770-200311000-00016
   Torabinejad M., 1995, US Patent, Patent No. [5769638, 5,769,638]
   Wang XH, 2008, DENT MATER, V24, P74, DOI 10.1016/j.dental.2007.02.006
   Zhao WY, 2008, J BIOMED MATER RES A, V85A, P336, DOI 10.1002/jbm.a.31523
   Zhao WY, 2005, BIOMATERIALS, V26, P6113, DOI 10.1016/j.biomaterials.2005.04.025
   Zhao WY, 2004, MATER LETT, V58, P2350, DOI 10.1016/j.matlet.2004.02.045
NR 43
TC 15
Z9 15
U1 1
U2 16
PU WILEY-BLACKWELL
PI MALDEN
PA COMMERCE PLACE, 350 MAIN ST, MALDEN 02148, MA USA
SN 0143-2885
J9 INT ENDOD J
JI Int. Endod. J.
PD APR
PY 2012
VL 45
IS 4
BP 326
EP 336
DI 10.1111/j.1365-2591.2011.01980.x
PG 11
WC Dentistry, Oral Surgery & Medicine
SC Dentistry, Oral Surgery & Medicine
GA 902QE
UT WOS:000301052200004
PM 22044176
DA 2018-10-19
ER

PT J
AU Maho, A
   Linden, S
   Arnould, C
   Detriche, S
   Delhalle, J
   Mekhalif, Z
AF Maho, A.
   Linden, S.
   Arnould, C.
   Detriche, S.
   Delhalle, J.
   Mekhalif, Z.
TI Tantalum oxide/carbon nanotubes composite coatings on titanium, and
   their functionalization with organophosphonic molecular films: A high
   quality scaffold for hydroxyapatite growth
SO JOURNAL OF COLLOID AND INTERFACE SCIENCE
LA English
DT Article
DE Titanium-based biomaterials; Tantalum oxide; Carbon nanotubes; Sol-gel
   co-deposition; Amino-tris-methylene phosphonic acid; Hydroxyapatite
ID TA2O5 THIN-FILMS; MULTIWALLED CARBON NANOTUBES; IONIC LIQUID; SURFACE
   MODIFICATION; OPTICAL-PROPERTIES; OXIDE-FILMS; NITI ALLOY;
   ELECTRODEPOSITION; BIOCOMPATIBILITY; CORROSION
AB Nowadays, titanium is a very commonly used biomaterial for the preparation of orthopedic and dental implants. Its excellent mechanical and biochemical bulk properties are nevertheless counterbalanced by its propensity to long term degradation in physiological conditions and its weak osseointegrative capacities. In this context, surface modifications can significantly hinder titanium weaknesses.
   The approach considered in this work relies on the preparation of thin composite coatings based on tantalum oxide and carbon nanotubes by sol-gel process. Tantalum is particularly interesting for its high biocompatibility and bioactivity, as well as its strong resistance to bio-corrosion. Carbon nanotubes are exploited to reinforce the compactness and homogeneity of the coatings, and can act as a favorable factor to strengthen the interaction with bone components by biomimicry. The composite layers are further modified with specific organophosphonic acid molecular films, able to chemically bind the tantalum oxide surface and improve the hydroxyapatite formation process.
   The characteristics and the qualities of these hybrid inorganic/organic coatings are evaluated by XPS, SEM, TEM, peeling tests, contact angle measurements, and electrochemical characterizations (free potential, polarization curves). (C) 2012 Elsevier Inc. All rights reserved.
C1 [Maho, A.; Linden, S.; Arnould, C.; Detriche, S.; Delhalle, J.; Mekhalif, Z.] Fac Univ Notre Dame Paix, Lab Chem & Electrochem Surfaces, B-5000 Namur, Belgium.
   [Maho, A.] Fond Format Rech Ind & Agr, B-1000 Brussels, Belgium.
RP Mekhalif, Z (reprint author), Fac Univ Notre Dame Paix, Lab Chem & Electrochem Surfaces, Rue Bruxelles 61, B-5000 Namur, Belgium.
EM zineb.mekhalif@fundp.ac.be
OI Maho, Anthony/0000-0002-3813-6240
FU FNRS-FRIA
FX A. Maho is grateful to FNRS-FRIA for fellowship.
CR Arnould C, 2010, J COLLOID INTERF SCI, V344, P390, DOI 10.1016/j.jcis.2010.01.023
   Arnould C, 2009, J COLLOID INTERF SCI, V336, P497, DOI 10.1016/j.jcis.2009.03.092
   Arnould C, 2008, ELECTROCHIM ACTA, V53, P5632, DOI 10.1016/j.electacta.2008.03.003
   Arnould C, 2010, J COLLOID INTERF SCI, V341, P75, DOI 10.1016/j.jcis.2009.09.030
   Arnould C, 2009, J ELECTROCHEM SOC, V156, pK186, DOI 10.1149/1.3206593
   Balazic Matej, 2007, International Journal of Nano and Biomaterials, V1, P3, DOI 10.1504/IJNBM.2007.016517
   Balla VK, 2010, ACTA BIOMATER, V6, P2329, DOI 10.1016/j.actbio.2009.11.021
   BANSAL NP, 1994, J MATER SCI, V29, P5065, DOI 10.1007/BF01151098
   BRINKER CJ, 1990, SOL GEL SCI PHYS CHE, P21
   Cacciafesta P, 2001, SURF SCI, V491, P405, DOI 10.1016/S0039-6028(01)01303-6
   Chaneliere C, 1998, MAT SCI ENG R, V22, P269, DOI 10.1016/S0927-796X(97)00023-5
   Cheng Y, 2006, J MATER SCI, V41, P4961, DOI 10.1007/s10853-006-0096-6
   Corbella C, 2003, SOLID STATE IONICS, V165, P15, DOI 10.1016/j.ssi.2003.08.018
   Datsyuk V, 2008, CARBON, V46, P833, DOI 10.1016/j.carbon.2008.02.012
   DETRICHE S, 2008, J NANOSCI NANOTECHNO, V8, P1
   Eisenbarth E, 2004, BIOMATERIALS, V25, P5705, DOI 10.1016/j.biomaterials.2004.01.021
   El Abedin SZ, 2005, ELECTROCHEM COMMUN, V7, P941, DOI 10.1016/j.elecom.2005.06.007
   Freese H. L., 2001, TITANIUM MED, P25
   Gawalt ES, 2003, LANGMUIR, V19, P200, DOI 10.1021/la0203436
   Geetha M, 2009, PROG MATER SCI, V54, P397, DOI 10.1016/j.pmatsci.2008.06.004
   Guirado-Lopez RA, 2007, J PHYS CHEM C, V111, P57, DOI 10.1021/kp064651e
   Hanawa T, 2010, WOODHEAD PUBL MATER, P3, DOI 10.1533/9781845699246.1.3
   Harris PJF, 2004, INT MATER REV, V49, P31, DOI 10.1179/095066004225010505
   Huang CJ, 2005, THIN SOLID FILMS, V478, P332, DOI 10.1016/j.tsf.2004.11.100
   Krupa D, 2005, ANAL BIOANAL CHEM, V381, P617, DOI 10.1007/s00216-004-2983-5
   Kukobo T., 2005, SCI ENG C, V25, P97
   Levine BR, 2006, BIOMATERIALS, V27, P4671, DOI 10.1016/j.biomaterials.2006.04.041
   Liao S, 2007, ACTA BIOMATER, V3, P669, DOI [10.1016/j.actbio.2007.03.007, 10.1016/j.aetbio.2007.03.007]
   Lintanf A, 2007, J PHYS CHEM C, V111, P5708, DOI 10.1021/jp0676585
   Martis P, 2010, ELECTROCHIM ACTA, V55, P5407, DOI 10.1016/j.electacta.2010.04.065
   Miyazaki T, 2002, BIOMATERIALS, V23, P827, DOI 10.1016/S0142-9612(01)00188-0
   Nadler M, 2008, CARBON, V46, P1384, DOI 10.1016/j.carbon.2008.05.024
   Narita N, 2009, NANO LETT, V9, P1406, DOI 10.1021/nl8030746
   Ozer N, 1997, J SOL-GEL SCI TECHN, V8, P703, DOI 10.1023/A:1018396900214
   Pouilleau J, 1997, MAT SCI ENG B-SOLID, V47, P235, DOI 10.1016/S0921-5107(97)00043-3
   Raman A, 2010, LANGMUIR, V26, P1747, DOI 10.1021/la904120s
   Shabalovskaya SA, 2002, BIO-MED MATER ENG, V12, P69
   Sirivisoot S, 2008, NANOTECHNOLOGY, V19, DOI 10.1088/0957-4484/19/29/295101
   Sun F, 2008, COLLOID SURFACE B, V67, P132, DOI 10.1016/j.colsurfb.2008.08.008
   Textor M, 2000, LANGMUIR, V16, P3257, DOI 10.1021/la990941t
   Tran N, 2009, WIRES NANOMED NANOBI, V1, P336, DOI 10.1002/wnan.23
   Viornery C, 2002, LANGMUIR, V18, P2582, DOI 10.1021/la010908i
   Webb K, 1998, J BIOMED MATER RES, V41, P422, DOI 10.1002/(SICI)1097-4636(19980905)41:3<422::AID-JBM12>3.0.CO;2-K
   Zaffe D, 2003, BIOMATERIALS, V24, P1093, DOI 10.1016/S0142-9612(02)00424-6
NR 44
TC 23
Z9 25
U1 4
U2 90
PU ACADEMIC PRESS INC ELSEVIER SCIENCE
PI SAN DIEGO
PA 525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA
SN 0021-9797
J9 J COLLOID INTERF SCI
JI J. Colloid Interface Sci.
PD APR 1
PY 2012
VL 371
BP 150
EP 158
DI 10.1016/j.jcis.2011.12.066
PG 9
WC Chemistry, Physical
SC Chemistry
GA 902CD
UT WOS:000301015300018
PM 22284449
DA 2018-10-19
ER

PT J
AU Bhardwaj, N
   Kundu, SC
AF Bhardwaj, Nandana
   Kundu, Subhas C.
TI Chondrogenic differentiation of rat MSCs on porous scaffolds of silk
   fibroin/chitosan blends
SO BIOMATERIALS
LA English
DT Article
DE Silk fibroin; Chitosan; Mesenchymal stem cells; Cartilage; Tissue
   engineering
ID MESENCHYMAL STEM-CELLS; TISSUE ENGINEERING APPLICATIONS; BOVINE
   ARTICULAR CHONDROCYTES; 3D SCAFFOLDS; CHITOSAN SCAFFOLDS; STROMAL CELLS;
   PORE-SIZE; CARTILAGE; BIOMATERIALS; REGENERATION
AB Adult bone marrow derived mesenchymal stem cells are undifferentiated, multipotential cells and have the potential to differentiate into multiple lineages like bone, cartilage or fat. In this study, polyelectrolyte complex silk fibroin/chitosan blended porous scaffolds were fabricated and examined for its ability to support in vitro chondrogenesis of mesenchymal stem cells. Silk fibroin matrices provide suitable substrate for cell attachment and proliferation while chitosan are promising biomaterial for cartilage repair due to it's structurally resemblance with glycosaminoglycans. We compared the formation of cartilaginous tissue in the silk fibroin/chitosan blended scaffolds with rat mesenchymal stem cells and cultured in vitro for 3 weeks. Additionally, pure silk fibroin scaffolds of non-mulberry silkworm, Antheraea mylitta and mulberry silkworm, Bombyx mori were also utilized for comparative studies. The constructs were analyzed for cell attachment, proliferation, differentiation, histological and immunohistochemical evaluations. Silk fibroin/chitosan blended scaffolds supported the cell attachment and proliferation as indicated by SEM observation, Confocal microscopy and metabolic activities. Alcian Blue and Safranin O histochemistry and expression of collagen II indicated the maintenance of chondrogenic phenotype in the constructs after 3 weeks of culture. Glycosaminoglycans and collagen accumulated in all the scaffolds and was highest in silk fibroin/chitosan blended scaffolds and pure silk fibroin scaffolds of A. mylitta. Chondrogenic differentiation of MSCs in the silk fibroin/chitosan and pure silk fibroin scaffolds was evident by real-time PCR analysis for cartilage-specific ECM gene markers. The results represent silk fibroin/chitosan blended 3D scaffolds as suitable scaffold for mesenchymal stem cells-based cartilage repair. (C) 2011 Elsevier Ltd. All rights reserved.
C1 [Bhardwaj, Nandana; Kundu, Subhas C.] Indian Inst Technol, Dept Biotechnol, Kharagpur 721302, W Bengal, India.
RP Kundu, SC (reprint author), Indian Inst Technol, Dept Biotechnol, Kharagpur 721302, W Bengal, India.
EM kundu@hijli.iitkgp.ernet.in
OI Bhardwaj, Dr. Nandana/0000-0002-7747-3661; Kundu, Subhas
   C./0000-0002-7170-2291
FU Department of Biotechnology; Department of Science and Technology.
   Government of India, New Delhi
FX This work is financially supported by Department of Biotechnology (also
   fellowship to Nandana Bhardwaj) and Department of Science and
   Technology. Government of India, New Delhi.
CR AYDELOTTE MB, 1988, CONNECT TISSUE RES, V18, P223, DOI 10.3109/03008208809016809
   Bhardwaj N, 2011, BIOMATERIALS, V32, P5773, DOI 10.1016/j.biomaterials.2011.04.061
   Bhardwaj N, 2011, CARBOHYD POLYM, V85, P325, DOI 10.1016/j.carbpol.2011.02.027
   Bolgen N, 2011, J TISSUE ENG REGEN M, V5, P770, DOI 10.1002/term.375
   Chelluri LK, 2011, STEM CELL STUD, V1, pe5
   Chlapanidas T, 2011, TISSUE ENG PT A, V17, P1725, DOI 10.1089/ten.tea.2010.0636
   Correia CR, 2011, TISSUE ENG PART C-ME, V17, P717, DOI 10.1089/ten.tec.2010.0467
   Dominici M, 2006, CYTOTHERAPY, V8, P315, DOI 10.1080/14653240600855905
   Fan HB, 2006, BIOMATERIALS, V27, P4573, DOI 10.1016/j.biomaterials.2006.04.013
   Grassel S, 2009, INT J MOL MED, V23, P745, DOI 10.3892/ijmm_00000188
   Griffon DJ, 2006, ACTA BIOMATER, V2, P313, DOI 10.1016/j.actbio.2005.12.007
   Hao T, 2010, OSTEOARTHR CARTILAGE, V18, P257, DOI 10.1016/j.joca.2009.08.007
   Hsieh-Bonassera ND, 2009, TISSUE ENG PT A, V15, P3513, DOI [10.1089/ten.tea.2008.0628, 10.1089/ten.TEA.2008.0628]
   Hui TY, 2008, BIOMATERIALS, V29, P3201, DOI 10.1016/j.biomaterials.2008.04.001
   Hwang NS, 2006, BIOMATERIALS, V27, P6015, DOI 10.1016/j.biomaterials.2006.06.033
   Karageorgiou V, 2005, BIOMATERIALS, V26, P5474, DOI 10.1016/j.biomaterials.2005.02.002
   Kawakami Y, 2006, CURR OPIN CELL BIOL, V18, P723, DOI 10.1016/j.ceb.2006.10.007
   Lee J. E., 2005, J TISSUE ENG REGEN M, V2, P41
   Lien SM, 2009, ACTA BIOMATER, V5, P670, DOI 10.1016/j.actbio.2008.09.020
   Mandal BB, 2008, MACROMOL BIOSCI, V8, P807, DOI 10.1002/mabi.200800113
   Mandal BB, 2009, BIOMATERIALS, V30, P5019, DOI 10.1016/j.biomaterials.2009.05.064
   Martin I, 2007, J BIOMECH, V40, P750, DOI 10.1016/j.jbiomech.2006.03.008
   Meinel L, 2004, BIOTECHNOL BIOENG, V88, P379, DOI 10.1002/bit.20252
   Nesic D, 2006, ADV DRUG DELIVER REV, V58, P300, DOI 10.1016/j.addr.2006.01.012
   Neves SC, 2011, BIOMATERIALS, V32, P1068, DOI 10.1016/j.biomaterials.2010.09.073
   Pelttari K, 2008, INJURY, V39, P58
   Prockop DJ, 1997, SCIENCE, V276, P71, DOI 10.1126/science.276.5309.71
   Sanchez-Adams J, 2012, BIOMATERIALS, V33, P109, DOI 10.1016/j.biomaterials.2011.09.038
   Sofia S, 2001, J BIOMED MATER RES, V54, P139, DOI 10.1002/1097-4636(200101)54:1<139::AID-JBM17>3.0.CO;2-7
   Sohier J, 2007, INT J PHARM, V332, P80, DOI 10.1016/j.ijpharm.2006.09.037
   Steinert AF, 2007, ARTHRITIS RES THER, V9, DOI 10.1186/ar2195
   Tigli RS, 2009, J TISSUE ENG REGEN M, V3, P348, DOI 10.1002/term.169
   Tsutsumi S, 2001, BIOCHEM BIOPH RES CO, V288, P413, DOI 10.1006/bbrc.2001.5777
   Tuli R, 2003, ARTHRITIS RES THER, V5, P235, DOI 10.1186/ar991
   Unger RE, 2007, BIOMATERIALS, V28, P3965, DOI 10.1016/j.biomaterials.2007.05.032
   Vepari C, 2007, PROG POLYM SCI, V32, P991, DOI 10.1016/j.progpolymsci.2007.05.013
   Wang YZ, 2005, BIOMATERIALS, V26, P7082, DOI 10.1016/j.biomaterials.2005.05.022
   Wu Y, 2009, J BIOACT COMPAT POLY, V24, P301
   Yan LP, 2012, ACTA BIOMATER, V8, P289, DOI 10.1016/j.actbio.2011.09.037
   Zhang XH, 2012, J MATER SCI-MATER M, V23, P315, DOI 10.1007/s10856-011-4476-3
NR 40
TC 89
Z9 103
U1 4
U2 100
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD APR
PY 2012
VL 33
IS 10
BP 2848
EP 2857
DI 10.1016/j.biomaterials.2011.12.028
PG 10
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 900VX
UT WOS:000300920900004
PM 22261099
DA 2018-10-19
ER

PT J
AU Cheng, K
   Shen, DL
   Smith, J
   Galang, G
   Sun, BM
   Zhang, JY
   Marban, E
AF Cheng, Ke
   Shen, Deliang
   Smith, Jeremy
   Galang, Giselle
   Sun, Baiming
   Zhang, Jinying
   Marban, Eduardo
TI Transplantation of platelet gel spiked with cardiosphere-derived cells
   boosts structural and functional benefits relative to gel
   transplantation alone in rats with myocardial infarction
SO BIOMATERIALS
LA English
DT Article
DE Cardiac stem cells; Platelet gel; Myocardial infarction; Cardiac
   regeneration
ID CARDIAC STEM-CELLS; REGENERATION; EXPANSION; CARDIOMYOCYTES; HYDROGEL;
   DELIVERY; ROLES
AB The emerging field of stem cell therapy and biomaterials has begun to provide promising strategies for the treatment of ischemic carcliomyopathy. Platelet gel and cardiosphere-derived cells (CDCs) are known to be beneficial when transplanted separately post-myocardial infarction (MI). We hypothesize that pre-seeding platelet gel with CDCs can enhance therapeutic efficacy. Platelet gel and CDCs were derived from venous blood and heart biopsies of syngeneic rats, respectively. In vitro, the viability, growth, and morphology of CDCs cultured in platelet gel were characterized. When delivered into infarcted rat hearts, platelet gel pre-seeded with CDCs was more efficiently populated with endogenous cardiomyocytes and endothelial cells than platelet gel alone. Recruitment of endogenous c-kit positive cells was enhanced in the hearts treated with gel with CDC. At 3 weeks, the hearts treated with CDC-seeded platelet gel exhibited the greatest attenuation of adverse left ventricular (LV) remodeling and the highest cardiac function (i.e., LV ejection fraction) as compared to hearts transplanted with Gel only or vehicle controls. Histological analysis revealed that, though some transplanted CDCs differentiated into cardiomyocytes and endothelial cells in the recipients' hearts, most of the incremental benefit arose from CDC-mediated endogenous repair. Pre-seeding platelet gel with CDCs enhanced the functional benefit of biomaterial therapy for treating myocardial infarction. (C) 2011 Elsevier Ltd. All rights reserved.
C1 [Cheng, Ke; Shen, Deliang; Smith, Jeremy; Galang, Giselle; Sun, Baiming; Marban, Eduardo] Cedars Sinai Med Ctr, Inst Heart, Los Angeles, CA 90048 USA.
   [Shen, Deliang; Zhang, Jinying] Zhengzhou Univ, Coll Med, Affiliated Hosp 1, Dept Cardiol, Zhengzhou 450052, Henan, Peoples R China.
RP Marban, E (reprint author), Cedars Sinai Med Ctr, Inst Heart, 8700 Beverly Blvd, Los Angeles, CA 90048 USA.
EM Eduardo.Marban@csmc.edu
FU NHLBI NIH HHS [R01 HL083109-08, R01 HL083109]
CR Bearzi C, 2007, P NATL ACAD SCI USA, V104, P14068, DOI 10.1073/pnas.0706760104
   Beltrami AP, 2003, CELL, V114, P763, DOI 10.1016/S0092-8674(03)00687-1
   Bryan N, 2009, BIOMATERIALS, V30, P180, DOI 10.1016/j.biomaterials.2008.09.003
   Cheng K, 2012, J AM COLL CARDIOL, V59, P245
   Cheng K, 2008, BIOMATERIALS, V29, P2802, DOI 10.1016/j.biomaterials.2008.03.015
   Cheng K, 2010, CIRC RES, V106, P1570, DOI 10.1161/CIRCRESAHA.109.212589
   Chimenti I, 2010, CIRC RES, V106, P971, DOI 10.1161/CIRCRESAHA.109.210682
   Christman KL, 2006, J AM COLL CARDIOL, V48, P907, DOI 10.1016/j.jacc.2006.06.005
   Christman KL, 2004, J AM COLL CARDIOL, V44, P654, DOI 10.1016/j.jacc.2004.04.040
   Cukierman E, 2001, SCIENCE, V294, P1708, DOI 10.1126/science.1064829
   Davis DR, 2010, J MOL CELL CARDIOL, V49, P312, DOI 10.1016/j.yjmcc.2010.02.019
   Frederick JR, 2010, CIRCULATION, V122, pS107, DOI [10.1161/C1RCULATIONAHA.109.930404, 10.1161/CIRCULATIONAHA.109.930404]
   Johnston PV, 2009, CIRCULATION, V120, P1075, DOI 10.1161/CIRCULATIONAHA.108.816058
   Kapoor N, 2011, J BIOL CHEM, V286, P14073, DOI 10.1074/jbc.M110.185298
   Lam CK, 2010, NATURE, V465, P478, DOI 10.1038/nature09001
   Lee ST, 2011, J AM COLL CARDIOL, V57, P455, DOI 10.1016/j.jacc.2010.07.049
   Li TS, 2011, CARDIOVASC RES, V89, P157, DOI 10.1093/cvr/cvq251
   Li TS, 2010, STEM CELLS, V28, P1178, DOI 10.1002/stem.438
   Li TS, 2010, STEM CELLS, V28, P2088, DOI 10.1002/stem.532
   Shapira-Schweitzer K, 2009, J MOL CELL CARDIOL, V46, P213, DOI 10.1016/j.yjmcc.2008.10.018
   Smith RR, 2007, CIRCULATION, V115, P896, DOI 10.1161/CIRCULATIONAHA.106.655209
   Stastna M, 2010, PROTEOMICS, V10, P245, DOI 10.1002/pmic.200900515
   Terrovitis J, 2009, J AM COLL CARDIOL, V54, P1619, DOI 10.1016/j.jacc.2009.04.097
   Wang HB, 2010, J CELL MOL MED, V14, P1044, DOI 10.1111/j.1582-4934.2010.01046.x
   Ye ZY, 2011, ADV DRUG DELIVER REV, V63, P688, DOI 10.1016/j.addr.2011.02.007
NR 25
TC 28
Z9 30
U1 1
U2 9
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD APR
PY 2012
VL 33
IS 10
BP 2872
EP 2879
DI 10.1016/j.biomaterials.2011.12.040
PG 8
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 900VX
UT WOS:000300920900006
PM 22243801
OA Green Accepted
DA 2018-10-19
ER

PT J
AU Roopan, SM
   Bharathi, A
   Kumar, R
   Khanna, VG
   Prabhakarn, A
AF Roopan, Selvaraj Mohana
   Bharathi, Annadurai
   Kumar, Rajendran
   Khanna, Venkatesh Gopiesh
   Prabhakarn, Arunachalam
TI Acaricidal, insecticidal, and larvicidal efficacy of aqueous extract of
   Annona squamosa L peel as biomaterial for the reduction of palladium
   salts into nanoparticles
SO COLLOIDS AND SURFACES B-BIOINTERFACES
LA English
DT Article
DE Biosynthesis; Annona squamosa L peel; Palladium; Nanoparticles
ID SILVER
AB In recent years the utilization of secondary metabolites from plant extract has emerged as a novel technology for the synthesis of various nanoparticles. In this paper we studied the potential of nanocrystalline palladium nanoparticles production using acaricidal, insecticidal and larvicidal efficacy of Annona squamosa L aqueous peel extract as the biomaterial for the first time. The synthesized nanoparticles were characterized and confirmed as palladium nanoparticles by using UV-visible spectroscopy, XRD and TEM analysis. The results clearly showed that the compounds containing -OH as a functional group played a critical role in capping the nanoparticles. Also the results highlight the possibility of green pathways to produce palladium nanoparticles. (C) 2011 Elsevier B.V. All rights reserved.
C1 [Roopan, Selvaraj Mohana; Bharathi, Annadurai] VIT Univ, Div Organ Chem, Sch Adv Sci, Vellore 632014, Tamil Nadu, India.
   [Kumar, Rajendran; Khanna, Venkatesh Gopiesh] VIT Univ, Sch Biosci & Technol, Div Biomol & Genet, Vellore 632014, Tamil Nadu, India.
   [Prabhakarn, Arunachalam] Natl Inst Technol, Tiruchchirappalli 620015, Tamil Nadu, India.
RP Roopan, SM (reprint author), VIT Univ, Div Organ Chem, Sch Adv Sci, Vellore 632014, Tamil Nadu, India.
EM mohanaroopan.s@gmail.com
RI Rajendran, Kumar/M-8905-2013; Arunachalam, Prabhakarn/A-2601-2016;
   Jebakumar Immanuel Edison, Thomas Nesakumar/N-8909-2015
OI Rajendran, Kumar/0000-0002-0178-317X; Arunachalam,
   Prabhakarn/0000-0002-6293-1631; Jebakumar Immanuel Edison, Thomas
   Nesakumar/0000-0003-4617-1385
FU SAIF, IIT madras
FX We thank the management of VIT University for providing all the
   facilities to carry out this work. One of the authors Dr. S.M. Roopan
   thank to Dr. F. Nawaz Khan for his support and encouragement. The
   authors also acknowledge the NMR support provided by SAIF, IIT madras,
   to carry out this work.
CR Kanchana A, 2010, NANO-MICRO LETT, V2, P169, DOI 10.5101/nml.v2i3.p169-176
   Konishi Y, 2007, J BIOTECHNOL, V128, P648, DOI 10.1016/j.jbiotec.2006.11.014
   Kotkar HM, 2002, PEST MANAG SCI, V58, P33, DOI [10.1002/ps.414, 10.1002/ps.414.abs]
   Leela A, 2008, AFR J BIOTECHNOL, V7, P3162
   Madhumitha G, 2012, PARASITOL RES, V111, P2189, DOI 10.1007/s00436-011-2671-2
   Nadagouda MN, 2008, GREEN CHEM, V10, P859, DOI 10.1039/b804703k
   Rahman MM, 2005, FITOTERAPIA, V76, P484, DOI 10.1016/j.fitote.2005.04.002
   Sathishkumar M, 2009, J HAZARD MATER, V171, P400, DOI 10.1016/j.jhazmat.2009.06.014
   Sathishkumar M., 2009, INT J MAT SCI, V4, P11
   Thigarajan S., 2009, BIOELECTROCHEMISTRY, V75, P163
   WAGNER H, 1980, PLANTA MED, V40, P77, DOI 10.1055/s-2008-1074944
   Yong P, 2002, BIOTECHNOL BIOENG, V80, P369, DOI 10.1002/bit.10369
NR 12
TC 74
Z9 75
U1 0
U2 12
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0927-7765
J9 COLLOID SURFACE B
JI Colloid Surf. B-Biointerfaces
PD APR 1
PY 2012
VL 92
BP 209
EP 212
DI 10.1016/j.colsurfb.2011.11.044
PG 4
WC Biophysics; Chemistry, Physical; Materials Science, Biomaterials
SC Biophysics; Chemistry; Materials Science
GA 900AM
UT WOS:000300859000030
PM 22205064
DA 2018-10-19
ER

PT J
AU Sena, P
   Manfredini, G
   Barbieri, C
   Mariani, F
   Tosi, G
   Ruozi, B
   Ferretti, M
   Marzona, L
   Palumbo, C
AF Sena, P.
   Manfredini, G.
   Barbieri, C.
   Mariani, F.
   Tosi, G.
   Ruozi, B.
   Ferretti, M.
   Marzona, L.
   Palumbo, C.
TI Application of poly-L-lactide screws in flat foot surgery: histological
   and radiological aspects of bio-absorption of degradable devices
SO HISTOLOGY AND HISTOPATHOLOGY
LA English
DT Article
DE PLLA screws; Flat foot; Bio-absorption; Histological analysis
ID SINUS TARSI SYNDROME; ORTHOPEDIC APPLICATIONS; POLY(DL-LACTIC ACID);
   FLEXIBLE FLATFOOT; CELL; BIOCOMPATIBILITY; FIXATION; IMPLANTS; FUSION
AB The flat foot in childhood is a condition frequently observed in orthopedic practice but it is still debated when and in which patients surgical corrective treatment is appropriate; recently, the application of poly-L-lactic-acid (PLLA) screws was proposed. The present study investigates a group of 33 patients treated with PLLA expansion endorthesis in order to evaluate the deformity correction. Clinical and radiological outcomes in patients were correlated with: a) morphological characterization of screws both before and after being removed from patients, when necessary; b) histological and bio-molecular evaluation of degradation processes of the implants, focusing attention on the correlation between the cellular cohort involved in inflammatory reaction and the bio-absorption degree of PLLA screws. Deformity correction was mostly achieved, with minimal need of screw removal; the results obtained clearly show the occurrence of chronic rather than acute inflammation in removed screw specimens.
   At the histological level, after biomaterial implantation, the sequence of events occurring in the surrounding tissues ultimately ends in the formation of foreign body giant cells (FBGCs) at the tissue/material interface; but the mechanisms which influence the fate of screw implants, i.e. the resolution of acute inflammation rather than the progression towards chronic inflammation, are of crucial importance for biodegradable materials like "polylactic acid". In fact, the FBGC response ensures a long-term mechanism which eliminates the foreign material from the body, but at the same time the implications of prolonged FBGC responses, which generate negative side effects, could significantly impede the healing progress.
C1 [Palumbo, C.] Univ Modena & Reggio Emilia, Dept Biomed Sci, Sect Human Morphol, Inst Anat,Area Policlin, I-41125 Modena, Italy.
   [Manfredini, G.; Barbieri, C.; Mariani, F.] Univ Hosp, Orthopaed & Traumatol Clin, Modena, Italy.
   [Tosi, G.; Ruozi, B.] Dept Pharmaceut Sci, Modena, Italy.
RP Palumbo, C (reprint author), Univ Modena & Reggio Emilia, Dept Biomed Sci, Sect Human Morphol, Inst Anat,Area Policlin, Via Pozzo 71, I-41125 Modena, Italy.
EM carla.palumbo@unimore.it
RI Palumbo, Carla/E-5802-2012; Ruozi, Barbara/D-5500-2015; Tosi,
   Giovanni/D-4547-2011; Ferretti, Marzia/F-1153-2016; Sena,
   Paola/G-9394-2016
OI Palumbo, Carla/0000-0003-0587-0112; Ruozi, Barbara/0000-0002-2400-9910;
   Tosi, Giovanni/0000-0001-8318-667X; Ferretti,
   Marzia/0000-0003-0280-3598; Sena, Paola/0000-0003-4724-8786; Mariani,
   Francesco/0000-0002-0650-3253
FU Fondazione di Vignola; Banca Popolare of Emilia Romagna
FX This study was supported by funds of Fondazione di Vignola 2010 and
   Banca Popolare of Emilia Romagna.
CR Agrawal CM, 1997, J BIOMED MATER RES, V38, P105, DOI 10.1002/(SICI)1097-4636(199722)38:2<105::AID-JBM4>3.0.CO;2-U
   Anderson J M, 1988, ASAIO Trans, V34, P101, DOI 10.1097/00002480-198804000-00005
   Anderson JM, 2001, ANNU REV MATER RES, V31, P81, DOI 10.1146/annurev.matsci.31.1.81
   Anderson JM, 2000, CURR OPIN HEMATOL, V7, P40, DOI 10.1097/00062752-200001000-00008
   Athanasiou KA, 1998, ARTHROSCOPY, V14, P726, DOI 10.1016/S0749-8063(98)70099-4
   Barber FA, 2006, ARTHROSCOPY, V22, P820, DOI 10.1016/j.arthro.2006.04.096
   Bostman O, 2000, BIOMATERIALS, V21, P2615, DOI 10.1016/S0142-9612(00)00129-0
   Bostman OM, 2000, CLIN ORTHOP RELAT R, P216
   Brodbeck WG, 2002, CYTOKINE, V18, P311, DOI 10.1006/cyto.2002.1048
   Burutaran JM, 1979, CHIR PIEDE, V3, P319
   Chen EH, 2007, FEBS LETT, V581, P2181, DOI 10.1016/j.febslet.2007.03.033
   Giannini S, 2003, CLIN ORTHOP RELAT R, P178, DOI 10.1097/01.blo.0000069897.31220.7a
   Giannini S, 2001, J BONE JOINT SURG AM, V83A, P73, DOI 10.2106/00004623-200100022-00003
   Giannini S., 1991, PIEDE PIATTO PROGR M, V2, P41
   Gretzer C, 2006, J BIOMAT SCI-POLYM E, V17, P669, DOI 10.1163/156856206777346340
   Gutierrez PR, 2005, FOOT ANKLE INT, V26, P918, DOI 10.1177/107110070502601104
   Helming L, 2007, EUR J IMMUNOL, V37, P33, DOI 10.1002/eji.200636788
   Jones JA, 2004, J BIOMAT SCI-POLYM E, V15, P567, DOI 10.1163/156856204323046843
   Keselowsky BG, 2007, BIOMATERIALS, V28, P3626, DOI 10.1016/j.biomaterials.2007.04.035
   Lee KB, 2008, ARTHROSCOPY, V24, P1130, DOI 10.1016/j.arthro.2008.05.007
   LI SM, 1990, J MATER SCI-MATER M, V1, P123, DOI 10.1007/BF00700871
   Luttikhuizen DT, 2006, TISSUE ENG, V12, P1955, DOI 10.1089/ten.2006.12.1955
   Matheson LA, 2004, J CELL PHYSIOL, V199, P8, DOI 10.1002/jcp.10412
   Maurus PB, 2004, OPER TECHN SPORT MED, V12, P158, DOI 10.1053/j.otsm.2004.07.015
   McNally AK, 2002, AM J PATHOL, V160, P621, DOI 10.1016/S0002-9440(10)64882-1
   Needleman RL, 2005, FOOT ANKLE INT, V26, P336, DOI 10.1177/107110070502600411
   Paparella Treccia R, 1977, PIEDE UOMO
   Petricca SE, 2006, ACTA BIOMATER, V2, P277, DOI 10.1016/j.actbio.2005.12.004
   Sambrook J, 1989, MOL CLONING LAB MANU
   Solheim E, 2000, J BIOMED MATER RES, V49, P257, DOI 10.1002/(SICI)1097-4636(200002)49:2<257::AID-JBM15>3.0.CO;2-5
   TAILLARD W, 1981, INT ORTHOP, V5, P117, DOI 10.1007/BF00267842
   Tang L., 1998, P NATL ACAD SCI USA, V21, P8841
   Warden W.H., 2008, ARTHROSCOPY J ARTHR, V24, p[370, e1, e3]
   Williams DF, 1981, ENG MED, V10, P5, DOI DOI 10.1243/EMED_JOUR_1981_010_004_02
   Wilson CJ, 2005, TISSUE ENG, V11, P1, DOI 10.1089/ten.2005.11.1
   Zdolsek J., 2007, TRANSL MED, V1, P5
NR 36
TC 5
Z9 8
U1 1
U2 8
PU F HERNANDEZ
PI MURCIA
PA PLAZA FUENSANTA 2-7 C, 30008 MURCIA, SPAIN
SN 0213-3911
J9 HISTOL HISTOPATHOL
JI Histol. Histopath.
PD APR
PY 2012
VL 27
IS 4
BP 485
EP 496
PG 12
WC Cell Biology; Pathology
SC Cell Biology; Pathology
GA 901DK
UT WOS:000300941700008
PM 22374726
DA 2018-10-19
ER

PT J
AU Sangha, AK
   Petridis, L
   Smith, JC
   Ziebell, A
   Parks, JM
AF Sangha, Amandeep K.
   Petridis, Loukas
   Smith, Jeremy C.
   Ziebell, Angela
   Parks, Jerry M.
TI Molecular simulation as a tool for studying lignin
SO ENVIRONMENTAL PROGRESS & SUSTAINABLE ENERGY
LA English
DT Article
DE biomass; recalcitrance; quantum chemistry; molecular dynamics
ID PHENETHYL PHENYL ETHERS; MEDICAGO-SATIVA L.; DENSITY FUNCTIONALS;
   SEMIEMPIRICAL METHODS; CONFORMATIONAL FLEXIBILITY;
   ALPHA/BETA-SELECTIVITIES; COMPUTATIONAL PREDICTION; NONCOVALENT
   INTERACTIONS; THERMOCHEMICAL KINETICS; DEHYDROGENATIVE POLYMER
AB Lignocellulosic biomass provides a sustainable source of sugars for biofuel and biomaterial production. However, biomass resistance to degradation imposes difficulties for economical conversion of plant carbohydrates to fermentable sugars. One of the key contributors to recalcitrance is lignin. Understanding the properties of lignin macromolecules in the cell wall matrix is useful for manipulating biomass structure to generate more easily degradable biomass. Along with experimental techniques such as 2D-NMR and mass spectrometry, computational techniques can be useful for characterizing the structural and energetic properties of the biomass assembly and its individual constituents. Here, we provide a brief introduction to lignin, review some of the recent, relevant scientific literature, and give our perspectives on the role of molecular simulation in understanding lignin structure. (C) 2011 American Institute of Chemical Engineers Environ Prog, 2012
C1 [Sangha, Amandeep K.; Petridis, Loukas; Smith, Jeremy C.; Parks, Jerry M.] Oak Ridge Natl Lab, UT ORNL Ctr Mol Biophys, Oak Ridge, TN 37831 USA.
   [Sangha, Amandeep K.; Petridis, Loukas; Smith, Jeremy C.; Parks, Jerry M.] BioEnergy Sci Ctr, Oak Ridge, TN USA.
   [Smith, Jeremy C.] Univ Tennessee, Dept Biochem & Cellular & Mol Biol, Knoxville, TN 37996 USA.
   [Ziebell, Angela] Natl Renewable Energy Lab, Natl Bioenergy Ctr, Golden, CO 80401 USA.
   [Ziebell, Angela] BioEnergy Sci Ctr, Golden, CO USA.
RP Parks, JM (reprint author), Oak Ridge Natl Lab, UT ORNL Ctr Mol Biophys, Oak Ridge, TN 37831 USA.
EM angela.ziebell@nrel.gov; parksjm@ornl.gov
RI Petridis, Loukas/B-3457-2009; Sangha, Amandeep/M-1784-2013; smith,
   jeremy/B-7287-2012; Parks, Jerry/B-7488-2009
OI Petridis, Loukas/0000-0001-8569-060X; Sangha,
   Amandeep/0000-0002-1787-9379; smith, jeremy/0000-0002-2978-3227; Parks,
   Jerry/0000-0002-3103-9333
FU Bioenergy Science Center, which is a United States Department of Energy
   Bioenergy Research Center; Office of Biological and Environmental
   Research in the Department of Energy Office of Science
FX This work was supported by the Bioenergy Science Center, which is a
   United States Department of Energy Bioenergy Research Center supported
   by the Office of Biological and Environmental Research in the Department
   of Energy Office of Science.
CR Aoyama W, 2002, J WOOD SCI, V48, P497, DOI 10.1007/BF00766646
   BECKE AD, 1993, J CHEM PHYS, V98, P5648, DOI 10.1063/1.464913
   Berlin A, 2005, APPL BIOCHEM BIOTECH, V121, P163, DOI 10.1385/ABAB:121:1-3:0163
   Besombes S, 2005, PLANT PHYSIOL BIOCH, V43, P299, DOI 10.1016/j.plaphy.2005.02.005
   Besombes S, 2005, PLANT PHYSIOL BIOCH, V43, P277, DOI 10.1016/j.plaphy.2005.02.004
   Besombes S, 2004, MAGN RESON CHEM, V42, P337, DOI 10.1002/mrc.1317
   Besombes S, 2004, BIOPOLYMERS, V73, P301, DOI 10.1002/bip.10587
   Beste A, 2008, J PHYS CHEM A, V112, P4982, DOI 10.1021/jp800767j
   Beste A, 2007, J PHYS CHEM A, V111, P12118, DOI 10.1021/jp075861+
   Beste A, 2010, ENERG FUEL, V24, P2857, DOI 10.1021/ef1001953
   Beste A, 2009, J ORG CHEM, V74, P2837, DOI 10.1021/jo9001307
   Bonawitz ND, 2010, ANNU REV GENET, V44, P337, DOI 10.1146/annurev-genet-102209-163508
   Brunow G., 1998, ACS SYM SER, V697, P131
   CHAI JD, 2009, PHYS CHEM CHEM PHYS, V10, P6615
   Chen F, 2007, NAT BIOTECHNOL, V25, P759, DOI 10.1038/nbt1316
   Chen YR, 2010, PHYTOCHEMISTRY, V71, P453, DOI 10.1016/j.phytochem.2009.11.012
   Cody GD, 1999, GEOCHIM COSMOCHIM AC, V63, P193, DOI 10.1016/S0016-7037(99)00029-0
   Cramer CJ, 2004, ESSENTIALS COMPUTATI
   Davin LB, 2005, CURR OPIN BIOTECH, V16, P407, DOI 10.1016/j.copbio.2005.06.011
   Davin LB, 1997, SCIENCE, V275, P362, DOI 10.1126/science.275.5298.362
   DEWAR MJS, 1985, J AM CHEM SOC, V107, P3902, DOI 10.1021/ja00299a024
   Donohoe BS, 2008, BIOTECHNOL BIOENG, V101, P913, DOI 10.1002/bit.21959
   Durbeej B, 2003, HOLZFORSCHUNG, V57, P150, DOI 10.1515/HF.2003.024
   Durbeej B, 2003, HOLZFORSCHUNG, V57, P466, DOI 10.1515/HF.2003.070
   Durbeej B, 2003, HOLZFORSCHUNG, V57, P59, DOI 10.1515/HF.2003.009
   Durbeej B, 2003, LECT NOTES COMPUTER, V2565, P267
   Elder T., LIGNIN LIGNANS ADV C, P321
   Eriksson T, 2002, ENZYME MICROB TECH, V31, P353, DOI 10.1016/S0141-0229(02)00134-5
   Freudenberg K., 1968, CONSTITUTION BIOSYNT
   Fu CX, 2011, P NATL ACAD SCI USA, V108, P3803, DOI 10.1073/pnas.1100310108
   Gallego-Giraldo L, 2011, NEW PHYTOL, V190, P627, DOI 10.1111/j.1469-8137.2010.03621.x
   Goerigk L, 2011, PHYS CHEM CHEM PHYS, V13, P6670, DOI 10.1039/c0cp02984j
   Himmel ME, 2007, SCIENCE, V315, P804, DOI 10.1126/science.1137016
   Jarvis MW, 2011, J PHYS CHEM A, V115, P428, DOI 10.1021/jp1076356
   Johjima T, 1999, P NATL ACAD SCI USA, V96, P1989, DOI 10.1073/pnas.96.5.1989
   Jorgensen H, 2007, BIOFUEL BIOPROD BIOR, V1, P119, DOI 10.1002/bbb.4
   JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869
   KARHUNEN P, 1995, TETRAHEDRON LETT, V36, P4501, DOI 10.1016/0040-4039(95)00769-9
   KARHUNEN P, 1995, TETRAHEDRON LETT, V36, P169, DOI 10.1016/0040-4039(94)02203-N
   Kobayashi T, 2005, J WOOD SCI, V51, P607, DOI 10.1007/s10086-005-0702-2
   Koch W., 2001, CHEM GUIDE DENSITY F
   LEE CT, 1988, PHYS REV B, V37, P785, DOI 10.1103/PhysRevB.37.785
   Liu CJ, 2011, MOLECULES, V16, P710, DOI 10.3390/molecules16010710
   Lu FC, 2010, CEREAL STRAW AS A RESOURCE FOR SUSTAINABLE BIOMATERIALS AND BIOFUELS: CHEMISTRY, EXTRACTIVES, LIGNINS, HEMICELLULOSES AND CELLULOSE, P169, DOI 10.1016/B978-0-444-53234-3.00006-7
   MacKerell AD, 1998, J PHYS CHEM B, V102, P3586, DOI 10.1021/jp973084f
   Mardis KL, 1999, J PHYS CHEM B, V103, P9879, DOI 10.1021/jp991499q
   Matthews JF, 2006, CARBOHYD RES, V341, P138, DOI 10.1016/j.carres.2005.09.028
   Mechin V, 2007, PHYTOCHEMISTRY, V68, P571, DOI 10.1016/j.phytochem.2006.11.024
   Miao YC, 2010, P NATL ACAD SCI USA, V107, P22728, DOI 10.1073/pnas.1007747108
   Monties B., 2010, BIOPOLYMERS LIGNIN H, P107
   Nielsen SO, 2004, J PHYS-CONDENS MAT, V16, pR481, DOI 10.1088/0953-8984/16/15/R03
   Palonen H, 2004, J BIOTECHNOL, V107, P65, DOI 10.1016/j.jbiotec.2003.09.011
   Parr R. G., 1994, DENSITY FUNCTIONAL T
   PETERSSON GA, 1988, J CHEM PHYS, V89, P2193, DOI 10.1063/1.455064
   Petridis L, 2011, PHYS REV E, V83, DOI 10.1103/PhysRevE.83.061911
   Petridis L, 2009, J COMPUT CHEM, V30, P457, DOI 10.1002/jcc.21075
   Ralph John, 2004, Phytochemistry Reviews, V3, P29, DOI 10.1023/B:PHYT.0000047809.65444.a4
   Reddy MSS, 2005, P NATL ACAD SCI USA, V102, P16573, DOI 10.1073/pnas.0505749102
   Repasky MP, 2002, J COMPUT CHEM, V23, P1601, DOI 10.1002/jcc.10162
   Rocha GB, 2006, J COMPUT CHEM, V27, P1101, DOI 10.1002/jcc.20425
   Rodrigo CP, 2011, J AM CHEM SOC, V133, P2632, DOI 10.1021/ja109218j
   Russell WR, 2006, BIOMACROMOLECULES, V7, P268, DOI 10.1021/bm050636o
   Russell WR, 1996, ARCH BIOCHEM BIOPHYS, V332, P357, DOI 10.1006/abbi.1996.0353
   Sarkanen K. V., 1971, LIGNINS OCCURRENCE F
   Schulz R, 2009, J CHEM THEORY COMPUT, V5, P2798, DOI 10.1021/ct900292r
   Selig MJ, 2007, BIOTECHNOL PROGR, V23, P1333, DOI 10.1021/bp0702018
   Senn HM, 2007, CURR OPIN CHEM BIOL, V11, P182, DOI 10.1016/j.cbpa.2007.01.684
   Senn HM, 2009, ANGEW CHEM INT EDIT, V48, P1198, DOI 10.1002/anie.200802019
   Sousa SF, 2007, J PHYS CHEM A, V111, P10439, DOI 10.1021/jp0734474
   Srinivas G, 2011, J CHEM THEORY COMPUT, V7, P2539, DOI 10.1021/ct200181t
   Stewart JJP, 2007, J MOL MODEL, V13, P1173, DOI 10.1007/s00894-007-0233-4
   STEWART JJP, 1989, J COMPUT CHEM, V10, P209, DOI 10.1002/jcc.540100208
   Tozzini V, 2005, CURR OPIN STRUC BIOL, V15, P144, DOI 10.1016/j.sbi.2005.02.005
   Wadenback J, 2004, HOLZFORSCHUNG, V58, P107, DOI 10.1515/HF.2004.015
   WARSHEL A, 1976, J MOL BIOL, V103, P227, DOI 10.1016/0022-2836(76)90311-9
   WHETTEN R, 1995, PLANT CELL, V7, P1001
   Whetten RW, 1998, ANNU REV PLANT PHYS, V49, P585, DOI 10.1146/annurev.arplant.49.1.585
   Zhao Y, 2006, J CHEM THEORY COMPUT, V2, P364, DOI 10.1021/ct0502763
   Zhao Y, 2008, THEOR CHEM ACC, V120, P215, DOI 10.1007/s00214-007-0310-x
   Zhao Y, 2008, ACCOUNTS CHEM RES, V41, P157, DOI 10.1021/ar700111a
NR 80
TC 21
Z9 22
U1 4
U2 60
PU WILEY-BLACKWELL
PI MALDEN
PA COMMERCE PLACE, 350 MAIN ST, MALDEN 02148, MA USA
SN 1944-7442
J9 ENVIRON PROG SUSTAIN
JI Environ. Prog. Sustain. Energy
PD APR
PY 2012
VL 31
IS 1
BP 47
EP 54
DI 10.1002/ep.10628
PG 8
WC GREEN & SUSTAINABLE SCIENCE & TECHNOLOGY; Engineering, Environmental;
   Engineering, Chemical; Environmental Sciences
SC Science & Technology - Other Topics; Engineering; Environmental Sciences
   & Ecology
GA 875NG
UT WOS:000299037100006
DA 2018-10-19
ER

PT J
AU Unukovych, D
   Khrapach, V
   Wickman, M
   Liljegren, A
   Mishalov, V
   Patlazhan, G
   Sandelin, K
AF Unukovych, Dmytro
   Khrapach, Vasyl
   Wickman, Marie
   Liljegren, Annelie
   Mishalov, Volodymyr
   Patlazhan, Gennadiy
   Sandelin, Kerstin
TI Polyacrylamide Gel Injections for Breast Augmentation: Management of
   Complications in 106 Patients, a Multicenter Study
SO WORLD JOURNAL OF SURGERY
LA English
DT Article
ID SOFT-TISSUE AUGMENTATION; HYDROGEL; CANCER; MAMMAPLASTY
AB Polyacrylamide gel (PAAG) was first manufactured in Ukraine in the late 1980s and introduced as a biomaterial for "breast augmentation without surgery." Since it is prohibited in most countries, PAAG injections are rare nowadays, but their consequences and long-term complications can be crucial.
   We identified 106 patients consecutively operated on for PAAG complications at three teaching Ukrainian hospitals between 1998 and 2009. All relevant sociodemographic, clinical, and treatment characteristics were collected. Forty-five (42%) patients were available for clinical follow-up.
   The majority (88%) had had bilateral PAAG injections. The mean volume of injected PAAG was 230 ml/breast (range = 50-400). Mean age at injection was 29 years (range = 17-49) and the mean time from the injection to complications was 6.1 years (SD = 4.1). Symptoms preceding debridement were pain in 85 patients (80%), breast hardening in 79 (74%), breast deformity in 77 (73%), lumps in 57 (54%), gel migration in 39 (37%), fistulas in 17 (16%), and gel leakage in 12 (11%). The surgical interventions in 199 breasts included gel evacuation alone in 107 (54%) or in combination with partial mastectomy in 65 (33%), partial mastectomy and partial pectoralis muscle resection in 12 (6%), or subcutaneous mastectomy in 15 (7%). Of the 199 operated breasts, 86 (43%) immediate and 58 (29%) delayed implant-based breast reconstructions were performed.
   Injections of PAAG can cause irreversible damage to the breast necessitating complex debridement procedures, even mastectomy and breast reconstruction. Despite numerous surgical interventions, gel remnants are still found on subsequent breast imaging. Although PAAG is prohibited in many countries, different types of injections with unknown long-term effects are currently being used. Making the public aware of the problems of injectables for breast augmentation is warranted.
C1 [Unukovych, Dmytro; Wickman, Marie; Sandelin, Kerstin] Karolinska Inst, Dept Mol Med & Surg, Stockholm, Sweden.
   [Unukovych, Dmytro; Khrapach, Vasyl; Mishalov, Volodymyr] Natl OO Bohomolets Med Univ, Dept Surg 4, Kiev, Ukraine.
   [Khrapach, Vasyl] Oleksandrivska City Clin Hosp, Dept Reconstruct Plast Surg, Kiev, Ukraine.
   [Wickman, Marie] Karolinska Univ Hosp, Dept Reconstruct Plast Surg, Stockholm, Sweden.
   [Liljegren, Annelie] Karolinska Inst, Dept Oncol Pathol, Stockholm, Sweden.
   [Liljegren, Annelie] Karolinska Univ Hosp, Dept Oncol, Stockholm, Sweden.
   [Patlazhan, Gennadiy] Odessa State Med Univ, Dept Reconstruct & Aesthet Med, Odessa, Ukraine.
   [Sandelin, Kerstin] Karolinska Univ Hosp, Dept Breast & Endocrine Surg, Stockholm, Sweden.
RP Unukovych, D (reprint author), Karolinska Inst, Dept Mol Med & Surg, Stockholm, Sweden.
EM dmytro.unukovych@ki.se
OI Unukovych, Dmytro/0000-0002-1357-9125; Mishalov,
   Vladimir/0000-0001-7263-7375; wickman chantereau,
   marie/0000-0001-5985-8579
CR Abdallah Abdallah, 2009, Gynaekologisch-Geburtshilfliche Rundschau, V49, P35, DOI 10.1159/000184444
   [Anonymous], 2005, INT J TOXICOL S2, V24, P21
   Brandberg Y, 1999, SCAND J PLAST RECONS, V33, P209
   Chasan PE, 2007, PLAST RECONSTR SURG, V120, P2034, DOI 10.1097/01.prs.0000267580.92163.33
   Chasan PE, 2007, PLAST RECONSTR SURG, V120, P2041
   Cheng NX, 2011, AESTHET PLAST SURG, V35, P365, DOI 10.1007/s00266-010-9617-4
   Cheng NX, 2009, AESTHET PLAST SURG, V33, P563, DOI 10.1007/s00266-008-9298-4
   Cheng NX, 2006, AESTHET PLAST SURG, V30, P215, DOI 10.1007/s00266-005-0081-5
   Cheng NX, 2002, AESTHET PLAST SURG, V26, P375, DOI 10.1007/s00266-002-2052
   Cheung K, 2009, EQ 5D USER GUIDE BAS
   Christensen LH, 2003, PLAST RECONSTR SURG, V111, P1883, DOI 10.1097/01.PRS.0000056873.87165.5A
   *EUROQOL GROUP, 1990, HLTH POLICY, V16, P199, DOI DOI 10.1016/0168-8510(90)90421-9
   Golicki D, 2010, POL ARCH MED WEWN, V120, P276
   Lee CJ, 2004, PLAST RECONSTR SURG, V114, P1967, DOI 10.1097/01.PRS.0000143922.64916.B3
   Lemperle G, 2006, PLAST RECONSTR SURG, V118, p92S, DOI 10.1097/01.prs.0000234672.69287.77
   Lui CY, 2008, AM J ROENTGENOL, V191, P677, DOI 10.2214/AJR.07.2733
   Luo SK, 2011, J PLAST RECONSTR AES, V64, P731, DOI 10.1016/j.bjps.2010.10.004
   Novaes WD, 2003, AESTHET PLAST SURG, V27, P376, DOI 10.1007/s00266-003-2119-x
   Pallua N, 2010, PLAST RECONSTR SURG, V125, P1797, DOI 10.1097/PRS.0b013e3181d18158
   Qiao Q, 2005, AESTHET PLAST SURG, V29, P156, DOI 10.1007/s00266-004-0099-0
   Qiao Q, 2005, AESTHET PLAST SURG, V29, P162
   Teo SY, 2008, AM J ROENTGENOL, V191, pW89, DOI 10.2214/AJR.07.3616
   WEWERS ME, 1990, RES NURS HEALTH, V13, P227, DOI 10.1002/nur.4770130405
   Xiao ZB, 2008, J PLAST RECONSTR AES, V61, P981, DOI 10.1016/j.bjps.2008.01.003
   Xu LY, 2006, CHINESE MED J-PEKING, V119, P1311
   Zarini E, 2004, PLAST RECONSTR SURG, V114, P934, DOI 10.1097/01.PRS.0000133125.22598
NR 26
TC 15
Z9 17
U1 0
U2 10
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 0364-2313
J9 WORLD J SURG
JI World J.Surg.
PD APR
PY 2012
VL 36
IS 4
BP 695
EP 701
DI 10.1007/s00268-011-1273-6
PG 7
WC Surgery
SC Surgery
GA 909UR
UT WOS:000301591200001
PM 21932147
DA 2018-10-19
ER

PT J
AU Grandfield, K
   Palmquist, A
   Engqvist, H
AF Grandfield, Kathryn
   Palmquist, Anders
   Engqvist, Hakan
TI High-resolution three-dimensional probes of biomaterials and their
   interfaces
SO PHILOSOPHICAL TRANSACTIONS OF THE ROYAL SOCIETY A-MATHEMATICAL PHYSICAL
   AND ENGINEERING SCIENCES
LA English
DT Review
DE electron tomography; interface; hydroxyapatite; bone; titanium dioxide;
   implant interface
ID TRANSMISSION ELECTRON-MICROSCOPY; HYDROXYAPATITE-BONE INTERFACE; 3
   DIMENSIONS; IN-VIVO; PHOSPHATE CERAMICS; MATERIALS SCIENCE; IMPLANT
   SURFACES; TOMOGRAPHY; TITANIUM; RECONSTRUCTION
AB Interfacial relationships between biomaterials and tissues strongly influence the success of implant materials and their long-term functionality. Owing to the inhomogeneity of biological tissues at an interface, in particular bone tissue, two-dimensional images often lack detail on the interfacial morphological complexity. Furthermore, the increasing use of nanotechnology in the design and production of biomaterials demands characterization techniques on a similar length scale. Electron tomography (ET) can meet these challenges by enabling high-resolution three-dimensional imaging of biomaterial interfaces. In this article, we review the fundamentals of ET and highlight its recent applications in probing the three-dimensional structure of bioceramics and their interfaces, with particular focus on the hydroxyapatite-bone interface, titanium dioxide-bone interface and a mesoporous titania coating for controlled drug release.
C1 [Grandfield, Kathryn; Engqvist, Hakan] Uppsala Univ, Dept Engn Sci, Angstrom Lab, S-75121 Uppsala, Sweden.
   [Palmquist, Anders] Univ Gothenburg, Sahlgrenska Acad, Dept Biomat, S-40530 Gothenburg, Sweden.
RP Grandfield, K (reprint author), Uppsala Univ, Dept Engn Sci, Angstrom Lab, S-75121 Uppsala, Sweden.
EM kathryn.grandfield@angstrom.uu.se
RI Palmquist, Anders/D-2171-2014
OI Engqvist, Hakan/0000-0001-9529-650X; Grandfield,
   Kathryn/0000-0002-0188-9580
FU VINNOVA of Sweden; IBCT; Natural Sciences and Engineering Research
   Council of Canada
FX The members of the Institute for Biomaterials and Cell Therapy (IBCT),
   Gothenburg, Sweden and the Canadian Centre for Electron Microscopy,
   Hamilton, Ontario, Canada are gratefully acknowledged for stimulating
   discussions, provision of samples or assistance with data acquisition.
   Financial support has been provided by the VINNOVA VinnVaxt Programme of
   Sweden, IBCT and the Natural Sciences and Engineering Research Council
   of Canada.
CR ADELL R, 1981, INT J ORAL MAXILLOF, V10, P387, DOI 10.1016/S0300-9785(81)80077-4
   Albrektsson T, 2004, INT J PROSTHODONT, V17, P536
   Aspenberg P, 2009, ACTA ORTHOP, V80, P119, DOI 10.1080/17453670902807466
   Attwood D, 2006, J BIOMED NANOTECHNOL, V2, P75, DOI 10.1166/jbn.2006.011
   Baumeister W, 1999, TRENDS CELL BIOL, V9, P81, DOI 10.1016/S0962-8924(98)01423-8
   Baumeister W, 2005, PROTEIN SCI, V14, P257, DOI 10.1110/ps.041148605
   Baumeister W, 2002, CURR OPIN STRUC BIOL, V12, P679, DOI 10.1016/S0959-440X(02)00378-0
   BERRIMAN J, 1984, ULTRAMICROSCOPY, V13, P351, DOI 10.1016/0304-3991(84)90001-9
   Bonfield W, 2006, PHILOS T ROY SOC A, V364, P227, DOI 10.1098/rsta.2005.1692
   Branemark R, 2011, NANOMED-NANOTECHNOL, V7, P220, DOI 10.1016/j.nano.2010.10.006
   Chen W, 2007, ELECTROCHEM COMMUN, V9, P382, DOI 10.1016/j.elecom.2006.10.002
   CROWTHER RA, 1970, PROC R SOC LON SER-A, V317, P319, DOI 10.1098/rspa.1970.0119
   DACULSI G, 1990, CALCIFIED TISSUE INT, V46, P20, DOI 10.1007/BF02555820
   DEBRUIJN JD, 1995, J BIOMED MATER RES, V29, P89, DOI 10.1002/jbm.820290113
   DELANGE GL, 1990, J BIOMED MATER RES, V24, P829, DOI 10.1002/jbm.820240704
   Deligianni DD, 2001, BIOMATERIALS, V22, P87, DOI 10.1016/S0142-9612(00)00174-5
   DEROSIER DJ, 1968, NATURE, V217, P130, DOI 10.1038/217130a0
   Dey A, 2010, NAT MATER, V9, P1010, DOI 10.1038/NMAT2900
   Ducheyne P, 1999, BIOMATERIALS, V20, P2287, DOI 10.1016/S0142-9612(99)00181-7
   Engqvist H, 2006, J BIOMED MATER RES A, V78A, P20, DOI 10.1002/jbm.a.30696
   Engqvist H, 2008, J MATER SCI-MATER M, V19, P467, DOI 10.1007/s10856-006-0042-9
   Flannigan DJ, 2010, P NATL ACAD SCI USA, V107, P9933, DOI 10.1073/pnas.1005653107
   Frank J., 2006, ELECT TOMOGRAPHY MET
   Fujita R, 2003, TISSUE CELL, V35, P427, DOI 10.1016/S0040-8166(03)00067-3
   GILBERT P, 1972, J THEOR BIOL, V36, P105, DOI 10.1016/0022-5193(72)90180-4
   GORDON R, 1974, INT REV CYTOL, V38, P111, DOI 10.1016/S0074-7696(08)60925-0
   Grandfield K, 2010, J R SOC INTERFACE, V7, P1497, DOI 10.1098/rsif.2010.0213
   Grandfield K, 2012, CLIN IMPLANT DENT R, V14, P461, DOI 10.1111/j.1708-8208.2009.00270.x
   Hagberg K, 2009, J REHABIL RES DEV, V46, P331, DOI 10.1682/JRRD.2008.06.0080
   Hallan G, 2007, J BONE JOINT SURG BR, V89B, P1574, DOI 10.1302/0301-620X.89B12.18969
   HART RG, 1968, SCIENCE, V159, P1464, DOI 10.1126/science.159.3822.1464
   Hawkes P., 1992, ELECT TOMOGRAPHY 3 D, P17
   Hemmerle J, 1997, J DENT RES, V76, P682, DOI 10.1177/00220345970760020901
   Hohmann-Marriott MF, 2009, NAT METHODS, V6, P729, DOI [10.1038/NMETH.1367, 10.1038/nmeth.1367]
   Jarmar T, 2008, J BIOMED MATER RES A, V87A, P1003, DOI 10.1002/jbm.a.31856
   Jones AC, 2009, BIOMATERIALS, V30, P1440, DOI 10.1016/j.biomaterials.2008.10.056
   Kwon OH, 2010, SCIENCE, V328, P1668, DOI 10.1126/science.1190470
   Landis WJ, 1996, J STRUCT BIOL, V117, P24, DOI 10.1006/jsbi.1996.0066
   LANDIS WJ, 1993, J STRUCT BIOL, V110, P39, DOI 10.1006/jsbi.1993.1003
   Landis WJ, 1996, MICROSC RES TECHNIQ, V33, P192
   LAWRENCE MC, 1992, ELECT TOMOGRAPHY 3 D, P197, DOI DOI 10.1007/978-1-4757-2163-8_8
   Leapman RD, 2004, ULTRAMICROSCOPY, V100, P115, DOI 10.1016/j.ultramic.2004.03.002
   LeGeros RZ, 2002, CLIN ORTHOP RELAT R, P81
   Leng Y, 2003, BIOMATERIALS, V24, P2125, DOI 10.1016/S0142-9612(03)00036-X
   Li HY, 2009, SCIENCE, V326, P1244, DOI 10.1126/science.1178583
   Liu XY, 2004, MAT SCI ENG R, V47, P49, DOI 10.1016/j.mser.2004.11.001
   Malmstrom J, 2008, J MATER SCI-MATER M, V19, P2983, DOI 10.1007/s10856-007-3045-2
   Mareau VH, 2007, MACROMOLECULES, V40, P9032, DOI 10.1021/ma070906q
   Midgley PA, 2003, ULTRAMICROSCOPY, V96, P413, DOI 10.1016/S0304-3991(03)00105-0
   Midgley PA, 2009, NAT MATER, V8, P271, DOI 10.1038/nmat2406
   Mobus G, 2007, MATER TODAY, V10, P18, DOI 10.1016/S1369-7021(07)70304-8
   Nudelman F, 2010, NAT MATER, V9, P1004, DOI 10.1038/NMAT2875
   Okuda M, 2010, J ELECTRON MICROSC, V59, P173, DOI 10.1093/jmicro/dfp055
   Palmquist A, 2012, J R SOC INTERFACE, V9, P396, DOI 10.1098/rsif.2011.0420
   Palmquist A, 2011, J BIOMED MATER RES B, V97B, P289, DOI 10.1002/jbm.b.31814
   Palmquist A, 2010, J BIOMED MATER RES A, V92A, P1476, DOI 10.1002/jbm.a.32439
   PENCZEK P, 1995, ULTRAMICROSCOPY, V60, P393, DOI 10.1016/0304-3991(95)00078-X
   Peter B, 2006, J BIOMED MATER RES A, V76A, P133, DOI 10.1002/jbm.a.30456
   Porter AE, 2002, BIOMATERIALS, V23, P725, DOI 10.1016/S0142-9612(01)00177-6
   Porter AE, 2006, MICRON, V37, P681, DOI 10.1016/j.micron.2006.03.006
   Radermacher M., 2006, ELECT TOMOGRAPHY MET, P245
   Sousa AA, 2011, J STRUCT BIOL, V174, P107, DOI 10.1016/j.jsb.2010.10.017
   Tengvall P, 2004, BIOMATERIALS, V25, P2133, DOI 10.1016/j.biomaterials.2003.08.049
   Weiss P, 2003, BIOMATERIALS, V24, P4591, DOI 10.1016/S0142-9612(03)00335-1
   Weyland M, 2003, MICROSC MICROANAL, V9, P542, DOI 10.1017/S1431927603030162
   Williams DF, 2008, BIOMATERIALS, V29, P2941, DOI 10.1016/j.biomaterials.2008.04.023
   Xin RL, 2005, BIOMATERIALS, V26, P6477, DOI 10.1016/j.biomaterials.2005.04.028
   Xue WC, 2004, BIOMATERIALS, V25, P415, DOI 10.1016/S0142-9612(03)00545-3
   Yan WQ, 1997, J BIOMED MATER RES, V37, P267, DOI 10.1002/(SICI)1097-4636(199711)37:2<267::AID-JBM17>3.0.CO;2-B
   Zehbe R, 2010, J R SOC INTERFACE, V7, P49, DOI 10.1098/rsif.2008.0539
   Zewail AH, 2005, PHILOS T ROY SOC A, V363, P315, DOI 10.1098/rsta.2004.1513
   Zewail AH, 2006, ANNU REV PHYS CHEM, V57, P65, DOI 10.1146/annurev.physchem.57.032905.104748
   Zewail AH, 2010, SCIENCE, V328, P187, DOI 10.1126/science.1166135
NR 73
TC 16
Z9 16
U1 1
U2 17
PU ROYAL SOC
PI LONDON
PA 6-9 CARLTON HOUSE TERRACE, LONDON SW1Y 5AG, ENGLAND
SN 1364-503X
J9 PHILOS T R SOC A
JI Philos. Trans. R. Soc. A-Math. Phys. Eng. Sci.
PD MAR 28
PY 2012
VL 370
IS 1963
SI SI
BP 1337
EP 1351
DI 10.1098/rsta.2011.0253
PG 15
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA 897FN
UT WOS:000300631900004
PM 22349245
OA Bronze
DA 2018-10-19
ER

PT J
AU Gunawidjaja, PN
   Mathew, R
   Lo, AYH
   Izquierdo-Barba, I
   Garcia, A
   Arcos, D
   Vallet-Regi, M
   Eden, M
AF Gunawidjaja, Philips N.
   Mathew, Renny
   Lo, Andy Y. H.
   Izquierdo-Barba, Isabel
   Garcia, Ana
   Arcos, Daniel
   Vallet-Regi, Maria
   Eden, Mattias
TI Local structures of mesoporous bioactive glasses and their surface
   alterations in vitro: inferences from solid-state nuclear magnetic
   resonance
SO PHILOSOPHICAL TRANSACTIONS OF THE ROYAL SOCIETY A-MATHEMATICAL PHYSICAL
   AND ENGINEERING SCIENCES
LA English
DT Article
DE silicate-based biomaterial; biomineralization; magic angle spinning
   Si-29 NMR; cross polarization; surface reactions
ID SIMULATED BODY-FLUID; CROSS-POLARIZATION; CALCIUM PHOSPHATES;
   MOLECULAR-DYNAMICS; APATITE FORMATION; NMR-SPECTROSCOPY; SILICATE GLASS;
   MAS NMR; SI-29; BIOGLASS
AB We review the benefits of using Si-29 and H-1 magic angle spinning (MAS) nuclear magnetic resonance (NMR) spectroscopy for probing the local structures of both bulk and surface portions of mesoporous bioactive glasses (MBGs) of the CaO-SiO2-(P2O5) system. These mesoporous materials exhibit an ordered pore arrangement, and are promising candidates for improved bone and tooth implants. We discuss experimental MAS NMR results from three MBGs displaying different Ca, Si and P contents: the Si-29 NMR spectra were recorded either directly by employing radio-frequency pulses to Si-29, or by magnetization transfers from neighbouring protons using cross polarization, thereby providing quantitative information about the silicate speciation present in the pore wall and at the MBG surface, respectively. The surface modifications were monitored for the three MBGs during their immersion in a simulated body fluid (SBF) for intervals between 30 min and one week. The results were formulated as a reaction sequence describing the interconversions between the distinct silicate species. We generally observed a depletion of Ca2+ ions at the MBG surface, and a minor condensation of the silicate-surface network over one week of SBF soaking.
C1 [Gunawidjaja, Philips N.; Mathew, Renny; Lo, Andy Y. H.; Eden, Mattias] Stockholm Univ, Arrhenius Lab, Dept Mat & Environm Chem, Div Phys Chem, S-10691 Stockholm, Sweden.
   [Izquierdo-Barba, Isabel; Garcia, Ana; Arcos, Daniel; Vallet-Regi, Maria] Univ Complutense Madrid, Fac Farm, Dept Quim Inorgan & Bioinorgan, E-28040 Madrid, Spain.
   [Izquierdo-Barba, Isabel; Garcia, Ana; Arcos, Daniel; Vallet-Regi, Maria] Networking Res Ctr Bioengn Biomat & Nanomed CIBER, Madrid, Spain.
RP Eden, M (reprint author), Stockholm Univ, Arrhenius Lab, Dept Mat & Environm Chem, Div Phys Chem, S-10691 Stockholm, Sweden.
EM mattias.eden@mmk.su.se
RI Vallet-Regi, Maria/M-3378-2014; Mathew, Renny/B-2148-2013; Garcia
   Fontecha, Ana/B-1301-2015; Arcos, Daniel/L-6167-2014; IZQUIERDO-BARBA,
   ISABEL/M-9921-2014
OI Vallet-Regi, Maria/0000-0002-6104-4889; Garcia Fontecha,
   Ana/0000-0002-8792-872X; Arcos, Daniel/0000-0002-5367-7272;
   IZQUIERDO-BARBA, ISABEL/0000-0002-4139-4646; Mathew,
   Renny/0000-0003-4041-2803
FU Swedish Research Council [VR-NT 2009-7551, 20104943]; Faculty of Natural
   Sciences at Stockholm University; Comunidad Autonoma de Madrid
   [S2009/MAT-1472]; Carl Trygger Foundation; Wenner-Gren Foundations;
   CICYT Spain [MAT 200800736]
FX This work was supported by the Swedish Research Council (contracts VR-NT
   2009-7551 and 20104943), the Faculty of Natural Sciences at Stockholm
   University, CICYT Spain (project MAT 200800736) and the Comunidad
   Autonoma de Madrid (project S2009/MAT-1472). P.N.G. and A.Y.H.L. were
   supported by postdoctoral grants from the Carl Trygger Foundation and
   the Wenner-Gren Foundations, respectively.
CR ANDERSSON OH, 1991, J NON-CRYST SOLIDS, V129, P145, DOI 10.1016/0022-3093(91)90090-S
   Baccile N, 2007, CHEM MATER, V19, P1343, DOI 10.1021/cm062545j
   Brinker CJ, 1999, ADV MATER, V11, P579, DOI 10.1002/(SICI)1521-4095(199905)11:7<579::AID-ADMA579>3.0.CO;2-R
   Christiansen SC, 2001, J AM CHEM SOC, V123, P4519, DOI 10.1021/ja004310t
   CHUANG IS, 1993, J AM CHEM SOC, V115, P8695, DOI 10.1021/ja00072a024
   CLARK AE, 1976, J AM CERAM SOC, V59, P37, DOI 10.1111/j.1151-2916.1976.tb09382.x
   Dietrich E, 2009, ADV ENG MATER, V11, pB98, DOI 10.1002/adem.200800400
   Eden M, 2011, J NON-CRYST SOLIDS, V357, P1587, DOI 10.1016/j.jnoncrysol.2010.11.101
   Eden M, 2011, J NON-CRYST SOLIDS, V357, P1595, DOI 10.1016/j.jnoncrysol.2010.11.098
   ENGELHARDT G, 1985, PHYS CHEM GLASSES, V26, P157
   Engelhardt G., 1987, HIGH RESOLUTION SOLI
   Ernst R.R., 1987, PRINCIPLES NUCL MAGN
   Garcia A, 2009, CHEM MATER, V21, P5474, DOI 10.1021/cm9022776
   Grunberg B, 2004, CHEM-EUR J, V10, P5689, DOI 10.1002/chem.200400351
   Gunawidjaja P. N., QUANTIFYING AP UNPUB
   Gunawidjaja PN, 2010, J PHYS CHEM C, V114, P19345, DOI 10.1021/jp105408c
   Hayakawa S, 1999, J AM CERAM SOC, V82, P2155
   HENCH LL, 1991, J AM CERAM SOC, V74, P1487, DOI 10.1111/j.1151-2916.1991.tb07132.x
   Hench LL, 2002, SCIENCE, V295, P1014, DOI 10.1126/science.1067404
   Hill R, 1996, J MATER SCI LETT, V15, P1122, DOI 10.1007/BF00539955
   Izquierdo-Barba I, 2008, CHEM MATER, V20, P3191, DOI DOI 10.1021/CM800172X
   KIM CY, 1989, J NON-CRYST SOLIDS, V113, P195, DOI 10.1016/0022-3093(89)90011-2
   KOKUBO T, 1990, J BIOMED MATER RES, V24, P721, DOI 10.1002/jbm.820240607
   Lebecq I, 2007, J BIOMED MATER RES A, V83A, P156, DOI 10.1002/jbm.a.31228
   Leonova E, 2008, J PHYS CHEM C, V112, P5552, DOI 10.1021/jp7107973
   Liu CHC, 1996, J AM CHEM SOC, V118, P5103, DOI 10.1021/ja954120w
   Lopez-Noriega A, 2006, CHEM MATER, V18, P3137, DOI 10.1021/cm060488o
   Lowenstam HA, 1989, BIOMINERALIZATION
   MACIEL GE, 1980, J AM CHEM SOC, V102, P7606, DOI 10.1021/ja00545a056
   MacKenzie K. J. D., 2002, MULTINUCLEAR SOLID S
   Mathew R, 2011, J PHYS CHEM C, V115, P20572, DOI 10.1021/jp206237n
   METZ G, 1994, J MAGN RESON SER A, V110, P219, DOI 10.1006/jmra.1994.1208
   O'Donnell MD, 2009, J MATER SCI-MATER M, V20, P1611, DOI 10.1007/s10856-009-3732-2
   OGINO M, 1980, J NON-CRYST SOLIDS, V38-9, P673, DOI 10.1016/0022-3093(80)90514-1
   OHTSUKI C, 1992, J NON-CRYST SOLIDS, V143, P84, DOI 10.1016/S0022-3093(05)80556-3
   Pedone A, 2009, J PHYS CHEM C, V113, P20773, DOI 10.1021/jp9071263
   Rahaman MN, 2011, ACTA BIOMATER, V7, P2355, DOI 10.1016/j.actbio.2011.03.016
   Sahai N, 2005, BIOMATERIALS, V26, P5763, DOI 10.1016/j.biomaterials.2005.02.037
   Salinas AJ, 2002, J BIOMED MATER RES, V61, P524, DOI 10.1002/jbm.10229
   Stevels J. M., 1960, PHILIPS TECH RUNDSCH, V9/10, P337
   STRNAD Z, 1992, BIOMATERIALS, V13, P317, DOI 10.1016/0142-9612(92)90056-T
   Tilocca A, 2011, P ROY SOC A-MATH PHY, V467, P2102, DOI 10.1098/rspa.2010.0519
   Tilocca A, 2010, LANGMUIR, V26, P545, DOI 10.1021/la902548f
   Tilocca A, 2009, P ROY SOC A-MATH PHY, V465, P1003, DOI 10.1098/rspa.2008.0462
   Vallet-Regi M, 2003, EUR J INORG CHEM, P1029
   Yan XX, 2006, BIOMATERIALS, V27, P3396, DOI 10.1016/j.biomaterials.2006.01.043
   Yan XX, 2004, ANGEW CHEM INT EDIT, V43, P5980, DOI 10.1002/anie.200460598
   YESINOWSKI JP, 1987, J AM CHEM SOC, V109, P6274, DOI 10.1021/ja00255a009
   Zhang P, 1997, J PHYS CHEM B, V101, P4004, DOI 10.1021/jp9700342
NR 49
TC 31
Z9 31
U1 2
U2 41
PU ROYAL SOC
PI LONDON
PA 6-9 CARLTON HOUSE TERRACE, LONDON SW1Y 5AG, ENGLAND
SN 1364-503X
J9 PHILOS T R SOC A
JI Philos. Trans. R. Soc. A-Math. Phys. Eng. Sci.
PD MAR 28
PY 2012
VL 370
IS 1963
SI SI
BP 1376
EP 1399
DI 10.1098/rsta.2011.0257
PG 24
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA 897FN
UT WOS:000300631900006
PM 22349247
OA Green Published, Other Gold
DA 2018-10-19
ER

PT J
AU Rimola, A
   Corno, M
   Garza, J
   Ugliengo, P
AF Rimola, Albert
   Corno, Marta
   Garza, Jorge
   Ugliengo, Piero
TI Ab initio modelling of protein-biomaterial interactions: influence of
   amino acid polar side chains on adsorption at hydroxyapatite surfaces
SO PHILOSOPHICAL TRANSACTIONS OF THE ROYAL SOCIETY A-MATHEMATICAL PHYSICAL
   AND ENGINEERING SCIENCES
LA English
DT Article
DE ab initio calculations; hydroxyapatite; amino acids; adsorption at
   surfaces
ID SOLID-STATE NMR; DRUG-DELIVERY; 01(1)OVER-BAR0 SURFACES; CALCIUM
   HYDROXYAPATITES; CONFORMATIONAL-CHANGES; GLYCINE ADSORPTION;
   CITRIC-ACID; STATHERIN; CRYSTALS; DYNAMICS
AB The adsorption from the gas phase of five different amino acids (AAs), namely Gly, Ser, Lys, Gln and Glu, on three surface models of hexagonal hydroxyapatite (HA) has been studied at B3LYP level with Gaussian type basis set within a periodic approach. The AA adsorption was simulated on the (001) and (010) stoichiometric surfaces, the latter both in its pristine and water-reacted form. Low/high AA coverage has been studied by doubling the HA unit cell size. The AAs have been docked to the HA surfaces following the electrostatic complementarity between the electrostatic potentials of AA and the bare HA. Gly adsorbs as a zwitterion at the (001) surface, whereas at the (010) ones, the proton of the COOH group is transferred to the surface resulting in an HA(+)/Gly(-) ion pair. For the other AAs, the common COOH-CH-NH2 moiety behaves like in Gly, while the specific side-chain functionalities adsorb at the HA surfaces by maximizing electrostatic and H-bond interactions. The interactions between the side chains and the HA surface impart a higher stability compared with the Gly case, with Glu being the strongest adsorbate owing to its high Ca affinity and H-bond donor propensity. For AAs of large size, the adsorption is more favourable in conditions of low coverage as repulsion between adjacent AAs is avoided. For all considered AAs, the strongest interaction is always established on the (010) faces rather than on the (001) one, therefore suggesting an easier growth along the c-direction of HA crystals from AA solutions.
C1 [Rimola, Albert; Corno, Marta; Ugliengo, Piero] Univ Turin, Dipartimento Chim IFM, NIS Ctr Excellence, I-10125 Turin, Italy.
   [Rimola, Albert; Corno, Marta; Ugliengo, Piero] Univ Turin, INSTM Mat Sci & Technol Natl Consortium, I-10125 Turin, Italy.
   [Rimola, Albert] Univ Autonoma Barcelona, Dept Quim, Bellaterra 08193, Spain.
   [Garza, Jorge] Univ Autonoma Metropolitana Iztapalapa, Dept Quim, Div Ciencias Basicas & Ingn, Mexico City 09340, DF, Mexico.
RP Ugliengo, P (reprint author), Univ Turin, Dipartimento Chim IFM, NIS Ctr Excellence, Via Pietro Giuria 7, I-10125 Turin, Italy.
EM piero.ugliengo@unito.it
RI Garza-Olguin, Jorge/N-3106-2016; ugliengo, piero/H-6373-2015; Rimola,
   Albert/K-1813-2014; Garza, Jorge/H-9395-2016; Corno, Marta/I-4310-2012
OI Garza-Olguin, Jorge/0000-0003-4249-6078; ugliengo,
   piero/0000-0001-8886-9832; Rimola, Albert/0000-0002-9637-4554; Garza,
   Jorge/0000-0003-4249-6078; Corno, Marta/0000-0001-7248-2705
FU MIUR [COFIN2006, Prot. 2006032335_005]; Regione Piemonte (Bando ricerca
   scientifica Piemonte 2004, Settore: Nanotecnologie e nanoscienze,
   'Materiali nanostrutturati biocompatibili per applicazioni biomediche');
   MICINN [CTQ2008-06381/BQU]
FX A.R. is indebted to 'Comissionat per a Universitats I Recerca del
   Deprtament D'Innovacio, Universitats I Empresa de la Generalitat de
   Catalunya'. Financial support from MIUR (Project COFIN2006, Prot.
   2006032335_005), from the Regione Piemonte (Bando ricerca scientifica
   Piemonte 2004, Settore: Nanotecnologie e nanoscienze, 'Materiali
   nanostrutturati biocompatibili per applicazioni biomediche'), and from
   MICINN through the CTQ2008-06381/BQU project is gratefully acknowledged.
   P.U. kindly acknowledges BSC-MN for the generous allowance of computing
   time through the 'BCV-2008-2-0013: Simulation of peptide folding induced
   by inorganic materials' and 'BCV-2008-3-0013: Simulation of peptide
   folding induced by inorganic materials II' projects.
CR Almora-Barrios N, 2009, LANGMUIR, V25, P5018, DOI 10.1021/la803842g
   Astala R, 2008, PHYS REV B, V78, DOI 10.1103/PhysRevB.78.075427
   BECKE AD, 1993, J CHEM PHYS, V98, P5648, DOI 10.1063/1.464913
   Brandes N, 2006, J COLLOID INTERF SCI, V299, P56, DOI 10.1016/j.jcis.2006.01.065
   Capriotti LA, 2007, J AM CHEM SOC, V129, P5281, DOI 10.1021/ja070356b
   Chen PH, 2008, J AM CHEM SOC, V130, P2862, DOI 10.1021/ja076607y
   Chen X, 2007, J PHYS CHEM C, V111, P1284, DOI 10.1021/jp0646630
   Civalleri B, 2008, CRYSTENGCOMM, V10, P405, DOI 10.1039/b715018k
   Corno M, 2007, EUR J MINERAL, V19, P757, DOI 10.1127/0935-1221/2007/0019-1764
   Corno M, 2006, PHYS CHEM CHEM PHYS, V8, P2464, DOI 10.1039/b602419j
   Corno M, 2010, PHYS CHEM CHEM PHYS, V12, P6309, DOI 10.1039/c002146f
   Corno M, 2009, LANGMUIR, V25, P2188, DOI 10.1021/la803253k
   Corral I, 2006, CHEM-EUR J, V12, P6787, DOI 10.1002/chem.200600127
   de Leeuw NH, 2007, CRYSTENGCOMM, V9, P1178, DOI 10.1039/b710974a
   De M, 2008, ADV MATER, V20, P4225, DOI 10.1002/adma.200703183
   Dovesi R., 2006, CRYSTAL06 USERS MANU
   Elangovan S, 2007, LANGMUIR, V23, P11200, DOI 10.1021/la7013978
   FH Jones, 2001, SURF SCI REP, V42, P75, DOI DOI 10.1016/S0167-5729(00)00011-X
   Filgueiras MRT, 2006, J CRYST GROWTH, V294, P60, DOI 10.1016/j.jcrysgro.2006.05.077
   Gibson JM, 2006, J AM CHEM SOC, V128, P5364, DOI 10.1021/ja056731m
   Goobes G, 2007, MAGN RESON CHEM, V45, pS32, DOI 10.1002/mrc.2123
   Goobes R, 2006, BIOCHEMISTRY-US, V45, P5576, DOI 10.1021/bi052321z
   Goobes R, 2007, BIOCHEMISTRY-US, V46, P4725, DOI 10.1021/bi602345a
   Gray JJ, 2004, CURR OPIN STRUC BIOL, V14, P110, DOI 10.1016/j.sbi.2003.12.001
   Grimme S, 2006, J COMPUT CHEM, V27, P1787, DOI 10.1002/jcc.20495
   GROSS D, 1955, J AM CHEM SOC, V77, P1678, DOI 10.1021/ja01611a085
   Hench LL, 2002, SCIENCE, V295, P1014, DOI 10.1126/science.1067404
   Hench LL, 1971, J BIOMED MATER RES S, V2, P117, DOI DOI 10.1002/JBM.820050611
   Hudson S, 2008, ANGEW CHEM INT EDIT, V47, P8582, DOI 10.1002/anie.200705238
   Kandori K, 2000, LANGMUIR, V16, P2301, DOI 10.1021/la9906424
   Kandori K, 2000, PHYS CHEM CHEM PHYS, V2, P2015, DOI 10.1039/a909396f
   Kandori K, 2007, LANGMUIR, V23, P2064, DOI 10.1021/la062562n
   Kirkham J, 2002, CURR OPIN COLLOID IN, V7, P124, DOI 10.1016/S1359-0294(02)00017-1
   Koutsopoulos S, 2000, J CRYST GROWTH, V216, P443, DOI 10.1016/S0022-0248(00)00415-2
   LEE CT, 1988, PHYS REV B, V37, P785, DOI 10.1103/PhysRevB.37.785
   LeGeros RZ, 2008, CHEM REV, V108, P4742, DOI 10.1021/cr800427g
   Linder R, 2005, CHEM PHYS LETT, V409, P260, DOI 10.1016/j.cplett.2005.04.109
   Linder R, 2008, CHEM PHYS LETT, V453, P1, DOI 10.1016/j.cplett.2007.12.069
   Long JR, 2001, BIOCHEMISTRY-US, V40, P15451, DOI 10.1021/bi010864c
   Makrodimitris K, 2007, J AM CHEM SOC, V129, P13713, DOI 10.1021/ja074602v
   Meng M, 2004, LANGMUIR, V20, P914, DOI 10.1021/la035336b
   Mkhonto D, 2002, J MATER CHEM, V12, P2633, DOI 10.1039/b204111a
   Morgan TT, 2008, NANO LETT, V8, P4108, DOI 10.1021/nl8019888
   Palazzo B, 2007, ADV FUNCT MATER, V17, P2180, DOI 10.1002/adfm.200600361
   Palmer LC, 2008, CHEM REV, V108, P4754, DOI 10.1021/cr8004422
   Pareek A, 2009, LANGMUIR, V25, P1453, DOI 10.1021/la802706y
   Ratner B. D., 2004, BIOMATERIAL SCI INTR
   Rimola A, 2011, J PHYS CHEM LETT, V2, P1390, DOI 10.1021/jz200457x
   Rimola A, 2009, PHYS CHEM CHEM PHYS, V11, P9005, DOI 10.1039/b913311a
   Rimola A, 2008, J AM CHEM SOC, V130, P16181, DOI 10.1021/ja806520d
   Rosseeva EV, 2007, GLASS PHYS CHEM+, V33, P283, DOI 10.1134/S1087659607030170
   Sato K, 2002, J AM CERAM SOC, V85, P3054
   Shafei G. ?M., 2001, J COLLOID INTERF SCI, V238, P160, DOI DOI 10.1006/JCIS.2001.7474
   Shaw WJ, 2004, J BIOL CHEM, V279, P40263, DOI 10.1074/jbc.C400322200
   Shaw WJ, 2000, J AM CHEM SOC, V122, P1709, DOI 10.1021/ja9842823
   Shen JW, 2008, BIOMATERIALS, V29, P513, DOI 10.1016/j.biomaterials.2007.10.016
   SIMMER JP, 1995, CRIT REV ORAL BIOL M, V6, P84, DOI 10.1177/10454411950060020701
   Vallet-Regi M, 2004, PROG SOLID STATE CH, V32, P1, DOI 10.1016/j.progsolidstchem.2004.07.001
   Vallet-Regi M, 2007, ANGEW CHEM INT EDIT, V46, P7548, DOI 10.1002/anie.200604488
   VoDinh T, 2007, NANOTECHNOLOGY IN BIOLOGY AND MEDICINE: METHODS, DEVICES, AND APPLICATIONS, P1
   Wallwork ML, 2001, LANGMUIR, V17, P2508, DOI 10.1021/la001281r
NR 61
TC 20
Z9 21
U1 4
U2 45
PU ROYAL SOC
PI LONDON
PA 6-9 CARLTON HOUSE TERRACE, LONDON SW1Y 5AG, ENGLAND
SN 1364-503X
J9 PHILOS T R SOC A
JI Philos. Trans. R. Soc. A-Math. Phys. Eng. Sci.
PD MAR 28
PY 2012
VL 370
IS 1963
SI SI
BP 1478
EP 1498
DI 10.1098/rsta.2011.0236
PG 21
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA 897FN
UT WOS:000300631900011
PM 22349252
OA Bronze
DA 2018-10-19
ER

PT J
AU Chen, G
   Wang, ZY
   Wang, H
   Zhao, XL
   Hu, J
   Wang, SH
   Zhang, SF
AF Chen, Gang
   Wang, Zhongyi
   Wang, Hui
   Zhao, Xiaolin
   Hu, Jiang
   Wang, Shaohai
   Zhang, Shaofeng
TI Effects of tetrahedral amorphous carbon film deposited on dental
   cobalt-chromium alloys on bacterial adhesion
SO SURFACE & COATINGS TECHNOLOGY
LA English
DT Article
DE Cobalt-chromium alloy; Tetrahedral amorphous carbon film; Surface
   roughness; Surface free energy; Bacterial adhesion
ID DIAMOND-LIKE CARBON; FILTERED CATHODIC VACUUM; SURFACE FREE-ENERGY;
   BIOMEDICAL APPLICATIONS; STREPTOCOCCUS-MUTANS; RAMAN-SPECTROSCOPY;
   BIOFILM FORMATION; DLC COATINGS; ION ENERGY; ARC
AB The dental cobalt-chromium alloys are an important biomaterial used in making artificial dentures. Bacterial adhesion to cobalt-chromium alloys usually results in severe complications such as periodontal infection, secondary caries, and denture stomatitis, which have severe adverse impacts on human health. Therefore, an effective method is needed to reduce the bacterial adhesion to dental cobalt-chromium alloys. The aim of this study was to investigate the effects of ta-C films deposited on a dental cobalt-chromium alloy on the adhesion of Streptococcus mutans (ATCC175), Actinomyces viscosus (ATCC19246) and Candida albicans (ATCC76615). A filtered cathodic vacuum arc (FCVA) technique was used to coat the cobalt-chromium alloy with a ta-C film. Atomic force microscopy (AFM), Raman spectroscopy and X-ray photoelectron spectroscopy (XPS) were used to analyze the surface characteristics of the coating. Surface roughness was detected. Surface free energy and its components were calculated by measuring the contact angle. The results showed that the maximum sp(3) fraction was achieved at 200 V substrate bias voltage. Compared with uncoated specimens, the ta-C film coated specimens had a lower surface roughness, a higher surface energy and a higher hydrophilicity. Most importantly, the adhesion of the three tested bacterial strains to the ta-C film coated cobalt-chromium alloy was significantly decreased. These results showed that ta-C film surface treatment could significantly reduce the bacterial adhesion to dental cobalt-chromium alloys, suggesting the potential of ta-C film surface treatment in artificial denture applications. (C) 2012 Elsevier B.V. All rights reserved.
C1 [Wang, Shaohai] Second Mil Med Univ, Dept Stomatol, Changhai Hosp, Shanghai 200433, Peoples R China.
   [Chen, Gang; Wang, Zhongyi; Wang, Hui; Zhang, Shaofeng] Fourth Mil Med Univ, Sch Stomatol, Dept Prosthodont, Xian 710032, Shaanxi Provinc, Peoples R China.
   [Chen, Gang; Zhao, Xiaolin] PLA, Hosp 32, Dept Stomatol, Xian 710054, Shaanxi Provinc, Peoples R China.
   [Hu, Jiang] Jilin Med Coll, Dept Stomatol, Affiliated Hosp, Changchun 132013, Jilin Province, Peoples R China.
RP Wang, SH (reprint author), Second Mil Med Univ, Dept Stomatol, Changhai Hosp, 168 Changhai Rd, Shanghai 200433, Peoples R China.
EM wangshaohai767@hotmail.com; chengang81146158@163.com
FU National Natural Science Foundation of China [30901699]
FX This work was in part supported by National Natural Science Foundation
   of China (30901699). The authors gratefully thank School of Electronic
   and Information Engineering at Xi'an Jiaotong University in China for
   the technical support.
CR Bollen CML, 1997, DENT MATER, V13, P258, DOI 10.1016/S0109-5641(97)80038-3
   Boxman RL, 1996, SURF COAT TECH, V86, P243, DOI 10.1016/S0257-8972(96)03023-X
   Bridgeport D A, 1993, J Prosthodont, V2, P144, DOI 10.1111/j.1532-849X.1993.tb00398.x
   Buergers R, 2007, J PROSTHET DENT, V98, P461, DOI 10.1016/S0022-3913(07)60146-2
   Busscher HJ, 2010, J DENT RES, V89, P657, DOI 10.1177/0022034510368644
   Capano MA, 1996, J VAC SCI TECHNOL A, V14, P431, DOI 10.1116/1.580101
   Cerca N, 2005, RES MICROBIOL, V156, P506, DOI 10.1016/j.resmic.2005.01.007
   Cheah LK, 1998, J NON-CRYST SOLIDS, V242, P40, DOI 10.1016/S0022-3093(98)00787-X
   Chen JS, 2001, J APPL PHYS, V89, P7814, DOI 10.1063/1.1375808
   Chhowalla M, 1997, J APPL PHYS, V81, P139, DOI 10.1063/1.364000
   COSTERTON JW, 1995, ANNU REV MICROBIOL, V49, P711, DOI 10.1146/annurev.mi.49.100195.003431
   Dearnaley G, 2005, SURF COAT TECH, V200, P2518, DOI 10.1016/j.surfcoat.2005.07.077
   Dingreville R, 2005, J MECH PHYS SOLIDS, V53, P1827, DOI 10.1016/j.jmps.2005.02.012
   Grill A, 1999, DIAM RELAT MATER, V8, P428, DOI 10.1016/S0925-9635(98)00262-3
   Han LA, 2011, APPL SURF SCI, V257, P6945, DOI 10.1016/j.apsusc.2011.03.039
   JACKSON ST, 1995, APPL SURF SCI, V90, P195, DOI 10.1016/0169-4332(95)00079-8
   Konicek A.R., 2010, J APPL PHYS, V107
   Liu C, 2008, COLLOID SURFACE B, V61, P182, DOI 10.1016/j.colsurfb.2007.08.008
   Lygre H, 2002, ACTA ODONTOL SCAND, V60, P1, DOI 10.1080/000163502753471925
   MCALLISTER EW, 1993, GASTROINTEST ENDOSC, V39, P422, DOI 10.1016/S0016-5107(93)70120-0
   Montanaro L, 2004, BIOMATERIALS, V25, P4457, DOI 10.1016/j.biomaterials.2003.11.031
   Pandey M, 2004, SURF COAT TECH, V182, P24, DOI 10.1016/S0257-8972(03)00876-4
   Pandiyaraj KN, 2010, DIAM RELAT MATER, V19, P1085, DOI 10.1016/j.diamond.2010.03.016
   Panwar OS, 2008, J VAC SCI TECHNOL B, V26, P566, DOI 10.1116/1.2884762
   Peng XL, 2001, SURF COAT TECH, V138, P23, DOI 10.1016/S0257-8972(00)01139-7
   Pereira-Cenci T, 2008, J APPL ORAL SCI, V16, P86, DOI 10.1590/S1678-77572008000200002
   Pereni CI, 2006, COLLOID SURFACE B, V48, P143, DOI 10.1016/j.colsurfb.2006.02.004
   Puckett SD, 2010, BIOMATERIALS, V31, P706, DOI 10.1016/j.biomaterials.2009.09.081
   QUIRYNEN M, 1990, J CLIN PERIODONTOL, V17, P138, DOI 10.1111/j.1600-051X.1990.tb01077.x
   Roach Michael, 2007, Dent Clin North Am, V51, P603, DOI 10.1016/j.cden.2007.04.001
   Robertson J, 2002, MAT SCI ENG R, V37, P129, DOI 10.1016/S0927-796X(02)00005-0
   Roy RK, 2007, J BIOMED MATER RES B, V83B, P72, DOI 10.1002/jbm.b.30768
   Schwan J, 1996, J APPL PHYS, V80, P440, DOI 10.1063/1.362745
   Sheeja D, 2001, SURF COAT TECH, V146, P410, DOI 10.1016/S0257-8972(01)01425-6
   Shi ZL, 2006, BIOMATERIALS, V27, P2440, DOI 10.1016/j.biomaterials.2005.11.036
   Soininen A, 2009, J BIOMED MATER RES B, V90B, P882, DOI 10.1002/jbm.b.31359
   Tay BK, 1998, SURF COAT TECH, V105, P155, DOI 10.1016/S0257-8972(98)00475-7
   Tay BK, 1999, SURF INTERFACE ANAL, V28, P231, DOI 10.1002/(SICI)1096-9918(199908)28:1<231::AID-SIA583>3.0.CO;2-3
   Taylor R, 1998, J PROSTHET DENT, V80, P592, DOI 10.1016/S0022-3913(98)70037-X
   Taylor RL, 1998, J MATER SCI-MATER M, V9, P17, DOI 10.1023/A:1008874326324
   Taylora M.B., 2011, THIN SOLID FILMS, V519, P3537
   Turgeon S., 2001, THIN SOLID FILMS, V394, P43
   Wang J, 2004, BIOMATERIALS, V25, P3163, DOI 10.1016/j.biomaterials.2003.10.010
   Wang YG, 2003, J APPL PHYS, V94, P1597, DOI 10.1063/1.1592007
   Xu S, 1996, J APPL PHYS, V79, P7234, DOI 10.1063/1.361440
   Yu X, 2007, SURF COAT TECH, V201, P4995, DOI 10.1016/j.surfcoat.2006.07.194
   Zhang H.S., 2008, REV SCI INSTRUM, V79
NR 47
TC 7
Z9 7
U1 1
U2 20
PU ELSEVIER SCIENCE SA
PI LAUSANNE
PA PO BOX 564, 1001 LAUSANNE, SWITZERLAND
SN 0257-8972
J9 SURF COAT TECH
JI Surf. Coat. Technol.
PD MAR 25
PY 2012
VL 206
IS 15
BP 3386
EP 3392
DI 10.1016/j.surfcoat.2012.01.059
PG 7
WC Materials Science, Coatings & Films; Physics, Applied
SC Materials Science; Physics
GA 927FF
UT WOS:000302891800007
DA 2018-10-19
ER

PT J
AU Daly, WH
AF Daly, William H.
TI Modification of chitosan, an underutilized biomaterial
SO ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY
LA English
DT Meeting Abstract
CT 243rd National Spring Meeting of the American-Chemical-Society
CY MAR 25-29, 2012
CL San Diego, CA
SP Amer Chem Soc
C1 [Daly, William H.] Louisiana State Univ, Dept Chem, Baton Rouge, LA 70803 USA.
EM chdaly@lsu.edu
NR 0
TC 0
Z9 0
U1 1
U2 1
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 0065-7727
J9 ABSTR PAP AM CHEM S
JI Abstr. Pap. Am. Chem. Soc.
PD MAR 25
PY 2012
VL 243
MA 214-POLY
PG 1
WC Chemistry, Multidisciplinary
SC Chemistry
GA 219JX
UT WOS:000324503204467
DA 2018-10-19
ER

PT J
AU Siedlecki, CA
AF Siedlecki, Christopher A.
TI Protein activity and thrombosis at biomaterial interfaces
SO ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY
LA English
DT Meeting Abstract
CT 11th International Biorelated Polymer Symposium / 243rd National Spring
   Meeting of the American-Chemical-Society (ACS)
CY MAR 25-29, 2012
CL San Diego, CA
SP Amer Chem Soc, Div Polymer Chem Inc, Amer Chem Soc
C1 [Siedlecki, Christopher A.] Penn State Univ, Hershey, PA 17033 USA.
EM csiedlecki@psu.edu
NR 0
TC 0
Z9 0
U1 0
U2 2
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 0065-7727
J9 ABSTR PAP AM CHEM S
JI Abstr. Pap. Am. Chem. Soc.
PD MAR 25
PY 2012
VL 243
MA 76-COLL
PG 1
WC Chemistry, Multidisciplinary
SC Chemistry
GA 219AH
UT WOS:000324475103534
DA 2018-10-19
ER

PT J
AU Sabri, F
   Cole, JA
   Scarbrough, MC
   Leventis, N
AF Sabri, Firouzeh
   Cole, Judith A.
   Scarbrough, Michael C.
   Leventis, Nicholas
TI Investigation of Polyurea-Crosslinked Silica Aerogels as a Neuronal
   Scaffold: A Pilot Study
SO PLOS ONE
LA English
DT Article
ID GELATIN-SILOXANE HYBRIDS; ACOUSTIC PROPERTIES; IN-VITRO; LAMININ;
   GROWTH; CELLS
AB Background: Polymer crosslinked aerogels are an attractive class of materials for future implant applications particularly as a biomaterial for the support of nerve growth. The low density and nano-porous structure of this material combined with large surface area, high mechanical strength, and tunable surface properties, make aerogels materials with a high potential in aiding repair of injuries of the peripheral nervous system. However, the interaction of neurons with aerogels remains to be investigated.
   Methodology: In this work the attachment and growth of neurons on clear polyurea crosslinked silica aerogels (PCSA) coated with: poly-L-lysine, basement membrane extract (BME), and laminin1 was investigated by means of optical and scanning electron microscopy. After comparing the attachment and growth capability of neurons on these different coatings, laminin1 and BME were chosen for nerve cell attachment and growth on PCSA surfaces. The behavior of neurons on treated petri dish surfaces was used as the control and behavior of neurons on treated PCSA discs was compared against it.
   Conclusions/Significance: This study demonstrates that: 1) untreated PCSA surfaces do not support attachment and growth of nerve cells, 2) a thin application of laminin1 layer onto the PCSA discs adhered well to the PCSA surface while also supporting growth and differentiation of neurons as evidenced by the number of processes extended and b3-tubulin expression, 3) three dimensional porous structure of PCSA remains intact after fixing protocols necessary for preservation of biological samples and 4) laminin1 coating proved to be the most effective method for attaching neurons to the desired regions on PCSA discs. This work provides the basis for potential use of PCSA as a biomaterial scaffold for neural regeneration.
C1 [Sabri, Firouzeh] Univ Memphis, Dept Phys, Memphis, TN 38152 USA.
   [Cole, Judith A.; Scarbrough, Michael C.] Univ Memphis, Dept Biol Sci, Memphis, TN 38152 USA.
   [Leventis, Nicholas] Missouri Univ Sci & Technol, Dept Chem, Rolla, MO USA.
RP Sabri, F (reprint author), Univ Memphis, Dept Phys, Memphis, TN 38152 USA.
EM fsabri@memphis.edu
CR Adams DN, 2005, J NEUROBIOL, V62, P134, DOI 10.1002/neu.20075
   Alberts B., 2004, ESSENTIAL CELL BIOL
   Ayers MR, 2001, J NON-CRYST SOLIDS, V285, P123, DOI 10.1016/S0022-3093(01)00442-2
   Banker G, 1991, CULTURING NERVE CELL
   Chang MC, 2003, BIOMATERIALS, V24, P2853, DOI 10.1016/S0142-9612(03)00115-7
   Coradin T, 2004, COLLOID SURFACE B, V35, P53, DOI 10.1016/j.colsurfb.2004.02.008
   Forest L, 1998, ULTRASONICS, V36, P477, DOI 10.1016/S0041-624X(97)00149-2
   FRICKE J, 1992, INT J HEAT MASS TRAN, V35, P2305, DOI 10.1016/0017-9310(92)90073-2
   Fricke J, 1986, SPRINGER P PHYS
   GIBIAT V, 1995, J NON-CRYST SOLIDS, V186, P244, DOI 10.1016/0022-3093(95)00049-6
   GRONAUER M, 1986, ACUSTICA, V59, P177
   Hanzawa Y, 1996, LANGMUIR, V12, P6167, DOI 10.1021/la960481t
   Husing N., 1998, ANGEW CHEM INT EDIT, V110, P22
   Kistler SS, 1931, NATURE, V127, P741, DOI 10.1038/127741a0
   KLEINMAN HK, 1986, BIOCHEMISTRY-US, V25, P312, DOI 10.1021/bi00350a005
   LEIN PJ, 1989, DEV BIOL, V136, P330, DOI 10.1016/0012-1606(89)90260-1
   Leventis N, 2002, NANO LETT, V2, P957, DOI 10.1021/nl025690e
   Leventis N, 2007, ACCOUNTS CHEM RES, V40, P874, DOI 10.1021/ar600033s
   Li Y., 2001, BIOTECHNOL BIOPROC E, V6, P311
   Long Y, 2008, J MANUF SCI E-T ASME, V130, DOI 10.1115/1.2896111
   Lyons L, 1999, 76 ANN M SE SECT APS, V54
   MCKEEHAN WL, 1976, J CELL BIOL, V71, P727, DOI 10.1083/jcb.71.3.727
   Mikos Antonios G., 2000, EJB Electronic Journal of Biotechnology, V3, P1
   Pierre AC, 2002, CHEM REV, V102, P4243, DOI 10.1021/cr0101306
   Power M, 2001, J NON-CRYST SOLIDS, V285, P303, DOI 10.1016/S0022-3093(01)00471-9
   Ren L, 2001, J NON-CRYST SOLIDS, V285, P116, DOI 10.1016/S0022-3093(01)00441-0
   Ren L, 2002, BIOMATERIALS, V23, P4765, DOI 10.1016/S0142-9612(02)00226-0
   Sabri F, 2011, P 3 ANN ORNL BIOM SC
   Smirnova I, 2004, J NON-CRYST SOLIDS, V350, P54, DOI 10.1016/j.jnoncrysol.2004.06.031
   Subramanian A, 2009, J BIOMED SCI, V16, DOI 10.1186/1423-0127-16-108
   Yim EKF, 2005, BIOMATERIALS, V26, P5405, DOI 10.1016/j.biomaterials.2005.01.058
   Yin W, 2010, J BIOMED MATER RES A, V92A, P1431, DOI 10.1002/jbm.a.32476
NR 32
TC 18
Z9 18
U1 1
U2 32
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD MAR 20
PY 2012
VL 7
IS 3
AR e33242
DI 10.1371/journal.pone.0033242
PG 7
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA 939YB
UT WOS:000303855700029
PM 22448239
OA DOAJ Gold, Green Published
DA 2018-10-19
ER

PT J
AU Tang, YJ
   Sun, J
   Fan, HS
   Zhang, XD
AF Tang, Yajun
   Sun, Jing
   Fan, Hongsong
   Zhang, Xingdong
TI An improved complex gel of modified gellan gum and carboxymethyl
   chitosan for chondrocytes encapsulation
SO CARBOHYDRATE POLYMERS
LA English
DT Article
DE Gellan gum; Oxidation; Carboxymethyl chitosan; Hydrogel; Tissue
   engineering
ID TISSUE ENGINEERING APPLICATIONS; DOUBLE-NETWORK HYDROGEL; CHONDROITIN
   SULFATE; OXIDIZED DEXTRAN; BIOMATERIAL; BIOPOLYMER; SCAFFOLDS; STRENGTH;
   DESIGN
AB Gellan gum is a candidate material for cartilage tissue engineering, but its application is limited by the high gelation (Coutinho et al., 2010) temperature and lack of mechanical strength. In this study, oxidized gellan gum was prepared and mixed with carboxymethyl chitosan to form a double-network complex hydrogel with significantly improved gelation temperature (T-gelation) and mechanical properties. The T-gelation was lowered from 42 degrees C to below physiological temperature by oxidation, and further reduced by complexing with carboxymethyl chitosan. The complex hydrogel showed an increased compressive modulus 01 278 kPa, and an ability to return to the original shape after release of the compressive load. In vitro chondrocytes encapsulation and proliferation experiments found that the complex hydrogel significantly enhanced the viability of the cells. These results suggest that, the complex gel of gellan gum and carboxymethyl chitosan is a promising material for cartilage tissue engineering. (C) 2011 Elsevier Ltd. All rights reserved.
C1 [Tang, Yajun; Sun, Jing; Fan, Hongsong; Zhang, Xingdong] Sichuan Univ, Natl Engn Res Ctr Biomat, Chengdu 610064, Peoples R China.
RP Fan, HS (reprint author), Sichuan Univ, Natl Engn Res Ctr Biomat, Chengdu 610064, Peoples R China.
EM hsfan@scu.edu.cn
FU National Natural Science Foundation of China [81071272]; Research Fund
   for the Doctoral Program of Higher Education of China [0900905111001]
FX This work has been financially supported by the National Natural Science
   Foundation of China (Contract Grant No. 81071272) and the Research Fund
   for the Doctoral Program of Higher Education of China (Contract Grant
   No. 0900905111001). The authors would thank Analytical and Testing
   Center of Sichuan University to supply help for NMR analysis, and Caili
   Huang for excellent mechanical test technical assistance.
CR Abreu FOMS, 2008, CARBOHYD POLYM, V74, P283, DOI 10.1016/j.carbpol.2008.02.017
   Balakrishnan B., 2010, CHEM REV, V111, P4453
   Bhardwaj N, 2011, BIOMATERIALS, V32, P5773, DOI 10.1016/j.biomaterials.2011.04.061
   Bryant SJ, 2005, ACTA BIOMATER, V1, P243, DOI 10.1016/j.actbio.2004.11.003
   Chan PS, 2007, AM J VET RES, V68, P709, DOI 10.2460/ajvr.68.7.709
   Chen QZ, 2008, MAT SCI ENG R, V59, P1, DOI 10.1016/j.mser.2007.08.001
   Chong AKS, 2006, J HAND SURG-AM, V31A, P349, DOI 10.1016/j.jhsa.2005.11.001
   Coutinho DF, 2010, BIOMATERIALS, V31, P7494, DOI 10.1016/j.biomaterials.2010.06.035
   DEASY PB, 1991, INT J PHARM, V73, P117, DOI 10.1016/0378-5173(91)90034-L
   Di Martino A, 2005, BIOMATERIALS, V26, P5983, DOI 10.1016/j.biomaterials.2005.03.016
   Drury JL, 2003, BIOMATERIALS, V24, P4337, DOI 10.1016/S0142-9612(03)00340-5
   Durmaz S, 2000, POLYMER, V41, P3693, DOI 10.1016/S0032-3861(99)00558-3
   Fu XF, 2007, CARBOHYD POLYM, V68, P511, DOI 10.1016/j.carbpol.2006.11.001
   Gong YH, 2009, J MATER CHEM, V19, P1968, DOI 10.1039/b818090c
   Hoffman AS, 2002, ADV DRUG DELIVER REV, V54, P3, DOI 10.1016/S0169-409X(01)00239-3
   JANSSON PE, 1983, CARBOHYD RES, V124, P135, DOI 10.1016/0008-6215(83)88361-X
   Jolles P., 1999, CHITIN CHITINASES
   Kim B-S, 2010, PROG POLYM SCI, V36, P238
   Kim IY, 2008, BIOTECHNOL ADV, V26, P1, DOI 10.1016/j.biotechadv.2007.07.009
   Kuo CK, 2001, BIOMATERIALS, V22, P511, DOI 10.1016/S0142-9612(00)00201-5
   Li Q, 2006, BIOMATERIALS, V27, P1027, DOI 10.1016/j.biomaterials.2005.07.019
   Lin YH, 2005, BIOMATERIALS, V26, P2105, DOI 10.1016/j.biomaterials.2004.06.011
   Liu C, 2007, CHEM ENG RES DES, V85, P1051, DOI [10.1205/cherd06196, 10.1205/cherd061915]
   Liu YX, 2009, BIOMATERIALS, V30, P196, DOI 10.1016/j.biomaterials.2008.09.041
   Lu GY, 2007, EUR POLYM J, V43, P3807, DOI 10.1016/j.eurpolymj.2007.06.016
   MOORHOUSE R, 1981, SOLUTION PROPERTIES, P111
   Muzzarelli R. A. A, 1982, CARBOHYD POLYM, V2, P312
   MUZZARELLI RAA, 1988, CARBOHYD POLYM, V8, P1, DOI 10.1016/0144-8617(88)90032-X
   MUZZARELLI RAA, 1994, INT J BIOL MACROMOL, V16, P177, DOI 10.1016/0141-8130(94)90048-5
   Nakayama A, 2004, ADV FUNCT MATER, V14, P1124, DOI 10.1002/adfm.200305197
   Oliveira JT, 2010, J BIOMED MATER RES A, V93A, P852, DOI 10.1002/jbm.a.32574
   Oliveira JT, 2010, J TISSUE ENG REGEN M, V5, P421
   Risbud MV, 2002, TRENDS BIOTECHNOL, V20, P351, DOI 10.1016/S0167-7799(02)02016-4
   Silva-Correia J, 2011, J TISSUE ENG REGEN M, V5, pE97, DOI 10.1002/term.363
   Sosa-Herrera MG, 2008, FOOD HYDROCOLLOID, V22, P934, DOI 10.1016/j.foodhyd.2007.05.003
   Takahashi R, 2004, BIOMACROMOLECULES, V5, P516, DOI 10.1021/bm034371u
   Tang J, 1996, CARBOHYD POLYM, V29, P11, DOI 10.1016/0144-8617(95)00124-7
   Wang DA, 2007, NAT MATER, V6, P385, DOI 10.1038/nmat1890
   Weng L, 2008, BIOMATERIALS, V29, P3905, DOI 10.1016/j.biomaterials.2008.06.025
   Xiao L Z. K. L. W., 2011, CARBOHYD POLYM, V84, P118
   Zhang HW, 2011, BIOMACROMOLECULES, V12, P1428, DOI 10.1021/bm101192b
NR 41
TC 41
Z9 41
U1 6
U2 56
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0144-8617
J9 CARBOHYD POLYM
JI Carbohydr. Polym.
PD MAR 17
PY 2012
VL 88
IS 1
BP 46
EP 53
DI 10.1016/j.carbpol.2011.11.058
PG 8
WC Chemistry, Applied; Chemistry, Organic; Polymer Science
SC Chemistry; Polymer Science
GA 896DO
UT WOS:000300545800007
DA 2018-10-19
ER

PT J
AU Periolatto, M
   Ferrero, F
   Vineis, C
AF Periolatto, Monica
   Ferrero, Franco
   Vineis, Claudia
TI Antimicrobial chitosan finish of cotton and silk fabrics by UV-curing
   with 2-hydroxy-2-methylphenylpropane-1-one
SO CARBOHYDRATE POLYMERS
LA English
DT Article
DE Biomaterial; Chitosan; Textile; Antibacterial; Cotton; Silk
ID PHYSICOMECHANICAL PROPERTIES; ACRYLIC-MONOMERS; FILMS; IRRADIATION;
   TEXTILES; SURFACE
AB The purpose of this work was to develop a textile finish based on radical UV-curing of chitosan on cotton and silk to confer antimicrobial properties. Fabrics were impregnated with a solution of 2% w chitosan in aqueous acetic acid (2% v/v) added of 2-hydroxy-2-methylphenylpropane-1-one (2% w/w with respect to chitosan) as photoinitiator and cured at room temperature by exposure to UV lamp for 60 s on both the sides. The antimicrobial activity of finished fabrics was tested according to ASTM standard test performed with Escherichia coli. Obtained results showed a strong antimicrobial activity conferred by the treatment, homogeneous on fabric surface, without affecting the hand properties of fabrics due to the low chitosan weight on (about 2%). The treatment durability to domestic laundering was tested after 5 cycles using either anionic or nonionic detergents. The antimicrobial activity resulted completely maintained after washing with a nonionic surfactant, while with anionic detergents the treatment durability was better for samples prepared with a deeper penetration of chitosan inside the fibers. The fabrics were characterized by dyeing tests, SEM and FTIR-ATR analyzes. (C) 2011 Elsevier Ltd. All rights reserved.
C1 [Periolatto, Monica; Ferrero, Franco] Politecn Torino, Dipartimento Sci Mat & Ingn Chim, I-10129 Turin, Italy.
   [Vineis, Claudia] CNR ISMAC, Ist Studio Macromol, I-13900 Biella, Italy.
RP Ferrero, F (reprint author), Politecn Torino, Dipartimento Sci Mat & Ingn Chim, Corso Duca degli Abruzzi 24, I-10129 Turin, Italy.
EM franco.ferrero@polito.it
OI Ferrero, Franco/0000-0001-5140-9525; VINEIS, CLAUDIA/0000-0003-4670-5586
CR Alam R, 2008, J POLYM ENVIRON, V16, P213, DOI 10.1007/s10924-008-0099-2
   Alonso D, 2009, CARBOHYD POLYM, V77, P536, DOI 10.1016/j.carbpol.2009.01.027
   Arai T, 2001, J APPL POLYM SCI, V80, P297, DOI 10.1002/1097-4628(20010411)80:2<297::AID-APP1099>3.3.CO;2-Q
   El-Tahlawy KF, 2005, CARBOHYD POLYM, V60, P421, DOI 10.1016/j.carbpol.2005.02.019
   Ferrero F, 2008, J APPL POLYM SCI, V107, P810, DOI 10.1002/app.27110
   Ferrero F, 2011, J NANOSCI NANOTECHNO, V11, P8663, DOI 10.1166/jnn.2011.3447
   Goy RC, 2009, POLIMEROS, V19, P241, DOI 10.1590/S0104-14282009000300013
   Hebeish A, 2011, CARBOHYD POLYM, V86, P936, DOI 10.1016/j.carbpol.2011.05.048
   Khan M, 2005, J POLYM ENVIRON, V13, P193, DOI 10.1007/s10924-005-2950-z
   Krijnen E., 1994, J COATED FABRICS, V24, P152
   Leal-Egana A, 2010, BIOTECHNOL APPL BIOC, V55, P155, DOI 10.1042/BA20090229
   Lim SH, 2004, CARBOHYD POLYM, V56, P227, DOI 10.1016/j.carbpol.2004.02.005
   Liu H, 2006, CARBOHYD POLYM, V64, P553, DOI 10.1016/j.carbpol.2005.11.007
   Muzzarelli RAA, 2009, CARBOHYD POLYM, V77, P1, DOI 10.1016/j.carbpol.2009.01.016
   Muzzarelli RAA, 2009, CARBOHYD POLYM, V76, P167, DOI 10.1016/j.carbpol.2008.11.002
   Princi E, 2006, EUR POLYM J, V42, P51, DOI 10.1016/j.eurpolymj.2005.08.005
   Saiki S, 2010, RADIAT PHYS CHEM, V79, P276, DOI 10.1016/j.radphyschem.2009.08.043
   Schindler W. D., 2004, CHEM FINISHING TEXTI
   SHIN Y, 1996, J KOREAN FIBER SOC, V33, P487
   Sionkowska A, 2006, SURF SCI, V600, P3775, DOI 10.1016/j.susc.2006.01.090
   Sionkowska A, 2005, POLYM DEGRAD STABIL, V88, P261, DOI 10.1016/j.polymdegradstab.2004.08.018
   SUDARSHAN NR, 1992, FOOD BIOTECHNOL, V6, P257, DOI 10.1080/08905439209549838
   Tsai GJ, 1999, J FOOD PROTECT, V62, P239, DOI 10.4315/0362-028X-62.3.239
NR 23
TC 28
Z9 29
U1 0
U2 38
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0144-8617
EI 1879-1344
J9 CARBOHYD POLYM
JI Carbohydr. Polym.
PD MAR 17
PY 2012
VL 88
IS 1
BP 201
EP 205
DI 10.1016/j.carbpol.2011.11.093
PG 5
WC Chemistry, Applied; Chemistry, Organic; Polymer Science
SC Chemistry; Polymer Science
GA 896DO
UT WOS:000300545800028
DA 2018-10-19
ER

PT J
AU Dang, QF
   Yan, JQ
   Lin, H
   Chen, XG
   Liu, CS
   Ji, QX
   Li, JJ
AF Dang, Qi Feng
   Yan, Jing Quan
   Lin, Hong
   Chen, Xi Guang
   Liu, Cheng Sheng
   Ji, Qiu Xia
   Li, Jing Jing
TI Design and evaluation of a highly porous thermosensitive hydrogel with
   low gelation temperature as a 3D culture system for Penaeus chinensis
   lymphoid cells
SO CARBOHYDRATE POLYMERS
LA English
DT Article
DE Chitosan; Low gelation temperature; Hydrogel; Biocompatibility; Cell
   encapsulation
ID IN-SITU; CHITOSAN; BIOMATERIAL; DEGRADATION; ADSORPTION; SURFACES;
   PROTEIN; GELS
AB The characterizations and biocompatibility of a highly porous chtosan-alpha,beta-glycerophosphate (CS-alpha,beta-GP) thermosensitive hydrogel with low gelation temperature and its feasibility as a 3D culture system for Penaeus chinensis lymphoid cells were investigated. A CS-alpha,beta-GP hydrogel that possesses a physiological pH and can form monolithic gels at 25 degrees C was designed. The properties of the CS-alpha,beta-GP hydrogel were characterized regarding rheological properties, gelation temperature, gelation time, pH, morphology, swelling properties and degradability. This hydrogel showed low BSA adsorption at physiological conditions. The cytotoxicity of the alpha,beta-GP to mouse embryo fibroblasts (MEFs) could be eliminated by washing the CS-alpha,beta-GP hydrogel 3 times with cell culture medium. The P. chinensis lymphoid cells cultured on the surface or encapsulated inside of the hydrogel could grow and reproduce. After 20 d culture on the surface or encapsulated inside of the hydrogel, the lymphoid cells were still had good activity and could be subcultured. (C) 2011 Elsevier Ltd. All rights reserved.
C1 [Chen, Xi Guang] Ocean Univ China, Coll Marine Life Sci, Qingdao 266003, Peoples R China.
   [Ji, Qiu Xia] Qingdao Univ, Coll Med, Affiliated Hosp, Qingdao 266001, Peoples R China.
RP Chen, XG (reprint author), Ocean Univ China, Coll Marine Life Sci, 5 Yushan Rd, Qingdao 266003, Peoples R China.
EM xgchen@ouc.edu.cn
RI Liu, Chengsheng/L-5296-2018
OI Liu, Chengsheng/0000-0002-1454-0193
FU National Natural Science Foundation of China (NSFC) [81071274,
   40876065]; International S&T Cooperation Program of China (ISTCP)
   [2011DFA31270]; Fundamental Research Funds for the Central Universities
   [841111042, 201213006]
FX This work was supported by grants from the National Natural Science
   Foundation of China (NSFC, 81071274 & 40876065), International S&T
   Cooperation Program of China (ISTCP, 2011DFA31270) and the Fundamental
   Research Funds for the Central Universities (841111042, 201213006).
CR Chenite A, 2000, BIOMATERIALS, V21, P2155, DOI 10.1016/S0142-9612(00)00116-2
   Cho JY, 2005, BIOMACROMOLECULES, V6, P3267, DOI 10.1021/bm050313s
   Chung HJ, 2005, CURR APPL PHYS, V5, P485, DOI 10.1016/j.cap.2005.01.015
   Dang QF, 2011, CARBOHYD POLYM, V83, P171, DOI 10.1016/j.carbpol.2010.07.038
   Fang C, 2006, EUR J PHARM SCI, V27, P27, DOI 10.1016/j.ejps.2005.08.002
   Ganji F, 2007, J SOL-GEL SCI TECHN, V42, P47, DOI 10.1007/s10971-006-9007-1
   Hoemann CD, 2007, J BIOMED MATER RES A, V83A, P521, DOI 10.1002/jbm.a.31365
   Huang Y, 2008, APPL SURF SCI, V255, P257, DOI 10.1016/j.apsusc.2008.06.192
   Kim S, 2010, BIOMATERIALS, V31, P4157, DOI 10.1016/j.biomaterials.2010.01.139
   Kraehenbuehl TP, 2009, BIOMATERIALS, V30, P4318, DOI 10.1016/j.biomaterials.2009.04.057
   Lang GH, 2002, AQUACULTURE, V213, P73, DOI 10.1016/S0044-8486(02)00142-4
   Morin C, 2004, J ELECTRON SPECTROSC, V137, P785, DOI 10.1016/j.elspec.2004.02.158
   Muzzarelli RAA, 1997, CELL MOL LIFE SCI, V53, P131, DOI 10.1007/PL00000584
   Rao SB, 1997, J BIOMED MATER RES, V34, P21, DOI 10.1002/(SICI)1097-4636(199701)34:1<21::AID-JBM4>3.0.CO;2-P
   Roughley P, 2006, BIOMATERIALS, V27, P388, DOI 10.1016/j.biomaterials.2005.06.037
   Tamura H, 2011, CARBOHYD POLYM, V84, P820, DOI 10.1016/j.carbpol.2010.06.001
   Tan HP, 2009, BIOMATERIALS, V30, P2499, DOI 10.1016/j.biomaterials.2008.12.080
   Wang LM, 2010, BIOMATERIALS, V31, P3976, DOI 10.1016/j.biomaterials.2010.01.131
   Wang T, 2009, ACTA BIOMATER, V5, P2939, DOI 10.1016/j.actbio.2009.04.040
   WANG WN, 2001, METHODS CELL SCI, V22, P277
   Zhang J, 2009, J MATER SCI-MATER M, V20, P991, DOI 10.1007/s10856-008-3656-2
   Zhang L, 2011, CARBOHYD POLYM, V84, P118, DOI 10.1016/j.carbpol.2010.11.009
NR 22
TC 15
Z9 17
U1 2
U2 30
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0144-8617
J9 CARBOHYD POLYM
JI Carbohydr. Polym.
PD MAR 17
PY 2012
VL 88
IS 1
BP 361
EP 368
DI 10.1016/j.carbpol.2011.12.014
PG 8
WC Chemistry, Applied; Chemistry, Organic; Polymer Science
SC Chemistry; Polymer Science
GA 896DO
UT WOS:000300545800049
DA 2018-10-19
ER

PT J
AU Akar, ST
   Arslan, S
   Alp, T
   Arslan, D
   Akar, T
AF Akar, Sibel Tunali
   Arslan, Sercan
   Alp, Tugba
   Arslan, Derya
   Akar, Tamer
TI Biosorption potential of the waste biomaterial obtained from Cucumis
   melo for the removal of Pb2+ ions from aqueous media: Equilibrium,
   kinetic, thermodynamic and mechanism analysis
SO CHEMICAL ENGINEERING JOURNAL
LA English
DT Article
DE Biosorption; Isotherm; Kinetic; Pb2+; Mechanism; Thermodynamic
ID LEAD(II) IONS; HEAVY-METALS; CU(II) IONS; BIOMASS; ADSORPTION; L.;
   SORPTION; WATER; ISOTHERMS; INDUSTRY
AB \ The potential use of a waste biosorbent material obtained from Cucumis melo (C. melo) for the removal of Pb2+ ions from aqueous solutions was investigated by considering equilibrium and kinetic aspects. The biosorption showed a pH dependent profile. An increase in biosorbent dosage up to 1.8 g L-1 caused an increase in the biosorption yield of the biosorbent. The relatively fast biosorption at all studied temperatures follows the pseudo-second-order kinetic model. Biosorption isotherm modeling shows the equilibrium data fitted to the Langmuir model with a maximum monolayer biosorption capacity of 3.64 x 10(-4) mol g(-1). The thermodynamic parameters indicated the biosorption of Pb2+ on the biomass was a spontaneous and endothermic process. Experiments conducted with multi-metal system demonstrated that the presence of co-ions slightly reduced the Pb2+ biosorption capacity of the biomass. The possible Pb2+ ion-biomaterial interactions were evaluated by the zeta potential, FTIR, SEM and EDX analysis. Results of this work showed the suggested biosorbent could be an effective and eco-friendly alternative for the removal of Pb2+ ions from contaminated solutions. (c) 2012 Elsevier B.V. All rights reserved.
C1 [Akar, Sibel Tunali; Akar, Tamer] Eskisehir Osmangazi Univ, Fac Arts & Sci, Dept Chem, Eskisehir, Turkey.
   [Arslan, Sercan; Alp, Tugba; Arslan, Derya] Eskisehir Osmangazi Univ, Grad Sch Nat & Appl Sci, Dept Chem, TR-26480 Eskisehir, Turkey.
RP Akar, ST (reprint author), Eskisehir Osmangazi Univ, Fac Arts & Sci, Dept Chem, Eskisehir, Turkey.
EM stunali@ogu.edu.tr
CR Ahluwalia SS, 2007, BIORESOURCE TECHNOL, V98, P2243, DOI 10.1016/j.biortech.2005.12.006
   Akar ST, 2009, J HAZARD MATER, V165, P126, DOI 10.1016/j.jhazmat.2008.09.089
   Akar T, 2005, MINER ENG, V18, P1099, DOI 10.1016/j.mineng.2005.03.002
   Akar T, 2009, J HAZARD MATER, V163, P1134, DOI 10.1016/j.jhazmat.2008.07.084
   Akar T, 2006, J ENVIRON SCI HEAL A, V41, P2587, DOI 10.1080/10934520600927989
   Akar T, 2006, BIORESOURCE TECHNOL, V97, P1780, DOI 10.1016/j.biortech.2005.09.009
   Al Rmalli SW, 2008, J HAZARD MATER, V152, P955, DOI 10.1016/j.jhazmat.2007.07.111
   Cayllahua JEB, 2010, CHEM ENG J, V161, P1, DOI 10.1016/j.cej.2010.03.025
   Blazquez G, 2010, CHEM ENG J, V160, P615, DOI 10.1016/j.cej.2010.03.085
   Chowdhury S, 2011, COLLOID SURFACE B, V88, P697, DOI 10.1016/j.colsurfb.2011.08.003
   Davis TA, 2003, WATER RES, V37, P4311, DOI 10.1016/S0043-1354(03)00293-8
   de Mello MLS, 2001, J FOOD COMPOS ANAL, V14, P69, DOI 10.1006/jfca.2000.0952
   Dubey SS, 2005, SEP PURIF TECHNOL, V41, P21, DOI 10.1016/j.seppur.2004.03.012
   Dubinin M.M., 1947, P ACAD SCI USSR PHYS, V55, P331
   Duke J. A., 1985, MED PLANTS CHINA
   Fabeiro C, 2002, AGR WATER MANAGE, V54, P93, DOI 10.1016/S0378-3774(01)00151-2
   Fan T, 2008, J HAZARD MATER, V160, P655, DOI 10.1016/j.jhazmat.2008.03.038
   Freundlich H, 1906, Z PHYS CHEM-STOCH VE, V57, P385
   Gupta VK, 2008, COLLOID SURFACE B, V64, P170, DOI 10.1016/j.colsurfb.2008.01.019
   Gupta VK, 2004, J COLLOID INTERF SCI, V271, P321, DOI 10.1016/j.jcis.2003.11.007
   HALL KR, 1966, IND ENG CHEM FUND, V5, P212, DOI 10.1021/i160018a011
   Han RP, 2005, J HAZARD MATER, V125, P266, DOI 10.1016/j.jhazmat.2005.05.031
   Hanif MA, 2007, J HAZARD MATER, V145, P501, DOI 10.1016/j.jhazmat.2007.01.022
   Hasany SM, 1996, APPL RADIAT ISOTOPES, V47, P467, DOI 10.1016/0969-8043(95)00310-X
   Hawari AH, 2007, PROCESS BIOCHEM, V42, P1546, DOI 10.1016/j.procbio.2007.08.009
   Ho YS, 1998, PROCESS SAF ENVIRON, V76, P183, DOI 10.1205/095758298529326
   HOBSON JP, 1969, J PHYS CHEM-US, V73, P2720, DOI 10.1021/j100842a045
   Hsu PC, 2002, TOXICOLOGY, V180, P33, DOI 10.1016/S0300-483X(02)00380-3
   Keen A, 2000, J POWER SOURCES, V88, P27, DOI 10.1016/S0378-7753(99)00507-8
   Lagergren S, 1898, KUNGLIGA SVENSKA VET, V24, P1, DOI DOI 10.1007/BF01501332
   Langmuir I, 1918, J AM CHEM SOC, V40, P1361, DOI 10.1021/ja02242a004
   Lawal OS, 2010, J HAZARD MATER, V177, P829, DOI 10.1016/j.jhazmat.2009.12.108
   Oliveira WE, 2008, J HAZARD MATER, V152, P1073, DOI 10.1016/j.jhazmat.2007.07.085
   Ozcan AS, 2007, SEPAR SCI TECHNOL, V42, P137, DOI 10.1080/01496390600956977
   Ozcan AS, 2009, DESALINATION, V244, P188, DOI 10.1016/j.desal.2008.05.023
   Qasier S., 2009, J HAZARD MATER, V166, P998
   Razmouski R, 2008, ECOL ENG, V34, P179, DOI 10.1016/j.ecoleng.2008.07.020
   Saeed A, 2005, J HAZARD MATER, V117, P65, DOI 10.1016/j.jhazmat.2004.09.008
   Sari A, 2007, BIOCHEM ENG J, V37, P151, DOI 10.1016/j.bej.2007.04.007
   Stagnari F, 2010, SCI HORTIC-AMSTERDAM, V126, P317, DOI 10.1016/j.scienta.2010.07.004
   Sud D, 2008, BIORESOURCE TECHNOL, V99, P6017, DOI 10.1016/j.biortech.2007.11.064
   Tanaka K, 2007, EUPHYTICA, V153, P233, DOI 10.1007/s10681-006-9259-4
   Tewari N, 2005, BIOCHEM ENG J, V23, P185, DOI 10.1016/j.bej.2005.01.011
   Tunali S, 2006, CHEM ENG J, V115, P203, DOI 10.1016/j.cej.2005.09.023
   Vijayaraghavan K, 2008, BIORESOURCE TECHNOL, V99, P2864, DOI 10.1016/j.biortech.2007.06.008
   Volesky B., 1990, BIOSORPTION HEAVY ME, P3
   Witek-Krowiak A, 2011, DESALINATION, V265, P126, DOI 10.1016/j.desal.2010.07.042
NR 47
TC 38
Z9 38
U1 2
U2 19
PU ELSEVIER SCIENCE SA
PI LAUSANNE
PA PO BOX 564, 1001 LAUSANNE, SWITZERLAND
SN 1385-8947
J9 CHEM ENG J
JI Chem. Eng. J.
PD MAR 15
PY 2012
VL 185
BP 82
EP 90
DI 10.1016/j.cej.2012.01.032
PG 9
WC Engineering, Environmental; Engineering, Chemical
SC Engineering
GA 913PY
UT WOS:000301891100009
DA 2018-10-19
ER

PT J
AU Yamada, M
   Nakayama, E
AF Yamada, Masanori
   Nakayama, Emiko
TI Preparation of DNA-cyclodextrin-silica composite by sol-gel method and
   its utilization as an environmental material
SO MATERIALS CHEMISTRY AND PHYSICS
LA English
DT Article
DE Biomaterial; Polymers; Composite material; Organic compounds; Sol-gel
   growth
ID CHEMISTRY; POLYMER
AB A DNA-cyclodextrin-silica composite was prepared by the sol-gel method. This composite possessed the bi-functions of double-stranded DNA, such as intercalation into DNA, and cyclodextrin, such as inclusion into its intramolecular cavity. Therefore, we demonstrated the accumulation of harmful compounds from an aqueous multi-component solution using a DNA-cyclodextrin-silica composite column. As a result, the DNA-cyclodextrin-silica composite column can effectively accumulate not only planar structure-containing harmful compounds, such as dioxin and polychlorobiphenyl (PCB) derivatives, but also non-planar structure containing compounds, such as bisphenol A and diethylstilbestrol, from an aqueous multi-component solution. The accumulated amount of these harmful compounds was more than 90%. Additionally, the DNA-cyclodextrin-silica composite column was recycled by the application of methanol. Therefore, the DNA-cyclodextrin-silica composite may have the potential to be used as an environmental material for the accumulation of harmful compounds from industrial or experimental waste. (C) 2012 Elsevier B.V. All rights reserved.
C1 [Yamada, Masanori; Nakayama, Emiko] Okayama Univ Sci, Fac Sci, Dept Chem, Kita Ku, Okayama 7000005, Japan.
RP Yamada, M (reprint author), Okayama Univ Sci, Fac Sci, Dept Chem, Kita Ku, Okayama 7000005, Japan.
EM myamada@chem.ous.ac.jp
FU MEXT (Ministry of Education, Culture, Sports, Science and Technology of
   Japan); Wesco Scientific Promotion Foundation
FX This work was supported by matching fund subsidy for private
   universities from MEXT (Ministry of Education, Culture, Sports, Science
   and Technology of Japan). Additionally, the part of this work was
   supported by Wesco Scientific Promotion Foundation.
CR Aoi K, 2000, POLYMER, V41, P2847, DOI 10.1016/S0032-3861(99)00476-0
   Avnir D, 2006, J MATER CHEM, V16, P1013, DOI 10.1039/5512706h
   Banyay M, 2003, BIOPHYS CHEM, V104, P477, DOI 10.1016/S0301-4622(03)00035-8
   Bender M.L., 1978, CYCRODEXTRIN CHEM
   Ehsan S, 2007, CHEMOSPHERE, V68, P150, DOI 10.1016/j.chemosphere.2006.12.018
   Ito N, 1996, J CHEM SOC PERK T 2, P965, DOI 10.1039/p29960000965
   Khan AR, 1998, CHEM REV, V98, P1977, DOI 10.1021/cr970012b
   Liu XD, 2007, ADV POLYM SCI, V209, P149, DOI 10.1007/12_2006_106
   Liu XD, 2008, CHEM SOC REV, V37, P2745, DOI 10.1039/b801433g
   Pierre A, 2001, J MATER SCI-MATER M, V12, P51, DOI 10.1023/A:1013857102461
   Saenger W., 1987, PRINCIPLES NUCL ACID
   Sainz-Rozas PR, 2005, J PHOTOCH PHOTOBIO A, V173, P248, DOI 10.1016/j.j.photochem.2005.04.022
   Satoh S, 2005, POLYM J, V37, P94, DOI 10.1295/polymj.37.94
   Silverstein R. M., 1998, SPECTROMETRIC IDENTI
   Szejtli J, 1998, CHEM REV, V98, P1743, DOI 10.1021/cr970022c
   TAKAHASHI K, 1984, TETRAHEDRON LETT, V25, P3331, DOI 10.1016/S0040-4039(01)81377-0
   Wang LL, 2001, CHEM MATER, V13, P1273, DOI 10.1021/cm000869g
   Wang X, 2006, SENSOR ACTUAT B-CHEM, V114, P565, DOI 10.1016/j.snb.2005.06.020
   WARING MJ, 1981, ANNU REV BIOCHEM, V50, P159, DOI 10.1146/annurev.bi.50.070181.001111
   Yamada M, 2002, CHEM-EUR J, V8, P1407, DOI 10.1002/1521-3765(20020315)8:6<1407::AID-CHEM1407>3.0.CO;2-L
   Yamada M, 2002, ENVIRON SCI TECHNOL, V36, P949, DOI 10.1021/es011008r
   Yamada M., 2009, ANAL CHIM ACTA, V674, P249
   Yamada M, 2011, MATER CHEM PHYS, V126, P278, DOI 10.1016/j.matchemphys.2010.11.026
   Yamada M, 2010, MATER CHEM PHYS, V124, P623, DOI 10.1016/j.matchemphys.2010.07.024
   Yamada M, 2008, BIOMACROMOLECULES, V9, P3341, DOI 10.1021/bm800984p
NR 25
TC 2
Z9 2
U1 5
U2 21
PU ELSEVIER SCIENCE SA
PI LAUSANNE
PA PO BOX 564, 1001 LAUSANNE, SWITZERLAND
SN 0254-0584
J9 MATER CHEM PHYS
JI Mater. Chem. Phys.
PD MAR 15
PY 2012
VL 133
IS 1
BP 278
EP 283
DI 10.1016/j.matchemphys.2012.01.022
PG 6
WC Materials Science, Multidisciplinary
SC Materials Science
GA 915MV
UT WOS:000302032300043
DA 2018-10-19
ER

PT J
AU Rao, GS
   Singh, V
   Singhal, LK
AF Rao, Sudhakar G.
   Singh, Vakil
   Singhal, L. K.
TI In vitro corrosion fatigue behavior of low nickel high nitrogen
   austenitic stainless steel
SO MATERIALS SCIENCE AND ENGINEERING A-STRUCTURAL MATERIALS PROPERTIES
   MICROSTRUCTURE AND PROCESSING
LA English
DT Article
DE In vitro corrosion fatigue; LCF; Low nickel stainless steel; High
   nitrogen austenitic stainless steel; Biomaterial; Deformation induced
   martensite
ID CRACK-GROWTH-BEHAVIOR; MEDICAL APPLICATIONS; ORTHOPEDIC IMPLANTS;
   MICROSTRUCTURE; TOXICITY; SPLEEN
AB Corrosion fatigue behavior of a new austenitic stainless steel, with relatively low nickel, high nitrogen and manganese (216L), and the usual 316L steel was studied in SBF, both in stress and strain control mode. Corrosion fatigue life of 216L in stress control mode was found to be longer to that of the 316L at +/- 450 MPa and there was opposite trend at high stress amplitudes. In strain control fatigue life of 216L was found longer than that of 316L both in air and in SBF over the strain amplitudes studied. The higher fatigue resistance of the 216L is attributed to high nitrogen content and higher stability of the austenite. (C) 2012 Elsevier B.V. All rights reserved.
C1 [Rao, Sudhakar G.; Singh, Vakil] Banaras Hindu Univ, Inst Technol, Dept Met Engn, Varanasi 221005, Uttar Pradesh, India.
   [Singhal, L. K.] Jindal Stainless Ltd, R&D Div, Hisar, Haryana, India.
RP Singh, V (reprint author), Banaras Hindu Univ, Inst Technol, Dept Met Engn, Varanasi 221005, Uttar Pradesh, India.
EM vakil@bhu.ac.in
RI Singh, Vakil/F-6689-2014; G, Sudhakar Rao/A-4241-2013; G, Sudhakar
   Rao/P-3569-2016
OI Singh, Vakil/0000-0003-4111-8016; G, Sudhakar Rao/0000-0002-2433-5118;
   G, Sudhakar Rao/0000-0002-2433-5118
CR [Anonymous], 1999, IARC MONOGRAPHS EVAL, V74, P65
   Baba H, 2006, CORROS SCI, V48, P2510, DOI 10.1016/j.corsci.2005.09.010
   Baba H, 2002, CORROS SCI, V44, P2393, DOI 10.1016/S0010-938X(02)00040-9
   CRAMERS M, 1977, ACTA ORTHOP SCAND, V48, P245, DOI 10.3109/17453677708988763
   Cullity B.D., 1978, ELEMENTS XRAY DIFFRA
   Dai QX, 2009, MAT SCI ENG A-STRUCT, V517, P257, DOI 10.1016/j.msea.2009.05.006
   Diener M, 2004, MATER MANUF PROCESS, V19, P111, DOI 10.1081/AMP-120027519
   Disegi J.A., 2000, INJURY, V31, P4
   DUBE VE, 1972, CANCER, V30, P1260, DOI 10.1002/1097-0142(197211)30:5<1260::AID-CNCR2820300518>3.0.CO;2-Y
   Ferreira ME, 2003, J TRACE ELEM MED BIO, V17, P45, DOI 10.1016/S0946-672X(03)80045-7
   Maeng WY, 2000, J NUCL MATER, V282, P32, DOI 10.1016/S0022-3115(00)00401-3
   Menzel J, 1996, ISIJ INT, V36, P893, DOI 10.2355/isijinternational.36.893
   MUDALI UK, 1986, WERKST KORROS, V37, P637, DOI 10.1002/maco.19860371206
   Nakajima M, 2010, PROCEDIA ENGINEER, V2, P323, DOI 10.1016/j.proeng.2010.03.036
   Oda A., 1974, Journal of the Society of Materials Science, Japan, V23, P279
   OGAWA T, 2004, P 3 INT C VER HIGH C, P366
   Olefjord I, 1996, CORROS SCI, V38, P1203, DOI 10.1016/0010-938X(96)00018-2
   Pereira MC, 1998, J BIOMED MATER RES, V40, P40, DOI 10.1002/(SICI)1097-4636(199804)40:1<40::AID-JBM5>3.0.CO;2-R
   PERREN SM, 1991, INJURY, V22, P1
   Rao VS, 2009, ISIJ INT, V49, P1902, DOI 10.2355/isijinternational.49.1902
   Reclaru L, 2006, ACTA BIOMATER, V2, P433, DOI 10.1016/j.actbio.2006.03.004
   Rondelli G, 2005, BIOMATERIALS, V26, P739, DOI 10.1016/j.biomaterials.2004.03.012
   ROSTOKER G, 1987, J BONE JOINT SURG AM, V69A, P1408
   Schmidt C, 2001, J BIOMED MATER RES, V54, P209, DOI 10.1002/1097-4636(200102)54:2<209::AID-JBM7>3.0.CO;2-7
   SIVAKUMAR M, 1994, J MATER ENG PERFORM, V3, P744, DOI 10.1007/BF02818375
   STERN M, 1957, J ELECTROCHEM SOC, V104, P56, DOI 10.1149/1.2428496
   TAKEMOTO T, 1986, T IRON STEEL I JPN, V26, P337
   Topic M, 2007, INT J FATIGUE, V29, P656, DOI 10.1016/j.ijfatigue.2006.07.007
   Tseng CM, 2003, MAT SCI ENG A-STRUCT, V344, P190, DOI 10.1016/S0921-5093(02)00404-5
   Uggowitzer J., 1996, ISIJ INT, V36, P901
   Uggowitzer PJ, 1996, ISIJ INT, V36, P901, DOI 10.2355/isijinternational.36.901
   Ustinovshikov Y, 1999, MAT SCI ENG A-STRUCT, V262, P82, DOI 10.1016/S0921-5093(98)01015-6
   WOODMAN J L, 1984, Journal of Orthopaedic Research, V1, P421
NR 33
TC 4
Z9 4
U1 0
U2 16
PU ELSEVIER SCIENCE SA
PI LAUSANNE
PA PO BOX 564, 1001 LAUSANNE, SWITZERLAND
SN 0921-5093
EI 1873-4936
J9 MAT SCI ENG A-STRUCT
JI Mater. Sci. Eng. A-Struct. Mater. Prop. Microstruct. Process.
PD MAR 15
PY 2012
VL 538
BP 224
EP 230
DI 10.1016/j.msea.2012.01.034
PG 7
WC Nanoscience & Nanotechnology; Materials Science, Multidisciplinary;
   Metallurgy & Metallurgical Engineering
SC Science & Technology - Other Topics; Materials Science; Metallurgy &
   Metallurgical Engineering
GA 913TV
UT WOS:000301901200029
DA 2018-10-19
ER

PT J
AU Tansil, NC
   Koh, LD
   Han, MY
AF Tansil, Natalia C.
   Koh, Leng Duei
   Han, Ming-Yong
TI Functional Silk: Colored and Luminescent
SO ADVANCED MATERIALS
LA English
DT Article
DE silk; Bombyx mori; fibroin; luminescence; biomaterials
ID BOMBYX-MORI SILK; MESENCHYMAL STEM-CELLS; CONTROLLED-RELEASE;
   2ND-HARMONIC GENERATION; MECHANICAL-PROPERTIES; SILVER NANOPARTICLES;
   EXTRACELLULAR-MATRIX; TRANSGENIC SILKWORMS; BIOMATERIAL COATINGS;
   FIBROIN BIOMATERIALS
AB Silkworm silk is among the most widely used natural fibers for textile and biomedical applications due to its extraordinary mechanical properties and superior biocompatibility. A number of physical and chemical processes have also been developed to reconstruct silk into various forms or to artificially produce silk-like materials. In addition to the direct use and the delicate replication of silk's natural structure and properties, there is a growing interest to introduce more new functionalities into silk while maintaining its advantageous intrinsic properties. In this review we assess various methods and their merits to produce functional silk, specifically those with color and luminescence, through post-processing steps as well as biological approaches. There is a highlight on intrinsically colored and luminescent silk produced directly from silkworms for a wide range of applications, and a discussion on the suitable molecular properties for being incorporated effectively into silk while it is being produced in the silk gland. With these understanding, a new generation of silk containing various functional materials (e.g., drugs, antibiotics and stimuli-sensitive dyes) would be produced for novel applications such as cancer therapy with controlled release feature, wound dressing with monitoring/sensing feature, tissue engineering scaffolds with antibacterial, anticoagulant or anti-inflammatory feature, and many others.
C1 [Tansil, Natalia C.; Koh, Leng Duei; Han, Ming-Yong] Inst Mat Res & Engn, Singapore 117602, Singapore.
   [Koh, Leng Duei; Han, Ming-Yong] Natl Univ Singapore, Dept Bioengn, Singapore 117576, Singapore.
RP Han, MY (reprint author), Inst Mat Res & Engn, 3 Res Link, Singapore 117602, Singapore.
EM my-han@imre.a-star.edu.sg
FU Institute of Materials Research & Engineering, Agency for Science,
   Technology and Research (A*STAR) Singapore
FX This work was supported by the Institute of Materials Research &
   Engineering, Agency for Science, Technology and Research (A*STAR)
   Singapore.
CR Altman GH, 2003, BIOMATERIALS, V24, P401, DOI 10.1016/S0142-9612(02)00353-8
   Altman GH, 2002, BIOMATERIALS, V23, P4131, DOI 10.1016/S0142-9612(02)00156-4
   Bettinger CJ, 2007, ADV MATER, V19, P2847, DOI 10.1002/adma.200602487
   Bozzi A, 2005, J PHOTOCH PHOTOBIO A, V172, P27, DOI 10.1016/j.jphotochem.2004.11.010
   Campbell FL, 1932, J ECON ENTOMOL, V25, P905, DOI 10.1093/jee/25.4.905
   Cha HJ, 1999, BIOTECHNOL BIOENG, V65, P316, DOI 10.1002/(SICI)1097-0290(19991105)65:3<316::AID-BIT9>3.3.CO;2-O
   Chang SQ, 2008, MATER LETT, V62, P3447, DOI 10.1016/j.matlet.2008.02.074
   Chu MQ, 2008, IEEE T NANOTECHNOL, V7, P308, DOI 10.1109/TNANO.2008.917836
   Craig CL, 1997, ANNU REV ENTOMOL, V42, P231, DOI 10.1146/annurev.ento.42.1.231
   Domachuk P, 2010, ADV MATER, V22, P249, DOI 10.1002/adma.200900821
   Dubas ST, 2006, COLLOID SURFACE A, V289, P105, DOI 10.1016/j.colsurfa.2006.04.012
   Eadie L, 2011, J R SOC INTERFACE, V8, P761, DOI 10.1098/rsif.2010.0487
   EDWARDS WF, 1921, TEXT WORLD, V60, P1111
   Fujimoto JG, 2003, NAT BIOTECHNOL, V21, P1361, DOI 10.1038/nbt892
   Ghosh S, 2008, ADV FUNCT MATER, V18, P1883, DOI 10.1002/adfm.200800040
   Goris A., 1936, B ACAD MED
   Gulrajani ML, 2008, J APPL POLYM SCI, V108, P614, DOI 10.1002/app.27584
   Hakimi O, 2007, COMPOS PART B-ENG, V38, P324, DOI 10.1016/j.compositesb.2006.06.012
   Hardy JG, 2008, POLYMER, V49, P4309, DOI 10.1016/j.polymer.2008.08.006
   He JH, 2004, CHEM MATER, V16, P2656, DOI [10.1021/cm049548l, 10.1021/cm0495481]
   Hofmann S, 2007, BIOMATERIALS, V28, P1152, DOI 10.1016/j.biomaterials.2006.10.019
   Jiang XQ, 2009, BIOMATERIALS, V30, P4522, DOI 10.1016/j.biomaterials.2009.05.021
   Jin HJ, 2002, BIOMACROMOLECULES, V3, P1233, DOI 10.1021/bm025581u
   Jin HJ, 2003, NATURE, V424, P1057, DOI 10.1038/nature01809
   Jucei C., 1930, B SOC ITAL B SPERIM, V5, P1056
   KANEKO M, 1991, J PHOTOCH PHOTOBIO A, V61, P373, DOI 10.1016/1010-6030(91)90020-T
   KAPLAN DL, 1994, SILK POLYM MAT SCI B, pCH1
   Kim D. Y., 2009, APPL PHYS LETT, V95
   Kim TG, 2006, TISSUE ENG, V12, P221, DOI 10.1089/ten.2006.12.221
   Kim UJ, 2005, BIOMATERIALS, V26, P2775, DOI 10.1016/j.biomaterials.2004.07.044
   Kim UJ, 2004, BIOMACROMOLECULES, V5, P786, DOI 10.1021/bm0345460
   KOLYER JOHN M., 1965, J RES LEPIDOPTERA, V4, P159
   Lawrence BD, 2008, J MATER SCI, V43, P6967, DOI 10.1007/s10853-008-2961-y
   Lawrence BD, 2008, BIOMACROMOLECULES, V9, P1214, DOI 10.1021/bm701235f
   Lee HJ, 2003, J MATER SCI, V38, P2199, DOI 10.1023/A:1023736416361
   Li GH, 2011, J COLLOID INTERF SCI, V358, P307, DOI 10.1016/j.jcis.2011.02.053
   Liivak O, 1998, MACROMOLECULES, V31, P2947, DOI 10.1021/ma971626l
   Liu JM, 2009, MOL BIOL REP, V36, P329, DOI 10.1007/s11033-007-9183-2
   Lombardi O. M., 1920, ANN SCUOLA AGR PORTI, V2, P1
   Lu Q, 2010, MACROMOL BIOSCI, V10, P359, DOI 10.1002/mabi.200900388
   Matsumoto K, 1996, J APPL POLYM SCI, V60, P503, DOI 10.1002/(SICI)1097-4628(19960425)60:4<503::AID-APP3>3.0.CO;2-S
   Mayes EL, 1998, ADV MATER, V10, P801, DOI 10.1002/(SICI)1521-4095(199807)10:10<801::AID-ADMA801>3.0.CO;2-I
   Myung SJ, 2008, MACROMOL RES, V16, P604, DOI 10.1007/BF03218567
   Nazarov R, 2004, BIOMACROMOLECULES, V5, P718, DOI 10.1021/bm034327e
   Omenetto FG, 2008, NAT PHOTONICS, V2, P641, DOI 10.1038/nphoton.2008.207
   Parker ST, 2009, ADV MATER, V21, P2411, DOI 10.1002/adma.200801580
   Perez-Rigueiro J, 2000, POLYMER, V41, P8433, DOI 10.1016/S0032-3861(00)00179-8
   Perez-Rigueiro J, 1998, J APPL POLYM SCI, V70, P2439, DOI 10.1002/(SICI)1097-4628(19981219)70:12<2439::AID-APP16>3.0.CO;2-J
   Perez-Rigueiro J, 2000, J APPL POLYM SCI, V75, P1270, DOI 10.1002/(SICI)1097-4628(20000307)75:10<1270::AID-APP8>3.3.CO;2-3
   Perez-Rigueiro J, 2002, J APPL POLYM SCI, V84, P1431, DOI 10.1002/app.10366
   Perez-Rigueiro J, 2001, J APPL POLYM SCI, V82, P1928, DOI 10.1002/app.2038
   Perry H, 2008, ADV MATER, V20, P3070, DOI 10.1002/adma.200800011
   Potiyaraj P, 2007, MATER LETT, V61, P2464, DOI 10.1016/j.matlet.2006.09.039
   Pritchard EM, 2011, EXPERT OPIN DRUG DEL, V8, P797, DOI 10.1517/17425247.2011.568936
   Ren DM, 2011, SMALL, V7, P1051, DOI 10.1002/smll.201002242
   Rice WL, 2008, BIOMATERIALS, V29, P2015, DOI 10.1016/j.biomaterials.2007.12.049
   Robinson T, 2001, BIORESOURCE TECHNOL, V77, P247, DOI 10.1016/S0960-8524(00)00080-8
   Royer C, 2005, TRANSGENIC RES, V14, P463, DOI 10.1007/s11248-005-4351-4
   Sakudoh T, 2007, P NATL ACAD SCI USA, V104, P8941, DOI 10.1073/pnas.0702860104
   Sakudoh T, 2011, GENETICS, V187, P965, DOI 10.1534/genetics.110.124982
   Sakudoh T, 2010, J BIOL CHEM, V285, P7739, DOI 10.1074/jbc.M109.074435
   Shao ZZ, 2002, NATURE, V418, P741, DOI 10.1038/418741a
   Sirichaisit J, 2003, BIOMACROMOLECULES, V4, P387, DOI 10.1021/bm0256956
   Somashekarappa H, 1996, J APPL POLYM SCI, V59, P1677, DOI 10.1002/(SICI)1097-4628(19960314)59:11<1677::AID-APP3>3.0.CO;2-L
   Somashekarappa H, 2002, MATER LETT, V53, P415, DOI 10.1016/S0167-577X(01)00517-1
   Stevens MM, 2005, SCIENCE, V310, P1135, DOI 10.1126/science.1106587
   Tamura T, 2000, NAT BIOTECHNOL, V18, P81
   Tansil NC, 2011, BIOMATERIALS, V32, P9576, DOI 10.1016/j.biomaterials.2011.08.081
   Tansil NC, 2011, ADV MATER, V23, P1463, DOI 10.1002/adma.201003860
   Tomita M, 2003, NAT BIOTECHNOL, V21, P52, DOI 10.1038/nbt771
   Unger RE, 2004, BIOMATERIALS, V25, P1069, DOI [10.1016/S0142-9612(03)00619-7, 10.1016/S0142-9612(03)00630-6]
   van Beek JD, 2002, P NATL ACAD SCI USA, V99, P10266, DOI 10.1073/pnas.152162299
   Vepari C, 2007, PROG POLYM SCI, V32, P991, DOI 10.1016/j.progpolymsci.2007.05.013
   Vollrath F, 1998, P ROY SOC B-BIOL SCI, V265, P817, DOI 10.1098/rspb.1998.0365
   Vollrath F, 2001, NATURE, V410, P541, DOI 10.1038/35069000
   Wang XY, 2007, J CONTROL RELEASE, V121, P190, DOI 10.1016/j.jconrel.2007.06.006
   Wang XQ, 2007, J CONTROL RELEASE, V117, P360, DOI 10.1016/j.jconrel.2006.11.021
   Wang XY, 2005, LANGMUIR, V21, P11335, DOI 10.1021/la051862m
   Watanabe Y., 1989, J SRRIC SCI JPN, V58, P87
   Xin XJ, 2007, BIOMATERIALS, V28, P316, DOI 10.1016/j.biomaterials.2006.08.042
   Yamao M, 1999, GENE DEV, V13, P511, DOI 10.1101/gad.13.5.511
   Yao J., 2001, MACROMOLECULES, V35, P6
   Ye WJ, 2005, POLYMER, V46, P10538, DOI 10.1016/j.polymer.2005.08.019
   Zhao CH, 2003, BIOPOLYMERS, V69, P253, DOI 10.1002/bip.10350
   Zipfel WR, 2003, P NATL ACAD SCI USA, V100, P7075, DOI 10.1073/pnas.0832308100
   Zoumi A, 2002, P NATL ACAD SCI USA, V99, P11014, DOI 10.1073/pnas.172368799
   Zuo B, 2006, J MATER SCI, V41, P3357, DOI 10.1007/s10853-005-5384-z
NR 87
TC 49
Z9 50
U1 3
U2 160
PU WILEY-V C H VERLAG GMBH
PI WEINHEIM
PA PO BOX 10 11 61, D-69451 WEINHEIM, GERMANY
SN 0935-9648
J9 ADV MATER
JI Adv. Mater.
PD MAR 15
PY 2012
VL 24
IS 11
BP 1388
EP 1397
DI 10.1002/adma.201104118
PG 10
WC Chemistry, Multidisciplinary; Chemistry, Physical; Nanoscience &
   Nanotechnology; Materials Science, Multidisciplinary; Physics, Applied;
   Physics, Condensed Matter
SC Chemistry; Science & Technology - Other Topics; Materials Science;
   Physics
GA 906HT
UT WOS:000301336500002
PM 22302383
DA 2018-10-19
ER

PT J
AU Pernites, RB
   Santos, CM
   Maldonado, M
   Ponnapati, RR
   Rodrigues, DF
   Advincula, RC
AF Pernites, Roderick B.
   Santos, Catherine M.
   Maldonado, Miguel
   Ponnapati, Ramakrishna R.
   Rodrigues, Debora F.
   Advincula, Rigoberto C.
TI Tunable Protein and Bacterial Cell Adsorption on Colloidally Templated
   Superhydrophobic Polythiophene Films
SO CHEMISTRY OF MATERIALS
LA English
DT Article
DE superhydrophobic; polythiophene; polystyrene particles;
   electropolymerization
ID SELF-ASSEMBLED MONOLAYERS; ANTIMICROBIAL PEPTIDES; SURFACE WETTABILITY;
   CONDUCTING POLYMERS; HIGH-CONTRAST; RESIST; COATINGS; ADHESION; DESIGN;
   TERTHIOPHENE
AB A facile approach for enabling or inhibiting the adsorption of protein and adhesion of bacterial cells on a potential-induced reversibly wettable polythiophene film is described. The superhydrophobic polymeric surface was first prepared by a two-step process that combines the layering of polystyrene (PS) latex particles via a Langmuir-Blodgett (LB)-like technique followed by cyclic voltammetric (CV)-electrodeposition of polythiophene from a terthiophene ester monomer. The polythiophene conducting polymer coating enabled control of the wettability of the surface by simply changing its redox property via potential switching. The influence of morphology on this switching behavior is also described. The wettability in return controls the adsorption of protein and adhesion of bacterial cells. For instance, the undoped polythiophene film, which is superhydrophobic, inhibits the adhesion of fibrinogen proteins and Escherichia coli (E. coli) cells. On the other hand, the doped film, which is hydrophilic, leads to increased attachment of both protein and bacteria. Unlike most synthetic antiwetting surfaces, the as-prepared superhydrophobic coating is nonfluorinated. It maintains its superhydrophobic property at a wide range of pH (pH 1-13) and temperature (below -10 degrees C and between 4 and 80 degrees C). Moreover, the surface demonstrated self-cleaning properties at a sliding angle as low as 3 degrees +/- 1. The proposed methodology and material should find application in the preparation of smart or tunable biomaterial surfaces that can be either resistant or susceptible to proteins and bacterial cell adhesion by a simple potential switching.
C1 [Pernites, Roderick B.; Advincula, Rigoberto C.] Univ Houston, Dept Chem, Houston, TX 77204 USA.
   [Maldonado, Miguel; Ponnapati, Ramakrishna R.; Advincula, Rigoberto C.] Univ Houston, Dept Chem & Biomol Engn, Houston, TX 77204 USA.
   [Santos, Catherine M.; Rodrigues, Debora F.] Univ Houston, Dept Civil & Environm Engn, Houston, TX 77204 USA.
RP Advincula, RC (reprint author), Univ Houston, Dept Chem, Univ Pk, Houston, TX 77204 USA.
EM radvincula@uh.edu
RI Rodrigues, Debora/H-4375-2012; Rodrigues, Debora/I-9895-2014
OI Rodrigues, Debora/0000-0002-3124-1443
FU NSF [CBET-0854979, DMR-10-06776, CHE-1041300]; Robert A. Welch
   Foundation [E-1551]
FX The authors would like to acknowledge partial funding from NSF
   CBET-0854979, DMR-10-06776, CHE-1041300, and Robert A. Welch Foundation,
   E-1551. We also acknowledge the technical support from Metrohm USA, Inc.
   (previously Brinkmann-Eco Chemie), KSV Instruments (Biotin), INFICON
   Inc. and Agilent Technologies.
CR Apodaca DC, 2011, ACS APPL MATER INTER, V3, P191, DOI 10.1021/am100805y
   Azioune A, 2002, LANGMUIR, V18, P1150, DOI 10.1021/la010444o
   BAIER RE, 1984, J BIOMED MATER RES, V18, P337, DOI 10.1002/jbm.820180404
   Banerjee I, 2011, ADV MATER, V23, P690, DOI 10.1002/adma.201001215
   Barthlott W, 1997, PLANTA, V202, P1, DOI 10.1007/s004250050096
   BAYER ME, 1990, J GEN MICROBIOL, V136, P867, DOI 10.1099/00221287-136-5-867
   Benhabbour SR, 2008, MACROMOLECULES, V41, P2567, DOI 10.1021/ma702074v
   BENMAKROHA Y, 1995, MED BIOL ENG COMPUT, V33, P811, DOI 10.1007/BF02523013
   Bers AV, 2004, BIOFOULING, V20, P43, DOI 10.1080/08927010410001655533
   Blossey R, 2003, NAT MATER, V2, P301, DOI 10.1038/nmat856
   BREDAS JL, 1985, ACCOUNTS CHEM RES, V18, P309, DOI 10.1021/ar00118a005
   Cassie ABD, 1944, T FARADAY SOC, V40, P0546, DOI 10.1039/tf9444000546
   Chapman RG, 2001, LANGMUIR, V17, P1225, DOI 10.1021/la001222d
   Chapman RG, 2000, J AM CHEM SOC, V122, P8303, DOI 10.1021/ja000774f
   Clarke ML, 2005, J PHYS CHEM B, V109, P22027, DOI 10.1021/jp054456k
   Close M, 2008, J WATER HEALTH, V6, P83, DOI 10.2166/wh.2007.020
   Darmanin T, 2009, J AM CHEM SOC, V131, P7928, DOI 10.1021/ja901392s
   Dash RR, 2009, J HAZARD MATER, V163, P1, DOI 10.1016/j.jhazmat.2008.06.051
   Deore B, 1999, ANAL SCI, V15, P827, DOI 10.2116/analsci.15.827
   Dopson M, 2008, BIOTECHNOL BIOENG, V99, P811, DOI 10.1002/bit.21628
   Feldman K, 1999, J AM CHEM SOC, V121, P10134, DOI 10.1021/ja991049b
   Feng XJ, 2006, ADV MATER, V18, P3063, DOI 10.1002/adma.200501961
   Ferrer MCC, 2010, LANGMUIR, V26, P14126, DOI 10.1021/la102315j
   FRENTZEN M, 1988, DEUT ZAHNAERZTL Z, V43, P719
   Gao XF, 2004, NATURE, V432, P36, DOI 10.1038/432036a
   Gaupp CL, 2002, MACROMOL RAPID COMM, V23, P885, DOI 10.1002/1521-3927(20021001)23:15<885::AID-MARC885>3.0.CO;2-X
   Gavrilescu M, 2009, J HAZARD MATER, V163, P475, DOI 10.1016/j.jhazmat.2008.07.103
   Genzer J, 2006, BIOFOULING, V22, P339, DOI 10.1080/08927010600980223
   Ghuysen J.-M., 1994, BACTERIAL CELL WALL
   Giesy JP, 2001, ENVIRON SCI TECHNOL, V35, P1339, DOI 10.1021/es001834k
   GOMBOTZ WR, 1991, J BIOMED MATER RES, V25, P1547, DOI 10.1002/jbm.820251211
   GOODMAN SL, 1990, J COLLOID INTERF SCI, V139, P561, DOI 10.1016/0021-9797(90)90129-C
   Hoipkemeier-Wilson L, 2004, BIOFOULING, V20, P53, DOI 10.1080/08927010410001662689
   Houde M, 2006, ENVIRON SCI TECHNOL, V40, P3463, DOI 10.1021/es052580b
   Huang JH, 2009, ACS APPL MATER INTER, V1, P2821, DOI 10.1021/am900573q
   Ikeda T, 2009, J AM CHEM SOC, V131, P9158, DOI 10.1021/ja902992c
   JEON SI, 1991, J COLLOID INTERF SCI, V142, P159, DOI 10.1016/0021-9797(91)90044-9
   Johnell M, 2005, BIOMATERIALS, V26, P1731, DOI 10.1016/j.biomaterials.2004.05.029
   Johnson R. E., 1963, ADV CHEM SER, V43, P112, DOI DOI 10.1021/BA-1964-0043.CH007
   Klement P, 2002, BIOMATERIALS, V23, P527, DOI 10.1016/S0142-9612(01)00135-1
   Koc Y, 2008, LAB CHIP, V8, P582, DOI 10.1039/b716509a
   Kumar A, 1998, CHEM MATER, V10, P896, DOI 10.1021/cm9706614
   Kumar A, 1996, MACROMOLECULES, V29, P7629, DOI 10.1021/ma960879w
   Kumar N, 2005, LANGMUIR, V21, P6652, DOI 10.1021/la050331v
   Kumar N, 2007, J PHYS CHEM B, V111, P4581, DOI 10.1021/jp068509p
   Lange U, 2008, ANAL CHIM ACTA, V614, P1, DOI 10.1016/j.aca.2008.02.068
   Lee W, 2004, LANGMUIR, V20, P7665, DOI 10.1021/la049411+
   Lehmann T, 1999, MACROMOL SYMP, V142, P1, DOI 10.1002/masy.19991420103
   Lichter JA, 2009, MACROMOLECULES, V42, P8573, DOI 10.1021/ma901356s
   Liu D, 2009, LANGMUIR, V25, P4526, DOI 10.1021/la8038957
   Liu M, 2009, ACS APPL MATER INTER, V1, P113, DOI 10.1021/am800042v
   Liu T, 2010, ELECTROCHIM ACTA, V55, P5281, DOI 10.1016/j.electacta.2010.04.082
   Ma ML, 2006, CURR OPIN COLLOID IN, V11, P193, DOI 10.1016/j.cocis.2006.06.002
   Marmur A, 2006, BIOFOULING, V22, P107, DOI 10.1080/08927010600562328
   Marmur A, 2003, LANGMUIR, V19, P8343, DOI 10.1021/la0344682
   Marquez M, 2004, LANGMUIR, V20, P10998, DOI 10.1021/la048155y
   Miwa M, 2000, LANGMUIR, V16, P5754, DOI [10.1021/la991660o, 10.1021/1a991660o]
   Mock U, 2005, J PHYS-CONDENS MAT, V17, pS639, DOI 10.1088/0953-8984/17/9/021
   MRKSICH M, 1995, LANGMUIR, V11, P4383, DOI 10.1021/la00011a034
   Oren Z, 1998, BIOPOLYMERS, V47, P451
   Ostuni E, 2001, LANGMUIR, V17, P6336, DOI 10.1021/la010552a
   Ostuni E, 2001, LANGMUIR, V17, P5605, DOI 10.1021/la010384m
   Otten A, 2004, LANGMUIR, V20, P2405, DOI 10.1021/la034961d
   Park JY, 2009, APPL MICROBIOL BIOT, V82, P415, DOI 10.1007/s00253-008-1799-1
   Pernites R, 2011, BIOSENS BIOELECTRON, V26, P2766, DOI 10.1016/j.bios.2010.10.027
   Pernites RB, 2010, MACROMOLECULES, V43, P9724, DOI 10.1021/ma101868y
   Pompe T, 2003, BIOMACROMOLECULES, V4, P1072, DOI 10.1021/bm034071c
   PRIME KL, 1993, J AM CHEM SOC, V115, P10714, DOI 10.1021/ja00076a032
   PRIME KL, 1991, SCIENCE, V252, P1164, DOI 10.1126/science.252.5009.1164
   RABINOW BE, 1994, J BIOMAT SCI-POLYM E, V6, P91, DOI 10.1163/156856295X00788
   RASCH B, 1994, J ELECTROANAL CHEM, V370, P109, DOI 10.1016/0022-0728(93)03158-L
   Reisch A, 2008, J MATER CHEM, V18, P4242, DOI 10.1039/b808467j
   Reisch A, 2009, LANGMUIR, V25, P3610, DOI 10.1021/la8037846
   RONCALI J, 1992, CHEM REV, V92, P711, DOI 10.1021/cr00012a009
   SADANA A, 1992, CHEM REV, V92, P1799, DOI 10.1021/cr00016a006
   Schwendeman I, 2001, ADV MATER, V13, P634, DOI 10.1002/1521-4095(200105)13:9<634::AID-ADMA634>3.0.CO;2-3
   Shai Y, 2002, BIOPOLYMERS, V66, P236, DOI 10.1002/bip.10260
   Shen MC, 2003, LANGMUIR, V19, P1692, DOI 10.1021/la0259297
   Shiu JY, 2007, ADV FUNCT MATER, V17, P2680, DOI 10.1002/adfm.200700122
   Shiu JY, 2010, LAB CHIP, V10, P556, DOI 10.1039/c000798f
   Sigal GB, 1998, J AM CHEM SOC, V120, P3464, DOI 10.1021/ja970819l
   Steele A, 2009, NANO LETT, V9, P501, DOI 10.1021/nl8037272
   Taranekar P, 2007, LANGMUIR, V23, P908, DOI 10.1021/la061820d
   Torstensson L., 2008, J AGR FOOD CHEM, V56, P6206
   Tsvetanova Z, 2006, NATO SCI PEACE SECUR, P463, DOI 10.1007/978-1-4020-5098-5_46
   Vinther FP, 2008, J ENVIRON QUAL, V37, P1710, DOI 10.2134/jeq2006.0201
   Wagner T, 1996, ACTA ZOOL-STOCKHOLM, V77, P213, DOI 10.1111/j.1463-6395.1996.tb01265.x
   Wei T, 2009, J PHYS CHEM C, V113, P2053, DOI 10.1021/jp806586n
   Welsh DM, 2002, MACROMOLECULES, V35, P6517, DOI 10.1021/ma0120409
   Xia C, 2001, LANGMUIR, V17, P7893, DOI 10.1021/la011259d
   Yakimov MM, 2007, CURR OPIN BIOTECH, V18, P257, DOI 10.1016/j.copbio.2007.04.006
   Yang Q, 2010, ACS APPL MATER INTER, V2, P3555, DOI 10.1021/am1007276
   Zhang H, 2005, SCI TECHNOL ADV MAT, V6, P236, DOI 10.1016/j.stam.2005.03.003
NR 93
TC 64
Z9 65
U1 5
U2 123
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 0897-4756
J9 CHEM MATER
JI Chem. Mat.
PD MAR 13
PY 2012
VL 24
IS 5
BP 870
EP 880
DI 10.1021/cm2007044
PG 11
WC Chemistry, Physical; Materials Science, Multidisciplinary
SC Chemistry; Materials Science
GA 907DN
UT WOS:000301398100013
DA 2018-10-19
ER

PT J
AU Pedraza, E
   Coronel, MM
   Fraker, CA
   Ricordi, C
   Stabler, CL
AF Pedraza, Eileen
   Coronel, Maria M.
   Fraker, Christopher A.
   Ricordi, Camillo
   Stabler, Cherie L.
TI Preventing hypoxia-induced cell death in beta cells and islets via
   hydrolytically activated, oxygen-generating biomaterials
SO PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF
   AMERICA
LA English
DT Article
DE tissue engineering; encapsulation; bioartificial pancreas; diabetes
ID BIOARTIFICIAL PANCREAS; GROWTH; DEVICE; TRANSPLANTATION
AB A major hindrance in engineering tissues containing highly metabolically active cells is the insufficient oxygenation of these implants, which results in dying or dysfunctional cells in portions of the graft. The development of methods to increase oxygen availability within tissue-engineered implants, particularly during the early engraftment period, would serve to allay hypoxia-induced cell death. Herein, we designed and developed a hydrolytically activated oxygen-generating biomaterial in the form of polydimethylsiloxane (PDMS)-encapsulated solid calcium peroxide, PDMS-CaO2. Encapsulation of solid peroxide within hydrophobic PDMS resulted in sustained oxygen generation, whereby a single disk generated oxygen for more than 6 wk at an average rate of 0.026 mM per day. The ability of this oxygen-generating material to support cell survival was evaluated using a beta cell line and pancreatic rat islets. The presence of a single PDMS-CaO2 disk eliminated hypoxia-induced cell dysfunction and death for both cell types, resulting in metabolic function and glucose-dependent insulin secretion comparable to that in normoxic controls. A single PDMS-CaO2 disk also sustained enhanced beta cell proliferation for more than 3 wk under hypoxic culture conditions. Incorporation of these materials within 3D constructs illustrated the benefits of these materials to prevent the development of detrimental oxygen gradients within large implants. Mathematical simulations permitted accurate prediction of oxygen gradients within 3D constructs and highlighted conditions under which supplementation of oxygen tension would serve to benefit cellular viability. Given the generality of this platform, the translation of these materials to other cell-based implants, as well as ischemic tissues in general, is envisioned.
C1 [Pedraza, Eileen; Coronel, Maria M.; Fraker, Christopher A.; Ricordi, Camillo; Stabler, Cherie L.] Univ Miami, Leonard M Miller Sch Med, Diabetes Res Inst, Miami, FL 33136 USA.
   [Ricordi, Camillo; Stabler, Cherie L.] Univ Miami, Dept Surg, Diabetes Res Inst, Miami, FL 33136 USA.
   [Ricordi, Camillo] Univ Miami, Dept Med, Diabetes Res Inst, Miami, FL 33136 USA.
   [Pedraza, Eileen; Coronel, Maria M.; Fraker, Christopher A.; Ricordi, Camillo; Stabler, Cherie L.] Univ Miami, Coll Engn, Dept Biomed Engn, Coral Gables, FL 33134 USA.
RP Stabler, CL (reprint author), Univ Miami, Leonard M Miller Sch Med, Diabetes Res Inst, Miami, FL 33136 USA.
EM cstabler@med.miami.edu
RI Stabler, Cherie/E-8227-2011
OI Coronel, Maria/0000-0001-9661-7221; Ricordi,
   Camillo/0000-0001-8092-7153; Fraker, Christopher/0000-0002-2010-0573
FU Juvenile Diabetes Research Institute Foundation Center [4-2004-361];
   Diabetes Research Institute Foundation; Department of Defense
   [N00244-07-C-1529]; National Institutes of Health, National Institute of
   Diabetes and Digestive and Kidney Diseases
FX We thank the Diabetes Research Institute (DRI) Preclinical and
   Translational Models Core for providing rat islets and the DRI
   Analytical Imaging Core for use of their facilities, as well as George
   McNamara for his assistance in image collection and processing. This
   research was supported by Juvenile Diabetes Research Institute
   Foundation Center Grant 4-2004-361, the Diabetes Research Institute
   Foundation, and by Department of Defense Grant N00244-07-C-1529. E.P.
   was supported by a National Institutes of Health, National Institute of
   Diabetes and Digestive and Kidney Diseases Predoctoral Fellowship.
CR Aldlercreutz P, 1982, EUR J APPL MICROBIOL, V16, P165
   Ballian N, 2007, WORLD J SURG, V31, P705, DOI 10.1007/s00268-006-0719-8
   Bloch K, 2006, TISSUE ENG, V12, P337, DOI 10.1089/ten.2006.12.337
   Cantley J, 2010, DIABETES OBES METAB, V12, P159, DOI 10.1111/j.1463-1326.2010.01276.x
   Curtis J., 2004, BIOMATERIALS SCI INT, P697
   DIONNE KE, 1993, DIABETES, V42, P12, DOI 10.2337/diabetes.42.1.12
   Ehrbar M, 2004, CIRC RES, V94, P1124, DOI 10.1161/01.RES.0000126411.29641.08
   FOLKMAN J, 1973, J EXP MED, V138, P745, DOI 10.1084/jem.138.4.745
   Harrison BS, 2007, BIOMATERIALS, V28, P4628, DOI 10.1016/j.biomaterials.2007.07.003
   HERMAN B, 1988, FASEB J, V2, P146
   Khademhosseini A, 2006, P NATL ACAD SCI USA, V103, P2480, DOI 10.1073/pnas.0507681102
   Ludwig B, 2010, HORM METAB RES, V42, P918, DOI 10.1055/s-0030-1267916
   Miao G, 2006, AM J TRANSPLANT, V6, P2636, DOI 10.1111/j.1600-6143.2006.01541.x
   Northup A, 2008, J HAZARD MATER, V152, P1164, DOI 10.1016/j.jhazmat.2007.07.096
   Oh SH, 2009, BIOMATERIALS, V30, P757, DOI 10.1016/j.biomaterials.2008.09.065
   Pileggi A, 2006, TRANSPLANTATION, V81, P1318, DOI 10.1097/01.tp.0000203858.41105.88
   Robb W L, 1968, Ann N Y Acad Sci, V146, P119, DOI 10.1111/j.1749-6632.1968.tb20277.x
   Sato Y, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.194738
   Semenza GL, 1999, ANNU REV CELL DEV BI, V15, P551, DOI 10.1146/annurev.cellbio.15.1.551
   Semenza GL, 2007, SCIENCE, V318, P62, DOI 10.1126/science.1147949
   Silva AI, 2006, MED RES REV, V26, P181, DOI 10.1002/med.20047
   Stabler C, 2001, BIOMATERIALS, V22, P1301, DOI 10.1016/S0142-9612(00)00282-9
   Tiedge M, 1997, DIABETES, V46, P1733, DOI 10.2337/diabetes.46.11.1733
   Watson JM, 1996, J MEMBRANE SCI, V110, P47, DOI 10.1016/0376-7388(95)00229-4
   Wu H, 1999, ANN NY ACAD SCI, V875, P105, DOI 10.1111/j.1749-6632.1999.tb08497.x
   Zisch AH, 2003, FASEB J, V17, P2260, DOI 10.1096/fj.02-1041fje
NR 26
TC 110
Z9 111
U1 4
U2 50
PU NATL ACAD SCIENCES
PI WASHINGTON
PA 2101 CONSTITUTION AVE NW, WASHINGTON, DC 20418 USA
SN 0027-8424
J9 P NATL ACAD SCI USA
JI Proc. Natl. Acad. Sci. U. S. A.
PD MAR 13
PY 2012
VL 109
IS 11
BP 4245
EP 4250
DI 10.1073/pnas.1113560109
PG 6
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA 907OH
UT WOS:000301426700047
PM 22371586
OA Green Published, Bronze
DA 2018-10-19
ER

PT J
AU Solorio, LD
   Vieregge, EL
   Dhami, CD
   Dang, PN
   Alsberg, E
AF Solorio, Loran D.
   Vieregge, Eran L.
   Dhami, Chirag D.
   Dang, Phuong N.
   Alsberg, Eben
TI Engineered cartilage via self-assembled hMSC sheets with incorporated
   biodegradable gelatin microspheres releasing transforming growth
   factor-beta 1
SO JOURNAL OF CONTROLLED RELEASE
LA English
DT Article
DE Tissue engineering; Biomaterial; Mesenchymal stem cell; Transforming
   growth factor; Microsphere
ID MESENCHYMAL STEM-CELLS; ARTICULAR-CARTILAGE; CHONDROGENIC
   DIFFERENTIATION; PROGENITOR CELLS; MECHANICAL-PROPERTIES;
   GROWTH-FACTORS; MARROW; DELIVERY; GENERATION; HYDROGELS
AB Self-assembling cell sheets have shown great potential for use in cartilage tissue engineering applications, as they provide an advantageous environment for the chondrogenic induction of human mesenchymal stem cells (hMSCs). We have engineered a system of self-assembled, microsphere-incorporated hMSC sheets capable of forming cartilage in the presence of exogenous transforming growth factor beta 1 (TGF-beta 1) or with TGF-beta 1 released from incorporated microspheres. Gelatin microspheres with two different degrees of crosslinking were used to enable different cell-mediated microsphere degradation rates. Biochemical assays, histological and immunohistochemical analyses, and biomechanical testing were performed to determine biochemical composition, structure, and equilibrium modulus in unconfined compression after 3 weeks of culture. The inclusion of microspheres with or without loaded TGF-beta 1 significantly increased sheet thickness and compressive equilibrium modulus, and enabled more uniform matrix deposition by comparison to control sheets without microspheres. Sheets incorporated with fast-degrading microspheres containing TGF-beta 1 produced significantly more GAG and GAG per DNA than all other groups tested and stained more intensely for type II collagen. These findings demonstrate improved cartilage formation in microsphere-incorporated cell sheets, and describe a tailorable system for the chondrogenic induction of hMSCs without necessitating culture in growth factor-containing medium. (C) 2011 Elsevier B.V. All rights reserved.
C1 [Solorio, Loran D.; Dhami, Chirag D.; Dang, Phuong N.; Alsberg, Eben] Case Western Reserve Univ, Dept Biomed Engn, Cleveland, OH 44106 USA.
   [Vieregge, Eran L.] Case Western Reserve Univ, Sch Med, Cleveland, OH 44106 USA.
   [Alsberg, Eben] Case Western Reserve Univ, Dept Orthopaed Surg, Cleveland, OH 44106 USA.
RP Alsberg, E (reprint author), Case Western Reserve Univ, Dept Biomed Engn, Wickenden Bldg,Rm 309,10900 Euclid Ave, Cleveland, OH 44106 USA.
EM loran.solorio@case.edu; eran.vieregge@case.edu; chirag.dhami@case.edu;
   phuong.dang@case.edu; eben.alsberg@case.edu
OI Alsberg, Eben/0000-0002-3487-4625
FU NIH/NIAMS [T32 AR007505]; National Science Foundation; Ohio Department
   of Development [09-071]; Ellison Medical Foundation
FX The authors would like to thank Angela Carlson, Amad Awadallah and Adam
   Whitney for technical assistance. This work was supported by NIH/NIAMS
   T32 AR007505 (LDS), a National Science Foundation Graduate Research
   Fellowship (PND), Biomedical Research and Technology Transfer Grant
   09-071 from the Ohio Department of Development (EA) and a New Scholar in
   Aging grant from the Ellison Medical Foundation (EA).
CR Alsberg E, 2006, EXPERT OPIN BIOL TH, V6, P847, DOI 10.1517/14712598.6.9.847
   Ando W, 2008, TISSUE ENG PT A, V14, P2041, DOI 10.1089/ten.tea.2008.0015
   BUSCHMANN MD, 1995, J BIOMECH ENG-T ASME, V117, P179, DOI 10.1115/1.2796000
   Ebert JR, 2011, AM J SPORT MED, V39, P753, DOI 10.1177/0363546510390476
   Elder SH, 2009, TISSUE ENG PT A, V15, P3025, DOI [10.1089/ten.tea.2008.0617, 10.1089/ten.TEA.2008.0617]
   FARNDALE RW, 1986, BIOCHIM BIOPHYS ACTA, V883, P173, DOI 10.1016/0304-4165(86)90306-5
   Hayashi K, 2011, ACTA BIOMATER, V7, P2797, DOI 10.1016/j.actbio.2011.04.013
   HAYNESWORTH SE, 1992, BONE, V13, P81, DOI 10.1016/8756-3282(92)90364-3
   Henderson JH, 2007, TISSUE ENG, V13, P843, DOI 10.1089/ten.2006.0256
   Holland TA, 2004, J CONTROL RELEASE, V94, P101, DOI 10.1016/j.jconrel.2003.09.007
   Hu JC, 2006, TISSUE ENG, V12, P1337, DOI 10.1089/ten.2006.12.1337
   Hu JC, 2006, TISSUE ENG, V12, P969, DOI 10.1089/ten.2006.12.969
   Ikada Y., 1998, ADV DRUG DELIV REV, V31, P287
   Johnstone B, 1998, EXP CELL RES, V238, P265, DOI 10.1006/excr.1997.3858
   Kelly DJ, 2007, J MATER SCI-MATER M, V18, P273, DOI 10.1007/s10856-006-0689-2
   Kretlow JD, 2007, ADV DRUG DELIVER REV, V59, P263, DOI 10.1016/j.addr.2007.03.013
   Lawrence RC, 2008, ARTHRITIS RHEUM, V58, P26, DOI 10.1002/art.23176
   Lennon DP, 1996, IN VITRO CELL DEV-AN, V32, P602
   Liang HC, 2004, J APPL POLYM SCI, V91, P4017, DOI 10.1002/app.13563
   Lima EG, 2007, OSTEOARTHR CARTILAGE, V15, P1025, DOI 10.1016/j.joca.2007.03.008
   Mackay AM, 1998, TISSUE ENG, V4, P415, DOI 10.1089/ten.1998.4.415
   Martin I, 2000, BIORHEOLOGY, V37, P141
   Mayer-Wagner S, 2010, TISSUE ENG PT A, V16, P513, DOI [10.1089/ten.tea.2009.0326, 10.1089/ten.TEA.2009.0326]
   McGowan KB, 2002, OSTEOARTHR CARTILAGE, V10, P580, DOI 10.1053/joca.2002.0794
   Mi FL, 2005, BIOMACROMOLECULES, V6, P975, DOI 10.1021/bm049335p
   Mikos AG, 2006, TISSUE ENG, V12, P3307, DOI 10.1089/ten.2006.12.3307
   Mow V, 2002, ANNU REV BIOMED ENG, V4, P175, DOI 10.1146/annurev.bioeng.4.110701.120309
   Murdoch AD, 2007, STEM CELLS, V25, P2786, DOI 10.1634/stemcells.2007-0374
   Naumann A, 2004, TISSUE ENG, V10, P1695, DOI 10.1089/ten.2004.10.1695
   Park H, 2005, BIOMATERIALS, V26, P7095, DOI 10.1016/j.biomaterials.2005.05.083
   Scharstuhl A, 2007, STEM CELLS, V25, P3244, DOI 10.1634/stemcells.2007.0300
   Solchaga LA, 2004, METH MOLEC MED, V100, P53
   Solchaga LA, 2005, J CELL PHYSIOL, V203, P398, DOI 10.1002/jcp.20238
   Solorio LD, 2010, J BIOMED MATER RES A, V92A, P1139, DOI 10.1002/jbm.a.32440
   Solorio L, 2010, J TISSUE ENG REGEN M, V4, P514, DOI 10.1002/term.267
   Sung HW, 1999, J BIOMAT SCI-POLYM E, V10, P63, DOI 10.1163/156856299X00289
   Tabata Y, 1999, J BIOACT COMPAT POL, V14, P371, DOI 10.1177/088391159901400501
   Toh WS, 2011, MOL PHARMACEUT, V8, P994, DOI 10.1021/mp100437a
   TOUYAMA R, 1994, CHEM PHARM BULL, V42, P1571
   Tran SC, 2011, BIOTECHNOL BIOENG, V108, P1421, DOI 10.1002/bit.23061
   Widuchowski W, 2007, KNEE, V14, P177, DOI 10.1016/j.knee.2007.02.001
   Yamamoto M, 2001, J BIOMAT SCI-POLYM E, V12, P77, DOI 10.1163/156856201744461
   Yoo JU, 1998, J BONE JOINT SURG AM, V80A, P1745, DOI 10.2106/00004623-199812000-00004
   Young S, 2005, J CONTROL RELEASE, V109, P256, DOI 10.1016/j.jconrel.2005.09.023
   Zhang LM, 2010, BIOTECHNOL LETT, V32, P1339, DOI 10.1007/s10529-010-0293-x
NR 45
TC 48
Z9 55
U1 2
U2 25
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0168-3659
J9 J CONTROL RELEASE
JI J. Control. Release
PD MAR 10
PY 2012
VL 158
IS 2
BP 224
EP 232
DI 10.1016/j.jconrel.2011.11.003
PG 9
WC Chemistry, Multidisciplinary; Pharmacology & Pharmacy
SC Chemistry; Pharmacology & Pharmacy
GA 923GG
UT WOS:000302607000006
PM 22100386
OA Green Accepted
DA 2018-10-19
ER

PT J
AU Kai, D
   Prabhakaran, MP
   Stahl, B
   Eblenkamp, M
   Wintermantel, E
   Ramakrishna, S
AF Kai, Dan
   Prabhakaran, Molamma P.
   Stahl, Benjamin
   Eblenkamp, Markus
   Wintermantel, Erich
   Ramakrishna, Seeram
TI Mechanical properties and in vitro behavior of nanofiber-hydrogel
   composites for tissue engineering applications
SO NANOTECHNOLOGY
LA English
DT Article
ID STRENGTH; FILMS
AB Hydrogel-based biomaterial systems have great potential for tissue reconstruction by serving as temporary scaffolds and cell delivery vehicles for tissue engineering (TE). Hydrogels have poor mechanical properties and their rapid degradation limits the development and application of hydrogels in TE. In this study, nanofiber reinforced composite hydrogels were fabricated by incorporating electrospun poly(epsilon-caprolactone) (PCL)/gelatin 'blend' or 'coaxial' nanofibers into gelatin hydrogels. The morphological, mechanical, swelling and biodegradation properties of the nanocomposite hydrogels were evaluated and the results indicated that the moduli and compressive strengths of the nanofiber reinforced hydrogels were remarkably higher than those of pure gelatin hydrogels. By increasing the amount of incorporated nanofibers into the hydrogel, the Young's modulus of the composite hydrogels increased from 3.29 +/- 1.02 kPa to 20.30 +/- 1.79 kPa, while the strain at break decreased from 66.0 +/- 1.1% to 52.0 +/- 3.0%. Compared to composite hydrogels with coaxial nanofibers, those with blend nanofibers showed higher compressive strength and strain at break, but with lower modulus and energy dissipation properties. Biocompatibility evaluations of the nanofiber reinforced hydrogels were carried out using bone marrow mesenchymal stem cells (BM-MSCs) by cell proliferation assay and immunostaining analysis. The nanocomposite hydrogel with 25 mg ml(-1) PCL/gelatin 'blend' nanofibers (PGB25) was found to enhance cell proliferation, indicating that the 'nanocomposite hydrogels' might provide the necessary mechanical support and could be promising cell delivery systems for tissue regeneration.
C1 [Prabhakaran, Molamma P.; Stahl, Benjamin] Natl Univ Singapore, Hlth Care & Energy Mat Lab, Nanosci & Nanotechnol Initiat, Fac Engn, Singapore 117576, Singapore.
   [Kai, Dan] Natl Univ Singapore, NUS Grad Sch Integrat Sci & Engn, Singapore 117576, Singapore.
   [Stahl, Benjamin; Eblenkamp, Markus; Wintermantel, Erich] Tech Univ Munich, Inst Med & Polymer Engn, Fac Mech Engn, Munich, Germany.
   [Ramakrishna, Seeram] Natl Univ Singapore, HEM Labs, NUSNNI, Singapore 117576, Singapore.
   [Ramakrishna, Seeram] Natl Univ Singapore, Dept Mech Engn, Singapore 117576, Singapore.
RP Prabhakaran, MP (reprint author), Natl Univ Singapore, Hlth Care & Energy Mat Lab, Nanosci & Nanotechnol Initiat, Fac Engn, E3-05-14,2 Engn Dr 3, Singapore 117576, Singapore.
EM nnimpp@nus.edu.sg
RI Prabhakaran, Molamma/M-8630-2013
FU NRF-Technion [R-398-001-065-592]; Nanoscience and Nanotechnology
   Initiative, Faculty of Engineering, National University of Singapore,
   Singapore
FX This research was supported by NRF-Technion grant (WBS No.
   R-398-001-065-592), and the Nanoscience and Nanotechnology Initiative,
   Faculty of Engineering, National University of Singapore, Singapore.
CR Bigi A, 2001, BIOMATERIALS, V22, P763, DOI 10.1016/S0142-9612(00)00236-2
   Buyanov AL, 2010, J MECH BEHAV BIOMED, V3, P102, DOI 10.1016/j.jmbbm.2009.06.001
   Drury JL, 2003, BIOMATERIALS, V24, P4337, DOI 10.1016/S0142-9612(03)00340-5
   Freeman JW, 2011, J BIOMECH, V44, P694, DOI 10.1016/j.jbiomech.2010.10.043
   Gong JP, 2003, ADV MATER, V15, P1155, DOI 10.1002/adma.200304907
   Hong Y, 2011, BIOMATERIALS, V32, P3387, DOI 10.1016/j.biomaterials.2011.01.025
   Hsieh A, 2010, SOFT MATTER, V6, P2227, DOI 10.1039/b924349f
   Huang T, 2007, ADV MATER, V19, P1622, DOI 10.1002/adma.200602533
   Kai D, 2011, J BIOMED MATER RES B, V98B, P379, DOI 10.1002/jbm.b.31862
   Lee WF, 2001, J APPL POLYM SCI, V82, P2487, DOI 10.1002/app.2099
   Lim SH, 2009, ADV DRUG DELIVER REV, V61, P1084, DOI 10.1016/j.addr.2009.07.011
   Lopergolo LC, 2002, J APPL POLYM SCI, V86, P662, DOI 10.1002/app.10929
   Screen HRC, 2010, ADV FUNCT MATER, V20, P738, DOI 10.1002/adfm.200901711
   Smith LA, 2008, SOFT MATTER, V4, P2144, DOI 10.1039/b807088c
   Stefanescu EA, 2008, POLYMER, V49, P3785, DOI 10.1016/j.polymer.2008.06.035
   Tong X, 2007, MATER LETT, V61, P1704, DOI 10.1016/j.matlet.2006.07.115
   Tronci G, 2010, J MATER CHEM, V20, P8875, DOI 10.1039/c0jm00883d
   Wu YT, 2009, J MATER CHEM, V19, P7340, DOI 10.1039/b909125d
   Zhou CJ, 2011, COLLOID SURFACE B, V84, P155, DOI 10.1016/j.colsurfb.2010.12.030
NR 19
TC 69
Z9 70
U1 9
U2 82
PU IOP PUBLISHING LTD
PI BRISTOL
PA TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND
SN 0957-4484
J9 NANOTECHNOLOGY
JI Nanotechnology
PD MAR 9
PY 2012
VL 23
IS 9
AR 095705
DI 10.1088/0957-4484/23/9/095705
PG 10
WC Nanoscience & Nanotechnology; Materials Science, Multidisciplinary;
   Physics, Applied
SC Science & Technology - Other Topics; Materials Science; Physics
GA 896XV
UT WOS:000300605600020
PM 22322583
DA 2018-10-19
ER

PT J
AU Chang, CT
   Ho, TY
   Lin, H
   Liang, JA
   Huang, HC
   Li, CC
   Lo, HY
   Wu, SL
   Huang, YF
   Hsiang, CY
AF Chang, Chung-Ta
   Ho, Tin-Yun
   Lin, Ho
   Liang, Ji-An
   Huang, Hui-Chi
   Li, Chia-Cheng
   Lo, Hsin-Yi
   Wu, Shih-Lu
   Huang, Yi-Fang
   Hsiang, Chien-Yun
TI 5-Fluorouracil Induced Intestinal Mucositis via Nuclear Factor-kappa B
   Activation by Transcriptomic Analysis and In Vivo Bioluminescence
   Imaging
SO PLOS ONE
LA English
DT Article
ID HOST-BIOMATERIAL INTERACTION; ALIMENTARY-TRACT MUCOSITIS; GLAND
   CANCER-CELLS; ORAL MUCOSITIS; MUCOSAL INJURY; BREAST-CANCER;
   CHEMOTHERAPY; EXPRESSION; THERAPY; PATHOBIOLOGY
AB 5-Fluorouracil (5-FU) is a commonly used drug for the treatment of malignant cancers. However, approximately 80% of patients undergoing 5-FU treatment suffer from gastrointestinal mucositis. The aim of this report was to identify the drug target for the 5-FU-induced intestinal mucositis. 5-FU-induced intestinal mucositis was established by intraperitoneally administering mice with 100 mg/kg 5-FU. Network analysis of gene expression profile and bioluminescent imaging were applied to identify the critical molecule associated with 5-FU-induced mucositis. Our data showed that 5-FU induced inflammation in the small intestine, characterized by the increased intestinal wall thickness and crypt length, the decreased villus height, and the increased myeloperoxidase activity in tissues and proinflammatory cytokine production in sera. Network analysis of 5-FU-affected genes by transcriptomic tool showed that the expression of genes was regulated by nuclear factor-kappa B (NF-kappa B), and NF-kappa B was the central molecule in the 5-FU-regulated biological network. NF-kappa B activity was activated by 5-FU in the intestine, which was judged by in vivo bioluminescence imaging and immunohistochemical staining. However, 5-aminosalicylic acid (5-ASA) inhibited 5-FU-induced NF-kappa B activation and proinflammatory cytokine production. Moreover, 5-FU-induced histological changes were improved by 5-ASA. In conclusion, our findings suggested that NF-kappa B was the critical molecule associated with the pathogenesis of 5-FU-induced mucositis, and inhibition of NF-kappa B activity ameliorated the mucosal damage caused by 5-FU.
C1 [Chang, Chung-Ta] Far Eastern Mem Hosp, Dept Emergency Med, Taipei, Taiwan.
   [Chang, Chung-Ta; Lin, Ho] Natl Chung Hsing Univ, Dept Life Sci, Taichung 40227, Taiwan.
   [Ho, Tin-Yun; Li, Chia-Cheng; Lo, Hsin-Yi] China Med Univ, Grad Inst Chinese Med, Taichung, Taiwan.
   [Ho, Tin-Yun] China Med Univ, Dept Nucl Med, Taichung, Taiwan.
   [Liang, Ji-An] China Med Univ Hosp, Dept Radiat Therapy & Oncol, Taichung, Taiwan.
   [Huang, Hui-Chi] China Med Univ, Sch Pharmaceut Sci & Chinese Med Resources, Taichung, Taiwan.
   [Wu, Shih-Lu] China Med Univ, Dept Biochem, Taichung, Taiwan.
   [Huang, Yi-Fang] Chang Gung Mem Hosp, Dept Prosthodont, Tao Yuan, Taiwan.
   [Hsiang, Chien-Yun] China Med Univ, Dept Microbiol, Taichung, Taiwan.
RP Chang, CT (reprint author), Far Eastern Mem Hosp, Dept Emergency Med, Taipei, Taiwan.
EM cyhsiang@mail.cmu.edu.tw
RI Huang, Hui-Chi/D-2042-2012; Hsiang, Chien-Yun/O-3853-2015; Ho,
   Tin-Yun/O-3889-2015
OI Huang, Hui-Chi/0000-0002-3645-6726; Huang, Yi-Fang/0000-0003-2569-999X;
   Chang, Chung-Ta/0000-0002-9211-1407
FU National Science Council; China Medical University [CMU99-S-06,
   CMU99-S-31, CMU100-S-16, CMU100-S-34, CMU100-TS-14]
FX This work was supported by grants from National Science Council and
   China Medical University (CMU99-S-06, CMU99-S-31, CMU100-S-16,
   CMU100-S-34, and CMU100-TS-14). The funders had no role in study design,
   data collection and analysis, decision to publish, or preparation of the
   manuscript.
CR Aota K, 2000, BIOCHEM BIOPH RES CO, V273, P1168, DOI 10.1006/bbrc.2000.3072
   Azuma M, 2001, BIOCHEM BIOPH RES CO, V282, P292, DOI 10.1006/bbrc.2001.4571
   Baeuerle PA, 1997, ADV IMMUNOL, V65, P111, DOI 10.1016/S0065-2776(08)60742-7
   Baldwin AS, 1996, ANNU REV IMMUNOL, V14, P649, DOI 10.1146/annurev.immunol.14.1.649
   Bantel H, 2000, AM J GASTROENTEROL, V95, P3452
   Barnes PJ, 1997, NEW ENGL J MED, V336, P1066, DOI 10.1056/NEJM199704103361506
   Bonizzi G, 2004, TRENDS IMMUNOL, V25, P280, DOI 10.1016/j.it.2004.03.008
   Bowen JM, 2006, SUPPORT CARE CANCER, V14, P713, DOI 10.1007/s00520-005-0004-7
   Campbell IK, 2000, J CLIN INVEST, V105, P1799, DOI 10.1172/JCI8298
   Chang CT, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023682
   Cheng HM, 2010, J ETHNOPHARMACOL, V132, P429, DOI 10.1016/j.jep.2010.08.022
   GRADISHAR WJ, 1990, ANN ONCOL, V1, P409, DOI 10.1093/oxfordjournals.annonc.a057793
   Ho TY, 2007, BIOMATERIALS, V28, P4370, DOI 10.1016/j.biomaterials.2007.07.005
   Hsiang CY, 2009, BIOMATERIALS, V30, P3042, DOI 10.1016/j.biomaterials.2009.02.016
   Kaltschmidt B, 2000, EUR J BIOCHEM, V267, P3828, DOI 10.1046/j.1432-1327.2000.01421.x
   Leitao RFC, 2007, CANCER CHEMOTH PHARM, V59, P603, DOI 10.1007/s00280-006-0301-y
   Logan RM, 2007, CANCER TREAT REV, V33, P448, DOI 10.1016/j.ctrv.2007.03.001
   Logan R, 2009, CANCER CHEMOTH PHARM, V63, P239, DOI 10.1007/s00280-008-0732-8
   Longley DB, 2003, NAT REV CANCER, V3, P330, DOI 10.1038/nrc.1074
   Melo MLP, 2008, CANCER CHEMOTH PHARM, V61, P775, DOI 10.1007/s00280-007-0534-4
   Motoori M, 2010, INT J ONCOL, V37, P1113, DOI 10.3892/ijo_00000763
   Naidu MUR, 2004, NEOPLASIA, V6, P423, DOI 10.1593/neo.04169
   Petty RD, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-434
   Pritchard DM, 1998, TOXICOL LETT, V103, P19, DOI 10.1016/S0378-4274(98)00273-2
   Sausville EA, 2001, HARRISONS PRINCIPLES, P530
   Schauer M, 2010, CLIN CANCER RES, V16, P330, DOI 10.1158/1078-0432.CCR-09-1673
   Smyth GK, 2005, STAT BIOL HEALTH, P397
   Soares PM, 2011, CANC CHEMOT IN PRESS
   Sonis SL, 2002, CRIT REV ORAL BIOL M, V13, P380, DOI 10.1177/154411130201300502
   Sonis ST, 2004, ORAL ONCOL, V40, P170, DOI 10.1016/S1368-8375(03)00148-9
   Sonis ST, 2004, CANCER-AM CANCER SOC, V100, P1995, DOI 10.1002/cncr.20162
   Sonis ST, 2004, NAT REV CANCER, V4, P277, DOI 10.1038/nrc1318
   Tomita N, 2000, J AM SOC NEPHROL, V11, P1244
   Treister Nathaniel, 2007, Curr Opin Otolaryngol Head Neck Surg, V15, P123, DOI 10.1097/MOO.0b013e3280523ad6
   Tsao DA, 2010, DNA CELL BIOL, V29, P285, DOI 10.1089/dna.2009.1006
   Williams PD, 2009, CANCER RES, V69, P8302, DOI 10.1158/0008-5472.CAN-09-0798
   Wu JT, 2005, J SURG RES, V123, P158, DOI 10.1016/j.jss.2004.06.006
   Wu SL, 2009, J PHARMACOL EXP THER, V330, P370, DOI 10.1124/jpet.109.152835
   Wu ZQ, 2010, BIOMED PHARMACOTHER, V64, P589, DOI 10.1016/j.biopha.2010.06.006
   Wu ZQ, 2011, CANC CHEMOT IN PRESS
NR 40
TC 38
Z9 41
U1 2
U2 13
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD MAR 7
PY 2012
VL 7
IS 3
AR e31808
DI 10.1371/journal.pone.0031808
PG 8
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA 929KK
UT WOS:000303060800004
PM 22412841
OA DOAJ Gold, Green Published
DA 2018-10-19
ER

PT J
AU Su, K
   Lau, TT
   Leong, WY
   Gong, YH
   Wang, DA
AF Su, Kai
   Lau, Ting Ting
   Leong, Wenyan
   Gong, Yihong
   Wang, Dong-An
TI Creating a Living Hyaline Cartilage Graft Free from Non-Cartilaginous
   Constituents: An Intermediate Role of a Biomaterial Scaffold
SO ADVANCED FUNCTIONAL MATERIALS
LA English
DT Article
DE scaffold-free grafts; cartilage; hydrogels; biomaterials; tissue
   engineering
ID TISSUE-ENGINEERED CARTILAGE; ARTICULAR-CARTILAGE; COMPOSITE SCAFFOLD;
   IN-VITRO; REPAIR; IMPLANTATION; DEFECTS; MODEL; CHONDROCYTES;
   COMPRESSION
AB A novel living hyaline cartilage graft (LhCG) with controllable dimensions and free of non-cartilaginous constituents for articular regeneration is developed. As a living graft for regenerative medicine, LhCG is purely living tissue based and truly scaffold-free. The process of neotissue formation in LhCG is mediated by an interim biomaterial-based novel scaffolding system. This design highlights a philosophy of using biomaterials in engineered regenerative medicine as a transient guiding facility rather than a permanent part of substitute. The fabrication is designed and practiced in a continuous and integrated process, which attributes to its simplicity in operation. Because of the intrinsic non-cell-adhesive property of hydrogel scaffolds, articular chondrocytes phenotype is always preserved throughout the whole procedure, which has been tested and approved both in vitro and in vivo. In situ grafting trials in a rabbit model showcase high success rates in both cartilage repair and graft-host integration. Beyond cartilage repair, this LhCG model may provide a living-tissue-based open platform or niche for multi-tissue regenerations.
C1 [Su, Kai; Lau, Ting Ting; Leong, Wenyan; Gong, Yihong; Wang, Dong-An] Nanyang Technol Univ, Div Bioengn, Sch Chem & Biomed Engn, Singapore 637457, Singapore.
RP Su, K (reprint author), Nanyang Technol Univ, Div Bioengn, Sch Chem & Biomed Engn, 70 Nanyang Dr,N1-3-B2-13, Singapore 637457, Singapore.
EM DAWang@ntu.edu.sg
RI Wang, Dong-an/G-6195-2010
FU Ministry of Education, Singapore [AcRF Tier 1 RG 64/08]
FX K.S. and T. T. L. contributed equally to this work. The work was
   financially supported by grant AcRF Tier 1 RG 64/08, Ministry of
   Education, Singapore.
CR Alsberg E, 2002, P NATL ACAD SCI USA, V99, P12025, DOI 10.1073/pnas.192291499
   Ando W, 2007, BIOMATERIALS, V28, P5462, DOI 10.1016/j.biomaterials.2007.08.030
   Appelman TP, 2011, BIOMATERIALS, V32, P1508, DOI 10.1016/j.biomaterials.2010.10.017
   Brehm W, 2006, OSTEOARTHR CARTILAGE, V14, P1214, DOI 10.1016/j.joca.2006.05.002
   Evans RC, 2006, BIOPHYS J, V91, P1541, DOI 10.1529/biophysj.105.080366
   Gong YH, 2010, TISSUE ENG PT A, V16, P3611, DOI [10.1089/ten.tea.2010.0219, 10.1089/ten.TEA.2010.0219]
   Grodzinsky AJ, 2000, ANNU REV BIOMED ENG, V2, P691, DOI 10.1146/annurev.bioeng.2.1.691
   HOMMINGA GN, 1991, ACTA ORTHOP SCAND, V62, P415, DOI 10.3109/17453679108996635
   Hunziker EB, 2002, OSTEOARTHR CARTILAGE, V10, P432, DOI 10.1053/joca.2002.0801
   Hwang CM, 2010, BIOFABRICATION, V2, DOI 10.1088/1758-5082/2/3/035003
   Kloxin AM, 2009, SCIENCE, V324, P59, DOI 10.1126/science.1169494
   Lefevre S, 2009, NAT MED, V15, P1414, DOI 10.1038/nm.2050
   Liu XH, 2011, NAT MATER, V10, P398, DOI [10.1038/NMAT2999, 10.1038/nmat2999]
   Loening AM, 2000, ARCH BIOCHEM BIOPHYS, V381, P205, DOI 10.1006/abbi.2000.1988
   Masuda K, 2003, J ORTHOPAED RES, V21, P139, DOI 10.1016/S0736-0266(02)00109-2
   Moutos FT, 2007, NAT MATER, V6, P162, DOI 10.1038/nmat1822
   Nagai T, 2008, TISSUE ENG PT A, V14, P1225, DOI 10.1089/ten.tea.2007.0225
   Newman AP, 1998, AM J SPORT MED, V26, P309, DOI 10.1177/03635465980260022701
   Ng SS, 2012, ACTA BIOMATER, V8, P244, DOI 10.1016/j.actbio.2011.08.018
   Ramallal M, 2004, WOUND REPAIR REGEN, V12, P337, DOI 10.1111/j.1067-1927.2004.012309.x
   ROUGHLEY PJ, 1994, MICROSC RES TECHNIQ, V28, P385, DOI 10.1002/jemt.1070280505
   SHAHGALDI BF, 1991, J BONE JOINT SURG BR, V73, P57
   Sherwood JK, 2002, BIOMATERIALS, V23, P4739, DOI 10.1016/S0142-9612(02)00223-5
   Stone KR, 1997, TRANSPLANTATION, V63, P640, DOI 10.1097/00007890-199703150-00005
   Waldman SD, 2004, TISSUE ENG, V10, P1323, DOI 10.1089/1076327042500210
   Waldman SD, 2003, J BONE JOINT SURG AM, V85A, P101, DOI 10.2106/00004623-200300002-00013
   Wang DA, 2004, ADV FUNCT MATER, V14, P1152, DOI 10.1002/adfm.200305018
   Wang DA, 2007, NAT MATER, V6, P385, DOI 10.1038/nmat1890
NR 28
TC 34
Z9 35
U1 2
U2 62
PU WILEY-V C H VERLAG GMBH
PI WEINHEIM
PA BOSCHSTRASSE 12, D-69469 WEINHEIM, GERMANY
SN 1616-301X
J9 ADV FUNCT MATER
JI Adv. Funct. Mater.
PD MAR 7
PY 2012
VL 22
IS 5
BP 972
EP 978
DI 10.1002/adfm.201102884
PG 7
WC Chemistry, Multidisciplinary; Chemistry, Physical; Nanoscience &
   Nanotechnology; Materials Science, Multidisciplinary; Physics, Applied;
   Physics, Condensed Matter
SC Chemistry; Science & Technology - Other Topics; Materials Science;
   Physics
GA 900ZO
UT WOS:000300931500009
DA 2018-10-19
ER

PT J
AU Mourino, V
   Cattalini, JP
   Boccaccini, AR
AF Mourino, Viviana
   Pablo Cattalini, Juan
   Boccaccini, Aldo R.
TI Metallic ions as therapeutic agents in tissue engineering scaffolds: an
   overview of their biological applications and strategies for new
   developments
SO JOURNAL OF THE ROYAL SOCIETY INTERFACE
LA English
DT Review
DE metallic ions; tissue engineering; scaffolds; bone; drug delivery;
   controlled release
ID PROTEIN-TYROSINE PHOSPHATASES; HUMAN ENDOTHELIAL-CELLS; OSTEOBLAST-LIKE
   CELLS; NECROSIS-FACTOR-ALPHA; IN-VITRO BIOACTIVITY; DRUG-DELIVERY;
   ALKALINE-PHOSPHATASE; GENE-EXPRESSION; TRACE-ELEMENTS; BONE-FORMATION
AB This article provides an overview on the application of metallic ions in the fields of regenerative medicine and tissue engineering, focusing on their therapeutic applications and the need to design strategies for controlling the release of loaded ions from biomaterial scaffolds. A detailed summary of relevant metallic ions with potential use in tissue engineering approaches is presented. Remaining challenges in the field and directions for future research efforts with focus on the key variables needed to be taken into account when considering the controlled release of metallic ions in tissue engineering therapeutics are also highlighted.
C1 [Mourino, Viviana; Pablo Cattalini, Juan] Univ Buenos Aires, Fac Pharm & Biochem, Dept Pharmaceut Technol, RA-1113 Buenos Aires, DF, Argentina.
   [Mourino, Viviana] Consejo Nacl Invest Cient & Tecn, RA-1033 Buenos Aires, DF, Argentina.
   [Boccaccini, Aldo R.] Univ Erlangen Nurnberg, Inst Biomat, Dept Mat Sci & Engn, D-91058 Erlangen, Germany.
RP Mourino, V (reprint author), Univ Buenos Aires, Fac Pharm & Biochem, Dept Pharmaceut Technol, 956 Junin St,6th Floor, RA-1113 Buenos Aires, DF, Argentina.
EM vmourino@ffyb.uba.ar; aldo.boccaccini@ww.uni-erlangen.de
RI Boccaccini, Aldo/C-7905-2013
CR Abou Neel EA, 2005, BIOMATERIALS, V26, P2247, DOI 10.1016/j.biomaterials.2004.07.024
   Abou Neel EA, 2009, J R SOC INTERFACE, V6, P435, DOI 10.1098/rsif.2008.0348
   Aedo F, 2007, NEUROCHEM INT, V50, P591, DOI 10.1016/j.neuint.2006.12.001
   Ahmed I, 2004, BIOMATERIALS, V25, P3223, DOI 10.1016/j.biomaterials.2003.10.013
   Aina V, 2009, ACTA BIOMATER, V5, P1211, DOI 10.1016/j.actbio.2008.10.020
   Arredondo Miguel, 2005, Molecular Aspects of Medicine, V26, P313, DOI 10.1016/j.mam.2005.07.010
   Balamurugan A, 2007, ACTA BIOMATER, V3, P255, DOI 10.1016/j.actbio.2006.09.005
   Bar-Or D, 2003, SHOCK, V20, P154, DOI 10.1097/01.shk.0000068318.49350.3a
   Barbucci R, 2005, BIOMACROMOLECULES, V6, P212, DOI 10.1021/bm049568g
   Baroli B, 2009, J PHARM SCI-US, V98, P1317, DOI 10.1002/jps.21528
   Barralet J, 2009, TISSUE ENG PT A, V15, P1601, DOI 10.1089/ten.tea.2007.0370
   Barrio DA, 2006, CAN J PHYSIOL PHARM, V84, P677, DOI 10.1139/Y06-022
   Barrio DA, 1997, J TRACE ELEM MED BIO, V11, P110, DOI 10.1016/S0946-672X(97)80035-1
   Barrio DA, 2003, J BIOL INORG CHEM, V8, P459, DOI 10.1007/s00775-002-0438-z
   Barrio DA, 2006, CAN J PHYSIOL PHARM, V84, P765, DOI 10.1139/Y06-021
   Beattie John H., 1992, Nutrition Research Reviews, V5, P167, DOI 10.1079/NRR19920013
   Bellantone M, 2002, ANTIMICROB AGENTS CH, V46, P1940, DOI 10.1128/AAC.46.6.1940-1945.2002
   Bellantone M, 2000, J BIOMED MATER RES, V51, P484, DOI 10.1002/1097-4636(20000905)51:3<484::AID-JBM24>3.0.CO;2-4
   Bernstein LR, 1998, PHARMACOL REV, V50, P665
   Bielby RC, 2005, TISSUE ENG, V11, P479, DOI 10.1089/ten.2005.11.479
   Bielby RC, 2004, TISSUE ENG, V10, P1018, DOI 10.1089/1076327041887664
   Blaker JJ, 2004, BIOMATERIALS, V25, P1319, DOI 10.1016/j.biomaterials.2003.08.007
   Bohner M, 2009, BIOMATERIALS, V30, P6403, DOI 10.1016/j.biomaterials.2009.08.007
   Boivin G, 1996, J BONE MINER RES, V11, P1302
   Bolsover SR, 2005, CELL CALCIUM, V37, P395, DOI 10.1016/j.ceca.2005.01.007
   Borkow G, 2008, MED HYPOTHESES, V70, P610, DOI 10.1016/j.mehy.2007.06.006
   Bose S, 2002, J MATER SCI-MATER M, V13, P23, DOI 10.1023/A:1013622216071
   Boyd D, 2006, J MATER SCI-MATER M, V17, P489, DOI 10.1007/s10856-006-8930-6
   Boyd D, 2009, J MATER SCI-MATER M, V20, P413, DOI 10.1007/s10856-008-3569-0
   Bunting S, 2005, J HAND SURG-BRIT EUR, V30B, P242, DOI 10.1016/j.jhsh.2004.11.003
   Cabanas MV, 2009, EUR J PHARM SCI, V37, P249, DOI 10.1016/j.ejps.2009.02.011
   Cadosch D, 2009, J BIOMED MATER RES A, V91A, P1252, DOI 10.1002/jbm.a.32625
   Castro C, 2005, EUR J PHARM BIOPHARM, V60, P401, DOI 10.1016/j.ejpb.2005.02.005
   Chen D, 1999, BIOL TRACE ELEM RES, V68, P225, DOI 10.1007/BF02783905
   Chen W, 2006, BIOMATERIALS, V27, P5512, DOI 10.1016/j.biomaterials.2006.07.003
   Chen XC, 2010, J BIOMED MATER RES B, V93B, P194, DOI 10.1002/jbm.b.31574
   Cho YH, 2002, INT J ANTIMICROB AG, V19, P576, DOI 10.1016/S0924-8579(02)00115-2
   Christodoulou I, 2005, J BIOMED MATER RES B, V74B, P529, DOI 10.1002/jbm.b.30249
   Christodoulou L, 2006, J BIOMED MATER RES B, V77B, P431, DOI 10.1002/jbm.b.30455
   Chua CK, 2004, J MATER SCI-MATER M, V15, P1113, DOI 10.1023/B:JMSM.0000046393.81449.a5
   Ciardelli G, 2004, J MATER SCI-MATER M, V15, P305, DOI 10.1023/B:JMSM.0000021092.03087.d4
   CIMA LG, 1991, J BIOMECH ENG-T ASME, V113, P143, DOI 10.1115/1.2891228
   Collery P, 2002, CRIT REV ONCOL HEMAT, V42, P283, DOI 10.1016/S1040-8428(01)00225-6
   Cooke MN, 2003, J BIOMED MATER RES B, V64B, P65, DOI 10.1002/jbm.b.10485
   Cortizo AM, 2006, INT J BIOCHEM CELL B, V38, P1171, DOI 10.1016/j.biocel.2005.12.007
   Crans D. C., 1998, VANADIUM COMPOUNDS C, V711, P82
   Cuncic C, 1999, J BIOL INORG CHEM, V4, P354, DOI 10.1007/s007750050322
   Dahl SG, 2001, BONE, V28, P446, DOI 10.1016/S8756-3282(01)00419-7
   Davis RR, 2007, J BIOMED MATER RES B, V83B, P505, DOI 10.1002/jbm.b.30823
   Davis RR, 2010, J BIOMED MATER RES A, V93A, P864, DOI 10.1002/jbm.a.32407
   Day RM, 2004, BIOMATERIALS, V25, P5857, DOI 10.1016/j.biomaterials.2004.01.043
   De Laporte L, 2007, ADV DRUG DELIVER REV, V59, P292, DOI 10.1016/j.addr.2007.03.017
   Denkena B, 2007, CIRP ANN-MANUF TECHN, V56, P113, DOI 10.1016/j.cirp.2007.05.029
   Dhariwala B, 2004, TISSUE ENG, V10, P1316, DOI 10.1089/ten.2004.10.1316
   Di Nunzio S, 2005, Italian patent, Patent No. [PCT/EP2005/056391, 2005056391]
   DIAMOND I, 1970, J NUTR, V100, P325
   Djokic SS, 1998, J ELECTROCHEM SOC, V145, P1426, DOI 10.1149/1.1838499
   Domingues ZR, 2004, BIOMATERIALS, V25, P327, DOI 10.1016/S0142-9612(03)00524-6
   Dubas ST, 2006, COLLOID SURFACE A, V289, P105, DOI 10.1016/j.colsurfa.2006.04.012
   DUELAND R, 1982, CLIN ORTHOP RELAT R, P264
   Etcheverry SB, 2002, J INORG BIOCHEM, V88, P94, DOI 10.1016/S0162-0134(01)00368-3
   Etcheverry SB, 2001, BIOMETALS, V15, P37, DOI 10.1023/A:1013183910203
   Fan W, 2010, BIOMATERIALS, V31, P3580, DOI 10.1016/j.biomaterials.2010.01.083
   Feng QL, 2000, J BIOMED MATER RES, V52, P662, DOI 10.1002/1097-4636(20001215)52:4<662::AID-JBM10>3.0.CO;2-3
   Feng WK, 2009, MOL PHARMACOL, V75, P174, DOI 10.1124/mol.108.051516
   Fisher JP, 2002, J BIOMED MATER RES, V59, P547, DOI 10.1002/jbm.1268
   Gentleman E, 2010, BIOMATERIALS, V31, P3949, DOI 10.1016/j.biomaterials.2010.01.121
   Gerard C, 2010, BIOMATERIALS, V31, P824, DOI 10.1016/j.biomaterials.2009.10.009
   Giavaresi G, 2005, BIOMATERIALS, V26, P3001, DOI 10.1016/j.biomaterials.2004.08.027
   Gielen M., 2005, METALLOTHERAPEUTIC D
   Giordano RA, 1996, J BIOMAT SCI-POLYM E, V8, P63, DOI 10.1163/156856297X00588
   GOKA TJ, 1976, P NATL ACAD SCI USA, V73, P604, DOI 10.1073/pnas.73.2.604
   Goldwaser I, 2000, J INORG BIOCHEM, V80, P21, DOI 10.1016/S0162-0134(00)00035-0
   Gorustovich AA, 2010, TISSUE ENG PART B-RE, V16, P199, DOI [10.1089/ten.teb.2009.0416, 10.1089/ten.TEB.2009.0416]
   Gough JE, 2004, BIOMATERIALS, V25, P2039, DOI 10.1016/j.biomaterials.2003.07.001
   Grynpas MD, 1996, BONE, V18, P253, DOI 10.1016/8756-3282(95)00484-X
   Guindy JS, 2004, INT J ORAL MAX IMPL, V19, P826
   Habibovic P, 2011, ACTA BIOMATER, V7, P3013, DOI 10.1016/j.actbio.2011.03.027
   Habraken WJEM, 2007, ADV DRUG DELIVER REV, V59, P234, DOI 10.1016/j.addr.2007.03.011
   HAFEZ Y, 1976, J NUTR, V106, P249
   Haimi S, 2009, ACTA BIOMATER, V5, P3122, DOI 10.1016/j.actbio.2009.04.006
   Hall SL, 1999, CALCIFIED TISSUE INT, V64, P163, DOI 10.1007/s002239900597
   Harris LD, 1998, J BIOMED MATER RES, V42, P396, DOI 10.1002/(SICI)1097-4636(19981205)42:3<396::AID-JBM7>3.0.CO;2-E
   Hartwig A, 2001, MUTAT RES-FUND MOL M, V475, P113, DOI 10.1016/S0027-5107(01)00074-4
   Hench LL, 2010, J R SOC INTERFACE, V7, pS379, DOI 10.1098/rsif.2010.0151.focus
   Hench LL, 2000, MATER RES INNOV, V3, P313, DOI 10.1007/s100190000055
   Hench LL, 2002, SCIENCE, V295, P1014, DOI 10.1126/science.1067404
   Hench LL, 1998, J AM CERAM SOC, V81, P1705
   Hesaraki S, 2010, J MATER SCI-MATER M, V21, P695, DOI 10.1007/s10856-009-3920-0
   Hetrick EM, 2006, CHEM SOC REV, V35, P780, DOI 10.1039/b515219b
   Hinoi E, 2004, J PHARMACOL SCI, V94, P215, DOI 10.1254/jphs.94.215
   Hollister SJ, 2005, NAT MATER, V4, P518, DOI 10.1038/nmat1421
   Hoppe A, 2011, BIOMATERIALS, V32, P2757, DOI 10.1016/j.biomaterials.2011.01.004
   Hu GF, 1998, J CELL BIOCHEM, V69, P326, DOI 10.1002/(SICI)1097-4644(19980601)69:3<326::AID-JCB10>3.0.CO;2-A
   Huber M, 2009, ACTA BIOMATER, V5, P172, DOI 10.1016/j.actbio.2008.07.032
   Hutmacher DW, 2001, J BIOMED MATER RES, V55, P203, DOI 10.1002/1097-4636(200105)55:2<203::AID-JBM1007>3.3.CO;2-Z
   Hutmacher DW, 2000, BIOMATERIALS, V21, P2529, DOI 10.1016/S0142-9612(00)00121-6
   Hutmacher DW, 2001, J BIOMAT SCI-POLYM E, V12, P107, DOI 10.1163/156856201744489
   Hutmacher DW, 2004, TRENDS BIOTECHNOL, V22, P354, DOI 10.1016/j.tibtech.2004.05.006
   Huyer G, 1997, J BIOL CHEM, V272, P843, DOI 10.1074/jbc.272.2.843
   Ikeuchi M, 2003, J BIOMED MATER RES A, V67A, P1115, DOI 10.1002/jbm.a.10041
   Isaac J, 2011, EUR CELLS MATER, V21, P130, DOI 10.22203/eCM.v021a11
   Jie X. W., 2006, MATER CHEM PHYS, V96, P90, DOI [10.1016/j.matchemphys.2005.06.045, DOI 10.1016/J.MATCHEMPHYS.2005.06.045]
   Jones JR, 2006, J MATER SCI-MATER M, V17, P989, DOI 10.1007/s10856-006-0434-x
   Kawamura H, 2003, J BIOMED MATER RES A, V65A, P468, DOI 10.1002/jbm.a.10524
   Kawamura H, 2000, J BIOMED MATER RES, V50, P184, DOI 10.1002/(SICI)1097-4636(200005)50:2<184::AID-JBM13>3.0.CO;2-3
   Kawashita M, 2000, BIOMATERIALS, V21, P393, DOI 10.1016/S0142-9612(99)00201-X
   Khalil S, 2005, RAPID PROTOTYPING J, V11, P9, DOI 10.1108/13552540510573347
   Kidoaki S, 2005, BIOMATERIALS, V26, P37, DOI 10.1016/j.biomaterials.2004.01.063
   Kim TN, 1998, J MATER SCI-MATER M, V9, P129, DOI 10.1023/A:1008811501734
   Kimakhe S, 1999, J BIOMED MATER RES, V47, P18, DOI 10.1002/(SICI)1097-4636(199910)47:1<18::AID-JBM3>3.0.CO;2-T
   Konur S, 2005, NEURON, V46, P401, DOI 10.1016/j.neuron.2005.04.022
   Kothapalli CR, 2009, ACTA BIOMATER, V5, P541, DOI 10.1016/j.actbio.2008.09.004
   Kraft CN, 2000, J BIOMED MATER RES, V49, P192, DOI 10.1002/(SICI)1097-4636(200002)49:2<192::AID-JBM6>3.0.CO;2-C
   Kumon H, 2001, INT J ANTIMICROB AG, V17, P311, DOI 10.1016/S0924-8579(00)00360-5
   Kwun IS, 2010, BONE, V46, P732, DOI 10.1016/j.bone.2009.11.003
   Ladon D, 2004, J ARTHROPLASTY, V19, P78, DOI 10.1016/j.arth.2004.09.010
   Landers R, 2002, BIOMATERIALS, V23, P4437, DOI 10.1016/S0142-9612(02)00139-4
   Landi E, 2007, ACTA BIOMATER, V3, P961, DOI 10.1016/j.actbio.2007.05.006
   Lang C, 2007, AM J PHYSIOL-LUNG C, V292, pL577, DOI 10.1152/ajplung.00280.2006
   LANGER R, 1993, SCIENCE, V260, P920, DOI 10.1126/science.8493529
   LANKFORD KL, 1989, J CELL BIOL, V109, P1229, DOI 10.1083/jcb.109.3.1229
   Lansdown ABG, 2007, WOUND REPAIR REGEN, V15, P2, DOI 10.1111/j.1524-475X.2006.00179.x
   Law NA, 1999, ADV INORG CHEM, V46, P305
   Lee SH, 2007, ADV DRUG DELIVER REV, V59, P339, DOI 10.1016/j.addr.2007.03.016
   Leong KF, 2003, BIOMATERIALS, V24, P2363, DOI 10.1016/S0142-9612(03)00030-9
   Li J, 2008, CHINESE CHEM LETT, V19, P1290, DOI 10.1016/j.cclet.2008.07.002
   Li M, 2008, J INORG BIOCHEM, V102, P1846, DOI 10.1016/j.jinorgbio.2008.06.007
   Li Y, 2009, J PHYS CONF SER, V187, DOI 10.1088/1742-6596/187/1/012024
   Linder MC, 1996, AM J CLIN NUTR, V63, P797
   Loboda A, 2005, CELL MOL BIOL, V51, P347, DOI 10.1170/T637
   Lutsenko S, 2008, BIOCHEM SOC T, V36, P1233, DOI 10.1042/BST0361233
   Machida-Sano I, 2009, BIOMED MATER, V4, DOI 10.1088/1748-6041/4/2/025008
   Maeno S, 2005, BIOMATERIALS, V26, P4847, DOI 10.1016/j.biomaterials.2005.01.006
   Marie PJ, 2010, BONE, V46, P571, DOI 10.1016/j.bone.2009.07.082
   Marie PJ, 2001, CALCIFIED TISSUE INT, V69, P121, DOI 10.1007/s002230010055
   Masse A, 2000, J BIOMED MATER RES, V53, P600, DOI 10.1002/1097-4636(200009)53:5<600::AID-JBM21>3.0.CO;2-D
   Mast D., 2008, UC 109 035 INVENTION
   Matsumoto N, 2009, ACTA BIOMATER, V5, P3157, DOI 10.1016/j.actbio.2009.04.010
   Mayer I, 2003, EUR J INORG CHEM, P1445
   Milman N, 2003, INT J HEMATOL, V77, P48, DOI 10.1007/BF02982602
   Miyai T, 2008, BIOMATERIALS, V29, P350, DOI 10.1016/j.biomaterials.2007.09.040
   Moioli EK, 2007, ADV DRUG DELIVER REV, V59, P308, DOI 10.1016/j.addr.2007.03.019
   Mooney DJ, 1996, BIOMATERIALS, V17, P1417, DOI 10.1016/0142-9612(96)87284-X
   Moroni L, 2008, J BIOMAT SCI-POLYM E, V19, P543, DOI 10.1163/156856208784089571
   Mourino V, 2011, SOFT MATTER, V7, P6705, DOI 10.1039/c1sm05331k
   Mourino V, 2010, ADV ENG MATER, V12, pB283, DOI 10.1002/adem.200980078
   Mourino V, 2010, J R SOC INTERFACE, V7, P209, DOI 10.1098/rsif.2009.0379
   MUNTHE E, 1986, ACTA PHARMACOL TOX, V59, P365
   Murphy S, 2009, J MATER SCI-MATER M, V20, P2207, DOI 10.1007/s10856-009-3789-y
   Murphy WL, 2002, TISSUE ENG, V8, P43, DOI 10.1089/107632702753503045
   Nanami M, 2005, ARTERIOSCL THROM VAS, V25, P2495, DOI 10.1161/01.ATV.0000190610.63878.20
   Newby PJ, 2011, J MATER SCI-MATER M, V22, P557, DOI 10.1007/s10856-011-4240-8
   NIELSEN FH, 1990, BIOL TRACE ELEM RES, V26-7, P599, DOI 10.1007/BF02992716
   Nxumalo F, 1998, J BIOL INORG CHEM, V3, P534, DOI 10.1007/s007750050265
   Nyman M, 2006, CHEM MATER, V18, P6425, DOI 10.1021/cm061797h
   Ohnishi S, 2007, STEM CELLS, V25, P1166, DOI 10.1634/stemcells.2006-0347
   Ovesen J, 2001, BONE, V29, P565, DOI 10.1016/S8756-3282(01)00616-0
   PARKE A, 1988, AM J PATHOL, V130, P173
   Pickup DM, 2009, J CHEM PHYS, V130, DOI 10.1063/1.3076057
   Popp JR, 2007, J BIOMED MATER RES A, V81A, P766, DOI 10.1002/jbm.a.31214
   POSNER BI, 1994, J BIOL CHEM, V269, P4596
   Pratten J, 2004, J BIOMATER APPL, V19, P47, DOI 10.1177/0885328204043200
   Rajalingam D, 2005, BIOCHEMISTRY-US, V44, P14431, DOI 10.1021/bi051387r
   Rezwan K, 2006, BIOMATERIALS, V27, P3413, DOI 10.1016/j.biomaterials.2006.01.039
   Rivera Garza M, 2000, MICROPOR MESOPOR MAT, V39, P431
   Rodriguez JP, 2002, J CELL BIOCHEM, V85, P92, DOI 10.1002/jcb.10111
   Rosenstein ED, 1999, RHEUM DIS CLIN N AM, V25, P929, DOI 10.1016/S0889-857X(05)70111-3
   Rouault TA, 2003, PLOS BIOL, V1, P326, DOI 10.1371/journal.pbio.0000079
   Rude RK, 2004, J NUTR, V134, P79
   Rude RK, 2003, CALCIFIED TISSUE INT, V72, P32, DOI 10.1007/s00223-001-1091-1
   Rupp ME, 2004, AM J INFECT CONTROL, V32, P445, DOI 10.1016/j.ajic.2004.05.002
   Rutherford JC, 2004, EUKARYOT CELL, V3, P1, DOI 10.1128/EC.3.1.1-13.2004
   Saboori A, 2009, MAT SCI ENG C-BIO S, V29, P335, DOI 10.1016/j.msec.2008.07.004
   Sachlos E., 2003, European Cells & Materials, V5, P29
   Salih V, 2007, BIOMED MATER, V2, P11, DOI 10.1088/1748-6041/2/1/003
   SALTMAN PD, 1993, J AM COLL NUTR, V12, P384, DOI 10.1080/07315724.1993.10718327
   Schulz M. J., 2009, UC 109 111 INVENTION
   Schulz M. J, 2009, UC 109 085 INVENTION
   Scior T, 2008, DRUG DES DEV THER, V2, P221, DOI 10.2147/DDDT.S3732
   Scior T, 2010, DRUG DES DEV THER, V4, P231
   Seale AP, 2005, BIOTECHNOL LETT, V27, P221, DOI 10.1007/s10529-004-7855-8
   Sen CK, 2002, AM J PHYSIOL-HEART C, V282, pH1821, DOI 10.1152/ajpheart.01015.2001
   Shanov V., 2008, UC 108 091 INVENTION
   Shanov V., 2009, UC 109 089 INVENTION
   Shukla R, 2008, BIOMETALS, V21, P205, DOI 10.1007/s10534-007-9109-4
   Sodian R, 2002, ASAIO J, V48, P12, DOI 10.1097/00002480-200201000-00004
   Sokolsky-Papkov M, 2007, ADV DRUG DELIVER REV, V59, P187, DOI 10.1016/j.addr.2007.04.001
   Soo J. P., 2003, J COLLOID INTERF SCI, V261, P238, DOI [10.1016/S0021-9797(03)00083-3, DOI 10.1016/S0021-9797(03)00083-3]
   Soundrapandian C, 2009, AAPS PHARMSCITECH, V10, P1158, DOI 10.1208/s12249-009-9308-0
   Stanislawski L, 1999, J BIOMED MATER RES, V48, P277, DOI 10.1002/(SICI)1097-4636(1999)48:3<277::AID-JBM11>3.0.CO;2-T
   Stevens MM, 2008, MATER TODAY, V11, P18, DOI 10.1016/S1369-7021(08)70086-5
   Storrie H, 2005, BIOMATERIALS, V26, P5492, DOI 10.1016/j.biomaterials.2005.01.043
   Takeda A, 2003, BRAIN RES REV, V41, P79, DOI 10.1016/S0165-0173(02)00234-5
   Tan KH, 2005, BIO-MED MATER ENG, V15, P113
   Tan SH, 2005, POLYMER, V46, P6128, DOI 10.1016/j.polymer.2005.05.068
   TAYLOR A, 1985, CLIN ENDOCRINOL META, V14, P703, DOI 10.1016/S0300-595X(85)80013-X
   Teo Wee-Eong, 2006, Biotechnology Journal, V1, P918, DOI 10.1002/biot.200600044
   Tessmar JK, 2007, ADV DRUG DELIVER REV, V59, P274, DOI 10.1016/j.addr.2007.03.020
   Thompson KH, 2003, SCIENCE, V300, P936, DOI 10.1126/science.1083004
   Thompson KH, 2000, J CHEM SOC DALTON, P2885, DOI 10.1039/b002753g
   Tracey AS, 2000, J INORG BIOCHEM, V80, P11, DOI 10.1016/S0162-0134(00)00033-7
   Tsang VL, 2004, ADV DRUG DELIVER REV, V56, P1635, DOI 10.1016/j.addr.2004.05.001
   Upreti RK, 1995, MOL CELL BIOCHEM, V153, P167, DOI 10.1007/BF01075934
   Valappil SP, 2009, ACTA BIOMATER, V5, P1198, DOI 10.1016/j.actbio.2008.09.019
   Valerio P, 2009, BIOMED MATER, V4, DOI 10.1088/1748-6041/4/4/045011
   Vallet-Regi M, 1999, J MATER CHEM, V9, P515, DOI 10.1039/a808679f
   Verron E, 2010, BRIT J PHARMACOL, V159, P1681, DOI 10.1111/j.1476-5381.2010.00665.x
   Vitale-Brovarone C, 2008, CHEM ENG J, V137, P129, DOI 10.1016/j.cej.2007.07.083
   VOLKER A, 2004, BIOMATERIALS, V25, P4383, DOI DOI 10.1016/J.BIOMATERIALS.2003.10.078
   Wang J, 2001, METABOLISM, V50, P667, DOI 10.1053/meta.2001.23294
   WARRELL RP, 1985, CANCER TREAT REP, V69, P653
   WARRELL RP, 1984, J CLIN INVEST, V73, P1487, DOI 10.1172/JCI111353
   WARRELL RP, 1990, ANN INTERN MED, V113, P847, DOI 10.7326/0003-4819-113-11-847
   Wassall MA, 1997, J BIOMED MATER RES, V36, P325, DOI 10.1002/(SICI)1097-4636(19970905)36:3<325::AID-JBM7>3.3.CO;2-L
   Wataha JC, 2010, J MATER SCI-MATER M, V21, P1289, DOI 10.1007/s10856-009-3941-8
   Wataha JC, 2009, J BIOMED MATER RES B, V91B, P489, DOI 10.1002/jbm.b.31402
   Webster TJ, 2002, J BIOMED MATER RES, V59, P312, DOI 10.1002/jbm.1247
   Westenberg D., 2000, P 100 GEN M AM SOC M
   Willerth SM, 2007, ADV DRUG DELIVER REV, V59, P325, DOI 10.1016/j.addr.2007.03.014
   WILSON J, 1992, J APPL BIOMATER, V3, P123, DOI 10.1002/jab.770030208
   Witte F, 2007, BIOMATERIALS, V28, P2163, DOI 10.1016/j.biomaterials.2006.12.027
   Wu CT, 2011, ACTA BIOMATER, V7, P1797, DOI 10.1016/j.actbio.2010.12.018
   Wu XM, 2003, ARCH BIOCHEM BIOPHYS, V420, P114, DOI 10.1016/j.abb.2003.09.013
   Xynos ID, 2000, BIOCHEM BIOPH RES CO, V276, P461, DOI 10.1006/bbrc.2000.3503
   Xynos ID, 2001, J BIOMED MATER RES, V55, P151, DOI 10.1002/1097-4636(200105)55:2<151::AID-JBM1001>3.3.CO;2-4
   YAMAGUCHI M, 1988, BIOCHEM PHARMACOL, V37, P4075, DOI 10.1016/0006-2952(88)90098-6
   YAMAGUCHI M, 1987, BIOCHEM PHARMACOL, V36, P4007, DOI 10.1016/0006-2952(87)90471-0
   Yamamoto K, 1996, DENT MATER, V12, P227, DOI 10.1016/S0109-5641(96)80027-3
   Yamasaki Y, 2003, BIOMATERIALS, V24, P4913, DOI 10.1016/S0142-9612(03)00414-9
   Yamasaki Y, 2002, J BIOMED MATER RES, V62, P99, DOI 10.1002/jbm.10220
   Yazar M, 2005, BIOL TRACE ELEM RES, V106, P123, DOI 10.1385/BTER:106:2:123
   Yeong WY, 2004, TRENDS BIOTECHNOL, V22, P643, DOI 10.1016/j.tibtech.2004.10.004
   Yin YQ, 2003, J NEUROSCI, V23, P2284
   Yoshida K, 1999, J BIOMED MATER RES, V47, P516, DOI 10.1002/(SICI)1097-4636(19991215)47:4<516::AID-JBM7>3.0.CO;2-E
   Yun YH, 2007, NANOTECHNOLOGY, V18, DOI 10.1088/0957-4484/18/46/465505
   Yun YH, 2007, NANO TODAY, V2, P30, DOI 10.1016/S1748-0132(07)70171-8
   Yun YH, 2009, MATER TODAY, V12, P22, DOI 10.1016/S1369-7021(09)70273-1
   Zhang G, 2007, ADV DRUG DELIVER REV, V59, P360, DOI 10.1016/j.addr.2007.03.018
   Zhang ML, 2010, J BIOMED MATER RES B, V93B, P252, DOI 10.1002/jbm.b.31582
   Zhang Y, 2002, J BIOMED MATER RES, V62, P378, DOI 10.1002/jbm.10312
   Zhou HJ, 2010, J MATER SCI-MATER M, V21, P2175, DOI 10.1007/s10856-010-4083-8
   Zhu LL, 2007, BIOCHEM BIOPH RES CO, V355, P307, DOI 10.1016/j.bbrc.2007.01.120
   Zreiqat H, 2002, J BIOMED MATER RES, V62, P175, DOI 10.1002/jbm.10270
   Zreiqat H, 2010, BIOMATERIALS, V31, P3175, DOI 10.1016/j.biomaterials.2010.01.024
NR 245
TC 137
Z9 138
U1 6
U2 59
PU ROYAL SOC
PI LONDON
PA 6-9 CARLTON HOUSE TERRACE, LONDON SW1Y 5AG, ENGLAND
SN 1742-5689
EI 1742-5662
J9 J R SOC INTERFACE
JI J. R. Soc. Interface
PD MAR 7
PY 2012
VL 9
IS 68
BP 401
EP 419
DI 10.1098/rsif.2011.0611
PG 19
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA 886QJ
UT WOS:000299868600001
PM 22158843
OA Other Gold, Green Published
DA 2018-10-19
ER

PT J
AU Lawrence, NJ
   Wells-Kingsbury, JM
   Ihrig, MM
   Fangman, TE
   Namavar, F
   Cheung, CL
AF Lawrence, Neil J.
   Wells-Kingsbury, Jamie M.
   Ihrig, Marcella M.
   Fangman, Teresa E.
   Namavar, Fereydoon
   Cheung, Chin Li
TI Controlling E. coli Adhesion on High-k Dielectric Bioceramics Films
   using Poly(amino acid) Multilayers
SO LANGMUIR
LA English
DT Article
ID BACTERIAL ADHESION; GLASS; ZIRCONIA; BIOMATERIAL; SURFACES; BIOFILMS;
   POLYELECTROLYTES; MALTOPHILIA; PROTECTION; INTERFACE
AB The influence of high-k dielectric bioceramics with poly(amino acid) multilayer coatings on the adhesion behavior of Escherichia coli (E. coli) was studied by evaluating the density of bacteria coverage on the surfaces of these materials. A biofilm forming K-12 strain (PHL628), a wild-type strain (JM109), and an engineered strain (XL1-Blue) of E. coli were examined for their adherence to zirconium oxide (ZrO2) and tantalum oxide (Ta2O5) surfaces functionalized with single and multiple layers of poly(amino acid) polyelectrolytes made by the layer-by-layer (LBL) deposition. Two poly(amino acids), poly(L-arginine) (PARG) and poly(L-aspartic acid) (PASP), were chosen for the functionalization schemes. All three strains were found to grow and preferentially adhere to bare bioceramic film surfaces over bare glass slides. The bioceramic and glass surfaces functionalized with positively charged poly(amino acid) top layers were observed to enhance the adhesion of these bacteria by up to 4-fold in terms of bacteria surface coverage. Minimal bacteria coverage was detected on surfaces functionalized with negatively charged poly(amino acid) top layers. The effect of different poly(amino acid) coatings to promote or minimize bacterial adhesion was observed to be drastically enhanced with the bioceramic substrates than with glass. Such observed enhancements were postulated to be attributed to the formation of higher density of poly(amino acids) coatings enabled by the high dielectric strength (k) of these bioceramics. The multilayer poly(amino acid) functionalization scheme was successfully applied to utilize this finding for micropatterning E. coli on bioceramic thin films.
C1 [Lawrence, Neil J.; Wells-Kingsbury, Jamie M.; Ihrig, Marcella M.; Cheung, Chin Li] Univ Nebraska, Dept Chem, Lincoln, NE 68588 USA.
   [Lawrence, Neil J.; Wells-Kingsbury, Jamie M.; Ihrig, Marcella M.; Cheung, Chin Li] Univ Nebraska, Nebraska Ctr Mat & Nanosci, Lincoln, NE 68588 USA.
   [Fangman, Teresa E.] Univ Nebraska, Morrison Microscopy Core Res Facil, Lincoln, NE 68588 USA.
   [Namavar, Fereydoon] Univ Nebraska Med Ctr, Dept Orthopaed Surg & Rehabil, Omaha, NE 68198 USA.
RP Cheung, CL (reprint author), Univ Nebraska, Dept Chem, Lincoln, NE 68588 USA.
EM ccheung2@unl.edu
RI Cheung, Chin Li/B-8270-2013
OI Lawrence, Neil/0000-0003-4022-8571
FU Nebraska Research Initiative; University of Nebraska; NASA
FX We thank Nebraska Research Initiative and University of Nebraska for
   financial support and the Nebraska Center for Biotechnology for the use
   of their Microscopy Core facilities. M.M.I. was partially supported by a
   NASA Nebraska Space Grant fellowship. We are grateful to Dr. Anthony Hay
   of Cornell University for the gift of PHL628, Dr. Renat Sabirianov, and
   Dr. Alex Rubinstein for helpful discussions and James Hilfiker of J. A.
   Woollam Co. Inc. for assistance with obtaining, and modeling
   ellipsometry data as well as helpful discussions.
CR Abu-Lail NI, 2003, ENVIRON SCI TECHNOL, V37, P2173, DOI 10.1021/es026159o
   Bishop PL, 2007, WATER SCI TECHNOL, V55, P19, DOI 10.2166/wst.2007.005
   Boulmedais F, 2004, BIOMATERIALS, V25, P2003, DOI 10.1016/j.biomaterials.2003.08.039
   Caruso F, 1998, J PHYS CHEM B, V102, P2011, DOI 10.1021/jp980198y
   Chanana M, 2005, NANO LETT, V5, P2605, DOI 10.1021/nl0521219
   Chemical Rubber Company, 2004, HDB CHEM PHYS
   Chevalier J, 2006, BIOMATERIALS, V27, P535, DOI 10.1016/j.biomaterials.2005.07.034
   Chua PH, 2008, BIOMATERIALS, V29, P1412, DOI 10.1016/j.biomaterials.2007.12.019
   Cras JJ, 1999, BIOSENS BIOELECTRON, V14, P683, DOI 10.1016/S0956-5663(99)00043-3
   Das T, 2011, LANGMUIR, V27, P10113, DOI 10.1021/la202013m
   Decher G, 1997, SCIENCE, V277, P1232, DOI 10.1126/science.277.5330.1232
   Di Bonaventura G, 2004, ANTIMICROB AGENTS CH, V48, P151, DOI 10.1128/AAC.48.1.151-160.2004
   Eberl H, 2006, MATH MODELING BIOFIL
   Etienne O, 2005, BIOMATERIALS, V26, P6704, DOI 10.1016/j.biomaterials.2005.04.068
   Etienne O, 2004, ANTIMICROB AGENTS CH, V48, P3662, DOI 10.1128/AAC.48.10.3662-3669.2004
   Gottenbos B, 2001, J ANTIMICROB CHEMOTH, V48, P7, DOI 10.1093/jac/48.1.7
   Halthur TJ, 2004, J AM CHEM SOC, V126, P17009, DOI 10.1021/ja0464645
   Harrop A.P.J, 1967, BRIT J APPL PHYS, V18, P739
   Hisbergues M, 2009, J BIOMED MATER RES B, V88B, P519, DOI 10.1002/jbm.b.31147
   Hong S.M., 2006, JPCS, P656
   Joanny JF, 1999, EUR PHYS J B, V9, P117, DOI 10.1007/s100510050747
   Jucker BA, 1996, J BACTERIOL, V178, P5472, DOI 10.1128/jb.178.18.5472-5479.1996
   KERN W, 1970, RCA REV, V31, P187
   Krogman KC, 2009, NAT MATER, V8, P512, DOI [10.1038/NMAT2430, 10.1038/nmat2430]
   Krsko P, 2009, ACTA BIOMATER, V5, P589, DOI 10.1016/j.actbio.2008.08.025
   Li BK, 2004, COLLOID SURFACE B, V36, P81, DOI 10.1016/j.colsurfb.2004.05.006
   Li JZ, 2009, FRONT COMPUT SCI CHI, V3, P302, DOI 10.1007/s11704-009-0031-5
   Li P, 2011, NAT MATER, V10, P149, DOI [10.1038/nmat2915, 10.1038/NMAT2915]
   Lin J, 1999, APPL PHYS LETT, V74, P2370, DOI 10.1063/1.123854
   Mitragotri S, 2009, NAT MATER, V8, P15, DOI [10.1038/NMAT2344, 10.1038/nmat2344]
   Mourino V, 2010, J R SOC INTERFACE, V7, P209, DOI 10.1098/rsif.2009.0379
   Namavar F., 2007, NANOTECHNOLOGY, V18
   Nel AE, 2009, NAT MATER, V8, P543, DOI [10.1038/nmat2442, 10.1038/NMAT2442]
   Noimark S, 2009, CHEM SOC REV, V38, P3435, DOI 10.1039/b908260c
   Onyiriuka EC, 1998, SURF INTERFACE ANAL, V26, P270, DOI 10.1002/(SICI)1096-9918(199804)26:4<270::AID-SIA371>3.0.CO;2-H
   Orme R, 2006, PROTEOMICS, V6, P4269, DOI 10.1002/pmic.200600193
   Ozin G. A., 2005, NANOCHEMISTRY CHEM A
   Pang X, 2004, LANGMUIR, V20, P2921, DOI 10.1021/la0361971
   Piconi C, 1999, BIOMATERIALS, V20, P1, DOI 10.1016/S0142-9612(98)00010-6
   Rosentritt M, 2009, J BIOMED MATER RES B, V91B, P257, DOI 10.1002/jbm.b.31397
   Rubinstein A., 2010, PHYS REV E, V82
   Sabirianov RF, 2011, PHYS CHEM CHEM PHYS, V13, P6597, DOI 10.1039/c0cp02389b
   Stevens MM, 2005, SCIENCE, V310, P1135, DOI 10.1126/science.1106587
   Tambyah PA, 2002, INFECT CONT HOSP EP, V23, P27, DOI 10.1086/501964
   Truong VK, 2010, BIOMATERIALS, V31, P3674, DOI 10.1016/j.biomaterials.2010.01.071
   Vadillo-Rodriguez V, 2006, ENVIRON SCI TECHNOL, V40, P2983, DOI 10.1021/es052365v
   Vidal O, 1998, J BACTERIOL, V180, P2442
   Weibel DB, 2005, LANGMUIR, V21, P6436, DOI 10.1021/la0471713c
   Xu C, 2003, J MATER CHEM, V13, P3044, DOI 10.1039/b307788h
   Yoshida T, 2003, APPL MICROBIOL BIOT, V62, P21, DOI 10.1007/s00253-003-1312-9
NR 50
TC 8
Z9 8
U1 1
U2 30
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 0743-7463
J9 LANGMUIR
JI Langmuir
PD MAR 6
PY 2012
VL 28
IS 9
BP 4301
EP 4308
DI 10.1021/la2033725
PG 8
WC Chemistry, Multidisciplinary; Chemistry, Physical; Materials Science,
   Multidisciplinary
SC Chemistry; Materials Science
GA 902KW
UT WOS:000301038000032
PM 22339263
DA 2018-10-19
ER

PT J
AU Kolmas, J
   Szwaja, M
   Kolodziejski, W
AF Kolmas, Joanna
   Szwaja, Maciej
   Kolodziejski, Waclaw
TI Solid-state NMR and IR characterization of commercial xenogeneic
   biomaterials used as bone substitutes
SO JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS
LA English
DT Article
DE Bone substitute; Xenogeneic biomaterial; Biological apatite; Solid-state
   NMR; Infrared spectroscopy; Powder diffraction
ID NANOCRYSTALLINE CARBONATED HYDROXYAPATITES; TRANSFORM
   INFRARED-SPECTROSCOPY; MAS NMR; PHYSICOCHEMICAL CHARACTERIZATION;
   CALCIUM PHOSPHATES; HYDROXYL-GROUPS; P-31; ENVIRONMENT; APATITES;
   COLLAGEN
AB Three commercial xenogeneic biomaterials (Gen-Os, Apatos Spongiosa and Apatos Cortical; all from Tecnoss Dental, Torino, Italy) originated from porcine bone were characterized by various analytical methods, such as powder X-ray diffraction (XRD), thermogravimetry (TGA), high-resolution solid-state nuclear magnetic resonance (ssNMR) and infrared spectroscopy (FT-IR). The studies were focused on structural properties and chemical compositions of the samples. It was found that the main constituents of the analyzed biomaterials were nanocrystalline apatite mineral, organic collagenous matrix and water. For comparison, synthetic carbonated hydroxyapatite and natural collagen type I from bovine tendon were used. Differences in various physicochemical parameters such as crystal size, specific surface area, concentration of structural hydroxyl groups, contents of CO32- and HPO42- ions and their location were discussed. It was shown that various techniques of ssNMR and elaborate analysis of the FT-IR spectra, applied together, provide valuable information on xenogeneic biomaterials. (C) 2011 Elsevier B.V. All rights reserved.
C1 [Kolmas, Joanna; Szwaja, Maciej; Kolodziejski, Waclaw] Med Univ Warsaw, Fac Pharm, Dept Inorgan & Analyt Chem, PL-02097 Warsaw, Poland.
RP Kolmas, J (reprint author), Med Univ Warsaw, Fac Pharm, Dept Inorgan & Analyt Chem, Ul Banacha 1, PL-02097 Warsaw, Poland.
EM joanna.kolmas@wum.edu.Pl
FU Medical University of Warsaw [FW-23/N/2011]
FX The Medical University of Warsaw is acknowledged for financial support
   (FW-23/N/2011).
CR Accorsi-Mendonça Thais, 2008, Braz. oral res., V22, P5, DOI 10.1590/S1806-83242008000100002
   Belbachir K, 2009, ANAL BIOANAL CHEM, V395, P829, DOI 10.1007/s00216-009-3019-y
   BESHAH K, 1990, J SOLID STATE CHEM, V84, P71, DOI 10.1016/0022-4596(90)90185-Z
   Cho GY, 2003, SCIENCE, V300, P1123, DOI 10.1126/science.1078470
   CLASEN ABS, 1997, ADV DENT RES, V11, P523, DOI DOI 10.1177/08959374970110042101
   Cruz Gabriela Alessandra da, 2007, Braz. Dent. J., V18, P129, DOI 10.1590/S0103-64402007000200008
   Dorozhkin SV, 2010, ACTA BIOMATER, V6, P715, DOI 10.1016/j.actbio.2009.10.031
   Eichert D., 2009, NANOCRYSTALLINE APAT
   Elliott JC, 1994, STRUCTURE CHEM APATI
   Figueiredo M, 2010, J BIOMED MATER RES B, V92B, P409, DOI 10.1002/jbm.b.31529
   Fleet ME, 2004, AM MINERAL, V89, P1422
   Huster D, 2008, ANNU REP NMR SPECTRO, V64, P127, DOI 10.1016/S0066-4103(08)00004-5
   Jarlbring M, 2006, LANGMUIR, V22, P4787, DOI 10.1021/la052837j
   Kaflak A, 2011, J MOL STRUCT, V997, P7, DOI 10.1016/j.molstruc.2011.04.013
   Kaflak A, 2011, J MOL STRUCT, V990, P263, DOI 10.1016/j.molstruc.2011.01.056
   Kolmas J, 2007, SOLID STATE NUCL MAG, V32, P53, DOI 10.1016/j.ssnmr.2007.08.001
   Kolmas J, 2007, CHEM COMMUN, P4390, DOI 10.1039/b708317c
   Kolodziejski W, 2005, TOP CURR CHEM, V246, P235, DOI 10.1007/b98652
   Magne D, 2001, J BONE MINER RES, V16, P750, DOI 10.1359/jbmr.2001.16.4.750
   Miller LM, 2001, BBA-GEN SUBJECTS, V1527, P11, DOI 10.1016/S0304-4165(01)00093-9
   Nannmark U, 2008, CLIN IMPLANT DENT R, V10, P264, DOI 10.1111/j.1708-8208.2007.00080.x
   REY C, 1989, CALCIFIED TISSUE INT, V45, P157, DOI 10.1007/BF02556059
   Rey Christian, 2006, Advances in Science and Technology, V49, P27, DOI 10.4028/www.scientific.net/AST.49.27
   REY C, 1990, CALCIFIED TISSUE INT, V46, P384, DOI 10.1007/BF02554969
   Slosarczyk A, 2005, J MOL STRUCT, V744, P657, DOI 10.1016/j.molstruc.2004.11.078
   Tadic D, 2004, BIOMATERIALS, V25, P987, DOI 10.1016/S0142-9612(03)00621-5
   Tudor C, 2008, ORAL SURG ORAL MED O, V105, P430, DOI 10.1016/j.tripleo.2007.07.037
   WU YT, 1994, J MOL BIOL, V244, P423, DOI 10.1006/jmbi.1994.1740
NR 28
TC 15
Z9 15
U1 0
U2 27
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0731-7085
EI 1873-264X
J9 J PHARMACEUT BIOMED
JI J. Pharm. Biomed. Anal.
PD MAR 5
PY 2012
VL 61
BP 136
EP 141
DI 10.1016/j.jpba.2011.11.008
PG 6
WC Chemistry, Analytical; Pharmacology & Pharmacy
SC Chemistry; Pharmacology & Pharmacy
GA 886NS
UT WOS:000299861700019
PM 22169471
DA 2018-10-19
ER

PT J
AU Costa, LMM
   de Olyveira, GM
   Basmaji, P
   Valido, DP
   Gois, PBP
   Cavlcante, RLA
   Xavier, L
AF Manzine Costa, Ligia Maria
   de Olyveira, Gabriel Molina
   Basmaji, Pierre
   Valido, Daisy Pereira
   Prata Gois, Placia Barreto
   Albuquerque Cavlcante Junior, Ricardo Luis
   Xavier Filho, Lauro
TI Novel Otoliths/Bacterial Cellulose Nanocomposites as a Potential Natural
   Product for Direct Dental Pulp Capping
SO JOURNAL OF BIOMATERIALS AND TISSUE ENGINEERING
LA English
DT Article
DE Bacterial Cellulose; Nanocomposites; Reparative Pulp Teeth
ID BACTERIAL CELLULOSE; BONE REGENERATION; SCAFFOLDS; SPONGES;
   BIOMATERIALS; COMPOSITES; REPAIR
AB In the present work, we report the first bionanocomposite material formed by otoliths/bacterial cellulose (BC) networks (OCBC). This biomaterial is an osteoinductor or be, stimulates the bone regeneration, enabling bigger migration of the cells for formation of the bone fabric. Otolith is a typical biomaterial which is composed of calcium carbonate and organic matrix, present in the inner ear of fishes. Since they are rich in minerals considered essential to the bone mineralization process on a protein matrix (otolith). The objective in this study was to analyze the regeneration capacity of bone defects treated with nanotoliths/bc network preparation and evaluated the response of the dental pulps of dog teeth to capping in comparison with control group. Otoliths/bc network stimulates the formation of mineralized tissue barrier and inducing the reparative pulp response, and hence work as a promising pulp capping material.
C1 [Manzine Costa, Ligia Maria; de Olyveira, Gabriel Molina] Univ Fed Abc, Dept Nanosci & Adv Mat, BR-09291210 Santo Andre, SP, Brazil.
   [Basmaji, Pierre] Innovatecs Biotechnol Res & Dev, BR-13566610 Sao Carlos, SP, Brazil.
   [Valido, Daisy Pereira; Prata Gois, Placia Barreto; Albuquerque Cavlcante Junior, Ricardo Luis; Xavier Filho, Lauro] Univ Tiradentes, IPT, Nat Prod & Biotechnol Lab, BR-49032490 Aracaju, Sergipe, Brazil.
RP de Olyveira, GM (reprint author), Univ Fed Abc, Dept Nanosci & Adv Mat, Rua Santa Adelia 166, BR-09291210 Santo Andre, SP, Brazil.
RI Manzine Costa, Ligia Maria/N-1780-2015
OI Manzine Costa, Ligia Maria/0000-0001-6483-7633
FU Innovatec's-Biotechnology Research and Development, Nanoskin(R) and
   UNIT-SE
FX This research was supported by Innovatec's-Biotechnology Research and
   Development, Nanoskin (R) and UNIT-SE.
CR Aslan M., 2004, J CONT DENT PRACT, V5, P114
   Barbanti Samuel H., 2005, Polímeros, V15, P13, DOI 10.1590/S0104-14282005000100006
   Basmaji P., 1996, Brazilian Patent, Patent No. [PI0604760-2, 06047602]
   Bhattarai S. J., 2005, BIOMATERIALS, V25, P2595
   Carvalho RS, 2003, AM J ORTHOD DENTOFAC, V123, P455, DOI 10.1067/mod.2003.59
   Chen GP, 2000, ADV MATER, V12, P455, DOI 10.1002/(SICI)1521-4095(200003)12:6<455::AID-ADMA455>3.0.CO;2-C
   Czaja W, 2006, BIOMATERIALS, V27, P145, DOI 10.1016/j.biomaterials.2005.07.035
   DAHLIN C, 1988, PLAST RECONSTR SURG, V81, P672, DOI 10.1097/00006534-198805000-00004
   Geiger M, 2003, ADV DRUG DELIVER REV, V55, P1613, DOI 10.1016/j.addr.2003.08.010
   Grande CJ, 2009, MAT SCI ENG C-BIO S, V29, P1098, DOI 10.1016/j.msec.2008.09.024
   Grande CJ, 2009, ACTA BIOMATER, V5, P1605, DOI 10.1016/j.actbio.2009.01.022
   Helenius G, 2006, J BIOMED MATER RES A, V76A, P431, DOI 10.1002/jbm.a.30570
   Hunziker EB, 2002, OSTEOARTHR CARTILAGE, V10, P432, DOI 10.1053/joca.2002.0801
   Iamaguti LS, 2008, PESQUISA VET BRASIL, V28, P195, DOI 10.1590/S0100-736X2008000400001
   Kacurakova M, 2002, CARBOHYD RES, V337, P1145, DOI 10.1016/S0008-6215(02)00102-7
   Kim BS, 2000, WORLD J UROL, V18, P2, DOI 10.1007/s003450050002
   Klemm D, 2005, ANGEW CHEM INT EDIT, V44, P3358, DOI 10.1002/anie.200460587
   Kose GT, 2004, TISSUE ENG, V10, P1234, DOI 10.1089/ten.2004.10.1234
   Kumari T. V., 2002, TRENDS BIOMATER ARTI, V15, P37
   Luginbuehl V, 2005, PHARM RES, V22, P940, DOI 10.1007/s11095-005-4589-9
   Macedo N., 2004, BRAZ J ORAL SCI, V3, P395
   Nakamoto K., 1963, INFRARED SPECTRA INO, P328
   Seol YJ, 2004, BIOTECHNOL LETT, V26, P1037, DOI 10.1023/B:BILE.0000032962.79531.fd
   Surma-Slusarska B, 2008, FIBRES TEXT EAST EUR, V16, P108
   Svensson A., 2005, BIOMATERIALS, V26, P431
   Taton TA, 2001, NATURE, V412, P491, DOI 10.1038/35087687
   Tuzlakoglu K, 2005, J MATER SCI-MATER M, V16, P1099, DOI 10.1007/s10856-005-4713-8
   Valido Daisy Pereira, 2010, J. Bras. Patol. Med. Lab., V46, P315, DOI 10.1590/S1676-24442010000400009
   Yang SF, 2001, TISSUE ENG, V7, P679, DOI 10.1089/107632701753337645
NR 29
TC 11
Z9 11
U1 2
U2 23
PU AMER SCIENTIFIC PUBLISHERS
PI VALENCIA
PA 26650 THE OLD RD, STE 208, VALENCIA, CA 91381-0751 USA
SN 2157-9083
J9 J BIOMATER TISS ENG
JI J. Biomater. Tissue Eng.
PD MAR
PY 2012
VL 2
IS 1
BP 48
EP 53
DI 10.1166/jbt.2012.1031
PG 6
WC Cell & Tissue Engineering
SC Cell Biology
GA 057NQ
UT WOS:000312570700005
DA 2018-10-19
ER

PT J
AU Yuvarani, I
   Kumar, SS
   Venkatesan, J
   Kim, SK
   Sudha, PN
AF Yuvarani, I.
   Kumar, S. Senthil
   Venkatesan, Jayachandran
   Kim, Se-Kwon
   Sudha, P. N.
TI Preparation and Characterization of Curcumin Coated Chitosan-Alginate
   Blend for Wound Dressing Application
SO JOURNAL OF BIOMATERIALS AND TISSUE ENGINEERING
LA English
DT Article
DE Chitosan; Alginate; Curcumin; Wound Healing; Co-Polymer
ID IN-VITRO; TISSUE; SPONGE
AB A biodegrable blend of Chitosan (CS) and Sodium Alginate (SA) was fabricated and used with curcumin for wound healing application. The chemical structure of the blend was characterized by Fourier Transform Infrared Spectroscopy (FTIR), Differential Scanning Calorimetry (DSC), Thermo Gravimetric Analysis (TGA), X-ray Diffraction (XRD) analysis and in vivo study. The physicochemical characteristic results suggested that strong chemical interaction and uniform dispersion was observed between Chitosan and Alginate. The in vivo animal tests were employed to confirm the biocompatibility of the blend as wound-dressing application. Addition of curcumin with Chitosan-Alginate improved its property in wound healing surface. An in vivo model revealed that Chitosan-alginate with curcumin blends had superior to Chitosan-Alginate and saline system. Based on the results, Chitosan-Alginate with curcumin powder will become a promising biomaterial for wound dressing application.
C1 [Yuvarani, I.; Sudha, P. N.] Manonmaniam Sundaranar Univ, Dept Chem, Tirunelveli 627012, Tamil Nadu, India.
   [Kumar, S. Senthil] Christian Med Coll & Hosp, Vellore 632001, Tamil Nadu, India.
   [Venkatesan, Jayachandran; Kim, Se-Kwon] Pukyong Natl Univ, Dept Chem, Pusan 608737, South Korea.
   [Venkatesan, Jayachandran; Kim, Se-Kwon] Pukyong Natl Univ, Marine Bioproc Res Ctr, Pusan 608737, South Korea.
   [Sudha, P. N.] Thiruvalluvar Univ, Dept Chem, DKM Coll, Vellore 632001, Tamil Nadu, India.
RP Kim, SK (reprint author), Pukyong Natl Univ, Dept Chem, Pusan 608737, South Korea.
RI Jayachandran, Venkatesan/B-8857-2013
OI Jayachandran, Venkatesan/0000-0002-6881-2297; Kim,
   Se-Kwon/0000-0001-6507-9539
CR BARTONE FF, 1988, J UROLOGY, V140, P1134, DOI 10.1016/S0022-5347(17)41980-X
   Chattopadhyay I, 2004, CURR SCI INDIA, V87, P44
   Chou TC, 2003, BIOCHEM BIOPH RES CO, V302, P480, DOI 10.1016/S0006-291X(03)00173-6
   Das, 1995, United States Patent, Patent No. [5,401,504, 5401504]
   Dash G K, 2011, ISRN Pharmacol, V2011, P847980, DOI 10.5402/2011/847980
   Di Martino A, 2005, BIOMATERIALS, V26, P5983, DOI 10.1016/j.biomaterials.2005.03.016
   Dong Y, 2010, CHINESE CHEM LETT, V21, P1011, DOI 10.1016/j.cclet.2010.04.010
   Felt O, 2000, J OCUL PHARMACOL TH, V16, P261, DOI 10.1089/jop.2000.16.261
   Felt O, 1998, DRUG DEV IND PHARM, V24, P979, DOI 10.3109/03639049809089942
   Hong HJ, 2008, BIOMATERIALS, V29, P4831, DOI 10.1016/j.biomaterials.2008.08.023
   Illum L, 1998, PHARMACEUT RES, V15, P1326
   Janis JE, 2010, PLAST RECONSTR SURG, V125, p230E, DOI 10.1097/PRS.0b013e3181d9a0d1
   Jayakumar R, 2011, BIOTECHNOL ADV, V29, P322, DOI 10.1016/j.biotechadv.2011.01.005
   Knill CJ, 2004, CARBOHYD POLYM, V55, P65, DOI 10.1016/j.carbpol.2003.08.004
   Kumar MNVR, 2004, CHEM REV, V104, P6017, DOI 10.1021/cr030441b
   Lai HL, 2003, INT J PHARM, V251, P175, DOI 10.1016/S0378-5173(02)00590-2
   Lee KY, 2009, ADV DRUG DELIVER REV, V61, P1020, DOI 10.1016/j.addr.2009.07.006
   Li DH, 2011, J NANOSCI NANOTECHNO, V11, P4733, DOI 10.1166/jnn.2011.4179
   Ma LH, 2007, J APPL POLYM SCI, V106, P394, DOI 10.1002/app.26463
   Mei D., 2009, J BIOMED BIOTECHNOL
   Meyer H., 2000, ADV CHITIN SCI, V4, P153
   Murakami K, 2010, BIOMATERIALS, V31, P83, DOI 10.1016/j.biomaterials.2009.09.031
   Paul W., 2004, TRENDS BIOMATERIALS, V18, P18
   Pei HN, 2008, J BIOMED MATER RES A, V85A, P566, DOI 10.1002/jbm.a.31223
   Roh DH, 2006, J MATER SCI-MATER M, V17, P547, DOI 10.1007/s10856-006-8938-y
   Ueno H, 2001, ADV DRUG DELIVER REV, V52, P105, DOI 10.1016/S0169-409X(01)00189-2
   Venkatesan J, 2010, MAR DRUGS, V8, P2252, DOI 10.3390/md8082252
   Wittaya-areekul S, 2006, INT J PHARM, V312, P113, DOI 10.1016/j.ijpharm.2006.01.003
   Zhao M, 2006, NATURE, V442, P457, DOI 10.1038/nature04925
NR 29
TC 20
Z9 21
U1 1
U2 42
PU AMER SCIENTIFIC PUBLISHERS
PI VALENCIA
PA 26650 THE OLD RD, STE 208, VALENCIA, CA 91381-0751 USA
SN 2157-9083
EI 2157-9091
J9 J BIOMATER TISS ENG
JI J. Biomater. Tissue Eng.
PD MAR
PY 2012
VL 2
IS 1
BP 54
EP 60
DI 10.1166/jbt.2012.1037
PG 7
WC Cell & Tissue Engineering
SC Cell Biology
GA 057NQ
UT WOS:000312570700006
DA 2018-10-19
ER

PT J
AU Tagaya, M
   Ikoma, T
   Hanagata, N
   Tanaka, J
AF Tagaya, Motohiro
   Ikoma, Toshiyuki
   Hanagata, Nobutaka
   Tanaka, Junzo
TI Analytical Investigation of Protein Mediation Between Biomaterials and
   Cells
SO MATERIALS EXPRESS
LA English
DT Review
DE QCM-D; Protein Adsorption; Cell Adhesion; Interfacial Viscoelasticity;
   Hydroxyapatite
ID QUARTZ-CRYSTAL MICROBALANCE; CALCIUM-PHOSPHATE COATINGS; SURFACE-PLASMON
   RESONANCE; SELF-ASSEMBLED MONOLAYERS; FETAL BOVINE SERUM; SPRAYED
   HYDROXYAPATITE COATINGS; INDUCED CONFORMATIONAL-CHANGES; GLOMERULAR
   BASEMENT MEMBRANE; SOLID-LIQUID INTERFACE; SHEAR-WAVE RESONATORS
AB When biomaterials are implanted into a body, proteins in the body fluid are adsorbed and the body cells adhere on the surfaces. Cells respond differently with different biomaterials. Hence, proper understanding of cellular response to biomaterial surfaces is crucial for successful tissue regeneration and integration. Quartz crystal microbalance with dissipation monitoring (QCM-D) is one of the most advanced in situ analyzing techniques to detect interfacial interactions of the protein adlayers between biomaterial surfaces and cells. This review article precisely describes how to analyze interfacial phenomena of the protein adsorption and subsequent cell adhesion using the QCM-D technique. In particular, we focus on understanding the biocompatibility of interfaces by explaining the role of biomaterial surfaces in protein-mediation. The viscoelastic properties of the interfaces are estimated by Voigt-based viscoelastic model obtained from the frequency shift (Delta f) and dissipation shift (Delta D) curves. Different protein adsorption and cell adhesion processes have been analyzed to different biomaterial surfaces. This approach clarifies several ambiguities of the interfacial phenomena between biomaterials and cells, and helps to design new biomaterials to be implanted in human body.
C1 [Tagaya, Motohiro] Nagaoka Univ Technol, Dept Mat Sci & Technol, Nagaoka, Niigata 9402188, Japan.
   [Tagaya, Motohiro; Ikoma, Toshiyuki; Hanagata, Nobutaka; Tanaka, Junzo] Natl Inst Mat Sci, Ctr Biomat, Tsukuba, Ibaraki 3050047, Japan.
   [Ikoma, Toshiyuki; Tanaka, Junzo] Tokyo Inst Technol, Dept Met & Ceram Sci, Meguro Ku, Tokyo 1528550, Japan.
RP Tagaya, M (reprint author), Nagaoka Univ Technol, Dept Mat Sci & Technol, Kamitomioka 1603-1, Nagaoka, Niigata 9402188, Japan.
EM tagaya@mst.nagaokaut.ac.jp
RI Ikoma, Toshiyuki/E-4288-2012
OI Ikoma, Toshiyuki/0000-0003-3154-1777
CR Abbott A, 2003, NATURE, V424, P870, DOI 10.1038/424870a
   Anselme K, 2000, BIOMATERIALS, V21, P667, DOI 10.1016/S0142-9612(99)00242-2
   AOKI H, 1987, MED PROG TECHNOL, V12, P213
   Areva S, 2002, CHEM MATER, V14, P1614, DOI 10.1021/cm0107272
   Arnold M, 2004, CHEMPHYSCHEM, V5, P383, DOI 10.1002/cphc.200301014
   Asanov AN, 1998, ANAL CHEM, V70, P1156, DOI 10.1021/ac970805y
   AZZAM RMA, 1977, PHYS MED BIOL, V22, P422, DOI 10.1088/0031-9155/22/3/002
   Bannasch H, 2003, CLIN PLAST SURG, V30, P573, DOI 10.1016/S0094-1298(03)00075-0
   Barrere F, 2008, MAT SCI ENG R, V59, P38, DOI 10.1016/j.mser.2007.12.001
   BEISSINGER RL, 1981, T AM SOC ART INT ORG, V27, P225
   Berglin M, 2009, LANGMUIR, V25, P5602, DOI 10.1021/la803686m
   Berthet-Colominas C., 1994, J MOL BIOL, V134, P431
   BOLON DA, 1972, POLYM ENG SCI, V12, P109, DOI 10.1002/pen.760120206
   Bose S, 2003, CHEM MATER, V15, P4464, DOI 10.1021/cm0303437
   Cady WG, 1921, PHYS REV, V17, P531
   Cans AS, 2001, ANAL CHEM, V73, P5805, DOI 10.1021/ac010777q
   Cao WP, 1996, CERAM INT, V22, P493, DOI 10.1016/0272-8842(95)00126-3
   Cheang P, 1996, J THERM SPRAY TECHN, V5, P310, DOI 10.1007/BF02645883
   Chen CS, 1997, SCIENCE, V276, P1425, DOI 10.1126/science.276.5317.1425
   Chen YL, 1999, J COLLOID INTERF SCI, V214, P38
   Choi KH, 2002, APPL PHYS LETT, V81, P1335, DOI 10.1063/1.1500777
   Chot NJ, 2007, ANAL CHEM, V79, P7027, DOI 10.1021/ac0709504
   Cleries L, 2000, BIOMATERIALS, V21, P967, DOI 10.1016/S0142-9612(99)00240-9
   Cross GH, 2004, J PHYS D APPL PHYS, V37, P74, DOI 10.1088/0022-3727/37/1/012
   Curie P., 1880, CR HEBD ACAD SCI, V91, P294
   Daculsi G, 1999, J BIOMED MATER RES, V47, P228, DOI 10.1002/(SICI)1097-4636(199911)47:2<228::AID-JBM13>3.0.CO;2-Z
   DEJARDIN P, 1995, LANGMUIR, V11, P4001, DOI 10.1021/la00010a061
   do Serro APVA, 2000, J BIOMED MATER RES, V49, P345
   Dolatshahi-Pirouz A, 2009, LANGMUIR, V25, P2971, DOI 10.1021/la803142u
   EBERSOLE RC, 1991, BIO-TECHNOL, V9, P450, DOI 10.1038/nbt0591-450
   Edvardsson M, 2009, ANAL CHEM, V81, P349, DOI 10.1021/ac801523w
   El-Ghannam A, 1999, J ORTHOPAED RES, V17, P340, DOI 10.1002/jor.1100170307
   Fernandez P, 2007, NEW J PHYS, V9, DOI 10.1088/1367-2630/9/11/419
   Fohlerova Z, 2007, BIOSENS BIOELECTRON, V22, P1896, DOI 10.1016/j.bios.2006.08.015
   Fredriksson C, 1998, LANGMUIR, V14, P248, DOI 10.1021/la971005l
   Fredriksson C, 1998, J MATER SCI-MATER M, V9, P785, DOI 10.1023/A:1008927624337
   Freeman NJ, 2004, J PHYS-CONDENS MAT, V16, pS2493, DOI 10.1088/0953-8984/16/26/023
   Fukuda J, 2006, BIOMATERIALS, V27, P1061, DOI 10.1016/j.biomaterials.2005.07.031
   Fukuda J, 2005, TISSUE ENG, V11, P1254, DOI 10.1089/ten.2005.11.1254
   Fukuda J, 2006, BIOMATERIALS, V27, P5259, DOI 10.1016/j.biomaterials.2006.05.044
   Furuzono T, 2009, J BIOMED MATER RES B, V89B, P77, DOI 10.1002/jbm.b.31189
   Giancotti FG, 1999, SCIENCE, V285, P1028, DOI 10.1126/science.285.5430.1028
   GLIMCHER MJ, 1984, PHILOS T R SOC B, V304, P479, DOI 10.1098/rstb.1984.0041
   Goobes R, 2006, BIOCHEMISTRY-US, V45, P5576, DOI 10.1021/bi052321z
   Grainger DW, 2003, J BIOMAT SCI-POLYM E, V14, P973, DOI 10.1163/156856203322381456
   Green RJ, 1999, BIOMATERIALS, V20, P385, DOI 10.1016/S0142-9612(98)00201-4
   Gurdak E, 2005, LANGMUIR, V21, P10684, DOI 10.1021/la051227g
   HALL CE, 1959, J BIOPHYS BIOCHEM CY, V5, P11, DOI 10.1083/jcb.5.1.11
   Hanagata N, 2006, BIOCHEM BIOPH RES CO, V344, P1234, DOI 10.1016/j.bbrc.2006.04.021
   Hanagata N, 2007, J BIOMED MATER RES A, V83A, P362, DOI 10.1002/jbm.a.31240
   Hashizume M, 2010, CHEM LETT, V39, P220, DOI 10.1246/cl.2010.220
   HAYNES CA, 1995, J COLLOID INTERF SCI, V169, P313, DOI 10.1006/jcis.1995.1039
   Hemmersam AG, 2005, COLLOID SURFACE B, V43, P208, DOI 10.1016/j.colsurfb.2005.04.007
   Hemmersam AG, 2008, J COLLOID INTERF SCI, V320, P110, DOI 10.1016/j.jcis.2007.11.047
   HENCH LL, 1984, SCIENCE, V226, P630, DOI 10.1126/science.6093253
   Hiroki A, 2005, J PHYS CHEM B, V109, P3364, DOI 10.1021/jp046405d
   Holmberg M, 2008, J MATER SCI-MATER M, V19, P2179, DOI 10.1007/s10856-007-3318-9
   Holmberg M, 2009, LANGMUIR, V25, P2081, DOI 10.1021/la8031978
   Hook F, 1998, LANGMUIR, V14, P729, DOI 10.1021/la970815u
   Hook F, 2002, COLLOID SURFACE B, V24, P155, DOI 10.1016/S0927-7765(01)00236-3
   Hook F, 2001, ANAL CHEM, V73, P5796, DOI 10.1021/ac0106501
   Hook F, 1998, J COLLOID INTERF SCI, V208, P63, DOI 10.1006/jcis.1998.5774
   HORBETT TA, 1984, THROMB HAEMOSTASIS, V51, P174
   Horbett TA, 1995, ACS SYM SER, V602, P1
   Huang S, 2000, EXP CELL RES, V261, P91, DOI 10.1006/excr.2000.5044
   Ikoma T, 1999, J SOLID STATE CHEM, V144, P272, DOI 10.1006/jssc.1998.8120
   Ikoma T, 2009, KEY ENG MATER, V396-398, P89, DOI 10.4028/www.scientific.net/KEM.396-398.89
   Ikoma T, 2007, J NANOSCI NANOTECHNO, V7, P822, DOI 10.1166/jnn.2007.523
   Ikoma T, 2009, J AM CERAM SOC, V92, P1125, DOI 10.1111/j.1551-2916.2009.02957.x
   Itokazu M, 1998, J BIOMED MATER RES, V39, P536, DOI 10.1002/(SICI)1097-4636(19980315)39:4<536::AID-JBM5>3.0.CO;2-K
   Janshoff A, 1996, EUR BIOPHYS J BIOPHY, V25, P93, DOI 10.1007/s002490050021
   Janshoff A, 2000, ANGEW CHEM INT EDIT, V39, P4004, DOI 10.1002/1521-3773(20001117)39:22<4004::AID-ANIE4004>3.0.CO;2-2
   Javidi M, 2009, ADV APPL CERAM, V108, P241, DOI 10.1179/174367608X353647
   KADOYA T, 1990, J CHROMATOGR, V515, P521, DOI 10.1016/S0021-9673(01)89349-3
   KANAZAWA KK, 1985, ANAL CHIM ACTA, V175, P99
   Kandori K, 2004, J COLLOID INTERF SCI, V273, P406, DOI 10.1016/j.jcis.2004.01.069
   Kasemo B, 2002, SURF SCI, V500, P656, DOI 10.1016/S0039-6028(01)01809-X
   KATZ EP, 1973, J MOL BIOL, V80, P1, DOI 10.1016/0022-2836(73)90230-1
   KAY MI, 1964, NATURE, V204, P1050, DOI 10.1038/2041050a0
   KEFALIDES NA, 1966, BIOCHEMISTRY-US, V5, P702, DOI 10.1021/bi00866a043
   KEFALIDES NA, 1969, BIOCHEMISTRY-US, V8, P4613, DOI 10.1021/bi00839a057
   KERN W, 1970, RCA REV, V31, P187
   Keselowsky BG, 2003, J BIOMED MATER RES A, V66A, P247, DOI 10.1002/jbm.a.10537
   Khademhosseini A, 2004, LAB CHIP, V4, P425, DOI 10.1039/b404842c
   Khademhosseini A, 2006, P NATL ACAD SCI USA, V103, P2480, DOI 10.1073/pnas.0507681102
   Kikuchi M, 2001, BIOMATERIALS, V22, P1705, DOI 10.1016/S0142-9612(00)00305-7
   Kim HW, 2005, J BIOMED MATER RES B, V74B, P686, DOI 10.1002/jbm.b.30236
   Koenig AL, 2003, J BIOMED MATER RES A, V64A, P20, DOI 10.1002/jbm.a.10316
   KOKUBO T, 1990, J NON-CRYST SOLIDS, V120, P138, DOI 10.1016/0022-3093(90)90199-V
   Kokubo T, 2006, BIOMATERIALS, V27, P2907, DOI 10.1016/j.biomaterials.2006.01.017
   KOKUBO T, 1990, J BIOMED MATER RES, V24, P721, DOI 10.1002/jbm.820240607
   KONASH PL, 1980, ANAL CHEM, V52, P1929, DOI 10.1021/ac50062a033
   Koumoulidis GC, 2003, J COLLOID INTERF SCI, V259, P254, DOI 10.1016/S0021-9797(02)00233-3
   Kurrat R, 1997, J COLLOID INTERF SCI, V185, P1, DOI 10.1006/jcis.1996.4528
   Lack FR, 1934, BELL SYST TECH J, V13, P453, DOI 10.1002/j.1538-7305.1934.tb00674.x
   Landau L. D., 1959, OSCILLATION MOTION V, P88
   LANDIS WJ, 1993, J STRUCT BIOL, V110, P39, DOI 10.1006/jsbi.1993.1003
   LANGER R, 1993, SCIENCE, V260, P920, DOI 10.1126/science.8493529
   Langford J, 2002, ANALYST, V127, P360, DOI 10.1039/b109684m
   Lassen B, 1996, J COLLOID INTERF SCI, V179, P470, DOI 10.1006/jcis.1996.0239
   Le Guillou-Buffello D, 2008, TISSUE ENG PT A, V14, P1445, DOI 10.1089/ten.tea.2007.0292
   Letic-Gavrilovic A, 2003, J MATER SCI-MATER M, V14, P95, DOI 10.1023/A:1022099208535
   Levenberg S, 2004, CURR TOP DEV BIOL, V61, P113, DOI 10.1016/S0070-2153(04)61005-2
   Li F, 2008, SENSOR ACTUAT B-CHEM, V128, P399, DOI 10.1016/j.snb.2007.06.032
   Liao SS, 2004, TISSUE ENG, V10, P73, DOI 10.1089/107632704322791718
   Lim GK, 1999, J MATER CHEM, V9, P1635, DOI 10.1039/a809644i
   Lima J, 2001, J BIOMED MATER RES, V55, P45, DOI 10.1002/1097-4636(200104)55:1<45::AID-JBM70>3.0.CO;2-0
   Liu P, 2008, J CRYST GROWTH, V310, P4672, DOI 10.1016/j.jcrysgro.2008.09.002
   Lord MS, 2008, BIOMATERIALS, V29, P2581, DOI 10.1016/j.biomaterials.2008.03.002
   Lord MS, 2006, BIOMATERIALS, V27, P4529, DOI 10.1016/j.biomaterials.2006.04.006
   Lubarsky GV, 2007, BIOSENS BIOELECTRON, V22, P1275, DOI 10.1016/j.bios.2006.05.024
   LUNDSTROM I, 1990, J COLLOID INTERF SCI, V136, P68, DOI 10.1016/0021-9797(90)90079-4
   Lunts C., 1980, J PHYS CHEM, V72, P1143
   LUTANIE E, 1992, P NATL ACAD SCI USA, V89, P9890, DOI 10.1073/pnas.89.20.9890
   Malmstrom J, 2007, LANGMUIR, V23, P9760, DOI 10.1021/la701233y
   Marques PAAP, 2003, BIOMATERIALS, V24, P451, DOI 10.1016/S0142-9612(02)00358-7
   Marx KA, 2005, ANAL BIOCHEM, V343, P23, DOI 10.1016/j.ab.2005.05.013
   Marx KA, 2003, BIOTECHNOL PROGR, V19, P987, DOI 10.1021/bp0201096
   Marx KA, 2001, BIOSENS BIOELECTRON, V16, P773, DOI 10.1016/S0956-5663(01)00219-6
   Marxer CM, 2003, ANAL BIOANAL CHEM, V377, P578, DOI 10.1007/s00216-003-2080-1
   Matsuda A, 2004, MAT SCI ENG C-BIO S, V24, P723, DOI 10.1016/j.msec.2004.08.047
   McClary KB, 2000, J BIOMED MATER RES, V50, P428, DOI 10.1002/(SICI)1097-4636(20000605)50:3<428::AID-JBM18>3.0.CO;2-H
   Michael KE, 2003, LANGMUIR, V19, P8033, DOI 10.1021/la034810a
   Miyazaki T, 2003, J MATER SCI-MATER M, V14, P569, DOI 10.1023/A:1024000821368
   Mizushima Y, 2006, J CONTROL RELEASE, V110, P260, DOI 10.1016/j.jconrel.2005.09.051
   Modin C, 2006, BIOMATERIALS, V27, P1346, DOI 10.1016/j.biomaterials.2005.09.022
   Monkawa A, 2006, BIOMATERIALS, V27, P5748, DOI 10.1016/j.biomaterials.2006.07.029
   Moseke C, 2009, MATERIALWISS WERKST, V40, P36, DOI 10.1002/mawe.200800414
   MURAMATSU H, 1988, ANAL CHEM, V60, P2142, DOI 10.1021/ac00170a032
   Nath N, 2004, SURF SCI, V570, P98, DOI 10.1016/j.susc.2004.06.182
   Nemoto R, 2004, J NANOPART RES, V6, P259, DOI 10.1023/B:NANO.0000034656.19386.99
   NOMURA T, 1982, ANAL CHIM ACTA, V142, P281, DOI 10.1016/S0003-2670(01)95290-0
   NORDE W, 1986, ADV COLLOID INTERFAC, V25, P267, DOI 10.1016/0001-8686(86)80012-4
   Nudelman F, 2010, NAT MATER, V9, P1004, DOI 10.1038/NMAT2875
   O'Sullivan CK, 1999, BIOSENS BIOELECTRON, V14, P663, DOI 10.1016/S0956-5663(99)00040-8
   OHTSUKI C, 1992, J NON-CRYST SOLIDS, V143, P84, DOI 10.1016/S0022-3093(05)80556-3
   Okuda M, 2011, MICROSC MICROANAL, V17, P788, DOI 10.1017/S1431927611011949
   Okuda M, 2009, MICRON, V40, P665, DOI 10.1016/j.micron.2009.04.001
   ONG JL, 1994, J BIOMED MATER RES, V28, P1337, DOI 10.1002/jbm.820281112
   Ozeki T, 2007, ANAL CHEM, V79, P79, DOI 10.1021/ac060873x
   Palmer A, 1999, BIOPHYS J, V76, P1063, DOI 10.1016/S0006-3495(99)77271-1
   Paul W, 2003, J BIOMATER APPL, V17, P253, DOI 10.1177/088532803030571
   Pavey Karl D, 2002, Expert Rev Mol Diagn, V2, P173, DOI 10.1586/14737159.2.2.173
   Payet V, 2008, SURF INTERFACE ANAL, V40, P215, DOI 10.1002/sia.2655
   Pei RJ, 2000, TALANTA, V53, P481, DOI 10.1016/S0039-9140(00)00495-1
   PIERSCHBACHER MD, 1984, NATURE, V309, P30, DOI 10.1038/309030a0
   Pollitt MJ, 2005, INT J PHARM, V298, P333, DOI 10.1016/j.ijpharm.2005.02.037
   PRIN C, 1995, BBA-GEN SUBJECTS, V1243, P287, DOI 10.1016/0304-4165(94)00187-3
   Rayleigh J. W., 1889, P LOND MATH SOC, V20, P225
   REDEPENNING J, 1993, ANAL CHEM, V65, P3378, DOI 10.1021/ac00071a008
   Roach P, 2005, J AM CHEM SOC, V127, P8168, DOI 10.1021/ja042898o
   Rodahl M, 1996, ANAL CHEM, V68, P2219, DOI 10.1021/ac951203m
   RODAHL M, 1995, REV SCI INSTRUM, V66, P3924, DOI 10.1063/1.1145396
   Rodahl M, 1996, SENSOR ACTUAT A-PHYS, V54, P448, DOI 10.1016/S0924-4247(97)80002-7
   Rodahl M, 1997, FARADAY DISCUSS, V107, P229, DOI 10.1039/a703137h
   Rodahl M, 1996, REV SCI INSTRUM, V67, P3238, DOI 10.1063/1.1147494
   Rouahi M, 2006, COLLOID SURFACE B, V47, P10, DOI 10.1016/j.colsurfb.2005.11.015
   RUOSLAHTI E, 1987, SCIENCE, V238, P491, DOI 10.1126/science.2821619
   SAUERBREY G, 1959, Z PHYS, V155, P206, DOI 10.1007/BF01337937
   Seitz R, 2005, APPL SURF SCI, V252, P154, DOI 10.1016/j.apsusc.2005.02.012
   Serro AP, 2004, J BIOMED MATER RES A, V70A, P420, DOI 10.1002/jbm.a.30096
   Serro AP, 1997, BIOMATERIALS, V18, P963, DOI 10.1016/S0142-9612(97)00031-8
   SHIMABAYASHI S, 1986, CHEM PHARM BULL, V34, P4474
   SODERQUIST ME, 1980, J COLLOID INTERF SCI, V75, P386, DOI 10.1016/0021-9797(80)90463-4
   SOWELL RR, 1974, J VAC SCI TECHNOL, V11, P474, DOI 10.1116/1.1318658
   SPIRO RG, 1967, J BIOL CHEM, V242, P1915
   Stadtman ER, 2003, AMINO ACIDS, V25, P207, DOI 10.1007/s00726-003-0011-2
   STEELE JG, 1992, J BIOMED MATER RES, V26, P681
   Suchanek W, 1998, J MATER RES, V13, P94, DOI 10.1557/JMR.1998.0015
   Sun LM, 2001, J BIOMED MATER RES, V58, P570, DOI 10.1002/jbm.1056.abs
   Tagaya Motohiro, 2011, IOP Conference Series: Materials Science and Engineering, V18, DOI 10.1088/1757-899X/18/19/192009
   Tagaya M, 2009, KEY ENG MATER, V396-398, P47, DOI 10.4028/www.scientific.net/KEM.396-398.47
   TAGAYA M, 2011, BIOCERAM DEV APPL, V1, P10165
   Tagaya M., 2012, HDB ADV CERAMICS MAT
   Tagaya M., 2011, BIOCERAM DEV APPL, V1
   Tagaya M, 2011, J PHYS CHEM C, V115, P22523, DOI 10.1021/jp208104z
   Tagaya M, 2011, MACROMOL BIOSCI, V11, P1586, DOI 10.1002/mabi.201100182
   Tagaya M, 2011, SCI TECHNOL ADV MAT, V12, DOI 10.1088/1468-6996/12/3/034411
   Tagaya M, 2011, LANGMUIR, V27, P7645, DOI 10.1021/la200621p
   Tagaya M, 2011, LANGMUIR, V27, P7635, DOI 10.1021/la200008z
   Tagaya M, 2010, SCI TECHNOL ADV MAT, V11, DOI 10.1088/1468-6996/11/4/045002
   Tagaya M, 2010, MATER SCI ENG B-ADV, V173, P176, DOI 10.1016/j.mseb.2010.01.034
   Tanahashi M, 1997, J BIOMED MATER RES, V34, P305
   Tanahashi M, 1996, J BIOMED MATER RES, V31, P243, DOI 10.1002/(SICI)1097-4636(199606)31:2<243::AID-JBM11>3.0.CO;2-M
   Toworfe GK, 2006, BIOMATERIALS, V27, P631, DOI 10.1016/j.biomaterials.2005.06.017
   TSUMAGARI A, 1999, BIOCERAMICS, V12, P361
   VANDENMEERAKKER JEAM, 1990, J ELECTROCHEM SOC, V137, P1239, DOI 10.1149/1.2086639
   VIG JR, 1985, J VAC SCI TECHNOL A, V3, P1027, DOI 10.1116/1.573115
   Voinova MV, 1999, PHYS SCRIPTA, V59, P391, DOI 10.1238/Physica.Regular.059a00391
   VROMAN L, 1969, SURF SCI, V16, P438, DOI 10.1016/0039-6028(69)90037-5
   Wang CX, 2000, SURF COAT TECH, V130, P39, DOI 10.1016/S0257-8972(00)00705-2
   Webster TJ, 1999, BIOMATERIALS, V20, P1221, DOI 10.1016/S0142-9612(99)00020-4
   Weerawardena A, 1998, LANGMUIR, V14, P575, DOI 10.1021/la971076k
   Wegener J, 2000, BIOPHYS J, V78, P2821, DOI 10.1016/S0006-3495(00)76825-1
   Wei M, 2005, J MATER SCI-MATER M, V16, P319, DOI 10.1007/s10856-005-0630-0
   Wei T, 2009, J PHYS CHEM C, V113, P2053, DOI 10.1021/jp806586n
   Xiao XF, 2006, MATER LETT, V60, P2627, DOI 10.1016/j.matlet.2006.01.048
   Yamamoto K, 1999, IEEE T SEMICONDUCT M, V12, P288, DOI 10.1109/66.778192
   Ye T, 2005, J PHYS CHEM B, V109, P9927, DOI 10.1021/jp0474273
   Yin G, 2002, CHEM ENG J, V87, P181, DOI 10.1016/S1385-8947(01)00248-0
   Yoshioka T, 2008, KEY ENG MATER, V361-363, P1119, DOI 10.4028/www.scientific.net/KEM.361-363.1119
   Yunoki S, 2006, MATER LETT, V60, P999, DOI 10.1016/j.matlet.2005.10.064
   Zeng HT, 1999, BIOMATERIALS, V20, P377, DOI 10.1016/S0142-9612(98)00184-7
   Zhitomirsky I, 2002, ADV COLLOID INTERFAC, V97, P279, DOI 10.1016/S0001-8686(01)00068-9
   Zhitomirsky I, 1997, J MATER SCI-MATER M, V8, P213, DOI 10.1023/A:1018587623231
   Zhou T, 2000, BIOTECHNOL PROGR, V16, P268, DOI 10.1021/bp000003f
   Zhu PX, 2001, J COLLOID INTERF SCI, V243, P31, DOI 10.1006/jcis.2001.7888
NR 207
TC 12
Z9 12
U1 1
U2 63
PU AMER SCIENTIFIC PUBLISHERS
PI VALENCIA
PA 26650 THE OLD RD, STE 208, VALENCIA, CA 91381-0751 USA
SN 2158-5849
EI 2158-5857
J9 MATER EXPRESS
JI Mater. Express
PD MAR
PY 2012
VL 2
IS 1
BP 1
EP 22
DI 10.1166/mex.2012.1053
PG 22
WC Nanoscience & Nanotechnology; Materials Science, Multidisciplinary
SC Science & Technology - Other Topics; Materials Science
GA 048LW
UT WOS:000311914000001
DA 2018-10-19
ER

PT J
AU Moraes, FC
   Cesarino, I
   Golinelli, DLC
   Machado, SAS
AF Moraes, Fernando C.
   Cesarino, Ivana
   Golinelli, Diego L. C.
   Machado, Sergio A. S.
TI Enzymatic Solid-Phase Reactor Based on Silica Organofunctionalized with
   p-Phenylenediamine for Electrochemical Detection of Phenolic Compounds
SO SENSOR LETTERS
LA English
DT Article
DE p-Phenylenediamine; Enzymatic Solid-Phase Reactor; Phenolic Compounds
ID SPHERICAL MESOPOROUS SILICA; COMPOSITE ELECTRODE; CARBON NANOTUBES;
   MOLECULAR-SIEVES; NATURAL-WATER; MERCURY IONS; THIN-FILMS; HYDROQUINONE;
   BIOSENSOR; SURFACES
AB A new biomaterial, based on silica organofunctionalized with p-phenylenediamine (p-PDA) and the enzyme peroxidase, was used in the development of an enzymatic solid-phase reactor. The analytical techniques used in the characterization showed that the organic ligand was incorporated into the silica matrix. Thus, the silica modified with p-PDA allowed the incorporation of peroxidase by the electrostatic interaction between the carboxylic groups present in the enzyme molecules and the amino groups attached to the silica. The enzymatic solid-phase reactor was used for chemical oxidation of phenols in 1, 4-benzoquinone that was then detected by chronoamperometry. The system allowed the analysis of hydroquinone with a detection limit of 83.6 nmol L-1. Thus, the new material has potential in the determination of phenolic compounds river water samples.
C1 [Moraes, Fernando C.; Cesarino, Ivana; Golinelli, Diego L. C.; Machado, Sergio A. S.] Univ Sao Paulo, Inst Quim Sao Carlos, BR-13566590 Sao Paulo, Brazil.
RP Moraes, FC (reprint author), Univ Sao Paulo, Inst Quim Sao Carlos, Av Trabalhador Sao Carlense 400, BR-13566590 Sao Paulo, Brazil.
EM fcmoreas@hotmail.com
RI Moraes, Fernando/C-7126-2013; Cesarino, Ivana/H-5772-2012
OI Cesarino, Ivana/0000-0002-0172-3759; Cesarino, Ivana/0000-0002-2296-3671
FU FAPESP [2010/11049-2, 2010/11567-3]
FX Financial support from the FAPESP (Processes 2010/11049-2 and
   2010/11567-3) is gratefully acknowledged.
CR Albertus F, 1997, ANAL CHIM ACTA, V355, P23, DOI 10.1016/S0003-2670(97)81608-X
   Analytical Methods Committee, 1987, ANALYST, V112, P199, DOI DOI 10.1039/AN9871200199
   Arana J, 2001, CHEMOSPHERE, V44, P1017, DOI 10.1016/S0045-6535(00)00359-3
   BAGSHAW SA, 1995, SCIENCE, V269, P1242, DOI 10.1126/science.269.5228.1242
   BECK JS, 1992, J AM CHEM SOC, V114, P10834, DOI 10.1021/ja00053a020
   BOWERS ML, 1991, ANAL CHIM ACTA, V243, P43, DOI 10.1016/S0003-2670(00)82538-6
   Cagnol F, 2004, CHEM COMMUN, P1742, DOI 10.1039/b403753g
   Cesarino I, 2008, ELECTROANAL, V20, P2301, DOI 10.1002/elan.200804325
   Cesarino I, 2010, ELECTROANAL, V22, P61, DOI 10.1002/elan.200900167
   Cesarino I, 2008, MATER RES-IBERO-AM J, V11, P465, DOI 10.1590/S1516-14392008000400015
   Etienne M, 2005, ELECTROCHEM COMMUN, V7, P1449, DOI 10.1016/j.elecom.2005.10.010
   Fan HY, 2000, NATURE, V405, P56, DOI 10.1038/35011026
   Feng X, 1997, SCIENCE, V276, P923, DOI 10.1126/science.276.5314.923
   Freire RS, 2002, ANALYST, V127, P258, DOI 10.1039/b110011d
   Freire RS, 2001, TALANTA, V54, P681, DOI 10.1016/S0039-9140(01)00318-6
   Hua ZL, 2001, J NON-CRYST SOLIDS, V292, P177, DOI 10.1016/S0022-3093(01)00806-7
   Huo QS, 1997, ADV MATER, V9, P974, DOI 10.1002/adma.19970091210
   Huo QS, 1997, CHEM MATER, V9, P14, DOI 10.1021/cm960464p
   KETTLE AJ, 1992, J BIOL CHEM, V267, P8319
   Leite OD, 2003, TALANTA, V59, P889, DOI 10.1016/S0039-9140(02)00650-1
   Lin CH, 2005, J PHARMACEUT BIOMED, V38, P414, DOI 10.1016/j.jpba.2005.01.031
   Mann S, 1996, NATURE, V382, P313, DOI 10.1038/382313a0
   Marcolino-Junior LH, 2001, J PHARMACEUT BIOMED, V25, P393, DOI 10.1016/S0731-7085(00)00516-1
   Margolese D, 2000, CHEM MATER, V12, P2448, DOI 10.1021/cm0010304
   Miyake Y, 2005, J CHEM ENG JPN, V38, P60, DOI 10.1252/jcej.38.60
   Miyake Y, 2002, PHYS CHEM CHEM PHYS, V4, P2680, DOI 10.1039/b200074c
   Mora MF, 2009, ANAL CHEM, V81, P1016, DOI 10.1021/ac802068n
   Moraes FC, 2009, ELECTROANAL, V21, P1091, DOI 10.1002/elan.200804522
   Perez-Quintanilla D, 2006, J HAZARD MATER, V134, P245, DOI 10.1016/j.jhazmat.2005.11.004
   Shimura N, 2005, B CHEM SOC JPN, V78, P1154, DOI 10.1246/bcsj.78.1154
   Sun AL, 2006, J SEP SCI, V29, P995, DOI 10.1002/jssc.200500448
   Teixeira MFD, 1999, LAB ROBOTICS AUTOMAT, V11, P163
   Thompson WR, 1997, LANGMUIR, V13, P2291, DOI 10.1021/la960795g
   Vieira IC, 2000, TALANTA, V52, P681, DOI 10.1016/S0039-9140(00)00420-3
   Vieira IC, 1999, ANAL CHIM ACTA, V398, P145, DOI 10.1016/S0003-2670(99)00455-9
   Walcarius A, 2008, ELECTROANAL, V20, P711, DOI 10.1002/elan.200704144
   Wang JQ, 2008, J PHYS CHEM C, V112, P5014, DOI 10.1021/jp7099948
   Yang H, 1996, NATURE, V381, P589, DOI 10.1038/381589a0
   Zhao DY, 1998, SCIENCE, V279, P548, DOI 10.1126/science.279.5350.548
   Zhao DY, 1998, CHEM COMMUN, P2499, DOI 10.1039/a804649b
   Zhao DY, 1998, J AM CHEM SOC, V120, P6024, DOI 10.1021/ja974025i
NR 41
TC 2
Z9 2
U1 2
U2 21
PU AMER SCIENTIFIC PUBLISHERS
PI VALENCIA
PA 26650 THE OLD RD, STE 208, VALENCIA, CA 91381-0751 USA
SN 1546-198X
J9 SENSOR LETT
JI Sens. Lett.
PD MAR-APR
PY 2012
VL 10
IS 3-4
BP 1031
EP 1038
DI 10.1166/sl.2012.2345
PG 8
WC Chemistry, Analytical; Electrochemistry; Instruments & Instrumentation;
   Physics, Applied
SC Chemistry; Electrochemistry; Instruments & Instrumentation; Physics
GA 009IE
UT WOS:000309018700052
DA 2018-10-19
ER

PT J
AU Jahani, H
   Kaviani, S
   Hassanpour-Ezatti, M
   Soleimani, M
   Kaviani, Z
   Zonoubi, Z
AF Jahani, Hoda
   Kaviani, Saeid
   Hassanpour-Ezatti, Majid
   Soleimani, Masoud
   Kaviani, Zeinab
   Zonoubi, Zahra
TI The Effect of Aligned and Random Electrospun Fibrous Scaffolds on Rat
   Mesenchymal Stem Cell Proliferation
SO CELL JOURNAL
LA English
DT Article
DE Tissue Engineering; PCL; Surface Modification; Mesenchymal Stem Cells
ID PLASMA TREATMENT; SURFACE MODIFICATION; DIFFERENTIATION; REGENERATION;
   CONSTRUCT; AFFINITY; COLLAGEN; FILM
AB Objective: The development of combining mesenchymal stem cells (MSCs) with surface modified three-dimensional (3D) biomaterial scaffold provides a desirable alternative for replacement of damaged and diseased tissue. Nanofibrous scaffolds serve as suitable environment for cell attachment and proliferation due to their similarity to the physical dimension of the natural extracellular matrix. In this study the properties of plasma treated poly-C-caprolactone nanofiber scaffolds (p-PCL) and unaltered PCL scaffolds were compared, and then p-PCL scaffolds were evaluated for MSC culture.
   Materials and Methods: Aligned and random PCL nanofibrus scaffolds were fabricated by electrospining and their surface modified with O-2 plasma treatment to enhance MSC proliferation, adhesion and interaction. Chemical and mechanical characterizations were carried out using scanning electron microscopy (SEM), water contact angle and tensile testing. Cell adhesion and morphology were evaluated using SEM 1 day after culture. Statistical analysis was carried out using one way analysis of variance (ANOVA).
   Results: The proliferation of MSCs were evaluated using 3-(4,5-Dimethylthiazol-2-yl)-2,5-Di-phenyltetrazolium Bromide(MTT) assay on day 1, 3, and 5 after cell culture. Results showed that the numbers of cells that had grown on PCL nanofibrous scaffolds were significantly higher than those of control surfaces without nanofibers. Furthermore, the proliferation of MSCs on random nanofiber was significantly higher compared to that on aligned nanofiber.
   Conclusion: This study showed that while both aligned and random plasma treated PCL nanofibrous scaffold are more suitable substrates for MSC growth than tissue culture plates, random nanofiber best supported the proliferation of MSCs.
C1 [Kaviani, Saeid; Soleimani, Masoud] Tarbiat Modares Univ, Fac Med Sci, Dept Hematol, Tehran, Iran.
   [Jahani, Hoda; Hassanpour-Ezatti, Majid] Shahed Univ, Fac Basic Sci, Dept Physiol, Tehran, Iran.
   [Kaviani, Zeinab] Fac Karaj Med Sci, Dept Med Sci, Karaj, Iran.
   [Zonoubi, Zahra] Shahid Beheshti Univ, Mahdiyeh Hosp, Dept Obstet & Gynecol, Tehran, Iran.
RP Kaviani, S (reprint author), Tarbiat Modares Univ, Fac Med Sci, Dept Hematol, POB 14115-331, Tehran, Iran.
EM kavianis@modares.ac.ir
FU Iranian Stem Cell Council
FX This project supported by the Iranian Stem Cell Council. There is no
   conflict of interest in this article.
CR Cheng ZY, 2004, BIOMATERIALS, V25, P1991, DOI 10.1016/j.biomaterials.2003.08.038
   Ghasemi-Mobarakeh L, 2008, BIOMATERIALS, V29, P4532, DOI 10.1016/j.biomaterials.2008.08.007
   Godara P, 2008, J CHEM TECHNOL BIOT, V83, P397, DOI 10.1002/jctb.1901
   Grace JM, 2003, J DISPER SCI TECHNOL, V24, P305, DOI 10.1081/DIS-120021793
   Greene G, 2003, LANGMUIR, V19, P5869, DOI 10.1021/la026940+
   Gunatillake Pathiraja A., 2003, European Cells & Materials, V5, P1
   Gupta D, 2009, ACTA BIOMATER, V5, P2560, DOI 10.1016/j.actbio.2009.01.039
   Krampera M, 2007, BONE, V40, P382, DOI 10.1016/j.bone.2006.09.006
   Li WJ, 2005, BIOMATERIALS, V26, P5158, DOI 10.1016/j.biomaterials.2005.01.002
   Park K, 2007, J BIOMAT SCI-POLYM E, V18, P369, DOI 10.1163/156856207780424997
   Prabhakaran MP, 2008, NANOTECHNOLOGY, V19, DOI 10.1088/0957-4484/19/45/455102
   Prabhakaran MP, 2009, BIOMATERIALS, V30, P4996, DOI 10.1016/j.biomaterials.2009.05.057
   Ryu GH, 2005, SURF COAT TECH, V193, P60, DOI 10.1016/j.surfcoat.2004.07.062
   Schantz JT, 2002, INT J ORAL MAX IMPL, V17, P161
   Schmidt CE, 2003, ANNU REV BIOMED ENG, V5, P293, DOI 10.1146/annurev.bioeng.5.011303.120731
   Shabani I, 2009, BIOCHEM BIOPH RES CO, V382, P129, DOI 10.1016/j.bbrc.2009.02.150
   Siri S, 2010, MATER SCI TECH-LOND, V26, P1292, DOI 10.1179/026708310X12798718274070
   Srouji S, 2008, J MATER SCI-MATER M, V19, P1249, DOI 10.1007/s10856-007-3218-z
   Tabesh H, 2009, NEUROCHEM INT, V54, P73, DOI 10.1016/j.neuint.2008.11.002
   Yang J, 2002, BIOMATERIALS, V23, P2607, DOI 10.1016/S0142-9612(01)00400-8
   Yang J, 2002, POLYM ADVAN TECHNOL, V13, P220, DOI 10.1002/pat.177
   Yoshimoto H, 2003, BIOMATERIALS, V24, P2077, DOI 10.1016/S0142-9612(02)00635-X
   [竺亚斌 Zhu Yabin], 2002, [材料研究学报, Chinese Journal of Materials Research], V16, P233
NR 23
TC 32
Z9 33
U1 0
U2 35
PU ROYAN INST
PI TEHRAN
PA PO BOX 19395-4644, TEHRAN, 00000, IRAN
SN 2228-5806
EI 2228-5814
J9 CELL J
JI Cell J.
PD SPR
PY 2012
VL 14
IS 1
BP 31
EP 38
PG 8
WC Cell Biology
SC Cell Biology
GA 002HX
UT WOS:000308523800005
PM 23626935
DA 2018-10-19
ER

PT J
AU Sousa, J
   Fernandes, BL
   Rebelatto, CLK
   Barchiki, F
   Abud, AP
   Brofman, P
   de Oliveira, S
   Buchi, D
   Fernandes, CR
AF Sousa, Jonatas
   Fernandes, Beatriz Luci
   Kuniyoshi Rebelatto, Carmem Lucia
   Barchiki, Fabiane
   Abud, Ana Paula
   Brofman, Paulo
   de Oliveira, Simone
   Buchi, Dorly
   Fernandes, Carlos Roberto
TI Osteoinduction Test of Anorthite by Human Mesenchymal Stem Cell Culture
SO MATERIALS RESEARCH-IBERO-AMERICAN JOURNAL OF MATERIALS
LA English
DT Article
DE osteogenesis; biocompatible materials; stem cells culture on
   biomaterials
ID BONE-GRAFT; DIFFERENTIATION; PHOSPHATE; SCAFFOLDS; SURGERY
AB In this work, adult stem cells of three volunteers were isolated, expanded and cultivated over samples of Anorthite in order to assess its osteoinductive capacity. Alkaline Phosphatase Analysis, ALP, was carried out at days 1, 7, 14 and 21, and the results showed similar behavior between the volunteers considering the initial value of each. For volunteer 1, between day 14 and 21, the decreasing of ALP was remarkable in the wells containing MSC only and MSC+BIO, from 59.9 to 26.3 U.L-1 and from 63.3 to 38.1 U.L-1, respectively, suggesting that the biomaterial was able to induce osteoblast formations. This osteoinduction property could be evidenced by Citochemistry where MSCs did not produce crystals of Calcium Oxalate or Calcium Phosphate, osteoblast compounds, without being stimulated by a chemical inducer, lending to the conclusion that the differentiation of MSC into osteoblast when cultivated on Anorthite, occurred exclusively by its influence, strongly suggesting that it is osteoinductive.
C1 [Sousa, Jonatas; Kuniyoshi Rebelatto, Carmem Lucia; Barchiki, Fabiane; Brofman, Paulo] Pontifical Catholic Univ Parana PUCPR, Curitiba, Parana, Brazil.
   [Fernandes, Beatriz Luci; Fernandes, Carlos Roberto] Inst Grade Basic Sci IGCB, Schroeder, Brazil.
   [Abud, Ana Paula; de Oliveira, Simone; Buchi, Dorly] Fed Univ Parana UFPR, Curitiba, Parana, Brazil.
RP Sousa, J (reprint author), Pontifical Catholic Univ Parana PUCPR, Curitiba, Parana, Brazil.
EM beatrizfernandes@igcb.org.br
FU CNPq
FX The authors thanks to CNPq for financial support.
CR Ciapetti G, 2006, BIOMATERIALS, V27, P6150, DOI 10.1016/j.biomaterials.2006.08.025
   Eagan MJ, 2009, CLIN SPORT MED, V28, P203, DOI 10.1016/j.csm.2008.10.009
   Fernandes BL, 2006, REV BRASILEIRA ENGEN, V24, P33
   Galli C, 2005, J PERIODONTOL, V76, P364, DOI 10.1902/jop.2005.76.3.364
   Henry J. B., 2008, DIAGNOSTICOS CLIN TR
   Jones AC, 2009, BIOMATERIALS, V30, P1440, DOI 10.1016/j.biomaterials.2008.10.056
   Kamitakahara M, 2008, J BIOMATER APPL, V23, P197, DOI 10.1177/0885328208096798
   Kasten P, 2008, J BIOMATER APPL, V23, P169, DOI 10.1177/0885328207088269
   Khong L, 2007, J BIOMATER APPL, V22, P223
   Lanza R, 2004, HDB STEM CELLS, V2, P13
   Patel MM, 2009, J HAND SURG-AM, V34A, P555, DOI 10.1016/j.jhsa.2009.01.019
   Pinheiro Thiago Cerizza, 2008, Rev. bras. ortop., V43, P433, DOI 10.1590/S0102-36162008001000003
   Porter JR, 2009, BIOMATERIALS, V30, P780, DOI 10.1016/j.biomaterials.2008.10.022
   Ratisoontorn C, 2005, BONE, V36, P627, DOI 10.1016/j.bone.2005.01.010
   Saldana L, 2009, ACTA BIOMATER, V5, P1294, DOI 10.1016/j.actbio.2008.11.022
   Smith GW, 2007, J ANIM SCI, V85, pE20, DOI 10.2527/jas.2006-479
   Sousa RC, 2008, J BIOMATER APPL, V22, P373, DOI 10.1177/0885328207078260
   STRZELECKI T, 1986, J BIOL CHEM, V261, P2197
   Zhang ZY, 2009, BIOMATERIALS, V30, P2694, DOI 10.1016/j.biomaterials.2009.01.028
NR 19
TC 0
Z9 0
U1 0
U2 3
PU UNIV FED SAO CARLOS, DEPT ENGENHARIA MATERIALS
PI SAO CARLOS
PA LABORATORIA DE MATERIAIS VITREOS, CAIXA POSTAL 676, SAO CARLOS,
   13565-905SP, BRAZIL
SN 1516-1439
J9 MATER RES-IBERO-AM J
JI Mater. Res.-Ibero-am. J. Mater.
PD MAR-APR
PY 2012
VL 15
IS 2
BP 224
EP 228
DI 10.1590/S1516-14392012005000009
PG 5
WC Materials Science, Multidisciplinary
SC Materials Science
GA 964SC
UT WOS:000305716000010
OA DOAJ Gold
DA 2018-10-19
ER

PT J
AU Perdigao, J
   Pinto, AM
   Monteiro, RCC
   Fernandes, FMB
   Laranjeira, P
   Veiga, JP
AF Perdigao, Jorge
   Pinto, Ana M.
   Monteiro, Regina C. C.
   Braz Fernandes, Francisco M.
   Laranjeira, Pedro
   Veiga, Joao P.
TI Degradation of dental ZrO2-based materials after hydrothermal fatigue.
   Part I: XRD, XRF, and FESEM analyses
SO DENTAL MATERIALS JOURNAL
LA English
DT Article
DE Zirconia; Electron microscopy; Thermal fatigue; Low-temperature
   degradation (LTD)
ID STABILIZED TETRAGONAL ZIRCONIA; FIXED PARTIAL DENTURES; Y-TZP; AGING
   SENSITIVITY; FEMORAL HEADS; CERAMICS; TRANSFORMATION; BIOMATERIAL;
   MIGRATION; PHASE
AB The aim was to investigate the effect of simulated low-temperature degradation (s-LTD) and hydrothermal fatigue on the degradation of three ZrO2-based dental materials. Lava, IPS, and NanoZr discs were randomly assigned to (1) Control-Storage in distilled water at 37 degrees C; (2) Aging at 134 degrees C for 5 h (s-LTD): (3) Thermocycling in saliva for 30,000 cycles (TF). XRD revealed that ZrO2 m phase was identified in all groups but TF increased the m phase only for Lava. Under the FESEM, Lava showed no alterations under s-LTD, but displayed corrosion areas up to 60 mu m wide after TF. We conclude that TE accelerated the degradation of Lava through an increase in the m phase and grain pull-out from the material surface.
C1 [Perdigao, Jorge] Univ Minnesota, Dept Restorat Sci, Minneapolis, MN 55455 USA.
   [Pinto, Ana M.; Laranjeira, Pedro] Univ Nova Lisboa, Fac Sci & Technol, CENIMAT I3N, Dept Mat Sci, P-2829516 Caparica, Portugal.
   [Monteiro, Regina C. C.; Braz Fernandes, Francisco M.; Veiga, Joao P.] Egas Moniz Hlth Sci Inst, CiiEM, Egas Moniz Interdisciplinar Res Ctr, P-2829511 Monte De Caparica, Caparica, Portugal.
RP Perdigao, J (reprint author), Univ Minnesota, Dept Restorat Sci, Minneapolis, MN 55455 USA.
EM perdi001@umn.edu
RI Veiga, Joao Pedro/J-3681-2013; MONTEIRO, REGINA/J-6051-2013; Perdigao,
   Jorge/F-5028-2016; Braz Fernandes, Francisco Manuel/E-6176-2011
OI Veiga, Joao Pedro/0000-0001-5324-1586; MONTEIRO,
   REGINA/0000-0002-9816-4390; Perdigao, Jorge/0000-0003-1841-6365; Braz
   Fernandes, Francisco Manuel/0000-0003-3185-0019
FU University of Minnesota; CENIMAT/I3N by the FCT/MCTES
FX Author JP acknowledges funding from the University of Minnesota for a
   sabbatical semester leave. Authors RCCM, FMBF, and JPV acknowledge the
   pluriannual funding of CENIMAT/I3N by the FCT/MCTES.
CR Aboushelib Moustafa N, 2008, J Prosthodont, V17, P538, DOI 10.1111/j.1532-849X.2008.00346.x
   ARVIDSON K, 1985, SCAND J DENT RES, V93, P467
   Ban S, 2008, JPN DENT SCI REV, V44, P3, DOI 10.1016/j.jdsr.2008.04.001
   BOUTZ MMR, 1995, J MATER SCI, V30, P1854, DOI 10.1007/BF00351622
   Casucci A, 2010, DENT MATER, V26, P751, DOI 10.1016/j.dental.2010.03.020
   Chevalier J, 2006, BIOMATERIALS, V27, P535, DOI 10.1016/j.biomaterials.2005.07.034
   Chevalier J, 2004, BIOMATERIALS, V25, P5539, DOI 10.1016/j.biomaterials.2004.01.002
   Chevalier J, 2009, J EUR CERAM SOC, V29, P1245, DOI 10.1016/j.jeurceramsoc.2008.08.025
   Chevalier J, 2007, ANNU REV MATER RES, V37, P1, DOI 10.1146/annurev.matsci.37.052506.084250
   Denry I, 2008, DENT MATER, V24, P299, DOI 10.1016/j.dental.2007.05.007
   Deville S, 2006, BIOMATERIALS, V27, P2186, DOI 10.1016/j.biomaterials.2005.11.021
   Deville S, 2005, J BIOMED MATER RES B, V72B, P239, DOI 10.1002/jbm.b.30123
   Deville S, 2004, ACTA MATER, V52, P5697, DOI 10.1016/j.actamat.2004.08.034
   DUH JG, 1989, J MATER SCI, V24, P4467, DOI 10.1007/BF00544531
   Fernandez-Fairen M, 2006, BIO-MED MATER ENG, V16, P415
   Fernandez-Fairen M, 2007, CLIN ORTHOP RELAT R, P122, DOI 10.1097/BLO.0b013eb4c3
   Food and Drug Administration, 1997, STEAM REST CAUS DET
   Food and Drug Administration, 2001, MED DEV REC REC ZIRC
   Gale MS, 1999, J DENT, V27, P89, DOI 10.1016/S0300-5712(98)00037-2
   GARVIE RC, 1975, NATURE, V258, P703, DOI 10.1038/258703a0
   Guo X, 2004, CHEM MATER, V16, P3988, DOI 10.1021/cm040167h
   Hannink RHJ, 2000, J AM CERAM SOC, V83, P461
   HEUER AH, 1987, J AM CERAM SOC, V70, P689, DOI 10.1111/j.1151-2916.1987.tb04865.x
   HUGHES AE, 1991, SOLID STATE IONICS, V46, P265, DOI 10.1016/0167-2738(91)90225-Z
   ISO, 2008, 13356 ISO
   ISO, 2008, 6872 ISO
   Kim JW, 2010, J DENT RES, V89, P91, DOI 10.1177/0022034509354193
   Kosmac T, 2010, J DENT RES B, V89
   LAWSON S, 1995, J EUR CERAM SOC, V15, P485, DOI 10.1016/0955-2219(95)00035-S
   LEPISTO TT, 1992, CORROSION GLASS CERA, P492
   Milleding P, 2002, J BIOMED MATER RES, V61, P541, DOI 10.1002/jbm.10109
   Milleding P, 2001, BIOMATERIALS, V22, P2545, DOI 10.1016/S0142-9612(00)00445-2
   Piconi C, 1999, BIOMATERIALS, V20, P1, DOI 10.1016/S0142-9612(98)00010-6
   Rothbrust F, 2010, J DENT RES B, V89
   Sailer I, 2006, QUINTESSENCE INT, V37, P685
   SCHMID HK, 1991, J AM CERAM SOC, V74, P387, DOI 10.1111/j.1151-2916.1991.tb06892.x
   Stanjek H, 2002, CLAY MINER, V37, P629, DOI 10.1180/0009855023740065
   Sundh A, 2005, DENT MATER, V21, P476, DOI 10.1016/j.dental.2004.07.013
   Tanaka K, 2003, J BIOMED MATER RES A, V67A, P200, DOI 10.1002/jbm.a.10006
   Toraya H., 1984, J AM CERAM SOC, V67, P119
   Von Steyern PV, 2005, J ORAL REHABIL, V32, P180, DOI 10.1111/j.1365-2842.2004.01437.x
   YOSHIMURA M, 1987, J MATER SCI LETT, V6, P465, DOI 10.1007/BF01756800
NR 42
TC 7
Z9 8
U1 1
U2 33
PU JAPANESE SOC DENTAL MATERIALS DEVICES
PI TOKYO
PA C/O KOKU HOKEN KYOKAI, 1-43-9 KOMAGOME TS BDG, KOMAGOME, TOSHIMA-KU,
   TOKYO, 170-0003, JAPAN
SN 0287-4547
J9 DENT MATER J
JI Dent. Mater. J.
PD MAR
PY 2012
VL 31
IS 2
BP 256
EP 265
DI 10.4012/dmj.2011-216
PG 10
WC Dentistry, Oral Surgery & Medicine; Materials Science, Biomaterials
SC Dentistry, Oral Surgery & Medicine; Materials Science
GA 952KA
UT WOS:000304790200012
PM 22447060
OA Bronze
DA 2018-10-19
ER

PT J
AU Maris, DA
   Maris, M
   Vasile, E
   Sarbu, R
   Maris, M
   Duta, L
   Dorcioman, G
   Mihailescu, IN
AF Maris, D. A.
   Maris, Maria
   Vasile, E.
   Sarbu, R.
   Maris, Marius
   Duta, L.
   Dorcioman, G.
   Mihailescu, I. N.
TI Bionic features of thin biomaterial layers deposited by PLD onto
   titanium implants
SO JOURNAL OF OPTOELECTRONICS AND ADVANCED MATERIALS
LA English
DT Article
DE Bionic features; Thin layers; Ti implants; PLD
ID SURFACE; BONE
AB We report on the successful deposition by PLO method of three biomaterials, hydroxiapatite doped with zirconia (ZrO2: HA), beta-tricalcium phosphate (beta-TCP) and bioglass (BG57), onto titanium substrates, for medical applications. The deposited implants have been investigated morphologically by Scanning Electron Microscopy, coupled with Energy Dispersive X-Ray Spectroscopy (EDS). The surface morphology of the implants presented roughness values very close to the ones defining the histological structure of bone. EDS spectra evidenced the absence of impurities in the deposited films. This study demonstrated that, at microscopic level, the morphology of BG57 thin films presented a superior quality as compared with ZrO2:HA and beta-TCP ones, emphasizing their capacity to cover the metallic implants, in form of thin films, making them suitable for applications in implantology.
C1 [Maris, D. A.; Maris, Maria] Ovidius Univ Constanta, Sch Dent Med, Constanta, Romania.
   [Vasile, E.] Metav Cercetare Dezvoltare SA, Bucharest, Romania.
   [Sarbu, R.] Ovidius Univ Constanta, Sch Pharm, Constanta, Romania.
   [Maris, Marius] Titu Maiorescu Med Univ, Bucharest, Romania.
   [Duta, L.; Dorcioman, G.; Mihailescu, I. N.] Natl Inst Lasers Plasma & Radiat Phys, Lasers Dept, Magurele, Romania.
RP Maris, M (reprint author), Ovidius Univ Constanta, Sch Dent Med, Constanta, Romania.
EM paromarismaria@yahoo.com
RI Vasile, Eugeniu/E-5460-2013; Mihailescu, Ion/A-5403-2011; Vasile,
   Eugeniu/I-6164-2016; Duta, Liviu Marian/G-3417-2011
OI Vasile, Eugeniu/0000-0002-5868-1932; Vasile,
   Eugeniu/0000-0002-5868-1932; Duta, Liviu Marian/0000-0002-6408-6056
FU Program Laplas 3
FX This work was partially funded by the Program Laplas 3.
CR Bornstein MM, 2003, INT J ORAL MAX IMPL, V18, P659
   Cooper LF, 2000, J PROSTHET DENT, V84, P522, DOI 10.1067/mpr.2000.111966
   da Silva M. H. Prado, 2000, MAT RES, V3
   Duta L, 2010, 2010 ADVANCED TECHNOLOGIES FOR ENHANCING QUALITY OF LIFE (AT-EQUAL), P127, DOI 10.1109/ATEQUAL.2010.27
   Giavaresi G, 2003, BIOMATERIALS, V24, P1583, DOI 10.1016/S0142-9612(02)00548-3
   Junqueira L. C., 2008, MEDEICALA CALLISTRO, V11, P153
   KASEMO B, 1983, J PROSTHET DENT, V49, P832, DOI 10.1016/0022-3913(83)90359-1
   Lopez-Esteban S, 2003, J EUR CERAM SOC, V23, P2921, DOI 10.1016/S0955-2219(03)00303-0
   Popescu AC, 2009, APPL SURF SCI, V255, P5486, DOI 10.1016/j.apsusc.2008.10.031
   Stan GE, 2010, THIN SOLID FILMS, V518, P5955, DOI 10.1016/j.tsf.2010.05.104
   WILKE HJ, 1990, ADV BIOMAT, V9, P309
NR 11
TC 1
Z9 1
U1 0
U2 13
PU NATL INST OPTOELECTRONICS
PI BUCHAREST-MAGURELE
PA 1 ATOMISTILOR ST, PO BOX MG-5, BUCHAREST-MAGURELE 76900, ROMANIA
SN 1454-4164
J9 J OPTOELECTRON ADV M
JI J. Optoelectron. Adv. Mater.
PD MAR-APR
PY 2012
VL 14
IS 3-4
BP 433
EP 438
PG 6
WC Materials Science, Multidisciplinary; Optics; Physics, Applied
SC Materials Science; Optics; Physics
GA 947KW
UT WOS:000304429900039
DA 2018-10-19
ER

PT J
AU Park, B
   Cho, CY
   Choi, KH
   Jeon, HG
AF Park, Byoungchoo
   Cho, Chan Youn
   Choi, Kyoung Ho
   Jeon, Hong Goo
TI Surface Plasmon Resonance Investigation of Optical Detection in
   Plasma-modified Phospholipid Layers
SO JOURNAL OF THE KOREAN PHYSICAL SOCIETY
LA English
DT Article
DE Atmospheric pressure plasmas; Biomaterial; Lecithin; Surface plasmon
   resonance; Thin metal film
ID ATTENUATED TOTAL REFLECTION; ATMOSPHERIC-PRESSURE; DISCHARGE PLASMA;
   GLOW-DISCHARGE; STERILIZATION; REMOVAL; AIR
AB We herein report on a study of surface plasmon resonance (SPR) in thin gold (Au) films coated with thin layers of phospholipid material, which had been exposed to an atmospheric pressure (AP) plasma containing both pure Ar and Ar mixed with O-2 (Ar/O-2, 0.8%). The phospholipid material that we used for the SPR experiments was lecithin, and the AP plasma system was applied in air by means of a radio-frequency (RF) plasma generator. A thin (similar to 60 nm) film of Au and a thin (similar to 15 nm) layer of lecithin were deposited and attached to the face of a prism, and surface plasmon modes were excited along the interfaces of the prism-Au-lecithin-air system by means of prism coupling using a He-Ne Laser (632.8 nm). The experimental SPR reflectance curves of the Au-lecithin-air modes were found to be shifted towards those of the Au-air mode with increasing applications of AP RF plasma treatment. From the shifts in the SPR curves, we found that the estimated thickness of the lecithin layer treated with a pure Ar plasma showed a linear decrease with etching rate of about 3 nm per treatment while the thickness of the lecithin layer treated with a mixed Ar/O-2 plasma showed a tendency to saturate following a large initial decrease (ca. 14 nm). All these results demonstrate that the use of SPR sensing could facilitate the detection of extremely small variations in plasma-treated films of biomaterials.
C1 [Park, Byoungchoo; Cho, Chan Youn; Choi, Kyoung Ho; Jeon, Hong Goo] Kwangwoon Univ, Dept Electrophys, Seoul 139701, South Korea.
RP Park, B (reprint author), Kwangwoon Univ, Dept Electrophys, Seoul 139701, South Korea.
EM bcpark@kw.ac.kr
OI Park, Byoungchoo/0000-0002-5046-8037
FU National Research Foundation of Korea (NRF); Korea government (MEST)
   [20100029416]; Kwangwoon University
FX This research was supported by the Basic Science Research Program
   through a National Research Foundation of Korea (NRF) grant funded by
   the Korea government (MEST) (20100029416). This research was also
   supported by Kwangwoon University (2012).
CR Allcock HR, 2007, LANGMUIR, V23, P8103, DOI 10.1021/1a700840j
   Ashwell GJ, 1996, ELECTRON LETT, V32, P2089, DOI 10.1049/el:19961376
   Cui NY, 2002, APPL SURF SCI, V189, P31, DOI 10.1016/S0169-4332(01)01035-2
   Dorai R, 2003, J PHYS D APPL PHYS, V36, P666, DOI 10.1088/0022-3727/36/6/309
   Engelsen D. D., 1975, PHOTOCHEM PHOTOBIOL, V21, P77
   Hackam R, 2001, IEEE ELECTR INSUL M, V17, P8, DOI 10.1109/57.954573
   Heavens O. S., 1965, OPTICAL PROPERTIES T
   Kelly Wintenberg K., 1999, J VAC SCI TECHNOL, V17, P1539, DOI [10.1116/1.581849, DOI 10.1116/1.581849]
   Kim HH, 2002, J ELECTROSTAT, V55, P25, DOI 10.1016/S0304-3886(01)00182-6
   KITAJIMA H, 1981, APPL OPTICS, V20, P1005, DOI 10.1364/AO.20.001005
   KLOPFLEISCH M, 1992, APPL OPTICS, V31, P5017, DOI 10.1364/AO.31.005017
   Kunz U, 1996, SENSOR ACTUAT B-CHEM, V32, P149, DOI 10.1016/0925-4005(96)80124-9
   Laroussi M, 1999, IEEE T PLASMA SCI, V27, P34, DOI 10.1109/27.763016
   Massines F, 1998, J PHYS D APPL PHYS, V31, P3411, DOI 10.1088/0022-3727/31/24/003
   MELENDEZ J, 1997, SENSOR ACTUAT B-CHEM, V38, P375
   Mendis DA, 2000, IEEE T PLASMA SCI, V28, P1304, DOI 10.1109/27.893321
   Moisan M, 2002, PURE APPL CHEM, V74, P349, DOI 10.1351/pac200274030349
   Montie TC, 2000, IEEE T PLASMA SCI, V28, P41, DOI 10.1109/27.842860
   Panikov NS, 2002, IEEE T PLASMA SCI, V30, P1424, DOI 10.1109/TPS.2002.804195
   Park BJ, 2003, PHYS PLASMAS, V10, P4539, DOI 10.1063/1.1613655
   Raether H, 1988, SPRINGER TRACTS MODE, V111
   Schutze A, 1998, IEEE T PLASMA SCI, V26, P1685, DOI 10.1109/27.747887
   Tendero C, 2006, SPECTROCHIM ACTA B, V61, P2, DOI 10.1016/j.sab.2005.10.003
NR 23
TC 0
Z9 0
U1 1
U2 11
PU KOREAN PHYSICAL SOC
PI SEOUL
PA 635-4, YUKSAM-DONG, KANGNAM-KU, SEOUL 135-703, SOUTH KOREA
SN 0374-4884
J9 J KOREAN PHYS SOC
JI J. Korean Phys. Soc.
PD MAR
PY 2012
VL 60
IS 6
BP 944
EP 949
DI 10.3938/jkps.60.944
PG 6
WC Physics, Multidisciplinary
SC Physics
GA 943DD
UT WOS:000304099800011
DA 2018-10-19
ER

PT J
AU Noyama, Y
   Miura, T
   Ishimoto, T
   Itaya, T
   Niinomi, M
   Nakano, T
AF Noyama, Yoshihiro
   Miura, Takuya
   Ishimoto, Takuya
   Itaya, Takahiro
   Niinomi, Mitsuo
   Nakano, Takayoshi
TI Bone Loss and Reduced Bone Quality of the Human Femur after Total Hip
   Arthroplasty under Stress-Shielding Effects by Titanium-Based Implant
SO MATERIALS TRANSACTIONS
LA English
DT Article
DE titanium; biomaterial; total hip arthroplasty; stress-shielding effect;
   biological apatite (BAp); preferential orientation; bone quality; finite
   element analysis (FEA)
ID MECHANICAL-PROPERTIES; FEMORAL STEM; EPIDEMIOLOGY; PROSTHESIS;
   DIMENSIONS; COMPONENTS; ANISOTROPY; ALIGNMENT; MODULUS; FAILURE
AB The present work was aimed at clarifying the stress-shielding effect caused by hip-joint implantation into a femur by using a human cadaver with a cementless hip implant. In particular, bone quality was assessed from the standpoint of preferential c-axis orientation of biological apatite (BAp). Comparing the implanted side to the non-implanted side, a finite element analysis (FEA) indicated that artificial hip-joint implantation had a significant stress-shielding effect on the femur. The results also showed a marked decrease in the degree of preferential BAp orientation as well as bone loss in the medial-proximal femur. This is the first report showing a reduction in the degree of preferential BAp orientation due to a stress-shielding effect after artificial hip-joint implantation. Since preferential BAp orientation is an important index for determining bone mechanical function, these findings should be taken into account in future artificial hip-joint designs, especially those involving the stem component. [doi:10.2320/matertrans.M2011358]
C1 [Noyama, Yoshihiro; Miura, Takuya; Ishimoto, Takuya; Itaya, Takahiro; Nakano, Takayoshi] Osaka Univ, Div Mat & Mfg Sci, Grad Sch Engn, Suita, Osaka 5650871, Japan.
   [Noyama, Yoshihiro] Nakashima Med Co Ltd, Dept Res, Okayama 7090625, Japan.
   [Noyama, Yoshihiro] Nakashima Med Co Ltd, Dev Div, Okayama 7090625, Japan.
   [Niinomi, Mitsuo] Tohoku Univ, Inst Mat Res, Dept Biomat Sci, Sendai, Miyagi 9808577, Japan.
RP Nakano, T (reprint author), Osaka Univ, Div Mat & Mfg Sci, Grad Sch Engn, 2-2 Yamadaoka, Suita, Osaka 5650871, Japan.
EM nakano@mat.eng.osaka-u.ac.jp
RI Niinomi, Mitsuo/B-5965-2011
FU Japan Society for the Promotion of Science (JSPS); "Super Special
   Consortia"
FX This work was supported by the Funding Program for Next Generation
   World-Leading Researchers from the Japan Society for the Promotion of
   Science (JSPS) and the "Super Special Consortia" for supporting the
   development of cutting-edge medical care (Cabinet office, Government of
   Japan; Ministry of Health, Labor and Welfare; Ministry of Education,
   Culture, Sports, Science, and Technology; and Ministry of Economy,
   Trade, and Industry). We thank Prof. H. Iwaki and Prof. A. Kobayashi of
   Graduate School of Medicine, Osaka City University for useful comments
   and discussion. We thank Prof. Y. Nakajima and Prof. H. Kiyama of
   Graduate School of Medicine, Osaka City University for providing the
   bone specimen. Finally, we thank the donor's family for their
   generosity.
CR Adolphson P, 1996, J ARTHROPLASTY, V11, P572, DOI 10.1016/S0883-5403(96)80112-4
   Akay M, 1996, J BIOMED MATER RES, V31, P167
   BONFIELD W, 1977, NATURE, V270, P453, DOI 10.1038/270453a0
   Bozic KJ, 2009, J BONE JOINT SURG AM, V91A, P128, DOI 10.2106/JBJS.H.00155
   Busse B, 2010, J BIOMED MATER RES A, V92A, P1440, DOI 10.1002/jbm.a.32432
   Fujitani W, 2010, MATER SCI FORUM, V654-656, P2216, DOI 10.4028/www.scientific.net/MSF.654-656.2216
   Gruen TA, 1979, CLIN ORTHOP RELAT R, V141, P17, DOI DOI 10.1097/00003086-197906000-00002
   Harkess J. W., 2007, CAMPBELLS OPERATIVE
   HARRIGAN TP, 1992, J ORTHOPAED RES, V10, P134, DOI 10.1002/jor.1100100116
   Hernandez CJ, 2006, BONE, V39, P1173, DOI 10.1016/j.bone.2006.06.001
   HUISKES R, 1992, CLIN ORTHOP RELAT R, P124
   Ishimoto T, 2004, PHOSPH RES B, V17, P77
   Ishimoto T, 2011, J MATER SCI-MATER M, V22, P969, DOI 10.1007/s10856-011-4266-y
   Karrholm J, 2002, J BONE JOINT SURG AM, V84A, P1651
   Klibanski A, 2001, JAMA-J AM MED ASSOC, V285, P785
   Lee JW, 2007, MATER TRANS, V48, P337, DOI 10.2320/matertrans.48.337
   Lindahl H, 2007, INJURY, V38, P651, DOI 10.1016/j.injury.2007.02.048
   Mahaisavariya B, 2002, MED ENG PHYS, V24, P617, DOI 10.1016/S1350-4533(02)00113-3
   Mallory T. H., 1988, CONT ORTHOP, V17, P21
   Nakano T, 2002, BONE, V31, P479, DOI 10.1016/S8756-3282(02)00850-5
   Nakano T, 2006, MATER TRANS, V47, P2233, DOI 10.2320/matertrans.47.2233
   Ni GX, 2007, J ORTHOP RES, V25, P1408, DOI 10.1002/jor.20388
   Noyama Y, 2010, MATER SCI FORUM, V638-642, P664, DOI 10.4028/www.scientific.net/MSF.638-642.664
   Schonning A, 2009, COMPUT AIDED DESIGN, V41, P566, DOI 10.1016/j.cad.2007.10.007
   Shiraishi A., 2009, BMC MUSCULOSKELET DI, V10
   Skoldenberg G., 2006, ACTA ORTHOP, V77, P386
   Turner AWL, 2005, J ORTHOP RES, V23, P705, DOI 10.1016/j.orthres.2005.02.002
   U.S. Department of Health and Human Services Centers for Disease Control and Prevention-National Center for Health Statistics, 2010, NAT HOSP DISCH SURV
   Vail TP, 1998, J BIOMECH, V31, P619, DOI 10.1016/S0021-9290(98)00061-X
   Viswanath B, 2007, SCRIPTA MATER, V57, P361, DOI 10.1016/j.scriptamat.2007.04.027
NR 30
TC 23
Z9 23
U1 2
U2 25
PU JAPAN INST METALS
PI SENDAI
PA 1-14-32, ICHIBANCHO, AOBA-KU, SENDAI, 980-8544, JAPAN
SN 1345-9678
EI 1347-5320
J9 MATER TRANS
JI Mater. Trans.
PD MAR
PY 2012
VL 53
IS 3
BP 565
EP 570
DI 10.2320/matertrans.M2011358
PG 6
WC Materials Science, Multidisciplinary; Metallurgy & Metallurgical
   Engineering
SC Materials Science; Metallurgy & Metallurgical Engineering
GA 933OU
UT WOS:000303372400019
OA Bronze
DA 2018-10-19
ER

PT J
AU Miao, PH
   He, CX
   Hu, YL
   Tabata, Y
   Gao, JQ
   Hu, ZJ
AF Miao, Pei-Hong
   He, Cai-Xia
   Hu, Yu-Lan
   Tabata, Yasuhiko
   Gao, Jian-Qing
   Hu, Zhong-Jie
TI Impregnation of plasmid DNA into three-dimensional PLGA scaffold
   enhances DNA expression of mesenchymal stem cells in vitro
SO PHARMAZIE
LA English
DT Article
ID OSTEOGENIC DIFFERENTIATION; PROLIFERATION; TISSUE
AB Current efforts had been made to undertake a three-dimensional (3-D) reverse transfection of bone marrow-derived mesenchymal stem cells (BM-MSCs) in PLGA scaffolds. As a kind of multipotent stem cells, BM-MSCs show great potential and tremendous capacity in the gene transfection field and PLGA 3-D scaffold has been shown to be a biomaterial that provides structural support to cells proliferation and tissue engineering. The objective of this study was to assess the transfection efficiency of BM-MSCs with a 3-D reverse transfection method by using PLGA scaffold and observe the SEM photographs of BM-MSCs cultured on PLGA scaffold. BM-MSCs were cultured in 3-D PLGA scaffold which was incorporated with pullulan-spermine/pGL3. It was shown that the gene expression duration of BM-MSCs transfected using 3D reverse method with pullulan-spermine/DNA in the presence of serum maintained 12 days at high levels as compared with the plasmid DNA in medium, and scanning electronic microscopy (SEM) photographs of BM-MSCs cultured on PLGA scaffold exhibited robust cell attachment and viability when cultured in PLGA scaffold in vitro. This study demonstrates that the 3-D reverse transfection method of BM-MSCs using PLGA scaffold could achieve long gene expression in a relatively high level, therefore this transfection system is promising in gene transfection and tissue engineering.
C1 [Miao, Pei-Hong; Hu, Zhong-Jie] Chinese Peoples Armed Police Forces, Dept Pharm, Zhejiang Prov Corps Hosp, Jiaxing 314000, Peoples R China.
   [He, Cai-Xia; Hu, Yu-Lan; Gao, Jian-Qing] Zhejiang Univ, Coll Pharmaceut Sci, Inst Pharmaceut, Hangzhou 310003, Zhejiang, Peoples R China.
   [Tabata, Yasuhiko] Kyoto Univ, Inst Frontier Med Sci, Field Tissue Engn, Kyoto, Japan.
RP Hu, ZJ (reprint author), Chinese Peoples Armed Police Forces, Dept Pharm, Zhejiang Prov Corps Hosp, Jiaxing 314000, Peoples R China.
EM Huzj05@sina.com
RI 胡, 瑜兰/I-8646-2014
FU National Natural Science Foundation of China [30873173, 81001410];
   Zhejiang Provincial Natural Science Foundation of China [R2090176];
   Fundamental Research Funds for the Central Universities [81001410]
FX This work was financially supported by the National Natural Science
   Foundation of China (30873173 to Jian-Qing Gao, 81001410 to Yu-Lan Hu);
   Zhejiang Provincial Natural Science Foundation of China (R2090176 to
   Jian-Qing Gao); the Fundamental Research Funds for the Central
   Universities (81001410 to Hu Yulan).
CR Catelas I, 2006, TISSUE ENG, V12, P2385, DOI 10.1089/ten.2006.12.2385
   Goh KL, 2003, J THEOR BIOL, V223, P259, DOI 10.1016/S0022-5193(03)00083-3
   Griffith M, 1999, SCIENCE, V286, P2169, DOI 10.1126/science.286.5447.2169
   He CX, 2011, PHARM RES       0224
   Ingber DE, 1995, J BIOMECH, V28, P1471, DOI 10.1016/0021-9290(95)00095-X
   LENNON DP, 1995, EXP CELL RES, V219, P211, DOI 10.1006/excr.1995.1221
   MuellerKlieser W, 1997, AM J PHYSIOL-CELL PH, V273, pC1109
   Niklason LE, 1999, SCIENCE, V284, P489, DOI 10.1126/science.284.5413.489
   Okazaki A, 2007, TISSUE ENG, V13, P245, DOI 10.1089/ten.2006.0185
   Richardson TP, 2001, NAT BIOTECHNOL, V19, P1029, DOI 10.1038/nbt1101-1029
   Tabata Y, 2003, TISSUE ENG, V9, pS5, DOI 10.1089/10763270360696941
   Takahashi Y, 2004, J BIOMAT SCI-POLYM E, V15, P41, DOI 10.1163/156856204322752228
   Zimmermann WH, 2000, BIOTECHNOL BIOENG, V68, P106
NR 13
TC 2
Z9 2
U1 1
U2 17
PU GOVI-VERLAG  PHARMAZEUTISCHER VERLAG GMBH
PI ESCHBORN
PA PHARMAZEUTISCCARL MANNICH STR 26, D-65760 ESCHBORN, GERMANY
SN 0031-7144
J9 PHARMAZIE
JI Pharmazie
PD MAR
PY 2012
VL 67
IS 3
BP 229
EP 232
DI 10.1691/ph.2012.1077
PG 4
WC Chemistry, Medicinal; Chemistry, Multidisciplinary; Pharmacology &
   Pharmacy
SC Pharmacology & Pharmacy; Chemistry
GA 930ZA
UT WOS:000303182300006
PM 22530304
DA 2018-10-19
ER

PT J
AU Pertile, R
   Moreira, S
   Andrade, F
   Domingues, L
   Gama, M
AF Pertile, Renata
   Moreira, Susana
   Andrade, Fabia
   Domingues, Lucilia
   Gama, Miguel
TI Bacterial cellulose modified using recombinant proteins to improve
   neuronal and mesenchymal cell adhesion
SO BIOTECHNOLOGY PROGRESS
LA English
DT Article
DE bacterial cellulose; recombinant protein production; CBM3; cell
   adhesion; MSCs neurotrophin expression
ID IN-VITRO; NEURITE OUTGROWTH; EXTRACELLULAR-MATRIX; SURFACE MODIFICATION;
   SYNTHETIC PEPTIDE; BINDING MODULES; IKVAV PEPTIDE; A-CHAIN; LAMININ;
   ATTACHMENT
AB A wide variety of biomaterials and bioactive molecules have been applied as scaffolds in neuronal tissue engineering. However, creating devices that enhance the regeneration of nervous system injuries is still a challenge, due the difficulty in providing an appropriate environment for cell growth and differentiation and active stimulation of nerve regeneration. In recent years, bacterial cellulose (BC) has emerged as a promising biomaterial for biomedical applications because of its properties such as high crystallinity, an ultrafine fiber network, high tensile strength, and biocompatibility. The small signaling peptides found in the proteins of extracellular matrix are described in the literature as promoters of adhesion and proliferation for several cell lineages on different surfaces. In this work, the peptide IKVAV was fused to a carbohydrate-binding module (CBM3) and used to modify BC surfaces, with the goal of promoting neuronal and mesenchymal stem cell (MSC) adhesion. The recombinant proteins IKVAV-CBM3 and (19)IKVAV-CBM3 were successfully expressed in E. coli, purified through affinity chromatography, and stably adsorbed to the BC membranes. The effect of these recombinant proteins, as well as RGD-CBM3, on cell adhesion was evaluated by MTS colorimetric assay. The results showed that the (19)IKVAV-CBM3 was able to significantly improve the adhesion of both neuronal and mesenchymal cells and had no effect on the other cell lineages tested. The MSC neurotrophin expression in cells grown on BC membranes modified with the recombinant proteins was also analyzed. (c) 2012 American Institute of Chemical Engineers Biotechnol. Prog., 2012
C1 [Pertile, Renata; Moreira, Susana; Andrade, Fabia; Domingues, Lucilia; Gama, Miguel] Univ Minho, Ctr Biol Engn, Braga, Portugal.
RP Gama, M (reprint author), Univ Minho, Ctr Biol Engn, Braga, Portugal.
EM fmgama@deb.uminho.pt
RI Gama, Miguel/I-3140-2015; Andrade, Fabia/F-6739-2012; Domingues,
   Lucilia/B-2191-2010; Moreira, Susana/J-1905-2015
OI Gama, Miguel/0000-0002-5655-0015; Domingues,
   Lucilia/0000-0003-1089-7627; Moreira, Susana/0000-0002-8333-3016;
   Pertile, Renata/0000-0003-4699-8817
FU European Union [E07D401931BR]; Fundacao para a Ciencia e a Tecnologia
   (FCT, Portugal) [SFRH/BPD/64726/2009]; Coordenacao de Aperfeicoamento de
   Pessoal de Nivel Superior (CAPES, Brazil)
FX Renata A. N. Pertile gratefully acknowledges support by the Programme Al
   beta an, the European Union Programme of High Level Scholarships for
   Latin America (Scholarship No. E07D401931BR). The author Susana Moreira
   is recipient of a SFRH/BPD/64726/2009 fellowship from Fundacao para a
   Ciencia e a Tecnologia (FCT, Portugal). Fabia K. Andrade is the
   recipient of a fellowship from Coordenacao de Aperfeicoamento de Pessoal
   de Nivel Superior (CAPES, Brazil).
CR Adams DN, 2005, J NEUROBIOL, V62, P134, DOI 10.1002/neu.20075
   ADAMS JC, 1993, DEVELOPMENT, V117, P1183
   Andrade FK, 2008, TISSUE ENG PT A, V14, P899
   Badylak SF, 2009, ACTA BIOMATER, V5, P1, DOI 10.1016/j.actbio.2008.09.013
   Barzilay R, 2006, ISRAEL MED ASSOC J, V8, P61
   BELLAMKONDA R, 1995, J NEUROSCI RES, V41, P501, DOI 10.1002/jnr.490410409
   Boontheekul T, 2003, CURR OPIN BIOTECH, V14, P559, DOI 10.1016/j.copbio.2003.08.004
   Cecchini M, 2007, NANOTECHNOLOGY, V18, DOI 10.1088/0957-4484/18/50/505103
   Chen F, 2007, MAT SCI ENG C-BIO S, V27, P325, DOI 10.1016/j.msec.2006.05.004
   Cook AD, 1997, J BIOMED MATER RES, V35, P513
   Coumans JV, 2001, J NEUROSCI, V21, P9334, DOI 10.1523/JNEUROSCI.21-23-09334.2001
   DAI WG, 1994, BIO-TECHNOL, V12, P797, DOI 10.1038/nbt0894-797
   Frisch SM, 1997, CURR OPIN CELL BIOL, V9, P701, DOI 10.1016/S0955-0674(97)80124-X
   Girotti A, 2004, J MATER SCI-MATER M, V15, P479, DOI 10.1023/B:JMSM.0000021124.58688.7a
   Hersel U, 2003, BIOMATERIALS, V24, P4385, DOI 10.1016/S0142-9612(03)00343-0
   Hubbell JA, 1999, CURR OPIN BIOTECH, V10, P123, DOI 10.1016/S0958-1669(99)80021-4
   Huber M, 1998, J BIOMED MATER RES, V41, P278, DOI 10.1002/(SICI)1097-4636(199808)41:2<278::AID-JBM13>3.0.CO;2-H
   Ishaug-Riley SL, 1998, BIOMATERIALS, V19, P1405, DOI 10.1016/S0142-9612(98)00021-0
   Jiang JJ, 2010, NEUROSCI RES, V66, P46, DOI 10.1016/j.neures.2009.09.1711
   Jonas R, 1998, POLYM DEGRAD STABIL, V59, P101, DOI 10.1016/S0141-3910(97)00197-3
   Jongpaiboonkit L, 2009, TISSUE ENG PT A, V15, P343, DOI 10.1089/ten.tea.2008.0096
   Kam L, 2002, BIOMATERIALS, V23, P511, DOI 10.1016/S0142-9612(01)00133-8
   Keselowsky BG, 2003, J BIOMED MATER RES A, V66A, P247, DOI 10.1002/jbm.a.10537
   Klein CL, 1999, J MATER SCI-MATER M, V10, P721, DOI 10.1023/A:1008975105243
   Klemm D, 2001, PROG POLYM SCI, V26, P1561, DOI 10.1016/S0079-6700(01)00021-1
   LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0
   Lehtio J, 2003, P NATL ACAD SCI USA, V100, P484, DOI 10.1073/pnas.212651999
   Lin X, 2006, BBA-GEN SUBJECTS, V1760, P1403, DOI 10.1016/j.bbagen.2006.05.010
   Lu SY, 2006, NANO LETT, V6, P1977, DOI 10.1021/nl061139w
   MACKAY AR, 1994, LAB INVEST, V70, P800
   Massia SP, 2000, BIOMATERIALS, V21, P2253, DOI 10.1016/S0142-9612(00)00151-4
   Massia SP, 2004, J BIOMED MATER RES A, V68A, P177, DOI 10.1002/jbm.a.20009
   MASSIA SP, 1991, J BIOMED MATER RES, V25, P223, DOI 10.1002/jbm.820250209
   Mello LR, 2001, ARQ NEURO-PSIQUIAT, V59, P372, DOI 10.1590/S0004-282X2001000300012
   Moreira SM, 2008, BMC BIOTECHNOL, V8, DOI 10.1186/1472-6750-8-78
   Nisbet DR, 2008, J BIOMED MATER RES B, V87B, P251, DOI 10.1002/jbm.b.31000
   NOMIZU M, 1995, FEBS LETT, V365, P227, DOI 10.1016/0014-5793(95)00475-O
   Nuttelman CR, 2005, MATRIX BIOL, V24, P208, DOI 10.1016/j.matbio.2005.03.004
   Orner BP, 2004, J AM CHEM SOC, V126, P10808, DOI 10.1021/ja0474291
   Patel N, 1998, FASEB J, V12, P1447
   Prabhakaran MP, 2008, TISSUE ENG PT A, V14, P1787, DOI 10.1089/ten.tea.2007.0393
   RANIERI JP, 1994, INT J DEV NEUROSCI, V12, P725, DOI 10.1016/0736-5748(94)90052-3
   SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463
   SEPHEL GC, 1989, BIOCHEM BIOPH RES CO, V162, P821, DOI 10.1016/0006-291X(89)92384-X
   Shaw D, 2003, J CRANIOFAC SURG, V14, P308, DOI 10.1097/00001665-200305000-00008
   Shin H, 2003, BIOMATERIALS, V24, P4353, DOI 10.1016/S0142-9612(03)00339-9
   Svensson A, 2005, BIOMATERIALS, V26, P419, DOI 10.1016/j.biomaterials.2004.02.049
   TASHIRO K, 1989, J BIOL CHEM, V264, P16174
   Tong YW, 2001, BIOMATERIALS, V22, P1029, DOI 10.1016/S0142-9612(00)00338-0
   Turner S, 1997, J VAC SCI TECHNOL B, V15, P2848, DOI 10.1116/1.589742
   Vandamme EJ, 1998, POLYM DEGRAD STABIL, V59, P93, DOI 10.1016/S0141-3910(97)00185-7
   Wang TW, 2006, J BIOMED MATER RES B, V79B, P379, DOI 10.1002/jbm.b.30552
   WIERZBA A, 1995, BIOTECHNOL BIOENG, V46, P185, DOI 10.1002/bit.260460302
   Willerth SM, 2007, ADV DRUG DELIVER REV, V59, P325, DOI 10.1016/j.addr.2007.03.014
   WOERLY S, 1994, J NEURAL TRANSP PLAS, V5, P245
   Woerly S, 1996, BIOMATERIALS, V17, P301, DOI 10.1016/0142-9612(96)85568-2
   Wu B, 2010, J HUAZHONG U SCI-MED, V30, P178, DOI 10.1007/s11596-010-0209-y
   Wu Yongchao, 2006, J Huazhong Univ Sci Technolog Med Sci, V26, P594, DOI 10.1007/s11596-006-0530-7
   Yamaoka T, 1999, INT J BIOL MACROMOL, V25, P265, DOI 10.1016/S0141-8130(99)00041-0
   Yang XB, 2001, BONE, V29, P523, DOI 10.1016/S8756-3282(01)00617-2
NR 60
TC 23
Z9 25
U1 7
U2 68
PU WILEY-BLACKWELL
PI MALDEN
PA COMMERCE PLACE, 350 MAIN ST, MALDEN 02148, MA USA
SN 8756-7938
J9 BIOTECHNOL PROGR
JI Biotechnol. Prog.
PD MAR-APR
PY 2012
VL 28
IS 2
BP 526
EP 532
DI 10.1002/btpr.1501
PG 7
WC Biotechnology & Applied Microbiology; Food Science & Technology
SC Biotechnology & Applied Microbiology; Food Science & Technology
GA 923GH
UT WOS:000302607100027
PM 22271600
DA 2018-10-19
ER

PT J
AU Martinez-Sanz, E
   Alkhraisat, MH
   Paradas, I
   Lopez, Y
   Maldonado, E
   Gonzalez-Meli, B
   Berenguer, B
   Lopez-Cabarcos, E
   Martinez, ML
   Martinez-Alvarez, C
AF Martinez-Sanz, Elena
   Alkhraisat, Mohammad H.
   Paradas, Irene
   Lopez, Yamila
   Maldonado, Estela
   Gonzalez-Meli, Beatriz
   Berenguer, Beatriz
   Lopez-Cabarcos, Enrique
   Luisa Martinez, Ma
   Martinez-Alvarez, Concepcion
TI Osteoinduction in the Palatal Submucosa by Injecting BMP-2 on 2
   Different Carriers
SO JOURNAL OF CRANIOFACIAL SURGERY
LA English
DT Article
DE Injectable carriers; rhBMP-2; collagen gel; brushite cement; cleft
   palate
ID BONE MORPHOGENETIC PROTEIN-2; BETA-TRICALCIUM PHOSPHATE; ABSORBABLE
   COLLAGEN SPONGE; RAT CALVARIAL OSTEOBLASTS; ALVEOLAR RIDGE DEFECTS;
   CLEFT-PALATE; ECTOPIC OSTEOINDUCTION; CELL-DIFFERENTIATION;
   DELIVERY-SYSTEM; TISSUE
AB In this work, we investigated the ability of injected recombinant human bone morphogenetic protein 2 (rhBMP-2) on brushite cement (a beta-tricalcium phosphate-based biomaterial) and collagen gel as carriers to induce osteogenic differentiation in the palatal submucosa of 10-day-old rats. This was part of a broader study aiming to create bone in the palatal submucosa at cleft palate edges in the search for a minimally invasive treatment. Thirteen treated animals, 7 with rhBMP-2/brushite cement and 6 with rhBMP-2/ collagen gel, were injected with 5 to 10 mu L of each biomaterial in the right palatal submucosa at the level between the second and third rugae. The contralateral site was uninjected and served as the control. Six weeks after injection, both brushite cement and collagen gel were histologically unrecognizable in all treated animals. New bone structures such as ossicles of woven bone were not detected. However, an augmentation in the thickness of the palatal fibromucosa was observed at the injection site of all palates. In addition, immunolabeling for osteopontin, proliferating cell nuclear antigen, and TUNEL revealed intense osteogenic induction at the injection site with both constructs, which was negative in the control site from the same specimens; no differences regarding cell proliferation and death were observed. The present study confirms the feasibility of generating osteogenic cells in the palatal submucosa by injecting low doses of rhBMP-2 in these 2 biomaterials, together with their inability to form bone.
C1 [Martinez-Sanz, Elena] CS Tarazona, Serv Aragones Salud, Sect Zaragoza 3, Tarazona 50500, Zaragoza, Spain.
   [Martinez-Sanz, Elena; Paradas, Irene; Lopez, Yamila; Maldonado, Estela; Martinez-Alvarez, Concepcion] Univ Complutense Madrid, Fac Med, Fac Odontol, Dept Anat & Embryol Humana 1, Madrid, Spain.
   [Alkhraisat, Mohammad H.; Lopez-Cabarcos, Enrique] Univ Complutense Madrid, Fac Farm, Dept Quim Fis 2, Madrid, Spain.
   [Gonzalez-Meli, Beatriz; Berenguer, Beatriz] Hosp Gen Univ Gregorio Maranon, Serv Cirugia Plast Pediat, Madrid, Spain.
   [Luisa Martinez, Ma] Univ San Pablo CEU, Fac Farm, Secc Opt, Dept Fis Aplicada & Opt, Madrid, Spain.
RP Martinez-Sanz, E (reprint author), CS Tarazona, Serv Aragones Salud, Sect Zaragoza 3, Plaza Joaquina Zamora 2, Tarazona 50500, Zaragoza, Spain.
EM emartinezsa@salud.aragon.es
RI Lopez Cabarcos, Enrique/L-5802-2014
OI Lopez Cabarcos, Enrique/0000-0003-2939-4130; MARTINEZ ALVAREZ, MARIA
   CONCEPCION/0000-0002-8089-3173; Alkhraisat,
   Mohammad/0000-0003-4422-4527; Martinez-Sanz, Elena/0000-0002-5492-8459
FU Spanish Ministry of Science and Innovation [PS09/01762]
FX The authors thank Alicia Cerro and Dolores Arroyo for their help with
   histology. The authors also thank Dr Tamimi and Tamara Fuerte for their
   kind help with the experiments. The authors thank the Spanish Ministry
   of Science and Innovation (PS09/01762) and Santander/Universidad
   Complutense de Madrid to the Complutense Research Group 920202.
CR Barboza EP, 2004, J PERIODONTOL, V75, P702, DOI 10.1902/jop.2004.75.5.702
   Bessa PC, 2008, J TISSUE ENG REGEN M, V2, P1, DOI 10.1002/term.63
   Bessa PC, 2008, J TISSUE ENG REGEN M, V2, P81, DOI 10.1002/term.74
   Bessho K, 2002, J BIOMED MATER RES, V61, P61, DOI 10.1002/jbm.10169
   Boyne PJ, 2001, J BONE JOINT SURG AM, V83A, pS146
   Chen D, 1997, CALCIFIED TISSUE INT, V60, P283, DOI 10.1007/s002239900230
   De Biase Pietro, 2005, Injury, V36 Suppl 3, pS43
   FUJIMURA K, 1995, BIOCHEM BIOPH RES CO, V208, P316, DOI 10.1006/bbrc.1995.1340
   HARRIS SE, 1994, J BONE MINER RES, V9, P855
   Hou LT, 2007, J PERIODONTOL, V78, P335, DOI 10.1902/jop.2007.060106
   Howell T. H., 1997, INT J PERIODONT REST, V17, P124
   Hunt DR, 2001, J PERIODONTOL, V72, P651, DOI 10.1902/jop.2001.72.5.651
   Hyun SJ, 2005, J PERIODONTOL, V76, P1667, DOI 10.1902/jop.2005.76.10.1667
   Jingushi Seiya, 2002, J Orthop Sci, V7, P490, DOI 10.1007/s007760200085
   Kaito T, 2005, BIOMATERIALS, V26, P73, DOI 10.1016/j.biomaterials.2004.02.010
   Kato M, 2006, BIOMATERIALS, V27, P3927, DOI 10.1016/j.biomaterials.2006.03.013
   Kato M, 2006, BIOMATERIALS, V27, P2035, DOI 10.1016/j.biomaterials.2005.10.007
   Keskin DS, 2005, BIOMATERIALS, V26, P4023, DOI 10.1016/j.biomaterials.2004.09.063
   Kim CS, 2005, BIOMATERIALS, V26, P2501, DOI 10.1016/j.biomaterials.2004.07.015
   Liang G, 2005, BIOMATERIALS, V26, P4265, DOI 10.1016/j.biomaterials.2004.10.035
   Martinez-Sanz E, 2011, LAB ANIM-UK, V45, P70, DOI 10.1258/la.2010.010044
   Martinez-Sanz E, 2011, J CONTROL RELEASE, V152, P232, DOI 10.1016/j.jconrel.2011.02.003
   Na K, 2007, BIOMATERIALS, V28, P2631, DOI 10.1016/j.biomaterials.2007.02.008
   Okubo Y, 2000, INT J ORAL MAX SURG, V29, P62, DOI 10.1016/S0901-5027(00)80127-7
   OWEN TA, 1990, J CELL PHYSIOL, V143, P420, DOI 10.1002/jcp.1041430304
   Resel E, 2007, J SURG RES, V138, P111, DOI 10.1016/j.jss.2006.07.033
   Sadove AM, 2004, CLIN PLAST SURG, V31, P231, DOI 10.1016/S0094-1298(03)00136-6
   Saito N, 2003, BONE, V32, P381, DOI 10.1016/S8756-3282(03)00028-0
   Schliephake H, 2010, ORAL MAXILLOFAC SURG, V14, P17, DOI 10.1007/s10006-009-0185-1
   Steffen T, 2000, CLIN ORTHOP RELAT R, P28
   Tamimi F, 2009, BIOMATERIALS, V30, P208, DOI 10.1016/j.biomaterials.2008.09.032
   URIST MR, 1984, CLIN ORTHOP RELAT R, P277
   URIST MR, 1965, SCIENCE, V150, P893, DOI 10.1126/science.150.3698.893
   WOZNEY JM, 1988, SCIENCE, V242, P1528, DOI 10.1126/science.3201241
   Zohar R, 1998, EUR J ORAL SCI, V106, P401, DOI 10.1111/j.1600-0722.1998.tb02206.x
NR 35
TC 5
Z9 6
U1 0
U2 11
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA 530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA
SN 1049-2275
J9 J CRANIOFAC SURG
JI J. Craniofac. Surg.
PD MAR
PY 2012
VL 23
IS 2
BP 594
EP 598
DI 10.1097/SCS.0b013e31824cd6c7
PG 5
WC Surgery
SC Surgery
GA 917JU
UT WOS:000302171700100
PM 22446423
DA 2018-10-19
ER

PT J
AU Scarano, A
   Perrotti, V
   Degidi, M
   Piattelli, A
   Iezzi, G
AF Scarano, Antonio
   Perrotti, Vittoria
   Degidi, Marco
   Piattelli, Adriano
   Iezzi, Giovanna
TI Bone Regeneration with Algae-Derived Hydroxyapatite: A Pilot Histologic
   and Histomorphometric Study in Rabbit Tibia Defects
SO INTERNATIONAL JOURNAL OF ORAL & MAXILLOFACIAL IMPLANTS
LA English
DT Article
DE algae-derived hydroxyapatite; bone regeneration; histology; rabbit
   defects
ID SINUS FLOOR AUGMENTATION; SURGICAL-TREATMENT; PERI-IMPLANTITIS; RED
   ALGAE; IN-VITRO; SUBSTITUTE; SCAFFOLDS
AB Purpose: Algipore is a biologic hydroxyapatite derived from calcifying maritime algae. The present study evaluated this material histologically and histomorphometrically after implantation in rabbit tibia defects for 4 weeks. Materials and Methods: Six New Zealand rabbits were used in this study. In each rabbit tibia, two 7-mm defects were prepared. Control defects were left empty, and test defects were filled with Algipore. Twenty-four specimens (12 test and 12 control) were retrieved and processed for histology. Results: In control sites, newly formed trabecular bone with large marrow spaces was plentiful in the most peripheral areas of the defects but sparse elsewhere. In contrast, in test sites, a large quantity of newly formed bone around the biomaterial particles was detected in the central medullary portion of the defect. In addition, in several areas, the biomaterial particles were bridged by newly formed bone. The percentage of contact between newly formed bone and biomaterial particles was 71.2%+/- 9.8%. Inside the central portion of the biomaterial particles, it was possible to see newly formed bone (about 35.3%+/- 4.8% in each particle). In test sites, newly formed bone represented 31.1%+/- 1.9% of the material, with residual biomaterial particles occupying 33.4%+/- 2.8% and marrow spaces another 34.7%+/- 4.3%. In the control sites, the values were 30.2%+/- 2.2% for newly formed bone and 68.7%+/- 4.1% for marrow spaces. A statistically significant difference was found in the percentage of marrow space between the two groups, but no significant difference was observed in the percentage of newly formed bone. Conclusions: The present rabbit study confirmed the high osteoconductivity and resorbability of this biomaterial. Int J Oral Maxillofac Implants 2012;27:336-340
C1 [Scarano, Antonio; Perrotti, Vittoria; Piattelli, Adriano; Iezzi, Giovanna] Univ G dAnnunzio, Sch Dent, Pescara, Italy.
RP Piattelli, A (reprint author), Via F Sciucchi 63, I-66100 Chieti, Italy.
EM apiattelli@unich.it
RI Scarano, Antonio/F-6961-2017
OI Scarano, Antonio/0000-0003-1374-6146
CR Ewers R, 2005, J ORAL MAXIL SURG, V63, P1712, DOI 10.1016/j.joms.2005.08.020
   Ewers R, 2004, CLIN ORAL IMPLAN RES, V15, P96, DOI 10.1111/j.1600-0501.2004.00987.x
   Hutmacher DW, 2000, BIOMATERIALS, V21, P2529, DOI 10.1016/S0142-9612(00)00121-6
   Jones AC, 2009, BIOMATERIALS, V30, P1440, DOI 10.1016/j.biomaterials.2008.10.056
   Kirmeier R, 2008, CLIN ORAL IMPLAN RES, V19, P366, DOI 10.1111/j.1600-0501.2007.01487.x
   Klongnoi B, 2006, J CLIN PERIODONTOL, V33, P500, DOI 10.1111/j.1600-051X.2006.00938.x
   Roos-Jansaker AM, 2007, J CLIN PERIODONTOL, V34, P723, DOI 10.1111/j.1600-051X.2007.01098.x
   Roos-Jansaker AM, 2007, J CLIN PERIODONTOL, V34, P625, DOI 10.1111/j.1600-051X.2007.01102.x
   Schenk R K, 1994, Int J Oral Maxillofac Implants, V9, P13
   Schopper C, 1999, J LONG-TERM EFF MED, V9, P203
   Schopper Christian, 2003, Clin Oral Implants Res, V14, P743
   Simunek A, 2005, CLIN ORAL IMPLAN RES, V16, P342, DOI 10.1111/j.1600-0501.2005.01097.x
   Thorwarth M, 2007, BRIT J ORAL MAX SURG, V45, P41, DOI 10.1016/j.bjoms.2006.03.013
   Turhani D, 2005, J ORAL MAXIL SURG, V63, P793, DOI 10.1016/j.jams.2005.02.015
   Turhani D, 2005, J ORAL MAXIL SURG, V63, P673, DOI 10.1016/j.joms.2005.01.006
   Wanschitz F, 2006, INT J ORAL MAX IMPL, V21, P433
NR 16
TC 6
Z9 6
U1 0
U2 8
PU QUINTESSENCE PUBLISHING CO INC
PI HANOVER PARK
PA 4350 CHANDLER DRIVE, HANOVER PARK, IL 60133 USA
SN 0882-2786
J9 INT J ORAL MAX IMPL
JI Int. J. Oral Maxillofac. Implants
PD MAR-APR
PY 2012
VL 27
IS 2
BP 336
EP 340
PG 5
WC Dentistry, Oral Surgery & Medicine
SC Dentistry, Oral Surgery & Medicine
GA 924AZ
UT WOS:000302664200011
PM 22442772
DA 2018-10-19
ER

PT J
AU Khanoki, SA
   Pasini, D
AF Khanoki, Sajad Arabnejad
   Pasini, Damiano
TI Multiscale Design and Multiobjective Optimization of Orthopedic Hip
   Implants with Functionally Graded Cellular Material
SO JOURNAL OF BIOMECHANICAL ENGINEERING-TRANSACTIONS OF THE ASME
LA English
DT Article
DE total hip replacement; cellular microstructure; lattice material; finite
   element method; asymptotic homogenization; multiobjective optimization
ID POROUS TANTALUM BIOMATERIAL; SPACE TOPOLOGY OPTIMIZATION; SCAFFOLD
   STRUCTURE LIBRARY; FINITE-ELEMENT-ANALYSIS; HOMOGENIZATION METHOD;
   MECHANICAL-PROPERTIES; FOLLOW-UP; PERIODIC MICROSTRUCTURES; PRIMARY
   STABILITY; DENTAL IMPLANT
AB Revision surgeries of total hip arthroplasty are often caused by a deficient structural compatibility of the implant. Two main culprits, among others, are bone-implant interface instability and bone resorption. To address these issues, in this paper we propose a novel type of implant, which, in contrast to current hip replacement implants made of either a fully solid or a foam material, consists of a lattice microstructure with nonhomogeneous distribution of material properties. A methodology based on multiscale mechanics and design optimization is introduced to synthesize a graded cellular implant that can minimize concurrently bone resorption and implant interface failure. The procedure is applied to the design of a 2D left implanted femur with optimized gradients of relative density. To assess the manufacturability of the graded cellular microstructure, a proof-of-concept is fabricated by using rapid prototyping. The results from the analysis are used to compare the optimized cellular implant with a fully dense titanium implant and a homogeneous foam implant with a relative density of 50%. The bone resorption and the maximum value of interface stress of the cellular implant are found to be over 70% and 50% less than the titanium implant while being 53% and 65% less than the foam implant. [DOI: 10.1115/1.4006115]
C1 [Khanoki, Sajad Arabnejad; Pasini, Damiano] McGill Univ, Dept Mech Engn, Montreal, PQ H3A 0C3, Canada.
RP Pasini, D (reprint author), McGill Univ, Dept Mech Engn, Room 372,MacDonald Engn Bldg, Montreal, PQ H3A 0C3, Canada.
EM sajad.arabnejadkhanoki@mail.mcgill.ca; Damiano.pasini@mcgill.ca
RI Pasini, Damiano/A-4391-2008
OI Pasini, Damiano/0000-0002-3021-7118
CR Abdul-Kadir MR, 2008, J BIOMECH, V41, P587, DOI 10.1016/j.jbiomech.2007.10.009
   Adam F, 2002, J ARTHROPLASTY, V17, P217, DOI 10.1054/arth.2002.30285
   Andrews EW, 2001, INT J MECH SCI, V43, P701, DOI 10.1016/S0020-7403(00)00043-6
   BENDSOE MP, 1988, COMPUT METHOD APPL M, V71, P197, DOI 10.1016/0045-7825(88)90086-2
   Bendsoe MP, 2003, TOPOLOGY OPTIMIZATIO
   Bidanda B., 2008, VIRTUAL PROTOTYPING
   Bobyn JD, 1999, J BONE JOINT SURG BR, V81B, P907, DOI 10.1302/0301-620X.81B5.9283
   Bobyn JD, 2004, J BONE JOINT SURG AM, V86A, P123, DOI 10.2106/00004623-200412002-00017
   Boyle C, 2011, J BIOMECH, V44, P1722, DOI 10.1016/j.jbiomech.2011.03.038
   Boyle C, 2011, J BIOMECH, V44, P935, DOI 10.1016/j.jbiomech.2010.11.029
   Bragdon CR, 2004, J BONE JOINT SURG AM, V86A, P105, DOI 10.2106/00004623-200412002-00015
   CARTER DR, 1989, J BIOMECH, V22, P231, DOI 10.1016/0021-9290(89)90091-2
   Chen JY, 1998, J MECH PHYS SOLIDS, V46, P789, DOI 10.1016/S0022-5096(98)00006-4
   Christensen RM, 2000, INT J SOLIDS STRUCT, V37, P93, DOI 10.1016/S0020-7683(99)00080-3
   Chua CK, 2003, INT J ADV MANUF TECH, V21, P291
   Chua CK, 2003, INT J ADV MANUF TECH, V21, P302
   Coelho PG, 2008, STRUCT MULTIDISCIP O, V35, P107, DOI 10.1007/s00158-007-0141-3
   Coelho PG, 2011, ADV ENG SOFTW, V42, P219, DOI 10.1016/j.advengsoft.2010.10.003
   Coelho PG, 2011, J BIOMECH, V44, P321, DOI 10.1016/j.jbiomech.2010.10.007
   Deb K, 2002, IEEE T EVOLUT COMPUT, V6, P182, DOI 10.1109/4235.996017
   Diaaz A.R., 1992, INT J NUMER METHODS, V35, P1487
   DUMONTET H, 1986, RAIRO-MATH MODEL NUM, V20, P265
   Fang Z, 2005, COMPUT AIDED DESIGN, V37, P65, DOI 10.1016/j.cad.2004.04.002
   Fraldi M, 2010, BIOMECH MODEL MECHAN, V9, P389, DOI 10.1007/s10237-009-0183-0
   Ghosh S, 2001, INT J SOLIDS STRUCT, V38, P2335, DOI 10.1016/S0020-7683(00)00167-0
   Gibson L. J, 1999, CELLULAR SOLIDS STRU
   Glassman AH, 2006, CLIN ORTHOP RELAT R, P64, DOI 10.1097/01.blo.0000246541.41951.20
   Grubl A, 2007, J ORTHOP RES, V25, P841, DOI 10.1002/jor.20381
   GUEDES JM, 1990, COMPUT METHOD APPL M, V83, P143, DOI 10.1016/0045-7825(90)90148-F
   Harrysson OLA, 2008, MAT SCI ENG C-BIO S, V28, P366, DOI 10.1016/j.msec.2007.04.022
   Harvey EJ, 1999, J BONE JOINT SURG AM, V81A, P93, DOI 10.2106/00004623-199901000-00013
   Hassani B, 1996, COMMUN NUMER METH EN, V12, P185
   Hassani B, 1998, COMPUT STRUCT, V69, P707, DOI 10.1016/S0045-7949(98)00131-X
   Hassani B, 1998, COMPUT STRUCT, V69, P719, DOI 10.1016/S0045-7949(98)00132-1
   Hassani B, 1998, COMPUT STRUCT, V69, P739, DOI 10.1016/S0045-7949(98)00133-3
   Hedia HS, 2006, J BIOMED MATER RES B, V79B, P42, DOI 10.1002/jbm.30509
   Hedia HS, 2004, BIO-MED MATER ENG, V14, P133
   Heinl P, 2008, ACTA BIOMATER, V4, P1536, DOI 10.1016/j.actbio.2008.03.013
   Hoffman O., 1967, J COMPOS MATER, V1, P200, DOI DOI 10.1177/002199836700100210
   Hollister SJ, 1992, COMPUTATIONAL MECHAN, V10, P73, DOI DOI 10.1007/BF00369853
   HUISKES R, 1992, CLIN ORTHOP RELAT R, P124
   Katti KS, 2004, COLLOID SURFACE B, V39, P133, DOI 10.1016/j.colsurfb.2003.12.002
   Kobayashi S, 2000, LANCET, V355, P1499, DOI 10.1016/S0140-6736(00)02164-4
   Kowalczyk P, 2001, J BIOMECH ENG-T ASME, V123, P396, DOI 10.1115/1.1392311
   Kruch S, 2007, J STRAIN ANAL ENG, V42, P215, DOI 10.1243/03093247JSA229
   KUIPER JH, 1992, RECENT ADVANCES IN COMPUTER METHODS IN BIOMECHANICS & BIOMEDICAL ENGINEERING, P76
   Kuiper JH, 1997, J BIOMECH ENG-T ASME, V119, P166, DOI 10.1115/1.2796076
   Kumar RS, 2004, INT J SOLIDS STRUCT, V41, P7399, DOI 10.1016/j.ijsolstr.2004.06.038
   Kurtz S, 2007, J BONE JOINT SURG AM, V89A, P780, DOI 10.2106/JBJS.F.00222
   Kurtz SM, 2011, CLIN ORTHOP RELAT R, V469, P2262, DOI 10.1007/s11999-011-1872-4
   Lefik M, 1996, ENG COMPUTATION, V13, P31, DOI 10.1108/02644409610128391
   Masters IG, 1996, COMPOS STRUCT, V35, P403, DOI 10.1016/S0263-8223(96)00054-2
   Matsui K, 2004, COMPUT STRUCT, V82, P593, DOI 10.1016/j.compstruc.2004.01.004
   Moen TC, 2011, CLIN ORTHOP RELAT R, V469, P382, DOI 10.1007/s11999-010-1500-8
   Murr LE, 2010, PHILOS T R SOC A, V368, P1999, DOI 10.1098/rsta.2010.0010
   Neumann DRP, 2010, J ARTHROPLASTY, V25, P700, DOI 10.1016/j.arth.2009.05.018
   Objet-Geometries I., 2011, OBJECT GEOMETRIES
   Pal B, 2009, P I MECH ENG H, V223, P471, DOI 10.1243/09544119JEIM488
   Parthasarathy J, 2010, J MECH BEHAV BIOMED, V3, P249, DOI 10.1016/j.jmbbm.2009.10.006
   Pellegrino C, 1999, INT J NUMER METH ENG, V46, P1609, DOI 10.1002/(SICI)1097-0207(19991210)46:10<1609::AID-NME716>3.0.CO;2-Q
   Rodrigues H, 2002, STRUCT MULTIDISCIP O, V24, P1, DOI 10.1007/s00158-002-0209-z
   Simone AE, 1998, ACTA MATER, V46, P2139, DOI 10.1016/S1359-6454(97)00421-7
   Stamp R, 2009, J MATER SCI-MATER M, V20, P1839, DOI 10.1007/s10856-009-3763-8
   SUZUKI K, 1991, COMPUT METHOD APPL M, V93, P291, DOI 10.1016/0045-7825(91)90245-2
   Thompson ID, 1998, P I MECH ENG H, V212, P127, DOI 10.1243/0954411981533908
   Trebse R, 2005, ACTA ORTHOP, V76, P169, DOI 10.1080/00016470510030535
   Viceconti M, 2006, J BIOMECH, V39, P1169, DOI 10.1016/j.jbiomech.2005.03.024
   Viceconti M, 2001, CLIN BIOMECH, V16, P765, DOI 10.1016/S0268-0033(01)00052-3
   Viceconti M, 2000, J BIOMECH, V33, P1611, DOI 10.1016/S0021-9290(00)00140-8
   Vichinsky EP, 1999, AM J HEMATOL, V62, P129, DOI 10.1002/(SICI)1096-8652(199911)62:3<129::AID-AJH1>3.0.CO;2-J
   Wang AJ, 2004, J ENG MATER-T ASME, V126, P137, DOI 10.1115/1.1646165
   Wang Hongqing V., 2005, THESIS GEORGIA I TEC
   Wang WX, 2006, COMPUT STRUCT, V84, P991, DOI 10.1016/j.compstruc.2006.02.013
   Warren WE, 2002, EUR J MECH A-SOLID, V21, P779, DOI 10.1016/S0997-7538(02)01236-6
   Watari F, 1997, COMPOS PART B-ENG, V28, P5, DOI 10.1016/S1359-8368(96)00021-2
   WEINANS H, 1992, J BIOMECH, V25, P1425, DOI 10.1016/0021-9290(92)90056-7
   WEINANS H, 1992, J ORTHOPAED RES, V10, P845, DOI 10.1002/jor.1100100614
   Yang SF, 2002, TISSUE ENG, V8, P1, DOI 10.1089/107632702753503009
   Zienkiewicz OC, 2005, FINITE ELEMENT METHOD FOR FLUID DYNAMICS, 6TH EDITION, P1
NR 79
TC 43
Z9 43
U1 3
U2 85
PU ASME
PI NEW YORK
PA TWO PARK AVE, NEW YORK, NY 10016-5990 USA
SN 0148-0731
J9 J BIOMECH ENG-T ASME
JI J. Biomech. Eng.-Trans. ASME
PD MAR
PY 2012
VL 134
IS 3
AR 031004
DI 10.1115/1.4006115
PG 10
WC Biophysics; Engineering, Biomedical
SC Biophysics; Engineering
GA 922XY
UT WOS:000302583200004
PM 22482684
DA 2018-10-19
ER

PT J
AU Pooyan, P
   Tannenbaum, R
   Garmestani, H
AF Pooyan, Parisa
   Tannenbaum, Rina
   Garmestani, Hamid
TI Mechanical behavior of a cellulose-reinforced scaffold in vascular
   tissue engineering
SO JOURNAL OF THE MECHANICAL BEHAVIOR OF BIOMEDICAL MATERIALS
LA English
DT Article; Proceedings Paper
CT 7th Symposium on Biological Materials Science (BMS)/Annual Meeting and
   Exhibition of the Minerals-Metals-and-Materials-Society (TMS)
CY FEB 27-MAR 03, 2011
CL San Diego, CA
SP Minerals, Met & Mat Soc (TMS)
DE Cellulose nanowhiskers; Renewable resources; Biomaterials; Polymer
   scaffold; Vascular tissue engineering; Fiber nanocomposite; Mechanical
   percolation
ID NANOCOMPOSITE MATERIALS; BLOOD-VESSEL; MICROBIAL CELLULOSE; WHISKERS;
   PERCOLATION; COMPOSITES; SURGERY; LATEX
AB Scaffolds constitute an essential structural component in tissue engineering of a vascular substitute for small grafts by playing a significant role in integrating the overall tissue constructs. The microstructure and mechanical properties of such scaffolds are important parameters to promote further cellular activities and neo-tissue development. Cellulose nanowhiskers (CNWs), an abundant, biocompatible material, could potentially constitute an acceptable candidate in scaffolding of a tissue-engineered vessel. Inspired by the advantages of cellulose and its derivatives, we have designed a biomaterial comprising CNWs embedded in a matrix of cellulose acetate propionate to fabricate a fully bio-based scaffold. To ensure uniform distribution, CNWs were delicately extracted from a multi-stage process and dispersed in an acetone suspension prior to the composite fabrication. Comparable to carbon nanotubes or kevlar, CNWs impart significant strength and directional rigidity even at 0.2 wt% and almost double that at only 3.0 wt%. To ensure the accuracy of our experimental data and to predict the unusual reinforcing effect of CNWs in a cellulose-based composite, homogenization schemes such as the mean field approach and the percolation technique were also investigated. Based on these comparisons, the tendency of CNWs to interconnect with one another through strong hydrogen bonding confirmed the formation of a three-dimensional rigid percolating network, fact which imparted an excellent mechanical stability to the entire structure at such low filler contents. Hence, our fibrous porous microstructure with improved mechanical properties could introduce a potential scaffold to withstand the physiological pressure and to mimic the profile features of native extracellular matrix in a human vessel. We believe that our nanohybrid design not only could expand the biomedical applications of renewable cellulose-based materials but also could provide a potential scaffold candidate in tissue engineering of small diameter grafts. (C) 2011 Elsevier Ltd. All rights reserved.
C1 [Tannenbaum, Rina] Boston Univ, Dept Mech Engn, Boston, MA 02215 USA.
   [Tannenbaum, Rina] Boston Univ, Dept Biomed Engn, Boston, MA USA.
   [Pooyan, Parisa] Georgia Inst Technol, George W Woodruff Sch Mech Engn, Atlanta, GA 30332 USA.
   [Pooyan, Parisa; Garmestani, Hamid] Georgia Inst Technol, Sch Mat Sci & Engn, Atlanta, GA 30332 USA.
RP Tannenbaum, R (reprint author), Boston Univ, Dept Mech Engn, Boston, MA 02215 USA.
EM rinatan@bu.edu
CR Angles MN, 2001, MACROMOLECULES, V34, P2921, DOI 10.1021/ma001555h
   BALBERG I, 1983, PHYS REV B, V28, P3799, DOI 10.1103/PhysRevB.28.3799
   Broadbent S.R., 1957, Proceedings of the Cambridge Philosophical Society, V53, P629
   Buryachenko V., 2007, MICROMECHANICS HETER
   Chazeau L, 1999, J APPL POLYM SCI, V71, P1797, DOI 10.1002/(SICI)1097-4628(19990314)71:11<1797::AID-APP9>3.0.CO;2-E
   Czaja W, 2006, BIOMATERIALS, V27, P145, DOI 10.1016/j.biomaterials.2005.07.035
   Czaja WK, 2007, BIOMACROMOLECULES, V8, P1, DOI 10.1021/bm060620d
   De Bartolo L, 2002, BIOMATERIALS, V23, P2485, DOI 10.1016/S0142-9612(01)00383-0
   DEGENNES PG, 1976, J PHYS LETT-PARIS, V37, pL1
   Dubief D, 1999, MACROMOLECULES, V32, P5765, DOI 10.1021/ma990274a
   Dufresne A, 1997, POLYM COMPOSITE, V18, P198, DOI 10.1002/pc.10274
   Dufresne A, 1999, MACROMOLECULES, V32, P7396, DOI 10.1021/ma990564r
   Entcheva E, 2004, BIOMATERIALS, V25, P5753, DOI 10.1016/j.biomaterials.2004.01.024
   FAVIER V, 1995, POLYM ADVAN TECHNOL, V6, P351, DOI 10.1002/pat.1995.220060514
   Favier V, 1997, POLYM ENG SCI, V37, P1732, DOI 10.1002/pen.11821
   GALGUT PN, 1990, BIOMATERIALS, V11, P561, DOI 10.1016/0142-9612(90)90078-5
   Gennes PG, 1979, SCALING CONCEPTS POL
   Gomes Guilherme da Silva, 2007, Mat. Res., V10, P469, DOI 10.1590/S1516-14392007000400023
   Hajji P, 1996, POLYM COMPOSITE, V17, P612, DOI 10.1002/pc.10651
   HALPIN JC, 1976, POLYM ENG SCI, V16, P344
   HALPIN JC, 1971, J COMPOS MATER, V5, P36, DOI 10.1177/002199837100500104
   HALPIN JC, 1972, J APPL PHYS, V43, P2235, DOI 10.1063/1.1661482
   HALPIN JC, 1969, J COMPOS MATER, V3, P720, DOI 10.1177/002199836900300416
   Helbert W, 1996, POLYM COMPOSITE, V17, P604, DOI 10.1002/pc.10650
   Hubbe M. A., 2008, BioResources, V3, P929
   Kakisis JD, 2005, J VASC SURG, V41, P349, DOI 10.1016/j.jvs.2004.12.026
   KINUGASA K, 1994, NEUROSURGERY, V34, P694, DOI 10.1227/00006123-199404000-00019
   Klemm D, 2001, PROG POLYM SCI, V26, P1561, DOI 10.1016/S0079-6700(01)00021-1
   Laghi I., 2007, CELLULOSE STRANDS
   Morin A, 2002, MACROMOLECULES, V35, P2190, DOI 10.1021/ma011493a
   Murugan R, 2007, TISSUE ENG, V13, P1845, DOI 10.1089/ten.2006.0078
   OUALI N, 1991, PLAST RUB COMPOS PRO, V16, P55
   Pooyan P.T., 2011, FABRICATION CE UNPUB
   Samir MASA, 2005, BIOMACROMOLECULES, V6, P612, DOI 10.1021/bm0493685
   Schumann D.A., 2005, ABSTRACTS PAPERS AM, V229, P152
   STAUFFER D, 1985, INTRO PERCOLATION TH
   Stevens MM, 2005, SCIENCE, V310, P1135, DOI 10.1126/science.1106587
   Takayanagi M., 1964, J POLYM SCI C, V5, P113, DOI DOI 10.1002/POLC.5070050111
   Temenoff J. S., 2006, BIOMATERIALS INTERSE
   Tsai S. W., 1967, COMP MAT WORKSH, P233
   Udhardt U.R.E., 2000, ABSTRACTS PAPERS AM, V219, P12
   WEINBERG CB, 1986, SCIENCE, V231, P397, DOI 10.1126/science.2934816
   Woo KM, 2007, BIOMATERIALS, V28, P335, DOI 10.1016/j.biomaterials.2006.06.013
   Xu CY, 2004, BIOMATERIALS, V25, P877, DOI 10.1016/S0142-9612(03)00593-3
   Zhang Z, 2004, BIOMATERIALS, V25, P177, DOI 10.1016/S0142-9612(03)00478-2
NR 45
TC 42
Z9 43
U1 1
U2 59
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 1751-6161
J9 J MECH BEHAV BIOMED
JI J. Mech. Behav. Biomed. Mater.
PD MAR
PY 2012
VL 7
SI SI
BP 50
EP 59
DI 10.1016/j.jmbbm.2011.09.009
PG 10
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 910YP
UT WOS:000301684800006
PM 22340684
DA 2018-10-19
ER

PT J
AU Yehezkeli, O
   Tel-Vered, R
   Wasserman, J
   Trifonov, A
   Michaeli, D
   Nechushtai, R
   Willner, I
AF Yehezkeli, Omer
   Tel-Vered, Ran
   Wasserman, Julian
   Trifonov, Alexander
   Michaeli, Dorit
   Nechushtai, Rachel
   Willner, Itamar
TI Integrated photosystem II-based photo-bioelectrochemical cells
SO NATURE COMMUNICATIONS
LA English
DT Article
ID SOLAR-ENERGY CONVERSION; SELF-ASSEMBLED MONOLAYERS; BIOFUEL CELLS;
   ENZYME ELECTRODES; GLUCOSE-OXIDASE; ARTIFICIAL PHOTOSYNTHESIS;
   PHOTOCATALYTIC PRODUCTION; REACTION CENTERS; GOLD ELECTRODE; REDOX
   ENZYMES
AB Photosynthesis is a sustainable process that converts light energy into chemical energy. Substantial research efforts are directed towards the application of the photosynthetic reaction centres, photosystems I and II, as active components for the light-induced generation of electrical power or fuel products. Nonetheless, no integrated photo-bioelectrochemical device that produces electrical power, upon irradiation of an aqueous solution that includes two inter-connected electrodes is known. Here we report the assembly of photobiofuel cells that generate electricity upon irradiation of biomaterial-functionalized electrodes in aqueous solutions. The cells are composed of electrically contacted photosystem II-functionalized photoanodes and an electrically wired bilirubin oxidase/carbon nanotubes-modified cathode. Illumination of the photoanodes yields the oxidation of water to O-2 and the transfer of electrons through the external circuit to the cathode, where O-2 is re-reduced to water.
C1 [Yehezkeli, Omer; Tel-Vered, Ran; Wasserman, Julian; Trifonov, Alexander; Willner, Itamar] Hebrew Univ Jerusalem, Inst Chem, Ctr Nanosci & Nanotechnol, IL-91904 Jerusalem, Israel.
   [Michaeli, Dorit; Nechushtai, Rachel] Hebrew Univ Jerusalem, Dept Plant Sci, Silberman Inst Life Sci, Minerva Ctr Biohybrid Complex Syst, IL-91904 Jerusalem, Israel.
RP Willner, I (reprint author), Hebrew Univ Jerusalem, Inst Chem, Ctr Nanosci & Nanotechnol, IL-91904 Jerusalem, Israel.
EM willnea@vms.huji.ac.il
FU European Research Council under the European Community [267574];
   Ministry of Science and Technology, Israel
FX This research is supported by the European Research Council under the
   European Community's Seventh Framework Programme (FP7/2007 2013)/ERC
   Advanced Grant agreement number 267574, NanoSensoMach project. O.Y.
   acknowledges the Levi Eshkol fellowship, The Ministry of Science and
   Technology, Israel.
CR Badura A, 2008, ELECTROANAL, V20, P1043, DOI 10.1002/elan.200804491
   Badura A, 2006, PHOTOCHEM PHOTOBIOL, V82, P1385, DOI 10.1562/2006-07-14-RC-969
   Badura A, 2011, ENERG ENVIRON SCI, V4, P3263, DOI 10.1039/c1ee01285a
   BARD AJ, 1995, ACCOUNTS CHEM RES, V28, P141, DOI 10.1021/ar00051a007
   Barton SC, 2004, CHEM REV, V104, P4867, DOI 10.1021/cr020719k
   Basshamj A., 1950, J BIOL CHEM, V185, P781
   Blankenship R.E, 2002, MOL MECH PHOTOSYNTHE
   Blankenship RE, 2011, SCIENCE, V332, P805, DOI 10.1126/science.1200165
   Broser M, 2010, J BIOL CHEM, V285, P26255, DOI 10.1074/jbc.M110.127589
   Buchner T. B., 2009, PHOTOSYNTHESIS THEOR
   CAUQUIL G, 1947, CR HEBD ACAD SCI, V225, P578, DOI 10.1002/hlca.19470300221
   Ferreira KN, 2004, SCIENCE, V303, P1831, DOI 10.1126/science.1093087
   Frasconi M, 2010, J AM CHEM SOC, V132, P9373, DOI 10.1021/ja102153f
   Fruk L, 2009, ANGEW CHEM INT EDIT, V48, P1550, DOI 10.1002/anie.200803098
   Gao F, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1000
   Garza LDL, 2003, J PHYS CHEM B, V107, P10252
   Gerard M, 2002, BIOSENS BIOELECTRON, V17, P345, DOI 10.1016/S0956-5663(01)00312-8
   Gratzel M, 2005, INORG CHEM, V44, P6841, DOI 10.1021/ic0508371
   GREENBAUM E, 1990, J PHYS CHEM-US, V94, P6151, DOI 10.1021/j100379a003
   Grimme RA, 2008, J AM CHEM SOC, V130, P6308, DOI 10.1021/ja800923y
   Gust D, 2001, ACCOUNTS CHEM RES, V34, P40, DOI 10.1021/ar9801301
   Ham MH, 2010, NAT CHEM, V2, P929, DOI [10.1038/nchem.822, 10.1038/NCHEM.822]
   Hambourger M, 2008, J AM CHEM SOC, V130, P2015, DOI 10.1021/ja077691k
   Hambourger M, 2009, CHEM SOC REV, V38, P25, DOI 10.1039/b800582f
   HELLER A, 1990, ACCOUNTS CHEM RES, V23, P128, DOI 10.1021/ar00173a002
   Heller A, 2004, PHYS CHEM CHEM PHYS, V6, P209, DOI 10.1039/b313149a
   HELLER A, 1992, J PHYS CHEM-US, V96, P3579, DOI 10.1021/j100188a007
   Iwuchukwu IJ, 2010, NAT NANOTECHNOL, V5, P73, DOI [10.1038/NNANO.2009.315, 10.1038/nnano.2009.315]
   Kalyanasundaram K, 2010, CURR OPIN BIOTECH, V21, P298, DOI 10.1016/j.copbio.2010.03.021
   Katz E, 1999, J ELECTROANAL CHEM, V479, P64, DOI 10.1016/S0022-0728(99)00425-8
   Lam KB, 2006, J MICROELECTROMECH S, V15, P1243, DOI 10.1109/JMEMS.2006.880296
   Lebedev N, 2006, J AM CHEM SOC, V128, P12044, DOI 10.1021/ja063367y
   Maly J, 2005, BIOSENS BIOELECTRON, V21, P923, DOI 10.1016/j.bios.2005.02.013
   Mano N, 2002, J AM CHEM SOC, V124, P12962, DOI 10.1021/ja028514g
   Meunier CF, 2011, CHEMCATCHEM, V3, P476, DOI 10.1002/cctc.201000410
   Millsaps JF, 2001, PHOTOCHEM PHOTOBIOL, V73, P630, DOI 10.1562/0031-8655(2001)073<0630:NPPPOH>2.0.CO;2
   Pessarakli M., 2005, HDB PHOTOSYNTHESIS
   RENGER G, 2008, PRIMARY PROCESSES PH
   Ringeisen BR, 2006, ENVIRON SCI TECHNOL, V40, P2629, DOI 10.1021/es052254w
   Rosenbaum M, 2010, CURR OPIN BIOTECH, V21, P259, DOI 10.1016/j.copbio.2010.03.010
   SCHUHMANN W, 1991, J AM CHEM SOC, V113, P1394, DOI 10.1021/ja00004a048
   Tender LM, 2002, NAT BIOTECHNOL, V20, P821, DOI 10.1038/nbt716
   Terasaki N, 2009, ANGEW CHEM INT EDIT, V48, P1585, DOI 10.1002/anie.200805748
   Trammell SA, 2004, BIOSENS BIOELECTRON, V19, P1649, DOI 10.1016/j.bios.2003.12.034
   Tsujimura S, 2001, ENZYME MICROB TECH, V29, P225, DOI 10.1016/S0141-0229(01)00374-X
   Utschig LM, 2011, J PHYS CHEM LETT, V2, P236, DOI 10.1021/jz101728v
   Wang J, 2008, CHEM REV, V108, P814, DOI 10.1021/cr068123a
   Willner I, 1996, J AM CHEM SOC, V118, P10321, DOI 10.1021/ja9608611
   WILLNER I, 1993, ADV MATER, V5, P912, DOI 10.1002/adma.19930051206
   Willner I, 2009, FUEL CELLS, V9, P7, DOI 10.1002/fuce.200800115
   Xiao Y, 2003, SCIENCE, V299, P1877, DOI 10.1126/science.1080664
   Yan YM, 2007, CHEM-EUR J, V13, P10168, DOI 10.1002/chem.200700806
   Yano J, 2006, SCIENCE, V314, P821, DOI 10.1126/science.1128186
   Yehezkeli O, 2011, ACS NANO, V5, P2385, DOI 10.1021/nn200313t
   Yehezkeli O, 2010, J PHYS CHEM B, V114, P14383, DOI 10.1021/jp100454u
   Yehezkeli O, 2010, ELECTROANAL, V22, P1817, DOI 10.1002/elan.201000197
   Yehezkeli O, 2009, CHEM-EUR J, V15, P2674, DOI 10.1002/chem.200801609
   Yella A, 2011, SCIENCE, V334, P629, DOI 10.1126/science.1209688
   Youngblood WJ, 2009, J AM CHEM SOC, V131, P926, DOI 10.1021/ja809108y
   Zayats M, 2008, ELECTROANAL, V20, P583, DOI 10.1002/elan.200704128
NR 60
TC 116
Z9 118
U1 5
U2 189
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 2041-1723
J9 NAT COMMUN
JI Nat. Commun.
PD MAR
PY 2012
VL 3
AR 742
DI 10.1038/ncomms1741
PG 7
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA 923PB
UT WOS:000302630100031
PM 22415833
OA DOAJ Gold
DA 2018-10-19
ER

PT J
AU Costa, DO
   Dixon, SJ
   Rizkalla, AS
AF Costa, Daniel O.
   Dixon, S. Jeffrey
   Rizkalla, Amin S.
TI One- and Three-Dimensional Growth of Hydroxyapatite Nanowires during
   Sol-Gel-Hydrothermal Synthesis
SO ACS APPLIED MATERIALS & INTERFACES
LA English
DT Article
DE hydrothermal; hydroxyapatite; nanorods; nanowires; polycaprolactone;
   sol-gel
ID STRUCTURAL EVOLUTION; PHASE EVOLUTION; ASPECT-RATIO; BONE; CRYSTALS;
   WHISKERS; NANOPARTICLES; MORPHOLOGIES; MECHANISMS; FACILE
AB Nanoscale hydroxyapatite (HA) is an optimal candidate biomaterial for bone tissue engineering because of its bioactive and osteoconductive properties. In this study, micro-and nanoscale HA particles with rod- and wirelike morphology were synthesized by a novel sol gel hydrothermal process. Sol gel chemistry was used to produce a dry gel containing amorphous calcium phosphate (ACP), which was used as a precursor material in a hydrothermal process. The sol-gel-hydrothermal products were characterized by scanning electron microscopy (SEM), X-ray diffraction (XRD), and Fourier transform infrared spectroscopy (FTIR) to determine particle morphology, crystal structure, and the presence of chemical functional groups. A pure HA crystal was synthesized, which underwent both one- and three-dimensional growth, resulting in tunable microrod and nanorod, and wire morphologies. The effects of solution pH and reaction time on particle diameter and length were assessed. Particle diameter ranged from 25 to 800 nm and decreased with an increase in solution pH, whereas both particle length and diameter increased as the hydrothermal process was prolonged. Nanowire HA powders (10-50 wt %) were mixed with poly(e-caprolactone) (PCL) to produce PCL/HA composites. Fracture surfaces of PCL/HA composites showed a well-dispersed and homogeneous distribution of HA nanowires within the PCL matrix. Mechanical testing revealed a significant (p < 0.05) increase in the Young's and compressive moduli of PCL/HA composites compared to PCL alone, with 50 wt % HA producing a 3-fold increase in Young's modulus from 193 to 665 MPa and 2-fold increase in compressive modulus from 230 to 487 MPa. These HA nanowires can be used to reinforce polymer composites and are excellent biomaterials for tissue engineering of bone.
C1 [Costa, Daniel O.; Rizkalla, Amin S.] Univ Western Ontario, Dept Chem & Biochem Engn, Fac Engn, London, ON N6A 5B9, Canada.
   [Dixon, S. Jeffrey] Univ Western Ontario, Schulich Sch Med & Dent, Dept Physiol & Pharmacol, London, ON N6A 5C1, Canada.
RP Rizkalla, AS (reprint author), Univ Western Ontario, Dept Chem & Biochem Engn, Fac Engn, London, ON N6A 5B9, Canada.
EM arizkalla@eng.uwo.ca
RI Dixon, S./G-3657-2013; Rizkalla, Amin/D-8845-2015
OI Dixon, S./0000-0001-9162-1686; Rizkalla, Amin/0000-0003-0548-3817
FU Natural Sciences and Engineering Research Council of Canada (NSERC);
   Canadian Institutes of Health Research (CIHR)
FX These studies were funded by the Natural Sciences and Engineering
   Research Council of Canada (NSERC) and the Canadian Institutes of Health
   Research (CIHR). D. O. Costa was supported in part by the Joint Motion
   Program - A CIHR Training Program in Musculoskeletal Health Research and
   Leadership. SEM micrographs and EDX analysis were performed by Dr. Todd
   Simpson and Tim Goldhawk of the Western Nanofabrication Facility.
   Poly(e-caprolactone) was generously donated by Solvay Chemicals Inc. We
   thank Bedilu Allo for valuable advice and stimulating discussion.
CR Cao MH, 2004, LANGMUIR, V20, P4784, DOI 10.1021/la0498197
   Chen JD, 2007, BIOMATERIALS, V28, P2275, DOI 10.1016/j.biomaterials.2007.01.033
   Chou YF, 2004, BIOMATERIALS, V25, P5323, DOI 10.1016/j.biomaterials.2003.12.037
   Chung EJ, 2011, J BIOMED MATER RES A, V96A, P29, DOI 10.1002/jbm.a.32953
   Cullity B. D., 1967, ELEMENTS XRAY DIFFRA, P514
   Eshtiagh-Hosseini H, 2007, MATER CHEM PHYS, V106, P310, DOI 10.1016/j.matchemphys.2007.06.002
   Fathi MH, 2007, MATER LETT, V61, P3978, DOI 10.1016/j.matlet.2007.01.028
   Gibson IR, 2002, J BIOMED MATER RES, V59, P697, DOI 10.1002/jbm.10044
   Hott M, 1997, J BIOMED MATER RES, V37, P508, DOI 10.1002/(SICI)1097-4636(19971215)37:4<508::AID-JBM9>3.0.CO;2-P
   Hou YD, 2007, J AM CERAM SOC, V90, P1738, DOI 10.1111/j.1551-2916.2007.01657.x
   Joint Committee on Chemical Analysis by Powder Diffraction Methods, 1960, POWD DIFFR FIL
   Kalinkin AM, 2005, INORG MATER+, V41, P1073, DOI 10.1007/s10789-005-0263-1
   Kim TG, 2005, INORG CHEM, V44, P9895, DOI 10.1021/ic051013m
   Koutsopoulos S, 2002, J BIOMED MATER RES, V62, P600, DOI 10.1002/jbm.10280
   Lalena J.N., 2008, INORGANIC MAT SYNTHE, Viii, P303
   LeGeros R Z, 1991, Monogr Oral Sci, V15, P1
   Lickorish D, 2007, BIOMATERIALS, V28, P1495, DOI 10.1016/j.biomaterials.2006.11.025
   Lin KL, 2011, NANOSCALE, V3, P3052, DOI 10.1039/c1nr10334b
   Lin KL, 2011, CRYSTENGCOMM, V13, P4850, DOI 10.1039/c0ce00835d
   Liu DM, 2001, BIOMATERIALS, V22, P1721, DOI 10.1016/S0142-9612(00)00332-X
   Liu DM, 2002, BIOMATERIALS, V23, P1679, DOI 10.1016/S0142-9612(01)00295-2
   Liu DM, 2002, BIOMATERIALS, V23, P1227, DOI 10.1016/S0142-9612(01)00242-3
   Liu TY, 2004, J BIOMED MATER RES B, V71B, P116, DOI 10.1002/jbm.b.30072
   Mizutani Y, 2005, J EUR CERAM SOC, V25, P3181, DOI 10.1016/j.jeurceramsoc.2004.07.028
   Muller FA, 2007, J AM CERAM SOC, V90, P3694, DOI 10.1111/J.1551-2916.2007.01967.x
   Neira IS, 2010, ACS APPL MATER INTER, V2, P3276, DOI 10.1021/am100710b
   Neira IS, 2009, CRYST GROWTH DES, V9, P466, DOI 10.1021/cg800738a
   Okuda T, 2008, BIOMATERIALS, V29, P2719, DOI 10.1016/j.biomaterials.2008.03.028
   Peng ZA, 2001, J AM CHEM SOC, V123, P1389, DOI 10.1021/ja0027766
   Roeder RK, 2003, J BIOMED MATER RES A, V67A, P801, DOI 10.1002/jbm.a.10140
   Sun F, 2011, ACTA BIOMATER, V7, P3813, DOI 10.1016/j.actbio.2011.07.002
   Sun YX, 2006, J PHYS CHEM SOLIDS, V68, P373, DOI 10.1016/j.jpcs.2006.11.026
   Wei GB, 2004, BIOMATERIALS, V25, P4749, DOI 10.1016/j.biomaterials.2003.12.005
   Wei K, 2006, J MACROMOL SCI A, V43, P1531, DOI 10.1080/10601320600896785
   Yu SH, 2003, ADV FUNCT MATER, V13, P639, DOI 10.1002/adfm.200304373
   Zhang CM, 2009, CRYST GROWTH DES, V9, P2725, DOI 10.1021/cg801353n
   Zhang HQ, 2010, ACTA BIOMATER, V6, P3216, DOI 10.1016/j.actbio.2010.02.011
   Zhou H, 2011, ACTA BIOMATER, V7, P2769, DOI 10.1016/j.actbio.2011.03.019
NR 38
TC 68
Z9 71
U1 8
U2 119
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 1944-8244
J9 ACS APPL MATER INTER
JI ACS Appl. Mater. Interfaces
PD MAR
PY 2012
VL 4
IS 3
BP 1490
EP 1499
DI 10.1021/am201735k
PG 10
WC Nanoscience & Nanotechnology; Materials Science, Multidisciplinary
SC Science & Technology - Other Topics; Materials Science
GA 914RD
UT WOS:000301968400049
PM 22296410
DA 2018-10-19
ER

PT J
AU Dupont, KM
   Boerckel, JD
   Stevens, HY
   Diab, T
   Kolambkar, YM
   Takahata, M
   Schwarz, EM
   Guldberg, RE
AF Dupont, Kenneth M.
   Boerckel, Joel D.
   Stevens, Hazel Y.
   Diab, Tamim
   Kolambkar, Yash M.
   Takahata, Masahiko
   Schwarz, Edward M.
   Guldberg, Robert E.
TI Synthetic scaffold coating with adeno-associated virus encoding BMP2 to
   promote endogenous bone repair
SO CELL AND TISSUE RESEARCH
LA English
DT Article
DE Synthetic scaffold; Large bone defect; Self-complementary
   adeno-associated virus (scAAV); Bone morphogenetic protein-2 (BMP2);
   Stem cells; Human
ID MESENCHYMAL STEM-CELLS; COLLAGEN-MIMETIC PEPTIDE; MORPHOGENETIC
   PROTEINS; AMNIOTIC-FLUID; DEFECT REPAIR; GENE DELIVERY; RHBMP-2;
   ALLOGRAFTS; THERAPY; MARROW
AB Biomaterial scaffolds functionalized to stimulate endogenous repair mechanisms via the incorporation of osteogenic cues offer a potential alternative to bone grafting for the treatment of large bone defects. We first quantified the ability of a self-complementary adeno-associated viral vector encoding bone morphogenetic protein 2 (scAAV2.5-BMP2) to enhance human stem cell osteogenic differentiation in vitro. In two-dimensional culture, scAAV2.5-BMP2-transduced human mesenchymal stem cells (hMSCs) displayed significant increases in BMP2 production and alkaline phosphatase activity compared with controls. hMSCs and human amniotic-fluid-derived stem cells (hAFS cells) seeded on scAAV2.5-BMP2-coated three-dimensional porous polymer Poly(epsilon-caprolactone) (PCL) scaffolds also displayed significant increases in BMP2 production compared with controls during 12 weeks of culture, although only hMSC-seeded scaffolds displayed significantly increased mineral formation. PCL scaffolds coated with scAAV2.5-BMP2 were implanted into critically sized immunocompromised rat femoral defects, both with or without pre-seeding of hMSCs, representing ex vivo and in vivo gene therapy treatments, respectively. After 12 weeks, defects treated with acellular scAAV2.5-BMP2-coated scaffolds displayed increased bony bridging and had significantly higher bone ingrowth and mechanical properties compared with controls, whereas defects treated with scAAV2.5-BMP2 scaffolds pre-seeded with hMSCs failed to display significant differences relative to controls. When pooled, defect treatment with scAAV2.5-BMP2-coated scaffolds, both with or without inclusion of pre-seeded hMSCs, led to significant increases in defect mineral formation at all time points and increased mechanical properties compared with controls. This study thus presents a novel acellular bone-graft-free endogenous repair therapy for orthotopic tissue-engineered bone regeneration.
C1 [Dupont, Kenneth M.; Boerckel, Joel D.; Stevens, Hazel Y.; Diab, Tamim; Kolambkar, Yash M.; Guldberg, Robert E.] Georgia Inst Technol, Parker H Petit Inst Bioengn & Biosci, Atlanta, GA 30332 USA.
   [Dupont, Kenneth M.; Boerckel, Joel D.; Stevens, Hazel Y.; Diab, Tamim; Guldberg, Robert E.] Georgia Inst Technol, George W Woodruff Sch Mech Engn, Atlanta, GA 30332 USA.
   [Dupont, Kenneth M.] Exponent Failure Anal Associates, Philadelphia, PA 19104 USA.
   [Kolambkar, Yash M.; Guldberg, Robert E.] Georgia Inst Technol, Wallace H Coulter Dept Biomed Engn, Atlanta, GA 30332 USA.
   [Takahata, Masahiko; Schwarz, Edward M.] Univ Rochester, Sch Med & Dent, Ctr Musculoskeletal Res, Rochester, NY 14642 USA.
RP Guldberg, RE (reprint author), Georgia Inst Technol, Parker H Petit Inst Bioengn & Biosci, 315 Ferst Dr, Atlanta, GA 30332 USA.
EM kennethmdupont@yahoo.com; robert.guldberg@me.gatech.edu
RI Boerckel, Joel/A-7223-2015; Takahata, Masahiko/E-1929-2012
FU National Institutes of Health [R01 AR051336]; National Institutes of
   Health PHS [DE19902/AR54041]; Musculoskeletal Transplant Foundation
FX Funding was provided by National Institutes of Health Grant R01 AR051336
   and PHS Awards DE19902/AR54041 and by a Musculoskeletal Transplant
   Foundation grant.
CR Arinzeh TL, 2003, J BONE JOINT SURG AM, V85A, P1927, DOI 10.2106/00004623-200310000-00010
   Awad HA, 2007, TISSUE ENG, V13, P1973, DOI 10.1089/ten.2006.0107
   BERREY BH, 1990, J BONE JOINT SURG AM, V72A, P825, DOI 10.2106/00004623-199072060-00005
   Betz OB, 2006, J BONE JOINT SURG AM, V88A, P355, DOI 10.2106/JBJS.E.00464
   Bucholz RW, 2002, CLIN ORTHOP RELAT R, P44
   Burastero G, 2010, BONE, V47, P117, DOI 10.1016/j.bone.2010.03.023
   Cahill KS, 2009, JAMA-J AM MED ASSOC, V302, P58, DOI 10.1001/jama.2009.956
   Chen D, 2004, GROWTH FACTORS, V22, P233, DOI 10.1080/08977190412331279890
   De Coppi P, 2007, NAT BIOTECHNOL, V25, P100, DOI 10.1038/nbt1274
   Delo DM, 2006, METHOD ENZYMOL, V419, P426, DOI 10.1016/S0076-6879(06)19017-5
   Dupont KM, 2010, P NATL ACAD SCI USA, V107, P3305, DOI 10.1073/pnas.0905444107
   Einhorn TA, 2003, J BONE JOINT SURG AM, V85A, P82, DOI 10.2106/00004623-200300003-00014
   Hutmacher DW, 2000, BIOMATERIALS, V21, P1169
   Ito H, 2005, NAT MED, V11, P291, DOI 10.1038/nm1190
   Jager M, 2007, J BONE MINER RES, V22, P1224, DOI 10.1359/JBMR.070414
   Kalfas I H, 2001, Neurosurg Focus, V10, pE1
   Kim SJ, 2007, BIOCHEM BIOPH RES CO, V360, P573, DOI 10.1016/j.bbrc.2007.06.081
   Koefoed M, 2005, MOL THER, V12, P212, DOI 10.1016/j.ymthe.2005.02.026
   Kolambkar YM, 2010, BIOMATERIALS, V32, P65
   Kumar S, 2010, MOL THER, V18, P1026, DOI 10.1038/mt.2009.315
   Kutner M, 2005, APPL LINEAR STAT MOD
   Le Blanc K, 2006, CURR OPIN IMMUNOL, V18, P586, DOI 10.1016/j.coi.2006.07.004
   LEE SC, 1994, J BIOMED MATER RES, V28, P1149, DOI 10.1002/jbm.820281005
   McCarty DM, 2001, GENE THER, V8, P1248, DOI 10.1038/sj.gt.3301514
   Meijer G.J., 2007, PLOS MED, V4, pe9, DOI DOI 10.1371/JOURNAL.PMED.0040009
   Mroz TE, 2008, J AM ACAD ORTHOP SUR, V16, P559, DOI 10.5435/00124635-200810000-00001
   Oest ME, 2007, J ORTHOP RES, V25, P941, DOI 10.1002/jor.20372
   Ohura K, 1999, J BIOMED MATER RES, V44, P168, DOI 10.1002/(SICI)1097-4636(199902)44:2<168::AID-JBM7>3.0.CO;2-4
   Peister A, 2009, TISSUE ENG PT A, V15, P3129, DOI [10.1089/ten.tea.2008.0536, 10.1089/ten.TEA.2008.0536]
   Peister A, 2008, BIO-MED MATER ENG, V18, P241, DOI 10.3233/BME-2008-0532
   Rabinowitz JE, 2004, J VIROL, V78, P4421, DOI 10.1128/JVI.78.9.4421-4432.2004
   Rai B, 2004, BIOMATERIALS, V25, P5499, DOI 10.1016/j.biomaterials.2004.01.007
   Rai B, 2007, J BIOMED MATER RES A, V81A, P888, DOI 10.1002/jbm.a.31142
   Reyes CD, 2007, BIOMATERIALS, V28, P3228, DOI 10.1016/j.biomaterials.2007.04.003
   Reyes CD, 2003, J BIOMED MATER RES A, V65A, P511, DOI 10.1002/jbm.a.10550
   Reyes CD, 2004, J BIOMED MATER RES A, V69A, P591, DOI 10.1002/jbm.a.30034
   Saito N, 2005, ADV DRUG DELIVER REV, V57, P1037, DOI 10.1016/j.addr.2004.12.016
   Schwarz EM, 2000, CLIN ORTHOP RELAT R, pS31
   Sekiya I, 2002, STEM CELLS, V20, P530, DOI 10.1634/stemcells.20-6-530
   Tseng SS, 2008, J BONE JOINT SURG AM, V90A, P92, DOI 10.2106/JBJS.G.01192
   Werntz JR, 1996, J ORTHOP RES, V14, P85, DOI 10.1002/jor.1100140115
   Wojtowicz AM, 2010, BIOMATERIALS, V31, P2574, DOI 10.1016/j.biomaterials.2009.12.008
   Wozney JM, 1998, CLIN ORTHOP RELAT R, P26
   Xiao X, 1998, J VIROL, V72, P2224
   YASKO AW, 1992, J BONE JOINT SURG AM, V74A, P659, DOI 10.2106/00004623-199274050-00005
   Yazici C, 2011, MOL THER IN PRESS
   Yazici C, 2008, BIOMATERIALS, V29, P3882, DOI 10.1016/j.biomaterials.2008.06.007
   Younger E M, 1989, J Orthop Trauma, V3, P192, DOI 10.1097/00005131-198909000-00002
   Zhang C, 2010, ACTA PHARMACOL SIN, V31, P821, DOI 10.1038/aps.2010.67
   Zhang W, 2007, TRANSPL P, V39, P3404, DOI 10.1016/j.transproceed.2007.06.092
NR 50
TC 34
Z9 38
U1 0
U2 23
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 0302-766X
J9 CELL TISSUE RES
JI Cell Tissue Res.
PD MAR
PY 2012
VL 347
IS 3
BP 575
EP 588
DI 10.1007/s00441-011-1197-3
PG 14
WC Cell Biology
SC Cell Biology
GA 916YG
UT WOS:000302138500008
PM 21695398
OA Green Accepted
DA 2018-10-19
ER

PT J
AU Nie, HM
   Lee, CH
   Tan, JL
   Lu, CY
   Mendelson, A
   Chen, M
   Embree, MC
   Kong, KM
   Shah, B
   Wang, S
   Cho, SK
   Mao, JJ
AF Nie, Hemin
   Lee, Chang Hun
   Tan, Jiali
   Lu, Chuanyong
   Mendelson, Avital
   Chen, Mo
   Embree, Mildred C.
   Kong, Kimi
   Shah, Bhranti
   Wang, Shuang
   Cho, Shoko
   Mao, Jeremy J.
TI Musculoskeletal tissue engineering by endogenous stem/progenitor cells
SO CELL AND TISSUE RESEARCH
LA English
DT Review
DE Cell delivery; Cell homing; Progenitor cells; Stem cells; Tissue
   engineering; Tissue regeneration
ID MESENCHYMAL STEM-CELLS; MARROW STROMAL CELLS; STIMULATE CHEMOTACTIC
   MIGRATION; HUMAN ARTICULAR CHONDROCYTES; HEPATOCYTE GROWTH-FACTOR;
   BONE-MARROW; PROGENITOR CELLS; MORPHOGENETIC PROTEINS; SKELETAL-MUSCLE;
   DIAMOND CONCEPT
AB From its inception, tissue engineering has had three tenets: cells, biomaterial scaffolds and signaling molecules. Among the triad, cells are the center piece, because cells are the building blocks of tissues. For decades, cell therapies have focused on the procurement, manipulation and delivery of healthy cells for the treatment of diseases or trauma. Given the complexity and potential high cost of cell delivery, there is recent and surging interest to orchestrate endogenous cells for tissue regeneration. Biomaterial scaffolds are vital for many but not all, tissue-engineering applications and serve to accommodate or promote multiple cellular functions. Signaling molecules can be produced by transplanted cells or endogenous cells, or delivered specifically to regulate cell functions. This review highlights recent work in tissue engineering and cell therapies, with a focus on harnessing the capacity of endogenous cells as an alternative or adjunctive approach for tissue regeneration.
C1 [Nie, Hemin; Lee, Chang Hun; Tan, Jiali; Lu, Chuanyong; Mendelson, Avital; Chen, Mo; Embree, Mildred C.; Kong, Kimi; Shah, Bhranti; Wang, Shuang; Cho, Shoko; Mao, Jeremy J.] Columbia Univ, TERML, Med Ctr, New York, NY 10032 USA.
RP Mao, JJ (reprint author), Columbia Univ, TERML, Med Ctr, 630 W 168 St,PH7E, New York, NY 10032 USA.
EM jmao@columbia.edu
RI Nie, Hemin/F-4295-2012
OI Nie, Hemin/0000-0002-3657-7333
FU NIH [RC2DEDE020767, R01EB009663, R01DE018248]
FX We thank Fen Guo and Jackie Melendez for technical and administrative
   assistance. Effort in the composition of this article is partially
   funded by NIH grants RC2DEDE020767, R01EB009663 and R01DE018248.
CR Agrawal V, 2010, P NATL ACAD SCI USA, V107, P3351, DOI 10.1073/pnas.0905851106
   Atala A, 2006, LANCET, V367, P1241, DOI 10.1016/S0140-6736(06)68438-9
   Barbash IM, 2003, CIRCULATION, V108, P863, DOI 10.1161/01.CIR.0000084828.50310.6A
   Belema-Bedada F, 2008, CELL STEM CELL, V2, P566, DOI 10.1016/j.stem.2008.03.003
   BRITTBERG M, 1994, NEW ENGL J MED, V331, P889, DOI 10.1056/NEJM199410063311401
   Bruder SP, 1999, CLIN ORTHOP RELAT R, pS68
   Chang C, 2003, OSTEOARTHR CARTILAGE, V11, P603, DOI 10.1016/S1063-4584(03)00087-6
   Chen JL, 2001, STROKE, V32, P1005, DOI 10.1161/01.STR.32.4.1005
   De Coppi P, 2007, NAT BIOTECHNOL, V25, P100, DOI 10.1038/nbt1274
   Dellavalle A, 2007, NAT CELL BIOL, V9, P255, DOI 10.1038/ncb1542
   El Tamer MK, 2009, J TISSUE ENG REGEN M, V3, P327, DOI 10.1002/term.173
   Fiedler J, 2006, BIOCHEM BIOPH RES CO, V345, P1177, DOI 10.1016/j.bbrc.2006.05.034
   Fiedler J, 2005, BIOCHEM BIOPH RES CO, V334, P561, DOI 10.1016/j.bbrc.2005.06.116
   Fiedler J, 2004, J CELL BIOCHEM, V93, P990, DOI 10.1002/jcb.20219
   Fiedler J, 2002, J CELL BIOCHEM, V87, P305, DOI 10.1002/jcb.10309
   Fodor William L, 2003, Reprod Biol Endocrinol, V1, P102, DOI 10.1186/1477-7827-1-102
   Fox JM, 2007, BRIT J HAEMATOL, V137, P491, DOI 10.1111/j.1365-2141.2007.06610.x
   Frenkel SR, 1996, ARTHRITIS RHEUM, V39, P1905, DOI 10.1002/art.1780391118
   FRIEDENS.AJ, 1966, J EMBRYOL EXP MORPH, V16, P381
   FRIEDENSTEIN AJ, 1968, TRANSPLANTATION, V6, P230, DOI 10.1097/00007890-196803000-00009
   Fujita T, 2004, J CELL BIOL, V166, P85, DOI 10.1083/jcb.200401138
   Gao Jizong, 2002, Tissue Engineering, V8, P827, DOI 10.1089/10763270260424187
   Giannoudis PV, 2008, INJURY, V39, pS5, DOI 10.1016/S0020-1383(08)70010-X
   Giannoudis PV, 2007, INJURY, V38, pS3, DOI 10.1016/S0020-1383(08)70003-2
   Giannoudis PV, 2007, INJURY, V38, pS1, DOI 10.1016/j.injury.2007.02.004
   Gojo S, 2003, EXP CELL RES, V288, P51, DOI 10.1016/S0014-4827(03)00132-0
   Gronthos S, 2002, J DENT RES, V81, P531, DOI 10.1177/154405910208100806
   Guilak F, 2006, J CELL PHYSIOL, V206, P229, DOI 10.1002/jcp.20463
   Guilak F, 2001, CLIN ORTHOP RELAT R, pS295
   Hidaka C, 2006, CELL TISSUE RES, V323, P127, DOI 10.1007/s00441-005-0050-y
   Hofstetter CP, 2002, P NATL ACAD SCI USA, V99, P2199, DOI 10.1073/pnas.042678299
   Imitola J, 2004, P NATL ACAD SCI USA, V101, P18117, DOI 10.1073/pnas.0408258102
   Jackson KA, 2001, J CLIN INVEST, V107, P1395, DOI 10.1172/JCI12150
   Jain RK, 2005, NAT BIOTECHNOL, V23, P821, DOI 10.1038/nbt0705-821
   Jiang CC, 2007, J ORTHOP RES, V25, P1277, DOI 10.1002/jor.20442
   Karp JM, 2009, CELL STEM CELL, V4, P206, DOI 10.1016/j.stem.2009.02.001
   Kirilak Y, 2006, INT J MOL MED, V17, P551
   Koike H, 2003, FASEB J, V17, P779, DOI 10.1096/fj.02-0754fje
   Kopen GC, 1999, P NATL ACAD SCI USA, V96, P10711, DOI 10.1073/pnas.96.19.10711
   Laird DJ, 2008, CELL, V132, P612, DOI 10.1016/j.cell.2008.01.041
   LANGER R, 1993, SCIENCE, V260, P920, DOI 10.1126/science.8493529
   Lee CH, 2010, J CLIN INVEST, V120, P3340, DOI 10.1172/JCI43230
   Lee CH, 2010, LANCET, V376, P440, DOI 10.1016/S0140-6736(10)60668-X
   Lee OK, 2004, BLOOD, V103, P1669, DOI 10.1182/blood-2003-05-1670
   Levenberg S, 2005, NAT BIOTECHNOL, V23, P879, DOI 10.1038/nbt1109
   Ponte AL, 2007, STEM CELLS, V25, P1737, DOI 10.1634/stemcells.2007-0054
   Mahmood A, 2003, NEUROSURGERY, V53, P697, DOI 10.1227/01.NEU.0000079333.61863.AA
   Maniwa S, 2001, ACTA ORTHOP SCAND, V72, P299, DOI 10.1080/00016470152846664
   Meng ER, 2008, STEM CELLS DEV, V17, P805, DOI 10.1089/scd.2008.0276
   Mishima Y, 2008, J ORTHOP RES, V26, P1407, DOI 10.1002/jor.20668
   Nakashima M, 2003, NAT BIOTECHNOL, V21, P1025, DOI 10.1038/nbt864
   Noh MJ, 2010, CYTOTHERAPY, V12, P384, DOI 10.3109/14653240903470639
   Ortiz LA, 2003, P NATL ACAD SCI USA, V100, P8407, DOI 10.1073/pnas.1432929100
   Ott HC, 2008, NAT MED, V14, P213, DOI 10.1038/nm1684
   Ozaki Y, 2007, STEM CELLS DEV, V16, P119, DOI 10.1089/scd.2006.0032
   Pangarkar N, 2010, REGEN MED, V5, P823, DOI 10.2217/RME.10.66
   Pelttari K, 2008, ARTHRITIS RHEUM, V58, P467, DOI 10.1002/art.23302
   Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143
   Reddi AH, 1998, NAT BIOTECHNOL, V16, P247, DOI 10.1038/nbt0398-247
   Richardson TP, 2001, NAT BIOTECHNOL, V19, P1029, DOI 10.1038/nbt1101-1029
   Richter W, 2009, J INTERN MED, V266, P390, DOI 10.1111/j.1365-2796.2009.02153.x
   Robey PG, 2011, TISSUE ENG PART B-RE, V17, P423, DOI 10.1089/ten.teb.2011.0199
   Scotti C, 2010, P NATL ACAD SCI USA, V107, P7251, DOI 10.1073/pnas.1000302107
   Seale P, 2001, DEV CELL, V1, P333, DOI 10.1016/S1534-5807(01)00049-1
   TAKEBAYASHI T, 1995, J CELL BIOL, V129, P1411, DOI 10.1083/jcb.129.5.1411
   Uchida K, 2007, J ORTHOP SCI, V12, P484, DOI 10.1007/s00776-007-1159-5
   URIST MR, 1983, SCIENCE, V220, P680, DOI 10.1126/science.6403986
   Warnke PH, 2004, LANCET, V364, P766, DOI 10.1016/S0140-6736(04)16935-3
   Weissman IL, 2006, NATURE, V439, P145, DOI 10.1038/439145a
   Weissman IL, 2002, NEW ENGL J MED, V346, P1576, DOI 10.1056/NEJMsb020693
   Woodruff MA, 2010, PROG POLYM SCI, V35, P1217, DOI 10.1016/j.progpolymsci.2010.04.002
   Zuk PA, 2002, MOL BIOL CELL, V13, P4279, DOI 10.1091/mbc.E02-02-0105
NR 72
TC 17
Z9 18
U1 1
U2 29
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 0302-766X
EI 1432-0878
J9 CELL TISSUE RES
JI Cell Tissue Res.
PD MAR
PY 2012
VL 347
IS 3
BP 665
EP 676
DI 10.1007/s00441-012-1339-2
PG 12
WC Cell Biology
SC Cell Biology
GA 916YG
UT WOS:000302138500015
PM 22382390
DA 2018-10-19
ER

PT J
AU Turner, NJ
   Badylak, SF
AF Turner, Neill J.
   Badylak, Stephen F.
TI Regeneration of skeletal muscle
SO CELL AND TISSUE RESEARCH
LA English
DT Review
DE Skeletal muscle; Repair; Stem cells; Microenvironment; Inflammation
ID HEPATOCYTE GROWTH-FACTOR; MESENCHYMAL STEM-CELLS; STRESS
   URINARY-INCONTINENCE; MARROW-DERIVED CELLS; DECELLULARIZED PERICARDIAL
   BIOMATERIAL; EXTRACELLULAR-MATRIX SCAFFOLDS; MULTIPOTENT PROGENITOR
   CELLS; BIAXIAL MECHANICAL-BEHAVIOR; MACROPHAGE-SECRETED FACTORS;
   MYOGENIC REGULATORY FACTORS
AB Skeletal muscle has a robust capacity for regeneration following injury. However, few if any effective therapeutic options for volumetric muscle loss are available. Autologous muscle grafts or muscle transposition represent possible salvage procedures for the restoration of mass and function but these approaches have limited success and are plagued by associated donor site morbidity. Cell-based therapies are in their infancy and, to date, have largely focused on hereditary disorders such as Duchenne muscular dystrophy. An unequivocal need exists for regenerative medicine strategies that can enhance or induce de novo formation of functional skeletal muscle as a treatment for congenital absence or traumatic loss of tissue. In this review, the three stages of skeletal muscle regeneration and the potential pitfalls in the development of regenerative medicine strategies for the restoration of functional skeletal muscle in situ are discussed.
C1 [Turner, Neill J.; Badylak, Stephen F.] Univ Pittsburgh, McGowan Inst Regenerat Med, Pittsburgh, PA 15219 USA.
   [Turner, Neill J.; Badylak, Stephen F.] Univ Pittsburgh, Dept Surg, Pittsburgh, PA 15219 USA.
RP Badylak, SF (reprint author), Univ Pittsburgh, McGowan Inst Regenerat Med, Bridgeside Point 2,450 Technol Dr, Pittsburgh, PA 15219 USA.
EM badylaks@upmc.edu
OI Turner, Neill/0000-0001-5024-5610; Badylak, Stephen/0000-0003-3555-0689
CR Aarimaa V, 2004, NEUROMUSCULAR DISORD, V14, P421, DOI 10.1016/j.nmd.2004.03.009
   Abedi M, 2007, BRIT J HAEMATOL, V138, P792, DOI 10.1111/j.1365-2141.2007.06720.x
   ABOOD EA, 1991, ACTA ANAT, V140, P201
   Abou-Khalil R, 2010, CELL CYCLE, V9, P892, DOI 10.4161/cc.9.5.10851
   Akhyari P, 2008, EUR J CARDIO-THORAC, V34, P229, DOI 10.1016/j.ejcts.2008.03.062
   Al-Shanti N, 2008, GROWTH FACTORS, V26, P61, DOI 10.1080/08977190802025024
   ALAMEDDINE HS, 1989, MUSCLE NERVE, V12, P544, DOI 10.1002/mus.880120705
   ALAMEDDINE HS, 1994, CELL TRANSPLANT, V3, P3
   Alessandri G, 2004, LANCET, V364, P1872, DOI 10.1016/S0140-6736(04)17443-6
   ALLEN RE, 1995, J CELL PHYSIOL, V165, P307, DOI 10.1002/jcp.1041650211
   Altomare L, 2010, INT J ARTIF ORGANS, V33, P535
   Ariganello MB, 2011, BIOMATERIALS, V32, P439, DOI 10.1016/j.biomaterials.2010.09.004
   Ariganello MB, 2010, J BIOMED MATER RES A, V93A, P280, DOI 10.1002/jbm.a.32554
   Arnold L, 2007, J EXP MED, V204, P1057, DOI 10.1084/jem.20070075
   Aurora A, 2007, J SHOULDER ELB SURG, V16, p171S, DOI 10.1016/j.jse.2007.03.008
   Bachrach E, 2006, MUSCLE NERVE, V34, P44, DOI 10.1002/mus.20560
   Badylak S, 2001, J SURG RES, V99, P282, DOI 10.1006/jsre.2001.6176
   Badylak SF, 2006, CELL TRANSPLANT, V15, pS29, DOI 10.3727/000000006783982368
   Badylak SF, 2001, EXP HEMATOL, V29, P1310, DOI 10.1016/S0301-472X(01)00729-9
   Badylak SE, 2008, SEMIN IMMUNOL, V20, P109, DOI 10.1016/j.smim.2007.11.003
   Badylak SF, 2008, TISSUE ENG PT A, V14, P1835, DOI 10.1089/ten.tea.2007.0264
   Badylak SF, 2007, BIOMATERIALS, V28, P3587, DOI 10.1016/j.biomaterials.2007.04.043
   Bailey AM, 2010, CURR STEM CELL RES T, V5, P95
   Beier JP, 2006, PLAST RECONSTR SURG, V118, P1113, DOI 10.1097/01.prs.0000221007.97115.1d
   Beier JP, 2009, BMC BIOTECHNOL, V9, DOI 10.1186/1472-6750-9-34
   Beiner J M, 2001, J Am Acad Orthop Surg, V9, P227
   BENOIT PW, 1970, J ANAT, V107, P547
   Biressi S, 2010, SEMIN CELL DEV BIOL, V21, P845, DOI 10.1016/j.semcdb.2010.09.003
   Bischoff R, 1997, DEV DYNAM, V208, P505, DOI 10.1002/(SICI)1097-0177(199704)208:4<505::AID-AJA6>3.0.CO;2-M
   Bittner RE, 1999, ANAT EMBRYOL, V199, P391, DOI 10.1007/s004290050237
   Borschel GH, 2006, PLAST RECONSTR SURG, V117, P2235, DOI 10.1097/01.prs.0000224295.54073.49
   Borschel GH, 2004, PLAST RECONSTR SURG, V113, P595, DOI 10.1097/01.PRS.0000101064.62289.2F
   Brigido SA, 2004, ORTHOPEDICS, V27, pS145
   Brown BN, 2009, BIOMATERIALS, V30, P1482, DOI 10.1016/j.biomaterials.2008.11.040
   Brunelli S, 2008, PHARMACOL RES, V58, P117, DOI 10.1016/j.phrs.2008.06.008
   Brzoska E, 2006, DIFFERENTIATION, V74, P105, DOI 10.1111/j.1432-0436.2005.00059.x
   Calve S, 2010, DEV BIOL, V344, P259, DOI 10.1016/j.ydbio.2010.05.007
   Cannon JG, 1998, MOL CELL BIOCHEM, V179, P159, DOI 10.1023/A:1006828425418
   CANTINI M, 1995, J NEUROPATH EXP NEUR, V54, P121, DOI 10.1097/00005072-199501000-00014
   Cantini M, 2002, NEUROL SCI, V23, P189, DOI 10.1007/s100720200060
   Carlson BM, 1996, J GERONTOL A-BIOL, V51, pB43, DOI 10.1093/gerona/51A.1.B43
   CARLSON BM, 1972, EXP NEUROL, V36, P239, DOI 10.1016/0014-4886(72)90020-9
   Carlson BM, 1998, J GERONTOL A-BIOL, V53, pB52, DOI 10.1093/gerona/53A.1.B52
   Carr LK, 2008, INT UROGYNECOL J, V19, P881, DOI 10.1007/s00192-007-0553-z
   Chakravarthy MV, 2001, INT J SPORT NUTR EXE, V11, pS44, DOI 10.1123/ijsnem.11.s1.s44
   Charge SBP, 2004, PHYSIOL REV, V84, P209, DOI 10.1152/physrev.00019.2003
   Chazaud B, 2009, EXERC SPORT SCI REV, V37, P18, DOI 10.1097/JES.0b013e318190ebdb
   Chen DH, 2010, LARYNGOSCOPE, V120, P353, DOI 10.1002/lary.20796
   Chen SE, 2005, AM J PHYSIOL-CELL PH, V289, pC1179, DOI 10.1152/ajpcell.00062.2005
   Collins CA, 2005, CELL, V122, P289, DOI 10.1016/j.cell.2005.05.010
   Collins Charlotte A., 2009, V482, P319, DOI 10.1007/978-1-59745-060-7_20
   Conconi MT, 2005, BIOMATERIALS, V26, P2567, DOI 10.1016/j.biomaterials.2004.07.035
   Cornelison DDW, 2001, DEV BIOL, V239, P79, DOI 10.1006/dbio.2001.0416
   Corselli M, 2010, ARTERIOSCL THROM VAS, V30, P1104, DOI 10.1161/ATVBAHA.109.191643
   Corti S, 2002, EXP CELL RES, V277, P74, DOI 10.1006/excr.2002.5543
   Cossu G, 2005, SEMIN CELL DEV BIOL, V16, P623, DOI 10.1016/j.semcdb.2005.07.003
   Counsel P, 2010, SEMIN MUSCULOSKEL R, V14, P162, DOI 10.1055/s-0030-1253158
   Crisan M, 2009, ANN NY ACAD SCI, V1176, P118, DOI 10.1111/j.1749-6632.2009.04967.x
   Crow BD, 2007, J ORTHOP RES, V25, P396, DOI 10.1002/jor.20232
   Das M, 2007, NEUROSCIENCE, V146, P481, DOI 10.1016/j.neuroscience.2007.01.068
   De Deyne Patrick G, 2005, Clin Podiatr Med Surg, V22, P521, DOI 10.1016/j.cpm.2005.07.006
   Deasy BM, 2004, CURR OPIN BIOTECH, V15, P419, DOI 10.1016/j.copbio.2004.08.004
   Deasy BM, 2009, MOL THER, V17, P1788, DOI 10.1038/mt.2009.136
   Dejardin LM, 2001, AM J SPORT MED, V29, P175, DOI 10.1177/03635465010290021001
   Dellavalle A, 2007, NAT CELL BIOL, V9, P255, DOI 10.1038/ncb1542
   Dennis RG, 2000, IN VITRO CELL DEV-AN, V36, P327
   Derwin KA, 2006, J BONE JOINT SURG AM, V88A, P2665, DOI 10.2106/JBJS.E.01307
   Dezawa M, 2005, SCIENCE, V309, P314, DOI 10.1126/science.1110364
   Dhawan V, 2007, TISSUE ENG, V13, P2813, DOI 10.1089/ten.2007.0003
   Di Benedetto G., 1994, Clinical Materials, V16, P137, DOI 10.1016/0267-6605(94)90109-0
   Dobsak P, 2006, CIRC J, V70, P75, DOI 10.1253/circj.70.75
   Drapeau C, 2010, CELL CYCLE, V9, P1819, DOI 10.4161/cc.9.9.11540
   el Andalousi RB, 2002, CELL TRANSPLANT, V11, P169, DOI 10.3727/096020198389898
   Ferrari G, 1998, SCIENCE, V279, P1528, DOI 10.1126/science.279.5356.1528
   Flaibani M, 2009, TISSUE ENG PT A, V15, P2447, DOI 10.1089/ten.tea.2008.0301
   FLORINI JR, 1989, AM J PHYSIOL, V256, pC701
   FOSTER AH, 1980, ANESTH ANALG, V59, P727
   Frenette J, 2000, AM J PATHOL, V156, P2103, DOI 10.1016/S0002-9440(10)65081-X
   Freytes DO, 2008, J BIOMED MATER RES B, V84B, P408, DOI 10.1002/jbm.b.30885
   Freytes DO, 2008, J BIOMED MATER RES A, V87A, P862, DOI 10.1002/jbm.a.31821
   Frystyk J, 2010, MED SCI SPORT EXER, V42, P58, DOI 10.1249/MSS.0b013e3181b07d2d
   Fukada S, 2002, J CELL SCI, V115, P1285
   Furuta A, 2008, INT UROGYNECOL J, V19, P1229, DOI 10.1007/s00192-008-0608-9
   Gal-Levi R, 1998, BBA-MOL CELL RES, V1402, P39, DOI 10.1016/S0167-4889(97)00124-9
   Galvez BG, 2006, J CELL BIOL, V174, P231, DOI 10.1083/jcb.200512085
   Garrett WE, 1996, AM J SPORT MED, V24, pS2, DOI 10.1177/036354659602406S02
   GARRETT WE, 1984, J HAND SURG-AM, V9A, P683, DOI 10.1016/S0363-5023(84)80014-3
   Gates CB, 2008, J AM ACAD ORTHOP SUR, V16, P68, DOI 10.5435/00124635-200802000-00004
   Ghosh J, 2006, J VASC SURG, V43, P142, DOI 10.1016/j.jvs.2005.08.041
   Gilbert TW, 2008, BIOMATERIALS, V29, P4775, DOI 10.1016/j.biomaterials.2008.08.022
   Gilbert TW, 2006, BIOMATERIALS, V27, P3675, DOI 10.1016/j.biomaterials.2006.02.014
   Gillies AR, 2011, TISSUE ENG PART C-ME, V17, P383, DOI [10.1089/ten.tec.2010.0438, 10.1089/ten.TEC.2010.0438]
   Gimble JM, 2003, CYTOTHERAPY, V5, P362, DOI 10.1080/14653240310003026
   Gowdak LHW, 2000, CIRCULATION, V102, P565
   Grabowska I, 2011, CELL BIOL INT, V35, P125, DOI 10.1042/CBI20090335
   Gregorevic P, 2004, J PHYSIOL-LONDON, V558, P549, DOI 10.1113/jphysiol.2004.066217
   Grenier G, 2005, TISSUE ENG, V11, P90, DOI 10.1089/ten.2005.11.90
   GRUBB BD, 1991, J PHYSIOL-LONDON, V441, P405, DOI 10.1113/jphysiol.1991.sp018758
   GRUBIC Z, 1995, NEURON, V14, P317, DOI 10.1016/0896-6273(95)90288-0
   Guiducci S, 2010, ANN INTERN MED, V153, P650, DOI [10.7326/0003-4819-153-10-201011160-00007, 10.1059/0003-4819-153-10-201011160-00007]
   Harel I, 2009, DEV CELL, V16, P822, DOI 10.1016/j.devcel.2009.05.007
   Hawke TJ, 2001, J APPL PHYSIOL, V91, P534
   Hayashi S, 2004, HISTOCHEM CELL BIOL, V122, P427, DOI 10.1007/s00418-004-0704-y
   Hocking AM, 2010, EXP CELL RES, V316, P2213, DOI 10.1016/j.yexcr.2010.05.009
   Hosokawa R, 2003, J DENT RES, V82, P558, DOI 10.1177/154405910308200714
   Hsu HH, 1997, BIOCHEM MOL MED, V60, P142, DOI 10.1006/bmme.1997.2570
   Huang NF, 2010, AM J TRANSL RES, V2, P43
   Huang YC, 2006, AM J PHYSIOL-CELL PH, V291, pC11, DOI 10.1152/ajpcell.00366.2005
   Huang YC, 2005, J APPL PHYSIOL, V98, P706, DOI 10.1152/japplphysiol.00273.2004
   Huard J, 2002, J BONE JOINT SURG AM, V84A, P822, DOI 10.2106/00004623-200205000-00022
   Huard J, 2002, GENE THER, V9, P1617, DOI 10.1038/sj.gt.3301816
   Huard J., 2008, Journal of Musculoskeletal & Neuronal Interactions, V8, P337
   Ikezawa M, 2003, HUM GENE THER, V14, P1535, DOI 10.1089/104303403322495043
   Izadpanah R, 2006, J CELL BIOCHEM, V99, P1285, DOI 10.1002/jcb.20904
   Jackson WM, 2009, J ORTHOP RES, V27, P1645, DOI 10.1002/jor.20924
   Jackson WM, 2010, J CELL MOL IN PRESS
   Jankowski RJ, 2002, GENE THER, V9, P642, DOI 10.1038/sj/gt/3301719
   Jarvinen TAH, 2000, CURR OPIN RHEUMATOL, V12, P155, DOI 10.1097/00002281-200003000-00010
   Jarvinen TAHJ, 2005, AM J SPORT MED, V33, P745, DOI 10.1177/0363546505274714
   Jarvinen TAH, 2007, BEST PRACT RES CL RH, V21, P317, DOI 10.1016/j.berh.2006.12.004
   Jensen LT, 1997, CARDIOVASC RES, V33, P535, DOI 10.1016/S0008-6363(96)00247-7
   JIRMANOVA I, 1972, Z ZELLFORSCH MIK ANA, V131, P77, DOI 10.1007/BF00307202
   Kagiwada H, 2008, J TISSUE ENG REGEN M, V2, P184, DOI 10.1002/term.79
   Kallestad KM, 2010, J CELL PHYSIOL, V222, P676, DOI 10.1002/jcp.21989
   Kania G, 2009, CIRC RES, V105, P462, DOI 10.1161/CIRCRESAHA.109.196287
   Kasemkijwattana C, 1998, CELL TRANSPLANT, V7, P585, DOI 10.1016/S0963-6897(98)00037-2
   Kim YT, 2007, MUSCLE NERVE, V36, P391, DOI 10.1002/mus.20827
   Kivela R, 2008, CARDIOVASC DIABETOL, V7, DOI 10.1186/1475-2840-7-13
   Ko R, 2006, J SURG RES, V135, P9, DOI 10.1016/j.jss.2006.02.007
   Kochupura PV, 2005, CIRCULATION, V112, pI144, DOI 10.1161/CIRCULATIONAHA.104.524355
   Kollias HD, 2008, J APPL PHYSIOL, V104, P579, DOI 10.1152/japplphysiol.01091.2007
   Koning M, 2009, J TISSUE ENG REGEN M, V3, P407, DOI 10.1002/term.190
   Kresse H, 2001, J CELL PHYSIOL, V189, P266, DOI 10.1002/jcp.10030
   Kubo H, 2008, CIRCULATION, V118, P649, DOI 10.1161/CIRCULATIONAHA.107.761031
   LaBarge MA, 2002, CELL, V111, P589, DOI 10.1016/S0092-8674(02)01078-4
   Ladak A, 2011, EXP NEUROL, V228, P242, DOI 10.1016/j.expneurol.2011.01.013
   Laprise P, 2002, J CELL PHYSIOL, V191, P69, DOI 10.1002/jcp.10075
   Larkin LM, 2006, IN VITRO CELL DEV-AN, V42, P75
   Launay T, 2001, J HISTOCHEM CYTOCHEM, V49, P887, DOI 10.1177/002215540104900709
   Lawrence DA, 2001, MOL CELL BIOCHEM, V219, P163, DOI 10.1023/A:1010819716023
   Lecourt S, 2010, EXP CELL RES, V316, P2513, DOI 10.1016/j.yexcr.2010.04.020
   Lefeuvre B, 1996, MECH DEVELOP, V58, P115, DOI 10.1016/S0925-4773(96)00564-3
   LEHTO MUK, 1991, ANN CHIR GYNAECOL FE, V80, P102
   Levenberg S, 2005, NAT BIOTECHNOL, V23, P879, DOI 10.1038/nbt1109
   Li J, 2009, EXP CELL RES, V315, P2284, DOI 10.1016/j.yexcr.2009.04.011
   Li QT, 2010, FOOT ANKLE INT, V31, P706, DOI 10.3113/FAI.2010.0706
   Liang R, 2006, J ORTHOP RES, V24, P811, DOI 10.1002/jor.20080
   Liao H, 2009, TISSUE ENG PART B-RE, V15, P319, DOI 10.1089/ten.teb.2009.0092
   Lin CS, 2010, HISTOL HISTOPATHOL, V25, P807, DOI 10.14670/HH-25.807
   Liu D, 2001, GENE DEV, V15, P2950, DOI 10.1101/gad.925901
   Ljubicic V, 2005, CAN J APPL PHYSIOL, V30, P625, DOI 10.1139/h05-144
   Lolmede K, 2009, J LEUKOCYTE BIOL, V85, P779, DOI 10.1189/jlb.0908579
   Mackey AL, 2007, J APPL PHYSIOL, V103, P425, DOI 10.1152/japplphysiol.00157.2007
   Malerba A, 2010, NEUROL RES, V32, P55, DOI 10.1179/174313209X380865
   Malerba A, 2009, EXP CELL RES, V315, P915, DOI 10.1016/j.yexcr.2009.01.005
   Mars T, 2001, PFLUG ARCH EUR J PHY, V442, pR177, DOI 10.1007/s004240100015
   Marzaro M, 2002, INT J MOL MED, V10, P177
   Mase Vincent J Jr, 2010, Orthopedics, V33, P511, DOI 10.3928/01477447-20100526-24
   MASSAGUE J, 1986, P NATL ACAD SCI USA, V83, P8206, DOI 10.1073/pnas.83.21.8206
   Matsumoto T, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001211
   Matziolis G, 2006, TISSUE ENG, V12, P361, DOI 10.1089/ten.2006.12.361
   McLoon LK, 2007, ORAL DIS, V13, P134, DOI 10.1111/j.1601-0825.2006.01353.x
   MEHRKE G, 1984, NEUROSCI LETT, V44, P235, DOI 10.1016/0304-3940(84)90028-4
   Mendler L, 2008, J HISTOCHEM CYTOCHEM, V56, P111, DOI 10.1369/jhc.7A7322.20071
   Menetrey J, 1999, AM J SPORT MED, V27, P222, DOI 10.1177/03635465990270021801
   Menetrey J, 2000, J BONE JOINT SURG BR, V82B, P131, DOI 10.1302/0301-620X.82B1.8954
   Merritt EK, 2010, TISSUE ENG PT A, V16, P2871, DOI [10.1089/ten.tea.2009.0826, 10.1089/ten.TEA.2009.0826]
   Messina S, 2007, FASEB J, V21, P3737, DOI 10.1096/fj.07-8459com
   Miller KJ, 2000, AM J PHYSIOL-CELL PH, V278, pC174
   MILLER RR, 1991, INT J DEV NEUROSCI, V9, P259, DOI 10.1016/0736-5748(91)90046-O
   MISHRA DK, 1995, J BONE JOINT SURG AM, V77, P1510, DOI 10.2106/00004623-199510000-00005
   Miura T, 2006, BIOCHEM BIOPH RES CO, V340, P675, DOI 10.1016/j.bbrc.2005.12.060
   Miyagoe Y, 1997, FEBS LETT, V415, P33, DOI 10.1016/S0014-5793(97)01007-7
   MONG FSF, 1988, EXPERIENTIA, V44, P601, DOI 10.1007/BF01953309
   Montarras D, 2005, SCIENCE, V309, P2064, DOI 10.1126/science.1114758
   Moon DG, 2008, TISSUE ENG PT A, V14, P473, DOI 10.1089/tea.2007.0104
   Muguruma Y, 2003, EXP HEMATOL, V31, P1323, DOI 10.1016/j.exphem.2003.09.003
   Nagasaka M, 2006, CLIN EXP PHARMACOL P, V33, P623, DOI 10.1111/j.1440-1681.2006.04417.x
   Natsu K, 2004, TISSUE ENG, V10, P1093, DOI 10.1089/ten.2004.10.1093
   Navarro-Sobrino M, 2010, MICROVASC RES, V80, P317, DOI 10.1016/j.mvr.2010.05.008
   Negroni E, 2009, MOL THER, V17, P1771, DOI 10.1038/mt.2009.167
   Nesti LJ, 2008, J BONE JOINT SURG AM, V90A, P2390, DOI 10.2106/JBJS.H.00049
   Nicolaidis SC, 2001, MICROSURG, V21, P241, DOI 10.1002/micr.1047
   Nieponice A, 2009, GASTROINTEST ENDOSC, V69, P289, DOI 10.1016/j.gie.2008.04.022
   Nieponice A, 2006, ANN THORAC SURG, V82, P2050, DOI 10.1016/j.athoracsur.2006.06.036
   Occleston NL, 2009, EXPERT OPIN INV DRUG, V18, P1231, DOI 10.1517/13543780903130594
   OKane S, 1997, INT J BIOCHEM CELL B, V29, P63, DOI 10.1016/S1357-2725(96)00120-3
   Owen SC, 2010, J BIOMED MATER RES A, V94A, P1321, DOI 10.1002/jbm.a.32834
   Padoin AV, 2008, PLAST RECONSTR SURG, V122, P614, DOI 10.1097/PRS.0b013e31817d5476
   Palermo AT, 2005, DEV BIOL, V279, P336, DOI 10.1016/j.ydbio.2004.12.024
   Park H, 2008, J TISSUE ENG REGEN M, V2, P279, DOI 10.1002/term.93
   Payne TR, 2005, GENE THER, V12, P1264, DOI 10.1038/sj.gt.3302521
   Peault B, 2007, MOL THER, V15, P867, DOI 10.1038/mt.sj.6300145
   PETTERSSON P, 1984, ACTA MED SCAND, V215, P447
   Philippou A, 2007, IN VIVO, V21, P45
   Phinney DG, 2007, CELL CYCLE, V6, P2884, DOI 10.4161/cc.6.23.5095
   Qu-Petersen ZQ, 2002, J CELL BIOL, V157, P851, DOI 10.1083/jcb.200108150
   Quintero AJ, 2009, CLIN SPORT MED, V28, P1, DOI 10.1016/j.csm.2008.08.009
   Renault V, 2000, EXP GERONTOL, V35, P711, DOI 10.1016/S0531-5565(00)00151-0
   Rieder E, 2005, CIRCULATION, V111, P2792, DOI 10.1161/CIRCULATIONAHA.104.473629
   Robinson KA, 2005, CIRCULATION, V112, pI135, DOI 10.1161/CIRCULATIONAHA.104.525436
   Rosu-Myles M, 2005, J CELL SCI, V118, P4343, DOI 10.1242/jcs.02555
   Rouger K, 2004, CELL TISSUE RES, V317, P319, DOI 10.1007/s00441-004-0911-9
   Rowlands AS, 2007, EXPERT REV MED DEVIC, V4, P709, DOI 10.1586/17434440.4.5.709
   Sacks MS, 1999, J BIOMED MATER RES, V46, P1, DOI 10.1002/(SICI)1097-4636(199907)46:1<1::AID-JBM1>3.0.CO;2-7
   Saito T, 1995, Tissue Eng, V1, P327, DOI 10.1089/ten.1995.1.327
   Sasaki D, 2007, UPSALA J MED SCI, V112, P175
   Sato K, 2003, MUSCLE NERVE, V28, P365, DOI 10.1002/mus.10436
   Saxena AK, 2001, BIO-MED MATER ENG, V11, P275
   SCHMALBRUCH H, 1976, TISSUE CELL, V8, P673, DOI 10.1016/0040-8166(76)90039-2
   SCHULTZ E, 1988, ANAT REC, V222, P12, DOI 10.1002/ar.1092220104
   Schultz GS, 2009, WOUND REPAIR REGEN, V17, P153, DOI 10.1111/j.1524-475X.2009.00466.x
   Serena E, 2008, NEUROL RES, V30, P207, DOI 10.1179/174313208X281109
   Serrano AL, 2008, CELL METAB, V7, P33, DOI 10.1016/j.cmet.2007.11.011
   Shah M, 1999, AM J PATHOL, V154, P1115, DOI 10.1016/S0002-9440(10)65364-3
   Sheehan SM, 2000, MUSCLE NERVE, V23, P239, DOI 10.1002/(SICI)1097-4598(200002)23:2<239::AID-MUS15>3.0.CO;2-U
   Sheehan SM, 1999, J CELL PHYSIOL, V181, P499, DOI 10.1002/(SICI)1097-4652(199912)181:3<499::AID-JCP14>3.0.CO;2-1
   Shen W, 2008, J CELL PHYSIOL, V214, P405, DOI 10.1002/jcp.21212
   Sherwood RI, 2006, TRENDS MOL MED, V12, P189, DOI 10.1016/j.molmed.2006.03.002
   Shibuya Seiji, 2003, Medical Electron Microscopy, V36, P213, DOI 10.1007/s00795-003-0227-y
   Shmelkov SV, 2005, CIRCULATION, V111, P1175, DOI 10.1161/01.CIR.0000157155.44008.0F
   Smaldone MC, 2008, WORLD J UROL, V26, P327, DOI 10.1007/s00345-008-0269-9
   Smith CA, 2007, J APPL PHYSIOL, V102, P755, DOI 10.1152/japplphysiol.01503.2005
   Snyder SJ, 2009, ARTHROSCOPY, V25, P329, DOI 10.1016/j.arthro.2008.05.023
   Springer ML, 1998, MOL CELL, V2, P549, DOI 10.1016/S1097-2765(00)80154-9
   STPIERRE BA, 1994, AM J PATHOL, V145, P1463
   STPIERRE BA, 1994, J APPL PHYSIOL, V77, P290
   Strle K, 2007, J NEUROIMMUNOL, V188, P48, DOI 10.1016/j.jneuroim.2007.05.003
   Sun DX, 2009, FASEB J, V23, P382, DOI 10.1096/fj.07-095901
   Suzuki S, 2002, BIOCHEM BIOPH RES CO, V292, P709, DOI 10.1006/bbrc.2002.6706
   Szalay K, 1997, EUR J CELL BIOL, V74, P391
   Tanaka Y, 2000, BRIT J PLAST SURG, V53, P51, DOI 10.1054/bjps.1999.3186
   Tatsumi R, 2002, MOL BIOL CELL, V13, P2909, DOI 10.1091/mbc.E02-01-0062
   Tatsumi R, 2004, MUSCLE NERVE, V30, P654, DOI 10.1002/mus.20114
   Tatsumi R, 1998, DEV BIOL, V194, P114, DOI 10.1006/dbio.1997.8803
   Tatsumi R, 2010, ANIM SCI J, V81, P11, DOI 10.1111/j.1740-0929.2009.00712.x
   Tedesco FS, 2010, J CLIN INVEST, V120, P11, DOI 10.1172/JCI40373
   Ten Broek RW, 2010, J CELL PHYSIOL, V224, P7, DOI 10.1002/jcp.22127
   Terada N, 2001, SCAND J PLAST RECONS, V35, P233
   Tidball JG, 2007, J PHYSIOL-LONDON, V578, P327, DOI 10.1113/jphysiol.2006.118265
   Tidball JG, 2010, AM J PHYSIOL-REG I, V298, pR1173, DOI 10.1152/ajpregu.00735.2009
   TIDBALL JG, 1995, MED SCI SPORT EXER, V27, P1022, DOI 10.1249/00005768-199507000-00011
   Tille JC, 2002, EXP CELL RES, V280, P179, DOI 10.1006/excr.2002.5635
   Torrente Y, 2007, CELL TRANSPLANT, V16, P563, DOI 10.3727/000000007783465064
   Torrente Y, 2004, J CLIN INVEST, V114, P182, DOI 10.1172/JCI200420325
   Torrente Y, 2003, CELL TRANSPLANT, V12, P91, DOI 10.3727/000000003783985115
   Tottey S, 2011, TISSUE ENG PT A, V17, P37, DOI [10.1089/ten.tea.2010.0188, 10.1089/ten.TEA.2010.0188]
   Tsujinaka T, 1996, J CLIN INVEST, V97, P244, DOI 10.1172/JCI118398
   Tu YK, 2008, INJURY, V39, pS75, DOI 10.1016/j.injury.2008.08.034
   Turner NJ, 2010, TISSUE ENG PT A, V16, P3309, DOI [10.1089/ten.tea.2010.0169, 10.1089/ten.TEA.2010.0169]
   Urbich C, 2004, CIRC RES, V95, P343, DOI 10.1161/01.RES.0000137877.89448.78
   Usas A, 2007, BIOMATERIALS, V28, P5401, DOI 10.1016/j.biomaterials.2007.09.008
   Vachon PH, 1996, J CELL BIOL, V134, P1483, DOI 10.1083/jcb.134.6.1483
   Valentin JE, 2010, BIOMATERIALS, V31, P7475, DOI 10.1016/j.biomaterials.2010.06.039
   Valentin JE, 2009, TISSUE ENG PT A, V15, P1687, DOI 10.1089/ten.tea.2008.0419
   VANDENBURGH HH, 1988, IN VITRO CELL DEV B, V24, P166
   Velleman SG, 2004, POULTRY SCI, V83, P245, DOI 10.1093/ps/83.2.245
   Vindigni V, 2004, PLAST RECONSTR SURG, V114, P1509, DOI 10.1097/01.PRS.0000138253.96709.E5
   Vitello L, 2004, BASIC APPL MYOL, V14, P45
   Voo S, 2008, EUR HEART J, V29, P241, DOI 10.1093/eurheartj/ehm542
   Vorotnikova E, 2010, MATRIX BIOL, V29, P690, DOI 10.1016/j.matbio.2010.08.007
   Wagner S, 2003, PFLUG ARCH EUR J PHY, V447, P14, DOI 10.1007/s00424-003-1135-7
   Wang X, 2008, CELL MOL NEUROBIOL, V28, P113, DOI 10.1007/s10571-007-9247-9
   Warren GL, 2002, FASEB J, V16, P1630, DOI 10.1096/fj.02-0187fje
   Washabaugh CH, 1998, DEV DYNAM, V211, P177, DOI 10.1002/(SICI)1097-0177(199802)211:2<177::AID-AJA6>3.0.CO;2-E
   Wehling M, 2001, J CELL BIOL, V155, P123, DOI 10.1083/jcb.200105110
   WHALEN RG, 1990, DEV BIOL, V141, P24, DOI 10.1016/0012-1606(90)90099-5
   Wilborn CD, 2009, J STRENGTH COND RES, V23, P2179, DOI 10.1519/JSC.0b013e3181bab493
   Wipff PJ, 2008, EUR J CELL BIOL, V87, P601, DOI 10.1016/j.ejcb.2008.01.012
   Wu LC, 1997, ARCH SURG-CHICAGO, V132, P753
   Wu XY, 2010, CELL TISSUE RES, V340, P549, DOI 10.1007/s00441-010-0978-4
   Xu R, 2009, CANCER METAST REV, V28, P167, DOI 10.1007/s10555-008-9178-z
   YABLONKAREUVENI Z, 1994, DEV BIOL, V164, P588, DOI 10.1006/dbio.1994.1226
   Yokoyama T, 2001, UROLOGY, V57, P826, DOI 10.1016/S0090-4295(00)01083-9
   Zuk PA, 2001, TISSUE ENG, V7, P211, DOI 10.1089/107632701300062859
NR 275
TC 96
Z9 100
U1 3
U2 74
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 0302-766X
EI 1432-0878
J9 CELL TISSUE RES
JI Cell Tissue Res.
PD MAR
PY 2012
VL 347
IS 3
BP 759
EP 774
DI 10.1007/s00441-011-1185-7
PG 16
WC Cell Biology
SC Cell Biology
GA 916YG
UT WOS:000302138500023
PM 21667167
DA 2018-10-19
ER

PT J
AU Duan, YH
   Liu, L
   Wang, L
   Guo, F
   Li, HP
   Shi, L
   Li, M
   Yin, DY
   Jiang, C
   Zhu, QS
AF Duan, Yonghong
   Liu, Lie
   Wang, Ling
   Guo, Fei
   Li, Haoping
   Shi, Lei
   Li, Mao
   Yin, Dayu
   Jiang, Chi
   Zhu, Qingsheng
TI Preliminary study of the biomechanical behavior and physical
   characteristics of tantalum (Ta)-coated prostheses
SO JOURNAL OF ORTHOPAEDIC SCIENCE
LA English
DT Article
ID POROUS TANTALUM; CORROSION BEHAVIOR; SCRATCH ADHESION; HARDNESS; BONE;
   COATINGS; PERFORMANCE; BIOMATERIAL; FABRICATION; IMPLANTS
AB Use of Ta biomaterials in medicine started in the middle of the last century. The good biocompatibility and chemical stability, and the unique physical characteristics of Ta metal have resulted in many possible developments of Ta biomaterials.
   In this study, histopathological observation, histomorphometric analysis, scanning electron microscope (SEM) observation, energy-dispersive X-ray spectroscopy (EDX) analysis, biomechanical testing, and examination of the coating's mechanical strength have been used to evaluate the value of clinical application of Ta-coated prostheses prepared by a plasma-spraying process.
   Histopathological observation has demonstrated that the periprosthetic new bone tissues tightly and stably adhere to the Ta coating after the implantation, with no signs of loosening. Early after implantation, there is no significant difference in periprosthetic bone volume and ultimate shear strength between Ta-coated and Ti-coated prostheses (P > 0.05). EDX analysis suggests that the ultimate shear stress does not damage Ta coating. Mechanical strength testing shows that the adhesive strength and Vicker's surface hardness (HV) of the Ta coating are significantly higher than those of the Ti coating (P < 0.01).
   Ta coating has good stability and bone biocompatibility; the extraordinary physical characteristics of Ta coating have great significance in maintaining prosthetic stability and surface porosity after implantation.
C1 [Duan, Yonghong; Shi, Lei; Li, Mao; Yin, Dayu; Zhu, Qingsheng] Fourth Mil Med Univ, Orthoped Inst Chinese Peoples Liberat Army, Xijing Hosp, Xian 710032, Shaanxi, Peoples R China.
   [Duan, Yonghong] 451 Hosp Chinese Peoples Liberat Army, Dept Orthopaed Surg, Xian 710061, Shaanxi, Peoples R China.
   [Liu, Lie] Baoji Cent Hosp, Dept Orthopaed Surg, Baoji 721008, Shaanxi, Peoples R China.
   [Wang, Ling] Fourth Mil Med Univ, Inst Hlth Stat, Xian 710032, Shaanxi, Peoples R China.
   [Guo, Fei] Linton Sanitarium Chinese Peoples Liberat Army, Dept Orthopaed Surg, Xian 710600, Shaanxi, Peoples R China.
   [Li, Haoping] 451 Hosp Chinese Peoples Liberat Army, Dept Stomatol, Xian 710061, Shaanxi, Peoples R China.
   [Jiang, Chi] Sichuan Inst Mat & Technol, Mianyang 621900, Sichuan, Peoples R China.
RP Zhu, QS (reprint author), Fourth Mil Med Univ, Orthoped Inst Chinese Peoples Liberat Army, Xijing Hosp, Xian 710032, Shaanxi, Peoples R China.
EM zhuqsh@126.com
CR Baas J, 2008, BIOMATERIALS, V29, P2915, DOI 10.1016/j.biomaterials.2008.03.010
   Balla VK, 2010, ACTA BIOMATER, V6, P3349, DOI 10.1016/j.actbio.2010.01.046
   Bobyn JD, 2004, J BONE JOINT SURG AM, V86A, P123, DOI 10.2106/00004623-200412002-00017
   Bull SJ, 2006, TRIBOL INT, V39, P99, DOI 10.1016/j.triboint.2005.04.013
   Castroverde CDM, 2010, AGR ISSUES POLICIES, P1
   Chang YS, 2003, CLIN BIOMECH, V18, P773, DOI 10.1016/S0268-0033(03)00138-4
   Chen YM, 2008, APPL SURF SCI, V255, P375, DOI 10.1016/j.apsusc.2008.06.110
   Davies JE, 2007, BIOMATERIALS, V28, P5058, DOI 10.1016/j.biomaterials.2007.07.049
   Friedrich C, 1996, THIN SOLID FILMS, V290, P216, DOI 10.1016/S0040-6090(96)09176-6
   Holt GE, 2009, J ARTHROPLASTY, V24, P1079, DOI 10.1016/j.arth.2008.08.010
   Iost A, 1996, SURF COAT TECH, V80, P117, DOI 10.1016/0257-8972(95)02697-5
   Lee GY, 2002, WEAR, V252, P322, DOI 10.1016/S0043-1648(01)00896-1
   Levine BR, 2006, BIOMATERIALS, V27, P4671, DOI 10.1016/j.biomaterials.2006.04.041
   Li Y, 2008, SURF COAT TECH, V202, P3017, DOI 10.1016/j.surfcoat.2007.11.003
   Long WJ, 2009, J ARTHROPLASTY, V24, P1086, DOI 10.1016/j.arth.2008.08.011
   Navarro M, 2008, J R SOC INTERFACE, V5, P1137, DOI 10.1098/rsif.2008.0151
   Rabinowicz E., 1961, WEAR, V4, P345
   Rodrigo A, 2001, SURF COAT TECH, V148, P8, DOI 10.1016/S0257-8972(01)01329-9
   Ryan G, 2006, BIOMATERIALS, V27, P2651, DOI 10.1016/j.biomaterials.2005.12.002
   Shahdad SA, 2007, DENT MATER, V23, P1079, DOI 10.1016/j.dental.2006.10.001
   Shuler MS, 2007, J ARTHROPLASTY, V22, P26, DOI 10.1016/j.arth.2006.03.007
   Sidhu K S, 2001, Spine J, V1, P331, DOI 10.1016/S1529-9430(01)00113-9
   Stilling M, 2009, CLIN ORTHOP RELAT R, V467, P2872, DOI 10.1007/s11999-009-0796-8
   VALLI J, 1987, WEAR, V115, P215, DOI 10.1016/0043-1648(87)90211-0
   Xie Y, 2001, SURF COAT TECH, V141, P15, DOI 10.1016/S0257-8972(01)01130-6
   Xue WC, 2005, BIOMATERIALS, V26, P3029, DOI 10.1016/j.biomaterials.2004.09.003
   Yang HP, 2010, ELECTROCHIM ACTA, V55, P2829, DOI 10.1016/j.electacta.2009.12.074
NR 27
TC 1
Z9 1
U1 1
U2 30
PU SPRINGER TOKYO
PI TOKYO
PA 1-11-11 KUDAN-KITA, CHIYODA-KU, TOKYO, 102-0073, JAPAN
SN 0949-2658
J9 J ORTHOP SCI
JI J. Orthop. Sci.
PD MAR
PY 2012
VL 17
IS 2
BP 173
EP 185
DI 10.1007/s00776-011-0191-7
PG 13
WC Orthopedics
SC Orthopedics
GA 918ZF
UT WOS:000302289600012
PM 22234374
DA 2018-10-19
ER

PT J
AU Gutierrez-Gonzalez, CF
   Smirnov, A
   Bartolome, JF
AF Gutierrez-Gonzalez, Carlos F.
   Smirnov, Anton
   Bartolome, Jose F.
TI Aging Effect on the Tribological Behavior of a Novel 3Y-TZP/Nb
   Biocomposite Against Ultra High Molecular Weight Polyethylene
SO JOURNAL OF THE AMERICAN CERAMIC SOCIETY
LA English
DT Article
ID FEMORAL-HEAD; ZIRCONIA; WEAR; COMPOSITES; NIOBIUM; DEGRADATION;
   CERAMICS; HIPS
AB The aim of this study was to evaluate the friction and wear behavior of ultra high molecular weight polyethylene (UHMWPE) against 3Y-TZP and a novel 3Y-TZP/niobium (Nb) biocomposite. The ceramic and the biocomposite materials were subjected to an accelerated aging process to evaluate the changes in the tribological behavior after this treatment. To carry out the tribological tests, a reciprocating pin-on-flat contact configuration was used. The results show a lower friction coefficient and wear rate for biocomposite/UHMWPE couples than those for 3Y-TZP/UHMWPE couples. The present study demonstrates that the excellent wear properties of this new biocomposite should never be influenced by aging. Based on these data, the potential of zirconia-Nb as an alternative bearing biomaterial is discussed.
C1 [Gutierrez-Gonzalez, Carlos F.] Univ Oviedo, CINN, Principado Asturias Consejo Super Invest Cient CS, Llanera 33428, Asturias, Spain.
   [Smirnov, Anton; Bartolome, Jose F.] CSIC, ICMM, E-28049 Madrid, Spain.
RP Gutierrez-Gonzalez, CF (reprint author), Univ Oviedo, CINN, Principado Asturias Consejo Super Invest Cient CS, Parque Tecnol Asturias, Llanera 33428, Asturias, Spain.
EM cf.gutierrez@cinn.es
RI Smirnov, Anton/K-2121-2017; Bartolome, Jose/B-1977-2010; Smirnov,
   Anton/F-9680-2017; Gutierrez-Gonzalez, Carlos/H-7312-2017
OI Smirnov, Anton/0000-0002-7970-2595; Bartolome, Jose/0000-0002-7515-4202;
   Gutierrez-Gonzalez, Carlos/0000-0002-4328-4635
FU Spanish Ministry of Science and Innovation (MICINN)
   [MAT2009-14542-C02-01]; JAE
FX This work was supported by the Spanish Ministry of Science and
   Innovation (MICINN) under the project MAT2009-14542-C02-01. C.F.
   Gutierrez-Gonzalez has been supported by JAE-Doc Programme 2009. A.
   Smirnov has been supported by JAE-Pre Programme 2010.
CR Bartolome JF, 2008, ACTA MATER, V56, P3358, DOI 10.1016/j.actamat.2008.03.021
   Bartolome JF, 2007, ACTA MATER, V55, P5924, DOI 10.1016/j.actamat.2007.07.004
   Cales B, 2000, CLIN ORTHOP RELAT R, P94
   Daniel M, 2006, CLIN ORTHOP RELAT R, P92, DOI 10.1097/01.blo.0000203472.88926.c8
   Fisher J, 1991, Proc Inst Mech Eng H, V205, P73, DOI 10.1243/PIME_PROC_1991_205_271_02
   Godley R, 2004, J MATER SCI-MATER M, V15, P1073, DOI 10.1023/B:JMSM.0000046388.07961.81
   Gutierrez-Gonzalez CF, 2010, J AM CERAM SOC, V93, P1842, DOI 10.1111/j.1551-2916.2010.03628.x
   Haraguchi K, 2001, J BONE JOINT SURG BR, V83B, P996, DOI 10.1302/0301-620X.83B7.12122
   Hernigou P, 2003, J BONE JOINT SURG BR, V85B, P504, DOI 10.1302/0301-620X.85B4.13397
   ISAAC GH, 1992, CLIN ORTHOP RELAT R, P115
   Kim DJ, 1997, J EUR CERAM SOC, V17, P897, DOI 10.1016/S0955-2219(96)00205-1
   Kim DJ, 1998, J AM CERAM SOC, V81, P2309
   Kim YH, 2001, J BONE JOINT SURG BR, V83B, P742, DOI 10.1302/0301-620X.83B5.10941
   KUMAR P, 1991, J BIOMED MATER RES, V25, P813, DOI 10.1002/jbm.820250703
   Matsuno H, 2001, BIOMATERIALS, V22, P1253, DOI 10.1016/S0142-9612(00)00275-1
   Piconi C, 1999, BIOMATERIALS, V20, P1, DOI 10.1016/S0142-9612(98)00010-6
   Sauer W. L., 1999, ASTM SPEC TECH PUBL, P1
   THEUNISSEN GSAM, 1992, J MATER SCI, V27, P4429, DOI 10.1007/BF00541576
   Tuan RS, 2008, J AM ACAD ORTHOP SUR, V16, pS42, DOI 10.5435/00124635-200800001-00010
   Wroblewski BM, 2003, J BONE JOINT SURG BR, V85B, P376, DOI 10.1302/0301-620X.85B3.13817
NR 20
TC 10
Z9 10
U1 0
U2 9
PU WILEY-BLACKWELL
PI MALDEN
PA COMMERCE PLACE, 350 MAIN ST, MALDEN 02148, MA USA
SN 0002-7820
J9 J AM CERAM SOC
JI J. Am. Ceram. Soc.
PD MAR
PY 2012
VL 95
IS 3
BP 851
EP 854
DI 10.1111/j.1551-2916.2011.05036.x
PG 4
WC Materials Science, Ceramics
SC Materials Science
GA 903IL
UT WOS:000301109700002
DA 2018-10-19
ER

PT J
AU Yu, L
   Zhang, Z
   Ding, JD
AF Yu, Lin
   Zhang, Zheng
   Ding, Jiandong
TI In vitro degradation and protein release of transparent and opaque
   physical hydrogels of block copolymers at body temperature
SO MACROMOLECULAR RESEARCH
LA English
DT Article
DE transparent gel; opaque gel; degradation; protein release; sol-gel
   transition; polymerization temperature
ID PEG-PCL-PEG; AQUEOUS-SOLUTIONS; TRIBLOCK COPOLYMERS; THERMOREVERSIBLE
   GELATION; THERMOSENSITIVE HYDROGEL; HYDROLYTIC DEGRADATION;
   POLY(ETHYLENE GLYCOL); MULTIBLOCK COPOLYMER; INJECTABLE HYDROGELS;
   DIBLOCK COPOLYMERS
AB Poly(D,L-lactide-co-glycolide)-b-poly(ethylene glycol)-b-poly(D,L-lactide-co-glycolide) (PLGA-PEGPLGA) triblock copolymers were synthesized at 130 and 160 A degrees C. The concentrated aqueous solutions of both specimens underwent reversible sol-to-(transparent gel)-to-(opaque gel) transitions upon heating but exhibited different critical gelation concentrations and transition temperatures, possibly due to the minor sequence differences between D,L-lactide (LA) and glycolide (GA) in the PLGA blocks. Aqueous solutions (20 wt%) of the copolymers synthesized at 130 and 160 A degrees C spontaneously formed an opaque gel and a transparent gel at body temperature, respectively. The resulting hydrogels displayed similar in vitro degradation profiles in phosphate buffer saline solutions at 37 A degrees C. Nevertheless, the late-stage releases of bovine serum albumin from the physical hydrogels differed. The present study reveals for the first time that transparent vs. opaque thermogel state influences some of their biomaterial-related properties via the "overheat degree" of the thermogelling systems at a given working temperature, usually 37 A degrees C.
C1 [Yu, Lin; Zhang, Zheng; Ding, Jiandong] Fudan Univ, State Key Lab Mol Engn Polymers, Dept Macromol Sci, Adv Mat Lab, Shanghai 200433, Peoples R China.
   [Yu, Lin; Ding, Jiandong] Fudan Univ, Key Lab Smart Drug Delivery, Minist Educ, Shanghai 201203, Peoples R China.
   [Yu, Lin; Ding, Jiandong] Fudan Univ, PLA, Sch Pharm, Shanghai 201203, Peoples R China.
RP Ding, JD (reprint author), Fudan Univ, State Key Lab Mol Engn Polymers, Dept Macromol Sci, Adv Mat Lab, Shanghai 200433, Peoples R China.
EM jdding1@fudan.edu.cn
FU Chinese Ministry of Science and Technology [2009CB930000]; NSF of China
   [50903021, 21034002]; Specialized Research Fund for the Doctoral Program
   of Higher Education of China [20090071120014]; School of Pharmacy of Key
   Lab of Smart Drug Delivery of Ministry of Education (Fudan University
   [SDD2011-11]
FX The group was supported by Chinese Ministry of Science and Technology
   (973 Program No. 2009CB930000), NSF of China (Grants No. 50903021 and
   No. 21034002), the Specialized Research Fund for the Doctoral Program of
   Higher Education of China (No. 20090071120014), and School of Pharmacy &
   The Open Project Program of Key Lab of Smart Drug Delivery of Ministry
   of Education (Fudan University) (No. SDD2011-11).
CR Behravesh E, 2002, BIOMACROMOLECULES, V3, P153, DOI 10.1021/bm010137x
   Chang GT, 2009, POLYMER, V50, P6111, DOI 10.1016/j.polymer.2009.10.036
   Choi YY, 2008, SOFT MATTER, V4, P2383, DOI 10.1039/b809116a
   Elstad NL, 2009, ADV DRUG DELIVER REV, V61, P785, DOI 10.1016/j.addr.2009.04.010
   GILDING DK, 1979, POLYMER, V20, P1459, DOI 10.1016/0032-3861(79)90009-0
   Gong CY, 2009, INT J PHARM, V365, P89, DOI 10.1016/j.ijpharm.2008.08.027
   He CL, 2008, J CONTROL RELEASE, V127, P189, DOI 10.1016/j.jconrel.2008.01.005
   Hiemstra C, 2007, J AM CHEM SOC, V129, P9918, DOI 10.1021/ja072113p
   Huynh DP, 2010, MACROMOL RES, V18, P192, DOI 10.1007/s13233-009-0182-0
   Hwang MJ, 2005, BIOMACROMOLECULES, V6, P885, DOI 10.1021/bm049347a
   Jaiswal M, 2010, BIOMED MATER, V5, DOI 10.1088/1748-6041/5/6/065014
   Jeong B, 1999, MACROMOLECULES, V32, P7064, DOI 10.1021/ma9908999
   Jeong B, 2000, J BIOMED MATER RES, V50, P171, DOI 10.1002/(SICI)1097-4636(200005)50:2<171::AID-JBM11>3.0.CO;2-F
   Jeong B, 2002, BIOMACROMOLECULES, V3, P865, DOI 10.1021/bm025536m
   Jeong B, 1997, NATURE, V388, P860, DOI 10.1038/42218
   Jeong Y, 2009, J CONTROL RELEASE, V137, P25, DOI 10.1016/j.jconrel.2009.03.008
   Jiang ZQ, 2008, MACROMOL RAPID COMM, V29, P1264, DOI 10.1002/marc.200800186
   Jiang ZQ, 2007, J POLYM SCI POL CHEM, V45, P4091, DOI 10.1002/pola.22222
   Joo MK, 2007, MACROMOLECULES, V40, P5111, DOI 10.1021/ma070008u
   Joo MK, 2009, J MATER CHEM, V19, P5891, DOI 10.1039/b902208b
   Kang YM, 2010, BIOMATERIALS, V31, P2453, DOI 10.1016/j.biomaterials.2009.11.115
   Kasperczyk J, 1996, POLYMER, V37, P201, DOI 10.1016/0032-3861(96)81088-3
   Kim DH, 2010, MACROMOL RES, V18, P387, DOI 10.1007/s13233-010-0405-4
   Kim HK, 2009, TISSUE ENG PT A, V15, P923, DOI 10.1089/ten.tea.2007.0407
   Kim MS, 2006, J POLYM SCI POL CHEM, V44, P5413, DOI 10.1002/pola.21659
   Kojarunchitt T, 2011, INT J PHARMACEUT, V408, P20, DOI 10.1016/j.ijpharm.2011.01.037
   Lee BH, 2004, MACROMOLECULES, V37, P4533, DOI 10.1021/ma0305838
   Lee DS, 2001, MACROMOL RAPID COMM, V22, P587, DOI 10.1002/1521-3927(20010501)22:8<587::AID-MARC587>3.0.CO;2-8
   Lee JY, 2010, INT J PHARMACEUT, V392, P51, DOI 10.1016/j.ijpharm.2010.03.033
   Loh XJ, 2008, BIOMATERIALS, V29, P2164, DOI 10.1016/j.biomaterials.2008.01.016
   Loh XJ, 2007, BIOMATERIALS, V28, P4113, DOI 10.1016/j.biomaterials.2007.05-016
   Loh XJ, 2007, BIOMACROMOLECULES, V8, P585, DOI 10.1021/bm0607933
   Loontjens CAM, 2007, MACROMOLECULES, V40, P7208, DOI 10.1021/ma071165w
   Moon HJ, 2011, BIOMACROMOLECULES, V12, P1234, DOI 10.1021/bm101518c
   Nagahama K, 2008, J POLYM SCI POL CHEM, V46, P6317, DOI 10.1002/pola.22943
   Tran NQ, 2011, MACROMOL RES, V19, P300, DOI 10.1007/s13233-011-0309-y
   Nguyen MK, 2009, BIOMACROMOLECULES, V10, P728, DOI 10.1021/bm900183j
   Park MR, 2010, POLYM DEGRAD STABIL, V95, P935, DOI 10.1016/j.polymdegradstab.2010.03.024
   Potta T, 2010, BIOMACROMOLECULES, V11, P1741, DOI 10.1021/bm100197y
   Shim WS, 2006, BIOMATERIALS, V27, P5178, DOI 10.1016/j.biomaterials.2006.05.038
   Tsitsilianis C, 2010, SOFT MATTER, V6, P2372, DOI 10.1039/b923947b
   Wu LB, 2004, BIOMATERIALS, V25, P5821, DOI 10.1016/j.biomaterials.2004.01.038
   Xuan JJ, 2010, INT J PHARMACEUT, V395, P317, DOI 10.1016/j.ijpharm.2010.05.042
   Yu L, 2006, ANGEW CHEM INT EDIT, V45, P2232, DOI 10.1002/anie.200503575
   Yu L, 2008, CHEM SOC REV, V37, P1473, DOI 10.1039/b713009k
   Yu L, 2008, INT J PHARM, V348, P95, DOI 10.1016/j.ijpharm.2007.07.026
   Yu L, 2007, J POLYM SCI POL CHEM, V45, P1122, DOI 10.1002/pola.21876
   Yu L, 2011, BIOMACROMOLECULES, V12, P1290, DOI 10.1021/bm101572j
   Yu L, 2010, BIOMACROMOLECULES, V11, P2169, DOI 10.1021/bm100549q
   Yu L, 2010, COLLOID POLYM SCI, V288, P1151, DOI 10.1007/s00396-010-2246-2
   Yu L, 2009, BIOMACROMOLECULES, V10, P1547, DOI 10.1021/bm900145g
   Zentner GM, 2001, J CONTROL RELEASE, V72, P203, DOI 10.1016/S0168-3659(01)00276-0
   Zhang H, 2010, J BIOMAT SCI-POLYM E, V21, P253, DOI 10.1163/156856209X415747
   Zhang Z, 2011, BIOMATERIALS, V32, P4725, DOI 10.1016/j.biomaterials.2011.03.046
   Zhang Z, 2010, BIOMATERIALS, V31, P7873, DOI 10.1016/j.biomaterials.2010.07.014
   Zhao LL, 2011, INT J PHARMACEUT, V410, P83, DOI 10.1016/j.ijpharm.2011.03.034
   Zheng Y, 2010, MACROMOL RES, V18, P1096, DOI 10.1007/s13233-010-1110-z
   Zheng YT, 2010, MACROMOL RES, V18, P974, DOI 10.1007/s13233-010-1002-2
   Zhu W, 2010, BIOMACROMOLECULES, V11, P3086, DOI 10.1021/bm100889j
NR 59
TC 17
Z9 17
U1 4
U2 63
PU POLYMER SOC KOREA
PI SEOUL
PA ROOM 601, HATCHON BUILDING, 831 YEOKSAM-DONG, KANGNAM-KU, SEOUL 135-792,
   SOUTH KOREA
SN 1598-5032
J9 MACROMOL RES
JI Macromol. Res.
PD MAR
PY 2012
VL 20
IS 3
SI SI
BP 234
EP 243
DI 10.1007/s13233-012-0049-7
PG 10
WC Polymer Science
SC Polymer Science
GA 918PG
UT WOS:000302262000003
DA 2018-10-19
ER

PT J
AU Isobe, Y
   Kosaka, T
   Kuwahara, G
   Mikami, H
   Saku, T
   Kodama, S
AF Isobe, Yoshihiro
   Kosaka, Toru
   Kuwahara, Go
   Mikami, Hiroshi
   Saku, Taro
   Kodama, Shohta
TI Oriented Collagen Scaffolds for Tissue Engineering
SO MATERIALS
LA English
DT Article
DE oriented collagen; three-dimensional; scaffold; biomaterial; tissue
   engineering
ID REGENERATION; ORIENTATION; ALIGNMENT; RECONSTRUCTION; GUIDANCE; FIBRILS;
   DESIGN; CELLS; GELS
AB Oriented collagen scaffolds were developed in the form of sheet, mesh and tube by arraying flow-oriented collagen string gels and dehydrating the arrayed gels. The developed collagen scaffolds can be any practical size with any direction of orientation for tissue engineering applications. The birefringence of the collagen scaffolds was quantitatively analyzed by parallel Nicols method. Since native collagen in the human body has orientations such as bone, cartilage, tendon and cornea, and the orientation has a special role for the function of human organs, the developed various types of three-dimensional oriented collagen scaffolds are expected to be useful biomaterials for tissue engineering and regenerative medicines.
C1 [Kuwahara, Go; Mikami, Hiroshi; Kodama, Shohta] Fukuoka Univ, Fac Med, Dept Regenerat Med & Transplantat, Jonan Ku, Fukuoka 8140133, Japan.
   [Isobe, Yoshihiro; Kosaka, Toru; Saku, Taro] Atree Inc, Tokyo 1500012, Japan.
RP Kodama, S (reprint author), Fukuoka Univ, Fac Med, Dept Regenerat Med & Transplantat, Jonan Ku, 7-45-1 Nanakuma, Fukuoka 8140133, Japan.
EM isobe@a-tree.co.jp; t-kosaka@a-tree.co.jp; kuwahara@fukuoka-u.ac.jp;
   mikkan0805@mac.com; saku@a-tree.co.jp; skodama@fukuoka-u.ac.jp
CR Albu MG, 2011, BIOMATERIALS APPLICATIONS FOR NANOMEDICINE, P333
   Atala A, 2008, PEDIATR RES, V63, P569, DOI 10.1203/PDR.0b013e3181660639
   Berthod F, 2001, MATRIX BIOL, V20, P463, DOI 10.1016/S0945-053X(01)00162-7
   Builles N, 2010, BIOMATERIALS, V31, P8313, DOI 10.1016/j.biomaterials.2010.07.066
   Cook James L, 2006, J Knee Surg, V19, P159
   DICKINSON RB, 1994, ANN BIOMED ENG, V22, P342, DOI 10.1007/BF02368241
   Duncan TJ, 2010, BIOMATERIALS, V31, P8996, DOI 10.1016/j.biomaterials.2010.08.042
   Ehara A, 2003, BIOMATERIALS, V24, P831, DOI 10.1016/S0142-9612(02)00411-8
   Guo C, 2007, BIOMATERIALS, V28, P1105, DOI 10.1016/j.biomaterials.2006.10.010
   Harley BA, 2010, J BIOMED MATER RES A, V92A, P1066, DOI 10.1002/jbm.a.32361
   Helary C., 2006, BIOMATERIALS, V27, P6411
   JONES SJ, 1975, CELL TISSUE RES, V159, P73
   Kirkwood JE, 2009, LANGMUIR, V25, P3200, DOI 10.1021/la803736x
   Knight DP, 1998, J BIOMED MATER RES, V41, P185, DOI 10.1002/(SICI)1097-4636(199808)41:2<185::AID-JBM2>3.3.CO;2-L
   Lai ES, 2011, ACTA BIOMATER, V7, P2448, DOI 10.1016/j.actbio.2011.03.012
   Mikami H., 2011, TERMIS EU 2011 ANN M, p45O4
   Parenteau-Bareil R, 2010, MATERIALS, V3, P1863, DOI 10.3390/ma3031863
   Marquez SP, 2009, ACTA BIOMATER, V5, P1839, DOI 10.1016/j.actbio.2009.02.011
   Popescu DC, 2005, ADV MATER, V17, P2324, DOI 10.1002/adma.200500039
   RIGGS CM, 1993, ANAT EMBRYOL, V187, P239
   Rosner BI, 2003, ANN BIOMED ENG, V31, P1383, DOI 10.1114/1.1626118
   Thompson D.M., 2004, ANN BIOMED ENG, V32, P1121
   Thompson DM, 2006, ANN BIOMED ENG, V34, P669, DOI 10.1007/s10439-005-9053-9
   Torbet J, 2007, BIOMATERIALS, V28, P4268, DOI 10.1016/j.biomaterials.2007.05.024
   Wilson DL, 2001, P NATL ACAD SCI USA, V98, P13660, DOI 10.1073/pnas.241323198
   Yokota T, 2008, J THORAC CARDIOV SUR, V136, P900, DOI 10.1016/j.jtcvs.2008.02.058
   Yost MJ, 2004, TISSUE ENG, V10, P273, DOI 10.1089/107632704322791916
   Zeugolis DI, 2008, J APPL POLYM SCI, V108, P2886, DOI 10.1002/app.27208
   Zhong SP, 2006, J BIOMED MATER RES A, V79A, P456, DOI 10.1002/jbm.a.30870
NR 29
TC 17
Z9 17
U1 3
U2 40
PU MDPI AG
PI BASEL
PA POSTFACH, CH-4005 BASEL, SWITZERLAND
SN 1996-1944
J9 MATERIALS
JI Materials
PD MAR
PY 2012
VL 5
IS 3
BP 501
EP 511
DI 10.3390/ma5030501
PG 11
WC Materials Science, Multidisciplinary
SC Materials Science
GA 916XF
UT WOS:000302135800009
PM 28817059
OA DOAJ Gold, Green Published
DA 2018-10-19
ER

PT J
AU Mekhail, M
   Almazan, G
   Tabrizian, M
AF Mekhail, Mina
   Almazan, Guillermina
   Tabrizian, Maryam
TI Oligodendrocyte-protection and remyelination post-spinal cord injuries:
   A review
SO PROGRESS IN NEUROBIOLOGY
LA English
DT Review
DE Spinal cord injuries; Remyelination; Oligodendrocyte; Biomaterials;
   Molecular therapies; Drug delivery systems
ID LEUKEMIA INHIBITORY FACTOR; CENTRAL-NERVOUS-SYSTEM; HIGH-DOSE
   METHYLPREDNISOLONE; SCHWANN-CELL TRANSPLANTATION; OLFACTORY ENSHEATHING
   CELLS; GLIAL PROGENITOR CELLS; CILIARY NEUROTROPHIC FACTOR; RANDOMIZED
   CONTROLLED-TRIAL; ADULT-RAT; FUNCTIONAL RECOVERY
AB In the past four decades, the main focus of investigators in the field of spinal cord regeneration has been to devise therapeutic measures that enhance neural regeneration. More recently, emphasis has been placed on enhancing remyelination and providing oligodendrocyte-protection after a spinal cord injury (SCI). Demyelination post-SCI is part of the cascading secondary injury that takes place immediately after the primary insult; therefore, therapeutic measures are needed to reduce oligodendrocyte death and/or enhance remyelination during the acute stage, preserving neurological functions that would be lost otherwise. In this review a thorough investigation of the oligodendrocyte-protective and remyelinative molecular therapies available to date is provided. The advent of new biomaterials shown to promote remyelination post-SCI is discussed mainly in the context of a combinatorial approach where the biomaterial also provides drug delivery capabilities. The aim of these molecular and biomaterial-based therapies is twofold: (1) oligodendrocyte-protective therapy, which involves protecting already existing oligodendrocytes from undergoing apoptosis/necrosis; and (2) inductive remyelination, which involves harnessing the remyelinative capabilities of endogenous oligodendrocyte precursor cells (OPCs) at the lesion site by providing a suitable environment for their migration, survival, proliferation and differentiation. From the evidence reported in the literature, we conclude that the use of a combinatorial approach including biomaterials and molecular therapies would provide advantages such as: (1) sustained release of the therapeutic molecule, (2) local delivery at the lesion site, and (3) an environment at the site of injury that promotes OPC migration, differentiation and remyelination. (C) 2012 Elsevier Ltd. All rights reserved.
C1 [Mekhail, Mina; Tabrizian, Maryam] McGill Univ, Dept Biomed Engn, Montreal, PQ H3A 2B4, Canada.
   [Almazan, Guillermina] McGill Univ, Dept Pharmacol & Therapeut, Montreal, PQ H3A 2B4, Canada.
   [Tabrizian, Maryam] McGill Univ, Fac Dent, Montreal, PQ H3A 2B4, Canada.
RP Tabrizian, M (reprint author), McGill Univ, Dept Biomed Engn, 3775 Univ St,Duff Med Bldg,Room 313, Montreal, PQ H3A 2B4, Canada.
EM mina.mekhail@mail.mcgill.ca; guillermina.almazan@mcgill.ca;
   maryam.tabrizian@mcgill.ca
FU CIHR regenerative medicine and nanomedicine; NSERC-discovery; MDEIE
FX This manuscript was made possible by grants from CIHR regenerative
   medicine and nanomedicine; NSERC-discovery; and the MDEIE grant.
CR Adams M, 2004, SPINAL CORD, V42, P273, DOI 10.1038/sj.sc.3101597
   Agudo M, 2008, GLIA, V56, P1263, DOI 10.1002/glia.20695
   Aktas Y, 2005, INT J PHARM, V298, P378, DOI 10.1016/j.ijpharm.2005.03.027
   Aktas Y, 2005, BIOCONJUGATE CHEM, V16, P1503, DOI 10.1021/bc050217o
   ALBERTS AW, 1988, AM J CARDIOL, V62, pJ10, DOI 10.1016/0002-9149(88)90002-1
   Althaus HH, 2008, J MOL NEUROSCI, V35, P65, DOI 10.1007/s12031-008-9053-y
   Asakura K, 1998, J NEUROSCI, V18, P7700
   Augst AD, 2006, MACROMOL BIOSCI, V6, P623, DOI 10.1002/mabi.200600069
   Azari MF, 2006, J NEUROPATH EXP NEUR, V65, P914, DOI 10.1097/01.jnen.0000235855.77716.25
   BARRES BA, 1994, NATURE, V367, P371, DOI 10.1038/367371a0
   Baumann N, 2001, PHYSIOL REV, V81, P871
   Beattie MS, 2002, NEURON, V36, P375, DOI 10.1016/S0896-6273(02)01005-X
   Beaumont E, 2009, NEUROSCIENCE, V163, P985, DOI 10.1016/j.neuroscience.2009.07.039
   Bieber AJ, 2002, GLIA, V37, P241, DOI 10.1002/glia.10033
   BLACK JA, 1991, BRAIN RES, V544, P59, DOI 10.1016/0006-8993(91)90885-Y
   BLAKEMORE WF, 1973, J NEUROL SCI, V20, P73, DOI 10.1016/0022-510X(73)90119-6
   Blight A R, 1985, Cent Nerv Syst Trauma, V2, P299
   BLIGHT AR, 1983, NEUROSCIENCE, V10, P521, DOI 10.1016/0306-4522(83)90150-1
   BLIGHT AR, 1989, J NEUROL SCI, V91, P15, DOI 10.1016/0022-510X(89)90073-7
   BOSTOCK H, 1976, NATURE, V263, P786, DOI 10.1038/263786a0
   Boyd JG, 2005, FASEB J, V19, P694, DOI 10.1096/fj.04-2833rev
   BRACKEN MB, 1984, JAMA-J AM MED ASSOC, V251, P45, DOI 10.1001/jama.251.1.45
   BRACKEN MB, 1990, NEW ENGL J MED, V322, P1405, DOI 10.1056/NEJM199005173222001
   Bracken MB, 1998, J NEUROSURG, V89, P699, DOI 10.3171/jns.1998.89.5.0699
   Bracken MB, 1997, JAMA-J AM MED ASSOC, V277, P1597, DOI 10.1001/jama.277.20.1597
   BUNGE RP, 1993, ADV NEUROL, V59, P75
   Burdick JA, 2006, BIOMATERIALS, V27, P452, DOI 10.1016/j.biomaterials.2005.06.034
   Butzkueven H, 2002, NAT MED, V8, P613, DOI 10.1038/nm06020-613
   Cai J, 2007, J BIOMED MATER RES A, V83A, P512, DOI 10.1002/jbm.a.31296
   Cao QL, 2005, J NEUROSCI, V25, P6947, DOI 10.1523/JNEUROSCI.1065-05.2005
   Carty ML, 2008, INT J DEV NEUROSCI, V26, P477, DOI 10.1016/j.ijdevneu.2008.02.005
   Casha S, 2001, NEUROSCIENCE, V103, P203, DOI 10.1016/S0306-4522(00)00538-8
   Casha S, 2009, NEUROSURGERY, V65, P410, DOI 10.1227/01.neu.0000358700.03703.a5
   Chen RW, 2007, NEUROSCI LETT, V418, P165, DOI 10.1016/j.neulet.2007.03.033
   Chen SW, 2009, CHIN J TRAUMATOL, V12, P55, DOI 10.3760/cma.j.issn.1008-1275.2009.01.011
   Chi GF, 2010, EXP NEUROL, V222, P304, DOI 10.1016/j.expneurol.2010.01.008
   Chowdhury I, 2008, COMP BIOCHEM PHYS B, V151, P10, DOI 10.1016/j.cbpb.2008.05.010
   Chvatal SA, 2008, BIOMATERIALS, V29, P1967, DOI 10.1016/j.biomaterials.2008.01.002
   Cohen-Adad J, 2011, NEUROIMAGE, V55, P1024, DOI 10.1016/j.neuroimage.2010.11.089
   Craighead MW, 1999, J NEUROSCI RES, V57, P236, DOI 10.1002/(SICI)1097-4547(19990715)57:2<236::AID-JNR9>3.0.CO;2-D
   Crowe MJ, 1997, NAT MED, V3, P73, DOI 10.1038/nm0197-73
   Cudrici C, 2006, J IMMUNOL, V176, P3173, DOI 10.4049/jimmunol.176.5.3173
   David S, 2003, ANNU REV NEUROSCI, V26, P411, DOI 10.1146/annurev.neuro.26.043002.094946
   Dawson MRL, 2003, MOL CELL NEUROSCI, V24, P476, DOI 10.1016/S1044-7431(03)00210-0
   De Nicola AF, 2006, J MOL NEUROSCI, V28, P3, DOI 10.1385/JMN/28:01:3
   De Nicola AF, 2003, ANN NY ACAD SCI, V1007, P317, DOI 10.1196/annals.1286.030
   Dery MA, 2009, NEUROSCI LETT, V453, P73, DOI 10.1016/j.neulet.2009.01.062
   DSOUZA S, 1995, J NEUROSCI, V15, P7293
   DUCKER TB, 1969, J NEUROSURG, V30, P270, DOI 10.3171/jns.1969.30.3part1.0270
   Emery E, 1998, J NEUROSURG, V89, P911, DOI 10.3171/jns.1998.89.6.0911
   ENGLAND JD, 1990, P NATL ACAD SCI USA, V87, P6777, DOI 10.1073/pnas.87.17.6777
   Faulkner J, 2005, TRANSPL IMMUNOL, V15, P131, DOI 10.1016/j.trim.2005.09.007
   Felleiter P., 2011, SPINE
   FELTS PA, 1992, BRAIN RES, V574, P178, DOI 10.1016/0006-8993(92)90815-Q
   FFRENCHCONSTANT C, 1986, NATURE, V319, P499, DOI 10.1038/319499a0
   Fortun J, 2009, NEUROSCI LETT, V456, P124, DOI 10.1016/j.neulet.2008.08.092
   FRANKLIN RJM, 1993, INT J DEV NEUROSCI, V11, P641, DOI 10.1016/0736-5748(93)90052-F
   Franklin RJM, 2008, NAT REV NEUROSCI, V9, P839, DOI 10.1038/nrn2480
   Frizzo MED, 2002, CELL MOL NEUROBIOL, V22, P353
   Frizzo MES, 2001, NEUROREPORT, V12, P879, DOI 10.1097/00001756-200103260-00051
   Garcia-Miguel Purificacion, 2005, Clin Transl Oncol, V7, P34, DOI 10.1007/s11883-005-0073-6
   GARD AL, 1995, DEVELOPMENT, V121, P2187
   Gensert JM, 1997, NEURON, V19, P197, DOI 10.1016/S0896-6273(00)80359-1
   Gerndt SJ, 1997, J TRAUMA, V42, P279, DOI 10.1097/00005373-199702000-00017
   Ghidoni I, 2008, CYTOTECHNOLOGY, V58, P49, DOI 10.1007/s10616-008-9161-0
   Girard C, 2005, J NEUROSCI, V25, P7924, DOI 10.1523/JNEUROSCI.4890-09.2005
   GLEDHILL RF, 1977, ANN NEUROL, V1, P552, DOI 10.1002/ana.410010607
   GRIFFITHS IR, 1983, J NEUROL SCI, V58, P335, DOI 10.1016/0022-510X(83)90093-X
   GROVES AK, 1993, NATURE, V362, P453, DOI 10.1038/362453a0
   Gu J, 1997, J NEUROSCI RES, V47, P626, DOI 10.1002/(SICI)1097-4547(19970315)47:6<626::AID-JNR8>3.0.CO;2-F
   Guest JD, 2005, EXP NEUROL, V192, P384, DOI 10.1016/j.expneurol.2004.11.033
   Guimaraes JS, 2010, BRAIN RES, V1329, P182, DOI 10.1016/j.brainres.2010.03.007
   Gupta D, 2006, BIOMATERIALS, V27, P2370, DOI 10.1016/j.biomaterials.2005.11.015
   HALL ED, 1982, SURG NEUROL, V18, P320, DOI 10.1016/0090-3019(82)90140-9
   Hall Edward D, 2004, NeuroRx, V1, P80, DOI 10.1007/BF03206569
   Hall ED, 2011, NEUROTHERAPEUTICS, V8, P152, DOI 10.1007/s13311-011-0026-4
   HARRISON BM, 1977, ANN NEUROL, V1, P542, DOI 10.1002/ana.410010606
   Hohlfeid R, 2004, P NATL ACAD SCI USA, V101, P14599, DOI 10.1073/pnas.0404874101
   Horner PJ, 2000, NATURE, V407, P963, DOI 10.1038/35039559
   Iannotti C, 2003, EXP NEUROL, V183, P379, DOI 10.1016/S0014-4886(03)00188-2
   Ibanez C, 2004, NEUROPATH APPL NEURO, V30, P80, DOI 10.1046/j.1365-2990.2003.0515.x
   Imai M, 2008, J NEUROSURG-SPINE, V8, P58, DOI 10.3171/SPI-08/01/058
   Ishii K, 2001, J NEUROSCI RES, V65, P500, DOI 10.1002/jnr.1180
   Jain A, 2006, BIOMATERIALS, V27, P497, DOI 10.1016/j.biomaterials.2005.07.008
   Jayakumar R, 2010, CARBOHYD POLYM, V82, P227, DOI 10.1016/j.carbpol.2010.04.074
   Jiang SC, 2003, NEUROREPORT, V14, P2463, DOI 10.1097/01.wnr.0000095494.09138.ff
   Jiang SC, 2007, PURINERG SIGNAL, V3, P411, DOI 10.1007/s11302-007-9079-6
   Jiang SC, 2008, PURINERG SIGNAL, V4, P61, DOI 10.1007/s11302-007-9093-8
   Johnson JR, 2000, J NEUROCHEM, V74, P1409, DOI 10.1046/j.1471-4159.2000.0741409.x
   KAHN MA, 1994, GLIA, V12, P87, DOI 10.1002/glia.440120202
   Kajana S, 2009, J SPINAL CORD MED, V32, P175, DOI 10.1080/10790268.2009.11760769
   Kakulas B A, 1999, J Spinal Cord Med, V22, P119
   Karatas H, 2009, J NEUROSCI, V29, P13761, DOI 10.1523/JNEUROSCI.4246-09.2009
   Kataoka K, 2001, J BIOMED MATER RES, V54, P373, DOI 10.1002/1097-4636(20010305)54:3<373::AID-JBM90>3.0.CO;2-Q
   Kavanaugh B, 2000, J NEUROSCI RES, V60, P725
   Keirstead HS, 2005, J NEUROSCI, V25, P4694, DOI 10.1523/JNEUROSCI.0311-05.2005
   Keirstead HS, 1998, GLIA, V22, P161, DOI 10.1002/(SICI)1098-1136(199802)22:2<161::AID-GLIA7>3.3.CO;2-Z
   Kerr BJ, 2005, GLIA, V51, P73, DOI 10.1002/glia.20177
   Kigerl KA, 2009, J NEUROSCI, V29, P13435, DOI 10.1523/JNEUROSCI.3257-09.2009
   Kim YT, 2009, BIOMATERIALS, V30, P2582, DOI 10.1016/j.biomaterials.2008.12.077
   King VR, 2010, NEUROSCIENCE, V168, P523, DOI 10.1016/j.neuroscience.2010.03.040
   King VR, 2010, BIOMATERIALS, V31, P4447, DOI 10.1016/j.biomaterials.2010.02.018
   King VR, 2006, BIOMATERIALS, V27, P485, DOI 10.1016/j.biomaterials.2005.06.033
   King VR, 2003, EXP NEUROL, V182, P383, DOI 10.1016/S0014-4886(03)00033-5
   KLEIN NC, 1995, MED CLIN N AM, V79, P789, DOI 10.1016/S0025-7125(16)30039-6
   Kocsis JD, 2009, NEUROSCI LETT, V456, P137, DOI 10.1016/j.neulet.2008.08.093
   Koopmans G.C., 2009, EXP NEUROL
   Kwon Brian K, 2004, Spine J, V4, P451, DOI 10.1016/j.spinee.2003.07.007
   Labombarda F, 2003, J NEUROCHEM, V87, P902, DOI 10.1046/j.1471-4159.2003.02055.x
   Lasiene J, 2008, J NEUROSCI, V28, P3887, DOI 10.1523/JNEUROSCI.4756-07.2008
   Lassmann H, 2007, BRAIN PATHOL, V17, P210, DOI 10.1111/j.1750-3639.2007.00064.x
   Lavdas AA, 2008, CURR MED CHEM, V15, P151
   Lee HC, 2007, SURG NEUROL, V68, pS37, DOI 10.1016/j.sumeu.2007.06.085
   Lee JHT, 2010, EXP NEUROL, V225, P219, DOI 10.1016/j.expneurol.2010.06.018
   Lee JM, 2008, J NEUROSCI, V28, P3141, DOI 10.1523/JNEUROSCI.5547-07.2008
   Lee R, 2001, SCIENCE, V294, P1945, DOI 10.1126/science.1065057
   Leipzig ND, 2009, BIOMATERIALS, V30, P6867, DOI 10.1016/j.biomaterials.2009.09.002
   Li WW, 2005, J NEUROIMMUNOL, V158, P58, DOI 10.1016/j.jneuroim.2004.08.011
   Li XG, 2009, BIOMATERIALS, V30, P1121, DOI 10.1016/j.biomaterials.2008.10.063
   Li Y, 1997, EXP NEUROL, V145, P397, DOI 10.1006/exnr.1997.6502
   Liao JK, 2005, ANNU REV PHARMACOL, V45, P89, DOI 10.1146/annurev.pharmtox.45.120403.095748
   Liu XZ, 1997, J NEUROSCI, V17, P5395
   LUDWIN SK, 1984, J NEUROL SCI, V64, P193, DOI 10.1016/0022-510X(84)90037-6
   Lytle JM, 2009, GLIA, V57, P270, DOI 10.1002/glia.20755
   Mackay-Sim A, 2011, EXP NEUROL, V229, P174, DOI 10.1016/j.expneurol.2010.08.025
   MAYER M, 1994, DEVELOPMENT, V120, P143
   McBride CB, 2003, MOL CELL NEUROSCI, V23, P383, DOI 10.1016/S1044-7431(03)00063-0
   McDonald JW, 2006, J NEUROTRAUM, V23, P345, DOI 10.1089/neu.2006.23.345
   MCDONALD WI, 1974, BRIT MED BULL, V30, P186, DOI 10.1093/oxfordjournals.bmb.a071192
   McTigue DM, 1998, J NEUROSCI, V18, P5354
   McTigue DM, 2001, J NEUROSCI, V21, P3392, DOI 10.1523/JNEUROSCI.21-10-03392.2001
   MERRILL JE, 1993, J IMMUNOL, V151, P2132
   Mo LH, 2010, BIOMATERIALS, V31, P2184, DOI 10.1016/j.biomaterials.2009.11.078
   Molano MD, 2002, J NEUROSURG, V96, P267, DOI 10.3171/spi.2002.96.3.0267
   Moretto MB, 2005, EXP NEUROL, V195, P400, DOI 10.1016/j.expneurol.2005.06.005
   Muzzarelli RAA, 2005, ADV POLYM SCI, V186, P151, DOI 10.1007/b136820
   Noble M., 2011, CURR OPIN NEUROL
   Nomura H, 2008, NEUROSURGERY, V63, P127, DOI 10.1227/01.NEU.0000316.143.88403.16
   Nomura H, 2008, TISSUE ENG PT A, V14, P649, DOI 10.1089/tea.2007.0180
   Norenberg MD, 2004, J NEUROTRAUM, V21, P429, DOI 10.1089/089771504323004575
   Nottingham S, 2002, EXP NEUROL, V177, P242, DOI 10.1006/exnr.2002.7975
   Onose G, 2009, SPINAL CORD, V47, P716, DOI 10.1038/sc.2009.52
   Oudega M, 2006, J NEUROTRAUM, V23, P453, DOI 10.1089/neu.2006.23.453
   Pannu R, 2004, J NEUROCHEM, V90, P69
   Park DH, 2011, STEM CELL REV REP, V7, P181, DOI 10.1007/s12015-010-9163-0
   Patist CM, 2004, BIOMATERIALS, V25, P1569, DOI 10.1016/S0142-9612(03)00503-9
   Pearse DD, 2007, GLIA, V55, P976, DOI 10.1002/glia.20490
   Pearse DD, 2004, NAT MED, V10, P610, DOI 10.1038/nm1056
   PETERS A, 1964, J ANAT, V98, P125
   Pettiford J.N., 2011, PEDIAT SURG INT
   Pinzon A, 2008, BRAIN RES, V1243, P146, DOI 10.1016/j.brainres.2008.09.047
   Poliak S, 2003, NAT REV NEUROSCI, V4, P968, DOI 10.1038/nrn1253
   Popovich PG, 2003, TRENDS PHARMACOL SCI, V24, P13, DOI 10.1016/S0165-6147(02)00006-8
   Prang P, 2006, BIOMATERIALS, V27, P3560, DOI 10.1016/j.biomaterials.2006.01.053
   Qian T, 2005, SPINAL CORD, V43, P199, DOI 10.1038/sj.sc.3101681
   Qiao F, 2006, AM J PATHOL, V169, P1039, DOI 10.2353/ajpath.2006.060248
   Qin YM, 2008, POLYM ADVAN TECHNOL, V19, P6, DOI 10.1002/pat.960
   Ramon-Cueto A, 2011, EXP NEUROL, V229, P181, DOI 10.1016/j.expneurol.2010.10.001
   Rathbone MP, 1999, PROG NEUROBIOL, V59, P663, DOI 10.1016/S0301-0082(99)00017-9
   REMAHL S, 1990, J NEUROCYTOL, V19, P313, DOI 10.1007/BF01188401
   RODRIGUEZ M, 1990, ANN NEUROL, V27, P12, DOI 10.1002/ana.410270104
   RUOSLAHTI E, 1981, J ORAL PATHOL MED, V10, P3, DOI 10.1111/j.1600-0714.1981.tb01242.x
   Saganova K, 2008, NEUROSCI LETT, V433, P246, DOI 10.1016/j.neulet.2008.01.041
   Saini HS, 2004, J NEUROCHEM, V89, P951, DOI 10.1111/j.1471-4159.2004.02365.x
   Sayer Faisal T, 2006, Spine J, V6, P335, DOI 10.1016/j.spinee.2005.11.001
   Schaal SM, 2006, EXP NEUROL, V198, P587, DOI 10.1016/j.expneurol.2006.02.088
   Schwab JM, 2006, PROG NEUROBIOL, V78, P91, DOI 10.1016/j.pneurobio.2005.12.004
   Sharma HS, 2007, CURR PHARM DESIGN, V13, P1841
   Slaets H, 2008, PROTEOMICS, V8, P1237, DOI 10.1002/pmic.200700641
   Soane L, 1999, J IMMUNOL, V163, P6132
   Souness JE, 2000, IMMUNOPHARMACOLOGY, V47, P127, DOI 10.1016/S0162-3109(00)00185-5
   Springer JE, 1999, NAT MED, V5, P943, DOI 10.1038/11387
   Stidworthy MF, 2003, BRAIN PATHOL, V13, P329
   Stirling DP, 2005, NEUROSCIENTIST, V11, P308, DOI 10.1177/1073858405275175
   Stirling DP, 2004, J NEUROSCI, V24, P2182, DOI 10.1523/JNEUROSCI.5275-03.2004
   Straley KS, 2010, J NEUROTRAUM, V27, P1, DOI 10.1089/neu.2009.0948
   Stuve O, 2003, CELL MOL LIFE SCI, V60, P2483, DOI 10.1007/s00018-003-3146-0
   Suberviola B, 2008, INJURY, V39, P748, DOI 10.1016/j.injury.2007.12.005
   Suzuki K, 1999, NEUROREPORT, V10, P2891, DOI 10.1097/00001756-199909290-00003
   Tabesh H, 2009, NEUROCHEM INT, V54, P73, DOI 10.1016/j.neuint.2008.11.002
   Talbott JF, 2005, EXP NEUROL, V192, P11, DOI 10.1016/j.expneurol.2004.05.038
   Tator CH, 1998, NEUROSURGERY, V42, P696, DOI 10.1097/00006123-199804000-00007
   TATOR CH, 1995, BRAIN PATHOL, V5, P407, DOI 10.1111/j.1750-3639.1995.tb00619.x
   Taylor SJ, 2004, J CONTROL RELEASE, V98, P281, DOI 10.1016/j.jconrel.2004.05.003
   Tetzlaff W, 2011, J NEUROTRAUM, V28, P1611, DOI 10.1089/neu.2009.1177
   Thein-Han WW, 2008, MATER SCI TECH-LOND, V24, P1062, DOI 10.1179/174328408X341753
   Thuret S, 2006, NAT REV NEUROSCI, V7, P628, DOI 10.1038/nrn1955
   Totoiu MO, 2005, J COMP NEUROL, V486, P373, DOI 10.1002/cne.20517
   Turnley AM, 2000, J NEUROCHEM, V74, P889, DOI 10.1046/j.1471-4159.2000.0740889.x
   VANEVERCOOREN AB, 1992, J NEUROIMMUNOL, V40, P235
   VARTANIAN T, 1995, MOL MED, V1, P732, DOI 10.1007/BF03401888
   Vos JP, 1996, PERSPECT DEV NEUROBI, V4, P39
   Wang G, 2010, BIOTECHNOL LETT, V32, P59, DOI 10.1007/s10529-009-0123-1
   Warringto AE, 2008, CURR TOP MICROBIOL, V318, P213
   Watanabe M, 2002, J NEUROSCI RES, V69, P826, DOI 10.1002/jnr.10338
   Webb AA, 2010, CAN VET J, V51, P485
   Weiner HL, 2009, ANN NEUROL, V65, P239, DOI 10.1002/ana.21640
   Whitaker CM, 2008, NEUROSCI LETT, V438, P200, DOI 10.1016/j.neulet.2008.03.087
   Woerly S, 1999, TISSUE ENG, V5, P467, DOI 10.1089/ten.1999.5.467
   Woerly S, 2004, J NEUROSCI RES, V75, P262, DOI 10.1002/jnr.10774
   Woerly S, 2001, J NEUROSCI RES, V66, P1187
   Woerly S, 1998, J BIOMAT SCI-POLYM E, V9, P681, DOI 10.1163/156856298X00091
   Woerly S, 2001, BIOMATERIALS, V22, P1095, DOI 10.1016/S0142-9612(00)00354-9
   Woerly S, 2001, INT J DEV NEUROSCI, V19, P63, DOI 10.1016/S0736-5748(00)00064-2
   Wright KT, 2011, STEM CELLS, V29, P169, DOI 10.1002/stem.570
   Wu Y, 2011, SPINAL CORD, V49, P867, DOI 10.1038/sc.2011.28
   Xu J, 2009, J NEUROSCI, V29, P2022, DOI 10.1523/JNEUROSCI.2621-08.2009
   Yan HL, 2000, J NEUROSCI RES, V62, P329, DOI 10.1002/1097-4547(20001101)62:3<329::AID-JNR2>3.0.CO;2-C
   Yeo JE, 2008, CELL PHYSIOL BIOCHEM, V21, P225, DOI 10.1159/000113764
   Yu LMY, 2007, J BIOMED MATER RES A, V82A, P243, DOI 10.1002/jbm.a.31069
   Yune TY, 2007, J NEUROSCI, V27, P7751, DOI 10.1523/JNEUROSCI.1661-07.2007
   Zahir T, 2008, CELL TRANSPLANT, V17, P245, DOI 10.3727/096368908784153887
   Zai LJ, 2005, GLIA, V50, P247, DOI 10.1002/glia.20176
   Zang DW, 2003, J NEUROTRAUM, V20, P1215, DOI 10.1089/089771503770802880
   Zawadzka M, 2010, CELL STEM CELL, V6, P578, DOI 10.1016/j.stem.2010.04.002
   Zhang J., 2011, FEBS LETT
   Zheng L, 2010, J MATER SCI-MATER M, V21, P1713, DOI 10.1007/s10856-010-4003-y
   Zimmermann H, 2007, APPL PHYS A-MATER, V89, P909, DOI 10.1007/s00339-007-4270-8
NR 218
TC 51
Z9 61
U1 0
U2 42
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0301-0082
EI 1873-5118
J9 PROG NEUROBIOL
JI Prog. Neurobiol.
PD MAR
PY 2012
VL 96
IS 3
BP 322
EP 339
DI 10.1016/j.pneurobio.2012.01.008
PG 18
WC Neurosciences
SC Neurosciences & Neurology
GA 921PI
UT WOS:000302489100003
PM 22307058
DA 2018-10-19
ER

PT J
AU Kozlovskaya, V
   Baggett, J
   Godin, B
   Liu, XW
   Kharlampieva, E
AF Kozlovskaya, Veronika
   Baggett, Jennifer
   Godin, Biana
   Liu, Xuewu
   Kharlampieva, Eugenia
TI Hydrogen-Bonded Multilayers of Silk Fibroin: From Coatings to
   Cell-Mimicking Shaped Microcontainers
SO ACS MACRO LETTERS
LA English
DT Article
ID POLYMER-FILMS; TANNIC-ACID; PH; BIOMATERIAL; ASSEMBLIES; STRENGTH
AB We present a novel type of all-aqueous nonionic layer-by-layer films of silk fibroin with synthetic macromolecules and a natural polyphenol. We found the multilayer growth and stability to be strongly pH-dependent. Silk assembled with poly(methacrylic) and tannic acids at pH = 3.5 disintegrated at pH similar to 5, while silk/poly(N-vinylcaprolactam) interactions were stable at low and high pH values; but resulted in thinner films at a high pH. The results suggest that the intermolecular interactions are primarily driven by hydrogen bonding with a considerable contribution of hydrophobic forces. We also demonstrated that cubical, spherical, and platelet capsules with silk-containing walls can be constructed using particulate sacrificial templates. This work sets a foundation for future explorations of natural and synthetic macromolecules assemblies as biomimetic materials with tunable properties.
C1 [Kozlovskaya, Veronika; Baggett, Jennifer; Kharlampieva, Eugenia] Univ Alabama, Dept Chem, Birmingham, AL 35294 USA.
   [Godin, Biana; Liu, Xuewu] Methodist Hosp, Dept Nanomed, Res Inst, Houston, TX 77030 USA.
RP Kharlampieva, E (reprint author), Univ Alabama, Dept Chem, Birmingham, AL 35294 USA.
EM ekharlam@uab.edu
OI Godin Vilentchouk, Biana/0000-0001-6089-6695
FU National Institute of Biomedical Imaging and Bioengineering
   [P30EB011319]; NIH [U54CA143837, 1U54CA151668-01]
FX The authors thank David Kaplan (Tufts University) for providing silk
   fibroin solution. This work was supported by Award No. P30EB011319 from
   the National Institute of Biomedical Imaging and Bioengineering (E.K).
   B.G. and XL. acknowledge the support from NIH U54CA143837 (CTO, PSOC)
   and NIH 1U54CA151668-01 (TCCN, CCNE).
CR Basal G, 2011, J APPL POLYM SCI, V121, P1885, DOI 10.1002/app.33651
   Chen X, 1997, J APPL POLYM SCI, V65, P2257, DOI 10.1002/(SICI)1097-4628(19970912)65:11<2257::AID-APP23>3.0.CO;2-Z
   Erel-Unal I, 2008, MACROMOLECULES, V41, P8737, DOI 10.1021/ma8013564
   Godin B, 2011, ACCOUNTS CHEM RES, V44, P979, DOI 10.1021/ar200077p
   Hirschberg JHKK, 2000, NATURE, V407, P167, DOI 10.1038/35025027
   Hu XA, 2010, BIOMACROMOLECULES, V11, P3178, DOI 10.1021/bm1010504
   Izumrudov VA, 2005, BIOMACROMOLECULES, V6, P1782, DOI 10.1021/bm050096v
   Keten S, 2008, NANO LETT, V8, P743, DOI 10.1021/nl0731670
   Kharlampieva E, 2005, MACROMOLECULES, V38, P10523, DOI 10.1021/ma0516891
   Kharlampieva E, 2006, POLYM REV, V46, P377, DOI 10.1080/15583720600945386
   Kharlampieva E, 2009, ADV MATER, V21, P3053, DOI 10.1002/adma.200803653
   Kozlovskaya V, 2011, CHEM COMMUN, V47, P8352, DOI 10.1039/c1cc12960k
   Lin DH, 2009, CARBON, V47, P2875, DOI 10.1016/j.carbon.2009.06.036
   Lutkenhaus JL, 2007, MACROMOLECULES, V40, P8367, DOI 10.1021/ma0713557CCC:$37.00
   Matsumoto A, 2006, J PHYS CHEM B, V110, P21630, DOI 10.1021/jp056350v
   Nogueira GM, 2010, LANGMUIR, V26, P8953, DOI 10.1021/la904741h
   Sashina ES, 2006, RUSS J APPL CHEM+, V79, P869, DOI 10.1134/S1070427206060012
   Shchepelina O, 2011, ADV MATER, V23, P4655, DOI 10.1002/adma.201102234
   Shutava T, 2005, MACROMOLECULES, V38, P2850, DOI 10.1021/ma047629x
   Stockton WB, 1997, MACROMOLECULES, V30, P2717, DOI 10.1021/ma9700486
   Sukhishvili SA, 2000, J AM CHEM SOC, V122, P9550, DOI 10.1021/ja002410t
   Sun Y., 1998, J POLYM SCI POL LETT, V35, P1405
   Vasconcelos A, 2008, BIOMACROMOLECULES, V9, P1299, DOI 10.1021/bm7012789
   Vepari C, 2007, PROG POLYM SCI, V32, P991, DOI 10.1016/j.progpolymsci.2007.05.013
   Wang LY, 1997, MACROMOL RAPID COMM, V18, P509, DOI 10.1002/marc.1997.030180609
   Wang XQ, 2010, BIOMATERIALS, V31, P1025, DOI 10.1016/j.biomaterials.2009.11.002
   Wang XY, 2005, LANGMUIR, V21, P11335, DOI 10.1021/la051862m
   Yoo JW, 2010, P NATL ACAD SCI USA, V107, P11205, DOI 10.1073/pnas.1000346107
NR 28
TC 21
Z9 21
U1 2
U2 54
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 2161-1653
J9 ACS MACRO LETT
JI ACS Macro Lett.
PD MAR
PY 2012
VL 1
IS 3
BP 384
EP 387
DI 10.1021/mz200118f
PG 4
WC Polymer Science
SC Polymer Science
GA 914RO
UT WOS:000301969600010
PM 22432092
OA Green Accepted
DA 2018-10-19
ER

PT J
AU Waizy, H
   Weizbauer, A
   Maibaum, M
   Witte, F
   Windhagen, H
   Lucas, A
   Denkena, B
   Meyer-Lindenberg, A
   Thorey, F
AF Waizy, Hazibullah
   Weizbauer, Andreas
   Maibaum, Matthias
   Witte, Frank
   Windhagen, Henning
   Lucas, Arne
   Denkena, Berend
   Meyer-Lindenberg, Andrea
   Thorey, Fritz
TI Biomechanical characterisation of a degradable magnesium-based (MgCa0.8)
   screw
SO JOURNAL OF MATERIALS SCIENCE-MATERIALS IN MEDICINE
LA English
DT Article
ID CANCELLOUS BONE SCREWS; IN-VITRO; FRACTURE FIXATION; ALLOYS; IMPLANTS;
   CORROSION; PERFORMANCE; STABILITY; ADDITIONS; CALCIUM
AB Magnesium alloys have been in the focus of research in recent years as degradable biomaterial. The purpose of this study was the biomechanical characterisation of MgCa0.8-screws. The maximum pull out force of screws was determined in a synthetic bone without corrosion and after fixed intervals of corrosion: 24, 48, 72 and 96 h. This in vitro study has been carried out with Hank's solution with a flow rate corresponding to the blood flow in natural bone. A maximum pull out force (F-max) of 201.5 +/- A 9.3 N was measured without corrosion. The biomechanical parameter decreased by 30% after 96 h in corrosive medium compared to the non-corrosion group. A maximum load capacity of 28 +/- A 7.6 N/h was determined. Our biomechanical data suggests that this biodegradable screw provides a promising bone-screw-fixation and has great potential for medical application.
C1 [Waizy, Hazibullah; Maibaum, Matthias; Windhagen, Henning; Thorey, Fritz] Hannover Med Sch, Dept Orthopaed Surg, D-30625 Hannover, Germany.
   [Weizbauer, Andreas; Witte, Frank] Hannover Med Sch, Lab Biomech & Biomat, D-30625 Hannover, Germany.
   [Lucas, Arne; Denkena, Berend] Leibnitz Univ Hanover, Inst Prod Engn & Machine Tools IFW, D-30823 Garbsen, Germany.
   [Meyer-Lindenberg, Andrea] Sch Vet Med Hanover, Small Anim Clin, D-30173 Hannover, Germany.
RP Waizy, H (reprint author), Hannover Med Sch, Dept Orthopaed Surg, Anna von Borries Str 1-7, D-30625 Hannover, Germany.
EM hazibullah.waizy@ddh-gruppe.de
OI Witte, Frank/0000-0001-9154-6217; Meyer-Lindenberg,
   Andrea/0000-0001-6137-3773
FU German Research Society (DFG) [SFB 599]
FX The authors gratefully acknowledge the financial support given by German
   Research Society (DFG) within the collaborative research project (SFB
   599). We thank Markus Badenhop for excellent technical support.
CR Brown GA, 2000, J ORTHOPAED RES, V18, P307, DOI 10.1002/jor.1100180220
   Chapman JR, 1996, J BIOMECH ENG-T ASME, V118, P391, DOI 10.1115/1.2796022
   CLAES L E, 1992, Clinical Materials, V10, P41, DOI 10.1016/0267-6605(92)90083-6
   Disegi J A, 2000, Injury, V31 Suppl 4, P2
   Erdmann N, 2011, ACTA BIOMATER, V7, P1421, DOI 10.1016/j.actbio.2010.10.031
   Florvaag B, 2010, J OROFAC ORTHOP, V71, P53, DOI 10.1007/s00056-010-9933-y
   Hartwig A, 2001, MUTAT RES-FUND MOL M, V475, P113, DOI 10.1016/S0027-5107(01)00074-4
   Huber WO, 2008, FOOT ANKLE INT, V29, P225, DOI 10.3113/FAI.2008.0225
   Janning C, 2010, ACTA BIOMATER, V6, P1861, DOI 10.1016/j.actbio.2009.12.037
   Kirkland NT, 2010, J BIOMED MATER RES B, V95B, P91, DOI 10.1002/jbm.b.31687
   Krause A, 2010, J MATER SCI, V45, P624, DOI 10.1007/s10853-009-3936-3
   LAHTINEN T, 1979, EUR J NUCL MED, V4, P435, DOI 10.1007/BF00300841
   Leung MTC, 2008, EUR J ORTHODONT, V30, P483, DOI 10.1093/ejo/cjm124
   Li YC, 2011, J MATER SCI, V46, P365, DOI 10.1007/s10853-010-4843-3
   Li ZJ, 2008, BIOMATERIALS, V29, P1329, DOI 10.1016/j.biomaterials.2007.12.021
   LOUKOTA RA, 1995, BRIT J ORAL MAX SURG, V33, P174, DOI 10.1016/0266-4356(95)90293-7
   Manivasagam G., 2010, RECENT PAT CORROS SC, V2, P40, DOI DOI 10.2174/1877610801002010040
   Nagels J, 2003, J SHOULDER ELB SURG, V12, P35, DOI 10.1067/mse.2003.22
   Revell PA, 2004, KEY ENG MAT, V254-2, P447, DOI 10.4028/www.scientific.net/KEM.254-256.447
   Song GL, 1999, ADV ENG MATER, V1, P11, DOI 10.1002/(SICI)1527-2648(199909)1:1<11::AID-ADEM11>3.0.CO;2-N
   Song GL, 2003, ADV ENG MATER, V5, P837, DOI 10.1002/adem.200310405
   Stiffler KS, 2004, CLIN TECH SMALL AN P, V19, P105, DOI 10.1053/j.ctsap.2004.09.002
   TAYLOR MS, 1994, J APPL BIOMATER, V5, P151, DOI 10.1002/jab.770050208
   van der Elst M, 1998, CLIN ORTHOP RELAT R, P192
   Witte F, 2005, BIOMATERIALS, V26, P3557, DOI 10.1016/j.biomaterials.2004.09.049
   Witte F, 2010, ACTA BIOMATER, V6, P1680, DOI 10.1016/j.actbio.2010.02.028
   Witte F, 2008, CURR OPIN SOLID ST M, V12, P63, DOI 10.1016/j.cossms.2009.04.001
   Xin YC, 2010, J ELECTROCHEM SOC, V157, pC238, DOI 10.1149/1.3421651
   Zeng RC, 2008, ADV ENG MATER, V10, pB3, DOI 10.1002/adem.200800035
NR 29
TC 17
Z9 17
U1 1
U2 26
PU SPRINGER
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 0957-4530
J9 J MATER SCI-MATER M
JI J. Mater. Sci.-Mater. Med.
PD MAR
PY 2012
VL 23
IS 3
BP 649
EP 655
DI 10.1007/s10856-011-4544-8
PG 7
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 910LY
UT WOS:000301639900005
PM 22210311
DA 2018-10-19
ER

PT J
AU Marcal, H
   Ahmed, T
   Badylak, SF
   Tottey, S
   Foster, LJR
AF Marcal, Helder
   Ahmed, Tania
   Badylak, Stephen F.
   Tottey, Stephen
   Foster, L. John R.
TI A comprehensive protein expression profile of extracellular matrix
   biomaterial derived from porcine urinary bladder
SO REGENERATIVE MEDICINE
LA English
DT Article
DE biomaterial; ECM; extracellular matrix; proteomics; scaffold; tissue
   engineering; tissue regeneration; UBM; urinary bladder matrix
ID INTERMEDIATE-FILAMENTS; MACULAR DEGENERATION; BIOLOGIC SCAFFOLDS;
   SKELETAL-MUSCLE; CELL MOTILITY; XIV COLLAGEN; IN-VIVO; TISSUE; GROWTH;
   DIFFERENTIATION
AB Aims: To generate a comprehensive profile of the protein composition of xenogeneic biomaterial, derived from porcine urinary bladder matrix (UBM). Materials & methods: Tunica layers and muscularis mucosa were removed from bladders using mechanical delamination. UBM was prepared using a solution of peracetic acid in ethanol, lyophilized then milled into powder. UBM biomaterial was subjected to tryptic digests and components separated using high-performance liquid chromatography with an ion trap mass spectrometer and identified through databases. Results: A repertoire of 129 proteins with neurotrophic, antiangiogenic and tumor-suppressive activities and those associated with tissue remodeling and wound repair were identified. Conclusion: This study provides the first insight into the complex nature of the UBM and how its application may be tailored for specific applications in regenerative medicine. We propose that the UBM be further investigated for reconstructive and regenerative remodeling of cardiac and dermal tissues, as well as peripheral nerves.
C1 [Marcal, Helder; Ahmed, Tania; Foster, L. John R.] Univ New S Wales, Ctr Adv Macromol, Sch Biotechnol & Biomol Sci, Bio Polymer Res Grp, Sydney, NSW 2052, Australia.
   [Badylak, Stephen F.; Tottey, Stephen] Univ Pittsburgh, McGowan Inst Regenerat Med, Pittsburgh, PA 15213 USA.
   [Badylak, Stephen F.] Univ Pittsburgh, Dept Surg, Pittsburgh, PA 15213 USA.
RP Foster, LJR (reprint author), Univ New S Wales, Ctr Adv Macromol, Sch Biotechnol & Biomol Sci, Bio Polymer Res Grp, Sydney, NSW 2052, Australia.
EM j.foster@unsw.edu.au
OI Badylak, Stephen/0000-0003-3555-0689
FU National Health and Medical Research Council (NHMRC) of Australia
   [1000674]; Fulbright Senior Scholarship
FX This study was supported by a Development grant from the National Health
   and Medical Research Council (NHMRC) of Australia to LJR Foster (grant
   no. 1000674) and a Fulbright Senior Scholarship (2009) to LJR Foster.
   The authors have no other relevant affiliations or financial involvement
   with any organization or entity with a financial interest in or
   financial conflict with the subject matter or materials discussed in the
   manuscript apart from those disclosed.
CR Agrawal V, 2009, J TISSUE ENG REGEN M, V3, P590, DOI 10.1002/term.200
   Altin JG, 1997, IMMUNOL CELL BIOL, V75, P430, DOI 10.1038/icb.1997.68
   Badylak S. F., 2010, FDN REGENERATIVE MED, P326
   Badylak SF, 2004, TRANSPL IMMUNOL, V12, P367, DOI 10.1016/j.trim.2003.12.016
   Badylak SF, 2009, ACTA BIOMATER, V5, P1, DOI 10.1016/j.actbio.2008.09.013
   Bellows CG, 1999, CELL TISSUE RES, V297, P249, DOI 10.1007/s004410051353
   Bereczki E, 2008, CONNECT TISSUE RES, V49, P129, DOI 10.1080/03008200802148504
   Bornslaeger EA, 1996, J CELL BIOL, V134, P985, DOI 10.1083/jcb.134.4.985
   Boruch AV, 2010, J SURG RES, V161, P217, DOI 10.1016/j.jss.2009.02.014
   Brown BN, 2009, BIOMATERIALS, V30, P1482, DOI 10.1016/j.biomaterials.2008.11.040
   Carson AE, 2009, REGEN MED, V4, P593, DOI 10.2217/RME.09.30
   Chang YY, 2004, BIOMATERIALS, V25, P3603, DOI 10.1016/j.biomaterials.2003.10.039
   Concannon CG, 2003, APOPTOSIS, V8, P61, DOI 10.1023/A:1021601103096
   Conway SJ, 2008, CURR GENOMICS, V9, P548, DOI 10.2174/138920208786847917
   Cook JL, 2001, TISSUE ENG, V7, P321, DOI 10.1089/10763270152044189
   Curtis AM, 2004, J BIOL CHEM, V279, P7091, DOI 10.1074/jbc.M311973200
   Davis NF, 2011, J MECH BEHAV BIOMED, V4, P375, DOI 10.1016/j.jmbbm.2010.11.005
   Dinnes DLM, 2008, J CHEM TECHNOL BIOT, V83, P482, DOI 10.1002/jctb.1854
   Forsberg EC, 2000, P NATL ACAD SCI USA, V97, P14494, DOI 10.1073/pnas.97.26.14494
   Freeman LJ, 2005, BIOCHEM J, V388, P1, DOI 10.1042/BJ20050368
   Freytes DO, 2006, J BIOMED MATER RES B, V78B, P327, DOI 10.1002/jbm.b.30491
   Gilbert TW, 2008, ANN THORAC SURG, V86, P967, DOI 10.1016/j.athoracsur.2008.04.071
   Gilbert TW, 2005, BIOMATERIALS, V26, P1431, DOI 10.1016/j.biomaterials.2004.04.042
   Goldoni S, 2008, INT J CANCER, V23, P2473
   Hirai M, 2007, J CELL BIOL, V176, P1061, DOI 10.1083/jcb.200611026
   Hsu DK, 2002, GLYCOCONJUGATE J, V19, P507, DOI 10.1023/B:GLYC.0000014080.95829.52
   Kao WWY, 2003, GLYCOCONJUGATE J, V19, P275, DOI 10.1023/A:1025396316169
   Kinsella MG, 2004, CRIT REV EUKAR GENE, V14, P203, DOI 10.1615/CritRevEukaryotGeneExpr.v14.i3.40
   Kontrogianni-Konstantopoulos A, 2004, AM J PHYSIOL-CELL PH, V287, pC209, DOI 10.1152/ajpcell.00497.2003
   Lampe AK, 2005, J MED GENET, V42, P673, DOI 10.1136/jmg.2002.002311
   LETHIAS C, 1993, J INVEST DERMATOL, V101, P92, DOI 10.1111/1523-1747.ep12360433
   Li J, 2003, MICROSC RES TECHNIQ, V60, P107, DOI 10.1002/jemt.10249
   Li ZL, 1997, J CELL BIOL, V139, P129, DOI 10.1083/jcb.139.1.129
   Lotery AJ, 2006, HUM MUTAT, V27, P568, DOI 10.1002/humu.20344
   Meng JJ, 1997, J BIOL CHEM, V272, P21495, DOI 10.1074/jbc.272.34.21495
   Mitchison TJ, 1996, CELL, V84, P371, DOI 10.1016/S0092-8674(00)81281-7
   Mizuno Y, 2001, P NATL ACAD SCI USA, V98, P6156, DOI 10.1073/pnas.111153298
   Mogilner A, 1996, BIOPHYS J, V71, P3030, DOI 10.1016/S0006-3495(96)79496-1
   Nikitovic D, 2008, IUBMB LIFE, V60, P818, DOI 10.1002/iub.131
   Nomura Y, 2006, CONNECT TISSUE RES, V47, P249, DOI 10.1080/03008200600846606
   Norris RA, 2009, J CELL COMMUN SIGNAL, V3, P275, DOI 10.1007/s12079-009-0063-5
   Ott HC, 2008, NAT MED, V14, P213, DOI 10.1038/nm1684
   Pajala A, 2009, HISTOL HISTOPATHOL, V24, P1207, DOI 10.14670/HH-24.1207
   Paul C, 2002, MOL CELL BIOL, V22, P816, DOI 10.1128/MCB.22.3.816-834.2002
   Petersen TH, 2010, SCIENCE, V329, P538, DOI 10.1126/science.1189345
   Peyton SR, 2006, BIOMATERIALS, V27, P4881, DOI 10.1016/j.biomaterials.2006.05.012
   Pradhan S, 2010, REGEN MED, V6, P961
   Puche AC, 1996, DEV BIOL, V179, P274, DOI 10.1006/dbio.1996.0257
   Reing JE, 2010, BIOMATERIALS, V31, P8626, DOI 10.1016/j.biomaterials.2010.07.083
   Reing JE.ZhangL, 2008, TISSUE ENG PART A, V5, P605
   Robinson K, 2005, CIRCULATION, V112, P137
   Ruoslahti E, 1996, ANNU REV CELL DEV BI, V12, P697, DOI 10.1146/annurev.cellbio.12.1.697
   Saussez S, 2006, CELL MOL LIFE SCI, V63, P686, DOI 10.1007/s00018-005-5458-8
   Shields KJ, 2004, TISSUE ENG, V10, P1510, DOI 10.1089/1076327042500373
   Stankus JJ, 2008, J BIOMAT SCI-POLYM E, V19, P635, DOI 10.1163/156856208784089599
   Stone EM, 2004, NEW ENGL J MED, V351, P346, DOI 10.1056/NEJMoa040833
   SYED F, 2010, BRIT J DERMATOL, V164, P83
   Tombran-Tink J, 2003, TRENDS MOL MED, V9, P244, DOI 10.1016/S1471-4914(03)00074-1
   Valentin JE, 2010, BIOMATERIALS, V31, P7475, DOI 10.1016/j.biomaterials.2010.06.039
   Wagstaff MJD, 1999, J BIOL CHEM, V274, P5061, DOI 10.1074/jbc.274.8.5061
   Wainwright JM, 2010, TISSUE ENG PART C-ME, V16, P525, DOI [10.1089/ten.tec.2009.0392, 10.1089/ten.TEC.2009.0392]
   Wang N, 2002, J MUSCLE RES CELL M, V23, P535, DOI 10.1023/A:1023470709071
   Xu R, 2009, CANCER METAST REV, V28, P167, DOI 10.1007/s10555-008-9178-z
   Yabe T, 2010, CURR MOL MED, V10, P259, DOI 10.2174/156652410791065354
   Yamagishi SI, 2010, CURR MOL MED, V10, P284, DOI 10.2174/156652410791065264
   Yang RY, 2003, CELL MOL LIFE SCI, V60, P267, DOI 10.1007/s000180300022
   Yoshio T, 2007, FEBS LETT, V581, P3777, DOI 10.1016/j.febslet.2007.06.073
   Young BB, 2000, DEV DYNAM, V217, P430, DOI 10.1002/(SICI)1097-0177(200004)217:4<430::AID-DVDY10>3.0.CO;2-5
   Zhou ZJ, 2004, CANCER RES, V64, P4699, DOI 10.1158/0008-5472.CAN-04-0810
   Zhu LM, 2006, NAT GENET, V38, P343, DOI 10.1038/ng1721
   Zoeller JJ, 2008, J CELL BIOL, V181, P381, DOI 10.1083/jcb.200708022
NR 71
TC 25
Z9 25
U1 0
U2 22
PU FUTURE MEDICINE LTD
PI LONDON
PA UNITEC HOUSE, 3RD FLOOR, 2 ALBERT PLACE, FINCHLEY CENTRAL, LONDON, N3
   1QB, ENGLAND
SN 1746-0751
J9 REGEN MED
JI Regen. Med.
PD MAR
PY 2012
VL 7
IS 2
BP 159
EP 166
DI 10.2217/RME.12.6
PG 8
WC Cell & Tissue Engineering; Engineering, Biomedical
SC Cell Biology; Engineering
GA 906EH
UT WOS:000301327200008
PM 22397606
DA 2018-10-19
ER

PT J
AU Kubinova, S
   Sykova, E
AF Kubinova, Sarka
   Sykova, Eva
TI Biomaterials combined with cell therapy for treatment of spinal cord
   injury
SO REGENERATIVE MEDICINE
LA English
DT Review
DE biomaterial; cell therapy; scaffold; spinal cord injury; stem cell;
   tissue engineering
ID NEURAL STEM-CELLS; POLY(2-HYDROXYETHYL METHACRYLATE) SCAFFOLDS;
   MAGNETIC-RESONANCE TRACKING; OLFACTORY-ENSHEATHING GLIA; SEEDED GUIDANCE
   CHANNELS; AXONAL REGENERATION; SCHWANN-CELLS; FUNCTIONAL RECOVERY;
   BIODEGRADABLE HYDROGEL; DELAYED IMPLANTATION
AB Spinal cord injury (SCI) is a devastating traumatic injury resulting in paralysis or sensory deficits due to tissue damage and the poor ability of axons to regenerate across the lesion. Despite extensive research, there is still no effective treatment that would restore lost function after SCI. A possible therapeutic approach would be to bridge the area of injury with a bioengineered scaffold that would create a stimulatory environment as well as provide guidance cues for the re-establishment of damaged axonal connections. Advanced scaffold design aims at the fabrication of complex materials providing the concomitant delivery of cells, neurotrophic factors or other bioactive substances to achieve a synergistic effect for treatment. This review summarizes the current utilization of scaffolding materials for SCI treatment in terms of their physicochemical properties and emphasizes their use in combination with various cell types, as well as with other combinatorial approaches promoting spinal cord repair.
C1 [Kubinova, Sarka; Sykova, Eva] Acad Sci Czech Republic, Inst Expt Med, Prague, Czech Republic.
   [Sykova, Eva] Charles Univ Prague, Dept Neurosci, Prague, Czech Republic.
   [Sykova, Eva] Charles Univ Prague, Ctr Cell Therapy & Tissue Repair, Prague, Czech Republic.
RP Kubinova, S (reprint author), Acad Sci Czech Republic, Inst Expt Med, Prague, Czech Republic.
EM sarka.k@biomed.cas.c2
RI Kubinova, Sarka/G-9922-2014; Sykova, Eva/H-2659-2014
FU Grant Agency of the Czech Republic [108/10/1560, P304/11/0731,
   P304/11/0653]; Grant Agency of the Academy of Sciences of the Czech
   Republic [1AA500390902, KAN200520804]; Ministry of Education, Youth and
   Sport of the Czech Republic [1M0538]
FX The financial support of the Grant Agency of the Czech Republic
   (108/10/1560, P304/11/0731, P304/11/0653), the Grant Agency of the
   Academy of Sciences of the Czech Republic (1AA500390902, KAN200520804)
   and the Ministry of Education, Youth and Sport of the Czech Republic
   (1M0538) is gratefully acknowledged. The authors have no other relevant
   affiliations or financial involvement with any organization or entity
   with a financial interest in or financial conflict with the subject
   matter or materials discussed in the manuscript apart from those
   disclosed.
CR Adams DN, 2005, J NEUROBIOL, V62, P134, DOI 10.1002/neu.20075
   Afshari FT, 2010, J NEUROSCI, V30, P4246, DOI 10.1523/JNEUROSCI.3351-09.2010
   Aghayan HR, 2011, CELL TISSUE IN PRESS
   Amemori T, 2010, CYTOTHERAPY, V12, P212, DOI 10.3109/14653240903440103
   Bakshi A, 2004, J NEUROSURG-SPINE, V1, P322, DOI 10.3171/spi.2004.1.3.0322
   Bamber NI, 2001, EUR J NEUROSCI, V13, P257, DOI 10.1046/j.1460-9568.2001.01387.x
   Baptiste DC, 2007, PROG BRAIN RES, V161, P217, DOI 10.1016/S0079-6123(06)61015-7
   Bradbury EJ, 2011, BRAIN RES BULL, V84, P306, DOI 10.1016/j.brainresbull.2010.06.015
   Bunge MB, 2008, J SPINAL CORD MED, V31, P262, DOI 10.1080/10790268.2008.11760720
   Cao HQ, 2009, ADV DRUG DELIVER REV, V61, P1055, DOI 10.1016/j.addr.2009.07.009
   Chan G, 2008, TRENDS BIOTECHNOL, V26, P382, DOI 10.1016/j.tibtech.2008.03.011
   Chau CH, 2004, FASEB J, V18, P194, DOI 10.1096/fj.03-0196fje
   Chen AQ, 1996, EXP NEUROL, V138, P261, DOI 10.1006/exnr.1996.0065
   Chen BK, 2009, J NEUROTRAUM, V26, P1759, DOI [10.1089/neu.2008.0610, 10.1089/neu.2008-0610]
   Chen BKK, 2011, BIOMATERIALS, V32, P8077, DOI 10.1016/j.biomaterials.2011.07.029
   Chen G, 2010, CHINESE MED J-PEKING, V123, P2424, DOI 10.3760/cma.j.issn.0366-6999.2010.17.025
   Cheung HY, 2007, COMPOS PART B-ENG, V38, P291, DOI 10.1016/j.compositesb.2006.06.014
   Cigognini D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019782
   Cloutier F, 2006, REGEN MED, V1, P469, DOI 10.2217/17460751.1.4.469
   Coutts M, 2008, EXP NEUROL, V209, P368, DOI 10.1016/j.expneurol.2007.09.002
   Dodla MC, 2008, BIOMATERIALS, V29, P33, DOI 10.1016/j.biomaterials.2007.08.045
   Engler AJ, 2006, CELL, V126, P677, DOI 10.1016/j.cell.2006.06.044
   Enzmann GU, 2005, EXP NEUROL, V195, P293, DOI 10.1016/j.expneurol.2005.04.021
   Fortun J, 2009, NEUROSCI LETT, V456, P124, DOI 10.1016/j.neulet.2008.08.092
   Fouad K, 2005, J NEUROSCI, V25, P1169, DOI 10.1523/JNEUROSCI.3562-04.2005
   Fournier E, 2003, BIOMATERIALS, V24, P3311, DOI 10.1016/S0142-9612(03)00161-3
   Gal P, 2009, CELL MOL NEUROBIOL, V29, P1025, DOI 10.1007/s10571-009-9392-4
   Gelain F, 2011, ACS NANO, V5, P227, DOI 10.1021/nn102461w
   Gopferich A, 1996, BIOMATERIALS, V17, P103, DOI 10.1016/0142-9612(96)85755-3
   Gros T, 2010, BIOMATERIALS, V31, P6719, DOI 10.1016/j.biomaterials.2010.04.035
   Gunn JW, 2005, J BIOMED MATER RES A, V72A, P91, DOI 10.1002/jbm.a.30203
   Guo J, 2007, NANOMED-NANOTECHNOL, V3, P311, DOI 10.1016/j.nano.2007.09.003
   Hamann MCJ, 2005, EXP NEUROL, V194, P106, DOI 10.1016/j.expneurol.2005.01.030
   Harkema S, 2011, LANCET, V377, P1938, DOI 10.1016/S0140-6736(11)60547-3
   Hatami M, 2009, CYTOTHERAPY, V11, P618, DOI 10.1080/14653240903005802
   Hejcl A, 2008, PHYSIOL RES, V57, pS121
   Hejcl A, 2008, J NEUROSURG-SPINE, V8, P67, DOI 10.3171/SPI-08/01/067
   Hejcl A, 2010, STEM CELLS DEV, V19, P1535, DOI 10.1089/scd.2009.0378
   Hill CE, 2006, GLIA, V53, P338, DOI 10.1002/glia.20287
   Hsu JYC, 2005, J NEUROSCI RES, V82, P472, DOI 10.1002/jnr.20662
   Huang JH, 2010, J BIOMED MATER RES A, V93A, P164, DOI 10.1002/jbm.a.32511
   Hulsebosch CE, 2002, ADV PHYSIOL EDUC, V26, P238, DOI 10.1152/advan.00039.2002
   Hurtado A, 2006, BIOMATERIALS, V27, P430, DOI 10.1016/j.biomaterials.2005.07.014
   Hurtado A, 2011, BIOMATERIALS, V32, P6068, DOI 10.1016/j.biomaterials.2011.05.006
   Huveneers S, 2009, J CELL SCI, V122, P1059, DOI 10.1242/jcs.039446
   Hwang DH, 2011, CELL TRANSPLANT, V20, P1361, DOI 10.3727/096368910X557155
   Iannotti C, 2003, EXP NEUROL, V183, P379, DOI 10.1016/S0014-4886(03)00188-2
   Itosaka H, 2009, NEUROPATHOLOGY, V29, P248, DOI 10.1111/j.1440-1789.2008.00971.x
   Jain A, 2006, BIOMATERIALS, V27, P497, DOI 10.1016/j.biomaterials.2005.07.008
   Johnson PJ, 2010, CELL TRANSPLANT, V19, P89, DOI 10.3727/096368909X477273
   Jones KS, 2008, SEMIN IMMUNOL, V20, P130, DOI 10.1016/j.smim.2007.11.005
   Joosten EAJ, 2004, J NEUROSCI RES, V77, P127, DOI 10.1002/jnr.20088
   Kadoya K, 2009, NEURON, V64, P165, DOI 10.1016/j.neuron.2009.09.016
   Kang KN, 2011, TISSUE ENG PT A, V17, P2143, DOI [10.1089/ten.tea.2011.0122, 10.1089/ten.TEA.2011.0122]
   Karimi-Abdolrezaee S, 2006, J NEUROSCI, V26, P3377, DOI 10.1523/JNEUROSCI.4184-05.2006
   Katz JS, 2009, WIRES NANOMED NANOBI, V1, P128, DOI 10.1002/wnan.010
   Keirstead HS, 2005, J NEUROSCI, V25, P4694, DOI 10.1523/JNEUROSCI.0311-05.2005
   Kozubenko N, 2010, 7 FENS FOR EUR NEUR
   Kozubenko N, 2010, CELL TRANSPLANT, V19, P471, DOI 10.3727/096368909X484707
   Krych AJ, 2009, ACTA BIOMATER, V5, P2551, DOI 10.1016/j.actbio.2009.03.021
   Kubinova S, 2011, J BIOMED MATER RES A, V99A, P618, DOI 10.1002/jbm.a.33221
   Kubinova S, 2010, BIOMATERIALS, V31, P5966, DOI 10.1016/j.biomaterials.2010.04.040
   Kubinova S, 2010, MINIM INVASIV THER, V19, P144, DOI 10.3109/13645706.2010.481398
   Kubinova S, 2010, NANOMEDICINE-UK, V5, P99, DOI [10.2217/nnm.09.93, 10.2217/NNM.09.93]
   Kubinova S, 2009, BIOMATERIALS, V30, P4601, DOI 10.1016/j.biomaterials.2009.05.007
   Leach JB, 2007, J NEURAL ENG, V4, P26, DOI 10.1088/1741-2560/4/2/003
   Lee H, 2010, P NATL ACAD SCI USA, V107, P3340, DOI 10.1073/pnas.0905437106
   Madigan NN, 2009, RESP PHYSIOL NEUROBI, V169, P183, DOI 10.1016/j.resp.2009.08.015
   Maquet V, 2001, BIOMATERIALS, V22, P1137, DOI 10.1016/S0142-9612(00)00357-4
   Martino G, 2006, NAT REV NEUROSCI, V7, P395, DOI 10.1038/nrn1908
   Min SH, 2011, SPINE, V36, pE155, DOI 10.1097/BRS.0b013e3181d8b92a
   Mollers S, 2009, TISSUE ENG PT A, V15, P461, DOI 10.1089/ten.tea.2007.0107
   Moore MJ, 2006, BIOMATERIALS, V27, P419, DOI 10.1016/j.biomaterials.2005.07.045
   Musoke-Zawedde P, 2006, BIOMED MATER, V1, P162, DOI 10.1088/1748-6041/1/3/011
   Nguyen EH, 2011, MACROMOL BIOSCI, V11, P483, DOI 10.1002/mabi.201000448
   Nisbet DR, 2008, J BIOMED MATER RES B, V87B, P251, DOI 10.1002/jbm.b.31000
   Nomura H, 2006, J NEUROTRAUM, V23, P496, DOI 10.1089/neu.2006.23.496
   Nomura H, 2008, NEUROSURGERY, V63, P127, DOI 10.1227/01.NEU.0000316.143.88403.16
   Nomura H, 2008, TISSUE ENG PT A, V14, P649, DOI 10.1089/tea.2007.0180
   Novikova LN, 2008, BIOMATERIALS, V29, P1198, DOI 10.1016/j.biomaterials.2007.11.033
   Okada S, 2005, FASEB J, V19, P1839, DOI 10.1096/fj.05-4082fje
   Olson HE, 2009, TISSUE ENG PT A, V15, P1797, DOI 10.1089/ten.tea.2008.0364
   Oudega M, 2006, J NEUROTRAUM, V23, P453, DOI 10.1089/neu.2006.23.453
   Oudega M, 2001, BIOMATERIALS, V22, P1125, DOI 10.1016/S0142-9612(00)00346-X
   Parr AM, 2008, NEUROSCIENCE, V155, P760, DOI 10.1016/j.neuroscience.2008.05.042
   Piantino J, 2006, EXP NEUROL, V201, P359, DOI 10.1016/j.expneurol.2006.04.020
   Prang P, 2006, BIOMATERIALS, V27, P3560, DOI 10.1016/j.biomaterials.2006.01.053
   Ramer MS, 2000, NATURE, V403, P312, DOI 10.1038/35002084
   Romanyuk N, 2011, 8 IBRO WORLD C NEUR
   Rossi SL, 2009, CURR OPIN BIOTECH, V20, P552, DOI 10.1016/j.copbio.2009.09.008
   Sandvig A, 2004, GLIA, V46, P225, DOI 10.1002/glia.10315
   Schlosshauer B, 2006, NEUROSURGERY, V59, P740, DOI 10.1227/01.NEU.0000235197.36789.42
   Silva NA, 2010, TISSUE ENG PT A, V16, P45, DOI [10.1089/ten.tea.2008.0559, 10.1089/ten.TEA.2008.0559]
   Silver J, 2004, NAT REV NEUROSCI, V5, P146, DOI 10.1038/nrn1326
   Stokols S, 2006, BIOMATERIALS, V27, P443, DOI 10.1016/j.biomaterials.2005.06.039
   Straley KS, 2010, J NEUROTRAUM, V27, P1, DOI 10.1089/neu.2009.0948
   Sykova E, 2005, ANN NY ACAD SCI, V1049, P146, DOI 10.1196/annals.1334.014
   Sykova E, 2006, NEURODEGENER DIS, V3, P62, DOI 10.1159/000092095
   Sykova E, 2006, CELL TRANSPLANT, V15, P675, DOI 10.3727/000000006783464381
   Teng YD, 2002, P NATL ACAD SCI USA, V99, P3024, DOI 10.1073/pnas.052678899
   Tetzlaff W, 2011, J NEUROTRAUM, V28, P1611, DOI 10.1089/neu.2009.1177
   Tewarie RDSN, 2009, J NEUROTRAUM, V26, P2313, DOI 10.1089/neu.2009.0987
   Thuret S, 2006, NAT REV NEUROSCI, V7, P628, DOI 10.1038/nrn1955
   Tsai EC, 2006, BIOMATERIALS, V27, P519, DOI 10.1016/j.biomaterials.2005.07.025
   Tsai EC, 2004, J NEUROTRAUM, V21, P789, DOI 10.1089/0897715041269687
   Tysseling VM, 2010, J NEUROSCI RES, V88, P3161, DOI 10.1002/jnr.22472
   Tysseling-Mattiace VM, 2008, J NEUROSCI, V28, P3814, DOI 10.1523/JNEUROSCI.0143-08.2008
   Uccelli A, 2011, BEST PRACT RES CL HA, V24, P59, DOI 10.1016/j.beha.2011.01.004
   Urdzikova L, 2006, J NEUROTRAUM, V23, P1379, DOI 10.1089/neu.2006.23.1379
   Vavrek R, 2007, J NEUROTRAUM, V24, P1667, DOI 10.1089/neu.2007.0290
   Wang DF, 2011, J NEUROSCI, V31, P9332, DOI 10.1523/JNEUROSCI.0983-11.2011
   Wang MD, 2011, TISSUE ENG PART B-RE, V17, P177, DOI 10.1089/ten.teb.2010.0648
   Wei YT, 2010, J BIOMED MATER RES B, V95B, P110, DOI 10.1002/jbm.b.31689
   Willerth SM, 2008, ADV DRUG DELIVER REV, V60, P263, DOI 10.1016/j.addr.2007.08.028
   Willerth SM, 2007, ADV DRUG DELIVER REV, V59, P325, DOI 10.1016/j.addr.2007.03.014
   Woerly S, 2001, BIOMATERIALS, V22, P1095, DOI 10.1016/S0142-9612(00)00354-9
   Woerly S, 2008, BIOMACROMOLECULES, V9, P2329, DOI 10.1021/bm800234r
   Wong DY, 2008, J NEUROTRAUM, V25, P1027, DOI 10.1089/neu.2007.0473
   Wright KT, 2011, STEM CELLS, V29, P169, DOI 10.1002/stem.570
   Xie JW, 2010, NANOSCALE, V2, P35, DOI 10.1039/b9nr00243j
   Xu XM, 2009, RESP PHYSIOL NEUROBI, V169, P171, DOI 10.1016/j.resp.2009.07.016
   Xu XM, 1999, EUR J NEUROSCI, V11, P1723, DOI 10.1046/j.1460-9568.1999.00591.x
   Xu XM, 1997, J NEUROCYTOL, V26, P1, DOI 10.1023/A:1018557923309
   XU XM, 1995, J COMP NEUROL, V351, P145, DOI 10.1002/cne.903510113
   XU XM, 1995, EXP NEUROL, V134, P261, DOI 10.1006/exnr.1995.1056
   Yu D, 2009, STEM CELLS, V27, P1212, DOI 10.1002/stem.26
   Yu L, 2006, PROG POLYM SCI, V31, P576, DOI 10.1016/j.progpolymsci.2006.03.002
   Zeng X, 2011, CELL TRANSP IN PRESS
NR 128
TC 30
Z9 34
U1 1
U2 53
PU FUTURE MEDICINE LTD
PI LONDON
PA UNITEC HOUSE, 3RD FLOOR, 2 ALBERT PLACE, FINCHLEY CENTRAL, LONDON, N3
   1QB, ENGLAND
SN 1746-0751
EI 1746-076X
J9 REGEN MED
JI Regen. Med.
PD MAR
PY 2012
VL 7
IS 2
BP 207
EP 224
DI 10.2217/RME.11.121
PG 18
WC Cell & Tissue Engineering; Engineering, Biomedical
SC Cell Biology; Engineering
GA 906EH
UT WOS:000301327200012
PM 22397610
DA 2018-10-19
ER

PT J
AU Aramwit, P
   Siritientong, T
   Srichana, T
AF Aramwit, Pornanong
   Siritientong, Tippawan
   Srichana, Teerapol
TI Potential applications of silk sericin, a natural protein from textile
   industry by-products
SO WASTE MANAGEMENT & RESEARCH
LA English
DT Review
DE Biomaterials; immunological responses; protein cross-linking; silk
   sericin
ID REDUCING OXIDATIVE STRESS; WASTE-WATER; EXTRACTION METHODS; CELL
   CULTURE; BOMBYX-MORI; RATS; PROLIFERATION; SEPARATION; RESPONSES;
   RECOVERY
AB Silk is composed of two major proteins, fibroin (fibrous protein) and sericin (globular, gumming protein). Fibroin has been used in textile manufacturing and for several biomaterial applications, whereas sericin is considered a waste material in the textile industry. Sericin has recently been found to activate the proliferation of several cell-lines and has also shown various biological activities. Sericin can form a gel by itself; however, after mixing with other polymers and cross-linking it can form a film or a scaffold with good characteristics that can be used in the cosmetic and pharmaceutical industries. Sericin is proven to cause no immunological responses, which has resulted in a more acceptable material for biological applications.
C1 [Aramwit, Pornanong; Siritientong, Tippawan] Chulalongkorn Univ, Fac Pharmaceut Sci, Dept Pharm Practice, Bangkok, Thailand.
   [Srichana, Teerapol] Prince Songkla Univ, Fac Pharmaceut Sci, Dept Pharmaceut Technol, Hat Yai, Songkla, Thailand.
RP Aramwit, P (reprint author), Chulalongkorn Univ, Fac Pharmaceut Sci, Dept Pharm Practice, Bangkok, Thailand.
EM aramwit@gmail.com
OI Srichana, Teerapol/0000-0002-4772-2276; Aramwit,
   Pornanong/0000-0001-7274-2431
FU National Research Council of Thailand; Thailand Research Fund
FX This work was supported by National Research Council of Thailand and the
   Thailand Research Fund.
CR Aramwit P, 2007, BIOSCI BIOTECH BIOCH, V71, P2473, DOI 10.1271/bbb.70243
   Aramwit P, 2010, INT J BIOL MACROMOL, V47, P668, DOI 10.1016/j.ijbiomac.2010.08.015
   Aramwit P, 2010, INT J MOL SCI, V11, P2200, DOI 10.3390/ijms11052200
   Aramwit P, 2010, BIOTECHNOL APPL BIOC, V55, P91, DOI 10.1042/BA20090186
   Aramwit P, 2009, J BIOSCI BIOENG, V107, P556, DOI 10.1016/j.jbiosc.2008.12.012
   Capar G, 2009, J MEMBRANE SCI, V342, P179, DOI 10.1016/j.memsci.2009.06.039
   Capar G, 2008, J MEMBRANE SCI, V325, P920, DOI 10.1016/j.memsci.2008.09.020
   Celedon JC, 2001, PEDIATRICS, V107, part. no., DOI 10.1542/peds.107.5.e80
   Chiellini E, 2003, PROG POLYM SCI, V28, P963, DOI 10.1016/S0079-6700(02)00149-1
   Cosgrove BD, 2008, HEPATOLOGY, V48, P276, DOI 10.1002/hep.22335
   Fabiani C, 1996, DESALINATION, V105, P1, DOI 10.1016/0011-9164(96)00050-1
   Fancy DA, 1999, P NATL ACAD SCI USA, V96, P6020, DOI 10.1073/pnas.96.11.6020
   Freddi G, 2003, J BIOTECHNOL, V106, P101, DOI 10.1016/j.jbiotec.2003.09.006
   Freshney RI, 2000, CULTURE ANIMAL CELLS
   GENNADIOS A, 1991, CEREAL FOOD WORLD, V36, P1004
   Gimenes ML, 2007, J MEMBRANE SCI, V295, P71, DOI 10.1016/j.memsci.2007.02.036
   Hsieh WC, 2007, COLLOID SURFACE B, V57, P250, DOI 10.1016/j.colsurfb.2007.02.004
   Kato N, 1998, BIOSCI BIOTECH BIOCH, V62, P145, DOI 10.1271/bbb.62.145
   Khan FD, 2006, TOXICOLOGY, V218, P90, DOI 10.1016/j.tox.2005.10.002
   Ki CS, 2007, INT J BIOL MACROMOL, V41, P346, DOI 10.1016/j.ijbiomac.2007.05.005
   Kim SJ, 2007, GAS PERMEATION WATER
   Kinsella JE, 1985, PHYSICOCHEMICAL FUNC
   Kundu SC, 2008, PROG POLYM SCI, V33, P998, DOI 10.1016/j.progpolymsci.2008.08.002
   Kweon HY, 2000, MACROMOL RAPID COMM, V21, P1302, DOI 10.1002/1521-3927(20001201)21:18<1302::AID-MARC1302>3.3.CO;2-Y
   Li YG, 2008, ALCOHOL ALCOHOLISM, V43, P246, DOI 10.1093/alcalc/agm164
   Limpeanchob N, 2010, J AGR FOOD CHEM, V58, P12519, DOI 10.1021/jf103157w
   Mandal BB, 2009, ACTA BIOMATER, V5, P3007, DOI 10.1016/j.actbio.2009.03.026
   Mandal BB, 2009, NANOTECHNOLOGY, V20, DOI 10.1088/0957-4484/20/35/355101
   Mase Keisuke, 2006, Journal of Insect Biotechnology and Sericology, V75, P85
   Mondal M., 2007, J ENVIRON SCI, V5, P63
   Nagura Masanobu, 2001, Journal of Insect Biotechnology and Sericology, V70, P149
   Nakamura K, 1984, SEN-I GAKKAISHI, V40, P327
   Nishida A, 2011, INT J PHARMACEUT, V407, P44, DOI 10.1016/j.ijpharm.2011.01.006
   Nomura M., 1995, Japan Patent, Patent No. [07-292240, 07292240, 07-292240A]
   Ogawa A, 2004, J BIOSCI BIOENG, V98, P217
   Ogawa A, 1999, Japan Patent Publication Number, Patent No. [11193210 A2, 11193210]
   Okazaki Y, 2010, BIOSCI BIOTECH BIOCH, V74, P1534, DOI 10.1271/bbb.100065
   Panilaitis B, 2003, BIOMATERIALS, V24, P3079, DOI 10.1016/S0142-9612(03)00158-3
   Park SY, 2010, TISSUE ENG PT A, V16, P1271, DOI [10.1089/ten.tea.2009.0328, 10.1089/ten.TEA.2009.0328]
   Poza P, 2002, ENG FRACT MECH, V69, P1035, DOI 10.1016/S0013-7944(01)00120-5
   Ren YJ, 2009, INT J BIOL MACROMOL, V44, P372, DOI 10.1016/j.ijbiomac.2009.02.004
   Sabato SF, 2001, J AGR FOOD CHEM, V49, P1397, DOI 10.1021/jf0005925
   Sheng HY, 2000, SILK, V2, P238
   Sloan F, 1997, J SOC DYERS COLOUR, V113, P46
   SOONG HK, 1984, OPHTHALMOLOGY, V91, P479
   Takahashi M, 2003, BIOTECHNOL LETT, V25, P1805, DOI 10.1023/A:1026284620236
   Takasu Y, 2002, BIOSCI BIOTECH BIOCH, V66, P2715, DOI 10.1271/bbb.66.2715
   Takasu Yoko, 2002, Journal of Insect Biotechnology and Sericology, V71, P151
   Tamada Y, 2004, J BIOMAT SCI-POLYM E, V15, P971, DOI 10.1163/1568562041526469
   Terada S, 2005, J BIOSCI BIOENG, V100, P667, DOI 10.1263/jbb.100.667
   Teramoto H, 2005, BIOMACROMOLECULES, V6, P2049, DOI 10.1021/bm0500547
   Teramoto H, 2005, BIOSCI BIOTECH BIOCH, V69, P845, DOI 10.1271/bbb.69.845
   Teramoto H, 2008, BIOSCI BIOTECH BIOCH, V72, P3189, DOI 10.1271/bbb.80375
   TOKUTAKE S, 1980, BIOCHEM J, V187, P413, DOI 10.1042/bj1870413
   Tsubouchi K, 2005, BIOSCI BIOTECH BIOCH, V69, P403, DOI 10.1271/bbb.69.403
   Tsuchiya Y., 1987, SEN-I GAKKAISHI, V43, P283
   Tsukada M., 1981, B SCI I TEXT FR, V10, P141
   Vaithanomsat P, 2008, SEP PURIF TECHNOL, V59, P129, DOI 10.1016/j.seppur.2007.05.039
   Voegeli R., 1993, COSMET TOILETRIES, V108, P101
   Wei DQ, 1989, ACTA POLYM SIN, V6, P740
   Whitaker JR, 1977, DENATURATION RENATUR
   Wilusz RE, 2008, J ORTHOP RES, V26, P504, DOI 10.1002/jor.20538
   Wu JH, 2007, FOOD CHEM, V103, P1255, DOI 10.1016/j.foodchem.2006.10.042
   Yamada H, 1998, Japan Patent Publication Number, Patent No. [10226653 A2, 10226653]
   Yao YQ, 2003, CHEM J CHINESE U, V24, P2327
   Yoshii F, 2000, Japan Patent Publication Number, Patent No. [2000-169736, 2000169736]
   Zaoming Wen, 1996, Journal of Investigational Allergology and Clinical Immunology, V6, P237
   Zhang YQ, 2004, BIOMATERIALS, V25, P3751, DOI 10.1016/j.biomaterials.2003.10.019
   Zhang YQ, 2002, BIOTECHNOL ADV, V20, P91, DOI 10.1016/S0734-9750(02)00003-4
   Zhaorigetu S, 2003, J PHOTOCH PHOTOBIO B, V71, P11, DOI 10.1016/S1011-1344(03)00092-7
   Zhaorigetu S, 2001, BIOSCI BIOTECH BIOCH, V65, P2181, DOI 10.1271/bbb.65.2181
   Zhou JA, 2010, INT J BIOL MACROMOL, V47, P514, DOI 10.1016/j.ijbiomac.2010.07.010
   Zhu Liang Jun, 1995, Journal of Sericultural Science of Japan, V64, P415
NR 73
TC 76
Z9 77
U1 5
U2 93
PU SAGE PUBLICATIONS LTD
PI LONDON
PA 1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND
SN 0734-242X
J9 WASTE MANAGE RES
JI Waste Manage. Res.
PD MAR
PY 2012
VL 30
IS 3
BP 217
EP 224
DI 10.1177/0734242X11404733
PG 8
WC Engineering, Environmental; Environmental Sciences
SC Engineering; Environmental Sciences & Ecology
GA 905SF
UT WOS:000301292900002
PM 21558082
DA 2018-10-19
ER

PT J
AU Shilo, S
   Roth, S
   Amzel, T
   Harel-Adar, T
   Grynspan, F
   Shoseyov, O
AF Shilo, S.
   Roth, S.
   Amzel, T.
   Harel-Adar, T.
   Grynspan, F.
   Shoseyov, O.
TI HUMAN RECOMBINANT TYPE-I COLLAGEN-BASED SCAFFOLDS, INNOVATIVE EFFECTIVE
   BIOMATERIAL FOR CUTANEOUS WOUND HEALING
SO WOUND REPAIR AND REGENERATION
LA English
DT Meeting Abstract
C1 [Shilo, S.; Roth, S.; Amzel, T.; Harel-Adar, T.; Grynspan, F.; Shoseyov, O.] CollPlant Ltd, Ness Ziona, Israel.
   [Shoseyov, O.] Hebrew Univ Jerusalem, IL-76100 Rehovot, Israel.
NR 0
TC 0
Z9 0
U1 1
U2 4
PU WILEY-BLACKWELL
PI MALDEN
PA COMMERCE PLACE, 350 MAIN ST, MALDEN 02148, MA USA
SN 1067-1927
J9 WOUND REPAIR REGEN
JI Wound Repair Regen.
PD MAR-APR
PY 2012
VL 20
IS 2
BP A40
EP A40
PG 1
WC Cell Biology; Dermatology; Medicine, Research & Experimental; Surgery
SC Cell Biology; Dermatology; Research & Experimental Medicine; Surgery
GA 901DY
UT WOS:000300943100112
DA 2018-10-19
ER

PT J
AU Canabady-Rochelle, LLS
   Belton, DJ
   Deschaume, O
   Currie, HA
   Kaplan, DL
   Perry, CC
AF Canabady-Rochelle, Laetitia L. S.
   Belton, David J.
   Deschaume, Olivier
   Currie, Heather A.
   Kaplan, David L.
   Perry, Carole C.
TI Bioinspired Silicification of Silica-Binding Peptide-Silk Protein
   Chimeras: Comparison of Chemically and Genetically Produced Proteins
SO BIOMACROMOLECULES
LA English
DT Article
ID SPIDER DRAGLINE SILK; TRANSFORM INFRARED-SPECTROSCOPY; BOMBYX-MORI;
   SECONDARY STRUCTURE; HEAVY-CHAIN; FIBROIN; BIOSILICIFICATION; SEQUENCE;
   NANOCONFINEMENT; BIOMATERIAL
AB Novel protein chimeras constituted of "silk" and a silica-binding peptide (KSLSRHDHIHHH) were synthesized by genetic or chemical approaches and their influence on silica-silk based chimera composite formation evaluated. Genetic chimeras were constructed from 6 or 15 repeats of the 32 amino acid consensus sequence of Nephila clavipes spider silk ([SGRGGLGGQG AGAAAAAGGA GQGGYGGLGSQG](n)) to which one silica binding peptide was fused at the N terminus. For the chemical chimera, 28 equiv of the silica binding peptide were chemically coupled to natural Bombyx mori silk after modification of tyrosine groups by diazonium coupling and EDC/NHS activation of all acid groups. After silica formation under mild, biomaterial-compatible conditions, the effect of peptide addition on the properties of the silk and chimeric silk-silica composite materials was explored. The composite biomaterial properties could be related to the extent of silica condensation and to the higher number of silica binding sites in the chemical chimera as compared with the genetically derived variants. In all cases, the structure of the protein/chimera in solution dictated the type of composite structure that formed with the silica deposition process having little effect on the secondary structural composition of the silk-based materials. Similarly to our study of genetic silk based chimeras containing the R5 peptide (SSKKSGSYSGSKGSKRRIL), the role of the chimeras (genetic and chemical) used in the present study resided more in aggregation and scaffolding than in the catalysis of condensation. The variables of peptide identity, silk construct (number of consensus repeats or silk source), and approach to synthesis (genetic or chemical) can be used to "tune" the properties of the composite materials formed and is a general approach that can be used to prepare a range of materials for biomedical and sensor-based applications.
C1 [Canabady-Rochelle, Laetitia L. S.; Belton, David J.; Deschaume, Olivier; Perry, Carole C.] Nottingham Trent Univ, Biomol & Mat Interface Res Grp, Sch Sci & Technol, Nottingham NG11 8NS, England.
   [Currie, Heather A.; Kaplan, David L.] Tufts Univ, Dept Biomed Engn, Bioengn & Biotechnol Ctr, Medford, MA 02155 USA.
RP Perry, CC (reprint author), Nottingham Trent Univ, Biomol & Mat Interface Res Grp, Sch Sci & Technol, Clifton Lane, Nottingham NG11 8NS, England.
EM Carole.Perry@ntu.ac.uk
OI Perry, Professor Carole/0000-0003-1517-468X; Deschaume,
   Olivier/0000-0001-6222-0947
FU EPSRC [EP/E048439/1]; AFOSR; NIH [5RO1DE017207-05]; Engineering and
   Physical Sciences Research Council [EP/E048439/1]
FX We would like to thank Dr. David Boocock for MALDI ToF MS analysis.
   Financial support from EPSRC (EP/E048439/1), the AFOSR, and the NIH
   (5RO1DE017207-05) made the work possible, and their support is
   gratefully acknowledged.
CR BARRETT EP, 1951, J AM CHEM SOC, V73, P373, DOI 10.1021/ja01145a126
   Barth A, 2000, PROG BIOPHYS MOL BIO, V74, P141, DOI 10.1016/S0079-6107(00)00021-3
   Belton DJ, 2008, P NATL ACAD SCI USA, V105, P5963, DOI 10.1073/pnas.0710809105
   Belton DJ, 2010, J PHYS CHEM B, V114, P9947, DOI 10.1021/jp101347q
   Bini E, 2006, BIOMACROMOLECULES, V7, P3139, DOI 10.1021/bm0607877
   Brzezinski MA, 2008, P NATL ACAD SCI USA, V105, P1391, DOI 10.1073/pnas.0711994105
   BYLER DM, 1986, BIOPOLYMERS, V25, P469, DOI 10.1002/bip.360250307
   Cheng C, 2008, ADV FUNCT MATER, V18, P2172, DOI 10.1002/adfm.200701130
   Currie HA, 2011, ADV FUNCT MATER, V21, P2889, DOI 10.1002/adfm.201100249
   Fan TX, 2009, PROG MATER SCI, V54, P542, DOI 10.1016/j.pmatsci.2009.02.001
   Feng XX, 2007, INT J BIOL MACROMOL, V40, P105, DOI 10.1016/j.ijbiomac.2006.06.011
   Foo CWP, 2006, P NATL ACAD SCI USA, V103, P9428, DOI 10.1073/pnas.0601096103
   Foo CWP, 2004, TRENDS BIOTECHNOL, V22, P577, DOI 10.1016/j.tibtech.2004.09.011
   Giesa T, 2011, NANO LETT, V11, P5038, DOI 10.1021/nl203108t
   GOORMAGHTIGH E, 1990, EUR J BIOCHEM, V193, P409, DOI 10.1111/j.1432-1033.1990.tb19354.x
   Gosline JM, 1999, J EXP BIOL, V202, P3295
   Grubb DT, 1997, MACROMOLECULES, V30, P2860, DOI 10.1021/ma961293c
   Ha SW, 2005, BIOMACROMOLECULES, V6, P2563, DOI 10.1021/bm050294m
   Hardy JG, 2008, POLYMER, V49, P4309, DOI 10.1016/j.polymer.2008.08.006
   HARRISON CC, 1995, J CHEM SOC FARADAY T, V91, P4287, DOI 10.1039/ft9959104287
   Huang J, 2007, BIOMATERIALS, V28, P2358, DOI 10.1016/j.biomaterials.2006.11.021
   Iler R, 1979, CHEM SILICA
   Inoue S, 2000, J BIOL CHEM, V275, P40517, DOI 10.1074/jbc.M006897200
   KAUPPINEN JK, 1981, APPL SPECTROSC, V35, P271, DOI 10.1366/0003702814732634
   Keten S, 2010, J R SOC INTERFACE, V7, P1709, DOI 10.1098/rsif.2010.0149
   Keten S, 2010, NAT MATER, V9, P359, DOI [10.1038/nmat2704, 10.1038/NMAT2704]
   KIKUCHI Y, 1992, GENE, V110, P151, DOI 10.1016/0378-1119(92)90642-3
   Kluge JA, 2008, TRENDS BIOTECHNOL, V26, P244, DOI 10.1016/j.tibtech.2008.02.006
   Kong J, 2007, ACTA BIOCH BIOPH SIN, V39, P549, DOI 10.1111/j.1745-7270.2007.00320.x
   Li CM, 2003, CURR OPIN SOLID ST M, V7, P265, DOI 10.1016/j.cossms.2003.09.011
   Mieszawska AJ, 2010, BIOMATERIALS, V31, P8902, DOI 10.1016/j.biomaterials.2010.07.109
   Mieszawska AJ, 2010, CHEM MATER, V22, P5780, DOI 10.1021/cm101940u
   MULLIN JB, 1955, ANAL CHIM ACTA, V12, P162, DOI 10.1016/S0003-2670(00)87825-3
   Murphy A.R.St., 2008, BIOMATERIALS, V29, P2829
   Patwardhan S.V., 2012, J AM CHEM SOC UNPUB
   Patwardhan SV, 2003, MAT SCI ENG C-BIO S, V23, P495, DOI 10.1016/S0928-4931(02)00278-3
   Patwardhan SV, 2005, CHEM COMMUN, P1113, DOI 10.1039/b416926c
   Perry Carole C., 2009, V47, P295, DOI 10.1007/978-3-540-88552-8_13
   Porter D, 2005, EUR PHYS J E, V16, P199, DOI 10.1140/epje/e2005-00021-2
   Poulsen N, 2003, P NATL ACAD SCI USA, V100, P12075, DOI 10.1073/pnas.2035131100
   Pozzolini M, 2004, MAR BIOTECHNOL, V6, P594, DOI 10.1007/s10126-004-3036-y
   Simmons AH, 1996, SCIENCE, V271, P84, DOI 10.1126/science.271.5245.84
   Sofia S, 2001, J BIOMED MATER RES, V54, P139, DOI 10.1002/1097-4636(200101)54:1<139::AID-JBM17>3.0.CO;2-7
   SUSI H, 1986, METHOD ENZYMOL, V130, P290
   TERMONIA Y, 1994, MACROMOLECULES, V27, P7378, DOI 10.1021/ma00103a018
   Vepari C, 2007, PROG POLYM SCI, V32, P991, DOI 10.1016/j.progpolymsci.2007.05.013
   Zhou CZ, 2001, PROTEINS, V44, P119, DOI 10.1002/prot.1078
NR 47
TC 23
Z9 24
U1 1
U2 71
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 1525-7797
EI 1526-4602
J9 BIOMACROMOLECULES
JI Biomacromolecules
PD MAR
PY 2012
VL 13
IS 3
BP 683
EP 690
DI 10.1021/bm201555c
PG 8
WC Biochemistry & Molecular Biology; Chemistry, Organic; Polymer Science
SC Biochemistry & Molecular Biology; Chemistry; Polymer Science
GA 906AU
UT WOS:000301318100013
PM 22229696
OA Green Accepted
DA 2018-10-19
ER

PT J
AU Kim, JS
   Chu, HS
   Park, KI
   Won, JI
   Jang, JH
AF Kim, J-S
   Chu, H. S.
   Park, K. I.
   Won, J-I
   Jang, J-H
TI Elastin-like polypeptide matrices for enhancing adeno-associated
   virus-mediated gene delivery to human neural stem cells
SO GENE THERAPY
LA English
DT Article
DE elastin-like polypeptide; adeno-associated virus; gene delivery;
   substrate-mediated delivery
ID LEBERS CONGENITAL AMAUROSIS; VIRAL VECTORS; IN-VIVO; PARKINSONS-DISEASE;
   LOCAL HYPERTHERMIA; DIRECTED EVOLUTION; PROTEIN ADSORPTION; PROGENITOR
   CELLS; THERAPY; IMMOBILIZATION
AB The successful development of efficient and safe gene delivery vectors continues to be a major obstacle to gene delivery in stem cells. In this study, we have developed an elastin-like polypeptide (ELP)-mediated adeno-associated virus (AAV) delivery system for transducing fibroblasts and human neural stem cells (hNSCs). AAVs have significant promise as therapeutic vectors because of their safety and potential for use in gene targeting in stem cell research. ELP has been recently employed as a biologically inspired 'smart' biomaterial that exhibits an inverse temperature phase transition, thereby demonstrating promise as a novel drug carrier. The ELP that was investigated in this study was composed of a repetitive penta-peptide with [Val-Pro-Gly-Val-Gly]. A novel AAV variant, AAV r3.45, which was previously engineered by directed evolution to enhance transduction in rat NSCs, was nonspecifically immobilized onto ELPs that were adsorbed beforehand on a tissue culture polystyrene surface (TCPS). The presence of different ELP quantities on the TCPS led to variations in surface morphology, roughness and wettability, which were ultimately key factors in the modulation of cellular transduction. Importantly, with substantially reduced viral quantities compared with bolus delivery, ELP-mediated AAV delivery significantly enhanced delivery efficiency in fibroblasts and hNSCs, which have great potential for use in tissue engineering applications and neurodegenerative disorder treatments, respectively. The enhancement of cellular transduction in stem cells, as well as the feasibility of ELPs for utilization in three-dimensional scaffolds, will contribute to the advancement of gene therapy for stem cell research and tissue regenerative medicine. Gene Therapy (2012) 19, 329-337; doi:10.1038/gt.2011.84; published online 9 June 2011
C1 [Won, J-I] Hongik Univ, Dept Chem Engn, Seoul 121791, South Korea.
   [Kim, J-S; Jang, J-H] Yonsei Univ, Dept Chem & Biomol Engn, Seoul 120749, South Korea.
   [Chu, H. S.] Seoul Natl Univ, Sch Chem & Biol Engn, Seoul, South Korea.
   [Park, K. I.] Yonsei Univ, Coll Med, Dept Pediat, Seoul 120749, South Korea.
   [Park, K. I.] Yonsei Univ, Coll Med, Project Med Sci BK21, Seoul 120749, South Korea.
RP Won, JI (reprint author), Hongik Univ, Dept Chem Engn, Seoul 121791, South Korea.
EM jiwon@hongik.ac.kr; j-jang@yonsei.ac.kr
RI Jang, Jae-Hyung/G-8030-2012
FU National Research Foundation (NRF); Korean government (MEST) through the
   Active Polymer Center for Pattern Integration [R11-2007-050-00000-0,
   NRF-20100015515]; Human Resources Development of the Korea Institute of
   Energy Technology Evaluation and Planning (KETEP); Korea government
   Ministry of Knowledge Economy [20104010100500]; Stem Cell Research
   Center, Healthcare Technology RD Project [A091159]; National Research
   Foundation of Korea by Korean Government [2010-0020289]
FX This work was supported by a National Research Foundation (NRF) grant
   funded by the Korean government (MEST) through the Active Polymer Center
   for Pattern Integration (No. R11-2007-050-00000-0) and NRF-20100015515.
   Additionally, this work was supported by the Human Resources Development
   of the Korea Institute of Energy Technology Evaluation and Planning
   (KETEP) grant funded by the Korea government Ministry of Knowledge
   Economy (No. 20104010100500). KIP was supported by the Stem Cell
   Research Center, Healthcare Technology R&D Project (A091159), and
   National Research Foundation of Korea grant (2010-0020289) by Korean
   Government.
CR Arima Y, 2007, BIOMATERIALS, V28, P3074, DOI 10.1016/j.biomaterials.2007.03.013
   Bainbridge JWB, 2008, NEW ENGL J MED, V358, P2231, DOI 10.1056/NEJMoa0802268
   Beer SJ, 1998, GENE THER, V5, P740, DOI 10.1038/sj.gt.3300647
   Bengali Z, 2005, BIOTECHNOL BIOENG, V90, P290, DOI 10.1002/bit.20393
   Betre H, 2002, BIOMACROMOLECULES, V3, P910, DOI 10.1021/bm0255037
   Betre H, 2006, J CONTROL RELEASE, V115, P175, DOI 10.1016/j.jconrel.2006.07.022
   Bidwell GL, 2007, BIOCHEM PHARMACOL, V73, P620, DOI 10.1016/j.bcp.2006.10.028
   Dreher MR, 2003, J CONTROL RELEASE, V91, P31, DOI 10.1016/S0168-3659(03)00216-5
   Fisher KJ, 1997, NAT MED, V3, P306, DOI 10.1038/nm0397-306
   Flannery JG, 1997, P NATL ACAD SCI USA, V94, P6916, DOI 10.1073/pnas.94.13.6916
   Ganesan R, 2010, BIOCHEM J, V430, P179, DOI 10.1042/BJ20100634
   Girotti A, 2004, J MATER SCI-MATER M, V15, P479, DOI 10.1023/B:JMSM.0000021124.58688.7a
   Hughes SM, 2002, MOL THER, V5, P16, DOI 10.1006/mthe.2001.0512
   Jang JH, 2010, GENE THER, V17, P1384, DOI 10.1038/gt.2010.81
   Jang JH, 2011, MOL THER, V19, P667, DOI 10.1038/mt.2010.287
   Jang JH, 2006, J BIOMED MATER RES A, V77A, P50, DOI 10.1002/jbm.a.30643
   Jang JH, 2004, EXPERT REV MED DEVIC, V1, P127, DOI 10.1586/17434440.1.1.127
   KAPLITT MG, 1994, NAT GENET, V8, P148, DOI 10.1038/ng1094-148
   Kaplitt MG, 2007, LANCET, V369, P2097, DOI 10.1016/S0140-6736(07)60982-9
   Kay MA, 2000, NAT GENET, V24, P257, DOI 10.1038/73464
   Kim JH, 2002, NATURE, V418, P50, DOI 10.1038/nature00900
   Kim YT, 2006, EXP NEUROL, V199, P222, DOI 10.1016/j.expneurol.2006.03.015
   Koerber JT, 2006, NAT PROTOC, V1, P701, DOI 10.1038/nprot.2006.93
   Lai K, 2003, NAT NEUROSCI, V6, P21, DOI 10.1038/nn983
   Maguire AM, 2008, NEW ENGL J MED, V358, P2240, DOI 10.1056/NEJMoa0802315
   Maheshri N, 2006, NAT BIOTECHNOL, V24, P198, DOI 10.1038/nbt1182
   Maitra A, 2005, NAT GENET, V37, P1099, DOI 10.1038/ng1631
   Meyer DE, 2001, J CONTROL RELEASE, V74, P213, DOI 10.1016/S0168-3659(01)00319-4
   Meyer DE, 2002, BIOMACROMOLECULES, V3, P357, DOI 10.1021/bm015630n
   Meyer DE, 2001, CANCER RES, V61, P1548
   Na K, 2010, LANGMUIR, V26, P11165, DOI 10.1021/la1013285
   NORDE W, 1991, BIOMATER SCI POLYM E, V2, P183
   Rabe M, 2011, ADV COLLOID INTERFAC, V162, P87, DOI 10.1016/j.cis.2010.12.007
   ROSE JA, 1971, J VIROL, V8, P766
   Russell DW, 1998, NAT GENET, V18, P325, DOI 10.1038/ng0498-325
   Schek RM, 2004, MOL THER, V9, P130, DOI 10.1016/j.ymthe.2003.10.002
   Shen H, 2004, NAT MATER, V3, P569, DOI 10.1038/nmat1179
   Shin SJ, 2010, BIOMATERIALS, V31, P4353, DOI 10.1016/j.biomaterials.2010.02.013
   Shin S, 2010, MOL THER, V18, P700, DOI 10.1038/mt.2009.300
   Smith-Arica JR, 2003, CLONING STEM CELLS, V5, P51, DOI 10.1089/153623003321512166
   TAKEDA N, 1995, BIOCHEMISTRY-US, V34, P5980, DOI 10.1021/bi00017a027
   Tao S, 2007, LAB CHIP, V7, P695, DOI 10.1039/b618583e
   Temple S, 2001, NATURE, V414, P112, DOI 10.1038/35102174
   URRY DW, 1985, BIOPOLYMERS, V24, P2345, DOI 10.1002/bip.360241212
   Zolotukhin S, 1999, GENE THER, V6, P973, DOI 10.1038/sj.gt.3300938
NR 45
TC 11
Z9 11
U1 1
U2 14
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 0969-7128
J9 GENE THER
JI Gene Ther.
PD MAR
PY 2012
VL 19
IS 3
BP 329
EP 337
DI 10.1038/gt.2011.84
PG 9
WC Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology;
   Genetics & Heredity; Medicine, Research & Experimental
SC Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology;
   Genetics & Heredity; Research & Experimental Medicine
GA 906OO
UT WOS:000301355800012
PM 21654823
DA 2018-10-19
ER

PT J
AU Poeschl, PW
   Ziya-Ghazvini, F
   Schicho, K
   Buchta, C
   Moser, D
   Seemann, R
   Ewers, R
   Schopper, C
AF Poeschl, Paul W.
   Ziya-Ghazvini, Farzad
   Schicho, Kurt
   Buchta, Christoph
   Moser, Doris
   Seemann, Rudolf
   Ewers, Rolf
   Schopper, Christian
TI Application of Platelet-Rich Plasma for Enhanced Bone Regeneration in
   Grafted Sinus
SO JOURNAL OF ORAL AND MAXILLOFACIAL SURGERY
LA English
DT Article
ID MAXILLARY SINUS; AUTOGENOUS BONE; DENTAL IMPLANTS; AUGMENTATION; FLOOR;
   HISTOMORPHOMETRY; COMBINATION; SAMPLES; HUMANS
AB Purpose: The present study was conducted to evaluate the effect of platelet-rich plasma (PRP) on new bone formation and remodeling after grafting of the maxillary sinus with an algae-derived hydroxyapatite AlgOss/C Graft/Algipore.
   Materials and Methods: Fourteen consecutive patients with severely atrophic maxillae underwent uni- or bilateral grafting of the maxillary sinus with a mixture of collected bone, algae-derived hydroxyapatite AlgOss/C Graft/Algipore (ratio 1: 10), and a combined addition of PRP and thrombin (Tissucol Kit; Baxter, Vienna, Austria) to allow for fast clotting. After an average healing period of 7.1 months bone samples were retrieved. Patients from a former consecutive series treated without PRP served as control group. Statistical analysis was done by Welch 2-sample t test and mixed linear model testing.
   Results: In the coronal specimen portions, mean values for newly formed bone area, biomaterial area and marrow space of 32.2% +/- 10.4%, 20.1% +/- 13.0%, and 47.7% +/- 8.5% were found with PRP, respectively. In the control group the corresponding values were 27.6% +/- 13.4%, 20.3% +/- 12.9%, and 52.1% +/- 9.3%. In the apical specimen portions in the PRP group, the newly formed bone area, biomaterial area, and marrow space was 25.7% +/- 15.0%, 23.4% +/- 14.9%, and 50.9% +/- 12.5%, respectively. The corresponding values in the control group were 17.0% +/- 8.6%, 34.5% +/- 11.2%, and 48.5% +/- 8.5%.
   Conclusions: Statistical evaluation of the samples proved significantly better overall resorption of algae-derived hydroxyapatite AlgOss/C Graft/Algipore and increased new bone formation when PRP was used, especially in the apical region. (c) 2012 American Association of Oral and Maxillofacial Surgeons J Oral Maxillofac Surg 70:657-664, 2012
C1 [Poeschl, Paul W.; Schicho, Kurt; Moser, Doris; Seemann, Rudolf; Ewers, Rolf; Schopper, Christian] Med Univ Vienna, Dept Craniomaxillofacial & Oral Surg, A-1090 Vienna, Austria.
   [Buchta, Christoph] Med Univ Vienna, Clin Dept Transfus Med, A-1090 Vienna, Austria.
   [Ewers, Rolf] Inst Cranio Maxillo Facial & Oral Rehabil Co Ltd, Ctr Telecommun & Nav Surg, Vienna, Austria.
RP Schicho, K (reprint author), Med Univ Vienna, Dept Craniomaxillofacial & Oral Surg, Waehringer Guertel 18-20, A-1090 Vienna, Austria.
EM kurt.schicho@meduniwien.ac.at
OI Buchta, Christoph/0000-0002-4153-8195
CR Aimetti M, 2008, INT J PERIODONT REST, V28, P585
   Betoni-Junior W, 2010, J ORAL IMPLANTOL
   Block MS, 1997, J ORAL MAXIL SURG, V55, P1281, DOI 10.1016/S0278-2391(97)90185-3
   BOYNE PJ, 1980, J ORAL SURG, V38, P613
   CAWOOD JI, 1988, INT J ORAL MAX SURG, V17, P232, DOI 10.1016/S0901-5027(88)80047-X
   Cricchio Giovanni, 2003, Clin Implant Dent Relat Res, V5, P161, DOI 10.1111/j.1708-8208.2003.tb00198.x
   Danesh-Meyer M J, 2001, J Int Acad Periodontol, V3, P48
   Donath K, 1988, TRENN DUENNSCHLIFF T
   Erben RG, 1997, J HISTOCHEM CYTOCHEM, V45, P307, DOI 10.1177/002215549704500215
   Ewers R, 1987, MAT RES SOC FALL M B, P353
   Ewers R, 1992, BIOMATERIALS HARD TI, P67
   Fuerst G, 2003, CLIN ORAL IMPLAN RES, V14, P500
   Jensen OT, 1998, INT J ORAL MAX IMPL, V13, P11
   Johansson B, 2001, DENTOMAXILLOFAC RAD, V30, P157, DOI 10.1038/sj.dmfr.4600601
   Kan JYK, 1999, J PROSTHET DENT, V82, P307, DOI 10.1016/S0022-3913(99)70085-5
   Kanno T, 2005, J ORAL MAXIL SURG, V63, P362, DOI 10.1016/j.joms.2004.07.016
   Kassolis JD, 2005, J CRANIOFAC SURG, V16, P280, DOI 10.1097/00001665-200503000-00015
   Kassolis JD, 2000, J PERIODONTOL, V71, P1654, DOI 10.1902/jop.2000.71.10.1654
   Lee CYS, 2009, J ORAL IMPLANTOL, V35, P164, DOI 10.1563/1548-1336-35.4.164
   Marx R E, 2001, Implant Dent, V10, P225
   Marx RE, 1998, ORAL SURG ORAL MED O, V85, P638, DOI 10.1016/S1079-2104(98)90029-4
   Raghoebar GM, 2005, CLIN ORAL IMPLAN RES, V16, P349, DOI 10.1111/j.1600-0501.2005.01115.x
   Raghoebar GM, 1999, MUND KIEFER GESICHTS, V3, pS65
   Rodriguez A, 2003, J ORAL MAXIL SURG, V61, P157, DOI 10.1053/joms.2003.50041
   SCHENK RK, 1991, HEFTE UNFALLHEILKD, V216, P23
   Schlegel KA, 2007, ORAL SURG ORAL MED O, V104, pE15, DOI 10.1016/j.tripleo.2007.04.021
   Schopper C, 1999, J LONG-TERM EFF MED, V9, P203
   Schopper Christian, 2003, Clin Oral Implants Res, V14, P743
   Schulte W, 1969, Dtsch Zahnarztl Z, V24, P854
   Torres J, 2009, J CLIN PERIODONTOL, V36, P677, DOI 10.1111/j.1600-051X.2009.01437.x
   Wheeler S L, 1996, Int J Oral Maxillofac Implants, V11, P26
   Wiltfang Joerg, 2003, Clin Oral Implants Res, V14, P213, DOI 10.1034/j.1600-0501.2003.140212.x
   Wood MR, 2004, J PROSTHET DENT, V92, P447, DOI 10.1016/j.prosdent.2004.08.003
   Yildirim M, 2000, CLIN ORAL IMPLAN RES, V11, P217, DOI 10.1034/j.1600-0501.2000.011003217.x
NR 34
TC 17
Z9 17
U1 0
U2 11
PU W B SAUNDERS CO-ELSEVIER INC
PI PHILADELPHIA
PA 1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA
SN 0278-2391
J9 J ORAL MAXIL SURG
JI J. Oral Maxillofac. Surg.
PD MAR
PY 2012
VL 70
IS 3
BP 657
EP 664
DI 10.1016/j.joms.2011.04.027
PG 8
WC Dentistry, Oral Surgery & Medicine
SC Dentistry, Oral Surgery & Medicine
GA 908QN
UT WOS:000301505300041
PM 21840102
DA 2018-10-19
ER

PT J
AU Aurand, ER
   Lampe, KJ
   Bjugstad, KB
AF Aurand, Emily R.
   Lampe, Kyle J.
   Bjugstad, Kimberly B.
TI Defining and designing polymers and hydrogels for neural tissue
   engineering
SO NEUROSCIENCE RESEARCH
LA English
DT Review
DE Polymer; Hydrogel; Drug delivery; Biocompatibility; Biomaterial; Nervous
   system; Neurodegeneration
ID POLY(ETHYLENE GLYCOL) HYDROGELS; MESENCHYMAL STEM-CELLS;
   SPINAL-CORD-INJURY; CENTRAL-NERVOUS-SYSTEM; BRAIN EXTRACELLULAR-MATRIX;
   HYALURONIC-ACID NETWORKS; SITU GELLING HYDROGELS; DRUG-DELIVERY SYSTEMS;
   IN-VIVO; MECHANICAL-PROPERTIES
AB The use of biomaterials, such as hydrogels, as neural cell delivery devices is becoming more common in areas of research such as stroke, traumatic brain injury, and spinal cord injury. When reviewing the available research there is some ambiguity in the type of materials used and results are often at odds. This review aims to provide the neuroscience community who may not be familiar with fundamental concepts of hydrogel construction, with basic information that would pertain to neural tissue applications, and to describe the use of hydrogels as cell and drug delivery devices. We will illustrate some of the many tunable properties of hydrogels and the importance of these properties in obtaining reliable and consistent results. It is our hope that this review promotes creative ideas for ways that hydrogels could be adapted and employed for the treatment of a broad range of neurological disorders. (C) 2011 Elsevier Ireland Ltd and the Japan Neuroscience Society. All rights reserved.
C1 [Aurand, Emily R.; Bjugstad, Kimberly B.] Univ Colorado Denver, Neurosci Program, Aurora, CO 80045 USA.
   [Bjugstad, Kimberly B.] Univ Colorado Denver, Dept Pediat, Aurora, CO 80045 USA.
   [Bjugstad, Kimberly B.] Univ Colorado Denver, Colorado Intellectual & Dev Disabil Res Ctr, Aurora, CO 80045 USA.
   [Lampe, Kyle J.] Stanford Univ, Dept Mat Sci & Engn, Stanford, CA 94305 USA.
RP Bjugstad, KB (reprint author), Univ Colorado Denver, Neurosci Program, Anschutz Med Campus,Mail Stop 8313,12800 E 19th A, Aurora, CO 80045 USA.
EM emily.aurand@ucdenver.edu; klampe@stanford.edu;
   kimberly.bjugstad@ucdenver.edu
OI Bjugstad, Kimberly/0000-0002-0473-5413
FU NINDS NIH HHS [R01NS052597, R01 NS052597, R01 NS052597-03]
CR Afshari FT, 2009, EXPERT REV MOL MED, V11, DOI 10.1017/S1462399409001288
   Ai Y, 2003, J COMP NEUROL, V461, P250, DOI 10.1002/cne.10689
   Aloisi F, 2001, GLIA, V36, P165, DOI 10.1002/glia.1106
   Anderson JM, 1997, ADV DRUG DELIVER REV, V28, P5, DOI 10.1016/S0169-409X(97)00048-3
   Anseth KS, 2002, J CONTROL RELEASE, V78, P199, DOI 10.1016/S0168-3659(01)00500-4
   Anseth KS, 1996, BIOMATERIALS, V17, P1647, DOI 10.1016/0142-9612(96)87644-7
   Banerjee A, 2009, BIOMATERIALS, V30, P4695, DOI 10.1016/j.biomaterials.2009.05.050
   Barker RA, 1996, EXP NEUROL, V141, P79, DOI 10.1006/exnr.1996.0141
   Bencherif SA, 2009, J BIOMED MATER RES A, V90A, P142, DOI 10.1002/jbm.a.32069
   Benkirane-Jessel N, 2004, ADV FUNCT MATER, V14, P174, DOI 10.1002/adfm.200304413
   Bhatia SK, 2010, BIOTECHNOL J, V5, P1309, DOI 10.1002/biot.201000230
   Biran R, 2005, EXP NEUROL, V195, P115, DOI 10.1016/j.expneurol.2005.04.020
   Bjugstad KB, 2010, J BIOMED MATER RES A, V95A, P79, DOI 10.1002/jbm.a.32809
   Bjugstad KB, 2008, EXP NEUROL, V211, P362, DOI 10.1016/j.expneurol.2008.01.025
   Bonneh-Barkay D, 2009, BRAIN PATHOL, V19, P573, DOI 10.1111/j.1750-3639.2008.00195.x
   Bowman CN, 2008, AICHE J, V54, P2775, DOI 10.1002/aic.11678
   Brannvall K, 2007, J NEUROSCI RES, V85, P2138, DOI 10.1002/jnr.21358
   Brem H, 2001, J CONTROL RELEASE, V74, P63, DOI 10.1016/S0168-3659(01)00311-X
   BREM H, 1990, BIOMATERIALS, V11, P699, DOI 10.1016/0142-9612(90)90030-T
   Broder JS, 2010, PSYCHIAT CLIN N AM, V33, P821, DOI 10.1016/j.psc.2010.08.006
   Bromberg L, 1996, J APPL POLYM SCI, V59, P459
   BRONDSTED H, 1991, BIOMATERIALS, V12, P584, DOI 10.1016/0142-9612(91)90056-G
   Brundin P, 2000, BRAIN, V123, P1380, DOI 10.1093/brain/123.7.1380
   Bryant SJ, 2000, J BIOMAT SCI-POLYM E, V11, P439, DOI 10.1163/156856200743805
   Bryant SJ, 2003, J BIOMED MATER RES A, V67A, P1430, DOI 10.1002/jbm.a.20003
   Bryant SJ, 2002, J BIOMED MATER RES, V59, P63, DOI 10.1002/jbm.1217
   Bryant SJ, 2008, PHARM RES-DORDR, V25, P2379, DOI 10.1007/s11095-008-9619-y
   Burdick JA, 2006, BIOMATERIALS, V27, P452, DOI 10.1016/j.biomaterials.2005.06.034
   Burdick JA, 2005, BIOMACROMOLECULES, V6, P386, DOI 10.1021/bm049508a
   Burdick JA, 2002, BIOMATERIALS, V23, P4315, DOI 10.1016/S0142-9612(02)00176-X
   Case LC, 2005, CURR BIOL, V15, pR749, DOI 10.1016/j.cub.2005.09.008
   Cayre M, 2009, PROG NEUROBIOL, V88, P41, DOI 10.1016/j.pneurobio.2009.02.001
   Chatterjee K, 2010, BIOMATERIALS, V31, P5051, DOI 10.1016/j.biomaterials.2010.03.024
   Cheung CY, 2008, ADV FUNCT MATER, V18, P3119, DOI 10.1002/adfm.200800566
   Chiu YL, 2009, BIOMATERIALS, V30, P4877, DOI 10.1016/j.biomaterials.2009.05.052
   Chudler E. H., 2011, BRAIN FACTS FIGURES
   Chung C, 2006, J BIOMED MATER RES A, V77A, P518, DOI 10.1002/jbm.a.30660
   Chung C, 2009, BIOMATERIALS, V30, P4287, DOI 10.1016/j.biomaterials.2009.04.040
   Chung C, 2009, TISSUE ENG PT A, V15, P243, DOI 10.1089/ten.tea.2008.0067
   Comolli N, 2009, ACTA BIOMATER, V5, P1046, DOI 10.1016/j.actbio.2008.10.008
   Cooke MJ, 2011, BIOMATERIALS, V32, P5688, DOI 10.1016/j.biomaterials.2011.04.032
   Cowin S.C., 2007, TISSUE MECH, P360
   Cruise GM, 1999, CELL TRANSPLANT, V8, P293, DOI 10.1177/096368979900800310
   Dadsetan M, 2011, ACTA BIOMATER, V7, P2080, DOI 10.1016/j.actbio.2011.01.012
   Dadsetan M, 2009, BIOMATERIALS, V30, P3874, DOI 10.1016/j.biomaterials.2009.04.018
   Danielsson P, 1996, EXP NEUROL, V139, P238, DOI 10.1006/exnr.1996.0097
   Darsalia V, 2011, J CEREBR BLOOD F MET, V31, P235, DOI 10.1038/jcbfm.2010.81
   Druecke D, 2004, J BIOMED MATER RES A, V68A, P10, DOI 10.1002/jbm.a..20016
   Drury JL, 2003, BIOMATERIALS, V24, P4337, DOI 10.1016/S0142-9612(03)00340-5
   DuBose JW, 2005, J BIOMED MATER RES A, V74A, P104, DOI 10.1002/jbm.a.30307
   EDELL DJ, 1992, IEEE T BIO-MED ENG, V39, P635, DOI 10.1109/10.141202
   Eigenbrot C, 1997, NAT STRUCT BIOL, V4, P435, DOI 10.1038/nsb0697-435
   Elbert DL, 1996, ANNU REV MATER SCI, V26, P365, DOI 10.1146/annurev.ms.26.080196.002053
   ELDRIDGE JH, 1991, INFECT IMMUN, V59, P2978
   Elisseeff J, 2000, J BIOMED MATER RES, V51, P164, DOI 10.1002/(SICI)1097-4636(200008)51:2<164::AID-JBM4>3.0.CO;2-W
   Elisseeff J, 2001, J ORTHOPAED RES, V19, P1098, DOI 10.1016/S0736-0266(01)00054-7
   Emerich DF, 2010, CELL TRANSPLANT, V19, P1063, DOI 10.3727/096368910X498278
   Emgard M, 1999, EXP NEUROL, V160, P279, DOI 10.1006/exnr.1999.7198
   Engler AJ, 2006, CELL, V126, P677, DOI 10.1016/j.cell.2006.06.044
   ERMAK TH, 1995, CELL TISSUE RES, V279, P433, DOI 10.1007/BF00318501
   Farmer TG, 2008, IND ENG CHEM RES, V47, P10053, DOI 10.1021/ie070957b
   Fitch MT, 2008, EXP NEUROL, V209, P294, DOI 10.1016/j.expneurol.2007.05.014
   Flanagan LA, 2002, NEUROREPORT, V13, P2411, DOI 10.1097/01.wnr.0000048003.96487.97
   Ford MC, 2006, P NATL ACAD SCI USA, V103, P2512, DOI 10.1073/pnas.0506020102
   Fournier E, 2003, BIOMATERIALS, V24, P3311, DOI 10.1016/S0142-9612(03)00161-3
   Fournier E, 2006, BIOMATERIALS, V27, P4963, DOI 10.1016/j.biomaterials.2006.04.045
   FREED CR, 1992, NEW ENGL J MED, V327, P1549, DOI 10.1056/NEJM199211263272202
   Fromstein JD, 2002, J BIOMAT SCI-POLYM E, V13, P391, DOI 10.1163/156856202320253929
   Georges PC, 2006, BIOPHYS J, V90, P3012, DOI 10.1529/biophysj.105.073114
   Gerecht S, 2007, BIOMATERIALS, V28, P4826, DOI 10.1016/j.biomaterials.2007.07.039
   Gopferich A, 1996, BIOMATERIALS, V17, P103, DOI 10.1016/0142-9612(96)85755-3
   GRABOWSKI M, 1994, EXP NEUROL, V127, P126, DOI 10.1006/exnr.1994.1086
   Guan JJ, 2005, BIOMATERIALS, V26, P3961, DOI 10.1016/j.biomaterials.2004.10.018
   Guan JJ, 2005, BIOMACROMOLECULES, V6, P2833, DOI 10.1021/bm0503322
   Gumera C, 2011, J MATER CHEM, V21, P7033, DOI 10.1039/c0jm04335d
   Gunn JW, 2005, J BIOMED MATER RES A, V72A, P91, DOI 10.1002/jbm.a.30203
   Guo X, 2010, ACTA BIOMATER, V6, P39, DOI 10.1016/j.actbio.2009.07.041
   Gurgo RD, 2002, J CLIN NEUROSCI, V9, P613, DOI 10.1054/jocn.2002.1080
   Ha JH, 1997, J CONTROL RELEASE, V49, P253, DOI 10.1016/S0168-3659(97)00096-5
   Hanisch UK, 2007, NAT NEUROSCI, V10, P1387, DOI 10.1038/nn1997
   Hawkins AM, 2011, ACTA BIOMATER, V7, P1956, DOI 10.1016/j.actbio.2011.01.024
   He SL, 2000, BIOMATERIALS, V21, P2389, DOI 10.1016/S0142-9612(00)00106-X
   Hedberg EL, 2005, BIOMATERIALS, V26, P4616, DOI 10.1016/j.biomaterials.2004.11.039
   Hejcl A, 2008, PHYSIOL RES, V57, pS121
   Hersel U, 2003, BIOMATERIALS, V24, P4385, DOI 10.1016/S0142-9612(03)00343-0
   Hirtz D, 2007, NEUROLOGY, V68, P326, DOI 10.1212/01.wnl.0000252807.38124.a3
   Hou QP, 2008, J PHARM SCI-US, V97, P3972, DOI 10.1002/jps.21310
   Hu M, 2009, BIOMATERIALS, V30, P3523, DOI 10.1016/j.biomaterials.2009.03.004
   Huebsch N, 2010, NAT MATER, V9, P518, DOI [10.1038/NMAT2732, 10.1038/nmat2732]
   Hunt NC, 2010, BIOTECHNOL LETT, V32, P733, DOI 10.1007/s10529-010-0221-0
   Hynd MR, 2007, J BIOMAT SCI-POLYM E, V18, P1223, DOI 10.1163/156856207782177909
   Hynes SR, 2009, J BIOMED MATER RES A, V89A, P499, DOI 10.1002/jbm.a.31987
   Jeong B, 2000, J BIOMED MATER RES, V50, P171, DOI 10.1002/(SICI)1097-4636(200005)50:2<171::AID-JBM11>3.0.CO;2-F
   Jeong B, 2000, J CONTROL RELEASE, V63, P155, DOI 10.1016/S0168-3659(99)00194-7
   Jeong B, 1997, NATURE, V388, P860, DOI 10.1038/42218
   Jessel N, 2003, ADV MATER, V15, P692, DOI 10.1002/adma.200304634
   Jewell CM, 2005, J CONTROL RELEASE, V106, P214, DOI 10.1016/j.jconrel.2005.04.014
   Jha AK, 2011, BIOMATERIALS, V32, P2466, DOI 10.1016/j.biomaterials.2010.12.024
   Johnson BQ, 2010, LARYNGOSCOPE, V120, P537, DOI 10.1002/lary.20782
   Johnson PJ, 2010, CELL TRANSPLANT, V19, P89, DOI 10.3727/096368909X477273
   Katz JS, 2009, WIRES NANOMED NANOBI, V1, P128, DOI 10.1002/wnan.010
   Keskar V, 2009, J TISSUE ENG REGEN M, V3, P486, DOI 10.1002/term.183
   Keskar V, 2009, TISSUE ENG PT A, V15, P1695, DOI 10.1089/ten.tea.2008.0238
   Kim JK, 2008, BIOMACROMOLECULES, V9, P149, DOI 10.1021/bm700924n
   Kim YT, 2004, BIOMATERIALS, V25, P2229, DOI 10.1016/j.biomaterials.2003.09.010
   Kloxin AM, 2010, ADV MATER, V22, P3484, DOI 10.1002/adma.200904179
   Kondziolka D, 2000, NEUROLOGY, V55, P565, DOI 10.1212/WNL.55.4.565
   Kraehenbuehl TP, 2008, BIOMATERIALS, V29, P2757, DOI 10.1016/j.biomaterials.2008.03.016
   Laird MD, 2008, NEUROSIGNALS, V16, P154, DOI 10.1159/000111560
   Lampe KJ, 2010, TISSUE ENG PT A, V16, P1857, DOI [10.1089/ten.tea.2009.0509, 10.1089/ten.TEA.2009.0509]
   Lampe KJ, 2011, J BIOMED MATER RES A, V96A, P595, DOI 10.1002/jbm.a.33011
   Lampe KJ, 2010, J BIOMED MATER RES A, V94A, P1162, DOI 10.1002/jbm.a.32787
   Lampe KJ, 2009, BIOTECHNOL BIOENG, V103, P1214, DOI 10.1002/bit.22352
   LANGONE F, 1995, BIOMATERIALS, V16, P347, DOI 10.1016/0142-9612(95)93851-4
   Lee CH, 2001, INT J PHARM, V221, P1, DOI 10.1016/S0378-5173(01)00691-3
   Lee KY, 2001, CHEM REV, V101, P1869, DOI 10.1021/cr000108x
   Lee YB, 2010, EXP NEUROL, V223, P645, DOI 10.1016/j.expneurol.2010.02.014
   Li RH, 1998, ADV DRUG DELIVER REV, V33, P87, DOI 10.1016/S0169-409X(98)00022-2
   Liechty WB, 2010, ANNU REV CHEM BIOMOL, V1, P149, DOI 10.1146/annurev-chembioeng-073009-100847
   Lin CC, 2009, BIOMATERIALS, V30, P4907, DOI 10.1016/j.biomaterials.2009.05.083
   Lin CC, 2009, PHARM RES-DORD, V26, P631, DOI 10.1007/s11095-008-9801-2
   LIN LFH, 1993, SCIENCE, V260, P1130, DOI 10.1126/science.8493557
   Lin S, 2011, PHARM RES-DORDR, V28, P1422, DOI 10.1007/s11095-011-0378-9
   Liu SQ, 2010, BIOMATERIALS, V31, P7298, DOI 10.1016/j.biomaterials.2010.06.001
   Lodish H., 2007, MOL CELL BIOL, P820
   Lutolf MP, 2003, P NATL ACAD SCI USA, V100, P5413, DOI 10.1073/pnas.0737381100
   Ma YL, 2010, J NUCL MED, V51, P7, DOI 10.2967/jnumed.109.066811
   Ma ZW, 2010, BIOMACROMOLECULES, V11, P1873, DOI 10.1021/bm1004299
   Magnusson JP, 2011, POLYM CHEM-UK, V2, P48, DOI 10.1039/c0py00210k
   Mahoney MJ, 2006, BIOMATERIALS, V27, P2265, DOI 10.1016/j.biomaterials.2005.11.007
   Mann BK, 2001, BIOMATERIALS, V22, P3045, DOI 10.1016/S0142-9612(01)00051-5
   Mansour HM, 2010, INT J MOL SCI, V11, P3298, DOI 10.3390/ijms11093298
   Martens PJ, 2003, BIOMACROMOLECULES, V4, P283, DOI 10.1021/bm025666v
   Mather ML, 2010, REGEN MED, V5, P809, DOI 10.2217/RME.10.32
   MCRAE A, 1992, MOL CHEM NEUROPATHOL, V16, P123, DOI 10.1007/BF03159965
   Mellott MB, 2001, BIOMATERIALS, V22, P929, DOI 10.1016/S0142-9612(00)00258-1
   Metters AT, 2000, POLYMER, V41, P3993, DOI 10.1016/S0032-3861(99)00629-1
   Meyer M, 1998, EXP BRAIN RES, V119, P345, DOI 10.1007/s002210050350
   Michel M, 2004, LANGMUIR, V20, P4835, DOI 10.1021/la049736q
   Minh KN, 2010, MACROMOL BIOSCI, V10, P563, DOI 10.1002/mabi.200900402
   Mironov V, 2005, BIOMATERIALS, V26, P7628, DOI 10.1016/j.biomaterials.2005.05.061
   Mithieux SM, 2009, BIOMATERIALS, V30, P431, DOI 10.1016/j.biomaterials.2008.10.018
   Moffat KL, 2008, P NATL ACAD SCI USA, V105, P7947, DOI 10.1073/pnas.0712150105
   Namba RM, 2009, ACTA BIOMATER, V5, P1884, DOI 10.1016/j.actbio.2009.01.036
   Nettles DL, 2004, ANN BIOMED ENG, V32, P391, DOI 10.1023/B:ABME.0000017552.65260.94
   Nguyen LH, 2011, BIOMATERIALS, V32, P6946, DOI 10.1016/j.biomaterials.2011.06.014
   Nichterwitz S, 2010, NEUROSCI LETT, V484, P118, DOI 10.1016/j.neulet.2010.08.028
   Nicodemus GD, 2008, TISSUE ENG PT B-REV, V14, P149, DOI 10.1089/ten.teb.2007.0332
   Nunamaker EA, 2011, J MECH BEHAV BIOMED, V4, P16, DOI 10.1016/j.jmbbm.2010.08.006
   Nuttelman CR, 2008, PROG POLYM SCI, V33, P167, DOI 10.1016/j.progpolymsci.2007.09.006
   Nuttelman CR, 2002, BIOMATERIALS, V23, P3617, DOI 10.1016/S0142-9612(02)00093-5
   Ostergaard K, 1996, EXP NEUROL, V142, P340, DOI 10.1006/exnr.1996.0203
   Pailler-Mattei C, 2008, MED ENG PHYS, V30, P599, DOI 10.1016/j.medengphy.2007.06.011
   Panigrahi M, 2011, INDIAN J CANCER, V48, P11, DOI 10.4103/0019-509X.76623
   Park J, 2010, J BIOMED MATER RES A, V93A, P1091, DOI 10.1002/jbm.a.32519
   Patterson J, 2010, BIOMATERIALS, V31, P7836, DOI 10.1016/j.biomaterials.2010.06.061
   Pearson RG, 2003, TISSUE ENG, V9, P201, DOI 10.1089/107632703764664675
   Peppas NA, 2006, ADV MATER, V18, P1345, DOI 10.1002/adma.200501612
   Peppas NA, 1999, J CONTROL RELEASE, V62, P81, DOI 10.1016/S0168-3659(99)00027-9
   Perale G, 2011, ACS CHEM NEUROSCI, V2, P336, DOI 10.1021/cn200030w
   Pettikiriarachchi JTS, 2010, AUST J CHEM, V63, P1143, DOI 10.1071/CH10159
   Place ES, 2009, CHEM SOC REV, V38, P1139, DOI 10.1039/b811392k
   Quirico-Santos T, 2010, ARQ NEURO-PSIQUIAT, V68, P799, DOI 10.1590/S0004-282X2010000500024
   Rabinovich SS, 2005, B EXP BIOL MED+, V139, P126, DOI 10.1007/s10517-005-0229-y
   Redmond DE, 2010, REJUV RES, V13, P188, DOI 10.1089/rej.2009.0960
   Rice MA, 2006, BIOMACROMOLECULES, V7, P1968, DOI 10.1021/bm060086+
   Rice MA, 2007, TISSUE ENG, V13, P683, DOI 10.1089/ten.2006.0142
   Rnjak J, 2009, BIOMATERIALS, V30, P6469, DOI 10.1016/j.biomaterials.2009.08.017
   Roberts JJ, 2011, J BIOMED MATER RES B, V99B, P158, DOI 10.1002/jbm.b.31883
   Ruel-Gariepy E, 2004, EUR J PHARM BIOPHARM, V58, P409, DOI 10.1016/j.ejpb.2004.03.019
   Ruoslahti E, 1996, GLYCOBIOLOGY, V6, P489, DOI 10.1093/glycob/6.5.489
   Saha K, 2008, BIOPHYS J, V95, P4426, DOI 10.1529/biophysj.108.132217
   Salmaso S, 2010, ISR J CHEM, V50, P160, DOI 10.1002/ijch.201000022
   Sanchis J, 2010, NANOMEDICINE-UK, V5, P915, DOI [10.2217/nnm.10.71, 10.2217/NNM.10.71]
   Santiago de Compostela, 2011, ENCY BRITANNICA
   SAWHNEY AS, 1993, MACROMOLECULES, V26, P581, DOI 10.1021/ma00056a005
   Schense JC, 2000, J BIOL CHEM, V275, P6813, DOI 10.1074/jbc.275.10.6813
   Schlosshauer B, 2003, BRAIN RES, V963, P321, DOI 10.1016/S0006-8993(02)03930-6
   Seib FP, 2009, BIOCHEM BIOPH RES CO, V389, P663, DOI 10.1016/j.bbrc.2009.09.051
   Seidlits SK, 2010, BIOMATERIALS, V31, P3930, DOI 10.1016/j.biomaterials.2010.01.125
   Senthilkumar KS, 2007, BEHAV BRAIN RES, V184, P11, DOI 10.1016/j.bbr.2007.06.025
   Shoichet MS, 2010, MACROMOLECULES, V43, P581, DOI 10.1021/ma901530r
   Shu XZ, 2006, J BIOMED MATER RES A, V79A, P902, DOI 10.1002/jbm.a.30831
   Shu XZ, 2004, J BIOMED MATER RES A, V68A, P365, DOI 10.1002/jbm.a.20002
   Slaughter BV, 2009, ADV MATER, V21, P3307, DOI 10.1002/adma.200802106
   Spiller KL, 2011, J TISSUE ENG REGEN M, V5, P636, DOI 10.1002/term.356
   Squire L.R., 2003, FUNDAMENTAL NEUROSCI, P67
   Stachowiak AN, 2005, ADV MATER, V17, P399, DOI 10.1002/adma.200400507
   Stammen JA, 2001, BIOMATERIALS, V22, P799, DOI 10.1016/S0142-9612(00)00242-8
   Stichel CC, 1998, CELL TISSUE RES, V294, P1, DOI 10.1007/s004410051151
   Suarez-Monteagudo C, 2009, RESTOR NEUROL NEUROS, V27, P151, DOI 10.3233/RNN-2009-0483
   Subramanian A, 2009, J BIOMED SCI, V16, DOI 10.1186/1423-0127-16-108
   Suggs LJ, 1999, CELL TRANSPLANT, V8, P345, DOI 10.1177/096368979900800402
   Sung JH, 2010, INT J PHARMACEUT, V392, P232, DOI 10.1016/j.ijpharm.2010.03.024
   Szarowski DH, 2003, BRAIN RES, V983, P23, DOI 10.1016/S0006-8993(03)03023-3
   Tate MC, 2001, BIOMATERIALS, V22, P1113, DOI 10.1016/S0142-9612(00)00348-3
   Thomasin C, 1996, J CONTROL RELEASE, V41, P131, DOI 10.1016/0168-3659(96)01363-6
   Turner JN, 1999, EXP NEUROL, V156, P33, DOI 10.1006/exnr.1998.6983
   Tzeng SY, 2010, SOFT MATTER, V6, P2208, DOI 10.1039/b923544b
   Ueki Y, 2010, BIOCHEM BIOPH RES CO, V394, P94, DOI 10.1016/j.bbrc.2010.02.115
   Uemura M, 2010, J NEUROSCI RES, V88, P542, DOI 10.1002/jnr.22223
   Van Tomme SR, 2008, INT J PHARM, V355, P1, DOI 10.1016/j.ijpharm.2008.01.057
   Vanderhooft JL, 2009, MACROMOL BIOSCI, V9, P20, DOI 10.1002/mabi.200800141
   von Burkersroda F, 2002, BIOMATERIALS, V23, P4221, DOI 10.1016/S0142-9612(02)00170-9
   Waters DJ, 2010, MACROMOLECULES, V43, P6861, DOI 10.1021/ma101070s
   Weber LM, 2008, TISSUE ENG PT A, V14, P1959, DOI 10.1089/ten.tea.2007.0238
   Weber RA, 2000, PLAST RECONSTR SURG, V106, P1036, DOI 10.1097/00006534-200010000-00013
   WEST JL, 1995, REACT POLYM, V25, P139, DOI 10.1016/0923-1137(94)00096-N
   West JL, 1999, MACROMOLECULES, V32, P241, DOI 10.1021/ma981296k
   Williams CG, 2005, BIOMATERIALS, V26, P1211, DOI 10.1016/j.biomaterials.2004.04.024
   WILLIAMS DF, 1987, J MATER SCI, V22, P3421, DOI 10.1007/BF01161439
   Wilson JT, 2008, NANO LETT, V8, P1940, DOI 10.1021/nl080694q
   Wong AMS, 2010, BIOCHEM SOC T, V38, P1484, DOI 10.1042/BST0381484
   Wood MD, 2010, BIOTECHNOL BIOENG, V106, P970, DOI 10.1002/bit.22766
   Yang CY, 2009, BIOMATERIALS, V30, P2881, DOI 10.1016/j.biomaterials.2009.01.056
   Yang JJ, 2010, J BIOMED MATER RES A, V95A, P531, DOI 10.1002/jbm.a.32875
   Young JL, 2011, BIOMATERIALS, V32, P1002, DOI 10.1016/j.biomaterials.2010.10.020
   Yu D, 2009, STEM CELLS, V27, P1212, DOI 10.1002/stem.26
   Yuh EL, 2010, NEUROIMAG CLIN N AM, V20, P597, DOI 10.1016/j.nic.2010.07.012
   Yurek DM, 1996, EXP NEUROL, V137, P105, DOI 10.1006/exnr.1996.0011
   Zhong J, 2010, NEUROREHAB NEURAL RE, V24, P636, DOI 10.1177/1545968310361958
   Zhou YS, 2011, INT J BIOL MACROMOL, V48, P408, DOI 10.1016/j.ijbiomac.2010.12.015
   Zhu JM, 2010, BIOMATERIALS, V31, P4639, DOI 10.1016/j.biomaterials.2010.02.044
   Zisch AH, 2003, FASEB J, V17, P2260, DOI 10.1096/fj.02-1041fje
NR 224
TC 64
Z9 66
U1 1
U2 96
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND
SN 0168-0102
EI 1872-8111
J9 NEUROSCI RES
JI Neurosci. Res.
PD MAR
PY 2012
VL 72
IS 3
BP 199
EP 213
DI 10.1016/j.neures.2011.12.005
PG 15
WC Neurosciences
SC Neurosciences & Neurology
GA 911EQ
UT WOS:000301700500001
PM 22192467
OA Green Accepted
DA 2018-10-19
ER

PT J
AU Kirkland, NT
   Birbilis, N
   Staiger, MP
AF Kirkland, N. T.
   Birbilis, N.
   Staiger, M. P.
TI Assessing the corrosion of biodegradable magnesium implants: A critical
   review of current methodologies and their limitations
SO ACTA BIOMATERIALIA
LA English
DT Review
DE Magnesium; In vitro; Biocorrosion; Biomaterial; Polarization
ID SIMULATED BODY-FLUID; IN-VITRO DEGRADATION; BULK-METALLIC GLASSES; MG-CA
   ALLOYS; Y-RE ALLOY; PURE MAGNESIUM; HANKS SOLUTION; BIO-CORROSION;
   MECHANICAL-PROPERTIES; CALCIUM-PHOSPHATE
AB Magnesium (Mg) and its alloys have been intensively studied as biodegradable implant materials, where their mechanical properties make them attractive candidates for orthopaedic applications. There are several commonly used in vitro tests, from simple mass loss experiments to more complex electrochemical methods, which provide information on the biocorrosion rates and mechanisms. The various methods each have their own unique benefits and limitations. Inappropriate test setup or interpretation of in vitro results creates the potential for flawed justification of subsequent in vivo experiments. It is therefore crucial to fully understand the correct usages of each experiment and the factors that need to be considered before drawing conclusions. This paper aims to elucidate the main benefits and limitations for each of the major in vitro methodologies that are used in examining the biodegradation behaviour of Mg and its alloys. (c) 2011 Acta Materialia Inc. Published by Elsevier Ltd. All rights reserved.
C1 [Kirkland, N. T.; Staiger, M. P.] Univ Canterbury, Dept Mech Engn, Christchurch 8020, New Zealand.
   [Kirkland, N. T.; Birbilis, N.] Monash Univ, Dept Mat Engn, Clayton, Vic 3800, Australia.
RP Staiger, MP (reprint author), Univ Canterbury, Dept Mech Engn, Private Bag 4800, Christchurch 8020, New Zealand.
EM mark.staiger@canterbury.ac.nz
RI Kirkland, Nicholas/E-5111-2012; Staiger, Mark/H-2102-2011
OI Kirkland, Nicholas/0000-0001-5043-3400; Staiger,
   Mark/0000-0002-1517-4404; Birbilis, Nick/0000-0002-7910-7470
FU New Zealand Foundation for Research, Science and Technology (FRST);
   Australian Research Council (ARC); Monash Centre for Electron Microscopy
   (MCEM)
FX The authors gratefully acknowledge financial support provided by the New
   Zealand Foundation for Research, Science and Technology (FRST), the
   Australian Research Council (ARC) and the Monash Centre for Electron
   Microscopy (MCEM).
CR AC Hanzi, 2007, LIGHT MET TECHN C CA
   Al-Abdullat Y, 2001, MATER TRANS, V42, P1777, DOI 10.2320/matertrans.42.1777
   Alvarez-Lopez M, 2010, ACTA BIOMATER, V6, P1763, DOI 10.1016/j.actbio.2009.04.041
   BARANENKO VI, 1989, SOV ATOM ENERGY+, V66, P30, DOI 10.1007/BF01121069
   Barranco V, 2010, PROG ORG COAT, V68, P347, DOI 10.1016/j.porgcoat.2010.02.009
   Barsoukov E, 2005, IMPEDANCE SPECTROSCOPY: THEORY, EXPERIMENT, AND APPLICATIONS, 2ND EDITION, P1, DOI 10.1002/0471716243
   Barton RS, 1960, PERMEABILITY SOME PL
   Bender S, 2007, MATER CORROS, V58, P977, DOI 10.1002/maco.200704091
   BERNABEU P, 1988, ELECTROCHIM ACTA, V33, P1129, DOI 10.1016/0013-4686(88)80204-4
   Birbilis N, 2005, ELECTROCHIM ACTA, V50, P3536, DOI 10.1016/j.electacta.2005.01.010
   Birbilis N, 2009, CORROS SCI, V51, P683, DOI 10.1016/j.corsci.2008.12.012
   Blawert C, 2008, SURF COAT TECH, V202, P2236, DOI 10.1016/j.surfcoat.2007.08.008
   Chang JW, 2007, ELECTROCHIM ACTA, V52, P3160, DOI 10.1016/j.electacta.2006.09.069
   Cheng XL, 2005, BIOMATERIALS, V26, P7350, DOI 10.1016/j.biomaterials.2005.05.047
   Chiu KY, 2007, SURF COAT TECH, V202, P590, DOI 10.1016/j.surfcoat.2007.06.035
   Contu F, 2003, J BIOMED MATER RES A, V67A, P246, DOI 10.1002/jbm.a.10113
   CROZIER TE, 1974, J CHEM ENG DATA, V19, P242, DOI 10.1021/je60062a007
   Cui F, 2008, FRONT MAT SCI CHINA, V2, P143
   Denkena B, 2007, CIRP ANN-MANUF TECHN, V56, P113, DOI 10.1016/j.cirp.2007.05.029
   Denkena B, 2005, 5 EUSPEN INT C MONTP
   Denkena B, 2005, 5 EUSP INT C MONTP
   Duffo GS, 2004, CORROSION-US, V60, P594, DOI 10.5006/1.3287764
   Eliezer A, 2010, ADV MATER RES-SWITZ, V95, P17, DOI 10.4028/www.scientific.net/AMR.95.17
   Fekry AM, 2009, ELECTROCHIM ACTA, V54, P7280, DOI 10.1016/j.electacta.2009.07.047
   Ghali E, 2004, J MATER ENG PERFORM, V13, P517, DOI 10.1361/10599490420665
   Ghali E, 2010, CONVENTIONAL ELECTRO
   Gosser D. K., 1993, CYCLIC VOLTAMMETRY S
   Gu CD, 2006, SURF COAT TECH, V200, P5413, DOI 10.1016/j.surfcoat.2005.07.001
   Gu XN, 2009, BIOMED MATER, V4, P8
   Gu XN, 2009, BIOMATERIALS, V30, P484, DOI 10.1016/j.biomaterials.2008.10.021
   Gunde P, 2010, J BIOMED MATER RES A, V92A, P409, DOI 10.1002/jbm.a.32350
   Hadzima B., 2003, Metallic Materials, V41, P174
   Hassel T., 2007, MAGNESIUM, P789
   He W, 2009, MAT SCI ENG C, V30, P167
   Hiromoto S, 2008, MATER TRANS, V49, P1456, DOI 10.2320/matertrans.MRA2008011
   Hiromoto S, 2008, CORROS SCI, V50, P3561, DOI 10.1016/j.corsci.2008.09.026
   Hoog CO, 2008, ADV ENG MATER, V10, P579, DOI 10.1002/adem.200800046
   Hort N, 2010, ACTA BIOMATER, V6, P1714, DOI 10.1016/j.actbio.2009.09.010
   Huang L, 2009, INTERMETALLICS, V17, P195, DOI 10.1016/j.intermet.2008.07.020
   Inoue H, 2002, CORROS SCI, V44, P603, DOI 10.1016/S0010-938X(01)00092-0
   International ASTM, 2004, G3172 INT ASTM
   International ASTM, 2004, G10289 INT ASTM
   Jackson DR, 2000, LANGMUIR, V16, P5449, DOI 10.1021/la991497x
   Kannan MB, 2008, SCRIPTA MATER, V59, P175, DOI 10.1016/j.scriptamat.2008.03.001
   Kannan MB, 2008, BIOMATERIALS, V29, P2306, DOI 10.1016/j.biomaterials.2008.02.003
   Kim WC, 2008, MATER LETT, V62, P4146, DOI 10.1016/j.matlet.2008.06.028
   Kirkland NT, 2010, CORROS SCI, V52, P287, DOI 10.1016/j.corsci.2009.09.033
   Kirkland NT, 2011, JOM-US, V63, P28, DOI 10.1007/s11837-011-0089-z
   Kirkland NT, 2010, J BIOMED MATER RES B, V95B, P91, DOI 10.1002/jbm.b.31687
   Krause C, 2006, C MET MAGN TECHN GLO, P329
   Kuwahara H, 2001, MATER TRANS, V42, P1317, DOI 10.2320/matertrans.42.1317
   LASIA A, 1999, MOD ASPECT ELECTROC, V32, P143, DOI DOI 10.1007/0-306-46916-22
   Lee JY, 2009, MET MATER INT, V15, P955, DOI 10.1007/s12540-009-0955-1
   Li LC, 2004, SURF COAT TECH, V185, P92, DOI 10.1016/j.surfcoat.2004.01.004
   Li ZJ, 2008, BIOMATERIALS, V29, P1329, DOI 10.1016/j.biomaterials.2007.12.021
   Lin HC, 2005, MAGNESIUM TECHNOLOGY 2005, P275
   Liu CL, 2010, CORROS SCI, V52, P3341, DOI 10.1016/j.corsci.2010.06.003
   Liu CL, 2007, J MATER RES, V22, P1806, DOI 10.1557/JMR.2007.0241
   Liu CL, 2007, MAT SCI ENG A-STRUCT, V456, P350, DOI 10.1016/j.msea.2006.12.020
   Liu L, 2006, J ALLOY COMPD, V425, P268, DOI 10.1016/j.jallcom.2006.01.048
   Lopez HY, 2006, KEY ENG MAT, V309-311, P453, DOI 10.4028/www.scientific.net/KEM.309-311.453
   Lorenz C, 2009, ACTA BIOMATER, V5, P2783, DOI 10.1016/j.actbio.2009.04.018
   LUNDER O, 1994, WERKST KORROS, V45, P331
   Macdonald JR, 1987, IMPEDANCE SPECTROSCO, P133
   MAKAR GL, 1993, INT MATER REV, V38, P138, DOI 10.1179/imr.1993.38.3.138
   Mareci D, 2007, ENVIRON ENG MANAG J, V6, P313, DOI 10.30638/eemj.2007.034
   Menini R, 2006, J ELECTROCHEM SOC, V153, pB13, DOI 10.1149/1.2128098
   Mueller W.D., 2007, MAT RES, V10, P5
   Mueller WD, 2010, ACTA BIOMATER, V6, P1749, DOI 10.1016/j.actbio.2009.12.048
   Mueller WD, 2009, J BIOMED MATER RES A, V90A, P487, DOI 10.1002/jbm.a.32106
   Ng WF, 2010, MAT SCI ENG C-MATER, V30, P898, DOI 10.1016/j.msec.2010.04.003
   Ng WF, 2010, SURF COAT TECH, V204, P1823, DOI 10.1016/j.surfcoat.2009.11.024
   NR Neelameggham, 2005, MAGNESIUM TECHNOLOGY
   Omanovic S, 1999, LANGMUIR, V15, P8315, DOI 10.1021/la990474f
   Pardo A, 2008, CORROS SCI, V50, P823, DOI 10.1016/j.corsci.2007.11.005
   Peng QM, 2010, BIOMATERIALS, V31, P398, DOI 10.1016/j.biomaterials.2009.09.065
   Pietak AM, 2007, J BIOMED MATER RES, V19, P407
   Piskarev IM, 2010, BIOPHYSICS-USSR, V55, P13
   Quach NC, 2008, CR CHIM, V11, P1043, DOI 10.1016/j.crci.2008.06.007
   Ren YB, 2007, KEY ENG MATER, V342-343, P601, DOI 10.4028/www.scientific.net/KEM.342-343.601
   Ren Yibin, 2007, Frontiers of Materials Science in China, V1, P401, DOI 10.1007/s11706-007-0073-2
   Rettig R, 2008, J BIOMED MATER RES A, V85A, P167, DOI 10.1002/jbm.a.31550
   Scharf C, 2005, ADV ENG MATER, V7, P1134, DOI 10.1002/adem.200500180
   Schranz D, 2006, CATHETER CARDIO INTE, V67, P671, DOI 10.1002/ccd.20756
   Seal CK, 2009, IOP CONF SER-MAT SCI, V4, DOI 10.1088/1757-899X/4/1/012011
   Seelig M., 1924, ARCH SURG-CHICAGO, V8, P669
   Shaw B. A., 2005, ASM HDB B, V13B, P205
   Shi P, 2009, J ALLOY COMPD, V469, P286, DOI 10.1016/j.jallcom.2008.01.102
   Shi ZM, 2011, CORROS SCI, V53, P226, DOI 10.1016/j.corsci.2010.09.016
   Shi ZM, 2010, CORROS SCI, V52, P579, DOI 10.1016/j.corsci.2009.10.016
   Song G, 1997, CORROS SCI, V39, P855, DOI 10.1016/S0010-938X(96)00172-2
   Song G, 2005, MATER CORROS, V56, P15, DOI 10.1002/maco.200403803
   Song G, 1997, CORROS SCI, V39, P1981, DOI 10.1016/S0010-938X(97)00090-5
   SONG G, 1998, CORROS SCI, V41, P249
   Song GL, 2005, ADV ENG MATER, V7, P563, DOI 10.1002/adem.200500013
   Song GL, 2004, MAT SCI ENG A-STRUCT, V366, P74, DOI 10.1016/j.msea.2003.08.060
   Song GL, 2003, ADV ENG MATER, V5, P837, DOI 10.1002/adem.200310405
   Song GL, 2001, MAGNESIUM TECHNOLOGY 2001, P255
   Song GL, 2007, ADV ENG MATER, V9, P298, DOI 10.1002/adem.200600252
   Song GL, 2007, CORROS SCI, V49, P1696, DOI 10.1016/j.corsci.2007.01.001
   Song YW, 2008, MATER LETT, V62, P3276, DOI 10.1016/j.matlet.2008.02.048
   Song YW, 2009, MAT SCI ENG C-BIO S, V29, P1039, DOI 10.1016/j.msec.2008.08.026
   Staiger MP, 2006, BIOMATERIALS, V27, P1728, DOI 10.1016/j.biomaterials.2005.10.003
   STERN M, 1957, J ELECTROCHEM SOC, V104, P56, DOI 10.1149/1.2428496
   Sudholz AD, 2009, J ALLOY COMPD, V471, P109, DOI 10.1016/j.jallcom.2008.03.128
   Tait W. S, 1994, INTRO ELECTROCHEMICA
   Thomaz TR, 2010, CORROS SCI, V52, P2235, DOI 10.1016/j.corsci.2010.03.010
   Uhlig H.H., 1963, CORROSION CORROSION
   Vojtech D, 2004, STENTS PRODUCTION BI
   VOJTICH D., 2006, KOVOVE MATER, P211
   Von Der Hoh N, 2006, BIOMATERIALIEN, V7, P122
   Wan YZ, 2008, APPL SURF SCI, V254, P5514, DOI 10.1016/j.apsusc.2008.02.117
   Wan YZ, 2008, MATER DESIGN, V29, P2034, DOI 10.1016/j.matdes.2008.04.017
   Wang H, 2008, MATER LETT, V62, P2476, DOI 10.1016/j.matlet.2007.12.052
   Wang H, 2008, ADV MATER RES-SWITZ, V32, P207, DOI 10.4028/0-87849-475-8.207
   Wang H., 2010, CORROS SCI, V52, P255
   Wang HX, 2010, ACTA BIOMATER, V6, P1743, DOI 10.1016/j.actbio.2009.12.009
   Wang H, 2007, ADV ENG MATER, V9, P967, DOI 10.1002/adem.200700200
   Wang J., 2002, ANAL ELECTROCHEMISTR
   Wang J, 2009, MATER SCI FORUM, V610-613, P1174, DOI 10.4028/www.scientific.net/MSF.610-613.1174
   Wang Y, 2008, MATER LETT, V62, P2185
   Wang Y, 2009, MAT SCI ENG C-BIO S, V29, P1311, DOI 10.1016/j.msec.2008.09.051
   Wen ZH, 2009, J ALLOY COMPD, V488, P392, DOI 10.1016/j.jallcom.2009.08.147
   Widmaier E. P., 2010, VANDERS HUMAN PHYSL
   WILHELM E, 1977, CHEM REV, V77, P219, DOI 10.1021/cr60306a003
   Winston R., 2008, CORROSION CORROSION, P43
   Witte F, 2006, BIOMATERIALS, V27, P1013, DOI 10.1016/j.biomaterials.2005.07.037
   Witte F, 2007, BIOMATERIALS, V28, P2163, DOI 10.1016/j.biomaterials.2006.12.027
   Witte F, 2010, ACTA BIOMATER, V6, P1680, DOI 10.1016/j.actbio.2010.02.028
   Wong HM, 2010, BIOMATERIALS, V31, P2084, DOI 10.1016/j.biomaterials.2009.11.111
   Wu GH, 2005, MAT SCI ENG A-STRUCT, V408, P255, DOI 10.1016/j.msea.2005.08.011
   XIN Yun-chang, 2008, J ELECTROCHEM SOC, V155, P178
   Xin YC, 2007, J MATER RES, V22, P2004, DOI 10.1557/JMR.2007.0233
   Xin YC, 2009, SURF COAT TECH, V203, P2554, DOI 10.1016/j.surfcoat.2009.02.074
   Xu LP, 2009, J MATER SCI-MATER M, V20, P859, DOI 10.1007/s10856-008-3648-2
   Xu LP, 2009, BIOMATERIALS, V30, P1512, DOI 10.1016/j.biomaterials.2008.12.001
   Yamamoto A, 2001, SCRIPTA MATER, V44, P1039, DOI 10.1016/S1359-6462(01)00662-5
   Yamamoto A, 2009, MAT SCI ENG C-BIO S, V29, P1559, DOI 10.1016/j.msec.2008.12.015
   Yan TT, 2010, MAT SCI ENG C-MATER, V30, P740, DOI 10.1016/j.msec.2010.03.007
   Yang JX, 2009, IEEE T PLASMA SCI, V37, P1161, DOI 10.1109/TPS.2009.2016664
   Yang L, 2009, MAT SCI ENG C-BIO S, V29, P1691, DOI 10.1016/j.msec.2009.01.014
   Yfantis C. D., 2006, WSEAS Transactions on Environment and Development, V2, P1110
   Yfantis CD, 2006, IN VITRO CORROSION B
   Yun Y, 2009, MAT SCI ENG C-MATER, V29, P1814, DOI 10.1016/j.msec.2009.02.008
   Zberg B, 2009, NAT MATER, V8, P887, DOI [10.1038/NMAT2542, 10.1038/nmat2542]
   Zeng RC, 2007, T NONFERR METAL SOC, V17, pS166
   Zeng RC, 2008, ADV ENG MATER, V10, pB3, DOI 10.1002/adem.200800035
   Zhang CY, 2010, SURF COAT TECH, V204, P3636, DOI 10.1016/j.surfcoat.2010.04.038
   Zhang E, 2005, SCRIPTA MATER, V53, P523, DOI 10.1016/j.scriptamat.2005.05.009
   Zhang EL, 2008, MAT SCI ENG A-STRUCT, V497, P111, DOI 10.1016/j.msea.2008.06.019
   Zhang EL, 2009, MAT SCI ENG C-BIO S, V29, P987, DOI 10.1016/j.msec.2008.08.024
   Zhang SX, 2010, ACTA BIOMATER, V6, P626, DOI 10.1016/j.actbio.2009.06.028
   Zhang SX, 2009, MAT SCI ENG C-MATER, V29, P1907, DOI 10.1016/j.msec.2009.03.001
   Zhang XL, 2009, CORROS SCI, V51, P581, DOI 10.1016/j.corsci.2008.12.005
   Zhao MC, 2008, CORROS SCI, V50, P1939, DOI [10.1016/j.corsci.2008.04.010, 10.1016/j.corsci.2008.04.01]
   Zhao MC, 2008, ADV ENG MATER, V10, P104, DOI 10.1002/adem.200700246
   Zhao MC, 2009, CORROS SCI, V51, P1277, DOI 10.1016/j.corsci.2009.03.014
   Zhao MC, 2008, CORROS SCI, V50, P3168, DOI 10.1016/j.corsci.2008.08.023
   Zheng YF, 2010, ACTA BIOMATER, V6, P1783, DOI 10.1016/j.actbio.2009.10.009
   Zhou W, 2010, CORROS SCI, V52, P1035, DOI 10.1016/j.corsci.2009.11.030
   Zhu LQ, 2006, SURF COAT TECH, V200, P2834, DOI 10.1016/j.surfcoat.2004.11.042
   Zhuang HY, 2008, MAT SCI ENG C-BIO S, V28, P1462, DOI 10.1016/j.msec.2008.04.001
NR 162
TC 331
Z9 340
U1 19
U2 295
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1742-7061
J9 ACTA BIOMATER
JI Acta Biomater.
PD MAR
PY 2012
VL 8
IS 3
BP 925
EP 936
DI 10.1016/j.actbio.2011.11.014
PG 12
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 902ZY
UT WOS:000301083900001
PM 22134164
HC Y
HP N
DA 2018-10-19
ER

PT J
AU Krishna, UM
   Martinez, AW
   Caves, JM
   Chaikof, EL
AF Krishna, Urlam Murali
   Martinez, Adam W.
   Caves, Jeffrey M.
   Chaikof, Elliot L.
TI Hydrazone self-crosslinking of multiphase elastin-like block copolymer
   networks
SO ACTA BIOMATERIALIA
LA English
DT Article
DE Elastin-mimetic; Block copolymer; Self-crosslinking; Viscoelasticity;
   Recombinant biomaterial
ID POLY(ALDEHYDE GULURONATE) HYDROGELS; DEXTRAN-BASED HYDROGELS; LINKED
   HYALURONIC-ACID; PROTEIN POLYMER; TISSUE-REPAIR; INJECTABLE HYDROGELS;
   LOCALIZED DELIVERY; POLYPEPTIDE; CONJUGATE; COLLAGEN
AB Biosynthetic strategies for the production of recombinant elastin-like protein (ELP) triblock copolymers have resulted in elastomeric protein hydrogels, formed through rapid physical crosslinking upon warming of concentrated solutions. However, the strength of physically crosslinked networks can be limited, and options for non-toxic chemical crosslinking of these networks are not optimal. In this report, we modify two recombinant elastin-like proteins with aldehyde and hydrazide functionalities. When combined, these modified recombinant proteins self-crosslink through hydrazone bonding without requiring initiators or producing by-products. Crosslinked materials are evaluated for water content and swelling upon hydration, and subject to tensile and compressive mechanical tests. Hydrazone crosslinking is a viable method for increasing the mechanical strength of elastin-like protein polymers, in a manner that is likely to lend itself to the biocompatible in situ formation of chemically and physically crosslinked ELP hydrogels. (c) 2011 Acta Materialia Inc. Published by Elsevier Ltd. All rights reserved.
C1 [Caves, Jeffrey M.; Chaikof, Elliot L.] Harvard Univ, Beth Israel Deaconess Med Ctr, Sch Med, Dept Surg, Boston, MA 02215 USA.
   [Krishna, Urlam Murali; Chaikof, Elliot L.] Emory Univ, Dept Surg, Atlanta, GA 30322 USA.
   [Martinez, Adam W.; Chaikof, Elliot L.] Emory Univ, Georgia Inst Technol, Dept Biomed Engn, Atlanta, GA 30332 USA.
   [Caves, Jeffrey M.; Chaikof, Elliot L.] Harvard Univ, Wyss Inst Biol Inspired Engn, Boston, MA 02215 USA.
RP Chaikof, EL (reprint author), Harvard Univ, Beth Israel Deaconess Med Ctr, Sch Med, Dept Surg, Boston, MA 02215 USA.
EM echaikof@bidmc.harvard.edu
FU NHLBI NIH HHS [R01 HL083867, R01 HL083867-05]
CR Bellingham CM, 2003, BIOPOLYMERS, V70, P445, DOI 10.1002/bip.10512
   BERGEL DH, 1961, J PHYSIOL-LONDON, V156, P445, DOI 10.1113/jphysiol.1961.sp006686
   Bergman K, 2009, J BIOMED MATER RES A, V91A, P1111, DOI 10.1002/jbm.a.32289
   Bouhadir KH, 2000, J PHARM SCI-US, V89, P910, DOI 10.1002/1520-6017(200007)89:7<910::AID-JPS8>3.0.CO;2-#
   Bouhadir KH, 2001, BIOMATERIALS, V22, P2625, DOI 10.1016/S0142-9612(01)00003-5
   Bouhadir KH, 1999, POLYMER, V40, P3575, DOI 10.1016/S0032-3861(98)00550-3
   Bulpitt P, 1999, J BIOMED MATER RES, V47, P152
   Caves JM, 2011, BIOMATERIALS, V32, P5371, DOI 10.1016/j.biomaterials.2011.04.009
   Caves JM, 2010, BIOMATERIALS, V31, P7175, DOI 10.1016/j.biomaterials.2010.05.014
   Caves JM, 2010, ADV MATER, V22, P2041, DOI 10.1002/adma.200903612
   Dahms SE, 1998, BRIT J UROL, V82, P411
   Dreher MR, 2003, J CONTROL RELEASE, V91, P31, DOI 10.1016/S0168-3659(03)00216-5
   Farran AJE, 2010, TISSUE ENG PT A, V16, P1247, DOI 10.1089/ten.tea.2009.0344
   Girotti A, 2004, J MATER SCI-MATER M, V15, P479, DOI 10.1023/B:JMSM.0000021124.58688.7a
   Herrero-Vanrell R, 2005, J CONTROL RELEASE, V102, P113, DOI 10.1016/j.jconrel.2004.10.001
   Hudson SP, 2010, BIOMATERIALS, V31, P1444, DOI 10.1016/j.biomaterials.2009.11.016
   Ito T, 2007, BIOMATERIALS, V28, P3418, DOI 10.1016/j.biomaterials.2007.04.017
   Ito T, 2007, BIOMATERIALS, V28, P1778, DOI 10.1016/j.biomaterials.2006.12.012
   Jia XQ, 2006, BIOMACROMOLECULES, V7, P3336, DOI 10.1021/bm0604956
   Jia XQ, 2004, BIOMATERIALS, V25, P4797, DOI 10.1016/j.biomaterials.2003.12.012
   Jordan SW, 2007, BIOMATERIALS, V28, P1191, DOI 10.1016/j.biomaterials.2006.09.048
   Kirker KR, 2002, BIOMATERIALS, V23, P3661, DOI 10.1016/S0142-9612(02)00100-X
   Lee J, 2001, BIOMACROMOLECULES, V2, P170, DOI 10.1021/bm0000900
   Lee KY, 2000, MACROMOLECULES, V33, P97, DOI 10.1021/ma991286z
   Lee KY, 2004, BIOMATERIALS, V25, P2461, DOI 10.1016/j.biomaterials.2003.09.030
   Lee KY, 2001, J BIOMED MATER RES, V56, P228, DOI 10.1002/1097-4636(200108)56:2<228::AID-JBM1089>3.0.CO;2-9
   Lim DW, 2008, BIOMACROMOLECULES, V9, P222, DOI 10.1021/bm7007982
   Liu JC, 2004, BIOMACROMOLECULES, V5, P497, DOI 10.1021/bm034340z
   Luo Y, 2000, J CONTROL RELEASE, V69, P169, DOI 10.1016/S0168-3659(00)00300-X
   Maia J, 2005, POLYMER, V46, P9604, DOI 10.1016/j.polymer.2005.07.089
   Maia J, 2009, ACTA BIOMATER, V5, P1948, DOI 10.1016/j.actbio.2009.02.008
   Martinez-Sanz E, 2011, J CONTROL RELEASE, V152, P232, DOI 10.1016/j.jconrel.2011.02.003
   Martino M, 2001, BIOPOLYMERS, V59, P29, DOI 10.1002/1097-0282(200107)59:1<29::AID-BIP1003>3.0.CO;2-F
   McHale MK, 2005, TISSUE ENG, V11, P1768, DOI 10.1089/ten.2005.11.1768
   Migneault I, 2004, BIOTECHNIQUES, V37, p[790, 8]
   MOHAN D, 1982, J BIOMECH, V15, P887, DOI 10.1016/0021-9290(82)90055-0
   Nagapudi K, 2002, MACROMOLECULES, V35, P1730, DOI 10.1021/ma011429t
   Nagapudi K, 2005, BIOMATERIALS, V26, P4695, DOI 10.1016/j.biomaterials.2004.11.027
   Nagapudi K, 2005, MACROMOLECULES, V38, P345, DOI 10.1021/ma0491199
   Nowatzki PJ, 2004, BIOMATERIALS, V25, P1261, DOI 10.1016/S0142-9612(03)000365-5
   Ossipov DA, 2008, MACROMOLECULES, V41, P3971, DOI 10.1021/ma800332c
   Richman GP, 2005, J CONTROL RELEASE, V101, P3, DOI 10.1016/j.jconrel.2004.07.034
   Sallach RE, 2009, BIOMATERIALS, V31, P779
   Sallach RE, 2006, J AM CHEM SOC, V128, P12014, DOI 10.1021/ja0638509
   Sallach RE, 2009, BIOMATERIALS, V30, P409, DOI 10.1016/j.biomaterials.2008.09.040
   Takei T, 2010, BIOMACROMOLECULES, V11, P3525, DOI 10.1021/bm1010068
   Trabbic-Carlson K, 2003, BIOMACROMOLECULES, V4, P572, DOI 10.1021/bm025671z
   Varghese OP, 2009, J AM CHEM SOC, V131, P8781, DOI 10.1021/ja902857b
   Vieth S, 2007, BIOPOLYMERS, V85, P199, DOI 10.1002/bip.20619
   Woodhouse KA, 2004, BIOMATERIALS, V25, P4543, DOI 10.1016/j.biomaterials.2003.11.013
   Wright ER, 2002, ADV FUNCT MATER, V12, P149, DOI 10.1002/1616-3028(20020201)12:2<149::AID-ADFM149>3.0.CO;2-N
   Wright ER, 2002, ADV DRUG DELIVER REV, V54, P1057, DOI 10.1016/S0169-409X(02)00059-5
   Wu XY, 2008, BIOMACROMOLECULES, V9, P1787, DOI 10.1021/bm800012x
   Wu XY, 2005, BIOMACROMOLECULES, V6, P3037, DOI 10.1021/bm0503468
   Yeo Y, 2007, BIOMATERIALS, V28, P3704, DOI 10.1016/j.biomaterials.2007.04.033
   Yeo Y, 2006, BIOMATERIALS, V27, P4698, DOI 10.1016/j.biomaterials.2006.04.043
NR 56
TC 21
Z9 21
U1 0
U2 40
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1742-7061
J9 ACTA BIOMATER
JI Acta Biomater.
PD MAR
PY 2012
VL 8
IS 3
BP 988
EP 997
DI 10.1016/j.actbio.2011.11.024
PG 10
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 902ZY
UT WOS:000301083900005
PM 22154858
OA Green Accepted
DA 2018-10-19
ER

PT J
AU Reis, LA
   Chiu, LLY
   Liang, Y
   Hyunh, K
   Momen, A
   Radisic, M
AF Reis, Lewis A.
   Chiu, Loraine L. Y.
   Liang, Yan
   Hyunh, Kent
   Momen, Abdul
   Radisic, Milica
TI A peptide-modified chitosan-collagen hydrogel for cardiac cell culture
   and delivery
SO ACTA BIOMATERIALIA
LA English
DT Article
DE Cardiac; Myocardial infarction; Biomaterial; Hydrogel; Peptide
ID MARROW STROMAL CELLS; TISSUE ENGINEERING APPLICATIONS; ACUTE
   MYOCARDIAL-INFARCTION; EMBRYONIC STEM-CELLS; IN-VITRO; INJECTABLE
   HYDROGEL; HEART-CELLS; CARDIOMYOCYTES; REGENERATION; SURVIVAL
AB Myocardial infarction (MI) results in the death of cardiomyocytes (CM) followed by scar formation and pathological remodeling of the heart. We propose that chitosan conjugated with the angiopoietin-1 derived peptide, QHREDGS, and mixed with collagen I forms a thermoresponsive hydrogel better suited for the survival and maturation of transplanted cardiomyocytes in vitro compared to collagen and chitosan-collagen hydrogels alone. Conjugation of QHREDGS peptide to chitosan does not interfere with the gelation, structure or mechanical properties of the hydrogel blends. The storage modulus of 2.5 mg ml(-1) 1:1 mass:mass (m:m) chitosan-collagen was measured to be 54.9 +/- 9.1 Pa, and the loss modulus 6.1 +/- 0.9 Pa. The dose-response of the QHREDGS peptide was assessed and it was found that CMs encapsulated in High-peptide gel (651 +/- 8 nmol peptide ml-gel(-1)) showed improved morphology, viability and metabolic activity in comparison to the Low-peptide (100 +/- 30 nmol peptide ml-gel(-1)) and Control (No Peptide) groups. Construct (CMs in hydrogel) functional properties were not significantly different between the groups; however, the success rate of obtaining a beating construct was improved in the hydrogel with the High amount of QHREDGS peptide immobilized compared to the Low and Control groups. Subcutaneous injection of hydrogel (Control, Low and High) with CMs in the back of Lewis rats illustrated its ability to localize at the site of injection and retain cells, with CM contractile apparati identified after seven days. The hydrogel was also able to successfully localize at the site of injection in a mouse MI model. (c) 2011 Acta Materialia Inc. Published by Elsevier Ltd. All rights reserved.
C1 [Radisic, Milica] Univ Toronto, Inst Biomat & Biomed Engn, Dept Chem Engn & Appl Chem, Toronto, ON M5S 3G9, Canada.
   [Momen, Abdul] Univ Hlth Network, Toronto Gen Res Inst, Toronto, ON M5S 3G9, Canada.
RP Radisic, M (reprint author), Univ Toronto, Inst Biomat & Biomed Engn, Dept Chem Engn & Appl Chem, 164 Coll St,Rm 407, Toronto, ON M5S 3G9, Canada.
EM m.radisic@utoronto.ca
CR Balasubramanian S, 2003, J BIOL CHEM, V278, P42214, DOI 10.1074/jbc.M303428200
   Bhana B, 2010, BIOTECHNOL BIOENG, V105, P1148, DOI 10.1002/bit.22647
   Bittira B, 2002, ANN THORAC SURG, V74, P1154, DOI 10.1016/S0003-4975(02)03857-2
   Boateng SY, 2005, AM J PHYSIOL-CELL PH, V288, pC30, DOI 10.1152/ajpcell.00199.2004
   Bock-Marquette I, 2004, NATURE, V432, P466, DOI 10.1038/nature03000
   Chen QZ, 2008, MAT SCI ENG R, V59, P1, DOI 10.1016/j.mser.2007.08.001
   Chiu LLY, 2011, J CONTROL RELEASE, V155, P376, DOI 10.1016/j.jconrel.2011.05.026
   Chiu LLY, 2010, BIOMATERIALS, V31, P226, DOI 10.1016/j.biomaterials.2009.09.039
   Christman KL, 2004, J AM COLL CARDIOL, V44, P654, DOI 10.1016/j.jacc.2004.04.040
   Christman KL, 2004, TISSUE ENG, V10, P403, DOI 10.1089/107632704323061762
   Crockford D, 2007, ANN NY ACAD SCI, V1112, P385, DOI 10.1196/annals.1415.051
   Dallabrida Susan M, 2005, Circ Res, V96, pe8, DOI 10.1161/01.RES.0000158285.57191.60
   Davis ME, 2005, CIRCULATION, V111, P442, DOI 10.1161/01.CIR.0000153847.47301.80
   DeForest CA, 2010, CHEM MATER, V22, P4783, DOI 10.1021/cm101391y
   Deng C, 2010, TISSUE ENG PT A, V16, P3099, DOI 10.1089/ten.tea.2009.0504
   Dengler J, 2011, BIOTECHNOL BIOENG, V108, P704, DOI 10.1002/bit.22987
   DeQuach JA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013039
   Duan Y, 2011, J CARDIOVASC TRANSL, V4, P605, DOI 10.1007/s12265-011-9304-0
   Elisseeff J, 1999, P NATL ACAD SCI USA, V96, P3104, DOI 10.1073/pnas.96.6.3104
   Eschenhagen T, 1997, FASEB J, V11, P683
   Fan VH, 2007, STEM CELLS, V25, P1241, DOI 10.1634/stemcells.2006-0320
   Fujimoto KL, 2009, BIOMATERIALS, V30, P4357, DOI 10.1016/j.biomaterials.2009.04.055
   Gerosa G, 2002, ANN THORAC SURG, V74, P1159
   GRABER ML, 1986, ANAL BIOCHEM, V156, P202, DOI 10.1016/0003-2697(86)90174-0
   Ikeda S, 2003, CURRENT PROTOCOLS FO, P1
   Ito Y, 2008, SOFT MATTER, V4, P46, DOI 10.1039/b708359a
   Iyer RK, 2009, J BIOMED MATER RES A, V89A, P616, DOI 10.1002/jbm.a.32014
   Kim IY, 2008, BIOTECHNOL ADV, V26, P1, DOI 10.1016/j.biotechadv.2007.07.009
   Kofidis T., 2005, CIRCULATION, V112, pI173
   Krzeminski TF, 2008, VASC PHARMACOL, V48, P100, DOI 10.1016/j.vph.2008.01.002
   Laflamme MA, 2005, NAT BIOTECHNOL, V23, P845, DOI 10.1038/nbt1117
   LI Q, 1992, J BIOACT COMPAT POL, V7, P370, DOI 10.1177/088391159200700406
   Lipinski MJ, 2007, J AM COLL CARDIOL, V50, P1761, DOI 10.1016/j.jacc.2007.07.041
   Lu WN, 2009, TISSUE ENG PT A, V15, P1437, DOI 10.1089/ten.tea.2008.0143
   Makino S, 1999, J CLIN INVEST, V103, P697, DOI 10.1172/JCI5298
   Mavroudis C, 2002, ANN THORAC SURG, V73, P1926
   Menasche P, 2008, SEMIN THORAC CARDIOV, V20, P131, DOI 10.1053/j.semtcvs.2008.03.001
   Minatoguchi S, 2004, CIRCULATION, V109, P2572, DOI 10.1161/01.CIR.0000129770.93985.3E
   Miyagi Y, 2011, BIOMATERIALS, V32, P1280, DOI 10.1016/j.biomaterials.2010.10.007
   Muller-Ehmsen J, 2002, J MOL CELL CARDIOL, V34, P107, DOI 10.1006/jmcc.2001.1491
   Murry CE, 2004, NATURE, V428, P664, DOI 10.1038/nature02446
   MUZZARELLI RAA, 1993, CARBOHYD POLYM, V20, P7, DOI 10.1016/0144-8617(93)90027-2
   Nicodemus GD, 2008, TISSUE ENG PT B-REV, V14, P149, DOI 10.1089/ten.teb.2007.0332
   Nygren JM, 2004, NAT MED, V10, P494, DOI 10.1038/nm1040
   Ontario HSFo, 2010, STAT
   Orlic D, 2001, NATURE, V410, P701, DOI 10.1038/35070587
   Patten RD, 1998, AM J PHYSIOL-HEART C, V274, pH1812, DOI 10.1152/ajpheart.1998.274.5.H1812
   Prasitsilp M, 2000, J MATER SCI-MATER M, V11, P773, DOI 10.1023/A:1008997311364
   Pulapura S, 1992, J Biomater Appl, V6, P216, DOI 10.1177/088532829200600303
   Radisic M, 2004, P NATL ACAD SCI USA, V101, P18129, DOI 10.1073/pnas.0407817101
   Radisic M, 2003, BIOTECHNOL BIOENG, V82, P403, DOI 10.1002/bit.10594
   Rask F, 2009, DEV INJECTIBLE HYDRO
   Rask F, 2010, SOFT MATTER, V6, P5089, DOI 10.1039/c0sm00362j
   Rask F, 2010, J BIOMED MATER RES A, V95A, P105, DOI 10.1002/jbm.a.32808
   Ravi Kumar Majeti N. V., 2000, REACTIVE FUNCTIONAL, V46, P1
   Reinecke H, 2000, J CELL BIOL, V149, P731, DOI 10.1083/jcb.149.3.731
   Reinecke H, 2002, J MOL CELL CARDIOL, V34, P241, DOI 10.1006/jmcc.2001.1507
   Rossomacha E, 2004, J HISTOTECHNOL, V27, P31, DOI 10.1179/his.2004.27.1.31
   Shake JG, 2002, ANN THORAC SURG, V73, P1919, DOI 10.1016/S0003-4975(02)03517-8
   Smart N, 2007, NATURE, V445, P177, DOI 10.1038/nature05383
   Suuronen EJ, 2006, CIRCULATION, V114, pI138
   Tan W, 2001, TISSUE ENG, V7, P203, DOI 10.1089/107632701300062831
   van Luyn MJ, 1998, J BIOMED MATER RES, P398
   Wall ST, 2006, CIRCULATION, V114, P2627, DOI 10.1161/CIRCULATIONAHA.106.657270
   Wang LM, 2011, ACTA BIOMATER, V7, P2410, DOI 10.1016/j.actbio.2011.02.029
   Whittingstall P, 2003, CURRENT PROTOCOLS FO, P1
   Wu J, 2011, BIOMATERIALS, V32, P579, DOI 10.1016/j.biomaterials.2010.08.098
   Yoon SJ, 2009, J BIOMED MATER RES B, V91B, P163, DOI 10.1002/jbm.b.31386
   Zhang M, 2001, J MOL CELL CARDIOL, V33, P907, DOI 10.1006/jmcc.2001.1367
   Zimmermann WH, 2004, BIOMATERIALS, V25, P1639, DOI 10.1016/S0142-9612(03)00521-0
NR 70
TC 60
Z9 60
U1 2
U2 91
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1742-7061
J9 ACTA BIOMATER
JI Acta Biomater.
PD MAR
PY 2012
VL 8
IS 3
BP 1022
EP 1036
DI 10.1016/j.actbio.2011.11.030
PG 15
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 902ZY
UT WOS:000301083900008
PM 22155066
DA 2018-10-19
ER

PT J
AU Ye, XF
   Hu, X
   Wang, HZ
   Liu, J
   Zhao, Q
AF Ye, Xiaofeng
   Hu, Xiang
   Wang, Haozhe
   Liu, Jun
   Zhao, Qiang
TI Polyelectrolyte multilayer film on decellularized porcine aortic valve
   can reduce the adhesion of blood cells without affecting the growth of
   human circulating progenitor cells
SO ACTA BIOMATERIALIA
LA English
DT Article
DE Polyelectrolyte multilayer film; Decellularized porcine aortic valve;
   Platelets; Thrombogenicity; Endothelial progenitor cells
ID BY-LAYER ASSEMBLIES; PLATELET-ADHESION; HEART-VALVES; HEPARIN; CHITOSAN;
   THROMBOGENICITY; POLYMERS; MATRIX
AB Polyelectrolyte multilayer film modification could be an effective method to reduce the immunological and inflammatory response of the xenogeneic scaffold in vivo, and may also be applied to tissue-engineered heart valve in contact with blood. The objectives of this study are to test heparin-chitosan multilayer film as an antithrombotic coating reagent for decellularized aortic heart valve and the biocompatibility of the modified valvular surface. The adhesion and geometric deformation of platelets were demonstrated by scanning electron microscopy. The quantitative assay of platelet activation was determined by measuring the production of soluble P-selectin. Moreover, the leukocytes adhesion, erythrocyte hemolysis, and whole blood clotting time studies were performed to gain information on the hemocompatibility of this biomaterial. Human-blood-derived endothelial progenitor cells (EPCs) were cultured and the adhesion and growth of EPCs on the surface-modified PDAV were assessed. The results showed that heparin-chitosan multilayer film could be coated on the decellularized valvular scaffolds, and improved their hemocompatibility with respect to a substantial reduction of platelet adhesion and activation. The modified valve also significantly reduced leukocytes adhesion, erythrocyte hemolysis, and whole blood clotting time. Seeding with EPCs achieved a confluent monolayer on the surface of the decellularized matrix. The in vitro studies performed in this work suggest that it may be reasonable to use heparin-chitosan multilayer film as a means of surface modification to improve the blood compatibility of decellularized valvular scaffold. (c) 2011 Acta Materialia Inc. Published by Elsevier Ltd. All rights reserved.
C1 [Ye, Xiaofeng; Hu, Xiang; Wang, Haozhe; Liu, Jun; Zhao, Qiang] Shanghai Jiao Tong Univ, Dept Cardiac Surg, Ruijin Hosp, Shanghai 200030, Peoples R China.
RP Zhao, Q (reprint author), Shanghai Jiao Tong Univ, Dept Cardiac Surg, Ruijin Hosp, Shanghai 200030, Peoples R China.
EM zq11607@rjh.com.cn
FU National Natural Science Foundation of China [81000096]
FX The research was partially financially supported by the National Natural
   Science Foundation of China (81000096).
CR Aldenhoff Yvette B. J., 2003, European Cells & Materials, V5, P61
   Biela SA, 2009, ACTA BIOMATER, V5, P2460, DOI 10.1016/j.actbio.2009.04.003
   Cebotari S, 2002, CIRCULATION, V106, pI63, DOI 10.1161/01.cir.0000032900.55215.85
   Dohmen PM, 2009, ANN THORAC CARDIOVAS, V15, P362
   Emery RW, 2005, ANN THORAC SURG, V79, P776, DOI 10.1016/j.athoracsur.2004.08.047
   Erdbrugger W, 2006, TISSUE ENG, V12, P2059, DOI 10.1089/ten.2006.12.2059
   Flanagan TC, 2006, BIOMATERIALS, V27, P2233, DOI 10.1016/j.biomaterials.2005.10.031
   Fu JH, 2006, J BIOMED MATER RES A, V79A, P665, DOI 10.1002/jbm.a.30819
   He Q, 2010, BIOMED MATER, V5, DOI 10.1088/1748-6041/5/5/055001
   Iwasaki Y, 2003, J BIOMED MATER RES A, V65A, P164, DOI 10.1002/jbm.a.10459
   Iwasaki Y, 1998, J BIOMAT SCI-POLYM E, V9, P801, DOI 10.1163/156856298X00163
   Kasimir MT, 2006, J HEART VALVE DIS, V15, P278
   Kasimir MT, 2005, THROMB HAEMOSTASIS, V94, P562, DOI 10.1160/TH05-01-0025
   Liu L, 2008, J BIOMED MATER RES B, V87B, P244, DOI 10.1002/jbm.b.31103
   Liu XK, 2008, LANGMUIR, V24, P12986, DOI 10.1021/la802674h
   Lundin M, 2011, LANGMUIR, V27, P7537, DOI 10.1021/la200441u
   Lundin M, 2010, LANGMUIR, V26, P3242, DOI 10.1021/la902968h
   Lupu C, 1999, ARTERIOSCL THROM VAS, V19, P2251, DOI 10.1161/01.ATV.19.9.2251
   Meng S, 2009, BIOMATERIALS, V30, P2276, DOI 10.1016/j.biomaterials.2008.12.075
   Motlagh D, 2006, BIOMATERIALS, V27, P4315, DOI 10.1016/j.biomaterials.2006.04.010
   Picart C, 2002, P NATL ACAD SCI USA, V99, P12531, DOI 10.1073/pnas.202486099
   Picart C, 2008, CURR MED CHEM, V15, P685, DOI 10.2174/092986708783885219
   Powell AK, 2004, GLYCOBIOLOGY, V14, p17R, DOI 10.1093/glycob/cwh051
   Rafii S, 2003, NAT MED, V9, P702, DOI 10.1038/nm0603-702
   Rao SB, 1997, J BIOMED MATER RES, V34, P21, DOI 10.1002/(SICI)1097-4636(199701)34:1<21::AID-JBM4>3.0.CO;2-P
   Ruan QC, 2009, J COLLOID INTERF SCI, V333, P725, DOI 10.1016/j.jcis.2009.02.003
   SANANTONIO JD, 1994, J CELL BIOL, V125, P1179, DOI 10.1083/jcb.125.5.1179
   Shih MF, 2006, INT J PHARM, V327, P117, DOI 10.1016/j.ijpharm.2006.07.043
   Simon P, 2003, EUR J CARDIO-THORAC, V23, P1002, DOI 10.1016/S1010-7940(03)00094-0
   Thierry B, 2003, BIOMACROMOLECULES, V4, P1564, DOI 10.1021/bm0341834
   Yuan WY, 2010, COLLOID SURFACE B, V76, P549, DOI 10.1016/j.colsurfb.2009.12.017
   Zhai WY, 2006, BIOMATERIALS, V27, P3684, DOI 10.1016/j.biomaterials.2006.02.008
   Zhou JY, 2010, BIOMATERIALS, V31, P2549, DOI 10.1016/j.biomaterials.2009.11.088
NR 33
TC 33
Z9 37
U1 0
U2 35
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1742-7061
EI 1878-7568
J9 ACTA BIOMATER
JI Acta Biomater.
PD MAR
PY 2012
VL 8
IS 3
BP 1057
EP 1067
DI 10.1016/j.actbio.2011.11.011
PG 11
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 902ZY
UT WOS:000301083900011
PM 22122977
DA 2018-10-19
ER

PT J
AU Sun, B
   Yi, M
   Yacoob, CC
   Nguyen, HT
   Shen, H
AF Sun, B.
   Yi, M.
   Yacoob, C. C.
   Nguyen, H. T.
   Shen, H.
TI Effect of surface chemistry on gene transfer efficiency mediated by
   surface-induced DNA-doped nanocomposites
SO ACTA BIOMATERIALIA
LA English
DT Article
DE Tissue engineering; Gene therapy; Surface-mediated gene delivery;
   Nanocomposites; Self-assembled monolayers (SAMs)
ID SELF-ASSEMBLED MONOLAYERS; CALCIUM-PHOSPHATE; INDUCED MINERALIZATION;
   FUNCTIONAL-GROUP; TOTAL HIP; NUCLEATION; HYDROXYAPATITE; SCAFFOLDS;
   SILVER; RAMAN
AB Surface-induced biomineralization represents an effective way of immobilizing DNA molecules on biomaterial surfaces to introduce DNA into cells in contact with or at an approximate distance from the biomaterial surfaces. Previous studies have investigated how the composition of mineralizing solutions affects the composition and pH responsiveness of nanocomposites and thus gene transfer efficiency in different cell types. This study investigates how the functional groups of a biomaterial surface affect the induction and crystallographic properties of nanocomposites and thus the gene transfer efficiency. Self-assembled monolayers with different termini were used to control the functional groups of a surface. It is demonstrated that the induction of DNA-doped nanocomposites depends on the surface functional groups, which is consistent with previous studies. The crystallographic properties did not vary significantly with the functional groups. DNA-doped nanocomposites induced by different surface functional groups resulted in different cellular uptake of DNA and thus gene transfer efficiency. The differential cellular uptake may be attributed to the interactions between nanocomposites and functional groups. The weaker inducer resulted in higher cellular uptake, and thus higher gene transfer efficiency. Together with other previous studies, the current results suggest that surface-mediated gene transfer by DNA-doped nanocomposites can be modulated through both mineralizing solutions and surface chemistries. (c) 2011 Acta Materialia Inc. Published by Elsevier Ltd. All rights reserved.
C1 [Sun, B.; Yi, M.; Yacoob, C. C.; Nguyen, H. T.; Shen, H.] Univ Washington, Dept Chem Engn, Seattle, WA 98195 USA.
RP Shen, H (reprint author), Univ Washington, Dept Chem Engn, Box 351750, Seattle, WA 98195 USA.
EM hs24@u.washington.edu
RI Sun, Bingbing/H-1843-2013; Sun, Bingbing/I-8197-2012
OI Sun, Bingbing/0000-0002-5444-5078
FU National Institutes of Health [R21EB007494]; National Science Foundation
FX This work was supported by grant R21EB007494 from the National
   Institutes of Health and by the National Science Foundation CAREER Award
   awarded to H. Shen. The authors gratefully acknowledge Prof. John C.
   Berg for the use of Goniometer for contact angle measurement.
CR ADDADI L, 1987, P NATL ACAD SCI USA, V84, P2732, DOI 10.1073/pnas.84.9.2732
   Aizenberg J, 2004, ADV MATER, V16, P1295, DOI 10.1002/adma.200400759
   Aizenberg J, 1999, J AM CHEM SOC, V121, P4500, DOI 10.1021/ja984254k
   Balkenende AR, 1998, LANGMUIR, V14, P5907, DOI 10.1021/la9801110
   Bennick A, 1977, CALCIUM BINDING PROT
   Bensebaa F, 1999, SPECTROCHIM ACTA A, V55, P1229, DOI 10.1016/S1386-1425(98)00286-8
   Blaker JJ, 2003, J BIOMED MATER RES A, V67A, P1401, DOI 10.1002/jbm.a.20055
   Campbell AA, 1996, J BIOMED MATER RES, V32, P111, DOI 10.1002/(SICI)1097-4636(199609)32:1<111::AID-JBM13>3.0.CO;2-P
   Campbell AA, 2000, J BIOMED MATER RES, V53, P400, DOI 10.1002/1097-4636(2000)53:4<400::AID-JBM14>3.0.CO;2-Z
   De Laporte L, 2007, ADV DRUG DELIVER REV, V59, P292, DOI 10.1016/j.addr.2007.03.017
   Dumbleton J, 2004, J BONE JOINT SURG AM, V86A, P2526, DOI 10.2106/00004623-200411000-00028
   FROSTMAN LM, 1994, LANGMUIR, V10, P576, DOI 10.1021/la00014a039
   Fu Q, 2008, ACTA BIOMATER, V4, P1854, DOI 10.1016/j.actbio.2008.04.019
   GEESINK RGT, 1990, CLIN ORTHOP RELAT R, P39
   GREENFIELD EM, 1984, AM ZOOL, V24, P925
   Hirata I, 2010, DENT MATER J, V29, P438, DOI 10.4012/dmj.2010-017
   Israelachvili JN, 1992, INTERMOLECULAR SURFA
   Kudelski A, 2003, LANGMUIR, V19, P3805, DOI 10.1021/la0209280
   Kudelski A, 2002, LANGMUIR, V18, P4741, DOI 10.1021/la011701s
   Kudelski A, 2009, J RAMAN SPECTROSC, V40, P2037, DOI 10.1002/jrs.2367
   Lacefield WR, 1988, BIOCERAMICS MAT CHAR
   LAIBINIS PE, 1992, J AM CHEM SOC, V114, P1990, DOI 10.1021/ja00032a009
   Liu DP, 2006, J BIOMED MATER RES A, V77A, P763, DOI 10.1002/jbm.a.30641
   Liu Q, 2002, BIOMATERIALS, V23, P3103, DOI 10.1016/S0142-9612(02)00050-9
   Liu X, 2009, BIOMATERIALS, V30, P2252, DOI 10.1016/j.biomaterials.2008.12.068
   Mendoza SM, 2007, LANGMUIR, V23, P582, DOI 10.1021/la0605539
   Murphy WL, 2004, J DENT RES, V83, P204, DOI 10.1177/154405910408300304
   Partridge KA, 2004, TISSUE ENG, V10, P295, DOI 10.1089/107632704322791934
   Sandhyarani N, 1999, J COLLOID INTERF SCI, V209, P154, DOI 10.1006/jcis.1998.5882
   Shen H, 2004, NAT MATER, V3, P569, DOI 10.1038/nmat1179
   Stephen M, 2001, BIOMINERALIZATION PR
   Suarez-Gonzalez D, 2010, J BIOMED MATER RES A, V95A, P222, DOI 10.1002/jbm.a.32833
   Sun BB, 2009, BIOMATERIALS, V30, P6386, DOI 10.1016/j.biomaterials.2009.08.006
   Tanahashi M, 1997, J BIOMED MATER RES, V34, P305
   Toworfe GK, 2006, BIOMATERIALS, V27, P631, DOI 10.1016/j.biomaterials.2005.06.017
   Vitale-Brovarone C, 2007, ACTA BIOMATER, V3, P199, DOI 10.1016/j.actbio.2006.07.012
   Wang H, 2005, LANGMUIR, V21, P2633, DOI 10.1021/la046810w
   Yan WQ, 1997, BIOMATERIALS, V18, P1185, DOI 10.1016/S0142-9612(97)00057-4
NR 38
TC 12
Z9 12
U1 0
U2 24
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1742-7061
EI 1878-7568
J9 ACTA BIOMATER
JI Acta Biomater.
PD MAR
PY 2012
VL 8
IS 3
BP 1109
EP 1116
DI 10.1016/j.actbio.2011.12.005
PG 8
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 902ZY
UT WOS:000301083900016
PM 22198137
OA Green Accepted
DA 2018-10-19
ER

PT J
AU Perni, S
   Kong, MG
   Prokopovich, P
AF Perni, Stefano
   Kong, Michael G.
   Prokopovich, Polina
TI Cold atmospheric pressure gas plasma enhances the wear performance of
   ultra-high molecular weight polyethylene
SO ACTA BIOMATERIALIA
LA English
DT Article
DE Cold atmospheric pressure gas plasma; Total joint and disc arthroplasty;
   Ultra-high molecular weight polyethylene; Wear simulation; Biomaterial
   modification
ID TOTAL KNEE ARTHROPLASTY; ION-IMPLANTATION; ELASTIC-MODULUS;
   CROSS-LINKING; UHMWPE; REPLACEMENT; OSTEOLYSIS; PARTICLES; RADIATION;
   FRICTION
AB Ultra-high molecular weight polyethylene (UHMWPE) is frequently employed in joint replacements because of its high biocompatibility; however, this material does not exhibit particularly strong wear performance, thus potentially reducing the longevity of such devices. Numerous techniques have been investigated to increase the resistance to wear of UHMWPE, but they are all based on expensive machinery and require a high level of safety precautions. Cold atmospheric pressure gas plasma treatment is an inexpensive process that has been used as a surface modification method and as a sterilization technique. We demonstrate for the first time that a helium/oxygen cold atmospheric pressure gas plasma can be used to enhance the wear performance of UHMWPE without affecting the cytocompatibility of the material. The exposure to a cold atmospheric pressure gas plasma results in a greater level of crosslinking of the polyethylene chains. As a consequence of the higher crosslinking, the material stiffness of the treated surface is increased. (C) 2011 Acta Materialia Inc. Published by Elsevier Ltd. All rights reserved.
C1 [Prokopovich, Polina] Cardiff Univ, Welsh Sch Pharm, Cardiff CF10 3NB, S Glam, Wales.
   [Perni, Stefano] UCL, Eastman Dent Inst, Div Microbial Dis, London WC1X 8LD, England.
   [Perni, Stefano] UCL, Dept Chem, Mat Chem Res Ctr, London WC1H 0AJ, England.
   [Kong, Michael G.] Univ Loughborough, Sch Elect Elect & Syst Engn, Loughborough LE11 3TU, Leics, England.
   [Prokopovich, Polina] Cardiff Univ, Sch Engn, Inst Med Engn & Med Phys, Cardiff CF10 3NB, S Glam, Wales.
RP Prokopovich, P (reprint author), Cardiff Univ, Welsh Sch Pharm, King Edward VII Ave, Cardiff CF10 3NB, S Glam, Wales.
EM prokopovichp@cardiff.ac.uk
RI kong, michael/I-1574-2014; Perni, Stefano/B-8158-2009
OI Perni, Stefano/0000-0002-3101-0098; Prokopovich,
   Polina/0000-0002-5700-9570
CR Affatato D, 2001, BIOMATERIALS, V22, P2325
   AMSTUTZ HC, 1992, CLIN ORTHOP RELAT R, P7
   Basak GC, 2011, APPL SURF SCI, V257, P2891, DOI 10.1016/j.apsusc.2010.10.087
   Birrell F, 1999, ANN RHEUM DIS, V58, P569, DOI 10.1136/ard.58.9.569
   Bracco P, 2005, POLYMER, V46, P10648, DOI 10.1016/j.polymer.2005.08.095
   Canal C, 2007, PLASMA PROCESS POLYM, V4, P445, DOI 10.1002/ppap.200600199
   Cao S, 2009, VACUUM S1, V83, pS54
   Cao Z, 2009, APPL PHYS LETT, V94, DOI 10.1063/1.3069276
   Cao Z, 2010, PLASMA SOURCES SCI T, V19
   Chen JS, 2003, J APPL PHYS, V93, P5103, DOI 10.1063/1.1559943
   Choy KL, 2003, PROG MATER SCI, V48, P57, DOI 10.1016/S0079-6425(01)00009-3
   Clohisy D, 2003, J BONE JOINT SURG S1, V80A, P4
   Devin CJ, 2008, J BONE JOINT SURG AM, V90A, P2230, DOI 10.2106/JBJS.G.01712
   Fasce L, 2010, SURF COAT TECH, V204, P3887, DOI 10.1016/j.surfcoat.2010.05.005
   Fridman G, 2008, PLASMA PROCESS POLYM, V5, P503, DOI 10.1002/ppap.200700154
   Gahr K.-H. Zum, 1987, MICROSTRUCTURE WEAR
   Galvin A, 2006, J MATER SCI-MATER M, V17, P235, DOI 10.1007/s10856-006-7309-z
   Ge SR, 2003, WEAR, V255, P1069, DOI 10.1016/S0043-1648(03)00269-2
   Girard-Lauriault PL, 2005, PLASMA PROCESS POLYM, V2, P263, DOI 10.1002/ppap.200400092
   Goldman M, 1998, J BIOMED MATER RES, V40, P378, DOI 10.1002/(SICI)1097-4636(19980605)40:3<378::AID-JBM6>3.0.CO;2-C
   GOODMAN S, 1995, J BONE JOINT SURG AM, V77A, P1025, DOI 10.2106/00004623-199507000-00008
   Grupp TM, 2010, ACTA BIOMATER, V6, P3601, DOI 10.1016/j.actbio.2010.04.003
   Grupp TM, 2010, BIOMATERIALS, V31, P523, DOI 10.1016/j.biomaterials.2009.09.064
   He LN, 2011, APPL SURF SCI, V257, P3547, DOI 10.1016/j.apsusc.2010.11.072
   HOMOLA AM, 1990, WEAR, V136, P65, DOI 10.1016/0043-1648(90)90072-I
   Ingham E, 2000, P I MECH ENG H, V214, P21, DOI 10.1243/0954411001535219
   Ingram JH, 2004, BIOMATERIALS, V25, P3511, DOI 10.1016/j.biomaterials.2003.10.054
   Kang L, 2008, J BIOMECH, V41, P340, DOI 10.1016/j.jbiomech.2007.09.005
   Kogelschatz U, 1999, PURE APPL CHEM, V71, P1819, DOI 10.1351/pac199971101819
   Kong MG, 2009, NEW J PHYS, V11, DOI 10.1088/1367-2630/11/11/115012
   Kuster MS, 2002, ORTHOPEDICS, V25, pS235
   Lewis G, 1997, J BIOMED MATER RES, V38, P55, DOI 10.1002/(SICI)1097-4636(199721)38:1<55::AID-JBM8>3.0.CO;2-G
   Lewis G, 2001, BIOMATERIALS, V22, P371, DOI 10.1016/S0142-9612(00)00195-2
   Liu DX, 2010, PLASMA PROCESS POLYM, V7, P846, DOI 10.1002/ppap.201000049
   Liu HJ, 2010, APPL SURF SCI, V256, P3941, DOI 10.1016/j.apsusc.2010.01.054
   Marcondes R, 2004, BRAZ J PHYS, V34, P1667
   Matthews JB, 2000, J BIOMED MATER RES, V52, P296, DOI 10.1002/1097-4636(200011)52:2<296::AID-JBM8>3.0.CO;2-9
   Medel FJ, 2008, P I MECH ENG H, V222, P877, DOI 10.1243/09544119JEIM386
   Muratoglu OK, 1999, BIOMATERIALS, V20, P1463, DOI 10.1016/S0142-9612(99)00039-3
   Naudie DDR, 2007, J AM ACAD ORTHOP SUR, V15, P53, DOI 10.5435/00124635-200701000-00006
   Oliver WC, 2004, J MATER RES, V19, P3, DOI 10.1557/jmr.2004.19.1.3
   OLIVER WC, 1992, J MATER RES, V7, P1564, DOI 10.1557/JMR.1992.1564
   Perni D, 2008, J FOOD PROTECT, V71, P302
   Perni S, 2008, J FOOD PROTECT, V71, P1619, DOI 10.4315/0362-028X-71.8.1619
   Perni S, 2007, APPL PHYS LETT, V90, DOI 10.1063/1.2458162
   Prokopovich P, 2011, ACTA BIOMATER, V7, P3914, DOI 10.1016/j.actbio.2011.06.036
   Prokopovich P, 2011, COLLOID SURFACE A, V383, P95, DOI 10.1016/j.colsurfa.2011.01.011
   Prokopovich P, 2010, LANGMUIR, V26, P17028, DOI 10.1021/la102208y
   Punt IM, 2009, BIOMATERIALS, V30, P2079, DOI 10.1016/j.biomaterials.2008.12.071
   Saikko V, 2006, P I MECH ENG H, V220, P723, DOI 10.1243/09544119JEIM146
   Sharkey PF, 2002, CLIN ORTHOP RELAT R, P7, DOI 10.1097/01.blo.0000036002.13841.32
   Torrisi L, 2004, RADIAT EFF DEFECT S, V159, P259, DOI 10.1080/10420150410001711813
   van Ooij A, 2007, SPINE, V32, P223, DOI 10.1097/01.brs.0000251370.56327.c6
   Visco AM, 2010, INT J POLYM ANAL CH, V15, P73, DOI 10.1080/10236660903518880
   Visco AM, 2008, J BIOMED MATER RES B, V89, P55
   Walsh JL, 2008, APPL PHYS LETT, V93, DOI 10.1063/1.2982497
   Walsh JL, 2007, APPL PHYS LETT, V91, DOI 10.1063/1.2825576
   Wang A, 1999, 45 ANN M ORTH RES SO
   Yu H, 2006, J APPL MICROBIOL, V101, P1323, DOI 10.1111/j.1365-2672.2006.03033.x
NR 59
TC 15
Z9 17
U1 2
U2 27
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1742-7061
J9 ACTA BIOMATER
JI Acta Biomater.
PD MAR
PY 2012
VL 8
IS 3
BP 1357
EP 1365
DI 10.1016/j.actbio.2011.12.007
PG 9
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 902ZY
UT WOS:000301083900043
PM 22202910
DA 2018-10-19
ER

PT J
AU Han, I
   Vagaska, B
   Seo, HJ
   Kang, JK
   Kwon, BJ
   Lee, MH
   Park, JC
AF Han, Inho
   Vagaska, Barbora
   Seo, Hyok Jin
   Kang, Jae Kyeong
   Kwon, Byeong-Ju
   Lee, Mi Hee
   Park, Jong-Chul
TI Promoted cell and material interaction on atmospheric pressure plasma
   treated titanium
SO APPLIED SURFACE SCIENCE
LA English
DT Article
DE Dental implant; Plasma; Atmospheric pressure; Surface modification;
   Osteoblast
ID SURFACE MODIFICATION; DENTAL IMPLANTS; BONE; ADHESION
AB Surface carbon contamination is a natural phenomenon. However, it interferes with cell-biomaterial interaction. In order to eliminate the interference, atmospheric pressure plasma treatment was employed. Dielectric barrier discharge treatment of titanium surface for less than 10 min turned titanium super-hydrophilic. Adsorption of fibronectin which is the major cell adhesive protein increased after plasma treatment. Cell attachment parameters of osteoblast cells such as population, cell area, perimeter, Feret's diameter and cytoskeleton development were also enhanced. Cell proliferation increased on the plasma treated titanium. In conclusion, dielectric barrier discharge type atmospheric pressure plasma system is effective to modify titanium surface and the modified titanium promotes cell and material interactions. (C) 2012 Elsevier B.V. All rights reserved.
C1 [Vagaska, Barbora; Seo, Hyok Jin; Kang, Jae Kyeong; Kwon, Byeong-Ju; Lee, Mi Hee; Park, Jong-Chul] Yonsei Univ, Coll Med, Dept Med Engn, Cellbiocontrol Lab, Seoul 120752, South Korea.
   [Han, Inho] Korean Intellectual Patent Off, Convergence Technol Exam Div 2, Taejon, South Korea.
   [Seo, Hyok Jin; Kwon, Byeong-Ju; Park, Jong-Chul] Yonsei Univ, Coll Med, Brain Korea Project Med Sci 21, Seoul 120752, South Korea.
RP Park, JC (reprint author), Yonsei Univ, Coll Med, Dept Med Engn, Cellbiocontrol Lab, 134 Shinchon Dong, Seoul 120752, South Korea.
EM parkjc@yuhs.ac
OI Vagaska, Barbora/0000-0001-7511-6428
FU National Research Foundation (NRF) of Korea; Korean Government (MEST)
   [2010-0002089]; Ministry for Health & Welfare, Republic of Korea
   [A100834]
FX This work was supported by National Research Foundation (NRF) of Korea
   Grant funded by the Korean Government (MEST) (grant number 2010-0002089)
   and was supported by a grant of the Korea Healthcare technology R&D
   Project, Ministry for Health & Welfare, Republic of Korea (grant number
   A100834). This article is dedicated to I. Han's lovely wife (Jeehae
   Choi) and pretty children (Jisu Han and Sangyoon Han).
CR Abe H, 2008, JPN J APPL PHYS, V47, P1435, DOI 10.1143/JJAP.47.1435
   Aita H, 2009, BIOMATERIALS, V30, P1015, DOI 10.1016/j.biomaterials.2008.11.004
   Anselme K, 2000, BIOMATERIALS, V21, P667, DOI 10.1016/S0142-9612(99)00242-2
   Attard NJ, 2005, J PROSTHET DENT, V94, P242, DOI 10.1016/j.prosdent.2005.04.015
   Bergkvist M, 2003, J BIOMED MATER RES A, V64A, P349, DOI 10.1002/jbm.a.10423
   Ehrenfest DMD, 2010, TRENDS BIOTECHNOL, V28, P198, DOI 10.1016/j.tibtech.2009.12.003
   Elias CN, 2010, EXPERT REV MED DEVIC, V7, P241, DOI [10.1586/erd.09.74, 10.1586/ERD.09.74]
   Flanagan TM, 2006, PHYS PLASMAS, V13, DOI 10.1063/1.2401155
   Hao L, 2007, J MATER SCI-MATER M, V18, P807, DOI 10.1007/s10856-006-0002-4
   Jonge L. T., 2008, PHARM RES, V25, P2357
   Lavenus S, 2010, NANOMEDICINE-UK, V5, P937, DOI [10.2217/nnm.10.54, 10.2217/NNM.10.54]
   Liu XY, 2004, MAT SCI ENG R, V47, P49, DOI 10.1016/j.mser.2004.11.001
   Paital SR, 2009, MAT SCI ENG R, V66, P1, DOI 10.1016/j.mser.2009.05.001
   Schwarz F, 2010, J CLIN PERIODONTOL, V37, P466, DOI 10.1111/j.1600-051X.2010.01533.x
   SMITH T, 1980, J COLLOID INTERF SCI, V75, P51, DOI 10.1016/0021-9797(80)90348-3
   Stanford CM, 2010, INT J MOL SCI, V11, P354, DOI 10.3390/ijms11010354
   Taylor CE, 1996, ANAL CHEM, V68, P2401, DOI 10.1021/ac950753h
   Tendero C, 2006, SPECTROCHIM ACTA B, V61, P2, DOI 10.1016/j.sab.2005.10.003
   Vandrovcova M, 2008, PHYS STATUS SOLIDI A, V205, P2252, DOI 10.1002/pssa.200879730
   VANOSS CJ, 1990, LANGMUIR, V6, P1711, DOI 10.1021/la00101a017
   Wall I, 2009, BONE, V45, P17, DOI 10.1016/j.bone.2009.03.662
   Yi CH, 2003, SURF COAT TECH, V171, P237, DOI 10.1016/S0257-8972(03)00278-0
NR 22
TC 7
Z9 8
U1 2
U2 13
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0169-4332
J9 APPL SURF SCI
JI Appl. Surf. Sci.
PD MAR 1
PY 2012
VL 258
IS 10
BP 4718
EP 4723
DI 10.1016/j.apsusc.2012.01.065
PG 6
WC Chemistry, Physical; Materials Science, Coatings & Films; Physics,
   Applied; Physics, Condensed Matter
SC Chemistry; Materials Science; Physics
GA 901TZ
UT WOS:000300991400077
DA 2018-10-19
ER

PT J
AU Mayer, A
   Kratz, K
   Hiebl, B
   Lendlein, A
   Jung, F
AF Mayer, Anke
   Kratz, Karl
   Hiebl, Bernhard
   Lendlein, Andreas
   Jung, Friedrich
TI Interaction of Angiogenically Stimulated Intermediate CD163(+)
   Monocytes/MacrophagesWith Soft Hydrophobic Poly(n-Butyl Acrylate)
   Networks With Elastic Moduli Matched to That of Human Arteries
SO ARTIFICIAL ORGANS
LA English
DT Article
DE Monocytes; Intermediate; Vascular endothelial growth factor; Cytokine
   delivery system; Biomaterial; Elasticity; Poly(n-butyl acrylate)
ID ENDOTHELIAL GROWTH-FACTOR; BIOMATERIAL SURFACE-CHEMISTRY; SCAVENGER
   RECEPTOR CD163; COMMON CAROTID-ARTERY; IN-VITRO; HUMAN MONOCYTES;
   IFN-GAMMA; BLOOD; CELLS; MACROPHAGES
AB The cell population of peripheral blood monocytes/macrophages (MO) is heterogeneous: The majority of the MO are CD14(++) CD16- and named "classical" (=MO1). Furthermore, two other subpopulations were described: CD14(++) CD16(+) ("intermediate"=MO2) and CD14(+) CD16(++) ("non-classical"=MO3). It is reported that MO2 possess anti-inflammatory properties and express the MO lineage marker CD163. On a hydrophilic neutrally charged acrylamide-based hydrogel human intermediate (CD14(++) CD16(+)), angiogenically stimulated CD163(++) monocytes/macrophages (aMO2) maintained a proangiogenic and noninflammatory status for at least 14 days. Here, we explored whether this aMO2 subset adhered to hydrophobic poly(n-butyl acrylate) networks (cPnBA) and also remained in its proangiogenic and noninflammatory status. Because substrate elasticity can impact adherence, morphology, and function of cells, cPnBAs with different Young's modulus (250 and 1100 kPa) were investigated, whereby their elasticity was tailored by variation of the cross-linker content and matched to the elasticity of human arteries. The cPnBAs exhibited similar surface properties (e. g., surface roughness), which were maintained after ethylene oxide sterilization and exposure in serum-free cell culture medium for 18 h at 37 degrees C. aMO2 were seeded on cPnBA samples (1.7 10(5) cells/1.33 cm(2)) in Dulbecco's modified Eagle medium (DMEM high glucose) supplemented with vascular endothelial growth factor 165 (VEGF-A(165), 10 ng/mL) and fetal calf serum (10 vol%) for 3 and 72 h. On both polymeric samples (n = 3 each), the numbers of adherent cells per unit area were significantly higher (P < 0.01; cPnBA0250: 3 h 13 +/- 5 cells/mm(2), 72 h 234 +/- 106 cells/mm(2); cPnBA1100: 3 h 14 +/- 3 cells/mm(2), 72 h 198 +/- 113 cells/mm(2)) compared to control cultures (glass, 3 h: 6 +/- 3 cells/mm(2), 72 h: 130 +/- 83 cells/mm(2)) and showed a typically spread morphology. Them RNA expression profile of the aMO2 was not influenced by the substrate elasticity. In the supernatant of aMO2 on cPnBA0250, significantly less VEGF-A(165) product was found than expected based on the mRNA level measured (P < 0.01). Tests with recombinant VEGF-A(165) then demonstrated that significantly more VEGF-A165 was adhered on cPnBA0250 than on cPnBA1100 (P < 0.01). Seeded on cPnBA, aMO2-unaffected by the elastic moduli of both substrates-seemed to remain in their subset status and secreted VEGF-A(165) without release of proinflammatory cytokines. These in vitro results might indicate that this MO subset can be used as cellular delivery system for proangiogenic and noninflammatory mediators to support the endothelialization of cPnBA.
C1 [Jung, Friedrich] Helmholtz Zentrum Geesthacht, Ctr Biomat Dev, D-14513 Teltow, Germany.
   Helmholtz Zentrum Geesthacht, Berlin Brandenburg Ctr Regenerat Therapies, Polymer Res Inst, D-14513 Teltow, Germany.
RP Jung, F (reprint author), Helmholtz Zentrum Geesthacht, Ctr Biomat Dev, Kantstr 55, D-14513 Teltow, Germany.
EM friedrich.jung@hzg.de
RI Jung, Friedrich/L-1301-2013; Kratz, Karl/K-7115-2013; Lendlein,
   Andreas/K-9553-2013
OI Jung, Friedrich/0000-0001-8098-7180; Kratz, Karl/0000-0002-9229-4266;
   Lendlein, Andreas/0000-0003-4126-4670; Hiebl,
   Bernhard/0000-0002-6450-0675
FU Berlin-Brandenburg Centre for Regenerative Therapies
FX This work was supported by a "Twinning" grant "Novel strategies for
   vascular regeneration after coronary interventions based on vascular
   healing drugs, improved stent hemocompatibility and pre-determined
   drug-release" from the Berlin-Brandenburg Centre for Regenerative
   Therapies.
CR Abramson SB, 2002, RHEUMATOLOGY, V41, P972, DOI 10.1093/rheumatology/41.9.972
   Akeson A, 2010, MICROVASC RES, V80, P65, DOI 10.1016/j.mvr.2010.02.001
   Alikhani M, 2004, J CELL PHYSIOL, V201, P341, DOI 10.1002/jcp.20067
   BACKE E, 1991, J CLIN PATHOL, V44, P936, DOI 10.1136/jcp.44.11.936
   Belge KU, 2002, J IMMUNOL, V168, P3536, DOI 10.4049/jimmunol.168.7.3536
   BERGSTROM K, 1994, J BIOMAT SCI-POLYM E, V6, P123
   Brodbeck WG, 2002, P NATL ACAD SCI USA, V99, P10287, DOI 10.1073/pnas.162124199
   Brodbeck WG, 2001, J BIOMED MATER RES, V55, P661, DOI 10.1002/1097-4636(20010615)55:4<661::AID-JBM1061>3.0.CO;2-F
   Buechler C, 2000, J LEUKOCYTE BIOL, V67, P97
   CIMA LG, 1994, J CELL BIOCHEM, V56, P155, DOI 10.1002/jcb.240560206
   Cornelissen AMH, 2000, J DENT RES, V79, P1782, DOI 10.1177/00220345000790100901
   Coyle CH, 2007, J BIOMATER APPL, V22, P55, DOI 10.1177/0885328206069152
   Cui J, 2011, POLYM ADVAN TECHNOL, V22, P126, DOI 10.1002/pat.1816
   DAVIGNON JL, 1990, INT J IMMUNOPHARMACO, V12, P691, DOI 10.1016/0192-0561(90)90107-X
   DeFail AJ, 2006, BIOMATERIALS, V27, P1579, DOI 10.1016/j.biomaterials.2005.08.013
   Dinarello CA, 2010, EUR J IMMUNOL, V40, P599, DOI 10.1002/eji.201040319
   Frankenberger M, 1996, BLOOD, V87, P373
   George ML, 2000, CLIN CANCER RES, V6, P3147
   Gerber JS, 2001, J IMMUNOL, V166, P6861, DOI 10.4049/jimmunol.166.11.6861
   Goldbach-Mansky R, 2009, ANN NY ACAD SCI, V1182, P111, DOI 10.1111/j.1749-6632.2009.05159.x
   Gordon S, 2003, NAT REV IMMUNOL, V3, P23, DOI 10.1038/nri978
   Grage-Griebenow E, 2001, J LEUKOCYTE BIOL, V69, P11
   Gratchev A, 2006, IMMUNOBIOLOGY, V211, P473, DOI 10.1016/j.imbio.2006.05.017
   Greenwald SE, 2000, J PATHOL, V190, P292, DOI 10.1002/(SICI)1096-9896(200002)190:3<292::AID-PATH528>3.0.CO;2-S
   Hao X, 2004, BIOCHEM BIOPH RES CO, V315, P1058, DOI 10.1016/j.bbrc.2004.01.165
   Hayashi T, 2007, BIOINTERPHASES, V2, P119, DOI 10.1116/1.2794712
   Heldin CH, 1999, PHYSIOL REV, V79, P1283
   Hiebl B, 2012, J BIOMAT SCI-POLYM E, V23, P901, DOI 10.1163/092050611X566144
   Hiebl B, 2010, CLIN HEMORHEOL MICRO, V46, P211, DOI 10.3233/CH-2010-1347
   Hoepken S, 2009, CLIN HEMORHEOL MICRO, V43, P157, DOI 10.3233/CH-2009-1230
   Jung F, 2010, MRS BULL, V35, P607, DOI 10.1557/mrs2010.529
   Kaplanski G, 2003, TRENDS IMMUNOL, V24, P25, DOI 10.1016/S1471-4906(02)00013-3
   Kodelja V, 1997, IMMUNOBIOLOGY, V197, P478, DOI 10.1016/S0171-2985(97)80080-0
   MacEwan MR, 2005, J BIOMED MATER RES A, V74A, P285, DOI 10.1002/jbm.a.30316
   MALEFYT RD, 1993, J IMMUNOL, V151, P6370
   Mantovani A, 2004, TRENDS IMMUNOL, V25, P677, DOI 10.1016/j.it.2004.09.015
   Mayer A, 2010, CLIN HEMORHEOL MICRO, V46, P217, DOI 10.3233/CH-2010-1348
   PATEL DJ, 1969, CIRC RES, V25, P765, DOI 10.1161/01.RES.25.6.765
   PATEL DJ, 1970, CIRC RES, V27, P149, DOI 10.1161/01.RES.27.2.149
   Patterson C, 2000, CIRCULATION, V102, P940, DOI 10.1161/01.CIR.102.9.940
   PULFORD K, 1992, IMMUNOLOGY, V75, P588
   RILEY WA, 1992, STROKE, V23, P952, DOI 10.1161/01.STR.23.7.952
   Shastri VP, 2009, ADV MATER, V21, P3231, DOI 10.1002/adma.200902200
   Shen MC, 2001, J BIOMED MATER RES, V57, P336, DOI 10.1002/1097-4636(20011205)57:3<336::AID-JBM1176>3.0.CO;2-E
   Skrzeczynska-Moncznik J, 2008, SCAND J IMMUNOL, V67, P152, DOI 10.1111/j.1365-3083.2007.02051.x
   Van Gorp H, 2010, MOL IMMUNOL, V47, P1650, DOI 10.1016/j.molimm.2010.02.008
   WAHL SM, 1994, J EXP MED, V180, P1587, DOI 10.1084/jem.180.5.1587
   Weigel T, 2006, EXPERT REV MED DEVIC, V3, P835, DOI 10.1586/17434440.3.6.835
   Worrall NK, 1997, AM J PHYSIOL-HEART C, V273, pH2565
   Xue L, 2002, SURGERY, V132, P259, DOI 10.1067/msy.2002.125720
   Ziegler-Heitbrock L, 2010, BLOOD, V116, pE74, DOI 10.1182/blood-2010-02-258558
   Zocalo Y, 2010, ARTIF ORGANS, V34, P677, DOI 10.1111/j.1525-1594.2009.00962.x
NR 52
TC 7
Z9 7
U1 2
U2 8
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0160-564X
EI 1525-1594
J9 ARTIF ORGANS
JI Artif. Organs
PD MAR
PY 2012
VL 36
IS 3
BP E28
EP E38
DI 10.1111/j.1525-1594.2011.01410.x
PG 11
WC Engineering, Biomedical; Transplantation
SC Engineering; Transplantation
GA 903JM
UT WOS:000301112600002
PM 22360779
DA 2018-10-19
ER

PT J
AU Luz, AP
   Pandolfelli, VC
AF Luz, A. P.
   Pandolfelli, V. C.
TI CaCO3 addition effect on the hydration and mechanical strength evolution
   of calcium aluminate cement for endodontic applications
SO CERAMICS INTERNATIONAL
LA English
DT Article
DE Calcium aluminate cement (CAC); Hydration; CaCO3; Monocarbonate
   (C(4)ACH(11))
ID CARBONATE
AB Calcium aluminate cement (CAC) hydrates conversion can be inhibited by adding CaCO3, leading to C(3)A center dot CaCO3 center dot 11H (3CaO center dot Al2O3 center dot CaCO3 center dot 11H(2)O) formation. However, despite its benefits, the stability of this monocarbonate hydrate is not fully understood, especially when the samples are kept in contact with liquid during the curing step. Thus, taking into account the increasing interest in the CAC application as a biomaterial in the endodontic area, this work addresses the evaluation of the mechanical strength and phase transformations of a commercial cement (Secar 71) containing 15 or 20 wt% of CaCO3. Compressive strength, apparent porosity, dimensional linear changes, X ray diffraction and thermogravimetric tests were carried out to evaluate samples immersed in water and kept at 37 degrees C between 1 and 30 days of curing. According to the collected results, CAH(10) and C(2)AH(8) formation were inhibited in CaCO3 containing compositions and the presence of the C(3)A center dot CaCO3 center dot 11H phase led to a significant cement mechanical strength increase. Nevertheless, the partial decomposition of this monocarbonate hydrate was detected at 37 degrees C in the range of 1-7 days and the continuous hydration of CA and CA(2) also affected the compressive strength behavior of the evaluated samples. (C) 2011 Elsevier Ltd and Techna Group S.r.l. All rights reserved.
C1 [Luz, A. P.; Pandolfelli, V. C.] Univ Fed Sao Carlos, Dept Mat Engn, BR-13565905 Sao Carlos, SP, Brazil.
RP Luz, AP (reprint author), Univ Fed Sao Carlos, Dept Mat Engn, Rod Washington Luiz,Km 235,CP 676, BR-13565905 Sao Carlos, SP, Brazil.
EM anapaula.light@gmail.com
OI da Luz, Ana Paula/0000-0002-5941-5388
FU Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)
FX The authors are grateful to the Conselho Nacional de Desenvolvimento
   Cientifico e Tecnologico (CNPq) for supporting this work and Kerneos
   Inc. (France) for supplying the cement.
CR Arora SC, 2009, MATH BOHEM, V134, P87
   Darweesh HHM, 2004, CERAM INT, V30, P145, DOI 10.1016/S0272-8842(03)00073-7
   Dweck J, 2000, THERMOCHIM ACTA, V346, P105, DOI 10.1016/S0040-6031(99)00369-X
   Engqvist H, 2004, BIOMATERIALS, V25, P2781, DOI 10.1016/j.biomaterials.2003.09.053
   FENTIMAN CH, 1985, CEMENT CONCRETE RES, V15, P622, DOI 10.1016/0008-8846(85)90061-4
   Jacobovitz M, 2009, ORAL SURG ORAL MED O, V108, P140, DOI 10.1016/j.tripleo.2009.03.013
   Kopanda J.E., 1987, PRODUCTION PROCESSES, V15212, P171
   Kraft L., 2002, THESIS UPPSALA U, P1
   Kuzel HJ, 1996, EUR J MINERAL, V8, P129
   Loof J., 2003, J MATER SCI-MATER M, V14, P1
   Loof J., 2008, THESIS UPPSALA U, P1
   Loof J, 2008, DENT MATER, V24, P653, DOI 10.1016/j.dental.2007.06.028
   Luz AP, 2011, CERAM INT, V37, P3789, DOI 10.1016/j.ceramint.2011.06.034
   Luz A.P., CERAMICA BR IN PRESS
   Oliveira IR, 2009, CERAM INT, V35, P1453, DOI 10.1016/j.ceramint.2008.07.024
   Pandolfelli V. C., 2009, Patent No, Patent No. [W02009067774, 2009067774]
   Parrot C., 2008, P IRE ANN C UK, P1
   Pena P., 1999, REFRACTARIOS MONOLIT, P85
   Pileggi RG, 2002, AM CERAM SOC BULL, V81, P37
   Ramachandran V.S., 1969, APPL DIFFERENTIAL TH, P206
   TORABINEJAD M, 1993, J ENDODONT, V19, P591, DOI 10.1016/S0099-2399(06)80271-2
   Ukrainczyk N, 2007, THERMOCHIM ACTA, V464, P7, DOI 10.1016/j.tca.2007.07.022
   Wojciech G.P., 1990, EFFECT LIMESTONE FIL, P241
NR 23
TC 19
Z9 20
U1 1
U2 13
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0272-8842
J9 CERAM INT
JI Ceram. Int.
PD MAR
PY 2012
VL 38
IS 2
BP 1417
EP 1425
DI 10.1016/j.ceramint.2011.09.021
PG 9
WC Materials Science, Ceramics
SC Materials Science
GA 895BZ
UT WOS:000300472500072
DA 2018-10-19
ER

PT J
AU Kundu, B
   Nandi, SK
   Roy, S
   Dandapat, N
   Soundrapandian, C
   Dana, S
   Mukherjee, P
   Mandal, TK
   Dasgupta, S
   Basu, D
AF Kundu, Biswanath
   Nandi, Samit Kumar
   Roy, Subhasis
   Dandapat, Nandadulal
   Soundrapandian, Chidambaram
   Dana, Someswar
   Mukherjee, Prasenjit
   Mandal, Tapan Kumar
   Dasgupta, Sudip
   Basu, Debabrata
TI Systematic approach to treat chronic osteomyelitis through
   ceftriaxone-sulbactam impregnated porous beta-tri calcium phosphate
   localized delivery system
SO CERAMICS INTERNATIONAL
LA English
DT Article
DE Pure beta-TCP; Ceftriaxone sulbactam; In vitro and in vivo; Simulated
   body fluid; New Zealand white rabbits; Pore size
ID IN-VITRO; TRICALCIUM PHOSPHATE; BONE-FORMATION; HYDROXYAPATITE; VIVO;
   RELEASE; IMPLANTS; SCAFFOLDS; RABBITS
AB Present investigation deals with in vitro and in vivo experimentation to treat chronic osteomyelitis, using pure beta-tri calcium phosphate porous scaffolds. A novel approach was given to treat such infections using the scaffolds and drug combinations consisting of ideal antibiotics. In vitro studies include variation of porosity with interconnectivity, pore-drug interfacial studies by SEM-EDAX and drug elution studies both in contact with PBS and SBF at ca. 37 degrees C. In vivo trials were based on experimental osteomyelitis in rabbit model in tibia by Staphylococcus aureus. Characterizations included histopathology, radiology and estimation of drug in both bone and serum for 42 days by HPLC and subsequent bone biomaterial interface by SEM. Samples having 60-65% porosity with average pore size ca. 55 mu m and higher interconnectivity (22-113 mu m), high adsorption efficiency (ca. 79%) of drug showed prolonged, sustained release of the drugs considered being sufficient to treat chronic osteomyelitis with desirable bone formation. (C) 2011 Elsevier Ltd and Techna Group S.r.l. All rights reserved.
C1 [Kundu, Biswanath; Dandapat, Nandadulal; Soundrapandian, Chidambaram; Dana, Someswar; Dasgupta, Sudip; Basu, Debabrata] CSIR Cent Glass & Ceram Res Inst, Bioceram & Coating Div, Kolkata, India.
   [Nandi, Samit Kumar; Roy, Subhasis; Mukherjee, Prasenjit] W Bengal Univ Anim & Fishery Sci, Dept Vet Surg & Radiol, Kolkata, India.
   [Mandal, Tapan Kumar] W Bengal Univ Anim & Fishery Sci, Dept Vet Pharmacol & Toxicol, Kolkata, India.
RP Nandi, SK (reprint author), 37 & 68 Kshudiram Bose Sarani, Kolkata 700037, India.
EM samitnandi1967@gmail.com
FU Department of Science and Technology, India [T.1 (7)/TIFA/2006-CGCRI];
   CSIR-CGCRI, India; West Bengal University of Animal and Fishery
   Sciences, Kolkata, India
FX The authors wish to express their sincere thanks for the financial
   support by Department of Science and Technology, India [T.1
   (7)/TIFA/2006-CGCRI] and the Director, CSIR-CGCRI, India and Vice
   Chancellor, West Bengal University of Animal and Fishery Sciences,
   Kolkata, India for their generous and kind support to this work. All the
   personnel related to the characterization of the materials are sincerely
   acknowledged.
CR aHorowitz R., 2009, INT J DENT IMPLANT B, V1, P2
   Basu D., 1997, HDB CERAMICS, V2, P168
   Bodhak S, 2010, ACTA BIOMATER, V6, P641, DOI 10.1016/j.actbio.2009.08.008
   Bodhak S, 2009, ACTA BIOMATER, V5, P2178, DOI 10.1016/j.actbio.2009.02.023
   Bueno EM, 2009, NAT REV RHEUMATOL, V5, P685, DOI 10.1038/nrrheum.2009.228
   Burgos AE, 2002, BIOMATERIALS, V23, P2519, DOI 10.1016/S0142-9612(01)00386-6
   Bush K, 1998, ADV EXP MED BIOL, V456, P71
   Bush Karen, 2002, Curr Opin Investig Drugs, V3, P1284
   Castro C, 2003, J CONTROL RELEASE, V93, P341, DOI 10.1016/j.jconrel.2003.09.004
   Cini R, 2001, ANN RHEUM DIS, V60, P962, DOI 10.1136/ard.60.10.962
   Conterno LO, 2009, COCHRANE DB SYST REV, V3
   Damron TA, 2007, NANOMEDICINE-UK, V2, P763, DOI 10.2217/17435889.2.6.763
   EGGLI PS, 1988, CLIN ORTHOP RELAT R, P127
   FOSSUM TW, 1992, SEMIN VET MED SURG, V7, P85
   Ginebra MP, 2006, J CONTROL RELEASE, V113, P102, DOI 10.1016/j.jconrel.2006.04.007
   Guinebretiere R, 2007, X-RAY DIFFRACTION BY POLYCRYSTALLINE MATERIALS, P155
   Hasegawa M, 2004, J BIOMED MATER RES B, V70B, P332, DOI 10.1002/jbm.b.30047
   HIGUCHI T, 1963, J PHARM SCI, V52, P1145, DOI 10.1002/jps.2600521210
   Hoque M., 1996, POSTTRAUMATIC OSTEOM
   Houghton TJ, 2008, J MED CHEM, V51, P6955, DOI 10.1021/jm801007z
   Itokazu M, 1998, BIOMATERIALS, V19, P817, DOI 10.1016/S0142-9612(97)00237-8
   Jinawath S, 2002, MAT SCI ENG C-BIO S, V22, P35, DOI 10.1016/S0928-4931(02)00110-8
   Joosten U, 2004, BIOMATERIALS, V25, P4287, DOI 10.1016/j.biomaterials.2003.10.083
   KOKUBO T, 1990, J BIOMED MATER RES, V24, P721, DOI 10.1002/jbm.820240607
   Korkusuz F, 2001, J BIOMED MATER RES, V55, P217, DOI 10.1002/1097-4636(200105)55:2<217::AID-JBM1008>3.0.CO;2-Y
   KUHNE JH, 1994, ACTA ORTHOP SCAND, V65, P246, DOI 10.3109/17453679408995448
   Kundu B, 2004, B MATER SCI, V27, P133, DOI 10.1007/BF02708495
   Kundu B, 2010, J MATER SCI-MATER M, V21, P2955, DOI 10.1007/s10856-010-4127-0
   Kundu B, 2010, PHARM RES-DORDR, V27, P1659, DOI 10.1007/s11095-010-0166-y
   KUTTY TRN, 1970, INDIAN J CHEM, V8, P655
   Lambotte J C, 1998, Chirurgie, V123, P572, DOI 10.1016/S0001-4001(99)80006-3
   Lebugle A, 2002, BIOMATERIALS, V23, P3517, DOI 10.1016/S0142-9612(02)00082-0
   LeGeros RZ, 2008, CHEM REV, V108, P4742, DOI 10.1021/cr800427g
   Mader JT, 1999, CLIN ORTHOP RELAT R, P47
   Mastrogiacomo M, 2006, BIOMATERIALS, V27, P3230, DOI 10.1016/j.biomaterials.2006.01.031
   Myers HM, 1991, MONOGRAPHS ORAL SCI, V15, P4
   Nakashima M, 2003, NAT BIOTECHNOL, V21, P1025, DOI 10.1038/nbt864
   Nandi SK, 2009, CERAM INT, V35, P1367, DOI 10.1016/j.ceramint.2008.07.022
   Nandi SK, 2009, MAT SCI ENG C-MATER, V29, P2478, DOI 10.1016/j.msec.2009.07.014
   NELSON DGA, 1982, CALCIFIED TISSUE INT, V34, pS69
   Netz DJA, 2001, INT J PHARM, V213, P117, DOI 10.1016/S0378-5173(00)00659-1
   NORDEN CW, 1970, J INFECT DIS, V122, P410, DOI 10.1093/infdis/122.5.410
   Pham Hai H, 2002, AAPS PharmSciTech, V3, pE1
   Rai B, 2005, J CONTROL RELEASE, V107, P330, DOI 10.1016/j.jconrel.2005.07.002
   Rodriguez-Lorenzo LM, 2001, BIOMATERIALS, V22, P1847, DOI 10.1016/S0142-9612(00)00366-5
   Sanchez E, 2001, EUR J PHARM BIOPHARM, V52, P151, DOI 10.1016/S0939-6411(01)00169-2
   Shrivastava SM, 2009, CURR DRUG THER, V4, P73, DOI 10.2174/157488509787081840
   Soundrapandian C., 2009, CRIT REV THER DRUG, V24, P493
   Soundrapandian C, 2009, AAPS PHARMSCITECH, V10, P1158, DOI 10.1208/s12249-009-9308-0
   Stigter M, 2004, J CONTROL RELEASE, V99, P127, DOI 10.1016/j.jconrel.2004.06.011
   Thomazeau H, 1997, Chirurgie, V121, P663
   Vallet-Regi MA, 2006, J MATER CHEM, V16, P26, DOI 10.1039/b509744d
   Vallet-Regi Maria, 2007, Drug Metab Lett, V1, P37, DOI 10.2174/187231207779814382
   Walenkamp GHIM, 1998, ACTA ORTHOP SCAND, V69, P518, DOI 10.3109/17453679808997790
NR 54
TC 9
Z9 9
U1 0
U2 10
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0272-8842
EI 1873-3956
J9 CERAM INT
JI Ceram. Int.
PD MAR
PY 2012
VL 38
IS 2
BP 1533
EP 1548
DI 10.1016/j.ceramint.2011.09.038
PG 16
WC Materials Science, Ceramics
SC Materials Science
GA 895BZ
UT WOS:000300472500086
DA 2018-10-19
ER

PT J
AU Renner, JN
   Kim, Y
   Cherry, KM
   Liu, JC
AF Renner, Julie N.
   Kim, Yeji
   Cherry, Kevin M.
   Liu, Julie C.
TI Modular cloning and protein expression of long, repetitive resilin-based
   proteins
SO PROTEIN EXPRESSION AND PURIFICATION
LA English
DT Article
DE Resilin; Lactose induction; Repetitive polypeptides; Modular cloning;
   Biomimetic protein; Biomaterials
ID RUBBER-LIKE PROTEIN; CELL ATTACHMENT ACTIVITY; MECHANICAL-PROPERTIES;
   FIBRONECTIN; POLYPEPTIDES; PEPTIDE
AB Resilin has emerged as a promising new biomaterial possessing attractive properties for tissue engineering applications. To date, proteins with repeating resilin motifs have been expressed with molecular weights less than 30 kDa. This work describes the development of resilin-based proteins (repeating motif derived from Anopheles gambiae) 50 kDa in size. A modular cloning scheme was utilized and features a recursive cloning technique that can seamlessly and precisely tune the number of resilin repeats. Previously-established resilin expression protocols (based on the Studier auto-induction method) were employed to express the proteins in Escherichia coli BL21(DE3)pLysS. Western blot and densitometry results demonstrated that only similar to 50% of expressed proteins were the desired molecular weight. This finding suggested that either protein truncation or degradation occurred during protein expression. Preventing leaky expression, lowering the culture temperature, and harvesting during exponential phase resulted in up to 94% of the expressed proteins having the desired molecular weight. These expression conditions differ from previously-published resilin expression methods and are recommended when expressing proteins with a larger number of repetitive resilin sequences. (C) 2011 Elsevier Inc. All rights reserved.
C1 [Renner, Julie N.; Kim, Yeji; Cherry, Kevin M.; Liu, Julie C.] Purdue Univ, Sch Chem Engn, W Lafayette, IN 47907 USA.
   [Liu, Julie C.] Purdue Univ, Weldon Sch Biomed Engn, W Lafayette, IN 47907 USA.
RP Liu, JC (reprint author), Purdue Univ, Sch Chem Engn, W Lafayette, IN 47907 USA.
EM jnrenner@purdue.edu; kim384@purdue.edu; kcherry@purdue.edu;
   julieliu@purdue.edu
RI Liu, Julie/H-7496-2013
OI Liu, Julie/0000-0003-0784-2529; Renner, Julie/0000-0002-6140-4346
FU Purdue School of Chemical Engineering and the College of Engineering;
   National Science Foundation [0927100-EEC]; Purdue Research Foundation;
   Purdue Summer Undergraduate Research Fellowship
FX This work was supported by the Purdue School of Chemical Engineering and
   the College of Engineering, the National Science Foundation (Award No.
   0927100-EEC and a Graduate Fellowship to J.N.R.), the Purdue Research
   Foundation, the Purdue Summer Undergraduate Research Fellowship Program,
   and the 3M Nontenured Faculty Award. We appreciate the kind gifts of E.
   coli expression host BL21(DE3)pLysS from Dr. Chongli Yuan (Purdue
   University) and plasmid pET28aRW from Dr. David Tirrell (California
   Institute of Technology). We thank Dr. Kristi Kiick's lab (University of
   Delaware) for intellectual discussions. Finally, we thank Breauna
   Campbell for her contributions to creating the gel image in Fig. 1C and
   Andrew Lundfelt for his contributions to the cloning scheme shown in
   Supplementary Fig. 1.
CR [Anonymous], 2003, CURRENT PROTOCOLS MO
   Carrico IS, 2007, J AM CHEM SOC, V129, P4874, DOI 10.1021/ja070200b
   Charati MB, 2009, SOFT MATTER, V5, P3412, DOI 10.1039/b910980c
   Chin JW, 2002, P NATL ACAD SCI USA, V99, P11020, DOI 10.1073/pnas.172226299
   D'Andrea LD, 2005, P NATL ACAD SCI USA, V102, P14215, DOI 10.1073/pnas.0505047102
   Dutta NK, 2011, ANGEW CHEM INT EDIT, V50, P4428, DOI 10.1002/anie.201007920
   Elvin CM, 2005, NATURE, V437, P999, DOI 10.1038/nature04085
   Gosline J, 2002, PHILOS T ROY SOC B, V357, P121, DOI 10.1098/rstb.2001.1022
   Grossman TH, 1998, GENE, V209, P95, DOI 10.1016/S0378-1119(98)00020-1
   Kim M, 2007, PROTEIN EXPRES PURIF, V52, P230, DOI 10.1016/j.pep.2006.11.003
   Li LQ, 2011, BIOMACROMOLECULES, V12, P2302, DOI 10.1021/bm200373p
   Liu CY, 2003, NEUROSURGERY, V52, P1154, DOI 10.1227/01.NEU.0000057747.93237.8F
   Lv S, 2010, NATURE, V465, P69, DOI 10.1038/nature09024
   Lyons RE, 2007, PROTEIN ENG DES SEL, V20, P25, DOI 10.1093/protein/gzl050
   Lyons RE, 2009, BIOMACROMOLECULES, V10, P3009, DOI 10.1021/bm900601h
   Meyer DE, 2004, BIOMACROMOLECULES, V5, P846, DOI 10.1021/bm034215n
   PIERSCHBACHER M, 1983, P NATL ACAD SCI-BIOL, V80, P1224, DOI 10.1073/pnas.80.5.1224
   PIERSCHBACHER MD, 1984, NATURE, V309, P30, DOI 10.1038/309030a0
   PIERSCHBACHER MD, 1984, P NATL ACAD SCI-BIOL, V81, P5985, DOI 10.1073/pnas.81.19.5985
   Qin GK, 2009, BIOMACROMOLECULES, V10, P3227, DOI 10.1021/bm900735g
   Studier FW, 2005, PROTEIN EXPRES PURIF, V41, P207, DOI 10.1016/j.pep.2005.01.016
   STUDIER FW, 1991, J MOL BIOL, V219, P37, DOI 10.1016/0022-2836(91)90855-Z
   Truong MY, 2010, BIOMATERIALS, V31, P4434, DOI 10.1016/j.biomaterials.2010.02.019
   Urry DW, 1997, J PHYS CHEM B, V101, P11007, DOI 10.1021/jp972167t
   WEISFOGH T, 1961, J MOL BIOL, V3, P520, DOI 10.1016/S0022-2836(61)80018-1
   WEISFOGH T, 1961, J MOL BIOL, V3, P648, DOI 10.1016/S0022-2836(61)80028-4
   WEISFOGH T, 1960, J EXP BIOL, V37, P889
NR 27
TC 16
Z9 16
U1 1
U2 25
PU ACADEMIC PRESS INC ELSEVIER SCIENCE
PI SAN DIEGO
PA 525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA
SN 1046-5928
J9 PROTEIN EXPRES PURIF
JI Protein Expr. Purif.
PD MAR
PY 2012
VL 82
IS 1
BP 90
EP 96
DI 10.1016/j.pep.2011.11.019
PG 7
WC Biochemical Research Methods; Biochemistry & Molecular Biology;
   Biotechnology & Applied Microbiology
SC Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology
GA 900WZ
UT WOS:000300923700014
PM 22173203
DA 2018-10-19
ER

PT J
AU Hagandora, CK
   Tudares, MA
   Almarza, AJ
AF Hagandora, Catherine K.
   Tudares, Mauro A.
   Almarza, Alejandro J.
TI The Effect of Magnesium Ion Concentration on the Fibrocartilage
   Regeneration Potential of Goat Costal Chondrocytes
SO ANNALS OF BIOMEDICAL ENGINEERING
LA English
DT Article
DE Fibrocartilage; Temporomandibular joint; Magnesium
ID TEMPOROMANDIBULAR-JOINT DISC; IN-VIVO CORROSION; EXTRACELLULAR-MATRIX;
   CYTOTOXICITY; ALLOYS; BETA
AB Magnesium has recently been explored as a potential biomaterial for degradable orthopedic implants but its effect on fibrocartilage remains unknown. The objective of this study was to assess the effect of high concentrations of magnesium ions on the matrix production of goat costal fibrochondrocytes in vitro. Cells were cultured using a scaffoldless approach with media containing magnesium chloride (MgCl2) or magnesium sulfate (MgSO4) at concentrations of 20, 50, and 100 mM in addition to the baseline magnesium concentration of 0.8 mM MgSO4. At 4 weeks, there were no significant differences in compressive tangent modulus and total matrix production between constructs cultured in 20 mM Mg2+ and the 0.8 mM Mg2+ control (435 +/- A 47 kPa). There was a significant decrease in compressive tangent modulus compared to the 0.8 mM Mg2+ constructs in the 50 mM MgCl2 and MgSO4 groups, while the 100 mM groups were not mechanically testable (p < 0.05). The collagen and glycosaminoglycan (GAG) content of the 50 and 100 mM MgCl2 and MgSO4 constructs was significantly lower than the control (6.9 +/- A 0.5% and 16.5 +/- A 1.3% per dry weight, respectively) (p < 0.05). The results show that goat costal fibrochondrocytes exhibit a high degree of resiliency to magnesium ion concentrations up to 20 mM in vitro.
C1 [Hagandora, Catherine K.; Tudares, Mauro A.; Almarza, Alejandro J.] Univ Pittsburgh, McGowan Inst Regenerat Med, Ctr Craniofacial Regenerat, Sch Dent Med,Dept Oral Biol,Dept Bioengn, Pittsburgh, PA 15261 USA.
RP Almarza, AJ (reprint author), Univ Pittsburgh, McGowan Inst Regenerat Med, Ctr Craniofacial Regenerat, Sch Dent Med,Dept Oral Biol,Dept Bioengn, 566 Salk Hall,3501 Terrace St, Pittsburgh, PA 15261 USA.
EM aja19@pitt.edu
FU National Science Foundation [0812348]
FX We gratefully acknowledge funding from the National Science Foundation
   under Grant No. 0812348. We would also like to thank Manasa P. Madoori
   for her help with the immunohistochemistry.
CR Almarza AJ, 2006, BRIT J ORAL MAX SURG, V44, P124, DOI 10.1016/j.bjoms.2005.05.002
   Anderson DEJ, 2009, ARCH ORAL BIOL, V54, P138, DOI 10.1016/j.archoralbio.2008.09.018
   Anderson DEJ, 2008, ANN BIOMED ENG, V36, P1992, DOI 10.1007/s10439-008-9572-2
   Athanasiou KA, 2009, TISSUE ENG TEMPOROMA
   Cohen B, 1998, J BIOMECH ENG-T ASME, V120, P491, DOI 10.1115/1.2798019
   Detamore MS, 2005, MATRIX BIOL, V24, P45, DOI 10.1016/j.matbio.2004.11.006
   Feyerabend F, 2006, TISSUE ENG, V12, P3545, DOI 10.1089/ten.2006.12.3545
   Fischer J, 2010, ACTA BIOMATER, V6, P1813, DOI 10.1016/j.actbio.2009.10.020
   Hagandora Catherine K, 2011, J Dent Biomech, V2011, P212385, DOI 10.4061/2011/212385
   Hsu JT, 2011, J ORAL MAXIL SURG, V69, P1320, DOI 10.1016/j.joms.2010.05.074
   Ingawale S, 2009, ANN BIOMED ENG, V37, P976, DOI 10.1007/s10439-009-9659-4
   Kapila S, 1998, LAB INVEST, V78, P925
   Kuttila M, 1998, J OROFAC PAIN, V12, P67
   Lee CH, 2009, OSTEOARTHR CARTILAGE, V17, P1485, DOI 10.1016/j.joca.2009.05.006
   Li LC, 2004, SURF COAT TECH, V185, P92, DOI 10.1016/j.surfcoat.2004.01.004
   LOESER RF, 1994, EXP CELL RES, V211, P17, DOI 10.1006/excr.1994.1053
   NIH, 2010, TMJ DIS
   Sergerie K, 2009, J BIOMECH, V42, P510, DOI 10.1016/j.jbiomech.2008.11.026
   WILKES CH, 1989, ARCH OTOLARYNGOL, V115, P469
   Witte F, 2006, BIOMATERIALS, V27, P1013, DOI 10.1016/j.biomaterials.2005.07.037
   Witte F, 2005, BIOMATERIALS, V26, P3557, DOI 10.1016/j.biomaterials.2004.09.049
NR 21
TC 13
Z9 13
U1 1
U2 14
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 0090-6964
J9 ANN BIOMED ENG
JI Ann. Biomed. Eng.
PD MAR
PY 2012
VL 40
IS 3
BP 688
EP 696
DI 10.1007/s10439-011-0433-z
PG 9
WC Engineering, Biomedical
SC Engineering
GA 898VJ
UT WOS:000300770200013
PM 22009314
DA 2018-10-19
ER

PT J
AU Follonier, S
   Panke, S
   Zinn, M
AF Follonier, Stephanie
   Panke, Sven
   Zinn, Manfred
TI Pressure to kill or pressure to boost: a review on the various effects
   and applications of hydrostatic pressure in bacterial biotechnology
SO APPLIED MICROBIOLOGY AND BIOTECHNOLOGY
LA English
DT Review
DE Pressure; High-pressure bioreactor; Bioprocesses; Food processing;
   Biomaterial disinfection; Protein refolding
ID DEEP-SEA BACTERIUM; CELL-DENSITY CULTIVATION; INCREASED AIR-PRESSURE;
   OXYGEN MASS-TRANSFER; SP. STRAIN DB-172F; ESCHERICHIA-COLI;
   INCLUSION-BODIES; CARBON-DIOXIDE; YARROWIA-LIPOLYTICA;
   LEPTOSPIRA-INTERROGANS
AB Much knowledge has been gained for the last 30 years about the effects of pressure on bacteria, and various pressure-based technologies have been designed. The development of modern molecular biology techniques (e.g., DNA microarrays) as well as the technological advances realized in the manufacturing of robust sampling and high-pressure devices has allowed these advances. Not only the direct effects on cell components (membranes, proteins, and nucleic acids) have been unraveled, but also the cellular response to pressure has been investigated by means of transcriptome and proteome analyses. Initially, research was performed by marine biologists who studied the microorganisms living in the deep sea at pressures of 1,000 bar. In parallel, food technologists developed pressure-based methods for inactivating microorganisms without altering the food properties as much as with temperature treatment. The preservation of specific product properties is also the rationale for pressure-based methods for the disinfection of biomaterials and for vaccine production. Therefore, attention was first focused on the "killing" potential of high pressure. On the other hand, there has been a growing interest in using elevated pressures (up to similar to 10 bar) for enhancing the productivity of bioprocesses. In this case, no killing effect was sought, but pressure was applied to "boost" the process by enhancing the oxygen transfer to the cell culture. This paper gives an overview on the effects of pressures in the range of 1 bar to 10 kbar on bacteria and presents the major and most recent achievements realized in the development of pressure-based biotechnological applications.
C1 [Zinn, Manfred] HES SO Valais Univ Appl Sci Western Switzerland, Inst Life Technol, CH-1950 Sion, Switzerland.
   [Follonier, Stephanie; Zinn, Manfred] Empa Swiss Fed Labs Mat Sci & Technol, Lab Biomat, CH-9014 St Gallen, Switzerland.
   [Panke, Sven] Swiss Fed Inst Technol, Dept Biosyst Sci & Engn D BSSE, Bioproc Lab, CH-4058 Basel, Switzerland.
RP Zinn, M (reprint author), HES SO Valais Univ Appl Sci Western Switzerland, Inst Life Technol, Rue Rawyl 47, CH-1950 Sion, Switzerland.
EM stephanie.follonier@hevs.ch; sven.panke@bsse.ethz.ch;
   manfred.zinn@hevs.ch
OI Follonier, Stephanie/0000-0002-8341-8845; Panke,
   Sven/0000-0002-9368-539X
FU Swiss National Science Foundation (SNF) [315200-116812/1]
FX This work was supported by the Swiss National Science Foundation (SNF),
   grant 315200-116812/1.
CR Aertsen A, 2005, MOL MICROBIOL, V58, P1381, DOI 10.1111/j.1365-2958.2005.04903.x
   Aertsen A, 2004, J BACTERIOL, V186, P6133, DOI 10.1128/jb.186.18.6133-6141.2004
   Aertsen A, 2008, HIGH PRESSURE MICROB, P87
   Aertsen A, 2009, TRENDS BIOTECHNOL, V27, P434, DOI 10.1016/j.tibtech.2009.04.001
   Aguedo M, 2005, BIOTECHNOL LETT, V27, P1617, DOI 10.1007/s10529-005-2517-z
   Arana ME, 2010, PROTEIN EXPRES PURIF, V70, P163, DOI 10.1016/j.pep.2009.10.010
   Arsene F, 2000, INT J FOOD MICROBIOL, V55, P3, DOI 10.1016/S0168-1605(00)00206-3
   Balduino K, 2010, MOL BIOTECHNOL, P1
   Balny C, 1997, COMP BIOCHEM PHYS A, V116, P299, DOI 10.1016/S0300-9629(96)00355-6
   BARTLETT D, 1989, NATURE, V342, P572, DOI 10.1038/342572a0
   Bartlett DH, 2002, BBA-PROTEIN STRUCT M, V1595, P367, DOI 10.1016/S0167-4838(01)00357-0
   BASSET J, 1956, ANN I PASTEUR PARIS, V90, P575
   Belo I, 2003, BIOTECHNOL PROGR, V19, P665, DOI 10.1021/bp0257067
   Black E. P., 2011, Nonthermal processing technologies for food, P51
   Bowman JP, 2008, MICROBIOL-SGM, V154, P462, DOI 10.1099/mic.0.2007/010314-0
   Brouillet M, 2009, J BIOMED MATER RES B, V91B, P348, DOI 10.1002/jbm.b.31408
   Brown P, 2003, P NATL ACAD SCI USA, V100, P6093, DOI 10.1073/pnas.1031826100
   Cabiscol Elisa, 2000, International Microbiology, V3, P3
   Chilton P., 1997, HIGH PRESSURE RES BI, P225
   Chura-Chambi RM, 2008, ANAL BIOCHEM, V379, P32, DOI 10.1016/j.ab.2008.04.024
   Collinge J, 2007, SCIENCE, V318, P930, DOI 10.1126/science.1138718
   Crisman RI, 2009, BIOTECHNOL BIOENG, V102, P483, DOI 10.1002/bit.22082
   DELONG EF, 1985, SCIENCE, V228, P1101, DOI 10.1126/science.3992247
   Demazeau G, 2011, J APPL MICROBIOL, V110, P1359, DOI 10.1111/j.1365-2672.2011.05000.x
   Diehl P, 2005, INT J MOL MED, V16, P285
   Diehl P, 2006, J ORTHOP SCI, V11, P380, DOI 10.1007/s00446-006-1031-z
   Diehl P, 2008, ANTICANCER RES, V28, P3877
   DIXON NM, 1989, J APPL BACTERIOL, V67, P109, DOI 10.1111/j.1365-2672.1989.tb03387.x
   DUFRESNE R, 1990, APPL MICROBIOL BIOT, V32, P526
   Eisenmenger MJ, 2009, ENZYME MICROB TECH, V45, P331, DOI 10.1016/j.enzmictec.2009.08.001
   El Moustaine D, 2011, J BIOL CHEM, V286, P13448, DOI 10.1074/jbc.M110.192872
   Fang JS, 2010, TRENDS MICROBIOL, V18, P413, DOI 10.1016/j.tim.2010.06.006
   Ferreira E, 2009, VACCINE, V27, P5332, DOI 10.1016/j.vaccine.2009.06.099
   Ferreira L, 2008, FOOD TECHNOL BIOTECH, V46, P146
   Foguel D, 2003, P NATL ACAD SCI USA, V100, P9831, DOI 10.1073/pnas.1734009100
   Follonier S, 2012, BIOTECHNOL BIOENG, V109, P451, DOI 10.1002/bit.23312
   Fradkin AH, 2010, BIOTECHNOL PROGR, V26, P743, DOI 10.1002/btpr.393
   Fraga TR, 2010, J BIOTECHNOL, V148, P156, DOI 10.1016/j.jbiotec.2010.04.007
   Garcia AF, 2004, J GEN VIROL, V85, P261, DOI 10.1099/vir.0.19410-0
   Gaspar LP, 2008, J VIROL METHODS, V150, P57, DOI 10.1016/j.jviromet.2008.03.002
   Gollwitzer Hans, 2009, Open Orthop J, V3, P1, DOI 10.2174/1874325000903010001
   GROSS M, 1993, EUR J BIOCHEM, V218, P463, DOI 10.1111/j.1432-1033.1993.tb18397.x
   Hauben KJA, 1997, APPL ENVIRON MICROB, V63, P945
   HAWLEY SA, 1971, BIOCHEMISTRY-US, V10, P2436, DOI 10.1021/bi00789a002
   Heinz V, 2010, J VERBRAUCH LEBENSM, V5, P73, DOI 10.1007/s00003-009-0311-x
   Hite BH, 1899, W VA U AGR EXP STA B, V58
   HUISMAN O, 1984, P NATL ACAD SCI-BIOL, V81, P4490, DOI 10.1073/pnas.81.14.4490
   Ishii A, 2005, EXTREMOPHILES, V9, P65, DOI 10.1007/s00792-004-0414-3
   Jia SR, 2009, KOREAN J CHEM ENG, V26, P1084, DOI 10.2478/s11814-009-0180-0
   John RJS, 2002, BIOTECHNOL PROGR, V18, p[3, 565]
   Kawano H, 2004, EXTREMOPHILES, V8, P367, DOI 10.1007/s00792-004-0397-0
   Knabben I, 2010, J BIOTECHNOL, V150, P73, DOI 10.1016/j.jbiotec.2010.07.006
   Knabben I, 2010, J BIOTECHNOL, V149, P60, DOI 10.1016/j.jbiotec.2010.06.007
   Knoll A, 2005, ADV BIOCHEM ENG BIOT, V92, P77, DOI 10.1007/b98918
   Knoll A, 2007, J BIOTECHNOL, V132, P167, DOI 10.1016/j.jbiotec.2007.06.010
   Lee SH, 2006, PROTEIN SCI, V15, P304, DOI 10.1110/ps.051813506
   Lefebvre BG, 2004, BIOTECHNOL PROGR, V20, P623, DOI 10.1021/bp034221v
   Lopes M, 2008, LETT APPL MICROBIOL, V46, P255, DOI 10.1111/j.1472-765X.2007.02299.x
   Lopes M, 2009, APPL BIOCHEM BIOTECH, V159, P46, DOI 10.1007/s12010-008-8359-0
   Ma XX, 2010, BIOTECHNOL APPL BIOC, V55, P169, DOI 10.1042/BA20090314
   Macgregor RB, 2002, BBA-PROTEIN STRUCT M, V1595, P266, DOI 10.1016/S0167-4838(01)00349-1
   Mackey B, 2008, HIGH PRESSURE MICROB, P53
   MAIER B, 2002, THESIS RHEINISCH WES
   Malavasi NV, 2011, PROCESS BIOCHEM, V46, P512, DOI 10.1016/j.procbio.2010.10.002
   Malone AS, 2006, APPL ENVIRON MICROB, V72, P2661, DOI 10.1128/AEM.72.4.2661-2671.2006
   Matsui T, 2006, PROCESS BIOCHEM, V41, P920, DOI 10.1016/j.procbio.2005.10.004
   MEERSMAN F, 2008, HIGH PRESSURE MICROB, P1
   Meersman F, 2006, CHEM SOC REV, V35, P908, DOI 10.1039/b517761h
   MEGANATHAN R, 1973, NATURE, V246, P525, DOI 10.1038/246525a0
   Mozhaev VV, 1996, PROTEINS, V24, P81, DOI 10.1002/(SICI)1097-0134(199601)24:1<81::AID-PROT6>3.0.CO;2-R
   Mukherjee A, 1998, P NATL ACAD SCI USA, V95, P2885, DOI 10.1073/pnas.95.6.2885
   Naal FD, 2008, J BIOMED MATER RES B, V87B, P19, DOI 10.1002/jbm.b.31059
   NOGER D, 2006, CHEM-ING-TECH, V78, P1381
   Oey I, 2008, TRENDS FOOD SCI TECH, V19, P320, DOI 10.1016/j.tifs.2008.04.001
   Oey I, 2008, TRENDS FOOD SCI TECH, V19, P300, DOI 10.1016/j.tifs.2007.09.002
   Oger PM, 2010, RES MICROBIOL, V161, P799, DOI 10.1016/j.resmic.2010.09.017
   Pagan R, 2000, APPL ENVIRON MICROB, V66, P2829, DOI 10.1128/AEM.66.7.2829-2834.2000
   Pinheiro R, 2000, ENZYME MICROB TECH, V26, P756, DOI 10.1016/S0141-0229(00)00168-X
   Qoronfleh MW, 2007, PROTEIN EXPRES PURIF, V55, P209, DOI 10.1016/j.pep.2007.05.014
   Qureshi MH, 1998, EXTREMOPHILES, V2, P93, DOI 10.1007/s007920050047
   Qureshi MH, 1998, FEMS MICROBIOL LETT, V161, P301, DOI 10.1016/S0378-1097(98)00087-1
   Rivalain N, 2010, BIOTECHNOL ADV, V28, P659, DOI 10.1016/j.biotechadv.2010.04.001
   Robey M, 2001, APPL ENVIRON MICROB, V67, P4901, DOI 10.1128/AEM.67.10.4901-4907.2001
   Roger H, 1895, ARCH PHYSL NORM PATH, V7, P12
   Sancho F, 1999, J FOOD ENG, V39, P247, DOI 10.1016/S0260-8774(98)00143-5
   Schauwecker J, 2011, ANTICANCER RES, V31, P1235
   Schmid A, 1999, BIOPROCESS ENG, V20, P91, DOI 10.1007/s004490050565
   Schmid A, 1998, EXTREMOPHILES, V2, P249, DOI 10.1007/s007920050067
   Schoner BE, 2005, MOL GENET METAB, V85, P318, DOI 10.1016/j.ymgme.2005.04.012
   SCHULZ E, 1976, FEBS LETT, V64, P40, DOI 10.1016/0014-5793(76)80243-8
   Schumpe A, 1982, GAS SOLUBILITIES MIC, P1
   Seefeldt MB, 2007, BIOTECHNOL BIOENG, V98, P476, DOI 10.1002/bit.21398
   Seefeldt MB, 2004, PROTEIN SCI, V13, P2639, DOI 10.1110/ps.04891204
   Shearer AEH, 2007, INNOV FOOD SCI EMERG, V8, P259, DOI 10.1016/j.ifset.2007.01.004
   Shearer AEH, 2009, J FOOD PROTECT, V72, P1500, DOI 10.4315/0362-028X-72.7.1500
   Sila DN, 2007, J FOOD ENG, V78, P755, DOI 10.1016/j.jfoodeng.2005.11.016
   Silva CCM, 2001, VACCINE, V19, P1511, DOI 10.1016/S0264-410X(00)00361-3
   SILVA JL, 1993, ANNU REV PHYS CHEM, V44, P89, DOI 10.1146/annurev.physchem.44.1.89
   Smeller L, 2002, BBA-PROTEIN STRUCT M, V1595, P11, DOI 10.1016/S0167-4838(01)00332-6
   St John RJ, 1999, P NATL ACAD SCI USA, V96, P13029, DOI 10.1073/pnas.96.23.13029
   St John RJ, 2001, J BIOL CHEM, V276, P46856, DOI 10.1074/jbc.M107671200
   Stretton S, 1998, ANTON LEEUW INT J G, V73, P79, DOI 10.1023/A:1000610225458
   Stretton S, 1996, FEMS MICROBIOL LETT, V140, P37
   Suzuki K., 1960, REV PHYS CHEM JAPAN, V29, P91
   Tedjo W, 2000, J FOOD SCI, V65, P1284, DOI 10.1111/j.1365-2621.2000.tb10597.x
   Thieringer HA, 1998, BIOESSAYS, V20, P49
   Tonello C., 2011, Nonthermal processing technologies for food, P36
   Torrent J, 2006, PROTEIN PEPTIDE LETT, V13, P271, DOI 10.2174/092986606775338371
   Torrent J, 2003, BIOCHEMISTRY-US, V42, P1318, DOI 10.1021/bi0269916
   Weiss EM, 2010, J IMMUNOTOXICOL, V7, P194, DOI 10.3109/15476911003657414
   Welch TJ, 1996, J BACTERIOL, V178, P5027, DOI 10.1128/jb.178.16.5027-5031.1996
   WELCH TJ, 1993, J BACTERIOL, V175, P7170
   Yaldagard M, 2008, AFR J BIOTECHNOL, V7, P2739
   Yamamoto S, 2010, BIOSCI BIOTECH BIOCH, V74, P525, DOI 10.1271/bbb.90715
   YANG JD, 1992, BIOTECHNOL PROGR, V8, P244, DOI 10.1021/bp00015a010
   YAYANOS AA, 1969, BIOPHYS J, V9, P1464, DOI 10.1016/S0006-3495(69)86466-0
   Zeece M, 2008, INNOV FOOD SCI EMERG, V9, P62, DOI 10.1016/j.ifset.2007.05.004
   Zhang HQ, 2011, NONTHERMAL PROCESSIN
   ZOBELL CE, 1964, J BACTERIOL, V87, P710
   ZOBELL CE, 1949, J BACTERIOL, V57, P179
NR 120
TC 20
Z9 20
U1 3
U2 63
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 0175-7598
J9 APPL MICROBIOL BIOT
JI Appl. Microbiol. Biotechnol.
PD MAR
PY 2012
VL 93
IS 5
BP 1805
EP 1815
DI 10.1007/s00253-011-3854-6
PG 11
WC Biotechnology & Applied Microbiology
SC Biotechnology & Applied Microbiology
GA 897NN
UT WOS:000300657900002
PM 22290643
DA 2018-10-19
ER

PT J
AU Gautier, H
   Plumecocq, A
   Amador, G
   Weiss, P
   Merle, C
   Bouler, JM
AF Gautier, Helene
   Plumecocq, Adrien
   Amador, Gilles
   Weiss, Pierre
   Merle, Christian
   Bouler, Jean-Michel
TI In Vitro Characterization of Calcium Phosphate Biomaterial Loaded with
   Linezolid for Osseous Bone Defect Implantation
SO JOURNAL OF BIOMATERIALS APPLICATIONS
LA English
DT Article
DE calcium phosphate; biomaterials; drug delivery system; linezolid;
   antibiotic
ID RESISTANT STAPHYLOCOCCUS-AUREUS; EXPERIMENTAL OSTEOMYELITIS;
   ENTEROCOCCUS-FAECIUM; DYNAMIC COMPACTION; JOINT INFECTIONS;
   DELIVERY-SYSTEM; VANCOMYCIN; CEMENT; PENETRATION; RELEASE
AB Osteomyelitis is a severe bone infection frequently caused by Staphylococcus aureus, which shows significant resistance to methicillin. One therapeutic treatment would be to insert a bone substitute loaded to an antibiotic, which would enable the bone to be filled while the illness is being treated. Linezolid is an oxazolidinone antibiotic with a large spectrum of action. It is effective against most Gram-positive bacteria and displays a specific mode of action. The aim of this work was to study the association of linezolid with a calcium phosphate-deficient apatite matrix. Granules containing 10% and 50% linezolid were prepared by wet granulation and characterized. Porosity analyses performed by mercury porosimetry and scanning electron microscopy revealed that grain porosity with 50% linezolid was higher than that of the grains containing 10% linezolid. NMR analyses showed no change in structure of linezolid when linked to calcium-deficient apatite. These results were confirmed by studying the antibacterial activity of linezolid, which remained proportional to the quantity of loaded linezolid, proving that the antibiotic released was active. The in vitro release time varied from 9 days for granules containing 10% linezolid to 26 days for granules containing 50% linezolid.
C1 [Gautier, Helene; Plumecocq, Adrien; Weiss, Pierre; Merle, Christian; Bouler, Jean-Michel] INSERM, U791, Lab Ingn Osteoarticulaire & Dent, LIOAD,Fac Chirurg Dent, F-44042 Nantes, France.
   [Gautier, Helene; Merle, Christian] Univ Nantes, Fac Pharm, Lab Pharm Galeni, F-44042 Nantes, France.
   [Amador, Gilles] Univ Nantes, Fac Med, Lab Therapeut Clin & Expt, F-44042 Nantes, France.
RP Gautier, H (reprint author), INSERM, U791, Lab Ingn Osteoarticulaire & Dent, LIOAD,Fac Chirurg Dent, 1 Pl A Ricordeau, F-44042 Nantes, France.
EM helene.gautier@univ-nantes.fr
RI GAUTIER, Helene/P-3011-2014; Weiss, Pierre/P-1372-2014
OI Weiss, Pierre/0000-0002-6159-8590; BOULER,
   Jean-Michel/0000-0001-9784-5584
CR Adembri C, 2008, INT J ANTIMICROB AG, V31, P122, DOI 10.1016/j.ijantimicag.2007.09.009
   Akpabie A, 2004, PATHOL BIOL, V52, P493, DOI 10.1016/j.patbio.2004.07.028
   Alvarez H., 2007, J BIOMED MATER RES B, V85B, P93
   Bassetti M, 2001, J INFECTION, V43, P148, DOI 10.1053/jinf.2001.0863
   Bohner M, 1997, J PHARM SCI, V86, P565, DOI 10.1021/js960405a
   Chai F, 2007, BIOMOL ENG, V24, P510, DOI 10.1016/j.bioeng.2007.08.001
   Darley ESR, 2004, J ANTIMICROB CHEMOTH, V53, P928, DOI 10.1093/jac/dkh191
   Diekema DJ, 2001, LANCET, V358, P1975, DOI 10.1016/S0140-6736(01)06964-1
   Ebner DC, 2008, BIOORGAN MED CHEM, V16, P2651, DOI 10.1016/j.bmc.2007.11.040
   Efstathopoulos N, 2008, INJURY, V39, P1384, DOI 10.1016/j.injury.2008.04.006
   Falagas ME, 2007, INT J ANTIMICROB AG, V29, P233, DOI 10.1016/j.ijantimicag.2006.08.030
   Faucheux C, 2009, J BIOMED MATER RES A, V89A, P46, DOI 10.1002/jbm.a.31989
   Fernandez-Roblas R, 2009, INT J ANTIMICROB AG, V33, P453, DOI 10.1016/j.ijantimicag.2008.11.001
   Gautier H, 2001, BIOMATERIALS, V22, P2481, DOI 10.1016/S0142-9612(00)00436-1
   Gautier H, 2000, BIOMATERIALS, V21, P243, DOI 10.1016/S0142-9612(99)00139-8
   Guillemot D, 2005, SCIENCE
   Hesaraki S, 2009, J BIOMED MATER RES B, V89B, P342, DOI 10.1002/jbm.b.31222
   Hofmann MP, 2009, ACTA BIOMATER, V5, P43, DOI 10.1016/j.actbio.2008.08.005
   Jacqueline C., 2005, Antibiotiques, V7, P225
   Kimakhe S, 1999, J BIOMED MATER RES, V47, P18, DOI 10.1002/(SICI)1097-4636(199910)47:1<18::AID-JBM3>3.0.CO;2-T
   Krisanapiboon A, 2006, J Orthop Surg (Hong Kong), V14, P315
   Kutscha-Lissberg F, 2003, ANTIMICROB AGENTS CH, V47, P3964, DOI 10.1128/AAC.47.12.3964-3966.2003
   Le Ray AM, 2005, ANTIMICROB AGENTS CH, V49, P3025, DOI 10.1128/AAC.49.7.3025-3027.2005
   LeGeros RZ, 2008, CHEM REV, V108, P4742, DOI 10.1021/cr800427g
   Liao CH, 2005, J ANTIMICROB CHEMOTH, V55, P598, DOI 10.1093/jac/dki041
   Lovering AM, 2002, J ANTIMICROB CHEMOTH, V50, P73, DOI 10.1093/jac/dkf/066
   Nam JR, 2008, J KOREAN NEUROSURG S, V43, P307, DOI 10.3340/jkns.2008.43.6.307
   Nandi SK, 2009, CERAM INT, V35, P1367, DOI 10.1016/j.ceramint.2008.07.022
   Ormos Z.D., 1994, HANDB POWD TECHNOL, V9, P359
   Oussedik SIS, 2008, J ARTHROPLASTY, V23, P273, DOI 10.1016/j.arth.2007.03.022
   Rana B, 2002, J ANTIMICROB CHEMOTH, V50, P747, DOI 10.1093/jac/dkf207
   Saito T., 2002, J BIOMED MATER RES B, V63, P45
   Sasaki S, 1999, J Orthop Sci, V4, P361, DOI 10.1007/s007760050117
   Sudo A, 2008, J ARTHROPLASTY, V23, P145, DOI 10.1016/j.arth.2006.09.009
   Till M, 2002, CLIN INFECT DIS, V34, P1412, DOI 10.1086/340265
   Tsiodras S, 2001, LANCET, V358, P207, DOI 10.1016/S0140-6736(01)05410-1
   Weigelt J, 2004, AM J SURG, V188, P760, DOI 10.1016/j.amsjurg.2004.08.045
NR 37
TC 3
Z9 3
U1 0
U2 15
PU SAGE PUBLICATIONS LTD
PI LONDON
PA 1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND
SN 0885-3282
J9 J BIOMATER APPL
JI J. Biomater. Appl.
PD MAR
PY 2012
VL 26
IS 7
BP 811
EP 828
DI 10.1177/0885328210381535
PG 18
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 890XV
UT WOS:000300181100003
PM 20876634
DA 2018-10-19
ER

PT J
AU Zhou, ZL
   Yu, PP
   Geller, HM
   Ober, CK
AF Zhou, Zhaoli
   Yu, Panpan
   Geller, Herbert M.
   Ober, Christopher K.
TI The role of hydrogels with tethered acetylcholine functionality on the
   adhesion and viability of hippocampal neurons and glial cells
SO BIOMATERIALS
LA English
DT Article
DE PEG-based hydrogels; Neurotransmitters; Acetylcholine functionality;
   Concentration-dependent manner
ID MEMBRANE-RECEPTORS; NEURITE OUTGROWTH; STEM-CELLS; POLYMER;
   DIFFERENTIATION; REGENERATION; ATTACHMENT; BEHAVIOR; SCAFFOLD; MODULUS
AB In neural tissue engineering, designing materials with the right chemical cues is crucial in providing a permissive microenvironment to encourage and guide neuronal cell attachment and differentiation. Modifying synthetic hydrogels with biologically active molecules has become an increasingly important route in this field to provide a successful biomaterial and cell interaction. This study presents a strategy of using the monomer 2-methacryloxyethyl trimethylammonium chloride (MAETAC) to provide tethered neurotransmitter acetylcholine-like functionality with a complete 2-acetoxy-N,N,N-trimethylethanaminium segment, thereby modifying the properties of commonly used, non-adhesive PEG-based hydrogels. The effect of the functional monomer concentration on the physical properties of the hydrogels was systematically studied, and the resulting hydrogels were also evaluated for mice hippocampal neural cell attachment and growth. Results from this study showed that MAETAC in the hydrogels promotes neuronal cell attachment and differentiation in a concentration-dependent manner, different proportions of MAETAC monomer in the reaction mixture produce hydrogels with different porous structures, swollen states, and mechanical strengths. Growth of mice hippocampal cells cultured on the hydrogels showed differences in number, length of processes and exhibited different survival rates. Our results indicate that chemical composition of the biomaterials is a key factor in neural cell attachment and growth, and integration of the appropriate amount of tethered neurotransmitter functionalities can be a simple and effective way to optimize existing biomaterials for neuronal tissue engineering applications. (C) 2011 Elsevier Ltd. All rights reserved.
C1 [Zhou, Zhaoli; Ober, Christopher K.] Cornell Univ, Dept Mat Sci & Engn, Ithaca, NY 14853 USA.
   [Zhou, Zhaoli; Ober, Christopher K.] Cornell Univ, Dept Chem & Chem Biol, Ithaca, NY 14853 USA.
   [Yu, Panpan; Geller, Herbert M.] NHLBI, Dev Neurobiol Sect, Div Intramural Res, NIH, Bethesda, MD 20892 USA.
RP Ober, CK (reprint author), Cornell Univ, Dept Mat Sci & Engn, Ithaca, NY 14853 USA.
EM cko3@cornell.edu
RI Yu, Panpan/A-4962-2013
OI Ober, Christopher/0000-0002-3805-3314; Geller,
   Herbert/0000-0002-7048-6144
FU National Science Foundation Materials Research Science and Engineering
   Center [DMR-0520404]; NIH [NSR01-044287]; Nanobiotechnology Centre
   (NBTC); STC of the National Science Foundation [ECS-9876771]; NHLBI
   Division of Intramural Research
FX We would like to acknowledge Dr. Ray Molloy and Professor Manfred Lindau
   for the initial cell studies. We would also like to acknowledge the use
   of the Microscopy and Imaging Facility at Cornell University and its
   facility manager, Carol Bayles, and the use of the electron microscope
   and the dynamic mechanical analyzer housed in the Cornell Center for
   Materials Research (CCMR), Shared Experimental Facilities, supported
   through the National Science Foundation Materials Research Science and
   Engineering Center Program (DMR-0520404) and the facility managers, John
   Hunt and Yuanming Zhang. We also acknowledge the assistance of the NHLBI
   DIR Light Microscopy Core Facility. This work was partially supported by
   NIH NSR01-044287 and by the Nanobiotechnology Centre (NBTC), an STC
   program of the National Science Foundation under agreement no.
   ECS-9876771, as well as the NHLBI Division of Intramural Research (P.Y.
   and H.M.G).
CR Banerjee A, 2009, BIOMATERIALS, V30, P4695, DOI 10.1016/j.biomaterials.2009.05.050
   Bernardini N, 2004, J NEUROCHEM, V88, P1533, DOI 10.1046/j.1471-4159.2003.02292.x
   BREWER GJ, 1993, J NEUROSCI RES, V35, P567, DOI 10.1002/jnr.490350513
   Constans A, 2004, SCIENTIST, V18, P40
   Dadhaniya PV, 2006, POLYM BULL, V57, P21, DOI 10.1007/s00289-006-0531-5
   Darr A, 2009, J MATER SCI-MATER M, V20, P33, DOI 10.1007/s10856-008-3540-0
   Gao J, 2006, P NATL ACAD SCI USA, V103, P16681, DOI 10.1073/pnas.0606237103
   Geckil H, 2010, NANOMEDICINE-UK, V5, P469, DOI [10.2217/nnm.10.12, 10.2217/NNM.10.12]
   Guarnieri D, 2010, ACTA BIOMATER, V6, P2532, DOI 10.1016/j.actbio.2009.12.050
   Gumera CB, 2007, ADV MATER, V19, P4404, DOI 10.1002/adma.200701747
   Hejcl A, 2008, PHYSIOL RES, V57, pS121
   Kim SJ, 2003, REACT FUNCT POLYM, V55, P53, DOI 10.1016/S1381-5148(02)00214-6
   Kioussis DR, 2005, POLYMER, V46, P9342, DOI 10.1016/j.polymer.2005.07.045
   Lecchi M, 2005, EUR J NEUROSCI, V21, P3182, DOI 10.1111/j.1460-9568.2005.04150.x
   Leipzig ND, 2009, BIOMATERIALS, V30, P6867, DOI 10.1016/j.biomaterials.2009.09.002
   Nisbet DR, 2008, J BIOMED MATER RES B, V87B, P251, DOI 10.1002/jbm.b.31000
   Park H, 2009, BIOMACROMOLECULES, V10, P541, DOI 10.1021/bm801197m
   Peppas NA, 1996, BIOMATERIALS, V17, P1553, DOI 10.1016/0142-9612(95)00307-X
   Saha K, 2008, BIOPHYS J, V95, P4426, DOI 10.1529/biophysj.108.132217
   Saifuddin U, 2003, J BIOMED MATER RES A, V66A, P184, DOI 10.1002/jbm.a.10552
   Schmidt CE, 2003, ANNU REV BIOMED ENG, V5, P293, DOI 10.1146/annurev.bioeng.5.011303.120731
   SMALL DH, 1995, J NEUROSCI, V15, P144
   Snyder SH, 2006, CELL, V125, P13, DOI 10.1016/j.cell.2006.03.023
   Sosnik A, 2005, J BIOMED MATER RES A, V75A, P295, DOI 10.1002/jbm.a.30419
   Stevens CF, 2003, NEURON, V40, P381, DOI 10.1016/S0896-6273(03)00643-3
   Subramanian A, 2009, J BIOMED SCI, V16, DOI 10.1186/1423-0127-16-108
   Tata AM, 2003, J NEUROSCI RES, V73, P227, DOI 10.1002/jnr.10650
   Tu Q, 2011, BIOMATERIALS, V32, P3253, DOI 10.1016/j.biomaterials.2011.01.044
   Vu TQ, 2005, BIOMATERIALS, V26, P1895, DOI 10.1016/j.biomaterials.2004.06.007
   WHITTERIDGE D, 1948, J NEUROL NEUROSUR PS, V11, P134, DOI 10.1136/jnnp.11.2.134
   Woerly S, 1996, BIOMATERIALS, V17, P301, DOI 10.1016/0142-9612(96)85568-2
   Woerly S, 2008, BIOMACROMOLECULES, V9, P2329, DOI 10.1021/bm800234r
   Yu LMY, 2008, MATER TODAY, V11, P36, DOI 10.1016/S1369-7021(08)70088-9
   Yu TT, 2005, BIOMATERIALS, V26, P1507, DOI 10.1016/j.biomaterials.2004.05.012
   Zhong YH, 2008, J R SOC INTERFACE, V5, P957, DOI 10.1098/rsif.2008.0071
   Zhu JM, 2010, BIOMATERIALS, V31, P4639, DOI 10.1016/j.biomaterials.2010.02.044
   Zohuriaan-Mehr MJ, 2008, IRAN POLYM J, V17, P451
NR 37
TC 16
Z9 16
U1 1
U2 20
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD MAR
PY 2012
VL 33
IS 8
BP 2473
EP 2481
DI 10.1016/j.biomaterials.2011.12.005
PG 9
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 895AY
UT WOS:000300469800007
PM 22196899
OA Green Accepted
DA 2018-10-19
ER

PT J
AU Yang, SP
   Yang, CY
   Lee, TM
   Lui, TS
AF Yang, Shih-Ping
   Yang, Chyun-Yu
   Lee, Tzer-Min
   Lui, Truan-Sheng
TI Effects of calcium-phosphate topography on osteoblast mechanobiology
   determined using a cytodetacher
SO MATERIALS SCIENCE & ENGINEERING C-MATERIALS FOR BIOLOGICAL APPLICATIONS
LA English
DT Article
DE Ca-P; Micropattern; Cell shape; Cell adhesion force; Nanonewton
   resolution
ID TITANIUM SUBSTRATA; QUANTITATIVE-ANALYSIS; CELL MECHANOBIOLOGY;
   ADHESION; COATINGS; SURFACE; DETACHMENT; PLATFORMS; RIGIDITY; IMPLANTS
AB The Human fetal osteoblast (hFOB) cell morphology, adhesion force, and proliferation on a calcium-phosphate (Ca-P) micropattern surface were investigated and the mechanobiology was investigated by a cytodetachment test. Ca-P-coated groove patterns with 3.0-mu m-deep grooves (C3), 4.5-mu m-deep grooves (C4), and 5.5-mu m-deep grooves (C5) were produced on silicon wafers using photolithography and wet etching techniques. The grooved substrates were coated with a 200-nm-thick layer of titanium (bond coat) and a 200-nm-thick layer of calcium phosphate (top coat) using a sputtering system. Smooth Ca-P-coated Si wafers were used as control surfaces. Analysis of the scanning electron microscopy observations shows that cells on the Ca-P micropattern showed spreading and elongation. The MTT (3-(4, 5-dimethylthiazol-2-yl)-2,5-diphenyitetrazolium bromide) assay indicated that 0 and C4 specimens had a significantly higher number of cells than did the control group after 5- and 15-day cultures. The cyto-compatibility of specimens was quantitatively evaluated using a cytodetacher, which directly measures the detachment shear force of an individual cell to the substrate. After 30-min culture, the cell adhesion forces were 38.4 nN for the smooth specimen, 140.8 nN for C3, 124.2 nN for C4, and 67.1 nN for C5. The results indicate that the cell adhesion force is influenced by cell shape and the Ca-P grooved patterns affect the cell shape and cytoskeletal structure, thus influence cell proliferation and cell adhesion force. The cytodetachment test with nanonewton resolution is a sensitive method for studying cell biomaterial interaction. (C) 2011 Elsevier B.V. All rights reserved.
C1 [Lee, Tzer-Min] Natl Cheng Kung Univ, Inst Oral Med, Tainan 701, Taiwan.
   [Yang, Chyun-Yu] Natl Cheng Kung Univ, Dept Orthoped, Tainan 701, Taiwan.
   [Yang, Shih-Ping; Lui, Truan-Sheng] Natl Cheng Kung Univ, Dept Mat Sci & Engn, Tainan 701, Taiwan.
RP Lee, TM (reprint author), Natl Cheng Kung Univ, Inst Oral Med, Tainan 701, Taiwan.
EM tmlee@mail.ncku.edu.tw
RI Lee, Tzer-Min/G-3713-2011
FU National Science Council, Taiwan [NSC 99-2221-E-006-093]; Medical Device
   Innovation Center, National Cheng Kung University
FX This study was supported by the National Science Council, Taiwan, under
   grant NSC 99-2221-E-006-093. The authors also appreciate the support
   from the Medical Device Innovation Center, National Cheng Kung
   University.
CR Alaerts JA, 2001, BIOMATERIALS, V22, P1635, DOI 10.1016/S0142-9612(00)00321-5
   Anselme K, 2000, BIOMATERIALS, V21, P667, DOI 10.1016/S0142-9612(99)00242-2
   Attard NJ, 2005, J PROSTHET DENT, V94, P242, DOI 10.1016/j.prosdent.2005.04.015
   Bershadsky AD, 2003, ANNU REV CELL DEV BI, V19, P677, DOI 10.1146/annurev.cellbio.19.111301.153011
   Biggs MJP, 2008, J MICROSC-OXFORD, V231, P28, DOI 10.1111/j.1365-2818.2008.02013.x
   Braber E.T., 1998, J BIOMED MAT SCI, V40, P291
   Bruinink A, 2001, BIOMATERIALS, V22, P2465, DOI 10.1016/S0142-9612(00)00434-8
   CHEHROUDI B, 1990, J BIOMED MATER RES, V24, P1203, DOI 10.1002/jbm.820240906
   Comella B.T.S., 2000, J MATER SCI-MATER M, V30, P567
   Furukawa KS, 2001, MAT SCI ENG C-BIO S, V17, P55, DOI 10.1016/S0928-4931(01)00336-8
   Kemkemer R, 2006, BIOPHYS J, V90, P4701, DOI 10.1529/biophysj.105.067967
   Kim DH, 2009, ANNU REV BIOMED ENG, V11, P203, DOI 10.1146/annurev-bioeng-061008-124915
   Kim DH, 2009, BIOMATERIALS, V30, P5433, DOI 10.1016/j.biomaterials.2009.06.042
   Krauspe R., 2007, J BIOMED BIOTECHNOL, P19
   LARSSON C, 1994, BIOMATERIALS, V15, P1062, DOI 10.1016/0142-9612(94)90092-2
   le Digabel J., 2010, MED BIOL ENG COMPUT, P965
   Lee KY, 2006, BIOMED MATER, V1, pR31, DOI 10.1088/1748-6041/1/2/R01
   Lee SW, 2009, CLIN ORAL IMPLAN RES, V20, P56, DOI 10.1111/j.1600-0501.2008.01597.x
   Leong K, 2009, LANGMUIR, V25, P4615, DOI 10.1021/la8037318
   Lim JY, 2007, TISSUE ENG, V13, P1879, DOI 10.1089/ten.2006.0154
   Lu X, 2003, J BIOMED MATER RES A, V66A, P677, DOI 10.1002/jbm.a.10022
   Montgomery D.C., 1976, DESIGN ANAL EXPT
   Motlagh D, 2003, BIOMATERIALS, V24, P2463, DOI 10.1016/S0142-9612(02)00644-0
   Ni M, 2009, INT J MOL SCI, V10, P5411, DOI 10.3390/ijms10125411
   Norman JJ, 2005, TISSUE ENG, V11, P378, DOI 10.1089/ten.2005.11.378
   OAKLEY C, 1993, J CELL SCI, V106, P343
   Ochsner M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009445
   Puleo David A, 2006, Dent Clin North Am, V50, P323, DOI 10.1016/j.cden.2006.03.001
   Reyes CD, 2003, J BIOMED MATER RES A, V67A, P328, DOI 10.1002/jbm.a.10122
   Thevenot P., 2008, CURR TOP MED CHEM, V8, P278
   Wang CC, 2009, J BIOMED MATER RES A, V88A, P370, DOI 10.1002/jbm.a.31604
   Wang CY, 2009, J BIOMED MATER RES A, V90A, P419, DOI 10.1002/jbm.a.32111
   Wang JW, 2010, CLIN ORAL IMPLAN RES, V21, P951, DOI 10.1111/j.1600-0501.2010.01935.x
   Yamamoto A, 2000, J BIOMED MATER RES, V50, P114, DOI 10.1002/(SICI)1097-4636(200005)50:2<114::AID-JBM4>3.3.CO;2-Y
   Yang MT, 2011, NAT PROTOC, V6, P187, DOI 10.1038/nprot.2010.189
   Yang SP, 2011, J MATER SCI-MATER M, V22, P1027, DOI 10.1007/s10856-011-4255-1
   Yang YZ, 2005, BIOMATERIALS, V26, P327, DOI 10.1016/j.biomaterials.2004.02.029
NR 37
TC 6
Z9 6
U1 1
U2 16
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0928-4931
J9 MAT SCI ENG C-MATER
JI Mater. Sci. Eng. C-Mater. Biol. Appl.
PD MAR 1
PY 2012
VL 32
IS 2
BP 254
EP 262
DI 10.1016/j.msec.2011.10.026
PG 9
WC Materials Science, Biomaterials
SC Materials Science
GA 897JU
UT WOS:000300647800027
DA 2018-10-19
ER

PT J
AU Giancola, G
   Lehman, RL
   Idol, JD
AF Giancola, Giorgiana
   Lehman, Richard L.
   Idol, James D.
TI Melt processing and domain morphology of PMMA/HDPE polymer blends
   prepared from powder precursors
SO POWDER TECHNOLOGY
LA English
DT Article
DE Polymers; Blends; Powders; Immiscible; FTIR; Extrusion
ID HIGH-DENSITY POLYETHYLENE
AB Powder polymer processing was used to prepare immiscible PMMA/HDPE blends from micrometer sized polymer spheres that were physically mixed prior to compression molding to a fused blended film. This two-stage mixing approach, initially as dry powders and subsequently during compression molding, seeks to minimize the time/temperature/shear to which delicate thermoplastic polymers would otherwise be exposed by conventional extrusion processing. The powder processing route effectively generates fine domain blends (3-10 mu m) similar to extruded blends, although some coalescence was present. Conformational effects were observed by FTIR at high wavenumbers, indicating intimate interfacial proximity. The spectral effects are similar to those observed in extruded pellet blends. This powder processing route will be useful for molding delicate thermoplastic polymers found in certain biomaterial, pharmaceutical, and cosmetic applications. (C) 2011 Elsevier B.V. All rights reserved.
C1 [Giancola, Giorgiana; Lehman, Richard L.; Idol, James D.] Rutgers State Univ, AMIPP Adv Polymer Ctr, Dept Mat Sci & Engn, Piscataway, NJ 08854 USA.
RP Lehman, RL (reprint author), Rutgers State Univ, AMIPP Adv Polymer Ctr, Dept Mat Sci & Engn, 607 Taylor Rd, Piscataway, NJ 08854 USA.
EM rllehman@rutgers.edu
FU Advanced Polymer Center at Rutgers University
FX The authors wish to thank the Advanced Polymer Center at Rutgers
   University for supporting this work. Invaluable technical assistance was
   provided by Dr. Pascal Delrieu and Kobo Products in the area of emulsion
   polymerized precursor materials, and by Dr. Stephen Miller of Rutgers
   University in the area of SEM microscopy and EDS analysis. Many thanks
   to the Jet Pulverizer Corporation for their assistance in providing the
   cyro-pulverized particles used in this study.
CR Chen Q, 2008, J POLYM SCI POL PHYS, V46, P431, DOI 10.1002/polb.21312
   Cherian Z, 2007, J APPL POLYM SCI, V103, P1616, DOI 10.1002/app.24955
   Devi T.R., 2010, INT J PHARM SCI REV, V2, P106
   Giancola G, 2010, MAT RES SOC, V1297, P10
   Giancola G., 2009, MAT RES SOC, V1209, DOI [10.1557/PROC-1209-YY07-01 1209-YY07-01, DOI 10.1557/PROC-1209-YY07-011209-YY07-01]
   Joshi J, 2006, APPL SPECTROSC, V60, P483, DOI 10.1366/000370206777412121
   Venter SAS, 2005, J APPL POLYM SCI, V96, P2273, DOI 10.1002/app.21111
   Zhang JH, 2007, MACROMOLECULES, V40, P8817, DOI 10.1021/ma0716480
   Zonghao L., 2005, POWDER TECHNOL, V160, P194
NR 9
TC 4
Z9 4
U1 0
U2 11
PU ELSEVIER SCIENCE SA
PI LAUSANNE
PA PO BOX 564, 1001 LAUSANNE, SWITZERLAND
SN 0032-5910
J9 POWDER TECHNOL
JI Powder Technol.
PD MAR
PY 2012
VL 218
BP 18
EP 22
DI 10.1016/j.powtec.2011.11.019
PG 5
WC Engineering, Chemical
SC Engineering
GA 895WC
UT WOS:000300526400004
DA 2018-10-19
ER

PT J
AU Mely, H
   Mathiot, JF
AF Mely, H.
   Mathiot, J-F
TI Double site-bond percolation model for biomaterial implants
SO APPLIED PHYSICS A-MATERIALS SCIENCE & PROCESSING
LA English
DT Article
ID INVASION PERCOLATION; GRAFT SUBSTITUTE; NATURAL CORAL; RESORPTION;
   RIGIDITY; LIMIT
AB We present a double site-bond percolation model to account, on the one hand, for the vascularization and/or resorption of biomaterial implant in bones, and on the other hand, for its mechanical continuity. The transformation of the implant into osseous material, and the dynamical formation/destruction of this osseous material is accounted for by creation and destruction of links and sites in two, entangled, networks. We identify the relevant parameters to describe the implant and its evolution, and separate their biological or chemical origin from their physical one. We classify the various phenomena in the two regimes, percolating or nonpercolating, of the networks. We present first numerical results in two dimensions.
C1 [Mely, H.; Mathiot, J-F] Clermont Univ, CNRS, IN2P3, Phys Corpusculaire Lab, F-63000 Clermont Ferrand, France.
RP Mathiot, JF (reprint author), Clermont Univ, CNRS, IN2P3, Phys Corpusculaire Lab, BP10448, F-63000 Clermont Ferrand, France.
EM mathiot@clermont.in2p3.fr
CR ADLER J, 1988, J PHYS A-MATH GEN, V21, P1387, DOI 10.1088/0305-4470/21/6/015
   AGRAWAL P, 1979, J PHYS A-MATH GEN, V12, P2073, DOI 10.1088/0305-4470/12/11/018
   Barbotteau Y, 2003, PHYS MED BIOL, V48, P3611, DOI 10.1088/0031-9155/48/21/011
   Braye F, 1996, BIOMATERIALS, V17, P1345, DOI 10.1016/0142-9612(96)88682-0
   Broadbent S.R., 1957, Proceedings of the Cambridge Philosophical Society, V53, P629
   CONIGLIO A, 1979, PHYS REV LETT, V42, P518, DOI 10.1103/PhysRevLett.42.518
   DUXBURY PM, 1995, PHYS REV B, V51, P3476, DOI 10.1103/PhysRevB.51.3476
   FURUBERG L, 1988, PHYS REV LETT, V61, P2117, DOI 10.1103/PhysRevLett.61.2117
   GUILLEMIN G, 1989, J BIOMED MATER RES, V23, P765, DOI 10.1002/jbm.820230708
   GUILLEMIN G, 1987, J BIOMED MATER RES, V21, P557, DOI 10.1002/jbm.820210503
   Hunt A, 2009, LECT NOTES PHYS, V771, P1, DOI 10.1007/978-3-540-89790-3_1
   IRIGARAY JL, 1993, J RADIOAN NUCL CH AR, V174, P93, DOI 10.1007/BF02040337
   Irigaray JL, 2001, BIOMATERIALS, V22, P629, DOI 10.1016/S0142-9612(00)00172-1
   Irigaray JL, 2000, J RADIOANAL NUCL CH, V244, P317, DOI 10.1023/A:1006754702817
   Moukarzel C, 1996, J PHYS A-MATH GEN, V29, P8079, DOI 10.1088/0305-4470/29/24/030
   Moukarzel C, 1999, PHYS REV E, V59, P2614, DOI 10.1103/PhysRevE.59.2614
   ROUX FX, 1988, J NEUROSURG, V69, P510, DOI 10.3171/jns.1988.69.4.0510
   Sahimi M, 1998, PHYSICA A, V260, P231, DOI 10.1016/S0378-4371(98)00328-8
   Stauffer D., 1994, INTRO PERCOLATION TH
   Vidales AM, 1996, EUROPHYS LETT, V36, P259, DOI 10.1209/epl/i1996-00219-7
NR 20
TC 0
Z9 0
U1 1
U2 2
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 0947-8396
J9 APPL PHYS A-MATER
JI Appl. Phys. A-Mater. Sci. Process.
PD MAR
PY 2012
VL 106
IS 3
BP 635
EP 644
DI 10.1007/s00339-011-6637-0
PG 10
WC Materials Science, Multidisciplinary; Physics, Applied
SC Materials Science; Physics
GA 892BD
UT WOS:000300260600023
DA 2018-10-19
ER

PT J
AU Kanthaswamy, S
   Premasuthan, A
   Ng, J
   Satkoski, J
   Goyal, V
AF Kanthaswamy, S.
   Premasuthan, A.
   Ng, J.
   Satkoski, J.
   Goyal, V.
TI Quantitative real-time PCR (qPCR) assay for human-dog-cat species
   identification and nuclear DNA quantification
SO FORENSIC SCIENCE INTERNATIONAL-GENETICS
LA English
DT Article
DE DNA quantification; Species identification; Human, dog and cat forensic
   DNA analysis
ID FORENSIC SAMPLES; DEVELOPMENTAL VALIDATION; DEGRADATION; TOOL
AB In the United States, human forensic evidence collected from crime scenes is usually comingled with biomaterial of canine and feline origins. Knowledge of the concentration of nuclear DNA extracted from a crime scene biological sample and the species from which the sample originated is essential for DNA profiling. The ability to accurately detect and quantify target DNA in mixed-species samples is crucial when target DNA may be overwhelmed by non-target DNA.
   We have designed and evaluated a species-specific (human, dog and cat) nuclear DNA identification assay based on the TaqMan (R) quantitative real-time PCR (qPCR) technology that can simultaneously detect and measure minute quantities of DNA specific to either humans, dogs and/or cats. The fluorogenic triplex assay employs primers and hydrolysis probes that target the human TH01 locus as well as the dog and cat Melanocortin 1 Receptor (MC1R) sequences in a species-specific manner. We also demonstrate that the assay is a highly sensitive, reliable and robust method for identifying and quantifying mixed-species templates of human-dog-cat origin with as little as 0.4 pg of human and cat nuclear DNA, respectively, and 4.0 pg of dog nuclear DNA. Published by Elsevier Ireland Ltd.
C1 [Kanthaswamy, S.; Premasuthan, A.; Ng, J.; Satkoski, J.; Goyal, V.] Univ Calif Davis, Mol Anthropol Lab, Dept Anthropol, Davis, CA 95616 USA.
   [Kanthaswamy, S.] Univ Calif Davis, Dept Environm Toxicol, Davis, CA 95616 USA.
RP Kanthaswamy, S (reprint author), Univ Calif Davis, Mol Anthropol Lab, Dept Anthropol, Davis, CA 95616 USA.
EM skanthaswamy@ucdavis.edu
FU National Institute of Justice [2008-DN-BX-K288]
FX This study was supported by a National Institute of Justice grant
   2008-DN-BX-K288 to SK. We wish to thank Joy Halverson (Questgen
   Forensics, Davis, CA), Eric Johnston (Scidera, Davis, CA) Marilyn
   Menotti (US National Cancer Research Institute), the UC Davis Veterinary
   Medicine Training Hospital (VMTH), and various human and non-human
   donors for their human, dog and cat samples. We would like to thank
   Vivek Goyal for his tremendous input in initiating the technical aspects
   of this project.
CR ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2
   Bustin SA, 2009, CLIN CHEM, V55, P611, DOI 10.1373/clinchem.2008.112797
   D'Andrea E., 1998, J FORENSIC SCI, V43, P1257
   Evans JJ, 2007, J FORENSIC SCI, V52, P93, DOI 10.1111/j.1556-4029.2006.00305.x
   Halverson JL, 2005, CROAT MED J, V46, P598
   Hudlow WR, 2008, FORENSIC SCI INT-GEN, V2, P108, DOI 10.1016/j.fsigen.2007.09.001
   Invitrogen, 2008, INV REAL TIM PCR THE
   Kanthaswamy S, 2009, J FORENSIC SCI, V54, P829, DOI 10.1111/j.1556-4029.2009.01080.x
   Lindquist CD, 2011, J FORENSIC SCI, V56, pS29, DOI 10.1111/j.1556-4029.2010.01605.x
   Melton T, 2007, J FORENSIC SCI, V52, P1305, DOI 10.1111/j.1556-4029.2007.00553.x
   Smalling BB, 2010, OPEN FORENSIC SCI J, V3, P22, DOI DOI 10.2174/1874402801003020022
   Swango KL, 2007, FORENSIC SCI INT, V170, P35, DOI 10.1016/j.forsciint.2006.09.002
   Swango KL, 2006, FORENSIC SCI INT, V158, P14, DOI 10.1016/j.forsciint.2005.04.034
   Timken MD, 2005, J FORENSIC SCI, V50, P1044
   Walker JA, 2004, GENOMICS, V83, P518, DOI 10.1016/j.ygeno.2003.09.003
   Wilson IG, 1997, APPL ENVIRON MICROB, V63, P3741
NR 16
TC 14
Z9 15
U1 0
U2 19
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND
SN 1872-4973
J9 FORENSIC SCI INT-GEN
JI Forensic Sci. Int.-Genet.
PD MAR
PY 2012
VL 6
IS 2
BP 290
EP 295
DI 10.1016/j.fsigen.2011.06.005
PG 6
WC Genetics & Heredity; Medicine, Legal
SC Genetics & Heredity; Legal Medicine
GA 893YC
UT WOS:000300392700029
PM 21764401
DA 2018-10-19
ER

PT J
AU Bai, YX
   Liu, YB
   Li, YF
   Zhang, Q
AF Bai, Yong Xiao
   Liu, Yao Bin
   Li, Yan Feng
   Zhang, Qi
TI Synthesis and characterization of amphiphilic antibacterial copolymers
SO POLYMERS FOR ADVANCED TECHNOLOGIES
LA English
DT Article
DE biological application; biomaterial; biopolymer; diblock copolymer;
   functional polymer
ID BIOLOGICALLY-ACTIVE POLYCATIONS; FREE-RADICAL POLYMERIZATION;
   ANTIMICROBIAL ACTIVITY; QUATERNARY AMMONIUM; RAFT; MELT
AB Macromolecule antimicrobials have been explored in foundational research and practical application due to their potential merit for reducing the residual toxicity, increasing their efficiency, selectivity, and prolonging the lifetime of the antimicrobial material. In this work, the quaternized poly(styrene)-b-poly(DMAEMA) diblock polymers are synthesized by reversible addition-fragmentation chain transfer polymerization (RAFT). The minimum inhibitory concentration (MIC) evaluation and optical density (OD) method demonstrated that the amphiphilic antibacterial biomaterials have exceptional antibacterial properties. The amphiphilic polycation has an admirable antibacterial property, and these quaternized diblocks are potent biocides and nonhemolytic. The relationship between the structure and activity is discussed with respect to molecular weight of the diblocks and bacteria structural dependence. Copyright (C) 2011 John Wiley & Sons, Ltd.
C1 [Bai, Yong Xiao] Lanzhou Univ, Inst Mat Sci & Engn, Key Lab Magnetism & Magnet Mat, Minist Educ, Lanzhou 730000, Peoples R China.
   [Liu, Yao Bin; Li, Yan Feng] Lanzhou Univ, Dept Chem & Chem Engn, Lanzhou 730000, Peoples R China.
   [Zhang, Qi] Lanzhou Univ, Sch Life Sci, Lanzhou 730000, Peoples R China.
RP Bai, YX (reprint author), Lanzhou Univ, Inst Mat Sci & Engn, Key Lab Magnetism & Magnet Mat, Minist Educ, Lanzhou 730000, Peoples R China.
EM baiyx@lzu.edu.cn
FU National Natural Science Foundation of China [50703017]; Gansu Province
   Natural Science Foundation [0710RJZA032]
FX We thank the National Natural Science Foundation of China (No.
   50703017), and the Gansu Province Natural Science Foundation (No.
   0710RJZA032) for the financial support of this work.
CR ALMDAL K, 1992, MACROMOLECULES, V25, P1743, DOI 10.1021/ma00032a019
   Barner-Kowollik C, 2003, J POLYM SCI POL CHEM, V41, P365, DOI 10.1002/pola.10567
   Butte A, 2001, MACROMOLECULES, V34, P5885, DOI 10.1021/ma002130y
   Chen C. Z., 1999, J CHEM SOC CHEM COMM, V10, P1585
   Chen C. Z., 1999, J CHEM SOC CHEM COMM, V47, P1585
   Chen CZS, 2000, BIOMACROMOLECULES, V1, P473, DOI 10.1021/bm0055495
   Chiefari J, 1998, MACROMOLECULES, V31, P5559, DOI 10.1021/ma9804951
   HAMLEY IW, 1993, MACROMOLECULES, V26, P5959, DOI 10.1021/ma00074a018
   Hudson MC, 1999, FEMS MICROBIOL LETT, V173, P279, DOI 10.1111/j.1574-6968.1999.tb13514.x
   IKEDA T, 1984, MAKROMOL CHEM, V185, P869
   IKEDA T, 1986, MAKROMOL CHEM, V187, P333
   IKEDA T, 1984, ANTIMICROB AGENTS CH, V26, P139, DOI 10.1128/AAC.26.2.139
   Kenawy ER, 1998, J CONTROL RELEASE, V50, P145, DOI 10.1016/S0168-3659(97)00126-0
   Laak E. A. T., 1991, ANTIMICROB AGENTS CH, V35, P2282
   Le T. P., 1998, WO., Patent No. 01478
   Rahn O., 1947, BACTERIOL REV, V1, P173
   ROBERTSON JA, 1981, ANTIMICROB AGENTS CH, V20, P53, DOI 10.1128/AAC.20.1.53
   Tomita T, 2000, MICROBIOL IMMUNOL, V44, P749, DOI 10.1111/j.1348-0421.2000.tb02559.x
   Zhang LF, 1996, J AM CHEM SOC, V118, P3168, DOI 10.1021/ja953709s
NR 19
TC 7
Z9 7
U1 2
U2 38
PU WILEY-BLACKWELL
PI MALDEN
PA COMMERCE PLACE, 350 MAIN ST, MALDEN 02148, MA USA
SN 1042-7147
J9 POLYM ADVAN TECHNOL
JI Polym. Adv. Technol.
PD MAR
PY 2012
VL 23
IS 3
BP 581
EP 587
DI 10.1002/pat.1928
PG 7
WC Polymer Science
SC Polymer Science
GA 887RA
UT WOS:000299945300040
DA 2018-10-19
ER

PT J
AU Silva, NRFA
   Bonfante, EA
   Martins, LM
   Valverde, GB
   Thompson, VP
   Ferencz, JL
   Coelho, PG
AF Silva, N. R. F. A.
   Bonfante, E. A.
   Martins, L. M.
   Valverde, G. B.
   Thompson, V. P.
   Ferencz, J. L.
   Coelho, P. G.
TI Reliability of Reduced-thickness and Thinly Veneered Lithium Disilicate
   Crowns
SO JOURNAL OF DENTAL RESEARCH
LA English
DT Article
DE biomaterial(s); ceramics; glass-ceramic; prosthetic dentistry;
   prosthodontics; restorative materials
ID BRITTLE LAYER STRUCTURES; FIXED PARTIAL DENTURES; CLINICAL FOLLOW-UP;
   ALL-CERAMIC CROWNS; ZIRCONIA; FAILURE; FATIGUE; DAMAGE; CONTACT; DESIGN
AB The present investigation hypothesized that the reliability of reduced-thickness monolithic lithium disilicate crowns is high relative to that of veneered zirconia (Y-TZP) and comparable with that of metal ceramic (MCR) systems. CAD/CAM first mandibular molar full-crown preparations were produced with uniform thicknesses of either 1.0-mm or 2.0-mm occlusal and axial reduction, then replicated in composite for standard crown dies. Monolithic 1.0-mm (MON) and 2.0-mm CAD/CAM lithium disilicate crowns, the latter with a buccal thin veneer (BTV) of 0.5 mm, were fabricated and then sliding-contact-fatigued (step-stress method) until failure or suspension (n = 18/group). Crack evolution was followed, and fractography of post mortem specimens was performed and compared with that of clinical specimens. Use level probability Weibull calculation (use load = 1,200 N) showed interval overlaps between MON and BTV. There was no significant difference between the Weibull characteristic failure loads of MON and BTV (1,535 N [90% CI 1,354-1,740] and 1,609 N [90% CI 1,512-1,712], respectively), which were significantly higher than that of Y-TZP (370 N [90% CI 322-427]) and comparable with that of MCR (1,304 N [90% CI 1,203-1,414]), validating the study hypothesis.
C1 [Silva, N. R. F. A.] NYU, Sch Dent, Dept Prosthodont, New York, NY 10010 USA.
   [Bonfante, E. A.] UNIGRANRIO Univ Sch Hlth Sci, Postgrad Program Dent, Rio De Janeiro, RJ, Brazil.
   [Martins, L. M.] Univ Fed Amazonas, Sch Dent, Dept Oral Rehabil, Manaus, Amazonas, Brazil.
   [Valverde, G. B.; Thompson, V. P.; Coelho, P. G.] NYU, Sch Dent, Dept Biomat & Biomimet, New York, NY 10010 USA.
RP Silva, NRFA (reprint author), NYU, Sch Dent, Dept Prosthodont, 345 E 24th St,Room 812, New York, NY 10010 USA.
EM nrd1@nyu.edu
RI Bonfante, Estevam/F-7238-2012; Martins, Leandro/E-8257-2012
OI Bonfante, Estevam/0000-0001-6867-8350; Thompson, Van
   P/0000-0003-0033-0344
FU NIDCR [P01 DE01976]; Ivoclar Vivadent and Marotta Dental Studio (NY,
   USA)
FX This project was supported by NIDCR Grant P01 DE01976. The authors are
   thankful to Yu Zhang from New York University for editorial support.
   Ivoclar Vivadent and Marotta Dental Studio (NY, USA) provided materials
   and laboratory support. The author(s) declare no potential conflicts of
   interest with respect to the research, authorship, and/or publication of
   this article.
CR Apel E, 2008, J MECH BEHAV BIOMED, V1, P313, DOI 10.1016/j.jmbbm.2007.11.005
   Bhowmick S, 2007, J BIOMED MATER RES B, V82B, P253, DOI 10.1002/jbm.b.30728
   Bonfante EA, 2009, EUR J ORAL SCI, V117, P194, DOI 10.1111/j.1600-0722.2008.00608.x
   Cehreli MC, 2009, J APPL ORAL SCI, V17, P49, DOI 10.1590/S1678-77572009000100010
   CHRISTEL P, 1989, J BIOMED MATER RES, V23, P45, DOI 10.1002/jbm.820230105
   Coelho PG, 2009, DENT MATER, V25, P1122, DOI 10.1016/j.dental.2009.03.009
   Coelho PG, 2009, J DENT RES, V88, P382, DOI 10.1177/0022034509333968
   Fasbinder DJ, 2010, J AM DENT ASSOC, V141, P10
   Groten M, 2010, INT J PROSTHODONT, V23, P429
   Guess Petra C, 2011, Dent Clin North Am, V55, P333, DOI 10.1016/j.cden.2011.01.005
   Guess PC, 2010, INT J PROSTHODONT, V23, P434
   Heintze SD, 2011, DENT MATER, V27, pE10, DOI 10.1016/j.dental.2010.09.004
   Kim JH, 2008, J DENT RES, V87, P671, DOI 10.1177/154405910808700706
   Kim JW, 2007, J DENT RES, V86, P1046, DOI 10.1177/154405910708601105
   Lawn BR, 1998, J AM CERAM SOC, V81, P1977, DOI 10.1111/j.1151-2916.1998.tb02580.x
   Lawn BR, 2002, J MATER RES, V17, P3019, DOI 10.1557/JMR.2002.0440
   Ortorp A, 2009, J DENT, V37, P731, DOI 10.1016/j.jdent.2009.06.002
   Reich S, 2010, INT J PROSTHODONT, V23, P214
   Rekow D, 2007, J MATER SCI-MATER M, V18, P47, DOI 10.1007/s10856-006-0661-1
   Rekow ED, 2011, J DENT RES, V90, P937, DOI 10.1177/0022034510391795
   Sailer I, 2006, QUINTESSENCE INT, V37, P685
   Silva NRFA, 2011, J DENT RES, V90, P104, DOI 10.1177/0022034510384617
   Silva NRFA, 2010, J DENT RES, V89, P1051, DOI 10.1177/0022034510375826
   Tinschert J, 2000, J DENT, V28, P529, DOI 10.1016/S0300-5712(00)00030-0
   TINSCHERT J, 2005, DTSCH ZAHNARZTL Z, V60, P435
   Von Steyern PV, 2005, J ORAL REHABIL, V32, P180, DOI 10.1111/j.1365-2842.2004.01437.x
   Zarone F, 2011, DENT MATER, V27, P83, DOI 10.1016/j.dental.2010.10.024
   Zhang Y, 2005, J BIOMED MATER RES B, V73B, P186, DOI 10.1002/jbm.b.30195
NR 28
TC 33
Z9 35
U1 4
U2 23
PU SAGE PUBLICATIONS INC
PI THOUSAND OAKS
PA 2455 TELLER RD, THOUSAND OAKS, CA 91320 USA
SN 0022-0345
J9 J DENT RES
JI J. Dent. Res.
PD MAR
PY 2012
VL 91
IS 3
BP 305
EP 310
DI 10.1177/0022034511433504
PG 6
WC Dentistry, Oral Surgery & Medicine
SC Dentistry, Oral Surgery & Medicine
GA 888HF
UT WOS:000299993800014
PM 22205635
OA Green Published
DA 2018-10-19
ER

PT J
AU Green, DW
   Watson, GS
   Watson, J
   Abraham, SJK
AF Green, David W.
   Watson, Gregory S.
   Watson, Jolanta
   Abraham, Samuel J. K.
TI New Biomimetic Directions in Regenerative Ophthalmology
SO ADVANCED HEALTHCARE MATERIALS
LA English
DT Review
ID STEM-CELL THERAPY; PIGMENT EPITHELIAL-CELLS; RETINAL PROGENITOR CELLS;
   BASEMENT-MEMBRANE; BRUCHS MEMBRANE; NANOSCALE TOPOGRAPHY;
   EXTRACELLULAR-MATRIX; SUBSTRATE TOPOGRAPHY; SURFACE-TOPOGRAPHY; FORCE
   MICROSCOPY
AB One of the most complete and permanent ways of treating many causes of visual impairment and blindness is to replace the entire affected tissue with pre-cultured ocular tissues supported and maintained on biomaterial frameworks. One direction towards enhancing ocular tissue regeneration on biomaterials, in the laboratory is by applying biomimicry. Specifically to engineer biomaterials with important functional elements of the native extracellular matrices, such as topography, that support and organise cells into coherent tissues. Further problems in regenerative ophthalmology can be potentially solved through application of biomimicry. They include, more efficient ways of moving and transplanting cultivated tissues into correct therapeutic locations inside the eye and scar-less, non-destructive healing of surgical incisions and wounds, to repair structural integrity of tissues at the ocular surface. Two examples are given to show this potential for redeveloping an ocular epithelium onto a nanostructured insect wing surface and producing an origami membrane modelled on deployable structures in nature. Efforts to harness natural innovation will eventually provide unique designs and structures that cannot for now be made synthetically, for regeneration of clinically acceptable ocular tissues.
C1 [Green, David W.] Queensland Eye Inst, Brisbane, Qld 4001, Australia.
   [Green, David W.] Univ Queensland, Australian Inst Bioengn & Nanotechnol, Brisbane, Qld 4072, Australia.
   [Abraham, Samuel J. K.] Yamanashi Univ, Fac Med, Nichi In Ctr Regenerat Med, Chuo 4093898, Japan.
   [Watson, Gregory S.; Watson, Jolanta] James Cook Univ, Sch Pharm & Mol Sci, Townsville, Qld 4811, Australia.
RP Green, DW (reprint author), Queensland Eye Inst, 41 Annerley Rd, Brisbane, Qld 4001, Australia.
EM dr.dwg@gmx.com
RI Watson, Gregory/D-2195-2009
OI Watson, Jolanta/0000-0002-5027-9025; Watson, Gregory/0000-0001-9843-9211
FU Prevent Blindness Foundation
FX This research was funded by the Prevent Blindness Foundation. DWG is
   immensely grateful to Professor Richard Oreffo and Professor Stephen
   Mann for their inspiration and guidance in his tissue engineering and
   biomimetics research over the last decade.
CR Abrams GA, 2003, UROL RES, V31, P341, DOI 10.1007/s00240-003-0347-9
   Abrams GA, 2000, CELL TISSUE RES, V299, P39, DOI 10.1007/s004419900074
   Abrams GA, 2000, CORNEA, V19, P57, DOI 10.1097/00003226-200001000-00012
   Badylak S. F., 2006, TISSUE ENG, V12, P509
   Ballios BG, 2010, BIOMATERIALS, V31, P2555, DOI 10.1016/j.biomaterials.2009.12.004
   Barker TH, 2011, BIOMATERIALS, V32, P4211, DOI 10.1016/j.biomaterials.2011.02.027
   Bettinger CJ, 2009, ANGEW CHEM INT EDIT, V48, P5406, DOI 10.1002/anie.200805179
   Bhushan B, 2009, PHILOS T R SOC A, V367, P1445, DOI 10.1098/rsta.2009.0011
   Biggs MJP, 2010, NANOMED-NANOTECHNOL, V6, P619, DOI 10.1016/j.nano.2010.01.009
   Bystrom B, 2006, INVEST OPHTH VIS SCI, V47, P777, DOI 10.1167/iovs.05-0367
   CALLADINE CR, 1978, INT J SOLIDS STRUCT, V14, P161, DOI 10.1016/0020-7683(78)90052-5
   Carson AE, 2009, REGEN MED, V4, P593, DOI 10.2217/RME.09.30
   Castellarin AA, 1998, EXP EYE RES, V66, P49, DOI 10.1006/exer.1997.0404
   Chakravarthy U., 2003, BRIT MED J, V326, P485
   Chen MC, 2007, BIOMACROMOLECULES, V8, P2774, DOI 10.1021/bm7004615
   Chun HJ, 2010, J GASTROEN HEPATOL, V25, P234, DOI 10.1111/j.1440-1746.2009.06152.x
   Coles BLK, 2004, P NATL ACAD SCI USA, V101, P15772, DOI 10.1073/pnas.0401596101
   Cranford S, 2010, NANOTECHNOL SCI APPL, V3, P127, DOI 10.2147/NSA.S9037
   Curtis A, 1997, BIOMATERIALS, V18, P1573, DOI 10.1016/S0142-9612(97)00144-0
   Dalby MJ, 2007, NAT MATER, V6, P997, DOI 10.1038/nmat2013
   Dalby Matthew J, 2007, Curr Stem Cell Res Ther, V2, P129, DOI 10.2174/157488807780599220
   Dalton BA, 1999, J BIOMED MATER RES, V45, P384, DOI 10.1002/(SICI)1097-4636(19990615)45:4<384::AID-JBM14>3.0.CO;2-O
   Diebold Y, 2010, PROG RETIN EYE RES, V29, P596, DOI 10.1016/j.preteyeres.2010.08.002
   Downing BR, 2005, J BIOMED MATER RES A, V72A, P47, DOI 10.1002/jbm.a.30210
   Dunn KC, 1996, EXP EYE RES, V62, P155, DOI 10.1006/exer.1996.0020
   Eiraku M, 2011, NATURE, V472, P51, DOI 10.1038/nature09941
   Fitton JH, 1998, J BIOMED MATER RES, V42, P245
   Flemming RG, 1999, BIOMATERIALS, V20, P573, DOI 10.1016/S0142-9612(98)00209-9
   Fujie T, 2009, ADV FUNCT MATER, V19, P2560, DOI 10.1002/adfm.200900103
   Gasiorowski JZ, 2008, BIOMEDICAL NANOSTRUCTURES, P297
   Gilbert A., 2006, BIOMATERIALS, V27, P3675
   Gumbiner BM, 1996, CELL, V84, P345, DOI 10.1016/S0092-8674(00)81279-9
   Herbert RC, 2000, J EXP BIOL, V203, P2945
   Hicks D., 2008, J BIOMED MATER RES A, V86A, P170
   Hynes RO, 2009, SCIENCE, V326, P1216, DOI 10.1126/science.1176009
   Hynes SR, 2010, GRAEF ARCH CLIN EXP, V248, P763, DOI 10.1007/s00417-009-1263-7
   Kim D-H., 2010, PNAS, V12, P565
   Kobayashi H, 2000, SOLID MECH APPL, V80, P211
   Kobayashi H., 2003, DYNAMICS ADV MAT SMA, P207
   Kolli S, 2010, STEM CELLS, V28, P597, DOI 10.1002/stem.276
   Kubota A, 2006, BIOMATERIALS, V27, P3639, DOI 10.1016/j.biomaterials.2006.02.018
   Kuribayashi K, 2006, MAT SCI ENG A-STRUCT, V419, P131, DOI 10.1016/j.msea.2005.12.016
   Lamba DA, 2006, P NATL ACAD SCI USA, V103, P12769, DOI 10.1073/pnas.0601990103
   Last JA, 2009, J STRUCT BIOL, V167, P19, DOI 10.1016/j.jsb.2009.03.012
   Lavik EB, 2005, BIOMATERIALS, V26, P3187, DOI 10.1016/j.biomaterials.2004.08.022
   Lawrence BD, 2009, BIOMATERIALS, V30, P1299, DOI 10.1016/j.biomaterials.2008.11.018
   Lee CJ, 2007, BIOMATERIALS, V28, P2192, DOI 10.1016/j.biomaterials.2007.01.018
   Levin LA, 2004, ARCH OPHTHALMOL-CHIC, V122, P621, DOI 10.1001/archopht.122.4.621
   Li Y.X., 2011, J BIOMIM BIOMATER TI, V10, P81
   Liliensiek SJ, 2006, J BIOMED MATER RES A, V79A, P185, DOI 10.1002/jbm.a.30744
   Liliensiek SJ, 2009, TISSUE ENG PT A, V15, P2643, DOI [10.1089/ten.tea.2008.0284, 10.1089/ten.TEA.2008.0284]
   Limb GA, 2006, CURR EYE RES, V31, P381, DOI 10.1080/02713680600681210
   Limb GA, 2008, BRIT MED BULL, V85, P47, DOI 10.1093/bmb/ldn008
   MacLaren RE, 2007, EYE, V21, P1352, DOI 10.1038/sj.eye.6702842
   MacLaren RE, 2006, NATURE, V444, P203, DOI 10.1038/nature05161
   Mahadevan L, 2005, SCIENCE, V307, P1740, DOI 10.1126/science.1105169
   Mallick SB, 2005, J PHYS CHEM B, V109, P19052, DOI 10.1021/jp053605w
   Mallick SB, 2006, ANAL BIOANAL CHEM, V386, P652, DOI 10.1007/s00216-006-0538-7
   Matsunuma H., 2010, STEM CELL BIOL REGEN, V3, P223
   Meng QH, 2009, J POLYM ENVIRON, V17, P212, DOI 10.1007/s10924-009-0141-z
   Moshiri A, 2004, INT J DEV BIOL, V48, P1003, DOI 10.1387/ijdb.041870am
   Mostov K, 2003, NAT CELL BIOL, V5, P287, DOI 10.1038/ncb0403-287
   Nishida K., 2006, BIOMATERIALS, V27, P3639
   Nistor G, 2010, J NEUROSCI METH, V190, P63, DOI 10.1016/j.jneumeth.2010.04.025
   Osakada F, 2008, NAT BIOTECHNOL, V26, P215, DOI 10.1038/nbt1384
   Patel S, 2007, NANO LETT, V7, P2122, DOI 10.1021/nl071182z
   Pellegrini G, 1999, J CELL BIOL, V145, P769, DOI 10.1083/jcb.145.4.769
   Peyman Gholam A, 2011, J Ophthalmic Vis Res, V6, P36
   Pickett GT, 2007, EPL-EUROPHYS LETT, V78, DOI 10.1209/0295-5075/78/48003
   Piterina AV, 2009, INT J MOL SCI, V10, P4375, DOI 10.3390/ijms10104375
   Rajnicek AM, 2008, BIOMATERIALS, V29, P2082, DOI 10.1016/j.biomaterials.2008.01.015
   Rama P, 2010, NEW ENGL J MED, V363, P147, DOI 10.1056/NEJMoa0905955
   Resnikoff S, 2004, B WORLD HEALTH ORGAN, V82, P844
   Rezai KA, 1997, GRAEF ARCH CLIN EXP, V235, P558, DOI 10.1007/BF00947084
   Sanchez C, 2005, NAT MATER, V4, P277, DOI 10.1038/nmat1339
   Schwab I R, 1999, Trans Am Ophthalmol Soc, V97, P891
   SERRUYS PW, 1994, NEW ENGL J MED, V331, P489, DOI 10.1056/NEJM199408253310801
   Shimomura M., 2010, Q REV, V37, P53
   Sommer L, 2006, ADV EXP MED BIOL, V589, P197
   Song F, 2004, J EXP BIOL, V207, P3035, DOI 10.1242/jeb.01122
   Sonoda S, 2009, NAT PROTOC, V4, P662, DOI 10.1038/nprot.2009.33
   Tao S, 2007, LAB CHIP, V7, P695, DOI 10.1039/b618583e
   Teixeira AI, 2006, BIOMATERIALS, V27, P3945, DOI 10.1016/j.biomaterials.2006.01.044
   Tezcaner A, 2008, J BIOMED MATER RES A, V86A, P170, DOI 10.1002/jbm.a.31600
   Tocce EJ, 2010, BIOMATERIALS, V31, P4064, DOI 10.1016/j.biomaterials.2010.01.101
   Tsai RJ, 2000, NEW ENGL J MED, V343, P86, DOI 10.1056/NEJM200007133430202
   Van Agtmael T, 2010, CELL TISSUE RES, V339, P167, DOI 10.1007/s00441-009-0866-y
   VRACKO R, 1974, AM J PATHOL, V77, P314
   Wang L., 2011, ADV BIOMIMETICS
   Wang LS, 2004, ADV MATER, V16, P1790, DOI 10.1002/adma.200400602
   Watson GS, 2008, BIOPHYS J, V94, P3352, DOI 10.1529/biophysj.107.109348
   Weinberger W. A., 2000, GRAEF ARCH CLIN EXP, V<IT>238</IT>, P631
   Wootton RJ, 2000, J EXP BIOL, V203, P2921
   YAMASAKI Y, 1994, NEPHRON, V66, P189, DOI 10.1159/000187800
   Yim EKF, 2005, NANOMED-NANOTECHNOL, V1, P10, DOI 10.1016/j.nano.2004.11.008
NR 95
TC 10
Z9 10
U1 2
U2 30
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 2192-2640
J9 ADV HEALTHC MATER
JI Adv. Healthc. Mater.
PD MAR
PY 2012
VL 1
IS 2
BP 140
EP 148
DI 10.1002/adhm.201100039
PG 9
WC Engineering, Biomedical; Nanoscience & Nanotechnology; Materials
   Science, Biomaterials
SC Engineering; Science & Technology - Other Topics; Materials Science
GA 092HN
UT WOS:000315111100001
PM 23184716
DA 2018-10-19
ER

PT J
AU Zhuang, WJ
   Yuan, DQ
   Li, JR
   Luo, ZP
   Zhou, HC
   Bashir, S
   Liu, JB
AF Zhuang, Wenjuan
   Yuan, Daqiang
   Li, Jian-Rong
   Luo, Zhiping
   Zhou, Hong-Cai
   Bashir, Sajid
   Liu, Jingbo
TI Highly Potent Bactericidal Activity of Porous Metal-Organic Frameworks
SO ADVANCED HEALTHCARE MATERIALS
LA English
DT Article
ID ZINC-OXIDE NANOPARTICLES; FERRITE COMPOSITE NANOPARTICLES; IRON-SULFUR
   CLUSTERS; ESCHERICHIA-COLI; ANTIBACTERIAL ACTIVITY;
   STAPHYLOCOCCUS-AUREUS; SILICA NANOPARTICLES; ENANTIOSELECTIVE
   SEPARATION; COORDINATION CHEMISTRY; BIOMATERIAL SYSTEM
AB Recent outbreaks of bacterial infection leading to human fatalities have been a motivational force for us to develop antibacterial agents with high potency and long-term stability. A novel cobalt (Co) based metal-organic framework (MOF) was tested and shown to be highly effective at inactivating model microorganisms. Gram-negative bacteria, Escherichia coli (strains DH5alpha and XL1-Blue) were selected to determine the antibacterial activities of the Co MOF. In this MOF, the Co serves as a central element and an octa-topic carboxylate ligand, tetrakis [(3,5-dicarboxyphenyl)-oxamethyl] methane (TDM8-) serves as a bridging linker. X-ray crystallographic studies indicate that Co-TDM crystallizes in tetragonal space group P4 2(1)m with a porous 3D framework.
   The potency of the Co-TDM disinfectant was evaluated using a minimal bactericidal concentration (MBC) benchmark and was determined to be 10-15 ppm within a short incubation time period (<60 min). Compared with previous work using silver nanoparticles and silver-modified TiO2 nano-composites over the same time period, the MBC and effectiveness of Co-TDM are superior. Electron microscopy images indicate that the Co-TDM displayed distinctive grain boundaries and well-developed reticulates. The Co active sites rapidly catalyzed the lipid peroxidation, causing rupture of the bacterial membrane followed by inactivation, with 100% recycling and high persistence (>4 weeks). This MOF-based approach may lead to a new paradigm for MOF applications in diverse biological fields due to their inherent porous structure, tunable surface functional groups, and adjustable metal coordination environments.
C1 [Zhuang, Wenjuan; Yuan, Daqiang; Li, Jian-Rong; Zhou, Hong-Cai; Liu, Jingbo] Texas A&M Univ, Dept Chem, College Stn, TX 77843 USA.
   [Yuan, Daqiang] Chinese Acad Sci, Fujian Inst Res Struct Matter, State Key Lab Struct Chem, Fuzhou 350002, Peoples R China.
   [Luo, Zhiping] Texas A&M Univ, Microscopy & Imaging Ctr, College Stn, TX 77843 USA.
   [Luo, Zhiping] Texas A&M Univ, Mat Sci & Engn Program, College Stn, TX 77843 USA.
   [Bashir, Sajid] Texas A&M Univ Kingsville, Chem Biol Res Grp, Kingsville, TX 78363 USA.
   [Bashir, Sajid; Liu, Jingbo] Lawrence Berkeley Natl Lab, Adv Light Source Div, Berkeley, CA USA.
   [Liu, Jingbo] Texas A&M Univ Kingsville, Kingsville, TX 78363 USA.
RP Zhou, HC (reprint author), Texas A&M Univ, Dept Chem, College Stn, TX 77843 USA.
EM zhou@chem.tamu.edu; jingbo.liu@tamuk.edu
RI Li, Jian-Rong (Jeff)/G-2781-2010; EFRC, CGS/I-6680-2012; Yuan,
   Daqiang/F-5695-2010; Stangl, Kristin/D-1502-2015; Zhou,
   Hong-Cai/A-3009-2011; Zhuang, Wenjuan/G-2784-2010; Luo,
   Zhiping/C-4435-2014
OI Yuan, Daqiang/0000-0003-4627-072X; Zhou, Hong-Cai/0000-0002-9029-3788;
   Luo, Zhiping/0000-0002-8264-6424; Bashir, Sajid/0000-0001-5356-8853
FU US Department of Energy (DOE), the Office of Science [DOE DE-SC0001015,
   DE-FC36-07GO17033, DE-AR0000073]; National Science Foundation [NSF
   CBET-0930079, NSF CBET-0821370]; National Natural Toxins Research Center
   at TAMUK; National Science Foundation/Department of Energy
   [NSF/CHE-0822838]; U.S. Department of Energy, Office of Science, Office
   of Basic Energy Sciences [DE-AC02-06CH11357]
FX The US Department of Energy (DOE), the Office of Science (DOE
   DE-SC0001015, DE-FC36-07GO17033, and DE-AR0000073), and the National
   Science Foundation (NSF CBET-0930079 and NSF CBET-0821370), are
   acknowledged for their financial support. Dr. J. Ying from the National
   Natural Toxins Research Center at TAMUK is also acknowledged for
   allowing us to conduct the bioassay. Dr. R. Perez-Ballestero, K.
   Chamakura are thanked for sharing unused MBC values from a previous
   study (TAMUK), and the Microscopy and Imaging Center and Materials
   Science and Engineering Program at TAMU and the Departments of Chemistry
   at TAMU and TAMUK are acknowledged for their technical support. The
   microcrystal diffraction of Co-TDM was carried out with the assistance
   of Yu-Sheng Chen at the Advanced Photon Source on beamline 15-ID-B at
   ChemMatCARS Sector 15, which is principally supported by the National
   Science Foundation/Department of Energy under grant number
   NSF/CHE-0822838. Use of the Advanced Photon Source was supported by the
   U.S. Department of Energy, Office of Science, Office of Basic Energy
   Sciences, under Contract No. DE-AC02-06CH11357.
CR Agar JN, 2000, BIOCHEMISTRY-US, V39, P7856, DOI 10.1021/bi000931a
   Balasubramanian R, 2006, J BACTERIOL, V188, P3182, DOI 10.1128/JB.188.9.3182-3191.2006
   Baldwin EL, 2004, BIOCHEMISTRY-US, V43, P728, DOI 10.1021/bi035472f
   Barras F, 2005, ADV MICROB PHYSIOL, V50, P41, DOI 10.1016/S0065-2911(05)50002-X
   Bashir S., 2011, INT J GREEN NANOTECH, V3, P118
   Bayer M. E., 1982, BACTERIAL OUTER MEMB
   Bhan A, 2008, ACCOUNTS CHEM RES, V41, P559, DOI 10.1021/ar700181t
   Birkmann B, 2009, CHEM-EUR J, V15, P9325, DOI 10.1002/chem.200901443
   BLACK AP, 1959, AM J PUBLIC HEALTH N, V49, P1060, DOI 10.2105/AJPH.49.8.1060
   Blatov V. A., 2006, IUCR COMPCOMM NEWSLE, V7, P4, DOI DOI 10.1039/B807165A
   Block S. S., 2001, DISINFECTION STERILI
   Borel C, 2006, CRYSTENGCOMM, V8, P666, DOI 10.1039/b605762d
   Brown CJ, 2009, J AM CHEM SOC, V131, P17530, DOI 10.1021/ja906386w
   Caulder DL, 1999, ACCOUNTS CHEM RES, V32, P975, DOI 10.1021/ar970224v
   Cevc G., 1987, PHOSPHOLIPID BILAYER, V5
   Chae HK, 2004, NATURE, V427, P523, DOI 10.1038/nature02311
   Chamakura K., 2010, COMMUNICATION   1202
   Chamakura K, 2011, COLLOID SURFACE B, V84, P88, DOI 10.1016/j.colsurfb.2010.12.020
   Chick H, 1910, J Hyg (Lond), V10, P237
   Chillappagari S, 2010, J BACTERIOL, V192, P2512, DOI 10.1128/JB.00058-10
   CHRISTMAN MF, 1989, P NATL ACAD SCI USA, V86, P3484, DOI 10.1073/pnas.86.10.3484
   Cooper EA, 1912, BIOCHEM J, V6, P362, DOI 10.1042/bj0060362
   CRAMER WA, 1983, BIOCHIM BIOPHYS ACTA, V737, P173, DOI 10.1016/0304-4157(83)90016-3
   Del Valle EMM, 2004, PROCESS BIOCHEM, V39, P1033, DOI 10.1016/S0032-9592(03)00258-9
   Delgado K, 2011, LETT APPL MICROBIOL, V53, P50, DOI 10.1111/j.1472-765X.2011.03069.x
   Delgado-Friedrichs O, 2007, PHYS CHEM CHEM PHYS, V9, P1035, DOI 10.1039/b615006c
   Delgado-Friedrichs O, 2006, ACTA CRYSTALLOGR A, V62, P350, DOI 10.1107/S0108767306022707
   Della Rocca J, 2011, ACCOUNTS CHEM RES, V44, P957, DOI 10.1021/ar200028a
   Denyer S. P., 1998, BIODETERIOR BIODEGRA, V<IT>41</IT>, P161
   Ding HG, 2004, BIOCHEM J, V379, P433, DOI 10.1042/BJ20031702
   Dinolfo PH, 2001, CHEM MATER, V13, P3113, DOI 10.1021/cm010176f
   Djaman O, 2004, J BIOL CHEM, V279, P44590, DOI 10.1074/jbc.M406487200
   Eddaoudi M, 2001, ACCOUNTS CHEM RES, V34, P319, DOI 10.1021/ar000034b
   FEE JA, 1991, MOL MICROBIOL, V5, P2599, DOI 10.1111/j.1365-2958.1991.tb01968.x
   Ferey G, 2005, SCIENCE, V309, P2040, DOI 10.1126/science.1116275
   Fontecave M, 2005, J BIOL INORG CHEM, V10, P713, DOI 10.1007/s00775-005-0025-1
   FRIBERG LARS, 1957, ACTA PATHOL ET MICROBIOL SCAND, V40, P67
   FRIBERG LARS, 1956, ACTA PATHOL ET MICROBIOL SCAND, V38, P135
   Frischmann PD, 2010, J AM CHEM SOC, V132, P7668, DOI 10.1021/ja910886g
   Furukawa H, 2010, SCIENCE, V329, P424, DOI 10.1126/science.1192160
   Gianneschi NC, 2005, ACCOUNTS CHEM RES, V38, P825, DOI 10.1021/ar980101q
   GUTTERIDGE JMC, 1983, FEBS LETT, V157, P37, DOI 10.1016/0014-5793(83)81111-9
   Hetrick EM, 2008, ACS NANO, V2, P235, DOI [10.1021/nn700191f, 10.1021/nn700191]
   Hetrick EM, 2009, BIOMATERIALS, V30, P2782, DOI 10.1016/j.biomaterials.2009.01.052
   Hoffmann P. N., 1981, DISINFECTANTS THEIR
   Jang SJ, 2010, MOL MICROBIOL, V78, P1448, DOI 10.1111/j.1365-2958.2010.07418.x
   JARVIS JQ, 1992, J OCCUP ENVIRON MED, V34, P620
   Jin T, 2011, J APPL MICROBIOL, V110, P704, DOI 10.1111/j.1365-2672.2011.04938.x
   Johnson DC, 2005, ANNU REV BIOCHEM, V74, P247, DOI 10.1146/annurev.biochem.74.082803.133518
   Jung WK, 2008, APPL ENVIRON MICROB, V74, P2171, DOI 10.1128/AEM.02001-07
   Kiley PJ, 2003, CURR OPIN MICROBIOL, V6, P181, DOI 10.1016/S1369-5274(03)00039-0
   KILINC K, 1992, BIOCHIM BIOPHYS ACTA, V1125, P189, DOI 10.1016/0005-2760(92)90044-V
   Kitagawa S, 2004, ANGEW CHEM INT EDIT, V43, P2334, DOI 10.1002/anie.200300610
   Koblenz TS, 2008, CHEM SOC REV, V37, P247, DOI 10.1039/b614961h
   Kopera E, 2004, CHEM RES TOXICOL, V17, P1452, DOI 10.1021/tx049842s
   Krebs C, 2001, BIOCHEMISTRY-US, V40, P14069, DOI 10.1021/bi015656z
   KRISTENSEN MARTIN, 1957, ACTA PATHOL ET MICROBIOL SCAND, V40, P216
   LABEDAN B, 1981, P NATL ACAD SCI-BIOL, V78, P215, DOI 10.1073/pnas.78.1.215
   Larsen RW, 2008, J AM CHEM SOC, V130, P11246, DOI 10.1021/ja802605v
   Lee SJ, 2008, ACCOUNTS CHEM RES, V41, P521, DOI 10.1021/ar700216n
   Lee SJ, 2008, J AM CHEM SOC, V130, P16828, DOI 10.1021/ja804014y
   Leininger S, 2000, CHEM REV, V100, P853, DOI 10.1021/cr9601324
   Lenaghan S., 2005, J EUKARYOT MICROBIOL, V<IT>52</IT>, p7S
   LETELLIER L, 1984, J BACTERIOL, V157, P789
   Li G, 2008, J AM CHEM SOC, V130, P4582, DOI 10.1021/ja078317n
   Lin X, 2009, J AM CHEM SOC, V131, P2159, DOI 10.1021/ja806624j
   Lipovsky A, 2011, LASER SURG MED, V43, P236, DOI 10.1002/lsm.21033
   Liu TF, 2010, ANGEW CHEM INT EDIT, V49, P4121, DOI 10.1002/anie.201000416
   Liu Y, 2009, J APPL MICROBIOL, V107, P1193, DOI 10.1111/j.1365-2672.2009.04303.x
   Liu Y., 2011, CRYSTENGCOMM, V<IT>46</IT>, P2608
   Loiseau L, 2005, J BIOL CHEM, V280, P26760, DOI 10.1074/jbc.M504067200
   Lu Z, 2009, J AM CHEM SOC, V131, P12532, DOI 10.1021/ja905101s
   Luo ZP, 2006, ACTA MATER, V54, P47, DOI 10.1016/j.actamat.2005.08.022
   Ma LQ, 2008, J AM CHEM SOC, V130, P13834, DOI 10.1021/ja804944r
   Ma LQ, 2009, J AM CHEM SOC, V131, P4610, DOI 10.1021/ja809590n
   Ma SQ, 2008, J AM CHEM SOC, V130, P1012, DOI 10.1021/ja0771639
   Martinez LR, 2009, J INVEST DERMATOL, V129, P2463, DOI 10.1038/jid.2009.95
   McKinlay AC, 2010, ANGEW CHEM INT EDIT, V49, P6260, DOI 10.1002/anie.201000048
   MCLaughlin A. C., 1969, J MAGN RESON, V31, P283
   Medina-Ramirez I., 2011, GREEN CHEM
   Medina-Ramirez I, 2011, DALTON T, V40, P1047, DOI 10.1039/c0dt00784f
   MELNIK M, 1982, INORG CHIM A-BIOINOR, V67, P117, DOI 10.1016/S0020-1693(00)85052-5
   Minear RA, 1996, ACS SYM SER, V649, P1
   Moorer W R, 2003, Int J Dent Hyg, V1, P138, DOI 10.1034/j.1601-5037.2003.00032.x
   MOORHOUSE CP, 1985, BIOCHIM BIOPHYS ACTA, V843, P261, DOI 10.1016/0304-4165(85)90147-3
   Morein S, 1996, J BIOL CHEM, V271, P6801, DOI 10.1074/jbc.271.12.6801
   Murase T, 2010, J AM CHEM SOC, V132, P2866, DOI 10.1021/ja9107275
   Nirmala M, 2011, PHYSICA B, V406, P911, DOI 10.1016/j.physb.2010.12.026
   Nitschke JR, 2003, P NATL ACAD SCI USA, V100, P11970, DOI 10.1073/pnas.1534925100
   Noro S, 2000, ANGEW CHEM INT EDIT, V39, P2082
   Northrop BH, 2009, ACCOUNTS CHEM RES, V42, P1554, DOI 10.1021/ar900077c
   Ollagnier-de Choudens S, 2003, J BIOL CHEM, V278, P17993, DOI 10.1074/jbc.M300285200
   Ollagnier-de-Choudens S, 2004, J BIOL INORG CHEM, V9, P828, DOI 10.1007/s00775-004-0581-9
   Ollagnier-de-Choudens S, 2001, J BIOL CHEM, V276, P22604, DOI 10.1074/jbc.M102902200
   Outten FW, 2004, MOL MICROBIOL, V52, P861, DOI 10.1111/j.1365-2958.2004.04025.x
   Palza H, 2010, MACROMOL RAPID COMM, V31, P563, DOI 10.1002/marc.200900791
   Pan XB, 2010, COLLOID SURFACE B, V77, P82, DOI 10.1016/j.colsurfb.2010.01.010
   Park H, 2011, J MICROBIOL METH, V84, P41, DOI 10.1016/j.mimet.2010.10.010
   Perry JJ, 2009, CHEM SOC REV, V38, P1400, DOI 10.1039/b807086p
   Pitt MA, 2007, CHEM SOC REV, V36, P1441, DOI 10.1039/b610405n
   Pulido MD, 2003, MUTAT RES-FUND MOL M, V533, P227, DOI 10.1016/j.mrfmmm.2003.07.015
   RAJCA A, 1994, J ORG CHEM, V59, P7701, DOI 10.1021/jo00104a027
   Rana S, 2006, ACTA BIOMATER, V2, P421, DOI 10.1016/j.actbio.2006.03.005
   Ranquet C, 2007, J BIOL CHEM, V282, P30442, DOI 10.1074/jbc.M702519200
   Ribeiro ACF, 2002, J CHEM ENG DATA, V47, P539, DOI 10.1021/je0101808
   Ribeiro ACF, 2009, J MOL LIQ, V146, P69, DOI 10.1016/j.molliq.2009.02.006
   Rit A, 2010, J AM CHEM SOC, V132, P4572, DOI 10.1021/ja101490d
   Rodrigue A, 2005, J BACTERIOL, V187, P2912, DOI 10.1128/JB.187.8.2912-2916.2005
   Rowsell JLC, 2004, MICROPOR MESOPOR MAT, V73, P3, DOI 10.1016/j.micromeso.2004.03.034
   Sato S, 2009, J AM CHEM SOC, V131, P6064, DOI 10.1021/ja900676f
   Scott WW, 1931, ANN SURG, V93, P587, DOI 10.1097/00000658-193102000-00009
   Seo JS, 2000, NATURE, V404, P982
   Sevinc BA, 2010, J BIOMED MATER RES B, V94B, P22, DOI 10.1002/jbm.b.31620
   SHELDRICK GM, 1990, ACTA CRYSTALLOGR A, V46, P467, DOI 10.1107/S0108767390000277
   Sluis P. v. d., 1990, ACTA CRYSTALLOGR A, V46, P194, DOI DOI 10.1107/S0108767389011189
   SNOW J, 1955, BRIT J ANAESTH, V27, P42, DOI 10.1093/bja/27.1.42
   Sommer R, 2001, WATER RES, V35, P3109, DOI 10.1016/S0043-1354(01)00030-6
   Song H. Y., 2006, EUR CELLS MATER, V11, P58
   Song J, 2011, COLLOID SURFACE B, V82, P651, DOI 10.1016/j.colsurfb.2010.10.027
   STORZ G, 1992, J NUTR, V122, P627, DOI 10.1093/jn/122.suppl_3.627
   Sunkara BK, 2008, ACTA BIOMATER, V4, P273, DOI 10.1016/j.actbio.2007.07.002
   Suzuki K, 2010, NAT CHEM, V2, P25, DOI [10.1038/nchem.446, 10.1038/NCHEM.446]
   Syed MA, 2010, NEW MICROBIOL, V33, P329
   Tan CR, 2011, CHEM COMMUN, V47, P4487, DOI 10.1039/c1cc10378d
   Tian J, 2007, CHEMMEDCHEM, V2, P129, DOI 10.1002/cmdc.200600171
   Tokumoto U, 2004, J BIOCHEM, V136, P199, DOI 10.1093/jb/mvh104
   Valko M, 2005, CURR MED CHEM, V12, P1161, DOI 10.2174/0929867053764635
   VENOSA AD, 1973, APPL MICROBIOL, V25, P735
   VINCENT GP, 1946, AM J PUBLIC HEALTH, V36, P1035
   Voronkov M. G., 1990, CHEM HETEROCYCL COMP, V26, P1077
   Walters A. H., 1948, IRISH J MED SCI, V<IT>94</IT>, P273
   Wang KB, 2011, CRYSTENGCOMM, V13, P5100, DOI 10.1039/c1ce05202k
   Weber DJ, 2006, INFECT CONT HOSP EP, V27, P1107, DOI 10.1086/507964
   WILSON DB, 1982, J BACTERIOL, V152, P1091
   WOESE CR, 1987, MICROBIOL REV, V51, P221
   Wong-Foy AG, 2006, J AM CHEM SOC, V128, P3494, DOI 10.1021/ja058213h
   Yaghi OM, 2003, NATURE, V423, P705, DOI 10.1038/nature01650
   Yuan DQ, 2010, ANGEW CHEM INT EDIT, V49, P5357, DOI 10.1002/anie.201001009
   Zelenak V, 2002, Met Based Drugs, V8, P269, DOI 10.1155/MBD.2002.269
   Zhao D, 2009, J AM CHEM SOC, V131, P9186, DOI 10.1021/ja901109t
   Zhuang WJ, 2010, CHEM COMMUN, V46, P5223, DOI 10.1039/c0cc00779j
NR 141
TC 35
Z9 35
U1 17
U2 235
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 2192-2640
EI 2192-2659
J9 ADV HEALTHC MATER
JI Adv. Healthc. Mater.
PD MAR
PY 2012
VL 1
IS 2
BP 225
EP 238
DI 10.1002/adhm.201100043
PG 14
WC Engineering, Biomedical; Nanoscience & Nanotechnology; Materials
   Science, Biomaterials
SC Engineering; Science & Technology - Other Topics; Materials Science
GA 092HN
UT WOS:000315111100012
PM 23184726
DA 2018-10-19
ER

PT J
AU Chen, IC
   Chiu, YW
   Hung, YC
AF Chen, I-Ching
   Chiu, Yi-Wen
   Hung, Yu-Chueh
TI Efficient Biopolymer Blue Organic Light-Emitting Devices with Low
   Driving Voltage
SO JAPANESE JOURNAL OF APPLIED PHYSICS
LA English
DT Article
ID DNA; OPTOELECTRONICS; COMPLEXES; POLYMERS; DIODES; FILMS; LAYER
AB We demonstrate blue organic light-emitting devices (OLEDs) with high luminance based on DNA biopolymer. We incorporated aromatic surfactant in the synthesis of DNA biopolymer, which results in lower operation voltage of biopolymer-based OLEDs and a turn-on voltage of 3.77 V was achieved. Maximum luminance of 12277 cd/m(2) and a 46.4% enhancement in luminous efficacy of blue OLED based on DNA biopolymer was demonstrated compared to the reference device. This demonstrates a viable and facile route to adjust the conductivity of DNA biopolymer and paves the way towards multifunctional biomaterial-based optoelectronic devices and applications. (C) 2012 The Japan Society of Applied Physics
C1 [Chen, I-Ching; Chiu, Yi-Wen; Hung, Yu-Chueh] Natl Tsing Hua Univ, Inst Photon Technol, Hsinchu 30013, Taiwan.
RP Chen, IC (reprint author), Natl Tsing Hua Univ, Inst Photon Technol, Hsinchu 30013, Taiwan.
EM ychung@ee.nthu.edu.tw
FU National Science Council of Taiwan [NSC99-2221-E-007-083]
FX We would like to thank Professor C.-H. Cheng in the Department of
   Chemistry, National Tsing Hua University, for the access of facilities.
   We also acknowledge financial support from the National Science Council
   of Taiwan (NSC99-2221-E-007-083).
CR Cho MJ, 2010, J POLYM SCI POL CHEM, V48, P1913, DOI 10.1002/pola.23958
   Grote JG, 2004, J PHYS CHEM B, V108, P8584, DOI 10.1021/jp038056d
   Hagen J. A., 2006, THESIS U CINCINNATI
   Hagen JA, 2006, APPL PHYS LETT, V88, DOI 10.1063/1.2197973
   HUNTER CA, 1990, J AM CHEM SOC, V112, P5525, DOI 10.1021/ja00170a016
   Kang JW, 2007, APPL PHYS LETT, V90, DOI 10.1063/1.2745224
   Kawabe Y, 2000, ADV MATER, V12, P1281, DOI 10.1002/1521-4095(200009)12:17<1281::AID-ADMA1281>3.0.CO;2-0
   Kim JS, 2005, APPL PHYS LETT, V87, DOI 10.1063/1.1992658
   Lin TY, 2011, PROC SPIE, V7935, DOI 10.1117/12.874228
   Moliton A, 2004, POLYM INT, V53, P1397, DOI 10.1002/pi.1587
   Morgado J, 2002, APPL PHYS LETT, V80, P2436, DOI 10.1063/1.1467981
   Nakamura K, 2010, APPL PHYS LETT, V97, DOI 10.1063/1.3512861
   Seeman NC, 2003, NATURE, V421, P427, DOI 10.1038/nature01406
   Stadler P, 2007, ORG ELECTRON, V8, P648, DOI 10.1016/j.orgel.2007.05.003
   Steckl AJ, 2007, NAT PHOTONICS, V1, P3, DOI 10.1038/nphoton.2006.56
   Sun QJ, 2009, ACS NANO, V3, P737, DOI 10.1021/nn8009079
   Wang LL, 2001, CHEM MATER, V13, P1273, DOI 10.1021/cm000869g
   Yan H, 2003, SCIENCE, V301, P1882, DOI 10.1126/science.1089389
   Yan H, 2004, ADV MATER, V16, P1948, DOI 10.1002/adma.200400627
NR 19
TC 13
Z9 13
U1 0
U2 7
PU IOP PUBLISHING LTD
PI BRISTOL
PA TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND
SN 0021-4922
EI 1347-4065
J9 JPN J APPL PHYS
JI Jpn. J. Appl. Phys.
PD MAR
PY 2012
VL 51
IS 3
AR 031601
DI 10.1143/JJAP.51.031601
PN 1
PG 3
WC Physics, Applied
SC Physics
GA 906MD
UT WOS:000301348400016
DA 2018-10-19
ER

PT J
AU Kolehmainen, K
   Willerth, SM
AF Kolehmainen, Kathleen
   Willerth, Stephanie M.
TI Preparation of 3D Fibrin Scaffolds for Stem Cell Culture Applications
SO JOVE-JOURNAL OF VISUALIZED EXPERIMENTS
LA English
DT Article
DE Bioengineering; Issue 61; Extracellular matrix; stem cells;
   biomaterials; drug delivery; cell culture
AB Stem cells are found in naturally occurring 3D microenvironments in vivo, which are often referred to as the stem cell niche (1). Culturing stem cells inside of 3D biomaterial scaffolds provides a way to accurately mimic these microenvironments, providing an advantage over traditional 2D culture methods using polystyrene as well as a method for engineering replacement tissues (2). While 2D tissue culture polystrene has been used for the majority of cell culture experiments, 3D biomaterial scaffolds can more closely replicate the microenvironments found in vivo by enabling more accurate establishment of cell polarity in the environment and possessing biochemical and mechanical properties similar to soft tissue. 3 A variety of naturally derived and synthetic biomaterial scaffolds have been investigated as 3D environments for supporting stem cell growth. While synthetic scaffolds can be synthesized to have a greater range of mechanical and chemical properties and often have greater reproducibility, natural biomaterials are often composed of proteins and polysaccharides found in the extracelluar matrix and as a result contain binding sites for cell adhesion and readily support cell culture. Fibrin scaffolds, produced by polymerizing the protein fibrinogen obtained from plasma, have been widely investigated for a variety of tissue engineering applications both in vitro and in vivo (4). Such scaffolds can be modified using a variety of methods to incorporate controlled release systems for delivering therapeutic factors (5). Previous work has shown that such scaffolds can be used to successfully culture embryonic stem cells and this scaffold-based culture system can be used to screen the effects of various growth factors on the differentiation of the stem cells seeded inside (6,7).
   This protocol details the process of polymerizing fibrin scaffolds from fibrinogen solutions using the enzymatic activity of thrombin. The process takes 2 days to complete, including an overnight dialysis step for the fibrinogen solution to remove citrates that inhibit polymerization. These detailed methods rely on fibrinogen concentrations determined to be optimal for embryonic and induced pluripotent stem cell culture. Other groups have further investigated fibrin scaffolds for a wide range of cell types and applications - demonstrating the versatility of this approach (8-12).
C1 [Kolehmainen, Kathleen] Univ Victoria, Dept Biol, Victoria, BC V8W 2Y2, Canada.
   [Willerth, Stephanie M.] Univ Victoria, Div Med Sci, Dept Mech Engn, Victoria, BC V8W 2Y2, Canada.
RP Willerth, SM (reprint author), Univ Victoria, Div Med Sci, Dept Mech Engn, Victoria, BC V8W 2Y2, Canada.
EM willerth@uvic.ca
OI Willerth, Stephanie/0000-0002-1665-7723
FU NSERC [402462]
FX The authors would like to acknowledge NSERC Discovery Grant 402462
   "Tissue engineered scaffolds for controlling induced pluripotent stem
   cell behavior".
CR Ahmed TAE, 2008, TISSUE ENG PT B-REV, V14, P199, DOI 10.1089/ten.teb.2007.0435
   BAIN G, 1995, DEV BIOL, V168, P342, DOI 10.1006/dbio.1995.1085
   Barsotti MC, 2011, CELL PROLIFERAT, V44, P33, DOI 10.1111/j.1365-2184.2010.00715.x
   Breen A, 2009, TISSUE ENG PART B-RE, V15, P201, DOI [10.1089/ten.teb.2008.0527, 10.1089/ten.TEB.2008.0527]
   Chen SJ, 2010, STEM CELLS DEV, V19, P1757, DOI 10.1089/scd.2009.0452
   DELLENBACK RJ, 1970, P SOC EXP BIOL MED, V134, P353
   Gorodetsky R, 2011, TISSUE ENG PART C-ME, V17, P745, DOI [10.1089/ten.tec.2010.0644, 10.1089/ten.TEC.2010.0644]
   Keung AJ, 2010, WIRES SYST BIOL MED, V2, P49, DOI 10.1002/wsbm.46
   Lee J, 2008, TISSUE ENG PT B-REV, V14, P61, DOI 10.1089/teb.2007.0150
   Li XJ, 2008, STEM CELLS, V26, P886, DOI 10.1634/stemcells.2007-0620
   Liu H, 2006, BIOMATERIALS, V27, P6004, DOI 10.1016/j.biomaterials.2006.06.016
   Lorentz K. M., 2011, BIOMATERIALS, V32, P430, DOI [10.1016/j.biomaterials.2010.08.109, DOI 10.1016/J.BIOMATERIALS.2010.08.109]
   Mooney R, 2010, TISSUE ENG PT A, V16, P1607, DOI [10.1089/ten.tea.2009.0372, 10.1089/ten.TEA.2009.0372]
   Park JS, 2011, BIOMATERIALS, V32, P1495, DOI 10.1016/j.biomaterials.2010.11.003
   Willerth SM, 2008, COMBINING STEM CELLS
   Willerth SM, 2007, STEM CELLS, V25, P2235, DOI 10.1634/stemcells.2007-0111
   Willerth SM, 2006, BIOMATERIALS, V27, P5990, DOI 10.1016/j.biomaterials.2006.07.036
   Willerth SM, 2008, STEM CELL RES, V1, P205, DOI 10.1016/j.scr.2008.05.006
NR 18
TC 5
Z9 6
U1 0
U2 13
PU JOURNAL OF VISUALIZED EXPERIMENTS
PI CAMBRIDGE
PA 1 ALEWIFE CENTER, STE 200, CAMBRIDGE, MA 02140 USA
SN 1940-087X
J9 JOVE-J VIS EXP
JI J. Vis. Exp.
PD MAR
PY 2012
IS 61
AR e3641
DI 10.3791/3641
PG 5
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA V36PF
UT WOS:000209222800019
PM 22415575
OA Green Published
DA 2018-10-19
ER

PT J
AU Park, SH
   Gil, ES
   Cho, H
   Mandal, BB
   Tien, LW
   Min, BH
   Kaplan, DL
AF Park, Sang-Hyug
   Gil, Eun Seok
   Cho, Hongsik
   Mandal, Biman B.
   Tien, Lee W.
   Min, Byoung-Hyun
   Kaplan, David L.
TI Intervertebral Disk Tissue Engineering Using Biphasic Silk Composite
   Scaffolds
SO TISSUE ENGINEERING PART A
LA English
DT Article
ID MESENCHYMAL STEM-CELLS; HUMAN NUCLEUS PULPOSUS; ANNULUS FIBROSUS;
   IN-VITRO; ARTICULAR-CARTILAGE; PROTEOGLYCAN PRODUCTION; 3-DIMENSIONAL
   CULTURE; END-PLATE; FIBRIN; DEGENERATION
AB Scaffolds composed of synthetic, natural, and hybrid materials have been investigated as options to restore intervertebral disk (IVD) tissue function. These systems fall short of the lamellar features of the native annulus fibrosus (AF) tissue or focus only on the nucleus pulposus (NP) tissue. However, successful regeneration of the entire IVD requires a combination approach to restore functions of both the AF and NP. To address this need, a biphasic biomaterial structure was generated by using silk protein for the AF and fibrin/hyaluronic acid (HA) gels for the NP. Two cell types, porcine AF cells and chondrocytes, were utilized. For the AF tissue, two types of scaffold morphologies, lamellar and porous, were studied with the porous system serving as a control. Toroidal scaffolds formed out of the lamellar, and porous silk materials were used to generate structures with an outer diameter of 8 mm, inner diameter of 3.5 mm, and a height of 3 mm (the interlamellar distance in the lamellar scaffold was 150-250 mu m, and the average pore sizes in the porous scaffolds were 100-250 mu m). The scaffolds were seeded with porcine AF cells to form AF tissue, whereas porcine chondrocytes were encapsulated in fibrin/HA hydrogels for the NP tissue and embedded in the center of the toroidal disk. Histology, biochemical assays, and gene expression indicated that the lamellar scaffolds supported AF-like tissue over 2 weeks. Porcine chondrocytes formed the NP phenotype within the hydrogel after 4 weeks of culture with the AF tissue that had been previously cultured for 2 weeks, for a total of 6 weeks of cultivation. This biphasic scaffold simulating in combination of both AF and NP tissues was effective in the formation of the total IVD in vitro.
C1 [Park, Sang-Hyug; Gil, Eun Seok; Mandal, Biman B.; Tien, Lee W.; Kaplan, David L.] Tufts Univ, Dept Biomed Engn, Medford, MA 02155 USA.
   [Cho, Hongsik] Univ Tennessee, Ctr Hlth Sci, Dept Orthopaed Surg, Memphis, TN 38163 USA.
   [Min, Byoung-Hyun] Ajou Univ, Sch Med, Dept Orthoped Surg, Suwon 441749, South Korea.
   [Min, Byoung-Hyun] Ajou Univ, Sch Med, Dept Mol Sci & Technol, Suwon 441749, South Korea.
RP Kaplan, DL (reprint author), Tufts Univ, Dept Biomed Engn, 4 Colby St, Medford, MA 02155 USA.
EM david.kaplan@tufts.edu
OI Min, Byoung-Hyun/0000-0001-8928-414X
FU NIH Tissue Engineering Resource Center [EB002520]; NIH [EB003210]
FX This project was supported by the NIH Tissue Engineering Resource Center
   (EB002520) and NIH EB003210.
CR Alini M, 2003, SPINE, V28, P446, DOI 10.1097/00007632-200303010-00007
   Aubin CE, 2004, MED BIOL ENG COMPUT, V42, P216, DOI 10.1007/BF02344634
   Baer AE, 2003, J BIOMECH ENG-T ASME, V125, P1, DOI 10.1115/1.1532790
   Boudreau Nancy J., 1999, Biochemical Journal, V339, P481, DOI 10.1042/0264-6021:3390481
   Boyd LM, 2006, EUR SPINE J, V15, pS414, DOI 10.1007/s00586-006-0172-2
   BROBERG KB, 1983, SPINE, V8, P151, DOI 10.1097/00007632-198303000-00006
   BUCKWALTER JA, 1989, J ORTHOP RES, V7, P146, DOI 10.1002/jor.1100070121
   Chang G, 2007, EUR SPINE J, V16, P1848, DOI 10.1007/s00586-007-0364-4
   Chang G, 2010, J BIOMED MATER RES A, V92A, P43, DOI 10.1002/jbm.a.32326
   Chen WH, 2006, J CELL PHYSIOL, V209, P744, DOI 10.1002/jcp.20765
   Cho H, 2011, EXP MOL MED, V43, P334, DOI 10.3858/emm.2011.43.6.036
   Chou CH, 2007, J BIOMED MATER RES A, V82A, P757, DOI 10.1002/bjm.a.31186
   Cloyd JM, 2007, EUR SPINE J, V16, P1892, DOI 10.1007/s00586-007-0443-6
   Diwan AD, 2000, ORTHOP CLIN N AM, V31, P453, DOI 10.1016/S0030-5898(05)70163-2
   Drury JL, 2003, BIOMATERIALS, V24, P4337, DOI 10.1016/S0142-9612(03)00340-5
   Eyrich D, 2007, BIOMATERIALS, V28, P55, DOI 10.1016/j.biomaterials.2006.08.027
   Eyrich D, 2006, ADV EXP MED BIOL, V585, P379
   Furderer S, 2002, ORTHOPADE, V31, P356, DOI 10.1007/s00132-001-0275-8
   Gorensek M, 2004, CELL MOL BIOL LETT, V9, P363
   Green T P, 1993, Eur Spine J, V2, P209, DOI 10.1007/BF00299448
   Gruber HE, 1997, MATRIX BIOL, V16, P285, DOI 10.1016/S0945-053X(97)90016-0
   Gruber HE, 1997, EXP CELL RES, V235, P13, DOI 10.1006/excr.1997.3647
   Gruber HE, 2006, BIOMATERIALS, V27, P371, DOI 10.1016/j.biomaterials.2005.06.032
   Gruber Helen E, 2004, Spine J, V4, P44, DOI 10.1016/S1529-9430(03)00425-X
   Hofmann S, 2006, TISSUE ENG, V12, P2729, DOI 10.1089/ten.2006.12.2729
   Hubbell JA, 2003, CURR OPIN BIOTECH, V14, P551, DOI 10.1016/j.copbio.2003.09.004
   HUMZAH MD, 1988, ANAT RECORD, V220, P337, DOI 10.1002/ar.1092200402
   Hutton WC, 2000, SPINE, V25, P2993, DOI 10.1097/00007632-200012010-00006
   Iatridis JC, 2005, J BIOMECH, V38, P557, DOI 10.1016/j.jbiomech.2004.03.038
   Kim AJ, 2010, OPEN TISSUE ENG REGE, V3, P28
   Kim HJ, 2005, BIOMATERIALS, V26, P4442, DOI 10.1016/j.biomaterials.2004.11.013
   Kim HJ, 2007, MACROMOL BIOSCI, V7, P643, DOI 10.1002/mabi.200700030
   Kluba T, 2005, SPINE, V30, P2743, DOI 10.1097/01.brs.0000192204.89160.6d
   Leung VYL, 2006, EUR SPINE J, V15, pS406, DOI 10.1007/s00586-006-0183-z
   Mandal BB, 2011, BIOMATERIALS, V32, P639, DOI 10.1016/j.biomaterials.2010.08.115
   Martin Michael D, 2002, Neurosurg Focus, V13, pE1
   Meinhart J, 1999, ANN PLAS SURG, V42, P673, DOI 10.1097/00000637-199906000-00016
   Mizuno H, 2006, BIOMATERIALS, V27, P362, DOI 10.1016/j.biomaterials.2005.06.042
   Mizuno H, 2004, SPINE, V29, P1290, DOI 10.1097/01.BRS.0000128264.46510.27
   Mwale F, 2004, Eur Cell Mater, V8, P58
   Mwale F, 2005, TISSUE ENG, V11, P130, DOI 10.1089/ten.2005.11.130
   Nesti LJ, 2008, TISSUE ENG PT A, V14, P1527, DOI 10.1089/ten.tea.2008.0215
   O'Halloran DM, 2007, TISSUE ENG, V13, P1927, DOI 10.1089/ten.2005.0608
   Park SH, 2009, ARTIF ORGANS, V33, P439, DOI 10.1111/j.1525-1594.2009.00744.x
   Park SH, 2005, ARTIF ORGANS, V29, P838, DOI 10.1111/j.1525-1594.2005.00137.x
   PARK SH, 2007, KEY ENG MATER, V342, P253
   Perka C, 2001, TISSUE ENG, V7, P359, DOI 10.1089/10763270152044215
   Perka C, 2000, CLIN EXP RHEUMATOL, V18, P13
   Pratsinis H, 2007, EUR SPINE J, V16, P1858, DOI 10.1007/s00586-007-0408-9
   Raghunath J, 2007, BIOTECHNOL APPL BIOC, V46, P73, DOI 10.1042/BA20060134
   Rajkhowa R, 2010, MACROMOL BIOSCI, V10, P599, DOI 10.1002/mabi.200900358
   Richardson SM, 2007, HISTOL HISTOPATHOL, V22, P1033, DOI 10.14670/HH-22.1033
   Richardson SM, 2008, CURR PAIN HEADACHE R, V12, P83, DOI 10.1007/s11916-008-0016-3
   Richardson SM, 2006, STEM CELLS, V24, P707, DOI 10.1634/stemcells.2005-0205
   ROBERTS S, 1991, SPINE, V16, P1030, DOI 10.1097/00007632-199109000-00003
   Rockwood DN, 2011, ACTA BIOMATER, V7, P144, DOI 10.1016/j.actbio.2010.07.020
   Rong Y, 2002, TISSUE ENG, V8, P1037, DOI 10.1089/107632702320934137
   Sakai D, 2006, BIOMATERIALS, V27, P346, DOI 10.1016/j.biomaterials.205.06.040
   Sakai D, 2003, BIOMATERIALS, V24, P3531, DOI 10.1016/S0142-9612(03)00222-9
   Sato Masato, 2003, J Biomed Mater Res A, V64, P248, DOI 10.1002/jbm.a.10287
   Schroeder Y, 2008, J ORTHOP RES, V26, P1141, DOI 10.1002/jor.20632
   Sebastine IM, 2007, P ANN INT IEEE EMBS, P6401
   Sha'ban M, 2008, J BIOMAT SCI-POLYM E, V19, P1219, DOI 10.1163/156856208785540163
   Shao XX, 2007, J BIOMED MATER RES A, V82A, P701, DOI 10.1002/bjm.a.31030
   Sive JI, 2002, J CLIN PATHOL-MOL PA, V55, P91
   Stern S, 2000, ACTA ORTHOP SCAND, V71, P496, DOI 10.1080/000164700317381207
   Sztrolovics R, 2002, J ORTHOPAED RES, V20, P257, DOI 10.1016/S0736-0266(01)00110-3
   THOMPSON JP, 1991, SPINE, V16, P253, DOI 10.1097/00007632-199103000-00001
   Urban JPG, 2003, ARTHRITIS RES THER, V5, P120, DOI 10.1186/ar629
   URBAN JPG, 1985, BIORHEOLOGY, V22, P145
   Wan YQ, 2008, BIOMATERIALS, V29, P643, DOI 10.1016/j.biomaterials.2007.10.031
   Watson D, 2010, AM J RHINOL ALLERGY, V24, pE19, DOI 10.2500/ajra.2010.24.3433
   WHITLEY CB, 1989, CLIN CHEM, V35, P374
   Yamaoka H, 2006, J BIOMED MATER RES A, V78A, P1, DOI 10.1002/jbm.a.30655
   Yoon DM, 2009, TISSUE ENG PT A, V15, P3449, DOI [10.1089/ten.tea.2009.0069, 10.1089/ten.TEA.2009.0069]
NR 75
TC 47
Z9 53
U1 4
U2 28
PU MARY ANN LIEBERT, INC
PI NEW ROCHELLE
PA 140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA
SN 1937-3341
J9 TISSUE ENG PT A
JI Tissue Eng. Part A
PD MAR
PY 2012
VL 18
IS 5-6
BP 447
EP 458
DI 10.1089/ten.tea.2011.0195
PG 12
WC Cell & Tissue Engineering; Biotechnology & Applied Microbiology; Cell
   Biology
SC Cell Biology; Biotechnology & Applied Microbiology
GA 901CQ
UT WOS:000300939700001
PM 21919790
OA Green Published
DA 2018-10-19
ER

PT J
AU Ghani, Y
   Coathup, MJ
   Hing, KA
   Blunn, GW
AF Ghani, Yaser
   Coathup, Melanie J.
   Hing, Karin A.
   Blunn, Gordon W.
TI Development of a hydroxyapatite coating containing silver for the
   prevention of peri-prosthetic infection
SO JOURNAL OF ORTHOPAEDIC RESEARCH
LA English
DT Article
DE infection; silver; hydroxyapatite coating; brushite; surface treatment;
   electrochemical deposition
ID IN-VITRO ANTIBACTERIAL; BRUSHITE COATINGS; TITANIUM; TRANSFORMATION;
   BIOMATERIAL; COMPONENTS; EFFICACY; SURFACE; ALLOYS; CELLS
AB We hypothesized that the electrochemical deposition of hydroxyapatite (EHA) can be used to incorporate silver (Ag), providing a controlled and sustained release of Ag ions at a bactericidal concentration. Six groups were investigated: electrochemical co-precipitation of HA and Ag (EHA/Ag); EHA pre-coated discs treated in AgN03 (EHA/AgN03); plasma sprayed HA (PHA) pre-coated discs treated in AgN03 (PHA/AgN03); EHA with 2 layers of Ag (EHA/Ag/2 layers); EHA coating only; and PHA coating only. Scanning electron microscopy (SEM) and energy dispersive X-ray (EDX) and X-ray diffraction (XRD) analyses quantified coating thickness, calcium/phosphorous ratio, and % atomic silver content, respectively. Inductively coupled plasma-mass spectrometry quantified the amount of Ag released in phosphate-buffered saline, and zone of inhibition tests on agar plates using a lawn of Staph aureus were quantified in each group. XRD and EDX analysis confirmed the presence of Ag in all coatings. EHA coated discs with two layers of Ag and the EHA discs soaked in AgN03 showed significantly higher zones of inhibition at all time points when compared with all other groups (except PHA/AgN03 on day 0). This study demonstrated that Ag ions can be incorporated into a HA coating using an electrochemical technique. (C) 2011 Orthopaedic Research Society Published by Wiley Periodicals, Inc. J Orthop Res 30:356363, 2012
C1 [Ghani, Yaser; Coathup, Melanie J.; Blunn, Gordon W.] Royal Natl Orthopaed Hosp Trust, Univ Coll London, John Scales Ctr Biomed Engn, Inst Orthopaed & Musculoskeletal Sci,Div Surg & I, Stanmore HA7 4LP, Middx, England.
   [Hing, Karin A.] Queen Mary Univ London, Sch Engn & Mat, Dept Mat, London E1 4NS, England.
   [Hing, Karin A.] Queen Mary Univ London, Sch Engn & Mat, IRC Biomed Mat, London E1 4NS, England.
RP Coathup, MJ (reprint author), Royal Natl Orthopaed Hosp Trust, Univ Coll London, John Scales Ctr Biomed Engn, Inst Orthopaed & Musculoskeletal Sci,Div Surg & I, Brockley Hill, Stanmore HA7 4LP, Middx, England.
EM m.coathup@ucl.ac.uk
FU Centre for Biomedical Engineering, UCL
FX This study was funded by the Centre for Biomedical Engineering, UCL. The
   study design, writing, and submission of this work were decided by the
   authors.
CR Bai XA, 2010, ACTA BIOMATER, V6, P2264, DOI 10.1016/j.actbio.2009.12.002
   BAUER TW, 1991, J BONE JOINT SURG AM, V73A, P1439, DOI 10.2106/00004623-199173100-00001
   Campbell AA, 2000, J BIOMED MATER RES, V53, P400, DOI 10.1002/1097-4636(2000)53:4<400::AID-JBM14>3.0.CO;2-Z
   Chen W, 2006, BIOMATERIALS, V27, P5512, DOI 10.1016/j.biomaterials.2006.07.003
   Clemens JAM, 1998, J BIOMED MATER RES, V40, P341, DOI 10.1002/(SICI)1097-4636(19980605)40:3<341::AID-JBM1>3.3.CO;2-V
   Da Silva MHP, 2001, SURF COAT TECH, V137, P270
   de la Riviere AB, 2000, J HEART VALVE DIS, V9, P123
   Dougherty SH, 1986, HDB BIOMATERIALS EVA, P276
   Garvin KL, 1992, T ORTHOP RES SOC, V17, P437
   Geesink RGT, 1993, ORTHOPEDIC SURG
   Geesink RGT, 1993, HYDROXYAPATITE COATI
   GRISTINA AG, 1987, SCIENCE, V237, P1588, DOI 10.1126/science.3629258
   Haddad FS, 2000, J BONE JOINT SURG BR, V82B, P807, DOI 10.1302/0301-620X.82B6.10486
   Hu C, 2007, APPL CATAL B-ENVIRON, V73, P345, DOI 10.1016/j.apcatb.2007.01.006
   Kim S, 2009, TOXICOL IN VITRO, V23, P1076, DOI 10.1016/j.tiv.2009.06.001
   Kumar M, 1999, J BIOMED MATER RES, V45, P302, DOI 10.1002/(SICI)1097-4636(19990615)45:4<302::AID-JBM4>3.0.CO;2-A
   Lansdown A B G, 2005, J Wound Care, V14, P155
   Lee IS, 2006, NUCL INSTRUM METH B, V242, P45, DOI 10.1016/j.nimb.2005.08.010
   Matsumoto N, 2009, ACTA BIOMATER, V5, P3157, DOI 10.1016/j.actbio.2009.04.010
   Norowski PA, 2009, J BIOMED MATER RES B, V88B, P530, DOI 10.1002/jbm.b.31152
   O'Sullivan C, 2010, J BIOMED MATER RES B, V95B, P141, DOI 10.1002/jbm.b.31694
   Parvizi J, 2004, CLIN ORTHOP RELAT R, P33, DOI 10.1097/01.blo.0000150116.65231.45
   PERRELLI G, 1992, SCI TOTAL ENVIRON, V120, P93, DOI 10.1016/0048-9697(92)90219-I
   Qu J, 2011, J BIOMED MATER RES B, V97B, P40, DOI 10.1002/jbm.b.31784
   Redepenning J, 1996, J BIOMED MATER RES, V30, P287
   REDEPENNING J, 1990, CHEM MATER, V2, P625, DOI 10.1021/cm00012a001
   Ruan HJ, 2009, CHINESE SCI BULL, V54, P4438, DOI 10.1007/s11434-009-0175-6
   Shi DL, 2002, J BIOMED MATER RES, V63, P71, DOI 10.1002/jbm.10087
   SHIRKHANZADEH M, 1995, MATER LETT, V24, P7, DOI 10.1016/0167-577X(95)00059-3
   Shirkhanzadeh M, 1998, J MATER SCI-MATER M, V9, P67, DOI 10.1023/A:1008838813120
   Shirkhanzadeh M, 1998, J MATER SCI-MATER M, V9, P385, DOI 10.1023/A:1013231529439
   Song WH, 2009, J BIOMED MATER RES A, V88A, P246, DOI 10.1002/jbm.a.31877
   Tweden KS, 1997, J HEART VALVE DIS, V6, P553
   Walenkamp GHIM, 1983, THESIS U NIJMEGEN NE
   WAN AT, 1991, CLIN CHEM, V37, P1683
   Wright JB, 1999, AM J INFECT CONTROL, V27, P344, DOI 10.1016/S0196-6553(99)70055-6
   Yamamoto A, 1998, J BIOMED MATER RES, V39, P331, DOI 10.1002/(SICI)1097-4636(199802)39:2<331::AID-JBM22>3.0.CO;2-E
   Yen SK, 2003, MATER CHEM PHYS, V77, P70, DOI 10.1016/S0254-0584(01)00562-4
   Zhitomirsky I, 2004, MATER LETT, V42, P262
   Zimmerli W, 2004, NEW ENGL J MED, V351, P1645, DOI 10.1056/NEJMra040181
NR 40
TC 16
Z9 19
U1 3
U2 29
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0736-0266
EI 1554-527X
J9 J ORTHOP RES
JI J. Orthop. Res.
PD MAR
PY 2012
VL 30
IS 3
BP 356
EP 363
DI 10.1002/jor.21543
PG 8
WC Orthopedics
SC Orthopedics
GA 879LG
UT WOS:000299330100004
PM 21901753
OA Bronze
DA 2018-10-19
ER

PT J
AU Farhadi, M
   Mirzadeh, H
   Solouk, A
   Asghari, A
   Jalessi, M
   Ghanbari, H
   Yazdanifard, P
AF Farhadi, Mohammad
   Mirzadeh, Hamid
   Solouk, Atefeh
   Asghari, Alimohamad
   Jalessi, Maryam
   Ghanbari, Hadi
   Yazdanifard, Parin
TI Collagen-immobilized patch for repairing small tympanic membrane
   perforations: In vitro and in vivo assays
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A
LA English
DT Article
DE tympanic membrane perforation; myringoplasty; collagen; polydimethyl
   siloxane
ID ACRYLIC-ACID; PAPER-PATCH; GRAFT; POLYDIMETHYLSILOXANE; TYMPANOPLASTY;
   MYRINGOPLASTY; POLYMERIZATION; RECONSTRUCTION; NANOCOMPOSITE;
   BIOMATERIALS
AB Tympanic membrane (TM) perforation is still one of the most common otology complications. New designs of biomaterials, and lately tissue-engineered composites and grafts, have thoroughly revolutionized the management of TM perforation. In this study, we examined a biologically modified collagen-immobilized polydimethyl siloxane patch to repair TM perforation. In vitro potential of the aforementioned patch as a scaffold to support fibroblast cell growth and adhesion was assessed. An in vivo assay of the patch for initiating repair of TM perforations also was investigated. In vitro assay showed that the patch has significantly increased cell adhesion and growth in comparison with unmodified ones (p < 0.05). In vivo study also showed an overall closure rate of TM perforation of 70% and an average gain of 15.75 +/- 4.29 dB in air-bone gap. This study shows that the preliminary in vivo evaluation of a modified siloxane patch in humans had promising results and is comparable to existing biomaterial patches. (C) 2011 Wiley Periodicals, Inc. J Biomed Mater Res Part A, 2012.
C1 [Mirzadeh, Hamid; Solouk, Atefeh; Asghari, Alimohamad] Amirkabir Univ Technol, Tehran Polytech, Fac Polymer Engn, Tehran, Iran.
   [Farhadi, Mohammad; Jalessi, Maryam; Ghanbari, Hadi; Yazdanifard, Parin] Univ Tehran Med Sci, Hazrat Rasoul Akram Hosp, ENT Head & Neck Res Ctr & Dept, Tehran, Iran.
RP Mirzadeh, H (reprint author), Amirkabir Univ Technol, Tehran Polytech, Fac Polymer Engn, Tehran, Iran.
EM mirzadeh@aut.ac.ir
RI Asghari, Alimohamad/C-8766-2012
OI Asghari, Alimohamad/0000-0002-9107-4309
FU Iran National Science Foundation, Tehran, Iran (The Collagen-Immobilized
   Siloxane Patch Preparation)
FX Contract grant sponsor: Iran National Science Foundation, Tehran, Iran
   (The Collagen-Immobilized Siloxane Patch Preparation)
CR Abbasi F, 2003, J POLYM SCI POL PHYS, V41, P2145, DOI 10.1002/polb.10559
   Abbasi F, 2001, POLYM INT, V50, P1279, DOI 10.1002/pi.783
   Aggarwal R, 2006, J LARYNGOLOTOL, V12, P429
   Garcia RB, 2011, ACTA OTORRINOLAR ESP, V62, P213, DOI 10.1016/j.otorri.2010.12.005
   Chen XW, 2010, CHINESE MED J-PEKING, V123, P301, DOI 10.3760/cma.j.issn.0366-6999.2010.03.009
   Demirpehlivan IA, 2011, EUR ARCH OTO-RHINO-L, V268, P471, DOI 10.1007/s00405-010-1473-y
   Deng ZH, 2009, TISSUE ENG PT A, V15, P3729, DOI [10.1089/ten.tea.2008.0460, 10.1089/ten.TEA.2008.0460]
   Dursun E, 2008, OTOLARYNG HEAD NECK, V138, P353, DOI 10.1016/j.otohns.2008.01.003
   Fishman AJ, 2005, OTOLARYNG HEAD NECK, V132, P906, DOI 10.1016/j.otohns.2004.12.013
   Ghassemifar R, 2010, J BIOMATER APPL, V24, P591, DOI 10.1177/0885328209104289
   GLASSCOCK ME, 1977, OTOLARYNG CLIN N AM, V10, P469
   Harvinder S, 2005, Med J Malaysia, V60, P585
   Karkhaneh A, 2007, J APPL POLYM SCI, V105, P2208, DOI 10.1002/app.26216
   Karkhaneh A, 2011, BRIT J OPHTHALMOL, V95, P405, DOI 10.1136/bjo.2009.178632
   Keshvari H, 2008, IRAN POLYM J, V17, P171
   Kim JH, 2010, TISSUE ENG PT A, V16, P225, DOI [10.1089/ten.tea.2009.0476, 10.1089/ten.TEA.2009.0476]
   Kim JH, 2009, J BIOMED MATER RES A, V90A, P446, DOI 10.1002/jbm.a.32119
   Kim J, 2010, WOUND REPAIR REGEN, V18, P132, DOI 10.1111/j.1524-475X.2009.00565.x
   Lai P, 2006, INT J PEDIATR OTORHI, V70, P1423, DOI 10.1016/j.ijporl.2006.02.012
   Laidlaw DW, 2001, LARYNGOSCOPE, V111, P702, DOI 10.1097/00005537-200104000-00025
   Lee SD, 1996, BIOMATERIALS, V17, P1599, DOI 10.1016/0142-9612(95)00316-9
   Levin B, 2010, OTOLARYNG HEAD NECK, V142, pS33, DOI 10.1016/j.otohns.2009.06.746
   Losi P, 2010, BIOMATERIALS, V31, P5336, DOI 10.1016/j.biomaterials.2010.03.033
   Mudry A, 2008, OTOLARYNG HEAD NECK, V139, P613, DOI 10.1016/j.otohns.2008.07.014
   Norman JJ, 2005, TISSUE ENG, V11, P378, DOI 10.1089/ten.2005.11.378
   Parvin A, 2008, J APPL POLYM SCI, V107, P2343, DOI 10.1002/app.27281
   Raj A, 2011, AM J OTOLARYNG, V32, P96, DOI 10.1016/j.amjoto.2009.10.007
   Sapci Tarik, 2006, Kulak Burun Bogaz Ihtis Derg, V16, P255
   SHEEHY JL, 1980, ANN OTO RHINOL LARYN, V89, P331, DOI 10.1177/000348948008900407
   Solouk Atefeh, 2011, Iranian Biomedical Journal, V15, P6
   Solouk A, 2011, IRAN POLYM J, V20, P91
   Tringali S, 2008, Ann Otolaryngol Chir Cervicofac, V125, P261, DOI 10.1016/j.aorl.2008.01.005
   Wang YZ, 2006, BIOMATERIALS, V27, P6064, DOI 10.1016/j.biomaterials.2006.07.008
NR 33
TC 12
Z9 13
U1 0
U2 12
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1549-3296
J9 J BIOMED MATER RES A
JI J. Biomed. Mater. Res. Part A
PD MAR
PY 2012
VL 100A
IS 3
BP 549
EP 553
DI 10.1002/jbm.a.33293
PG 5
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 880NP
UT WOS:000299414400002
PM 22162221
DA 2018-10-19
ER

PT J
AU Ovod, V
   Scott, EA
   Flake, MM
   Parker, SR
   Bateman, RJ
   Elbert, DL
AF Ovod, Vitaliy
   Scott, Evan A.
   Flake, Megan M.
   Parker, Stanley R.
   Bateman, Randall J.
   Elbert, Donald L.
TI Exposure of the lysine in the gamma chain dodecapeptide of human
   fibrinogen is not enhanced by adsorption to poly(ethylene terephthalate)
   as measured by biotinylation and mass spectrometry
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A
LA English
DT Article
DE fibrinogen; protein adsorption; mass spectrometry; conformational
   change; gamma chain dodecapeptide; biomaterial; poly(ethylene
   terephthalate)
ID ATOMIC-FORCE MICROSCOPY; PLATELET-ADHESION; CONFORMATIONAL-CHANGES;
   ADSORBED FIBRINOGEN; IMMOBILIZED FIBRINOGEN; COMPETITIVE BEHAVIOR;
   MONOCLONAL-ANTIBODY; RELAXATION KINETICS; BINDING-SITE; C-DOMAIN
AB Conformational changes in adsorbed fibrinogen may enhance the exposure of platelet adhesive sites that are inaccessible in solution. To test this hypothesis, mass spectrometric methods were developed to quantify chemical modification of lysine residues following adsorption of fibrinogen to biomaterials. The quantitative method used an internal standard consisting of isotope-labeled fibrinogen secreted by human HepG2 cells in culture. Lysine residues in the internal standard were partially reacted with NHS-biotin. For the experimental samples, normal human fibrinogen was adsorbed to poly(ethylene terephthalate) (PET) particles. The adsorbed fibrinogen was reacted with NHS-biotin and then eluted from the particles. Constant amounts of internal standard were added to sample fibrinogen and analyzed by liquid chromatography/tandem mass spectrometry. Biotinylation of the lysine residue in the platelet-adhesive gamma chain dodecapeptide (GCDP) was quantified by comparison with the internal standard. Approximately 80% of the GCDP peptides were biotinylated when fibrinogen was reacted with NHS-biotin in solution or adsorbed onto PET. These results are generally consistent with previous antibody binding studies and suggest that other regions of fibrinogen may be crucial in promoting platelet adhesion to materials. The results do not directly address but are consistent with the hypothesis that only activated platelets adhere to adsorbed fibrinogen. (C) 2011 Wiley Periodicals, Inc. J Biomed Mater Res Part A, 2012.
C1 [Ovod, Vitaliy; Scott, Evan A.; Flake, Megan M.; Parker, Stanley R.; Elbert, Donald L.] Washington Univ, Dept Biomed Engn, St Louis, MO 63130 USA.
   [Ovod, Vitaliy; Scott, Evan A.; Flake, Megan M.; Parker, Stanley R.; Elbert, Donald L.] Washington Univ, Ctr Mat Innovat, St Louis, MO USA.
   [Ovod, Vitaliy; Bateman, Randall J.] Washington Univ, Sch Med, Dept Neurol, Hope Ctr Neurol Disorders, St Louis, MO 63110 USA.
   [Ovod, Vitaliy; Bateman, Randall J.] Washington Univ, Sch Med, Alzheimers Dis Res Ctr, St Louis, MO USA.
RP Elbert, DL (reprint author), Washington Univ, Dept Biomed Engn, St Louis, MO 63130 USA.
EM elbert@biomed.wustl.edu
RI Elbert, Donald/B-2040-2008
OI Elbert, Donald/0000-0001-6480-9536; Bateman,
   Randall/0000-0002-7729-1702; Scott, Evan/0000-0002-8945-2892
FU NIH [R21 HL090744, K23 AG030946]
FX Contract grant sponsor: NIH; contract grant numbers: R21 HL090744, K23
   AG030946
CR Agnihotri A, 2004, LANGMUIR, V20, P8846, DOI 10.1021/la049239
   Azim-Zadeh O, 2007, J BIOL CHEM, V282, P21609, DOI 10.1074/jbc.M610921200
   Balasubramanian V, 1999, J BIOMED MATER RES, V44, P253, DOI 10.1002/(SICI)1097-4636(19990305)44:3<253::AID-JBM3>3.0.CO;2-K
   Randall JB, 2006, NAT MED, V12, P856, DOI 10.1038/nm1438
   Bonnefoy A, 2000, BIOPHYS J, V78, P2834, DOI 10.1016/S0006-3495(00)76826-3
   Bonnefoy A, 2001, ANN NY ACAD SCI, V936, P459
   Bowley SR, 2009, BIOCHEMISTRY-US, V48, P8656, DOI 10.1021/bi900239b
   Clarke ML, 2005, J PHYS CHEM B, V109, P22027, DOI 10.1021/jp054456k
   Elbert DL, 2008, J PROTEOME RES, V7, P4546, DOI 10.1021/pr800386u
   FARRELL DH, 1992, P NATL ACAD SCI USA, V89, P10729, DOI 10.1073/pnas.89.22.10729
   Fears KP, 2009, LANGMUIR, V25, P9319, DOI 10.1021/la901885d
   Grunkemeier J, 1996, J BIOMAT SCI-POLYM E, V8, P189, DOI 10.1163/156856296X00246
   HORBETT TA, 1994, J BIOMAT SCI-POLYM E, V6, P15, DOI 10.1163/156856295X00724
   Hylton DM, 2005, J BIOMED MATER RES A, V73A, P349, DOI 10.1002/jbm.a.30295
   Kollman JM, 2009, BIOCHEMISTRY-US, V48, P3877, DOI 10.1021/bi802205g
   LINDON JN, 1986, BLOOD, V68, P355
   Lishko VK, 2002, BIOCHEMISTRY-US, V41, P12942, DOI 10.1021/bi026324c
   Moskowitz KA, 1998, THROMB HAEMOSTASIS, V79, P824
   NICODEME E, 1995, ARTERIOSCL THROM VAS, V15, P1660, DOI 10.1161/01.ATV.15.10.1660
   Pandi L, 2009, BIOCHEMISTRY-US, V48, P7201, DOI 10.1021/bi900647g
   Podolnikova NP, 2003, J BIOL CHEM, V278, P32251, DOI 10.1074/jbc.M300410200
   RAMSDEN JJ, 1993, PHYS REV LETT, V71, P295, DOI 10.1103/PhysRevLett.71.295
   SAVAGE B, 1991, J BIOL CHEM, V266, P11227
   Scott EA, 2007, BIOMATERIALS, V28, P3904, DOI 10.1016/j.biomaterials.2007.05.022
   SHIBA E, 1991, AM J PHYSIOL, V260, pC965
   Sinz A, 2003, J MASS SPECTROM, V38, P1225, DOI 10.1002/JMS.559
   Sit PS, 1999, THROMB HAEMOSTASIS, V82, P1053
   Soman P, 2008, LANGMUIR, V24, P8801, DOI 10.1021/la801227e
   Tsai WB, 1999, J BIOMED MATER RES, V44, P130, DOI 10.1002/(SICI)1097-4636(199902)44:2<130::AID-JBM2>3.0.CO;2-9
   Tunc S, 2005, COLLOID SURFACE B, V42, P219, DOI 10.1016/j.colsurfb.2005.03.004
   Wertz CF, 1999, LANGMUIR, V15, P8884, DOI 10.1021/la990089q
   Wertz CF, 2001, LANGMUIR, V17, P3006, DOI 10.1021/la0017781
   Xia N, 2003, J BIOMED MATER RES A, V67A, P179, DOI 10.1002/jbm.a.10063
NR 33
TC 3
Z9 3
U1 0
U2 10
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1549-3296
EI 1552-4965
J9 J BIOMED MATER RES A
JI J. Biomed. Mater. Res. Part A
PD MAR
PY 2012
VL 100A
IS 3
BP 622
EP 631
DI 10.1002/jbm.a.33285
PG 10
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 880NP
UT WOS:000299414400010
PM 22213354
OA Green Accepted
DA 2018-10-19
ER

PT J
AU Walkowiak-Przybylo, M
   Klimek, L
   Okroj, W
   Jakubowski, W
   Chwilka, M
   Czajka, A
   Walkowiak, B
AF Walkowiak-Przybylo, M.
   Klimek, L.
   Okroj, W.
   Jakubowski, W.
   Chwilka, M.
   Czajka, A.
   Walkowiak, B.
TI Adhesion, activation, and aggregation of blood platelets and biofilm
   formation on the surfaces of titanium alloys Ti6Al4V and Ti6Al7Nb
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A
LA English
DT Article
DE titanium alloys; biocompatibility; platelet adhesion; platelet
   activation; bacterial colonization
ID BIOMATERIALS; FIBRINOGEN; MECHANISMS; ADSORPTION; IMPLANTS; BEHAVIOR;
   ALBUMIN; METALS; MODEL; FLOW
AB Titanium alloys are still on the top list of fundamental materials intended for dental, orthopedics, neurological, and cardiovascular implantations. Recently, a special attention has been paid to vanadium-free titanium alloy, Ti6Al7Nb, that seems to represent higher biocompatibility than traditional Ti6Al4V alloy. Surprisingly, these data are not thoroughly elaborated in the literature; particularly there is a lack of comparative experiments conducted simultaneously and at the same conditions. Our study fills these shortcomings in the field of blood contact and microbiological colonization. To observe platelets adhesion and biofilm formation on the surfaces of compared titanium alloys, fluorescence microscope Olympus GX71 and scanning electron microscope HITACHI S-3000N were used. Additionally, flow cytometry analysis of platelets aggregation and activation in the whole blood after contact with sample surface, as an essential tool for biomaterial thrombocompatibility assessment, was proposed. As a result of our study it was demonstrated that polished surfaces of Ti6Al7Nb and Ti6Al4V alloys after contact with whole citrated blood and E. coli bacterial cells exhibit a considerable difference. Overall, it was established that Ti6Al4V has distinct tendency to higher thrombogenicity, more excessive bacterial biofilm formation and notable cytotoxic properties in comparison to Ti6Al7Nb. However, we suggest these studies should be extended for other types of cells and biological objects. (C) 2012 Wiley Periodicals, Inc. J Biomed Mater Res Part A, 2012.
C1 [Walkowiak-Przybylo, M.; Klimek, L.] Tech Univ Lodz, Dept Mat Res, PL-90924 Lodz, Poland.
   [Klimek, L.] Med Univ Lodz, Dept Dent Tech, PL-92231 Lodz, Poland.
   [Okroj, W.; Jakubowski, W.; Chwilka, M.; Czajka, A.; Walkowiak, B.] Tech Univ Lodz, Dept Biophys, PL-90924 Lodz, Poland.
RP Walkowiak-Przybylo, M (reprint author), Tech Univ Lodz, Dept Mat Res, Stefanowskiego 1-15, PL-90924 Lodz, Poland.
EM mmwalkowiak@wp.pl
RI Jakubowski, Witold/S-1137-2018; Klimek, Leszek/K-5958-2015
OI Jakubowski, Witold/0000-0003-1751-609X; Klimek,
   Leszek/0000-0003-3617-8225; Walkowiak, Bogdan/0000-0003-4867-5456
FU mnt-era.net DIAHAP
FX Contract grant sponsor: mnt-era.net DIAHAP
CR [Anonymous], 10993 EN ISO
   Chin MYH, 2007, BIOMATERIALS, V28, P2032, DOI 10.1016/j.biomaterials.2006.12.014
   Colman RW, 2006, HEMOSTASIS THROMBOSI, P17
   Devine DM, 2009, EUR CELLS MATER, V18, P40, DOI 10.22203/eCM.v018a04
   DION I, 1993, BIOMATERIALS, V14, P122, DOI 10.1016/0142-9612(93)90222-N
   Eliades T, 1997, INT J ORAL MAX IMPL, V12, P621
   Goodman SL, 1999, J BIOMED MATER RES, V45, P240, DOI 10.1002/(SICI)1097-4636(19990605)45:3<240::AID-JBM12>3.3.CO;2-3
   Harris LG, 2007, J MATER SCI-MATER M, V18, P1151, DOI 10.1007/s10856-007-0143-0
   Hong J, 1999, THROMB HAEMOSTASIS, V82, P58
   Jakubowski W, 2008, ADV APPL CERAM, V107, P217, DOI 10.1179/174367608X263395
   Kao WJ, 1999, J MATER SCI-MATER M, V10, P601, DOI 10.1023/A:1008971222932
   Khan MA, 1999, BIOMATERIALS, V20, P631, DOI 10.1016/S0142-9612(98)00217-8
   Khan Muhammad Shoaib, 2008, J Ayub Med Coll Abbottabad, V20, P23
   Kumar TRS, 2002, J MATER SCI-MATER M, V13, P751, DOI 10.1023/A:1016162706391
   LEE JH, 2001, WATER BIOMATERIALS S, P127
   Lukomska-Szymanska M, 2009, DENT MED PROBL, V46, P424
   Michelson AD, 2000, METHODS, V21, P259, DOI 10.1006/meth.2000.1006
   Ngwa HA, 2009, TOXICOL APPL PHARM, V240, P273, DOI 10.1016/j.taap.2009.07.025
   Nonckreman CJ, 2010, COLLOID SURFACE B, V77, P139, DOI 10.1016/j.colsurfb.2010.01.014
   Okroj W, 2006, DIAM RELAT MATER, V15, P1535, DOI 10.1016/j.diamond.2005.12.033
   Okroj W, 2005, ENG BIOMATERIALS, V43/44, P13
   Okroj W, 2009, ACTA BIOENG BIOMECH, V11, P45
   Paszenda Z., 2010, J ACHIEV MAT MANUFAC, V38, P24
   Schierholz JM, 2001, J HOSP INFECT, V49, P87, DOI 10.1053/jhin.2001.1052
   SHARMA NC, 1981, P NATL ACAD SCI-BIOL, V78, P7750, DOI 10.1073/pnas.78.12.7750
   Steinemann S. G., 1996, Injury, V27, pSC16
   Takami J, 1998, ARTIF ORGANS, V22, P753
   Tanaka Y, 2009, J ARTIF ORGANS, V12, P182, DOI 10.1007/s10047-009-0468-1
   Tran H.A.M., 2006, HEMOSTASIS THROMBOSI, P1673
   Truong C. Ta., 1998, LANGMUIR, V14, P2435
   Venkataraman B.V., 2005, ASIAN J EXP SCI, V19, P127
   Williams DF, 2008, BIOMATERIALS, V29, P2941, DOI 10.1016/j.biomaterials.2008.04.023
   Wu YG, 2005, J BIOMED MATER RES A, V74A, P722, DOI 10.1002/jbm.a.30381
   Yamano S, 2010, CLIN ORAL IMPLANT RE, P1
NR 34
TC 9
Z9 9
U1 0
U2 26
PU WILEY-BLACKWELL
PI MALDEN
PA COMMERCE PLACE, 350 MAIN ST, MALDEN 02148, MA USA
SN 1549-3296
J9 J BIOMED MATER RES A
JI J. Biomed. Mater. Res. Part A
PD MAR
PY 2012
VL 100A
IS 3
BP 768
EP 775
DI 10.1002/jbm.a.34006
PG 8
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 880NP
UT WOS:000299414400025
PM 22238248
DA 2018-10-19
ER

PT J
AU Chin, LK
   Calabro, A
   Walker, E
   Derwin, KA
AF Chin, LiKang
   Calabro, Anthony
   Walker, Esteban
   Derwin, Kathleen A.
TI Mechanical properties of tyramine substituted-hyaluronan enriched fascia
   extracellular matrix
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A
LA English
DT Article
DE extracellular matrix (ECM); hyaluronan; hyaluronic acid; mechanical
   properties; biocompatibility; tendon
ID ROTATOR CUFF TEARS; TISSUE RECONSTRUCTION; ACHILLES-TENDON; IN-VITRO;
   TENSILE; REPAIR; BIOMATERIALS; DEGENERATION; RELAXATION; SUBMUCOSA
AB Naturally occurring biomaterial scaffolds derived from extracellular matrix (ECM) have been the topic of recent investigation in the context of rotator cuff tendon repair. We previously reported a method to treat fascia ECM with high molecular weight tyramine substituted-hyaluronan (TS-HA) for use as a tendon augmentation scaffold. The presence of crosslinked TS-HA in fascia was associated with an increased macrophage and giant cell response compared to water-treated controls after implantation in a rat abdominal wall model. The objective of this study was to determine the extent to which TS-HA treatment was associated with mechanical property changes of fascia after implantation in the rat model. Fascia samples in all groups demonstrated time-dependent decreases in mechanical properties. TS-HA-treated fascia with crosslinking exhibited a lower toe modulus, a trend toward lower toe stiffness, and a higher transition strain than water-treated controls not only after implantation, but also at time zero. TS-HA treatment, with or without crosslinking, had no significant effect on time-zero or post-implantation load relaxation ratio, load relaxation rate, linear-region stiffness, or linear-region modulus. Our findings demonstrated that the particular TS-HA treatment employed in this study decreased the low-load elastic mechanical properties of fascia ECM, in keeping with the heightened macrophage and giant cell host response seen previously. This work provides a starting point and guidance for investigating alternative HA treatment strategies. (C) 2012 Wiley Periodicals, Inc. J Biomed Mater Res Part A, 2012.
C1 [Chin, LiKang; Calabro, Anthony; Derwin, Kathleen A.] Cleveland Clin, Dept Biomed Engn, Lerner Res Inst, Cleveland, OH 44106 USA.
   [Chin, LiKang] Case Western Reserve Univ, Dept Biomed Engn, Cleveland, OH 44106 USA.
   [Walker, Esteban] Cleveland Clin, Dept Quantitat Hlth Sci, Cleveland, OH 44106 USA.
   [Chin, LiKang; Calabro, Anthony; Derwin, Kathleen A.] Cleveland Clin, Orthoped Res Ctr, Cleveland, OH 44106 USA.
RP Derwin, KA (reprint author), Cleveland Clin, Dept Biomed Engn, Lerner Res Inst, Cleveland, OH 44106 USA.
EM derwink@ccf.org
FU National Institutes of Health [R01AR056633, F31AR057305, T32AR50959];
   Ohio Third Frontier [BRTT05-30]
FX Contract grant sponsor: National Institutes of Health; contract grant
   numbers: R01AR056633, F31AR057305, T32AR50959; Contract grant sponsor:
   Ohio Third Frontier; contract grant number: BRTT05-30
CR Anderson JM, 2008, SEMIN IMMUNOL, V20, P86, DOI 10.1016/j.smim.2007.11.004
   Arnoczky SP, 2007, AM J SPORT MED, V35, P763, DOI 10.1177/0363546506296043
   Atkinson TS, 1999, J BIOMECH, V32, P907, DOI 10.1016/S0021-9290(99)00089-5
   Aurora A, 2011, J BIOMED MATER RES A, V99A, P221, DOI 10.1002/jbm.a.33179
   Badylak S, 2002, J SURG RES, V103, P190, DOI 10.1006/jsre.2001.6349
   Badylak SE, 2002, SEMIN CELL DEV BIOL, V13, P377, DOI 10.1016/S1084-9521(02)00094-0
   Brown BN, 2009, BIOMATERIALS, V30, P1482, DOI 10.1016/j.biomaterials.2008.11.040
   Cantor Jerome O., 2006, Inflammation & Allergy Drug Targets, V5, P257, DOI 10.2174/187152806779010936
   Cheung JT, 2011, MED ENG PHYS, V28, P379
   Chin LK, 2011, J MATER SCI-MATER M, V22, P1465, DOI 10.1007/s10856-011-4325-4
   Clavert P, 2001, SURG RADIOL ANAT, V23, P259, DOI 10.1007/s00276-001-0259-8
   Cofield RH, 2001, J BONE JOINT SURG AM, V83A, P71, DOI 10.2106/00004623-200101000-00010
   Colombat M, 2008, EUR RESPIR J, V32, P1399, DOI 10.1183/09031936.00132007
   COMPER WD, 1978, PHYSIOL REV, V58, P255
   Cook JL, 2008, AM J VET RES, V69, P148, DOI 10.2460/ajvr.69.1.148
   Darr A, 2009, J MATER SCI-MATER M, V20, P33, DOI 10.1007/s10856-008-3540-0
   Day AJ, 2005, TRENDS IMMUNOL, V26, P637, DOI 10.1016/j.it.2005.09.009
   Derwin KA, 2008, J BIOMED MATER RES A, V84A, P500, DOI 10.1002/jbm.a.31455
   Duenwald SE, 2009, ANN BIOMED ENG, V37, P1131, DOI 10.1007/s10439-009-9687-0
   Eshel H, 2001, ANN BIOMED ENG, V29, P164, DOI 10.1114/1.1349697
   FLATOW EL, 2002, T ORTHOP RES SOC, V27, P621
   Goutallier D, 2003, J SHOULDER ELB SURG, V12, P550, DOI 10.1016/S1058-2746(03)00211-8
   Hansen KA, 2002, J BIOMECH ENG-T ASME, V124, P72, DOI 10.1115/1.1427698
   Hodde J, 2006, ANZ J SURG, V76, P1096, DOI 10.1111/j.1445-2197.2006.03948.x
   Huang HJ, 2011, CLIN BIOMECH, V26, P419, DOI 10.1016/j.clinbiomech.2010.12.006
   Iannotti JP, 1994, J AM ACAD ORTHOP SUR, V2, P87
   Lake SP, 2009, J ORTHOP RES, V27, P1596, DOI 10.1002/jor.20938
   Leigh DR, J ORTHOP RES, DOI [10.1002/jor.21529, DOI 10.1002/J0R.21529]
   Leitschuh PH, 1996, J ORTHOPAED RES, V14, P830, DOI 10.1002/jor.1100140522
   Lin TW, 2005, J BIOMECH, V38, P99, DOI 10.1016/j.jbiomech.2004.03.008
   MacLauchlan S, 2009, J LEUKOCYTE BIOL, V85, P617, DOI 10.1189/jlb.1008588
   McDevitt CA, 2003, J BIOMED MATER RES A, V67A, P637, DOI 10.1002/jbm.a.10144
   MILGROM C, 1995, J BONE JOINT SURG BR, V77B, P296
   Ng BH, 2005, P I MECH ENG H, V219, P349, DOI 10.1243/095441105X34239
   Noble PW, 2002, MATRIX BIOL, V21, P25, DOI 10.1016/S0945-053X(01)00184-6
   Reing JE, 2009, TISSUE ENG PT A, V15, P605, DOI 10.1089/ten.tea.2007.0425
   RILEY GP, 1994, ANN RHEUM DIS, V53, P359, DOI 10.1136/ard.53.6.359
   ROBERTS JM, 1983, CLIN ORTHOP RELAT R, P244
   Tammi MI, 2002, J BIOL CHEM, V277, P4581, DOI 10.1074/jbc.R100037200
   Tempelhof S, 1999, J SHOULDER ELB SURG, V8, P296, DOI 10.1016/S1058-2746(99)90148-9
   THOMAS E D, 1963, Surg Forum, V14, P442
   Thomopoulos S, 2002, J SHOULDER ELB SURG, V11, P239, DOI 10.1067/mse.2002.122228
   TOOLE BP, 1971, DEV BIOL, V25, P57, DOI 10.1016/0012-1606(71)90019-4
   Uhthoff Hans K, 2003, J Orthop Sci, V8, P449, DOI 10.1007/s10776-002-0624-5
   Valentin JE, 2006, J BONE JOINT SURG AM, V88A, P2673, DOI 10.2106/JBJS.E.01008
   Walter AJ, 2003, J UROLOGY, V169, P1907, DOI 10.1097/01.ju.0000061180.21353.a5
   Webster NL, 2006, J LEUKOCYTE BIOL, V80, P1052, DOI 10.1189/jlb0306152
   WOO SLY, 1986, J BIOMECH, V19, P399, DOI 10.1016/0021-9290(86)90016-3
   WOO SLY, 2000, ORTHOPAEDIC BASIC SC, P581
   Yildirim Y, 2006, FOOT ANKLE INT, V27, P121, DOI 10.1177/107110070602700209
NR 50
TC 10
Z9 10
U1 1
U2 7
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1549-3296
EI 1552-4965
J9 J BIOMED MATER RES A
JI J. Biomed. Mater. Res. Part A
PD MAR
PY 2012
VL 100A
IS 3
BP 786
EP 793
DI 10.1002/jbm.a.34025
PG 8
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 880NP
UT WOS:000299414400027
PM 22238019
OA Green Accepted
DA 2018-10-19
ER

PT J
AU Monick, MM
   Beach, SRH
   Plume, J
   Sears, R
   Gerrard, M
   Brody, GH
   Philibert, RA
AF Monick, Martha M.
   Beach, Steven R. H.
   Plume, Jeff
   Sears, Rory
   Gerrard, Meg
   Brody, Gene H.
   Philibert, Robert A.
TI Coordinated changes in AHRR methylation in lymphoblasts and pulmonary
   macrophages from smokers
SO AMERICAN JOURNAL OF MEDICAL GENETICS PART B-NEUROPSYCHIATRIC GENETICS
LA English
DT Article
DE smoking; methylation; epigenetics; AHRR
ID ARYL-HYDROCARBON RECEPTOR; EPIGENETIC REGULATION; GENE-EXPRESSION;
   SMOKING; BLOOD; TRANSCRIPTION; DISCOVERY; PATHWAYS; CANCER; TUMORS
AB Smoking is associated with a wide variety of adverse health outcomes including cancer, chronic obstructive pulmonary disease, diabetes, depression, and heart disease. Unfortunately, the molecular mechanisms through which these effects are conveyed are not clearly understood. To examine the potential role of epigenetic factors in these processes, we examined the relationship of smoking to genome wide methylation and gene expression using biomaterial from two independent samples, lymphoblast DNA and RNA (n=119) and lung alveolar macrophage DNA (n=19). We found that in both samples current smoking status was associated with significant changes in DNA methylation, in particular at the aryl hydrocarbon receptor repressor (AHRR), a known tumor suppressor. Both baseline DNA methylation and smoker associated DNA methylation signatures at AHRR were highly correlated (r=0.94 and 0.45, respectively). DNA methylation at the most differentially methylated AHRR CpG residue in both samples, cg0557592, was significantly associated with AHRR gene expression. Pathway analysis of lymphoblast data (genes with most significant methylation changes) demonstrated enrichment in protein kinase C pathways and in TGF beta signaling pathways. For alveolar macrophages, pathway analysis demonstrated alterations in inflammation-related processes. We conclude that smoking is associated with functionally significant genome wide changes in DNA methylation in both lymphoblasts and pulmonary macrophages and that further integrated investigations of these epigenetic effects of smoking on carcinogenesis and other related co-morbidities are indicated. (C) 2012 Wiley Periodicals, Inc.
C1 [Plume, Jeff; Philibert, Robert A.] Univ Iowa, Neurosci Program, Iowa City, IA USA.
   [Plume, Jeff; Philibert, Robert A.] Univ Iowa, Genet Program, Iowa City, IA USA.
   [Beach, Steven R. H.; Plume, Jeff; Brody, Gene H.; Philibert, Robert A.] Univ Georgia, Athens, GA 30602 USA.
   [Gerrard, Meg] Dartmouth Med Sch, Dept Psychiat, Lebanon, NH USA.
   [Philibert, Robert A.] Univ Iowa, Dept Psychiat, Iowa City, IA 52242 USA.
   [Monick, Martha M.; Sears, Rory] Univ Iowa, Dept Med, Iowa City, IA 52242 USA.
RP Philibert, RA (reprint author), Rm 2-126 MEB Psychiat Res MEB, Iowa City, IA 52242 USA.
EM robert-philibert@uiowa.edu
FU National Institute on Drug Abuse [P30 DA027827, NIH RO1 HL096625, NIH
   R21HL109589, DA015789, MH080898, UL1RR024979]; National Center for
   Research Resources, NCRR) [NIH RO1 HL096625, NIH R21HL109589,
   UL1RR024979]; Center for Contextual Genetics and Prevention Science [P30
   DA027827];  [DA021898];  [DA018871]
FX Grant sponsor: National Institute on Drug Abuse; Grant number: P30
   DA027827, NIH RO1 HL096625, NIH R21HL109589, DA015789, MH080898, and
   UL1RR024979.; The work in this study was supported by DA015789 and
   MH080898 to Dr. Philibert and DA021898 and DA018871 to Dr. Gerrard. This
   work was also supported by NIH RO1 HL096625 and NIH R21HL109589 to M. M
   (Grant Number UL1RR024979 from the National Center for Research
   Resources, NCRR). Additional support for these studies was derived from
   the Center for Contextual Genetics and Prevention Science (Grant Number
   P30 DA027827, GB) funded by the National Institute on Drug Abuse. The
   University of Iowa has filed intellectual property right claims on some
   of the material related to this manuscript on behalf of Dr. Philibert.
   The content is solely the responsibility of the authors and does not
   necessarily represent the official views of the National Institutes of
   Health.
CR Andersson P, 2002, P NATL ACAD SCI USA, V99, P9990, DOI 10.1073/pnas.152906299
   BENJAMINI Y, 1995, J ROY STAT SOC B MET, V57, P289
   Breitling LP, 2011, AM J HUM GENET, V88, P450, DOI 10.1016/j.ajhg.2011.03.003
   BUCHOLZ KK, 1994, J STUD ALCOHOL, V55, P149, DOI 10.15288/jsa.1994.55.149
   CAPUTO JL, 1991, J TISSUE CULTURE MET, V13, P39
   *CDC, 2005, MMWR-MORBID MORTAL W, V54, P625
   Chahrour M, 2007, NEURON, V56, P422, DOI 10.1016/j.neuron.2007.10.001
   Chang HSW, 2004, CANCER, V101, P125, DOI 10.1002/cncr.20323
   Davis WW, 2010, TRENDS SMOKING PREVA
   Dindot SV, 2009, GENOME RES, V19, P1374, DOI 10.1101/gr.089185.108
   Farthing CR, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000116
   Fleiss JL, 1981, STAT METHODS RATES P
   Grafodatskaya D, 2009, GENOMICS, V95, P73
   Gumus ZH, 2008, CANCER PREV RES, V1, P100, DOI 10.1158/1940-6207.CAPR-08-0007
   Gurrieri F, 2009, ENDOCRIN DEV, V14, P20, DOI 10.1159/000207473
   Haarmann-Stemmann T, 2007, DRUG METAB DISPOS, V35, P2262, DOI 10.1124/dmd.107.016253
   Heintzman ND, 2009, NATURE, V459, P108, DOI 10.1038/nature07829
   Kharchenko PV, 2010, NATURE, V471, P480
   King Brian, 2011, Morbidity and Mortality Weekly Report, V60, P1207
   Kohler BA, 2011, J NATL CANCER I, V103, P714, DOI 10.1093/jnci/djr077
   Launay JM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007959
   Lewinski A, 2007, NEUROENDOCRINOL LETT, V28, P77
   Martey CA, 2005, AM J PHYSIOL-LUNG C, V289, pL391, DOI 10.1152/ajplung.00062.2005
   Meek MD, 1999, ENVIRON RES, V80, P9, DOI 10.1006/enrs.1998.3872
   Monick MM, 2008, J IMMUNOL, V180, P7485, DOI 10.4049/jimmunol.180.11.7485
   Monick MM, 2006, J IMMUNOL, V177, P1636, DOI 10.4049/jimmunol.177.3.1636
   Monick MM, 2010, J IMMUNOL, V185, P5425, DOI 10.4049/jimmunol.1001603
   Opitz CA, 2011, NATURE, V478, P197, DOI 10.1038/nature10491
   Pai AA, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001316
   Philibert RA, 2008, AM J MED GENET B, V147B, P565, DOI 10.1002/ajmg.b.30778
   Philibert RA, 2010, AM J MED GENET B, V153B, P619, DOI 10.1002/ajmg.b.31031
   Rollins B, 2010, AM J MED GENET B, V153B, P919, DOI 10.1002/ajmg.b.31062
   Shapiro SD, 2005, AM J RESP CELL MOL, V32, P367, DOI 10.1165/rcmb.F296
   Shimizu Y, 2000, P NATL ACAD SCI USA, V97, P779, DOI 10.1073/pnas.97.2.779
   Suga Y, 2008, ONCOL REP, V20, P1137, DOI 10.3892/or_00000121
   Suzuki MM, 2008, NAT REV GENET, V9, P465, DOI 10.1038/nrg2341
   Tchevkina E, 2005, ONCOGENE, V24, P329, DOI 10.1038/sj.onc.1208094
   Tsankova N, 2007, NAT REV NEUROSCI, V8, P355, DOI 10.1038/nrn2132
   Wu H, 2010, SCIENCE, V329, P444, DOI 10.1126/science.1190485
   Yates W., 1998, WAY INDIVIDUALITY ME, P95
   Zeeberg B., 2003, GENOME BIOL, V4, P1, DOI DOI 10.1186/GB-2003-4-2-P1
NR 41
TC 120
Z9 125
U1 0
U2 10
PU WILEY-BLACKWELL
PI MALDEN
PA COMMERCE PLACE, 350 MAIN ST, MALDEN 02148, MA USA
SN 1552-4841
J9 AM J MED GENET B
JI Am. J. Med. Genet. B
PD MAR
PY 2012
VL 159B
IS 2
BP 141
EP 151
DI 10.1002/ajmg.b.32021
PG 11
WC Genetics & Heredity; Psychiatry
SC Genetics & Heredity; Psychiatry
GA 875LS
UT WOS:000299032000002
PM 22232023
OA Green Accepted
DA 2018-10-19
ER

PT J
AU Kang, EY
   Yeon, B
   Moon, HJ
   Jeong, B
AF Kang, Eun Young
   Yeon, Bora
   Moon, Hyo Jung
   Jeong, Byeongmoon
TI PEG-L-PAF and PEG-D-PAF: Comparative Study on Thermogellation and
   Biodegradation
SO MACROMOLECULES
LA English
DT Article
ID SOL-GEL TRANSITION; D-AMINO ACIDS; BLOCK-COPOLYMERS; DRUG-DELIVERY;
   SECONDARY STRUCTURE; CONTROLLED-RELEASE; HYDROGELS; POLYPEPTIDE;
   DEGRADATION; SEQUENCE
AB L-Polypeptides and D-polypeptides can be prepared from natural L-amino acids and non-natural D-amino acids, respectively. In this study, poly(ethylene glycol)-poly(L-alanine-co-L-phenyl alanine) (PEG-L-PAF) and poly-(ethylene glycol)-poly(D-alanine-co-D-phenyl alanine) (PEG-D-PAF) with similar molecular weight and composition, but different stereochemistry were investigated, focusing on thermogelling behavior and biodegradation. The sol-to-gel transition temperature of both PEG-L-PAF and PEG-D-PAF aqueous solutions decreased from 26 to 7 degrees C as the concentration increased from 4.0 wt % to 9.0 wt %. Dynamic light scattering, transmission electron microscopy, circular dichroism spectra, and C-13 NMR spectra suggested that the sol-to-gel transition involved changes in molecular assemblies resulting from dehydration of PEG for both PEG-L-PAF and PEG-D-PAF. In particular, the significant differences between PEG-L-PAF and PEG-D-PAF were observed for histocompatibility as well as in vitro/in vivo degradation. Only PEG-L-PAF was significantly degraded by cathepsin B and elastase, as well as under in vivo conditions. The histocompatibility assayed by the H&E staining method showed that formation of the collagen capsule around the PEG-D-PAF gel was thicker than the PEG-L-PAF gel, indicating that acute inflammation was milder with PEG-L-PAF gel than with PEG-D-PAP gel. Current study emphasizes the significance of stereochemistry in biomaterial development.
C1 [Kang, Eun Young; Yeon, Bora; Moon, Hyo Jung; Jeong, Byeongmoon] Ewha Womans Univ, Dept Bioinspired Sci WCU, Dept Chem & Nano Sci, Seoul 120750, South Korea.
RP Jeong, B (reprint author), Ewha Womans Univ, Dept Bioinspired Sci WCU, Dept Chem & Nano Sci, 52 Ewhayeodae Gil, Seoul 120750, South Korea.
EM bjeong@ewha.ac.kr
FU National Research Foundation of Korea (NRF); Korea government (MEST)
   [2011-0000376, 2011-0001340, R31-2008-000-10010-0]
FX This work was supported by National Research Foundation of Korea (NRF)
   grants funded by the Korea government (MEST) (Grant Nos. 2011-0000376,
   2011-0001340, and R31-2008-000-10010-0)
CR Borisova O, 2011, SOFT MATTER, V7, P10824, DOI 10.1039/c1sm06600e
   Braga PC, 2006, PHARMACOLOGY, V77, P130, DOI 10.1159/000093790
   Brubaker C.E.., 2011, BIOMACROMOL IN PRESS, DOI dx.doi.org/10.1021/bm201261d
   Cai XJ, 2011, J MATER CHEM, V21, P14639, DOI 10.1039/c1jm11693b
   Cha C, 2009, ADV FUNCT MATER, V19, P3056, DOI 10.1002/adfm.200900865
   Choi YY, 2008, SOFT MATTER, V4, P2383, DOI 10.1039/b809116a
   Huynh CT, 2011, SOFT MATTER, V7, P8984, DOI 10.1039/c1sm05919j
   Dang QF, 2011, CARBOHYD POLYM, V83, P171, DOI 10.1016/j.carbpol.2010.07.038
   Durani S, 2008, ACCOUNTS CHEM RES, V41, P1301, DOI 10.1021/ar700265t
   Fredriksson C., 2008, MATERIALS, V2, P1908
   Garripelli VK, 2011, ACTA BIOMATER, V7, P1984, DOI 10.1016/j.actbio.2011.02.005
   Hu JM, 2010, MACROMOLECULES, V43, P5184, DOI 10.1021/ma100813m
   Huynh DP, 2009, J CONTROL RELEASE, V137, P20, DOI 10.1016/j.jconrel.2009.02.021
   Hwang MJ, 2005, BIOMACROMOLECULES, V6, P885, DOI 10.1021/bm049347a
   Jeong Y, 2009, J CONTROL RELEASE, V137, P25, DOI 10.1016/j.jconrel.2009.03.008
   Joo MK, 2009, J MATER CHEM, V19, P5891, DOI 10.1039/b902208b
   Kang YM, 2010, BIOMATERIALS, V31, P2453, DOI 10.1016/j.biomaterials.2009.11.115
   Kim S, 2003, BIOMACROMOLECULES, V4, P1214, DOI 10.1021/bm0340467
   Kim SY, 2007, MACROMOLECULES, V40, P5519, DOI 10.1021/ma070190z
   Kopecek J, 2003, EUR J PHARM SCI, V20, P1, DOI 10.1016/S0928-0987(03)00164-7
   Kopecek J, 2010, ADV DRUG DELIVER REV, V62, P122, DOI 10.1016/j.addr.2009.10.004
   Lee BH, 2002, MACROMOLECULES, V35, P3876, DOI 10.1021/ma012093q
   Lee KY, 2001, CHEM REV, V101, P1869, DOI 10.1021/cr000108x
   Lim Y. B., 2009, ANGEW CHEM, V121, P1629
   Loh XJ, 2007, EXPERT OPIN THER PAT, V17, P965, DOI 10.1517/13543776.17.8.965
   Lutolf MP, 2003, P NATL ACAD SCI USA, V100, P5413, DOI 10.1073/pnas.0737381100
   Moon HJ, 2011, BIOMACROMOLECULES, V12, P1234, DOI 10.1021/bm101518c
   Morihara Y, 2005, J POLYM SCI POL CHEM, V43, P6048, DOI 10.1002/pola.21097
   Oh HJ, 2008, MACROMOLECULES, V41, P8204, DOI 10.1021/ma8014504
   Park D, 2011, BIOMATERIALS, V32, P777, DOI 10.1016/j.biomaterials.2010.09.044
   Park H, 2007, J AM CHEM SOC, V129, P1518, DOI 10.1021/ja067724g
   Park M.H., 2011, ACC CHEM RES, V10, DOI 1021/ar200162j
   Park SH, 2011, SOFT MATTER, V7, P6515, DOI 10.1039/c1sm05505d
   Sela M, 1997, FASEB J, V11, P449
   Soyez H, 1996, ADV DRUG DELIVER REV, V21, P81, DOI 10.1016/S0169-409X(96)00400-0
   Sun B, 2011, J MATER SCI-MATER M, V22, P2111, DOI 10.1007/s10856-011-4386-4
   Tugyi R, 2005, P NATL ACAD SCI USA, V102, P413, DOI 10.1073/pnas.0407677102
   WADE D, 1990, P NATL ACAD SCI USA, V87, P4761, DOI 10.1073/pnas.87.12.4761
   Wang J, 2009, MACROMOL RAPID COMM, V30, P845, DOI 10.1002/marc.200800744
   Wang W., 2010, SOFT MATTER, V6, P3851
   Wright ER, 2002, ADV DRUG DELIVER REV, V54, P1057, DOI 10.1016/S0169-409X(02)00059-5
   Yu L, 2008, CHEM SOC REV, V37, P1473, DOI 10.1039/b713009k
   Yu L, 2011, BIOMACROMOLECULES, V12, P1290, DOI 10.1021/bm101572j
   Yu L, 2010, BIOMACROMOLECULES, V11, P2169, DOI 10.1021/bm100549q
   Zhang Z, 2011, BIOMATERIALS, V32, P4725, DOI 10.1016/j.biomaterials.2011.03.046
   Zhou HY, 2011, CARBOHYD POLYM, V83, P1643, DOI 10.1016/j.carbpol.2010.10.022
NR 46
TC 24
Z9 24
U1 2
U2 33
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 0024-9297
J9 MACROMOLECULES
JI Macromolecules
PD FEB 28
PY 2012
VL 45
IS 4
BP 2007
EP 2013
DI 10.1021/ma202809c
PG 7
WC Polymer Science
SC Polymer Science
GA 898QN
UT WOS:000300757000031
DA 2018-10-19
ER

PT J
AU Rackwitz, L
   Eden, L
   Reppenhagen, S
   Reichert, JC
   Jakob, F
   Walles, H
   Pullig, O
   Tuan, RS
   Rudert, M
   Noth, U
AF Rackwitz, Lars
   Eden, Lars
   Reppenhagen, Stephan
   Reichert, Johannes C.
   Jakob, Franz
   Walles, Heike
   Pullig, Oliver
   Tuan, Rocky S.
   Rudert, Maximilian
   Noeth, Ulrich
TI Stem cell- and growth factor-based regenerative therapies for avascular
   necrosis of the femoral head
SO STEM CELL RESEARCH & THERAPY
LA English
DT Review
ID AUTOLOGOUS CHONDROCYTE IMPLANTATION; COLONY-STIMULATING FACTOR; CORE
   DECOMPRESSION; OSTEOCHONDRAL ALLOGRAFTS; OSTEOGENESIS IMPERFECTA;
   SEGMENTAL COLLAPSE; MESENCHYMAL CELLS; PROGENITOR CELLS; STROMAL CELLS;
   SHEEP MODEL
AB Avascular necrosis (AVN) of the femoral head is a debilitating disease of multifactorial genesis, predominately affects young patients, and often leads to the development of secondary osteoarthritis. The evolving field of regenerative medicine offers promising treatment strategies using cells, biomaterial scaffolds, and bioactive factors, which might improve clinical outcome. Early stages of AVN with preserved structural integrity of the subchondral plate are accessible to retrograde surgical procedures, such as core decompression to reduce the intraosseous pressure and to induce bone remodeling. The additive application of concentrated bone marrow aspirates, ex vivo expanded mesenchymal stem cells, and osteogenic or angiogenic growth factors (or both) holds great potential to improve bone regeneration. In contrast, advanced stages of AVN with collapsed subchondral bone require an osteochondral reconstruction to preserve the physiological joint function. Analogously to strategies for osteochondral reconstruction in the knee, anterograde surgical techniques, such as osteochondral transplantation (mosaicplasty), matrix-based autologous chondrocyte implantation, or the use of acellular scaffolds alone, might preserve joint function and reduce the need for hip replacement. This review summarizes recent experimental accomplishments and initial clinical findings in the field of regenerative medicine which apply cells, growth factors, and matrices to address the clinical problem of AVN.
C1 [Rackwitz, Lars; Eden, Lars; Reppenhagen, Stephan; Reichert, Johannes C.; Jakob, Franz; Pullig, Oliver; Rudert, Maximilian; Noeth, Ulrich] Univ Wurzburg, Orthopaed Ctr Musculoskeletal Res, Dept Orthopaed Surg Konig Ludwig Haus, D-97074 Wurzburg, Germany.
   [Walles, Heike] Univ Wurzburg, Inst Tissue Engn & Regenerat Med, D-97070 Wurzburg, Germany.
   [Tuan, Rocky S.] Univ Pittsburgh, Ctr Cellular & Mol Engn, Dept Orthopaed Surg, Sch Med, Pittsburgh, PA 15219 USA.
RP Noth, U (reprint author), Univ Wurzburg, Orthopaed Ctr Musculoskeletal Res, Dept Orthopaed Surg Konig Ludwig Haus, Brettreichstr 11, D-97074 Wurzburg, Germany.
EM u-noeth.klh@uni-wuerzburg.de
RI Rudert, Max/B-2041-2017; Jakob, Prof. Dr. Franz/F-9894-2015; Walles,
   Prof. Dr. Heike/M-1289-2015; EDEN, LORRAINE/B-3271-2013; Jakob,
   Franz/D-8526-2015
FU European Union; VascuBone; Commonwealth of Pennsylvania Department of
   Health
FX This project is funded, in part, by a grant from the European Union, 7th
   Framework Program HEALTH (FP-7), and VascuBone (LR, HW, FJ, MR, OP, and
   UN) and, in part, by a grant from the Commonwealth of Pennsylvania
   Department of Health (RST). The Department specifically disclaims
   responsibility for any analyses, interpretations, or conclusions. The
   surgical technique of stem cell application was developed in cooperation
   with Aastrom Biosciences, Inc.
CR Akimau P, 2006, ACTA ORTHOP, V77, P333, DOI 10.1080/17453670610046208
   Baksh D, 2004, J CELL MOL MED, V8, P301, DOI 10.1111/j.1582-4934.2004.tb00320.x
   Brittberg M, 2010, AM J SPORTS MED, V8, P1259
   Brunt Keith R., 2007, V139, P197
   Caplan AI, 2006, J CELL BIOCHEM, V98, P1076, DOI 10.1002/jcb.20886
   Chen CC, 2009, J BONE JOINT SURG AM, V91A, P2390, DOI 10.2106/JBJS.H.01814
   FAIRBANK AC, 1995, J BONE JOINT SURG BR, V77B, P42
   Feng Y, 2010, BONE, V46, P32, DOI 10.1016/j.bone.2009.09.001
   Ferrara N, 2004, ENDOCR REV, V25, P581, DOI 10.1210/er.2003-0027
   FICAT RP, 1985, J BONE JOINT SURG BR, V67, P3
   Gangji Valerie, 2005, J Bone Joint Surg Am, V87 Suppl 1, P106, DOI 10.2106/JBJS.D.02662
   Gangji V, 2011, BONE, V49, P1005, DOI 10.1016/j.bone.2011.07.032
   Ganz R, 2001, J BONE JOINT SURG BR, V83B, P1119, DOI 10.1302/0301-620X.83B8.11964
   GHERARDI E, 1990, NATURE, V346, P228, DOI 10.1038/346228b0
   Gille J, 2010, KNEE SURG SPORT TR A, V18, P1456, DOI 10.1007/s00167-010-1042-3
   Griffin MD, 2010, HUM GENE THER, V21, P1641, DOI 10.1089/hum.2010.156
   Gruber R, 2000, CYTOKINE, V12, P1630, DOI 10.1006/cyti.2000.0760
   Hernigou P, 2002, CLIN ORTHOP RELAT R, P14, DOI 10.1097/01.blo.0000038472.05771.79
   Hernigou P, 2005, J BONE JOINT SURG BR, V87B, P896, DOI 10.1302/0301-620X.87B7.16289
   Hernigou P, 2004, OPER TECH ORTHOP, V14, P68, DOI DOI 10.1053/J.0T0.2004.03.001
   Horwitz EM, 1999, NAT MED, V5, P309, DOI 10.1038/6529
   Horwitz EM, 2002, P NATL ACAD SCI USA, V99, P8932, DOI 10.1073/pnas.132252399
   Kawate K, 2006, ARTIF ORGANS, V30, P960, DOI 10.1111/j.1525-1594.2006.00333.x
   KOO KH, 1995, J BONE JOINT SURG BR, V77B, P870
   Lieberman Jay R, 2003, Instr Course Lect, V52, P337
   Lieberman JR, 2004, CLIN ORTHOP RELAT R, P139, DOI 10.1097/01.blo.0000150312.53937.6f
   McGrory BJ, 2007, J BONE JOINT SURG AM, V89A, P1194, DOI 10.2106/JBJS.F.00302
   MEYERS MH, 1985, CLIN ORTHOP RELAT R, P111
   MEYERS MH, 1983, CLIN ORTHOP RELAT R, P107
   Mont MA, 1998, J BONE JOINT SURG BR, V80B, P56, DOI 10.1302/0301-620X.80B1.7989
   Mont MA, 2003, CLIN ORTHOP RELAT R, P84, DOI 10.1097/01.blo.0000096826.67494.38
   MONT MA, 1995, J BONE JOINT SURG AM, V77A, P459, DOI 10.2106/00004623-199503000-00018
   Mont MA, 2001, J BONE JOINT SURG AM, V83A, P1013, DOI 10.2106/00004623-200107000-00006
   Mont MA, 1996, CLIN ORTHOP RELAT R, P169
   MONT MA, 1998, CLIN ORTHOP S, V355, P314
   Muller I, 2008, LEUKEMIA, V22, P2054, DOI 10.1038/leu.2008.217
   Noth U, 2007, ORTHOPADE, V36, P466, DOI 10.1007/s00132-007-1087-2
   Noth U, 2010, OSTEOLOGIE, V19, P53
   Noth U, 2010, ADV DRUG DELIVER REV, V62, P765, DOI 10.1016/j.addr.2010.04.004
   Reddi AH, 2003, ANN RHEUM DIS, V62, P73
   Rittmeister M, 2005, ORTHOPADE, V34, P320, DOI 10.1007/s00132-005-0776-y
   Schachinger V, 2004, J AM COLL CARDIOL, V44, P1690, DOI 10.1016/j.jacc.2004.08.014
   Schneider CK, 2010, NAT REV DRUG DISCOV, V9, P195, DOI 10.1038/nrd3052
   Schneider U, 2011, AM J SPORT MED, V39, P2558, DOI 10.1177/0363546511423369
   Seyler Thorsten M, 2007, Instr Course Lect, V56, P221
   Seyler TM, 2008, CLIN ORTHOP RELAT R, V466, P1125, DOI 10.1007/s11999-008-0211-x
   Simank HG, 2004, ORTHOPADE, V33, P68, DOI 10.1007/s00132-003-0541-z
   Simank HG, 2001, GROWTH FACTORS, V19, P247, DOI 10.3109/08977190109001090
   Sotereanos Nicholas G, 2008, Orthopedics, V31, P177
   Steadman JR, 2001, CLIN ORTHOP RELAT R, V391, P362, DOI DOI 10.1097/00003086-200110001-00033
   STEINBERG ME, 1995, J BONE JOINT SURG BR, V77B, P34
   Steinberg ME, 2004, ORTHOP CLIN N AM, V35, P273, DOI 10.1016/j.ocl.2004.02.005
   Tang TT, 2007, J BONE JOINT SURG BR, V89B, P127, DOI 10.1302/0301-620X.89B1.18350
   Toth ZE, 2008, BLOOD, V111, P5544, DOI 10.1182/blood-2007-10-119073
   Tsumaki N, 1999, J CELL BIOL, V144, P161, DOI 10.1083/jcb.144.1.161
   Vail TP, 1997, OSTEONECROSIS ETIOLO, P43
   Wen Q, 2008, GENE THER, V15, P1523, DOI 10.1038/gt.2008.110
   Wu XH, 2008, J RHEUMATOL, V35, P2241, DOI 10.3899/jrheum.071209
   Yan ZQ, 2009, J ORTHOP RES, V27, P442, DOI 10.1002/jor.20759
   Yang C, 2003, CHINESE MED J-PEKING, V116, P1544
NR 60
TC 38
Z9 43
U1 1
U2 30
PU BIOMED CENTRAL LTD
PI LONDON
PA 236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND
SN 1757-6512
J9 STEM CELL RES THER
JI Stem Cell Res. Ther.
PD FEB 22
PY 2012
VL 3
AR 7
DI 10.1186/scrt98
PG 9
WC Cell Biology; Medicine, Research & Experimental
SC Cell Biology; Research & Experimental Medicine
GA 911NT
UT WOS:000301725500001
PM 22356811
OA DOAJ Gold, Green Published
DA 2018-10-19
ER

PT J
AU Singelyn, JM
   Sundaramurthy, P
   Johnson, TD
   Schup-Magoffin, PJ
   Hu, DP
   Faulk, DM
   Wang, J
   Mayle, KM
   Bartels, K
   Salvatore, M
   Kinsey, AM
   DeMaria, AN
   Dib, N
   Christman, KL
AF Singelyn, Jennifer M.
   Sundaramurthy, Priya
   Johnson, Todd D.
   Schup-Magoffin, Pamela J.
   Hu, Diane P.
   Faulk, Denver M.
   Wang, Jean
   Mayle, Kristine M.
   Bartels, Kendra
   Salvatore, Michael
   Kinsey, Adam M.
   DeMaria, Anthony N.
   Dib, Nabil
   Christman, Karen L.
TI Catheter-Deliverable Hydrogel Derived From Decellularized Ventricular
   Extracellular Matrix Increases Endogenous Cardiomyocytes and Preserves
   Cardiac Function Post-Myocardial Infarction
SO JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
LA English
DT Article
DE biomaterial; extracellular matrix; heart failure; myocardial infarction;
   scaffold
ID FIBROBLAST-GROWTH-FACTOR; AUTOLOGOUS MYOBLAST TRANSPLANTATION;
   TH2-RESTRICTED IMMUNE-RESPONSE; MARROW-CELL TRANSPLANTATION; ACUTE
   MYOCARDIAL-INFARCTION; ISCHEMIC-HEART FAILURE; SKELETAL MYOBLASTS;
   INTRACORONARY INJECTION; STEM-CELLS; FOLLOW-UP
AB Objectives This study evaluated the use of an injectable hydrogel derived from ventricular extracellular matrix (ECM) for treating myocardial infarction (MI) and its ability to be delivered percutaneously.
   Background Injectable materials offer promising alternatives to treat MI. Although most of the examined materials have shown preserved or improved cardiac function in small animal models, none have been specifically designed for the heart, and few have translated to catheter delivery in large animal models.
   Methods We have developed a myocardial-specific hydrogel, derived from decellularized ventricular ECM, which self-assembles when injected in vivo. Female Sprague-Dawley rats underwent ischemia reperfusion followed by injection of the hydrogel or saline 2 weeks later. The implantation response was assessed via histology and immunohistochemistry, and the potential for arrhythmogenesis was examined using programmed electrical stimulation 1 week post-injection. Cardiac function was analyzed with magnetic resonance imaging 1 week pre-injection and 4 weeks post-MI. In a porcine model, we delivered the hydrogel using the NOGA-guided MyoStar catheter (Biologics Delivery Systems, Irwindale, California), and utilized histology to assess retention of the material.
   Results We demonstrate that injection of the material in the rat MI model increases endogenous cardiomyocytes in the infarct area and maintains cardiac function without inducing arrhythmias. Furthermore, we demonstrate feasibility of transendocardial catheter injection in a porcine model.
   Conclusions To our knowledge, this is the first in situ gelling material to be delivered via transendocardial injection in a large animal model, a critical step towards the translation of injectable materials for treating MI in humans. Our results warrant further study of this material in a large animal model of MI and suggest this may be a promising new therapy for treating MI. (J Am Coll Cardiol 2012;59:751-63) (C) 2012 by the American College of Cardiology Foundation
C1 [Singelyn, Jennifer M.; Sundaramurthy, Priya; Johnson, Todd D.; Schup-Magoffin, Pamela J.; Hu, Diane P.; Faulk, Denver M.; Wang, Jean; Mayle, Kristine M.; Christman, Karen L.] Univ Calif San Diego, Dept Bioengn, La Jolla, CA 92093 USA.
   [Bartels, Kendra; DeMaria, Anthony N.; Dib, Nabil] Univ Calif San Diego, Sch Med, La Jolla, CA 92093 USA.
   [Salvatore, Michael; Kinsey, Adam M.] Ventrix Inc, San Diego, CA USA.
RP Christman, KL (reprint author), Univ Calif San Diego, Dept Bioengn, 9500 Gilman Dr,MC 0412, La Jolla, CA 92093 USA.
EM christman@bioeng.ucsd.edu
FU National Institutes of Health (NIH); NIH Roadmap for Medical Research
   [1-DP2-OD004309]; Wallace H. Coulter Foundation (Miami, Florida)
FX From the *Department of Bioengineering, University of California, San
   Diego, La Jolla, California; dagger School of Medicine, University of
   California, San Diego, San Diego, California; and Ventrix, Inc., San
   Diego, California. This research was supported in part by the National
   Institutes of Health (NIH) Director's New Innovator Award Program, part
   of the NIH Roadmap for Medical Research, through grant number
   1-DP2-OD004309, the Wallace H. Coulter Foundation (Miami, Florida), and
   National Science Foundation grant NSF 1014429. Mr. Salvatore and Dr.
   Kinsey are employees of Ventrix, Inc. Dr. DeMaria is on the scientific
   advisory board of Ventrix, Inc. Dr. Dib is a consultant for Biologics
   Delivery System. Drs. Dib and Christman hold equity interest in Ventrix,
   Inc. All other authors have reported that they have no relationships
   relevant to the contents of this paper to disclose. Joshua M. Hare, MD,
   FACC, FAHA, served as Guest Editor of this paper.
CR Allman AJ, 2002, TISSUE ENG, V8, P53, DOI 10.1089/107632702753503054
   Allman AJ, 2001, TRANSPLANTATION, V71, P1631, DOI 10.1097/00007890-200106150-00024
   ARGRAVES WS, 1990, J CELL BIOL, V111, P3155, DOI 10.1083/jcb.111.6.3155
   ARGRAVES WS, 1989, CELL, V58, P623, DOI 10.1016/0092-8674(89)90097-4
   AVIEZER D, 1994, CELL, V79, P1005, DOI 10.1016/0092-8674(94)90031-0
   Badylak SF, 2002, HEART SURG FORUM, V6, pE20
   Badylak SF, 2009, ACTA BIOMATER, V5, P1, DOI 10.1016/j.actbio.2008.09.013
   Beltrami AP, 2001, NEW ENGL J MED, V344, P1750, DOI 10.1056/NEJM200106073442303
   Beltrami AP, 2003, CELL, V114, P763, DOI 10.1016/S0092-8674(03)00687-1
   Chachques Juan C, 2007, J Interv Cardiol, V20, P188, DOI 10.1111/j.1540-8183.2007.00255.x
   Christman KL, 2006, J AM COLL CARDIOL, V48, P907, DOI 10.1016/j.jacc.2006.06.005
   Christman KL, 2004, J AM COLL CARDIOL, V44, P654, DOI 10.1016/j.jacc.2004.04.040
   Christman KL, 2004, TISSUE ENG, V10, P403, DOI 10.1089/107632704323061762
   Costandi PN, 2007, MAGN RESON MED, V57, P714, DOI 10.1002/mrm.21182
   Costandi PN, 2006, AM J PHYSIOL-HEART C, V291, pH2971, DOI 10.1152/ajpheart.00571.2006
   Dai WD, 2005, J AM COLL CARDIOL, V46, P714, DOI 10.1016/j.jacc.2005.04.056
   Davis ME, 2005, CIRC RES, V97, P8, DOI 10.1161/01.RES.0000173376.39447.01
   DeQuach JA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013039
   Dib N, 2005, CIRCULATION, V112, P1748, DOI 10.1161/CIRCULATIONAHA.105.547810
   Dib N, 2002, J ENDOVASC THER, V9, P313, DOI 10.1583/1545-1550(2002)009<0313:ETOASM>2.0.CO;2
   Dib Nabil, 2006, Journal of Pharmacological and Toxicological Methods, V53, P256, DOI 10.1016/j.vascn.2005.10.005
   Dib Nabil, 2006, Journal of Pharmacological and Toxicological Methods, V54, P71, DOI 10.1016/j.vascn.2005.12.002
   Dorn GW, 2008, J MOL MED, V86, P1085, DOI 10.1007/s00109-008-0362-y
   Fernandes S, 2006, CARDIOVASC RES, V69, P348, DOI 10.1016/j.cardiores.2005.10.003
   Freyman T, 2006, EUR HEART J, V27, P1114, DOI 10.1093/eurheartj/ehi818
   Freytes DO, 2008, BIOMATERIALS, V29, P1630, DOI 10.1016/j.biomaterials.2007.12.014
   Fuchs S, 2003, J AM COLL CARDIOL, V41, P1721, DOI 10.1016/S0735-1097(03)00328-0
   Fuchs S, 2006, AM J CARDIOL, V97, P823, DOI 10.1016/j.amjcard.2005.09.132
   Huang NF, 2006, NAT PROTOC, V1, P1596, DOI 10.1038/nprot.2006.188
   Ifkovits JL, 2010, P NATL ACAD SCI USA, V107, P11507, DOI 10.1073/pnas.1004097107
   IOZZO RV, 1994, MATRIX BIOL, V14, P203, DOI 10.1016/0945-053X(94)90183-X
   Jawad H, 2007, J TISSUE ENG REGEN M, V1, P327, DOI 10.1002/term.46
   Jugdutt BI, 2003, CIRCULATION, V108, P1395, DOI 10.1161/01.CIR.0000085658.98621.49
   Kachenoura N, 2007, J MAGN RESON IMAGING, V26, P1127, DOI 10.1002/jmri.21103
   Kofidis T, 2004, J THORAC CARDIOV SUR, V128, P571, DOI 10.1016/j.jtcvs.2004.05.021
   Kolettis TM, 2006, CARDIOVASC RES, V69, P299, DOI 10.1016/j.cardiores.2005.12.007
   Krause K, 2009, HEART, V95, P1145, DOI 10.1136/hrt.2008.155077
   Krenger W, 1996, IMMUNOL RES, V15, P50, DOI 10.1007/BF02918284
   Kreuzberg MM, 2006, P NATL ACAD SCI USA, V103, P5959, DOI 10.1073/pnas.0508512103
   Krishnamurthy P, 2009, CIRC RES, V104, pE9, DOI 10.1161/CIRCRESAHA.108.188243
   Laham RJ, 2000, J AM COLL CARDIOL, V36, P2132, DOI 10.1016/S0735-1097(00)00988-8
   Laham RJ, 1999, DRUG METAB DISPOS, V27, P821
   Landa N, 2008, CIRCULATION, V117, P1388, DOI 10.1161/CIRCULATIONAHA.107.727420
   Leor J, 2009, J AM COLL CARDIOL, V54, P1014, DOI 10.1016/j.jacc.2009.06.010
   Limana F, 2007, CIRC RES, V101, P1255, DOI 10.1161/CIRCRESAHA.107.150755
   Lin YD, 2010, CIRCULATION, V122, pS132, DOI 10.1161/CIRCULATIONAHA.110.939512
   Lloyd-Jones D, 2009, CIRCULATION, V119, P480, DOI 10.1161/CIRCULATIONAHA.108.191259
   Lu WN, 2009, TISSUE ENG PT A, V15, P1437, DOI 10.1089/ten.tea.2008.0143
   Lunde K, 2006, NEW ENGL J MED, V355, P1199, DOI 10.1056/NEJMoa055706
   Lutolf MP, 2005, NAT BIOTECHNOL, V23, P47, DOI 10.1038/nbt1055
   Mann DL, 1999, CIRCULATION, V100, P999, DOI 10.1161/01.CIR.100.9.999
   Menasche P, 2003, J AM COLL CARDIOL, V41, P1078, DOI 10.1016/S0735-1097(03)00092-5
   Nahrendorf M, 2003, MED IMAGE ANAL, V7, P369, DOI 10.1016/S1361-8415(03)00011-2
   Nelson DM, 2011, ACTA BIOMATER, V7, P1, DOI 10.1016/j.actbio.2010.06.039
   Ott HC, 2008, NAT MED, V14, P213, DOI 10.1038/nm1684
   Perin EC, 2003, CIRCULATION, V107, P2294, DOI 10.1161/01.CIR.0000070596.30552.8B
   Rane AA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021571
   Roell W, 2007, NATURE, V450, P819, DOI 10.1038/nature06321
   Schrickel JW, 2002, BASIC RES CARDIOL, V97, P452, DOI 10.1107/s00395-002-0374-7
   Silva GV, 2004, TEX HEART I J, V31, P214
   Singelyn JM, 2010, J CARDIOVASC TRANSL, V3, P478, DOI 10.1007/s12265-010-9202-x
   Singelyn JM, 2009, BIOMATERIALS, V30, P5409, DOI 10.1016/j.biomaterials.2009.06.045
   Singh VK, 1999, IMMUNOL RES, V20, P147, DOI 10.1007/BF02786470
   Smits PC, 2003, J AM COLL CARDIOL, V42, P2063, DOI 10.1016/j.jacc.2003.06.017
   Uriel S, 2009, TISSUE ENG PART C-ME, V15, P309, DOI 10.1089/ten.tec.2008.0309
   Villarreal FJ, 2003, CIRCULATION, V108, P1487, DOI 10.1161/01.CIR.0000089090.05757.34
   Wang T, 2009, EUR J HEART FAIL, V11, P14, DOI 10.1093/eurjhf/hfn009
   Whitelock JM, 1999, MATRIX BIOL, V18, P163, DOI 10.1016/S0945-053X(99)00014-1
   Zhao ZQ, 2010, J AM COLL CARDIOL, V55, P1250, DOI 10.1016/j.jacc.2009.10.049
NR 69
TC 136
Z9 145
U1 1
U2 58
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0735-1097
J9 J AM COLL CARDIOL
JI J. Am. Coll. Cardiol.
PD FEB 21
PY 2012
VL 59
IS 8
BP 751
EP 763
DI 10.1016/j.jacc.2011.10.888
PG 13
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA 893YI
UT WOS:000300393400010
PM 22340268
OA Bronze, Green Accepted
DA 2018-10-19
ER

PT J
AU Scaglione, S
   Giannoni, P
   Bianchini, P
   Sandri, M
   Marotta, R
   Firpo, G
   Valbusa, U
   Tampieri, A
   Diaspro, A
   Bianco, P
   Quarto, R
AF Scaglione, Silvia
   Giannoni, Paolo
   Bianchini, Paolo
   Sandri, Monica
   Marotta, Roberto
   Firpo, Giuseppe
   Valbusa, Ugo
   Tampieri, Anna
   Diaspro, Alberto
   Bianco, Paolo
   Quarto, Rodolfo
TI Order versus Disorder: in vivo bone formation within osteoconductive
   scaffolds
SO SCIENTIFIC REPORTS
LA English
DT Article
ID CALCIUM-PHOSPHATE CERAMICS; STEM-CELLS; POROUS HYDROXYAPATITE;
   TRICALCIUM PHOSPHATE; BIOLOGICAL TISSUES; OSTEOINDUCTION; BIOCERAMICS;
   COLLAGEN; VITRO; BIOMATERIALS
AB In modern biomaterial design the generation of an environment mimicking some of the extracellular matrix features is envisaged to support molecular cross-talk between cells and scaffolds during tissue formation/remodeling. In bone substitutes chemical biomimesis has been particularly exploited; conversely, the relevance of pre-determined scaffold architecture for regenerated bone outputs is still unclear. Thus we aimed to demonstrate that a different organization of collagen fibers within newly formed bone under unloading conditions can be generated by differently architectured scaffolds. An ordered and confined geometry of hydroxyapatite foams concentrated collagen fibers within the pores, and triggered their self-assembly in a cholesteric-banded pattern, resulting in compact lamellar bone. Conversely, when progenitor cells were loaded onto nanofibrous collagen-based sponges, new collagen fibers were distributed in a nematic phase, resulting mostly in woven isotropic bone. Thus specific biomaterial design relevantly contributes to properly drive collagen fibers assembly to target bone regeneration.
C1 [Scaglione, Silvia; Giannoni, Paolo; Quarto, Rodolfo] Adv Biotechnol Ctr CBA, I-16145 Genoa, Italy.
   [Scaglione, Silvia] IEIIT Res Natl Council CNR, I-16149 Genoa, Italy.
   [Bianchini, Paolo; Marotta, Roberto; Diaspro, Alberto] Italian Inst Technol, I-16100 Genoa, Italy.
   [Sandri, Monica; Tampieri, Anna] Natl Res Inst, Inst Sci & Technol Ceram Mat, ISTEC CNR, I-48018 Faenza, Italy.
   [Firpo, Giuseppe; Valbusa, Ugo] SC Nanobiotecnol IST, I-16132 Genoa, Italy.
   [Firpo, Giuseppe; Valbusa, Ugo] Phys Dept DIFI, Nanomed Lab, I-16132 Genoa, Italy.
   [Bianco, Paolo] Univ Roma La Sapienza, Dept Mol Med, I-00161 Rome, Italy.
   [Quarto, Rodolfo] Univ Genoa, Dept Expt Med DIMES, I-16145 Genoa, Italy.
RP Scaglione, S (reprint author), Adv Biotechnol Ctr CBA, Largo R Benzi 10, I-16145 Genoa, Italy.
EM silvia.scaglione@cnr.it
RI Scaglione, Silvia/B-7124-2014; Marotta, Roberto/B-5382-2014; Bianchini,
   Paolo/A-9500-2008; Diaspro, Alberto/E-7833-2010
OI Scaglione, Silvia/0000-0002-9464-3554; Bianchini,
   Paolo/0000-0001-6457-751X; Diaspro, Alberto/0000-0002-4916-5928;
   Valbusa, Ugo/0000-0001-8940-5183; Sandri, Monica/0000-0001-5782-3137;
   Quarto, Rodolfo/0000-0002-1146-894X
FU MIUR [RBPR05RSM2, RBIP068JL9]
FX We thank MIUR for partial funding of the work (Prot. n. RBPR05RSM2;
   RBIP068JL9). We thank Roberta Martinetti (Finceramica, Faenza, I) for
   provision of the scaffolds.
CR Barrilleaux B, 2006, TISSUE ENG, V12, P3007, DOI 10.1089/ten.2006.12.3007
   Bianchini P, 2008, J BIOPHOTONICS, V1, P443, DOI 10.1002/jbio.200810060
   Bianco P, 1998, J CLIN INVEST, V101, P1737, DOI 10.1172/JCI2361
   Bianco P, 2001, NATURE, V414, P118, DOI 10.1038/35102181
   Boyde A, 1999, BONE, V24, P579, DOI 10.1016/S8756-3282(99)00083-6
   Campagnola PJ, 2002, BIOPHYS J, V82, P493, DOI 10.1016/S0006-3495(02)75414-3
   Cancedda R, 2003, STEM CELLS, V21, P610, DOI 10.1634/stemcells.21-5-610
   Chang BS, 2000, BIOMATERIALS, V21, P1291, DOI 10.1016/S0142-9612(00)00030-2
   Cheng LJ, 2010, ACTA BIOMATER, V6, P1569, DOI 10.1016/j.actbio.2009.10.050
   El-Ghannam A, 2005, EXPERT REV MED DEVIC, V2, P87, DOI 10.1586/17434440.2.1-87
   Gauthier O, 1998, BIOMATERIALS, V19, P133, DOI 10.1016/S0142-9612(97)00180-4
   Giraud-Guille MM, 2003, J BIOMECH, V36, P1571, DOI 10.1016/S0021-9290(03)00134-9
   GiraudGuille MM, 1996, INT REV CYTOL, V166, P59, DOI 10.1016/S0074-7696(08)62506-1
   GIRAUDGUILLE MM, 1988, CALCIFIED TISSUE INT, V42, P167, DOI 10.1007/BF02556330
   GOSHIMA J, 1991, CLIN ORTHOP RELAT R, P298
   Hollister SJ, 2002, BIOMATERIALS, V23, P4095, DOI 10.1016/S0142-9612(02)00148-5
   Hutmacher DW, 2007, J TISSUE ENG REGEN M, V1, P245, DOI 10.1002/term.24
   KADLER KE, 1990, ANN NY ACAD SCI, V580, P214, DOI 10.1111/j.1749-6632.1990.tb17930.x
   Kadler KE, 1996, BIOCHEM J, V316, P1
   Karageorgiou V, 2005, BIOMATERIALS, V26, P5474, DOI 10.1016/j.biomaterials.2005.02.002
   Kon E, 2000, J BIOMED MATER RES, V49, P328
   Kondo N, 2006, BIOMATERIALS, V27, P4419, DOI 10.1016/j.biomaterials.2006.04.016
   Li SH, 2003, TISSUE ENG, V9, P535, DOI 10.1089/107632703322066714
   Lighezan R, 2009, ROM J MORPHOL EMBRYO, V50, P613
   Livingston TL, 2003, J MATER SCI-MATER M, V14, P211, DOI 10.1023/A:1022824505404
   Logeart-Avramoglou D, 2005, J CELL MOL MED, V9, P72, DOI 10.1111/j.1582-4934.2005.tb00338.x
   Lu JX, 1999, J MATER SCI-MATER M, V10, P111, DOI 10.1023/A:1008973120918
   Mastrogiacomo M, 2006, BIOMATERIALS, V27, P3230, DOI 10.1016/j.biomaterials.2006.01.031
   Oreffo ROC, 1999, BONE, V25, p5S, DOI 10.1016/S8756-3282(99)00124-6
   Ripamonti U, 1996, BIOMATERIALS, V17, P31, DOI 10.1016/0142-9612(96)80752-6
   Tampieri A, 2003, J BIOMED MATER RES A, V67A, P618, DOI 10.1002/jbm.a.10039
   Wu LB, 2005, J BIOMED MATER RES A, V75A, P767, DOI 10.1002/jbm.a.30487
   Yuan HP, 1999, BIOMATERIALS, V20, P1799, DOI 10.1016/S0142-9612(99)00075-7
NR 33
TC 31
Z9 31
U1 0
U2 30
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 2045-2322
J9 SCI REP-UK
JI Sci Rep
PD FEB 17
PY 2012
VL 2
AR 274
DI 10.1038/srep00274
PG 6
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA 896QQ
UT WOS:000300585100002
PM 22355786
OA DOAJ Gold, Green Published
DA 2018-10-19
ER

PT J
AU Gopi, D
   Ansari, MT
   Shinyjoy, E
   Kavitha, L
AF Gopi, D.
   Ansari, M. Thameem
   Shinyjoy, E.
   Kavitha, L.
TI Synthesis and spectroscopic characterization of magnetic hydroxyapatite
   nanocomposite using ultrasonic irradiation
SO SPECTROCHIMICA ACTA PART A-MOLECULAR AND BIOMOLECULAR SPECTROSCOPY
LA English
DT Article
DE Magnetic hydroxyapatite; Ultrasonication; Biomaterial; Nanocomposite;
   TEM
ID BONE-FORMATION; PARTICLES; NANOPARTICLES; NANOCRYSTALS; HYPERTHERMIA;
   VECTORS; FIELDS
AB Nowadays magnetic hydroxyapatite (m-HAP) has potential applications in biomedicine more especially for bone cancer treatment. In this paper the functionalization of the hydroxyapatite (HAP) with magnetite nanoparticle (MNP) through ultrasonic irradiation technique is reported and its spectral investigation has been carried out. The ultrasonic irradiation with two different frequencies of 28 kHz and 35 kHz at the power of 150 and 320W, respectively, was employed for the synthesis of m-HAP. The ultrasound irradiation of 35 kHz at 320W shows the efficient diffusion of MNP to the HAP host matrix leads to the formation of m-HAP. The ultrasonic irradiation technique does not require stabilizers as in the case of coprecipitation method hence the final product of pure m-HAP is obtained. The X-ray diffraction pattern shows the formation of magnetite nanoparticles which are functionalized with hydroxyapatite host matrix. The vibrating sample magnetometer curve exhibits the super paramagnetic property of the samples and the saturation magnetization (M-s) value of the functionalized magnetic hydroxyapatite. The M-s value is found to be much less than that of pure magnetite nanoparticle and this decrement in M-s is clue to the hindrance of magnetic domain of the particles with HAP. The portrayed Raman spectra discriminate between the m-HAP and MNP with corresponding vibrational modes of frequencies. The transmission electron micrograph shows excellent morphology of functionalized m-HAP in nanometer range. The atomic force microscopic investigation shows the 3-dimensional view of crust and trench shape of m-HAP. All these results confirm the formation of magnetic hydroxyapatite nanocomposite with typical magnetic property for biological applications. (C) 2011 Elsevier B.V. All rights reserved.
C1 [Gopi, D.; Ansari, M. Thameem; Shinyjoy, E.] Periyar Univ, Dept Chem, Salem 636011, Tamil Nadu, India.
   [Kavitha, L.] Periyar Univ, Dept Phys, Salem 636011, Tamil Nadu, India.
   [Gopi, D.; Kavitha, L.] Periyar Univ, Ctr Nanosci & Nanotechnol, Salem 636011, Tamil Nadu, India.
   [Kavitha, L.] Abdus Salam Int Ctr Theoret Phys, Trieste, Italy.
RP Gopi, D (reprint author), Periyar Univ, Dept Chem, Salem 636011, Tamil Nadu, India.
EM dhanaraj_gopi@yahoo.com; louiskavitha@yahoo.co.in
RI Louis, Kavitha/B-9313-2017; Gopi, Dhanaraj/A-9163-2012
OI Louis, Kavitha/0000-0002-8893-2050; Gopi, Dhanaraj/0000-0001-6662-1238
FU Indian Council of Medical Research (ICMR), India [2010-08660,
   5/20/11(Bio)/10-NCD-I]; Department of Science Technology (DST), New
   Delhi, India [SR/FTP/ETA-04/2009, DST/TSG/NTS/2011/73-G]; Tamilnadu
   State Council for Science and Technology (TNSCST), Tamilnadu;
   UGC-Networking Resource Centre of School of Chemistry
FX One of the authors D. Gopi acknowledges the financial support from
   Indian Council of Medical Research (ICMR, IRIS ID No. 2010-08660, Ref.
   No: 5/20/11(Bio)/10-NCD-I), India, Department of Science Technology
   (DST-Young Scientist No: SR/FTP/ETA-04/2009, DST/TSG/NTS/2011/73-G), New
   Delhi, India and Tamilnadu State Council for Science and Technology
   (TNSCST), Tamilnadu in the form of major research projects. M. Thameem
   acknowledges the UGC-Networking Resource Centre of School of Chemistry,
   for Ph.D., visiting student fellowship, Central Instruments Laboratory
   and Centre for Nanotechnology, University of Hyderabad. India for
   availing the instrumentation facilities. L. Kavitha acknowledges the
   Junior Associateship from The Abdus Salam International Centre for
   Theoretical Physics (ICTP), Italy.
CR Ajeesh M, 2010, J MATER SCI-MATER M, V21, P1427, DOI 10.1007/s10856-010-4005-9
   Arruebo M, 2006, CHEM MATER, V18, P1911, DOI 10.1021/cm051646z
   Askanneiad A, 2008, MATER LETT, V62, P478, DOI 10.1016/j.matlet.2007.05.082
   Askarinejad A, 2009, CHEM ENG J, V150, P569, DOI 10.1016/j.cej.2009.03.005
   BEE A, 1995, J MAGN MAGN MATER, V149, P6, DOI 10.1016/0304-8853(95)00317-7
   del Real RP, 2002, CHEM MATER, V14, P64, DOI 10.1021/cm011020i
   Filho FP, 2008, PHYSICA B, V403, P3826, DOI 10.1016/j.physb.2008.07.017
   Gopi D, 2008, SPECTROCHIM ACTA A, V70, P1243, DOI 10.1016/j.saa.2008.02.015
   Gopi D, 2016, ARAB J CHEM, V9, pS829, DOI 10.1016/j.arabjc.2011.08.005
   Gopi D, 2009, SPECTROCHIM ACTA A, V74, P282, DOI 10.1016/j.saa.2009.05.021
   Gopi D., 2010, CURR APPL PHYS, V11, P590
   Hilger I, 2002, ACAD RADIOL, V9, P198, DOI 10.1016/S1076-6332(03)80171-X
   Ikenaga M., 1991, BIOCERAMICS, V4, P255
   Jeong U, 2007, ADV MATER, V19, P33, DOI 10.1002/adma.200600674
   Khongwar JK, 2008, MATER RES BULL, V43, P418, DOI 10.1016/j.materresbull.2007.02.039
   Kim J, 2006, J AM CHEM SOC, V128, P688, DOI 10.1021/ja0565875
   Kuda O, 2009, J MATER PROCESS TECH, V209, P1960, DOI 10.1016/j.jmatprotec.2008.04.061
   Leventouri T, 2005, BIOMATERIALS, V26, P4924, DOI 10.1016/j.biomaterials.2005.01.017
   Li GD, 2008, APPL SURF SCI, V255, P559, DOI 10.1016/j.apsusc.2008.06.100
   Mir A, 2010, J MATER SCI-MATER M, V21, P2365, DOI 10.1007/s10856-010-4090-9
   Mirestean C, 2007, J OPTOELECTRON ADV M, V9, P764
   Ohkubo C, 1997, IN VIVO, V11, P221
   OHURA K, 1991, J APPL BIOMATER, V2, P153, DOI 10.1002/jab.770020303
   Parast MSY, 2011, ULTRASON SONOCHEM, V18, P375, DOI 10.1016/j.ultsonch.2010.07.001
   Perkas N, 2009, ULTRASON SONOCHEM, V16, P132, DOI 10.1016/j.ultsonch.2008.04.014
   Ruksudjarlt A, 2008, CURR APPL PHYS, V8, P270, DOI 10.1016/j.cap.2007.10.076
   Wakiya N, 2010, MATER SCI ENG B-ADV, V173, P195, DOI 10.1016/j.mseb.2009.12.013
   Wu H. C., 2007, NANOTECHNOLOGY, V18
   Wu HC, 2010, ADV FUNCT MATER, V20, P67, DOI 10.1002/adfm.200901108
   Yamamoto Y, 2003, J DENT RES, V82, P962, DOI 10.1177/154405910308201205
   Yan QC, 1998, MED ENG PHYS, V20, P397, DOI 10.1016/S1350-4533(98)00051-4
   Zhang HR, 2006, ANAL CHEM, V78, P609, DOI 10.1021/ac051720x
NR 32
TC 16
Z9 17
U1 1
U2 28
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 1386-1425
J9 SPECTROCHIM ACTA A
JI Spectroc. Acta Pt. A-Molec. Biomolec. Spectr.
PD FEB 15
PY 2012
VL 87
BP 245
EP 250
DI 10.1016/j.saa.2011.11.047
PG 6
WC Spectroscopy
SC Spectroscopy
GA 899JS
UT WOS:000300812800033
PM 22177219
DA 2018-10-19
ER

PT J
AU Carreon, H
   Barriuso, S
   Barrera, G
   Gonzalez-Carrasco, JL
   Caballero, FG
AF Carreon, H.
   Barriuso, S.
   Barrera, G.
   Gonzalez-Carrasco, J. L.
   Caballero, F. G.
TI Assessment of blasting induced effects on medical 316 LVM stainless
   steel by contacting and non-contacting thermoelectric power techniques
SO SURFACE & COATINGS TECHNOLOGY
LA English
DT Article
DE Grit blasting; Thermoelectric measurements; Residual stresses;
   Biomaterial
ID MECHANICAL-PROPERTIES; ALLOY; TI-6AL-4V; OSSEOINTEGRATION;
   MICROSTRUCTURE; PRECIPITATION; IMPLANTS
AB Grit blasting is a low cost surface modification treatment widely used to enhance mechanical fixation of implants through increasing their roughness. As a result of the severe surface plastic deformation, beneath the surface it produces additional effects such as grain size refinement, work hardening and compressive residual stresses, which are generally evaluated with destructive techniques. In this research work, the blasting induced effects by Al2O3 and ZrO2 particles and their evolution after annealing at 700 degrees C were evaluated in 316LVM (Low Vacuum Melting) stainless steel specimens using two non-destructive thermoelectric techniques (NDTT), the non-contacting and contacting thermoelectric power measurements. Microstructural analysis and microhardness measurements performed beneath the blasted surface reveals that the non-contact NDTT results correlate well with the reversion of the alpha'-martensite developed during blasting, whereas the contact NDTT results are closely related to the grain size refinement and work hardening and the expected evolution of compressive residual stresses. Potential of these techniques to monitor subsurface changes in blasting processes and others severe surface plastic deformation techniques are clearly envisaged. (C) 2011 Elsevier B.V. All rights reserved.
C1 [Carreon, H.; Barrera, G.] Inst Invest Met UMSNH IIM, Morelia, Michoacan, Mexico.
   [Barriuso, S.; Gonzalez-Carrasco, J. L.; Caballero, F. G.] Ctr Nacl Invest Met CENIM CSIC, E-28040 Madrid, Spain.
   [Gonzalez-Carrasco, J. L.] Ctr Invest Biomed Red Bioingn Biomat & Nanomed CI, Madrid, Spain.
RP Carreon, H (reprint author), Inst Invest Met UMSNH IIM, Ciudad Univ, Morelia, Michoacan, Mexico.
EM hcarreon@umich.mx
RI CABALLERO, FRANCISCA/A-4292-2008
OI Caballero, Francisca/0000-0002-5548-7659; Gonzalez-Carrasco, Jose
   Luis/0000-0003-2004-4505; CARREON, HECTOR/0000-0002-4803-0650
FU CONACYT (Mexico) [CB-80883, MAT2009-14695-C04]
FX This work was performed at UMSNH (Mexico) and CENIM-CSIC (Spain) with a
   partial funding from CONACYT (Mexico) under projects CB-80883 and
   MAT2009-14695-C04. H. Carreon wishes to thank CONACYT (Mexico) for the
   financial support during the sabbatical in CENIM-CSIC and S. Barriuso to
   CSIC for the JAE predoc.
CR Altenberger I, 1999, MAT SCI ENG A-STRUCT, V264, P1, DOI 10.1016/S0921-5093(98)01121-6
   Aparicio C, 2004, KEY ENG MAT, V254-2, P737, DOI 10.4028/www.scientific.net/KEM.254-256.737
   Caballero FG, 2005, SCRIPTA MATER, V52, P501, DOI 10.1016/j.scriptamat.2004.11.005
   Caballero FG, 2004, SCRIPTA MATER, V50, P1061, DOI 10.1016/j.scriptamat.2003.12.017
   Capdevila C, 2008, J MATER SCI, V43, P3889, DOI 10.1007/s10853-007-2228-z
   Carabajar S, 2000, MAT SCI ENG A-STRUCT, V281, P132, DOI 10.1016/S0921-5093(99)00737-6
   Carreon H, 2002, RES NONDESTRUCT EVAL, V14, P59, DOI 10.1007/s00164-002-0001-x
   Carreon H, 2008, WEAR, V265, P255, DOI 10.1016/j.wear.2007.10.005
   Carreon H, 2007, J ALLOY COMPD, V427, P183, DOI 10.1016/j.jallcom.2006.03.004
   Carreon H, 2006, NDT&E INT, V39, P433, DOI 10.1016/j.ndteint.2006.01.001
   Dieter G.E., 1989, MECH METALLURGY, P319
   Ferrer JP, 2007, ACTA MATER, V55, P2075, DOI 10.1016/j.actamat.2006.11.010
   Frutos E, 2010, ACTA MATER, V58, P4191, DOI 10.1016/j.actamat.2010.04.010
   HALL EO, 1951, P PHYS SOC LOND B, V64, P747, DOI 10.1088/0370-1301/64/9/303
   Hu JT, 1998, APPL PHYS LETT, V73, P467, DOI 10.1063/1.121902
   Jinno T, 1998, J BIOMED MATER RES, V42, P20, DOI 10.1002/(SICI)1097-4636(199810)42:1<20::AID-JBM4>3.0.CO;2-Q
   Juzeliunas E, 2006, J SOLID STATE ELECTR, V10, P700, DOI 10.1007/s10008-006-0114-2
   Lee SJ, 2009, MAT SCI ENG A-STRUCT, V515, P32, DOI 10.1016/j.msea.2009.02.010
   Cuellar EL, 2011, J ALLOY COMPD, V509, P7297, DOI 10.1016/j.jallcom.2011.04.101
   Lopez E., 2009, J ALLOY COMPD, V467, P572
   Maslov K, 2001, MATER EVAL, V59, P1081
   Multigner M, 2010, SURF COAT TECH, V205, P1830, DOI 10.1016/j.surfcoat.2010.07.126
   Multigner M, 2009, MAT SCI ENG C-BIO S, V29, P1357, DOI 10.1016/j.msec.2008.11.002
   PETCH NJ, 1953, J IRON STEEL I, V174, P25
   Sarasola M., 2001, REV METAL, V35, P124
   Tavrin Y., 2001, REV PROGR QNDE, V20, P1710
   Wennerberg A, 1996, Int J Oral Maxillofac Implants, V11, P38
NR 27
TC 10
Z9 11
U1 0
U2 8
PU ELSEVIER SCIENCE SA
PI LAUSANNE
PA PO BOX 564, 1001 LAUSANNE, SWITZERLAND
SN 0257-8972
J9 SURF COAT TECH
JI Surf. Coat. Technol.
PD FEB 15
PY 2012
VL 206
IS 11-12
BP 2941
EP 2946
DI 10.1016/j.surfcoat.2011.12.026
PG 6
WC Materials Science, Coatings & Films; Physics, Applied
SC Materials Science; Physics
GA 902CX
UT WOS:000301017300029
DA 2018-10-19
ER

PT J
AU Hsu, W
   Chen, YL
   Horng, JC
AF Hsu, Wei
   Chen, Yi-Lun
   Horng, Jia-Cherng
TI Promoting Self-Assembly of Collagen-Related Peptides into Various
   Higher-Order Structures by Metal-Histidine Coordination
SO LANGMUIR
LA English
DT Article
ID TRIPLE-HELICAL PEPTIDES; DESIGNED PEPTIDES; MIMETIC PEPTIDES; STABILITY;
   MICROFLORETTES; ASSOCIATION; HYDROGEL; GELS
AB Collagen is an important and widely used biomaterial and therapeutic. The construction of large-scale collagen structures via the self-assembly of small collagen-related peptides has been extensively studied in the past decade. Here, we report a highly effective and simple means to assemble small synthetic collagen-related peptides into various higher-order structures by utilizing metal histidine coordination. In this work, two short collagen-related peptides in which histidine residues were incorporated as metal binding sites were designed and chemically synthesized: HG(PPG)(9)GH (X9) and HG(PPG)(4)(PHG)(PPG)(4)GH (PHG). Circular dichroism measurements indicated that these two peptides form only marginally stable collagen triple helices but that their stability can be increased upon the addition of metal ions. Dynamic light scattering analyses, turbidity measurements, TEM, and SEM results demonstrated the metal ion-dependent self-assembly of X9 and PHG into supramolecular structures ranging from various nanofibrils to microscale spherical, laminated, and granulated assemblies. The topology and size of these higher-order structures depends both on the metal ion identity and the location of the binding sites. Most intriguingly, the assembled fibrils show similar D-periodicity to that of natural collagen. Our results demonstrate that metal-histidine coordination can serve as an effective force to induce the self-assembly of unstable collagen-related peptides into higher-order structures.
C1 [Horng, Jia-Cherng] Natl Tsing Hua Univ, Dept Chem, Hsinchu 30013, Taiwan.
   Natl Tsing Hua Univ, Frontier Res Ctr Fundamental & Appl Sci Matters, Hsinchu 30013, Taiwan.
RP Horng, JC (reprint author), Natl Tsing Hua Univ, Dept Chem, Hsinchu 30013, Taiwan.
EM jchorng@mx.nthu.edu.tw
FU Taiwan National Science Council [NSC 99-2113-M-007-016-MY2, NSC
   98-2119-M-007-011]; National Tsing Hua University [100N2011E1]
FX We are thankful to the Taiwan National Science Council (NSC
   99-2113-M-007-016-MY2 and NSC 98-2119-M-007-011) and National Tsing Hua
   University (100N2011E1) for support of this work, and to Prof. Chia-Min
   Yang for providing the DLS spectrometer. We are particularly grateful to
   Dr. Matthew Shoulders (The Scripps Research Institute) for reading our
   manuscript and valuable suggestions.
CR Brodsky B, 2005, ADV PROTEIN CHEM, V70, P301, DOI 10.1016/S0065-3233(05)70009-7
   Brodsky B, 2008, BIOPOLYMERS, V89, P345, DOI 10.1002/bip.20958
   Cejas MA, 2008, P NATL ACAD SCI USA, V105, P8513, DOI 10.1073/pnas.0800291105
   Cejas MA, 2007, J AM CHEM SOC, V129, P2202, DOI 10.1021/ja066986f
   Chen CC, 2011, BIOCHEMISTRY-US, V50, P2381, DOI 10.1021/bi1018573
   Engel J, 2005, TOP CURR CHEM, V247, P7, DOI 10.1007/b103818
   Jenkins CL, 2005, ORG LETT, V7, P2619, DOI 10.1021/ol050780m
   Kar K, 2009, BIOCHEMISTRY-US, V48, P7959, DOI 10.1021/bi900496m
   Koide T, 2005, BIOORG MED CHEM LETT, V15, P5230, DOI 10.1016/j.bmcl.2005.08.041
   Kotch FW, 2006, P NATL ACAD SCI USA, V103, P3028, DOI 10.1073/pnas.0508783103
   Lutolf MP, 2005, NAT BIOTECHNOL, V23, P47, DOI 10.1038/nbt1055
   O'Leary LER, 2011, NAT CHEM, V3, P821, DOI [10.1038/nchem.1123, 10.1038/NCHEM.1123]
   Paramonov SE, 2005, MACROMOLECULES, V38, P7555, DOI 10.1021/ma0514065
   Perez CMR, 2011, MACROMOL BIOSCI, V11, P1426, DOI 10.1002/mabi.201100230
   Pires MM, 2012, LANGMUIR, V28, P1993, DOI 10.1021/la203848r
   Pires MM, 2011, J AM CHEM SOC, V133, P14469, DOI 10.1021/ja2042645
   Pires MM, 2011, BIOMACROMOLECULES, V12, P2429, DOI 10.1021/bm2004934
   Pires MM, 2009, ANGEW CHEM INT EDIT, V48, P7813, DOI 10.1002/anie.200902375
   Pires MM, 2009, J AM CHEM SOC, V131, P2706, DOI 10.1021/ja8088845
   Przybyla DE, 2008, J AM CHEM SOC, V130, P12610, DOI 10.1021/ja804942w
   Przybyla DE, 2010, J AM CHEM SOC, V132, P7866, DOI 10.1021/ja103148t
   Przybyla DE, 2010, BIOCHEMISTRY-US, V49, P4411, DOI 10.1021/bi902129p
   Rele S, 2007, J AM CHEM SOC, V129, P14780, DOI 10.1021/ja0758990
   Shoulders MD, 2009, ANNU REV BIOCHEM, V78, P929, DOI 10.1146/annurev.biochem.77.032207.120833
   Yamazaki CM, 2008, J PEPT SCI, V14, P186
   Yamazaki CM, 2008, BIOPOLYMERS, V90, P816, DOI 10.1002/bip.21100
   Yu SM, 2011, SOFT MATTER, V7, P7927, DOI 10.1039/c1sm05329a
NR 27
TC 28
Z9 28
U1 0
U2 61
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 0743-7463
J9 LANGMUIR
JI Langmuir
PD FEB 14
PY 2012
VL 28
IS 6
BP 3194
EP 3199
DI 10.1021/la204351w
PG 6
WC Chemistry, Multidisciplinary; Chemistry, Physical; Materials Science,
   Multidisciplinary
SC Chemistry; Materials Science
GA 890IO
UT WOS:000300138500019
PM 22243030
DA 2018-10-19
ER

PT J
AU Fajardo, AR
   Lopes, LC
   Pereira, AGB
   Rubira, AF
   Muniz, EC
AF Fajardo, Andre R.
   Lopes, Lais C.
   Pereira, Antonio G. B.
   Rubira, Adley F.
   Muniz, Edvani C.
TI Polyelectrolyte complexes based on pectin-NH2 and chondroitin sulfate
SO CARBOHYDRATE POLYMERS
LA English
DT Article
DE Polyelectrolyte complex; Pectin; Pectin functionalized; Chondroitin
   sulfate; Polysaccharides
ID DRUG-DELIVERY; HYDROGEL; RELEASE
AB This work reports on the formation and characterization of a polyelectrolyte complex based on pectin (PT), functionalized with primary amine groups (PT-NH2), and chondroitin sulfate (CS). From the simple mixture of PT-NH2 and CS, in acid conditions, it was formed a polyelectrolyte complex, labeled as PT-NH2/CS complex, which was confirmed through FTIR spectroscopy. The electrostatic interactions among the protonated amine groups from PT-NH2 and the sulfate groups from CS are responsible by complex formation. XRD patterns and thermal analysis showed that the complex formation disrupts some interactions present on the PT-NH2 and CS, but on the other hand, others are created. SEM images showed that the PT-NH2/CS complex presents a porous and rough morphology. PT-NH2/CS complex is new material that maintains the properties of CS with synergic association of properties from both polymers, which could maximize its applicability as biomaterial, for example. (C) 2011 Elsevier Ltd. All rights reserved.
C1 [Fajardo, Andre R.; Lopes, Lais C.; Pereira, Antonio G. B.; Rubira, Adley F.; Muniz, Edvani C.] State Univ Maringa UEM, Dept Chem, GMPC, BR-87020900 Maringa, Parana, Brazil.
RP Fajardo, AR (reprint author), State Univ Maringa UEM, Dept Chem, GMPC, Av Colombo 5790, BR-87020900 Maringa, Parana, Brazil.
EM drefajardo@hotmail.com
RI LOPES, LAIS CRISTINE/F-5343-2018; Fajardo, Andre/H-1783-2012; Inomat,
   Inct/H-9989-2013; Basso Pereira, Antonio Guilherme/B-1041-2012
OI LOPES, LAIS CRISTINE/0000-0002-9499-0775; Fajardo,
   Andre/0000-0001-5362-6478; Muniz, Edvani/0000-0001-6685-1519
FU CNPq; CAPES
FX L.C.L. thanks to CNPq by the undergraduate fellowship, A.R.F. thanks to
   CAPES by the doctoral fellowship, and E.C.M. thanks to CNPq by the
   financial support.
CR Block JA, 2010, OSTEOARTHR CARTILAGE, V18, P5, DOI 10.1016/j.joca.2009.07.005
   Chronakis IS, 1997, FOOD HYDROCOLLOID, V11, P271, DOI 10.1016/S0268-005X(97)80056-2
   Fajardo AR, 2010, CARBOHYD POLYM, V80, P934, DOI 10.1016/j.carbpol.2010.01.009
   Huang LY, 2008, COLLOID SURFACE B, V61, P43, DOI 10.1016/j.colsurfb.2007.07.004
   Huang LL, 2010, CARBOHYD POLYM, V80, P168, DOI 10.1016/j.carbpol.2009.11.007
   Jayakumar R, 2010, BIOTECHNOL ADV, V28, P142, DOI 10.1016/j.biotechadv.2009.11.001
   Katav T, 2008, J CONTROL RELEASE, V130, P183, DOI 10.1016/j.jconrel.2008.06.002
   Kirker KR, 2002, BIOMATERIALS, V23, P3661, DOI 10.1016/S0142-9612(02)00100-X
   Lammers G, 2009, BIOMATERIALS, V30, P6213, DOI 10.1016/j.biomaterials.2009.07.050
   Langer R, 2009, ADV MATER, V21, P3235, DOI 10.1002/adma.200902589
   LARSSON B, 1981, BIOCHEM PHARMACOL, V30, P2963, DOI 10.1016/0006-2952(81)90260-4
   Lutz R, 2009, FOOD HYDROCOLLOID, V23, P786, DOI 10.1016/j.foodhyd.2008.04.009
   Macdonald ML, 2010, BIOMACROMOLECULES, V11, P2053, DOI 10.1021/bm100413w
   Mata YN, 2009, CHEM ENG J, V150, P289, DOI 10.1016/j.cej.2009.01.001
   Naggar V. F., 1992, STP PHARMA SCI, V2, P227
   Piai JF, 2010, J MOL LIQ, V156, P28, DOI 10.1016/j.molliq.2010.05.017
   RUBINSTEIN A, 1992, PHARMACEUT RES, V9, P276, DOI 10.1023/A:1018910128452
   SALYERS AA, 1979, AM J CLIN NUTR, V32, P158
   SALYERS AA, 1980, J BACTERIOL, V143, P772
   Sinha VR, 2001, INT J PHARM, V224, P19, DOI 10.1016/S0378-5173(01)00720-7
   SINTOV A, 1995, BIOMATERIALS, V16, P473, DOI 10.1016/0142-9612(95)98820-5
   Staub E, 2002, FEBS LETT, V527, P114, DOI 10.1016/S0014-5793(02)03195-2
   Sungthongjeen S, 1999, DRUG DEV IND PHARM, V25, P1271, DOI 10.1081/DDC-100102298
   Sutar PB, 2008, J MATER SCI-MATER M, V19, P2247, DOI 10.1007/s10856-007-3162-y
   Theocharis AD, 2006, ADV PHARMACOL, V53, P281, DOI 10.1016/S1054-3589(05)53013-8
   Uygun BE, 2009, TISSUE ENG PT A, V15, P3499, DOI 10.1089/ten.TEA.2008.0405
   Victor XV, 2009, J BIOL CHEM, V284, P25842, DOI 10.1074/jbc.M109.043208
   Volpi N, 2004, CARBOHYD POLYM, V55, P273, DOI 10.1016/j.carbpol.2003.09.010
   Wang SC, 2007, INT J PHARM, V329, P103, DOI 10.1016/j.ijpharm.2006.08.041
   Yoshimura T, 2005, POLYM BULL, V55, P123, DOI 10.1007/s00289-005-0422-1
NR 30
TC 19
Z9 20
U1 1
U2 44
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0144-8617
EI 1879-1344
J9 CARBOHYD POLYM
JI Carbohydr. Polym.
PD FEB 14
PY 2012
VL 87
IS 3
BP 1950
EP 1955
DI 10.1016/j.carbpol.2011.09.096
PG 6
WC Chemistry, Applied; Chemistry, Organic; Polymer Science
SC Chemistry; Polymer Science
GA 887XZ
UT WOS:000299969700010
OA Bronze
DA 2018-10-19
ER

PT J
AU Wu, EC
   Zhang, SG
   Hauser, CAE
AF Wu, Elizabeth C.
   Zhang, Shuguang
   Hauser, Charlotte A. E.
TI Self-Assembling Peptides as Cell-Interactive Scaffolds
SO ADVANCED FUNCTIONAL MATERIALS
LA English
DT Article
DE self-assembly; peptides; scaffold; tissue engineering
ID AMPHIPHILE NANOFIBERS; STEM-CELLS; EXTRACELLULAR-MATRIX; COMPLEMENTARY
   OLIGOPEPTIDE; REGENERATIVE MEDICINE; BONE REGENERATION; PROTEIN FIBER;
   IN-VITRO; HYDROGELS; DIFFERENTIATION
AB Cell and tissue engineering therapies for regenerative medicine as well as cell-based assays require an understanding of the interactions between cells with the surrounding microenvironment at the nanoscale. Engineering a cell-interactive scaffold therefore entails control over the nanostructure of the biomaterial. Peptides that are able to self-assemble into 3D scaffolds have emerged as interesting biomaterials for directing cell behavior, with desirable properties such as the capability of tuning the nanostructure by modulating the amino acid composition. Here, an overview of the development of self-assembling peptide hydrogels as functional cell scaffolds is presented, highlighting recent work on incorporating features such as bioactive ligands, growth factor delivery, controlled degradation, and formulation into microgels for defined cell microenvironments.
C1 [Wu, Elizabeth C.; Zhang, Shuguang; Hauser, Charlotte A. E.] ASTAR, Inst Bioengn & Nanotechnol, The Nanos 138669, Singapore.
RP Wu, EC (reprint author), ASTAR, Inst Bioengn & Nanotechnol, 31 Biopolis Way, The Nanos 138669, Singapore.
EM chauser@ibn.a-star.edu.sg
RI Hauser, Charlotte/B-6850-2015; Hauser, Charlotte/C-1321-2014
OI Hauser, Charlotte/0000-0001-8251-7246
FU Institute of Bioengineering and Nanotechnology (Biomedical Research
   Council, Agency for Science, Technology and Research (A*STAR),
   Singapore)
FX The authors thank Dr. Yihua Eva Loo, Dr. Wei Yang Seow, Archana Mishra,
   and Anupama Lakshmanan for their help with proofreading. This work was
   supported by the Institute of Bioengineering and Nanotechnology
   (Biomedical Research Council, Agency for Science, Technology and
   Research (A*STAR), Singapore).
CR Aggeli A, 1997, NATURE, V386, P259, DOI 10.1038/386259a0
   Aggeli A, 2003, J AM CHEM SOC, V125, P9619, DOI 10.1021/ja021047i
   Andukuri A, 2011, ACTA BIOMATER, V7, P225, DOI 10.1016/j.actbio.2010.08.013
   Angeloni NL, 2011, BIOMATERIALS, V32, P1091, DOI 10.1016/j.biomaterials.2010.10.003
   Ayala R, 2011, BIOMATERIALS, V32, P3700, DOI 10.1016/j.biomaterials.2011.02.004
   Bakota EL, 2011, BIOMACROMOLECULES, V12, P1651, DOI 10.1021/bm200035r
   Banwell EF, 2009, NAT MATER, V8, P596, DOI [10.1038/nmat2479, 10.1038/NMAT2479]
   Beachley V, 2010, PROG POLYM SCI, V35, P868, DOI 10.1016/j.progpolymsci.2010.03.003
   Botchwey EA, 2001, J BIOMED MATER RES, V55, P242
   Bromley EHC, 2009, J AM CHEM SOC, V131, P928, DOI 10.1021/ja804231a
   Brun P, 2011, ACTA BIOMATER, V7, P2526, DOI 10.1016/j.actbio.2011.02.025
   Cavalli S, 2010, CHEM SOC REV, V39, P241, DOI 10.1039/b906701a
   Chau Y, 2008, BIOMATERIALS, V29, P1713, DOI 10.1016/j.biomaterials.2007.11.046
   Chow LW, 2011, BIOMATERIALS, V32, P1574, DOI 10.1016/j.biomaterials.2010.10.048
   Chow LW, 2010, BIOMATERIALS, V31, P6154, DOI 10.1016/j.biomaterials.2010.04.002
   Cui HG, 2010, BIOPOLYMERS, V94, P1, DOI 10.1002/bip.21328
   Davis ME, 2006, P NATL ACAD SCI USA, V103, P8155, DOI 10.1073/pnas.0602877103
   Discher DE, 2009, SCIENCE, V324, P1673, DOI 10.1126/science.1171643
   Dutta RC, 2010, BIOTECHNOL ADV, V28, P764, DOI 10.1016/j.biotechadv.2010.06.002
   Dutta RC, 2009, BIOTECHNOL ADV, V27, P334, DOI 10.1016/j.biotechadv.2009.02.002
   Ellis-Behnke RG, 2006, P NATL ACAD SCI USA, V103, P5054, DOI 10.1073/pnas.0600559103
   Elzey DM, 2001, ACTA MATER, V49, P849, DOI 10.1016/S1359-6454(00)00395-5
   Firth A, 2006, NANOMEDICINE-UK, V1, P189, DOI 10.2217/17435889.1.2.189
   Fisher OZ, 2010, ACCOUNTS CHEM RES, V43, P419, DOI 10.1021/ar900226q
   Fung SY, 2011, ADV FUNCT MATER, V21, P2456, DOI 10.1002/adfm.201002497
   Galler KM, 2008, TISSUE ENG PT A, V14, P2051, DOI 10.1089/ten.tea.2007.0413
   Galler KM, 2010, J AM CHEM SOC, V132, P3217, DOI 10.1021/ja910481t
   Gelain F, 2007, MACROMOL BIOSCI, V7, P544, DOI 10.1002/mabi.200700033
   Gelain F, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000119
   Gelain F, 2011, ACS NANO, V5, P1845, DOI 10.1021/nn102663a
   Gelain F, 2010, J CONTROL RELEASE, V145, P231, DOI 10.1016/j.jconrel.2010.04.026
   Ghanaati S, 2009, BIOMATERIALS, V30, P6202, DOI 10.1016/j.biomaterials.2009.07.063
   Giano MC, 2011, BIOMATERIALS, V32, P6471, DOI 10.1016/j.biomaterials.2011.05.052
   Haines-Butterick L, 2007, P NATL ACAD SCI USA, V104, P7791, DOI 10.1073/pnas.0701980104
   Haines-Butterick LA, 2008, BIOMATERIALS, V29, P4164, DOI 10.1016/j.biomaterials.2008.07.009
   Hartgerink JD, 2001, SCIENCE, V294, P1684, DOI 10.1126/science.1063187
   Hauser CAE, 2011, P NATL ACAD SCI USA, V108, P1361, DOI 10.1073/pnas.1014796108
   Hauser CAE, 2010, CHEM SOC REV, V39, P2780, DOI 10.1039/b921448h
   Holmes TC, 2000, P NATL ACAD SCI USA, V97, P6728, DOI 10.1073/pnas.97.12.6728
   Horii A, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000190
   Hosseinkhani H, 2006, BIOMATERIALS, V27, P4079, DOI 10.1016/j.biomaterials.2006.03.030
   Ikeda M, 2011, ADV MATER, V23, P2819, DOI 10.1002/adma.201004658
   Jun HW, 2005, ADV MATER, V17, P2612, DOI 10.1002/adma.200500855
   Jung JP, 2010, BIOPOLYMERS, V94, P49, DOI 10.1002/bip.21326
   Justice BA, 2009, DRUG DISCOV TODAY, V14, P102, DOI 10.1016/j.drudis.2008.11.006
   Kao B, 2009, TISSUE ENG PT A, V15, P2385, DOI 10.1089/ten.tea.2008.0362
   Kelleher CM, 2010, J R SOC INTERFACE, V7, pS717, DOI 10.1098/rsif.2010.0345.focus
   Kim JH, 2011, BIOMATERIALS, V32, P6080, DOI 10.1016/j.biomaterials.2011.05.003
   Kirkham J, 2007, J DENT RES, V86, P426, DOI 10.1177/154405910708600507
   Kisiday J, 2002, P NATL ACAD SCI USA, V99, P9996, DOI 10.1073/pnas.142309999
   Kokkoli E, 2006, SOFT MATTER, V2, P1015, DOI 10.1039/b608929a
   Kopesky PW, 2011, TISSUE ENG PT A, V17, P83, DOI [10.1089/ten.tea.2010.0198, 10.1089/ten.TEA.2010.0198]
   Kumada Y, 2010, SOFT MATTER, V6, P5073, DOI 10.1039/c0sm00333f
   Kumada Y, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010305
   Kyle S, 2010, BIOMATERIALS, V31, P9395, DOI 10.1016/j.biomaterials.2010.08.051
   Kyle S, 2009, TRENDS BIOTECHNOL, V27, P423, DOI 10.1016/j.tibtech.2009.04.002
   Lock LT, 2007, TISSUE ENG, V13, P1399, DOI 10.1089/ten.2007.0047
   Mahmoud ZN, 2011, BIOMATERIALS, V32, P3712, DOI 10.1016/j.biomaterials.2010.12.002
   Mahmoud ZN, 2010, BIOMATERIALS, V31, P7468, DOI 10.1016/j.biomaterials.2010.06.041
   Mata A, 2010, BIOMATERIALS, V31, P6004, DOI 10.1016/j.biomaterials.2010.04.013
   Melkoumian Z, 2010, NAT BIOTECHNOL, V28, P606, DOI 10.1038/nbt.1629
   Menasche P, 2004, CURR OPIN CARDIOL, V19, P154, DOI 10.1097/00001573-200403000-00016
   Misawa H, 2006, CELL TRANSPLANT, V15, P903, DOI 10.3727/000000006783981369
   Mishra A, 2011, NANO TODAY, V6, P232, DOI 10.1016/j.nantod.2011.05.001
   Papapostolou D, 2007, P NATL ACAD SCI USA, V104, P10853, DOI 10.1073/pnas.0700801104
   Prestwich GD, 2007, J CELL BIOCHEM, V101, P1370, DOI 10.1002/jeb.21386
   Rajagopal K, 2004, CURR OPIN STRUC BIOL, V14, P480, DOI 10.1016/j.sbi.2004.06.006
   Rajangam K, 2008, BIOMATERIALS, V29, P3298, DOI 10.1016/j.biomaterials.2008.04.008
   Rozkiewicz DI, 2011, ANGEW CHEM INT EDIT, V50, P6324, DOI 10.1002/anie.201100821
   Ryadnov MG, 2003, NAT MATER, V2, P329, DOI 10.1038/nmat885
   Sargeant TD, 2008, BIOMATERIALS, V29, P161, DOI 10.1016/j.biomaterials.2007.09.012
   Schmidt JJ, 2011, TISSUE ENG PT A, V17, P2687, DOI 10.1089/ten.tea.2010.0685
   Shah RN, 2010, P NATL ACAD SCI USA, V107, P3293, DOI 10.1073/pnas.0906501107
   Silva GA, 2004, SCIENCE, V303, P1352, DOI 10.1126/science.1093783
   Slaughter BV, 2009, ADV MATER, V21, P3307, DOI 10.1002/adma.200802106
   Sun JH, 2010, MAT SCI ENG C-MATER, V30, P975, DOI 10.1016/j.msec.2010.04.018
   Sun JH, 2010, J HUAZHONG U SCI-MED, V30, P173, DOI 10.1007/s11596-010-0208-z
   Tian YF, 2011, SOFT MATTER, V7, P6005, DOI 10.1039/c1sm05504f
   Tsuda Y, 2010, LANGMUIR, V26, P2645, DOI [10.1021/la902827y, 10.1021/la002827y]
   Van Tomme SR, 2008, INT J PHARM, V355, P1, DOI 10.1016/j.ijpharm.2008.01.057
   Wang Y, 2010, BIOMATERIALS, V31, P5122, DOI 10.1016/j.biomaterials.2010.03.007
   Wheeldon I, 2011, NANOTECHNOLOGY, V22, DOI 10.1088/0957-4484/22/21/212001
   Williams RJ, 2011, BIOMATERIALS, V32, P5304, DOI 10.1016/j.biomaterials.2011.03.078
   Wu LC, 2011, BIOMATERIALS, V32, P5341, DOI 10.1016/j.biomaterials.2011.04.014
   Yan CQ, 2010, SOFT MATTER, V6, P5143, DOI 10.1039/c0sm00642d
   Yang YL, 2009, NANO TODAY, V4, P193, DOI 10.1016/j.nantod.2009.02.009
   Yang ZH, 2011, INT J NANOMED, V6, P303, DOI 10.2147/IJN.S15279
   Zamanian B, 2010, SMALL, V6, P937, DOI 10.1002/smll.200902326
   ZHANG SG, 1993, P NATL ACAD SCI USA, V90, P3334, DOI 10.1073/pnas.90.8.3334
   ZHANG SG, 1995, BIOMATERIALS, V16, P1385, DOI 10.1016/0142-9612(95)96874-Y
   Zhang SG, 2003, NAT BIOTECHNOL, V21, P1171, DOI 10.1038/nbt874
   Zhang SM, 2010, NAT MATER, V9, P594, DOI [10.1038/nmat2778, 10.1038/NMAT2778]
   Zhang ZX, 2010, BIOTECHNOL BIOPROC E, V15, P545, DOI 10.1007/s12257-009-3076-2
   Zhao XB, 2010, CHEM SOC REV, V39, P3480, DOI 10.1039/b915923c
   Zhou M, 2009, BIOMATERIALS, V30, P2523, DOI 10.1016/j.biomaterials.2009.01.010
NR 95
TC 62
Z9 64
U1 7
U2 130
PU WILEY-V C H VERLAG GMBH
PI WEINHEIM
PA POSTFACH 101161, 69451 WEINHEIM, GERMANY
SN 1616-301X
EI 1616-3028
J9 ADV FUNCT MATER
JI Adv. Funct. Mater.
PD FEB 8
PY 2012
VL 22
IS 3
BP 456
EP 468
DI 10.1002/adfm.201101905
PG 13
WC Chemistry, Multidisciplinary; Chemistry, Physical; Nanoscience &
   Nanotechnology; Materials Science, Multidisciplinary; Physics, Applied;
   Physics, Condensed Matter
SC Chemistry; Science & Technology - Other Topics; Materials Science;
   Physics
GA 884UL
UT WOS:000299734200001
DA 2018-10-19
ER

PT J
AU Sivaraman, B
   Latour, RA
AF Sivaraman, Balakrishnan
   Latour, Robert A.
TI Time-Dependent Conformational Changes in Adsorbed Albumin and Its Effect
   on Platelet Adhesion
SO LANGMUIR
LA English
DT Article
ID SELF-ASSEMBLED MONOLAYERS; VON-WILLEBRAND-FACTOR; DRUG-ELUTING STENTS;
   PROTEIN SECONDARY STRUCTURE; CIRCULAR-DICHROISM SPECTRA;
   HIGH-DENSITY-LIPOPROTEIN; ATOMIC-FORCE MICROSCOPY; HUMAN SERUM-ALBUMIN;
   BIOMATERIAL SURFACES; THROMBUS FORMATION
AB Recent studies have shown that platelets can adhere to adsorbed albumin (Alb) through a receptor-mediated mechanism, but only if the Alb undergoes more than a critical degree of adsorption-induced unfolding. The objectives of this research were to investigate whether Alb that was initially adsorbed in a manner that induced unfolding that was less than this critical level would undergo further unfolding with time and, if so, whether this would induce the onset of platelet adhesion once this critical level was exceeded. To address these questions, CD spectropolarimetry was used to monitor the structure of Alb on OH- and CH3-functionalized alkanethiol self-assembled monolayer surfaces, with the Alb initially adsorbed under conditions resulting in degrees of unfolding that were below this critical level, and then the adsorbed Alb layers were aged over 6 months in sterile physiological saline at 37 degrees C. Platelet adhesion to Alb was quantified at selected time points via a lactate dehydrogenase (LDH) assay. The results indicate that an adsorbed Alb layer does undergo further structural changes with increasing residence time and supports platelet adhesion once it unfolds beyond the previously determined critical level. These results may be relevant to the clinically observed problem of the onset of late-thrombosis, which occurs on cardiovascular implants such as drug-eluting stents.
C1 [Sivaraman, Balakrishnan; Latour, Robert A.] Clemson Univ, Dept Bioengn, Clemson, SC 29634 USA.
RP Latour, RA (reprint author), Clemson Univ, Dept Bioengn, Clemson, SC 29634 USA.
EM latourr@clemson.edu
RI Sivaraman, Balakrishnan/G-6886-2012
OI Sivaraman, Balakrishnan/0000-0002-4538-8665
FU NIH from the National Center for Research Resources [P20 RR-016461]; NIH
   from the National Institute of Bioimaging and Bioengineering [P20
   RR-021949]
FX The authors thank numerous volunteers for kindly donating blood for
   these studies as well as the staff at the Redfern Health Center at
   Clemson University for their assistance with the blood-draw process. We
   are grateful to Mr. Aby Abraham Thyparambil for technical assistance. We
   are also grateful to Dr. James Harriss at Clemson University, for
   fabrication of the gold-coated surfaces used in our studies. This
   project was partially supported by NIH Grant Nos, P20 RR-016461 from the
   National Center for Research Resources and P20 RR-021949 from the
   National Institute of Bioimaging and Bioengineering.
CR Agnihotri A, 2004, LANGMUIR, V20, P8846, DOI 10.1021/la049239
   AKAIKE T, 1979, KOBUNSHI RONBUNSHU, V36, P217, DOI 10.1295/koron.36.217
   [Anonymous], 2008, ENCY BIOMATERIALS BI, P270
   BAIN CD, 1989, J AM CHEM SOC, V111, P321, DOI 10.1021/ja00183a049
   Balasubramanian V, 1999, J BIOMED MATER RES, V44, P253, DOI 10.1002/(SICI)1097-4636(19990305)44:3<253::AID-JBM3>3.0.CO;2-K
   Becker DM, 2006, JAMA-J AM MED ASSOC, V295, P1420, DOI 10.1001/jama.295.12.1420
   Cazenave Jean-Pierre, 2004, Methods Mol Biol, V272, P13
   Coelho MAN, 2003, LANGMUIR, V19, P7544, DOI 10.1021/la034445n
   Cornelius RM, 2011, J BIOMED MATER RES A, V99A, P109, DOI 10.1002/jbm.a.33169
   Cornelius RM, 2011, J BIOMED MATER RES A, V98A, P7, DOI 10.1002/jbm.a.33084
   Cornelius RM, 2002, J BIOMED MATER RES, V60, P622, DOI 10.1002/jbm.10117
   Cornelius RM, 2002, BIOMATERIALS, V23, P3583, DOI 10.1016/S0142-9612(02)00083-2
   Curry S, 1998, NAT STRUCT BIOL, V5, P827, DOI 10.1038/1869
   Damodaran S, 2003, ANAL BIOANAL CHEM, V376, P182, DOI 10.1007/s00216-003-1873-6
   Dee K.C., 2002, INTRO TISSUE BIOMATE, P37
   DEFEIJTER JA, 1978, BIOPOLYMERS, V17, P1759, DOI 10.1002/bip.1978.360170711
   Fears KP, 2009, LANGMUIR, V25, P9319, DOI 10.1021/la901885d
   Finn AV, 2007, ARTERIOSCL THROM VAS, V27, P1500, DOI 10.1161/ATVBAHA.107.144220
   Finn AV, 2007, CIRCULATION, V115, P2435, DOI 10.1161/CIRCULATIONAHA.107.693739
   Flynn NT, 2003, LANGMUIR, V19, P10909, DOI 10.1021/la035331e
   Freedman JE, 2007, CIRCULATION, V115, P2468, DOI 10.1161/CIRCULATIONAHA.107.699165
   Gooding JJ, 2003, ELECTROANAL, V15, P81, DOI 10.1002/elan.200390017
   Gorbet MB, 2004, BIOMATERIALS, V25, P5681, DOI 10.1016/j.biomaterials.2004.01.023
   Greenfield NJ, 2006, NAT PROTOC, V1, P2876, DOI 10.1038/nprot.2006.202
   Grunkemeier JM, 2001, J BIOMAT SCI-POLYM E, V12, P1, DOI 10.1163/156856201744416
   HORBETT TA, 1994, J BIOMAT SCI-POLYM E, V6, P15, DOI 10.1163/156856295X00724
   Hylton DM, 2005, J BIOMED MATER RES A, V73A, P349, DOI 10.1002/jbm.a.30295
   JANATOVA J, 1968, J BIOL CHEM, V243, P3612
   Joner M, 2006, J AM COLL CARDIOL, V48, P193, DOI 10.1016/j.jacc.2006.03.042
   Kim J. S., 2010, AM HEART J, V159
   Kim JS, 2009, CIRCULATION, V120, pS989
   Knetsch MLW, 2006, BIOMATERIALS, V27, P2813, DOI 10.1016/j.biomaterials.2005.12.025
   KOTTKEMARCHANT K, 1989, BIOMATERIALS, V10, P147, DOI 10.1016/0142-9612(89)90017-3
   Kwak D, 2005, J BIOMED MATER RES A, V74A, P69, DOI 10.1002/jbm.a.30365
   LENK TJ, 1991, LANGMUIR, V7, P1755, DOI 10.1021/la00056a030
   LINDON JN, 1986, BLOOD, V68, P355
   LIU WR, 1991, BIOTECHNOL BIOENG, V37, P177, DOI 10.1002/bit.260370210
   Love JC, 2005, CHEM REV, V105, P1103, DOI 10.1021/cr0300789
   Marois Y, 1996, BIOMATERIALS, V17, P3, DOI 10.1016/0142-9612(96)80749-6
   Nakazawa G, 2008, CIRCULATION, V118, P1138, DOI 10.1161/CIRCULATIONAHA.107.762047
   Nonckreman CJ, 2007, J BIOMED MATER RES A, V81A, P791, DOI 10.1002/jbm.a.31111
   PAUL L, 1981, J COLLOID INTERF SCI, V84, P546, DOI 10.1016/0021-9797(81)90245-9
   Qiu JS, 2005, J CHROMATOGR A, V1073, P263, DOI 10.1016/j.chroma.2004.10.045
   RAPOZA R J, 1989, Journal of Biomaterials Science Polymer Edition, V1, P99, DOI 10.1163/156856289X00091
   RAPOZA RJ, 1990, J COLLOID INTERF SCI, V136, P480, DOI 10.1016/0021-9797(90)90395-5
   Roach P, 2005, J AM CHEM SOC, V127, P8168, DOI 10.1021/ja042898o
   Sivaraman B, 2010, BIOMATERIALS, V31, P1036, DOI 10.1016/j.biomaterials.2009.10.017
   Sivaraman B, 2010, BIOMATERIALS, V31, P832, DOI 10.1016/j.biomaterials.2009.10.008
   Sivaraman B, 2009, LANGMUIR, V25, P3050, DOI 10.1021/la8036814
   Soman P, 2008, LANGMUIR, V24, P8801, DOI 10.1021/la801227e
   Sreerama N, 2000, ANAL BIOCHEM, V287, P252, DOI 10.1006/abio.2000.4880
   Suggs LJ, 1999, BIOMATERIALS, V20, P683, DOI 10.1016/S0142-9612(98)00226-9
   TAMADA Y, 1995, BIOMATERIALS, V16, P259, DOI 10.1016/0142-9612(95)92126-Q
   Tanaka M, 2000, BIOMATERIALS, V21, P1471, DOI 10.1016/S0142-9612(00)00031-4
   Tsai WB, 1999, J BIOMED MATER RES, V44, P130, DOI 10.1002/(SICI)1097-4636(199902)44:2<130::AID-JBM2>3.0.CO;2-9
   VROMAN L, 1969, SURF SCI, V16, P438, DOI 10.1016/0039-6028(69)90037-5
   Wertz CF, 2001, LANGMUIR, V17, P3006, DOI 10.1021/la0017781
   Wu YG, 2008, J BIOMED MATER RES A, V85A, P829, DOI 10.1002/jbm.a.31505
NR 58
TC 27
Z9 27
U1 1
U2 27
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 0743-7463
J9 LANGMUIR
JI Langmuir
PD FEB 7
PY 2012
VL 28
IS 5
BP 2745
EP 2752
DI 10.1021/la204777x
PG 8
WC Chemistry, Multidisciplinary; Chemistry, Physical; Materials Science,
   Multidisciplinary
SC Chemistry; Materials Science
GA 886OU
UT WOS:000299864500054
PM 22191731
OA Green Accepted
DA 2018-10-19
ER

PT J
AU Daly, W
   Yao, L
   Zeugolis, D
   Windebank, A
   Pandit, A
AF Daly, W.
   Yao, L.
   Zeugolis, D.
   Windebank, A.
   Pandit, A.
TI A biomaterials approach to peripheral nerve regeneration: bridging the
   peripheral nerve gap and enhancing functional recovery
SO JOURNAL OF THE ROYAL SOCIETY INTERFACE
LA English
DT Review
DE peripheral nerve conduit; topographical guidance; molecular therapy;
   Schwann cells; stem cells; neurotrophic factors
ID MESENCHYMAL STEM-CELLS; GLYCOLIC ACID) CONDUITS; CROSS-LINKED GELATIN;
   IN-VIVO EVALUATION; SCHWANN-CELLS; NEUROTROPHIC FACTOR; GUIDANCE
   CHANNELS; GROWTH-FACTOR; AXONAL REGENERATION; COLLAGEN FILAMENTS
AB Microsurgical techniques for the treatment of large peripheral nerve injuries (such as the gold standard autograft) and its main clinically approved alternative-hollow nerve guidance conduits (NGCs)-have a number of limitations that need to be addressed. NGCs, in particular, are limited to treating a relatively short nerve gap (4 cm in length) and are often associated with poor functional recovery. Recent advances in biomaterials and tissue engineering approaches are seeking to overcome the limitations associated with these treatment methods. This review critically discusses the advances in biomaterial-based NGCs, their limitations and where future improvements may be required. Recent developments include the incorporation of topographical guidance features and/or intraluminal structures, which attempt to guide Schwann cell (SC) migration and axonal regrowth towards their distal targets. The use of such strategies requires consideration of the size and distribution of these topographical features, as well as a suitable surface for cell-material interactions. Likewise, cellular and molecular-based therapies are being considered for the creation of a more conductive nerve microenvironment. For example, hurdles associated with the short half-lives and low stability of molecular therapies are being surmounted through the use of controlled delivery systems. Similarly, cells (SCs, stem cells and genetically modified cells) are being delivered with biomaterial matrices in attempts to control their dispersion and to facilitate their incorporation within the host regeneration process. Despite recent advances in peripheral nerve repair, there are a number of key factors that need to be considered in order for these new technologies to reach the clinic.
C1 [Daly, W.; Yao, L.; Zeugolis, D.; Pandit, A.] Natl Univ Ireland, Network Excellence Funct Biomat NFB, Galway, Ireland.
   [Windebank, A.] Mayo Clin, Rochester, MA USA.
RP Pandit, A (reprint author), Natl Univ Ireland, Network Excellence Funct Biomat NFB, Newcastle Rd, Galway, Ireland.
EM abhay.pandit@nuigalway.ie
RI 李, 涵/B-4995-2012; Daly, William/O-1714-2013; Yao, Li/J-1372-2016;
   Pandit, Abhay/B-6187-2008
OI Pandit, Abhay/0000-0002-6292-4933; zeugolis,
   dimitrios/0000-0002-7599-5191
FU Science Foundation Ireland [07/SRC/B1163, 08/RFP/ENM1218]
FX This material is based upon works supported by the Science Foundation
   Ireland under Grant No. 07/SRC/B1163 and Science Foundation Ireland
   Research Frontiers Program (08/RFP/ENM1218).
CR Abu-Rub MT, 2011, SOFT MATTER, V7, P2770, DOI 10.1039/c0sm01062f
   Alluin O, 2009, BIOMATERIALS, V30, P363, DOI 10.1016/j.biomaterials.2008.09.043
   Armstrong SJ, 2007, TISSUE ENG, V13, P2863, DOI 10.1089/ten.2007.0055
   Barras FM, 2002, J NEUROSCI RES, V70, P746, DOI 10.1002/jnr.10434
   Belkas JS, 2004, NEUROL RES, V26, P151, DOI 10.1179/016164104225013798
   Bellamkonda RV, 2006, BIOMATERIALS, V27, P3515, DOI 10.1016/j.biomaterials.2006.02.030
   Boeshore KL, 2004, J NEUROBIOL, V59, P216, DOI 10.1002/neu.10308
   Bosse F, 2006, J NEUROCHEM, V96, P1441, DOI 10.1111/j.1471-4159.2005.03635.x
   Bozkurt A, 2009, BIOMATERIALS, V30, P169, DOI 10.1016/j.biomaterials.2008.09.017
   Brenner MJ, 2006, LARYNGOSCOPE, V116, P1685, DOI 10.1097/01.mlg.0000229469.31749.91
   Bunting S, 2005, J HAND SURG-BRIT EUR, V30B, P242, DOI 10.1016/j.jhsh.2004.11.003
   Caddick J, 2006, GLIA, V54, P840, DOI 10.1002/glia.20421
   Cai J, 2005, J BIOMED MATER RES A, V75A, P374, DOI 10.1002/jbm.a.30432
   Chang CJ, 2009, J BIOMED MATER RES A, V91A, P586, DOI 10.1002/jbm.a.32252
   Chang CJ, 2006, BIOMATERIALS, V27, P1035, DOI 10.1016/j.biomaterials.2005.07.003
   Chang CJ, 2004, ULTRASOUND MED BIOL, V30, P1079, DOI 10.1016/j.ultrasmedbio.2004.06.005
   Chen YS, 2005, BIOMATERIALS, V26, P3911, DOI 10.1016/j.biomaterials.2004.09.060
   Chew SY, 2007, ADV FUNCT MATER, V17, P1288, DOI 10.1002/adfm.200600441
   CHIONO V, 2009, INT REV NEUROBIOL, P173
   Chung HJ, 2007, ADV DRUG DELIVER REV, V59, P249, DOI 10.1016/j.addr.2007.03.015
   Clements IP, 2009, BIOMATERIALS, V30, P3834, DOI 10.1016/j.biomaterials.2009.04.022
   Colangelo AM, 2008, J NEUROSCI, V28, P2698, DOI 10.1523/JNEUROSCI.5201-07.2008
   D'Antonio M, 2006, GLIA, V53, P501, DOI 10.1002/glia.20309
   Dash BC, 2011, J CONTROL RELEASE, V152, P382, DOI 10.1016/j.jconrel.2011.03.006
   de Ruiter GC, 2008, NEUROSURGERY, V63, P144, DOI [10.1227/01.NEU.0000335081.47352.78, 10.1227/01.NEU.0000319521.28683.75]
   Deister C, 2006, J NEURAL ENG, V3, P172, DOI 10.1088/1741-2560/3/2/011
   Deumens R, 2010, PROG NEUROBIOL, V92, P245, DOI 10.1016/j.pneurobio.2010.10.002
   di Summa PG, 2011, NEUROSCIENCE, V181, P278, DOI 10.1016/j.neuroscience.2011.02.052
   di Summa PG, 2010, J PLAST RECONSTR AES, V63, P1544, DOI 10.1016/j.bjps.2009.09.012
   Ding F, 2010, TISSUE ENG PT A, V16, P3779, DOI [10.1089/ten.tea.2010.0299, 10.1089/ten.TEA.2010.0299]
   Evans GRD, 2002, BIOMATERIALS, V23, P841, DOI 10.1016/S0142-9612(01)00190-9
   Fan WM, 2008, MICROSURG, V28, P238, DOI 10.1002/micr.20488
   Fine EG, 2002, EUR J NEUROSCI, V15, P589, DOI 10.1046/j.1460-9568.2002.01892.x
   Greenberg DA, 2005, NATURE, V438, P954, DOI 10.1038/nature04481
   Griffin J, 2010, ACTA BIOMATER, V6, P1917, DOI 10.1016/j.actbio.2009.11.023
   Gu JH, 2012, J TISSUE ENG REGEN M, V6, P163, DOI 10.1002/term.407
   Haastert K, 2006, NEUROBIOL DIS, V21, P138, DOI 10.1016/j.nbd.2005.06.020
   Hadlock T, 2000, TISSUE ENG, V6, P119, DOI 10.1089/107632700320748
   Hobson MI, 2002, ANN ROY COLL SURG, V84, P47
   Hoffman-Kim D, 2010, ANNU REV BIOMED ENG, V12, P203, DOI 10.1146/annurev-bioeng-070909-105351
   Hu XY, 2009, TISSUE ENG PT A, V15, P3297, DOI 10.1089/ten.TEA.2009.0017
   Hung V, 2008, J HAND SURG-AM, V33A, P313, DOI 10.1016/j.jhsa.2007.12.008
   Ijpma FFA, 2008, J HAND SURG-EUR VOL, V33E, P581, DOI 10.1177/1753193408091349
   Itoh S, 2003, BRAIN RES, V993, P111, DOI 10.1016/j.brainres.2003.09.003
   Itoh S, 2001, J RECONSTR MICROSURG, V17, P115, DOI 10.1055/s-2001-12700
   Itoh S, 1999, J MATER SCI-MATER M, V10, P129, DOI 10.1023/A:1008977221827
   Jiang X, 2010, EXP NEUROL, V223, P86, DOI 10.1016/j.expneurol.2009.09.009
   Jimenez CR, 2005, MOL CELL PROTEOMICS, V4, P120, DOI 10.1074/mcp.M400076-MCP200
   Kaewkhaw R, 2011, GLIA, V59, P734, DOI 10.1002/glia.21145
   Kalbermatten DF, 2008, J PLAST RECONSTR AES, V61, P669, DOI 10.1016/j.bjps.2007.12.015
   KIERNAN J, 1998, HUMAN NERVOUS SYSTEM, P16
   Kim H, 2008, BIOTECHNOL PROGR, V24, P932, DOI [10.1021/bp070352a, 10.1021/bp.070352a]
   Kim YT, 2008, BIOMATERIALS, V29, P3117, DOI 10.1016/j.biomaterials.2008.03.042
   Kingham PJ, 2007, EXP NEUROL, V207, P267, DOI 10.1016/j.expneurol.2007.06.029
   Koh HS, 2010, J NEURAL ENG, V7, DOI 10.1088/1741-2560/7/4/046003
   Kubo T, 2002, J NEUROCHEM, V82, P1129, DOI 10.1046/j.1471-4159.2002.01060.x
   Ladak A, 2011, EXP NEUROL, V228, P242, DOI 10.1016/j.expneurol.2011.01.013
   Lee DY, 2006, J CRANIO MAXILL SURG, V34, P50, DOI 10.1016/jcm.2005.07.011
   Lee JH, 2011, J R SOC INTERFACE, V8, P998, DOI 10.1098/rsif.2010.0613
   Lee S. K., 2000, J AM ACAD ORTHOP SUR, V8, P243, DOI DOI 10.5435/00124635-200007000-00005
   Li QF, 2006, MICROSURG, V26, P116, DOI 10.1002/micr.20192
   Lietz M, 2006, BIOMATERIALS, V27, P1425, DOI 10.1016/j.biomaterials.2005.08.007
   Liu JJ, 2011, J BIOMED MATER RES A, V96A, P13, DOI 10.1002/jbm.a.32946
   Longo Frank M., 2005, Current Medicinal Chemistry - Central Nervous System Agents, V5, P29
   Lundborg G, 2000, J HAND SURG-AM, V25A, P391, DOI 10.1053/jhsu.2000.4165
   Madduri S, 2010, BIOMATERIALS, V31, P2323, DOI 10.1016/j.biomaterials.2009.11.073
   Madduri S, 2010, BIOMATERIALS, V31, P8402, DOI 10.1016/j.biomaterials.2010.07.052
   Madduri S, 2010, J PERIPHER NERV SYST, V15, P93, DOI 10.1111/j.1529-8027.2010.00257.x
   Madduri S, 2010, J CONTROL RELEASE, V143, P168, DOI 10.1016/j.jconrel.2009.12.017
   Mahoney MJ, 2005, BIOMATERIALS, V26, P771, DOI 10.1016/j.biomaterials.2004.03.015
   Matsumoto K, 2000, BRAIN RES, V868, P315, DOI 10.1016/S0006-8993(00)02207-1
   McGrath AM, 2010, BRAIN RES BULL, V83, P207, DOI 10.1016/j.brainresbull.2010.07.001
   Moradzadeh A, 2008, EXP NEUROL, V212, P370, DOI 10.1016/j.expneurol.2008.04.012
   Mosahebi A, 2001, GLIA, V34, P8, DOI 10.1002/glia.1035
   Mukhatyar V, 2009, ADV MATER, V21, P4670
   Nagarajan R, 2002, P NATL ACAD SCI USA, V99, P8998, DOI 10.1073/pnas.132080999
   Ngo TTB, 2003, J NEUROSCI RES, V72, P227, DOI 10.1002/jnr.10570
   Nichols CM, 2004, EXP NEUROL, V190, P347, DOI 10.1016/j.expneurol.2004.08.003
   Nichterwitz S, 2010, NEUROSCI LETT, V484, P118, DOI 10.1016/j.neulet.2010.08.028
   Nomura H, 2006, J NEUROTRAUM, V23, P496, DOI 10.1089/neu.2006.23.496
   Oh SH, 2008, BIOMATERIALS, V29, P1601, DOI 10.1016/j.biomaterials.2007.11.036
   Oliveira JT, 2010, NEUROSCIENCE, V170, P1295, DOI 10.1016/j.neuroscience.2010.08.042
   Pabari A, 2010, J PLAST RECONSTR AES, V63, P1941, DOI 10.1016/j.bjps.2009.12.010
   Panseri S, 2008, BMC BIOTECHNOL, V8, DOI 10.1186/1472-6750-8-39
   Park SC, 2010, J BIOMED MATER RES B, V94B, P359, DOI 10.1002/jbm.b.31659
   Peleshok J, 2006, BIOCHEM SOC T, V34, P612, DOI 10.1042/BST0340612
   Pettersson J, 2010, J PLAST RECONSTR AES, V63, P1893, DOI 10.1016/j.bjps.2009.11.024
   Piquilloud G, 2007, EUR J NEUROSCI, V26, P1109, DOI 10.1111/j.1460-9568.2007.05748.x
   POLLARD JD, 1973, ACTA NEUROPATHOL, V23, P152, DOI 10.1007/BF00685769
   Radtke C, 2009, INT J DEV NEUROSCI, V27, P817, DOI 10.1016/j.ijdevneu.2009.08.006
   Rangappa N, 2000, J BIOMED MATER RES, V51, P625, DOI 10.1002/1097-4636(20000915)51:4<625::AID-JBM10>3.0.CO;2-U
   Rethore G, 2010, SMALL, V6, P488, DOI 10.1002/smll.200901253
   Ribeiro-Resende VT, 2009, BIOMATERIALS, V30, P5251, DOI 10.1016/j.biomaterials.2009.07.007
   Ruiter GCW, 2009, NEUROSURG FOCUS, V26, DOI 10.3171/FOC.2009.26.2.E5
   Rutkowski GE, 2004, J NEURAL ENG, V1, P151, DOI 10.1088/1741-2560/1/3/004
   Santiago LY, 2009, CELL TRANSPLANT, V18, P145, DOI 10.3727/096368909788341289
   Schense JC, 2000, NAT BIOTECHNOL, V18, P415
   Schmitte R, 2010, J NEUROSCI METH, V186, P202, DOI 10.1016/j.jneumeth.2009.11.023
   Shen H, 2010, J BIOMED MATER RES B, V95B, P161, DOI 10.1002/jbm.b.31696
   Siemionow M, 2007, J RECONSTR MICROSURG, V23, P511, DOI 10.1055/s-2007-1022694
   Siemionow M, 2010, MICROSURG, V30, P574, DOI 10.1002/micr.20799
   Siemionow M, 2009, INT REV NEUROBIOL, V87, P141, DOI 10.1016/S0074-7742(09)87008-6
   Sierpinski P, 2008, BIOMATERIALS, V29, P118, DOI 10.1016/j.biomaterials.2007.08.023
   Stang F, 2005, BIOMATERIALS, V26, P3083, DOI 10.1016/j.biomaterials.2004.07.060
   Timmer M, 2003, CELL TRANSPLANT, V12, P265, DOI 10.3727/000000003108746821
   Toba T, 2001, J BIOMED MATER RES, V58, P622, DOI 10.1002/jbm.1061
   Wang CY, 2011, ACTA BIOMATER, V7, P634, DOI 10.1016/j.actbio.2010.09.011
   Wang DY, 2008, J BIOMED MATER RES A, V85A, P434, DOI 10.1002/jbm.a.31568
   Wang SF, 2009, ACTA BIOMATER, V5, P1531, DOI 10.1016/j.actbio.2008.12.015
   Wang XD, 2005, BRAIN, V128, P1897, DOI 10.1093/brain/awh517
   Webster NJG, 2008, BMC NEUROSCI, V9, DOI 10.1186/1471-2202-9-S2-S1
   WILLIAMS LR, 1983, J COMP NEUROL, V218, P460, DOI 10.1002/cne.902180409
   WINTER JO, 2002, BIOMIMETIC MAT DESIG, P375
   Wood MD, 2010, BIOTECHNOL BIOENG, V106, P970, DOI 10.1002/bit.22766
   Wood MD, 2009, ACTA BIOMATER, V5, P959, DOI 10.1016/j.actbio.2008.11.008
   Xie JW, 2010, NANOSCALE, V2, P35, DOI 10.1039/b9nr00243j
   Xu XY, 2003, BIOMATERIALS, V24, P2405, DOI 10.1016/S0142-9612(03)00109-1
   Yang Y, 2005, J CONTROL RELEASE, V104, P433, DOI 10.1016/j.jconrel.2005.02.022
   Yao L, 2010, BIOMATERIALS, V31, P5789, DOI 10.1016/j.biomaterials.2010.03.081
   Yao L, 2009, ACTA BIOMATER, V5, P580, DOI 10.1016/j.actbio.2008.09.002
   Yoshii S, 2003, J BIOMED MATER RES A, V67A, P467, DOI 10.1002/jbm.a.10103
   Yoshii S, 2001, J BIOMED MATER RES, V56, P400, DOI 10.1002/1097-4636(20010905)56:3<400::AID-JBM1109>3.0.CO;2-7
   Yoshii S, 2001, BRAIN RES, V888, P158, DOI 10.1016/S0006-8993(00)03025-0
   Yu XJ, 2003, TISSUE ENG, V9, P421, DOI 10.1089/107632703322066606
   Yu XJ, 1999, TISSUE ENG, V5, P291, DOI 10.1089/ten.1999.5.291
   Zhou FQ, 2006, PHILOS T R SOC B, V361, P1575, DOI 10.1098/rstb.2006.1882
NR 126
TC 209
Z9 213
U1 10
U2 135
PU ROYAL SOC
PI LONDON
PA 6-9 CARLTON HOUSE TERRACE, LONDON SW1Y 5AG, ENGLAND
SN 1742-5689
EI 1742-5662
J9 J R SOC INTERFACE
JI J. R. Soc. Interface
PD FEB 7
PY 2012
VL 9
IS 67
BP 202
EP 221
DI 10.1098/rsif.2011.0438
PG 20
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA 866KR
UT WOS:000298380100002
PM 22090283
OA Green Published, Bronze
HC Y
HP N
DA 2018-10-19
ER

PT J
AU Almeida, CR
   Vasconcelos, DP
   Goncalves, RM
   Barbosa, MA
AF Almeida, Catarina R.
   Vasconcelos, Daniela P.
   Goncalves, Raquel M.
   Barbosa, Mario A.
TI Enhanced mesenchymal stromal cell recruitment via natural killer cells
   by incorporation of inflammatory signals in biomaterials
SO JOURNAL OF THE ROYAL SOCIETY INTERFACE
LA English
DT Article
DE tissue regeneration; inflammation; biomaterials; natural killer cells;
   mesenchymal stem cells
ID HUMAN OSTEOBLASTIC CELLS; STEM-CELLS; T-CELLS; INTERFERON-GAMMA; NK
   CELLS; IN-VIVO; PROLIFERATION; ACETYLATION; FIBRINOGEN; RECEPTORS
AB An exacerbated inflammatory response questions biomaterial biocompatibility, but on the other hand, inflammation has a central role in the regulation of tissue regeneration. Therefore, it may be argued that an 'ideal' inflammatory response is crucial to achieve efficient tissue repair/regeneration. Natural killer (NK) cells, being one of the first populations arriving at an injury site, can have an important role in regulating bone repair/regeneration, particularly through interactions with mesenchymal stem/stromal cells (MSCs). Here, we studied how biomaterials designed to incorporate inflammatory signals affected NK cell behaviour and NK cell-MSC interactions. Adsorption of the pro-inflammatory molecule fibrinogen (Fg) to chitosan films led to a 1.5-fold increase in adhesion of peripheral blood human NK cells, without an increase in cytokine secretion. Most importantly, it was found that NK cells are capable of stimulating a threefold increase in human bone marrow MSC invasion, a key event taking place in tissue repair, but did not affect the expression of the differentiation marker alkaline phosphatase (ALP). Of significant importance, this NK cell-mediated MSC recruitment was modulated by Fg adsorption. Designing novel biomaterials leading to rational modulation of the inflammatory response is proposed as an alternative to current bone regeneration strategies.
C1 [Almeida, Catarina R.; Vasconcelos, Daniela P.; Goncalves, Raquel M.; Barbosa, Mario A.] INEB Inst Engn Biomed, Biomat Div, NEWTherapies Grp, P-4150180 Oporto, Portugal.
   [Vasconcelos, Daniela P.; Barbosa, Mario A.] Univ Porto, Inst Ciencias Biomed Abel Salazar, P-4100 Oporto, Portugal.
   [Barbosa, Mario A.] Univ Porto, Fac Engn, P-4100 Oporto, Portugal.
RP Almeida, CR (reprint author), INEB Inst Engn Biomed, Biomat Div, NEWTherapies Grp, Rua Campo Alegre 823, P-4150180 Oporto, Portugal.
EM cralmeid@ineb.up.pt
RI Barbosa, Mario/F-5964-2011; Almeida, Catarina/A-7018-2012; Goncalves,
   Raquel/C-5940-2012
OI Barbosa, Mario/0000-0003-3568-7482; Almeida,
   Catarina/0000-0001-6670-6004; Goncalves, Raquel/0000-0003-2841-0485;
   Vasconcelos, Daniela/0000-0002-9242-2336
FU 'COMPETE-Programa Operacional Factores de Competitividade' (FEDER
   component); Fundacao para a Ciencia e a Tecnologia
   [PTDC/SAU-BEB/099954/2008, SFRH/BPD/48533/2008]
FX Samples of BM were collected by Servico de Ortopedia e Traumatologia
   from Hospital de S.Joao after ethics committee approval and informed
   consent. We thank Dr Cristina C. Barrias for size-exclusion
   chromatography, Dr M. Cristina L. Martins for help with the
   radiolabelling, Dr Trigo Cabral and Dr Nuno Neves (Servico de Ortopedia
   e Traumatologia, Hospital de S.Joao) for BM samples and Instituto
   Portugues do Sangue for buffy coats. This work was supported by
   'COMPETE-Programa Operacional Factores de Competitividade' (FEDER
   component) and by Fundacao para a Ciencia e a Tecnologia' (OE
   component-project reference PTDC/SAU-BEB/099954/2008). C. R. A. was
   funded by Fundacao para a Ciencia e a Tecnologia (SFRH/BPD/48533/2008).
CR Agaiby AD, 1999, J ANAT, V195, P531, DOI 10.1046/j.1469-7580.1999.19540531.x
   Aggarwal S, 2005, BLOOD, V105, P1815, DOI 10.1182/blood-2004-04-1559
   Agnihotri SA, 2004, J CONTROL RELEASE, V100, P5, DOI 10.1016/j.jconrel.2004.08.010
   Amaral IF, 2007, J BIOMAT SCI-POLYM E, V18, P469, DOI 10.1163/156856207780425068
   Amaral IF, 2006, J BIOMED MATER RES A, V76A, P335, DOI 10.1002/jbm.a.30522
   Anderson JM, 2008, SEMIN IMMUNOL, V20, P86, DOI 10.1016/j.smim.2007.11.004
   Anfossi N, 2006, IMMUNITY, V25, P331, DOI 10.1016/j.immuni.2006.06.013
   Barbosa JN, 2010, J BIOMED MATER RES A, V93A, P20, DOI 10.1002/jbm.a.32499
   Barbosa M.A., 2005, ITBM RBM, V26, P212, DOI DOI 10.1016/J.RBMRET.2005.04.006
   Berger J, 2004, EUR J PHARM BIOPHARM, V57, P35, DOI 10.1016/s0939-6411(03)00160-7
   Bryceson YT, 2006, IMMUNOL REV, V214, P73, DOI 10.1111/j.1600-065X.2006.00457.x
   Caplan AI, 2007, J CELL PHYSIOL, V213, P341, DOI 10.1002/jcp.21200
   Champagne CM, 2002, BONE, V30, P26, DOI 10.1016/S8756-3282(01)00638-X
   Culley FJ, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000159
   Dimitriou R, 2005, INJURY, V36, P1392, DOI 10.1016/j.injury.2005.07.019
   Dominici M, 2006, CYTOTHERAPY, V8, P315, DOI 10.1080/14653240600855905
   Drew AF, 2001, BLOOD, V97, P3691, DOI 10.1182/blood.V97.12.3691
   Duque G, 2009, STEM CELLS, V27, P550, DOI 10.1634/stemcells.2008-0886
   Dustin ML, 2007, CURR OPIN CELL BIOL, V19, P529, DOI 10.1016/j.ceb.2007.08.003
   Flick MJ, 2004, EXP BIOL MED, V229, P1105
   Gerstenfeld LC, 2003, J BONE MINER RES, V18, P1584, DOI 10.1359/jbmr.2003.18.9.1584
   Gerstenfeld LC, 2001, CELLS TISSUES ORGANS, V169, P285, DOI 10.1159/000047893
   Goncalves RM, 2009, BIOMATERIALS, V30, P6879, DOI 10.1016/j.biomaterials.2009.09.010
   Gotherstrom C, 2011, CYTOTHERAPY, V13, P269, DOI 10.3109/14653249.2010.523077
   Hemeda H, 2010, STEM CELLS DEV, V19, P693, DOI 10.1089/scd.2009.0365
   HOEN ENM, 2006, BLOOD, V109, P670, DOI DOI 10.1182/BLOOD-2006-07-036509
   Honczarenko M, 2006, STEM CELLS, V24, P1030, DOI 10.1634/stemcells.2005-0319
   Jacobs R, 2001, EUR J IMMUNOL, V31, P3121, DOI 10.1002/1521-4141(2001010)31:10<3121::AID-IMMU3121>3.0.CO;2-4
   Jewett A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009874
   Krampera M, 2006, STEM CELLS, V24, P386, DOI 10.1634/stemcells.2005-0008
   LIIPPO J, 2009, NATURAL KILLER CELLS, P519
   Lishko VK, 2002, BIOCHEMISTRY-US, V41, P12942, DOI 10.1021/bi026324c
   Maeda Y, 2004, J NUTR, V134, P945
   Mountziaris PM, 2008, TISSUE ENG PT B-REV, V14, P179, DOI 10.1089/ten.teb.2008.0038
   MUTO S, 1993, J CLIN IMMUNOL, V13, P175, DOI 10.1007/BF00919970
   Mwale F, 2005, TISSUE ENG, V11, P130, DOI 10.1089/ten.2005.11.130
   Oliveira SM, 2009, TISSUE ENG PT A, V15, P635, DOI 10.1089/ten.tea.2008.0052
   Peled E, 2007, J BIOMED MATER RES A, V80A, P874, DOI 10.1002/jbm.a.30928
   Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143
   Poggi A, 2005, J IMMUNOL, V175, P6352, DOI 10.4049/jimmunol.175.10.6352
   Prabaharan M, 2009, INT J BIOL MACROMOL, V44, P320, DOI 10.1016/j.ijbiomac.2009.01.005
   Pradier A, 2011, CELL TRANSPLANT, V20, P681, DOI 10.3727/096368910X536545
   Rasmusson I, 2003, TRANSPLANTATION, V76, P1208, DOI 10.1097/01.TP.0000082540.43730.80
   Rifas L, 2003, J CELL BIOCHEM, V88, P650, DOI 10.1002/jcb.10436
   Rifas L, 2006, J CELL BIOCHEM, V98, P706, DOI 10.1002/jcb.20933
   Robertson MJ, 2002, J LEUKOCYTE BIOL, V71, P173
   Rodrigues SN, 2006, BIOMATERIALS, V27, P5357, DOI 10.1016/j.biomaterials.2006.06.010
   ROSS GD, 1993, CLIN EXP IMMUNOL, V92, P181
   Salem HK, 2010, STEM CELLS, V28, P585, DOI 10.1002/stem.269
   Selmani Z, 2008, STEM CELLS, V26, P212, DOI 10.1634/stemcells.2007-0554
   Siddappa R, 2007, J ORTHOP RES, V25, P1029, DOI 10.1002/jor.20402
   Soderstrom K, 2010, P NATL ACAD SCI USA, V107, P13028, DOI 10.1073/pnas.1000546107
   Sotiropoulou PA, 2006, STEM CELLS, V24, P74, DOI 10.1634/stemcells.2004-0359
   Spaggiari GM, 2006, BLOOD, V107, P1484, DOI 10.1182/blood-2005-07-2775
   Spaggiari GM, 2008, BLOOD, V111, P1327, DOI 10.1182/blood-2007-02-074997
   TANG LP, 1993, J EXP MED, V178, P2147, DOI 10.1084/jem.178.6.2147
   Tseng HC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011590
   Vivier E, 2008, NAT IMMUNOL, V9, P503, DOI 10.1038/ni1582
   Zaharoff DA, 2007, VACCINE, V25, P2085, DOI 10.1016/j.vaccine.2006.11.034
NR 59
TC 36
Z9 37
U1 1
U2 17
PU ROYAL SOC
PI LONDON
PA 6-9 CARLTON HOUSE TERRACE, LONDON SW1Y 5AG, ENGLAND
SN 1742-5689
J9 J R SOC INTERFACE
JI J. R. Soc. Interface
PD FEB 7
PY 2012
VL 9
IS 67
BP 261
EP 271
DI 10.1098/rsif.2011.0357
PG 11
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA 866KR
UT WOS:000298380100006
PM 21752807
OA Bronze, Green Published
DA 2018-10-19
ER

PT J
AU Feng, XL
   Liu, QT
   Cao, RB
   Zhou, B
   Ma, ZY
   Deng, WL
   Wei, JC
   Qiu, YF
   Wang, FQ
   Gu, JY
   Wang, FJ
   Zheng, QS
   Ishag, H
   Chen, PY
AF Feng, Xiu-Li
   Liu, Qing-Tao
   Cao, Rui-Bing
   Zhou, Bin
   Ma, Zhi-Yong
   Deng, Wen-Lei
   Wei, Jian-Chao
   Qiu, Ya-Feng
   Wang, Fang-Quan
   Gu, Jin-Yan
   Wang, Feng-Juan
   Zheng, Qi-Sheng
   Ishag, Hassan
   Chen, Pu-Yan
TI Identification and Characterization of Novel Immunomodulatory
   Bursal-derived Pentapeptide-II (BPP-II)
SO JOURNAL OF BIOLOGICAL CHEMISTRY
LA English
DT Article
ID P53 TUMOR-SUPPRESSOR; B-CELL DEVELOPMENT; IN-VIVO; DIFFERENTIATING
   HORMONE; APOPTOTIC RESPONSE; FAMILY-MEMBERS; FABRICIUS; PROTEIN; CANCER;
   DEATH
AB The bursa of Fabricius, the acknowledged central humoral immune organ, plays a vital role in B lymphocyte differentiation. However, there are few reports of the molecular basis of the mechanism on immune induction and potential antitumor activity of bursal-derived peptides. In this paper, a novel bursal-derived pentapeptide-II (BPP-II, MTLTG) was isolated and exerted immunomodulatory functions on antibody responses in vitro. Gene microarray analyses demonstrated that BPP-II regulated expression of 2478 genes in a mouse-derived hybridoma cell line. Immune-related gene ontology functional procedures were employed for further functional analysis. Furthermore, the majority of BPP-II-regulated pathways were associated with immune responses and tumor processes. Moreover, BPP-II exhibited immunomodulatory effects on antigen-specific immune responses in vivo, including enhancement of avian influenza virus (H9N2 subtype)-specific antibody and cytokine production and modification of T cell immunophenotypes and lymphocyte proliferation. Finally, BPP-II triggered p53 expression and stabilization and selectively inhibited tumor cell proliferation. These data identified the multifunctional factor, BPP-II, as a novel biomaterial representing an important linking between the humoral central immune system and immune induction, including antitumor. Information generated in this study elucidates further the mechanisms involved in humoral immune system and represents the potential basis of effective immunotherapeutic strategies for treating human tumors and immune improvement.
C1 [Feng, Xiu-Li; Cao, Rui-Bing; Zhou, Bin; Deng, Wen-Lei; Wang, Fang-Quan; Gu, Jin-Yan; Wang, Feng-Juan; Ishag, Hassan; Chen, Pu-Yan] Nanjing Agr Univ, Dept Agr China, Div Key Lab Anim Dis Diag & Immunol, Nanjing 210095, Jiangsu, Peoples R China.
   [Liu, Qing-Tao] Yangzhou Univ, Yangzhou 225009, Peoples R China.
   [Ma, Zhi-Yong; Wei, Jian-Chao; Qiu, Ya-Feng] Chinese Acad Agr Sci, Shanghai Vet Res Inst, Shanghai 200241, Peoples R China.
   [Zheng, Qi-Sheng] Engn Res Ctr, Div Natl Vet Biol Med, Nanjing 210014, Peoples R China.
RP Chen, PY (reprint author), Nanjing Agr Univ, Dept Agr China, Div Key Lab Anim Dis Diag & Immunol, Nanjing 210095, Jiangsu, Peoples R China.
EM puyanchen@yahoo.com.cn
FU Ministry of Agriculture, China [200803020]; Jiangsu Higher Education
   Institutions (PAPD)
FX This work was supported by Grant 200803020 from the National Agriculture
   Special Research Project for Nonprofit Trades, Ministry of Agriculture,
   China, and by a project funded by the Priority Academic Program
   Development of Jiangsu Higher Education Institutions (PAPD).
CR Adam JK, 2003, PHARMACOL THERAPEUT, V99, P113, DOI 10.1016/S0163-7258(03)00056-1
   Arakawa H, 2004, DEV DYNAM, V229, P458, DOI 10.1002/dvdy.10495
   Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556
   AUDHYA T, 1986, SCIENCE, V231, P997, DOI 10.1126/science.3484838
   BABA T, 1977, IMMUNOLOGY, V32, P271
   Beurel E, 2008, J BIOL CHEM, V283, P21934, DOI 10.1074/jbc.M802481200
   BRAND A, 1976, SCIENCE, V193, P319, DOI 10.1126/science.180600
   Brooks CL, 2006, MOL CELL, V21, P307, DOI 10.1016/j.molcel.2006.01.020
   CHAPPEY O, 1994, J IMMUNOL METHODS, V172, P219, DOI 10.1016/0022-1759(94)90109-0
   Chernov AV, 2010, J BIOL CHEM, V285, P19647, DOI 10.1074/jbc.M109.088153
   Del-Val M, 2002, MOL IMMUNOL, V39, P235, DOI 10.1016/S0161-5890(02)00104-9
   Deng L, 2005, J BIOL CHEM, V280, P27561, DOI 10.1074/jbc.M502660200
   Dombrowicz D., 1998, IMMUNITY, V8, P517
   Du JA, 2006, J BIOL CHEM, V281, P37416, DOI 10.1074/jbc.M605063200
   Du LH, 2004, J BIOL CHEM, V279, P11957, DOI 10.1074/jbc.M304935200
   Feng XL, 2012, AMINO ACIDS, V42, P2215, DOI 10.1007/s00726-011-0961-8
   Feng XL, 2011, PEPTIDES, V32, P1103, DOI 10.1016/j.peptides.2011.04.020
   Feng XL, 2010, PEPTIDES, V31, P1562, DOI 10.1016/j.peptides.2010.05.007
   Fred D., 2008, AVIAN IMMUNOLOGY, P1
   Gorr SU, 2008, PEPTIDES, V29, P2118, DOI 10.1016/j.peptides.2008.09.019
   Gromme M, 2002, MOL IMMUNOL, V39, P181, DOI 10.1016/S0161-5890(02)00101-3
   He L, 2007, NATURE, V447, P1130, DOI 10.1038/nature05939
   Hegde AN, 2004, PROG NEUROBIOL, V73, P311, DOI 10.1016/j/.pneurobio.2004.05.005
   Hokibara Sho, 2000, Archivum Immunologiae et Therapiae Experimentalis, V48, P267
   Igney FH, 2002, NAT REV CANCER, V2, P277, DOI 10.1038/nrc776
   Lamprecht B, 2010, NAT MED, V16, P571, DOI 10.1038/nm.2129
   LANZAVECCHIA A, 1990, ANNU REV IMMUNOL, V8, P773, DOI 10.1146/annurev.iy.08.040190.004013
   LASSILA O, 1989, CELL IMMUNOL, V122, P319, DOI 10.1016/0008-8749(89)90080-4
   Lawrence MC, 2011, J BIOL CHEM, V286, P1025, DOI 10.1074/jbc.M110.158675
   Lecompte O, 2008, TRENDS BIOCHEM SCI, V33, P453, DOI 10.1016/j.tibs.2008.07.002
   Lee JT, 2010, CELL DEATH DIFFER, V17, P86, DOI 10.1038/cdd.2009.77
   Li DY, 2011, AMINO ACIDS, V40, P505, DOI 10.1007/s00726-010-0663-7
   Mandapathil M, 2010, J BIOL CHEM, V285, P7176, DOI 10.1074/jbc.M109.047423
   Mikoshiba K, 2007, J NEUROCHEM, V102, P1426, DOI 10.1111/j.1471-4159.2007.04825.x
   Moody TW, 2004, J BIOL CHEM, V279, P23580, DOI 10.1074/jbc.M401938200
   MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4
   NAGATA S, 1995, SCIENCE, V267, P1449, DOI 10.1126/science.7533326
   Niiro H, 2002, NAT REV IMMUNOL, V2, P945, DOI 10.1038/nri955
   OLTVAI ZN, 1993, CELL, V74, P609, DOI 10.1016/0092-8674(93)90509-O
   Pal S, 2007, J BIOL CHEM, V282, P8969, DOI 10.1074/jbc.M605927200
   Qiu YF, 2008, BIOCHEM BIOPH RES CO, V377, P151, DOI 10.1016/j.bbrc.2008.09.117
   Ranger AM, 2001, NAT GENET, V28, P113, DOI 10.1038/88815
   Ratcliffe MJH, 2006, DEV COMP IMMUNOL, V30, P101, DOI 10.1016/j.dci.2005.06.018
   Riese MJ, 2011, J BIOL CHEM, V286, P5254, DOI 10.1074/jbc.M110.171884
   Rosenberg SA, 2004, NAT MED, V10, P909, DOI 10.1038/nm1100
   Rosse T, 1998, NATURE, V391, P496
   Saville MK, 2004, J BIOL CHEM, V279, P42169, DOI 10.1074/jbc.M403362200
   SCHMID I, 1992, CYTOMETRY, V13, P204, DOI 10.1002/cyto.990130216
   Thanos CD, 1999, PROTEIN SCI, V8, P1708, DOI 10.1110/ps.8.8.1708
   Vikstrom I, 2010, SCIENCE, V330, P1095, DOI 10.1126/science.1191793
   Walton MI, 2005, MOL CANCER THER, V4, P1369, DOI 10.1158/1535-7163.MCT-04-0341
   Xu WW, 2010, IMMUNITY, V33, P340, DOI 10.1016/j.immuni.2010.08.015
   Xu WF, 2005, J INTERF CYTOK RES, V25, P113, DOI 10.1089/jir.2005.25.113
   Yamaguchi H, 2004, J BIOL CHEM, V279, P39431, DOI 10.1074/jbc.M401530200
   Yoshida K, 2006, J BIOL CHEM, V281, P5734, DOI 10.1074/jbc.M512074200
NR 55
TC 6
Z9 10
U1 0
U2 14
PU AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC
PI BETHESDA
PA 9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA
SN 0021-9258
J9 J BIOL CHEM
JI J. Biol. Chem.
PD FEB 3
PY 2012
VL 287
IS 6
BP 3798
EP 3807
DI 10.1074/jbc.M111.273854
PG 10
WC Biochemistry & Molecular Biology
SC Biochemistry & Molecular Biology
GA 894EX
UT WOS:000300410900017
PM 22184121
OA Bronze, Green Published
DA 2018-10-19
ER

PT J
AU Cranford, SW
   Tarakanova, A
   Pugno, NM
   Buehler, MJ
AF Cranford, Steven W.
   Tarakanova, Anna
   Pugno, Nicola M.
   Buehler, Markus J.
TI Nonlinear material behaviour of spider silk yields robust webs
SO NATURE
LA English
DT Article
ID NATURALLY COMPLIANT STRUCTURES; MECHANICAL-PROPERTIES; DRAGLINE SILK;
   BIOMATERIAL; TOUGHNESS; STRENGTH; DESIGN; NANOSTRUCTURE; PERFORMANCE;
   ORIENTATION
AB Natural materials are renowned for exquisite designs that optimize function, as illustrated by the elasticity of blood vessels, the toughness of bone and the protection offered by nacre(1-5). Particularly intriguing are spider silks, with studies having explored properties ranging from their protein sequence(6) to the geometry of a web(7). This material system(8), highly adapted to meet a spider's many needs, has superior mechanical properties(9-15). In spite of much research into the molecular design underpinning the outstanding performance of silk fibres(1,6,10,13,16,17), and into the mechanical characteristics of web-like structures(18-21), it remains unknown how the mechanical characteristics of spider silk contribute to the integrity and performance of a spider web. Here we report web deformation experiments and simulations that identify the nonlinear response of silk threads to stress-involving softening at a yield point and substantial stiffening at large strain until failure-as being crucial to localize load-induced deformation and resulting in mechanically robust spider webs. Control simulations confirmed that a nonlinear stress response results in superior resistance to structural defects in the web compared to linear elastic or elastic-plastic (softening) material behaviour. We also show that under distributed loads, such as those exerted by wind, the stiff behaviour of silk under small deformation, before the yield point, is essential in maintaining the web's structural integrity. The superior performance of silk in webs is therefore not due merely to its exceptional ultimate strength and strain, but arises from the nonlinear response of silk threads to strain and their geometrical arrangement in a web.
C1 [Cranford, Steven W.; Tarakanova, Anna; Buehler, Markus J.] MIT, Dept Civil & Environm Engn, LAMM, Cambridge, MA 02139 USA.
   [Cranford, Steven W.; Tarakanova, Anna; Buehler, Markus J.] MIT, Ctr Mat Sci & Engn, Cambridge, MA 02139 USA.
   [Tarakanova, Anna] Cornell Univ, Dept Appl & Engn Phys, Ithaca, NY 14853 USA.
   [Pugno, Nicola M.] Politecn Torino, Dept Struct Engn & Geotech, Lab Bioinspired Nanomech Giuseppe Maria Pugno, I-10129 Turin, Italy.
   [Buehler, Markus J.] MIT, Ctr Computat Engn, Cambridge, MA 02139 USA.
RP Buehler, MJ (reprint author), MIT, Dept Civil & Environm Engn, LAMM, 77 Massachusetts Ave, Cambridge, MA 02139 USA.
EM mbuehler@mit.edu
RI Pugno, Nicola/C-2289-2014; Cranford, Steven/H-4260-2012; Buehler,
   Markus/C-4580-2008
OI Buehler, Markus/0000-0002-4173-9659
FU Office of Naval Research [N000141010562]; Army Research Office
   [W911NF-09-1-0541, W911NF-10-1-0127]; MIT-Italy (MITOR); Robert A. Brown
   Presidential Fellowship; METREGEN; European Research Council, under the
   European Union [279985]
FX This work was supported primarily by the Office of Naval Research
   (N000141010562) with additional support from the National Science
   Foundation (MRSEC DMR-0819762, the NSF-REU programme, as well as
   CMMI-0642545) and the Army Research Office (W911NF-09-1-0541 and
   W911NF-10-1-0127). Support from the MIT-Italy programme (MITOR) and a
   Robert A. Brown Presidential Fellowship is gratefully acknowledged.
   N.M.P. is supported by the METREGEN grant (2009-2012) "Metrology on a
   cellular and macromolecular scale for regenerative medicine". An Ideas
   Starting Grant 2011 BIHSNAM on "Bio-inspired hierarchical super
   nanomaterials" was awarded to N.M.P. from the European Research Council,
   under the European Union's Seventh Framework Programme
   (FP7/2007-2013)/ERC grant (agreement number 279985). All simulations
   have been carried out at MIT's Laboratory for Atomistic and Molecular
   Mechanics (LAMM). We acknowledge assistance from S. and E. Buehler in
   taking photographs of the spider web.
CR Agnarsson I, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011234
   Aizenberg J, 2005, SCIENCE, V309, P275, DOI 10.1126/science.1112255
   Alam MS, 2007, MECH MATER, V39, P145, DOI 10.1016/j.mechmat.2006.04.005
   Alam MS, 2005, INT J DAMAGE MECH, V14, P365, DOI [10.1177/1056789505054313, 10.1177/105678950504313]
   Aoyanagi Y, 2010, PHYS REV LETT, V104, DOI 10.1103/PhysRevLett.104.038102
   Buehler MJ, 2006, NATURE, V439, P307, DOI 10.1038/nature04408
   Du N, 2006, BIOPHYS J, V91, P4528, DOI 10.1529/biophysj.106.089144
   FOELIX RF, 1996, BIOL SPIDERS
   Gao HJ, 2003, P NATL ACAD SCI USA, V100, P5597, DOI 10.1073/pnas.0631609100
   Gosline JM, 1999, J EXP BIOL, V202, P3295
   Kamat S, 2000, NATURE, V405, P1036
   Keten S, 2010, J R SOC INTERFACE, V7, P1709, DOI 10.1098/rsif.2010.0149
   Keten S, 2010, APPL PHYS LETT, V96, DOI 10.1063/1.3385388
   Keten S, 2010, NAT MATER, V9, P359, DOI [10.1038/nmat2704, 10.1038/NMAT2704]
   Ko FK, 2004, BIOMACROMOLECULES, V5, P780, DOI 10.1021/bm0345099
   Ko KK, 2002, MATER RES SOC SYMP P, V702, P17
   Lefevre T, 2007, BIOPHYS J, V92, P2885, DOI 10.1529/biophysj.106.100339
   Nova A, 2010, NANO LETT, V10, P2626, DOI 10.1021/nl101341w
   Omenetto FG, 2010, SCIENCE, V329, P528, DOI 10.1126/science.1188936
   Pugno NM, 2004, PHILOS MAG, V84, P2829, DOI 10.1080/14786430412331280382
   Rammensee S, 2008, P NATL ACAD SCI USA, V105, P6590, DOI 10.1073/pnas.0709246105
   Shao ZZ, 2002, NATURE, V418, P741, DOI 10.1038/418741a
   Swanson BO, 2007, J EXP ZOOL PART A, V307A, P654, DOI 10.1002/jez.420
   Swanson BO, 2009, INTEGR COMP BIOL, V49, P21, DOI 10.1093/icb/icp013
   TERMONIA Y, 1994, MACROMOLECULES, V27, P7378, DOI 10.1021/ma00103a018
   van Beek JD, 2002, P NATL ACAD SCI USA, V99, P10266, DOI 10.1073/pnas.152162299
   Vepari C, 2007, PROG POLYM SCI, V32, P991, DOI 10.1016/j.progpolymsci.2007.05.013
   Vollrath F, 1999, INT J BIOL MACROMOL, V24, P81, DOI 10.1016/S0141-8130(98)00076-2
   VOLLRATH F, 1992, SCI AM, V266, P70, DOI 10.1038/scientificamerican0392-70
   Vollrath F, 1996, P ROY SOC B-BIOL SCI, V263, P147, DOI 10.1098/rspb.1996.0023
   VOLLRATH F, 1985, NATURWISSENSCHAFTEN, V72, P666, DOI 10.1007/BF00497445
   Vollrath F, 2007, ANNU REV ECOL EVOL S, V38, P819, DOI 10.1146/annurev.ecolsys.37.091305.110221
   Vollrath F, 2010, NATURE, V466, P319, DOI 10.1038/466319a
NR 33
TC 177
Z9 181
U1 17
U2 285
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 0028-0836
J9 NATURE
JI Nature
PD FEB 2
PY 2012
VL 482
IS 7383
BP 72
EP U91
DI 10.1038/nature10739
PG 7
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA 884RN
UT WOS:000299726000037
PM 22297972
HC Y
HP N
DA 2018-10-19
ER

PT J
AU Livingstone, P
AF Livingstone, Paul
TI The Indispensable Biomaterial
SO R&D MAGAZINE
LA English
DT Article
EM paul.livingstone@advantagemedia.com
NR 0
TC 0
Z9 0
U1 0
U2 0
PU ADVANTAGE BUSINESS MEDIA
PI ROCKAWAY
PA 100 ENTERPRISE DR, SUITE 600, BOX 912, ROCKAWAY, NJ 07866-0912 USA
SN 0746-9179
J9 R&D MAG
JI R D Mag.
PD FEB
PY 2012
VL 54
IS 1
BP 20
EP 21
PG 2
WC Engineering, Industrial; Multidisciplinary Sciences
SC Engineering; Science & Technology - Other Topics
GA 904QD
UT WOS:000301212100005
DA 2018-10-19
ER

PT J
AU Dastidar, TG
   Netravali, AN
AF Dastidar, Trina Ghosh
   Netravali, Anil N.
TI Improving Resin and Film Forming Properties of Native Starches by
   Chemical and Physical Modification
SO JOURNAL OF BIOBASED MATERIALS AND BIOENERGY
LA English
DT Review
DE Native Starch; Chemical Modification; Thermoplastic Modification;
   Thermosetting Modification; Resins; Films; Plasticizer; Blending
ID ESCULENTA CRANTZ STARCH; HEAT-MOISTURE TREATMENT; FREEZE-THAW STABILITY;
   HYDROXYPROPYL MAIZE STARCHES; CANAVALIA-ENSIFORMIS STARCH; WATER-VAPOR
   PERMEABILITY; X-RAY-SCATTERING; CROSS-LINKING; CORN STARCH;
   MECHANICAL-PROPERTIES
AB Starch is a yearly renewable and biodegradable source of polysaccharides produced by plants and is the second most available biomaterial in nature, next to only cellulose. This has provided an incentive to a growing number of researchers, scientists and engineers to prepare starch based materials as 'green' alternatives to plastics and resins obtained from petroleum based resources. Through these research efforts, in recent years, significant progress has been made in understanding the relationship between structure and functionality of starches obtained from various sources. Various chemical and physical modifications of starch have helped in synthesizing biobased green materials with tunable properties that are suitable for a myriad of industrial applications. Starch has also been modified for use as resin and film forming. Starch based resin with improved mechanical, thermal, electronic and/or optical properties, compared to those of petroleum based resins, could be easily used with natural fibers for 'green' composite manufacturing. At the end of their life they could be easily disposed of or composted instead of putting into landfills. In addition, depending on the modification, the starch based resins may have the advantage of exhibiting biocompatibility. This review presents a comprehensive discussion on starch and their chemical and physical modifications and fundamental structure-property relationships as well as various applications.
C1 [Dastidar, Trina Ghosh; Netravali, Anil N.] Cornell Univ, Dept Fiber Sci & Apparel Design, Ithaca, NY 14853 USA.
RP Netravali, AN (reprint author), Cornell Univ, Dept Fiber Sci & Apparel Design, Ithaca, NY 14853 USA.
EM ann2@cornell.edu
CR Abdollahzadeh E, 2008, STARCH-STARKE, V60, P398, DOI 10.1002/star.200700677
   Ackar D, 2010, CARBOHYD POLYM, V81, P76, DOI 10.1016/j.carbpol.2010.01.058
   Aggarwal P, 1998, THERMOCHIM ACTA, V324, P1, DOI 10.1016/S0040-6031(98)00517-6
   AGGOUR YA, 1993, STARCH-STARKE, V45, P55, DOI 10.1002/star.19930450206
   AIYELEYE FB, 1993, STARCH-STARKE, V45, P443, DOI 10.1002/star.19930451209
   [Anonymous], 1995, CARBOHYDR POLYM, V261-270, P27
   Ao ZH, 2007, CARBOHYD POLYM, V67, P46, DOI 10.1016/j.carbpol.2006.04.013
   Arvanitoyannis I, 1997, FOOD CHEM, V60, P593, DOI 10.1016/S0308-8146(97)00038-1
   Arvanitoyannis I, 1998, CARBOHYD POLYM, V36, P105, DOI 10.1016/S0144-8617(98)00017-4
   Ayoub AS, 2009, J PLAST FILM SHEET, V25, P25, DOI 10.1177/8756087909336493
   Babic J, 2009, J FOOD SCI TECH MYS, V46, P423
   BADER HG, 1994, STARCH-STARKE, V46, P229, DOI 10.1002/star.19940460606
   Zamudio-Flores PB, 2010, J APPL POLYM SCI, V115, P991, DOI 10.1002/app.31047
   Bastos DC, 2009, ULTRAMICROSCOPY, V109, P1089, DOI 10.1016/j.ultramic.2009.03.031
   Bayazeed A, 1998, STARCH-STARKE, V50, P89, DOI 10.1002/1521-379X(199803)50:2/3<89::AID-STAR89>3.0.CO;2-B
   Bayer RK, 2007, J APPL POLYM SCI, V104, P689, DOI 10.1002/app.24527
   Betancur AD, 1997, J AGR FOOD CHEM, V45, P378, DOI 10.1021/jf960272e
   Betancur-Ancona D, 2002, STARCH-STARKE, V54, P540, DOI 10.1002/1521-379X(200211)54:11<540::AID-STAR540>3.0.CO;2-#
   Bhandari PN, 2002, CARBOHYD POLYM, V48, P233, DOI 10.1016/S0144-8617(01)00310-1
   Bhardwaj R, 2006, BIOMACROMOLECULES, V7, P2044, DOI 10.1021/bm050897y
   BILIADERIS CG, 1990, CEREAL CHEM, V67, P240
   Billmers RL, 1996, ABSTR PAP AM CHEM S, V212, P10
   BILLMERS RL, 1995, ABSTR PAP AM CHEM S, V209, P114
   Biresaw G, 2003, J AM OIL CHEM SOC, V80, P697, DOI 10.1007/s11746-003-0760-7
   Biresaw G, 2001, J POLYM SCI POL PHYS, V39, P920, DOI 10.1002/polb.1067
   Biresaw G., 2008, J SYNTHETIC LUBRICAT, V17-30, P35
   Blazek J, 2009, CARBOHYD POLYM, V75, P705, DOI 10.1016/j.carbpol.2008.09.017
   Blazek J, 2008, CARBOHYD POLYM, V71, P380, DOI 10.1016/j.carbpol.2007.06.010
   Blazek J, 2010, J CEREAL SCI, V51, P265, DOI 10.1016/j.jcs.2009.12.003
   Blennow A, 2002, TRENDS PLANT SCI, V7, P445, DOI 10.1016/S1360-1385(02)02332-4
   Bossard F, 2008, POLYM ENG SCI, V48, P1862, DOI 10.1002/pen.21160
   Boutboul A, 2002, CARBOHYD POLYM, V47, P73, DOI 10.1016/S0144-8617(01)00160-6
   BUTLER LE, 1986, STARCH-STARKE, V38, P156, DOI 10.1002/star.19860380503
   Buwalda P., 2008, ABSTRACTS PAPERS AM
   Cao XD, 2008, CARBOHYD POLYM, V71, P119, DOI 10.1016/j.carbpol.2007.05.023
   Carvalho AJF, 2005, IND CROP PROD, V21, P331, DOI 10.1016/j.indcrop.2004.04.027
   Chaudhary AL, 2008, CARBOHYD POLYM, V74, P907, DOI 10.1016/j.carbpol.2008.05.017
   Chaudhary AL, 2009, CARBOHYD POLYM, V78, P917, DOI 10.1016/j.carbpol.2009.07.023
   Chen YX, 2006, J APPL POLYM SCI, V102, P1539, DOI 10.1002/app.23323
   Chi H, 2008, FOOD CHEM, V106, P923, DOI 10.1016/j.foodchem.2007.07.002
   Chillo S, 2008, J FOOD ENG, V88, P159, DOI 10.1016/j.jfoodeng.2008.02.002
   Cho Y., 2009, CHEM MATER, V3183-3193, P19
   Choi HS, 2009, CARBOHYD POLYM, V78, P862, DOI 10.1016/j.carbpol.2009.07.005
   Chuenkamol B, 2007, FOOD HYDROCOLLOID, V21, P1123, DOI 10.1016/j.foodhyd.2006.08.013
   Chung HJ, 2005, STARCH-STARKE, V57, P354, DOI 10.1002/star.200400372
   Chung YL, 2010, CARBOHYD POLYM, V79, P391, DOI 10.1016/j.carbpol.2009.08.021
   Cizova A, 2007, STARCH-STARKE, V59, P482, DOI 10.1002/star.200700651
   Daramola B, 2007, J FOOD AGRIC ENVIRON, V5, P50
   Das A. B., 2009, CARBOHYD POLYM, V80, P725
   Das AB, 2010, CARBOHYD POLYM, V80, P725, DOI 10.1016/j.carbpol.2009.12.018
   De Graaf RA, 2003, ADV POLYM TECH, V22, P56, DOI 10.1002/adv.10034
   Deetae P, 2008, CARBOHYD POLYM, V73, P351, DOI 10.1016/j.carbpol.2007.12.004
   Demirgoz D, 2000, POLYM DEGRAD STABIL, V70, P161, DOI 10.1016/S0141-3910(00)00102-6
   Du XF, 2007, STARCH-STARKE, V59, P609, DOI 10.1002/star.200700604
   Elomaa M, 2004, CARBOHYD POLYM, V57, P261, DOI 10.1016/j.carbpol.2004.05.003
   Fang JM, 2002, CARBOHYD POLYM, V47, P245, DOI 10.1016/S0144-8617(01)00187-4
   FISCHER SK, 1977, STARKE, V29, P232, DOI 10.1002/star.19770290705
   Gui-Jie M., 2006, J APPL POLYM SCI, V102, P5854
   Hamdi G, 2001, J MICROENCAPSUL, V18, P373, DOI 10.1080/02652040010019505
   Hamdi G, 1999, PHARMACEUT RES, V16, P867, DOI 10.1023/A:1018878120100
   HAMERSTRAND GE, 1960, CEREAL CHEM, V37, P519
   He JH, 2008, BIOMACROMOLECULES, V9, P175, DOI 10.1021/bm700951s
   Heinze T, 2005, MACROMOL SYMP, V223, P13, DOI 10.1002/masy.200550502
   Heinze T, 2004, CELLULOSE, V11, P239, DOI 10.1023/B:CELL.0000025386.68486.a4
   Heinze T, 1999, STARCH-STARKE, V51, P11, DOI 10.1002/(SICI)1521-379X(199901)51:1<11::AID-STAR11>3.0.CO;2-2
   HELLMAN NN, 1954, CEREAL CHEM, V31, P495
   HOOVER R, 1988, STARCH-STARKE, V40, P383, DOI 10.1002/star.19880401005
   HOOVER R, 1994, CARBOHYD RES, V252, P33, DOI 10.1016/0008-6215(94)84121-7
   HOOVER R, 1994, CARBOHYD RES, V261, P13, DOI 10.1016/0008-6215(94)80002-2
   Huda MS, 2005, J MATER SCI, V40, P4221, DOI 10.1007/s10853-005-1998-4
   IMBERTY A, 1988, BIOPOLYMERS, V27, P1205, DOI 10.1002/bip.360270803
   Imberty A., 1998, J MOL BIOL, V201, P365
   Ishigaki T, 1999, WORLD J MICROB BIOT, V15, P321, DOI 10.1023/A:1008919218289
   Izydorczyk MS, 2001, J I BREWING, V107, P119, DOI 10.1002/j.2050-0416.2001.tb00084.x
   Jang WY, 2007, J IND ENG CHEM, V13, P457
   JENKINS PJ, 1994, J POLYM SCI POL PHYS, V32, P1579, DOI 10.1002/polb.1994.090320829
   Jeon YS, 1999, STARCH-STARKE, V51, P90, DOI 10.1002/(SICI)1521-379X(199903)51:2<90::AID-STAR90>3.3.CO;2-D
   Jonhed A, 2003, STARCH-STARKE, V55, P569, DOI 10.1002/star.200300204
   Jyothi AN, 2007, J SCI FOOD AGR, V87, P1964, DOI 10.1002/jsfa.2952
   Jyothi AN, 2006, STARCH-STARKE, V58, P292, DOI 10.1002/star.200500468
   Jyothi AN, 2005, STARCH-STARKE, V57, P556, DOI 10.1002/star.200500429
   Jyothi AN, 2005, STARCH-STARKE, V57, P319, DOI 10.1002/star.200400374
   Kalambur SB, 2004, POLYM INT, V53, P1413, DOI 10.1002/pi.1478
   KARTHA KPR, 1985, STARKE, V37, P270, DOI 10.1002/star.19850370806
   Katepetch C., 2008, ABSTRACTS PAPERS AM
   Kaur L, 2004, CARBOHYD POLYM, V55, P211, DOI 10.1016/j.carbpol.2003.09.011
   Kenar JA, 2009, IND CROP PROD, V29, P45, DOI 10.1016/j.indcrop.2008.04.004
   KHALIL MI, 1995, STARCH-STARKE, V47, P394, DOI 10.1002/star.19950471005
   Kim YJ, 2003, CARBOHYD POLYM, V53, P289, DOI 10.1016/S0144-8617(03)00075-4
   Korhonen O, 2000, PHARMACEUT RES, V17, P1138, DOI 10.1023/A:1026470032434
   Krogars K, 2003, EUR J PHARM BIOPHARM, V56, P215, DOI 10.1016/S0939-6411(03)00064-X
   KULICKE WM, 1990, STARCH-STARKE, V42, P134, DOI 10.1002/star.19900420404
   Kunaik L., 2006, STARCH, V110-116, P2006
   Kunlan Li, 2001, Carbohydrate Research, V331, P9, DOI 10.1016/S0008-6215(00)00311-6
   Kvien I, 2007, J MATER SCI, V42, P8163, DOI 10.1007/s10853-007-1699-2
   Lafargue D, 2007, BIOMACROMOLECULES, V8, P3950, DOI 10.1021/bm7009637
   Lafargue D, 2007, CARBOHYD POLYM, V70, P101, DOI 10.1016/j.carbpol.2007.03.019
   Leeman AM, 2006, CARBOHYD POLYM, V65, P306, DOI 10.1016/j.carbpol.2006.01.019
   LELOUP VM, 1992, CARBOHYD POLYM, V18, P189, DOI 10.1016/0144-8617(92)90063-V
   Limberger VM, 2008, QUIM NOVA, V31, P84, DOI 10.1590/S0100-40422008000100018
   Liu H, 1999, CARBOHYD POLYM, V40, P175, DOI 10.1016/S0144-8617(99)00052-1
   Liu H. S., 2009, CARBOHYD POLYM, V77, P662
   Liu HJ, 1997, CARBOHYD POLYM, V34, P283, DOI 10.1016/S0144-8617(97)00130-6
   Liu WJ, 2005, POLYMER, V46, P2710, DOI 10.1016/j.polymer.2005.01.027
   Liu ZQ, 2008, J AGR FOOD CHEM, V56, P11499, DOI 10.1021/jf802317q
   LOHMAR R, 1950, J AM CHEM SOC, V72, P5717, DOI 10.1021/ja01168a093
   Lopez OV, 2008, CARBOHYD POLYM, V73, P573, DOI 10.1016/j.carbpol.2007.12.023
   Lorenz K., 2006, STARCH, V50-54, P34
   Lourdin D, 1995, CARBOHYD POLYM, V27, P261, DOI 10.1016/0144-8617(95)00071-2
   Mao GJ, 2006, J APPL POLYM SCI, V102, P5854, DOI 10.1002/app.24947
   Mathew S, 2007, FOOD CHEM, V105, P579, DOI 10.1016/j.foodchem.2007.04.032
   Mirmoghtadaie L, 2009, FOOD CHEM, V116, P709, DOI 10.1016/j.foodchem.2009.03.019
   Mishra S, 2006, FOOD HYDROCOLLOID, V20, P557, DOI 10.1016/j.foodhyd.2005.01.001
   MITA T, 1992, CARBOHYD POLYM, V17, P269, DOI 10.1016/0144-8617(92)90169-Q
   MOORTHY SN, 1985, STARKE, V37, P307, DOI 10.1002/star.19850370906
   Morris CE, 1996, IND ENG CHEM RES, V35, P950, DOI 10.1021/ie950540i
   Mulhbacher J, 2005, INT J PHARM, V297, P22, DOI 10.1016/j.ijpharm.2005.02.033
   Mulhbacher J, 2001, J CONTROL RELEASE, V76, P51, DOI 10.1016/S0168-3659(01)00425-4
   Mulhbacher J, 2004, INT J PHARMACEUT, V278, P231, DOI 10.1016/j.ijpharm.2004.03.008
   Myllarinen P, 2002, CARBOHYD POLYM, V48, P41, DOI 10.1016/S0144-8617(01)00208-9
   Ntawukulilyayo JD, 1996, INT J PHARMACEUT, V128, P73, DOI 10.1016/0378-5173(95)04223-7
   Ntawukulilyayo JD, 1996, INT J PHARM, V139, P79, DOI 10.1016/0378-5173(96)04575-9
   Onofre FO, 2010, INT J PHARMACEUT, V385, P104, DOI 10.1016/j.ijpharm.2009.10.038
   Pang SC, 2011, CARBOHYD POLYM, V84, P424, DOI 10.1016/j.carbpol.2010.12.002
   Passauer L. P., 2008, ABSTRACTS PAPERS AM, V1053, P235
   Passauer L, 2010, CARBOHYD POLYM, V82, P809, DOI 10.1016/j.carbpol.2010.05.050
   Passauer L, 2009, STARCH-STARKE, V61, P628, DOI 10.1002/star.200900169
   Passauer L, 2009, STARCH-STARKE, V61, P621, DOI 10.1002/star.200900168
   Pereira CS, 1998, J MATER SCI-MATER M, V9, P825, DOI 10.1023/A:1008944127971
   Pereira K. D., 2007, CIENCIA TECNOLOGIA A, V88-92, P27
   Petersson M, 2005, FOOD HYDROCOLLOID, V19, P123, DOI 10.1016/j.foodhyd.2004.04.021
   Phillips DL, 1998, ANAL LETT, V31, P2105
   Raatikainen P, 2002, DRUG DEV IND PHARM, V28, P165, DOI 10.1081/DDC-120002450
   Raina CS, 2006, EUR FOOD RES TECHNOL, V223, P561, DOI 10.1007/s00217-005-0239-z
   Raquez JM, 2007, INT POLYM PROC, V22, P463, DOI 10.3139/217.2076
   Raquez JM, 2008, POLYM ENG SCI, V48, P1747, DOI 10.1002/pen.21136
   Raquez JM, 2008, CARBOHYD POLYM, V74, P159, DOI 10.1016/j.carbpol.2008.01.027
   Reddy N, 2010, FOOD CHEM, V118, P702, DOI 10.1016/j.foodchem.2009.05.050
   Reis AV, 2008, J POLYM SCI POL CHEM, V46, P2567, DOI 10.1002/pola.22588
   Reis RL, 1997, ADV POLYM TECH, V16, P263, DOI 10.1002/(SICI)1098-2329(199711)16:4<263::AID-ADV2>3.0.CO;2-T
   Ren LL, 2010, CARBOHYD POLYM, V82, P1010, DOI 10.1016/j.carbpol.2010.05.041
   Rindlav A, 1997, CARBOHYD POLYM, V34, P25, DOI 10.1016/S0144-8617(97)00093-3
   Rundle RE, 1944, J AM CHEM SOC, V66, P130, DOI 10.1021/ja01229a037
   Saha MC, 2008, MAT SCI ENG A-STRUCT, V479, P213, DOI 10.1016/j.msea.2007.06.060
   SEOW CC, 1993, STARCH-STARKE, V45, P85, DOI 10.1002/star.19930450303
   Shogren RL, 2000, STARCH-STARKE, V52, P196, DOI 10.1002/1521-379X(200007)52:6/7<196::AID-STAR196>3.0.CO;2-4
   Shogren RL, 2006, CARBOHYD POLYM, V64, P16, DOI 10.1016/j.carbpol.2005.10.018
   Shogren RL, 2003, CARBOHYD POLYM, V52, P319, DOI 10.1016/S0144-8617(02)00305-3
   Shon KJ, 2006, STARCH-STARKE, V58, P177, DOI 10.1002/star.200500456
   Simkovic I, 1996, CARBOHYD POLYM, V30, P25, DOI 10.1016/S0144-8617(96)00060-4
   Simsek S, 2009, FOOD CHEM, V115, P832, DOI 10.1016/j.foodchem.2008.12.093
   Singh N, 2004, FOOD CHEM, V86, P601, DOI 10.1016/j.foodchem.2003.10.008
   Sitohy MZ, 2000, STARCH-STARKE, V52, P95, DOI 10.1002/1521-379X(200006)52:4<095::AID-STAR95>3.0.CO;2-X
   Sitohy MZ, 2001, STARCH-STARKE, V53, P27, DOI 10.1002/1521-379X(200101)53:1<27::AID-STAR27>3.0.CO;2-L
   Steeneken PAM, 2008, CARBOHYD RES, V343, P2278, DOI 10.1016/j.carres.2008.04.034
   Stevens ES, 2003, BIOCYCLE, V44, P24
   Stevens ES, 2002, BIOCYCLE, V43, P42
   Takahashi K, 2002, BIOSCI BIOTECH BIOCH, V66, P1276, DOI 10.1271/bbb.66.1276
   Tarvainen M, 2003, EUR J PHARM SCI, V19, P363, DOI 10.1016/S0928-0987(03)00137-4
   Tarvainen M, 2002, J PHARM SCI, V91, P282, DOI 10.1002/jps.10027
   Teixeira EM, 2007, CARBOHYD POLYM, V69, P619, DOI 10.1016/j.carbpol.2007.01.022
   Tessler MM, 1996, J ENVIRON POLYM DEGR, V4, P85, DOI 10.1007/BF02074869
   Thirathumthavorn D., 2007, STARCH, V59, P493
   Tomasik P, 2004, ADV CARBOHYD CHEM BI, V59, P175, DOI 10.1016/S0065-2318(04)59005-4
   Torres AV, 2007, J APPL POLYM SCI, V106, P3994, DOI 10.1002/app.27051
   TRUBIANO PC, 1994, ABSTR PAP AM CHEM S, V208, P151
   vanSoest JJG, 1997, TRENDS BIOTECHNOL, V15, P208, DOI 10.1016/S0167-7799(97)01021-4
   vanSoest JJG, 1996, IND CROP PROD, V5, P11, DOI 10.1016/0926-6690(95)00048-8
   Varavinit S, 2003, STARCH-STARKE, V55, P410, DOI 10.1002/star.200300185
   Vorwerg W, 2004, STARCH-STARKE, V56, P297, DOI 10.1002/star.200300244
   Waigh TA, 1997, MACROMOLECULES, V30, P3813, DOI 10.1021/ma970075w
   Waigh TA, 1999, BIOPOLYMERS, V49, P91, DOI 10.1002/(SICI)1097-0282(199901)49:1<91::AID-BIP9>3.3.CO;2-0
   Waliszewski KN, 2003, CARBOHYD POLYM, V52, P237, DOI 10.1016/S0144-8617(02)00270-9
   Wang LF, 1997, ABSTR PAP AM CHEM S, V213, P254
   Wang SJ, 2006, J POLYM ENVIRON, V14, P65, DOI 10.1007/s10924-005-8708-9
   Wang X, 2008, SCI CHINA SER B, V51, P859, DOI 10.1007/s11426-008-0089-1
   Whistler RL, 1944, IND ENG CHEM, V36, P796, DOI 10.1021/ie50417a005
   Wickramasinghe HAM, 2009, FOOD SCI BIOTECHNOL, V18, P118
   WING RE, 1975, J APPL POLYM SCI, V19, P847, DOI 10.1002/app.1975.070190320
   WOLFF IA, 1951, IND ENG CHEM, V43, P911, DOI 10.1021/ie50496a038
   WOOTTON M, 1984, STARKE, V36, P207, DOI 10.1002/star.19840360605
   WOOTTON M, 1983, STARKE, V35, P92, DOI 10.1002/star.19830350306
   Wu Y, 2009, CARBOHYD POLYM, V76, P299, DOI 10.1016/j.carbpol.2008.10.031
   Wu YP, 2006, CARBOHYD POLYM, V65, P109, DOI 10.1016/j.carbpol.2005.12.031
   WU YS, 1990, CEREAL CHEM, V67, P202
   WURZBURG OB, 1986, NUTR REV, V44, P74
   Xu YX, 2005, CARBOHYD POLYM, V59, P521, DOI 10.1016/j.carbpol.2004.11.007
   Xu YX, 2004, CEREAL CHEM, V81, P735, DOI 10.1094/CCHEM.2004.81.6.735
   Yang C. Q., 1998, FOURIER TRANSFORM SP, V661-664, P753
   Yang CQ, 2000, RES CHEM INTERMEDIAT, V26, P515, DOI 10.1163/156856700X00507
   Yoon SD, 2006, J APPL POLYM SCI, V100, P3733, DOI 10.1002/app.23303
   Yun YH, 2006, J POLYM ENVIRON, V14, P71, DOI 10.1007/s10924-005-8709-8
   Zhang LM, 2005, J BIOACT COMPAT POL, V20, P491, DOI 10.1177/0883911505055163
   Zhang SD, 2010, J POLYM RES, V17, P43, DOI 10.1007/s10965-009-9288-5
   Zhu JF, 2007, POLYM-PLAST TECHNOL, V46, P1135, DOI 10.1080/03602550701558116
   Zullo R, 2009, CARBOHYD POLYM, V77, P376, DOI 10.1016/j.carbpol.2009.01.007
NR 196
TC 7
Z9 7
U1 2
U2 81
PU AMER SCIENTIFIC PUBLISHERS
PI VALENCIA
PA 26650 THE OLD RD, STE 208, VALENCIA, CA 91381-0751 USA
SN 1556-6560
J9 J BIOBASED MATER BIO
JI J. Biobased Mater. Bioenergy
PD FEB
PY 2012
VL 6
IS 1
BP 1
EP 24
DI 10.1166/jbmb.2012.1196
PG 24
WC Chemistry, Applied; Energy & Fuels; Materials Science, Biomaterials
SC Chemistry; Energy & Fuels; Materials Science
GA 932GW
UT WOS:000303279500001
DA 2018-10-19
ER

PT J
AU Potarniche, CG
   Vuluga, Z
   Donescu, D
   Christiansen, JD
   Eugeniu, V
   Radovici, C
   Serban, S
   Ghiurea, M
   Somoghi, R
   Beckmann, S
AF Potarniche, C. G.
   Vuluga, Z.
   Donescu, D.
   Christiansen, J. de C.
   Eugeniu, V.
   Radovici, C.
   Serban, S.
   Ghiurea, M.
   Somoghi, R.
   Beckmann, S.
TI Morphology study of layered silicate/chitosan nanohybrids
SO SURFACE AND INTERFACE ANALYSIS
LA English
DT Article
DE chitosan; montmorillonite; nanocomposite; biomaterial
ID STRUCTURE-PROPERTY RELATIONSHIP; CHITOSAN; NANOCOMPOSITES; DERIVATIVES;
   COMPOSITES; DELIVERY; NANOCLAY
AB Modification of clay with biopolymers has been of high interest in recent years. These new materials may be used for drug delivery systems and as biomaterials due to their high biocompatible properties and because they have the advantage of being biodegradable. The modification of montmorillonite (MMT) with chitosan was done in solution, at ratio 1 : 2 and at room temperature, or at stages of high temperature, and subjected to a microwave treatment. The influence of pH was observed upon the intercalation process. The obtained materials were characterized through X-ray diffraction (XRD), thermogravimetrical analyses (TGA), Fourier transform infrared spectroscopy (FTIR), atomic force microscopy (AFM), scanning electron microscopy (SEM) and transmission electron microscopy (TEM). Using such a mixed treatment, the basal distance of modified MMT increased up to 3.6 nm. The results show the intercalation of chitosan between the layers of MMT and obtaining of intercalated and partial exfoliated nanocomposites. Copyright (C) 2011 John Wiley & Sons, Ltd.
C1 [Potarniche, C. G.; Christiansen, J. de C.] Aalborg Univ, Dept Mech & Mfg Engn, DK-9220 Aalborg, Denmark.
   [Potarniche, C. G.; Vuluga, Z.; Donescu, D.; Radovici, C.; Serban, S.; Ghiurea, M.; Somoghi, R.] Natl RD Inst Chem & Petrochem ICECHIM, Bucharest 060021, Romania.
   [Eugeniu, V.] METAV CD, Bucharest, Romania.
   [Beckmann, S.] Tech Fachhsch Wildau, D-15745 Wildau, Germany.
RP Potarniche, CG (reprint author), Aalborg Univ, Dept Mech & Mfg Engn, Fibigerstr 16, DK-9220 Aalborg, Denmark.
EM gabi@m-tech.aau.dk
RI Somoghi, Raluca/E-8969-2016; Vasile, Eugeniu/E-5460-2013; Vasile,
   Eugeniu/I-6164-2016; Christiansen, Jesper deClaville/F-2840-2010;
   Ghiurea, Marius/C-4717-2011; Sanporean, Catalina-Gabriela/F-9533-2012
OI Somoghi, Raluca/0000-0002-7648-3147; Vasile,
   Eugeniu/0000-0002-5868-1932; Vasile, Eugeniu/0000-0002-5868-1932;
   Christiansen, Jesper deClaville/0000-0001-5501-7019; Sanporean,
   Catalina-Gabriela/0000-0001-7621-9410
FU PNII [71-029]
FX The authors gratefully acknowledge the financial support of this
   research by the PNII 71-029 Project.
CR Altinisik A, 2009, POLYM COMPOSITE, V30, P1035, DOI 10.1002/pc.20651
   Azab AK, 2007, J BIOMED MATER RES A, V83A, P414, DOI 10.1002/jbm.a.31256
   Chen XC, 2003, SURF INTERFACE ANAL, V35, P369, DOI 10.1002/sia.1544
   Clark GL, 1936, J PHYS CHEM-US, V40, P863, DOI 10.1021/j150376a001
   Cole KC, 2008, MACROMOLECULES, V41, P834, DOI 10.1021/ma0628329
   Darder M, 2003, CHEM MATER, V15, P3774, DOI 10.1021/cm0343047
   Kabiri K, 2007, IRAN POLYM J, V16, P147
   Katti K.S., 2008, BIOMED MATER, V3, P1, DOI DOI 10.1088/1748-6041/3/3/034122
   Kean T, 2010, ADV DRUG DELIVER REV, V62, P3, DOI 10.1016/j.addr.2009.09.004
   Liu ZH, 2008, ADV DRUG DELIVER REV, V60, P1650, DOI 10.1016/j.addr.2008.09.001
   Park JH, 2010, ADV DRUG DELIVER REV, V62, P28, DOI 10.1016/j.addr.2009.10.003
   Ray SS, 2005, PROG MATER SCI, V50, P962, DOI 10.1016/j.pmatsci.2005.05.002
   Ray SS, 2003, MACROMOLECULES, V36, P2355, DOI 10.1021/ma021728y
   Rhim JW, 2006, J AGR FOOD CHEM, V54, P5814, DOI 10.1021/jf060658h
   Vartiainen J, 2010, J APPL POLYM SCI, V116, P3638, DOI 10.1002/app.31922
   Wang SF, 2005, POLYM DEGRAD STABIL, V90, P123, DOI 10.1016/j.polymdegradstab.2005.03.001
   Wang SF, 2006, J POLYM SCI POL CHEM, V44, P686, DOI 10.1002/pola.20941
   Xu YX, 2006, J APPL POLYM SCI, V99, P1684, DOI 10.1002/app.226646
   Yang ST, 2008, NANOTECHNOLOGY, V19, DOI 10.1088/0957-4484/19/39/395101
NR 19
TC 9
Z9 9
U1 0
U2 43
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0142-2421
EI 1096-9918
J9 SURF INTERFACE ANAL
JI Surf. Interface Anal.
PD FEB
PY 2012
VL 44
IS 2
BP 200
EP 207
DI 10.1002/sia.3797
PG 8
WC Chemistry, Physical
SC Chemistry
GA 931WA
UT WOS:000303248800011
DA 2018-10-19
ER

PT J
AU Kavya, KC
   Dixit, R
   Jayakumar, R
   Nair, SV
   Chennazhi, KP
AF Kavya, K. C.
   Dixit, Rachna
   Jayakumar, R.
   Nair, Shantikumar V.
   Chennazhi, Krishna Prasad
TI Synthesis and Characterization of Chitosan/Chondroitin Sulfate/Nano-SiO2
   Composite Scaffold for Bone Tissue Engineering
SO JOURNAL OF BIOMEDICAL NANOTECHNOLOGY
LA English
DT Article
DE Chitosan; Chondroitin Sulfate; Biomaterials; Tissue Engineering; Bone
   Regeneration
ID IN-VITRO; BIOMEDICAL APPLICATIONS; CARBON NANOTUBES; NANO-SCAFFOLDS;
   CHITOSAN; NANOPARTICLES; COLLAGEN; CELLS; CHITIN; VIVO
AB Chitosan, a natural polymer, is a biomaterial which is known to be osteoconductive but lacking in mechanical strength. In this work, to further enhance the mechanical property and biocompatibility of chitosan, we combined it with both chondroitin sulfate, a natural glycosaminoglycan found in bone, and nano-SiO2. The composite scaffold of chitosan/chondroitin sulfate/nano-SiO2 was fabricated by lyophilization. The nanocomposite scaffold showed enhanced porosity, degradation, mechanical integrity, biomineralization and protein adsorption. Biocompatibility and cell attachment-proliferation studies performed using MG-63 cells, advocate its better performance in vitro. To improve the cell seeding efficiency, we coated the scaffold surface with fibrin, which enhanced the initial cell attachment. The cumulative results suggest this novel nanocomposite scaffold to be a suitable candidate for bone tissue engineering.
C1 [Kavya, K. C.; Dixit, Rachna; Jayakumar, R.; Nair, Shantikumar V.; Chennazhi, Krishna Prasad] Amrita Inst Med Sci & Res Ctr, Amrita Ctr Nanosci & Mol Med, Cochin 682041, Kerala, India.
RP Nair, SV (reprint author), Amrita Inst Med Sci & Res Ctr, Amrita Ctr Nanosci & Mol Med, Cochin 682041, Kerala, India.
OI Chennazhi, Krishna Prasad/0000-0002-9390-0328
FU Department of Science and Technology, the Government of India through
   the National Nanoscience and Nanotechnology Initiative; Department of
   Biotechnology (DBT), Government of India [BT/PR13585/NNT/28/474/2010]
FX The authors are grateful to the Department of Science and Technology,
   the Government of India, for funding this work through the National
   Nanoscience and Nanotechnology Initiative, monitored by Professor C. N.
   R. Rao. The authors are also thankful to the Department of Biotechnology
   (DBT), Government of India, for providing the fund under the scheme of
   Nanoscience and Nanotechnology Program (Ref. No.
   BT/PR13585/NNT/28/474/2010). The authors gratefully acknowledge
   infrastructure support from Amrita Institute of Medical Sciences. The
   authors also thank Sajin.P.Ravi and Sreeja.V.Nair for their technical
   support.
CR Allen LT, 2006, BIOMATERIALS, V27, P3096, DOI 10.1016/j.biomaterials.2006.01.019
   Bhattacharyya S, 2009, J BIOMED NANOTECHNOL, V5, P69, DOI 10.1166/jbn.2009.032
   Bispo VM, 2010, J BIOMED NANOTECHNOL, V6, P166, DOI 10.1166/jbn.2010.1110
   CARLISLE EM, 1970, SCIENCE, V167, P279, DOI 10.1126/science.167.3916.279
   Csaba N, 2009, J BIOMED NANOTECHNOL, V5, P162, DOI 10.1166/jbn.2009.1017
   Ehrlich H, 2007, HDB BIOMINERALIZATIO, V1, P23
   Ehrlich H., 2008, J MEMBRANE SCI, V326, P254
   Ehrlich H, 2010, INT GEOL REV, V52, P661, DOI 10.1080/00206811003679521
   Ehrlich H, 2010, CHEM MATER, V22, P1462, DOI 10.1021/cm9026607
   Ehrlich H, 2010, J BIOMED MATER RES B, V92B, P542, DOI 10.1002/jbm.b.31551
   Facca S, 2011, J BIOMED NANOTECHNOL, V7, P482, DOI 10.1166/jbn.2011.1311
   Feng ZQ, 2010, J BIOMED NANOTECHNOL, V6, P658, DOI 10.1166/jbn.2010.1159
   Fu J, 2010, J BIOMED NANOTECHNOL, V6, P725, DOI 10.1166/jbn.2010.1135
   Han B, 2011, J BIOMED NANOTECHNOL, V7, P377, DOI 10.1166/jbn.2011.1288
   He JK, 2009, ACTA BIOMATER, V5, P453, DOI 10.1016/j.actbio.2008.07.002
   Hong ZK, 2008, ACTA BIOMATER, V4, P1297, DOI 10.1016/j.actbio.2008.03.007
   Jamilpour N, 2011, J BIOMED NANOTECHNOL, V7, P542, DOI 10.1166/jbn.2011.1319
   Jayakumar R, 2010, CARBOHYD POLYM, V82, P227, DOI 10.1016/j.carbpol.2010.04.074
   Jiankang H., 2007, POLYMER, V48, P4578, DOI DOI 10.1016/J.POLYMER.2007.05.048
   Jones JR, 2007, BIOMATERIALS, V28, P1653, DOI 10.1016/j.biomaterials.2006.11.022
   Kazemzadeh Narbat M., 2006, IRAN BIOMED J, V10, P215
   Kokubo T, 2006, BIOMATERIALS, V27, P2907, DOI 10.1016/j.biomaterials.2006.01.017
   LANGER R, 1993, SCIENCE, V260, P920, DOI 10.1126/science.8493529
   Lin YS, 2010, J BIOMED NANOTECHNOL, V6, P247, DOI 10.1166/jbn.2010.1122
   Madhumathi K., 2009, INT J BIOL MACROMOL, V3, P289
   Manjubala I, 2006, ACTA BIOMATER, V2, P75, DOI 10.1016/j.actbio.2005.09.007
   Mao JS, 2003, BIOMATERIALS, V24, P1067, DOI 10.1016/S0142-9612(02)00442-8
   Martinez V. S., 2010, J NANOSCI NANOTECHNO, V10, P2826
   Martins AM, 2009, TISSUE ENG PT A, V15, P1953, DOI 10.1089/ten.tea.2008.0023
   Mieszawska A., 2010, BIOMATERIALS, V34, P8902
   Muzzarelli RAA, 2011, CARBOHYD POLYM, V83, P1433, DOI 10.1016/j.carbpol.2010.10.044
   Muzzarelli RAA, 2009, CARBOHYD POLYM, V76, P167, DOI 10.1016/j.carbpol.2008.11.002
   Nagarwal RC, 2010, J BIOMED NANOTECHNOL, V6, P648, DOI 10.1166/jbn.2010.1168
   Padilla S, 2006, ACTA BIOMATER, V2, P331, DOI 10.1016/j.actbio.2006.01.006
   Perez P.M.L., 2010, J MATER CHEM, V20, P483
   Peter M, 2010, CARBOHYD POLYM, V80, P687, DOI 10.1016/j.carbpol.2009.11.050
   Pieper JS, 2000, BIOMATERIALS, V21, P581, DOI 10.1016/S0142-9612(99)00222-7
   Poinern GEJ, 2010, J BIOMED NANOTECHNOL, V6, P497, DOI 10.1166/jbn.2010.1148
   Pokharkar V, 2009, J BIOMED NANOTECHNOL, V5, P233, DOI 10.1166/jbn.2009.1027
   Rafeeqi T, 2010, J BIOMED NANOTECHNOL, V6, P710, DOI 10.1166/jbn.2010.1167
   Sahithi K, 2010, J BIOMED NANOTECHNOL, V6, P333, DOI 10.1166/jbn.2010.1138
   Saranya N, 2011, J BIOMED NANOTECHNOL, V7, P238, DOI 10.1166/jbn.2011.1283
   SCHWARZ K, 1972, NATURE, V239, P333, DOI 10.1038/239333a0
   Shokrgozar MA, 2011, J BIOMED NANOTECHNOL, V7, P276, DOI 10.1166/jbn.2011.1284
   Sujatha G, 2011, J BIOMED NANOTECHNOL, V7, P43, DOI 10.1166/jbn.2011.1193
   Tierney CM, 2009, J MECH BEHAV BIOMED, V2, P202, DOI 10.1016/j.jmbbm.2008.08.007
   Valdes O, 2009, J BIOMED NANOTECHNOL, V5, P716, DOI 10.1166/jbn.2009.1088
   Vijayalakshmi U.U., 2005, TRENDS BIOMATER ARTI, V18, P101
   Vural I, 2011, J BIOMED NANOTECHNOL, V7, P426, DOI 10.1166/jbn.2011.1294
   Webster TJ, 2000, BIOMATERIALS, V21, P1803, DOI 10.1016/S0142-9612(00)00075-2
   Weitzmann M. N., 2010, U.S Patent, Patent No. 20100297246
   Winer JP, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006382
   Wu P, 2009, J BIOMED NANOTECHNOL, V5, P557, DOI 10.1166/jbn.2009.1073
   Xing ZC, 2011, J NANOSCI NANOTECHNO, V11, P61, DOI 10.1166/jnn.2011.3551
   Yang WJ, 2010, J BIOMED NANOTECHNOL, V6, P254, DOI 10.1166/jbn.2010.1123
   Yang WJ, 2009, J BIOMED NANOTECHNOL, V5, P591, DOI 10.1166/jbn.2009.1067
   Yuan NY, 2008, DESALINATION, V234, P166, DOI 10.1016/j.desal.2007.09.083
   Zeng S, 2011, J BIOMED NANOTECHNOL, V7, P549, DOI 10.1166/jbn.2011.1316
   Zohuriaan Mehr MJ, 2005, TRENDS BIOMATERIALS, V14, P235
NR 59
TC 48
Z9 50
U1 1
U2 36
PU AMER SCIENTIFIC PUBLISHERS
PI VALENCIA
PA 26650 THE OLD RD, STE 208, VALENCIA, CA 91381-0751 USA
SN 1550-7033
EI 1550-7041
J9 J BIOMED NANOTECHNOL
JI J. Biomed. Nanotechnol.
PD FEB
PY 2012
VL 8
IS 1
BP 149
EP 160
DI 10.1166/jbn.2012.1363
PG 12
WC Nanoscience & Nanotechnology; Materials Science, Biomaterials
SC Science & Technology - Other Topics; Materials Science
GA 926JW
UT WOS:000302828300015
PM 22515103
DA 2018-10-19
ER

PT J
AU Tenke, P
   Koves, B
   Nagy, K
   Hultgren, SJ
   Mendling, W
   Wullt, B
   Grabe, M
   Wagenlehner, FME
   Cek, M
   Pickard, R
   Botto, H
   Naber, KG
   Johansen, TEB
AF Tenke, Peter
   Koeves, Bela
   Nagy, Karoly
   Hultgren, Scott J.
   Mendling, Werner
   Wullt, Bjoern
   Grabe, Magnus
   Wagenlehner, Florian M. E.
   Cek, Mete
   Pickard, Robert
   Botto, Henry
   Naber, Kurt G.
   Johansen, Truls E. Bjerklund
TI Update on biofilm infections in the urinary tract
SO WORLD JOURNAL OF UROLOGY
LA English
DT Article
DE Biofilm; Urinary tract infection; Catheter; Encrustation
ID UROPATHOGENIC ESCHERICHIA-COLI; URETERAL STENTS; BACTERIAL VAGINOSIS;
   ANIMAL-MODEL; PATHOGENESIS; PREVENTION; CATHETERS; PROSTHESES; CULTURES;
   HEPARIN
AB Purpose Biofilm infections have a major role in implants or devices placed in the human body. As part of the endourological development, a great variety of foreign bodies have been designed, and with the increasing number of biomaterial devices used in urology, biofilm formation and device infection is an issue of growing importance.
   Methods A literature search was performed in the Medline database regarding biofilm formation and the role of biofilms in urogenital infections using the following items in different combinations: "biofilm," "urinary tract infection," "bacteriuria," "catheter," "stent," and "encrustation." The studies were graded using the Oxford Centre for Evidence-based Medicine classification.
   Results The authors present an update on the mechanism of biofilm formation in the urinary tract with special emphasis on the role of biofilms in lower and upper urinary tract infections, as well as on biofilm formation on foreign bodies, such as catheters, ureteral stents, stones, implants, and artificial urinary sphincters. The authors also summarize the different methods developed to prevent biofilm formation on urinary foreign bodies.
   Conclusions Several different approaches are being investigated for preventing biofilm formation, and some promising results have been obtained. However, an ideal method has not been developed. Future researches have to aim at identifying effective mechanisms for controlling biofilm formation and to develop antimicrobial agents effective against bacteria in biofilms.
C1 [Tenke, Peter; Koeves, Bela; Nagy, Karoly] S Pest Hosp, Dept Urol, H-1204 Budapest, Hungary.
   [Hultgren, Scott J.] Washington Univ, Dept Mol Microbiol, Sch Med, St Louis, MO 63011 USA.
   [Mendling, Werner] Vivantes Klinikum Urban, Clin Obstet & Gynecol, D-10967 Berlin, Germany.
   [Wullt, Bjoern; Grabe, Magnus] Lund Univ, Dept Urol, Malmo Univ Hosp, S-22401 Malmo, Sweden.
   [Wagenlehner, Florian M. E.] Univ Giessen, Clin Urol Pediat Urol & Androl, D-735392 Giessen, Germany.
   [Cek, Mete] Trakya Med Fac, Dept Urol, TR-22030 Edirne, Turkey.
   [Pickard, Robert] Freeman Rd Hosp, Dept Urol, Newcastle Upon Tyne NE7 7DN, Tyne & Wear, England.
   [Botto, Henry] Hop Foch, Serv Urol, F-92151 Suresnes, France.
   [Naber, Kurt G.] Tech Univ Munich, D-80333 Munich, Germany.
   [Johansen, Truls E. Bjerklund] Arhus Univ Hosp, Dept Urol, DK-8200 Aarhus N, Denmark.
RP Tenke, P (reprint author), S Pest Hosp, Dept Urol, 1 Koves Str, H-1204 Budapest, Hungary.
EM tenke.peter@jahndelpest.hu
OI Koves, Bela/0000-0001-6886-0750
FU NIAID NIH HHS [R01 AI029549, R01 AI048689]; NIDDK NIH HHS [R01 DK051406,
   P50 DK064540]
CR Cadieux PA, 2006, J UROLOGY, V175, P2331, DOI 10.1016/S0022-5347(06)00252-7
   Carson CC, 2004, J UROLOGY, V171, P1611, DOI 10.1097/01.ju.0000118245.66976.e1
   De Ridder DJMK, 2005, EUR UROL, V48, P991, DOI 10.1016/j.eururo.2005.07.018
   Denstedt JD, 2000, WORLD J UROL, V18, P237, DOI 10.1007/PL00007074
   Farsi HMA, 1995, J ENDOUROL, V9, P469, DOI 10.1089/end.1995.9.469
   Hachem R, 2009, ANTIMICROB AGENTS CH, V53, P5145, DOI 10.1128/AAC.00718-09
   Hazan Z, 2006, ANTIMICROB AGENTS CH, V50, P4144, DOI 10.1128/AAC.00418-06
   Henry GD, 2004, J UROLOGY, V172, P153, DOI 10.1097/01.ju.0000132141.48587.f1
   Hola V, 2010, FEMS IMMUNOL MED MIC, V59, P525, DOI 10.1111/j.1574-695X.2010.00703.x
   Ikinger U, 2007, 25 WORLD C END SWL C
   Justice SS, 2004, P NATL ACAD SCI USA, V101, P1333, DOI 10.1073/pnas.0308125100
   Lange D, 2009, J UROLOGY, V182, P1194, DOI 10.1016/j.juro.2009.05.008
   LICHT MR, 1995, J UROLOGY, V154, P387, DOI 10.1016/S0022-5347(01)67058-7
   Morris NS, 1999, WORLD J UROL, V17, P345, DOI 10.1007/s003450050159
   Mysorekar IU, 2006, P NATL ACAD SCI USA, V103, P14170, DOI 10.1073/pnas.0602136103
   Nagy K, 2011, 26 ANN EAU C 2011 MA
   Nickel J, 1990, INT UROGYNECOL J PEL, V1, P218
   NICKEL JC, 1994, J ANTIMICROB CHEMOTH, V33, P31, DOI 10.1093/jac/33.suppl_A.31
   NICKEL JC, 1990, BRIT J UROL, V66, P47, DOI 10.1111/j.1464-410X.1990.tb14864.x
   NICKEL JC, 1987, BRIT J UROL, V59, P21, DOI 10.1111/j.1464-410X.1987.tb04573.x
   Rajpurkar A, 2004, J SEX MED, V1, P215, DOI 10.1111/j.1743-6109.2004.04031.x
   REID G, 1992, J UROLOGY, V148, P1592, DOI 10.1016/S0022-5347(17)36976-8
   Reid G, 2001, INT J ANTIMICROB AG, V17, P317, DOI 10.1016/S0924-8579(00)00353-8
   Reid G, 2001, INT J ANTIMICROB AG, V17, P319
   Riedl CR, 2002, INT J ANTIMICROB AG, V19, P507, DOI 10.1016/S0924-8579(02)00097-3
   Rosen DA, 2007, PLOS MED, V4, P1949, DOI 10.1371/journal.pmed.0040329
   RUGGIERI MR, 1987, J UROLOGY, V138, P423, DOI 10.1016/S0022-5347(17)43177-6
   Sarica S, 2010, EUR J PHYS REHAB MED, V46, P473
   Schumm K, 2008, COCHRANE DB SYST REV, V2, DOI [10.1002/14651858.CD004013.pub1, DOI 10.1002/14651858.CD004013.PUB1]
   Shigeta M, 1997, CHEMOTHERAPY, V43, P137, DOI 10.1159/000239548
   Sobel JD, 2000, ANNU REV MED, V51, P349, DOI 10.1146/annurev.med.51.1.349
   Stickler DJ, 2010, SPINAL CORD, V48, P784, DOI 10.1038/sc.2010.32
   Swidsinski A, 2005, OBSTET GYNECOL, V106, P1013, DOI 10.1097/01.AOG.0000183594.45524.d2
   Swidsinski A, 2008, AM J OBSTET GYNECOL, V198, P97, DOI DOI 10.1016/J.AJ0G.2007.06.039
   Tenke P, 2006, WORLD J UROL, V24, P13, DOI 10.1007/s00345-005-0050-2
NR 35
TC 50
Z9 53
U1 0
U2 34
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 0724-4983
J9 WORLD J UROL
JI World J. Urol.
PD FEB
PY 2012
VL 30
IS 1
BP 51
EP 57
DI 10.1007/s00345-011-0689-9
PG 7
WC Urology & Nephrology
SC Urology & Nephrology
GA 920LK
UT WOS:000302405800007
PM 21590469
OA Green Accepted
DA 2018-10-19
ER

PT J
AU Rubner, MM
   Achatz, DE
   Mader, HS
   Stolwijk, JA
   Wegener, J
   Harms, GS
   Wolfbeis, OS
   Wagenknecht, HA
AF Rubner, Moritz M.
   Achatz, Daniela E.
   Mader, Heike S.
   Stolwijk, Judith A.
   Wegener, Joachim
   Harms, Gregory S.
   Wolfbeis, Otto S.
   Wagenknecht, Hans-Achim
TI DNA "Nanolamps": "Clicked" DNA Conjugates with Photon Upconverting
   Nanoparticles as Highly Emissive Biomaterial
SO CHEMPLUSCHEM
LA English
DT Article
DE cycloaddition; DNA; fluorescence; imaging; nanoparticles
ID CONVERTING PHOSPHOR REPORTERS; UP-CONVERSION; LUMINESCENT NANOPARTICLES;
   TERMINAL ALKYNES; NUCLEIC-ACIDS; NANOCRYSTALS; AZIDES; CELLS
AB Upconverting nanoparticles (UCNPs) are a highly attractive tool owing to their unique property of showing visible luminescence when excited in the near-infrared (NIR) region. Plain UCNPs have no biorecognition capabilities, but functionalization of their surface with azido groups renders them conjugatable to ethynyl-modified oligonucleotides in a bioorthogonal fashion. Single-stranded DNA was covalently attached to the surface of UCNPs by click chemistry and purified by size exclusion chromatography (SEC) at elevated temperature. Covalent attachment was evidenced by diffuse reflectance infrared Fourier transform (DRIFT) spectroscopy. DNA conjugation makes the particle soluble in water and enables it to recognize its counter strand. Such UCNPs are capable of nonspecifically crossing cell membranes. Confocal microscopy reveals the high potential of the bright UCNPs for live cell imaging in the NIR, where the UCNP-DNA conjugates can be considered to act as a kind of nano-sized lamp. Furthermore, cross-linking of those DNA nanolamps yields highly emissive aggregates.
C1 [Achatz, Daniela E.; Mader, Heike S.; Stolwijk, Judith A.; Wegener, Joachim; Wolfbeis, Otto S.] Univ Regensburg Germany, Inst Analyt Chem Chemo & Biosensors, D-93040 Regensburg, Germany.
   [Rubner, Moritz M.; Wagenknecht, Hans-Achim] Karlsruhe Inst Technol, Inst Organ Chem, D-76131 Karlsruhe, Germany.
   [Harms, Gregory S.] Univ Wurzburg Germany, Bioimaging Ctr, D-97080 Wurzburg, Germany.
   [Harms, Gregory S.] Univ Wurzburg Germany, Rudolf Virchow Ctr, D-97080 Wurzburg, Germany.
RP Wolfbeis, OS (reprint author), Univ Regensburg Germany, Inst Analyt Chem Chemo & Biosensors, D-93040 Regensburg, Germany.
EM Wagenknecht@kit.edu
RI Wolfbeis, Otto/D-2855-2009; Wegener, Joachim/A-1234-2011
OI Wolfbeis, Otto/0000-0002-6124-2842; 
FU Deutsche Forschungsgemeinschaft; Karlsruhe Institute of Technology
   (KIT); University of Regensburg
FX Financial support by the Deutsche Forschungsgemeinschaft, Karlsruhe
   Institute of Technology (KIT), and the University of Regensburg is
   gratefully acknowledged.
CR Achatz DE, 2011, TOP CURR CHEM, V300, P29, DOI 10.1007/128_2010_98
   Auzel F, 2004, CHEM REV, V104, P139, DOI 10.1021/cr020357g
   Berndl S, 2009, BIOCONJUGATE CHEM, V20, P558, DOI 10.1021/bc8004864
   Chatteriee DK, 2008, BIOMATERIALS, V29, P937, DOI 10.1016/j.biomaterials.2007.10.051
   Corstjens PLAM, 2003, ANAL BIOCHEM, V312, P191, DOI 10.1016/S0003-2697(02)00505-5
   Escribano P, 2008, J MATER CHEM, V18, P23, DOI 10.1039/b710800a
   Gramlich P. M. E., 2008, ANGEW CHEM, V120, P8478
   Gramlich PME, 2008, ANGEW CHEM INT EDIT, V47, P8350, DOI 10.1002/anie.200802077
   Jiang S, 2009, NANOTECHNOLOGY, V20, DOI 10.1088/0957-4484/20/15/155101
   Kumar M, 2009, LANGMUIR, V25, P6024, DOI 10.1021/la900936p
   Lachmann D, 2010, BEILSTEIN J ORG CHEM, V6, DOI 10.3762/bjoc.6.13
   Mader HS, 2010, CURR OPIN CHEM BIOL, V14, P582, DOI 10.1016/j.cbpa.2010.08.014
   Mader HS, 2010, CHEM-EUR J, V16, P5416, DOI 10.1002/chem.201000117
   Park YI, 2009, ADV MATER, V21, P4467, DOI 10.1002/adma.200901356
   Rostovtsev V. V., 2002, ANGEW CHEM, V114, P2708, DOI DOI 10.1002/1521-3757(20020715)114:14<2708::AID-ANGE2708>3.0.CO;2-0
   Rostovtsev VV, 2002, ANGEW CHEM INT EDIT, V41, P2596, DOI 10.1002/1521-3773(20020715)41:14<2596::AID-ANIE2596>3.0.CO;2-4
   Shen J, 2008, DALTON T, P5687, DOI 10.1039/b805306e
   Sletten E. M., 2009, ANGEW CHEM, V121, P7108, DOI DOI 10.1002/ANGE.200900942
   Sletten EM, 2009, ANGEW CHEM INT EDIT, V48, P6974, DOI 10.1002/anie.200900942
   Sokolova V., 2008, ANGEW CHEM, V120, P1402
   Sokolova V, 2008, ANGEW CHEM INT EDIT, V47, P1382, DOI 10.1002/anie.200703039
   Tornoe CW, 2002, J ORG CHEM, V67, P3057, DOI 10.1021/jo011148j
   van de Rijke F, 2001, NAT BIOTECHNOL, V19, P273, DOI 10.1038/85734
   Verma A, 2010, SMALL, V6, P12, DOI 10.1002/smll.200901158
   Wang F, 2009, CHEM SOC REV, V38, P976, DOI 10.1039/b809132n
   Wang LY, 2006, CHEM COMMUN, P2557, DOI 10.1039/b604871d
   Wang LY, 2005, ANGEW CHEM INT EDIT, V44, P6054, DOI 10.1002/anie.200501907
   Wang LY, 2010, ANGEW CHEM, V117, P6208, DOI 10.1002/ange.200501907
   Wang M, 2009, J PHYS CHEM C, V113, P19021, DOI 10.1021/jp906394z
   Yi GS, 2004, NANO LETT, V4, P2191, DOI 10.1021/nl048680h
NR 30
TC 13
Z9 13
U1 2
U2 52
PU WILEY-V C H VERLAG GMBH
PI WEINHEIM
PA POSTFACH 101161, 69451 WEINHEIM, GERMANY
SN 2192-6506
J9 CHEMPLUSCHEM
JI ChemPlusChem
PD FEB
PY 2012
VL 77
IS 2
BP 129
EP 134
DI 10.1002/cplu.201100055
PG 6
WC Chemistry, Multidisciplinary
SC Chemistry
GA 912YZ
UT WOS:000301839800008
DA 2018-10-19
ER

PT J
AU Desmet, T
   Poleunis, C
   Delcorte, A
   Dubruel, P
AF Desmet, T.
   Poleunis, C.
   Delcorte, A.
   Dubruel, P.
TI Double protein functionalized poly-epsilon-caprolactone surfaces: in
   depth ToF-SIMS and XPS characterization
SO JOURNAL OF MATERIALS SCIENCE-MATERIALS IN MEDICINE
LA English
DT Article
ID TISSUE ENGINEERING APPLICATIONS; CELL-ADHESION; ENDOTHELIUM
   REGENERATION; BIOMEDICAL APPLICATIONS; MECHANICAL-PROPERTIES; HUMAN
   OSTEOBLASTS; STROMAL CELLS; GELATIN; SCAFFOLDS; POLYCAPROLACTONE
AB In biomaterial research, great attention has focussed on the immobilization of biomolecules with the aim to increase cell-adhesive properties of materials. Many different strategies can be applied. In previously published work, our group focussed on the treatment of poly-epsilon-caprolactone (PCL) films by an Ar-plasma, followed by the grafting of 2-aminoethyl methacrylate (AEMA) under UV-irradiation. The functional groups introduced, enabled the subsequent covalent immobilisation of gelatin. The obtained coating was finally applied for the physisorption of fibronectin. The successful PCL surface functionalization was preliminary confirmed using XPS, wettability studies, AFM and SEM. In the present article, we report on an in-depth characterization of the materials developed using ToF-SIMS and XPS analysis. The homogeneous AEMA grafting and the subsequent protein coating steps could be confirmed by both XPS and ToF-SIMS. Using ToF-SIMS, it was possible to demonstrate the presence of polymethacrylates on the surface. From peak deconvoluted XPS results (C- and N-peak), the presence of proteins could be confirmed. Using ToF-SIMS, different positive ions, correlating to specific amino-acids could be identified. Importantly, the gelatin and the fibronectin coatings could be qualitatively distinguished. Interestingly for biomedical applications, ethylene oxide sterilization did not affect the surface chemical composition. This research clearly demonstrates the complementarities of XPS and ToF-SIMS in biomedical surface modification research.
C1 [Desmet, T.; Dubruel, P.] Univ Ghent, Polymer Chem & Biomat Res Grp, B-9000 Ghent, Belgium.
   [Poleunis, C.; Delcorte, A.] Catholic Univ Louvain, Inst Condensed Matter & Nanosci IMCN Bio & Soft M, B-1348 Louvain, Belgium.
RP Dubruel, P (reprint author), Univ Ghent, Polymer Chem & Biomat Res Grp, Krijgslaan 281 S4 Bis, B-9000 Ghent, Belgium.
EM Peter.Dubruel@ugent.be
FU Ghent University (UGent); UGent Multidisciplinary Research Partnership
   Nano- and biophotonics; Catholic University of Louvain-la-Neuve
FX The authors would like to thank Ghent University (UGent, BOF project),
   the UGent Multidisciplinary Research Partnership Nano- and biophotonics
   (2010-2015) and the Catholic University of Louvain-la-Neuve for
   financial support. A special thanks to Claude Poleunis for performing
   ToF-SIMS, to Michel Genet for his support in the XPS interpretation and
   to Thomas Billiet for the interesting discussions.
CR Altankov G, 2000, J BIOMED MATER RES, V52, P219, DOI 10.1002/1097-4636(200010)52:1<219::AID-JBM28>3.0.CO;2-F
   Amato I, 2007, BIOMATERIALS, V28, P3668, DOI 10.1016/j.biomaterials.2007.04.038
   Badylak S, 1999, BIOMATERIALS, V20, P2257, DOI 10.1016/S0142-9612(99)00156-8
   Briggs D., 1998, SURFACE ANAL POLYM X
   Bullett NA, 2004, APPL SURF SCI, V235, P395, DOI 10.1016/j.apsusc.2004.02.058
   Canavan HE, 2007, LANGMUIR, V23, P50, DOI 10.1021/la062330o
   Cheng ZY, 2004, BIOMATERIALS, V25, P1991, DOI 10.1016/j.biomaterials.2003.08.038
   Chi YS, 2005, B KOREAN CHEM SOC, V26, P361
   Chim H, 2006, INT J ORAL MAX SURG, V35, P928, DOI 10.1016/j.ijom.2006.03.024
   Chong MSK, 2007, MAT SCI ENG C-BIO S, V27, P309, DOI 10.1016/j.msec.2006.03.008
   Desmet T., 2008, TISSUE ENG ROLES MAT, P141
   Desmet T, 2010, MACROMOL BIOSCI, V10, P1484, DOI 10.1002/mabi.201000147
   Desmet T, 2009, BIOMACROMOLECULES, V10, P2351, DOI 10.1021/bm900186s
   Detrait E, 1999, J BIOMED MATER RES, V45, P404, DOI 10.1002/(SICI)1097-4636(19990615)45:4<404::AID-JBM16>3.3.CO;2-W
   Farquet P, 2007, NUCL INSTRUM METH B, V265, P187, DOI 10.1016/j.nimb.2007.08.070
   Gabriel M, 2006, J BIOMAT SCI-POLYM E, V17, P567, DOI 10.1163/156856206776986288
   Genet Michel J., 2008, P177, DOI 10.1007/978-0-387-76921-9_5
   Goddard JM, 2007, PROG POLYM SCI, V32, P698, DOI 10.1016/j.progpolymsci.2007.04.002
   Hsu SH, 2007, J BIOMED MATER RES B, V80B, P519, DOI 10.1002/jbm.b.30626
   Hutmacher DW, 2001, J BIOMED MATER RES, V55, P203, DOI 10.1002/1097-4636(200105)55:2<203::AID-JBM1007>3.3.CO;2-Z
   Jagielski J, 2007, NUCL INSTRUM METH B, V261, P690, DOI 10.1016/j.nimb.2007.03.021
   Ma ZW, 2005, TISSUE ENG, V11, P1149, DOI 10.1089/ten.2005.11.1149
   Marletta G, 2007, BIOMATERIALS, V28, P1132, DOI 10.1016/j.biomaterials.2006.10.027
   Marletta G, 2005, BIOMATERIALS, V26, P4793, DOI 10.1016/j.biomaterials.2004.11.047
   Mathieson I, 1996, INT J ADHES ADHES, V16, P29, DOI 10.1016/0143-7496(96)88482-X
   Olah L, 2006, POLYM ADVAN TECHNOL, V17, P889, DOI 10.1002/pat.768
   Perale G, 2008, J APPL POLYM SCI, V108, P1591, DOI 10.1002/app.27875
   Ren JR, 2008, APPL SURF SCI, V255, P263, DOI 10.1016/j.apsusc.2008.06.181
   Savarino L, 2007, BIOMATERIALS, V28, P3101, DOI 10.1016/j.biomaterials.2007.03.011
   Shin YM, 2008, BIOMACROMOLECULES, V9, P1772, DOI 10.1021/bm701410g
   Shor L, 2007, BIOMATERIALS, V28, P5291, DOI 10.1016/j.biomaterials.2007.08.018
   Sioshansi P, 1996, SURF COAT TECH, V83, P175, DOI 10.1016/0257-8972(95)02838-2
   Siow KS, 2006, PLASMA PROCESS POLYM, V3, P392, DOI 10.1002/ppap.200600021
   SUZUKI M, 1986, MACROMOLECULES, V19, P1804, DOI 10.1021/ma00161a005
   Thompson KL, 2008, POLYM DEGRAD STABIL, V93, P1460, DOI 10.1016/j.polymdegradstab.2008.05.013
   Tiaw KS, 2005, BIOMATERIALS, V26, P763, DOI 10.1016/j.biomaterials.2004.03.010
   Truica-Marasescu F, 2008, MACROMOL CHEM PHYSIC, V209, P1043, DOI 10.1002/macp.200800089
   Ulubayram K, 2002, J BIOMATER APPL, V16, P227, DOI 10.1106/088532802021178
   Van Vlierberghe S, 2007, BIOMACROMOLECULES, V8, P331, DOI 10.1021/bm060684o
   Vickerman JC, 1996, WILEY STATIC SIMS LI
   Vlierberghe S. V., 2009, MACROMOL BIOSCI, V9, P1105
   Vogel V, 1995, PROTEINS INTERFACES
   Wang F, 2004, RAPID PROTOTYPING J, V10, P42, DOI 10.1108/13552540410512525
   Wirsen A, 2005, BIOMACROMOLECULES, V6, P2697, DOI 10.1021/bm050169a
   Wirsen A, 2005, BIOMACROMOLECULES, V6, P2281, DOI 10.1021/bm050170+
   Yang Q, 2005, LANGMUIR, V21, P10717, DOI 10.1016/la051797g
   Yang Q, 2005, CHEM J CHINESE U, V26, P189
   Yu HY, 2007, J MEMBRANE SCI, V302, P235, DOI 10.1016/j.memsci.2007.06.061
   Yu TT, 2005, BIOMATERIALS, V26, P1507, DOI 10.1016/j.biomaterials.2004.05.012
   Zein I, 2002, BIOMATERIALS, V23, P1169, DOI 10.1016/S0142-9612(01)00232-0
   Zhu AP, 2009, ACTA BIOMATER, V5, P2033, DOI 10.1016/j.actbio.2009.02.016
   Zhu YB, 2004, BIOMATERIALS, V25, P423, DOI 10.1016/S0142-9612(03)00549-0
   Zhu YB, 2002, BIOMACROMOLECULES, V3, P1312, DOI 10.1021/bm020074y
   Zhu YB, 2002, BIOMATERIALS, V23, P4889, DOI 10.1016/S0142-9612(02)00247-8
   Zhu YB, 2004, TISSUE ENG, V10, P53, DOI 10.1089/107632704322791691
NR 55
TC 10
Z9 11
U1 0
U2 32
PU SPRINGER
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 0957-4530
J9 J MATER SCI-MATER M
JI J. Mater. Sci.-Mater. Med.
PD FEB
PY 2012
VL 23
IS 2
BP 293
EP 305
DI 10.1007/s10856-011-4527-9
PG 13
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 910MF
UT WOS:000301640800008
PM 22203514
DA 2018-10-19
ER

PT J
AU de Vasconcellos, LMR
   Oliveira, FN
   Leite, DD
   de Vasconcellos, LGO
   do Prado, RF
   Ramos, CJ
   Graca, MLD
   Cairo, CAA
   Carvalho, YR
AF Reis de Vasconcellos, Luana Marotta
   Oliveira, Fernanda Nascimento
   Leite, Daniel de Oliveira
   Oliveira de Vasconcellos, Luis Gustavo
   do Prado, Renata Falchete
   Ramos, Carolina Judica
   de Alencastro Graca, Mario Lima
   Alves Cairo, Carlos Alberto
   Carvalho, Yasmin Rodarte
TI Novel production method of porous surface Ti samples for biomedical
   application
SO JOURNAL OF MATERIALS SCIENCE-MATERIALS IN MEDICINE
LA English
DT Article
ID TITANIUM IMPLANTS; MECHANICAL-PROPERTIES; TISSUE INGROWTH; DENTAL
   IMPLANTS; BONE INGROWTH; OSTEOGENESIS; FIXATION; METALS; ALLOY; DOGS
AB A porous implant material with adequate pore structure and the appropriate mechanical properties for bone ingrowth has long been sought. This article presents details of the development, characterization and in vivo evaluations of powder metallurgy-processed titanium samples exhibiting a dense core with an integrated porous surface for biomedical applications. A space-holder method was applied to investigate the effects of different percentages and particle sizes of the urea on bone neoformation in 30 rabbits. The samples were previously characterized using scanning electron microscopy and mechanical testing. After 8 and 12 weeks of implantation, bone ingrowth was histologically and histometrically analyzed and push-out testing was performed. This study demonstrated that the association of a dense core integrated with the greatest number of interconnected pores of the smallest size is a promising biomaterial for bone tissue engineering. This sample exhibits appropriate mechanical properties combined with increased bone ingrowth, providing enhanced resistance to displacement.
C1 [Reis de Vasconcellos, Luana Marotta; Oliveira, Fernanda Nascimento; Leite, Daniel de Oliveira; Oliveira de Vasconcellos, Luis Gustavo; do Prado, Renata Falchete; Ramos, Carolina Judica; Alves Cairo, Carlos Alberto; Carvalho, Yasmin Rodarte] Univ Estadual Paulista UNESP, Dept Biosci & Oral Diag, Sao Jose dos Campos Sch Dent, BR-12245000 Sao Jose Dos Campos, SP, Brazil.
   [de Alencastro Graca, Mario Lima] CTA, Div Mat, Air & Space Inst, BR-12245000 Sao Jose Dos Campos, SP, Brazil.
RP de Vasconcellos, LMR (reprint author), Univ Estadual Paulista UNESP, Dept Biosci & Oral Diag, Sao Jose dos Campos Sch Dent, Av Engn Francisco Jose Longo,777 Jd Sao Dimas, BR-12245000 Sao Jose Dos Campos, SP, Brazil.
EM luanamrv@gmail.com
RI Carvalho, Yasmin/E-5546-2012; Vasconcellos, Luana Marotta Reis
   d/M-8326-2014; Prado, Renata/G-5066-2011
OI Carvalho, Yasmin/0000-0003-3773-2646; Vasconcellos, Luana Marotta Reis
   d/0000-0003-4344-0578; 
FU State of Sao Paulo Research (FAPESP), Brazil [2005/03709-4]
FX This study was supported by research grant 2005/03709-4, awarded by the
   State of Sao Paulo Research (FAPESP), Brazil.
CR An YB, 2005, MATER CHEM PHYS, V95, P242, DOI 10.1016/j.matchemphys.2005.06.011
   Baril E, 2011, J MATER SCI-MATER M, V22, P1321, DOI 10.1007/s10856-011-4309-4
   Barrabes A, 2008, MAT SCI ENG C-BIO S, V28, P23, DOI 10.1016/j.msec.2007.02.001
   Bottino MC, 2009, J BIOMED MATER RES A, V88A, P689, DOI 10.1002/jbm.a.31912
   Brentel Aline Scalone, 2006, J. Appl. Oral Sci., V14, P213, DOI 10.1590/S1678-77572006000300013
   Consolaro Alberto, 2010, Dental Press J. Orthod., V15, P19, DOI 10.1590/S2176-94512010000300003
   Deporter D A, 1996, Int J Oral Maxillofac Implants, V11, P87
   DEPORTER DA, 1986, J DENT RES, V65, P1064, DOI 10.1177/00220345860650080501
   Dewidar MM, 2006, MET MATER INT, V12, P193, DOI 10.1007/BF03027531
   Kuboki Y, 1998, J BIOMED MATER RES, V39, P190, DOI 10.1002/(SICI)1097-4636(199802)39:2<190::AID-JBM4>3.0.CO;2-K
   Li JP, 2007, BIOMATERIALS, V28, P2810, DOI 10.1016/j.biomaterials.2007.02.020
   Li JP, 2006, J MATER SCI-MATER M, V17, P179, DOI 10.1007/s10856-006-6822-4
   Mendonca G, 2008, BIOMATERIALS, V29, P3822, DOI 10.1016/j.biomaterials.2008.05.012
   Nugroho AW, 2010, J MATER SCI-MATER M, V21, P3103, DOI 10.1007/s10856-010-4162-x
   Oliveira M.V., 2002, Mat. Res., V5, P269, DOI 10.1590/S1516-14392002000300009
   Otsuki B, 2006, BIOMATERIALS, V27, P5892, DOI 10.1016/j.biomaterials.2006.08.013
   Pilliar R M, 1998, Implant Dent, V7, P305, DOI 10.1097/00008505-199807040-00009
   Pilliar R M, 1998, Oral Health, V88, P61
   PILLIAR RM, 1983, CLIN ORTHOP RELAT R, P42
   Faria PEP, 2010, CLIN IMPLANT DENT R, V12, P72, DOI 10.1111/j.1708-8208.2008.00132.x
   de Vasconcellos LMR, 2008, MATER RES-IBERO-AM J, V11, P275, DOI 10.1590/S1516-14392008000300008
   Ryan G, 2006, BIOMATERIALS, V27, P2651, DOI 10.1016/j.biomaterials.2005.12.002
   Thelen S, 2004, J BIOMED MATER RES A, V69A, P601, DOI 10.1002/jbm.a.20100
   Torres FG, 2007, COMPOS SCI TECHNOL, V67, P1139, DOI 10.1016/j.compscitech.2006.05.018
   Vasconcellos L., 2010, BRAZ ORAL RES, V2, P407
   Vasconcellos LMR, 2008, J MATER SCI-MATER M, V19, P2851, DOI 10.1007/s10856-008-3421-6
   Vasconcellos Luana Marotta Reis de, 2010, Braz. oral res., V24, P399, DOI 10.1590/S1806-83242010000400005
   Wazen RM, 2010, J BIOMED MATER RES B, V94B, P64, DOI 10.1002/jbm.b.31624
NR 28
TC 18
Z9 18
U1 3
U2 30
PU SPRINGER
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 0957-4530
EI 1573-4838
J9 J MATER SCI-MATER M
JI J. Mater. Sci.-Mater. Med.
PD FEB
PY 2012
VL 23
IS 2
BP 357
EP 364
DI 10.1007/s10856-011-4515-0
PG 8
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 910MF
UT WOS:000301640800015
PM 22183791
DA 2018-10-19
ER

PT J
AU Schloegl, W
   Klein, A
   Furst, R
   Leicht, U
   Volkmer, E
   Schieker, M
   Jus, S
   Guebitz, GM
   Stachel, I
   Meyer, M
   Wiggenhorn, M
   Friess, W
AF Schloegl, W.
   Klein, A.
   Fuerst, R.
   Leicht, U.
   Volkmer, E.
   Schieker, M.
   Jus, S.
   Guebitz, G. M.
   Stachel, I.
   Meyer, M.
   Wiggenhorn, M.
   Friess, W.
TI Residual transglutaminase in collagen - Effects, detection,
   quantification, and removal
SO EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS
LA English
DT Article
DE Collagen; ELISA; Enzyme; Protein; Transglutaminase; Western blot
ID DERMAL SHEEP COLLAGEN; IN-VITRO DEGRADATION; MICROBIAL TRANSGLUTAMINASE;
   CROSS-LINKING; BIOMATERIAL; MATRICES; FIBERS; SITU
AB In the present study, we developed an enzyme-linked immunosorbent assay (ELISA) for microbial transglutaminase (mTG) from Streptomyces mobaraensis to overcome the lack of a quantification method for mTG. We further performed a detailed follow-on-analysis of insoluble porcine collagen type I enzymatically modified with mTG primarily focusing on residuals of mTG. Repeated washing (4x) reduced mTG-levels in the washing fluids but did not quantitatively remove mTG from the material (p < 0.000001). Substantial amounts of up to 40% of the enzyme utilized in the crosslinking mixture remained associated with the modified collagen. Binding was non-covalent as could be demonstrated by Western blot analysis. Acidic and alkaline dialysis of mTG treated collagen material enabled complete removal the enzyme. Treatment with guanidinium chloride, urea, or sodium chloride was less effective in reducing the mTG content. (C) 2011 Elsevier B.V. All rights reserved.
C1 [Schloegl, W.; Klein, A.; Friess, W.] Univ Munich, Dept Pharm Pharmaceut Technol & Biopharmaceut, D-81377 Munich, Germany.
   [Fuerst, R.] Univ Munich, Dept Pharm, D-81377 Munich, Germany.
   [Leicht, U.; Volkmer, E.; Schieker, M.] Univ Munich, Ctr Clin, D-81377 Munich, Germany.
   [Jus, S.; Guebitz, G. M.] Graz Univ Technol, Inst Environm Biotechnol, A-8010 Graz, Austria.
   [Stachel, I.; Meyer, M.] Res Inst Leather & Plast Sheeting, Freiberg, Germany.
   [Wiggenhorn, M.] Coriolis Pharma Serv GmbH, Martinsried, Germany.
RP Schloegl, W (reprint author), Univ Munich, Dept Pharm Pharmaceut Technol & Biopharmaceut, Butenandtstr 5, D-81377 Munich, Germany.
EM winfried.schloegl@gmx.de
RI Meyer, Michael/A-6227-2016; Schieker, Matthias/J-6511-2015
OI Meyer, Michael/0000-0003-2934-9962; Schieker,
   Matthias/0000-0002-1230-3653
FU AiF-project "Collagen modification by enzymatic technologies" (COMET);
   Bavarian Research Foundation
FX We thank the German AiF-project "Collagen modification by enzymatic
   technologies" (COMET) for financial support. The above work is embedded
   in the "ForZebRA"-project and therefore supported by the Bavarian
   Research Foundation.
CR ANDO H, 1989, AGR BIOL CHEM TOKYO, V53, P2613, DOI 10.1080/00021369.1989.10869735
   Besheer A, 2009, J PHARM SCI-US, V98, P4420, DOI 10.1002/jps.21675
   Chen RN, 2005, BIOMATERIALS, V26, P4229, DOI 10.1016/j.biomaterials.2004.11.012
   Ciardelli G, 2010, J BIOMED MATER RES A, V92A, P137, DOI 10.1002/jbm.a.32344
   Collighan RJ, 2004, J AM LEATHER CHEM AS, V99, P293
   Damink LHHO, 1996, BIOMATERIALS, V17, P679, DOI 10.1016/0142-9612(96)86737-8
   DAMINK LHHO, 1995, J BIOMED MATER RES, V29, P139, DOI 10.1002/jbm.820290202
   David Y. S. C., 2005, BIOMATERIALS, V26, P6518
   FOLK JE, 1980, ANNU REV BIOCHEM, V49, P517, DOI 10.1146/annurev.bi.49.070180.002505
   FOLK JE, 1965, J BIOL CHEM, V240, P2951
   Fontana A, 2008, ADV DRUG DELIVER REV, V60, P13, DOI 10.1016/j.addr.2007.06.015
   Friess W, 1998, EUR J PHARM BIOPHARM, V45, P113, DOI 10.1016/S0939-6411(98)00017-4
   Friess W, 2001, EUR J PHARM BIOPHARM, V51, P259, DOI 10.1016/S0939-6411(01)00136-9
   Garcia Y, 2008, BIOMATERIALS, V29, P857, DOI 10.1016/j.biomaterials.2007.10.053
   Halloran O D., 2006, TISSUE ENG, V12, P1467
   KANAJI T, 1993, J BIOL CHEM, V268, P11565
   Kashiwagi T, 2002, J BIOL CHEM, V277, P44252, DOI 10.1074/jbc.M203933200
   Meyer M, 2010, MAT SCI ENG C-MATER, V30, P1266, DOI 10.1016/j.msec.2010.07.005
   Miles CA, 1999, BIOPHYS J, V76, P3243, DOI 10.1016/S0006-3495(99)77476-X
   Miles CA, 2005, J MOL BIOL, V346, P551, DOI 10.1016/j.jmb.2004.12.001
   Raghunath M, 1998, ARCH DERMATOL RES, V290, P621, DOI 10.1007/s004030050362
   RANGANAYAKI MD, 1982, J FOOD SCI, V47, P705, DOI 10.1111/j.1365-2621.1982.tb12695.x
   Rault I, 1996, J MATER SCI-MATER M, V7, P215, DOI 10.1007/BF00119733
   RUSSELL AE, 1972, BIOCHEM J, V127, P855, DOI 10.1042/bj1270855
   SPEER DP, 1980, J BIOMED MATER RES, V14, P753, DOI 10.1002/jbm.820140607
   Stachel I, 2010, BIOMACROMOLECULES, V11, P698, DOI 10.1021/bm901284x
   Zeugois DI, 2010, J BIOMED MATER RES A, V92A, P1310, DOI 10.1002/jbm.a.32383
   Zeugolis DI, 2010, POLYM INT, V59, P1403, DOI 10.1002/pi.2882
   Zhang YJ, 2006, CURR OPIN CHEM BIOL, V10, P658, DOI 10.1016/j.cbpa.2006.09.020
   Zhu Y, 1995, APPL MICROBIOL BIOT, V44, P277, DOI 10.1007/s002530050554
NR 30
TC 4
Z9 4
U1 3
U2 18
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0939-6411
J9 EUR J PHARM BIOPHARM
JI Eur. J. Pharm. Biopharm.
PD FEB
PY 2012
VL 80
IS 2
BP 282
EP 288
DI 10.1016/j.ejpb.2011.10.018
PG 7
WC Pharmacology & Pharmacy
SC Pharmacology & Pharmacy
GA 907GU
UT WOS:000301406600006
PM 22079174
DA 2018-10-19
ER

PT J
AU Francolini, I
   Crisante, F
   Martinelli, A
   D'Ilario, L
   Piozzi, A
AF Francolini, I.
   Crisante, F.
   Martinelli, A.
   D'Ilario, L.
   Piozzi, A.
TI Synthesis of biomimetic segmented polyurethanes as antifouling
   biomaterials
SO ACTA BIOMATERIALIA
LA English
DT Article
DE Polyurethanes; Heparin-like polymers; Antifouling surfaces; Biomimetic
   polymers; Bacterial adhesion
ID CENTRAL VENOUS CATHETERS; IN-VITRO ACTIVITY; FUNCTIONALIZED
   POLYURETHANES; STAPHYLOCOCCUS-EPIDERMIDIS; INTRAVASCULAR CATHETERS;
   ELUTING STENTS; HEPARIN; POLYMERS; SURFACES; ADSORPTION
AB Controlling the non-specific adsorption of proteins, cells and bacteria onto biomaterial surfaces is of crucial importance for the development of medical devices with specific levels of performance. Among the strategies pursued to control the interactions between material surfaces and biological tissues, the immobilization of non-fouling polymers on biomaterial surfaces as well as the synthesis of the so-called biomimetic polymers are considered promising approaches to elicit specific cellular responses. In this study, in order to obtain materials able to prevent infectious and thrombotic complications related to the use of blood-contacting medical devices, heparin-mimetic segmented polyurethanes were synthesized and fully characterized. Specifically, sulfate or sulfamate groups, known to be responsible for the biological activity of heparin, were introduced into the side chain of a carboxylated polyurethane. Due to the introduction of these groups, the obtained polymers possessed a higher hard/soft phase segregation (lower glass transition temperatures) and a greater hydrophilicity than the pristine polymer. In addition, the synthesized polymers were able to significantly delay the activated partial thromboplastin time, this increased hemocompatibility being related both to polymer hydrophilicity and to the presence of the -SO3H groups. This last feature was also responsible for the ability of these biomimetic polymers to prevent the adhesion of a strain of Staphylococcus epidermidis. (C) 2011 Acts Materialia Inc. Published by Elsevier Ltd. All rights reserved.
C1 [Francolini, I.; Crisante, F.; Martinelli, A.; D'Ilario, L.; Piozzi, A.] Univ Roma La Sapienza, Dept Chem, I-00185 Rome, Italy.
RP Francolini, I (reprint author), Univ Roma La Sapienza, Dept Chem, Piazzale Aldo Moro 5, I-00185 Rome, Italy.
EM iolanda.francolini@uniroma1.it
RI Martinelli, Andrea/F-3374-2011; D'Ilario, Lucio/M-1351-2015
OI Martinelli, Andrea/0000-0002-6401-9988; D'Ilario,
   Lucio/0000-0001-8851-8469; Francolini, Iolanda/0000-0002-0180-2334
FU Italian Ministry for Universities and Research M.I.U.R.
FX This work was supported by a grant to A.P. from the Italian Ministry for
   Universities and Research M.I.U.R. (National Project).
CR Abdelkefi Abderrahman, 2007, J Support Oncol, V5, P273
   Acharjee Subroto, 2010, Crit Pathw Cardiol, V9, P203, DOI 10.1097/HPC.0b013e318200f5ea
   Alves NM, 2010, SMALL, V6, P2208, DOI 10.1002/smll.201000233
   Baldwin AD, 2010, BIOPOLYMERS, V94, P128, DOI 10.1002/bip.21334
   Barbucci R, 1998, J THROMB THROMBOLYS, V6, P109, DOI 10.1023/A:1008841303634
   Barbucci R, 2002, BIOMATERIALS, V23, P1967, DOI 10.1016/S0142-9612(01)00323-4
   Bentolila A, 2000, POLYM ADVAN TECHNOL, V11, P377, DOI 10.1002/1099-1581(200008/12)11:8/12<377::AID-PAT985>3.0.CO;2-D
   Borner HG, 2010, J POLYM SCI POL CHEM, V48, P1, DOI 10.1002/pola.23727
   Capila I, 2002, ANGEW CHEM INT EDIT, V41, P391
   Chaftari AM, 2010, CANCER, V117, P2551
   Chen SF, 2010, POLYMER, V51, P5283, DOI 10.1016/j.polymer.2010.08.022
   Chen SF, 2006, LANGMUIR, V22, P8186, DOI 10.1021/la061012m
   Daemen J, 2007, LANCET, V369, P667, DOI 10.1016/S0140-6736(07)60314-6
   Darouiche RO, 2005, ANN SURG, V242, P193, DOI 10.1097/01.sla.0000171874.29934.61
   Donelli G, 2007, ANTIMICROB AGENTS CH, V51, P2733, DOI 10.1128/AAC.01249-06
   Donelli G, 2006, J APPL MICROBIOL, V100, P615, DOI 10.1111/j.1365-2672.2005.02801.x
   Donelli G, 2001, J CHEMOTHERAPY, V13, P595, DOI 10.1179/joc.2001.13.6.595
   Donelli Gianfranco, 2006, Surg Infect (Larchmt), V7 Suppl 2, pS25
   Drotleff S, 2004, EUR J PHARM BIOPHARM, V58, P385, DOI 10.1016/j.ejpb.2004.03.018
   ESPERSEN F, 1994, J MED MICROBIOL, V40, P37, DOI 10.1099/00222615-40-1-37
   Flemming RG, 2000, BIOMATERIALS, V21, P273, DOI 10.1016/S0142-9612(99)00176-3
   Francolini I, 2006, MACROMOL RAPID COMM, V27, P233, DOI 10.1002/marc.200500786
   Francolini I, 2010, ACTA BIOMATER, V6, P3482, DOI 10.1016/j.actbio.2010.03.042
   Galliani S, 1996, J LAB CLIN MED, V127, P71, DOI 10.1016/S0022-2143(96)90168-7
   Gong FR, 2010, ACTA BIOMATER, V6, P534, DOI 10.1016/j.actbio.2009.07.013
   Gumusderelioglu M, 2011, CARBOHYD RES, V346, P606, DOI 10.1016/j.carres.2010.12.007
   Hasegawa T, 2002, J BIOMED MATER RES, V63, P333, DOI 10.1002/jbm.10210
   Jain G, 2009, CLIN J AM SOC NEPHRO, V4, P1787, DOI 10.2215/CJN.03920609
   KAJIYAMA T, 1970, POLYM J, V1, P548, DOI 10.1295/polymj.1.548
   KOBERSTEIN JT, 1992, MACROMOLECULES, V25, P6195, DOI 10.1021/ma00049a017
   KRISTINSSON KG, 1989, J MED MICROBIOL, V28, P249, DOI 10.1099/00222615-28-4-249
   Li JH, 2010, COLLOID SURFACE B, V78, P343, DOI 10.1016/j.colsurfb.2010.03.027
   Logeart-Avramoglou D, 1999, J BIOMED MATER RES, V48, P578, DOI 10.1002/(SICI)1097-4636(1999)48:4<578::AID-JBM26>3.0.CO;2-8
   Magnani A, 2000, J BIOMAT SCI-POLYM E, V11, P801, DOI 10.1163/156856200744020
   Mao C, 2004, ADV COLLOID INTERFAC, V110, P5, DOI 10.1016/j.cis.2004.02.001
   MARCONI W, 1995, BIOMATERIALS, V16, P449, DOI 10.1016/0142-9612(95)98817-X
   Marconi W, 1997, BIOMATERIALS, V18, P885, DOI 10.1016/S0142-9612(97)00015-X
   MARCONI W, 1991, EUR POLYM J, V27, P135, DOI 10.1016/0014-3057(91)90211-6
   OKANO T, 1981, J BIOMED MATER RES, V15, P393, DOI 10.1002/jbm.820150310
   OKANO T, 1978, MAKROMOL CHEM, V179, P1121
   Ostuni E, 2001, LANGMUIR, V17, P5605, DOI 10.1021/la010384m
   Piozzi A, 2004, J CHEMOTHERAPY, V16, P446, DOI 10.1179/joc.2004.16.5.446
   PRIME KL, 1991, SCIENCE, V252, P1164, DOI 10.1126/science.252.5009.1164
   Raad II, 2011, BIOMATERIALS, V32, P2689, DOI 10.1016/j.biomaterials.2010.12.015
   Rana S, 2010, POLYM BULL, V64, P401, DOI 10.1007/s00289-009-0175-3
   Rouet V, 2006, J BIOMED MATER RES A, V78A, P792, DOI 10.1002/jbm.a.30723
   Ruggeri V, 2007, J BIOMED MATER RES A, V81A, P287, DOI 10.1002/jbm.a.30984
   RUSSELL PB, 1987, J CLIN MICROBIOL, V25, P1083
   Schuler M, 2009, J BIOMED MATER RES B, V91B, P517, DOI 10.1002/jbm.b.31425
   Schwartz RS, 2004, CIRCULATION, V110, P2498, DOI 10.1161/01.CIR.0000145164.85178.2E
   Shedden L, 2009, P I MECH ENG H, V223, P515, DOI 10.1243/09544119JEIM541
   Shen MC, 2002, J BIOMAT SCI-POLYM E, V13, P367, DOI 10.1163/156856202320253910
   Silver HS, 1992, BIOMATERIALS, V13, P339
   Statz AR, 2005, J AM CHEM SOC, V127, P7972, DOI 10.1021/ja0522534
   Stevens KNJ, 2011, BIOMATERIALS, V32, P1264, DOI 10.1016/j.biomaterials.2010.10.042
   Sun XJ, 2011, TISSUE ENG PT A, V17, P2369, DOI [10.1089/ten.tea.2011.0027, 10.1089/ten.TEA.2011.0027]
   Tanaka M, 2002, BIOMACROMOLECULES, V3, P36, DOI 10.1021/bm010072y
   Tseng PY, 2006, BIOMATERIALS, V27, P2627, DOI 10.1016/j.biomaterials.2005.10.032
   TSENG YC, 1992, J BIOMED MATER RES, V26, P373, DOI 10.1002/jbm.820260308
   VARLET J, 1990, J POLYM SCI POL PHYS, V28, P2691, DOI 10.1002/polb.1990.090281315
   Vaudaux P, 1990, J Biomater Appl, V5, P134, DOI 10.1177/088532829000500204
   West SL, 2004, BIOMATERIALS, V25, P1195, DOI 10.1016/j.biomaterials.2003.08.010
   Xu FM, 2011, MACROMOL BIOSCI, V11, P257, DOI 10.1002/mabi.201000313
   Zoulalian V, 2010, LANGMUIR, V26, P74, DOI 10.1021/la902110j
NR 64
TC 19
Z9 20
U1 0
U2 75
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1742-7061
J9 ACTA BIOMATER
JI Acta Biomater.
PD FEB
PY 2012
VL 8
IS 2
BP 549
EP 558
DI 10.1016/j.actbio.2011.10.024
PG 10
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 902YZ
UT WOS:000301081400009
PM 22051237
DA 2018-10-19
ER

PT J
AU Coad, BR
   Lu, Y
   Meagher, L
AF Coad, Bryan R.
   Lu, Yi
   Meagher, Laurence
TI A substrate-independent method for surface grafting polymer layers by
   atom transfer radical polymerization: Reduction of protein adsorption
SO ACTA BIOMATERIALIA
LA English
DT Article
DE Biomaterial interface engineering; Surface-initiated ATRP; Polymer
   brush; Low-fouling biomaterials
ID METHACRYLATE) BRUSHES; POLY(2-HYDROXYETHYL METHACRYLATE); INITIATED
   POLYMERIZATION; CHEMICAL-MODIFICATION; AMBIENT-TEMPERATURE; COPOLYMER
   BRUSHES; CHAIN-LENGTH; PLASMA; GROWTH; FUNCTIONALIZATION
AB A general method for producing low-fouling biomaterials on any surface by surface-initiated grafting of polymer brushes is presented. Our procedure uses radiofrequency glow discharge thin film deposition followed by macro-initiator coupling and then surface-initiated atom transfer radical polymerization (SI-ATRP) to prepare neutral polymer brushes on planar substrates. Coatings were produced on substrates with variable interfacial composition and mechanical properties such as hard inorganic/metal substrates (silicon and gold) or flexible (perfluorinated poly(ethylene-co-propylene) film) and rigid (microtitre plates) polymeric materials. First, surfaces were functionalized via deposition of an allylamine plasma polymer thin film followed by covalent coupling of a macro-initiator composed partly of ATRP initiator groups. Successful grafting of a hydrophilic polymer layer was achieved by SI-ATRP of N,N'-dimethylacrylamide in aqueous media at room temperature. We exemplified how this method could be used to create surface coatings with significantly reduced protein adsorption on different material substrates. Protein binding experiments using labelled human serum albumin on grafted materials resulted in quantitative evidence for low-fouling compared to control surfaces. Crown Copyright (C) 2011 Published by Elsevier Ltd. on behalf of Acta Materialia Inc. All rights reserved.
C1 [Coad, Bryan R.; Lu, Yi; Meagher, Laurence] CSIRO Mat Sci & Engn, Clayton, Vic 3168, Australia.
   [Coad, Bryan R.; Meagher, Laurence] Cooperat Res Ctr Polymers, Notting Hill, Vic 3168, Australia.
RP Coad, BR (reprint author), Univ S Australia, Ian Wark Res Inst, Mawson Inst, Mawson Lakes, SA 5095, Australia.
EM Bryan.Coad@unisa.edu.au
RI Meagher, Laurence/G-1412-2012; Coad, Bryan/B-4505-2009
OI Meagher, Laurence/0000-0002-2055-6159; Coad, Bryan/0000-0003-3297-3977
FU International Association for the Exchange of Students for Technical
   Experience; Cooperative Research Centre for Polymers
FX We acknowledge the efforts of The International Association for the
   Exchange of Students for Technical Experience (Y.L.) and the Cooperative
   Research Centre for Polymers for funding (B.R.C.). We are grateful to
   Mr. John Bentley for assistance in europium labelling of HSA, and Dr. Jo
   Cosgriff and Dr. Roger Mulder for assistance with NMR.
CR Ayres N, 2007, LANGMUIR, V23, P182, DOI 10.1021/la0615261
   Barbey R, 2009, CHEM REV, V109, P5437, DOI 10.1021/cr900045a
   Bernards MT, 2008, MACROMOLECULES, V41, P4216, DOI 10.1021/ma800185y
   Bruening ML, 2008, LANGMUIR, V24, P7663, DOI 10.1021/la800179z
   Chen XY, 2004, LANGMUIR, V20, P587, DOI 10.1021/la0353024
   Coad BR, 2007, LANGMUIR, V23, P11791, DOI 10.1021/la7001703c
   Coad BR, 2007, BIOTECHNOL BIOENG, V97, P574, DOI 10.1002/bit.21283
   Coessens V, 2001, PROG POLYM SCI, V26, P337, DOI 10.1016/S0079-6700(01)00003-X
   DEGENNES PG, 1980, MACROMOLECULES, V13, P1069, DOI 10.1021/ma60077a009
   Desai SM, 2003, POLYMER, V44, P7645, DOI 10.1016/j.polymer.2003.09.060
   Dong R, 2007, BIOMACROMOLECULES, V8, P3082, DOI 10.1021/bm700493v
   Edmondson S, 2004, CHEM SOC REV, V33, P14, DOI 10.1039/b210143m
   Edmondson S, 2004, J MATER CHEM, V14, P730, DOI 10.1039/b312513k
   Edmondson S, 2007, MACROMOLECULES, V40, P5271, DOI 10.1021/ma070876r
   Edmondson S, 2009, POLYM INT, V58, P307, DOI 10.1002/pi.2529
   Ejaz M, 2001, POLYMER, V42, P6811, DOI 10.1016/S0032-3861(01)00192-6
   Fan XW, 2006, BIOMACROMOLECULES, V7, P2443, DOI 10.1021/bm060276k
   Feng W, 2005, MACROMOL RAPID COMM, V26, P1383, DOI 10.1002/marc.200500335
   Feng W, 2005, LANGMUIR, V21, P5980, DOI 10.1021/la050277i
   Fristrup CJ, 2009, SOFT MATTER, V5, P4623, DOI 10.1039/b821815c
   Gao X, 2008, LANGMUIR, V24, P8303, DOI 10.1021/la800729c
   GRIESSER HJ, 1989, VACUUM, V39, P485, DOI 10.1016/0042-207X(89)90272-8
   Halperin A, 1999, LANGMUIR, V15, P2525, DOI 10.1021/la981356f
   Hucknall A, 2009, ADV MATER, V21, P2441, DOI 10.1002/adma.200900383
   Husseman M, 1999, MACROMOLECULES, V32, P1424, DOI 10.1021/ma981290v
   Ignatova M, 2006, LANGMUIR, V22, P255, DOI 10.1021/la051954b
   Janzen J, 2004, J BIOMAT SCI-POLYM E, V15, P1121, DOI 10.1163/1568562041753043
   Jiang XW, 2008, ADV FUNCT MATER, V18, P27, DOI 10.1002/adfm.200700789
   Kaur S, 2007, LANGMUIR, V23, P13085, DOI 10.1021/la701329r
   Kim JB, 2000, J AM CHEM SOC, V122, P7616, DOI 10.1021/ja001652q
   Kizhakkedathu JN, 2009, LANGMUIR, V25, P3794, DOI 10.1021/la803690q
   Lai BFL, 2010, BIOMATERIALS, V31, P6710, DOI 10.1016/j.biomaterials.2010.05.052
   Lee BS, 2007, BIOMACROMOLECULES, V8, P3922, DOI 10.1021/bm7009043
   Lee SB, 2004, BIOMACROMOLECULES, V5, P877, DOI 10.1021/bm034352k
   Lego B, 2008, LANGMUIR, V24, P379, DOI 10.1021/la703051b
   Leinweber FC, 2001, FRESEN J ANAL CHEM, V370, P781, DOI 10.1007/s002160000682
   Lokuge I, 2007, LANGMUIR, V23, P305, DOI 10.1021/la060813m
   Meagher L, 2008, COMMONWEALTH SCI IND, P2052045
   Miller MD, 2004, J CHROMATOGR A, V1044, P323, DOI 10.1016/j.chroma.2004.04.071
   Nagase K, 2008, LANGMUIR, V24, P10981, DOI 10.1021/la801949w
   Nagase K, 2008, LANGMUIR, V24, P511, DOI 10.1021/la701839s
   NORDE W, 1978, J COLLOID INTERF SCI, V66, P257, DOI 10.1016/0021-9797(78)90303-X
   Ohno K, 2010, MACROMOLECULES, V43, P5569, DOI 10.1021/ma10013258
   Pasche S, 2005, LANGMUIR, V21, P6508, DOI 10.1021/la050386x
   Piech M, 2006, MACROMOLECULES, V39, P915, DOI 10.1021/ma0512760
   Pyun J, 2003, MACROMOL RAPID COMM, V24, P1043, DOI 10.1002/marc.200300078
   Ratner BD, 2004, ANNU REV BIOMED ENG, V6, P41, DOI 10.1146/annurev.bioeng.6.040803.140027
   Savina IN, 2007, SOFT MATTER, V3, P1176, DOI 10.1039/b706654f
   Schepelina O, 2008, LANGMUIR, V24, P14188, DOI 10.1021/la802453z
   Short RD, 2001, ROY SOC CH, P119, DOI 10.1039/9781847550736-00119
   Siow KS, 2006, PLASMA PROCESS POLYM, V3, P392, DOI 10.1002/ppap.200600021
   Stadler V, 2008, LANGMUIR, V24, P8151, DOI 10.1021/la800772m
   TANUMA S, 1993, SURF INTERFACE ANAL, V20, P77, DOI 10.1002/sia.740200112
   Teare DOH, 2005, J PHYS CHEM B, V109, P22407, DOI 10.1021/jp052869f
   Teare DOH, 2005, LANGMUIR, V21, P11425, DOI 10.1021/la051772h
   Teare DOH, 2005, J PHYS CHEM B, V109, P20923, DOI 10.1021/jp052767p
   Teare DOH, 2005, LANGMUIR, V21, P10818, DOI 10.1021/la051566+
   Tsujii Y., 2006, SURFACE INITIATED PO, V1, P1
   Tugulu S, 2008, BIOMACROMOLECULES, V9, P906, DOI 10.1021/bm7012939
   Unsal E, 2006, ANAL CHEM, V78, P5868, DOI 10.1021/ac060506I
   Unsworth LD, 2008, LANGMUIR, V24, P1924, DOI 10.1021/la702310t
   Vasilev K, 2009, CHEM COMMUN, P3600, DOI 10.1039/b904367e
   Vermette P, 2002, LANGMUIR, V18, P10137, DOI 10.1021/la0202834
   Xiao DQ, 2002, LANGMUIR, V18, P9971, DOI 10.1021/la0205553
   Xu D, 2004, J COLLOID INTERF SCI, V279, P78, DOI 10.1016/j.jcis.2004.06.062
   Xu FJ, 2007, LANGMUIR, V23, P8585, DOI 10.1021/la7011342
   Xu FJ, 2004, BIOMACROMOLECULES, V5, P2392, DOI 10.1021/bm049675a
   Yameen B, 2009, LANGMUIR, V25, P6214, DOI 10.1021/la900010z
   Yoshikawa C, 2006, MACROMOLECULES, V39, P2284, DOI 10.1021/ma0520242
   Zhai GQ, 2006, J APPL POLYM SCI, V102, P2590, DOI 10.1002/app.24698
   Zhao B, 2000, MACROMOLECULES, V33, P8813, DOI 10.1021/ma000433m
   Zhao C, 2011, LANGMUIR, V27, P4906, DOI 10.1021/la200061h
   Zou YQ, 2009, MACROMOLECULES, V42, P3258, DOI 10.1021/ma8025699
NR 73
TC 36
Z9 36
U1 4
U2 58
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1742-7061
J9 ACTA BIOMATER
JI Acta Biomater.
PD FEB
PY 2012
VL 8
IS 2
BP 608
EP 618
DI 10.1016/j.actbio.2011.10.006
PG 11
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 902YZ
UT WOS:000301081400015
PM 22023749
OA Green Published
DA 2018-10-19
ER

PT J
AU Hempel, U
   Hintze, V
   Moller, S
   Schnabelrauch, M
   Scharnweber, D
   Dieter, P
AF Hempel, Ute
   Hintze, Vera
   Moeller, Stephanie
   Schnabelrauch, Matthias
   Scharnweber, Dieter
   Dieter, Peter
TI Artificial extracellular matrices composed of collagen I and sulfated
   hyaluronan with adsorbed transforming growth factor beta 1 promote
   collagen synthesis of human mesenchymal stromal cells
SO ACTA BIOMATERIALIA
LA English
DT Article
DE Artificial extracellular matrix; Collagen synthesis; Glycosaminoglycans;
   Mesenchymal stromal cells; Sulfated hyaluronan
ID HEPARAN-SULFATE; BIOCHEMICAL-ANALYSIS; BONE-CELLS; STEM-CELLS;
   GLYCOSAMINOGLYCANS; PROTEOGLYCANS; PROTEIN; BINDING; DIFFERENTIATION;
   QUANTITATION
AB Sulfated glycosaminoglycans (GAG) are multifunctional components of the extracellular matrix and are involved in the regulation of adhesion, proliferation and differentiation of cells. The effects of GAG are mediated in general by their interactions with cations and water, and in particular by their binding to growth factors. The aim of this study was to generate artificial extracellular matrices (aECM) containing collagen I and hyaluronan sulfate (HyaS), which are capable of adsorbing and releasing transforming growth factor beta 1 (TGF-beta 1), and to promote collagen synthesis of cultured human mesenchymal stromal cells (hMSC). For the preparation of aECM, monosulfated Hya (HyaS1) or trisulfated Hya (HyaS3) were used; the natural chondroitin-4-sulfate was used as a control. As applied for the in vitro experiments, the resulting matrices were composed of 93-98% collagen I and 2-7% GAG derivative. Adsorption of TGF-beta 1 to the aECM and release from the aECM was dependent on the degree of sulfation of hyaluronan. Collagen synthesis of hMSC was promoted only by aECM with adsorbed TCF-beta 1; the bare aECM had a slightly inhibitory effect on collagen synthesis. The promoting effect did not correlate either to the amount of adsorbed TGF-beta 1 nor to the release of TGF-beta 1, indicating that the correct presentation of TGF-beta 1 to the cells might be critical. The results indicate that sulfated hyaluronan-containing aECM have the potential to control both the adsorption and release of TGF-beta 1, and thereby promote collagen synthesis of hMSC. Thus, these aECM might be a useful tool for different tissue-engineering applications to enhance bone formation when used for biomaterial coating. (C) 2011 Acta Materialia Inc. Published by Elsevier Ltd. All rights reserved.
C1 [Hempel, Ute; Dieter, Peter] Tech Univ Dresden, Inst Physiol Chem, Carl Gustav Carus Fac Med, D-01307 Dresden, Germany.
   [Hintze, Vera; Scharnweber, Dieter] Tech Univ Dresden, Max Bergmann Ctr Biomat, D-01069 Dresden, Germany.
   [Moeller, Stephanie; Schnabelrauch, Matthias] INNOVENT eV, Biomat Dept, D-07745 Jena, Germany.
RP Hempel, U (reprint author), Tech Univ Dresden, Inst Physiol Chem, Carl Gustav Carus Fac Med, Fiedlerstr 42, D-01307 Dresden, Germany.
EM Ute.Hempel@tu-dresden.de
FU Deutsche Forschungsgemeinschaft [SFB/TR67]; BMBF
FX The authors thank Carolin Preissler and Bettina Schober for their
   excellent technical assistance. The authors are very grateful to Prof.
   Bornhauser and colleagues from the stem cell laboratory of the
   University Hospital in Dresden for providing the bone marrow stromal
   cells. This work was supported by Deutsche Forschungsgemeinschaft grants
   to U.H., V.H., S.M., M.S. and D.S. (SFB/TR67 projects B1, A2, and A3)
   and by a BMBF Grant to P.D.
CR Arnott JA, 2007, J CELL PHYSIOL, V210, P843, DOI 10.1002/jcp.20917
   Barbucci R, 2005, BIOMACROMOLECULES, V6, P638, DOI 10.1021/bm049642v
   Bi YM, 2005, J BIOL CHEM, V280, P30481, DOI 10.1074/jbc.M500573200
   Bismar H, 1999, BONE, V24, P565, DOI 10.1016/S8756-3282(99)00082-4
   Bjornsson S, 1998, ANAL BIOCHEM, V256, P229, DOI 10.1006/abio.1997.2494
   Cohen M, 2006, EMBO J, V25, P302, DOI 10.1038/sj.emboj.7600960
   Cohen M, 2004, CHEMBIOCHEM, V5, P1993
   CURRIE GA, 1981, BRIT J CANCER, V43, P335, DOI 10.1038/bjc.1981.53
   DELANY AM, 1994, J CELL BIOCHEM, V56, P295, DOI 10.1002/jcb.240560304
   Di Lullo GA, 2002, J BIOL CHEM, V277, P4223, DOI 10.1074/jbc.M110709200
   Douglas T, 2007, BIOMOL ENG, V24, P455, DOI 10.1016/j.bioeng.2007.07.008
   FARNDALE RW, 1986, BIOCHIM BIOPHYS ACTA, V883, P173, DOI 10.1016/0304-4165(86)90306-5
   Fischer U, 2003, BIOMATERIALS, V24, P2631, DOI 10.1016/S0142-9612(03)00068-1
   GALLAGHER JT, 1992, GLYCOBIOLOGY, V2, P523, DOI 10.1093/glycob/2.6.523
   GALLAGHER JT, 1986, BIOCHEM J, V236, P313, DOI 10.1042/bj2360313
   Grzesik WJ, 2002, J BIOL CHEM, V277, P43638, DOI 10.1074/jbc.M202124200
   Hintze V, 2009, BIOMACROMOLECULES, V10, P3290, DOI 10.1021/bm9008827
   Holzmann J, 2006, OSTEOARTHR CARTILAGE, V14, P514
   Imberty A, 2007, CARBOHYD RES, V342, P430, DOI 10.1016/j.carres.2006.12.019
   JUNQUEIRA LCU, 1980, CONNECT TISSUE RES, V7, P91, DOI 10.3109/03008208009152293
   Kunze R, 2010, GLYCOCONJUGATE J, V27, P151, DOI 10.1007/s10719-009-9270-9
   LOCCI P, 1995, CELL TISSUE RES, V281, P317
   Lord MS, 2009, J BIOMED MATER RES A, V91A, P635, DOI 10.1002/jbm.a.32219
   Lortat-Jacob H, 2002, P NATL ACAD SCI USA, V99, P1229, DOI 10.1073/pnas.032497699
   LOWRY OH, 1951, J BIOL CHEM, V193, P265
   Magnani A, 1998, POLYM INT, V46, P225, DOI 10.1002/(SICI)1097-0126(199807)46:3<225::AID-PI45>3.0.CO;2-I
   Mania VM, 2009, IUBMB LIFE, V61, P447, DOI 10.1002/iub.167
   Manton KJ, 2007, STEM CELLS, V25, P2845, DOI 10.1634/stemcells.2007-0065
   Manton KJ, 2006, J CELL PHYSIOL, V209, P219, DOI 10.1002/jcp.20727
   Morgan MR, 2007, NAT REV MOL CELL BIO, V8, P957, DOI 10.1038/nrm2289
   Nagahata M, 2004, BIOCHEM BIOPH RES CO, V315, P603, DOI 10.1016/j.bbrc.2004.01.098
   Nagira T, 2007, BIOMATERIALS, V28, P844, DOI 10.1016/j.biomaterials.2006.09.041
   Nurcombe V, 2007, CRIT REV EUKAR GENE, V17, P159, DOI 10.1615/CritRevEukarGeneExpr.v17.i2.50
   Oswald J, 2004, STEM CELLS, V22, P377, DOI 10.1634/stemcells.22-3-377
   Parker RB, 2010, ACS CHEM BIOL, V51, P35
   PRINCE CW, 1983, J NUTR, V113, P1576
   Schaefer L, 2010, CELL TISSUE RES, V339, P237, DOI 10.1007/s00441-009-0821-y
   SCUTT A, 1992, ANAL BIOCHEM, V203, P290, DOI 10.1016/0003-2697(92)90315-X
   Tang Y, 2009, NAT MED, V15, P757, DOI 10.1038/nm.1979
   Theoleyre S, 2006, BIOCHEM BIOPH RES CO, V347, P460, DOI 10.1016/j.bbrc.2006.06.120
   van der Harst MR, 2004, OSTEOARTHR CARTILAGE, V12, P752, DOI 10.1016/j.joca.2004.05.004
   Vives RR, 2004, J BIOL CHEM, V279, P54327, DOI 10.1074/jbc.M409760200
   WHITEMAN P, 1973, BIOCHEM J, V131, P343, DOI 10.1042/bj1310343
NR 43
TC 46
Z9 49
U1 0
U2 15
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1742-7061
J9 ACTA BIOMATER
JI Acta Biomater.
PD FEB
PY 2012
VL 8
IS 2
BP 659
EP 666
DI 10.1016/j.actbio.2011.10.026
PG 8
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 902YZ
UT WOS:000301081400021
PM 22061106
DA 2018-10-19
ER

PT J
AU Kang, MY
   Rico, CW
   Lee, SC
AF Kang, Mi Young
   Rico, Catherine W.
   Lee, Sang Chul
TI In vitro Antioxidative and Antimutagenic Activities of Oak Mushroom
   (Lentinus edodes) and King Oyster Mushroom (Pleurotus eryngii)
   Byproducts
SO FOOD SCIENCE AND BIOTECHNOLOGY
LA English
DT Article
DE Lentinus edodes; Pleurotus eryngii; mushroom byproduct; antioxidant;
   antimutagenic
ID LIPID-PEROXIDATION; SOS CHROMOTEST; EXTRACTS; INHIBITION; ASSAY
AB The in vitro antioxidative and antimutagenic activities of ethanolic extracts from oak mushroom (Lentinus edodes) and king oyster mushroom (Pleurotus eryngii) byproducts were investigated. The antioxidant capacity of the extracts was assessed by determining the ferricyanide reducing power, scavenging activity on nitrite, DPPH radical, superoxide anions and hydroxyl radicals, ferrous ion chelating ability, and inhibitory effect on linoleic acid peroxidation and xanthine oxidase. The antimutagenic activity, on the other hand, was based on the suppression of mitomycin C-induced mutagenesis in Escherichia coli cells. Both the mushroom extracts showed strong antioxidative and antimutagenic effects at higher concentrations. In general, extracts from the oak mushroom byproduct had greater antioxidative and antimutagenic abilities than that of the king oyster extract. Results of this study demonstrate that the mushroom byproducts possess strong antioxidant capacity in vitro and may be useful as a functional biomaterial in the preparation of health-promoting food products and animal feeds.
C1 [Lee, Sang Chul] Kyungpook Natl Univ, Div Plant Biosci, Taegu 702701, South Korea.
   [Kang, Mi Young; Rico, Catherine W.] Kyungpook Natl Univ, Dept Food Sci & Nutr, Taegu 702701, South Korea.
RP Lee, SC (reprint author), Kyungpook Natl Univ, Div Plant Biosci, Taegu 702701, South Korea.
EM leesc@knu.ac.kr
FU Kyungpook National University (KNU)
FX The authors are grateful to Kyungpook National University (KNU) for
   their financial support and assistance for the completion of this study.
CR AURAND LW, 1977, J DAIRY SCI, V60, P363, DOI 10.3168/jds.S0022-0302(77)83874-5
   Caglarirmak N, 2007, FOOD CHEM, V105, P1188, DOI 10.1016/j.foodchem.2007.02.021
   CARTER P, 1971, ANAL BIOCHEM, V40, P450, DOI 10.1016/0003-2697(71)90405-2
   Chang ST, 2004, MUSHROOMS CULTIVATIO, P23
   Cheung LM, 2003, FOOD CHEM, V81, P249, DOI 10.1016/S0308-8146(02)00419-3
   Fukushima M, 2001, EXP BIOL MED, V226, P758, DOI 10.1177/153537020222600808
   Jayakumar T, 2009, INNOV FOOD SCI EMERG, V10, P228
   Jeon TW, 2002, KOREAN J FOOD PRESER, V9, P369
   Kathatun K., 2007, MYMENSINGH MED J, V16, P94
   KATO H, 1987, AGR BIOL CHEM TOKYO, V51, P1333, DOI 10.1080/00021369.1987.10868212
   Lopes GKB, 1999, BBA-GEN SUBJECTS, V1472, P142, DOI 10.1016/S0304-4165(99)00117-8
   MacDonald-Wicks LK, 2006, J SCI FOOD AGR, V86, P2046, DOI 10.1002/jsfa.2603
   Mau JL, 1998, J AGR FOOD CHEM, V46, P4587, DOI 10.1021/jf980508+
   MERSCHSUNDERMANN V, 1991, MUTAT RES, V252, P51, DOI 10.1016/0165-1161(91)90251-3
   MILLER JA, 1994, CANCER LETT, V83, P9, DOI 10.1016/0304-3835(94)90292-5
   Misuda H., 1966, EIYO TO SHOKURYO, V19, P210
   MITSUTA K, 1990, B CHEM SOC JPN, V63, P187, DOI 10.1246/bcsj.63.187
   NORO T, 1987, CHEM PHARM BULL, V35, P4314
   Oyaizu M., 1986, JPN J NUTR, V44, P307
   QUILLARDET P, 1985, MUTAT RES, V147, P65, DOI 10.1016/0165-1161(85)90020-2
   ROSEN GM, 1981, P NATL ACAD SCI-BIOL, V78, P7346, DOI 10.1073/pnas.78.12.7346
   Sano Mitsuaki, 2002, International Journal of Medicinal Mushrooms, V4, P37
   SMITH JE, 2002, BIOTECHNOL LETT, V24, P1845
   Wang BS, 2008, FOOD CHEM, V107, P1198, DOI 10.1016/j.foodchem.2007.09.049
   Wasser SP, 2002, APPL MICROBIOL BIOT, V60, P258, DOI 10.1007/s00253-002-1076-7
   YEN GC, 1995, J AGR FOOD CHEM, V43, P27, DOI 10.1021/jf00049a007
   Yoon MR, 2008, J CLIN BIOCHEM NUTR, V43, P118, DOI 10.3164/jcbn.2008056
NR 27
TC 10
Z9 11
U1 0
U2 19
PU KOREAN SOCIETY FOOD SCIENCE & TECHNOLOGY-KOSFOST
PI SEOUL
PA #605, KOREA SCI TECHNOL CENT, 635-4 YEOKSAM-DONG, KANGNAM-GU, SEOUL,
   135-703, SOUTH KOREA
SN 1226-7708
J9 FOOD SCI BIOTECHNOL
JI Food Sci. Biotechnol.
PD FEB
PY 2012
VL 21
IS 1
BP 167
EP 173
DI 10.1007/s10068-012-0021-5
PG 7
WC Food Science & Technology
SC Food Science & Technology
GA 902YS
UT WOS:000301080700021
DA 2018-10-19
ER

PT J
AU Tarakanova, A
   Buehler, MJ
AF Tarakanova, Anna
   Buehler, Markus J.
TI A Materiomics Approach to Spider Silk: Protein Molecules to Webs
SO JOM
LA English
DT Article
ID DRAGLINE SILK; MECHANICAL FUNCTION; BIOMATERIAL; TOUGHNESS; STRENGTH;
   PERFORMANCE; NANOCONFINEMENT; NANOSTRUCTURE; DEFORMATION; EVOLUTION
AB The exceptional mechanical properties of hierarchical self-assembling silk biopolymers have been extensively studied experimentally and in computational investigations. A series of recent studies has been conducted to examine structure-function relationships across different length scales in silk, ranging from atomistic models of protein constituents to the spider web architecture. Silk is an exemplary natural material because its superior properties stem intrinsically from the synergistic cooperativity of hierarchically organized components, rather than from the superior properties of the building blocks themselves. It is composed of beta-sheet nanocrystals interspersed within less orderly amorphous domains, where the underlying molecular structure is dominated by weak hydrogen bonding. Protein chains are organized into fibrils, which pack together to form threads of a spider web. In this article we survey multiscale studies spanning length scales from angstroms to centimeters, from the amino acid sequence defining silk components to an atomistically derived spider web model, with the aim to bridge varying levels of hierarchy to elucidate the mechanisms by which structure at each composite level contributes to organization and material phenomena at subsequent levels. The work demonstrates that the web is a highly adapted system where both material and hierarchical structure across all length scales is critical for its functional properties.
C1 [Tarakanova, Anna; Buehler, Markus J.] MIT, LAMM, Dept Civil & Environm Engn, Cambridge, MA 02139 USA.
RP Tarakanova, A (reprint author), MIT, LAMM, Dept Civil & Environm Engn, 77 Massachusetts Ave, Cambridge, MA 02139 USA.
EM mbuehler@mit.edu
RI Buehler, Markus/C-4580-2008
OI Buehler, Markus/0000-0002-4173-9659
FU Robert A. Brown Presidential Fellowship
FX Primary support from ONR, AFOSR, and NSF is acknowledged. A.T.
   acknowledges support from a Robert A. Brown Presidential Fellowship.
CR Agnarsson I, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011234
   Ayoub NA, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000514
   Bratzel G, 2012, J MECH BEHAV BIOMED, V7, P30, DOI 10.1016/j.jmbbm.2011.07.012
   BROOKS BR, 1983, J COMPUT CHEM, V4, P187, DOI 10.1002/jcc.540040211
   Buehler M. J., 2010, NANOTECHNOL SCI APPL, V3, P127
   Buehler MJ, 2010, NANO TODAY, V5, P379, DOI 10.1016/j.nantod.2010.08.001
   Buehler MJ, 2009, NAT MATER, V8, P175, DOI 10.1038/nmat2387
   Cranford SW, 2012, NATURE, V482, P72, DOI 10.1038/nature10739
   Du N, 2006, BIOPHYS J, V91, P4528, DOI 10.1529/biophysj.106.089144
   Du N, 2011, ADV FUNCT MATER, V21, P772, DOI 10.1002/adfm.201001397
   Feig M, 2004, J MOL GRAPH MODEL, V22, P377, DOI 10.1016/j.jmgm.2003.12.005
   Fratzl P, 2009, NATURE, V462, P442, DOI 10.1038/nature08603
   Giesa T, 2011, NANO LETT, V11, P5038, DOI 10.1021/nl203108t
   Gosline JM, 1999, J EXP BIOL, V202, P3295
   Heim M, 2010, CHEM SOC REV, V39, P156, DOI 10.1039/b813273a
   Holland GP, 2008, J AM CHEM SOC, V130, P9871, DOI 10.1021/ja8021208
   Jelinski LW, 1998, CURR OPIN SOLID ST M, V3, P237, DOI 10.1016/S1359-0286(98)80097-1
   Jenkins JE, 2010, BIOMACROMOLECULES, V11, P192, DOI 10.1021/bm9010672
   Keten S, 2010, J R SOC INTERFACE, V7, P1709, DOI 10.1098/rsif.2010.0149
   Keten S, 2010, APPL PHYS LETT, V96, DOI 10.1063/1.3385388
   Keten S, 2010, NAT MATER, V9, P359, DOI [10.1038/nmat2704, 10.1038/NMAT2704]
   Kummerlen J, 1996, MACROMOLECULES, V29, P2920, DOI 10.1021/ma951098i
   Lazardis T., 1999, GENETICS, V35, P133
   Ma BY, 2002, PROTEIN SCI, V11, P2335, DOI 10.1110/ps.4270102
   Nova A, 2010, NANO LETT, V10, P2626, DOI 10.1021/nl101341w
   Omenetto FG, 2010, SCIENCE, V329, P528, DOI 10.1126/science.1188936
   Rammensee S, 2008, P NATL ACAD SCI USA, V105, P6590, DOI 10.1073/pnas.0709246105
   Rising A., 2010, CELL MOL LIFE SCI, V68, P169
   Sen D, 2011, SCI REP-UK, V1, DOI 10.1038/srep00035
   Spivak DI, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023911
   Sugita Y, 1999, CHEM PHYS LETT, V314, P141, DOI 10.1016/S0009-2614(99)01123-9
   Swanson BO, 2007, J EXP ZOOL PART A, V307A, P654, DOI 10.1002/jez.420
   Swanson BO, 2009, INTEGR COMP BIOL, V49, P21, DOI 10.1093/icb/icp013
   van Beek JD, 2002, P NATL ACAD SCI USA, V99, P10266, DOI 10.1073/pnas.152162299
   Vepari C, 2007, PROG POLYM SCI, V32, P991, DOI 10.1016/j.progpolymsci.2007.05.013
   Vollrath F, 1999, INT J BIOL MACROMOL, V24, P81, DOI 10.1016/S0141-8130(98)00076-2
   Vollrath F, 1996, P ROY SOC B-BIOL SCI, V263, P147, DOI 10.1098/rspb.1996.0023
   Vollrath F, 2007, ANNU REV ECOL EVOL S, V38, P819, DOI 10.1146/annurev.ecolsys.37.091305.110221
   Vollrath F, 2010, NATURE, V466, P319, DOI 10.1038/466319a
NR 39
TC 30
Z9 32
U1 2
U2 39
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 1047-4838
J9 JOM-US
JI JOM
PD FEB
PY 2012
VL 64
IS 2
BP 214
EP 225
DI 10.1007/s11837-012-0250-3
PG 12
WC Materials Science, Multidisciplinary; Metallurgy & Metallurgical
   Engineering; Mineralogy; Mining & Mineral Processing
SC Materials Science; Metallurgy & Metallurgical Engineering; Mineralogy;
   Mining & Mineral Processing
GA 902LQ
UT WOS:000301040000006
OA Bronze
DA 2018-10-19
ER

PT J
AU Sternheim, A
   Backstein, D
   Kuzyk, PRT
   Goshua, G
   Berkovich, Y
   Safir, O
   Gross, AE
AF Sternheim, A.
   Backstein, D.
   Kuzyk, P. R. T.
   Goshua, G.
   Berkovich, Y.
   Safir, O.
   Gross, A. E.
TI Porous metal revision shells for management of contained acetabular bone
   defects at a mean follow-up of six years A COMPARISON BETWEEN UP TO 50%
   BLEEDING HOST BONE CONTACT AND MORE THAN 50% CONTACT
SO JOURNAL OF BONE AND JOINT SURGERY-BRITISH VOLUME
LA English
DT Article
ID TOTAL HIP-ARTHROPLASTY; TANTALUM BIOMATERIAL; RECONSTRUCTION; RINGS;
   SURGERY; CLASSIFICATION; RELIABILITY; INGROWTH; CAGES; CUPS
AB We report the use of porous metal acetabular revision shells in the treatment of contained bone loss. The outcomes of 53 patients with 5 50% acetabular bleeding host bone contact were compared with a control group of 49 patients with >50% to 85% bleeding host bone contact. All patients were treated with the same type of trabecular metal acetabular revision shell. The mean age at revision was 62.4 years (42 to 80) and the mean follow-up of both groups was 72.4 months (60 to 102). Clinical, radiological and functional outcomes were assessed. There were four (7.5%) mechanical failures in the 5 50% host bone contact group and no failures in the >50% host bone contact group (p = 0.068). Out of both groups combined there were four infections (3.9%) and five recurrent dislocations (4.9%) with a stable acetabular component construct that were revised to a constrained liner. Given the complexity of the reconstructive challenge, porous metal revision acetabular shells show acceptable failure rates at five to ten years' follow-up in the setting of significant contained bone defects. This favourable outcome might be due to the improved initial stability achieved by a high coefficient of friction between the acetabular implant and the host bone, and the high porosity, which affords good bone ingrowth.
C1 [Sternheim, A.; Backstein, D.; Kuzyk, P. R. T.; Goshua, G.; Berkovich, Y.; Safir, O.; Gross, A. E.] Univ Toronto, Mt Sinai Hosp, Toronto, ON M5G 1X5, Canada.
RP Sternheim, A (reprint author), Univ Toronto, Mt Sinai Hosp, 600 Univ Ave,Suite 476A, Toronto, ON M5G 1X5, Canada.
EM amirsternheim@gmail.com
CR Bobyn JD, 1999, J BONE JOINT SURG BR, V81B, P907, DOI 10.1302/0301-620X.81B5.9283
   Bobyn JD, 2004, J BONE JOINT SURG AM, V86A, P123, DOI 10.2106/00004623-200412002-00017
   BOBYN JD, 1980, CLIN ORTHOP RELAT R, P291
   Boscainos PJ, 2007, CLIN ORTHOP RELAT R, P159, DOI 10.1097/BLO.0b013e3181560c6c
   Busch VJJF, 2011, J BONE JOINT SURG AM, V93A, P367, DOI 10.2106/JBJSJ.01532
   Campbell DG, 2001, J ARTHROPLASTY, V16, P83, DOI 10.1054/arth.2001.19157
   Davies JH, 2011, J ARTHROPLASTY
   DELEE JG, 1976, CLIN ORTHOP RELAT R, P20
   Garcia-Cimbrelo E, 1999, J ARTHROPLASTY, V14, P397, DOI 10.1016/S0883-5403(99)90094-3
   Garcia-Cimbrelo E, 2010, CLIN ORTHOP RELAT R, V468, P3304, DOI 10.1007/s11999-010-1395-4
   Garellick G, 2009, SWEDISH HIP ARTHROPL
   Goodman S, 2004, J ARTHROPLASTY, V19, P436, DOI 10.1016/j.arth.2003.11.015
   Gross AE, 2004, ORTHOPEDICS, V27, P969
   HARRIS WH, 1969, J BONE JOINT SURG AM, VA 51, P737, DOI 10.2106/00004623-196951040-00012
   Lakstein D, 2010, HIP INT, V20, P102
   Lakstein D, 2009, CLIN ORTHOP RELAT R, V467, P2318, DOI 10.1007/s11999-009-0772-3
   Levine BR, 2006, BIOMATERIALS, V27, P4671, DOI 10.1016/j.biomaterials.2006.04.041
   Paprosky W G, 1994, J Arthroplasty, V9, P33, DOI 10.1016/0883-5403(94)90135-X
   Saleh KJ, 2001, J BONE JOINT SURG AM, V83A, P1040, DOI 10.2106/00004623-200107000-00009
   Schatzker J, 1999, CLIN ORTHOP RELAT R, P187
   Schlegel UJ, 2008, ORTHOPADE, V37, P904, DOI 10.1007/s00132-008-1314-5
   Skytta ET, 2011, J ARTHROPLASTY, V26, P342, DOI 10.1016/j.arth.2010.01.106
   Symeonides PP, 2009, J ARTHROPLASTY, V24, P168, DOI 10.1016/j.arth.2007.10.009
   Van Kleunen JP, 2009, J ARTHROPLASTY, V24, P64, DOI 10.1016/j.arth.2009.02.001
NR 24
TC 29
Z9 33
U1 0
U2 1
PU BRITISH EDITORIAL SOC BONE JOINT SURGERY
PI LONDON
PA 22 BUCKINGHAM STREET, LONDON WC2N 6ET, ENGLAND
SN 0301-620X
J9 J BONE JOINT SURG BR
JI J. Bone Joint Surg.-Br. Vol.
PD FEB
PY 2012
VL 94B
IS 2
BP 158
EP 162
DI 10.1302/0301-620X.94B2.27871
PG 5
WC Orthopedics; Surgery
SC Orthopedics; Surgery
GA 893WF
UT WOS:000300387700003
PM 22323678
DA 2018-10-19
ER

PT J
AU Gonzalez, S
   Pellicer, E
   Fornell, J
   Blanquer, A
   Barrios, L
   Ibanez, E
   Solsona, P
   Surinach, S
   Baro, MD
   Nogues, C
   Sort, J
AF Gonzalez, S.
   Pellicer, E.
   Fornell, J.
   Blanquer, A.
   Barrios, L.
   Ibanez, E.
   Solsona, P.
   Surinach, S.
   Baro, M. D.
   Nogues, C.
   Sort, J.
TI Improved mechanical performance and delayed corrosion phenomena in
   biodegradable Mg-Zn-Ca alloys through Pd-alloying
SO JOURNAL OF THE MECHANICAL BEHAVIOR OF BIOMEDICAL MATERIALS
LA English
DT Article
DE Nanoindentation; Biomaterial; Corrosion; Elastic properties
ID BULK METALLIC-GLASS; MAGNESIUM ALLOYS; BONE; IMPLANTS
AB The influence of partial substitution of Mg by Pd on the microstructure, mechanical properties and corrosion behaviour of Mg72-xZn23Ca5Pdx (x = 0, 2 and 6 at.%) alloys, synthesized by copper mould casting, is investigated. While the Mg72Zn23Ca5 alloy is mainly amorphous, the addition of Pd decreases the glass-forming ability, thus favouring the formation of crystalline phases. From a mechanical viewpoint, the hardness increases with the addition of Pd, from 2.71 GPa for x = 0 to 3.9 GPa for x = 6, mainly due to the formation of high-strength phases. In turn, the wear resistance is maximized for an intermediate Pd content (i.e., Mg70Zn23Ca5Pd2). Corrosion tests in a simulated body fluid (Hank's solution) indicate that Pd causes a shift in the corrosion potential towards more positive values, thus delaying the biodegradability of this alloy. Moreover, since the cytotoxic studies with mouse preosteoblasts do not show dead cells after culturing for 27 h, these alloys are potential candidates to be used as biomaterials. (C) 2011 Elsevier Ltd. All rights reserved.
C1 [Gonzalez, S.; Pellicer, E.; Fornell, J.; Solsona, P.; Surinach, S.; Baro, M. D.] Univ Autonoma Barcelona, Dept Fis, Fac Ciencies, E-08193 Bellaterra, Spain.
   [Blanquer, A.; Barrios, L.; Ibanez, E.; Nogues, C.] Univ Autonoma Barcelona, Dept Biol Cel Lular Fisiol & Immunol, E-08193 Bellaterra, Spain.
   [Sort, J.] Univ Autonoma Barcelona, ICREA, E-08193 Bellaterra, Spain.
   [Sort, J.] Univ Autonoma Barcelona, Dept Fis, E-08193 Bellaterra, Spain.
RP Gonzalez, S (reprint author), Univ Autonoma Barcelona, Dept Fis, Fac Ciencies, E-08193 Bellaterra, Spain.
EM Sergio.Gonzalez@uab.es; Eva.Pellicer.icn@uab.cat
RI Ibanez, Elena/K-4320-2014; Solsona, Pau/L-9542-2014; Pellicer,
   Eva/G-2917-2014; Gonzalez, Sergio/A-4852-2010; Sort, Jordi/F-6582-2014;
   Barrios, Leonardo/L-3315-2014; Nogues, Carme/A-2339-2009; Surinach,
   Santiago/A-1749-2009; BAI, JIE/D-7448-2016; Baro, Maria
   Dolors/A-2096-2009
OI Ibanez, Elena/0000-0002-0275-6958; Solsona, Pau/0000-0001-9274-2447;
   Pellicer, Eva/0000-0002-8901-0998; Sort, Jordi/0000-0003-1213-3639;
   Barrios, Leonardo/0000-0002-6151-8503; Nogues,
   Carme/0000-0002-6361-8559; Surinach, Santiago/0000-0001-8125-0594; Baro,
   Maria Dolors/0000-0002-8636-1063; Blanquer, Andreu/0000-0002-3551-1885;
   Gonzalez Sanchez, Sergio/0000-0002-0211-7822
FU Spanish Ministry of Science and Innovation; ICREA;  [2009-SGR-1292]; 
   [2009-SGR-282];  [MAT2011-27380-C02-01];  [TEC2008-06883-C03-03]; ICREA
FX We acknowledge O. Castell and E. Rossinyol (Servei de Microscopia, UAB)
   for their technical support with the SEM observations. This work has
   been partially financed by the 2009-SGR-1292, 2009-SGR-282,
   MAT2011-27380-C02-01 and MINAHE3 (TEC2008-06883-C03-03) research
   projects. S.G. and J.F. acknowledge the Juan de la Cierva contract and
   the Ph.D. Fellowship from the Spanish Ministry of Science and
   Innovation, respectively. M.D.B. was partially supported by an ICREA
   Academia award.
CR Ambrose CG, 2004, ANN BIOMED ENG, V32, P171, DOI 10.1023/B:ABME.0000007802.59936.fc
   Bamberger M., 2002, MAGNESIUM TECHNOLOGY
   Black J., 1998, HDB BIOMATERIALS PRO
   Fekry AM, 2011, INT J ELECTROCHEM SC, V6, P1342
   Fornell J, 2010, ACTA MATER, V58, P6256, DOI 10.1016/j.actamat.2010.07.047
   Geetha M, 2009, PROG MATER SCI, V54, P397, DOI 10.1016/j.pmatsci.2008.06.004
   Gonzalez S, 2009, INTERMETALLICS, V17, P968, DOI 10.1016/j.intermet.2009.04.012
   Gu X, 2005, J MATER RES, V20, P1935, DOI 10.1557/JMR.2005.0245
   Gu XN, 2010, BIOMATERIALS, V31, P1093, DOI 10.1016/j.biomaterials.2009.11.015
   Hufnagel TC, 2006, PHYS REV B, V73, DOI 10.1103/PhysRevB.73.064204
   Jardim PM, 2002, MICROSC MICROANAL, V8, P487, DOI 10.1017/S1431927602010413
   Kielhorn J, 2002, INT J HYG ENVIR HEAL, V205, P417, DOI 10.1078/1438-4639-00180
   Li ZJ, 2008, BIOMATERIALS, V29, P1329, DOI 10.1016/j.biomaterials.2007.12.021
   Milman YV, 2008, J PHYS D APPL PHYS, V41, DOI 10.1088/0022-3727/41/7/074013
   Nagels J, 2003, J SHOULDER ELB SURG, V12, P35, DOI 10.1067/mse.2003.22
   Ng WF, 2010, MAT SCI ENG C-MATER, V30, P898, DOI 10.1016/j.msec.2010.04.003
   Oak JJ, 2008, J NON-CRYST SOLIDS, V354, P1828, DOI 10.1016/j.jnoncrysol.2007.10.025
   OBERLE TL, 1951, JOM-J MIN MET MAT S, V3, P438
   OLIVER WC, 1992, J MATER RES, V7, P1564, DOI 10.1557/JMR.1992.1564
   Park WW, 2001, MET MATER-KOREA, V7, P9, DOI 10.1007/BF03026931
   Qin FX, 2009, MATER TRANS, V50, P605, DOI 10.2320/matertrans.MRA2008221
   Shepelev D, 2009, J MATER SCI, V44, P5627, DOI 10.1007/s10853-009-3793-0
   Song GL, 2005, ADV ENG MATER, V7, P563, DOI 10.1002/adem.200500013
   Song GL, 2007, CORROS SCI, V49, P1696, DOI 10.1016/j.corsci.2007.01.001
   Staiger MP, 2006, BIOMATERIALS, V27, P1728, DOI 10.1016/j.biomaterials.2005.10.003
   Tekaya A, 2009, J MATER SCI, V44, P4930, DOI 10.1007/s10853-009-3752-9
   Tsui TY, 1995, MATER RES SOC SYMP P, V383, P447, DOI 10.1557/PROC-383-447
   Wataha JC, 2000, J PROSTHET DENT, V83, P223, DOI 10.1016/S0022-3913(00)80016-5
   Whitters C.J., 2005, MAT SCI ENG A-STRUCT, V400-401, P467
   Witte F, 2005, BIOMATERIALS, V26, P3557, DOI 10.1016/j.biomaterials.2004.09.049
   Yang FQ, 2009, J PHYS D APPL PHYS, V42, DOI 10.1088/0022-3727/42/6/065401
   Zberg B, 2009, NAT MATER, V8, P887, DOI [10.1038/NMAT2542, 10.1038/nmat2542]
   Zhang EL, 2009, J BIOMED MATER RES A, V90A, P882, DOI 10.1002/jbm.a.32132
   Zhang SX, 2010, ACTA BIOMATER, V6, P626, DOI 10.1016/j.actbio.2009.06.028
NR 34
TC 31
Z9 32
U1 2
U2 54
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 1751-6161
J9 J MECH BEHAV BIOMED
JI J. Mech. Behav. Biomed. Mater.
PD FEB
PY 2012
VL 6
BP 53
EP 62
DI 10.1016/j.jmbbm.2011.09.014
PG 10
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 905LS
UT WOS:000301274300007
PM 22301173
DA 2018-10-19
ER

PT J
AU Rudra, JS
   Sun, T
   Bird, KC
   Daniels, MD
   Gasiorowski, JZ
   Chong, AS
   Collier, JH
AF Rudra, Jai S.
   Sun, Tao
   Bird, Katelyn C.
   Daniels, Melvin D.
   Gasiorowski, Joshua Z.
   Chong, Anita S.
   Collier, Joel H.
TI Modulating Adaptive Immune Responses to Peptide Self-Assemblies
SO ACS NANO
LA English
DT Article
DE self-assembly; vaccine; biomaterial; tissue engineering; scaffold
ID NANOFIBER SCAFFOLDS; ENDOTHELIAL-CELLS; DRUG-DELIVERY; T-CELLS;
   HYDROGELS; DISPLAY; EPITOPE; ENCAPSULATION; DETERMINANTS; BIOMATERIALS
AB Self-assembling peptides and peptide derivatives have received significant interest for several biomedical applications, including tissue engineering, wound healing, cell delivery, drug delivery, and vaccines. This class of materials has exhibited significant variability in immunogenicity, with many peptides eliciting no detectable antibody responses but others eliciting very strong responses without any supplemental adjuvants. Presently, strategies for either avoiding strong antibody responses or specifically inducing them are not well-developed, even though they are critical for the use of these materials both within tissue engineering and within immunotherapies. Here, we Investigated the molecular determinants and immunological mechanisms leading to the significant immunogenicity of the self-assembling peptide OVA-Q11, which has been shown previously to elicit strong antibody responses in mice. We show that these responses can last for at least a year. Using adoptive transfer experiments and T cell knockout models, we found that these strong antibody responses were T cell-dependent, suggesting a route for avoiding or ensuring immunogenicity. Indeed, by deleting amino acid regions in the peptide recognized by T cells, immunogenicity could be significantly diminished. lmmunogenicity could also be attenuated by mutating key residues in the self-assembling domain, thus preventing fibrillization. A second self-assembling peptide, KFE8, was also nonimmunogenic, but nanofibers of OVA-KFE8 elicited strong antibody responses similar to OVA-Q11, indicating that the adjuvant action was not dependent on the specific self-assembling peptide sequence. These findings will facilitate the design of self-assembled peptide biomaterials, both for applications where immunogenicity is undesirable and where it Is advantageous.
C1 [Rudra, Jai S.; Sun, Tao; Bird, Katelyn C.; Daniels, Melvin D.; Gasiorowski, Joshua Z.; Chong, Anita S.; Collier, Joel H.] Univ Chicago, Dept Surg, Chicago, IL 60637 USA.
   [Collier, Joel H.] Univ Chicago, Comm Mol Med, Chicago, IL 60637 USA.
   [Chong, Anita S.] Univ Chicago, Comm Immunol, Chicago, IL 60637 USA.
RP Collier, JH (reprint author), Univ Chicago, Dept Surg, 5841 S Maryland Ave, Chicago, IL 60637 USA.
EM collier@uchicago.edu
RI Sun, Tao/F-8233-2012
FU National Institutes of Health (NIBIB) [1R01EB009701]; NIAID
   [1R21A1094444]; Chicago Biomedical Consortium (CBC); Chicago Community
   Trust
FX TEM was performed at the University of Chicago Electron Microscopy core
   facility. CD was performed at the University of Chicago Biophysics core
   facility. This work was supported by the National Institutes of Health
   (NIBIB, 1R01EB009701; NIAID, 1R21A1094444), and the Chicago Biomedical
   Consortium (CBC) with support from the Searle Funds at The Chicago
   Community Trust. This publication is solely the responsibility of the
   authors and does not necessarily represent the official views of the NIH
   or the CBC.
CR Allman AJ, 2001, TRANSPLANTATION, V71, P1631, DOI 10.1097/00007890-200106150-00024
   Altunbas A, 2011, BIOMATERIALS, V32, P5906, DOI 10.1016/j.biomaterials.2011.04.069
   Ansaloni L, 2007, J INVEST SURG, V20, P237, DOI 10.1080/08941930701481296
   Boato F, 2007, ANGEW CHEM INT EDIT, V46, P9015, DOI 10.1002/anie.200702805
   Chackerian B, 2001, J CLIN INVEST, V108, P415, DOI 10.1172/JCI200111849
   Collier JH, 2008, SOFT MATTER, V4, P2310, DOI 10.1039/b805563g
   Davis ME, 2006, P NATL ACAD SCI USA, V103, P8155, DOI 10.1073/pnas.0602877103
   Davis ME, 2005, CIRCULATION, V111, P442, DOI 10.1161/01.CIR.0000153847.47301.80
   De Koker S, 2011, CHEM SOC REV, V40, P320, DOI 10.1039/b914943k
   Defrance T, 2011, CURR OPIN IMMUNOL, V23, P330, DOI 10.1016/j.coi.2011.03.004
   DINTZIS HM, 1976, P NATL ACAD SCI USA, V73, P3671, DOI 10.1073/pnas.73.10.3671
   Ghasparian A, 2011, CHEMBIOCHEM, V12, P100, DOI 10.1002/cbic.201000536
   Haines-Butterick L, 2007, P NATL ACAD SCI USA, V104, P7791, DOI 10.1073/pnas.0701980104
   Holmes TC, 2000, P NATL ACAD SCI USA, V97, P6728, DOI 10.1073/pnas.97.12.6728
   Hsieh PCH, 2006, J CLIN INVEST, V116, P237, DOI 10.1172/JCI25878
   Huang RL, 2011, SOFT MATTER, V7, P6222, DOI 10.1039/c1sm05375b
   Ilyinskii PO, 2008, VACCINE, V26, P3223, DOI 10.1016/j.vaccine.2008.03.078
   Jung JP, 2008, BIOMATERIALS, V29, P2143, DOI 10.1016/j.biomaterials.2008.01.008
   Jung JP, 2011, INTEGR BIOL-UK, V3, P185, DOI 10.1039/c0ib00112k
   Jung JP, 2009, BIOMATERIALS, V30, P2400, DOI 10.1016/j.biomaterials.2009.01.033
   Kaba SA, 2009, J IMMUNOL, V183, P7268, DOI 10.4049/jimmunol.0901957
   Kaltgrad E, 2007, CHEMBIOCHEM, V8, P1455, DOI 10.1002/cbic.200700225
   Kuroda E, 2011, IMMUNITY, V34, P514, DOI 10.1016/j.immuni.2011.03.019
   Law B, 2006, BIOMACROMOLECULES, V7, P1261, DOI 10.1021/bm050920f
   Lim YB, 2009, CHEM SOC REV, V38, P925, DOI 10.1039/b809741k
   Liu S, 2008, MACROMOLECULES, V41, P764, DOI 10.1021/ma702128a
   Mahmoud ZN, 2011, BIOMATERIALS, V32, P3712, DOI 10.1016/j.biomaterials.2010.12.002
   Marini DM, 2002, NANO LETT, V2, P295, DOI 10.1021/nl015697g
   McKinstry KK, 2010, IMMUNOLOGY, V130, P1, DOI 10.1111/j.1365-2567.2010.03259.x
   MOND JJ, 1995, ANNU REV IMMUNOL, V13, P655, DOI 10.1146/annurev.immunol.13.1.655
   Nielsen M, 2010, IMMUNOLOGY, V130, P319, DOI 10.1111/j.1365-2567.2010.03268.x
   Puffer EB, 2007, ACS CHEM BIOL, V2, P252, DOI 10.1021/cb600489g
   Robertson JM, 2000, J IMMUNOL, V164, P4706, DOI 10.4049/jimmunol.164.9.4706
   Rudra JS, 2010, P NATL ACAD SCI USA, V107, P622, DOI 10.1073/pnas.0912124107
   Savin T, 2007, SOFT MATTER, V3, P1194, DOI 10.1039/b700434f
   Schneider A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001410
   Schroeder U, 2009, J MOL BIOL, V386, P1368, DOI 10.1016/j.jmb.2008.11.023
   SCHULTZ CL, 1991, CURR OPIN IMMUNOL, V3, P350, DOI 10.1016/0952-7915(91)90037-2
   Silva GA, 2004, SCIENCE, V303, P1352, DOI 10.1126/science.1093783
   Slaughter BV, 2009, ADV MATER, V21, P3307, DOI 10.1002/adma.200802106
   Tysseling-Mattiace VM, 2008, J NEUROSCI, V28, P3814, DOI 10.1523/JNEUROSCI.0143-08.2008
   Webber MJ, 2010, ACTA BIOMATER, V6, P3, DOI 10.1016/j.actbio.2009.07.031
   Wu M, 2011, MOL BIOSYST, V7, P2040, DOI 10.1039/c0mb00271b
   Yoshimi R, 2009, J CRANIOFAC SURG, V20, P1523, DOI 10.1097/SCS.0b013e3181b09b7e
NR 44
TC 125
Z9 127
U1 7
U2 113
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 1936-0851
J9 ACS NANO
JI ACS Nano
PD FEB
PY 2012
VL 6
IS 2
BP 1557
EP 1564
DI 10.1021/nn204530r
PG 8
WC Chemistry, Multidisciplinary; Chemistry, Physical; Nanoscience &
   Nanotechnology; Materials Science, Multidisciplinary
SC Chemistry; Science & Technology - Other Topics; Materials Science
GA 898QW
UT WOS:000300757900066
PM 22273009
OA Green Accepted
DA 2018-10-19
ER

PT J
AU Ning, ZL
   Chang, ZD
   Li, WJ
   Sun, CY
   Zhang, JH
   Liu, Y
AF Ning Zhanglei
   Chang Zhidong
   Li Wenjun
   Sun Changyan
   Zhang Jinghua
   Liu Yang
TI Solvothermal Synthesis and Optical Performance of One-dimensional
   Strontium Hydroxyapatite Nanorod
SO CHINESE JOURNAL OF CHEMICAL ENGINEERING
LA English
DT Article
DE strontium hydroxyapatite; biomaterial; solvothermal synthesis; optical
   performance
ID SUBSTITUTED HYDROXYAPATITES; HYDROTHERMAL SYNTHESIS; DOPED
   HYDROXYAPATITE; CALCIUM-PHOSPHATE; NANOSTRUCTURES; COATINGS; EU3+; SR
AB One-dimensional strontium hydroxyapatite (Sr-HAp) nanorods were successfully synthesized by a simple solvothermal method. The products were characterized via X-ray diffraction (XRD), Fourier transform infrared (FT-IR), cold field emission scanning electron microscopy (FESEM), transmission electron microscopy (TEM), photoluminescence (PL) excitation and emission spectra. The experimental results indicated that oleic acid as a surfactant played a key role in confining the growth of the Sr-HAp powders. A possible formation mechanism of the one-dimensional nanorod was proposed and elaborated. Moreover, the as-obtained Sr-HAp samples showed an intense and bright emission band centered at 460 nm under long-wavelength UV light excitation and the contents of NaOH used in the synthetic process had an obvious impact on the optical performance of Sr-HAp powders. The possible luminescent mechanism of the Sr-HAp samples was discussed.
C1 [Ning Zhanglei; Chang Zhidong; Li Wenjun; Sun Changyan] Univ Sci & Technol Beijing, Sch Chem & Biol Engn, Beijing 100083, Peoples R China.
   [Zhang Jinghua; Liu Yang] Beijing Ctr Phys & Chem Anal, Beijing 100089, Peoples R China.
RP Chang, ZD (reprint author), Univ Sci & Technol Beijing, Sch Chem & Biol Engn, Beijing 100083, Peoples R China.
EM zdchang@ustb.edu.cn; wjli@sas.ustb.edu.cn
FU National Natural Science Foundation of China [20876157]; Fundamental
   Research Funds for the Central Universities [FRF-BR-10-002A]
FX Supported by the National Natural Science Foundation of China (20876157)
   and the Fundamental Research Funds for the Central Universities
   (FRF-BR-10-002A).
CR Bronstein LM, 2007, CHEM MATER, V19, P3624, DOI 10.1021/cm062948j
   Capuccini C, 2008, ACTA BIOMATER, V4, P1885, DOI 10.1016/j.actbio.2008.05.005
   Graeve OA, 2010, BIOMATERIALS, V31, P4259, DOI 10.1016/j.biomaterials.2010.02.009
   Han YC, 2009, J SOL-GEL SCI TECHN, V49, P125, DOI 10.1007/s10971-008-1832-y
   He QJ, 2007, MATER LETT, V61, P141, DOI 10.1016/j.matlet.2006.04.082
   Kim TG, 2005, INORG CHEM, V44, P9895, DOI 10.1021/ic051013m
   Landi E, 2008, ACTA BIOMATER, V4, P656, DOI 10.1016/j.actbio.2007.10.010
   Landi E, 2007, ACTA BIOMATER, V3, P961, DOI 10.1016/j.actbio.2007.05.006
   Lebugle A, 2006, CHEM COMMUN, P606, DOI 10.1039/b515164c
   Lieber CM, 1998, SOLID STATE COMMUN, V107, P607, DOI 10.1016/S0038-1098(98)00209-9
   Lin KL, 2009, CRYST GROWTH DES, V9, P177, DOI 10.1021/cg800129u
   Neira IS, 2009, CRYST GROWTH DES, V9, P466, DOI 10.1021/cg800738a
   Salarian M, 2009, CERAM INT, V35, P2563, DOI 10.1016/j.ceramint.2009.02.031
   Wang X, 2005, NATURE, V437, P121, DOI 10.1038/nature03968
   Yang CC, 2006, J CRYST GROWTH, V293, P113, DOI 10.1016/j.jcrysgro.2006.05.012
   Yang C, 2008, J COLLOID INTERF SCI, V328, P203, DOI 10.1016/j.jcis.2008.09.010
   Yang PP, 2008, BIOMATERIALS, V29, P4341, DOI 10.1016/j.biomaterials.2008.07.042
   Zhang CM, 2009, LANGMUIR, V25, P13591, DOI 10.1021/la9019684
   Zhang CM, 2009, CRYST GROWTH DES, V9, P2725, DOI 10.1021/cg801353n
   Zhang X, 2009, J COLLOID INTERF SCI, V329, P103, DOI 10.1016/j.jcis.2008.09.076
   Zhao XH, 2009, CHINESE J CHEM ENG, V17, P667, DOI 10.1016/S1004-9541(08)60261-X
NR 21
TC 11
Z9 12
U1 3
U2 40
PU CHEMICAL INDUSTRY PRESS
PI BEIJING
PA NO. 3 HUIXINLI CHAOYANGQU, BEIJING 100029, PEOPLES R CHINA
SN 1004-9541
J9 CHINESE J CHEM ENG
JI Chin. J. Chem. Eng.
PD FEB
PY 2012
VL 20
IS 1
BP 89
EP 94
DI 10.1016/S1004-9541(12)60367-X
PG 6
WC Engineering, Chemical
SC Engineering
GA 902AO
UT WOS:000301011200014
DA 2018-10-19
ER

PT J
AU Chen, Y
   Ding, X
   Li, YL
AF Chen, Ying
   Ding, Xin
   Li, Yuling
TI Comparison of Biostability between Poly(trimethylene terephthalate)
   Filaments and PET for Vascular Prostheses When Exposed to Hydrolytic and
   Enzymatic Degradation
SO FIBERS AND POLYMERS
LA English
DT Article
DE Poly(trimethylene terephthalate); Poly(ethylene terephthalate);
   Hydrolytic degradation; Enzymatic degradation; Biostability
ID INFRARED-SPECTROSCOPY; MECHANICAL-PROPERTIES; THERMAL-ANALYSIS; GRAFTS;
   CRYSTALLIZATION; POLYESTER
AB The purpose of this paper is to study the biostability of PTT samples as an implantable biomaterial. In this study accelerated hydrolytic and enzymatic degradation tests were performed on PTT filaments so as to predict the relative rates of in vivo biodegradation. PTT filaments were subjected to a highly alkaline environment (pH 13.5) for periods of up to 10 days, and to PBS buffer and neutral enzymatic papain solutions for up to 9 weeks. Changes in weight loss, surface appearance, filament diameter, thermal properties, infra-red spectrum and tensile modulus were monitored over these time periods. PET samples were also exposed to the same solutions as a comparison to FIT samples. The results show that PTT filaments are more stable in alkaline solution, but less stable in PBS neutral buffer and enzymatic papain environments compared to PET filaments. The decrease of tensile moduli of the degraded PTT samples confirms the decrease of crystallinity and conform change of the trimethylene glycol conformers during the degradation.
C1 [Chen, Ying; Ding, Xin; Li, Yuling] Donghua Univ, Coll Text, Shanghai 201620, Peoples R China.
   [Ding, Xin; Li, Yuling] Minist Educ, Key Lab Text Sci & Technol, Shanghai 201020, Peoples R China.
RP Ding, X (reprint author), Donghua Univ, Coll Text, Shanghai 201620, Peoples R China.
EM xding@dhu.edu.cn
FU 111 Project Biomedical Textile Materials Science and Technology
   [B07024]; Key Lab of Silk Engineering, Soochow University, P. R. China;
   China Scholarship Council
FX This project was sponsored by the '111 Project (B07024) Biomedical
   Textile Materials Science and Technology' and the Key Lab of Silk
   Engineering, Soochow University, P. R. China. The authors extend their
   appreciation to the China Scholarship Council for the financial support
   and to Dr. Martin W. King for his professional support.
CR BALLARA A, 1989, POLYM DEGRAD STABIL, V26, P361, DOI 10.1016/0141-3910(89)90114-6
   Bos GW, 1998, ARCH PHYSIOL BIOCHEM, V106, P100, DOI 10.1076/apab.106.2.100.4384
   Chen KQ, 2004, J APPL POLYM SCI, V91, P1967, DOI 10.1002/app.13424
   Chen Y., 2008, 2008 INT S FIB BAS S, P261
   Cheng G., 2010, DISCRETE CONT DYN-B, P1
   Deepal S. R., 2002, THESIS N CAROLINA ST
   Eberl A, 2008, J BIOTECHNOL, V135, P45, DOI 10.1016/j.jbiotec.2008.02.015
   Gonzalez I, 2006, J APPL POLYM SCI, V102, P3246, DOI 10.1002/app.24643
   HELLENER G, 1994, BIOMATERIALS, V15, P1115, DOI 10.1016/0142-9612(94)90231-3
   Kim JH, 2001, J APPL POLYM SCI, V82, P99, DOI 10.1002/app.1828
   King W. M., 2001, J TEXTILE APPAREL TE, V1, P1
   Kint D, 1999, POLYM INT, V48, P346, DOI 10.1002/(SICI)1097-0126(199905)48:5<346::AID-PI156>3.0.CO;2-N
   Moghe AK., 2002, THESIS N CAROLINA ST
   Muller RJ, 2001, J BIOTECHNOL, V86, P87, DOI 10.1016/S0168-1656(00)00407-7
   Noun M., 2007, TEXTILES SUSTAINABLE
   Riepe G, 1997, EUR J VASC ENDOVASC, V13, P540, DOI 10.1016/S1078-5884(97)80062-7
   ROGGENDORF E, 1976, J BIOMED MATER RES, V10, P123, DOI 10.1002/jbm.820100112
   Salacinski HJ, 2001, J BIOMATER APPL, V15, P241, DOI 10.1106/NA5T-J57A-JTDD-FD04
   Sarkar S, 2006, EUR J VASC ENDOVASC, V31, P627, DOI 10.1016/j.ejvs.2006.01.006
   Vasanthan N, 2007, J POLYM SCI POL PHYS, V45, P1675, DOI 10.1002/polb.21196
   WILLIAMS DF, 1987, J MATER SCI, V22, P3421, DOI 10.1007/BF01161439
   Wu T, 2005, EUR POLYM J, V41, P2216, DOI 10.1016/j.eurpolymj.2005.04.025
   Yamen M, 2008, J POLYM SCI POL PHYS, V46, P1497, DOI 10.1002/polb.21485
NR 23
TC 4
Z9 4
U1 0
U2 17
PU KOREAN FIBER SOC
PI SEOUL
PA KOREA SCIENCE TECHNOLOGY CTR #501 635-4 YEOGSAM-DONG, KANGNAM-GU, SEOUL
   135-703, SOUTH KOREA
SN 1229-9197
J9 FIBER POLYM
JI Fiber. Polym.
PD FEB
PY 2012
VL 13
IS 2
BP 169
EP 176
DI 10.1007/s12221-012-0169-x
PG 8
WC Materials Science, Textiles; Polymer Science
SC Materials Science; Polymer Science
GA 901JC
UT WOS:000300962200006
DA 2018-10-19
ER

PT J
AU Jebahi, S
   Saoudi, M
   Badraoui, R
   Rebai, T
   Oudadesse, H
   Ellouz, Z
   Keskese, H
   El Feki, A
   El Feki, H
AF Jebahi, Samira
   Saoudi, Mongi
   Badraoui, Riadh
   Rebai, Tarek
   Oudadesse, Hassane
   Ellouz, Zoubaier
   Keskese, Hassib
   El Feki, Abdelfattah
   El Feki, Hafed
TI Biologic Response to Carbonated Hydroxyapatite Associated with
   Orthopedic Device: Experimental Study in a Rabbit Model
SO KOREAN JOURNAL OF PATHOLOGY
LA English
DT Article
DE Biocompatible materials; Testing bone substitute
ID CALCIUM-PHOSPHATE CEMENT; BONE; RESORPTION; FIXATION; IMPLANTS
AB Background: Carbonated hydroxyapatite (CHA) and related calcium phosphates have been studied for many years as implant materials due to their similarity with the mineral phase of bone. The main limitation of CHA ceramics as well as other bioactive materials is that they have poor mechanical proprieties. It is thought that the mechanical device can cause an increase in metabolic activity and bone healing. In this study we investigated the reactivity and tissue behaviour of implanted CHA biomaterial reinforced by mini external fixator. Methods: The evaluation of biomaterial biocompatibility and osteogenesis was performed on a rabbit model over a period of 6 weeks by radiological, histological and scanning electron microscopy (SEM) coupled with energy dispersive X-ray SEM-energy-dispersive X-ray (EDX) analysis. Results: While rabbits treated with CHA exhibited more bone formation, and fibrous tissue was observed when empty bone defects were observed. EDX analysis detected little calcium and phosphorus on the surface of the bone that was not implanted, while high content of calcium (62.7%) and phosphorus (38%) was found on the interface bone cement. Conclusions: Bone repairing showed that the mini external fixator stimulated the ossification which was pushed when grafted by CHA. This effect may play an important role in the prevention of implant loosening.
C1 [Jebahi, Samira; Saoudi, Mongi; El Feki, Abdelfattah] Sci Fac Sfax, Dept Life Sci, Anim Ecophysiol Lab, Sfax, Tunisia.
   [Jebahi, Samira; Badraoui, Riadh; Rebai, Tarek] Med Fac Sfax, Histol Lab, Sfax, Tunisia.
   [Jebahi, Samira; El Feki, Hafed] Sci Fac Sfax, Lab Sci Mat & Environm, Sfax, Tunisia.
   [Jebahi, Samira; Oudadesse, Hassane] Univ Rennes 1, CNRS, UMR 6226, F-35042 Rennes, France.
   [Jebahi, Samira; Ellouz, Zoubaier; Keskese, Hassib] Med Fac Sfax, Lab Orthopaed & Traumatol, Sfax, Tunisia.
RP Jebahi, S (reprint author), Sci Fac Sfax, Dept Life Sci, Anim Ecophysiol Lab, Sfax, Tunisia.
EM jbahisamira@yahoo.fr
CR Badraoui R, 2007, CR BIOL, V330, P897, DOI 10.1016/j.crvi.2007.09.002
   Doi Y, 1998, J BIOMED MATER RES, V39, P603, DOI 10.1002/(SICI)1097-4636(19980315)39:4<603::AID-JBM15>3.3.CO;2-8
   EINHORN TA, 1984, J BONE JOINT SURG AM, V66A, P274, DOI 10.2106/00004623-198466020-00015
   Eriksson C, 2007, J BIOMED MATER RES A, V83A, P1062, DOI 10.1002/jbm.a.31433
   FRIEDLAENDER GE, 1992, ORTHOPEDICS, V15, P1171
   Huh GY, 1988, KOREAN J PAHTOL, V22, P489
   Kotoura Y, 1987, Gan To Kagaku Ryoho, V14, P1423
   Landi E, 2003, J EUR CERAM SOC, V23, P2931, DOI 10.1016/S0955-2219(03)00304-2
   Liljensten Elisabeth, 2003, Clin Implant Dent Relat Res, V5, P95, DOI 10.1111/j.1708-8208.2003.tb00190.x
   Mastrogiacomo M, 2006, BIOMATERIALS, V27, P3230, DOI 10.1016/j.biomaterials.2006.01.031
   Mino-Farina N, 2009, VET J, V179, P264, DOI 10.1016/j.tvjl.2007.09.011
   Okumura M, 1997, J BIOMED MATER RES, V37, P122, DOI 10.1002/(SICI)1097-4636(199710)37:1<122::AID-JBM15>3.3.CO;2-3
   Ooms EM, 2002, J BIOMED MATER RES, V61, P9, DOI 10.1002/jbm.10029
   Pan HB, 2010, ACTA BIOMATER, V6, P4181, DOI 10.1016/j.actbio.2010.05.013
   REY C, 1991, CALCIFIED TISSUE INT, V49, P251, DOI 10.1007/BF02556214
   Theiss F, 2005, BIOMATERIALS, V26, P4383, DOI 10.1016/j.biomaterials.2004.11.056
   Tieanboon P, 2009, ASIAN BIOMED, V3, P177
   Tsukeoka T, 2005, J BIOMED MATER RES B, V75B, P168, DOI 10.1002/jbm.b.30282
   Yuan HP, 2000, BIOMATERIALS, V21, P1283, DOI 10.1016/S0142-9612(00)00016-8
NR 19
TC 3
Z9 3
U1 0
U2 5
PU KOREAN SOCIETY PATHOLOGISTS
PI SEOUL
PA ROOM 702 KOREAN MED ASSOC BLDG, 302-75 ICHON, 1 DONG, YOUNGSAN-GU,
   SEOUL, 140-721, SOUTH KOREA
SN 1738-1843
J9 KOREAN J PATHOL
JI Korean J. Pathol.
PD FEB
PY 2012
VL 46
IS 1
BP 48
EP 54
DI 10.4132/KoreanJPathol.2012.46.1.48
PG 7
WC Pathology
SC Pathology
GA 901RY
UT WOS:000300985700008
PM 23109978
OA Other Gold, Green Published
DA 2018-10-19
ER

PT J
AU Zhou, YL
   An, J
   Luo, DM
   Hu, WY
   Li, YC
   Hodgson, P
   Wen, CE
AF Zhou, Y. -L.
   An, J.
   Luo, D. -M.
   Hu, W. -Y.
   Li, Y. C.
   Hodgson, P.
   Wen, C. E.
TI Microstructures and mechanical properties of as cast Mg-Zr-Ca alloys for
   biomedical applications
SO MATERIALS TECHNOLOGY
LA English
DT Article
DE Mg-Zr-Ca alloy; Mechanical property; Microstructure; Metallic
   biomaterial
ID MAGNESIUM ALLOYS; BIOMATERIALS; CORROSION
AB The microstructures and mechanical properties of as cast Mg-Zr-Ca alloys were investigated for potential use in biomedical applications. The Mg-Zr-Ca alloys were fabricated by commercial pure Mg (99.9 mass-%), Ca (99.9 mass-%) and master Mg-33 mass-% Zr alloy. The microstructures of the alloys were examined by X-ray diffraction analysis and optical microscopy, and the mechanical properties were determined from tensile tests. The experimental results indicate that the Mg-Zr-Ca alloys with 1 mass-% Ca are composed of one single a phase; these alloys with 2 mass-% Ca consist of both Mg2Ca and alpha phase, and all the alloys exhibit typical coarse microstructures. An increase in Zr increases the strength of Mg-Zr-Ca alloys with 1 mass-% Ca, and the formation of Mg2Ca decreases the strength of the alloys. Mg-1Zr-1Ca alloy (mass-%) has the highest strength and best ductility among all the studied alloys.
C1 [Zhou, Y. -L.; An, J.; Luo, D. -M.] Foshan Univ, Dept Mechatron Engn, Foshan 528000, Peoples R China.
   [Hu, W. -Y.] Hunan Univ, Dept Appl Phys, Changsha 410082, Hunan, Peoples R China.
   [Li, Y. C.; Hodgson, P.] Deakin Univ, Inst Technol Res & Innovat, Geelong, Vic 3217, Australia.
   [Wen, C. E.] Swinburne Univ Technol, Fac Engn & Ind Sci, IRIS, Melbourne, Vic, Australia.
RP Zhou, YL (reprint author), Foshan Univ, Dept Mechatron Engn, Foshan 528000, Peoples R China.
EM ylzhou@fosu.edu.cn
RI Li, Yuncang/I-5832-2012; Wen, Cuie/I-2872-2012; Hu, Wangyu/B-5762-2009
OI Li, Yuncang/0000-0003-4290-4772; Wen, Cuie/0000-0001-8008-3536; Hu,
   Wangyu/0000-0001-7416-3994
FU Key Scientific and Technological Projects of Guangdong Province, China
   [2008B010600003];  [AISRF-BF030031]
FX The authors would like to thank the financial support for this work from
   the fund of the Key Scientific and Technological Projects of Guangdong
   Province, China (grant no. 2008B010600003) and AISRF-BF030031,
   Australia.
CR [艾延龄 AI Yanling], 2005, [机械工程材料, Materials for Mechanical Engineering], V29, P3
   ASM International, 1992, ASM HDB, V3
   Gu XN, 2009, BIOMATERIALS, V30, P484, DOI 10.1016/j.biomaterials.2008.10.021
   Kim WC, 2008, MATER LETT, V62, P4146, DOI 10.1016/j.matlet.2008.06.028
   Li ZJ, 2008, BIOMATERIALS, V29, P1329, DOI 10.1016/j.biomaterials.2007.12.021
   Long M, 1998, BIOMATERIALS, V19, P1621, DOI 10.1016/S0142-9612(97)00146-4
   Song GL, 2007, CORROS SCI, V49, P1696, DOI 10.1016/j.corsci.2007.01.001
   Staiger MP, 2006, BIOMATERIALS, V27, P1728, DOI 10.1016/j.biomaterials.2005.10.003
   Wan YZ, 2008, MATER DESIGN, V29, P2034, DOI 10.1016/j.matdes.2008.04.017
   Xu H, 2007, MAGNESIUM ALLOYS FAB
NR 10
TC 7
Z9 7
U1 0
U2 7
PU MANEY PUBLISHING
PI LEEDS
PA STE 1C, JOSEPHS WELL, HANOVER WALK, LEEDS LS3 1AB, W YORKS, ENGLAND
SN 1066-7857
J9 MATER TECHNOL
JI Mater. Technol.
PD FEB
PY 2012
VL 27
IS 1
BP 52
EP 54
DI 10.1179/175355511X13240279340200
PG 3
WC Materials Science, Multidisciplinary
SC Materials Science
GA 899ZE
UT WOS:000300854400018
DA 2018-10-19
ER

PT J
AU Vogler, EA
AF Vogler, Erwin A.
TI Protein adsorption in three dimensions
SO BIOMATERIALS
LA English
DT Article
DE Review; Protein adsorption; Blood; Solution depletion; QCM; Tensiometry
ID SELF-ASSEMBLED MONOLAYERS; SURFACE-PLASMON RESONANCE;
   HUMAN-SERUM-ALBUMIN; QUARTZ-CRYSTAL MICROBALANCE; SOFT CONTACT-LENSES;
   RANDOM SEQUENTIAL ADSORPTION; SCALED INTERFACIAL ACTIVITY; ATOMIC-FORCE
   MICROSCOPY; SOLID LIQUID ADSORPTION; AIR-WATER-INTERFACE
AB Recent experimental and theoretical work clarifying the physical chemistry of blood-protein adsorption from aqueous-buffer solution to various kinds of surfaces is reviewed and interpreted within the context of biomaterial applications, especially toward development of cardiovascular biomaterials. The importance of this subject in biomaterials surface science is emphasized by reducing the "protein-adsorption problem" to three core questions that require quantitative answer. An overview of the protein-adsorption literature identifies some of the sources of inconsistency among many investigators participating in more than five decades of focused research. A tutorial on the fundamental biophysical chemistry of protein adsorption sets the stage for a detailed discussion of the kinetics and thermodynamics of protein adsorption, including adsorption competition between two proteins for the same adsorbent immersed in a binary-protein mixture. Both kinetics and steady-state adsorption can be rationalized using a single interpretive paradigm asserting that protein molecules partition from solution into a three-dimensional (3D) interphase separating bulk solution from the physical-adsorbent surface. Adsorbed protein collects in one-or-more adsorbed layers, depending on protein size, solution concentration, and adsorbent surface energy (water wettability). The adsorption process begins with the hydration of an adsorbent surface brought into contact with an aqueous-protein solution. Surface hydration reactions instantaneously form a thin, pseudo-2D interface between the adsorbent and protein solution. Protein molecules rapidly diffuse into this newly formed interface, creating a truly 3D interphase that inflates with arriving proteins and fills to capacity within milliseconds at mg/mL bulk-solution concentrations C-B. This inflated interphase subsequently undergoes time-dependent (minutes-to-hours) decrease in volume V-I by expulsion of either-or-both interphase water and initially adsorbed protein. lnterphase protein concentration C-I increases as V-I decreases, resulting in slow reduction in interfacial energetics. Steady state is governed by a net partition coefficient P = (C-I/C-B). In the process of occupying space within the interphase, adsorbing protein molecules must displace an equivalent volume of interphase water. lnterphase water is itself associated with surface-bound water through a network of transient hydrogen bonds. Displacement of interphase water thus requires an amount of energy that depends on the adsorbent surface chemistry/energy. This "adsorption dehydration" step is the significant free energy cost of adsorption that controls the maximum amount of protein that can be adsorbed at steady state to a unit adsorbent surface area (the adsorbent capacity). As adsorbent hydrophilicity increases, adsorbent capacity monotonically decreases because the energetic cost of surface dehydration increases, ultimately leading to no protein adsorption near an adsorbent water wettability (surface energy) characterized by a water contact angle theta -> 65 degrees. Consequently, protein does not adsorb (accumulate at interphase concentrations greater than bulk solution) to more hydrophilic adsorbents exhibiting theta < 65 degrees. For adsorbents bearing strong Lewis acid/base chemistry such as ion-exchange resins, protein/surface interactions can be highly favorable, causing protein to adsorb in multilayers in a relatively thick interphase.
   A straightforward, three-component free enrgy relationship captures salient features of protein adsorption to all surfaces predicting that the overall free energy of protein adsorption Delta G(ads)(o) is a relatively small multiple of thermal energy for any surface chemistry (except perhaps for bioengineered surfaces bearing specific ligands for adsorbing protein) because a surface chemistry that interacts chemically with proteins must also interact with water through hydrogen bonding. In this way, water moderates protein adsorption to any surface by competing with adsorbing protein molecules. This Leading Opinion ends by proposing several changes to the protein-adsorption paradigm that might advance answers to the three core questions that frame the "protein-adsorption problem" that is so fundamental to biomaterials surface science. (C) 2011 Elsevier Ltd. All rights reserved.
C1 [Vogler, Erwin A.] Penn State Univ, Dept Mat Sci & Engn, University Pk, PA 16802 USA.
   [Vogler, Erwin A.] Penn State Univ, Dept Bioengn, University Pk, PA 16802 USA.
RP Vogler, EA (reprint author), Penn State Univ, Dept Mat Sci & Engn, University Pk, PA 16802 USA.
EM eav3@psu.edu
FU National Institute of Health [PHS R01HL069965]; Department of
   Bioengineering, The Pennsylvania State University; Department of
   Materials Science and Engineering, The Pennsylvania State University
FX This work was supported by National Institute of Health grant PHS
   R01HL069965. The author is grateful to a long list of collaborators and
   students with whom he has had the pleasure of exploring the many facets
   of protein adsorption over many years. Special among these collaborators
   are Dr. Anandi Krishnan and (now) Professors Hyeran Noh, Naris Barnthip,
   and Purnendu Parhi. Author thanks Ms. Qiaoling Huang for a careful read
   of the manuscript. Author appreciates support from the Departments of
   Bioengineering and Materials Science and Engineering, The Pennsylvania
   State University.
CR Adamczyk Z, 2011, LANGMUIR, V26, P11
   Anderson NL, 2002, MOL CELL PROTEOMICS, V1, P845, DOI 10.1074/mcp.R200007-MCP200
   Andrade JD, 1986, ADV POLYM SCI, V79, P3
   Anraku M, 2003, PHARMACEUT RES, V20, P684, DOI 10.1023/A:1023219420935
   Ariola FS, 2006, BIOMATERIALS, V27, P3404, DOI 10.1016/j.biomaterials.2006.02.005
   Armstrong KF, 1972, ANATOMY PHYSL NURSES
   AVEYARD R, 1973, INTRO PRINCIPLES SUR
   Ballantine D., 1997, ACOUSTIC WAVE SENSOR
   Barngrover D., 1986, MAMMALIAN CELL TECHN, P131
   Barnthip N, 2008, BIOMATERIALS, V29, P3062, DOI 10.1016/j.biomaterials.2008.03.043
   Barnthip N, 2009, BIOMATERIALS, V30, P6495, DOI 10.1016/j.biomaterials.2009.08.016
   Bashforth F, 1883, ATTEMPT TEST THEORIE
   Benjamins J, 2006, LANGMUIR, V22, P6181, DOI 10.1021/la060441h
   Beverung CJ, 1999, BIOPHYS CHEM, V81, P59, DOI 10.1016/S0301-4622(99)00082-4
   Birdi KS, 1997, HDB SURFACE COLLOID, P763
   Bond WN, 1937, PHILOS MAG, V24, P864
   Brash J, 1971, CHEM BIOSURFACES, P177
   Brash J L, 1969, J Biomed Mater Res, V3, P175, DOI 10.1002/jbm.820030114
   BRASH JL, 1993, J BIOMAT SCI-POLYM E, V4, P591, DOI 10.1163/156856293X00816
   BRASH JL, 1984, THROMB HAEMOSTASIS, V51, P326
   Brien CP, 2008, LANGMUIR, P14
   BRYNDA E, 1984, J BIOMED MATER RES, V18, P685, DOI 10.1002/jbm.820180609
   CASTILLO EJ, 1985, BIOMATERIALS, V6, P338, DOI 10.1016/0142-9612(85)90089-4
   CASTILLO EJ, 1986, BIOMATERIALS, V7, P9, DOI 10.1016/0142-9612(86)90081-5
   CASTILLO EJ, 1986, BIOMATERIALS, V7, P89, DOI 10.1016/0142-9612(86)90062-1
   CASTILLO EJ, 1984, BIOMATERIALS, V5, P319, DOI 10.1016/0142-9612(84)90029-2
   Cha P, 2008, LANGMUIR, V24, P2553, DOI 10.1021/la703310k
   Chalikian TV, 1996, J MOL BIOL, V260, P588, DOI 10.1006/jmbi.1996.0423
   Chalikian TV, 1996, BIOPOLYMERS, V39, P619, DOI 10.1002/(SICI)1097-0282(199611)39:5<619::AID-BIP1>3.0.CO;2-Z
   Chapman RG, 2001, LANGMUIR, V17, P1225, DOI 10.1021/la001222d
   Chapman RG, 2000, J AM CHEM SOC, V122, P8303, DOI 10.1021/ja000774f
   Chen WY, 2003, LANGMUIR, V19, P9395, DOI 10.1021/la034783o
   CHOTHIA C, 1975, NATURE, V254, P304, DOI 10.1038/254304a0
   CLAESSON PM, 1995, ADV COLLOID INTERFAC, V57, P161, DOI 10.1016/0001-8686(95)00241-H
   Clark AJ, 2007, LANGMUIR, V23, P5591, DOI 10.1021/la0635350
   CLARK DC, 1990, J COLLOID INTERF SCI, V138, P207, DOI 10.1016/0021-9797(90)90196-U
   COLLINS KD, 1995, P NATL ACAD SCI USA, V92, P5553, DOI 10.1073/pnas.92.12.5553
   Cooper SL, 1982, PROTEIN ADSORPTION B, P234
   Cramer CJ, 1999, CHEM REV, V99, P2161, DOI 10.1021/cr960149m
   Derand H, 1998, BIOPOLYMERS INTERFAC, P393
   DESBUQUOIS B, 1974, BIOCHEM J, V143, P83, DOI 10.1042/bj1430083
   du Nouy PL, 1925, J EXP MED, V41, P779, DOI 10.1084/jem.41.6.779
   DuNouy PL., 1926, SURFACE EQUILIBRIA B
   Durchschlag H, 2001, BIOPHYS CHEM, V93, P141, DOI 10.1016/S0301-4622(01)00217-4
   Efimova YM, 2005, J RADIOANAL NUCL CH, V264, P91, DOI 10.1007/s10967-005-0679-8
   ELWING H, 1987, J BIOMED MATER RES, V21, P1023, DOI 10.1002/jbm.820210808
   Elwing H, 1998, BIOMATERIALS, V19, P397, DOI 10.1016/S0142-9612(97)00112-9
   Extrand CW, 1998, J COLLOID INTERF SCI, V207, P11, DOI 10.1006/jcis.1998.5743
   Extrand CW, 2003, LANGMUIR, V19, P646, DOI 10.1021/la0259609
   Fang F, 2003, J CHEM PHYS, V119, P1053, DOI 10.1063/1.1578992
   FEDER J, 1980, J THEOR BIOL, V87, P237, DOI 10.1016/0022-5193(80)90358-6
   Feeder J, 1980, J COLLOID INTERF SCI, V78, P144
   Feijen J, 1978, J COLLOID INTERF SCI, V66, P136
   Feijter J. D., 1978, BIOPOLYMERS, V17, P1759
   Feldman K, 1999, J AM CHEM SOC, V121, P10134, DOI 10.1021/ja991049b
   Fernsler J, 2011, LANGMUIR, V27, P148, DOI 10.1021/la103316j
   Fowkes F.M., 1987, J ADHES SCI TECHNOL, V1, P7, DOI DOI 10.1163/156856187X00049
   Freshney RI, 1983, CULTURE ANIMAL CELLS
   FROMMER MA, 1968, J PHYS CHEM-US, V72, P2862, DOI 10.1021/j100854a029
   GAINES GL, 1957, J PHYS CHEM-US, V61, P1408, DOI 10.1021/j150556a033
   Gao LC, 2008, LANGMUIR, V24, P9183, DOI 10.1021/la8014578
   Gao LC, 2009, LANGMUIR, V25, P14105, DOI 10.1021/la902206c
   Gerstein M, 1996, P NATL ACAD SCI USA, V93, P10167, DOI 10.1073/pnas.93.19.10167
   Ghasemi H, 2010, J PHYS CHEM C, V114, P5088, DOI 10.1021/jp911259n
   Gibbs J. W., 1961, SCI PAPERS JW GIBBS
   GIRAULT HHJ, 1984, J COLLOID INTERF SCI, V101, P257, DOI 10.1016/0021-9797(84)90026-2
   Golas A, 2010, BIOMATERIALS, V31, P1068, DOI 10.1016/j.biomaterials.2009.10.039
   Gong P, 2004, J COLLOID INTERF SCI, V278, P81, DOI 10.1016/j.jcis.2004.05.023
   GRAHAM DE, 1979, J COLLOID INTERF SCI, V70, P415, DOI 10.1016/0021-9797(79)90049-3
   Green RJ, 1997, BIOMATERIALS, V18, P405, DOI 10.1016/S0142-9612(96)00141-X
   Guggenheim E.A., 1967, THERMODYNAMICS ADV T
   Guyton AC, 2006, TXB MED PHYSL
   Handley J, 2001, ANAL CHEM, p225A
   HANSEN FK, 1991, J COLLOID INTERF SCI, V141, P1, DOI 10.1016/0021-9797(91)90296-K
   Harder P, 1998, J PHYS CHEM B, V102, P426, DOI 10.1021/jp972635z
   Harkins WD, 1917, J AM CHEM SOC, V39, P354, DOI 10.1021/ja02248a003
   Hartvig RA, 2011, LANGMUIR, V27, P2634, DOI 10.1021/la104720n
   Head-Gordon T, 2002, CHEM REV, V102, P2651, DOI 10.1021/cr0006831
   HENNIKER JC, 1949, REV MOD PHYS, V21, P322, DOI 10.1103/RevModPhys.21.322
   Henry C, 1996, ANAL CHEM, V68, pA625, DOI 10.1021/ac962094u
   Hiemenz P. C., 1977, PRINCIPLES COLLOID S
   Hofmeister F., 1888, ARCH EXP PATHOL PH, V24, P247, DOI DOI 10.1007/BF01918191
   Holmberg M, 2007, ANAL BIOCHEM, V361, P120, DOI 10.1016/j.ab.2006.11.016
   Hook F, 1998, LANGMUIR, V14, P729, DOI 10.1021/la970815u
   Hook F, 2002, COLLOID SURFACE B, V24, P155, DOI 10.1016/S0927-7765(01)00236-3
   Hook F, 2001, ANAL CHEM, V73, P5796, DOI 10.1021/ac0106501
   HORBETT T, 1982, BIOMATERIALS INTERFA, P234
   Horbett T. A., 1996, INTERFACIAL PHENOMEN, P351
   HORBETT TA, 1993, CARDIOVASC PATHOL, V2, pS137
   HORBETT TA, 1975, ADV CHEM SER, P230
   Horbett TA, 2004, BIOMATERIALS SCI INT, P237
   Horbett Thomas A., 1996, P133
   HUNTER JR, 1990, J COLLOID INTERF SCI, V137, P462, DOI 10.1016/0021-9797(90)90421-J
   HUSSAIN AA, 1995, ANAL BIOCHEM, V224, P221, DOI 10.1006/abio.1995.1033
   HUSSAIN AA, 1993, ANAL BIOCHEM, V214, P495, DOI 10.1006/abio.1993.1528
   JEON JS, 1992, APPL SPECTROSC, V46, P1644, DOI 10.1366/0003702924926826
   Jung SY, 2003, J AM CHEM SOC, V125, P12782, DOI 10.1021/ja037263o
   Kamusewitz H, 1997, POLYMER SURFACES AND INTERFACES: CHARACTERIZATION, MODIFICATION AND APPLICATION, P125
   KANAZAWA KK, 1985, ANAL CHIM ACTA, V175, P99
   Kane RS, 2003, LANGMUIR, V19, P2388, DOI 10.1021/la020737x
   Kao P., 2010, BIOMATERIALS, V32, P969, DOI DOI 10.1016/J.BIOMATERIALS.2010.09.075
   Kao P, 2009, MEAS SCI TECHNOL, V20
   Knezic D, 2002, THERMODYNAMIC PROPER
   Krishnan A, 2004, LANGMUIR, V20, P5071, DOI 10.1021/la036218r
   Krishnan A, 2006, J R SOC INTERFACE, V3, P283, DOI 10.1098/rsif.2005.0087
   Krishnan A, 2003, LANGMUIR, V19, P10342, DOI 10.1021/la035308t
   Krishnan A, 2005, J BIOMED MATER RES A, V75A, P445, DOI 10.1002/jbm.a.30444
   Krishnan A, 2005, BIOMATERIALS, V26, P3445, DOI 10.1016/j.biomaterials.2004.09.016
   Krishnan A, 2004, J BIOMED MATER RES A, V68A, P544, DOI 10.1002/jbm.a.20104
   Krishnan A, 2006, BIOMATERIALS, V27, P3187, DOI 10.1016/j.biomaterials.2005.12.032
   Krishnan A, 2005, COLLOID SURFACE B, V43, P95, DOI 10.1016/j.colsurfb.2005.04.003
   Kruse P., 1973, TISSUE CULTURE METHO
   Ktano H, 2001, LANGMUIR, V17, P1889
   LANDER LM, 1993, LANGMUIR, V9, P2237, DOI 10.1021/la00032a055
   Langmuir I., 1918, ADSORPTION GASES PLA, P1361, DOI DOI 10.1021/JA02242A004
   Lassen B, 1996, J COLLOID INTERF SCI, V180, P339, DOI 10.1006/jcis.1996.0312
   Lassen B, 1997, J COLLOID INTERF SCI, V186, P9, DOI 10.1006/jcis.1996.4529
   Latour RA, 2006, J BIOMED MATER RES A, V78A, P843, DOI 10.1002/jbm.a.30818
   Lee JH, 1998, J BIOMED MATER RES, V41, P304, DOI 10.1002/(SICI)1097-4636(199808)41:2<304::AID-JBM16>3.0.CO;2-K
   LEE SH, 1988, J COLLOID INTERF SCI, V125, P365, DOI 10.1016/0021-9797(88)90001-X
   Leibner ES, 2009, ACTA BIOMATER, V5, P1389, DOI 10.1016/j.actbio.2008.11.003
   LEONARD EF, 1991, J BIOMAT SCI-POLYM E, V3, P95, DOI 10.1163/156856292X00105
   Lim JY, 2004, J BIOMED MATER RES A, V68A, P504, DOI 10.1002/jbm.a.20087
   Lin JC, 1996, J COLLOID INTERF SCI, V182, P315, DOI 10.1006/jcis.1996.0470
   LIN SY, 1990, AICHE J, V36, P1785, DOI 10.1002/aic.690361202
   Liu XM, 2007, BIOMATERIALS, V28, P4535, DOI 10.1016/j.biomaterials.2007.06.016
   Lu C., 1984, APPL PIEZOELECTRIC Q
   Lu JR, 1999, LANGMUIR, V15, P6975, DOI 10.1021/la990131h
   Malmsten M, 1998, SURFACTANT SCI SERIE, V75, P656
   MARGEL S, 1993, J BIOMED MATER RES, V27, P1463, DOI 10.1002/jbm.820271202
   MILLER S, 1987, NATURE, V328, P834, DOI 10.1038/328834a0
   MILLER S, 1987, J MOL BIOL, V196, P641, DOI 10.1016/0022-2836(87)90038-6
   MRKSICH M, 1995, LANGMUIR, V11, P4383, DOI 10.1021/la00011a034
   NEUMANN AW, 1979, SURF COLLOID SCI, V11, P31, DOI DOI 10.1007/978-1-4615-7969-4_2
   Noh H, 2008, BIOMATERIALS, V29, P2033, DOI 10.1016/j.biomaterials.2008.01.017
   Noh H, 2006, BIOMATERIALS, V27, P5801, DOI 10.1016/j.biomaterials.2006.08.005
   Noh H, 2007, BIOMATERIALS, V28, P405, DOI 10.1016/j.biomaterials.2006.09.006
   Noh H, 2006, BIOMATERIALS, V27, P5780, DOI 10.1016/j.biomaterials.2006.07.038
   NORDE W, 1986, ADV COLLOID INTERFAC, V25, P267, DOI 10.1016/0001-8686(86)80012-4
   OSBORNE JC, 1984, J BIOL CHEM, V259, P347
   Ostuni E, 2003, LANGMUIR, V19, P1861, DOI 10.1021/la020649c
   Parhi P, 2010, J ADHES SCI TECHNOL, V24, P853, DOI 10.1163/016942409X12598231567907
   Parhi P, 2009, BIOMATERIALS, V30, P6814, DOI 10.1016/j.biomaterials.2009.09.005
   Park JB, 1984, BIOMATERIALS SCI ENG
   Paul J, 1965, CELL TISSUE CULTURE
   Pertsin AJ, 2000, LANGMUIR, V16, P8829, DOI 10.1021/1a000340y
   PRIME KL, 1993, J AM CHEM SOC, V115, P10714, DOI 10.1021/ja00076a032
   Pugnaloni LA, 2003, LANGMUIR, V19, P1923, DOI 10.1021/la026874b
   Purves WK, 2004, LIFE SCI BIOL
   Putnam F.W., 1975, PLASMA PROTEINS STRU, P58
   RATNER BD, 1993, J BIOMED MATER RES, V27, P837, DOI 10.1002/jbm.820270702
   Ratner BD, 2004, BIOMATERIALS SCI INT
   RICHARDS FM, 1977, ANNU REV BIOPHYS BIO, V6, P151, DOI 10.1146/annurev.bb.06.060177.001055
   Robeson JL, 1996, LANGMUIR, V12, P6104, DOI 10.1021/la960476p
   Robinson G. W. Z., 1996, WATER BIOL CHEM PHYS
   Rosen M.J., 1978, SURFACTANTS INTERFAC
   Sagvolden G, 1998, LANGMUIR, V14, P5984, DOI 10.1021/la980271b
   Satulovsky J, 2000, P NATL ACAD SCI USA, V97, P9037, DOI 10.1073/pnas.150236197
   Seigel RR, 1997, ANAL CHEM, V69, P3321, DOI 10.1021/ac970047b
   Sethuraman A, 2004, LANGMUIR, V20, P7779, DOI 10.1021/la049454q
   Sheardown H, 1997, COLLOID SURFACE B, V10, P29, DOI 10.1016/S0927-7765(97)00045-3
   SHIRAHAMA H, 1990, J COLLOID INTERF SCI, V139, P177, DOI 10.1016/0021-9797(90)90455-W
   Slomkowski S, 2003, CR CHIM, V6, P1393, DOI 10.1016/j.crci.2003.10.003
   STEINER RF, 1962, CHEM REV, V62, P457, DOI 10.1021/cr60219a004
   STENBERG E, 1991, J COLLOID INTERF SCI, V143, P513, DOI 10.1016/0021-9797(91)90284-F
   Strey R, 1999, J PHYS CHEM B, V103, P9112, DOI 10.1021/jp990306w
   Sullivan C. K. O, 1999, BIOSENS BIOELECTRON, V14, P663
   SWENDSEN RH, 1981, PHYS REV A, V24, P504, DOI 10.1103/PhysRevA.24.504
   Szleifer I, 1997, BIOPHYS J, V72, P595, DOI 10.1016/S0006-3495(97)78698-3
   Terashima H, 2002, J COLLOID INTERF SCI, V245, P81, DOI 10.1006/jcis.2001.7984
   Teske CA, 2005, J PHYS CHEM B, V109, P13811, DOI 10.1021/jp050713+
   Tsai J, 1999, J MOL BIOL, V290, P253, DOI 10.1006/jmbi.1999.2829
   Vaidya SS, 2005, LANGMUIR, V21, P5852, DOI 10.1021/la046766k
   Van Wagenen RA, 1982, PROBING PROTEIN ADSO, P351
   VASQUEZ M, 1994, CHEM REV, V94, P2183, DOI 10.1021/cr00032a002
   Vinogradov S.N., 1971, HYDROGEN BONDING
   Vogler E.A., 2001, WATER BIOMATERIALS S, P150
   Vogler E. A., 2001, WATER BIOMATERIALS S, P269
   VOGLER EA, 1995, J BIOMED MATER RES, V29, P1005, DOI 10.1002/jbm.820290813
   Vogler EA, 1998, ADV COLLOID INTERFAC, V74, P69, DOI 10.1016/S0001-8686(97)00040-7
   Vogler EA, 1996, J ELECTRON SPECTROSC, V81, P237, DOI 10.1016/0368-2048(96)02526-1
   VOGLER EA, 1993, LANGMUIR, V9, P497, DOI 10.1021/la00026a023
   VOGLER EA, 1995, J BIOMED MATER RES, V29, P1017, DOI 10.1002/jbm.820290814
   VOGLER EA, 1992, LANGMUIR, V8, P2005, DOI 10.1021/la00044a022
   VOGLER EA, 1992, LANGMUIR, V8, P2013, DOI 10.1021/la00044a023
   Vogler EA, 1999, J BIOMAT SCI-POLYM E, V10, P1015, DOI 10.1163/156856299X00667
   Vogler EA, 2001, BIOMATERIALS SCI INT, P4
   Vogler EA, 2011, BIOMATERIALS, V32, P6670, DOI 10.1016/j.biomaterials.2011.05.066
   Vogler EA, 2009, BIOMATERIALS, V30, P1857, DOI 10.1016/j.biomaterials.2008.12.041
   Volger EA, 1993, WETTABILITY, P184
   VROMAN L, 1972, B NEW YORK ACAD MED, V48, P302
   VROMAN L, 1994, J BIOMAT SCI-POLYM E, V6, P223
   VROMAN L, 1986, J COLLOID INTERF SCI, V111, P391, DOI 10.1016/0021-9797(86)90042-1
   VROMAN L, 1975, ADV CHEM SER, P255
   WAHLGREN M, 1991, TRENDS BIOTECHNOL, V9, P201, DOI 10.1016/0167-7799(91)90064-O
   WALKER JM, 2002, PROTEIN PROTOCOLS HD
   WALTERS RR, 1984, ANAL BIOCHEM, V140, P190, DOI 10.1016/0003-2697(84)90152-0
   Williams D.F., 1998, HDB BIOMATERIAL PROP, P481
   Williams DF, 2008, BIOMATERIALS, V29, P2941, DOI 10.1016/j.biomaterials.2008.04.023
   WILLIAMS DF, 1987, J MATER SCI, V22, P3421, DOI 10.1007/BF01161439
   Williams DF, 1993, MED DEVIC TECHNO OCT
   WILLS PR, 1993, ARCH BIOCHEM BIOPHYS, V300, P206, DOI 10.1006/abbi.1993.1029
   WOJCIECHOWSKI P, 1986, J COLLOID INTERF SCI, V111, P455, DOI 10.1016/0021-9797(86)90048-2
   WOJCIECHOWSKI P, 1991, Journal of Biomaterials Science Polymer Edition, V2, P203
   Xu LC, 2007, BIOMATERIALS, V28, P3273, DOI 10.1016/j.biomaterials.2007.03.032
   Xu X, 2008, J PHYS CHEM B
   Xu XHN, 1998, SCIENCE, V281, P1650, DOI 10.1126/science.281.5383.1650
   Yaminsky VV, 2010, LANGMUIR, V26, P8061, DOI 10.1021/la904481d
   Yaminsky VV, 2010, LANGMUIR, V26, P8075, DOI 10.1021/la904482n
   Yaminsky VV, 2001, CURR OPIN COLLOID IN, V6, P342, DOI 10.1016/S1359-0294(01)00104-2
   YOUNG ME, 1980, BIOTECHNOL BIOENG, V22, P947, DOI 10.1002/bit.260220504
   Zettlernoyer AC, 1969, HYDROPHOBIC SURFACES, P1
   Zhou C, 2004, LANGMUIR, V20, P5870, DOI 10.1021/la036251d
   Zhuo R, 2005, ACTA BIOMATER, V1, P583, DOI 10.1016/j.actbio.2005.05.005
   Zhuo R, 2005, BIOMATERIALS, V26, P2965, DOI 10.1016/j.biomaterials.2004.08.008
   Zhuo R, 2007, BIOMATERIALS, V28, P4355, DOI 10.1016/j.biomaterials.2007.06.019
   Zhuo R, 2006, BIOMATERIALS, V27, P4325, DOI 10.1016/j.biomaterials.2006.04.001
NR 217
TC 222
Z9 222
U1 16
U2 399
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD FEB
PY 2012
VL 33
IS 5
BP 1201
EP 1237
DI 10.1016/j.biomaterials.2011.10.059
PG 37
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 895CO
UT WOS:000300474000001
PM 22088888
OA Green Accepted
HC Y
HP N
DA 2018-10-19
ER

EF